the	O
binding	B-T038
orientations	B-T082
of	O
structurally	B-T082
-	O
related	O
ligands	B-T103
can	O
differ	O
;	O
a	O
caution	O
##ary	O
note	O
crystal	B-T103
structures	I-T103
can	O
identify	O
ligand	B-T038
-	I-T038
receptor	I-T038
interactions	I-T038
and	O
assist	O
the	O
development	O
of	O
novel	O
therapeutics	B-T058
,	O
but	O
experimental	O
challenges	O
sometimes	O
necess	O
##itate	O
the	O
use	O
of	O
homologous	B-T103
proteins	I-T103
.	O
trop	B-T103
##ise	I-T103
##tron	I-T103
is	O
an	O
ortho	B-T103
##st	I-T103
##eric	I-T103
ligand	I-T103
at	O
both	O
5	B-T103
-	I-T103
ht	I-T103
##3	I-T103
and	O
α	B-T103
##7	I-T103
nach	I-T103
receptors	I-T103
and	O
its	O
binding	B-T038
orientation	B-T082
has	O
been	O
determined	O
in	O
the	O
structural	B-T082
homologue	I-T082
ach	B-T103
##bp	I-T103
(	O
pd	O
##bi	O
##d	O
:	O
2	O
##w	O
##nc	O
)	O
.	O
co	O
-	O
crystall	O
##isation	O
with	O
a	O
structurally	B-T082
-	O
related	O
ligand	B-T103
,	O
gran	B-T103
##ise	I-T103
##tron	I-T103
,	O
reveals	O
an	O
almost	O
identical	O
orientation	B-T082
(	O
pd	O
##bi	O
##d	O
;	O
2	O
##ym	O
##e	O
)	O
.	O
however	O
,	O
there	O
is	O
a	O
>	O
1000	O
-	O
fold	O
difference	O
in	O
the	O
affinity	O
of	O
trop	B-T103
##ise	I-T103
##tron	I-T103
at	O
5	B-T103
-	I-T103
ht	I-T103
##3	I-T103
versus	O
α	B-T103
##7	I-T103
nach	I-T103
receptors	I-T103
,	O
and	O
α	B-T103
##7	I-T103
nach	I-T103
receptors	I-T103
do	O
not	O
bind	B-T038
gran	B-T103
##ise	I-T103
##tron	I-T103
.	O
these	O
striking	O
pharmacological	O
differences	O
prompt	O
questions	O
about	O
which	O
receptor	B-T103
the	O
crystal	B-T103
structures	I-T103
most	O
closely	O
represent	O
and	O
whether	O
the	O
ligand	B-T103
orientations	B-T082
are	O
correct	O
.	O
here	O
we	O
probe	O
the	O
binding	B-T038
orientation	B-T082
of	O
trop	B-T103
##ise	I-T103
##tron	I-T103
and	O
gran	B-T103
##ise	I-T103
##tron	I-T103
at	O
5	B-T103
-	I-T103
ht	I-T103
##3	I-T103
receptors	I-T103
by	O
in	O
silico	O
modelling	O
and	O
docking	B-T038
,	O
radioligand	B-T038
binding	I-T038
on	O
cysteine	B-T103
-	O
substituted	B-T038
5	B-T103
-	I-T103
ht	I-T103
##3	I-T103
receptor	I-T103
mutants	B-T038
transiently	O
expressed	B-T038
in	O
hek	B-T017
293	I-T017
cells	I-T017
,	O
and	O
synthetic	O
modification	O
of	O
the	O
ligands	B-T103
.	O
for	O
15	O
of	O
the	O
23	O
cysteine	B-T103
substitutions	B-T038
,	O
the	O
effects	O
on	O
trop	B-T103
##ise	I-T103
##tron	I-T103
and	O
gran	B-T103
##ise	I-T103
##tron	I-T103
were	O
different	O
.	O
structure	O
-	O
activity	O
relationships	O
on	O
synthesised	O
derivatives	O
of	O
both	O
ligands	B-T103
were	O
also	O
consistent	O
with	O
different	O
orientations	B-T082
,	O
revealing	O
that	O
contrary	O
to	O
the	O
crystallographic	B-T058
evidence	O
from	O
ach	B-T103
##bp	I-T103
,	O
the	O
two	O
ligands	B-T103
adopt	O
different	O
orientations	B-T082
in	O
the	O
5	B-T103
-	I-T103
ht	I-T103
##3	I-T103
receptor	I-T103
binding	B-T103
site	I-T103
.	O
our	O
results	O
show	O
that	O
even	O
quite	O
structurally	B-T082
similar	O
molecules	O
can	O
adopt	O
different	O
orientations	B-T082
in	O
the	O
same	O
binding	B-T103
site	I-T103
,	O
and	O
that	O
caution	O
may	O
be	O
needed	O
when	O
using	O
homologous	B-T103
proteins	I-T103
to	O
predict	O
ligand	B-T038
binding	I-T038
.	O

the	O
role	O
of	O
catheter	B-T058
ablation	I-T058
in	O
the	O
management	B-T058
of	O
atrial	B-T038
fibrillation	I-T038
atrial	B-T038
fibrillation	I-T038
is	O
driven	O
by	O
spontaneous	O
electrical	B-T038
activation	I-T038
emerging	O
from	O
the	O
pulmonary	B-T017
veins	I-T017
.	O
catheter	B-T058
ablation	I-T058
using	O
either	O
radiofrequency	B-T058
or	O
cryo	B-T058
##thermal	I-T058
energy	I-T058
electrically	O
isolates	O
these	O
veins	B-T017
from	O
the	O
left	B-T017
atrium	I-T017
,	O
both	O
reducing	O
the	O
burden	O
of	O
atrial	B-T038
fibrillation	I-T038
episodes	O
and	O
improving	O
the	O
patient	O
'	O
s	O
symptoms	B-T033
.	O
catheter	B-T058
ablation	I-T058
is	O
superior	O
to	O
anti	B-T103
##arr	I-T103
##y	I-T103
##ht	I-T103
##h	I-T103
##mic	I-T103
drugs	I-T103
when	O
patients	O
are	O
carefully	O
selected	O
.	O
underlying	O
medical	B-T201
problems	I-T201
-	O
including	O
obesity	B-T038
,	O
hypertension	B-T038
and	O
obstructive	B-T038
sleep	I-T038
apnoea	I-T038
-	O
should	O
be	O
optimally	O
treated	O
before	O
considering	O
ablation	B-T058
.	O
although	O
this	O
treatment	B-T058
has	O
the	O
potential	O
to	O
cure	O
patients	O
of	O
their	O
symptoms	B-T033
,	O
they	O
should	O
be	O
aware	O
of	O
the	O
important	O
associated	O
procedural	B-T033
complications	I-T033
.	O

metabolite	B-T103
mapping	O
by	O
consecutive	O
nanostructure	O
and	O
silver	B-T058
-	I-T058
assisted	I-T058
mass	I-T058
spectrometry	I-T058
imaging	I-T058
on	O
tissue	B-T017
sections	I-T017
nanostructure	B-T058
-	I-T058
based	I-T058
mass	I-T058
spectrometry	I-T058
imaging	I-T058
(	O
msi	B-T058
)	O
is	O
a	O
promising	O
technology	O
for	O
molecular	B-T058
imaging	I-T058
of	O
small	B-T103
molecules	I-T103
,	O
without	O
the	O
complex	O
chemical	O
background	O
typically	O
encountered	O
in	O
matrix	B-T058
-	I-T058
assisted	I-T058
molecular	I-T058
imaging	I-T058
approaches	O
.	O
here	O
,	O
we	O
have	O
enhanced	O
these	O
surfaces	B-T082
with	O
silver	B-T103
(	O
ag	B-T103
)	O
to	O
provide	O
a	O
second	O
tier	O
of	O
msi	B-T170
data	I-T170
from	O
a	O
single	O
sample	O
.	O
msi	B-T170
data	I-T170
was	O
acquired	O
through	O
the	O
application	O
of	O
laser	B-T058
desorption	I-T058
/	I-T058
ionization	I-T058
mass	I-T058
spectrometry	I-T058
to	O
biological	O
samples	O
imprinted	O
onto	O
desorption	O
/	O
ionization	O
on	O
silicon	O
(	O
dio	O
##s	O
)	O
substrates	O
.	O
following	O
initial	O
analysis	B-T062
,	O
ultra	O
-	O
thin	O
ag	O
layers	O
were	O
overl	O
##aid	O
onto	O
the	O
followed	O
by	O
msi	B-T058
analysis	I-T058
(	O
ag	B-T058
-	I-T058
dio	I-T058
##s	I-T058
msi	I-T058
)	O
.	O
this	O
approach	O
was	O
first	O
demonstrated	O
for	O
finger	O
##mark	O
small	B-T103
molecules	I-T103
including	O
environmental	B-T082
contaminants	O
and	O
seb	B-T031
##um	I-T031
components	O
.	O
subsequently	O
,	O
this	O
bimodal	O
method	O
was	O
translated	O
to	O
lipids	B-T103
and	O
metabolites	B-T103
in	O
fore	B-T017
-	I-T017
stomach	I-T017
sections	I-T017
from	O
a	O
6	B-T103
-	I-T103
bromo	I-T103
##isa	I-T103
##tin	I-T103
chemopre	O
##vent	O
##ative	O
murine	B-T038
mouse	I-T038
model	I-T038
.	O
dio	B-T058
##s	I-T058
msi	I-T058
allowed	O
mapping	O
of	O
common	O
ions	B-T103
in	O
finger	O
##marks	O
as	O
well	O
as	O
6	B-T103
-	I-T103
bromo	I-T103
##isa	I-T103
##tin	I-T103
metabolites	B-T103
and	O
lipids	B-T103
in	O
murine	B-T017
fore	I-T017
-	I-T017
stomach	I-T017
.	O
furthermore	O
,	O
dio	B-T058
##s	I-T058
msi	I-T058
was	O
complemented	O
by	O
the	O
ag	B-T058
-	I-T058
dio	I-T058
##s	I-T058
msi	I-T058
of	O
ag	B-T103
-	I-T103
adduct	I-T103
##able	I-T103
lipids	I-T103
such	O
as	O
wax	B-T103
esters	I-T103
in	O
finger	O
##marks	O
and	O
cholesterol	B-T103
in	O
murine	B-T017
fore	I-T017
-	I-T017
stomach	I-T017
.	O
gastrointestinal	B-T031
acid	I-T031
condensation	O
products	B-T103
of	O
6	B-T103
-	I-T103
bromo	I-T103
##isa	I-T103
##tin	I-T103
,	O
such	O
as	O
the	O
6	B-T103
,	I-T103
6	I-T103
'	I-T103
-	I-T103
dib	I-T103
##rom	I-T103
##oin	I-T103
##di	I-T103
##ru	I-T103
##bin	I-T103
mapped	O
herein	O
,	O
are	O
very	O
challenging	O
to	O
isolate	B-T058
and	O
characterize	O
.	O
by	O
re	O
-	O
analyzing	O
the	O
same	O
tissue	B-T017
imprin	O
##ts	O
,	O
this	O
metabolite	B-T103
was	O
readily	O
detected	O
by	O
dio	O
##s	O
,	O
placed	O
in	O
a	O
tissue	O
-	O
specific	O
spatial	O
context	O
,	O
and	O
subsequently	O
overl	O
##aid	O
with	O
additional	O
lipid	B-T038
distributions	I-T038
acquired	O
using	O
ag	B-T058
-	I-T058
dio	I-T058
##s	I-T058
msi	I-T058
.	O
the	O
ability	O
to	O
place	O
metabolite	B-T103
and	O
lipid	B-T103
classes	O
in	O
a	O
tissue	O
-	O
specific	O
context	O
makes	O
this	O
novel	O
method	O
suited	O
to	O
msi	B-T058
analyses	I-T058
where	O
the	O
collection	O
of	O
additional	O
information	O
from	O
the	O
same	O
sample	O
maxim	O
##ises	O
resource	O
use	O
,	O
and	O
also	O
maxim	O
##ises	O
the	O
number	O
of	O
annotated	O
small	B-T103
molecules	I-T103
,	O
in	O
particular	O
for	O
metabolites	B-T103
that	O
are	O
typically	O
undetectable	B-T201
with	O
traditional	O
platforms	O
.	O
copyright	O
©	O
2017	O
john	O
wiley	O
&	O
sons	O
,	O
ltd	O
.	O

expression	B-T038
and	O
methylation	B-T038
in	O
posttraumatic	B-T038
stress	I-T038
disorder	I-T038
and	O
resilience	O
;	O
evidence	O
of	O
a	O
role	O
for	O
odor	B-T103
##ant	I-T103
receptors	I-T103
post	B-T038
-	I-T038
traumatic	I-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
is	O
a	O
common	O
and	O
potentially	O
disabling	O
disorder	O
that	O
develops	O
in	O
1	O
/	O
5	O
to	O
1	O
/	O
3	O
of	O
people	B-T098
exposed	O
to	O
severe	O
trauma	B-T037
.	O
twin	B-T170
studies	I-T170
indicate	O
that	O
genetic	O
factors	O
account	O
for	O
at	O
least	O
one	O
third	O
of	O
the	O
variance	O
in	O
the	O
risk	O
for	O
developing	O
ptsd	B-T038
,	O
however	O
,	O
the	O
specific	O
role	O
for	O
genetic	O
factors	O
in	O
the	O
pathogenesis	B-T038
of	O
ptsd	B-T038
is	O
not	O
well	O
understood	O
.	O
we	O
studied	O
genome	B-T062
-	I-T062
wide	I-T062
gene	B-T038
expression	I-T038
and	O
dna	B-T038
methylation	I-T038
profiles	O
in	O
12	O
participants	B-T098
with	O
ptsd	B-T038
and	O
12	O
participants	B-T098
who	O
were	O
resili	O
##ent	O
to	O
similar	O
severity	O
trauma	B-T037
exposure	O
.	O
close	O
to	O
4000	O
genes	B-T017
were	O
differentially	O
expressed	B-T038
with	O
adjusted	O
p	O
<	O
0	O
.	O
05	O
,	O
fold	O
-	O
change	O
>	O
2	O
,	O
with	O
all	O
but	O
3	O
upregulated	B-T038
with	O
ptsd	B-T038
.	O
eight	O
odor	B-T103
##ant	I-T103
/	I-T103
olfactory	I-T103
receptor	I-T103
related	O
genes	B-T017
were	O
up	B-T038
-	I-T038
regulated	I-T038
with	O
ptsd	B-T038
as	O
well	O
as	O
genes	B-T017
related	O
to	O
immune	B-T038
activation	I-T038
,	O
the	O
gamma	B-T103
-	I-T103
aminobutyric	I-T103
acid	I-T103
a	I-T103
(	I-T103
gabaa	I-T103
)	I-T103
receptor	I-T103
,	O
and	O
vitamin	B-T038
d	I-T038
synthesis	I-T038
.	O
no	O
differences	O
with	O
adjusted	O
significance	O
for	O
dna	B-T038
methylation	I-T038
were	O
found	O
.	O
we	O
conclude	O
that	O
increased	O
gene	B-T038
expression	I-T038
may	O
play	O
an	O
important	O
role	O
in	O
ptsd	B-T038
and	O
this	O
expression	B-T038
may	O
not	O
be	O
a	O
consequence	O
of	O
dna	B-T038
methylation	I-T038
.	O
the	O
role	O
of	O
odor	B-T103
##ant	I-T103
receptor	I-T103
expression	O
warrants	O
independent	O
replication	B-T038
.	O

a	O
rare	O
cause	O
of	O
gastric	B-T038
obstruction	I-T038
:	O
light	O
##ers	O
swallowing	B-T038
the	O
majority	O
of	O
swallow	B-T033
##ed	I-T033
foreign	I-T033
bodies	I-T033
are	O
thro	O
##w	O
##n	O
spontaneously	O
without	O
causing	O
complications	B-T038
in	O
the	O
digestive	B-T022
system	I-T022
.	O
multiple	O
number	O
of	O
foreign	B-T037
bodies	I-T037
may	O
be	O
swallow	B-T038
##ed	I-T038
by	O
psychiatric	O
patients	O
which	O
delay	O
diagnosis	O
and	O
increase	O
the	O
complication	B-T038
rate	O
.	O
long	O
and	O
hard	O
objects	B-T037
cann	O
##ot	O
pass	O
through	O
the	O
pyl	B-T017
##orus	I-T017
,	O
and	O
may	O
cause	O
obstruction	B-T038
,	O
ulceration	B-T038
,	O
bleeding	B-T038
and	O
perforation	B-T033
.	O
endoscopy	B-T058
is	O
used	O
as	O
an	O
effective	O
method	O
in	O
such	O
cases	O
.	O
an	O
exploratory	B-T058
lapa	I-T058
##ra	I-T058
##to	I-T058
##my	I-T058
was	O
performed	O
after	O
unsuccessful	O
endoscopic	B-T082
foreign	B-T037
object	I-T037
removal	B-T058
in	O
a	O
28	O
-	O
year	O
-	O
old	O
schizophrenic	B-T038
patient	O
with	O
gastric	B-T038
outlet	I-T038
obstruction	I-T038
due	O
to	O
multiple	O
cigarette	O
light	O
##er	O
swallowing	B-T038
.	O
ten	O
light	O
##ers	O
were	O
removed	O
from	O
the	O
stomach	B-T017
through	O
gastro	B-T058
##to	I-T058
##my	I-T058
and	O
one	O
more	O
light	O
##er	O
was	O
removed	O
from	O
the	O
descending	B-T017
colon	I-T017
by	O
milk	B-T058
##ing	I-T058
through	O
the	O
an	B-T017
##us	I-T017
.	O
the	O
aim	O
of	O
this	O
paper	O
is	O
to	O
discuss	O
encountered	O
difficulties	B-T033
in	O
psychiatric	O
patients	O
who	O
underwent	O
surgery	B-T058
due	O
to	O
intake	O
of	O
foreign	B-T037
bodies	I-T037
.	O

cobal	B-T103
##amin	I-T103
protection	O
against	O
oxidative	B-T038
stress	I-T038
in	O
the	O
acid	O
##ophilic	O
iron	B-T007
-	I-T007
oxidizing	I-T007
bacterium	I-T007
leptosp	B-T007
##ir	I-T007
##ill	I-T007
##um	I-T007
group	I-T007
ii	I-T007
cf	I-T007
-	I-T007
1	I-T007
members	O
of	O
the	O
genus	O
leptosp	B-T007
##ir	I-T007
##ill	I-T007
##um	I-T007
are	O
aerobic	O
iron	B-T007
-	I-T007
oxidizing	I-T007
bacteria	I-T007
belonging	O
to	O
the	O
phylum	B-T007
nitros	I-T007
##pir	I-T007
##a	I-T007
.	O
they	O
are	O
important	O
members	O
of	O
microbial	O
communities	O
that	O
catalyze	O
the	O
biom	O
##ining	O
of	O
sulf	B-T103
##idic	I-T103
ore	I-T103
##s	I-T103
,	O
thereby	O
solubil	O
##izing	O
metal	B-T103
ions	I-T103
.	O
these	O
microorganisms	O
live	O
under	O
extremely	O
acidic	O
and	O
metal	B-T103
-	O
loaded	O
environments	B-T082
and	O
thus	O
must	O
tolerate	O
high	O
concentrations	O
of	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
.	O
cobal	B-T103
##amin	I-T103
(	O
vitamin	B-T103
b12	I-T103
)	O
is	O
a	O
cobalt	B-T103
-	O
containing	O
tetrap	B-T103
##yr	I-T103
##role	I-T103
cofactor	B-T103
involved	O
in	O
intramolecular	O
rearrangement	O
reactions	O
and	O
has	O
recently	O
been	O
suggested	O
to	O
be	O
an	O
intracellular	B-T082
antioxidant	B-T103
.	O
in	O
this	O
work	O
,	O
we	O
investigated	O
the	O
effect	O
of	O
the	O
exogenous	O
addition	O
of	O
cobal	B-T103
##amin	I-T103
on	O
oxidative	B-T038
stress	I-T038
parameters	O
in	O
leptosp	B-T007
##ir	I-T007
##ill	I-T007
##um	I-T007
group	I-T007
ii	I-T007
strain	I-T007
cf	I-T007
-	I-T007
1	I-T007
.	O
our	O
results	O
revealed	O
that	O
the	O
external	B-T168
supplementation	I-T168
of	O
cobal	B-T103
##amin	I-T103
reduces	O
the	O
levels	O
of	O
intracellular	B-T082
ross	B-T103
and	O
the	O
damage	O
to	O
biomolecules	B-T103
,	O
and	O
also	O
stimulates	O
the	O
growth	B-T038
and	O
survival	B-T038
of	I-T038
cells	I-T038
exposed	O
to	O
oxidative	B-T038
stress	I-T038
exerted	O
by	O
ferric	B-T103
ion	I-T103
,	O
hydrogen	B-T103
peroxide	I-T103
,	O
chromat	B-T103
##e	I-T103
and	O
diam	B-T103
##ide	I-T103
.	O
furthermore	O
,	O
exposure	O
of	O
strain	B-T007
cf	I-T007
-	I-T007
1	I-T007
to	O
oxidative	B-T038
stress	I-T038
elicit	O
##ors	O
resulted	O
in	O
the	O
transcriptional	B-T038
activation	I-T038
of	O
the	O
cb	B-T017
##ia	I-T017
gene	I-T017
encoding	O
cb	B-T103
##ia	I-T103
of	O
the	O
cobal	B-T103
##amin	I-T103
biosynthetic	B-T038
pathway	I-T038
.	O
altogether	O
,	O
these	O
data	O
suggest	O
that	O
cobal	B-T103
##amin	I-T103
plays	O
an	O
important	O
role	O
in	O
redox	B-T038
protection	O
of	O
leptosp	B-T007
##ir	I-T007
##ill	I-T007
##um	I-T007
strain	I-T007
cf	I-T007
-	I-T007
1	I-T007
,	O
supporting	O
survival	O
of	O
this	O
microorganism	O
under	O
extremely	O
oxidative	O
environmental	O
conditions	O
.	O
understanding	O
the	O
mechanisms	O
underlying	O
the	O
protective	O
effect	O
of	O
cobal	B-T103
##amin	I-T103
against	O
oxidative	B-T038
stress	I-T038
may	O
help	O
to	O
develop	O
strategies	O
to	O
make	O
biom	O
##ining	O
processes	O
more	O
effective	O
.	O

muscle	B-T017
synerg	O
##ies	O
after	O
stroke	B-T038
are	O
correlated	O
with	O
peri	O
##les	O
##ional	O
high	O
gamma	O
movements	O
can	O
be	O
factor	O
##ed	O
into	O
modules	O
termed	O
[UNK]	O
muscle	B-T017
synerg	O
##ies	O
[UNK]	O
.	O
after	O
stroke	B-T038
,	O
abnormal	B-T033
synerg	O
##ies	O
are	O
linked	O
to	O
impaired	O
movements	O
;	O
however	O
,	O
their	O
neural	B-T017
basis	O
is	O
not	O
understood	O
.	O
in	O
a	O
single	O
subject	O
,	O
we	O
examined	O
how	O
electroc	B-T058
##ortic	I-T058
##ography	I-T058
signals	I-T058
from	O
the	O
peri	O
##les	O
##ional	O
cortex	B-T017
were	O
associated	O
with	O
synerg	O
##ies	O
.	O
the	O
measured	O
synerg	O
##ies	O
contained	O
a	O
mix	O
of	O
both	O
normal	O
and	O
abnormal	B-T033
patterns	B-T082
and	O
were	O
remarkably	O
similar	O
to	O
those	O
described	O
in	O
past	O
work	O
.	O
interestingly	O
,	O
we	O
found	O
that	O
both	O
normal	O
and	O
abnormal	B-T033
synerg	O
##ies	O
were	O
correlated	O
with	O
peri	O
##les	O
##ional	O
high	O
gamma	O
.	O
given	O
the	O
link	O
between	O
high	O
gamma	O
and	O
cortical	B-T033
spiking	I-T033
,	O
our	O
results	O
suggest	O
that	O
peri	B-T033
##les	I-T033
##ional	I-T033
spiking	I-T033
may	O
organize	O
synerg	O
##ies	O
after	O
stroke	B-T038
.	O

neo	B-T204
##sp	I-T204
##ora	I-T204
can	I-T204
##inum	I-T204
in	O
axis	B-T204
deer	I-T204
(	O
axis	B-T204
axis	I-T204
)	O
and	O
fall	B-T204
##ow	I-T204
deer	I-T204
(	O
dam	B-T204
##a	I-T204
dam	I-T204
##a	I-T204
)	O
in	O
northern	B-T082
mexico	B-T082
serum	B-T031
samples	I-T031
from	O
18	O
axis	B-T204
deer	I-T204
(	O
axis	B-T204
axis	I-T204
)	O
and	O
19	O
fall	B-T204
##ow	I-T204
deer	I-T204
(	O
dam	B-T204
##a	I-T204
dam	I-T204
##a	I-T204
)	O
were	O
analyzed	O
with	O
an	O
enzyme	B-T058
-	I-T058
linked	I-T058
immunosorbent	I-T058
assay	I-T058
for	O
neo	B-T103
##sp	I-T103
##ora	I-T103
can	I-T103
##inum	I-T103
antibodies	I-T103
.	O
two	O
axis	B-T204
(	O
11	O
%	O
)	O
and	O
two	O
fall	B-T204
##ow	I-T204
deer	I-T204
(	O
11	O
%	O
)	O
were	O
positive	B-T033
for	O
n	B-T103
.	I-T103
can	I-T103
##inum	I-T103
antibodies	I-T103
.	O

folate	B-T103
-	O
conjugated	B-T082
gene	B-T017
-	O
carrying	B-T038
microbub	B-T074
##bles	I-T074
with	O
focused	B-T058
ultrasound	I-T058
for	O
concurrent	O
blood	B-T017
-	I-T017
brain	I-T017
barrier	I-T017
opening	O
and	O
local	B-T082
gene	B-T038
delivery	I-T038
previous	O
studies	B-T062
have	O
demonstrated	O
that	O
circulating	O
dna	B-T103
-	O
encapsulated	O
microbub	B-T074
##bles	I-T074
(	O
mbs	B-T074
)	O
combined	O
with	O
focused	B-T058
ultrasound	I-T058
(	O
fus	B-T058
)	O
can	O
be	O
used	O
for	O
local	B-T082
blood	B-T017
-	I-T017
brain	I-T017
barrier	I-T017
(	O
bbb	B-T017
)	O
opening	O
and	O
gene	B-T038
delivery	I-T038
.	O
however	O
,	O
few	O
studies	B-T062
focused	O
on	O
how	O
to	O
increase	O
the	O
efficiency	O
of	O
gene	B-T038
delivery	I-T038
to	O
brain	B-T038
tumors	I-T038
after	O
the	O
released	O
gene	B-T017
penetrating	O
the	O
bbb	B-T017
.	O
here	O
,	O
we	O
proposed	O
the	O
use	O
of	O
folate	B-T103
-	O
conjugated	O
dna	O
-	O
loaded	O
cationic	B-T074
mbs	I-T074
(	O
fcm	B-T074
##bs	I-T074
)	O
.	O
when	O
combined	O
with	O
fus	B-T058
as	O
a	O
trigger	O
for	O
bbb	B-T017
opening	O
,	O
fcm	B-T074
##bs	I-T074
were	O
converted	O
into	O
nanometer	O
-	O
sized	B-T082
vesicles	B-T017
that	O
were	O
transported	B-T038
to	O
the	O
brain	B-T017
parenchyma	B-T017
.	O
the	O
fcm	B-T074
##bs	I-T074
can	O
selectively	O
aggregate	O
around	O
tumor	B-T017
cells	I-T017
that	O
overexpressed	B-T038
the	O
folate	B-T103
receptor	I-T103
,	O
thus	O
enhancing	O
gene	B-T038
delivery	I-T038
via	O
folate	B-T103
-	O
stimulated	O
endocytosis	B-T038
.	O
our	O
results	O
confirmed	O
that	O
fcm	B-T074
##bs	I-T074
can	O
carry	B-T038
dna	B-T103
on	O
the	O
surface	B-T082
of	O
the	O
mb	B-T074
shell	O
and	O
have	O
good	O
targeting	O
ability	O
on	O
c6	B-T017
glioma	I-T017
cells	I-T017
.	O
in	O
addition	O
,	O
the	O
optimized	O
fus	B-T058
parameters	O
for	O
fcm	B-T074
##bs	I-T074
-	O
enhanced	O
gene	B-T038
delivery	I-T038
were	O
confirmed	O
by	O
cell	B-T017
experiments	B-T062
(	O
center	O
frequency	O
=	O
1	O
mhz	O
;	O
acoustic	O
pressure	O
=	O
700	O
kpa	O
;	O
pulse	O
repetition	O
frequency	O
=	O
5	O
hz	O
;	O
cycle	O
number	O
=	O
1000	O
##0	O
;	O
exposure	O
time	O
=	O
1	O
min	O
;	O
fcm	B-T074
##bs	I-T074
concentration	O
=	O
4	O
×	O
10	O
(	O
7	O
)	O
mb	O
/	O
ml	O
)	O
.	O
in	B-T082
vivo	I-T082
data	O
also	O
indicated	B-T033
that	O
fcm	B-T074
##bs	I-T074
show	O
better	O
gene	B-T017
transfection	B-T038
efficiency	O
than	O
mbs	B-T074
without	O
folate	B-T103
conjugation	B-T038
and	O
the	O
traditional	O
approach	B-T082
of	O
directly	O
injecting	B-T058
the	O
gene	B-T017
.	O
this	O
study	B-T062
described	O
our	O
novel	O
development	O
of	O
multifunctional	O
mbs	B-T074
for	O
fus	B-T058
-	O
triggered	O
gene	B-T038
delivery	I-T038
/	O
therapy	B-T058
.	O

psycho	B-T038
##genic	I-T038
non	I-T038
-	I-T038
epileptic	I-T038
seizure	I-T038
in	O
patients	O
with	O
intellectual	B-T038
disability	I-T038
with	O
special	O
focus	O
on	O
choice	O
of	O
therapeutic	B-T058
intervention	I-T058
there	O
have	O
been	O
a	O
number	O
of	O
studies	B-T062
exploring	O
treatments	B-T058
for	O
psycho	B-T038
##genic	I-T038
non	I-T038
-	I-T038
epileptic	I-T038
seizure	I-T038
(	O
pn	B-T038
##es	I-T038
)	O
but	O
largely	O
neglect	B-T033
##ing	I-T033
the	O
si	O
##z	O
##able	O
subgroup	B-T170
of	O
patients	O
with	O
intellectual	B-T038
disability	I-T038
(	O
id	B-T038
)	O
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
attempted	O
to	O
demonstrate	O
effects	O
and	O
preferred	O
modes	O
of	O
therapeutic	B-T058
intervention	I-T058
in	O
pn	B-T038
##es	I-T038
patients	O
with	O
id	B-T038
being	O
treated	O
at	O
a	O
japanese	B-T092
municipal	I-T092
center	I-T092
with	O
a	O
short	O
referral	B-T058
chain	I-T058
.	O
we	O
examined	B-T033
46	O
pn	B-T038
##es	I-T038
patients	O
with	O
id	B-T038
(	O
id	B-T038
group	O
)	O
and	O
106	O
pn	B-T038
##es	I-T038
patients	O
without	O
id	B-T038
(	O
non	B-T033
-	I-T033
id	I-T033
group	O
)	O
retrospectively	O
in	O
case	O
charts	O
.	O
in	O
addition	O
to	O
examining	B-T033
basic	O
demographic	O
and	O
clinical	B-T170
data	I-T170
,	O
effects	O
of	O
different	O
therapeutic	B-T058
intervention	I-T058
were	O
examined	B-T033
as	O
a	O
function	O
of	O
decrease	O
or	O
disappearance	O
of	O
pn	B-T038
##es	I-T038
attacks	O
in	O
the	O
id	B-T038
group	O
.	O
age	O
at	O
the	O
first	O
visit	B-T058
as	O
well	O
as	O
pn	B-T038
##es	I-T038
onset	O
was	O
younger	O
in	O
the	O
id	B-T038
than	O
in	O
the	O
non	B-T033
-	I-T033
id	I-T033
group	O
(	O
t	O
=	O
2	O
.	O
65	O
##1	O
,	O
p	O
=	O
0	O
.	O
009	O
;	O
t	O
=	O
3	O
.	O
52	O
##8	O
,	O
p	O
=	O
0	O
.	O
001	O
,	O
respectively	O
)	O
.	O
pn	B-T038
##es	I-T038
-	O
free	O
ratio	O
at	O
the	O
last	O
visit	B-T058
tended	O
to	O
be	O
higher	O
in	O
the	O
non	B-T033
-	I-T033
id	I-T033
group	O
(	O
chi	O
square	O
=	O
3	O
.	O
45	O
##5	O
;	O
p	O
=	O
0	O
.	O
06	O
##3	O
)	O
.	O
psychosis	B-T038
was	O
more	O
often	O
encountered	O
in	O
the	O
id	B-T038
group	O
(	O
chi	O
square	O
=	O
13	O
.	O
44	O
##3	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
although	O
cognitive	B-T058
therapy	I-T058
and	O
pharmac	B-T058
##o	I-T058
-	I-T058
therapeutic	I-T058
approaches	O
were	O
quite	O
similarly	O
distributed	O
in	O
both	O
groups	O
,	O
environmental	B-T082
adjustment	O
was	O
often	O
introduced	O
in	O
the	O
id	B-T038
group	O
(	O
44	O
%	O
)	O
as	O
compared	O
to	O
the	O
non	B-T033
-	I-T033
id	I-T033
group	O
(	O
15	O
%	O
)	O
(	O
chi	O
square	O
=	O
14	O
.	O
299	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
brief	O
weekly	O
visit	B-T058
service	I-T058
is	O
also	O
more	O
often	O
utilized	O
by	O
the	O
patients	O
with	O
id	B-T038
(	O
54	O
%	O
)	O
than	O
by	O
those	O
without	O
id	B-T038
(	O
35	O
%	O
)	O
(	O
chi	O
square	O
=	O
5	O
.	O
021	O
,	O
p	O
=	O
0	O
.	O
025	O
)	O
.	O
optimal	O
treatment	B-T058
approaches	O
in	O
this	O
si	O
##z	O
##able	O
patient	O
subgroup	B-T170
should	O
be	O
the	O
subject	O
of	O
future	O
prospective	B-T062
studies	I-T062
.	O

intrinsic	B-T082
rif	B-T103
##amycin	I-T103
resistance	O
of	O
mycobacterium	B-T007
abscess	I-T007
##us	I-T007
is	O
mediated	O
by	O
adp	B-T103
-	I-T103
rib	I-T103
##osyltransferase	I-T103
mab	B-T017
_	I-T017
05	I-T017
##91	I-T017
rifampicin	B-T103
,	O
a	O
potent	O
first	O
-	O
line	O
tb	B-T103
drug	I-T103
of	O
the	O
rif	B-T103
##amycin	I-T103
group	I-T103
,	O
shows	O
only	O
little	O
activity	O
against	O
the	O
emerging	O
pathogen	O
mycobacterium	B-T007
abscess	I-T007
##us	I-T007
.	O
reportedly	O
,	O
bacterial	B-T038
resistance	I-T038
to	O
rifampicin	B-T103
is	O
associated	O
with	O
polymorphisms	B-T038
in	O
the	O
target	O
gene	B-T017
rp	I-T017
##ob	I-T017
or	O
the	O
presence	O
of	O
enzymes	B-T103
that	O
modify	O
and	O
thereby	O
inactivate	O
rifampicin	B-T103
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
role	O
of	O
the	O
mab	B-T017
_	I-T017
05	I-T017
##91	I-T017
(	O
arr	B-T017
##ma	I-T017
##b	I-T017
)	O
-	O
encoded	O
rifampicin	B-T103
adp	B-T103
-	I-T103
rib	I-T103
##osyltransferase	I-T103
(	O
arr	B-T103
_	I-T103
mab	I-T103
)	O
in	O
innate	O
high	O
-	O
level	O
rifampicin	B-T103
resistance	O
in	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
.	O
recombinant	O
escherichia	B-T007
coli	I-T007
and	O
mycobacterium	B-T007
tuberculosis	I-T007
strains	O
expressing	B-T038
mab	B-T017
_	I-T017
05	I-T017
##91	I-T017
were	O
generated	O
,	O
as	O
was	O
an	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
deletion	B-T038
mutant	I-T038
deficient	O
for	O
mab	B-T017
_	I-T017
05	I-T017
##91	I-T017
.	O
mic	B-T058
assays	I-T058
were	O
used	O
to	O
study	O
susceptibility	O
to	O
rifampicin	B-T103
and	O
c2	B-T103
##5	I-T103
carbam	I-T103
##ate	I-T103
-	O
modified	O
rif	B-T103
##amycin	I-T103
derivatives	I-T103
.	O
heterologous	O
expression	B-T038
of	O
mab	B-T017
_	I-T017
05	I-T017
##91	I-T017
conferred	O
rifampicin	B-T103
resistance	O
to	O
e	B-T007
.	I-T007
coli	I-T007
and	O
m	B-T007
.	I-T007
tuberculosis	I-T007
rif	B-T103
##amycin	I-T103
mic	B-T033
values	I-T033
were	O
consistently	O
lower	O
for	O
the	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
δ	B-T017
##arr	I-T017
##ma	I-T017
##b	I-T017
mutant	I-T017
as	O
compared	O
with	O
the	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
atcc	I-T007
1997	I-T007
##7	I-T007
parental	O
type	O
strain	O
.	O
the	O
rif	B-T103
##amycin	I-T103
wt	B-T017
phenotype	O
was	O
restored	O
after	O
complementation	O
of	O
the	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
δ	B-T017
##arr	I-T017
##ma	I-T017
##b	I-T017
mutant	I-T017
with	O
arr	B-T103
##ma	I-T103
##b	I-T103
further	O
mic	B-T033
data	I-T033
demonstrated	O
that	O
a	O
c2	B-T103
##5	I-T103
modification	B-T033
increases	O
rif	B-T103
##amycin	I-T103
activity	O
in	O
wt	B-T017
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
however	O
,	O
mic	B-T062
studies	I-T062
in	O
the	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
δ	B-T017
##arr	I-T017
##ma	I-T017
##b	I-T017
mutant	I-T017
suggest	O
that	O
c2	B-T103
##5	I-T103
modified	O
rif	B-T103
##amycin	I-T103
##s	I-T103
are	O
still	O
subject	O
to	O
modification	B-T033
by	O
arr	B-T103
_	I-T103
mab	I-T103
conclusions	O
:	O
our	O
findings	O
identify	O
arr	B-T103
_	I-T103
mab	I-T103
as	O
the	O
major	O
innate	O
rif	B-T103
##amycin	I-T103
resistance	O
determinant	O
of	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
.	O
our	O
data	O
also	O
indicate	O
that	O
arr	B-T103
_	I-T103
mab	I-T103
-	O
mediated	O
rif	B-T103
##amycin	I-T103
resistance	O
in	O
m	B-T007
.	I-T007
abscess	I-T007
##us	I-T007
can	O
only	O
in	O
part	O
be	O
overcome	O
by	O
c2	B-T103
##5	I-T103
carbam	I-T103
##ate	I-T103
modification	B-T033
.	O

histopathological	O
evaluation	B-T058
of	O
the	O
effectiveness	O
of	O
glyc	B-T103
##yrrh	I-T103
##iz	I-T103
##ic	I-T103
acid	I-T103
as	O
a	O
radio	B-T058
##pro	I-T058
##te	I-T058
##ct	I-T058
##or	I-T058
against	O
the	O
development	O
of	O
radiation	B-T038
-	I-T038
induced	I-T038
lung	I-T038
fibrosis	I-T038
radiotherapy	B-T058
of	O
the	O
thorax	B-T082
often	O
causes	O
lung	B-T038
inflammation	I-T038
leading	O
to	O
fibrosis	B-T038
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
whether	O
the	O
use	O
of	O
glyc	B-T103
##yrrh	I-T103
##iz	I-T103
##ic	I-T103
acid	I-T103
(	O
gla	B-T103
)	O
could	O
improve	O
the	O
development	O
of	O
lung	B-T038
fibrosis	I-T038
in	O
irradiated	B-T058
animals	B-T204
.	O
wistar	B-T204
rats	I-T204
were	O
divided	O
into	O
four	O
groups	O
.	O
group	O
a	O
rats	B-T204
received	O
thoracic	O
irradiation	O
.	O
rats	B-T204
in	O
group	O
b	O
received	O
gla	B-T103
and	O
irradiation	B-T058
.	O
group	O
c	O
received	O
gla	B-T103
and	O
no	O
irradiation	B-T058
.	O
group	O
d	O
received	O
no	O
gla	B-T103
and	O
irradiation	B-T058
.	O
gla	B-T103
was	O
administered	O
at	O
a	O
dose	O
of	O
4	O
mg	O
/	O
kg	O
body	O
weight	O
using	O
an	O
intraperitoneal	B-T058
injection	I-T058
one	O
hour	O
before	O
thoracic	O
irradiation	O
.	O
radiation	B-T058
therapy	I-T058
was	O
delivered	O
on	O
a	O
cobalt	B-T103
-	I-T103
60	I-T103
unit	O
using	O
a	O
single	O
fraction	O
of	O
16	O
gy	O
.	O
the	O
animals	B-T204
were	O
sacrificed	O
at	O
32	O
weeks	O
following	O
thoracic	O
irradiation	O
.	O
the	O
lungs	B-T017
were	O
dissected	O
and	O
blind	O
histopathological	O
evaluation	B-T058
was	O
performed	O
.	O
histopathologically	O
,	O
a	O
decrease	O
(	O
statistically	O
not	O
significant	O
)	O
in	O
the	O
thickening	B-T033
of	O
alveolar	B-T017
or	O
bronchial	B-T017
wall	I-T017
,	O
formation	O
of	O
fibrous	B-T017
bands	I-T017
,	O
and	O
superimposed	O
collagen	B-T103
were	O
noted	O
in	O
the	O
animals	B-T204
in	O
group	O
b	O
as	O
compared	O
to	O
the	O
animals	B-T204
in	O
group	O
a	O
.	O
in	O
this	O
experimental	B-T062
study	I-T062
,	O
administration	O
of	O
gla	B-T103
one	O
hour	O
before	O
thoracic	O
irradiation	O
may	O
be	O
a	O
protective	B-T103
agent	I-T103
against	O
radiation	B-T038
-	I-T038
induced	I-T038
fibrosis	I-T038
in	O
animals	B-T204
and	O
this	O
model	B-T038
could	O
be	O
used	O
in	O
future	O
studies	O
.	O

involvement	O
of	O
vascular	B-T017
aldosterone	B-T103
synthase	I-T103
in	O
phosphate	B-T103
-	O
induced	O
osteogenic	B-T033
transformation	I-T033
of	O
vascular	B-T017
smooth	B-T017
muscle	I-T017
cells	I-T017
vascular	B-T038
calcification	I-T038
resulting	O
from	O
hyperphosph	B-T038
##atemia	I-T038
is	O
a	O
major	O
determinant	O
of	O
mortality	O
in	O
chronic	B-T038
kidney	I-T038
disease	I-T038
(	O
ckd	B-T038
)	O
.	O
vascular	B-T038
calcification	I-T038
is	O
driven	O
by	O
aldosterone	B-T103
-	O
sensitive	O
osteogenic	B-T033
transformation	I-T033
of	O
vascular	B-T017
smooth	B-T017
muscle	I-T017
cells	I-T017
(	O
vsmcs	B-T017
)	O
.	O
we	O
show	O
that	O
even	O
in	O
absence	O
of	O
exogenous	O
aldosterone	B-T103
,	O
silencing	B-T038
and	O
pharmacological	B-T038
inhibition	I-T038
(	O
spironolactone	B-T103
,	O
ep	B-T103
##ler	I-T103
##enone	I-T103
)	O
of	O
the	O
mineralocorticoid	B-T103
receptor	I-T103
(	O
mr	B-T103
)	O
ameliorated	O
phosphate	B-T103
-	O
induced	O
oste	B-T033
##o	I-T033
-	I-T033
/	O
chondrogenic	B-T033
transformation	I-T033
of	O
primary	O
human	B-T204
aortic	B-T017
smooth	B-T017
muscle	I-T017
cells	I-T017
(	O
ha	B-T017
##osm	I-T017
##cs	I-T017
)	O
.	O
high	O
phosphate	B-T103
concentrations	O
up	B-T038
-	I-T038
regulated	I-T038
aldosterone	B-T103
synthase	I-T103
(	O
cyp	B-T103
##11	I-T103
##b2	I-T103
)	O
expression	B-T038
in	O
ha	B-T017
##osm	I-T017
##cs	I-T017
.	O
silencing	B-T038
and	O
deficiency	B-T038
of	O
cyp	B-T103
##11	I-T103
##b2	I-T103
in	O
vsmcs	B-T017
ameliorated	O
phosphate	B-T103
-	O
induced	O
osteogenic	O
reprogramming	O
and	O
calcification	B-T038
.	O
phosphate	B-T103
treatment	O
was	O
followed	O
by	O
nuclear	B-T038
export	I-T038
of	O
apex	B-T103
##1	I-T103
,	O
a	O
cyp	B-T017
##11	I-T017
##b2	I-T017
transcriptional	B-T103
repressor	I-T103
.	O
apex	B-T103
##1	I-T103
silencing	B-T038
up	B-T038
-	I-T038
regulated	I-T038
cyp	B-T017
##11	I-T017
##b2	I-T017
expression	B-T038
and	O
stimulated	O
oste	B-T033
##o	I-T033
-	I-T033
/	O
chondrogenic	B-T033
transformation	I-T033
.	O
apex	B-T103
##1	I-T103
overexpression	B-T038
blunted	O
the	O
phosphate	B-T103
-	O
induced	O
oste	B-T033
##o	I-T033
-	I-T033
/	O
chondrogenic	B-T033
transformation	I-T033
and	O
calcification	B-T038
of	O
ha	B-T017
##osm	I-T017
##cs	I-T017
.	O
cyp	B-T017
##11	I-T017
##b2	I-T017
expression	B-T038
was	O
higher	O
in	O
aortic	B-T017
tissue	B-T017
of	O
hyperphosph	B-T038
##ate	I-T038
##mic	I-T038
kl	B-T204
##oth	I-T204
##o	I-T204
-	I-T204
hypo	I-T204
##mo	I-T204
##rp	I-T204
##hi	I-T204
##c	I-T204
(	I-T204
kl	I-T204
/	I-T204
kl	I-T204
)	I-T204
mice	I-T204
than	O
in	O
wild	B-T017
-	I-T017
type	I-T017
mice	B-T204
.	O
in	O
adrenal	B-T204
##ectomized	I-T204
kl	I-T204
/	I-T204
kl	I-T204
mice	I-T204
,	O
spironolactone	B-T103
treatment	O
still	O
significantly	O
ameliorated	O
aortic	B-T017
oste	O
##oin	O
##duc	O
##tive	O
reprogramming	O
.	O
our	O
findings	O
suggest	O
that	O
vsmcs	B-T017
express	O
aldosterone	B-T103
synthase	I-T103
,	O
which	O
is	O
up	B-T038
-	I-T038
regulated	I-T038
by	O
phosphate	B-T103
-	O
induced	O
disruption	O
of	O
apex	B-T103
##1	I-T103
-	O
dependent	O
gene	B-T038
suppression	I-T038
.	O
vascular	B-T017
cyp	B-T103
##11	I-T103
##b2	I-T103
may	O
contribute	O
to	O
stimulation	O
of	O
vsmcs	B-T017
oste	B-T033
##o	I-T033
-	I-T033
/	O
chondrogenic	B-T033
transformation	I-T033
during	O
hyperphosph	B-T038
##atemia	I-T038
.	O

medication	B-T058
recon	I-T058
##cil	I-T058
##iation	I-T058
during	O
hospitalization	B-T058
and	O
in	O
hospital	O
-	O
home	O
interface	O
:	O
an	O
observational	B-T062
retrospective	I-T062
study	I-T062
medication	O
errors	O
are	O
one	O
of	O
the	O
leading	O
causes	O
of	O
patient	O
harms	O
.	O
medication	B-T058
recon	I-T058
##cil	I-T058
##iation	I-T058
is	O
a	O
fundamental	O
process	O
that	O
to	O
be	O
effective	O
,	O
it	O
should	O
be	O
embr	O
##aced	O
during	O
each	O
single	O
care	B-T058
transition	I-T058
.	O
our	O
objectives	O
were	O
to	O
investigate	O
current	O
medication	B-T058
recon	I-T058
##cil	I-T058
##iation	I-T058
practices	O
in	O
the	O
2	O
fon	B-T092
##da	I-T092
##z	I-T092
##ione	I-T092
tos	I-T092
##can	I-T092
##a	I-T092
gab	I-T092
##ri	I-T092
##ele	I-T092
mon	I-T092
##aster	I-T092
##io	I-T092
hospitals	I-T092
and	O
comprehensively	O
assess	O
the	O
quality	O
of	O
medication	B-T058
recon	I-T058
##cil	I-T058
##iation	I-T058
practices	O
between	O
inpatient	O
and	O
outpatient	O
care	O
by	O
analyzing	B-T062
the	O
medication	O
patterns	O
6	O
months	O
before	O
admission	B-T058
,	O
during	O
hospitalization	B-T058
,	O
and	O
9	O
months	O
after	O
discharge	B-T058
for	O
a	O
selected	O
group	O
of	O
patients	O
with	O
cardiovascular	B-T038
diseases	I-T038
.	O
a	O
retrospective	B-T062
observational	I-T062
study	I-T062
was	O
conducted	O
in	O
the	O
cardio	B-T092
##thoracic	I-T092
department	I-T092
of	O
the	O
fon	B-T092
##da	I-T092
##z	I-T092
##ione	I-T092
tos	I-T092
##can	I-T092
##a	I-T092
gab	I-T092
##ri	I-T092
##ele	I-T092
mon	I-T092
##aster	I-T092
##io	I-T092
hospitals	I-T092
.	O
medication	B-T170
history	I-T170
was	O
reviewed	O
for	O
all	O
the	O
patients	O
admitted	B-T058
from	O
and	O
discharged	B-T058
to	O
the	O
community	O
,	O
from	O
january	O
to	O
march	O
2013	O
.	O
patients	O
were	O
excluded	O
if	O
they	O
had	O
less	O
than	O
4	O
drugs	B-T058
or	O
less	O
than	O
2	O
drugs	B-T058
for	O
cardiovascular	B-T022
system	I-T022
in	O
their	O
prescription	B-T170
list	I-T170
at	O
admission	B-T058
or	O
if	O
they	O
died	O
during	O
follow	B-T058
-	I-T058
up	I-T058
.	O
we	O
selected	O
71	O
##4	O
patients	O
,	O
and	O
we	O
obtained	O
the	O
clinical	B-T170
charts	I-T170
and	O
all	O
drug	B-T170
prescriptions	I-T170
collected	O
during	O
patients	O
'	O
hospitalization	B-T058
by	O
the	O
electronic	O
clinical	O
recording	O
system	O
.	O
we	O
also	O
analyzed	B-T062
the	O
list	B-T170
of	I-T170
prescriptions	I-T170
of	O
this	O
sample	O
of	O
patients	O
,	O
from	O
6	O
months	O
before	O
admission	B-T058
to	O
9	O
months	O
after	O
discharge	B-T058
,	O
extracted	O
from	O
the	O
regional	B-T170
prescription	I-T170
registry	I-T170
.	O
in	O
the	O
resulting	O
sample	O
,	O
prescriptions	B-T170
were	O
analyzed	B-T062
to	O
assess	O
unintentional	O
discrepancies	B-T033
.	O
the	O
study	B-T062
included	O
298	O
patients	O
(	O
mean	O
age	O
,	O
71	O
.	O
2	O
years	O
)	O
,	O
according	O
to	O
the	O
inclusion	O
and	O
exclusion	O
criteria	O
.	O
among	O
14	O
,	O
57	O
##3	O
prescriptions	B-T170
analyzed	B-T062
,	O
we	O
found	O
43	O
##63	O
discrepancies	B-T033
(	O
14	O
.	O
6	O
discrepancies	B-T033
per	O
patient	O
)	O
.	O
among	O
these	O
discrepancies	B-T033
,	O
131	O
##0	O
were	O
classified	O
as	O
unintentional	O
(	O
4	O
.	O
4	O
discrepancies	B-T033
per	O
patient	O
)	O
.	O
among	O
unintentional	O
discrepancies	B-T033
,	O
only	O
63	O
(	O
4	O
.	O
8	O
%	O
)	O
took	O
place	O
during	O
hospitalization	B-T058
.	O
although	O
at	O
the	O
hospital	O
-	O
home	O
interface	O
,	O
33	O
.	O
1	O
%	O
of	O
unintentional	O
discrepancies	B-T033
were	O
detected	O
through	O
the	O
comparison	O
between	O
the	O
patients	O
'	O
declared	O
therapy	O
and	O
the	O
previous	O
medication	O
consumption	O
and	O
62	O
.	O
1	O
%	O
were	O
identified	O
in	O
the	O
comparison	O
between	O
the	O
prescription	B-T170
at	O
the	O
discharge	B-T058
and	O
the	O
following	O
medication	O
pattern	O
at	O
home	B-T082
.	O
medication	O
errors	O
have	O
important	O
implications	O
for	O
patient	B-T058
safety	I-T058
,	O
and	O
their	O
identification	O
is	O
a	O
main	O
target	O
for	O
improving	O
clinical	O
practice	O
.	O
the	O
comparison	O
between	O
the	O
medication	O
patterns	O
acquired	O
through	O
the	O
regional	B-T170
prescription	I-T170
registry	I-T170
before	O
and	O
after	O
hospitalization	B-T058
outlined	O
critical	O
touch	O
##point	O
in	O
the	O
current	O
medication	B-T058
recon	I-T058
##cil	I-T058
##iation	I-T058
process	O
,	O
calling	O
for	O
the	O
definition	O
of	O
shared	O
medication	B-T058
recon	I-T058
##cil	I-T058
##iation	I-T058
standards	O
between	O
hospitals	B-T092
and	O
primary	B-T058
care	I-T058
services	I-T058
to	O
minimize	O
medication	O
discrepancies	O
and	O
enhance	O
patient	B-T058
safety	I-T058
.	O

perman	O
##ence	O
can	O
be	O
def	O
##ended	O
in	O
donation	O
after	O
the	O
circulatory	B-T058
-	I-T058
respiratory	I-T058
determination	I-T058
of	I-T058
death	I-T058
(	O
dcd	B-T058
##d	I-T058
)	O
,	O
the	O
dead	B-T038
donor	B-T098
rule	B-T170
requires	O
that	O
the	O
donor	B-T098
be	O
dead	B-T038
before	O
organ	B-T058
proc	I-T058
##urement	I-T058
can	O
proceed	O
.	O
under	O
the	O
relevant	O
limb	O
of	O
the	O
uniform	B-T170
determination	I-T170
of	I-T170
death	I-T170
act	I-T170
1981	I-T170
(	I-T170
usa	I-T170
)	I-T170
,	O
a	O
person	B-T098
is	O
dead	B-T038
when	O
the	O
cessation	O
of	O
circulatory	O
-	O
respiratory	O
function	O
is	O
'	O
irreversible	B-T033
'	O
.	O
critic	B-T097
##s	I-T097
of	O
current	O
practice	B-T038
in	O
dcd	B-T058
##d	I-T058
have	O
argued	O
that	O
the	O
donor	B-T098
is	O
not	O
dead	B-T038
at	O
the	O
time	O
organs	B-T017
are	O
proc	B-T058
##ured	I-T058
,	O
and	O
so	O
the	O
proc	B-T058
##urement	I-T058
of	I-T058
organs	I-T058
from	O
these	O
donors	B-T098
viol	O
##ates	O
the	O
dead	B-T038
donor	B-T098
rule	B-T170
.	O
we	O
offer	B-T033
a	O
new	O
argument	O
here	O
in	O
defence	O
of	O
current	O
dcd	B-T058
##d	I-T058
practice	B-T038
,	O
and	O
,	O
in	O
particular	O
,	O
of	O
the	O
interpretation	B-T170
of	O
the	O
requirement	O
of	O
'	O
irrevers	B-T033
##ibility	I-T033
'	O
as	O
perman	O
##ence	O
.	O

draft	B-T082
genome	I-T082
sequence	I-T082
of	O
bacillus	B-T007
cereus	I-T007
la	I-T007
##200	I-T007
##7	I-T007
,	O
a	O
human	B-T103
-	I-T103
pathogenic	I-T103
isolate	I-T103
harboring	O
anthr	B-T103
##ax	I-T103
-	I-T103
like	I-T103
plasmids	I-T103
we	O
present	O
the	O
genome	B-T082
sequence	I-T082
of	O
bacillus	B-T007
cereus	I-T007
la	I-T007
##200	I-T007
##7	I-T007
,	O
a	O
strain	O
isolated	O
in	O
2007	O
from	O
a	O
fatal	B-T038
pneumonia	I-T038
case	B-T170
in	O
louis	B-T082
##iana	I-T082
.	O
sequence	B-T058
-	I-T058
based	I-T058
genome	I-T058
analysis	I-T058
revealed	O
that	O
la	B-T007
##200	I-T007
##7	I-T007
carries	B-T033
a	O
plasmid	B-T103
highly	O
similar	O
to	O
bacillus	B-T007
anthrac	I-T007
##is	I-T007
px	I-T007
##o1	I-T007
,	O
including	O
the	O
genes	B-T017
responsible	O
for	O
the	O
production	B-T103
and	O
regulation	B-T038
of	O
anthr	B-T103
##ax	I-T103
toxin	I-T103
.	O

improving	O
the	O
sexual	O
health	O
of	O
young	O
people	O
with	O
mobility	B-T033
impairments	I-T033
:	O
challenges	B-T058
and	O
recommendations	O
this	O
mixed	B-T062
-	I-T062
method	I-T062
study	I-T062
(	O
a	O
)	O
describes	O
challenges	B-T058
to	O
providing	O
sexual	O
health	O
services	B-T058
to	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
from	O
the	O
perspective	B-T082
of	O
health	B-T097
care	I-T097
providers	I-T097
and	O
experts	B-T097
and	O
(	O
b	O
)	O
describes	O
and	O
compares	O
sexual	O
health	O
-	O
related	O
experiences	B-T038
of	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
.	O
secondary	O
data	O
analysis	O
of	O
my	O
path	O
,	O
a	O
study	B-T062
focused	O
on	O
the	O
transition	O
to	O
adulthood	O
for	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
.	O
using	O
an	O
exploratory	B-T062
sequential	I-T062
design	I-T062
,	O
qualitative	O
data	O
(	O
n	O
=	O
10	O
)	O
were	O
analyzed	B-T062
using	O
systematic	O
content	O
analysis	O
followed	O
by	O
quantitative	O
analysis	O
of	O
survey	O
data	O
(	O
n	O
=	O
337	O
)	O
.	O
challenges	B-T058
included	O
not	O
talk	O
##ing	O
about	O
sex	O
,	O
managing	O
sexual	B-T038
development	I-T038
,	O
adaptation	B-T038
and	O
instruction	B-T170
,	O
parent	O
roles	O
,	O
and	O
safety	O
.	O
survey	B-T170
data	O
showed	O
that	O
youth	O
with	O
mobility	B-T033
impairments	I-T033
are	O
diverse	O
in	O
their	O
experiences	B-T038
with	O
sexual	O
behavior	O
and	O
sources	B-T033
of	O
sexual	O
health	O
information	O
.	O
although	O
connected	O
with	O
primary	B-T097
care	I-T097
providers	I-T097
,	O
few	O
received	O
information	O
about	O
sexual	O
health	O
.	O
interventions	B-T058
to	O
improve	B-T033
youths	O
'	O
well	O
-	O
being	O
should	O
include	O
comprehensive	B-T058
care	I-T058
and	O
education	O
that	O
promotes	O
and	O
supports	O
healthy	O
sexual	B-T038
development	I-T038
.	O

proliferation	B-T038
-	O
enhancing	O
effects	O
of	O
gastro	B-T103
##din	I-T103
on	O
rs	B-T017
##c	I-T017
##96	I-T017
schwann	I-T017
cells	I-T017
by	O
regulating	B-T038
erk1	B-T103
/	O
2	B-T103
and	O
pi3k	B-T103
signaling	B-T038
pathways	I-T038
the	O
proliferation	B-T038
and	O
migration	B-T038
of	O
schwann	B-T017
cells	I-T017
(	O
scs	B-T017
)	O
are	O
essential	O
in	O
the	O
process	O
of	O
peripheral	B-T058
nerve	I-T058
repair	I-T058
.	O
a	O
large	O
amount	O
of	O
studies	O
focused	O
on	O
the	O
promotion	O
of	O
the	O
growth	B-T038
of	O
scs	B-T017
for	O
cell	B-T058
based	I-T058
therapy	I-T058
.	O
gastro	B-T103
##din	I-T103
(	O
gas	B-T103
)	O
,	O
the	O
main	O
constituent	O
of	O
a	O
chinese	B-T091
traditional	I-T091
herbal	B-T103
medicine	I-T103
named	O
gastro	B-T204
##di	I-T204
##a	I-T204
el	I-T204
##ata	I-T204
blu	I-T204
##me	I-T204
,	O
has	O
been	O
reported	B-T058
to	O
be	O
associated	O
with	O
neuroprotective	B-T038
properties	I-T038
.	O
besides	O
,	O
gas	B-T103
activated	O
mapk	B-T103
and	O
pi3k	B-T103
signaling	B-T038
pathways	I-T038
which	O
are	O
often	O
involved	O
in	O
growth	B-T038
of	O
nerve	B-T017
cells	I-T017
were	O
also	O
reported	B-T058
.	O
based	O
on	O
the	O
hypothesis	O
that	O
gas	B-T103
may	O
have	O
an	O
effect	O
on	O
scs	B-T017
growth	B-T038
,	O
we	O
studied	O
the	O
effect	O
of	O
gas	B-T103
on	O
rat	B-T204
rs	B-T017
##c	I-T017
##96	I-T017
schwann	I-T017
cells	I-T017
(	O
scs	B-T017
)	O
and	O
further	O
explored	O
the	O
underlying	O
mechanism	O
.	O
various	O
concentration	O
of	O
gas	B-T103
(	O
0	O
##μm	O
,	O
50	O
##μm	O
,	O
100	O
##μm	O
,	O
and	O
200	O
##μm	O
)	O
was	O
used	O
for	O
treatment	B-T058
of	O
rs	B-T017
##c	I-T017
##96	I-T017
scs	I-T017
,	O
with	O
the	O
cell	B-T038
proliferation	I-T038
and	O
gene	B-T038
expression	I-T038
of	O
several	O
neurotrophic	B-T103
factors	I-T103
to	O
be	O
detected	O
.	O
regulation	B-T038
of	I-T038
mapk	B-T103
and	O
pi3k	B-T103
signaling	B-T038
pathways	I-T038
were	O
assayed	O
by	O
detecting	O
phosphorylation	B-T038
of	O
erk1	B-T103
/	O
2	B-T103
and	O
akt	B-T103
.	O
the	O
results	O
showed	O
that	O
gas	B-T103
could	O
effectively	O
promote	O
proliferation	B-T038
of	O
rs	B-T017
##c	I-T017
##96	I-T017
scs	I-T017
in	O
a	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
manner	O
.	O
the	O
best	O
performance	O
was	O
obtained	O
at	O
the	O
concentration	O
of	O
200	O
##μm	O
.	O
exploration	B-T058
of	O
the	O
underlying	O
mechanism	O
showed	O
that	O
gas	B-T103
probably	O
affects	O
scs	B-T017
metabolism	B-T038
through	O
inhibiting	O
erk1	B-T103
/	O
2	B-T103
phosphorylation	B-T038
and	O
activating	O
akt	B-T103
phosphorylation	B-T038
in	O
rs	B-T017
##c	I-T017
##96	I-T017
scs	I-T017
.	O
this	O
study	O
may	O
provide	O
reference	O
for	O
its	O
application	O
in	O
treatment	B-T058
of	O
peripheral	B-T037
nerve	I-T037
injuries	I-T037
.	O

fine	B-T082
structure	I-T082
of	O
the	O
anterior	B-T017
median	I-T017
eyes	I-T017
of	O
the	O
fun	B-T082
##nel	I-T082
-	O
web	B-T204
spider	I-T204
age	B-T204
##len	I-T204
##a	I-T204
labyrinth	I-T204
##ica	I-T204
(	O
ara	B-T204
##nea	I-T204
##e	I-T204
:	O
age	B-T204
##len	I-T204
##idae	I-T204
)	O
only	O
few	O
electron	B-T058
microscopic	I-T058
studies	I-T058
exist	O
on	O
the	O
structure	B-T082
of	O
the	O
main	O
eyes	B-T017
(	O
anterior	B-T017
median	I-T017
eyes	I-T017
,	O
am	B-T017
##e	I-T017
)	O
of	O
web	B-T204
spider	I-T204
##s	I-T204
.	O
the	O
present	O
paper	O
provides	O
details	O
on	O
the	O
anatomy	B-T017
of	O
the	O
am	B-T017
##e	I-T017
in	O
the	O
fun	O
##nel	O
-	O
web	O
spider	B-T204
age	B-T204
##len	I-T204
##a	I-T204
labyrinth	I-T204
##ica	I-T204
.	O
the	O
retina	B-T017
consists	O
of	O
two	O
separate	O
regions	B-T082
with	O
differently	O
arranged	O
photoreceptor	B-T017
cells	I-T017
.	O
its	O
central	B-T082
part	I-T082
has	O
sensory	B-T017
cells	I-T017
with	O
rhabd	B-T017
##omeres	I-T017
on	O
2	O
,	O
3	O
,	O
or	O
4	O
sides	O
,	O
whereas	O
those	O
of	O
the	O
ventral	B-T082
retina	B-T017
have	O
only	O
two	O
rhabd	B-T017
##omeres	I-T017
on	O
opposite	O
sides	O
.	O
in	O
addition	O
,	O
the	O
rhabd	B-T017
##omeres	I-T017
of	O
the	O
ventral	B-T082
retina	B-T017
are	O
arranged	O
in	O
a	O
specific	O
way	O
:	O
whereas	O
in	O
the	O
most	O
ventral	B-T082
part	O
they	O
form	O
long	B-T082
tang	I-T082
##ential	I-T082
row	I-T082
##s	I-T082
,	O
those	O
towards	O
the	O
center	B-T082
are	O
detached	O
and	O
are	O
arranged	O
radial	O
##ly	O
.	O
all	O
sensory	B-T017
cells	I-T017
are	O
wr	O
##apped	O
by	O
unp	B-T033
##igm	I-T033
##ented	I-T033
pigment	B-T017
cell	I-T017
processes	B-T038
.	O
in	O
age	B-T204
##len	I-T204
##id	I-T204
spider	B-T204
##s	I-T204
the	O
axons	B-T017
of	O
the	O
sensory	B-T017
cells	I-T017
exit	O
from	O
the	O
middle	O
of	O
the	O
cell	B-T017
body	I-T017
;	O
their	O
fine	B-T082
structure	I-T082
and	O
course	O
through	O
the	O
eye	B-T074
cup	I-T074
is	O
described	O
in	O
detail	O
.	O
in	O
the	O
central	B-T082
part	I-T082
of	O
the	O
retina	B-T017
efferent	O
nerve	B-T017
fibres	I-T017
were	O
found	O
forming	O
synapses	B-T082
along	O
the	O
distal	B-T082
region	I-T082
of	O
the	O
receptor	B-T017
cells	I-T017
.	O
a	O
muscle	B-T017
is	O
attached	O
laterally	O
to	O
each	O
eye	B-T074
cup	I-T074
that	O
allows	O
mainly	O
rotational	B-T082
movements	B-T038
of	O
the	O
eyes	B-T017
.	O
the	O
optical	O
performance	O
(	O
image	O
resolution	O
)	O
of	O
these	O
main	O
eyes	B-T017
with	O
relatively	O
few	O
visual	B-T017
cells	I-T017
is	O
discussed	O
.	O

committee	O
opinion	O
no	O
.	O
70	O
##1	O
summary	O
:	O
choosing	O
the	O
route	B-T082
of	O
hysterectomy	B-T058
for	O
benign	O
disease	B-T038
hysterectomy	B-T058
is	O
one	O
of	O
the	O
most	O
frequently	O
performed	O
surgical	B-T058
procedures	I-T058
in	O
the	O
united	B-T082
states	I-T082
.	O
selection	O
of	O
the	O
route	B-T082
of	O
hysterectomy	B-T058
for	O
benign	O
causes	O
can	O
be	O
influenced	O
by	O
the	O
size	B-T082
and	O
shape	B-T082
of	O
the	O
vagina	B-T017
and	O
uterus	B-T017
;	O
accessibility	O
to	O
the	O
uterus	B-T017
;	O
extent	O
of	O
extra	B-T038
##uterine	I-T038
disease	I-T038
;	O
the	O
need	O
for	O
concurrent	O
procedures	O
;	O
surgeon	B-T097
training	O
and	O
experience	B-T038
;	O
average	O
case	O
volume	O
;	O
available	O
hospital	B-T092
technology	B-T058
,	O
devices	B-T074
,	O
and	O
support	O
;	O
whether	O
the	O
case	O
is	O
emergent	O
or	O
scheduled	O
;	O
and	O
preference	O
of	O
the	O
informed	O
patient	O
.	O
vaginal	B-T058
and	O
laparoscopic	B-T058
procedures	I-T058
are	O
considered	O
[UNK]	O
minimally	O
invasive	O
[UNK]	O
surgical	O
approaches	O
because	O
they	O
do	O
not	O
require	O
a	O
large	O
abdominal	B-T058
incision	I-T058
and	O
,	O
thus	O
,	O
typically	O
are	O
associated	O
with	O
shortened	O
hospitalization	B-T058
and	O
postoperative	O
recovery	O
times	O
compared	O
with	O
open	O
abdominal	B-T058
hysterectomy	I-T058
.	O
minimally	O
invasive	O
approaches	O
to	O
hysterectomy	B-T058
should	O
be	O
performed	O
,	O
whenever	O
feasible	O
,	O
based	O
on	O
their	O
well	O
-	O
documented	O
advantages	O
over	O
abdominal	B-T058
hysterectomy	I-T058
.	O
the	O
vaginal	B-T082
approach	I-T082
is	O
preferred	O
among	O
the	O
minimally	O
invasive	O
approaches	O
.	O
laparoscopic	B-T058
hysterectomy	I-T058
is	O
a	O
preferable	O
alternative	O
to	O
open	O
abdominal	B-T058
hysterectomy	I-T058
for	O
those	O
patients	O
in	O
whom	O
a	O
vaginal	B-T058
hysterectomy	I-T058
is	O
not	O
indicated	O
or	O
feasible	O
.	O
although	O
minimally	O
invasive	O
approaches	O
to	O
hysterectomy	B-T058
are	O
the	O
preferred	O
route	B-T082
,	O
open	B-T058
abdominal	B-T058
hysterectomy	I-T058
remains	O
an	O
important	O
surgical	O
option	O
for	O
some	O
patients	O
.	O
the	O
obstetric	B-T097
##ian	I-T097
-	O
gynec	B-T097
##ologist	I-T097
should	O
discuss	O
the	O
options	O
with	O
patients	O
and	O
make	O
clear	O
recommendations	O
on	O
which	O
route	B-T082
of	O
hysterectomy	B-T058
will	O
maximize	O
benefits	O
and	O
minimize	O
risks	O
given	O
the	O
specific	O
clinical	O
situation	O
.	O
the	O
relative	O
advantages	O
and	O
disadvantages	O
of	O
the	O
approaches	O
to	O
hysterectomy	B-T058
should	O
be	O
discussed	O
in	O
the	O
context	O
of	O
the	O
patient	O
'	O
s	O
values	O
and	O
preferences	O
,	O
and	O
the	O
patient	O
and	O
health	B-T097
care	I-T097
provider	I-T097
should	O
together	O
determine	O
the	O
best	O
course	O
of	O
action	O
after	O
this	O
discussion	O
.	O

does	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
application	O
during	O
spine	B-T058
surgery	I-T058
create	O
vancomycin	O
-	O
resistant	O
organism	O
?	O
surgical	B-T038
site	I-T038
infection	I-T038
(	O
ssi	B-T038
)	O
following	O
spine	B-T058
surgery	I-T058
is	O
a	O
morbid	O
and	O
expensive	O
complication	O
.	O
the	O
use	O
of	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
is	O
emerging	O
as	O
a	O
solution	O
to	O
reduce	O
ssi	B-T038
.	O
the	O
development	O
of	O
vancomycin	O
-	O
resistant	O
pathogens	O
is	O
an	O
understand	O
##able	O
concern	O
.	O
to	O
determine	O
the	O
occurrence	O
of	O
vancomycin	O
-	O
resistant	O
ssi	B-T038
in	O
patients	O
with	O
and	O
without	O
use	O
of	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
.	O
patients	O
undergoing	O
elective	O
spine	B-T058
surgery	I-T058
were	O
dichotom	O
##ized	O
based	O
on	O
whether	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
was	O
applied	O
.	O
outcome	O
was	O
occurrence	O
of	O
ssi	B-T038
requiring	O
return	O
to	O
the	O
operating	B-T092
room	I-T092
within	O
postoperative	O
90	O
days	O
.	O
the	O
intra	O
##w	O
##ound	O
culture	O
and	O
vancomycin	B-T103
minimal	B-T058
inhibitory	I-T058
concentrations	I-T058
(	O
mic	B-T058
)	O
were	O
reviewed	O
.	O
analyses	O
were	O
conducted	O
to	O
compare	O
the	O
pathogen	O
profile	O
and	O
mic	B-T058
for	O
vancomycin	B-T103
in	O
patients	O
who	O
received	O
vancomycin	B-T103
and	O
those	O
who	O
did	O
not	O
.	O
of	O
the	O
total	O
280	O
##2	O
patients	O
,	O
43	O
%	O
(	O
n	O
=	O
121	O
##5	O
)	O
had	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
application	O
during	O
the	O
index	O
surgery	O
.	O
the	O
use	O
of	O
vancomycin	B-T103
was	O
associated	O
with	O
significantly	O
lower	O
deep	O
ssi	B-T038
rates	B-T017
(	O
1	O
.	O
6	O
%	O
[	O
n	O
=	O
20	O
]	O
vs	O
2	O
.	O
5	O
%	O
[	O
n	O
=	O
40	O
]	O
,	O
p	O
=	O
.	O
02	O
)	O
.	O
the	O
occurrence	O
of	O
staphylococcus	B-T007
aureus	I-T007
ssi	B-T038
was	O
significantly	O
lower	O
in	O
the	O
patients	O
who	O
had	O
application	O
of	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
(	O
32	O
%	O
vs	O
65	O
%	O
,	O
p	O
=	O
.	O
003	O
)	O
.	O
none	O
of	O
the	O
patients	O
who	O
had	O
application	O
of	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
powder	I-T103
,	O
and	O
subsequently	O
developed	O
an	O
s	B-T007
aureus	I-T007
ssi	B-T038
,	O
demonstrated	O
pathogens	O
with	O
resistance	B-T033
to	I-T033
vancomycin	I-T033
.	O
all	O
patients	O
had	O
mic	B-T058
<	O
2	O
μg	O
/	O
ml	O
,	O
the	O
vancomycin	B-T103
susceptibility	O
threshold	O
.	O
the	O
occurrence	O
of	O
gram	B-T038
-	I-T038
negative	I-T038
ssi	B-T038
(	O
28	O
%	O
vs	O
7	O
%	O
)	O
and	O
culture	B-T033
negative	I-T033
fluid	I-T033
collection	I-T033
(	O
16	O
%	O
vs	O
5	O
%	O
)	O
was	O
higher	O
in	O
the	O
vancomycin	B-T103
cohort	B-T098
.	O
the	O
use	O
of	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
during	O
the	O
index	O
spine	B-T058
surgery	I-T058
was	O
protective	O
against	O
ssi	B-T038
following	O
spine	B-T058
surgery	I-T058
.	O
the	O
application	O
of	O
intra	B-T103
##w	I-T103
##ound	I-T103
vancomycin	I-T103
during	O
index	O
surgery	O
does	O
not	O
appear	O
to	O
create	O
vancomycin	O
-	O
resistant	O
organisms	O
in	O
the	O
event	O
of	O
an	O
ssi	B-T038
.	O

the	O
use	O
of	O
neonatal	O
extracorporeal	B-T058
life	I-T058
support	I-T058
in	O
pediatric	O
cardiac	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
the	O
aim	O
of	O
the	O
study	O
is	O
to	O
evaluate	B-T058
extracorporeal	B-T058
life	I-T058
support	I-T058
system	I-T058
(	O
ecl	B-T058
##s	I-T058
)	O
employed	O
in	O
neonates	O
in	O
pediatric	O
cardiac	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
.	O
twenty	O
-	O
five	O
neonates	O
that	O
required	O
ecl	B-T058
##s	I-T058
in	O
between	O
november	O
2010	O
and	O
november	O
2015	O
were	O
evaluated	B-T058
.	O
the	O
median	O
age	O
was	O
12	O
days	O
(	O
range	O
3	O
-	O
28	O
days	O
)	O
and	O
the	O
median	O
body	O
weight	O
was	O
3	O
kg	O
(	O
range	O
2	O
.	O
5	O
-	O
5	O
kg	O
)	O
.	O
ven	B-T082
##oar	I-T082
##ter	I-T082
##ial	I-T082
ecl	B-T058
##s	I-T058
was	O
performed	O
in	O
all	O
of	O
the	O
cases	O
.	O
asc	B-T017
##end	I-T017
##an	I-T017
aorta	I-T017
-	O
right	B-T017
atrial	I-T017
cannulation	B-T058
in	O
22	O
patients	O
and	O
neck	B-T082
cannulation	B-T058
in	O
three	O
patients	O
were	O
performed	O
.	O
the	O
reason	O
for	O
ecl	B-T058
##s	I-T058
was	O
e	B-T058
-	I-T058
cpr	I-T058
in	O
two	O
patients	O
,	O
inability	B-T033
to	I-T033
wean	I-T033
from	O
cardiopulmonary	B-T058
bypass	I-T058
(	O
cpb	B-T058
)	O
in	O
seven	O
patients	O
,	O
respiratory	B-T038
insufficiency	I-T038
and	O
hypoxia	B-T038
in	O
nine	O
patients	O
,	O
low	B-T038
cardiac	I-T038
output	I-T038
(	O
lc	B-T038
##os	I-T038
)	O
in	O
seven	O
patients	O
.	O
median	O
duration	O
of	O
ecl	B-T058
##s	I-T058
was	O
four	O
days	O
(	O
range	O
1	O
-	O
15	O
)	O
.	O
hemorrhagic	O
complications	B-T038
developed	O
in	O
15	O
,	O
renal	O
complications	O
in	O
13	O
,	O
pulmonary	B-T038
complications	I-T038
in	O
12	O
,	O
infectious	B-T038
complications	B-T038
in	O
11	O
,	O
neurologic	B-T038
complications	I-T038
in	O
three	O
and	O
mechanical	B-T038
complications	I-T038
in	O
two	O
of	O
the	O
patients	O
.	O
weaning	B-T033
was	O
successful	O
in	O
15	O
of	O
the	O
patients	O
.	O
eleven	O
patients	O
were	O
successfully	O
discharged	B-T058
.	O
ecl	B-T058
##s	I-T058
is	O
an	O
important	O
treatment	B-T058
option	I-T058
that	O
is	O
performed	O
successfully	O
in	O
many	O
centers	B-T092
around	O
the	O
world	B-T098
to	O
maintain	O
life	B-T058
support	I-T058
in	O
patients	O
unresponsive	O
to	O
medical	O
treatment	O
.	O
the	O
utilization	O
of	O
this	O
modality	O
especially	O
in	O
newborns	O
with	O
congenital	B-T017
heart	I-T017
disease	I-T017
should	O
be	O
taken	O
into	O
consideration	O
.	O

hospital	B-T092
clo	I-T092
##w	I-T092
##ning	I-T092
:	O
a	O
paediatric	B-T097
##ian	I-T097
'	I-T097
s	I-T097
view	B-T038
this	O
study	B-T062
investigates	O
the	O
current	O
position	O
of	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
from	O
the	O
perspective	B-T038
of	O
paediatric	B-T097
##ians	I-T097
and	O
paediatric	O
residents	O
.	O
a	O
total	O
of	O
14	O
attending	B-T097
paediatric	I-T097
##ians	I-T097
and	O
paediatric	O
residents	O
participated	O
in	O
two	O
focus	O
group	O
sessions	O
.	O
data	O
were	O
analysed	B-T062
using	O
atlas	B-T170
.	I-T170
ti	I-T170
5	I-T170
.	I-T170
0	I-T170
.	O
in	O
general	B-T082
,	O
physicians	B-T097
reported	B-T170
positive	B-T033
experiences	B-T038
regarding	O
the	O
interaction	B-T033
between	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
and	O
paediatric	O
patients	O
on	O
the	O
ward	B-T092
.	O
physicians	B-T097
were	O
more	O
interested	B-T038
in	O
research	B-T062
on	O
children	O
'	O
s	O
perception	O
of	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
than	O
in	O
research	B-T062
on	O
the	O
clinical	O
efficacy	O
of	O
hospital	B-T092
clo	I-T092
##w	I-T092
##ning	I-T092
.	O
no	O
direct	O
collaboration	O
between	O
physicians	B-T097
and	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
was	O
reported	B-T170
.	O
however	O
,	O
physicians	B-T097
proposed	O
conditions	O
which	O
may	O
stream	O
##line	O
their	O
encounters	O
with	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
such	O
as	O
clear	O
communication	O
prior	O
to	O
hospital	B-T097
clo	I-T097
##w	I-T097
##n	I-T097
visits	B-T058
,	O
and	O
the	O
condition	O
that	O
visits	O
do	O
not	O
impede	O
medical	B-T058
interventions	I-T058
.	O
overall	O
,	O
paediatric	B-T097
##ians	I-T097
and	O
paediatric	O
residents	O
view	B-T038
the	O
positive	B-T033
impact	O
on	O
paediatric	O
patients	O
as	O
the	O
most	O
important	O
aspect	O
of	O
hospital	B-T097
clo	I-T097
##w	I-T097
##n	I-T097
visits	B-T058
,	O
rather	O
than	O
the	O
clinical	O
efficacy	O
of	O
hospital	B-T092
clo	I-T092
##w	I-T092
##ning	I-T092
.	O
in	O
light	O
of	O
the	O
growing	O
number	O
of	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
worldwide	B-T098
,	O
this	O
article	B-T170
provides	O
recommendations	O
for	O
arr	O
##angi	O
##ng	O
their	O
encounters	O
with	O
paediatric	B-T097
##ians	I-T097
and	O
paediatric	O
residents	O
to	O
maintain	O
optimal	O
health	B-T058
care	I-T058
.	O
what	O
is	O
known	O
:	O
•	O
previous	O
studies	B-T062
show	O
a	O
clinically	O
significant	O
pain	B-T033
-	O
and	O
anxiety	B-T033
-	O
reducing	O
effect	O
of	O
hospital	B-T092
clo	I-T092
##w	I-T092
##ning	I-T092
in	O
paediatric	O
patients	O
admitted	B-T058
to	I-T058
hospitals	I-T058
or	O
undergoing	O
(	O
invasive	O
)	O
medical	B-T058
procedures	I-T058
.	O
•	O
in	O
general	O
,	O
paediatric	B-T097
##ians	I-T097
have	O
positive	B-T033
ideas	O
about	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
,	O
asi	O
##de	O
from	O
personal	O
pre	O
##ju	O
##di	O
##ces	O
.	O
what	O
is	O
new	O
:	O
•	O
this	O
novel	O
study	B-T062
gives	O
deeper	O
insight	B-T038
into	O
day	O
-	O
to	O
-	O
day	O
interaction	B-T033
between	O
paediatric	B-T097
##ians	I-T097
and	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
on	O
the	O
ward	B-T092
.	O
•	O
this	O
study	B-T062
provides	O
recommendations	O
for	O
clinical	B-T170
practice	I-T170
to	O
arr	O
##ange	O
encounters	O
between	O
physicians	B-T097
and	O
hospital	B-T097
clo	I-T097
##w	I-T097
##ns	I-T097
during	O
hospital	B-T097
clo	I-T097
##w	I-T097
##n	I-T097
visits	B-T058
.	O

wi	B-T038
##edema	I-T038
##nn	I-T038
-	I-T038
ra	I-T038
##ute	I-T038
##ns	I-T038
##tra	I-T038
##uch	I-T038
syndrome	I-T038
with	O
bilateral	B-T082
tars	B-T017
##al	I-T017
kin	I-T017
##k	I-T017
:	O
three	O
sutures	B-T058
for	O
correction	O
the	O
authors	O
describe	O
a	O
5	O
-	O
month	O
-	O
old	O
male	O
infant	O
with	O
wi	B-T038
##edema	I-T038
##nn	I-T038
-	I-T038
ra	I-T038
##ute	I-T038
##ns	I-T038
##tra	I-T038
##uch	I-T038
syndrome	I-T038
,	O
which	O
is	O
an	O
extremely	O
rare	O
condition	B-T038
.	O
he	O
had	O
tars	B-T017
##al	I-T017
kin	I-T017
##k	I-T017
in	O
upper	B-T017
eyelid	I-T017
##s	I-T017
in	O
both	B-T017
eyes	I-T017
.	O
the	O
authors	O
treated	O
bilateral	B-T082
tars	B-T017
##al	I-T017
kin	I-T017
##k	I-T017
with	O
an	O
ever	B-T058
##ting	I-T058
suture	B-T058
via	O
a	O
transc	B-T082
##on	I-T082
##junctiv	I-T082
##al	I-T082
approach	I-T082
under	O
local	B-T058
anesthesia	I-T058
.	O

psychological	O
distress	O
is	O
more	O
prevalent	O
in	O
fertile	B-T038
age	O
and	O
premenopausal	B-T038
women	B-T098
with	O
pcos	B-T038
symptoms	B-T033
-	O
15	O
-	O
yr	O
follow	B-T058
-	I-T058
up	I-T058
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
(	O
pcos	B-T038
)	O
is	O
associated	O
with	O
increased	O
psychological	O
distress	O
;	O
obesity	B-T038
and	O
hyper	B-T038
##and	I-T038
##rogen	I-T038
##ism	I-T038
being	O
suggested	O
as	O
key	O
promoters	O
.	O
to	O
investigate	O
the	O
prevalence	O
of	O
anxiety	B-T038
/	O
depression	B-T038
and	O
their	O
coexistence	O
in	O
women	B-T098
with	O
pcos	B-T038
/	O
pcos	B-T038
symptoms	B-T033
at	O
age	O
s	O
31	O
and	O
46	O
.	O
the	O
roles	O
of	O
obesity	B-T038
,	O
hyper	B-T038
##and	I-T038
##rogen	I-T038
##ism	I-T038
and	O
awareness	B-T038
of	O
pcos	B-T038
on	O
psychological	O
distress	O
were	O
also	O
assessed	O
.	O
population	B-T062
based	I-T062
follow	I-T062
-	I-T062
up	I-T062
.	O
northern	B-T082
finland	I-T082
birth	O
cohort	O
1966	O
with	O
15	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
.	O
at	O
age	O
31	O
a	O
questionnaire	B-T062
-	I-T062
based	I-T062
screening	I-T062
for	O
oligo	B-T038
##amen	I-T038
##orrhea	I-T038
(	O
oa	B-T038
)	O
and	O
hirs	B-T038
##ut	I-T038
##ism	I-T038
(	O
h	B-T038
)	O
:	O
218	O
##8	O
asymptomatic	B-T033
(	O
controls	O
)	O
,	O
331	O
oa	B-T038
,	O
323	O
h	B-T038
,	O
125	O
oa	B-T038
+	O
h	B-T038
(	O
pcos	B-T038
)	O
.	O
46	O
year	O
old	O
follow	B-T058
-	I-T058
up	I-T058
:	O
157	O
##6	O
controls	O
,	O
239	O
oa	B-T038
,	O
231	O
h	B-T038
and	O
85	O
pcos	B-T038
.	O
questionnaire	B-T062
-	I-T062
based	I-T062
screening	I-T062
for	O
anxiety	B-T038
and	O
depression	B-T033
symptoms	I-T033
(	O
hop	B-T170
##kins	I-T170
symptom	I-T170
checklist	I-T170
-	I-T170
25	I-T170
)	O
and	O
previously	O
diagnosed	B-T033
/	O
treated	B-T033
depression	B-T038
at	O
age	O
31	O
and	O
46	O
.	O
bmi	B-T201
,	O
serum	O
testosterone	O
/	O
free	B-T058
androgen	I-T058
index	I-T058
(	O
fa	B-T058
##i	I-T058
)	O
and	O
awareness	B-T038
of	O
polycystic	B-T038
ovaries	I-T038
/	O
pcos	B-T038
on	O
psychological	O
distress	O
were	O
also	O
assessed	O
.	O
population	O
-	O
based	O
prevalence	O
of	O
anxiety	B-T038
and	O
/	O
or	O
depression	B-T038
in	O
women	B-T098
with	O
pcos	B-T038
/	O
pcos	B-T038
symptoms	B-T033
at	O
age	O
s	O
31	O
and	O
46	O
.	O
anxiety	B-T038
and	O
/	O
or	O
depression	B-T033
symptoms	I-T033
,	O
their	O
coexistence	O
and	O
rate	O
of	O
depression	B-T038
were	O
increased	O
at	O
age	O
31	O
and	O
46	O
in	O
women	B-T098
with	O
pcos	B-T038
or	O
isolated	O
h	B-T038
compared	O
with	O
controls	O
.	O
high	O
bmi	B-T201
or	O
hyper	B-T038
##and	I-T038
##rogen	I-T038
##ism	I-T038
did	O
not	O
associate	O
with	O
increased	O
anxiety	B-T038
or	O
depression	B-T033
symptoms	I-T033
.	O
the	O
awareness	B-T038
of	O
pcos	B-T038
was	O
associated	O
with	O
increased	O
anxiety	B-T038
.	O
women	B-T098
with	O
pcos	B-T038
or	O
isolated	O
h	B-T038
present	O
more	O
often	O
with	O
anxiety	B-T038
and	O
/	O
or	O
depression	B-T033
symptoms	I-T033
and	O
their	O
coexistence	O
compared	O
with	O
controls	O
.	O
high	O
bmi	B-T201
or	O
hyper	B-T038
##and	I-T038
##rogen	I-T038
##ism	I-T038
did	O
not	O
provoke	O
psychological	O
distress	O
in	O
pcos	B-T038
.	O
the	O
awareness	B-T038
of	O
pcos	B-T038
increased	O
anxiety	B-T038
but	O
did	O
not	O
associate	O
with	O
severe	O
anxiety	B-T038
or	O
depression	B-T038
.	O

common	O
laboratory	B-T092
parameters	B-T033
for	O
differentiating	O
between	O
community	B-T038
-	I-T038
acquired	I-T038
and	O
healthcare	B-T038
-	I-T038
associated	I-T038
pneumonia	I-T038
the	O
correct	O
diagnosis	B-T033
of	O
healthcare	B-T038
-	I-T038
associated	I-T038
pneumonia	I-T038
(	O
hca	B-T038
##p	I-T038
)	O
as	O
opposed	O
to	O
community	B-T038
-	I-T038
acquired	I-T038
pneumonia	I-T038
is	O
essential	O
for	O
the	O
selection	O
of	O
a	O
correct	O
empirical	O
antimicrobial	B-T103
approach	O
,	O
reserv	O
##ing	O
the	O
broad	O
-	O
spectrum	O
or	O
highly	O
potent	O
antimicrobial	B-T058
therapies	I-T058
for	O
resistant	O
strains	O
most	O
commonly	O
present	O
in	O
hca	B-T038
##p	I-T038
,	O
whereas	O
treating	O
the	O
less	O
resistant	O
strains	O
,	O
most	O
commonly	O
associated	O
with	O
community	O
and	O
long	B-T092
-	I-T092
term	I-T092
care	I-T092
facility	I-T092
-	O
acquired	B-T038
infections	I-T038
,	O
with	O
a	O
more	O
targeted	O
empirical	O
approach	O
.	O
the	O
standard	O
approach	O
today	O
is	O
to	O
differentiate	O
between	O
the	O
two	O
based	O
on	O
the	O
medical	B-T033
history	I-T033
of	O
the	O
past	O
90	O
days	O
prior	O
to	O
admission	B-T058
.	O
measurable	O
,	O
quantitative	O
assessment	B-T058
may	O
be	O
able	O
to	O
assist	O
in	O
this	O
decision	B-T038
.	O
the	O
objective	O
of	O
this	O
study	O
is	O
to	O
find	O
a	O
measurable	O
method	B-T170
of	O
differentiating	O
between	O
community	B-T038
-	I-T038
acquired	I-T038
and	O
healthcare	B-T038
-	I-T038
associated	I-T038
pneumonia	I-T038
##s	I-T038
.	O
the	O
records	B-T170
of	O
126	O
patients	O
admitted	B-T058
with	O
a	O
diagnosis	B-T033
of	O
pneumonia	B-T038
were	O
divided	O
into	O
two	O
groups	O
based	O
on	O
the	O
probable	O
cause	O
of	O
their	O
disease	O
,	O
in	O
accordance	O
with	O
common	B-T038
practice	I-T038
.	O
the	O
routine	O
laboratory	B-T058
work	I-T058
taken	O
upon	O
adm	B-T058
##itt	I-T058
##ance	I-T058
was	O
analyzed	B-T062
using	O
logistic	B-T062
##al	I-T062
regression	I-T062
and	O
student	O
'	O
s	O
t	O
-	O
test	O
.	O
we	O
have	O
found	O
that	O
the	O
red	B-T058
blood	I-T058
cell	I-T058
distribution	I-T058
width	I-T058
and	O
the	O
neutrophil	B-T017
-	O
to	O
-	O
lymphocyte	B-T017
ratio	O
,	O
both	O
routine	B-T033
parameters	I-T033
obtained	O
in	O
a	O
simple	O
blood	B-T058
count	I-T058
,	O
can	O
each	O
assist	O
in	O
differentiating	O
between	O
community	B-T038
-	I-T038
acquired	I-T038
and	O
healthcare	B-T038
-	I-T038
associated	I-T038
pneumonia	I-T038
##s	I-T038
.	O
we	O
have	O
found	O
two	O
statistically	O
significant	O
parameters	O
that	O
may	O
be	O
used	O
as	O
adjunct	O
##s	O
to	O
the	O
medical	B-T033
history	I-T033
,	O
chest	B-T058
radiography	I-T058
and	O
other	B-T033
parameters	I-T033
in	O
forming	O
an	O
immediate	O
clinical	O
impression	O
of	O
a	O
patient	O
presenting	O
with	O
pneumonia	B-T038
.	O

assessing	O
the	O
benefits	O
of	O
targeted	O
drug	B-T074
delivery	I-T074
by	O
nanocar	O
##riers	O
:	O
a	O
partic	O
##o	O
/	O
pharmacokinetic	O
framework	O
an	O
in	B-T082
vivo	I-T082
kinetic	O
framework	O
is	O
introduced	O
to	O
analyze	B-T062
and	O
predict	O
the	O
quantitative	O
advantage	O
of	O
using	O
nanocar	O
##riers	O
to	O
deliver	B-T074
drugs	I-T074
,	O
especially	O
anticancer	B-T103
agents	I-T103
,	O
compared	O
to	O
administering	B-T058
the	O
same	O
drugs	B-T103
in	O
their	O
free	O
form	O
.	O
this	O
framework	O
recognizes	O
three	O
levels	O
of	O
kinetics	B-T038
.	O
first	O
is	O
the	O
partic	O
##okinetic	O
##s	O
associated	O
with	O
deposition	O
of	O
nanocar	O
##riers	O
into	O
tissues	B-T017
associated	O
with	O
drug	O
effect	O
and	O
toxicity	B-T037
,	O
their	O
residence	B-T082
inside	O
those	O
tissues	B-T017
,	O
and	O
elimination	O
of	O
the	O
nanocar	O
##riers	O
from	O
the	O
body	B-T204
.	O
second	O
is	O
the	O
release	B-T033
pattern	I-T033
in	O
time	O
of	O
free	O
drug	O
from	O
the	O
nanocar	O
##riers	O
.	O
third	O
is	O
the	O
pharmacokinetics	B-T038
of	O
free	O
drug	O
,	O
as	O
it	O
relates	O
to	O
deposition	O
and	O
elimination	O
processes	O
in	O
the	O
target	O
and	O
toxicity	B-T037
associated	O
tissues	B-T017
,	O
and	O
total	B-T033
body	I-T033
clearance	I-T033
.	O
a	O
figure	O
of	O
merit	O
,	O
the	O
drug	O
targeting	O
index	O
(	O
dti	O
)	O
,	O
is	O
used	O
to	O
quantitate	O
the	O
benefit	O
of	O
nanocar	O
##rier	O
based	O
drug	B-T074
delivery	I-T074
by	O
considering	O
the	O
effects	O
of	O
preferential	O
deposition	O
of	O
nanoparticles	O
into	O
target	O
tissues	B-T017
and	O
relative	O
avoidance	O
of	O
tissues	B-T017
associated	O
with	O
drug	B-T037
toxicity	I-T037
,	O
compared	O
to	O
drug	B-T103
that	O
is	O
administered	B-T058
in	O
its	O
free	O
form	O
.	O
general	O
methods	B-T170
are	O
derived	O
for	O
calculating	O
dti	O
when	O
appropriate	O
partic	O
##okinetic	O
,	O
pharmacokinetic	O
,	O
and	O
drug	O
release	O
rate	O
information	O
is	O
available	O
,	O
and	O
it	O
is	O
shown	O
that	O
relatively	O
simple	O
alg	O
##eb	O
##ra	O
##ic	O
forms	O
result	O
when	O
some	O
common	O
assumptions	O
are	O
made	O
.	O
this	O
approach	O
may	O
find	O
use	O
in	O
developing	B-T091
and	O
selecting	O
nanocar	O
##rier	O
formulations	O
,	O
either	O
for	O
populations	B-T098
or	O
for	O
individuals	B-T098
.	O

boston	B-T074
kerat	I-T074
##oprost	I-T074
##he	I-T074
##sis	I-T074
type	I-T074
1	I-T074
:	O
a	O
randomized	B-T062
controlled	I-T062
trial	I-T062
of	O
fresh	O
versus	O
frozen	O
corneal	O
donor	O
carriers	O
with	O
long	O
-	O
term	O
follow	B-T058
-	I-T058
up	I-T058
to	O
compare	O
the	O
long	O
-	O
term	O
clinical	O
outcomes	O
of	O
fresh	O
versus	O
frozen	O
corneal	O
graft	O
carriers	O
for	O
the	O
boston	B-T074
kerat	I-T074
##oprost	I-T074
##he	I-T074
##sis	I-T074
type	I-T074
1	I-T074
(	O
b	B-T074
-	I-T074
kp	I-T074
##ro	I-T074
)	O
.	O
prospective	O
,	O
single	O
-	O
center	O
,	O
nonb	O
##lin	O
##ded	O
,	O
randomized	B-T062
controlled	I-T062
trial	I-T062
.	I-T062
all	O
participants	B-T098
were	O
followed	O
through	O
the	O
initial	O
study	B-T170
protocol	I-T170
of	O
24	O
months	O
and	O
were	O
approached	O
to	O
enter	O
an	O
extension	O
phase	O
,	O
with	O
continuing	O
follow	B-T058
-	I-T058
up	I-T058
visits	I-T058
to	O
60	O
months	O
.	O
all	O
patients	O
undergoing	O
b	B-T058
-	I-T058
kp	I-T058
##ro	I-T058
surgery	I-T058
between	O
october	O
2008	O
and	O
december	O
2009	O
by	O
a	O
single	O
experienced	B-T097
surgeon	I-T097
at	O
the	O
centre	O
hospital	B-T092
##ier	I-T092
de	I-T092
l	I-T092
'	I-T092
univers	I-T092
##ite	I-T092
de	I-T092
mont	I-T092
##re	I-T092
##al	I-T092
using	O
an	O
allograft	B-T017
carrier	I-T017
were	O
considered	O
.	O
patients	O
were	O
excluded	O
if	O
they	O
had	O
previously	O
undergone	O
b	B-T074
-	I-T074
kp	I-T074
##ro	I-T074
implantation	B-T058
.	O
participants	B-T098
were	O
randomized	B-T033
individually	O
to	O
receive	O
a	O
b	B-T074
-	I-T074
kp	I-T074
##ro	I-T074
using	O
a	O
frozen	O
or	O
a	O
fresh	O
corneal	B-T017
graft	I-T017
carrier	I-T017
on	O
the	O
basis	O
of	O
tissue	B-T017
availability	O
on	O
the	O
day	O
of	O
surgery	B-T058
,	O
as	O
determined	O
by	O
the	O
local	O
eye	B-T092
bank	I-T092
.	O
the	O
primary	O
outcome	O
measure	O
was	O
device	B-T033
retention	I-T033
at	O
24	O
and	O
60	O
months	O
.	O
secondary	O
outcome	O
measures	O
included	O
surgical	B-T033
feasibility	I-T033
,	O
visual	B-T201
acuity	I-T201
(	O
va	B-T201
)	O
,	O
and	O
complications	B-T038
.	O
thirty	O
-	O
seven	O
eyes	B-T017
of	O
37	O
patients	O
were	O
enrolled	O
in	O
the	O
initial	O
study	B-T170
protocol	I-T170
,	O
with	O
19	O
eyes	B-T017
randomized	B-T062
to	O
fresh	O
and	O
18	O
to	O
frozen	O
carrier	B-T017
grafts	I-T017
.	O
thirty	O
-	O
six	O
eyes	B-T017
were	O
followed	O
through	O
to	O
24	O
months	O
,	O
with	O
1	O
lost	O
to	O
follow	B-T058
-	I-T058
up	I-T058
.	O
of	O
these	O
,	O
26	O
were	O
enrolled	O
in	O
the	O
extension	O
(	O
11	O
eyes	B-T017
with	O
a	O
frozen	O
and	O
15	O
eyes	B-T017
with	O
a	O
fresh	O
carrier	B-T017
graft	I-T017
)	O
.	O
there	O
were	O
no	O
differences	O
in	O
the	O
baseline	O
characteristics	O
of	O
patients	O
enrolled	O
in	O
the	O
extension	O
phase	O
versus	O
those	O
who	O
were	O
not	O
.	O
at	O
60	O
months	O
,	O
median	O
corrected	O
distance	O
va	B-T201
)	O
in	O
the	O
fresh	O
group	O
had	O
improved	B-T033
to	O
20	O
/	O
150	O
from	O
a	O
baseline	O
of	O
counting	O
fingers	O
,	O
whereas	O
the	O
frozen	O
group	O
improved	B-T033
to	O
20	O
/	O
400	O
from	O
a	O
baseline	O
of	O
hand	O
motions	O
.	O
device	B-T033
retention	I-T033
was	O
100	O
%	O
at	O
24	O
months	O
and	O
96	O
%	O
at	O
60	O
months	O
.	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
rate	O
of	O
complications	B-T038
between	O
groups	O
.	O
fresh	O
and	O
frozen	O
corneal	B-T098
donors	I-T098
offer	O
similar	O
clinical	O
outcomes	O
when	O
used	O
as	O
carriers	B-T017
for	O
the	O
b	B-T074
-	I-T074
kp	I-T074
##ro	I-T074
,	O
with	O
no	O
significant	O
differences	O
in	O
device	B-T033
retention	I-T033
,	O
visual	B-T033
rehabilitation	I-T033
,	O
or	O
rates	O
of	O
complications	B-T038
at	O
24	O
or	O
60	O
months	O
.	O

fluorescence	B-T058
hypers	I-T058
##pec	I-T058
##tral	I-T058
imaging	I-T058
(	O
fh	B-T058
##si	I-T058
)	O
using	O
a	O
spectral	O
##ly	O
resolved	B-T033
detector	B-T074
array	I-T074
the	O
ability	O
to	O
resolve	O
multiple	O
fluorescent	O
emissions	O
from	O
different	O
biological	O
targets	O
in	O
video	O
rate	O
applications	O
,	O
such	O
as	O
endoscopy	B-T058
and	O
intraoperative	B-T058
imaging	I-T058
,	O
has	O
traditionally	O
been	O
limited	O
by	O
the	O
use	O
of	O
filter	O
-	O
based	O
imaging	B-T074
systems	I-T074
.	I-T074
hypers	B-T058
##pec	I-T058
##tral	I-T058
imaging	I-T058
(	O
hs	B-T058
##i	I-T058
)	O
facilitates	O
the	O
detection	B-T058
of	O
both	O
spatial	B-T082
and	O
spectral	O
information	O
in	O
a	O
single	O
data	O
acquisition	O
,	O
however	O
,	O
instrumentation	O
for	O
hs	B-T058
##i	I-T058
is	O
typically	O
complex	O
,	O
bulky	O
and	O
expensive	O
.	O
we	O
sought	O
to	O
overcome	O
these	O
limitations	O
using	O
a	O
novel	O
robust	O
and	O
low	O
cost	O
hs	B-T058
##i	I-T058
camera	B-T074
based	O
on	O
a	O
spectral	B-T074
##ly	I-T074
resolved	I-T074
detector	I-T074
array	I-T074
(	O
sr	B-T074
##da	I-T074
)	O
.	O
we	O
integrated	O
this	O
hs	B-T058
##i	I-T058
camera	B-T074
into	O
a	O
wide	B-T033
-	I-T033
field	I-T033
reflectance	B-T058
-	I-T058
based	I-T058
imaging	O
system	O
operating	O
in	O
the	O
near	O
-	O
infrared	O
range	O
to	O
assess	O
the	O
suitability	O
for	O
in	B-T058
vivo	I-T058
imaging	I-T058
of	O
exogenous	O
fluorescent	B-T103
contrast	I-T103
agents	I-T103
.	O
using	O
this	O
fluorescence	B-T058
hs	I-T058
##i	I-T058
(	O
fh	B-T058
##si	I-T058
)	O
system	O
,	O
we	O
were	O
able	O
to	O
accurately	O
resolve	O
the	O
presence	O
and	O
concentration	O
of	O
at	O
least	O
7	O
fluorescent	B-T103
dyes	I-T103
in	O
solution	O
.	O
we	O
also	O
demonstrate	O
high	O
spectral	O
unm	O
##ix	O
##ing	O
precision	O
,	O
signal	O
linearity	O
with	O
dye	B-T103
concentration	O
and	O
at	O
depth	B-T082
in	O
tissue	B-T017
mimicking	O
phantoms	O
,	O
and	O
delineate	B-T033
4	O
fluorescent	B-T103
dyes	I-T103
in	B-T082
vivo	I-T082
.	O
our	O
approach	O
,	O
including	O
statistical	O
background	O
removal	O
,	O
could	O
be	O
directly	O
generalised	B-T082
to	O
broader	O
spectral	O
ranges	O
,	O
for	O
example	O
,	O
to	O
resolve	O
tissue	B-T017
reflectance	B-T058
or	O
autofluorescence	B-T058
and	O
in	O
future	O
be	O
tailored	O
to	O
video	O
rate	O
applications	O
requiring	O
snap	O
##sh	O
##ot	O
hs	B-T058
##i	I-T058
data	O
acquisition	O
.	O

efficient	O
genome	B-T062
editing	I-T062
of	O
differentiated	O
renal	B-T017
epithelial	B-T017
cells	I-T017
recent	O
advances	O
in	O
genome	B-T062
editing	I-T062
technologies	I-T062
have	O
enabled	O
the	O
rapid	O
and	O
precise	O
manipulation	O
of	O
genomes	O
,	O
including	O
the	O
targeted	B-T062
introduction	I-T062
,	O
alteration	B-T062
,	O
and	O
removal	B-T062
of	I-T062
genomic	I-T062
sequences	I-T062
.	O
however	O
,	O
respective	O
methods	B-T170
have	O
been	O
described	O
mainly	O
in	O
non	B-T170
-	I-T170
differentiated	I-T170
or	O
haploid	B-T017
cell	B-T170
types	I-T170
.	O
genome	B-T062
editing	I-T062
of	O
well	O
-	O
differentiated	O
renal	B-T017
epithelial	B-T017
cells	I-T017
has	O
been	O
hampered	O
by	O
a	O
range	O
of	O
technological	B-T033
issues	I-T033
,	O
including	O
optimal	O
design	O
,	O
efficient	O
expression	B-T062
of	I-T062
multiple	I-T062
genome	I-T062
editing	I-T062
constructs	I-T062
,	O
attain	O
##able	O
mutation	O
rates	O
,	O
and	O
best	O
screening	B-T170
strategies	I-T170
.	O
here	O
,	O
we	O
present	O
an	O
easily	O
implement	O
##able	O
workflow	O
for	O
the	O
rapid	O
generation	B-T062
of	I-T062
targeted	I-T062
heterozygous	I-T062
and	I-T062
homozygous	I-T062
genomic	I-T062
sequence	I-T062
alterations	I-T062
in	O
renal	B-T017
cells	B-T017
using	O
transcription	B-T103
activator	I-T103
-	I-T103
like	I-T103
effector	I-T103
nuclease	I-T103
##s	I-T103
(	O
tal	B-T103
##ens	I-T103
)	O
and	O
the	O
clustered	B-T103
regularly	I-T103
intersp	I-T103
##aced	I-T103
short	I-T103
pal	I-T103
##ind	I-T103
##romic	I-T103
repeat	I-T103
(	I-T103
crispr	I-T103
)	I-T103
system	I-T103
.	O
we	O
demonstrate	O
the	O
versatility	O
of	O
established	O
protocols	B-T170
by	O
generating	O
novel	O
cellular	O
models	O
for	O
studying	B-T062
autosomal	B-T017
dominant	I-T017
polycystic	I-T017
kidney	I-T017
disease	I-T017
(	O
adp	B-T017
##kd	I-T017
)	O
.	O
furthermore	O
,	O
we	O
show	O
that	O
cell	B-T062
culture	I-T062
-	I-T062
validated	I-T062
genetic	I-T062
modifications	I-T062
can	O
be	O
readily	O
applied	O
to	O
mouse	B-T017
embryonic	I-T017
stem	I-T017
cells	I-T017
(	O
mes	B-T017
##cs	I-T017
)	O
for	O
the	O
generation	O
of	O
corresponding	O
mouse	B-T204
models	B-T204
.	O
the	O
described	O
procedure	O
for	O
efficient	O
genome	B-T062
editing	I-T062
can	O
be	O
applied	O
to	O
any	O
cell	B-T170
type	I-T170
to	O
study	B-T062
physiological	B-T038
and	O
pathophysiological	B-T038
functions	I-T038
in	O
the	O
context	O
of	O
precisely	O
engineered	B-T017
genotypes	I-T017
.	O

c	B-T103
-	I-T103
5a	I-T103
-	I-T103
substituted	I-T103
valid	I-T103
##amine	I-T103
type	I-T103
glycos	B-T103
##idase	I-T103
inhibitors	I-T103
a	O
series	O
of	O
n	B-T103
-	I-T103
alkyl	I-T103
derivatives	I-T103
of	O
the	O
d	B-T103
-	I-T103
galactosidase	I-T103
inhibitor	B-T103
1	B-T103
,	I-T103
4	I-T103
-	I-T103
di	I-T103
-	I-T103
epi	I-T103
-	I-T103
valid	I-T103
##amine	I-T103
featuring	O
lipophilic	O
substituents	O
at	O
position	O
c	O
-	O
5a	O
was	O
prepared	O
and	O
screened	B-T058
for	O
their	O
glycos	B-T103
##idase	I-T103
inhibitory	B-T038
properties	I-T038
.	O
products	O
turned	O
out	O
selective	O
for	O
β	B-T103
-	I-T103
galactosidase	I-T103
##s	I-T103
as	O
well	O
as	O
β	B-T103
-	I-T103
glucosidase	I-T103
##s	I-T103
.	O

anatomic	O
assessment	B-T058
of	O
the	O
left	O
main	O
bifurcation	O
and	O
dynamic	O
bifurcation	O
angles	O
using	O
computed	B-T058
tomography	I-T058
angiography	I-T058
an	O
understanding	O
of	O
the	O
left	B-T017
main	I-T017
coronary	I-T017
artery	I-T017
(	O
lm	B-T017
##ca	I-T017
)	O
anatomy	B-T017
is	O
important	O
for	O
accurate	O
diagnosis	O
and	O
therapeutic	B-T058
.	O
we	O
aimed	O
to	O
investigate	O
lm	B-T017
##ca	I-T017
anatomy	B-T017
via	O
128	B-T058
-	I-T058
multis	I-T058
##lic	I-T058
##ed	I-T058
coronary	I-T058
computed	I-T058
-	I-T058
tomography	I-T058
-	I-T058
angiography	I-T058
(	O
cct	B-T058
##a	I-T058
)	O
in	O
patients	O
with	O
normal	O
lm	B-T017
##ca	I-T017
.	O
a	O
total	O
of	O
201	O
cct	B-T058
##a	I-T058
studies	B-T062
were	O
included	O
in	O
this	O
study	B-T062
.	O
anatomical	B-T017
features	I-T017
of	O
lm	B-T017
##ca	I-T017
including	O
cross	B-T082
-	I-T082
sectional	I-T082
areas	I-T082
of	O
the	O
lm	B-T017
##ca	I-T017
ost	B-T082
##ial	I-T082
,	O
lm	B-T017
##ca	I-T017
distal	B-T082
,	O
lad	B-T017
ost	I-T017
##ial	I-T017
and	O
lc	B-T017
##x	I-T017
ost	B-T082
##ial	I-T082
,	O
and	O
degree	O
of	O
tape	O
##ring	O
and	O
lm	B-T017
##ca	I-T017
bifurcation	O
angles	O
(	O
ba	O
)	O
in	O
the	O
form	O
of	O
lm	B-T017
##ca	I-T017
-	O
lc	B-T017
##x	I-T017
ba	O
,	O
lm	B-T017
##ca	I-T017
-	O
lad	B-T017
ba	O
,	O
lad	B-T017
-	O
lc	B-T017
##x	I-T017
ba	O
at	O
end	O
-	O
diastole	O
and	O
end	O
-	O
systole	O
.	O
the	O
mean	O
age	O
was	O
55	O
±	O
11	O
with	O
55	O
.	O
7	O
%	O
males	O
.	O
rca	B-T017
was	O
dominant	O
in	O
173	O
(	O
86	O
.	O
1	O
%	O
)	O
patients	O
.	O
mean	O
lm	B-T017
##ca	I-T017
length	O
was	O
10	O
.	O
0	O
##±4	O
.	O
5	O
mm	O
.	O
the	O
mean	O
values	O
of	O
lm	B-T017
##ca	I-T017
ost	B-T082
##ial	I-T082
,	O
lm	B-T017
##ca	I-T017
distal	B-T082
,	O
lad	B-T017
ost	I-T017
##ial	I-T017
and	O
lc	B-T017
##x	I-T017
ost	B-T082
##ial	I-T082
areas	B-T082
were	O
18	O
.	O
2	O
##±5	O
.	O
1	O
mm	O
##²	O
,	O
13	O
.	O
2	O
##±4	O
.	O
0	O
,	O
9	O
.	O
0	O
##±3	O
.	O
2	O
mm	O
##²	O
and	O
7	O
.	O
6	O
##±2	O
.	O
8	O
mm	O
##²	O
,	O
respectively	O
.	O
lm	B-T017
##ca	I-T017
ost	B-T082
##ial	I-T082
-	O
distal	B-T082
area	B-T082
,	O
lm	B-T017
##ca	I-T017
distal	B-T082
-	O
lad	B-T017
ost	I-T017
##ial	I-T017
area	B-T082
and	O
lm	B-T017
##ca	I-T017
distal	B-T082
-	O
lc	B-T017
##x	I-T017
ost	B-T082
##ial	I-T082
area	O
ratios	O
were	O
≥1	O
.	O
44	O
-	O
<	O
1	O
.	O
69	O
in	O
47	O
(	O
23	O
.	O
4	O
%	O
)	O
,	O
53	O
(	O
26	O
.	O
4	O
%	O
)	O
,	O
47	O
(	O
23	O
.	O
4	O
%	O
)	O
patients	O
,	O
respectively	O
,	O
and	O
were	O
≥1	O
.	O
69	O
-	O
<	O
1	O
.	O
96	O
in	O
19	O
(	O
9	O
.	O
5	O
%	O
)	O
,	O
24	O
(	O
11	O
.	O
9	O
%	O
)	O
,	O
40	O
(	O
19	O
.	O
9	O
%	O
)	O
patients	O
respectively	O
.	O
systolic	O
motion	O
modifies	O
lm	B-T017
##ca	I-T017
bas	O
;	O
systolic	O
motion	O
beg	O
##ets	O
an	O
increment	O
of	O
lm	B-T017
##ca	I-T017
-	O
lad	B-T017
angle	O
in	O
72	O
.	O
6	O
%	O
of	O
patients	O
and	O
decrement	O
of	O
lad	B-T017
-	O
lc	B-T017
##x	I-T017
angle	O
in	O
75	O
.	O
6	O
%	O
of	O
the	O
patients	O
.	O
patients	O
with	O
t	O
-	O
shaped	O
lad	B-T017
-	O
lc	B-T017
##x	I-T017
ba	O
was	O
shown	O
to	O
have	O
significantly	O
longer	O
lm	B-T017
##ca	I-T017
,	O
larger	O
lad	B-T017
ost	I-T017
##ial	I-T017
area	B-T082
,	O
larger	O
lc	B-T017
##x	I-T017
ost	B-T082
##ial	I-T082
area	B-T082
and	O
higher	O
diastolic	O
-	O
to	O
-	O
systolic	O
range	O
(	O
ds	O
##r	O
)	O
of	O
lad	B-T017
-	O
lc	B-T017
##x	I-T017
ba	O
compared	O
to	O
patients	O
with	O
y	O
-	O
shaped	O
lad	B-T017
-	O
lc	B-T017
##x	I-T017
ba	O
.	O
lm	B-T017
##ca	I-T017
with	O
t	B-T082
-	I-T082
shaped	I-T082
distal	I-T082
ba	O
was	O
found	O
to	O
have	O
significantly	O
longer	O
lm	B-T017
##ca	I-T017
,	O
larger	O
lad	B-T017
ost	I-T017
##ial	I-T017
area	B-T082
,	O
larger	O
lc	B-T017
##x	I-T017
ost	B-T082
##ial	I-T082
area	B-T082
and	O
higher	O
ds	O
##r	O
of	O
distal	B-T082
ba	O
compared	O
to	O
patients	O
with	O
y	B-T082
-	I-T082
shaped	I-T082
distal	I-T082
ba	O
.	O
these	O
findings	B-T033
may	O
provide	O
useful	O
information	O
for	O
lm	B-T017
##ca	I-T017
bifurcation	B-T058
stenting	I-T058
or	O
designing	O
dedicated	O
stents	B-T074
for	O
lm	B-T017
##ca	I-T017
.	O

next	B-T062
-	I-T062
generation	I-T062
sequencing	I-T062
approaches	O
to	O
define	O
the	O
role	O
of	O
the	O
autophagy	B-T038
lysosomal	I-T038
pathway	I-T038
in	O
human	B-T204
disease	B-T038
:	O
the	O
example	O
of	O
lys	B-T170
##ople	I-T170
##x	I-T170
next	B-T062
-	I-T062
generation	I-T062
sequencing	I-T062
(	I-T062
ngs	I-T062
)	I-T062
technologies	I-T062
have	O
deeply	O
changed	O
the	O
throughput	O
of	O
genetic	B-T058
testing	I-T058
allowing	O
analyzing	O
millions	O
of	O
dna	O
fragments	O
in	O
parallel	O
.	O
one	O
key	O
application	O
is	O
the	O
understanding	O
of	O
genetically	O
heterogeneous	B-T033
and	O
complex	B-T038
diseases	I-T038
where	O
50	O
-	O
100	O
different	O
genes	B-T017
may	O
converge	O
to	O
control	O
the	O
same	O
pathways	B-T038
.	O
these	O
disorders	B-T038
cann	O
##ot	O
be	O
studied	O
using	O
traditional	O
approaches	O
,	O
based	O
on	O
gene	B-T062
-	I-T062
by	I-T062
-	I-T062
gene	I-T062
san	I-T062
##ger	I-T062
sequencing	I-T062
.	O
we	O
have	O
set	O
up	O
an	O
ngs	B-T062
protocol	B-T170
based	O
on	O
a	O
specific	O
selection	O
of	O
dna	B-T103
regions	I-T103
belonging	O
to	O
about	O
900	O
genes	B-T017
of	O
the	O
autophagy	B-T038
-	I-T038
lysosomal	I-T038
(	I-T038
alp	I-T038
)	I-T038
pathway	I-T038
.	O
we	O
here	O
specify	O
all	O
the	O
technical	O
steps	O
and	O
challenges	B-T058
of	O
our	O
protocol	B-T170
,	O
named	O
lys	B-T170
##ople	I-T170
##x	I-T170
.	O
this	O
is	O
based	O
on	O
the	O
halo	O
##plex	O
technology	O
and	O
together	O
with	O
high	O
-	O
coverage	O
sequencing	O
empower	O
##s	O
a	O
high	O
and	O
uniform	O
coverage	O
of	O
alp	B-T017
genes	I-T017
.	O
lys	B-T170
##ople	I-T170
##x	I-T170
out	O
##pl	O
##ays	O
other	O
ngs	B-T062
applications	O
in	O
sensitivity	O
and	O
specificity	O
,	O
providing	O
an	O
accurate	O
picture	O
of	O
all	O
variations	O
in	O
alp	B-T017
genes	I-T017
.	O

bilirubin	B-T103
and	O
atherosclerotic	B-T038
diseases	B-T038
bilirubin	B-T103
is	O
the	O
final	O
product	O
of	O
heme	B-T038
catabolism	I-T038
in	O
the	O
systemic	O
circulation	O
.	O
for	O
decades	O
,	O
increased	O
serum	B-T031
/	O
plasma	B-T031
bilirubin	B-T103
levels	O
were	O
considered	O
an	O
om	O
##inous	O
sign	B-T033
of	O
an	O
underlying	O
liver	B-T038
disease	I-T038
.	O
however	O
,	O
data	O
from	O
recent	O
years	O
convincing	O
##ly	O
suggest	O
that	O
mildly	O
elevated	O
bilirubin	B-T103
concentrations	O
are	O
associated	O
with	O
protection	O
against	O
various	O
oxidative	B-T038
stress	I-T038
-	O
mediated	O
diseases	B-T038
,	O
atherosclerotic	B-T038
conditions	O
being	O
the	O
most	O
clinically	O
relevant	O
.	O
although	O
scarce	O
data	O
on	O
beneficial	O
effects	O
of	O
bilirubin	B-T103
had	O
been	O
published	O
also	O
in	O
the	O
past	O
,	O
it	O
took	O
until	O
1994	O
when	O
the	O
first	O
clinical	B-T062
study	I-T062
demonstrated	O
an	O
increased	O
risk	O
of	O
coronary	B-T038
heart	I-T038
disease	I-T038
in	O
subjects	O
with	O
low	O
serum	B-T031
bilirubin	B-T103
levels	O
,	O
and	O
bilirubin	B-T103
was	O
found	O
to	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
atherosclerotic	B-T038
diseases	B-T038
independent	O
of	O
standard	O
risk	B-T033
factors	I-T033
.	O
consistent	O
with	O
these	O
results	O
,	O
we	O
proved	O
in	O
our	O
own	O
studies	B-T062
,	O
that	O
subjects	O
with	O
mild	O
elevation	O
of	O
serum	O
levels	O
of	O
uncon	O
##jugated	O
bilirubin	O
(	O
benign	O
hyperbil	B-T038
##irubin	I-T038
##emia	I-T038
,	O
gil	B-T038
##bert	I-T038
syndrome	I-T038
)	O
have	O
much	O
lower	O
prevalence	O
/	O
incidence	O
of	O
coronary	B-T038
heart	I-T038
as	O
well	O
as	O
peripheral	B-T038
vascular	I-T038
disease	I-T038
.	O
we	O
have	O
also	O
demonstrated	O
that	O
this	O
association	O
is	O
even	O
more	O
general	O
,	O
with	O
serum	B-T031
bilirubin	B-T103
being	O
a	O
biomarker	B-T201
of	O
numerous	O
other	O
diseases	B-T038
,	O
often	O
associated	O
with	O
increased	O
risk	O
of	O
atherosclerosis	B-T038
.	O
in	O
addition	O
,	O
very	O
recent	O
data	O
have	O
demonstrated	O
biological	B-T038
pathways	I-T038
modulated	O
by	O
bilirubin	B-T103
,	O
which	O
are	O
responsible	O
for	O
observed	O
strong	O
clinical	O
associations	O
.	O

correlation	O
of	O
cardiopulmonary	B-T058
exercise	I-T058
testing	I-T058
parameters	O
with	O
quality	O
of	O
life	O
in	O
stable	B-T033
copd	B-T038
patients	O
the	O
precise	O
head	O
to	O
head	O
relationships	O
between	O
cardio	B-T058
-	I-T058
pulmonary	I-T058
exercise	I-T058
testing	I-T058
(	O
cpe	B-T058
##t	I-T058
)	O
parameters	O
and	O
patients	O
'	O
daily	B-T033
symptoms	I-T033
/	O
activities	O
and	O
the	O
disease	B-T038
social	O
/	O
emotional	B-T201
impact	I-T201
are	O
less	O
well	O
defined	O
.	O
in	O
this	O
study	O
,	O
the	O
correlation	O
of	O
copd	B-T038
daily	B-T033
symptoms	I-T033
and	O
quality	O
of	O
life	O
[	O
assessed	O
by	O
st	B-T170
.	I-T170
geor	I-T170
##ge	I-T170
'	I-T170
s	I-T170
respiratory	I-T170
questionnaire	I-T170
(	O
sg	B-T170
##r	I-T170
##q	I-T170
)	O
]	O
and	O
copd	B-T038
severity	B-T170
index	I-T170
(	O
bod	B-T170
##e	I-T170
-	I-T170
index	I-T170
)	O
with	O
cpe	B-T058
##t	I-T058
parameters	O
were	O
investigated	O
.	O
symptom	B-T033
-	O
limited	O
cpe	B-T058
##t	I-T058
was	O
performed	O
in	O
37	O
consecutive	O
copd	B-T038
(	O
gold	O
i	O
-	O
iii	O
)	O
subjects	O
during	O
non	O
-	O
exacerbation	B-T038
phase	O
.	O
the	O
sg	B-T170
##r	I-T170
##q	I-T170
was	O
also	O
completed	O
by	O
each	O
patient	O
.	O
sg	B-T201
##r	I-T201
##q	I-T201
-	I-T201
score	I-T201
correlated	O
negatively	B-T033
with	O
fev1	B-T058
(	O
r	O
=	O
-	O
0	O
.	O
49	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
predicted	O
maximal	B-T033
work	I-T033
-	I-T033
rate	I-T033
(	O
%	B-T033
wr	I-T033
-	I-T033
max	I-T033
)	O
(	O
r	O
=	O
-	O
0	O
.	O
44	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
v	B-T033
'	I-T033
o2	I-T033
/	O
wr	B-T201
(	O
r	O
=	O
-	O
0	O
.	O
52	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
breathing	O
reserve	O
(	O
r	O
=	O
-	O
0	O
.	O
50	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
however	O
it	O
did	B-T033
not	I-T033
correlate	I-T033
with	O
peak	B-T033
-	I-T033
v	I-T033
'	I-T033
o2	I-T033
%	O
predicted	O
(	O
r	O
=	O
-	O
0	O
.	O
27	O
,	O
p	O
=	O
0	O
.	O
10	O
)	O
.	O
in	O
20	O
(	O
54	O
.	O
1	O
%	O
)	O
subjects	O
in	O
which	O
leg	O
fatigue	O
was	O
the	O
main	O
cause	O
for	O
stopping	O
the	O
test	O
,	O
peak	B-T033
-	I-T033
v	I-T033
'	I-T033
o2	I-T033
,	O
%	B-T033
wr	I-T033
-	I-T033
max	I-T033
,	O
hr	O
-	O
reserve	O
and	O
breathing	O
reserve	O
were	O
higher	O
(	O
p	O
=	O
0	O
.	O
04	O
,	O
<	O
0	O
.	O
01	O
,	O
0	O
.	O
04	O
and	O
<	O
0	O
.	O
01	O
respectively	O
)	O
than	O
the	O
others	O
.	O
there	O
was	O
also	O
a	O
significant	O
correlation	O
between	O
bod	B-T170
##e	I-T170
-	I-T170
index	I-T170
and	O
∆	B-T033
##vo	I-T033
##2	I-T033
/	O
∆	B-T201
##wr	I-T201
(	O
r	O
=	O
-	O
0	O
.	O
64	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
breathing	O
-	O
reserve	O
(	O
r	O
=	O
-	O
0	O
.	O
38	O
,	O
p	O
=	O
0	O
.	O
018	O
)	O
.	O
the	O
observed	O
relationships	O
between	O
cpe	B-T058
##t	I-T058
parameter	O
and	O
daily	O
subjective	B-T038
complaints	I-T038
in	O
copd	B-T038
were	O
not	O
strong	O
.	O
those	O
who	O
discontinued	O
the	O
cpe	B-T058
##t	I-T058
because	O
of	O
leg	O
fatigue	O
were	O
in	O
the	O
earlier	O
stages	O
of	O
copd	B-T038
.	O
significant	O
negative	B-T033
correlation	O
between	O
∆	B-T033
##vo	I-T033
##2	I-T033
/	O
∆	B-T201
##wr	I-T201
and	O
bod	B-T170
##e	I-T170
-	I-T170
index	I-T170
suggests	O
that	O
along	O
with	O
copd	B-T038
progression	B-T038
,	O
regardless	O
of	O
negative	O
past	O
history	O
,	O
other	O
comorbidities	O
such	O
as	O
cardiac	O
/	O
musculoskeletal	B-T033
problems	I-T033
should	O
be	O
sought	O
.	O

the	O
clinical	O
and	O
economic	O
burden	O
of	O
significant	O
bleeding	B-T038
during	O
lung	B-T058
resection	I-T058
surgery	I-T058
:	O
a	O
retrospective	B-T062
matched	I-T062
cohort	I-T062
analysis	I-T062
of	O
real	O
-	O
world	B-T098
data	O
the	O
objective	O
of	O
this	O
retrospective	B-T062
study	I-T062
was	O
to	O
quantify	O
the	O
clinical	O
and	O
economic	O
burden	O
of	O
significant	O
bleeding	B-T038
in	O
lung	B-T058
resection	I-T058
surgery	I-T058
in	O
the	O
us	B-T082
.	O
this	O
study	B-T062
utilized	O
2009	O
-	O
2012	O
data	O
from	O
the	O
prem	B-T170
##ier	I-T170
perspective	I-T170
database	I-T170
(	I-T170
tm	I-T170
)	I-T170
.	O
adult	O
patients	O
with	O
primary	B-T058
pulmonary	I-T058
lobectomy	I-T058
or	O
segment	B-T058
##ectomy	I-T058
procedures	I-T058
were	O
categorized	O
by	O
the	O
surgical	O
approach	O
(	O
vats	B-T058
vs	O
open	B-T058
)	O
and	O
primary	O
diagnosis	O
(	O
primary	B-T058
or	O
metastatic	B-T058
lung	I-T058
cancer	I-T058
vs	O
non	B-T058
-	I-T058
lung	I-T058
cancer	I-T058
)	O
.	O
patients	O
requiring	O
≥3	O
units	O
of	O
blood	B-T103
products	I-T103
with	O
at	O
least	O
1	O
unit	O
of	O
prb	B-T103
##cs	I-T103
:	O
[UNK]	O
significant	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
;	O
those	O
requiring	O
<	O
3	O
units	O
:	O
[UNK]	O
non	B-T033
-	I-T033
significant	I-T033
bleeding	B-T038
[UNK]	O
cohort	B-T098
;	O
and	O
those	O
not	O
requiring	O
blood	B-T103
products	I-T103
:	O
[UNK]	O
no	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
.	O
a	O
matched	O
cohort	B-T062
analysis	I-T062
was	O
performed	O
between	O
the	O
[UNK]	O
significant	O
bleeding	B-T038
[UNK]	O
and	O
the	O
[UNK]	O
no	O
bleeding	B-T038
cohort	B-T098
[UNK]	O
using	O
matching	O
variables	O
:	O
hospital	B-T092
,	O
lung	B-T058
cancer	I-T058
diagnosis	I-T058
,	O
year	O
of	O
surgery	O
,	O
apr	O
-	O
drg	O
severity	O
score	O
,	O
procedure	B-T201
type	I-T201
and	O
approach	O
,	O
age	O
,	O
and	O
gender	O
.	O
the	O
[UNK]	O
all	O
-	O
patient	O
[UNK]	O
cohort	B-T098
comprised	O
21	O
,	O
42	O
##9	O
patients	O
:	O
213	O
[UNK]	O
significant	O
bleeding	B-T038
[UNK]	O
;	O
2	O
,	O
780	O
[UNK]	O
non	B-T033
-	I-T033
significant	I-T033
bleeding	B-T038
[UNK]	O
;	O
and	O
18	O
,	O
43	O
##6	O
[UNK]	O
no	O
bleeding	B-T038
[UNK]	O
.	O
overall	O
incidence	O
of	O
significant	O
chest	B-T082
bleeding	B-T038
was	O
0	O
.	O
99	O
%	O
.	O
patients	O
from	O
[UNK]	O
significant	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
and	O
[UNK]	O
non	B-T033
-	I-T033
significant	I-T033
bleeding	B-T038
[UNK]	O
cohort	B-T098
had	O
2	O
.	O
5	O
days	O
and	O
2	O
days	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
longer	O
length	O
of	O
stay	O
in	O
the	O
hospital	B-T092
compared	O
to	O
those	O
in	O
the	O
[UNK]	O
no	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
,	O
respectively	O
.	O
overall	O
,	O
hospital	O
costs	O
for	O
[UNK]	O
significant	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
were	O
higher	O
than	O
[UNK]	O
no	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
for	O
those	O
who	O
were	O
covered	O
under	O
medicare	O
(	O
$	O
59	O
,	O
87	O
##1	O
vs	O
$	O
23	O
,	O
64	O
##1	O
)	O
,	O
were	O
≥	O
##76	O
years	O
of	O
age	O
(	O
$	O
64	O
,	O
010	O
vs	O
$	O
24	O
,	O
243	O
)	O
,	O
had	O
greater	O
severity	O
of	O
illness	O
(	O
$	O
97	O
,	O
81	O
##3	O
vs	O
$	O
51	O
,	O
87	O
##1	O
)	O
and	O
underwent	O
open	O
segment	B-T058
##ectomy	I-T058
(	O
$	O
74	O
,	O
220	O
vs	O
$	O
21	O
,	O
90	O
##3	O
)	O
.	O
hospital	O
costs	O
for	O
[UNK]	O
significant	O
bleeding	B-T038
[UNK]	O
cohort	B-T098
and	O
[UNK]	O
non	B-T033
-	I-T033
significant	I-T033
bleeding	B-T038
[UNK]	O
were	O
significantly	O
higher	O
(	O
$	O
11	O
,	O
58	O
##9	O
and	O
$	O
5	O
,	O
280	O
,	O
respectively	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
than	O
no	O
bleeding	B-T038
cohort	B-T098
.	O
although	O
significant	O
bleeding	B-T038
during	O
lung	B-T058
resection	I-T058
surgery	I-T058
is	O
rare	O
,	O
patients	O
with	O
such	O
complication	B-T038
could	O
stay	O
longer	O
at	O
the	O
hospital	B-T092
and	O
cost	O
an	O
average	O
of	O
$	O
13	O
,	O
103	O
more	O
than	O
those	O
without	O
.	O

surgical	B-T058
excision	I-T058
of	O
heterotopic	B-T038
ossification	I-T038
leads	O
to	O
re	O
-	O
emergence	O
of	O
mesenchymal	B-T017
stem	I-T017
cell	I-T017
populations	I-T017
responsible	O
for	O
recurrence	O
trauma	O
-	O
induced	O
heterotopic	B-T038
ossification	I-T038
(	O
ho	B-T038
)	O
occurs	O
after	O
severe	O
musculoskeletal	B-T037
injuries	I-T037
and	O
burns	B-T037
,	O
and	O
presents	O
a	O
significant	O
barrier	O
to	O
patient	O
rehabilitation	B-T058
.	O
interestingly	O
,	O
the	O
incidence	O
of	O
ho	B-T038
significantly	O
increases	O
with	O
repeated	B-T058
operations	I-T058
and	O
after	O
resection	B-T058
of	O
previous	O
ho	B-T038
.	O
treatment	B-T058
of	O
established	O
heterotopic	B-T038
ossification	I-T038
is	O
challenging	O
because	O
surgical	B-T058
excision	I-T058
is	O
often	O
incomplete	O
,	O
with	O
evidence	O
of	O
persistent	O
heterotopic	O
bone	O
.	O
as	O
a	O
result	O
,	O
patients	O
may	O
continue	O
to	O
report	O
the	O
signs	B-T033
or	I-T033
symptoms	I-T033
of	O
ho	B-T038
,	O
including	O
chronic	B-T033
pain	I-T033
,	O
nonh	O
##eal	O
##ing	O
wounds	B-T037
,	O
and	O
joint	B-T033
restriction	I-T033
.	O
in	O
this	O
study	B-T062
,	O
we	O
designed	O
a	O
model	B-T038
of	O
recurrent	O
ho	B-T038
that	O
occurs	O
after	O
surgical	B-T058
excision	I-T058
of	O
mature	O
ho	B-T038
in	O
a	O
mouse	B-T038
model	I-T038
of	O
hind	B-T017
-	I-T017
limb	I-T017
achilles	I-T017
'	I-T017
tendon	I-T017
transection	B-T058
with	O
dorsal	B-T082
burn	B-T037
injury	I-T037
.	O
we	O
first	O
demonstrated	O
that	O
key	O
signaling	B-T038
mediators	B-T103
of	O
ho	B-T038
,	O
including	O
bone	B-T038
morphogenetic	I-T038
protein	I-T038
signaling	I-T038
,	O
are	O
diminished	O
in	O
mature	B-T017
bone	I-T017
.	O
however	O
,	O
upon	O
surgical	B-T058
excision	I-T058
,	O
we	O
have	O
noted	O
upregulation	B-T038
of	O
downstream	B-T082
mediators	B-T103
of	O
osteogenic	O
differentiation	O
,	O
including	O
psma	B-T103
##d	I-T103
1	I-T103
/	O
5	B-T103
.	O
additionally	O
,	O
surgical	B-T058
excision	I-T058
resulted	O
in	O
re	O
-	O
emergence	O
of	O
a	O
mesenchymal	B-T017
cell	I-T017
population	I-T017
marked	O
by	O
expression	O
of	O
platelet	B-T103
-	I-T103
derived	I-T103
growth	I-T103
factor	I-T103
receptor	I-T103
-	I-T103
α	I-T103
(	O
pdgf	B-T103
##r	I-T103
##α	I-T103
)	O
and	O
present	B-T033
in	O
the	O
initial	O
developing	O
ho	B-T038
lesion	B-T033
but	O
absent	O
in	O
mature	O
ho	B-T038
.	O
in	O
the	O
recurrent	O
lesion	B-T033
,	O
these	O
pdgf	B-T103
##r	I-T103
##α	I-T103
+	O
mesenchymal	B-T017
cells	I-T017
are	O
also	O
highly	O
proliferative	B-T038
,	O
similar	O
to	O
the	O
initial	O
developing	O
ho	B-T038
lesion	B-T033
.	O
these	O
findings	O
indicate	O
that	O
surgical	B-T058
excision	I-T058
of	O
ho	B-T038
results	O
in	O
recurrence	O
through	O
similar	O
mesenchymal	B-T017
cell	I-T017
populations	I-T017
and	O
signaling	B-T038
mechanisms	O
that	O
are	O
present	B-T033
in	O
the	O
initial	O
developing	O
ho	B-T038
lesion	B-T033
.	O
these	O
results	O
are	O
consistent	O
with	O
findings	B-T033
in	O
patients	O
that	O
new	O
foci	B-T082
of	O
ectopic	B-T017
bone	I-T017
can	O
develop	O
in	O
excision	B-T058
sites	B-T082
and	O
are	O
likely	O
related	O
to	O
de	O
novo	O
formation	O
rather	O
than	O
extension	O
of	O
unres	B-T170
##ected	I-T170
bone	B-T017
.	O
stem	O
cells	O
translational	O
medicine	O
2017	O
;	O
6	O
:	O
79	O
##9	O
-	O
80	O
##6	O
.	O

basal	B-T082
ryanodine	B-T038
receptor	I-T038
activity	I-T038
suppresses	O
autophagic	B-T017
flux	O
the	O
inositol	B-T103
1	I-T103
,	I-T103
4	I-T103
,	I-T103
5	I-T103
-	I-T103
trisphosphate	I-T103
receptors	I-T103
(	O
ip3	B-T103
##rs	I-T103
)	O
and	O
intracellular	B-T038
ca	I-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
signaling	I-T038
are	O
critically	O
involved	O
in	O
regulating	B-T038
different	O
steps	O
of	O
autophagy	B-T038
,	O
a	O
lysosomal	B-T017
degradation	O
pathway	O
.	O
the	O
ryanodine	B-T103
receptors	I-T103
(	O
ryr	B-T103
)	O
,	O
intracellular	B-T038
ca	I-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
-	I-T038
release	I-T038
channels	I-T038
mainly	O
expressed	B-T038
in	O
excit	B-T033
##able	I-T033
cell	B-T170
types	I-T170
including	O
muscle	B-T017
and	O
neurons	B-T017
,	O
have	O
however	O
not	O
yet	O
been	O
extensively	O
studied	B-T062
in	O
relation	O
to	O
autophagy	B-T038
.	O
yet	O
,	O
aberrant	O
expression	B-T038
and	O
excessive	O
activity	O
of	O
ryr	B-T103
##s	I-T103
in	O
these	O
tissues	B-T017
has	O
been	O
implicated	O
in	O
the	O
onset	O
of	O
several	O
diseases	B-T038
including	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
,	O
where	O
impaired	O
autophagy	B-T038
regulation	B-T038
contributes	O
to	O
the	O
pathology	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
determined	B-T058
whether	O
pharmacological	B-T038
ryr	B-T103
inhibition	O
could	O
modulate	B-T082
autophagic	B-T017
flux	O
in	O
ectopic	B-T082
ryr	B-T103
-	O
expressing	B-T038
models	B-T170
,	O
like	O
hek293	B-T017
cells	I-T017
and	O
in	O
cell	B-T170
types	I-T170
that	O
endogenously	O
express	B-T038
ryr	B-T103
s	O
,	O
like	O
c2	B-T017
##c12	I-T017
myoblasts	I-T017
and	O
primary	O
hippocampal	B-T017
neurons	B-T017
.	O
importantly	O
,	O
ryr	B-T103
##3	I-T103
overexpression	B-T038
in	O
hek293	B-T017
cells	I-T017
impaired	O
the	O
autophagic	B-T017
flux	O
.	O
conversely	O
,	O
in	O
all	O
cell	B-T017
models	B-T170
tested	O
,	O
pharmacological	B-T038
inhibition	O
of	O
endogenous	O
or	O
ectopic	B-T082
##ally	I-T082
expressed	B-T038
ryr	B-T103
##s	I-T103
,	O
using	O
dan	B-T103
##tr	I-T103
##ole	I-T103
##ne	I-T103
or	O
ryanodine	B-T103
,	O
augmented	O
autophagic	B-T017
flux	O
by	O
increasing	O
lysosomal	B-T017
turn	B-T038
-	I-T038
over	I-T038
(	O
number	O
of	O
autophag	B-T017
##osomes	I-T017
and	O
auto	B-T017
##lys	I-T017
##osomes	I-T017
measured	O
as	O
mch	B-T103
##erry	I-T103
-	O
lc3	B-T103
punct	I-T103
##ae	I-T103
/	O
cell	B-T017
increased	O
from	O
70	O
.	O
37	O
##±7	O
.	O
81	O
in	O
control	O
hek	B-T017
ryr	I-T017
##3	I-T017
cells	I-T017
to	O
111	O
.	O
18	O
##±7	O
.	O
72	O
and	O
98	O
.	O
14	O
##±7	O
.	O
31	O
after	O
dan	B-T103
##tr	I-T103
##ole	I-T103
##ne	I-T103
and	O
ryanodine	B-T103
treatments	B-T058
,	O
respectively	O
)	O
.	O
moreover	O
,	O
in	O
differentiated	B-T038
c2	B-T017
##c12	I-T017
cells	I-T017
,	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
demonstrated	O
that	O
dan	B-T103
##tr	I-T103
##ole	I-T103
##ne	I-T103
treatment	B-T058
decreased	O
the	O
number	O
of	O
early	O
autophagic	B-T017
vacuoles	B-T017
from	O
5	O
.	O
9	O
##±2	O
.	O
97	O
to	O
1	O
.	O
8	O
##±1	O
.	O
03	O
per	O
cellular	B-T017
cross	B-T082
section	I-T082
.	O
the	O
modulation	O
of	O
the	O
autophagic	B-T017
flux	O
could	O
be	O
linked	O
to	O
the	O
functional	O
inhibition	O
of	O
ryr	B-T103
channels	I-T103
as	O
both	O
ryr	B-T103
inhibitors	B-T103
efficiently	O
diminished	O
the	O
number	O
of	O
cells	B-T017
showing	O
spontaneous	O
ryr	B-T103
##3	I-T103
activity	O
in	O
the	O
hek293	B-T017
cell	I-T017
model	B-T170
(	O
from	O
41	O
.	O
14	O
%	O
±	O
##2	O
.	O
12	O
in	O
control	O
cells	B-T017
to	O
18	O
.	O
70	O
%	O
±	O
##2	O
.	O
25	O
and	O
9	O
.	O
74	O
%	O
±	O
##2	O
.	O
67	O
after	O
dan	B-T103
##tr	I-T103
##ole	I-T103
##ne	I-T103
and	O
ryanodine	B-T103
treatments	B-T058
,	O
respectively	O
)	O
.	O
in	O
conclusion	O
,	O
basal	B-T082
ryr	B-T103
-	O
mediated	O
ca	B-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
-	I-T038
release	I-T038
events	I-T038
suppress	O
autophagic	B-T017
flux	O
at	O
the	O
level	O
of	O
the	O
lysosomes	B-T017
.	O

fgf	B-T103
##21	I-T103
is	O
a	O
biomarker	B-T201
for	O
mitochondrial	B-T038
translation	I-T038
and	O
mtdna	B-T103
maintenance	O
disorders	B-T038
to	O
validate	O
new	O
mitochondrial	B-T017
myopathy	I-T017
serum	B-T031
biomarkers	B-T201
for	O
diagnostic	B-T058
use	I-T058
.	O
we	O
analyzed	B-T062
serum	B-T031
fgf	B-T103
##21	I-T103
(	O
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
)	O
and	O
gdf	B-T103
##15	I-T103
from	O
patients	O
with	O
(	O
1	O
)	O
mitochondrial	B-T038
diseases	I-T038
and	O
(	O
2	O
)	O
nonm	B-T038
##ito	I-T038
##ch	I-T038
##ondr	I-T038
##ial	I-T038
disorders	I-T038
partially	O
overlapping	O
with	O
mitochondrial	B-T038
disorder	I-T038
phenotypes	O
.	O
we	O
(	O
3	O
)	O
did	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
in	O
mitochondrial	B-T038
disease	I-T038
and	O
(	O
4	O
)	O
analyzed	B-T062
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
and	O
skeletal	B-T017
muscle	I-T017
fgf	B-T103
##21	I-T103
expression	B-T038
in	O
6	O
mouse	B-T204
models	B-T204
with	O
different	O
muscle	B-T017
-	O
manifesting	O
mitochondrial	B-T033
dysfunctions	I-T033
.	O
we	O
report	O
that	O
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
consistently	O
increases	O
in	O
primary	O
mitochondrial	B-T017
myopathy	I-T017
,	O
especially	O
in	O
patients	O
with	O
mitochondrial	B-T038
translation	I-T038
defects	B-T017
or	O
mitochondrial	B-T033
dna	I-T033
(	I-T033
mtdna	I-T033
)	I-T033
deletions	I-T033
(	O
67	O
##5	O
and	O
34	O
##7	O
pg	O
/	O
ml	O
,	O
respectively	O
;	O
controls	O
:	O
66	O
pg	O
/	O
ml	O
,	O
p	O
<	O
0	O
.	O
0001	O
for	O
both	O
)	O
.	O
this	O
is	O
corroborated	O
in	O
mice	B-T204
(	O
mtdna	B-T033
deletions	I-T033
1	O
,	O
163	O
vs	O
37	O
##9	O
pg	O
/	O
ml	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
however	O
,	O
patients	O
and	O
mice	B-T204
with	O
structural	B-T017
respiratory	I-T017
chain	I-T017
subunit	I-T017
or	I-T017
assembly	I-T017
factor	I-T017
defects	I-T017
showed	O
low	O
induction	O
(	O
human	B-T204
335	O
pg	O
/	O
ml	O
,	O
p	O
<	O
0	O
.	O
05	O
;	O
mice	B-T204
335	O
pg	O
/	O
ml	O
,	O
not	B-T033
significant	I-T033
)	O
.	O
overall	O
specificities	O
of	O
fgf	B-T103
##21	I-T103
and	O
gdf	B-T103
##15	I-T103
to	O
find	O
patients	O
with	O
mitochondrial	B-T017
myopathy	I-T017
were	O
89	O
.	O
3	O
%	O
vs	O
86	O
.	O
4	O
%	O
,	O
and	O
sensitivities	O
67	O
.	O
3	O
%	O
and	O
76	O
.	O
0	O
%	O
,	O
respectively	O
.	O
however	O
,	O
gdf	B-T103
##15	I-T103
was	O
increased	O
also	O
in	O
a	O
wide	O
range	O
of	O
nonm	O
##ito	O
##ch	O
##ondr	O
##ial	O
conditions	O
.	O
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
is	O
a	O
specific	O
biomarker	B-T201
for	O
muscle	B-T017
-	O
manifesting	O
defects	B-T017
of	O
mitochondrial	B-T038
translation	I-T038
,	O
including	O
mitochondrial	B-T017
transfer	B-T103
-	I-T103
rna	I-T103
mutations	B-T038
and	O
primary	O
and	O
secondary	O
mtdna	B-T033
deletions	I-T033
,	O
the	O
most	O
common	O
causes	O
of	O
mitochondrial	B-T038
disease	I-T038
.	O
however	O
,	O
normal	O
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
does	O
not	B-T033
exclude	O
structural	B-T017
respiratory	I-T017
chain	I-T017
complex	I-T017
or	I-T017
assembly	I-T017
factor	I-T017
defects	I-T017
,	O
important	O
to	O
acknowled	O
##ge	O
in	O
diagnostics	B-T058
.	O
this	O
study	B-T062
provides	O
class	B-T170
iii	I-T170
evidence	O
that	O
elevated	O
s	B-T103
-	I-T103
fgf	I-T103
##21	I-T103
accurately	O
distinguishes	O
patients	O
with	O
mitochondrial	B-T017
myo	I-T017
##path	I-T017
##ies	I-T017
from	O
patients	O
with	O
other	O
conditions	O
,	O
and	O
fgf	B-T103
##21	I-T103
and	O
gdf	B-T103
##15	I-T103
mitochondrial	B-T017
myopathy	I-T017
from	O
other	O
myo	B-T038
##path	I-T038
##ies	I-T038
.	O

visual	B-T058
analytic	I-T058
##s	I-T058
for	O
pattern	B-T038
discovery	I-T038
in	O
home	B-T058
care	I-T058
.	O
clinical	O
relevance	O
for	O
quality	O
improvement	O
visualization	B-T038
can	O
reduce	O
the	O
cognitive	O
load	O
of	O
information	O
,	O
allowing	O
users	O
to	O
easily	O
interpret	O
and	O
assess	O
large	O
amounts	O
of	O
data	O
.	O
the	O
purpose	O
of	O
our	O
study	O
was	O
to	O
examine	O
home	B-T170
health	I-T170
data	I-T170
using	O
visual	B-T058
analysis	I-T058
techniques	I-T058
to	O
discover	O
clinically	O
salient	O
associations	O
between	O
patient	O
characteristics	O
with	O
problem	O
-	O
oriented	O
health	O
outcomes	O
of	O
older	B-T058
adult	I-T058
home	I-T058
health	I-T058
patients	I-T058
during	O
the	O
home	B-T058
health	I-T058
service	I-T058
period	O
.	O
knowledge	B-T170
,	O
behavior	O
and	O
status	O
ratings	O
at	O
discharge	B-T058
as	O
well	O
as	O
change	O
from	O
admission	B-T058
to	O
discharge	B-T058
that	O
was	O
coded	O
using	O
the	O
om	B-T170
##ah	I-T170
##a	I-T170
system	I-T170
was	O
collected	O
from	O
a	O
dataset	B-T170
on	O
98	O
##8	O
de	O
-	O
identified	O
patient	O
data	O
from	O
15	O
home	B-T092
health	I-T092
agencies	I-T092
.	O
spss	B-T170
visualization	I-T170
design	I-T170
##er	I-T170
v1	I-T170
.	I-T170
0	I-T170
was	O
used	O
to	O
visually	B-T058
analyze	I-T058
patterns	I-T058
between	O
independent	O
and	O
outcome	O
variables	O
using	O
heat	O
maps	O
and	O
histograms	O
.	O
visualization	B-T038
##s	I-T038
suggesting	O
clinical	B-T033
salience	I-T033
were	O
tested	O
for	O
significance	O
using	O
correlation	B-T062
analysis	I-T062
.	O
the	O
mean	O
age	O
of	O
the	O
patients	O
was	O
80	O
years	O
,	O
with	O
the	O
majority	O
female	O
(	O
66	O
%	O
)	O
.	O
of	O
the	O
150	O
visualization	B-T038
##s	I-T038
,	O
69	O
potentially	O
meaningful	O
patterns	O
were	O
statistically	O
evaluated	O
through	O
bivariate	O
associations	O
,	O
revealing	O
21	O
significant	O
associations	O
.	O
further	O
,	O
14	O
associations	O
between	O
episode	O
length	O
and	O
char	B-T170
##ls	I-T170
##on	I-T170
co	I-T170
-	I-T170
morbidity	I-T170
index	I-T170
mainly	O
with	O
urinary	O
related	O
diagnoses	O
and	O
problems	O
remained	O
significant	O
after	O
adjustment	O
analyses	O
.	O
through	O
visual	B-T058
analysis	I-T058
,	O
the	O
adverse	O
association	O
of	O
the	O
longer	O
home	B-T058
health	I-T058
episode	I-T058
length	O
and	O
higher	O
char	B-T170
##ls	I-T170
##on	I-T170
co	I-T170
-	I-T170
morbidity	I-T170
index	I-T170
with	O
behavior	B-T033
or	I-T033
status	I-T033
outcomes	I-T033
for	O
patients	O
with	O
impaired	O
urinary	O
function	O
was	O
revealed	O
.	O
we	O
have	O
demonstrated	O
the	O
use	O
of	O
visual	B-T058
analysis	I-T058
to	O
discover	O
novel	O
patterns	O
that	O
described	O
high	O
-	O
needs	O
subgroups	B-T170
among	O
the	O
older	O
home	O
health	O
patient	O
population	O
.	O
the	O
effective	O
presentation	O
of	O
these	O
data	O
patterns	O
can	O
allow	O
clinicians	B-T097
to	O
identify	O
areas	O
of	O
patient	O
improvement	O
,	O
and	O
time	O
periods	O
that	O
are	O
most	O
effective	O
for	O
implementing	O
home	B-T058
health	I-T058
interventions	I-T058
to	O
improve	O
patient	B-T058
outcomes	I-T058
.	O

tetra	B-T103
##brom	I-T103
##obi	I-T103
##sp	I-T103
##he	I-T103
##no	I-T103
##l	I-T103
a	I-T103
activates	O
the	O
hepatic	B-T017
interferon	B-T038
pathway	I-T038
in	O
rats	B-T204
tetra	B-T103
##brom	I-T103
##obi	I-T103
##sp	I-T103
##he	I-T103
##no	I-T103
##l	I-T103
a	I-T103
(	O
tb	B-T103
##bp	I-T103
##a	I-T103
)	O
is	O
a	O
widely	O
used	O
flame	B-T103
retard	I-T103
##ant	I-T103
in	O
printed	O
circuit	O
boards	O
,	O
paper	O
,	O
and	O
textile	O
##s	O
.	O
in	O
a	O
two	O
-	O
year	O
study	B-T062
,	O
tb	B-T103
##bp	I-T103
##a	I-T103
showed	O
evidence	O
of	O
uterine	B-T038
tumors	I-T038
in	O
female	O
wistar	B-T204
-	I-T204
han	I-T204
rats	I-T204
and	O
liver	B-T038
and	O
colon	B-T038
tumors	I-T038
in	O
b6	B-T204
##c3	I-T204
##f1	I-T204
mice	I-T204
.	O
in	O
order	O
to	O
gain	O
further	O
insight	O
into	O
early	O
gene	B-T017
and	O
pathway	B-T038
changes	O
leading	O
to	O
cancer	B-T038
,	O
we	O
exposed	O
female	O
wistar	B-T204
han	I-T204
rats	I-T204
to	O
tb	B-T103
##bp	I-T103
##a	I-T103
at	O
0	O
,	O
25	O
,	O
250	O
,	O
or	O
1000	O
##mg	O
/	O
kg	O
(	O
oral	O
gavage	O
in	O
corn	B-T103
oil	I-T103
,	O
5	O
##×	O
/	O
week	O
)	O
for	O
13	O
weeks	O
.	O
because	O
at	O
the	O
end	O
of	O
the	O
tb	B-T103
##bp	I-T103
##a	I-T103
exposure	O
period	O
,	O
there	O
were	O
no	O
treatment	O
-	O
related	O
effects	O
on	O
body	O
weights	O
,	O
liver	B-T033
or	O
uterus	B-T033
lesions	I-T033
,	O
and	O
liver	O
and	O
uterine	O
organ	O
weights	O
were	O
within	O
10	O
%	O
of	O
controls	O
,	O
only	O
the	O
high	O
dose	O
animals	B-T204
were	O
analyzed	B-T062
.	O
analysis	B-T062
of	O
the	O
hepatic	B-T017
and	O
uterine	B-T017
transcriptome	B-T082
##s	I-T082
showed	O
tb	B-T103
##bp	I-T103
##a	I-T103
-	O
induced	O
changes	O
primarily	O
in	O
the	O
liver	B-T017
(	O
1000	O
##mg	O
/	O
kg	O
)	O
,	O
with	O
159	O
transcripts	B-T103
corresponding	O
to	O
132	O
genes	B-T017
differentially	O
expressed	B-T038
compared	O
to	O
controls	O
(	O
fd	O
##r	O
=	O
0	O
.	O
05	O
)	O
.	O
pathway	B-T170
analysis	I-T170
showed	O
activation	O
of	O
interferon	B-T103
(	O
ifn	B-T103
)	O
and	O
metabolic	B-T038
networks	I-T038
.	O
tb	B-T103
##bp	I-T103
##a	I-T103
induced	O
few	O
molecular	O
changes	O
in	O
the	O
uterus	B-T017
.	O
activation	O
of	O
the	O
interferon	B-T038
pathway	I-T038
in	O
the	O
liver	B-T017
occurred	O
after	O
13	O
-	O
weeks	O
of	O
tb	B-T103
##bp	I-T103
##a	I-T103
exposure	O
,	O
and	O
with	O
longer	O
term	O
tb	B-T103
##bp	I-T103
##a	I-T103
exposure	O
this	O
may	O
lead	O
to	O
immunomodulatory	B-T058
changes	O
that	O
contribute	O
to	O
carcinogenic	B-T038
processes	I-T038
.	O

medulloblastoma	B-T038
:	O
molecular	B-T038
pathways	I-T038
and	O
histopathological	O
classification	B-T170
malignant	B-T038
brain	I-T038
tumors	I-T038
are	O
the	O
leading	O
cause	O
of	O
cancer	B-T038
death	B-T033
among	O
pediatric	O
patients	O
,	O
and	O
medulloblastoma	B-T038
constitutes	O
20	O
%	O
of	O
them	O
.	O
currently	O
,	O
the	O
treatment	B-T058
is	O
risk	O
-	O
adapted	O
.	O
maximum	O
surgical	B-T058
resection	I-T058
is	O
recommended	O
,	O
always	O
followed	O
by	O
chemotherapy	B-T058
and	O
neuro	B-T022
##axis	I-T022
radiotherapy	B-T058
.	O
in	O
spite	O
of	O
the	O
improving	O
survival	O
rate	O
,	O
survivors	O
suc	O
##cu	O
##mb	O
to	O
treatment	B-T058
-	O
induced	O
side	B-T038
effects	I-T038
.	O
to	O
reduce	O
toxic	B-T037
effects	I-T037
,	O
molecular	B-T058
-	I-T058
targeted	I-T058
treatment	I-T058
is	O
proposed	O
.	O
medulloblastoma	B-T038
research	B-T062
is	O
very	O
robust	O
,	O
and	O
new	O
articles	B-T170
on	O
the	O
subject	O
are	O
published	O
daily	O
.	O
in	O
the	O
current	O
review	B-T170
we	O
have	O
tried	O
to	O
bring	O
together	O
molecular	O
pathophysiology	O
of	O
the	O
neoplasm	B-T038
and	O
current	O
pathological	O
classification	B-T170
,	O
thus	O
making	O
an	O
effort	O
to	O
relate	O
tumor	B-T062
biology	I-T062
and	O
the	O
histological	B-T201
picture	I-T201
.	O

transcriptome	B-T082
and	O
metabol	O
##ome	O
analyses	B-T062
of	O
gluc	B-T103
##osin	I-T103
##olate	I-T103
##s	I-T103
in	O
two	O
broc	B-T204
##co	I-T204
##li	I-T204
cultivars	I-T204
following	O
jas	B-T103
##mon	I-T103
##ate	I-T103
treatment	O
for	O
the	O
induction	O
of	O
gluc	B-T103
##osin	I-T103
##olate	I-T103
defense	O
to	O
trich	B-T204
##opl	I-T204
##us	I-T204
##ia	I-T204
ni	I-T204
(	O
hub	O
##ner	O
)	O
lepid	B-T204
##optera	I-T204
##n	I-T204
larvae	B-T204
growth	B-T038
is	O
influenced	O
by	O
host	O
plant	B-T204
gluc	B-T103
##osin	I-T103
##olate	I-T103
(	O
gs	B-T103
)	O
concentrations	O
,	O
which	O
are	O
,	O
in	O
turn	O
,	O
influenced	O
by	O
the	O
phyto	B-T103
##ho	I-T103
##r	I-T103
##mon	I-T103
##e	I-T103
jas	B-T103
##mon	I-T103
##ate	I-T103
(	O
ja	B-T103
)	O
.	O
in	O
order	O
to	O
elucidate	O
insect	B-T204
resistance	O
biomarkers	B-T038
to	O
lepid	B-T204
##optera	I-T204
##n	I-T204
pests	O
,	O
transcriptome	B-T082
and	O
metabol	O
##ome	O
analyses	B-T062
following	O
ja	B-T103
treatments	O
were	O
conducted	O
with	O
two	O
broc	B-T204
##co	I-T204
##li	I-T204
cultivars	I-T204
,	O
green	B-T204
mag	I-T204
##ic	I-T204
and	O
vi	B-T204
-	I-T204
158	I-T204
,	O
which	O
have	O
differentially	O
induced	O
indole	B-T103
gss	I-T103
,	O
neo	B-T103
##gluc	I-T103
##obr	I-T103
##ass	I-T103
##icin	I-T103
and	O
gluc	B-T103
##obr	I-T103
##ass	I-T103
##icin	I-T103
,	O
respectively	O
.	O
to	O
test	O
these	O
two	O
inducible	O
gss	B-T103
on	O
growth	B-T038
of	O
cab	B-T204
##ba	I-T204
##ge	I-T204
loop	I-T204
##er	I-T204
(	O
trich	B-T204
##opl	I-T204
##us	I-T204
##ia	I-T204
ni	I-T204
)	O
,	O
eight	O
neonate	O
cab	B-T204
##ba	I-T204
##ge	I-T204
loop	I-T204
##er	I-T204
larvae	I-T204
were	O
placed	O
onto	O
each	O
of	O
three	O
plants	B-T204
per	O
ja	B-T103
treatments	O
(	O
0	O
,	O
100	O
,	O
200	O
,	O
400	O
µm	O
)	O
three	O
days	O
after	O
treatment	O
.	O
after	O
five	O
days	O
of	O
feeding	O
,	O
weight	O
of	O
larvae	B-T204
and	O
their	O
survival	O
rate	O
was	O
found	O
to	O
decrease	O
with	O
increasing	O
ja	B-T103
concentrations	O
in	O
both	O
broc	B-T204
##co	I-T204
##li	I-T204
cultivars	I-T204
.	O
ja	B-T103
-	O
inducible	O
gss	B-T103
were	O
measured	O
by	O
high	B-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
.	O
neo	B-T103
##gluc	I-T103
##obr	I-T103
##ass	I-T103
##icin	I-T103
in	O
green	B-T204
mag	I-T204
##ic	I-T204
and	O
gluc	B-T103
##obr	I-T103
##ass	I-T103
##icin	I-T103
in	O
vi	B-T204
-	I-T204
158	I-T204
leaves	B-T204
were	O
increased	O
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O
one	O
or	O
both	O
of	O
these	O
gluc	B-T103
##osin	I-T103
##olate	I-T103
##s	I-T103
and	O
/	O
or	O
their	O
hydrolysis	O
products	O
showed	O
significant	O
inverse	O
correlations	O
with	O
larval	B-T204
weight	O
and	O
survival	O
(	O
five	O
days	O
after	O
treatment	O
)	O
while	O
being	O
positively	B-T033
correlated	O
with	O
the	O
number	O
of	O
days	O
to	O
pup	B-T038
##ation	I-T038
.	O
this	O
implies	O
that	O
these	O
two	O
ja	B-T103
-	O
inducible	O
gluc	B-T103
##osin	I-T103
##olate	I-T103
##s	I-T103
can	O
influence	O
the	O
growth	B-T038
and	O
survival	O
of	O
cab	B-T204
##ba	I-T204
##ge	I-T204
loop	I-T204
##er	I-T204
larvae	I-T204
.	O
transcriptome	B-T058
profiling	I-T058
supported	O
the	O
observed	O
changes	O
in	O
gluc	B-T103
##osin	I-T103
##olate	I-T103
and	O
their	O
hydrolysis	O
product	O
concentrations	O
following	O
ja	B-T103
treatments	O
.	O
several	O
genes	B-T017
related	O
to	O
gs	B-T103
metabolism	B-T038
differentiate	O
the	O
two	O
broc	B-T204
##co	I-T204
##li	I-T204
cultivars	I-T204
in	O
their	O
pattern	B-T082
of	O
transcriptional	B-T038
response	O
to	O
ja	B-T103
treatments	O
.	O
indicative	O
of	O
the	O
corresponding	O
change	O
in	O
indole	B-T103
gs	I-T103
concentrations	O
,	O
transcripts	B-T103
of	O
the	O
transcription	B-T103
factor	I-T103
myb	B-T103
##12	I-T103
##2	I-T103
,	O
core	O
structure	O
biosynthesis	O
genes	B-T017
(	O
cyp	B-T017
##79	I-T017
##b2	I-T017
,	O
ugt	B-T017
##74	I-T017
##b1	I-T017
,	O
sur	B-T017
##1	I-T017
,	O
so	B-T017
##t1	I-T017
##6	I-T017
,	O
so	B-T017
##t1	I-T017
##7	I-T017
,	O
and	O
so	B-T017
##t1	I-T017
##8	I-T017
)	O
,	O
an	O
indole	O
gluc	O
##osin	O
##olate	O
side	O
chain	O
modification	B-T033
gene	B-T017
(	O
igm	B-T017
##t1	I-T017
)	O
,	O
and	O
several	O
gluc	B-T103
##osin	I-T103
##olate	I-T103
hydrolysis	O
genes	O
(	O
tg	B-T017
##g1	I-T017
,	O
tg	B-T017
##g2	I-T017
,	O
and	O
es	B-T017
##m1	I-T017
)	O
were	O
significantly	O
increased	O
in	O
green	B-T204
mag	I-T204
##ic	I-T204
(	O
statistically	O
significant	O
in	O
most	O
cases	O
at	O
400	O
µm	O
)	O
while	O
ugt	B-T017
##74	I-T017
##b1	I-T017
and	O
myb	B-T017
##12	I-T017
##2	I-T017
were	O
significantly	O
increased	O
in	O
vi	B-T204
-	I-T204
158	I-T204
.	O
therefore	O
,	O
these	O
metabolite	B-T103
and	O
transcript	B-T103
biomarker	B-T038
results	O
indicate	O
that	O
transcriptome	B-T058
profiling	I-T058
can	O
identify	O
genes	B-T017
associated	O
with	O
the	O
formation	O
of	O
two	O
different	O
indole	B-T103
gs	I-T103
and	O
their	O
hydrolysis	O
products	O
.	O
therefore	O
,	O
these	O
metabolite	B-T103
and	O
transcript	B-T103
biomarkers	B-T038
could	O
be	O
useful	O
in	O
an	O
effective	O
marker	B-T038
-	O
assisted	O
breeding	B-T038
strategy	O
for	O
resistance	O
to	O
general	O
##ist	O
lepid	B-T204
##optera	I-T204
##n	I-T204
pests	O
in	O
broc	B-T204
##co	I-T204
##li	I-T204
and	O
potentially	O
other	O
brassica	B-T168
vegetables	I-T168
.	O

synchron	O
##isms	O
between	O
bud	B-T204
and	O
camb	B-T017
##ium	I-T017
phenol	O
##og	O
##y	O
in	O
black	B-T204
spr	I-T204
##uce	I-T204
:	O
early	O
-	O
flushing	O
proven	O
##ances	O
exhibit	O
early	O
xylem	B-T204
formation	O
bud	B-T204
and	O
camb	B-T017
##ial	I-T017
phenol	O
##og	O
##y	O
represent	O
the	O
adaptation	B-T038
of	O
species	B-T170
to	O
the	O
local	B-T082
environment	B-T082
that	O
allows	O
the	O
growing	O
season	O
to	O
be	O
maximize	O
##d	O
while	O
minimizing	O
the	O
risk	O
of	O
fr	B-T103
##ost	I-T103
for	O
the	O
developing	O
tissues	B-T017
.	O
the	O
temporal	O
relationship	O
between	O
the	O
apical	B-T082
and	O
radial	O
merist	B-T204
##ems	I-T204
can	O
help	O
in	O
the	O
understanding	O
of	O
tree	B-T204
growth	B-T038
as	O
a	O
whole	O
process	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
compare	O
camb	B-T017
##ial	I-T017
phenol	O
##og	O
##y	O
in	O
black	B-T204
spr	I-T204
##uce	I-T204
(	O
pic	B-T204
##ea	I-T204
mari	I-T204
##ana	I-T204
(	O
mill	O
.	O
)	O
b	O
.	O
s	O
.	O
p	O
.	O
)	O
proven	O
##ances	O
classified	B-T170
as	O
early	O
and	O
late	O
bud	B-T204
flushing	O
.	O
the	O
different	O
phases	O
of	O
camb	B-T017
##ial	I-T017
phenol	O
##og	O
##y	O
were	O
assessed	O
on	O
wood	O
microc	B-T082
##ores	I-T082
sampled	O
weekly	O
from	O
april	O
to	O
october	O
in	O
2014	O
and	O
2015	O
from	O
61	O
trees	B-T204
growing	B-T038
in	O
a	O
proven	O
##ance	O
trial	O
in	O
quebec	B-T082
,	O
canada	B-T082
.	O
trees	B-T204
showing	O
an	O
early	O
bud	B-T204
flush	O
also	O
exhibited	O
early	O
reactivation	O
of	O
xylem	B-T204
differentiation	B-T038
,	O
although	O
an	O
average	O
difference	O
of	O
12	O
days	O
for	O
buds	B-T204
corresponded	O
to	O
small	O
although	O
significant	O
differences	O
of	O
4	O
days	O
for	O
xylem	B-T204
.	O
proven	O
##ances	O
with	O
early	O
bud	B-T204
flush	O
had	O
an	O
early	O
bud	B-T204
set	O
and	O
completed	O
xylem	B-T204
formation	O
earlier	O
than	O
late	O
bud	B-T204
flush	O
proven	O
##ances	O
.	O
no	B-T033
significant	I-T033
difference	O
in	O
the	O
period	O
of	O
xylem	B-T204
formation	O
and	O
total	O
growth	B-T038
was	O
observed	O
between	O
the	O
flushing	O
classes	O
.	O
our	O
results	B-T033
demonstrate	O
that	O
the	O
eco	O
##type	O
differentiation	B-T038
of	O
black	B-T204
spr	I-T204
##uce	I-T204
proven	O
##ances	O
represented	O
by	O
the	O
phenol	O
##og	O
##ical	O
adaptation	B-T038
of	O
buds	B-T204
to	O
the	O
local	B-T082
climate	O
corresponds	O
to	O
specific	O
growth	B-T038
dynamics	O
of	O
the	O
xylem	B-T204
.	O

unaffected	O
twins	B-T038
discordant	I-T038
for	O
affective	B-T038
disorders	I-T038
show	O
changes	O
in	O
anterior	B-T017
call	I-T017
##osal	I-T017
white	B-T017
matter	I-T017
microstructure	B-T082
the	O
neurobiological	B-T091
mechanisms	O
mediating	O
an	O
increased	O
risk	O
to	O
develop	O
affective	B-T038
disorders	I-T038
remain	O
poorly	O
understood	O
.	O
in	O
a	O
group	B-T098
of	I-T098
individuals	I-T098
with	O
a	O
family	B-T033
history	I-T033
of	O
major	B-T038
depressive	I-T038
(	O
mdd	B-T038
)	O
or	O
bipolar	B-T038
disorder	I-T038
(	O
bd	B-T038
)	O
,	O
we	O
investigated	O
the	O
microstructural	O
properties	O
of	O
white	B-T017
matter	I-T017
fiber	O
tracts	O
,	O
that	O
is	O
,	O
cing	B-T017
##ulum	I-T017
bundle	I-T017
,	O
unc	B-T017
##inate	I-T017
fasci	I-T017
##cu	I-T017
##lu	I-T017
##s	I-T017
,	O
anterior	B-T017
limb	I-T017
of	I-T017
the	I-T017
internal	I-T017
capsule	I-T017
,	O
and	O
corpus	B-T017
callosum	I-T017
,	O
that	O
facilitate	O
the	O
communication	O
between	O
brain	B-T082
regions	I-T082
implicated	O
in	O
affective	B-T038
disorders	I-T038
.	O
eighty	O
-	O
nine	O
healthy	O
mono	O
-	O
or	O
di	O
##z	O
##yg	O
##otic	O
twins	O
with	O
a	O
co	O
-	O
twin	O
diagnosed	B-T033
with	O
mdd	B-T038
or	O
bd	B-T038
(	O
high	B-T098
-	I-T098
risk	I-T098
)	O
and	O
57	O
healthy	O
twins	O
with	O
a	O
co	O
-	O
twin	O
with	O
no	B-T033
familial	I-T033
history	I-T033
of	I-T033
affective	B-T038
disorders	I-T038
(	O
low	O
-	O
risk	O
)	O
were	O
included	O
in	O
a	O
diffusion	B-T058
tensor	I-T058
imaging	I-T058
study	I-T058
.	O
the	O
high	B-T098
-	I-T098
risk	I-T098
group	I-T098
showed	O
decreased	O
fractional	B-T058
anisotropy	I-T058
(	O
fa	B-T058
)	O
,	O
a	O
measure	O
of	O
water	B-T103
diffusion	O
directional	O
##ity	O
,	O
and	O
increased	O
radial	O
diffusivity	O
in	O
the	O
anterior	B-T017
region	I-T017
of	I-T017
corpus	I-T017
callosum	I-T017
compared	O
to	O
the	O
low	B-T098
-	I-T098
risk	I-T098
group	I-T098
.	O
this	O
abnormality	B-T033
was	O
not	O
associated	O
with	O
zyg	O
##osity	O
or	O
type	O
of	O
depressive	B-T038
disorder	I-T038
of	O
co	O
-	O
twin	O
.	O
the	O
observed	O
decreased	O
anterior	B-T017
call	I-T017
##osal	I-T017
fiber	I-T017
fa	B-T058
in	O
the	O
high	B-T098
-	I-T098
risk	I-T098
group	I-T098
may	O
be	O
indicative	O
of	O
a	O
compromised	O
inter	O
##hemispheric	O
communication	O
between	O
left	B-T017
and	O
right	B-T017
frontal	I-T017
regions	I-T017
critically	O
involved	O
in	O
mood	O
regulation	O
.	O
reduced	O
anterior	B-T017
call	I-T017
##osal	I-T017
fa	B-T058
may	O
act	O
as	O
a	O
vulnerability	O
marker	B-T201
for	O
affective	B-T038
disorders	I-T038
in	O
individuals	B-T098
at	O
familial	O
risk	O
.	O

efficacy	O
of	O
42	O
pharmacologic	B-T103
cot	B-T058
##reatment	I-T058
strategies	O
added	O
to	O
antipsychotic	B-T103
monotherapy	B-T058
in	O
schizophrenia	B-T038
:	O
systematic	O
overview	O
and	O
quality	O
appraisal	O
of	O
the	O
meta	B-T062
-	I-T062
analytic	I-T062
evidence	O
limited	O
treatment	B-T058
responses	O
in	O
schizophrenia	B-T038
prompted	O
the	O
testing	O
of	O
combining	O
an	O
antipsychotic	B-T103
drug	I-T103
treatment	B-T058
with	O
a	O
second	O
psychotropic	B-T103
medication	B-T103
.	O
a	O
comprehensive	O
evaluation	B-T058
of	O
the	O
efficacy	O
of	O
multiple	O
medication	B-T103
combinations	B-T103
is	O
missing	O
.	O
to	O
summarize	O
and	O
compare	O
the	O
meta	B-T062
-	I-T062
analytically	I-T062
determined	O
efficacy	O
of	O
pharmacologic	B-T103
combination	B-T103
strategies	O
of	O
antipsychotic	B-T103
drugs	I-T103
in	O
adults	O
with	O
schizophrenia	B-T038
.	O
systematic	O
search	O
of	O
pubmed	B-T170
and	O
psycinfo	O
until	O
may	O
13	O
,	O
2016	O
.	O
meta	B-T062
-	I-T062
analyses	I-T062
of	O
randomized	B-T062
clinical	I-T062
trials	I-T062
comparing	O
the	O
efficacy	O
of	O
antipsychotic	B-T103
drugs	I-T103
combined	O
with	O
other	O
antipsychotic	B-T103
or	O
non	B-T103
##anti	I-T103
##psychotic	I-T103
medications	I-T103
vs	O
placebo	B-T103
##s	I-T103
or	O
antipsychotic	B-T103
monotherapy	B-T058
among	O
adults	O
with	O
schizophrenia	B-T038
.	O
independent	O
reviewers	B-T098
extracted	O
the	O
data	O
and	O
assessed	O
the	O
quality	O
of	O
the	O
methods	B-T170
of	O
the	O
included	O
meta	B-T062
-	I-T062
analyses	I-T062
using	O
a	O
measurement	B-T170
tool	I-T170
to	I-T170
assess	I-T170
systematic	I-T170
reviews	I-T170
(	O
ams	B-T170
##ta	I-T170
##r	I-T170
)	O
,	O
adding	O
6	O
new	O
items	O
to	O
rate	O
their	O
quality	O
.	O
effect	O
sizes	O
,	O
expressed	O
as	O
standardized	B-T201
mean	I-T201
difference	I-T201
/	O
hedge	O
##s	O
g	O
or	O
risk	O
ratio	O
,	O
were	O
compared	O
separately	O
for	O
combinations	B-T103
with	O
any	O
antipsychotic	B-T103
drug	I-T103
and	O
for	O
combinations	B-T103
with	O
clozapine	B-T103
.	O
the	O
primary	O
outcome	O
was	O
total	O
symptom	B-T033
reduction	O
.	O
secondary	O
outcomes	O
included	O
positive	B-T033
and	O
negative	B-T033
symptoms	B-T033
,	O
treatment	B-T058
recommendations	I-T058
by	O
authors	O
,	O
study	O
-	O
defined	O
ineff	B-T033
##ica	I-T033
##ci	I-T033
##es	I-T033
,	O
cognitive	O
and	O
depressive	B-T033
symptoms	I-T033
,	O
discontinuation	B-T058
of	O
treatment	B-T058
because	O
of	O
any	O
cause	O
,	O
and	O
ineff	B-T033
##ica	I-T033
##ci	I-T033
##es	I-T033
or	O
intoler	O
##abilities	O
.	O
of	O
339	O
##7	O
publications	O
,	O
29	O
meta	B-T062
-	I-T062
analyses	I-T062
testing	O
42	O
combination	B-T103
strategies	O
in	O
38	O
##1	O
individual	B-T098
trials	O
and	O
among	O
19	O
83	O
##3	O
participants	B-T098
were	O
included	O
.	O
for	O
total	O
symptom	B-T033
reductions	B-T058
,	O
32	O
strategies	O
that	O
augmented	O
any	O
antipsychotic	B-T103
drug	I-T103
and	O
5	O
strategies	O
that	O
augmented	O
clozapine	B-T103
were	O
examined	O
.	O
fourteen	O
combination	B-T103
treatments	B-T058
outperformed	O
controls	O
(	O
standard	B-T201
mean	I-T201
difference	I-T201
/	O
hedge	O
##s	O
g	O
,	O
-	O
1	O
.	O
27	O
[	O
95	O
%	O
ci	O
,	O
-	O
2	O
.	O
35	O
to	O
-	O
0	O
.	O
19	O
]	O
to	O
-	O
0	O
.	O
23	O
[	O
95	O
%	O
ci	O
,	O
-	O
0	O
.	O
44	O
to	O
-	O
0	O
.	O
02	O
]	O
;	O
p	O
=	O
.	O
05	O
)	O
.	O
no	O
combination	B-T103
strategies	O
with	O
clozapine	B-T103
outperformed	O
controls	O
.	O
the	O
quality	O
of	O
the	O
methods	B-T170
of	O
the	O
meta	B-T062
-	I-T062
analyses	I-T062
was	O
generally	O
high	O
(	O
mean	O
score	O
,	O
9	O
of	O
a	O
maximum	O
score	O
of	O
11	O
)	O
but	O
the	O
quality	O
of	O
the	O
meta	B-T062
-	I-T062
analyzed	I-T062
studies	I-T062
was	O
low	O
(	O
mean	O
score	O
,	O
2	O
.	O
8	O
of	O
a	O
maximum	O
score	O
of	O
8	O
)	O
.	O
treatment	B-T058
recommendations	I-T058
correlated	O
with	O
the	O
effect	O
size	O
(	O
correlation	O
coefficient	O
,	O
0	O
.	O
22	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
35	O
-	O
0	O
.	O
10	O
;	O
p	O
<	O
.	O
001	O
)	O
,	O
yet	O
effect	O
sizes	O
were	O
inversely	O
correlated	O
with	O
study	O
quality	O
(	O
correlation	O
coefficient	O
,	O
-	O
0	O
.	O
06	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
01	O
to	O
-	O
0	O
.	O
12	O
;	O
p	O
=	O
.	O
02	O
)	O
.	O
meta	B-T062
-	I-T062
analyses	I-T062
of	O
21	O
interventions	O
fully	O
or	O
partially	O
recommended	O
their	O
use	O
,	O
with	O
recommendations	O
being	O
positively	B-T033
correlated	O
with	O
the	O
effect	O
sizes	O
of	O
the	O
pooled	O
intervention	O
.	O
however	O
,	O
the	O
effect	O
sizes	O
were	O
inversely	O
correlated	O
with	O
meta	B-T062
-	I-T062
analyzed	I-T062
study	I-T062
quality	O
,	O
reducing	O
confidence	B-T038
in	O
these	O
recommendations	O
.	O
higher	O
-	O
quality	O
trials	O
and	O
patient	O
-	O
based	O
meta	B-T062
-	I-T062
analyses	I-T062
are	O
needed	O
to	O
determine	O
whether	O
subpopulations	B-T098
might	O
benefit	O
from	O
combination	B-T103
treatment	B-T058
,	O
as	O
no	O
single	O
strategy	O
can	O
be	O
recommended	O
for	O
patients	O
with	O
schizophrenia	B-T038
based	O
on	O
the	O
current	O
meta	B-T062
-	I-T062
analytic	I-T062
literature	B-T170
.	O

dox	B-T103
##ifl	I-T103
##uridine	I-T103
-	O
conjugated	B-T082
2	B-T103
-	I-T103
5a	I-T103
analog	B-T103
shows	O
strong	O
rnase	B-T103
l	I-T103
activation	O
ability	O
and	O
tumor	B-T038
suppressive	I-T038
effect	O
rnase	B-T103
l	I-T103
is	O
activated	O
by	O
2	B-T103
'	I-T103
,	I-T103
5	I-T103
'	I-T103
-	I-T103
oligo	I-T103
##aden	I-T103
##ylate	I-T103
##s	I-T103
(	O
2	B-T103
-	I-T103
5a	I-T103
)	O
at	O
subn	O
##ano	O
##mo	O
##la	O
##r	O
levels	O
to	O
cleave	B-T082
single	B-T103
-	I-T103
stranded	I-T103
rna	I-T103
.	O
we	O
previously	O
reported	B-T170
the	O
hypothesis	O
that	O
the	O
introduction	O
of	O
an	O
8	B-T103
-	I-T103
methyl	I-T103
##adenosine	I-T103
residue	O
at	O
the	O
2	O
'	O
-	O
terminus	B-T082
of	O
the	O
2	B-T103
-	I-T103
5a	I-T103
tetramer	I-T103
shifts	O
the	O
2	B-T103
-	I-T103
5a	I-T103
binding	B-T103
site	I-T103
of	O
rnase	B-T103
l	I-T103
.	O
in	O
this	O
study	B-T062
,	O
we	O
synthesized	O
various	O
5	O
'	O
-	O
modified	O
2	B-T103
-	I-T103
5a	I-T103
analog	B-T103
s	O
with	O
8	B-T103
-	I-T103
methyl	I-T103
##adenosine	I-T103
at	O
the	O
2	O
'	O
-	O
terminus	B-T082
.	O
the	O
dox	B-T103
##ifl	I-T103
##uridine	I-T103
-	O
conjugated	B-T082
8	B-T103
-	I-T103
methyl	I-T103
##adenosine	I-T103
-	O
substituted	O
2	B-T103
-	I-T103
5a	I-T103
analog	B-T103
was	O
significantly	O
more	O
effective	O
as	O
an	O
activator	O
of	O
rnase	B-T103
l	I-T103
than	O
the	O
parent	O
5	O
'	O
-	O
monoph	B-T038
##ophor	I-T038
##ylated	I-T038
2	B-T103
-	I-T103
5a	I-T103
tetramer	I-T103
and	O
showed	O
a	O
tumor	B-T038
suppressive	I-T038
effect	O
against	O
human	B-T204
cervical	B-T038
cancer	I-T038
cells	B-T017
.	O

endpoints	O
for	O
screening	B-T058
thyroid	B-T038
cancer	I-T038
in	O
the	O
republic	B-T082
of	I-T082
korea	I-T082
:	O
thyroid	B-T017
specialists	B-T097
'	O
perspectives	B-T038
cancer	B-T058
screening	I-T058
is	O
aimed	O
primarily	O
at	O
reducing	O
deaths	B-T033
from	O
the	O
specific	O
cancer	B-T038
.	O
thyroid	B-T038
-	I-T038
specific	I-T038
cancer	I-T038
mortality	O
may	O
be	O
the	O
most	O
amb	O
##iti	O
##ous	O
endpoint	O
for	O
obtaining	O
estimates	O
of	O
screening	B-T058
effect	O
.	O
numerous	O
observations	B-T058
have	O
accumulated	B-T033
over	O
the	O
years	O
,	O
indicating	O
that	O
thyroid	B-T038
cancer	I-T038
mortality	O
endpoint	O
has	O
been	O
difficult	O
to	O
study	O
and	O
is	O
confounded	O
by	O
population	O
heterogeneity	O
,	O
provision	B-T058
of	O
randomization	B-T062
,	O
and	O
requirement	O
of	O
large	O
cohorts	B-T098
with	O
sufficiently	O
long	B-T058
follow	I-T058
-	I-T058
up	I-T058
due	O
to	O
the	O
excellent	O
prognosis	B-T201
of	I-T201
the	I-T201
cancer	I-T201
.	O
accordingly	O
,	O
it	O
may	O
be	O
important	O
to	O
reconsider	O
how	O
to	O
best	O
measure	O
thyroid	B-T038
cancer	I-T038
screening	B-T058
efficacy	O
.	O
recommendations	O
against	O
thyroid	B-T038
cancer	I-T038
screening	B-T058
should	O
be	O
based	O
upon	O
trials	O
designed	O
to	O
evaluate	O
its	O
effectiveness	O
not	O
only	O
in	O
significant	O
reduction	O
in	O
cancer	B-T038
mortality	O
,	O
but	O
also	O
of	O
other	O
distinct	O
endpoint	O
s	O
.	O
it	O
is	O
desirable	O
to	O
evaluate	O
derivative	O
endpoints	O
that	O
can	O
reliably	O
predict	O
reductions	O
in	O
mortality	O
.	O
the	O
term	O
[UNK]	O
derivative	O
[UNK]	O
means	O
a	O
variable	O
that	O
is	O
related	O
to	O
the	O
true	O
endpoint	O
and	O
is	O
likely	O
to	O
be	O
observable	O
before	O
the	O
primary	O
endpoint	O
.	O
derivative	O
endpoints	O
may	O
include	O
thyroid	B-T038
cancer	I-T038
incidence	O
,	O
the	O
proportion	O
of	O
early	O
-	O
stage	O
tumors	B-T038
detected	B-T033
,	O
more	O
treatable	B-T201
stage	I-T201
,	O
the	O
identification	O
of	O
small	O
tumors	O
(	O
to	O
maintain	O
in	O
observation	O
)	O
,	O
decrease	O
in	O
the	O
number	O
of	O
people	O
who	O
develop	O
metastatic	B-T038
disease	I-T038
,	O
the	O
increased	O
chance	O
of	O
lesser	O
extent	O
surgery	B-T058
,	O
and	O
the	O
application	O
of	O
minimally	O
invasive	O
approaches	O
,	O
as	O
well	O
as	O
no	O
need	O
for	O
lifelong	O
thyroid	B-T058
replacement	I-T058
therapy	I-T058
,	O
a	O
consistent	O
follow	B-T058
-	I-T058
up	I-T058
,	O
low	O
-	O
dose	O
or	O
no	O
ra	B-T058
##i	I-T058
administration	I-T058
and	O
risk	B-T170
factor	I-T170
assessments	I-T170
where	O
case	B-T058
findings	I-T058
should	O
be	O
continuous	O
.	O
the	O
korean	B-T170
guidelines	I-T170
for	O
thyroid	B-T038
cancer	I-T038
national	O
-	O
level	O
screening	B-T058
were	O
published	O
by	O
a	O
relevant	O
group	O
of	O
multidisciplinary	B-T058
thyroid	I-T058
experts	I-T058
.	O
it	O
was	O
concluded	O
that	O
the	O
evidence	O
is	O
insufficient	O
to	O
balance	O
the	O
benefits	O
and	O
harms	O
of	O
thyroid	B-T038
cancer	I-T038
screening	B-T058
.	O
however	O
,	O
the	O
paper	O
seems	O
to	O
raise	O
the	O
necessary	O
investment	O
##s	O
in	O
future	O
research	B-T062
and	O
demand	O
a	O
complete	O
analysis	B-T062
for	O
derivative	O
endpoints	O
,	O
and	O
offer	O
screening	B-T058
participants	B-T098
with	O
complete	O
information	O
necessary	O
to	B-T038
make	I-T038
decisions	I-T038
that	O
will	O
provide	O
them	O
with	O
the	O
most	O
value	O
when	O
a	O
small	O
thyroid	B-T038
cancer	I-T038
is	O
screen	O
-	O
identified	O
.	O

healthcare	B-T058
usage	O
and	O
economic	O
impact	O
of	O
non	B-T033
-	I-T033
treated	I-T033
obesity	B-T038
in	O
italy	B-T082
:	O
findings	O
from	O
a	O
retrospective	O
administrative	B-T033
and	O
clinical	B-T170
database	I-T170
analysis	B-T062
investigate	O
the	O
prevalence	O
of	O
obesity	B-T038
in	O
italy	B-T082
and	O
examine	O
its	O
resource	O
consumption	B-T033
and	O
economic	O
impact	O
on	O
the	O
italian	B-T082
national	B-T170
healthcare	I-T170
system	I-T170
(	O
nhs	B-T170
)	O
.	O
retrospective	O
,	O
observational	B-T062
and	O
real	B-T062
-	I-T062
life	I-T062
study	I-T062
.	O
data	O
from	O
three	O
health	B-T092
units	I-T092
from	O
northern	B-T082
(	O
berg	B-T082
##am	I-T082
##o	I-T082
,	O
lo	B-T082
##mb	I-T082
##ard	I-T082
##y	I-T082
)	O
,	O
central	B-T082
(	O
gross	B-T082
##eto	I-T082
,	O
tu	B-T082
##sc	I-T082
##an	I-T082
##y	I-T082
)	O
and	O
southern	B-T082
(	O
nap	B-T082
##les	I-T082
,	O
camp	B-T082
##ania	I-T082
)	O
italy	B-T082
.	O
all	O
patients	O
aged	O
≥1	O
##8	O
years	O
with	O
at	O
least	O
one	O
recorded	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
measurement	O
between	O
1	O
january	O
2009	O
and	O
31	O
december	O
2012	O
were	O
included	O
.	O
information	O
retrieved	O
from	O
the	O
databases	B-T170
included	O
primary	O
care	O
data	O
,	O
medical	B-T170
prescriptions	I-T170
,	O
specialist	B-T058
consultations	I-T058
and	O
hospital	B-T170
discharge	I-T170
records	I-T170
from	O
2009	O
-	O
2013	O
.	O
costs	O
associated	O
with	O
these	O
data	O
were	O
also	O
calculated	O
.	O
data	O
are	O
presented	O
for	O
two	O
time	O
periods	O
(	O
1	O
year	O
after	O
bmi	B-T201
measurement	O
and	O
study	O
end	O
)	O
.	O
primary	O
-	O
to	O
estimate	O
health	O
resources	O
consumption	B-T033
and	O
the	O
associated	O
economic	O
impact	O
on	O
the	O
italian	B-T082
nhs	B-T170
.	O
secondary	O
-	O
the	O
prevalence	O
and	O
characteristics	O
of	O
subjects	B-T098
by	O
bmi	B-T201
category	B-T170
.	O
20	O
159	O
adult	O
subjects	B-T098
with	O
at	O
least	O
one	O
documented	B-T033
bmi	I-T033
measurement	O
.	O
subjects	B-T098
with	O
bmi	B-T201
≥3	O
##0	O
kg	O
/	O
m	O
(	O
2	O
)	O
were	O
defined	O
as	O
obese	B-T038
.	O
the	O
prevalence	O
of	O
obesity	B-T038
was	O
22	O
.	O
2	O
%	O
(	O
n	O
=	O
44	O
##71	O
)	O
and	O
increased	O
with	O
age	O
.	O
at	O
the	O
1	O
-	O
year	O
observation	B-T062
period	O
,	O
obese	B-T038
subjects	B-T098
who	O
did	O
not	O
receive	O
treatment	B-T058
for	O
their	O
obesity	B-T038
experienced	O
longer	O
durations	O
of	O
hospitalisation	B-T058
(	O
median	O
length	O
:	O
5	O
days	O
vs	O
3	O
days	O
)	O
,	O
used	O
more	O
prescription	B-T103
drugs	I-T103
(	O
75	O
.	O
0	O
%	O
vs	O
57	O
.	O
7	O
%	O
)	O
,	O
required	O
more	O
specialised	O
outpatient	O
healthcare	B-T058
(	O
mean	O
number	O
:	O
5	O
.	O
3	O
vs	O
4	O
.	O
4	O
)	O
and	O
were	O
associated	O
with	O
greater	O
costs	O
,	O
primarily	O
owing	O
to	O
prescription	B-T103
drugs	I-T103
and	O
hospital	B-T058
admissions	I-T058
(	O
mean	O
annual	O
cost	O
per	O
year	O
per	O
patient	O
:	O
€	O
##46	O
##0	O
.	O
6	O
vs	O
€	O
##28	O
##8	O
.	O
0	O
for	O
drug	B-T170
prescriptions	I-T170
,	O
€	O
##42	O
##2	O
.	O
7	O
vs	O
€	O
279	O
.	O
2	O
for	O
hospitalisation	B-T058
##s	I-T058
and	O
€	O
##28	O
##3	O
.	O
2	O
vs	O
€	O
##25	O
##1	O
.	O
7	O
for	O
outpatient	B-T058
care	I-T058
)	O
,	O
compared	O
with	O
normal	B-T033
weight	I-T033
subjects	B-T098
.	O
similar	O
findings	O
were	O
observed	O
for	O
the	O
period	O
up	O
to	O
data	O
cut	O
-	O
off	O
(	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
of	O
2	O
.	O
7	O
years	O
)	O
.	O
untreated	B-T033
obesity	B-T038
has	O
a	O
significant	O
economic	O
impact	O
on	O
the	O
italian	B-T082
healthcare	B-T170
system	I-T170
,	O
highlighting	O
the	O
need	O
to	O
raise	O
awareness	B-T038
and	O
proactive	O
##ly	O
treat	B-T058
obese	O
subjects	B-T098
.	O

characterization	O
of	O
phyto	B-T103
##ch	I-T103
##rome	I-T103
interacting	I-T103
factors	I-T103
from	O
the	O
moss	B-T204
phys	B-T204
##com	I-T204
##itre	I-T204
##ll	I-T204
##a	I-T204
pat	I-T204
##ens	I-T204
illustrates	O
conservation	O
of	O
phyto	B-T103
##ch	I-T103
##rome	I-T103
signaling	I-T103
modules	I-T103
in	O
land	B-T204
plants	I-T204
across	O
the	O
plant	B-T204
kingdom	I-T204
,	O
phyto	B-T103
##ch	I-T103
##rome	I-T103
(	O
ph	B-T103
##y	I-T103
)	O
photoreceptors	B-T017
play	O
an	O
important	O
role	O
during	O
adaptive	O
and	O
developmental	O
responses	O
to	O
light	O
.	O
in	O
arabidopsis	B-T204
thaliana	I-T204
,	O
light	O
-	O
activated	O
phys	B-T103
accumulate	O
in	O
the	O
nucleus	B-T017
,	O
where	O
they	O
regulate	O
downstream	B-T103
signaling	I-T103
components	I-T103
,	O
such	O
as	O
phyto	B-T103
##ch	I-T103
##rome	I-T103
interacting	I-T103
factors	I-T103
(	O
pi	B-T103
##fs	I-T103
)	O
.	O
pi	B-T103
##fs	I-T103
are	O
transcription	B-T103
factors	I-T103
that	O
act	O
as	O
repressor	B-T103
##s	I-T103
of	O
photo	B-T038
##mo	I-T038
##rp	I-T038
##hog	I-T038
##enes	I-T038
##is	I-T038
;	O
their	O
inhibition	B-T038
by	O
phys	B-T103
leads	O
to	O
substantial	O
changes	O
in	O
gene	B-T038
expression	I-T038
.	O
the	O
nuclear	B-T038
function	I-T038
of	O
phys	B-T103
,	O
however	O
,	O
has	O
so	O
far	O
been	O
investigated	O
in	O
only	O
a	O
few	O
non	B-T204
-	I-T204
seed	I-T204
plants	I-T204
.	O
here	O
,	O
we	O
identified	O
putative	O
target	O
genes	B-T017
of	O
ph	B-T103
##y	I-T103
signaling	B-T038
in	O
the	O
moss	B-T204
phys	B-T204
##com	I-T204
##itre	I-T204
##ll	I-T204
##a	I-T204
pat	I-T204
##ens	I-T204
and	O
found	O
light	B-T017
-	I-T017
regulated	I-T017
genes	I-T017
that	O
are	O
putative	O
ortholog	B-T017
##s	I-T017
of	O
pi	B-T017
##f	I-T017
-	I-T017
controlled	I-T017
genes	I-T017
in	O
arabidopsis	B-T204
.	O
phylogenetic	B-T062
analyses	I-T062
revealed	O
that	O
an	O
ancestral	O
pi	B-T017
##f	I-T017
-	I-T017
like	I-T017
gene	I-T017
was	O
already	O
present	O
in	O
strept	B-T204
##ophyte	I-T204
algae	I-T204
,	O
i	O
.	O
e	O
.	O
,	O
before	O
the	O
water	O
-	O
to	O
-	O
land	O
transition	O
of	O
plants	B-T204
.	O
the	O
pi	B-T103
##f	I-T103
homologs	I-T103
in	O
the	O
genome	B-T017
of	O
p	B-T204
.	I-T204
pat	I-T204
##ens	I-T204
resemble	O
arabidopsis	B-T204
pi	B-T103
##fs	I-T103
in	O
their	O
protein	B-T103
domain	I-T103
structure	I-T103
,	O
molecular	O
properties	O
,	O
and	O
physiological	O
effects	O
,	O
albeit	O
with	O
notable	O
differences	O
in	O
the	O
motif	O
-	O
dependent	O
ph	B-T103
##y	I-T103
interaction	O
.	O
our	O
results	O
suggest	O
that	O
p	B-T204
.	I-T204
pat	I-T204
##ens	I-T204
pi	B-T103
##fs	I-T103
are	O
involved	O
in	O
ph	B-T103
##y	I-T103
signaling	B-T038
.	O
the	O
ph	B-T038
##y	I-T038
-	I-T038
pi	I-T038
##f	I-T038
signaling	I-T038
node	I-T038
that	O
relay	O
##s	O
light	O
signals	O
to	O
target	O
genes	B-T017
has	O
been	O
largely	O
conserved	O
during	O
land	B-T204
plant	I-T204
evolution	B-T038
,	O
with	O
evidence	O
of	O
lineage	O
-	O
specific	O
diversification	O
.	O

a	O
window	O
on	O
the	O
study	B-T058
of	I-T058
aversive	I-T058
instrumental	B-T038
learning	I-T038
:	O
strains	O
,	O
performance	O
,	O
neuroendocrine	B-T022
,	O
and	O
immunologic	B-T022
systems	I-T022
the	O
avoidance	B-T038
response	O
is	O
present	O
in	O
pathological	O
anxiety	B-T033
and	O
interferes	O
with	O
normal	O
daily	O
functions	O
.	O
the	O
aim	O
of	O
this	O
article	O
is	O
to	O
shed	O
light	O
on	O
performance	O
markers	O
of	O
active	O
avoidance	O
(	O
aa	O
)	O
using	O
two	O
different	O
rat	B-T204
strains	I-T204
,	O
sprague	B-T204
-	I-T204
dawley	I-T204
(	O
sd	B-T204
)	O
and	O
wistar	B-T204
.	O
specifically	O
,	O
good	O
and	O
poor	O
perform	O
##ers	O
were	O
evaluated	B-T058
regarding	O
anxiety	B-T033
traits	O
exhibited	O
in	O
the	O
elevated	O
plus	O
maze	O
(	O
ep	O
##m	O
)	O
and	O
corticosterone	B-T058
levels	I-T058
and	O
motor	B-T038
activity	I-T038
in	O
the	O
open	B-T058
field	I-T058
test	I-T058
.	O
in	O
addition	O
,	O
the	O
plasma	B-T058
levels	I-T058
of	O
interleukin	B-T103
-	I-T103
6	I-T103
(	O
il	B-T103
-	I-T103
6	I-T103
)	O
,	O
interleukin	B-T103
-	I-T103
1beta	I-T103
(	O
il	B-T103
-	I-T103
1beta	I-T103
)	O
,	O
nerve	B-T103
growth	I-T103
factor	I-T103
beta	I-T103
(	O
ngf	B-T103
-	I-T103
beta	I-T103
)	O
,	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
-	I-T103
alpha	I-T103
(	O
tnf	B-T103
-	I-T103
alpha	I-T103
)	O
and	O
cytokine	B-T103
-	I-T103
induced	I-T103
neutrophil	I-T103
chemoattractant	I-T103
1	I-T103
(	O
cin	B-T103
##c	I-T103
-	I-T103
1	I-T103
)	O
were	O
compared	O
in	O
the	O
good	O
and	O
poor	O
perform	O
##ers	O
to	O
better	O
understand	O
the	O
role	O
of	O
the	O
immunologic	B-T022
system	I-T022
in	O
aversive	B-T058
learning	I-T058
.	O
behavioral	B-T170
criteria	I-T170
were	O
employed	O
to	O
identify	O
subpopulations	B-T098
of	O
sd	B-T204
and	O
wistar	B-T204
rats	I-T204
based	O
on	O
their	O
behavioral	B-T170
scores	I-T170
during	O
a	O
two	O
-	O
way	O
aa	O
test	B-T170
.	O
the	O
animals	B-T204
were	O
tested	B-T170
for	O
anxiety	B-T033
-	O
like	O
behavior	O
in	O
the	O
ep	O
##m	O
and	O
motor	B-T038
activity	I-T038
in	O
the	O
open	B-T058
-	I-T058
field	I-T058
test	I-T058
.	O
plasma	B-T058
corticosterone	I-T058
levels	I-T058
were	O
measured	O
at	O
the	O
end	O
of	O
the	O
avoidance	B-T038
test	B-T170
.	O
cytokine	B-T058
levels	I-T058
of	O
il	B-T103
-	I-T103
6	I-T103
,	O
il	B-T103
-	I-T103
1beta	I-T103
,	O
ngf	B-T103
-	I-T103
beta	I-T103
,	O
tnf	B-T103
-	I-T103
alpha	I-T103
,	O
and	O
cin	B-T103
##c	I-T103
-	I-T103
1	I-T103
were	O
measured	O
in	O
the	O
plasma	B-T031
of	O
the	O
wistar	B-T204
rats	I-T204
.	O
sixty	O
-	O
six	O
percent	O
of	O
the	O
wistar	B-T204
rats	I-T204
and	O
35	O
%	O
of	O
the	O
sd	B-T204
rats	I-T204
exhibited	O
a	O
poor	O
performance	O
.	O
this	O
feature	O
was	O
associated	O
with	O
a	O
decrease	O
in	O
anxiety	B-T033
-	O
like	O
behavior	O
in	O
the	O
ep	O
##m	O
.	O
the	O
poor	O
and	O
good	O
perform	O
##ers	O
exhibited	O
lower	O
levels	B-T058
of	I-T058
corticosterone	I-T058
compared	O
with	O
the	O
control	B-T204
animals	I-T204
,	O
which	O
suggests	O
that	O
training	O
alters	O
corticosterone	B-T058
levels	I-T058
,	O
thereby	O
leading	O
to	O
hypoc	B-T038
##ort	I-T038
##iso	I-T038
##li	I-T038
##sm	I-T038
,	O
independent	O
of	O
the	O
performance	O
.	O
the	O
cin	B-T103
##c	I-T103
-	I-T103
1	I-T103
levels	O
were	O
increased	O
in	O
the	O
poor	O
perform	O
##ers	O
,	O
which	O
reinforce	O
##s	O
the	O
role	O
of	O
immunologic	B-T022
system	I-T022
activation	O
in	O
learning	B-T038
deficits	I-T038
.	O
our	O
study	O
provides	O
a	O
better	O
understanding	O
of	O
the	O
complex	O
interactions	O
that	O
underlie	O
neuro	O
##immune	O
consequences	O
and	O
their	O
implications	O
for	O
performance	O
.	O

executive	B-T038
functions	I-T038
deficits	O
impair	O
extinction	B-T038
of	O
generalization	B-T038
of	O
fear	B-T038
of	O
movement	O
-	O
related	O
pain	O
generalization	B-T038
of	O
fear	B-T038
of	O
movement	O
-	O
related	O
pain	O
across	O
novel	O
but	O
similar	O
movements	B-T038
can	O
lead	O
to	O
fear	B-T038
responses	I-T038
to	O
movements	B-T038
that	O
are	O
actually	O
not	O
associated	O
with	O
pain	B-T033
.	O
the	O
peak	O
-	O
shift	O
effect	O
describes	O
a	O
phenomenon	O
whereby	O
particular	O
novel	O
movements	B-T038
elicit	O
even	O
greater	O
fear	B-T038
responses	I-T038
than	O
the	O
original	O
pain	B-T033
-	I-T033
prov	I-T033
##oking	I-T033
movement	B-T038
(	O
cs	B-T038
+	I-T038
)	O
,	O
because	O
they	O
represent	O
a	O
more	O
extreme	O
version	O
of	O
the	O
cs	B-T038
+	I-T038
.	O
there	O
is	O
great	O
variance	O
in	O
the	O
propensity	O
to	O
general	B-T038
##ize	I-T038
as	O
well	O
as	O
the	O
speed	O
of	O
extinction	B-T038
learning	I-T038
when	O
these	O
novel	O
movements	B-T038
are	O
not	O
followed	O
by	O
pain	B-T033
.	O
it	O
can	O
be	O
argued	O
that	O
this	O
variance	O
may	O
be	O
associated	O
with	O
executive	B-T038
function	I-T038
capacity	I-T038
,	O
as	O
individuals	B-T098
may	O
be	O
unable	O
to	O
intentional	O
##ly	O
inhibit	B-T038
fear	I-T038
responses	I-T038
.	O
this	O
study	O
examined	B-T033
whether	O
executive	B-T038
function	I-T038
capacity	I-T038
contributes	O
to	O
generalization	B-T038
and	O
extinction	B-T038
of	O
generalization	B-T038
as	O
well	O
as	O
peak	O
-	O
shift	O
of	O
conditioned	O
fear	O
of	O
movement	O
-	O
related	O
pain	O
and	O
expectancy	O
.	O
healthy	B-T098
participants	I-T098
performed	O
a	O
proprioceptive	O
fear	B-T038
conditioning	I-T038
task	I-T038
.	O
executive	B-T038
function	I-T038
tests	I-T038
assessing	O
updating	O
,	O
switching	O
,	O
and	O
inhibition	B-T038
were	O
used	O
to	O
predict	O
changes	O
in	O
(	O
extinction	B-T038
of	O
)	O
fear	B-T038
of	O
movement	O
-	O
related	O
pain	O
and	O
pain	B-T033
expectancy	O
generalization	B-T038
.	O
low	B-T038
inhibitory	I-T038
capacity	I-T038
was	O
associated	O
with	O
slower	O
extinction	B-T038
of	O
generalized	B-T038
fear	I-T038
of	O
movement	O
-	O
related	O
pain	O
and	O
pain	B-T033
expectancy	O
.	O
evidence	O
was	O
found	O
in	O
favor	O
of	O
an	O
area	O
-	O
shift	O
,	O
rather	O
than	O
a	O
peak	O
-	O
shift	O
effect	O
,	O
which	O
implies	O
that	O
the	O
peak	O
conditioned	B-T038
fear	I-T038
response	I-T038
extended	O
to	O
,	O
but	O
did	O
not	O
shift	O
to	O
a	O
novel	O
stimulus	O
.	O
participants	B-T098
with	O
low	O
inhibitory	B-T038
capacity	I-T038
may	O
have	O
difficulties	O
with	O
##holding	O
fear	B-T038
responses	I-T038
,	O
leading	O
to	O
a	O
slower	O
decrease	O
of	O
generalized	B-T038
fear	I-T038
over	O
time	O
.	O
the	O
findings	B-T033
may	O
be	O
relevant	O
to	O
inform	O
treatments	O
.	O
low	B-T038
inhibitory	I-T038
capacity	I-T038
is	O
not	O
associated	O
with	O
slower	O
generalization	B-T038
,	O
but	O
extinction	B-T038
of	O
fear	B-T038
generalization	B-T038
.	O
fear	B-T038
elicited	O
by	O
a	O
novel	O
safe	O
movement	B-T038
,	O
situated	O
outside	O
the	O
cs	B-T038
+	I-T038
/	I-T038
-	I-T038
continuum	O
on	O
the	O
cs	B-T038
+	I-T038
side	O
,	O
can	O
be	O
as	O
strong	O
as	O
to	O
the	O
original	O
stimulus	O
predicting	O
the	O
pain	O
-	O
onset	O
.	O

reimbursement	O
based	O
on	O
value	O
in	O
knee	B-T058
surgery	I-T058
:	O
what	O
you	O
need	O
to	O
know	O
about	O
the	O
medicare	B-T170
access	I-T170
and	I-T170
children	I-T170
'	I-T170
s	I-T170
health	I-T170
insurance	I-T170
program	I-T170
re	I-T170
##aut	I-T170
##ho	I-T170
##ri	I-T170
##zation	I-T170
act	I-T170
of	I-T170
2015	I-T170
health	O
care	O
cost	O
is	O
consuming	O
a	O
large	O
portion	O
of	O
the	O
nation	O
'	O
s	O
gross	O
domestic	O
product	O
while	O
placing	O
added	O
economic	O
burdens	O
on	O
physicians	B-T097
and	O
their	O
patients	O
.	O
with	O
total	B-T058
joint	I-T058
replacement	I-T058
being	O
one	O
of	O
the	O
early	O
-	O
targeted	O
procedures	B-T058
in	O
the	O
evolving	O
health	B-T092
care	I-T092
environment	I-T092
,	O
knee	B-T097
surgeons	I-T097
will	O
benefit	O
from	O
developing	O
a	O
critical	O
knowledge	O
on	O
health	O
care	O
reforms	O
and	O
their	O
financial	O
implications	O
.	O
the	O
medicare	B-T170
access	I-T170
and	I-T170
children	I-T170
'	I-T170
s	I-T170
health	I-T170
insurance	I-T170
program	I-T170
re	I-T170
##aut	I-T170
##ho	I-T170
##ri	I-T170
##zation	I-T170
act	I-T170
represents	O
a	O
cohes	O
##ive	O
movement	O
toward	O
value	O
-	O
based	O
payment	O
reform	O
and	O
contains	O
several	O
unch	O
##arter	O
##ed	O
ru	O
##lings	O
that	O
require	O
detailed	O
attention	O
by	O
knee	B-T097
surgeons	I-T097
.	O
in	O
this	O
article	O
,	O
we	O
provide	O
a	O
contextual	O
framework	O
of	O
health	B-T170
care	I-T170
legislation	I-T170
that	O
has	O
led	O
to	O
the	O
formation	O
of	O
the	O
current	O
health	B-T170
policy	I-T170
,	O
and	O
present	O
a	O
comprehensive	O
summary	B-T170
and	O
update	O
on	O
the	O
merit	B-T170
-	I-T170
based	I-T170
incentive	I-T170
payment	I-T170
systems	I-T170
and	O
alternative	B-T170
payment	I-T170
models	I-T170
reimbursement	I-T170
models	I-T170
.	O

opto	B-T062
##gene	I-T062
##tic	I-T062
demonstration	O
of	O
functional	O
innervation	B-T038
of	O
mouse	B-T204
colon	B-T017
by	O
neurons	B-T017
derived	O
from	O
transplanted	O
neural	B-T017
cells	I-T017
cell	B-T058
therapy	I-T058
offers	O
the	O
potential	O
to	O
treat	O
gastrointestinal	B-T038
motility	I-T038
disorders	I-T038
caused	O
by	O
diseased	B-T017
or	O
absent	O
enteric	B-T082
neurons	B-T017
.	O
we	O
examined	O
whether	O
neurons	B-T017
generated	O
from	O
transplanted	O
enteric	B-T082
neural	B-T017
cells	I-T017
provide	O
a	O
functional	O
innervation	B-T038
of	O
bowel	B-T017
smooth	B-T017
muscle	I-T017
in	O
mice	B-T204
.	O
enteric	B-T082
neural	B-T017
cells	I-T017
expressing	O
the	O
light	B-T103
-	I-T103
sensitive	I-T103
ion	I-T103
channel	I-T103
,	O
channel	B-T103
##rh	I-T103
##od	I-T103
##opsin	I-T103
,	O
were	O
isolated	O
from	O
the	O
fetal	O
or	O
postnatal	O
mouse	B-T204
bowel	B-T017
and	O
transplanted	O
into	O
the	O
distal	B-T017
colon	I-T017
of	O
3	O
-	O
to	O
4	O
-	O
week	O
-	O
old	O
wild	B-T017
-	I-T017
type	I-T017
recipient	B-T204
mice	I-T204
.	O
intracellular	B-T082
electrophysiological	B-T058
recordings	I-T058
of	O
responses	O
to	O
light	O
stimulation	O
of	O
the	O
transplanted	O
cells	B-T017
were	O
made	O
from	O
colonic	B-T017
smooth	B-T017
muscle	I-T017
cells	I-T017
in	O
recipient	B-T204
mice	I-T204
.	O
electrical	O
stimulation	O
of	O
endogenous	O
enteric	B-T082
neurons	B-T017
was	O
used	O
as	O
a	O
control	O
.	O
the	O
axons	B-T017
of	O
graft	B-T017
-	O
derived	O
neurons	B-T017
formed	O
a	O
plexus	B-T017
in	O
the	O
circular	B-T017
muscle	I-T017
layer	I-T017
.	O
selective	O
stimulation	O
of	O
graft	B-T017
-	O
derived	O
cells	B-T017
by	O
light	O
resulted	O
in	O
excitatory	B-T038
and	O
inhibitory	B-T038
junction	I-T038
potentials	I-T038
,	O
the	O
electrical	O
events	O
underlying	O
contraction	B-T038
and	O
relaxation	B-T038
,	O
respectively	O
,	O
in	O
colonic	B-T017
muscle	B-T017
cells	I-T017
.	O
graft	B-T017
-	O
derived	O
excitatory	B-T017
and	O
inhibitory	B-T017
motor	I-T017
neurons	I-T017
released	O
the	O
same	O
neurotransmitters	B-T103
as	O
endogenous	O
motor	B-T017
neurons	I-T017
-	O
acetylcholine	B-T103
and	O
a	O
combination	O
of	O
adenosine	B-T103
triphosphate	I-T103
and	O
nitric	B-T103
oxide	I-T103
,	O
respectively	O
.	O
graft	B-T017
-	O
derived	O
neurons	B-T017
also	O
included	O
interneurons	B-T017
that	O
provided	O
synaptic	O
inputs	O
to	O
motor	O
neurons	B-T017
,	O
but	O
the	O
pharmacologic	O
properties	O
of	O
interneurons	B-T017
varied	O
with	O
the	O
age	O
of	O
the	O
donors	B-T098
from	O
which	O
enteric	B-T082
neural	B-T017
cells	I-T017
were	O
obtained	O
.	O
enteric	B-T082
neural	B-T017
cells	I-T017
transplanted	O
into	O
the	O
bowel	B-T017
give	O
rise	O
to	O
multiple	O
functional	O
types	O
of	O
neurons	B-T017
that	O
integrate	O
and	O
provide	O
a	O
functional	O
innervation	B-T038
of	O
the	O
smooth	B-T017
muscle	I-T017
of	O
the	O
bowel	B-T017
wall	I-T017
.	O
circuits	O
composed	O
of	O
both	O
motor	B-T017
neurons	I-T017
and	O
interneurons	B-T017
were	O
established	O
,	O
but	O
the	O
age	O
at	O
which	O
cells	B-T017
are	O
isolated	O
influences	O
the	O
neurotransmitter	B-T103
phenotype	O
of	O
interneurons	B-T017
that	O
are	O
generated	O
.	O

ceft	B-T103
##aro	I-T103
##line	I-T103
fos	I-T103
##amil	I-T103
for	O
community	B-T038
-	I-T038
acquired	I-T038
pneumonia	I-T038
and	O
skin	B-T022
and	O
skin	B-T038
structure	I-T038
infections	I-T038
:	O
a	O
systematic	B-T170
review	I-T170
background	O
ceft	B-T103
##aro	I-T103
##line	I-T103
is	O
a	O
parental	O
##ly	O
administered	O
cephalosporin	B-T103
that	O
has	O
an	O
in	O
vitro	O
expanded	B-T082
spectrum	O
of	O
activity	B-T038
compared	O
with	O
other	O
cephalosporins	B-T103
yet	O
data	O
is	O
conflicting	O
regarding	O
its	O
place	O
in	O
therapy	B-T058
.	O
aim	O
of	O
the	O
review	B-T170
to	O
compare	O
the	O
efficacy	O
and	O
safety	O
of	O
ceft	B-T103
##aro	I-T103
##line	I-T103
against	O
standard	O
antibiotic	B-T103
regimens	B-T058
for	O
community	B-T038
-	I-T038
acquired	I-T038
pneumonia	I-T038
(	O
cap	B-T038
)	O
and	O
complicated	B-T038
skin	I-T038
and	I-T038
skin	I-T038
structure	I-T038
infections	I-T038
(	O
css	B-T038
##sis	I-T038
)	O
.	O
method	O
the	O
databases	B-T170
of	O
medline	B-T170
,	O
ebs	B-T170
##co	I-T170
,	O
and	O
embase	B-T170
were	O
searched	O
up	O
to	O
june	O
2016	O
.	O
manual	O
review	O
of	O
references	O
was	O
completed	O
and	O
experts	B-T097
in	O
the	O
field	O
were	O
contacted	O
for	O
unpublished	B-T170
data	I-T170
.	O
randomized	B-T062
controlled	I-T062
trials	I-T062
of	O
ceft	B-T103
##aro	I-T103
##line	I-T103
in	O
cap	B-T038
or	O
css	B-T038
##si	I-T038
populations	B-T098
were	O
included	O
.	O
outcomes	O
included	O
clinical	B-T033
cure	I-T033
,	O
mortality	O
,	O
adverse	B-T038
events	I-T038
,	O
serious	B-T033
adverse	I-T033
events	I-T033
,	O
and	O
discontinuation	B-T058
due	O
to	O
adverse	B-T038
events	I-T038
.	O
meta	B-T170
-	I-T170
analysis	I-T170
was	O
used	O
to	O
pool	O
results	O
for	O
these	O
outcomes	O
.	O
we	O
performed	O
subgroup	B-T170
analyses	B-T062
for	O
gram	B-T038
positive	I-T038
infections	I-T038
in	O
cap	B-T038
and	O
infections	B-T038
caused	O
by	O
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
in	O
css	B-T038
##sis	I-T038
.	O
risk	O
of	O
bias	O
was	O
assessed	O
for	O
all	O
studies	B-T062
.	O
results	O
six	O
trials	O
(	O
three	O
for	O
each	O
indication	O
)	O
were	O
included	O
,	O
each	O
of	O
which	O
had	O
an	O
unclear	O
or	O
high	O
risk	O
of	O
bias	O
in	O
at	O
least	O
one	O
domain	O
.	O
for	O
cap	B-T038
,	O
ceft	B-T103
##aro	I-T103
##line	I-T103
was	O
significantly	O
more	O
efficacious	O
in	O
achieving	O
clinical	B-T033
cure	I-T033
than	O
ceftriaxone	B-T103
[	O
risk	O
ratio	O
(	O
rr	O
)	O
1	O
.	O
11	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
1	O
.	O
04	O
-	O
1	O
.	O
19	O
;	O
i	O
(	O
2	O
)	O
=	O
47	O
%	O
]	O
.	O
for	O
css	B-T038
##sis	I-T038
,	O
there	O
was	O
no	O
significant	O
difference	O
in	O
clinical	B-T033
cure	I-T033
between	O
ceft	B-T103
##aro	I-T103
##line	I-T103
and	O
vancomycin	B-T103
plus	O
azt	B-T103
##re	I-T103
##ona	I-T103
##m	I-T103
(	O
rr	O
1	O
.	O
01	O
,	O
95	O
%	O
ci	O
0	O
.	O
97	O
-	O
1	O
.	O
05	O
;	O
i	O
(	O
2	O
)	O
=	O
0	O
%	O
)	O
.	O
no	O
differences	O
were	O
found	O
for	O
overall	O
mortality	O
,	O
serious	B-T033
adverse	I-T033
events	I-T033
,	O
discontinuation	B-T058
due	O
to	O
adverse	B-T038
events	I-T038
,	O
and	O
overall	O
adverse	B-T038
events	I-T038
.	O
conclusion	O
ceft	B-T103
##aro	I-T103
##line	I-T103
is	O
a	O
viable	O
therapeutic	B-T058
alternative	I-T058
for	O
patients	O
with	O
cap	B-T038
and	O
css	B-T038
##sis	I-T038
,	O
yet	O
identified	O
risks	O
of	O
bias	O
and	O
poor	B-T033
external	I-T033
validity	I-T033
preclude	O
it	O
from	O
being	O
recommended	O
as	O
a	O
first	B-T103
-	I-T103
line	I-T103
agent	I-T103
.	O

monitoring	B-T058
proteolytic	B-T038
processing	I-T038
events	O
by	O
quantitative	B-T058
mass	I-T058
spectrometry	I-T058
protease	B-T038
activity	I-T038
plays	O
a	O
key	O
role	O
in	O
a	O
wide	O
variety	O
of	O
biological	B-T038
processes	I-T038
including	O
gene	B-T038
expression	I-T038
,	O
protein	B-T038
turnover	I-T038
and	O
development	B-T038
.	O
mis	B-T033
##reg	I-T033
##ulation	I-T033
of	O
these	O
proteins	B-T103
has	O
been	O
associated	O
with	O
many	O
cancer	O
types	O
such	O
as	O
prostate	B-T038
,	O
breast	B-T038
,	O
and	O
skin	B-T038
cancer	I-T038
.	O
thus	O
,	O
the	O
identification	O
of	O
protease	B-T103
substrates	O
will	O
provide	O
key	O
information	O
to	O
understand	B-T038
proteolysis	B-T038
-	O
related	O
pathologies	B-T091
.	O
areas	O
covered	O
:	O
proteomics	B-T091
-	O
based	O
methods	B-T170
to	O
investigate	O
proteolysis	B-T038
activity	I-T038
,	I-T038
focusing	O
on	O
substrate	O
identification	O
,	O
protease	B-T103
specificity	O
and	O
their	O
applications	B-T058
in	O
systems	B-T091
biology	I-T091
are	O
reviewed	O
.	O
their	O
quantification	O
strategies	O
,	O
challenges	B-T058
and	O
pitfalls	O
are	O
underline	O
##d	O
and	O
the	O
biological	O
implications	O
of	O
protease	B-T103
malfunction	O
are	O
highlighted	O
.	O
expert	O
commentary	O
:	O
dysregulated	B-T033
protease	B-T038
activity	I-T038
is	O
a	O
hallmark	O
for	O
some	O
disease	B-T038
pathologies	B-T091
such	O
as	O
cancer	B-T038
.	O
current	O
biochemical	O
approaches	O
are	O
low	O
throughput	O
and	O
some	O
are	O
limited	O
by	O
the	O
amount	O
of	O
sample	O
required	O
to	O
obtain	O
reliable	O
results	B-T033
.	O
mass	B-T058
spectrometry	I-T058
based	O
proteomics	B-T091
provides	O
a	O
suitable	O
platform	O
to	O
investigate	O
protease	B-T038
activity	I-T038
,	O
providing	O
information	O
about	O
substrate	O
specificity	O
and	O
mapping	B-T058
cleavage	B-T082
sites	I-T082
.	O

autologous	B-T103
vs	O
irradiated	B-T103
homologous	I-T103
cost	I-T103
##al	I-T103
cartilage	I-T103
as	O
graft	B-T103
material	I-T103
in	O
rhin	B-T058
##oplasty	I-T058
studies	O
comparing	O
surgical	O
results	O
of	O
rhin	B-T058
##oplasty	I-T058
using	O
autologous	B-T103
cost	I-T103
##al	I-T103
cartilage	I-T103
(	O
acc	B-T103
)	O
and	O
irradiated	B-T103
homologous	I-T103
cost	I-T103
##al	I-T103
cartilage	I-T103
(	O
ihc	B-T103
##c	I-T103
)	O
are	O
rare	O
.	O
to	O
compare	O
the	O
clinical	B-T033
results	I-T033
of	O
major	O
augmentation	B-T058
rhin	I-T058
##oplasty	I-T058
using	O
acc	B-T103
vs	O
ihc	B-T103
##c	I-T103
and	O
analyze	O
the	O
histologic	O
properties	O
of	O
both	O
types	O
of	O
cartilage	B-T017
.	O
a	O
retrospective	B-T062
clinical	I-T062
study	I-T062
was	O
conducted	O
among	O
patients	O
who	O
had	O
undergone	O
rhin	B-T058
##ose	I-T058
##pt	I-T058
##oplasty	I-T058
using	O
acc	B-T103
or	O
ihc	B-T103
##c	I-T103
from	O
january	O
1	O
,	O
2009	O
,	O
to	O
december	O
31	O
,	O
2014	O
.	O
patients	O
were	O
followed	B-T058
up	I-T058
for	O
more	O
than	O
1	O
year	O
after	O
surgery	B-T058
and	O
the	O
histologic	O
characteristics	O
of	O
acc	B-T103
and	O
ihc	B-T103
##c	I-T103
were	O
compared	O
.	O
the	O
details	O
of	O
the	O
surgical	B-T058
procedures	I-T058
and	O
complications	O
,	O
including	O
war	O
##ping	O
,	O
infection	B-T038
,	O
resorption	B-T038
,	O
and	O
/	O
or	O
donor	B-T082
-	I-T082
site	I-T082
morbidity	O
,	O
were	O
evaluated	B-T058
by	O
reviewing	O
medical	B-T170
records	I-T170
and	O
facial	O
photographs	O
.	O
patients	O
'	O
subjective	O
satisfaction	B-T038
with	O
aesthetic	O
and	O
functional	O
results	O
was	O
evaluated	B-T058
using	O
a	O
questionnaire	B-T170
.	O
the	O
details	O
of	O
the	O
surgical	B-T058
procedures	I-T058
and	O
complications	O
,	O
including	O
war	O
##ping	O
,	O
infection	B-T038
,	O
resorption	B-T038
,	O
and	O
/	O
or	O
donor	B-T082
-	I-T082
site	I-T082
morbidity	O
;	O
patients	O
'	O
subjective	O
satisfaction	B-T038
with	O
aesthetic	O
and	O
functional	O
results	O
'	O
objective	O
evaluation	B-T058
of	O
surgical	B-T058
outcomes	O
,	O
including	O
symmetry	O
,	O
dorsal	B-T082
height	O
,	O
dorsal	B-T082
length	O
,	O
dorsal	B-T082
width	O
,	O
tip	B-T033
projection	I-T033
,	O
tip	B-T033
rotation	I-T033
,	O
tip	B-T033
width	I-T033
,	O
and	O
overall	O
result	O
;	O
and	O
histologic	O
structures	B-T082
.	O
objective	O
evaluation	B-T058
of	O
surgical	B-T058
outcomes	O
was	O
graded	O
using	O
the	O
objective	O
rhin	B-T058
##oplasty	I-T058
outcome	B-T033
score	I-T033
,	O
which	O
assessed	O
symmetry	O
,	O
dorsal	B-T082
height	O
,	O
dorsal	B-T082
length	O
,	O
dorsal	B-T082
width	O
,	O
tip	B-T033
projection	I-T033
,	O
tip	B-T033
rotation	I-T033
,	O
tip	B-T033
width	I-T033
,	O
and	O
overall	O
result	O
.	O
histologic	O
structures	O
were	O
evaluated	B-T058
using	O
hematoxylin	B-T058
and	I-T058
eosin	I-T058
,	O
mass	B-T058
##on	I-T058
trich	I-T058
##rome	I-T058
,	O
alc	B-T058
##ian	I-T058
blue	I-T058
,	O
and	O
ver	B-T058
##ho	I-T058
##eff	I-T058
elastic	I-T058
stains	I-T058
.	O
a	O
total	O
of	O
63	O
patients	O
(	O
27	O
males	O
and	O
36	O
females	O
;	O
mean	O
[	O
sd	O
]	O
age	O
,	O
30	O
.	O
6	O
[	O
9	O
.	O
5	O
]	O
years	O
)	O
had	O
rhin	B-T058
##ose	I-T058
##pt	I-T058
##oplasty	I-T058
using	O
acc	B-T103
and	O
20	O
(	O
9	O
males	O
and	O
11	O
females	O
;	O
mean	O
[	O
sd	O
]	O
age	O
,	O
35	O
.	O
4	O
[	O
15	O
.	O
4	O
]	O
years	O
)	O
had	O
rhin	B-T058
##ose	I-T058
##pt	I-T058
##oplasty	I-T058
using	O
ihc	B-T103
##c	I-T103
.	O
among	O
observed	O
complications	O
,	O
only	O
notable	O
resorption	B-T038
occurred	O
more	O
frequently	O
in	O
patients	O
using	O
ihc	B-T103
##c	I-T103
(	O
6	O
[	O
30	O
%	O
]	O
)	O
than	O
with	O
acc	B-T103
(	O
2	O
[	O
3	O
%	O
]	O
)	O
(	O
p	O
=	O
.	O
002	O
)	O
.	O
in	O
subjective	O
evaluations	B-T058
of	O
aesthetic	O
satisfaction	B-T038
,	O
patients	O
who	O
received	O
acc	B-T103
showed	O
significantly	O
greater	O
satisfaction	B-T038
(	O
37	O
of	O
51	O
patients	O
[	O
73	O
%	O
]	O
were	O
very	O
satisfied	O
)	O
than	O
did	O
those	O
who	O
received	O
ihc	B-T103
##c	I-T103
(	O
6	O
of	O
20	O
[	O
30	O
%	O
]	O
)	O
(	O
p	O
=	O
.	O
001	O
)	O
.	O
however	O
,	O
there	O
was	O
no	O
between	O
-	O
group	O
difference	O
in	O
subjective	O
functional	O
outcomes	O
:	O
4	O
of	O
51	O
patients	O
receiving	O
acc	B-T103
(	O
8	O
%	O
)	O
and	O
5	O
of	O
20	O
receiving	O
ihc	B-T103
##c	I-T103
(	O
25	O
%	O
)	O
were	O
satisfied	B-T038
(	O
p	O
=	O
.	O
50	O
)	O
and	O
45	O
of	O
51	O
receiving	O
acc	B-T103
(	O
88	O
%	O
)	O
and	O
15	O
of	O
20	O
receiving	O
ihc	B-T103
##c	I-T103
(	O
75	O
%	O
)	O
were	O
very	O
satisfied	O
(	O
p	O
=	O
.	O
15	O
)	O
.	O
regarding	O
objective	O
aesthetic	O
outcomes	O
,	O
all	O
scores	O
for	O
both	O
acc	B-T103
and	O
ihc	B-T103
##c	I-T103
were	O
more	O
than	O
3	O
.	O
1	O
(	O
between	O
good	O
and	O
excellent	O
)	O
.	O
histologic	B-T058
analyses	I-T058
showed	O
larger	O
,	O
more	O
evenly	O
distributed	O
,	O
uniform	O
chondrocytes	B-T017
and	O
more	O
collagens	B-T103
and	O
proteoglycan	B-T103
contents	O
in	O
acc	B-T103
than	O
in	O
ihc	B-T103
##c	I-T103
.	O
compared	O
with	O
patients	O
receiving	O
ihc	B-T103
##c	I-T103
,	O
those	O
receiving	O
acc	B-T103
for	O
rhin	B-T058
##ose	I-T058
##pt	I-T058
##oplasty	I-T058
showed	O
superior	O
aesthetic	O
satisfaction	B-T038
;	O
acc	B-T103
also	O
had	O
less	O
frequent	O
notable	O
resorption	B-T038
.	O
autologous	B-T103
cost	I-T103
##al	I-T103
cartilage	I-T103
also	O
had	O
better	O
histologic	O
properties	O
than	O
ihc	B-T103
##c	I-T103
did	O
,	O
suggesting	O
it	O
as	O
an	O
ideal	O
graft	B-T103
material	I-T103
with	O
less	O
chance	O
of	O
long	O
-	O
term	O
resorption	B-T038
.	O
3	O
.	O

botulinum	B-T103
toxin	I-T103
use	O
in	O
refractory	B-T033
pain	I-T033
and	O
other	O
symptoms	B-T033
in	O
parkinsonism	B-T038
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
and	O
other	O
parkinsonian	B-T038
syndromes	I-T038
are	O
chronic	O
,	O
progressive	O
neurodegenerative	B-T038
diseases	I-T038
.	O
with	O
advancing	O
disease	B-T038
,	O
both	O
motor	B-T033
and	O
non	B-T033
-	I-T033
motor	I-T033
symptoms	I-T033
represent	O
a	O
considerable	O
burden	O
and	O
symptom	B-T033
relief	B-T033
and	O
quality	O
of	O
life	O
improvement	O
become	O
the	O
main	O
goal	B-T170
of	O
treatment	B-T058
.	O
botulinum	B-T103
toxins	I-T103
(	O
bt	B-T103
##x	I-T103
)	O
are	O
an	O
effective	O
treatment	B-T058
modality	O
for	O
many	O
neurological	B-T038
conditions	I-T038
.	O
to	O
understand	O
the	O
potential	O
usefulness	O
of	O
bt	B-T103
##x	I-T103
in	O
this	O
population	B-T098
,	O
we	O
performed	O
a	O
retrospective	O
chart	B-T058
review	I-T058
of	O
all	O
patients	O
with	O
a	O
clinical	B-T058
diagnosis	I-T058
of	O
idiopathic	B-T038
pd	I-T038
and	O
atypical	B-T038
parkinsonism	I-T038
who	O
received	O
treatment	O
with	O
bt	B-T058
##x	I-T058
injections	I-T058
in	O
our	O
center	B-T092
from	O
1995	O
to	O
2014	O
for	O
a	O
variety	O
of	O
symptoms	B-T033
.	O
response	O
to	O
bt	B-T103
##x	I-T103
was	O
assessed	O
using	O
a	O
subjective	B-T170
clinical	I-T170
global	I-T170
impression	I-T170
.	O
records	B-T170
of	O
160	O
patients	O
were	O
reviewed	O
.	O
probable	O
idiopathic	B-T038
pd	I-T038
was	O
the	O
diagnosis	B-T033
in	O
117	O
patients	O
(	O
73	O
.	O
1	O
%	O
)	O
.	O
the	O
main	O
indication	O
for	O
bt	B-T103
##x	I-T103
treatment	B-T058
was	O
pain	B-T033
(	O
50	O
.	O
6	O
%	O
of	O
cases	O
)	O
.	O
other	O
indications	O
were	O
the	O
treatment	B-T058
of	O
functional	O
impairment	O
resulting	O
from	O
dystonia	B-T033
(	O
26	O
.	O
25	O
%	O
)	O
,	O
sial	B-T038
##orrhea	I-T038
(	O
18	O
.	O
75	O
%	O
)	O
,	O
freezing	B-T033
of	I-T033
gait	I-T033
,	O
and	O
camp	B-T017
##to	I-T017
##cor	I-T017
##mia	I-T017
.	O
considering	O
pain	B-T033
as	O
indication	O
,	O
81	O
%	O
of	O
all	O
patients	O
with	O
pd	B-T038
reported	B-T058
benefits	O
after	O
the	O
first	O
bt	B-T058
##x	I-T058
injections	I-T058
.	O
this	O
benefit	O
was	O
maintained	O
after	O
the	O
last	B-T058
recorded	I-T058
visit	I-T058
without	O
significant	O
difference	O
in	O
outcome	O
compared	O
with	O
the	O
first	O
injection	B-T058
(	O
p	O
=	O
0	O
.	O
06	O
##7	O
)	O
.	O
similar	O
results	O
were	O
observed	O
in	O
patients	O
with	O
atypical	B-T038
parkinsonism	I-T038
.	O
our	O
results	O
confirm	O
the	O
safety	O
and	O
efficacy	O
of	O
different	O
uses	O
of	O
bt	B-T103
##x	I-T103
in	O
the	O
symptomatic	O
treatment	O
of	O
patients	O
with	O
parkinsonism	B-T038
even	O
in	O
advanced	O
stages	O
of	O
the	O
disease	B-T038
,	O
and	O
suggest	O
bt	B-T103
##x	I-T103
treatment	B-T058
could	O
have	O
a	O
safe	O
and	O
useful	O
role	O
in	O
the	O
treatment	O
of	O
pain	B-T033
in	O
this	O
population	B-T098
.	O

problem	O
-	O
based	O
learning	O
using	O
patient	B-T170
-	I-T170
simulated	I-T170
videos	I-T170
showing	O
daily	O
life	O
for	O
a	O
comprehensive	O
clinical	O
approach	O
we	O
examined	O
whether	O
problem	O
-	O
based	O
learning	O
tut	B-T170
##orial	I-T170
##s	I-T170
using	O
patient	B-T170
-	I-T170
simulated	I-T170
videos	I-T170
showing	O
daily	O
life	O
are	O
more	O
practical	O
for	O
clinical	O
learning	B-T038
,	O
compared	O
with	O
traditional	O
paper	O
-	O
based	O
problem	O
-	O
based	O
learning	O
,	O
for	O
the	O
consideration	O
rate	B-T033
of	I-T033
psychosocial	I-T033
issues	I-T033
and	O
the	O
recall	B-T033
rate	I-T033
for	O
experienced	B-T038
learning	I-T038
.	O
twenty	O
-	O
two	O
groups	O
with	O
120	O
fifth	O
-	O
year	O
students	B-T098
were	O
each	O
assigned	O
paper	O
-	O
based	O
problem	O
-	O
based	O
learning	O
and	O
video	B-T170
-	O
based	O
problem	O
-	O
based	O
learning	O
using	O
patient	B-T170
-	I-T170
simulated	I-T170
videos	I-T170
.	O
we	O
compared	O
target	O
achievement	B-T033
rates	I-T033
in	O
questionnaires	B-T170
using	O
the	O
wilcoxon	B-T170
signed	I-T170
-	I-T170
rank	I-T170
test	I-T170
and	O
discussion	O
contents	O
diversity	O
using	O
the	O
mann	O
-	O
whitney	O
u	O
test	O
.	O
a	O
follow	B-T062
-	I-T062
up	I-T062
survey	B-T170
used	O
a	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
to	O
measure	O
students	B-T098
'	O
recall	O
of	O
cases	O
in	O
three	O
categories	B-T170
:	O
video	B-T170
,	O
paper	O
,	O
and	O
non	O
-	O
experienced	O
.	O
video	B-T170
-	O
based	O
problem	O
-	O
based	O
learning	O
displayed	O
significantly	O
higher	O
achievement	B-T033
rates	I-T033
for	O
imag	O
##ining	O
authentic	O
patients	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
incorporating	O
a	O
comprehensive	O
approach	O
including	O
psychosocial	O
aspects	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
satisfaction	O
with	O
sessions	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
no	O
significant	O
differences	O
existed	O
in	O
the	O
discussion	O
contents	O
diversity	O
regarding	O
the	O
international	O
classification	O
of	O
primary	O
care	O
second	O
edition	O
codes	O
and	O
chapter	O
types	O
or	O
in	O
the	O
rate	B-T033
of	I-T033
psychological	I-T033
codes	I-T033
.	O
in	O
a	O
follow	B-T062
-	I-T062
up	I-T062
survey	B-T170
comparing	O
video	B-T170
and	O
paper	O
groups	O
to	O
non	O
-	O
experienced	O
groups	O
,	O
the	O
rates	O
were	O
higher	O
for	O
video	B-T170
(	O
χ	O
(	O
2	O
)	O
=	O
24	O
.	O
319	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
paper	O
(	O
χ	O
(	O
2	O
)	O
=	O
11	O
.	O
134	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
although	O
the	O
video	B-T170
rate	O
tended	O
to	O
be	O
higher	O
than	O
the	O
paper	O
rate	O
,	O
no	O
significant	O
difference	O
was	O
found	O
between	O
the	O
two	O
.	O
patient	B-T170
-	I-T170
simulated	I-T170
videos	I-T170
showing	O
daily	O
life	O
facilitate	O
imag	O
##ining	O
true	O
patients	O
and	O
support	O
a	O
comprehensive	O
approach	O
that	O
foster	O
##s	O
better	O
memory	B-T038
.	O
the	O
clinical	O
patient	B-T170
-	I-T170
simulated	I-T170
video	I-T170
method	O
is	O
more	O
practical	O
and	O
clinical	O
problem	B-T170
-	I-T170
based	I-T170
tut	I-T170
##orial	I-T170
##s	I-T170
can	O
be	O
implemented	O
if	O
we	O
create	O
patient	B-T170
-	I-T170
simulated	I-T170
videos	I-T170
for	O
each	O
symptom	B-T033
as	O
teaching	O
materials	O
.	O

multip	B-T062
##ara	I-T062
##met	I-T062
##ric	I-T062
estimation	I-T062
of	O
brain	B-T038
hemodynamics	I-T038
with	O
mr	B-T058
fingerprinting	I-T058
asl	I-T058
assessment	B-T058
of	O
brain	B-T038
hemodynamics	I-T038
without	O
exogenous	O
contrast	B-T103
agents	I-T103
is	O
of	O
increasing	O
importance	O
in	O
clinical	O
applications	O
.	O
this	O
study	O
aims	O
to	O
develop	O
an	O
mr	B-T058
perfusion	I-T058
technique	I-T058
that	O
can	O
provide	O
noncon	B-T033
##trast	I-T033
and	O
multip	B-T062
##ara	I-T062
##met	I-T062
##ric	I-T062
estimation	I-T062
of	O
hemodynamic	B-T038
markers	B-T074
.	O
we	O
devised	O
an	O
arterial	B-T058
spin	I-T058
labeling	I-T058
(	O
asl	B-T058
)	O
method	O
based	O
on	O
the	O
principle	O
of	O
mr	B-T058
fingerprinting	I-T058
(	O
mr	B-T058
##f	I-T058
)	O
,	O
referred	O
to	O
as	O
mr	B-T058
##f	I-T058
-	I-T058
asl	I-T058
.	O
by	O
taking	O
advantage	O
of	O
the	O
rich	O
information	O
contained	O
in	O
mr	B-T058
##f	I-T058
sequence	I-T058
,	O
up	O
to	O
seven	O
hemodynamic	B-T038
parameters	B-T033
can	O
be	O
estimated	O
concomitantly	O
.	O
feasibility	B-T062
demonstration	I-T062
,	O
flip	O
angle	O
optimization	O
,	O
comparison	O
with	O
look	B-T058
-	I-T058
lock	I-T058
##er	I-T058
asl	I-T058
,	O
reproducibility	O
test	O
,	O
sensitivity	O
to	O
hypercapnia	B-T033
challenge	I-T033
,	O
and	O
initial	O
clinical	O
application	O
in	O
an	O
intracranial	B-T058
sten	I-T058
##o	I-T058
-	I-T058
occlusive	I-T058
process	I-T058
,	O
mo	B-T038
##ya	I-T038
##mo	I-T038
##ya	I-T038
disease	I-T038
,	O
were	O
performed	O
to	O
evaluate	O
this	O
technique	O
.	O
magnetic	B-T058
resonance	I-T058
fingerprinting	I-T058
asl	I-T058
provided	O
estimation	O
of	O
up	O
to	O
seven	O
parameters	B-T033
,	O
including	O
b1	O
+	O
,	O
tissue	B-T017
t1	O
,	O
cerebral	B-T033
blood	I-T033
flow	I-T033
(	O
cbf	B-T033
)	O
,	O
tissue	B-T017
bolus	B-T033
arrival	I-T033
time	I-T033
(	O
bat	B-T033
)	O
,	O
pass	O
-	O
through	O
arterial	B-T017
bat	B-T033
,	O
pass	O
-	O
through	O
blood	B-T201
volume	I-T201
,	O
and	O
pass	O
-	O
through	O
blood	B-T058
travel	I-T058
time	I-T058
.	O
coefficients	O
of	O
variation	O
of	O
the	O
estimated	O
parameters	B-T033
ranged	O
from	O
0	O
.	O
2	O
to	O
9	O
.	O
6	O
%	O
.	O
hypercapnia	B-T033
resulted	O
in	O
an	O
increase	O
in	O
cbf	B-T033
by	O
57	O
.	O
7	O
%	O
,	O
and	O
a	O
decrease	O
in	O
bat	B-T033
by	O
13	O
.	O
7	O
and	O
24	O
.	O
8	O
%	O
in	O
tissue	B-T017
and	O
vessels	B-T017
,	O
respectively	O
.	O
patients	O
with	O
mo	B-T038
##ya	I-T038
##mo	I-T038
##ya	I-T038
disease	I-T038
showed	O
diminished	O
cbf	B-T033
and	O
length	O
##ened	O
bat	B-T033
that	O
could	B-T033
not	I-T033
be	I-T033
detected	I-T033
with	O
regular	O
asl	B-T058
.	O
magnetic	B-T058
resonance	I-T058
fingerprinting	I-T058
asl	I-T058
is	O
a	O
promising	O
technique	O
for	O
noncon	B-T033
##trast	I-T033
,	O
multip	B-T062
##ara	I-T062
##met	I-T062
##ric	I-T062
perfusion	B-T058
assessment	I-T058
.	O
magn	O
reson	O
med	O
,	O
2016	O
.	O
©	O
2016	O
international	B-T092
society	I-T092
for	I-T092
magnetic	I-T092
resonance	I-T092
in	I-T092
medicine	I-T092
.	O

effectiveness	O
of	O
off	O
##load	O
##ing	O
methods	B-T058
in	O
preventing	O
primary	O
diabetic	B-T038
foot	I-T038
ulcers	I-T038
in	O
adults	O
with	O
diabetes	B-T038
:	O
a	O
systematic	B-T170
review	I-T170
the	O
incidence	O
of	O
foot	B-T038
ulceration	I-T038
related	O
to	O
diabetes	B-T038
is	O
increasing	O
.	O
many	O
foot	B-T058
care	I-T058
professionals	B-T097
recommend	O
off	O
##load	O
##ing	O
measures	O
as	O
part	O
of	O
management	O
strategies	O
for	O
modulating	O
excess	O
pressure	O
to	O
prevent	O
development	O
of	O
diabetic	B-T038
foot	I-T038
ulcers	I-T038
(	O
df	B-T038
##us	I-T038
)	O
.	O
these	O
measures	O
may	O
include	O
pad	B-T058
##ding	I-T058
,	O
insol	O
##es	O
/	O
ortho	B-T074
##tic	I-T074
devices	I-T074
and	O
foot	O
##we	O
##ar	O
.	O
there	O
is	O
a	O
lack	O
of	O
evidence	O
-	O
based	O
guidance	O
on	O
the	O
effectiveness	O
of	O
the	O
different	O
off	O
##load	O
##ing	O
options	O
for	O
preventing	O
primary	O
ulceration	B-T038
in	O
those	O
with	O
diabetes	B-T038
.	O
to	O
identify	O
,	O
critically	O
appra	O
##ise	O
and	O
synthesize	O
the	O
best	O
available	O
evidence	O
on	O
methods	B-T058
of	O
off	O
##load	O
##ing	O
to	O
prevent	O
the	O
development	O
,	O
and	O
reduce	O
the	O
risk	O
,	O
of	O
primary	O
foot	B-T038
ulceration	I-T038
in	O
adults	O
with	O
diabetes	B-T038
.	O
the	O
question	O
addressed	B-T170
by	O
the	O
review	B-T170
was	O
:	O
what	O
is	O
the	O
effectiveness	O
of	O
methods	B-T058
of	O
off	O
##load	O
##ing	O
in	O
preventing	O
primary	O
df	B-T038
##us	I-T038
in	O
adults	O
with	O
diabetes	B-T038
?	O
adults	O
18	O
years	O
and	O
older	O
with	O
diabetes	B-T038
mellitus	I-T038
,	O
regardless	O
of	O
age	O
,	O
gender	O
,	O
ethnicity	O
,	O
duration	O
or	O
type	O
of	O
diabetes	B-T038
,	O
with	O
no	O
history	B-T033
of	O
df	B-T038
##us	I-T038
and	O
in	O
any	O
clinical	O
setting	O
will	O
be	O
included	O
.	O
interventions	B-T058
will	O
include	O
all	O
external	O
methods	B-T058
of	O
off	O
##load	O
##ing	O
.	O
all	O
compar	O
##ators	O
will	O
be	O
considered	O
.	O
studies	B-T062
that	O
utilize	O
interventions	B-T058
not	O
considered	O
usual	O
practice	B-T058
in	O
the	O
prevention	O
of	O
df	B-T038
##us	I-T038
will	O
be	O
excluded	O
.	O
the	O
primary	O
outcome	O
will	O
be	O
primary	O
foot	B-T038
ulceration	I-T038
.	O
the	O
secondary	O
outcome	O
will	O
be	O
indications	O
of	O
changes	O
in	O
plantar	B-T082
pressure	O
.	O
this	O
review	B-T170
will	O
consider	O
all	O
quantitative	O
study	B-T062
designs	I-T062
.	O
a	O
three	O
-	O
step	O
strategy	O
for	O
published	O
and	O
unpublished	O
literature	B-T170
will	O
be	O
used	O
.	O
fourteen	O
databases	B-T170
will	O
be	O
searched	O
for	O
studies	B-T062
in	O
english	O
up	O
to	O
november	O
2013	O
.	O
the	O
j	B-T170
##bi	I-T170
-	I-T170
mast	I-T170
##ari	I-T170
extraction	I-T170
tool	I-T170
was	O
used	O
to	O
extract	O
relevant	O
data	O
.	O
results	O
were	O
summarized	O
using	O
narrative	O
and	O
tables	B-T170
.	O
three	O
studies	B-T062
which	O
examined	O
the	O
effectiveness	O
of	O
four	O
different	O
off	O
##load	O
##ing	O
interventions	B-T058
met	O
the	O
inclusion	O
criteria	O
.	O
there	O
is	O
limited	O
evidence	O
that	O
use	O
of	O
a	O
foot	O
##we	O
##ar	O
system	O
(	O
prototype	O
sho	O
##e	O
plus	O
polyurethane	O
or	O
cor	O
##k	O
insol	O
##e	O
)	O
may	O
prevent	O
a	O
break	O
in	O
the	O
skin	B-T022
;	O
use	O
of	O
customized	O
rigid	O
ortho	B-T074
##tic	I-T074
devices	I-T074
may	O
contribute	O
to	O
a	O
reduction	O
in	O
the	O
grade	O
and	O
number	O
of	O
callus	B-T017
##es	I-T017
;	O
and	O
a	O
manufactured	O
sho	O
##e	O
plus	O
customized	O
insol	O
##e	O
may	O
reduce	O
plantar	B-T082
pressure	O
and	O
therefore	O
reduce	O
the	O
potential	O
risk	O
of	O
skin	B-T038
ulceration	I-T038
.	O
there	O
is	O
limited	O
and	O
low	O
-	O
quality	O
evidence	O
that	O
in	O
a	O
population	B-T098
of	O
adults	O
with	O
diabetes	B-T038
with	O
no	O
history	B-T033
of	O
df	B-T038
##u	I-T038
,	O
the	O
use	O
of	O
foot	O
##we	O
##ar	O
with	O
customized	O
or	O
pref	O
##abric	O
##ated	O
ortho	B-T074
##tic	I-T074
devices	I-T074
may	O
provide	O
some	O
reduction	O
in	O
plantar	B-T082
pressure	O
and	O
therefore	O
help	O
to	O
prevent	O
a	O
primary	O
df	B-T038
##u	I-T038
.	O
there	O
is	O
a	O
lack	O
of	O
evidence	O
on	O
the	O
relative	O
effectiveness	O
of	O
different	O
off	O
##load	O
##ing	O
options	O
.	O

the	O
longitudinal	B-T082
effects	O
of	O
parenting	O
on	O
adaptive	O
behavior	O
in	O
children	O
with	O
fragile	B-T038
x	I-T038
syndrome	I-T038
several	O
studies	B-T062
have	O
reported	O
declines	O
in	O
adaptive	O
behavior	O
amongst	O
children	O
with	O
fragile	B-T038
x	I-T038
syndrome	I-T038
(	O
fx	B-T038
##s	I-T038
)	O
starting	O
in	O
middle	O
childhood	O
.	O
we	O
examined	B-T033
the	O
effects	O
of	O
maternal	O
respons	O
##ivity	O
on	O
adaptive	O
behavior	O
in	O
55	O
children	O
with	O
fx	B-T038
##s	I-T038
visited	O
5	O
-	O
6	O
times	O
in	O
their	O
homes	B-T092
from	O
early	O
through	O
middle	O
childhood	O
.	O
our	O
analyses	B-T062
indicated	O
that	O
sustained	O
maternal	O
respons	O
##ivity	O
had	O
a	O
significant	O
positive	O
impact	O
on	O
the	O
trajectories	O
of	O
communication	O
and	O
to	O
a	O
lesser	O
extent	O
other	O
adaptive	O
behavior	O
domains	O
through	O
middle	O
childhood	O
with	O
many	O
effects	O
remaining	O
significant	O
after	O
controlling	O
for	O
autism	B-T033
symptoms	I-T033
and	O
developmental	B-T038
level	I-T038
.	O
for	O
children	O
who	O
showed	O
declines	O
in	O
adaptive	O
behavior	O
during	O
middle	O
childhood	O
,	O
sustained	O
high	O
levels	O
of	O
maternal	O
respons	O
##ivity	O
minimized	O
the	O
amount	O
of	O
decline	O
observed	O
in	O
the	O
communication	O
,	O
social	O
##ization	O
,	O
and	O
daily	O
living	O
domains	O
.	O

lamp	B-T103
-	I-T103
2	I-T103
mediates	O
oxidative	B-T038
stress	I-T038
-	O
dependent	O
cell	B-T038
death	I-T038
in	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
treated	B-T058
lung	B-T017
epithelium	B-T017
cells	I-T017
zinc	B-T103
is	O
an	O
essential	O
element	B-T103
for	O
the	O
biological	B-T022
system	I-T022
.	O
however	O
,	O
excessive	O
exogenous	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
would	O
disrupt	O
cellular	B-T038
zn	I-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
homeostasis	I-T038
and	O
cause	B-T037
toxicity	I-T037
.	O
in	O
particular	O
,	O
zinc	B-T103
salts	I-T103
or	O
zno	B-T103
nanoparticles	O
exposure	O
could	O
induce	O
respiratory	B-T037
injury	I-T037
.	O
although	O
previous	O
studies	O
have	O
indicated	O
that	O
organelle	B-T017
damage	O
(	O
including	O
mitochondria	B-T017
or	O
lysosomes	B-T017
)	O
and	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
production	O
are	O
involved	O
in	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
induced	O
toxicity	B-T037
,	O
the	O
interplay	O
between	O
mitochondria	B-T017
/	O
lysosomes	B-T017
damage	O
and	O
ros	B-T103
production	O
is	O
obscure	O
.	O
herein	O
,	O
we	O
demonstrated	O
that	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
could	O
induce	O
deg	B-T038
##lyc	I-T038
##osylation	I-T038
of	O
lysosome	B-T103
-	I-T103
associated	I-T103
membrane	I-T103
protein	I-T103
1	I-T103
and	O
2	B-T103
(	O
lamp	B-T103
-	I-T103
1	I-T103
and	O
lamp	B-T103
-	I-T103
2	I-T103
)	O
,	O
which	O
primarily	O
locate	O
in	O
late	O
endosomes	B-T017
/	O
lysosomes	B-T017
,	O
in	O
a549	B-T017
lung	I-T017
epithelium	I-T017
cells	I-T017
.	O
intriguing	O
##ly	O
,	O
lamp	B-T017
-	I-T017
2	I-T017
knockdown	B-T062
further	O
aggravated	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
mediated	O
ros	B-T103
production	O
and	O
cell	B-T038
death	I-T038
,	O
indicating	O
lamp	B-T103
-	I-T103
2	I-T103
(	O
not	O
lamp	B-T103
-	I-T103
1	I-T103
)	O
was	O
involved	O
in	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
induced	O
toxicity	B-T037
.	O
our	O
results	O
provide	O
a	O
new	O
insight	O
that	O
lamp	B-T103
-	I-T103
2	I-T103
contributes	O
to	O
the	O
ros	B-T103
clearance	O
and	O
cell	B-T038
death	I-T038
induced	O
by	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
treatment	B-T058
,	O
which	O
would	O
help	O
us	O
to	O
get	O
a	O
better	O
understanding	O
of	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
induced	O
toxicity	B-T037
in	O
respiratory	B-T022
system	I-T022
.	O

extracellular	B-T017
self	O
-	O
assembly	O
of	O
functional	O
and	O
tunable	B-T103
protein	I-T103
conjugates	I-T103
from	O
bacillus	B-T007
subtilis	I-T007
the	O
ability	O
to	O
stably	O
and	O
specifically	O
conjugate	B-T038
recombinant	B-T103
proteins	I-T103
to	O
one	O
another	O
is	O
a	O
powerful	O
approach	O
for	O
engineering	B-T062
multifunctional	O
enzymes	B-T103
,	O
protein	O
therapeutics	O
,	O
and	O
novel	O
biological	B-T103
materials	I-T103
.	O
while	O
many	O
of	O
these	O
applications	O
have	O
been	O
illustrated	O
through	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
intracellular	B-T082
protein	B-T038
conjugation	I-T038
methods	O
,	O
extracellular	B-T017
self	O
-	O
assembly	O
of	O
protein	B-T103
conjugates	I-T103
offers	O
unique	O
advantages	O
:	O
simplify	O
##ing	O
purification	B-T058
,	O
reducing	O
toxicity	B-T037
and	O
burden	O
,	O
and	O
enabling	O
tun	O
##ability	O
.	O
exploiting	O
the	O
recently	O
described	O
sp	B-T058
##yt	I-T058
##ag	I-T058
-	I-T058
sp	I-T058
##yc	I-T058
##atch	I-T058
##er	I-T058
system	I-T058
,	O
we	O
describe	O
here	O
how	O
enzymes	B-T103
and	O
structural	B-T103
proteins	I-T103
can	O
be	O
genetically	B-T038
encoded	I-T038
to	O
covalently	B-T038
conjugate	B-T038
in	O
culture	B-T103
media	I-T103
following	O
programm	B-T038
##able	I-T038
secretion	I-T038
from	O
bacillus	B-T007
subtilis	I-T007
.	O
using	O
this	O
approach	O
,	O
we	O
demonstrate	O
how	O
self	B-T038
-	I-T038
conjugation	I-T038
of	O
a	O
secreted	B-T038
industrial	O
enzyme	B-T103
,	O
xy	B-T103
##na	I-T103
,	O
dramatically	O
increases	O
its	O
resilience	O
to	O
boiling	O
,	O
and	O
we	O
show	O
that	O
cellular	B-T017
consor	I-T017
##tia	I-T017
can	O
be	O
engineered	B-T062
to	O
self	O
-	O
assemble	O
functional	O
protein	B-T103
-	I-T103
protein	I-T103
conjugates	I-T103
with	O
tunable	O
composition	O
.	O
this	O
novel	O
genetically	B-T038
encoded	I-T038
modular	O
system	O
provides	O
a	O
flexible	O
strategy	O
for	O
protein	B-T038
conjugation	I-T038
harness	O
##ing	O
the	O
substantial	O
advantages	O
of	O
extracellular	B-T017
self	O
-	O
assembly	O
.	O

linking	O
phenol	O
##og	O
##ical	O
events	O
in	O
migratory	B-T204
pass	I-T204
##erine	I-T204
##s	I-T204
with	O
a	O
changing	O
climate	O
:	O
50	O
years	O
in	O
the	O
la	B-T082
##ure	I-T082
##l	I-T082
highl	I-T082
##ands	I-T082
of	I-T082
pen	I-T082
##ns	I-T082
##ylv	I-T082
##ania	I-T082
advanced	O
timing	O
of	O
both	O
seasonal	O
migration	O
and	O
reproduction	B-T038
in	O
birds	B-T204
has	O
been	O
strongly	O
associated	O
with	O
a	O
warming	O
climate	O
for	O
many	O
bird	B-T204
species	B-T170
.	O
phenol	O
##og	O
##ical	O
responses	O
to	O
climate	O
linking	O
these	O
stages	O
may	O
ultimately	O
impact	O
fitness	O
.	O
we	O
analyzed	B-T062
five	O
decades	O
of	O
banding	O
data	O
from	O
17	O
migratory	B-T204
bird	I-T204
species	B-T170
to	O
investigate	O
1	O
)	O
how	O
spring	O
arrival	O
related	O
to	O
timing	O
of	O
breeding	B-T038
,	O
2	O
)	O
if	O
the	O
interval	O
between	O
arrival	O
and	O
breeding	B-T038
has	O
changed	O
with	O
increasing	O
spring	O
temperatures	O
,	O
and	O
3	O
)	O
whether	O
arrival	O
timing	O
or	O
breeding	B-T038
timing	O
best	O
predicted	O
local	B-T033
productivity	I-T033
.	O
four	O
of	O
17	O
species	B-T170
,	O
all	O
mid	B-T204
-	I-T204
to	I-T204
long	I-T204
-	I-T204
distance	I-T204
migrants	I-T204
,	O
hatch	B-T038
##ed	I-T038
young	O
earlier	O
in	O
years	O
when	O
migrants	B-T098
arr	O
##ived	O
earlier	O
to	O
the	O
breeding	O
grounds	O
(	O
~	O
1	O
:	O
1	O
day	O
advancement	O
)	O
.	O
the	O
interval	O
between	O
arrival	O
on	O
breeding	O
grounds	O
and	O
appearance	O
of	O
juveniles	O
shortened	O
with	O
warm	O
##er	O
spring	O
temperatures	O
for	O
12	O
species	B-T170
(	O
1	O
-	O
6	O
days	O
for	O
every	O
1	O
##°c	O
increase	O
)	O
and	O
over	O
time	O
for	O
seven	O
species	B-T170
(	O
1	O
-	O
8	O
days	O
per	O
decade	O
)	O
,	O
suggesting	O
that	O
some	O
migratory	B-T204
pass	I-T204
##erine	I-T204
##s	I-T204
adapt	O
to	O
climate	O
change	O
by	O
laying	B-T038
more	O
quickly	O
after	O
arrival	B-T033
or	O
reducing	O
the	O
time	O
from	O
laying	B-T038
to	O
fle	O
##dg	O
##ing	O
.	O
we	O
found	O
more	O
support	O
for	O
the	O
former	O
,	O
that	O
the	O
rate	O
of	O
reproductive	B-T038
advancement	I-T038
was	O
higher	O
than	O
that	O
for	O
arrival	B-T033
in	O
warm	O
years	O
.	O
timing	O
of	O
spring	O
arrival	O
and	O
breeding	B-T038
were	O
both	O
poor	O
predictors	O
of	O
avian	B-T204
productivity	O
for	O
most	O
migrants	B-T204
analyzed	B-T062
.	O
nevertheless	O
,	O
we	O
found	O
evidence	O
that	O
fitness	B-T038
benefits	O
may	O
occur	O
from	O
shifts	O
to	O
earlier	O
spring	O
arrival	O
for	O
the	O
multi	B-T204
-	I-T204
bro	I-T204
##oded	I-T204
song	I-T204
spar	I-T204
##row	I-T204
.	O
our	O
results	O
uniquely	O
demonstrate	O
that	O
co	O
-	O
occurring	O
avian	B-T204
species	B-T170
are	O
phenol	O
##og	O
##ically	O
plastic	O
in	O
their	O
response	O
to	O
climate	O
change	O
on	O
their	O
breeding	O
grounds	O
.	O
if	O
migrants	B-T098
continue	O
to	O
show	O
a	O
weaker	O
response	O
to	O
temperatures	O
during	O
migration	O
than	O
breeding	B-T038
,	O
and	O
the	O
window	O
between	O
arrival	O
and	O
optimal	B-T038
breeding	I-T038
shorten	O
##s	O
further	O
,	O
biological	O
constraints	O
to	O
plasticity	O
may	O
limit	O
the	O
ability	O
of	O
species	B-T170
to	O
adapt	O
successfully	O
to	O
future	O
warming	O
.	O

unt	O
##ype	O
##able	O
hepatitis	B-T005
c	I-T005
virus	I-T005
subtypes	B-T170
in	O
pakistan	B-T082
:	O
a	O
neglected	O
section	O
diagnostic	O
##ally	O
unt	O
##ype	O
##able	O
subtypes	B-T170
contribute	O
a	O
considerable	O
percent	O
of	O
hepatitis	B-T005
c	I-T005
virus	I-T005
(	O
hcv	B-T005
)	O
subtypes	B-T170
in	O
pakistan	B-T082
.	O
in	O
the	O
present	O
study	B-T062
,	O
chronically	B-T038
infected	I-T038
hcv	B-T005
patients	O
with	O
known	O
viremia	B-T038
were	O
subjected	O
to	O
hcv	B-T005
genotyping	O
.	O
among	O
the	O
total	O
retrieved	O
samples	O
,	O
92	O
.	O
7	O
%	O
(	O
64	O
/	O
69	O
)	O
were	O
found	O
type	O
##able	O
while	O
7	O
.	O
24	O
%	O
(	O
5	O
/	O
69	O
)	O
were	O
diagnostic	O
##ally	O
unt	O
##ype	O
##able	O
.	O
in	O
conclusion	O
,	O
the	O
presence	O
of	O
large	O
number	O
of	O
unt	O
##ype	O
##able	O
hcv	B-T005
subtypes	B-T170
emphasizes	O
the	O
need	O
of	O
an	O
updated	O
type	O
-	O
specific	O
genotyping	O
assay	B-T058
and	O
consideration	O
of	O
primers	B-T103
for	O
proportionally	O
rare	O
subtypes	B-T170
to	O
minimize	O
the	O
number	O
of	O
unt	O
##ype	O
##able	O
hcv	B-T005
subtypes	B-T170
.	O

primary	O
management	B-T058
and	O
outcome	O
-	O
open	B-T037
laryng	I-T037
##otracheal	I-T037
trauma	I-T037
acute	O
external	O
injury	O
to	O
the	O
larynx	B-T017
is	O
both	O
life	B-T033
threatening	I-T033
and	O
a	O
potential	O
long	O
term	O
management	O
challenge	O
.	O
as	O
ot	B-T097
##orh	I-T097
##inol	I-T097
##aryng	I-T097
##ologist	I-T097
we	O
must	O
be	O
prepared	O
and	O
well	O
vers	O
##ed	O
to	O
manage	O
these	O
patients	O
.	O
in	O
our	O
study	O
seven	O
patients	O
of	O
open	B-T037
laryngeal	I-T037
trauma	I-T037
##s	I-T037
were	O
managed	O
by	O
primary	B-T058
closure	I-T058
.	O
in	O
five	O
patients	O
nature	B-T037
of	I-T037
injury	I-T037
was	O
known	O
in	O
other	O
two	O
patients	O
exact	O
nature	B-T037
of	I-T037
injury	I-T037
was	O
not	O
known	O
.	O
after	O
primary	B-T058
closure	I-T058
five	O
patients	O
with	O
known	O
injury	B-T037
survived	O
and	O
two	O
patients	O
with	O
unknown	O
injury	B-T037
died	B-T038
.	O
as	O
per	O
our	O
experience	B-T033
,	O
we	O
recommend	O
primary	B-T058
closure	I-T058
,	O
if	O
the	O
exact	O
nature	B-T037
of	I-T037
injury	I-T037
is	O
known	O
as	O
the	O
outcome	O
is	O
definitely	O
favourable	B-T033
.	O

salvage	B-T058
therapy	I-T058
with	O
ceft	B-T103
##olo	I-T103
##z	I-T103
##ane	I-T103
-	I-T103
taz	I-T103
##obac	I-T103
##ta	I-T103
##m	I-T103
for	O
multidrug	B-T007
-	I-T007
resistant	I-T007
pseudomonas	I-T007
aeruginosa	I-T007
infections	B-T038
infections	B-T038
caused	O
by	O
multidrug	B-T007
-	I-T007
resistant	I-T007
pseudomonas	I-T007
aeruginosa	I-T007
(	O
mdr	B-T007
##pa	I-T007
)	O
present	O
a	O
major	O
problem	O
for	O
therapeutic	B-T058
management	I-T058
.	O
we	O
report	O
here	O
our	O
experience	O
with	O
12	O
patients	O
with	O
a	O
severe	O
mdr	B-T007
##pa	I-T007
infection	B-T038
(	O
6	O
of	O
which	O
were	O
pneumonia	B-T038
)	O
who	O
received	O
salvage	B-T058
therapy	I-T058
with	O
ceft	B-T103
##olo	I-T103
##z	I-T103
##ane	I-T103
-	I-T103
taz	I-T103
##obac	I-T103
##ta	I-T103
##m	I-T103
after	O
inappropriate	O
empirical	B-T058
treatment	I-T058
and	O
/	O
or	O
suboptimal	O
targeted	O
treatment	B-T058
.	O
although	O
10	O
of	O
the	O
12	O
patients	O
(	O
83	O
.	O
3	O
%	O
)	O
experienced	O
septic	B-T038
shock	I-T038
,	O
only	O
3	O
patients	O
(	O
25	O
%	O
)	O
died	B-T038
during	O
the	O
follow	B-T058
-	I-T058
up	I-T058
period	O
.	O
microbiological	B-T058
cure	O
in	O
7	O
patients	O
(	O
58	O
.	O
3	O
%	O
)	O
was	O
observed	O
.	O

on	B-T082
-	I-T082
site	I-T082
fertility	B-T058
preservation	I-T058
services	I-T058
for	O
adolescents	O
and	O
young	O
adults	O
in	O
a	O
comprehensive	B-T092
cancer	I-T092
center	I-T092
adolescents	O
and	O
young	O
adults	O
(	O
ay	O
##as	O
)	O
receiving	O
cancer	B-T058
treatments	I-T058
that	O
may	O
impair	B-T038
fertility	I-T038
should	O
receive	O
counseling	B-T058
about	O
risk	B-T033
of	I-T033
infertility	I-T033
and	O
options	O
for	O
fertility	B-T058
preservation	I-T058
(	O
fp	B-T058
)	O
before	O
treatment	B-T058
and	O
/	O
or	O
during	O
survivorship	O
.	O
our	O
objective	B-T170
was	O
to	O
define	O
the	O
ay	O
##a	O
patient	O
population	B-T098
referred	O
to	O
an	O
on	B-T058
-	I-T058
site	I-T058
fertility	I-T058
consultation	I-T058
service	I-T058
within	O
a	O
comprehensive	B-T092
cancer	I-T092
center	I-T092
and	O
determine	O
factors	O
associated	O
with	O
patients	O
proceeding	O
with	O
fp	B-T058
treatment	I-T058
.	O
we	O
conducted	O
a	O
retrospective	B-T062
chart	I-T062
review	I-T062
of	O
ay	O
##a	O
women	B-T098
who	O
completed	O
a	O
consultation	B-T058
at	O
the	O
md	B-T058
and	I-T058
##erson	I-T058
fertility	I-T058
preservation	I-T058
and	I-T058
family	I-T058
building	I-T058
service	I-T058
during	O
the	O
first	O
year	O
of	O
service	O
.	O
records	B-T170
of	O
154	O
referred	O
ay	O
##a	O
patients	O
were	O
reviewed	O
for	O
age	O
,	O
ethnicity	B-T098
,	O
cancer	O
type	O
grav	B-T033
##idity	I-T033
and	O
parity	B-T033
,	O
survivorship	O
status	O
,	O
and	O
decision	O
to	O
pursue	O
fp	B-T058
treatment	I-T058
.	O
patients	O
(	O
mean	O
age	O
29	O
.	O
7	O
)	O
were	O
caucasian	B-T098
(	O
55	O
%	O
)	O
,	O
hispanic	B-T098
(	O
23	O
%	O
)	O
,	O
and	O
african	B-T098
american	I-T098
(	O
10	O
%	O
)	O
.	O
the	O
majority	O
of	O
women	B-T098
(	O
67	O
%	O
)	O
were	O
seen	O
for	O
fp	B-T058
before	O
cancer	B-T058
treatment	I-T058
and	O
the	O
remaining	O
sought	O
options	O
for	O
family	B-T058
building	I-T058
while	O
in	O
survivorship	O
.	O
the	O
most	O
common	O
cancer	O
types	O
were	O
hematologic	B-T038
(	O
29	O
%	O
)	O
,	O
breast	B-T038
(	O
25	O
%	O
)	O
,	O
and	O
gynecologic	B-T038
(	O
23	O
%	O
)	O
.	O
patients	O
referred	O
to	O
an	O
on	B-T058
-	I-T058
site	I-T058
fertility	I-T058
consultation	I-T058
service	I-T058
were	O
medically	O
and	O
ethnic	O
##ally	O
diverse	O
.	O
interest	O
in	O
fertility	O
counseling	O
and	O
treatment	B-T058
was	O
apparent	O
in	O
both	O
survivorship	O
pre	B-T058
-	I-T058
and	I-T058
postc	I-T058
##ancer	I-T058
treatment	I-T058
.	O
although	O
the	O
referral	B-T058
group	O
was	O
ethnic	O
##ally	O
diverse	O
,	O
caucasian	B-T098
women	B-T098
were	O
most	O
likely	O
to	O
pursue	O
fp	B-T058
treatment	I-T058
compared	O
to	O
women	B-T098
of	O
other	O
ethnic	O
##ities	O
.	O

prostate	O
external	O
beam	O
radiotherapy	O
combined	O
with	O
high	B-T058
-	I-T058
dose	I-T058
-	I-T058
rate	I-T058
brachytherapy	I-T058
:	O
dose	O
-	O
volume	O
parameters	B-T033
from	O
deform	B-T170
##ably	I-T170
-	I-T170
registered	I-T170
plans	I-T170
correlate	O
with	O
late	O
gastrointestinal	B-T038
complications	I-T038
derivation	O
of	O
dose	O
-	O
volume	O
correlated	O
with	O
toxicity	O
for	O
multi	B-T058
-	I-T058
modal	I-T058
treatments	I-T058
can	O
be	O
difficult	O
due	O
to	O
the	O
perceived	O
need	O
for	O
voxel	B-T058
-	I-T058
by	I-T058
-	I-T058
voxel	I-T058
dose	I-T058
accumulation	I-T058
.	O
with	O
data	O
available	O
for	O
a	O
single	O
-	O
institution	B-T092
cohort	B-T098
with	O
long	O
follow	B-T058
-	I-T058
up	I-T058
,	O
an	O
investigation	O
was	O
undertaken	O
into	O
rectal	B-T082
dose	O
-	O
volume	O
effects	O
for	O
gastrointestinal	B-T033
toxicities	I-T033
after	O
deform	O
##ably	O
-	O
register	O
##ing	O
each	O
phase	O
of	O
a	O
combined	O
external	O
beam	O
radiotherapy	O
(	O
eb	O
##rt	O
)	O
/	O
high	B-T058
-	I-T058
dose	I-T058
-	I-T058
rate	I-T058
(	I-T058
hd	I-T058
##r	I-T058
)	I-T058
brachytherapy	I-T058
prostate	B-T058
treatment	I-T058
.	O
one	O
hundred	O
and	O
eighteen	O
patients	O
received	O
eb	O
##rt	O
in	O
23	O
fractions	O
of	O
2	O
gy	O
and	O
hd	B-T058
##r	I-T058
(	O
tg	B-T170
##43	I-T170
algorithm	I-T170
)	O
in	O
3	O
fractions	O
of	O
6	O
.	O
5	O
gy	O
.	O
results	O
for	O
the	O
late	B-T170
effects	I-T170
of	I-T170
normal	I-T170
tissues	I-T170
-	I-T170
subjective	I-T170
,	I-T170
objective	I-T170
,	I-T170
management	I-T170
and	I-T170
analytic	I-T170
toxicity	I-T170
assessments	I-T170
were	O
available	O
with	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
of	O
72	O
months	O
.	O
the	O
hd	B-T058
##r	I-T058
ct	B-T058
was	O
deform	O
##ably	O
-	O
registered	O
to	O
the	O
eb	O
##rt	O
ct	B-T058
.	O
doses	O
were	O
corrected	O
for	O
dose	B-T058
fractionation	I-T058
.	O
rectum	B-T017
dose	B-T170
-	I-T170
volume	I-T170
histogram	I-T170
(	O
dv	B-T170
##h	I-T170
)	O
parameters	B-T033
were	O
calculated	O
in	O
two	O
ways	O
.	O
(	O
1	O
)	O
distribution	B-T170
-	I-T170
adding	I-T170
:	O
parameters	B-T033
were	O
calculated	O
after	O
the	O
eb	O
##rt	O
dose	O
distribution	O
was	O
3d	O
-	O
summed	O
with	O
the	O
registered	O
hd	B-T058
##r	I-T058
dose	O
distribution	O
.	O
(	O
2	O
)	O
parameter	B-T170
-	I-T170
adding	I-T170
:	O
the	O
eb	O
##rt	O
dv	B-T170
##h	I-T170
parameters	B-T033
were	O
added	O
to	O
hd	B-T058
##r	I-T058
dv	B-T170
##h	I-T170
parameters	B-T033
.	O
logistic	B-T062
regressions	I-T062
and	O
mann	O
-	O
whitney	O
u	O
-	O
tests	O
were	O
used	O
to	O
correlate	O
parameters	B-T033
with	O
late	O
peak	O
toxicity	O
(	O
dichotom	O
##ised	O
at	O
grade	B-T170
1	O
or	O
2	O
)	O
.	O
the	O
48	O
-	O
80	O
,	O
40	O
-	O
63	O
and	O
49	O
-	O
55	O
gy	O
dose	O
regions	B-T082
from	O
distribution	B-T170
-	I-T170
adding	I-T170
were	O
significantly	O
correlated	O
with	O
rectal	B-T038
bleeding	I-T038
,	O
urgency	B-T038
/	O
ten	B-T033
##es	I-T033
##mus	I-T033
and	O
stool	B-T033
frequency	I-T033
respectively	O
.	O
additionally	O
,	O
urgency	B-T038
/	O
ten	B-T033
##es	I-T033
##mus	I-T033
and	O
anorectal	B-T033
pain	I-T033
were	O
associated	O
with	O
the	O
25	O
-	O
26	O
gy	O
and	O
44	O
-	O
48	O
gy	O
dose	O
regions	B-T082
from	O
distribution	B-T170
-	I-T170
adding	I-T170
respectively	O
.	O
parameter	B-T170
-	I-T170
adding	I-T170
also	O
indicated	O
the	O
low	O
-	O
mid	B-T082
dose	O
region	B-T082
was	O
significantly	O
correlated	O
with	O
stool	B-T033
frequency	I-T033
and	O
proct	B-T038
##itis	I-T038
.	O
this	O
study	B-T062
confirms	B-T033
significant	O
dose	B-T170
-	I-T170
histogram	I-T170
effects	O
for	O
gastrointestinal	B-T033
toxicities	I-T033
after	O
including	O
deform	B-T170
##able	I-T170
registration	I-T170
to	O
combine	O
phases	O
of	O
eb	O
##rt	O
/	O
hd	B-T058
##r	I-T058
prostate	B-T038
cancer	I-T038
treatment	B-T058
.	O
the	O
findings	B-T033
from	O
distribution	B-T170
-	I-T170
adding	I-T170
were	O
in	O
most	O
cases	O
consistent	O
with	O
those	O
from	O
parameter	B-T170
-	I-T170
adding	I-T170
.	O
the	O
mid	B-T082
-	O
high	O
dose	O
range	O
and	O
near	O
maximum	O
doses	O
were	O
important	O
for	O
rectal	B-T038
bleeding	I-T038
.	O
the	O
distribution	B-T170
-	I-T170
adding	I-T170
mid	B-T082
-	O
high	O
dose	O
range	O
was	O
also	O
important	O
for	O
stool	B-T033
frequency	I-T033
and	O
urgency	B-T038
/	O
ten	B-T033
##es	I-T033
##mus	I-T033
.	O
we	O
encourage	O
additional	O
studies	B-T062
in	O
a	O
variety	O
of	O
institutions	O
using	O
a	O
variety	O
of	O
dose	B-T058
accumulation	I-T058
methods	I-T058
with	O
appropriate	O
inter	O
-	O
fraction	O
motion	O
management	O
.	O
nct	O
nct00	O
##19	O
##38	O
##56	O
.	O
retrospectively	O
registered	O
12	O
september	O
2005	O
.	O

the	O
genome	B-T017
-	O
scale	O
dna	B-T038
-	I-T038
binding	I-T038
profile	B-T058
of	O
barr	B-T103
,	O
a	O
β	B-T103
-	I-T103
alanine	I-T103
responsive	O
transcription	B-T103
factor	I-T103
in	O
the	O
archae	O
##on	O
sulfo	O
##lo	O
##bu	O
##s	O
acid	O
##ocal	O
##da	O
##ri	O
##us	O
the	O
leucine	B-T103
-	I-T103
responsive	I-T103
regulatory	I-T103
protein	I-T103
(	O
lrp	B-T103
)	O
family	B-T103
is	O
a	O
widespread	O
family	B-T103
of	O
regulatory	B-T103
transcription	I-T103
factors	I-T103
in	O
prokaryotes	O
.	O
barr	B-T103
is	O
an	O
lrp	B-T103
-	O
like	O
transcription	B-T103
factor	I-T103
in	O
the	O
model	O
archae	O
##on	O
sulfo	O
##lo	O
##bu	O
##s	O
acid	O
##ocal	O
##da	O
##ri	O
##us	O
that	O
activates	O
the	O
expression	B-T038
of	O
a	O
β	B-T017
-	I-T017
alanine	I-T017
aminotransferase	I-T017
gene	I-T017
,	O
which	O
is	O
involved	O
in	O
β	B-T038
-	I-T038
alanine	I-T038
degradation	I-T038
.	O
in	O
contrast	O
to	O
classical	O
lrp	B-T103
-	O
like	O
transcription	B-T103
factors	I-T103
,	O
barr	B-T103
is	O
not	B-T033
responsive	I-T033
to	O
any	O
of	O
the	O
α	B-T103
-	I-T103
amino	I-T103
acids	I-T103
but	O
interacts	O
specifically	O
with	O
β	B-T103
-	I-T103
alanine	I-T103
.	O
besides	O
the	O
juxt	O
##ap	O
##osed	O
β	B-T017
-	I-T017
alanine	I-T017
aminotransferase	I-T017
gene	I-T017
,	O
other	O
regulatory	O
targets	O
of	O
barr	B-T103
have	O
not	O
yet	O
been	O
identified	O
although	O
β	B-T103
-	I-T103
alanine	I-T103
is	O
the	O
precursor	B-T103
of	O
coenzyme	B-T103
a	I-T103
and	O
thus	O
an	O
important	O
central	O
metabolite	B-T103
.	O
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
extend	O
the	O
knowledge	O
of	O
the	O
dna	B-T038
-	I-T038
binding	I-T038
characteristics	O
of	O
barr	B-T103
and	O
of	O
its	O
corresponding	O
regul	B-T017
##on	I-T017
from	O
a	O
local	B-T082
to	O
a	O
genome	B-T017
-	O
wide	O
perspective	O
.	O
we	O
characterized	O
the	O
genome	B-T058
-	I-T058
wide	I-T058
binding	I-T058
profile	I-T058
of	O
barr	B-T103
using	O
chromatin	B-T058
immunoprecip	I-T058
##ation	I-T058
combined	O
with	O
high	B-T062
-	I-T062
throughput	I-T062
sequencing	I-T062
(	O
chip	B-T062
-	I-T062
seq	I-T062
)	O
.	O
this	O
revealed	O
21	O
genomic	B-T017
binding	B-T038
loci	B-T082
.	O
high	O
-	O
enrichment	O
binding	B-T038
regions	I-T038
were	O
validated	O
to	O
interact	O
with	O
purified	O
barr	B-T103
protein	I-T103
in	O
vitro	O
using	O
electrophoretic	B-T058
mobility	I-T058
shift	I-T058
assays	I-T058
and	O
almost	O
all	O
targets	O
were	O
also	O
shown	O
to	O
harbour	O
a	O
conserved	B-T082
semi	B-T103
-	I-T103
pal	I-T103
##ind	I-T103
##romic	I-T103
binding	B-T082
motif	I-T082
.	O
only	O
a	O
small	O
subset	O
of	O
enriched	O
genomic	B-T017
sites	I-T017
are	O
located	O
in	O
intergenic	B-T103
regions	I-T103
at	O
a	O
relative	O
short	O
distance	O
to	O
a	O
promoter	B-T103
,	O
and	O
qrt	B-T058
-	I-T058
pcr	I-T058
analysis	I-T058
demonstrated	O
that	O
only	O
one	O
additional	O
operon	B-T017
is	O
under	O
activation	O
of	O
barr	B-T103
,	O
namely	O
the	O
glutamine	B-T017
synthase	I-T017
operon	I-T017
.	O
the	O
latter	O
is	O
also	O
a	O
target	O
of	O
other	O
lrp	B-T103
-	O
like	O
transcription	B-T103
factors	I-T103
.	O
detailed	O
inspection	O
of	O
the	O
barr	B-T103
chip	B-T033
-	I-T033
seq	I-T033
profile	I-T033
at	O
the	O
β	B-T103
-	I-T103
alanine	I-T103
aminotransferase	I-T103
promoter	I-T103
region	I-T103
in	O
combination	O
with	O
binding	B-T082
motif	I-T082
predictions	O
indicate	O
that	O
the	O
operator	B-T103
structure	I-T103
is	O
more	O
complicated	O
than	O
previously	O
anticipated	O
,	O
consisting	O
of	O
multiple	B-T103
(	I-T103
major	I-T103
and	I-T103
auxiliary	I-T103
)	I-T103
operators	I-T103
.	O
barr	B-T103
has	O
a	O
limited	O
regul	B-T017
##on	I-T017
,	O
and	O
includes	O
also	O
glutamine	B-T017
synthase	I-T017
genes	I-T017
besides	O
the	O
previously	O
characterized	O
β	B-T017
-	I-T017
alanine	I-T017
aminotransferase	I-T017
.	O
regulation	B-T038
of	O
glutamine	B-T103
synthase	I-T103
is	O
suggestive	O
of	O
a	O
link	O
between	O
β	B-T038
-	I-T038
alanine	I-T038
and	O
α	B-T038
-	I-T038
amino	I-T038
acid	I-T038
metabolism	I-T038
in	O
s	O
.	O
acid	O
##ocal	O
##da	O
##ri	O
##us	O
.	O
furthermore	O
,	O
this	O
work	O
reveals	O
that	O
the	O
barr	B-T103
regul	B-T017
##on	I-T017
overlaps	O
with	O
that	O
of	O
other	O
lrp	B-T103
-	O
like	O
regulators	O
.	O

prevalence	O
of	O
hpv	B-T005
genotypes	O
in	O
cervical	B-T038
adenocarcinoma	I-T038
:	O
a	O
study	B-T062
in	O
greek	B-T098
women	B-T098
to	O
study	B-T062
the	O
prevalence	O
of	O
human	B-T005
papillomavirus	I-T005
(	O
hpv	B-T005
)	O
genotypes	O
among	O
cervical	B-T038
adenocarcinomas	I-T038
in	O
greek	B-T098
women	B-T098
.	O
the	O
study	O
group	O
comprised	O
78	O
adenocarcinoma	B-T038
cases	O
(	O
20	O
in	B-T038
situ	I-T038
and	O
58	O
invasive	B-T038
)	O
.	O
hpv	B-T103
dna	I-T103
was	O
amplified	B-T038
using	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
(	O
pcr	B-T062
)	O
and	O
hpv	B-T005
genotypes	O
were	O
identified	O
by	O
reverse	B-T062
hybridization	I-T062
.	O
there	O
was	O
a	O
high	O
prevalence	O
of	O
hpv	B-T038
infection	I-T038
both	O
for	O
in	B-T038
situ	I-T038
(	O
95	O
%	O
)	O
or	O
invasive	B-T038
(	I-T038
94	I-T038
.	I-T038
83	I-T038
%	I-T038
)	I-T038
adenocarcinomas	I-T038
,	O
comprising	O
also	O
cancers	B-T038
of	O
unusual	O
morphology	O
.	O
hpv	B-T005
16	I-T005
was	O
the	O
commonest	O
strain	O
(	O
n	O
=	O
57	O
,	O
73	O
.	O
08	O
%	O
)	O
followed	O
by	O
hpv	B-T005
18	I-T005
(	O
n	O
=	O
28	O
,	O
35	O
.	O
90	O
%	O
)	O
.	O
interestingly	O
,	O
13	O
cases	O
(	O
16	O
.	O
67	O
%	O
)	O
were	O
also	O
hpv	B-T005
52	I-T005
positive	I-T005
(	O
as	O
co	B-T038
-	I-T038
infection	I-T038
with	O
hpv	B-T005
16	I-T005
or	O
18	B-T005
)	O
.	O
all	O
other	O
strains	O
with	O
the	O
exception	O
of	O
hpv	B-T005
66	I-T005
were	O
found	O
only	O
as	O
co	B-T038
-	I-T038
infections	I-T038
.	O
no	O
significant	O
age	O
difference	O
was	O
noted	O
in	O
terms	O
of	O
any	O
hpv	B-T005
strain	O
positivity	B-T033
.	O
hpv	B-T103
dna	I-T103
was	O
found	O
in	O
the	O
large	O
majority	O
of	O
cervical	B-T038
adenocarcinomas	I-T038
.	O
as	O
opposed	O
to	O
other	O
studies	B-T062
,	O
hpv	B-T005
52	I-T005
was	O
the	O
third	O
most	O
commonly	O
encountered	B-T058
strain	O
after	O
hpv	B-T005
16	I-T005
and	O
hpv	B-T005
18	I-T005
.	O
the	O
above	O
findings	O
would	O
probably	O
be	O
of	O
help	O
in	O
decision	B-T038
making	I-T038
concerning	O
vaccination	B-T058
policy	B-T170
for	O
the	O
prevention	O
of	O
hpv	B-T038
infection	I-T038
in	O
greece	B-T082
.	O

clinicopathological	B-T091
relevance	O
of	O
kines	B-T103
##in	I-T103
family	I-T103
member	I-T103
18	I-T103
##a	I-T103
expression	B-T038
in	O
invasive	B-T038
breast	I-T038
cancer	I-T038
recently	O
,	O
kines	B-T103
##in	I-T103
motor	B-T103
proteins	I-T103
have	O
been	O
focused	O
on	O
as	O
targets	O
for	O
cancer	B-T058
therapy	I-T058
.	O
kines	B-T103
##ins	I-T103
are	O
microtubule	B-T103
-	O
based	O
motor	B-T103
proteins	I-T103
that	O
mediate	O
diverse	O
functions	O
within	O
the	O
cell	B-T017
,	O
including	O
the	O
transport	B-T038
of	O
vesicles	B-T017
,	O
organelles	B-T017
,	O
chromosomes	B-T017
and	O
protein	B-T103
complexes	I-T103
,	O
as	O
well	O
as	O
the	O
movement	B-T038
of	I-T038
microtubules	I-T038
.	O
in	O
the	O
current	O
study	O
,	O
the	O
expression	B-T038
of	O
kines	B-T103
##in	I-T103
family	I-T103
member	I-T103
18	I-T103
##a	I-T103
(	O
ki	B-T103
##f1	I-T103
##8	I-T103
##a	I-T103
)	O
,	O
a	O
member	B-T103
of	I-T103
kines	I-T103
##in	I-T103
superfamily	I-T103
,	O
was	O
investigated	O
in	O
breast	B-T038
cancer	I-T038
using	O
immunohistochemistry	B-T058
,	O
and	O
its	O
effect	O
on	O
breast	B-T038
cancer	I-T038
prognosis	O
was	O
examined	O
.	O
ki	B-T103
##f1	I-T103
##8	I-T103
##a	I-T103
expression	O
level	O
was	O
significantly	O
associated	O
with	O
lymph	B-T038
node	I-T038
metastasis	I-T038
(	O
p	O
=	O
0	O
.	O
047	O
)	O
.	O
in	O
patients	O
with	O
high	O
levels	O
of	O
ki	B-T103
##f1	I-T103
##8	I-T103
##a	I-T103
expression	B-T038
,	O
survival	O
was	O
significantly	O
poorer	O
compared	O
to	O
patients	O
with	O
low	O
levels	O
of	O
ki	B-T103
##f1	I-T103
##8	I-T103
##a	I-T103
expression	B-T038
(	O
disease	O
-	O
free	O
survival	O
,	O
p	O
=	O
0	O
.	O
030	O
)	O
.	O
multivariate	O
analysis	O
revealed	O
that	O
venous	B-T033
invasion	I-T033
(	O
hazard	O
ratio	O
,	O
9	O
.	O
22	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
3	O
.	O
90	O
-	O
23	O
.	O
66	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
ki	B-T103
##f1	I-T103
##8	I-T103
##a	I-T103
expression	B-T038
(	O
hazard	O
ratio	O
,	O
3	O
.	O
20	O
;	O
95	O
%	O
confidence	O
interval	O
,	O
1	O
.	O
34	O
-	O
6	O
.	O
09	O
;	O
p	O
=	O
0	O
.	O
010	O
)	O
were	O
independent	O
predictive	B-T170
factors	I-T170
for	O
lymph	B-T038
node	I-T038
metastasis	I-T038
.	O
ki	B-T103
##f1	I-T103
##8	I-T103
##a	I-T103
may	O
be	O
a	O
useful	O
predictive	B-T170
marker	B-T201
for	O
lymph	B-T038
node	I-T038
metastasis	I-T038
in	O
breast	B-T038
cancer	I-T038
,	O
which	O
could	O
facilitate	O
curative	O
adjuvant	O
treatment	B-T058
.	O

influence	O
of	O
yeast	B-T204
and	O
lactic	B-T007
acid	I-T007
bacterium	I-T007
on	O
the	O
constituent	O
profile	B-T058
of	O
soy	B-T168
sa	I-T168
##uce	I-T168
during	O
fermentation	B-T038
soy	B-T168
sa	I-T168
##uce	I-T168
is	O
a	O
japanese	B-T082
traditional	O
season	B-T168
##ing	I-T168
composed	O
of	O
various	O
constituents	O
that	O
are	O
produced	O
by	O
various	O
microbes	O
during	O
a	O
long	O
-	O
term	O
fermentation	B-T038
process	I-T038
.	O
due	O
to	O
the	O
complexity	O
of	O
the	O
process	O
,	O
the	O
investigation	B-T062
of	O
the	O
constituent	O
profile	B-T058
during	O
fermentation	B-T038
is	O
difficult	B-T033
.	O
metabolomics	B-T091
,	O
the	O
comprehensive	O
study	B-T062
of	O
low	O
molecular	O
weight	O
compounds	O
in	O
biological	O
samples	O
,	O
is	O
thought	O
to	O
be	O
a	O
promising	O
strategy	O
for	O
deep	O
understanding	B-T038
of	O
the	O
constituent	O
contribution	O
to	O
food	O
flavor	O
characteristics	O
.	O
therefore	O
,	O
metabolomics	B-T091
is	O
suitable	O
for	O
the	O
analysis	B-T062
of	O
soy	B-T168
sa	I-T168
##uce	I-T168
fermentation	B-T038
.	O
unfortunately	O
,	O
only	O
few	O
and	O
unre	O
##fin	O
##ed	O
studies	B-T062
of	O
soy	B-T168
sa	I-T168
##uce	I-T168
fermentation	B-T038
using	O
metabolomics	B-T091
approach	B-T082
have	O
been	O
reported	B-T170
.	O
therefore	O
,	O
we	O
investigated	O
changes	O
in	O
low	O
molecular	O
weight	O
hydrophilic	O
and	O
volatile	B-T103
compounds	I-T103
of	O
soy	B-T168
sa	I-T168
##uce	I-T168
using	O
gas	B-T058
chromatography	I-T058
/	I-T058
mass	I-T058
spectrometry	I-T058
(	O
gc	B-T058
/	I-T058
ms	I-T058
)	O
-	O
based	O
non	O
-	O
targeted	O
metabolic	B-T091
profiling	I-T091
.	O
the	O
data	O
were	O
analyzed	B-T062
by	O
statistical	O
analysis	O
to	O
evaluate	O
influences	O
of	O
yeast	B-T204
and	O
lactic	B-T007
acid	I-T007
bacterium	I-T007
on	O
the	O
constituent	O
profile	B-T058
.	O
consequently	O
,	O
our	O
results	O
suggested	O
a	O
novel	O
finding	B-T033
that	O
lactic	B-T007
acid	I-T007
bacterium	I-T007
affected	O
the	O
production	O
of	O
several	O
constituents	O
such	O
as	O
cyclo	B-T103
##ten	I-T103
##e	I-T103
,	O
fur	B-T103
##fu	I-T103
##ral	I-T103
,	O
fur	B-T103
##fu	I-T103
##ryl	I-T103
alcohol	I-T103
and	O
meth	B-T103
##ional	I-T103
in	O
the	O
soy	B-T168
sa	I-T168
##uce	I-T168
fermentation	B-T038
process	I-T038
.	O

the	O
lost	O
art	O
of	O
the	O
splen	B-T058
##orrh	I-T058
##aphy	I-T058
in	O
the	O
case	O
of	O
the	O
hemodynamic	B-T038
##ally	I-T038
unstable	I-T038
child	O
,	O
splen	B-T058
##orrh	I-T058
##aphy	I-T058
is	O
preferred	O
to	O
splenectomy	B-T058
to	O
aver	O
##t	O
posts	B-T038
##plen	I-T038
##ectomy	I-T038
sepsis	B-T038
.	O
however	O
,	O
successful	O
splen	B-T058
##orrh	I-T058
##aphy	I-T058
requires	O
familiarity	B-T038
with	O
the	O
procedure	B-T058
.	O
we	O
sought	O
to	O
determine	O
how	O
many	O
splen	B-T058
##ectomies	I-T058
or	O
splen	B-T058
##orrh	I-T058
##aph	I-T058
##ies	I-T058
for	O
trauma	B-T037
the	O
average	O
pediatric	B-T097
surgeon	I-T097
can	O
be	O
expected	O
to	O
perform	O
during	O
their	O
career	O
.	O
the	O
pediatric	B-T170
health	I-T170
information	I-T170
system	I-T170
(	I-T170
phi	I-T170
##s	I-T170
)	I-T170
database	I-T170
was	O
quer	O
##ied	O
for	O
patients	O
≤	O
##18	O
years	O
coded	O
with	O
an	O
international	B-T170
classification	I-T170
of	I-T170
diseases	I-T170
9	I-T170
##th	I-T170
edition	I-T170
diagnosis	O
code	O
of	O
a	O
splenic	B-T037
injury	I-T037
from	O
2004	O
to	O
2013	O
.	O
age	O
,	O
gender	O
,	O
grade	B-T170
of	O
splenic	B-T037
injury	I-T037
,	O
and	O
operations	B-T058
performed	O
were	O
extracted	O
.	O
numbers	O
of	O
pediatric	B-T097
surgeons	I-T097
per	O
hospital	B-T092
were	O
obtained	O
.	O
95	O
##67	O
children	O
were	O
identified	O
.	O
2	O
.	O
1	O
%	O
underwent	O
a	O
splenectomy	B-T058
and	O
0	O
.	O
8	O
%	O
underwent	O
a	O
splen	B-T058
##orrh	I-T058
##aphy	I-T058
.	O
the	O
average	O
surgeon	B-T097
performed	O
0	O
.	O
6	O
(	O
sd	O
=	O
0	O
.	O
6	O
)	O
splen	B-T058
##ectomies	I-T058
and	O
0	O
.	O
2	O
(	O
sd	O
=	O
0	O
.	O
4	O
)	O
splen	B-T058
##orrh	I-T058
##aph	I-T058
##ies	I-T058
for	O
trauma	B-T037
.	O
if	O
these	O
rates	O
remain	O
constant	O
over	O
time	O
,	O
the	O
average	O
surgeon	B-T097
would	O
perform	O
1	O
.	O
8	O
(	O
sd	O
=	O
1	O
.	O
7	O
)	O
splen	B-T058
##ectomies	I-T058
and	O
0	O
.	O
6	O
(	O
sd	O
=	O
1	O
.	O
1	O
)	O
splen	B-T058
##orrh	I-T058
##aph	I-T058
##ies	I-T058
for	O
trauma	B-T037
over	O
a	O
30	O
-	O
year	O
surgical	O
career	O
.	O
nonoperative	B-T058
management	I-T058
is	O
associated	O
with	O
a	O
host	O
of	O
benefits	O
,	O
but	O
has	O
resulted	O
in	O
a	O
decrease	O
in	O
the	O
experience	O
level	O
of	O
the	O
pediatric	B-T097
surgeons	I-T097
expected	O
to	O
perform	O
an	O
emergency	O
splenectomy	B-T058
or	O
splen	B-T058
##orrh	I-T058
##aphy	I-T058
when	O
the	O
unusual	O
occasion	O
arises	O
.	O

comparison	O
of	O
occlusive	O
and	O
open	B-T082
application	O
in	O
a	O
psoriasis	B-T062
plaque	I-T062
test	I-T062
design	I-T062
,	O
exempl	O
##arily	O
using	O
investigations	O
of	O
map	B-T103
##ra	I-T103
##cor	I-T103
##at	I-T103
0	O
.	O
1	O
%	O
ointment	B-T103
versus	O
vehicle	B-T103
and	O
reference	O
drugs	B-T103
psoriasis	B-T062
plaque	I-T062
tests	I-T062
(	O
ppt	B-T062
##s	I-T062
)	O
are	O
important	O
tools	O
in	O
the	O
early	O
phases	O
of	O
antip	B-T103
##so	I-T103
##ri	I-T103
##atic	I-T103
drug	B-T091
development	I-T091
.	O
two	O
distinct	O
ppt	B-T062
design	I-T062
variants	O
(	O
open	O
vs	O
.	O
occluded	O
drug	O
application	O
)	O
are	O
commonly	O
used	O
,	O
but	O
no	O
previous	O
work	O
has	O
aimed	O
to	O
directly	O
compare	O
and	O
contrast	O
their	O
performance	O
.	O
we	O
compared	O
the	O
antip	B-T103
##so	I-T103
##ri	I-T103
##atic	I-T103
efficacy	O
of	O
map	B-T103
##ra	I-T103
##cor	I-T103
##at	I-T103
0	O
.	O
1	O
%	O
ointment	B-T103
and	O
reference	O
drugs	B-T103
reported	O
in	O
2	O
separate	O
studies	B-T062
,	O
representing	O
open	B-T062
and	O
occluded	B-T062
ppt	I-T062
designs	I-T062
.	O
the	O
drug	O
effect	O
size	O
was	O
measured	O
by	O
sonography	B-T058
(	O
mean	O
change	O
in	O
echo	O
-	O
poor	O
band	O
thickness	O
)	O
,	O
chrom	B-T058
##ame	I-T058
##try	I-T058
,	O
and	O
standardized	O
clinical	O
assessment	O
.	O
antip	B-T103
##so	I-T103
##ri	I-T103
##atic	I-T103
effects	O
were	O
detectable	O
for	O
the	O
study	B-T062
drugs	B-T103
in	O
both	O
occluded	B-T062
and	O
open	B-T062
ppt	I-T062
##s	I-T062
.	O
differences	O
between	O
the	O
potency	O
of	O
antip	B-T103
##so	I-T103
##ri	I-T103
##atic	I-T103
drugs	I-T103
and	O
vehicle	B-T103
were	O
observable	O
.	O
the	O
total	O
antip	B-T103
##so	I-T103
##ri	I-T103
##atic	I-T103
effect	O
size	O
appeared	O
to	O
be	O
higher	O
in	O
the	O
occluded	B-T062
ppt	I-T062
than	O
the	O
open	B-T062
ppt	I-T062
,	O
despite	O
the	O
shorter	O
treatment	O
duration	O
(	O
2	O
vs	O
.	O
4	O
weeks	O
)	O
.	O
effect	O
dynamics	O
over	O
time	O
revealed	O
greater	O
differences	O
between	O
some	O
study	B-T062
drugs	B-T103
in	O
the	O
open	B-T062
ppt	I-T062
compared	O
to	O
the	O
occluded	B-T062
ppt	I-T062
.	O
taking	O
the	O
higher	O
technical	O
challenges	O
for	O
the	O
open	B-T062
ppt	I-T062
into	O
account	O
,	O
we	O
recommend	O
the	O
occluded	B-T062
ppt	I-T062
as	O
a	O
standard	O
screening	B-T062
setting	O
in	O
early	O
drug	B-T091
development	I-T091
.	O
in	O
special	O
cases	O
,	O
considering	O
certain	O
drug	B-T103
aspects	O
or	O
study	B-T062
objectives	O
that	O
would	O
require	O
procedural	O
adaptations	O
,	O
an	O
open	B-T062
ppt	I-T062
could	O
be	O
the	O
better	O
-	O
suited	O
design	O
.	O
finally	O
,	O
both	O
ppt	B-T062
models	O
show	O
clear	O
advantages	O
:	O
classification	B-T170
as	O
phase	B-T062
i	I-T062
studies	I-T062
,	O
small	O
number	O
of	O
psoriatic	O
subjects	O
,	O
relatively	O
short	O
study	B-T062
duration	O
,	O
excellent	O
discrimination	O
between	O
compounds	B-T103
and	O
concentrations	O
,	O
parallel	O
measurement	O
of	O
treatment	B-T201
response	I-T201
,	O
and	O
go	O
/	O
no	O
go	O
decisions	O
very	O
early	O
in	O
clinical	B-T062
development	I-T062
.	O

the	O
pla2	B-T017
gene	I-T017
mediates	O
the	O
humoral	B-T038
immune	I-T038
responses	I-T038
in	O
bact	B-T204
##roc	I-T204
##era	I-T204
dorsal	I-T204
##is	I-T204
(	I-T204
hen	I-T204
##del	I-T204
)	I-T204
the	O
phospholipase	B-T017
a2	I-T017
(	I-T017
pla2	I-T017
)	I-T017
gene	I-T017
encodes	O
the	O
enzyme	B-T103
that	O
catalyzes	O
the	O
hydrolysis	O
of	O
phospholipids	B-T103
(	O
pls	B-T103
)	O
from	O
the	O
sn	B-T082
-	I-T082
2	I-T082
position	I-T082
.	O
however	O
,	O
little	O
is	O
known	O
about	O
its	O
role	B-T170
in	O
humoral	B-T038
immune	I-T038
responses	I-T038
.	O
in	O
this	O
study	B-T062
,	O
we	O
investigated	O
the	O
expression	O
profile	O
of	O
pla2	B-T017
in	O
different	O
tissues	B-T017
and	O
developmental	O
stages	O
in	O
bact	B-T204
##roc	I-T204
##era	I-T204
dorsal	I-T204
##is	I-T204
(	I-T204
hen	I-T204
##del	I-T204
)	I-T204
,	O
and	O
the	O
results	O
showed	O
that	O
the	O
transcriptional	B-T038
level	O
of	O
pla2	B-T017
was	O
high	O
in	O
the	O
egg	O
and	O
mature	B-T038
stage	I-T038
and	O
in	O
the	O
testis	B-T017
tissue	B-T017
.	O
bacterial	B-T038
infection	I-T038
increased	O
the	O
expression	B-T038
of	O
pla2	B-T017
,	O
and	O
the	O
highest	O
degree	O
of	O
up	B-T038
-	I-T038
regulation	I-T038
appeared	O
in	O
the	O
fat	B-T017
body	I-T017
.	O
silencing	B-T038
pla2	B-T017
influenced	O
the	O
expression	B-T038
of	O
immune	B-T017
-	I-T017
related	I-T017
genes	I-T017
,	O
including	O
myd88	B-T017
and	O
def	B-T103
##ensin	I-T103
in	O
the	O
toll	B-T038
pathway	I-T038
and	O
reli	B-T103
##sh	I-T103
and	O
dip	B-T103
##ter	I-T103
##icin	I-T103
in	O
the	O
im	O
##d	O
pathway	O
.	O
moreover	O
,	O
the	O
expression	B-T038
of	O
myd88	B-T017
and	O
def	B-T103
##ensin	I-T103
was	O
down	B-T038
-	I-T038
regulated	I-T038
significantly	O
in	O
the	O
ds	B-T017
-	I-T017
pla2	I-T017
group	O
compared	O
with	O
those	O
in	O
the	O
ds	B-T103
-	I-T103
egfp	I-T103
group	O
when	O
b	B-T204
.	I-T204
dorsal	I-T204
##is	I-T204
was	O
infected	B-T033
with	O
l	B-T007
.	I-T007
monocytogenes	I-T007
and	O
s	B-T007
.	I-T007
aureus	I-T007
,	O
indicating	O
that	O
pla2	B-T017
was	O
involved	O
in	O
the	O
activation	B-T038
of	O
the	O
toll	B-T038
pathway	I-T038
.	O
meanwhile	O
,	O
infection	B-T038
with	O
l	B-T007
.	I-T007
monocytogenes	I-T007
and	O
e	B-T007
.	I-T007
coli	I-T007
,	O
which	O
activate	O
the	O
im	O
##d	O
pathway	O
,	O
does	O
not	O
increase	O
the	O
mrna	B-T103
levels	O
of	O
reli	B-T103
##sh	I-T103
and	O
dip	B-T103
##ter	I-T103
##icin	I-T103
in	O
the	O
ds	B-T017
-	I-T017
pla2	I-T017
group	O
as	O
severely	O
as	O
it	O
increases	O
those	O
in	O
the	O
ds	B-T103
-	I-T103
egfp	I-T103
group	O
,	O
indicating	O
that	O
the	O
im	O
##d	O
pathway	O
was	O
also	O
repressed	O
after	O
silencing	B-T038
pla2	B-T017
.	O
notably	O
,	O
the	O
development	O
of	O
lipid	B-T017
droplets	I-T017
in	O
fat	B-T017
body	I-T017
cells	B-T017
was	O
influenced	O
by	O
silencing	B-T038
pla2	B-T017
,	O
implying	O
that	O
pla2	B-T017
affects	O
the	O
function	O
of	O
fat	B-T017
body	I-T017
tissue	B-T017
.	O
these	O
results	O
suggest	O
that	O
the	O
pla2	B-T017
gene	I-T017
may	O
mediate	O
humoral	B-T038
immune	I-T038
responses	I-T038
by	O
reducing	O
lipid	B-T038
storage	I-T038
in	O
fat	B-T017
body	I-T017
cells	B-T017
in	O
b	B-T204
.	I-T204
dorsal	I-T204
##is	I-T204
.	O

integrating	O
palliative	B-T091
care	I-T091
in	O
pediatric	B-T091
oncology	I-T091
:	O
evidence	O
for	O
an	O
evolving	O
paradigm	O
for	O
comprehensive	B-T058
cancer	O
care	O
the	O
demonstrated	O
benefit	O
of	O
integrating	O
palliative	B-T091
care	I-T091
(	O
pc	B-T091
)	O
into	O
cancer	B-T058
treatment	I-T058
has	O
triggered	O
an	O
increased	O
need	O
for	O
pc	B-T091
services	O
.	O
the	O
trajectory	O
of	O
integrating	O
pc	B-T091
in	O
comprehensive	B-T058
cancer	B-T092
centers	I-T092
,	I-T092
particularly	O
pediatric	B-T092
centers	I-T092
,	O
is	O
unknown	O
.	O
we	O
describe	O
our	O
8	O
-	O
year	O
experience	O
of	O
initiating	O
and	O
establishing	O
pc	B-T091
with	O
the	O
quality	B-T058
of	I-T058
life	I-T058
service	I-T058
(	O
qol	B-T058
##s	I-T058
)	O
at	O
st	B-T092
.	I-T092
jud	I-T092
##e	I-T092
children	I-T092
'	I-T092
s	I-T092
research	I-T092
hospital	I-T092
.	O
we	O
retrospectively	O
reviewed	O
records	B-T170
of	I-T170
patients	I-T170
seen	O
by	O
the	O
qol	B-T058
##s	I-T058
(	O
n	O
=	O
61	O
##5	O
)	O
from	O
march	O
2007	O
to	O
december	O
2014	O
.	O
variables	O
analyzed	O
for	O
each	O
year	O
,	O
using	O
descriptive	O
statistics	O
,	O
included	O
diagnostic	B-T170
groups	I-T170
,	O
qol	B-T058
##s	I-T058
encounters	B-T058
,	O
goals	B-T058
of	I-T058
care	I-T058
,	O
duration	B-T201
of	I-T201
survival	I-T201
,	O
and	O
location	B-T082
of	I-T082
death	I-T082
.	O
total	O
qol	B-T058
##s	I-T058
patient	O
encounters	B-T058
increased	O
from	O
58	O
(	O
2007	O
)	O
to	O
1	O
,	O
297	O
(	O
2014	O
)	O
,	O
new	O
consult	B-T058
##s	I-T058
increased	O
from	O
17	O
(	O
2007	O
)	O
to	O
115	O
(	O
2014	O
)	O
,	O
and	O
mean	O
encounters	B-T058
per	O
patient	O
increased	O
from	O
5	O
.	O
06	O
(	O
2007	O
)	O
to	O
16	O
.	O
11	O
(	O
2014	O
)	O
.	O
goal	B-T058
of	I-T058
care	I-T058
at	O
initial	O
consultation	O
shifted	O
from	O
primarily	O
comfort	B-T038
to	O
an	O
increasing	O
goal	B-T170
of	I-T170
cure	I-T170
.	O
the	O
median	O
number	O
of	O
days	O
from	O
initial	O
consult	O
to	O
death	B-T033
increased	O
from	O
52	O
days	O
(	O
2008	O
)	O
to	O
223	O
days	O
(	O
2014	O
)	O
.	O
a	O
trend	O
toward	O
increased	O
outpatient	O
location	B-T082
of	I-T082
death	I-T082
was	O
noted	O
with	O
42	O
%	O
outpatient	O
deaths	B-T033
in	O
2007	O
,	O
increasing	O
to	O
a	O
majority	O
in	O
each	O
subsequent	O
year	O
(	O
range	O
,	O
51	O
%	O
-	O
74	O
%	O
)	O
.	O
hospital	O
-	O
wide	O
,	O
patients	O
receiving	O
pc	B-T091
services	O
before	O
death	B-T033
increased	O
from	O
approximately	O
50	O
%	O
to	O
nearly	O
100	O
%	O
.	O
since	O
its	O
inception	O
,	O
the	O
qol	B-T058
##s	I-T058
experienced	O
a	O
dramatic	O
increase	O
in	O
referrals	B-T058
and	O
encounters	B-T058
per	O
patient	O
,	O
increased	O
use	O
by	O
all	O
clinical	B-T058
services	I-T058
,	O
a	O
trend	O
toward	O
earlier	O
consultation	B-T058
and	O
longer	O
term	O
follow	B-T058
-	I-T058
up	I-T058
,	O
increasing	O
outpatient	O
location	B-T082
of	I-T082
death	I-T082
,	O
and	O
near	O
-	O
universal	O
pc	B-T091
involvement	O
at	O
the	O
end	B-T058
-	I-T058
of	I-T058
-	I-T058
life	I-T058
.	O
the	O
successful	O
integration	O
of	O
pc	B-T091
in	O
a	O
comprehensive	B-T058
cancer	B-T092
center	I-T092
,	O
and	O
the	O
resulting	O
potential	O
for	O
improved	O
care	O
provision	O
over	O
time	O
,	O
can	O
serve	O
as	O
a	O
model	B-T170
for	O
other	O
programs	O
on	O
a	O
broad	O
scale	O
.	O

systemic	B-T103
matrix	I-T103
metalloproteinase	I-T103
-	I-T103
8	I-T103
response	B-T038
in	O
chronic	B-T038
tonsill	I-T038
##itis	I-T038
the	O
development	O
of	O
several	O
life	O
-	O
long	O
diseases	B-T038
,	O
such	O
as	O
coronary	B-T038
heart	I-T038
disease	I-T038
,	O
is	O
affected	O
by	O
low	O
-	O
grade	O
systemic	O
inflammation	B-T038
.	O
data	O
on	O
the	O
potential	O
long	O
-	O
term	O
health	O
effects	O
of	O
chronic	B-T038
tonsill	I-T038
##itis	I-T038
are	O
limited	O
.	O
many	O
inflammatory	B-T038
conditions	O
present	O
with	O
enhanced	O
systemic	B-T103
matrix	I-T103
metalloproteinase	I-T103
(	B-T103
mmp	I-T103
)	I-T103
-	I-T103
8	I-T103
response	B-T038
.	O
in	O
head	B-T038
and	I-T038
neck	I-T038
cancer	I-T038
,	O
high	O
plasma	B-T031
level	O
of	O
tissue	B-T103
inhibitor	I-T103
of	I-T103
metalloproteinase	I-T103
(	B-T103
timp	I-T103
)	I-T103
-	I-T103
1	I-T103
predicts	O
poor	B-T033
prognosis	I-T033
.	O
we	O
analyzed	O
s	B-T103
-	I-T103
mmp	I-T103
-	I-T103
8	I-T103
with	O
immuno	B-T058
##fluor	I-T058
##ometric	I-T058
assay	I-T058
and	O
s	B-T103
-	I-T103
timp	I-T103
-	I-T103
1	I-T103
with	O
an	O
immunosorbent	B-T058
assay	I-T058
in	O
175	O
consecutive	O
patients	O
undergoing	O
tonsillectomy	B-T058
for	O
benign	B-T038
tonsill	I-T038
##ar	I-T038
disease	I-T038
,	O
and	O
in	O
33	O
control	O
patients	O
with	O
tonsill	B-T038
##ar	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
.	O
tonsill	B-T017
##ar	I-T017
human	B-T005
papillomavirus	I-T005
(	O
hpv	B-T005
)	O
status	O
was	O
determined	O
by	O
pcr	B-T062
.	O
in	O
patients	O
with	O
benign	B-T038
tonsill	I-T038
##ar	I-T038
disease	I-T038
,	O
chronic	B-T038
tonsill	I-T038
##itis	I-T038
without	O
hypertrophy	B-T038
was	O
associated	O
with	O
enhanced	O
systemic	B-T103
mmp	I-T103
-	I-T103
8	I-T103
response	B-T038
.	O
compared	O
to	O
patients	O
with	O
benign	B-T038
tonsill	I-T038
##ar	I-T038
disease	I-T038
,	O
patients	O
with	O
tonsill	B-T038
##ar	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
had	O
significantly	O
higher	O
concentrations	O
of	O
s	B-T103
-	I-T103
mmp	I-T103
-	I-T103
8	I-T103
and	O
s	B-T103
-	I-T103
timp	I-T103
-	I-T103
1	I-T103
.	O
neither	O
s	B-T103
-	I-T103
mmp	I-T103
-	I-T103
8	I-T103
nor	O
s	B-T103
-	I-T103
timp	I-T103
-	I-T103
1	I-T103
correlated	O
with	O
tonsill	B-T017
##ar	I-T017
hpv	B-T005
positivity	B-T033
.	O

correlation	O
between	O
the	O
histopathology	O
of	O
chronic	B-T038
urticaria	I-T038
and	O
its	O
clinical	O
picture	O
chronic	B-T038
urticaria	I-T038
is	O
characterized	O
by	O
transient	O
,	O
prur	O
##itic	O
lesions	O
of	O
varying	O
sizes	B-T082
,	O
with	O
central	B-T082
pall	B-T033
##or	I-T033
and	O
well	O
-	O
defined	O
edges	O
,	O
with	O
disease	B-T038
duration	O
longer	O
than	O
six	O
weeks	O
.	O
its	O
cellular	B-T038
infiltrate	I-T038
consists	O
of	O
neutrophils	B-T017
,	O
lymphocytes	B-T017
and	O
eosinophils	B-T017
.	O
there	O
is	O
a	O
subgroup	O
of	O
patients	O
with	O
eosinophilic	B-T017
or	O
neutrophilic	B-T038
urticaria	I-T038
,	O
resistant	O
to	O
the	O
treatment	B-T058
with	O
antihist	B-T103
##amines	I-T103
,	O
but	O
that	O
respond	O
to	O
a	O
combination	O
of	O
antihist	B-T103
##amine	I-T103
with	O
other	O
drugs	B-T103
.	O
to	O
evaluate	O
the	O
present	O
infiltration	B-T038
in	O
chronic	B-T038
urticaria	I-T038
biopsies	B-T058
and	O
correlate	O
it	O
with	O
the	O
clinical	O
disease	O
activity	O
and	O
response	B-T201
to	I-T201
treatment	I-T201
.	O
forty	O
-	O
one	O
patients	O
with	O
chronic	B-T038
urticaria	I-T038
were	O
classified	O
according	O
to	O
the	O
score	O
of	O
severity	O
of	O
the	O
disease	B-T038
,	O
response	B-T201
to	I-T201
treatment	I-T201
and	O
type	O
of	O
perivascular	B-T038
infiltrate	I-T038
.	O
inflammatory	B-T031
infiltrates	I-T031
were	O
divided	O
in	O
eosinophilic	B-T017
(	O
46	O
.	O
30	O
%	O
)	O
,	O
neutrophilic	B-T017
and	O
mixed	O
.	O
an	O
association	O
was	O
found	O
between	O
the	O
eosinophilic	B-T031
infiltrate	I-T031
and	O
clinical	O
scores	O
of	O
greater	O
severity	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
.	O
this	O
association	O
shows	O
that	O
the	O
eosinophilic	B-T031
inflammatory	I-T031
infiltrates	I-T031
den	O
##ote	O
high	O
clinical	B-T033
activity	I-T033
,	O
which	O
means	O
more	O
severe	O
and	O
ex	O
##uber	O
##ant	O
clinical	O
pictures	O
of	O
the	O
disease	B-T038
.	O

targeting	O
brain	B-T017
and	O
peripheral	B-T038
plasticity	I-T038
of	O
the	O
lipid	B-T103
##ome	I-T103
in	O
acute	O
kain	B-T103
##ic	I-T103
acid	I-T103
-	O
induced	O
epileptic	B-T038
seizures	I-T038
in	O
mice	B-T204
via	O
quantitative	B-T058
mass	I-T058
spectrometry	I-T058
epilepsy	B-T038
is	O
a	O
highly	O
common	O
chronic	B-T038
neurological	I-T038
disorder	I-T038
,	O
manifested	O
in	O
many	O
different	O
types	O
,	O
affecting	O
~	O
1	O
%	O
of	O
the	O
worldwide	O
human	B-T204
population	B-T098
.	O
the	O
molecular	B-T038
mechanisms	I-T038
of	O
epilept	B-T038
##ogenesis	I-T038
have	O
not	O
yet	O
been	O
clarified	O
,	O
and	O
pharmac	O
##oresistance	O
exhibited	O
by	O
30	O
-	O
40	O
%	O
of	O
epilepsy	B-T038
patients	O
remains	O
a	O
major	O
obstacle	O
in	O
medical	O
care	B-T058
.	O
growing	O
evidence	O
indicates	O
a	O
role	O
of	O
lipid	B-T103
signalling	B-T038
pathways	I-T038
in	O
epilept	B-T038
##ogenesis	I-T038
,	O
thus	O
lipid	B-T103
signals	B-T038
emerge	O
as	O
potential	O
biomarkers	B-T201
for	O
the	O
onset	O
and	O
evolving	O
course	O
of	O
the	O
epileptic	B-T038
disorder	I-T038
,	O
as	O
well	O
as	O
potential	O
therapeutic	B-T103
agents	I-T103
and	O
targets	O
.	O
for	O
this	O
purpose	O
,	O
we	O
applied	O
a	O
lipid	B-T103
##omic	I-T103
strategy	B-T062
to	O
unravel	O
lipid	B-T103
alterations	O
in	O
brain	B-T082
regions	I-T082
,	O
periphery	B-T017
tissues	I-T017
and	O
plasma	B-T031
that	O
are	O
specific	O
for	O
acute	O
epileptic	B-T038
seizures	I-T038
in	O
mice	B-T204
at	O
1h	O
after	O
seizure	B-T038
induction	O
by	O
systemic	B-T062
kain	B-T103
##ic	I-T103
acid	I-T103
injection	B-T062
as	O
compared	O
to	O
vehicle	O
controls	O
.	O
specifically	O
,	O
levels	O
of	O
(	O
i	O
)	O
selected	O
phospholipids	B-T103
and	O
sphingomyelin	B-T103
##s	I-T103
,	O
(	O
ii	O
)	O
the	O
endocannab	B-T103
##inoids	I-T103
ana	B-T103
##nd	I-T103
##amide	I-T103
(	O
ae	B-T103
##a	I-T103
)	O
and	O
2	B-T103
-	I-T103
arachid	I-T103
##on	I-T103
##oyl	I-T103
glycerol	I-T103
(	O
2	B-T103
-	I-T103
ag	I-T103
)	O
,	O
and	O
the	O
endocannab	B-T103
##inoid	I-T103
-	O
related	O
compounds	B-T103
ole	B-T103
##oyl	I-T103
##ethanol	I-T103
##amide	I-T103
(	O
oe	B-T103
##a	I-T103
)	O
and	O
palmitoyl	B-T103
##ethanol	I-T103
##amide	I-T103
(	O
pea	B-T103
)	O
,	O
(	O
iii	O
)	O
arachidonic	B-T103
acid	I-T103
(	O
aa	B-T103
)	O
,	O
(	O
iv	O
)	O
selected	O
eicosan	B-T103
##oids	I-T103
,	O
and	O
(	O
v	O
)	O
fatty	B-T103
acyl	I-T103
content	O
of	O
lipid	B-T103
##ome	I-T103
were	O
determined	O
in	O
pul	B-T062
##ver	I-T062
##ized	I-T062
tissues	B-T017
from	O
six	O
brain	B-T082
regions	I-T082
of	O
kain	B-T103
##ic	I-T103
acid	I-T103
induced	O
epileptic	B-T038
seizure	I-T038
models	O
and	O
vehicle	O
controls	O
:	O
hypothalamus	B-T017
,	O
hippocampus	B-T017
,	O
thalamus	B-T017
,	O
striatum	B-T017
,	O
cerebellum	B-T017
and	O
cerebral	B-T017
cortex	I-T017
,	O
and	O
from	O
peripheral	B-T082
organs	B-T017
,	O
such	O
as	O
heart	B-T017
and	O
lungs	B-T017
,	O
and	O
in	O
plasma	B-T031
.	O
alterations	O
in	O
lipid	B-T103
levels	O
after	O
acute	O
epileptic	B-T038
seizures	I-T038
as	O
compared	O
to	O
non	O
-	O
seizure	O
controls	O
were	O
found	O
to	O
be	O
brain	B-T082
region	I-T082
-	O
and	O
periphery	B-T017
tissue	I-T017
-	O
specific	O
,	O
including	O
specific	O
plasma	B-T031
lipid	B-T103
correlates	O
,	O
highlighting	O
their	O
value	O
as	O
marker	B-T201
candidates	I-T201
in	O
translational	O
research	B-T062
studies	I-T062
,	O
and	O
/	O
or	O
drug	B-T062
discovery	I-T062
and	O
response	B-T058
monitoring	I-T058
.	O

learned	B-T038
help	I-T038
##lessness	I-T038
at	O
fifty	O
:	O
insights	B-T038
from	O
neuroscience	B-T091
learned	B-T038
help	I-T038
##lessness	I-T038
,	O
the	O
failure	O
to	O
escape	B-T038
shock	B-T038
induced	O
by	O
uncontrol	O
##lab	O
##le	O
aversive	O
events	O
,	O
was	O
discovered	O
half	O
a	O
century	O
ago	O
.	O
sel	B-T204
##igm	I-T204
##an	I-T204
and	I-T204
ma	I-T204
##ier	I-T204
(	O
196	O
##7	O
)	O
theor	O
##ized	O
that	O
animals	B-T204
learned	B-T038
that	O
outcomes	O
were	O
independent	O
of	O
their	O
responses	O
-	O
that	O
nothing	O
they	O
did	O
matter	O
##ed	O
-	O
and	O
that	O
this	O
learning	B-T038
underm	O
##ined	O
trying	O
to	O
escape	B-T038
.	O
the	O
mechanism	O
of	O
learned	B-T038
help	I-T038
##lessness	I-T038
is	O
now	O
very	O
well	O
-	O
chart	O
##ed	O
biologically	O
,	O
and	O
the	O
original	O
theory	O
got	O
it	O
backward	O
.	O
pass	O
##ivity	O
in	O
response	O
to	O
shock	B-T038
is	O
not	O
learned	B-T038
.	O
it	O
is	O
the	O
default	O
,	O
unl	O
##ear	O
##ned	O
response	O
to	O
prolonged	O
aversive	O
events	O
and	O
it	O
is	O
mediated	O
by	O
the	O
serotonergic	B-T038
activity	I-T038
of	O
the	O
dorsal	B-T017
raphe	I-T017
nucleus	I-T017
,	O
which	O
in	O
turn	O
inhibits	O
escape	B-T038
.	O
this	O
pass	O
##ivity	O
can	O
be	O
overcome	O
by	O
learning	B-T038
control	O
,	O
with	O
the	O
activity	O
of	O
the	O
medial	B-T017
prefrontal	I-T017
cortex	I-T017
,	O
which	O
subs	O
##erves	O
the	O
detection	B-T033
of	O
control	O
leading	O
to	O
the	O
automatic	O
inhibition	O
of	O
the	O
dorsal	B-T017
raphe	I-T017
nucleus	I-T017
.	O
so	O
animals	B-T204
learn	B-T038
that	O
they	O
can	O
control	O
aversive	O
events	O
,	O
but	O
the	O
passive	O
failure	O
to	O
learn	B-T038
to	O
escape	B-T038
is	O
an	O
unl	O
##ear	O
##ned	O
reaction	O
to	O
prolonged	O
aversive	O
stimulation	O
.	O
in	O
addition	O
,	O
alterations	O
of	O
the	O
ventromedial	B-T017
prefrontal	I-T017
cortex	I-T017
-	O
dorsal	B-T017
raphe	I-T017
pathway	O
can	O
come	O
to	O
subs	O
##erve	O
the	O
expectation	O
of	O
control	O
.	O
we	O
speculate	O
that	O
default	O
pass	O
##ivity	O
and	O
the	O
compens	O
##ating	O
detection	B-T033
and	O
expectation	O
of	O
control	O
may	O
have	O
substantial	O
implications	O
for	O
how	O
to	O
treat	O
depression	B-T038
.	O
(	O
psycinfo	O
database	O
record	O

inhibition	B-T038
of	O
step	B-T103
##61	I-T103
ameliorate	O
##s	O
deficits	O
in	O
mouse	B-T204
and	O
hips	B-T017
##c	I-T017
-	O
based	O
schizophrenia	B-T038
models	B-T038
the	O
brain	B-T017
-	O
specific	O
tyrosine	B-T103
phosphatase	I-T103
,	O
step	B-T103
(	O
striatal	B-T103
-	I-T103
enriched	I-T103
protein	I-T103
tyrosine	I-T103
phosphatase	I-T103
)	O
is	O
an	O
important	O
regulator	O
of	O
synaptic	B-T038
function	I-T038
.	O
step	B-T103
normally	O
opp	O
##oses	O
synaptic	B-T082
strengthening	O
by	O
increasing	O
n	B-T103
-	I-T103
methyl	I-T103
d	I-T103
-	I-T103
aspartate	I-T103
glutamate	I-T103
receptor	I-T103
(	O
nmdar	B-T103
)	O
internalization	O
through	O
dephosphorylation	B-T038
of	O
glu	B-T103
##n2	I-T103
##b	I-T103
and	O
inactivation	B-T038
of	O
the	O
kinases	B-T103
extracellular	B-T103
signal	I-T103
-	I-T103
regulated	I-T103
kinase	I-T103
1	I-T103
/	O
2	B-T103
and	O
f	B-T103
##yn	I-T103
.	O
here	O
we	O
show	O
that	O
step	B-T103
##61	I-T103
is	O
elevated	O
in	O
the	O
cortex	B-T017
in	O
the	O
nr	B-T017
##g1	I-T017
(	I-T017
+	I-T017
/	I-T017
-	I-T017
)	I-T017
knockout	B-T038
mouse	B-T038
model	I-T038
of	O
schizophrenia	B-T038
(	O
sz	B-T038
)	O
.	O
genetic	O
reduction	B-T058
or	O
pharmacological	O
inhibition	O
of	O
step	B-T103
prevents	O
the	O
loss	O
of	O
nmdar	B-T103
##s	I-T103
from	O
synaptic	B-T017
membranes	I-T017
and	O
reverse	O
##s	O
behavioral	B-T038
deficits	I-T038
in	O
nr	B-T017
##g1	I-T017
(	I-T017
+	I-T017
/	I-T017
-	I-T017
)	I-T017
mice	B-T204
.	O
step	B-T103
##61	I-T103
protein	I-T103
is	O
also	O
increased	O
in	O
cortical	B-T017
lysates	O
from	O
the	O
central	B-T022
nervous	I-T022
system	I-T022
-	O
specific	O
erbb2	B-T103
/	O
4	B-T103
mouse	B-T038
model	I-T038
of	O
sz	B-T038
,	O
as	O
well	O
as	O
in	O
human	B-T017
induced	I-T017
pluripotent	I-T017
stem	I-T017
cell	I-T017
(	O
hips	B-T017
##c	I-T017
)	O
-	O
derived	O
forebrain	B-T017
neurons	B-T017
and	O
ng	B-T017
##n2	I-T017
-	O
induced	O
excitatory	B-T017
neurons	I-T017
,	O
from	O
two	O
independent	O
sz	B-T038
patient	O
cohorts	B-T098
.	O
in	O
these	O
selected	O
sz	B-T038
models	B-T038
,	O
increased	O
step	B-T103
##61	I-T103
protein	B-T058
levels	I-T058
likely	O
reflect	O
reduced	O
ubiquitination	B-T038
and	O
degradation	B-T038
.	O
these	O
convergent	O
findings	B-T033
from	O
mouse	B-T204
and	O
hips	B-T017
##c	I-T017
sz	B-T038
models	B-T038
provide	O
evidence	O
for	O
step	B-T103
##61	I-T103
dysfunction	O
in	O
sz	B-T038
.	O
molecular	O
psychiatry	O
advance	O
online	O
publication	O
,	O
18	O
october	O
2016	O
;	O
doi	O
:	O
10	O
.	O
103	O
##8	O
/	O
mp	O
.	O
2016	O
.	O
163	O
.	O

delayed	O
recognition	B-T038
of	O
deterioration	B-T033
of	O
patients	O
in	O
general	O
wards	O
is	O
mostly	O
caused	O
by	O
human	B-T204
related	O
monitoring	B-T058
failures	O
:	O
a	O
root	O
cause	O
analysis	O
of	O
unplanned	O
icu	B-T058
admissions	I-T058
an	O
unplanned	O
icu	B-T058
admission	I-T058
of	O
an	O
inpatient	O
is	O
a	O
serious	B-T033
adverse	I-T033
event	I-T033
(	O
sa	B-T033
##e	I-T033
)	O
.	O
so	O
far	O
,	O
no	O
in	O
depth	O
-	O
study	O
has	O
been	O
performed	O
to	O
systematically	O
analyse	O
the	O
root	O
causes	O
of	O
unplanned	O
icu	B-T058
-	I-T058
admissions	I-T058
.	O
the	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
identify	O
the	O
healthcare	B-T097
worker	I-T097
-	O
,	O
organisational	O
-	O
,	O
technical	B-T097
,	O
-	O
disease	B-T038
-	O
and	O
patient	O
-	O
related	O
causes	O
that	O
contribute	O
to	O
acute	O
unplanned	O
icu	B-T058
admissions	I-T058
from	O
general	O
wards	O
using	O
a	O
root	O
-	O
cause	O
analysis	O
tool	O
called	O
prism	B-T058
##a	I-T058
-	I-T058
medical	I-T058
.	O
although	O
a	O
track	O
and	O
trigger	O
system	O
(	O
me	O
##ws	O
)	O
was	O
introduced	O
in	O
our	O
hospital	B-T092
a	O
few	O
years	O
ago	O
,	O
it	O
was	O
implemented	O
without	O
a	O
clear	O
protocol	B-T058
.	O
therefore	O
,	O
the	O
secondary	O
aim	O
was	O
to	O
assess	O
the	O
adherence	O
to	O
a	O
track	O
and	O
trigger	O
system	O
to	O
identify	O
deterioration	B-T033
on	O
general	O
hospital	O
wards	O
in	O
patients	O
eventually	O
transferred	O
to	O
the	O
icu	B-T092
.	O
retrospective	B-T062
observational	I-T062
study	I-T062
in	O
49	O
consecutive	O
adult	O
patients	O
acutely	O
admitted	B-T058
to	O
the	O
intensive	B-T092
care	I-T092
unit	I-T092
from	O
a	O
general	B-T058
nursing	I-T058
ward	I-T058
.	O
1	O
.	O
prism	B-T062
##a	I-T062
-	I-T062
analysis	I-T062
on	O
root	O
causes	O
of	O
unplanned	O
icu	B-T058
admissions	I-T058
2	O
.	O
assessment	O
of	O
protocol	B-T058
adherence	O
to	O
the	O
early	B-T033
warning	I-T033
score	I-T033
system	I-T033
.	O
out	O
of	O
49	O
cases	O
,	O
156	O
root	O
causes	O
were	O
identified	O
.	O
the	O
most	O
frequent	O
root	O
causes	O
were	O
healthcare	B-T097
worker	I-T097
related	O
(	O
46	O
%	O
)	O
,	O
which	O
were	O
mainly	O
failures	O
in	O
monitoring	B-T058
the	O
patient	O
.	O
they	O
were	O
followed	O
by	O
disease	B-T038
-	O
related	O
(	O
45	O
%	O
)	O
,	O
patient	O
-	O
related	O
causes	O
(	O
7	O
,	O
5	O
%	O
)	O
,	O
and	O
organisational	O
root	O
causes	O
(	O
3	O
%	O
)	O
.	O
in	O
only	O
40	O
%	O
of	O
the	O
patients	O
vital	O
parameters	O
were	O
monitored	O
as	O
was	O
instructed	O
by	O
the	O
doctor	B-T097
.	O
47	O
##7	O
vital	O
parameter	O
sets	O
were	O
found	O
in	O
the	O
48	O
hours	O
before	O
icu	B-T058
admission	I-T058
,	O
in	O
only	O
1	O
%	O
a	O
correct	O
me	O
##ws	O
was	O
explicitly	O
documented	B-T058
in	O
the	O
record	O
.	O
this	O
in	B-T062
-	I-T062
depth	I-T062
analysis	I-T062
demonstrates	O
that	O
almost	O
half	O
of	O
the	O
unplanned	O
icu	B-T058
admissions	I-T058
from	O
the	O
general	O
ward	O
had	O
healthcare	B-T097
worker	I-T097
related	O
root	O
causes	O
,	O
mostly	O
due	O
to	O
monitoring	B-T058
failures	O
in	O
clinically	B-T033
deterior	I-T033
##ating	I-T033
patients	O
.	O
in	O
order	O
to	O
reduce	O
unplanned	O
icu	B-T058
admissions	I-T058
,	O
improving	O
the	O
monitoring	B-T058
of	O
patients	O
is	O
therefore	O
warranted	O
.	O

obes	B-T038
##ogenic	I-T038
eating	O
behaviors	O
mediate	O
the	O
relationships	O
between	O
psychological	B-T033
problems	I-T033
and	O
bmi	B-T201
in	O
children	O
to	O
examine	O
the	O
association	O
between	O
psychological	B-T033
problems	I-T033
and	O
weight	O
status	O
in	O
children	O
aged	O
3	O
.	O
5	O
to	O
4	O
years	O
and	O
test	O
whether	O
obes	B-T038
##ogenic	I-T038
eating	O
behaviors	O
mediate	O
this	O
relationship	O
.	O
this	O
study	O
is	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
secondary	I-T062
analysis	I-T062
of	O
data	O
from	O
first	O
-	O
time	O
mothers	O
(	O
n	O
=	O
194	O
)	O
in	O
the	O
control	O
arm	O
of	O
the	O
no	B-T062
##ur	I-T062
##ish	I-T062
randomized	I-T062
controlled	I-T062
trial	I-T062
.	O
at	O
child	O
age	O
3	O
.	O
5	O
to	O
4	O
years	O
,	O
maternal	O
-	O
reported	O
child	O
eating	O
behaviors	O
and	O
psychological	B-T033
problems	I-T033
were	O
collected	O
via	O
valid	O
tools	O
,	O
and	O
child	O
weight	O
and	O
height	O
data	B-T062
were	I-T062
collected	I-T062
by	O
trained	O
study	O
staff	O
.	O
pearson	B-T170
'	I-T170
s	I-T170
correlations	I-T170
and	O
linear	O
regressions	O
examined	O
associations	O
between	O
eating	O
behaviors	O
,	O
psychological	B-T033
problems	I-T033
,	O
and	O
bmi	B-T201
z	O
score	O
.	O
multiple	O
mediation	O
models	O
were	O
tested	O
by	O
assessing	O
indirect	O
effects	O
of	O
psychological	B-T033
problems	I-T033
on	O
bmi	B-T201
z	O
score	O
via	O
obes	B-T038
##ogenic	I-T038
eating	O
behaviors	O
.	O
peer	B-T098
problems	B-T033
were	O
associated	O
with	O
both	O
higher	O
food	B-T168
responsiveness	O
and	O
emotional	B-T038
over	I-T038
##ea	I-T038
##ting	I-T038
and	O
directly	O
with	O
higher	O
bmi	B-T201
z	O
score	O
.	O
this	O
relationship	O
was	O
partially	O
mediated	O
by	O
emotional	B-T038
over	I-T038
##ea	I-T038
##ting	I-T038
.	O
both	O
emotional	B-T038
over	I-T038
##ea	I-T038
##ting	I-T038
and	O
food	B-T168
responsiveness	O
fully	O
mediated	O
the	O
association	O
between	O
emotional	B-T038
problems	I-T038
and	O
bmi	B-T201
z	O
score	O
,	O
and	O
food	B-T168
responsiveness	O
fully	O
mediated	O
the	O
association	O
between	O
conduct	B-T038
problems	I-T038
and	O
bmi	B-T201
z	O
score	O
.	O
the	O
findings	O
suggest	O
that	O
children	O
with	O
psychological	B-T033
problems	I-T033
may	O
also	O
display	O
obes	B-T038
##ogenic	I-T038
eating	O
behaviors	O
,	O
which	O
may	O
result	O
in	O
higher	O
bmi	B-T201
.	O
this	O
needs	O
to	O
be	O
considered	O
in	O
the	O
clinical	B-T058
management	I-T058
of	O
both	O
pediatric	O
overweight	B-T033
/	O
obesity	B-T038
and	O
psychological	B-T033
problems	I-T033
.	O

xylan	B-T103
-	I-T103
based	I-T103
temperature	O
/	O
ph	O
sensitive	O
hydrogels	B-T103
for	O
drug	B-T103
controlled	I-T103
release	I-T103
xylan	B-T103
-	I-T103
based	I-T103
temperature	O
/	O
ph	O
sensitive	O
hydrogels	B-T103
were	O
prepared	O
by	O
the	O
crosslinking	B-T038
copolymer	I-T038
##ization	I-T038
of	O
xylan	B-T103
with	O
n	B-T103
-	I-T103
isopropyl	I-T103
##acrylamide	I-T103
(	O
nip	B-T103
##am	I-T103
)	O
and	O
acrylic	B-T103
acid	I-T103
(	O
aa	B-T103
)	O
using	O
n	B-T103
,	I-T103
n	I-T103
-	I-T103
methylene	I-T103
##bi	I-T103
##s	I-T103
-	I-T103
acrylamide	I-T103
(	O
mb	B-T103
##a	I-T103
)	O
as	O
a	O
cross	B-T103
-	I-T103
linker	I-T103
and	O
2	B-T103
,	I-T103
2	I-T103
-	I-T103
dimethoxy	I-T103
-	I-T103
2	I-T103
-	I-T103
phenyl	I-T103
##acet	I-T103
##ophenone	I-T103
as	O
a	O
photoin	B-T103
##iti	I-T103
##ator	I-T103
via	O
ultraviolet	O
irradiation	O
.	O
the	O
influence	O
of	O
the	O
nip	B-T103
##am	I-T103
,	O
aa	B-T103
and	O
mb	B-T103
##a	I-T103
amount	O
on	O
properties	O
of	O
xylan	B-T103
-	I-T103
based	I-T103
hydrogels	B-T103
was	O
discussed	O
.	O
the	O
morphology	O
and	O
interactions	O
of	O
hydrogels	B-T103
were	O
characterized	O
by	O
sem	B-T058
and	O
ftir	B-T062
.	O
the	O
lower	O
critical	O
solution	O
temperature	O
(	O
lcs	O
##t	O
)	O
of	O
hydrogels	B-T103
was	O
investigated	O
by	O
dsc	B-T058
.	O
the	O
results	O
indicated	O
that	O
the	O
lcs	O
##t	O
of	O
hydrogels	B-T103
emerged	O
at	O
around	O
34	O
##°c	O
and	O
increased	O
with	O
increasing	O
the	O
aa	B-T103
content	O
.	O
the	O
drug	B-T103
encapsulation	O
efficiency	O
of	O
as	O
-	O
prepared	O
hydrogels	B-T103
reached	O
to	O
97	O
.	O
60	O
%	O
and	O
the	O
cumulative	O
release	O
rate	O
of	O
acetyls	B-T103
##alic	I-T103
##ylic	I-T103
acid	I-T103
was	O
90	O
.	O
12	O
%	O
and	O
26	O
.	O
35	O
%	O
in	O
the	O
intestinal	B-T017
and	O
gastric	B-T031
fluid	I-T031
,	O
respectively	O
.	O
xylan	B-T103
-	I-T103
based	I-T103
hydrogels	B-T103
were	O
proved	O
to	O
be	O
biocompatible	O
with	O
nih	B-T017
##3t3	I-T017
cell	I-T017
by	O
mtt	B-T062
assay	I-T062
and	O
showed	O
the	O
promising	O
application	O
as	O
drug	B-T103
carriers	I-T103
for	O
the	O
intestinal	B-T017
-	O
targeted	O
oral	B-T058
drug	I-T058
delivery	I-T058
.	O

integrating	O
one	B-T091
health	I-T091
in	O
national	B-T170
health	I-T170
policies	I-T170
of	O
developing	O
countries	O
:	O
india	B-T082
'	I-T082
s	I-T082
lost	O
opportunities	O
globally	O
,	O
the	O
threat	O
of	O
infectious	B-T038
diseases	I-T038
,	O
particularly	O
emerging	B-T038
infectious	I-T038
diseases	I-T038
,	O
originating	O
at	O
the	O
human	B-T204
-	O
animal	B-T204
-	O
environment	B-T082
interface	O
,	O
has	O
caught	O
health	O
systems	O
off	O
guard	O
.	O
with	O
forec	O
##asts	O
that	O
future	O
pathogen	O
emergence	B-T038
will	O
be	O
centred	O
in	O
hots	O
##pots	O
in	O
asia	B-T082
,	O
africa	B-T082
,	O
and	O
latin	B-T082
america	I-T082
,	O
the	O
need	O
to	O
prepare	O
policy	B-T170
frameworks	I-T170
that	O
can	O
combat	O
this	O
threat	O
is	O
urgent	O
.	O
emergence	B-T038
of	I-T038
diseases	I-T038
such	O
as	O
avian	B-T038
influenza	I-T038
and	O
ebola	B-T038
virus	I-T038
disease	I-T038
,	O
which	O
threatened	O
social	O
disruption	O
,	O
have	O
established	O
the	O
need	O
for	O
inters	B-T058
##ector	I-T058
##al	I-T058
coordination	I-T058
/	I-T058
collaboration	I-T058
.	O
these	O
events	O
led	O
to	O
the	O
initiation	O
of	O
establishing	O
institutional	B-T033
##ised	I-T033
collaborative	O
frameworks	O
in	O
india	B-T082
to	O
adopt	O
a	O
one	B-T091
health	I-T091
approach	I-T091
to	O
disease	B-T058
prevention	I-T058
and	I-T058
control	I-T058
.	O
however	O
,	O
the	O
gains	O
made	O
in	O
influenza	B-T038
control	O
could	O
not	O
be	O
adapted	O
to	O
other	O
infectious	B-T038
diseases	I-T038
.	O
inters	B-T058
##ector	I-T058
##al	I-T058
coordination	I-T058
was	O
briefly	O
carried	O
out	O
,	O
more	O
as	O
a	O
reactive	O
response	O
to	O
threats	O
.	O
the	O
systemic	O
failure	O
to	O
sustain	O
such	O
efforts	O
have	O
therefore	O
,	O
only	O
underm	O
##ined	O
a	O
coordinated	O
response	O
.	O
the	O
recent	O
draft	B-T170
national	B-T170
health	I-T170
policy	I-T170
,	O
2015	O
,	O
has	O
also	O
failed	O
to	O
establish	O
the	O
need	O
for	O
inters	B-T058
##ector	I-T058
##al	I-T058
coordination	I-T058
in	O
disease	B-T058
control	I-T058
approaches	I-T058
.	O
neglect	O
##ing	O
the	O
need	O
to	O
endors	O
##e	O
linkages	B-T170
between	O
human	B-T204
health	O
,	O
animal	B-T204
health	O
and	O
husband	O
##ry	O
,	O
agriculture	O
,	O
and	O
environmental	B-T082
sectors	B-T082
,	O
has	O
led	O
to	O
dup	O
##lic	O
##ative	O
and	O
weak	B-T033
response	I-T033
systems	I-T033
.	O
the	O
absence	O
of	O
health	B-T058
impact	I-T058
assessment	I-T058
with	O
respect	O
to	O
the	O
development	O
agenda	O
in	O
policies	B-T170
,	O
has	O
cast	O
negative	B-T033
effects	O
on	O
the	O
health	O
and	O
wellbeing	B-T170
of	I-T170
man	I-T170
,	O
animal	B-T204
,	O
and	O
the	O
environment	B-T082
.	O
lack	O
of	O
attention	O
to	O
building	O
core	O
capacity	O
in	O
these	O
critical	O
sectors	B-T082
has	O
further	O
raised	O
challenges	B-T058
in	O
designing	O
and	O
deploy	O
##ing	O
mitigation	O
strategies	O
.	O
with	O
developing	O
countries	O
like	O
india	B-T082
being	O
home	O
to	O
a	O
major	O
portion	B-T082
of	O
the	O
world	B-T098
'	I-T098
s	I-T098
poor	O
##est	O
livestock	B-T097
farmers	I-T097
,	O
the	O
absence	O
of	O
a	O
policy	B-T170
discourse	O
that	O
endors	O
##es	O
the	O
one	B-T091
health	I-T091
approach	I-T091
in	O
development	O
and	O
health	B-T170
policies	I-T170
is	O
a	O
major	O
hur	B-T038
##dle	I-T038
in	O
eliminating	O
poverty	O
and	O
poverty	O
-	O
related	O
diseases	B-T038
.	O
the	O
adoption	O
of	O
one	B-T091
health	I-T091
approaches	I-T091
in	O
health	O
and	O
related	O
sector	B-T082
##al	I-T082
policies	B-T170
is	O
a	O
critical	O
policy	B-T170
requirement	O
for	O
india	B-T082
and	O
other	O
developing	O
countries	O
.	O
the	O
goal	O
should	O
be	O
to	O
not	O
just	O
establish	O
preparedness	B-T033
plans	B-T038
,	O
but	O
also	O
to	O
encourage	O
a	O
policy	O
environment	O
where	O
assessment	B-T058
and	O
mitigation	O
of	O
downstream	B-T082
impacts	O
of	O
different	O
agenda	O
are	O
incorporated	O
.	O

vestibular	B-T038
disorders	I-T038
and	O
nausea	B-T033
during	O
head	B-T038
and	O
neck	B-T038
intensity	B-T058
-	I-T058
modulated	I-T058
radiation	I-T058
therapy	I-T058
we	O
studied	O
whether	O
there	O
is	O
a	O
relationship	O
between	O
nausea	B-T033
and	O
vestibular	B-T038
disorders	I-T038
in	O
patients	O
treated	B-T058
with	I-T058
intensity	B-T058
modulated	I-T058
radiation	I-T058
therapy	I-T058
(	O
imrt	B-T058
)	O
for	O
head	B-T038
and	O
neck	B-T038
cancer	I-T038
.	O
we	O
performed	O
a	O
prospective	B-T062
single	I-T062
-	I-T062
centre	I-T062
study	I-T062
that	O
enrolled	B-T058
31	O
patients	O
.	O
a	O
video	B-T058
##n	I-T058
##yst	I-T058
##ag	I-T058
##mo	I-T058
##graphy	I-T058
was	O
carried	O
out	O
before	O
and	O
within	O
15	O
days	O
after	O
radiation	B-T058
therapy	I-T058
for	O
each	O
patient	O
.	O
nausea	B-T033
was	O
assessed	O
at	O
baseline	O
,	O
every	O
week	O
,	O
and	O
at	O
the	O
post	B-T058
-	I-T058
radiotherapy	I-T058
video	B-T058
##n	I-T058
##yst	I-T058
##ag	I-T058
##mo	I-T058
##graphy	I-T058
visit	O
.	O
twenty	O
-	O
six	O
patients	O
had	O
benefited	O
from	O
a	O
complete	O
interpret	O
##able	O
video	B-T058
##n	I-T058
##yst	I-T058
##ag	I-T058
##mo	I-T058
##graphy	I-T058
.	O
for	O
14	O
of	O
these	O
patients	O
vestibular	B-T033
damage	I-T033
was	O
diagnosed	B-T033
post	B-T058
-	I-T058
radiotherapy	I-T058
.	O
during	O
irradiation	O
,	O
six	O
patients	O
felt	O
nause	B-T033
##ous	I-T033
,	O
but	O
without	O
dizziness	B-T033
.	O
in	O
univariate	O
analysis	O
,	O
we	O
found	O
a	O
relationship	O
statistically	O
significant	O
between	O
the	O
average	O
dose	O
received	O
by	O
the	O
vestib	B-T082
##ules	I-T082
and	O
vestibular	B-T038
disorder	I-T038
video	B-T058
##n	I-T058
##yst	I-T058
##ag	I-T058
##mo	I-T058
##graphy	I-T058
(	O
p	O
=	O
0	O
.	O
001	O
,	O
odds	O
ratio	O
[	O
or	O
]	O
:	O
1	O
.	O
08	O
[	O
1	O
.	O
025	O
-	O
.	O
138	O
]	O
)	O
,	O
but	O
there	O
was	O
no	B-T033
relationship	O
between	O
vestibular	B-T038
disorder	I-T038
video	B-T058
##n	I-T058
##yst	I-T058
##ag	I-T058
##mo	I-T058
##graphy	I-T058
and	O
nausea	B-T033
(	O
p	O
=	O
0	O
.	O
70	O
##1	O
)	O
.	O
irradiation	O
of	O
the	O
vestibular	B-T022
system	I-T022
during	O
imrt	B-T058
does	O
not	O
seem	O
to	O
explain	O
the	O
nausea	B-T033
.	O

natural	O
competence	O
for	O
transformation	B-T038
while	O
most	O
molecular	O
biologists	O
are	O
familiar	O
with	O
the	O
artificial	O
transformation	B-T038
of	I-T038
bacteria	I-T038
in	O
the	O
context	O
of	O
laboratory	B-T092
cloning	B-T062
experiments	B-T062
,	O
natural	O
competence	O
for	O
transformation	B-T038
refers	O
to	O
a	O
specific	O
physiological	O
state	O
in	O
which	O
prokaryotes	O
are	O
able	O
to	O
take	O
up	O
genetic	B-T017
material	I-T017
from	O
their	O
surrounding	B-T082
##s	I-T082
.	O
occasionally	O
,	O
such	O
absorbed	O
dna	B-T103
is	O
recombin	O
##ed	O
into	O
the	O
organism	O
'	O
s	O
own	O
genome	B-T017
,	O
resulting	O
in	O
natural	O
transformation	B-T038
(	O
figure	O
1	O
)	O
.	O
as	O
a	O
consequence	O
,	O
natural	O
competence	O
for	O
transformation	B-T038
is	O
considered	O
a	O
primary	O
mode	O
of	O
horizontal	B-T038
gene	I-T038
transfer	I-T038
(	O
hg	B-T038
##t	I-T038
)	O
in	O
prokaryotes	O
,	O
together	O
with	O
conjugation	B-T038
(	O
direct	O
cell	B-T017
to	O
cell	B-T017
transfer	O
of	O
dna	B-T103
via	O
a	O
specialized	O
conjug	B-T017
##al	I-T017
pil	I-T017
##us	I-T017
)	O
and	O
phage	B-T005
transduction	B-T038
(	O
dna	B-T103
transfer	O
mediated	O
by	O
viruses	B-T005
)	O
.	O
hg	B-T038
##t	I-T038
plays	O
a	O
major	O
role	O
in	O
bacterial	O
evolution	B-T038
,	O
and	O
past	O
research	B-T062
has	O
demonstrated	O
that	O
hg	B-T038
##t	I-T038
,	O
including	O
natural	O
competence	O
for	O
transformation	B-T038
,	O
contributes	O
to	O
the	O
emergence	O
of	O
pathogens	O
and	O
the	O
spread	O
of	O
virulence	B-T103
factors	I-T103
.	O
indeed	O
,	O
fre	O
##der	O
##ick	O
gr	O
##iff	O
##ith	O
discovered	O
natural	O
competence	O
for	O
transformation	B-T038
in	O
192	O
##8	O
while	O
he	O
was	O
investigating	O
the	O
exchange	B-T038
of	O
pathogenic	B-T033
traits	O
in	O
pneum	B-T007
##ococci	I-T007
.	O
due	O
to	O
the	O
increase	O
in	O
the	O
abundance	O
and	O
spread	O
of	O
multidrug	B-T007
-	I-T007
resistant	I-T007
microbes	I-T007
,	O
research	B-T062
on	O
hg	B-T038
##t	I-T038
is	O
even	O
more	O
important	O
today	O
than	O
ever	O
before	O
.	O

meta	B-T062
-	I-T062
analysis	I-T062
of	O
29	O
experiments	B-T062
evaluating	B-T058
the	O
effects	O
of	O
rapamycin	B-T103
on	O
life	O
span	O
in	O
the	O
laboratory	B-T204
mouse	I-T204
rapamycin	B-T103
has	O
favorable	O
effects	O
on	O
aging	B-T038
in	O
mice	B-T204
and	O
may	O
eventually	O
be	O
applied	O
to	O
encourage	O
[UNK]	O
healthy	O
aging	B-T038
[UNK]	O
in	O
humans	B-T204
.	O
this	O
study	B-T062
analyzed	B-T062
raw	O
data	O
from	O
29	O
survival	B-T062
studies	I-T062
of	O
rapamycin	B-T103
-	O
and	O
control	O
-	O
treated	O
mice	B-T204
,	O
with	O
the	O
goals	B-T170
of	O
estimating	O
summary	B-T170
statistics	B-T170
and	O
identifying	O
factors	O
associated	O
with	O
effect	O
size	O
heterogeneity	O
.	O
meta	B-T062
-	I-T062
analysis	I-T062
demonstrated	O
significant	O
heterogeneity	O
across	O
studies	B-T058
,	O
with	O
hazard	O
ratio	O
(	O
hr	O
)	O
estimates	O
ranging	O
from	O
0	O
.	O
22	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
:	O
0	O
.	O
06	O
-	O
0	O
.	O
82	O
)	O
to	O
0	O
.	O
92	O
(	O
95	O
%	O
ci	O
:	O
0	O
.	O
65	O
-	O
1	O
.	O
28	O
)	O
.	O
sex	O
was	O
the	O
major	O
factor	O
accounting	O
for	O
effect	O
size	O
variation	O
,	O
and	O
mortality	O
was	O
decreased	O
more	O
in	O
females	O
(	O
hr	O
=	O
0	O
.	O
41	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
35	O
-	O
0	O
.	O
48	O
)	O
as	O
compared	O
with	O
males	O
(	O
hr	O
=	O
0	O
.	O
63	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
55	O
-	O
0	O
.	O
71	O
)	O
.	O
rapamycin	B-T103
effects	O
were	O
also	O
genotype	O
dependent	O
,	O
however	O
,	O
with	O
stronger	O
survivorship	O
increases	O
in	O
hybrid	O
mice	B-T204
(	O
14	O
.	O
4	O
%	O
;	O
95	O
%	O
ci	O
:	O
12	O
.	O
5	O
-	O
16	O
.	O
3	O
%	O
)	O
relative	O
to	O
pure	O
inbred	B-T204
strains	I-T204
(	O
8	O
.	O
8	O
%	O
;	O
95	O
%	O
ci	O
:	O
6	O
.	O
2	O
-	O
11	O
.	O
6	O
%	O
)	O
.	O
number	O
needed	O
to	O
treat	O
was	O
applied	O
as	O
an	O
effect	O
size	O
metric	O
,	O
which	O
consistently	O
identified	O
early	O
senescence	B-T033
as	O
the	O
age	O
of	O
peak	O
treatment	O
benefit	O
.	O
these	O
results	O
provide	O
synthesis	O
of	O
existing	O
data	O
to	O
support	O
the	O
potential	O
translation	B-T062
of	O
findings	B-T033
from	O
mouse	B-T204
to	O
primate	B-T204
species	I-T204
.	O
because	O
rapamycin	B-T103
'	I-T103
s	I-T103
effect	O
on	O
survival	O
depends	O
on	O
sex	O
and	O
genotype	O
,	O
further	O
work	O
is	O
justified	O
to	O
understand	O
how	O
these	O
factors	O
shape	O
treatment	O
response	O
.	O

synaptic	B-T082
and	O
neuronal	B-T017
autoantibody	B-T103
-	O
associated	O
psychiatric	B-T038
syndromes	I-T038
:	O
controversies	O
and	O
hypotheses	O
autoimmune	B-T038
encephalitis	I-T038
(	O
ae	B-T038
)	O
mediated	O
by	O
antibodies	B-T103
against	O
synaptic	B-T082
and	O
neuronal	B-T017
surface	B-T082
targets	O
frequently	O
presents	B-T033
with	O
a	O
psychiatric	B-T038
syndrome	I-T038
.	O
in	O
these	O
patients	O
,	O
removal	B-T058
of	I-T058
autoantibodies	B-T103
treat	O
##s	O
the	O
disease	B-T038
and	O
outcomes	O
are	O
closely	O
linked	O
to	O
early	O
intervention	B-T058
.	O
the	O
discovery	O
of	O
these	O
autoantibodies	B-T103
in	O
isolated	O
psychiatric	B-T038
syndromes	I-T038
has	O
raised	O
the	O
possibility	O
that	O
these	O
patients	O
may	O
derive	O
similar	O
benefits	O
from	O
immunotherapy	B-T058
,	O
a	O
potentially	O
transformation	O
##al	O
approach	B-T082
to	O
the	O
treatment	O
of	O
mental	B-T038
illness	I-T038
.	O
although	O
open	B-T062
-	I-T062
label	I-T062
case	I-T062
series	I-T062
suggest	O
impressive	O
therapeutic	O
outcomes	O
,	O
the	O
pathological	O
relevance	O
of	O
these	O
autoantibodies	B-T103
outside	O
of	O
canonical	O
presentations	O
is	O
debated	O
.	O
the	O
advent	O
of	O
diagnostic	B-T170
criteria	I-T170
for	O
ae	B-T038
attempts	O
to	O
facilitate	O
its	O
prompt	O
identification	O
but	O
risks	O
prematurely	O
neglect	O
##ing	O
the	O
potential	O
scientific	O
and	O
clinical	B-T033
significance	I-T033
of	O
isolated	O
syndromes	B-T038
that	O
do	O
not	O
satisfy	O
these	O
criteria	O
.	O
here	O
,	O
we	O
propose	O
using	O
a	O
syndrome	B-T038
-	O
level	O
taxonomy	O
that	O
has	O
occasional	O
,	O
but	O
not	O
necessary	O
,	O
overlap	O
with	O
ae	B-T038
:	O
synaptic	B-T082
and	O
neuronal	B-T017
autoantibody	B-T103
-	O
associated	O
psychiatric	B-T038
syndromes	I-T038
or	O
[UNK]	O
snap	B-T038
##s	I-T038
[UNK]	O
.	O
this	O
will	O
prevent	O
confusion	O
with	O
ae	B-T038
and	O
act	B-T170
heuristic	I-T170
##ally	I-T170
to	O
promote	O
active	O
investigation	B-T058
into	O
this	O
rare	O
example	O
of	O
psychopathology	B-T091
defined	B-T170
on	O
a	O
molecular	O
level	O
.	O
we	O
suggest	O
that	O
this	O
concept	O
would	O
have	O
application	O
in	O
other	O
autoantibody	B-T103
-	O
associated	O
syndromes	B-T038
including	O
seizure	B-T033
,	O
cognitive	O
,	O
and	O
movement	B-T038
disorders	I-T038
,	O
in	O
which	O
similar	O
issues	B-T033
arise	O
.	O
we	O
review	O
putative	O
direct	O
and	O
indirect	O
mechanisms	O
and	O
outline	O
experimentally	O
test	O
##able	O
hypotheses	O
that	O
would	O
help	O
to	O
determine	O
prospectively	B-T062
in	O
whom	O
autoantibody	B-T103
detection	B-T058
is	O
relevant	O
,	O
and	O
as	O
important	O
,	O
in	O
whom	O
it	O
is	O
not	O
.	O
we	O
summarize	O
a	O
pragmatic	O
approach	O
to	O
autoantibody	B-T103
testing	O
and	O
management	B-T058
in	O
severe	O
mental	B-T038
illness	I-T038
in	O
order	O
to	O
promptly	O
diagnose	B-T033
ae	B-T038
and	O
advocate	O
a	O
research	B-T062
-	O
orient	B-T033
##ated	I-T033
experimental	O
medicine	B-T103
paradigm	O
for	O
snap	B-T038
##s	I-T038
,	O
where	O
there	O
is	O
greater	O
equip	B-T103
##ois	I-T103
##e	I-T103
.	O
we	O
conclude	O
that	O
snap	B-T038
##s	I-T038
remains	O
a	O
nascent	O
area	O
of	O
clinical	O
neuroscience	B-T091
with	O
great	O
potential	O
and	O
in	O
ongoing	O
need	O
of	O
psychiatry	B-T091
-	O
led	O
basic	O
and	O
clinical	B-T062
research	I-T062
.	O

glycated	B-T103
hemoglobin	I-T103
(	O
hba1c	B-T103
)	O
correlation	O
with	O
severity	O
of	O
coronary	B-T038
artery	I-T038
disease	I-T038
in	O
non	B-T033
-	I-T033
diabetic	I-T033
patients	O
-	O
a	O
hospital	B-T092
based	I-T092
study	B-T062
from	O
north	B-T082
-	I-T082
eastern	I-T082
india	I-T082
glycated	B-T033
hemoglobin	I-T033
(	I-T033
hba1c	I-T033
)	I-T033
levels	I-T033
are	O
predictive	O
of	O
cardiovascular	B-T038
disease	I-T038
and	O
mortality	O
in	O
patients	O
with	O
diabetes	B-T038
mellitus	I-T038
,	O
however	O
,	O
association	O
of	O
hba1c	B-T103
with	O
coronary	B-T038
artery	I-T038
disease	I-T038
(	O
cad	B-T038
)	O
in	O
non	B-T033
-	I-T033
diabetics	I-T033
is	O
inconsistent	O
.	O
to	O
evaluate	B-T058
the	O
correlation	O
between	O
hba1c	B-T033
level	I-T033
and	O
severity	O
of	O
cad	B-T038
in	O
non	O
-	O
diabetic	O
patients	O
using	O
synt	O
##ax	O
score	O
in	O
a	O
cohort	B-T098
of	O
proven	O
cad	B-T038
on	O
angiography	B-T058
at	O
ga	B-T092
##u	I-T092
##ha	I-T092
##ti	I-T092
medical	I-T092
college	I-T092
,	O
gu	B-T082
##wa	I-T082
##ha	I-T082
##ti	I-T082
,	I-T082
ass	I-T082
##am	I-T082
,	O
india	B-T082
,	O
which	O
is	O
a	O
major	O
tertiary	B-T092
care	I-T092
hospital	I-T092
of	O
north	B-T082
-	I-T082
eastern	I-T082
india	I-T082
.	O
we	O
prospectively	O
collected	O
data	O
of	O
non	O
-	O
diabetic	O
patients	O
with	O
proven	O
cad	B-T038
on	O
angiography	B-T058
from	O
june	O
2014	O
to	O
june	O
2015	O
.	O
patients	O
were	O
divided	O
into	O
four	O
groups	O
(	O
interquartile	O
##s	O
)	O
according	O
to	O
hba1c	B-T033
levels	I-T033
,	O
less	O
than	O
4	O
.	O
8	O
%	O
,	O
4	O
.	O
8	O
%	O
to	O
5	O
.	O
1	O
%	O
,	O
5	O
.	O
1	O
%	O
to	O
5	O
.	O
6	O
%	O
,	O
and	O
5	O
.	O
6	O
%	O
to	O
6	O
.	O
5	O
%	O
.	O
severity	O
of	O
cad	B-T038
was	O
assessed	O
using	O
synt	O
##ax	O
score	O
and	O
the	O
number	O
of	O
coronary	O
vessels	O
diseased	O
.	O
we	O
compared	O
different	O
quartiles	O
of	O
hba1c	B-T103
with	O
regard	O
to	O
synt	O
##ax	O
score	O
and	O
number	O
of	O
diseased	O
vessels	O
.	O
a	O
total	O
of	O
34	O
##6	O
patients	O
were	O
included	O
in	O
the	O
study	B-T062
.	O
mean	O
age	O
was	O
58	O
.	O
1	O
##±1	O
##0	O
.	O
4	O
years	O
.	O
of	O
the	O
total	O
91	O
.	O
9	O
%	O
(	O
318	O
)	O
were	O
males	O
,	O
44	O
.	O
8	O
%	O
(	O
155	O
)	O
were	O
hypertensives	B-T033
,	O
29	O
.	O
2	O
%	O
(	O
101	O
)	O
were	O
smokers	B-T033
and	O
34	O
.	O
7	O
%	O
(	O
120	O
)	O
were	O
dyslipid	B-T033
##emic	I-T033
.	O
we	O
found	O
that	O
cad	B-T038
severity	O
by	O
synt	O
##ax	O
score	O
as	O
well	O
as	O
number	O
of	O
vessels	B-T017
involved	O
was	O
significantly	O
different	O
among	O
quartiles	O
(	O
p	O
-	O
values	O
<	O
0	O
.	O
001	O
and	O
<	O
0	O
.	O
001	O
respectively	O
)	O
.	O
increase	O
in	O
hba1c	B-T033
level	I-T033
was	O
strongly	O
correlated	O
with	O
disease	O
severity	O
and	O
higher	O
synt	O
##ax	O
score	O
.	O
a	O
significant	O
increase	O
was	O
noted	O
in	O
the	O
mean	O
number	O
of	O
diseased	O
vessels	O
(	O
p	O
-	O
value	O
<	O
0	O
.	O
001	O
)	O
as	O
hba1c	B-T033
level	I-T033
increases	O
.	O
age	O
,	O
gender	O
,	O
hypertension	B-T038
and	O
dyslipidemia	B-T038
did	O
not	O
show	O
significant	O
difference	O
among	O
quartiles	O
however	O
smoking	O
was	O
found	O
to	O
be	O
an	O
independent	O
predictor	O
of	O
severity	O
of	O
cad	B-T038
by	O
synt	O
##ax	O
score	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
from	O
this	O
clinical	B-T062
study	I-T062
,	O
we	O
can	O
conclude	O
that	O
a	O
significant	O
correlation	O
exists	O
between	O
hba1c	B-T103
and	O
severity	O
of	O
cad	B-T038
by	O
synt	O
##ax	O
score	O
as	O
well	O
as	O
number	O
of	O
vessels	B-T017
involved	O
in	O
non	B-T033
-	I-T033
diabetes	I-T033
.	O

lac	B-T037
##eration	I-T037
of	O
a	O
branch	B-T082
of	I-T082
the	O
prof	B-T017
##und	I-T017
##a	I-T017
femoris	I-T017
artery	I-T017
caused	O
by	O
a	O
spike	B-T033
of	O
the	O
displaced	B-T082
lesser	B-T017
troch	I-T017
##anter	I-T017
in	O
an	O
inter	B-T082
-	I-T082
troch	I-T082
##anteric	I-T082
femoral	B-T037
fracture	I-T037
.	O
a	O
case	B-T170
report	I-T170
injury	B-T037
of	O
femoral	B-T017
vessels	I-T017
is	O
an	O
extremely	O
rare	O
complication	B-T038
in	O
intert	B-T082
##roch	I-T082
##anteric	I-T082
femoral	B-T037
fractures	I-T037
.	O
in	O
most	O
cases	O
reported	B-T058
,	O
the	O
vascular	B-T038
lesion	I-T038
involves	O
the	O
superficial	B-T017
femoral	I-T017
artery	I-T017
,	O
whereas	O
in	O
very	O
few	O
cases	O
does	O
it	O
involve	O
the	O
prof	B-T017
##und	I-T017
##a	I-T017
femoris	I-T017
artery	I-T017
.	O
we	O
report	B-T170
a	O
case	O
of	O
acute	B-T038
bleeding	I-T038
due	O
to	O
lac	B-T037
##eration	I-T037
of	O
a	O
perfor	B-T033
##ating	I-T033
branch	B-T082
of	I-T082
the	O
prof	B-T017
##und	I-T017
##a	I-T017
femoris	I-T017
artery	I-T017
caused	O
by	O
a	O
sharp	B-T033
fragment	O
of	O
the	O
displaced	B-T082
lesser	B-T017
troch	I-T017
##anter	I-T017
in	O
an	O
intert	B-T082
##roch	I-T082
##anteric	I-T082
femoral	B-T037
fracture	I-T037
;	O
the	O
lesion	B-T033
was	O
treated	O
by	O
transcatheter	B-T058
embolization	I-T058
.	O
the	O
arterial	B-T037
injury	I-T037
may	O
be	O
iatrogenic	O
,	O
occurring	O
during	O
intramedullary	B-T082
internal	B-T058
fixation	I-T058
,	O
or	O
less	O
frequently	O
,	O
the	O
injury	B-T037
may	O
be	O
due	O
to	O
the	O
fracture	B-T037
itself	O
,	O
caused	O
by	O
a	O
sharp	B-T033
bone	B-T037
fragment	I-T037
that	O
damages	O
the	O
prof	B-T017
##und	I-T017
##a	I-T017
femoris	I-T017
artery	I-T017
or	O
one	O
of	O
its	O
perfor	B-T033
##ating	I-T033
branches	B-T082
.	O
we	O
believe	O
that	O
intert	B-T082
##roch	I-T082
##anteric	I-T082
femoral	B-T037
fractures	I-T037
with	O
av	B-T037
##ulse	I-T037
##d	I-T037
lesser	B-T017
troch	I-T017
##anter	I-T017
are	O
at	O
risk	O
for	O
femoral	B-T017
vessel	I-T017
injuries	B-T037
caused	O
by	O
the	O
displaced	B-T082
bone	B-T017
spike	B-T033
,	O
and	O
we	O
advis	O
##e	O
meticulous	O
clinical	O
and	O
laboratory	B-T058
monitoring	I-T058
pre	O
-	O
and	O
post	O
-	O
operatively	O
to	O
prevent	O
serious	O
complications	O
.	O

ocular	B-T038
hypotensive	I-T038
effect	O
of	O
the	O
novel	O
ep	B-T103
##3	I-T103
/	O
fp	B-T103
agonist	B-T103
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
versus	O
xa	B-T103
##la	I-T103
##tan	I-T103
:	O
results	O
of	O
a	O
28	O
-	O
day	O
,	O
double	B-T062
-	I-T062
masked	I-T062
,	O
randomised	O
study	B-T062
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
is	O
being	O
developed	O
for	O
the	O
reduction	O
of	O
intraocular	B-T038
pressure	I-T038
(	O
iop	B-T038
)	O
in	O
patients	O
with	O
ocular	B-T038
hypertension	I-T038
(	O
oh	B-T038
##t	I-T038
)	O
and	O
open	B-T038
-	I-T038
angle	I-T038
glaucoma	I-T038
(	O
oa	B-T038
##g	I-T038
)	O
.	O
this	O
study	B-T062
compared	O
the	O
novel	O
dual	O
ep	B-T103
##3	I-T103
/	O
fp	B-T103
agonist	B-T103
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
with	O
the	O
fp	B-T103
agonist	B-T103
xa	B-T103
##la	I-T103
##tan	I-T103
.	O
adults	O
(	O
n	O
=	O
123	O
)	O
with	O
bilateral	O
mild	O
/	O
moderate	O
oa	B-T038
##g	I-T038
or	O
oh	B-T038
##t	I-T038
,	O
with	O
unm	O
##edic	O
##ated	O
iop	B-T038
of	O
≥2	O
##4	O
mm	O
hg	O
at	O
8	O
:	O
00	O
hours	O
,	O
≥2	O
##1	O
mm	O
hg	O
at	O
10	O
:	O
00	O
hours	O
and	O
≤	O
##36	O
mm	O
hg	O
,	O
were	O
randomised	O
1	O
:	O
1	O
to	O
receive	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
(	O
0	O
.	O
003	O
%	O
,	O
30	O
μg	O
/	O
ml	O
)	O
or	O
xa	B-T103
##la	I-T103
##tan	I-T103
(	O
0	O
.	O
005	O
%	O
,	O
50	O
μg	O
/	O
ml	O
)	O
once	O
daily	O
for	O
28	O
days	O
.	O
day	O
29	O
mean	O
diurnal	O
iop	B-T038
was	O
-	O
7	O
.	O
2	O
mm	O
hg	O
for	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
vs	O
-	O
6	O
.	O
6	O
mm	O
hg	O
for	O
xa	B-T103
##la	I-T103
##tan	I-T103
.	O
at	O
08	O
:	O
00	O
hours	O
,	O
the	O
iop	B-T038
##s	I-T038
were	O
comparable	O
,	O
and	O
at	O
all	O
later	O
time	O
points	O
the	O
decrease	O
in	O
iop	B-T038
was	O
greater	O
for	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
.	O
on	O
day	O
29	O
,	O
the	O
odds	O
of	O
a	O
mean	O
iop	B-T038
reduction	O
of	O
≤	O
-	O
25	O
%	O
,	O
≤	O
-	O
30	O
%	O
and	O
≤	O
-	O
35	O
%	O
for	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
were	O
2	O
.	O
39	O
,	O
2	O
.	O
37	O
and	O
4	O
.	O
85	O
times	O
more	O
,	O
respectively	O
,	O
than	O
the	O
odds	O
for	O
xa	B-T103
##la	I-T103
##tan	I-T103
(	O
p	O
<	O
0	O
.	O
05	O
,	O
post	B-T062
hoc	I-T062
analyses	I-T062
)	O
.	O
the	O
percentage	O
of	O
subjects	O
achieving	O
target	O
iop	B-T038
##s	I-T038
on	O
day	O
29	O
(	O
≤	O
##17	O
,	O
≤	O
##16	O
and	O
≤	O
##15	O
mm	O
hg	O
)	O
was	O
greater	O
for	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
than	O
for	O
xa	B-T103
##la	I-T103
##tan	I-T103
;	O
the	O
odds	O
of	O
achieving	O
an	O
iop	B-T038
≤	O
##15	O
mm	O
hg	O
for	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
were	O
2	O
.	O
4	O
times	O
more	O
than	O
the	O
odds	O
for	O
xa	B-T103
##la	I-T103
##tan	I-T103
(	O
p	O
<	O
0	O
.	O
01	O
,	O
post	B-T062
hoc	I-T062
analysis	I-T062
)	O
.	O
subjects	O
randomised	O
to	O
receive	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
were	O
more	O
likely	O
to	O
achieve	O
a	O
greater	O
per	O
cent	O
reduction	O
in	O
iop	B-T038
and	O
were	O
more	O
likely	O
to	O
achieve	O
target	O
iop	B-T038
##s	I-T038
than	O
those	O
receiving	O
xa	B-T103
##la	I-T103
##tan	I-T103
.	O
the	O
effects	O
of	O
on	B-T103
##o	I-T103
-	I-T103
90	I-T103
##54	I-T103
in	O
reducing	O
iop	B-T038
appear	O
to	O
persist	O
longer	O
than	O
those	O
of	O
xa	B-T103
##la	I-T103
##tan	I-T103
.	O
nct0	O
##20	O
##83	O
##28	O
##9	O
,	O
results	O
.	O

methylation	B-T062
analysis	I-T062
of	O
brca1	B-T017
and	O
apc	B-T017
in	O
breast	B-T038
cancer	I-T038
and	O
it	O
'	O
s	O
relationship	O
to	O
clinicopathological	O
features	O
promoter	B-T038
methylation	I-T038
of	O
tumor	B-T017
suppressor	I-T017
genes	I-T017
is	O
an	O
important	O
epigenetic	B-T038
alteration	I-T038
that	O
occurs	O
in	O
the	O
primary	O
stages	O
of	O
human	B-T204
tumors	B-T038
,	O
including	O
breast	B-T038
cancer	I-T038
.	O
identification	O
of	O
methylated	B-T017
genes	I-T017
and	O
their	O
relationship	O
to	O
clinical	O
features	O
can	O
contribute	O
to	O
the	O
prognosis	B-T058
and	O
early	B-T058
detection	I-T058
of	O
tumors	B-T038
.	O
in	O
this	O
study	B-T062
,	O
we	O
explored	O
the	O
methylation	B-T038
status	O
of	O
apc	B-T017
and	O
brca1	B-T017
genes	I-T017
and	O
their	O
relationship	O
to	O
clinical	O
factors	O
in	O
breast	B-T038
cancer	I-T038
patients	O
.	O
brca1	B-T017
and	O
apc	B-T017
promoter	B-T038
methylation	I-T038
was	O
examined	O
by	O
methylation	B-T038
-	O
specific	B-T062
multiplex	I-T062
ligation	I-T062
-	I-T062
dependent	I-T062
probe	I-T062
amplification	I-T062
(	O
ms	B-T062
-	I-T062
ml	I-T062
##pa	I-T062
)	O
assay	B-T058
in	O
formalin	B-T017
-	I-T017
fixed	I-T017
paraffin	I-T017
embedded	I-T017
(	I-T017
ffp	I-T017
##e	I-T017
)	I-T017
breast	I-T017
tissue	I-T017
from	O
75	O
patients	O
.	O
apc	B-T017
promoter	B-T038
methylation	I-T038
was	O
detected	B-T033
in	O
30	O
.	O
67	O
%	O
breast	B-T038
cancer	I-T038
tissues	B-T017
and	O
brca1	B-T017
was	O
methylated	B-T038
in	O
9	O
.	O
33	O
%	O
of	O
breast	B-T038
tumors	I-T038
.	O
methylation	B-T038
of	O
apc	B-T017
was	O
associated	O
with	O
low	O
histological	B-T170
grade	I-T170
(	O
p	O
=	O
0	O
.	O
006	O
)	O
and	O
methylation	B-T038
of	O
brca1	B-T017
was	O
related	O
with	O
lymph	B-T017
node	I-T017
metastasis	B-T038
(	O
p	O
=	O
0	O
.	O
017	O
)	O
.	O
these	O
findings	B-T033
suggest	O
that	O
the	O
methylation	B-T038
status	O
of	O
apc	B-T017
and	O
brca1	B-T017
can	O
be	O
a	O
predictive	B-T201
marker	I-T201
for	O
early	B-T058
detection	I-T058
and	O
better	O
management	B-T058
of	O
breast	B-T038
cancer	I-T038
patients	O
.	O

diabetes	B-T038
and	O
breast	B-T038
cancer	I-T038
mortality	O
in	O
black	B-T098
women	I-T098
breast	B-T038
cancer	I-T038
mortality	O
is	O
higher	O
in	O
black	B-T098
women	I-T098
than	O
in	O
white	B-T098
women	I-T098
.	O
the	O
prevalence	O
of	O
type	B-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
is	O
also	O
higher	O
,	O
yet	O
data	O
on	O
whether	O
diabetes	B-T038
affects	O
breast	B-T038
cancer	I-T038
mortality	O
in	O
this	O
population	B-T098
are	O
lacking	O
.	O
we	O
investigated	O
the	O
relation	O
of	O
diabetes	B-T038
at	O
the	O
time	O
of	O
breast	B-T038
cancer	I-T038
diagnosis	B-T033
to	O
breast	B-T038
cancer	I-T038
mortality	O
in	O
the	O
black	B-T098
women	I-T098
'	I-T098
s	I-T098
health	B-T058
study	B-T062
,	O
a	O
prospective	B-T062
cohort	I-T062
study	I-T062
.	O
1	O
,	O
62	O
##1	O
black	B-T098
women	I-T098
with	O
invasive	O
breast	B-T038
cancer	I-T038
diagnosed	B-T033
in	O
1995	O
-	O
2013	O
were	O
followed	O
by	O
mailed	O
questionnaires	B-T170
and	O
searches	O
of	O
the	O
national	B-T170
death	I-T170
index	I-T170
.	O
multivariable	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
was	O
used	O
to	O
compute	O
hazard	O
ratios	O
(	O
hrs	O
)	O
for	O
diabetes	B-T038
in	O
relation	O
to	O
breast	B-T038
cancer	I-T038
mortality	O
and	O
all	O
-	O
cause	O
mortality	O
,	O
with	O
adjustment	O
for	O
age	O
,	O
stage	B-T201
,	O
treatment	B-T058
modality	I-T058
,	O
estrogen	B-T103
receptor	I-T103
(	O
er	B-T103
)	O
status	O
,	O
and	O
body	B-T201
mass	I-T201
index	I-T201
.	O
there	O
were	O
36	O
##8	O
deaths	B-T033
during	O
follow	B-T058
-	I-T058
up	I-T058
,	O
of	O
which	O
273	O
were	O
due	O
to	O
breast	B-T038
cancer	I-T038
.	O
breast	B-T038
cancer	I-T038
mortality	O
was	O
significantly	O
increased	O
in	O
women	B-T098
who	O
had	O
been	O
diagnosed	B-T033
with	O
diabetes	B-T038
at	O
least	O
5	O
years	O
before	O
breast	B-T038
cancer	I-T038
occurrence	O
,	O
hr	O
1	O
.	O
86	O
(	O
95	O
%	O
ci	O
1	O
.	O
20	O
-	O
2	O
.	O
89	O
)	O
,	O
with	O
elevations	B-T082
observed	O
for	O
both	O
er	B-T033
+	I-T033
and	O
er	B-T033
-	I-T033
breast	B-T038
cancer	I-T038
.	O
all	O
-	O
cause	O
mortality	O
was	O
also	O
higher	O
in	O
diabetics	B-T033
,	O
with	O
hrs	O
of	O
1	O
.	O
54	O
(	O
95	O
%	O
ci	O
1	O
.	O
12	O
-	O
2	O
.	O
07	O
)	O
overall	O
and	O
2	O
.	O
26	O
(	O
95	O
%	O
ci	O
1	O
.	O
62	O
-	O
3	O
.	O
15	O
)	O
for	O
≥5	O
-	O
year	O
duration	O
of	O
diabetes	B-T038
relative	O
to	O
non	B-T033
-	I-T033
diabetics	I-T033
.	O
our	O
results	B-T033
present	B-T033
the	O
first	O
solid	O
evidence	O
of	O
a	O
positive	B-T033
association	O
of	O
type	B-T038
2	I-T038
diabetes	I-T038
with	O
breast	B-T038
cancer	I-T038
mortality	O
in	O
black	B-T098
women	I-T098
.	O
given	O
the	O
higher	O
prevalence	O
and	O
earlier	B-T033
onset	I-T033
of	O
type	B-T038
2	I-T038
diabetes	I-T038
in	O
black	B-T098
women	I-T098
,	O
it	O
is	O
likely	O
that	O
diabetes	B-T038
contributes	O
to	O
racial	B-T098
disparities	B-T033
in	O
breast	B-T038
cancer	I-T038
mortality	O
.	O

transcriptional	B-T038
enhancement	I-T038
of	O
sm	B-T017
##n	I-T017
levels	B-T033
in	O
motoneurons	B-T017
is	O
crucial	O
for	O
proper	O
axon	B-T017
morphology	O
in	O
zebrafish	B-T204
an	O
unresolved	O
my	O
##st	O
##ery	O
in	O
the	O
field	O
of	O
spinal	B-T038
muscular	I-T038
atrophy	I-T038
(	O
sma	B-T038
)	O
is	O
why	O
a	O
reduction	O
of	O
the	O
ubiquitously	O
expressed	O
sm	B-T103
##n	I-T103
protein	I-T103
causes	O
defects	O
mostly	O
in	O
motoneurons	B-T017
.	O
we	O
addressed	O
the	O
possibility	O
that	O
this	O
restricted	O
vulnerability	O
stems	O
from	O
elevated	O
sm	B-T038
##n	I-T038
expression	I-T038
in	O
motoneurons	B-T017
.	O
to	O
explore	O
this	O
,	O
we	O
established	O
an	O
ex	B-T074
vivo	I-T074
zebrafish	B-T204
culture	I-T074
system	I-T074
of	O
gfp	B-T103
-	O
marked	O
motoneurons	B-T017
to	O
quantitatively	O
measure	O
sm	B-T033
##n	I-T033
protein	I-T033
and	O
sm	B-T103
##n	I-T103
mrna	I-T103
levels	O
as	O
well	O
as	O
promoter	O
activity	O
in	O
motoneurons	B-T017
versus	O
other	O
cell	B-T017
types	O
.	O
importantly	O
,	O
we	O
uncovered	O
that	O
sm	B-T033
##n	I-T033
levels	I-T033
are	O
elevated	O
in	O
motoneurons	B-T017
by	O
means	O
of	O
transcriptional	B-T038
activation	I-T038
.	O
in	O
addition	O
,	O
we	O
identified	O
the	O
ets	B-T103
family	I-T103
transcription	I-T103
factor	I-T103
et	I-T103
##v	I-T103
##5b	I-T103
to	O
be	O
responsible	O
for	O
increased	O
sm	B-T038
##n	I-T038
transcription	I-T038
in	O
motoneurons	B-T017
.	O
moreover	O
,	O
we	O
established	O
that	O
the	O
additional	O
supply	O
of	O
sm	B-T103
##n	I-T103
protein	I-T103
in	O
motoneurons	B-T017
is	O
necessary	O
for	O
proper	O
axon	B-T038
##ogenesis	I-T038
in	O
a	O
cell	B-T038
-	I-T038
autonomous	I-T038
manner	I-T038
.	O
these	O
findings	B-T033
demonstrate	O
the	O
reliance	O
of	O
motoneurons	B-T017
on	O
more	O
sm	B-T103
##n	I-T103
,	O
thereby	O
adding	O
a	O
novel	O
piece	O
of	O
evidence	O
for	O
their	O
increased	O
vulnerability	B-T201
under	O
sma	B-T038
conditions	I-T038
.	O

associations	O
between	O
major	O
life	O
events	O
and	O
adherence	O
,	O
glycemic	B-T058
control	I-T058
,	I-T058
and	O
psychosocial	O
characteristics	O
in	O
teen	B-T098
##s	I-T098
with	O
type	B-T038
1	I-T038
diabetes	I-T038
this	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
assessed	O
the	O
type	O
of	O
major	O
life	O
events	O
occurring	O
in	O
a	O
contemporary	O
sample	O
of	O
teen	B-T098
##s	I-T098
with	O
type	B-T038
1	I-T038
diabetes	I-T038
and	O
the	O
association	O
between	O
event	O
frequency	O
and	O
demographic	O
,	O
diabetes	B-T058
management	I-T058
,	O
and	O
psychosocial	O
characteristics	O
.	O
parents	O
of	O
178	O
teen	B-T098
##s	I-T098
completed	O
the	O
life	O
events	O
checklist	B-T170
to	O
report	O
major	O
events	O
teen	B-T098
##s	I-T098
had	O
experienced	O
in	O
the	O
last	O
year	O
:	O
42	O
%	O
experienced	O
0	O
to	O
1	O
event	O
(	O
n	O
=	O
75	O
)	O
,	O
32	O
%	O
experienced	O
2	O
to	O
3	O
events	O
(	O
n	O
=	O
57	O
)	O
,	O
and	O
26	O
%	O
experienced	O
4	O
+	O
events	O
(	O
n	O
=	O
46	O
)	O
.	O
teen	B-T098
##s	I-T098
and	O
parents	O
completed	O
validated	O
measures	O
of	O
treatment	O
adherence	O
,	O
diabetes	B-T038
-	O
specific	O
self	B-T038
-	I-T038
efficacy	I-T038
,	O
quality	O
of	O
life	O
,	O
and	O
diabetes	B-T038
-	O
specific	O
family	B-T033
conflict	I-T033
.	O
parent	O
-	O
youth	O
interview	O
and	O
chart	B-T058
review	I-T058
provided	O
demographics	B-T062
and	O
diabetes	B-T058
management	I-T058
data	O
.	O
mean	O
number	O
of	O
events	O
/	O
teen	B-T098
was	O
2	O
.	O
6	O
±	O
2	O
.	O
7	O
(	O
range	O
=	O
0	O
-	O
15	O
)	O
.	O
the	O
most	O
common	O
events	O
were	O
[UNK]	O
hospitalization	B-T058
of	O
a	O
family	O
member	O
[UNK]	O
(	O
24	O
%	O
)	O
,	O
[UNK]	O
getting	B-T033
a	I-T033
bad	I-T033
report	I-T033
card	I-T033
[UNK]	O
(	O
20	O
%	O
)	O
,	O
[UNK]	O
serious	O
arguments	O
between	O
parents	O
[UNK]	O
(	O
19	O
%	O
)	O
,	O
and	O
[UNK]	O
serious	B-T033
illness	I-T033
/	O
injury	B-T037
in	O
a	O
family	O
member	O
[UNK]	O
(	O
19	O
%	O
)	O
.	O
compared	O
with	O
teen	B-T098
##s	I-T098
experiencing	O
0	O
to	O
1	O
event	O
,	O
teen	B-T098
##s	I-T098
experiencing	O
4	O
+	O
events	O
were	O
less	O
likely	O
to	O
have	O
married	O
parents	O
(	O
p	O
=	O
.	O
01	O
)	O
and	O
a	O
parent	O
with	O
a	O
college	B-T170
degree	I-T170
(	O
p	O
=	O
.	O
006	O
)	O
.	O
teen	B-T098
s	O
with	O
4	O
+	O
events	O
had	O
significantly	O
poorer	O
adherence	O
(	O
p	O
=	O
.	O
002	O
teen	B-T098
,	O
p	O
=	O
.	O
02	O
parent	O
)	O
,	O
lower	O
self	B-T038
-	I-T038
efficacy	I-T038
(	O
p	O
=	O
.	O
03	O
teen	B-T098
,	O
p	O
<	O
.	O
0001	O
parent	O
)	O
,	O
poorer	O
quality	O
of	O
life	O
(	O
p	O
<	O
.	O
0001	O
teen	B-T098
,	O
p	O
<	O
.	O
0001	O
parent	O
)	O
,	O
and	O
more	O
conflict	B-T033
(	O
p	O
=	O
.	O
006	O
teen	B-T098
,	O
p	O
=	O
.	O
02	O
parent	O
)	O
than	O
teen	B-T098
##s	I-T098
with	O
fewer	O
events	O
.	O
in	O
a	O
multivariate	B-T170
model	I-T170
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
21	O
,	O
p	O
<	O
.	O
0001	O
)	O
controlling	O
for	O
demographic	O
and	O
diabetes	B-T058
management	I-T058
characteristics	O
,	O
fewer	O
events	O
was	O
associated	O
with	O
lower	O
a1c	B-T103
(	O
p	O
=	O
.	O
000	O
##9	O
)	O
.	O
occurrence	O
of	O
more	O
major	O
life	O
events	O
was	O
associated	O
with	O
poorer	O
diabetes	B-T058
care	I-T058
and	O
a1c	B-T103
and	O
more	O
negative	O
psychosocial	O
qualities	O
in	O
teen	B-T098
##s	I-T098
with	O
type	B-T038
1	I-T038
diabetes	I-T038
.	O

host	O
immune	B-T038
recognition	I-T038
of	O
the	O
epidemic	O
cystic	B-T038
fibrosis	I-T038
pathogen	O
burkholderia	B-T007
dol	I-T007
##osa	I-T007
burkholderia	B-T007
dol	I-T007
##osa	I-T007
caused	O
an	O
outbreak	O
in	O
the	O
cystic	B-T038
fibrosis	I-T038
(	O
cf	B-T038
)	O
clinic	O
at	O
boston	B-T092
children	I-T092
'	I-T092
s	I-T092
hospital	I-T092
from	O
1998	O
to	O
2005	O
and	O
led	O
to	O
the	O
infection	B-T038
of	O
over	O
40	O
patients	O
,	O
many	O
of	O
whom	O
died	B-T038
due	O
to	O
complications	B-T038
from	O
infection	B-T038
by	O
this	O
organism	B-T007
.	O
to	O
assess	O
whether	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
significantly	O
contributes	O
to	O
disease	B-T038
or	O
is	O
recognized	O
by	O
the	O
host	O
immune	B-T038
response	I-T038
,	O
mice	B-T204
were	O
infected	B-T033
with	O
a	O
sequenced	O
outbreak	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
strain	I-T007
,	O
au	B-T007
##01	I-T007
##58	I-T007
,	O
and	O
responses	O
compared	O
to	O
the	O
well	O
-	O
studied	O
cf	B-T038
pathogen	O
,	O
pseudomonas	B-T007
aeruginosa	I-T007
in	O
parallel	O
,	O
mice	B-T204
were	O
also	O
infected	B-T033
with	O
a	O
polar	O
flag	B-T017
##ellin	I-T017
mutant	B-T038
of	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
to	O
examine	O
the	O
role	O
of	O
flagella	B-T017
in	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
lung	B-T017
colonization	B-T033
.	O
the	O
results	O
showed	O
a	O
higher	O
persistence	B-T038
in	O
the	O
host	O
by	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
strains	I-T007
and	O
yet	O
neutrophil	B-T017
recruitment	O
and	O
cytokine	B-T103
production	O
were	O
lower	O
compared	O
to	O
p	B-T007
.	I-T007
aeruginosa	I-T007
the	O
ability	O
of	O
host	O
immune	B-T017
cells	I-T017
to	O
recognize	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
was	O
then	O
assessed	O
and	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
induced	O
a	O
robust	O
cytokine	B-T103
response	O
in	O
cultured	B-T017
cells	I-T017
and	O
this	O
effect	O
was	O
dependent	O
on	O
the	O
flagella	B-T017
only	O
when	O
bacteria	B-T007
were	O
dead	B-T038
.	O
together	O
,	O
these	O
results	O
suggest	O
that	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
can	O
be	O
recognized	O
by	O
host	B-T017
cells	I-T017
in	O
vitro	O
but	O
may	O
avoid	O
or	O
suppress	O
the	O
host	O
immune	B-T038
response	I-T038
in	B-T082
vivo	I-T082
through	O
unknown	O
mechanisms	O
.	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
was	O
then	O
compared	O
to	O
other	O
burkholderia	B-T007
species	I-T007
and	O
found	O
to	O
induce	O
similar	O
levels	O
of	O
cytokine	B-T103
production	O
despite	O
being	O
internalized	O
by	O
macrophages	B-T017
more	O
than	O
b	B-T007
.	I-T007
cen	I-T007
##oc	I-T007
##ep	I-T007
##acia	I-T007
strains	I-T007
.	O
these	O
data	O
suggest	O
that	O
b	B-T007
.	I-T007
dol	I-T007
##osa	I-T007
au	I-T007
##01	I-T007
##58	I-T007
may	O
act	O
differently	O
with	O
host	B-T017
cells	I-T017
and	O
is	O
it	O
recognized	O
differently	O
by	O
immune	B-T022
systems	I-T022
compared	O
other	O
burkholderia	B-T007
strains	I-T007
or	O
species	B-T170
.	O

neuro	B-T038
-	I-T038
behcet	I-T038
disease	I-T038
presenting	O
as	O
a	O
solitary	O
cerebellar	B-T038
hemorrhagic	I-T038
lesion	B-T033
:	O
a	O
case	B-T170
report	I-T170
and	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
behcet	B-T038
'	I-T038
s	I-T038
disease	I-T038
is	O
a	O
heterogeneous	B-T033
,	O
multis	B-T038
##ystem	I-T038
,	O
inflammatory	B-T038
disorder	I-T038
of	O
unknown	O
etiology	O
.	O
the	O
classic	O
triad	O
of	O
oral	B-T038
and	O
genital	B-T038
ulceration	I-T038
##s	I-T038
in	O
conjunction	O
with	O
uveitis	B-T038
was	O
originally	O
described	O
by	O
the	O
turkish	B-T098
dermat	B-T097
##ologist	I-T097
hu	O
##lu	O
##si	O
behcet	O
in	O
193	O
##7	O
,	O
but	O
associated	B-T033
symptoms	I-T033
of	O
the	O
cardiovascular	B-T022
,	O
central	B-T022
nervous	I-T022
,	O
pulmonary	O
,	O
and	O
gastrointestinal	B-T022
systems	I-T022
were	O
later	O
identified	O
.	O
in	O
fact	O
,	O
behcet	B-T038
'	I-T038
s	I-T038
disease	I-T038
with	O
neurological	B-T038
involvement	I-T038
(	O
neuro	B-T038
-	I-T038
behcet	I-T038
'	I-T038
s	I-T038
disease	I-T038
)	O
is	O
not	O
uncommon	O
.	O
patients	O
with	O
neuro	B-T038
-	I-T038
behcet	I-T038
'	I-T038
s	I-T038
disease	I-T038
typically	O
exhibit	O
a	O
diverse	O
array	O
of	O
symptoms	B-T033
,	O
most	O
commonly	O
in	O
the	O
brainstem	B-T017
and	O
die	B-T017
##nc	I-T017
##ephal	I-T017
##ic	I-T017
regions	B-T082
.	O
herein	O
,	O
we	O
report	B-T170
an	O
unusual	O
case	O
of	O
neuro	B-T038
-	I-T038
behcet	I-T038
'	I-T038
s	I-T038
disease	I-T038
in	O
a	O
patient	O
who	O
presented	O
with	O
a	O
solitary	O
cerebellar	B-T038
hemorrhage	I-T038
.	O
a	O
39	O
-	O
year	O
-	O
old	O
asian	B-T098
woman	B-T098
was	O
admitted	B-T058
to	O
our	O
hospital	B-T092
with	O
complaints	B-T033
of	O
a	O
sudden	O
speech	B-T033
difficulty	I-T033
that	O
had	O
manifested	O
the	O
same	O
morning	O
,	O
and	O
dizziness	B-T033
and	O
mild	O
vomiting	B-T033
experienced	O
over	O
the	O
previous	O
3	O
days	O
.	O
magnetic	B-T170
resonance	I-T170
images	I-T170
revealed	O
target	O
-	O
like	O
hemorrhagic	B-T038
lesions	B-T033
in	O
the	O
right	B-T017
hemisphere	I-T017
of	I-T017
the	I-T017
cerebellum	I-T017
.	O
risk	B-T033
factors	I-T033
that	O
may	O
result	O
in	O
cerebellar	B-T038
hemorrhage	I-T038
,	O
such	O
as	O
high	B-T038
blood	I-T038
pressure	I-T038
or	O
bleeding	B-T038
diat	I-T038
##he	I-T038
##sis	I-T038
,	O
were	O
ruled	O
out	O
,	O
and	O
subsequent	O
brain	B-T017
angiograms	B-T058
were	O
normal	O
.	O
these	O
findings	B-T033
suggest	O
that	O
the	O
patient	O
'	O
s	O
cerebellar	B-T038
hemorrhage	I-T038
could	O
have	O
been	O
due	O
to	O
intracranial	B-T082
vasculitis	B-T038
in	O
a	O
rare	O
,	O
if	O
not	O
unique	O
,	O
complication	B-T038
of	O
neuro	B-T038
-	I-T038
behcet	I-T038
'	I-T038
s	I-T038
disease	I-T038
.	O

hif	B-T103
-	I-T103
1α	I-T103
overexpression	B-T038
improves	B-T033
transplanted	B-T058
bone	I-T058
mesenchymal	I-T058
stem	I-T058
cells	I-T058
survival	B-T038
in	O
rat	B-T038
mcao	I-T038
stroke	I-T038
model	I-T038
bone	B-T017
mesenchymal	I-T017
stem	I-T017
cells	I-T017
(	O
bmscs	B-T017
)	O
death	B-T038
after	O
transplantation	B-T058
is	O
a	O
serious	O
obstacle	O
impacting	O
on	O
the	O
outcome	O
of	O
cell	B-T058
therapy	I-T058
for	O
cerebral	B-T038
infarction	I-T038
.	O
this	O
study	B-T062
was	O
aimed	O
to	O
investigate	O
whether	O
modification	O
of	O
bmscs	B-T017
with	O
hypoxia	B-T103
-	I-T103
inducible	I-T103
factor	I-T103
1α	I-T103
(	O
hif	B-T103
-	I-T103
1α	I-T103
)	O
could	O
enhance	O
the	O
survival	B-T038
of	O
the	O
implanted	B-T058
bmscs	I-T058
.	O
bmscs	B-T017
were	O
isolated	B-T058
from	O
wistar	B-T204
rats	I-T204
,	O
and	O
were	O
infected	B-T038
with	O
hif	B-T103
-	I-T103
1α	I-T103
-	I-T103
gfp	I-T103
lentiviral	I-T103
vector	I-T103
or	O
hif	B-T103
-	I-T103
1α	I-T103
sirna	I-T103
.	O
the	O
modified	O
bmscs	B-T017
were	O
exposed	O
to	O
oxygen	B-T038
-	I-T038
glucose	I-T038
deprivation	I-T038
(	I-T038
og	I-T038
##d	I-T038
)	I-T038
condition	I-T038
,	O
cellular	B-T038
viability	I-T038
and	O
apoptosis	B-T038
were	O
then	O
assessed	O
.	O
an	O
inhibitor	B-T103
of	O
ampk	B-T103
(	O
compound	B-T103
c	I-T103
)	O
was	O
used	O
to	O
detect	B-T058
whether	O
ampk	B-T103
and	O
mtor	B-T103
were	O
implicated	O
in	O
the	O
functions	O
of	O
hif	B-T103
-	I-T103
1α	I-T103
on	O
bmscs	B-T038
survival	I-T038
.	O
besides	O
,	O
ultrastructure	O
of	O
bmscs	B-T017
was	O
observed	O
and	O
the	O
expression	B-T038
of	I-T038
autophagy	I-T038
markers	I-T038
was	O
measured	O
.	O
the	O
modified	O
bmscs	B-T017
were	O
transplanted	B-T058
into	O
middle	B-T017
cerebral	I-T017
artery	I-T017
occlusion	I-T017
(	O
mcao	B-T017
)	O
model	B-T038
of	I-T038
rats	I-T038
,	O
and	O
the	O
cerebral	B-T038
infarction	I-T038
volume	O
and	O
neurological	B-T038
function	I-T038
was	O
assessed	O
.	O
the	O
results	O
indicated	O
that	O
hif	B-T038
-	I-T038
1α	I-T038
overexpression	I-T038
protected	O
og	B-T038
##d	I-T038
induced	O
injury	B-T037
by	O
promoting	O
cellular	B-T038
viability	I-T038
and	O
inhibiting	B-T038
apoptosis	B-T038
.	O
ampk	B-T103
was	O
activated	O
while	O
mtor	B-T103
was	O
inactivated	O
by	O
hif	B-T038
-	I-T038
1α	I-T038
overexpression	I-T038
,	O
and	O
that	O
might	O
be	O
through	O
which	O
hif	B-T103
-	I-T103
1α	I-T103
function	O
##ed	O
bmscs	B-T038
survival	I-T038
.	O
hif	B-T038
-	I-T038
1α	I-T038
overexpression	I-T038
promoted	O
autophagy	B-T038
;	O
more	O
important	O
,	O
compound	B-T103
c	I-T103
abolished	O
the	O
induction	B-T038
of	I-T038
hif	I-T038
-	I-T038
1α	I-T038
on	O
autophagy	B-T038
.	O
transplantation	B-T058
of	I-T058
the	I-T058
overexpressed	I-T058
hif	I-T058
-	I-T058
1α	I-T058
of	I-T058
bmscs	I-T058
into	O
the	O
mcao	B-T038
rats	I-T038
reduced	O
brain	B-T038
infarct	I-T038
volume	O
and	O
improved	B-T033
neurobehavioral	O
outcome	O
;	O
besides	O
,	O
it	O
inhibited	O
pro	B-T103
-	I-T103
inflammatory	I-T103
cytokines	I-T103
generation	O
while	O
promoted	O
neurotrophin	B-T103
secretion	B-T038
.	O
in	O
conclusion	O
,	O
hif	B-T103
-	I-T103
1α	I-T103
might	O
be	O
contributed	O
in	O
the	O
survival	B-T038
of	I-T038
bmscs	I-T038
by	O
regulating	O
the	O
activation	B-T038
of	I-T038
ampk	I-T038
and	I-T038
mtor	I-T038
,	O
as	O
well	O
as	O
by	O
promoting	O
autophagy	B-T038
.	O

consecutive	O
endovascular	B-T058
treatment	I-T058
of	O
20	O
ruptured	O
very	O
small	O
(	O
<	O
3	O
mm	O
)	O
anterior	B-T038
communicating	I-T038
artery	I-T038
aneurysms	I-T038
small	O
aneurysms	B-T038
located	O
at	O
the	O
anterior	B-T017
communicating	I-T017
artery	I-T017
carry	O
significant	O
procedural	O
challenges	O
due	O
to	O
a	O
complex	O
anatomy	B-T017
.	O
recent	O
advances	O
in	O
endovascular	B-T058
technologies	I-T058
have	O
expanded	O
the	O
use	O
of	O
coil	B-T058
embolization	I-T058
for	O
small	O
aneurysm	B-T038
treatment	O
.	O
however	O
,	O
limited	O
reports	O
describe	O
their	O
safety	O
and	O
efficacy	O
profiles	O
in	O
very	O
small	O
anterior	B-T038
communicating	I-T038
artery	I-T038
aneurysms	I-T038
.	O
we	O
sought	O
to	O
review	O
and	O
report	O
the	O
immediate	O
and	O
long	O
-	O
term	O
clinical	O
as	O
well	O
as	O
radiographic	O
outcomes	O
of	O
consecutive	O
patients	O
with	O
ruptured	O
very	O
small	O
anterior	B-T038
communicating	I-T038
artery	I-T038
aneurysms	I-T038
treated	O
with	O
current	O
endovascular	B-T058
coil	I-T058
embolization	I-T058
techniques	I-T058
.	O
a	O
prospectively	O
maintained	O
single	O
-	O
institution	O
neuro	B-T170
##end	I-T170
##ovascular	I-T170
database	I-T170
was	O
accessed	O
to	O
identify	O
consecutive	O
cases	O
of	O
very	O
small	O
(	O
<	O
3	O
mm	O
)	O
ruptured	O
anterior	B-T038
communicating	I-T038
artery	I-T038
aneurysms	I-T038
treated	O
endovascular	O
##ly	O
between	O
2006	O
and	O
2013	O
.	O
a	O
total	O
of	O
20	O
patients	O
with	O
ruptured	O
very	O
small	O
(	O
<	O
3	O
mm	O
)	O
anterior	B-T038
communicating	I-T038
artery	I-T038
aneurysms	I-T038
were	O
consecutively	O
treated	O
with	O
coil	B-T058
embolization	I-T058
.	O
the	O
average	O
maximum	O
diameter	O
was	O
2	O
.	O
66	O
±	O
0	O
.	O
41	O
mm	O
.	O
complete	O
aneurysm	B-T058
occlusion	I-T058
was	O
achieved	O
for	O
17	O
(	O
85	O
%	O
)	O
aneurysms	B-T038
and	O
near	O
-	O
complete	O
aneurysm	B-T058
occlusion	I-T058
for	O
3	O
(	O
15	O
%	O
)	O
aneurysms	B-T038
.	O
intraoperative	O
perforation	B-T033
was	O
seen	O
in	O
2	O
(	O
10	O
%	O
)	O
patients	O
without	O
any	O
clinical	O
worsening	O
or	O
need	O
for	O
an	O
external	O
ventricular	O
drain	O
.	O
a	O
thromboembolic	B-T038
event	I-T038
occurred	O
in	O
1	O
(	O
5	O
%	O
)	O
patient	O
without	O
clinical	O
worsening	O
or	O
radiologic	B-T038
infarct	I-T038
.	O
median	O
clinical	O
follow	B-T058
-	I-T058
up	I-T058
was	O
12	O
(	O
±	O
##14	O
.	O
1	O
)	O
months	O
and	O
median	O
imaging	O
follow	B-T058
-	I-T058
up	I-T058
was	O
12	O
(	O
±	O
##18	O
.	O
4	O
)	O
months	O
.	O
this	O
report	O
describes	O
the	O
largest	O
series	O
of	O
consecutive	O
endovascular	B-T058
treatments	I-T058
of	O
ruptured	O
very	O
small	O
anterior	B-T038
communicating	I-T038
artery	I-T038
aneurysms	I-T038
.	O
these	O
findings	O
suggest	O
that	O
coil	B-T058
embolization	I-T058
of	O
very	O
small	O
aneurysms	B-T038
in	O
this	O
location	B-T082
can	O
be	O
performed	O
with	O
acceptable	O
rates	O
of	O
complications	B-T038
and	O
recanalization	B-T058
.	O

modulation	B-T082
of	O
interleukin	B-T103
##s	I-T103
in	O
sepsis	B-T038
-	O
associated	O
clotting	B-T038
disorders	I-T038
:	O
interplay	O
with	O
hemostatic	B-T038
der	I-T038
##angement	I-T038
interleukin	B-T103
##s	I-T103
play	O
a	O
central	B-T082
role	O
in	O
the	O
immune	B-T022
system	I-T022
and	O
are	O
involved	O
in	O
a	O
variety	O
of	O
immunological	B-T038
,	O
inflammatory	B-T038
,	O
and	O
infectious	B-T038
disease	I-T038
states	O
including	O
sepsis	B-T038
syndrome	I-T038
.	O
levels	O
of	O
interleukin	B-T103
##s	I-T103
may	O
correlate	O
with	O
overall	O
survival	O
and	O
may	O
directly	O
or	O
indirectly	O
affect	B-T038
some	O
of	O
the	O
regulators	B-T103
of	O
coagulation	B-T038
and	O
fibrinolysis	B-T038
,	O
thereby	O
disrupting	O
hemostasis	B-T038
and	O
thrombosis	B-T038
.	O
our	O
hypothesis	O
is	O
that	O
in	O
sepsis	B-T038
-	I-T038
associated	I-T038
coagul	I-T038
##opathies	I-T038
(	O
sac	B-T038
##s	I-T038
)	O
,	O
interleukin	B-T103
##s	I-T103
may	O
be	O
upregulated	B-T038
,	O
leading	O
to	O
hemostatic	B-T038
imbalance	I-T038
by	O
generating	O
thromb	B-T103
##ogenic	I-T103
mediators	I-T103
.	O
we	O
profile	O
##d	O
the	O
levels	O
of	O
interleukin	B-T103
##s	I-T103
il	B-T103
-	I-T103
1α	I-T103
,	O
il	B-T103
-	I-T103
1β	I-T103
,	O
il	B-T103
-	I-T103
2	I-T103
,	O
il	B-T103
-	I-T103
4	I-T103
,	O
il	B-T103
-	I-T103
6	I-T103
,	O
il	B-T103
-	I-T103
8	I-T103
,	O
and	O
il	B-T103
-	I-T103
10	I-T103
in	O
addition	O
to	O
d	B-T103
-	I-T103
dimer	I-T103
(	O
dd	B-T103
)	O
in	O
patients	O
with	O
sac	B-T038
and	O
in	O
normal	O
donors	B-T098
.	O
we	O
observed	O
the	O
highest	O
increase	O
in	O
interleukin	B-T103
##s	I-T103
il	B-T103
-	I-T103
6	I-T103
(	O
322	O
-	O
fold	O
)	O
,	O
il	B-T103
-	I-T103
8	I-T103
(	O
48	O
-	O
fold	O
)	O
,	O
il	B-T103
-	I-T103
10	I-T103
(	O
72	O
-	O
fold	O
)	O
,	O
and	O
dd	B-T103
(	O
18	O
-	O
fold	O
)	O
.	O
this	O
suggests	O
that	O
interleukin	B-T103
##s	I-T103
such	O
as	O
il	B-T103
-	I-T103
6	I-T103
and	O
il	B-T103
-	I-T103
10	I-T103
have	O
a	O
close	O
association	O
with	O
coagulopathy	B-T038
and	O
fibrinolytic	O
dysregulation	O
in	O
sepsis	B-T038
and	O
can	O
be	O
considered	O
as	O
candidates	B-T103
for	O
potential	O
therapeutic	O
targets	O
in	O
sac	B-T038
.	O

the	O
complete	O
chloroplast	B-T017
genome	I-T017
sequence	B-T082
of	O
the	O
medicinal	B-T204
plant	I-T204
swe	B-T204
##rt	I-T204
##ia	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
using	O
the	O
pac	O
##bi	O
##o	O
rs	O
ii	O
platform	O
swe	B-T204
##rt	I-T204
##ia	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
is	O
an	O
important	O
medicinal	B-T204
plant	I-T204
that	O
has	O
great	O
economic	O
and	O
medicinal	B-T103
value	I-T103
and	O
is	O
found	O
on	O
the	O
qi	O
##ng	O
##hai	O
tib	O
##etan	O
plateau	O
.	O
the	O
complete	O
chloroplast	B-T017
(	I-T017
cp	I-T017
)	I-T017
genome	I-T017
of	O
s	B-T204
.	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
is	O
153	O
,	O
43	O
##1	O
bp	O
in	O
size	O
,	O
with	O
a	O
pair	O
of	O
inverted	B-T103
repeat	I-T103
(	I-T103
ir	I-T103
)	I-T103
regions	I-T103
of	O
25	O
,	O
76	O
##1	O
bp	O
each	O
that	O
separate	O
an	O
large	B-T082
single	I-T082
-	I-T082
copy	I-T082
(	I-T082
ls	I-T082
##c	I-T082
)	I-T082
region	I-T082
of	O
83	O
,	O
56	O
##7	O
bp	O
and	O
an	O
a	O
small	B-T082
single	I-T082
-	I-T082
copy	I-T082
(	I-T082
ssc	I-T082
)	I-T082
region	I-T082
of	O
18	O
,	O
342	O
bp	O
.	O
the	O
s	B-T204
.	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
cp	B-T017
genome	I-T017
encodes	O
84	O
protein	B-T017
-	I-T017
coding	I-T017
genes	I-T017
,	O
37	O
transfer	B-T103
rna	I-T103
(	O
trna	B-T103
)	O
genes	B-T017
,	O
and	O
eight	O
ribosomal	B-T017
rna	I-T017
(	I-T017
rrna	I-T017
)	I-T017
genes	I-T017
.	O
the	O
identity	O
,	O
number	O
,	O
and	O
gc	O
content	O
of	O
s	B-T204
.	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
cp	B-T017
genes	I-T017
were	O
similar	O
to	O
those	O
in	O
the	O
genomes	B-T017
of	O
other	O
gent	B-T204
##iana	I-T204
##les	I-T204
species	B-T170
.	O
via	O
analysis	B-T062
of	O
the	O
repeat	B-T082
structure	I-T082
,	O
11	O
forward	O
repeats	B-T082
,	O
eight	O
pal	B-T103
##ind	I-T103
##romic	I-T103
repeats	I-T103
,	O
and	O
one	O
reverse	O
repeat	O
were	O
detected	B-T033
in	O
the	O
s	B-T204
.	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
cp	B-T017
genome	I-T017
.	O
there	O
are	O
45	O
ssr	B-T103
##s	I-T103
in	O
the	O
s	B-T204
.	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
cp	B-T017
genome	I-T017
,	O
the	O
majority	O
of	O
which	O
are	O
mononucle	B-T103
##otides	I-T103
found	O
in	O
all	O
other	O
gent	B-T204
##iana	I-T204
##les	I-T204
species	B-T170
.	O
an	O
entire	O
cp	B-T017
genome	I-T017
comparison	B-T062
study	I-T062
of	O
s	B-T204
.	I-T204
muss	I-T204
##oti	I-T204
##i	I-T204
and	O
two	O
other	O
species	B-T170
in	O
gent	B-T204
##iana	I-T204
##ce	I-T204
##ae	I-T204
was	O
conducted	O
.	O
the	O
complete	O
cp	B-T017
genome	I-T017
sequence	B-T082
provides	O
intrag	B-T017
##enic	I-T017
information	O
for	O
the	O
cp	B-T017
genetic	B-T062
engineering	I-T062
of	O
this	O
medicinal	B-T204
plant	I-T204
.	O

comparison	O
of	O
methods	O
for	O
isolating	B-T058
primary	O
hepatocytes	B-T017
from	O
mini	B-T204
pigs	I-T204
successful	O
porcine	B-T204
hepatocyte	B-T017
isolation	B-T058
is	O
crucial	O
for	O
the	O
development	O
of	O
bio	B-T074
##art	I-T074
##ific	I-T074
##ial	I-T074
liver	I-T074
devices	I-T074
and	O
hepatocyte	B-T058
transplantation	I-T058
.	O
serv	B-T103
##a	I-T103
collagenase	I-T103
nb	I-T103
grades	I-T103
are	O
formulated	O
collagenase	B-T103
##s	I-T103
that	O
are	O
suitable	O
for	O
various	O
tissue	B-T017
isolation	B-T058
applications	O
.	O
n	B-T103
-	I-T103
acetylcysteine	I-T103
(	O
nac	B-T103
)	O
can	O
improve	O
the	O
viability	O
of	O
human	B-T204
hepatocytes	B-T017
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
compare	O
the	O
effectiveness	O
of	O
two	O
collagenase	B-T103
##s	I-T103
and	O
effect	O
of	O
nac	B-T103
on	O
hepatocyte	B-T017
isolation	B-T058
from	O
porcine	B-T204
liver	B-T017
tissue	I-T017
.	O
porcine	B-T204
hepatocytes	B-T017
were	O
isolated	B-T058
using	O
the	O
perfusion	B-T058
method	I-T058
from	O
bam	O
##a	O
mini	B-T204
pigs	I-T204
assigned	O
to	O
the	O
serv	B-T103
##a	I-T103
nb	I-T103
4	I-T103
group	O
(	O
n	O
=	O
6	O
)	O
,	O
the	O
serv	B-T103
##a	I-T103
nb	I-T103
8	I-T103
group	O
(	O
n	O
=	O
6	O
)	O
,	O
or	O
the	O
nb	B-T103
8	I-T103
+	O
nac	B-T103
group	O
(	O
n	O
=	O
6	O
)	O
.	O
viability	O
and	O
yield	O
were	O
defined	O
as	O
fresh	O
hepatocytes	B-T017
and	O
their	O
spheroids	B-T033
formation	I-T033
after	O
24	O
-	O
hour	O
rock	B-T058
##er	I-T058
culture	I-T058
in	O
serum	B-T103
-	I-T103
free	I-T103
medium	I-T103
.	O
metabolic	B-T038
function	I-T038
was	O
assessed	O
by	O
gene	B-T038
expression	I-T038
,	O
albumin	B-T103
,	O
and	O
urea	B-T103
synthesis	B-T038
.	O
all	O
procedures	O
resulted	O
in	O
successful	O
hepatocyte	B-T017
isolation	B-T058
.	O
cells	B-T017
from	O
the	O
nb	B-T103
8	I-T103
+	O
nac	B-T103
group	O
had	O
(	O
97	O
.	O
8	O
##±1	O
.	O
9	O
)	O
%	O
viability	O
,	O
which	O
was	O
higher	O
than	O
the	O
nb	B-T103
8	I-T103
group	O
with	O
(	O
94	O
.	O
4	O
##±2	O
.	O
4	O
)	O
%	O
and	O
the	O
nb	B-T103
4	I-T103
group	O
with	O
(	O
94	O
.	O
5	O
##±3	O
.	O
2	O
)	O
%	O
(	O
p	O
<	O
.	O
001	O
)	O
.	O
the	O
final	O
cell	B-T017
yield	O
reached	O
(	O
11	O
.	O
8	O
##±1	O
.	O
0	O
)	O
×	O
##10	O
(	O
9	O
)	O
cells	B-T017
in	O
the	O
nb	B-T103
8	I-T103
+	O
nac	B-T103
group	O
,	O
compared	O
to	O
(	O
9	O
.	O
5	O
##±2	O
.	O
1	O
)	O
×	O
##10	O
(	O
9	O
)	O
cells	B-T017
in	O
the	O
nb	B-T103
8	I-T103
group	O
(	O
p	O
<	O
.	O
01	O
)	O
and	O
(	O
9	O
.	O
1	O
##±1	O
.	O
1	O
)	O
×	O
##10	O
(	O
9	O
)	O
cells	B-T017
in	O
the	O
nb	B-T103
4	I-T103
group	O
(	O
p	O
<	O
.	O
001	O
)	O
.	O
the	O
secretion	B-T038
of	O
albumin	B-T103
was	O
superior	O
in	O
the	O
nb	B-T103
8	I-T103
+	O
nac	B-T103
group	O
at	O
a	O
concentration	O
of	O
(	O
425	O
.	O
8	O
##±3	O
##5	O
.	O
3	O
)	O
ng	O
/	O
ml	O
compared	O
to	O
the	O
nb	B-T103
8	I-T103
group	O
(	O
339	O
.	O
1	O
##±3	O
##2	O
.	O
6	O
)	O
ng	O
/	O
ml	O
(	O
p	O
<	O
.	O
001	O
)	O
and	O
nb	B-T103
4	I-T103
group	O
(	O
293	O
.	O
6	O
##±4	O
##3	O
.	O
3	O
)	O
ng	O
/	O
ml	O
(	O
p	O
<	O
.	O
01	O
)	O
.	O
the	O
injury	B-T037
of	O
hepatocytes	B-T017
also	O
decreased	O
in	O
the	O
nb	B-T103
8	I-T103
+	O
nac	B-T103
group	O
(	O
p	O
<	O
.	O
01	O
)	O
.	O
the	O
data	O
are	O
presented	O
as	O
means	O
±	O
sd	O
.	O
formulated	O
collagenase	B-T103
serv	I-T103
##a	I-T103
nb	I-T103
8	I-T103
and	O
nac	B-T103
could	O
improve	O
the	O
porcine	B-T204
hepatocyte	B-T017
isolation	B-T058
,	O
resulting	O
in	O
higher	O
yields	O
of	O
viable	O
cells	O
.	O

chronic	O
adiponectin	B-T038
deficiency	I-T038
leads	O
to	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
-	O
like	O
cognitive	B-T038
impairments	I-T038
and	O
pathologies	B-T091
through	O
ampk	B-T103
inactivation	O
and	O
cerebral	B-T017
insulin	B-T038
resistance	I-T038
in	O
aged	O
mice	B-T204
insulin	B-T038
resistance	I-T038
is	O
the	O
major	O
pathogenesis	B-T038
underlying	O
type	B-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
(	O
t2dm	B-T038
)	O
and	O
these	O
patients	O
have	O
doubled	O
risk	O
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
.	O
increasing	O
evidence	O
suggests	O
that	O
insulin	B-T038
resistance	I-T038
plays	O
an	O
important	O
role	O
in	O
ad	O
pathogenesis	B-T038
,	O
possibly	O
due	O
to	O
abnormal	O
gsk3	B-T103
##β	I-T103
activation	B-T038
,	O
causing	O
intra	B-T017
-	I-T017
and	O
extracellular	B-T017
amyloid	O
-	O
beta	O
(	O
aβ	O
)	O
accumulation	O
.	O
adiponectin	B-T103
(	O
apn	B-T103
)	O
is	O
an	O
adip	B-T103
##okine	I-T103
with	O
insulin	O
-	O
sensitizing	O
and	O
anti	O
-	O
inflammatory	O
effects	O
.	O
reduced	O
circulatory	O
apn	B-T103
level	O
is	O
associated	O
with	O
insulin	B-T038
resistance	I-T038
and	O
t2dm	B-T038
.	O
the	O
role	O
of	O
apn	B-T103
in	O
ad	B-T038
has	O
not	O
been	O
elucidated	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
aim	O
to	O
examine	O
if	O
adiponectin	B-T038
deficiency	I-T038
would	O
lead	O
to	O
cerebral	B-T017
insulin	B-T038
resistance	I-T038
,	O
cognitive	B-T038
decline	I-T038
and	O
alzheimer	B-T038
'	I-T038
s	I-T038
-	I-T038
like	I-T038
pathology	I-T038
in	O
mice	B-T204
.	O
to	O
study	B-T062
the	O
role	O
of	O
adiponectin	B-T103
in	O
cognitive	B-T038
functions	I-T038
,	O
we	O
employed	O
adiponectin	B-T038
-	I-T038
knockout	I-T038
(	B-T204
apn	I-T204
-	I-T204
ko	I-T204
)	I-T204
mice	I-T204
and	O
demonstrated	O
chronic	O
apn	B-T038
deficiency	I-T038
in	O
their	O
cns	B-T022
.	O
behavioral	B-T058
tests	I-T058
were	O
performed	O
to	O
study	B-T062
the	O
cognition	B-T038
##s	I-T038
of	O
male	O
apn	B-T204
-	I-T204
ko	I-T204
mice	I-T204
.	O
brains	B-T017
and	O
tissue	B-T017
lysates	O
were	O
collected	O
to	O
study	B-T062
the	O
pathophysiological	O
and	O
molecular	B-T038
changes	I-T038
in	O
the	O
brain	B-T017
of	O
apn	B-T204
-	I-T204
ko	I-T204
mice	I-T204
.	O
sh	B-T017
-	I-T017
sy5y	I-T017
neuroblastoma	I-T017
cell	I-T017
line	I-T017
was	O
used	O
to	O
study	B-T062
the	O
molecular	B-T038
mechanism	I-T038
upon	O
apn	B-T103
and	O
insulin	O
treatment	O
.	O
aged	O
apn	B-T103
-	O
deficient	O
mice	B-T204
displayed	O
spatial	B-T038
memory	I-T038
and	O
learning	B-T038
impairments	B-T038
,	O
fear	O
-	O
conditioned	O
memory	B-T038
deficit	I-T038
as	O
well	O
as	O
anxiety	B-T033
.	O
these	O
mice	B-T204
also	O
developed	O
ad	B-T038
pathologies	B-T038
including	O
increased	O
cerebral	B-T017
aβ	B-T103
##42	I-T103
level	O
,	O
aβ	O
deposition	O
,	O
hyperphosph	B-T103
##orylated	I-T103
tau	I-T103
proteins	I-T103
,	O
microgl	B-T038
##iosis	I-T038
and	O
astrogl	B-T038
##iosis	I-T038
with	O
increased	O
cerebral	B-T017
il	B-T103
-	I-T103
1β	I-T103
and	O
tnfα	B-T103
levels	O
that	O
associated	O
with	O
increased	O
neuronal	B-T038
apoptosis	I-T038
and	O
reduced	O
synaptic	B-T082
proteins	B-T033
levels	I-T033
,	O
suggesting	O
apn	B-T038
deficiency	I-T038
may	O
lead	O
to	O
neuronal	O
and	O
synaptic	O
loss	O
in	O
the	O
brain	B-T017
.	O
ad	B-T038
pathologies	O
-	O
associated	O
apn	B-T103
-	O
ko	B-T204
mice	I-T204
displayed	O
attenuated	O
ampk	B-T103
phosphorylation	B-T038
and	O
impaired	O
insulin	B-T038
signaling	I-T038
including	O
decreased	O
akt	B-T103
induction	O
and	O
increased	O
gsk3	B-T103
##β	I-T103
activation	B-T038
in	O
the	O
hippocampus	B-T017
and	O
frontal	B-T017
cortex	I-T017
.	O
aged	O
apn	B-T103
-	O
ko	O
mice	B-T204
developed	O
hippocampal	B-T017
insulin	B-T038
resistance	I-T038
with	O
reduced	O
pak	B-T103
##t	I-T103
induction	O
upon	O
intracerebral	O
insulin	B-T058
injection	I-T058
.	O
consistently	O
,	O
apn	B-T103
treatment	B-T058
in	O
sh	O
-	O
sy5y	O
cells	O
with	O
insulin	B-T038
resistance	I-T038
and	O
overexpressing	B-T038
aβ	O
induce	O
higher	O
pak	B-T103
##t	I-T103
levels	O
through	O
adip	B-T103
##or	I-T103
##1	I-T103
upon	O
insulin	O
treatment	O
whereas	O
the	O
induction	O
was	O
blocked	B-T038
by	O
compound	B-T103
c	I-T103
,	O
indicating	O
apn	B-T103
can	O
enhance	O
neuronal	O
insulin	B-T038
sensitivity	I-T038
through	O
ampk	B-T103
activation	O
.	O
our	O
results	O
indicated	O
that	O
chronic	O
apn	B-T038
deficiency	I-T038
inactivated	O
ampk	B-T103
causing	O
insulin	O
desensitization	O
and	O
elicited	O
ad	B-T038
-	I-T038
like	I-T038
pathogenesis	I-T038
in	O
aged	O
mice	B-T204
which	O
also	O
developed	O
significant	O
cognitive	B-T038
impairments	I-T038
and	O
psychiatric	B-T033
symptoms	I-T033
.	O

20	B-T103
##s	I-T103
immuno	I-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
##s	I-T103
remove	O
formaldehyde	B-T103
-	O
damaged	O
cytoplasmic	B-T103
proteins	I-T103
suppressing	O
caspase	B-T038
-	I-T038
independent	I-T038
cell	I-T038
death	I-T038
immuno	B-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
##s	I-T103
are	O
known	O
for	O
their	O
involvement	O
in	O
antigen	B-T038
presentation	I-T038
.	O
however	O
,	O
their	O
broad	B-T082
tissue	B-T017
presence	B-T033
and	O
other	O
evidence	O
are	O
indicative	O
of	O
non	B-T038
##immune	I-T038
functions	I-T038
.	O
we	O
examined	O
a	O
role	O
for	O
immuno	B-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
##s	I-T103
in	O
cellular	B-T038
responses	I-T038
to	O
the	O
endogenous	O
and	O
environmental	B-T103
carcinogen	I-T103
formaldehyde	B-T103
(	O
fa	B-T103
)	O
that	O
binds	O
to	O
cytosolic	B-T017
and	O
nuclear	B-T103
proteins	I-T103
producing	O
prote	B-T038
##otoxic	I-T038
stress	I-T038
and	O
genotoxic	O
dna	B-T103
-	O
histone	B-T103
crosslink	O
##s	O
.	O
we	O
found	O
that	O
immuno	B-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
##s	I-T103
were	O
important	O
for	O
suppression	O
of	O
a	O
caspase	B-T038
-	I-T038
independent	I-T038
cell	I-T038
death	I-T038
and	O
the	O
long	O
-	O
term	O
survival	O
of	O
fa	B-T017
-	I-T017
treated	I-T017
cells	I-T017
.	O
all	O
major	O
genotoxic	O
responses	O
to	O
fa	B-T103
,	O
including	O
replication	B-T038
inhibition	I-T038
and	O
activation	O
of	O
the	O
transcription	B-T103
factor	I-T103
p53	I-T103
and	O
the	O
apical	B-T082
atm	B-T103
and	O
atr	B-T103
kinases	I-T103
,	O
were	O
unaffected	O
by	O
immuno	B-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
inactivity	O
.	O
immuno	O
##pro	O
##te	O
##asome	O
inhibition	O
enhanced	O
activation	O
of	O
the	O
cytosolic	B-T017
protein	B-T103
damage	O
sensor	B-T103
hs	I-T103
##f1	I-T103
,	O
elevated	O
levels	O
of	O
k	B-T038
##48	I-T038
-	I-T038
poly	I-T038
##ub	I-T038
##iqu	I-T038
##itin	I-T038
##ated	I-T038
cytoplasmic	B-T103
proteins	I-T103
and	O
increased	O
depletion	O
of	O
uncon	O
##jugated	O
ubiquitin	B-T103
.	O
we	O
further	O
found	O
that	O
fa	B-T103
induced	O
the	O
disassembly	O
of	O
26	B-T103
##s	I-T103
immuno	I-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
##s	I-T103
,	O
but	O
not	O
standard	O
26	B-T103
##s	I-T103
proteasome	I-T103
##s	I-T103
,	O
releasing	O
the	O
20	B-T103
##s	I-T103
catalytic	I-T103
immuno	I-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
.	O
fa	B-T017
-	I-T017
treated	I-T017
cells	I-T017
also	O
had	O
higher	O
amounts	O
of	O
small	O
activators	B-T103
pa	I-T103
##28	I-T103
##α	I-T103
##β	I-T103
and	O
pa	B-T103
##28	I-T103
##γ	I-T103
bound	O
to	O
20	B-T103
##s	I-T103
particles	I-T103
.	O
our	O
findings	O
highlight	O
the	O
significance	O
of	O
non	O
##nu	O
##cle	O
##ar	O
damage	O
in	O
fa	B-T103
injury	O
and	O
reveal	O
a	O
major	O
role	O
for	O
immuno	B-T103
##pro	I-T103
##te	I-T103
##asome	I-T103
##s	I-T103
in	O
elimination	O
of	O
fa	O
-	O
damaged	O
cytoplasmic	B-T103
proteins	I-T103
through	O
ubiquitin	B-T103
-	O
independent	O
proteolysis	B-T038
.	O

functional	B-T062
analyses	I-T062
of	O
oc	B-T103
##rh	I-T103
##s1	I-T103
and	O
oc	B-T103
##uer	I-T103
##1	I-T103
involved	O
in	O
udp	B-T103
-	I-T103
l	I-T103
-	I-T103
rhamn	I-T103
##ose	I-T103
biosynthesis	O
in	O
ornith	B-T204
##og	I-T204
##alu	I-T204
##m	I-T204
cauda	I-T204
##t	I-T204
##um	I-T204
udp	B-T103
-	I-T103
l	I-T103
-	I-T103
rhamn	I-T103
##ose	I-T103
(	O
udp	B-T103
-	I-T103
rh	I-T103
##a	I-T103
)	O
is	O
an	O
important	O
sugar	B-T103
donor	I-T103
for	O
the	O
synthesis	O
of	O
rhamn	B-T103
##ose	I-T103
-	O
containing	O
compounds	B-T103
in	O
plants	B-T204
.	O
however	O
,	O
only	O
a	O
few	O
enzymes	B-T103
and	O
their	O
encoding	O
genes	B-T017
involved	O
in	O
udp	B-T103
-	I-T103
rh	I-T103
##a	I-T103
biosynthesis	O
are	O
available	O
in	O
plants	B-T204
.	O
here	O
,	O
two	O
genes	B-T017
encoding	O
rhamn	B-T103
##ose	I-T103
synthase	I-T103
(	O
rh	B-T103
##s	I-T103
)	O
and	O
bi	B-T103
-	I-T103
functional	I-T103
udp	B-T103
-	I-T103
4	I-T103
-	I-T103
keto	I-T103
-	I-T103
6	I-T103
-	I-T103
deoxy	I-T103
-	I-T103
d	I-T103
-	I-T103
glucose	I-T103
(	O
udp	B-T103
-	I-T103
4	I-T103
##k	I-T103
##6	I-T103
##dg	I-T103
)	O
3	B-T103
,	I-T103
5	I-T103
-	I-T103
epi	I-T103
##mer	I-T103
##ase	I-T103
/	I-T103
udp	I-T103
-	I-T103
4	I-T103
-	I-T103
keto	I-T103
-	I-T103
l	I-T103
-	I-T103
rhamn	I-T103
##ose	I-T103
(	O
udp	B-T103
-	I-T103
4	I-T103
##k	I-T103
##r	I-T103
)	O
4	B-T103
-	I-T103
keto	I-T103
-	I-T103
reductase	I-T103
(	O
u	B-T103
##er	I-T103
)	O
were	O
isolated	O
from	O
ornith	B-T204
##og	I-T204
##alu	I-T204
##m	I-T204
cauda	I-T204
##t	I-T204
##um	I-T204
based	O
on	O
the	O
rna	B-T103
-	O
seq	B-T170
data	I-T170
.	O
the	O
oc	B-T017
##rh	I-T017
##s1	I-T017
gene	I-T017
has	O
an	O
orf	B-T017
(	O
open	B-T017
reading	I-T017
frame	I-T017
)	O
of	O
2019	O
bp	O
encoding	O
a	O
tri	B-T017
-	I-T017
functional	I-T017
rh	I-T017
##s	I-T017
enzyme	I-T017
.	O
in	O
vitro	O
enzymatic	B-T058
assays	I-T058
revealed	O
oc	B-T103
##rh	I-T103
##s1	I-T103
can	O
really	O
convert	O
udp	B-T103
-	I-T103
d	I-T103
-	I-T103
glucose	I-T103
(	O
udp	B-T103
-	I-T103
glc	I-T103
)	O
into	O
udp	B-T103
-	I-T103
rh	I-T103
##a	I-T103
via	O
three	O
consecutive	O
reactions	O
.	O
biochemical	O
evidences	O
indicated	O
that	O
the	O
recombinant	B-T103
oc	I-T103
##rh	I-T103
##s1	I-T103
was	O
active	O
in	O
the	O
ph	O
range	O
of	O
5	O
-	O
11	O
and	O
over	O
the	O
temperature	O
range	O
of	O
0	O
-	O
60	O
°c	O
.	O
the	O
km	O
value	O
of	O
oc	B-T103
##rh	I-T103
##s1	I-T103
for	O
udp	B-T103
-	I-T103
glc	I-T103
was	O
determined	O
to	O
be	O
1	O
.	O
52	O
×	O
10	O
(	O
-	O
4	O
)	O
m	O
.	O
oc	B-T103
##rh	I-T103
##s1	I-T103
is	O
a	O
multi	B-T103
-	I-T103
domain	I-T103
protein	I-T103
with	O
two	O
sets	O
of	O
cofactor	B-T038
-	I-T038
binding	I-T038
motifs	I-T038
.	O
the	O
cofactors	B-T038
dependent	O
properties	O
of	O
oc	B-T103
##rh	I-T103
##s1	I-T103
were	O
thus	O
characterized	O
in	O
this	O
research	B-T062
.	O
moreover	O
,	O
the	O
n	B-T103
-	I-T103
terminal	I-T103
portion	I-T103
of	I-T103
oc	I-T103
##rh	I-T103
##s1	I-T103
(	O
oc	B-T103
##rh	I-T103
##s1	I-T103
-	I-T103
n	I-T103
)	O
was	O
observed	O
to	O
metabol	O
##ize	O
udp	B-T103
-	I-T103
glc	I-T103
to	O
form	O
intermediate	O
udp	O
-	O
4	O
##k	O
##6	O
##dg	O
.	O
oc	B-T017
##uer	I-T017
##1	I-T017
contains	O
an	O
orf	B-T017
of	O
90	O
##6	O
bp	O
encoding	O
a	O
polypeptide	B-T103
of	O
301	O
aa	B-T103
.	O
oc	B-T103
##uer	I-T103
##1	I-T103
shared	O
high	O
similarity	O
with	O
the	O
carboxy	B-T103
-	I-T103
terminal	I-T103
domain	I-T103
of	I-T103
oc	I-T103
##rh	I-T103
##s1	I-T103
(	O
oc	B-T103
##rh	I-T103
##s1	I-T103
-	I-T103
c	I-T103
)	O
,	O
suggesting	O
its	O
intrinsic	O
ability	O
of	O
converting	O
udp	O
-	O
4	O
##k	O
##6	O
##dg	O
into	O
udp	B-T103
-	I-T103
rh	I-T103
##a	I-T103
.	O
it	O
was	O
thus	O
reasonably	O
inferred	O
that	O
udp	B-T103
-	I-T103
glc	I-T103
could	O
be	O
bio	O
-	O
transformed	O
into	O
udp	B-T103
-	I-T103
rh	I-T103
##a	I-T103
under	O
the	O
collab	O
##orating	O
action	O
of	O
oc	B-T103
##rh	I-T103
##s1	I-T103
-	I-T103
n	I-T103
and	O
oc	B-T103
##uer	I-T103
##1	I-T103
.	O
the	O
subsequently	O
biochemical	B-T058
assay	I-T058
verified	O
this	O
notion	O
.	O
importantly	O
,	O
expression	B-T033
profiles	I-T033
of	O
oc	B-T103
##rh	I-T103
##s1	I-T103
and	O
oc	B-T103
##uer	I-T103
##1	I-T103
revealed	O
their	O
possible	O
involvement	O
in	O
the	O
biosynthesis	O
of	O
rhamn	B-T103
##ose	I-T103
-	O
containing	O
polysaccharides	B-T103
in	O
o	B-T204
.	I-T204
cauda	I-T204
##t	I-T204
##um	I-T204
.	O

expressions	B-T038
of	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
,	O
pd	B-T103
-	I-T103
l1	I-T103
and	O
foxp3	B-T103
+	O
til	B-T017
##s	I-T017
in	O
stage	B-T038
i	I-T038
nsclc	I-T038
guiding	O
adjuvant	B-T058
chemotherapy	I-T058
decisions	B-T038
currently	O
,	O
adjuvant	B-T058
chemotherapy	I-T058
is	O
recommended	O
for	O
patients	O
with	O
high	B-T033
risk	I-T033
stage	B-T038
i	I-T038
non	I-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
(	O
nsclc	B-T038
)	O
.	O
however	O
,	O
identifying	O
high	B-T033
risk	I-T033
patients	O
remains	O
a	O
challenge	O
.	O
this	O
study	B-T062
aims	O
to	O
identify	O
the	O
patient	O
cohorts	B-T098
more	O
likely	O
to	O
benefit	O
from	O
adjuvant	B-T058
chemotherapy	I-T058
based	O
on	O
the	O
tumor	B-T038
micro	O
-	O
immune	O
environment	B-T082
.	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
significantly	O
associated	O
with	O
disease	O
-	O
free	O
survival	O
(	O
dfs	O
)	O
and	O
overall	O
surv	O
##ial	O
(	O
os	O
)	O
(	O
p	O
=	O
0	O
.	O
002	O
;	O
0	O
.	O
040	O
)	O
.	O
patients	O
with	O
high	O
risk	O
factors	O
may	O
also	O
predict	O
shorter	O
dfs	O
(	O
p	O
=	O
0	O
.	O
05	O
##6	O
)	O
.	O
when	O
compared	O
together	O
,	O
patients	O
with	O
high	O
-	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
showed	O
better	O
dfs	O
than	O
patients	O
with	O
low	O
-	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
,	O
no	O
matter	O
their	O
risk	O
factors	O
status	O
.	O
there	O
'	O
s	O
no	B-T033
correlation	I-T033
between	O
pd	B-T103
-	I-T103
l1	I-T103
expressions	B-T038
and	O
survival	O
.	O
pd	B-T103
-	I-T103
l1	I-T103
was	O
highly	O
expressed	B-T038
in	O
men	B-T098
,	O
squamous	O
and	O
well	O
differentiated	O
carcinoma	B-T038
.	O
in	O
addition	O
,	O
foxp3	B-T103
+	O
til	B-T017
##s	I-T017
alone	O
did	O
##n	O
'	O
t	O
show	O
any	O
prognostic	O
effects	O
,	O
but	O
low	O
-	O
foxp3	B-T103
/	O
high	O
-	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
were	O
associated	O
with	O
prolonged	O
dfs	O
(	O
p	O
=	O
0	O
.	O
031	O
)	O
.	O
a	O
total	O
of	O
126	O
patients	O
with	O
surgically	O
resected	O
stage	B-T038
i	I-T038
nsclc	I-T038
were	O
included	O
to	O
perform	O
immunohistochemistry	B-T058
of	O
cd8	B-T103
+	O
tumor	B-T017
infiltrating	I-T017
lymphocytes	I-T017
(	O
til	B-T017
##s	I-T017
)	O
,	O
programmed	B-T103
death	I-T103
ligand	I-T103
-	I-T103
1	I-T103
(	O
pd	B-T103
-	I-T103
l1	I-T103
)	O
and	O
fork	B-T103
##head	I-T103
box	I-T103
p3	I-T103
(	O
foxp3	B-T103
)	O
+	O
til	B-T017
##s	I-T017
.	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
are	O
effective	O
prognostic	O
predictors	O
.	O
patients	O
with	O
surgically	O
resected	O
stage	B-T038
i	I-T038
nsclc	I-T038
showing	O
low	O
cd8	B-T103
+	O
til	B-T017
##s	I-T017
could	O
be	O
considered	O
for	O
adjuvant	B-T058
chemotherapy	I-T058
,	O
even	O
if	O
they	O
have	O
no	O
high	B-T033
risk	I-T033
features	O
.	O

whole	B-T058
-	I-T058
body	I-T058
strength	I-T058
training	I-T058
with	O
hub	O
##er	O
motion	O
lab	O
and	O
traditional	B-T058
strength	I-T058
training	I-T058
in	O
cardiac	B-T058
rehabilitation	I-T058
:	O
a	O
randomized	B-T062
controlled	I-T062
study	I-T062
isometric	B-T058
strengthening	I-T058
has	O
been	O
rarely	O
studied	O
in	O
patients	O
with	O
coronary	B-T038
heart	I-T038
disease	I-T038
(	O
chd	B-T038
)	O
,	O
mainly	O
because	O
of	O
possible	O
potential	B-T038
side	I-T038
effects	I-T038
and	O
lack	O
of	O
appropriate	O
and	O
reliable	O
devices	O
.	O
we	O
aimed	O
to	O
compare	O
2	O
different	O
modes	O
of	O
resistance	B-T058
training	I-T058
,	O
an	O
isometric	O
mode	O
with	O
the	O
hub	O
##er	O
motion	O
lab	O
(	O
hm	O
##l	O
)	O
and	O
traditional	B-T058
strength	I-T058
training	I-T058
(	O
tst	B-T058
)	O
,	O
in	O
chd	B-T038
patients	O
undergoing	O
a	O
cardiac	B-T058
rehabilitation	I-T058
program	O
.	O
we	O
randomly	O
assigned	O
50	O
patients	O
to	O
hm	O
##l	O
or	O
tst	B-T058
.	O
patients	O
underwent	O
complete	O
blinded	B-T062
evaluation	B-T058
before	O
and	O
after	O
the	O
rehabilitation	B-T058
program	I-T058
,	O
including	O
testing	B-T058
for	I-T058
cardiopulmonary	I-T058
exercise	I-T058
,	O
maximal	B-T058
isometric	I-T058
voluntary	I-T058
contraction	I-T058
,	O
endothelial	B-T017
function	O
and	O
body	O
composition	O
.	O
after	O
4	O
weeks	O
of	O
training	O
(	O
16	O
sessions	O
)	O
,	O
the	O
groups	O
did	O
not	O
differ	O
in	O
body	O
composition	O
,	O
anthropometric	B-T062
characteristics	O
,	O
or	O
endothelial	B-T017
function	O
.	O
with	O
hm	O
##l	O
,	O
peak	O
power	O
output	O
(	O
p	O
=	O
0	O
.	O
035	O
)	O
,	O
maximal	O
heart	B-T201
rate	I-T201
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
gain	O
of	O
force	O
measured	O
in	O
the	O
chest	O
press	O
position	O
(	O
p	O
<	O
0	O
.	O
02	O
)	O
were	O
greater	O
after	O
versus	O
before	O
training	O
.	O
both	O
protocols	B-T170
appeared	O
to	O
be	O
well	O
tolerated	O
,	O
safe	O
and	O
feasible	O
for	O
these	O
chd	B-T038
patients	O
.	O
a	O
training	B-T170
protocol	I-T170
involving	O
6	O
##s	O
phases	O
of	O
isometric	B-T038
contractions	I-T038
with	O
10	O
##s	O
of	O
passive	O
recovery	B-T038
on	O
an	O
hm	O
##l	O
device	O
could	O
be	O
safely	O
implemented	O
in	O
rehabilitation	B-T058
programs	I-T058
for	O
patients	O
with	O
chd	B-T038
and	O
improve	O
functional	O
outcomes	O
.	O

the	O
bind	B-T074
##ex	I-T074
(	I-T074
®	I-T074
)	I-T074
ultrasound	I-T074
device	I-T074
:	O
reliability	O
of	O
cortical	B-T017
bone	I-T017
thickness	O
measures	O
and	O
their	O
relationship	O
to	O
regional	B-T082
bone	B-T201
mineral	I-T201
density	I-T201
the	O
bind	B-T074
##ex	I-T074
(	I-T074
®	I-T074
)	I-T074
quantitative	I-T074
ultrasound	I-T074
(	I-T074
qu	I-T074
##s	I-T074
)	I-T074
device	I-T074
is	O
currently	O
available	O
and	O
this	O
study	B-T062
analyzed	B-T062
(	O
i	O
)	O
its	O
relative	O
and	O
absolute	O
intra	O
-	O
and	O
inter	O
-	O
session	O
reliability	O
and	O
(	O
ii	O
)	O
the	O
relationship	O
between	O
the	O
data	O
provided	O
by	O
bind	B-T074
##ex	I-T074
(	I-T074
®	I-T074
)	I-T074
-	I-T074
qu	I-T074
##s	I-T074
and	O
the	O
bone	B-T201
mineral	I-T201
density	I-T201
(	O
bmd	B-T201
)	O
measured	O
by	O
dual	B-T058
-	I-T058
energy	I-T058
x	I-T058
-	I-T058
ray	I-T058
absorptiometry	I-T058
at	O
corresponding	O
skeletal	B-T082
sites	I-T082
in	O
young	B-T098
and	O
healthy	B-T098
subjects	I-T098
(	O
age	O
:	O
25	O
.	O
0	O
±	O
3	O
.	O
6	O
years	O
)	O
.	O
bind	B-T074
##ex	I-T074
(	I-T074
®	I-T074
)	I-T074
-	I-T074
qu	I-T074
##s	I-T074
calculate	O
##s	O
a	O
density	B-T201
index	I-T201
on	O
the	O
basis	O
of	O
the	O
thickness	O
of	O
cortical	B-T017
bone	I-T017
measured	O
at	O
the	O
distal	B-T017
radius	I-T017
and	O
the	O
distal	B-T017
plus	O
proximal	B-T017
tibia	I-T017
.	O
the	O
data	O
show	O
a	O
very	O
good	O
relative	O
and	O
absolute	O
intra	O
-	O
(	O
icc	O
=	O
0	O
.	O
97	O
##7	O
,	O
cv	O
=	O
1	O
.	O
5	O
%	O
)	O
and	O
inter	O
-	O
session	O
reliability	O
(	O
icc	O
=	O
0	O
.	O
97	O
##8	O
,	O
cv	O
=	O
1	O
.	O
4	O
%	O
)	O
for	O
the	O
density	B-T201
index	I-T201
.	O
the	O
highest	O
positive	B-T033
correlations	O
were	O
found	O
between	O
cortical	B-T017
thickness	O
and	O
bmd	B-T201
for	O
the	O
distal	B-T017
radius	I-T017
and	O
distal	B-T017
tibia	I-T017
(	O
r	O
⩾	O
0	O
.	O
71	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
data	O
indicate	O
that	O
the	O
bind	B-T074
##ex	I-T074
(	I-T074
®	I-T074
)	I-T074
-	I-T074
qu	I-T074
##s	I-T074
parameters	B-T033
are	O
repeatable	O
within	O
and	O
between	O
measurement	O
sessions	O
.	O
furthermore	O
,	O
the	O
measurements	O
reflect	O
the	O
bmd	B-T201
at	O
specific	O
skeletal	B-T082
sites	I-T082
.	O
bind	B-T074
##ex	I-T074
(	I-T074
®	I-T074
)	I-T074
-	I-T074
qu	I-T074
##s	I-T074
might	O
be	O
a	O
useful	O
tool	O
for	O
the	O
measurement	O
of	O
skeletal	B-T038
adaptations	I-T038
.	O

interobserver	O
and	O
intra	O
##observer	O
reliability	O
of	O
clinical	O
assessments	O
in	O
knee	B-T038
osteoarthritis	I-T038
clinical	O
examination	O
of	O
the	O
knee	B-T017
is	O
subject	O
to	O
measurement	O
error	O
.	O
the	O
aim	O
of	O
this	O
analysis	O
was	O
to	O
determine	O
interobserver	O
and	O
intra	O
##observer	O
reliability	O
of	O
commonly	O
used	O
clinical	O
tests	O
in	O
patients	O
with	O
knee	B-T038
osteoarthritis	I-T038
(	O
oa	B-T038
)	O
.	O
we	O
studied	O
subjects	O
with	O
symptomatic	O
knee	B-T038
oa	I-T038
who	O
were	O
participants	B-T098
in	O
an	O
open	B-T062
-	I-T062
label	I-T062
clinical	I-T062
trial	I-T062
of	O
intra	B-T058
##articular	I-T058
steroid	I-T058
therapy	I-T058
.	O
following	O
standardization	B-T062
of	O
the	O
clinical	B-T058
test	I-T058
procedures	I-T058
,	O
2	O
clinicians	B-T097
assessed	B-T058
25	O
subjects	O
independently	O
at	O
the	O
same	O
visit	B-T058
,	O
and	O
the	O
same	O
clinician	B-T097
assessed	B-T058
88	O
subjects	O
over	O
an	O
interval	O
period	O
of	O
2	O
-	O
10	O
weeks	O
;	O
in	O
both	O
cases	O
prior	O
to	O
the	O
steroid	B-T058
intervention	B-T058
.	O
clinical	O
examination	O
included	O
assessment	B-T058
of	O
bony	O
enlargement	O
,	O
cre	B-T038
##pi	I-T038
##t	I-T038
##us	I-T038
,	O
quadriceps	B-T033
wasting	I-T033
,	O
knee	B-T033
effusion	I-T033
,	O
joint	B-T082
-	I-T082
line	I-T082
and	O
ans	B-T017
##erine	I-T017
tenderness	B-T033
,	O
and	O
knee	B-T033
range	I-T033
of	I-T033
movement	I-T033
(	O
rom	B-T033
)	O
.	O
intraclass	O
correlation	O
coefficients	O
(	O
icc	O
)	O
,	O
estimated	O
kappa	O
(	O
κ	O
)	O
,	O
weighted	O
kappa	O
(	O
κ	O
##ω	O
)	O
,	O
and	O
bland	O
-	O
altman	O
plots	O
were	O
used	O
to	O
determine	O
interobserver	O
and	O
intra	O
##observer	O
levels	O
of	O
agreement	O
.	O
using	O
land	O
##is	O
and	O
ko	O
##ch	O
criteria	O
,	O
interobserver	O
κ	O
scores	O
were	O
moderate	O
for	O
patellofemoral	B-T082
joint	I-T082
(	O
κ	O
=	O
0	O
.	O
53	O
)	O
and	O
ans	B-T017
##erine	I-T017
tenderness	B-T033
(	O
κ	O
=	O
0	O
.	O
48	O
)	O
;	O
good	O
for	O
bony	O
enlargement	O
(	O
κ	O
=	O
0	O
.	O
66	O
)	O
,	O
quadriceps	B-T033
wasting	I-T033
(	O
κ	O
=	O
0	O
.	O
78	O
)	O
,	O
cre	B-T038
##pi	I-T038
##t	I-T038
##us	I-T038
(	O
κ	O
=	O
0	O
.	O
78	O
)	O
,	O
medial	B-T082
tib	B-T082
##io	I-T082
##fe	I-T082
##mo	I-T082
##ral	I-T082
joint	I-T082
tenderness	B-T033
(	O
κ	O
=	O
0	O
.	O
76	O
)	O
,	O
and	O
effusion	B-T033
assessed	O
by	O
ball	B-T033
##ott	I-T033
##ement	I-T033
(	O
κ	O
=	O
0	O
.	O
73	O
)	O
and	O
bul	B-T058
##ge	I-T058
sign	I-T058
(	O
κ	O
##ω	O
=	O
0	O
.	O
78	O
)	O
;	O
and	O
excellent	O
for	O
lateral	B-T082
tib	B-T082
##io	I-T082
##fe	I-T082
##mo	I-T082
##ral	I-T082
joint	I-T082
tenderness	B-T033
(	O
κ	O
=	O
1	O
.	O
00	O
)	O
,	O
flexion	B-T038
(	O
icc	O
=	O
0	O
.	O
97	O
)	O
,	O
and	O
extension	O
(	O
icc	O
=	O
0	O
.	O
87	O
)	O
rom	B-T033
.	O
intra	O
##observer	O
κ	O
scores	O
were	O
moderate	O
for	O
lateral	B-T082
tib	B-T082
##io	I-T082
##fe	I-T082
##mo	I-T082
##ral	I-T082
joint	I-T082
tenderness	B-T033
(	O
κ	O
=	O
0	O
.	O
60	O
)	O
;	O
good	O
for	O
cre	O
##pi	O
##t	O
##us	O
(	O
κ	O
=	O
0	O
.	O
78	O
)	O
,	O
effusion	B-T033
assessed	O
by	O
ball	B-T033
##ott	I-T033
##ement	I-T033
test	I-T033
(	O
κ	O
=	O
0	O
.	O
77	O
)	O
,	O
patellofemoral	B-T082
joint	I-T082
(	O
κ	O
=	O
0	O
.	O
66	O
)	O
,	O
medial	B-T082
tib	B-T082
##io	I-T082
##fe	I-T082
##mo	I-T082
##ral	I-T082
joint	I-T082
(	O
κ	O
=	O
0	O
.	O
64	O
)	O
,	O
and	O
ans	B-T017
##erine	I-T017
tenderness	B-T033
(	O
κ	O
=	O
0	O
.	O
73	O
)	O
;	O
and	O
excellent	O
for	O
effusion	B-T033
assessed	O
by	O
bul	B-T058
##ge	I-T058
sign	I-T058
(	O
κ	O
##ω	O
=	O
0	O
.	O
83	O
)	O
,	O
bony	O
enlargement	O
(	O
κ	O
=	O
0	O
.	O
98	O
)	O
,	O
quadriceps	B-T033
wasting	I-T033
(	O
κ	O
=	O
0	O
.	O
83	O
)	O
,	O
flexion	B-T038
(	O
icc	O
=	O
0	O
.	O
99	O
)	O
,	O
and	O
extension	O
(	O
icc	O
=	O
0	O
.	O
96	O
)	O
rom	B-T033
.	O
among	O
individuals	B-T098
with	O
symptomatic	O
knee	B-T038
oa	I-T038
,	O
the	O
reliability	O
of	O
clinical	O
examination	O
of	O
the	O
knee	B-T017
was	O
at	O
least	O
good	O
for	O
the	O
majority	O
of	O
clinical	B-T033
signs	I-T033
of	O
knee	B-T038
oa	I-T038
.	O

nosocomial	B-T038
pneumonia	I-T038
caused	O
by	O
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
treated	B-T058
with	I-T058
linezolid	B-T103
or	O
vancomycin	B-T103
:	O
a	O
secondary	O
economic	O
analysis	O
of	O
resource	O
use	O
from	O
a	O
spanish	B-T082
perspective	O
adopting	O
a	O
unique	O
spanish	B-T082
perspective	O
,	O
this	O
study	B-T062
aims	O
to	O
assess	O
healthcare	O
resource	O
utilization	O
(	O
hc	O
##ru	O
)	O
and	O
the	O
costs	O
of	O
treating	O
nosocomial	B-T038
pneumonia	I-T038
(	O
np	B-T038
)	O
produced	O
by	O
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
(	O
mrsa	B-T007
)	O
in	O
hospitalized	B-T033
adults	I-T033
using	O
linezolid	B-T103
or	O
vancomycin	B-T103
.	O
an	O
evaluation	O
is	O
also	O
made	O
of	O
the	O
renal	B-T038
failure	I-T038
rate	O
and	O
related	O
economic	O
outcomes	O
between	O
study	O
groups	O
.	O
an	O
economic	O
post	O
hoc	O
evaluation	O
of	O
a	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
multicenter	B-T062
phase	I-T062
4	I-T062
study	I-T062
was	O
carried	O
out	O
.	O
nosocomial	B-T038
pneumonia	I-T038
due	O
to	O
mrsa	B-T007
in	O
hospitalized	B-T033
adults	I-T033
.	O
the	O
modified	O
intent	O
to	O
treat	O
(	O
mit	O
##t	O
)	O
population	B-T098
comprised	O
224	O
linezolid	B-T103
-	O
and	O
224	O
vancomycin	B-T103
-	O
treated	B-T058
patients	O
.	O
costs	O
and	O
hc	O
##ru	O
were	O
evaluated	O
between	O
patients	O
administered	O
either	O
linezolid	B-T103
or	O
vancomycin	B-T103
,	O
and	O
between	O
patients	O
who	O
developed	O
renal	B-T038
failure	I-T038
and	O
those	O
who	O
did	O
not	O
.	O
analysis	O
of	O
hc	O
##ru	O
outcomes	O
and	O
costs	O
.	O
total	O
costs	O
were	O
similar	O
between	O
the	O
linezolid	B-T103
-	O
(	O
€	O
##17	O
,	O
78	O
##2	O
##±	O
##€	O
##9	O
,	O
61	O
##5	O
)	O
and	O
vancomycin	B-T103
-	O
treated	B-T058
patients	O
(	O
€	O
##17	O
,	O
42	O
##3	O
##±	O
##€	O
##9	O
,	O
460	O
)	O
(	O
p	O
=	O
.	O
69	O
)	O
.	O
the	O
renal	B-T038
failure	I-T038
rate	O
was	O
significantly	O
lower	O
in	O
the	O
linezolid	B-T103
-	O
treated	B-T058
patients	O
(	O
4	O
%	O
vs	O
.	O
15	O
%	O
;	O
p	O
<	O
.	O
001	O
)	O
.	O
the	O
total	O
costs	O
tended	O
to	O
be	O
higher	O
in	O
patients	O
who	O
developed	O
renal	B-T038
failure	I-T038
(	O
€	O
##19	O
,	O
62	O
##6	O
##±	O
##€	O
##10	O
,	O
84	O
##0	O
vs	O
.	O
€	O
##17	O
,	O
38	O
##8	O
##±	O
##€	O
##9	O
,	O
36	O
##9	O
;	O
p	O
=	O
.	O
14	O
)	O
.	O
among	O
the	O
patients	O
who	O
developed	O
renal	B-T038
failure	I-T038
,	O
hc	O
##ru	O
(	O
days	O
on	O
mechanical	B-T058
ventilation	I-T058
:	O
13	O
.	O
2	O
##±1	O
##0	O
.	O
7	O
vs	O
.	O
7	O
.	O
6	O
##±3	O
.	O
6	O
days	O
;	O
p	O
=	O
.	O
21	O
;	O
icu	O
stay	O
:	O
14	O
.	O
4	O
##±1	O
##0	O
.	O
5	O
vs	O
.	O
9	O
.	O
9	O
##±6	O
.	O
6	O
days	O
;	O
p	O
=	O
.	O
30	O
;	O
hospital	O
stay	O
:	O
19	O
.	O
5	O
##±	O
##9	O
.	O
5	O
vs	O
.	O
16	O
.	O
1	O
##±1	O
##1	O
.	O
0	O
days	O
;	O
p	O
=	O
.	O
26	O
)	O
and	O
cost	O
(	O
€	O
##17	O
,	O
219	O
##±	O
##€	O
##8	O
,	O
79	O
##2	O
vs	O
.	O
€	O
##20	O
,	O
263	O
##±	O
##€	O
##11	O
,	O
350	O
;	O
p	O
=	O
.	O
51	O
)	O
tended	O
to	O
be	O
lower	O
in	O
the	O
linezolid	B-T103
-	O
vs	O
.	O
vancomycin	B-T103
-	O
treated	B-T058
patients	O
.	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
costs	O
per	O
patient	O
-	O
day	O
between	O
cohorts	B-T098
after	O
correcting	O
for	O
mortality	O
(	O
€	O
##100	O
##0	O
vs	O
.	O
€	O
##1	O
,	O
010	O
;	O
p	O
=	O
.	O
98	O
)	O
.	O
from	O
a	O
spanish	B-T082
perspective	O
,	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
total	O
costs	O
between	O
the	O
linezolid	B-T103
and	O
vancomycin	B-T103
pneumonia	B-T038
cohorts	B-T098
.	O
the	O
drug	O
cost	O
corresponding	O
to	O
linezolid	B-T103
was	O
partially	O
offset	O
by	O
fewer	O
renal	B-T038
failure	I-T038
adverse	B-T038
events	I-T038
.	O

low	O
-	O
intensity	O
pulsed	O
ultrasound	O
reduces	O
periodontal	B-T038
atrophy	I-T038
in	O
occlusal	B-T038
hypo	O
##functional	O
teeth	B-T017
to	O
clarify	O
whether	O
low	O
-	O
intensity	O
pulsed	O
ultrasound	O
(	O
lip	O
##us	O
)	O
exposure	O
has	O
recovery	O
effects	O
on	O
the	O
hypo	O
##functional	O
periodontal	B-T017
ligament	I-T017
(	O
pdl	B-T017
)	O
and	O
interr	B-T017
##adic	I-T017
##ular	I-T017
alveolar	I-T017
bone	I-T017
(	O
ira	B-T017
##b	I-T017
)	O
.	O
twelve	O
-	O
week	O
-	O
old	O
male	O
sprague	B-T204
-	I-T204
dawley	I-T204
rats	I-T204
were	O
divided	O
into	O
three	O
groups	B-T098
(	O
n	O
=	O
5	O
each	O
)	O
:	O
a	O
normal	B-T038
occlusion	I-T038
(	O
c	O
)	O
group	B-T098
,	O
an	O
occlusal	B-T038
hypo	O
##function	O
(	O
h	O
)	O
group	B-T098
,	O
and	O
an	O
occlusal	B-T098
hypo	I-T098
##function	I-T098
group	I-T098
subjected	O
to	O
lip	O
##us	O
(	O
hl	O
)	O
treatment	B-T058
.	O
hypo	O
##functional	O
occlusion	B-T038
of	O
the	O
maxillary	B-T017
first	I-T017
molar	I-T017
(	O
m1	B-T017
)	O
of	O
the	O
h	B-T098
and	O
hl	B-T098
groups	I-T098
was	O
induced	O
by	O
the	O
bite	B-T058
-	I-T058
raising	I-T058
technique	I-T058
.	O
only	O
the	O
hl	B-T098
group	I-T098
was	O
irradiated	O
with	O
lip	O
##us	O
for	O
5	O
days	O
.	O
the	O
ira	B-T017
##b	I-T017
and	O
pdl	B-T017
of	O
m1	B-T017
were	O
examined	O
by	O
microc	B-T058
##omp	I-T058
##uted	I-T058
tomography	I-T058
(	O
micro	B-T058
-	I-T058
ct	I-T058
)	O
analysis	B-T062
.	O
to	O
quantify	O
mrna	B-T103
expression	B-T038
of	O
cytokines	B-T103
involved	O
in	O
pdl	B-T017
proliferation	O
and	O
development	O
,	O
real	B-T062
-	I-T062
time	I-T062
reverse	I-T062
transcription	I-T062
quantitative	I-T062
pcr	I-T062
(	O
qrt	B-T062
-	I-T062
pcr	I-T062
)	O
was	O
performed	O
for	O
twist	B-T017
family	I-T017
bh	I-T017
##l	I-T017
##h	I-T017
transcription	I-T017
factor	I-T017
1	I-T017
(	O
twist	B-T017
##1	I-T017
)	O
,	O
peri	B-T017
##ostin	I-T017
,	O
and	O
connective	B-T017
tissue	I-T017
growth	I-T017
factor	I-T017
(	O
ctgf	B-T017
)	O
in	O
the	O
pdl	B-T017
samples	O
.	O
micro	B-T058
-	I-T058
ct	I-T058
analysis	B-T062
showed	O
that	O
the	O
pdl	B-T017
volume	O
was	O
decreased	O
in	O
the	O
h	B-T098
group	I-T098
compared	O
with	O
that	O
of	O
the	O
c	B-T098
and	O
hl	B-T098
groups	I-T098
.	O
both	O
bone	O
volume	O
per	O
tissue	O
volume	O
(	O
bv	O
/	O
tv	O
)	O
of	O
ira	B-T017
##b	I-T017
was	O
decreased	O
in	O
the	O
h	B-T098
group	I-T098
compared	O
with	O
that	O
in	O
the	O
c	B-T098
group	I-T098
.	O
lip	O
##us	O
exposure	O
restored	O
bv	O
/	O
tv	O
in	O
the	O
ira	B-T017
##b	I-T017
of	O
the	O
hl	B-T098
group	I-T098
.	O
qrt	B-T062
-	I-T062
pcr	I-T062
analysis	B-T062
showed	O
that	O
twist	B-T017
##1	I-T017
,	O
peri	B-T017
##ostin	I-T017
,	O
and	O
ctgf	B-T017
mrna	B-T103
levels	O
were	O
decreased	O
in	O
the	O
h	B-T098
group	I-T098
and	O
increased	O
in	O
the	O
hl	B-T098
group	I-T098
.	O
lip	O
##us	O
exposure	O
reduced	O
the	O
atrophic	B-T038
changes	O
of	O
alveolar	B-T017
bone	I-T017
by	O
inducing	O
the	O
upregulation	B-T038
of	O
peri	B-T017
##ostin	I-T017
and	O
ctgf	B-T017
expression	B-T038
to	O
promote	O
pdl	B-T017
healing	B-T038
after	O
induction	B-T058
of	O
occlusal	B-T038
hypo	O
##function	O
.	O

serum	B-T058
c	I-T058
-	I-T058
reactive	I-T058
protein	I-T058
in	O
children	O
with	O
liver	B-T038
disease	I-T038
and	O
ascites	B-T033
the	O
diagnosis	B-T062
of	O
peritonitis	B-T038
as	O
a	O
complication	B-T038
of	O
cirrhosis	B-T038
is	O
an	O
important	O
clinical	O
problem	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
serum	B-T058
c	I-T058
-	I-T058
reactive	I-T058
protein	I-T058
levels	I-T058
as	O
a	O
diagnostic	B-T201
factor	I-T201
for	O
spontaneous	B-T038
bacterial	I-T038
peritonitis	I-T038
(	O
sbp	B-T038
)	O
in	O
child	O
patients	O
with	O
liver	B-T038
disease	I-T038
.	O
in	O
this	O
study	B-T062
,	O
150	O
children	O
diagnosed	B-T062
with	O
liver	B-T038
disease	I-T038
and	O
ascites	B-T033
upon	O
admission	B-T058
to	O
nem	B-T092
##az	I-T092
##ee	I-T092
teaching	I-T092
hospital	I-T092
(	O
sh	B-T082
##ira	I-T082
##z	I-T082
,	O
iran	B-T082
)	O
were	O
examined	B-T033
.	O
patients	O
were	O
divided	O
into	O
spontaneous	B-T038
bacterial	I-T038
peritonitis	I-T038
and	O
sterile	B-T031
asc	I-T031
##etic	I-T031
fluid	I-T031
groups	I-T031
according	O
to	O
the	O
pmn	B-T058
count	I-T058
≥	O
250	O
/	O
mm	O
(	O
3	O
)	O
in	O
the	O
asc	B-T031
##etic	I-T031
fluids	I-T031
.	O
routine	B-T058
laboratory	I-T058
tests	I-T058
were	O
conducted	O
and	O
quantitative	O
c	B-T058
-	I-T058
reactive	I-T058
protein	I-T058
(	I-T058
crp	I-T058
)	I-T058
levels	I-T058
were	O
measured	O
for	O
all	O
of	O
the	O
patients	O
.	O
accuracy	O
,	O
sensitivity	O
,	O
and	O
specificity	O
of	O
crp	B-T058
was	O
evaluated	O
for	O
diagnosis	B-T062
of	O
sbp	B-T038
.	O
of	O
150	O
cirrhotic	B-T038
patients	O
,	O
109	O
patients	O
presented	O
without	O
sbp	B-T038
(	O
52	O
.	O
29	O
%	O
male	B-T098
,	O
mean	O
age	O
:	O
5	O
.	O
02	O
±	O
4	O
.	O
49	O
years	O
)	O
and	O
41	O
patients	O
presented	O
with	O
sbp	B-T038
(	O
51	O
.	O
21	O
%	O
male	B-T098
,	O
mean	O
age	O
:	O
4	O
.	O
71	O
years	O
)	O
.	O
cell	B-T058
counts	I-T058
,	O
protein	B-T033
levels	I-T033
,	O
albumin	B-T033
levels	I-T033
,	O
and	O
lactate	B-T058
dehydrogen	I-T058
##ize	I-T058
(	I-T058
ldh	I-T058
)	I-T058
levels	I-T058
of	O
the	O
asc	B-T031
##etic	I-T031
fluid	I-T031
and	O
serum	B-T031
samples	I-T031
in	O
the	O
sbp	B-T038
group	O
were	O
higher	O
than	O
the	O
rates	O
for	O
those	O
without	O
sbp	B-T038
(	O
p	O
<	O
0	O
.	O
05	O
(	O
.	O
the	O
mean	O
±	O
sd	O
of	O
crp	B-T058
in	O
the	O
sbp	B-T038
group	O
(	O
36	O
.	O
89	O
±	O
23	O
.	O
43	O
)	O
increased	O
significantly	O
compared	O
to	O
the	O
rate	O
among	O
those	O
without	O
sbp	B-T038
(	O
21	O
.	O
59	O
±	O
15	O
.	O
43	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
the	O
percentages	O
for	O
sensitivity	O
and	O
specificity	O
of	O
crp	B-T058
,	O
the	O
diagnosis	B-T062
of	O
sbp	B-T038
based	O
on	O
the	O
pmn	B-T058
count	I-T058
≥	O
250	O
/	O
mm	O
(	O
3	O
)	O
,	O
and	O
cultured	B-T033
ascites	I-T033
were	O
69	O
.	O
23	O
%	O
,	O
90	O
.	O
25	O
%	O
,	O
88	O
.	O
43	O
%	O
,	O
and	O
84	O
.	O
32	O
%	O
,	O
respectively	O
.	O
the	O
areas	O
under	O
the	O
curve	O
of	O
crp	B-T058
for	O
sbp	B-T038
based	O
on	O
the	O
pmn	B-T058
count	I-T058
≥	O
250	O
/	O
mm	O
(	O
3	O
)	O
and	O
cultured	B-T033
ascites	I-T033
was	O
0	O
.	O
94	O
(	O
ci	O
95	O
%	O
:	O
0	O
.	O
90	O
to	O
0	O
.	O
96	O
)	O
and	O
0	O
.	O
85	O
(	O
ci	O
95	O
%	O
:	O
0	O
.	O
84	O
to	O
0	O
.	O
92	O
)	O
,	O
respectively	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
our	O
study	B-T062
showed	O
that	O
crp	B-T058
is	O
a	O
marker	O
with	O
high	O
sensitivity	O
and	O
specificity	O
for	O
the	O
diagnosis	B-T062
of	O
sbp	B-T038
in	O
cirrhotic	B-T038
children	O
.	O

mechanisms	O
of	O
compensation	B-T058
in	O
the	O
gait	B-T033
of	O
patients	O
with	O
drop	B-T038
foot	I-T038
drop	B-T038
foot	I-T038
is	O
a	O
complex	O
syndrome	B-T038
,	O
with	O
multiple	O
interactions	O
between	O
joints	B-T082
and	O
muscles	B-T017
.	O
abnormalities	B-T033
in	O
movement	B-T033
patterns	I-T033
can	O
be	O
measured	O
using	O
motion	B-T058
capture	I-T058
techniques	I-T058
,	O
but	O
identifying	O
compensation	B-T058
mechanisms	O
remains	O
challenging	O
.	O
in	O
order	O
to	O
identify	O
compensatory	O
mechanisms	O
in	O
patients	O
with	O
drop	B-T038
foot	I-T038
,	O
this	O
study	B-T062
evaluated	O
a	O
sample	O
of	O
15	O
such	O
patients	O
using	O
a	O
computerized	O
gait	B-T074
analysis	I-T074
system	I-T074
,	O
as	O
compared	O
to	O
a	O
group	O
of	O
15	O
healthy	B-T098
subjects	I-T098
.	O
four	O
classes	O
of	O
parameters	O
were	O
distinguished	O
,	O
falling	B-T033
in	O
differing	O
intervals	O
of	O
percentage	O
differences	O
between	O
the	O
groups	B-T098
in	O
the	O
study	B-T062
.	O
the	O
first	O
class	O
comprised	O
two	O
kinematic	B-T091
parameters	I-T091
for	O
which	O
the	O
values	O
of	O
percentage	O
differences	O
in	O
the	O
control	O
group	O
were	O
more	O
than	O
100	O
%	O
greater	O
than	O
for	O
the	O
patient	O
group	O
.	O
the	O
second	O
class	O
comprised	O
two	O
kinetic	O
parameters	O
falling	B-T033
in	O
the	O
interval	O
of	O
100	O
-	O
49	O
%	O
.	O
in	O
the	O
third	O
class	O
,	O
in	O
the	O
49	O
-	O
20	O
%	O
interval	O
the	O
main	O
differences	O
were	O
observed	O
for	O
spatiotemporal	B-T062
parameters	I-T062
,	O
whereas	O
in	O
the	O
20	O
-	O
4	O
%	O
interval	O
the	O
differences	O
were	O
distributed	O
similarly	O
for	O
kinematic	B-T091
,	O
kinetic	O
and	O
spatiotemporal	B-T062
parameters	I-T062
.	O
these	O
differences	O
in	O
gait	B-T033
pattern	I-T033
between	O
the	O
groups	B-T098
may	O
be	O
related	O
to	O
both	O
primary	O
motor	B-T033
deficits	I-T033
and	O
secondary	O
compensatory	O
mechanisms	O
.	O
generally	O
,	O
we	O
conclude	O
that	O
drop	B-T038
foot	I-T038
affects	O
the	O
patients	O
'	O
overall	O
kinematic	B-T091
and	O
kinetic	O
gait	B-T033
parameters	O
,	O
with	O
compensation	B-T058
seen	O
as	O
a	O
chain	O
originating	O
from	O
a	O
change	O
of	O
movement	B-T038
within	O
the	O
ankle	B-T082
joint	I-T082
.	O

histopathology	B-T091
of	O
the	O
fil	B-T017
##um	I-T017
terminal	I-T017
##e	I-T017
in	O
children	O
with	O
and	O
without	O
tethered	B-T038
cord	I-T038
syndrome	I-T038
with	O
attention	O
to	O
the	O
elastic	B-T017
tissue	I-T017
within	O
the	O
fil	B-T017
##um	I-T017
to	O
compare	O
histologically	O
trans	O
##ected	O
fil	B-T017
##a	I-T017
from	O
pediatric	O
patients	O
with	O
tethered	B-T038
cord	I-T038
syndrome	I-T038
(	O
tcs	B-T038
)	O
,	O
with	O
and	O
without	O
a	O
low	B-T082
con	B-T017
##us	I-T017
,	O
with	O
controls	O
,	O
focusing	O
on	O
collagenous	B-T017
and	O
elastic	B-T017
tissue	I-T017
.	O
thirty	O
fil	B-T017
##a	I-T017
from	O
patients	O
with	O
tcs	B-T038
,	O
including	O
5	O
where	O
minimal	O
cau	B-T058
##ter	I-T058
##y	I-T058
was	O
used	O
prior	O
to	O
fil	B-T017
##um	I-T017
section	B-T058
,	O
were	O
compared	O
with	O
fil	B-T017
##a	I-T017
from	O
27	O
pediatric	O
cadavers	B-T017
without	O
tcs	B-T038
(	O
controls	O
)	O
.	O
sections	O
of	O
fil	B-T017
##a	I-T017
were	O
stained	B-T058
with	O
h	B-T058
&	I-T058
e	I-T058
,	O
mass	B-T058
##on	I-T058
trich	I-T058
##rome	I-T058
and	O
ver	B-T058
##ho	I-T058
##eff	I-T058
von	I-T058
gi	I-T058
##es	I-T058
##on	I-T058
elastic	I-T058
stains	I-T058
,	O
and	O
7	O
with	O
gor	B-T058
##d	I-T058
##on	I-T058
and	I-T058
sweet	I-T058
'	I-T058
s	I-T058
reticul	I-T058
##in	I-T058
stain	I-T058
.	O
fil	B-T017
##a	I-T017
from	O
controls	O
showed	O
loose	O
fibrous	B-T017
connective	I-T017
tissue	I-T017
(	O
fc	B-T017
##t	I-T017
)	O
with	O
thin	O
and	O
evenly	O
dispersed	O
elastic	B-T017
fibers	I-T017
(	O
efs	B-T017
)	O
.	O
reticul	B-T103
##in	I-T103
fibers	I-T103
(	O
rfs	B-T103
)	O
were	O
seen	O
in	O
blood	B-T017
vessel	I-T017
walls	I-T017
and	O
nerve	B-T017
tw	O
##ig	O
##s	O
.	O
fat	B-T103
was	O
identified	O
microscopically	O
in	O
2	O
fil	B-T017
##a	I-T017
.	O
all	O
fil	B-T017
##a	I-T017
from	O
patients	O
with	O
tcs	B-T038
had	O
dense	B-T017
fc	I-T017
##t	I-T017
.	O
the	O
efs	B-T017
were	O
in	O
normal	O
numbers	O
in	O
17	O
,	O
and	O
focal	B-T082
##ly	I-T082
or	O
diffusely	O
decreased	O
in	O
13	O
.	O
all	O
25	O
patients	O
where	O
the	O
fil	B-T017
##a	I-T017
were	O
cau	B-T058
##ter	I-T058
##ized	I-T058
during	O
resection	B-T058
had	O
thick	O
and	O
coiled	B-T082
efs	B-T017
.	O
coil	B-T082
##ing	I-T082
was	O
not	O
seen	O
when	O
minimal	O
cau	B-T058
##ter	I-T058
##y	I-T058
was	O
applied	O
.	O
rfs	B-T103
were	O
seen	O
in	O
blood	B-T017
vessel	I-T017
walls	I-T017
and	O
nerve	O
tw	O
##ig	O
##s	O
.	O
fat	B-T103
was	O
identified	O
in	O
19	O
patients	O
.	O
findings	B-T033
were	O
similar	O
,	O
whether	O
the	O
con	B-T017
##us	I-T017
termination	O
was	O
normal	O
or	O
low	B-T082
.	O
the	O
fil	B-T017
##a	I-T017
of	O
all	O
patients	O
with	O
tcs	B-T038
,	O
whether	O
or	O
not	O
the	O
con	B-T017
##us	I-T017
was	O
low	B-T082
,	O
showed	O
abnormal	B-T033
fc	B-T017
##t	I-T017
.	O
efs	B-T017
were	O
decreased	O
in	O
48	O
%	O
of	O
patients	O
;	O
however	O
,	O
there	O
were	O
thick	O
and	O
coiled	B-T082
efs	B-T017
in	O
all	O
patients	O
.	O
coil	B-T082
##ing	I-T082
of	O
efs	B-T017
,	O
initially	O
thought	O
to	O
be	O
an	O
abnormality	B-T033
in	O
patients	O
,	O
is	O
considered	O
most	O
likely	O
to	O
be	O
a	O
result	O
of	O
cau	B-T058
##ter	I-T058
##y	I-T058
(	O
i	O
.	O
e	O
.	O
,	O
artifact	O
##ual	O
/	O
iatrogenic	O
coil	B-T082
##ing	I-T082
)	O
.	O

impact	O
sports	O
and	O
bone	B-T037
fractures	I-T037
among	O
adolescents	O
the	O
objective	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
investigate	O
the	O
effects	O
of	O
different	O
sports	O
on	O
stress	B-T037
fractures	I-T037
among	O
adolescents	O
during	O
a	O
9	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
period	O
.	O
the	O
sample	B-T098
was	O
composed	O
of	O
184	O
adolescents	O
divided	O
into	O
three	O
groups	B-T098
(	O
impact	O
sports	O
[	O
n	O
=	O
102	O
]	O
;	O
swimming	O
[	O
n	O
=	O
35	O
]	O
;	O
non	O
-	O
sports	O
[	O
n	O
=	O
47	O
]	O
)	O
.	O
the	O
occurrence	O
of	O
stress	B-T037
fracture	I-T037
was	O
reported	O
by	O
participants	B-T098
and	O
coa	B-T097
##ches	I-T097
.	O
as	O
potential	O
confounders	O
we	O
considered	O
age	O
,	O
sex	O
,	O
resistance	B-T058
training	I-T058
,	O
body	O
composition	O
variables	O
and	O
age	O
at	O
peak	O
of	O
height	O
velocity	O
.	O
there	O
were	O
13	O
adolescents	O
who	O
reported	O
fractures	B-T037
during	O
the	O
9	O
-	O
month	O
period	O
.	O
bone	B-T201
mineral	I-T201
density	I-T201
values	O
were	O
higher	O
in	O
adolescents	O
engaged	O
in	O
impact	O
sports	O
(	O
p	O
-	O
value	O
=	O
0	O
.	O
002	O
)	O
.	O
independently	O
of	O
confounders	O
,	O
the	O
risk	O
of	O
stress	B-T037
fracture	I-T037
was	O
lower	O
in	O
adolescents	O
engaged	O
in	O
impact	O
sports	O
than	O
in	O
non	O
-	O
active	O
adolescents	O
(	O
hazard	O
ratio	O
[	O
hr	O
]	O
=	O
0	O
.	O
23	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
=	O
0	O
.	O
05	O
to	O
0	O
.	O
98	O
]	O
)	O
,	O
while	O
swimming	O
practice	B-T038
was	O
not	O
associated	O
to	O
lower	O
risk	O
of	O
fracture	B-T037
(	O
hr	O
=	O
0	O
.	O
49	O
[	O
95	O
%	O
ci	O
=	O
0	O
.	O
09	O
to	O
2	O
.	O
55	O
]	O
)	O
.	O
in	O
conclusion	O
,	O
the	O
findings	B-T033
from	O
this	O
study	B-T062
indicate	O
the	O
importance	O
of	O
sports	O
participation	O
among	O
adolescents	O
in	O
the	O
reduction	O
of	O
stress	B-T037
fracture	I-T037
risk	O
,	O
especially	O
with	O
impact	O
sports	O
.	O
more	O
importantly	O
,	O
these	O
results	O
could	O
be	O
relevant	O
for	O
recogn	O
##ising	O
adolescents	O
in	O
danger	O
of	O
not	O
reaching	O
their	O
potential	O
for	O
peak	O
bone	B-T201
mass	I-T201
and	O
later	O
an	O
increased	O
risk	O
of	O
fractures	B-T037
.	O

remote	B-T082
ischemic	B-T058
conditioning	I-T058
and	O
renal	B-T017
protection	O
over	O
the	O
course	O
of	O
the	O
last	O
2	O
decades	O
,	O
the	O
concept	O
of	O
remote	B-T082
ischemic	B-T058
conditioning	I-T058
(	O
ri	B-T058
##c	I-T058
)	O
has	O
attracted	O
considerable	O
research	B-T062
interest	B-T038
,	O
because	O
ri	B-T058
##c	I-T058
,	O
in	O
most	O
of	O
its	O
emb	O
##odi	O
##ments	O
offers	O
an	O
inexpensive	O
way	O
of	O
protecting	O
tissues	B-T017
against	O
ischemic	O
damage	B-T037
infl	O
##icted	O
by	O
a	O
number	O
of	O
medical	O
conditions	O
or	O
procedures	B-T058
.	O
acute	B-T037
kidney	I-T037
injury	I-T037
(	O
aki	B-T037
)	O
is	O
a	O
common	O
side	O
effect	O
in	O
the	O
context	O
of	O
various	O
medical	B-T058
procedures	I-T058
,	O
and	O
ri	B-T058
##c	I-T058
has	O
been	O
suggested	O
as	O
a	O
means	O
of	O
reducing	O
its	O
incidence	O
.	O
outcomes	O
regarding	O
kidney	B-T038
function	I-T038
have	O
been	O
reported	O
in	O
numerous	O
studies	B-T062
that	O
evaluated	O
the	O
effects	O
of	O
ri	B-T058
##c	I-T058
in	O
a	O
variety	O
of	O
settings	O
(	O
eg	O
,	O
cardiac	B-T058
surgery	I-T058
,	O
interventions	B-T058
requiring	O
intravenous	B-T082
administration	I-T082
of	O
contrast	B-T103
media	I-T103
)	O
.	O
although	O
several	O
individual	O
studies	B-T062
have	O
implied	O
a	O
beneficial	O
effect	O
of	O
ri	B-T058
##c	I-T058
in	O
preserving	O
kidney	B-T038
function	I-T038
,	O
3	O
recently	O
published	O
randomized	B-T062
controlled	I-T062
trials	I-T062
evaluating	O
more	O
than	O
1000	O
patients	O
each	O
(	O
effect	O
of	O
remote	B-T058
ischemic	I-T058
preconditioning	I-T058
in	O
the	O
cardiac	B-T058
surgery	I-T058
,	O
remote	B-T058
ischaemic	I-T058
preconditioning	I-T058
for	O
heart	B-T058
surgery	I-T058
,	O
and	O
e	B-T058
ri	B-T058
##c	I-T058
ca	I-T058
)	O
were	O
negative	B-T033
.	O
however	O
,	O
aki	B-T037
or	O
any	O
other	O
index	O
of	O
renal	B-T038
function	I-T038
was	O
not	O
a	O
stand	O
-	O
alone	O
primary	O
end	O
point	O
in	O
any	O
of	O
these	O
trials	B-T062
.	O
on	O
the	O
other	O
hand	O
,	O
a	O
range	O
of	O
meta	B-T062
-	I-T062
analyses	I-T062
(	O
each	O
including	O
thousands	O
of	O
participants	B-T098
)	O
have	O
reported	O
mixed	O
results	O
,	O
with	O
the	O
most	O
recent	O
among	O
them	O
showing	O
benefit	O
from	O
ri	B-T058
##c	I-T058
,	O
pin	O
##point	O
##ing	O
at	O
the	O
same	O
time	O
a	O
number	O
of	O
shortcomings	O
in	O
published	B-T170
studies	B-T062
,	O
adversely	O
affecting	O
the	O
quality	O
of	O
available	B-T170
data	I-T170
.	O
the	O
present	O
review	B-T170
provides	O
a	O
critical	O
appraisal	O
of	O
the	O
current	O
state	O
of	O
this	O
field	O
of	O
research	B-T062
.	O
it	O
is	O
the	O
opinion	O
of	O
the	O
authors	B-T097
of	O
this	O
review	B-T170
that	O
there	O
is	O
a	O
clear	O
need	O
for	O
a	O
common	O
clinical	B-T062
trial	I-T062
framework	O
for	O
ischemic	B-T058
conditioning	I-T058
studies	B-T062
.	O
if	O
the	O
current	O
bab	O
##el	O
of	O
definitions	B-T170
,	O
procedures	O
,	O
outcomes	O
,	O
and	O
goals	B-T170
persists	I-T170
,	O
it	O
is	O
most	O
likely	O
that	O
soon	O
ischemic	B-T058
conditioning	I-T058
will	O
be	O
[UNK]	O
yes	O
##ter	O
##day	O
'	O
s	O
news	O
[UNK]	O
with	O
no	O
definitive	O
conclusions	O
having	O
been	O
reached	O
in	O
terms	O
of	O
its	O
real	O
clinical	B-T058
utility	I-T058
.	O

a	O
comparison	O
of	O
outcomes	O
in	O
morbidly	B-T038
obese	I-T038
,	O
obese	B-T038
and	O
non	O
-	O
obese	O
patients	O
undergoing	O
primary	B-T058
total	I-T058
knee	I-T058
and	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
obesity	B-T038
is	O
a	O
growing	O
public	B-T092
health	O
issue	O
with	O
the	O
prevalence	O
of	O
morbid	B-T033
obesity	I-T033
,	I-T033
(	I-T033
body	I-T033
mass	I-T033
index	I-T033
(	I-T033
bmi	I-T033
)	I-T033
≥	I-T033
40	I-T033
kg	I-T033
/	I-T033
m	I-T033
(	I-T033
2	I-T033
)	I-T033
)	I-T033
increasing	O
.	O
there	O
is	O
some	O
evidence	O
these	O
patients	O
have	O
more	O
peri	B-T038
-	I-T038
and	I-T038
post	I-T038
-	I-T038
operative	I-T038
complications	I-T038
and	O
poorer	O
outcomes	O
when	O
undergoing	O
arthroplasty	B-T058
procedures	I-T058
.	O
this	O
audit	O
aimed	O
to	O
determine	O
and	O
compare	O
the	O
outcomes	O
of	O
non	O
-	O
obese	O
,	O
obese	B-T038
and	O
morbidly	B-T038
obese	I-T038
patients	O
undergoing	O
arthroplasty	B-T058
at	O
our	O
institution	B-T092
.	O
this	O
was	O
a	O
retrospective	B-T058
audit	I-T058
of	O
patients	O
from	O
our	O
institution	B-T092
who	O
had	O
undergone	O
total	B-T058
knee	I-T058
(	O
tka	B-T058
)	O
or	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
(	O
tha	B-T058
)	O
in	O
2009	O
.	O
data	O
collected	O
were	O
:	O
age	O
,	O
gender	O
,	O
bmi	B-T201
,	O
length	O
of	O
stay	O
(	O
los	O
)	O
,	O
oxford	B-T201
knee	I-T201
or	O
hip	B-T201
score	I-T201
(	O
ok	B-T201
##s	I-T201
/	O
oh	B-T201
##s	I-T201
)	O
,	O
satisfaction	O
and	O
complications	B-T038
up	O
to	O
two	O
years	O
post	B-T058
operation	I-T058
.	O
patients	O
were	O
divided	O
into	O
three	O
groups	O
:	O
bmi	O
<	O
30	O
,	O
bmi	B-T201
30	I-T201
-	I-T201
40	I-T201
and	O
bmi	B-T033
>	I-T033
40	I-T033
.	O
outcomes	O
for	O
each	O
bmi	B-T201
group	O
were	O
compared	O
.	O
101	O
##4	O
tka	B-T058
and	O
90	O
##6	O
tha	B-T058
operations	B-T058
were	O
included	O
.	O
when	O
compared	O
to	O
obese	B-T038
and	O
non	O
-	O
obese	O
patients	O
,	O
morbidly	B-T038
obese	I-T038
patients	O
undergoing	O
tka	B-T058
had	O
a	O
mean	O
los	O
one	O
day	O
longer	O
,	O
a	O
mean	B-T201
ok	I-T201
##s	I-T201
four	O
points	O
lower	O
and	O
higher	O
rates	O
of	O
postoperative	B-T038
problems	I-T038
,	O
37	O
%	O
vs	O
.	O
21	O
%	O
.	O
for	O
tha	B-T058
patients	O
there	O
was	O
no	O
difference	O
in	O
los	O
,	O
oh	B-T201
##s	I-T201
score	I-T201
was	O
two	O
points	O
lower	O
for	O
each	O
increasing	O
bmi	B-T201
category	B-T170
and	O
postoperative	B-T038
problems	I-T038
increase	O
from	O
25	O
%	O
for	O
non	O
-	O
obese	O
to	O
31	O
%	O
for	O
obese	B-T038
and	O
38	O
%	O
for	O
morbidly	B-T038
obese	I-T038
patients	O
.	O
these	O
results	O
will	O
be	O
useful	O
in	O
informing	O
obese	B-T038
patients	O
of	O
their	O
potential	O
outcomes	O
following	O
tka	B-T058
or	O
tha	B-T058
.	O
these	O
patients	O
can	O
then	O
make	O
a	O
more	O
informed	O
choice	O
before	O
proceeding	O
with	O
arthroplasty	B-T058
.	O

reduction	O
in	O
hospital	B-T092
-	I-T092
wide	I-T092
clinical	B-T058
laboratory	I-T058
specimen	I-T058
identification	I-T058
errors	O
following	O
process	O
interventions	O
:	O
a	O
10	O
-	O
year	O
retrospective	B-T062
observational	I-T062
study	I-T062
accurate	O
patient	B-T058
identification	I-T058
and	O
specimen	O
labeling	O
at	O
the	O
time	O
of	O
collection	O
are	O
crucial	O
steps	O
in	O
the	O
prevention	B-T062
of	O
medical	O
errors	O
,	O
thereby	O
improving	O
patient	B-T058
safety	I-T058
.	O
all	O
patient	B-T031
specimen	I-T031
identification	O
errors	O
that	O
occurred	O
in	O
the	O
outpatient	B-T082
department	I-T082
(	O
op	B-T082
##d	I-T082
)	O
,	O
emergency	B-T092
department	I-T092
(	O
ed	B-T092
)	O
,	O
and	O
inpatient	B-T082
department	I-T082
(	O
ipd	B-T082
)	O
of	O
a	O
3	O
,	O
800	O
-	O
bed	O
academic	B-T092
medical	I-T092
center	I-T092
in	O
taiwan	B-T082
were	O
documented	B-T058
and	O
analyzed	O
retrospectively	O
from	O
2005	O
to	O
2014	O
.	O
to	O
reduce	O
such	O
errors	O
,	O
the	O
following	O
series	O
of	O
strategies	O
were	O
implemented	O
:	O
a	O
restrictive	O
specimen	O
acceptance	O
policy	O
for	O
the	O
ed	B-T092
and	O
ipd	B-T082
in	O
2006	O
;	O
a	O
computer	O
-	O
assisted	O
barc	B-T170
##ode	I-T170
positive	B-T170
patient	I-T170
identification	I-T170
system	I-T170
for	O
the	O
ed	B-T092
and	O
ipd	B-T082
in	O
2007	O
and	O
2010	O
,	O
and	O
automated	O
sample	O
labeling	O
combined	O
with	O
electronic	O
identification	O
systems	O
introduced	O
to	O
the	O
op	B-T082
##d	I-T082
in	O
2009	O
.	O
of	O
the	O
2000	O
##34	O
##5	O
specimens	B-T031
collected	O
in	O
2005	O
,	O
102	O
##3	O
(	O
0	O
.	O
05	O
##11	O
%	O
)	O
were	O
identified	B-T033
as	O
having	O
patient	B-T058
identification	I-T058
errors	O
,	O
compared	O
with	O
58	O
errors	O
(	O
0	O
.	O
001	O
##5	O
%	O
)	O
among	O
37	O
##61	O
##23	O
##8	O
specimens	B-T031
collected	O
in	O
2014	O
,	O
after	O
serial	O
interventions	B-T058
;	O
this	O
represents	O
a	O
97	O
%	O
relative	O
reduction	O
.	O
the	O
total	O
number	O
(	O
rate	O
)	O
of	O
institutional	O
identification	O
errors	O
contributed	O
from	O
the	O
ed	B-T092
,	O
ipd	B-T082
,	O
and	O
op	B-T082
##d	I-T082
over	O
a	O
10	O
-	O
year	O
period	O
were	O
42	O
##3	O
(	O
0	O
.	O
105	O
##8	O
%	O
)	O
,	O
55	O
##6	O
(	O
0	O
.	O
05	O
##87	O
%	O
)	O
,	O
and	O
44	O
(	O
0	O
.	O
006	O
##7	O
%	O
)	O
errors	O
before	O
the	O
interventions	B-T058
,	O
and	O
3	O
(	O
0	O
.	O
000	O
##7	O
%	O
)	O
,	O
52	O
(	O
0	O
.	O
004	O
##5	O
%	O
)	O
and	O
3	O
(	O
0	O
.	O
0001	O
%	O
)	O
after	O
interventions	B-T058
,	O
representing	O
relative	O
99	O
%	O
,	O
92	O
%	O
and	O
98	O
%	O
reductions	O
,	O
respectively	O
.	O
accurate	O
patient	B-T058
identification	I-T058
is	O
a	O
challenge	O
of	O
patient	B-T058
safety	I-T058
in	O
different	O
health	O
settings	O
.	O
the	O
data	B-T033
collected	I-T033
in	O
our	O
study	B-T062
indicate	O
that	O
a	O
restrictive	O
specimen	O
acceptance	O
policy	O
,	O
computer	B-T058
-	I-T058
generated	I-T058
positive	B-T170
identification	I-T170
systems	I-T170
,	O
and	O
interdisciplinary	O
cooperation	O
can	O
significantly	O
reduce	O
patient	B-T058
identification	I-T058
errors	O
.	O

urticaria	B-T038
##l	I-T038
ex	B-T033
##anth	I-T033
##ema	I-T033
due	O
to	O
hepatitis	B-T038
b	I-T038
in	O
a	O
pregnant	B-T098
woman	I-T098
,	O
mimicking	O
a	O
polymorphic	B-T038
eruption	I-T038
of	O
pregnancy	B-T038
hepatitis	B-T038
b	I-T038
virus	I-T038
(	I-T038
hbv	I-T038
)	I-T038
infection	I-T038
in	I-T038
pregnant	I-T038
women	I-T038
is	O
very	O
rare	O
in	O
western	B-T082
countries	I-T082
,	O
thus	O
,	O
cutaneous	B-T082
manifestation	O
of	O
hbv	B-T038
infection	I-T038
may	O
be	O
confused	O
with	O
a	O
dermat	B-T038
##osis	I-T038
specific	O
of	O
pregnancy	B-T038
.	O
we	O
report	O
a	O
39	O
-	O
year	O
-	O
old	O
woman	B-T098
who	O
presented	O
in	O
her	O
20th	O
week	O
of	O
pregnancy	B-T038
with	O
a	O
prur	B-T038
##itic	I-T038
rash	I-T038
,	O
which	O
consisted	O
of	O
generalized	O
erythemat	B-T033
##ous	I-T033
plaques	I-T033
,	O
some	O
of	O
them	O
with	O
a	O
purple	B-T033
centre	I-T033
.	O
serology	B-T058
testing	I-T058
showed	O
acute	B-T038
hbv	I-T038
infection	I-T038
,	O
and	O
a	O
biopsy	B-T058
revealed	O
a	O
superficial	B-T082
and	O
interstitial	B-T033
perivascular	I-T033
inflammatory	I-T033
infiltrate	I-T033
of	O
lymphocytes	B-T017
and	O
eosinophils	B-T017
.	O
a	O
diagnosis	B-T033
of	O
ex	B-T033
##anth	I-T033
##ema	I-T033
due	O
to	O
acute	B-T038
hepatitis	I-T038
b	I-T038
infection	I-T038
was	O
established	O
.	O
the	O
patient	O
delivered	B-T033
a	O
clinically	B-T033
healthy	I-T033
boy	I-T033
,	O
who	O
was	O
given	O
the	O
first	O
dose	O
of	O
the	O
hbv	B-T058
vaccine	I-T058
and	O
intravenous	B-T103
specific	I-T103
immunoglobulin	I-T103
,	O
followed	O
by	O
the	O
second	O
dose	O
2	O
months	O
later	O
,	O
and	O
did	O
not	O
get	O
infected	B-T033
with	O
hbv	B-T005
.	O
to	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
case	O
describing	O
hbv	B-T038
ex	B-T033
##anth	I-T033
##ema	I-T033
in	O
a	O
pregnant	B-T098
woman	I-T098
,	O
which	O
led	O
to	O
early	O
action	O
for	O
the	O
newborn	O
,	O
avoiding	O
vertical	B-T038
transmission	I-T038
and	O
its	O
high	O
prevalence	O
of	O
cirrhosis	B-T038
and	O
hepatocellular	B-T038
carcinoma	I-T038
.	O

incident	O
fracture	B-T037
associated	O
with	O
increased	O
risk	O
of	O
mortality	O
even	O
after	O
adjusting	O
for	O
frailty	B-T033
status	O
in	O
elderly	B-T098
japanese	B-T098
men	B-T098
:	O
the	O
fu	O
##ji	O
##wa	O
##ra	O
-	O
ky	O
##o	O
osteoporosis	O
risk	O
in	O
men	O
(	O
form	O
##en	O
)	O
cohort	O
study	O
frail	B-T033
elderly	B-T098
individuals	B-T098
have	O
elevated	O
risks	O
of	O
both	O
fracture	B-T037
and	O
mortality	O
.	O
we	O
found	O
that	O
incident	O
fractures	B-T037
were	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
death	B-T033
even	O
after	O
adjusting	O
for	O
pre	B-T037
-	I-T037
fracture	I-T037
frailty	B-T033
status	O
as	O
represented	O
by	O
physical	B-T058
performance	I-T058
tests	I-T058
and	O
laboratory	B-T058
tests	I-T058
for	O
common	O
geriatric	O
diseases	B-T038
in	O
community	O
-	O
dwelling	O
elderly	B-T098
japanese	B-T098
men	B-T098
.	O
while	O
fractures	B-T037
reportedly	O
increase	O
the	O
risk	O
of	O
mortality	O
,	O
frailty	B-T033
may	O
complicate	O
this	O
association	O
,	O
generating	O
a	O
false	B-T033
-	I-T033
positive	I-T033
result	I-T033
.	O
we	O
evaluated	B-T058
this	O
association	O
after	O
adjusting	O
for	O
pre	B-T037
-	I-T037
fracture	I-T037
levels	O
of	O
frailty	B-T033
.	O
we	O
examined	B-T033
1998	O
community	O
-	O
dwelling	O
ambulatory	O
men	B-T098
aged	O
≥	O
##65	O
years	O
at	O
baseline	O
in	O
the	O
fu	O
##ji	O
##wa	O
##ra	O
-	O
ky	O
##o	O
osteoporosis	O
risk	O
in	O
men	O
study	O
for	O
frailty	B-T033
status	O
as	O
represented	O
by	O
activities	O
of	O
daily	O
living	O
(	O
adl	O
)	O
,	O
physical	B-T058
performance	I-T058
tests	I-T058
(	O
grip	O
strength	O
,	O
one	O
-	O
foot	O
standing	O
balance	O
with	O
eyes	O
open	O
,	O
timed	B-T058
10	I-T058
-	I-T058
m	I-T058
walk	I-T058
)	O
,	O
and	O
laboratory	B-T058
sera	B-T031
tests	I-T058
.	O
participants	B-T098
were	O
then	O
followed	O
for	O
5	O
years	O
for	O
incident	O
clinical	O
fractures	B-T037
and	O
death	B-T033
.	O
effects	O
of	O
incident	O
fracture	B-T037
on	O
death	B-T033
were	O
determined	O
by	O
cox	B-T170
proportional	I-T170
hazards	I-T170
model	I-T170
with	O
the	O
first	O
fracture	B-T037
during	O
follow	B-T058
-	I-T058
up	I-T058
as	O
a	O
time	O
-	O
dependent	O
predictor	O
and	O
with	O
frailty	B-T170
status	I-T170
indices	I-T170
as	O
covariates	O
.	O
we	O
identified	O
111	O
fractures	B-T037
in	O
99	O
men	B-T098
and	O
138	O
deaths	B-T033
during	O
the	O
follow	B-T058
-	I-T058
up	I-T058
period	O
(	O
median	B-T082
follow	B-T058
-	I-T058
up	I-T058
,	O
4	O
.	O
5	O
years	O
)	O
.	O
participants	B-T098
with	O
incident	O
fractures	B-T037
did	O
not	B-T033
have	I-T033
significantly	I-T033
worse	I-T033
frailty	B-T033
status	O
##es	O
,	O
but	O
did	O
show	O
a	O
significantly	O
higher	O
cumulative	O
mortality	O
rate	O
than	O
those	O
without	O
fractures	B-T037
(	O
p	O
=	O
0	O
.	O
004	O
##7	O
)	O
.	O
age	O
-	O
adjusted	O
hazard	O
ratio	O
(	O
hr	O
)	O
of	O
death	B-T033
for	O
incident	O
fracture	B-T037
was	O
3	O
.	O
57	O
(	O
95	O
%	O
confidence	O
interval	O
:	O
2	O
.	O
05	O
,	O
6	O
.	O
24	O
)	O
.	O
when	O
adjusted	O
for	O
physical	O
performance	O
,	O
this	O
decreased	O
to	O
2	O
.	O
77	O
(	O
1	O
.	O
51	O
,	O
5	O
.	O
06	O
)	O
,	O
but	O
remained	O
significant	O
.	O
the	O
hr	O
showed	O
no	B-T033
significant	I-T033
change	I-T033
when	O
adjusted	O
for	O
laboratory	O
test	O
results	O
(	O
3	O
.	O
96	O
(	O
2	O
.	O
26	O
,	O
6	O
.	O
94	O
)	O
)	O
.	O
exclusion	O
of	O
deaths	B-T033
within	O
the	O
first	O
24	O
months	O
of	O
follow	B-T058
-	I-T058
up	I-T058
did	O
not	B-T033
alter	I-T033
these	O
results	B-T033
.	O
incident	O
clinical	O
fracture	B-T037
was	O
associated	O
with	O
an	O
elevated	O
risk	O
of	O
death	B-T033
independently	B-T033
of	O
pre	B-T037
-	I-T037
fracture	I-T037
levels	O
of	O
frailty	B-T033
in	O
community	O
-	O
dwelling	O
elderly	B-T098
men	B-T098
.	O

the	O
role	O
of	O
the	O
iron	B-T058
stain	I-T058
in	O
assessing	O
intracranial	B-T038
hemorrhage	I-T038
the	O
timing	O
of	O
the	O
breakdown	O
of	O
red	B-T017
blood	I-T017
cells	I-T017
and	O
organization	O
of	O
hemorrhage	B-T038
has	O
significance	O
in	O
the	O
catabolism	B-T038
of	O
heme	B-T103
and	O
the	O
processing	O
of	O
iron	B-T103
,	O
but	O
also	O
has	O
a	O
practical	O
application	O
in	O
terms	O
of	O
assign	O
##ing	O
,	O
or	O
attempting	O
to	O
assign	O
,	O
a	O
time	O
course	O
with	O
respect	O
to	O
traumatic	B-T037
events	O
(	O
e	O
.	O
g	O
.	O
contusion	B-T037
##s	I-T037
and	O
hemorrhages	B-T038
)	O
.	O
attempts	O
to	O
date	B-T037
contusion	I-T037
##s	I-T037
,	O
however	O
,	O
have	O
generally	O
been	O
unsuccessful	O
by	O
macroscopic	O
observation	O
,	O
whereas	O
the	O
microscopic	B-T058
observations	I-T058
provide	O
broad	O
data	O
but	O
are	O
also	O
anatomically	O
imprec	O
##ise	O
as	O
a	O
function	O
of	O
time	O
.	O
intracranial	B-T033
lesions	I-T033
are	O
of	O
particular	O
significance	O
with	O
respect	O
to	O
the	O
timing	O
of	O
organizing	O
hemorrhage	B-T038
given	O
the	O
acute	O
,	O
and	O
often	O
life	B-T033
-	I-T033
threatening	I-T033
nature	O
of	O
the	O
hemorrhages	B-T038
,	O
and	O
the	O
medic	B-T058
##ole	I-T058
##gal	I-T058
investigation	I-T058
into	O
potential	O
crime	O
##s	O
.	O
of	O
concern	O
is	O
that	O
the	O
pr	B-T058
##ussian	I-T058
blue	I-T058
reaction	I-T058
for	O
iron	B-T103
,	O
a	O
relatively	O
straightforward	O
histochemical	B-T058
reaction	O
that	O
has	O
been	O
in	O
use	O
for	O
over	O
150	O
years	O
,	O
is	O
sometimes	O
suggested	O
as	O
a	O
diagnostic	B-T058
test	I-T058
for	O
chronic	O
##ity	O
.	O
therefore	O
,	O
this	O
study	B-T062
examined	B-T033
the	O
utility	O
of	O
the	O
pr	B-T103
##ussian	I-T103
blue	I-T103
iron	I-T103
stain	I-T103
in	O
living	O
patients	O
with	O
intracranial	B-T038
hemorrhages	I-T038
and	O
well	O
-	O
defined	O
symptom	O
onset	O
,	O
to	O
test	O
whether	O
the	O
presence	B-T033
of	O
pr	B-T103
##ussian	I-T103
blue	I-T103
reactivity	O
could	O
be	O
correlated	O
with	O
chronic	O
##ity	O
.	O
it	O
was	O
found	B-T033
that	O
out	O
of	O
12	O
cases	O
with	O
intracranial	B-T038
hemorrhage	I-T038
,	O
eight	O
cases	O
showed	O
at	O
least	O
focal	B-T103
iron	I-T103
reactivity	O
.	O
the	O
duration	O
from	O
symptom	O
onset	O
to	O
surgery	B-T058
in	O
those	O
eight	O
cases	O
ranged	O
from	O
<	O
24	O
hours	O
to	O
more	O
than	O
3	O
days	O
.	O
of	O
those	O
cases	O
with	O
no	B-T033
iron	I-T033
reactivity	I-T033
,	O
the	O
duration	O
from	O
symptom	O
onset	O
to	O
surgery	B-T058
ranged	O
from	O
<	O
24	O
hours	O
to	O
six	O
days	O
.	O
in	O
conclusion	O
,	O
the	O
pr	B-T058
##ussian	I-T058
blue	I-T058
reaction	I-T058
was	O
unreliable	O
as	O
an	O
indicator	B-T103
of	O
timing	O
in	O
intracranial	B-T038
hemorrhage	I-T038
.	O
the	O
use	O
of	O
the	O
pr	B-T058
##ussian	I-T058
blue	I-T058
reaction	I-T058
as	O
an	O
independent	B-T103
indicator	I-T103
of	O
chronic	O
##ity	O
is	O
therefore	O
not	O
valid	O
and	O
can	O
be	O
misleading	O
.	O
caution	O
is	O
indicated	B-T033
when	O
employing	O
iron	B-T058
staining	I-T058
for	O
timing	O
purposes	O
,	O
as	O
its	O
only	O
use	O
is	O
to	O
highlight	O
,	O
as	O
opposed	O
to	O
identify	O
,	O
pre	O
-	O
existing	O
lesions	B-T033
.	O
with	O
respect	O
to	O
brain	B-T038
lesions	I-T038
,	O
the	O
pr	B-T058
##ussian	I-T058
blue	I-T058
reaction	I-T058
should	O
not	O
be	O
used	O
in	O
place	O
of	O
the	O
clinical	O
timing	O
of	O
the	O
neurologic	B-T033
decline	I-T033
,	O
or	O
clinical	B-T170
data	I-T170
that	O
is	O
otherwise	O
more	O
accurate	O
and	O
less	O
susceptible	O
to	O
false	B-T033
positive	I-T033
results	I-T033
.	O

vaccination	B-T058
of	O
piglets	B-T204
at	O
2	O
and	O
3	O
weeks	O
of	O
age	O
with	O
ing	B-T103
##el	I-T103
##vac	I-T103
prrs	I-T103
##flex	I-T103
##®	I-T103
eu	I-T103
provides	O
protection	O
against	O
heterologous	O
field	O
challenge	O
in	O
the	O
face	O
of	O
homologous	O
maternally	B-T103
derived	I-T103
antibodies	I-T103
due	O
to	O
difficulties	O
in	O
eradic	B-T058
##ating	I-T058
porcine	B-T038
reproductive	I-T038
and	I-T038
respiratory	I-T038
syndrome	I-T038
(	O
prrs	B-T038
)	O
linked	O
to	O
bios	O
##ecu	O
##ri	O
##ty	O
challenges	O
,	O
transmission	B-T038
of	I-T038
the	I-T038
virus	I-T038
and	O
the	O
lack	O
of	O
efficient	O
div	B-T103
##a	I-T103
vaccines	I-T103
,	O
successful	O
control	O
of	O
prrs	B-T038
requires	O
a	O
combination	O
of	O
strict	O
management	B-T058
measures	I-T058
and	O
vaccination	B-T058
of	O
both	O
sows	O
and	O
piglets	B-T204
.	O
the	O
present	O
study	B-T062
aimed	O
to	O
assess	O
the	O
efficacy	O
of	O
a	O
recently	O
developed	O
ml	B-T103
##v	I-T103
vaccine	I-T103
(	O
ing	B-T103
##el	I-T103
##vac	I-T103
prrs	I-T103
##flex	I-T103
##®	I-T103
eu	I-T103
)	O
in	O
piglets	B-T204
at	O
2	O
and	O
3	O
-	O
weeks	O
of	O
age	O
in	O
the	O
presence	B-T033
of	O
homologous	O
maternally	B-T103
derived	I-T103
antibodies	I-T103
as	O
the	O
dams	O
were	O
vaccinated	B-T058
with	O
the	O
same	O
vaccine	B-T103
strain	I-T103
(	O
repro	B-T103
##cy	I-T103
##c	I-T103
##®	I-T103
prrs	I-T103
eu	I-T103
)	O
.	O
the	O
study	B-T062
was	O
carried	O
out	O
on	O
a	O
hung	B-T204
##arian	I-T204
far	I-T204
##row	I-T204
to	O
fin	O
##ish	O
farm	B-T082
naturally	B-T033
infected	I-T033
with	O
prrsv	B-T005
.	O
the	O
study	B-T062
was	O
designed	O
as	O
a	O
blind	B-T062
,	O
placebo	B-T062
controlled	I-T062
side	O
by	O
side	O
trial	O
.	O
orf	B-T103
##5	I-T103
sequence	O
similarity	O
of	O
the	O
vaccine	B-T103
strain	I-T103
and	O
the	O
resident	B-T098
field	I-T098
strain	I-T098
was	O
87	O
.	O
8	O
%	O
.	O
prrs	B-T038
specific	O
real	B-T062
-	I-T062
time	I-T062
quantitative	I-T062
pcr	I-T062
was	O
performed	O
from	O
serum	B-T031
samples	I-T031
to	O
measure	O
both	O
the	O
viral	B-T058
load	I-T058
and	O
the	O
frequency	O
of	O
virus	B-T033
positive	I-T033
animals	B-T204
.	O
at	O
the	O
time	O
of	O
the	O
natural	B-T038
infection	I-T038
observed	O
in	O
the	O
control	O
group	O
at	O
10	O
-	O
12	O
weeks	O
of	O
age	O
,	O
the	O
number	O
of	O
vir	B-T033
##aemic	I-T033
animals	B-T204
did	O
not	O
increase	O
significantly	O
in	O
the	O
vaccinated	B-T058
group	O
.	O
to	O
understand	O
the	O
infection	B-T038
dynamics	O
,	O
positive	B-T033
pcr	B-T062
samples	O
with	O
low	O
ct	O
values	O
were	O
sequenced	O
(	O
orf	B-T103
##5	I-T103
)	O
and	O
the	O
data	O
analysis	O
indicated	B-T033
the	O
circulation	B-T033
of	O
wild	O
type	O
virus	O
in	O
both	O
groups	O
,	O
however	O
wild	O
type	O
virus	B-T005
was	O
only	O
found	O
in	O
non	O
-	O
vaccinated	O
animals	O
.	O
our	O
data	O
indicate	O
that	O
piglets	B-T204
vaccinated	B-T058
at	O
as	O
early	O
as	O
2	O
weeks	O
of	O
age	O
with	O
ing	B-T103
##el	I-T103
##vac	I-T103
prrs	I-T103
##flex	I-T103
##®	I-T103
eu	I-T103
were	O
protected	O
both	O
in	O
terms	O
of	O
proportion	O
of	O
vir	B-T033
##aemic	I-T033
animals	B-T204
and	O
vir	B-T038
##aemia	I-T038
levels	O
.	O
it	O
has	O
to	O
be	O
highlighted	O
that	O
these	O
results	O
were	O
achieved	O
in	O
piglets	B-T204
with	O
high	O
levels	O
of	O
homologous	O
maternally	B-T103
derived	I-T103
antibodies	I-T103
(	O
mda	B-T103
)	O
at	O
the	O
time	O
of	O
vaccination	B-T058
.	O

investigating	O
effects	O
of	O
acidic	O
ph	O
on	O
proliferation	B-T038
,	O
invasion	B-T038
and	O
drug	B-T103
-	O
induced	O
apoptosis	B-T038
in	O
lymphoblastic	B-T038
leukemia	I-T038
some	O
studies	O
have	O
shown	O
that	O
extracellular	B-T082
ph	O
in	O
tumors	B-T038
,	O
which	O
results	O
in	O
tumor	B-T038
progression	I-T038
,	O
is	O
less	O
than	O
that	O
in	O
normal	O
tissues	B-T017
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
the	O
effects	O
of	O
extracellular	B-T082
acidic	O
ph	O
on	O
proliferation	B-T038
,	O
invasion	B-T038
,	O
and	O
drug	B-T103
-	O
induced	O
apoptosis	B-T038
in	O
acute	B-T017
lymphoblastic	I-T017
cells	I-T017
.	O
the	O
cells	B-T017
were	O
cultured	O
in	O
different	O
ph	O
(	O
ph	O
6	O
.	O
6	O
and	O
ph	O
7	O
.	O
4	O
)	O
for	O
12	O
days	O
.	O
cell	B-T038
proliferation	I-T038
was	O
assessed	O
by	O
mtt	B-T062
assay	I-T062
and	O
cell	B-T038
invasion	I-T038
was	O
assayed	O
by	O
invasion	B-T058
assay	I-T058
and	O
gene	B-T062
expression	I-T062
analysis	I-T062
of	O
mmp	B-T103
-	I-T103
9	I-T103
.	O
drug	B-T103
-	O
induced	O
apoptosis	B-T038
was	O
evaluated	O
after	O
exposure	O
to	O
doxorubicin	B-T103
for	O
24	O
hours	O
by	O
annexin	B-T103
v	I-T103
/	O
pi	B-T103
staining	B-T058
and	O
gene	B-T062
expression	I-T062
analysis	I-T062
of	O
bax	B-T103
pro	I-T103
-	I-T103
apoptotic	I-T103
protein	I-T103
.	O
the	O
results	O
indicated	O
the	O
enhanced	O
growth	B-T038
and	O
invasion	B-T038
of	O
leukemic	B-T038
cells	B-T017
at	O
ph	O
6	O
.	O
6	O
(	O
p	O
≤	O
0	O
.	O
05	O
)	O
.	O
furthermore	O
,	O
the	O
cells	B-T017
at	O
ph	O
6	O
.	O
6	O
were	O
resistant	O
to	O
apoptosis	B-T038
by	O
doxorubicin	B-T103
(	O
p	O
≤	O
0	O
.	O
05	O
)	O
.	O
it	O
can	O
be	O
concluded	O
that	O
acidic	O
ph	O
increases	O
the	O
proliferation	B-T038
,	O
invasion	B-T038
and	O
reduces	O
the	O
drug	B-T103
-	O
induced	O
apoptosis	B-T038
in	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
.	O
extracellular	B-T082
acidity	O
can	O
influence	O
the	O
behavior	O
of	O
leukemic	B-T038
cells	B-T017
and	O
therefore	O
,	O
the	O
manipulation	O
of	O
extracellular	B-T031
liquid	I-T031
can	O
be	O
selected	O
as	O
a	O
therapeutic	B-T058
strategy	I-T058
for	O
leukemia	B-T038
,	O
especially	O
for	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
.	O

catastrophic	B-T038
health	O
expenditure	O
:	O
a	O
comparative	O
analysis	O
of	O
empty	O
-	O
nest	O
and	O
non	O
-	O
empty	O
-	O
nest	O
households	O
with	O
senior	B-T098
##s	I-T098
in	O
sh	B-T082
##and	I-T082
##ong	I-T082
,	I-T082
china	I-T082
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
compare	O
the	O
catastrophic	B-T038
health	O
expenditure	O
(	O
che	O
)	O
prevalence	O
and	O
its	O
determinants	O
between	O
empty	O
-	O
nest	O
and	O
non	O
-	O
empty	O
-	O
nest	O
elderly	B-T098
households	O
.	O
sh	B-T082
##and	I-T082
##ong	I-T082
province	I-T082
of	I-T082
china	I-T082
.	O
a	O
total	O
of	O
276	O
##1	O
elderly	B-T098
households	O
are	O
included	O
in	O
the	O
analysis	B-T062
.	O
che	O
incidence	O
among	O
elderly	B-T098
households	O
was	O
44	O
.	O
9	O
%	O
.	O
the	O
che	O
incidence	O
of	O
empty	O
-	O
nest	O
single	B-T033
##s	I-T033
(	O
59	O
.	O
3	O
%	O
,	O
p	O
=	O
0	O
.	O
000	O
,	O
or	O
=	O
3	O
.	O
19	O
)	O
and	O
empty	O
-	O
nest	O
couples	O
(	O
52	O
.	O
9	O
%	O
,	O
p	O
=	O
0	O
.	O
000	O
,	O
or	O
=	O
2	O
.	O
45	O
)	O
are	O
both	O
statistically	O
higher	O
than	O
that	O
of	O
non	O
-	O
empty	O
-	O
nest	O
elderly	B-T098
households	O
(	O
31	O
.	O
4	O
%	O
)	O
.	O
an	O
inverse	O
association	O
was	O
observed	O
between	O
che	O
incidence	O
and	O
income	O
level	O
in	O
all	O
elderly	B-T098
household	O
types	O
.	O
factors	O
including	O
1	O
or	O
more	O
household	O
elderly	B-T098
members	I-T098
with	O
non	B-T038
-	I-T038
communicable	I-T038
chronic	I-T038
diseases	I-T038
in	O
the	O
past	O
6	O
months	O
,	O
1	O
or	O
more	O
elderly	B-T098
household	O
members	O
being	O
hospitalised	B-T033
in	O
the	O
past	O
year	O
and	O
lower	O
household	O
income	O
,	O
are	O
significant	O
risk	B-T033
factors	I-T033
for	O
che	O
in	O
all	O
3	O
household	O
types	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
health	B-T058
insurance	I-T058
status	O
was	O
found	O
to	O
be	O
a	O
significant	O
determinant	O
of	O
che	O
among	O
empty	O
-	O
nest	O
single	B-T033
##s	I-T033
and	O
non	O
-	O
empty	O
-	O
nest	O
households	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
che	O
incidence	O
among	O
elderly	B-T098
households	O
is	O
high	O
in	O
china	B-T082
.	O
empty	O
-	O
nest	O
households	O
are	O
at	O
higher	O
risk	O
for	O
che	O
than	O
non	O
-	O
empty	O
-	O
nest	O
households	O
.	O
based	O
on	O
these	O
findings	B-T033
,	O
we	O
suggest	O
that	O
special	O
insurance	B-T058
be	O
developed	O
to	O
broad	B-T082
##en	I-T082
the	O
coverage	O
of	O
health	B-T058
services	I-T058
and	O
height	O
##en	O
the	O
reimbursement	B-T058
rate	I-T058
for	O
empty	O
-	O
nest	O
elderly	B-T098
in	O
the	O
existing	O
health	B-T058
insurance	I-T058
schemes	B-T170
.	O
financial	O
and	O
social	O
protection	O
interventions	O
are	O
also	O
essential	O
for	O
identif	O
##ie	O
d	O
at	O
-	O
risk	O
subgroups	B-T170
among	O
different	O
types	O
of	O
elderly	B-T098
households	O
.	O

synthesis	O
of	O
1	B-T103
,	I-T103
2	I-T103
-	I-T103
diox	I-T103
##etan	I-T103
##es	I-T103
as	O
thermo	B-T103
##chem	I-T103
##ilum	I-T103
##inescent	I-T103
labels	I-T103
for	O
ultras	B-T058
##ensitive	I-T058
bioassays	I-T058
:	O
rational	O
prediction	O
of	O
ole	B-T103
##fin	I-T103
photo	O
##oxygenation	O
outcome	O
by	O
using	O
a	O
chemo	B-T058
##met	I-T058
##ric	I-T058
approach	I-T058
great	O
interest	O
in	O
new	O
thermo	O
##chem	O
##ilum	O
##inescent	O
(	O
tc	O
##l	O
)	O
molecules	O
,	O
for	O
example	O
,	O
in	O
bio	B-T058
##analy	I-T058
##tical	I-T058
assays	I-T058
,	O
has	O
prompted	O
the	O
design	O
and	O
synthesis	O
of	O
a	O
small	O
library	B-T092
of	O
more	O
than	O
30	O
ole	B-T103
##fin	I-T103
##s	I-T103
to	O
be	O
subjected	O
to	O
photo	O
##oxygenation	O
,	O
with	O
the	O
aim	O
of	O
obtaining	O
new	O
1	B-T103
,	I-T103
2	I-T103
-	I-T103
diox	I-T103
##etan	I-T103
##e	I-T103
-	I-T103
based	I-T103
tc	B-T103
##l	I-T103
labels	I-T103
with	O
optimized	O
properties	O
.	O
fluorine	B-T103
atoms	O
on	O
the	O
acr	B-T103
##ida	I-T103
##n	I-T103
system	O
remarkably	O
stabilize	O
1	B-T103
,	I-T103
2	I-T103
-	I-T103
diox	I-T103
##etan	I-T103
##es	I-T103
when	O
they	O
are	O
located	O
in	O
the	O
3	O
-	O
and	O
/	O
or	O
6	O
-	O
position	O
(	O
4	O
h	O
and	O
4	O
i	O
)	O
.	O
on	O
the	O
other	O
hand	O
,	O
2	B-T103
,	I-T103
7	I-T103
-	I-T103
difluor	I-T103
##inated	I-T103
acr	I-T103
##ida	I-T103
##n	I-T103
diox	I-T103
##etan	I-T103
##e	I-T103
(	O
4	O
j	O
)	O
showed	O
a	O
significantly	O
enhanced	O
fluorescence	O
quantum	O
yield	O
with	O
respect	O
to	O
the	O
unsu	B-T103
##bs	I-T103
##tituted	I-T103
diox	I-T103
##etan	I-T103
##e	I-T103
(	O
4	O
a	O
)	O
.	O
some	O
of	O
the	O
synthesized	O
ole	B-T103
##fin	I-T103
##s	I-T103
did	O
not	O
undergo	O
singlet	O
oxygen	O
addition	O
and	O
a	O
rationale	O
was	O
sought	O
to	O
ease	O
the	O
photo	O
##oxygenation	O
step	O
,	O
leading	O
to	O
the	O
tc	B-T103
##l	I-T103
diox	I-T103
##etan	I-T103
##es	I-T103
.	O
a	O
chemo	B-T058
##met	I-T058
##ric	I-T058
approach	I-T058
has	O
been	O
adopted	O
to	O
exploit	O
principal	B-T062
component	I-T062
analysis	I-T062
and	O
linear	B-T062
discriminant	I-T062
analysis	I-T062
of	O
the	O
structural	B-T082
and	O
electronic	B-T170
molecular	I-T170
descriptors	I-T170
obtained	O
by	O
dft	O
optimization	O
##s	O
of	O
ole	B-T103
##fin	I-T103
##s	I-T103
3	O
.	O
this	O
approach	B-T082
allows	O
the	O
steric	O
and	O
electronic	O
parameters	O
that	O
govern	O
diox	B-T103
##etan	I-T103
##e	I-T103
formation	O
to	O
be	O
revealed	O
.	O

fibrinogen	B-T103
:	O
a	O
marker	B-T201
in	O
predicting	O
diabetic	B-T038
foot	I-T038
ulcer	I-T038
severity	O
aims	O
.	O
to	O
examine	B-T058
whether	O
fibrinogen	B-T033
levels	I-T033
are	O
a	O
valuable	O
biomarker	B-T201
for	O
assessing	B-T058
disease	O
severity	O
and	O
monitoring	B-T058
disease	B-T038
progression	I-T038
in	O
patients	O
with	O
diabetic	B-T038
foot	I-T038
ulcer	I-T038
(	O
df	B-T038
##u	I-T038
)	O
.	O
methods	O
.	O
a	O
retrospective	B-T062
study	I-T062
was	O
designed	O
to	O
examine	O
the	O
utility	O
of	O
fibrinogen	B-T103
in	O
estimating	O
disease	O
severity	O
in	O
patients	O
with	O
df	B-T038
##u	I-T038
admitted	B-T058
to	O
our	O
hospital	B-T092
between	O
january	O
2015	O
and	O
january	O
2016	O
.	O
in	O
total	O
,	O
152	O
patients	O
with	O
df	B-T038
##u	I-T038
were	O
enrolled	O
in	O
the	O
study	O
group	O
,	O
and	O
52	O
age	O
and	O
gender	O
matched	O
people	O
with	O
diabetes	B-T038
but	O
no	O
df	B-T038
##u	I-T038
were	O
included	O
as	O
the	O
control	O
group	O
.	O
df	B-T038
##u	I-T038
severity	O
was	O
assessed	O
using	O
wa	O
##gn	O
##er	O
criteria	O
.	O
results	O
.	O
patients	O
with	O
df	B-T038
##u	I-T038
were	O
divided	O
into	O
2	O
subgroups	B-T170
based	O
on	O
the	O
wa	O
##gn	O
##er	O
criteria	O
.	O
mean	O
fibrinogen	B-T033
values	I-T033
were	O
significantly	O
higher	O
in	O
patients	O
with	O
df	B-T038
##u	I-T038
grade	B-T170
≧	O
3	O
compared	O
to	O
those	O
with	O
df	B-T038
##u	I-T038
grades	B-T170
1	O
-	O
2	O
(	O
5	O
.	O
23	O
±	O
1	O
.	O
37	O
g	O
/	O
l	O
versus	O
3	O
.	O
61	O
±	O
1	O
.	O
04	O
g	O
/	O
l	O
)	O
.	O
using	O
roc	O
statistic	O
,	O
a	O
cut	O
-	O
off	O
value	O
of	O
5	O
.	O
13	O
g	O
/	O
l	O
indicated	O
the	O
possible	O
amputation	B-T058
with	O
a	O
sensitivity	O
of	O
81	O
.	O
8	O
%	O
and	O
a	O
specificity	O
of	O
78	O
.	O
9	O
%	O
(	O
positive	O
predictive	O
value	O
[	O
ppv	O
]	O
78	O
.	O
6	O
%	O
,	O
negative	O
predictive	O
value	O
[	O
89	O
.	O
0	O
%	O
]	O
)	O
.	O
fibrinogen	B-T033
values	I-T033
were	O
found	O
to	O
be	O
correlated	O
with	O
crp	B-T033
levels	I-T033
,	O
neutrophil	B-T058
,	O
and	O
wbc	B-T058
count	I-T058
.	O
conclusions	O
.	O
fibrinogen	B-T033
levels	I-T033
might	O
be	O
a	O
valuable	O
tool	O
for	O
assessing	B-T058
the	O
disease	O
severity	O
and	O
monitoring	B-T058
the	O
disease	B-T038
progression	I-T038
in	O
patients	O
with	O
df	B-T038
##u	I-T038
.	O

effects	O
of	O
high	O
-	O
intensity	O
training	O
on	O
cardiovascular	O
risk	O
factors	O
in	O
premenopausal	B-T033
and	O
postmenopausal	B-T033
women	B-T098
menopause	B-T038
is	O
associated	O
with	O
increased	O
risk	O
of	O
cardiovascular	B-T038
disease	I-T038
and	O
the	O
causal	O
factors	O
have	O
been	O
proposed	O
to	O
be	O
the	O
loss	O
of	O
estrogen	B-T103
and	O
the	O
subsequent	O
alterations	O
of	O
the	O
hormonal	B-T103
milieu	I-T103
.	O
however	O
,	O
which	O
factors	O
contribute	O
to	O
the	O
deterioration	O
of	O
cardiometabolic	O
health	O
in	O
postmenopausal	B-T033
women	B-T098
is	O
debated	O
as	O
the	O
menopausal	B-T038
transition	O
is	O
also	O
associated	O
with	O
increased	O
age	O
and	O
fat	O
mass	O
.	O
furthermore	O
,	O
indications	O
of	O
reduced	O
cardiometabolic	O
adaptations	B-T038
to	O
exercise	O
in	O
postmenopausal	B-T033
women	B-T098
add	O
to	O
the	O
adverse	B-T038
health	O
profile	O
.	O
we	O
sought	O
to	O
evaluate	B-T058
risk	B-T033
factors	I-T033
for	O
type	B-T038
2	I-T038
diabetes	I-T038
and	O
cardiovascular	B-T038
disease	I-T038
in	O
late	O
premenopausal	B-T033
and	O
early	O
postmenopausal	B-T033
women	B-T098
,	O
matched	O
by	O
age	O
and	O
body	O
composition	O
,	O
and	O
investigate	O
the	O
effect	O
of	O
high	O
-	O
intensity	O
training	O
.	O
a	O
3	O
-	O
month	O
high	O
-	O
intensity	O
aerobic	O
training	O
intervention	B-T058
,	O
involving	O
healthy	O
,	O
nonobese	B-T033
,	O
late	O
premenopausal	B-T033
(	O
n	O
=	O
40	O
)	O
and	O
early	O
postmenopausal	B-T033
(	O
n	O
=	O
39	O
)	O
women	B-T098
was	O
conducted	O
and	O
anthropometric	B-T201
##s	I-T201
,	O
body	O
composition	O
,	O
blood	B-T038
pressure	I-T038
,	O
lipid	O
profile	O
,	O
glucose	O
tolerance	O
,	O
and	O
maximal	B-T201
oxygen	I-T201
consumption	I-T201
were	O
determined	O
at	O
baseline	O
and	O
after	O
the	O
intervention	B-T058
.	O
at	O
baseline	O
,	O
the	O
groups	B-T098
matched	O
in	O
anthropometric	B-T201
##s	I-T201
and	O
body	O
composition	O
,	O
and	O
only	O
differed	O
by	O
4	O
.	O
2	O
years	O
in	O
age	O
(	O
mean	O
[	O
95	O
%	O
confidence	O
limits	O
]	O
49	O
.	O
2	O
[	O
48	O
.	O
5	O
-	O
49	O
.	O
9	O
]	O
vs	O
53	O
.	O
4	O
[	O
52	O
.	O
4	O
-	O
54	O
.	O
4	O
]	O
years	O
)	O
.	O
time	O
since	O
last	O
menstrual	B-T038
period	I-T038
for	O
the	O
postmenopausal	B-T033
women	B-T098
was	O
(	O
mean	O
[	O
95	O
%	O
confid	O
##ec	O
##nc	O
##e	O
limits	O
]	O
3	O
.	O
1	O
[	O
2	O
.	O
6	O
-	O
3	O
.	O
7	O
]	O
years	O
)	O
.	O
hormonal	B-T033
levels	I-T033
(	O
estrogen	B-T103
,	O
follicle	B-T103
stimulation	I-T103
hormone	I-T103
,	O
luteinizing	B-T103
hormone	I-T103
)	O
confirmed	O
menopausal	B-T201
status	I-T201
.	O
at	O
baseline	O
the	O
postmenopausal	B-T033
women	B-T098
had	O
higher	O
total	B-T103
cholesterol	I-T103
(	O
p	O
<	O
.	O
001	O
)	O
,	O
low	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
-	I-T103
cholesterol	I-T103
(	O
p	O
<	O
.	O
05	O
)	O
,	O
and	O
high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
-	I-T103
cholesterol	I-T103
(	O
p	O
<	O
.	O
001	O
)	O
than	O
the	O
premenopausal	B-T033
women	B-T098
.	O
the	O
training	O
intervention	B-T058
reduced	O
body	O
weight	O
(	O
p	O
<	O
.	O
01	O
)	O
,	O
waist	B-T201
circumference	I-T201
(	O
p	O
<	O
.	O
01	O
)	O
,	O
and	O
improved	B-T033
body	O
composition	O
by	O
increasing	O
lean	B-T201
body	I-T201
mass	I-T201
(	O
p	O
<	O
.	O
001	O
)	O
and	O
decreasing	B-T033
fat	O
mass	O
(	O
p	O
<	O
.	O
001	O
)	O
similarly	O
in	O
both	O
groups	B-T098
.	O
moreover	O
,	O
training	O
resulted	O
in	O
lower	B-T033
diastolic	I-T033
blood	I-T033
pressure	I-T033
(	O
p	O
<	O
.	O
05	O
)	O
,	O
resting	B-T033
heart	I-T033
rate	I-T033
(	O
p	O
<	O
.	O
001	O
)	O
,	O
total	B-T103
cholesterol	I-T103
(	O
p	O
<	O
.	O
01	O
)	O
,	O
low	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
-	I-T103
cholesterol	I-T103
(	O
p	O
<	O
.	O
01	O
)	O
,	O
total	B-T103
cholesterol	I-T103
/	O
high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
-	I-T103
cholesterol	I-T103
index	O
(	O
p	O
<	O
.	O
01	O
)	O
,	O
and	O
improved	B-T033
plasma	B-T058
insulin	I-T058
concentration	I-T058
during	O
the	O
oral	B-T058
glucose	I-T058
tolerance	I-T058
test	I-T058
(	O
p	O
<	O
.	O
05	O
)	O
in	O
both	O
groups	B-T098
.	O
cardiovascular	O
risk	O
factors	O
are	O
similar	O
in	O
late	O
premenopausal	B-T033
and	O
early	O
postmenopausal	B-T033
women	B-T098
,	O
matched	O
by	O
age	O
and	O
body	O
composition	O
,	O
with	O
the	O
exception	O
that	O
postmenopausal	B-T033
women	B-T098
have	O
higher	O
high	B-T058
-	I-T058
and	O
low	B-T058
-	I-T058
density	I-T058
lipoprotein	I-T058
-	I-T058
cholesterol	I-T058
levels	I-T058
.	O
a	O
3	O
-	O
month	O
intervention	B-T058
of	O
high	O
-	O
intensity	O
aerobic	O
training	O
reduces	O
risk	B-T033
factors	I-T033
for	O
type	B-T038
2	I-T038
.	I-T038
diabetes	I-T038
and	O
cardiovascular	B-T038
disease	I-T038
to	O
a	O
similar	O
extent	O
in	O
late	O
premenopausal	B-T033
and	O
early	O
postmenopausal	B-T033
women	B-T098
.	O

genotyping	B-T058
of	O
german	B-T098
and	O
austria	B-T098
##n	I-T098
ta	B-T007
##yl	I-T007
##orel	I-T007
##la	I-T007
equ	I-T007
##igen	I-T007
##ital	I-T007
##is	I-T007
isolates	B-T103
using	O
repetitive	B-T062
extra	I-T062
##genic	I-T062
pal	I-T062
##ind	I-T062
##romic	I-T062
(	I-T062
rep	I-T062
)	I-T062
pcr	I-T062
and	O
pulsed	B-T058
-	I-T058
field	I-T058
gel	I-T058
electrophoresis	I-T058
(	O
pfge	B-T058
)	O
a	O
total	O
of	O
124	O
ta	B-T007
##yl	I-T007
##orel	I-T007
##la	I-T007
(	I-T007
t	I-T007
.	I-T007
)	I-T007
equ	I-T007
##igen	I-T007
##ital	I-T007
##is	I-T007
and	O
five	O
t	B-T007
.	I-T007
asi	I-T007
##ni	I-T007
##gen	I-T007
##ital	I-T007
##is	I-T007
field	O
isolates	B-T103
collected	O
between	O
2002	O
and	O
2014	O
were	O
available	O
for	O
genotyping	B-T058
using	O
rep	B-T062
-	I-T062
(	I-T062
repetitive	I-T062
extra	I-T062
##genic	I-T062
pal	I-T062
##ind	I-T062
##romic	I-T062
)	I-T062
pcr	I-T062
and	O
pfge	B-T058
(	O
pulsed	B-T058
-	I-T058
field	I-T058
gel	I-T058
electrophoresis	I-T058
)	O
.	O
the	O
study	B-T062
comprised	O
79	O
t	B-T007
.	I-T007
equ	I-T007
##igen	I-T007
##ital	I-T007
##is	I-T007
field	O
isolates	B-T103
originating	O
from	O
ten	O
defined	O
breeds	B-T038
of	O
german	B-T204
horses	I-T204
and	O
revealed	O
a	O
spectrum	O
of	O
five	O
rep	B-T082
(	O
rep	O
-	O
e1	O
-	O
e4	O
,	O
rep	O
-	O
e3	O
##a	O
)	O
and	O
15	O
pfge	B-T058
(	O
te	O
-	O
a1	O
-	O
a	O
##9	O
,	O
te	O
-	O
b1	O
-	O
b3	O
,	O
te	O
-	O
c	O
,	O
te	O
-	O
e1	O
,	O
and	O
te	O
-	O
e2	O
)	O
genotypes	O
.	O
t	B-T007
.	I-T007
equ	I-T007
##igen	I-T007
##ital	I-T007
##is	I-T007
field	O
isolates	B-T103
(	O
n	O
=	O
40	O
)	O
obtained	O
from	O
austria	B-T204
##n	I-T204
lip	I-T204
##izz	I-T204
##ane	I-T204
##r	I-T204
horses	I-T204
were	O
differentiated	O
into	O
three	O
rep	B-T082
(	O
rep	O
-	O
e1	O
,	O
rep	O
-	O
e3	O
##a	O
,	O
and	O
rep	O
-	O
e4	O
)	O
and	O
three	O
pfge	B-T058
genotypes	O
(	O
te	O
-	O
a2	O
,	O
te	O
-	O
a5	O
,	O
and	O
te	O
-	O
d	O
)	O
;	O
those	O
isolated	O
from	O
four	O
austria	B-T204
##n	I-T204
tro	I-T204
##tt	I-T204
##ers	I-T204
belonged	O
to	O
the	O
rep	B-T082
/	O
pfge	B-T058
genotype	O
rep	O
-	O
e2	O
/	O
te	O
-	O
a1	O
.	O
interestingly	O
,	O
a	O
t	B-T007
.	I-T007
equ	I-T007
##igen	I-T007
##ital	I-T007
##is	I-T007
isolate	B-T103
recovered	O
from	O
a	O
holstein	B-T204
##er	I-T204
stall	I-T204
##ion	I-T204
living	O
in	O
south	B-T082
africa	I-T082
revealed	O
the	O
rep	B-T082
/	O
pfge	B-T058
genotype	O
rep	O
-	O
e1	O
/	O
te	O
-	O
a5	O
which	O
was	O
otherwise	O
exclusively	O
present	B-T033
in	O
the	O
majority	O
of	O
austria	B-T204
##n	I-T204
lip	I-T204
##izz	I-T204
##ane	I-T204
##r	I-T204
horses	I-T204
in	O
our	O
study	B-T062
.	O
the	O
type	O
strain	O
included	O
in	O
this	O
study	B-T062
revealed	O
the	O
genotype	O
rep	B-T082
/	O
pfge	B-T058
rep	O
-	O
e1	O
/	O
te	O
-	O
f	O
.	O
six	O
strains	O
of	O
t	B-T007
.	I-T007
asi	I-T007
##ni	I-T007
##gen	I-T007
##ital	I-T007
##is	I-T007
including	O
the	O
type	O
strain	O
were	O
separated	O
into	O
three	O
rep	B-T082
(	O
rep	O
-	O
a1	O
-	O
a3	O
)	O
and	O
six	O
pfge	B-T058
genotypes	O
(	O
ta	O
-	O
a1	O
,	O
ta	O
-	O
a2	O
,	O
ta	O
-	O
a3	O
,	O
ta	O
-	O
b	O
,	O
ta	O
-	O
c	O
,	O
ta	O
-	O
d	O
)	O
.	O
overall	O
,	O
the	O
generated	O
rep	B-T082
and	O
pfge	B-T058
genotypes	O
showed	O
a	O
good	O
correlation	O
,	O
whereas	O
rep	B-T062
-	I-T062
pcr	I-T062
proved	O
to	O
be	O
a	O
suitable	B-T058
method	I-T058
for	O
molecular	B-T058
epidemiological	I-T058
screening	I-T058
of	O
t	B-T007
.	I-T007
equ	I-T007
##igen	I-T007
##ital	I-T007
##is	I-T007
and	O
t	B-T007
.	I-T007
asi	I-T007
##ni	I-T007
##gen	I-T007
##ital	I-T007
##is	I-T007
isolates	B-T103
that	O
should	O
be	O
differentiated	O
in	O
detail	O
by	O
genotyping	B-T058
using	O
pfge	B-T058
.	O

comparative	O
kinematic	B-T058
gait	I-T058
analysis	I-T058
in	O
young	O
and	O
old	O
be	B-T204
##agle	I-T204
dogs	I-T204
age	O
-	O
related	O
involution	B-T038
in	O
dogs	B-T204
involves	O
loss	B-T033
of	I-T033
muscle	I-T033
mass	I-T033
and	O
changes	O
in	O
connective	B-T017
tissue	I-T017
and	O
articular	B-T017
cartilage	I-T017
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	B-T033
whether	O
an	O
age	O
-	O
related	O
influence	O
on	O
joint	O
mobility	O
can	O
be	O
detected	B-T033
in	O
the	O
absence	O
of	O
diseases	B-T038
.	O
five	O
young	O
(	O
ø	O
2	O
.	O
0	O
years	O
)	O
and	O
five	O
old	O
(	O
ø	O
10	O
.	O
4	O
years	O
)	O
healthy	O
and	O
sound	B-T204
be	I-T204
##agle	I-T204
dogs	I-T204
were	O
measured	O
during	O
locomotion	B-T038
on	O
a	O
treadmill	O
by	O
computer	O
-	O
assisted	O
gait	B-T058
analysis	I-T058
.	O
angles	B-T082
of	O
the	O
shoulder	B-T082
,	O
elbow	B-T082
,	O
carpal	B-T082
,	O
hip	B-T082
,	O
sti	B-T082
##fl	I-T082
##e	I-T082
and	O
tars	B-T082
##al	I-T082
joints	I-T082
were	O
analyzed	B-T062
,	O
including	O
joint	O
angle	O
progression	O
curves	O
,	O
minimum	O
and	O
maximum	O
joint	B-T082
angles	B-T082
and	O
range	B-T201
of	I-T201
motion	I-T201
(	O
rom	B-T201
)	O
.	O
the	O
old	O
group	O
showed	O
a	O
smaller	O
maximum	O
joint	B-T082
angle	B-T082
(	O
p	O
=	O
0	O
.	O
037	O
)	O
and	O
rom	B-T201
(	O
p	O
=	O
0	O
.	O
037	O
)	O
of	O
the	O
carpal	B-T082
joint	I-T082
and	O
similar	O
tendencies	O
in	O
the	O
shoulder	B-T082
,	O
elbow	B-T082
and	O
carpal	B-T082
joint	I-T082
.	O
the	O
descriptive	B-T170
analysis	I-T170
of	O
the	O
progression	O
curves	O
revealed	O
less	B-T033
flexion	I-T033
and	O
extension	O
of	O
the	O
joints	B-T082
of	O
the	O
forelimb	B-T082
.	O
this	O
indicates	O
restricted	O
joint	O
mobility	O
of	O
the	O
forelimb	B-T082
but	O
primarily	O
of	O
the	O
carpal	B-T082
joint	I-T082
.	O
findings	O
in	O
the	O
joints	B-T082
of	O
the	O
hindlimb	B-T017
were	O
not	O
consistent	O
;	O
contrasting	O
alterations	O
may	O
be	O
due	O
to	O
a	O
compensatory	O
mechanism	O
.	O
as	O
most	O
alterations	O
were	O
found	B-T033
in	O
the	O
distal	B-T082
joints	I-T082
,	O
these	O
should	O
receive	O
particular	B-T038
attention	I-T038
when	O
examining	O
elderly	B-T204
dogs	I-T204
.	O

altered	O
interr	B-T082
##eg	I-T082
##ional	I-T082
correlations	O
between	O
serotonin	B-T103
transporter	I-T103
availability	O
and	O
cerebral	O
glucose	B-T038
metabolism	I-T038
in	O
schizophrenia	B-T038
:	O
a	O
high	B-T058
-	I-T058
resolution	I-T058
pet	I-T058
study	O
using	O
[	B-T103
(	I-T103
11	I-T103
)	I-T103
c	I-T103
]	I-T103
das	I-T103
##b	I-T103
and	O
[	B-T103
(	I-T103
18	I-T103
)	I-T103
f	I-T103
]	I-T103
fdg	I-T103
the	O
purpose	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
patterns	O
of	O
interr	B-T082
##eg	I-T082
##ional	I-T082
correlations	O
of	O
serotonin	B-T103
transporter	I-T103
(	O
sert	B-T103
)	O
availability	O
with	O
glucose	B-T038
metabolism	I-T038
using	O
7	B-T058
-	I-T058
tesla	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
and	O
high	B-T058
-	I-T058
resolution	I-T058
positron	I-T058
emission	I-T058
tomography	I-T058
(	O
pet	B-T058
)	O
with	O
(	B-T103
11	I-T103
)	I-T103
c	I-T103
-	I-T103
3	I-T103
-	I-T103
amino	I-T103
-	I-T103
4	I-T103
-	I-T103
(	I-T103
2	I-T103
-	I-T103
dimethyl	I-T103
##amino	I-T103
##methyl	I-T103
##phenyl	I-T103
##thio	I-T103
)	I-T103
benzo	I-T103
##nit	I-T103
##rile	I-T103
(	O
[	B-T103
(	I-T103
11	I-T103
)	I-T103
c	I-T103
]	I-T103
das	I-T103
##b	I-T103
)	O
and	O
[	B-T103
(	I-T103
18	I-T103
)	I-T103
f	I-T103
]	I-T103
fluorodeoxyglucose	I-T103
(	O
[	B-T103
(	I-T103
18	I-T103
)	I-T103
f	I-T103
]	I-T103
fdg	I-T103
)	O
in	O
antipsychotic	O
-	O
free	O
patients	O
with	O
schizophrenia	B-T038
in	O
order	O
to	O
shed	O
new	O
light	O
on	O
the	O
disrupted	O
functional	O
connectivity	O
in	O
schizophrenia	B-T038
.	O
nineteen	O
patients	O
with	O
schizophrenia	B-T038
and	O
18	O
healthy	O
controls	O
underwent	O
high	B-T058
-	I-T058
resolution	I-T058
pet	I-T058
and	O
mri	B-T058
.	O
the	O
binding	O
potential	O
(	O
bp	O
##nd	O
)	O
of	O
[	B-T103
(	I-T103
11	I-T103
)	I-T103
c	I-T103
]	I-T103
das	I-T103
##b	I-T103
and	O
standardized	O
uptake	O
value	O
ratio	O
(	O
suv	O
##r	O
)	O
of	O
[	B-T103
(	I-T103
18	I-T103
)	I-T103
f	I-T103
]	I-T103
fdg	I-T103
were	O
obtained	O
.	O
in	O
sert	B-T103
availability	O
,	O
the	O
region	B-T082
of	I-T082
interest	I-T082
(	O
roi	B-T082
)	O
-	O
based	O
analyses	B-T062
showed	O
no	O
significant	O
group	O
differences	O
in	O
any	O
region	B-T082
,	O
except	O
for	O
the	O
anterior	B-T082
hippocampus	B-T017
where	O
the	O
sert	B-T103
availability	O
was	O
lower	O
in	O
patients	O
with	O
schizophrenia	B-T038
than	O
in	O
controls	O
.	O
the	O
roi	B-T082
-	O
and	O
voxel	O
-	O
based	O
analyses	B-T062
revealed	O
that	O
the	O
[	B-T103
(	I-T103
18	I-T103
)	I-T103
f	I-T103
]	I-T103
fdg	I-T103
suv	O
##r	O
values	O
were	O
significantly	O
lower	O
in	O
patients	O
than	O
in	O
controls	O
in	O
the	O
right	B-T017
superior	I-T017
frontal	I-T017
gyrus	I-T017
and	O
medial	B-T082
part	I-T082
of	O
the	O
left	B-T017
superior	I-T017
frontal	I-T017
gyrus	I-T017
.	O
regarding	O
the	O
interr	B-T082
##eg	I-T082
##ional	I-T082
correlations	O
of	O
[	B-T103
(	I-T103
11	I-T103
)	I-T103
c	I-T103
]	I-T103
das	I-T103
##b	I-T103
bp	O
##nd	O
with	O
[	B-T103
(	I-T103
18	I-T103
)	I-T103
f	I-T103
]	I-T103
fdg	I-T103
suv	O
##r	O
,	O
more	O
widespread	O
positive	B-T033
correlations	O
across	O
the	O
brain	B-T082
regions	I-T082
were	O
observed	O
in	O
control	O
subjects	O
than	O
in	O
patients	O
with	O
schizophrenia	B-T038
.	O
notably	O
,	O
the	O
patients	O
and	O
control	O
subjects	O
showed	O
statistically	O
significant	O
differences	O
in	O
correlations	O
between	O
the	O
sert	B-T103
availability	O
in	O
the	O
parietal	B-T017
and	O
temporal	B-T017
cortices	I-T017
and	O
the	O
glucose	B-T038
metabolism	I-T038
in	O
the	O
posterior	B-T017
cingulate	I-T017
cortex	I-T017
.	O
these	O
results	O
suggest	O
abnormal	B-T033
functional	O
connectivity	O
between	O
the	O
higher	B-T082
-	I-T082
order	I-T082
cortical	I-T082
regions	I-T082
in	O
schizophrenia	B-T038
and	O
a	O
possible	O
important	O
role	O
of	O
the	O
posterior	B-T017
cingulate	I-T017
gyrus	I-T017
and	O
its	O
related	O
circuitry	O
in	O
the	O
pathophysiology	O
of	O
schizophrenia	B-T038
.	O

risk	B-T033
factors	I-T033
for	O
hepatitis	B-T038
c	I-T038
virus	I-T038
infection	I-T038
in	O
the	O
colombia	O
##n	O
caribbean	B-T082
coast	I-T082
:	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
an	O
estimated	O
6	O
.	O
8	O
-	O
8	O
.	O
9	O
million	O
people	B-T098
are	O
infected	B-T033
with	O
hepatitis	B-T005
c	I-T005
virus	I-T005
in	O
latin	B-T082
america	I-T082
,	O
of	O
which	O
less	O
than	O
1	O
%	O
receives	O
antiviral	B-T058
treatment	I-T058
.	O
studies	B-T062
so	O
far	O
in	O
colombia	B-T082
have	O
attempted	O
to	O
determine	O
the	O
prevalence	O
of	O
the	O
disease	B-T038
in	O
some	O
risk	O
groups	B-T098
,	O
thus	O
preventing	O
the	O
identification	O
of	O
other	O
factors	O
potentially	O
involved	O
in	O
the	O
spread	O
of	O
the	O
infection	B-T038
.	O
to	O
identify	O
traditional	O
and	O
non	O
-	O
traditional	O
risk	B-T033
factors	I-T033
for	O
chronic	B-T038
hepatitis	I-T038
c	I-T038
in	O
the	O
colombia	O
##n	O
caribbean	B-T082
coast	I-T082
.	O
this	O
was	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
(	O
1	O
:	O
3	O
)	O
matched	O
by	O
health	B-T097
care	I-T097
provider	I-T097
and	O
age	O
(	O
±	O
10	O
years	O
)	O
conducted	O
at	O
the	O
primary	B-T058
care	I-T058
level	I-T058
of	O
gastroenter	B-T091
##ology	I-T091
and	O
hepat	B-T091
##ology	I-T091
outpatient	B-T058
services	I-T058
.	O
all	O
patients	O
with	O
a	O
positive	B-T033
elisa	B-T058
underwent	O
a	O
confirmatory	O
viral	O
load	O
test	O
.	O
a	O
multivariate	O
logistic	O
regression	O
analysis	O
identified	O
the	O
independent	O
predictors	O
of	O
infection	B-T038
.	O
blood	B-T058
transfusion	I-T058
(	O
or	O
=	O
159	O
.	O
2	O
;	O
95	O
%	O
ci	O
:	O
35	O
.	O
4	O
-	O
71	O
##5	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
history	B-T201
of	I-T201
hospitalization	I-T201
before	O
1994	O
(	O
or	O
=	O
4	O
.	O
7	O
;	O
95	O
%	O
ci	O
:	O
1	O
.	O
3	O
-	O
17	O
.	O
1	O
;	O
p	O
=	O
0	O
.	O
018	O
)	O
were	O
identified	O
as	O
the	O
only	O
two	O
independent	O
predictors	O
of	O
infection	B-T038
.	O
it	O
is	O
necessary	O
to	O
check	O
the	O
reproducibility	O
of	O
these	O
results	O
and	O
to	O
conduct	O
cost	O
-	O
effectiveness	O
studies	B-T062
before	O
recommend	O
##ing	O
their	O
use	O
in	O
the	O
design	O
of	O
new	B-T062
screening	I-T062
strategies	I-T062
.	O

matrix	B-T058
solid	I-T058
-	I-T058
phase	I-T058
dispersion	I-T058
combined	O
to	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
for	O
the	O
determination	B-T058
of	O
para	B-T103
##be	I-T103
##n	I-T103
preserv	B-T103
##atives	I-T103
in	O
moll	B-T204
##us	I-T204
##ks	I-T204
a	O
method	B-T170
for	I-T170
the	I-T170
extraction	I-T170
and	O
determination	B-T058
of	O
seven	O
para	B-T103
##bens	I-T103
,	O
esters	B-T103
of	O
4	B-T103
-	I-T103
hydroxybenz	I-T103
##oic	I-T103
acid	I-T103
,	O
widely	O
used	O
as	O
preserv	B-T103
##atives	I-T103
in	O
personal	O
care	O
products	O
,	O
pharmaceuticals	B-T103
,	O
etc	O
.	O
,	O
and	O
two	O
chlorinated	B-T103
derivatives	I-T103
(	O
mono	B-T103
-	I-T103
and	O
di	B-T103
-	I-T103
chloro	I-T103
methyl	I-T103
para	I-T103
##be	I-T103
##n	I-T103
)	O
from	O
moll	B-T204
##us	I-T204
##k	I-T204
samples	O
was	O
developed	O
by	O
combining	O
matrix	B-T058
solid	I-T058
-	I-T058
phase	I-T058
dispersion	I-T058
(	O
msp	B-T058
##d	I-T058
)	O
and	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
.	O
msp	B-T170
##d	I-T170
parameters	I-T170
,	O
such	O
as	O
solvent	B-T103
,	O
solid	O
support	O
and	O
clean	O
-	O
up	O
sorbent	O
,	O
were	O
optimized	O
.	O
besides	O
,	O
since	O
blank	O
problems	O
were	O
observed	O
for	O
some	O
para	B-T103
##bens	I-T103
,	O
these	O
were	O
investigated	O
and	O
blank	O
##s	O
were	O
tackle	O
##d	O
by	O
precl	O
##ea	O
##ning	O
all	O
sorbent	O
##s	O
prior	O
to	O
use	O
.	O
under	O
final	O
conditions	O
,	O
0	O
.	O
5	O
##g	O
of	O
freeze	B-T058
-	I-T058
dried	I-T058
moll	B-T204
##us	I-T204
##k	I-T204
were	O
dispersed	B-T082
with	O
1	O
.	O
2	O
##g	O
of	O
silica	B-T103
and	O
packed	O
into	O
a	O
cartrid	B-T170
##ge	I-T170
containing	O
3	O
##g	O
of	O
c18	B-T103
,	O
as	O
on	O
-	O
line	O
clean	O
-	O
up	O
sorbent	O
.	O
this	O
cartrid	B-T170
##ge	I-T170
was	O
eluted	O
with	O
10	O
##ml	O
of	O
acetonitrile	B-T103
,	O
evap	O
##orated	O
and	O
reconstituted	O
in	O
methanol	B-T103
for	O
analysis	B-T062
.	O
in	O
the	O
validation	B-T062
stage	O
,	O
successful	O
linearity	O
(	O
r	O
(	O
2	O
)	O
>	O
0	O
.	O
999	O
)	O
,	O
recoveries	O
(	O
between	O
71	O
and	O
117	O
%	O
for	O
most	O
analytes	O
)	O
,	O
precision	O
(	O
rsd	O
lower	O
than	O
21	O
%	O
)	O
and	O
limits	O
of	O
detection	O
and	O
quantification	O
(	O
lod	O
and	O
lo	B-T062
##q	I-T062
,	O
lower	O
than	O
0	O
.	O
4	O
and	O
1	O
.	O
4	O
##ng	O
##g	O
(	O
-	O
1	O
)	O
dry	O
weight	O
respectively	O
)	O
levels	O
were	O
achieved	O
.	O
finally	O
,	O
the	O
new	O
methodology	B-T170
was	O
applied	O
to	O
muss	B-T204
##el	I-T204
,	O
cla	B-T204
##m	I-T204
and	O
cock	B-T204
##le	I-T204
samples	O
.	O
methyl	B-T103
para	I-T103
##be	I-T103
##n	I-T103
was	O
above	O
the	O
lo	O
##q	O
in	O
five	O
of	O
the	O
six	O
samples	O
(	O
not	O
found	O
in	O
one	O
cla	B-T204
##m	I-T204
sample	O
)	O
at	O
concentrations	O
up	O
to	O
7	O
##ng	O
##g	O
(	O
-	O
1	O
)	O
dry	O
weight	O
.	O
ethyl	B-T103
para	I-T103
##be	I-T103
##n	I-T103
was	O
found	O
above	O
the	O
lo	O
##q	O
in	O
muss	B-T204
##el	I-T204
and	O
cock	B-T204
##le	I-T204
samples	O
at	O
a	O
concentration	O
level	O
around	O
0	O
.	O
3	O
##ng	O
##g	O
(	O
-	O
1	O
)	O
.	O
n	B-T103
-	I-T103
propyl	I-T103
para	I-T103
##be	I-T103
##n	I-T103
was	O
only	O
above	O
the	O
lo	O
##q	O
in	O
one	O
muss	B-T204
##el	I-T204
sample	O
.	O

delineation	O
of	O
b	B-T017
-	I-T017
cell	I-T017
epitopes	B-T103
of	O
salmonella	B-T007
enterica	I-T007
serovar	I-T007
typhi	I-T007
hem	B-T103
##olysin	I-T103
e	I-T103
:	O
potential	O
antibody	B-T103
therapeutic	B-T058
target	O
hem	B-T103
##olysin	I-T103
e	I-T103
(	O
hl	B-T103
##y	I-T103
##e	I-T103
)	O
is	O
an	O
immunogenic	O
novel	O
pore	B-T017
-	O
forming	O
toxin	B-T103
involved	O
in	O
the	O
pathogenesis	B-T038
of	O
typh	B-T038
##oid	I-T038
fever	I-T038
.	O
thus	O
,	O
mapping	O
of	O
b	B-T017
-	I-T017
cell	I-T017
epitopes	B-T103
of	O
salmonella	B-T007
enterica	I-T007
serovar	I-T007
typhi	I-T007
(	O
s	B-T007
.	I-T007
typhi	I-T007
)	O
is	O
critical	O
to	O
identify	O
key	O
immunogenic	O
regions	O
of	O
hl	B-T103
##y	I-T103
##e	I-T103
.	O
a	O
random	O
20	O
-	O
mer	O
peptide	B-T103
library	I-T103
was	O
used	O
for	O
biop	O
##anning	O
with	O
enriched	O
anti	B-T103
-	I-T103
hl	I-T103
##y	I-T103
##e	I-T103
polyclonal	I-T103
antibodies	I-T103
from	O
typh	B-T038
##oid	I-T038
patient	O
sera	B-T031
.	O
bioinformatic	B-T091
tools	B-T170
were	O
used	O
to	O
refine	O
,	O
analyze	B-T062
and	O
map	O
the	O
enriched	O
peptide	O
sequences	O
against	O
the	O
protein	B-T103
to	O
identify	O
the	O
epitopes	B-T103
.	O
the	O
analysis	B-T062
identified	O
both	O
linear	B-T082
and	O
conformational	O
epitopes	B-T103
on	O
the	O
hl	B-T103
##y	I-T103
##e	I-T103
protein	I-T103
.	O
the	O
predicted	O
linear	B-T082
ga	B-T082
##aa	I-T082
##gi	I-T082
##va	I-T082
##g	I-T082
and	O
conformational	O
epitope	B-T103
py	B-T082
##s	I-T082
##q	I-T082
##es	I-T082
##v	I-T082
##ls	I-T082
##ads	I-T082
##q	I-T082
##n	I-T082
##q	I-T082
##k	I-T082
were	O
further	O
validated	O
against	O
the	O
pooled	O
sera	B-T031
.	O
the	O
identified	O
epitopes	B-T103
were	O
then	O
used	O
to	O
isolate	B-T058
epitope	B-T103
specific	O
monoclonal	B-T103
antibodies	I-T103
by	O
antibody	B-T103
phage	B-T062
display	I-T062
.	O
monoclonal	B-T103
scfv	I-T103
antibodies	B-T103
were	O
enriched	O
for	O
both	O
linear	B-T082
and	O
conformational	O
epitopes	B-T103
.	O
molecular	B-T170
docking	I-T170
was	O
performed	O
to	O
elucidate	O
the	O
antigen	B-T038
-	I-T038
antibody	I-T038
interaction	I-T038
of	O
the	O
monoclonal	B-T103
antibodies	I-T103
against	O
the	O
epitopes	B-T103
on	O
the	O
hl	B-T103
##y	I-T103
##e	I-T103
monomer	B-T103
and	O
oligomer	O
structure	O
.	O
an	O
in	O
-	O
depth	O
view	O
of	O
the	O
mechanistic	O
and	O
positional	O
characteristics	O
of	O
the	O
antibodies	B-T103
and	O
epitope	B-T103
for	O
hl	B-T103
##y	I-T103
##e	I-T103
was	O
successfully	O
accomplished	O
by	O
a	O
combination	O
of	O
phage	B-T062
display	I-T062
and	O
bioinformatic	B-T091
analysis	B-T062
.	O
the	O
predicted	O
function	O
and	O
structure	B-T082
of	O
the	O
antibodies	B-T103
highlights	O
the	O
possibility	O
of	O
utilizing	O
the	O
antibodies	B-T103
as	O
neutralizing	B-T103
agents	I-T103
for	O
typh	B-T038
##oid	I-T038
fever	I-T038
.	O

the	O
clinical	O
prognosis	O
of	O
implants	B-T074
that	O
are	O
placed	O
against	O
super	B-T038
-	I-T038
eru	I-T038
##pt	I-T038
##ed	I-T038
opposing	O
dentition	B-T017
if	O
teeth	B-T017
are	O
missing	B-T017
,	O
super	B-T038
-	I-T038
eruption	I-T038
of	I-T038
teeth	I-T038
in	O
the	O
opposing	O
arch	O
can	O
occur	O
in	O
the	O
area	B-T082
and	O
can	O
change	O
the	O
occlusal	B-T038
plane	I-T038
.	O
when	O
missing	B-T017
teeth	I-T017
are	O
replaced	O
with	O
implants	B-T074
,	O
the	O
oral	B-T097
surgeon	I-T097
must	O
determine	O
whether	O
or	O
not	O
the	O
super	B-T017
-	I-T017
eru	I-T017
##pt	I-T017
##ed	I-T017
teeth	I-T017
need	O
to	O
be	O
treated	O
in	O
order	O
to	O
normalize	B-T062
the	O
occlusal	B-T038
plane	I-T038
.	O
in	O
this	O
study	B-T062
,	O
we	O
evaluated	B-T058
the	O
clinical	O
prognosis	O
of	O
dentition	B-T017
after	O
implant	B-T058
placement	I-T058
and	O
prosthetic	B-T058
treatment	I-T058
were	O
completed	O
in	O
an	O
occlusal	B-T038
plane	I-T038
altered	O
by	O
super	B-T017
-	I-T017
eru	I-T017
##pt	I-T017
##ed	I-T017
teeth	I-T017
in	O
the	O
opposing	O
arch	O
without	O
additional	O
treatment	O
of	O
the	O
super	B-T017
-	I-T017
eru	I-T017
##pt	I-T017
##ed	I-T017
teeth	I-T017
.	O
twenty	O
-	O
two	O
patients	O
(	O
9	O
males	O
,	O
13	O
females	O
)	O
were	O
treated	O
with	O
implants	B-T074
and	O
prosthetic	B-T074
##s	I-T074
without	O
addressing	O
the	O
super	B-T038
-	I-T038
eru	I-T038
##pt	I-T038
##ed	I-T038
opposing	O
dentition	B-T017
from	O
april	O
2004	O
to	O
august	O
2012	O
at	O
se	B-T082
##ou	I-T082
##l	I-T082
national	B-T092
university	I-T092
bund	I-T092
##ang	I-T092
hospital	I-T092
.	O
a	O
total	O
of	O
33	O
implants	B-T074
were	O
placed	O
.	O
values	O
of	O
crest	B-T038
##al	I-T038
bone	I-T038
loss	I-T038
,	O
survival	O
rates	O
,	O
and	O
surgical	B-T038
and	O
prosthetic	B-T038
complications	I-T038
for	O
an	O
average	O
of	O
29	O
.	O
6	O
months	O
after	O
prosthetic	B-T058
loading	I-T058
were	O
recorded	O
.	O
in	O
one	O
case	O
,	O
the	O
cover	B-T074
screw	I-T074
was	O
exposed	O
after	O
implant	B-T058
surgery	I-T058
.	O
the	O
mean	O
crest	B-T038
##al	I-T038
bone	I-T038
loss	I-T038
was	O
0	O
.	O
09	O
##±0	O
.	O
30	O
mm	O
.	O
of	O
the	O
33	O
implants	B-T074
,	O
31	O
survived	O
,	O
a	O
survival	O
rate	O
of	O
93	O
.	O
94	O
%	O
.	O
a	O
prosthetic	B-T038
complication	I-T038
occurred	O
in	O
one	O
case	O
but	O
function	O
##ed	O
well	O
after	O
correction	O
.	O
favorable	O
clinical	B-T033
results	I-T033
from	O
prosthetic	B-T038
complications	I-T038
,	O
crest	B-T038
##al	I-T038
bone	I-T038
loss	I-T038
,	O
and	O
implant	B-T074
survival	O
rates	O
were	O
exhibited	O
in	O
implants	B-T074
next	O
to	O
a	O
super	B-T017
-	I-T017
eru	I-T017
##pt	I-T017
##ed	I-T017
opposing	I-T017
tooth	I-T017
.	O

exercise	O
increases	O
lactoferrin	B-T103
,	O
but	O
decreases	O
lysozyme	B-T103
in	O
salivary	B-T082
granulocytes	B-T017
intracellular	B-T103
lactoferrin	I-T103
(	O
lac	B-T103
)	O
and	O
lysozyme	B-T103
(	O
lys	B-T103
)	O
content	O
play	O
an	O
important	O
role	O
in	O
regulating	O
inflammation	B-T038
and	O
promoting	O
host	B-T038
protection	I-T038
.	O
while	O
exercise	O
has	O
demonstrated	O
an	O
increase	O
in	O
lac	B-T103
and	O
lys	B-T103
concentration	O
in	O
exocrine	B-T031
solutions	I-T031
,	O
little	O
is	O
known	O
regarding	O
intracellular	O
concentration	O
changes	O
in	O
response	O
to	O
exercise	O
.	O
to	O
quantify	O
intracellular	O
lac	B-T103
and	O
lys	B-T103
concentration	O
before	O
and	O
after	O
exercise	O
in	O
salivary	B-T082
cd45	B-T017
(	I-T017
+	I-T017
)	I-T017
cd15	I-T017
(	I-T017
+	I-T017
)	I-T017
cells	I-T017
.	O
11	O
males	O
(	O
20	O
.	O
3	O
±	O
0	O
.	O
8	O
years	O
,	O
57	O
.	O
2	O
±	O
7	O
.	O
6	O
ml	O
/	O
kg	O
/	O
min	O
vo2	O
##p	O
##k	O
,	O
11	O
.	O
1	O
±	O
3	O
.	O
9	O
%	O
body	B-T201
fat	I-T201
)	O
ran	O
for	O
45	O
min	O
at	O
75	O
%	O
of	O
vo2	O
##p	O
##k	O
.	O
12	O
ml	O
of	O
stimulated	B-T031
saliva	I-T031
were	O
collected	O
pre	O
and	O
immediately	O
post	O
exercise	O
.	O
saliva	B-T031
was	O
filtered	O
through	O
a	O
30	O
-	O
µm	O
filter	O
before	O
analysis	O
of	O
leukocytes	B-T017
(	O
cd45	B-T017
(	I-T017
+	I-T017
)	I-T017
)	O
and	O
granulocytes	B-T017
(	O
cd45	B-T017
(	I-T017
+	I-T017
)	I-T017
cd15	I-T017
(	I-T017
+	I-T017
)	I-T017
)	O
using	O
flow	B-T058
cytometry	I-T058
.	O
median	O
fluorescent	O
intensity	O
(	O
mf	O
##i	O
)	O
of	O
lac	B-T103
increased	O
from	O
pre	O
(	O
64	O
,	O
268	O
±	O
46	O
,	O
036	O
mf	O
##i	O
)	O
to	O
post	O
(	O
117	O
,	O
134	O
±	O
88	O
,	O
115	O
mf	O
##i	O
)	O
exercise	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
lys	B-T103
mf	O
##i	O
decreased	O
with	O
exercise	O
(	O
pre	O
:	O
16	O
,	O
93	O
##3	O
±	O
82	O
##49	O
;	O
post	O
:	O
11	O
,	O
61	O
##6	O
±	O
68	O
##75	O
)	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
acute	O
running	O
resulted	O
in	O
an	O
increased	O
lac	B-T103
concentration	O
which	O
could	O
lead	O
to	O
a	O
decrease	O
in	O
inflammation	B-T038
,	O
adding	O
further	O
evidence	O
of	O
the	O
anti	O
-	O
inflammatory	O
effects	O
of	O
exercise	O
.	O
conversely	O
,	O
the	O
exercise	O
-	O
associated	O
decrease	O
of	O
intracellular	B-T103
lys	I-T103
content	O
could	O
be	O
the	O
cause	O
of	O
increased	O
lys	B-T103
in	O
exocrine	B-T031
solutions	I-T031
.	O

the	O
impact	O
of	O
diabetes	B-T038
on	O
the	O
risk	O
of	O
prostate	B-T038
cancer	I-T038
development	O
according	O
to	O
body	B-T201
mass	I-T201
index	I-T201
:	O
a	O
10	O
-	O
year	O
nationwide	O
cohort	O
study	O
purpose	O
:	O
we	O
examined	O
the	O
association	O
between	O
obesity	B-T038
and	O
prostate	B-T038
cancer	I-T038
both	O
with	O
and	O
without	O
diabetic	B-T038
patients	O
included	O
in	O
the	O
analysis	O
using	O
nationally	O
representative	O
data	O
of	O
the	O
korean	B-T098
population	I-T098
from	O
the	O
national	B-T058
health	I-T058
insurance	I-T058
system	I-T058
(	O
nh	B-T058
##is	I-T058
)	O
.	O
materials	O
and	O
methods	O
:	O
of	O
the	O
42	O
##4	O
,	O
71	O
##2	O
participants	B-T098
who	O
underwent	O
health	B-T058
examinations	I-T058
in	O
2002	O
-	O
2008	O
,	O
139	O
,	O
51	O
##9	O
men	B-T098
≥	I-T098
##40	I-T098
years	I-T098
old	I-T098
and	O
without	O
prostate	B-T038
cancer	I-T038
were	O
followed	O
from	O
the	O
beginning	O
of	O
2002	O
to	O
the	O
end	O
of	O
2012	O
.	O
multivariate	O
adjusted	O
cox	B-T170
regression	I-T170
analysis	I-T170
was	O
conducted	O
to	O
examine	O
the	O
hazard	O
ratio	O
(	O
hr	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
for	O
the	O
association	O
between	O
prostate	B-T038
cancer	I-T038
and	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
both	O
with	O
and	O
without	O
diabetes	B-T038
.	O
results	O
:	O
the	O
hr	O
for	O
prostate	B-T038
cancer	I-T038
according	O
to	O
the	O
existence	O
of	O
diabetes	B-T038
was	O
stratified	O
by	O
bmi	B-T201
in	O
both	O
age	O
-	O
and	O
multivariable	O
-	O
adjusted	O
models	O
.	O
in	O
the	O
population	B-T098
without	O
diabetes	B-T038
,	O
the	O
hr	O
for	O
prostate	B-T038
cancer	I-T038
significantly	O
increased	O
as	O
bmi	B-T201
increased	O
beyond	O
the	O
reference	O
range	O
in	O
a	O
model	O
adjusted	O
for	O
age	O
and	O
multiple	O
variables	O
;	O
however	O
,	O
the	O
increase	O
in	O
the	O
hr	O
was	O
small	O
.	O
in	O
the	O
population	B-T098
with	O
diabetes	B-T038
,	O
the	O
hr	O
for	O
prostate	B-T038
cancer	I-T038
significantly	O
increased	O
as	O
bmi	B-T201
increased	O
from	O
<	O
18	O
.	O
5	O
kg	O
/	O
m	O
(	O
2	O
)	O
to	O
within	O
the	O
reference	O
range	O
(	O
18	O
.	O
5	O
to	O
22	O
.	O
9	O
)	O
in	O
the	O
multivariable	O
-	O
adjusted	O
model	O
.	O
in	O
addition	O
,	O
a	O
marked	O
decrease	O
in	O
hr	O
in	O
the	O
population	B-T098
with	O
bmi	B-T201
of	O
<	O
18	O
.	O
5	O
kg	O
/	O
m	O
(	O
2	O
)	O
was	O
seen	O
compared	O
to	O
the	O
reference	O
or	O
higher	O
bmi	B-T201
population	B-T098
.	O
conclusion	O
:	O
this	O
population	B-T098
-	O
based	O
study	O
shows	O
the	O
evidence	O
of	O
association	O
between	O
obesity	B-T038
and	O
development	O
of	O
prostate	B-T038
cancer	I-T038
,	O
and	O
the	O
risk	B-T033
increases	I-T033
vary	O
according	O
to	O
the	O
change	O
of	O
bmi	B-T201
category	O
and	O
the	O
existence	O
of	O
diabetes	B-T038
.	O

choroidal	O
vascularity	O
index	O
:	O
a	O
novel	O
optical	B-T058
coherence	I-T058
tomography	I-T058
based	O
parameter	O
in	O
patients	O
with	O
exud	B-T038
##ative	I-T038
age	I-T038
-	I-T038
related	I-T038
macular	I-T038
degeneration	I-T038
to	O
evaluate	O
choroidal	B-T017
structural	B-T082
changes	O
in	O
exud	B-T038
##ative	I-T038
age	I-T038
-	I-T038
related	I-T038
macular	I-T038
degeneration	I-T038
(	O
amd	B-T038
)	O
using	O
choroidal	O
vascularity	O
index	O
computed	O
from	O
image	O
bin	O
##ari	O
##zation	O
on	O
spectral	B-T058
domain	I-T058
optical	I-T058
coherence	I-T058
tomography	I-T058
with	O
enhanced	O
depth	B-T058
imaging	I-T058
.	O
this	O
prospective	O
case	B-T062
series	I-T062
included	O
42	O
consecutive	O
patients	O
with	O
unilateral	B-T082
exud	B-T038
##ative	I-T038
amd	I-T038
.	O
choroidal	B-T017
images	B-T058
were	O
segmented	O
into	O
luminal	B-T082
area	B-T082
and	O
stromal	O
area	O
.	O
choroidal	O
vascularity	O
index	O
was	O
defined	O
as	O
the	O
ratio	O
of	O
luminal	B-T082
area	B-T082
to	O
total	O
choroid	O
area	B-T082
.	O
mean	O
choroidal	O
vascularity	O
index	O
and	O
mean	O
choroidal	O
thickness	O
between	O
study	B-T062
and	O
fellow	O
eyes	B-T017
of	O
the	O
same	O
patient	O
with	O
dry	O
amd	B-T038
were	O
compared	O
using	O
student	O
'	O
s	O
t	O
-	O
test	O
.	O
there	O
was	O
a	O
significantly	O
lower	O
choroidal	O
vascularity	O
index	O
in	O
eyes	B-T017
with	O
exud	B-T038
##ative	I-T038
amd	I-T038
(	O
60	O
.	O
14	O
±	O
4	O
.	O
55	O
vs	O
.	O
62	O
.	O
75	O
±	O
4	O
.	O
82	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
luminal	B-T082
area	I-T082
(	O
p	O
<	O
0	O
.	O
01	O
)	O
was	O
decreased	O
in	O
eyes	B-T017
with	O
exud	B-T038
##ative	I-T038
amd	I-T038
but	O
there	O
was	O
no	O
significant	O
difference	O
in	O
total	O
choroid	O
area	B-T082
(	O
p	O
=	O
0	O
.	O
05	O
)	O
and	O
choroidal	O
thickness	O
(	O
p	O
=	O
0	O
.	O
93	O
)	O
between	O
study	B-T062
and	O
fellow	O
eyes	B-T017
.	O
eyes	B-T017
with	O
exud	B-T038
##ative	I-T038
amd	I-T038
demonstrated	O
reduced	O
choroidal	O
vascularity	O
index	O
but	O
insignificant	O
differences	O
in	O
choroidal	O
thickness	O
compared	O
with	O
their	O
fellow	O
eyes	B-T017
.	O
choroidal	O
vascularity	O
index	O
may	O
be	O
a	O
potential	O
noninvasive	B-T033
tool	I-T033
for	O
studying	B-T062
structural	B-T082
changes	O
in	O
choroid	B-T017
and	O
monitoring	O
choroidal	B-T038
disease	I-T038
in	O
exud	B-T038
##ative	I-T038
amd	I-T038
.	O

incidence	O
of	O
environmental	O
and	O
genetic	O
factors	O
causing	O
congenital	B-T017
cataract	I-T017
in	O
children	O
of	O
la	O
##ho	O
##re	O
to	O
check	O
the	O
incidence	O
of	O
environmental	O
and	O
genetic	O
factors	O
causing	O
congenital	B-T017
cataract	I-T017
in	O
infants	O
.	O
the	O
descriptive	B-T062
study	I-T062
was	O
conducted	O
at	O
lay	B-T092
##ton	I-T092
ra	I-T092
##h	I-T092
##ma	I-T092
##t	I-T092
##ull	I-T092
##ah	I-T092
bene	I-T092
##vo	I-T092
##len	I-T092
##t	I-T092
trust	I-T092
,	O
la	O
##ho	O
##re	O
,	O
pakistan	B-T082
,	O
from	O
october	O
2013	O
to	O
april	O
2014	O
,	O
and	O
comprised	O
children	O
under	O
15	O
years	O
of	O
age	O
who	O
had	O
rubella	O
syndrome	O
,	O
herpes	B-T038
simplex	I-T038
,	O
birth	B-T033
trauma	I-T033
,	O
trisomy	B-T038
21	I-T038
,	O
nan	B-T038
##ce	I-T038
-	I-T038
hor	I-T038
##an	I-T038
syndrome	I-T038
or	O
low	B-T038
##e	I-T038
'	I-T038
s	I-T038
syndrome	I-T038
.	O
of	O
the	O
38	O
,	O
000	O
cases	O
examined	O
,	O
120	O
(	O
0	O
.	O
3	O
%	O
)	O
patients	O
were	O
diagnosed	B-T033
with	O
congenital	B-T017
cataract	I-T017
.	O
of	O
them	O
,	O
52	O
(	O
43	O
.	O
33	O
%	O
)	O
were	O
aged	O
between	O
2	O
and	O
5	O
years	O
,	O
22	O
(	O
18	O
.	O
33	O
%	O
)	O
<	O
11	O
years	O
and	O
10	O
(	O
8	O
.	O
33	O
%	O
)	O
?	O
15	O
years	O
.	O
bilateral	B-T038
congenital	I-T038
cataract	I-T038
was	O
observed	O
in	O
91	O
(	O
75	O
.	O
83	O
%	O
)	O
patients	O
and	O
unilateral	B-T038
congenital	I-T038
cataract	I-T038
in	O
29	O
(	O
24	O
.	O
17	O
%	O
)	O
.	O
environmental	O
factors	O
caused	O
72	O
(	O
62	O
.	O
07	O
%	O
)	O
cases	O
and	O
genetic	O
factors	O
caused	O
44	O
(	O
37	O
.	O
93	O
%	O
)	O
.	O
.	O
congenital	B-T017
cataract	I-T017
predominated	O
in	O
boys	O
compared	O
to	O
girls	O
.	O
early	O
diagnosis	B-T033
and	O
adequate	O
therapy	B-T058
requires	O
specific	O
technology	O
,	O
as	O
well	O
as	O
long	O
-	O
term	O
and	O
permanent	O
care	O
.	O
.	O

intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
in	O
the	O
prevention	O
of	O
postoperative	B-T038
endophthalmitis	I-T038
:	O
an	O
experience	B-T038
from	O
hong	B-T082
kong	I-T082
the	O
purpose	O
was	O
to	O
study	B-T062
the	O
effect	O
of	O
introducing	O
intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
,	O
which	O
was	O
compound	B-T058
##ed	I-T058
by	O
a	O
hospital	O
pharmacy	O
,	O
on	O
postoperative	B-T038
endophthalmitis	I-T038
in	O
a	O
tertiary	O
eye	O
centre	O
in	O
hong	B-T082
kong	I-T082
.	O
all	O
cases	O
that	O
underwent	O
cataract	B-T058
surgeries	I-T058
over	O
a	O
12	O
-	O
year	O
period	O
(	O
january	O
2004	O
to	O
december	O
2015	O
)	O
were	O
included	O
.	O
the	O
routine	O
use	O
of	O
intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
at	O
the	O
end	O
of	O
cataract	B-T058
surgery	I-T058
was	O
introduced	O
at	O
our	O
centre	O
after	O
april	O
2010	O
.	O
all	O
cef	B-T103
##uro	I-T103
##xime	I-T103
aliqu	O
##ots	O
were	O
prepared	O
by	O
the	O
hospital	O
pharmacy	O
using	O
an	O
aseptic	B-T058
compound	I-T058
##ing	I-T058
technique	O
.	O
the	O
rates	O
of	O
postoperative	B-T038
endophthalmitis	I-T038
before	O
april	O
2010	O
(	O
group	O
1	O
,	O
no	O
intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
)	O
and	O
after	O
april	O
2010	O
(	O
group	O
2	O
,	O
routine	O
use	O
of	O
intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
)	O
were	O
compared	O
.	O
a	O
total	O
of	O
30	O
,	O
42	O
##8	O
eyes	B-T017
(	O
7	O
,	O
332	O
in	O
group	O
1	O
and	O
23	O
,	O
09	O
##6	O
in	O
group	O
2	O
)	O
were	O
studied	O
.	O
eight	O
cases	O
developed	O
postoperative	B-T038
endophthalmitis	I-T038
(	O
1	O
.	O
09	O
in	O
1000	O
;	O
0	O
.	O
11	O
%	O
)	O
in	O
group	O
1	O
whereas	O
no	O
cases	O
developed	O
endophthalmitis	B-T038
(	O
0	O
%	O
)	O
in	O
group	O
2	O
.	O
the	O
rate	O
of	O
reduction	O
was	O
statistically	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
seven	O
out	O
of	O
eight	O
cases	O
of	O
endophthalmitis	B-T038
were	O
confirmed	O
by	O
positive	B-T033
culture	I-T033
.	O
organisms	O
identified	O
were	O
group	B-T007
g	I-T007
streptococcus	I-T007
(	O
two	O
cases	O
)	O
,	O
group	B-T007
b	I-T007
streptococcus	I-T007
,	O
staphylococcus	B-T007
aureus	I-T007
,	O
serr	B-T007
##atia	I-T007
marc	I-T007
##es	I-T007
##cens	I-T007
,	O
and	O
coagulase	B-T007
-	I-T007
negative	I-T007
staphylococcus	I-T007
(	O
two	O
cases	O
)	O
.	O
antibiotic	B-T033
susceptibility	I-T033
testing	B-T033
results	I-T033
were	O
available	O
in	O
six	O
cases	O
.	O
four	O
out	O
of	O
six	O
organisms	O
were	O
susceptible	O
to	O
the	O
penicillin	B-T103
group	I-T103
.	O
no	B-T033
adverse	I-T033
events	I-T033
related	O
to	O
the	O
use	O
of	O
intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
were	O
encountered	O
.	O
the	O
use	O
of	O
intrac	B-T082
##amer	I-T082
##al	I-T082
cef	B-T103
##uro	I-T103
##xime	I-T103
could	O
significantly	O
reduce	O
the	O
rate	O
of	O
postoperative	B-T038
endophthalmitis	I-T038
in	O
a	O
tertiary	O
centre	O
in	O
hong	B-T082
kong	I-T082
.	O
the	O
use	O
of	O
aseptic	B-T058
compound	I-T058
##ing	I-T058
to	O
prepare	O
cef	B-T103
##uro	I-T103
##xime	I-T103
aliqu	O
##ots	O
by	O
hospital	O
pharmacy	O
appeared	O
to	O
be	O
safe	O
and	O
efficacious	O
.	O

the	O
impact	O
on	O
productivity	O
of	O
a	O
hypothetical	O
tax	O
on	O
sugar	B-T168
-	I-T168
sweet	I-T168
##ened	I-T168
beverages	I-T168
to	O
quantify	O
the	O
potential	O
impact	O
of	O
an	O
additional	O
20	O
%	O
tax	O
on	O
sugar	B-T168
-	I-T168
sweet	I-T168
##ened	I-T168
beverages	I-T168
(	O
ssb	B-T168
##s	I-T168
)	O
on	O
productivity	O
in	O
australia	B-T082
.	O
we	O
used	O
a	O
multi	B-T170
-	I-T170
state	I-T170
life	I-T170
##ta	I-T170
##ble	I-T170
markov	I-T170
model	I-T170
to	O
examine	B-T033
the	O
potential	O
impact	O
of	O
an	O
additional	O
20	O
%	O
tax	O
on	O
ssb	B-T168
##s	I-T168
on	O
total	O
lifetime	O
productivity	O
in	O
the	O
paid	O
and	O
unp	O
##aid	O
sectors	O
of	O
the	O
economy	O
.	O
the	O
study	B-T098
population	I-T098
consisted	O
of	O
australian	B-T098
##s	I-T098
aged	O
20	O
years	O
or	O
older	B-T098
in	O
2010	O
,	O
whose	O
health	O
and	O
other	O
relevant	O
outcomes	O
were	O
modelled	B-T062
over	O
their	O
remaining	O
lifetime	O
.	O
the	O
ssb	B-T168
##s	I-T168
tax	O
was	O
estimated	O
to	O
reduce	O
the	O
number	O
of	O
people	B-T098
with	O
obesity	B-T038
by	O
1	O
.	O
96	O
%	O
of	O
the	O
entire	O
population	B-T098
(	O
43	O
##7	O
,	O
000	O
fewer	O
persons	B-T098
with	O
obesity	B-T038
)	O
,	O
and	O
reduce	O
the	O
number	O
of	O
employees	B-T097
with	O
obesity	B-T038
by	O
317	O
,	O
000	O
persons	B-T098
.	O
these	O
effects	O
translated	O
into	O
productivity	O
gains	O
in	O
the	O
paid	O
sector	O
of	O
au	O
$	O
75	O
##1	O
million	O
for	O
the	O
working	O
-	O
age	O
population	B-T098
(	O
95	O
%	O
confidence	O
interval	O
:	O
au	O
$	O
56	O
##5	O
million	O
to	O
au	O
$	O
95	O
##4	O
million	O
)	O
,	O
using	O
the	O
human	O
capital	O
approach	B-T082
.	O
in	O
the	O
unp	O
##aid	O
sector	O
,	O
the	O
potential	O
productivity	O
gains	O
amounted	O
to	O
au	O
$	O
117	O
##2	O
million	O
(	O
au	O
$	O
92	O
##9	O
million	O
to	O
au	O
$	O
143	O
##5	O
million	O
)	O
using	O
the	O
replacement	B-T170
cost	I-T170
method	I-T170
.	O
these	O
productivity	O
benefits	O
are	O
in	O
addition	O
to	O
the	O
health	O
benefits	O
of	O
35	O
,	O
000	O
life	O
years	O
gained	O
and	O
a	O
reduction	O
in	O
healthcare	O
costs	O
of	O
au	O
$	O
425	O
million	O
.	O
an	O
additional	O
20	O
%	O
tax	O
on	O
ssb	B-T168
##s	I-T168
not	O
only	O
improves	B-T033
health	O
outcomes	O
and	O
reduces	O
healthcare	O
costs	O
,	O
but	O
provides	O
productivity	O
gains	O
in	O
both	O
the	O
paid	O
and	O
unp	O
##aid	O
sectors	O
of	O
the	O
economy	O
.	O

a	O
systematic	B-T170
review	I-T170
of	O
the	O
diagnostic	O
and	O
prognostic	O
value	O
of	O
urinary	O
protein	B-T103
biomarkers	B-T201
in	O
urothelial	B-T038
bladder	I-T038
cancer	I-T038
for	O
over	O
80	O
years	O
,	O
cyst	B-T058
##oscopy	I-T058
has	O
remained	O
the	O
gold	O
-	O
standard	O
for	O
detecting	B-T033
tumours	B-T038
of	O
the	O
urinary	B-T017
bladder	I-T017
.	O
since	O
bladder	B-T038
tumours	I-T038
have	O
a	O
tendency	O
to	O
rec	O
##ur	O
and	O
progress	B-T038
,	O
many	O
patients	O
are	O
subjected	O
to	O
repeated	O
cyst	B-T058
##oscop	I-T058
##ies	I-T058
during	O
long	O
-	O
term	O
surveillance	B-T058
,	O
with	O
the	O
procedure	B-T058
being	O
both	O
unpleasant	O
for	O
the	O
patient	O
and	O
expensive	O
for	O
healthcare	B-T097
providers	I-T097
.	O
the	O
identification	O
and	O
validation	B-T062
of	O
bladder	B-T038
tumour	I-T038
specific	O
molecular	B-T201
markers	I-T201
in	O
urine	B-T031
could	O
enable	O
tumour	B-T038
detection	B-T033
and	O
reduce	O
reliance	O
on	O
cyst	B-T058
##oscopy	I-T058
,	O
and	O
numerous	O
classes	O
of	O
biomarkers	B-T201
have	O
been	O
studied	O
.	O
proteins	B-T103
represent	O
the	O
most	O
intensively	O
studied	O
class	O
of	O
biom	O
##olecule	O
in	O
this	O
setting	O
.	O
as	O
an	O
aid	O
to	O
researchers	B-T097
searching	O
for	O
better	O
urinary	O
biomarkers	B-T201
,	O
we	O
report	O
a	O
comprehensive	B-T170
systematic	I-T170
review	I-T170
of	O
the	O
literature	B-T170
and	O
a	O
search	O
##able	O
database	B-T170
of	O
proteins	B-T103
that	O
have	O
been	O
investigated	B-T058
to	O
date	O
.	O
our	O
objective	O
was	O
to	O
classify	O
these	O
proteins	B-T103
as	O
:	O
1	O
)	O
those	O
with	O
robustly	O
characterised	O
sensitivity	O
and	O
specificity	O
for	O
bladder	B-T038
cancer	I-T038
detection	B-T033
;	O
2	O
)	O
those	O
that	O
show	O
potential	O
but	O
further	O
investigation	B-T058
is	O
required	O
;	O
3	O
)	O
those	O
unlikely	O
to	O
warrant	O
further	O
investigation	B-T058
;	O
and	O
4	O
)	O
those	O
investigated	B-T058
as	O
prognostic	O
markers	O
.	O
this	O
work	O
should	O
help	O
to	O
priori	O
##tise	O
certain	O
biomarkers	B-T201
for	O
rigorous	B-T062
validation	I-T062
,	O
whilst	O
preventing	O
waste	O
##d	O
effort	O
on	O
proteins	B-T103
that	O
have	O
shown	O
no	O
association	O
what	O
##so	O
##ever	O
with	O
the	O
disease	B-T038
,	O
or	O
only	O
modest	O
biomarker	B-T201
performance	O
despite	O
large	O
-	O
scale	O
efforts	O
at	O
validation	B-T062
.	O

pharmacological	B-T038
actions	I-T038
of	O
glucagon	B-T103
-	I-T103
like	I-T103
peptide	I-T103
-	I-T103
1	I-T103
,	O
gastric	B-T103
inhibitory	I-T103
polypeptide	I-T103
,	O
and	O
glucagon	B-T103
glucagon	B-T103
family	I-T103
of	O
peptide	B-T103
hormones	I-T103
is	O
a	O
group	O
of	O
structurally	O
related	O
brain	B-T103
-	I-T103
gut	I-T103
peptides	I-T103
that	O
exert	O
their	O
pleiotropic	B-T038
actions	I-T038
through	O
interactions	O
with	O
unique	B-T170
members	I-T170
of	I-T170
class	I-T170
b1	I-T170
g	B-T103
protein	I-T103
-	I-T103
coupled	I-T103
receptors	I-T103
(	O
gpcrs	B-T103
)	O
.	O
they	O
are	O
key	O
regulators	O
of	O
hormonal	O
homeostasis	B-T038
and	O
are	O
important	O
drug	B-T074
targets	I-T074
for	O
metabolic	B-T038
disorders	I-T038
such	O
as	O
type	B-T038
-	I-T038
2	I-T038
diabetes	I-T038
mellitus	I-T038
(	O
t2dm	B-T038
)	O
,	O
obesity	B-T038
,	O
and	O
dysregulation	B-T038
##s	I-T038
of	I-T038
the	I-T038
nervous	I-T038
systems	I-T038
such	O
as	O
migraine	B-T038
,	O
anxiety	B-T038
,	O
depression	B-T038
,	O
neurodegeneration	B-T038
,	O
psychiatric	B-T038
disorders	I-T038
,	O
and	O
cardiovascular	B-T038
diseases	I-T038
.	O
the	O
current	O
review	O
aims	O
to	O
provide	O
a	O
detailed	O
overview	O
of	O
the	O
current	O
understanding	O
of	O
the	O
pharmacological	B-T038
actions	I-T038
and	O
therapeutic	B-T058
advances	I-T058
of	O
three	O
members	O
within	O
this	O
family	O
including	O
glucagon	B-T103
-	I-T103
like	I-T103
peptide	I-T103
-	I-T103
1	I-T103
(	O
glp	B-T103
-	I-T103
1	I-T103
)	O
,	O
gastric	B-T103
inhibitory	I-T103
polypeptide	I-T103
(	O
gip	B-T103
)	O
,	O
and	O
glucagon	B-T103
.	O

mir	B-T017
-	I-T017
27	I-T017
##b	I-T017
inhibits	O
gastric	B-T038
cancer	I-T038
metastasis	B-T038
by	O
targeting	O
nr	B-T103
##2	I-T103
##f2	I-T103
increasing	O
attention	B-T038
is	O
focused	O
on	O
the	O
down	B-T038
-	I-T038
regulation	I-T038
of	O
mirnas	B-T103
in	O
cancer	B-T038
process	I-T038
.	O
nuclear	B-T103
receptor	I-T103
subfamily	I-T103
2	I-T103
(	O
nr	B-T103
##2	I-T103
##f2	I-T103
,	O
also	O
known	O
as	O
cou	B-T103
##p	I-T103
-	I-T103
tf	I-T103
##ii	I-T103
)	O
is	O
involved	O
in	O
the	O
development	O
of	O
many	O
types	O
of	O
cancers	B-T038
,	O
but	O
its	O
role	O
in	O
gastric	B-T038
cancer	I-T038
remains	O
elusive	O
.	O
in	O
this	O
experiment	B-T062
,	O
onc	B-T170
##om	I-T170
##ine	I-T170
and	O
kaplan	B-T170
-	I-T170
meier	I-T170
database	I-T170
revealed	O
that	O
nr	B-T103
##2	I-T103
##f2	I-T103
was	O
up	B-T038
-	I-T038
regulated	I-T038
in	O
gastric	B-T038
cancer	I-T038
and	O
that	O
the	O
high	O
nr	B-T103
##2	I-T103
##f2	I-T103
expression	B-T038
contributed	O
to	O
poor	O
survival	O
.	O
microrna	B-T017
-	I-T017
27	I-T017
##b	I-T017
was	O
targeted	O
and	O
down	B-T038
-	I-T038
regulated	I-T038
by	O
nr	B-T103
##2	I-T103
##f2	I-T103
in	O
human	B-T204
gastric	B-T038
cancer	I-T038
tissues	B-T017
and	O
cells	B-T017
.	O
the	O
ectopic	B-T038
expression	I-T038
of	O
mir	B-T017
-	I-T017
27	I-T017
##b	I-T017
inhibited	O
gastric	B-T038
cancer	I-T038
cell	B-T038
proliferation	I-T038
and	O
tumor	O
growth	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O
assays	B-T058
suggested	O
that	O
the	O
overexpression	B-T038
of	O
mir	B-T017
-	I-T017
27	I-T017
##b	I-T017
could	O
promote	O
mg	B-T017
##c	I-T017
-	I-T017
80	I-T017
##3	I-T017
cells	I-T017
'	O
migration	B-T038
and	O
invasion	B-T038
and	O
retard	O
their	O
metastasis	B-T038
to	O
the	O
liver	B-T017
.	O
in	O
addition	O
,	O
down	B-T038
-	I-T038
regulation	I-T038
of	O
mir	B-T017
-	I-T017
27	I-T017
##b	I-T017
enhanced	O
ge	B-T017
##s	I-T017
-	I-T017
1	I-T017
cells	I-T017
'	O
proliferation	B-T038
and	O
metastasis	B-T038
in	O
vitro	O
.	O
these	O
findings	B-T033
reveal	O
that	O
mir	B-T017
-	I-T017
27	I-T017
##b	I-T017
is	O
a	O
tumor	B-T017
suppressor	I-T017
in	O
gastric	B-T038
cancer	I-T038
and	O
a	O
biomarker	B-T201
for	O
improving	O
patients	O
'	O
survival	O
.	O

feasibility	B-T062
of	O
a	O
transition	O
intervention	B-T058
aimed	O
at	O
adolescents	O
with	O
chronic	B-T038
illness	I-T038
international	O
guidelines	B-T170
recommend	O
planned	O
and	O
structured	O
transition	O
programmes	B-T058
for	O
adolescents	O
with	O
chronic	B-T038
illness	I-T038
because	O
inadequate	O
transition	O
may	O
lead	O
to	O
poor	B-T033
disease	I-T033
control	I-T033
and	O
risk	O
of	O
lacking	O
outpatient	B-T058
follow	I-T058
-	I-T058
up	I-T058
.	O
to	O
investigate	O
the	O
feasibility	B-T062
of	O
a	O
transition	O
intervention	B-T058
aimed	O
at	O
adolescents	O
with	O
chronic	B-T038
illness	I-T038
focusing	B-T038
on	O
declines	O
,	O
drop	B-T098
-	I-T098
outs	I-T098
,	O
no	O
-	O
shows	O
and	O
advantages	O
and	O
disadvantages	O
of	O
participating	O
.	O
we	O
invited	O
236	O
adolescents	O
(	O
12	O
-	O
20	O
years	O
)	O
with	O
juvenile	B-T038
idiopathic	I-T038
arthritis	I-T038
(	O
jia	B-T038
)	O
to	O
participate	O
in	O
a	O
randomised	B-T062
controlled	I-T062
trial	I-T062
(	O
rct	B-T062
)	O
transition	O
intervention	B-T058
.	O
reasons	O
for	O
decline	O
and	O
drop	B-T098
-	I-T098
outs	I-T098
were	O
calculated	O
.	O
adolescents	O
'	O
experiences	B-T038
of	O
advantages	O
and	O
disadvantages	O
of	O
participating	O
and	O
reasons	O
for	O
no	O
-	O
shows	O
were	O
investigated	O
through	O
focus	O
groups	O
and	O
telephone	B-T062
interviews	I-T062
,	O
which	O
were	O
analysed	B-T062
using	O
thematic	B-T062
analysis	B-T062
.	O
one	O
hundred	O
and	O
twenty	O
of	O
the	O
236	O
eligible	O
patients	O
declined	O
to	O
participate	O
in	O
the	O
intervention	B-T058
and	O
20	O
%	O
dropped	B-T098
out	I-T098
during	O
the	O
intervention	B-T058
.	O
unsp	O
##ec	O
##ified	O
declines	O
and	O
practical	B-T033
issues	I-T033
were	O
the	O
most	O
common	O
reason	O
to	O
decline	O
,	O
and	O
'	O
do	O
not	O
wish	O
to	O
continue	O
'	O
was	O
the	O
most	O
common	O
reason	O
to	O
drop	B-T098
-	I-T098
out	I-T098
.	O
reasons	O
for	O
no	O
-	O
shows	O
were	O
forget	O
##ting	O
and	O
being	O
too	O
bus	O
##y	O
.	O
advantages	O
of	O
participating	O
were	O
stated	O
as	O
'	O
participating	O
without	O
parents	O
'	O
,	O
'	O
trust	O
and	O
confidential	O
##ity	O
'	O
,	O
'	O
being	O
able	O
to	O
set	O
the	O
agenda	O
'	O
and	O
'	O
responsiveness	O
'	O
.	O
disadvantages	O
were	O
'	O
unclear	O
aim	O
of	O
the	O
study	B-T062
'	O
,	O
'	O
meeting	O
others	O
with	O
jia	B-T038
'	O
,	O
'	O
too	O
few	O
convers	O
##ations	O
'	O
and	O
'	O
transport	O
issues	B-T033
'	O
.	O
many	O
adolescents	O
had	O
difficulties	B-T033
understanding	B-T038
the	O
aim	O
of	O
the	O
intervention	B-T058
.	O
however	O
,	O
most	O
participants	O
appreciated	O
the	O
convers	O
##ations	O
about	O
identity	O
as	O
well	O
as	O
the	O
trust	O
and	O
confidential	O
##ity	O
in	O
the	O
communication	O
.	O
in	O
the	O
future	O
,	O
adolescents	O
should	O
be	O
offered	O
more	O
individually	O
organis	O
##ed	O
programmes	B-T058
according	O
to	O
their	O
preferences	O
and	O
needs	O
in	O
cooperation	O
with	O
parents	O
and	O
health	B-T097
care	I-T097
providers	I-T097
.	O

temporal	O
upregulation	B-T038
of	O
host	B-T103
surface	I-T103
receptors	I-T103
provides	O
a	O
window	O
of	O
opportunity	O
for	O
bacterial	B-T038
adhesion	I-T038
and	O
disease	B-T038
host	B-T103
surface	I-T103
receptors	I-T103
provide	O
bacteria	B-T007
with	O
a	O
foot	O
##hold	O
from	O
which	O
to	O
attach	O
,	O
colon	O
##ize	O
and	O
,	O
in	O
some	O
cases	O
,	O
invade	O
tissue	B-T017
and	O
elicit	O
human	B-T204
disease	B-T038
.	O
in	O
this	O
review	O
,	O
we	O
discuss	O
several	O
key	O
host	B-T103
receptors	I-T103
and	O
cognate	B-T017
adhes	I-T017
##ins	I-T017
that	O
function	O
in	O
bacterial	B-T007
pathogenesis	B-T038
.	O
in	O
particular	O
,	O
we	O
examine	O
the	O
elevated	O
expression	O
of	O
host	B-T103
surface	I-T103
receptors	I-T103
such	O
as	O
cea	B-T103
##cam	I-T103
-	I-T103
1	I-T103
,	O
cea	B-T103
##cam	I-T103
-	I-T103
6	I-T103
,	O
icam	B-T103
-	I-T103
1	I-T103
and	O
paf	B-T103
##r	I-T103
in	O
response	B-T038
to	I-T038
specific	I-T038
stimuli	I-T038
.	O
we	O
explore	O
how	O
upregulated	B-T038
receptors	I-T038
,	O
in	O
turn	O
,	O
expose	O
the	O
host	O
to	O
a	O
range	O
of	O
bacterial	B-T038
infections	I-T038
in	O
the	O
respiratory	B-T022
tract	I-T022
.	O
it	O
is	O
apparent	O
that	O
exploitation	O
of	O
receptor	B-T103
induction	O
for	O
bacterial	B-T038
adherence	I-T038
is	O
not	O
unique	O
to	O
one	O
body	B-T022
system	I-T022
,	O
but	O
is	O
also	O
observed	O
in	O
the	O
central	B-T022
nervous	I-T022
,	O
gastrointestinal	B-T022
and	O
urogenital	B-T022
systems	I-T022
.	O
prokaryotic	O
pathogens	B-T038
which	O
utilize	O
this	O
mechanism	O
for	O
their	O
infectivity	B-T038
include	O
streptococcus	B-T007
pneumoniae	I-T007
,	O
haemophilus	B-T007
influenzae	I-T007
,	O
neisseria	B-T007
meningitidis	I-T007
and	O
escherichia	B-T007
coli	I-T007
.	O
a	O
number	O
of	O
approaches	O
have	O
been	O
used	O
,	O
in	O
both	O
in	B-T062
vitro	I-T062
and	O
in	B-T062
vivo	I-T062
experimental	I-T062
models	I-T062
,	O
to	O
inhibit	O
bacterial	B-T038
attachment	I-T038
to	O
temporally	O
expressed	O
host	B-T103
receptors	I-T103
.	O
some	O
of	O
these	O
novel	O
strategies	O
may	O
advance	O
future	O
targeted	O
interventions	B-T058
for	O
the	O
prevention	B-T058
and	O
treatment	B-T058
of	O
bacterial	B-T038
disease	I-T038
.	O

structural	B-T082
insights	B-T038
into	O
5	B-T103
-	I-T103
ht1a	I-T103
/	O
d4	B-T103
selectivity	O
of	O
way	B-T103
-	I-T103
100	I-T103
##63	I-T103
##5	I-T103
analogues	B-T103
:	O
molecular	B-T062
modeling	I-T062
,	O
synthesis	O
,	O
and	O
in	O
vitro	O
binding	B-T038
the	O
res	O
##urge	O
##nc	O
##e	O
of	O
interest	O
in	O
5	B-T103
-	I-T103
ht1a	I-T103
receptors	I-T103
as	O
a	O
therapeutic	O
target	O
requires	O
the	O
existence	O
of	O
highly	O
selective	O
5	B-T103
-	I-T103
ht1a	I-T103
ligands	B-T103
.	O
to	O
date	O
,	O
way	B-T103
-	I-T103
100	I-T103
##63	I-T103
##5	I-T103
has	O
been	O
the	O
proto	B-T103
##ty	I-T103
##pic	I-T103
##al	I-T103
antagonist	I-T103
of	O
these	O
receptors	B-T103
.	O
however	O
,	O
this	O
compound	O
also	O
has	O
significant	O
affinity	O
for	O
and	O
activity	O
at	O
d4	B-T103
dopamine	I-T103
receptors	I-T103
.	O
in	O
this	O
context	O
,	O
this	O
work	O
was	O
aimed	O
at	O
better	O
understanding	O
the	O
5	B-T103
-	I-T103
ht1a	I-T103
/	O
d4	B-T103
selectivity	O
of	O
way	B-T103
-	I-T103
100	I-T103
##63	I-T103
##5	I-T103
and	O
analogues	B-T103
from	O
a	O
structural	B-T082
point	O
of	O
view	O
.	O
in	O
silico	O
investigations	O
revealed	O
two	O
key	O
interactions	O
for	O
the	O
5	B-T103
-	I-T103
ht1a	I-T103
/	O
d4	B-T103
selectivity	O
of	O
way	B-T103
-	I-T103
100	I-T103
##63	I-T103
##5	I-T103
and	O
analogues	B-T103
.	O
first	O
,	O
a	O
hydrogen	O
bond	O
only	O
found	O
with	O
the	O
ser	B-T103
7	I-T103
.	I-T103
36	I-T103
of	O
d4	B-T103
receptor	I-T103
appeared	O
to	O
be	O
the	O
key	O
for	O
a	O
higher	O
d4	B-T103
affinity	O
for	O
newly	O
synthesized	O
aza	B-T103
analogues	B-T103
.	O
the	O
role	O
of	O
ser	B-T103
7	I-T103
.	I-T103
36	I-T103
was	O
confirmed	O
as	O
the	O
affinity	O
of	O
aza	B-T103
analogues	B-T103
for	O
the	O
mutant	B-T038
d4	B-T103
receptor	I-T103
s	I-T103
##7	I-T103
.	I-T103
36	I-T103
##a	I-T103
was	O
reduced	O
.	O
then	O
,	O
the	O
formation	O
of	O
another	O
hydrogen	O
bond	O
with	O
the	O
conserved	O
ser	B-T103
5	I-T103
.	I-T103
42	I-T103
residue	I-T103
appeared	O
to	O
be	O
also	O
critical	O
for	O
d4	B-T103
binding	B-T038
.	O

pan	B-T103
##itum	I-T103
##umab	I-T103
-	O
associated	O
encephalopathy	B-T038
after	O
accidental	O
intra	O
-	O
arterial	O
application	B-T058
through	O
disl	B-T074
##ocated	I-T074
central	I-T074
venous	I-T074
access	I-T074
device	I-T074
acute	O
central	B-T022
nervous	I-T022
system	I-T022
(	O
cns	B-T022
)	O
toxicity	B-T037
and	O
immune	O
-	O
related	O
side	B-T038
effects	I-T038
are	O
increasingly	O
recognized	O
with	O
the	O
use	O
of	O
monoclonal	B-T103
antibodies	I-T103
for	O
cancer	B-T058
therapy	I-T058
.	O
here	O
,	O
we	O
report	O
a	O
patient	O
who	O
developed	O
of	O
acute	B-T033
-	I-T033
onset	I-T033
encephalopathy	I-T033
and	O
coma	B-T038
,	O
which	O
began	O
shortly	O
after	O
administration	O
of	O
pan	B-T103
##itum	I-T103
##umab	I-T103
for	O
the	O
treatment	B-T058
of	O
metastatic	B-T038
colorectal	I-T038
cancer	I-T038
.	O
echocardiography	B-T058
revealed	O
that	O
the	O
drug	B-T103
had	O
been	O
infused	O
into	O
the	O
left	B-T017
cardiac	I-T017
ventricle	I-T017
via	O
a	O
disl	B-T074
##ocated	I-T074
central	I-T074
venous	I-T074
line	I-T074
.	O
diffusion	B-T058
-	I-T058
weighted	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
disclosed	O
multiple	O
cortical	B-T033
hyperint	I-T033
##ensities	I-T033
,	O
which	O
were	O
preferentially	O
located	O
in	O
the	O
frontal	B-T017
lobes	I-T017
.	O
while	O
the	O
neurological	B-T038
condition	I-T038
improved	O
within	O
a	O
few	O
days	O
,	O
the	O
patient	O
died	B-T038
4	O
weeks	O
later	O
.	O
it	O
seems	O
likely	O
that	O
the	O
administration	O
of	O
the	O
antibody	B-T103
via	O
the	O
intra	O
-	O
arterial	O
route	O
contributed	O
to	O
the	O
development	O
of	O
this	O
condition	B-T038
.	O
toxic	B-T037
encephalopathy	I-T037
may	O
be	O
a	O
hitherto	O
unrecognized	O
complication	B-T038
of	O
pan	B-T103
##itum	I-T103
##umab	I-T103
treatment	B-T058
and	O
should	O
be	O
taken	O
into	O
consideration	O
in	O
patients	O
developing	O
cns	B-T022
symptoms	B-T033
undergoing	O
this	O
therapy	B-T058
.	O

fluorescence	B-T058
-	I-T058
and	O
magnetic	B-T058
-	I-T058
activated	I-T058
cell	I-T058
sorting	I-T058
strategies	O
to	O
separate	O
spermatozoa	B-T017
involving	O
plur	O
##al	O
contributors	B-T098
from	O
biological	O
mixtures	O
for	O
human	B-T058
identification	I-T058
no	O
effective	O
method	O
has	O
been	O
developed	O
to	O
distinguish	O
sperm	B-T017
cells	I-T017
originating	O
from	O
different	O
men	B-T098
in	O
multi	O
-	O
suspect	O
sexual	B-T038
assault	I-T038
cases	O
.	O
here	O
we	O
combined	O
mac	B-T058
##s	I-T058
and	O
facs	B-T058
to	O
isolate	B-T058
single	O
donor	B-T098
sperm	B-T017
cells	I-T017
from	O
forensic	O
mixture	O
samples	O
including	O
female	B-T098
vaginal	B-T017
epithelial	B-T017
cells	I-T017
and	O
sperm	B-T017
cells	I-T017
from	O
multiple	O
contributors	B-T098
.	O
sperm	B-T017
##s	I-T017
from	O
vaginal	O
swab	O
were	O
isolated	O
by	O
mac	B-T058
##s	I-T058
using	O
fitc	B-T103
-	O
conjugated	O
a	B-T103
kinase	I-T103
anchor	I-T103
protein	I-T103
3	I-T103
(	O
ak	B-T103
##ap	I-T103
##3	I-T103
)	O
antibody	B-T103
;	O
target	B-T098
individual	I-T098
sperm	B-T017
cells	I-T017
involving	O
two	O
or	O
three	O
donors	B-T098
were	O
separated	O
by	O
facs	B-T058
using	O
fitc	B-T103
-	O
labeled	O
blood	B-T103
group	I-T103
a	I-T103
/	I-T103
b	I-T103
antigen	I-T103
antibody	B-T103
.	O
this	O
procedure	O
was	O
further	O
tested	O
in	O
two	O
mock	B-T033
multi	O
-	O
suspect	O
sexual	B-T038
assault	I-T038
samples	O
and	O
one	O
practical	B-T074
case	I-T074
##work	I-T074
sample	O
.	O
our	O
results	O
showed	O
that	O
complete	O
single	O
donor	B-T098
str	B-T103
profiles	I-T103
could	O
be	O
successfully	O
obtained	O
from	O
sperm	B-T017
/	O
epithelial	B-T017
cell	I-T017
and	O
sperm	B-T017
mixtures	O
from	O
two	O
contributors	B-T098
.	O
for	O
unbalanced	O
sperm	B-T017
/	O
epithelial	B-T017
cells	I-T017
and	O
sperm	B-T017
cells	I-T017
mixtures	O
,	O
sensitivity	O
results	O
revealed	O
that	O
target	B-T033
cells	I-T033
could	O
be	O
detected	B-T033
at	O
as	O
low	O
as	O
1	O
:	O
32	O
and	O
1	O
:	O
8	O
mixed	O
ratios	O
,	O
respectively	O
.	O
although	O
highly	O
relies	O
on	O
cell	B-T058
number	I-T058
and	O
blood	B-T201
types	I-T201
or	O
secret	O
##or	O
status	O
of	O
the	O
individuals	B-T098
,	O
this	O
procedure	O
would	O
still	O
be	O
useful	O
tools	O
for	O
forensic	B-T058
dna	I-T058
analysis	I-T058
of	O
multi	O
-	O
suspect	O
sexual	B-T038
assault	I-T038
cases	O
by	O
the	O
combined	O
use	O
of	O
facs	B-T058
and	O
mac	B-T058
##s	I-T058
based	O
on	O
sperm	B-T017
-	O
specific	O
ak	B-T103
##ap	I-T103
##3	I-T103
antigen	B-T103
and	O
human	B-T204
blood	B-T033
type	I-T033
antigen	I-T033
.	O

functional	O
characterization	O
of	O
pneumocystis	B-T204
carinii	I-T204
inositol	B-T103
transporter	I-T103
1	I-T103
fungi	B-T204
in	O
the	O
genus	B-T204
pneumocystis	I-T204
live	O
in	O
the	O
lungs	B-T017
of	O
mammals	B-T204
,	O
where	O
they	O
can	O
cause	O
a	O
fatal	O
pneumonia	B-T038
(	O
pcp	B-T038
[	O
pneumocystis	B-T038
pneumonia	I-T038
]	O
)	O
in	O
hosts	O
with	O
compromised	O
immune	B-T022
systems	I-T022
.	O
the	O
absence	O
of	O
a	O
continuous	O
in	O
vitro	O
culture	B-T058
system	I-T058
for	O
any	O
species	B-T170
of	O
pneumocystis	B-T204
has	O
led	O
to	O
limited	O
understanding	O
of	O
these	O
fungi	B-T204
,	O
especially	O
for	O
the	O
discovery	O
of	O
new	O
therapies	B-T058
.	O
we	O
recently	O
reported	O
that	O
pneumocystis	B-T204
carinii	I-T204
,	O
pneumocystis	B-T204
mur	I-T204
##ina	I-T204
,	O
and	O
most	O
significantly	O
,	O
pneumocystis	B-T204
ji	I-T204
##rov	I-T204
##ec	I-T204
##ii	I-T204
lack	O
both	O
enzymes	B-T103
necessary	O
for	O
myo	B-T038
-	I-T038
inositol	I-T038
biosynthesis	I-T038
but	O
contain	O
genes	B-T017
with	I-T017
homolog	I-T017
##ies	I-T017
to	O
fungal	B-T204
myo	B-T103
-	I-T103
inositol	I-T103
transporters	B-T103
.	O
since	O
myo	B-T103
-	I-T103
inositol	I-T103
is	O
essential	O
for	O
eukaryotic	B-T017
viability	B-T038
,	O
the	O
primary	O
transporter	B-T103
,	O
it	B-T103
##r1	I-T103
,	O
was	O
functionally	O
and	O
structurally	B-T082
characterized	O
in	O
p	B-T204
.	I-T204
carinii	I-T204
the	O
predicted	O
structure	B-T103
of	O
p	B-T204
.	I-T204
carinii	I-T204
it	B-T103
##r1	I-T103
(	O
pci	B-T103
##tr	I-T103
##1	I-T103
)	O
contained	O
12	O
transmembrane	B-T017
alpha	B-T082
-	I-T082
helices	I-T082
with	O
intracellular	B-T082
c	B-T082
and	O
n	B-T082
termini	I-T082
,	O
consistent	O
with	O
other	O
inositol	B-T103
transporters	B-T103
.	O
the	O
apparent	O
km	O
was	O
0	O
.	O
94	O
±	O
0	O
.	O
08	O
(	O
mean	O
±	O
standard	O
deviation	O
)	O
,	O
suggesting	O
that	O
myo	B-T038
-	I-T038
inositol	I-T038
transport	I-T038
in	O
p	B-T204
.	I-T204
carinii	I-T204
is	O
likely	O
through	O
a	O
low	O
-	O
affinity	O
,	O
highly	O
selective	O
transport	B-T038
system	I-T038
,	O
as	O
no	O
other	O
sugars	B-T103
or	O
inositol	B-T103
stereois	B-T103
##omers	I-T103
were	O
significant	O
competitive	B-T038
inhibitors	B-T103
.	O
glucose	B-T038
transport	I-T038
was	O
shown	O
to	O
use	O
a	O
different	O
transport	B-T038
system	O
.	O
the	O
myo	B-T038
-	I-T038
inositol	I-T038
transport	I-T038
was	O
distinct	O
from	O
mammalian	B-T204
transporters	B-T103
,	O
as	O
it	O
was	O
not	O
sodium	B-T038
dependent	I-T038
and	O
was	O
cytochalasin	B-T103
b	I-T103
resistant	O
.	O
inositol	B-T038
transport	I-T038
in	O
these	O
fungi	B-T204
offers	O
an	O
attractive	O
new	O
drug	B-T103
target	O
because	O
of	O
the	O
reliance	O
of	O
the	O
fungi	B-T204
on	O
its	O
transport	B-T038
,	O
clear	O
differences	O
between	O
the	O
mammalian	B-T204
and	O
fungal	B-T204
transporters	B-T103
,	O
and	O
the	O
ability	O
of	O
the	O
host	O
to	O
both	O
synthesize	O
and	O
transport	B-T038
this	O
critical	O
nutrient	B-T168
,	O
predicting	O
low	O
toxicity	B-T037
of	O
potential	O
inhibitors	B-T103
to	O
the	O
fungal	B-T204
transporter	B-T103
.	O
myo	B-T103
-	I-T103
inositol	I-T103
is	O
a	O
sugar	B-T103
##like	I-T103
nutrient	B-T168
that	O
is	O
essential	O
for	O
life	O
in	O
most	O
organisms	O
.	O
humans	B-T204
and	O
microbes	O
alike	O
can	O
obtain	O
it	O
by	O
making	O
it	O
,	O
which	O
involves	O
only	O
2	O
enzymes	B-T103
,	O
by	O
taking	O
it	O
from	O
the	O
environment	B-T082
by	O
a	O
transport	B-T038
process	I-T038
,	O
or	O
by	O
recycling	O
it	O
from	O
other	O
cellular	B-T017
constituents	O
.	O
inspection	O
of	O
the	O
genomes	B-T017
of	O
the	O
pathogenic	O
fungi	O
of	O
the	O
genus	B-T204
pneumocystis	I-T204
showed	O
that	O
these	O
pneumonia	B-T038
-	O
causing	O
parasites	B-T204
could	O
not	O
make	O
myo	B-T103
-	I-T103
inositol	I-T103
,	O
as	O
they	O
lacked	O
the	O
2	O
enzymes	B-T103
.	O
instead	O
,	O
we	O
found	O
evidence	O
of	O
inositol	B-T103
transporters	B-T103
,	O
which	O
would	O
import	O
the	O
sugar	B-T103
from	O
the	O
lungs	B-T017
where	O
the	O
fungi	B-T204
reside	O
.	O
in	O
the	O
present	O
report	O
,	O
we	O
characterized	O
the	O
transport	B-T038
of	O
myo	B-T103
-	I-T103
inositol	I-T103
in	O
the	O
fungus	B-T204
and	O
found	O
that	O
the	O
transporter	B-T103
was	O
highly	O
selective	O
for	O
myo	B-T103
-	I-T103
inositol	I-T103
and	O
did	O
not	O
transport	B-T038
any	O
other	O
molecules	O
.	O
the	O
transport	B-T038
was	O
distinct	O
from	O
that	O
in	O
mammalian	B-T017
cells	I-T017
,	O
and	O
since	O
mammals	B-T204
can	O
both	O
make	O
and	O
transport	B-T038
myo	B-T103
-	I-T103
inositol	I-T103
,	O
while	O
pneumocystis	B-T204
fungi	I-T204
must	O
transport	B-T038
it	O
,	O
this	O
process	O
offers	O
a	O
potential	O
new	O
drug	B-T103
target	O
.	O

5	B-T103
-	I-T103
bromo	I-T103
-	I-T103
2	I-T103
-	I-T103
aryl	I-T103
benz	I-T103
##imidazole	I-T103
derivatives	I-T103
as	O
non	B-T103
-	I-T103
cytotoxic	I-T103
potential	O
dual	O
inhibitors	B-T103
of	O
α	B-T103
-	I-T103
glucosidase	I-T103
and	O
urease	B-T103
enzymes	I-T103
on	O
the	O
basis	O
of	O
previous	O
report	B-T170
on	O
promising	O
α	B-T103
-	I-T103
glucosidase	I-T103
inhibitory	B-T038
activity	I-T038
of	O
5	B-T103
-	I-T103
bromo	I-T103
-	I-T103
2	I-T103
-	I-T103
aryl	I-T103
benz	I-T103
##imidazole	I-T103
derivatives	I-T103
,	O
these	O
derivatives	O
were	O
further	O
screened	B-T058
for	O
urease	B-T103
inhibitory	B-T038
and	O
cytotoxicity	B-T058
activity	I-T058
in	O
order	O
to	O
get	O
more	O
potent	O
and	O
non	B-T103
-	I-T103
cytotoxic	I-T103
potential	O
dual	O
inhibitor	B-T103
for	O
the	O
patients	O
suffering	O
from	O
diabetes	B-T038
as	O
well	O
as	O
peptic	B-T038
ulcer	I-T038
.	O
in	O
this	O
study	B-T062
,	O
all	O
compounds	B-T103
showed	O
varying	O
degree	O
of	O
potency	O
in	O
the	O
range	O
of	O
(	O
ic50	O
=	O
8	O
.	O
15	O
##±0	O
.	O
03	O
-	O
35	O
##4	O
.	O
67	O
##±0	O
.	O
19	O
##μm	O
)	O
as	O
compared	O
to	O
standard	O
thio	B-T103
##urea	I-T103
(	O
ic50	O
=	O
21	O
.	O
25	O
##±0	O
.	O
15	O
##μm	O
)	O
.	O
it	O
is	O
worth	O
mention	O
##ing	O
that	O
derivatives	B-T103
7	I-T103
(	O
ic50	O
=	O
12	O
.	O
07	O
##±0	O
.	O
05	O
##μm	O
)	O
,	O
8	B-T103
(	O
ic50	O
=	O
10	O
.	O
57	O
##±0	O
.	O
12	O
##μm	O
)	O
,	O
11	B-T103
(	O
ic50	O
=	O
13	O
.	O
76	O
##±0	O
.	O
02	O
##μm	O
)	O
,	O
14	B-T103
(	O
ic50	O
=	O
15	O
.	O
70	O
##±0	O
.	O
12	O
##μm	O
)	O
and	O
22	B-T103
(	O
ic50	O
=	O
8	O
.	O
15	O
##±0	O
.	O
03	O
##μm	O
)	O
were	O
found	O
to	O
be	O
more	O
potent	B-T103
inhibitors	I-T103
than	O
standard	O
.	O
all	O
compounds	B-T103
were	O
also	O
evaluated	O
for	O
cytotoxicity	B-T058
towards	O
3t3	B-T017
mouse	B-T017
fibroblast	I-T017
cell	I-T017
line	I-T017
and	O
found	O
to	O
be	O
completely	O
non	B-T033
-	I-T033
toxic	I-T033
.	O
previously	O
benz	B-T103
##imidazole	I-T103
1	I-T103
-	I-T103
25	I-T103
were	O
also	O
showed	O
α	B-T103
-	I-T103
glucosidase	I-T103
inhibitory	B-T038
potential	I-T038
.	O
in	O
silico	O
studies	B-T062
were	O
performed	O
on	O
the	O
lead	B-T103
molecules	I-T103
i	O
.	O
e	O
.	O
2	B-T103
,	O
7	B-T103
,	O
8	B-T103
,	O
11	B-T103
,	O
14	B-T103
,	O
and	O
22	B-T103
,	O
in	O
order	O
to	O
rational	O
##ize	O
the	O
binding	B-T038
interaction	I-T038
of	O
compounds	B-T103
with	O
the	O
active	O
site	O
of	O
urease	B-T103
enzyme	I-T103
.	O

a	O
novel	O
insulin	O
/	O
glucose	O
model	B-T170
after	O
a	O
mixed	B-T058
-	I-T058
meal	I-T058
test	I-T058
in	O
patients	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
on	O
insulin	B-T074
pump	I-T074
therapy	B-T058
current	O
closed	B-T074
-	I-T074
loop	I-T074
insulin	I-T074
delivery	I-T074
methods	I-T074
stem	O
from	O
sophisticated	O
models	O
of	O
the	O
glucose	O
-	O
insulin	O
(	O
g	O
/	O
i	O
)	O
system	O
,	O
mostly	O
based	O
on	O
complex	O
studies	B-T062
employing	B-T033
glucose	O
tracer	O
technology	O
.	O
we	O
tested	O
the	O
performance	O
of	O
a	O
new	O
minimal	B-T170
model	I-T170
(	O
glu	B-T170
##kins	I-T170
##lo	I-T170
##op	I-T170
2	I-T170
.	I-T170
0	I-T170
)	O
of	O
the	O
g	O
/	O
i	O
system	O
to	O
characterize	O
the	O
glucose	O
and	O
insulin	O
dynamics	O
during	O
multiple	O
mixed	B-T058
meal	I-T058
tests	I-T058
(	O
mmt	B-T058
)	O
of	O
different	O
sizes	B-T082
in	O
patients	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
(	O
t1d	B-T038
)	O
on	O
insulin	B-T074
pump	I-T074
therapy	B-T058
(	O
continuous	B-T058
subcutaneous	I-T058
insulin	I-T058
infusion	I-T058
,	O
cs	B-T058
##ii	I-T058
)	O
.	O
the	O
glu	B-T170
##kins	I-T170
##lo	I-T170
##op	I-T170
2	I-T170
.	I-T170
0	I-T170
identified	O
the	O
g	O
/	O
i	O
system	O
,	O
provided	O
a	O
close	O
fit	O
of	O
the	O
g	O
/	O
i	O
time	O
-	O
courses	O
and	O
showed	O
acceptable	O
reproducibility	O
of	O
the	O
g	O
/	O
i	O
system	O
parameters	B-T033
in	O
repeated	O
studies	B-T062
of	O
identical	O
and	O
double	O
-	O
sized	O
mmt	B-T058
##s	I-T058
.	O
this	O
model	B-T170
can	O
provide	O
a	O
fairly	O
good	O
and	O
reproducible	O
description	B-T170
of	O
the	O
g	O
/	O
i	O
system	O
in	O
t1d	B-T038
patients	O
on	O
cs	B-T058
##ii	I-T058
,	O
and	O
it	O
may	O
be	O
applied	O
to	O
create	O
a	O
bank	O
of	O
[UNK]	B-T058
virtual	I-T058
[UNK]	I-T058
patients	I-T058
.	O
our	O
results	B-T033
might	O
be	O
relevant	O
at	O
improving	O
the	O
architecture	O
of	O
up	O
##coming	O
closed	O
-	O
loop	O
cs	B-T058
##ii	I-T058
systems	O
.	O

social	O
capital	O
and	O
healthy	O
ageing	B-T038
in	O
indonesia	B-T082
a	O
large	O
international	O
literature	B-T170
has	O
found	O
a	O
positive	B-T033
association	O
between	O
social	O
capital	O
and	O
measures	O
of	O
physical	B-T033
and	O
mental	B-T038
health	I-T038
.	O
however	O
,	O
there	O
is	O
a	O
paucity	O
of	O
research	B-T062
on	O
the	O
links	O
between	O
social	O
capital	O
and	O
healthy	O
ageing	B-T038
in	O
a	O
developing	O
country	O
environment	B-T082
,	O
where	O
universal	O
social	O
security	O
coverage	O
is	O
absent	O
and	O
health	O
infrastructure	O
is	O
poor	O
.	O
in	O
this	O
paper	O
,	O
we	O
develop	O
and	O
empirically	O
test	O
a	O
model	B-T170
of	O
the	O
linkages	B-T170
between	O
social	O
capital	O
and	O
the	O
health	O
outcomes	O
for	O
older	B-T098
adults	I-T098
in	O
indonesia	B-T082
,	O
using	O
data	O
from	O
the	O
indonesia	B-T170
##n	I-T170
family	I-T170
life	I-T170
survey	I-T170
-	I-T170
east	I-T170
(	O
if	B-T170
##ls	I-T170
-	I-T170
east	I-T170
)	O
,	O
conducted	O
in	O
2012	O
.	O
using	O
multivariate	B-T170
regression	I-T170
analysis	I-T170
,	O
we	O
examine	O
whether	O
social	O
capital	O
plays	O
a	O
role	O
in	O
mitigating	O
poor	O
health	O
among	O
older	B-T098
individuals	B-T098
aged	O
50	O
years	O
and	O
above	O
in	O
indonesia	B-T082
'	O
s	O
most	O
vulnerable	B-T082
provinces	I-T082
.	O
we	O
test	O
the	O
robustness	O
of	O
these	O
social	O
capital	O
variables	O
across	O
different	O
health	O
measures	O
(	O
self	O
-	O
assessed	O
health	O
,	O
activities	O
of	O
daily	O
living	O
(	O
adl	O
)	O
,	O
measures	O
of	O
chronic	B-T038
illness	I-T038
and	O
mental	B-T038
health	I-T038
measures	O
)	O
,	O
as	O
well	O
as	O
across	O
different	O
demographic	O
groups	O
,	O
after	O
controlling	O
for	O
an	O
array	B-T082
of	O
socio	O
-	O
economic	O
,	O
demographic	O
and	O
geographic	B-T082
characteristics	O
.	O
our	O
findings	B-T033
show	O
that	O
access	B-T082
to	O
better	O
social	O
capital	O
(	O
using	O
measures	O
of	O
neighbourhood	B-T098
trust	O
and	O
community	O
participation	O
)	O
is	O
associated	O
with	O
a	O
higher	O
degree	O
of	O
physical	O
mobility	O
,	O
independence	O
,	O
and	O
mental	B-T038
well	I-T038
-	I-T038
being	I-T038
among	O
older	B-T098
individuals	B-T098
but	O
has	O
no	O
influence	O
on	O
chronic	B-T038
illnesses	I-T038
.	O
these	O
results	O
are	O
consistent	O
when	O
we	O
estimate	O
samples	O
disag	O
##gr	O
##eg	O
##ated	O
by	O
gender	O
,	O
rural	B-T033
/	O
urban	O
residence	B-T082
,	O
and	O
by	O
age	O
categories	B-T170
.	O
from	O
a	O
policy	B-T170
perspective	O
these	O
results	O
point	O
to	O
the	O
importance	O
of	O
social	O
capital	O
measures	O
in	O
moder	O
##ating	O
the	O
influence	O
of	O
poor	O
health	O
,	O
particularly	O
in	O
the	O
activities	O
of	O
daily	O
living	O
.	O

reflections	B-T062
on	O
hip	O
fracture	O
recovery	O
from	O
older	B-T098
adults	I-T098
enrolled	O
in	O
a	O
clinical	B-T062
trial	I-T062
this	O
study	B-T062
describes	O
patients	O
'	O
perspectives	O
on	O
recovery	O
during	O
participation	O
in	O
a	O
randomized	B-T062
controlled	I-T062
trial	I-T062
that	O
tested	B-T170
a	O
postoperative	O
hip	B-T037
fracture	I-T037
management	O
program	O
(	O
b4	B-T092
clinic	I-T092
)	O
,	O
compared	O
with	O
usual	O
care	O
,	O
on	O
mobility	O
.	O
semistructured	B-T082
qualitative	O
interviews	O
were	O
conducted	O
with	O
50	O
older	B-T098
adults	I-T098
with	O
hip	B-T037
fracture	I-T037
(	O
from	O
both	O
groups	B-T098
)	O
twice	O
over	O
12	O
months	O
.	O
a	O
total	O
of	O
32	O
women	B-T098
(	O
64	O
%	O
)	O
and	O
18	O
men	B-T098
(	O
36	O
%	O
)	O
participated	O
in	O
the	O
study	B-T062
with	O
a	O
mean	O
age	O
at	O
baseline	O
of	O
82	O
(	O
range	O
=	O
65	O
-	O
98	O
)	O
years	O
.	O
a	O
total	O
of	O
40	O
participants	B-T098
reported	B-T058
recovery	O
goals	B-T170
at	O
some	O
point	O
during	O
their	O
recovery	O
from	O
hip	B-T037
fracture	I-T037
but	O
only	O
18	O
participants	B-T098
realized	O
their	O
goals	B-T170
within	O
12	O
months	O
.	O
recovering	B-T038
mobility	O
,	O
returning	O
to	O
pref	O
##ra	O
##ct	O
##ure	O
activities	O
,	O
and	O
obtaining	O
stable	O
health	O
were	O
the	O
most	O
commonly	O
reported	B-T058
goals	B-T170
.	O
participants	B-T098
described	O
good	O
social	B-T058
support	I-T058
,	O
access	B-T082
to	O
physiotherapy	B-T058
,	O
and	O
positive	B-T033
perspective	O
as	O
most	O
important	O
to	O
recovery	O
.	O
these	O
factors	O
were	O
influenced	O
by	O
participants	B-T098
'	O
knowledge	B-T170
,	O
resources	O
,	O
and	O
monthly	O
contact	O
with	O
study	B-T062
staff	B-T097
(	O
perceived	B-T038
as	O
a	O
form	O
of	O
social	B-T058
support	I-T058
)	O
.	O
the	O
most	O
frequently	O
reported	B-T058
barriers	O
to	O
participants	B-T098
'	O
recovery	O
were	O
the	O
onset	O
of	O
complications	B-T038
,	O
pain	B-T033
,	O
and	O
limited	O
access	O
to	O
physiotherapy	B-T058
.	O
potential	O
implications	O
of	O
these	O
findings	B-T033
include	O
design	O
and	O
modification	B-T033
of	O
new	O
or	O
preexisting	O
fracture	B-T037
programs	O
,	O
priori	O
##tizing	O
patient	B-T058
engagement	I-T058
and	O
enhanced	O
knowledge	B-T170
for	O
future	O
clinical	B-T062
research	I-T062
in	O
hip	O
fracture	O
recovery	O
.	O

successful	B-T058
restoration	I-T058
of	O
severely	O
mut	O
##ila	O
##ted	O
primary	B-T017
incisors	I-T017
using	O
a	O
novel	O
method	O
to	O
retain	O
zirconia	O
crowns	B-T074
-	O
two	O
year	O
results	O
this	O
manuscript	B-T170
describes	O
a	O
simple	O
reliable	O
technique	O
for	O
restoring	B-T058
severely	O
mut	O
##ila	O
##ted	O
primary	B-T017
anterior	I-T017
teeth	I-T017
.	O
a	O
rigid	O
glass	B-T103
ionomer	I-T103
post	I-T103
is	O
created	O
over	O
which	O
zirconia	O
crowns	B-T074
can	O
be	O
fitted	O
to	O
achieve	O
a	O
long	O
-	O
term	O
stable	O
esthetic	B-T058
restoration	B-T058
for	O
primary	B-T017
anterior	I-T017
teeth	I-T017
.	O
children	O
aged	O
2	O
-	O
5	O
years	O
with	O
two	O
up	O
to	O
six	O
extensively	O
decay	B-T038
##ed	I-T038
upper	B-T017
primary	I-T017
incisors	I-T017
were	O
included	O
.	O
fu	B-T103
##ji	I-T103
ix	I-T103
was	O
condensed	O
into	O
an	O
intrac	B-T058
##anal	I-T058
space	I-T058
created	O
to	O
a	O
depth	B-T082
of	O
3m	O
##m	O
,	O
to	O
provide	O
a	O
core	B-T082
which	O
also	O
extended	O
3m	O
##m	O
supra	B-T058
##ging	I-T058
##ival	I-T058
##ly	I-T058
.	O
crown	B-T058
preparations	I-T058
were	O
completed	O
upon	O
these	O
cores	B-T082
.	O
zirconia	O
crowns	B-T074
(	O
nu	B-T170
##sm	I-T170
##ile	I-T170
,	O
hous	B-T082
##ton	I-T082
texas	I-T082
usa	B-T082
)	O
were	O
fitted	O
and	O
cemented	B-T031
over	O
the	O
prepared	O
cores	B-T082
.	O
all	O
patients	O
were	O
recalled	B-T058
at	O
regular	O
intervals	O
.	O
twenty	O
-	O
three	O
healthy	O
children	O
with	O
86	O
restorations	B-T058
participated	O
in	O
the	O
study	B-T062
.	O
the	O
overall	O
survival	O
of	O
the	O
restorations	B-T058
was	O
95	O
.	O
3	O
%	O
after	O
12	O
months	O
and	O
80	O
.	O
2	O
%	O
after	O
24	O
months	O
.	O
according	O
to	O
kaplan	B-T062
-	I-T062
meier	I-T062
survival	I-T062
analysis	I-T062
,	O
the	O
median	O
survival	O
time	O
was	O
not	O
reached	O
while	O
the	O
estimated	O
mean	O
survival	O
time	O
was	O
22	O
.	O
9	O
months	O
.	O
this	O
newly	O
described	O
clinical	B-T058
technique	I-T058
is	O
simple	O
and	O
reliable	O
to	O
use	O
for	O
restoration	B-T058
of	O
extensively	O
decay	B-T038
##ed	I-T038
primary	B-T017
incisors	I-T017
.	O
use	O
of	O
zirconia	O
crowns	B-T074
retained	O
using	O
this	O
technique	O
offers	O
superior	O
esthetic	O
,	O
durable	O
restorations	B-T058
with	O
remarkable	O
gingival	B-T033
response	I-T033
up	O
to	O
24	O
months	O
.	O

a	O
quasi	B-T062
-	I-T062
experimental	I-T062
study	I-T062
of	O
a	O
reminis	B-T058
##cence	I-T058
program	I-T058
focused	O
on	O
auto	B-T038
##bi	I-T038
##ographical	I-T038
memory	I-T038
in	O
institutional	O
##ized	O
older	B-T098
adults	I-T098
with	O
cognitive	B-T038
impairment	I-T038
working	O
with	O
past	B-T038
memories	I-T038
through	O
reminis	B-T058
##cence	I-T058
interventions	I-T058
has	O
been	O
practiced	O
for	O
several	O
decades	O
with	O
successful	O
outcomes	O
on	O
mental	B-T038
health	I-T038
in	O
older	B-T098
adults	I-T098
.	O
few	O
studies	B-T062
however	O
have	O
focused	O
on	O
auto	B-T038
##bi	I-T038
##ographical	I-T038
memory	I-T038
recall	B-T038
in	O
older	O
individuals	O
with	O
cognitive	B-T038
impairment	I-T038
.	O
this	O
study	B-T062
aims	O
to	O
analyze	O
the	O
impact	O
of	O
an	O
individual	B-T098
reminis	B-T058
##cence	I-T058
program	I-T058
in	O
a	O
group	O
of	O
older	O
persons	O
with	O
cognitive	B-T038
decline	I-T038
living	O
in	O
nursing	B-T092
homes	I-T092
on	O
the	O
dimensions	O
of	O
cognition	B-T038
,	O
auto	B-T038
##bi	I-T038
##ographical	I-T038
memory	I-T038
,	O
mood	B-T038
,	O
behavior	O
and	O
anxiety	B-T038
.	O
a	O
two	O
-	O
group	O
pre	B-T170
-	I-T170
test	I-T170
and	I-T170
post	I-T170
-	I-T170
test	I-T170
design	I-T170
with	O
single	B-T058
blinded	I-T058
assessment	I-T058
was	O
conducted	O
.	O
forty	O
-	O
one	O
participants	B-T098
were	O
randomized	O
to	O
an	O
experimental	B-T098
group	I-T098
(	O
n	O
=	O
20	O
)	O
and	O
a	O
control	O
group	O
(	O
n	O
=	O
21	O
)	O
.	O
the	O
first	O
group	O
attended	O
five	O
weekly	O
individual	B-T098
reminis	O
##cence	O
sessions	O
.	O
changes	O
in	O
the	O
outcome	O
measures	O
were	O
examined	B-T033
for	O
cognition	B-T038
(	O
mont	B-T170
##re	I-T170
##al	I-T170
cognitive	I-T170
assessment	I-T170
;	O
auto	B-T170
##bi	I-T170
##ographical	I-T170
memory	I-T170
test	I-T170
)	O
,	O
behavior	O
(	O
alzheimer	B-T170
disease	I-T170
assessment	I-T170
subscale	I-T170
non	I-T170
-	I-T170
cog	I-T170
)	O
and	O
emotional	B-T033
status	I-T033
(	O
corne	B-T170
##ll	I-T170
scale	I-T170
for	I-T170
depression	I-T170
in	O
dementia	B-T038
;	O
geriatric	B-T170
depression	I-T170
scale	I-T170
,	O
and	O
geriatric	B-T170
anxiety	I-T170
inventory	I-T170
)	O
.	O
participants	B-T098
attending	O
reminis	O
##cence	O
sessions	O
exhibited	O
better	O
outcomes	O
compared	O
to	O
the	O
control	O
group	O
in	O
cognition	B-T038
,	O
anxiety	B-T038
and	O
depression	B-T038
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
presented	O
a	O
higher	O
number	O
of	O
retrieved	B-T038
auto	O
##bi	O
##ographical	O
events	O
,	O
specificity	O
of	O
evoked	O
memories	B-T038
and	O
positive	O
valence	O
of	O
events	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
also	O
presented	O
lower	O
latency	O
time	O
for	O
recall	B-T038
##ing	I-T038
events	O
,	O
and	O
lower	O
negative	O
recalled	B-T038
events	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
this	O
study	O
supports	O
the	O
potential	O
value	O
of	O
reminis	B-T058
##cence	I-T058
therapy	I-T058
in	O
improving	O
the	O
recall	B-T038
of	O
auto	B-T038
##bi	I-T038
##ographical	I-T038
memory	I-T038
.	O
reminis	B-T058
##cence	I-T058
therapy	I-T058
can	O
be	O
helpful	O
to	O
maintain	O
or	O
improve	O
cognitive	B-T038
function	I-T038
,	O
decrease	O
anxiety	B-T038
and	O
manage	O
depressive	B-T033
symptoms	I-T033
and	O
altered	O
behavior	O
,	O
but	O
further	O
investigation	O
is	O
needed	O
to	O
clarify	O
long	O
-	O
term	O
effects	O
.	O

post	O
endodontic	B-T033
pain	I-T033
following	O
single	O
-	O
visit	O
root	B-T058
canal	I-T058
preparation	I-T058
with	O
rotary	B-T074
vs	O
reciproc	B-T074
##ating	I-T074
instruments	I-T074
:	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
randomized	B-T062
clinical	I-T062
trials	I-T062
in	O
endodontic	B-T058
therapy	I-T058
,	O
continuous	O
rotary	O
instrumentation	O
reduced	O
debris	O
compared	O
to	O
reciprocal	O
instrumentation	O
,	O
which	O
might	O
affect	O
the	O
incidence	O
of	O
post	B-T033
-	I-T033
endodontic	I-T033
pain	I-T033
(	O
pp	B-T033
)	O
.	O
the	O
aim	O
of	O
our	O
study	B-T062
was	O
to	O
assess	O
whether	O
pp	B-T033
incidence	O
and	O
levels	O
were	O
influenced	O
by	O
the	O
choice	O
of	O
rotary	B-T074
or	O
reciprocal	B-T074
instruments	I-T074
.	O
in	O
this	O
meta	B-T062
-	I-T062
analysis	I-T062
the	O
pubmed	B-T170
and	O
em	B-T170
databases	I-T170
were	O
searched	O
for	O
prospective	O
clinical	B-T062
randomized	I-T062
trials	I-T062
published	O
before	O
april	O
20	O
,	O
2016	O
,	O
using	O
combinations	O
of	O
the	O
keywords	O
:	O
root	B-T058
canal	I-T058
preparation	I-T058
/	O
instrumentation	O
/	O
treatment	B-T058
/	O
therapy	B-T058
;	O
post	O
-	O
operative	O
/	O
endodontic	B-T033
pain	I-T033
;	O
reciprocal	B-T074
and	O
rotary	B-T074
instruments	I-T074
.	O
three	O
studies	B-T062
were	O
included	O
,	O
involving	O
a	O
total	O
of	O
1	O
,	O
317	O
patients	O
,	O
65	O
##9	O
treated	O
with	O
reciproc	B-T074
##ating	I-T074
instruments	I-T074
and	O
65	O
##8	O
treated	O
with	O
rotary	B-T074
instruments	I-T074
.	O
pp	B-T033
was	O
reported	O
in	O
139	O
patients	O
in	O
the	O
reciproc	B-T098
##ating	I-T098
group	I-T098
and	O
172	O
in	O
the	O
rotary	B-T098
group	I-T098
.	O
the	O
pp	B-T033
incidence	O
odds	O
ratio	O
was	O
1	O
.	O
27	O
with	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
(	O
0	O
.	O
25	O
,	O
6	O
.	O
52	O
)	O
favoring	O
rotary	B-T074
instruments	I-T074
.	O
the	O
mild	O
,	O
moderate	O
and	O
severe	O
pp	B-T033
levels	O
odds	O
ratios	O
were	O
0	O
.	O
31	O
(	O
0	O
.	O
11	O
,	O
0	O
.	O
84	O
)	O
,	O
2	O
.	O
24	O
(	O
0	O
.	O
66	O
,	O
7	O
.	O
59	O
)	O
and	O
11	O
.	O
71	O
(	O
0	O
.	O
63	O
,	O
218	O
.	O
15	O
)	O
,	O
respectively	O
.	O
no	O
evidence	O
of	O
publication	O
bias	O
was	O
found	O
.	O
rotary	B-T074
instrument	I-T074
choice	O
in	O
endodontic	B-T058
therapy	I-T058
is	O
associated	O
with	O
a	O
lower	O
incidence	O
of	O
pp	B-T033
than	O
reciproc	B-T074
##ating	I-T074
instruments	I-T074
,	O
while	O
reciproc	B-T074
##ating	I-T074
instruments	I-T074
are	O
associated	O
with	O
less	O
mild	O
pp	B-T033
incidence	O
.	O

forest	O
protected	B-T082
areas	I-T082
governance	O
in	O
z	B-T082
##imb	I-T082
##ab	I-T082
##we	I-T082
:	O
shift	O
needed	O
away	O
from	O
a	O
long	B-T033
history	I-T033
of	O
local	B-T082
community	O
exclusion	O
in	O
this	O
literature	O
review	O
based	O
paper	O
we	O
explored	O
the	O
concept	O
of	O
exclusion	O
of	O
local	B-T082
communities	O
from	O
accessing	O
resources	O
in	O
forest	O
protected	B-T082
areas	I-T082
(	O
fp	B-T082
##as	I-T082
)	O
in	O
z	B-T082
##imb	I-T082
##ab	I-T082
##we	I-T082
.	O
we	O
discussed	O
the	O
colon	B-T170
##ial	I-T170
and	O
post	O
-	O
colon	B-T170
##ial	I-T170
forms	I-T170
,	O
causes	O
and	O
mechanisms	O
of	O
exclusion	O
and	O
their	O
social	O
,	O
economic	O
and	O
ecological	O
outcomes	O
.	O
we	O
examined	B-T033
the	O
range	O
of	O
powers	O
emb	O
##odi	O
##ed	O
in	O
and	O
exercised	O
through	O
various	O
mechanisms	O
,	O
processes	O
and	O
social	O
relations	O
and	O
their	O
impact	O
on	O
local	B-T082
communities	O
'	O
access	O
to	O
fp	B-T082
##a	I-T082
resources	O
and	O
associated	O
benefits	O
along	O
the	O
historical	O
trajectory	O
of	O
forest	O
governance	O
in	O
z	B-T082
##imb	I-T082
##ab	I-T082
##we	I-T082
.	O
results	O
showed	O
that	O
the	O
forms	O
and	O
extent	B-T082
of	O
exclusion	O
changed	O
over	O
time	O
in	O
tandem	O
with	O
the	O
shifting	O
political	O
and	O
economic	O
landscape	O
.	O
during	O
the	O
colon	O
##ial	O
period	O
,	O
it	O
was	O
total	O
exclusion	O
whereby	O
people	B-T098
were	O
ev	O
##icted	O
from	O
forest	O
land	O
as	O
well	O
as	O
being	O
den	O
##ied	O
access	O
to	O
basic	O
resources	O
for	O
their	O
live	O
##li	O
##hood	O
##s	O
.	O
local	B-T082
communities	O
'	O
access	O
to	O
low	O
value	O
fp	B-T082
##a	I-T082
resources	O
improved	B-T033
during	O
the	O
post	O
-	O
colon	O
##ial	O
period	O
but	O
access	O
to	O
high	O
value	O
resources	O
like	O
commercial	O
tim	O
##ber	O
as	O
well	O
as	O
sharing	O
income	O
benefits	O
derived	O
from	O
fp	B-T082
##a	I-T082
commercial	O
activities	O
remained	O
a	O
pip	O
##e	O
dre	O
##am	O
.	O
regulation	O
,	O
legitim	O
##ation	O
,	O
force	O
and	O
markets	O
constituted	O
the	O
mixture	O
of	O
the	O
power	O
elements	O
that	O
fp	B-T082
##a	I-T082
governing	O
authorities	O
used	O
to	O
exclude	O
local	B-T082
communities	O
.	O
these	O
powers	O
remained	O
intact	O
despite	O
attempts	O
at	O
collaborative	O
governance	O
in	O
the	O
1990s	O
.	O
however	O
,	O
from	O
the	O
year	O
2000	O
,	O
local	B-T082
communities	O
expressed	O
their	O
dissatisfaction	B-T038
with	O
the	O
central	O
##ised	O
exclusion	O
##ary	O
governance	O
system	O
by	O
invading	O
the	O
fp	B-T082
##as	I-T082
rendering	O
them	O
un	B-T033
##go	I-T033
##vern	I-T033
##able	I-T033
.	O
there	O
is	O
therefore	O
a	O
need	O
for	O
policy	B-T170
reform	O
within	O
the	O
fp	B-T082
##a	I-T082
sector	B-T082
to	O
improve	B-T033
the	O
current	O
dir	O
##e	O
situation	O
.	O

zebrafish	B-T204
akt	B-T017
##2	I-T017
is	O
essential	O
for	O
survival	O
,	O
growth	B-T038
,	O
bone	B-T038
development	I-T038
,	O
and	O
glucose	B-T038
homeostasis	I-T038
as	O
one	O
of	O
three	O
akt	B-T103
isoforms	B-T103
,	O
akt	B-T103
##2	I-T103
plays	O
a	O
key	O
role	O
in	O
the	O
regulation	B-T038
of	O
widely	O
divergent	O
cellular	B-T038
processes	I-T038
in	O
mammals	B-T204
.	O
however	O
,	O
its	O
role	O
and	O
underlying	O
mechanisms	O
in	O
zebrafish	B-T204
remain	O
largely	O
unknown	O
.	O
to	O
elucidate	O
the	O
function	O
of	O
akt	B-T017
##2	I-T017
in	O
zebrafish	B-T204
,	O
we	O
generated	O
zebrafish	B-T204
lacking	O
akt	B-T017
##2	I-T017
gene	I-T017
via	O
crispr	B-T038
/	I-T038
cas9	I-T038
technology	O
.	O
akt	B-T017
##2	I-T017
-	O
null	O
zebrafish	B-T204
exhibit	O
partial	O
lethality	B-T033
and	O
severe	O
growth	B-T038
deficiency	O
,	O
which	O
is	O
different	O
from	O
those	O
observed	O
in	O
akt	B-T017
##2	I-T017
-	O
null	O
mice	B-T204
.	O
furthermore	O
,	O
akt	B-T017
##2	I-T017
-	O
null	O
zebrafish	B-T204
display	O
deficiency	O
in	O
fin	B-T038
ray	I-T038
development	I-T038
,	O
but	O
their	O
cartilage	B-T017
is	O
not	O
affected	O
.	O
similar	O
to	O
observations	B-T062
in	O
akt	B-T017
##2	I-T017
-	O
null	O
mice	B-T204
,	O
akt	B-T017
##2	I-T017
-	O
null	O
zebrafish	B-T204
display	O
impaired	O
glucose	B-T038
homeostasis	I-T038
.	O
however	O
,	O
in	O
contrast	O
to	O
that	O
in	O
akt	B-T017
##2	I-T017
-	O
null	O
mice	B-T204
,	O
insulin	B-T058
level	I-T058
is	O
lower	O
in	O
akt	B-T017
##2	I-T017
-	O
null	O
zebrafish	B-T204
,	O
implicating	O
the	O
symptoms	B-T033
of	O
type	B-T038
i	I-T038
diabetes	I-T038
exhibited	O
in	O
akt	B-T017
##2	I-T017
-	O
null	O
zebrafish	B-T204
.	O
in	O
addition	O
,	O
transcriptome	B-T058
analysis	I-T058
reveals	O
that	O
the	O
genes	B-T017
involved	O
in	O
metabolism	B-T038
and	O
osteogenesis	B-T038
are	O
disturbed	O
in	O
akt	B-T017
##2	I-T017
-	O
null	O
zebrafish	B-T204
.	O
taken	O
together	O
,	O
these	O
data	O
not	O
only	O
support	O
an	O
important	O
role	O
of	O
akt	B-T017
##2	I-T017
in	O
zebrafish	B-T204
survival	O
,	O
growth	B-T038
,	O
bone	B-T038
development	I-T038
and	O
glucose	B-T038
homeostasis	I-T038
,	O
but	O
also	O
suggest	O
that	O
akt	B-T017
##2	I-T017
has	O
divergent	O
functions	O
between	O
mice	B-T204
and	O
zebrafish	B-T204
,	O
even	O
though	O
they	O
are	O
evolutionarily	B-T038
conserved	B-T038
.	O

gold	B-T103
-	O
nanos	B-T074
##po	I-T074
##ng	I-T074
##e	I-T074
-	O
based	O
multist	B-T103
##im	I-T103
##uli	I-T103
-	I-T103
responsive	I-T103
drug	I-T103
vehicles	I-T103
for	O
targeted	O
chemo	B-T058
-	I-T058
photothermal	I-T058
therapy	I-T058
gold	B-T103
-	O
nanos	B-T074
##po	I-T074
##ng	I-T074
##e	I-T074
-	O
based	O
multist	B-T103
##im	I-T103
##uli	I-T103
-	I-T103
responsive	I-T103
drug	I-T103
vehicles	I-T103
are	O
constructed	O
for	O
combined	O
chemo	B-T058
-	I-T058
photothermal	I-T058
therapy	I-T058
with	O
pin	O
##point	O
##ed	O
drug	B-T103
delivery	O
and	O
release	O
capabilities	O
and	O
minimized	O
nonspecific	O
systemic	O
spread	O
of	O
drugs	B-T103
,	O
remarkably	O
enhancing	O
the	O
therapeutic	O
efficiency	O
while	O
minimizing	O
acute	O
side	B-T038
effects	I-T038
.	O

the	O
underlying	O
inflammatory	B-T038
chronic	I-T038
disease	I-T038
influences	O
infliximab	B-T103
pharmacokinetics	O
infliximab	B-T103
is	O
an	O
anti	B-T103
-	I-T103
tumor	I-T103
necrosis	I-T103
factor	I-T103
monoclonal	B-T103
antibody	I-T103
approved	O
in	O
chronic	B-T038
inflammatory	I-T038
diseases	I-T038
such	O
as	O
rheumatoid	B-T038
arthritis	I-T038
(	O
ra	B-T038
)	O
,	O
psoriatic	B-T038
arthritis	I-T038
(	O
psa	B-T038
)	O
,	O
ankylosing	B-T038
spondylitis	I-T038
(	O
as	B-T038
)	O
,	O
crohn	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
cd	B-T038
)	O
and	O
ulcerative	B-T038
colitis	I-T038
(	O
uc	B-T038
)	O
.	O
infliximab	B-T103
pharmacokinetics	O
is	O
variable	O
between	O
patients	O
,	O
but	O
influence	O
of	O
the	O
underlying	B-T038
disease	I-T038
was	O
never	O
assessed	O
.	O
this	O
study	O
aimed	O
at	O
assessing	O
this	O
influence	O
using	O
a	O
cohort	B-T098
of	O
patients	B-T058
monitored	I-T058
in	O
a	O
single	O
center	O
and	O
with	O
the	O
same	O
assay	B-T058
.	O
infliximab	B-T103
trough	O
concentrations	O
were	O
determined	O
on	O
samples	B-T058
collected	I-T058
between	O
weeks	O
0	O
and	O
22	O
after	O
treatment	O
initiation	O
in	O
218	O
patients	O
treated	O
for	O
ra	B-T038
,	O
psa	B-T038
,	O
as	B-T038
,	O
cd	B-T038
or	O
uc	B-T038
.	O
infliximab	B-T103
pharmacokinetics	O
was	O
analyzed	B-T062
by	O
a	O
one	O
-	O
compartment	O
population	B-T098
model	O
with	O
first	O
-	O
order	O
elimination	B-T033
rate	O
constant	O
.	O
in	O
as	B-T038
patients	O
,	O
volume	O
of	O
distribution	O
(	O
v	O
)	O
and	O
elimination	B-T033
clearance	O
(	O
cl	O
)	O
were	O
5	O
.	O
4	O
l	O
and	O
0	O
.	O
24	O
l	O
/	O
day	O
,	O
respectively	O
.	O
in	O
cd	B-T038
and	O
uc	B-T038
patients	O
,	O
v	O
was	O
49	O
%	O
and	O
52	O
%	O
higher	O
than	O
in	O
as	B-T038
,	O
respectively	O
,	O
and	O
cl	O
was	O
47	O
%	O
and	O
60	O
%	O
higher	O
than	O
in	O
as	B-T038
,	O
respectively	O
.	O
in	O
ra	B-T038
patients	O
,	O
cl	O
was	O
49	O
%	O
higher	O
than	O
in	O
as	B-T038
patients	O
.	O
simulations	B-T062
showed	O
that	O
without	O
methotrexate	B-T103
,	O
a	O
3	O
mg	O
/	O
kg	O
dosing	O
regimen	B-T058
would	O
lead	O
only	O
16	O
%	O
of	O
ra	B-T038
patients	O
to	O
reach	O
the	O
target	O
concentration	O
(	O
2	O
.	O
5	O
mg	O
/	O
l	O
)	O
at	O
week	O
22	O
,	O
whereas	O
target	O
concentrations	O
would	O
be	O
reached	O
in	O
approximately	O
half	O
of	O
ra	B-T038
patients	O
cot	O
##re	O
##ated	O
with	O
methotrexate	B-T103
,	O
as	O
well	O
as	O
half	O
of	O
cd	B-T038
(	O
3	O
.	O
5	O
mg	O
/	O
l	O
)	O
and	O
uc	B-T038
(	O
3	O
.	O
7	O
mg	O
/	O
l	O
)	O
patients	O
.	O
the	O
suboptimal	O
##ity	O
of	O
approved	O
dosing	O
regimens	B-T058
supports	O
the	O
development	O
of	O
dosing	O
optimization	O
based	O
on	O
concentration	O
measurements	O
.	O

expressed	B-T038
microrna	B-T103
associated	O
with	O
high	O
rate	O
of	O
egg	B-T038
production	I-T038
in	O
chicken	B-T204
ovarian	B-T017
follicles	I-T017
microrna	B-T103
(	O
mirna	B-T103
)	O
is	O
a	O
highly	O
conserved	O
class	O
of	O
small	O
noncoding	B-T103
rna	I-T103
about	O
19	O
-	O
24	O
nucleotides	B-T103
in	O
length	O
that	O
function	O
in	O
a	O
specific	O
manner	O
to	O
post	B-T038
-	I-T038
transcriptionally	I-T038
regulate	I-T038
gene	B-T038
expression	I-T038
in	O
organisms	O
.	O
tissue	B-T017
mirna	B-T103
expression	B-T038
studies	B-T062
have	O
discovered	O
a	O
myriad	O
of	O
functions	O
for	O
mirnas	B-T103
in	O
various	O
aspects	O
,	O
but	O
a	O
role	O
for	O
mirnas	B-T103
in	O
chicken	B-T204
ovarian	B-T017
tissue	I-T017
at	O
300	O
days	O
of	O
age	O
has	O
not	O
hitherto	O
been	O
reported	O
.	O
in	O
this	O
study	O
,	O
we	O
performed	O
the	O
first	O
mirna	B-T103
analysis	B-T062
of	O
ovarian	B-T017
tissues	I-T017
in	O
chickens	B-T204
with	O
low	O
and	O
high	O
rates	O
of	O
egg	B-T038
production	I-T038
using	O
high	B-T062
-	I-T062
throughput	I-T062
sequencing	I-T062
.	O
by	O
comparing	O
low	O
rate	O
of	O
egg	B-T038
production	I-T038
chickens	B-T204
with	O
high	O
rate	O
of	O
egg	B-T038
production	I-T038
chickens	B-T204
,	O
17	O
significantly	O
differentially	O
expressed	B-T038
mirnas	B-T103
were	O
found	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
including	O
11	O
known	O
and	O
six	O
novel	O
mirnas	B-T103
.	O
we	O
found	O
that	O
all	O
11	O
known	O
mirnas	B-T103
were	O
involved	O
mainly	O
in	O
pathways	B-T038
of	O
reproduction	B-T038
regulation	B-T038
,	O
such	O
as	O
steroid	B-T038
hormone	I-T038
biosynthesis	I-T038
and	O
dopaminergic	B-T082
synapse	I-T082
.	O
additionally	O
,	O
expression	B-T038
profiling	O
of	O
six	O
randomly	O
selected	O
differentially	O
regulated	B-T038
mirnas	B-T103
were	O
validated	O
by	O
quantitative	B-T062
real	I-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
rt	B-T062
-	I-T062
qpcr	I-T062
)	O
.	O
some	O
mirnas	B-T103
,	O
such	O
as	O
gg	B-T017
##a	I-T017
-	I-T017
mir	I-T017
-	I-T017
34	I-T017
##b	I-T017
,	O
gg	B-T017
##a	I-T017
-	I-T017
mir	I-T017
-	I-T017
34	I-T017
##c	I-T017
and	O
gg	B-T017
##a	I-T017
-	I-T017
mir	I-T017
-	I-T017
216	I-T017
##b	I-T017
,	O
were	O
reported	O
to	O
regulate	B-T038
processes	O
such	O
as	O
proliferation	B-T038
,	O
cell	B-T038
cycle	I-T038
,	O
apoptosis	B-T038
and	O
metastasis	B-T038
and	O
were	O
expressed	B-T038
differentially	O
in	O
ovaries	B-T017
of	O
chickens	B-T204
with	O
high	O
rates	O
of	O
egg	B-T038
production	I-T038
,	O
suggesting	O
that	O
these	O
mirnas	B-T103
have	O
an	O
important	O
role	O
in	O
ovary	B-T017
development	B-T038
and	O
reproductive	B-T038
management	I-T038
of	O
chicken	B-T204
.	O
furthermore	O
,	O
we	O
uncovered	O
that	O
a	O
significantly	O
up	B-T038
-	I-T038
regulated	I-T038
mirna	B-T103
-	O
gg	B-T017
##a	I-T017
-	I-T017
mir	I-T017
-	I-T017
200	I-T017
##a	I-T017
-	I-T017
3p	I-T017
-	O
is	O
ubiquitous	O
in	O
reproduction	B-T038
-	O
regulation	B-T038
-	O
related	O
pathways	B-T038
.	O
this	O
mirna	B-T103
may	O
play	O
a	O
special	O
central	O
role	O
in	O
the	O
reproductive	B-T038
management	I-T038
of	O
chicken	B-T204
,	O
and	O
needs	O
to	O
be	O
further	O
studied	O
for	O
confirmation	O
.	O

gene	B-T017
-	O
based	O
genome	B-T062
-	I-T062
wide	I-T062
association	I-T062
study	I-T062
identified	O
19	B-T017
##p1	I-T017
##3	I-T017
.	I-T017
3	I-T017
for	O
lean	B-T201
body	I-T201
mass	I-T201
lean	B-T201
body	I-T201
mass	I-T201
(	O
lb	B-T201
##m	I-T201
)	O
is	O
a	O
complex	O
trait	O
for	O
human	B-T204
health	O
.	O
to	O
identify	O
genomic	B-T017
loci	I-T017
underlying	O
lb	B-T201
##m	I-T201
,	O
we	O
performed	O
a	O
gene	B-T017
-	O
based	O
genome	B-T062
-	I-T062
wide	I-T062
association	I-T062
study	I-T062
of	O
lean	O
mass	O
index	O
(	O
lm	O
##i	O
)	O
in	O
1000	O
unrelated	B-T033
caucasian	B-T098
subjects	B-T098
,	O
and	O
replicated	O
in	O
228	O
##3	O
unrelated	B-T033
caucasians	B-T098
subjects	B-T098
.	O
gene	B-T017
-	O
based	O
association	B-T062
analyses	I-T062
highlighted	O
the	O
significant	O
associations	O
of	O
three	O
genes	B-T017
u	B-T017
##qc	I-T017
##r	I-T017
,	O
tcf	B-T017
##3	I-T017
and	O
mb	B-T017
##d3	I-T017
in	O
one	O
single	O
locus	B-T017
19	B-T017
##p1	I-T017
##3	I-T017
.	I-T017
3	I-T017
(	O
discovery	O
p	O
=	O
6	O
.	O
10	O
×	O
10	O
(	O
-	O
5	O
)	O
,	O
1	O
.	O
65	O
×	O
10	O
(	O
-	O
4	O
)	O
and	O
1	O
.	O
10	O
×	O
10	O
(	O
-	O
4	O
)	O
;	O
replication	O
p	O
=	O
2	O
.	O
21	O
×	O
10	O
(	O
-	O
3	O
)	O
,	O
1	O
.	O
84	O
×	O
10	O
(	O
-	O
3	O
)	O
and	O
6	O
.	O
95	O
×	O
10	O
(	O
-	O
3	O
)	O
;	O
combined	O
p	O
=	O
2	O
.	O
26	O
×	O
10	O
(	O
-	O
6	O
)	O
,	O
4	O
.	O
86	O
×	O
10	O
(	O
-	O
6	O
)	O
and	O
1	O
.	O
15	O
×	O
10	O
(	O
-	O
5	O
)	O
,	O
respectively	O
)	O
.	O
these	O
results	O
,	O
together	O
with	O
the	O
known	O
functional	O
relevance	O
of	O
the	O
three	O
genes	B-T017
to	O
lm	O
##i	O
,	O
suggested	O
that	O
the	O
19	B-T017
##p1	I-T017
##3	I-T017
.	I-T017
3	I-T017
region	B-T082
containing	O
u	B-T017
##qc	I-T017
##r	I-T017
,	O
tcf	B-T017
##3	I-T017
and	O
mb	B-T017
##d3	I-T017
genes	I-T017
was	O
a	O
novel	O
locus	B-T017
underlying	O
lean	B-T201
mass	I-T201
variation	O
.	O

incontinence	B-T038
-	O
associated	O
dermatitis	B-T038
:	O
reducing	O
adverse	B-T038
events	I-T038
incontinence	B-T038
-	O
associated	O
dermatitis	B-T038
(	O
iad	B-T038
)	O
is	O
a	O
common	O
problem	B-T033
in	O
patients	O
with	O
faecal	B-T038
and	O
/	O
or	O
urinary	B-T038
incontinence	I-T038
.	O
urine	B-T031
alters	O
the	O
normal	O
skin	B-T022
flora	B-T033
and	O
increases	O
permeability	O
of	O
the	O
stratum	B-T017
corneum	I-T017
and	O
faecal	B-T031
enzymes	B-T103
on	O
the	O
skin	B-T022
contribute	O
to	O
skin	O
damage	O
.	O
faecal	B-T031
bacteria	B-T007
can	O
then	O
penetrate	O
the	O
skin	B-T022
,	O
increasing	O
the	O
risk	O
of	O
secondary	B-T038
infection	I-T038
.	O
however	O
,	O
iad	B-T038
can	O
be	O
prevented	B-T058
and	O
healed	O
with	O
timely	O
and	O
appropriate	O
skin	B-T058
clean	I-T058
##sin	I-T058
##g	I-T058
and	O
skin	O
protection	O
.	O
this	O
includes	O
appropriate	O
use	O
of	O
containment	O
devices	O
.	O
this	O
article	O
also	O
looks	O
at	O
hart	B-T074
##mann	I-T074
incontinence	I-T074
pads	I-T074
that	O
have	O
been	O
developed	O
to	O
absorb	O
the	O
fluids	O
that	O
cause	O
iad	B-T038
and	O
maintain	O
the	O
skin	B-T022
'	I-T022
s	I-T022
acidic	O
ph	O
.	O
the	O
acidic	O
ph	O
of	O
the	O
skin	B-T022
contributes	O
to	O
its	O
barrier	B-T038
function	I-T038
and	O
defence	O
against	O
infection	B-T038
.	O
therefore	O
,	O
maintaining	O
an	O
acidic	O
ph	O
will	O
help	O
protect	O
the	O
skin	B-T022
from	O
damage	O
.	O

primitive	B-T038
neuro	I-T038
##ect	I-T038
##odermal	I-T038
tumors	I-T038
of	O
the	O
female	B-T017
genital	I-T017
tract	I-T017
:	O
a	O
morphologic	O
,	O
immunohistochemical	O
,	O
and	O
molecular	O
study	B-T062
of	O
19	O
cases	O
primary	B-T038
primitive	I-T038
neuro	I-T038
##ect	I-T038
##odermal	I-T038
tumor	I-T038
(	O
pn	B-T038
##et	I-T038
)	O
of	O
the	O
female	B-T017
genital	I-T017
tract	I-T017
is	O
rare	O
,	O
and	O
its	O
proper	O
classification	B-T170
remains	O
unclear	O
.	O
the	O
clinical	O
,	O
histologic	O
,	O
and	O
immunophen	B-T058
##otypic	I-T058
features	O
as	O
well	O
as	O
ew	B-T017
##sr	I-T017
##1	I-T017
rearrangement	B-T038
status	O
of	O
19	O
gynecologic	B-T082
pn	B-T038
##ets	I-T038
,	O
including	O
10	O
ovarian	B-T017
,	O
8	O
uterine	B-T017
,	O
and	O
1	O
vulvar	B-T017
tumors	B-T038
,	O
are	O
herein	O
reported	B-T170
.	O
patient	O
age	O
ranged	O
from	O
12	O
to	O
68	O
years	O
,	O
with	O
a	O
median	O
age	O
of	O
20	O
and	O
51	O
years	O
among	O
those	O
with	O
ovarian	B-T017
and	O
uterine	B-T017
pn	B-T038
##ets	I-T038
,	O
respectively	O
.	O
morphologic	O
features	O
of	O
central	B-T022
nervous	I-T022
system	I-T022
(	O
cns	B-T022
)	O
tumors	B-T038
were	O
seen	O
in	O
15	O
pn	B-T038
##ets	I-T038
,	O
including	O
9	O
medulloblastoma	B-T038
##s	I-T038
,	O
3	O
ependym	B-T038
##omas	I-T038
,	O
2	O
medull	B-T038
##oe	I-T038
##pi	I-T038
##the	I-T038
##li	I-T038
##omas	I-T038
,	O
and	O
1	O
glioblastoma	B-T038
,	O
consistent	O
with	O
central	B-T038
pn	I-T038
##et	I-T038
.	O
the	O
remaining	O
4	O
pn	B-T038
##ets	I-T038
were	O
composed	O
entirely	O
of	O
undifferentiated	O
small	B-T017
round	I-T017
blue	I-T017
cells	I-T017
and	O
were	O
classified	O
as	O
ewing	B-T038
sarcoma	I-T038
/	I-T038
peripheral	I-T038
pn	I-T038
##et	I-T038
.	O
eight	O
pn	B-T038
##ets	I-T038
were	O
associated	O
with	O
another	O
tumor	B-T038
type	O
,	O
including	O
5	O
ovarian	B-T017
mature	B-T038
cystic	I-T038
teratoma	I-T038
##s	I-T038
,	O
2	O
endometrial	O
low	O
-	O
grade	O
endometri	B-T038
##oid	I-T038
carcinomas	I-T038
,	O
and	O
a	O
uterine	B-T038
carcin	I-T038
##osarcoma	I-T038
.	O
by	O
immunohistochemistry	B-T058
,	O
17	O
pn	B-T038
##ets	I-T038
expressed	O
at	O
least	O
1	O
marker	B-T103
of	O
neuronal	B-T033
differentiation	I-T033
,	O
including	O
synapt	B-T103
##ophys	I-T103
##in	I-T103
,	O
nse	B-T103
,	O
cd56	B-T103
,	O
s100	B-T103
,	O
and	O
chrom	B-T103
##ogranin	I-T103
in	O
10	O
,	O
8	O
,	O
14	O
,	O
8	O
,	O
and	O
1	O
tumors	B-T038
,	O
respectively	O
.	O
gfap	B-T103
was	O
positive	O
in	O
4	O
pn	B-T038
##ets	I-T038
,	O
all	O
of	O
which	O
were	O
of	O
central	O
type	O
.	O
membranous	B-T017
cd	B-T103
##99	I-T103
and	O
nuclear	B-T082
fl	B-T103
##i	I-T103
-	I-T103
1	I-T103
staining	B-T058
was	O
seen	O
in	O
10	O
and	O
16	O
tumors	B-T038
,	O
respectively	O
,	O
and	O
concurrent	O
expression	B-T038
of	O
both	O
markers	B-T103
was	O
seen	O
in	O
both	O
central	B-T038
and	O
ewing	B-T038
sarcoma	I-T038
/	I-T038
peripheral	I-T038
pn	I-T038
##et	I-T038
s	O
.	O
all	O
tumors	B-T038
expressed	B-T038
vimentin	B-T103
,	O
whereas	O
keratin	B-T103
cocktail	O
(	O
cam	B-T103
##5	I-T103
.	I-T103
2	I-T103
,	O
ae	O
##1	O
/	O
ae	O
##3	O
)	O
staining	B-T058
was	O
only	O
focal	O
##ly	O
present	O
in	O
4	O
pn	B-T038
##ets	I-T038
.	O
fluorescence	B-T062
in	I-T062
situ	I-T062
hybridization	I-T062
was	O
successful	O
in	O
all	O
cases	O
and	O
confirmed	O
ew	B-T017
##sr	I-T017
##1	I-T017
rearrangement	B-T038
in	O
2	O
of	O
4	O
tumors	B-T038
demonstrating	O
morphologic	O
features	O
of	O
ewing	B-T038
sarcoma	I-T038
/	I-T038
peripheral	I-T038
pn	I-T038
##et	I-T038
and	O
concurrent	O
cd	B-T103
##99	I-T103
and	O
fl	B-T103
##i	I-T103
-	I-T103
1	I-T103
expression	B-T038
.	O
in	O
conclusion	O
,	O
central	B-T038
and	O
ewing	B-T038
sarcoma	I-T038
/	I-T038
peripheral	I-T038
pn	I-T038
##ets	I-T038
may	O
be	O
encountered	O
in	O
the	O
female	B-T017
genital	I-T017
tract	I-T017
with	O
central	B-T038
pn	I-T038
##ets	I-T038
being	O
more	O
common	O
.	O
central	B-T038
pn	I-T038
##ets	I-T038
show	O
a	O
spectrum	O
of	O
morphologic	O
features	O
that	O
overlaps	O
with	O
cns	B-T022
tumors	B-T038
but	O
lack	O
ew	B-T017
##sr	I-T017
##1	I-T017
rearrangement	B-T038
s	O
.	O
gfap	B-T103
expression	B-T038
supports	O
a	O
morphologic	O
impression	O
of	O
central	B-T038
pn	I-T038
##et	I-T038
and	O
is	O
absent	O
in	O
ewing	O
sarcoma	B-T038
/	I-T038
peripheral	I-T038
pn	I-T038
##et	I-T038
.	O
ewing	B-T038
sarcoma	I-T038
/	I-T038
peripheral	I-T038
pn	I-T038
##ets	I-T038
lack	O
morphologic	O
features	O
of	O
cns	B-T022
tumors	B-T038
.	O

reass	O
##emb	O
##ly	O
of	O
excit	O
##able	O
domains	O
after	O
cns	B-T022
axon	B-T038
regeneration	I-T038
action	B-T038
potential	I-T038
initiation	I-T038
and	O
propagation	B-T038
in	O
myelinated	O
axons	O
require	O
ion	B-T038
channel	I-T038
clustering	I-T038
at	O
axon	B-T017
initial	I-T017
segments	I-T017
(	B-T017
ais	I-T017
)	O
and	O
nodes	B-T082
of	I-T082
ran	I-T082
##vi	I-T082
##er	I-T082
.	O
disruption	O
of	O
these	O
domains	O
after	O
injury	B-T037
impairs	O
nervous	B-T038
system	I-T038
function	I-T038
.	O
traditionally	O
,	O
injured	O
cns	B-T022
axons	B-T017
are	O
considered	O
refractory	B-T038
to	O
regeneration	B-T038
,	O
but	O
some	O
recent	O
approaches	O
challenge	O
this	O
view	O
by	O
showing	O
robust	O
long	O
-	O
distance	O
regeneration	B-T038
.	O
however	O
,	O
whether	O
these	O
approaches	O
allow	O
rem	B-T038
##yelination	I-T038
and	O
promote	O
the	O
ree	O
##st	O
##ablish	O
##ment	O
of	O
ais	B-T017
and	O
nodes	B-T082
of	I-T082
ran	I-T082
##vi	I-T082
##er	I-T082
is	O
unknown	O
.	O
using	O
mouse	B-T204
optic	B-T017
nerve	I-T017
crush	B-T037
as	O
a	O
model	B-T038
for	O
cns	B-T022
traumatic	B-T037
injury	I-T037
,	O
we	O
performed	O
a	O
detailed	O
analysis	B-T062
of	O
ais	B-T017
and	O
node	B-T082
disruption	O
after	O
nerve	B-T037
crush	I-T037
.	O
we	O
found	O
significant	O
disruption	O
of	O
ais	B-T017
and	O
loss	O
of	O
nodes	B-T082
within	O
days	O
of	O
the	O
crush	B-T037
,	O
and	O
complete	O
loss	O
of	O
nodes	B-T082
1	O
week	O
after	O
injury	B-T037
.	O
genetic	B-T038
deletion	I-T038
of	O
the	O
tumor	B-T017
suppressor	I-T017
phosphatase	I-T017
and	I-T017
tens	I-T017
##in	I-T017
homolog	I-T017
(	O
pten	B-T017
)	O
in	O
retinal	B-T017
ganglion	I-T017
cells	I-T017
(	O
rgcs	B-T017
)	O
,	O
coupled	O
with	O
stimulation	B-T038
of	O
rgcs	B-T017
by	O
inflammation	B-T038
and	O
camp	B-T103
,	O
dramatically	O
enhanced	O
regeneration	B-T038
.	O
with	O
this	O
treat	B-T062
##men	I-T062
t	O
,	O
we	O
found	O
significant	O
ree	O
##st	O
##ablish	O
##ment	O
of	O
rgc	B-T017
ais	B-T017
,	O
rem	B-T038
##yelination	I-T038
,	O
and	O
even	O
reass	O
##emb	O
##ly	O
of	O
nodes	B-T082
in	O
regions	B-T082
proximal	I-T082
,	O
within	B-T082
,	O
and	O
distal	B-T082
to	O
the	O
crush	B-T037
site	B-T082
.	O
rem	B-T038
##yelination	I-T038
began	O
near	B-T082
the	I-T082
retina	I-T082
,	O
progressed	O
distally	B-T082
,	O
and	O
was	O
confirmed	O
by	O
electron	B-T058
microscopy	I-T058
.	O
although	O
axons	B-T017
grew	B-T038
rapidly	O
,	O
rem	B-T038
##yelination	I-T038
and	O
nodal	B-T038
ion	I-T038
channel	I-T038
clustering	I-T038
was	O
much	O
slower	O
.	O
finally	O
,	O
genetic	B-T038
deletion	I-T038
of	O
ank	B-T103
##yrin	I-T103
##g	I-T103
from	O
rgcs	B-T017
to	O
block	O
ais	B-T017
reass	O
##emb	O
##ly	O
did	O
not	O
affect	O
axon	B-T038
regeneration	I-T038
,	O
indicating	O
that	O
preservation	O
of	O
neuronal	B-T082
polarity	I-T082
is	O
not	B-T033
required	I-T033
for	O
axon	B-T038
regeneration	I-T038
.	O
together	O
,	O
our	O
results	O
demonstrate	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
regenerating	B-T038
cns	B-T022
axons	B-T017
can	O
be	O
rem	B-T038
##yelinated	I-T038
and	O
reass	O
##emb	O
##le	O
new	O
ais	B-T017
and	O
nodes	B-T082
of	I-T082
ran	I-T082
##vi	I-T082
##er	I-T082
.	O
we	O
show	O
,	O
for	O
the	O
first	O
time	O
,	O
that	O
regenerated	B-T038
cns	B-T022
axons	B-T017
have	O
the	O
capacity	O
to	O
both	O
rem	B-T038
##yelin	I-T038
##ate	I-T038
and	O
reass	O
##emb	O
##le	O
the	O
axon	B-T017
initial	I-T017
segments	I-T017
and	O
nodes	B-T082
of	I-T082
ran	I-T082
##vi	I-T082
##er	I-T082
necessary	O
for	O
rapid	O
and	O
efficient	O
action	B-T038
potential	I-T038
propagation	I-T038
.	O

evidence	O
for	O
instructions	O
-	O
based	O
updating	O
of	O
task	B-T058
-	I-T058
set	I-T058
representations	I-T058
:	O
the	O
informed	O
fad	B-T038
##e	I-T038
##out	I-T038
effect	I-T038
the	O
cognitive	B-T038
system	I-T038
can	O
be	O
updated	O
rapidly	O
and	O
efficiently	O
to	O
maximize	O
performance	B-T058
in	O
cognitive	B-T038
tasks	I-T038
.	O
this	O
paper	O
used	O
a	O
task	O
-	O
switching	O
task	O
to	O
explore	O
updating	O
at	O
the	O
level	O
of	O
the	O
plausible	O
task	O
-	O
sets	O
held	O
for	O
future	O
performance	B-T058
.	O
previous	O
research	B-T062
suggested	O
a	O
[UNK]	O
fad	B-T038
##e	I-T038
##out	I-T038
effect	I-T038
[UNK]	O
,	O
performance	B-T058
improvement	B-T058
when	O
moving	O
from	O
task	O
-	O
switching	O
context	O
to	O
single	O
-	O
task	O
context	O
,	O
yet	O
this	O
effect	O
could	O
reflect	O
passive	O
learning	B-T038
rather	O
than	O
intentional	O
control	O
.	O
in	O
a	O
novel	O
[UNK]	O
informed	O
fad	O
##e	O
##out	O
paradigm	O
[UNK]	O
,	O
one	O
of	O
two	O
tasks	O
was	O
can	O
##cel	O
##ed	O
for	O
a	O
certain	O
number	O
of	O
trials	O
and	O
participants	B-T098
were	O
informed	O
or	O
unin	B-T033
##formed	I-T033
regarding	O
task	O
can	O
##cel	O
##ation	O
.	O
the	O
[UNK]	O
informed	O
fad	B-T038
##e	I-T038
##out	I-T038
effect	I-T038
[UNK]	O
indicates	O
better	O
performance	B-T058
in	O
the	O
informed	O
than	O
unin	B-T033
##formed	I-T033
fad	B-T038
##e	I-T038
##out	I-T038
after	O
one	O
informed	O
trial	O
had	O
been	O
executed	O
.	O
however	O
,	O
the	O
results	O
regarding	O
the	O
first	O
trial	O
were	O
inconclusive	O
.	O
possible	O
underlying	O
mechanisms	O
are	O
discussed	O
.	O

individual	B-T098
leg	B-T017
muscle	I-T017
contributions	O
to	O
the	O
cost	O
of	O
walking	O
:	O
effects	O
of	O
age	O
and	O
walking	O
speed	O
this	O
study	B-T062
examined	B-T033
the	O
contributions	O
of	O
individual	B-T098
muscles	B-T017
to	O
changes	O
in	O
energetic	O
cost	O
of	O
transport	O
(	O
cot	O
)	O
over	O
seven	O
walking	O
speeds	O
,	O
and	O
compared	O
results	O
between	O
healthy	O
young	O
and	O
elderly	B-T098
subjects	I-T098
.	O
twenty	O
six	O
participants	B-T098
(	O
13	O
young	O
aged	O
18	O
-	O
30	O
;	O
13	O
old	B-T098
aged	I-T098
70	O
-	O
80	O
)	O
were	O
recruited	O
.	O
cot	O
(	O
o2	O
/	O
kg	O
body	O
mass	O
/	O
km	O
)	O
was	O
calculated	O
by	O
standard	O
##izing	O
the	O
mean	B-T201
oxygen	I-T201
consumption	I-T201
recorded	O
during	O
steady	O
state	O
walking	O
.	O
electromyography	B-T058
signals	O
from	O
10	O
leg	B-T017
muscles	I-T017
were	O
used	O
to	O
calculate	O
the	O
cumulative	O
activity	O
required	O
to	O
travers	O
##e	O
a	O
unit	O
of	O
distance	O
(	O
cma	O
##pd	O
)	O
for	O
each	O
muscle	B-T017
at	O
each	O
speed	O
.	O
in	O
the	O
old	B-T098
group	I-T098
cma	O
##pd	O
was	O
correlated	O
with	O
cot	O
,	O
presented	O
higher	O
and	O
more	O
variable	O
values	O
,	O
and	O
showed	O
greater	O
increases	O
around	O
optimal	O
speed	O
for	O
all	O
studied	O
muscles	B-T017
.	O
soleus	B-T017
cma	O
##pd	O
was	O
independent	O
of	O
speed	O
in	O
the	O
young	O
group	O
,	O
but	O
this	O
was	O
not	O
evident	O
with	O
aging	B-T038
.	O
greater	O
energy	O
cost	O
of	O
walking	O
in	O
older	B-T098
individuals	B-T098
seems	O
to	O
be	O
attributable	O
to	O
increased	O
energy	O
cost	O
of	O
all	O
lower	B-T017
limb	I-T017
muscles	I-T017
.	O

preliminary	O
randomized	B-T062
controlled	I-T062
trial	I-T062
of	O
habit	B-T058
reversal	I-T058
training	I-T058
for	O
treatment	B-T058
of	O
hair	B-T038
pull	I-T038
##ing	I-T038
in	O
youth	O
this	O
study	B-T062
evaluated	B-T058
the	O
treatment	B-T058
efficacy	O
of	O
habit	B-T058
reversal	I-T058
training	I-T058
(	O
hrt	B-T058
)	O
relative	O
to	O
treatment	O
as	O
usual	O
(	O
tau	O
)	O
for	O
children	O
and	O
adolescents	O
aged	O
7	O
-	O
17	O
years	O
with	O
a	O
primary	O
diagnosis	B-T062
of	O
trich	B-T038
##oti	I-T038
##ll	I-T038
##oman	I-T038
##ia	I-T038
(	O
tt	B-T038
##m	I-T038
)	O
.	O
an	O
initial	O
assessment	B-T058
consisting	O
of	O
semistructured	O
interviews	O
and	O
rating	O
scales	O
was	O
conducted	O
.	O
participants	B-T098
(	O
n	O
=	O
40	O
,	O
85	O
%	O
female	O
)	O
meeting	O
diagnostic	B-T170
criteria	I-T170
for	O
tt	B-T038
##m	I-T038
were	O
randomized	B-T062
to	O
either	O
8	O
weekly	O
sessions	O
of	O
hrt	B-T058
by	O
trained	O
therapists	O
or	O
8	O
weeks	O
of	O
tau	O
.	O
one	O
week	O
after	O
the	O
final	O
hrt	B-T058
session	O
or	O
final	O
tau	O
week	O
,	O
patients	O
completed	O
a	O
posttreatment	B-T058
assessment	I-T058
,	O
followed	O
by	O
1	O
-	O
and	O
3	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
assessments	B-T058
.	O
all	O
assessments	B-T058
were	O
conducted	O
by	O
a	O
trained	O
rater	B-T097
who	O
was	O
blinded	B-T062
to	O
treatment	B-T058
condition	O
.	O
the	O
group	O
by	O
time	O
analysis	O
of	O
variance	O
yielded	O
a	O
significant	O
interaction	O
on	O
the	O
national	B-T092
institute	I-T092
of	I-T092
mental	I-T092
health	I-T092
-	O
trich	O
##oti	O
##ll	O
##oman	O
##ia	O
severity	O
scale	O
total	O
score	O
(	O
f1	O
,	O
38	O
=	O
16	O
.	O
47	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
η	O
(	O
2	O
)	O
p	O
=	O
0	O
.	O
30	O
)	O
.	O
the	O
mean	O
score	O
decreased	O
from	O
12	O
.	O
67	O
±	O
4	O
.	O
60	O
at	O
baseline	O
to	O
5	O
.	O
62	O
±	O
4	O
.	O
38	O
at	O
posttreatment	B-T058
in	O
the	O
hrt	B-T058
group	B-T098
(	O
t2	O
##0	O
=	O
5	O
.	O
99	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
d	O
=	O
1	O
.	O
31	O
)	O
,	O
whereas	O
the	O
tau	O
group	B-T098
changed	O
from	O
10	O
.	O
42	O
±	O
4	O
.	O
35	O
to	O
9	O
.	O
32	O
±	O
4	O
.	O
11	O
(	O
t1	O
##8	O
=	O
1	O
.	O
34	O
,	O
p	O
=	O
0	O
.	O
20	O
,	O
d	O
=	O
0	O
.	O
31	O
)	O
.	O
the	O
massachusetts	O
general	O
hospital	O
-	O
hair	O
pull	O
##ing	O
scale	O
total	O
score	O
decreased	O
from	O
15	O
.	O
14	O
±	O
3	O
.	O
86	O
at	O
baseline	O
to	O
7	O
.	O
14	O
±	O
5	O
.	O
54	O
at	O
posttreatment	B-T058
in	O
the	O
hrt	B-T058
group	B-T098
(	O
t2	O
##0	O
=	O
6	O
.	O
16	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
d	O
=	O
1	O
.	O
34	O
)	O
;	O
the	O
tau	O
group	B-T098
changed	O
from	O
14	O
.	O
16	O
±	O
4	O
.	O
51	O
to	O
12	O
.	O
26	O
±	O
4	O
.	O
34	O
(	O
t1	O
##8	O
=	O
1	O
.	O
50	O
,	O
p	O
=	O
0	O
.	O
15	O
,	O
d	O
=	O
0	O
.	O
34	O
)	O
.	O
on	O
the	O
clinical	B-T170
global	I-T170
impressions	I-T170
-	I-T170
improvement	I-T170
,	O
16	O
/	O
21	O
participants	B-T098
(	O
76	O
%	O
)	O
were	O
rated	O
as	O
treatment	B-T058
responders	B-T098
in	O
the	O
hrt	B-T058
group	B-T098
versus	O
4	O
/	O
19	O
(	O
21	O
%	O
)	O
in	O
the	O
tau	O
group	B-T098
(	O
χ	O
(	O
2	O
)	O
=	O
12	O
.	O
13	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
v	O
=	O
0	O
.	O
55	O
)	O
.	O
at	O
1	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
,	O
10	O
-	O
12	O
treatment	B-T058
responders	B-T098
who	O
completed	O
the	O
assessment	B-T058
maintained	O
improvement	O
.	O
at	O
3	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
,	O
six	O
of	O
eight	O
maintained	O
improvement	O
.	O
hrt	B-T058
can	O
be	O
an	O
effective	O
treatment	B-T058
for	O
tt	B-T038
##m	I-T038
in	O
youth	O
.	O

le	B-T103
##on	I-T103
##urine	I-T103
attenuates	O
hyperalgesia	B-T033
in	O
mice	B-T204
with	O
induced	O
adeno	B-T038
##my	I-T038
##osis	I-T038
background	O
adeno	B-T038
##my	I-T038
##osis	I-T038
,	O
defined	O
as	O
the	O
invasion	B-T038
of	O
endometrial	B-T017
glands	I-T017
and	O
stroma	B-T017
into	O
the	O
myometrium	B-T017
,	O
is	O
a	O
common	O
gynecological	B-T038
disorder	I-T038
.	O
in	O
the	O
present	O
study	O
we	O
report	B-T170
on	O
the	O
effect	O
of	O
le	B-T103
##on	I-T103
##urine	I-T103
on	O
icr	B-T204
mice	I-T204
with	O
adeno	B-T038
##my	I-T038
##osis	I-T038
induced	O
by	O
neonatal	O
tamoxifen	B-T103
.	O
material	O
and	O
methods	O
after	O
being	O
treated	O
with	O
tamoxifen	B-T103
for	O
4	O
,	O
8	O
,	O
and	O
12	O
weeks	O
,	O
we	O
assessed	O
body	O
weight	O
and	O
pain	B-T033
modulation	O
in	O
mice	B-T204
in	O
hot	O
##plate	O
tests	B-T058
.	O
the	O
mice	B-T204
were	O
divided	O
into	O
5	O
groups	O
:	O
a	O
low	O
-	O
dose	O
le	B-T103
##on	I-T103
##urine	I-T103
treatment	B-T058
group	O
,	O
a	O
high	O
-	O
dose	O
le	B-T103
##on	I-T103
##urine	I-T103
treatment	B-T058
group	O
,	O
a	O
valproic	B-T103
acid	I-T103
(	O
vpa	B-T103
)	O
treatment	B-T058
group	O
,	O
a	O
vehicle	B-T103
only	O
treatment	B-T058
group	O
,	O
and	O
a	O
blank	O
control	O
group	O
.	O
we	O
evaluated	B-T058
body	O
weight	O
,	O
pain	O
modulation	O
in	O
hot	O
##plate	O
tests	B-T058
,	O
and	O
the	O
depth	B-T082
of	O
myometrial	B-T082
infiltration	B-T038
.	O
immunoreactivity	O
staining	B-T058
of	O
progesterone	B-T103
receptor	I-T103
(	O
pr	B-T103
)	O
,	O
nuclear	B-T103
factor	I-T103
-	I-T103
κb	I-T103
phosphorylated	I-T103
-	I-T103
p65	I-T103
(	O
p	B-T103
-	I-T103
p65	I-T103
)	O
,	O
cyclooxygenase	B-T103
-	I-T103
2	I-T103
(	O
cox	B-T103
-	I-T103
2	I-T103
)	O
,	O
and	O
oxytocin	B-T103
receptor	I-T103
(	O
ot	B-T103
##r	I-T103
)	O
was	O
evaluated	B-T058
by	O
immunohistochemistry	B-T058
.	O
results	O
the	O
measurement	O
of	O
the	O
body	O
weight	O
,	O
myometrial	B-T082
infiltration	B-T038
,	O
and	O
pain	O
modulation	O
showed	O
that	O
neonatal	O
tamoxifen	B-T103
treatment	B-T058
led	O
to	O
adeno	B-T038
##my	I-T038
##osis	I-T038
.	O
le	B-T103
##on	I-T103
##urine	I-T103
treatment	B-T058
appeared	O
to	O
decrease	O
hyperalgesia	B-T033
and	O
myometrial	B-T082
infiltration	B-T038
.	O
immunoreactivity	O
staining	B-T058
showed	O
decreased	O
p	B-T103
-	I-T103
p65	I-T103
,	O
cox	B-T103
-	I-T103
2	I-T103
,	O
and	O
ot	B-T103
##r	I-T103
protein	B-T038
expressions	I-T038
.	O
conclusions	O
our	O
results	O
indicate	O
that	O
le	B-T103
##on	I-T103
##urine	I-T103
attenuates	O
hyperalgesia	B-T033
in	O
mice	B-T204
with	O
induced	O
adeno	B-T038
##my	I-T038
##osis	I-T038
via	O
down	B-T038
-	I-T038
regulating	I-T038
expressions	B-T038
of	O
p	B-T103
-	I-T103
p65	I-T103
,	O
cox	B-T103
-	I-T103
2	I-T103
,	O
and	O
ot	B-T103
##r	I-T103
,	O
and	O
could	O
be	O
beneficial	O
for	O
treating	O
adeno	B-T038
##my	I-T038
##osis	I-T038
.	O

acute	B-T038
complicated	I-T038
sinusitis	I-T038
:	O
ten	O
years	O
experience	B-T038
from	O
the	O
university	B-T092
hospital	I-T092
of	O
the	O
west	B-T082
ind	I-T082
##ies	I-T082
complicated	B-T038
sinusitis	I-T038
is	O
rare	B-T038
.	O
it	O
might	O
not	O
be	O
identified	O
early	O
and	O
might	O
expose	O
the	O
patient	O
to	O
an	O
unfavourable	O
outcome	O
.	O
there	O
is	O
a	O
paucity	O
of	O
data	O
regarding	O
this	O
condition	B-T038
in	O
the	O
caribbean	B-T082
.	O
this	O
study	B-T062
was	O
undertaken	O
to	O
describe	O
the	O
clinical	O
characteristics	O
and	O
treatment	O
outcomes	O
of	O
patients	O
admitted	B-T058
with	O
this	O
condition	B-T038
.	O
a	O
retrospective	O
chart	O
review	O
was	O
performed	O
on	O
patients	O
admitted	B-T058
to	O
the	O
university	B-T092
hospital	I-T092
of	I-T092
the	I-T092
west	I-T092
ind	I-T092
##ies	I-T092
(	O
uh	B-T092
##wi	I-T092
)	O
with	O
complicated	B-T038
sinusitis	I-T038
between	O
1999	O
to	O
2011	O
.	O
the	O
data	O
was	O
analysed	B-T062
using	O
spss	B-T170
statistics	I-T170
22	I-T170
software	I-T170
.	O
there	O
were	O
30	O
patients	O
(	O
23	O
males	O
and	O
7	O
females	O
)	O
.	O
the	O
mean	O
(	O
sd	O
)	O
age	O
was	O
19	O
(	O
13	O
.	O
96	O
)	O
years	O
.	O
twenty	O
-	O
two	O
had	O
orbital	B-T082
complications	B-T038
,	O
two	O
had	O
intracranial	B-T082
complications	B-T038
and	O
one	O
had	O
both	O
.	O
the	O
most	O
common	O
organisms	O
isolated	O
were	O
streptococcus	B-T007
and	O
the	O
most	O
common	O
sensitivity	O
was	O
to	O
amoxicillin	B-T103
and	O
clavul	B-T103
##inic	I-T103
acid	I-T103
.	O
sixteen	O
patients	O
who	O
had	O
an	O
external	B-T082
surgical	O
approach	O
had	O
a	O
mean	O
(	O
sd	O
)	O
hospital	O
stay	O
of	O
8	O
.	O
8	O
(	O
3	O
.	O
71	O
)	O
days	O
compared	O
to	O
three	O
patients	O
who	O
had	O
a	O
purely	O
endoscopic	B-T082
approach	I-T082
who	O
had	O
a	O
mean	O
(	O
sd	O
)	O
hospital	O
stay	O
of	O
7	O
.	O
67	O
(	O
0	O
.	O
57	O
##7	O
)	O
days	O
.	O
there	O
was	O
no	B-T033
statistical	O
difference	O
in	O
mean	O
hospital	O
stay	O
between	O
these	O
two	O
groups	O
(	O
95	O
%	O
ci	O
,	O
-	O
3	O
.	O
49	O
-	O
5	O
.	O
78	O
;	O
p	O
=	O
0	O
.	O
60	O
##9	O
)	O
.	O
the	O
mean	O
duration	O
of	O
hospital	O
stay	O
for	O
those	O
treated	B-T058
medically	I-T058
was	O
six	O
days	O
versus	O
ten	O
days	O
for	O
the	O
surgical	O
group	O
.	O
the	O
mean	O
difference	O
was	O
three	O
days	O
(	O
95	O
%	O
ci	O
,	O
0	O
.	O
193	O
-	O
6	O
.	O
59	O
##5	O
;	O
p	O
=	O
0	O
.	O
039	O
)	O
.	O
acute	B-T038
complicated	I-T038
sinusitis	I-T038
is	O
seen	O
more	O
commonly	O
in	O
adolescent	O
males	O
.	O
the	O
most	O
common	O
complication	B-T038
was	O
orbital	B-T082
.	O
surgical	B-T058
treatment	I-T058
is	O
indicated	O
for	O
those	O
patients	O
who	O
fail	O
medical	O
management	O
and	O
should	O
consist	O
of	O
an	O
endoscopic	B-T082
approach	I-T082
which	O
may	O
be	O
combined	O
with	O
open	O
approaches	O
if	O
indicated	O
.	O

automated	O
characterization	O
and	O
counting	O
of	O
ki	B-T103
-	I-T103
67	I-T103
protein	I-T103
for	O
breast	B-T038
cancer	I-T038
prognosis	B-T058
:	O
a	O
quantitative	O
immunohistochemistry	B-T058
approach	B-T082
ki	B-T103
-	I-T103
67	I-T103
protein	I-T103
expression	B-T038
plays	O
an	O
important	O
role	O
in	O
predicting	O
the	O
proliferative	O
status	O
of	O
tumour	B-T017
cell	I-T017
s	O
and	O
deciding	O
the	O
future	O
course	O
of	O
therapy	B-T058
in	O
breast	B-T038
cancer	I-T038
.	O
immunohistochemical	B-T058
(	I-T058
ihc	I-T058
)	I-T058
determination	I-T058
of	O
ki	B-T058
-	I-T058
67	I-T058
score	I-T058
or	O
labelling	B-T058
index	I-T058
,	O
by	O
estimating	O
the	O
fraction	O
of	O
ki67	B-T103
positively	B-T033
stained	O
tumour	B-T017
cells	I-T017
,	O
is	O
the	O
most	O
widely	O
practiced	O
method	B-T058
to	O
assess	O
tumour	B-T038
proliferation	O
(	O
do	O
##ws	O
##ett	O
et	O
al	O
.	O
2011	O
)	O
.	O
accurate	O
manual	B-T058
counting	I-T058
of	O
these	O
cells	B-T017
(	O
specifically	O
nuclei	B-T017
)	O
due	O
to	O
complex	O
and	O
dense	O
distribution	O
of	O
cells	B-T017
,	O
therefore	O
,	O
becomes	O
critical	O
and	O
presents	O
a	O
major	O
challenge	O
to	O
pathologists	B-T097
.	O
in	O
this	O
paper	O
,	O
we	O
suggest	O
a	O
hybrid	B-T170
clustering	I-T170
algorithm	I-T170
to	O
quantify	O
the	O
proliferative	O
index	O
of	O
breast	B-T017
cancer	I-T017
cells	I-T017
based	O
on	O
automated	B-T058
counting	I-T058
of	O
ki	B-T103
-	I-T103
67	I-T103
nuclei	B-T017
.	O
the	O
proposed	O
methodology	B-T058
initially	O
pre	O
-	O
processes	O
the	O
ihc	B-T058
images	B-T170
of	O
ki	B-T103
-	I-T103
67	I-T103
stained	O
slides	O
of	O
breast	B-T038
cancer	I-T038
.	O
the	O
rg	O
##b	O
images	O
are	O
converted	O
to	O
grey	O
,	O
l	O
*	O
a	O
*	O
b	O
*	O
,	O
hs	O
##i	O
,	O
y	O
##cb	O
##cr	O
,	O
y	O
##i	O
##q	O
and	O
xy	O
##z	O
colour	B-T170
space	I-T170
.	O
all	O
the	O
stained	O
cells	B-T017
are	O
then	O
characterized	O
by	O
two	B-T058
stage	I-T058
segmentation	I-T058
process	I-T058
.	O
fuzzy	B-T170
c	I-T170
-	I-T170
means	I-T170
quantif	O
##ies	O
all	O
the	O
stained	O
cells	B-T017
as	O
one	O
cluster	O
.	O
the	O
blue	O
channel	O
of	O
the	O
first	B-T170
stage	I-T170
output	O
is	O
given	O
as	O
input	O
to	O
k	B-T062
-	I-T062
means	I-T062
algorithm	I-T062
,	O
which	O
provides	O
separate	O
cluster	O
for	O
ki	B-T103
-	I-T103
67	I-T103
positive	O
and	O
negative	O
cells	B-T017
.	O
the	O
count	O
of	O
positive	O
and	O
negative	O
nuclei	B-T017
is	O
used	O
to	O
calculate	B-T058
the	O
f	O
-	O
measure	O
for	O
each	O
colour	B-T170
space	I-T170
.	O
a	O
comparative	B-T062
study	I-T062
of	O
our	O
work	O
with	O
the	O
expert	O
opinion	O
is	O
studied	O
to	O
evaluate	O
the	O
error	O
rate	O
.	O
the	O
positive	O
and	O
negative	O
nuclei	B-T017
detection	B-T033
results	O
for	O
all	O
colour	B-T170
space	I-T170
s	O
are	O
compared	O
with	O
the	O
ground	O
truth	O
for	O
validation	O
and	O
f	O
-	O
measure	O
is	O
calculated	B-T058
.	O
the	O
f	O
-	O
measure	O
for	O
l	O
*	O
a	O
*	O
b	O
*	O
colour	B-T170
space	I-T170
(	O
0	O
.	O
88	O
##47	O
)	O
provides	O
the	O
best	O
statistical	O
result	O
as	O
compared	O
to	O
grey	O
,	O
hs	O
##i	O
,	O
y	O
##cb	O
##cr	O
,	O
y	O
##i	O
##q	O
and	O
xy	O
##z	O
colour	B-T170
space	I-T170
.	O
further	O
,	O
a	O
study	B-T062
is	O
carried	O
out	O
to	O
count	O
nuclei	B-T017
manually	B-T058
and	O
automatically	B-T058
from	O
the	O
proposed	O
algorithm	B-T170
with	O
an	O
average	O
error	O
rate	O
of	O
6	O
.	O
84	O
%	O
which	O
is	O
significant	O
.	O
the	O
study	B-T062
provides	O
an	O
automated	O
count	O
of	O
positive	O
and	O
negative	O
nuclei	B-T017
using	O
l	O
*	O
a	O
*	O
b	O
*	O
colour	B-T170
space	I-T170
and	O
hybrid	O
segmentation	O
technique	O
.	O
computerized	B-T058
evaluation	I-T058
of	O
proliferation	O
index	O
can	O
aid	O
pathologist	B-T097
in	O
assessing	O
breast	B-T038
cancer	I-T038
severity	O
.	O
the	O
proposed	O
methodology	B-T058
,	O
further	O
,	O
has	O
the	O
potential	O
advantage	O
of	O
saving	O
time	O
and	O
assisting	B-T058
in	O
decision	O
making	O
over	O
the	O
present	O
manual	B-T058
procedure	I-T058
and	O
could	O
evolve	O
as	O
an	O
assist	O
##ive	O
pathological	O
decision	O
support	O
system	O
.	O

network	O
analysis	B-T062
reveals	O
why	O
xyle	B-T007
##ll	I-T007
##a	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
will	O
persist	O
in	O
europe	B-T082
the	O
insect	B-T204
vector	I-T204
borne	O
bacterium	B-T007
xyle	B-T007
##ll	I-T007
##a	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
was	O
first	O
detected	O
in	O
olive	B-T204
trees	I-T204
in	O
southern	B-T082
italy	I-T082
in	O
2013	O
,	O
and	O
identified	O
as	O
the	O
main	O
cul	O
##pri	O
##t	O
behind	O
the	O
'	O
olive	B-T038
quick	I-T038
decline	I-T038
syndrome	I-T038
'	O
.	O
since	O
then	O
,	O
the	O
disease	B-T038
has	O
spread	O
rapidly	O
through	O
italy	B-T082
'	I-T082
s	I-T082
main	O
olive	B-T103
oil	I-T103
producing	O
region	B-T082
.	O
the	O
epidemiology	B-T062
of	O
the	O
outbreak	O
is	O
largely	O
unst	O
##udied	O
,	O
with	O
the	O
list	O
of	O
x	B-T007
.	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
hosts	O
and	O
vectors	B-T204
in	O
europe	B-T082
likely	O
incomplete	O
,	O
and	O
the	O
role	O
humans	B-T204
play	O
in	O
dispersal	O
unknown	O
.	O
these	O
knowledge	B-T170
gaps	B-T082
have	O
led	O
to	O
management	O
strategies	O
based	O
on	O
general	O
assumptions	O
that	O
require	O
,	O
among	O
others	O
,	O
local	O
vector	O
control	O
and	O
,	O
in	O
certain	O
areas	O
,	O
the	O
destruction	O
of	O
infected	B-T204
plants	I-T204
and	O
healthy	O
ones	O
around	O
them	O
in	O
an	O
attempt	O
to	O
eradicate	O
or	O
hal	O
##t	O
the	O
spreading	O
pest	B-T038
.	O
here	O
we	O
show	O
that	O
,	O
regardless	O
of	O
epidemiological	O
uncertainties	B-T033
,	O
the	O
mer	O
##e	O
distribution	O
of	O
olive	B-T204
orch	O
##ards	O
in	O
southern	B-T082
italy	I-T082
makes	O
the	O
chances	O
of	O
eradic	O
##ating	O
x	B-T007
.	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
from	O
the	O
region	B-T082
extremely	O
sl	O
##im	O
.	O
our	O
results	O
imply	O
that	O
southern	B-T082
italy	I-T082
is	O
becoming	O
a	O
reservoir	B-T082
for	O
x	B-T007
.	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
.	O
as	O
a	O
consequence	O
,	O
management	O
strategies	O
should	O
keep	O
the	O
prevalence	O
of	O
x	B-T007
.	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
in	O
the	O
region	B-T082
as	O
low	O
as	O
possible	O
,	O
primarily	O
through	O
vector	O
control	O
,	O
les	O
##t	O
the	O
pathogen	O
,	O
that	O
has	O
also	O
been	O
detected	O
in	O
southern	B-T082
france	I-T082
and	O
the	O
island	B-T082
of	I-T082
mall	I-T082
##or	I-T082
##ca	I-T082
(	O
spain	B-T082
)	O
,	O
continues	O
spreading	O
through	O
italy	B-T082
and	O
europe	B-T082
.	O

zik	B-T005
##a	I-T005
virus	I-T005
disrupts	O
phospho	B-T103
-	I-T103
tb	I-T103
##k1	I-T103
localization	B-T038
and	O
mitosis	B-T038
in	O
human	B-T204
neuro	O
##epithelial	O
stem	B-T017
cells	I-T017
and	O
radial	B-T017
glia	I-T017
the	O
mechanisms	O
underlying	O
zik	B-T005
##a	I-T005
virus	I-T005
(	O
zikv	B-T005
)	O
-	O
related	O
microc	B-T017
##ephal	I-T017
##y	I-T017
and	O
other	O
neurodevelop	O
##ment	O
defects	O
remain	O
poorly	O
understood	B-T038
.	O
here	O
,	O
we	O
describe	O
the	O
derivation	O
and	O
characterization	O
,	O
including	O
single	B-T082
-	I-T082
cell	I-T082
rna	I-T082
-	I-T082
seq	I-T082
,	O
of	O
neocortical	B-T017
and	O
spinal	B-T017
cord	I-T017
neuro	O
##epithelial	O
stem	B-T017
(	I-T017
nes	I-T017
)	I-T017
cells	I-T017
to	O
model	O
early	O
human	B-T204
neurodevelop	O
##ment	O
and	O
zikv	B-T005
-	O
related	O
neuropath	B-T038
##ogenesis	I-T038
.	O
by	O
analyzing	O
human	B-T204
nes	B-T017
cells	I-T017
,	O
organ	O
##otypic	O
fetal	B-T017
brain	B-T017
slices	O
,	O
and	O
a	O
zikv	B-T005
-	O
infected	B-T033
micr	B-T017
##encephalic	I-T017
brain	B-T017
,	O
we	O
show	O
that	O
zikv	B-T005
infect	B-T033
##s	I-T033
both	O
neocortical	B-T017
and	O
spinal	B-T017
nes	B-T017
cells	I-T017
as	O
well	O
as	O
their	O
fetal	B-T017
homolog	O
,	O
radial	B-T017
glial	I-T017
cells	I-T017
(	O
rgcs	B-T017
)	O
,	O
causing	O
disrupted	O
mit	B-T038
##oses	I-T038
,	O
supern	O
##umer	O
##ary	O
centros	B-T017
##omes	I-T017
,	O
structural	B-T082
dis	O
##organization	O
,	O
and	O
cell	B-T038
death	I-T038
.	O
zikv	B-T038
infection	I-T038
of	O
nes	B-T017
cells	I-T017
and	O
rgcs	B-T017
causes	O
centros	B-T017
##omal	I-T017
depletion	O
and	O
mitochondrial	B-T017
sequestration	O
of	O
phospho	B-T103
-	I-T103
tb	I-T103
##k1	I-T103
during	O
mitosis	B-T038
.	O
we	O
also	O
found	O
that	O
nucleoside	B-T103
analogs	I-T103
inhibit	O
zikv	B-T005
replication	B-T038
in	O
nes	B-T017
cells	I-T017
,	O
protecting	O
them	O
from	O
zikv	B-T005
-	O
induced	O
ptb	B-T103
##k1	I-T103
rel	B-T038
##ocalization	I-T038
and	O
cell	B-T038
death	I-T038
.	O
we	O
established	O
a	O
model	B-T170
system	I-T170
of	O
human	B-T204
neural	B-T017
stem	I-T017
cells	I-T017
to	O
reveal	O
cellular	B-T017
and	O
molecular	O
mechanisms	O
underlying	O
neurodevelopmental	O
defects	O
associated	O
with	O
zikv	B-T038
infection	I-T038
and	O
its	O
potential	O
treatment	B-T058
.	O

is	O
total	B-T058
elbow	I-T058
arthroplasty	I-T058
safe	O
as	O
an	O
outpatient	B-T058
procedure	I-T058
?	O
ambulatory	B-T092
surgery	I-T092
centers	I-T092
are	O
the	O
preferred	B-T092
setting	I-T092
for	O
many	O
procedures	O
formerly	O
performed	O
in	O
a	O
hospital	B-T092
setting	B-T092
.	O
this	O
study	B-T062
sought	O
to	O
determine	O
whether	O
outpatient	O
total	B-T058
elbow	I-T058
arthroplasty	I-T058
(	O
tea	B-T058
)	O
is	O
as	O
safe	O
as	O
inpatient	O
tea	B-T058
.	O
a	O
retrospective	B-T062
analysis	I-T062
was	O
performed	O
of	O
inpatient	O
(	O
ip	O
)	O
versus	O
outpatient	O
(	O
op	O
)	O
tea	B-T058
by	O
a	O
single	O
surgeon	B-T097
over	O
a	O
period	O
of	O
18	O
years	O
.	O
demographic	B-T062
,	O
social	O
,	O
and	O
comorbidity	O
measures	O
as	O
well	O
as	O
complication	B-T038
rates	O
were	O
analyzed	B-T062
and	O
stratified	O
by	O
ip	O
or	O
op	O
status	O
.	O
bivariate	O
comparison	O
showed	O
increased	O
prevalence	O
of	O
coronary	B-T038
artery	I-T038
disease	I-T038
in	O
the	O
op	O
group	B-T098
(	O
32	O
%	O
vs	O
.	O
7	O
%	O
)	O
and	O
increased	O
age	O
in	O
the	O
ip	O
group	B-T098
(	O
68	O
years	O
vs	O
.	O
58	O
years	O
)	O
.	O
all	O
other	O
demographic	B-T062
,	O
social	O
,	O
and	O
comorbidity	O
factors	O
were	O
comparable	O
between	O
the	O
ip	O
and	O
op	O
groups	B-T098
,	O
although	O
more	O
infections	B-T038
were	O
seen	O
in	O
the	O
ip	O
group	B-T098
.	O
the	O
surgeons	B-T097
'	I-T097
initial	B-T038
learning	I-T038
curve	I-T038
occurred	O
mostly	O
within	O
the	O
ip	O
group	B-T098
.	O
most	O
important	O
,	O
no	O
difference	O
in	O
complication	B-T038
rate	O
was	O
observed	O
between	O
the	O
ip	O
and	O
op	O
groups	B-T098
.	O

abnormal	B-T033
metabolic	O
brain	B-T017
network	B-T038
associated	O
with	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
:	O
replication	O
on	O
a	O
new	O
european	B-T098
sample	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
identify	O
the	O
specific	O
metabolic	O
brain	B-T017
pattern	B-T082
characteristic	O
for	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
:	O
parkinson	O
'	O
s	O
disease	O
-	O
related	O
pattern	O
(	O
pdr	O
##p	O
)	O
,	O
using	O
network	B-T038
analysis	O
of	O
[	O
18f	O
]	O
-	O
fluorodeoxyglucose	O
positron	O
emission	O
tomography	O
(	O
fdg	O
-	O
pet	O
)	O
brain	B-T017
images	B-T170
in	O
a	O
cohort	B-T098
of	O
sl	B-T082
##oven	I-T082
##ian	I-T082
pd	B-T038
patients	O
.	O
twenty	O
pd	B-T038
patients	O
(	O
age	O
70	O
.	O
1	O
±	O
7	O
.	O
8	O
years	O
,	O
movement	B-T170
disorder	I-T170
society	I-T170
unified	I-T170
parkinson	I-T170
'	I-T170
s	I-T170
disease	I-T170
motor	I-T170
rating	I-T170
scale	I-T170
(	O
mds	B-T170
-	I-T170
upd	I-T170
##rs	I-T170
-	I-T170
iii	I-T170
)	O
38	O
.	O
3	O
±	O
12	O
.	O
2	O
;	O
disease	O
duration	O
4	O
.	O
3	O
±	O
4	O
.	O
1	O
years	O
)	O
and	O
20	O
age	O
-	O
matched	O
normal	O
controls	O
(	O
ncs	O
)	O
underwent	O
fdg	O
-	O
pet	O
brain	B-T058
imaging	I-T058
.	O
an	O
automatic	O
voxel	O
-	O
based	O
scaled	O
subp	O
##rof	O
##ile	O
model	O
/	O
principal	O
component	O
analysis	O
(	O
ss	O
##m	O
/	O
pca	O
)	O
was	O
applied	O
to	O
these	O
scans	B-T058
for	O
pdr	O
##p	O
-	O
sl	B-T082
##oven	I-T082
##ia	I-T082
identification	O
.	O
the	O
pattern	O
was	O
characterized	O
by	O
relative	O
hyper	B-T033
##met	I-T033
##abolism	I-T033
in	O
pallidum	B-T017
,	O
putamen	B-T017
,	O
thalamus	B-T017
,	O
brain	B-T017
stem	I-T017
,	O
and	O
cerebellum	B-T017
associated	O
with	O
hypo	B-T033
##met	I-T033
##abolism	I-T033
in	O
sensorimotor	B-T017
cortex	I-T017
,	O
posterior	B-T017
parietal	I-T017
,	O
occipital	B-T082
,	O
and	O
frontal	B-T017
cortices	I-T017
.	O
the	O
expression	O
of	O
pdr	O
##p	O
-	O
sl	B-T082
##oven	I-T082
##ia	I-T082
discriminated	O
pd	B-T038
patients	O
from	O
ncs	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
correlated	O
positively	O
with	O
patients	O
'	O
clinical	O
score	O
(	O
mds	B-T170
-	I-T170
upd	I-T170
##rs	I-T170
-	I-T170
iii	I-T170
,	O
p	O
=	O
0	O
.	O
03	O
)	O
.	O
additionally	O
,	O
its	O
topography	B-T170
agrees	O
well	O
with	O
the	O
original	O
pdr	O
##p	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
identified	O
in	O
american	B-T098
cohort	B-T098
of	O
pd	B-T038
patients	O
.	O
we	O
validated	O
the	O
pdr	O
##p	O
-	O
sl	B-T082
##oven	I-T082
##ia	I-T082
expression	O
on	O
additional	O
fdg	O
-	O
pet	O
scans	B-T058
of	O
20	O
pd	B-T038
patients	O
,	O
20	O
ncs	O
,	O
and	O
25	O
patients	O
with	O
atypical	B-T038
parkinsonism	I-T038
(	O
ap	B-T038
)	O
.	O
we	O
confirmed	O
that	O
the	O
expression	O
of	O
pdr	O
##p	O
-	O
sl	B-T082
##oven	I-T082
##ia	I-T082
manifests	O
good	O
diagnostic	O
accuracy	O
with	O
specificity	O
and	O
sensitivity	O
of	O
85	O
-	O
90	O
%	O
at	O
optimal	O
pattern	O
expression	O
cutoff	O
for	O
discrimination	O
of	O
pd	B-T038
patients	O
and	O
ncs	O
and	O
is	O
not	O
expressed	O
in	O
ap	B-T038
.	O
pdr	O
##p	O
-	O
sl	B-T082
##oven	I-T082
##ia	I-T082
proves	O
to	O
be	O
a	O
robust	O
and	O
reproducible	O
functional	B-T058
imaging	I-T058
biomarker	B-T201
independent	O
of	O
patient	O
population	B-T098
.	O
it	O
accurately	O
differentiate	O
##s	O
pd	B-T038
patients	O
from	O
ncs	O
and	O
ap	B-T038
and	O
correlates	O
well	O
with	O
the	O
clinical	O
measure	O
of	O
pd	B-T038
progression	B-T038
.	O

altered	O
ph	O
gradient	O
at	O
the	O
plasma	B-T017
membrane	I-T017
of	O
osteosarcoma	B-T038
cells	B-T017
is	O
a	O
key	O
mechanism	O
of	O
drug	B-T038
resistance	I-T038
current	O
therapy	B-T058
of	O
osteosarcoma	B-T038
(	O
os	B-T038
)	O
,	O
the	O
most	O
common	O
primary	B-T038
bone	I-T038
malignancy	I-T038
,	O
is	O
based	O
on	O
a	O
combination	O
of	O
surgery	O
and	O
chemotherapy	O
.	O
multidrug	O
resistance	O
mediated	O
by	O
p	B-T103
-	I-T103
glycoprotein	I-T103
(	O
p	B-T103
-	I-T103
gp	I-T103
)	O
overexpression	B-T038
has	O
been	O
previously	O
associated	O
with	O
treatment	B-T033
failure	I-T033
and	O
progression	B-T038
of	O
os	B-T038
,	O
although	O
other	O
mechanisms	O
may	O
also	O
play	O
a	O
role	O
.	O
we	O
considered	O
the	O
typical	O
acidic	O
extracellular	O
ph	O
(	O
phe	O
)	O
of	O
sarcomas	B-T038
,	O
and	O
found	O
that	O
doxorubicin	B-T103
(	O
dx	B-T103
##r	I-T103
)	O
cytotoxicity	B-T038
is	O
reduced	O
in	O
p	B-T017
-	I-T017
gp	I-T017
negative	O
os	B-T038
cells	B-T017
cultured	I-T017
at	O
phe	O
6	O
.	O
5	O
compared	O
to	O
standard	O
7	O
.	O
4	O
.	O
short	O
-	O
time	O
(	O
24	O
-	O
48	O
hours	O
)	O
exposure	O
to	O
low	O
phe	O
significantly	O
increased	O
the	O
number	O
and	O
acidity	B-T033
of	O
lysosomes	B-T017
,	O
and	O
the	O
combination	O
of	O
dx	B-T103
##r	I-T103
with	O
omeprazole	B-T103
,	O
a	O
proton	B-T103
pump	I-T103
inhibitor	I-T103
targeting	O
lysosomal	B-T038
acidity	I-T038
,	O
significantly	O
enhanced	O
dx	B-T103
##r	I-T103
cytotoxicity	B-T038
.	O
in	O
os	B-T038
xenografts	B-T103
,	O
the	O
combination	B-T058
treatment	I-T058
of	O
dx	B-T103
##r	I-T103
and	O
omeprazole	B-T103
significantly	B-T038
reduced	I-T038
tumor	O
volume	O
and	O
body	B-T033
weight	I-T033
loss	I-T033
.	O
the	O
impaired	B-T037
toxicity	I-T037
of	O
dx	B-T103
##r	I-T103
at	O
low	O
phe	O
was	O
not	O
associated	O
with	O
increased	O
autophagy	B-T038
or	O
lysosomal	B-T038
acidification	I-T038
,	O
but	O
rather	O
,	O
as	O
shown	O
by	O
sna	B-T103
##r	I-T103
##f	I-T103
staining	B-T058
,	O
with	O
a	O
reversal	O
of	O
the	O
ph	O
gradient	O
at	O
the	O
plasma	B-T017
membrane	I-T017
(	O
δ	O
##ph	O
##cm	O
)	O
,	O
eventually	O
leading	O
to	O
a	O
reduced	O
dx	B-T103
##r	I-T103
intracellular	B-T082
accumulation	B-T033
.	O
finally	O
,	O
the	O
reversal	O
of	O
δ	O
##ph	O
##cm	O
in	O
os	B-T038
cells	B-T017
promoted	O
resistance	O
not	O
only	O
to	O
dx	B-T103
##r	I-T103
,	O
but	O
also	O
to	O
cisplatin	B-T103
and	O
methotrexate	B-T103
,	O
and	O
,	O
to	O
a	O
lesser	O
extent	O
,	O
to	O
vincristine	B-T103
.	O
altogether	O
,	O
our	O
findings	O
show	O
that	O
,	O
in	O
os	B-T038
cells	B-T017
,	O
short	O
-	O
term	O
acidosis	B-T038
induces	O
resistance	O
to	O
different	O
chemotherapeutic	B-T103
drugs	I-T103
by	O
a	O
reversal	O
of	O
δ	O
##ph	O
##cm	O
,	O
suggesting	O
that	O
buffer	B-T103
therapies	B-T058
or	O
regimens	B-T170
including	O
proton	B-T103
pump	I-T103
inhibitors	I-T103
in	O
combination	O
to	O
low	O
concentrations	O
of	O
conventional	O
anticancer	B-T103
agents	I-T103
may	O
offer	O
novel	O
solutions	O
to	O
overcome	O
drug	B-T038
resistance	I-T038
.	O

bayesian	O
and	O
phylogen	B-T062
##ic	I-T062
approaches	I-T062
for	O
studying	O
relationships	O
among	O
table	B-T204
olive	I-T204
cultivars	I-T204
to	O
enhance	O
table	B-T204
olive	I-T204
tree	I-T204
authentic	O
##ation	O
,	O
relationship	O
,	O
and	O
productivity	O
,	O
we	O
consider	O
the	O
analysis	B-T062
of	O
18	O
worldwide	O
table	B-T204
olive	I-T204
cultivars	I-T204
(	O
ole	B-T204
##a	I-T204
europ	I-T204
##aea	I-T204
l	I-T204
.	I-T204
)	O
based	O
on	O
morphological	O
,	O
biological	O
,	O
and	O
physicochemical	B-T038
markers	I-T038
analyzed	O
by	O
bioinformatic	B-T170
and	O
bios	B-T170
##ta	I-T170
##tistic	I-T170
tools	I-T170
.	O
accordingly	O
,	O
we	O
assess	O
the	O
relationships	O
between	O
the	O
studied	O
varieties	O
,	O
on	O
the	O
one	O
hand	O
,	O
and	O
the	O
potential	O
productivity	O
-	O
quantitative	O
parameter	O
links	O
on	O
the	O
other	O
hand	O
.	O
the	O
bioinformatic	B-T170
analysis	B-T062
based	O
on	O
the	O
graphical	O
representation	O
of	O
the	O
matrix	B-T062
of	I-T062
euc	I-T062
##li	I-T062
##de	I-T062
##an	I-T062
distances	I-T062
,	O
the	O
principal	O
components	O
analysis	O
,	O
unw	B-T062
##eight	I-T062
##ed	I-T062
pair	I-T062
group	I-T062
method	I-T062
with	O
arithmetic	O
mean	O
,	O
and	O
principal	B-T062
coordinate	I-T062
analysis	I-T062
(	O
pco	B-T062
##a	I-T062
)	O
revealed	O
three	O
major	O
clusters	O
which	O
were	O
not	O
correlated	O
with	O
the	O
geographic	B-T082
origin	B-T033
.	O
the	O
statistical	O
analysis	O
based	O
on	O
ken	O
##da	O
##ll	O
'	O
s	O
and	O
spearman	O
correlation	O
coefficients	O
suggests	O
two	O
highly	O
significant	O
associations	O
with	O
both	O
fruit	B-T168
color	O
and	O
poll	B-T038
##ini	I-T038
##zation	I-T038
and	O
the	O
productivity	O
character	O
.	O
these	O
results	O
are	O
confirmed	O
by	O
the	O
multiple	O
linear	O
regression	O
prediction	O
models	O
.	O
in	O
fact	O
,	O
based	O
on	O
the	O
coefficient	O
of	O
determination	O
(	O
r	O
(	O
2	O
)	O
)	O
value	O
,	O
the	O
best	O
model	B-T170
demonstrated	O
the	O
power	O
of	O
the	O
poll	B-T038
##ini	I-T038
##zation	I-T038
on	O
the	O
tree	O
productivity	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
84	O
##6	O
)	O
.	O
moreover	O
,	O
the	O
derived	O
directed	B-T170
acycl	I-T170
##ic	I-T170
graph	I-T170
showed	O
that	O
only	O
two	O
direct	O
influences	O
are	O
detected	B-T033
:	O
effect	O
of	O
tolerance	O
on	O
fruit	B-T168
and	O
stone	O
symmetry	O
on	O
side	O
and	O
effect	O
of	O
tolerance	O
on	O
stone	O
form	O
and	O
oil	B-T103
content	O
on	O
the	O
other	O
side	O
.	O
this	O
work	O
provides	O
better	O
understanding	O
of	O
the	O
diversity	O
available	O
in	O
worldwide	O
table	B-T204
olive	I-T204
cultivars	I-T204
and	O
supplies	O
an	O
important	O
contribution	O
for	O
olive	B-T204
breeding	B-T038
and	O
authentic	O
##ity	O
.	O

molecular	O
detection	B-T058
of	O
infection	B-T038
homogeneity	O
and	O
impact	O
of	O
mil	B-T103
##te	I-T103
##fo	I-T103
##sin	I-T103
##e	I-T103
treatment	O
in	O
a	O
syrian	B-T204
golden	I-T204
hamster	I-T204
model	O
of	O
leishmania	B-T204
don	I-T204
##ovan	I-T204
##i	I-T204
and	O
l	B-T204
.	I-T204
infant	I-T204
##um	I-T204
visceral	B-T038
leishmaniasis	I-T038
control	O
of	O
visceral	B-T038
leishmaniasis	I-T038
caused	O
by	O
leishmania	B-T204
infant	I-T204
##um	I-T204
and	O
leishmania	B-T204
don	I-T204
##ovan	I-T204
##i	I-T204
primarily	O
relies	O
on	O
chemotherapy	B-T058
using	O
an	O
increasingly	O
compromised	O
repertoire	O
of	O
anti	B-T103
##le	I-T103
##ishman	I-T103
##ial	I-T103
compounds	I-T103
.	O
for	O
evaluation	B-T058
of	O
novel	O
drugs	B-T103
,	O
the	O
syrian	B-T204
golden	I-T204
hamster	I-T204
is	O
considered	O
as	O
a	O
clinically	O
relevant	O
laboratory	B-T170
model	I-T170
.	O
in	O
this	O
study	B-T062
,	O
two	O
molecular	B-T058
parasite	I-T058
detection	I-T058
assays	I-T058
were	O
developed	O
targeting	O
cathepsin	B-T103
-	I-T103
like	I-T103
cysteine	I-T103
protease	I-T103
b	I-T103
(	O
cpb	B-T103
)	O
dna	B-T103
and	O
18s	O
rrna	B-T103
to	O
achieve	O
absolute	O
am	B-T204
##astig	I-T204
##ote	I-T204
quantification	O
in	O
the	O
major	O
target	O
organs	B-T017
liver	B-T017
and	O
spleen	B-T017
.	O
both	O
quantitative	B-T062
pcr	I-T062
(	B-T062
qpcr	I-T062
)	I-T062
techniques	I-T062
showed	O
excellent	O
agreement	O
with	O
a	O
strong	O
correlation	O
with	O
the	O
conventional	O
microscopic	B-T058
reading	I-T058
of	O
gi	B-T058
##ems	I-T058
##a	I-T058
-	I-T058
stained	I-T058
tissue	B-T017
smears	B-T058
.	O
using	O
multiple	O
single	O
tissue	B-T017
pieces	I-T017
and	O
all	O
three	O
detection	B-T033
methods	B-T170
,	O
we	O
confirmed	O
homogeneity	O
of	O
infection	B-T038
in	O
liver	B-T017
and	O
spleen	B-T017
and	O
the	O
robustness	O
of	O
extrap	O
##ola	O
##ting	O
whole	O
organ	O
burdens	O
from	O
a	O
small	O
single	O
tissue	B-T017
piece	I-T017
.	O
comparison	O
of	O
pre	O
-	O
and	O
post	O
-	O
treatment	O
burdens	O
in	O
infected	B-T033
hamsters	B-T204
using	O
the	O
three	O
detection	B-T033
methods	B-T170
consistently	O
revealed	O
a	O
stronger	O
parasite	B-T204
reduction	O
in	O
the	O
spleen	B-T017
compared	O
to	O
the	O
liver	B-T017
,	O
indicating	O
an	O
organ	B-T017
-	O
dependent	O
clearance	O
efficacy	O
for	O
mil	B-T103
##te	I-T103
##fo	I-T103
##sin	I-T103
##e	I-T103
.	O
in	O
conclusion	O
,	O
this	O
study	B-T062
in	O
the	O
hamster	B-T204
demonstrated	O
high	O
homogeneity	O
of	O
infection	B-T038
in	O
liver	B-T017
and	O
spleen	B-T017
and	O
advocates	O
the	O
use	O
of	O
molecular	O
detection	B-T058
methods	B-T170
for	O
assessment	B-T058
of	O
low	O
(	O
post	O
-	O
treatment	O
)	O
tissue	B-T017
burdens	O
.	O

custom	O
ocular	B-T074
prosthesis	I-T074
in	O
rehabilitation	B-T058
of	O
a	O
child	O
operated	O
for	O
retinoblastoma	B-T038
a	O
maxillofacial	O
prosth	O
##odon	O
##tis	O
##t	O
forms	O
an	O
important	O
link	O
in	O
the	O
interdisciplinary	O
management	B-T058
of	I-T058
a	I-T058
patient	I-T058
with	O
an	B-T017
##opt	I-T017
##hal	I-T017
##mo	I-T017
##sis	I-T017
.	O
prosthetic	B-T058
management	I-T058
of	O
an	O
an	B-T017
##opt	I-T017
##hal	I-T017
##mic	I-T017
defect	I-T017
aims	O
to	O
deliver	O
a	O
well	O
-	O
fitting	O
ocular	B-T074
prosthesis	I-T074
that	O
can	O
mimic	O
the	O
original	O
eye	B-T017
as	O
closely	O
as	O
possible	O
,	O
and	O
thus	O
restoring	O
the	O
patient	O
'	O
s	O
self	B-T038
-	I-T038
confidence	I-T038
and	O
thereby	O
rehabil	O
##itating	O
them	O
in	O
the	O
society	B-T092
.	O
the	O
fabrication	B-T058
of	O
a	O
custom	O
ocular	B-T074
prosthesis	I-T074
is	O
a	O
demanding	O
art	O
.	O
this	O
case	B-T170
report	I-T170
presents	O
a	O
simplified	O
technique	O
for	O
the	O
fabrication	B-T058
of	O
a	O
custom	O
ocular	B-T074
prosthesis	I-T074
for	O
a	O
child	O
who	O
had	O
lost	O
his	O
eye	B-T017
to	O
enucleation	B-T058
following	O
retinoblastoma	B-T038
.	O
early	O
and	O
effective	O
rehabilitation	B-T058
of	O
the	O
defect	O
goes	O
a	O
long	O
way	O
in	O
restoring	O
the	O
self	O
-	O
image	O
of	O
a	O
child	O
in	O
its	O
early	O
character	O
building	O
age	O
.	O

recessive	B-T038
mutations	I-T038
in	O
mst	B-T103
##o1	I-T103
cause	O
mitochondrial	B-T038
dynamics	I-T038
impairment	O
,	O
leading	O
to	O
myopathy	B-T038
and	O
ataxia	B-T033
we	O
report	O
here	O
the	O
first	O
families	O
carrying	O
recessive	O
variants	O
in	O
the	O
mst	B-T017
##o1	I-T017
gene	I-T017
:	O
compound	O
heterozygous	O
mutations	B-T038
were	O
identified	O
in	O
two	O
sister	O
##s	O
and	O
in	O
an	O
unrelated	B-T033
singleton	O
case	O
,	O
who	O
presented	O
a	O
multis	O
##ystem	O
complex	O
phenotype	O
mainly	O
characterized	O
by	O
myopathy	B-T038
and	O
cerebellar	B-T033
ataxia	I-T033
.	O
human	B-T103
mst	I-T103
##o1	I-T103
is	O
a	O
poorly	O
studied	O
protein	O
,	O
suggested	O
to	O
have	O
mitochondrial	B-T038
localization	I-T038
and	O
to	O
regulate	B-T038
morphology	O
and	O
distribution	B-T038
of	I-T038
mitochondria	I-T038
.	O
as	O
for	O
other	O
mutations	B-T038
affecting	O
genes	B-T017
involved	O
in	O
mitochondrial	B-T038
dynamics	I-T038
,	O
no	O
biochemical	O
defects	O
typical	O
of	O
mitochondrial	B-T038
disorders	I-T038
were	O
reported	B-T058
.	O
studies	O
in	O
patients	O
'	O
fibroblasts	B-T017
revealed	O
that	O
mst	B-T103
##o1	I-T103
protein	I-T103
levels	O
were	O
strongly	O
reduced	O
,	O
the	O
mitochondrial	B-T033
network	I-T033
was	I-T033
fragmented	I-T033
and	O
the	O
fusion	O
events	O
among	O
mitochondria	B-T017
were	O
decreased	O
,	O
confirming	O
the	O
deleterious	B-T038
effect	I-T038
of	O
the	O
identified	O
variants	O
and	O
the	O
role	O
of	O
mst	B-T103
##o1	I-T103
in	O
modulating	B-T082
mitochondrial	B-T038
dynamics	I-T038
.	O
we	O
also	O
found	O
that	O
mst	O
##o1	O
is	O
mainly	O
a	O
cytosolic	B-T103
protein	I-T103
.	O
these	O
findings	O
indicate	O
recessive	B-T038
mutations	I-T038
in	O
mst	B-T103
##o1	I-T103
as	O
a	O
new	O
cause	O
for	O
inherited	O
neuromuscular	B-T038
disorders	I-T038
with	O
multis	O
##ystem	O
features	O
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

construct	B-T033
##ive	I-T033
and	I-T033
unpro	I-T033
##duc	I-T033
##tive	I-T033
processing	I-T033
of	O
traumatic	B-T038
experiences	I-T038
in	O
trauma	B-T058
-	I-T058
focused	I-T058
cognitive	I-T058
-	I-T058
behavioral	I-T058
therapy	I-T058
for	O
youth	O
although	O
there	O
is	O
substantial	O
evidence	O
to	O
support	O
the	O
efficacy	O
of	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
treatments	I-T058
(	O
cbt	B-T058
)	O
for	O
posttraumatic	B-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
,	O
there	O
is	O
some	O
debate	O
about	O
how	O
these	O
treatments	B-T058
have	O
their	O
effects	O
.	O
modern	O
learning	O
theory	O
and	O
cognitive	B-T170
and	I-T170
emotional	I-T170
processing	I-T170
theories	I-T170
highlight	O
the	O
importance	O
of	O
reducing	O
avoidance	B-T038
,	O
facilitating	O
the	O
construct	O
##ive	O
processing	O
of	O
fear	O
##ed	O
experiences	O
,	O
and	O
strengthening	O
new	O
inhibitory	B-T038
learning	I-T038
.	O
we	O
examined	O
variables	O
thought	O
to	O
be	O
associated	O
with	O
unpro	B-T033
##duc	I-T033
##tive	I-T033
and	I-T033
construct	I-T033
##ive	I-T033
processing	I-T033
of	O
traumatic	B-T038
experiences	I-T038
in	O
a	O
sample	O
of	O
81	O
youth	O
with	O
elevated	O
ptsd	B-T038
symptoms	B-T033
,	O
who	O
received	O
trauma	B-T058
-	I-T058
focused	I-T058
cognitive	I-T058
behavioral	I-T058
therapy	I-T058
(	O
tf	B-T058
-	I-T058
cbt	I-T058
)	O
for	O
abuse	B-T033
or	O
traumatic	B-T038
interpersonal	O
loss	O
.	O
sessions	O
during	O
the	O
trauma	B-T058
narrative	I-T058
phase	I-T058
of	O
tf	B-T058
-	I-T058
cbt	I-T058
were	O
coded	O
for	O
indicators	O
of	O
unpro	B-T033
##duc	I-T033
##tive	I-T033
processing	I-T033
(	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
,	O
rumin	B-T038
##ation	I-T038
,	O
avoidance	B-T038
)	O
and	O
construct	B-T033
##ive	I-T033
processing	I-T033
(	O
dece	B-T033
##nt	I-T033
##ering	I-T033
,	O
accommodation	B-T033
of	I-T033
corrective	I-T033
information	I-T033
)	O
,	O
as	O
well	O
as	O
levels	O
of	O
negative	O
emotion	O
.	O
in	O
previous	O
analyses	O
of	O
this	O
trial	O
(	O
ready	O
et	O
al	O
.	O
,	O
2015	O
)	O
,	O
more	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
during	O
the	O
narrative	B-T058
phase	I-T058
predicted	O
less	O
improvement	O
in	O
internalizing	B-T033
symptoms	I-T033
at	O
posttreatment	O
and	O
a	O
worsening	O
of	O
externalizing	B-T033
symptoms	I-T033
over	O
the	O
12	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
.	O
in	O
contrast	O
,	O
more	O
accommodation	B-T033
predicted	I-T033
improvement	I-T033
in	O
internalizing	B-T033
symptoms	I-T033
and	O
also	O
moderated	O
the	O
negative	B-T033
effects	O
of	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
on	O
internalizing	B-T033
and	I-T033
externalizing	I-T033
symptoms	I-T033
.	O
the	O
current	O
study	O
examined	O
correlates	O
of	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
and	O
accommodation	B-T033
.	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
was	O
associated	O
with	O
more	O
rumin	B-T038
##ation	I-T038
,	O
less	O
dece	O
##nt	O
##ering	O
,	O
and	O
more	O
negative	O
emotion	O
,	O
suggesting	O
immersion	B-T058
in	O
trauma	B-T038
-	O
related	O
material	O
.	O
accommodation	B-T033
was	O
associated	O
with	O
less	O
avoidance	B-T038
and	O
more	O
dece	B-T033
##nt	I-T033
##ering	I-T033
,	O
suggesting	O
a	O
healthy	O
distance	O
from	O
trauma	B-T038
-	O
related	O
material	O
that	O
might	O
allow	O
for	O
processing	O
and	O
cognitive	B-T038
change	I-T038
.	O
dece	O
##nt	O
##ering	O
also	O
predicted	O
improvement	O
in	O
externalizing	B-T033
symptoms	I-T033
at	O
posttreatment	O
.	O
rumin	B-T038
##ation	I-T038
and	O
avoidance	B-T038
showed	O
important	O
associations	O
with	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
and	O
accommodation	B-T033
,	O
respectively	O
,	O
but	O
did	O
not	O
predict	O
treatment	O
outcomes	O
.	O
this	O
study	O
identifies	O
correlates	O
of	O
over	B-T033
##gener	I-T033
##al	I-T033
##ization	I-T033
and	O
accommodation	B-T033
that	O
might	O
shed	O
light	O
on	O
how	O
these	O
variables	O
relate	O
to	O
unpro	B-T033
##duc	I-T033
##tive	I-T033
and	I-T033
construct	I-T033
##ive	I-T033
processing	I-T033
of	O
traumatic	B-T038
experiences	I-T038
.	O

de	O
rit	O
##is	O
ratio	O
(	O
ast	O
/	O
alt	O
)	O
as	O
a	O
significant	B-T201
prognostic	I-T201
factor	I-T201
in	O
patients	O
with	O
upper	B-T038
tract	I-T038
urothelial	I-T038
cancer	I-T038
treated	O
with	O
surgery	O
we	O
investigated	O
the	O
clinical	B-T170
prognostic	I-T170
value	I-T170
of	O
preoperative	O
de	O
rit	O
##is	O
ratio	O
(	O
aspartate	O
aminotransferase	O
[	O
ast	O
]	O
/	O
alanine	O
aminotransferase	O
[	O
alt	O
]	O
)	O
on	O
postsurgical	B-T033
survival	O
outcomes	O
in	O
patients	O
with	O
upper	B-T038
tract	I-T038
urothelial	I-T038
cancer	I-T038
(	O
ut	B-T038
##uc	I-T038
)	O
.	O
we	O
retrospectively	B-T062
analyzed	I-T062
the	O
data	O
of	O
62	O
##3	O
patients	O
who	O
underwent	O
radical	B-T058
nephr	I-T058
##our	I-T058
##ete	I-T058
##ct	I-T058
##omy	I-T058
for	O
ut	B-T038
##uc	I-T038
.	O
multivariate	O
regression	O
tests	B-T170
were	O
performed	O
to	O
identify	O
possible	O
associations	O
between	O
adverse	B-T038
pathologic	I-T038
events	I-T038
and	O
ast	O
/	O
alt	O
.	O
the	O
risk	O
of	O
postoperative	O
progression	O
and	O
survival	O
were	O
tested	O
using	O
kaplan	O
-	O
meier	O
analyses	O
and	O
cox	B-T170
proportional	I-T170
hazards	I-T170
models	I-T170
.	O
according	O
to	O
the	O
receiver	O
operator	O
characteristic	O
curve	O
of	O
ast	O
/	O
alt	O
for	O
cancer	O
-	O
specific	O
mortality	O
,	O
patients	O
with	O
ast	O
/	O
alt	O
value	O
≥1	O
.	O
5	O
were	O
regarded	O
as	O
the	O
high	O
ast	O
/	O
alt	O
group	O
,	O
and	O
the	O
remaining	O
patients	O
formed	O
the	O
low	O
ast	O
/	O
alt	O
group	O
.	O
in	O
kaplan	O
-	O
meier	O
analyses	O
,	O
the	O
high	O
ast	O
/	O
alt	O
group	O
showed	O
worse	O
progression	O
-	O
free	O
survival	O
(	O
pfs	O
)	O
,	O
cancer	O
-	O
specific	O
survival	O
(	O
css	O
)	O
,	O
and	O
overall	O
survival	O
(	O
all	O
p	O
<	O
.	O
001	O
)	O
.	O
elevated	O
ast	O
/	O
alt	O
was	O
associated	O
with	O
higher	O
t	B-T170
stage	I-T170
(	O
hazard	O
ratio	O
[	O
hr	O
]	O
,	O
1	O
.	O
57	O
##7	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
,	O
1	O
.	O
07	O
##7	O
-	O
2	O
.	O
311	O
;	O
p	O
=	O
.	O
033	O
)	O
and	O
higher	B-T170
cellular	I-T170
grade	I-T170
(	O
hr	O
,	O
1	O
.	O
53	O
##8	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
034	O
-	O
2	O
.	O
287	O
;	O
p	O
=	O
.	O
041	O
)	O
in	O
multivariate	O
regression	O
tests	B-T170
.	O
in	O
multivariate	O
cox	O
analyses	O
,	O
high	O
ast	O
/	O
alt	O
was	O
revealed	O
as	O
an	O
independent	O
predictor	O
of	O
pfs	O
(	O
hr	O
,	O
2	O
.	O
335	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
63	O
##3	O
-	O
3	O
.	O
340	O
;	O
p	O
<	O
.	O
001	O
)	O
,	O
css	O
(	O
hr	O
,	O
2	O
.	O
550	O
;	O
1	O
.	O
68	O
##9	O
-	O
3	O
.	O
85	O
##1	O
;	O
p	O
<	O
.	O
001	O
)	O
,	O
and	O
overall	O
survival	O
(	O
hr	O
,	O
2	O
.	O
06	O
##9	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
40	O
##9	O
-	O
3	O
.	O
038	O
;	O
p	O
<	O
.	O
001	O
)	O
.	O
elevated	O
preoperative	O
ast	O
/	O
alt	O
was	O
a	O
significant	O
predictor	O
of	O
worse	B-T033
postoperative	O
survival	O
in	O
patients	O
surgically	B-T058
treated	I-T058
for	O
ut	B-T038
##uc	I-T038
.	O
further	O
large	O
prospective	B-T062
studies	I-T062
are	O
needed	O
for	O
better	O
understanding	O
of	O
the	O
prognostic	B-T170
value	I-T170
of	O
preoperative	O
ast	O
/	O
alt	O
.	O

progressive	O
occlusion	O
and	O
recanalization	B-T058
after	O
endovascular	B-T058
treatment	I-T058
for	O
287	O
unr	B-T038
##up	I-T038
##ture	I-T038
##d	I-T038
small	I-T038
aneurysms	I-T038
(	O
<	O
5	O
##mm	O
)	O
:	O
a	O
single	B-T092
-	I-T092
center	I-T092
6	O
-	O
year	O
experience	B-T038
we	O
aimed	O
to	O
investigate	O
the	O
effect	O
of	O
coil	B-T082
##ing	I-T082
for	O
small	O
unr	B-T038
##up	I-T038
##ture	I-T038
##d	I-T038
intracranial	I-T038
aneurysms	I-T038
(	O
ui	B-T038
##as	I-T038
)	O
﹤	O
##5	O
##mm	O
)	O
on	O
progressive	O
occl	O
##us	O
##io	O
n	O
and	O
recanalization	B-T058
,	O
and	O
the	O
dub	O
##ious	O
factors	O
related	O
to	O
progressive	O
occlusion	O
and	O
recanalization	B-T058
among	O
ui	B-T038
##as	I-T038
without	O
complete	O
occlusion	O
.	O
a	O
total	O
of	O
264	O
patients	O
with	O
287	O
small	O
ui	B-T038
##as	I-T038
were	O
coiled	O
in	O
our	O
institute	B-T092
between	O
june	O
2009	O
and	O
december	O
2014	O
.	O
all	O
ui	B-T038
##as	I-T038
enrolled	O
were	O
divided	O
into	O
small	O
(	O
3	O
-	O
5	O
##mm	O
)	O
and	O
very	O
small	O
(	O
<	O
3m	O
##m	O
)	O
group	O
s	O
,	O
and	O
ui	B-T038
##as	I-T038
without	O
initial	O
complete	O
occlusion	O
were	O
divided	O
into	O
progressive	O
,	O
stable	O
and	O
recanalization	B-T058
groups	O
.	O
baseline	O
characteristics	O
,	O
procedure	B-T058
-	O
related	O
complications	B-T038
,	O
angiographic	B-T058
follow	B-T058
-	I-T058
up	I-T058
results	I-T058
,	O
and	O
clinical	O
outcomes	O
were	O
statistically	O
analyzed	O
.	O
among	O
287	O
aneurysms	B-T038
,	O
211	O
aneurysms	B-T038
(	O
73	O
.	O
5	O
%	O
)	O
were	O
completely	O
coiled	O
,	O
three	O
(	O
1	O
.	O
2	O
%	O
)	O
intraoperative	O
ruptures	B-T037
and	O
12	O
(	O
4	O
.	O
2	O
%	O
)	O
perioperative	O
thromboembolic	B-T038
events	I-T038
occurred	O
.	O
angiographic	B-T058
follow	B-T058
-	I-T058
up	I-T058
was	O
available	O
for	O
174	O
patients	O
(	O
65	O
.	O
9	O
%	O
)	O
,	O
the	O
incidence	O
of	O
recanalization	B-T058
was	O
5	O
.	O
7	O
%	O
.	O
among	O
56	O
aneurysms	B-T038
without	O
complete	O
occlusion	O
,	O
43	O
(	O
76	O
.	O
8	O
%	O
)	O
had	O
progressive	O
occlusion	O
and	O
6	O
(	O
10	O
.	O
7	O
%	O
)	O
had	O
recanalization	B-T058
.	O
anatomic	B-T033
results	I-T033
of	O
initial	O
and	O
follow	B-T058
-	I-T058
up	I-T058
between	O
small	O
and	O
very	O
small	O
groups	O
were	O
similar	O
in	O
both	O
groups	O
.	O
on	O
logistic	O
regression	O
analysis	O
,	O
smaller	O
size	B-T082
(	O
<	O
3m	O
##m	O
)	O
without	O
complete	O
occlusion	O
related	O
to	O
recanalization	B-T058
(	O
or	O
,	O
8	O
.	O
0	O
,	O
95	O
%	O
ci	O
,	O
1	O
.	O
3	O
-	O
50	O
.	O
0	O
,	O
p	O
=	O
0	O
.	O
026	O
)	O
.	O
our	O
study	B-T062
suggested	O
that	O
coil	B-T058
embolization	I-T058
of	O
small	O
ui	B-T038
##as	I-T038
can	O
achieve	O
a	O
high	O
rate	O
of	O
progressive	O
occlusion	O
and	O
low	O
rate	O
of	O
recanalization	B-T058
during	O
follow	B-T058
-	I-T058
up	I-T058
.	O
anatomic	B-T033
results	I-T033
of	O
initial	O
and	O
follow	B-T058
-	I-T058
up	I-T058
between	O
small	O
(	O
3	O
-	O
5	O
##mm	O
)	O
and	O
very	O
small	O
(	O
<	O
3m	O
##m	O
)	O
groups	O
were	O
similar	O
in	O
both	O
groups	O
.	O
what	O
'	O
s	O
more	O
,	O
smaller	O
size	O
(	O
<	O
3m	O
##m	O
)	O
without	O
complete	O
occlusion	O
may	O
relate	O
to	O
recanalization	B-T058
.	O

annexin	B-T103
a1	I-T103
restores	O
aβ	B-T103
##1	I-T103
-	I-T103
42	I-T103
-	O
induced	O
blood	B-T058
-	I-T058
brain	I-T058
barrier	I-T058
disruption	I-T058
through	O
the	O
inhibition	B-T038
of	O
rhoa	B-T038
-	I-T038
rock	I-T038
signaling	I-T038
pathway	I-T038
the	O
blood	B-T017
-	I-T017
brain	I-T017
barrier	I-T017
(	O
bbb	B-T017
)	O
is	O
composed	O
of	O
brain	B-T017
capillary	I-T017
endothelial	B-T017
cells	I-T017
and	O
has	O
an	O
important	O
role	O
in	O
maintaining	O
homeostasis	B-T038
of	O
the	O
brain	B-T017
separating	O
the	O
blood	B-T031
from	O
the	O
parenchyma	B-T017
of	O
the	O
central	B-T022
nervous	I-T022
system	I-T022
(	O
cns	B-T022
)	O
.	O
it	O
is	O
widely	O
known	O
that	O
disruption	B-T058
of	I-T058
the	I-T058
bbb	I-T058
occurs	O
in	O
various	O
neurodegenerative	B-T038
diseases	I-T038
,	O
including	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
.	O
annexin	B-T103
a1	I-T103
(	O
anx	B-T103
##a1	I-T103
)	O
,	O
an	O
anti	B-T103
-	I-T103
inflammatory	I-T103
messenger	I-T103
,	O
is	O
expressed	B-T038
in	O
brain	B-T017
endothelial	I-T017
cells	I-T017
and	O
regulates	O
the	O
bbb	B-T017
integrity	O
.	O
however	O
,	O
its	O
role	O
and	O
mechanism	O
for	O
protecting	O
bbb	B-T017
in	O
ad	B-T038
have	O
not	O
been	O
identified	O
.	O
we	O
found	O
that	O
β	B-T103
-	I-T103
amyloid	I-T103
1	I-T103
-	I-T103
42	I-T103
(	O
aβ	B-T103
##42	I-T103
)	O
-	O
induced	O
bbb	B-T058
disruption	I-T058
was	O
rescued	O
by	O
human	B-T103
recombinant	I-T103
anx	I-T103
##a1	I-T103
(	O
hr	B-T103
##anx	I-T103
##a1	I-T103
)	O
in	O
the	O
murine	B-T103
brain	B-T017
endothelial	I-T017
cell	I-T017
line	I-T017
bend	I-T017
.	I-T017
3	I-T017
.	I-T017
also	O
,	O
anx	B-T103
##a1	I-T103
was	O
decreased	O
in	O
the	O
bend	B-T017
.	I-T017
3	I-T017
cells	I-T017
,	O
the	O
capillaries	B-T017
of	O
5	O
##x	O
##fa	O
##d	O
mice	O
,	O
and	O
the	O
human	B-T031
serum	I-T031
of	O
patients	O
with	O
ad	B-T038
.	O
to	O
find	O
out	O
the	O
mechanism	O
by	O
which	O
anx	B-T103
##a1	I-T103
recover	O
##s	O
the	O
bbb	B-T017
integrity	O
in	O
ad	B-T038
,	O
the	O
rhoa	B-T038
-	I-T038
rock	I-T038
signaling	I-T038
pathway	I-T038
was	O
examined	O
in	O
both	O
aβ	B-T103
##42	I-T103
-	O
treated	O
bend	B-T017
.	I-T017
3	I-T017
cells	I-T017
and	O
the	O
capillaries	B-T017
of	O
5	O
##x	O
##fa	O
##d	O
mice	O
as	O
rhoa	B-T103
was	O
activated	O
in	O
both	O
cases	O
.	O
rhoa	O
inhibitors	O
alleviated	O
aβ	B-T103
##42	I-T103
-	O
induced	O
bbb	B-T058
disruption	I-T058
and	O
constitutively	O
overexpressed	B-T038
rhoa	B-T103
-	I-T103
gtp	I-T103
(	O
active	O
form	O
of	O
rhoa	B-T103
)	O
attenuated	O
the	O
protective	O
effect	O
of	O
anx	B-T103
##a1	I-T103
.	O
when	O
pericytes	B-T017
were	O
coculture	B-T058
##d	I-T058
with	O
bend	B-T017
.	I-T017
3	I-T017
cells	I-T017
,	O
aβ	B-T103
##42	I-T103
-	O
induced	O
rhoa	O
activation	O
of	O
bend	B-T017
.	I-T017
3	I-T017
cells	I-T017
was	O
inhibited	O
by	O
the	O
secretion	B-T038
of	O
anx	B-T103
##a1	I-T103
from	O
pericytes	B-T017
.	O
taken	O
together	O
,	O
our	O
results	O
suggest	O
that	O
anx	B-T103
##a1	I-T103
restores	O
aβ	B-T103
##42	I-T103
-	O
induced	O
bbb	B-T058
disruption	I-T058
through	O
inhibition	B-T038
of	O
rhoa	B-T038
-	I-T038
rock	I-T038
signaling	I-T038
pathway	I-T038
and	O
we	O
propose	O
anx	B-T103
##a1	I-T103
as	O
a	O
therapeutic	B-T103
reagent	I-T103
,	O
protecting	O
against	O
the	O
breakdown	B-T058
of	I-T058
the	I-T058
bbb	I-T058
in	O
ad	B-T038
.	O

the	O
sil	B-T103
##ora	I-T103
##ne	I-T103
-	I-T103
based	I-T103
resin	I-T103
composites	I-T103
:	O
a	O
review	B-T170
this	O
article	B-T170
aims	O
to	O
review	B-T170
the	O
research	B-T062
done	O
on	O
the	O
sil	B-T103
##ora	I-T103
##ne	I-T103
-	I-T103
based	I-T103
resin	I-T103
composites	I-T103
(	O
sb	B-T103
##r	I-T103
##c	I-T103
)	O
regarding	O
polymerization	O
shrinkage	O
and	O
contraction	O
stresses	O
and	O
their	O
ability	O
to	O
improve	O
the	O
shortcomings	O
of	O
the	O
methacrylate	B-T103
-	I-T103
based	I-T103
resin	I-T103
composites	I-T103
(	O
mr	B-T103
##bc	I-T103
)	O
.	O
special	O
attention	O
is	O
given	O
to	O
their	O
physical	O
and	O
mechanical	O
properties	O
,	O
bond	O
strength	O
,	O
marginal	B-T058
adaptation	I-T058
,	O
and	O
cus	O
##p	O
deflection	O
.	O
the	O
clinical	B-T033
significance	I-T033
of	O
this	O
material	O
is	O
critically	O
appra	O
##ised	O
with	O
a	O
focus	O
on	O
the	O
ability	O
of	O
sb	B-T103
##r	I-T103
##c	I-T103
to	O
strengthen	O
the	O
tooth	B-T017
structure	I-T017
as	O
a	O
direct	O
restorative	O
material	O
.	O
a	O
search	O
of	O
english	O
peer	B-T170
-	I-T170
reviewed	I-T170
dental	I-T170
literature	I-T170
(	O
2003	O
-	O
2015	O
)	O
from	O
pubmed	B-T170
and	O
medline	B-T170
databases	B-T170
was	O
conducted	O
with	O
the	O
terms	O
[UNK]	O
low	O
shrinkage	O
[UNK]	O
and	O
[UNK]	O
sil	B-T103
##ora	I-T103
##ne	I-T103
composites	I-T103
.	O
[UNK]	O
the	O
list	O
was	O
screened	O
,	O
and	O
70	O
articles	B-T170
that	O
were	O
relevant	O
to	O
the	O
objectives	B-T170
of	O
this	O
work	O
were	O
included	O
.	O

a	O
three	O
perspective	B-T062
study	I-T062
of	O
the	O
sense	O
of	O
home	B-T082
of	O
nursing	O
home	O
residents	O
:	O
the	O
views	O
of	O
residents	O
,	O
care	B-T097
professionals	I-T097
and	O
relatives	O
the	O
sense	O
of	O
home	B-T082
of	O
nursing	O
home	O
residents	O
is	O
a	O
multifactorial	B-T033
phenomenon	O
which	O
is	O
important	O
for	O
the	O
quality	O
of	O
living	O
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
is	O
to	O
investigate	O
the	O
factors	O
influencing	O
the	O
sense	O
of	O
home	B-T082
of	O
older	O
adults	O
residing	O
in	O
the	O
nursing	B-T092
home	I-T092
from	O
the	O
perspective	O
of	O
residents	O
,	O
relatives	O
and	O
care	B-T097
professionals	I-T097
.	O
a	O
total	O
of	O
78	O
participants	B-T098
(	O
n	O
=	O
24	O
residents	O
,	O
n	O
=	O
18	O
relatives	O
and	O
n	O
=	O
26	O
care	B-T097
professionals	I-T097
)	O
from	O
4	O
nursing	B-T092
homes	I-T092
in	O
the	O
netherlands	B-T082
engaged	O
in	O
a	O
qualitative	B-T062
study	I-T062
,	O
in	O
which	O
photography	O
was	O
as	O
a	O
supportive	O
tool	O
for	O
subsequent	O
interviews	O
and	O
focus	O
groups	O
.	O
the	O
data	O
were	O
analyzed	O
based	O
on	O
open	O
ended	O
coding	O
,	O
axial	O
coding	O
and	O
selective	O
coding	O
.	O
the	O
sense	O
of	O
home	B-T082
of	O
nursing	O
home	O
residents	O
is	O
influenced	O
by	O
a	O
number	O
of	O
jointly	O
identified	O
factors	O
,	O
including	O
the	O
building	O
and	O
interior	O
design	O
;	O
eating	O
and	O
drinking	O
;	O
autonomy	O
and	O
control	O
;	O
involvement	O
of	O
relatives	O
;	O
engagement	O
with	O
others	O
and	O
activities	O
;	O
quality	B-T058
of	I-T058
care	I-T058
are	O
shared	O
themes	O
.	O
residents	O
and	O
relatives	O
stressed	O
the	O
importance	O
of	O
having	O
a	O
connection	O
with	O
nature	O
and	O
the	O
outdoor	B-T082
##s	I-T082
,	O
as	O
well	O
as	O
coping	O
strategies	O
.	O
relatives	O
and	O
care	B-T097
professionals	I-T097
emphasized	O
the	O
role	O
the	O
organization	B-T092
of	O
facilitation	O
of	O
care	O
played	O
,	O
as	O
well	O
as	O
making	O
residents	O
feel	O
like	O
they	O
still	O
matter	O
.	O
the	O
sense	O
of	O
home	B-T082
of	O
nursing	O
home	O
residents	O
is	O
influenced	O
by	O
a	O
multitude	O
of	O
factors	O
related	O
to	O
the	O
psychology	O
of	O
the	O
residents	O
,	O
and	O
the	O
social	O
and	O
built	O
environmental	O
contexts	O
.	O
a	O
holistic	O
understanding	O
of	O
which	O
factors	O
influence	O
the	O
sense	O
of	O
home	B-T082
of	O
residents	O
can	O
lead	O
to	O
strategies	O
to	O
optimize	O
this	O
sense	O
of	O
home	B-T082
.	O
this	O
study	B-T062
also	O
indicated	O
that	O
the	O
nursing	B-T092
home	I-T092
has	O
a	O
dual	O
nature	O
as	O
a	O
place	O
of	O
residence	B-T082
and	O
a	O
place	B-T082
where	O
people	B-T098
are	O
supported	O
through	O
numerous	O
care	O
strategies	O
.	O

identification	O
of	O
a	O
group	O
of	O
x	B-T103
##ths	I-T103
genes	B-T017
responding	O
to	O
heavy	B-T103
metal	I-T103
mercury	B-T103
,	O
salinity	O
and	O
drought	O
stresses	O
in	O
medic	B-T204
##ago	I-T204
trunc	I-T204
##at	I-T204
##ula	I-T204
xyl	B-T103
##ogluc	I-T103
##an	I-T103
endo	I-T103
##trans	I-T103
##gluc	I-T103
##osyl	I-T103
##ase	I-T103
/	I-T103
hydrolase	I-T103
##s	I-T103
(	O
x	B-T103
##th	I-T103
)	O
are	O
one	O
of	O
the	O
key	O
enzymes	B-T103
regulating	B-T038
cell	B-T038
wall	I-T038
construction	I-T038
,	O
extension	O
and	O
metabolism	O
.	O
in	O
the	O
study	B-T062
,	O
44	O
x	B-T103
##th	I-T103
protein	I-T103
genes	B-T017
from	O
medic	B-T204
##ago	I-T204
trunc	I-T204
##at	I-T204
##ula	I-T204
genome	B-T017
were	O
identified	O
using	O
bioinformatics	B-T091
,	O
microarray	O
and	O
rt	B-T062
-	I-T062
pcr	I-T062
.	O
each	O
x	B-T103
##th	I-T103
was	O
showed	O
to	O
possess	O
a	O
highly	B-T082
conserved	I-T082
domain	I-T082
(	O
(	O
d	O
/	O
n	O
)	O
-	O
e	O
-	O
(	O
i	O
/	O
l	O
/	O
f	O
/	O
v	O
)	O
-	O
d	O
-	O
(	O
f	O
/	O
i	O
/	O
l	O
)	O
-	O
e	O
-	O
(	O
f	O
/	O
l	O
)	O
-	O
l	O
-	O
g	O
)	O
,	O
and	O
most	O
of	O
x	B-T103
##ths	I-T103
possess	O
four	O
cys	B-T103
in	O
the	O
c	B-T082
terminal	I-T082
region	I-T082
,	O
which	O
suggests	O
the	O
potential	O
for	O
generating	O
disulfide	B-T082
bonds	I-T082
.	O
based	O
on	O
the	O
x	B-T103
##th	I-T103
protein	B-T082
sequences	I-T082
,	O
these	O
x	B-T103
##ths	I-T103
can	O
be	O
classified	O
into	O
three	O
major	O
families	B-T103
and	O
each	O
family	B-T103
can	O
be	O
subdivided	O
into	O
more	O
groups	O
.	O
examination	O
of	O
the	O
genomic	B-T082
location	I-T082
of	O
x	B-T017
##th	I-T017
genes	I-T017
on	O
m	B-T204
.	I-T204
trunc	I-T204
##at	I-T204
##ula	I-T204
chromosomes	B-T017
showed	O
that	O
the	O
evolution	B-T038
##al	I-T038
expansion	I-T038
of	O
the	O
genes	B-T017
was	O
possibly	O
attributed	O
to	O
localized	B-T082
gene	B-T038
duplications	I-T038
.	O
to	O
investigate	O
the	O
possible	O
involvement	O
of	O
the	O
x	B-T103
##ths	I-T103
responding	O
to	O
heavy	B-T103
metals	I-T103
and	O
other	O
abiotic	O
stresses	O
,	O
the	O
x	B-T017
##th	I-T017
genes	I-T017
were	O
exposed	O
to	O
heavy	B-T103
metal	I-T103
(	O
hg	B-T103
or	O
cu	B-T103
)	O
,	O
salt	O
and	O
drought	O
stresses	O
.	O
there	O
were	O
28	O
,	O
21	O
and	O
21	O
mtx	B-T017
##th	I-T017
genes	I-T017
found	O
to	O
respond	O
to	O
hg	B-T103
##cl2	I-T103
,	O
salt	O
and	O
drought	O
stresses	O
,	O
respectively	O
,	O
but	O
their	O
expression	B-T038
were	O
different	O
under	O
the	O
stresses	O
.	O
some	O
of	O
the	O
x	B-T017
##th	I-T017
genes	I-T017
were	O
well	O
confirmed	O
by	O
quantitative	O
rt	B-T062
-	I-T062
pcr	I-T062
(	O
qrt	B-T062
-	I-T062
pcr	I-T062
)	O
.	O
we	O
further	O
specified	O
expression	B-T038
of	O
a	O
x	B-T017
##th	I-T017
gene	I-T017
med	B-T017
##tr	I-T017
##4	I-T017
##g1	I-T017
##28	I-T017
##58	I-T017
##0	I-T017
(	O
mtx	B-T017
##th	I-T017
##3	I-T017
)	O
under	O
different	O
environmental	O
stresses	O
,	O
and	O
showed	O
that	O
mtx	B-T017
##th	I-T017
##3	I-T017
was	O
induced	O
by	O
hg	B-T103
exposure	O
.	O
these	O
results	O
indicated	O
that	O
a	O
group	O
of	O
mtx	B-T017
##ths	I-T017
could	O
be	O
differentially	O
expressed	B-T038
under	O
the	O
environmental	O
stresses	O
.	O

aggl	O
##omer	O
##ation	O
of	O
luminescent	O
porous	B-T082
silicon	B-T103
nanoparticles	O
in	O
colloidal	B-T103
solutions	I-T103
we	O
have	O
prepared	B-T033
colloidal	B-T103
solutions	I-T103
of	O
clusters	O
composed	O
from	O
porous	B-T082
silicon	B-T103
nanoparticles	O
in	O
methanol	B-T103
,	O
water	B-T103
and	O
phosphate	O
-	O
buffered	O
saline	O
(	O
pbs	O
)	O
.	O
even	O
if	O
the	O
size	B-T082
of	O
the	O
nanocl	O
##ust	O
##ers	O
is	O
between	O
60	O
and	O
500	O
nm	O
,	O
due	O
to	O
their	O
highly	O
porous	B-T082
[UNK]	B-T082
cau	I-T082
##li	I-T082
##flower	I-T082
[UNK]	I-T082
-	I-T082
like	I-T082
structure	I-T082
,	O
the	O
porous	B-T082
silicon	B-T103
nanoparticles	O
are	O
composed	O
of	O
interconnected	B-T082
nanocrystals	O
having	O
around	O
2	O
.	O
5	O
nm	O
in	O
size	B-T082
and	O
showing	O
strong	O
visible	O
luminescence	O
in	O
the	O
orange	O
-	O
red	O
spectral	O
region	B-T082
(	O
centred	O
at	O
600	O
-	O
700	O
nm	O
)	O
.	O
hydrophilic	O
behaviour	O
and	O
good	O
solubility	O
of	O
the	O
nanocl	O
##ust	O
##ers	O
in	O
water	B-T103
and	O
water	B-T103
-	O
based	O
solutions	O
were	O
obtained	O
by	O
adding	O
hydrogen	B-T103
peroxide	I-T103
into	O
the	O
etching	O
solution	O
during	O
preparation	O
and	O
16	O
min	O
long	O
after	O
-	O
bath	O
in	O
hydrogen	B-T103
peroxide	I-T103
.	O
by	O
simple	O
filtration	O
of	O
the	O
solutions	O
with	O
syringe	B-T074
filters	I-T074
,	O
we	O
have	O
extracted	O
smaller	O
nanocl	O
##ust	O
##ers	O
with	O
sizes	B-T082
of	O
approx	O
.	O
60	O
-	O
70	O
nm	O
;	O
however	O
,	O
these	O
nanocl	O
##ust	O
##ers	O
in	O
water	B-T103
and	O
pbs	O
solution	O
(	O
ph	O
neutral	O
)	O
are	O
prone	O
to	O
aggl	O
##omer	O
##ation	O
,	O
as	O
was	O
confirmed	B-T033
by	O
zeta	O
potential	O
measurements	O
.	O
when	O
the	O
samples	O
were	O
left	O
at	O
ambient	O
conditions	O
for	O
several	O
weeks	O
,	O
the	O
typical	O
nanocl	O
##ust	O
##er	O
size	B-T082
increased	O
to	O
approx	O
.	O
330	O
-	O
400	O
nm	O
and	O
then	O
remained	O
stable	O
.	O
however	O
,	O
both	O
freshly	O
filtered	O
and	O
aged	O
samples	O
(	O
with	O
aggl	O
##omer	O
##ated	O
porous	B-T082
silicon	B-T103
nanoparticles	O
)	O
of	O
porous	B-T082
silicon	B-T103
in	O
water	B-T103
and	O
pbs	O
solutions	O
can	O
be	O
further	O
used	O
for	O
biological	O
studies	B-T062
or	O
as	O
luminescent	O
markers	B-T201
in	O
living	B-T017
cells	I-T017
.	O

evaluation	B-T058
and	O
treatment	O
of	O
anemia	B-T038
in	O
premature	B-T038
infants	I-T038
anemia	B-T038
in	O
preterm	O
infants	O
is	O
the	O
pathophysiological	O
process	O
with	O
greater	O
and	O
more	O
rapid	O
decline	O
in	O
hemoglobin	B-T103
compared	O
to	O
the	O
physiological	O
anemia	B-T038
in	O
infants	O
.	O
there	O
is	O
a	O
need	O
for	O
transfusions	B-T058
and	O
administration	B-T058
of	O
human	B-T103
recombinant	I-T103
erythropoietin	I-T103
.	O
to	O
determine	O
the	O
frequency	O
of	O
anemia	B-T038
in	O
premature	B-T038
infants	I-T038
at	O
the	O
pediatric	B-T092
clinic	I-T092
,	I-T092
university	I-T092
clinical	I-T092
center	I-T092
sar	I-T092
##a	I-T092
##je	I-T092
##vo	I-T092
,	O
as	O
well	O
as	O
parameter	O
values	O
in	O
the	O
blood	B-T058
count	I-T058
of	O
premature	B-T038
infants	I-T038
and	O
to	O
explore	O
a	O
relationship	O
between	O
blood	B-T058
transfusions	I-T058
with	O
the	O
advent	O
of	O
intraventricular	B-T038
hemorrhage	I-T038
(	O
determine	O
treatment	O
outcome	O
in	O
preterm	O
infants	O
)	O
.	O
research	B-T062
is	O
retrospective	B-T062
study	I-T062
and	O
it	O
included	O
the	O
period	O
of	O
six	O
months	O
in	O
year	O
2014	O
.	O
research	B-T062
included	O
100	O
patients	O
,	O
gestational	O
age	O
<	O
37	O
weeks	O
(	O
premature	B-T038
infants	I-T038
)	O
.	O
data	O
were	O
collected	O
by	O
examining	B-T033
the	O
medical	B-T170
records	I-T170
of	O
patients	O
at	O
the	O
pediatric	B-T092
clinic	I-T092
,	I-T092
uc	I-T092
##cs	I-T092
.	O
the	O
first	O
group	O
of	O
patients	O
were	O
premature	B-T038
infants	I-T038
of	O
gestational	O
age	O
≤	O
32	O
weeks	O
(	O
62	O
/	O
100	O
)	O
and	O
the	O
second	O
group	O
were	O
premature	B-T038
infants	I-T038
of	O
gestational	O
age	O
33	O
-	O
37	O
weeks	O
(	O
38	O
/	O
100	O
)	O
.	O
among	O
the	O
patients	O
,	O
5	O
%	O
were	O
boys	O
and	O
46	O
%	O
girls	O
.	O
there	O
was	O
significant	O
difference	O
in	O
birth	O
weight	O
and	O
apgar	O
score	O
among	O
the	O
groups	O
.	O
in	O
the	O
first	O
group	O
,	O
there	O
were	O
27	O
.	O
42	O
%	O
of	O
deaths	B-T033
,	O
while	O
in	O
the	O
second	O
group	O
,	O
there	O
were	O
only	O
10	O
.	O
53	O
%	O
of	O
deaths	B-T033
.	O
there	O
was	O
a	O
significant	O
difference	O
in	O
the	O
length	O
of	O
treatment	O
.	O
there	O
was	O
a	O
statistically	O
significant	O
difference	O
in	O
the	O
need	O
for	O
transfusion	B-T058
among	O
the	O
groups	O
.	O
18	O
patients	O
in	O
the	O
first	O
group	O
required	O
a	O
transfusion	B-T058
,	O
while	O
in	O
the	O
second	O
group	O
only	O
3	O
patients	O
.	O
preterm	O
infants	O
of	O
gestational	O
age	O
≤	O
32	O
weeks	O
are	O
likely	O
candidates	O
for	O
blood	B-T058
transfusion	I-T058
during	O
treatment	O
.	O
preterm	O
infants	O
of	O
gestational	O
age	O
≤	O
32	O
weeks	O
have	O
the	O
risk	O
of	O
intracranial	B-T038
bleeding	I-T038
associated	O
with	O
the	O
application	B-T058
of	O
blood	B-T058
transfusion	I-T058
in	O
the	O
first	O
week	O
of	O
life	O
.	O

pre	B-T038
-	I-T038
hypertension	I-T038
,	O
pre	B-T038
-	I-T038
diabetes	I-T038
or	O
both	O
:	O
which	O
is	O
best	O
at	O
predicting	O
cardiovascular	B-T033
events	I-T033
in	O
the	O
long	O
term	O
?	O
the	O
present	O
study	B-T062
aimed	O
to	O
assess	O
the	O
value	O
of	O
pre	B-T038
-	I-T038
diabetes	I-T038
and	O
pre	B-T038
-	I-T038
hypertension	I-T038
in	O
predicting	O
cardiovascular	B-T033
events	I-T033
.	O
a	O
population	O
-	O
based	O
,	O
cross	B-T062
-	I-T062
sectional	I-T062
survey	I-T062
was	O
conducted	O
,	O
representing	O
a	O
large	O
sample	O
of	O
the	O
general	O
iranian	B-T098
population	B-T098
aged	O
35	O
years	O
and	O
older	O
from	O
the	O
is	B-T082
##fa	I-T082
##han	I-T082
province	I-T082
and	O
determined	O
using	O
a	O
random	B-T062
,	I-T062
multistage	I-T062
cluster	I-T062
-	I-T062
sampling	I-T062
10	O
-	O
year	O
cohort	B-T098
.	O
the	O
five	O
end	O
points	O
considered	O
as	O
study	O
outcome	O
were	O
unstable	B-T038
angina	I-T038
(	O
ua	B-T038
)	O
,	O
acute	O
occurrence	O
of	O
myocardial	B-T038
infarction	I-T038
(	O
mi	B-T038
)	O
,	O
sudden	B-T038
cardiac	I-T038
death	I-T038
(	O
scd	B-T038
)	O
,	O
brain	O
stroke	O
and	O
cardiovascular	B-T038
disease	I-T038
(	O
cvd	B-T038
)	O
.	O
of	O
the	O
63	O
##23	O
subjects	O
scheduled	O
for	O
assessment	B-T058
of	O
diabetes	B-T038
state	I-T038
61	O
##7	O
were	O
diabetics	B-T033
and	O
71	O
##2	O
were	O
pre	B-T033
-	I-T033
diabetic	I-T033
.	O
in	O
addition	O
,	O
of	O
these	O
subjects	O
,	O
175	O
##4	O
had	O
hypertension	B-T038
and	O
2500	O
had	O
pre	B-T038
-	I-T038
hypertension	I-T038
.	O
analysing	O
only	O
pre	B-T038
-	I-T038
hypertension	I-T038
,	O
pre	B-T038
-	I-T038
diabetes	I-T038
and	O
its	O
combination	O
and	O
adjusted	O
for	O
gender	O
and	O
age	O
variables	O
,	O
pre	B-T038
-	I-T038
hypertension	I-T038
and	O
pre	B-T038
-	I-T038
diabetes	I-T038
status	O
together	O
,	O
could	O
only	O
effectively	O
predict	O
occurrence	O
of	O
mi	B-T038
(	O
hazard	O
ratio	O
(	O
hr	O
)	O
=	O
3	O
.	O
21	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
:	O
1	O
.	O
06	O
-	O
9	O
.	O
76	O
,	O
p	O
=	O
0	O
.	O
04	O
)	O
.	O
in	O
the	O
same	O
cox	B-T170
regression	I-T170
models	I-T170
,	O
pre	B-T038
-	I-T038
hypertension	I-T038
status	O
could	O
predict	O
ua	B-T038
and	O
cvd	B-T038
occurrence	O
(	O
hr	O
=	O
2	O
.	O
94	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
68	O
-	O
5	O
.	O
14	O
,	O
p	O
<	O
0	O
.	O
001	O
and	O
hr	O
=	O
1	O
.	O
74	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
23	O
-	O
2	O
.	O
47	O
,	O
p	O
=	O
0	O
.	O
002	O
,	O
respectively	O
)	O
.	O
however	O
,	O
pre	B-T038
-	I-T038
diabetes	I-T038
status	O
could	O
not	O
predict	O
any	O
of	O
these	O
events	O
after	O
adjustment	O
for	O
gender	O
and	O
age	O
.	O
our	O
data	O
provide	O
valuable	O
evidence	O
of	O
the	O
triggering	O
role	O
of	O
pre	B-T038
-	I-T038
hypertension	I-T038
and	O
pre	B-T038
-	I-T038
diabetes	I-T038
together	O
,	O
on	O
appearance	O
and	O
progression	B-T038
of	O
mi	B-T038
even	O
in	O
healthy	B-T098
individuals	I-T098
and	O
the	O
significant	O
predicting	O
value	O
of	O
pre	B-T038
-	I-T038
hypertension	I-T038
on	O
the	O
occurrence	O
of	O
ua	B-T038
and	O
cvd	B-T038
.	O
in	O
this	O
regard	O
,	O
the	O
value	O
of	O
pre	B-T038
-	I-T038
hypertension	I-T038
and	O
pre	B-T038
-	I-T038
diabetes	I-T038
together	O
,	O
and	O
the	O
pre	B-T038
-	I-T038
hypertension	I-T038
state	O
alone	O
,	O
are	O
clearly	O
superior	O
to	O
pre	B-T038
-	I-T038
diabetes	I-T038
state	O
alone	O
in	O
predicting	O
cardiovascular	B-T033
events	I-T033
.	O

food	O
security	O
and	O
the	O
nutritional	B-T033
status	I-T033
of	O
children	O
in	O
foster	O
care	O
:	O
new	O
horizon	O
##s	O
in	O
the	O
protection	O
of	O
a	O
fragile	O
population	O
the	O
nutritional	B-T033
status	I-T033
of	O
foster	O
children	O
,	O
the	O
quality	O
of	O
daily	B-T168
men	I-T168
##us	I-T168
in	O
group	B-T092
homes	I-T092
and	O
the	O
food	O
security	O
inside	O
these	O
organizations	B-T092
have	O
been	O
poorly	O
studied	O
and	O
this	O
study	B-T062
means	O
to	O
investigate	O
them	O
.	O
a	O
sample	O
of	O
125	O
children	O
,	O
ranging	O
in	O
age	O
from	O
0	O
-	O
17	O
years	O
,	O
among	O
seven	O
group	B-T092
homes	I-T092
(	O
group	O
a	O
)	O
was	O
compared	O
with	O
121	O
children	O
of	O
the	O
general	B-T098
population	I-T098
we	O
(	O
group	O
b	O
)	O
.	O
to	O
evaluate	O
nutritional	B-T033
status	I-T033
,	O
bmi	O
percentiles	O
were	O
used	O
.	O
mean	O
percentiles	O
of	O
both	O
groups	O
were	O
compared	O
through	O
statistical	O
analysis	O
.	O
both	O
nutritional	B-T033
and	O
caloric	O
daily	O
distributions	O
in	O
each	O
organization	B-T092
were	O
obtained	O
using	O
the	O
24	O
-	O
hour	O
recall	B-T170
method	I-T170
.	O
a	O
specific	O
questionnaire	B-T170
was	O
administered	O
to	O
evaluate	O
food	O
security	O
.	O
from	O
the	O
analysis	B-T062
of	O
mean	O
bmi	B-T201
-	O
for	O
-	O
age	O
(	O
or	O
height	O
-	O
for	O
-	O
length	O
)	O
percentiles	O
,	O
did	O
not	O
observe	O
statistically	O
significant	O
differences	O
between	O
group	O
a	O
and	O
group	O
b	O
.	O
the	O
average	O
daily	O
nutrient	B-T033
and	O
calorie	B-T033
distribution	I-T033
in	O
group	B-T092
homes	I-T092
proves	O
to	O
be	O
nearly	B-T033
optimal	I-T033
with	O
the	O
exception	O
of	O
a	O
slight	O
excess	O
in	O
proteins	B-T168
and	O
a	O
slight	O
deficiency	O
in	O
pufas	B-T103
.	O
moreover	O
,	O
a	O
low	B-T033
intake	I-T033
of	O
iron	B-T033
and	O
calcium	B-T201
was	O
revealed	O
.	O
all	O
organizations	B-T092
obtained	O
a	O
[UNK]	O
high	O
food	O
security	O
[UNK]	O
profile	O
.	O
nutritional	B-T033
conditions	I-T033
of	O
foster	O
children	O
are	O
no	O
worse	O
than	O
that	O
of	O
children	O
of	O
the	O
general	B-T098
population	I-T098
.	O
foster	O
care	O
provides	O
the	O
necessary	O
conditions	O
to	O
support	O
their	O
growth	B-T038
.	O

traumatic	B-T037
brain	I-T037
injury	I-T037
and	O
depression	B-T038
in	O
a	O
community	O
-	O
based	O
sample	O
:	O
a	O
cohort	O
study	O
across	O
the	O
adult	O
life	O
span	O
to	O
determine	O
whether	O
self	O
-	O
reported	O
traumatic	B-T037
brain	I-T037
injuries	I-T037
(	O
tbi	B-T037
##s	I-T037
)	O
are	O
associated	O
with	O
[UNK]	O
cases	O
[UNK]	O
of	O
clinically	B-T033
significant	I-T033
depression	B-T038
in	O
the	O
general	O
community	O
.	O
to	O
examine	O
interactions	O
between	O
variables	O
previously	O
linked	O
to	O
depression	B-T038
after	O
a	O
tbi	B-T037
.	O
population	B-T098
-	O
based	O
community	O
study	B-T062
(	O
can	B-T082
##ber	I-T082
##ra	I-T082
and	O
que	O
##an	O
##be	O
##yan	O
,	O
australia	B-T082
)	O
.	O
three	O
age	B-T098
cohorts	I-T098
:	O
young	O
,	O
middle	O
-	O
aged	O
,	O
and	O
older	B-T098
adults	O
(	O
aged	O
20	O
-	O
24	O
,	O
40	O
-	O
44	O
,	O
and	O
60	O
-	O
64	O
years	O
at	O
baseline	O
)	O
randomly	O
selected	O
from	O
the	O
elect	O
##oral	O
roll	O
and	O
followed	O
across	O
3	O
waves	O
(	O
4	O
years	O
apart	O
)	O
.	O
a	O
total	O
of	O
73	O
##97	O
,	O
66	O
##21	O
,	O
and	O
60	O
##42	O
people	B-T098
provided	O
their	O
tbi	B-T037
history	O
in	O
waves	O
1	O
to	O
3	O
.	O
lifetime	O
(	O
tbi	O
##life	O
##time	O
:	O
sustained	O
at	O
any	O
time	O
since	O
birth	B-T038
)	O
,	O
recent	O
(	O
tbi	O
##rec	O
##ent	O
:	O
in	O
the	O
preceding	O
4	O
years	O
)	O
,	O
and	O
multiple	O
(	O
tbi	O
##mu	O
##lt	O
##ipl	O
##e	O
:	O
more	O
than	O
1	O
)	O
tbi	B-T037
##s	I-T037
,	O
current	O
depression	B-T038
,	O
and	O
known	O
risk	B-T033
factors	I-T033
for	O
depression	B-T038
(	O
age	O
,	O
sex	O
,	O
marital	O
/	O
employment	B-T033
status	I-T033
,	O
prior	O
history	O
of	O
depression	B-T038
,	O
medical	B-T033
conditions	I-T033
,	O
recent	O
life	O
events	O
,	O
alcohol	O
consumption	O
,	O
social	O
support	O
,	O
physical	O
activity	O
)	O
.	O
generalized	O
estimating	O
equations	O
demonstrated	O
a	O
significant	O
association	O
between	O
sustaining	O
a	O
tbi	B-T037
and	O
experiencing	O
clinically	B-T033
significant	I-T033
depression	B-T038
(	O
cases	O
)	O
,	O
even	O
after	O
controlling	O
for	O
multiple	O
demographic	O
and	O
health	O
/	O
lifestyle	O
factors	O
.	O
there	O
is	O
an	O
end	O
##uring	O
association	O
between	O
depression	B-T038
and	O
tbi	B-T037
,	O
suggesting	O
that	O
,	O
following	O
a	O
tbi	B-T037
,	O
individuals	B-T098
should	O
be	O
monitored	B-T097
and	O
supported	O
to	O
optimize	O
their	O
long	O
-	O
term	O
psychological	B-T038
health	I-T038
.	O

derivation	O
of	O
a	O
predictive	O
score	O
for	O
hemorrhagic	B-T038
progression	O
of	O
cerebral	B-T037
contusion	I-T037
##s	I-T037
in	O
moderate	O
and	O
severe	O
traumatic	O
brain	O
injury	O
after	O
traumatic	B-T037
brain	I-T037
injury	I-T037
(	O
tbi	B-T037
)	O
,	O
hemorrhagic	B-T038
progression	O
of	O
contusion	B-T037
##s	I-T037
(	O
hpc	B-T037
##s	I-T037
)	O
occurs	O
frequently	O
.	O
however	O
,	O
there	O
is	O
no	O
established	O
predictive	O
score	O
to	O
identify	O
high	B-T033
-	I-T033
risk	I-T033
patients	O
for	O
hpc	B-T037
.	O
consecutive	O
patients	O
who	O
were	O
hospitalized	B-T033
(	O
2008	O
-	O
2013	O
)	O
with	O
non	O
-	O
penetrating	O
moderate	O
or	O
severe	O
tbi	O
were	O
studied	O
.	O
the	O
primary	O
outcome	O
was	O
hpc	B-T037
,	O
defined	O
by	O
both	O
a	O
relative	O
increase	O
in	O
contusion	B-T037
volume	O
by	O
≥3	O
##0	O
%	O
and	O
an	O
absolute	O
increase	O
by	O
≥10	O
ml	O
on	O
serial	O
imaging	O
.	O
logistic	B-T170
regression	I-T170
models	I-T170
were	O
created	O
to	O
identify	O
independent	O
risk	B-T033
factors	I-T033
for	O
hpc	B-T037
.	O
the	O
hpc	B-T037
score	O
was	O
then	O
derived	O
based	O
on	O
the	O
final	B-T170
model	I-T170
.	O
among	O
a	O
total	O
of	O
286	O
eligible	O
patients	O
,	O
61	O
(	O
21	O
%	O
)	O
patients	O
developed	O
hpc	B-T037
.	O
on	O
univariate	O
analyses	O
,	O
hpc	B-T037
was	O
associated	O
with	O
older	O
age	O
,	O
higher	B-T033
initial	I-T033
blood	I-T033
pressure	I-T033
,	O
antiplatelet	B-T103
medications	I-T103
,	O
anticoagulants	B-T103
,	O
subarachnoid	B-T038
hemorrhage	I-T038
(	O
sah	B-T038
)	O
subdural	B-T038
hematoma	I-T038
(	O
sdh	B-T038
)	O
,	O
skull	B-T037
fracture	I-T037
,	O
frontal	B-T017
contusion	B-T037
,	O
larger	O
contusion	B-T037
volume	O
,	O
and	O
shorter	O
interval	O
from	O
injury	B-T037
to	O
initial	B-T058
ct	I-T058
.	O
in	O
the	O
final	B-T170
model	I-T170
,	O
sah	B-T038
(	O
or	O
6	O
.	O
33	O
,	O
95	O
%	O
ci	O
,	O
1	O
.	O
80	O
-	O
22	O
.	O
23	O
)	O
,	O
sdh	B-T038
(	O
or	O
3	O
.	O
46	O
,	O
95	O
%	O
ci	O
,	O
1	O
.	O
39	O
-	O
8	O
.	O
63	O
)	O
,	O
and	O
skull	B-T037
fracture	I-T037
(	O
or	O
2	O
.	O
67	O
,	O
95	O
%	O
ci	O
,	O
1	O
.	O
28	O
-	O
5	O
.	O
58	O
)	O
were	O
associated	O
with	O
hpc	B-T037
.	O
based	O
on	O
these	O
factors	O
,	O
the	O
hpc	B-T037
score	O
was	O
derived	O
(	O
sah	B-T038
=	O
2	O
points	O
,	O
sdh	B-T038
=	O
1	O
point	O
,	O
and	O
skull	B-T037
fracture	I-T037
=	O
1	O
point	O
)	O
.	O
this	O
score	O
had	O
an	O
area	O
under	O
the	O
receiver	O
operating	O
curve	O
of	O
0	O
.	O
77	O
.	O
patients	O
with	O
a	O
score	O
of	O
0	O
-	O
2	O
had	O
a	O
4	O
.	O
0	O
%	O
incidence	O
of	O
hpc	B-T037
,	O
while	O
patients	O
with	O
a	O
score	O
of	O
3	O
-	O
4	O
had	O
a	O
34	O
.	O
6	O
%	O
incidence	O
of	O
hpc	B-T037
.	O
a	O
simple	O
hpc	B-T037
score	O
was	O
developed	O
for	O
early	O
risk	O
stratification	O
of	O
hpc	B-T037
in	O
patients	O
with	O
moderate	O
or	O
severe	O
tbi	O
.	O

covalent	B-T103
modulators	I-T103
of	O
the	O
vacuolar	B-T103
atpase	I-T103
the	O
vacuolar	B-T103
h	I-T103
(	I-T103
+	I-T103
)	I-T103
atpase	I-T103
(	O
v	B-T103
-	I-T103
atpase	I-T103
)	O
is	O
a	O
complex	B-T103
multis	O
##ub	O
##un	O
##it	O
machine	O
that	O
regulates	B-T038
important	O
cellular	B-T038
processes	I-T038
through	O
controlling	O
acidity	O
of	O
intracellular	B-T082
compartments	B-T017
in	O
eukaryotes	B-T204
.	O
existing	O
small	B-T103
-	I-T103
molecule	I-T103
modulators	B-T103
of	O
v	B-T103
-	I-T103
atpase	I-T103
either	O
are	O
restricted	O
to	O
targeting	B-T038
one	O
membranous	O
subunit	O
of	O
v	B-T103
-	I-T103
atpase	I-T103
or	O
have	O
poorly	O
understood	B-T038
mechanisms	O
of	O
action	O
.	O
small	B-T103
molecules	I-T103
with	O
novel	O
and	O
defined	O
mechanisms	O
of	O
inhibition	B-T038
are	O
thus	O
needed	O
to	O
functionally	O
characterize	O
v	B-T103
-	I-T103
atpase	I-T103
and	O
to	O
fully	O
evaluate	O
the	O
therapeutic	O
relevance	O
of	O
v	B-T103
-	I-T103
atpase	I-T103
in	O
human	B-T204
diseases	B-T038
.	O
we	O
have	O
discovered	O
electrophilic	O
quin	B-T103
##azoline	I-T103
##s	I-T103
that	O
covalently	B-T038
modify	I-T038
a	O
soluble	O
catalytic	B-T082
subunit	I-T082
of	O
v	B-T103
-	I-T103
atpase	I-T103
with	O
high	O
potency	O
and	O
ex	O
##quis	O
##ite	O
proteomic	O
selectivity	O
as	O
revealed	O
by	O
fluorescence	B-T058
imaging	I-T058
and	O
chemical	B-T058
proteomic	I-T058
activity	I-T058
-	I-T058
based	I-T058
profiling	I-T058
.	O
the	O
site	B-T082
of	O
covalent	O
modification	O
was	O
mapped	O
to	O
a	O
cysteine	B-T103
residue	O
located	B-T082
in	I-T082
a	O
region	B-T082
of	O
v	B-T103
-	I-T103
atpase	I-T103
subunit	B-T103
a	I-T103
that	O
is	O
thought	B-T038
to	O
regulate	B-T038
the	O
dissociation	B-T038
of	O
v	B-T103
-	I-T103
atpase	I-T103
.	O
we	O
further	O
demonstrate	O
that	O
a	O
previously	O
reported	O
v	B-T103
-	I-T103
atpase	I-T103
inhibitor	I-T103
,	O
3	B-T103
-	I-T103
bromo	I-T103
##pyruvate	I-T103
,	O
also	O
targets	O
the	O
same	O
cysteine	B-T103
residue	O
and	O
that	O
our	O
electrophilic	O
quin	B-T103
##azoline	I-T103
##s	I-T103
modulate	B-T082
the	O
function	O
of	O
v	B-T103
-	I-T103
atpase	I-T103
in	O
cells	B-T017
.	O
with	O
their	O
well	O
-	O
defined	O
mechanism	O
of	O
action	O
and	O
high	O
proteomic	O
specificity	O
,	O
the	O
described	O
quin	B-T103
##azoline	I-T103
##s	I-T103
offer	O
a	O
powerful	O
set	O
of	O
chemical	B-T103
probes	I-T103
to	O
investigate	O
the	O
physiological	O
and	O
pathological	O
roles	O
of	O
v	B-T103
-	I-T103
atpase	I-T103
.	O

the	O
prognostic	B-T201
value	I-T201
of	O
extran	B-T033
##odal	I-T033
extension	I-T033
in	O
human	B-T005
papillomavirus	I-T005
-	O
associated	O
oropharyngeal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
extran	B-T033
##odal	I-T033
(	I-T033
or	I-T033
extrac	I-T033
##apsular	I-T033
)	I-T033
extension	I-T033
(	O
ene	B-T033
)	O
is	O
an	O
adverse	B-T201
prognostic	I-T201
factor	I-T201
in	O
patients	O
with	O
head	B-T038
and	I-T038
neck	I-T038
cancers	I-T038
who	O
undergo	O
primary	B-T058
surgery	I-T058
.	O
however	O
,	O
the	O
significance	O
of	O
ene	B-T033
in	O
human	B-T038
papillomavirus	I-T038
(	I-T038
hpv	I-T038
)	I-T038
-	I-T038
positive	I-T038
oropharyngeal	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	I-T038
ops	I-T038
##cc	I-T038
)	I-T038
is	O
not	O
well	O
established	O
,	O
and	O
single	B-T092
-	I-T092
institution	I-T092
studies	B-T062
have	O
not	O
established	O
that	O
ene	B-T033
predicts	O
inferior	B-T082
outcome	O
.	O
the	O
authors	O
investigated	O
the	O
prognostic	B-T201
value	I-T201
of	O
ene	B-T033
in	O
hpv	B-T005
-	O
positive	B-T033
patients	O
who	O
underwent	O
primary	B-T058
surgery	I-T058
and	O
whether	O
adjuvant	B-T058
chemoradiation	I-T058
improved	O
overall	O
survival	O
(	O
os	O
)	O
compared	O
with	O
radiation	O
alone	O
in	O
ene	B-T033
-	O
positive	B-T033
patients	O
.	O
patients	O
who	O
underwent	O
primary	B-T058
surgery	I-T058
for	O
pathologic	O
t1	O
(	O
pt	O
##1	O
)	O
through	O
pt	B-T038
##4	I-T038
tumors	I-T038
,	O
pathologic	O
n1	O
(	O
pn	O
##1	O
)	O
through	O
pn	B-T017
##3	I-T017
lymph	I-T017
node	I-T017
status	O
,	O
hpv	B-T038
-	I-T038
positive	I-T038
ops	I-T038
##cc	I-T038
were	O
identified	O
in	O
the	O
national	O
cancer	O
data	O
base	O
from	O
2010	O
through	O
2012	O
.	O
features	O
associated	O
with	O
ene	B-T033
were	O
analyzed	B-T062
.	O
univ	B-T170
##ariable	I-T170
and	I-T170
multivariable	I-T170
cox	I-T170
regression	I-T170
analyses	I-T170
identified	O
predictors	O
of	O
os	O
.	O
the	O
effect	O
of	O
adjuvant	O
treatment	O
on	O
os	O
in	O
ene	B-T033
-	O
positive	B-T033
cohort	O
was	O
also	O
evaluated	B-T058
.	O
in	O
total	O
,	O
104	O
##3	O
patients	O
met	O
inclusion	O
criteria	O
,	O
among	O
whom	O
43	O
.	O
5	O
%	O
were	O
ene	B-T033
-	O
positive	B-T033
.	O
of	O
the	O
ene	B-T033
-	O
positive	B-T033
patients	O
who	O
had	O
treatment	B-T058
details	O
available	O
,	O
72	O
%	O
received	O
concurrent	B-T058
chemoradiotherapy	I-T058
,	O
16	O
%	O
received	O
radiotherapy	B-T058
,	O
and	O
12	O
%	O
received	O
no	O
adjuvant	O
treatment	O
.	O
after	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
of	O
28	O
.	O
4	O
months	O
,	O
ene	B-T033
was	O
associated	O
with	O
worse	B-T033
3	O
-	O
year	O
os	O
(	O
89	O
.	O
3	O
%	O
vs	O
93	O
.	O
6	O
%	O
;	O
p	O
=	O
.	O
01	O
)	O
.	O
on	O
multivariable	B-T170
analysis	I-T170
that	O
included	O
involved	O
lymph	B-T017
nodes	I-T017
,	O
only	O
ene	B-T033
,	O
lympho	B-T033
##vascular	I-T033
invasion	I-T033
,	O
pt	B-T038
##3	I-T038
/	I-T038
pt	I-T038
##4	I-T038
tumors	I-T038
,	O
and	O
char	O
##ls	O
##on	O
-	O
de	O
##y	O
##o	O
score	O
were	O
associated	O
with	O
worse	B-T033
os	O
.	O
among	O
ene	B-T033
-	O
positive	B-T033
patients	O
,	O
there	O
was	O
no	O
difference	O
in	O
3	O
-	O
year	O
os	O
between	O
those	O
who	O
received	O
adjuvant	B-T058
concurrent	I-T058
chemoradiotherapy	I-T058
versus	O
radiotherapy	B-T058
alone	I-T058
(	O
89	O
.	O
6	O
%	O
vs	O
89	O
.	O
3	O
%	O
,	O
respectively	O
;	O
p	O
=	O
.	O
55	O
)	O
.	O
propensity	O
score	O
-	O
matched	O
comparison	O
revealed	O
similar	O
results	O
.	O
ene	B-T033
is	O
associated	O
with	O
inferior	B-T082
os	O
in	O
patients	O
with	O
hpv	B-T038
-	I-T038
positive	I-T038
ops	I-T038
##cc	I-T038
.	O
however	O
,	O
os	O
was	O
not	B-T033
better	I-T033
with	O
adjuvant	B-T058
chemoradiotherapy	I-T058
compared	O
with	O
radiotherapy	B-T058
alone	I-T058
in	O
ene	B-T033
-	O
positive	B-T033
patients	O
.	O
the	O
current	O
findings	O
support	O
the	O
need	O
for	O
prospective	B-T062
studies	I-T062
of	O
adjuvant	B-T058
chemoradiation	I-T058
in	O
hpv	B-T005
-	O
positive	B-T033
patients	O
with	O
ene	B-T033
.	O
cancer	O
2017	O
.	O
©	O
2017	O
american	O
cancer	O
society	O
.	O

isolation	O
and	O
characterization	O
of	O
burkholderia	B-T007
sp	I-T007
.	I-T007
strain	I-T007
cca	I-T007
##53	I-T007
exhibiting	O
lignin	B-T038
##olytic	I-T038
potential	O
microbial	O
degradation	B-T038
of	O
lignin	B-T103
releases	O
ferment	B-T103
##able	I-T103
sugars	I-T103
,	O
effective	O
utilization	O
of	O
which	O
could	O
support	O
biof	B-T103
##uel	I-T103
production	O
from	O
lignoc	B-T103
##ell	I-T103
##ulosic	I-T103
biomass	O
.	O
in	O
the	O
present	O
study	B-T062
,	O
a	O
lignin	B-T038
-	I-T038
degrading	I-T038
bacterium	B-T007
was	O
isolated	O
from	O
leaf	B-T204
soil	O
and	O
identified	O
as	O
burkholderia	B-T007
sp	I-T007
.	I-T007
based	O
on	O
16s	B-T103
rrna	I-T103
gene	B-T058
sequencing	I-T058
.	O
this	O
strain	O
was	O
named	O
cca	B-T007
##53	I-T007
,	O
and	O
its	O
lignin	B-T038
-	I-T038
degrading	I-T038
capability	O
was	O
assessed	O
by	O
observing	O
its	O
growth	B-T038
on	O
medium	B-T103
containing	O
alkali	B-T103
lignin	I-T103
or	O
lignin	B-T103
-	O
associated	O
aromatic	B-T103
monomers	I-T103
as	O
the	O
sole	O
carbon	B-T103
source	B-T033
.	O
alkali	B-T103
lignin	I-T103
and	O
at	O
least	O
eight	O
lignin	B-T103
-	O
associated	O
aromatic	B-T103
monomers	I-T103
supported	O
growth	B-T038
of	O
this	O
strain	O
,	O
and	O
the	O
most	O
effective	O
utilization	O
was	O
observed	O
for	O
p	B-T103
-	I-T103
hydroxybenz	I-T103
##ene	I-T103
monomers	I-T103
.	O
these	O
findings	B-T033
indicate	O
that	O
burkholderia	B-T007
sp	I-T007
.	I-T007
strain	I-T007
cca	I-T007
##53	I-T007
has	O
fragment	O
##ary	O
activity	O
for	O
lignin	B-T038
degradation	I-T038
.	O

using	O
language	O
for	O
social	B-T033
interaction	I-T033
:	O
communication	O
mechanisms	O
promote	O
recovery	O
from	O
chronic	O
non	B-T038
-	I-T038
flu	I-T038
##ent	I-T038
aphasia	I-T038
clinical	B-T062
research	I-T062
highlights	O
the	O
importance	O
of	O
mass	O
##ed	O
practice	O
in	O
the	O
rehabilitation	B-T058
of	O
chronic	O
post	O
-	O
stroke	O
aphasia	B-T038
.	O
however	O
,	O
while	O
necessary	O
,	O
mass	O
##ed	O
practice	O
may	O
not	O
be	O
sufficient	O
for	O
ensuring	O
progress	O
in	O
speech	B-T058
-	I-T058
language	I-T058
therapy	I-T058
.	O
motivated	O
by	O
recent	O
advances	O
in	O
neuroscience	B-T091
,	O
it	O
has	O
been	O
claimed	O
that	O
using	O
language	O
as	O
a	O
tool	O
for	O
communication	O
and	O
social	B-T033
interaction	I-T033
leads	O
to	O
synergistic	O
effects	O
in	O
left	B-T082
peri	I-T082
##s	I-T082
##ylv	I-T082
##ian	I-T082
el	I-T082
##o	I-T082
##que	I-T082
##nt	I-T082
areas	I-T082
.	O
here	O
,	O
we	O
conducted	O
a	O
crossover	O
randomized	O
controlled	O
trial	O
to	O
determine	O
the	O
influence	O
of	O
communicative	O
language	B-T038
function	I-T038
on	O
the	O
outcome	O
of	O
intensive	B-T058
aphasia	I-T058
therapy	I-T058
.	O
eighteen	O
individuals	B-T098
with	O
left	O
-	O
hemisphere	O
lesions	O
and	O
chronic	O
non	B-T038
-	I-T038
flu	I-T038
##ent	I-T038
aphasia	I-T038
each	O
received	O
two	O
types	O
of	O
training	O
in	O
counter	O
##balanced	O
order	O
:	O
(	O
i	O
)	O
intensive	B-T058
language	I-T058
-	I-T058
action	I-T058
therapy	I-T058
(	O
il	B-T058
##at	I-T058
,	O
an	O
extended	O
form	O
of	O
constraint	B-T058
-	I-T058
induced	I-T058
aphasia	I-T058
therapy	I-T058
)	O
embedding	O
verbal	B-T058
ut	I-T058
##tera	I-T058
##nc	I-T058
##es	I-T058
in	O
the	O
context	O
of	O
communication	O
and	O
social	B-T033
interaction	I-T033
,	O
and	O
(	O
ii	O
)	O
naming	B-T170
therapy	I-T170
focusing	O
on	O
speech	B-T058
production	I-T058
per	I-T058
se	I-T058
.	O
both	O
types	O
of	O
training	O
were	O
delivered	O
with	O
the	O
same	O
high	O
intensity	O
(	O
3	O
.	O
5	O
h	O
per	O
session	O
)	O
and	O
duration	O
(	O
six	O
consecutive	O
working	O
days	O
)	O
,	O
with	O
therapy	B-T058
materials	O
and	O
number	B-T033
of	I-T033
ut	I-T033
##tera	I-T033
##nc	I-T033
##es	I-T033
matched	O
between	O
treatment	B-T058
groups	I-T058
.	O
a	O
standardized	O
aphasia	B-T038
test	B-T058
battery	I-T058
revealed	O
significantly	O
improved	O
language	O
performance	O
with	O
il	B-T058
##at	I-T058
,	O
independent	O
of	O
when	O
this	O
method	B-T170
was	O
administered	O
.	O
in	O
contrast	O
,	O
naming	B-T170
therapy	I-T170
tended	O
to	O
benefit	O
language	O
performance	O
only	O
when	O
given	O
at	O
the	O
onset	O
of	O
the	O
treatment	B-T058
,	O
but	O
not	O
when	O
applied	O
after	O
previous	O
intensive	O
training	O
.	O
the	O
current	O
results	O
challenge	O
the	O
notion	O
that	O
mass	O
##ed	O
practice	O
alone	O
promotes	O
recovery	O
from	O
chronic	O
post	O
-	O
stroke	O
aphasia	B-T038
.	O
instead	O
,	O
our	O
results	O
demonstrate	O
that	O
using	O
language	O
for	O
communication	O
and	O
social	B-T033
interaction	I-T033
increases	O
the	O
efficacy	O
of	O
intensive	B-T058
aphasia	I-T058
therapy	I-T058
.	O

pi3k	B-T103
/	O
akt	B-T103
pathway	B-T038
:	O
a	O
potential	O
therapeutic	O
target	O
for	O
chronic	B-T033
pain	I-T033
chronic	B-T033
pain	I-T033
is	O
among	O
the	O
most	O
disabling	O
and	O
costly	O
disorders	B-T038
,	O
with	O
prevalence	O
ranging	O
from	O
10	O
%	O
to	O
55	O
%	O
.	O
however	O
,	O
current	O
therapeutic	O
strategies	O
for	O
chronic	B-T033
pain	I-T033
are	O
unsatisfactory	O
due	O
to	O
our	O
poor	O
understanding	B-T038
of	O
its	O
mechanisms	O
.	O
thus	O
,	O
novel	O
therapeutic	O
targets	O
need	O
to	O
be	O
found	O
in	O
order	O
to	O
improve	B-T033
these	O
patients	O
'	O
quality	O
of	O
life	O
.	O
pi3k	B-T103
and	O
its	O
downstream	B-T082
akt	B-T103
are	O
widely	O
expressed	B-T038
in	O
the	O
spinal	B-T017
cord	I-T017
,	O
particularly	O
in	O
the	O
laminae	B-T017
i	I-T017
-	I-T017
iv	I-T017
of	O
the	O
dorsal	B-T017
horn	I-T017
,	O
where	O
nociceptive	B-T017
c	I-T017
and	O
a	B-T017
##δ	I-T017
fibers	I-T017
of	O
primary	O
afferents	B-T017
principally	O
terminate	O
.	O
recent	O
studies	B-T062
have	O
demonstrated	O
their	O
critical	O
roles	O
in	O
the	O
development	O
and	O
maintenance	O
of	O
chronic	B-T033
pain	I-T033
.	O
in	O
this	O
review	B-T170
,	O
we	O
summarized	O
the	O
roles	O
and	O
mechanisms	O
of	O
pi3k	B-T103
/	O
akt	B-T103
pathway	B-T038
in	O
the	O
progression	B-T038
of	O
chronic	B-T033
pain	I-T033
through	O
sciatic	B-T037
nerve	I-T037
injury	I-T037
,	O
diabetic	B-T038
neuropathy	I-T038
,	O
spinal	B-T037
cord	I-T037
injury	I-T037
,	O
bone	B-T038
cancer	I-T038
,	O
opioid	O
tolerance	O
,	O
or	O
opioid	B-T103
-	O
induced	O
hyperalgesia	B-T033
.	O

1	O
in	O
100	O
babies	O
:	O
the	O
fetal	B-T017
alcohol	I-T017
spectrum	I-T017
disorder	I-T017
pathway	O
alcohol	B-T168
consumed	O
during	O
pregnancy	B-T038
is	O
the	O
nation	O
'	O
s	O
leading	O
preventable	O
cause	O
of	O
developmental	B-T038
disabilities	I-T038
and	O
birth	B-T017
defects	I-T017
.	O
one	O
in	O
100	O
babies	O
is	O
estimated	O
to	O
be	O
born	B-T038
with	O
alcohol	B-T038
-	I-T038
related	I-T038
damage	I-T038
,	O
according	O
to	O
the	O
world	B-T092
health	I-T092
organization	I-T092
.	O
fetal	B-T017
alcohol	I-T017
spectrum	I-T017
disorders	I-T017
(	O
fas	B-T017
##ds	I-T017
)	O
are	O
more	O
common	O
than	O
autism	B-T038
but	O
are	O
under	O
-	O
diagnosed	B-T033
.	O

lactate	B-T103
induces	O
osteoblast	B-T038
differentiation	I-T038
by	O
stabilization	B-T038
of	O
hif	B-T103
##1	I-T103
##α	I-T103
aerobic	O
glycolysis	O
is	O
involved	O
in	O
osteoblast	B-T038
differentiation	I-T038
induced	O
by	O
wnt	B-T038
signaling	I-T038
or	O
pth	B-T103
treatment	O
.	O
however	O
,	O
it	O
is	O
still	O
unclear	O
whether	O
lactate	B-T103
,	O
the	O
end	O
product	O
of	O
aerobic	O
glycolysis	O
,	O
plays	O
any	O
role	O
in	O
osteoblast	B-T038
differentiation	I-T038
.	O
herein	O
we	O
report	O
that	O
in	O
cultures	B-T058
of	O
osteoblast	B-T017
-	I-T017
lineage	I-T017
cells	I-T017
,	O
lactate	B-T103
promoted	O
alkaline	B-T103
phosphatase	I-T103
-	O
positive	O
cell	B-T038
formation	I-T038
,	O
increased	O
the	O
activity	B-T038
of	O
alkaline	B-T103
phosphatase	I-T103
,	O
and	O
induced	O
the	O
expression	B-T038
of	O
osteocalcin	B-T103
.	O
this	O
osteoblast	B-T038
differentiation	I-T038
-	O
inducing	O
effect	O
of	O
lactate	B-T103
can	O
be	O
inhibited	O
by	O
blocking	O
its	O
entry	O
into	O
cells	B-T017
with	O
mct	B-T103
##1	I-T103
sirna	B-T103
or	O
inhibitors	B-T103
,	O
and	O
by	O
interfering	O
with	O
its	O
metabolism	B-T038
by	O
using	O
specific	O
sirnas	B-T103
for	O
ldh	B-T103
##b	I-T103
and	O
pd	B-T103
##h	I-T103
.	O
moreover	O
,	O
lactate	B-T103
stabilized	O
hif	B-T103
##1	I-T103
##α	I-T103
expression	B-T038
and	O
inhibited	O
hif	B-T103
##1	I-T103
##α	I-T103
activity	O
,	O
with	O
bay	B-T103
##87	I-T103
-	I-T103
224	I-T103
##3	I-T103
lowering	O
the	O
osteoblast	B-T038
differentiation	I-T038
-	O
inducing	O
effect	O
of	O
lactate	B-T103
.	O
thus	O
,	O
these	O
findings	B-T033
reveal	O
an	O
unrecognized	O
role	O
for	O
aerobic	O
glycolysis	O
in	O
osteoblast	B-T038
differentiation	I-T038
via	O
its	O
end	O
product	O
,	O
lactate	B-T103
.	O

cobalt	B-T074
-	I-T074
60	I-T074
machines	I-T074
and	O
medical	B-T074
linear	I-T074
accelerator	I-T074
##s	I-T074
:	O
competing	O
technologies	O
for	O
external	B-T058
beam	I-T058
radiotherapy	I-T058
medical	B-T074
linear	I-T074
accelerator	I-T074
##s	I-T074
(	O
lin	B-T074
##acs	I-T074
)	O
and	O
cobalt	B-T074
-	I-T074
60	I-T074
machines	I-T074
are	O
both	O
mature	O
technologies	O
for	O
external	B-T058
beam	I-T058
radiotherapy	I-T058
.	O
a	O
comparison	O
is	O
made	O
between	O
these	O
two	O
technologies	O
in	O
terms	O
of	O
infrastructure	B-T170
and	O
maintenance	O
,	O
dosimetry	B-T058
,	O
shielding	B-T033
requirements	O
,	O
staffing	O
,	O
costs	O
,	O
security	O
,	O
patient	O
throughput	O
and	O
clinical	O
use	O
.	O
infrastructure	B-T170
and	O
maintenance	O
are	O
more	O
demanding	O
for	O
lin	B-T074
##acs	I-T074
due	O
to	O
the	O
complex	O
electric	O
component	O
##ry	O
.	O
in	O
dosimetry	B-T058
,	O
a	O
higher	O
beam	O
energy	O
,	O
modulated	B-T082
dose	O
rate	O
and	O
smaller	O
focal	O
spot	O
size	O
mean	O
that	O
it	O
is	O
easier	B-T033
to	O
create	O
an	O
optimised	O
treatment	B-T058
with	O
a	O
lin	B-T074
##ac	I-T074
for	O
conformal	O
dose	O
coverage	O
of	O
the	O
tumour	B-T038
while	O
sparing	O
healthy	B-T017
organs	I-T017
at	O
risk	O
.	O
in	O
shielding	B-T033
,	O
the	O
requirements	O
for	O
a	O
concrete	O
bun	O
##ker	O
are	O
similar	O
for	O
cobalt	B-T074
-	I-T074
60	I-T074
machines	I-T074
and	O
lin	B-T074
##acs	I-T074
but	O
extra	O
shielding	B-T033
and	O
protection	O
from	O
neutron	O
##s	O
are	O
required	O
for	O
lin	B-T074
##acs	I-T074
.	O
staffing	O
levels	O
can	O
be	O
higher	O
for	O
lin	B-T074
##acs	I-T074
and	O
more	O
staff	O
training	O
is	O
required	O
for	O
lin	B-T074
##acs	I-T074
.	O
life	O
cycle	O
costs	O
are	O
higher	O
for	O
lin	B-T074
##acs	I-T074
,	O
especially	O
multi	B-T074
-	I-T074
energy	I-T074
lin	I-T074
##acs	I-T074
.	O
security	O
is	O
more	O
complex	O
for	O
cobalt	B-T074
-	I-T074
60	I-T074
machines	I-T074
because	O
of	O
the	O
high	O
activity	O
radioactive	B-T103
source	I-T103
.	O
patient	O
throughput	O
can	O
be	O
affected	O
by	O
source	B-T033
decay	O
for	O
cobalt	B-T074
-	I-T074
60	I-T074
machines	I-T074
but	O
poor	O
maintenance	O
and	O
breakdown	O
##s	O
can	O
severely	O
affect	O
patient	O
throughput	O
for	O
lin	B-T074
##acs	I-T074
.	O
in	O
clinical	O
use	O
,	O
more	O
complex	O
treatment	B-T058
techniques	O
are	O
easier	B-T033
to	O
achieve	O
with	O
lin	B-T074
##acs	I-T074
,	O
and	O
the	O
availability	O
of	O
electron	O
beams	O
on	O
high	O
-	O
energy	O
lin	B-T074
##acs	I-T074
can	O
be	O
useful	O
for	O
certain	O
treatments	B-T058
.	O
in	O
summary	O
,	O
there	O
is	O
no	O
simple	O
answer	O
to	O
the	O
question	O
of	O
the	O
choice	O
of	O
either	O
cobalt	B-T074
-	I-T074
60	I-T074
machines	I-T074
or	O
lin	B-T074
##acs	I-T074
for	O
radiotherapy	B-T058
in	O
low	B-T033
-	I-T033
and	O
middle	O
-	O
income	O
countries	B-T082
.	O
in	O
fact	O
a	O
radiotherapy	B-T092
department	I-T092
with	O
a	O
combination	O
of	O
technologies	O
,	O
including	O
ortho	B-T092
##vo	I-T092
##lt	I-T092
##age	I-T092
x	I-T092
-	I-T092
ray	I-T092
units	I-T092
,	O
may	O
be	O
an	O
option	O
.	O
local	B-T082
needs	O
,	O
conditions	O
and	O
resources	O
will	O
have	O
to	O
be	O
factor	O
##ed	O
into	O
any	O
decision	B-T038
on	O
technology	O
taking	O
into	O
account	O
the	O
characteristics	O
of	O
both	O
forms	O
of	O
tele	B-T058
##therapy	I-T058
,	O
with	O
the	O
primary	O
goal	B-T170
being	O
the	O
sustainability	O
of	O
the	O
radiotherapy	B-T092
service	I-T092
over	O
the	O
useful	O
lifetime	O
of	O
the	O
equipment	O
.	O

promoting	O
healthy	O
growth	B-T038
or	O
feeding	O
obesity	B-T038
?	O
the	O
need	O
for	O
evidence	O
-	O
based	O
overs	O
##ight	O
of	O
infant	O
nutritional	B-T168
supplement	I-T168
claims	O
the	O
developmental	B-T170
origins	I-T170
of	I-T170
health	I-T170
and	I-T170
disease	I-T170
(	O
do	B-T170
##had	I-T170
)	O
model	O
recognizes	O
growth	B-T038
in	O
infancy	O
and	O
childhood	O
as	O
a	O
fundamental	O
determinant	O
of	O
lifespan	O
health	O
.	O
evidence	O
of	O
long	O
-	O
term	O
health	O
risks	O
among	O
small	O
neonates	O
who	O
subsequently	O
grow	O
rapidly	O
poses	O
a	O
challenge	O
for	O
interventions	B-T058
aiming	O
to	O
support	O
healthy	O
growth	B-T038
,	O
not	O
merely	O
drive	O
weight	B-T033
gain	I-T033
.	O
defining	O
healthy	O
growth	B-T038
beyond	O
[UNK]	O
getting	O
big	O
##ger	O
[UNK]	O
is	O
essential	O
as	O
infant	O
and	O
young	O
child	O
feeding	O
industries	O
expand	O
.	O
liquid	O
-	O
based	O
nutritional	B-T168
supplements	I-T168
,	O
originally	O
formulated	B-T168
for	O
undern	B-T038
##ourished	I-T038
children	O
,	O
are	O
increasingly	O
marketed	O
for	O
and	O
consumed	O
by	O
children	O
generally	O
.	O
clarifying	O
the	O
nature	O
of	O
the	O
evident	O
##iary	O
base	O
on	O
which	O
structure	O
/	O
function	O
claims	O
promoting	O
[UNK]	O
healthy	O
growth	B-T038
[UNK]	O
are	O
constructed	O
is	O
important	O
to	O
cur	O
##b	O
inval	O
##id	O
generalization	O
##s	O
.	O
evidence	O
points	O
to	O
changing	O
social	O
beliefs	O
and	O
cultural	O
practices	B-T038
surrounding	O
supplementary	B-T058
feeding	I-T058
,	O
raising	O
specific	O
concerns	O
about	O
the	O
long	O
-	O
term	O
health	O
consequences	O
of	O
an	O
associated	O
altered	O
feeding	O
culture	O
,	O
including	O
reduced	O
dietary	B-T168
variety	O
and	O
weight	B-T033
gain	I-T033
.	O
reassess	O
##ing	O
the	O
evidence	O
for	O
and	O
relevance	O
of	O
dietary	B-T168
supplements	I-T168
'	I-T168
[UNK]	O
promoting	O
healthy	O
growth	B-T038
[UNK]	O
claims	O
for	O
otherwise	O
healthy	O
children	O
is	O
both	O
needed	O
in	O
a	O
time	O
of	O
global	O
obesity	B-T038
and	O
an	O
opportunity	O
to	O
refine	O
intervention	B-T058
approaches	I-T058
among	O
small	O
children	O
for	O
whom	O
rapid	O
subsequent	O
growth	B-T038
in	O
early	O
life	O
augments	O
risk	O
for	O
chronic	B-T038
disease	I-T038
.	O
scientific	O
and	O
health	B-T058
care	I-T058
partnerships	B-T092
are	O
needed	O
to	O
consider	O
current	O
governmental	O
overs	O
##ight	O
short	O
##fall	O
##s	O
in	O
protecting	O
vulnerable	O
populations	B-T098
from	O
overc	O
##ons	O
##ump	O
##tion	O
.	O
this	O
is	O
important	O
because	O
we	O
may	O
be	O
doing	O
more	O
harm	O
than	O
good	O
.	O

hetero	B-T103
##pro	I-T103
##tein	I-T103
complex	B-T103
formation	O
of	O
bovine	B-T103
lactoferrin	I-T103
and	O
pea	O
protein	O
isolate	B-T103
:	O
a	O
multis	O
##cale	O
structural	O
analysis	O
associative	O
electrostatic	O
interactions	O
between	O
two	O
opposite	O
##ly	O
charged	O
globular	O
proteins	O
,	O
lactoferrin	B-T103
(	O
lf	B-T103
)	O
and	O
pea	O
protein	O
isolate	B-T103
(	O
ppi	O
)	O
,	O
the	O
latter	O
being	O
a	O
mixture	O
of	O
vic	B-T103
##ilin	I-T103
,	O
leg	B-T103
##umin	I-T103
,	O
and	O
conv	B-T103
##ici	I-T103
##lin	I-T103
,	O
was	O
studied	B-T062
with	O
a	O
specific	O
ppi	O
/	O
lf	B-T103
molar	O
ratio	O
at	O
room	B-T033
temperature	I-T033
.	O
structural	B-T082
aspects	O
of	O
the	O
electrostatic	O
complexes	B-T103
probed	O
at	O
different	O
length	O
scales	O
were	O
investigated	O
as	O
a	O
function	O
of	O
ph	O
by	O
means	O
of	O
different	O
complementary	O
techniques	O
,	O
namely	O
,	O
with	O
dynamic	B-T058
light	I-T058
scattering	I-T058
,	O
small	O
-	O
angle	O
x	O
-	O
ray	O
scattering	O
(	O
sax	O
##s	O
)	O
,	O
turbidity	B-T058
measurements	I-T058
,	O
and	O
atomic	B-T058
force	I-T058
microscopy	I-T058
(	O
afm	B-T058
)	O
.	O
irrespective	O
of	O
the	O
applied	O
techniques	O
,	O
the	O
results	B-T033
consistently	O
displayed	O
that	O
complexation	B-T103
between	O
lf	B-T103
and	O
ppi	O
did	O
occur	O
.	O
in	O
an	O
optimum	O
narrow	O
range	O
of	O
ph	O
5	O
.	O
0	O
-	O
5	O
.	O
8	O
,	O
a	O
viscous	O
liquid	B-T033
phase	O
of	O
complex	B-T103
coa	O
##cer	O
##va	O
##te	O
was	O
obtained	O
upon	O
mild	O
centrifugation	B-T058
of	O
the	O
turb	O
##id	O
lf	B-T103
-	O
ppi	O
mixture	O
with	O
a	O
maximum	O
rh	O
,	O
turbidity	O
and	O
the	O
ζ	O
-	O
potential	O
being	O
close	O
to	O
zero	O
observed	O
at	O
ph	O
5	O
.	O
4	O
.	O
in	O
particular	O
,	O
the	O
sax	O
##s	O
data	O
demonstrated	O
that	O
the	O
coa	O
##cer	O
##va	O
##tes	O
were	O
densely	O
assembled	O
with	O
a	O
roughly	O
spherical	B-T082
size	B-T082
distribution	B-T082
exhibiting	O
a	O
maximum	O
extension	O
of	O
∼	O
##80	O
nm	O
at	O
ph	O
5	O
.	O
4	O
.	O
equally	O
,	O
afm	B-T058
image	B-T058
analysis	I-T058
showed	O
size	B-T082
distributions	B-T082
containing	O
most	O
frequent	O
cluster	O
sizes	B-T082
around	O
40	O
-	O
80	O
nm	O
with	O
spherical	B-T082
to	O
ellip	B-T082
##tical	I-T082
shapes	I-T082
(	O
axis	O
aspect	O
ratio	O
≤	O
2	O
)	O
as	O
well	O
as	O
less	O
frequent	O
elongated	O
to	O
chain	O
##like	O
structures	B-T082
.	O
the	O
most	O
frequently	O
observed	O
compact	O
complexes	B-T103
,	O
we	O
identify	O
as	O
mainly	O
leading	O
to	O
lf	B-T103
-	O
ppi	O
coa	O
##cer	O
##vation	O
,	O
whereas	O
for	O
the	O
less	O
frequent	O
chain	O
-	O
like	O
aggregates	O
,	O
we	O
hypothesize	O
that	O
additionally	O
ppi	O
-	O
ppi	O
facilitated	O
complexes	B-T103
exist	O
.	O

defining	O
,	O
describing	B-T170
,	O
and	O
categor	O
##izing	O
public	B-T058
health	I-T058
infrastructure	I-T058
priorities	O
for	O
tropical	O
cyclo	O
##ne	O
,	O
flood	O
,	O
storm	O
,	O
tor	O
##na	O
##d	O
##o	O
,	O
and	O
ts	O
##una	O
##mi	O
-	O
related	O
disasters	O
the	O
study	B-T062
aim	O
was	O
to	O
undertake	O
a	O
qualitative	O
research	O
literature	B-T170
review	I-T170
to	O
analyze	O
available	O
databases	B-T170
to	O
define	O
,	O
describe	B-T170
,	O
and	O
categor	O
##ize	O
public	B-T058
health	I-T058
infrastructure	I-T058
(	O
phi	B-T058
)	O
priorities	O
for	O
tropical	O
cyclo	O
##ne	O
,	O
flood	O
,	O
storm	O
,	O
tor	O
##na	O
##d	O
##o	O
,	O
and	O
ts	O
##una	O
##mi	O
-	O
related	O
disasters	O
.	O
five	O
electronic	O
publication	B-T170
databases	I-T170
were	O
searched	O
to	O
define	O
,	O
describe	B-T170
,	O
or	O
categor	O
##ize	O
phi	B-T058
and	O
discuss	O
tropical	O
cyclo	O
##ne	O
,	O
flood	O
,	O
storm	O
,	O
tor	O
##na	O
##d	O
##o	O
,	O
and	O
ts	O
##una	O
##mi	O
-	O
related	O
disasters	O
and	O
their	O
impact	O
on	O
phi	B-T058
.	O
the	O
data	O
were	O
analyzed	O
through	O
aggregation	O
of	O
individual	O
articles	B-T170
to	O
create	O
an	O
overall	O
data	O
description	O
.	O
the	O
data	O
were	O
grouped	O
into	O
phi	B-T058
themes	O
,	O
which	O
were	O
then	O
priori	O
##ti	O
##zed	O
on	O
the	O
basis	O
of	O
degree	O
of	O
interdep	O
##end	O
##ency	O
.	O
sixty	O
-	O
seven	O
relevant	O
articles	B-T170
were	O
identified	O
.	O
phi	B-T058
was	O
categorized	O
into	O
13	O
themes	O
with	O
a	O
total	O
of	O
158	O
descriptors	B-T170
.	O
the	O
highest	O
priority	O
phi	B-T058
identified	O
was	O
workforce	O
.	O
this	O
was	O
followed	O
by	O
water	O
,	O
sanitation	O
,	O
equipment	O
,	O
communication	O
,	O
physical	O
structure	O
,	O
power	O
,	O
governance	B-T170
,	O
prevention	O
,	O
supplies	O
,	O
service	O
,	O
transport	O
,	O
and	O
surveillance	O
.	O
this	O
review	B-T170
identified	O
workforce	O
as	O
the	O
most	O
important	O
of	O
the	O
13	O
thematic	O
areas	O
related	O
to	O
phi	B-T058
and	O
disasters	O
.	O
if	O
its	O
functionality	O
fails	O
,	O
workforce	O
has	O
the	O
greatest	O
impact	O
on	O
the	O
performance	O
of	O
health	B-T058
services	I-T058
.	O
if	O
addressed	O
post	O
-	O
disaster	O
,	O
the	O
remaining	O
forms	O
of	O
phi	B-T058
will	O
then	O
be	O
progressively	O
addressed	O
.	O
these	O
findings	O
are	O
a	O
step	O
toward	O
providing	O
an	O
evidence	O
base	O
to	O
inform	O
phi	B-T058
priorities	O
in	O
the	O
disaster	O
setting	O
.	O
(	O
disaster	O
med	O
public	O
health	O
preparedness	O
.	O
2016	O
;	O
10	O
:	O
59	O
##8	O
-	O
61	O
##0	O
)	O
.	O

nitrogen	B-T038
utilization	I-T038
efficiency	O
and	O
prediction	O
of	O
nitrogen	B-T103
excretion	B-T038
in	O
sheep	B-T204
offered	B-T033
fresh	B-T204
perennial	I-T204
rye	I-T204
##grass	I-T204
(	O
)	O
nitrogen	B-T103
excretion	B-T038
from	O
sheep	B-T204
production	B-T082
systems	I-T082
is	O
an	O
important	O
source	O
of	O
nitrate	B-T103
,	O
ammonia	B-T103
,	O
and	O
nitrous	B-T103
oxide	I-T103
responsible	O
for	O
groundwater	B-T082
pollution	O
and	O
global	O
warming	O
.	O
the	O
present	O
study	B-T062
aimed	O
to	O
identify	O
key	O
parameters	O
influencing	O
n	B-T038
utilization	I-T038
efficiency	O
and	O
develop	O
prediction	O
equations	O
for	O
manure	O
n	B-T103
,	O
feces	B-T031
n	B-T103
,	O
and	O
urine	B-T031
n	B-T103
outputs	O
in	O
sheep	B-T204
.	O
data	O
used	O
were	O
collected	O
from	O
82	O
sheep	B-T204
offered	B-T033
fresh	B-T204
perennial	I-T204
rye	I-T204
##grass	I-T204
(	O
)	O
as	O
the	O
sole	B-T168
diet	I-T168
in	O
6	O
metabolism	B-T038
experiments	B-T062
(	O
data	O
from	O
non	B-T168
-	I-T168
grass	I-T168
-	I-T168
only	I-T168
diets	I-T168
were	O
not	O
used	O
)	O
.	O
sheep	B-T204
were	O
from	O
breeds	B-T170
of	O
highl	B-T098
##ander	I-T098
,	O
tex	B-T204
##el	I-T204
,	O
scot	B-T204
##tis	I-T204
##h	I-T204
black	I-T204
##fa	I-T204
##ce	I-T204
,	O
and	O
sw	B-T204
##ale	I-T204
##da	I-T204
##le	I-T204
at	O
the	O
age	O
of	O
5	O
to	O
18	O
mo	O
and	O
weighing	O
from	O
24	O
.	O
5	O
to	O
62	O
.	O
7	O
kg	O
.	O
herb	B-T204
##age	I-T204
was	O
harvested	O
daily	O
from	O
6	O
sw	B-T204
##ards	I-T204
of	O
contrasting	O
harvest	O
dates	O
(	O
may	O
to	O
december	O
)	O
,	O
offering	B-T033
wide	O
variation	O
in	O
feed	O
value	O
to	O
cover	O
the	O
range	O
that	O
would	O
be	O
offered	B-T033
in	O
most	O
practical	O
farm	B-T082
situations	I-T082
.	O
before	O
the	O
comm	O
##ence	O
##ment	O
of	O
each	O
study	B-T062
,	O
the	O
experimental	O
sw	B-T204
##ard	I-T204
was	O
harvested	O
at	O
a	O
residual	O
height	O
of	O
4	O
cm	O
and	O
allowed	O
to	O
grow	B-T038
for	O
2	O
to	O
4	O
wk	O
to	O
target	O
an	O
average	O
preg	O
##ra	O
##zing	O
sw	B-T204
##ard	I-T204
height	O
in	O
a	O
range	O
of	O
8	O
to	O
15	O
cm	O
depending	O
on	O
the	O
time	O
of	O
year	O
.	O
sheep	B-T204
were	O
housed	B-T082
in	O
individual	O
pen	O
##s	O
for	O
14	O
d	O
and	O
then	O
transferred	B-T033
to	I-T033
individual	O
metabolism	B-T038
cr	O
##ates	O
for	O
4	O
d	O
with	O
feed	O
intake	O
and	O
feces	B-T031
and	O
urine	B-T031
outputs	O
measured	O
.	O
data	O
were	O
analyzed	B-T062
using	O
the	O
linear	O
mixed	O
model	O
procedure	O
to	O
develop	O
prediction	O
equations	O
for	O
feces	B-T031
n	O
,	O
urine	B-T031
n	O
,	O
and	O
manure	O
n	B-T103
outputs	O
using	O
n	B-T033
intake	I-T033
,	O
herb	B-T204
##age	I-T204
chemical	O
composition	O
,	O
and	O
digestibility	O
with	O
effects	O
of	O
sex	O
,	O
breed	B-T170
,	O
and	O
experimental	O
periods	O
removed	O
.	O
nitrogen	B-T103
intake	O
was	O
the	O
best	O
single	O
predictor	O
for	O
n	B-T103
output	O
in	O
feces	B-T031
,	O
urine	B-T031
,	O
and	O
manure	O
,	O
and	O
the	O
value	O
for	O
prediction	O
of	O
manure	O
n	B-T103
output	O
was	O
greater	O
than	O
those	O
for	O
feces	B-T031
n	B-T103
and	O
urine	B-T031
n	B-T103
(	O
0	O
.	O
86	O
vs	O
.	O
0	O
.	O
70	O
and	O
0	O
.	O
77	O
,	O
respectively	O
;	O
<	O
0	O
.	O
001	O
)	O
.	O
animal	B-T204
bw	O
and	O
herb	B-T204
##age	I-T204
dm	O
,	O
ether	O
extract	O
,	O
nd	B-T168
##f	I-T168
,	O
ad	B-T168
##f	I-T168
,	O
water	B-T058
soluble	I-T058
carbohydrate	I-T058
,	O
and	O
de	O
concentrations	O
and	O
n	B-T103
digestibility	O
were	O
also	O
used	O
to	O
predict	O
n	B-T103
outputs	O
because	O
n	B-T103
intake	O
may	O
not	O
be	O
available	O
in	O
commercial	O
practice	O
.	O
the	O
prediction	O
equations	O
for	O
n	B-T038
util	I-T038
##iz	I-T038
##ati	I-T038
##o	I-T038
n	O
efficiency	O
indicated	O
that	O
increasing	O
feeding	O
level	O
and	O
me	O
concentration	O
and	O
reducing	O
n	B-T033
concentration	I-T033
could	O
improve	B-T033
n	B-T038
utilization	I-T038
efficiency	O
and	O
shift	O
n	B-T103
excretion	B-T038
into	O
feces	B-T031
rather	B-T033
than	I-T033
urine	B-T031
(	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
equations	O
developed	O
in	O
the	O
current	O
study	B-T062
provide	O
an	O
approach	B-T082
for	O
sheep	B-T204
producers	B-T098
to	O
quantify	O
n	B-T103
excretion	B-T038
against	O
production	O
and	O
,	O
consequently	O
,	O
to	O
develop	O
their	O
own	O
mitigation	B-T062
strategies	I-T062
to	O
reduce	O
the	O
environmental	O
impact	O
of	O
sheep	B-T204
production	B-T082
systems	I-T082
.	O

measure	B-T058
up	I-T058
pressure	I-T058
down	I-T058
:	I-T058
provider	I-T058
tool	I-T058
##ki	I-T058
##t	I-T058
to	O
improve	O
hypertension	B-T038
control	B-T038
hypertension	B-T038
is	O
one	O
of	O
the	O
most	O
important	O
risk	B-T033
factors	I-T033
for	O
heart	B-T038
disease	I-T038
,	O
stroke	B-T038
,	O
kidney	B-T038
failure	I-T038
,	O
and	O
diabetes	B-T038
complications	I-T038
.	O
nearly	O
one	O
in	O
three	O
americans	B-T098
adults	O
has	O
high	B-T038
blood	I-T038
pressure	I-T038
,	O
and	O
the	O
cost	O
associated	O
with	O
treating	B-T058
this	O
condition	B-T038
is	O
sta	O
##gg	O
##ering	O
.	O
the	O
measure	B-T058
up	I-T058
pressure	I-T058
down	I-T058
:	I-T058
provider	I-T058
tool	I-T058
##ki	I-T058
##t	I-T058
to	O
improve	O
hypertension	B-T038
control	B-T038
is	O
a	O
resource	O
developed	O
by	O
the	O
american	B-T092
medical	I-T092
group	I-T092
foundation	I-T092
in	O
partnership	B-T092
with	O
the	O
american	B-T092
medical	I-T092
group	I-T092
association	I-T092
.	O
the	O
goal	B-T170
of	O
this	O
tool	B-T170
##ki	I-T170
##t	I-T170
is	O
to	O
mobil	O
##ize	O
health	B-T097
care	I-T097
practitioners	I-T097
to	O
work	O
together	O
through	O
team	O
-	O
based	O
approaches	O
to	O
achieve	O
an	O
80	O
%	O
control	B-T038
rate	O
of	O
high	B-T038
blood	I-T038
pressure	I-T038
among	O
their	O
patient	O
population	O
.	O
the	O
tool	B-T170
##ki	I-T170
##t	I-T170
can	O
be	O
used	O
by	O
health	B-T097
educators	I-T097
,	O
clinic	B-T097
administrators	I-T097
,	O
physicians	B-T097
,	O
students	B-T098
,	O
and	O
other	O
clinic	B-T097
staff	I-T097
as	O
a	O
step	O
-	O
by	O
-	O
step	O
resource	O
for	O
developing	O
the	O
infrastructure	B-T062
needed	O
to	O
better	O
identify	O
and	O
treat	B-T058
individuals	B-T098
with	O
high	B-T038
blood	I-T038
pressure	I-T038
or	O
other	O
chronic	B-T038
conditions	I-T038
.	I-T038

biochemical	O
and	O
proteomic	B-T091
analyses	B-T062
of	O
the	O
physiological	B-T038
response	I-T038
induced	O
by	O
individual	O
housing	O
in	O
gilts	B-T204
provide	O
new	O
potential	O
stress	B-T038
markers	B-T201
the	O
objective	O
assessment	B-T058
of	O
animal	B-T204
stress	B-T038
and	O
welfare	O
requires	O
proper	O
laboratory	B-T092
biomarkers	B-T201
.	O
in	O
this	O
work	O
,	O
we	O
have	O
analyzed	O
the	O
changes	O
in	O
serum	B-T031
composition	B-T201
in	O
gilts	B-T204
after	O
switching	O
their	O
housing	O
,	O
from	O
pen	O
to	O
individual	O
stall	O
##s	O
,	O
which	O
is	O
generally	O
accepted	O
to	O
cause	O
animal	B-T204
discomfort	B-T033
.	O
blood	B-T031
and	O
saliva	B-T031
samples	I-T031
were	O
collected	O
a	O
day	O
before	O
and	O
up	O
to	O
four	O
days	O
after	O
changing	O
the	O
housing	O
system	O
.	O
biochemical	O
analyses	B-T062
showed	O
adaptive	O
changes	O
in	O
lipid	B-T103
and	O
protein	B-T038
metabolism	I-T038
after	O
the	O
housing	O
switch	O
,	O
whereas	O
cortisol	B-T103
and	O
muscular	B-T017
markers	B-T201
showed	O
a	O
large	O
variability	O
between	O
animals	B-T204
.	O
2d	B-T058
-	I-T058
dig	I-T058
##e	I-T058
and	O
it	B-T170
##ra	I-T170
##q	I-T170
proteomic	B-T091
approaches	O
revealed	O
variations	O
in	O
serum	B-T103
protein	I-T103
composition	B-T201
after	O
changing	O
housing	O
and	O
diet	O
of	O
gilts	B-T204
.	O
both	O
techniques	O
showed	O
alterations	O
in	O
two	O
main	O
homeostatic	B-T038
mechanisms	I-T038
:	O
the	O
innate	O
immune	O
and	O
redox	B-T038
systems	O
.	O
the	O
acute	B-T103
phase	I-T103
proteins	I-T103
haptoglobin	B-T103
,	O
apolipoprotein	B-T103
a	I-T103
-	I-T103
i	I-T103
and	O
α1	O
-	O
antich	O
##ym	O
##otrypsin	O
3	O
,	O
and	O
the	O
antioxidant	B-T103
enzyme	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
2	I-T103
were	O
found	O
differentially	O
expressed	O
by	O
2d	B-T058
-	I-T058
dig	I-T058
##e	I-T058
.	O
other	O
proteins	B-T103
related	O
to	O
the	O
innate	O
immune	O
system	O
,	O
including	O
lact	B-T103
##otr	I-T103
##ans	I-T103
##fer	I-T103
##rin	I-T103
,	O
prote	B-T103
##gr	I-T103
##in	I-T103
3	I-T103
and	O
galectin	B-T103
1	I-T103
were	O
also	O
identified	O
by	O
it	B-T170
##ra	I-T170
##q	I-T170
,	O
as	O
well	O
as	O
oxidative	B-T038
stress	I-T038
enzymes	B-T103
such	O
as	O
perox	B-T103
##ired	I-T103
##oxin	I-T103
2	I-T103
and	O
glutathione	B-T103
peroxidase	I-T103
3	I-T103
.	O
proteomics	B-T091
also	O
revealed	O
the	O
decrease	O
of	O
apolipoprotein	B-T103
##s	I-T103
,	O
and	O
the	O
presence	O
of	O
intracellular	B-T082
proteins	B-T103
in	O
serum	B-T031
,	O
which	O
may	O
indicate	O
physical	O
injury	O
to	O
tissues	B-T017
.	O
housing	O
of	O
gilts	B-T204
in	O
individual	O
stall	O
##s	O
and	O
diet	O
change	O
increase	O
lipid	B-T103
and	O
protein	B-T038
catabolism	I-T038
,	O
oxidative	B-T038
stress	I-T038
,	O
activate	O
the	O
innate	O
immune	O
system	O
and	O
cause	O
a	O
certain	O
degree	O
of	O
tissue	B-T037
damage	I-T037
.	O
we	O
propose	O
that	O
valuable	O
assays	O
for	O
stress	B-T058
assessment	I-T058
in	O
gilts	B-T204
may	O
be	O
based	O
on	O
a	O
score	O
composed	O
by	O
a	O
combination	O
of	O
salivary	O
cortisol	O
,	O
lipid	B-T103
metabolites	B-T103
,	O
innate	O
immunity	O
and	O
oxidative	B-T038
stress	I-T038
markers	B-T201
and	O
intracellular	B-T082
proteins	B-T103
.	O

molar	B-T017
loss	I-T017
and	O
powder	B-T058
diet	I-T058
leads	O
to	O
memory	B-T038
deficit	I-T038
and	O
modifies	O
the	O
mrna	B-T038
expression	I-T038
of	O
brain	B-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
in	O
the	O
hippocampus	B-T017
of	O
adult	O
mice	B-T204
it	O
is	O
known	O
that	O
tooth	B-T017
loss	I-T017
is	O
known	O
to	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
and	O
soft	B-T058
diet	I-T058
feeding	O
induces	O
memory	B-T038
impairment	I-T038
.	O
recent	O
studies	O
have	O
shown	O
that	O
brain	B-T103
-	I-T103
derived	I-T103
neurotrophic	I-T103
factor	I-T103
(	O
bdnf	B-T103
)	O
is	O
associated	O
with	O
tooth	B-T017
loss	I-T017
or	O
soft	B-T058
diet	I-T058
in	O
young	O
animal	B-T204
model	I-T204
,	O
and	O
that	O
bdnf	B-T017
expression	B-T038
is	O
decreased	O
in	O
patients	O
with	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
.	O
however	O
,	O
single	O
or	O
combined	O
effect	O
of	O
tooth	B-T017
loss	I-T017
and	O
/	O
or	O
soft	B-T058
diet	I-T058
on	O
brain	O
function	O
has	O
not	O
fully	O
understood	O
.	O
here	O
we	O
examined	O
the	O
effect	O
of	O
molar	B-T017
loss	I-T017
and	O
powder	B-T058
diet	I-T058
on	O
memory	B-T038
ability	I-T038
and	O
the	O
expression	B-T038
of	O
bdnf	B-T017
mrna	I-T017
in	O
the	O
hippocampus	B-T017
of	O
adult	O
c57bl	B-T204
/	I-T204
6j	I-T204
mice	I-T204
.	O
twenty	O
eight	O
-	O
weeks	O
-	O
old	O
c57bl	B-T204
/	I-T204
6j	I-T204
mice	I-T204
were	O
divided	O
into	O
intact	O
molar	O
group	O
and	O
extracted	O
molar	O
group	O
.	O
they	O
were	O
randomly	B-T062
divided	O
into	O
the	O
i	O
/	O
s	O
group	O
(	O
intact	O
upper	B-T017
molar	I-T017
teeth	I-T017
/	O
solid	B-T168
diet	I-T168
feeding	O
)	O
,	O
the	O
e	O
/	O
s	O
group	O
(	O
extracted	B-T058
upper	B-T017
molar	I-T017
teeth	I-T017
/	O
solid	B-T168
diet	I-T168
feeding	O
)	O
,	O
the	O
i	O
/	O
p	O
group	O
(	O
intact	O
upper	B-T017
molar	I-T017
teeth	I-T017
/	O
powder	B-T058
diet	I-T058
feeding	O
)	O
,	O
and	O
the	O
e	O
/	O
p	O
group	O
(	O
extracted	O
upper	B-T017
molar	I-T017
teeth	I-T017
/	O
powder	B-T058
diet	I-T058
feeding	O
)	O
.	O
the	O
observation	O
periods	O
were	O
4	O
and	O
16	O
-	O
week	O
.	O
to	O
analyze	B-T062
the	O
memory	B-T038
ability	I-T038
,	O
the	O
step	O
-	O
through	O
passive	O
avoidance	O
test	O
was	O
conducted	O
.	O
bdnf	B-T017
-	I-T017
related	I-T017
mrna	I-T017
in	O
the	O
hippocampus	B-T017
was	O
analyzed	B-T062
by	O
real	B-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
rt	B-T062
-	I-T062
pcr	I-T062
)	O
.	O
at	O
4	O
weeks	O
later	O
,	O
we	O
performed	O
memory	B-T058
test	I-T058
and	O
isolated	O
brains	B-T017
to	O
analyze	B-T062
.	O
there	O
were	O
no	O
differences	O
in	O
memory	B-T038
function	I-T038
and	O
bdnf	B-T017
mrna	I-T017
level	O
between	O
these	O
four	O
groups	O
.	O
however	O
,	O
at	O
16	O
weeks	O
later	O
,	O
e	O
/	O
s	O
and	O
e	O
/	O
p	O
group	O
showed	O
memory	B-T038
impairment	I-T038
,	O
and	O
decreased	O
level	O
of	O
bdnf	B-T017
mrna	I-T017
.	O
whereas	O
,	O
the	O
powder	B-T058
diet	I-T058
had	O
no	O
effect	O
on	O
memory	B-T038
function	I-T038
and	O
bdnf	B-T017
mrna	I-T017
level	O
even	O
at	O
16	O
weeks	O
later	O
.	O
these	O
results	O
suggest	O
that	O
the	O
effect	O
of	O
molar	B-T017
loss	I-T017
and	O
powder	B-T058
diet	I-T058
on	O
memory	B-T038
function	I-T038
and	O
bdnf	B-T017
mrna	I-T017
levels	O
were	O
different	O
,	O
molar	B-T017
loss	I-T017
may	O
have	O
a	O
greater	O
long	O
-	O
term	O
effect	O
on	O
memory	B-T038
ability	I-T038
than	O
powder	B-T058
diet	I-T058
does	O
.	O

ma	B-T017
##f1	I-T017
-	O
mediated	O
regulation	B-T038
of	O
yeast	B-T204
rna	B-T103
polymerase	I-T103
iii	I-T103
is	O
correlated	O
with	O
cca	B-T038
addition	I-T038
at	I-T038
the	I-T038
3	I-T038
'	I-T038
end	I-T038
of	I-T038
trna	B-T103
precursors	I-T103
in	O
eukaryotic	B-T017
cells	I-T017
trna	B-T038
synthesis	I-T038
is	O
negatively	B-T033
regulated	B-T038
by	O
the	O
protein	B-T103
ma	I-T103
##f1	I-T103
,	O
conserved	O
from	O
yeast	B-T204
to	O
humans	B-T204
.	O
ma	B-T017
##f1	I-T017
from	O
yeast	B-T204
saccharomyces	B-T204
cerevisiae	I-T204
mediates	O
repression	B-T038
of	O
trna	B-T038
transcription	I-T038
when	O
cells	B-T017
are	O
transferred	O
from	O
medium	B-T103
with	O
glucose	B-T103
to	O
medium	B-T103
with	O
glycerol	B-T103
,	O
a	O
non	B-T038
-	I-T038
ferment	I-T038
##able	I-T038
carbon	B-T103
source	B-T033
.	O
the	O
strain	O
with	O
deleted	O
gene	B-T017
encoding	O
ma	B-T017
##f1	I-T017
(	O
ma	B-T017
##f1	I-T017
##δ	I-T017
)	O
is	O
viable	O
but	O
accumulates	O
trna	B-T103
precursors	I-T103
.	O
in	O
this	O
study	B-T062
trna	B-T103
precursors	I-T103
were	O
analysed	B-T062
by	O
rna	B-T058
-	I-T058
seq	I-T058
and	O
northern	O
hybridization	O
in	O
wild	B-T017
type	I-T017
strain	O
and	O
ma	B-T017
##f1	I-T017
##δ	I-T017
mutant	B-T017
grown	O
in	O
glucose	B-T103
medium	B-T103
or	O
upon	O
shift	O
to	O
repress	O
##ive	O
conditions	O
.	O
a	O
negative	B-T033
effect	O
of	O
ma	B-T017
##f1	I-T017
##δ	I-T017
mutant	B-T017
on	O
the	O
addition	B-T038
of	I-T038
the	I-T038
auxiliary	I-T038
cca	I-T038
nucleotides	I-T038
to	I-T038
the	I-T038
3	I-T038
'	I-T038
end	I-T038
of	I-T038
pre	I-T038
-	I-T038
trnas	I-T038
was	O
observed	O
in	O
cells	B-T017
shifted	O
to	O
unfavourable	O
growth	B-T038
conditions	O
.	O
this	O
effect	O
was	O
reduced	O
by	O
overexpression	B-T038
of	O
the	O
yeast	B-T204
cca	B-T017
##1	I-T017
gene	I-T017
encoding	O
atp	B-T103
(	I-T103
ctp	I-T103
)	I-T103
:	I-T103
trna	I-T103
nucle	I-T103
##otidyl	I-T103
##transferase	I-T103
.	O
the	O
cca	B-T082
sequence	I-T082
at	O
the	O
3	O
'	O
end	O
is	O
important	O
for	O
export	O
of	O
trna	B-T103
precursors	I-T103
from	O
the	O
nucleus	B-T017
and	O
essential	O
for	O
trna	B-T038
char	I-T038
##ging	I-T038
with	O
amino	B-T103
acids	I-T103
.	O
data	O
presented	O
here	O
indicate	O
that	O
cca	B-T038
-	I-T038
addition	I-T038
to	I-T038
intron	B-T103
-	I-T038
containing	I-T038
end	I-T038
-	I-T038
processed	I-T038
trna	I-T038
precursors	I-T038
is	O
a	O
limiting	O
step	O
in	O
trna	B-T038
maturation	I-T038
when	O
there	O
is	O
no	O
ma	B-T017
##f1	I-T017
mediated	O
rna	B-T103
polymerase	I-T103
iii	I-T103
(	O
pol	B-T103
iii	I-T103
)	O
repression	B-T038
.	O
the	O
correlation	O
between	O
cca	B-T082
synthesis	B-T038
and	O
pol	B-T103
iii	I-T103
regulation	B-T038
by	O
ma	B-T017
##f1	I-T017
could	O
be	O
important	O
in	O
coordination	O
of	O
trna	B-T038
transcription	I-T038
,	O
processing	B-T038
and	O
regulation	B-T038
of	I-T038
translation	I-T038
.	O

the	O
physiological	O
role	O
and	O
regulation	B-T038
of	O
aquaporin	B-T103
##s	I-T103
in	O
teleost	O
germ	B-T017
cells	I-T017
the	O
unic	O
##ellular	O
germ	B-T017
cells	I-T017
and	O
gamet	B-T017
##es	I-T017
of	O
ovip	B-T038
##aro	I-T038
##us	I-T038
teleost	O
##s	O
lack	O
the	O
osm	B-T038
##oreg	I-T038
##ulatory	I-T038
organs	B-T017
present	O
in	O
juveniles	O
and	O
adults	O
,	O
yet	O
during	O
development	B-T038
and	O
particularly	O
at	O
spawning	O
,	O
they	O
face	O
tremendous	O
osmotic	O
challenges	B-T033
when	O
released	O
into	O
the	O
external	B-T082
aquatic	O
environment	O
.	O
increasing	O
evidence	O
suggests	O
that	O
transmembrane	B-T103
water	I-T103
channels	I-T103
(	O
aquaporin	B-T103
##s	I-T103
)	O
evolved	O
to	O
play	O
vital	O
adaptive	O
roles	O
that	O
mitigate	O
the	O
osmotic	O
and	O
oxidative	B-T038
stress	I-T038
problems	B-T033
of	O
the	O
developing	B-T038
oocytes	B-T017
,	O
embryos	B-T017
and	O
spermatozoa	B-T017
.	O
in	O
this	O
chapter	O
,	O
we	O
provide	O
a	O
short	O
overview	O
of	O
the	O
diversity	O
of	O
the	O
aquaporin	B-T103
superfamily	O
in	O
teleost	O
##s	O
,	O
and	O
summarize	O
the	O
findings	O
that	O
uncovered	O
a	O
highly	O
specific	O
molecular	B-T038
regulation	I-T038
of	O
aquaporin	B-T103
##s	I-T103
during	O
o	B-T038
##ogenesis	I-T038
and	O
spermatogenesis	B-T038
.	O
we	O
further	O
review	O
the	O
multiple	O
functions	O
that	O
these	O
channels	B-T103
play	O
during	O
the	O
establishment	O
of	O
egg	B-T017
bu	B-T038
##oy	I-T038
##ancy	I-T038
and	O
the	O
activation	O
and	O
detoxification	B-T058
of	O
spermatozoa	B-T017
in	O
the	O
marine	B-T082
environment	B-T082
.	O

visual	O
outcome	O
,	O
endocrine	B-T038
function	I-T038
and	O
tumor	B-T038
control	O
after	O
fractionated	B-T058
stereotactic	I-T058
radiation	I-T058
therapy	I-T058
of	O
crani	B-T038
##oph	I-T038
##aryng	I-T038
##io	I-T038
##mas	I-T038
in	I-T038
adults	I-T038
:	O
findings	O
in	O
a	O
prospective	B-T062
cohort	I-T062
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
examine	B-T058
visual	O
outcome	O
,	O
endocrine	B-T038
function	I-T038
and	O
tumor	B-T038
control	O
in	O
a	O
prospective	B-T062
cohort	I-T062
of	O
crani	B-T038
##oph	I-T038
##aryng	I-T038
##io	I-T038
##ma	I-T038
patients	O
,	O
treated	B-T058
with	I-T058
fractionated	B-T058
stereotactic	I-T058
radiation	I-T058
therapy	I-T058
(	O
fs	B-T058
##rt	I-T058
)	O
.	O
sixteen	O
adult	O
patients	O
with	O
crani	B-T038
##oph	I-T038
##aryng	I-T038
##io	I-T038
##mas	I-T038
were	O
eligible	O
for	O
analysis	B-T062
.	O
they	O
were	O
treated	B-T058
with	I-T058
linear	B-T074
accelerator	I-T074
-	I-T074
based	I-T074
fs	B-T058
##rt	I-T058
during	O
1999	O
-	O
2015	O
.	O
in	O
all	O
cases	O
,	O
diagnosis	B-T062
was	O
confirmed	O
by	O
histological	O
analysis	B-T062
.	O
the	O
prescription	B-T058
dose	O
to	O
the	O
tumor	B-T038
was	O
54	O
gy	O
(	O
median	O
,	O
range	O
48	O
-	O
54	O
)	O
in	O
1	O
.	O
8	O
or	O
2	O
.	O
0	O
gy	O
per	O
fraction	O
,	O
and	O
the	O
maximum	O
radiation	O
dose	O
to	O
the	O
optic	B-T017
nerves	I-T017
and	O
chi	B-T017
##asm	I-T017
was	O
54	O
.	O
2	O
gy	O
(	O
median	O
,	O
range	O
48	O
.	O
6	O
-	O
60	O
.	O
0	O
)	O
for	O
the	O
cohort	B-T098
.	O
serial	O
ophthalm	B-T058
##ological	I-T058
and	O
endocrine	B-T058
evaluations	I-T058
and	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
scans	B-T058
were	O
performed	O
at	O
regular	O
intervals	O
.	O
median	O
follow	B-T058
-	I-T058
up	I-T058
was	O
3	O
.	O
3	O
years	O
(	O
range	O
1	O
.	O
1	O
-	O
14	O
.	O
1	O
)	O
,	O
3	O
.	O
7	O
years	O
(	O
range	O
0	O
.	O
8	O
-	O
15	O
.	O
2	O
)	O
,	O
and	O
3	O
.	O
6	O
years	O
(	O
range	O
0	O
.	O
7	O
-	O
13	O
.	O
1	O
)	O
for	O
visual	O
outcome	O
,	O
endocrine	B-T038
function	I-T038
,	O
and	O
tumor	B-T038
control	O
,	O
respectively	O
.	O
visual	B-T201
acuity	I-T201
impairment	O
was	O
present	O
in	O
10	O
patients	O
(	O
62	O
.	O
5	O
%	O
)	O
and	O
visual	B-T033
field	I-T033
defects	I-T033
were	O
present	O
in	O
12	O
patients	O
(	O
75	O
%	O
)	O
before	O
fs	B-T058
##rt	I-T058
.	O
one	O
patient	O
developed	O
radiation	B-T038
-	I-T038
induced	I-T038
optic	I-T038
neuropathy	I-T038
at	O
seven	O
years	O
after	O
fs	B-T058
##rt	I-T058
.	O
thirteen	O
of	O
16	O
patients	O
(	O
81	O
.	O
3	O
%	O
)	O
had	O
pituitary	B-T038
deficiency	I-T038
before	O
fs	B-T058
##rt	I-T058
,	O
and	O
did	O
not	O
develop	O
further	O
pituitary	B-T038
deficiency	I-T038
after	O
fs	B-T058
##rt	I-T058
.	O
mean	O
tumor	O
volume	O
pre	O
-	O
fs	B-T058
##rt	I-T058
was	O
2	O
.	O
72	O
cm	O
(	O
3	O
)	O
(	O
range	O
0	O
.	O
20	O
-	O
9	O
.	O
90	O
)	O
and	O
post	O
-	O
fs	B-T058
##rt	I-T058
1	O
.	O
2	O
cm	O
(	O
3	O
)	O
(	O
range	O
0	O
.	O
00	O
-	O
13	O
.	O
10	O
)	O
.	O
tumor	B-T038
control	O
rate	O
was	O
81	O
.	O
3	O
%	O
at	O
two	O
,	O
five	O
,	O
and	O
10	O
years	O
after	O
fs	B-T058
##rt	I-T058
.	O
fs	B-T058
##rt	I-T058
was	O
relatively	O
safe	O
in	O
this	O
prospective	O
cohort	B-T098
of	O
crani	B-T038
##oph	I-T038
##aryng	I-T038
##io	I-T038
##mas	I-T038
,	O
with	O
only	O
one	O
case	O
of	O
radiation	B-T038
-	I-T038
induced	I-T038
optic	I-T038
neuropathy	I-T038
and	O
no	O
case	O
of	O
new	O
endocrin	B-T038
##opathy	I-T038
.	O
tumor	B-T038
control	O
rate	O
was	O
acceptable	O
.	O

entrapment	B-T038
of	O
the	O
posterior	B-T017
femoral	I-T017
cutaneous	I-T017
nerve	I-T017
and	O
its	O
inferior	B-T017
cl	I-T017
##une	I-T017
##al	I-T017
branches	I-T017
:	O
anatomical	B-T082
basis	I-T082
of	O
surgery	B-T091
for	O
inferior	B-T033
cl	I-T033
##une	I-T033
##al	I-T033
neuralgia	I-T033
the	O
apparent	O
failure	O
of	O
pud	B-T017
##end	I-T017
##al	I-T017
nerve	I-T017
surgery	B-T091
in	O
some	O
patients	O
has	O
led	O
us	O
to	O
suggest	O
the	O
possibility	O
of	O
entrapment	B-T038
of	O
other	O
adjacent	B-T017
nerve	I-T017
structures	I-T017
,	O
leading	O
to	O
the	O
concept	O
of	O
inferior	B-T033
cl	I-T033
##une	I-T033
##al	I-T033
neuralgia	I-T033
.	O
via	O
its	O
numerous	O
collateral	B-T017
branches	I-T017
,	O
the	O
posterior	B-T017
femoral	I-T017
cutaneous	I-T017
nerve	I-T017
innerv	O
##ates	O
a	O
very	O
extensive	O
territory	O
including	O
the	O
posterior	B-T082
surface	I-T082
of	I-T082
the	I-T082
thigh	I-T082
,	O
the	O
infra	B-T017
##glut	I-T017
##eal	I-T017
fold	I-T017
,	O
the	O
skin	B-T022
over	O
the	O
isch	B-T017
##ial	I-T017
tuber	I-T017
##osity	I-T017
,	O
but	O
also	O
the	O
lateral	B-T082
anal	I-T082
region	I-T082
,	O
scr	B-T017
##ot	I-T017
##um	I-T017
or	O
lab	B-T017
##ium	I-T017
maj	I-T017
##us	I-T017
via	O
its	O
perineal	B-T017
branch	I-T017
.	O
we	O
described	O
the	O
pathophysiological	O
features	O
of	O
cl	B-T033
##une	I-T033
##al	I-T033
neuralgia	I-T033
,	O
the	O
surgical	B-T058
technique	I-T058
and	O
our	O
preliminary	O
results	O
.	O
we	O
performed	O
a	O
transm	B-T058
##uscular	I-T058
approach	I-T058
leading	O
to	O
the	O
fat	B-T017
of	O
the	O
deep	O
glute	B-T082
##al	I-T082
region	I-T082
.	O
exploration	B-T058
was	O
continued	O
cranial	O
##ly	O
undern	O
##ea	O
##th	O
the	O
pir	B-T017
##iformis	I-T017
,	O
looking	O
for	O
potential	O
entrapment	B-T038
##s	I-T038
affecting	O
the	O
posterior	B-T017
femoral	I-T017
cutaneous	I-T017
nerve	I-T017
and	O
the	O
sciatic	B-T017
nerve	I-T017
.	O
nerve	B-T058
decompression	I-T058
on	O
the	O
lateral	B-T082
surface	I-T082
of	O
the	O
isch	B-T017
##ial	I-T017
tuber	I-T017
##osity	I-T017
was	O
then	O
performed	O
.	O
a	O
constant	O
anatomical	B-T082
finding	I-T082
must	O
be	O
highlighted	O
:	O
the	O
presence	O
of	O
a	O
lateral	B-T017
fibrous	I-T017
expansion	B-T058
from	O
the	O
isch	B-T017
##ium	I-T017
passing	O
behind	O
the	O
nerves	B-T017
and	O
vessels	B-T017
,	O
especially	O
the	O
posterior	B-T017
femoral	I-T017
cutaneous	I-T017
nerve	I-T017
and	O
its	O
perineal	B-T017
branches	I-T017
.	O
in	O
our	O
patients	O
,	O
release	O
of	O
this	O
expansion	B-T058
allowed	O
decompression	B-T058
of	O
the	O
nerve	B-T038
trapped	I-T038
by	O
this	O
expansion	B-T058
.	O
cl	B-T033
##une	I-T033
##al	I-T033
neuralgia	I-T033
constitutes	O
a	O
distinct	O
entity	O
of	O
perineal	B-T033
pain	I-T033
,	O
which	O
must	O
be	O
identified	O
and	O
distinguished	O
from	O
pud	B-T038
##end	I-T038
##al	I-T038
neuralgia	I-T038
.	O
surgery	B-T091
should	O
be	O
performed	O
via	O
a	O
transglut	B-T082
##eal	I-T082
approach	I-T082
.	O
a	O
lateral	B-T017
isch	I-T017
##ial	I-T017
obstacle	O
must	O
be	O
investigated	O
,	O
in	O
the	O
form	O
of	O
a	O
constant	O
fibrous	B-T017
expansion	B-T058
,	O
which	O
,	O
like	O
a	O
retina	B-T017
##cu	I-T017
##lu	I-T017
##m	I-T017
,	O
can	O
cause	O
nerve	B-T038
entrapment	I-T038
.	O

fragment	B-T103
-	O
based	O
discovery	O
of	O
5	B-T103
-	I-T103
aryl	I-T103
##isa	I-T103
##tin	I-T103
-	O
based	O
inhibitors	B-T103
of	O
matrix	B-T103
metalloproteinases	I-T103
2	I-T103
and	O
13	B-T103
matrix	B-T103
metalloproteinases	I-T103
(	O
mmps	B-T103
)	O
are	O
well	O
-	O
established	O
targets	O
for	O
several	O
pathologies	B-T038
.	O
in	O
particular	O
,	O
mmp	B-T103
-	I-T103
2	I-T103
and	O
mmp	B-T103
-	I-T103
13	I-T103
play	O
a	O
prominent	O
role	O
in	O
cancer	B-T038
progression	I-T038
.	O
in	O
this	O
study	B-T062
,	O
a	O
structure	B-T058
-	I-T058
based	I-T058
screening	I-T058
campaign	O
was	O
applied	O
to	O
priori	O
##ti	O
##ze	O
metalloproteinase	B-T103
-	O
oriented	O
fragments	B-T103
.	O
this	O
computational	O
model	O
was	O
applied	O
to	O
a	O
representative	O
fragment	B-T103
set	O
from	O
the	O
public	O
##ally	O
available	O
ed	B-T170
##as	I-T170
##a	I-T170
scientific	I-T170
compound	I-T170
library	I-T170
.	O
these	O
fragments	B-T103
were	O
priori	O
##ti	O
##zed	O
,	O
and	O
the	O
top	O
-	O
ranking	O
hits	O
were	O
tested	O
in	O
a	O
biological	B-T058
assay	I-T058
to	O
validate	B-T062
the	O
model	O
.	O
two	O
scaffolds	B-T103
showed	O
consistent	O
activity	O
in	O
the	O
assay	B-T058
,	O
and	O
the	O
is	B-T103
##atin	I-T103
-	I-T103
based	I-T103
compounds	I-T103
were	O
the	O
most	O
interesting	O
.	O
these	O
latter	O
fragments	B-T103
have	O
significant	O
potential	O
as	O
tools	O
for	O
the	O
design	O
and	O
realization	O
of	O
novel	O
mmp	B-T103
inhibitors	I-T103
.	O
in	O
addition	O
to	O
their	O
micromolar	O
activity	O
,	O
the	O
chemical	O
synthesis	O
affords	O
flexible	O
and	O
creative	B-T082
access	I-T082
to	O
their	O
analogues	B-T103
.	O

a	O
neuronal	B-T017
pi	B-T103
(	I-T103
3	I-T103
,	I-T103
4	I-T103
,	I-T103
5	I-T103
)	I-T103
p3	I-T103
-	O
dependent	O
program	O
of	O
oligodendrocyte	B-T017
precursor	O
recruitment	O
and	O
myelination	B-T038
the	O
molecular	B-T038
trigger	I-T038
of	O
cns	B-T022
myelination	B-T038
is	O
unknown	O
.	O
by	O
targeting	O
pten	B-T103
in	O
cerebellar	B-T017
granule	I-T017
cells	I-T017
and	O
activating	O
the	O
akt	B-T103
##1	I-T103
-	O
mtor	B-T103
pathway	B-T038
,	O
we	O
increased	O
the	O
cal	O
##iber	O
of	O
normally	O
unm	B-T017
##yelinated	I-T017
axons	I-T017
and	O
the	O
expression	B-T038
of	O
numerous	O
genes	B-T017
encoding	O
regulatory	B-T103
proteins	I-T103
.	O
this	O
led	O
to	O
the	O
expansion	B-T038
of	O
genetically	B-T017
wild	I-T017
-	I-T017
type	I-T017
oligodendrocyte	B-T017
progenitor	B-T017
cells	I-T017
,	O
oligodendrocyte	B-T017
differentiation	B-T038
and	O
de	O
novo	O
myelination	B-T038
of	O
parallel	B-T017
fibers	I-T017
.	O
thus	O
,	O
a	O
neuronal	B-T017
program	O
dependent	O
on	O
the	O
phosphoinositide	B-T103
pi	B-T103
(	I-T103
3	I-T103
,	I-T103
4	I-T103
,	I-T103
5	I-T103
)	I-T103
p3	I-T103
is	O
sufficient	O
to	O
trigger	B-T038
all	O
steps	O
of	O
myelination	B-T038
.	O

spontaneous	B-T038
activity	I-T038
is	O
correlated	O
with	O
coding	O
density	O
in	O
primary	B-T082
auditory	I-T082
cortex	I-T082
sensory	B-T017
neurons	I-T017
across	O
sensory	O
modalities	O
and	O
specific	O
processing	O
areas	O
have	O
diverse	O
levels	O
of	O
spontaneous	O
firing	O
rates	O
(	O
sf	O
##rs	O
)	O
in	O
the	O
absence	O
of	O
sensory	O
stimuli	O
.	O
however	O
,	O
the	O
functional	O
significance	O
of	O
this	O
spontaneous	B-T038
activity	I-T038
is	O
not	O
well	O
-	O
understood	O
.	O
previous	O
studies	B-T062
in	O
the	O
auditory	B-T022
system	I-T022
have	O
demonstrated	O
that	O
different	O
levels	O
of	O
spontaneous	B-T038
activity	I-T038
are	O
correlated	O
with	O
a	O
variety	O
of	O
physiological	O
and	O
anatomic	O
properties	O
,	O
suggesting	O
that	O
neurons	B-T017
with	O
differing	O
sf	O
##rs	O
make	O
unique	O
contributions	O
to	O
the	O
encoding	O
of	O
auditory	B-T038
stimuli	I-T038
.	O
additionally	O
,	O
altered	O
sf	O
##rs	O
are	O
a	O
correlate	O
of	O
tinnitus	B-T033
,	O
arising	O
in	O
several	O
auditory	B-T017
areas	I-T017
after	O
exposure	O
to	O
ot	O
##otoxic	O
substances	O
and	O
noise	O
trauma	B-T037
.	O
in	O
this	O
study	B-T062
,	O
we	O
recorded	O
single	O
-	O
unit	O
activity	O
from	O
primary	B-T082
auditory	I-T082
cortex	I-T082
of	O
awake	O
marmos	B-T204
##et	I-T204
monkeys	B-T204
while	O
delivering	O
wide	O
-	O
band	O
random	O
-	O
spectrum	O
stimuli	O
and	O
white	B-T170
gaussian	I-T170
noise	I-T170
(	O
wg	B-T170
##n	I-T170
)	O
to	O
examine	O
any	O
divergence	B-T082
##s	I-T082
in	O
stimulus	O
encoding	O
properties	O
across	O
sf	O
##r	O
classes	O
.	O
we	O
found	O
that	O
higher	O
levels	O
of	O
spontaneous	B-T038
activity	I-T038
were	O
associated	O
with	O
both	O
higher	O
levels	O
of	O
activation	O
relative	O
to	O
suppression	O
across	O
a	O
variety	O
of	O
wide	O
-	O
band	O
stimuli	O
and	O
higher	O
driven	O
rates	O
in	O
response	O
to	O
wg	B-T170
##n	I-T170
.	O
moreover	O
,	O
response	O
latencies	O
to	O
wg	B-T170
##n	I-T170
were	O
negatively	O
correlated	O
with	O
the	O
level	O
of	O
activation	O
in	O
response	O
to	O
both	O
stimulus	O
types	O
.	O
these	O
findings	O
are	O
consistent	O
with	O
a	O
novel	O
view	O
of	O
the	O
role	O
spontaneous	B-T038
spiking	I-T038
may	O
play	O
during	O
normal	O
stimulus	O
processing	O
in	O
primary	B-T082
auditory	I-T082
cortex	I-T082
and	O
how	O
it	O
may	O
malfunction	O
in	O
cases	O
of	O
tinnitus	B-T033
.	O

spine	B-T037
fracture	I-T037
prevalence	O
in	O
a	O
nationally	O
representative	O
sample	O
of	O
us	B-T082
women	B-T098
and	O
men	B-T098
aged	O
≥	O
##40	O
years	O
:	O
results	O
from	O
the	O
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
(	O
nh	B-T062
##anes	I-T062
)	O
2013	O
-	O
2014	O
spine	B-T037
fracture	I-T037
prevalence	O
is	O
similar	O
in	O
men	B-T098
and	O
women	B-T098
,	O
increasing	O
from	O
<	O
5	O
%	O
in	O
those	O
<	O
60	O
to	O
11	O
%	O
in	O
those	O
70	O
-	O
79	O
and	O
18	O
%	O
in	O
those	O
≥	O
##80	O
years	O
.	O
prevalence	O
was	O
higher	O
with	O
age	O
,	O
lower	O
bone	B-T201
mineral	I-T201
density	I-T201
(	O
bmd	B-T201
)	O
,	O
and	O
in	O
those	O
meeting	O
criteria	O
for	O
spine	B-T058
imaging	I-T058
.	O
most	O
subjects	B-T062
with	O
spine	B-T037
fractures	I-T037
were	O
unaware	B-T033
of	O
them	O
.	O
spine	B-T037
fractures	I-T037
have	O
substantial	O
medical	O
significance	O
but	O
are	O
seldom	O
recognized	O
.	O
this	O
study	O
collected	O
contemporary	O
nationally	O
representative	O
spine	B-T037
fracture	I-T037
prevalence	O
data	O
.	O
cross	B-T062
-	I-T062
sectional	I-T062
analysis	I-T062
of	O
333	O
##0	O
us	B-T082
adults	O
aged	O
≥	O
##40	O
years	O
participating	O
in	O
nh	B-T062
##anes	I-T062
2013	O
-	O
2014	O
with	O
evaluable	O
vertebral	B-T037
fracture	I-T037
assessment	O
(	O
vf	B-T058
##a	I-T058
)	O
.	O
vf	B-T058
##a	I-T058
was	O
graded	O
by	O
semiquantitative	O
measurement	O
.	O
bmd	B-T201
and	O
an	O
osteoporosis	B-T038
questionnaire	B-T170
were	O
collected	O
.	O
overall	O
spine	B-T037
fracture	I-T037
prevalence	O
was	O
5	O
.	O
4	O
%	O
and	O
similar	O
in	O
men	B-T098
and	O
women	B-T098
.	O
prevalence	O
increased	O
with	O
age	O
from	O
<	O
5	O
%	O
in	O
those	O
<	O
60	O
to	O
11	O
%	O
in	O
those	O
70	O
-	O
79	O
and	O
18	O
%	O
in	O
those	O
≥	O
##80	O
years	O
.	O
fractures	B-T037
were	O
more	O
common	O
in	O
non	B-T098
-	I-T098
hispanic	I-T098
whites	I-T098
and	O
in	O
people	O
with	O
lower	O
body	B-T201
mass	I-T201
index	I-T201
and	O
bmd	B-T201
.	O
among	O
subjects	B-T062
with	O
spine	B-T037
fracture	I-T037
,	O
26	O
%	O
met	O
bmd	B-T201
criteria	O
for	O
osteoporosis	B-T038
.	O
prevalence	O
was	O
higher	O
in	O
subjects	B-T062
who	O
met	O
national	O
osteoporosis	O
foundation	O
(	O
no	O
##f	O
)	O
criteria	O
for	O
spine	B-T058
imaging	I-T058
(	O
14	O
vs	O
4	O
.	O
7	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
only	O
8	O
%	O
of	O
people	O
with	O
a	O
spine	B-T037
fracture	I-T037
diagnosed	B-T033
by	O
vf	B-T058
##a	I-T058
had	O
a	O
self	B-T062
-	I-T062
reported	I-T062
fracture	B-T037
,	O
and	O
among	O
those	O
who	O
self	B-T062
-	I-T062
reported	I-T062
a	O
spine	B-T037
fracture	I-T037
,	O
only	O
21	O
%	O
were	O
diagnosed	B-T033
with	O
fracture	B-T037
by	O
vf	B-T058
##a	I-T058
.	O
spine	B-T037
fracture	I-T037
prevalence	O
is	O
similar	O
in	O
women	B-T098
and	O
men	B-T098
and	O
increases	O
with	O
age	O
and	O
lower	O
bmd	B-T201
,	O
although	O
most	O
subjects	B-T062
with	O
spine	B-T037
fracture	I-T037
do	O
not	O
meet	O
bmd	B-T201
criteria	O
for	O
osteoporosis	B-T038
.	O
since	O
most	O
(	O
>	O
90	O
%	O
)	O
individuals	B-T098
were	O
unaware	B-T033
of	O
their	O
spine	B-T037
fractures	I-T037
,	O
lateral	B-T082
spine	B-T058
imaging	I-T058
is	O
needed	O
to	O
identify	O
these	O
women	B-T098
and	O
men	B-T098
.	O
spine	B-T037
fracture	I-T037
prevalence	O
was	O
threefold	O
higher	O
in	O
individuals	B-T098
meeting	O
no	O
##f	O
criteria	O
for	O
spine	B-T058
imaging	I-T058
(	O
∼	O
##1	O
in	O
7	O
undergoing	O
vf	B-T058
##a	I-T058
)	O
.	O
identifying	O
spine	B-T037
fractures	I-T037
as	O
part	O
of	O
comprehensive	O
risk	B-T058
assessment	I-T058
may	O
improve	B-T033
clinical	B-T058
decision	I-T058
making	I-T058
.	O

pulmonary	B-T038
function	I-T038
and	O
health	O
-	O
related	O
quality	O
of	O
life	O
1	O
-	O
year	O
follow	B-T058
up	I-T058
after	O
cardiac	B-T058
surgery	I-T058
pulmonary	B-T038
function	I-T038
is	O
severely	O
reduced	O
in	O
the	O
early	O
period	O
after	O
cardiac	B-T058
surgery	I-T058
,	O
and	O
impairments	B-T038
have	O
been	O
described	O
up	O
to	O
4	O
-	O
6	O
months	O
after	O
surgery	O
.	O
evaluation	B-T058
of	O
pulmonary	B-T038
function	I-T038
in	O
a	O
longer	O
perspective	O
is	O
lacking	O
.	O
in	O
this	O
prospective	B-T062
study	I-T062
pulmonary	B-T038
function	I-T038
and	O
health	O
-	O
related	O
quality	O
of	O
life	O
were	O
investigated	O
1	O
year	O
after	O
cardiac	B-T058
surgery	I-T058
.	O
pulmonary	B-T038
function	I-T038
measurements	O
,	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
sf	B-T170
-	I-T170
36	I-T170
)	O
,	O
dyspnoea	B-T033
,	O
subjective	O
breathing	B-T038
and	O
cough	B-T033
##ing	I-T033
ability	O
and	O
pain	B-T033
were	O
evaluated	B-T058
before	O
and	O
1	O
year	O
after	O
surgery	O
in	O
150	O
patients	O
undergoing	O
coronary	B-T058
artery	I-T058
bypass	I-T058
grafting	I-T058
,	O
valve	B-T058
surgery	I-T058
or	O
combined	O
surgery	B-T058
.	O
one	O
year	O
after	O
surgery	O
the	O
forced	B-T201
vital	I-T201
capacity	I-T201
and	O
forced	B-T038
expiratory	I-T038
volume	I-T038
in	O
1	O
s	O
were	O
significantly	O
decreased	O
(	O
by	O
4	O
-	O
5	O
%	O
)	O
compared	O
to	O
preoperative	O
values	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
saturation	B-T038
of	I-T038
peripheral	I-T038
oxygen	I-T038
was	O
unchanged	B-T033
1	O
year	O
postoperatively	O
compared	O
to	O
baseline	O
.	O
a	O
significantly	O
improved	B-T033
health	O
-	O
related	O
quality	O
of	O
life	O
was	O
found	O
1	O
year	O
after	O
surgery	O
,	O
with	O
improvements	O
in	O
all	O
eight	O
aspects	O
of	O
sf	B-T170
-	I-T170
36	I-T170
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
sternotomy	B-T058
-	O
related	O
pain	B-T033
was	O
low	O
1	O
year	O
postoperatively	O
at	O
rest	O
(	O
median	O
0	O
[	O
min	O
-	O
max	O
;	O
0	O
-	O
7	O
]	O
)	O
,	O
while	O
taking	O
a	O
deep	B-T033
breath	I-T033
(	O
0	O
[	O
0	O
-	O
4	O
]	O
)	O
and	O
while	O
cough	B-T033
##ing	I-T033
(	O
0	O
[	O
0	O
-	O
8	O
]	O
)	O
.	O
a	O
more	O
pronounced	O
decrease	O
in	O
pulmonary	B-T038
function	I-T038
was	O
associated	O
with	O
dyspnoea	B-T033
limitations	O
and	O
impaired	B-T038
subjective	O
breathing	B-T038
and	O
cough	B-T033
##ing	I-T033
ability	O
.	O
one	O
year	O
after	O
cardiac	B-T058
surgery	I-T058
static	O
and	O
dynamic	O
lung	B-T058
function	I-T058
measurements	I-T058
were	O
slightly	O
decreased	O
,	O
while	O
health	O
-	O
related	O
quality	O
of	O
life	O
was	O
improved	B-T033
in	O
comparison	O
to	O
preoperative	O
values	O
.	O
measured	O
levels	O
of	O
pain	B-T033
were	O
low	O
and	O
saturation	B-T038
of	I-T038
peripheral	I-T038
oxygen	I-T038
was	O
same	O
as	O
preoperatively	O
.	O

musculoskeletal	B-T033
pain	I-T033
profile	B-T170
of	O
obese	B-T038
individuals	B-T098
attending	O
a	O
multidisciplinary	O
weight	O
management	O
service	O
obesity	B-T038
is	O
associated	O
with	O
numerous	O
chronic	B-T038
diseases	I-T038
,	O
including	O
musculoskeletal	B-T033
(	I-T033
ms	I-T033
##k	I-T033
)	I-T033
pain	I-T033
,	O
which	O
impacts	O
on	O
quality	O
of	O
life	O
(	O
qol	O
)	O
.	O
there	O
is	O
,	O
however	O
,	O
limited	O
research	O
providing	O
a	O
comprehensive	O
ms	B-T033
##k	I-T033
pain	I-T033
profile	B-T170
of	O
an	O
obese	B-T038
cohort	B-T098
.	O
this	O
retrospective	B-T062
study	I-T062
utilized	O
a	O
patient	O
database	B-T170
at	O
a	O
national	O
weight	O
management	O
service	O
(	O
wm	O
##s	O
)	O
.	O
following	O
ethical	O
approval	B-T170
,	O
an	O
##onym	O
##ized	O
patient	O
data	O
were	O
statistically	O
analyzed	O
to	O
develop	O
a	O
pain	B-T033
profile	B-T170
,	O
investigate	O
relationships	O
between	O
pain	B-T033
,	O
sleep	B-T038
,	O
and	O
function	B-T033
,	O
and	O
explore	O
variables	O
associated	O
with	O
having	O
low	B-T033
back	I-T033
pain	I-T033
(	O
lbp	B-T033
)	O
and	O
knee	B-T033
pain	I-T033
.	O
overall	O
,	O
91	O
##5	O
individuals	B-T098
attended	O
the	O
wm	O
##s	O
from	O
january	O
2011	O
to	O
september	O
2015	O
[	O
male	B-T098
,	O
35	O
%	O
(	O
n	O
=	O
318	O
;	O
ci	O
=	O
32	O
-	O
38	O
)	O
;	O
female	B-T098
,	O
65	O
%	O
(	O
n	O
=	O
59	O
##7	O
;	O
ci	O
=	O
62	O
-	O
68	O
)	O
;	O
mean	O
age	O
44	O
.	O
6	O
]	O
.	O
mean	O
bmi	B-T201
was	O
50	O
.	O
7	O
kg	O
/	O
m2	O
[	O
class	O
iii	O
obese	B-T038
(	O
bmi	B-T201
≥	O
##40	O
kg	O
/	O
m2	O
)	O
,	O
92	O
%	O
(	O
n	O
=	O
83	O
##5	O
;	O
ci	O
=	O
91	O
-	O
94	O
)	O
]	O
.	O
approximately	O
91	O
%	O
reported	O
ms	B-T033
##k	I-T033
pain	I-T033
:	O
lbp	B-T033
,	O
69	O
%	O
(	O
n	O
=	O
53	O
##9	O
;	O
ci	O
=	O
65	O
-	O
72	O
)	O
[	O
mean	O
nrs	O
7	O
.	O
4	O
]	O
;	O
knee	B-T033
pain	I-T033
,	O
58	O
%	O
(	O
n	O
=	O
44	O
##7	O
;	O
ci	O
=	O
55	O
-	O
61	O
)	O
[	O
mean	O
nrs	O
6	O
.	O
8	O
]	O
.	O
class	O
iii	O
obese	B-T038
and	O
multi	O
-	O
site	O
pain	B-T033
patients	O
had	O
lower	O
qol	O
and	O
physical	O
activity	O
levels	O
,	O
reduced	O
sleep	B-T038
,	O
and	O
poorer	O
physical	B-T033
function	I-T033
than	O
less	O
obese	B-T038
patients	O
and	O
those	O
without	O
pain	B-T033
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
relationships	O
were	O
found	O
between	O
demographic	O
,	O
pain	B-T033
,	O
self	B-T062
-	I-T062
report	I-T062
,	O
psychological	O
,	O
and	O
functional	O
measures	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
patients	O
who	O
sle	B-T033
##pt	I-T033
fewer	I-T033
hours	I-T033
and	O
had	O
poorer	O
functional	B-T033
outcomes	I-T033
were	O
more	O
likely	O
to	O
have	O
lbp	B-T033
;	O
patients	O
who	O
were	O
divor	B-T033
##ced	I-T033
,	O
had	O
lower	O
qol	O
,	O
and	O
more	O
frequent	O
noct	B-T038
##uria	I-T038
were	O
more	O
likely	O
to	O
have	O
knee	B-T033
pain	I-T033
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
multi	O
-	O
site	O
ms	B-T033
##k	I-T033
pain	I-T033
is	O
prevalent	O
and	O
severe	O
in	O
obese	B-T038
patients	O
and	O
is	O
negatively	B-T033
associated	O
with	O
most	O
self	O
-	O
report	O
and	O
functional	B-T033
outcomes	I-T033
.	O
this	O
high	O
prevalence	O
suggests	O
pain	B-T058
management	I-T058
strategies	O
must	O
be	O
considered	O
when	O
treating	B-T058
obesity	B-T038
.	O

neurotrophin	B-T103
##s	I-T103
and	O
specific	B-T103
receptors	I-T103
in	O
the	O
oviduct	B-T017
tracts	I-T017
of	O
japanese	B-T204
quail	I-T204
(	O
cot	B-T204
##urn	I-T204
##ix	I-T204
cot	I-T204
##urn	I-T204
##ix	I-T204
japonica	I-T204
)	O
neurotrophin	B-T103
##s	I-T103
(	O
ngf	B-T103
,	O
bdnf	B-T103
and	O
nt	B-T103
-	I-T103
3	I-T103
)	O
and	O
their	O
specific	B-T103
receptors	I-T103
(	O
tr	B-T103
##ka	I-T103
,	O
trkb	B-T103
and	O
tr	B-T103
##kc	I-T103
)	O
were	O
studied	B-T062
in	O
the	O
oviduct	B-T017
of	O
egg	B-T038
laying	I-T038
quail	B-T204
##s	I-T204
.	O
neurotrophin	B-T103
##s	I-T103
(	O
nts	B-T103
)	O
are	O
mainly	O
involved	O
in	O
the	O
development	O
and	O
maintenance	O
of	O
neuronal	B-T017
populations	I-T017
in	O
the	O
central	B-T022
and	O
peripheral	B-T022
nervous	I-T022
system	I-T022
,	O
but	O
also	O
in	O
reproductive	B-T022
system	I-T022
.	O
in	O
this	O
survey	O
,	O
we	O
first	O
studied	B-T062
the	O
morphological	O
organization	B-T038
of	O
the	O
quail	B-T204
oviduct	B-T017
,	O
distinguished	O
in	O
inf	B-T017
##und	I-T017
##ib	I-T017
##ulum	I-T017
,	O
magn	B-T017
##um	I-T017
,	O
isthmus	B-T017
,	O
uterus	B-T017
and	O
vagina	B-T017
,	O
and	O
then	O
we	O
analyzed	B-T062
the	O
expression	B-T038
and	O
localization	B-T038
of	O
nts	B-T103
and	O
tr	B-T103
##ks	I-T103
receptors	I-T103
in	O
the	O
whole	O
tracts	B-T017
.	O
by	O
western	B-T058
blotting	I-T058
we	O
detected	O
that	O
the	O
investigated	O
nts	B-T103
and	O
tr	B-T103
##ks	I-T103
receptors	I-T103
are	O
expressed	B-T038
in	O
all	O
oviduct	B-T017
##al	I-T017
tracts	I-T017
.	O
by	O
immunohistochemistry	B-T058
we	O
were	O
able	O
to	O
define	O
the	O
distribution	O
of	O
nts	B-T103
and	O
tr	B-T103
##ks	I-T103
.	O
specifically	O
,	O
ngf	B-T103
,	O
bdnf	B-T103
and	O
nt	B-T103
##3	I-T103
were	O
localized	O
in	O
lining	O
and	O
ductal	B-T017
epithelial	I-T017
cells	I-T017
,	O
and	O
ngf	B-T103
was	O
also	O
detected	O
in	O
secretory	B-T017
cells	I-T017
of	O
tubular	B-T017
glands	I-T017
and	O
in	O
nervous	B-T017
fibers	I-T017
of	O
vessel	B-T017
wall	I-T017
.	O
tr	B-T103
##ka	I-T103
and	O
trkb	B-T103
were	O
present	O
in	O
the	O
lining	O
and	O
ductal	B-T017
epithelium	I-T017
;	O
tr	B-T103
##ka	I-T103
and	O
tr	B-T103
##kc	I-T103
were	O
present	O
in	O
nervous	B-T017
fibers	I-T017
of	O
vessel	B-T017
wall	I-T017
in	O
all	O
oviduct	B-T017
##al	I-T017
tracts	I-T017
.	O
furthermore	O
,	O
we	O
also	O
observed	O
ngf	B-T103
and	O
bdnf	B-T103
co	O
-	O
localized	O
with	O
tr	B-T103
##ka	I-T103
and	O
trkb	B-T103
in	O
cells	B-T017
of	O
the	O
lining	O
and	O
ductal	B-T017
epithelium	I-T017
,	O
suggesting	O
an	O
autocrine	O
mechanism	O
of	O
action	O
.	O

evaluation	O
of	O
math	O
##isen	O
'	O
s	O
technique	O
for	O
ureteral	B-T058
re	I-T058
##implantation	I-T058
in	O
children	O
with	O
primary	O
vesico	B-T038
##ureter	I-T038
##al	I-T038
reflux	I-T038
although	O
cross	B-T058
-	I-T058
trig	I-T058
##onal	I-T058
ureteral	I-T058
re	I-T058
##implantation	I-T058
(	I-T058
cohen	I-T058
)	I-T058
is	O
a	O
commonly	O
used	O
technique	O
in	O
children	O
,	O
it	O
represents	O
a	O
non	B-T038
-	I-T038
physiological	I-T038
transfer	I-T038
of	O
the	O
ureteral	B-T082
orifice	I-T082
##s	I-T082
and	O
may	O
prove	O
challenging	O
with	O
regard	O
to	O
endoscopic	B-T058
ureteral	I-T058
operations	I-T058
in	O
later	O
life	O
.	O
in	O
196	O
##4	O
,	O
math	O
##isen	O
described	O
an	O
alternative	O
method	O
of	O
ureteral	B-T058
re	I-T058
##implantation	I-T058
with	O
lateralization	O
of	O
the	O
neo	O
##hi	O
##atus	O
,	O
creating	O
an	O
orthotopic	B-T082
course	O
of	O
the	O
submucosal	B-T017
ureter	I-T017
.	O
we	O
have	O
evaluated	O
success	O
and	O
complication	O
rates	O
of	O
both	O
techniques	O
that	O
were	O
applied	O
sequentially	O
at	O
our	O
departments	B-T092
.	O
forty	O
-	O
eight	O
consecutive	O
patients	O
(	O
83	O
ureter	B-T098
##s	I-T098
,	O
24	O
males	B-T098
/	O
24	O
females	B-T098
)	O
following	O
math	B-T058
##isen	I-T058
re	I-T058
##implantation	I-T058
were	O
compared	O
with	O
53	O
consecutive	O
patients	O
(	O
98	O
ureter	B-T098
##s	I-T098
,	O
30	O
males	B-T098
/	O
23	O
females	B-T098
)	O
following	O
cohen	B-T058
re	I-T058
##implantation	I-T058
.	O
inclusion	O
criteria	O
were	O
primary	O
vesico	B-T038
##ureter	I-T038
##al	I-T038
reflux	I-T038
(	O
v	B-T038
##ur	I-T038
)	O
and	O
no	O
previous	O
intervention	B-T058
.	O
reflux	B-T038
grades	B-T170
(	O
math	O
##isen	O
58	O
ureter	B-T098
##s	I-T098
/	O
69	O
.	O
9	O
%	O
v	B-T033
##ur	I-T033
≥	I-T033
iii	I-T033
;	O
cohen	O
66	O
ureter	B-T098
##s	I-T098
/	O
66	O
.	O
7	O
%	O
v	B-T033
##ur	I-T033
≥	I-T033
iii	I-T033
)	O
and	O
the	O
occur	O
##ence	O
of	O
other	O
complicating	O
factors	O
(	O
ureter	B-T017
##ocele	I-T017
##s	I-T017
,	O
meg	B-T017
##au	I-T017
##ret	I-T017
##ers	I-T017
,	O
posterior	B-T017
urethral	I-T017
valves	I-T017
)	O
in	O
both	O
groups	O
were	O
comparable	O
.	O
after	O
cohen	B-T058
'	I-T058
s	I-T058
re	I-T058
##implantation	I-T058
there	O
were	O
no	O
immediate	O
complications	B-T038
requiring	O
intervention	B-T058
;	O
during	O
follow	B-T058
-	I-T058
up	I-T058
(	O
mean	O
28	O
.	O
2	O
months	O
)	O
three	O
patients	O
(	O
5	O
.	O
6	O
%	O
)	O
suffered	B-T038
febrile	B-T038
urinary	I-T038
tract	I-T038
infections	I-T038
(	O
uti	B-T038
##s	I-T038
)	O
,	O
of	O
which	O
one	O
(	O
1	O
.	O
8	O
%	O
)	O
was	O
diagnosed	B-T033
with	O
a	O
persisting	O
v	B-T038
##ur	I-T038
.	O
persistent	O
hydroneph	B-T038
##rose	I-T038
##s	I-T038
(	O
≥	O
##ii	O
sf	B-T038
##u	I-T038
)	O
were	O
recorded	O
in	O
six	O
patients	O
(	O
13	O
.	O
2	O
%	O
)	O
.	O
after	O
re	B-T058
##implantation	I-T058
using	O
math	O
##isen	O
'	O
s	O
technique	O
,	O
two	O
patients	O
(	O
4	O
.	O
1	O
%	O
)	O
suffered	B-T038
significant	O
intravesical	O
bleeding	O
;	O
during	O
follow	B-T058
-	I-T058
up	I-T058
(	O
mean	O
23	O
.	O
06	O
months	O
)	O
four	O
patients	O
(	O
8	O
.	O
3	O
%	O
)	O
suffered	B-T038
febrile	B-T038
uti	I-T038
##s	I-T038
,	O
and	O
seven	O
patients	O
(	O
14	O
.	O
5	O
%	O
)	O
were	O
diagnosed	B-T033
with	O
persisting	O
v	B-T038
##ur	I-T038
after	O
a	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
of	O
10	O
.	O
8	O
months	O
.	O
the	O
patients	O
with	O
persistent	O
v	B-T038
##ur	I-T038
had	O
more	O
commonly	O
high	O
-	O
grade	O
(	O
iv	O
and	O
v	O
)	O
v	B-T038
##ur	I-T038
initially	O
,	O
compared	O
to	O
the	O
whole	O
group	O
.	O
two	O
patients	O
(	O
4	O
.	O
1	O
%	O
)	O
had	O
persistent	O
hydroneph	B-T038
##rose	I-T038
##s	I-T038
(	O
≥	O
##ii	O
sf	B-T038
##u	I-T038
)	O
.	O
math	O
##isen	O
'	O
s	O
technique	O
for	O
ureteral	B-T058
re	I-T058
##implantation	I-T058
yielded	O
a	O
significantly	O
(	O
p	O
=	O
0	O
.	O
025	O
##6	O
patients	O
,	O
p	O
=	O
0	O
.	O
006	O
ureter	O
##ore	O
##nal	O
units	O
)	O
lower	B-T082
success	O
rate	O
(	O
85	O
.	O
5	O
%	O
patients	O
,	O
89	O
.	O
2	O
%	O
ureter	O
##ore	O
##nal	O
units	O
)	O
in	O
comparison	O
with	O
cohen	O
'	O
s	O
technique	O
(	O
98	O
.	O
2	O
%	O
patients	O
,	O
99	O
%	O
ureter	O
##ore	O
##nal	O
units	O
)	O
.	O
although	O
there	O
was	O
no	O
intervention	B-T058
for	O
obstruction	B-T038
,	O
persistent	O
hydronephrosis	B-T038
was	O
more	O
common	O
in	O
the	O
cohen	O
group	O
(	O
13	O
.	O
2	O
%	O
vs	O
.	O
4	O
.	O
1	O
%	O
,	O
n	O
.	O
s	O
.	O
)	O
.	O
despite	O
the	O
advantages	O
of	O
an	O
orthotopic	B-T082
ureteral	B-T082
orifice	I-T082
close	O
to	O
the	O
bladder	B-T017
neck	I-T017
,	O
as	O
achieved	O
by	O
math	B-T058
##isen	I-T058
'	I-T058
s	I-T058
re	I-T058
##implantation	I-T058
,	O
cross	B-T058
-	I-T058
trig	I-T058
##onal	I-T058
ureteral	I-T058
re	I-T058
##implantation	I-T058
proved	O
more	O
reliable	O
for	O
v	B-T038
##ur	I-T038
correction	O
.	O
as	O
regards	O
optimizing	O
the	O
results	O
,	O
patient	B-T062
selection	I-T062
for	O
either	O
technique	O
could	O
prove	O
essential	O
.	O
nevertheless	O
,	O
as	O
regards	O
the	O
difficulties	O
with	O
ectopic	B-T082
ureteral	B-T082
orifice	I-T082
##s	I-T082
in	O
the	O
cohen	O
technique	O
in	O
the	O
long	O
-	O
term	O
follow	B-T058
-	I-T058
up	I-T058
,	O
the	O
concept	O
of	O
anatomic	O
,	O
orthotopic	B-T082
ureteral	B-T058
re	I-T058
##implantation	I-T058
should	O
be	O
pursued	O
and	O
the	O
technique	O
should	O
be	O
further	O
refined	O
.	O

management	O
of	O
tachyarrhythm	B-T033
##ia	I-T033
during	O
pregnancy	B-T038
maternal	B-T033
tachyarrhythm	B-T033
##ia	I-T033
is	O
a	O
common	O
complication	B-T038
during	O
pregnancy	B-T038
due	O
to	O
hormonal	B-T033
changes	I-T033
that	O
enhance	O
pre	O
-	O
existing	O
arrhythmias	B-T033
or	O
induce	O
new	O
arrhythmias	B-T033
in	O
the	O
presence	B-T033
of	O
congenital	B-T017
heart	I-T017
defects	I-T017
in	O
pregnant	B-T098
females	I-T098
.	O
presence	B-T033
of	O
tachyarrhythm	B-T033
##ia	I-T033
during	O
pregnancy	B-T038
poses	O
risk	O
to	O
the	O
mother	O
and	O
fetus	B-T017
,	O
calling	B-T038
for	O
proper	B-T058
treatment	I-T058
with	O
medications	B-T103
.	O
use	O
of	O
antiarrhythmic	B-T103
drugs	I-T103
in	O
cases	O
of	O
maternal	B-T033
tachyarrhythm	B-T033
##ia	I-T033
must	O
give	O
due	O
consideration	O
of	O
potential	O
teratogenic	B-T038
side	I-T038
effects	I-T038
.	O
utilization	O
of	O
antiarrhythmic	B-T103
drugs	I-T103
during	O
pregnancy	B-T038
has	O
been	O
well	O
studied	B-T062
;	O
some	O
result	O
in	O
minimal	O
fetal	B-T017
harm	B-T037
or	O
none	O
at	O
all	O
.	O
new	O
techniques	O
,	O
such	O
as	O
cardiac	B-T058
ablation	I-T058
,	O
have	O
also	O
been	O
implemented	O
with	O
minimal	O
or	O
no	O
radiation	B-T037
exposure	I-T037
to	O
the	O
fetus	B-T017
or	O
mother	O
.	O
pregnant	B-T098
women	I-T098
with	O
tachyarrhythm	B-T033
##ia	I-T033
have	O
been	O
successfully	O
treated	B-T033
with	O
little	O
to	O
no	O
impact	O
on	O
the	O
developing	O
fetus	O
as	O
result	O
of	O
increasing	O
experience	B-T038
with	O
antiarrhythmic	B-T103
drugs	I-T103
and	O
progress	O
of	O
new	O
procedural	O
techniques	O
.	O

can	O
inorganic	B-T103
phosphate	I-T103
explain	O
sag	O
during	O
unf	O
##used	O
tet	B-T038
##anic	I-T038
contractions	I-T038
of	O
skeletal	B-T017
muscle	I-T017
?	O
we	O
test	O
the	O
hypothesis	O
that	O
cytosolic	B-T017
inorganic	B-T103
phosphate	I-T103
(	O
pi	B-T103
)	O
can	O
account	O
for	O
the	O
contraction	B-T038
-	O
induced	O
reductions	O
in	O
twitch	B-T033
duration	O
which	O
impair	O
summation	O
and	O
cause	O
force	O
to	O
decline	O
(	O
sag	O
)	O
during	O
unf	O
##used	O
tet	B-T038
##anic	I-T038
contractions	I-T038
of	O
fast	B-T017
-	I-T017
twitch	I-T017
muscle	I-T017
.	O
a	O
five	O
-	O
state	O
model	O
of	O
cross	B-T038
##bridge	I-T038
cycling	I-T038
was	O
used	O
to	O
simulate	O
twitch	B-T033
and	O
unf	O
##used	O
tet	B-T038
##anic	I-T038
contractions	I-T038
.	O
as	O
pi	B-T103
concentration	O
(	O
[	O
pi	B-T103
]	O
)	O
was	O
increased	O
from	O
0	O
to	O
30	O
mmol	O
·	O
l	O
(	O
-	O
1	O
)	O
,	O
twitch	B-T033
duration	O
decreased	O
,	O
with	O
progressive	O
reductions	B-T058
in	O
sensitivity	O
to	O
pi	B-T103
as	O
[	O
pi	B-T103
]	O
was	O
increased	O
.	O
when	O
unf	O
##used	O
tet	O
##ani	O
were	O
simulated	B-T062
with	O
rising	O
[	O
pi	B-T103
]	O
,	O
sag	O
was	O
most	O
pronounced	O
when	O
initial	O
[	O
pi	B-T103
]	O
was	O
low	O
,	O
and	O
when	O
the	O
magnitude	O
of	O
[	O
pi	B-T103
]	O
increase	O
was	O
large	O
.	O
fast	B-T033
-	I-T033
twitch	I-T033
extensor	B-T017
digitorum	I-T017
longus	I-T017
(	I-T017
ed	I-T017
##l	I-T017
)	I-T017
muscles	I-T017
(	O
sag	O
-	O
prone	O
,	O
typically	O
low	O
basal	O
[	O
pi	B-T103
]	O
)	O
and	O
slow	B-T033
-	I-T033
twitch	I-T033
soleus	B-T017
muscles	I-T017
(	O
sag	O
-	O
resistant	B-T038
,	O
typically	O
high	O
basal	O
[	O
pi	B-T103
]	O
)	O
were	O
isolated	O
from	O
14	O
female	O
c57bl	B-T204
/	I-T204
6	I-T204
mice	I-T204
.	O
muscles	B-T017
were	O
sequentially	O
incubated	B-T058
in	O
solutions	O
containing	O
either	O
glucose	B-T103
or	O
pyruvate	B-T103
to	O
create	O
typical	O
and	O
low	O
pi	B-T103
environments	B-T082
,	O
respectively	O
.	O
twitch	B-T033
duration	O
was	O
greater	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
pyruvate	B-T103
than	O
glucose	B-T103
in	O
both	O
muscles	B-T017
.	O
stimuli	O
applied	O
at	O
intervals	O
approximately	O
three	O
times	O
the	O
time	O
to	O
peak	O
twitch	B-T033
tension	O
resulted	O
in	O
sag	O
of	O
35	O
.	O
0	O
±	O
3	O
.	O
7	O
%	O
in	O
glucose	B-T103
and	O
50	O
.	O
5	O
±	O
1	O
.	O
4	O
%	O
in	O
pyruvate	B-T103
in	O
the	O
ed	B-T017
##l	I-T017
(	O
pyruvate	B-T103
>	O
glucose	B-T103
;	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
and	O
3	O
.	O
9	O
±	O
0	O
.	O
3	O
%	O
in	O
glucose	B-T103
and	O
37	O
.	O
8	O
±	O
2	O
.	O
7	O
%	O
in	O
pyruvate	B-T103
in	O
the	O
soleus	B-T017
(	O
pyruvate	B-T103
>	O
glucose	B-T103
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
influence	O
of	O
pi	B-T103
on	O
cross	B-T038
##bridge	I-T038
cycling	I-T038
provides	O
a	O
ten	O
##able	O
mechanism	O
for	O
sag	O
.	O
moreover	O
,	O
the	O
low	O
basal	O
[	O
pi	B-T103
]	O
in	O
fast	B-T033
-	I-T033
twitch	I-T033
relative	O
to	O
slow	B-T033
-	I-T033
twitch	I-T033
muscle	I-T033
has	O
promise	O
as	O
an	O
explanation	B-T170
for	O
the	O
fiber	B-T017
-	I-T017
type	I-T017
dependency	O
of	O
sag	O
.	O

renal	B-T038
arterial	I-T038
myc	I-T038
##otic	I-T038
aneurysm	I-T038
after	O
kidney	B-T058
transplantation	I-T058
myc	B-T038
##otic	I-T038
aneurysm	I-T038
is	O
a	O
rare	O
condition	O
mostly	O
attributable	O
to	O
candida	B-T204
or	O
aspergillus	B-T204
species	I-T204
.	O
about	O
20	O
cases	O
of	O
candida	B-T204
-	O
related	O
arteritis	B-T038
have	O
been	O
reported	O
in	O
kidney	B-T058
transplant	I-T058
patients	O
.	O
herein	O
,	O
we	O
report	B-T170
the	O
case	O
of	O
a	O
40	O
-	O
year	O
-	O
old	O
man	O
who	O
received	O
a	O
kidney	B-T017
from	O
a	O
deceased	O
donor	B-T098
in	O
whom	O
an	O
accidental	O
digestive	O
wound	O
was	O
made	O
during	O
organ	B-T058
retrieval	I-T058
.	O
he	O
presented	O
with	O
sudden	O
an	B-T038
##uria	I-T038
47	O
days	O
after	O
renal	B-T058
transplantation	I-T058
revealing	O
a	O
large	O
myc	B-T038
##otic	I-T038
aneurysm	I-T038
of	O
the	O
kidney	B-T017
graft	I-T017
renal	B-T017
artery	I-T017
.	O
organs	B-T017
derived	O
from	O
donors	B-T098
in	O
whom	O
a	O
digestive	O
bre	O
##ach	O
is	O
noticed	O
should	O
be	O
used	O
with	O
caution	O
.	O

cd	O
##f	O
-	O
quanti	O
##le	O
distributions	O
for	O
modelling	B-T170
random	O
variables	O
on	O
the	O
unit	B-T170
interval	I-T170
this	O
paper	O
introduces	O
a	O
two	O
-	O
parameter	O
family	O
of	O
distributions	O
for	O
modelling	B-T170
random	O
variables	O
on	O
the	O
(	O
0	O
,	O
1	O
)	O
interval	B-T170
by	O
applying	O
the	O
cumulative	O
distribution	O
function	O
of	O
one	O
'	O
parent	O
'	O
distribution	O
to	O
the	O
quanti	O
##le	O
function	B-T170
of	O
another	O
.	O
family	O
members	O
have	O
explicit	O
probability	O
density	O
functions	B-T170
,	O
cumulative	O
distribution	O
functions	O
and	O
quanti	O
##le	O
s	O
in	O
a	O
location	B-T082
parameter	O
and	O
a	O
dispersion	B-T082
parameter	O
.	O
they	O
capture	O
a	O
wide	O
variety	O
of	O
shapes	B-T082
that	O
the	O
beta	O
and	O
ku	O
##mar	O
##as	O
##wa	O
##my	O
distributions	O
cann	B-T033
##ot	I-T033
.	O
they	O
are	O
amenable	O
to	O
likelihood	B-T170
inference	I-T170
,	O
and	O
enable	O
a	O
wide	O
variety	O
of	O
quanti	O
##le	O
regression	B-T170
models	I-T170
,	O
with	O
predictors	O
for	O
both	O
the	O
location	B-T082
and	O
dispersion	B-T082
parameters	O
.	O
we	O
demonstrate	O
their	O
applicability	O
to	O
psychological	B-T091
research	B-T062
problems	I-T062
and	O
their	O
utility	O
in	O
modelling	B-T170
real	B-T170
data	I-T170
.	O

new	O
diterp	B-T103
##enoids	I-T103
from	O
cler	B-T204
##odend	I-T204
##ran	I-T204
##th	I-T204
##us	I-T204
spi	I-T204
##ca	I-T204
##t	I-T204
##us	I-T204
two	O
new	O
diterp	B-T103
##enoids	I-T103
,	O
neo	B-T103
##orth	I-T103
##osi	I-T103
##ph	I-T103
##on	I-T103
##ones	I-T103
b	I-T103
and	O
c	B-T103
(	O
1	B-T103
and	O
2	B-T103
)	O
,	O
and	O
one	O
known	O
diterp	B-T103
##enoid	I-T103
,	O
were	O
isolated	O
from	O
the	O
aerial	B-T204
parts	I-T204
of	O
cler	B-T204
##odend	I-T204
##ran	I-T204
##th	I-T204
##us	I-T204
spi	I-T204
##ca	I-T204
##t	I-T204
##us	I-T204
.	O
their	O
structures	B-T082
including	O
absolute	O
configurations	B-T082
were	O
determined	O
by	O
comprehensive	O
spectroscopic	B-T058
analyses	I-T058
and	O
x	B-T058
-	I-T058
ray	I-T058
crystallographic	I-T058
methods	I-T058
.	O
no	O
compound	O
was	O
found	O
to	O
inhibit	O
fibronectin	B-T103
production	O
at	O
the	O
concentration	O
of	O
20	O
μm	O
.	O

basic	B-T062
science	I-T062
and	O
pathogenesis	B-T038
of	O
ageing	B-T038
with	O
hiv	B-T038
:	O
potential	O
mechanisms	O
and	O
biomarkers	B-T201
:	O
the	O
increased	O
prevalence	O
of	O
age	O
-	O
related	O
comorbidities	O
and	O
mortality	O
is	O
wor	B-T033
##ris	I-T033
##ome	I-T033
in	O
ageing	B-T038
hiv	B-T038
-	I-T038
infected	I-T038
patients	O
.	O
here	O
,	O
we	O
aim	O
to	O
analyse	B-T062
the	O
different	O
ageing	B-T038
mechanisms	O
with	O
regard	O
to	O
hiv	B-T038
infection	I-T038
.	O
ageing	B-T038
results	O
from	O
the	O
time	O
-	O
dependent	O
accumulation	B-T033
of	O
random	O
cellular	O
damage	O
.	O
epigenetic	B-T038
modifications	I-T038
and	O
mitochondrial	B-T103
dna	I-T103
hapl	O
##ogroup	O
##s	O
modulate	B-T082
ageing	B-T038
.	O
in	O
antiretroviral	B-T058
treatment	I-T058
-	O
controlled	O
patients	O
,	O
epigenetic	B-T038
clock	I-T038
appears	O
to	O
be	O
advanced	O
,	O
and	O
some	O
hapl	O
##ogroup	O
##s	O
are	O
associated	O
with	O
hiv	B-T038
infection	I-T038
severity	O
.	O
telomere	B-T038
shortening	I-T038
is	O
enhanced	O
in	O
hiv	B-T038
-	I-T038
infected	I-T038
patients	O
because	O
of	O
hiv	B-T005
and	O
some	O
nucleoside	B-T103
analogue	I-T103
reverse	B-T103
transcriptase	I-T103
inhibitors	I-T103
.	O
mitochondria	B-T017
-	O
related	O
oxidative	B-T038
stress	I-T038
and	O
mitochondrial	B-T103
dna	I-T103
mutations	B-T038
are	O
increased	O
during	O
ageing	B-T038
and	O
also	O
by	O
some	O
nucleoside	B-T103
analogue	I-T103
reverse	B-T103
transcriptase	I-T103
inhibitors	I-T103
.	O
overall	O
,	O
increased	O
inflammation	B-T038
or	O
'	O
inflamm	B-T038
##age	I-T038
##ing	I-T038
'	O
is	O
a	O
major	O
driver	O
of	O
ageing	B-T038
and	O
could	O
result	O
from	O
cell	B-T038
senescence	I-T038
with	O
secreted	O
proinflammatory	B-T103
mediators	I-T103
,	O
altered	O
gut	O
microbiota	O
,	O
and	O
coinfection	B-T038
##s	I-T038
.	O
in	O
hiv	B-T038
-	I-T038
infected	I-T038
patients	O
,	O
the	O
level	O
of	O
inflammation	B-T038
and	O
innate	O
immunity	O
activation	O
is	O
enhanced	O
and	O
related	O
to	O
most	O
comorbidities	O
and	O
to	O
mortality	O
.	O
this	O
status	O
could	O
result	O
,	O
in	O
addition	O
to	O
age	O
,	O
from	O
the	O
virus	B-T005
itself	O
or	O
viral	B-T103
protein	I-T103
released	O
from	O
reservoirs	O
,	O
from	O
hiv	B-T005
-	O
enhanced	O
gut	B-T017
permeability	O
and	O
dys	B-T038
##biosis	I-T038
,	O
from	O
antiretroviral	B-T058
treatment	I-T058
,	O
from	O
frequent	O
cytomegalovirus	B-T005
and	O
hepatitis	B-T005
c	I-T005
virus	I-T005
coinfection	B-T038
##s	I-T038
,	O
and	O
also	O
from	O
personal	O
and	O
environmental	O
factors	O
,	O
as	O
central	O
fat	B-T033
accumulation	I-T033
or	O
smoking	O
.	O
adaptive	B-T038
immune	I-T038
activation	O
and	O
immunos	B-T038
##enes	I-T038
##cence	I-T038
are	O
associated	O
with	O
comorbidities	O
and	O
mortality	O
in	O
the	O
general	B-T098
population	I-T098
but	O
are	O
less	O
predictive	O
in	O
hiv	B-T038
-	I-T038
infected	I-T038
patients	O
.	O
biomarkers	B-T201
to	O
evaluate	B-T058
ageing	B-T038
in	O
hiv	B-T038
-	I-T038
infected	I-T038
patients	O
are	O
required	O
.	O
numerous	O
systemic	O
or	O
cellular	B-T017
inflammatory	I-T017
,	O
immune	O
activation	O
,	O
oxidative	B-T038
stress	I-T038
,	O
or	O
senescence	O
markers	B-T201
can	O
be	O
tested	O
in	O
serum	B-T031
or	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
.	O
the	O
novel	O
european	B-T082
study	B-T062
to	O
establish	O
biomarkers	B-T201
of	O
human	B-T170
ageing	I-T170
mark	I-T170
-	I-T170
age	I-T170
algorithm	I-T170
,	O
evaluating	B-T058
the	O
biological	O
age	O
,	O
is	O
currently	O
assessed	O
in	O
hiv	B-T038
-	I-T038
infected	I-T038
patients	O
and	O
reveals	O
an	O
advanced	O
biological	O
age	O
.	O
some	O
enhanced	O
inflammatory	O
or	O
innate	O
immune	O
activation	O
markers	B-T201
are	O
interesting	O
but	O
still	O
not	O
validated	O
for	O
the	O
patient	O
'	O
s	O
follow	B-T058
-	I-T058
up	I-T058
.	O
to	O
be	O
able	O
to	O
assess	O
patients	O
'	O
biological	O
age	O
is	O
an	O
important	O
objective	O
to	O
improve	O
their	O
health	O
##sp	O
##an	O
.	O

development	O
and	O
initial	O
validation	B-T062
of	O
the	O
resp	O
##ira	O
##tor	O
comfort	B-T038
,	O
wearing	B-T038
experience	I-T038
,	O
and	O
function	O
instrument	B-T074
[	O
r	B-T074
-	I-T074
com	I-T074
##fi	I-T074
filtering	O
face	O
-	O
piece	O
resp	O
##ira	O
##tors	O
(	O
ffr	O
##s	O
)	O
are	O
worn	O
to	O
protect	O
health	B-T097
care	I-T097
personnel	I-T097
from	O
airborne	B-T103
particles	I-T103
;	O
however	O
,	O
clinical	B-T062
studies	I-T062
have	O
demonstrated	O
that	O
ffr	O
adherence	O
is	O
relatively	O
low	O
in	O
some	O
settings	O
,	O
in	O
part	B-T082
,	O
due	O
to	O
discomfort	B-T033
and	O
intolerance	B-T038
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
develop	O
and	O
initially	O
evaluate	O
the	O
psychometric	O
properties	O
of	O
an	O
instrument	B-T074
designed	O
to	O
measure	O
the	O
comfort	B-T038
and	O
tolerability	O
of	O
ffr	O
##s	O
.	O
instrument	B-T074
items	O
were	O
developed	O
through	O
literature	B-T170
reviews	I-T170
,	O
focus	O
groups	O
,	O
and	O
several	O
iter	B-T033
##ations	I-T033
of	O
ranking	B-T170
and	O
ref	O
##ining	O
by	O
experts	B-T097
.	O
psychometric	B-T058
evaluation	I-T058
of	O
the	O
instrument	B-T074
was	O
conducted	O
using	O
ras	B-T170
##ch	I-T170
partial	I-T170
cred	I-T170
##it	I-T170
model	I-T170
(	O
pcm	B-T170
)	O
analysis	B-T062
.	O
piv	B-T170
##ot	I-T170
anchoring	I-T170
was	O
used	O
to	O
specify	O
the	O
threshold	O
defining	O
item	O
difficulty	O
;	O
in	O
our	O
analyses	B-T062
,	O
this	O
was	O
the	O
point	O
that	O
participants	B-T098
moved	O
from	O
possessing	O
none	O
of	O
the	O
trait	O
to	O
some	O
of	O
the	O
trait	O
.	O
the	O
final	O
instrument	B-T074
was	O
completed	O
by	O
165	O
health	B-T097
care	I-T097
personnel	I-T097
from	O
3	O
veterans	B-T098
health	B-T058
administration	I-T058
facilities	I-T058
,	O
and	O
data	O
were	O
analyzed	B-T062
using	O
ras	B-T170
##ch	I-T170
pcm	I-T170
.	O
seven	O
items	O
were	O
removed	O
because	O
they	O
:	O
(	O
1	O
)	O
viol	O
##ated	O
the	O
assumption	O
of	O
independence	O
;	O
(	O
2	O
)	O
were	O
mis	O
-	O
fitting	O
;	O
and	O
/	O
or	O
(	O
3	O
)	O
were	O
deemed	O
not	O
relevant	O
.	O
category	B-T170
function	O
analysis	B-T062
demonstrated	O
that	O
all	O
categories	B-T170
progressed	O
mono	O
##tonic	O
##ally	O
.	O
principal	O
components	O
analysis	O
demonstrated	O
the	O
existence	O
of	O
three	O
subscales	O
(	O
discomfort	B-T033
,	O
general	O
wearing	B-T038
experience	I-T038
,	O
and	O
function	O
)	O
.	O
final	O
reliability	O
analyses	B-T062
showed	O
that	O
the	O
scale	O
had	O
moderate	O
to	O
high	O
person	O
reliability	O
and	O
high	O
item	O
reliability	O
.	O
the	O
final	O
instrument	B-T074
contained	O
21	O
items	O
.	O
until	O
now	O
,	O
to	O
our	O
knowledge	B-T038
no	O
instrument	B-T074
with	O
evidence	O
supporting	O
its	O
reliability	O
and	O
validity	O
to	O
assess	O
discomfort	B-T033
and	O
tolerance	O
of	O
ffr	O
##s	O
among	O
health	B-T097
care	I-T097
personnel	I-T097
has	O
been	O
published	O
.	O
a	O
21	O
-	O
item	O
psychometric	O
##ally	O
sound	O
measure	O
of	O
comfort	B-T038
and	O
tolerability	O
of	O
ffr	O
##s	O
,	O
resp	O
##ira	O
##tor	O
comfort	B-T038
,	O
wearing	B-T038
experience	I-T038
,	O
and	O
function	O
instrument	B-T074
(	O
r	B-T074
-	I-T074
com	I-T074
##fi	I-T074
)	O
,	O
was	O
developed	O
.	O
the	O
significance	O
of	O
developing	O
such	O
an	O
instrument	B-T074
is	O
that	O
it	O
will	O
help	O
identify	O
resp	O
##ira	O
##tors	O
that	O
are	O
likely	O
to	O
have	O
better	O
adherence	O
in	O
practice	B-T038
settings	O
.	O
the	O
r	B-T074
-	I-T074
com	I-T074
##fi	I-T074
may	O
be	O
used	O
within	B-T082
and	O
beyond	O
the	O
va	B-T092
healthcare	I-T092
system	I-T092
as	O
a	O
psychometric	B-T074
##ally	I-T074
sound	I-T074
instrument	I-T074
to	O
evaluate	O
the	O
comfort	B-T038
and	O
tolerability	O
of	O
resp	O
##ira	O
##tors	O
,	O
including	O
developmental	O
prototype	O
##s	O
.	O

strategies	O
for	O
successful	O
clinical	O
teaching	O
this	O
article	B-T170
is	O
one	O
in	O
a	O
series	O
on	O
the	O
roles	O
of	O
adjunct	B-T097
clinical	I-T097
faculty	I-T097
and	O
prec	B-T097
##eptors	I-T097
,	O
who	O
teach	O
nursing	B-T097
students	I-T097
and	O
new	O
graduates	B-T098
to	O
apply	O
knowledge	B-T170
in	O
clinical	O
settings	O
.	O
this	O
article	B-T170
describes	O
teaching	O
strategies	O
as	O
well	O
as	O
the	O
importance	O
of	O
the	O
learning	O
environment	O
.	O

prostate	B-T103
-	I-T103
specific	I-T103
antigen	I-T103
increase	O
during	O
dut	B-T103
##aster	I-T103
##ide	I-T103
to	O
indicate	O
the	O
need	O
for	O
prostate	B-T058
biopsy	I-T058
:	O
influence	O
of	O
prostatic	B-T038
inflammation	I-T038
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
analyze	B-T062
the	O
significance	O
of	O
an	O
increase	O
in	O
total	O
prostate	O
-	O
specific	O
antigen	O
(	O
psa	O
)	O
serum	O
levels	O
despite	O
dut	B-T103
##aster	I-T103
##ide	I-T103
treatment	B-T058
as	O
a	O
predictor	O
of	O
prostate	B-T038
cancer	I-T038
(	O
pc	B-T038
)	O
at	O
biopsy	B-T058
.	O
we	O
focused	O
our	O
attention	O
on	O
the	O
rate	O
of	O
the	O
first	O
psa	B-T103
increase	O
and	O
on	O
the	O
influence	O
of	O
prostatic	B-T038
inflammation	I-T038
.	O
from	O
2011	O
to	O
2016	O
,	O
365	O
men	B-T098
with	O
a	O
previous	O
negative	O
prostate	B-T058
biopsy	I-T058
and	O
persistent	O
elevated	O
psa	B-T103
levels	O
received	O
dut	B-T103
##aster	I-T103
##ide	I-T103
treatment	B-T058
.	O
the	O
population	B-T098
was	O
followed	O
for	O
a	O
range	O
of	O
12	O
-	O
48	O
months	O
.	O
one	O
hundred	O
twelve	O
cases	O
with	O
a	O
confirmed	O
psa	B-T103
increase	O
>	O
0	O
.	O
5	O
ng	O
/	O
ml	O
over	O
the	O
nadir	O
value	O
during	O
the	O
follow	B-T058
-	I-T058
up	I-T058
were	O
included	O
in	O
group	O
a	O
and	O
underwent	O
a	O
new	O
prostate	B-T058
biopsy	I-T058
.	O
in	O
group	O
a	O
,	O
the	O
psa	B-T103
increase	O
was	O
associated	O
with	O
pc	B-T038
at	O
the	O
re	B-T058
-	I-T058
biopsy	I-T058
in	O
66	O
%	O
of	O
cases	O
.	O
the	O
percentage	O
of	O
psa	B-T033
reduction	I-T033
after	O
6	O
months	O
of	O
treatment	B-T058
was	O
not	O
a	O
significant	O
indicator	B-T201
of	O
the	O
risk	O
for	O
pc	B-T038
.	O
the	O
distribution	O
of	O
inflammatory	B-T033
infiltrates	I-T033
significantly	O
(	O
p	O
<	O
00	O
.	O
01	O
)	O
varied	O
from	O
positive	O
to	O
negative	O
prostate	B-T058
biopsies	I-T058
.	O
the	O
relative	O
risk	O
for	O
pc	B-T038
at	O
biopsy	B-T058
significantly	O
increase	O
d	O
according	O
to	O
psa	B-T103
level	O
during	O
dut	B-T103
##aster	I-T103
##ide	I-T103
.	O
treatment	B-T058
with	O
dut	B-T103
##aster	I-T103
##ide	I-T103
can	O
help	O
to	O
analyze	B-T062
psa	B-T103
kinetic	O
.	O
a	O
persistent	O
prostatic	B-T038
inflammation	I-T038
is	O
a	O
factor	O
able	O
to	O
reduce	O
the	O
performance	O
of	O
psa	B-T103
kinetic	O
during	O
dut	B-T103
##aster	I-T103
##ide	I-T103
treatment	B-T058
.	O

physicochemical	O
characterization	O
of	O
chitosan	B-T103
-	O
hyaluronan	B-T103
-	O
coated	O
solid	O
lipid	B-T074
nanoparticles	I-T074
for	O
the	O
targeted	O
delivery	B-T058
of	O
paclitaxel	B-T103
:	O
a	O
proof	B-T062
-	I-T062
of	I-T062
-	I-T062
concept	I-T062
study	I-T062
in	O
breast	B-T017
cancer	I-T017
cells	I-T017
to	O
investigate	O
the	O
potential	O
of	O
modified	O
solid	B-T074
lipid	I-T074
nanoparticles	I-T074
(	O
sln	B-T074
)	O
for	O
the	O
delivery	O
of	O
paclitaxel	B-T103
(	O
pax	B-T103
)	O
.	O
sln	B-T103
loaded	I-T103
with	I-T103
pax	I-T103
were	O
prepared	O
via	O
modified	O
high	B-T058
-	I-T058
pressure	I-T058
hot	I-T058
homogen	I-T058
##ization	I-T058
.	O
formulation	B-T062
parameters	I-T062
were	O
optimized	O
to	O
obtain	O
a	O
high	B-T074
-	I-T074
quality	I-T074
delivery	I-T074
system	I-T074
.	O
sln	B-T074
cores	O
were	O
coated	O
,	O
layer	O
-	O
by	O
-	O
layer	O
,	O
with	O
a	O
chitosan	B-T103
and	O
hyaluronan	B-T103
(	O
ha	B-T103
)	O
shell	O
.	O
selectivity	O
toward	O
ha	B-T103
receptors	B-T103
was	O
tested	O
in	O
a	O
breast	B-T017
cancer	I-T017
cell	I-T017
line	I-T017
,	O
mcf	B-T017
-	I-T017
7	I-T017
.	O
stable	O
and	O
reproducible	O
nano	O
-	O
sized	O
and	O
negatively	O
charged	O
nanoparticles	O
resulted	O
.	O
findings	O
reveal	O
that	O
chitosan	B-T103
-	O
ha	B-T103
-	O
coated	O
sln	B-T074
facilitated	O
the	O
targeting	O
,	O
cellular	B-T038
uptake	I-T038
and	O
the	O
time	O
-	O
/	O
dose	O
-	O
controlled	O
delivery	O
and	O
release	O
of	O
pax	B-T103
,	O
enhancing	O
intrinsic	O
chemotherapeutic	O
activities	O
.	O
sln	B-T074
are	O
suitable	O
carrier	B-T074
candidates	I-T074
for	O
nano	B-T091
-	I-T091
oncology	I-T091
given	O
their	O
localized	O
,	O
and	O
potent	O
cytotoxic	B-T103
potential	I-T103
overcoming	B-T033
multidrug	B-T038
-	I-T038
resistant	I-T038
cancer	I-T038
cells	I-T038
.	O

impact	O
of	O
soil	O
salinity	O
on	O
the	O
structure	B-T082
of	O
the	O
bacterial	B-T007
endop	B-T204
##hy	I-T204
##tic	I-T204
community	O
identified	O
from	O
the	O
roots	B-T204
of	O
cal	B-T204
##iph	I-T204
medic	I-T204
(	O
medic	B-T204
##ago	I-T204
trunc	I-T204
##at	I-T204
##ula	I-T204
)	O
in	O
addition	O
to	O
being	O
a	O
forage	B-T204
crop	I-T204
,	O
cal	B-T204
##iph	I-T204
medic	I-T204
(	O
medic	B-T204
##ago	I-T204
trunc	I-T204
##at	I-T204
##ula	I-T204
)	O
is	O
also	O
a	O
model	B-T062
leg	I-T062
##ume	I-T062
plant	I-T062
and	O
is	O
used	O
for	O
research	O
focusing	O
on	O
the	O
molecular	O
characterization	O
of	O
the	O
interaction	O
between	O
rhiz	B-T007
##obia	I-T007
and	O
plants	B-T204
.	O
however	O
,	O
the	O
endop	O
##hy	O
##tic	O
microbiome	O
in	O
this	O
plant	B-T204
is	O
poorly	O
defined	O
.	O
endop	B-T204
##hy	I-T204
##tic	I-T204
bacteria	B-T007
play	O
a	O
role	O
in	O
supplying	O
plants	B-T204
with	O
the	O
basic	O
requirements	O
necessary	O
for	O
growth	B-T038
and	O
development	B-T038
.	O
moreover	O
,	O
these	O
bacteria	B-T007
also	O
play	O
a	O
role	O
in	O
the	O
mechanism	O
of	O
salinity	O
stress	O
adaptation	B-T038
in	O
plants	B-T204
.	O
as	O
a	O
pre	O
##lu	O
##de	O
to	O
the	O
isolation	B-T058
and	O
utilization	O
of	O
these	O
bacteria	B-T007
in	O
cal	B-T204
##iph	I-T204
medic	I-T204
farming	B-T082
,	O
41	O
bacterial	B-T007
ot	B-T170
##us	I-T170
were	O
identified	O
in	O
this	O
project	O
from	O
within	O
the	O
interior	B-T082
of	O
the	O
roots	B-T204
of	O
this	O
plant	B-T204
by	O
pyrosequencing	B-T058
of	O
the	O
small	B-T017
ribosomal	I-T017
subunit	I-T017
gene	I-T017
(	O
16s	B-T017
rdna	I-T017
)	O
using	O
a	O
cultivation	B-T058
-	I-T058
independent	I-T058
approach	I-T058
.	O
in	O
addition	O
,	O
the	O
differential	O
abundance	O
of	O
these	O
bacteria	B-T007
was	O
studied	O
following	O
exposure	O
of	O
the	O
plants	B-T204
to	O
salinity	O
stress	O
.	O
about	O
29	O
,	O
06	O
##4	O
high	O
-	O
quality	O
reads	O
were	O
obtained	O
from	O
the	O
sequencing	B-T058
of	O
six	O
libraries	B-T017
prepared	O
from	O
control	B-T017
and	O
salinity	B-T017
-	I-T017
treated	I-T017
tissues	I-T017
.	O
statistical	O
analysis	O
revealed	O
that	O
the	O
abundance	O
of	O
~	O
70	O
%	O
of	O
the	O
ot	B-T170
##us	I-T170
was	O
significantly	O
(	O
p	O
≤	O
0	O
.	O
05	O
)	O
altered	O
in	O
roots	B-T204
that	O
were	O
exposed	O
to	O
salinity	O
stress	O
.	O
sequence	B-T058
analysis	I-T058
showed	O
a	O
similarity	O
between	O
some	O
of	O
the	O
identified	O
species	B-T170
and	O
other	O
,	O
known	O
,	O
growth	B-T007
-	I-T007
promoting	I-T007
bacteria	I-T007
,	O
marine	O
and	O
salt	B-T007
-	I-T007
stressed	I-T007
soil	I-T007
-	I-T007
borne	I-T007
bacteria	I-T007
,	O
and	O
nitrogen	B-T007
-	I-T007
fixing	I-T007
bacterial	I-T007
isolates	B-T103
.	O
determination	O
of	O
the	O
amend	O
##ments	O
to	O
the	O
bacteria	B-T007
l	O
community	O
due	O
to	O
salinity	O
stress	O
in	O
cal	B-T204
##iph	I-T204
medic	I-T204
provides	O
a	O
crucial	O
step	O
toward	O
developing	O
an	O
understanding	O
of	O
the	O
association	O
of	O
these	O
endop	B-T204
##hy	I-T204
##tes	I-T204
,	O
under	O
salt	O
stress	O
conditions	O
,	O
in	O
this	O
model	B-T062
plant	I-T062
.	O
to	O
provide	O
direct	O
evidence	O
regarding	O
their	O
growth	O
promoting	O
activity	O
,	O
a	O
group	O
of	O
endop	B-T204
##hy	I-T204
##tic	I-T204
bacteria	B-T007
were	O
isolated	O
from	O
inside	O
of	O
plant	B-T204
roots	I-T204
using	O
a	O
cultivation	B-T058
-	I-T058
dependent	I-T058
approach	I-T058
.	O
several	O
of	O
these	O
isolates	B-T103
were	O
able	O
to	O
produce	O
acc	B-T103
-	I-T103
deaminase	I-T103
,	O
ammonia	B-T103
and	O
iaa	B-T103
;	O
and	O
to	O
solubil	O
##ize	O
zn	B-T103
+	I-T103
2	I-T103
and	O
po	B-T103
##4	I-T103
-	I-T103
3	I-T103
.	O
this	O
data	O
is	O
consistent	O
with	O
the	O
predicted	O
occurrence	O
(	O
based	O
on	O
cultivation	B-T058
-	I-T058
independent	I-T058
techniques	I-T058
)	O
of	O
these	O
bacteria	B-T007
and	O
provides	O
some	O
insight	O
into	O
the	O
importance	O
of	O
the	O
endop	B-T204
##hy	I-T204
##tic	I-T204
bacteria	B-T007
in	O
cal	B-T204
##iph	I-T204
medic	I-T204
when	O
grown	O
under	O
normal	O
and	O
saline	O
conditions	O
.	O

ank	B-T103
##af	I-T103
##la	I-T103
##vin	I-T103
and	O
mon	B-T103
##ascin	I-T103
induce	O
apoptosis	B-T038
in	O
activated	O
hepatic	B-T017
stellate	I-T017
cells	I-T017
through	O
suppression	O
of	O
the	O
akt	B-T103
/	O
nf	B-T103
-	I-T103
κb	I-T103
/	O
p38	B-T103
signaling	B-T038
pathway	I-T038
the	O
increased	O
proliferation	B-T038
of	O
activated	O
hepatic	B-T017
stellate	I-T017
cells	I-T017
(	O
hscs	B-T017
)	O
is	O
associated	O
with	O
hepatic	B-T038
fibrosis	I-T038
and	O
excessive	O
extracellular	B-T017
matrix	I-T017
(	O
ecm	B-T017
)	O
-	O
protein	B-T103
production	O
.	O
we	O
examined	O
the	O
inhibitory	O
effects	O
of	O
the	O
mon	B-T204
##asc	I-T204
##us	I-T204
purp	I-T204
##ure	I-T204
##us	I-T204
-	O
fermented	O
metabolites	B-T103
,	O
ank	B-T103
##af	I-T103
##la	I-T103
##vin	I-T103
and	O
mon	B-T103
##ascin	I-T103
(	O
15	O
and	O
30	O
μm	O
)	O
,	O
on	O
the	O
akt	B-T103
/	O
nuclear	B-T103
factor	I-T103
(	I-T103
nf	I-T103
)	I-T103
-	I-T103
κb	I-T103
and	O
p38	B-T103
mitogen	I-T103
-	I-T103
activated	I-T103
protein	I-T103
kinase	I-T103
(	O
mapk	B-T103
)	O
signaling	B-T038
pathways	I-T038
in	O
hsc	B-T017
-	I-T017
t6	I-T017
(	O
activated	B-T017
hepatic	I-T017
stellate	I-T017
cell	I-T017
line	I-T017
)	O
.	O
ank	B-T103
##af	I-T103
##la	I-T103
##vin	I-T103
and	O
mon	B-T103
##ascin	I-T103
(	O
30	O
μm	O
)	O
induced	O
apoptosis	B-T038
and	O
significantly	O
inhibited	O
cell	B-T038
growth	I-T038
(	O
cell	B-T038
via	I-T038
##bil	I-T038
##ities	I-T038
:	O
80	O
.	O
2	O
±	O
5	O
.	O
43	O
%	O
and	O
62	O
.	O
8	O
±	O
8	O
.	O
20	O
%	O
,	O
respectively	O
,	O
versus	O
control	B-T017
cells	I-T017
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
apoptosis	B-T038
and	O
g1	B-T038
phase	I-T038
arrest	I-T038
(	O
g1	O
phase	O
percentages	O
:	O
76	O
.	O
1	O
±	O
2	O
.	O
85	O
%	O
and	O
79	O
.	O
9	O
±	O
1	O
.	O
80	O
%	O
,	O
respectively	O
,	O
versus	O
control	B-T017
cells	I-T017
65	O
.	O
9	O
±	O
4	O
.	O
94	O
%	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
correlated	O
with	O
increased	O
p53	B-T103
and	O
p21	B-T103
levels	B-T033
and	O
caspase	B-T038
3	I-T038
activity	I-T038
and	O
decreased	O
cyclin	B-T103
d1	I-T103
and	O
bcl	B-T017
-	I-T017
2	I-T017
-	I-T017
family	I-T017
protein	I-T017
levels	B-T033
(	O
p	O
<	O
0	O
.	O
05	O
,	O
all	O
cases	O
)	O
.	O
the	O
apoptotic	O
effects	O
of	O
ank	B-T103
##af	I-T103
##la	I-T103
##vin	I-T103
and	O
mon	B-T103
##ascin	I-T103
were	O
hsc	B-T017
-	I-T017
t6	I-T017
-	O
specific	O
,	O
suggesting	O
their	O
potential	O
in	O
treating	O
liver	B-T038
fibrosis	I-T038
.	O

adverse	O
outcomes	O
in	O
older	B-T098
adults	I-T098
attending	O
emergency	B-T092
departments	I-T092
:	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
the	O
identification	B-T170
of	I-T170
senior	I-T170
##s	I-T170
at	I-T170
risk	I-T170
(	I-T170
is	I-T170
##ar	I-T170
)	I-T170
screening	I-T170
tool	I-T170
older	B-T098
adults	I-T098
are	O
frequent	O
users	O
of	O
emergency	B-T058
services	I-T058
and	O
demonstrate	O
high	O
rates	O
of	O
adverse	O
outcomes	O
following	O
emergency	B-T058
care	I-T058
.	O
to	O
perform	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
the	O
identification	B-T170
of	I-T170
senior	I-T170
##s	I-T170
at	I-T170
risk	I-T170
(	I-T170
is	I-T170
##ar	I-T170
)	I-T170
screening	I-T170
tool	I-T170
,	O
to	O
determine	O
its	O
predictive	O
value	O
in	O
identifying	O
adults	O
≥	O
##65	O
years	O
at	O
risk	O
of	O
functional	B-T033
decline	I-T033
,	O
unplanned	O
emergency	B-T058
department	I-T058
(	I-T058
ed	I-T058
)	I-T058
readmission	I-T058
,	O
emergency	O
hospitalisation	B-T058
or	O
death	B-T033
within	O
180	O
days	O
after	O
index	O
ed	B-T058
visit	I-T058
/	O
hospitalisation	B-T058
.	O
a	O
systematic	O
literature	B-T170
search	O
was	O
conducted	O
in	O
pubmed	B-T170
,	O
embase	B-T170
,	O
cinahl	B-T170
,	O
ebs	B-T170
##co	I-T170
and	O
the	O
cochrane	B-T170
library	I-T170
to	O
identify	O
validation	B-T062
and	O
impact	O
analysis	B-T062
studies	O
of	O
the	O
is	B-T170
##ar	I-T170
tool	I-T170
.	O
a	O
pre	O
-	O
specified	O
is	B-T170
##ar	I-T170
score	O
of	O
≥2	O
(	O
maximum	O
score	O
6	O
points	O
)	O
was	O
used	O
to	O
identify	O
patients	O
at	O
high	B-T033
risk	I-T033
of	I-T033
adverse	O
outcomes	O
.	O
a	O
bivariate	B-T170
random	I-T170
effects	I-T170
model	I-T170
generated	O
pooled	O
estimates	O
of	O
sensitivity	O
and	O
specificity	O
.	O
statistical	O
heterogeneity	O
was	O
explored	O
and	O
methodological	O
quality	O
was	O
assessed	O
using	O
validated	O
criteria	O
.	O
thirty	O
-	O
two	O
validation	B-T062
studies	I-T062
(	O
n	O
=	O
12	O
,	O
93	O
##9	O
)	O
are	O
included	O
.	O
at	O
≥2	O
,	O
the	O
pooled	O
sensitivity	O
of	O
the	O
is	B-T170
##ar	I-T170
for	O
predicting	O
ed	B-T092
return	O
,	O
emergency	O
hospitalisation	B-T058
and	O
mortality	O
at	O
6	O
months	O
is	O
0	O
.	O
80	O
(	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
0	O
.	O
70	O
-	O
0	O
.	O
87	O
)	O
,	O
0	O
.	O
82	O
(	O
95	O
%	O
ci	O
0	O
.	O
74	O
-	O
0	O
.	O
88	O
)	O
and	O
0	O
.	O
87	O
(	O
95	O
%	O
ci	O
0	O
.	O
75	O
-	O
0	O
.	O
94	O
)	O
,	O
respectively	O
,	O
with	O
a	O
pooled	O
specificity	O
of	O
0	O
.	O
31	O
(	O
95	O
%	O
ci	O
0	O
.	O
24	O
-	O
0	O
.	O
38	O
)	O
,	O
0	O
.	O
32	O
(	O
95	O
%	O
ci	O
0	O
.	O
24	O
-	O
0	O
.	O
41	O
)	O
and	O
0	O
.	O
35	O
(	O
95	O
%	O
ci	O
0	O
.	O
26	O
-	O
0	O
.	O
44	O
)	O
.	O
similar	O
values	O
are	O
demonstrated	O
at	O
30	O
and	O
90	O
days	O
.	O
three	O
heterogeneous	O
impact	O
analysis	B-T062
studies	O
examined	B-T033
the	O
clinical	O
implementation	O
of	O
the	O
is	B-T170
##ar	I-T170
and	O
reported	O
mixed	O
findings	O
across	O
patient	O
and	O
process	O
outcomes	O
.	O
the	O
is	B-T170
##ar	I-T170
has	O
modest	O
predictive	O
accuracy	O
and	O
may	O
serve	O
as	O
a	O
decision	B-T038
-	I-T038
making	I-T038
adjunct	O
when	O
determining	O
which	O
older	B-T098
adults	I-T098
can	O
be	O
safely	O
discharged	B-T058
.	O

decreased	O
frequencies	O
of	O
peripheral	B-T031
blood	I-T031
cd4	B-T017
+	I-T017
cd25	I-T017
+	I-T017
cd1	I-T017
##27	I-T017
-	I-T017
foxp3	I-T017
+	I-T017
in	O
patients	O
with	O
graves	B-T038
'	I-T038
disease	I-T038
and	O
graves	B-T038
'	I-T038
orbit	I-T038
##opathy	I-T038
:	O
enhancing	O
effect	O
of	O
insulin	B-T103
growth	I-T103
factor	I-T103
-	I-T103
1	I-T103
on	O
treg	B-T017
cells	I-T017
graves	B-T038
'	I-T038
orbit	I-T038
##opathy	I-T038
(	O
go	B-T038
)	O
is	O
characterized	O
by	O
orbital	B-T017
t	I-T017
cell	I-T017
infiltration	B-T038
.	O
we	O
evaluated	B-T058
the	O
regulatory	B-T017
t	I-T017
(	I-T017
treg	I-T017
)	I-T017
cell	I-T017
fractions	O
induced	O
with	O
igf	B-T103
-	I-T103
1	I-T103
in	O
graves	B-T038
'	I-T038
disease	I-T038
(	O
gd	B-T038
)	O
with	O
and	O
without	O
go	B-T038
.	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
(	O
pbmcs	B-T017
)	O
were	O
obtained	O
from	O
13	O
patients	O
with	O
gd	B-T038
without	O
eye	B-T033
manifestations	I-T033
;	O
10	O
patients	O
with	O
active	O
go	B-T038
;	O
and	O
12	O
patients	O
with	O
nodular	B-T038
goiter	I-T038
(	O
ng	B-T038
)	O
.	O
all	O
the	O
patients	O
from	O
gd	B-T038
,	O
go	B-T038
,	O
and	O
ng	B-T038
were	O
subclinical	O
hyperth	O
##yroid	O
.	O
we	O
analyzed	B-T062
the	O
expression	B-T058
of	I-T058
treg	I-T058
cell	I-T058
markers	I-T058
(	O
cd4	B-T103
,	O
cd25	B-T103
,	O
cd1	B-T103
##27	I-T103
(	I-T103
-	I-T103
)	I-T103
,	O
foxp3	B-T103
)	O
on	O
t	B-T017
cells	I-T017
and	O
their	O
ability	O
to	O
respond	B-T170
to	I-T170
igf	B-T103
-	I-T103
1	I-T103
stimulation	O
.	O
in	O
patients	O
with	O
gd	B-T038
without	O
go	B-T038
,	O
we	O
found	O
lowered	O
percentages	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
foxp3	I-T017
(	I-T017
+	I-T017
)	I-T017
cells	I-T017
,	O
as	O
compared	O
to	O
nodular	B-T038
goiter	I-T038
1	O
.	O
77	O
vs	O
.	O
5	O
.	O
42	O
%	O
(	O
p	O
=	O
0	O
.	O
027	O
##6	O
)	O
.	O
similarly	O
,	O
significantly	O
reduced	O
frequencies	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
cd25	I-T017
(	I-T017
+	I-T017
)	I-T017
cd1	I-T017
##27	I-T017
(	I-T017
-	I-T017
)	I-T017
foxp3	I-T017
(	I-T017
+	I-T017
)	I-T017
and	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
cd25	I-T017
(	I-T017
+	I-T017
)	I-T017
cd1	I-T017
##27	I-T017
(	I-T017
-	I-T017
)	I-T017
cells	I-T017
were	O
observed	O
in	O
gd	B-T038
patients	O
as	O
compared	O
to	O
nodular	B-T038
goiter	I-T038
patients	O
with	O
hyperth	B-T038
##yr	I-T038
##e	I-T038
##osis	I-T038
,	O
(	O
0	O
.	O
7	O
vs	O
.	O
1	O
.	O
48	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
007	O
##1	O
)	O
and	O
(	O
14	O
.	O
5	O
vs	O
.	O
37	O
.	O
2	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
005	O
##1	O
)	O
,	O
respectively	O
.	O
in	O
go	B-T038
with	O
active	O
go	B-T038
,	O
only	O
the	O
percentage	O
of	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
cd25	I-T017
(	I-T017
+	I-T017
)	I-T017
cd1	I-T017
##27	I-T017
(	I-T017
-	I-T017
)	I-T017
cells	I-T017
was	O
found	O
to	O
be	O
decreased	O
versus	O
nodular	B-T038
goiter	I-T038
(	O
9	O
.	O
35	O
vs	O
.	O
37	O
.	O
2	O
)	O
(	O
p	O
=	O
0	O
.	O
027	O
##5	O
)	O
.	O
stimulation	O
of	O
pbmc	B-T017
derived	O
from	O
go	B-T038
patients	O
with	O
igf	B-T103
-	I-T103
1	I-T103
resulted	O
in	O
significant	O
increase	O
of	O
frequency	O
of	O
both	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
foxp3	I-T017
(	I-T017
+	I-T017
)	I-T017
and	O
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
cd25	I-T017
(	I-T017
+	I-T017
)	I-T017
cd1	I-T017
##27	I-T017
(	I-T017
-	I-T017
)	I-T017
foxp3	I-T017
cells	I-T017
.	O
decreased	O
frequencies	O
of	O
peripheral	B-T031
blood	I-T031
cd4	B-T017
(	I-T017
+	I-T017
)	I-T017
cd25	I-T017
(	I-T017
+	I-T017
)	I-T017
cd1	I-T017
##27	I-T017
(	I-T017
-	I-T017
)	I-T017
foxp3	I-T017
(	I-T017
+	I-T017
)	I-T017
in	O
patients	O
with	O
gd	B-T038
and	O
go	B-T038
could	O
be	O
an	O
useful	B-T201
marker	I-T201
of	O
autoimmune	B-T038
process	I-T038
and	O
perhaps	O
a	O
possible	O
target	O
for	O
future	O
therapies	O
.	O
this	O
is	O
the	O
first	O
study	B-T062
demonstrating	O
treg	B-T017
-	O
enhancing	O
effects	O
of	O
igf	B-T103
-	I-T103
1	I-T103
.	O
thus	O
igf	B-T103
-	I-T103
1	I-T103
can	O
be	O
accounted	O
for	O
modulating	B-T082
treg	B-T017
cell	I-T017
-	O
related	O
action	O
in	O
go	B-T038
.	O

hybrid	O
autom	O
##ata	O
models	O
of	O
cardiac	B-T017
ventricular	I-T017
electrophysiology	B-T058
for	O
real	O
-	O
time	O
computational	O
applications	O
virtual	O
heart	O
models	O
have	O
been	O
proposed	O
for	O
closed	O
loop	O
validation	B-T062
of	O
safety	O
-	O
critical	O
embedded	O
medical	B-T074
devices	I-T074
,	O
such	O
as	O
pacemaker	B-T074
##s	I-T074
.	O
these	O
models	O
must	O
react	O
in	O
real	O
-	O
time	O
to	O
off	O
-	O
the	O
-	O
shelf	O
medical	B-T074
devices	I-T074
.	O
real	O
-	O
time	O
performance	O
can	O
be	O
obtained	O
by	O
implementing	O
models	O
in	O
computer	O
hardware	O
,	O
and	O
methods	O
of	O
comp	O
##iling	O
classes	O
of	O
hybrid	O
autom	O
##ata	O
(	O
ha	O
)	O
onto	O
fpg	B-T074
##a	I-T074
have	O
been	O
developed	O
.	O
models	O
of	O
ventricular	B-T017
cardiac	I-T017
cell	I-T017
electrophysiology	B-T058
have	O
been	O
described	O
using	O
ha	O
which	O
capture	O
the	O
complex	O
nonlinear	O
behavior	O
of	O
biological	O
systems	O
.	O
however	O
,	O
many	O
models	O
that	O
have	O
been	O
used	O
for	O
closed	O
-	O
loop	O
validation	B-T062
of	O
pacemaker	B-T074
##s	I-T074
are	O
highly	O
abstract	O
and	O
do	O
not	O
capture	O
important	O
characteristics	O
of	O
the	O
dynamic	O
rate	O
response	O
.	O
we	O
developed	O
a	O
new	O
ha	O
model	O
of	O
cardiac	B-T017
cells	I-T017
which	O
captures	O
dynamic	O
behavior	O
and	O
we	O
implemented	O
the	O
model	O
in	O
hardware	O
.	O
this	O
potentially	O
enables	O
modeling	B-T062
the	O
heart	B-T017
with	O
over	O
1	O
million	O
dynamic	O
cells	B-T017
,	O
making	O
the	O
approach	O
ideal	O
for	O
closed	O
loop	O
testing	O
of	O
medical	B-T074
devices	I-T074
.	O

barriers	O
and	O
facilitators	O
to	O
smoking	O
cessation	O
in	O
a	O
cancer	B-T038
context	O
:	O
a	O
qualitative	B-T062
study	I-T062
of	O
patient	O
,	O
family	O
and	O
professional	B-T097
views	O
continued	O
smoking	O
after	O
cancer	B-T038
adversely	B-T038
affects	I-T038
quality	B-T033
of	I-T033
life	I-T033
and	O
survival	O
,	O
but	O
one	O
fifth	O
of	O
cancer	B-T038
survivors	O
still	O
smoke	O
.	O
despite	O
its	O
demands	O
,	O
cancer	B-T038
presents	O
an	O
opportunity	O
for	O
positive	B-T033
behaviour	O
change	O
.	O
smoking	O
often	O
occurs	O
in	O
social	B-T098
groups	I-T098
,	O
therefore	O
interventions	B-T058
which	O
target	O
families	O
and	O
individuals	B-T098
may	O
be	O
more	O
successful	O
.	O
this	O
qualitative	B-T062
study	I-T062
explored	O
patients	O
,	O
family	O
members	O
and	O
health	B-T097
professionals	I-T097
'	O
views	O
and	O
experiences	B-T038
of	O
smoking	O
and	O
smoking	O
cessation	O
after	O
cancer	B-T038
,	O
in	O
order	O
to	O
inform	O
future	O
interventions	B-T058
.	O
in	O
-	O
depth	O
qualitative	O
interviews	O
(	O
n	O
=	O
67	O
)	O
with	O
29	O
patients	O
,	O
14	O
family	O
members	O
and	O
24	O
health	B-T097
professionals	I-T097
.	O
data	O
were	O
analysed	O
using	O
the	O
'	O
framework	O
'	O
method	O
.	O
few	O
patient	O
s	O
and	O
family	O
members	O
had	O
used	O
national	B-T058
health	I-T058
service	I-T058
(	O
nhs	B-T058
)	O
smoking	O
cessation	O
services	B-T058
and	O
more	O
than	O
half	O
still	O
smoked	O
.	O
most	O
recalled	O
little	O
'	O
smoking	O
-	O
related	O
'	O
discussion	B-T058
with	O
clinicians	B-T097
but	O
were	O
receptive	O
to	O
talk	O
##ing	O
open	O
##ly	O
.	O
clinicians	B-T097
revealed	O
several	O
barriers	O
to	O
discussion	B-T058
.	O
participants	B-T098
'	O
continued	O
smoking	O
was	O
explained	O
by	O
the	O
stress	B-T033
of	O
diagnosis	B-T058
;	O
desire	O
to	O
maintain	O
personal	O
control	O
;	O
and	O
lack	O
of	O
connection	O
between	O
smoking	O
,	O
cancer	B-T038
and	O
health	O
.	O
a	O
range	O
of	O
barriers	O
to	O
smoking	O
cessation	O
exist	O
for	O
patients	O
and	O
family	O
members	O
.	O
these	O
are	O
insufficient	O
##ly	O
assessed	O
and	O
considered	O
by	O
clinicians	B-T097
.	O
interventions	B-T058
must	O
be	O
more	O
effectively	O
integrated	O
into	O
routine	O
practice	O
.	O

identification	O
and	O
characterization	O
of	O
dich	B-T007
##el	I-T007
##obacter	I-T007
nod	I-T007
##osus	I-T007
serogroup	B-T170
h	I-T170
from	O
ovine	B-T204
foot	B-T038
##rot	I-T038
in	O
india	B-T082
a	O
total	O
of	O
56	O
foot	O
swabs	O
were	O
collected	O
from	O
inter	B-T082
digital	I-T082
spaces	I-T082
of	O
sheep	B-T204
with	O
foot	B-T038
##rot	I-T038
lesions	B-T033
were	O
screened	B-T058
for	O
16	O
rrna	B-T103
of	O
dich	B-T007
##el	I-T007
##obacter	I-T007
nod	I-T007
##osus	I-T007
by	O
pcr	B-T062
.	O
out	O
of	O
the	O
56	O
samples	O
,	O
38	O
(	O
67	O
.	O
85	O
%	O
)	O
were	O
found	O
to	O
be	O
positive	B-T033
.	O
all	O
the	O
positive	B-T033
samples	O
were	O
subjected	O
to	O
multiplex	B-T062
pcr	I-T062
targeting	B-T062
fim	I-T062
##a	I-T062
gene	I-T062
for	O
identification	O
of	O
serogroup	B-T170
##s	I-T170
of	O
d	B-T007
.	I-T007
nod	I-T007
##osus	I-T007
.	O
serogroup	B-T170
h	I-T170
was	O
found	O
along	O
with	O
serogroup	B-T170
b	I-T170
in	O
12	O
(	O
55	O
.	O
26	O
%	O
)	O
samples	O
and	O
with	O
serogroup	B-T170
i	I-T170
in	O
8	O
(	O
22	O
.	O
2	O
%	O
)	O
samples	O
.	O
the	O
serogroup	B-T170
h	I-T170
was	O
identified	O
for	O
the	O
first	O
time	O
from	O
the	O
indian	B-T082
subc	I-T082
##ontin	I-T082
##ent	I-T082
.	O
the	O
phylogenetic	B-T062
analysis	I-T062
of	O
the	O
present	O
sequence	B-T082
with	O
the	O
available	O
serogroup	B-T170
h	I-T170
sequences	B-T082
of	O
genbank	B-T170
revealed	O
to	O
be	O
in	O
close	O
association	O
with	O
the	O
serotype	B-T170
h1	I-T170
.	O

efficacy	O
of	O
pegylated	B-T103
liposomal	I-T103
etoposide	I-T103
nanoparticles	I-T103
on	O
breast	B-T017
cancer	I-T017
cell	I-T017
lines	I-T017
this	O
study	O
aimed	O
to	O
investigate	O
the	O
efficacy	O
of	O
pegylated	B-T103
liposomal	I-T103
etoposide	I-T103
nanoparticles	I-T103
(	O
nps	O
)	O
against	O
t	B-T038
-	I-T038
47	I-T038
##d	I-T038
and	O
mcf	B-T017
-	I-T017
7	I-T017
breast	I-T017
cancer	I-T017
cell	I-T017
lines	I-T017
.	O
pegylated	B-T103
liposomal	I-T103
etoposide	I-T103
nps	I-T103
were	O
prepared	O
by	O
reverse	O
phase	O
evaporation	O
method	O
.	O
the	O
size	B-T082
,	O
size	B-T082
distribution	I-T082
,	O
and	O
zeta	O
potential	O
of	O
the	O
nps	B-T103
was	O
measured	O
by	O
a	O
zeta	B-T074
##si	I-T074
##zer	I-T074
instrument	I-T074
.	O
the	O
cytotoxicity	B-T038
of	O
nps	B-T103
was	O
insp	O
##ected	O
by	O
methyl	B-T062
thiaz	I-T062
##ol	I-T062
tetrazolium	I-T062
assay	I-T062
.	O
the	O
release	O
pattern	O
of	O
the	O
drug	O
from	O
the	O
vesicles	O
was	O
studied	O
by	O
the	O
dialysis	O
method	O
.	O
drug	O
loading	O
and	O
encapsulation	O
efficiency	O
(	O
ee	O
)	O
were	O
also	O
measured	O
.	O
the	O
mean	B-T082
size	I-T082
,	O
size	B-T082
distribution	I-T082
,	O
and	O
zeta	O
potential	O
of	O
pegylated	B-T103
liposomal	I-T103
etoposide	I-T103
nps	I-T103
were	O
49	O
##1	O
±	O
15	O
.	O
5	O
nm	O
,	O
0	O
.	O
50	O
##4	O
±	O
0	O
.	O
14	O
,	O
and	O
-	O
35	O
.	O
8	O
±	O
2	O
.	O
5	O
mv	O
,	O
respectively	O
.	O
drug	O
loading	O
and	O
ee	O
were	O
10	O
.	O
3	O
±	O
1	O
.	O
6	O
%	O
and	O
99	O
.	O
1	O
±	O
2	O
.	O
8	O
%	O
,	O
respectively	O
.	O
the	O
etoposide	O
release	O
in	O
the	O
formulation	O
was	O
estimated	O
at	O
about	O
3	O
.	O
48	O
%	O
after	O
48	O
h	O
.	O
the	O
cytotoxicity	B-T038
effect	I-T038
of	O
etoposide	B-T103
nps	I-T103
on	O
t	B-T038
-	I-T038
47	I-T038
##d	I-T038
and	O
mcf	B-T017
-	I-T017
7	I-T017
cell	I-T017
lines	I-T017
of	I-T017
breast	I-T017
cancer	I-T017
showed	O
higher	O
antitumor	O
activity	O
as	O
compared	O
with	O
those	O
of	O
the	O
free	O
drug	O
.	O
liposome	B-T103
-	I-T103
based	I-T103
nps	I-T103
may	O
hold	O
great	O
potential	O
as	O
a	O
drug	B-T074
delivery	I-T074
system	I-T074
.	O

cro	B-T103
##cetin	I-T103
improves	B-T033
the	O
quality	O
of	O
in	O
vitro	O
-	O
produced	O
bovine	B-T204
embryos	B-T017
:	O
implications	O
for	O
blastocyst	B-T038
development	I-T038
,	O
cryo	O
##to	O
##ler	O
##ance	O
,	O
and	O
apoptosis	B-T038
the	O
aim	O
of	O
this	O
work	O
was	O
to	O
assess	O
the	O
effect	O
of	O
supplementation	B-T058
of	O
bovine	B-T204
culture	B-T103
medium	I-T103
with	O
the	O
natural	B-T103
antioxidant	I-T103
cro	B-T103
##cetin	I-T103
on	O
in	O
vitro	O
blastocyst	B-T038
development	I-T038
and	O
quality	O
.	O
this	O
was	O
evaluated	B-T058
as	O
cryo	O
##to	O
##ler	O
##ance	O
,	O
apoptosis	B-T170
index	I-T170
,	O
and	O
total	B-T058
cells	I-T058
number	I-T058
and	O
allocation	O
.	O
aba	O
##tt	O
##oir	O
-	O
derived	O
oocytes	B-T017
were	O
matured	O
and	O
fertilized	O
in	O
vitro	O
according	O
to	O
standard	O
procedure	O
.	O
twenty	O
hours	O
after	O
ivf	B-T058
,	O
presumptive	O
zyg	B-T017
##otes	I-T017
were	O
cultured	B-T058
in	O
synthetic	B-T017
oviduct	I-T017
fluid	O
medium	O
,	O
supplemented	O
with	O
0	O
,	O
1	O
,	O
2	O
.	O
5	O
,	O
and	O
5	O
μm	O
cro	B-T103
##cetin	I-T103
(	O
experiment	O
1	O
)	O
at	O
39	O
°c	O
under	O
humid	O
##ified	O
air	O
with	O
5	O
%	O
co2	B-T103
,	O
7	O
%	O
o2	B-T103
,	O
and	O
88	O
%	O
n2	B-T103
.	O
on	O
day	O
7	O
,	O
embryo	O
yields	O
were	O
assessed	O
and	O
the	O
blastocysts	B-T017
were	O
vitr	O
##ified	O
by	O
cryo	B-T170
##to	I-T170
##p	I-T170
method	I-T170
in	O
16	O
.	O
5	O
%	O
ethylene	B-T103
glycol	I-T103
,	O
16	O
.	O
5	O
%	O
dmso	B-T103
,	O
and	O
0	O
.	O
5	O
m	O
sucrose	B-T103
.	O
finally	O
,	O
blastocysts	B-T017
produced	O
on	O
day	O
8	O
in	O
the	O
absence	O
(	O
control	O
)	O
and	O
presence	B-T033
of	O
1	O
μm	O
cro	B-T103
##cetin	I-T103
were	O
used	O
for	O
terminal	B-T062
deoxynucleotidyl	I-T062
transferase	I-T062
-	I-T062
mediated	I-T062
dutp	I-T062
nick	I-T062
end	I-T062
labelling	I-T062
and	O
differential	B-T058
staining	I-T058
to	O
evaluate	B-T058
,	O
respectively	O
,	O
the	O
apoptotic	O
rate	O
and	O
the	O
allocation	O
of	O
cells	B-T017
into	O
inner	B-T017
cell	I-T017
mass	I-T017
(	O
icm	B-T017
)	O
and	O
troph	B-T017
##ect	I-T017
##oderm	I-T017
(	O
te	B-T017
)	O
lineages	O
(	O
experiment	O
2	O
)	O
.	O
embryo	B-T038
development	I-T038
was	O
higher	O
in	O
the	O
1	O
μm	O
cro	O
##cetin	O
group	O
compared	O
to	O
the	O
control	O
,	O
both	O
in	O
terms	O
of	O
total	O
embryo	B-T017
output	O
(	O
37	O
.	O
7	O
±	O
4	O
.	O
2	O
%	O
,	O
52	O
.	O
9	O
±	O
6	O
.	O
3	O
%	O
,	O
40	O
.	O
9	O
±	O
7	O
.	O
6	O
%	O
,	O
and	O
42	O
.	O
4	O
±	O
8	O
.	O
7	O
%	O
,	O
respectively	O
,	O
with	O
0	O
,	O
1	O
,	O
2	O
.	O
5	O
,	O
and	O
5	O
μm	O
;	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
grade	B-T170
1	I-T170
and	O
2	B-T170
blastocysts	B-T017
(	O
33	O
.	O
6	O
±	O
4	O
.	O
9	O
%	O
,	O
46	O
.	O
1	O
±	O
7	O
.	O
3	O
%	O
,	O
37	O
.	O
8	O
±	O
7	O
.	O
9	O
%	O
,	O
and	O
39	O
.	O
4	O
±	O
7	O
.	O
9	O
%	O
,	O
respectively	O
,	O
with	O
0	O
,	O
1	O
,	O
2	O
.	O
5	O
,	O
and	O
5	O
μm	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
moreover	O
,	O
the	O
percentage	O
of	O
fast	B-T038
-	I-T038
developing	I-T038
embryos	I-T038
increased	O
in	O
1	O
μm	O
cro	O
##cetin	O
group	O
compared	O
to	O
the	O
control	O
(	O
23	O
.	O
4	O
±	O
4	O
.	O
7	O
%	O
,	O
32	O
.	O
7	O
±	O
6	O
.	O
6	O
%	O
,	O
27	O
.	O
2	O
±	O
6	O
.	O
6	O
%	O
,	O
and	O
30	O
.	O
1	O
±	O
7	O
.	O
2	O
%	O
,	O
respectively	O
,	O
with	O
0	O
,	O
1	O
,	O
2	O
.	O
5	O
,	O
and	O
5	O
μm	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
in	O
addition	O
,	O
the	O
enrichment	O
of	O
culture	O
medium	O
with	O
1	O
μm	O
cro	B-T103
##cetin	I-T103
improved	B-T033
embryo	B-T017
cryo	O
##to	O
##ler	O
##ance	O
compared	O
to	O
the	O
control	O
,	O
as	O
indicated	O
by	O
higher	O
hatching	B-T038
rates	O
recorded	O
after	O
48	O
hours	O
post	B-T103
##wa	I-T103
##r	I-T103
##ming	I-T103
culture	I-T103
(	O
46	O
.	O
5	O
%	O
vs	O
.	O
60	O
.	O
4	O
%	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
furthermore	O
,	O
1	O
μm	O
cro	B-T103
##cetin	I-T103
decreased	O
both	O
the	O
average	O
number	O
(	O
9	O
.	O
9	O
±	O
0	O
.	O
4	O
vs	O
.	O
7	O
.	O
1	O
±	O
0	O
.	O
3	O
)	O
and	O
the	O
percentage	O
of	O
apoptotic	O
cells	B-T017
(	O
7	O
.	O
1	O
±	O
0	O
.	O
4	O
vs	O
.	O
4	O
.	O
2	O
±	O
0	O
.	O
2	O
)	O
in	O
blastocysts	B-T017
compared	O
to	O
the	O
control	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
however	O
,	O
no	O
differences	O
were	O
recorded	O
in	O
the	O
average	O
number	O
of	O
icm	B-T017
,	O
te	B-T017
,	O
and	O
total	O
cells	B-T017
between	O
1	O
μm	O
cro	B-T103
##cetin	I-T103
and	O
control	O
groups	O
.	O
in	O
conclusion	O
,	O
the	O
enrichment	O
of	O
bovine	O
culture	O
medium	O
with	O
1	O
μm	O
cro	B-T103
##cetin	I-T103
increased	O
both	O
blastocyst	O
yield	O
and	O
quality	O
,	O
as	O
indicated	O
by	O
the	O
improved	B-T033
chron	B-T170
##ology	I-T170
of	O
embryo	B-T038
development	I-T038
,	O
increased	O
resistance	O
to	O
cryopreservation	B-T058
,	O
and	O
reduced	O
incidence	O
of	O
apoptosis	B-T038
.	O

validating	B-T062
signs	B-T033
and	I-T033
symptoms	I-T033
from	O
an	O
actual	O
mass	O
casual	O
##ty	O
incident	O
to	O
characterize	O
an	O
irr	O
##itant	O
gas	O
syndrome	O
agent	O
(	O
ig	O
##sa	O
)	O
exposure	O
:	O
a	O
first	O
step	O
in	O
the	O
development	O
of	O
a	O
novel	O
ig	O
##sa	O
triage	B-T058
algorithm	B-T170
chemical	B-T033
exposures	I-T033
can	O
pose	O
a	O
significant	O
threat	O
to	O
life	O
.	O
rapid	O
assessment	B-T058
by	O
first	O
responders	O
/	O
emergency	B-T097
nurses	I-T097
is	O
required	O
to	O
reduce	O
death	B-T038
and	O
disability	B-T033
.	O
currently	O
,	O
no	O
informatics	B-T170
tools	I-T170
for	O
irr	O
##itant	O
gas	O
syndrome	O
agent	O
s	O
(	O
ig	O
##sa	O
)	O
exposures	O
exist	O
to	O
process	O
victims	O
efficiently	O
,	O
continuously	O
monitor	B-T058
for	O
latent	O
signs	B-T033
/	I-T033
symptoms	I-T033
,	O
or	O
make	O
triage	B-T058
recommendations	O
.	O
this	O
study	B-T062
describes	O
the	O
first	O
step	O
in	O
developing	O
ed	B-T092
informatics	B-T170
tools	I-T170
for	O
chemical	O
incidents	O
:	O
validation	B-T062
of	O
signs	B-T033
/	I-T033
symptoms	I-T033
that	O
characterize	O
an	O
ig	O
##sa	O
syndrome	B-T038
.	O
data	O
abstracted	O
from	O
146	O
patients	O
treated	B-T058
for	O
chlorine	O
exposure	O
in	O
one	O
emergency	B-T092
department	I-T092
during	O
a	O
2005	O
train	O
der	O
##ail	O
##ment	O
and	O
152	O
patients	O
not	O
exposed	O
to	O
chlorine	O
(	O
a	O
comparison	O
group	O
)	O
were	O
mapped	O
to	O
93	O
possible	O
signs	B-T033
/	I-T033
symptoms	I-T033
within	O
2	O
tools	B-T170
(	O
wise	B-T170
##r	I-T170
and	O
chem	B-T170
##m	I-T170
-	I-T170
is	I-T170
##t	I-T170
)	O
designed	O
to	O
assist	O
emergency	B-T097
responders	I-T097
/	O
emergency	B-T097
nurses	I-T097
with	O
managing	O
hazardous	B-T103
material	I-T103
exposures	O
.	O
infer	O
##ential	O
statistics	O
(	O
χ	O
(	O
2	O
)	O
/	O
fisher	B-T170
'	I-T170
s	I-T170
exact	I-T170
test	I-T170
)	O
and	O
diagnostics	B-T058
tests	I-T058
were	O
used	O
to	O
examine	O
mapped	O
signs	B-T033
/	I-T033
symptoms	I-T033
of	O
persons	B-T098
who	O
were	O
and	O
were	O
not	O
exposed	O
to	O
chlorine	O
.	O
three	O
clusters	O
of	O
signs	B-T033
/	I-T033
symptoms	I-T033
are	O
statistically	O
associated	O
with	O
an	O
ig	O
##sa	O
syndrome	B-T038
(	O
p	O
<	O
.	O
01	O
)	O
:	O
respiratory	O
(	O
short	B-T033
##ness	I-T033
of	I-T033
breath	I-T033
,	O
wheezing	B-T033
,	O
cough	B-T033
##ing	I-T033
,	O
and	O
cho	B-T038
##king	I-T038
)	O
;	O
chest	B-T033
discomfort	I-T033
(	O
tight	B-T033
##ness	I-T033
,	O
pain	B-T033
,	O
and	O
burning	B-T033
)	O
,	O
and	O
eye	B-T017
,	O
nose	B-T017
and	O
/	O
or	O
throat	B-T017
(	O
pain	B-T033
,	O
irritation	O
,	O
and	O
burning	B-T033
)	O
.	O
the	O
syndrome	B-T038
requires	O
the	O
presence	B-T033
of	O
signs	B-T033
/	I-T033
symptoms	I-T033
from	O
at	O
least	O
2	O
of	O
these	O
clusters	O
.	O
the	O
latency	O
period	O
must	O
also	O
be	O
considered	O
for	O
exposed	B-T098
/	O
potentially	O
exposed	B-T098
persons	I-T098
.	O
this	O
study	B-T062
uses	O
actual	O
patient	O
data	O
from	O
a	O
chemical	O
incident	O
to	O
characterize	O
and	O
validate	B-T062
signs	B-T033
/	I-T033
symptoms	I-T033
of	O
an	O
ig	O
##sa	O
syndrome	B-T038
.	O
validating	B-T062
signs	B-T033
/	I-T033
symptoms	I-T033
is	O
the	O
first	O
step	O
in	O
developing	O
new	O
ed	B-T092
informatics	B-T170
tools	I-T170
with	O
the	O
potential	O
to	O
revolution	O
##ize	O
the	O
process	O
by	O
which	O
emergency	B-T097
nurses	I-T097
manage	O
triage	B-T058
victims	O
of	O
chemical	O
incidents	O
.	O

comparative	O
proteomic	B-T058
analysis	I-T058
reveals	O
alterations	O
in	O
development	B-T038
and	O
photosynthesis	O
-	O
related	O
proteins	B-T103
in	O
diploid	O
and	O
trip	B-T038
##lo	I-T038
##id	I-T038
rice	B-T204
polyploid	B-T038
##y	I-T038
has	O
pivotal	O
influences	O
on	O
rice	B-T204
(	O
oryz	B-T204
##a	I-T204
sativa	I-T204
l	I-T204
.	I-T204
)	O
morphology	O
and	O
physiology	B-T038
,	O
and	O
is	O
very	O
important	O
for	O
understanding	O
rice	B-T204
domestic	O
##ation	O
and	O
improving	O
agricultural	O
traits	O
.	O
diploid	O
(	O
dp	O
)	O
and	O
trip	B-T038
##lo	I-T038
##id	I-T038
(	O
tp	B-T038
)	O
rice	B-T204
shows	O
differences	O
in	O
morphological	O
parameters	B-T033
,	O
such	O
as	O
plant	B-T204
height	O
,	O
leaf	B-T204
length	O
,	O
leaf	B-T204
width	O
and	O
the	O
physiological	O
index	B-T170
of	O
chlorophyll	B-T103
content	O
.	O
however	O
,	O
the	O
underlying	O
mechanisms	O
determining	O
these	O
morphological	O
differences	O
are	O
remain	O
to	O
be	O
defined	O
.	O
to	O
better	O
understand	O
the	O
proteomic	B-T103
changes	O
between	O
dp	O
and	O
tp	B-T038
,	O
tandem	O
mass	O
tags	O
(	O
tmt	O
)	O
mass	O
spectrometry	O
(	O
ms	O
)	O
/	O
ms	B-T058
was	O
used	O
to	O
detect	O
the	O
significant	O
changes	O
to	O
protein	B-T038
expression	I-T038
between	O
dp	O
and	O
tp	B-T038
.	O
results	O
indicated	O
that	O
both	O
photosynthesis	O
and	O
metabolic	O
pathways	O
were	O
highly	O
significantly	O
associated	O
with	O
proteomic	B-T038
alteration	I-T038
between	O
dp	O
and	O
tp	B-T038
based	O
on	O
biological	B-T038
process	I-T038
and	O
pathway	B-T058
enrichment	I-T058
analysis	I-T058
,	O
and	O
13	O
higher	O
abundance	O
chloroplast	B-T103
proteins	I-T103
involving	O
in	O
these	O
two	O
pathways	B-T038
were	O
identified	O
in	O
tp	B-T038
.	O
quantitative	B-T062
real	I-T062
-	I-T062
time	I-T062
pcr	I-T062
analysis	I-T062
demonstrated	O
that	O
5	O
of	O
the	O
13	O
chloroplast	B-T103
proteins	I-T103
atp	B-T103
##f	I-T103
,	O
psa	B-T103
##a	I-T103
,	O
psa	B-T103
##b	I-T103
,	O
ps	B-T103
##bb	I-T103
and	O
rb	B-T103
##l	I-T103
in	O
tp	B-T038
were	O
higher	O
abundance	O
compared	O
with	O
those	O
in	O
dp	O
.	O
this	O
study	B-T062
integrates	O
morphology	O
,	O
physiology	B-T038
and	O
proteomic	B-T058
profiling	I-T058
alteration	O
of	O
dp	O
and	O
tp	B-T038
to	O
address	O
their	O
underlying	O
different	O
molecular	B-T038
mechanisms	I-T038
.	O
our	O
finding	O
revealed	O
that	O
atp	B-T103
##f	I-T103
,	O
psa	B-T103
##a	I-T103
,	O
psa	B-T103
##b	I-T103
,	O
ps	B-T103
##bb	I-T103
and	O
rb	B-T103
##l	I-T103
can	O
induce	O
considerable	O
expression	B-T038
changes	O
in	O
tp	B-T038
and	O
may	O
affect	O
the	O
development	B-T038
and	O
growth	B-T038
of	O
rice	B-T204
through	O
photosynthesis	O
and	O
metabolic	O
pathways	O
.	O

non	O
-	O
specific	O
transient	O
mutual	O
##ism	O
between	O
the	O
plant	B-T204
parasitic	I-T204
nematode	I-T204
,	O
burs	B-T204
##aph	I-T204
##elen	I-T204
##ch	I-T204
##us	I-T204
xyl	I-T204
##ophilus	I-T204
,	O
and	O
the	O
opportunistic	O
bacterium	B-T007
serr	B-T007
##atia	I-T007
quin	I-T007
##iv	I-T007
##ora	I-T007
##ns	I-T007
bx	I-T007
##f1	I-T007
,	O
a	O
plant	B-T038
-	I-T038
growth	I-T038
promoting	O
pine	B-T204
endop	B-T204
##hy	I-T204
##te	I-T204
with	O
antagonistic	B-T103
effects	O
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
understand	O
the	O
biological	O
role	O
of	O
serr	B-T007
##atia	I-T007
quin	I-T007
##iv	I-T007
##ora	I-T007
##ns	I-T007
bx	I-T007
##f1	I-T007
,	O
a	O
bacterium	B-T007
commonly	O
found	O
associated	O
with	O
burs	B-T204
##aph	I-T204
##elen	I-T204
##ch	I-T204
##us	I-T204
xyl	I-T204
##ophilus	I-T204
,	O
the	O
plant	B-T204
parasitic	I-T204
nematode	I-T204
responsible	O
for	O
pine	B-T204
wil	B-T038
##t	I-T038
disease	I-T038
.	O
therefore	O
,	O
we	O
studied	O
strain	B-T007
bx	I-T007
##f1	I-T007
effect	O
in	O
pine	B-T204
wil	B-T038
##t	I-T038
disease	I-T038
.	O
we	O
found	O
that	O
strain	B-T007
bx	I-T007
##f1	I-T007
promoted	O
in	O
vitro	O
nematode	B-T204
reproduction	B-T038
.	O
moreover	O
,	O
the	O
presence	O
of	O
bacteria	B-T007
led	O
to	O
the	O
absence	O
of	O
nematode	B-T204
chitin	B-T017
##ase	I-T017
gene	I-T017
(	I-T017
bx	I-T017
##ch	I-T017
##t	I-T017
-	I-T017
1	I-T017
)	I-T017
expression	B-T038
,	O
suggesting	O
an	O
effect	O
for	O
bacterial	B-T007
chitin	B-T103
##ase	I-T103
in	O
nematode	B-T204
reproduction	B-T038
.	O
nevertheless	O
,	O
strain	B-T007
bx	I-T007
##f1	I-T007
was	O
unable	O
to	O
colon	B-T033
##ize	I-T033
the	O
nematode	B-T204
interior	O
,	O
bind	O
to	O
its	O
cuticle	O
with	O
high	O
affinity	O
or	O
protect	O
the	O
nematode	B-T204
from	O
xenobiotic	B-T103
stress	B-T038
.	O
interestingly	O
,	O
strain	B-T007
bx	I-T007
##f1	I-T007
was	O
able	O
to	O
promote	O
tomato	B-T204
and	O
pine	B-T204
plant	B-T038
-	I-T038
growth	I-T038
,	O
as	O
well	O
as	O
to	O
colon	B-T033
##ize	I-T033
its	O
interior	O
,	O
thus	O
,	O
acting	O
like	O
a	O
plant	B-T038
-	I-T038
growth	I-T038
promoting	O
endop	B-T204
##hy	I-T204
##te	I-T204
.	O
consequently	O
,	O
strain	B-T007
bx	I-T007
##f1	I-T007
failed	O
to	O
induce	O
wil	B-T033
##ting	I-T033
symptoms	I-T033
when	O
inoculated	O
in	O
pine	B-T204
shoot	B-T204
artificial	O
incisions	O
.	O
this	O
bacterium	B-T007
also	O
presented	O
strong	O
antagonistic	B-T103
activities	O
against	O
fungi	B-T204
and	O
bacteria	B-T007
isolated	O
from	O
pin	B-T204
##us	I-T204
pin	I-T204
##aster	I-T204
.	O
our	O
results	O
suggest	O
that	O
b	B-T204
.	I-T204
xyl	I-T204
##ophilus	I-T204
does	O
not	O
possess	O
a	O
strict	O
symbiotic	O
community	O
capable	O
of	O
inducing	O
pine	B-T204
wil	B-T038
##t	I-T038
disease	I-T038
symptoms	B-T033
as	O
previously	O
hypothesized	O
.	O
we	O
show	O
that	O
bacteria	B-T007
like	O
bx	B-T007
##f1	I-T007
,	O
which	O
possess	O
plant	B-T038
-	I-T038
growth	I-T038
promoting	O
and	O
antagonistic	B-T103
effects	O
,	O
may	O
be	O
opportunistic	O
##ally	O
associated	O
with	O
b	B-T204
.	I-T204
xyl	I-T204
##ophilus	I-T204
,	O
possibly	O
acquired	O
from	O
the	O
bacterial	B-T007
endop	B-T204
##hy	I-T204
##tic	I-T204
community	I-T204
of	O
the	O
host	O
pine	B-T204
.	O

intrapartum	O
cervical	B-T037
lac	I-T037
##eration	I-T037
and	O
subsequent	O
pregnancy	B-T033
outcomes	I-T033
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
describe	O
pregnancy	B-T033
outcomes	I-T033
,	O
including	O
cervical	O
insufficiency	O
and	O
preterm	B-T033
birth	I-T033
,	O
in	O
the	O
subsequent	O
pregnancy	B-T038
following	O
an	O
intrapartum	O
cervical	B-T037
lac	I-T037
##eration	I-T037
.	O
retrospective	O
cohort	B-T098
of	O
women	B-T098
with	O
their	O
first	O
two	O
consecutive	O
singleton	B-T038
pregnancies	I-T038
carried	O
to	O
≥	O
20	O
(	O
0	O
/	O
7	O
)	O
weeks	O
'	O
gestation	B-T038
within	O
a	O
tertiary	B-T092
health	I-T092
care	I-T092
system	I-T092
from	O
2002	O
to	O
2012	O
.	O
cervical	B-T037
lac	I-T037
##eration	I-T037
cases	O
were	O
identified	O
by	O
icd	B-T170
##9	I-T170
codes	I-T170
and	O
included	O
if	O
suture	B-T058
repair	I-T058
was	O
required	O
.	O
in	O
this	O
study	B-T062
,	O
55	O
women	B-T098
were	O
confirmed	B-T033
to	O
have	O
a	O
cervical	B-T037
lac	I-T037
##eration	I-T037
in	O
the	O
first	O
delivery	B-T038
;	O
43	O
lac	B-T037
##eration	I-T037
##s	I-T037
after	O
vaginal	B-T058
delivery	I-T058
(	B-T058
vd	I-T058
)	I-T058
and	O
12	O
after	O
cesarean	B-T058
delivery	I-T058
(	B-T058
cd	I-T058
)	I-T058
.	O
the	O
median	O
gestational	O
age	O
of	O
the	O
first	O
delivery	B-T038
was	O
40	O
(	O
0	O
/	O
7	O
)	O
weeks	O
and	O
the	O
median	O
birth	O
weight	O
3	O
,	O
54	O
##5	O
g	O
;	O
these	O
did	O
not	O
differ	O
between	O
vd	B-T058
and	O
cd	B-T058
.	O
in	O
the	O
second	O
pregnancy	B-T038
,	O
2	O
of	O
55	O
women	B-T098
(	O
4	O
.	O
6	O
%	O
)	O
had	O
a	O
prophylactic	O
cerc	B-T058
##la	I-T058
##ge	I-T058
placed	O
;	O
1	O
carried	O
to	O
term	B-T038
and	O
the	O
other	O
delivered	B-T033
at	O
35	O
(	O
6	O
/	O
7	O
)	O
weeks	O
.	O
in	O
total	O
,	O
four	O
women	B-T098
(	O
9	O
.	O
3	O
%	O
)	O
delivered	B-T033
the	O
second	O
pregnancy	B-T038
<	O
37	O
weeks	O
:	O
three	O
had	O
a	O
prior	O
term	B-T038
vd	B-T058
and	O
one	O
had	O
a	O
prior	O
34	O
weeks	O
vd	B-T058
.	O
there	O
was	O
only	O
one	O
case	O
of	O
recurrent	O
cervical	B-T037
lac	I-T037
##eration	I-T037
,	O
occurring	O
in	O
the	O
setting	O
of	O
vaginal	B-T058
deliveries	I-T058
.	O
obstetric	O
cervical	B-T037
lac	I-T037
##eration	I-T037
##s	I-T037
are	O
uncommon	O
.	O
complications	B-T038
in	O
the	O
following	O
pregnancy	B-T038
were	O
low	O
,	O
despite	O
lack	O
of	O
additional	O
prophylactic	O
cerc	B-T058
##la	I-T058
##ge	I-T058
use	O
.	O

nationwide	O
reduction	O
in	O
the	O
number	O
of	O
corneal	B-T058
transplantations	I-T058
for	O
keratoconus	B-T038
following	O
the	O
implementation	O
of	O
cross	O
-	O
linking	O
keratoconus	B-T038
is	O
characterized	O
by	O
corneal	B-T038
ect	I-T038
##asia	I-T038
and	O
irregular	B-T038
astigmatism	I-T038
,	O
which	O
can	O
lead	O
to	O
diminished	B-T038
vision	I-T038
and	O
corneal	B-T033
scarring	I-T033
.	O
approximately	O
10	O
-	O
20	O
%	O
of	O
patients	O
with	O
keratoconus	B-T038
eventually	O
require	O
a	O
corneal	B-T058
transplant	I-T058
.	O
corneal	O
cross	O
-	O
linking	O
(	O
cx	O
##l	O
)	O
is	O
a	O
relatively	O
new	O
treatment	B-T058
that	O
may	O
help	O
prevent	O
the	O
need	O
for	O
corneal	B-T058
transplantation	I-T058
.	O
here	O
,	O
we	O
investigated	O
whether	O
the	O
introduction	O
of	O
cx	O
##l	O
has	O
reduced	O
the	O
number	O
of	O
corneal	B-T058
transplants	I-T058
performed	O
annually	O
.	O
data	O
regarding	O
the	O
transplantation	B-T058
procedures	I-T058
performed	O
in	O
patients	O
under	O
the	O
age	O
of	O
50	O
years	O
were	O
extracted	O
from	O
the	O
dutch	B-T170
national	I-T170
organ	I-T170
transplant	I-T170
registry	I-T170
.	O
the	O
number	O
of	O
corneal	B-T058
transplants	I-T058
performed	O
prior	O
to	O
(	O
i	O
.	O
e	O
.	O
in	O
2005	O
through	O
2007	O
)	O
and	O
following	O
the	O
introduction	O
of	O
cx	O
##l	O
(	O
i	O
.	O
e	O
.	O
in	O
2012	O
through	O
2014	O
)	O
were	O
compared	O
.	O
furthermore	O
,	O
a	O
trend	O
analysis	O
on	O
annual	O
kerat	B-T058
##oplast	I-T058
##ies	I-T058
over	O
time	O
was	O
performed	O
.	O
approximately	O
25	O
%	O
fewer	O
corneal	B-T058
transplants	I-T058
were	O
performed	O
in	O
the	O
3	O
-	O
year	O
period	O
following	O
the	O
introduction	O
of	O
cx	O
##l	O
compared	O
to	O
the	O
3	O
-	O
year	O
period	O
prior	O
to	O
the	O
introduction	O
of	O
cx	O
##l	O
(	O
201	O
versus	O
269	O
transplants	B-T058
,	O
respectively	O
;	O
p	O
=	O
0	O
.	O
005	O
)	O
.	O
age	O
,	O
gender	O
and	O
visual	B-T201
acuity	I-T201
were	O
similar	O
between	O
the	O
patient	O
groups	O
in	O
the	O
two	O
time	O
periods	O
.	O
trend	O
analysis	O
also	O
demonstrated	O
a	O
significant	O
decrease	O
in	O
the	O
amount	O
of	O
corneal	B-T058
transplants	I-T058
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
significantly	O
fewer	O
corneal	B-T058
transplants	I-T058
were	O
performed	O
for	O
treating	O
keratoconus	B-T038
following	O
the	O
nationwide	O
introduction	O
of	O
cx	O
##l	O
.	O
this	O
reduction	O
suggests	O
that	O
corneal	O
cross	O
-	O
linking	O
can	O
significantly	O
reduce	O
the	O
need	O
for	O
corneal	B-T058
transplantation	I-T058
.	O

multivariate	O
imaging	B-T058
genetics	B-T062
study	I-T062
of	O
mri	B-T058
gray	B-T017
matter	I-T017
volume	O
and	O
snps	B-T082
reveals	O
biological	O
pathways	O
correlated	O
with	O
brain	B-T017
structural	B-T082
differences	O
in	O
attention	B-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
attention	B-T038
deficit	I-T038
hyperactivity	I-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
is	O
a	O
prevalent	O
neurodevelopmental	B-T038
disorder	I-T038
affecting	O
children	O
,	O
adolescents	O
,	O
and	O
adults	O
.	O
its	O
etiology	O
is	O
not	O
well	O
understood	O
,	O
but	O
it	O
is	O
increasingly	O
believed	O
to	O
result	O
from	O
diverse	O
pathophys	B-T038
##iol	I-T038
##og	I-T038
##ies	I-T038
that	O
affect	O
the	O
structure	B-T082
and	O
function	O
of	O
specific	O
brain	O
circuits	O
.	O
although	O
one	O
of	O
the	O
best	O
-	O
studied	O
neurobiological	B-T038
abnormalities	I-T038
in	O
adhd	B-T038
is	O
reduced	O
fronto	B-T017
-	I-T017
striatal	I-T017
-	I-T017
cerebellar	I-T017
gray	I-T017
matter	I-T017
(	O
gm	B-T017
)	O
volume	O
,	O
its	O
specific	O
genetic	O
correlates	O
are	O
largely	O
unknown	O
.	O
in	O
this	O
study	B-T062
,	O
t1	O
-	O
weighted	O
mr	O
images	O
of	O
brain	O
structure	O
were	O
collected	O
from	O
198	O
adolescents	O
(	O
63	O
adhd	B-T038
-	O
diagnosed	B-T033
)	O
.	O
a	O
multivariate	O
parallel	O
independent	O
component	O
analysis	O
(	O
para	O
-	O
ica	O
)	O
technique	O
-	O
identified	O
imaging	B-T058
genetic	O
relationships	O
between	O
regional	B-T082
gm	B-T017
volume	O
and	O
single	B-T082
nucleotide	I-T082
polymorphism	I-T082
data	O
.	O
para	O
-	O
ica	O
analyses	O
extracted	O
14	O
components	O
from	O
genetic	B-T170
data	I-T170
and	O
9	O
from	O
mr	B-T058
data	O
.	O
an	O
iterative	B-T062
cross	I-T062
-	I-T062
validation	I-T062
using	O
randomly	O
chosen	O
subsam	O
##ples	O
indicated	O
acceptable	O
stability	O
of	O
these	O
ica	O
solutions	O
.	O
a	O
series	O
of	O
partial	O
correlation	O
analyses	O
controlling	O
for	O
age	O
,	O
sex	O
,	O
and	O
ethnicity	O
revealed	O
two	O
genotype	O
-	O
phenotype	O
component	O
pairs	O
significantly	O
differed	O
between	O
adhd	B-T038
and	O
non	B-T033
-	I-T033
adhd	I-T033
groups	O
,	O
after	O
a	O
bonferroni	O
correction	O
for	O
multiple	O
comparisons	O
.	O
the	O
brain	B-T017
phenotype	O
component	O
not	O
only	O
included	O
structures	B-T082
frequently	O
found	O
to	O
have	O
abnormally	O
low	O
volume	O
in	O
previous	O
adhd	B-T038
studies	B-T062
but	O
was	O
also	O
significantly	O
associated	O
with	O
adhd	B-T038
differences	O
in	O
symptom	B-T033
severity	I-T033
and	O
performance	O
on	O
cognitive	B-T170
tests	I-T170
frequently	O
found	O
to	O
be	O
impaired	O
in	O
patients	O
diagnosed	B-T033
with	O
the	O
disorder	B-T038
.	O
pathway	B-T170
analysis	I-T170
of	O
the	O
genotype	O
component	O
identified	O
several	O
different	O
biological	O
pathways	O
linked	O
to	O
these	O
structural	B-T082
abnormalities	B-T033
in	O
adhd	B-T038
.	O
some	O
of	O
these	O
pathways	O
implicate	O
well	O
-	O
known	O
dopaminergic	B-T038
neurotransmission	I-T038
and	O
neurodevelop	O
##ment	O
hypothesized	O
to	O
be	O
abnormal	B-T033
in	O
adhd	B-T038
.	O
other	O
more	O
recently	O
implicated	O
pathways	O
included	O
glutamatergic	B-T038
and	O
gaba	B-T038
-	I-T038
er	I-T038
##ic	I-T038
physiological	I-T038
systems	I-T038
;	O
others	O
might	O
reflect	O
sources	O
of	O
shared	O
liability	O
to	O
disturbances	O
commonly	O
found	O
in	O
adhd	B-T038
,	O
such	O
as	O
sleep	B-T033
abnormalities	I-T033
.	O

characterization	O
of	O
exposure	B-T037
in	O
epidemiological	B-T062
studies	I-T062
on	O
air	O
pollution	O
from	O
biodegradable	O
wastes	O
:	O
misclass	B-T170
##ification	I-T170
and	O
comparison	O
of	O
exposure	B-T037
assessment	B-T058
strategies	B-T062
the	O
assignment	O
of	O
exposure	B-T037
is	O
one	O
of	O
the	O
main	O
challenges	O
faced	O
by	O
environmental	B-T082
epidem	B-T097
##iol	I-T097
##og	I-T097
##ists	I-T097
.	O
however	O
,	O
misclass	B-T170
##ification	I-T170
of	O
exposures	B-T037
has	O
not	O
been	O
explored	O
in	O
population	B-T098
epidemiological	B-T062
studies	I-T062
on	O
air	O
pollution	O
from	O
biodegradable	O
wastes	O
.	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
the	O
use	O
of	O
different	O
approaches	O
for	O
assessing	O
exposure	B-T037
to	O
air	O
pollution	O
from	O
biodegradable	O
wastes	O
by	O
analyzing	B-T062
(	O
1	O
)	O
the	O
misclass	B-T170
##ification	I-T170
of	O
exposure	B-T037
that	O
is	O
committed	O
by	O
using	O
these	O
surrogate	O
##s	O
,	O
(	O
2	O
)	O
the	O
existence	O
of	O
differenti	O
##a	O
l	O
misclass	B-T170
##ification	I-T170
(	O
3	O
)	O
the	O
effects	O
that	O
misclass	B-T170
##ification	I-T170
may	O
have	O
on	O
health	O
effect	O
estimates	O
and	O
the	O
interpretation	O
of	O
epidemiological	B-T062
results	O
,	O
and	O
(	O
4	O
)	O
the	O
ability	O
of	O
the	O
exposure	B-T037
measures	O
to	O
predict	O
health	O
outcomes	O
using	O
10	O
-	O
fold	O
cross	B-T062
validation	I-T062
.	O
four	O
different	O
exposure	B-T037
assessment	B-T058
approaches	O
were	O
studied	B-T062
:	O
ammonia	B-T103
concentrations	O
at	O
the	O
residence	B-T082
(	O
metric	O
i	O
)	O
,	O
distance	O
to	O
the	O
closest	O
source	B-T033
(	O
metric	O
ii	O
)	O
,	O
number	O
of	O
sources	B-T033
within	O
certain	O
distances	O
from	O
the	O
residence	B-T082
(	O
metric	O
iiia	O
,	O
b	O
)	O
and	O
location	B-T082
in	O
a	O
specific	O
region	B-T082
(	O
metric	O
iv	O
)	O
.	O
exposure	B-T170
-	I-T170
response	I-T170
models	I-T170
based	O
on	O
metric	O
i	O
provided	O
the	O
highest	O
predictive	O
ability	O
(	O
72	O
.	O
3	O
%	O
)	O
and	O
good	O
##ness	O
-	O
of	O
-	O
fit	O
,	O
followed	O
by	O
iv	O
,	O
iii	O
and	O
ii	O
.	O
when	O
compared	O
to	O
metric	O
i	O
,	O
metric	O
iv	O
yielded	O
the	O
best	O
results	O
for	O
exposure	B-T037
misclass	B-T170
##ification	I-T170
analysis	B-T062
and	O
interpretation	O
of	O
health	O
effect	O
estimates	O
,	O
followed	O
by	O
metric	O
iiib	O
,	O
iiia	O
and	O
ii	O
.	O
the	O
study	B-T062
showed	O
that	O
modelled	O
nh3	B-T103
concentrations	O
provide	O
more	O
accurate	O
estimations	O
of	O
true	O
exposure	B-T037
than	O
distances	O
-	O
based	O
surrogate	O
##s	O
,	O
and	O
that	O
distance	O
-	O
based	O
surrogate	O
##s	O
(	O
especially	O
those	O
based	O
on	O
distance	O
to	O
the	O
closest	O
point	O
source	B-T033
)	O
are	O
imprec	O
##ise	O
methods	O
to	O
identify	O
exposed	O
populations	B-T098
,	O
although	O
they	O
may	O
be	O
useful	O
for	O
initial	O
studies	B-T062
.	O

recombinant	O
mhc	B-T017
tetramer	I-T017
##s	I-T017
for	O
isolation	B-T058
of	O
virus	B-T005
-	O
specific	O
cd8	B-T017
(	I-T017
+	I-T017
)	I-T017
cells	I-T017
from	O
healthy	O
donors	O
:	O
potential	O
approach	O
for	O
cell	B-T058
therapy	I-T058
of	O
posttransplant	B-T038
cytomegalovirus	I-T038
infection	I-T038
patients	O
undergoing	O
allogeneic	O
hematopoietic	B-T058
stem	I-T058
cell	I-T058
transplantation	I-T058
have	O
a	O
high	O
risk	O
of	O
cytomegalovirus	B-T038
reactivation	I-T038
,	O
which	O
in	O
the	O
absence	O
of	O
t	B-T038
-	I-T038
cell	I-T038
immunity	I-T038
can	O
result	O
in	O
the	O
development	O
of	O
an	O
acute	B-T033
inflammatory	I-T033
reaction	I-T033
and	O
damage	B-T037
of	I-T037
internal	I-T037
organs	I-T037
.	O
transfusion	B-T058
of	O
the	O
virus	O
-	O
specific	O
donor	B-T017
t	I-T017
-	I-T017
lymphocytes	I-T017
represents	O
an	O
alternative	O
to	O
a	O
highly	O
toxic	O
and	O
often	O
ineffective	O
antiviral	B-T058
therapy	I-T058
.	O
potentially	O
promising	O
cell	B-T058
therapy	I-T058
approach	O
comprises	O
transfusion	B-T058
of	O
cytotoxic	B-T017
t	I-T017
-	I-T017
lymphocytes	I-T017
,	O
specific	O
to	O
the	O
viral	B-T103
antigens	I-T103
,	O
immediately	O
after	O
their	O
isolation	B-T058
from	O
the	O
donor	B-T038
'	I-T038
s	I-T038
blood	I-T038
circulation	I-T038
without	O
any	O
in	O
vitro	O
expansion	O
.	O
specific	O
t	B-T017
-	I-T017
cells	I-T017
could	O
be	O
separated	O
from	O
potentially	O
allo	B-T017
##re	I-T017
##active	I-T017
lymphocytes	I-T017
using	O
recombinant	O
major	B-T017
histocompatibility	I-T017
complex	I-T017
(	O
mhc	B-T017
)	O
multim	O
##ers	O
,	O
carrying	O
synthetic	O
viral	O
peptides	O
.	O
rapid	O
transfusion	B-T058
of	O
virus	B-T005
-	O
specific	O
t	B-T017
-	I-T017
cells	I-T017
to	O
patients	O
has	O
several	O
crucial	O
advantages	O
in	O
comparison	O
with	O
methods	O
based	O
on	O
the	O
in	O
vitro	O
expansion	O
of	O
the	O
cells	B-T017
.	O
about	O
30	O
%	O
of	O
hematopoietic	O
stem	O
cell	O
donors	O
and	O
46	O
%	O
of	O
transplant	O
recipients	O
at	O
the	O
national	B-T092
research	I-T092
center	I-T092
for	I-T092
hematology	I-T092
were	O
carriers	O
of	O
the	O
hla	B-T017
-	I-T017
a	I-T017
*	I-T017
02	I-T017
allele	I-T017
.	O
moreover	O
,	O
94	O
%	O
of	O
russian	B-T098
donors	O
have	O
an	O
immune	B-T038
response	I-T038
against	O
the	O
cytomegalovirus	B-T005
(	O
cmv	B-T005
)	O
.	O
using	O
recombinant	O
hla	B-T017
-	I-T017
a	I-T017
*	I-T017
02	I-T017
multim	O
##ers	O
carrying	O
an	O
immunodom	O
##inant	O
cytomegalovirus	B-T103
peptide	I-T103
(	O
nl	B-T103
##v	I-T103
)	O
,	O
we	O
have	O
shown	O
that	O
the	O
majority	O
of	O
healthy	O
donors	O
have	O
pronounced	O
t	B-T038
-	I-T038
cell	I-T038
immunity	I-T038
against	O
this	O
antigen	B-T103
,	O
whereas	O
shortly	O
after	O
the	O
transplantation	B-T058
the	O
patients	O
do	O
not	O
have	O
specific	O
t	B-T017
-	I-T017
lymphocytes	I-T017
.	O
the	O
donor	B-T017
cells	I-T017
have	O
the	O
immune	O
phenotype	O
of	O
memory	B-T017
cells	I-T017
and	O
can	O
be	O
activated	B-T038
and	O
proliferate	B-T038
after	O
stimulation	O
with	O
the	O
specific	O
antigen	B-T103
.	O
donor	B-T033
lymphocytes	I-T033
can	O
be	O
substantially	O
enriched	O
to	O
significant	O
purity	O
by	O
magnetic	B-T058
separation	I-T058
with	O
recombinant	O
mhc	B-T017
multim	O
##ers	O
and	O
are	O
not	O
activated	O
upon	O
coc	B-T058
##ult	I-T058
##ivation	I-T058
with	O
the	O
antigen	B-T103
-	O
presenting	O
cells	B-T017
from	O
hla	B-T103
-	O
incompatible	B-T098
donors	I-T098
without	O
addition	O
of	O
the	O
specific	O
antigen	B-T103
.	O
this	O
study	B-T062
demonstrated	O
that	O
strong	O
immune	B-T038
response	I-T038
to	O
cmv	B-T005
of	O
healthy	O
donors	O
and	O
prevalence	O
of	O
hla	B-T017
-	I-T017
a	I-T017
*	I-T017
02	I-T017
allele	I-T017
in	O
the	O
russian	B-T098
population	I-T098
make	O
it	O
possible	O
to	O
isolate	O
a	O
significant	O
number	O
of	O
virus	O
-	O
specific	O
cells	B-T017
using	O
hla	B-T017
-	I-T017
a	I-T017
*	I-T017
02	I-T017
-	I-T017
nl	I-T017
##v	I-T017
multim	O
##ers	O
.	O
after	O
the	O
transfusion	B-T058
,	O
these	O
cells	B-T017
should	O
protect	O
patients	O
from	O
cmv	B-T005
without	O
development	O
of	O
allogeneic	O
immune	B-T038
response	I-T038
.	O

economic	O
burden	O
of	O
illness	B-T033
among	O
patients	O
with	O
severe	B-T033
asthma	I-T033
in	O
a	O
managed	O
care	O
setting	O
despite	O
intensive	O
pharmacotherapy	B-T058
,	O
a	O
considerable	O
number	O
of	O
patients	O
with	O
severe	B-T033
asthma	I-T033
have	O
inadequate	O
disease	B-T038
control	O
.	O
patients	O
with	O
severe	B-T033
asthma	I-T033
who	O
experience	B-T038
exacerbations	B-T033
consume	O
significant	O
health	O
care	O
resources	O
.	O
to	O
assess	O
health	O
care	O
resource	O
utilization	O
and	O
associated	O
costs	O
among	O
patients	O
with	O
persistent	O
severe	B-T033
asthma	I-T033
who	O
experienced	B-T038
exacerbations	B-T033
compared	O
with	O
patients	O
with	O
persistent	O
but	O
nons	O
##ever	O
##e	O
asthma	B-T038
.	O
this	O
retrospective	O
analysis	B-T062
of	O
a	O
national	B-T170
administrative	I-T170
claims	I-T170
database	I-T170
identified	O
patients	O
aged	O
≥	O
12	O
years	O
who	O
had	O
at	O
least	O
1	O
medical	O
claim	O
with	O
an	O
asthma	B-T038
diagnosis	B-T033
in	O
2012	O
and	O
had	O
continuous	O
medical	O
and	O
pharmacy	O
coverage	O
under	O
a	O
commercial	B-T170
or	O
medicare	O
advantage	O
plan	O
from	O
january	O
1	O
,	O
2012	O
,	O
to	O
december	O
31	O
,	O
2013	O
.	O
patients	O
were	O
assigned	O
to	O
1	O
of	O
2	O
mutually	O
exclusive	O
cohorts	B-T098
-	O
persistent	B-T038
asthma	I-T038
(	O
pa	B-T038
)	O
or	O
severe	B-T033
asthma	I-T033
(	O
sa	B-T033
)	O
-	O
according	O
to	O
an	O
established	O
algorithm	B-T170
based	O
on	O
asthma	B-T038
-	O
related	O
health	O
care	O
resource	O
use	O
and	O
pharmacy	O
claims	O
for	O
controller	B-T103
medication	I-T103
.	O
sa	B-T033
patients	O
were	O
required	O
to	O
meet	O
pa	B-T038
criteria	O
and	O
also	O
have	O
evidence	O
of	O
≥2	O
asthma	B-T033
exacerbations	I-T033
in	O
2012	O
.	O
asthma	B-T038
-	O
related	O
health	O
care	O
resource	O
utilization	O
and	O
costs	O
were	O
computed	O
from	O
asthma	B-T038
medication	B-T058
use	O
(	O
rescue	O
and	O
controller	O
therapy	O
)	O
and	O
medical	O
claims	O
with	O
an	O
asthma	B-T038
diagnosis	B-T033
in	O
the	O
primary	B-T082
position	I-T082
in	O
2012	O
and	O
2013	O
.	O
adherence	O
to	O
controller	O
therapy	O
was	O
assessed	O
over	O
365	O
days	O
by	O
using	O
the	O
proportion	O
of	O
days	O
covered	O
(	O
pdc	O
)	O
,	O
starting	O
with	O
the	O
first	O
claim	O
for	O
controller	O
therapy	O
in	O
2012	O
.	O
differences	O
between	O
the	O
pa	B-T038
and	O
sa	B-T033
cohorts	B-T098
were	O
analyzed	B-T062
by	O
t	B-T170
-	I-T170
test	I-T170
for	O
continuous	O
variables	O
and	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
for	O
categorical	O
variables	O
.	O
asthma	B-T038
-	O
related	O
costs	O
in	O
2013	O
were	O
also	O
analyzed	B-T062
using	O
a	O
generalized	O
linear	O
model	O
with	O
a	O
gamma	O
distribution	O
and	O
log	B-T170
link	I-T170
,	O
adjusted	O
for	O
patient	O
demographics	O
(	O
age	O
,	O
gender	O
,	O
region	B-T082
,	O
and	O
insurance	O
type	O
)	O
and	O
quan	O
-	O
char	O
##ls	O
##on	O
comorbidity	O
score	O
.	O
a	O
total	O
of	O
65	O
,	O
35	O
##9	O
patients	O
were	O
included	O
:	O
63	O
,	O
59	O
##7	O
(	O
97	O
.	O
3	O
%	O
)	O
pa	B-T038
patients	O
and	O
1	O
,	O
76	O
##2	O
sa	B-T033
patients	O
(	O
2	O
.	O
7	O
%	O
)	O
.	O
compared	O
with	O
the	O
pa	B-T038
cohort	B-T098
,	O
the	O
sa	B-T033
cohort	B-T098
was	O
older	O
(	O
mean	O
age	O
=	O
50	O
.	O
8	O
years	O
vs	O
.	O
46	O
.	O
5	O
years	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
had	O
higher	O
mean	O
comorbidity	O
score	O
(	O
1	O
.	O
47	O
vs	O
.	O
1	O
.	O
31	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
mean	O
count	O
of	O
all	O
asthma	B-T038
medications	B-T058
fill	O
##s	O
was	O
2	O
.	O
2	O
-	O
fold	O
(	O
2012	O
)	O
and	O
2	O
.	O
1	O
-	O
fold	O
(	O
2013	O
)	O
higher	O
in	O
the	O
sa	B-T033
cohort	B-T098
,	I-T098
compared	O
with	O
the	O
pa	B-T038
cohort	B-T098
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
mean	O
pdc	O
for	O
all	O
oral	B-T103
and	O
inhaled	B-T038
controller	B-T058
therapy	I-T058
was	O
also	O
higher	O
in	O
the	O
sa	B-T033
cohort	B-T098
compared	O
with	O
the	O
pa	B-T038
cohort	B-T098
(	O
0	O
.	O
80	O
vs	O
.	O
0	O
.	O
65	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
sa	B-T033
patients	O
had	O
a	O
significantly	O
greater	O
mean	O
count	O
of	O
asthma	B-T038
-	O
related	O
hospitalizations	B-T058
,	O
emergency	B-T058
room	I-T058
visits	I-T058
,	O
and	O
ambulatory	O
visits	O
in	O
2012	O
and	O
2013	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
unadjusted	O
mean	O
annual	O
asthma	B-T038
-	O
related	O
costs	O
in	O
the	O
sa	B-T033
versus	O
pa	B-T038
cohorts	B-T098
were	O
$	O
6	O
,	O
49	O
##6	O
versus	O
$	O
2	O
,	O
73	O
##9	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
2012	O
and	O
$	O
5	O
,	O
174	O
versus	O
$	O
1	O
,	O
77	O
##5	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
2013	O
.	O
higher	O
asthma	B-T038
-	O
related	O
costs	O
were	O
driven	O
by	O
greater	O
mean	O
annual	O
asthma	B-T038
medication	B-T058
costs	O
in	O
2012	O
(	O
$	O
4	O
,	O
54	O
##5	O
vs	O
.	O
$	O
1	O
,	O
73	O
##8	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
2013	O
(	O
$	O
4	O
,	O
06	O
##8	O
vs	O
.	O
$	O
1	O
,	O
348	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
adjusted	O
mean	O
annual	O
asthma	B-T038
-	O
related	O
costs	O
in	O
2013	O
were	O
$	O
3	O
,	O
336	O
greater	O
(	O
cost	O
ratio	O
=	O
2	O
.	O
87	O
##8	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
the	O
sa	B-T033
cohort	B-T098
,	O
and	O
adjusted	O
mean	O
annual	O
asthma	B-T038
medication	B-T058
costs	O
were	O
$	O
2	O
,	O
67	O
##2	O
higher	O
(	O
cost	O
ratio	O
=	O
2	O
.	O
98	O
##2	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
the	O
sa	B-T033
cohort	B-T098
.	O
patients	O
with	O
sa	B-T033
who	O
experienced	B-T038
2	O
or	O
more	O
exacerbations	B-T033
had	O
2	O
.	O
1	O
-	O
fold	O
greater	O
use	O
of	O
controller	B-T058
medications	I-T058
across	O
both	O
study	O
years	O
and	O
were	O
more	O
adherent	O
to	O
controller	O
therapy	O
than	O
patients	O
with	O
pa	B-T038
.	O
despite	O
more	O
intensive	O
pharmacotherapy	B-T058
,	O
sa	B-T033
patients	O
incurred	O
2	O
.	O
9	O
-	O
fold	O
higher	O
adjusted	O
asthma	B-T038
-	O
related	O
costs	O
and	O
3	O
-	O
fold	O
higher	O
adjusted	O
asthma	B-T038
medication	B-T058
costs	O
than	O
pa	B-T038
patients	O
.	O
patients	O
with	O
sa	B-T033
consistently	O
demonstrated	O
a	O
higher	O
rate	O
of	O
health	B-T058
care	I-T058
utilization	O
.	O
funding	O
for	O
this	O
study	B-T062
(	O
ho	O
-	O
14	O
-	O
144	O
##43	O
)	O
was	O
provided	O
by	O
gla	B-T092
##x	I-T092
##osm	I-T092
##ith	I-T092
##kl	I-T092
##ine	I-T092
(	O
gsk	B-T092
)	O
.	O
all	O
listed	O
authors	B-T097
meet	O
the	O
criteria	O
for	O
authors	O
##hip	O
set	O
forth	O
by	O
the	O
international	O
committee	O
for	O
medical	O
journal	O
editor	O
##s	O
.	O
alb	O
##ers	O
,	O
fors	O
##ha	O
##g	O
,	O
and	O
y	O
##ance	O
##y	O
are	O
employees	B-T097
of	O
gsk	B-T092
and	O
hold	O
stock	O
in	O
gsk	B-T092
.	O
dal	O
##al	O
,	O
nag	O
##ar	O
,	O
and	O
or	O
##te	O
##ga	O
were	O
employees	B-T097
of	O
gsk	B-T092
at	O
the	O
time	O
this	O
research	B-T062
was	O
conducted	O
.	O
cha	O
##st	O
##ek	O
and	O
ko	O
##r	O
##re	O
##r	O
are	O
employees	B-T097
of	O
opt	O
##um	O
,	O
which	O
received	O
consulting	O
fee	O
##s	O
from	O
gsk	B-T092
for	O
research	B-T062
related	O
to	O
this	O
study	B-T062
.	O
study	O
concept	O
and	O
design	O
were	O
contributed	O
by	O
cha	O
##st	O
##ek	O
,	O
nag	O
##ar	O
,	O
and	O
dal	O
##al	O
.	O
ko	O
##r	O
##re	O
##r	O
took	O
the	O
lead	O
in	O
data	B-T062
collection	I-T062
,	O
along	O
with	O
cha	O
##st	O
##ek	O
,	O
and	O
data	O
interpretation	O
was	O
performed	O
by	O
cha	O
##st	O
##ek	O
,	O
or	O
##te	O
##ga	O
,	O
fors	O
##ha	O
##g	O
,	O
and	O
dal	O
##al	O
.	O
the	O
manuscript	B-T170
was	O
written	O
by	O
cha	O
##st	O
##ek	O
and	O
dal	O
##al	O
and	O
revised	O
by	O
alb	O
##ers	O
and	O
y	O
##ancy	O
,	O
assisted	O
by	O
the	O
other	O
authors	B-T097
.	O

gh	B-T103
##32	I-T103
family	I-T103
activity	B-T038
:	O
a	O
topological	B-T082
approach	O
through	O
protein	O
contact	O
networks	O
the	O
application	O
of	O
protein	O
contact	O
networks	O
methodology	O
allowed	O
to	O
highlight	O
a	O
novel	O
response	O
of	O
border	O
region	O
between	O
the	O
two	O
domains	B-T082
to	I-T082
substrate	I-T082
binding	I-T082
.	O
glycoside	B-T103
hydrolase	I-T103
##s	I-T103
(	O
gh	B-T103
)	O
are	O
enzymes	B-T103
that	O
mainly	O
hydroly	O
##ze	O
the	O
glycos	O
##idic	O
bond	O
between	O
two	O
carbohydrates	B-T103
or	O
a	O
carbohydrate	B-T103
and	O
a	O
non	O
-	O
carbohydrate	O
moiety	O
.	O
these	O
enzymes	B-T103
are	O
involved	O
in	O
many	O
fundamental	O
and	O
diverse	O
biological	B-T038
processes	I-T038
in	O
plants	B-T204
.	O
we	O
have	O
focused	O
on	O
the	O
gh	B-T103
##32	I-T103
family	I-T103
,	O
including	O
enzymes	B-T103
very	O
similar	O
in	O
both	O
sequence	B-T082
and	O
structure	O
,	O
each	O
having	O
however	O
clear	O
specificities	O
of	O
substrate	O
preferences	O
and	O
kinetic	O
properties	O
.	O
structural	B-T103
and	O
topological	B-T082
differences	O
among	O
proteins	B-T103
of	O
the	O
gh	B-T103
##32	I-T103
family	I-T103
have	O
been	O
here	O
identified	O
by	O
means	O
of	O
an	O
emerging	O
approach	O
(	O
protein	O
contact	O
network	O
,	O
pc	O
##n	O
)	O
based	O
on	O
the	O
formal	O
##ization	O
of	O
3d	B-T082
structures	I-T082
as	O
contact	O
networks	O
among	O
amino	B-T082
-	I-T082
acid	I-T082
residues	I-T082
.	O
the	O
pc	O
##n	O
approach	O
proved	O
successful	O
in	O
both	O
reconstruct	O
##ing	O
the	O
already	O
known	O
functional	O
domains	B-T082
and	O
in	O
identifying	O
the	O
structural	B-T103
counterpart	O
of	O
the	O
properties	O
of	O
gh	B-T103
##32	I-T103
enzymes	I-T103
,	O
which	O
remain	O
uncertain	O
,	O
like	O
their	O
allosteric	O
character	O
.	O
the	O
main	O
outcome	O
of	O
the	O
study	O
was	O
the	O
discovery	O
of	O
the	O
activation	B-T038
upon	O
binding	B-T038
of	I-T038
the	I-T038
border	I-T038
(	I-T038
cleft	I-T038
)	I-T038
region	I-T038
between	O
the	O
two	O
domains	B-T082
.	O
this	O
reveals	O
the	O
allosteric	O
nature	O
of	O
the	O
enzymatic	B-T038
activity	I-T038
for	O
all	O
the	O
analyzed	O
forms	O
in	O
the	O
gh	B-T103
##32	I-T103
family	I-T103
,	O
a	O
character	O
yet	O
to	O
be	O
highlighted	O
in	O
biochemical	B-T058
studies	I-T058
.	O
furthermore	O
,	O
we	O
have	O
been	O
able	O
to	O
recognize	O
a	O
topological	B-T082
signature	I-T082
(	O
graph	O
energy	O
)	O
of	O
the	O
different	O
affinity	O
of	O
the	O
enzymes	B-T103
towards	O
small	O
and	O
large	O
substrates	O
.	O

genetic	O
diversity	O
of	O
ta	B-T204
##enia	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
(	O
ces	B-T204
##to	I-T204
##da	I-T204
:	O
cyclo	B-T204
##ph	I-T204
##yll	I-T204
##ide	I-T204
##a	I-T204
)	O
from	O
la	B-T082
##o	I-T082
people	I-T082
'	I-T082
s	I-T082
dem	I-T082
##ocratic	I-T082
republic	I-T082
and	O
northeastern	B-T082
thailand	B-T082
based	O
on	O
mitochondrial	B-T103
dna	I-T103
ta	B-T204
##enia	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
is	O
a	O
tape	B-T204
##worm	I-T204
found	O
in	O
cattle	B-T204
worldwide	O
.	O
analysis	B-T062
of	O
genetic	O
diversity	O
in	O
different	O
geographical	O
populations	O
of	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
not	O
only	O
helps	O
to	O
understand	O
the	O
origin	O
,	O
transmission	O
and	O
spread	O
of	O
this	O
organism	O
,	O
but	O
also	O
to	O
evaluate	O
the	O
selection	O
pressures	O
acting	O
on	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
and	O
how	O
it	O
is	O
responding	O
to	O
them	O
.	O
however	O
,	O
there	O
are	O
few	O
reports	O
of	O
the	O
genetic	O
variability	O
of	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
populations	I-T204
in	O
different	O
regions	B-T082
of	O
the	O
world	B-T098
,	O
including	O
la	B-T082
##o	I-T082
pdr	I-T082
and	O
thailand	B-T082
.	O
we	O
report	O
the	O
genetic	B-T103
diversity	I-T103
of	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
populations	I-T204
in	O
la	B-T082
##o	I-T082
pdr	I-T082
and	O
northeastern	B-T082
thailand	B-T082
together	O
with	O
sequences	B-T082
of	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
from	O
other	O
countries	B-T082
deposited	O
in	O
genbank	B-T170
.	O
mitochondrial	B-T017
cox	I-T017
##1	I-T017
sequence	B-T058
analysis	I-T058
revealed	O
that	O
15	O
and	O
8	O
haplotypes	O
were	O
identified	O
in	O
30	O
and	O
21	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
isolates	O
from	O
la	B-T082
##o	I-T082
pdr	I-T082
and	O
northeastern	B-T082
thailand	B-T082
,	O
respectively	O
.	O
fifty	O
-	O
three	O
haplotypes	O
were	O
identified	O
from	O
98	O
sequences	B-T082
.	O
phylogenetic	B-T062
tree	I-T062
and	O
haplotype	B-T062
network	I-T062
analyses	I-T062
revealed	O
that	O
global	O
isolates	O
of	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
were	O
genetically	O
divided	O
into	O
five	O
groups	O
(	O
a	O
,	O
b	O
,	O
c1	O
,	O
c2	O
and	O
d	O
)	O
.	O
ta	B-T204
##enia	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
isolates	O
from	O
la	B-T082
##o	I-T082
pdr	I-T082
and	O
northeastern	B-T082
thailand	B-T082
belonged	O
to	O
either	O
group	O
a	O
or	O
b	O
.	O
ta	B-T204
##enia	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
from	O
western	B-T082
thailand	B-T082
clustered	O
in	O
groups	O
c1	O
,	O
c2	O
and	O
d	O
,	O
and	O
populations	B-T204
from	O
the	O
northeast	B-T082
and	O
western	B-T082
thailand	B-T082
were	O
found	O
to	O
be	O
genetically	O
distinct	O
.	O
ta	B-T204
##enia	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
isolates	O
in	O
la	B-T082
##o	I-T082
pdr	I-T082
and	O
thailand	B-T082
were	O
also	O
found	O
to	O
be	O
genetically	O
diverse	O
but	O
the	O
degree	O
of	O
genetic	B-T038
differentiation	I-T038
was	O
low	O
.	O
ta	B-T204
##enia	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
populations	I-T204
from	O
la	B-T082
##o	I-T082
pdr	I-T082
and	O
northeastern	B-T082
thailand	B-T082
are	O
genetically	O
distinct	O
from	O
the	O
population	B-T204
in	O
western	B-T082
thailand	B-T082
and	O
it	O
is	O
proposed	O
that	O
t	B-T204
.	I-T204
sag	I-T204
##ina	I-T204
##ta	I-T204
has	O
been	O
dispersed	O
by	O
different	O
transmission	O
routes	O
in	O
southeast	B-T082
asia	I-T082
.	O

sex	O
life	O
and	O
impact	O
of	O
operative	O
intervention	B-T058
on	O
sex	B-T033
life	I-T033
-	I-T033
related	I-T033
pain	I-T033
in	O
degenerative	B-T038
spinal	B-T017
conditions	O
:	O
an	O
analysis	B-T062
of	O
the	O
sport	B-T062
study	I-T062
this	O
study	B-T062
is	O
a	O
therapeutic	B-T062
retrospective	I-T062
cohort	I-T062
study	I-T062
objectives	O
.	O
:	O
this	O
study	B-T062
aims	O
to	O
determine	O
whether	O
sexual	B-T038
function	I-T038
is	O
relevant	O
for	O
patients	O
with	O
spinal	B-T017
stenosis	I-T017
(	O
sps	B-T017
)	O
and	O
degenerative	B-T038
spondyl	I-T038
##olis	I-T038
##thesis	I-T038
(	O
ds	B-T038
)	O
and	O
to	O
determine	O
the	O
impact	O
of	O
operative	O
inter	O
v	O
##q	O
##ave	O
##nt	O
##ion	O
on	O
sexual	B-T038
function	I-T038
for	O
these	O
patients	O
.	O
the	O
benefits	O
of	O
nonoperative	O
versus	O
operative	O
treatment	O
for	O
patients	O
with	O
sps	B-T017
and	O
ds	B-T038
with	O
regards	O
to	O
sexual	B-T038
function	I-T038
are	O
unknown	O
.	O
demographic	O
,	O
treatment	O
,	O
and	O
follow	B-T058
-	I-T058
up	I-T058
data	O
,	O
including	O
the	O
os	O
##west	O
##ry	O
disability	O
index	O
(	O
od	O
##i	O
)	O
,	O
were	O
obtained	O
on	O
patients	O
enrolled	O
in	O
the	O
sport	B-T062
study	I-T062
.	O
based	O
on	O
the	O
response	O
to	O
question	O
#	O
9	O
in	O
the	O
od	O
##i	O
,	O
patients	O
were	O
classified	O
into	O
a	O
sexual	O
life	O
relevant	O
(	O
sl	O
##r	O
)	O
or	O
sexual	O
life	O
not	O
relevant	O
(	O
nr	O
)	O
group	O
.	O
univariate	O
and	O
multivariate	O
analysis	O
of	O
patient	O
characteristics	O
comparing	O
the	O
nr	O
and	O
sl	O
##r	O
group	O
were	O
performed	O
.	O
operative	O
treatment	O
groups	O
were	O
compared	O
to	O
the	O
nonoperative	O
group	O
with	O
regards	O
to	O
response	O
to	O
od	O
##i	O
question	O
#	O
9	O
to	O
determine	O
the	O
impact	O
of	O
surgery	B-T058
on	O
sexual	B-T038
function	I-T038
.	O
a	O
total	O
of	O
123	O
##5	O
patients	O
were	O
included	O
to	O
determine	O
relevance	O
of	O
sex	O
life	O
.	O
three	O
hundred	O
sixty	O
-	O
six	O
patients	O
(	O
29	O
%	O
)	O
were	O
included	O
in	O
the	O
nr	O
group	O
.	O
eight	O
hundred	O
sixty	O
-	O
nine	O
patients	O
(	O
71	O
%	O
)	O
were	O
included	O
in	O
the	O
sl	O
##r	O
group	O
.	O
patients	O
that	O
were	O
older	B-T098
,	O
female	O
,	O
unm	B-T098
##arr	I-T098
##ied	I-T098
,	O
had	O
three	O
or	O
more	O
stenotic	O
levels	O
,	O
and	O
had	O
central	O
stenosis	O
were	O
more	O
likely	O
to	O
be	O
in	O
the	O
nr	O
group	O
.	O
eight	O
hundred	O
twenty	O
-	O
five	O
patients	O
were	O
included	O
in	O
the	O
analysis	B-T062
comparing	O
operative	O
versus	O
nonoperative	O
treatment	O
.	O
at	O
all	O
follow	B-T058
-	I-T058
up	I-T058
time	O
points	O
,	O
the	O
operative	O
groups	O
had	O
a	O
lower	O
percentage	O
of	O
patients	O
reporting	O
pain	B-T033
with	O
their	O
sex	O
life	O
compared	O
to	O
the	O
nonoperative	O
group	O
(	O
p	O
<	O
0	O
.	O
05	O
at	O
all	O
time	O
points	O
except	O
between	O
more	O
than	O
one	O
level	O
fusion	O
and	O
nonoperative	O
at	O
4	O
years	O
'	O
follow	B-T058
-	I-T058
up	I-T058
)	O
.	O
sex	O
life	O
is	O
a	O
relevant	O
consideration	O
for	O
the	O
majority	O
of	O
patients	O
with	O
ds	B-T038
and	O
sps	B-T017
;	O
operative	O
treatment	O
leads	O
to	O
improved	B-T033
sex	B-T033
life	I-T033
-	I-T033
related	I-T033
pain	I-T033
.	O
3	O
.	O

master	O
##s	O
athletes	O
:	O
exempl	O
##ars	O
of	O
successful	B-T038
aging	I-T038
?	O
global	B-T098
population	I-T098
aging	B-T038
has	O
raised	B-T033
academic	I-T033
interest	I-T033
in	O
successful	B-T038
aging	I-T038
to	O
a	O
public	O
policy	O
priority	O
.	O
currently	O
there	O
is	O
no	O
consensus	O
regarding	O
the	O
definition	O
of	O
successful	B-T038
aging	I-T038
.	O
however	O
,	O
a	O
synthesis	O
of	O
research	O
shows	O
successful	B-T038
aging	I-T038
can	O
be	O
defined	O
as	O
a	O
late	B-T038
-	I-T038
life	I-T038
process	I-T038
of	I-T038
change	I-T038
characterized	O
by	O
high	B-T033
physical	I-T033
,	O
psychological	B-T038
,	O
cognitive	B-T038
,	O
and	O
social	O
functioning	O
.	O
master	O
##s	O
athletes	O
systematically	O
train	O
for	O
,	O
and	O
compete	O
in	O
,	O
organized	O
forms	O
of	O
team	O
and	O
individual	O
sport	O
specifically	O
designed	O
for	O
older	B-T098
adults	I-T098
.	O
master	O
##s	O
athletes	O
are	O
often	O
proposed	O
as	O
exempl	O
##ars	O
of	O
successful	B-T038
aging	I-T038
.	O
however	O
,	O
their	O
aging	B-T033
status	I-T033
has	O
never	O
been	O
examined	O
using	O
a	O
comprehensive	O
multidimensional	B-T082
successful	B-T038
aging	I-T038
definition	O
.	O
here	O
,	O
we	O
examine	O
the	O
successful	B-T170
aging	I-T170
literature	I-T170
,	O
propose	O
a	O
successful	B-T038
aging	I-T038
definition	O
based	O
on	O
this	O
literature	B-T170
,	O
present	O
evidence	O
which	O
suggests	O
master	O
##s	O
athletes	O
could	O
be	O
considered	O
exempl	O
##ars	O
of	O
successful	B-T038
aging	I-T038
according	O
to	O
the	O
proposed	O
definition	O
,	O
and	O
list	O
future	O
experimental	B-T062
research	I-T062
directions	O
.	O

early	O
hippocampal	B-T017
volume	B-T033
loss	I-T033
as	O
a	O
marker	B-T201
of	O
eventual	O
memory	B-T038
deficits	I-T038
caused	O
by	O
repeated	B-T033
stress	I-T033
exposure	O
to	O
severe	O
and	O
prolonged	O
stress	B-T033
has	O
detrimental	B-T033
effects	I-T033
on	O
the	O
hippocampus	B-T017
.	O
however	O
,	O
relatively	O
little	O
is	O
known	O
about	O
the	O
gradual	O
changes	O
in	O
hippocampal	B-T017
structure	I-T017
,	O
and	O
its	O
behavioral	O
consequences	O
,	O
over	O
the	O
course	O
of	O
repeated	B-T033
stress	I-T033
.	O
behavioral	B-T058
analyses	I-T058
during	O
10	O
days	O
of	O
chronic	O
stress	O
pointed	O
to	O
a	O
delayed	O
decline	O
in	O
spatial	B-T038
memory	I-T038
,	O
the	O
full	O
impact	O
of	O
which	O
is	O
evident	O
only	O
after	O
the	O
end	O
of	O
stress	B-T033
.	O
in	O
contrast	O
,	O
concurrent	O
volumetric	O
measurements	O
in	O
the	O
same	O
animals	B-T204
revealed	O
significant	O
reduction	O
in	O
hippocampal	B-T017
volumes	O
in	O
stressed	B-T033
animals	B-T204
relative	O
to	O
their	O
unst	B-T033
##ressed	I-T033
counterparts	I-T033
,	O
as	O
early	O
as	O
the	O
third	O
day	O
of	O
stress	B-T033
.	O
notably	O
,	O
animals	B-T204
that	O
were	O
behavioral	O
##ly	O
the	O
worst	O
affected	O
at	O
the	O
end	O
of	O
chronic	O
stress	O
suffered	B-T038
the	O
most	O
pronounced	O
early	B-T033
loss	I-T033
in	I-T033
hippocampal	I-T033
volume	I-T033
.	O
together	O
,	O
these	O
findings	O
support	O
the	O
view	O
that	O
not	O
only	O
is	O
smaller	O
hippocampal	B-T017
volume	O
linked	O
to	O
stress	B-T033
-	O
induced	O
memory	B-T038
deficits	I-T038
,	O
but	O
it	O
may	O
also	O
act	O
as	O
an	O
early	O
risk	B-T033
factor	I-T033
for	O
the	O
eventual	O
development	O
of	O
cognitive	B-T038
impairments	I-T038
seen	O
in	O
stress	O
-	O
related	O
psychiatric	O
disorders	O
.	O

γ	B-T103
-	I-T103
but	I-T103
##enol	I-T103
##ide	I-T103
and	O
furan	B-T103
##one	I-T103
derivatives	I-T103
from	O
the	O
soil	O
-	O
derived	O
fungus	B-T204
aspergillus	B-T204
scler	I-T204
##oti	I-T204
##orum	I-T204
ps	B-T204
##u	I-T204
-	I-T204
rs	I-T204
##pg	I-T204
##17	I-T204
##8	I-T204
chromatographic	B-T058
separation	I-T058
of	O
the	O
broth	B-T103
extract	O
of	O
the	O
soil	O
-	O
derived	O
fungus	B-T204
aspergillus	B-T204
scler	I-T204
##oti	I-T204
##orum	I-T204
ps	B-T204
##u	I-T204
-	I-T204
rs	I-T204
##pg	I-T204
##17	I-T204
##8	I-T204
resulted	O
in	O
isolation	O
of	O
four	O
γ	B-T103
-	I-T103
but	I-T103
##enol	I-T103
##ide	I-T103
-	I-T103
furan	I-T103
##one	I-T103
dimers	I-T103
,	O
asper	B-T103
##sc	I-T103
##ler	I-T103
##oti	I-T103
##or	I-T103
##ones	I-T103
a	I-T103
-	I-T103
d	I-T103
,	O
a	O
furan	B-T103
##one	I-T103
derivative	I-T103
,	O
asper	B-T103
##sc	I-T103
##ler	I-T103
##oti	I-T103
##or	I-T103
##one	I-T103
e	I-T103
,	O
and	O
two	O
γ	B-T103
-	I-T103
but	I-T103
##enol	I-T103
##ide	I-T103
derivatives	I-T103
,	O
asper	B-T103
##sc	I-T103
##ler	I-T103
##oti	I-T103
##or	I-T103
##ones	I-T103
f	I-T103
and	O
g	B-T103
,	O
together	O
with	O
six	O
known	O
compounds	O
,	O
penicill	B-T103
##ic	I-T103
acid	I-T103
,	O
dihydrop	B-T103
##enic	I-T103
##illi	I-T103
##c	I-T103
acid	I-T103
,	O
5	B-T103
,	I-T103
6	I-T103
-	I-T103
dihydro	I-T103
-	I-T103
6	I-T103
-	I-T103
hydroxyp	I-T103
##enic	I-T103
##illi	I-T103
##c	I-T103
acid	I-T103
,	O
6	B-T103
-	I-T103
methoxy	I-T103
-	I-T103
5	I-T103
,	I-T103
6	I-T103
-	I-T103
dihydrop	I-T103
##enic	I-T103
##illi	I-T103
##c	I-T103
acid	I-T103
,	O
coc	B-T103
##ul	I-T103
##no	I-T103
##l	I-T103
and	O
(	B-T103
4	I-T103
##r	I-T103
,	I-T103
5	I-T103
##r	I-T103
)	I-T103
-	I-T103
4	I-T103
,	I-T103
5	I-T103
-	I-T103
dihydroxy	I-T103
-	I-T103
3	I-T103
-	I-T103
methoxy	I-T103
-	I-T103
5	I-T103
-	I-T103
methyl	I-T103
##cycl	I-T103
##ohex	I-T103
-	I-T103
2	I-T103
-	I-T103
en	I-T103
-	I-T103
1	I-T103
-	I-T103
one	I-T103
.	O
their	O
structures	B-T170
were	O
determined	O
by	O
spectroscopic	B-T058
evidence	I-T058
.	O
for	O
asper	B-T103
##sc	I-T103
##ler	I-T103
##oti	I-T103
##or	I-T103
##ones	I-T103
a	I-T103
and	O
b	B-T103
,	O
the	O
structures	B-T170
were	O
confirmed	O
by	O
single	B-T058
-	I-T058
crystal	I-T058
x	I-T058
-	I-T058
ray	I-T058
diffraction	I-T058
crystallography	I-T058
.	O
penicill	O
##ic	O
acid	O
displayed	O
weak	O
antibacterial	B-T033
activity	I-T033
against	O
staphylococcus	B-T007
aureus	I-T007
and	O
escherichia	B-T007
coli	I-T007
with	O
equal	O
mic	B-T033
values	I-T033
of	O
128	O
μg	O
/	O
ml	O
,	O
and	O
it	O
was	O
nonc	O
##yt	O
##otoxic	O
towards	O
african	B-T204
green	I-T204
monkey	I-T204
kidney	B-T017
fibroblast	B-T017
cells	I-T017
.	O

psychometric	B-T058
properties	O
of	O
the	O
japanese	O
version	B-T170
of	O
short	O
forms	O
of	O
the	O
pain	B-T170
catastroph	I-T170
##izing	I-T170
scale	I-T170
in	O
participants	B-T098
with	O
musculoskeletal	B-T033
pain	I-T033
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
the	O
pain	B-T170
catastroph	I-T170
##izing	I-T170
scale	I-T170
(	O
pcs	B-T170
)	O
is	O
a	O
commonly	O
used	O
as	O
measure	O
of	O
pain	B-T038
catastroph	I-T038
##izing	I-T038
.	O
the	O
scale	B-T170
comprises	O
13	O
items	O
related	O
to	O
magnification	B-T058
,	O
rumin	B-T038
##ation	I-T038
,	O
and	O
help	B-T038
##lessness	I-T038
.	O
to	O
facilitate	O
quick	O
screening	B-T058
and	O
to	O
reduce	O
participant	B-T098
'	I-T098
s	I-T098
burden	O
,	O
the	O
four	O
-	O
item	O
and	O
six	O
-	O
item	O
short	O
forms	O
of	O
the	O
english	O
version	B-T170
of	O
the	O
pcs	B-T170
were	O
developed	O
.	O
the	O
purpose	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
evaluate	B-T058
the	O
psychometric	B-T058
properties	O
of	O
a	O
japanese	O
version	B-T170
of	O
the	O
short	O
forms	O
of	O
pcs	B-T170
using	O
a	O
contemporary	O
approach	O
called	O
ras	B-T062
##ch	I-T062
analysis	I-T062
.	O
a	O
total	O
of	O
216	O
patients	O
with	O
musculoskeletal	B-T038
disorders	I-T038
were	O
recruited	O
in	O
this	O
study	B-T062
.	O
participants	B-T098
completed	O
study	B-T062
measures	O
,	O
which	O
included	O
the	O
pain	B-T201
intensity	I-T201
,	O
the	O
pain	B-T170
catastroph	I-T170
##izing	I-T170
scale	I-T170
(	O
pcs	B-T170
)	O
,	O
and	O
the	O
tamp	B-T170
##a	I-T170
scale	I-T170
of	I-T170
kines	I-T170
##iop	I-T170
##ho	I-T170
##bia	I-T170
(	O
ts	B-T170
##k	I-T170
)	O
.	O
furthermore	O
,	O
the	O
four	O
-	O
item	O
(	O
items	O
3	O
,	O
6	O
,	O
8	O
,	O
and	O
11	O
)	O
and	O
six	O
-	O
item	O
(	O
items	O
4	O
,	O
5	O
,	O
6	O
,	O
10	O
,	O
11	O
,	O
and	O
13	O
)	O
short	O
forms	O
of	O
the	O
japanese	O
version	B-T170
of	O
pcs	B-T170
were	O
measured	O
.	O
we	O
used	O
ras	B-T062
##ch	I-T062
analysis	I-T062
to	O
analyze	O
the	O
psychometric	B-T058
properties	O
of	O
the	O
original	O
,	O
four	O
-	O
item	O
,	O
and	O
six	O
-	O
item	O
short	O
forms	O
of	O
pcs	B-T170
.	O
ras	B-T062
##ch	I-T062
analysis	I-T062
showed	O
that	O
both	O
short	O
forms	O
of	O
pcs	B-T170
had	O
acceptable	O
internal	O
consistency	O
,	O
unid	B-T082
##imensional	I-T082
##ity	I-T082
,	O
and	O
no	O
notable	O
dif	O
and	O
were	O
functional	O
on	O
the	O
category	B-T170
rating	I-T170
scale	I-T170
.	O
however	O
,	O
four	O
-	O
item	O
short	O
form	O
of	O
pcs	B-T170
had	O
two	O
mis	O
##fi	O
##t	O
items	O
.	O
six	O
-	O
item	O
short	O
form	O
of	O
pcs	B-T170
has	O
acceptable	O
psychometric	B-T058
properties	O
and	O
is	O
suitable	O
for	O
use	O
in	O
participants	B-T098
with	O
musculoskeletal	B-T033
pain	I-T033
.	O
thus	O
,	O
six	O
-	O
item	O
can	O
be	O
used	O
as	O
brief	O
instruments	B-T074
to	O
evaluate	B-T058
pain	B-T038
catastroph	I-T038
##izing	I-T038
.	O

shear	O
and	O
extension	O
##al	O
properties	O
of	O
ke	B-T103
##fi	I-T103
##ran	I-T103
ke	B-T103
##fi	I-T103
##ran	I-T103
is	O
a	O
neutral	B-T103
polysaccharide	I-T103
constituted	O
by	O
glucose	B-T103
and	O
galactose	B-T103
produced	O
by	O
lactobacillus	B-T007
ke	I-T007
##fi	I-T007
##ran	I-T007
##of	I-T007
##aciens	I-T007
.	O
it	O
is	O
included	O
into	O
ke	B-T168
##fi	I-T168
##r	I-T168
grains	I-T168
and	O
has	O
several	O
health	O
promoting	O
properties	O
.	O
in	O
the	O
present	O
work	O
,	O
shear	O
and	O
extension	O
##al	O
properties	O
of	O
different	O
ke	B-T103
##fi	I-T103
##ran	I-T103
aqueous	O
dispersions	O
(	O
0	O
.	O
5	O
,	O
1	O
and	O
2	O
%	O
wt	O
.	O
)	O
were	O
assessed	O
and	O
compared	O
to	O
other	O
neutral	B-T103
gum	I-T103
##s	I-T103
commonly	O
used	O
in	O
food	B-T168
,	O
cosmetic	O
and	O
pharmaceu	B-T092
##tics	I-T092
industries	I-T092
(	O
methyl	B-T103
##cellulose	I-T103
,	O
locus	O
##t	O
bean	O
gum	O
and	O
guar	B-T103
gum	I-T103
)	O
.	O
ke	B-T103
##fi	I-T103
##ran	I-T103
showed	O
shear	O
flow	O
characteristics	O
similar	O
to	O
that	O
displayed	O
by	O
other	O
representative	O
neutral	B-T103
gum	I-T103
##s	I-T103
,	O
although	O
it	O
always	O
yielded	O
lower	O
visco	O
##si	O
##ties	O
at	O
a	O
given	O
concentration	O
.	O
for	O
each	O
gum	B-T103
system	O
it	O
was	O
possible	O
to	O
find	O
a	O
correlation	O
between	O
dynamic	O
and	O
steady	O
shear	O
properties	O
by	O
a	O
master	B-T082
curve	I-T082
including	O
both	O
the	O
apparent	O
and	O
complex	O
visco	O
##si	O
##ties	O
.	O
when	O
studying	O
extension	O
##al	O
properties	O
of	O
selected	O
gum	B-T103
##s	I-T103
at	O
2	O
%	O
wt	O
.	O
by	O
means	O
of	O
a	O
capillary	O
break	O
-	O
up	O
rhe	O
##ometer	O
,	O
ke	B-T103
##fi	I-T103
##ran	I-T103
solutions	O
did	O
not	O
show	O
important	O
extension	O
##al	O
properties	O
,	O
displaying	O
a	O
behaviour	O
close	O
the	O
new	O
##ton	O
##ian	O
.	O

fluoride	B-T103
concentration	O
in	O
saliva	B-T031
and	O
biofilm	B-T007
fluid	I-T007
following	O
the	O
application	B-T058
of	O
three	O
fluoride	B-T103
var	I-T103
##nish	I-T103
##es	I-T103
most	O
of	O
the	O
commercially	O
available	O
fluoride	B-T103
var	I-T103
##nish	I-T103
##es	I-T103
(	O
fv	B-T103
)	O
have	O
not	O
been	O
evaluated	B-T058
for	O
their	O
car	B-T038
##io	I-T038
##static	I-T038
properties	I-T038
.	O
consequently	O
,	O
the	O
aim	O
of	O
this	O
in	B-T082
vivo	I-T082
study	B-T062
was	O
to	O
investigate	B-T058
intra	B-T082
-	O
oral	B-T082
fluoride	B-T103
retention	O
and	O
clearance	B-T033
patterns	I-T033
from	O
three	O
different	O
fv	B-T103
.	O
eighteen	O
subjects	B-T098
(	O
7	O
-	O
11	O
years	O
)	O
participated	O
in	O
a	O
laboratory	B-T092
analys	O
##t	O
-	O
blinded	B-T062
,	O
randomized	B-T062
,	O
crossover	B-T062
study	I-T062
comparing	O
the	O
ability	O
of	O
5	O
%	O
sodium	B-T103
fluoride	I-T103
var	I-T103
##nish	I-T103
##es	I-T103
(	O
cavity	B-T103
##sh	I-T103
##ield	I-T103
-	I-T103
cs	I-T103
,	O
enamel	B-T103
pro	I-T103
-	I-T103
ep	I-T103
,	O
van	B-T103
##ish	I-T103
-	I-T103
v	I-T103
)	O
to	O
enhance	O
fluoride	B-T103
concentrations	O
in	O
biofilm	B-T007
fluid	I-T007
,	O
centrifug	B-T031
##ed	I-T031
and	O
whole	O
saliva	B-T031
over	O
a	O
period	O
of	O
48	O
##h	O
after	O
a	O
single	O
fv	B-T103
application	O
.	O
similar	O
fluoride	B-T103
concentration	O
×	O
time	O
patterns	O
were	O
noted	B-T170
for	O
all	O
investigated	O
fv	B-T103
and	O
studied	B-T062
variables	O
,	O
with	O
the	O
highest	O
fluoride	B-T103
concentrations	O
observed	O
for	O
the	O
first	O
biological	O
sample	O
collected	O
after	O
fv	B-T103
application	O
(	O
30	O
##min	O
)	O
.	O
mean	O
##±	O
##se	O
(	O
area	O
under	O
fluoride	O
clearance	O
curve	O
)	O
values	O
were	O
(	O
μg	O
f	O
/	O
g	O
or	O
ml	O
##×	O
##min	O
)	O
:	O
biofilm	B-T007
fluid	I-T007
-	O
cs	B-T103
(	O
47	O
##2	O
##±1	O
##91	O
)	O
,	O
ep	B-T103
(	O
42	O
##3	O
##±7	O
##5	O
)	O
,	O
v	B-T103
(	O
126	O
##4	O
##±2	O
##79	O
)	O
;	O
centrifug	B-T031
##ed	I-T031
saliva	B-T031
-	O
cs	B-T103
(	O
42	O
##±7	O
)	O
,	O
ep	B-T103
(	O
19	O
##±3	O
)	O
,	O
v	B-T103
(	O
41	O
##±	O
##8	O
)	O
;	O
whole	O
saliva	B-T031
-	O
cs	B-T103
(	O
68	O
##±1	O
##1	O
)	O
,	O
ep	B-T103
(	O
64	O
##±1	O
##0	O
)	O
,	O
v	B-T103
(	O
60	O
##±7	O
)	O
.	O
v	B-T103
delivered	O
more	O
fluoride	B-T103
to	O
biofilm	B-T007
fluid	I-T007
than	O
cs	B-T103
(	O
p	O
=	O
0	O
.	O
011	O
##6	O
)	O
and	O
ep	B-T103
(	O
p	O
=	O
0	O
.	O
006	O
##5	O
)	O
,	O
which	O
did	O
not	O
differ	O
(	O
p	O
=	O
0	O
.	O
27	O
)	O
.	O
for	O
centrifug	B-T031
##ed	I-T031
saliva	B-T031
,	O
cs	B-T103
and	O
v	B-T103
were	O
not	O
significantly	O
different	O
(	O
p	O
=	O
0	O
.	O
86	O
)	O
,	O
but	O
resulted	O
in	O
higher	O
fluoride	B-T103
retention	O
than	O
ep	B-T103
(	O
p	O
<	O
0	O
.	O
000	O
##8	O
)	O
.	O
no	O
significant	O
differences	O
among	O
fv	B-T103
were	O
observed	O
for	O
whole	O
saliva	B-T031
(	O
p	O
=	O
0	O
.	O
79	O
)	O
.	O
the	O
present	B-T033
study	B-T062
has	O
shown	O
that	O
fv	B-T103
vary	O
in	O
their	O
ability	O
to	O
deliver	O
fluoride	B-T103
intra	B-T082
-	O
orally	B-T082
potentially	O
related	O
to	O
formulation	O
differences	O
.	O
to	O
what	O
extent	B-T082
the	O
present	B-T033
findings	B-T033
relate	O
to	O
clinical	O
efficacy	O
remains	O
,	O
however	O
,	O
to	O
be	O
determined	B-T058
.	O
clinical	B-T062
research	I-T062
that	O
investigates	B-T058
fluoride	B-T103
release	O
patterns	B-T082
into	O
saliva	B-T031
and	O
biofilm	B-T007
fluid	I-T007
from	O
different	O
fv	B-T103
products	I-T103
is	O
insufficient	O
.	O
more	O
research	B-T062
is	O
needed	O
to	O
investigate	B-T058
different	O
fv	B-T103
formulations	I-T103
for	O
their	O
efficacy	O
in	O
order	O
to	O
help	O
clinicians	B-T097
make	O
better	O
evidence	O
based	O
treatment	O
choices	O
.	O

effects	O
of	O
obesity	B-T038
on	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
system	O
in	O
heart	B-T017
,	O
adipose	B-T017
tissue	I-T017
and	O
liver	B-T017
:	O
study	B-T062
in	O
the	O
experimental	B-T170
model	I-T170
of	O
z	B-T204
##ucker	I-T204
rats	I-T204
suppression	B-T103
of	I-T103
tumorigenicity	I-T103
2	I-T103
(	O
st	B-T103
##2	I-T103
)	O
mediates	O
the	O
effect	O
of	O
interleukin	B-T103
-	I-T103
33	I-T103
(	O
il	B-T103
-	I-T103
33	I-T103
)	O
.	O
few	O
data	O
are	O
reported	O
on	O
the	O
relationship	O
between	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
and	O
obesity	B-T038
.	O
we	O
aimed	O
to	O
investigate	O
effects	O
of	O
obesity	B-T038
on	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
system	O
in	O
heart	B-T017
,	O
adipose	B-T017
tissue	I-T017
and	O
liver	B-T017
in	O
a	O
rodent	B-T038
model	I-T038
of	O
obesity	B-T038
.	O
the	O
relationship	O
of	O
cardiac	B-T017
expression	B-T038
of	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
system	O
with	O
natriuretic	B-T103
peptides	I-T103
(	O
nps	B-T103
)	O
system	O
and	O
inflammatory	B-T038
mediators	I-T038
was	O
also	O
studied	O
.	O
mrna	B-T038
expression	I-T038
of	O
il	B-T017
-	I-T017
33	I-T017
/	O
st	B-T017
##2	I-T017
system	O
was	O
evaluated	O
in	O
cardiac	B-T058
,	O
adipose	B-T017
and	O
hepatic	B-T058
biopsies	I-T058
from	O
obese	B-T204
z	I-T204
##ucker	I-T204
rats	I-T204
(	O
o	B-T204
)	O
and	O
controls	O
(	O
co	O
)	O
.	O
expression	B-T038
levels	O
of	O
sst	B-T103
##2	I-T103
was	O
significantly	O
lower	O
in	O
o	B-T204
rats	I-T204
compared	O
with	O
co	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
in	O
all	O
tissues	B-T017
.	O
besides	O
,	O
the	O
mrna	B-T103
levels	O
of	O
il	B-T017
-	I-T017
33	I-T017
decreased	O
significant	O
in	O
fat	O
of	O
o	B-T204
respect	O
to	O
co	O
,	O
while	O
,	O
expression	B-T038
levels	O
of	O
st	B-T017
##2	I-T017
##l	I-T017
was	O
significantly	O
higher	O
in	O
liver	B-T017
of	O
co	O
than	O
in	O
o	B-T204
.	O
a	O
strong	O
relationship	O
of	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
with	O
nps	B-T103
and	O
classical	O
inflammatory	B-T038
mediators	I-T038
was	O
observed	O
in	O
cardiac	B-T017
tissue	I-T017
.	O
expression	B-T038
of	O
sst	B-T103
##2	I-T103
in	O
cardiac	B-T017
,	O
adipose	B-T017
and	O
liver	B-T017
tissue	I-T017
decreased	O
in	O
o	B-T204
compared	O
with	O
controls	O
,	O
suggesting	O
an	O
involvement	O
for	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
system	O
in	O
molecular	B-T038
mechanisms	I-T038
of	O
obesity	B-T038
.	O
the	O
strong	O
relationships	O
with	O
np	B-T103
systems	O
and	O
inflammatory	B-T038
mediators	I-T038
could	O
suggest	O
an	O
involvement	O
for	O
il	B-T103
-	I-T103
33	I-T103
/	O
st	B-T103
##2	I-T103
in	O
molecular	B-T038
pathways	I-T038
leading	O
to	O
cardiac	B-T033
dysfunction	I-T033
and	O
inflammation	B-T038
associated	O
with	O
obesity	B-T038
.	O

functional	O
impairment	O
in	O
children	O
with	O
externalizing	B-T038
behavior	I-T038
disorders	I-T038
:	O
psychometric	B-T058
properties	O
of	O
the	O
we	B-T170
##iss	I-T170
functional	I-T170
impairment	I-T170
rating	I-T170
scale	I-T170
-	I-T170
parent	I-T170
report	I-T170
in	O
a	O
german	B-T082
clinical	O
sample	O
to	O
examine	O
the	O
psychometric	B-T058
properties	O
of	O
a	O
german	B-T082
adaptation	O
of	O
the	O
we	B-T170
##iss	I-T170
functional	I-T170
impairment	I-T170
rating	I-T170
scale	I-T170
-	I-T170
parent	I-T170
report	I-T170
(	O
w	B-T170
##fi	I-T170
##rs	I-T170
-	I-T170
p	I-T170
)	O
in	O
a	O
clinical	O
sample	O
of	O
children	O
(	O
4	O
-	O
12	O
years	O
)	O
with	O
externalizing	B-T038
behavior	I-T038
disorders	I-T038
.	O
data	O
were	O
collected	O
within	O
two	O
clinical	B-T062
trials	I-T062
(	O
n	O
=	O
264	O
)	O
.	O
factorial	O
validity	O
,	O
reliability	O
,	O
and	O
divergent	O
validity	O
from	O
symptoms	B-T033
of	O
adhd	B-T038
and	O
opposition	B-T038
##al	I-T038
def	I-T038
##iant	I-T038
disorder	I-T038
(	O
odd	B-T038
)	O
were	O
assessed	O
.	O
confirmatory	O
factor	O
analyses	O
revealed	O
that	O
a	O
bif	B-T170
##act	I-T170
##or	I-T170
model	I-T170
consistent	O
with	O
the	O
theoretical	O
assumption	O
of	O
a	O
general	B-T170
construct	I-T170
of	O
impairment	O
(	O
total	O
scale	O
)	O
and	O
additional	O
specific	O
factors	O
(	O
subscales	O
)	O
provided	O
satisfactory	O
data	O
fit	O
.	O
model	B-T170
-	O
based	O
reliability	O
estimates	O
showed	O
that	O
both	O
the	O
general	B-T170
construct	I-T170
and	O
specific	O
factors	O
accounted	O
for	O
item	O
variance	O
.	O
internal	O
consist	O
##encies	O
were	O
>	O
.	O
70	O
,	O
part	O
-	O
whole	O
corrected	O
item	O
-	O
scale	O
correlations	O
mostly	O
>	O
.	O
30	O
.	O
correlations	O
between	O
the	O
w	B-T170
##fi	I-T170
##rs	I-T170
-	I-T170
p	I-T170
scales	I-T170
and	O
adhd	B-T038
and	O
odd	B-T038
symptoms	B-T033
were	O
low	O
to	O
moderate	O
.	O
the	O
results	O
support	O
the	O
factorial	O
validity	O
,	O
reliability	O
,	O
and	O
divergent	O
validity	O
of	O
the	O
w	B-T170
##fi	I-T170
##rs	I-T170
-	I-T170
p	I-T170
.	O

unusual	O
asymptomatic	B-T038
presentation	I-T038
of	O
bladder	B-T038
cancer	I-T038
metastatic	B-T038
to	I-T038
the	I-T038
penis	I-T038
penile	B-T038
metastasis	I-T038
is	O
an	O
extremely	B-T038
rare	I-T038
event	I-T038
and	O
mainly	O
originate	O
from	O
primary	O
pelvic	B-T017
tumor	B-T082
sites	I-T082
such	O
us	O
urinary	B-T017
bladder	I-T017
,	O
gastro	B-T022
-	I-T022
intestinal	I-T022
tract	I-T022
and	O
prostate	B-T017
and	O
more	O
rarely	O
from	O
respiratory	B-T022
system	I-T022
,	O
bone	B-T038
tumors	I-T038
and	O
melanoma	B-T038
.	O
here	O
we	O
describe	O
the	O
unusual	O
presentation	O
of	O
two	O
bladder	B-T038
urothelial	I-T038
cancer	I-T038
metastatic	O
to	O
the	O
penis	B-T017
with	O
no	B-T033
relevant	I-T033
clinical	I-T033
symptoms	I-T033
.	O
namely	O
,	O
a	O
69	O
years	O
-	O
old	O
man	O
with	O
a	O
war	O
##thy	O
lesions	B-T033
of	O
the	O
fore	O
##sk	O
##in	O
and	O
the	O
gla	O
##ns	O
mis	O
##und	O
##ers	O
##to	O
##od	O
for	O
a	O
condyl	B-T038
##omat	I-T038
##a	I-T038
that	O
at	O
histological	B-T058
and	O
immunohistochemical	O
analysis	O
showed	O
a	O
bladder	B-T038
urothelial	I-T038
carcinoma	I-T038
;	O
and	O
a	O
71	O
years	O
-	O
old	O
man	O
with	O
red	O
##dis	O
##h	O
skin	O
lesion	O
of	O
the	O
gla	O
##ns	O
,	O
a	O
previous	O
history	B-T033
of	I-T033
bladder	I-T033
and	O
urethral	B-T038
carcinoma	I-T038
and	O
histological	B-T033
paget	I-T033
##oid	I-T033
spread	I-T033
of	O
urothelial	B-T038
cancer	I-T038
to	B-T017
the	I-T017
gla	I-T017
##ns	I-T017
.	O
recurrent	B-T038
bladder	I-T038
urothelial	I-T038
carcinoma	I-T038
is	O
usually	O
a	O
visceral	B-T017
disease	B-T038
that	O
rarely	O
presents	O
as	O
a	O
superficial	O
asymptomatic	B-T033
skin	B-T038
lesion	I-T038
.	O
the	O
two	O
reported	O
cases	B-T033
were	I-T033
asymptomatic	I-T033
superficial	B-T038
penis	I-T038
metastases	I-T038
with	O
a	O
relatively	O
slow	O
growth	O
and	O
a	O
fair	B-T033
##y	I-T033
good	I-T033
prognosis	I-T033
after	O
conservative	O
surgical	O
approach	O
.	O
accurate	O
clinical	O
examination	O
of	O
the	O
penis	O
is	O
mandatory	O
for	O
males	O
with	O
history	B-T033
of	I-T033
bladder	I-T033
cancer	I-T033
.	O

development	B-T038
of	O
chrys	B-T103
##in	I-T103
loaded	O
pol	B-T103
##ox	I-T103
##amer	I-T103
micelles	O
and	O
toxicity	O
evaluation	B-T058
in	O
fish	B-T204
embryos	B-T017
pol	B-T103
##ox	I-T103
##amer	I-T103
micelles	B-T103
promise	O
safety	O
and	O
efficacy	O
for	O
many	O
water	B-T103
insoluble	O
drugs	B-T103
.	O
chrys	B-T103
##in	I-T103
has	O
been	O
reported	O
to	O
have	O
anticancer	O
,	O
anti	O
-	O
inflammatory	O
,	O
antioxidant	B-T038
,	O
and	O
anti	B-T038
-	I-T038
aromatase	I-T038
activities	I-T038
but	O
its	O
water	B-T103
insoluble	O
properties	O
limit	O
its	O
pharmaceutical	B-T091
application	I-T091
.	O
in	O
the	O
present	O
study	O
,	O
chrys	B-T103
##in	I-T103
loaded	O
pol	B-T103
##ox	I-T103
##amer	I-T103
micelles	B-T103
were	O
developed	O
.	O
two	O
types	O
of	O
pol	B-T103
##ox	I-T103
##amers	I-T103
,	O
plur	B-T103
##onic	I-T103
f	I-T103
-	I-T103
68	I-T103
and	O
plur	B-T103
##onic	I-T103
f	I-T103
-	I-T103
127	I-T103
were	O
compared	O
.	O
it	O
was	O
found	O
that	O
chrys	B-T103
##in	I-T103
loaded	O
plur	B-T103
##onic	I-T103
f	I-T103
-	I-T103
68	I-T103
micelles	B-T103
(	O
cs	B-T103
-	I-T103
p	I-T103
##68	I-T103
)	O
and	O
chrys	B-T103
##in	I-T103
loaded	O
plur	B-T103
##onic	I-T103
f	I-T103
-	I-T103
127	I-T103
micelles	B-T103
(	O
cs	B-T103
-	I-T103
p1	I-T103
##27	I-T103
)	O
obviously	O
increase	O
the	O
aqueous	O
solubility	O
of	O
chrys	B-T103
##in	I-T103
.	O
the	O
results	O
also	O
indicated	O
that	O
the	O
type	O
of	O
polymer	B-T103
and	O
ratio	O
of	O
drug	B-T103
to	O
polymer	B-T103
affected	O
size	B-T082
and	O
desirable	O
characteristics	O
of	O
the	O
micelles	B-T103
.	O
the	O
micelle	B-T103
system	I-T103
of	O
cs	B-T103
-	I-T103
p	I-T103
##68	I-T103
and	O
cs	B-T103
-	I-T103
p1	I-T103
##27	I-T103
formed	O
at	O
drug	B-T103
to	O
polymer	B-T103
ratios	O
of	O
1	O
:	O
4	O
and	O
1	O
:	O
2	O
,	O
respectively	O
,	O
was	O
found	O
to	O
be	O
the	O
most	O
suitable	O
monod	O
##isperse	O
##d	O
system	O
with	O
a	O
nanos	O
##ize	O
-	O
range	O
diameter	O
.	O
the	O
in	O
vivo	O
study	O
in	O
zebrafish	B-T204
eggs	B-T017
indicates	O
that	O
the	O
toxicity	O
of	O
cs	B-T103
-	I-T103
p	I-T103
##68	I-T103
and	O
cs	B-T103
-	I-T103
p1	I-T103
##27	I-T103
is	O
a	O
dose	O
response	O
.	O
cs	B-T103
-	I-T103
p	I-T103
##68	I-T103
and	O
cs	B-T103
-	I-T103
p1	I-T103
##27	I-T103
at	O
a	O
drug	O
dose	O
of	O
10	O
ng	O
/	O
ml	O
or	O
less	O
is	O
safe	O
for	O
zebrafish	B-T204
embryo	B-T017
growth	B-T038
.	O
the	O
results	O
of	O
this	O
study	B-T062
indicate	O
enhanced	O
water	O
solubility	O
of	O
chrys	B-T103
##in	I-T103
.	O
chrys	B-T103
##in	I-T103
loaded	O
pol	B-T103
##ox	I-T103
##amer	I-T103
micelles	B-T103
are	O
promising	O
for	O
further	O
use	O
in	O
in	O
vivo	O
studies	O
in	O
mammalian	B-T204
animals	B-T204
and	O
humans	B-T204
.	O

assessment	B-T058
of	O
demographic	O
and	O
path	B-T033
##oa	I-T033
##nat	I-T033
##omic	I-T033
risk	I-T033
factors	I-T033
in	O
recurrent	O
patellofemoral	B-T082
instability	B-T033
the	O
war	B-T170
##ps	I-T170
/	I-T170
sta	I-T170
##id	I-T170
classification	I-T170
employs	O
clinical	O
assessment	B-T058
of	O
presenting	O
features	O
and	O
anatomic	O
characteristics	O
to	O
identify	O
two	O
distinct	O
subsets	B-T170
of	O
patients	O
within	O
the	O
patellofemoral	B-T033
instability	I-T033
population	O
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
further	O
define	O
the	O
specific	O
demographics	O
and	O
the	O
prevalence	O
of	O
risky	O
path	O
##oa	O
##nat	O
##om	O
##ies	O
in	O
patients	O
classified	O
as	O
either	O
war	B-T170
##ps	I-T170
or	O
sta	B-T170
##id	I-T170
presenting	O
with	O
recurrent	O
patellofemoral	B-T082
instability	B-T033
.	O
a	O
secondary	O
purpose	O
was	O
to	O
further	O
validate	O
the	O
war	B-T170
##ps	I-T170
/	I-T170
sta	I-T170
##id	I-T170
classification	I-T170
with	O
the	O
ban	B-T170
##ff	I-T170
patella	I-T170
instability	I-T170
instrument	I-T170
(	O
bp	B-T170
##ii	I-T170
)	O
,	O
the	O
mar	B-T170
##x	I-T170
activity	I-T170
scale	I-T170
and	O
the	O
patellar	B-T017
instability	B-T170
severity	I-T170
score	I-T170
(	O
iss	B-T170
)	O
.	O
a	O
convenience	O
sample	O
of	O
50	O
patients	O
with	O
recurrent	O
patellofemoral	B-T082
instability	B-T033
,	O
including	O
25	O
war	B-T170
##ps	I-T170
and	O
25	O
sta	B-T170
##id	I-T170
subtype	I-T170
patients	O
,	O
were	O
assessed	O
.	O
clinical	B-T170
data	I-T170
were	O
collected	O
including	O
assessment	B-T058
of	O
demographic	O
risk	B-T033
factors	I-T033
(	O
sex	O
,	O
bmi	B-T201
,	O
bilateral	B-T082
##ity	I-T082
of	O
symptoms	B-T033
,	O
affected	B-T082
limb	B-T017
side	I-T017
and	O
age	O
at	O
first	O
dislocation	B-T037
)	O
and	O
path	B-T033
##oa	I-T033
##nat	I-T033
##omic	I-T033
risk	I-T033
factors	I-T033
(	O
tt	O
-	O
tg	O
distance	O
,	O
patella	B-T017
height	O
,	O
patellar	O
tilt	O
,	O
grade	B-T170
of	O
troch	B-T038
##lear	I-T038
dysplasia	I-T038
,	O
be	O
##ight	O
##on	O
score	O
and	O
rotational	B-T033
abnormalities	I-T033
of	O
the	O
tibia	B-T017
or	O
femur	B-T017
)	O
.	O
patients	O
completed	O
the	O
bp	B-T170
##ii	I-T170
and	O
the	O
mar	B-T170
##x	I-T170
activity	I-T170
scale	I-T170
.	O
the	O
iss	B-T170
was	O
calculated	B-T058
from	O
the	O
clinical	B-T170
assessment	I-T170
data	I-T170
.	O
patients	O
were	O
stratified	O
into	O
the	O
war	B-T170
##ps	I-T170
or	O
sta	B-T170
##id	I-T170
subtypes	I-T170
for	O
comparative	O
analysis	O
.	O
an	O
independent	O
t	B-T170
test	I-T170
was	O
used	O
to	O
compare	O
demographics	O
,	O
the	O
path	B-T033
##oa	I-T033
##nat	I-T033
##omic	I-T033
risk	I-T033
factors	I-T033
and	O
subjective	O
measures	O
between	O
the	O
groups	O
.	O
convergent	O
validity	O
was	O
tested	O
with	O
a	O
pearson	O
r	O
correlation	O
coefficient	O
between	O
the	O
war	O
##ps	O
/	O
sta	O
##id	O
and	O
iss	B-T170
scores	I-T170
.	O
demographic	O
risk	O
factors	O
statistically	O
associated	O
with	O
a	O
war	B-T170
##ps	I-T170
subtype	I-T170
included	O
female	O
sex	O
,	O
age	O
at	O
first	O
dislocation	B-T037
and	O
bilateral	B-T082
##ity	I-T082
.	O
path	B-T033
##oa	I-T033
##nat	I-T033
##omic	I-T033
risk	I-T033
factors	I-T033
statistically	O
associated	O
with	O
a	O
war	B-T170
##ps	I-T170
subtype	I-T170
included	O
troch	B-T038
##lear	I-T038
dysplasia	I-T038
,	O
tt	O
-	O
tg	O
distance	O
,	O
generalized	O
ligament	B-T038
##ous	I-T038
laxity	I-T038
,	O
patellar	O
tilt	O
and	O
rotational	B-T033
abnormalities	I-T033
.	O
the	O
independent	O
t	B-T170
test	I-T170
revealed	O
a	O
significant	O
difference	O
between	O
the	O
iss	B-T170
scores	O
:	O
war	B-T170
##ps	I-T170
subtype	I-T170
(	O
m	O
=	O
4	O
.	O
4	O
,	O
sd	O
=	O
1	O
.	O
1	O
)	O
and	O
sta	B-T170
##id	I-T170
subtype	I-T170
(	O
m	O
=	O
2	O
.	O
5	O
,	O
sd	O
=	O
1	O
.	O
5	O
)	O
;	O
t	O
(	O
48	O
)	O
=	O
5	O
.	O
2	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O
the	O
relationship	O
between	O
the	O
war	O
##ps	O
/	O
sta	O
##id	O
and	O
the	O
iss	B-T170
scores	I-T170
,	O
measured	O
using	O
a	O
pearson	O
r	O
correlation	O
coefficient	O
,	O
demonstrated	O
a	O
strong	O
relationship	O
:	O
r	O
=	O
-	O
0	O
.	O
61	O
,	O
n	O
=	O
50	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O
this	O
study	B-T062
has	O
demonstrated	O
statistically	O
significant	O
evidence	O
that	O
certain	O
demographics	O
and	O
path	O
##oa	O
##nat	O
##om	O
##ies	O
are	O
more	O
prevalent	O
in	O
each	O
of	O
the	O
war	B-T170
##ps	I-T170
and	O
sta	B-T170
##id	I-T170
patellofemoral	B-T082
instability	B-T033
subtypes	B-T170
.	O
there	O
was	O
no	O
difference	O
in	O
quality	O
-	O
of	O
-	O
life	O
or	O
activity	O
level	O
between	O
the	O
subtypes	B-T170
.	O
the	O
war	O
##ps	O
/	O
sta	O
##id	O
score	O
demonstrated	O
convergent	O
validity	O
to	O
the	O
iss	B-T170
and	O
divergent	O
validity	O
to	O
the	O
bp	B-T170
##ii	I-T170
score	I-T170
and	O
the	O
mar	B-T170
##x	I-T170
activity	I-T170
scale	I-T170
.	O
this	O
study	B-T062
has	O
further	O
validated	O
both	O
the	O
war	B-T170
##ps	I-T170
/	I-T170
sta	I-T170
##id	I-T170
classification	I-T170
and	O
the	O
iss	B-T170
of	O
patients	O
that	O
present	O
with	O
recurrent	O
patellofemoral	B-T082
instability	B-T033
.	O
iii	O
.	O

preventing	O
youth	O
internalizing	O
symptoms	O
through	O
the	O
famil	O
##ias	O
unid	O
##as	O
intervention	O
:	O
examining	O
variation	O
in	O
response	B-T201
prevention	O
programs	O
that	O
strengthen	O
parenting	O
and	O
family	O
functioning	O
have	O
been	O
found	O
to	O
reduce	B-T058
poor	O
behavioral	O
outcomes	O
in	O
adolescents	O
,	O
including	O
substance	B-T038
use	I-T038
,	O
hiv	O
risk	O
,	O
externalizing	O
and	O
internalizing	O
problems	O
.	O
however	O
,	O
there	O
is	O
evidence	O
that	O
not	O
all	O
youth	O
benefit	O
similarly	O
from	O
these	O
programs	O
.	O
famil	O
##ias	O
unid	O
##as	O
is	O
a	O
family	O
-	O
focused	O
intervention	O
designed	O
to	O
prevent	O
substance	B-T038
use	I-T038
and	O
sexual	B-T033
risk	I-T033
among	O
hispanic	B-T098
youth	O
and	O
has	O
recently	O
demonstrated	O
un	O
##antic	O
##ipa	O
##ted	O
reductions	B-T058
in	O
internalizing	O
symptoms	O
for	O
some	O
youth	O
.	O
this	O
paper	O
examines	O
variation	O
in	O
intervention	O
response	O
for	O
internalizing	O
symptoms	O
using	O
individual	O
-	O
level	O
data	O
pooled	O
across	O
four	O
distinct	O
famil	O
##ias	O
unid	O
##as	O
trials	B-T062
:	O
(	O
1	O
)	O
266	O
eighth	B-T033
grade	I-T033
students	B-T098
recruited	O
from	O
the	O
general	O
school	B-T098
population	I-T098
;	O
(	O
2	O
)	O
160	O
ninth	B-T033
grade	I-T033
students	B-T098
from	O
the	O
general	O
school	B-T098
population	I-T098
;	O
(	O
3	O
)	O
213	O
adolescents	O
with	O
conduct	B-T038
,	O
aggression	O
,	O
and	O
/	O
or	O
attention	O
problems	O
;	O
and	O
(	O
4	O
)	O
242	O
adolescents	O
with	O
a	O
delinqu	B-T038
##ency	I-T038
history	O
.	O
causal	O
inference	O
growth	O
mixture	O
modeling	O
suggests	O
a	O
three	O
-	O
class	B-T170
model	B-T170
.	O
the	O
two	O
largest	O
classes	B-T170
represent	O
youth	O
with	O
low	O
(	O
60	O
%	O
)	O
and	O
medium	O
(	O
27	O
%	O
)	O
internalizing	O
symptoms	O
at	O
baseline	O
,	O
and	O
both	O
intervention	O
and	O
control	O
participants	B-T098
show	O
reductions	B-T058
in	O
internalizing	O
symptoms	O
.	O
the	O
third	O
class	B-T170
(	O
13	O
%	O
)	O
represents	O
youth	O
with	O
high	O
levels	O
of	O
baseline	O
internalizing	O
symptoms	O
who	O
remain	O
at	O
steady	O
levels	O
of	O
internalizing	O
symptoms	O
when	O
exposed	O
to	O
the	O
intervention	O
,	O
but	O
who	O
experience	O
an	O
increase	O
in	O
symptoms	O
under	O
the	O
control	O
condition	O
.	O
female	O
gender	O
,	O
low	O
baseline	O
levels	O
of	O
parent	O
-	O
adolescent	O
communication	O
,	O
and	O
older	B-T098
age	I-T098
were	O
associated	O
with	O
membership	O
in	O
the	O
high	B-T033
-	I-T033
risk	I-T033
class	B-T170
.	O
these	O
synthesis	O
analyses	O
involving	O
a	O
large	O
sample	O
of	O
youth	O
with	O
varying	O
initial	O
risk	O
levels	O
represent	O
a	O
further	O
step	O
toward	O
strengthening	O
our	O
knowledge	O
of	O
preventive	O
intervention	O
response	B-T201
and	O
improving	O
preventive	O
interventions	O
.	O

habitual	O
physical	O
activity	O
is	O
associated	O
with	O
improved	O
anthropometric	O
and	O
androgen	B-T103
##ic	I-T103
profile	B-T058
in	O
pcos	B-T038
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
to	O
examine	O
the	O
effect	O
of	O
habitual	O
physical	O
activity	O
(	O
pa	O
)	O
on	O
the	O
metabolic	B-T038
and	O
hormonal	B-T058
profiles	I-T058
of	O
women	B-T098
with	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
.	O
anthropometric	O
,	O
metabolic	O
and	O
hormonal	B-T058
assessment	I-T058
and	O
determination	O
of	O
habitual	O
pa	O
levels	O
with	O
a	O
digital	B-T074
ped	I-T074
##ometer	I-T074
were	O
evaluated	O
in	O
84	O
women	B-T098
with	O
pcos	B-T038
and	O
67	O
age	O
-	O
and	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
-	O
matched	O
controls	O
.	O
pa	O
status	O
was	O
defined	O
according	O
to	O
number	O
of	O
steps	O
(	O
≥	O
##75	O
##00	O
steps	O
,	O
active	O
,	O
or	O
<	O
750	O
##0	O
steps	O
,	O
sedentary	O
)	O
.	O
bmi	B-T201
was	O
lower	O
in	O
active	O
women	B-T098
from	O
both	O
groups	O
.	O
active	O
pcos	B-T038
women	B-T098
presented	O
lower	O
waist	B-T201
circumference	I-T201
(	O
wc	B-T201
)	O
and	O
lipid	O
accumulation	O
product	O
(	O
lap	O
)	O
values	O
versus	O
sedentary	O
pcos	B-T038
women	B-T098
.	O
in	O
the	O
control	O
group	O
,	O
active	O
women	B-T098
also	O
had	O
lower	O
wc	B-T201
,	O
lower	O
values	O
for	O
fasting	O
and	O
120	O
-	O
min	O
insulin	B-T103
,	O
and	O
lower	O
lap	O
than	O
sedentary	O
controls	O
.	O
in	O
the	O
pcos	B-T038
group	O
,	O
androgen	B-T103
levels	O
were	O
lower	O
in	O
active	O
versus	O
sedentary	B-T098
women	I-T098
(	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
in	O
the	O
control	O
group	O
,	O
free	B-T033
androgen	I-T033
index	I-T033
(	O
fa	B-T033
##i	I-T033
)	O
was	O
also	O
lower	O
in	O
active	O
versus	O
sedentary	B-T098
women	I-T098
(	O
p	O
=	O
0	O
.	O
018	O
)	O
.	O
homeostasis	B-T058
model	I-T058
assessment	I-T058
of	O
insulin	B-T038
resistance	I-T038
and	O
2000	O
daily	O
step	O
increments	O
were	O
independent	O
predictors	O
of	O
fa	B-T033
##i	I-T033
.	O
each	O
2000	O
daily	O
step	O
increment	O
was	O
associated	O
with	O
a	O
decrease	O
of	O
1	O
.	O
07	O
in	O
fa	B-T033
##i	I-T033
.	O
habitual	O
pa	O
was	O
associated	O
with	O
a	O
better	O
anthropometric	O
and	O
androgen	B-T103
##ic	I-T103
profile	B-T058
in	O
pcos	B-T038
.	O

epidemiology	B-T091
of	O
poly	B-T005
##omavirus	I-T005
bk	I-T005
(	O
bk	B-T005
##v	I-T005
)	O
and	O
the	O
emergent	O
african	B-T082
variant	O
in	O
kidney	B-T017
and	O
bone	B-T017
marrow	I-T017
transplant	O
recipients	O
in	O
the	O
fund	B-T092
##aci	I-T092
##on	I-T092
val	I-T092
##le	I-T092
del	I-T092
lil	I-T092
##i	I-T092
in	I-T092
cal	I-T092
##i	I-T092
,	O
colombia	B-T082
to	O
describe	O
the	O
epidemiology	B-T091
of	O
bk	B-T005
##v	I-T005
and	O
to	O
assess	O
the	O
presence	B-T033
of	O
the	O
african	B-T082
variant	O
in	O
bone	B-T017
marrow	I-T017
and	O
kidney	B-T033
transplant	I-T033
patients	I-T033
who	O
have	O
suspected	O
bk	B-T005
##v	I-T005
reactivation	O
.	O
a	O
descriptive	B-T062
study	I-T062
was	O
conducted	O
,	O
using	O
institutional	B-T170
records	I-T170
,	O
at	O
the	O
fund	B-T092
##aci	I-T092
##on	I-T092
val	I-T092
##le	I-T092
del	I-T092
lil	I-T092
##i	I-T092
,	I-T092
cal	I-T092
##i	I-T092
-	O
colombia	B-T082
.	O
the	O
overall	O
prevalence	O
of	O
bk	B-T005
##v	I-T005
during	O
the	O
study	O
period	O
was	O
51	O
%	O
.	O
the	O
african	B-T082
variant	O
was	O
identified	O
in	O
49	O
.	O
4	O
%	O
of	O
samples	O
that	O
were	O
positive	B-T033
for	O
bk	B-T005
##v	I-T005
.	O
50	O
.	O
6	O
%	O
of	O
the	O
samples	O
were	O
found	O
to	O
have	O
the	O
wild	B-T017
strain	O
of	O
bk	B-T005
##v	I-T005
.	O
among	O
bk	B-T005
##v	I-T005
positive	B-T033
patients	O
,	O
57	O
%	O
were	O
kidney	B-T033
transplant	I-T033
recipients	I-T033
and	O
43	O
%	O
were	O
bone	B-T017
marrow	I-T017
transplant	O
recipients	O
.	O
this	O
is	O
the	O
first	O
epidemiological	B-T062
study	I-T062
describing	O
the	O
african	B-T082
variant	O
of	O
bk	B-T005
##v	I-T005
in	O
colombia	B-T082
.	O

the	O
relationship	O
between	O
thoracic	B-T082
configuration	B-T082
and	O
changes	O
in	O
volumes	O
of	O
hemi	B-T082
##th	I-T082
##orac	I-T082
##es	I-T082
in	O
upright	B-T033
sitting	I-T033
[	O
purpose	O
]	O
some	O
patients	O
with	O
respiratory	B-T038
disease	I-T038
exhibit	O
asymmetrical	O
movement	O
of	O
the	O
thorax	O
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
the	O
relationship	O
of	O
thoracic	B-T082
configuration	B-T082
with	O
changes	O
in	O
thoracic	B-T201
volume	I-T201
in	O
13	O
sedentary	O
healthy	O
men	B-T098
.	O
[	O
subjects	O
and	O
methods	O
]	O
in	O
upright	B-T033
sitting	I-T033
,	O
84	O
reflective	O
markers	O
were	O
placed	O
on	O
the	O
anterior	B-T082
and	O
posterior	B-T082
aspects	O
of	O
the	O
trunk	B-T082
to	O
record	O
thoracic	B-T201
volume	I-T201
during	O
quiet	O
and	O
vol	B-T038
##itional	I-T038
deep	B-T033
breathing	I-T033
.	O
using	O
a	O
three	B-T074
-	I-T074
dimensional	I-T074
motion	I-T074
analyzer	I-T074
,	O
the	O
difference	O
in	O
volume	O
within	O
the	O
upper	B-T082
and	O
lower	B-T082
hemi	B-T082
##th	I-T082
##orac	I-T082
##es	I-T082
was	O
measured	O
.	O
for	O
calculation	O
of	O
the	O
thoracic	B-T201
volume	I-T201
six	O
imag	B-T082
##inary	I-T082
hexa	I-T082
##hed	I-T082
##ra	I-T082
were	O
visualized	O
for	O
the	O
upper	B-T082
and	O
lower	B-T082
thorax	B-T082
using	O
four	O
reflective	O
markers	O
for	O
each	O
on	O
the	O
anterior	B-T082
and	O
posterior	B-T082
aspects	O
of	O
the	O
thorax	B-T082
.	O
each	O
hexa	B-T082
##hed	I-T082
##ron	I-T082
was	O
then	O
divided	O
into	O
three	O
imag	O
##inary	O
triangular	O
pyr	O
##amid	O
##s	O
to	O
calculate	O
positional	O
vectors	B-T082
.	O
finally	O
,	O
the	O
volume	O
for	O
both	O
the	O
hexa	B-T082
##hed	I-T082
##ra	I-T082
and	O
triangular	O
pyr	O
##amid	O
##s	O
was	O
calculated	O
.	O
four	O
thoracic	B-T201
volumes	I-T201
were	O
obtained	O
.	O
[	O
results	O
]	O
the	O
findings	O
showed	O
that	O
the	O
left	B-T082
upper	B-T082
and	O
right	B-T082
lower	B-T082
hemi	B-T082
##th	I-T082
##orax	I-T082
yielded	O
significantly	O
larger	O
thoracic	B-T201
volumes	I-T201
.	O
[	O
conclusion	O
]	O
in	O
conclusion	O
the	O
left	B-T082
upper	B-T082
and	O
right	B-T082
lower	B-T082
hemi	B-T082
##th	I-T082
##orac	I-T082
##es	I-T082
were	O
found	O
to	O
expand	B-T082
more	O
than	O
their	O
corresponding	O
sides	B-T082
.	O
understanding	O
the	O
characteristics	O
of	O
thoracic	B-T082
excursion	B-T033
during	O
quiet	O
and	O
vol	B-T038
##itional	I-T038
deep	B-T033
breathing	I-T033
could	O
be	O
of	O
value	O
in	O
assessment	B-T058
and	O
instruction	B-T170
of	O
breathing	O
techniques	O
to	O
patients	O
.	O

targeted	B-T058
therapy	I-T058
in	O
gastric	B-T038
cancer	I-T038
gastric	B-T038
cancer	I-T038
is	O
the	O
fourth	O
most	O
common	O
cancer	B-T038
worldwide	O
.	O
surgery	B-T058
in	O
combination	O
with	O
multimodal	B-T058
therapy	I-T058
provides	O
the	O
only	O
curative	B-T033
therapy	I-T033
until	O
now	O
.	O
the	O
importance	O
of	O
targeted	B-T058
therapy	I-T058
became	O
clear	O
over	O
the	O
last	O
few	O
years	O
.	O
due	O
to	O
the	O
implication	O
of	O
her2	B-T017
and	O
angiogenesis	B-T038
-	O
directed	O
targeted	B-T058
therapies	I-T058
major	O
advances	O
in	O
the	O
treatment	B-T058
of	O
gastric	B-T038
cancer	I-T038
could	O
be	O
reached	O
.	O
nevertheless	O
,	O
benefits	O
in	O
survival	O
remain	O
unsatisfactory	O
and	O
the	O
development	O
of	O
resistance	O
to	O
monoclonal	B-T103
antibodies	I-T103
is	O
arising	O
.	O
a	O
comprehensive	O
and	O
comparative	B-T062
literature	B-T170
research	B-T062
was	O
performed	O
to	O
evaluate	B-T058
the	O
status	O
of	O
her2	B-T017
and	O
angiogenesis	B-T038
-	O
directed	O
targeted	B-T058
therapy	I-T058
in	O
gastric	B-T038
cancer	I-T038
.	O
up	O
to	O
now	O
,	O
trastuzumab	B-T103
and	O
ram	B-T103
##uc	I-T103
##ir	I-T103
##umab	I-T103
are	O
the	O
only	O
agents	B-T103
showing	O
remarkable	O
benefits	O
in	O
the	O
therapy	B-T058
for	O
the	O
patients	O
suffering	O
from	O
gastric	B-T038
cancer	I-T038
.	O
the	O
limitations	O
of	O
targeted	B-T058
therapies	I-T058
in	O
gastric	B-T038
cancer	I-T038
are	O
mainly	O
associated	O
with	O
the	O
development	O
of	O
secondary	O
resistance	O
.	O
addition	O
of	O
targeted	B-T058
therapy	I-T058
in	O
second	B-T058
-	I-T058
line	I-T058
treatment	I-T058
is	O
beneficial	O
when	O
compared	O
with	O
chemotherapy	B-T058
alone	O
.	O
nevertheless	O
,	O
results	O
in	O
first	B-T058
-	I-T058
line	I-T058
treatment	I-T058
remain	O
modest	O
.	O
therefore	O
,	O
new	O
therapeutic	B-T103
agents	I-T103
and	O
combinations	B-T103
in	O
the	O
first	B-T058
-	I-T058
line	I-T058
treatment	I-T058
of	O
gastric	B-T038
cancer	I-T038
are	O
urgently	O
needed	O
and	O
remain	O
to	O
be	O
validated	O
in	O
clinical	B-T062
trials	I-T062
.	O

medial	B-T017
patellofemoral	I-T017
ligament	I-T017
reconstruction	B-T058
femoral	B-T017
tunnel	O
accuracy	O
:	O
relationship	O
to	O
disease	B-T038
-	O
specific	O
quality	O
of	O
life	O
medial	B-T017
patellofemoral	I-T017
ligament	I-T017
(	O
mp	B-T017
##fl	I-T017
)	O
reconstruction	B-T058
is	O
a	O
procedure	O
aimed	O
to	O
ree	O
##st	O
##ablish	O
the	O
check	O
##rein	O
to	O
lateral	B-T037
patellar	I-T037
translation	I-T037
in	O
patients	O
with	O
symptomatic	B-T037
patellofemoral	I-T037
instability	I-T037
.	O
correct	O
femoral	B-T017
tunnel	O
position	B-T082
is	O
thought	O
to	O
be	O
crucial	O
to	O
successful	O
mp	B-T017
##fl	I-T017
reconstruction	B-T058
,	O
but	O
the	O
accuracy	O
of	O
this	O
statement	O
in	O
terms	O
of	O
patient	B-T058
outcomes	I-T058
has	O
not	O
been	O
tested	O
.	O
to	O
assess	O
the	O
accuracy	O
of	O
femoral	B-T017
tunnel	O
placement	B-T058
in	O
an	O
mp	B-T017
##fl	I-T017
reconstruction	B-T058
cohort	B-T098
and	O
to	O
determine	O
the	O
correlation	O
between	O
tunnel	O
accuracy	O
and	O
a	O
validated	B-T062
disease	B-T038
-	O
specific	O
,	O
patient	O
-	O
reported	O
quality	O
-	O
of	O
-	O
life	O
outcome	O
measure	O
.	O
case	O
series	O
;	O
level	O
of	O
evidence	O
,	O
4	O
.	O
between	O
june	O
2008	O
and	O
february	O
2014	O
,	O
a	O
total	O
of	O
206	O
subjects	B-T098
underwent	O
an	O
mp	B-T017
##fl	I-T017
reconstruction	B-T058
.	O
lateral	B-T082
radiographs	B-T058
were	O
measured	O
to	O
determine	O
the	O
accuracy	O
of	O
the	O
femoral	B-T017
tunnel	O
by	O
measuring	O
the	O
distance	O
from	O
the	O
center	O
of	O
the	O
femoral	B-T017
tunnel	O
to	O
the	O
sch	O
##ott	O
##le	O
point	O
.	O
ban	O
##ff	O
patella	O
instability	O
instrument	O
(	O
bp	O
##ii	O
)	O
scores	O
were	O
collected	O
a	O
mean	O
24	O
months	O
postoperatively	O
.	O
a	O
total	O
of	O
155	O
(	O
79	O
.	O
5	O
%	O
)	O
subjects	O
had	O
adequate	O
postoperative	O
lateral	B-T082
radiographs	B-T058
and	O
complete	O
bp	O
##ii	O
scores	O
.	O
the	O
mean	O
duration	O
of	O
follow	B-T058
-	I-T058
up	I-T058
(	O
±	O
sd	O
)	O
was	O
24	O
.	O
4	O
±	O
8	O
.	O
2	O
months	O
(	O
range	O
,	O
12	O
-	O
74	O
months	O
)	O
.	O
measurement	O
from	O
the	O
center	B-T082
of	O
the	O
femoral	B-T017
tunnel	O
to	O
the	O
sch	O
##ott	O
##le	O
point	O
resulted	O
in	O
143	O
(	O
92	O
.	O
3	O
%	O
)	O
tunnel	O
s	O
being	O
categorized	O
as	O
[UNK]	O
good	O
[UNK]	O
or	O
[UNK]	O
ideal	O
.	O
[UNK]	O
there	O
were	O
8	O
failures	B-T038
in	O
the	O
cohort	B-T098
,	O
none	O
of	O
which	O
occurred	O
in	O
mal	B-T082
##position	I-T082
##ed	I-T082
tunnel	O
##s	O
.	O
the	O
mean	O
distance	O
from	O
the	O
center	B-T082
of	O
the	O
mp	B-T017
##fl	I-T017
tunnel	O
to	O
the	O
center	B-T082
of	O
the	O
sch	O
##ott	O
##le	O
point	O
was	O
5	O
.	O
9	O
±	O
4	O
.	O
2	O
mm	O
(	O
range	O
,	O
0	O
.	O
5	O
-	O
25	O
.	O
9	O
mm	O
)	O
.	O
the	O
mean	O
postoperative	O
bp	O
##ii	O
score	O
was	O
65	O
.	O
2	O
±	O
22	O
.	O
5	O
(	O
range	O
,	O
9	O
.	O
2	O
-	O
100	O
)	O
.	O
pearson	B-T170
r	I-T170
correlation	I-T170
demonstrated	O
no	B-T033
statistically	I-T033
significant	I-T033
relationship	O
between	O
accuracy	O
of	O
femoral	B-T017
tunnel	O
position	B-T082
and	O
bp	O
##ii	O
score	O
(	O
r	O
=	O
-	O
0	O
.	O
08	O
;	O
95	O
%	O
ci	O
,	O
-	O
0	O
.	O
24	O
to	O
0	O
.	O
08	O
)	O
.	O
there	O
was	O
no	O
evidence	O
of	O
a	O
correlation	O
between	O
the	O
accuracy	O
of	O
mp	B-T017
##fl	I-T017
reconstruction	B-T058
femoral	B-T017
tunnel	O
in	O
relation	O
to	O
the	O
sch	O
##ott	O
##le	O
point	O
and	O
disease	B-T038
-	O
specific	O
quality	O
-	O
of	O
-	O
life	O
scores	O
.	O
graft	B-T038
failure	I-T038
was	O
not	O
related	O
to	O
femoral	B-T017
tunnel	O
placement	B-T058
.	O
the	O
patellofemoral	B-T037
instability	I-T037
population	O
is	O
complex	O
,	O
and	O
patients	O
present	O
with	O
multiple	O
risk	B-T033
factors	I-T033
that	O
,	O
in	O
addition	O
to	O
the	O
accuracy	O
of	O
femoral	O
tunnel	O
position	B-T082
,	O
contribute	O
to	O
quality	O
of	O
life	O
and	O
warrant	O
further	O
investigation	B-T058
.	O

zebrafish	B-T204
adult	B-T017
pigment	I-T017
stem	I-T017
cells	I-T017
are	O
multipotent	B-T017
and	O
form	B-T017
pigment	I-T017
cells	I-T017
by	O
a	O
progressive	O
fate	B-T038
restriction	I-T038
process	I-T038
:	O
clonal	B-T058
analysis	I-T058
identifies	O
shared	O
origin	O
of	O
all	O
pigment	B-T017
cell	I-T017
types	I-T017
skin	B-T033
pigment	I-T033
pattern	B-T038
formation	I-T038
is	O
a	O
paradigm	O
##atic	O
example	O
of	O
pattern	B-T038
formation	I-T038
.	O
in	O
zebrafish	B-T204
,	O
the	O
adult	O
body	B-T017
strip	I-T017
##es	I-T017
are	O
generated	O
by	O
coordinated	O
rearrangement	B-T038
of	O
three	O
distinct	O
pigment	B-T017
cell	I-T017
-	I-T017
types	I-T017
,	O
black	O
melanocytes	B-T017
,	O
sh	O
##in	O
##y	O
irid	B-T017
##ophores	I-T017
and	O
yellow	O
xanth	B-T017
##ophores	I-T017
.	O
a	O
stem	B-T017
cell	I-T017
origin	I-T017
of	O
melanocytes	B-T017
and	O
irid	B-T017
##ophores	I-T017
has	O
been	O
proposed	O
although	O
the	O
potency	O
of	O
those	O
stem	B-T017
cells	I-T017
has	O
remained	O
unclear	O
.	O
xanth	B-T017
##ophores	I-T017
,	O
however	O
,	O
seemed	O
to	O
originate	O
predominantly	O
from	O
proliferation	B-T038
of	O
embryonic	B-T017
xanth	B-T017
##ophores	I-T017
.	O
now	O
,	O
data	O
from	O
sing	O
##h	O
et	O
al	O
.	O
shows	O
that	O
all	O
three	O
cell	B-T017
-	I-T017
types	I-T017
derive	O
from	O
shared	O
stem	B-T017
cells	I-T017
,	O
and	O
that	O
these	O
cells	B-T017
generate	O
peripheral	B-T082
neural	B-T017
cell	I-T017
-	I-T017
types	I-T017
too	O
.	O
furthermore	O
,	O
clonal	B-T017
compositions	O
are	O
best	O
explained	O
by	O
a	O
progressive	O
fate	B-T038
restriction	I-T038
model	I-T038
generating	O
the	O
individual	O
cell	B-T017
-	I-T017
types	I-T017
.	O
the	O
numbers	O
of	O
adult	B-T017
pigment	I-T017
stem	I-T017
cells	I-T017
associated	O
with	O
the	O
dorsal	B-T017
root	I-T017
ganglia	I-T017
remain	B-T033
low	O
,	O
but	O
progenitor	B-T017
numbers	O
increase	O
significantly	O
during	O
larval	B-T038
development	I-T038
up	O
to	O
metamorphosis	B-T038
,	O
likely	O
via	O
production	O
of	O
partially	O
restricted	O
progenitors	B-T017
on	O
the	O
spinal	B-T017
nerves	I-T017
.	O

obstructive	O
acute	B-T038
pancreatitis	I-T038
secondary	O
to	O
peg	B-T074
tube	I-T074
migration	B-T033
percutaneous	B-T058
gastrostomy	I-T058
is	O
a	O
well	O
-	O
established	O
method	O
of	O
providing	O
enteral	B-T058
nutrition	I-T058
to	O
patients	O
incap	O
##able	O
of	O
oral	O
intake	O
,	O
or	O
for	O
whom	O
oral	O
intake	O
is	O
insufficient	O
to	O
meet	O
metabolic	O
needs	O
.	O
in	O
comparison	O
to	O
total	B-T058
parenteral	I-T058
nutrition	I-T058
,	O
enteral	B-T058
feeding	I-T058
is	O
advantageous	O
in	O
that	O
it	O
helps	O
maintain	O
gut	B-T017
mucosal	B-T017
integrity	O
,	O
which	O
decreases	O
the	O
risk	O
of	O
bacterial	B-T038
translocation	I-T038
through	O
the	O
gastrointestinal	B-T022
tract	I-T022
.	O
complications	B-T038
include	O
bleeding	B-T038
,	O
aspiration	B-T038
,	O
internal	B-T037
organ	I-T037
injury	I-T037
,	O
perforation	B-T038
,	O
peri	B-T038
##ostom	I-T038
##al	I-T038
leaks	I-T038
,	O
tube	B-T037
disl	I-T037
##odg	I-T037
##ement	I-T037
,	O
and	O
occlusion	B-T038
.	O
acute	B-T038
pancreatitis	I-T038
secondary	O
to	O
percutaneous	B-T074
gastrostomy	I-T074
tube	I-T074
migration	B-T033
is	O
rare	O
.	O
we	O
present	O
a	O
patient	O
with	O
acute	O
obstructive	O
pancreatitis	B-T038
secondary	O
to	O
percutaneous	B-T074
gastrostomy	I-T074
tube	I-T074
migration	B-T033
.	O

the	O
multi	B-T170
-	I-T170
center	I-T170
evaluation	I-T170
of	I-T170
the	I-T170
accuracy	I-T170
of	I-T170
the	I-T170
contrast	I-T170
medium	I-T170
induced	I-T170
pd	I-T170
/	I-T170
pa	I-T170
ratio	I-T170
in	O
predicting	O
ffr	B-T201
(	O
mem	B-T170
##ent	I-T170
##o	I-T170
-	O
ffr	B-T201
)	O
study	B-T062
adenosine	B-T103
administration	B-T058
is	O
needed	O
for	O
the	O
achievement	O
of	O
maximal	O
hyper	B-T038
##aemia	I-T038
fractional	B-T201
flow	I-T201
reserve	I-T201
(	O
ffr	B-T201
)	O
assessment	B-T058
.	O
the	O
objective	O
was	O
to	O
test	O
the	O
accuracy	O
of	O
pd	O
/	O
pa	B-T033
ratio	O
registered	O
during	O
submaximal	O
hyper	B-T038
##aemia	I-T038
induced	O
by	O
non	B-T103
-	I-T103
ionic	I-T103
contrast	I-T103
medium	I-T103
(	O
contrast	B-T201
ffr	I-T201
[	O
cf	B-T201
##fr	I-T201
]	O
)	O
in	O
predicting	O
ffr	B-T201
and	O
comparing	O
it	O
to	O
the	O
performance	O
of	O
resting	B-T033
pd	O
/	O
pa	B-T033
in	O
a	O
collaborative	O
registry	O
of	O
92	O
##6	O
patients	O
enrolled	O
in	O
10	O
hospitals	B-T092
from	O
four	O
european	O
countries	O
(	O
italy	B-T082
,	O
spain	B-T082
,	O
france	B-T082
and	O
portugal	B-T082
)	O
.	O
resting	B-T033
pd	O
/	O
pa	B-T033
,	O
cf	B-T201
##fr	I-T201
and	O
ffr	B-T201
were	O
measured	O
in	O
1	O
,	O
026	O
coronary	B-T038
stenoses	I-T038
functionally	O
evaluated	O
using	O
commercially	O
available	O
pressure	B-T074
wires	I-T074
.	O
cf	B-T201
##fr	I-T201
was	O
obtained	O
after	O
intracoronary	O
injection	O
of	O
contrast	B-T103
medium	I-T103
,	O
while	O
ffr	B-T201
was	O
measured	O
after	O
administration	B-T058
of	O
adenosine	B-T103
.	O
resting	B-T033
pd	O
/	O
pa	B-T033
and	O
cf	B-T201
##fr	I-T201
were	O
significantly	O
higher	O
than	O
ffr	B-T201
(	O
0	O
.	O
93	O
##±0	O
.	O
05	O
vs	O
.	O
0	O
.	O
87	O
##±0	O
.	O
08	O
vs	O
.	O
0	O
.	O
84	O
##±0	O
.	O
08	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
a	O
strong	O
correlation	O
and	O
a	O
close	O
agreement	O
at	O
bland	B-T170
-	I-T170
altman	I-T170
analysis	I-T170
between	O
cf	B-T201
##fr	I-T201
and	O
ffr	B-T201
were	O
observed	O
(	O
r	O
=	O
0	O
.	O
90	O
,	O
p	O
<	O
0	O
.	O
001	O
and	O
95	O
%	O
ci	O
of	O
disagreement	O
:	O
from	O
-	O
0	O
.	O
042	O
to	O
0	O
.	O
11	O
)	O
.	O
roc	O
curve	O
analysis	B-T062
showed	O
an	O
excellent	O
accuracy	O
(	O
89	O
%	O
)	O
of	O
the	O
cf	B-T201
##fr	I-T201
cut	O
-	O
off	O
of	O
≤0	O
.	O
85	O
in	O
predicting	O
an	O
ffr	B-T201
value	O
≤0	O
.	O
80	O
(	O
auc	O
0	O
.	O
95	O
[	O
95	O
%	O
ci	O
:	O
0	O
.	O
94	O
-	O
0	O
.	O
96	O
]	O
)	O
,	O
significantly	O
better	O
than	O
that	O
observed	O
using	O
resting	B-T033
pd	O
/	O
pa	B-T033
(	O
auc	O
:	O
0	O
.	O
90	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
88	O
-	O
0	O
.	O
91	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
a	O
cf	B-T201
##fr	I-T201
/	O
ffr	B-T201
hybrid	B-T170
approach	I-T170
showed	O
a	O
significantly	O
lower	O
number	O
of	O
lesions	B-T033
requiring	O
adenosine	B-T103
than	O
a	O
resting	B-T033
pd	O
/	O
pa	B-T033
/	O
ffr	B-T201
hybrid	B-T170
approach	I-T170
(	O
22	O
%	O
vs	O
.	O
44	O
%	O
,	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
cf	B-T201
##fr	I-T201
is	O
accurate	O
in	O
predicting	O
the	O
functional	O
significance	O
of	O
coronary	B-T038
stenosis	I-T038
.	O
this	O
could	O
allow	O
limiting	O
the	O
use	O
of	O
adenosine	B-T103
to	O
obtain	O
ffr	B-T201
to	O
a	O
minority	O
of	O
stenoses	B-T038
with	O
considerable	O
savings	O
of	O
time	O
and	O
costs	O
.	O

sleep	B-T033
loss	I-T033
promotes	O
astrocytic	O
phagocytosis	B-T038
and	O
microglial	B-T038
activation	I-T038
in	O
mouse	B-T017
cerebral	I-T017
cortex	I-T017
we	O
previously	O
found	O
that	O
mer	B-T103
##t	I-T103
##k	I-T103
and	O
its	O
ligand	B-T103
gas	I-T103
##6	I-T103
,	O
astrocytic	O
genes	B-T017
involved	O
in	O
phagocytosis	B-T038
,	O
are	O
upregulated	B-T038
after	O
acute	O
sleep	B-T033
deprivation	I-T033
.	O
these	O
results	O
suggested	O
that	O
astrocytes	B-T017
may	O
engage	O
in	O
phagocytic	B-T038
activity	I-T038
during	O
extended	B-T082
wake	B-T038
,	O
but	O
direct	O
evidence	O
was	O
lacking	O
.	O
studies	B-T062
in	O
humans	B-T204
and	O
rodents	B-T204
also	O
found	B-T033
that	O
sleep	B-T033
loss	I-T033
increases	O
peripheral	B-T082
markers	B-T201
of	O
inflammation	B-T038
,	O
but	O
whether	O
these	O
changes	O
are	O
associated	O
with	O
neuroinflammation	O
and	O
/	O
or	O
activation	B-T038
of	O
microglia	B-T017
,	O
the	O
brain	B-T017
'	I-T017
s	I-T017
resident	O
innate	B-T017
immune	I-T017
cells	I-T017
,	O
was	O
unknown	O
.	O
here	O
we	O
used	O
serial	B-T058
block	I-T058
-	I-T058
face	I-T058
scanning	I-T058
electron	I-T058
microscopy	I-T058
to	O
obtain	O
3d	O
volume	O
measurements	O
of	O
synapses	B-T082
and	O
surrounding	B-T082
astrocytic	O
processes	B-T038
in	O
mouse	B-T204
frontal	B-T017
cortex	I-T017
after	O
6	O
-	O
8	O
h	O
of	O
sleep	B-T038
,	O
spontaneous	O
wake	B-T038
,	O
or	O
sleep	B-T033
deprivation	I-T033
(	O
sd	B-T033
)	O
and	O
after	O
chronic	O
(	O
∼	O
##5	O
d	O
)	O
sleep	O
restriction	O
(	O
cs	O
##r	O
)	O
.	O
astrocytic	O
phagocytosis	B-T038
,	O
mainly	O
of	O
presynaptic	B-T017
components	I-T017
of	I-T017
large	I-T017
synapses	I-T017
,	O
increased	O
after	O
both	O
acute	O
and	O
chronic	O
sleep	B-T033
loss	I-T033
relative	O
to	O
sleep	B-T038
and	O
wake	B-T038
.	O
mer	B-T103
##t	I-T103
##k	I-T103
expression	B-T038
and	O
lipid	B-T038
peroxidation	I-T038
in	O
synapt	B-T017
##oneu	I-T017
##ros	I-T017
##omes	I-T017
also	O
increased	O
to	O
a	O
similar	O
extent	B-T082
after	O
short	O
and	O
long	O
sleep	B-T033
loss	I-T033
,	O
suggesting	O
that	O
astrocytic	O
phagocytosis	B-T038
may	O
represent	O
the	O
brain	B-T017
'	I-T017
s	I-T017
response	O
to	O
the	O
increase	O
in	O
synaptic	B-T038
activity	I-T038
associated	O
with	O
prolonged	O
wake	B-T038
,	O
clearing	O
worn	O
components	O
of	O
heavily	O
used	O
synapses	B-T082
.	O
using	O
confocal	B-T058
microscopy	I-T058
,	O
we	O
then	O
found	B-T033
that	O
cs	O
##r	O
but	O
not	O
sd	B-T033
mice	B-T204
show	O
morphological	B-T082
signs	B-T033
of	O
microglial	B-T038
activation	I-T038
and	O
enhanced	O
microglial	O
phagocytosis	B-T038
of	O
synaptic	B-T017
elements	I-T017
,	O
without	O
obvious	O
signs	B-T033
of	O
neuroinflammation	O
in	O
the	O
csf	B-T031
.	O
because	O
low	O
-	O
level	O
sustained	O
microglia	B-T038
activation	I-T038
can	O
lead	O
to	O
abnormal	B-T033
responses	O
to	O
a	O
secondary	O
insult	O
,	O
these	O
results	O
suggest	O
that	O
chronic	O
sleep	B-T033
loss	I-T033
,	O
through	O
microglia	B-T017
priming	B-T038
,	O
may	O
predispose	O
the	O
brain	B-T017
to	O
further	B-T082
damage	O
.	O
significance	O
statement	O
we	O
find	B-T033
that	O
astrocytic	O
phagocytosis	B-T038
of	O
synaptic	B-T017
elements	I-T017
,	O
mostly	O
of	O
presynaptic	B-T017
origin	I-T017
and	O
in	O
large	O
synapses	B-T082
,	O
is	O
upregulated	B-T038
already	O
after	O
a	O
few	O
hours	O
of	O
sleep	B-T033
deprivation	I-T033
and	O
shows	O
a	O
further	B-T082
significant	O
increase	O
after	O
prolonged	O
and	O
severe	O
sleep	B-T033
loss	I-T033
,	O
suggesting	O
that	O
it	O
may	O
promote	O
the	O
house	O
##ke	O
##eping	O
of	O
heavily	O
used	O
and	O
strong	O
synapses	B-T082
in	O
response	O
to	O
the	O
increased	O
neuronal	B-T017
activity	B-T038
of	O
extended	B-T082
wake	B-T038
.	O
by	O
contrast	O
,	O
chronic	O
sleep	O
restriction	O
but	O
not	O
acute	O
sleep	B-T033
loss	I-T033
activates	B-T038
microglia	B-T017
,	O
promotes	O
their	O
phagocytic	B-T038
activity	I-T038
,	O
and	O
does	O
so	O
in	O
the	O
absence	O
of	O
overt	O
signs	B-T033
of	O
neuroinflammation	O
,	O
suggesting	O
that	O
like	O
many	O
other	O
stressors	O
,	O
extended	B-T082
sleep	O
disruption	O
may	O
lead	O
to	O
a	O
state	O
of	O
sustained	O
microglia	B-T038
activation	I-T038
,	O
perhaps	O
increasing	O
the	O
brain	B-T017
'	I-T017
s	I-T017
susceptibility	O
to	O
other	O
forms	O
of	O
damage	O
.	O

cross	O
-	O
species	O
rhesus	B-T204
cytomegalovirus	B-T038
infection	I-T038
of	O
cynomolgus	B-T204
macaques	I-T204
cytomegalovirus	B-T005
##es	I-T005
(	O
cmv	B-T005
)	O
are	O
highly	O
species	O
-	O
specific	O
due	O
to	O
mill	O
##enn	O
##ia	O
of	O
co	B-T038
-	I-T038
evolution	I-T038
and	O
adaptation	B-T038
to	O
their	O
host	O
,	O
with	O
no	O
successful	O
experimental	O
cross	O
-	O
species	B-T170
infection	B-T038
in	O
primates	B-T204
reported	O
to	O
date	O
.	O
accordingly	O
,	O
full	O
genome	B-T017
phylogenetic	B-T062
analysis	I-T062
of	O
multiple	O
new	O
cmv	B-T005
field	O
isolates	B-T103
derived	O
from	O
two	O
closely	O
related	O
nonhuman	B-T204
primate	I-T204
species	B-T170
,	O
indian	B-T033
-	I-T033
origin	I-T033
rhesus	B-T204
macaques	I-T204
(	O
rm	B-T204
)	O
and	O
ma	B-T082
##ur	I-T082
##iti	I-T082
##an	I-T082
-	O
origin	O
cynomolgus	B-T204
macaques	I-T204
(	O
mcm	B-T204
)	O
,	O
revealed	O
distinct	O
and	O
tight	O
lineage	O
clustering	O
according	O
to	O
the	O
species	B-T033
of	I-T033
origin	I-T033
,	O
with	O
mcm	B-T204
cmv	B-T005
isolates	B-T103
mirror	O
##ing	O
the	O
limited	O
genetic	O
diversity	O
of	O
their	O
primate	B-T204
host	O
that	O
underwent	O
a	O
population	O
bottleneck	O
400	O
years	O
ago	O
.	O
despite	O
the	O
ability	O
of	O
rhesus	B-T204
cmv	B-T005
(	O
rh	B-T005
##cm	I-T005
##v	I-T005
)	O
laboratory	B-T017
strain	I-T017
68	O
-	O
1	O
to	O
replicate	O
efficiently	O
in	O
mcm	B-T204
fibroblasts	B-T017
and	O
potently	O
inhibit	B-T038
antigen	I-T038
presentation	I-T038
to	O
mcm	B-T204
t	B-T017
cells	I-T017
in	O
vitro	O
,	O
rh	B-T005
##cm	I-T005
##v	I-T005
68	O
-	O
1	O
failed	O
to	O
productive	O
##ly	O
infect	B-T038
mcm	B-T204
in	B-T082
vivo	I-T082
,	O
even	O
in	O
the	O
absence	O
of	O
host	O
cd8	B-T017
+	I-T017
t	I-T017
and	O
nk	B-T017
cells	I-T017
.	O
in	O
contrast	O
,	O
rh	B-T005
##cm	I-T005
##v	I-T005
clone	B-T017
68	O
-	O
1	O
.	O
2	O
,	O
genetically	O
repaired	B-T058
to	O
express	B-T038
the	O
homologues	B-T017
of	O
the	O
hcmv	B-T005
anti	B-T038
-	I-T038
apoptosis	I-T038
gene	B-T103
ul	I-T103
##36	I-T103
and	O
epithelial	B-T038
cell	I-T038
tropism	I-T038
genes	B-T103
ul	I-T103
##12	I-T103
##8	I-T103
and	O
ul	B-T103
##130	I-T103
absent	O
in	O
68	O
-	O
1	O
,	O
efficiently	O
infected	B-T038
mcm	B-T098
as	O
evidenced	O
by	O
the	O
induction	B-T038
of	O
transgene	B-T017
-	O
specific	O
t	B-T017
cells	I-T017
and	O
virus	B-T038
shedding	I-T038
.	O
recombinant	B-T103
variants	I-T103
of	O
rh	B-T005
##cm	I-T005
##v	I-T005
68	O
-	O
1	O
and	O
68	O
-	O
1	O
.	O
2	O
revealed	O
that	O
expression	B-T038
of	O
either	O
ul	B-T103
##36	I-T103
or	O
ul	B-T103
##12	I-T103
##8	I-T103
together	O
with	O
ul	B-T103
##130	I-T103
enabled	O
productive	O
mcm	B-T098
infection	B-T038
,	O
indicating	O
that	O
multiple	O
layers	O
of	O
cross	O
-	O
species	B-T170
restriction	O
operate	O
even	O
between	O
closely	O
related	O
hosts	O
.	O
cumulative	O
##ly	O
,	O
these	O
results	O
implicate	O
cell	B-T038
tropism	I-T038
and	O
ev	O
##asion	O
of	O
apoptosis	B-T038
as	O
critical	O
determinants	O
of	O
cmv	B-T005
transmission	B-T038
across	O
primate	B-T204
species	B-T170
barriers	O
,	O
and	O
extend	O
the	O
macaque	B-T204
model	B-T170
of	O
human	B-T204
cmv	B-T005
infection	B-T038
and	O
immunology	B-T091
to	O
mcm	B-T098
,	O
a	O
nonhuman	B-T204
primate	I-T204
species	B-T170
with	O
uniquely	O
simplified	O
host	O
immuno	B-T091
##gene	I-T091
##tics	I-T091
.	O

the	O
influence	O
of	O
cognitive	O
load	O
on	O
metabolic	B-T038
cost	O
of	O
transport	O
during	O
over	O
##ground	O
walking	O
in	O
healthy	O
,	O
young	O
adults	O
our	O
aim	O
was	O
to	O
examine	O
whether	O
cognitive	B-T038
processing	I-T038
during	O
walking	O
increases	O
the	O
metabolic	B-T038
cost	O
of	O
transport	O
in	O
healthy	O
young	O
adults	O
.	O
twenty	O
healthy	O
,	O
young	O
adults	O
completed	O
five	O
conditions	O
:	O
(	O
1	O
)	O
walking	O
at	O
a	O
self	O
-	O
selected	O
speed	O
(	O
spontaneous	O
single	O
-	O
task	O
)	O
,	O
(	O
2	O
)	O
seated	B-T033
resting	O
(	O
baseline	O
)	O
,	O
(	O
3	O
)	O
performing	O
cognitive	B-T038
task	O
while	O
seated	B-T033
(	O
cognitive	B-T038
single	O
-	O
task	O
)	O
,	O
(	O
4	O
)	O
walking	O
while	O
simultaneously	O
performing	O
the	O
cognitive	B-T038
task	O
(	O
dual	O
-	O
task	O
)	O
,	O
and	O
(	O
5	O
)	O
single	O
-	O
task	O
walking	O
at	O
a	O
speed	O
that	O
matched	O
the	O
participant	B-T098
'	I-T098
s	I-T098
dual	O
-	O
task	O
gait	O
speed	O
(	O
matched	O
single	O
-	O
task	O
)	O
.	O
rate	O
of	O
oxygen	O
consumption	O
(	O
vo2	O
)	O
was	O
recorded	O
during	O
all	O
conditions	O
.	O
gait	O
speed	O
and	O
cost	O
of	O
walking	O
(	O
cw	O
;	O
oxygen	B-T201
consumed	I-T201
per	I-T201
distance	I-T201
travel	I-T201
##ed	I-T201
)	O
were	O
recorded	O
during	O
all	O
walking	O
conditions	O
.	O
reaction	O
time	O
and	O
accuracy	O
of	O
responses	O
in	O
the	O
cognitive	B-T038
task	O
were	O
recorded	O
during	O
all	O
cognitive	B-T038
task	O
conditions	O
.	O
data	O
from	O
the	O
fifth	O
minute	O
of	O
each	O
5	O
-	O
min	O
condition	O
were	O
analyzed	B-T062
.	O
there	O
was	O
no	O
difference	O
in	O
vo2	O
between	O
the	O
dual	O
-	O
task	O
and	O
matched	O
single	O
-	O
task	O
walking	O
conditions	O
.	O
vo2	O
in	O
the	O
seated	B-T033
cognitive	B-T038
condition	O
was	O
significantly	O
smaller	O
than	O
both	O
walking	O
conditions	O
,	O
but	O
was	O
not	O
significantly	O
different	O
than	O
zero	O
.	O
cw	O
was	O
significantly	O
greater	O
during	O
the	O
matched	O
single	O
-	O
task	O
walking	O
condition	O
than	O
during	O
the	O
dual	O
-	O
task	O
walking	O
condition	O
.	O
however	O
,	O
the	O
difference	O
in	O
cw	O
was	O
so	O
small	O
that	O
it	O
is	O
unlikely	O
to	O
be	O
clinically	O
significant	O
(	O
0	O
.	O
008	O
ml	O
##o2	O
/	O
kg	O
/	O
m	O
,	O
95	O
%	O
ci	O
0	O
.	O
002	O
-	O
0	O
.	O
014	O
)	O
.	O
cognitive	B-T038
processing	I-T038
while	O
walking	O
may	O
not	O
increase	O
energy	O
demands	O
of	O
walking	O
in	O
healthy	O
young	O
adults	O
.	O
maintaining	O
non	O
-	O
preferred	O
gait	O
speed	O
(	O
matched	O
speed	O
)	O
over	O
##ground	O
continuously	O
for	O
5	O
min	O
may	O
require	O
attentional	B-T038
resources	O
,	O
and	O
thereby	O
increase	O
metabolic	B-T038
costs	O
relative	O
to	O
walking	O
at	O
habitual	O
speed	O
.	O

utility	O
of	O
post	B-T058
-	I-T058
mortem	I-T058
genetic	B-T062
testing	I-T062
in	O
cases	O
of	O
sudden	B-T038
arrhythmic	I-T038
death	I-T038
syndrome	I-T038
sudden	B-T038
arrhythmic	I-T038
death	I-T038
syndrome	I-T038
(	O
sad	B-T038
##s	I-T038
)	O
describes	O
a	O
sudden	B-T038
death	I-T038
with	O
negative	O
autopsy	B-T058
and	O
toxicological	O
analysis	B-T062
.	O
cardiac	B-T038
genetic	I-T038
disease	I-T038
is	O
a	O
likely	O
etiology	O
.	O
this	O
study	B-T062
investigated	O
the	O
clinical	O
utility	O
and	O
combined	O
yield	O
of	O
post	B-T058
-	I-T058
mortem	I-T058
genetic	B-T062
testing	I-T062
(	O
molecular	B-T058
autopsy	I-T058
)	O
in	O
cases	O
of	O
sad	B-T038
##s	I-T038
and	O
comprehensive	O
clinical	B-T058
evaluation	I-T058
of	O
surviving	O
relatives	O
.	O
we	O
evaluated	B-T058
302	O
expert	O
##ly	O
validated	O
sad	B-T038
##s	I-T038
cases	O
with	O
suitable	O
dna	B-T103
(	O
median	O
age	O
:	O
24	O
years	O
;	O
65	O
%	O
males	O
)	O
who	O
underwent	O
next	O
-	O
generation	O
sequencing	B-T058
using	O
an	O
extended	O
panel	O
of	O
77	O
primary	B-T017
electrical	I-T017
disorder	I-T017
and	O
cardiomyopathy	B-T017
genes	I-T017
.	O
pathogenic	B-T033
and	O
likely	O
pathogenic	O
variants	O
were	O
classified	O
using	O
american	B-T092
college	I-T092
of	I-T092
medical	I-T092
genetics	I-T092
(	O
ac	B-T092
##mg	I-T092
)	O
consensus	B-T170
guidelines	I-T170
.	O
the	O
yield	O
of	O
combined	O
molecular	B-T058
autopsy	I-T058
and	O
clinical	B-T058
evaluation	I-T058
in	O
82	O
surviving	O
families	O
was	O
evaluated	B-T058
.	O
a	O
gene	B-T062
-	I-T062
level	I-T062
rare	I-T062
variant	I-T062
association	I-T062
analysis	I-T062
was	O
conducted	O
in	O
sad	B-T038
##s	I-T038
cases	O
versus	O
controls	O
.	O
a	O
clinically	O
action	O
##able	O
pathogenic	B-T033
or	O
likely	O
pathogenic	O
variant	O
was	O
identified	O
in	O
40	O
of	O
302	O
cases	O
(	O
13	O
%	O
)	O
.	O
the	O
main	O
etiologies	O
established	O
were	O
catecholamine	B-T038
##r	I-T038
##gic	I-T038
polymorphic	I-T038
ventricular	I-T038
tachycardia	I-T038
and	O
long	B-T038
qt	I-T038
syndrome	I-T038
(	O
17	O
[	O
6	O
%	O
]	O
and	O
11	O
[	O
4	O
%	O
]	O
,	O
respectively	O
)	O
.	O
gene	B-T062
-	I-T062
based	I-T062
rare	I-T062
variants	I-T062
association	I-T062
analysis	I-T062
showed	O
enrichment	O
of	O
rare	O
predicted	O
deleterious	O
variants	O
in	O
ryr	B-T017
##2	I-T017
(	O
p	O
=	O
5	O
×	O
10	O
(	O
-	O
5	O
)	O
)	O
.	O
combining	O
molecular	B-T058
autopsy	I-T058
with	O
clinical	B-T058
evaluation	I-T058
in	O
surviving	O
families	O
increased	O
diagnostic	O
yield	O
from	O
26	O
%	O
to	O
39	O
%	O
.	O
molecular	B-T058
autopsy	I-T058
for	O
electrical	B-T017
disorder	I-T017
and	O
cardiomyopathy	B-T017
genes	I-T017
,	O
using	O
ac	B-T092
##mg	I-T092
guidelines	B-T170
for	O
variant	B-T170
classification	I-T170
,	O
identified	O
a	O
modest	O
but	O
realistic	O
yield	O
in	O
sad	B-T038
##s	I-T038
.	O
our	O
data	O
highlighted	O
the	O
predominant	O
role	O
of	O
catecholamine	B-T038
##r	I-T038
##gic	I-T038
polymorphic	I-T038
ventricular	I-T038
tachycardia	I-T038
and	O
long	B-T038
qt	I-T038
syndrome	I-T038
,	O
especially	O
the	O
ryr	B-T017
##2	I-T017
gene	I-T017
,	O
as	O
well	O
as	O
the	O
minimal	O
yield	O
from	O
other	O
genes	B-T017
.	O
furthermore	O
,	O
we	O
showed	O
the	O
enhanced	O
utility	O
of	O
combined	O
clinical	B-T058
and	O
genetic	O
evaluation	O
.	O

diagnostic	O
utility	O
of	O
additional	O
conventional	O
techniques	B-T058
after	O
endobronchial	B-T058
ultrasonography	I-T058
guidance	B-T058
during	O
trans	B-T058
##br	I-T058
##onch	I-T058
##ial	I-T058
biopsy	I-T058
endobronchial	B-T058
ultrasonography	I-T058
with	O
a	O
guide	B-T074
sheath	I-T074
trans	B-T058
##br	I-T058
##onch	I-T058
##ial	I-T058
biopsy	I-T058
(	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
)	O
has	O
been	O
used	O
to	O
diagnose	B-T033
peripheral	B-T033
pulmonary	I-T033
lesions	I-T033
(	O
pp	B-T033
##ls	I-T033
)	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
evaluated	O
the	O
diagnostic	O
utility	O
of	O
conventional	O
tb	B-T058
##b	I-T058
after	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
.	O
a	O
retrospective	B-T062
analysis	I-T062
of	O
patients	O
who	O
underwent	O
conventional	O
tb	B-T058
##b	I-T058
after	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
for	O
pp	B-T033
##l	I-T033
between	O
august	O
1	O
,	O
2012	O
and	O
december	O
31	O
,	O
2014	O
.	O
we	O
performed	O
multivariate	O
analysis	O
to	O
examine	O
the	O
association	O
of	O
various	O
clinical	O
factors	O
,	O
including	O
eb	B-T058
##us	I-T058
probe	B-T074
distance	O
and	O
sample	O
size	O
area	B-T082
,	O
with	O
diagnostic	O
yield	O
.	O
of	O
88	O
eligible	O
patients	O
,	O
57	O
(	O
65	O
%	O
)	O
were	O
successfully	O
diagnosed	B-T033
by	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
.	O
in	O
31	O
patients	O
not	O
diagnosed	B-T033
by	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
,	O
15	O
(	O
48	O
%	O
)	O
were	O
successfully	O
diagnosed	B-T033
by	O
additional	O
conventional	O
tb	B-T058
##b	I-T058
.	O
ground	B-T033
glass	I-T033
opacity	I-T033
(	O
gg	B-T033
##o	I-T033
)	O
was	O
a	O
significant	O
factor	O
associated	O
with	O
the	O
diagnostic	O
yield	O
of	O
additional	O
conventional	O
tb	B-T058
##b	I-T058
following	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
.	O
multivariate	O
analysis	O
and	O
receiver	O
operator	O
curves	O
revealed	O
that	O
distance	O
between	O
the	O
pp	B-T033
##l	I-T033
and	O
the	O
eb	B-T058
##us	I-T058
probe	B-T074
of	O
less	O
than	O
2	O
.	O
55	O
mm	O
favored	O
the	O
utility	O
of	O
conventional	O
tb	B-T058
##b	I-T058
.	O
additional	O
conventional	O
tb	B-T058
##b	I-T058
after	O
eb	B-T058
##us	I-T058
-	O
gs	B-T074
tb	B-T058
##b	I-T058
could	O
be	O
a	O
useful	O
procedure	B-T058
for	O
the	O
diagnosis	B-T033
of	O
ground	B-T033
glass	I-T033
opacity	I-T033
pp	B-T033
##ls	I-T033
and	O
in	O
cases	O
of	O
a	O
distance	O
of	O
less	O
than	O
2	O
.	O
55	O
mm	O
between	O
the	O
eb	B-T058
##us	I-T058
probe	B-T074
and	O
the	O
lesion	B-T033
.	O

twist	O
##ing	O
method	O
for	O
reducing	O
friction	O
during	O
insertion	B-T058
of	O
a	O
sheath	B-T074
introduce	B-T074
##r	I-T074
and	O
a	O
sheath	B-T074
##less	I-T074
guiding	I-T074
catheter	I-T074
a	O
sheath	O
##less	O
system	O
that	O
inserts	B-T058
a	O
catheter	B-T074
directly	O
into	O
the	O
artery	B-T017
can	O
reduce	O
puncture	O
site	B-T082
-	O
related	O
complications	B-T038
through	O
a	O
2	O
-	O
fr	O
reduction	O
of	O
the	O
outer	B-T082
diameter	I-T082
.	O
however	O
,	O
the	O
gap	B-T082
between	O
the	O
dil	B-T074
##ator	I-T074
and	O
the	O
guiding	B-T074
catheter	I-T074
of	O
the	O
sheath	O
##less	O
system	O
is	O
larger	O
than	O
the	O
gap	B-T082
between	O
the	O
dil	B-T074
##ator	I-T074
and	O
sheath	B-T074
of	O
the	O
introduce	B-T074
##r	I-T074
system	I-T074
,	O
resulting	O
in	O
stronger	O
insertion	B-T058
resistance	O
.	O
a	O
twist	O
##ing	O
method	O
with	O
rapid	O
alternating	O
rotation	O
of	O
a	O
device	B-T074
to	O
the	O
left	O
and	O
right	O
during	O
insertion	B-T058
can	O
reduce	O
the	O
insertion	B-T058
resistance	O
.	O
this	O
method	O
can	O
be	O
effective	O
with	O
the	O
sheath	O
##less	O
system	O
which	O
has	O
a	O
larger	O
gap	B-T082
.	O
to	O
examine	O
the	O
effect	O
of	O
size	B-T082
reduction	O
on	O
the	O
sheath	O
##less	O
system	O
and	O
the	O
effect	O
of	O
insertion	B-T058
resistance	O
reduction	O
using	O
the	O
twist	O
##ing	O
method	O
,	O
we	O
developed	O
an	O
insertion	B-T058
simulator	B-T074
and	O
compared	O
insertion	B-T058
resistance	O
to	O
a	O
5	B-T074
-	I-T074
fr	I-T074
sheath	I-T074
introduce	B-T074
##r	I-T074
and	O
a	O
5	O
-	O
fr	O
sheath	O
##less	O
system	O
,	O
with	O
and	O
without	O
the	O
twist	O
##ing	O
method	O
.	O
the	O
insertion	B-T058
simulator	B-T074
push	O
##ed	O
a	O
sheath	B-T074
introduce	B-T074
##r	I-T074
or	O
a	O
sheath	O
##less	O
system	O
toward	O
a	O
mock	B-T033
artery	B-T017
consisted	O
with	O
a	O
5	O
-	O
mm	O
urethane	O
and	O
a	O
1	O
-	O
mm	O
rubber	O
sheet	O
by	O
an	O
electrical	O
motor	O
with	O
or	O
without	O
twist	O
##ing	O
motion	O
generated	O
by	O
a	O
cran	O
##k	O
shaft	O
.	O
insertion	B-T058
resistance	O
during	O
the	O
penetration	O
was	O
measured	O
by	O
a	O
tension	B-T074
meter	I-T074
.	O
the	O
insertion	B-T058
resistance	O
was	O
less	O
with	O
the	O
5	O
-	O
fr	O
sheath	O
##less	O
system	O
than	O
with	O
the	O
5	B-T074
-	I-T074
fr	I-T074
sheath	I-T074
introduce	B-T074
##r	I-T074
.	O
the	O
resistance	O
reduced	O
further	O
with	O
use	O
of	O
twist	O
##ing	O
for	O
both	O
the	O
sheath	B-T074
##ed	I-T074
and	O
sheath	B-T074
##less	I-T074
catheters	I-T074
.	O
in	O
conclusion	O
,	O
the	O
experiment	O
suggests	O
the	O
benefits	O
of	O
twist	O
##ing	O
insertion	B-T058
of	O
a	O
sheath	B-T074
##less	I-T074
guiding	I-T074
catheter	I-T074
for	O
reduction	O
of	O
puncture	O
site	B-T082
-	O
related	O
complications	B-T038
.	O

quantitative	O
assessment	O
of	O
fluorescent	B-T103
proteins	I-T103
the	O
advent	O
of	O
fluorescent	B-T103
proteins	I-T103
(	O
fps	B-T103
)	O
for	O
genetic	B-T062
labeling	I-T062
of	O
molecules	O
and	O
cells	B-T017
has	O
revolution	O
##ized	O
fluorescence	B-T058
microscopy	I-T058
.	O
genetic	O
manipulations	O
have	O
created	O
a	O
vast	O
array	O
of	O
bright	O
and	O
stable	O
fps	B-T103
spanning	O
blue	O
to	O
red	O
spectral	O
regions	O
.	O
common	O
to	O
auto	B-T058
##fluores	I-T058
##cent	I-T058
fps	B-T103
is	O
their	O
tight	O
β	O
-	O
barrel	O
structure	O
,	O
which	O
provides	O
the	O
rigidity	O
and	O
chemical	B-T103
environment	B-T082
needed	O
for	O
effect	O
##ual	O
fluorescence	O
.	O
despite	O
the	O
common	O
structure	B-T082
,	O
each	O
fp	B-T103
has	O
unique	O
properties	O
.	O
thus	O
,	O
there	O
is	O
no	O
single	O
'	O
best	O
'	O
fp	B-T103
for	O
every	O
circumst	O
##ance	O
,	O
and	O
each	O
fp	B-T103
has	O
advantages	O
and	O
disadvantages	O
.	O
to	O
guide	O
decisions	O
about	O
which	O
fp	B-T103
is	O
right	O
for	O
a	O
given	O
application	O
,	O
we	O
have	O
quantitatively	O
characterized	O
the	O
brightness	O
,	O
photos	B-T033
##ta	I-T033
##bil	I-T033
##ity	I-T033
,	O
ph	O
stability	O
and	O
monomeric	B-T103
properties	O
of	O
more	O
than	O
40	O
fps	B-T103
to	O
enable	O
straightforward	O
and	O
direct	O
comparison	O
between	O
them	O
.	O
we	O
focus	O
on	O
popular	O
and	O
/	O
or	O
top	O
-	O
performing	O
fps	B-T103
in	O
each	O
spectral	O
region	O
.	O

three	B-T082
-	I-T082
dimensional	I-T082
hy	B-T058
##co	I-T058
##s	I-T058
##y	I-T058
with	O
perfluoro	B-T103
##prop	I-T103
##ane	I-T103
-	I-T103
albumin	I-T103
microspheres	I-T103
as	O
contrast	B-T103
agents	I-T103
and	O
normal	O
saline	O
injections	B-T058
into	O
the	O
pelvic	B-T082
cavity	I-T082
for	O
morphological	O
assessment	B-T058
of	O
the	O
fallopian	B-T017
tube	I-T017
in	O
infertile	B-T038
women	B-T098
to	O
apply	O
the	O
three	B-T082
-	I-T082
dimensional	I-T082
(	O
3d	B-T082
)	O
hyster	B-T058
##osal	I-T058
##ping	I-T058
##o	I-T058
-	I-T058
contrast	I-T058
sonography	I-T058
(	O
hy	B-T058
##co	I-T058
##s	I-T058
##y	I-T058
)	O
with	O
perfluoro	B-T103
##prop	I-T103
##ane	I-T103
-	I-T103
albumin	I-T103
microspheres	I-T103
as	O
contrast	B-T103
agents	I-T103
and	O
normal	O
saline	O
injections	B-T058
into	O
the	O
pelvic	B-T082
cavity	I-T082
for	O
assessment	B-T058
of	I-T058
the	I-T058
tubal	I-T058
patency	I-T058
and	O
adhesions	B-T038
of	I-T038
fimbr	I-T038
##ial	I-T038
parts	I-T038
.	O
fifty	O
-	O
five	O
infertile	B-T038
female	O
patients	O
were	O
recruited	O
to	O
undergo	O
3d	B-T082
hy	B-T058
##co	I-T058
##s	I-T058
##y	I-T058
with	O
normal	O
saline	O
injected	B-T058
into	O
the	O
pelvic	B-T082
cavity	I-T082
,	O
in	O
which	O
the	O
tubal	O
patency	O
was	O
observed	O
by	O
visualizing	O
the	O
spill	O
##age	O
of	O
contrast	B-T103
agents	I-T103
from	O
the	O
fimbr	B-T017
##iae	I-T017
,	O
and	O
the	O
fimbr	B-T038
##ial	I-T038
adhesion	I-T038
was	O
confirmed	O
by	O
the	O
finger	B-T082
-	I-T082
like	I-T082
projections	I-T082
of	O
the	O
fimbr	B-T017
##iae	I-T017
and	O
their	O
floating	O
and	O
moving	O
status	O
.	O
of	O
the	O
55	O
patients	O
,	O
bilateral	B-T033
tubal	I-T033
patency	I-T033
was	O
observed	O
in	O
44	O
(	O
80	O
.	O
0	O
%	O
)	O
,	O
unilateral	B-T033
tubal	I-T033
patency	I-T033
and	O
the	O
other	O
partial	B-T038
occlusion	I-T038
in	O
7	O
(	O
12	O
.	O
7	O
%	O
)	O
,	O
unilateral	B-T082
partial	B-T038
occlusion	I-T038
and	O
the	O
other	O
complete	B-T038
occlusion	I-T038
in	O
3	O
(	O
5	O
.	O
4	O
%	O
)	O
,	O
and	O
bilateral	B-T082
complete	B-T038
occlusion	I-T038
in	O
1	O
(	O
1	O
.	O
8	O
%	O
)	O
.	O
the	O
fimbr	B-T017
##ial	I-T017
parts	I-T017
were	O
observed	O
in	O
105	O
fallopian	B-T017
tubes	I-T017
,	O
among	O
which	O
101	O
were	O
seen	O
with	O
the	O
finger	O
-	O
like	O
fimbr	B-T017
##iae	I-T017
flo	O
##ated	O
and	O
moved	O
in	O
the	O
pelvic	B-T082
cavity	I-T082
,	O
whereas	O
4	O
tubes	O
were	O
not	O
because	O
of	O
adhesion	B-T038
to	O
the	O
pelvic	B-T082
cavity	I-T082
(	O
n	O
=	O
3	O
)	O
or	O
the	O
ovary	B-T017
and	O
intestine	B-T017
(	O
n	O
=	O
1	O
)	O
.	O
more	O
than	O
three	O
visible	O
,	O
quite	O
long	O
,	O
and	O
distributed	O
evenly	O
finger	B-T082
-	I-T082
like	I-T082
projection	I-T082
s	O
were	O
present	O
for	O
the	O
patent	B-T082
fimbr	B-T017
##ial	I-T017
parts	I-T017
;	O
however	O
,	O
fewer	O
,	O
flat	B-T082
,	O
and	O
not	O
evenly	O
distributed	O
finger	B-T082
-	I-T082
like	I-T082
projection	I-T082
s	O
were	O
present	O
for	O
the	O
adhesive	B-T038
tubes	I-T038
.	O
no	O
serious	O
complications	B-T038
occurred	O
during	O
or	O
after	O
this	O
procedure	B-T058
.	O
combination	O
of	O
3d	B-T082
hy	B-T058
##co	I-T058
##s	I-T058
##y	I-T058
with	O
normal	O
saline	O
injected	B-T058
into	O
the	O
pelvic	B-T082
cavity	I-T082
may	O
be	O
a	O
feasible	O
and	O
safe	O
procedure	B-T058
to	O
assess	O
tubal	O
patency	O
and	O
adhesions	B-T038
of	I-T038
the	I-T038
fimbr	I-T038
##ial	I-T038
parts	I-T038
.	O

outcomes	O
of	O
chest	B-T058
wall	I-T058
resections	I-T058
in	O
pediatric	O
sarcoma	B-T038
patients	O
chest	B-T038
wall	I-T038
tumors	I-T038
in	O
pediatric	O
patients	O
are	O
rare	O
.	O
this	O
study	B-T062
evaluates	O
outcomes	O
in	O
pediatric	O
patients	O
who	O
have	O
undergone	O
chest	B-T058
wall	I-T058
resections	I-T058
secondary	O
to	O
sarcomas	B-T038
.	O
a	O
retrospective	B-T062
review	I-T062
was	O
performed	O
for	O
patients	O
<	O
19	O
##years	O
old	O
who	O
underwent	O
chest	B-T058
wall	I-T058
resections	I-T058
for	O
sarcoma	B-T038
1999	O
-	O
2014	O
at	O
the	O
university	B-T092
of	I-T092
texas	I-T092
md	I-T092
and	I-T092
##erson	I-T092
cancer	I-T092
center	I-T092
.	O
of	O
44	O
patients	O
,	O
ewing	B-T038
'	I-T038
s	I-T038
sarcoma	I-T038
(	O
n	O
=	O
18	O
)	O
and	O
osteosarcoma	B-T038
(	O
n	O
=	O
16	O
)	O
were	O
most	O
common	O
.	O
other	O
sarcomas	B-T038
included	O
synovial	B-T038
sarcoma	I-T038
,	O
chondros	B-T038
##arcoma	I-T038
,	O
and	O
rhabdomyosarcoma	B-T038
.	O
gor	B-T103
##e	I-T103
-	I-T103
tex	I-T103
®	O
or	O
a	O
mar	B-T103
##lex	I-T103
##™	I-T103
mesh	I-T103
and	O
methyl	B-T103
methacrylate	I-T103
sandwich	I-T103
was	O
used	O
in	O
22	O
patients	O
,	O
and	O
9	O
children	O
did	O
not	O
require	O
reconstruction	O
.	O
twenty	O
-	O
four	O
(	O
54	O
.	O
5	O
%	O
)	O
patients	O
had	O
normal	O
activity	O
,	O
3	O
(	O
6	O
.	O
8	O
%	O
)	O
had	O
occasional	B-T033
discomfort	I-T033
,	O
2	O
(	O
4	O
.	O
5	O
%	O
)	O
had	O
pain	B-T038
impairing	I-T038
function	I-T038
,	O
7	O
(	O
15	O
.	O
9	O
%	O
)	O
required	O
medication	B-T103
or	O
physical	B-T058
therapy	I-T058
for	O
impairment	B-T038
,	O
and	O
8	O
(	O
18	O
.	O
2	O
%	O
)	O
needed	O
additional	O
surgery	B-T091
.	O
five	O
children	O
(	O
11	O
.	O
4	O
%	O
)	O
developed	O
scoliosis	B-T017
,	O
and	O
all	O
of	O
these	O
patients	O
had	O
posterior	B-T082
rib	B-T038
tumors	I-T038
.	O
median	O
overall	O
survival	O
for	O
the	O
entire	B-T098
cohort	I-T098
was	O
41	O
.	O
9	O
##±1	O
##1	O
.	O
82	O
months	O
.	O
histology	B-T091
(	O
p	O
=	O
0	O
.	O
003	O
)	O
,	O
location	B-T082
of	O
tumor	B-T038
on	O
the	O
rib	B-T017
##s	I-T017
(	O
p	O
=	O
0	O
.	O
007	O
)	O
,	O
and	O
surgical	B-T017
margins	I-T017
(	O
p	O
=	O
0	O
.	O
011	O
)	O
were	O
significantly	O
associated	O
with	O
overall	O
survival	O
.	O
tumors	B-T038
on	O
the	O
middle	O
and	O
posterior	B-T082
(	O
p	O
=	O
0	O
.	O
003	O
)	O
portions	O
of	O
the	O
rib	B-T017
##s	I-T017
had	O
a	O
lower	O
chance	O
of	O
death	B-T038
.	O
scoliosis	B-T017
is	O
more	O
common	O
in	O
posterior	B-T082
rib	B-T058
resections	I-T058
.	O
histology	B-T091
,	O
location	B-T082
of	O
the	O
tumor	B-T038
,	O
and	O
surgical	B-T017
margins	I-T017
impact	O
survival	O
,	O
but	O
,	O
type	O
of	O
reconstruction	O
does	O
not	O
.	O
iii	O
.	O
treatment	B-T062
study	I-T062
.	O

cha	O
##sin	O
##g	O
gh	O
##osts	O
:	O
allop	O
##oly	O
##ploid	O
origin	O
of	O
oxy	B-T204
##ri	I-T204
##a	I-T204
sinensis	I-T204
(	O
polyg	B-T204
##ona	I-T204
##ce	I-T204
##ae	I-T204
)	O
from	O
its	O
only	O
diploid	O
congen	O
##er	O
and	O
an	O
unknown	O
ancestor	O
reconstruct	O
##ing	O
the	O
origin	O
of	O
a	O
polyploid	B-T038
species	B-T170
is	O
particularly	O
challenging	O
when	O
an	O
ancestor	O
has	O
become	O
extinc	O
##t	O
.	O
under	O
such	O
circumstances	O
,	O
the	O
extinc	O
##t	O
donor	O
of	O
a	O
genome	B-T017
found	O
in	O
the	O
polyploid	B-T038
may	O
be	O
treated	O
as	O
a	O
'	O
gh	O
##ost	O
'	O
species	B-T170
in	O
that	O
its	O
prior	O
existence	O
is	O
recognized	O
through	O
the	O
presence	O
of	O
its	O
genome	B-T017
in	O
the	O
polyploid	B-T038
.	O
in	O
this	O
study	O
,	O
we	O
aimed	O
to	O
determine	O
the	O
polyploid	B-T038
origin	O
of	O
oxy	B-T204
##ri	I-T204
##a	I-T204
sinensis	I-T204
(	O
2n	O
=	O
40	O
)	O
for	O
which	O
only	O
one	O
congen	O
##eric	O
species	B-T170
is	O
known	O
,	O
that	O
is	O
diploid	O
o	B-T204
.	I-T204
dig	I-T204
##yn	I-T204
##a	I-T204
(	O
2n	O
=	O
14	O
)	O
.	O
genomic	B-T062
in	I-T062
situ	I-T062
hybridization	I-T062
(	O
gis	B-T062
##h	I-T062
)	O
,	O
transcriptome	B-T058
,	O
phylogenetic	B-T062
and	O
demographic	B-T062
analyses	I-T062
,	O
and	O
ecological	B-T170
niche	I-T170
modelling	I-T170
were	O
conducted	O
for	O
this	O
purpose	O
.	O
gis	B-T062
##h	I-T062
revealed	O
that	O
o	B-T204
.	I-T204
sinensis	I-T204
comprised	O
14	O
chromosomes	B-T017
from	O
o	B-T204
.	I-T204
dig	I-T204
##yn	I-T204
##a	I-T204
and	O
26	O
chromosomes	B-T017
from	O
an	O
unknown	O
ancestor	O
.	O
transcriptome	B-T058
analysis	I-T058
indicated	O
that	O
following	O
divergence	B-T082
from	O
o	B-T204
.	I-T204
dig	I-T204
##yn	I-T204
##a	I-T204
,	O
involving	O
genome	B-T038
duplication	I-T038
around	O
12	O
million	O
years	O
ago	O
(	O
ma	O
)	O
,	O
a	O
second	O
genome	B-T038
duplication	I-T038
occurred	O
approximately	O
6	O
ma	O
to	O
give	O
rise	O
to	O
o	B-T204
.	I-T204
sinensis	I-T204
.	O
oxy	B-T204
##ri	I-T204
##a	I-T204
sinensis	I-T204
was	O
shown	O
to	O
contain	O
homologous	B-T082
gene	I-T082
sequences	I-T082
divergent	B-T082
from	O
those	O
present	O
in	O
o	B-T204
.	I-T204
dig	I-T204
##yn	I-T204
##a	I-T204
in	O
addition	O
to	O
a	O
set	O
that	O
clustered	B-T017
with	O
those	O
in	O
o	B-T204
.	I-T204
dig	I-T204
##yn	I-T204
##a	I-T204
.	O
coales	B-T170
##cent	I-T170
simulations	I-T170
indicated	O
that	O
o	B-T204
.	I-T204
sinensis	I-T204
expanded	O
its	O
distribution	O
approximately	O
6	O
-	O
7	O
ma	O
,	O
possibly	O
following	O
the	O
second	O
polyploid	B-T038
##ization	I-T038
event	I-T038
,	O
whereas	O
o	B-T204
.	I-T204
dig	I-T204
##yn	I-T204
##a	I-T204
expanded	O
its	O
range	O
much	O
later	O
.	O
it	O
was	O
also	O
indicated	O
that	O
the	O
distributions	O
of	O
both	O
species	B-T170
contracted	O
and	O
re	O
-	O
expanded	O
during	O
the	O
plei	O
##st	O
##ocene	O
climatic	O
oscillations	O
.	O
ecological	B-T170
niche	I-T170
modelling	I-T170
similarly	O
suggested	O
that	O
both	O
species	B-T170
experienced	O
changes	O
in	O
their	O
distribution	O
##al	O
ranges	O
in	O
response	O
to	O
quaternary	O
climatic	O
changes	O
.	O
the	O
extinction	O
of	O
the	O
unknown	O
'	O
gh	O
##ost	O
'	O
tetrap	B-T038
##lo	I-T038
##id	I-T038
species	B-T170
implicated	O
in	O
the	O
origin	O
of	O
o	B-T204
.	I-T204
sinensis	I-T204
could	O
have	O
resulted	O
from	O
superior	O
adaptation	B-T038
of	O
o	B-T204
.	I-T204
sinensis	I-T204
to	O
repeated	O
climatic	O
changes	O
in	O
the	O
region	O
where	O
it	O
now	O
occurs	O
.	O

biochemical	O
studies	B-T062
of	O
amylase	B-T103
,	O
lipase	B-T103
and	O
protease	B-T103
in	O
call	B-T204
##os	I-T204
##obr	I-T204
##uch	I-T204
##us	I-T204
macula	I-T204
##t	I-T204
##us	I-T204
(	O
cole	B-T204
##optera	I-T204
:	O
chrys	B-T204
##omel	I-T204
##idae	I-T204
)	O
populations	B-T098
fed	O
with	O
vign	B-T204
##a	I-T204
un	I-T204
##gu	I-T204
##icul	I-T204
##ata	I-T204
grain	B-T168
cultivated	B-T062
with	O
diaz	B-T007
##otrophic	I-T007
bacteria	I-T007
strains	I-T007
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
enzymatic	B-T038
activity	I-T038
of	O
homogenates	O
of	O
insects	B-T204
fed	O
on	O
grain	B-T168
of	O
cow	B-T204
##pe	I-T204
##a	I-T204
,	O
vign	B-T204
##a	I-T204
un	I-T204
##gu	I-T204
##icul	I-T204
##ata	I-T204
(	I-T204
l	I-T204
.	I-T204
)	I-T204
,	O
cultivars	B-T204
grown	O
with	O
different	O
nitrogen	B-T103
sources	O
.	O
for	O
the	O
experiment	O
we	O
used	O
aliqu	O
##ots	O
of	O
the	O
homogenate	O
of	O
100	O
uns	O
##ex	O
##ed	O
adult	O
insects	B-T204
,	O
emerged	O
from	O
10	O
g	O
of	O
grain	B-T168
obtained	O
from	O
four	O
cow	B-T204
##pe	I-T204
##a	I-T204
cultivars	B-T204
:	O
'	O
brs	B-T204
aca	I-T204
##ua	I-T204
'	O
,	O
'	O
brs	B-T204
car	I-T204
##ij	I-T204
##o	I-T204
'	O
,	O
'	O
brs	B-T204
pu	I-T204
##ja	I-T204
##nt	I-T204
##e	I-T204
'	O
,	O
and	O
'	O
brs	B-T204
tap	I-T204
##ai	I-T204
##hu	I-T204
##m	I-T204
'	O
grown	O
under	O
different	O
regimes	O
of	O
nitrogen	B-T103
sources	O
:	O
mineral	B-T103
fertilizer	B-T103
,	O
inoculation	B-T058
with	O
strains	B-T007
of	I-T007
diaz	I-T007
##otrophs	I-T007
(	O
br	B-T007
326	I-T007
##7	I-T007
,	O
br	B-T007
326	I-T007
##2	I-T007
,	O
br	B-T007
329	I-T007
##9	I-T007
;	O
in	B-T007
##pa	I-T007
03	I-T007
-	I-T007
11	I-T007
##b	I-T007
,	O
03	B-T007
-	I-T007
84	I-T007
uf	I-T007
##la	I-T007
,	O
as	O
well	O
as	O
the	O
control	O
(	O
with	O
soil	O
nitrogen	B-T103
)	O
.	O
the	O
parameters	O
evaluated	O
were	O
enzymatic	B-T038
activities	I-T038
of	O
insect	B-T204
protease	B-T103
,	O
amylase	B-T103
and	O
lipase	B-T103
and	O
the	O
starch	B-T103
content	O
of	O
the	O
grains	B-T168
.	O
there	O
were	O
differences	O
in	O
the	O
enzymatic	B-T038
activity	I-T038
of	O
amylase	B-T103
,	O
lipase	B-T103
and	O
protease	B-T103
of	O
insect	B-T204
homogenate	O
according	O
to	O
the	O
food	B-T168
source	O
.	O
a	O
lower	O
activity	B-T038
of	I-T038
the	I-T038
enzyme	I-T038
amylase	B-T103
from	O
c	B-T204
.	I-T204
macula	I-T204
##t	I-T204
##us	I-T204
homogenate	O
was	O
observed	O
when	O
insects	B-T204
were	O
fed	O
grain	B-T168
of	O
the	O
cultivar	B-T204
brs	I-T204
car	I-T204
##ij	I-T204
##o	I-T204
.	O
a	O
lower	O
activity	B-T038
of	I-T038
lipase	I-T038
enzyme	I-T038
from	O
c	B-T204
.	I-T204
macula	I-T204
##t	I-T204
##us	I-T204
homogenate	O
was	O
observed	O
when	O
the	O
insects	B-T204
fed	O
on	O
grain	B-T168
from	O
the	O
interaction	O
of	O
the	O
cultivar	B-T204
tap	I-T204
##ai	I-T204
##hu	I-T204
##m	I-T204
inoculated	O
with	O
br	B-T007
326	I-T007
##2	I-T007
diaz	I-T007
##otrophs	I-T007
.	O
the	O
lowest	O
proteolytic	B-T038
activity	I-T038
was	O
observed	O
in	O
homogenate	O
of	O
insects	B-T204
fed	O
on	O
interaction	O
of	O
'	O
brs	B-T204
car	I-T204
##ij	I-T204
##o	I-T204
'	O
inoculated	O
with	O
br	B-T007
326	I-T007
##2	I-T007
diaz	I-T007
##otroph	I-T007
s	O
.	O
starch	B-T103
content	O
correlated	O
positively	O
with	O
the	O
amylase	B-T038
activity	I-T038
of	O
c	B-T204
.	I-T204
macula	I-T204
##t	I-T204
##us	I-T204
homogenate	O
.	O
the	O
cultivar	B-T204
brs	I-T204
car	I-T204
##ij	I-T204
##o	I-T204
had	O
a	O
different	O
behavior	O
from	O
the	O
other	O
cultivars	B-T204
,	O
according	O
to	O
the	O
cluster	B-T062
analysis	I-T062
.	O

systems	O
toxicology	B-T091
:	O
real	O
world	B-T098
applications	O
and	O
opportunities	O
systems	O
toxicology	B-T091
aims	O
to	O
change	O
the	O
basis	O
of	O
how	O
adverse	O
biological	O
effects	O
of	O
xenobiotics	B-T103
are	O
characterized	O
from	O
empirical	O
end	O
points	O
to	O
describing	O
modes	O
of	O
action	O
as	O
adverse	O
outcome	O
pathways	O
and	O
perturbed	O
networks	O
.	O
toward	O
this	O
aim	O
,	O
systems	O
toxicology	B-T091
entails	O
the	O
integration	O
of	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
toxicity	B-T037
data	O
with	O
computational	O
modeling	O
.	O
this	O
evolving	O
approach	O
depends	O
critically	O
on	O
data	O
reliability	O
and	O
relevance	O
,	O
which	O
in	O
turn	O
depends	O
on	O
the	O
quality	O
of	O
experimental	B-T170
models	I-T170
and	O
bio	B-T062
##analysis	I-T062
techniques	I-T062
used	O
to	O
generate	O
toxicological	O
data	O
.	O
systems	O
toxicology	B-T091
involves	O
the	O
use	O
of	O
large	O
-	O
scale	O
data	B-T170
streams	I-T170
(	O
[UNK]	O
big	O
data	O
[UNK]	O
)	O
,	O
such	O
as	O
those	O
derived	O
from	O
omics	B-T062
measurements	I-T062
that	O
require	O
computational	O
means	O
for	O
obtaining	O
informative	O
results	O
.	O
thus	O
,	O
integrative	B-T062
analysis	I-T062
of	O
multiple	O
molecular	O
measurements	O
,	O
particularly	O
acquired	O
by	O
omics	B-T058
strategies	I-T058
,	O
is	O
a	O
key	O
approach	O
in	O
systems	O
toxicology	B-T091
.	O
in	O
recent	O
years	O
,	O
there	O
have	O
been	O
significant	O
advances	O
centered	O
on	O
in	O
vitro	O
test	O
systems	O
and	O
bio	B-T058
##analy	I-T058
##tical	I-T058
strategies	I-T058
,	O
yet	O
a	O
front	O
##ier	O
challenge	O
concerns	O
linking	O
observed	O
network	O
perturbations	O
to	O
phenotypes	O
,	O
which	O
will	O
require	O
understanding	O
pathways	O
and	O
networks	O
that	O
give	O
rise	O
to	O
adverse	O
responses	O
.	O
this	O
summary	B-T170
perspective	O
from	O
a	O
2016	O
systems	O
toxicology	B-T091
meeting	O
,	O
an	O
international	O
conference	O
held	O
in	O
the	O
alp	B-T082
##s	I-T082
of	O
switzerland	B-T082
,	O
describes	O
the	O
limitations	O
and	O
opportunities	O
of	O
selected	O
emerging	O
applications	O
in	O
this	O
rapidly	O
advancing	O
field	O
.	O
systems	O
toxicology	B-T091
aims	O
to	O
change	O
the	O
basis	O
of	O
how	O
adverse	O
biological	O
effects	O
of	O
xenobiotics	B-T103
are	O
characterized	O
,	O
from	O
empirical	O
end	O
points	O
to	O
pathways	O
of	O
toxicity	B-T037
.	O
this	O
requires	O
the	O
integration	O
of	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
data	O
with	O
computational	O
modeling	O
.	O
test	O
systems	O
and	O
bio	B-T058
##analy	I-T058
##tical	I-T058
technologies	I-T058
have	O
made	O
significant	O
advances	O
,	O
but	O
ensuring	O
data	O
reliability	O
and	O
relevance	O
is	O
an	O
ongoing	O
concern	O
.	O
the	O
major	O
challenge	O
facing	O
the	O
new	O
pathway	O
approach	O
is	O
determining	O
how	O
to	O
link	O
observed	O
network	O
perturbations	O
to	O
phenotypic	O
toxicity	B-T037
.	O

potentiation	B-T058
of	O
lps	B-T103
-	O
induced	B-T038
apoptotic	B-T038
cell	I-T038
death	I-T038
in	O
human	B-T017
hepatoma	I-T017
hepg2	I-T017
cells	I-T017
by	O
aspirin	B-T103
via	O
ros	B-T103
and	O
mitochondrial	B-T033
dysfunction	I-T033
:	O
protection	O
by	O
n	B-T103
-	I-T103
acetyl	I-T103
cysteine	I-T103
cytotoxicity	B-T038
and	O
inflammation	B-T038
-	O
associated	B-T038
toxic	O
responses	O
have	O
been	O
observed	O
to	O
be	O
induced	O
by	O
bacterial	O
lipopolysaccharide	B-T103
##s	I-T103
(	O
lps	B-T103
)	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
respectively	O
.	O
use	O
of	O
nonsteroidal	B-T103
anti	I-T103
-	I-T103
inflammatory	I-T103
drugs	I-T103
(	O
nsaids	B-T103
)	O
,	O
such	O
as	O
aspirin	B-T103
,	O
has	O
been	O
reported	B-T058
to	O
be	O
beneficial	O
in	O
inflammation	B-T038
-	O
associated	B-T038
diseases	I-T038
like	O
cancer	B-T038
,	O
diabetes	B-T038
and	O
cardiovascular	B-T038
disorders	I-T038
.	O
their	O
precise	O
molecular	O
mechanisms	O
,	O
however	O
,	O
are	O
not	O
clearly	O
understood	O
.	O
our	O
previous	O
studies	B-T062
on	O
aspirin	B-T103
treated	B-T058
hepg2	B-T017
cells	I-T017
strongly	O
suggest	O
cell	B-T038
cycle	I-T038
arrest	I-T038
and	O
induction	O
of	O
apoptosis	B-T038
associated	O
with	O
mitochondrial	B-T033
dysfunction	I-T033
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
have	O
further	O
demonstrated	O
that	O
hepg2	B-T017
cells	I-T017
treated	B-T058
with	I-T058
lps	B-T103
alone	O
or	O
in	O
combination	O
with	O
aspirin	B-T103
induces	O
subcellular	B-T017
toxic	B-T038
responses	I-T038
which	O
are	O
accompanied	O
by	O
increase	O
in	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
production	O
,	O
oxidative	B-T038
stress	I-T038
,	O
mitochondrial	B-T033
respiratory	I-T033
dysfunction	I-T033
and	O
apoptosis	B-T038
.	O
the	O
lps	B-T103
/	O
aspirin	B-T103
induced	O
toxicity	B-T037
was	O
attenuated	O
by	O
pre	O
-	O
treatment	O
of	O
cells	B-T017
with	O
n	B-T103
-	I-T103
acetyl	I-T103
cysteine	I-T103
(	O
nac	B-T103
)	O
.	O
alterations	O
in	O
oxidative	B-T038
stress	I-T038
and	O
glutathione	B-T103
-	O
dependent	O
redox	B-T038
-	I-T038
homeostasis	I-T038
were	O
more	O
pronounced	O
in	O
mitochondria	B-T017
compared	O
to	O
extra	O
-	O
mitochondrial	B-T017
cellular	B-T017
compartments	I-T017
.	O
pre	O
-	O
treatment	O
of	O
hepg2	B-T017
cells	I-T017
with	O
nac	B-T103
exhibited	O
a	O
selective	O
protection	O
in	O
redox	B-T038
homeostasis	I-T038
and	O
mitochondrial	B-T033
dysfunction	I-T033
.	O
our	O
results	O
suggest	O
that	O
the	O
altered	O
redox	B-T038
metabolism	I-T038
,	O
oxidative	B-T038
stress	I-T038
and	O
mitochondrial	B-T017
function	O
in	O
hepg2	B-T017
cells	I-T017
play	O
a	O
critical	O
role	O
in	O
lps	B-T103
/	O
aspirin	B-T103
-	O
induced	O
cytotoxicity	B-T038
.	O
these	O
results	O
may	O
help	O
in	O
better	O
understanding	O
the	O
pharmacological	O
,	O
toxicological	O
and	O
therapeutic	O
properties	O
of	O
nsaids	B-T103
in	O
cancer	B-T017
cells	I-T017
exposed	O
to	O
bacterial	B-T103
endotoxin	I-T103
##s	I-T103
.	O

sc	B-T103
##opar	I-T103
##one	I-T103
inhibits	O
lps	B-T103
-	O
simulated	O
inflammatory	B-T038
response	I-T038
by	O
suppressing	O
irf	B-T103
##3	I-T103
and	O
erk	B-T103
in	O
bv	B-T017
-	I-T017
2	I-T017
microglial	I-T017
cells	I-T017
microglia	B-T017
activation	B-T038
and	O
the	O
release	O
of	O
various	O
inflammatory	O
cytokines	B-T103
are	O
largely	O
related	O
to	O
neurological	O
diseases	O
,	O
including	O
parkinson	B-T038
'	I-T038
s	I-T038
,	O
alzheimer	B-T038
'	I-T038
s	I-T038
,	O
and	O
other	O
brain	B-T038
diseases	I-T038
.	O
the	O
suppression	O
of	O
microglial	B-T017
cells	I-T017
using	O
natural	O
bioactive	B-T103
compounds	I-T103
has	O
become	O
increasingly	O
important	O
for	O
brain	O
therapy	O
owing	O
to	O
the	O
expected	O
beneficial	O
effect	O
of	O
lower	O
toxicity	O
.	O
sc	B-T103
##opar	I-T103
##one	I-T103
(	O
6	B-T103
,	I-T103
7	I-T103
-	I-T103
dimethoxy	I-T103
##co	I-T103
##uma	I-T103
##rin	I-T103
)	O
,	O
a	O
major	O
bioactive	B-T103
compound	I-T103
found	B-T033
in	O
various	O
plant	B-T170
parts	I-T170
,	O
including	O
the	O
inner	O
shell	O
of	O
chest	B-T168
##nut	I-T168
(	O
cast	B-T204
##ane	I-T204
##a	I-T204
cre	I-T204
##nat	I-T204
##a	I-T204
)	O
,	O
was	O
evaluated	O
on	O
lipopolysaccharide	B-T103
(	O
lps	B-T103
)	O
-	O
activated	O
bv	B-T017
-	I-T017
2	I-T017
microglia	I-T017
cells	I-T017
.	O
the	O
results	O
indicated	B-T033
that	O
sc	B-T103
##opar	I-T103
##one	I-T103
suppresses	O
the	O
lps	B-T103
-	O
stimulated	O
increase	O
of	O
neuro	B-T038
##inflammatory	I-T038
responses	I-T038
and	O
inhibited	O
the	O
pro	O
-	O
inflammatory	O
cytokine	B-T103
production	O
in	O
the	O
bv	B-T017
-	I-T017
2	I-T017
microglial	I-T017
cells	I-T017
.	O
a	O
mechanistic	O
study	O
showed	O
that	O
sc	B-T103
##opar	I-T103
##one	I-T103
specifically	O
inhibited	O
the	O
lps	B-T103
-	O
stimulated	O
activation	B-T038
via	O
a	O
major	O
regulation	B-T038
of	O
irf	B-T103
-	I-T103
3	I-T103
and	O
a	O
regulation	B-T038
of	O
erk	B-T103
,	O
whereby	O
the	O
phosphorylation	B-T038
in	O
the	O
bv	B-T017
-	I-T017
2	I-T017
microglial	I-T017
cells	I-T017
is	O
blocked	O
.	O
these	O
data	O
suggest	O
that	O
sc	B-T103
##opar	I-T103
##one	I-T103
has	O
anti	O
-	O
neuro	O
##inflammatory	O
effects	O
in	O
lps	B-T103
-	O
activated	O
bv	B-T017
-	I-T017
2	I-T017
microglial	I-T017
cells	I-T017
,	O
and	O
could	O
possibly	O
be	O
used	O
in	O
the	O
development	O
of	O
novel	O
drugs	B-T103
for	O
the	O
prevention	O
and	O
treatment	O
of	O
neuro	O
##inflammatory	O
diseases	O
.	O

highly	O
fluorescent	O
gold	B-T103
nanocl	O
##ust	O
##ers	O
stabilized	O
by	O
food	B-T103
proteins	I-T103
:	O
from	O
preparation	O
to	O
application	O
in	O
detection	B-T058
of	O
food	B-T168
contaminants	O
and	O
bioactive	O
nutrients	O
applications	O
of	O
nanotechnology	O
in	O
food	B-T168
have	O
rapidly	O
increased	O
in	O
the	O
past	O
decades	O
.	O
ultra	O
-	O
small	O
gold	O
nanocl	O
##ust	O
##ers	O
(	O
au	O
ncs	O
)	O
,	O
composed	O
of	O
several	O
to	O
roughly	O
a	O
hundred	O
atoms	O
,	O
represent	O
a	O
kind	O
of	O
novel	O
nanomaterials	O
.	O
the	O
au	O
ncs	O
directed	O
by	O
food	B-T103
proteins	I-T103
have	O
drawn	O
considerable	O
research	O
attention	O
due	O
to	O
their	O
environmentally	O
friendly	O
preparation	O
,	O
strong	O
fluorescence	O
,	O
excellent	O
photo	O
-	O
stability	O
and	O
favorable	O
biocompatibility	O
.	O
these	O
interesting	O
protein	O
-	O
au	O
hybrids	O
have	O
opened	O
up	O
a	O
new	O
area	O
at	O
the	O
nano	B-T092
-	I-T092
bio	I-T092
-	I-T092
food	I-T092
interface	I-T092
,	O
not	O
only	O
did	O
they	O
provide	O
the	O
missing	O
link	O
between	O
single	B-T103
metal	I-T103
atoms	I-T103
and	O
plasmonic	B-T062
metal	O
nanoparticles	O
,	O
but	O
also	O
developed	O
the	O
hybrid	B-T103
system	I-T103
between	O
biom	O
##acr	O
##omol	O
##ecu	O
##le	O
and	O
inorganic	O
ions	B-T103
.	O
in	O
this	O
review	O
,	O
we	O
highlighted	O
the	O
synthesis	O
strategies	O
and	O
optical	O
properties	O
of	O
the	O
au	O
ncs	O
stabilized	O
by	O
typical	O
food	B-T103
proteins	I-T103
as	O
well	O
as	O
their	O
applications	O
in	O
detection	B-T058
of	O
food	B-T168
contaminants	O
or	O
bioactive	O
nutrients	O
.	O
in	O
addition	O
,	O
we	O
discussed	O
current	O
challenges	O
and	O
future	O
development	O
in	O
food	B-T103
proteins	I-T103
directed	O
gold	O
nanocl	O
##ust	O
##ers	O
for	O
size	O
-	O
controlled	O
synthesis	O
and	O
multifunctional	O
applications	O
.	O

the	O
association	O
between	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
repeats	B-T082
and	O
risk	O
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
and	O
amyotrophic	B-T038
lateral	I-T038
sclerosis	I-T038
:	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
is	O
the	O
most	O
common	O
genetic	O
cause	O
of	O
amyotrophic	B-T038
lateral	I-T038
sclerosis	I-T038
(	O
als	B-T038
)	O
and	O
frontotemporal	B-T038
dementia	I-T038
(	O
ft	B-T038
##d	I-T038
)	O
in	O
caucasian	B-T098
populations	I-T098
.	O
however	O
,	O
the	O
relationship	O
between	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
repeats	B-T082
and	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
was	O
not	O
clear	O
.	O
additionally	O
,	O
there	O
were	O
few	O
articles	B-T170
assessing	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
in	O
other	O
ethnic	O
##ities	O
with	O
als	B-T038
.	O
in	O
this	O
meta	B-T062
-	I-T062
analysis	I-T062
,	O
we	O
aimed	O
to	O
investigate	O
the	O
relationship	O
between	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
repeat	B-T038
expansions	I-T038
(	O
≥3	O
##0	O
repeats	B-T082
)	O
and	O
intermediate	B-T082
repeat	B-T082
copies	I-T082
(	O
20	O
-	O
29	O
repeats	B-T082
)	O
and	O
ad	B-T038
or	O
als	B-T038
.	O
the	O
results	O
suggested	O
positive	B-T033
correlations	O
between	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
repeat	B-T038
expansions	I-T038
and	O
the	O
risk	O
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
or	O
=	O
6	O
.	O
36	O
,	O
95	O
%	O
ci	O
=	O
3	O
.	O
13	O
-	O
12	O
.	O
92	O
,	O
and	O
p	O
<	O
0	O
.	O
00001	O
)	O
,	O
while	O
intermediate	B-T082
repeat	B-T082
copies	I-T082
of	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
gene	I-T017
were	O
not	O
associated	O
with	O
the	O
risk	O
of	O
the	O
disease	B-T038
.	O
c9	B-T017
##or	I-T017
##f	I-T017
##72	I-T017
repeat	B-T038
expansions	I-T038
were	O
positively	B-T033
correlated	O
with	O
the	O
risk	O
of	O
familial	B-T038
and	O
sporadic	B-T038
als	I-T038
(	O
or	O
=	O
293	O
.	O
25	O
,	O
95	O
%	O
ci	O
=	O
148	O
.	O
17	O
-	O
58	O
##0	O
.	O
38	O
,	O
and	O
p	O
<	O
0	O
.	O
00001	O
;	O
or	O
=	O
35	O
.	O
57	O
,	O
95	O
%	O
ci	O
=	O
19	O
.	O
61	O
-	O
64	O
.	O
51	O
,	O
and	O
p	O
<	O
0	O
.	O
00001	O
)	O
.	O
there	O
was	O
a	O
positive	B-T033
correlation	O
between	O
the	O
gene	O
variations	O
and	O
als	B-T038
risk	O
among	O
caucasians	B-T098
and	O
asians	B-T098
(	O
or	O
=	O
57	O
.	O
56	O
,	O
95	O
%	O
ci	O
=	O
36	O
.	O
73	O
-	O
90	O
.	O
22	O
,	O
and	O
p	O
<	O
0	O
.	O
00001	O
;	O
or	O
=	O
6	O
.	O
35	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
39	O
-	O
29	O
.	O
02	O
,	O
and	O
p	O
=	O
0	O
.	O
02	O
)	O
.	O

cs	B-T103
-	O
peg	B-T103
decorated	O
plga	B-T103
nano	I-T103
-	I-T103
prototype	I-T103
for	O
delivery	O
of	O
bioactive	B-T103
compounds	I-T103
:	O
a	O
novel	O
approach	B-T082
for	O
induction	O
of	O
apoptosis	B-T038
in	O
hepg2	B-T017
cell	I-T017
line	I-T017
polymer	B-T103
-	O
based	O
nanoparticles	O
are	O
used	O
as	O
vectors	B-T082
for	O
cancer	B-T038
drug	O
delivery	O
.	O
the	O
bioactive	B-T103
compounds	I-T103
(	O
quercetin	B-T103
,	O
ell	B-T103
##agic	I-T103
acid	I-T103
and	O
gall	B-T103
##ic	I-T103
acid	I-T103
)	O
are	O
well	O
known	O
to	O
be	O
not	O
only	O
antioxidants	B-T103
but	O
also	O
chemopreventive	B-T103
candidates	I-T103
against	O
various	O
types	O
of	O
cancers	B-T038
.	O
to	O
circumvent	O
the	O
low	O
bioavailability	O
and	O
the	O
short	O
half	O
-	O
life	O
time	O
obstacles	O
,	O
we	O
hypothesized	O
a	O
novel	O
plga	B-T103
nano	I-T103
-	I-T103
platform	I-T103
functionalized	O
with	O
cs	B-T103
and	O
peg	B-T103
to	O
encaps	O
##ulate	O
these	O
phytochemical	B-T103
##s	I-T103
.	O
this	O
encapsulation	O
will	O
protect	O
the	O
compounds	B-T103
from	O
the	O
phagocytic	B-T038
uptake	I-T038
and	O
deliver	O
plga	B-T103
-	I-T103
cs	I-T103
-	I-T103
peg	I-T103
nano	I-T103
-	I-T103
prototype	I-T103
with	O
high	O
biodegrad	O
##ability	O
and	O
bios	O
##afe	O
##ty	O
.	O
three	O
consequent	O
types	O
of	O
plga	B-T103
-	I-T103
based	I-T103
nanocomposites	I-T103
were	O
prepared	O
and	O
characterized	O
.	O
furthermore	O
,	O
we	O
investigated	O
the	O
newly	O
synthesized	O
nano	O
-	O
formulations	O
against	O
human	B-T204
hepatocellular	B-T038
carcinoma	I-T038
(	O
hepg2	B-T017
)	O
and	O
colorectal	B-T038
cancer	I-T038
(	O
hct	B-T017
116	I-T017
)	O
cell	B-T017
lines	I-T017
using	O
cell	B-T038
growth	I-T038
inhibition	I-T038
assays	B-T058
,	O
followed	O
by	O
apoptosis	B-T038
and	O
necrosis	B-T038
assays	B-T058
using	O
flow	B-T058
cytometry	I-T058
to	O
detect	B-T058
the	O
underlying	O
mechanism	O
of	O
hepg2	B-T017
cell	B-T038
death	I-T038
.	O
through	O
mal	O
##vern	O
zeta	O
size	O
##r	O
,	O
we	O
recorded	O
that	O
the	O
average	O
diameters	O
of	O
the	O
nano	O
-	O
prototype	O
##s	O
ranged	O
from	O
150	O
to	O
300	O
##nm	O
.	O
the	O
cytotoxic	B-T058
activity	I-T058
of	O
quercetin	B-T103
,	O
ell	B-T103
##agic	I-T103
acid	I-T103
,	O
and	O
gall	B-T103
##ic	I-T103
acid	I-T103
-	O
encapsulated	O
plga	B-T103
,	O
plga	B-T103
-	I-T103
cs	I-T103
,	O
and	O
plga	B-T103
-	I-T103
cs	I-T103
-	I-T103
peg	I-T103
nano	I-T103
-	I-T103
prototype	I-T103
##s	I-T103
it	O
has	O
been	O
found	B-T033
that	O
they	O
reduce	O
the	O
ic50	O
##s	O
of	O
the	O
hepg2	B-T017
cells	I-T017
values	O
by	O
2	O
.	O
2	O
,	O
2	O
.	O
9	O
,	O
2	O
.	O
8	O
-	O
folds	O
,	O
1	O
,	O
1	O
.	O
5	O
,	O
2	O
.	O
7	O
-	O
folds	O
,	O
and	O
0	O
.	O
9	O
,	O
0	O
.	O
7	O
,	O
1	O
.	O
5	O
-	O
folds	O
,	O
respectively	O
.	O
mechanistically	O
,	O
the	O
nano	O
-	O
platforms	O
of	O
quercetin	B-T103
seem	O
to	O
be	O
dependent	O
on	O
both	O
apoptosis	B-T038
and	O
necrosis	B-T038
,	O
while	O
those	O
of	O
ell	B-T103
##agic	I-T103
acid	I-T103
and	O
gall	B-T103
##ic	I-T103
acid	I-T103
are	O
mainly	O
dependent	O
on	O
apoptosis	B-T038
.	O
cs	B-T103
-	O
peg	B-T103
-	O
blend	O
##ed	O
plga	B-T103
nano	O
-	O
delivery	O
system	O
of	O
quercetin	B-T103
,	O
ell	B-T103
##agic	I-T103
acid	I-T103
and	O
gall	B-T103
##ic	I-T103
acid	I-T103
can	O
potentiate	O
apoptosis	B-T038
-	I-T038
mediated	I-T038
cell	B-T038
death	I-T038
in	O
hepg2	B-T017
cell	I-T017
line	I-T017
.	O

cxcr4	B-T103
(	O
cd18	B-T103
##4	I-T103
)	O
expression	B-T038
on	O
stem	B-T058
cell	I-T058
harvest	I-T058
and	O
cd34	B-T103
(	I-T103
+	I-T103
)	I-T103
cells	B-T017
post	O
-	O
transplant	O
cxcr4	B-T103
is	O
a	O
receptor	B-T103
for	O
stromal	B-T103
-	I-T103
derived	I-T103
factor	I-T103
-	I-T103
1	I-T103
(	O
sdf	B-T103
-	I-T103
1	I-T103
)	O
,	O
a	O
molecule	O
that	O
has	O
a	O
chemotactic	B-T038
activity	O
for	O
lymphocytes	B-T017
and	O
is	O
important	O
in	O
homing	B-T038
of	O
hematopoietic	B-T017
stem	I-T017
cells	I-T017
to	O
their	O
adult	B-T017
marrow	I-T017
.	O
we	O
evaluated	B-T058
the	O
cxcr4	B-T103
(	O
cd18	B-T103
##4	I-T103
)	O
expression	B-T038
in	O
the	O
harvest	B-T017
cells	I-T017
and	O
in	O
the	O
post	O
-	O
transplant	O
bone	B-T017
marrow	I-T017
(	O
bm	B-T017
)	O
and	O
its	O
relation	O
to	O
engraftment	B-T038
,	O
as	O
determined	O
by	O
the	O
consensus	O
criteria	O
and	O
chimerism	O
.	O
this	O
is	O
a	O
prospective	B-T062
study	I-T062
which	O
included	O
30	O
patients	O
undergoing	O
hematopoietic	B-T058
stem	I-T058
cell	I-T058
transplantation	I-T058
;	O
15	O
patients	O
received	O
autograft	B-T058
and	O
15	O
patients	O
received	O
allograft	B-T058
on	O
dates	O
between	O
january	O
2012	O
and	O
may	O
2014	O
.	O
we	O
assessed	O
cd18	B-T103
##4	I-T103
(	O
cxcr4	B-T103
)	O
using	O
flow	B-T058
cytometry	I-T058
in	O
the	O
harvest	B-T017
cells	I-T017
together	O
with	O
post	O
-	O
transplant	O
bm	B-T017
assessment	B-T058
on	O
day	O
28	O
and	O
day	O
90	O
for	O
complete	O
morphologic	B-T082
,	O
molecular	O
studies	O
,	O
and	O
detection	B-T058
of	O
cd18	B-T103
##4	I-T103
expression	B-T038
on	O
cd34	B-T103
(	I-T103
+	I-T103
)	I-T103
cells	B-T017
with	O
chimerism	O
studies	O
on	O
total	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
.	O
diagnoses	B-T033
of	O
the	O
enrolled	O
patients	O
were	O
as	O
follows	O
:	O
seven	O
(	O
24	O
.	O
1	O
%	O
)	O
with	O
acute	B-T038
myeloid	I-T038
leukemia	I-T038
,	O
eight	O
(	O
27	O
.	O
6	O
%	O
)	O
with	O
multiple	B-T038
myeloma	I-T038
,	O
four	O
(	O
13	O
.	O
8	O
%	O
)	O
with	O
acute	B-T038
lymphoblastic	I-T038
leukemia	I-T038
,	O
three	O
(	O
10	O
.	O
3	O
%	O
)	O
with	O
non	B-T038
-	I-T038
hodgkin	I-T038
lymphoma	I-T038
,	O
two	O
(	O
6	O
.	O
9	O
%	O
)	O
with	O
myelodysplastic	B-T038
syndromes	I-T038
,	O
two	O
(	O
6	O
.	O
9	O
%	O
)	O
with	O
aplastic	B-T038
anemia	I-T038
,	O
two	O
(	O
6	O
.	O
9	O
%	O
)	O
with	O
chronic	B-T038
myeloid	I-T038
leukemia	I-T038
,	O
one	O
(	O
3	O
.	O
4	O
%	O
)	O
with	O
hodgkin	B-T038
lymphoma	I-T038
,	O
and	O
one	O
(	O
3	O
.	O
4	O
%	O
)	O
with	O
plasmacyt	B-T038
##omas	I-T038
.	O
one	O
patient	O
died	B-T033
and	O
was	O
excluded	O
from	O
the	O
study	B-T062
because	O
there	O
were	O
not	O
enough	O
data	O
about	O
engraftment	B-T038
.	O
there	O
was	O
no	B-T033
statistical	O
significance	O
between	O
the	O
level	B-T033
of	O
cd18	B-T103
##4	I-T103
in	O
stem	B-T058
cell	I-T058
harvest	I-T058
and	O
the	O
prediction	O
of	O
successful	O
engraftment	B-T038
(	O
p	O
>	O
0	O
.	O
05	O
)	O
as	O
well	O
as	O
in	O
day	O
28	O
bm	B-T031
sample	I-T031
(	O
p	O
>	O
0	O
.	O
05	O
)	O
,	O
whereas	O
there	O
was	O
a	O
statistical	O
significance	O
between	O
the	O
level	B-T033
of	O
cd18	B-T103
##4	I-T103
in	O
day	O
90	O
bm	B-T031
sample	I-T031
and	O
the	O
occurrence	O
of	O
successful	O
engraftment	B-T038
(	O
p	O
=	O
0	O
.	O
002	O
)	O
.	O
sdf	B-T103
-	I-T103
1	I-T103
/	O
cxcr4	B-T103
axis	O
plays	O
a	O
crucial	O
role	O
in	O
engraftment	B-T038
;	O
however	O
,	O
more	O
studies	O
are	O
warranted	O
to	O
assess	O
their	O
expression	B-T038
post	O
-	O
transplant	O
.	O
evaluating	O
the	O
ligand	O
(	O
chemokine	B-T103
,	O
sdf	B-T103
-	I-T103
1	I-T103
)	O
or	O
its	O
receptor	B-T103
(	O
cxcr4	B-T103
)	O
may	O
serve	O
as	O
potential	O
surrogate	O
markers	O
for	O
assessment	B-T058
of	O
engraftment	B-T038
.	O

knock	B-T062
##ing	I-T062
down	I-T062
tcf	B-T017
##8	I-T017
inhibits	O
high	B-T033
glucose	I-T033
-	O
and	O
angiotensin	B-T103
ii	I-T103
-	O
induced	O
epithelial	B-T038
to	I-T038
mesenchymal	I-T038
transition	I-T038
in	O
podocytes	B-T017
epithelial	B-T038
to	I-T038
mesenchymal	I-T038
transition	I-T038
(	O
emt	B-T038
)	O
is	O
a	O
physiological	B-T038
phenomenon	I-T038
in	O
mammalian	B-T204
embryogenesis	B-T038
by	O
which	O
epithelial	B-T017
cells	I-T017
become	O
mesenchymal	B-T017
stem	I-T017
cells	I-T017
.	O
studies	O
have	O
indicated	O
that	O
an	O
inappropriate	O
emt	B-T038
plays	O
a	O
key	O
role	O
in	O
a	O
variety	O
of	O
pathogenic	B-T033
processes	O
such	O
as	O
embryonic	B-T038
development	I-T038
and	O
tumor	B-T038
metastasis	I-T038
.	O
moreover	O
,	O
recent	O
studies	O
have	O
indicated	O
emt	B-T038
also	O
plays	O
an	O
important	O
role	O
in	O
renal	B-T038
fibrosis	I-T038
.	O
in	O
the	O
current	O
study	O
,	O
glucose	B-T103
and	O
angiotensin	B-T103
ii	I-T103
promoted	O
emt	B-T038
in	O
podocytes	B-T017
as	O
well	O
as	O
changes	O
in	O
the	O
cellular	B-T201
morphology	I-T201
of	O
podocytes	B-T017
.	O
a	O
high	O
concentration	O
of	O
glucose	B-T103
and	O
angiotensin	B-T103
ii	I-T103
also	O
promoted	O
podocyte	B-T017
movement	B-T038
and	O
migration	B-T038
.	O
moreover	O
,	O
a	O
high	O
concentration	O
of	O
glucose	B-T103
and	O
angiotensin	B-T103
ii	I-T103
promoted	O
tcf	B-T017
##8	I-T017
expression	B-T038
.	O
inhibiting	O
tcf	B-T017
##8	I-T017
expression	B-T038
with	O
sirna	B-T103
reversed	O
emt	B-T038
in	O
podocytes	B-T017
in	O
the	O
presence	O
of	O
a	O
high	O
concentration	O
of	O
glucose	B-T103
and	O
angiotensin	B-T103
.	O
inhibiting	O
tcf	B-T017
##8	I-T017
expression	B-T038
also	O
reversed	O
changes	O
in	O
cellular	B-T201
morphology	I-T201
and	O
podocyte	B-T017
movement	B-T038
and	O
migration	B-T038
.	O
therefore	O
,	O
glucose	B-T103
and	O
angiotensin	B-T103
ii	I-T103
may	O
promote	O
emt	B-T038
in	O
podocytes	B-T017
via	O
tcf	B-T017
##8	I-T017
.	O

development	O
of	O
a	O
novel	O
near	O
-	O
infrared	O
fluorescent	O
ther	B-T091
##ano	I-T091
##st	I-T091
##ic	I-T091
comb	B-T103
##ret	I-T103
##ast	I-T103
##ain	I-T103
a	I-T103
-	I-T103
4	I-T103
analogue	B-T103
,	O
y	B-T103
##k	I-T103
-	I-T103
5	I-T103
-	I-T103
252	I-T103
,	O
to	O
target	O
triple	B-T038
negative	I-T038
breast	I-T038
cancer	I-T038
the	O
treatment	B-T058
of	O
triple	B-T038
negative	I-T038
breast	I-T038
cancer	I-T038
(	O
tnbc	B-T038
)	O
is	O
a	O
significant	O
challenge	O
to	O
cancer	B-T062
research	I-T062
.	O
the	O
lack	O
of	O
hormone	B-T103
receptors	I-T103
limits	O
the	O
treatment	B-T058
options	O
available	O
to	O
patients	O
with	O
this	O
diagnosis	B-T033
,	O
for	O
##cing	O
them	O
to	O
end	O
##ure	O
prolonged	O
radiation	B-T058
and	O
chemotherapy	B-T058
.	O
anti	B-T058
-	I-T058
angiogenesis	I-T058
is	O
a	O
chemotherapeutic	O
strategy	O
that	O
targets	O
the	O
vasculature	B-T017
of	O
tumors	B-T038
.	O
comb	B-T103
##ret	I-T103
##astatin	I-T103
a	I-T103
-	I-T103
4	I-T103
(	O
ca	B-T103
-	I-T103
4	I-T103
)	O
is	O
a	O
well	O
-	O
known	O
vasculature	B-T017
-	O
disrupting	O
agent	O
,	O
which	O
has	O
been	O
shown	O
to	O
effectively	O
kill	O
a	O
variety	O
of	O
cancers	B-T038
through	O
inhibition	O
of	O
tubulin	B-T103
polymerization	O
.	O
due	O
to	O
its	O
toxicity	B-T037
,	O
small	O
molecule	O
analogues	B-T103
of	O
ca	B-T103
-	I-T103
4	I-T103
have	O
been	O
sought	O
out	O
.	O
we	O
have	O
designed	O
a	O
novel	O
dual	O
action	O
ca	B-T103
-	I-T103
4	I-T103
prodrug	B-T103
,	O
y	B-T103
##k	I-T103
-	I-T103
5	I-T103
-	I-T103
252	I-T103
,	O
which	O
releases	O
the	O
drug	B-T103
through	O
a	O
disulfide	O
bond	O
cleavage	O
mechanism	O
and	O
contains	O
a	O
near	O
-	O
infrared	O
(	O
nir	O
)	O
fluorophore	O
,	O
which	O
allows	O
fluorescence	O
monitoring	O
of	O
cleavage	O
.	O
this	O
disulfide	O
linkage	O
causes	O
ca	B-T103
-	I-T103
4	I-T103
to	O
become	O
effective	O
only	O
when	O
released	O
by	O
glutathione	B-T103
(	O
gsh	B-T103
)	O
reducing	O
the	O
toxicity	B-T037
of	O
the	O
drug	B-T103
while	O
simultaneously	O
releasing	O
the	O
nir	O
fluorophore	O
.	O
therefore	O
the	O
prodrug	B-T103
,	O
y	B-T103
##k	I-T103
-	I-T103
5	I-T103
-	I-T103
252	I-T103
,	O
represents	O
a	O
novel	O
ca	B-T103
-	I-T103
4	I-T103
analogue	B-T103
which	O
has	O
reduced	O
toxicity	B-T037
and	O
can	O
be	O
used	O
for	O
ther	B-T091
##ano	I-T091
##st	I-T091
##ics	I-T091
imaging	B-T058
.	O

eco	B-T062
##hydro	I-T062
##lo	I-T062
##gic	I-T062
##al	I-T062
modeling	I-T062
and	O
environmental	B-T082
flow	O
regime	O
in	O
the	O
form	O
##os	O
##o	O
river	O
,	O
min	B-T082
##as	I-T082
ger	I-T082
##ai	I-T082
##s	I-T082
state	I-T082
,	O
brazil	B-T082
this	O
paper	B-T170
aimed	O
at	O
determining	O
the	O
environmental	B-T082
flow	O
regime	O
in	O
a	O
1	O
km	O
stretch	O
of	O
the	O
form	O
##os	O
##o	O
river	O
,	O
mg	B-T082
,	O
using	O
river	B-T062
##2	I-T062
##d	I-T062
model	I-T062
.	O
to	O
carry	O
out	O
the	O
eco	B-T062
##hydro	I-T062
##lo	I-T062
##gic	I-T062
##al	I-T062
modeling	I-T062
,	O
the	O
following	O
information	O
was	O
used	O
:	O
bath	O
##ymet	O
##ry	O
,	O
physical	O
and	O
hydraulic	O
features	O
,	O
and	O
the	O
habitat	B-T082
suitability	O
index	O
for	O
species	B-T170
of	O
the	O
hypo	B-T204
##st	I-T204
##omus	I-T204
aur	I-T204
##og	I-T204
##ut	I-T204
##ta	I-T204
##t	I-T204
##us	I-T204
.	O
in	O
the	O
river	B-T062
##2	I-T062
##d	I-T062
,	O
the	O
weighted	O
usa	O
##ble	O
areas	B-T082
were	O
determined	O
from	O
the	O
average	O
long	O
-	O
term	O
stream	O
##flow	O
##s	O
with	O
percentage	O
from	O
10	O
%	O
to	O
100	O
%	O
.	O
those	O
stream	O
##flow	O
##s	O
were	O
simulated	O
for	O
the	O
later	O
construction	O
of	O
optimization	O
matrices	B-T082
that	O
maximize	O
the	O
habitat	B-T082
area	B-T082
throughout	O
the	O
year	O
.	O
for	O
h	B-T204
.	I-T204
aur	I-T204
##og	I-T204
##ut	I-T204
##ta	I-T204
##t	I-T204
##us	I-T204
juvenile	O
,	O
higher	O
values	O
of	O
weighted	O
usa	O
##ble	O
area	B-T082
were	O
associated	O
with	O
the	O
percentage	O
of	O
60	O
%	O
and	O
70	O
%	O
of	O
the	O
average	O
long	O
-	O
term	O
stream	O
##flow	O
##s	O
in	O
october	O
and	O
september	O
,	O
respectively	O
.	O
for	O
h	B-T204
.	I-T204
aur	I-T204
##og	I-T204
##ut	I-T204
##ta	I-T204
##t	I-T204
##us	I-T204
adult	O
,	O
the	O
highest	O
value	O
of	O
weighted	O
usa	O
##ble	O
area	B-T082
was	O
associated	O
with	O
the	O
percentage	O
of	O
100	O
%	O
of	O
the	O
average	O
long	O
-	O
term	O
stream	O
##flow	O
in	O
september	O
.	O
the	O
environmental	B-T082
flows	O
found	B-T033
for	O
this	O
stretch	O
of	O
the	O
form	O
##os	O
##o	O
river	O
varied	O
over	O
the	O
year	O
.	O
the	O
lowest	O
environmental	B-T082
flow	O
was	O
observed	O
in	O
december	O
(	O
2	O
.	O
85	O
m3	O
s	O
-	O
1	O
)	O
,	O
while	O
the	O
highest	O
was	O
observed	O
in	O
may	O
(	O
4	O
.	O
13	O
m3	O
s	O
-	O
1	O
)	O
.	O
this	O
paper	B-T170
shows	O
the	O
importance	O
of	O
eco	B-T062
##hydro	I-T062
##lo	I-T062
##gic	I-T062
##al	I-T062
studies	I-T062
in	O
forming	O
a	O
basis	O
for	O
water	O
resources	O
management	O
actions	O
.	O

cerebral	B-T038
toxoplasmosis	I-T038
in	O
patients	O
with	O
acquired	B-T038
immune	I-T038
deficiency	I-T038
syndrome	I-T038
in	O
the	O
neurological	B-T092
emergency	I-T092
department	I-T092
of	O
a	O
tertiary	B-T092
hospital	I-T092
cerebral	B-T038
toxoplasmosis	I-T038
is	O
the	O
most	O
common	O
cause	O
of	O
space	B-T082
occupying	O
brain	B-T038
lesion	I-T038
in	O
patients	O
with	O
hiv	O
/	O
aids	O
in	O
brazil	B-T082
.	O
in	O
the	O
post	O
-	O
haart	O
era	O
,	O
it	O
is	O
responsible	O
for	O
high	O
rates	O
of	O
morbidity	O
and	O
mortality	O
worldwide	O
.	O
this	O
study	B-T062
consists	O
of	O
a	O
case	B-T062
series	I-T062
of	O
56	O
patients	O
diagnosed	B-T033
with	O
cerebral	B-T038
toxoplasmosis	I-T038
whose	O
clinical	O
features	O
,	O
brain	B-T058
imaging	I-T058
and	O
cerebrospinal	B-T031
fluid	I-T031
aspects	O
were	O
analyzed	B-T062
.	O
cerebral	B-T038
toxoplasmosis	I-T038
led	O
to	O
the	O
diagnosis	B-T033
of	O
infection	B-T038
by	O
the	O
human	B-T005
immunodeficiency	I-T005
virus	I-T005
(	O
hiv	B-T005
)	O
in	O
27	O
(	O
48	O
.	O
2	O
%	O
)	O
of	O
the	O
patients	O
,	O
while	O
29	O
(	O
51	O
.	O
2	O
%	O
)	O
others	O
already	O
knew	O
to	O
be	O
hiv	B-T033
seropositive	I-T033
.	O
however	O
,	O
at	O
the	O
time	O
of	O
diagnosis	B-T033
of	O
cerebral	B-T038
toxoplasmosis	I-T038
,	O
only	O
9	O
(	O
16	O
.	O
6	O
%	O
)	O
reported	B-T058
being	O
under	O
antiretroviral	B-T058
therapy	I-T058
and	O
5	O
(	O
8	O
.	O
9	O
%	O
)	O
were	O
receiving	O
primary	O
prophylaxis	B-T058
for	O
toxoplasmosis	B-T038
.	O
headache	B-T033
,	O
strength	B-T033
deficit	I-T033
and	O
fever	B-T033
were	O
the	O
most	O
frequent	O
signs	B-T033
and	I-T033
symptoms	I-T033
throughout	O
the	O
study	B-T062
.	O
fifty	O
-	O
three	O
patients	O
showed	O
changes	O
consistent	O
with	O
toxoplasmosis	B-T038
in	O
ct	B-T058
or	O
mri	B-T058
.	O
thirty	O
-	O
four	O
(	O
60	O
.	O
7	O
%	O
)	O
csf	B-T031
samples	I-T031
were	O
positive	B-T033
in	O
the	O
indirect	B-T058
haem	I-T058
##agglutination	I-T058
test	I-T058
and	O
for	O
the	O
reaction	O
of	O
toxoplasma	B-T103
gondii	I-T103
igg	I-T103
elisa	B-T058
,	O
while	O
31	O
(	O
55	O
.	O
4	O
%	O
)	O
were	O
positive	B-T033
in	O
the	O
direct	B-T058
haem	I-T058
##agglutination	I-T058
test	I-T058
.	O
fifty	O
(	O
89	O
.	O
3	O
%	O
)	O
patients	O
underwent	O
first	B-T058
-	I-T058
line	I-T058
treatment	I-T058
for	O
toxoplasmosis	B-T038
.	O
cerebral	B-T038
toxoplasmosis	I-T038
is	O
still	O
a	O
very	O
relevant	O
neurological	B-T038
disease	I-T038
in	O
individuals	B-T098
with	O
aids	B-T038
admitted	B-T058
to	O
neurology	B-T091
emergency	B-T092
departments	I-T092
.	O
early	B-T058
diagnosis	I-T058
and	O
initiation	O
of	O
empiric	B-T033
treatment	I-T033
and	O
antiretroviral	B-T058
therapy	I-T058
are	O
important	O
for	O
good	O
prognosis	B-T058
.	O

multi	O
##ta	O
##r	O
##get	O
sensing	B-T058
of	I-T058
glucose	I-T058
and	O
cholesterol	B-T058
based	O
on	O
janus	B-T103
hydrogel	I-T103
microparticles	I-T103
a	O
visualized	O
sensing	B-T058
method	I-T058
for	I-T058
glucose	I-T058
and	O
cholesterol	B-T058
was	O
developed	O
based	O
on	O
the	O
hemispheres	O
of	O
the	O
same	O
janus	B-T103
hydrogel	I-T103
microparticles	I-T103
.	O
single	O
-	O
phase	O
and	O
janus	B-T103
hydrogel	I-T103
microparticles	I-T103
were	O
both	O
generated	O
using	O
a	O
centrifugal	O
microfluidic	O
chip	O
.	O
for	O
glucose	B-T058
sensing	I-T058
,	O
concanavalin	B-T103
a	I-T103
and	O
fluorescein	B-T103
labeled	I-T103
dextran	I-T103
used	O
for	O
competitive	B-T058
binding	I-T058
assay	I-T058
were	O
encapsulated	O
in	O
alginate	B-T103
microparticles	B-T103
,	O
and	O
the	O
fluorescence	O
of	O
the	O
microparticles	B-T103
was	O
positively	B-T033
correlated	O
with	O
glucose	B-T103
concentration	O
.	O
for	O
cholesterol	B-T058
sensing	I-T058
,	O
the	O
microparticles	B-T103
embedded	O
with	O
γ	O
-	O
fe2	O
##o3	O
nanoparticles	O
were	O
used	O
as	O
catalyst	O
for	O
the	O
oxidation	B-T038
of	O
3	B-T103
,	I-T103
3	I-T103
'	I-T103
,	I-T103
5	I-T103
,	I-T103
5	I-T103
'	I-T103
-	I-T103
tetramethyl	I-T103
##benz	I-T103
##idine	I-T103
by	O
h2o2	B-T103
,	O
an	O
enzymatic	B-T103
hydrolysis	O
product	O
of	O
cholesterol	B-T103
.	O
and	O
the	O
color	O
transition	O
was	O
more	O
sensitive	O
in	O
the	O
microparticles	B-T103
than	O
in	O
solutions	O
,	O
indicating	O
the	O
microparticles	B-T103
are	O
more	O
applicable	O
for	O
visualized	O
determination	B-T058
.	O
furthermore	O
,	O
janus	B-T103
microparticles	I-T103
were	O
employed	B-T033
for	O
multi	O
##ta	O
##r	O
##get	O
sensing	O
in	O
the	O
two	O
heme	O
##sp	O
##here	O
##s	O
,	O
and	O
glucose	B-T103
and	O
cholesterol	B-T103
were	O
detected	B-T033
within	O
the	O
same	O
microparticles	B-T103
without	O
obvious	O
interference	O
.	O
besides	O
,	O
the	O
particles	B-T103
could	O
be	O
manipulated	O
by	O
an	O
external	B-T082
magnetic	O
field	O
.	O
the	O
glucose	B-T033
and	O
cholesterol	B-T033
levels	I-T033
were	O
measured	O
in	O
human	B-T204
serum	B-T031
utilizing	O
the	O
microparticles	B-T103
,	O
which	O
confirmed	B-T033
the	O
potential	O
application	O
of	O
the	O
microparticles	B-T103
in	O
real	O
sample	O
detection	B-T058
.	O

inhibitory	O
effects	O
of	O
lactobacillus	B-T007
rhamn	I-T007
##osus	I-T007
and	O
lactobacillus	B-T007
case	I-T007
##i	I-T007
on	O
candida	B-T204
biofilm	B-T007
of	O
denture	B-T033
surface	I-T033
candida	B-T204
albicans	I-T204
biofilm	B-T007
is	O
associated	O
with	O
denture	B-T038
-	I-T038
related	I-T038
stomatitis	I-T038
and	O
oral	B-T038
candidiasis	I-T038
of	O
elderly	B-T098
.	O
probiotics	B-T007
are	O
beneficial	O
bacteria	B-T007
and	O
have	O
antibacterial	B-T033
activity	I-T033
against	O
pathogenic	B-T007
bacteria	I-T007
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
investigate	O
the	O
antifungal	B-T033
activity	I-T033
of	O
various	O
probiotics	B-T007
against	O
c	B-T204
.	I-T204
albicans	I-T204
and	O
the	O
inhibitory	O
effects	O
of	O
probiotics	B-T007
on	O
candida	B-T204
biofilm	B-T007
on	O
the	O
denture	B-T033
surface	I-T033
.	O
the	O
spent	B-T103
culture	I-T103
media	I-T103
of	O
various	O
probiotics	B-T007
were	O
investigated	O
the	O
antifungal	O
efficacy	O
against	O
c	B-T204
.	I-T204
albicans	I-T204
.	O
candida	B-T204
biofilm	B-T007
was	O
formed	O
on	O
a	O
denture	O
base	O
resin	O
and	O
was	O
then	O
treated	O
with	O
lactobacillus	B-T007
rhamn	I-T007
##osus	I-T007
and	O
lactobacillus	B-T007
case	I-T007
##i	I-T007
.	O
also	O
,	O
the	O
biofilm	B-T007
s	O
of	O
l	B-T007
.	I-T007
rhamn	I-T007
##osus	I-T007
and	O
l	B-T007
.	I-T007
case	I-T007
##i	I-T007
were	O
formed	O
and	O
were	O
sequentially	O
treated	O
with	O
c	B-T204
.	I-T204
albicans	I-T204
.	O
colony	O
-	O
forming	O
units	O
of	O
c	B-T204
.	I-T204
albicans	I-T204
on	O
the	O
denture	B-T033
surface	I-T033
were	O
counted	O
after	O
spreading	O
on	O
agar	B-T103
plate	B-T074
.	O
the	O
denture	O
base	O
resin	O
was	O
treated	O
with	O
the	O
spent	B-T103
culture	I-T103
media	I-T103
for	O
30	O
days	O
,	O
after	O
which	O
the	O
denture	B-T033
surface	I-T033
roughness	B-T033
was	O
analyzed	O
with	O
an	O
atomic	B-T058
force	I-T058
microscope	I-T058
.	O
l	B-T007
.	I-T007
rhamn	I-T007
##osus	I-T007
and	O
l	B-T007
.	I-T007
case	I-T007
##i	I-T007
exhibited	O
stronger	O
antifungal	B-T033
activity	I-T033
than	O
other	O
probiotics	B-T007
.	O
the	O
spent	B-T103
culture	I-T103
medium	I-T103
of	O
l	B-T007
.	I-T007
rhamn	I-T007
##osus	I-T007
and	O
l	B-T007
.	I-T007
case	I-T007
##i	I-T007
exhibited	O
the	O
antifungal	B-T033
activity	I-T033
against	O
blast	B-T204
##ocon	I-T204
##idia	I-T204
and	O
biofilm	B-T007
of	O
c	B-T204
.	I-T204
albicans	I-T204
.	O
l	B-T007
.	I-T007
rhamn	I-T007
##osus	I-T007
and	O
l	B-T007
.	I-T007
case	I-T007
##i	I-T007
showed	O
the	O
antifungal	B-T033
activity	I-T033
against	O
candida	B-T204
biofilm	B-T007
,	O
and	O
the	O
biofilm	B-T007
of	O
l	B-T007
.	I-T007
rhamn	I-T007
##osus	I-T007
and	O
l	B-T007
.	I-T007
case	I-T007
##i	I-T007
inhibited	O
formation	O
of	O
candida	B-T204
biofilm	B-T007
on	O
denture	B-T033
surface	I-T033
.	O
neither	O
of	O
the	O
probiotics	B-T007
affected	O
the	O
surface	B-T033
roughness	I-T033
of	O
the	O
denture	O
base	O
resin	O
.	O
l	B-T007
.	I-T007
rhamn	I-T007
##osus	I-T007
and	O
l	B-T007
.	I-T007
case	I-T007
##i	I-T007
may	O
be	O
the	O
ideal	O
probiotics	B-T007
for	O
the	O
prevention	O
and	O
treatment	O
of	O
denture	B-T038
-	I-T038
related	I-T038
stomatitis	I-T038
.	O

a	O
novel	O
quantitative	B-T062
pcr	I-T062
detects	O
bab	B-T204
##esia	I-T204
infection	B-T038
in	O
patients	O
not	O
identified	O
by	O
currently	O
available	O
non	O
-	O
nucleic	O
acid	O
amplification	O
tests	O
ticks	B-T204
transmit	O
bab	B-T204
##esia	I-T204
microti	I-T204
,	O
the	O
causative	B-T033
agents	I-T033
of	O
bab	B-T038
##esi	I-T038
##osis	I-T038
in	O
north	B-T082
america	I-T082
and	O
europe	B-T082
.	O
bab	B-T038
##esi	I-T038
##osis	I-T038
is	O
now	O
endemic	B-T038
in	O
northeastern	B-T082
usa	B-T082
and	O
affects	O
people	B-T098
of	O
all	O
ages	O
.	O
bab	B-T204
##esia	I-T204
species	I-T204
infect	O
erythrocytes	B-T017
and	O
can	O
be	O
transmitted	B-T038
through	O
blood	B-T058
transfusion	I-T058
.	O
whole	B-T031
blood	I-T031
and	O
blood	B-T103
products	I-T103
,	O
which	O
are	O
not	O
tested	O
for	O
bab	B-T204
##esia	I-T204
,	O
can	O
cause	O
transfusion	B-T058
-	O
transmitted	B-T038
bab	B-T038
##esi	I-T038
##osis	I-T038
(	O
tt	B-T038
##b	I-T038
)	O
resulting	O
in	O
severe	O
consequences	O
in	O
the	O
immuno	B-T033
-	I-T033
compromised	I-T033
patients	O
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
epidemiological	B-T062
evaluation	I-T062
of	O
bab	B-T038
##esi	I-T038
##osis	I-T038
in	O
a	O
tick	B-T038
-	I-T038
infested	I-T038
state	I-T038
.	O
we	O
examined	B-T033
blood	B-T031
samples	I-T031
from	O
192	O
patients	O
who	O
visited	O
clinics	B-T092
during	O
the	O
active	O
tick	B-T038
-	I-T038
borne	I-T038
diseases	I-T038
season	O
,	O
using	O
a	O
newly	O
developed	O
qpcr	B-T062
assay	I-T062
that	O
uses	O
the	O
specific	O
molecular	B-T103
be	I-T103
##aco	I-T103
##n	I-T103
probe	I-T103
.	O
due	O
to	O
the	O
absence	O
of	O
clear	O
symptom	B-T033
##ology	I-T033
,	O
clinical	O
laboratories	O
did	O
not	O
test	O
131	O
samples	B-T031
by	O
ifa	B-T058
,	O
fish	B-T062
or	O
microscopic	B-T058
examination	I-T058
of	O
gi	B-T103
##ems	I-T103
##a	I-T103
-	I-T103
stained	I-T103
blood	B-T058
smears	I-T058
.	O
bab	B-T204
##esia	I-T204
infection	B-T038
was	O
detected	O
in	O
all	O
age	O
groups	O
by	O
fish	B-T062
and	O
microscopy	B-T058
;	O
notably	O
patients	O
>	O
40	O
years	O
of	O
age	O
represented	O
64	O
%	O
of	O
tested	O
samples	B-T031
and	O
13	O
%	O
were	O
younger	O
patients	O
.	O
we	O
tested	O
all	O
samples	B-T031
using	O
qpcr	B-T062
and	O
found	O
that	O
38	O
%	O
were	O
positive	B-T033
for	O
bab	B-T204
##esia	I-T204
.	O
of	O
28	O
samples	B-T031
that	O
were	O
positive	B-T033
by	O
fish	B-T062
,	O
27	O
(	O
96	O
%	O
)	O
were	O
also	O
positive	B-T033
by	O
qpcr	B-T062
indicating	O
high	O
congru	O
##ency	O
between	O
nucleic	B-T058
acid	I-T058
based	I-T058
tests	I-T058
.	O
interestingly	O
,	O
of	O
78	O
asymptomatic	B-T033
samples	B-T031
not	O
tested	O
by	O
fish	B-T062
,	O
22	O
were	O
positive	B-T033
by	O
our	O
qpcr	B-T062
.	O
direct	O
detection	B-T058
of	O
bab	B-T204
##esia	I-T204
relies	O
upon	O
microscopic	B-T058
examination	I-T058
of	O
patient	O
blood	B-T058
smears	I-T058
,	O
which	O
is	O
labor	O
intensive	O
,	O
difficult	O
to	O
scale	O
up	O
,	O
requires	O
specific	O
expertise	O
and	O
is	O
hence	O
,	O
often	O
not	O
performed	O
.	O
in	O
fact	O
,	O
a	O
clinical	O
laboratory	O
examined	B-T033
only	O
23	O
of	O
86	O
blood	B-T031
samples	I-T031
obtained	O
from	O
two	O
different	O
counties	B-T082
by	O
microscopy	B-T058
.	O
by	O
considering	O
individuals	B-T098
positive	B-T033
for	O
bab	B-T204
##esia	I-T204
infection	B-T038
when	O
results	O
from	O
currently	O
available	O
microscopy	B-T058
,	O
fish	B-T062
or	O
serological	B-T058
tests	I-T058
were	O
positive	B-T033
,	O
we	O
found	O
that	O
our	O
qpcr	B-T062
is	O
highly	O
sensitive	O
(	O
96	O
.	O
2	O
%	O
)	O
and	O
showed	O
a	O
specificity	O
of	O
70	O
.	O
5	O
%	O
for	O
bab	B-T204
##esia	I-T204
.	O
robust	O
qpcr	B-T062
using	O
specific	O
probes	B-T103
can	O
be	O
highly	O
useful	O
for	O
efficient	O
and	O
appropriate	O
diagnosis	B-T062
of	O
bab	B-T038
##esi	I-T038
##osis	I-T038
in	O
patients	O
in	O
conjunction	O
with	O
conventional	O
diagnostics	B-T062
,	O
or	O
as	O
a	O
stand	O
-	O
alone	O
test	O
,	O
especially	O
for	O
don	O
##ated	O
blood	B-T058
screening	I-T058
.	O
the	O
use	O
of	O
a	O
nucleic	B-T058
acid	I-T058
amplification	I-T058
test	I-T058
based	O
screening	B-T058
of	I-T058
blood	I-T058
and	O
blood	B-T103
products	I-T103
could	O
prevent	O
tt	B-T038
##b	I-T038
.	O

alcohol	B-T058
brief	I-T058
intervention	I-T058
in	O
primary	B-T058
care	I-T058
:	O
blood	B-T038
pressure	I-T038
outcomes	O
in	O
hypertensive	B-T038
patients	O
in	O
clinical	B-T062
trials	I-T062
alcohol	B-T058
brief	I-T058
intervention	I-T058
(	O
bi	B-T058
)	O
in	O
adult	O
primary	B-T058
care	I-T058
has	O
been	O
efficacious	O
in	O
reducing	O
alcohol	O
consumption	O
,	O
but	O
we	O
know	O
little	O
about	O
its	O
impact	O
on	O
health	O
outcomes	O
.	O
hypertension	B-T038
is	O
a	O
prevalent	O
and	O
costly	O
chronic	B-T033
condition	I-T033
in	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	I-T082
and	O
worldwide	O
,	O
and	O
alcohol	O
use	O
is	O
a	O
modifiable	O
hypertension	B-T038
risk	B-T033
factor	I-T033
.	O
to	O
evaluate	O
the	O
effect	O
of	O
receiving	O
bi	B-T058
for	O
unhealthy	O
drinking	O
on	O
blood	B-T038
pressure	I-T038
(	I-T038
bp	I-T038
)	I-T038
control	I-T038
among	O
adult	O
hypertensive	B-T038
patients	O
by	O
analyzing	O
secondary	O
data	O
from	O
a	O
clustered	B-T062
,	O
randomized	B-T062
controlled	I-T062
trial	I-T062
on	O
alcohol	B-T058
screening	I-T058
,	O
brief	O
intervention	O
and	O
referral	O
to	O
treatment	O
(	O
sb	O
##ir	O
##t	O
)	O
implementation	O
by	O
primary	B-T097
care	I-T097
physicians	I-T097
(	O
pcp	B-T097
intervention	I-T097
arm	I-T097
)	O
and	O
non	B-T097
-	I-T097
physician	I-T097
providers	I-T097
and	O
medical	B-T097
assistants	I-T097
(	O
npp	B-T097
&	O
ma	B-T097
intervention	I-T097
arm	I-T097
)	O
in	O
a	O
large	O
,	O
integrated	B-T092
health	I-T092
care	I-T092
delivery	I-T092
system	I-T092
.	O
observational	B-T062
,	O
prospective	B-T062
cohort	I-T062
study	I-T062
.	O
38	O
##11	O
adult	O
hypertensive	B-T038
primary	O
care	O
patients	O
screening	B-T058
positive	O
for	O
past	O
-	O
year	O
heavy	O
drinking	O
at	O
baseline	O
,	O
of	O
which	O
142	O
##2	O
(	O
37	O
%	O
)	O
had	O
an	O
electronic	B-T170
health	I-T170
record	I-T170
bp	B-T038
measure	O
at	O
baseline	O
and	O
18	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
.	O
change	B-T033
in	I-T033
bp	I-T033
and	O
controlled	B-T038
bp	I-T038
(	O
systolic	O
/	O
diastolic	O
bp	O
<	O
140	O
/	O
90	O
mmhg	O
)	O
.	O
overall	O
no	O
significant	O
associations	O
were	O
found	O
between	O
alcohol	B-T058
bi	I-T058
and	O
bp	B-T033
change	I-T033
at	O
18	O
-	O
month	O
follow	B-T058
-	I-T058
up	I-T058
when	O
analyzing	O
the	O
combined	O
sample	O
of	O
subjects	B-T098
in	O
both	O
intervention	B-T097
arms	I-T097
.	O
however	O
,	O
moder	O
##ation	O
analyses	O
found	O
that	O
receiving	O
bi	B-T058
for	O
positive	O
past	O
-	O
year	O
unhealthy	O
drinking	O
was	O
positively	O
associated	O
with	O
better	O
bp	B-T038
control	I-T038
at	O
18	O
##months	O
in	O
the	O
pcp	B-T097
intervention	I-T097
arm	I-T097
,	O
and	O
for	O
those	O
with	O
lower	O
heavy	O
drinking	O
frequency	O
and	O
poor	O
bp	B-T038
control	I-T038
at	O
the	O
index	B-T058
screening	I-T058
.	O
our	O
findings	O
suggest	O
that	O
hypertensive	B-T038
patients	O
may	O
benefit	O
from	O
receiving	O
physician	B-T097
brief	O
intervention	O
for	O
unhealthy	O
alcohol	O
use	O
in	O
primary	B-T058
care	I-T058
.	O
findings	O
also	O
highlight	O
potential	O
population	O
-	O
level	O
benefits	O
of	O
alcohol	B-T058
bi	I-T058
if	O
widely	O
applied	O
,	O
suggesting	O
a	O
need	O
for	O
the	O
development	O
of	O
innovative	O
strategies	O
to	O
facilitate	O
sb	O
##ir	O
##t	O
delivery	O
in	O
primary	B-T058
care	I-T058
settings	O
.	O

right	B-T017
ventricular	I-T017
response	O
during	O
exercise	O
in	O
patients	O
with	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
right	B-T017
ventricular	I-T017
(	O
rv	B-T017
)	O
pump	B-T038
function	I-T038
is	O
of	O
essential	O
clinical	O
and	O
prognostic	B-T170
importance	O
in	O
a	O
variety	O
of	O
heart	B-T038
and	O
lung	B-T038
diseases	I-T038
.	O
while	O
the	O
evaluation	B-T058
of	O
rv	B-T017
performance	O
at	O
rest	O
has	O
been	O
implemented	O
in	O
the	O
clinical	O
setting	O
,	O
it	O
is	O
unknown	O
whether	O
this	O
assessment	B-T058
during	O
exercise	O
may	O
provide	O
additional	O
benefit	O
.	O
with	O
this	O
aim	O
,	O
we	O
evaluated	B-T058
the	O
exercise	O
-	O
induced	O
pulmonary	B-T058
arterial	I-T058
systolic	I-T058
pressure	I-T058
(	O
pas	B-T058
##p	I-T058
)	O
increase	O
during	O
exercise	O
in	O
patients	O
with	O
severe	O
chronic	B-T038
obstructive	I-T038
pulmonary	I-T038
disease	I-T038
(	O
copd	B-T038
)	O
as	O
an	O
expression	O
of	O
rv	B-T017
contractile	O
reserve	O
.	O
cardiopulmonary	B-T058
exercise	I-T058
testing	I-T058
(	O
cpe	B-T058
##t	I-T058
)	O
with	O
synchron	B-T058
##ic	I-T058
echocardiography	I-T058
was	O
performed	O
in	O
81	O
patients	O
.	O
patients	O
were	O
classified	B-T170
into	O
two	O
groups	O
according	O
to	O
an	O
exercise	O
-	O
induced	O
pas	B-T058
##p	I-T058
increase	O
above	O
30	O
##mm	O
##hg	O
(	O
high	O
psa	B-T058
##p	I-T058
)	O
or	O
below	O
30	O
##mm	O
##hg	O
(	O
low	O
psa	B-T058
##p	I-T058
)	O
during	O
maximal	O
exercise	O
.	O
patients	O
were	O
then	O
followed	O
for	O
three	O
years	O
.	O
sixteen	O
patients	O
(	O
20	O
%	O
)	O
had	O
low	O
psa	B-T058
##p	I-T058
and	O
65	O
(	O
80	O
%	O
)	O
showed	O
high	O
psa	B-T058
##p	I-T058
.	O
these	O
were	O
not	B-T033
significant	I-T033
clinical	O
and	O
functional	O
differences	O
.	O
low	O
psa	B-T058
##p	I-T058
was	O
associated	O
with	O
a	O
significantly	O
lower	O
peak	O
vo2	B-T033
(	O
mean	O
(	O
sd	O
)	O
,	O
35	O
(	O
2	O
)	O
%	O
predicted	O
)	O
compared	O
to	O
high	O
psa	B-T058
##p	I-T058
response	O
(	O
peak	O
vo2	B-T033
45	O
(	O
3	O
)	O
%	O
predicted	O
)	O
,	O
p	O
=	O
0	O
.	O
045	O
.	O
factors	O
associated	O
with	O
mortality	O
were	O
age	O
and	O
exercise	O
-	O
induced	O
pas	B-T058
##p	I-T058
.	O
seventeen	O
patients	O
died	O
during	O
the	O
three	O
years	O
of	O
follow	B-T058
-	I-T058
up	I-T058
(	O
7	O
(	O
39	O
%	O
)	O
in	O
the	O
low	O
psa	B-T058
##p	I-T058
group	O
and	O
only	O
10	O
(	O
1	O
%	O
)	O
in	O
the	O
high	O
psa	B-T058
##p	I-T058
group	O
,	O
p	O
=	O
0	O
.	O
041	O
)	O
.	O
cardiopulmonary	B-T058
exercise	I-T058
testing	I-T058
with	O
a	O
synchron	B-T058
##ic	I-T058
echocardiography	I-T058
may	O
be	O
a	O
useful	O
tool	O
for	O
the	O
assessment	B-T058
of	O
rv	B-T017
contractile	O
reserve	O
in	O
severe	O
copd	B-T038
patients	O
.	O
exercise	O
-	O
induced	O
psa	B-T058
##p	I-T058
emerges	O
as	O
a	O
possible	O
prognostic	B-T201
factor	I-T201
in	O
these	O
patients	O
.	O

glucose	B-T038
metabolism	I-T038
-	O
weighted	B-T058
imaging	I-T058
with	O
chemical	B-T058
exchange	I-T058
-	I-T058
sensitive	I-T058
mri	I-T058
of	O
2	B-T103
-	I-T103
deoxyglucose	I-T103
(	O
2d	B-T103
##g	I-T103
)	O
in	O
brain	B-T017
:	O
sensitivity	O
and	O
biological	O
sources	B-T033
recent	B-T062
proof	I-T062
-	I-T062
of	I-T062
-	I-T062
principle	I-T062
studies	I-T062
have	O
demonstrated	O
the	O
feasibility	O
of	O
measuring	O
the	O
uptake	B-T038
and	O
metabolism	B-T038
of	O
non	O
-	O
labeled	O
2	B-T103
-	I-T103
deoxy	I-T103
-	I-T103
d	I-T103
-	I-T103
glucose	I-T103
(	O
2d	B-T103
##g	I-T103
)	O
by	O
a	O
chemical	B-T058
exchange	I-T058
-	I-T058
sensitive	I-T058
spin	I-T058
-	I-T058
lock	I-T058
(	I-T058
ces	I-T058
##l	I-T058
)	I-T058
mri	I-T058
approach	I-T058
.	O
in	O
order	O
to	O
gain	O
better	O
understanding	O
of	O
this	O
new	O
approach	O
,	O
we	O
performed	O
dynamic	O
in	B-T082
vivo	I-T082
ces	B-T058
##l	I-T058
mri	I-T058
on	O
healthy	O
rat	B-T204
brains	B-T017
with	O
an	O
intravenous	O
injection	O
of	O
2d	B-T103
##g	I-T103
under	O
various	O
conditions	O
at	O
9	O
.	O
4	O
##t	O
.	O
for	O
three	O
2d	B-T103
##g	I-T103
doses	O
of	O
0	O
.	O
25	O
,	O
0	O
.	O
5	O
and	O
1g	O
/	O
kg	O
,	O
we	O
found	O
that	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
signals	O
increased	O
linearly	O
with	O
injection	B-T058
dose	O
at	O
the	O
initial	O
(	O
<	O
20	O
##min	O
)	O
but	O
not	O
the	O
later	O
period	O
(	O
>	O
40	O
##min	O
)	O
suggesting	O
time	O
-	O
dependent	O
differential	O
weighting	O
##s	O
of	O
2d	B-T103
##g	I-T103
transport	B-T038
and	O
metabolism	B-T038
.	O
remaining	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
studies	O
were	O
performed	O
with	O
0	O
.	O
25	O
##g	O
/	O
kg	O
2d	B-T103
##g	I-T103
.	O
since	O
a	O
higher	O
isoflurane	B-T103
level	O
reduces	O
glucose	B-T038
metabolism	I-T038
and	O
increases	O
blood	B-T038
flow	I-T038
,	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
was	O
measured	O
under	O
0	O
.	O
5	O
%	O
,	O
1	O
.	O
5	O
%	O
and	O
2	O
.	O
2	O
%	O
isoflurane	B-T103
.	O
the	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
signal	O
was	O
reduced	O
at	O
higher	O
isoflurane	B-T103
levels	O
correlating	O
well	O
with	O
the	O
2d	B-T103
##g	I-T103
phosphorylation	B-T038
in	O
the	O
intracellular	B-T082
space	I-T082
.	O
to	O
detect	O
regional	O
heterogene	O
##ities	O
of	O
glucose	B-T038
metabolism	I-T038
,	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
with	O
0	O
.	O
33	O
##×	O
##0	O
.	O
33	O
##×	O
##1	O
.	O
50	O
##mm	O
(	O
3	O
)	O
resolution	O
was	O
obtained	O
,	O
which	O
indeed	O
showed	O
a	O
higher	O
response	O
in	O
the	O
cortex	B-T017
compared	O
to	O
the	O
corpus	B-T017
callosum	I-T017
.	O
lastly	O
,	O
unlike	O
ces	B-T058
##l	I-T058
mri	I-T058
with	O
the	O
injection	B-T058
of	O
non	B-T103
-	I-T103
transport	I-T103
##able	I-T103
mannitol	I-T103
,	O
the	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
response	O
decreased	O
with	O
an	O
increased	O
spin	O
-	O
lock	O
pulse	O
power	O
confirming	O
that	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
is	O
dominated	O
by	O
chemical	B-T103
exchange	B-T201
processes	O
in	O
the	O
extravas	O
##cu	O
##la	O
##r	O
space	O
.	O
taken	O
together	O
,	O
our	O
results	O
showed	O
that	O
2d	B-T103
##g	I-T103
-	O
ces	B-T058
##l	I-T058
mri	I-T058
signals	O
mainly	O
indicate	O
glucose	B-T038
transport	I-T038
and	O
metabolism	B-T038
and	O
may	O
be	O
a	O
useful	O
biomarker	B-T201
for	O
metabolic	O
studies	B-T062
of	O
normal	B-T017
and	O
diseased	B-T038
brains	B-T017
.	O

keeping	O
the	O
spirit	O
##s	O
up	O
:	O
the	O
effect	O
of	O
teachers	B-T097
'	I-T097
and	O
parents	O
'	O
emotional	B-T058
support	I-T058
on	O
children	O
'	O
s	O
working	B-T038
memory	I-T038
performance	B-T038
working	B-T038
memory	I-T038
,	O
used	O
to	O
temporarily	B-T038
store	I-T038
and	O
mentally	O
manipulate	O
information	O
,	O
is	O
important	O
for	O
children	O
'	O
s	O
learning	B-T038
.	O
it	O
is	O
therefore	O
valuable	O
to	O
understand	O
which	O
(	O
contextual	O
)	O
factors	O
promote	O
or	O
hinder	O
working	B-T038
memory	I-T038
performance	B-T038
.	O
recent	O
research	B-T062
shows	O
positive	B-T033
associations	O
between	O
positive	B-T033
parent	O
-	O
child	O
and	O
teacher	O
-	O
student	O
interactions	O
and	O
working	B-T038
memory	I-T038
performance	B-T038
and	O
development	O
.	O
however	O
,	O
no	O
study	B-T062
has	O
yet	O
experimentally	O
investigated	O
how	O
parents	O
and	O
teachers	B-T097
affect	O
working	B-T038
memory	I-T038
performance	B-T038
.	O
based	O
on	O
attachment	O
theory	O
,	O
the	O
current	O
study	B-T062
investigated	O
the	O
role	O
of	O
parent	O
and	O
teacher	B-T097
emotional	B-T058
support	I-T058
in	O
promoting	O
working	B-T038
memory	I-T038
performance	B-T038
by	O
buffering	O
the	O
negative	B-T033
effect	O
of	O
social	B-T038
stress	I-T038
.	O
questionnaires	B-T170
and	O
an	O
experimental	B-T062
session	I-T062
were	O
completed	O
by	O
170	O
children	O
from	O
grade	O
1	O
to	O
2	O
(	O
mage	O
=	O
7	O
years	O
6	O
months	O
,	O
sd	O
=	O
7	O
months	O
)	O
.	O
questionnaires	B-T170
were	O
used	O
to	O
assess	O
children	O
'	O
s	O
perceptions	B-T038
of	O
the	O
teacher	O
-	O
student	O
and	O
parent	O
-	O
child	O
relationship	O
.	O
during	O
an	O
experimental	B-T062
session	I-T062
,	O
working	B-T038
memory	I-T038
was	O
measured	O
with	O
the	O
cor	O
##si	O
task	O
backward	O
(	O
mil	O
##ner	O
,	O
1971	O
)	O
in	O
a	O
pre	O
-	O
and	O
post	O
-	O
test	O
design	O
.	O
in	O
-	O
between	O
the	O
tests	B-T170
stress	B-T033
was	O
induced	O
in	O
the	O
children	O
using	O
the	O
cy	O
##ber	O
##ball	O
paradigm	O
(	O
willi	O
##ams	O
et	O
al	O
.	O
,	O
2000	O
)	O
.	O
emotional	B-T058
support	I-T058
was	O
manipulated	O
(	O
between	O
-	O
subjects	O
)	O
through	O
an	O
audio	B-T170
message	B-T170
(	O
either	O
a	O
weather	O
report	B-T170
,	O
a	O
supportive	B-T058
message	B-T170
of	O
a	O
stra	B-T098
##ng	I-T098
##er	I-T098
,	O
a	O
supportive	B-T058
message	B-T170
of	O
a	O
parent	O
,	O
or	O
a	O
supportive	B-T058
message	B-T170
of	O
a	O
teacher	B-T097
)	O
.	O
results	O
of	O
repeated	O
measures	O
anova	O
showed	O
no	O
clear	O
effect	O
of	O
the	O
stress	B-T033
induction	O
.	O
nevertheless	O
,	O
an	O
effect	O
of	O
parent	O
and	O
teacher	B-T097
support	B-T058
was	O
found	O
and	O
depended	O
on	O
the	O
quality	O
of	O
the	O
parent	O
-	O
child	O
relationship	O
.	O
when	O
children	O
had	O
a	O
positive	B-T033
relationship	O
with	O
their	O
parent	O
,	O
support	B-T058
of	O
parents	O
and	O
teachers	B-T097
had	O
little	O
effect	O
on	O
working	B-T038
memory	I-T038
performance	B-T038
.	O
when	O
children	O
had	O
a	O
negative	B-T033
relationship	O
with	O
their	O
parent	O
,	O
a	O
supportive	B-T058
message	B-T170
of	O
that	O
parent	O
decreased	O
working	B-T038
memory	I-T038
performance	B-T038
,	O
while	O
a	O
supportive	B-T058
message	B-T170
from	O
the	O
teacher	B-T097
increased	O
performance	B-T038
.	O
in	O
sum	O
,	O
the	O
current	O
study	B-T062
suggests	O
that	O
parents	O
and	O
teachers	B-T097
can	O
support	B-T058
working	B-T038
memory	I-T038
performance	B-T038
by	O
being	O
supportive	B-T058
for	O
the	O
child	O
.	O
teacher	B-T097
support	B-T058
is	O
most	O
effective	O
when	O
the	O
child	O
has	O
a	O
negative	B-T033
relationship	O
with	O
the	O
parent	O
.	O
these	O
insights	O
can	O
give	O
direction	O
to	O
specific	O
measures	O
aimed	O
at	O
preventing	O
and	O
resolving	B-T033
working	B-T038
memory	I-T038
problems	B-T033
and	O
related	O
issues	B-T033
.	O

intravitreal	O
chemotherapy	B-T058
in	O
the	O
management	B-T058
of	O
vitreous	B-T038
disease	I-T038
in	O
retinoblastoma	B-T038
to	O
evaluate	O
the	O
therapeutic	O
outcome	O
of	O
intravitreal	O
melphalan	B-T103
injection	B-T103
in	O
the	O
management	B-T058
of	O
vitreous	B-T038
disease	I-T038
in	O
patients	O
with	O
retinoblastoma	B-T038
.	O
we	O
particularly	O
aimed	O
to	O
assess	O
whether	O
higher	O
melphalan	B-T103
dose	O
with	O
lower	O
number	O
of	O
injections	B-T103
was	O
more	O
effective	O
and	O
associated	O
with	O
fewer	O
side	B-T038
effects	I-T038
.	O
this	O
retrospective	B-T062
,	O
interventional	B-T062
,	O
noncomp	B-T062
##arative	I-T062
,	O
and	O
nonrandom	B-T062
##ized	I-T062
study	I-T062
included	O
39	O
eyes	B-T017
of	O
37	O
patients	O
.	O
vitreous	B-T033
seeds	I-T033
were	O
classified	B-T170
as	O
dust	B-T038
,	O
sphere	B-T038
,	O
and	O
cloud	B-T038
types	I-T038
.	O
intravitreal	O
injections	B-T103
were	O
performed	O
through	O
pars	B-T017
plan	I-T017
##a	I-T017
free	O
of	O
any	O
visible	O
tumor	B-T038
using	O
30	B-T074
-	I-T074
g	I-T074
needle	I-T074
.	O
response	B-T038
of	I-T038
the	I-T038
seeds	I-T038
(	O
disappearance	B-T033
,	O
conversion	O
into	O
inactive	B-T033
debris	I-T033
,	O
or	O
progression	B-T038
)	O
and	O
enucleation	B-T058
rate	O
were	O
determined	O
as	O
outcome	O
measures	O
.	O
all	O
patients	O
previously	O
received	O
systemic	B-T058
or	O
intra	B-T058
-	I-T058
arterial	I-T058
chemotherapy	I-T058
.	O
vitreous	B-T033
seeding	I-T033
was	O
primary	O
in	O
54	O
%	O
of	O
eyes	B-T017
and	O
secondary	O
in	O
46	O
%	O
of	O
eyes	B-T017
.	O
vitreous	B-T033
seeds	I-T033
were	O
classified	B-T170
as	O
dust	B-T038
in	O
9	O
(	O
23	O
.	O
1	O
%	O
)	O
eyes	B-T017
,	O
sphere	B-T038
in	O
24	O
(	O
61	O
.	O
5	O
%	O
)	O
eyes	B-T017
,	O
and	O
cloud	B-T038
in	O
6	O
(	O
15	O
.	O
4	O
%	O
)	O
eyes	B-T017
.	O
melphalan	B-T103
dose	O
varied	O
between	O
20	O
and	O
40	O
µg	O
and	O
20	O
(	O
51	O
.	O
3	O
%	O
)	O
eyes	B-T017
received	O
>	O
30	O
µg	O
.	O
the	O
total	O
number	O
of	O
injections	B-T103
was	O
70	O
(	O
range	O
1	O
-	O
5	O
,	O
mean	O
1	O
.	O
8	O
per	O
eye	B-T017
)	O
.	O
various	O
types	O
of	O
regression	B-T038
were	O
obtained	O
in	O
27	O
(	O
69	O
.	O
2	O
%	O
)	O
eyes	B-T017
.	O
sphere	B-T038
-	I-T038
type	I-T038
seeds	I-T038
were	O
the	O
most	O
responsive	O
to	O
melphalan	B-T103
.	O
nonresp	O
##ons	O
##e	O
and	O
disease	B-T038
progression	I-T038
were	O
noted	O
in	O
12	O
(	O
30	O
.	O
8	O
%	O
)	O
eyes	B-T017
.	O
after	O
a	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
of	O
11	O
.	O
8	O
months	O
,	O
17	O
(	O
44	O
%	O
)	O
eyes	B-T017
were	O
enucle	O
##ated	O
.	O
vitreous	B-T038
hemorrhage	I-T038
(	O
18	O
%	O
)	O
and	O
retinal	B-T017
pigment	I-T017
epithelial	I-T017
alterations	O
(	O
8	O
%	O
)	O
were	O
the	O
most	O
common	O
side	B-T038
effects	I-T038
.	O
intravitreal	O
melphalan	B-T103
at	O
30	O
-	O
40	O
µg	O
in	O
1	O
or	O
2	O
injections	B-T103
proved	O
effective	O
in	O
69	O
.	O
2	O
%	O
of	O
eyes	B-T017
with	O
vitreous	B-T038
disease	I-T038
.	O

the	O
four	O
-	O
component	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
as	O
a	O
promising	B-T103
agent	I-T103
for	O
food	O
biop	O
##res	O
##ervation	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
is	O
the	O
only	O
four	O
-	O
component	O
bacteri	B-T103
##ocin	I-T103
described	O
to	O
date	O
.	O
as	O
it	O
inhibits	B-T038
the	I-T038
growth	I-T038
of	O
a	O
wide	O
range	O
of	O
gram	B-T007
-	I-T007
positive	I-T007
bacteria	I-T007
,	O
including	O
listeria	B-T007
monocytogenes	I-T007
strains	O
isolated	O
from	O
food	B-T168
,	O
its	O
potential	O
for	O
improving	O
food	O
safety	O
was	O
investigated	O
in	O
this	O
study	O
.	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
(	O
10	O
,	O
240	O
##au	O
/	O
ml	O
)	O
proved	O
to	O
be	O
bactericidal	B-T103
,	O
but	O
not	O
extensively	O
lytic	O
,	O
against	O
listeria	B-T007
##l	I-T007
strains	O
.	O
the	O
antibacterial	O
activity	O
of	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
(	O
16	O
##au	O
/	O
ml	O
)	O
was	O
then	O
tested	O
in	O
uh	B-T058
##t	I-T058
-	I-T058
treated	I-T058
sk	B-T168
##im	I-T168
##med	I-T168
milk	I-T168
inoculated	B-T058
with	O
the	O
food	B-T168
-	O
associated	O
l	B-T007
.	I-T007
monocytogenes	I-T007
l12	I-T007
strain	I-T007
(	O
4	O
-	O
log	O
cfu	O
/	O
ml	O
)	O
during	O
storage	O
at	O
4	O
##°c	O
for	O
one	O
week	O
.	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
caused	O
a	O
time	O
-	O
dependent	O
reduction	O
in	O
the	O
listeria	B-T007
##l	I-T007
viable	B-T058
cell	I-T058
counts	I-T058
(	O
5	O
.	O
51	O
-	O
log	O
units	O
)	O
up	O
to	O
7	O
##days	O
of	O
incubation	B-T058
.	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
was	O
neither	O
toxic	O
to	O
the	O
vero	B-T017
and	O
the	O
l	B-T017
-	I-T017
92	I-T017
##9	I-T017
cell	I-T017
lines	I-T017
nor	O
exhibited	O
a	O
hemolytic	B-T038
activity	I-T038
against	O
sheep	B-T204
red	B-T017
blood	I-T017
cells	I-T017
.	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
proved	O
to	O
be	O
completely	O
stable	O
for	O
one	O
month	O
at	O
25	O
##°c	O
,	O
16	O
##week	O
##s	O
at	O
4	O
##°c	O
and	O
20	O
##week	O
##s	O
at	O
-	O
20	O
##°c	O
.	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
exhibited	O
a	O
time	O
-	O
dependent	O
susceptibility	O
to	O
simulated	O
gastric	B-T031
juice	I-T031
and	O
bile	B-T103
salts	I-T103
mimicking	O
gastrointestinal	O
conditions	O
.	O
the	O
entrapment	B-T038
of	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
in	O
an	O
alginate	B-T103
/	O
gelatin	B-T103
matrix	I-T103
revealed	O
that	O
this	O
bacteri	B-T103
##ocin	I-T103
can	O
be	O
released	O
from	O
this	O
matrix	O
.	O
moreover	O
,	O
it	O
remained	O
adsorbed	O
to	O
and	O
active	O
on	O
a	O
low	B-T103
-	I-T103
density	I-T103
polyethylene	I-T103
plastic	I-T103
surface	O
suggesting	O
that	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
may	O
be	O
employed	O
in	O
bioactive	O
packaging	O
to	O
control	B-T038
the	I-T038
growth	I-T038
of	O
undesirable	O
bacteria	B-T007
.	O
taken	O
together	O
these	O
results	O
suggest	O
that	O
aure	B-T103
##ocin	I-T103
a	I-T103
##70	I-T103
is	O
a	O
promising	B-T103
alternative	I-T103
to	O
be	O
used	O
in	O
food	O
applications	O
.	O

vaginal	B-T038
infections	I-T038
of	O
alb	B-T082
##ania	I-T082
##n	I-T082
women	B-T098
infected	B-T038
with	O
hpv	B-T005
and	O
their	O
impact	O
in	O
intraepithelial	B-T038
cervical	I-T038
lesions	I-T038
evidenced	O
by	O
pap	B-T058
test	I-T058
cervical	B-T058
cytology	I-T058
is	O
the	O
best	O
single	O
method	O
for	O
large	O
screening	B-T058
of	O
the	O
population	O
in	O
identifying	O
precancerous	O
lesions	O
of	O
the	O
uterine	B-T017
cervix	I-T017
.	O
to	O
estimate	O
the	O
frequency	O
of	O
human	B-T033
papillomavirus	I-T033
(	I-T033
hpv	I-T033
)	I-T033
positivity	I-T033
in	O
a	O
group	O
of	O
alb	B-T082
##ania	I-T082
##n	I-T082
women	B-T098
,	O
the	O
prevalence	O
of	O
vaginal	B-T038
coinfection	I-T038
##s	I-T038
,	O
and	O
the	O
relationship	O
of	O
coinfection	B-T038
##s	I-T038
with	O
hpv	B-T005
,	O
as	O
well	O
as	O
their	O
role	O
in	O
metaplasia	B-T038
or	O
cervical	B-T038
intraepithelial	I-T038
lesions	I-T038
(	O
cin	B-T038
)	O
.	O
in	O
this	O
retrospective	B-T062
study	I-T062
,	O
207	O
##5	O
vaginal	B-T058
smears	I-T058
were	O
examined	O
.	O
the	O
pap	B-T058
##anic	I-T058
##ola	I-T058
##ou	I-T058
stain	I-T058
was	O
used	O
for	O
all	O
slides	O
.	O
the	O
new	O
bet	O
##he	O
##sd	O
##a	O
system	O
2001	O
was	O
used	O
for	O
the	O
interpretations	B-T058
of	I-T058
the	I-T058
smears	I-T058
.	O
data	O
analysis	O
was	O
completed	O
using	O
the	O
statistical	O
package	O
for	O
the	O
social	O
sciences	O
version	O
19	O
.	O
0	O
.	O
prevalence	O
of	O
hpv	B-T033
positivity	I-T033
was	O
43	O
.	O
9	O
%	O
with	O
an	O
average	O
age	O
of	O
35	O
.	O
48	O
±	O
9	O
.	O
27	O
years	O
.	O
candida	B-T038
coinfection	I-T038
resulted	O
in	O
57	O
.	O
8	O
%	O
of	O
hpv	B-T033
positive	I-T033
women	B-T098
with	O
a	O
significant	O
relationship	O
between	O
them	O
.	O
gard	B-T038
##ner	I-T038
##ella	I-T038
coinfection	I-T038
resulted	O
in	O
36	O
(	O
23	O
%	O
)	O
,	O
mixed	O
flora	O
in	O
34	O
(	O
8	O
%	O
)	O
,	O
and	O
trich	B-T038
##omonas	I-T038
vaginalis	I-T038
in	O
50	O
%	O
of	O
hpv	B-T033
positive	I-T033
woman	B-T098
.	O
among	O
the	O
women	B-T098
with	O
positive	B-T033
hpv	I-T033
,	O
19	O
%	O
had	O
cin	B-T038
,	O
8	O
%	O
had	O
metaplasia	B-T038
,	O
and	O
1	O
%	O
had	O
metaplasia	B-T038
and	O
cin	B-T038
;	O
9	O
%	O
of	O
the	O
women	B-T098
with	O
hpv	B-T005
had	O
cin	B-T038
##1	I-T038
and	O
one	O
of	O
the	O
coinfection	B-T038
##s	I-T038
.	O
there	O
is	O
a	O
strong	O
relationship	O
between	O
cin	B-T038
##1	I-T038
and	O
hpv	B-T033
positivity	I-T033
as	O
well	O
as	O
between	O
cin	B-T038
##1	I-T038
and	O
coinfection	B-T038
##s	I-T038
.	O
hpv	B-T038
infection	I-T038
is	O
a	O
major	O
factor	O
contributing	O
to	O
metaplasia	B-T038
,	O
and	O
bacterial	B-T038
coinfection	I-T038
##s	I-T038
in	O
hpv	B-T033
positive	I-T033
women	B-T098
have	O
a	O
statistically	O
significant	O
impact	O
in	O
the	O
development	O
of	O
metaplasia	B-T038
.	O

mismatch	B-T038
repair	I-T038
incomp	O
##atib	O
##ilities	O
in	O
diverse	O
yeast	B-T204
populations	O
an	O
elevated	O
mutation	O
rate	O
can	O
provide	O
cells	B-T017
with	O
a	O
source	B-T033
of	O
mutations	B-T038
to	O
adapt	O
to	O
changing	O
environments	B-T082
.	O
we	O
identified	O
a	O
negative	B-T033
epist	B-T038
##atic	I-T038
interaction	I-T038
involving	O
naturally	O
occurring	O
variants	O
in	O
the	O
ml	B-T017
##h1	I-T017
and	O
pms	B-T017
##1	I-T017
mismatch	B-T038
repair	I-T038
(	O
mmr	B-T038
)	O
genes	B-T017
of	O
saccharomyces	B-T204
cerevisiae	I-T204
we	O
hypothesized	O
that	O
this	O
mmr	B-T038
incompatibility	O
,	O
created	O
through	O
mating	B-T038
between	O
divergent	O
s	B-T204
.	I-T204
cerevisiae	I-T204
,	O
yields	O
mut	O
##ator	O
progeny	O
that	O
can	O
rapidly	O
but	O
transiently	O
adapt	O
to	O
an	O
environmental	O
stress	O
.	O
here	O
we	O
analyzed	B-T062
the	O
ml	B-T017
##h1	I-T017
and	O
pms	B-T017
##1	I-T017
genes	I-T017
across	O
101	O
##0	O
s	B-T204
.	I-T204
cerevisiae	I-T204
natural	O
isolates	B-T103
spanning	O
a	O
wide	O
range	O
of	O
ecological	O
sources	B-T033
(	O
tree	B-T204
exudates	B-T031
,	O
drosophila	B-T204
,	O
fruits	B-T168
,	O
and	O
various	O
fermentation	B-T038
and	O
clinical	O
isolates	B-T103
)	O
and	O
geographical	B-T082
sources	B-T033
(	O
europe	B-T082
,	O
america	B-T082
,	O
africa	B-T082
,	O
and	O
asia	B-T082
)	O
.	O
we	O
identified	O
one	O
homozygous	O
clinical	O
isolate	B-T103
and	O
18	O
heterozygous	O
isolates	B-T103
containing	O
the	O
incompatible	O
mmr	B-T038
genotype	O
.	O
the	O
ml	B-T017
##h1	I-T017
-	O
pms	B-T017
##1	I-T017
gene	I-T017
combination	O
isolated	O
from	O
the	O
homozygous	O
clinical	O
isolate	B-T103
conferred	O
a	O
mut	O
##ator	O
phenotype	O
when	O
expressed	B-T038
in	O
the	O
s2	O
##88	O
##c	O
laboratory	B-T092
background	O
.	O
using	O
a	O
novel	O
reporter	B-T103
to	O
measure	O
mutation	O
rates	O
,	O
we	O
showed	O
that	O
the	O
overall	O
mutation	O
rate	O
in	O
the	O
homozygous	O
incompatible	O
background	O
was	O
similar	O
to	O
that	O
seen	O
in	O
compatible	O
strains	O
,	O
indicating	O
the	O
presence	O
of	O
suppressor	B-T038
mutations	I-T038
in	O
the	O
clinical	O
isolate	B-T103
that	O
lowered	O
its	O
mutation	O
rate	O
.	O
this	O
observation	B-T062
and	O
the	O
identification	O
of	O
18	O
heterozygous	O
isolates	B-T103
,	O
which	O
can	O
lead	O
to	O
mmr	B-T038
incompatible	O
genotypes	O
in	O
the	O
offspring	O
,	O
are	O
consistent	O
with	O
an	O
elevated	O
mutation	O
rate	O
rapidly	O
but	O
transiently	O
facilitating	O
adaptation	B-T038
.	O
to	O
avoid	O
long	O
-	O
term	O
fitness	B-T038
costs	O
,	O
the	O
incompatibility	O
is	O
apparently	O
buffered	B-T103
by	O
mating	B-T038
or	O
by	O
acquiring	O
suppressors	B-T038
.	O
these	O
observations	B-T062
highlight	O
effective	O
strategies	O
in	O
eukaryotes	B-T204
to	O
avoid	O
long	O
-	O
term	O
fitness	B-T038
costs	O
associated	O
with	O
elevated	O
mutation	O
rates	O
.	O

the	O
use	O
of	O
oc	B-T204
##im	I-T204
##um	I-T204
american	I-T204
##um	I-T204
essential	B-T103
oil	I-T103
against	O
the	O
pathogens	O
aeromonas	B-T007
hydroph	I-T007
##ila	I-T007
and	O
gyr	B-T204
##oda	I-T204
##ct	I-T204
##yl	I-T204
##us	I-T204
sp	I-T204
.	I-T204
in	O
silver	B-T204
catfish	I-T204
(	O
rh	B-T204
##am	I-T204
##di	I-T204
##a	I-T204
que	I-T204
##len	I-T204
)	O
the	O
bactericidal	B-T033
activity	I-T033
(	O
mic	B-T058
-	I-T058
test	I-T058
)	O
of	O
oc	B-T204
##im	I-T204
##um	I-T204
american	I-T204
##um	I-T204
(	O
infl	B-T204
##orescence	I-T204
##s	I-T204
)	O
essential	B-T103
oil	I-T103
(	O
oa	B-T103
##e	I-T103
##o	I-T103
)	O
against	O
aeromonas	B-T007
hydroph	I-T007
##ila	I-T007
was	O
determined	O
in	O
this	O
study	O
.	O
it	O
was	O
also	O
investigated	O
the	O
potential	O
of	O
oa	B-T103
##e	I-T103
##o	I-T103
and	O
the	O
main	O
compound	O
found	O
in	O
the	O
oil	B-T103
(	O
lin	B-T103
##alo	I-T103
##ol	I-T103
)	O
at	O
sub	O
##in	O
##hib	O
##itory	O
concentrations	O
to	O
be	O
inhibitors	B-T103
of	O
hemolysis	B-T038
caused	O
by	O
aer	B-T007
.	I-T007
hydroph	I-T007
##ila	I-T007
in	O
fish	B-T204
erythrocytes	B-T017
.	O
an	O
in	O
vivo	O
experiment	O
was	O
conducted	O
to	O
evaluate	O
survival	O
of	O
fish	B-T204
(	O
rh	B-T204
##am	I-T204
##di	I-T204
##a	I-T204
que	I-T204
##len	I-T204
)	O
experimentally	B-T062
infected	B-T033
with	O
aer	B-T007
.	I-T007
hydroph	I-T007
##ila	I-T007
and	O
exposed	O
to	O
oa	B-T103
##e	I-T103
##o	I-T103
.	O
a	O
second	O
experiment	B-T062
was	O
conducted	O
to	O
evaluate	O
the	O
in	O
vitro	O
and	O
in	O
vivo	O
activity	O
of	O
oa	B-T103
##e	I-T103
##o	I-T103
(	O
mix	O
from	O
infl	B-T204
##orescence	I-T204
##s	I-T204
and	O
leaves	B-T204
)	O
against	O
the	O
parasite	B-T204
gyr	I-T204
##oda	I-T204
##ct	I-T204
##yl	I-T204
##us	I-T204
sp	I-T204
.	I-T204
the	O
oa	B-T103
##e	I-T103
##o	I-T103
showed	O
weak	O
in	O
vitro	O
activity	O
against	O
aer	B-T007
.	I-T007
hydroph	I-T007
##ila	I-T007
(	O
640	O
##0	O
μg	O
ml	O
(	O
-	O
1	O
)	O
)	O
.	O
at	O
sub	O
##in	O
##hib	O
##itory	O
concentrations	O
oa	B-T103
##e	I-T103
##o	I-T103
(	O
100	O
μg	O
ml	O
(	O
-	O
1	O
)	O
)	O
inhibited	O
hemolysis	B-T038
(	O
90	O
%	O
)	O
caused	O
by	O
aer	B-T007
.	I-T007
hydroph	I-T007
##ila	I-T007
in	O
fish	B-T204
erythrocytes	B-T017
,	O
however	O
,	O
lin	B-T103
##alo	I-T103
##ol	I-T103
did	O
not	O
present	O
hemolysis	B-T038
inhibition	O
activity	O
.	O
at	O
low	O
concentrations	O
(	O
10	O
and	O
20	O
mg	O
l	O
(	O
-	O
1	O
)	O
)	O
added	O
to	O
the	O
water	B-T103
oa	B-T103
##e	I-T103
##o	I-T103
promoted	O
survival	O
of	O
experimentally	O
infected	B-T033
fish	B-T204
with	O
aer	B-T007
.	I-T007
hydroph	I-T007
##ila	I-T007
.	O
lastly	O
,	O
oa	B-T103
##e	I-T103
##o	I-T103
-	O
mix	O
(	O
50	O
mg	O
l	O
(	O
-	O
1	O
)	O
)	O
was	O
effective	O
against	O
gyr	B-T204
##oda	I-T204
##ct	I-T204
##yl	I-T204
##us	I-T204
sp	I-T204
.	I-T204
significantly	O
reducing	O
(	O
60	O
%	O
)	O
the	O
number	O
of	O
parasites	B-T204
in	O
the	O
fish	B-T204
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

quantitative	O
determination	B-T058
of	O
five	O
metabolites	B-T103
of	O
aspirin	B-T103
by	O
uh	B-T058
##plc	I-T058
-	I-T058
ms	I-T058
/	O
ms	B-T058
coupled	O
with	O
enzymatic	B-T038
reaction	I-T038
and	O
its	O
application	O
to	O
evaluate	O
the	O
effects	O
of	O
aspirin	B-T103
dosage	O
on	O
the	O
metabolic	B-T038
profile	I-T038
acetyls	B-T103
##alic	I-T103
##ylic	I-T103
acid	I-T103
(	O
aspirin	B-T103
,	O
asa	B-T103
)	O
is	O
a	O
fam	O
##ous	O
drug	B-T103
for	O
cardiovascular	B-T038
diseases	I-T038
in	O
recent	O
years	O
.	O
effects	O
of	O
asa	B-T103
dosage	O
on	O
the	O
metabolic	B-T038
profile	I-T038
have	O
not	O
been	O
fully	O
understood	O
.	O
the	O
purpose	O
of	O
our	O
study	B-T062
is	O
to	O
establish	O
a	O
rapid	O
and	O
reliable	O
method	B-T058
to	O
quantify	O
asa	B-T103
metabolites	B-T103
in	O
biological	B-T031
matrices	I-T031
,	O
especially	O
for	O
glucuronide	B-T103
metabolites	B-T103
whose	O
standards	O
are	O
not	O
commercially	O
available	O
.	O
then	O
we	O
applied	O
this	O
method	B-T058
to	O
evaluate	O
the	O
effects	O
of	O
asa	B-T103
dosage	O
on	O
the	O
metabolic	B-T038
and	O
excretion	B-T038
profile	O
of	O
asa	B-T103
metabolites	B-T103
in	O
rat	B-T204
urine	B-T031
.	O
salicylic	B-T103
acid	I-T103
(	O
sa	B-T103
)	O
,	O
gent	B-T103
##isic	I-T103
acid	I-T103
(	O
ga	B-T103
)	O
and	O
salic	B-T103
##yl	I-T103
##uric	I-T103
acid	I-T103
(	O
su	B-T103
##a	I-T103
)	O
were	O
determined	O
directly	O
by	O
uh	B-T058
##plc	I-T058
-	I-T058
ms	I-T058
/	O
ms	B-T058
,	O
while	O
salic	B-T103
##yl	I-T103
phenolic	I-T103
glucuronide	I-T103
(	O
sap	B-T103
##g	I-T103
)	O
and	O
salic	B-T103
##yl	I-T103
##uric	I-T103
acid	I-T103
phenolic	I-T103
glucuronide	I-T103
(	O
su	B-T103
##ap	I-T103
##g	I-T103
)	O
were	O
quantified	O
indirectly	O
by	O
measuring	O
the	O
released	O
sa	B-T103
and	O
su	B-T103
##a	I-T103
from	O
sap	B-T103
##g	I-T103
and	O
su	B-T103
##ap	I-T103
##g	I-T103
after	O
β	B-T103
-	I-T103
glucuronidase	I-T103
digestion	B-T038
.	O
su	B-T103
##a	I-T103
and	O
su	B-T103
##ap	I-T103
##g	I-T103
were	O
the	O
major	O
metabolites	B-T103
of	O
asa	B-T103
in	O
rat	B-T204
urine	B-T031
24	O
h	O
after	O
asa	B-T103
administration	O
,	O
which	O
accounted	O
for	O
50	O
%	O
(	O
su	B-T103
##a	I-T103
)	O
and	O
26	O
%	O
(	O
su	B-T103
##ap	I-T103
##g	I-T103
)	O
.	O
when	O
asa	B-T103
dosage	O
was	O
increased	O
,	O
the	O
contributions	O
dropped	O
to	O
32	O
%	O
and	O
18	O
%	O
,	O
respectively	O
.	O
the	O
excretion	B-T038
of	O
other	O
three	O
metabolites	B-T103
(	O
ga	B-T103
,	O
sa	B-T103
and	O
sap	B-T103
##g	I-T103
)	O
however	O
showed	O
remarkable	O
increases	O
by	O
16	O
%	O
,	O
6	O
%	O
and	O
4	O
%	O
,	O
respectively	O
.	O
in	O
addition	O
,	O
su	B-T103
##a	I-T103
and	O
su	B-T103
##ap	I-T103
##g	I-T103
were	O
mainly	O
excreted	B-T038
in	O
the	O
time	O
period	O
of	O
12	O
-	O
24	O
h	O
,	O
while	O
ga	B-T103
was	O
excreted	B-T038
in	O
the	O
earlier	O
time	O
periods	O
(	O
0	O
-	O
4	O
h	O
and	O
4	O
-	O
8	O
h	O
)	O
.	O
sa	B-T103
was	O
mainly	O
excreted	B-T038
in	O
the	O
time	O
period	O
of	O
0	O
-	O
4	O
h	O
and	O
12	O
-	O
24	O
h	O
.	O
and	O
the	O
excretion	B-T038
of	O
sap	B-T103
##g	I-T103
was	O
equally	O
distributed	O
in	O
the	O
four	O
time	O
periods	O
.	O
we	O
went	O
further	O
to	O
show	O
that	O
the	O
excretion	B-T038
of	O
five	O
metabolites	B-T103
in	O
rat	B-T204
urine	B-T031
was	O
delayed	O
when	O
asa	B-T103
dosage	O
was	O
increased	O
.	O
in	O
conclusion	O
,	O
we	O
have	O
developed	O
a	O
rapid	O
and	O
sensitive	O
method	B-T058
to	O
determine	O
the	O
five	O
asa	B-T103
metabolites	B-T103
(	O
sa	B-T103
,	O
ga	B-T103
,	O
su	B-T103
##a	I-T103
,	O
sap	B-T103
##g	I-T103
and	O
su	B-T103
##ap	I-T103
##g	I-T103
)	O
in	O
rat	B-T204
urine	B-T031
.	O
we	O
showed	O
that	O
asa	B-T103
dosage	O
could	O
significantly	O
influence	O
the	O
metabolic	B-T038
and	O
excretion	B-T038
profile	O
of	O
asa	B-T103
metabolites	B-T103
in	O
rat	B-T204
urine	B-T031
.	O

the	O
effects	O
of	O
clinical	O
supervision	O
on	O
supervis	B-T098
##ees	I-T098
and	O
patients	O
in	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
therapy	I-T058
:	O
a	O
study	B-T170
protocol	I-T170
for	O
a	O
systematic	B-T170
review	I-T170
clinical	O
supervision	O
by	O
a	O
senior	O
therapist	O
is	O
a	O
very	O
common	O
practice	B-T038
in	O
psycho	B-T097
##therap	I-T097
##ist	I-T097
training	O
and	O
psychiatric	O
care	O
settings	O
.	O
though	O
clinical	O
supervision	O
is	O
advocated	O
by	O
most	O
educational	O
and	O
governing	O
institutions	O
,	O
the	O
effects	O
of	O
clinical	O
supervision	O
on	O
the	O
supervis	B-T098
##ees	I-T098
'	O
competence	O
,	O
e	O
.	O
g	O
.	O
,	O
attitudes	B-T038
,	O
behaviors	O
,	O
and	O
skills	O
,	O
as	O
well	O
as	O
on	O
treatment	O
outcomes	O
and	O
other	O
patient	O
variables	O
are	O
debated	O
and	O
largely	O
unknown	O
.	O
evidence	O
-	O
based	O
practice	O
is	O
advocated	O
in	O
clinical	O
settings	O
but	O
has	O
not	O
yet	O
been	O
fully	O
implemented	O
in	O
educational	O
or	O
clinical	O
training	O
settings	O
.	O
the	O
aim	O
of	O
this	O
systematic	B-T170
review	I-T170
is	O
to	O
synthesize	O
and	O
present	O
the	O
empirical	B-T170
literature	I-T170
regarding	O
effects	O
of	O
clinical	O
supervision	O
in	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
therapy	I-T058
.	O
this	O
study	O
will	O
include	O
a	O
systematic	B-T170
review	I-T170
of	O
the	O
literature	B-T170
to	O
identify	O
studies	O
that	O
have	O
empirically	O
investigated	O
the	O
effects	O
of	O
supervision	O
on	O
supervised	B-T097
psycho	I-T097
##therap	I-T097
##ists	I-T097
and	O
/	O
or	O
the	O
supervis	O
##ees	O
'	O
patients	O
.	O
a	O
comprehensive	O
search	O
strategy	O
will	O
be	O
conducted	O
to	O
identify	O
published	O
controlled	O
studies	O
indexed	B-T170
in	O
the	O
medline	B-T170
,	O
embase	B-T170
,	O
psycinfo	O
,	O
and	O
cochrane	B-T170
library	I-T170
databases	I-T170
.	O
data	O
on	O
supervision	O
outcomes	O
in	O
both	O
psycho	B-T097
##therap	I-T097
##ists	I-T097
and	O
their	O
patients	O
will	O
be	O
extracted	O
,	O
synthesized	O
,	O
and	O
reported	B-T170
.	O
risk	O
of	O
bias	O
and	O
quality	O
of	O
the	O
included	O
studies	O
will	O
be	O
assessed	O
systematically	O
.	O
this	O
systematic	B-T170
review	I-T170
will	O
rigorously	O
follow	O
established	O
guidelines	B-T170
for	O
systematic	B-T170
reviews	I-T170
in	O
order	O
to	O
summarize	O
and	O
present	O
the	O
evidence	O
base	O
for	O
clinical	O
supervision	O
in	O
cognitive	B-T058
-	I-T058
behavioral	I-T058
therapy	I-T058
and	O
may	O
aid	O
further	O
research	B-T062
and	O
discussion	O
in	O
this	O
area	O
.	O
prosp	O
##ero	O
cr	O
##d4	O
##20	O
##160	O
##46	O
##83	O
##4	O
.	O

breakthrough	O
vir	B-T038
##ida	I-T038
##ns	I-T038
streptococcal	I-T038
bacteremia	I-T038
in	O
allogeneic	B-T058
hematopoietic	I-T058
stem	I-T058
cell	I-T058
transplant	I-T058
recipients	O
receiving	O
levofloxacin	B-T103
prophylaxis	B-T058
in	O
a	O
japanese	B-T082
hospital	B-T092
breakthrough	O
vir	B-T038
##ida	I-T038
##ns	I-T038
streptococcal	I-T038
bacteremia	I-T038
(	O
vs	B-T038
##b	I-T038
)	O
in	O
patients	O
with	O
hematological	B-T038
malignancy	I-T038
receiving	O
levofloxacin	B-T103
prophylaxis	B-T058
is	O
a	O
major	O
blood	B-T038
stream	I-T038
infection	I-T038
(	O
bsi	B-T038
)	O
occurring	O
during	O
febrile	B-T038
neutropenia	I-T038
.	O
however	O
,	O
clinical	B-T170
data	I-T170
focused	O
on	O
vs	B-T038
##b	I-T038
in	O
allogeneic	B-T058
hematopoietic	I-T058
stem	I-T058
cell	I-T058
transplant	I-T058
(	O
allo	B-T058
-	I-T058
hsct	I-T058
)	O
recipients	O
are	O
lacking	O
.	O
the	O
medical	B-T170
records	I-T170
of	O
allo	B-T058
-	I-T058
hsct	I-T058
recipients	O
who	O
received	O
oral	O
levofloxacin	B-T103
prophylaxis	B-T058
between	O
january	O
2011	O
and	O
august	O
2013	O
at	O
tor	B-T092
##ano	I-T092
##mon	I-T092
hospital	I-T092
were	O
reviewed	O
to	O
evaluate	B-T058
breakthrough	O
vs	B-T038
##b	I-T038
.	O
stored	O
vir	B-T007
##ida	I-T007
##ns	I-T007
streptococcal	I-T007
(	O
vg	B-T007
##s	I-T007
)	O
species	B-T170
were	O
identified	O
by	O
using	O
sod	B-T017
##a	I-T017
gene	I-T017
sequencing	B-T058
,	O
and	O
were	O
assessed	O
for	O
drug	B-T038
susceptibility	I-T038
.	O
among	O
the	O
184	O
allo	B-T058
-	I-T058
hsct	I-T058
recipients	O
on	O
levofloxacin	B-T103
prophylaxis	B-T058
,	O
28	O
(	O
15	O
.	O
2	O
%	O
)	O
experienced	O
breakthrough	O
vs	B-T038
##b	I-T038
.	O
all	O
of	O
the	O
28	O
recipients	O
with	O
vs	B-T038
##b	I-T038
were	O
treated	O
with	O
a	O
cef	B-T103
##epi	I-T103
##me	I-T103
-	O
based	O
or	O
piperacillin	B-T103
/	I-T103
taz	I-T103
##obac	I-T103
##ta	I-T103
##m	I-T103
-	O
based	O
regimen	B-T058
.	O
the	O
susceptibility	B-T038
rates	O
of	O
the	O
vg	B-T007
##s	I-T007
strains	O
for	O
levofloxacin	B-T103
,	O
cef	B-T103
##epi	I-T103
##me	I-T103
,	O
piperacillin	B-T103
/	I-T103
taz	I-T103
##obac	I-T103
##ta	I-T103
##m	I-T103
,	O
meropenem	B-T103
,	O
and	O
vancomycin	B-T103
were	O
0	O
%	O
,	O
95	O
%	O
,	O
100	O
%	O
,	O
100	O
%	O
,	O
and	O
100	O
%	O
,	O
respectively	O
.	O
both	O
the	O
mic	B-T058
##50	I-T058
(	O
minimum	B-T058
inhibitory	I-T058
concentration	I-T058
)	O
and	O
the	O
mic	B-T058
##90	I-T058
of	O
ceftazid	B-T103
##im	I-T103
(	O
0	O
.	O
5	O
μg	O
/	O
ml	O
and	O
2	O
μg	O
/	O
ml	O
,	O
respectively	O
)	O
were	O
higher	O
than	O
the	O
mic	B-T058
##90	I-T058
of	O
all	O
the	O
other	O
anti	B-T103
-	I-T103
pseudo	I-T103
##mon	I-T103
##al	I-T103
beta	I-T103
-	I-T103
lactams	I-T103
(	O
ap	B-T103
##bl	I-T103
##s	I-T103
)	O
.	O
only	O
1	O
vg	B-T007
##s	I-T007
strain	O
had	O
a	O
penicillin	B-T103
mic	B-T058
≥	O
2	O
μg	O
/	O
ml	O
by	O
the	O
et	B-T058
##est	I-T058
(	O
3	O
.	O
6	O
%	O
)	O
.	O
there	O
were	O
no	O
cases	O
with	O
acute	B-T033
respiratory	I-T033
distress	I-T033
syndrome	I-T033
(	O
ards	B-T033
)	O
that	O
was	O
associated	O
with	O
vs	B-T038
##b	I-T038
,	O
although	O
the	O
rate	O
of	O
vir	B-T038
##ida	I-T038
##ns	I-T038
group	I-T038
streptococcal	I-T038
shock	I-T038
syndrome	I-T038
was	O
high	O
(	O
26	O
%	O
)	O
.	O
the	O
crude	O
30	O
-	O
day	O
mortality	O
rate	O
in	O
the	O
vs	B-T038
##b	I-T038
group	O
(	O
10	O
.	O
7	O
%	O
)	O
did	O
not	O
differ	O
significantly	O
from	O
that	O
in	O
the	O
bsi	B-T038
without	O
vs	B-T038
##b	I-T038
group	O
(	O
9	O
.	O
3	O
%	O
)	O
or	O
non	O
-	O
bsi	B-T038
group	O
(	O
7	O
.	O
0	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
77	O
)	O
.	O
also	O
,	O
vs	B-T038
##b	I-T038
was	O
not	O
a	O
risk	B-T033
factor	I-T033
for	O
all	O
-	O
cause	O
mortality	O
up	O
to	O
60	O
days	O
following	O
allo	B-T058
-	I-T058
hsct	I-T058
(	O
p	O
=	O
0	O
.	O
43	O
)	O
.	O
ap	B-T103
##bl	I-T103
with	O
increased	O
anti	B-T033
-	I-T033
vg	I-T033
##s	I-T033
activity	I-T033
(	O
ap	B-T033
##bl	I-T033
-	I-T033
va	I-T033
)	O
monotherapy	B-T058
would	O
typically	O
be	O
optimal	O
for	O
treating	O
the	O
vg	B-T007
##s	I-T007
strains	O
in	O
this	O
setting	O
.	O
indication	O
of	O
adding	O
an	O
empiric	O
anti	B-T103
-	I-T103
gram	I-T103
-	I-T103
positive	I-T103
agent	I-T103
to	O
ap	B-T033
##bl	I-T033
-	I-T033
va	I-T033
for	O
treating	O
vs	B-T038
##b	I-T038
should	O
depend	O
on	O
local	B-T082
factors	O
,	O
such	O
as	O
the	O
susceptibility	B-T038
results	O
.	O
in	O
addition	O
,	O
breakthrough	O
vs	B-T038
##b	I-T038
is	O
probably	O
not	O
a	O
major	O
cause	B-T033
of	I-T033
death	I-T033
in	O
allo	B-T058
-	I-T058
hsct	I-T058
settings	O
,	O
where	O
beta	B-T103
-	I-T103
lactam	I-T103
non	B-T007
-	I-T007
susceptible	I-T007
vg	I-T007
##s	I-T007
and	O
the	O
ards	B-T033
are	O
rare	O
.	O

the	O
effects	O
of	O
captopril	B-T103
on	O
lipopolysaccharide	B-T103
induced	O
learning	B-T038
and	O
memory	B-T038
impairments	I-T038
and	O
the	O
brain	B-T017
cytokine	B-T103
levels	O
and	O
oxidative	O
damage	B-T037
in	O
rats	B-T204
renin	B-T022
-	I-T022
angiotensin	I-T022
system	I-T022
has	O
a	O
role	O
in	O
inflammation	B-T038
and	O
also	O
involves	O
in	O
learning	B-T038
and	O
memory	B-T038
.	O
in	O
the	O
present	O
study	O
,	O
the	O
effects	O
of	O
captopril	B-T103
on	O
lipopolysaccharide	B-T103
(	O
lps	B-T103
)	O
induced	O
learning	B-T038
and	O
memory	B-T038
impairments	I-T038
,	O
hippocampal	B-T017
cytokine	B-T103
levels	O
and	O
brain	B-T017
tissues	I-T017
oxidative	O
damage	B-T037
was	O
investigated	O
.	O
the	O
rats	B-T204
were	O
divided	O
and	O
treated	O
:	O
[	O
1	O
]	O
saline	O
(	O
control	O
)	O
,	O
[	O
2	O
]	O
lps	B-T103
(	O
1	O
##mg	O
/	O
kg	O
)	O
,	O
[	O
3	O
-	O
5	O
]	O
10	O
,	O
50	O
or	O
100	O
##mg	O
/	O
kg	O
captopril	B-T103
30	O
##min	O
before	O
lps	B-T103
.	O
the	O
treatment	B-T058
was	O
started	O
since	O
six	O
days	O
before	O
the	O
behavioral	B-T058
experiments	I-T058
and	O
continued	O
during	O
the	O
behavioral	B-T058
tests	I-T058
(	O
lps	B-T103
injection	B-T058
two	O
h	O
before	O
each	O
behavioral	B-T058
experiment	I-T058
)	O
.	O
administration	B-T058
of	O
lps	B-T103
prolonged	O
the	O
escape	O
latency	O
and	O
travel	O
##ed	O
path	O
to	O
find	O
the	O
platform	O
in	O
morris	B-T058
water	I-T058
maze	I-T058
(	I-T058
mw	I-T058
##m	I-T058
)	I-T058
test	I-T058
(	O
p	O
<	O
0	O
.	O
01	O
-	O
p	O
<	O
0	O
.	O
001	O
)	O
while	O
,	O
shortened	O
the	O
latency	O
to	O
enter	O
the	O
dark	O
compartment	O
in	O
passive	O
avoidance	O
(	O
pa	O
)	O
test	B-T058
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
pretreatment	O
by	O
all	O
doses	O
of	O
captopril	B-T103
improved	O
performances	O
of	O
the	O
rats	B-T204
in	O
mw	B-T058
##m	I-T058
(	O
p	O
<	O
0	O
.	O
05	O
-	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
also	O
prolonged	O
the	O
latency	O
to	O
enter	O
the	O
dark	O
in	O
pa	O
test	B-T058
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
lps	B-T103
also	O
increased	O
il	B-T103
-	I-T103
6	I-T103
,	O
tnf	B-T103
-	I-T103
α	I-T103
,	O
malondialdehyde	B-T103
(	O
mda	B-T103
)	O
and	O
nitric	B-T103
oxide	I-T103
(	O
no	B-T103
)	O
metabolites	B-T103
in	O
the	O
hippocampal	B-T017
tissues	B-T017
(	O
p	O
<	O
0	O
.	O
05	O
-	O
p	O
<	O
0	O
.	O
001	O
)	O
which	O
were	O
prevented	B-T058
by	O
captopril	B-T103
(	O
p	O
<	O
0	O
.	O
05	O
-	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
thiol	B-T103
,	O
superoxide	B-T103
dismutase	I-T103
(	O
sod	B-T103
)	O
and	O
catalase	B-T103
(	O
cat	B-T103
)	O
in	O
the	O
hippocampus	B-T017
of	O
lps	B-T103
group	O
were	O
lower	O
than	O
the	O
control	O
(	O
p	O
<	O
0	O
.	O
001	O
)	O
while	O
,	O
they	O
were	O
enhanced	O
when	O
the	O
an	B-T204
##ia	I-T204
##ml	I-T204
##s	I-T204
were	O
pretreated	O
by	O
captopril	B-T103
(	O
p	O
<	O
0	O
.	O
01	O
-	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
results	O
of	O
present	O
study	O
showed	O
that	O
captopril	B-T103
improved	O
the	O
lps	B-T103
-	O
induced	O
learning	B-T038
and	O
memory	B-T038
impairments	I-T038
in	O
rats	B-T204
which	O
were	O
accompanied	O
with	O
attenuating	O
hippocampal	B-T017
cytokine	B-T103
levels	O
and	O
improving	O
the	O
brain	B-T017
tissues	I-T017
oxidative	O
damage	B-T037
criteria	O
.	O

interaction	O
of	O
the	O
antimicrobial	B-T103
peptides	I-T103
rhesus	B-T103
θ	I-T103
-	I-T103
def	I-T103
##ensin	I-T103
and	O
porcine	B-T204
prote	B-T103
##gr	I-T103
##in	I-T103
-	I-T103
1	I-T103
with	O
anionic	B-T103
phospholipid	I-T103
monolayers	I-T103
a	O
combination	O
of	O
langmuir	B-T170
isotherm	I-T170
,	O
bre	B-T058
##ws	I-T058
##ter	I-T058
angle	I-T058
microscopy	I-T058
(	O
bam	B-T058
)	O
,	O
and	O
neutron	B-T062
reflect	I-T062
##ivity	I-T062
studies	I-T062
have	O
been	O
performed	O
to	O
gain	O
insight	O
into	O
the	O
effects	O
on	O
model	O
bacterial	B-T017
cell	I-T017
membranes	I-T017
of	O
the	O
antimicrobial	B-T103
peptides	I-T103
,	O
rhesus	B-T103
θ	I-T103
-	I-T103
def	I-T103
##ensin	I-T103
1	I-T103
(	O
rt	B-T103
##d	I-T103
-	I-T103
1	I-T103
)	O
,	O
and	O
porcine	B-T204
prote	B-T103
##gr	I-T103
##in	I-T103
1	I-T103
(	O
pg	B-T103
-	I-T103
1	I-T103
)	O
.	O
the	O
peptides	B-T103
were	O
interacted	O
with	O
monolayers	B-T103
spread	O
at	O
the	O
air	O
-	O
water	B-T103
interface	O
and	O
prepared	O
from	O
a	O
3	O
:	O
1	O
molar	O
mixture	O
of	O
phosphatidylethanolamine	B-T103
and	O
phosphatidyl	B-T103
##glycerol	I-T103
used	O
to	O
approximate	O
the	O
cell	B-T017
membranes	I-T017
of	O
gram	B-T007
positive	I-T007
bacteria	I-T007
.	O
the	O
langmuir	O
film	O
balance	O
measurements	O
show	O
that	O
both	O
peptides	B-T103
perturb	O
the	O
lipid	B-T103
monolayers	I-T103
causing	O
an	O
increase	O
in	O
surface	O
pressure	O
,	O
and	O
the	O
bam	B-T058
studies	O
show	O
that	O
each	O
results	O
in	O
the	O
formation	O
of	O
small	B-T082
domains	I-T082
within	O
the	O
lipid	O
films	O
,	O
around	O
5	O
μm	O
diameter	O
.	O
the	O
overall	O
change	O
in	O
monolayer	B-T103
surface	O
pressure	O
caused	O
by	O
pg	B-T103
-	I-T103
1	I-T103
,	O
however	O
,	O
is	O
a	O
little	O
more	O
pronounced	O
than	O
that	O
due	O
to	O
rt	B-T103
##d	I-T103
-	I-T103
1	I-T103
(	O
+	O
8	O
.	O
5	O
mn	O
·	O
m	O
(	O
-	O
1	O
)	O
vs	O
+	O
5	O
.	O
5	O
mn	O
·	O
m	O
(	O
-	O
1	O
)	O
)	O
,	O
and	O
the	O
rate	O
of	O
its	O
initial	O
interaction	O
with	O
the	O
monolayer	B-T103
is	O
a	O
little	O
more	O
rapid	O
than	O
that	O
for	O
rt	B-T103
##d	I-T103
-	I-T103
1	I-T103
.	O
the	O
neutron	O
reflect	O
##ivity	O
studies	O
also	O
show	O
differences	O
for	O
pg	B-T103
-	I-T103
1	I-T103
and	O
rt	B-T103
##d	I-T103
-	I-T103
1	I-T103
,	O
with	O
the	O
model	O
fits	O
to	O
these	O
data	O
showing	O
that	O
the	O
more	O
amphiphilic	B-T103
pg	B-T103
-	I-T103
1	I-T103
becomes	O
fully	O
embedded	B-T058
within	O
the	O
lipid	O
film	O
-	O
causing	O
an	O
extension	O
of	O
the	O
lipid	O
acyl	O
chains	O
but	O
leaving	O
the	O
thickness	O
of	O
the	O
lipid	O
head	O
##group	O
layer	O
unaffected	O
-	O
while	O
rt	B-T103
##d	I-T103
-	I-T103
1	I-T103
is	O
seen	O
to	O
insert	O
less	O
deeply	O
-	O
causing	O
the	O
same	O
extension	O
of	O
the	O
lipid	O
acyl	O
chains	O
as	O
pg	B-T103
-	I-T103
1	I-T103
but	O
also	O
causing	O
a	O
significant	O
increase	O
in	O
thickness	O
of	O
the	O
lipid	O
head	O
##group	O
layer	O
.	O
the	O
various	O
differing	O
effects	O
of	O
the	O
two	O
peptides	B-T103
on	O
anionic	B-T103
lipid	I-T103
monolayers	I-T103
are	O
discussed	O
in	O
the	O
context	O
of	O
their	O
differing	O
hemolytic	B-T058
activities	I-T058
,	O
and	O
their	O
proposed	O
differing	O
prop	O
##ensities	O
to	O
form	O
transmembrane	B-T017
pores	B-T017
.	O

risk	O
of	O
cancer	O
in	O
patients	O
with	O
heart	B-T038
failure	I-T038
who	O
use	O
digoxin	B-T103
:	O
a	O
10	O
-	O
year	O
follow	B-T062
-	I-T062
up	I-T062
study	I-T062
and	O
cell	B-T017
-	O
based	O
verification	O
heart	B-T038
failure	I-T038
(	O
hf	B-T038
)	O
is	O
the	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
in	O
the	O
world	B-T098
and	O
digoxin	B-T103
remains	O
one	O
of	O
the	O
oldest	O
therapies	B-T058
for	O
hf	B-T038
.	O
however	O
,	O
its	O
safety	O
and	O
efficacy	O
have	O
been	O
controversial	O
since	O
its	O
initial	O
use	O
and	O
there	O
is	O
uncertainty	B-T033
about	O
its	O
long	O
-	O
term	O
efficacy	O
and	O
safety	O
.	O
recently	O
,	O
the	O
repositioning	B-T058
of	O
cardiac	B-T103
glycosides	I-T103
is	O
to	O
function	O
in	O
anti	B-T058
-	I-T058
tumor	I-T058
activity	I-T058
via	O
multiple	O
working	O
pathways	O
.	O
it	O
is	O
interesting	O
to	O
compare	O
the	O
potential	O
effects	O
of	O
digoxin	B-T103
in	O
clinical	O
patients	O
and	O
cell	B-T017
lines	I-T017
.	O
first	O
,	O
we	O
analyze	O
patient	B-T170
information	I-T170
retrieved	O
from	O
the	O
national	B-T170
health	I-T170
insurance	I-T170
research	I-T170
database	I-T170
of	O
taiwan	B-T082
between	O
january	O
1	O
,	O
2000	O
and	O
december	O
31	O
,	O
2000	O
.	O
this	O
retrospective	B-T062
study	I-T062
included	O
a	O
study	O
cohort	B-T098
(	O
1	O
,	O
219	O
patients	O
)	O
and	O
a	O
comparison	O
cohort	B-T098
.	O
our	O
analytical	O
data	O
suggested	O
that	O
patients	O
taking	O
digoxin	B-T103
are	O
at	O
an	O
increased	O
risk	O
of	O
cancers	O
,	O
including	O
breast	B-T038
,	O
liver	B-T038
,	O
and	O
lung	B-T038
cancers	I-T038
,	O
during	O
the	O
10	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
period	I-T058
.	O
in	O
contrast	O
to	O
the	O
anti	B-T058
-	I-T058
tumor	I-T058
function	I-T058
of	O
digoxin	B-T103
,	O
we	O
further	O
examined	O
the	O
potential	O
pathway	O
of	O
digoxin	B-T103
via	O
the	O
cell	B-T017
-	O
based	O
strategy	O
using	O
several	O
breast	B-T038
cancer	I-T038
cell	B-T017
lines	I-T017
,	O
including	O
mcf	B-T017
-	I-T017
7	I-T017
,	O
bt	B-T017
-	I-T017
47	I-T017
##4	I-T017
,	O
mad	B-T017
-	I-T017
mb	I-T017
-	I-T017
231	I-T017
,	O
and	O
zr	B-T017
-	I-T017
75	I-T017
-	I-T017
1	I-T017
.	O
digoxin	B-T103
consistently	O
exerted	O
its	O
cytotoxicity	B-T038
to	O
these	O
four	O
cell	B-T017
lines	I-T017
with	O
various	O
range	O
of	O
concentration	O
.	O
however	O
,	O
the	O
proliferation	O
of	O
zr	B-T017
-	I-T017
75	I-T017
-	I-T017
1	I-T017
cells	I-T017
was	O
the	O
only	O
cell	B-T017
lines	I-T017
induced	O
by	O
digoxin	B-T103
and	O
the	O
others	O
were	O
dramatically	O
suppressed	O
by	O
digoxin	B-T103
.	O
the	O
responsiveness	O
of	O
srs	B-T017
##f3	I-T017
to	O
digoxin	B-T103
might	O
be	O
involved	O
with	O
cell	B-T170
-	I-T170
type	I-T170
differences	O
.	O
in	O
summary	O
,	O
we	O
combined	O
a	O
cohort	O
study	O
for	O
digoxin	B-T103
treatment	B-T058
for	O
hf	B-T038
patients	O
with	O
a	O
cell	B-T017
-	O
based	O
strategy	O
that	O
addresses	O
the	O
translation	O
issue	O
,	O
which	O
revealed	O
the	O
complexity	O
of	O
personalized	B-T058
medicine	I-T058
.	O

collecting	B-T062
and	O
reporting	B-T062
safety	I-T062
data	I-T062
and	O
monitoring	B-T062
trial	I-T062
conduct	I-T062
in	O
pragmatic	B-T062
trials	I-T062
pragmatic	B-T062
trials	I-T062
offer	O
the	O
opportunity	O
to	O
obtain	O
real	O
-	O
life	O
data	O
on	O
the	O
relative	O
effectiveness	O
and	O
safety	O
of	O
a	O
treatment	B-T058
before	O
or	O
after	O
market	O
author	O
##isation	O
.	O
this	O
is	O
the	O
pen	O
##ult	O
##ima	O
##te	O
paper	O
in	O
a	O
series	O
of	O
eight	O
,	O
describing	O
the	O
impact	O
of	O
design	O
choices	O
on	O
the	O
practical	O
implementation	O
of	O
pragmatic	B-T062
trials	I-T062
.	O
this	O
paper	O
focuses	O
on	O
the	O
practical	O
challenges	O
of	O
collecting	B-T062
and	O
reporting	B-T062
safety	I-T062
data	I-T062
and	O
of	O
monitoring	B-T062
trial	I-T062
conduct	I-T062
while	O
maintaining	O
routine	O
clinical	O
care	O
practice	O
.	O
current	O
ich	B-T170
guidance	O
recommends	O
that	O
,	O
all	O
serious	B-T033
adverse	I-T033
events	I-T033
(	O
sa	B-T033
##es	I-T033
)	O
and	O
all	O
drug	B-T103
-	O
related	O
events	O
must	O
be	O
reported	O
in	O
an	O
interventional	B-T058
trial	B-T062
.	O
in	O
line	O
with	O
current	O
guidance	O
,	O
we	O
propose	O
a	O
risk	O
based	O
approach	B-T082
to	O
the	O
collection	B-T062
of	O
non	B-T033
-	O
drug	B-T103
related	O
non	B-T033
-	I-T033
serious	I-T033
aes	I-T033
,	O
and	O
even	O
serious	O
events	O
not	O
related	O
to	O
treatment	B-T058
based	O
on	O
the	O
risk	O
profile	O
of	O
the	O
medicine	B-T103
/	O
class	O
in	O
the	O
patient	O
population	B-T098
of	O
interest	O
.	O
different	O
options	O
available	O
to	O
support	O
the	O
collection	B-T062
and	O
reporting	B-T062
of	I-T062
safety	I-T062
data	I-T062
whilst	O
minimizing	O
study	B-T062
-	O
related	O
follow	B-T058
-	I-T058
up	I-T058
visits	I-T058
are	O
discussed	O
.	O
a	O
risk	O
-	O
based	O
approach	B-T082
to	O
monitoring	B-T062
trial	I-T062
conduct	I-T062
is	O
also	O
discussed	O
,	O
highlighting	O
the	O
difference	O
in	O
the	O
balance	O
of	O
risks	O
likely	O
to	O
occur	O
in	O
a	O
pragmatic	B-T062
trial	I-T062
compared	O
to	O
traditional	O
clinical	B-T062
trials	I-T062
,	O
and	O
the	O
careful	O
consideration	O
that	O
must	O
be	O
given	O
to	O
the	O
mitigation	O
and	O
management	B-T058
of	I-T058
these	I-T058
risks	I-T058
in	O
order	O
to	O
maintain	O
routine	O
care	O
.	O

transfusion	B-T091
medicine	I-T091
in	O
medical	O
education	O
:	O
an	O
analysis	B-T062
of	O
curricula	O
##r	O
grid	O
##s	O
in	O
brazil	B-T082
and	O
a	O
review	O
of	O
the	O
current	B-T170
literature	I-T170
blood	B-T058
transfusions	I-T058
are	O
one	O
of	O
the	O
most	O
performed	O
medical	B-T058
procedures	I-T058
in	O
the	O
world	B-T098
.	O
thus	O
,	O
as	O
education	O
in	O
transfusion	B-T091
medicine	I-T091
is	O
vital	O
to	O
medical	B-T033
care	I-T033
,	O
it	O
should	O
aim	O
to	O
promote	O
a	O
responsible	O
practice	O
with	O
the	O
rational	O
use	O
of	O
blood	B-T031
by	O
doctors	B-T097
.	O
this	O
study	O
aims	O
to	O
investigate	O
the	O
situation	O
of	O
the	O
teaching	O
of	O
transfusion	B-T091
medicine	I-T091
in	O
medical	B-T092
schools	I-T092
in	O
brazil	B-T082
.	O
the	O
websites	B-T170
of	O
the	O
249	O
brazilian	B-T098
medical	B-T092
schools	I-T092
in	O
operation	O
in	O
june	O
2015	O
were	O
visited	O
and	O
the	O
curricula	B-T170
of	O
the	O
medical	O
courses	O
were	O
investigated	O
in	O
respect	O
to	O
the	O
presence	O
or	O
absence	O
of	O
a	O
transfusion	B-T091
medicine	I-T091
discipline	I-T091
.	O
when	O
available	O
,	O
the	O
subject	O
grid	O
##s	O
were	O
analyzed	B-T062
to	O
verify	O
whether	O
a	O
description	B-T170
of	I-T170
content	I-T170
regarding	O
transfusion	B-T091
medicine	I-T091
was	O
given	O
within	O
other	O
disciplines	O
.	O
of	O
the	O
249	O
medical	B-T092
school	I-T092
sites	O
visited	O
,	O
information	O
on	O
the	O
curriculum	B-T170
was	O
obtained	O
from	O
178	O
.	O
of	O
the	O
medical	B-T092
schools	I-T092
that	O
published	O
their	O
curriculum	B-T170
,	O
132	O
(	O
74	O
.	O
1	O
%	O
)	O
did	O
not	O
have	O
disciplines	B-T091
of	I-T091
transfusion	I-T091
medicine	I-T091
or	O
hematology	B-T091
and	O
only	O
seven	O
(	O
3	O
.	O
9	O
%	O
)	O
had	O
a	O
discipline	B-T091
of	I-T091
transfusion	I-T091
medicine	I-T091
in	O
the	O
curricula	O
##r	O
grid	O
.	O
education	O
on	O
transfusion	B-T091
medicine	I-T091
is	O
of	O
fundamental	O
importance	O
for	O
safe	B-T058
and	I-T058
efficient	I-T058
transfusion	I-T058
practices	I-T058
.	O
deficiencies	O
in	O
medical	O
knowledge	B-T170
of	O
this	O
subject	O
have	O
been	O
found	O
worldwide	O
.	O
the	O
results	O
of	O
this	O
study	O
indicate	O
a	O
possible	O
deficiency	O
in	O
teaching	O
the	O
basic	O
##s	O
of	O
this	O
specialty	O
.	O
thus	O
,	O
additional	O
prospective	B-T062
studies	I-T062
to	O
assess	O
the	O
knowledge	B-T170
and	O
practice	O
of	O
transfusion	B-T091
medicine	I-T091
in	O
brazilian	B-T098
medical	B-T092
schools	I-T092
are	O
warranted	O
,	O
which	O
could	O
prompt	O
a	O
discussion	O
on	O
the	O
importance	O
of	O
offering	O
training	O
in	O
transfusion	B-T091
medicine	I-T091
to	O
medical	B-T097
students	I-T097
.	O

epidemiological	O
patterns	B-T082
of	O
bovine	B-T204
bes	B-T038
##no	I-T038
##iti	I-T038
##osis	I-T038
in	O
an	O
endemic	O
beef	B-T204
cattle	I-T204
herd	O
reared	O
under	O
extensive	O
conditions	O
bovine	B-T204
bes	B-T038
##no	I-T038
##iti	I-T038
##osis	I-T038
is	O
a	O
parasitic	B-T038
disease	I-T038
caused	O
by	O
the	O
protozoan	B-T204
bes	B-T204
##no	I-T204
##iti	I-T204
##a	I-T204
bes	I-T204
##no	I-T204
##iti	I-T204
.	O
described	O
many	O
decades	O
ago	O
,	O
recent	O
epidemiological	B-T062
studies	I-T062
reveal	O
its	O
important	O
spread	O
within	O
europe	B-T082
in	O
the	O
last	O
years	O
.	O
to	O
date	O
,	O
many	O
epidemiological	O
aspects	O
related	O
to	O
life	O
cycle	O
,	O
routes	O
of	O
transmission	B-T038
,	O
incidence	O
rates	O
and	O
associated	O
risk	B-T033
factors	I-T033
are	O
lacking	O
;	O
hence	O
,	O
the	O
establishment	O
of	O
appropriate	B-T058
disease	I-T058
control	I-T058
programmes	B-T170
poses	O
an	O
important	O
challenge	O
.	O
thus	O
,	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
determine	O
the	O
epidemiological	O
pattern	B-T082
of	O
the	O
disease	B-T038
in	O
an	O
endemic	O
herd	O
reared	O
under	O
extensive	O
conditions	O
(	O
spanish	B-T082
pyrene	B-T082
##es	I-T082
)	O
by	O
identifying	O
main	O
factors	O
associated	O
with	O
infection	B-T038
and	O
clinical	B-T038
disease	I-T038
dynamics	O
.	O
the	O
study	B-T062
population	I-T062
consisted	O
of	O
276	O
brown	B-T204
swiss	I-T204
and	O
pir	B-T204
##ena	I-T204
##ica	I-T204
adult	O
animals	O
and	O
145	O
calves	B-T204
born	B-T038
and	O
weaned	B-T033
at	O
the	O
farm	B-T082
during	O
the	O
study	B-T062
.	O
three	O
sampling	O
time	O
frames	O
were	O
used	O
:	O
january	O
2010	O
,	O
september	O
2010	O
and	O
february	O
2011	O
,	O
which	O
allowed	O
us	O
to	O
differentiate	O
two	O
periods	O
designated	O
as	O
mountain	B-T082
and	O
valley	B-T082
periods	O
.	O
the	O
data	O
related	O
to	O
animals	B-T204
(	O
breed	B-T170
,	O
sex	O
and	O
age	O
)	O
and	O
herd	O
management	O
(	O
animal	O
grouping	O
and	O
time	O
in	O
housing	O
)	O
were	O
recorded	O
.	O
the	O
data	B-T062
collection	I-T062
methodology	O
was	O
mainly	O
based	O
on	O
clinical	O
examinations	O
and	O
defining	O
the	O
serological	O
status	O
against	O
bovine	B-T204
bes	B-T038
##no	I-T038
##iti	I-T038
##osis	I-T038
by	O
the	O
immunofluorescent	B-T058
antibody	I-T058
testing	I-T058
of	O
blood	B-T031
samples	I-T031
.	O
the	O
total	O
prevalence	O
among	O
adult	O
animals	O
was	O
38	O
.	O
34	O
%	O
(	O
ci	O
95	O
%	O
:	O
34	O
.	O
53	O
-	O
42	O
.	O
07	O
)	O
,	O
with	O
18	O
.	O
54	O
%	O
of	O
seropositive	O
animals	B-T204
showing	O
clinical	O
signs	O
.	O
in	O
regard	O
to	O
the	O
cumulative	O
incidence	O
,	O
34	O
.	O
57	O
%	O
of	O
new	O
infections	B-T038
were	O
detected	B-T033
during	O
the	O
mountain	B-T082
period	O
,	O
in	O
contrast	O
to	O
the	O
24	O
.	O
59	O
%	O
observed	O
in	O
the	O
valley	B-T082
period	O
.	O
the	O
incidence	O
density	O
was	O
0	O
.	O
05	O
##8	O
and	O
0	O
.	O
06	O
##1	O
new	O
infections	B-T038
per	O
animal	B-T204
-	O
month	O
for	O
the	O
mountain	B-T082
and	O
valley	B-T082
periods	O
,	O
respectively	O
.	O
according	O
to	O
the	O
sero	B-T062
##epid	I-T062
##em	I-T062
##iological	I-T062
study	I-T062
,	O
the	O
seroconversion	O
probability	O
of	O
b	B-T204
.	I-T204
bes	I-T204
##no	I-T204
##iti	I-T204
infection	B-T038
was	O
directly	O
associated	O
with	O
the	O
number	O
of	O
seropositive	O
cows	B-T204
with	O
whom	O
an	O
animal	B-T204
had	O
been	O
stable	O
##d	O
as	O
well	O
as	O
the	O
housing	O
period	O
duration	O
,	O
supporting	O
horizontal	B-T038
transmission	I-T038
by	O
close	O
contact	O
as	O
one	O
of	O
the	O
most	O
important	O
methods	O
of	O
disease	B-T038
spread	O
.	O
in	O
addition	O
,	O
the	O
risk	O
of	O
developing	O
the	O
clinical	O
course	O
increased	O
with	O
age	O
,	O
and	O
the	O
presence	B-T033
of	O
clinical	B-T033
signs	I-T033
was	O
related	O
to	O
higher	O
antibody	B-T038
responses	I-T038
.	O
among	O
calves	B-T204
(	O
from	O
3	O
.	O
1	O
to	O
7	O
.	O
1	O
months	O
old	O
)	O
sampled	O
once	O
at	O
weaning	B-T033
,	O
the	O
total	O
seroprevalence	B-T062
was	O
15	O
.	O
17	O
%	O
(	O
ci	O
95	O
%	O
:	O
9	O
.	O
36	O
-	O
21	O
.	O
04	O
)	O
,	O
and	O
the	O
chronic	O
stage	O
was	O
observed	O
in	O
three	O
animals	B-T204
,	O
supporting	O
the	O
ability	O
of	O
b	B-T204
.	I-T204
bes	I-T204
##no	I-T204
##iti	I-T204
to	O
infect	B-T038
and	O
even	O
cause	O
disease	B-T038
in	O
animals	B-T204
less	O
than	O
6	O
months	O
old	O
.	O
finally	O
,	O
the	O
risk	O
of	O
calf	B-T204
seroconversion	O
was	O
positively	O
related	O
to	O
the	O
serological	O
status	O
of	O
the	O
cows	B-T204
,	O
suggesting	O
postnatal	O
transmission	B-T038
between	O
dams	B-T204
and	O
offspring	B-T204
by	O
contact	O
during	O
the	O
suckling	B-T204
period	O
.	O

binding	O
of	O
dead	B-T103
-	I-T103
box	I-T103
helicase	I-T103
dh	B-T103
##h1	I-T103
to	O
the	O
5	B-T103
'	I-T103
utr	I-T103
of	O
ash	B-T017
##1	I-T017
mrna	B-T103
repress	B-T038
##es	I-T038
localized	O
translation	B-T038
of	O
ash	B-T017
##1	I-T017
in	O
yeast	B-T204
cells	B-T017
local	B-T038
translation	I-T038
of	O
specific	O
mrnas	B-T103
is	O
regulated	B-T038
by	O
dynamic	O
changes	O
in	O
their	O
subcellular	B-T017
localization	O
,	O
and	O
these	O
changes	O
are	O
due	O
to	O
complex	O
mechanisms	O
controlling	O
cytoplasmic	B-T017
mrna	B-T038
transport	I-T038
.	O
the	O
budding	B-T204
yeast	I-T204
saccharomyces	B-T204
cerevisiae	I-T204
is	O
well	O
suited	O
to	O
studying	O
these	O
mechanisms	O
because	O
many	O
of	O
its	O
transcripts	B-T103
are	O
transported	B-T038
from	O
the	O
mother	B-T017
cell	I-T017
to	O
the	O
budding	B-T038
daughter	B-T017
cell	I-T017
.	O
here	O
,	O
we	O
investigated	O
the	O
translational	B-T038
control	I-T038
of	O
ash	B-T017
##1	I-T017
mrna	B-T103
after	O
transport	B-T038
and	O
localization	O
.	O
we	O
show	O
that	O
although	O
ash	B-T017
##1	I-T017
transcripts	B-T103
were	O
translated	B-T038
after	O
they	O
reached	O
the	O
bud	B-T017
-	I-T017
tip	I-T017
,	O
some	O
mrnas	B-T103
were	O
bound	O
by	O
the	O
rna	B-T103
-	I-T103
binding	I-T103
protein	I-T103
pu	B-T103
##f6	I-T103
and	O
were	O
non	B-T033
-	I-T033
polys	I-T033
##omal	I-T033
.	O
we	O
also	O
found	O
that	O
the	O
dead	B-T103
-	I-T103
box	I-T103
helicase	I-T103
dh	B-T103
##h1	I-T103
complexed	O
with	O
the	O
untranslated	B-T103
ash	B-T017
##1	I-T017
mrna	B-T103
and	O
pu	B-T103
##f6	I-T103
.	O
loss	O
of	O
dh	B-T103
##h1	I-T103
affected	O
local	B-T038
translation	I-T038
of	O
ash	B-T017
##1	I-T017
mrna	B-T103
and	O
resulted	O
in	O
del	O
##ocalization	O
of	O
ash	B-T017
##1	I-T017
transcript	B-T103
in	O
the	O
bud	B-T204
.	O
for	O
##ci	O
##bl	O
##y	O
shifting	O
the	O
non	B-T033
-	I-T033
polys	I-T033
##omal	I-T033
ash	B-T017
##1	I-T017
mrna	B-T103
into	O
polys	B-T017
##omes	I-T017
was	O
associated	O
with	O
dh	B-T103
##h1	I-T103
dissociation	B-T038
.	O
we	O
further	O
demonstrated	O
that	O
dh	B-T103
##h1	I-T103
is	O
not	O
recruited	O
to	O
ash	B-T017
##1	I-T017
mrna	B-T103
co	B-T038
-	I-T038
transcriptionally	I-T038
,	O
suggesting	O
that	O
it	O
could	O
bind	O
to	O
ash	B-T017
##1	I-T017
mrna	B-T103
within	O
the	O
cytoplasm	B-T017
.	O
of	O
note	O
,	O
dh	B-T103
##h1	I-T103
bound	O
to	O
the	O
5	B-T103
utr	I-T103
of	O
ash	B-T017
##1	I-T017
mrna	B-T103
and	O
inhibited	O
its	O
translation	B-T038
in	O
vitro	O
.	O
these	O
results	O
suggest	O
that	O
after	O
localization	O
to	O
the	O
bud	B-T017
tip	I-T017
,	I-T017
a	O
portion	B-T082
of	O
the	O
localized	B-T082
ash	B-T017
##1	I-T017
mrna	B-T103
becomes	O
translational	B-T038
##ly	I-T038
inactive	O
,	O
because	O
of	O
binding	O
of	O
dh	B-T103
##h1	I-T103
and	O
pu	B-T103
##f6	I-T103
to	O
the	O
5	B-T103
'	I-T103
and	I-T103
3	I-T103
'	I-T103
utr	I-T103
##s	I-T103
of	O
ash	B-T017
##1	I-T017
mrna	B-T103
.	O

evaluation	B-T058
of	O
the	O
effects	O
of	O
intravenous	B-T082
and	O
percutaneous	B-T082
low	B-T058
level	I-T058
laser	I-T058
therapy	I-T058
in	O
the	O
management	B-T058
of	O
shoulder	B-T082
myof	B-T038
##asc	I-T038
##ial	I-T038
pain	I-T038
syndrome	I-T038
myof	B-T038
##asc	I-T038
##ial	I-T038
pain	I-T038
syndrome	I-T038
(	O
mps	B-T038
)	O
treatment	B-T058
is	O
challenging	O
with	O
a	O
high	O
recurrence	O
rate	O
and	O
still	O
lacks	O
a	O
clear	O
treatment	B-T058
frame	I-T058
.	O
therefore	O
research	O
on	O
new	O
,	O
more	O
efficient	O
and	O
long	O
lasting	O
effect	O
treatment	B-T058
modalities	O
is	O
necessary	O
.	O
this	O
study	O
looked	O
at	O
the	O
effects	O
of	O
intravenous	B-T082
laser	B-T058
therapy	I-T058
(	O
iv	B-T058
##l	I-T058
)	O
and	O
percutaneous	B-T082
low	B-T058
level	I-T058
laser	I-T058
(	O
pl	B-T058
##ll	I-T058
)	O
in	O
the	O
management	B-T058
of	O
shoulder	B-T082
mps	B-T038
.	O
in	O
this	O
randomized	B-T062
controlled	I-T062
trial	I-T062
,	O
30	O
patients	O
fulfilling	O
inclusion	O
criteria	O
were	O
randomly	O
equally	O
allocated	O
to	O
3	O
groups	O
,	O
control	O
,	O
iv	B-T098
##l	I-T098
and	O
pl	B-T098
##ll	I-T098
.	O
control	O
group	O
received	O
12	O
sessions	O
of	O
placebo	B-T062
low	B-T058
level	I-T058
laser	I-T058
,	O
iv	B-T098
##l	I-T098
group	I-T098
received	O
12	O
sessions	O
of	O
iv	B-T058
##l	I-T058
therapy	I-T058
,	O
and	O
pl	B-T098
##ll	I-T098
group	I-T098
received	O
12	O
sessions	O
of	O
pl	B-T058
##ll	I-T058
therapy	I-T058
.	O
all	O
patients	O
were	O
trained	O
for	O
better	O
body	O
posture	O
,	O
body	O
mechanics	O
,	O
gent	B-T058
##le	I-T058
massage	I-T058
of	O
trigger	B-T082
points	I-T082
,	O
stretching	B-T058
exercises	I-T058
of	O
affected	O
muscle	B-T017
(	O
trapez	B-T017
##ius	I-T017
)	O
,	O
and	O
received	O
10	O
mg	O
of	O
oral	B-T082
nor	B-T103
##tri	I-T103
##pt	I-T103
##yline	I-T103
regimen	B-T058
every	O
night	O
for	O
3	O
months	O
.	O
outcomes	O
included	O
pain	O
severity	O
,	O
functional	O
disability	O
,	O
and	O
quality	O
of	O
life	O
.	O
patients	O
were	O
assessed	O
using	O
numeric	B-T170
rating	I-T170
scale	I-T170
(	O
nrs	B-T170
)	O
,	O
pain	B-T170
disability	I-T170
index	I-T170
(	O
pdi	B-T170
)	O
,	O
and	O
short	B-T170
form	I-T170
health	I-T170
survey	I-T170
(	O
sf	B-T170
-	I-T170
12	I-T170
)	O
.	O
data	B-T033
collected	I-T033
were	O
analyzed	B-T062
using	O
analysis	O
of	O
variance	O
(	O
anova	O
)	O
,	O
mann	B-T170
-	I-T170
whitney	I-T170
and	O
t	B-T170
tests	I-T170
.	O
the	O
mean	O
of	O
pdi	B-T170
and	O
maximum	O
pain	B-T201
intensity	I-T201
during	O
day	O
and	O
night	O
significantly	O
reduced	O
in	O
both	O
pl	B-T098
##ll	I-T098
and	O
iv	B-T098
##l	I-T098
groups	I-T098
compared	O
to	O
control	O
group	O
.	O
although	O
pain	O
severity	O
and	O
pdi	B-T170
reduction	O
was	O
more	O
pronounced	O
in	O
iv	B-T098
##l	I-T098
group	I-T098
compared	O
to	O
pl	B-T098
##ll	I-T098
group	I-T098
,	O
the	O
differences	O
were	O
not	O
statistically	O
significant	O
.	O
also	O
,	O
quality	O
of	O
life	O
statistically	O
significantly	O
improved	O
in	O
both	O
iv	B-T098
##l	I-T098
and	O
pl	B-T098
##ll	I-T098
groups	I-T098
compared	O
to	O
control	O
group	O
was	O
more	O
,	O
and	O
although	O
higher	O
in	O
iv	B-T098
##l	I-T098
group	I-T098
,	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
when	O
compared	O
to	O
pl	B-T098
##ll	I-T098
group	I-T098
.	O
no	B-T033
side	I-T033
effects	I-T033
were	O
observed	O
in	O
the	O
intervention	B-T098
groups	I-T098
.	O
intravenous	B-T082
laser	B-T058
and	O
pl	B-T058
##ll	I-T058
therapy	I-T058
had	O
a	O
positive	O
effect	O
on	O
pain	O
severity	O
and	O
pdi	B-T170
reduction	O
,	O
and	O
quality	O
of	O
life	O
in	O
this	O
study	O
.	O
also	O
no	B-T033
adverse	I-T033
event	I-T033
was	O
recorded	O
.	O
thus	O
,	O
intravenous	B-T082
lasers	B-T058
and	O
pl	B-T058
##ll	I-T058
therapy	I-T058
seem	O
to	O
be	O
effective	O
complementary	O
modalities	O
in	O
managing	B-T058
patients	O
with	O
shoulder	B-T082
mps	B-T038
.	O

allergen	B-T103
val	O
##ency	O
,	O
dose	O
,	O
and	O
fc	B-T103
##ε	I-T103
##ri	I-T103
occupancy	O
set	O
thresholds	O
for	O
secretory	B-T038
responses	I-T038
to	O
pen	B-T103
a	I-T103
1	I-T103
and	O
motiv	O
##ate	O
design	O
of	O
hypoal	B-T103
##ler	I-T103
##gens	I-T103
ag	B-T103
-	O
mediated	O
crosslinking	O
of	O
ige	B-T103
-	O
fc	B-T103
##ε	I-T103
##ri	I-T103
complexes	B-T103
activates	O
mast	B-T017
cells	I-T017
and	O
basophils	B-T017
,	O
initiating	O
the	O
allergic	B-T038
response	I-T038
.	O
of	O
34	O
donors	O
recruited	O
having	O
self	B-T062
-	I-T062
reported	I-T062
shrimp	B-T038
allergy	I-T038
,	O
only	O
35	O
%	O
had	O
significant	O
levels	O
of	O
shrimp	B-T103
-	I-T103
specific	I-T103
ige	I-T103
in	O
serum	B-T031
and	O
measurable	O
basophil	B-T017
secretory	B-T038
responses	B-T038
to	O
rpe	O
##n	O
a	O
1	O
(	O
shrimp	B-T204
tropomyosin	B-T103
)	O
.	O
we	O
report	O
that	O
degranulation	O
is	O
linked	O
to	O
the	O
number	O
of	O
fc	B-T103
##ε	I-T103
##ri	I-T103
occupied	O
with	O
allergen	B-T103
-	I-T103
specific	I-T103
ige	I-T103
,	O
as	O
well	O
as	O
the	O
dose	O
and	O
val	O
##ency	O
of	O
pen	B-T103
a	I-T103
1	I-T103
.	O
using	O
clustered	B-T062
regularly	I-T062
intersp	I-T062
##aced	I-T062
pal	I-T062
##ind	I-T062
##romic	I-T062
repeat	I-T062
-	I-T062
based	I-T062
gene	I-T062
editing	I-T062
,	O
human	O
rb	O
##l	O
(	O
r	O
##α	O
##ko	O
)	O
cells	O
were	O
created	O
that	O
exclusively	O
express	O
the	O
human	O
fc	B-T103
##ε	I-T103
##ri	I-T103
##α	I-T103
subunit	O
.	O
pen	B-T103
a	I-T103
1	I-T103
-	O
specific	B-T103
ige	I-T103
was	O
affinity	O
purified	O
from	O
shrimp	B-T204
-	O
positive	B-T033
plasma	B-T031
.	O
cells	O
primed	O
with	O
a	O
range	O
of	O
pen	B-T103
a	I-T103
1	I-T103
-	O
specific	B-T103
ige	I-T103
and	O
challenged	O
with	O
pen	B-T103
a	I-T103
1	I-T103
showed	O
a	O
bell	O
-	O
shaped	O
dose	O
response	B-T038
for	I-T038
secretion	I-T038
,	O
with	O
optimal	O
pen	B-T103
a	I-T103
1	I-T103
doses	O
of	O
0	O
.	O
1	O
-	O
10	O
ng	O
/	O
ml	O
.	O
mathematical	B-T170
modeling	I-T170
provided	O
estimates	O
of	O
receptor	B-T038
aggregation	I-T038
kinetics	O
based	O
on	O
fc	B-T103
##ε	I-T103
##ri	I-T103
occupancy	O
with	O
ige	B-T103
and	O
allergen	B-T103
dose	O
.	O
maximal	O
degranulation	O
was	O
elicited	O
when	O
∼	O
##27	O
##00	O
i	O
ge	B-T103
-	O
fc	B-T103
##ε	I-T103
##ri	I-T103
complexes	B-T103
were	O
occupied	O
with	O
specific	B-T103
ige	I-T103
and	O
challenged	O
with	O
pen	B-T103
a	I-T103
1	I-T103
(	O
ige	B-T103
epitope	B-T103
val	O
##ency	O
of	O
≥	O
##8	O
)	O
,	O
although	O
measurable	O
responses	O
were	O
achieved	O
when	O
only	O
a	O
few	O
hundred	O
fc	B-T103
##ε	I-T103
##ri	I-T103
were	O
occupied	O
.	O
prolonged	O
periods	O
of	O
pepsin	B-T103
-	O
mediated	O
pen	B-T103
a	I-T103
1	I-T103
proteolysis	B-T038
,	O
which	O
simulate	O
##s	O
gastric	O
digestion	B-T038
,	O
were	O
required	O
to	O
diminish	O
secretory	B-T038
responses	I-T038
.	O
recombinant	O
fragments	O
(	O
60	O
-	O
79	O
aa	O
)	O
,	O
which	O
together	O
span	O
the	O
entire	O
length	O
of	O
tropomyosin	B-T103
,	O
were	O
weak	O
secret	O
##agog	O
##ues	O
.	O
these	O
fragments	O
have	O
reduced	O
dimerization	B-T038
capacity	O
,	O
compete	O
with	O
intact	O
pen	B-T103
a	I-T103
1	I-T103
for	O
binding	O
to	O
ige	B-T103
-	O
fc	B-T103
##ε	I-T103
##ri	I-T103
complexes	B-T103
,	O
and	O
represent	O
a	O
starting	O
point	O
for	O
the	O
design	O
of	O
promising	O
hypoal	B-T103
##ler	I-T103
##gens	I-T103
for	O
immunotherapy	B-T058
.	O

anterolateral	B-T082
entorhinal	B-T017
cortex	I-T017
volume	O
predicted	O
by	O
altered	O
intra	B-T170
-	I-T170
item	I-T170
config	I-T170
##ural	I-T170
processing	I-T170
recent	O
functional	O
imaging	B-T058
studies	I-T058
have	O
proposed	O
that	O
the	O
human	B-T204
entorhinal	B-T017
cortex	I-T017
is	O
subdivided	O
into	O
functionally	O
distinct	O
anterolateral	B-T082
(	O
ale	B-T017
##r	I-T017
##c	I-T017
)	O
and	O
poster	O
##omedial	O
(	O
pme	B-T017
##r	I-T017
##c	I-T017
)	O
subreg	B-T082
##ions	I-T082
.	O
the	O
ale	B-T017
##r	I-T017
##c	I-T017
overlaps	O
with	O
regions	O
that	O
are	O
affected	O
earliest	O
by	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
pathology	B-T038
,	O
yet	O
its	O
cognitive	B-T038
function	I-T038
remains	O
poorly	O
understood	O
.	O
previous	O
human	B-T204
fmri	B-T058
studies	I-T058
have	O
focused	O
on	O
its	O
role	O
in	O
object	O
memory	B-T038
,	O
but	O
rodent	B-T204
studies	B-T204
on	O
the	O
putative	O
##ly	O
homologous	O
lateral	O
entorhinal	B-T017
cortex	I-T017
suggest	O
that	O
it	O
also	O
plays	O
an	O
important	O
role	O
in	O
representing	O
spatial	B-T082
properties	I-T082
of	O
objects	O
.	O
in	O
order	O
to	O
investigate	O
the	O
cognitive	O
effects	O
of	O
human	B-T204
ale	B-T017
##r	I-T017
##c	I-T017
volume	O
differences	O
,	O
we	O
developed	O
an	O
eye	O
##trac	O
##king	O
-	O
based	O
task	O
to	O
evaluate	B-T058
intra	B-T170
-	I-T170
item	I-T170
config	I-T170
##ural	I-T170
processing	I-T170
(	O
i	O
.	O
e	O
.	O
,	O
processing	O
the	O
arrangement	B-T082
of	O
an	O
object	O
'	O
s	O
features	O
)	O
,	O
and	O
used	O
manual	B-T058
segmentation	I-T058
based	O
on	O
a	O
recently	O
-	O
developed	B-T170
protocol	I-T170
to	O
delineate	O
the	O
ale	B-T017
##r	I-T017
##c	I-T017
/	O
pme	B-T017
##r	I-T017
##c	I-T017
as	O
well	O
as	O
other	O
medial	B-T017
temporal	I-T017
lobe	I-T017
(	O
mt	B-T017
##l	I-T017
)	O
subreg	B-T082
##ions	I-T082
.	O
in	O
a	O
group	O
of	O
older	O
adult	O
men	B-T098
and	O
women	B-T098
at	O
varying	O
stages	O
of	O
brain	B-T038
atrophy	I-T038
and	O
cognitive	B-T038
decline	I-T038
,	O
we	O
found	O
that	O
intra	B-T170
-	I-T170
item	I-T170
config	I-T170
##ural	I-T170
processing	I-T170
-	O
regardless	O
of	O
an	O
object	O
'	O
s	O
novelty	O
-	O
was	O
strongly	O
predicted	O
by	O
ale	B-T017
##r	I-T017
##c	I-T017
volume	O
,	O
but	O
not	O
by	O
the	O
volume	O
of	O
any	O
other	O
mt	B-T017
##l	I-T017
subreg	I-T017
##ion	I-T017
.	O
these	O
results	O
provide	O
the	O
first	O
evidence	O
that	O
the	O
human	B-T204
ale	B-T017
##r	I-T017
##c	I-T017
plays	O
a	O
role	O
in	O
supporting	O
a	O
distinct	O
aspect	O
of	O
object	O
processing	O
,	O
namely	O
attending	O
to	O
the	O
arrangement	B-T082
of	O
an	O
object	O
'	O
s	O
component	O
features	O
.	O
significance	O
statement	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
pathology	B-T038
appears	O
earliest	O
in	O
brain	B-T082
regions	I-T082
that	O
overlap	O
with	O
the	O
anterolateral	B-T082
entorhinal	B-T017
cortex	I-T017
(	O
ale	B-T017
##r	I-T017
##c	I-T017
)	O
.	O
however	O
,	O
the	O
cognitive	B-T038
role	I-T038
of	O
the	O
ale	B-T017
##r	I-T017
##c	I-T017
is	O
poorly	O
understood	O
.	O
previous	O
human	B-T062
studies	I-T062
treat	B-T058
the	O
ale	B-T017
##r	I-T017
##c	I-T017
as	O
an	O
extension	O
of	O
the	O
neighboring	O
perir	B-T082
##hi	I-T082
##nal	I-T082
cortex	I-T082
,	O
supporting	O
object	O
memory	B-T038
.	O
animal	B-T204
studies	I-T204
suggest	O
that	O
the	O
ale	B-T017
##r	I-T017
##c	I-T017
may	O
support	O
the	O
spatial	B-T082
properties	I-T082
of	O
objects	O
.	O
in	O
a	O
group	O
of	O
older	O
adult	O
humans	B-T204
at	O
the	O
earliest	O
stages	O
of	O
cognitive	B-T038
decline	I-T038
,	O
we	O
show	O
that	O
ale	B-T017
##r	I-T017
##c	I-T017
volume	O
selectively	O
predicted	O
config	B-T170
##ural	I-T170
processing	I-T170
(	O
attention	B-T038
to	O
the	O
spatial	B-T082
arrangement	I-T082
of	O
an	O
object	O
'	O
s	O
parts	O
)	O
.	O
this	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
a	O
cognitive	B-T038
role	I-T038
related	O
to	O
ale	B-T017
##r	I-T017
##c	I-T017
volume	O
in	O
humans	B-T204
.	O
this	O
task	O
can	O
be	O
adapted	O
to	O
serve	O
as	O
an	O
early	B-T170
detection	I-T170
method	I-T170
for	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
pathology	B-T038
.	O

historical	O
environment	B-T082
is	O
reflected	O
in	O
modern	O
population	O
genetics	O
and	O
bioge	O
##ography	O
of	O
an	O
island	B-T082
endemic	O
liz	B-T204
##ard	I-T204
(	O
xa	B-T204
##nt	I-T204
##us	I-T204
##ia	I-T204
rivers	I-T204
##iana	I-T204
reticul	I-T204
##ata	I-T204
)	O
the	O
restricted	O
distribution	O
and	O
isolation	O
of	O
island	B-T082
endemic	O
##s	O
often	O
produces	O
unique	O
genetic	O
and	O
phenotypic	O
diversity	O
of	O
conservation	O
interest	O
to	O
management	O
agencies	B-T092
.	O
however	O
,	O
these	O
isolated	O
species	B-T170
,	O
especially	O
those	O
with	O
sensitive	O
life	O
history	O
traits	O
,	O
are	O
at	O
high	B-T033
risk	I-T033
for	O
the	O
adverse	B-T038
effects	I-T038
of	O
genetic	B-T038
drift	I-T038
and	O
habitat	B-T082
degradation	O
by	O
non	B-T204
-	I-T204
native	I-T204
wildlife	I-T204
.	O
here	O
,	O
we	O
study	B-T062
the	O
population	B-T098
genetic	O
diversity	O
,	O
structure	B-T082
,	O
and	O
stability	O
of	O
a	O
classic	O
[UNK]	O
island	B-T204
giant	I-T204
[UNK]	O
(	O
xa	B-T204
##nt	I-T204
##us	I-T204
##ia	I-T204
rivers	I-T204
##iana	I-T204
,	O
the	O
island	B-T204
night	I-T204
liz	I-T204
##ard	I-T204
)	O
on	O
san	B-T082
cle	I-T082
##ment	I-T082
##e	I-T082
island	I-T082
,	O
california	B-T082
following	O
the	O
removal	O
of	O
fer	B-T204
##al	I-T204
goats	I-T204
.	O
using	O
dna	B-T103
microsatellites	B-T103
,	O
we	O
found	O
that	O
this	O
population	B-T098
is	O
reasonably	O
genetically	O
robust	O
despite	O
historical	O
grazing	B-T038
,	O
with	O
similar	O
effective	O
population	O
sizes	O
and	O
genetic	O
diversity	O
metrics	O
across	O
all	O
sampling	O
locations	B-T082
irrespective	O
of	O
habitat	B-T082
type	O
and	O
degree	O
of	O
degradation	O
.	O
however	O
,	O
we	O
also	O
found	O
strong	O
site	B-T082
-	I-T082
specific	I-T082
patterns	B-T082
of	O
genetic	O
variation	O
and	O
low	O
genetic	O
diversity	O
compared	O
to	O
mainland	B-T204
congeners	I-T204
,	O
warrant	O
##ing	O
continued	O
special	O
management	O
as	O
an	O
island	B-T082
endemic	O
.	O
we	O
identify	O
both	O
high	O
and	O
low	O
elevation	B-T082
areas	I-T082
that	O
remain	O
valuable	O
rep	O
##osi	O
##tor	O
##ies	O
of	O
genetic	O
diversity	O
and	O
provide	O
a	O
case	B-T170
study	I-T170
for	O
other	O
low	O
-	O
dispersal	O
coastal	B-T082
organisms	O
in	O
the	O
face	O
of	O
future	O
climate	O
change	O
.	O

production	O
of	O
laccase	B-T103
by	O
coch	B-T204
##li	I-T204
##ob	I-T204
##olus	I-T204
sp	I-T204
.	I-T204
isolated	O
from	O
plastic	O
dum	O
##ped	O
soils	O
and	O
their	O
ability	O
to	O
degrade	O
low	B-T103
molecular	I-T103
weight	I-T103
pvc	I-T103
one	O
of	O
the	O
ut	O
##most	O
man	O
-	O
made	O
problems	O
faced	O
today	O
has	O
been	O
the	O
ever	O
-	O
increasing	O
plastic	O
waste	O
filling	O
the	O
world	O
.	O
it	O
accounts	O
for	O
an	O
estimated	O
20	O
-	O
30	O
%	O
(	O
by	O
volume	O
)	O
of	O
municipal	O
solid	O
waste	O
in	O
landfill	O
sites	O
worldwide	O
.	O
research	O
on	O
plastic	O
biodegradation	O
has	O
been	O
steadily	O
growing	O
over	O
the	O
past	O
four	O
decades	O
.	O
several	O
fungi	B-T204
have	O
been	O
identified	O
that	O
produce	O
enzymes	B-T103
capable	O
of	O
plastic	O
degradation	O
in	O
various	O
laboratory	O
conditions	O
.	O
this	O
paper	O
presents	O
a	O
study	O
that	O
determined	O
the	O
ability	O
of	O
fungi	B-T204
to	O
degrade	O
low	B-T103
molecular	I-T103
weight	I-T103
polyvinyl	I-T103
chloride	I-T103
(	O
pvc	B-T103
)	O
by	O
the	O
enzyme	B-T103
laccase	I-T103
.	O
we	O
have	O
isolated	O
a	O
fungal	B-T204
species	B-T170
,	O
coch	B-T204
##li	I-T204
##ob	I-T204
##olus	I-T204
sp	I-T204
.	I-T204
,	O
from	O
plastic	O
dum	O
##ped	O
soils	O
and	O
they	O
were	O
cultured	B-T058
on	O
cz	B-T103
##ap	I-T103
##ek	I-T103
dox	I-T103
agar	I-T103
sla	I-T103
##nts	I-T103
at	O
30	O
##°c	O
.	O
the	O
effectiveness	O
of	O
this	O
fungal	B-T204
species	B-T170
on	O
the	O
degradation	O
of	O
commercial	O
low	B-T103
molecular	I-T103
weight	I-T103
polyvinyl	I-T103
chloride	I-T103
(	O
pvc	B-T103
)	O
was	O
studied	O
under	O
laboratory	O
conditions	O
.	O
significant	O
differences	O
were	O
observed	O
from	O
the	O
ftir	B-T062
,	O
gc	B-T058
-	I-T058
ms	I-T058
,	O
and	O
sem	B-T058
results	O
in	O
between	O
control	O
and	O
coch	B-T204
##li	I-T204
##ob	I-T204
##olus	I-T204
sp	I-T204
.	I-T204
treated	O
pvc	B-T103
.	O

fingerprint	O
-	O
based	O
background	B-T033
check	I-T033
##s	I-T033
for	O
personal	B-T097
care	I-T097
workers	I-T097
:	O
stakeholder	B-T098
views	O
of	O
policy	B-T170
criteria	O
decision	B-T098
makers	I-T098
face	O
difficult	O
choices	O
when	O
task	O
##ed	O
with	O
identifying	O
and	O
implementing	O
appropriate	O
mechanisms	O
for	O
protecting	B-T033
the	O
elderly	B-T098
and	O
other	O
vulnerable	B-T033
adults	I-T033
from	O
abuse	O
.	O
a	O
pilot	B-T062
project	I-T062
involving	O
fingerprint	O
-	O
based	O
criminal	B-T098
history	O
background	B-T033
check	I-T033
##s	I-T033
for	O
personal	B-T097
care	I-T097
workers	I-T097
in	O
michigan	O
has	O
supplied	O
an	O
opportunity	O
to	O
examine	O
one	O
such	O
mechanism	O
.	O
in	O
conjunction	O
with	O
the	O
pilot	B-T062
project	I-T062
,	O
we	O
have	O
conducted	O
a	O
stakeholder	B-T097
analysis	B-T062
with	O
the	O
aim	O
of	O
informing	O
decision	B-T098
makers	I-T098
about	O
stakeholder	B-T098
perceptions	B-T038
of	O
standard	O
policy	B-T170
criteria	O
like	O
effectiveness	O
,	O
efficiency	O
,	O
and	O
equity	O
.	O
we	O
employed	O
focus	O
groups	O
and	O
a	O
web	B-T170
-	I-T170
based	I-T170
survey	I-T170
to	O
collect	B-T062
data	O
from	O
stakeholders	B-T098
.	O
while	O
stakeholders	B-T098
generally	O
see	O
fingerprint	O
-	O
based	O
background	B-T033
check	I-T033
##s	I-T033
for	O
personal	B-T097
care	I-T097
workers	I-T097
as	O
potentially	O
effective	O
and	O
as	O
a	O
net	O
benefit	O
,	O
they	O
also	O
point	O
to	O
a	O
variety	O
of	O
conting	O
##encies	O
.	O
they	O
also	O
recognize	O
difficulties	B-T033
and	O
constraints	O
for	O
government	B-T092
involvement	O
.	O
this	O
preliminary	B-T062
analysis	I-T062
provides	O
solid	O
foundation	O
##al	O
information	O
for	O
decision	B-T098
makers	I-T098
and	O
for	O
more	O
extensive	O
benefit	O
-	O
cost	O
analysis	O
.	O

closing	O
the	O
loop	O
in	O
adults	O
,	O
children	O
and	O
adolescents	O
with	O
suboptimal	B-T033
##ly	I-T033
controlled	I-T033
type	I-T033
1	I-T033
diabetes	I-T033
under	O
free	O
living	O
conditions	O
:	O
a	O
psychosocial	O
subst	B-T062
##ud	I-T062
##y	I-T062
the	O
objective	O
was	O
to	O
explore	O
psychosocial	B-T033
experiences	I-T033
of	O
closed	B-T074
loop	I-T074
technology	I-T074
for	O
adults	O
,	O
children	O
,	O
and	O
adolescents	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
and	O
their	O
parents	O
taking	O
part	O
in	O
two	O
multicenter	B-T062
,	O
free	O
-	O
living	O
,	O
randomized	B-T062
crossover	B-T062
home	I-T062
studies	I-T062
.	O
participants	B-T098
using	O
insulin	B-T074
pump	I-T074
therapy	B-T058
were	O
randomized	B-T062
to	O
either	O
12	O
weeks	O
of	O
automated	O
closed	O
-	O
loop	O
glucose	B-T103
control	I-T103
,	O
then	O
12	O
weeks	O
of	O
sensor	O
augmented	O
insulin	B-T074
pump	I-T074
therapy	B-T058
(	O
open	O
loop	O
)	O
,	O
or	O
vice	O
versa	O
.	O
closed	O
loop	O
was	O
used	O
for	O
24	O
hours	O
by	O
adults	O
and	O
overnight	O
only	O
by	O
children	O
and	O
adolescents	O
.	O
participants	B-T098
completed	O
the	O
diabetes	B-T170
technology	I-T170
questionnaire	I-T170
(	O
dt	B-T170
##q	I-T170
)	O
periodically	O
and	O
shared	O
their	O
views	B-T082
in	O
semistructured	O
interviews	O
.	O
this	O
analysis	B-T062
characterizes	O
the	O
impact	O
of	O
the	O
technology	O
,	O
positive	B-T033
and	O
negative	O
aspects	O
of	O
living	O
with	O
the	O
device	B-T074
,	O
alongside	O
participants	B-T098
'	O
expectations	O
,	O
hope	B-T038
##s	I-T038
,	O
and	O
anxi	B-T033
##eties	I-T033
.	O
participants	B-T098
were	O
32	O
adults	O
,	O
age	O
38	O
.	O
6	O
±	O
9	O
.	O
6	O
years	O
,	O
55	O
%	O
male	O
,	O
and	O
26	O
children	O
,	O
mean	O
age	O
12	O
years	O
(	O
range	O
6	O
-	O
18	O
years	O
)	O
,	O
54	O
%	O
male	O
.	O
dt	B-T170
##q	I-T170
results	O
indicated	O
moderately	O
favorable	O
impact	O
of	O
,	O
and	O
satisfaction	O
with	O
,	O
both	O
open	O
and	O
closed	O
loop	O
interventions	B-T058
,	O
but	O
little	O
evidence	O
of	O
a	O
comparative	O
advantage	O
of	O
either	O
.	O
key	O
positive	B-T033
themes	I-T033
included	O
perceived	O
improved	B-T103
blood	I-T103
glucose	I-T103
control	I-T103
,	O
improved	B-T033
general	I-T033
well	I-T033
-	I-T033
being	I-T033
,	O
particularly	O
on	O
waking	B-T038
,	O
improved	B-T038
sleep	I-T038
,	O
reduced	O
burden	O
of	O
diabetes	B-T038
,	O
and	O
visibility	O
of	O
data	O
.	O
key	O
negative	O
themes	O
included	O
having	O
to	O
carry	O
around	O
the	O
equipment	O
and	O
disl	O
##ike	O
of	O
the	O
pump	B-T074
and	O
second	O
cannula	B-T074
(	O
ie	O
,	O
sensor	O
)	O
inserted	O
.	O
overall	O
,	O
participants	B-T098
reported	O
a	O
positive	B-T033
experience	O
of	O
the	O
closed	B-T074
loop	I-T074
technology	I-T074
.	O
results	O
are	O
consistent	O
with	O
previous	O
research	O
with	O
size	B-T082
of	O
equipment	O
continuing	O
to	O
be	O
a	O
problem	B-T033
.	O
progress	O
is	O
being	O
made	O
in	O
the	O
usability	O
of	O
the	O
closed	B-T074
-	I-T074
loop	I-T074
system	I-T074
.	O

effects	O
of	O
environmental	B-T082
factors	O
and	O
metallic	B-T103
electrodes	B-T074
on	O
ac	O
electrical	O
conduction	O
through	O
dna	B-T103
molecule	I-T103
deoxyribonucleic	B-T103
acid	I-T103
(	I-T103
dna	I-T103
)	I-T103
is	O
one	O
of	O
the	O
best	O
candidate	O
materials	O
for	O
various	O
device	O
applications	O
such	O
as	O
in	O
electrodes	B-T074
for	O
rech	O
##arge	O
##able	O
batteries	O
,	O
biosensors	O
,	O
molecular	B-T074
electronics	I-T074
,	O
medical	B-T074
-	O
and	O
biomedical	B-T074
-	O
applications	O
etc	O
.	O
hence	O
,	O
it	O
is	O
worth	O
##while	O
to	O
examine	O
the	O
mechanism	O
of	O
charge	O
transport	O
in	O
the	O
dna	B-T103
molecule	I-T103
,	O
however	O
,	O
still	O
a	O
question	O
without	O
a	O
clear	O
answer	O
is	O
dna	B-T103
a	O
molecular	O
conducting	O
material	O
(	O
wire	O
)	O
,	O
semiconductor	O
,	O
or	O
insulator	O
?	O
the	O
answer	O
,	O
after	O
the	O
published	O
data	O
,	O
is	O
still	O
ambiguous	O
without	O
any	O
confirmed	O
and	O
clear	O
scientific	O
answer	O
.	O
dna	B-T103
is	O
found	O
to	O
be	O
always	O
surrounded	O
with	O
different	O
electric	O
charges	O
,	O
ions	B-T103
,	O
and	O
dipole	O
##s	O
.	O
these	O
surrounding	O
charges	O
and	O
electric	O
barrier	O
(	O
s	O
)	O
due	O
to	O
metallic	B-T103
electrodes	B-T074
(	O
as	O
environmental	B-T082
factors	O
(	O
efs	O
)	O
)	O
play	O
a	O
substantial	O
role	O
when	O
measuring	O
the	O
electrical	O
conductivity	O
through	O
λ	B-T103
-	I-T103
double	I-T103
helix	I-T103
(	I-T103
dna	I-T103
)	I-T103
molecule	I-T103
suspended	O
between	O
metallic	B-T103
electrodes	B-T074
.	O
we	O
found	O
that	O
strong	O
frequency	O
dependence	O
of	O
ac	O
-	O
complex	O
conductivity	O
comes	O
from	O
the	O
electrical	O
conduction	O
of	O
efs	O
.	O
this	O
leads	O
to	O
superimp	O
##osing	O
serious	O
incorrect	O
experimental	B-T062
data	O
to	O
measured	O
ones	O
.	O
at	O
1	O
mhz	O
,	O
we	O
carried	O
out	O
a	O
first	O
control	O
experiment	B-T062
on	O
electrical	O
conductivity	O
with	O
and	O
without	O
the	O
presence	O
of	O
dna	B-T103
molecule	I-T103
.	O
if	O
there	O
are	O
possible	O
electrical	O
conduction	O
due	O
to	O
stra	O
##y	O
ions	B-T103
and	O
contribution	O
of	O
substrate	O
,	O
we	O
will	O
detected	O
them	O
.	O
this	O
control	O
experiment	B-T062
revealed	O
that	O
there	O
is	O
an	O
important	O
role	O
played	O
by	O
the	O
environmental	B-T082
-	O
charges	O
around	O
dna	B-T103
molecule	I-T103
and	O
any	O
experiment	B-T062
should	O
consider	O
this	O
role	O
.	O
we	O
have	O
succeeded	O
to	O
measure	O
both	O
electrical	O
conductivity	O
due	O
to	O
efs	O
(	O
σ	O
env	O
)	O
and	O
electrical	O
conductivity	O
due	O
to	O
dna	B-T103
molecule	I-T103
(	O
σ	B-T103
dna	I-T103
)	O
independently	O
by	O
carrying	O
the	O
measurements	O
at	O
different	O
dna	B-T103
-	O
lengths	O
and	O
subtr	O
##acting	O
the	O
data	O
.	O
we	O
carried	O
out	O
measurements	O
as	O
a	O
function	O
of	O
frequency	O
(	O
f	O
)	O
and	O
temperature	O
(	O
t	O
)	O
in	O
the	O
ranges	O
0	O
.	O
1	O
hz	O
<	O
f	O
<	O
1	O
mhz	O
and	O
288	O
k	O
<	O
t	O
<	O
343	O
k	O
.	O
the	O
measured	O
conductivity	O
(	O
σ	O
mes	O
)	O
port	O
##ra	O
##ys	O
a	O
metal	B-T103
-	O
like	O
behavior	O
at	O
high	O
frequencies	O
near	O
1	O
mhz	O
.	O
however	O
,	O
we	O
found	O
that	O
σ	B-T103
dna	I-T103
was	O
far	O
from	O
this	O
behavior	O
because	O
the	O
conduction	O
due	O
to	O
efs	O
superimp	O
##oses	O
σ	B-T103
dna	I-T103
,	O
in	O
particular	O
at	O
low	O
frequencies	O
.	O
by	O
measuring	O
the	O
electrical	O
conductivity	O
at	O
different	O
lengths	O
:	O
40	O
,	O
60	O
,	O
80	O
,	O
and	O
100	O
nm	O
,	O
we	O
have	O
succeeded	O
not	O
only	O
to	O
separate	O
the	O
electrical	O
conduction	O
of	O
the	O
dna	B-T103
molecule	I-T103
from	O
all	O
efs	O
effects	O
that	O
surround	O
the	O
molecule	B-T103
,	O
but	O
also	O
to	O
present	O
accurate	O
values	O
of	O
σ	B-T103
dna	I-T103
and	O
the	O
dielectric	O
constant	O
of	O
the	O
molecule	O
ε	B-T103
'	I-T103
dna	I-T103
as	O
a	O
function	O
of	O
temperature	O
and	O
frequency	O
.	O
furthermore	O
,	O
in	O
order	O
to	O
explain	O
these	O
data	O
,	O
we	O
present	O
a	O
model	O
describing	O
the	O
electrical	O
conduction	O
through	O
dna	B-T103
molecule	I-T103
:	O
dna	B-T103
is	O
a	O
classical	O
semiconductor	O
with	O
charges	O
,	O
dipole	O
##s	O
and	O
ions	B-T103
that	O
result	O
in	O
creation	O
of	O
localized	O
energy	O
-	O
states	O
(	O
less	O
)	O
in	O
the	O
extended	O
bands	O
and	O
in	O
the	O
energy	O
gap	O
of	O
the	O
dna	B-T103
molecule	I-T103
.	O
this	O
model	O
explains	O
clearly	O
the	O
mechanism	O
of	O
charge	O
transfer	O
mechanism	O
in	O
the	O
dna	B-T103
,	O
and	O
it	O
shed	O
##s	O
light	O
on	O
why	O
the	O
charge	O
transfer	O
through	O
the	O
dna	B-T103
can	O
lead	O
to	O
insula	O
##ting	O
,	O
semiconduc	O
##ting	O
,	O
or	O
metallic	B-T103
behavior	O
on	O
the	O
same	O
time	O
.	O
the	O
model	O
considers	O
charges	O
on	O
dna	B-T103
,	O
in	O
the	O
extended	O
bands	O
,	O
either	O
could	O
be	O
free	O
to	O
move	O
under	O
electric	O
field	O
or	O
localized	O
in	O
potential	O
wells	O
/	O
hill	O
##s	O
.	O
localization	O
of	O
charges	O
in	O
dna	B-T103
is	O
an	O
intrinsic	O
structural	B-T082
-	O
property	O
of	O
this	O
solit	O
##air	O
##e	O
molecule	O
.	O
at	O
all	O
temperatures	O
,	O
the	O
expected	O
increase	O
in	O
thermal	O
-	O
induced	O
charge	O
is	O
attributed	O
to	O
the	O
del	O
##ocalization	O
of	O
holes	O
(	O
or	O
/	O
and	O
electrons	B-T103
)	O
in	O
potential	O
hill	O
##s	O
(	O
or	O
/	O
and	O
potential	O
wells	O
)	O
which	O
accurately	O
accounts	O
for	O
the	O
total	O
electric	O
and	O
dielectric	O
behavior	O
through	O
dna	B-T103
molecule	I-T103
.	O
we	O
succeeded	O
to	O
fit	O
the	O
experiment	B-T062
al	O
data	O
to	O
the	O
proposed	O
model	O
with	O
reasonable	O
magnitudes	O
of	O
potential	O
hill	O
##s	O
/	O
wells	O
that	O
are	O
in	O
the	O
energy	O
range	O
from	O
0	O
.	O
06	O
##8	O
ev	O
.	O

comparison	O
of	O
leishmania	B-T204
typing	B-T058
results	B-T033
obtained	O
from	O
16	O
european	B-T082
clinical	B-T092
laboratories	I-T092
in	O
2014	O
leishmaniasis	B-T038
is	O
endemic	O
in	O
southern	B-T082
europe	I-T082
,	O
and	O
in	O
other	O
european	B-T082
countries	B-T082
cases	O
are	O
diagnosed	B-T033
in	O
travel	B-T097
##lers	I-T097
who	O
have	O
visited	O
affected	B-T033
areas	I-T033
both	O
within	B-T082
the	O
continent	B-T082
and	O
beyond	O
.	O
prompt	O
and	O
accurate	O
diagnosis	B-T033
poses	O
a	O
challenge	O
in	O
clinical	B-T170
practice	I-T170
in	O
europe	B-T082
.	O
different	O
methods	B-T170
exist	O
for	O
identification	O
of	O
the	O
infecting	B-T033
leishmania	B-T204
species	B-T170
.	O
sixteen	O
clinical	B-T092
laboratories	I-T092
in	O
10	O
european	B-T082
countries	B-T082
,	O
plus	O
israel	B-T082
and	O
turkey	B-T082
,	O
conducted	O
a	O
study	B-T062
to	O
assess	O
their	O
genotyping	B-T058
performance	O
.	O
dna	B-T103
from	O
21	O
prom	B-T204
##astig	I-T204
##ote	I-T204
cultures	I-T204
of	O
13	O
species	B-T170
was	O
analysed	B-T062
blind	O
##ly	O
by	O
the	O
routinely	O
used	O
typing	B-T058
method	B-T170
.	O
five	O
different	O
molecular	B-T103
targets	I-T103
were	O
used	O
,	O
which	O
were	O
analysed	B-T062
with	O
pcr	B-T062
-	I-T062
based	I-T062
methods	B-T170
.	O
different	O
levels	O
of	O
identification	O
were	O
achieved	B-T033
,	O
and	O
either	O
the	O
leishmania	B-T204
subgen	O
##us	O
,	O
species	B-T170
complex	O
,	O
or	O
actual	O
species	B-T170
were	O
reported	B-T170
.	O
the	O
overall	O
error	O
rate	O
of	O
strains	O
placed	O
in	O
the	O
wrong	O
complex	O
or	O
species	B-T170
was	O
8	O
.	O
5	O
%	O
.	O
various	O
reasons	O
for	O
incorrect	O
typing	B-T058
were	O
identified	O
.	O
the	O
study	B-T062
shows	O
there	O
is	O
considerable	O
room	O
for	O
improvement	O
and	O
standard	B-T062
##isation	I-T062
of	O
leishmania	B-T204
typing	B-T058
.	O
the	O
use	O
of	O
well	O
validated	B-T062
standard	O
operating	O
procedures	O
is	O
recommended	O
,	O
covering	O
testing	O
,	O
interpretation	B-T170
,	O
and	O
reporting	B-T058
guidelines	B-T170
.	O
application	O
of	O
the	O
internal	B-T082
transcribed	O
spacer	B-T103
1	I-T103
of	O
the	O
rdna	B-T103
array	O
should	O
be	O
restricted	O
to	O
old	O
world	O
samples	O
,	O
while	O
the	O
heat	B-T017
-	I-T017
shock	I-T017
protein	I-T017
70	I-T017
gene	I-T017
and	O
the	O
mini	B-T103
-	I-T103
exon	I-T103
can	O
be	O
applied	O
globally	O
.	O

multi	O
-	O
component	O
model	O
of	O
intramural	B-T038
hematoma	I-T038
a	O
novel	O
multi	O
-	O
component	O
model	O
is	O
introduced	O
for	O
studying	B-T062
interaction	O
between	O
blood	B-T038
flow	I-T038
and	O
deform	B-T033
##ing	I-T033
aortic	B-T017
wall	I-T017
with	O
intramural	B-T038
hematoma	I-T038
(	O
im	B-T038
##h	I-T038
)	O
.	O
the	O
aortic	B-T017
wall	I-T017
is	O
simulated	B-T062
by	O
a	O
composite	O
structure	O
subm	O
##ode	O
##l	O
representing	O
material	O
properties	O
of	O
the	O
three	O
main	O
wall	B-T017
layers	I-T017
.	O
the	O
im	B-T038
##h	I-T038
is	O
described	O
by	O
a	O
por	O
##oe	O
##lastic	O
##ity	O
subm	O
##ode	O
##l	O
which	O
takes	O
into	O
account	O
both	O
the	O
pressure	O
inside	O
hematoma	B-T038
and	O
its	O
deformation	B-T033
.	O
the	O
subm	O
##ode	O
##l	O
of	O
the	O
hematoma	B-T038
is	O
fully	O
coupled	O
with	O
the	O
aortic	O
subm	O
##ode	O
##l	O
as	O
well	O
as	O
with	O
the	O
subm	O
##ode	O
##l	O
of	O
the	O
pulsatile	O
blood	O
flow	O
.	O
model	B-T062
simulations	I-T062
are	O
used	O
to	O
investigate	O
the	O
relation	O
between	O
the	O
peak	O
wall	O
stress	O
,	O
hematoma	B-T038
thickness	O
and	O
permeability	O
in	O
patients	O
of	O
different	O
age	O
.	O
the	O
results	O
indicate	O
that	O
an	O
increase	O
in	O
hematoma	B-T038
thickness	O
leads	O
to	O
larger	O
wall	B-T033
stress	I-T033
,	O
which	O
is	O
in	O
agreement	O
with	O
clinical	B-T170
data	I-T170
.	O
further	O
simulations	B-T062
demonstrate	O
that	O
a	O
hematoma	B-T038
with	O
smaller	O
permeability	O
results	O
in	O
larger	O
wall	B-T033
stress	I-T033
,	O
suggesting	O
that	O
blood	B-T038
coagulation	I-T038
in	O
hematoma	B-T038
might	O
increase	O
its	O
mechanical	B-T033
stability	I-T033
.	O
this	O
is	O
in	O
agreement	O
with	O
previous	O
experimental	O
observations	B-T062
of	O
coagulation	B-T038
having	O
a	O
beneficial	O
effect	O
on	O
the	O
condition	O
of	O
a	O
patient	O
with	O
the	O
im	B-T038
##h	I-T038
.	O

the	O
antineoplastic	B-T103
drug	I-T103
,	O
trastuzumab	B-T103
,	O
dysreg	B-T033
##ulates	I-T033
metabolism	B-T038
in	O
ips	B-T017
##c	I-T017
-	O
derived	O
cardiomyocytes	B-T017
the	O
targeted	B-T058
erbb2	I-T058
therapy	I-T058
,	O
trastuzumab	B-T103
,	O
has	O
had	O
a	O
tremendous	O
impact	O
on	O
management	B-T058
of	O
patients	O
with	O
her2	B-T038
+	I-T038
breast	I-T038
cancer	I-T038
,	O
leading	O
to	O
development	O
and	O
increased	O
use	O
of	O
further	O
her2	B-T103
targeted	B-T058
therapies	I-T058
.	O
the	O
major	O
clinical	O
side	B-T038
effect	I-T038
is	O
cardiotoxicity	B-T037
but	O
the	O
mechanism	O
is	O
largely	O
unknown	O
.	O
on	O
the	O
basis	O
that	O
gene	B-T038
expression	I-T038
is	O
known	O
to	O
be	O
altered	O
in	O
multiple	O
models	B-T170
of	O
heart	B-T038
failure	I-T038
,	O
we	O
examined	O
differential	B-T038
gene	I-T038
expression	I-T038
of	O
ips	B-T017
##c	I-T017
-	O
derived	O
cardiomyocytes	B-T017
treated	O
at	O
day	O
11	O
with	O
the	O
erbb2	B-T103
targeted	O
monoclonal	B-T103
antibody	I-T103
,	O
trastuzumab	B-T103
for	O
48	O
h	O
and	O
the	O
small	B-T103
molecule	I-T103
tyrosine	I-T103
kinase	I-T103
inhibitor	I-T103
of	O
egfr	B-T103
and	O
erbb2	B-T103
.	O
transcriptome	B-T058
sequencing	I-T058
was	O
performed	O
on	O
four	O
replicates	O
from	O
each	O
group	O
(	O
48	O
h	O
untreated	O
,	O
48	O
h	O
trastuzumab	B-T103
and	O
48	O
h	O
lapa	B-T103
##tinib	I-T103
)	O
and	O
differential	B-T038
gene	I-T038
expression	I-T038
analyses	B-T062
were	O
performed	O
on	O
each	O
treatment	O
group	O
relative	O
to	O
untreated	O
cardiomyocytes	B-T017
.	O
51	O
##7	O
and	O
135	O
##8	O
genes	B-T017
were	O
differentially	B-T038
expressed	I-T038
,	O
p	O
<	O
0	O
.	O
05	O
,	O
respectively	O
in	O
cardiomyocytes	B-T017
treated	O
with	O
trastuzumab	B-T103
and	O
lapa	B-T103
##tinib	I-T103
.	O
gene	B-T170
ontology	I-T170
analyses	B-T062
revealed	O
in	O
cardiomyocytes	B-T017
treated	O
with	O
trastuzumab	B-T103
,	O
significant	O
down	B-T038
-	I-T038
regulation	I-T038
of	O
genes	B-T017
involved	O
in	O
small	B-T038
molecule	I-T038
metabolism	I-T038
(	O
p	O
=	O
3	O
.	O
22	O
—	O
10	O
(	O
-	O
9	O
)	O
)	O
and	O
cholesterol	B-T103
(	O
p	O
=	O
0	O
.	O
01	O
)	O
and	O
sterol	B-T103
(	O
p	O
=	O
0	O
.	O
03	O
)	O
processing	O
.	O
we	O
next	O
measured	O
glucose	B-T038
uptake	I-T038
and	O
lactate	B-T103
production	O
in	O
ips	B-T017
##c	I-T017
-	O
derived	O
cardiomyocytes	B-T017
13	O
days	O
post	O
-	O
plating	O
,	O
treated	O
with	O
trastuzumab	B-T103
up	O
to	O
96	O
h	O
.	O
we	O
observed	O
significantly	O
decreased	O
glucose	B-T038
uptake	I-T038
from	O
the	O
media	B-T103
of	O
ips	B-T017
##c	I-T017
-	O
derived	O
cardiomyocytes	B-T017
treated	O
with	O
trastuzumab	B-T103
as	O
early	O
as	O
24	O
h	O
(	O
p	O
=	O
0	O
.	O
001	O
)	O
and	O
consistently	O
up	O
to	O
96	O
h	O
(	O
p	O
=	O
0	O
.	O
03	O
)	O
.	O
our	O
study	B-T062
suggests	O
dysregulation	B-T033
of	O
cardiac	B-T017
gene	B-T038
expression	I-T038
and	O
metabolism	B-T038
as	O
key	O
elements	O
of	O
erbb2	B-T017
signaling	B-T038
that	O
could	O
potentially	O
be	O
early	O
biomarkers	B-T201
of	O
cardiotoxicity	B-T037
.	O

development	O
of	O
a	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
method	O
for	O
quantitative	O
analysis	O
of	O
trace	O
d	B-T103
-	I-T103
amino	I-T103
acids	I-T103
d	B-T103
-	I-T103
amino	I-T103
acids	I-T103
have	O
recently	O
attracted	O
much	O
attention	B-T038
in	O
various	O
research	B-T062
fields	I-T062
including	O
medical	O
,	O
clinical	O
and	O
food	O
industry	O
due	O
to	O
their	O
important	O
biological	B-T038
functions	I-T038
that	O
differ	O
from	O
l	B-T103
-	I-T103
amino	I-T103
acid	I-T103
.	O
most	O
chiral	O
amino	B-T103
acid	I-T103
separation	O
techniques	O
require	O
complicated	O
derivatization	O
procedures	O
in	O
order	O
to	O
achieve	O
the	O
desirable	O
chromatographic	O
behavior	O
and	O
detect	B-T033
##ability	I-T033
.	O
thus	O
,	O
the	O
aim	O
of	O
this	O
research	B-T062
is	O
to	O
develop	O
a	O
highly	O
sensitive	O
analytical	O
method	O
for	O
the	O
enanti	O
##ose	O
##par	O
##ation	O
of	O
chiral	O
amino	B-T103
acids	I-T103
without	O
any	O
derivatization	O
process	O
using	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
(	O
lc	B-T058
-	I-T058
ms	I-T058
/	I-T058
ms	I-T058
)	O
.	O
by	O
optimizing	O
ms	O
/	O
ms	O
parameters	O
,	O
we	O
established	O
a	O
quantification	O
method	O
that	O
allowed	O
the	O
simultaneous	O
analysis	B-T062
of	O
18	O
d	B-T103
-	I-T103
amino	I-T103
acids	I-T103
with	O
high	O
sensitivity	O
and	O
reproducibility	O
.	O
additionally	O
,	O
we	O
applied	O
the	O
method	O
to	O
food	O
sample	O
(	O
vine	B-T103
##gar	I-T103
)	O
for	O
the	O
validation	B-T062
,	O
and	O
successfully	O
quantified	O
trace	O
levels	O
of	O
d	B-T103
-	I-T103
amino	I-T103
acids	I-T103
in	O
samples	O
.	O
these	O
results	B-T033
demonstrated	O
the	O
applicability	O
and	O
feasibility	O
of	O
the	O
lc	B-T058
-	I-T058
ms	I-T058
/	I-T058
ms	I-T058
method	O
as	O
a	O
novel	O
,	O
effective	O
tool	O
for	O
d	B-T103
-	I-T103
amino	I-T103
acid	I-T103
measurement	O
in	O
various	O
biological	O
samples	O
.	O

a	O
case	O
of	O
acute	O
hepatitis	B-T038
e	I-T038
infection	I-T038
in	O
a	O
patient	O
with	O
non	B-T038
-	I-T038
hodgkin	I-T038
lymphoma	I-T038
treated	B-T058
successfully	O
with	O
ribavirin	B-T103
we	O
present	O
the	O
case	O
of	O
a	O
man	B-T098
who	O
,	O
following	O
immunosuppressive	B-T058
treatment	I-T058
for	O
non	B-T038
-	I-T038
hodgkin	I-T038
lymphoma	I-T038
,	O
became	O
infected	B-T033
with	O
viral	B-T038
hepatitis	I-T038
e	I-T038
.	O
acute	O
hepatitis	B-T038
e	I-T038
virus	I-T038
infection	I-T038
should	O
be	O
considered	O
in	O
patients	O
with	O
der	O
##anged	O
liver	B-T038
function	I-T038
on	O
a	O
background	O
of	O
haematological	B-T038
malignancies	I-T038
or	O
immunosuppression	B-T038
,	O
even	O
without	O
travel	O
to	O
endemic	B-T082
regions	I-T082
.	O
whilst	O
clearance	O
is	O
usually	O
spontaneous	O
in	O
immune	O
-	O
competent	O
individuals	B-T098
,	O
these	O
at	O
-	O
risk	O
groups	O
may	O
develop	O
a	O
more	O
complicated	O
and	O
protracted	B-T033
disease	I-T033
course	I-T033
.	O
thus	O
awareness	O
is	O
important	O
as	O
additional	O
treatment	B-T058
with	O
ribavirin	B-T103
or	O
pegylated	B-T103
interferon	I-T103
may	O
be	O
required	O
,	O
as	O
in	O
this	O
case	O
,	O
in	O
order	O
to	O
help	O
achieve	O
eradication	B-T058
.	O

synchronous	O
vitell	B-T103
##ogenin	I-T103
expression	B-T038
and	O
sexual	B-T038
maturation	I-T038
during	O
migration	B-T038
are	O
negatively	B-T033
correlated	O
with	O
juvenile	B-T103
hormone	I-T103
levels	O
in	O
my	B-T204
##thi	I-T204
##mn	I-T204
##a	I-T204
separ	I-T204
##ata	I-T204
annual	O
migration	B-T038
of	O
pests	O
between	O
different	O
seasonal	O
habitats	B-T082
can	O
lead	O
to	O
serious	O
crop	B-T204
damage	O
.	O
reproductive	B-T038
imm	O
##aturity	O
is	O
generally	O
associated	O
with	O
the	O
migratory	B-T038
process	I-T038
(	O
o	B-T038
##ogenesis	I-T038
-	O
flight	B-T038
syndrome	I-T038
)	O
,	O
but	O
the	O
mechanism	O
of	O
reproductive	O
development	O
during	O
migration	B-T038
varies	O
unpredict	B-T033
##ably	I-T033
.	O
here	O
,	O
the	O
vitell	B-T017
##ogenin	I-T017
gene	I-T017
(	O
msv	B-T017
##g	I-T017
)	O
and	O
three	O
key	O
regulatory	B-T017
enzyme	I-T017
genes	I-T017
(	O
ms	B-T017
##j	I-T017
##ham	I-T017
##t	I-T017
,	O
ms	B-T017
##j	I-T017
##he	I-T017
##h	I-T017
and	O
ms	B-T017
##j	I-T017
##he	I-T017
)	O
related	O
to	O
juvenile	B-T103
hormone	I-T103
(	O
jh	B-T103
)	O
synthesis	O
and	O
degradation	B-T038
were	O
identified	O
and	O
characterized	O
in	O
my	B-T204
##thi	I-T204
##mn	I-T204
##a	I-T204
separ	I-T204
##ata	I-T204
.	O
the	O
relative	B-T038
expression	I-T038
of	O
msv	B-T017
##g	I-T017
varied	O
significantly	O
in	O
response	O
to	O
seasonal	O
changes	O
and	O
was	O
significantly	O
correlated	O
with	O
stages	O
of	O
ovarian	B-T038
development	I-T038
.	O
the	O
relatively	O
low	O
levels	O
of	O
jh	B-T103
titer	O
did	O
not	O
differ	O
significantly	O
in	O
male	O
moth	B-T204
##s	I-T204
but	O
slightly	O
increased	O
in	O
female	B-T098
adults	I-T098
during	O
the	O
migratory	B-T038
season	I-T038
,	O
which	O
was	O
consistent	O
with	O
changes	O
in	O
mrna	B-T103
levels	O
for	O
ms	B-T017
##j	I-T017
##ham	I-T017
##t	I-T017
,	O
ms	B-T017
##j	I-T017
##he	I-T017
##h	I-T017
and	O
ms	B-T017
##j	I-T017
##he	I-T017
.	O
jh	B-T103
titer	O
was	O
negatively	B-T033
associated	O
with	O
relative	O
seasonal	O
levels	O
of	O
vitell	B-T103
##ogenin	I-T103
mrna	B-T103
transcripts	B-T103
and	O
with	O
ovarian	B-T038
development	I-T038
in	O
migrating	B-T038
m	B-T204
.	I-T204
separ	I-T204
##ata	I-T204
.	O
the	O
synchrony	O
of	O
msv	B-T038
##g	I-T038
expression	I-T038
with	O
sexual	B-T038
maturation	I-T038
highlighted	O
the	O
potential	O
of	O
msv	B-T017
##g	I-T017
transcript	B-T103
levels	O
to	O
serve	O
as	O
an	O
index	B-T170
to	O
monitor	O
the	O
adult	O
reproductive	B-T038
status	O
.	O
in	O
addition	O
,	O
the	O
level	O
of	O
jh	B-T103
and	O
sexual	B-T038
maturity	I-T038
were	O
correlated	O
with	O
the	O
extent	O
of	O
jh	B-T103
in	O
regulating	B-T038
the	O
msv	B-T038
##g	I-T038
expression	I-T038
and	O
reproduction	B-T038
during	O
seasonal	O
northern	B-T038
and	I-T038
southern	I-T038
migration	B-T038
.	O

resistance	O
exercise	O
in	O
pregnancy	B-T038
and	O
outcome	B-T033
as	O
the	O
health	O
benefits	O
of	O
exercise	O
are	O
increasingly	O
recognized	O
,	O
the	O
traditional	B-T058
advice	I-T058
to	O
rest	O
during	O
pregnancy	B-T038
has	O
changed	O
toward	O
a	O
more	O
healthy	O
and	O
active	O
pregnancy	B-T038
,	O
therefore	O
different	O
forms	O
of	O
exercise	O
have	O
been	O
integrated	O
into	O
the	O
life	O
of	O
the	O
pregnant	B-T098
woman	I-T098
.	O
although	O
the	O
benefits	O
of	O
using	O
a	O
combination	O
of	O
resistance	O
and	O
aerobic	B-T058
exercises	I-T058
are	O
not	O
yet	O
determined	O
,	O
studies	B-T062
about	O
resistance	O
and	O
strengthen	O
training	O
programs	O
are	O
few	O
although	O
no	B-T033
adverse	I-T033
outcomes	B-T033
were	O
reported	O
.	O

cdc	B-T103
##45	I-T103
-	O
induced	O
loading	O
of	O
human	B-T103
rpa	I-T103
onto	O
single	B-T103
-	I-T103
stranded	I-T103
dna	I-T103
cell	B-T103
division	I-T103
cycle	I-T103
protein	I-T103
45	I-T103
(	O
cdc	B-T103
##45	I-T103
)	O
is	O
an	O
essential	O
component	O
of	O
the	O
eukaryotic	B-T204
replicative	O
dna	B-T103
helicase	I-T103
.	O
we	O
found	O
that	O
human	B-T103
cdc	I-T103
##45	I-T103
forms	O
a	O
complex	B-T103
with	O
the	O
single	B-T103
-	I-T103
stranded	I-T103
dna	I-T103
(	I-T103
ssdna	I-T103
)	I-T103
binding	I-T103
protein	I-T103
rpa	I-T103
.	O
moreover	O
,	O
it	O
actively	O
loads	O
rpa	B-T103
onto	O
nascent	O
ssdna	B-T103
.	O
pull	B-T058
-	I-T058
down	I-T058
assays	I-T058
and	O
surface	B-T062
plasmon	I-T062
resonance	I-T062
studies	I-T062
revealed	O
that	O
cdc	B-T103
##45	I-T103
-	O
bound	B-T038
rpa	B-T103
complexed	B-T103
with	O
ssdna	B-T103
in	O
the	O
8	O
-	O
10	O
nucleotide	B-T038
binding	I-T038
mode	O
,	O
but	O
dissociated	B-T038
when	O
rpa	B-T103
covered	O
a	O
30	B-T082
-	I-T082
mer	I-T082
.	O
real	B-T058
-	I-T058
time	I-T058
analysis	I-T058
of	O
rpa	B-T103
-	O
ssdna	B-T103
binding	B-T038
demonstrated	O
that	O
cdc	B-T103
##45	I-T103
catalytically	O
loaded	O
rpa	B-T103
onto	O
ssdna	B-T103
.	O
this	O
placement	O
reaction	O
required	O
physical	O
contacts	O
of	O
cdc	B-T103
##45	I-T103
with	O
the	O
rpa	B-T082
##70	I-T082
##a	I-T082
subd	I-T082
##oma	I-T082
##in	I-T082
.	O
our	O
results	O
imply	O
that	O
cdc	B-T103
##45	I-T103
controlled	O
stabilization	B-T058
of	O
the	O
8	O
-	O
nt	B-T103
rpa	B-T103
binding	B-T038
mode	O
,	O
the	O
subsequent	O
rpa	B-T103
transition	O
into	O
30	B-T082
-	I-T082
mer	I-T082
mode	O
and	O
facilitated	O
an	O
ordered	O
binding	B-T038
to	O
ssdna	B-T103
.	O
we	O
propose	O
that	O
a	O
cdc	B-T103
##45	I-T103
-	O
mediated	O
loading	O
guarantee	O
##s	O
a	O
sea	O
##ml	O
##ess	O
deposition	O
of	O
rpa	B-T103
on	O
newly	O
emerging	O
ssdna	B-T103
at	O
the	O
nascent	O
replication	B-T017
fork	I-T017
.	O

incidence	O
and	O
effect	O
of	O
variant	O
histology	B-T091
on	O
oncological	O
outcomes	O
in	O
patients	O
with	O
bladder	B-T038
cancer	I-T038
treated	O
with	O
radical	B-T058
cystectomy	I-T058
we	O
sought	O
to	O
describe	O
incidence	O
of	O
histological	O
variants	O
after	O
radical	B-T058
cystectomy	I-T058
(	O
rc	B-T058
)	O
due	O
to	O
bladder	B-T038
cancer	I-T038
(	O
bca	B-T038
)	O
.	O
moreover	O
,	O
we	O
investigated	O
survival	O
outcomes	O
accounting	O
for	O
this	O
parameter	O
.	O
we	O
retrospectively	O
evaluated	B-T058
data	O
from	O
1	O
,	O
06	O
##7	O
patients	O
with	O
bca	B-T038
treated	O
with	O
rc	B-T058
between	O
1990	O
and	O
2013	O
at	O
a	O
single	B-T092
tertiary	I-T092
care	I-T092
referral	I-T092
center	I-T092
.	O
all	O
specimen	O
were	O
evaluated	B-T058
by	O
dedicated	O
uro	B-T097
##path	I-T097
##ologists	I-T097
.	O
univ	B-T170
##ariable	I-T170
and	I-T170
multivariable	I-T170
cox	I-T170
regression	I-T170
analyses	I-T170
tested	O
the	O
effect	O
of	O
different	O
histopathological	O
variant	O
on	O
recurrence	O
,	O
cancer	O
-	O
specific	O
mortality	O
(	O
cs	O
##m	O
)	O
,	O
and	O
overall	O
mortality	O
(	O
om	O
)	O
after	O
accounting	O
for	O
all	O
available	O
confounders	O
.	O
of	O
1	O
,	O
06	O
##7	O
patients	O
,	O
72	O
##9	O
(	O
68	O
.	O
3	O
%	O
)	O
harbored	O
pure	B-T038
urothelial	I-T038
bca	I-T038
while	O
338	O
(	O
31	O
.	O
7	O
%	O
)	O
were	O
found	O
to	O
have	O
a	O
variant	O
.	O
considering	O
uncommon	O
variants	O
,	O
21	O
(	O
2	O
.	O
0	O
%	O
)	O
were	O
sarcoma	B-T038
##to	I-T038
##id	I-T038
,	O
10	O
(	O
0	O
.	O
9	O
%	O
)	O
lympho	B-T038
##epi	I-T038
##te	I-T038
##li	I-T038
##al	I-T038
,	O
19	O
(	O
1	O
.	O
8	O
%	O
)	O
small	B-T038
cell	I-T038
,	O
109	O
(	O
10	O
.	O
2	O
%	O
)	O
squamous	B-T038
,	O
89	O
(	O
8	O
.	O
3	O
%	O
)	O
microp	B-T038
##apillary	I-T038
,	O
23	O
(	O
2	O
.	O
2	O
%	O
)	O
glandular	B-T038
,	O
34	O
(	O
3	O
.	O
2	O
%	O
)	O
mixed	O
variants	O
,	O
and	O
33	O
(	O
3	O
.	O
1	O
%	O
)	O
were	O
found	O
with	O
other	O
types	O
of	O
variants	O
.	O
with	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
of	O
6	O
.	O
2	O
years	O
,	O
343	O
recurrence	O
,	O
365	O
cs	O
##m	O
,	O
and	O
45	O
##1	O
om	O
were	O
recorded	O
,	O
respectively	O
.	O
at	O
multivariable	B-T170
cox	I-T170
regression	I-T170
analyses	I-T170
,	O
the	O
presence	O
of	O
small	B-T038
cell	I-T038
variant	I-T038
was	O
associated	O
with	O
higher	O
recurrence	O
(	O
hazard	O
ratio	O
[	O
hr	O
]	O
=	O
3	O
.	O
47	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
cs	O
##m	O
(	O
hr	O
=	O
3	O
.	O
30	O
,	O
p	O
<	O
0	O
.	O
04	O
)	O
,	O
and	O
om	O
(	O
hr	O
=	O
2	O
.	O
97	O
,	O
p	O
<	O
0	O
.	O
003	O
)	O
as	O
compared	O
with	O
pure	O
urothelial	B-T038
cancer	I-T038
.	O
conversely	O
,	O
no	O
survival	O
differences	O
were	O
recorded	O
considering	O
other	O
histological	O
variants	O
(	O
all	O
p	O
>	O
0	O
.	O
1	O
)	O
.	O
our	O
study	O
confirms	O
that	O
histological	O
variant	O
is	O
not	O
an	O
infrequent	O
event	O
at	O
rc	B-T058
specimen	O
.	O
however	O
,	O
in	O
our	O
single	B-T092
-	I-T092
center	I-T092
series	I-T092
,	O
only	O
patients	O
found	O
with	O
small	B-T038
cell	I-T038
variant	I-T038
were	O
associated	O
with	O
a	O
negative	B-T033
effect	O
on	O
survival	O
after	O
rc	B-T058
.	O

expression	B-T038
of	O
caspase	B-T103
3	I-T103
in	O
ovarian	B-T017
follicle	I-T017
cells	B-T017
of	O
the	O
liz	B-T204
##ard	I-T204
pod	B-T204
##arc	I-T204
##is	I-T204
sic	I-T204
##ula	I-T204
in	O
this	O
study	O
,	O
our	O
aim	O
was	O
to	O
determine	O
whether	O
caspase	B-T103
3	I-T103
plays	O
a	O
role	O
,	O
during	O
prev	B-T038
##ite	I-T038
##ll	I-T038
##ogenesis	I-T038
,	O
in	O
the	O
ovarian	B-T017
follicular	B-T017
epithelium	I-T017
of	O
the	O
liz	B-T204
##ard	I-T204
pod	B-T204
##arc	I-T204
##is	I-T204
sic	I-T204
##ula	I-T204
.	O
we	O
investigated	O
the	O
presence	O
and	O
localization	O
of	O
prof	O
##orm	O
and	O
active	O
caspase	B-T103
3	I-T103
by	O
enzyme	B-T058
assay	I-T058
,	O
western	B-T058
blotting	I-T058
and	O
immunocytochemistry	B-T058
.	O
in	O
parallel	O
,	O
a	O
fragment	O
of	O
caspase	B-T017
3	I-T017
was	O
cloned	B-T058
for	O
the	O
first	O
time	O
in	O
this	O
species	B-T170
,	O
sequenced	O
and	O
used	O
for	O
in	B-T062
situ	I-T062
hybridization	I-T062
to	O
localize	B-T082
messenger	O
##s	O
and	O
analysed	O
by	O
a	O
phylogenetic	B-T062
survey	I-T062
to	O
shed	O
light	O
on	O
its	O
homology	O
with	O
rep	B-T204
##til	I-T204
##ian	I-T204
caspases	B-T103
.	O
results	O
demonstrated	O
that	O
:	O
(	O
1	O
)	O
the	O
follicle	B-T017
cells	B-T017
expressed	B-T038
a	O
caspase	B-T103
of	O
the	O
3	O
/	O
7	O
group	O
and	O
the	O
mrna	B-T103
for	O
caspase	B-T103
3	I-T103
was	O
transcribed	B-T038
in	O
the	O
stem	O
phase	O
and	O
was	O
completely	O
translated	B-T038
during	O
cell	B-T038
differentiation	I-T038
;	O
(	O
2	O
)	O
the	O
prof	B-T103
##orm	I-T103
protein	I-T103
was	O
stored	O
during	O
the	O
differentiated	O
(	O
nurse	O
)	O
stage	O
and	O
activated	O
at	O
the	O
end	O
of	O
prev	B-T038
##ite	I-T038
##ll	I-T038
##ogenesis	I-T038
prov	O
##oking	O
the	O
degeneration	B-T038
of	I-T038
cells	I-T038
;	O
(	O
3	O
)	O
the	O
predicted	O
protein	B-T082
sequence	I-T082
,	O
although	O
partial	O
,	O
had	O
a	O
strong	O
similarity	O
with	O
the	O
known	O
rep	B-T204
##til	I-T204
##ian	I-T204
caspases	B-T103
3	I-T103
.	O
the	O
epithelial	B-T017
cells	I-T017
of	O
the	O
ovarian	B-T017
follicle	I-T017
,	O
therefore	O
,	O
do	O
not	O
employ	O
caspase	B-T103
3	I-T103
during	O
the	O
nurse	O
stage	O
but	O
,	O
instead	O
,	O
prepare	O
for	O
apoptosis	B-T038
long	O
before	O
the	O
process	O
actually	O
begins	O
.	O
the	O
relevance	O
of	O
this	O
strategy	O
is	O
discussed	O
.	O

long	B-T103
noncoding	I-T103
rnas	I-T103
in	O
cardiovascular	B-T038
pathology	I-T038
,	O
diagnosis	B-T062
,	O
and	O
therapy	B-T058
vast	O
parts	O
of	O
mammalian	B-T204
genomes	B-T017
encode	O
for	O
transcripts	B-T103
that	O
are	O
not	O
further	O
translated	B-T038
into	I-T038
proteins	I-T038
.	O
the	O
purpose	O
of	O
the	O
majority	O
of	O
such	O
noncoding	B-T103
ribonucle	I-T103
##ic	I-T103
acids	I-T103
(	B-T103
rnas	I-T103
)	I-T103
remained	O
paradoxical	O
for	O
a	O
long	O
time	O
.	O
however	O
,	O
a	O
growing	O
body	O
of	O
evidence	O
demonstrates	O
that	O
long	B-T103
noncoding	I-T103
rnas	I-T103
are	O
dynamically	O
expressed	B-T038
in	O
different	O
cell	B-T017
types	I-T017
,	O
diseases	B-T038
,	O
or	O
developmental	O
stages	O
to	O
exec	O
##ute	O
a	O
wide	O
variety	O
of	O
regulatory	O
roles	O
at	O
virtually	O
every	O
step	O
of	O
gene	B-T038
expression	I-T038
and	O
translation	B-T038
.	O
indeed	O
,	O
long	B-T103
noncoding	I-T103
rnas	I-T103
influence	O
gene	B-T038
expression	I-T038
via	O
epigenetic	B-T038
modulations	I-T038
,	O
through	O
regulating	B-T038
alternative	B-T038
splicing	I-T038
,	O
or	O
by	O
acting	O
as	O
molecular	O
sponges	O
.	O
the	O
abundance	O
of	O
long	B-T103
noncoding	I-T103
rnas	I-T103
in	O
the	O
cardiovascular	B-T022
system	I-T022
indicates	O
that	O
they	O
may	O
be	O
part	O
of	O
a	O
complex	O
regulatory	B-T038
network	I-T038
governing	O
physiology	O
and	O
pathology	B-T038
of	O
the	O
heart	B-T017
.	O
in	O
this	O
review	O
,	O
we	O
discuss	O
the	O
multifaceted	B-T082
functions	O
of	O
long	B-T103
noncoding	I-T103
rnas	I-T103
and	O
highlight	O
the	O
current	B-T170
literature	I-T170
with	O
an	O
emphasis	O
on	O
cardiac	B-T038
development	I-T038
and	O
disease	B-T038
.	O
furthermore	B-T082
,	O
as	O
the	O
enormous	O
spectrum	O
of	O
long	B-T103
noncoding	I-T103
rnas	I-T103
potentially	O
opens	O
up	O
new	O
avenues	O
for	O
diagnosis	B-T062
and	O
prevention	B-T058
of	O
heart	B-T038
failure	I-T038
,	O
we	O
ultimately	O
evaluate	O
the	O
fu	O
##t	O
##uristic	O
prospects	O
of	O
long	B-T103
noncoding	I-T103
rnas	I-T103
as	O
biomarkers	B-T201
,	O
and	O
therapeutic	O
targets	B-T103
for	O
the	O
treatment	B-T058
of	O
cardiovascular	B-T038
disorders	I-T038
,	O
as	O
well	O
.	O

the	O
effects	O
of	O
messages	B-T170
about	O
the	O
causes	O
of	O
obesity	B-T038
on	O
disciplinary	O
action	O
decisions	B-T038
for	O
overweight	B-T038
employees	B-T097
we	O
investigated	O
the	O
impact	O
of	O
messages	B-T170
about	O
the	O
causes	O
of	O
obesity	B-T038
(	O
controllable	B-T033
or	O
uncontrol	O
##lab	O
##le	O
)	O
on	O
the	O
disciplinary	O
action	O
consequences	O
selected	O
for	O
obese	B-T038
employees	B-T097
in	O
response	O
to	O
a	O
work	O
-	O
related	O
mist	O
##ake	O
.	O
participants	B-T098
read	O
about	O
either	O
the	O
controllable	B-T033
or	O
uncontrol	O
##lab	O
##le	O
causes	O
of	O
obesity	B-T038
before	O
reviewing	O
an	O
oste	O
##ns	O
##ible	O
employee	B-T097
file	O
that	O
included	O
a	O
description	O
of	O
an	O
employee	B-T097
mist	O
##ake	O
.	O
depending	O
on	O
condition	O
,	O
the	O
file	O
contained	O
a	O
photo	O
of	O
the	O
employee	B-T097
that	O
either	O
depicted	O
them	O
as	O
obese	B-T038
or	O
average	O
weight	O
.	O
participants	B-T098
were	O
more	O
willing	O
to	O
with	O
##hold	O
a	O
raise	O
or	O
promotion	O
from	O
an	O
obese	B-T038
employee	B-T097
than	O
from	O
an	O
average	O
-	O
weight	O
employee	B-T097
.	O
further	O
,	O
there	O
was	O
little	O
evidence	O
that	O
the	O
messages	B-T170
about	O
the	O
causes	O
of	O
obesity	B-T038
affected	O
participants	B-T098
'	O
perceived	B-T033
control	I-T033
and	O
self	B-T038
-	I-T038
efficacy	I-T038
for	O
healthy	O
behaviors	O
.	O

effects	O
of	O
regular	O
water	O
-	O
and	O
land	O
-	O
based	O
exercise	O
on	O
physical	B-T033
function	I-T033
after	O
5	O
years	O
:	O
a	O
long	B-T062
-	I-T062
term	I-T062
study	I-T062
on	O
the	O
well	O
-	O
being	O
of	O
older	B-T098
japanese	I-T098
adults	B-T098
to	O
investigate	O
the	O
effects	O
of	O
5	O
years	O
of	O
physical	O
exercise	O
on	O
functional	O
parameters	O
among	O
older	B-T098
japanese	I-T098
adults	B-T098
who	O
carried	O
out	O
water	O
-	O
or	O
land	O
-	O
based	O
exercise	O
.	O
we	O
retrospectively	O
investigated	O
data	O
from	O
57	O
##0	O
##7	O
medical	B-T058
examinations	I-T058
and	O
enrolled	B-T058
77	O
older	B-T098
adults	I-T098
into	O
the	O
study	B-T062
.	O
eligible	O
participants	B-T098
had	O
to	O
be	O
aged	O
≥	O
##60	O
years	O
,	O
and	O
engaged	O
in	O
water	O
-	O
based	O
exercise	O
(	O
n	O
=	O
38	O
)	O
or	O
a	O
combination	O
of	O
water	O
-	O
and	O
land	O
-	O
based	O
exercise	O
(	O
n	O
=	O
39	O
)	O
for	O
at	O
least	O
80	O
%	O
of	O
their	O
total	O
exercise	O
time	O
for	O
over	O
5	O
years	O
at	O
our	O
fitness	B-T092
center	I-T092
.	O
in	O
statistical	O
analysis	O
,	O
a	O
two	O
-	O
way	O
repeated	O
-	O
measures	O
analysis	O
of	O
variance	O
was	O
carried	O
out	O
to	O
examine	B-T033
the	O
effects	O
over	O
time	O
and	O
by	O
exercise	B-T033
type	I-T033
,	O
and	O
the	O
changes	O
in	O
each	O
parameter	O
over	O
5	O
years	O
were	O
also	O
compared	O
between	O
the	O
two	O
groups	O
.	O
we	O
found	B-T033
significant	O
main	O
effects	O
and	O
an	O
interaction	O
between	O
time	O
and	O
exercise	B-T033
type	I-T033
for	O
gait	O
speed	O
,	O
with	O
an	O
early	O
decline	O
in	O
the	O
combined	O
exercise	O
group	O
,	O
as	O
well	O
as	O
significant	O
main	O
effects	O
of	O
time	O
,	O
showing	O
a	O
functional	B-T033
decline	I-T033
in	O
grip	O
strength	O
,	O
one	B-T082
-	I-T082
leg	I-T082
standing	I-T082
time	O
and	O
step	B-T033
/	I-T033
height	I-T033
ratio	O
in	O
both	O
exercise	B-T033
types	I-T033
at	O
the	O
5	O
-	O
year	O
follow	B-T058
up	I-T058
.	O
the	O
5	O
-	O
year	O
changes	O
in	O
each	O
parameter	O
did	O
not	O
differ	O
between	O
the	O
two	O
groups	O
despite	O
the	O
frequency	B-T033
of	I-T033
exercise	I-T033
,	O
even	O
though	O
we	O
found	B-T033
a	O
negative	B-T033
correlation	O
between	O
changes	O
in	O
one	B-T082
-	I-T082
leg	I-T082
standing	I-T082
time	O
and	O
total	O
amount	O
of	O
water	O
-	O
based	O
exercise	O
.	O
contrary	O
to	O
expectations	O
,	O
these	O
results	O
suggest	O
that	O
regular	O
engagement	O
in	O
water	O
-	O
based	O
exercise	O
,	O
even	O
combined	O
with	O
land	O
-	O
based	O
exercise	O
,	O
might	O
have	O
poor	O
long	O
-	O
term	O
benefits	O
for	O
maintaining	O
physical	O
performance	O
in	O
older	B-T098
adults	I-T098
.	O
ger	O
##iatr	O
ger	O
##onto	O
##l	O
int	O
2017	O
;	O
•	O
•	O
:	O
•	O
•	O
-	O
•	O
•	O
.	O

optimal	O
duration	O
of	O
coronary	B-T058
ligation	I-T058
and	O
reperfusion	B-T058
for	O
reperfusion	B-T037
injury	I-T037
study	B-T062
in	O
a	O
rat	B-T204
model	O
reperfusion	B-T037
injury	I-T037
(	O
ri	B-T037
)	O
has	O
an	O
important	O
impact	O
on	O
the	O
clinical	O
prognosis	B-T201
for	O
patients	O
with	O
acute	O
myocardial	O
injury	O
who	O
had	O
their	O
coronary	B-T082
blood	B-T038
flow	I-T038
ree	O
##st	O
##ablish	O
##ed	O
.	O
however	O
,	O
no	O
studies	B-T062
to	O
date	O
have	O
investigated	O
the	O
time	O
##fr	O
##ame	O
of	O
coronary	B-T038
occlusion	I-T038
and	O
reperfusion	B-T058
effects	O
on	O
ri	B-T037
.	O
a	O
total	O
of	O
100	O
rats	B-T204
were	O
divided	O
into	O
4	O
groups	O
based	O
on	O
the	O
coronary	B-T058
ligation	I-T058
period	O
:	O
30	O
,	O
60	O
,	O
120	O
,	O
and	O
180	O
min	O
,	O
and	O
each	O
group	O
was	O
further	O
divided	O
into	O
5	O
subgroups	O
with	O
different	O
reperfusion	B-T058
periods	O
:	O
0	O
,	O
30	O
,	O
60	O
,	O
120	O
,	O
and	O
180	O
min	O
.	O
r0	O
was	O
the	O
baseline	O
of	O
each	O
subgroup	O
.	O
all	O
animals	B-T204
received	O
the	O
same	O
protocols	B-T170
for	O
designed	O
ligation	B-T058
and	O
reperfusion	B-T058
periods	O
.	O
evans	B-T103
blue	I-T103
and	O
2	B-T103
,	I-T103
3	I-T103
,	I-T103
5	I-T103
-	I-T103
triphenyl	I-T103
##tetr	I-T103
##azolium	I-T103
chloride	I-T103
were	O
used	O
to	O
distinguish	O
different	O
myocardial	O
injury	O
areas	B-T082
:	O
area	B-T082
at	O
risk	O
(	O
aa	B-T082
##r	I-T082
)	O
and	O
myocardial	B-T038
necrosis	I-T038
.	O
the	O
differences	O
of	O
the	O
ratios	O
of	O
the	O
necrotic	B-T038
area	B-T082
to	O
aa	B-T082
##r	I-T082
between	O
each	O
subgroup	O
and	O
baseline	O
were	O
further	O
averaged	O
to	O
calculate	O
an	O
overall	O
value	O
of	O
each	O
heart	B-T017
.	O
the	O
relative	O
ri	B-T037
percentages	O
showed	O
significant	O
differences	O
(	O
0	O
.	O
8	O
±	O
2	O
.	O
3	O
%	O
,	O
4	O
.	O
9	O
±	O
3	O
.	O
3	O
%	O
,	O
10	O
.	O
8	O
±	O
3	O
.	O
1	O
%	O
,	O
and	O
20	O
.	O
3	O
±	O
3	O
.	O
6	O
%	O
respectively	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
at	O
different	O
time	O
points	O
of	O
reperfusion	B-T058
but	O
not	O
at	O
different	O
time	O
points	O
of	O
ligation	B-T058
(	O
p	O
=	O
0	O
.	O
59	O
##3	O
)	O
.	O
the	O
effects	O
of	O
different	O
time	O
courses	O
in	O
ri	B-T037
showed	O
that	O
the	O
l12	O
##0	O
##r1	O
##80	O
group	O
(	O
43	O
.	O
4	O
±	O
2	O
.	O
3	O
%	O
)	O
had	O
the	O
highest	O
ri	B-T037
difference	O
with	O
the	O
baseline	O
group	O
.	O
maximal	O
ri	B-T037
occurred	O
at	O
the	O
time	O
##fr	O
##ame	O
of	O
l12	O
##0	O
##r1	O
##80	O
in	O
our	O
animal	O
model	O
.	O
this	O
result	O
may	O
be	O
utilized	O
to	O
assess	O
the	O
substantial	O
benefits	O
of	O
ri	B-T058
therapies	I-T058
in	O
an	O
experimental	B-T038
rat	I-T038
model	I-T038
setting	O
.	O

does	O
video	O
laryng	O
##oscopy	O
offer	O
advantages	O
over	O
direct	B-T058
laryng	I-T058
##oscopy	I-T058
during	O
cardiopulmonary	B-T058
resuscitation	I-T058
?	O
interruption	O
of	O
chest	O
compression	O
##s	O
should	O
be	O
minimized	O
because	O
of	O
its	O
negative	B-T033
effects	O
on	O
survival	O
.	O
this	O
randomized	B-T062
,	O
controlled	O
,	O
cross	B-T062
-	I-T062
over	I-T062
study	I-T062
aimed	O
to	O
analyze	B-T062
the	O
effectiveness	O
of	O
mac	B-T074
##int	I-T074
##osh	I-T074
,	O
mill	B-T074
##er	I-T074
,	O
mcc	B-T074
##oy	I-T074
and	O
mcg	B-T074
##ra	I-T074
##th	I-T074
laryng	I-T074
##oscope	I-T074
##s	I-T074
during	O
with	O
or	O
without	O
chest	O
compression	O
##s	O
in	O
the	O
scope	O
of	O
a	O
simulated	O
cardiopulmonary	B-T058
resuscitation	I-T058
scenario	O
.	O
the	O
time	O
required	O
for	O
successful	O
tracheal	B-T058
intubation	I-T058
,	O
number	B-T201
of	I-T201
attempts	I-T201
,	O
dental	B-T037
trauma	I-T037
severity	O
and	O
the	O
need	O
for	O
optimization	O
man	O
##oe	O
##uv	O
##res	O
were	O
recorded	B-T033
during	O
cardiopulmonary	B-T058
resuscitation	I-T058
with	O
and	O
without	O
chest	O
compression	O
##s	O
.	O
the	O
experience	B-T038
with	O
computer	O
games	O
during	O
the	O
last	O
10	O
years	O
were	O
asked	O
to	O
the	O
participants	B-T098
and	O
recorded	B-T033
.	O
mcc	B-T074
##oy	I-T074
laryng	I-T074
##oscope	I-T074
yielded	O
the	O
shortest	O
time	O
for	O
successful	O
tracheal	B-T058
intubation	I-T058
both	O
in	O
the	O
presence	B-T033
of	O
and	O
without	O
chest	O
compression	O
##s	O
.	O
during	O
the	O
use	O
of	O
mcc	B-T074
##oy	I-T074
laryng	I-T074
##oscope	I-T074
##s	I-T074
,	O
fewer	O
tracheal	B-T058
intubation	I-T058
attempts	O
,	O
lower	O
incidence	O
of	O
dental	B-T037
trauma	I-T037
and	O
lower	O
visual	B-T201
analogue	I-T201
scale	I-T201
scores	I-T201
on	O
the	O
ease	O
of	O
intubation	B-T058
were	O
recorded	B-T033
.	O
participants	B-T098
who	O
are	O
experienced	B-T038
computer	O
game	O
players	B-T098
using	O
mac	B-T074
##int	I-T074
##osh	I-T074
,	O
mcc	B-T074
##oy	I-T074
and	O
mcg	B-T074
##ra	I-T074
##th	I-T074
achieved	B-T033
successful	O
tracheal	B-T058
intubation	I-T058
in	O
a	O
significantly	O
shorter	O
time	O
during	O
resuscitation	B-T058
without	O
chest	O
compression	O
##s	O
.	O
dental	B-T037
trauma	I-T037
incidence	O
and	O
number	O
of	O
tracheal	B-T058
intubation	I-T058
attempts	O
did	O
not	O
show	O
any	O
significant	O
difference	O
between	O
the	O
four	O
laryng	B-T074
##oscope	I-T074
##s	I-T074
being	O
related	O
to	O
the	O
rate	O
of	O
playing	O
computer	O
games	O
.	O
mcg	O
##ra	O
##th	O
video	O
laryng	O
##oscope	O
##s	O
do	O
not	O
appear	O
to	O
have	O
advantages	O
over	O
direct	B-T058
laryng	I-T058
##oscope	I-T058
##s	I-T058
for	O
sec	O
##uring	O
a	O
smooth	O
and	O
successful	O
tracheal	B-T058
intubation	I-T058
during	O
rhythmic	O
chest	O
compression	O
##s	O
.	O
we	O
believe	O
that	O
as	O
mcc	B-T074
##oy	I-T074
laryng	I-T074
##oscope	I-T074
provided	O
tracheal	B-T058
intubation	I-T058
in	O
a	O
shorter	O
time	O
and	O
with	O
fewer	O
attempts	O
,	O
this	O
laryng	B-T074
##oscope	I-T074
may	O
increase	O
the	O
success	O
rate	O
of	O
resuscitation	B-T058
.	O

new	O
metabolites	B-T103
from	O
the	O
sponge	B-T204
-	O
derived	O
fungus	B-T204
aspergillus	B-T204
syd	I-T204
##ow	I-T204
##ii	I-T204
j	I-T204
##05	I-T204
##b	I-T204
-	I-T204
7	I-T204
##f	I-T204
-	I-T204
4	I-T204
two	O
new	O
metabolites	B-T103
,	O
dio	B-T103
##r	I-T103
##cin	I-T103
##olic	I-T103
acid	I-T103
(	O
1	O
)	O
and	O
β	B-T103
-	I-T103
d	I-T103
-	I-T103
glucopyranosyl	I-T103
aspergillus	I-T103
##ene	I-T103
a	I-T103
(	O
8	O
)	O
,	O
together	O
with	O
six	O
diphenyl	B-T103
##ether	I-T103
##s	I-T103
(	O
2	O
-	O
7	O
)	O
,	O
a	O
di	B-T103
##ket	I-T103
##op	I-T103
##iper	I-T103
##azine	I-T103
(	O
9	O
)	O
,	O
a	O
chrom	B-T103
##one	I-T103
(	O
10	O
)	O
and	O
a	O
xanth	B-T103
##one	I-T103
(	O
11	O
)	O
were	O
isolated	O
from	O
the	O
fungus	B-T204
aspergillus	B-T204
syd	I-T204
##ow	I-T204
##ii	I-T204
derived	O
from	O
the	O
marine	B-T204
sponge	I-T204
ste	B-T204
##ll	I-T204
##ett	I-T204
##a	I-T204
sp	I-T204
.	O
the	O
planar	O
structures	O
and	O
their	O
relative	O
configurations	B-T082
were	O
elucidated	O
by	O
analysing	O
1d	O
,	O
2d	O
nmr	O
and	O
hr	B-T058
##esi	I-T058
##ms	I-T058
data	O
.	O
compound	B-T103
8	O
is	O
the	O
first	O
glycoside	B-T103
of	O
phenolic	B-T103
bis	B-T103
##abol	I-T103
##ane	I-T103
sesquiterp	I-T103
##enes	I-T103
.	O
compounds	B-T103
1	I-T103
and	I-T103
8	I-T103
exhibited	O
mild	O
cytotoxicity	B-T038
against	O
kb	B-T017
(	O
human	B-T017
nasopharyngeal	I-T017
carcinoma	I-T017
cells	I-T017
)	O
,	O
hepg2	B-T017
(	O
human	B-T017
liver	I-T017
cancer	I-T017
cells	I-T017
)	O
and	O
hct	B-T017
116	I-T017
(	O
human	B-T017
colon	I-T017
cancer	I-T017
cells	I-T017
)	O
.	O
all	O
compounds	B-T103
were	O
evaluated	B-T058
for	O
antibacterial	O
activity	O
and	O
their	O
abilities	O
to	O
suppress	O
lps	B-T103
-	O
induced	O
nitric	B-T103
oxide	I-T103
(	O
no	B-T103
)	O
production	O
.	O
compounds	B-T103
2	I-T103
and	I-T103
4	I-T103
-	I-T103
7	I-T103
showed	O
mild	O
antibacterial	B-T033
activity	I-T033
against	O
human	B-T204
pathogen	O
staphylococcus	B-T007
aureus	I-T007
and	O
fish	B-T204
pathogens	O
streptococcus	B-T007
in	I-T007
##iae	I-T007
and	O
vibrio	B-T007
ich	I-T007
##thy	I-T007
##oe	I-T007
##nt	I-T007
##eri	I-T007
,	O
and	O
compounds	B-T103
4	I-T103
and	I-T103
7	I-T103
weakly	O
suppressed	O
no	B-T103
production	O
.	O

efficacy	O
of	O
intravenous	B-T082
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
for	O
refractory	O
acute	B-T038
decompensated	I-T038
heart	I-T038
failure	I-T038
unresponsive	O
to	O
adjunct	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
to	O
assess	O
the	O
efficacy	O
of	O
intravenous	B-T082
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
in	O
patients	O
with	O
acute	B-T038
decompensated	I-T038
heart	I-T038
failure	I-T038
(	O
adh	B-T038
##f	I-T038
)	O
who	O
were	O
determined	O
to	O
be	O
loop	B-T103
diuretic	I-T103
resistant	O
and	O
refractory	O
to	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
.	O
retrospective	B-T062
cohort	I-T062
study	I-T062
with	O
patients	O
serving	O
as	O
their	O
own	O
controls	O
.	O
large	O
,	O
academic	B-T092
,	O
tertiary	B-T092
care	I-T092
hospital	I-T092
.	O
forty	O
-	O
five	O
patients	O
with	O
adh	B-T038
##f	I-T038
who	O
had	O
an	O
inadequate	O
response	O
to	O
high	O
-	O
dose	O
loop	B-T103
diuretics	I-T103
and	O
then	O
received	O
at	O
least	O
one	O
dose	O
of	O
oral	B-T082
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
5	O
mg	O
or	O
greater	O
(	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
index	O
dose	O
)	O
followed	O
by	O
at	O
least	O
one	O
dose	O
of	O
intravenous	B-T082
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
500	O
mg	O
(	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
index	O
dose	O
)	O
if	O
the	O
response	O
to	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
was	O
considered	O
inadequate	O
,	O
according	O
to	O
the	O
institutional	B-T170
protocol	I-T170
,	O
between	O
february	O
4	O
,	O
2013	O
,	O
and	O
february	O
28	O
,	O
2015	O
,	O
were	O
included	O
.	O
if	O
multiple	O
doses	O
of	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
were	O
administered	B-T058
,	O
the	O
last	O
dose	O
given	O
before	O
the	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
index	O
dose	O
was	O
considered	O
the	O
index	O
dose	O
;	O
the	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
index	O
dose	O
had	O
to	O
have	O
been	O
administered	B-T058
more	O
than	O
2	O
hours	O
before	O
the	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
index	O
dose	O
.	O
data	O
for	O
a	O
total	O
of	O
90	O
diuretic	B-T103
doses	O
(	O
45	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
,	O
45	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
)	O
were	O
included	O
in	O
the	O
analysis	B-T062
.	O
the	O
median	O
dose	O
of	O
loop	B-T103
diuretic	I-T103
in	O
intravenous	B-T082
furosemide	B-T103
equivalents	O
given	O
over	O
the	O
24	O
-	O
hour	O
period	O
before	O
the	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
index	O
dose	O
was	O
400	O
mg	O
.	O
the	O
average	O
length	O
of	O
stay	O
was	O
34	O
.	O
7	O
days	O
,	O
and	O
in	O
-	O
hospital	O
mortality	O
was	O
35	O
.	O
6	O
%	O
(	O
16	O
/	O
45	O
patients	O
)	O
.	O
the	O
primary	O
end	O
point	O
of	O
a	O
net	B-T033
-	I-T033
negative	I-T033
urine	B-T201
output	I-T201
of	O
500	O
ml	O
or	O
greater	O
during	O
the	O
12	O
hours	O
after	O
the	O
index	O
dose	O
occurred	O
in	O
42	O
.	O
2	O
%	O
(	O
19	O
/	O
45	O
patients	O
)	O
and	O
35	O
.	O
5	O
%	O
(	O
16	O
/	O
45	O
patients	O
)	O
for	O
the	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
and	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
doses	O
,	O
respectively	O
(	O
p	O
=	O
0	O
.	O
58	O
##1	O
)	O
.	O
the	O
median	O
12	O
-	O
hour	O
urine	B-T201
output	I-T201
following	O
administration	O
of	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
was	O
81	O
##0	O
ml	O
(	O
interquartile	O
range	O
[	O
iqr	O
]	O
86	O
##6	O
ml	O
)	O
versus	O
107	O
##5	O
ml	O
(	O
iqr	O
94	O
##0	O
ml	O
)	O
following	O
administration	O
of	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
(	O
p	O
=	O
0	O
.	O
36	O
##3	O
)	O
.	O
compared	O
with	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
,	O
the	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
doses	O
did	O
not	O
result	O
in	O
an	O
increase	O
in	O
urine	B-T201
output	I-T201
of	O
at	O
least	O
500	O
ml	O
during	O
the	O
12	O
hours	O
following	O
the	O
dose	O
relative	O
to	O
the	O
12	O
hours	O
before	O
the	O
dose	O
(	O
31	O
.	O
1	O
%	O
vs	O
22	O
.	O
2	O
%	O
,	O
p	O
=	O
0	O
.	O
75	O
##4	O
)	O
.	O
no	O
significant	O
difference	O
in	O
achievement	O
of	O
net	B-T033
-	I-T033
negative	I-T033
urine	B-T201
output	I-T201
of	O
500	O
ml	O
or	O
greater	O
during	O
the	O
12	O
hours	O
following	O
the	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
or	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
dose	O
was	O
noted	O
(	O
42	O
.	O
2	O
%	O
for	O
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
vs	O
35	O
.	O
5	O
%	O
for	O
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
,	O
p	O
=	O
0	O
.	O
58	O
##1	O
)	O
.	O
the	O
addition	O
of	O
intravenous	B-T082
chloro	B-T103
##thiaz	I-T103
##ide	I-T103
did	O
not	O
result	O
in	O
improved	B-T033
diuresis	B-T038
in	O
patients	O
with	O
adh	B-T038
##f	I-T038
determined	O
to	O
be	O
refractory	O
to	O
loop	B-T103
diuretic	I-T103
s	O
and	O
adjunctive	O
oral	B-T082
met	B-T103
##ola	I-T103
##zo	I-T103
##ne	I-T103
.	O

surface	B-T082
mediated	O
cooperative	O
interactions	B-T038
of	I-T038
drugs	I-T038
enhance	O
mechanical	O
forces	O
for	O
antibiotic	B-T103
action	O
the	O
alarm	O
##ing	O
increase	O
of	O
pathogenic	O
bacteria	O
that	O
are	O
resistant	B-T038
to	I-T038
multiple	I-T038
antibiotics	I-T038
is	O
now	O
recognized	O
as	O
a	O
major	O
health	O
issue	O
fuel	O
##ling	O
demand	B-T058
for	O
new	O
drugs	B-T103
.	O
bacterial	B-T038
resistance	I-T038
is	O
often	O
caused	O
by	O
molecular	B-T033
changes	I-T033
at	O
the	O
bacterial	B-T033
surface	I-T033
,	O
which	O
alter	O
the	O
nature	O
of	O
specific	O
drug	B-T038
-	I-T038
target	I-T038
interactions	I-T038
.	O
here	O
,	O
we	O
identify	O
a	O
novel	O
mechanism	O
by	O
which	O
drug	B-T038
-	I-T038
target	I-T038
interactions	I-T038
in	O
resistant	B-T007
bacteria	I-T007
can	O
be	O
enhanced	O
.	O
we	O
examined	O
the	O
surface	B-T082
forces	O
generated	O
by	O
four	O
antibiotics	B-T103
;	O
vancomycin	B-T103
,	O
ris	B-T103
##to	I-T103
##my	I-T103
##cin	I-T103
,	O
chloro	B-T103
##ere	I-T103
##mo	I-T103
##my	I-T103
##cin	I-T103
and	O
ori	B-T103
##ta	I-T103
##va	I-T103
##nc	I-T103
##in	I-T103
against	O
drug	O
-	O
susceptible	O
and	O
drug	B-T007
-	I-T007
resistant	I-T007
targets	I-T007
on	O
a	O
cant	O
##ile	O
##ver	O
and	O
demonstrated	O
significant	O
differences	O
in	O
mechanical	O
response	O
when	O
drug	B-T007
-	I-T007
resistant	I-T007
targets	I-T007
are	O
challenged	O
with	O
different	O
antibiotics	B-T103
although	O
no	O
significant	O
differences	O
were	O
observed	O
when	O
using	O
susceptible	O
targets	O
.	O
remarkably	O
,	O
the	O
binding	B-T038
affinity	I-T038
for	O
ori	B-T103
##ta	I-T103
##va	I-T103
##nc	I-T103
##in	I-T103
against	O
drug	B-T007
-	I-T007
resistant	I-T007
targets	I-T007
(	O
70	O
nm	O
)	O
was	O
found	O
to	O
be	O
11	O
,	O
000	O
times	O
stronger	O
than	O
for	O
vancomycin	B-T103
(	O
800	O
μm	O
)	O
,	O
a	O
powerful	O
antibiotic	B-T103
used	O
as	O
the	O
last	O
res	B-T058
##ort	I-T058
treatment	I-T058
for	O
streptococcal	B-T007
and	O
staphylococcal	B-T007
bacteria	I-T007
including	O
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
(	O
mrsa	B-T007
)	O
.	O
using	O
an	O
exactly	B-T170
solv	I-T170
##able	I-T170
model	I-T170
,	O
which	O
takes	O
into	O
account	O
the	O
solvent	B-T103
and	O
membrane	B-T017
effects	O
,	O
we	O
demonstrate	O
that	O
drug	B-T038
-	I-T038
target	I-T038
interactions	I-T038
are	O
strengthened	O
by	O
pronounced	B-T038
poly	I-T038
##val	I-T038
##ent	I-T038
interactions	I-T038
catalyzed	O
by	O
the	O
surface	B-T082
itself	O
.	O
these	O
findings	O
further	O
enhance	O
our	O
understanding	B-T038
of	O
antibiotic	O
mode	O
of	O
action	O
and	O
will	O
enable	O
development	O
of	O
more	O
effective	O
therapies	B-T058
.	O

neonatal	B-T038
infections	I-T038
:	O
case	B-T170
definition	I-T170
and	O
guidelines	B-T170
for	O
data	B-T062
collection	I-T062
,	O
analysis	B-T062
,	O
and	O
presentation	O
of	O
immunisation	B-T058
safety	O
data	O
maternal	B-T033
vaccination	B-T058
is	O
an	O
important	O
area	O
of	O
research	B-T062
and	O
requires	O
appropriate	O
and	O
internationally	O
comparable	O
definitions	B-T170
and	O
safety	B-T170
standards	I-T170
.	O
the	O
ga	B-T097
##ia	I-T097
group	I-T097
,	O
part	O
of	O
the	O
bright	B-T097
##on	I-T097
collaboration	I-T097
was	O
created	O
with	O
the	O
mand	O
##ate	O
of	O
propos	O
##ing	O
standardised	O
definitions	B-T170
applicable	O
to	O
maternal	B-T033
vaccine	B-T103
research	B-T062
.	O
this	O
study	B-T062
proposes	O
international	O
definitions	B-T170
for	O
neonatal	B-T038
infections	I-T038
.	O
the	O
neonatal	B-T038
infections	I-T038
ga	B-T097
##ia	I-T097
working	B-T098
group	I-T098
performed	O
a	O
literature	B-T170
review	O
using	O
medline	B-T170
,	O
embase	B-T170
and	O
the	O
cochrane	O
collaboration	O
and	O
collected	O
definitions	B-T170
in	O
use	O
in	O
neonatal	O
and	O
public	O
health	O
networks	O
.	O
the	O
common	O
criteria	O
derived	O
from	O
the	O
extensive	O
search	O
formed	O
the	O
basis	O
for	O
a	O
consensus	O
process	O
that	O
resulted	O
in	O
three	O
separate	O
definitions	B-T170
for	O
neonatal	O
blood	B-T038
stream	I-T038
infections	I-T038
(	O
bsi	B-T038
)	O
,	O
meningitis	B-T038
and	O
lower	B-T038
respiratory	I-T038
tract	I-T038
infections	I-T038
(	O
lr	B-T038
##ti	I-T038
)	O
.	O
for	O
each	O
definition	B-T170
three	O
levels	O
of	O
evidence	O
are	O
proposed	O
to	O
ensure	O
the	O
applicability	O
of	O
the	O
definitions	B-T170
to	O
different	O
settings	O
.	O
recommendations	O
about	O
data	B-T062
collection	I-T062
,	O
analysis	B-T062
and	O
presentation	O
are	O
presented	O
and	O
harmon	B-T062
##ized	I-T062
with	O
the	O
bright	B-T097
##on	I-T097
collaboration	I-T097
and	O
ga	B-T097
##ia	I-T097
format	B-T170
and	O
other	O
existing	O
international	B-T170
standards	I-T170
for	O
study	B-T062
reporting	B-T062
.	O

assessing	O
the	O
physiological	O
relevance	O
of	O
alternate	O
architectures	B-T082
of	O
the	O
p7	B-T103
protein	I-T103
of	O
hepatitis	B-T005
c	I-T005
virus	I-T005
in	O
different	O
environments	B-T082
the	O
vir	B-T038
##opo	I-T038
##rin	I-T038
p7	B-T103
of	O
the	O
hepatitis	B-T005
c	I-T005
virus	I-T005
forms	O
multim	B-T103
##eric	I-T103
channels	I-T103
eligible	O
for	O
ion	B-T038
transport	I-T038
across	O
the	O
endoplasmic	B-T017
reticulum	I-T017
membrane	I-T017
.	O
currently	O
the	O
subject	O
of	O
many	O
studies	B-T062
and	O
discussion	O
,	O
the	O
molecular	O
assembly	O
of	O
the	O
ion	B-T103
channel	I-T103
and	O
the	O
structural	B-T082
characteristics	O
of	O
the	O
p7	B-T103
monomer	B-T103
are	O
not	O
yet	O
fully	O
understood	O
.	O
structural	B-T082
investigation	O
of	O
p7	B-T103
has	O
been	O
carried	O
out	O
only	O
in	O
detergent	B-T103
environments	B-T082
,	O
making	O
the	O
interpretation	O
of	O
the	O
experimental	O
results	O
somewhat	O
questionable	O
.	O
here	O
,	O
we	O
analyze	B-T062
by	O
means	O
of	O
molecular	O
dynamics	O
simulations	O
the	O
structure	B-T082
of	O
the	O
p7	B-T103
monomer	B-T103
as	O
a	O
function	O
of	O
its	O
sequence	B-T082
,	O
initial	O
conformation	B-T082
and	O
environment	B-T082
.	O
we	O
investigate	O
the	O
conductance	O
properties	O
of	O
three	O
models	O
of	O
a	O
hexa	O
##mer	O
##ic	O
p7	B-T103
ion	B-T103
channel	I-T103
by	O
examining	O
ion	B-T038
translocation	I-T038
in	O
a	O
pure	O
lipid	B-T017
bilayer	I-T017
.	O
it	O
is	O
noteworthy	O
that	O
although	O
none	O
of	O
the	O
models	O
reflects	O
the	O
experimentally	O
observed	O
trend	O
to	O
conduct	O
preferentially	O
cations	B-T103
,	O
we	O
were	O
able	O
to	O
identify	O
the	O
position	B-T082
and	O
orientation	B-T082
of	O
titr	O
##atable	O
acidic	O
or	O
basic	O
residues	O
playing	O
a	O
crucial	O
role	O
in	O
ion	B-T103
selectivity	O
and	O
in	O
the	O
overall	O
conductance	O
of	O
the	O
channel	B-T103
.	O
in	O
addition	O
,	O
too	O
compact	O
a	O
packing	B-T038
of	O
the	O
monomers	B-T103
leads	O
to	O
channel	B-T103
collapse	O
rather	O
than	O
formation	O
of	O
a	O
reasonable	O
pore	B-T017
,	O
amenable	O
to	O
ion	B-T038
translocation	I-T038
.	O
the	O
present	O
findings	O
are	O
env	O
##ision	O
##ed	O
to	O
help	O
assess	O
the	O
physiological	O
relevance	O
of	O
p7	B-T103
ion	B-T103
channel	I-T103
models	O
consisting	O
of	O
multim	B-T082
##eric	I-T082
structures	I-T082
obtained	O
in	O
non	O
-	O
native	O
environments	B-T082
.	O

intestinal	B-T017
microp	B-T074
##atch	I-T074
##es	I-T074
for	O
oral	B-T082
insulin	O
delivery	O
diabetes	B-T038
mellitus	I-T038
has	O
become	O
a	O
major	O
public	O
health	O
issue	O
that	O
has	O
almost	O
reached	O
epidemic	O
proportions	O
worldwide	O
.	O
injectable	O
insulin	O
has	O
been	O
typically	O
utilized	O
for	O
the	O
management	B-T058
of	O
this	O
chronic	B-T038
disease	I-T038
.	O
however	O
,	O
lack	B-T033
of	I-T033
patient	I-T033
compliance	I-T033
with	O
injectable	B-T103
formulations	O
has	O
spur	O
##red	O
the	O
development	O
of	O
oral	B-T082
insulin	B-T103
formulations	O
,	O
which	O
although	O
appeal	O
##ing	O
,	O
face	O
several	O
delivery	B-T058
challenges	B-T058
.	O
we	O
have	O
developed	O
novel	O
muco	O
##adhes	O
##ive	O
intestinal	B-T017
patches	B-T074
,	O
several	O
hundred	O
micrometer	O
##s	O
in	O
dimension	O
(	O
microp	B-T074
##atch	I-T074
##es	I-T074
)	O
that	O
address	O
the	O
challenges	B-T058
of	O
oral	B-T082
insulin	O
delivery	O
.	O
the	O
microp	B-T074
##atch	I-T074
##es	I-T074
adhere	O
to	O
the	O
intestinal	B-T017
mucosa	I-T017
,	O
release	O
their	O
drug	B-T103
load	O
rapidly	O
within	O
30	O
min	O
and	O
are	O
effective	O
in	O
lowering	B-T033
blood	I-T033
glucose	I-T033
levels	I-T033
in	B-T082
vivo	I-T082
.	O
when	O
insulin	B-T103
-	O
loaded	O
microp	B-T074
##atch	I-T074
##es	I-T074
were	O
administered	B-T058
with	O
a	O
permeation	B-T103
enhancer	I-T103
and	O
protease	B-T103
inhibitor	I-T103
,	O
a	O
peak	O
efficacy	O
of	O
34	O
%	O
drop	B-T033
in	I-T033
blood	I-T033
glucose	I-T033
levels	I-T033
was	O
observed	O
within	O
3	O
h	O
.	O
efficacy	O
further	O
improved	O
to	O
41	O
%	O
when	O
microp	B-T074
##atch	I-T074
##es	I-T074
were	O
administered	B-T058
in	O
multiple	B-T201
doses	I-T201
.	O
here	O
,	O
we	O
describe	O
the	O
design	O
of	O
microp	B-T074
##atch	I-T074
##es	I-T074
as	O
an	O
oral	B-T082
insulin	B-T103
formulation	O
and	O
report	O
their	O
in	B-T082
vivo	I-T082
efficacy	O
.	O

identification	O
of	O
mineral	B-T103
-	O
binding	O
peptides	B-T103
that	O
discriminate	O
between	O
chalc	B-T103
##opyr	I-T103
##ite	I-T103
and	O
en	B-T103
##arg	I-T103
##ite	I-T103
innovative	O
approaches	O
to	O
the	O
separation	O
of	O
minerals	B-T103
and	O
subsequent	O
extraction	B-T058
of	O
metals	B-T103
are	O
imperative	O
owing	O
to	O
the	O
increasing	O
mineral	B-T103
##og	I-T103
##ical	I-T103
complexity	O
of	O
ore	B-T103
deposits	I-T103
that	O
are	O
difficult	O
or	O
even	O
impossible	B-T033
to	O
separate	O
into	O
slurr	O
##ies	O
or	O
solutions	O
containing	O
only	O
the	O
minerals	B-T103
or	O
metals	B-T103
of	O
interest	O
.	O
low	O
recovery	O
of	O
metal	B-T103
is	O
typical	O
for	O
these	O
complex	O
deposits	B-T103
leading	O
to	O
significant	O
losses	O
to	O
tail	B-T103
##ings	I-T103
.	O
in	O
addition	O
,	O
the	O
minerals	B-T103
often	O
contain	O
impurities	O
,	O
some	O
toxic	O
,	O
which	O
are	O
difficult	O
and	O
costly	O
to	O
control	O
or	O
manage	O
during	O
the	O
processing	O
of	O
a	O
concentrate	O
or	O
other	O
mineral	B-T103
product	O
.	O
one	O
example	O
of	O
this	O
complex	O
situation	O
is	O
the	O
significant	O
economic	O
and	O
environmental	B-T082
costs	O
associated	O
with	O
dil	O
##uting	O
and	O
processing	O
copper	B-T103
concentrates	O
containing	O
arsenic	B-T103
(	O
in	O
the	O
form	O
of	O
the	O
mineral	B-T103
en	I-T103
##arg	I-T103
##ite	I-T103
,	O
cu	B-T103
##3	I-T103
ass	I-T103
##4	I-T103
)	O
in	O
the	O
production	O
of	O
pure	O
copper	B-T103
.	O
to	O
overcome	O
these	O
separation	O
problems	B-T033
,	O
we	O
have	O
utilized	O
phage	B-T062
display	I-T062
to	O
identify	O
peptides	B-T103
that	O
demonstrate	O
selective	O
recognition	O
of	O
en	B-T103
##arg	I-T103
##ite	I-T103
and	O
the	O
arsenic	B-T103
-	O
free	O
copper	B-T103
sulfide	I-T103
,	O
chalc	B-T103
##opyr	I-T103
##ite	I-T103
.	O
screening	O
of	O
two	O
random	O
peptide	B-T103
phage	I-T103
display	I-T103
libraries	I-T103
resulted	O
in	O
the	O
identification	O
of	O
an	O
en	B-T103
##arg	I-T103
##ite	I-T103
-	O
selective	O
peptide	B-T103
with	O
the	O
sequence	B-T082
mh	I-T082
##k	I-T082
##pt	I-T082
##v	I-T082
##hi	I-T082
##kg	I-T082
##pt	I-T082
and	O
a	O
chalc	B-T103
##opyr	I-T103
##ite	I-T103
-	O
selective	O
peptide	B-T103
with	O
the	O
sequence	B-T082
rk	I-T082
##k	I-T082
##kc	I-T082
##kg	I-T082
##nc	I-T082
##cyt	I-T082
##p	I-T082
##q	I-T082
.	O
mineral	B-T103
-	O
binding	O
selectivity	O
was	O
demonstrated	O
by	O
binding	O
studies	B-T062
,	O
zeta	O
potential	O
determination	B-T058
and	O
immuno	B-T091
##chem	I-T091
##istry	I-T091
.	O
peptides	B-T103
that	O
have	O
the	O
ability	B-T033
to	O
discriminate	O
between	O
en	B-T103
##arg	I-T103
##ite	I-T103
and	O
chalc	B-T103
##opyr	I-T103
##ite	I-T103
provide	O
a	O
green	O
##er	O
option	O
for	O
the	O
separation	O
of	O
arsenic	B-T103
containing	O
contaminants	O
from	O
copper	B-T103
concentrates	O
.	O
this	O
represents	O
the	O
first	O
step	O
towards	O
a	O
major	O
advance	O
in	O
the	O
replacement	O
or	O
reduction	O
of	O
toxic	O
collect	O
##ors	O
as	O
well	O
as	O
reducing	O
the	O
level	O
of	O
arsenic	B-T103
-	O
bearing	O
minerals	B-T103
in	O
the	O
early	O
stages	O
of	O
mineral	B-T103
processing	O
.	O
biotechn	O
##ol	O
.	O
bio	O
##eng	O
.	O
2016	O
;	O
999	O
##9	O
:	O
1	O
-	O
8	O
.	O
©	O
2016	O
wiley	O
periodicals	O
,	O
inc	O
.	O

emergency	B-T092
department	I-T092
use	O
and	O
barriers	O
to	O
wellness	O
:	O
a	O
survey	B-T170
of	O
emergency	B-T092
department	I-T092
frequent	O
users	B-T098
there	O
is	O
no	O
common	O
understanding	O
of	O
how	O
needs	O
of	O
emergency	B-T092
department	I-T092
(	O
ed	B-T092
)	O
frequent	O
users	B-T098
differ	O
from	O
other	O
patients	O
.	O
this	O
study	B-T062
sought	O
to	O
examine	O
how	O
to	O
best	O
serve	O
this	O
population	B-T098
.	O
examinations	B-T058
of	O
why	O
ed	B-T092
frequent	O
users	B-T098
present	B-T033
to	O
the	O
ed	B-T092
,	O
what	O
barriers	O
to	O
care	B-T058
exist	O
,	O
and	O
what	O
service	O
offering	O
##s	O
may	O
help	O
these	O
patients	O
achieve	O
an	O
optimal	O
level	O
of	O
health	O
were	O
conducted	O
.	O
we	O
performed	O
a	O
prospective	B-T062
study	I-T062
of	O
frequent	O
ed	B-T092
users	B-T098
in	O
an	O
adult	O
only	O
,	O
level	B-T092
1	I-T092
trauma	I-T092
center	I-T092
with	O
approximately	O
90	O
,	O
000	O
visits	B-T058
per	O
year	O
.	O
frequent	O
ed	B-T092
users	B-T098
were	O
defined	O
as	O
those	O
who	O
make	O
four	O
or	O
more	O
ed	B-T058
visits	I-T058
in	O
a	O
12	O
month	O
period	O
.	O
participants	B-T098
were	O
administered	O
a	O
pilot	O
##ed	O
structured	O
interview	O
by	O
a	O
trained	B-T097
researcher	I-T097
query	B-T170
##ing	I-T170
demographics	O
,	O
ed	B-T092
usage	O
,	O
perceived	O
barriers	O
to	O
care	B-T058
,	O
and	O
potential	O
aids	O
to	O
maintaining	O
health	O
.	O
of	O
1	O
,	O
52	O
##3	O
screened	B-T058
patients	O
,	O
297	O
were	O
identified	O
as	O
frequent	O
ed	B-T092
users	B-T098
.	O
one	O
hundred	O
frequent	O
ed	B-T092
users	B-T098
were	O
enrolled	O
.	O
the	O
mean	O
age	O
was	O
48	O
years	O
(	O
95	O
%	O
ci	O
45	O
-	O
51	O
)	O
.	O
the	O
majority	O
of	O
subjects	B-T098
were	O
female	B-T098
(	O
64	O
%	O
,	O
64	O
/	O
100	O
,	O
95	O
%	O
ci	O
55	O
-	O
73	O
%	O
)	O
,	O
white	B-T098
(	O
61	O
%	O
,	O
60	O
/	O
98	O
,	O
95	O
%	O
ci	O
52	O
-	O
71	O
%	O
)	O
and	O
insured	O
by	O
medicaid	O
(	O
55	O
%	O
,	O
47	O
/	O
86	O
,	O
95	O
%	O
ci	O
44	O
-	O
65	O
%	O
)	O
or	O
medicare	O
(	O
23	O
%	O
,	O
20	O
/	O
86	O
,	O
95	O
%	O
ci	O
14	O
-	O
32	O
%	O
)	O
.	O
subjects	B-T098
had	O
a	O
median	O
of	O
6	O
ed	B-T058
visits	I-T058
,	O
and	O
2	O
inpatient	O
admissions	O
in	O
the	O
past	O
12	O
months	O
at	O
this	O
hospital	B-T092
.	O
most	O
frequent	O
ed	B-T092
users	B-T098
(	O
61	O
%	O
,	O
59	O
/	O
96	O
,	O
95	O
%	O
ci	O
52	O
-	O
71	O
%	O
)	O
stated	O
the	O
primary	O
reason	O
for	O
their	O
visit	B-T058
was	O
that	O
they	O
felt	O
that	O
their	O
health	O
problem	O
could	O
only	O
be	O
treated	O
in	O
an	O
ed	B-T092
.	O
transportation	O
presented	O
as	O
a	O
major	O
barrier	O
to	O
few	O
patients	O
(	O
7	O
%	O
,	O
7	O
/	O
95	O
,	O
95	O
%	O
ci	O
3	O
-	O
14	O
%	O
)	O
.	O
subjects	B-T098
stated	O
that	O
[UNK]	O
after	B-T058
-	I-T058
hours	I-T058
options	I-T058
,	O
besides	O
the	O
ed	B-T092
for	O
minor	O
health	O
issues	O
[UNK]	O
(	O
63	O
%	O
,	O
60	O
/	O
95	O
,	O
95	O
%	O
ci	O
53	O
-	O
73	O
%	O
)	O
and	O
having	O
[UNK]	O
a	O
nurse	B-T097
to	O
work	O
with	O
you	O
one	B-T058
-	I-T058
on	I-T058
-	I-T058
one	I-T058
to	O
help	O
manage	O
health	B-T058
care	I-T058
needs	O
[UNK]	O
(	O
53	O
%	O
,	O
50	O
/	O
95	O
,	O
95	O
%	O
ci	O
43	O
-	O
63	O
%	O
)	O
would	O
be	O
most	O
helpful	O
in	O
achieving	O
optimal	O
health	O
.	O
this	O
study	B-T062
characterized	O
ed	B-T092
frequent	O
users	B-T098
and	O
identified	O
several	O
opportunities	O
to	O
better	O
serve	O
this	O
population	B-T098
.	O
by	O
understanding	O
barriers	O
to	O
care	B-T058
from	O
the	O
patient	O
perspective	O
,	O
health	O
systems	O
can	O
potentially	O
address	O
unmet	O
needs	O
that	O
prevent	O
wellness	O
in	O
this	O
population	B-T098
.	O

fair	O
##ness	O
:	O
the	O
hidden	O
challenge	B-T058
for	O
competency	O
-	O
based	O
postgraduate	O
medical	O
education	O
programs	O
competency	O
-	O
based	O
medical	O
education	O
systems	O
allow	O
institutions	O
to	O
individual	O
##ize	O
teaching	O
practices	O
to	O
meet	O
the	O
needs	O
of	O
diverse	B-T098
learners	I-T098
.	O
yet	O
,	O
the	O
focus	O
on	O
continuous	O
improvement	O
and	O
individual	O
##ization	O
of	O
curricula	B-T170
does	O
not	O
ex	O
##emp	O
##t	O
programs	O
from	O
treating	O
learners	B-T098
in	O
a	O
fair	B-T033
manner	I-T033
.	O
when	O
learners	B-T098
fail	O
to	O
meet	O
key	O
competencies	O
and	O
are	O
placed	O
on	O
prob	O
##ation	O
or	O
dism	O
##iss	O
##ed	O
from	O
training	O
programs	O
,	O
issues	B-T033
of	O
fair	O
##ness	O
may	O
form	O
the	O
basis	O
of	O
their	O
legal	B-T170
claims	I-T170
.	O
in	O
a	O
literature	O
search	O
,	O
we	O
found	O
no	O
in	O
-	O
depth	O
examination	O
of	O
fair	O
##ness	O
.	O
in	O
this	O
paper	O
,	O
we	O
utilize	O
a	O
systems	O
lens	O
to	O
examine	B-T033
fair	O
##ness	O
within	O
postgraduate	O
medical	O
education	O
contexts	O
,	O
focusing	O
on	O
educational	B-T033
opportunities	I-T033
,	O
assessment	B-T058
practices	I-T058
,	O
decision	O
-	O
making	O
processes	O
,	O
fair	O
##ness	O
from	O
a	O
legal	O
stand	O
##point	O
,	O
and	O
fair	O
##ness	O
in	O
the	O
context	O
of	O
the	O
learning	O
environment	O
.	O
while	O
we	O
provide	O
examples	O
of	O
fair	O
##ness	O
issues	B-T033
within	O
us	B-T082
training	O
programs	O
,	O
concerns	O
regarding	O
fair	O
##ness	O
are	O
relevant	O
in	O
any	O
medical	O
education	O
system	O
which	O
utilizes	O
a	O
competency	O
-	O
based	O
education	O
framework	O
.	O
assessment	O
overs	O
##ight	O
committees	B-T097
and	O
annual	O
programm	O
##atic	O
evaluations	O
,	O
while	O
recommended	O
,	O
will	O
not	O
guarantee	O
fair	O
##ness	O
within	O
postgraduate	O
medical	O
education	O
programs	O
,	O
but	O
they	O
can	O
provide	O
a	O
window	O
into	O
'	O
hidden	O
'	O
threats	O
to	O
fair	O
##ness	O
,	O
as	O
every	O
##thi	O
##ng	O
from	O
training	O
experiences	O
to	O
assessment	B-T058
practices	I-T058
may	O
be	O
examined	B-T033
by	O
these	O
committees	B-T097
.	O
one	O
of	O
the	O
first	O
steps	O
programs	O
can	O
take	O
is	O
to	O
recognize	O
that	O
threats	O
to	O
fair	O
##ness	O
may	O
exist	O
in	O
any	O
educational	O
program	O
,	O
including	O
their	O
own	O
,	O
and	O
begin	O
convers	O
##ations	O
about	O
how	O
to	O
address	O
these	O
issues	B-T033
.	O

2	B-T103
,	I-T103
8	I-T103
-	I-T103
dihydroxy	I-T103
##aden	I-T103
##ine	I-T103
nephropathy	B-T038
identified	O
as	O
cause	O
of	O
end	B-T038
-	I-T038
stage	I-T038
renal	I-T038
disease	I-T038
after	O
renal	B-T058
transplant	I-T058
adenine	B-T038
phosphor	I-T038
##ib	I-T038
##osyltransferase	I-T038
deficiency	I-T038
is	O
a	O
rare	O
autosomal	B-T038
recessive	I-T038
disorder	I-T038
of	O
uric	B-T103
acid	I-T103
metabolism	B-T038
that	O
leads	O
to	O
formation	O
and	O
excretion	B-T038
of	O
2	B-T103
,	I-T103
8	I-T103
-	I-T103
dihydroxy	I-T103
##aden	I-T103
##ine	I-T103
into	O
urine	B-T031
.	O
the	O
low	O
solubility	O
of	O
2	B-T103
,	I-T103
8	I-T103
-	I-T103
dihydroxy	I-T103
##aden	I-T103
##ine	I-T103
results	O
in	O
precipitation	O
and	O
formation	O
of	O
urinary	B-T033
crystals	I-T033
and	O
renal	B-T038
stones	I-T038
.	O
patients	O
with	O
this	O
disorder	B-T038
usually	O
have	O
recurrent	B-T038
nephr	I-T038
##olith	I-T038
##iasis	I-T038
and	O
can	O
develop	O
nephropathy	B-T038
secondary	I-T038
to	O
crystal	B-T031
precipitation	O
in	O
the	O
renal	B-T017
parenchyma	I-T017
.	O
the	O
disease	B-T038
is	O
most	O
often	O
under	B-T033
##diagnosed	I-T033
and	O
can	O
rec	O
##ur	O
in	O
renal	B-T058
transplant	I-T058
,	O
causing	O
graft	B-T038
failure	I-T038
.	O
lack	O
of	O
specific	O
clinical	O
manifestations	O
,	O
chemical	O
and	O
radiologic	O
features	O
identical	O
to	O
those	O
shown	O
with	O
uric	B-T031
acid	I-T031
stones	I-T031
,	O
and	O
lack	B-T033
of	I-T033
awareness	I-T033
among	O
clinicians	B-T097
are	O
among	O
the	O
causes	O
for	O
the	O
under	B-T033
##diagn	I-T033
##oses	I-T033
of	O
this	O
treatable	O
disease	B-T038
.	O
allopurinol	B-T103
,	O
a	O
xanthine	B-T103
dehydrogenase	I-T103
inhibitor	B-T103
,	O
is	O
the	O
mainstay	O
of	O
treatment	O
,	O
supported	O
by	O
high	O
fluid	B-T201
intake	I-T201
and	O
dietary	B-T058
modifications	I-T058
.	O
the	O
possibility	O
of	O
adenine	B-T038
phosphor	I-T038
##ib	I-T038
##osyl	I-T038
transferase	I-T038
deficiency	I-T038
should	O
be	O
considered	O
in	O
all	O
cases	O
of	O
uro	B-T038
##lit	I-T038
##hi	I-T038
##asis	I-T038
in	O
children	O
,	O
patients	O
with	O
recurrent	O
uro	O
##lit	O
##hi	O
##asis	O
,	O
and	O
patients	O
with	O
uro	B-T038
##lit	I-T038
##hi	I-T038
##asis	I-T038
associated	O
with	O
renal	B-T038
failure	I-T038
of	O
unknown	O
cause	O
,	O
including	O
patients	O
with	O
end	B-T038
-	I-T038
stage	I-T038
renal	I-T038
disease	I-T038
and	O
renal	O
transplant	O
recipients	O
.	O
here	O
,	O
we	O
report	O
a	O
case	O
of	O
a	O
41	O
-	O
year	O
-	O
old	O
female	O
patient	O
who	O
had	O
a	O
late	O
diagnosis	O
of	O
2	B-T103
,	I-T103
8	I-T103
-	I-T103
dihydroxy	I-T103
##aden	I-T103
##ine	I-T103
nephropathy	B-T038
-	O
induced	O
end	B-T038
-	I-T038
stage	I-T038
renal	I-T038
disease	I-T038
,	O
made	O
on	O
the	O
native	O
nephrectomy	B-T058
that	O
accompanied	O
the	O
renal	B-T058
transplant	I-T058
,	O
and	O
who	O
had	O
a	O
timely	O
intervention	O
that	O
prevented	O
recurrence	B-T038
in	O
the	O
graft	B-T058
.	O

post	O
-	O
synthetic	O
conversion	O
of	O
5	B-T103
-	I-T103
piv	I-T103
##alo	I-T103
##yl	I-T103
##oxy	I-T103
##methyl	I-T103
##uridine	I-T103
present	B-T033
in	O
a	O
support	O
-	O
bound	O
rna	B-T103
oligomer	O
into	O
biologically	O
relevant	O
derivatives	B-T103
of	O
5	B-T103
-	I-T103
methyl	I-T103
##uridine	I-T103
a	O
post	O
-	O
synthetic	O
reaction	O
of	O
5	B-T103
-	I-T103
piv	I-T103
##alo	I-T103
##yl	I-T103
##oxy	I-T103
##methyl	I-T103
##uridine	I-T103
(	O
present	B-T033
in	O
a	O
support	O
-	O
bound	O
rna	B-T103
oligomer	O
)	O
with	O
various	O
nucleophilic	B-T103
reagents	I-T103
furn	O
##ished	O
efficiently	O
the	O
corresponding	O
products	O
bearing	O
one	O
ao	O
##f	O
the	O
trna	B-T038
w	I-T038
##ob	I-T038
##ble	I-T038
5	B-T103
-	I-T103
methyl	I-T103
##uridine	I-T103
##s	I-T103
(	O
mn	B-T103
##m	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
,	O
cm	B-T103
##nm	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
,	O
τ	B-T103
##m	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
,	O
nm	B-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
,	O
in	B-T103
##m	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
or	O
cn	B-T103
##m	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
)	O
.	O
the	O
syntheses	O
of	O
oligo	B-T103
##ri	I-T103
##bon	I-T103
##ucleotide	I-T103
##s	I-T103
modified	O
with	O
in	B-T103
##m	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
and	O
cn	B-T103
##m	I-T103
(	I-T103
5	I-T103
)	I-T103
u	I-T103
are	O
reported	O
for	O
the	O
first	O
time	O
.	O

description	O
of	O
the	O
first	O
species	B-T170
of	O
fi	B-T204
##oria	I-T204
##nt	I-T204
##e	I-T204
##on	I-T204
ol	I-T204
##mi	I-T204
(	O
hym	B-T204
##eno	I-T204
##pt	I-T204
##era	I-T204
,	O
dry	B-T204
##ini	I-T204
##da	I-T204
##e	I-T204
)	O
from	O
the	O
af	B-T082
##rot	I-T082
##ropical	I-T082
region	I-T082
fi	B-T204
##oria	I-T204
##nt	I-T204
##e	I-T204
##on	I-T204
sul	I-T204
##ca	I-T204
##t	I-T204
##ums	I-T204
##p	I-T204
.	O
n	O
.	O
is	O
described	O
from	O
fi	B-T082
##anar	I-T082
##ants	I-T082
##oa	I-T082
province	I-T082
(	O
mad	B-T082
##agas	I-T082
##car	I-T082
)	O
.	O
it	O
is	O
the	O
first	O
species	B-T170
of	O
fi	B-T204
##oria	I-T204
##nt	I-T204
##e	I-T204
##on	I-T204
found	O
in	O
the	O
af	B-T082
##rot	I-T082
##ropical	I-T082
region	I-T082
.	O
the	O
genus	B-T170
fi	B-T204
##oria	I-T204
##nt	I-T204
##e	I-T204
##on	I-T204
can	O
be	O
distinguished	O
from	O
the	O
closely	O
related	O
genus	B-T170
cong	B-T204
##ant	I-T204
##e	I-T204
##on	I-T204
by	O
the	O
distal	B-T082
part	O
of	O
the	O
stigma	B-T017
##l	I-T017
vein	I-T017
,	O
which	O
is	O
as	O
long	O
as	O
,	O
or	O
shorter	B-T033
than	O
the	O
proximal	B-T082
part	O
of	O
the	O
stigma	B-T017
##l	I-T017
vein	I-T017
(	O
longer	O
than	O
the	O
proximal	B-T082
part	O
of	O
the	O
vein	B-T017
in	O
cong	B-T204
##ant	I-T204
##e	I-T204
##on	I-T204
)	O
.	O

total	O
arsenic	B-T103
,	O
cadmium	B-T103
,	O
and	O
lead	B-T103
determination	B-T058
in	O
brazilian	B-T168
rice	I-T168
samples	O
using	O
icp	B-T058
-	I-T058
ms	I-T058
this	O
study	B-T062
is	O
aimed	O
at	O
investigating	O
a	O
suitable	O
method	B-T170
for	O
rice	B-T168
sample	O
preparation	O
as	O
well	O
as	O
validating	B-T062
and	O
applying	O
the	O
method	B-T170
for	O
monitoring	O
the	O
concentration	O
of	O
total	O
arsenic	B-T103
,	O
cadmium	B-T103
,	O
and	O
lead	B-T103
in	O
rice	B-T168
by	O
using	O
inductively	B-T058
coupled	I-T058
plasma	I-T058
mass	I-T058
spectrometry	I-T058
(	O
icp	B-T058
-	I-T058
ms	I-T058
)	O
.	O
various	O
rice	B-T168
sample	O
preparation	O
procedures	O
were	O
evaluated	O
.	O
the	O
analytical	O
method	O
was	O
validated	B-T062
by	O
measuring	O
several	O
parameters	B-T033
including	O
limit	O
of	O
detection	O
(	O
lod	O
)	O
,	O
limit	O
of	O
quantification	O
(	O
lo	O
##q	O
)	O
,	O
linearity	O
,	O
relative	O
bias	O
,	O
and	O
repeatability	O
.	O
regarding	O
the	O
sample	O
preparation	O
,	O
recoveries	O
of	O
spiked	O
samples	O
were	O
within	O
the	O
acceptable	O
range	O
from	O
89	O
.	O
3	O
to	O
98	O
.	O
2	O
%	O
for	O
mu	O
##ff	O
##le	O
furn	O
##ace	O
,	O
94	O
.	O
2	O
to	O
103	O
.	O
3	O
%	O
for	O
heating	O
block	O
,	O
81	O
.	O
0	O
to	O
115	O
.	O
0	O
%	O
for	O
hot	O
plate	O
,	O
and	O
92	O
.	O
8	O
to	O
108	O
.	O
2	O
%	O
for	O
microwave	O
.	O
validation	B-T062
parameters	B-T033
showed	O
that	O
the	O
method	B-T170
fits	O
for	O
its	O
purpose	O
,	O
being	O
the	O
total	O
arsenic	B-T103
,	O
cadmium	B-T103
,	O
and	O
lead	B-T103
within	O
the	O
brazilian	O
legislation	O
limits	O
.	O
the	O
method	B-T170
was	O
applied	O
for	O
analyzing	B-T062
37	O
rice	B-T168
samples	O
(	O
including	O
polish	B-T168
##ed	I-T168
,	O
brown	B-T168
,	O
and	O
par	B-T168
##bo	I-T168
##iled	I-T168
)	O
,	O
consumed	O
by	O
the	O
brazilian	O
population	O
.	O
the	O
total	O
arsenic	B-T103
,	O
cadmium	B-T103
,	O
and	O
lead	B-T103
contents	O
were	O
lower	O
than	O
the	O
established	O
legisl	O
##ative	O
values	O
,	O
except	O
for	O
total	O
arsenic	B-T103
in	O
one	O
brown	B-T168
rice	I-T168
sample	O
.	O
this	O
study	B-T062
indicated	O
the	O
need	O
to	O
establish	O
monitoring	O
programs	O
for	O
emphasizing	O
the	O
study	B-T062
on	O
this	O
type	O
of	O
cereal	B-T168
,	O
aiming	O
at	O
promoting	O
the	O
public	B-T170
health	I-T170
.	O

the	O
effects	O
of	O
gestational	O
use	O
of	O
antidepressants	B-T103
and	O
antipsychotics	B-T103
on	O
neonatal	O
outcomes	O
for	O
women	B-T098
with	O
severe	O
mental	B-T038
illness	I-T038
psychotropic	B-T103
medication	I-T103
use	O
occurs	O
in	O
8	O
%	O
of	O
pregnancies	B-T038
,	O
with	O
rates	O
increasing	O
,	O
and	O
often	O
multiple	O
medications	B-T103
prescribed	O
.	O
this	O
study	B-T062
aims	O
to	O
determine	O
if	O
the	O
use	O
of	O
psychotropic	B-T103
medication	I-T103
,	O
in	O
a	O
cohort	B-T098
of	O
women	B-T098
with	O
severe	O
mental	B-T038
illness	I-T038
,	O
increases	O
rates	O
of	O
special	B-T058
care	I-T058
nurse	I-T058
##ry	I-T058
admission	B-T058
and	O
reports	B-T170
differences	O
between	O
antidepressant	B-T103
and	O
antipsychotic	B-T103
medication	I-T103
use	O
either	O
alone	O
or	O
in	O
combination	B-T103
.	O
a	O
retrospective	B-T062
database	I-T062
analysis	I-T062
from	I-T062
a	I-T062
cohort	I-T062
with	O
severe	O
mental	B-T038
illness	I-T038
in	O
pregnancy	B-T038
identified	O
268	O
pregnant	B-T098
women	I-T098
who	O
were	O
grouped	B-T170
according	O
to	O
medication	B-T103
type	O
.	O
demographic	O
,	O
obstetric	O
and	O
neonatal	O
variables	O
were	O
analysed	B-T062
using	O
t	B-T170
-	I-T170
tests	I-T170
,	O
χ	O
(	O
2	O
)	O
,	O
analysis	B-T062
of	O
variance	O
and	O
logistic	O
regression	O
analysis	O
for	O
special	B-T058
care	I-T058
nurse	I-T058
##ry	I-T058
admission	B-T058
.	O
the	O
medication	O
groups	O
consisted	O
of	O
:	O
women	B-T098
taking	O
no	O
psychotropic	O
medications	O
(	O
n	O
=	O
67	O
)	O
;	O
those	O
taking	O
antipsychotics	O
(	O
n	O
=	O
87	O
)	O
;	O
those	O
taking	O
antidepressants	O
(	O
n	O
=	O
55	O
)	O
;	O
those	O
taking	O
and	O
a	O
combination	O
of	O
antidepressants	O
/	O
antipsychotics	O
(	O
n	O
=	O
59	O
)	O
.	O
rates	O
of	O
special	B-T058
care	I-T058
nurse	I-T058
##ry	I-T058
admission	B-T058
in	O
women	B-T098
who	O
took	O
psychotropic	B-T103
medication	I-T103
(	O
41	O
.	O
3	O
%	O
)	O
were	O
elevated	O
compared	O
to	O
those	O
who	O
did	O
not	O
(	O
26	O
.	O
9	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
035	O
)	O
,	O
and	O
were	O
significantly	O
raised	O
when	O
compared	O
to	O
the	O
general	B-T098
population	I-T098
(	O
p	O
<	O
0	O
.	O
000	O
)	O
.	O
no	O
significant	O
difference	O
occurred	O
between	O
the	O
medication	O
groups	O
.	O
a	O
significant	O
adjusted	O
odds	O
ratio	O
of	O
2	O
.	O
79	O
(	O
95	O
%	O
ci	O
1	O
.	O
286	O
-	O
6	O
.	O
049	O
)	O
was	O
found	B-T033
for	O
special	B-T058
care	I-T058
nurse	I-T058
##ry	I-T058
and	O
psychiatric	B-T058
admission	I-T058
during	O
pregnancy	B-T038
but	O
not	O
for	O
psychotropic	B-T103
medication	I-T103
.	O
rates	O
of	O
special	B-T058
care	I-T058
nurse	I-T058
##ry	I-T058
admission	B-T058
are	O
elevated	O
in	O
neonates	O
of	O
women	B-T098
with	O
severe	O
mental	B-T038
illness	I-T038
taking	O
psychotropic	B-T103
medication	I-T103
,	O
but	O
were	O
not	O
different	O
for	O
monotherapy	O
or	O
polyt	B-T058
##her	I-T058
##ap	I-T058
##y	I-T058
when	O
prescribing	O
antidepressants	B-T103
or	O
antipsychotic	B-T103
medication	I-T103
.	O
additional	O
vulnerability	O
occurs	O
in	O
the	O
neonates	O
of	O
women	B-T098
with	O
a	O
mental	B-T038
illness	I-T038
and	O
paediatric	B-T097
presence	O
at	O
delivery	B-T038
is	O
recommended	O
.	O

towards	O
culturally	B-T058
competent	I-T058
paediatric	I-T058
oncology	I-T058
care	I-T058
.	O
a	O
qualitative	B-T062
study	I-T062
from	O
the	O
perspective	O
of	O
care	B-T097
providers	I-T097
in	O
order	O
to	O
gain	O
more	O
insight	O
on	O
the	O
influence	O
of	O
ethnic	B-T033
diversity	O
in	O
paediatric	B-T091
cancer	O
care	O
,	O
the	O
perspectives	O
of	O
care	B-T097
providers	I-T097
were	O
explored	O
.	O
semi	O
-	O
structured	O
interviews	O
were	O
conducted	O
among	O
12	O
paediatric	B-T097
oncologists	I-T097
and	O
13	O
nurses	B-T097
of	O
two	O
different	O
paediatric	B-T092
oncology	I-T092
wards	I-T092
and	O
were	O
analysed	B-T062
using	O
a	O
framework	B-T170
method	I-T170
.	O
we	O
found	O
that	O
care	B-T097
providers	I-T097
described	O
the	O
contact	O
with	O
turkish	B-T098
and	O
mor	B-T098
##occ	I-T098
##an	I-T098
parents	O
as	O
more	O
difficult	O
.	O
they	O
offered	O
two	O
reasons	O
for	O
this	O
:	O
(	O
1	O
)	O
language	B-T033
barriers	I-T033
between	O
care	B-T097
provider	I-T097
and	O
parents	O
hindered	O
the	O
exchange	O
of	O
information	O
;	O
(	O
2	O
)	O
cultural	O
barriers	O
between	O
care	B-T097
provider	I-T097
and	O
parents	O
about	O
sharing	O
the	O
diagnosis	B-T033
and	O
palliative	O
perspective	O
hindered	O
communication	O
.	O
care	B-T097
providers	I-T097
reported	O
different	O
solutions	O
to	O
deal	O
with	O
these	O
barriers	O
,	O
such	O
as	O
using	O
an	O
interpret	B-T097
##er	I-T097
and	O
improving	O
their	O
cultural	B-T170
knowledge	I-T170
about	O
their	O
patients	O
.	O
they	O
,	O
however	O
,	O
were	O
not	O
using	O
interpret	B-T097
##ers	I-T097
sufficiently	O
and	O
were	O
unaware	O
of	O
the	O
importance	O
of	O
eliciting	B-T038
parents	O
'	O
perspectives	O
.	O
communication	O
techniques	O
to	O
overcome	O
dilemmas	O
between	O
parents	O
and	O
care	B-T097
providers	I-T097
were	O
not	O
used	O
and	O
care	B-T097
providers	I-T097
were	O
unaware	O
of	O
stereotyp	O
##es	O
and	O
pre	O
##ju	O
##di	O
##ce	O
.	O
care	B-T097
providers	I-T097
should	O
be	O
offered	O
insight	O
in	O
cultural	O
barriers	O
they	O
are	O
unaware	O
of	O
.	O
training	O
in	O
cultural	O
competence	O
might	O
be	O
a	O
possibility	O
to	O
overcome	O
manifest	O
barriers	O
.	O

real	O
-	O
time	O
monitoring	B-T058
of	O
vesicle	B-T017
ph	O
in	O
an	O
endocytic	B-T038
pathway	B-T038
using	O
an	O
egf	B-T103
-	O
conjugated	B-T103
two	I-T103
-	I-T103
photon	I-T103
probe	I-T103
herein	O
,	O
we	O
developed	O
a	O
ratio	B-T103
##met	I-T103
##ric	I-T103
two	I-T103
-	I-T103
photon	I-T103
probe	I-T103
(	O
bh	B-T103
##s	I-T103
##3	I-T103
-	O
egf	B-T103
)	O
,	O
derived	O
from	O
a	O
ph	O
sensitive	O
dye	O
and	O
epidermal	B-T103
growth	I-T103
factor	I-T103
(	O
egf	B-T103
)	O
,	O
for	O
real	O
-	O
time	O
monitoring	B-T058
and	O
quantitative	O
analysis	B-T062
of	O
acidic	B-T082
luminal	I-T082
ph	O
values	O
during	O
endocytic	B-T038
pathway	B-T038
activity	I-T038
.	O
two	O
-	O
photon	O
microscopy	O
imaging	O
with	O
bh	B-T103
##s	I-T103
##3	I-T103
-	O
egf	B-T103
allows	O
the	O
quantitative	O
analysis	B-T062
of	O
ph	O
distributions	O
of	O
single	O
vesicles	B-T017
and	O
their	O
dynamics	O
in	O
receptor	B-T038
-	I-T038
mediated	I-T038
endocytosis	I-T038
in	O
real	O
-	O
time	O
.	O

an	O
influenza	B-T005
a	I-T005
virus	I-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
anti	B-T033
-	I-T033
neuraminidase	I-T033
monoclonal	B-T103
antibody	I-T103
with	O
prophylactic	B-T058
and	I-T058
therapeutic	I-T058
activity	I-T058
in	B-T082
vivo	I-T082
zoonotic	B-T038
a	B-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
avian	I-T005
influenza	I-T005
viruses	I-T005
emerged	O
in	O
china	B-T082
in	O
2013	O
and	O
continue	O
to	O
be	O
a	O
threat	O
to	O
human	B-T204
public	B-T058
health	I-T058
,	O
having	O
infected	B-T033
over	O
800	O
individuals	B-T098
with	O
a	O
mortality	O
rate	O
approaching	O
40	O
%	O
.	O
treatment	B-T058
options	I-T058
for	O
people	O
infected	B-T033
with	O
a	B-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
include	O
the	O
use	O
of	O
neuraminidase	B-T103
(	I-T103
na	I-T103
)	I-T103
inhibitors	I-T103
.	O
however	O
,	O
like	O
other	O
influenza	B-T005
viruses	I-T005
,	O
a	B-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
can	O
become	O
resistant	O
to	O
these	O
drugs	B-T103
.	O
the	O
use	O
of	O
monoclonal	B-T103
antibodies	I-T103
is	O
a	O
rapidly	O
developing	O
strategy	O
for	O
controlling	O
influenza	B-T005
virus	I-T005
infection	B-T038
.	O
here	O
we	O
generated	O
a	O
murine	B-T204
monoclonal	B-T103
antibody	I-T103
(	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
)	O
directed	O
against	O
the	O
na	O
of	O
a	B-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
and	O
show	O
that	O
prophylactic	O
systemic	O
administration	O
of	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
fully	O
protected	O
mice	O
from	O
lethal	O
challenge	O
with	O
wild	B-T017
-	I-T017
type	I-T017
a	B-T005
/	I-T005
an	I-T005
##hu	I-T005
##i	I-T005
/	I-T005
1	I-T005
/	I-T005
2013	I-T005
(	O
h7	B-T005
##n	I-T005
##9	I-T005
)	O
.	O
further	O
,	O
post	O
-	O
infection	B-T038
treatment	B-T058
with	O
a	O
single	O
systemic	O
dose	O
of	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
at	O
either	O
24	O
,	O
48	O
or	O
72	O
h	O
post	O
a	B-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
challenge	O
resulted	O
in	O
both	O
dose	O
-	O
and	O
time	O
-	O
dependent	O
protection	O
of	O
up	O
to	O
100	O
%	O
of	O
mice	B-T204
,	O
demonstrating	O
therapeutic	O
potential	O
for	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
.	O
epitope	B-T058
mapping	I-T058
revealed	O
that	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
binds	B-T038
near	O
the	O
enzyme	B-T103
active	O
site	O
of	O
na	O
,	O
and	O
functional	O
characterization	O
showed	O
that	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
inhibits	O
the	O
enzyme	B-T038
activity	I-T038
of	O
na	O
and	O
restrict	O
##s	O
the	O
cell	O
-	O
to	O
-	O
cell	O
spread	O
of	O
the	O
virus	B-T005
in	O
cultured	B-T017
cells	I-T017
.	O
affinity	O
analysis	B-T062
also	O
revealed	O
that	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
binds	B-T038
equally	O
well	O
to	O
recombinant	B-T103
na	O
of	O
wild	B-T017
-	I-T017
type	I-T017
a	B-T005
/	I-T005
an	I-T005
##hu	I-T005
##i	I-T005
/	I-T005
1	I-T005
/	I-T005
2013	I-T005
and	O
to	O
a	O
variant	O
na	O
carrying	O
a	O
r2	O
##89	O
##k	O
mutation	B-T038
known	O
to	O
infer	O
na	B-T103
##i	I-T103
resistance	O
.	O
these	O
results	O
suggest	O
that	O
3c	B-T103
##10	I-T103
-	I-T103
3	I-T103
has	O
the	O
potential	O
to	O
be	O
used	O
as	O
a	O
therapeutic	O
to	O
treat	O
a	B-T005
(	I-T005
h7	I-T005
##n	I-T005
##9	I-T005
)	I-T005
infections	B-T038
either	O
as	O
an	O
alternative	O
to	O
,	O
or	O
in	O
combination	O
with	O
,	O
current	O
na	O
antiviral	B-T103
inhibitors	I-T103
.	O

effects	O
of	O
transplanted	B-T058
human	B-T204
cord	B-T031
blood	I-T031
-	O
mononuclear	O
cells	O
on	O
pulmonary	B-T038
hypertension	I-T038
in	O
immunodeficient	O
mice	O
and	O
their	O
distribution	O
to	O
investigate	B-T058
the	O
effects	O
of	O
human	B-T204
umbilical	B-T031
cord	I-T031
blood	I-T031
-	O
derived	O
mononuclear	O
cell	O
(	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
)	O
transplantation	B-T058
on	O
pulmonary	B-T038
hypertension	I-T038
(	O
ph	B-T038
)	O
induced	O
by	O
monoc	B-T103
##rotal	I-T103
##ine	I-T103
(	O
mct	B-T103
)	O
in	O
immunodeficient	O
mice	O
and	O
their	O
distribution	O
.	O
mct	B-T103
was	O
administered	O
to	O
balb	B-T204
/	I-T204
c	I-T204
slc	I-T204
-	I-T204
nu	I-T204
/	I-T204
nu	I-T204
mice	I-T204
,	O
and	O
ph	B-T038
was	O
induced	O
in	O
mice	B-T204
4	O
weeks	O
later	O
.	O
fresh	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
##s	O
harvested	B-T058
from	O
a	O
human	B-T204
donor	B-T098
after	O
her	O
delivery	O
were	O
injected	O
intravenously	O
into	O
those	O
ph	B-T038
mice	B-T204
.	O
the	O
medial	B-T082
thickness	O
of	O
pulmonary	B-T017
arterioles	I-T017
,	O
ratio	O
of	O
right	B-T017
ventricular	I-T017
to	O
septum	B-T017
plus	O
left	B-T017
ventricular	I-T017
weight	O
(	O
rv	B-T017
/	O
s	B-T017
+	O
lv	B-T017
)	O
,	O
and	O
ratio	O
of	O
acceleration	O
time	O
to	O
ejection	B-T201
time	I-T201
of	O
pulmonary	O
blood	O
flow	O
waveform	O
(	O
at	O
/	O
et	B-T201
)	O
were	O
determined	O
4	O
weeks	O
after	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
transplantation	B-T058
.	O
to	O
reveal	O
the	O
incorporation	O
into	O
the	O
lung	B-T017
,	O
cmt	B-T103
##mr	I-T103
-	O
labeled	B-T103
hu	B-T031
##cb	I-T031
-	O
mnc	O
##s	O
were	O
observed	O
in	O
the	O
lung	B-T017
by	O
fluorescent	B-T058
microscopy	I-T058
.	O
dir	B-T103
-	I-T103
labeled	I-T103
hu	B-T031
##cb	I-T031
-	O
mnc	O
##s	O
were	O
detected	B-T033
in	O
the	O
lung	B-T017
and	O
other	O
organs	B-T017
by	O
bioluminescence	O
images	O
.	O
medial	B-T082
thickness	O
,	O
rv	B-T017
/	O
s	B-T017
+	O
lv	B-T017
and	O
at	O
/	O
et	B-T201
were	O
significantly	O
improved	B-T033
4	O
weeks	O
after	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
transplantation	B-T058
compared	O
with	O
those	O
in	O
mice	B-T204
without	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
transplantation	B-T058
.	O
cmt	B-T103
##mr	I-T103
-	O
positive	B-T033
hu	B-T031
##cb	I-T031
-	O
mnc	O
##s	O
were	O
observed	O
in	O
the	O
lung	B-T017
3	O
hours	O
after	O
transplantation	B-T058
.	O
bioluminescence	B-T038
signals	O
were	O
detected	B-T033
more	O
strongly	O
in	O
the	O
lung	B-T017
than	O
in	O
other	O
organs	B-T017
for	O
24	O
hours	O
after	O
transplantation	B-T058
.	O
the	O
results	O
indicate	B-T033
that	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
##s	O
are	O
incorporated	O
into	O
the	O
lung	B-T017
early	O
after	O
hu	B-T031
##cb	I-T031
-	O
mnc	O
transplantation	B-T058
and	O
improve	B-T033
mct	B-T103
-	O
induced	O
ph	B-T038
.	O
j	O
.	O
med	O
.	O
invest	O
.	O
64	O
:	O
43	O
-	O
49	O
,	O
february	O
,	O
2017	O
.	O

atypical	O
microglial	B-T017
response	O
to	O
biod	B-T103
##ies	I-T103
##el	I-T103
exhaust	I-T103
in	O
healthy	O
and	O
hypertensive	B-T038
rats	B-T204
accumulating	O
evidence	O
suggests	O
a	O
deleterious	O
role	O
for	O
urban	B-T082
air	O
pollution	O
in	O
central	B-T038
nervous	I-T038
system	I-T038
(	I-T038
cns	I-T038
)	I-T038
diseases	I-T038
and	O
neurodevelopmental	B-T038
disorders	I-T038
.	O
microglia	B-T017
,	O
the	O
resident	O
innate	O
immune	B-T017
cells	I-T017
and	O
sentinel	B-T103
##s	I-T103
in	O
the	O
brain	B-T017
,	O
are	O
a	O
common	O
source	B-T033
of	O
neuroinflammation	O
and	O
are	O
implicated	O
in	O
air	O
pollution	O
-	O
induced	O
cns	B-T038
effects	I-T038
.	O
while	O
renewable	O
energy	O
,	O
such	O
as	O
soy	B-T103
-	I-T103
based	I-T103
biof	I-T103
##uel	I-T103
,	O
is	O
of	O
increasing	O
public	B-T098
interest	B-T038
,	O
there	O
is	O
little	O
information	O
on	O
how	O
soy	B-T103
biof	I-T103
##uel	I-T103
may	O
affect	O
the	O
brain	B-T017
,	O
especially	O
in	O
people	B-T098
with	O
preexisting	B-T033
disease	I-T033
conditions	I-T033
.	O
to	O
address	O
this	O
,	O
male	O
spontaneously	B-T204
hypertensive	I-T204
rats	I-T204
(	O
shr	B-T204
)	O
and	O
normotensive	B-T033
wistar	B-T204
kyoto	I-T204
(	I-T204
wky	I-T204
)	I-T204
rats	I-T204
were	O
exposed	O
to	O
100	B-T103
%	I-T103
soy	I-T103
-	I-T103
based	I-T103
biod	I-T103
##ies	I-T103
##el	I-T103
exhaust	I-T103
(	O
100	B-T103
##s	I-T103
##bd	I-T103
##e	I-T103
;	O
0	O
,	O
50	O
,	O
150	O
and	O
500	O
##μg	O
/	O
m	O
(	O
3	O
)	O
)	O
by	O
inhalation	B-T038
,	O
4h	O
/	O
day	O
for	O
4	O
weeks	O
(	O
5	O
days	O
/	O
week	O
)	O
.	O
ionized	B-T103
calcium	I-T103
-	I-T103
binding	I-T103
adapt	I-T103
##er	I-T103
molecule	I-T103
-	I-T103
1	I-T103
(	O
ib	B-T103
##a	I-T103
-	I-T103
1	I-T103
)	O
staining	B-T058
of	O
microglia	B-T017
in	O
the	O
substantia	B-T017
nigra	I-T017
revealed	O
significant	O
changes	O
in	O
morphology	O
with	O
100	B-T103
##s	I-T103
##bd	I-T103
##e	I-T103
exposure	O
in	O
rats	B-T204
from	O
both	O
genotypes	O
,	O
where	O
shr	B-T204
were	O
less	O
sensitive	O
.	O
ac	B-T038
##onit	I-T038
##ase	I-T038
activity	I-T038
was	O
inhibited	O
in	O
the	O
frontal	B-T017
cortex	I-T017
and	O
cerebellum	B-T017
of	O
wky	B-T204
rats	I-T204
exposed	O
to	O
100	B-T103
##s	I-T103
##bd	I-T103
##e	I-T103
.	O
no	O
consistent	O
changes	O
occurred	O
in	O
pro	O
-	O
inflammatory	O
cytokine	B-T103
expression	B-T038
,	O
nitrate	B-T103
##d	I-T103
protein	I-T103
,	O
or	O
arginase	B-T103
##1	I-T103
expression	B-T038
in	O
brain	B-T082
regions	I-T082
from	O
either	O
rat	B-T204
strain	I-T204
exposed	O
to	O
100	B-T103
##s	I-T103
##bd	I-T103
##e	I-T103
.	O
however	O
,	O
while	O
ib	B-T103
##a	I-T103
-	I-T103
1	I-T103
mrna	B-T038
expression	I-T038
was	O
not	O
modified	O
,	O
cx	B-T103
##3c	I-T103
##r1	I-T103
mrna	B-T038
expression	I-T038
was	O
lower	O
in	O
the	O
striatum	B-T017
of	O
100	B-T103
##s	I-T103
##bd	I-T103
##e	I-T103
exposed	B-T204
rats	I-T204
regardless	O
of	O
genotype	O
,	O
suggesting	O
a	O
downregulation	B-T038
of	O
the	O
fractal	B-T103
##kin	I-T103
##e	I-T103
receptor	I-T103
on	O
microglia	B-T017
in	O
this	O
brain	B-T082
region	I-T082
.	O
together	O
,	O
these	O
data	O
indicate	O
that	O
while	O
microglia	B-T017
are	O
detecting	B-T033
and	O
responding	O
to	O
100	B-T103
##s	I-T103
##bd	I-T103
##e	I-T103
exposure	O
with	O
changes	O
in	O
morphology	O
,	O
there	O
is	O
reduced	O
expression	B-T038
of	O
cx	B-T103
##3c	I-T103
##r1	I-T103
regardless	O
of	O
genetic	O
background	O
and	O
the	O
activation	O
response	O
is	O
atypical	O
without	O
traditional	O
inflammatory	B-T201
markers	I-T201
of	O
m1	B-T017
or	O
m2	B-T017
activation	O
in	O
the	O
brain	B-T017
.	O

cxcl	B-T103
##14	I-T103
-	O
cxcr4	B-T103
and	O
cxcl	B-T103
##12	I-T103
-	O
cxcr4	B-T103
axes	O
may	O
play	O
important	O
roles	O
in	O
the	O
unique	O
invasion	B-T033
process	O
of	O
endometri	B-T038
##oid	I-T038
carcinoma	I-T038
with	O
mel	B-T082
##f	I-T082
-	I-T082
pattern	I-T082
myo	B-T033
##in	I-T033
##vas	I-T033
##ion	I-T033
the	O
term	O
[UNK]	O
mel	B-T082
##f	I-T082
-	I-T082
pattern	I-T082
myometrial	B-T082
invasion	B-T033
[UNK]	O
(	O
mel	B-T082
##f	I-T082
pattern	I-T082
)	O
den	O
##otes	O
an	O
unusual	O
morphology	O
of	O
myometrial	B-T082
invasion	B-T033
in	O
endometri	B-T038
##oid	I-T038
carcinomas	I-T038
,	O
and	O
is	O
associated	O
with	O
frequent	O
lympho	B-T033
##vascular	I-T033
invasion	I-T033
and	O
lymph	B-T038
node	I-T038
metastasis	I-T038
.	O
in	O
this	O
study	O
,	O
tumor	B-T017
cells	I-T017
were	O
directly	O
collected	O
from	O
a	O
mel	B-T082
##f	I-T082
pattern	I-T082
site	O
,	O
using	O
laser	B-T058
microdiss	I-T058
##ection	I-T058
.	O
comprehensive	O
microarray	B-T058
analysis	I-T058
of	O
the	O
genes	B-T017
was	O
conducted	O
,	O
and	O
based	O
on	O
the	O
results	O
,	O
expression	B-T038
of	O
a	O
metastasis	B-T103
progression	I-T103
gene	I-T103
,	I-T103
cxcr4	I-T103
,	O
and	O
its	O
ligands	B-T038
cxcl	B-T103
##14	I-T103
and	O
cxcl	B-T103
##12	I-T103
,	O
was	O
further	O
investigated	O
.	O
in	O
vitro	O
studies	O
of	O
endometri	B-T038
##oid	I-T038
carcinoma	I-T038
cell	B-T017
lines	I-T017
revealed	O
elevated	O
invasion	B-T033
activity	O
in	O
a	O
manner	O
dependent	O
on	O
the	O
cxcl	B-T103
##14	I-T103
-	O
cxcr4	B-T103
or	O
cxcl	B-T103
##12	I-T103
-	O
cxcr4	B-T103
axis	O
.	O
immunohistochemical	O
analysis	O
of	O
93	O
(	O
mel	O
##f	O
group	O
,	O
46	O
;	O
non	O
-	O
mel	O
##f	O
group	O
,	O
47	O
)	O
cases	O
illustrated	O
cxcr4	B-T103
was	O
expressed	B-T038
in	O
all	O
endometri	B-T038
##oid	I-T038
carcinomas	I-T038
,	O
while	O
based	O
on	O
cxcl	B-T103
##14	I-T103
and	O
cxcl	B-T103
##12	I-T103
expression	B-T038
score	O
,	O
high	O
proportions	O
of	O
cells	B-T017
were	O
positive	B-T033
at	O
the	O
sites	B-T082
of	O
the	O
mel	B-T082
##f	I-T082
pattern	I-T082
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
there	O
was	O
no	B-T033
significant	I-T033
difference	I-T033
in	O
progression	O
-	O
free	O
survival	O
or	O
overall	O
survival	O
between	O
mel	O
##f	O
group	O
and	O
non	O
-	O
mel	O
##f	O
group	O
by	O
kaplan	O
-	O
meier	O
analysis	O
.	O
these	O
findings	O
suggest	O
a	O
possibility	O
that	O
cells	B-T017
at	O
the	O
sites	B-T082
of	O
mel	B-T082
##f	I-T082
pattern	I-T082
had	O
acquired	O
increased	O
invasiveness	B-T038
through	O
the	O
function	B-T038
of	O
the	O
cxcl	B-T103
##14	I-T103
-	O
cxcr4	B-T103
and	O
cxcl	B-T103
##12	I-T103
-	O
cxcr4	B-T103
axes	O
.	O

a	O
double	B-T062
-	I-T062
blind	I-T062
randomized	B-T062
controlled	I-T062
trial	I-T062
of	O
maternal	B-T038
postpartum	I-T038
de	B-T058
##worm	I-T058
##ing	I-T058
to	O
improve	O
infant	O
weight	B-T033
gain	I-T033
in	O
the	O
peru	O
##vian	O
amazon	O
nutritional	B-T058
interventions	I-T058
targeting	O
the	O
critical	O
growth	O
and	O
development	O
period	O
before	O
two	O
years	O
of	O
age	O
can	O
have	O
the	O
greatest	O
impact	O
on	O
health	O
trajectories	O
over	O
the	O
life	O
course	O
.	O
compelling	O
evidence	O
has	O
demonstrated	O
that	O
interventions	B-T058
invest	O
##ing	O
in	O
maternal	O
health	O
in	O
the	O
first	O
1000	O
days	O
of	O
life	O
are	O
beneficial	O
for	O
both	O
mothers	O
and	O
their	O
children	O
.	O
one	O
such	O
potential	O
intervention	B-T058
is	O
de	B-T058
##worm	I-T058
##ing	I-T058
integrated	O
into	O
maternal	O
postpartum	O
care	O
in	O
areas	B-T082
where	O
soil	O
-	O
transmitted	O
helminth	B-T204
(	O
st	B-T204
##h	I-T204
)	O
infections	B-T038
are	O
endemic	B-T038
.	O
from	O
february	O
to	O
august	O
2014	O
,	O
101	O
##0	O
mother	O
-	O
infant	O
pairs	O
were	O
recruited	O
into	O
a	O
trial	B-T062
aimed	O
at	O
assessing	B-T058
the	O
effectiveness	O
of	O
maternal	B-T038
postpartum	I-T038
de	B-T058
##worm	I-T058
##ing	I-T058
on	O
infant	O
and	O
maternal	O
health	O
outcomes	O
.	O
following	O
delivery	B-T038
,	O
mothers	O
were	O
randomly	O
assigned	O
to	O
receive	O
either	O
single	O
-	O
dose	O
400	O
mg	O
alb	B-T103
##endazole	I-T103
or	O
placebo	B-T103
.	O
participants	B-T098
were	O
followed	B-T058
-	I-T058
up	I-T058
at	O
1	O
and	O
6	O
months	O
postpartum	O
.	O
there	O
was	O
no	B-T033
statistically	I-T033
significant	I-T033
difference	O
in	O
mean	O
weight	B-T033
gain	I-T033
between	O
infants	O
in	O
the	O
experimental	O
and	O
control	O
groups	O
(	O
mean	O
difference	O
:	O
-	O
0	O
.	O
02	O
;	O
95	O
%	O
ci	O
:	O
-	O
0	O
.	O
1	O
,	O
0	O
.	O
08	O
)	O
at	O
6	O
months	O
of	O
age	O
.	O
further	O
,	O
de	B-T058
##worm	I-T058
##ing	I-T058
had	O
no	O
effect	O
on	O
measured	O
infant	O
morbidity	O
indicators	B-T170
.	O
however	O
,	O
ad	B-T170
hoc	I-T170
analyses	I-T170
restricted	O
to	O
mothers	O
who	O
tested	O
positive	B-T033
for	O
st	B-T204
##hs	I-T204
at	O
baseline	O
suggest	O
that	O
infants	O
of	O
mothers	O
in	O
the	O
experimental	O
group	O
had	O
greater	O
mean	O
length	O
gain	O
in	O
cm	O
(	O
mean	O
difference	O
:	O
0	O
.	O
8	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
1	O
,	O
1	O
.	O
4	O
)	O
and	O
length	O
-	O
for	O
-	O
age	O
z	O
-	O
score	O
(	O
mean	O
difference	O
:	O
0	O
.	O
5	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
2	O
,	O
0	O
.	O
8	O
)	O
at	O
6	O
months	O
of	O
age	O
.	O
in	O
a	O
study	B-T098
population	I-T098
composed	O
of	O
both	O
st	B-T038
##h	I-T038
-	I-T038
infected	I-T038
and	O
uninfected	O
mothers	O
,	O
maternal	B-T038
postpartum	I-T038
de	B-T058
##worm	I-T058
##ing	I-T058
was	O
insufficient	O
to	O
impact	O
infant	O
growth	B-T038
and	O
morbidity	O
indicators	B-T170
up	O
to	O
6	O
months	O
postpartum	O
.	O
among	O
st	B-T038
##h	I-T038
-	I-T038
infected	I-T038
mothers	O
,	O
however	O
,	O
important	O
improvements	O
in	O
infant	O
length	O
gain	O
and	O
length	O
-	O
for	O
-	O
age	O
were	O
observed	O
.	O
the	O
benefits	O
of	O
maternal	B-T038
postpartum	I-T038
de	B-T058
##worm	I-T058
##ing	I-T058
should	O
be	O
further	O
investigated	O
in	O
study	B-T098
populations	I-T098
having	O
higher	O
overall	O
prevalences	O
and	O
intensities	B-T170
of	O
st	B-T038
##h	I-T038
infections	I-T038
and	O
,	O
in	O
particular	O
,	O
where	O
wh	B-T038
##ip	I-T038
##worm	I-T038
and	O
hook	B-T038
##worm	I-T038
infections	I-T038
are	O
of	O
public	B-T058
health	I-T058
concern	I-T058
.	O
clinicaltrials	O
.	O
gov	O
(	O
nct0	O
##17	O
##48	O
##92	O
##9	O
)	O
.	O

a	O
fast	B-T170
small	I-T170
-	I-T170
sample	I-T170
kernel	I-T170
independence	I-T170
test	I-T170
for	O
microbiome	O
community	O
-	O
level	B-T062
association	I-T062
analysis	I-T062
to	O
fully	O
understand	O
the	O
role	O
of	O
microbiome	O
in	O
human	B-T204
health	O
and	O
diseases	B-T038
,	O
researchers	B-T097
are	O
increasingly	O
interested	O
in	O
assessing	O
the	O
relationship	O
between	O
microbiome	O
composition	O
and	O
host	O
genomic	B-T017
data	O
.	O
the	O
dimensionality	B-T082
of	O
the	O
data	O
as	O
well	O
as	O
complex	O
relationships	O
between	O
microbiota	O
and	O
host	O
genomics	B-T017
pose	O
considerable	O
challenges	B-T058
for	O
analysis	B-T062
.	O
in	O
this	O
article	O
,	O
we	O
apply	O
a	O
kernel	B-T170
rv	I-T170
coefficient	I-T170
(	I-T170
kr	I-T170
##v	I-T170
)	I-T170
test	I-T170
to	O
evaluate	O
the	O
overall	O
association	O
between	O
host	O
gene	B-T038
expression	I-T038
and	O
microbiome	O
composition	O
.	O
the	O
kr	B-T170
##v	I-T170
statistic	I-T170
can	O
capture	O
nonlinear	O
correlations	O
and	O
complex	O
relationships	O
among	O
the	O
individual	O
data	O
types	O
and	O
between	O
gene	B-T038
expression	I-T038
and	O
microbiome	O
composition	O
through	O
measuring	O
general	O
dependency	O
.	O
testing	O
proceeds	O
via	O
a	O
similar	O
route	O
as	O
existing	O
tests	B-T170
of	O
the	O
generalized	O
rv	O
coefficients	O
and	O
allows	O
for	O
rapid	O
p	O
-	O
value	O
calculation	O
.	O
strategies	O
to	O
allow	O
adjustment	O
for	O
confounding	O
effects	O
,	O
which	O
is	O
crucial	O
for	O
avoiding	O
misleading	O
results	O
,	O
and	O
to	O
alleviate	O
the	O
problem	B-T033
of	O
selecting	O
the	O
most	O
favorable	O
kernel	B-T170
are	O
considered	O
.	O
simulation	B-T062
studies	I-T062
show	O
that	O
kr	O
##v	O
is	O
useful	O
in	O
testing	O
statistical	O
independence	O
with	O
finite	O
samples	O
given	O
the	O
kernel	B-T170
##s	I-T170
are	O
appropriately	O
chosen	O
,	O
and	O
can	O
powerful	O
##ly	O
identify	O
existing	O
associations	O
between	O
microbiome	O
composition	O
and	O
host	O
genomic	B-T017
data	O
while	O
protecting	O
type	B-T170
i	I-T170
error	O
.	O
we	O
apply	O
the	O
kr	O
##v	O
to	O
a	O
microbiome	O
study	B-T062
examining	O
the	O
relationship	O
between	O
host	O
transcriptome	B-T082
and	O
microbiome	O
composition	O
within	O
the	O
context	O
of	O
inflammatory	B-T038
bowel	I-T038
disease	I-T038
and	O
are	O
able	O
to	O
derive	O
new	O
biological	O
insights	O
and	O
provide	O
formal	O
inference	O
on	O
prior	O
qualitative	O
observations	O
.	O

datasets	B-T170
for	O
the	O
validation	B-T062
of	O
the	O
[UNK]	O
in	B-T082
vivo	I-T082
[UNK]	O
sirna	B-T103
-	O
silencing	B-T038
of	O
cd40	B-T017
and	O
for	O
the	O
detection	B-T058
of	O
new	O
markers	B-T038
of	O
atherosclerosis	B-T038
progression	B-T038
in	O
apoe	B-T017
-	O
deficient	O
mice	B-T204
data	O
presented	O
in	O
this	O
data	O
in	O
brief	O
article	O
correspond	O
to	O
the	O
article	O
[UNK]	O
in	B-T082
vivo	I-T082
[UNK]	O
silencing	B-T038
of	O
cd40	B-T017
reduces	O
progression	B-T038
of	O
experimental	B-T062
atherogenesis	B-T038
through	O
a	O
nf	B-T103
##κb	I-T103
/	O
mir	B-T103
-	I-T103
125	I-T103
##b	I-T103
axis	O
and	O
reveals	O
new	O
potential	O
mediators	B-T103
in	O
the	O
pathogenesis	B-T038
of	O
atherosclerosis	B-T038
[UNK]	O
(	O
m	B-T170
.	I-T170
hu	I-T170
##es	I-T170
##o	I-T170
,	O
l	B-T170
.	I-T170
de	I-T170
ram	I-T170
##on	I-T170
,	O
e	B-T170
.	I-T170
nav	I-T170
##arr	I-T170
##o	I-T170
,	O
e	B-T170
.	I-T170
rip	I-T170
##oll	I-T170
,	O
j	B-T170
.	I-T170
m	I-T170
.	I-T170
cruz	I-T170
##ado	I-T170
,	O
j	B-T170
.	I-T170
m	I-T170
.	I-T170
gr	I-T170
##in	I-T170
##y	I-T170
##o	I-T170
,	O
j	B-T170
.	I-T170
torr	I-T170
##as	I-T170
,	O
2016	O
)	O
[	O
1	O
]	O
.	O
here	O
,	O
we	O
describe	O
the	O
validation	B-T062
of	O
the	O
silencing	B-T038
of	O
cd40	B-T017
expression	B-T038
with	O
a	O
specific	O
sirna	B-T103
in	O
apoe	B-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
mouse	B-T204
aortas	B-T017
,	O
and	O
its	O
systemic	O
effects	O
on	O
splenic	B-T017
lymphocytic	B-T170
subpopulations	I-T170
as	O
well	O
as	O
on	O
the	O
infiltration	B-T038
of	O
aortic	B-T017
intima	I-T017
by	O
f4	B-T017
/	I-T017
80	I-T017
(	I-T017
+	I-T017
)	I-T017
,	O
galectin	B-T017
-	I-T017
3	I-T017
(	I-T017
+	I-T017
)	I-T017
macrophages	I-T017
or	O
by	O
nf	B-T017
-	I-T017
κb	I-T017
(	I-T017
+	I-T017
)	I-T017
cells	I-T017
.	O
we	O
also	O
show	O
the	O
output	O
of	O
a	O
gene	B-T170
ontology	I-T170
and	O
tl	B-T062
##da	I-T062
analysis	I-T062
which	O
allowed	O
the	O
detection	B-T058
of	O
potential	O
mediators	B-T103
of	O
atherosclerosis	B-T038
progression	B-T038
.	O
we	O
provide	O
the	O
scientific	O
community	O
with	O
a	O
set	O
of	O
genes	B-T017
whose	O
expression	B-T038
is	O
increased	O
during	O
atherosclerosis	B-T038
progression	B-T038
but	O
downregulated	B-T038
upon	O
cd40	B-T017
silencing	B-T038
.	O

lycopene	B-T103
and	O
risk	O
of	O
cardiovascular	B-T038
diseases	I-T038
:	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
of	O
observational	O
studies	O
the	O
aim	O
of	O
current	O
meta	B-T062
-	I-T062
analysis	I-T062
was	O
to	O
investigate	O
the	O
relation	O
between	O
lycopene	B-T103
and	O
risk	O
of	O
cardiovascular	B-T038
diseases	I-T038
(	O
cvd	B-T038
)	O
.	O
studies	B-T062
concerning	O
about	O
the	O
association	O
between	O
lycopene	B-T103
and	O
risk	O
of	O
cvd	B-T038
were	O
searched	O
on	O
pubmed	B-T170
,	O
embase	B-T170
,	O
and	O
web	B-T170
of	I-T170
science	I-T170
from	O
inception	O
to	O
october	O
2016	O
.	O
a	O
total	O
of	O
14	O
eligible	B-T062
studies	I-T062
were	O
identified	O
.	O
a	O
significantly	O
inverse	O
association	O
with	O
a	O
pooled	O
risk	O
ratio	O
(	O
rr	O
)	O
of	O
0	O
.	O
83	O
(	O
95	O
%	O
ci	O
:	O
0	O
.	O
76	O
-	O
0	O
.	O
90	O
)	O
was	O
shown	O
between	O
lycopene	B-T103
exposure	O
and	O
risk	O
of	O
cvd	B-T038
.	O
findings	B-T033
were	O
similar	O
restricting	O
to	O
dietary	B-T168
studies	B-T062
(	O
rr	O
=	O
0	O
.	O
87	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
79	O
-	O
0	O
.	O
96	O
)	O
and	O
biomarker	B-T201
studies	B-T062
(	O
rr	O
=	O
0	O
.	O
74	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
62	O
-	O
0	O
.	O
87	O
)	O
.	O
dietary	B-T168
lycopene	B-T103
intake	O
was	O
statistically	O
significant	O
for	O
coronary	B-T038
heart	I-T038
disease	I-T038
(	O
chd	B-T038
)	O
(	O
rr	O
:	O
0	O
.	O
87	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
76	O
-	O
0	O
.	O
98	O
)	O
and	O
stroke	B-T038
(	O
rr	O
:	O
0	O
.	O
83	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
69	O
-	O
0	O
.	O
96	O
)	O
.	O
the	O
pooled	O
risk	O
estimate	O
was	O
generally	O
similar	O
for	O
lycopene	B-T103
biomarker	B-T201
concentrations	O
,	O
but	O
the	O
association	O
was	O
only	O
statistically	O
significant	O
for	O
stroke	B-T038
(	O
rr	O
:	O
0	O
.	O
65	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
42	O
-	O
0	O
.	O
87	O
)	O
.	O
subgroup	B-T170
analyses	B-T062
showed	O
that	O
retrospective	B-T062
and	O
low	O
quality	O
studies	B-T062
were	O
statistically	O
significant	O
sources	O
of	O
heterogeneity	O
.	O
higher	O
lycopene	B-T103
exposure	O
is	O
inversely	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
cvd	B-T038
.	O
further	O
well	O
-	O
designed	O
randomized	B-T062
clinical	I-T062
trials	I-T062
are	O
required	O
to	O
assess	O
the	O
role	O
of	O
lycopene	B-T103
on	O
cvd	B-T038
.	O

assembly	B-T038
of	I-T038
the	I-T038
outer	I-T038
##most	I-T038
spore	I-T038
layer	I-T038
:	O
pieces	O
of	O
the	O
puzz	O
##le	O
are	O
coming	O
together	O
certain	O
endos	B-T007
##por	I-T007
##e	I-T007
-	I-T007
forming	I-T007
soil	I-T007
dwelling	I-T007
bacteria	I-T007
are	O
important	O
human	B-T204
,	O
animal	B-T204
or	O
insect	B-T204
pathogens	O
.	O
these	O
organisms	O
produce	O
spores	O
containing	O
an	O
outer	B-T017
layer	I-T017
,	O
the	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
.	O
the	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
is	O
the	O
site	O
of	O
interactions	O
between	O
the	O
spore	O
and	O
the	O
soil	O
environment	B-T082
and	O
between	O
the	O
spore	O
and	O
the	O
infected	B-T033
host	O
during	O
the	O
initial	O
stages	O
of	O
infection	B-T038
.	O
the	O
composition	B-T201
and	O
assembly	B-T038
process	I-T038
of	I-T038
the	I-T038
exo	I-T038
##sp	I-T038
##ori	I-T038
##um	I-T038
are	O
poorly	O
understood	O
.	O
this	O
is	O
partly	O
due	O
to	O
the	O
extreme	O
stability	O
of	O
the	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
that	O
has	O
proven	O
to	O
be	O
refractive	O
to	O
existing	O
methods	O
to	O
dec	O
##onstr	O
##uct	O
the	O
intact	O
structure	B-T082
into	O
its	O
component	O
parts	B-T082
.	O
although	O
more	O
than	O
20	O
proteins	B-T103
have	O
been	O
identified	O
as	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
-	O
associated	O
,	O
their	O
abundance	O
,	O
relationship	O
to	O
other	O
proteins	B-T103
and	O
the	O
processes	O
by	O
which	O
they	O
are	O
assembled	B-T038
to	I-T038
create	I-T038
the	I-T038
exo	I-T038
##sp	I-T038
##ori	I-T038
##um	I-T038
are	O
largely	O
unknown	O
.	O
in	O
this	O
issue	O
of	O
molecular	B-T091
microbiology	I-T091
,	O
terr	O
##y	O
,	O
jia	O
##ng	O
,	O
and	O
colleagues	O
in	O
per	O
bull	O
##ough	O
'	O
s	O
laboratory	B-T092
show	O
that	O
the	O
ex	B-T103
##s	I-T103
##y	I-T103
protein	I-T103
is	O
a	O
major	O
structural	B-T103
protein	I-T103
of	O
the	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
basal	I-T017
layer	I-T017
of	O
b	B-T007
.	I-T007
cereus	I-T007
family	I-T007
spores	O
and	O
that	O
it	O
can	O
self	O
-	O
assemble	O
into	O
complex	O
structures	B-T082
that	O
possess	O
many	O
of	O
the	O
structural	B-T082
features	O
characteristic	O
of	O
the	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
basal	I-T017
layer	I-T017
.	O
the	O
authors	B-T097
refined	O
a	O
model	B-T170
for	O
exo	B-T038
##sp	I-T038
##ori	I-T038
##um	I-T038
assembly	I-T038
.	O
their	O
findings	B-T033
may	O
have	O
implications	O
for	O
exo	B-T017
##sp	I-T017
##ori	I-T017
##um	I-T017
formation	O
in	O
other	O
spore	B-T007
forming	I-T007
bacteria	I-T007
,	O
including	O
clostridium	B-T007
species	I-T007
.	O

management	B-T058
of	O
skin	B-T038
and	I-T038
soft	I-T038
-	I-T038
tissue	I-T038
infections	I-T038
at	O
a	O
community	O
teaching	B-T092
hospital	I-T092
using	O
a	O
severity	O
-	O
of	O
-	O
illness	O
tool	O
skin	B-T038
and	I-T038
soft	I-T038
-	I-T038
tissue	I-T038
infections	I-T038
(	O
sst	B-T038
##is	I-T038
)	O
encompass	O
a	O
diverse	O
range	O
of	O
infections	B-T038
of	O
varying	O
severity	O
.	O
the	O
clinical	B-T170
resource	I-T170
efficiency	I-T170
support	I-T170
team	I-T170
(	I-T170
crest	I-T170
)	I-T170
scoring	I-T170
system	I-T170
stratif	B-T170
##ies	I-T170
patients	O
into	O
four	O
classes	B-T170
(	O
i	O
=	O
least	O
severe	O
to	O
iv	O
=	O
most	O
severe	O
)	O
based	O
on	O
the	O
standardized	B-T170
early	I-T170
warning	I-T170
score	I-T170
(	O
sew	B-T170
##s	I-T170
)	O
.	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
apply	O
crest	B-T170
to	O
hospitalized	O
patients	O
with	O
sst	B-T038
##is	I-T038
in	O
order	O
to	O
quantify	O
disease	O
severity	O
and	O
evaluate	B-T058
appropriateness	O
of	O
antibiotic	B-T103
management	O
.	O
this	O
was	O
a	O
retrospective	B-T062
,	O
hypothesis	O
-	O
generating	O
,	O
single	O
-	O
centre	O
evaluation	B-T058
of	O
hospitalized	O
patients	O
with	O
sst	B-T038
##is	I-T038
admitted	B-T058
in	O
2011	O
.	O
based	O
on	O
crest	B-T170
classification	O
,	O
the	O
empirical	O
antimicrobial	B-T103
choices	O
were	O
categorized	O
as	O
appropriate	O
,	O
over	B-T058
-	I-T058
treatment	I-T058
or	O
under	B-T058
-	I-T058
treatment	I-T058
.	O
a	O
total	O
of	O
36	O
##9	O
patients	O
were	O
screened	O
and	O
200	O
met	O
the	O
inclusion	O
criteria	O
.	O
the	O
majority	O
of	O
patients	O
were	O
classified	B-T170
as	O
either	O
crest	B-T170
class	O
i	O
(	O
n	O
=	O
68	O
)	O
or	O
class	O
i	O
i	O
(	O
n	O
=	O
102	O
)	O
.	O
over	B-T058
-	I-T058
treatment	I-T058
was	O
more	O
common	O
in	O
the	O
less	O
severe	O
classes	B-T170
(	O
88	O
%	O
and	O
32	O
%	O
in	O
class	O
i	O
and	O
class	O
ii	O
,	O
respectively	O
;	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
sixty	O
-	O
three	O
percent	O
of	O
class	O
i	O
(	O
n	O
=	O
43	O
)	O
were	O
over	B-T058
-	I-T058
treated	I-T058
due	O
to	O
both	O
the	O
use	O
of	O
intravenous	O
antibiotic	B-T103
s	O
when	O
oral	B-T058
therapy	I-T058
was	O
sufficient	O
and	O
use	O
of	O
unnecess	O
##arily	O
broad	B-T103
-	I-T103
spectrum	I-T103
antibiotics	I-T103
.	O
in	O
contrast	O
,	O
25	O
%	O
(	O
n	O
=	O
26	O
)	O
of	O
class	O
ii	O
were	O
over	B-T058
-	I-T058
treated	I-T058
due	O
to	O
use	O
of	O
unnecess	O
##arily	O
broad	B-T103
-	I-T103
spectrum	I-T103
antibiotics	I-T103
.	O
overall	O
clinical	B-T033
failure	I-T033
rates	O
remained	O
low	O
with	O
only	O
1	O
%	O
,	O
4	O
%	O
and	O
17	O
%	O
of	O
patients	O
unable	O
to	O
achieve	O
initial	O
response	B-T201
in	O
class	O
ii	O
,	O
class	O
iii	O
and	O
class	O
iv	O
.	O
retrospective	O
application	B-T058
of	O
crest	B-T170
identified	O
opportunities	O
to	O
improve	O
the	O
management	B-T058
of	O
sst	B-T038
##is	I-T038
.	O
crest	B-T170
can	O
be	O
of	O
great	O
value	O
in	O
discriminating	O
less	O
-	O
severe	O
sst	B-T038
##is	I-T038
,	O
which	O
can	O
be	O
treated	B-T058
on	O
an	O
outpatient	O
basis	O
.	O

increased	O
rhoa	B-T103
activity	O
predicts	O
worse	B-T033
overall	O
survival	O
in	O
patients	O
undergoing	O
surgical	B-T058
resection	I-T058
for	O
la	B-T170
##uren	I-T170
diffuse	B-T038
-	I-T038
type	I-T038
gastric	I-T038
adenocarcinoma	I-T038
several	O
studies	O
have	O
reported	O
a	O
high	O
rate	O
of	O
rhoa	B-T017
mutations	B-T038
in	O
the	O
la	B-T170
##uren	I-T170
diffuse	B-T038
-	I-T038
type	I-T038
gastric	I-T038
adenocarcinoma	I-T038
(	O
ga	B-T038
)	O
but	O
not	O
in	O
intestinal	B-T038
-	I-T038
type	I-T038
ga	I-T038
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
if	O
rhoa	B-T103
activity	O
is	O
prognostic	B-T201
for	O
overall	O
survival	O
(	O
os	O
)	O
in	O
patients	O
with	O
resectable	O
ga	B-T038
.	O
retrospective	B-T062
review	I-T062
was	O
performed	O
on	O
a	O
prospective	O
database	O
of	O
ga	B-T038
patients	O
who	O
underwent	O
potentially	O
curative	B-T058
resection	I-T058
between	O
2003	O
and	O
2012	O
at	O
a	O
single	B-T092
institution	I-T092
.	O
tissue	B-T017
microarrays	O
were	O
constructed	O
from	O
surgical	O
specimens	O
and	O
analyzed	O
for	O
phosphorylated	B-T103
rhoa	B-T103
,	O
a	O
marker	B-T201
of	O
inactive	O
rhoa	B-T103
signaling	B-T038
.	O
os	O
was	O
estimated	O
by	O
the	O
kaplan	B-T062
-	I-T062
meier	I-T062
method	I-T062
,	O
and	O
multivariate	O
analysis	O
was	O
performed	O
by	O
cox	B-T170
proportional	I-T170
hazards	I-T170
regression	I-T170
modeling	I-T170
.	O
one	O
hundred	O
thirty	O
-	O
six	O
patients	O
with	O
diffuse	B-T038
-	I-T038
type	I-T038
ga	I-T038
and	O
129	O
patients	O
with	O
intestinal	B-T038
-	I-T038
type	I-T038
ga	I-T038
were	O
examined	O
.	O
compared	O
to	O
intestinal	B-T038
-	I-T038
type	I-T038
ga	I-T038
,	O
diffuse	B-T038
-	I-T038
type	I-T038
ga	I-T038
tumors	B-T038
were	O
significantly	O
associated	O
with	O
increased	O
tumor	B-T082
size	I-T082
and	O
advanced	B-T170
tumor	I-T170
,	I-T170
node	I-T170
,	I-T170
metastasis	I-T170
(	I-T170
tnm	I-T170
)	I-T170
classification	I-T170
system	I-T170
stage	I-T170
.	O
in	O
patients	O
with	O
diffuse	B-T038
-	I-T038
type	I-T038
ga	I-T038
,	O
high	O
rhoa	B-T103
activity	O
was	O
associated	O
with	O
significantly	O
worse	B-T033
os	O
when	O
compared	O
to	O
low	O
rhoa	B-T103
activity	O
(	O
5	O
-	O
year	O
os	O
52	O
.	O
5	O
vs	O
.	O
81	O
.	O
0	O
%	O
,	O
p	O
=	O
0	O
.	O
017	O
)	O
.	O
this	O
difference	O
in	O
os	O
was	O
not	O
observed	O
in	O
patients	O
with	O
intestinal	B-T038
-	I-T038
type	I-T038
ga	I-T038
(	O
5	O
-	O
year	O
os	O
83	O
.	O
9	O
vs	O
.	O
81	O
.	O
6	O
%	O
,	O
p	O
=	O
0	O
.	O
76	O
##6	O
)	O
.	O
on	O
multivariate	O
analysis	O
of	O
diffuse	B-T038
-	I-T038
type	I-T038
ga	I-T038
patients	O
,	O
high	O
rhoa	B-T103
activity	O
was	O
an	O
independent	O
negative	O
prognostic	B-T201
factor	I-T201
for	O
os	O
(	O
hazard	O
ratio	O
2	O
.	O
38	O
,	O
95	O
%	O
confidence	O
interval	O
1	O
.	O
07	O
-	O
5	O
.	O
28	O
)	O
.	O
increased	O
rhoa	B-T103
activity	O
is	O
predictive	O
of	O
worse	B-T033
os	O
in	O
patients	O
with	O
diffuse	B-T038
-	I-T038
type	I-T038
ga	I-T038
who	O
undergo	O
potentially	O
curative	B-T058
surgical	I-T058
resection	I-T058
.	O
along	O
with	O
findings	O
from	O
genomic	B-T091
studies	I-T091
,	O
these	O
results	O
suggest	O
rhoa	B-T103
may	O
be	O
a	O
novel	O
therapeutic	B-T058
target	O
in	O
diffuse	B-T038
-	I-T038
type	I-T038
ga	I-T038
.	O

low	O
intensity	O
sprint	B-T058
training	I-T058
with	O
blood	O
flow	O
restriction	O
improves	O
100	O
m	O
dash	O
we	O
investigated	O
the	O
effects	O
of	O
practical	O
blood	O
flow	O
restriction	O
(	O
pb	O
##fr	O
)	O
of	O
leg	B-T017
muscles	I-T017
during	O
sprint	B-T058
training	I-T058
on	O
the	O
100	O
m	O
dash	O
time	O
in	O
well	B-T098
-	I-T098
trained	I-T098
sport	I-T098
students	I-T098
.	O
participants	B-T098
performed	O
6	O
##x10	O
##0	O
m	O
sprint	O
##s	O
at	O
60	O
-	O
70	O
%	O
of	O
their	O
maximal	O
100	O
m	O
sprint	O
##ing	O
speed	O
twice	O
a	O
week	O
for	O
6	O
weeks	O
,	O
either	O
with	O
(	O
ig	B-T098
;	O
n	O
=	O
12	O
)	O
or	O
without	O
pb	O
##fr	O
(	O
cg	O
;	O
n	O
=	O
12	O
)	O
.	O
the	O
100	O
m	O
dash	O
time	O
significantly	O
decreased	O
more	O
in	O
the	O
ig	B-T098
(	O
-	O
0	O
.	O
38	O
##±0	O
.	O
24	O
s	O
)	O
than	O
in	O
the	O
cg	O
(	O
-	O
0	O
.	O
16	O
##±0	O
.	O
17	O
s	O
)	O
.	O
the	O
muscle	B-T017
thickness	O
of	O
the	O
rectus	B-T017
femoris	I-T017
increased	O
only	O
in	O
the	O
ig	B-T098
,	O
while	O
no	O
group	O
by	O
time	O
interactions	O
were	O
found	O
for	O
the	O
muscle	B-T017
thickness	O
of	O
the	O
biceps	B-T017
femoris	I-T017
and	O
the	O
biceps	B-T017
brach	I-T017
##ii	I-T017
.	O
the	O
maximal	O
isometric	O
force	O
,	O
measured	O
using	O
a	O
leg	O
press	O
,	O
did	O
not	B-T033
change	I-T033
in	O
either	O
group	O
.	O
however	O
,	O
the	O
rate	O
of	O
force	O
development	O
improved	O
in	O
the	O
ig	B-T098
.	O
growth	B-T103
hormone	I-T103
,	O
testosterone	B-T103
,	O
insulin	B-T103
-	I-T103
like	I-T103
growth	I-T103
factor	I-T103
1	I-T103
,	O
and	O
cortisol	B-T103
concentrations	O
did	O
not	B-T033
significantly	I-T033
differ	I-T033
between	O
both	O
groups	O
at	O
any	O
measurement	O
time	O
point	O
(	O
pre	O
,	O
1	O
min	O
,	O
20	O
min	O
,	O
120	O
min	O
,	O
and	O
24	O
h	O
after	O
the	O
six	O
all	O
-	O
out	O
sprint	O
##s	O
of	O
the	O
first	O
training	O
session	O
)	O
.	O
the	O
muscle	B-T017
damage	I-T017
marker	B-T201
h	B-T103
-	I-T103
fabp	I-T103
increased	O
significantly	O
more	O
in	O
the	O
cg	O
than	O
in	O
the	O
ig	B-T098
.	O
the	O
pb	O
##fr	O
improved	O
the	O
100	O
m	O
dash	O
time	O
significantly	O
more	O
than	O
low	O
-	O
intensity	O
sprint	B-T058
interval	I-T058
training	I-T058
alone	O
.	O
other	O
noted	O
benefits	O
of	O
training	O
with	O
pb	O
##fr	O
were	O
a	O
decreased	O
level	O
of	O
muscle	B-T017
damage	I-T017
,	O
a	O
greater	O
increase	O
of	O
the	O
rectus	B-T017
femoris	I-T017
muscle	I-T017
thickness	O
,	O
and	O
a	O
higher	O
rate	O
of	O
force	O
development	O
.	O
however	O
,	O
the	O
tested	O
hormones	B-T103
were	O
unable	O
to	O
explain	O
the	O
additional	O
beneficial	O
effects	O
.	O

polymeric	B-T103
nanostructure	O
compiled	O
with	O
multifunctional	O
components	O
to	O
exert	O
tumor	B-T038
-	O
targeted	B-T062
delivery	I-T062
of	O
antiangiogenic	B-T038
gene	B-T017
for	O
tumor	O
growth	O
suppression	O
nucleic	B-T103
acid	I-T103
-	I-T103
based	I-T103
therapy	B-T058
has	O
emerged	O
as	O
a	O
revolution	O
##ary	O
methodology	O
for	O
treatment	O
of	O
the	O
diseases	B-T038
related	O
to	O
protein	B-T103
dysfunction	O
;	O
however	O
,	O
lack	O
of	O
systemically	O
applicable	O
synthetic	B-T062
delivery	I-T062
systems	I-T062
limits	O
its	O
current	O
usage	O
in	O
local	O
applications	O
,	O
particularly	O
for	O
dna	B-T103
-	I-T103
based	I-T103
therapy	B-T058
with	O
regard	O
to	O
the	O
poor	O
bioavailability	O
in	O
the	O
systemic	O
administrations	O
.	O
to	O
overcome	O
this	O
obstacle	O
,	O
we	O
compiled	O
multiple	O
chemistry	B-T058
-	I-T058
based	I-T058
strategies	I-T058
into	O
the	O
manufacture	O
of	O
the	O
gene	B-T062
delivery	I-T062
formulations	I-T062
to	O
pursue	O
improved	B-T033
tolerability	O
of	O
dna	B-T103
to	O
the	O
enzymatic	B-T038
degradation	B-T038
in	O
the	O
biological	O
milieu	B-T082
and	O
prolonged	B-T038
retention	I-T038
in	O
the	O
systemic	O
circulation	O
.	O
here	O
,	O
we	O
constructed	O
a	O
distinctive	O
multilayer	O
##ed	O
functional	O
architecture	O
:	O
plasmid	B-T103
dna	I-T103
(	O
pd	B-T103
##na	I-T103
)	O
was	O
electrostatic	O
##ally	O
complexed	O
with	O
cationic	B-T103
poly	B-T103
(	I-T103
lysine	I-T103
)	I-T103
(	O
polyp	B-T103
##lex	I-T103
)	O
as	O
the	O
interior	B-T082
pd	B-T103
##na	I-T103
reservoir	O
,	O
which	O
was	O
further	O
cross	O
-	O
linked	O
by	O
redox	B-T038
-	O
responsive	O
disulfide	B-T103
cross	O
-	O
linking	O
to	O
minimize	O
the	O
occurrence	O
of	O
polyp	B-T103
##lex	I-T103
disassembly	O
through	O
exchange	B-T038
reaction	I-T038
with	O
the	O
biological	O
charged	B-T103
components	I-T103
.	O
still	O
,	O
the	O
pd	B-T103
##na	I-T103
reservoir	O
was	O
spatially	O
protected	O
by	O
a	O
sequential	O
thermo	O
##respons	O
##ive	O
poly	B-T103
(	I-T103
n	I-T103
-	I-T103
isopropyl	I-T103
##acrylamide	I-T103
)	I-T103
pal	O
##isa	O
##de	O
as	O
the	O
intermediate	O
barrier	O
and	O
a	O
biocompatible	B-T103
hydrophilic	O
poly	B-T103
(	I-T103
ethylene	I-T103
glycol	I-T103
)	I-T103
(	O
peg	B-T103
)	O
shell	O
with	O
the	O
aim	O
of	O
preventing	O
the	O
accessibility	O
of	O
the	O
biological	O
species	B-T170
,	O
particularly	O
the	O
nuclease	B-T103
degradation	O
to	O
the	O
pd	B-T103
##na	I-T103
pay	O
##load	O
.	O
subsequent	O
investigations	B-T058
validated	O
the	O
util	O
##ities	O
of	O
these	O
strategies	O
in	O
accomplish	O
##ing	O
prolonged	O
blood	B-T031
retention	B-T038
.	O
in	O
an	O
attempt	O
to	O
apply	O
this	O
method	B-T170
for	O
tumor	O
therapy	B-T058
,	O
ligand	B-T103
cyclic	I-T103
(	I-T103
arg	I-T103
-	I-T103
gly	I-T103
-	I-T103
asp	I-T103
)	I-T103
peptide	I-T103
was	O
attached	O
at	O
the	O
distal	O
end	O
of	O
peg	B-T103
,	O
validating	O
prompted	O
tumor	B-T038
-	O
targeted	O
delivery	O
and	O
gene	B-T038
expression	I-T038
of	O
the	O
loaded	O
antiangiogenic	B-T038
gene	B-T017
at	O
the	O
targeted	O
tumor	B-T017
cells	I-T017
and	O
accordingly	O
exert	B-T038
##ing	I-T038
anti	B-T038
##angi	I-T038
##ogenesis	I-T038
of	O
the	O
tumors	B-T038
for	O
abrog	O
##ation	O
of	O
tumor	O
growth	O
.	O
together	O
with	O
its	O
excellent	O
safe	O
profile	O
,	O
the	O
proposed	O
formulation	O
suggests	O
potential	O
utility	O
as	O
a	O
practical	O
gene	B-T062
delivery	I-T062
system	I-T062
for	O
treatment	O
of	O
intractable	O
diseases	B-T038
.	O

repetitive	B-T058
transcranial	I-T058
magnetic	I-T058
stimulation	I-T058
improves	O
cognitive	B-T038
function	I-T038
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
patients	O
repetitive	B-T058
transcranial	I-T058
magnetic	I-T058
stimulation	I-T058
(	O
rtms	B-T058
)	O
acts	O
as	O
a	O
kind	O
of	O
widely	O
-	O
applied	O
and	O
non	O
-	O
invasive	O
method	O
in	O
the	O
intervention	B-T058
of	O
some	O
neurological	B-T038
disorders	I-T038
.	O
this	O
prospective	B-T062
,	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	B-T062
-	I-T062
controlled	I-T062
trial	I-T062
investigates	O
the	O
effect	O
of	O
rtms	B-T058
on	O
30	O
cases	O
of	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
participants	B-T098
,	O
who	O
were	O
classified	O
into	O
mild	O
and	O
moderate	O
groups	B-T098
.	O
neuropsychological	B-T058
tests	I-T058
were	O
carried	O
out	O
using	O
the	O
ad	B-T170
assessment	I-T170
scale	I-T170
-	O
cognitive	B-T170
subscale	I-T170
(	O
ada	B-T170
##s	I-T170
-	O
cog	B-T170
)	O
,	O
mini	B-T058
-	I-T058
mental	I-T058
state	I-T058
examination	I-T058
(	O
mmse	B-T058
)	O
,	O
mont	B-T170
##re	I-T170
##al	I-T170
cognitive	I-T170
assessment	I-T170
(	O
mo	B-T170
##ca	I-T170
)	O
,	O
and	O
world	B-T170
health	I-T170
organization	I-T170
university	I-T170
of	I-T170
california	I-T170
-	I-T170
los	I-T170
angeles	I-T170
,	I-T170
auditory	I-T170
verbal	I-T170
learning	I-T170
test	I-T170
(	O
who	B-T170
-	I-T170
ucl	I-T170
##a	I-T170
av	I-T170
##lt	I-T170
)	O
before	O
,	O
immediately	O
after	O
,	O
and	O
6	O
weeks	O
after	O
the	O
intervention	B-T058
.	O
in	O
this	O
work	O
,	O
data	O
from	O
30	O
ad	B-T038
patients	O
revealed	O
that	O
there	O
was	O
no	O
obvious	O
interaction	O
effect	O
of	O
time	O
-	O
by	O
-	O
group	O
.	O
the	O
ada	B-T170
##s	I-T170
-	O
cog	B-T170
,	O
mmse	B-T058
and	O
who	B-T170
-	I-T170
ucl	I-T170
##a	I-T170
av	I-T170
##lt	I-T170
score	O
in	O
the	O
rtms	B-T058
group	B-T098
was	O
significantly	O
improved	O
compared	O
with	O
baseline	O
##s	O
at	O
6	O
weeks	O
after	O
treatment	B-T058
(	O
all	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
meanwhile	O
,	O
mo	B-T170
##ca	I-T170
scores	O
were	O
also	O
obviously	O
ameliorated	B-T033
in	O
the	O
mild	O
ad	B-T038
patients	O
with	O
rtms	B-T058
.	O
besides	O
,	O
subgroup	B-T062
analysis	I-T062
showed	O
that	O
the	O
effect	O
of	O
rtms	B-T058
on	O
the	O
memory	B-T038
and	O
language	O
of	O
mild	O
ad	B-T038
patients	O
was	O
superior	O
to	O
those	O
of	O
moderate	O
ad	B-T038
patients	O
.	O
in	O
conclusion	O
,	O
our	O
findings	B-T033
suggested	O
that	O
repetitive	B-T058
transcranial	I-T058
magnetic	I-T058
stimulation	I-T058
improves	O
cognitive	B-T038
function	I-T038
,	O
memory	B-T038
and	O
language	O
level	O
of	O
ad	B-T038
patients	O
,	O
especially	O
in	O
the	O
mild	O
stage	O
of	O
ad	B-T038
.	O
thus	O
,	O
rtms	B-T058
can	O
be	O
recommended	O
as	O
a	O
promising	O
adjuvant	B-T058
therapy	I-T058
combined	O
with	O
cholinesterase	B-T103
inhibitors	I-T103
at	O
the	O
mild	O
stage	O
of	O
ad	B-T038
patients	O
.	O

novel	O
and	O
lost	O
forests	O
in	O
the	O
upper	B-T082
midw	I-T082
##estern	I-T082
united	I-T082
states	I-T082
,	O
from	O
new	O
estimates	O
of	O
settlement	O
-	O
era	O
composition	O
,	O
stem	B-T204
density	O
,	O
and	O
biomass	O
euro	O
##americ	O
##an	O
land	O
-	O
use	O
and	O
its	O
leg	O
##acies	O
have	O
transformed	O
forest	O
structure	O
and	O
composition	O
across	O
the	O
united	B-T082
states	I-T082
(	O
us	B-T082
)	O
.	O
more	O
accurate	O
reconstructions	O
of	O
historical	B-T082
states	I-T082
are	O
critical	O
to	O
understanding	O
the	O
processes	O
governing	O
past	O
,	O
current	O
,	O
and	O
future	O
forest	O
dynamics	O
.	O
here	O
we	O
present	O
new	O
grid	O
##ded	O
(	O
8	O
##x	O
##8	O
##k	O
##m	O
)	O
reconstructions	O
of	O
pre	O
-	O
settlement	O
(	O
1800	O
##s	O
)	O
forest	O
composition	O
and	O
structure	O
from	O
the	O
upper	B-T082
midw	I-T082
##estern	I-T082
us	I-T082
(	O
minnesota	B-T082
,	O
wisconsin	B-T082
,	O
and	O
most	O
of	O
michigan	O
)	O
,	O
using	O
19th	O
century	B-T170
public	I-T170
land	I-T170
survey	I-T170
system	I-T170
(	O
pls	B-T170
##s	I-T170
)	O
,	O
with	O
estimates	O
of	O
relative	O
composition	O
,	O
above	B-T082
-	I-T082
ground	I-T082
biomass	O
,	O
stem	B-T204
density	O
,	O
and	O
basal	B-T082
area	I-T082
for	O
28	O
tree	B-T204
types	O
.	O
this	O
mapping	O
is	O
more	O
robust	O
than	O
past	O
efforts	O
,	O
using	O
spatially	O
varying	O
correction	O
factors	O
to	O
accommodate	O
sampling	B-T170
design	I-T170
,	O
az	O
##im	O
##uth	O
##al	O
cens	O
##oring	O
,	O
and	O
biases	O
in	O
tree	B-T204
selection	O
.	O
we	O
compare	O
pre	O
-	O
settlement	O
to	O
modern	O
forests	O
using	O
us	B-T082
forest	O
service	O
forest	B-T170
inventory	I-T170
and	I-T170
analysis	I-T170
(	I-T170
fi	I-T170
##a	I-T170
)	I-T170
data	I-T170
to	O
show	O
the	O
prevalence	O
of	O
lost	O
forests	O
(	O
pre	O
-	O
settlement	O
forests	O
with	O
no	O
current	O
analog	O
)	O
,	O
and	O
novel	O
forests	O
(	O
modern	O
forests	O
with	O
no	O
past	O
analogs	O
)	O
.	O
differences	O
between	O
pre	O
-	O
settlement	O
and	O
modern	O
forests	O
are	O
spatially	O
structured	O
owing	O
to	O
differences	O
in	O
land	O
-	O
use	O
impacts	O
and	O
accompanying	O
ecological	O
responses	O
.	O
modern	O
forests	O
are	O
more	O
homogeneous	O
,	O
and	O
eco	O
##ton	O
##al	O
gradients	O
are	O
more	O
diffuse	B-T082
today	O
than	O
in	O
the	O
past	O
.	O
novel	O
forest	O
assemblages	O
represent	O
28	O
%	O
of	O
all	O
fi	B-T170
##a	I-T170
cells	O
,	O
and	O
28	O
%	O
of	O
pre	O
-	O
settlement	O
forests	O
no	B-T033
longer	I-T033
exist	O
in	O
a	O
modern	O
context	O
.	O
lost	O
forests	O
include	O
tam	B-T204
##ara	I-T204
##ck	I-T204
forests	O
in	O
northeastern	B-T082
minnesota	B-T082
,	O
hem	B-T204
##lock	I-T204
and	O
ced	B-T204
##ar	I-T204
dominated	O
forests	O
in	O
north	B-T082
-	I-T082
central	I-T082
wisconsin	I-T082
and	O
along	O
the	O
upper	B-T082
penins	I-T082
##ula	I-T082
of	I-T082
michigan	I-T082
,	O
and	O
el	B-T204
##m	I-T204
,	O
oak	B-T204
,	O
bass	B-T204
##wood	I-T204
and	O
iron	B-T204
##wood	I-T204
forests	O
along	O
the	O
forest	O
-	O
pra	B-T082
##ir	I-T082
##ie	I-T082
boundary	I-T082
in	O
south	B-T082
central	I-T082
minnesota	I-T082
and	O
eastern	B-T082
wisconsin	B-T082
.	O
novel	O
fi	B-T170
##a	I-T170
forest	O
assemblages	O
are	O
distributed	O
evenly	O
across	O
the	O
region	B-T082
,	O
but	O
novelty	O
shows	O
a	O
strong	O
relationship	O
to	O
spatial	O
distance	O
from	O
remnant	O
forests	O
in	O
the	O
upper	B-T082
midw	I-T082
##est	I-T082
,	O
with	O
novelty	O
predicted	O
at	O
between	O
20	O
to	O
60	O
##k	O
##m	O
from	O
remnants	O
,	O
depending	O
on	O
historical	O
forest	O
type	O
.	O
the	O
spatial	B-T082
relationships	O
between	O
remnant	O
and	O
novel	O
forests	O
,	O
shifts	O
in	O
eco	O
##ton	O
##e	O
structure	O
and	O
the	O
loss	O
of	O
historic	O
forest	O
types	O
point	O
to	O
significant	O
challenges	O
for	O
land	O
managers	B-T097
if	O
landscape	B-T082
restoration	O
is	O
a	O
priority	O
.	O
the	O
spatial	O
signals	O
of	O
novelty	O
and	O
ecological	O
change	O
also	O
point	O
to	O
potential	O
challenges	O
in	O
using	O
modern	O
spatial	B-T082
distributions	I-T082
of	O
species	B-T204
and	O
communities	O
and	O
their	O
relationship	O
to	O
underlying	O
ge	O
##ophysical	O
and	O
climatic	O
attributes	O
in	O
understanding	O
potential	O
responses	O
to	O
changing	O
climate	O
.	O
the	O
signal	O
of	O
human	B-T204
settlement	O
on	O
modern	O
forests	O
is	O
broad	B-T082
,	O
spatially	O
varying	O
and	O
acts	O
to	O
homogen	O
##ize	O
modern	O
forests	O
relative	O
to	O
their	O
historic	O
counterparts	O
,	O
with	O
significant	O
implications	O
for	O
future	O
management	O
.	O

prevalence	O
of	O
self	B-T062
-	I-T062
reported	I-T062
prescription	B-T103
drug	I-T103
use	O
in	O
a	O
national	O
sample	O
of	O
u	B-T082
.	I-T082
s	I-T082
.	O
drivers	B-T098
drug	B-T103
-	O
involved	O
driving	O
has	O
become	O
an	O
increasing	O
concern	O
.	O
although	O
the	O
focus	O
has	O
been	O
on	O
illegal	B-T103
drugs	I-T103
,	O
there	O
is	O
evidence	O
that	O
prescribed	B-T103
medications	I-T103
can	O
impair	B-T033
driving	I-T033
ability	I-T033
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
determine	B-T058
the	O
self	B-T062
-	I-T062
reported	I-T062
prevalence	O
of	O
prescription	B-T103
drug	I-T103
use	O
,	O
including	O
medical	O
and	O
nonm	B-T033
##edical	I-T033
use	O
,	O
among	O
a	O
nationally	O
representative	O
sample	O
of	O
drivers	B-T098
and	O
to	O
report	O
related	O
driver	B-T098
characteristics	O
.	O
as	O
part	O
of	O
the	O
2013	O
-	O
2014	O
national	B-T062
road	I-T062
##side	I-T062
survey	I-T062
,	O
drivers	B-T098
from	O
60	O
sites	O
were	O
randomly	O
recruited	O
and	O
asked	O
to	O
complete	O
a	O
survey	O
on	O
prescription	B-T103
drug	I-T103
use	O
.	O
almost	O
20	O
%	O
of	O
drivers	B-T098
reported	O
using	O
a	O
prescription	B-T103
drug	I-T103
within	O
the	O
past	O
2	O
days	O
,	O
with	O
the	O
most	O
common	B-T103
drug	I-T103
class	I-T103
being	O
sedative	B-T103
##s	I-T103
(	O
8	O
.	O
0	O
%	O
)	O
,	O
followed	O
by	O
antidepressants	B-T103
(	O
7	O
.	O
7	O
%	O
)	O
,	O
narcotic	B-T103
##s	I-T103
(	O
7	O
.	O
5	O
%	O
)	O
,	O
and	O
stimulants	B-T103
(	O
3	O
.	O
9	O
%	O
)	O
.	O
drivers	B-T098
who	O
reported	O
prescription	B-T103
drug	I-T103
use	O
were	O
significantly	O
more	O
likely	O
to	O
be	O
female	O
,	O
older	B-T098
,	O
non	O
-	O
hispanic	O
white	O
,	O
and	O
report	O
disability	B-T033
.	O
three	O
of	O
four	O
drivers	B-T098
who	O
reported	O
medication	B-T103
use	O
(	O
78	O
.	O
2	O
%	O
)	O
said	O
the	O
drug	B-T103
was	O
prescribed	O
for	O
their	O
use	O
;	O
the	O
odds	O
of	O
using	O
without	O
a	O
prescription	B-T170
were	O
significantly	O
higher	O
for	O
males	O
,	O
black	B-T098
/	I-T098
african	I-T098
american	I-T098
,	O
and	O
hispanic	B-T098
drivers	B-T098
,	O
and	O
lower	O
for	O
older	B-T098
drivers	B-T098
.	O
among	O
those	O
with	O
a	O
prescription	B-T170
,	O
taking	O
more	O
than	O
prescribed	O
was	O
most	O
common	O
for	O
narcotic	B-T103
##s	I-T103
(	O
6	O
.	O
8	O
%	O
)	O
,	O
followed	O
by	O
sedative	B-T103
##s	I-T103
(	O
4	O
.	O
8	O
%	O
)	O
,	O
stimulants	B-T103
(	O
3	O
.	O
8	O
%	O
)	O
,	O
and	O
antidepressants	B-T103
(	O
1	O
.	O
5	O
%	O
)	O
.	O
these	O
findings	O
help	O
to	O
identify	O
drivers	B-T098
using	O
potentially	O
impairing	O
prescription	B-T103
drugs	I-T103
,	O
both	O
medically	O
and	O
nonm	B-T033
##edical	I-T033
##ly	I-T033
,	O
and	O
may	O
inform	O
the	O
targeting	O
of	O
interventions	B-T058
to	O
reduce	O
impaired	B-T033
driving	I-T033
related	O
to	O
medications	B-T170
.	O

a	O
practical	B-T097
guide	I-T097
to	O
forensic	B-T091
nursing	I-T091
:	O
incorporating	O
forensic	B-T091
principles	O
into	O
nursing	B-T058
practice	I-T058
am	B-T204
##ar	I-T204
ang	I-T204
##ela	I-T204
f	I-T204
and	O
se	B-T204
##k	I-T204
##ula	I-T204
l	I-T204
kat	I-T204
##hl	I-T204
##een	I-T204
a	O
practical	B-T097
guide	I-T097
to	O
forensic	B-T091
nursing	I-T091
:	O
incorporating	O
forensic	B-T091
principles	O
into	O
nursing	B-T058
practice	I-T058
39	O
##2p	O
##p	O
us	O
$	O
59	O
.	O
95	O
sigma	O
theta	O
tau	O
international	O
hon	O
##or	O
society	O
of	O
nursing	O
97	O
##81	O
##94	O
##0	O
##44	O
##63	O
##49	O
194	O
##0	O
##44	O
##63	O
##41	O
[	O
formula	O
:	O
see	O
text	O
geor	B-T204
##ge	I-T204
ber	I-T204
##nar	I-T204
##d	I-T204
sh	I-T204
##aw	I-T204
described	O
brit	B-T098
##ons	I-T098
and	O
americans	B-T098
as	O
'	O
divided	O
by	O
a	O
common	O
language	O
'	O
,	O
and	O
that	O
is	O
made	O
very	O
clear	O
in	O
this	O
fasci	B-T170
##nat	I-T170
##ing	I-T170
publication	I-T170
that	O
describes	O
in	O
depth	O
the	O
roles	B-T170
and	I-T170
responsibilities	I-T170
of	O
forensic	B-T097
nurses	I-T097
in	O
the	O
us	B-T082
.	O

bx	B-T005
##b1	I-T005
phage	I-T005
recombin	B-T103
##ase	I-T103
assist	O
##s	O
genome	B-T062
engineering	I-T062
in	O
drosophila	B-T204
melanogaster	I-T204
rapid	O
and	O
reliable	O
genome	B-T062
modifications	I-T062
provide	O
the	O
basis	O
for	O
detailed	O
in	B-T082
vivo	I-T082
functional	B-T058
analysis	I-T058
of	O
any	O
genomic	O
entity	O
(	O
gene	B-T017
,	O
regulatory	B-T082
dna	I-T082
,	O
non	B-T103
-	I-T103
coding	I-T103
rna	I-T103
,	O
etc	O
)	O
.	O
with	O
the	O
advent	O
of	O
crispr	B-T103
/	O
cas9	B-T062
genome	I-T062
editing	I-T062
technology	I-T062
,	O
manipulation	O
of	O
a	O
particular	O
genomic	B-T017
locus	I-T017
has	O
become	O
a	O
routine	O
undertaking	O
in	O
variety	O
of	O
model	O
organisms	O
,	O
including	O
the	O
fruit	B-T204
fly	I-T204
drosophila	I-T204
melanogaster	I-T204
.	O
to	O
further	O
divers	O
##ify	O
the	O
available	O
tools	O
for	O
genome	B-T062
engineering	I-T062
,	O
we	O
successfully	O
harness	O
##ed	O
the	O
phage	B-T005
recombin	B-T103
##ase	I-T103
bx	I-T103
##b1	I-T103
to	O
perform	O
recombin	O
##ase	O
-	O
mediated	O
cassette	O
exchange	O
(	O
rm	O
##ce	O
)	O
in	O
d	B-T204
.	I-T204
melanogaster	I-T204
.	O
we	O
demonstrate	O
that	O
bx	B-T005
##b1	I-T005
possesses	O
highly	O
efficient	O
recombin	B-T038
##ase	I-T038
activity	I-T038
and	O
could	O
be	O
used	O
alone	O
or	O
in	O
conjunction	O
with	O
other	O
currently	O
available	O
recombin	B-T103
##ases	I-T103
for	O
creating	O
platforms	O
for	O
cassette	O
exchange	O
of	O
targeted	B-T017
loci	I-T017
.	O

lung	B-T033
nodule	I-T033
in	O
french	B-T082
gu	I-T082
##iana	I-T082
in	O
a	O
immunocompetent	B-T201
patient	O
we	O
report	O
the	O
case	O
of	O
an	O
immunocompetent	B-T201
french	B-T098
soldi	B-T097
##er	I-T097
station	O
##ed	O
in	O
french	B-T082
gu	I-T082
##iana	I-T082
,	O
who	O
developed	O
symptomatic	O
pulmonary	B-T038
hist	I-T038
##oplasmosis	I-T038
.	O

antenatal	O
stressful	O
life	O
events	O
and	O
postpartum	O
depressive	B-T033
symptoms	I-T033
in	O
the	O
united	B-T082
states	I-T082
:	O
the	O
role	O
of	O
women	B-T098
'	I-T098
s	I-T098
socioeconomic	O
status	O
indices	B-T170
at	O
the	O
state	O
level	O
approximately	O
10	O
%	O
-	O
20	O
%	O
of	O
women	B-T098
suffer	B-T038
from	O
postpartum	B-T038
depression	I-T038
(	O
ppd	B-T038
)	O
,	O
important	O
predictors	O
of	O
which	O
are	O
antenatal	O
stressful	O
life	O
event	O
(	O
sle	O
)	O
experiences	O
.	O
the	O
association	O
between	O
women	B-T098
'	I-T098
s	I-T098
state	O
-	O
level	O
socioeconomic	O
status	O
(	O
ses	O
)	O
and	O
ppd	B-T038
has	O
not	O
been	O
explored	O
.	O
this	O
study	B-T062
aimed	O
to	O
examine	O
whether	O
the	O
association	O
between	O
antenatal	O
sle	O
and	O
ppd	B-T038
symptoms	B-T033
was	O
moderated	O
by	O
women	B-T098
'	I-T098
s	I-T098
state	O
-	O
level	O
ses	O
.	O
data	O
from	O
the	O
2009	O
-	O
2011	O
pregnancy	B-T170
risk	I-T170
assessment	I-T170
monitoring	I-T170
system	I-T170
(	O
pra	B-T170
##ms	I-T170
)	O
were	O
used	O
.	O
state	O
-	O
level	O
women	B-T098
'	I-T098
s	I-T098
employment	O
/	O
ear	O
##ning	O
##s	O
and	O
social	O
/	O
economic	O
autonomy	O
indices	B-T170
were	O
computed	O
from	O
indicators	B-T103
published	O
by	O
the	O
institute	B-T092
of	I-T092
women	I-T092
'	I-T092
s	I-T092
policy	I-T092
research	I-T092
(	O
i	B-T092
##w	I-T092
##pr	I-T092
)	O
.	O
multilevel	O
multivariable	O
logistic	O
regression	O
analyses	O
were	O
performed	O
.	O
among	O
91	O
,	O
253	O
women	B-T098
with	O
valid	O
responses	O
,	O
11	O
.	O
3	O
%	O
had	O
ppd	B-T038
symptoms	B-T033
,	O
prevalence	O
ranging	O
from	O
7	O
.	O
1	O
%	O
in	O
ill	B-T082
##ino	I-T082
##is	I-T082
to	O
17	O
.	O
1	O
%	O
in	O
ar	B-T082
##ka	I-T082
##ns	I-T082
##as	I-T082
.	O
women	B-T098
who	O
experienced	O
all	O
four	O
stressor	O
categories	B-T170
,	O
including	O
partner	B-T098
related	B-T033
,	O
traumatic	O
,	O
emotional	B-T033
,	O
and	O
financial	O
,	O
had	O
the	O
highest	O
odds	O
(	O
adjusted	O
odds	O
ratio	O
[	O
aor	O
]	O
:	O
5	O
.	O
43	O
;	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
:	O
5	O
.	O
36	O
-	O
5	O
.	O
51	O
)	O
of	O
ppd	B-T038
symptoms	B-T033
.	O
the	O
odds	O
of	O
experiencing	O
ppd	B-T038
symptoms	B-T033
decreased	O
with	O
an	O
increase	O
in	O
the	O
state	O
-	O
level	O
social	O
/	O
economic	O
autonomy	O
index	B-T170
(	O
aor	O
:	O
0	O
.	O
75	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
64	O
-	O
0	O
.	O
88	O
)	O
.	O
there	O
was	O
significant	O
cross	O
-	O
level	O
interaction	O
between	O
number	O
of	O
stressor	O
categories	B-T170
experienced	O
and	O
state	O
-	O
level	O
index	B-T170
.	O
screening	O
for	O
antenatal	O
sle	O
##s	O
can	O
help	O
identify	O
women	B-T098
at	O
risk	O
for	O
ppd	B-T038
symptoms	B-T033
.	O
that	O
the	O
odds	O
of	O
having	O
ppd	B-T038
symptoms	B-T033
decreased	O
with	O
increasing	O
state	O
-	O
level	O
social	O
/	O
economic	O
autonomy	O
and	O
women	B-T098
residing	O
in	O
states	B-T082
with	O
lower	O
indices	B-T170
were	O
more	O
vulnerable	O
to	O
the	O
impacts	O
of	O
antenatal	O
stressors	O
,	O
could	O
have	O
policy	O
implications	O
related	O
to	O
improving	O
the	O
ses	O
of	O
women	B-T098
in	O
these	O
states	B-T082
.	O

aquaporin	B-T103
-	I-T103
2	I-T103
excretion	B-T038
in	O
hospitalized	O
patients	O
with	O
cirrhosis	B-T038
:	O
relation	O
to	O
development	O
of	O
renal	B-T038
insufficiency	I-T038
and	O
mortality	O
urinary	O
aquaporin	B-T103
-	I-T103
2	I-T103
(	O
aqp	B-T103
##2	I-T103
)	O
is	O
a	O
parameter	O
of	O
water	B-T038
transport	I-T038
in	O
the	O
principal	B-T017
cells	I-T017
in	O
the	O
distal	B-T082
part	I-T082
of	O
the	O
nephron	B-T017
and	O
involved	O
in	O
water	B-T038
retention	I-T038
in	O
cirrhosis	B-T038
and	O
may	O
be	O
a	O
marker	B-T201
of	O
renal	B-T038
function	I-T038
.	O
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
evaluate	O
aqp	B-T103
##2	I-T103
as	O
a	O
predictor	B-T170
of	O
renal	B-T038
insufficiency	I-T038
and	O
death	B-T038
in	O
patients	O
with	O
cirrhosis	B-T038
.	O
urine	B-T031
samples	I-T031
from	O
199	O
patients	O
(	O
90	O
patients	O
without	O
organ	B-T033
failure	I-T033
[	O
group	O
1	O
]	O
,	O
58	O
patients	O
with	O
organ	B-T033
failure	I-T033
excluding	O
renal	B-T038
failure	I-T038
[	O
group	O
2	O
]	O
,	O
and	O
51	O
patients	O
with	O
organ	B-T033
failure	I-T033
including	O
renal	B-T038
failure	I-T038
[	O
group	O
3	O
]	O
)	O
from	O
the	O
can	B-T062
##onic	I-T062
study	I-T062
were	O
analyzed	O
for	O
urine	B-T031
aqp	B-T103
##2	I-T103
and	O
urine	B-T201
osmolality	I-T201
.	O
there	O
was	O
no	O
difference	O
in	O
aqp	B-T103
##2	I-T103
between	O
the	O
three	O
groups	O
.	O
urine	B-T201
osmolality	I-T201
was	O
significantly	O
lower	O
in	O
patients	O
in	O
group	O
3	O
versus	O
group	O
1	O
and	O
group	O
2	O
(	O
p	O
=	O
0	O
.	O
0004	O
)	O
.	O
no	B-T033
relation	I-T033
was	O
found	O
between	O
aqp	B-T103
##2	I-T103
and	O
glomerular	B-T058
filtration	I-T058
rate	I-T058
or	O
creatinine	B-T103
;	O
however	O
,	O
aqp	B-T103
##2	I-T103
was	O
a	O
significant	O
predictor	B-T170
of	O
the	O
development	O
of	O
renal	B-T038
insufficiency	I-T038
(	O
p	O
=	O
0	O
.	O
048	O
##5	O
)	O
.	O
in	O
a	O
univariate	O
analysis	O
,	O
aqp	B-T103
##2	I-T103
was	O
a	O
significant	O
predictor	B-T170
of	O
14	O
and	O
28	O
-	O
day	O
survival	O
,	O
but	O
this	O
was	O
not	O
confirmed	O
in	O
multivariate	O
analysis	O
.	O
aquaporin	B-T103
-	I-T103
2	I-T103
was	O
not	O
associated	O
with	O
disease	O
severity	O
or	O
markers	O
of	O
renal	B-T038
function	I-T038
but	O
was	O
a	O
predictor	B-T170
for	O
the	O
development	O
of	O
renal	B-T038
insufficiency	I-T038
and	O
death	B-T038
.	O
therefore	O
,	O
its	O
future	O
use	O
as	O
marker	B-T201
of	O
renal	B-T038
insufficiency	I-T038
could	O
be	O
promising	O
,	O
but	O
further	O
research	B-T062
is	O
needed	O
before	O
it	O
can	O
be	O
considered	O
a	O
clinical	O
useful	O
tool	O
.	O

mobile	O
phone	O
use	O
,	O
behavioural	B-T038
problems	I-T038
and	O
concentration	B-T038
capacity	O
in	O
adolescents	O
:	O
a	O
prospective	B-T062
study	I-T062
the	O
aim	O
of	O
this	O
study	B-T062
is	O
to	O
prospectively	O
investigate	O
whether	O
exposure	O
to	O
radiofrequency	O
electromagnetic	O
fields	O
(	O
rf	O
-	O
emf	O
)	O
emitted	O
by	O
mobile	O
phone	O
##s	O
and	O
other	O
wireless	O
communication	O
devices	O
is	O
related	O
to	O
behavioural	B-T038
problems	I-T038
or	O
concentration	B-T038
capacity	O
in	O
adolescents	O
.	O
the	O
herm	B-T062
##es	I-T062
(	O
health	O
effects	O
related	O
to	O
mobile	O
phone	O
use	O
in	O
adolescents	O
)	O
study	O
sample	O
consisted	O
of	O
43	O
##9	O
swiss	B-T098
adolescents	O
aged	O
12	O
-	O
17	O
years	O
.	O
behavioural	B-T038
problems	I-T038
were	O
assessed	O
using	O
the	O
strengths	B-T170
and	I-T170
difficulties	I-T170
questionnaire	I-T170
(	O
sd	B-T170
##q	I-T170
)	O
,	O
concentration	B-T038
capacity	O
of	O
the	O
adolescents	O
was	O
measured	O
by	O
means	O
of	O
a	O
standardized	O
computerized	O
cognitive	O
test	O
named	O
fak	B-T170
##t	I-T170
.	O
cross	B-T062
-	I-T062
sectional	I-T062
and	O
longitudinal	B-T062
(	O
1	O
##y	O
##ear	O
of	O
follow	B-T033
-	I-T033
up	I-T033
)	O
analyses	B-T062
were	O
performed	O
to	O
investigate	O
possible	O
associations	O
between	O
behavioural	B-T038
problems	I-T038
and	O
concentration	B-T038
capacity	O
and	O
different	O
exposure	O
measures	O
:	O
self	B-T062
-	I-T062
reported	I-T062
and	O
operator	B-T097
-	O
recorded	O
wireless	O
communication	O
device	O
use	O
,	O
cumulative	O
rf	O
-	O
emf	O
brain	B-T017
and	O
whole	B-T017
body	I-T017
dose	O
and	O
measured	O
personal	O
rf	O
-	O
emf	O
exposure	O
.	O
in	O
the	O
cross	B-T062
-	I-T062
sectional	I-T062
analyses	I-T062
behavioural	B-T038
problems	I-T038
were	O
associated	O
with	O
several	O
self	B-T170
-	I-T170
reported	I-T170
wireless	O
device	O
use	O
measures	O
but	O
not	O
operator	B-T097
-	O
recorded	O
mobile	O
phone	O
use	O
measures	O
,	O
concentration	B-T038
capacity	O
was	O
associated	O
with	O
several	O
self	B-T062
-	I-T062
reported	I-T062
and	O
operator	B-T097
-	O
recorded	O
exposures	O
.	O
the	O
longitudinal	B-T062
analyses	I-T062
point	O
towards	O
absence	O
of	O
associations	O
.	O
the	O
lack	O
of	O
consistent	O
exposure	O
-	O
response	O
patterns	B-T082
in	O
the	O
longitudinal	B-T062
analyses	I-T062
suggests	O
that	O
behavioural	B-T038
problems	I-T038
and	O
concentration	B-T038
capacity	O
are	O
not	O
affected	O
by	O
the	O
use	O
of	O
wireless	O
communication	O
devices	O
or	O
rf	O
-	O
emf	O
exposure	O
.	O
information	O
bias	O
and	O
reverse	O
causality	O
are	O
likely	O
explanations	B-T170
for	O
the	O
observed	O
cross	B-T062
-	I-T062
sectional	I-T062
findings	I-T062
.	O

mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
participates	O
in	O
esophageal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
invasion	B-T038
and	O
metastasis	B-T038
via	O
smad	B-T017
##7	I-T017
pathway	B-T038
mediated	O
emt	B-T038
escc	B-T038
is	O
a	O
life	B-T033
-	I-T033
threatening	I-T033
disease	B-T038
due	O
to	O
invasion	B-T038
and	O
metastasis	B-T038
in	O
the	O
early	O
stage	O
.	O
great	O
efforts	O
had	O
been	O
made	O
to	O
detect	B-T033
the	O
molecular	O
mechanisms	O
which	O
led	O
to	O
the	O
invasion	B-T038
and	O
metastasis	B-T038
in	O
escc	B-T038
.	O
recent	O
evidence	O
had	O
suggested	O
that	O
deregulation	O
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
took	O
an	O
important	O
role	O
in	O
cancers	B-T038
.	O
however	O
,	O
its	O
role	O
and	O
functional	O
mechanism	O
in	O
escc	B-T038
had	O
seldom	O
been	O
elucidated	O
.	O
the	O
expression	O
levels	O
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
were	O
detected	B-T033
in	O
escc	B-T038
tissues	B-T017
and	O
cell	B-T017
lines	I-T017
by	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
methods	I-T062
.	O
then	O
,	O
the	O
invasion	B-T038
,	O
metastasis	B-T038
and	O
proliferation	B-T038
ability	O
of	O
escc	B-T038
cell	B-T017
lines	I-T017
transfected	B-T038
with	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
mimics	O
were	O
analyzed	B-T062
separately	O
by	O
transwell	B-T058
invasion	I-T058
assay	I-T058
,	O
wound	B-T058
healing	I-T058
assay	I-T058
and	O
cell	B-T062
proliferation	I-T062
assay	I-T062
.	O
finally	O
,	O
the	O
target	B-T017
gene	I-T017
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
was	O
studied	O
and	O
verified	O
by	O
luciferase	B-T058
activity	I-T058
assay	I-T058
.	O
and	O
the	O
role	O
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
in	O
emt	B-T038
was	O
also	O
investigated	O
by	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
and	O
western	B-T058
blot	I-T058
assay	I-T058
.	O
we	O
showed	O
that	O
the	O
expression	O
levels	O
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
were	O
decreased	O
both	O
in	O
escc	B-T038
tissues	B-T017
and	O
cell	B-T017
lines	I-T017
.	O
furthermore	O
,	O
the	O
expression	O
levels	O
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
were	O
negatively	O
linked	O
to	O
lymph	B-T017
node	I-T017
metastasis	B-T038
in	O
escc	B-T038
tissues	B-T017
.	O
restoration	O
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
in	O
ec	B-T017
-	I-T017
1	I-T017
cells	I-T017
by	O
using	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
mimics	O
could	O
decrease	O
the	O
invasion	B-T038
,	O
metastasis	B-T038
and	O
proliferation	B-T038
of	O
ec	B-T017
-	I-T017
1	I-T017
cells	I-T017
,	O
indicating	O
its	O
role	O
in	O
inhibition	O
on	O
the	O
invasion	B-T038
and	O
metastasis	B-T038
ability	O
of	O
escc	B-T038
cells	B-T017
and	O
tissues	B-T017
.	O
in	O
addition	O
,	O
we	O
demonstrated	O
that	O
smad	B-T017
##7	I-T017
was	O
a	O
specific	O
target	B-T017
gene	I-T017
for	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
by	O
luciferase	B-T058
activity	I-T058
assay	I-T058
and	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
could	O
not	O
only	O
negatively	B-T033
regulate	B-T038
smad	B-T017
##7	I-T017
expression	B-T038
but	O
also	O
participate	O
in	O
emt	B-T038
via	O
smad	B-T017
##7	I-T017
,	O
because	O
overexpression	B-T038
of	O
smad	B-T017
##7	I-T017
could	O
partly	O
enhance	O
the	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
anti	B-T033
-	I-T033
emt	I-T033
function	O
.	O
our	O
results	O
described	O
that	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
-	O
smad	B-T017
##7	I-T017
pathway	B-T038
contributed	O
to	O
escc	B-T038
invasion	B-T038
and	O
metastasis	B-T038
and	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
mir	B-T017
-	I-T017
42	I-T017
##4	I-T017
-	I-T017
5p	I-T017
perhaps	O
provided	O
a	O
strategy	O
for	O
preventing	O
tumor	B-T033
invasion	I-T033
,	O
metastasis	B-T038
.	O

it	O
takes	O
bi	O
##king	O
to	O
learn	B-T038
:	O
physical	O
activity	O
improves	B-T033
learning	B-T038
a	O
second	B-T033
language	I-T033
recent	O
studies	B-T062
have	O
shown	O
that	O
concurrent	O
physical	O
activity	O
enhances	O
learning	B-T038
a	O
completely	O
unfamiliar	O
l2	B-T033
vocabulary	B-T170
as	O
compared	O
to	O
learning	B-T038
it	O
in	O
a	O
static	O
condition	O
.	O
in	O
this	O
paper	O
we	O
report	O
a	O
study	B-T062
whose	O
aim	O
is	O
twofold	O
:	O
to	O
test	O
for	O
possible	B-T033
positive	B-T033
effects	O
of	O
physical	O
activity	O
when	O
l2	B-T033
learning	B-T038
has	O
already	O
reached	O
some	O
level	O
of	O
proficiency	O
,	O
and	O
to	O
test	O
whether	O
the	O
assumed	O
better	O
performance	O
when	O
engaged	O
in	O
physical	O
activity	O
is	O
limited	O
to	O
the	O
linguistic	O
level	O
probed	O
at	O
training	O
(	O
i	O
.	O
e	O
.	O
l2	B-T033
vocabulary	B-T170
tested	O
by	O
means	O
of	O
a	O
word	B-T062
-	I-T062
picture	I-T062
verification	I-T062
task	I-T062
)	O
,	O
or	O
whether	O
it	O
extends	O
also	O
to	O
the	O
sentence	B-T170
level	O
(	O
which	O
was	O
tested	O
by	O
means	O
of	O
a	O
sentence	B-T062
semantic	I-T062
judgment	I-T062
task	I-T062
)	O
.	O
the	O
results	O
show	O
that	O
chinese	B-T098
speakers	I-T098
with	O
basic	O
knowledge	O
of	O
english	O
benefited	O
from	O
physical	O
activity	O
while	O
learning	B-T038
a	O
set	O
of	O
new	O
words	B-T170
.	O
furthermore	O
,	O
their	O
better	O
performance	O
emerged	O
also	O
at	O
the	O
sent	B-T170
##ential	I-T170
level	O
,	O
as	O
shown	O
by	O
their	O
performance	O
in	O
a	O
semantic	B-T062
judgment	I-T062
task	I-T062
.	O
finally	O
,	O
an	O
interesting	O
temporal	O
asymmetry	O
between	O
the	O
lexical	O
and	O
the	O
sent	B-T170
##ential	I-T170
level	O
emerges	O
,	O
with	O
the	O
difference	O
between	O
the	O
experimental	O
and	O
control	O
group	O
emerging	O
from	O
the	O
1st	O
testing	O
session	O
at	O
the	O
lexical	O
level	O
but	O
after	O
several	O
weeks	O
at	O
the	O
sent	B-T170
##ential	I-T170
level	O
.	O

genital	B-T038
and	O
extra	B-T038
##gen	I-T038
##ital	I-T038
gonorrh	I-T038
##ea	I-T038
and	O
chlamydia	B-T038
in	O
children	O
and	O
adolescents	O
evaluated	B-T058
for	O
sexual	B-T037
abuse	I-T037
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
describe	O
the	O
use	O
of	O
a	O
nucleic	B-T058
acid	I-T058
amplification	I-T058
test	I-T058
in	O
detecting	B-T058
genital	B-T007
and	O
extra	B-T007
##gen	I-T007
##ital	I-T007
neisseria	I-T007
gonorrhoeae	I-T007
(	O
ng	B-T007
)	O
and	O
chlamydia	B-T007
trachomatis	I-T007
(	O
ct	B-T007
)	O
in	O
children	O
and	O
adolescents	O
assessed	O
for	O
sexual	B-T037
abuse	I-T037
/	O
assault	B-T038
.	O
the	O
charts	O
of	O
children	O
aged	O
0	O
to	O
17	O
years	O
,	O
consecutively	O
evaluated	B-T058
for	O
sexual	O
victimization	O
,	O
in	O
emergency	B-T092
department	I-T092
and	O
outpatient	B-T092
settings	I-T092
were	O
reviewed	O
.	O
data	O
extracted	O
included	O
age	O
,	O
sex	O
,	O
type	O
of	O
sexual	O
contact	O
,	O
an	O
##ogen	O
##ital	O
findings	B-T033
,	O
previous	O
sexual	O
contact	O
,	O
toxicology	B-T033
results	I-T033
,	O
and	O
sites	B-T082
tested	B-T058
for	O
ng	B-T007
and	O
ct	B-T007
.	O
of	O
the	O
131	O
##9	O
patients	O
who	O
were	O
tested	B-T058
,	O
57	O
##9	O
were	O
tested	B-T058
at	O
more	O
than	O
1	O
site	B-T082
,	O
and	O
120	O
had	O
at	O
least	O
1	O
infected	B-T033
site	B-T082
.	O
chlamydia	B-T007
trachomatis	I-T007
was	O
identified	O
in	O
104	O
patients	O
,	O
and	O
ng	B-T007
was	O
found	O
in	O
33	O
.	O
in	O
bivariate	O
analysis	O
,	O
a	O
positive	O
test	O
was	O
associated	O
with	O
female	O
sex	O
,	O
age	O
older	O
than	O
11	O
years	O
,	O
previous	O
sexual	O
contact	O
,	O
acute	O
or	O
healed	O
genital	B-T037
injury	I-T037
,	O
drug	O
/	O
alcohol	O
intoxication	O
,	O
and	O
examination	B-T058
within	O
72	O
hours	O
of	O
sexual	O
contact	O
.	O
fifty	O
-	O
one	O
patients	O
had	O
positive	B-T033
anal	B-T017
tests	B-T058
,	O
and	O
24	O
had	O
positive	B-T033
oral	B-T082
tests	B-T058
.	O
more	O
than	O
75	O
%	O
of	O
patients	O
with	O
positive	B-T033
extra	B-T058
##gen	I-T058
##ital	I-T058
tests	I-T058
had	O
additional	O
positive	B-T033
tests	B-T058
or	O
an	O
##ogen	O
##ital	O
injury	B-T037
.	O
most	O
with	O
a	O
positive	B-T033
anal	B-T017
(	O
59	O
%	O
)	O
or	O
oral	B-T082
(	O
77	O
%	O
)	O
test	B-T058
did	O
not	O
report	O
that	O
the	O
ass	O
##ail	O
##ant	O
'	O
s	O
genital	B-T017
##s	I-T017
came	O
into	O
contact	O
with	O
that	O
site	B-T082
.	O
positive	B-T033
tests	B-T058
for	O
ng	B-T007
and	O
ct	B-T007
in	O
patients	O
evaluated	B-T058
for	O
sexual	O
victimization	O
may	O
represent	O
infection	B-T038
from	O
sexual	O
contact	O
,	O
contiguous	O
spread	O
of	O
infection	B-T038
,	O
or	O
the	O
presence	O
of	O
infected	B-T031
ass	I-T031
##ail	I-T031
##ant	I-T031
secretions	I-T031
.	O
relying	O
on	O
patient	O
reports	O
of	O
symptoms	B-T033
,	O
or	O
types	O
of	O
sexual	O
contact	O
,	O
to	O
determine	O
need	O
for	O
testing	O
may	O
miss	O
ng	B-T038
and	O
ct	B-T038
infections	I-T038
in	O
patients	O
evaluated	B-T058
for	O
sexual	O
victimization	O
.	O

vasopressin	B-T103
regulates	B-T038
the	I-T038
growth	I-T038
of	O
the	O
biliary	O
epithelium	O
in	O
polycystic	B-T017
liver	I-T017
disease	I-T017
the	O
neuroh	B-T103
##yp	I-T103
##ophys	I-T103
##ial	I-T103
hormone	I-T103
arginine	B-T103
vasopressin	I-T103
(	O
avp	B-T103
)	O
acts	O
by	O
three	O
distinct	O
receptor	B-T103
subtypes	O
:	O
v1	B-T103
##a	I-T103
,	O
v1	B-T103
##b	I-T103
,	O
and	O
v2	B-T103
.	O
in	O
the	O
liver	B-T017
,	O
avp	B-T103
is	O
involved	O
in	O
ure	B-T038
##ogenesis	I-T038
,	O
glycogen	B-T038
##olysis	I-T038
,	O
neo	O
##gluc	O
##ogenesis	O
and	O
regeneration	B-T038
.	O
no	O
data	O
exist	O
about	O
the	O
presence	B-T033
of	O
avp	B-T103
in	O
the	O
biliary	O
epithelium	O
.	O
cholangi	O
##ocytes	O
are	O
the	O
target	B-T017
cells	I-T017
in	O
a	O
number	O
of	O
animal	B-T038
models	I-T038
of	O
cholestasis	B-T038
,	O
including	O
bile	B-T017
duct	I-T017
ligation	B-T058
(	O
bd	B-T058
##l	I-T058
)	O
,	O
and	O
in	O
several	O
human	B-T204
pathologies	B-T091
,	O
such	O
as	O
polycystic	B-T017
liver	I-T017
disease	I-T017
characterized	O
by	O
the	O
presence	B-T033
of	O
cysts	B-T038
that	O
bud	O
from	O
the	O
biliary	O
epithelium	O
.	O
in	B-T082
vivo	I-T082
,	O
liver	B-T017
fragments	B-T031
from	O
normal	O
and	O
bd	B-T058
##l	I-T058
mice	B-T204
and	O
rats	B-T204
as	O
well	O
as	O
liver	B-T017
samples	I-T017
from	O
normal	O
and	O
adp	B-T017
##kd	I-T017
patients	O
were	O
collected	O
to	O
evaluate	O
:	O
(	O
i	O
)	O
intrahepatic	B-T082
bile	B-T017
duct	I-T017
mass	B-T033
by	O
immunohistochemistry	B-T058
for	O
cytokeratin	B-T103
-	I-T103
19	I-T103
;	O
and	O
(	O
ii	O
)	O
expression	O
of	O
v1	B-T103
##a	I-T103
,	O
v1	B-T103
##b	I-T103
and	O
v2	B-T103
by	O
immunohistochemistry	B-T058
,	O
immunofluorescence	B-T058
and	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
.	O
in	O
vitro	O
,	O
small	O
and	O
large	O
mouse	B-T204
cholangi	O
##ocytes	O
,	O
h	B-T017
##69	I-T017
(	O
non	O
-	O
malignant	O
human	B-T204
cholangi	O
##ocytes	O
)	O
and	O
lc	B-T017
##de	I-T017
(	O
human	B-T204
cholangi	O
##ocytes	O
from	O
the	O
cystic	B-T017
epithelium	I-T017
)	O
were	O
stimulated	B-T038
with	O
vasopressin	B-T103
in	O
the	O
absence	O
/	O
presence	B-T033
of	O
avp	B-T103
antagonists	I-T103
such	O
as	O
opc	B-T103
-	I-T103
312	I-T103
##60	I-T103
and	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
,	O
before	O
assessing	O
cellular	B-T038
growth	I-T038
by	O
mtt	B-T058
assay	I-T058
and	O
camp	B-T103
levels	O
.	O
cholangi	O
##ocytes	O
express	O
v2	B-T103
receptor	I-T103
that	O
was	O
upregulated	B-T038
following	O
bd	B-T058
##l	I-T058
and	O
in	O
adp	B-T017
##kd	I-T017
liver	B-T017
samples	I-T017
.	O
administration	B-T058
of	O
avp	B-T103
increased	O
proliferation	B-T038
and	O
camp	B-T103
levels	O
of	O
small	O
cholangi	O
##ocytes	O
and	O
lc	B-T017
##de	I-T017
cells	I-T017
.	O
we	O
found	O
no	O
effect	O
in	O
the	O
proliferation	B-T038
of	O
large	O
mouse	B-T204
cholangi	O
##ocytes	O
and	O
h	B-T017
##69	I-T017
cells	I-T017
.	O
increases	O
were	O
blocked	O
by	O
preincubation	O
with	O
the	O
avp	B-T103
antagonists	I-T103
.	O
these	O
results	O
showed	O
that	O
avp	B-T103
and	O
its	O
receptors	B-T103
may	O
be	O
important	O
in	O
the	O
modulation	O
of	O
the	O
proliferation	B-T033
rate	I-T033
of	O
the	O
biliary	O
epithelium	O
.	O

pancreatic	B-T038
cancer	I-T038
:	O
a	O
survival	B-T062
analysis	I-T062
study	B-T062
in	O
ok	B-T082
##la	I-T082
##hom	I-T082
##a	I-T082
pancreatic	B-T038
cancer	I-T038
is	O
among	O
the	O
most	O
dead	B-T038
##ly	I-T038
cancers	I-T038
.	O
risk	B-T033
factors	I-T033
associated	O
with	O
the	O
disease	B-T038
include	O
age	O
,	O
race	B-T098
,	O
sex	O
,	O
smoking	B-T201
status	I-T201
,	O
and	O
diabetes	O
status	O
.	O
we	O
conducted	O
a	O
prospective	B-T062
analysis	I-T062
of	O
risk	B-T033
factors	I-T033
and	O
length	O
of	O
survival	O
among	O
pancreatic	O
cancer	O
patients	O
living	O
in	O
ok	B-T082
##la	I-T082
##hom	I-T082
##a	I-T082
between	O
1997	O
and	O
2012	O
(	O
n	O
=	O
6	O
,	O
291	O
)	O
.	O
kaplan	O
-	O
meier	O
survival	O
curves	O
were	O
created	O
followed	O
by	O
the	O
log	O
-	O
rank	O
test	O
to	O
compare	O
difference	O
in	O
the	O
survival	B-T201
time	I-T201
.	O
cox	B-T170
proportional	I-T170
hazard	I-T170
regression	I-T170
models	I-T170
were	O
used	O
to	O
examine	O
the	O
strength	O
of	O
association	O
through	O
the	O
estimated	O
hazard	O
ratios	O
.	O
the	O
median	O
survival	O
time	O
of	O
the	O
cohort	B-T098
was	O
three	O
months	O
.	O
significant	O
risk	B-T033
factors	I-T033
for	O
reduced	O
survival	B-T201
times	I-T201
included	O
age	O
,	O
stage	B-T170
at	I-T170
diagnosis	I-T170
,	O
and	O
year	O
of	O
diagnosis	O
.	O
results	B-T033
are	O
in	O
agreement	O
with	O
previous	O
research	B-T033
findings	I-T033
.	O
there	O
have	O
been	O
small	O
but	O
noteworthy	O
improvements	O
in	O
survival	B-T201
times	I-T201
for	O
pancreatic	O
cancer	O
patients	O
in	O
ok	B-T082
##la	I-T082
##hom	I-T082
##a	I-T082
.	O
length	O
of	O
survival	O
during	O
the	O
study	B-T062
period	I-T062
was	O
significantly	O
associated	O
with	O
known	O
risk	B-T033
factors	I-T033
such	O
as	O
age	O
and	O
stage	B-T170
of	I-T170
diagnosis	I-T170
.	O

the	O
nurse	O
-	O
patient	O
communication	O
:	O
voice	O
##s	O
from	O
nursing	B-T097
students	I-T097
effective	O
communication	O
skills	O
have	O
been	O
found	O
to	O
be	O
one	O
of	O
the	O
pivotal	O
factors	O
in	O
building	O
positive	O
interpersonal	O
relationships	O
.	O
little	O
is	O
known	O
about	O
nursing	B-T097
undergraduate	I-T097
##s	I-T097
'	O
perspectives	O
on	O
communicating	O
with	O
patients	O
.	O
this	O
study	B-T062
aimed	O
to	O
explore	O
nursing	B-T097
students	I-T097
'	I-T097
perspectives	O
and	O
experiences	B-T038
of	O
nurse	O
-	O
patient	O
communication	O
in	O
their	O
clinical	O
placement	O
.	O
the	O
participants	B-T098
included	O
21	O
second	B-T098
-	I-T098
year	I-T098
undergraduate	I-T098
##s	I-T098
and	O
21	O
first	B-T098
-	I-T098
year	I-T098
master	I-T098
'	I-T098
s	I-T098
students	I-T098
.	O
interviews	O
were	O
conducted	O
in	O
cant	O
##ones	O
##e	O
and	O
then	O
transcribed	O
in	O
chinese	O
and	O
translated	O
into	O
english	O
.	O
a	O
content	O
analysis	O
approach	B-T082
was	O
adopted	O
to	O
analyze	O
the	O
data	O
.	O
five	O
themes	O
emerged	O
from	O
the	O
interview	O
data	O
.	O
'	O
the	O
necessity	O
of	O
nurse	O
-	O
patient	O
communication	O
'	O
reveals	O
why	O
the	O
students	B-T098
valued	O
nurse	O
-	O
patient	O
communication	O
.	O
'	O
the	O
convers	B-T033
##ation	I-T033
contents	I-T033
'	O
describes	O
the	O
content	B-T033
of	I-T033
the	I-T033
convers	I-T033
##ations	I-T033
that	O
students	B-T098
typically	O
had	O
with	O
patients	O
.	O
the	O
third	O
theme	O
is	O
'	O
self	B-T033
-	I-T033
reflection	I-T033
on	O
the	O
nurse	O
-	O
patient	O
communication	O
'	O
.	O
the	O
last	O
two	O
themes	O
,	O
'	O
the	O
communication	O
pattern	O
in	O
different	O
hospital	B-T092
settings	I-T092
'	O
and	O
'	O
the	O
obstacles	O
imped	O
##ing	O
nurse	O
-	O
patient	O
communication	O
'	O
,	O
are	O
about	O
the	O
students	B-T098
'	I-T098
communication	O
styles	O
in	O
different	O
hospitals	B-T092
and	O
the	O
barriers	O
they	O
encounter	O
.	O
to	O
improve	B-T033
students	B-T098
'	I-T098
communication	O
skills	O
,	O
educators	B-T097
and	O
clinical	B-T097
staff	I-T097
should	O
listen	O
to	O
students	B-T098
,	O
enhance	O
students	B-T098
'	I-T098
reflective	O
skills	O
and	O
strengthen	O
their	O
confidence	B-T038
.	O
through	O
understanding	B-T038
students	B-T098
'	I-T098
difficulties	O
in	O
the	O
nurse	O
-	O
patient	O
communication	O
experience	B-T038
and	O
the	O
skills	O
that	O
they	O
lack	O
,	O
educators	B-T097
can	O
provide	O
them	O
with	O
helpful	O
recommendations	O
to	O
improve	B-T033
their	O
communication	O
skills	O
in	O
clinical	O
practice	O
.	O
the	O
results	O
of	O
this	O
study	B-T062
reveal	O
that	O
students	B-T098
'	I-T098
nurse	O
-	O
patient	O
communication	O
skills	O
need	O
to	O
be	O
improved	B-T033
.	O

is	O
uv	O
-	O
induced	O
electron	O
-	O
driven	O
proton	O
transfer	O
active	O
in	O
a	O
chemically	O
modified	O
a	B-T103
·	O
t	B-T103
dna	B-T103
base	B-T038
pair	I-T038
?	O
transient	B-T058
electronic	I-T058
and	I-T058
vibrational	I-T058
absorption	I-T058
spectro	I-T058
##sc	I-T058
##op	I-T058
##ies	I-T058
have	O
been	O
used	O
to	O
investigate	O
whether	O
uv	O
-	O
induced	O
electron	O
-	O
driven	O
proton	O
transfer	O
(	O
ed	O
##pt	O
)	O
mechanisms	O
are	O
active	O
in	O
a	O
chemically	O
modified	O
adenine	B-T103
-	O
thymine	B-T103
(	O
a	B-T103
·	O
t	B-T103
)	O
dna	B-T103
base	B-T038
pair	I-T038
.	O
to	O
enhance	O
the	O
fraction	O
of	O
biologically	O
relevant	O
wat	O
##son	O
-	O
crick	O
(	O
wc	O
)	O
hydrogen	O
-	O
bonding	O
motifs	B-T082
and	O
eliminate	O
undes	O
##ired	O
ho	O
##ogs	O
##teen	O
structures	O
,	O
a	O
chemically	O
modified	O
derivative	O
of	O
a	B-T103
was	O
synthesized	O
,	O
8	B-T103
-	I-T103
(	I-T103
tert	I-T103
-	I-T103
butyl	I-T103
)	I-T103
-	I-T103
9	I-T103
-	I-T103
ethyl	I-T103
##aden	I-T103
##ine	I-T103
(	O
8	B-T103
##t	I-T103
##ba	I-T103
)	O
.	O
equimolar	O
solutions	O
of	O
8	B-T103
##t	I-T103
##ba	I-T103
and	O
sily	B-T103
##l	I-T103
-	I-T103
protected	I-T103
t	I-T103
nucleosides	B-T103
in	O
chloroform	B-T103
yield	O
a	O
mixture	O
of	O
wc	B-T038
pairs	I-T038
,	O
reverse	B-T038
wc	I-T038
pairs	I-T038
,	O
and	O
residual	B-T103
monomers	I-T103
.	O
unlike	O
previous	O
transient	B-T058
absorption	I-T058
studies	I-T058
of	O
wc	O
guanine	B-T103
-	O
cytos	B-T103
##in	I-T103
e	O
(	O
g	B-T103
·	O
c	B-T103
)	O
pairs	B-T038
,	O
no	O
clear	O
spectroscopic	O
or	O
kinetic	O
evidence	O
was	O
identified	O
for	O
the	O
participation	O
of	O
ed	O
##pt	O
in	O
the	O
excited	O
-	O
state	O
relaxation	O
dynamics	O
of	O
8	B-T103
##t	I-T103
##ba	I-T103
·	O
t	B-T103
pairs	B-T038
,	O
although	O
ultrafast	O
(	O
sub	O
-	O
100	O
fs	O
)	O
ed	O
##pt	O
cann	O
##ot	O
be	O
disc	O
##ounted	O
.	O
monomer	O
-	O
like	O
dynamics	O
are	O
proposed	O
to	O
dominate	O
in	O
8	B-T103
##t	I-T103
##ba	I-T103
·	O
t	B-T103
.	O

ampk	B-T103
-	O
autophagy	B-T038
inhibition	O
sensitiz	O
##es	O
ica	B-T103
##ritin	I-T103
-	O
induced	O
anti	B-T033
-	I-T033
colorectal	I-T033
cancer	I-T033
cell	B-T038
activity	I-T038
the	O
current	O
research	B-T062
studied	O
the	O
potential	O
effect	O
of	O
autophagy	B-T038
on	O
ica	B-T103
##ritin	I-T103
-	O
induced	O
anti	B-T033
-	I-T033
colorectal	I-T033
cancer	I-T033
(	O
crc	B-T038
)	O
cell	B-T038
activity	I-T038
.	O
treatment	O
of	O
ica	B-T103
##ritin	I-T103
in	O
both	O
primary	O
and	O
established	O
(	O
ht	B-T017
-	I-T017
29	I-T017
)	O
crc	B-T038
cells	B-T017
induced	O
feedback	O
activation	O
of	O
autophagy	B-T038
,	O
evidenced	O
by	O
p	B-T017
##62	I-T017
degradation	B-T038
,	O
bec	B-T017
##lin	I-T017
-	I-T017
1	I-T017
and	O
autophagy	B-T017
-	I-T017
related	I-T017
gene	I-T017
-	I-T017
5	I-T017
(	O
atg	B-T017
-	I-T017
5	I-T017
)	O
upregulation	B-T038
,	O
as	O
well	O
as	O
light	B-T103
chain	I-T103
3b	I-T103
(	O
lc3	B-T103
##b	I-T103
)	O
-	O
gfp	B-T103
punct	O
##a	O
formation	O
.	O
pharmacological	O
inhibiting	O
of	O
autophagy	B-T038
dramatically	O
potentiated	O
ica	B-T103
##ritin	I-T103
-	O
induced	O
crc	B-T038
cell	B-T038
death	I-T038
and	O
apoptosis	B-T038
.	O
meanwhile	O
,	O
shrna	B-T103
-	O
mediated	O
knockdown	B-T062
of	O
bec	B-T017
##lin	I-T017
-	I-T017
1	I-T017
or	O
atg	B-T017
-	I-T017
5	I-T017
also	O
sensitized	O
ica	B-T103
##ritin	I-T103
-	O
induced	O
crc	B-T038
cell	B-T038
death	I-T038
and	O
apoptosis	B-T038
.	O
ica	B-T103
##ritin	I-T103
activated	O
amp	B-T103
-	I-T103
activated	I-T103
protein	I-T103
kinase	I-T103
(	O
ampk	B-T103
)	O
signaling	B-T038
in	O
crc	B-T038
cells	B-T017
,	O
functioning	O
as	O
the	O
upstream	O
signaling	B-T038
for	O
autophagy	B-T038
activation	O
.	O
shrna	B-T103
/	O
sirna	B-T103
-	O
mediated	O
knockdown	B-T062
of	O
ampk	B-T017
##α	I-T017
##1	I-T017
inhibited	O
ica	B-T103
##ritin	I-T103
-	O
induced	O
autophagy	B-T038
activation	O
,	O
but	O
exacerbated	O
crc	B-T038
cell	B-T038
death	I-T038
.	O
on	O
the	O
other	O
hand	O
,	O
the	O
ampk	B-T103
activator	O
compound	B-T103
13	I-T103
(	O
c1	B-T103
##3	I-T103
)	O
or	O
the	O
autophagy	B-T038
activator	O
mh	B-T103
##y1	I-T103
##48	I-T103
##5	I-T103
attenuated	O
ica	B-T103
##ritin	I-T103
-	O
induced	O
cytotoxicity	B-T038
.	O
in	O
nude	B-T204
mice	I-T204
,	O
ica	B-T103
##ritin	I-T103
(	O
oral	B-T058
administration	I-T058
)	O
-	O
induced	O
ht	B-T017
-	I-T017
29	I-T017
tumor	O
growth	O
inhibition	O
was	O
potentiated	O
when	O
combined	O
with	O
ampk	B-T017
##α	I-T017
##1	I-T017
shrna	B-T103
knockdown	B-T062
in	O
tumors	B-T038
.	O
we	O
conclude	O
that	O
feedback	O
activation	O
of	O
ampk	B-T103
-	O
autophagy	B-T038
pathway	B-T038
could	O
be	O
a	O
primary	O
resistance	O
factor	O
of	O
ica	B-T103
##ritin	I-T103
.	O

successful	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
at	O
a	O
small	B-T092
regional	I-T092
hospital	I-T092
prenatal	B-T058
diagnosis	I-T058
of	O
complex	O
congenital	B-T017
heart	I-T017
disease	I-T017
(	O
chd	B-T017
)	O
has	O
been	O
shown	O
to	O
improve	B-T033
newborn	B-T033
outcomes	O
.	O
the	O
rate	O
of	O
prenatal	B-T058
diagnosis	I-T058
and	O
access	B-T082
to	O
fetal	B-T058
echocardiography	I-T058
vary	O
widely	O
across	O
the	O
united	B-T082
states	I-T082
.	O
a	O
clinical	B-T058
fetal	I-T058
tele	I-T058
-	I-T058
echo	I-T058
service	O
was	O
established	O
at	O
king	B-T092
'	I-T092
s	I-T092
daughters	I-T092
medical	I-T092
center	I-T092
(	O
kd	B-T092
##mc	I-T092
)	O
in	O
ash	B-T082
##land	I-T082
,	O
ky	B-T082
,	O
a	O
region	O
in	O
eastern	B-T082
ken	I-T082
##t	I-T082
##uck	I-T082
##y	I-T082
that	O
is	O
3	O
h	O
from	O
the	O
nearest	O
congenital	B-T097
heart	I-T097
surgeon	I-T097
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
if	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
utilizing	O
local	B-T097
son	I-T097
##ograph	I-T097
##ers	I-T097
at	O
a	O
small	B-T092
regional	I-T092
hospital	I-T092
can	O
accurately	O
and	O
efficiently	O
identify	O
fetuses	B-T017
with	O
complex	O
chd	B-T017
.	O
medical	B-T170
records	I-T170
were	O
reviewed	O
for	O
all	O
mother	O
-	O
infant	O
pairs	O
who	O
had	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
##es	I-T058
performed	O
at	O
kd	B-T092
##mc	I-T092
and	O
interpreted	O
by	O
university	B-T092
of	I-T092
louis	I-T092
##vi	I-T092
##ll	I-T092
##e	I-T092
pediatric	I-T092
cardiology	I-T092
between	O
march	O
2011	O
and	O
december	O
2013	O
.	O
findings	B-T033
on	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
were	O
compared	O
to	O
newborn	O
echo	B-T058
and	O
clinical	O
course	O
,	O
and	O
divided	O
into	O
four	O
groups	O
:	O
(	O
1	O
)	O
correct	O
-	O
no	O
difference	O
between	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
and	O
newborn	O
echo	B-T058
,	O
(	O
2	O
)	O
likely	O
correct	O
-	O
normal	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
and	O
benign	O
newborn	O
course	O
,	O
(	O
3	O
)	O
major	O
difference	O
-	O
one	O
that	O
affected	O
newborn	B-T033
clinical	O
course	O
,	O
and	O
(	O
4	O
)	O
minor	O
difference	O
-	O
did	O
not	O
affect	O
clinical	O
course	O
.	O
seventy	O
-	O
five	O
mother	O
-	O
infant	O
pairs	O
were	O
analyzed	B-T062
.	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
##es	I-T058
were	O
correct	O
in	O
21	O
%	O
,	O
likely	O
correct	O
in	O
56	O
%	O
,	O
showed	O
major	O
differences	O
in	O
0	O
%	O
,	O
and	O
showed	O
minor	O
differences	O
in	O
23	O
%	O
.	O
for	O
identifying	O
complex	O
chd	B-T017
,	O
fetal	B-T058
tele	I-T058
-	I-T058
echo	I-T058
had	O
a	O
sensitivity	O
and	O
specificity	O
of	O
100	O
%	O
.	O
the	O
average	O
number	O
of	O
fetal	B-T058
echocardiogram	I-T058
##s	I-T058
per	O
mother	O
-	O
infant	O
pair	O
was	O
1	O
.	O
1	O
.	O
fetal	B-T058
tele	I-T058
-	I-T058
echocardiography	I-T058
performed	O
by	O
local	B-T097
son	I-T097
##ograph	I-T097
##ers	I-T097
at	O
a	O
small	B-T092
regional	I-T092
hospital	I-T092
can	O
accurately	O
and	O
efficiently	O
identify	O
fetuses	B-T017
with	O
complex	O
chd	B-T017
.	O

the	O
emerging	O
contribution	O
of	O
social	B-T204
wasp	I-T204
##s	I-T204
to	O
grape	B-T038
rot	I-T038
disease	I-T038
ecology	O
grape	B-T038
sour	I-T038
(	I-T038
bun	I-T038
##ch	I-T038
)	I-T038
rot	I-T038
is	O
a	O
polym	O
##ic	O
##rob	O
##ial	O
disease	O
of	O
vine	B-T082
##ya	I-T082
##rd	I-T082
##s	I-T082
that	O
causes	O
millions	O
of	O
dollars	O
in	O
lost	O
reven	O
##ue	O
per	O
year	O
due	O
to	O
decreased	O
quality	O
of	O
grape	B-T168
##s	I-T168
and	O
resultant	B-T168
wine	I-T168
.	O
the	O
disease	B-T038
is	O
associated	O
with	O
damaged	O
ber	B-T168
##ries	I-T168
infected	B-T033
with	O
a	O
community	O
of	O
acetic	B-T007
acid	I-T007
bacteria	I-T007
,	O
yeasts	B-T204
,	O
and	O
filamentous	B-T204
fungi	I-T204
that	O
results	O
in	O
rot	O
##ting	O
ber	B-T168
##ries	I-T168
with	O
high	O
amounts	O
of	O
undesirable	O
volatile	O
acidity	B-T103
.	O
many	O
insect	B-T204
species	B-T170
cause	O
the	O
initial	O
grape	B-T168
ber	B-T168
##ry	I-T168
damage	O
that	O
can	O
lead	O
to	O
this	O
disease	B-T038
,	O
but	O
most	O
studies	B-T062
have	O
focused	O
on	O
the	O
role	O
of	O
fruit	B-T204
flies	I-T204
in	O
facilitating	O
symptoms	B-T033
and	O
vector	B-T204
##ing	I-T204
the	O
microorganisms	O
of	O
this	O
disease	B-T038
complex	O
.	O
like	O
fruit	B-T204
flies	I-T204
,	O
social	B-T204
wasp	I-T204
##s	I-T204
are	O
abundant	O
in	O
vine	B-T082
##ya	I-T082
##rd	I-T082
##s	I-T082
where	O
they	O
feed	O
on	O
rip	B-T168
##e	I-T168
ber	I-T168
##ries	I-T168
and	O
cause	O
significant	O
damage	O
,	O
while	O
also	O
dispers	B-T082
##ing	I-T082
yeasts	B-T204
involved	O
in	O
wine	B-T168
fermentation	B-T038
.	O
despite	O
this	O
,	O
their	O
possible	O
role	O
in	O
disease	B-T038
facilitation	O
and	O
dispersal	B-T038
of	I-T038
grape	I-T038
rot	I-T038
##s	I-T038
has	O
not	O
been	O
explored	O
.	O
we	O
tested	O
the	O
hypothesis	O
that	O
the	O
paper	B-T204
wasp	I-T204
poli	O
##st	O
##es	O
dom	O
##in	O
##ulus	O
could	O
facilitate	O
grape	B-T038
sour	I-T038
rot	I-T038
in	O
the	O
absence	O
of	O
other	O
insect	B-T204
vectors	I-T204
.	O
using	O
marker	B-T058
gene	I-T058
sequencing	I-T058
we	O
characterized	O
the	O
bacterial	B-T007
and	O
fungal	B-T204
community	O
of	O
wild	O
-	O
caught	O
adults	O
.	O
we	O
used	O
a	O
sterilized	O
foraging	B-T082
arena	I-T082
to	O
determine	O
if	O
these	O
wasp	B-T204
##s	I-T204
transfer	O
viable	O
microorganisms	O
when	O
foraging	O
.	O
we	O
then	O
tested	O
if	O
wasp	B-T204
##s	I-T204
harboring	O
their	O
native	B-T098
microbial	O
community	O
,	O
or	O
those	O
inoculated	B-T058
with	O
sour	B-T038
rot	I-T038
,	O
had	O
an	O
effect	O
on	O
grape	B-T038
sour	I-T038
rot	I-T038
incidence	O
and	O
severity	O
using	O
a	O
laboratory	B-T082
foraging	I-T082
arena	I-T082
.	O
we	O
found	O
that	O
all	O
wasp	B-T204
##s	I-T204
harbor	O
some	O
portion	O
of	O
the	O
sour	B-T038
rot	I-T038
microbial	O
community	O
and	O
that	O
they	O
have	O
the	O
ability	O
to	O
transfer	O
viable	O
microorganisms	O
when	O
foraging	O
.	O
foraging	O
by	O
inoculated	B-T058
and	O
unin	B-T204
##oc	I-T204
##ulated	I-T204
wasp	I-T204
##s	I-T204
led	O
to	O
an	O
increase	O
in	O
ber	B-T038
##ry	I-T038
rot	I-T038
disease	I-T038
symptom	B-T033
severity	O
and	O
incidence	O
.	O
our	O
results	B-T033
indicate	O
that	O
paper	B-T204
wasp	I-T204
##s	I-T204
can	O
facilitate	O
sour	B-T038
rot	I-T038
diseases	I-T038
in	O
the	O
absence	O
of	O
other	B-T204
vectors	I-T204
and	O
that	O
the	O
mechanism	O
of	O
this	O
facilitation	O
may	O
include	O
both	O
increasing	O
host	O
susceptibility	B-T201
and	O
transmitting	O
these	O
microbial	O
communities	O
to	O
the	O
grape	B-T168
##s	I-T168
.	O
social	B-T204
wasp	I-T204
##s	I-T204
are	O
underst	O
##udied	O
but	O
relevant	O
players	O
in	O
the	O
sour	B-T038
rot	I-T038
ecology	O
of	O
vine	B-T082
##ya	I-T082
##rd	I-T082
##s	I-T082
.	O

attenuation	O
of	O
high	B-T103
glucose	I-T103
-	O
induced	O
rat	B-T204
cardiomyocyte	B-T017
apoptosis	B-T038
by	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
via	O
intervention	B-T058
of	O
ho	B-T103
-	I-T103
1	I-T103
/	O
nr	B-T103
##f	I-T103
-	I-T103
2	I-T103
and	O
the	O
pi3k	O
/	O
akt	O
signaling	O
pathway	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
,	O
a	O
glucagon	B-T103
-	I-T103
like	I-T103
peptide	I-T103
-	I-T103
1	I-T103
receptor	I-T103
agonist	I-T103
,	O
demonstrated	O
cytoprotective	B-T038
actions	I-T038
beyond	O
glycemic	B-T033
control	I-T033
in	O
recent	O
studies	O
.	O
the	O
aims	O
of	O
the	O
present	O
study	B-T062
were	O
to	O
investigate	O
the	O
effects	O
of	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
on	O
high	B-T103
glucose	I-T103
(	O
hg	B-T103
)	O
-	O
induced	O
cardiomyocyte	B-T017
apoptosis	B-T038
and	O
the	O
possible	O
mechanisms	O
.	O
rat	B-T204
cardiomyocytes	B-T017
were	O
divided	O
into	O
3	O
groups	O
:	O
normal	B-T103
glucose	I-T103
group	O
(	O
ng	B-T103
group	O
)	O
,	O
hg	B-T103
group	O
and	O
hg	B-T103
+	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
group	O
(	O
hg	B-T103
+	O
ex	B-T103
group	O
)	O
.	O
cardiomyocyte	B-T017
apoptosis	B-T038
was	O
evaluated	O
by	O
double	B-T058
-	I-T058
staining	I-T058
with	O
annexin	B-T103
v	I-T103
-	I-T103
fluorescein	I-T103
isothiocyanate	I-T103
(	O
fitc	B-T103
)	O
/	O
propidium	B-T103
iodide	I-T103
(	O
pi	B-T103
)	O
and	O
flow	B-T058
cytometry	I-T058
.	O
intracellular	B-T082
reactive	O
oxygen	O
species	O
(	O
ros	O
)	O
production	O
was	O
detected	B-T033
by	O
2	B-T103
’	I-T103
,	I-T103
7	I-T103
’	I-T103
-	I-T103
dichloro	I-T103
##di	I-T103
##hydro	I-T103
##fluores	I-T103
##cein	I-T103
di	I-T103
##acetate	I-T103
(	O
dc	B-T103
##hf	I-T103
-	I-T103
da	I-T103
)	O
incubation	B-T058
and	O
fluorescence	B-T058
microscopy	I-T058
.	O
ly294002	B-T103
(	O
ly	B-T103
)	O
,	O
a	O
phosphoinositide	B-T103
3	I-T103
-	I-T103
kinase	I-T103
(	O
pi3k	B-T103
)	O
pathway	B-T038
inhibitor	O
,	O
was	O
added	O
to	O
the	O
medium	B-T103
of	O
the	O
hg	B-T103
+	O
ex	B-T103
+	O
ly	B-T103
group	O
for	O
further	O
western	B-T058
blot	I-T058
analysis	I-T058
.	O
the	O
proteins	B-T103
analyzed	B-T062
involved	O
oxidative	B-T038
stress	I-T038
-	O
associated	B-T103
proteins	I-T103
,	O
heme	B-T103
oxygenase	I-T103
-	I-T103
1	I-T103
(	O
ho	B-T103
-	I-T103
1	I-T103
)	O
and	O
nuclear	B-T103
factor	I-T103
e2	I-T103
-	I-T103
related	I-T103
factor	I-T103
2	I-T103
(	O
nr	B-T103
##f	I-T103
-	I-T103
2	I-T103
)	O
,	O
and	O
apoptosis	B-T038
-	O
associated	B-T103
proteins	I-T103
,	O
caspase	B-T103
-	I-T103
3	I-T103
,	O
bax	B-T103
/	I-T103
b	I-T103
-	I-T103
cell	I-T103
lymphoma	I-T103
2	I-T103
(	O
bcl	B-T103
-	I-T103
2	I-T103
)	O
and	O
p	B-T103
-	I-T103
akt	I-T103
/	O
akt	B-T103
.	O
hg	B-T103
treatment	O
induced	O
cardiomyocyte	B-T017
apoptosis	B-T038
(	O
p	O
=	O
0	O
.	O
00	O
)	O
and	O
clearly	O
upregulated	B-T038
ros	B-T103
production	O
(	O
p	O
=	O
0	O
.	O
00	O
)	O
;	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
co	B-T058
-	I-T058
incubation	I-T058
also	O
ameliorated	O
cardiomyocyte	B-T017
apoptosis	B-T038
(	O
p	O
=	O
0	O
.	O
004	O
)	O
and	O
decreased	O
ros	B-T103
(	O
p	O
=	O
0	O
.	O
00	O
)	O
level	O
significantly	O
.	O
ho	B-T103
-	I-T103
1	I-T103
and	O
nr	B-T103
##f	I-T103
-	I-T103
2	I-T103
protein	B-T038
expression	I-T038
levels	O
decreased	O
significantly	O
in	O
the	O
hg	B-T103
group	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
but	O
the	O
levels	O
were	O
elevated	O
by	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
intervention	B-T058
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
furthermore	O
,	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
attenuated	O
hg	B-T103
-	O
induced	O
higher	O
protein	B-T038
expression	I-T038
,	O
including	O
cleaved	O
caspase	B-T103
-	I-T103
3	I-T103
and	O
bax	B-T103
,	O
increased	O
the	O
expression	B-T038
of	O
bcl	B-T103
-	I-T103
2	I-T103
protein	I-T103
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
however	O
,	O
these	O
impacts	O
of	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
were	O
counteracted	O
significantly	O
by	O
co	B-T058
-	I-T058
incubation	I-T058
with	O
ly294002	B-T103
.	O
in	O
addition	O
,	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
ameliorated	O
hg	B-T103
-	O
induced	O
p	B-T103
-	I-T103
akt	I-T103
/	O
akt	B-T103
lower	B-T038
expression	I-T038
,	O
and	O
this	O
impact	O
was	O
also	O
suppressed	O
by	O
ly294002	B-T103
.	O
ex	B-T103
##end	I-T103
##in	I-T103
-	I-T103
4	I-T103
ameliorate	O
##s	O
hg	B-T103
-	O
induced	O
cardiomyocyte	B-T017
apoptosis	B-T038
,	O
and	O
the	O
mechanisms	O
may	O
involve	O
anti	B-T038
-	I-T038
oxidative	I-T038
stress	I-T038
via	O
the	O
ho	B-T103
-	I-T103
1	I-T103
/	O
nr	B-T103
##f	I-T103
-	I-T103
2	I-T103
system	O
,	O
as	O
well	O
as	O
intervention	B-T058
of	O
the	O
pi3k	O
/	O
akt	O
signaling	O
pathway	O
.	O

neurological	B-T033
decline	I-T033
in	O
an	O
elderly	B-T098
with	O
repaired	O
myel	B-T017
##omening	I-T017
##ocele	I-T017
complicated	O
with	O
lumbar	B-T038
canal	I-T038
stenosis	I-T038
:	O
a	O
case	B-T170
report	I-T170
tethered	B-T038
cord	I-T038
syndrome	I-T038
is	O
a	O
well	O
-	O
known	O
complication	B-T038
after	O
myel	B-T017
##omening	I-T017
##ocele	I-T017
(	O
mmc	B-T017
)	O
repair	B-T058
in	O
childhood	O
.	O
however	O
,	O
late	O
complications	B-T038
in	O
adults	O
with	O
a	O
repaired	O
mmc	B-T017
are	O
not	O
well	O
understood	O
.	O
in	O
particular	O
,	O
the	O
influence	O
of	O
a	O
degenerative	B-T017
spinal	I-T017
deformity	I-T017
on	O
a	O
sustained	O
tethered	B-T033
cord	I-T033
is	O
still	O
unclear	O
.	O
a	O
63	O
-	O
year	O
-	O
old	O
man	O
with	O
a	O
repaired	O
mmc	B-T017
presented	O
with	O
a	O
progressive	B-T033
gait	I-T033
disturbance	I-T033
and	O
numb	B-T033
##ness	I-T033
in	O
both	O
lower	B-T017
limbs	I-T017
.	O
magnetic	B-T170
resonance	I-T170
images	I-T170
demonstrated	O
that	O
the	O
tethered	B-T033
spinal	I-T033
cord	I-T033
was	O
compressed	O
by	O
severe	O
canal	B-T038
stenosis	I-T038
along	O
the	O
entire	B-T082
lumbar	I-T082
spine	I-T082
.	O
after	O
a	O
multi	B-T058
-	I-T058
level	I-T058
lumbar	I-T058
decompression	I-T058
surgery	B-T058
,	O
the	O
patient	O
recovered	O
to	O
baseline	O
neurological	O
status	O
.	O
in	O
adults	O
with	O
a	O
repaired	O
mmc	B-T017
,	O
lumbar	B-T038
canal	I-T038
stenosis	I-T038
should	O
be	O
investigated	O
as	O
a	O
possible	O
cause	O
of	O
late	O
neurological	B-T033
decline	I-T033
.	O
clinical	O
manifestations	O
may	O
be	O
complicated	O
by	O
the	O
coexistence	O
of	O
both	O
the	O
original	O
and	O
subsequent	O
neurological	B-T038
disorders	I-T038
.	O
because	O
these	O
additional	O
disorders	B-T038
result	O
from	O
compressive	B-T038
myelopathy	I-T038
,	O
early	O
surgical	B-T058
decompression	I-T058
is	O
indicated	O
to	O
avoid	O
irreversible	O
spinal	B-T038
cord	I-T038
dysfunction	I-T038
.	O

altered	O
expression	B-T038
of	O
the	O
ol	B-T017
##r	I-T017
##59	I-T017
,	O
eth	B-T017
##e1	I-T017
,	O
and	O
slc	B-T017
##10	I-T017
##a2	I-T017
genes	I-T017
in	O
the	O
liver	B-T017
of	O
f344	B-T204
rats	I-T204
by	O
neonatal	O
thyroid	B-T037
hormone	I-T037
disruption	I-T037
many	O
concerns	O
have	O
been	O
expressed	O
regarding	O
the	O
possible	O
adverse	O
effects	O
of	O
thyroid	B-T037
hormone	I-T037
-	I-T037
disrupting	I-T037
chemicals	B-T103
in	O
the	O
environment	B-T082
.	O
the	O
disruption	B-T037
of	I-T037
thyroid	I-T037
hormones	I-T037
in	O
the	O
neonatal	O
period	O
may	O
lead	O
to	O
permanent	O
effects	O
on	O
thyroid	B-T103
hormone	I-T103
homeostasis	B-T038
as	O
well	O
as	O
related	O
developmental	B-T038
disorders	I-T038
,	O
as	O
thyroid	B-T103
hormones	I-T103
are	O
essential	O
for	O
regulating	B-T038
the	I-T038
growth	I-T038
and	O
differentiation	B-T033
of	I-T033
many	I-T033
tissues	I-T033
.	O
to	O
understand	O
the	O
long	O
-	O
term	O
alteration	O
in	O
gene	B-T038
expressions	I-T038
by	O
neonatal	O
administration	B-T058
of	I-T058
thyroid	I-T058
hormone	I-T058
-	O
like	O
chemicals	O
in	O
general	O
,	O
we	O
identified	O
genes	B-T038
whose	I-T038
expression	I-T038
was	O
altered	O
in	O
the	O
liver	B-T017
,	O
an	O
important	O
component	O
of	O
the	O
thyroid	B-T103
hormone	I-T103
axis	O
,	O
by	O
neonatal	O
exposure	O
to	O
triiodothyronine	B-T103
(	O
t3	B-T103
)	O
.	O
t3	B-T103
was	O
administered	B-T058
to	O
male	B-T204
f344	I-T204
rats	I-T204
on	O
postnatal	O
days	O
1	O
,	O
3	O
,	O
and	O
5	O
(	O
week	O
0	O
)	O
.	O
at	O
8	O
weeks	O
of	O
age	O
,	O
cdna	B-T062
microarray	I-T062
analysis	I-T062
was	O
used	O
to	O
identify	O
hepatic	B-T082
genes	B-T017
whose	O
expression	B-T038
was	O
altered	O
by	O
neonatal	O
exposure	O
to	O
t3	B-T103
.	O
among	O
the	O
up	B-T038
-	I-T038
regulated	I-T038
genes	I-T038
that	O
were	O
identified	O
,	O
the	O
expression	B-T038
of	O
ol	B-T017
##r	I-T017
##59	I-T017
,	O
eth	B-T017
##e1	I-T017
,	O
and	O
slc	B-T017
##10	I-T017
##a2	I-T017
increased	O
specifically	O
in	O
rats	B-T204
neonatal	O
##ly	O
exposed	O
to	O
t3	B-T103
.	O
interestingly	O
,	O
altered	O
hepatic	B-T082
expression	B-T038
of	I-T038
these	I-T038
genes	I-T038
indeed	O
increased	O
when	O
a	O
hydroxylated	B-T103
poly	I-T103
##brom	I-T103
##inated	I-T103
diphenyl	I-T103
ether	I-T103
(	O
pb	B-T103
##de	I-T103
)	O
,	O
oh	B-T103
-	I-T103
bde	I-T103
##42	I-T103
,	O
which	O
is	O
capable	O
of	O
binding	B-T038
to	I-T038
the	I-T038
tr	I-T038
,	O
was	O
given	O
neonatal	O
##ly	O
.	O
our	O
data	O
demonstrated	O
that	O
neonatal	O
exposure	O
to	O
thyroid	B-T103
hormones	I-T103
could	O
affect	O
the	O
long	O
-	O
term	O
expression	B-T038
of	I-T038
the	I-T038
genes	I-T038
,	O
which	O
could	O
be	O
useful	O
markers	O
for	O
neonatal	B-T038
effects	I-T038
by	O
thyroid	B-T103
hormone	I-T103
-	O
disrupting	B-T103
chemicals	I-T103
.	O
copyright	O
©	O
2017	O
john	O
wiley	O
&	O
sons	O
,	O
ltd	O
.	O

high	O
-	O
throughput	O
analysis	O
of	O
the	O
igg	B-T103
n	I-T103
-	I-T103
glyc	I-T103
##ome	I-T103
by	O
uplc	B-T058
-	O
fl	O
##r	O
as	O
biological	O
and	O
clinical	O
relevance	O
of	O
glycosylation	O
is	O
becoming	O
more	O
apparent	O
,	O
interest	O
in	O
large	B-T062
scale	I-T062
studies	I-T062
of	O
the	O
glyc	B-T103
##ome	I-T103
is	O
growing	O
.	O
glycans	B-T103
attached	O
to	O
immunoglobulin	B-T103
g	I-T103
(	O
igg	B-T103
)	O
were	O
shown	O
to	O
be	O
essential	O
for	O
its	O
function	B-T038
and	O
igg	B-T103
glycosylation	O
was	O
shown	O
to	O
change	O
with	O
various	O
processes	O
,	O
making	O
igg	B-T103
one	O
of	O
the	O
most	O
studied	O
glycoproteins	B-T103
.	O
many	O
approaches	B-T082
including	O
liquid	B-T058
chromatography	I-T058
,	O
capillary	B-T058
gel	I-T058
electrophoresis	I-T058
,	O
and	O
mass	B-T058
spectrometry	I-T058
were	O
developed	O
to	O
study	B-T062
igg	B-T103
glycosylation	O
.	O
generation	O
of	O
high	O
-	O
quality	O
glyc	O
##omics	O
data	O
in	O
a	O
high	O
-	O
throughput	O
fashion	O
requires	O
reproducible	O
and	O
robust	O
sample	O
preparation	O
and	O
accurate	O
and	O
reliable	O
quantitative	O
analysis	O
.	O
this	O
chapter	O
presents	O
a	O
protocol	B-T170
for	O
an	O
optimized	O
and	O
high	O
-	O
throughput	O
igg	B-T103
n	I-T103
-	I-T103
glycan	I-T103
release	O
,	O
fluorescent	B-T058
labeling	I-T058
and	O
clean	O
##up	O
,	O
and	O
analysis	B-T062
of	O
fluorescently	O
labeled	O
igg	B-T103
n	I-T103
-	I-T103
glycans	I-T103
by	O
hydrophilic	B-T058
interaction	I-T058
liquid	I-T058
chromatography	I-T058
(	O
hil	B-T058
##ic	I-T058
)	O
on	O
an	O
ultra	B-T058
performance	I-T058
liquid	I-T058
chromatography	I-T058
(	O
uplc	B-T058
)	O
system	O
with	O
fluorescence	O
(	O
fl	O
##r	O
)	O
detection	B-T058
.	O

mag	B-T103
##r	I-T103
alone	O
is	O
insufficient	O
to	O
confer	O
cellular	B-T038
calcium	I-T038
responses	I-T038
to	O
magnetic	O
stimulation	B-T058
magnetic	O
manipulation	B-T058
of	O
cell	B-T038
activity	I-T038
offers	O
advantages	O
over	O
optical	B-T058
manipulation	I-T058
but	O
an	O
ideal	O
tool	O
remains	O
elusive	O
.	O
the	O
mag	B-T103
##r	I-T103
protein	I-T103
was	O
found	O
through	O
its	O
interaction	B-T038
with	O
crypt	B-T103
##ochrome	I-T103
(	O
cry	B-T103
)	O
and	O
the	O
protein	B-T103
in	O
solution	O
appeared	O
to	O
respond	O
to	O
magnetic	O
stimulation	B-T058
(	O
ms	B-T058
)	O
.	O
after	O
we	O
initiated	O
an	O
investigation	B-T058
on	O
the	O
specific	O
role	O
of	O
mag	B-T103
##r	I-T103
in	O
cellular	B-T038
response	I-T038
to	O
ms	B-T058
,	O
a	O
subsequent	O
study	B-T062
claimed	O
that	O
mag	B-T103
##r	I-T103
expression	B-T038
alone	O
could	O
achieve	O
cellular	B-T038
activation	I-T038
by	O
ms	B-T058
.	O
here	O
we	O
report	O
that	O
despite	O
systematically	O
testing	O
different	O
ways	O
of	O
measuring	O
intracellular	B-T082
calcium	B-T103
and	O
different	O
ms	B-T058
protocols	B-T170
,	O
it	O
was	O
not	O
possible	O
to	O
detect	B-T033
any	O
cellular	B-T017
or	O
neuronal	B-T017
responses	O
to	O
ms	B-T058
in	O
mag	B-T103
##r	I-T103
-	O
expressing	B-T038
hek	B-T017
cells	I-T017
or	O
primary	O
neurons	B-T017
from	O
the	O
dorsal	B-T082
root	B-T017
ganglion	I-T017
and	O
the	O
hippocampus	B-T017
.	O
by	O
contrast	O
,	O
in	O
neurons	B-T017
co	B-T038
-	I-T038
expressing	I-T038
mag	B-T103
##r	I-T103
and	O
channel	B-T103
##rh	I-T103
##od	I-T103
##op	I-T103
##in	I-T103
,	O
optical	B-T058
but	O
not	O
ms	B-T058
increased	O
calcium	B-T038
influx	I-T038
in	O
hippocampal	B-T017
neurons	B-T017
.	O
our	O
results	O
indicate	O
that	O
mag	B-T103
##r	I-T103
alone	O
is	O
not	O
sufficient	O
to	O
confer	O
cellular	B-T017
magnetic	B-T038
responses	I-T038
.	O

an	O
approach	O
for	O
liposome	B-T103
immobilization	B-T058
using	O
steric	O
##ally	O
stabilized	O
micelles	B-T103
(	O
ss	B-T103
##ms	I-T103
)	O
as	O
a	O
precursor	O
for	O
bio	B-T058
-	I-T058
layer	I-T058
interfer	I-T058
##ometry	I-T058
-	O
based	O
interaction	O
studies	B-T062
non	O
-	O
fluid	O
##ic	O
bio	B-T058
-	I-T058
layer	I-T058
interfer	I-T058
##ometry	I-T058
(	O
bl	B-T058
##i	I-T058
)	O
has	O
rapidly	O
become	O
a	O
standard	O
tool	O
for	O
monitoring	O
almost	O
all	O
biomolecular	O
interactions	O
in	O
a	O
label	O
-	O
free	O
,	O
real	O
-	O
time	O
and	O
high	O
-	O
throughput	O
manner	O
.	O
high	O
-	O
efficiency	O
screening	B-T058
methods	I-T058
which	O
measure	O
the	O
kinetics	O
of	O
liposomes	B-T103
with	O
a	O
variety	O
of	O
compounds	B-T103
require	O
the	O
immobilization	B-T058
of	O
liposomes	B-T103
.	O
in	O
this	O
work	O
,	O
a	O
method	O
is	O
described	O
for	O
immobil	B-T058
##izing	I-T058
liposomes	B-T103
for	O
interaction	O
studies	B-T062
,	O
based	O
on	O
the	O
biophysical	O
principles	O
of	O
this	O
biosensor	O
platform	O
.	O
the	O
immobilization	B-T058
approach	O
includes	O
the	O
loading	O
of	O
dsp	B-T103
##e	I-T103
-	I-T103
peg	I-T103
(	I-T103
2000	I-T103
)	I-T103
-	O
biotin	B-T103
containing	O
steric	O
##ally	O
stabilized	O
micelles	B-T103
(	O
ss	B-T103
##ms	I-T103
)	O
which	O
are	O
restr	O
##uctured	O
in	O
a	O
buffer	O
change	O
step	O
,	O
resulting	O
in	O
an	O
accessible	O
substrate	O
for	O
liposome	B-T103
immobilization	B-T058
.	O
liposomes	B-T103
in	O
a	O
concentration	O
of	O
5	O
##mm	O
of	O
varying	O
composition	B-T201
and	O
fluidity	O
were	O
immobilized	B-T058
on	O
the	O
sensor	O
surface	B-T082
by	O
inserting	O
the	O
hydrophobic	O
residues	O
of	O
the	O
former	O
loaded	O
ss	B-T103
##ms	I-T103
.	O
this	O
proof	O
of	O
principle	O
was	O
carried	O
out	O
using	O
cytochrome	B-T103
c	I-T103
as	O
a	O
membrane	O
-	O
interacting	O
model	O
protein	B-T103
.	O
the	O
binding	B-T038
of	O
cytochrome	B-T103
c	I-T103
to	O
the	O
immobilized	B-T058
liposomes	B-T103
was	O
demonstrated	O
,	O
and	O
the	O
derived	O
kinetic	O
and	O
affinity	O
constants	O
were	O
similar	O
to	O
values	O
given	O
in	O
the	O
literature	B-T170
.	O
in	O
order	O
to	O
obtain	O
a	O
detailed	O
understanding	B-T038
of	O
this	O
surface	B-T082
,	O
and	O
to	O
show	O
the	O
integrity	O
of	O
the	O
liposomes	B-T103
,	O
confocal	B-T058
fluorescence	I-T058
microscopy	I-T058
was	O
used	O
.	O
images	O
of	O
immobilized	B-T058
liposomes	B-T103
containing	O
calc	B-T103
##ein	I-T103
in	O
the	O
aqueous	O
core	B-T082
indicated	B-T033
intact	O
vesicles	B-T017
.	O
a	O
combination	O
of	O
this	O
simple	O
liposome	B-T103
immobilization	B-T058
approach	O
,	O
the	O
possibility	O
of	O
automation	O
on	O
bl	B-T058
##i	I-T058
systems	O
with	O
high	O
throughput	O
within	O
an	O
acceptable	O
times	O
##cale	O
and	O
excellent	O
reproducibility	O
makes	O
this	O
assay	B-T058
suitable	O
for	O
basic	O
research	B-T062
as	O
well	O
as	O
for	O
industrial	O
and	O
regulatory	B-T170
applications	I-T170
.	O

bone	B-T017
extracellular	B-T017
matrix	I-T017
hydrogel	B-T103
enhances	O
osteogenic	B-T038
differentiation	I-T038
of	O
c2	B-T017
##c12	I-T017
myoblasts	I-T017
and	O
mouse	B-T204
primary	O
calv	B-T017
##arial	I-T017
cells	B-T017
hydrogel	B-T103
scaffolds	I-T103
derived	O
from	O
the	O
extracellular	B-T017
matrix	I-T017
(	O
ecm	B-T017
)	O
of	O
mammalian	B-T017
tissues	I-T017
have	O
been	O
successfully	O
used	O
to	O
promote	O
tissue	B-T038
repair	I-T038
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
osteogenic	B-T038
potential	I-T038
of	O
ecm	B-T017
hydrogels	B-T103
prepared	O
from	O
demineral	B-T103
##ized	I-T103
and	O
decel	B-T103
##lu	I-T103
##la	I-T103
##ri	I-T103
##zed	I-T103
bovine	I-T103
bone	I-T103
in	O
the	O
presence	O
and	O
absence	O
of	O
osteogenic	B-T103
medium	I-T103
.	O
culture	B-T058
of	O
c2	B-T017
##c12	I-T017
and	O
mouse	B-T204
primary	O
calv	B-T017
##arial	I-T017
cells	B-T017
(	O
mpc	B-T017
##s	I-T017
)	O
on	O
decel	B-T103
##lu	I-T103
##la	I-T103
##ri	I-T103
##zed	I-T103
bone	I-T103
ecm	I-T103
(	O
bec	B-T103
##m	I-T103
)	O
and	O
demineral	B-T103
##ized	I-T103
bone	I-T103
matrix	I-T103
(	O
db	B-T103
##m	I-T103
)	O
gels	B-T103
resulted	O
in	O
increased	O
expression	B-T058
of	O
osteogenic	B-T038
gene	I-T038
markers	I-T038
,	O
including	O
a	O
3	O
.	O
6	O
-	O
and	O
13	O
.	O
4	O
-	O
fold	O
increase	O
in	O
osteopontin	B-T103
and	O
15	O
.	O
7	O
-	O
and	O
27	O
.	O
1	O
-	O
fold	O
increase	O
in	O
osteocalcin	B-T103
when	O
mpc	B-T017
##s	I-T017
were	O
cultured	B-T058
upon	O
bec	B-T103
##m	I-T103
with	O
basal	B-T103
and	O
osteogenic	B-T103
media	I-T103
,	O
respectively	O
.	O
bec	B-T103
##m	I-T103
hydrogels	B-T103
stimulated	O
the	O
osteogenic	B-T038
differentiation	I-T038
of	O
c2	B-T017
##c12	I-T017
and	O
mpc	B-T017
##s	I-T017
even	O
in	O
the	O
absence	O
of	O
osteogenic	B-T103
medium	I-T103
.	O
these	O
results	O
suggest	O
that	O
bec	B-T103
##m	I-T103
hydrogel	B-T103
scaffolds	I-T103
may	O
have	O
great	O
utility	O
in	O
future	O
clinical	O
applications	O
for	O
bone	B-T017
tissue	B-T058
engineering	I-T058
.	O
©	O
2017	O
wiley	O
periodicals	O
,	O
inc	O
.	O
j	O
biom	O
##ed	O
mater	O
res	O
part	O
b	O
:	O
appl	O
biom	O
##ater	O
,	O
2017	O
.	O

emergence	O
of	O
family	B-T091
medicine	I-T091
in	O
ethiopia	B-T082
[	O
corrected	O
]	O
:	O
an	O
international	O
collaborative	O
education	B-T170
model	I-T170
family	B-T091
medicine	I-T091
(	O
fm	B-T091
)	O
is	O
a	O
new	O
specialty	B-T091
in	O
ethiopia	B-T082
.	O
the	O
first	B-T097
seven	I-T097
family	I-T097
physicians	I-T097
graduate	B-T098
##d	I-T098
in	O
february	O
2016	O
from	O
the	O
in	O
##au	O
##gu	O
##ral	O
residency	O
programme	B-T170
at	O
addi	B-T092
##s	I-T092
aba	I-T092
##ba	I-T092
university	I-T092
.	O
cooperation	O
amongst	O
ethiopia	B-T098
##n	I-T098
and	O
exp	O
##atri	O
##ate	O
decision	B-T097
-	I-T097
makers	I-T097
and	O
physicians	B-T097
was	O
needed	O
to	O
begin	O
the	O
programme	B-T170
.	O
intentional	O
replacement	O
of	O
exp	O
##atri	O
##ates	O
with	O
ethiopia	B-T098
##n	I-T098
family	B-T097
physicians	I-T097
has	O
begun	O
.	O
barriers	O
include	O
lack	O
of	O
understanding	B-T038
of	O
fm	B-T091
and	O
the	O
human	O
and	O
financial	O
resources	O
needed	O
for	O
scaling	O
up	O
the	O
programme	B-T170
.	O
regular	O
programme	B-T170
review	O
with	O
resident	B-T097
physician	I-T097
involvement	O
has	O
allowed	O
the	O
fm	B-T091
training	O
programme	O
to	O
adapt	O
and	O
fit	O
the	O
ethiopia	B-T098
##n	I-T098
context	O
.	O
further	O
successes	O
will	O
result	O
from	O
ongoing	O
support	O
and	O
advocacy	O
from	O
the	O
federal	O
ministry	O
of	O
health	O
and	O
other	O
ethiopia	B-T098
##n	I-T098
,	O
african	B-T098
,	O
and	O
international	O
primary	O
care	O
organisations	O
.	O

clinical	B-T058
observation	I-T058
of	O
treatment	O
of	O
chronic	B-T038
subdural	I-T038
hematoma	I-T038
with	O
novel	B-T074
double	I-T074
needle	I-T074
minimally	I-T074
invasive	I-T074
aspiration	I-T074
technology	I-T074
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
to	O
explore	O
the	O
clinical	O
effects	O
,	O
including	O
the	O
prevention	O
of	O
complications	B-T038
,	O
of	O
the	O
treatment	O
of	O
chronic	B-T038
subdural	I-T038
hematoma	I-T038
with	O
double	B-T074
needle	I-T074
aspiration	I-T074
.	O
the	O
clinical	B-T170
data	I-T170
of	O
31	O
patients	O
with	O
chronic	B-T038
subdural	I-T038
hematoma	I-T038
treated	O
by	O
double	B-T074
yl	I-T074
-	I-T074
1	I-T074
needle	I-T074
double	O
skull	B-T058
drilling	I-T058
and	O
31	O
controls	O
treated	O
by	O
traditional	O
drilling	B-T058
and	O
drainage	B-T058
were	O
analyzed	O
retrospectively	O
.	O
in	O
the	O
yl	B-T074
-	I-T074
1	I-T074
needle	I-T074
group	O
,	O
only	O
1	O
patient	O
was	O
with	O
hematoma	B-T038
recurrence	B-T038
,	O
1	O
patient	O
was	O
with	O
intracranial	B-T038
pneum	I-T038
##oc	I-T038
##ephal	I-T038
##us	I-T038
,	O
and	O
the	O
remaining	O
patients	O
who	O
were	O
followed	O
up	O
for	O
3	O
months	O
achieved	O
a	O
clinical	B-T033
cure	I-T033
.	O
in	O
the	O
traditional	B-T058
drilling	I-T058
and	O
drainage	B-T058
group	O
,	O
13	O
patients	O
were	O
with	O
hematoma	B-T038
recurrence	B-T038
within	O
3	O
months	O
after	O
the	O
operation	B-T058
and	O
7	O
patients	O
were	O
with	O
postoperative	O
intracranial	B-T038
pneum	I-T038
##oc	I-T038
##ephal	I-T038
##us	I-T038
.	O
the	O
method	B-T170
of	O
double	B-T074
yl	I-T074
-	I-T074
1	I-T074
needle	I-T074
is	O
better	O
than	O
the	O
traditional	B-T058
drilling	I-T058
and	O
drainage	B-T058
method	I-T058
for	O
the	O
treatment	O
of	O
chronic	B-T038
subdural	I-T038
hematoma	I-T038
because	O
it	O
reduces	O
the	O
postoperative	O
recurrence	B-T038
rate	O
and	O
complications	B-T038
.	O

design	O
,	O
synthesis	O
,	O
molecular	B-T170
docking	I-T170
,	O
anti	B-T103
-	I-T103
proteus	I-T103
mir	I-T103
##abilis	I-T103
and	O
urease	B-T103
inhibition	B-T038
of	O
new	O
fluoroquinolone	B-T103
carboxylic	I-T103
acid	I-T103
derivatives	I-T103
new	O
hydrox	B-T103
##amic	I-T103
acid	I-T103
,	O
hydr	B-T103
##azide	I-T103
and	O
amide	B-T103
derivatives	I-T103
of	O
ciprofloxacin	B-T103
in	O
addition	O
to	O
their	O
analogues	B-T103
of	O
levofloxacin	B-T103
were	O
prepared	O
and	O
identified	O
by	O
different	O
spectroscopic	O
techniques	O
.	O
some	O
of	O
the	O
prepared	O
compounds	B-T103
revealed	O
good	O
activity	B-T038
against	O
the	O
urease	B-T103
splitting	O
bacteria	B-T007
,	O
proteus	B-T007
mir	I-T007
##abilis	I-T007
.	O
the	O
urease	B-T103
inhibitory	B-T038
activity	I-T038
was	O
investigated	O
using	O
indo	B-T058
##phenol	I-T058
method	I-T058
.	O
most	O
of	O
the	O
tested	B-T170
compounds	B-T103
showed	O
better	O
activity	B-T038
than	O
the	O
reference	O
acet	B-T103
##ohydro	I-T103
##xa	I-T103
##mic	I-T103
acid	I-T103
(	O
aha	B-T103
)	O
.	O
the	O
ciprofloxacin	B-T103
hydr	I-T103
##azide	I-T103
derivative	I-T103
3a	I-T103
and	O
levofloxacin	B-T103
hydrox	I-T103
##amic	I-T103
acid	I-T103
7	I-T103
experienced	O
the	O
highest	O
activity	B-T038
(	O
ic50	O
=	O
1	O
.	O
22	O
##μm	O
and	O
2	O
.	O
20	O
##μm	O
,	O
respectively	O
)	O
.	O
molecular	B-T170
docking	I-T170
study	I-T170
revealed	O
high	O
spontaneous	O
binding	B-T038
ability	I-T038
of	O
the	O
tested	B-T170
compounds	B-T103
to	O
the	O
active	O
site	O
of	O
urease	B-T103
.	O

total	O
fluorescence	O
fingerprinting	O
of	O
pesticides	B-T103
:	O
a	O
reliable	O
approach	O
for	O
continuous	O
monitoring	O
of	O
soils	O
and	O
waters	O
the	O
present	O
work	O
relates	O
to	O
the	O
creation	O
/	O
extension	O
of	O
a	O
database	B-T170
of	O
total	B-T058
excitation	I-T058
-	I-T058
emission	I-T058
and	I-T058
total	I-T058
synchronous	I-T058
fluorescence	I-T058
matrices	I-T058
(	O
tee	B-T058
##ms	I-T058
and	I-T058
ts	I-T058
##fm	I-T058
##s	I-T058
)	O
along	O
with	O
optimal	B-T058
synchronous	I-T058
fluorescence	I-T058
spectra	I-T058
(	O
sf	B-T058
##s	I-T058
)	O
to	O
fingerprint	O
pesticides	B-T103
widely	O
used	O
in	O
mor	B-T082
##occ	I-T082
##o	I-T082
.	O
this	O
spectrometric	B-T058
multi	I-T058
-	I-T058
component	I-T058
fingerprinting	I-T058
may	O
permit	O
the	O
direct	O
detection	B-T058
of	I-T058
pesticides	I-T058
persisting	B-T103
in	I-T103
soil	I-T103
or	O
water	B-T103
.	O
the	O
objective	O
of	O
the	O
current	O
investigation	O
is	O
to	O
detect	B-T058
four	I-T058
pesticide	I-T058
remains	O
in	O
agricultural	B-T082
soils	I-T082
by	O
applying	O
the	O
spectrometric	B-T058
fingerprinting	I-T058
results	O
.	O
they	O
are	O
the	O
commercial	O
:	O
i	O
)	O
insecticide	B-T103
ax	I-T103
##ler	I-T103
##a	I-T103
5	I-T103
##g	I-T103
(	O
carbam	B-T103
##ate	I-T103
)	O
,	O
ii	O
)	O
fungi	B-T103
##ci	I-T103
##de	I-T103
ors	I-T103
##alis	I-T103
5	I-T103
%	I-T103
sc	I-T103
(	O
triazole	B-T103
)	O
,	O
iii	O
)	O
insecticide	B-T103
force	I-T103
0	I-T103
,	I-T103
5	I-T103
g	I-T103
(	O
pyreth	B-T103
##rin	I-T103
##oid	I-T103
)	O
and	O
iv	O
)	O
insecticide	B-T103
proc	I-T103
##la	I-T103
##im	I-T103
05	I-T103
sg	I-T103
(	O
non	O
-	O
assigned	O
)	O
.	O
the	O
agricultural	O
plant	O
##ations	O
monitored	O
are	O
located	O
in	O
the	O
great	B-T082
agricultural	I-T082
do	I-T082
##uk	I-T082
##kal	I-T082
##a	I-T082
region	I-T082
at	O
the	O
western	B-T082
atlantic	I-T082
side	I-T082
of	O
mor	B-T082
##occ	I-T082
##o	I-T082
,	O
where	O
these	O
chemicals	B-T103
are	O
in	O
large	O
sal	O
##e	O
and	O
use	O
.	O

modified	O
frailty	B-T170
index	I-T170
predicts	O
postoperative	B-T033
outcomes	O
in	O
older	O
gastrointestinal	B-T038
cancer	I-T038
patients	O
frailty	B-T033
disproportionately	O
impacts	O
older	O
patients	O
with	O
gastrointestinal	B-T038
cancer	I-T038
,	O
rendering	O
them	O
at	O
increased	B-T033
risk	I-T033
for	I-T033
poor	I-T033
outcomes	I-T033
.	O
a	O
frailty	B-T170
index	I-T170
may	O
aid	O
in	O
preoperative	O
risk	O
stratification	B-T062
.	O
we	O
hypothesized	O
that	O
high	O
modified	B-T033
frailty	I-T033
index	I-T033
(	I-T033
mf	I-T033
##i	I-T033
)	I-T033
scores	I-T033
are	O
associated	O
with	O
adverse	B-T033
outcomes	I-T033
after	O
tumor	B-T038
resection	B-T058
in	O
older	O
,	O
gastrointestinal	B-T038
cancer	I-T038
patients	O
.	O
patients	O
(	O
60	O
-	O
90	O
years	O
old	O
)	O
who	O
underwent	O
gastrointestinal	O
tumor	O
resection	O
were	O
identified	O
in	O
the	O
2005	O
-	O
2012	O
ns	B-T033
##qi	I-T033
##p	I-T033
participant	B-T098
use	O
file	O
.	O
mf	B-T033
##i	I-T033
was	O
defined	O
by	O
11	O
previously	O
described	O
,	O
preoperative	O
variables	O
.	O
frailty	B-T033
was	O
defined	O
by	O
an	O
mf	B-T033
##i	I-T033
score	I-T033
>	O
0	O
.	O
27	O
.	O
the	O
postoperative	B-T058
course	I-T058
was	O
evaluated	B-T058
using	O
univariate	O
and	O
multivariate	O
analysis	O
.	O
41	O
45	O
##5	O
patients	O
(	O
mean	O
age	O
72	O
.	O
4	O
years	O
,	O
47	O
.	O
4	O
%	O
female	O
)	O
were	O
identified	O
.	O
the	O
most	O
prevalent	B-T082
form	I-T082
of	O
cancer	B-T038
was	O
colorectal	B-T038
(	O
69	O
.	O
3	O
%	O
,	O
n	O
=	O
28	O
70	O
##8	O
)	O
and	O
2	O
.	O
8	O
%	O
of	O
patients	O
were	O
frail	B-T033
(	O
n	O
=	O
1	O
,	O
164	O
)	O
.	O
frail	B-T033
patients	O
were	O
significantly	O
more	O
likely	O
to	O
have	O
increased	O
length	O
of	O
stay	O
(	O
11	O
.	O
7	O
vs	O
9	O
.	O
0	O
days	O
)	O
,	O
major	O
complications	B-T038
(	O
29	O
.	O
1	O
%	O
vs	O
17	O
.	O
9	O
%	O
)	O
,	O
and	O
30	O
-	O
day	O
mortality	O
(	O
5	O
.	O
6	O
%	O
vs	O
2	O
.	O
5	O
%	O
)	O
,	O
(	O
all	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
multivariate	O
analysis	O
identified	O
mf	B-T033
##i	I-T033
as	O
an	O
independent	O
predictor	O
of	O
major	O
complications	B-T038
(	O
or	O
1	O
.	O
52	O
,	O
95	O
%	O
ci	O
1	O
.	O
39	O
-	O
1	O
.	O
65	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
30	O
-	O
day	O
mortality	O
(	O
or	O
1	O
.	O
48	O
,	O
95	O
%	O
ci	O
1	O
.	O
24	O
-	O
1	O
.	O
75	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
mf	B-T033
##i	I-T033
was	O
associated	O
with	O
the	O
incidence	O
of	O
postoperative	B-T033
complications	B-T038
and	O
mortality	O
in	O
older	O
surgical	O
patients	O
with	O
gastrointestinal	B-T038
cancer	I-T038
.	O

empty	O
capsid	B-T017
##s	I-T017
and	O
macrophage	B-T017
inhibition	O
/	O
depletion	O
increase	O
ra	B-T103
##av	I-T103
transgene	B-T017
expression	B-T038
in	O
joints	B-T082
of	O
both	O
healthy	O
and	O
arthritic	B-T038
mice	B-T204
gene	B-T058
therapy	I-T058
has	O
potential	O
to	O
treat	B-T058
rheumatic	B-T038
diseases	I-T038
;	O
however	O
,	O
the	O
presence	B-T033
of	O
macrophages	B-T017
in	O
the	O
joint	B-T082
might	O
hamper	O
adeno	B-T005
-	I-T005
associated	I-T005
viral	I-T005
vector	B-T103
-	O
mediated	O
gene	O
delivery	O
.	O
here	O
we	O
demonstrate	O
that	O
in	O
arthritic	B-T038
,	O
but	O
also	O
in	O
healthy	O
,	O
mice	B-T204
administration	B-T058
of	I-T058
agents	I-T058
that	O
influence	O
macrophage	B-T017
activity	O
/	O
number	O
and	O
/	O
or	O
addition	O
of	O
empty	O
dec	B-T017
##oy	I-T017
capsid	I-T017
##s	I-T017
substantially	O
improve	B-T033
the	O
efficacy	O
of	O
recombinant	O
adeno	B-T005
-	I-T005
associated	I-T005
viral	I-T005
vector	B-T103
5	O
transgene	B-T017
expression	B-T038
in	O
the	O
joint	B-T082
.	O
pretreatment	O
with	O
triamcinolone	B-T103
or	O
clo	B-T103
##dro	I-T103
##nat	I-T103
##e	I-T103
liposomes	B-T103
improved	B-T033
luciferase	B-T103
expression	B-T038
over	O
a	O
period	O
of	O
4	O
weeks	O
.	O
similar	O
results	O
were	O
seen	O
when	O
empty	O
dec	B-T017
##oy	I-T017
capsid	I-T017
##s	I-T017
were	O
added	O
to	O
full	O
genome	B-T017
containing	O
capsid	B-T017
##s	I-T017
in	O
a	O
5	O
:	O
1	O
ratio	O
.	O
in	O
a	O
study	B-T062
to	O
assess	O
the	O
duration	O
of	O
expression	B-T038
as	O
well	O
as	O
to	O
investigate	O
the	O
combination	O
of	O
these	O
two	O
approaches	O
,	O
we	O
observed	O
a	O
synergistic	O
enhancement	O
of	O
gene	B-T038
expression	I-T038
,	O
sustained	O
for	O
at	O
least	O
12	O
weeks	O
.	O
the	O
enhancement	O
of	O
gene	B-T038
expression	I-T038
was	O
independent	O
of	O
the	O
route	O
of	O
administration	O
of	O
triamcinolone	B-T103
(	O
intra	B-T082
-	I-T082
articular	I-T082
or	O
intramuscular	B-T082
)	O
.	O
in	O
healthy	O
mice	B-T204
it	O
was	O
demonstrated	O
that	O
the	O
combination	O
improved	B-T033
expression	B-T038
of	O
the	O
transgene	B-T017
significantly	O
,	O
in	O
a	O
serotype	B-T170
independent	O
manner	O
.	O
these	O
data	O
have	O
implications	O
for	O
future	O
applications	O
of	O
gene	B-T058
therapy	I-T058
to	O
the	O
joint	B-T082
and	O
for	O
other	O
tissues	B-T017
with	O
an	O
abundance	O
of	O
macrophages	B-T017
.	O

ge	B-T082
##olo	I-T082
##cal	I-T082
##ization	I-T082
of	O
influenza	B-T038
outbreak	O
within	O
an	O
acute	B-T058
care	I-T058
population	B-T098
:	O
a	O
layered	O
-	O
surveillance	O
approach	B-T082
we	O
seek	O
to	O
use	O
a	O
novel	O
layered	O
-	O
surveillance	O
approach	B-T082
to	O
localize	B-T082
influenza	B-T038
clusters	O
within	O
an	O
acute	B-T058
care	I-T058
population	B-T098
.	O
the	O
first	O
layer	O
of	O
this	O
system	O
is	O
a	O
syndromic	B-T038
surveillance	B-T058
screen	I-T058
to	O
guide	O
rapid	O
polymerase	O
chain	O
reaction	O
testing	O
.	O
the	O
second	O
layer	O
is	O
ge	B-T082
##olo	I-T082
##cal	I-T082
##ization	I-T082
and	O
cluster	B-T062
analysis	I-T062
of	O
these	O
patients	O
.	O
we	O
posit	O
that	O
any	O
identified	O
clusters	O
could	O
represent	O
at	B-T098
-	I-T098
risk	I-T098
populations	I-T098
who	O
could	O
serve	O
as	O
high	O
-	O
yield	O
targets	O
for	O
preventive	O
medical	O
interventions	O
.	O
this	O
was	O
a	O
prospective	B-T062
observational	I-T062
surveillance	I-T062
study	I-T062
.	O
patients	O
were	O
screened	B-T058
with	O
a	O
previously	O
derived	O
clinical	B-T170
decision	I-T170
guideline	I-T170
that	O
has	O
a	O
90	O
%	O
sensitivity	O
and	O
30	O
%	O
specificity	O
for	O
influenza	B-T038
.	O
patients	O
received	O
points	O
for	O
the	O
following	O
signs	B-T033
and	I-T033
symptoms	I-T033
within	O
the	O
past	O
7	O
days	O
:	O
cough	B-T033
(	O
2	O
points	O
)	O
,	O
headache	B-T033
(	O
1	O
point	O
)	O
,	O
subjective	O
fever	O
(	O
1	O
point	O
)	O
,	O
and	O
documented	B-T033
fever	I-T033
at	O
triage	B-T058
(	O
temperature	O
>	O
38	O
##°c	O
[	O
100	O
.	O
4	O
##°	O
##f	O
]	O
)	O
(	O
1	O
point	O
)	O
.	O
patients	O
scoring	O
3	O
points	O
or	O
higher	O
were	O
indicated	B-T033
for	O
influenza	B-T038
testing	O
.	O
patients	O
were	O
tested	O
with	O
xp	B-T058
##ert	I-T058
flu	I-T058
(	O
cep	B-T092
##he	I-T092
##id	I-T092
,	O
sun	B-T082
##n	I-T082
##y	I-T082
##val	I-T082
##e	I-T082
,	O
ca	B-T082
)	O
,	O
a	O
rapid	O
polymerase	O
chain	O
reaction	O
test	O
.	O
positive	B-T033
results	O
were	O
mapped	O
with	O
arc	B-T170
##gi	I-T170
##s	I-T170
(	O
esr	B-T092
##i	I-T092
,	O
red	B-T082
##lands	I-T082
,	O
ca	B-T082
)	O
and	O
analyzed	B-T062
with	O
kernel	B-T062
density	I-T062
estimation	I-T062
to	O
create	O
heat	O
maps	O
.	O
there	O
were	O
1	O
,	O
360	O
patients	O
tested	O
with	O
xp	B-T058
##ert	I-T058
flu	I-T058
with	O
retriev	O
##able	O
addresses	B-T170
within	O
the	O
greater	O
pho	O
##en	O
##ix	O
met	O
##ro	O
area	O
.	O
one	O
hundred	O
sixty	O
-	O
seven	O
(	O
12	O
%	O
)	O
of	O
them	O
tested	O
positive	B-T033
for	I-T033
influenza	I-T033
a	I-T033
and	O
23	O
(	O
2	O
%	O
)	O
tested	O
positive	B-T033
for	I-T033
influenza	I-T033
b	I-T033
.	O
the	O
influenza	B-T005
a	I-T005
virus	I-T005
exhibited	O
a	O
clear	O
cluster	O
pattern	B-T082
within	O
this	O
patient	O
population	B-T098
.	O
the	O
dense	O
##st	O
cluster	O
was	O
located	B-T082
in	O
an	O
approximately	O
1	O
-	O
square	O
-	O
mil	O
##e	O
region	B-T082
southeast	B-T082
of	O
our	O
hospital	B-T092
.	O
our	O
layered	O
-	O
surveillance	O
approach	B-T082
was	O
effective	O
in	O
localizing	B-T082
a	O
cluster	O
of	O
influenza	O
a	O
outbreak	O
.	O
this	O
region	B-T082
may	O
house	O
a	O
high	O
-	O
yield	O
target	O
population	B-T098
for	O
public	B-T058
health	I-T058
intervention	I-T058
.	O
further	O
collaborative	O
efforts	O
will	O
be	O
made	O
between	O
our	O
hospital	B-T092
and	O
the	O
mari	B-T082
##cop	I-T082
##a	I-T082
county	I-T082
department	B-T092
of	I-T092
public	I-T092
health	I-T092
to	O
perform	O
a	O
series	O
of	O
community	O
vaccination	B-T058
events	O
before	O
the	O
next	O
influenza	B-T038
season	O
.	O
we	O
hope	O
these	O
efforts	O
will	O
ultimately	O
serve	O
to	O
reduce	O
the	O
burden	O
of	O
this	O
disease	B-T038
on	O
our	O
patient	O
population	B-T098
,	O
and	O
that	O
this	O
system	O
will	O
serve	O
as	O
a	O
framework	O
for	O
future	O
investigations	B-T058
loc	O
##ating	O
at	B-T098
-	I-T098
risk	I-T098
populations	I-T098
.	O

implementation	O
of	O
infrared	B-T058
and	O
raman	B-T058
modalities	O
for	O
glycosaminoglycan	B-T103
characterization	B-T170
in	O
complex	O
systems	O
glycosaminoglycans	B-T103
(	O
gag	B-T103
##s	I-T103
)	O
are	O
natural	O
,	O
linear	B-T082
and	O
negatively	B-T103
charged	I-T103
hetero	B-T103
##po	I-T103
##lys	I-T103
##accharides	I-T103
which	O
are	O
incident	O
in	O
every	O
mammalian	B-T204
tissue	B-T017
.	O
they	O
consist	O
of	O
repeating	O
dis	B-T103
##accharide	I-T103
units	O
,	O
which	O
are	O
composed	O
of	O
either	O
sulfated	B-T103
or	O
non	B-T103
-	I-T103
sulfated	I-T103
monos	I-T103
##accharides	I-T103
.	O
depending	O
on	O
tissue	B-T017
types	O
,	O
gag	B-T103
##s	I-T103
exhibit	O
structural	B-T082
heterogeneity	O
such	O
as	O
the	O
position	B-T082
and	O
degree	O
of	O
sulf	O
##ation	O
or	O
within	O
their	O
dis	B-T103
##accharide	I-T103
units	O
composition	O
being	O
heparin	B-T103
,	O
heparan	B-T103
sulfate	I-T103
,	O
chondroitin	B-T103
##e	I-T103
sulfate	I-T103
,	O
dermat	B-T103
##an	I-T103
sulfate	I-T103
,	O
kerat	B-T103
##an	I-T103
sulfate	I-T103
,	O
and	O
hyaluronic	B-T103
acid	I-T103
.	O
they	O
are	O
covalently	B-T038
linked	I-T038
to	O
a	O
core	B-T082
protein	B-T103
(	O
proteoglycans	B-T103
)	O
or	O
as	O
free	O
chains	O
(	O
hyaluronan	B-T103
)	O
.	O
gag	B-T103
##s	I-T103
affect	O
cell	B-T017
properties	O
and	O
functions	B-T038
either	O
by	O
direct	O
interaction	O
with	O
cell	B-T103
receptors	I-T103
or	O
by	O
sequestration	O
of	O
growth	B-T103
factors	I-T103
.	O
these	O
evidences	O
of	O
diver	O
##t	O
biological	O
roles	O
of	O
gag	B-T103
##s	I-T103
make	O
their	O
characterization	B-T170
at	O
cell	B-T017
and	O
tissue	B-T017
levels	O
of	O
importance	O
.	O
thus	O
,	O
non	O
-	O
invasive	O
techniques	O
are	O
interesting	O
to	O
investigate	O
,	O
to	O
qualitatively	O
and	O
quantitatively	O
characterize	O
gag	B-T103
##s	I-T103
in	O
vitro	O
in	O
order	O
to	O
use	O
them	O
as	O
diagnostic	O
biomarkers	B-T201
and	O
/	O
or	O
as	O
therapeutic	O
targets	B-T074
in	O
several	O
human	B-T204
diseases	B-T038
including	O
cancer	B-T038
.	O
infrared	B-T058
and	O
raman	B-T058
microsp	I-T058
##ectr	I-T058
##oscop	I-T058
##ies	I-T058
and	O
imaging	B-T058
are	O
sensitive	O
enough	O
to	O
differentiate	O
and	O
classify	B-T170
gag	B-T103
types	O
and	O
subtypes	B-T170
in	O
spite	O
of	O
their	O
close	O
molecular	B-T082
structures	I-T082
.	O
spectroscopic	B-T058
markers	O
characteristic	O
of	O
reference	O
gag	B-T103
molecules	O
were	O
identified	O
.	O
beyond	O
these	O
investigations	B-T058
of	O
the	O
standard	O
gag	B-T103
spectral	O
signature	O
,	O
infrared	B-T058
and	O
raman	B-T058
spectral	O
signatures	O
of	O
gag	B-T103
were	O
searched	O
in	O
complex	O
biological	O
systems	O
like	O
cells	B-T017
.	O
the	O
aim	O
of	O
the	O
present	O
review	O
is	O
to	O
describe	O
the	O
implementation	O
of	O
these	O
complementary	O
vibrational	B-T058
spectroscopy	I-T058
techniques	I-T058
,	O
and	O
to	O
discuss	O
their	O
potentials	O
,	O
advantages	O
and	O
disadvantages	O
for	O
gag	B-T103
analysis	B-T058
.	O
in	O
addition	O
,	O
this	O
review	O
presents	O
new	O
data	O
as	O
we	O
show	O
for	O
the	O
first	O
time	O
gag	B-T103
infrared	B-T058
and	O
raman	B-T058
spectral	O
signatures	O
from	O
conditioned	B-T103
media	I-T103
and	O
live	B-T017
cells	I-T017
,	O
respectively	O
.	O

differential	B-T038
regulation	I-T038
of	O
spontaneous	O
and	O
evoked	O
inhibitory	B-T038
synaptic	I-T038
transmission	I-T038
in	O
somatosensory	B-T017
cortex	I-T017
by	O
retinoic	B-T103
acid	I-T103
retinoic	B-T103
acid	I-T103
(	O
ra	B-T103
)	O
,	O
a	O
developmental	O
morph	B-T103
##ogen	I-T103
,	O
has	O
emerged	O
in	O
recent	O
studies	O
as	O
a	O
novel	O
synaptic	B-T038
signaling	B-T103
molecule	I-T103
that	O
acts	O
in	O
mature	O
hippocampal	B-T017
neurons	B-T017
to	O
modulate	O
excitatory	B-T038
and	O
inhibitory	B-T038
synaptic	I-T038
transmission	I-T038
in	O
the	O
context	O
of	O
homeostatic	B-T038
synaptic	B-T038
plasticity	I-T038
.	O
however	O
,	O
it	O
is	O
unclear	O
whether	O
ra	B-T103
is	O
capable	O
of	O
modulating	O
neural	O
circuits	O
outside	B-T082
of	O
the	O
hippocampus	B-T017
,	O
and	O
if	O
so	O
,	O
whether	O
the	O
mode	O
of	O
ra	O
'	O
s	O
action	O
at	O
synapses	B-T082
is	O
similar	O
to	O
that	O
within	B-T082
the	O
hippocampal	B-T017
network	O
.	O
here	O
we	O
explore	O
for	O
the	O
first	O
time	O
ra	B-T103
'	O
s	O
synaptic	B-T038
function	I-T038
outside	B-T082
the	O
hippocampus	B-T017
and	O
uncover	O
a	O
novel	O
function	O
of	O
all	B-T103
-	I-T103
trans	I-T103
retinoic	I-T103
acid	I-T103
at	O
inhibitory	B-T017
synapses	I-T017
.	O
acute	O
ra	B-T103
treatment	O
increases	O
spontaneous	O
inhibitory	B-T038
synaptic	I-T038
transmission	I-T038
in	O
l2	B-T017
/	I-T017
3	I-T017
pyramidal	I-T017
neurons	I-T017
of	O
the	O
somatosensory	B-T017
cortex	I-T017
,	O
and	O
this	O
effect	O
requires	O
expression	O
of	O
ra	B-T103
'	I-T103
s	I-T103
receptor	I-T103
rar	B-T103
##α	I-T103
both	O
pre	B-T038
-	I-T038
and	I-T038
post	I-T038
-	I-T038
synaptic	I-T038
##ally	I-T038
.	O
intriguing	O
##ly	O
,	O
ra	B-T103
does	O
not	O
seem	O
to	O
affect	O
evoked	O
inhibitory	B-T038
transmission	I-T038
assayed	O
with	O
either	O
extracellular	B-T017
stimulation	O
or	O
direct	O
activation	B-T038
of	I-T038
action	I-T038
potentials	I-T038
in	O
presynaptic	B-T017
interneurons	B-T017
at	O
connected	O
pairs	O
of	O
interneurons	B-T017
and	O
pyramidal	B-T017
neurons	I-T017
.	O
taken	O
together	O
,	O
these	O
results	O
suggest	O
that	O
ra	B-T103
'	I-T103
s	I-T103
action	O
at	O
synapses	B-T082
is	O
not	O
mono	O
##ton	O
##ous	O
,	O
but	O
is	O
diverse	O
depending	O
on	O
the	O
type	O
of	O
synaptic	B-T038
connection	I-T038
(	O
excitatory	B-T038
versus	O
inhibitory	B-T038
)	O
and	O
circuit	O
(	O
hippocampal	B-T017
versus	O
cortical	B-T017
)	I-T017
.	O
thus	O
,	O
synaptic	B-T038
signaling	I-T038
of	O
ra	B-T103
may	O
mediate	O
multi	O
-	O
facet	O
##ed	O
regulation	B-T038
of	I-T038
synaptic	I-T038
plasticity	I-T038
.	O
in	O
addition	O
to	O
its	O
classic	O
roles	O
in	O
brain	B-T038
development	I-T038
,	O
retinoic	B-T103
acid	I-T103
(	O
ra	B-T103
)	O
has	O
recently	O
been	O
shown	O
to	O
regulate	B-T038
excitatory	B-T038
and	O
inhibitory	B-T038
transmission	I-T038
in	O
the	O
adult	O
brain	B-T017
.	O
here	O
,	O
the	O
authors	B-T097
show	O
that	O
in	O
layer	B-T017
2	I-T017
/	I-T017
3	I-T017
(	O
l2	B-T017
/	I-T017
3	I-T017
)	O
of	O
the	O
somatosensory	B-T017
cortex	I-T017
(	O
s1	B-T017
)	O
,	O
acute	O
ra	B-T103
induces	O
increases	O
in	O
spontaneous	O
but	O
not	O
action	B-T038
-	I-T038
potential	I-T038
evoked	O
transmission	B-T038
,	O
and	O
that	O
this	O
requires	O
retinoic	B-T103
acid	I-T103
receptor	I-T103
(	O
rar	B-T103
##α	I-T103
)	O
both	O
in	O
presynaptic	B-T017
pv	B-T103
-	O
positive	O
interneurons	B-T017
and	O
postsynaptic	O
pyramidal	B-T017
(	I-T017
pn	I-T017
)	I-T017
neurons	I-T017
.	O

development	O
of	O
the	O
four	O
-	O
item	O
letter	O
and	O
shape	O
drawing	O
test	O
(	O
ls	O
##d	O
-	O
4	O
)	O
:	O
a	O
brief	O
bedside	B-T058
test	I-T058
of	O
visuospatial	O
function	O
conventional	O
bedside	B-T058
tests	I-T058
of	O
visuospatial	O
function	O
such	O
as	O
the	O
clock	O
drawing	O
(	O
cdt	O
)	O
and	O
inters	O
##ecting	O
penta	O
##go	O
##ns	O
(	O
ipt	O
)	O
lack	O
consistency	O
in	O
delivery	O
and	O
interpretation	B-T033
.	O
we	O
compared	O
performance	O
on	O
a	O
novel	O
test	O
of	O
visuospatial	O
ability	O
-	O
the	O
ls	O
##d	O
-	O
with	O
the	O
ipt	O
,	O
cdt	O
and	O
mmse	B-T058
in	O
180	O
acute	O
elderly	B-T098
medical	O
inpatients	O
[	O
mean	O
age	O
79	O
.	O
7	O
##±7	O
.	O
1	O
(	O
range	O
62	O
-	O
96	O
)	O
;	O
91	O
females	O
(	O
50	O
.	O
6	O
%	O
)	O
]	O
.	O
124	O
(	O
69	O
%	O
)	O
scored	O
≤	O
##23	O
on	O
the	O
mmse	B-T058
;	O
60	O
with	O
mild	O
(	O
score	O
18	O
-	O
23	O
)	O
and	O
64	O
with	O
severe	O
(	O
score	O
≤	O
##17	O
)	O
impairment	O
.	O
78	O
(	O
43	O
%	O
)	O
scored	O
≥	O
##6	O
on	O
the	O
cdt	O
,	O
while	O
for	O
the	O
ipt	O
,	O
87	O
(	O
47	O
%	O
)	O
scored	O
≥	O
##4	O
.	O
the	O
cdt	O
and	O
ipt	O
agreed	B-T033
on	O
the	O
classification	B-T170
of	O
138	O
patients	O
(	O
77	O
%	O
)	O
with	O
modest	O
-	O
strong	O
agreement	O
with	O
the	O
mmse	B-T058
categories	B-T170
.	O
correlation	O
between	O
the	O
ls	O
##d	O
and	O
visuospatial	O
tests	O
was	O
high	O
.	O
a	O
four	B-T170
-	I-T170
item	I-T170
version	I-T170
of	O
the	O
ls	O
##d	O
incorporating	O
items	O
1	O
,	O
10	O
,	O
12	O
,	O
15	O
had	O
high	O
correlation	O
with	O
the	O
ls	O
##d	O
-	O
15	O
and	O
strong	O
association	O
with	O
mmse	B-T058
categories	B-T170
.	O
the	O
ls	O
##d	O
-	O
4	O
provides	O
a	O
brief	O
and	O
easily	B-T033
interpreted	O
bedside	B-T058
test	I-T058
of	O
visuospatial	O
function	O
that	O
has	O
high	O
coverage	O
of	O
elderly	B-T098
patients	O
with	O
neurocognitive	B-T038
impairment	I-T038
,	O
good	O
agreement	O
with	O
conventional	O
tests	O
of	O
visuospatial	O
ability	O
and	O
favourable	O
ability	O
to	O
identify	O
significant	O
cognitive	B-T038
impairment	I-T038
.	O
[	O
181	O
words	O
]	O
.	O

human	B-T204
umbilical	B-T031
cord	I-T031
blood	I-T031
-	O
derived	O
neural	B-T017
stem	I-T017
cell	I-T017
line	I-T017
as	O
a	O
screening	B-T058
model	O
for	O
toxicity	B-T037
the	O
aim	O
was	O
to	O
investigate	O
whether	O
a	O
human	B-T204
neural	B-T017
stem	I-T017
cell	I-T017
(	O
nsc	B-T017
)	O
line	B-T017
derived	O
from	O
human	B-T204
umbilical	B-T031
cord	I-T031
blood	I-T031
(	O
hu	B-T031
##cb	I-T031
)	O
can	O
be	O
used	O
for	O
toxicity	B-T037
study	B-T062
.	O
toxicity	B-T037
of	O
both	O
neurotoxic	O
environmental	B-T082
xenobiotics	B-T103
,	O
methyl	B-T103
mercury	I-T103
chloride	I-T103
(	O
ch3	B-T103
##hg	I-T103
##cl	I-T103
)	O
,	O
lead	B-T103
acetate	I-T103
(	O
ch3	B-T103
##co	I-T103
##op	I-T103
##b	I-T103
)	O
,	O
and	O
chlorpyr	B-T103
##ifos	I-T103
(	O
cp	B-T103
)	O
,	O
and	O
non	B-T033
-	I-T033
neurotoxic	I-T033
insecticide	B-T103
,	O
dichlor	B-T103
##vo	I-T103
##s	I-T103
,	O
as	O
well	O
as	O
non	B-T033
-	I-T033
neurotoxic	I-T033
drugs	B-T103
,	O
theophylline	B-T103
and	O
acetaminophen	B-T103
were	O
assessed	O
.	O
additionally	O
,	O
differentiation	O
of	O
neuronal	O
and	O
glial	B-T017
cell	I-T017
lines	I-T017
derived	O
from	O
hu	B-T031
##cb	I-T031
was	O
elucidated	O
.	O
it	O
was	O
observed	O
that	O
ch3	B-T103
##hg	I-T103
##cl	I-T103
was	O
more	O
toxic	O
to	O
human	B-T204
nscs	B-T017
in	O
comparison	O
to	O
ch3	B-T103
##co	I-T103
##op	I-T103
##b	I-T103
and	O
cp	B-T103
.	O
the	O
minimum	B-T033
inhibitory	I-T033
concentration	I-T033
(	I-T033
mic	I-T033
)	I-T033
value	I-T033
against	O
nscs	B-T017
was	O
3	O
,	O
10	O
,	O
and	O
300	O
mg	O
/	O
l	O
,	O
in	O
each	O
staining	B-T058
process	I-T058
,	O
acridine	B-T103
orange	I-T103
/	O
ethidium	B-T103
bromide	I-T103
(	O
ao	B-T103
/	O
eb	B-T103
)	O
staining	B-T058
,	O
3	B-T103
-	I-T103
(	I-T103
4	I-T103
,	I-T103
5	I-T103
-	I-T103
dimethyl	I-T103
##thiaz	I-T103
##ol	I-T103
-	I-T103
2	I-T103
-	I-T103
yl	I-T103
)	I-T103
2	I-T103
,	I-T103
5	I-T103
-	I-T103
diphenyl	I-T103
tetrazolium	I-T103
bromide	I-T103
(	O
mtt	B-T103
)	O
assay	B-T058
,	O
and	O
hoechst	O
staining	O
,	O
for	O
ch3	B-T103
##hg	I-T103
##cl	I-T103
,	O
cp	B-T103
,	O
and	O
ch3	B-T103
##co	I-T103
##op	I-T103
##b	I-T103
,	O
respectively	O
.	O
ch3	B-T103
##hg	I-T103
##cl	I-T103
had	O
the	O
lc	O
##25	O
value	O
as	O
10	O
.	O
0	O
,	O
14	O
.	O
4	O
,	O
and	O
12	O
.	O
7	O
mg	O
/	O
l	O
,	O
by	O
staining	B-T058
method	I-T058
mentioned	O
in	O
succession	O
.	O
cp	B-T103
had	O
the	O
lc	O
##25	O
value	O
as	O
21	O
.	O
9	O
,	O
23	O
.	O
7	O
,	O
and	O
18	O
.	O
4	O
mg	O
/	O
l	O
;	O
similarly	O
,	O
ch3	B-T103
##co	I-T103
##op	I-T103
##b	I-T103
had	O
lc	O
##25	O
values	O
,	O
successively	O
as	O
61	O
##6	O
.	O
9	O
,	O
71	O
##9	O
.	O
2	O
,	O
and	O
89	O
##0	O
.	O
3	O
mg	O
/	O
l	O
.	O
lc50	O
values	O
ranged	O
from	O
18	O
.	O
2	O
to	O
21	O
.	O
7	O
mg	O
/	O
l	O
for	O
ch3	B-T103
##hg	I-T103
##cl	I-T103
,	O
56	O
.	O
4	O
to	O
60	O
.	O
2	O
mg	O
/	O
l	O
for	O
cp	B-T103
,	O
and	O
1000	O
to	O
146	O
##0	O
.	O
1	O
for	O
ch3	B-T103
##co	I-T103
##op	I-T103
##b	I-T103
.	O
theophylline	B-T103
,	O
acetaminophen	B-T103
,	O
and	O
dichlor	B-T103
##vo	I-T103
##s	I-T103
had	O
no	O
impact	O
on	O
the	O
viability	O
of	O
nscs	B-T017
.	O
this	O
work	O
justified	O
that	O
hu	B-T031
##cb	I-T031
-	O
nsc	B-T017
model	O
can	O
be	O
used	O
for	O
toxicity	B-T037
study	B-T062
.	O

multis	B-T038
##ensory	I-T038
integration	I-T038
in	O
the	O
virtual	B-T038
hand	I-T038
illusion	I-T038
with	O
active	B-T038
movement	I-T038
improving	O
the	O
sense	B-T033
of	I-T033
immersion	I-T033
is	O
one	O
of	O
the	O
core	O
issues	O
in	O
virtual	O
reality	O
.	O
perceptual	O
illusion	O
##s	O
of	O
ownership	O
can	O
be	O
perceived	B-T038
over	O
a	O
virtual	O
body	O
in	O
a	O
multis	B-T058
##ensory	I-T058
virtual	O
reality	O
environment	O
.	O
rubber	B-T074
hand	I-T074
and	O
virtual	B-T038
hand	I-T038
illusion	I-T038
##s	I-T038
showed	O
that	O
body	O
ownership	O
can	O
be	O
manipulated	O
by	O
applying	O
suitable	O
visual	B-T058
and	O
tactile	B-T058
stimulation	I-T058
.	O
in	O
this	O
study	O
,	O
we	O
investigate	O
the	O
effects	O
of	O
multis	B-T038
##ensory	I-T038
integration	I-T038
in	O
the	O
virtual	B-T038
hand	I-T038
illusion	I-T038
with	O
active	B-T038
movement	I-T038
.	O
a	O
virtual	O
xyl	O
##oph	O
##one	O
playing	O
system	O
which	O
can	O
interactive	O
##ly	O
provide	O
synchronous	O
visual	B-T058
,	O
tactile	B-T058
,	O
and	O
auditory	B-T058
stimulation	I-T058
was	O
constructed	O
.	O
we	O
conducted	O
two	O
experiments	O
regarding	O
different	O
movement	O
conditions	O
and	O
different	O
sensory	B-T058
stimulations	I-T058
.	O
our	O
results	O
demonstrate	O
that	O
multis	B-T038
##ensory	I-T038
integration	I-T038
with	O
free	O
active	B-T038
movement	I-T038
can	O
improve	O
the	O
sense	B-T038
of	I-T038
immersion	O
in	O
virtual	O
reality	O
.	O

biomimetic	O
whit	B-T103
##lock	I-T103
##ite	I-T103
inorganic	O
nanoparticles	O
-	O
mediated	O
in	B-T082
situ	I-T082
remodeling	B-T038
and	O
rapid	O
bone	B-T038
regeneration	I-T038
bone	B-T038
remodeling	I-T038
process	O
relies	O
on	O
complex	O
signaling	B-T038
pathway	I-T038
between	O
osteoblasts	B-T017
and	O
osteoclasts	B-T017
and	O
control	O
mechanisms	O
to	O
achieve	O
homeostasis	B-T038
of	O
their	O
growth	B-T038
and	O
differentiation	B-T038
.	O
despite	O
previous	O
achievements	O
in	O
understanding	O
complicated	O
signaling	B-T038
pathways	I-T038
between	O
cells	B-T017
and	O
bone	B-T017
extracellular	B-T017
matrices	I-T017
during	O
bone	B-T038
remodeling	I-T038
process	O
,	O
a	O
role	O
of	O
local	O
ionic	B-T103
concentration	O
remains	O
to	O
be	O
elucidated	O
.	O
here	O
,	O
we	O
demonstrate	O
that	O
synthetic	O
whit	B-T103
##lock	I-T103
##ite	I-T103
(	O
wh	B-T103
:	I-T103
ca1	I-T103
##8	I-T103
##mg	I-T103
##2	I-T103
(	I-T103
hp	I-T103
##o4	I-T103
)	I-T103
2	I-T103
(	I-T103
po	I-T103
##4	I-T103
)	I-T103
12	I-T103
)	I-T103
nanoparticles	O
can	O
recapit	O
##ulate	O
early	O
-	O
stage	O
of	O
bone	B-T038
regeneration	I-T038
through	O
stimulating	O
osteogenic	B-T038
differentiation	I-T038
,	O
prohib	O
##iting	O
osteoclast	B-T017
##ic	I-T017
activity	O
,	O
and	O
transforming	B-T038
into	O
mechanically	O
enhanced	O
hydroxyapatite	B-T103
(	O
hap	B-T103
)	O
-	O
neo	B-T017
bone	I-T017
tissues	I-T017
by	O
continuous	O
supply	O
of	O
po	B-T103
##4	I-T103
(	I-T103
3	I-T103
-	I-T103
)	I-T103
and	O
mg	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
under	O
physiological	O
conditions	O
.	O
in	O
addition	O
,	O
based	O
on	O
their	O
structural	B-T062
analysis	I-T062
,	O
the	O
dynamic	O
phase	O
transformation	B-T038
from	O
wh	B-T103
into	O
hap	B-T103
contributed	O
as	O
a	O
key	O
factor	O
for	O
rapid	O
bone	B-T038
regeneration	I-T038
with	O
dense	O
##r	O
hierarchical	O
neo	B-T017
-	I-T017
bone	I-T017
structure	B-T082
.	O
our	O
findings	B-T033
suggest	O
a	O
ground	O
##break	O
##ing	O
concept	O
of	O
'	O
living	O
bone	B-T017
minerals	B-T103
'	O
that	O
actively	O
communicate	B-T038
with	O
the	O
surrounding	O
system	O
to	O
induce	O
self	O
-	O
healing	O
,	O
while	O
previous	O
notion	O
##s	O
about	O
bone	B-T017
minerals	B-T103
have	O
been	O
limited	O
to	O
passive	O
products	O
of	O
cellular	B-T017
mineralization	O
.	O

lign	B-T103
##ans	I-T103
from	O
the	O
fruits	B-T168
of	O
sch	B-T204
##isa	I-T204
##nd	I-T204
##ra	I-T204
chin	I-T204
##ensis	I-T204
(	I-T204
tur	I-T204
##c	I-T204
##z	I-T204
.	I-T204
)	I-T204
ba	I-T204
##ill	I-T204
inhibit	O
propr	B-T017
##ote	I-T017
##in	I-T017
convert	I-T017
##ase	I-T017
subtilis	I-T017
##in	I-T017
/	I-T017
ke	I-T017
##xin	I-T017
type	I-T017
9	I-T017
expression	B-T038
bioactivity	B-T058
-	I-T058
guided	I-T058
fractionation	I-T058
of	O
the	O
fruits	B-T168
of	O
sch	B-T204
##isa	I-T204
##nd	I-T204
##ra	I-T204
chin	I-T204
##ensis	I-T204
,	O
using	O
the	O
propr	B-T017
##ote	I-T017
##in	I-T017
convert	I-T017
##ase	I-T017
subtilis	I-T017
##in	I-T017
-	I-T017
ke	I-T017
##xin	I-T017
type	I-T017
9	I-T017
(	O
pcs	B-T017
##k	I-T017
##9	I-T017
)	O
mrna	B-T038
expression	I-T038
screening	B-T058
assay	I-T058
,	O
led	O
to	O
isolation	O
of	O
two	O
previously	O
unknown	O
lign	B-T103
##ans	I-T103
,	O
14	B-T103
-	I-T103
tig	I-T103
##lo	I-T103
##yl	I-T103
##sc	I-T103
##hi	I-T103
##nl	I-T103
##ign	I-T103
##an	I-T103
d	I-T103
and	O
rel	B-T103
-	I-T103
(	I-T103
7	I-T103
##r	I-T103
,	I-T103
8	I-T103
##r	I-T103
,	I-T103
7	I-T103
'	I-T103
r	I-T103
,	I-T103
8	I-T103
'	I-T103
r	I-T103
)	I-T103
-	I-T103
mang	I-T103
##li	I-T103
##sin	I-T103
e	I-T103
,	O
along	O
with	O
28	O
known	O
compounds	O
.	O
all	O
structures	B-T170
were	O
established	O
by	O
nmr	B-T058
spectroscopic	I-T058
data	O
as	O
well	O
as	O
cd	B-T058
and	O
ms	B-T058
analysis	B-T062
.	O
all	O
isolates	O
were	O
tested	O
for	O
their	O
inhibitory	O
activities	O
on	O
the	O
mrna	B-T038
expression	I-T038
of	O
pcs	B-T017
##k	I-T017
##9	I-T017
.	O
of	O
the	O
tested	O
compounds	O
,	O
four	O
of	O
the	O
compounds	O
rel	B-T103
-	I-T103
(	I-T103
7	I-T103
##r	I-T103
,	I-T103
8	I-T103
##r	I-T103
,	I-T103
7	I-T103
'	I-T103
r	I-T103
,	I-T103
8	I-T103
'	I-T103
r	I-T103
)	I-T103
-	I-T103
mang	I-T103
##li	I-T103
##sin	I-T103
e	I-T103
,	O
(	B-T103
-	I-T103
)	I-T103
-	I-T103
sch	I-T103
##isa	I-T103
##nd	I-T103
##rin	I-T103
c	I-T103
,	O
sch	B-T103
##in	I-T103
##li	I-T103
##gn	I-T103
##an	I-T103
d	I-T103
,	O
and	O
(	B-T103
+	I-T103
)	I-T103
-	I-T103
sch	I-T103
##isa	I-T103
##nd	I-T103
##rol	I-T103
b	I-T103
potently	O
inhibited	O
pcs	B-T017
##k	I-T017
##9	I-T017
mrna	B-T038
expression	I-T038
with	O
ic50	O
values	O
of	O
3	O
.	O
15	O
,	O
3	O
.	O
85	O
,	O
0	O
.	O
36	O
,	O
and	O
1	O
.	O
10	O
μm	O
,	O
respectively	O
.	O
furthermore	O
,	O
sch	O
##in	O
##li	O
##gn	O
##an	O
d	O
and	O
(	B-T103
+	I-T103
)	I-T103
-	I-T103
sch	I-T103
##isa	I-T103
##nd	I-T103
##rol	I-T103
b	I-T103
were	O
found	O
to	O
suppress	O
pcs	B-T103
##k	I-T103
##9	I-T103
protein	B-T038
expressions	I-T038
and	O
sch	B-T103
##in	I-T103
##li	I-T103
##gn	I-T103
##an	I-T103
d	I-T103
deemed	O
to	O
increase	O
low	B-T103
density	I-T103
lipoprotein	I-T103
receptor	I-T103
expression	O
.	O

decompression	B-T058
surgery	I-T058
alone	O
versus	O
decompression	B-T058
plus	O
fusion	B-T058
in	O
symptomatic	O
lumbar	B-T038
spinal	I-T038
stenosis	I-T038
:	O
a	O
swiss	B-T098
prospective	B-T062
multi	I-T062
-	I-T062
center	I-T062
cohort	I-T062
study	I-T062
with	O
3	O
years	O
of	O
follow	B-T062
-	I-T062
up	I-T062
retrospective	B-T062
analysis	I-T062
of	O
a	O
prospective	B-T062
,	I-T062
multicenter	I-T062
cohort	I-T062
study	I-T062
.	O
to	O
estimate	O
the	O
added	O
effect	O
of	O
surgical	B-T058
fusion	I-T058
as	O
compared	O
to	O
decompression	B-T058
surgery	I-T058
alone	O
in	O
symptomatic	O
lumbar	B-T038
spinal	I-T038
stenosis	I-T038
patients	O
with	O
spondyl	B-T038
##olis	I-T038
##thesis	I-T038
.	O
the	O
optimal	B-T058
surgical	I-T058
management	I-T058
of	O
lumbar	B-T038
spinal	I-T038
stenosis	I-T038
patients	O
with	O
spondyl	B-T038
##olis	I-T038
##thesis	I-T038
remains	O
controversial	O
.	O
patients	O
of	O
the	O
ls	B-T062
##os	I-T062
with	O
confirmed	O
dls	B-T038
##s	I-T038
and	O
spondyl	B-T038
##olis	I-T038
##thesis	I-T038
were	O
enrolled	O
in	O
this	O
study	O
.	O
the	O
outcomes	B-T062
of	O
this	O
study	O
were	O
spinal	B-T017
stenosis	I-T017
measure	O
(	O
ss	O
##m	O
)	O
symptoms	B-T033
(	O
score	O
range	O
1	O
-	O
5	O
,	O
best	O
-	O
worst	O
)	O
and	O
function	O
(	O
1	O
-	O
4	O
)	O
over	O
time	O
,	O
measured	O
at	O
baseline	O
,	O
6	O
,	O
12	O
,	O
24	O
and	O
36	O
months	O
follow	B-T062
-	I-T062
up	I-T062
.	O
in	O
order	O
to	O
quantify	O
the	O
effect	O
of	O
fusion	B-T058
surgery	I-T058
as	O
compared	O
to	O
decompression	B-T058
alone	O
and	O
number	B-T033
of	I-T033
decomp	I-T033
##ressed	I-T033
levels	I-T033
,	O
we	O
used	O
mixed	O
effects	O
models	O
and	O
accounted	O
for	O
the	O
repeated	B-T062
observations	I-T062
in	O
main	O
outcomes	B-T062
(	O
ss	O
##m	O
symptoms	B-T033
and	O
ss	O
##m	O
function	O
)	O
over	O
time	O
.	O
in	O
addition	O
to	O
individual	O
patients	O
'	O
random	O
effects	O
,	O
we	O
also	O
fitted	O
random	O
slopes	O
for	O
follow	B-T033
-	I-T033
up	I-T033
time	O
points	O
and	O
compared	O
these	O
two	O
approaches	O
with	O
ak	B-T170
##ai	I-T170
##ke	I-T170
'	I-T170
s	I-T170
information	I-T170
criterion	I-T170
(	O
aic	B-T170
)	O
and	O
the	O
chi	B-T170
-	I-T170
squared	I-T170
test	I-T170
.	O
confounders	O
were	O
adjusted	O
with	O
fixed	O
effects	O
for	O
age	O
,	O
gender	O
,	O
bmi	B-T201
,	O
diabetes	B-T038
,	O
cir	O
##s	O
musculoskeletal	B-T038
disorders	I-T038
and	O
duration	B-T103
of	O
symptoms	B-T033
.	O
one	O
hundred	O
and	O
thirty	O
-	O
one	O
patients	O
undergoing	O
decompression	B-T058
surgery	I-T058
alone	O
(	O
n	O
=	O
85	O
)	O
or	O
decompression	B-T058
plus	O
fusion	B-T058
surgery	I-T058
(	O
n	O
=	O
46	O
)	O
were	O
included	O
in	O
this	O
study	O
.	O
in	O
the	O
multiple	O
mixed	O
effects	O
model	O
the	O
adjusted	O
effect	O
of	O
fusion	B-T058
versus	O
decompression	B-T058
alone	I-T058
surgery	I-T058
on	O
ss	O
##m	O
symptoms	B-T033
was	O
0	O
.	O
06	O
(	O
95	O
%	O
confidence	O
interval	O
,	O
ci	O
:	O
-	O
0	O
.	O
16	O
to	O
0	O
.	O
27	O
)	O
and	O
-	O
0	O
.	O
07	O
(	O
95	O
%	O
ci	O
:	O
-	O
0	O
.	O
25	O
to	O
0	O
.	O
10	O
)	O
on	O
ss	O
##m	O
function	O
,	O
respectively	O
.	O
among	O
the	O
patients	O
with	O
degenerative	B-T038
lumbar	I-T038
spinal	I-T038
stenosis	I-T038
and	O
spondyl	B-T038
##olis	I-T038
##thesis	I-T038
our	O
study	O
confirms	O
that	O
in	O
the	O
two	O
groups	O
,	O
decompression	B-T058
alone	O
and	O
decompression	B-T058
plus	O
fusion	B-T058
,	O
patients	O
distinctive	O
##ly	O
benefited	O
from	O
surgical	B-T058
treatment	I-T058
.	O
when	O
adjusted	O
for	O
confounders	O
,	O
fusion	B-T058
surgery	I-T058
was	O
not	O
associated	O
with	O
a	O
more	O
favorable	O
outcome	B-T062
in	O
both	O
ss	O
##m	O
scores	O
as	O
compared	O
to	O
decompression	B-T058
alone	I-T058
surgery	I-T058
.	O
3	O
.	O

non	O
-	O
pharmacological	O
treatments	B-T058
for	O
pain	B-T058
relief	I-T058
:	O
tens	B-T058
and	O
acupuncture	B-T058
acupuncture	B-T058
and	O
transcutaneous	B-T058
electrical	I-T058
nerve	I-T058
stimulation	I-T058
(	O
tens	B-T058
)	O
are	O
non	O
-	O
pharmacological	O
methods	O
that	O
have	O
been	O
used	O
for	O
mill	O
##enn	O
##ia	O
to	O
relieve	B-T058
pain	I-T058
.	O
as	O
with	O
all	O
complementary	B-T058
treatments	I-T058
,	O
efficacy	O
evaluations	B-T058
face	O
two	O
hur	O
##dle	O
##s	O
:	O
the	O
non	O
-	O
feasibility	O
of	O
double	B-T062
-	I-T062
blind	I-T062
##ing	I-T062
and	O
the	O
difficulty	O
in	O
identifying	O
the	O
optimal	O
control	O
population	O
or	O
treatment	B-T058
.	O
nevertheless	O
,	O
recent	O
studies	O
of	O
good	O
methodological	O
quality	O
have	O
demonstrated	O
benefits	O
in	O
many	O
types	O
of	O
pain	B-T033
compared	O
to	O
conventional	O
treatment	B-T058
.	O
the	O
mechanisms	O
of	O
action	O
of	O
acupuncture	B-T058
and	O
tens	B-T058
,	O
which	O
are	O
increasingly	O
well	O
understood	O
,	O
involve	O
endogenous	O
pain	B-T058
control	I-T058
systems	I-T058
,	O
cerebral	B-T038
plasticity	I-T038
,	O
and	O
nonspecific	O
effects	O
(	O
e	O
.	O
g	O
.	O
,	O
expectations	O
and	O
placebo	O
effect	O
)	O
.	O
no	O
serious	O
adverse	B-T038
effects	I-T038
have	O
been	O
reported	O
.	O
these	O
data	O
support	O
the	O
more	O
widespread	O
use	O
of	O
non	O
-	O
pharmacological	O
pain	B-T058
management	I-T058
,	O
most	O
notably	O
in	O
patients	O
with	O
chronic	B-T033
pain	I-T033
inadequate	O
##ly	O
relieved	O
by	O
medications	B-T103
alone	O
.	O

engagement	O
of	O
cellular	B-T103
prion	I-T103
protein	I-T103
with	O
the	O
co	B-T103
-	I-T103
chaperone	I-T103
hsp70	B-T103
/	I-T103
90	B-T103
organizing	I-T103
protein	I-T103
regulates	O
the	O
proliferation	B-T038
of	O
glioblastoma	B-T017
stem	I-T017
-	I-T017
like	I-T017
cells	I-T017
glioblastoma	B-T038
(	O
gbm	B-T038
)	O
,	O
a	O
highly	O
aggressive	O
brain	B-T038
tumor	I-T038
,	O
contains	O
a	O
subpopulation	O
of	O
glioblastoma	B-T017
stem	I-T017
-	I-T017
like	I-T017
cells	I-T017
(	O
gs	B-T017
##cs	I-T017
)	O
that	O
play	O
roles	O
in	O
tumor	B-T038
maintenance	O
,	O
invasion	B-T038
,	O
and	O
therapeutic	B-T038
resistance	I-T038
.	O
gs	B-T017
##cs	I-T017
are	O
therefore	O
a	O
promising	O
target	O
for	O
gbm	B-T038
treatment	O
.	O
our	O
group	O
identified	O
the	O
cellular	B-T103
prion	I-T103
protein	I-T103
(	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
)	O
and	O
its	O
partner	O
,	O
the	O
co	B-T103
-	I-T103
chaperone	I-T103
hsp70	B-T103
/	I-T103
90	B-T103
organizing	I-T103
protein	I-T103
(	O
hop	B-T103
)	O
,	O
as	O
potential	O
target	O
candidates	O
due	O
to	O
their	O
role	O
in	O
gbm	B-T038
tumorigenesis	B-T038
and	O
in	O
neural	B-T017
stem	I-T017
cell	I-T017
maintenance	O
.	O
gs	B-T017
##cs	I-T017
expressing	O
different	O
levels	O
of	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
were	O
cultured	B-T058
as	O
neuros	B-T017
##ph	I-T017
##eres	I-T017
with	O
growth	B-T103
factors	I-T103
,	O
and	O
characterized	O
with	O
stem	B-T017
cells	I-T017
markers	B-T082
and	O
adhesion	B-T082
molecules	I-T082
markers	I-T082
through	O
immunofluorescence	B-T058
and	O
flow	B-T058
cytometry	I-T058
.	O
we	O
than	O
evaluated	O
gs	B-T017
##c	I-T017
self	B-T038
-	I-T038
renewal	I-T038
and	O
proliferation	B-T038
by	O
clonal	B-T058
density	I-T058
assays	I-T058
and	O
brdu	B-T058
incorporation	I-T058
,	O
respectively	O
,	O
in	O
front	O
of	O
recombinant	O
hop	B-T103
treatment	O
,	O
combined	O
or	O
not	O
with	O
a	O
hop	B-T103
peptide	B-T103
which	O
mimics	O
the	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
binding	B-T103
site	I-T103
.	O
stable	O
silencing	B-T038
of	O
hop	B-T103
was	O
also	O
performed	O
in	O
parental	O
and	O
/	O
or	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
-	O
depleted	O
cell	B-T017
populations	I-T017
,	O
and	O
proliferation	B-T038
in	O
vitro	O
and	O
tumor	O
growth	O
in	B-T082
vivo	I-T082
were	O
evaluated	O
.	O
migration	B-T058
assays	I-T058
were	O
performed	O
on	O
laminin	B-T103
-	I-T103
1	I-T103
pre	O
-	O
coated	O
glass	O
.	O
we	O
observed	O
that	O
,	O
when	O
gbm	B-T038
cells	B-T017
are	O
cultured	B-T058
as	O
neuros	B-T017
##ph	I-T017
##eres	I-T017
,	O
they	O
express	O
specific	O
stem	B-T082
##ness	I-T082
markers	I-T082
such	O
as	O
cd133	B-T103
,	O
cd15	B-T103
,	O
oct4	B-T103
,	O
and	O
sox2	B-T103
;	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
is	O
upregulated	O
compared	O
to	O
monolayer	B-T058
culture	I-T058
and	O
co	O
-	O
localizes	O
with	O
cd133	B-T103
.	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
silencing	B-T038
downreg	O
##ulates	O
the	O
expression	B-T038
of	I-T038
molecules	I-T038
associated	O
with	O
cancer	B-T017
stem	I-T017
cells	I-T017
,	O
upreg	O
##ulates	O
markers	B-T082
of	O
cell	B-T038
differentiation	I-T038
and	O
affects	O
gs	B-T017
##c	I-T017
self	B-T038
-	I-T038
renewal	I-T038
,	O
pointing	O
to	O
a	O
pivotal	O
role	O
for	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
in	O
the	O
maintenance	O
of	O
gs	B-T017
##cs	I-T017
.	O
exogenous	O
hop	B-T103
treatment	O
increases	O
proliferation	B-T038
and	O
self	B-T038
-	I-T038
renewal	I-T038
of	O
gs	B-T017
##cs	I-T017
in	O
a	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
-	O
dependent	O
manner	O
while	O
hop	B-T103
knockdown	O
disturb	O
##s	O
the	O
proliferation	B-T038
process	I-T038
.	O
in	B-T082
vivo	I-T082
,	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
and	O
/	O
or	O
hop	B-T103
knockdown	O
potently	O
inhibits	O
the	O
growth	B-T038
of	O
subcutaneously	O
implanted	O
glioblastoma	B-T038
cells	B-T017
.	O
in	O
addition	O
,	O
disruption	O
of	O
the	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
-	I-T103
hop	B-T103
complex	I-T103
by	O
a	O
hop	B-T103
peptide	B-T103
,	O
which	O
mimics	O
the	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
binding	B-T103
site	I-T103
,	O
affects	O
gs	B-T017
##c	I-T017
self	B-T038
-	I-T038
renewal	I-T038
and	O
proliferation	B-T038
indicating	O
that	O
the	O
hop	B-T103
-	I-T103
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
complex	I-T103
is	O
required	O
for	O
gs	B-T017
##c	I-T017
stem	O
##ness	O
.	O
furthermore	O
,	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
-	O
depleted	O
gs	B-T017
##cs	I-T017
downreg	O
##ulate	O
cell	B-T017
adhesion	B-T103
-	I-T103
related	I-T103
proteins	I-T103
and	O
impair	O
cell	B-T038
migration	I-T038
indicating	O
a	O
putative	O
role	O
for	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
in	O
the	O
cell	B-T033
surface	I-T033
stability	I-T033
of	O
cell	B-T103
adhesion	I-T103
molecules	I-T103
and	O
gbm	B-T038
cell	O
invasiveness	B-T038
,	O
respectively	O
.	O
in	O
conclusion	O
,	O
our	O
results	O
show	O
that	O
the	O
modulation	O
of	O
hop	B-T103
-	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
engagement	O
or	O
the	O
decrease	O
of	O
prp	B-T103
(	I-T103
c	I-T103
)	I-T103
and	O
hop	B-T103
expression	B-T038
may	O
represent	O
a	O
potential	O
therapeutic	B-T058
intervention	I-T058
in	O
gbm	B-T038
,	O
regulating	O
glioblastoma	B-T017
stem	I-T017
-	I-T017
like	I-T017
cell	I-T017
self	B-T038
-	I-T038
renewal	I-T038
,	O
proliferation	B-T038
,	O
and	O
migration	B-T038
.	O

bone	O
degeneration	O
and	O
its	O
recovery	O
in	O
sm	B-T017
##p3	I-T017
##0	I-T017
/	I-T017
gn	I-T017
##l	I-T017
-	O
knockout	B-T204
mice	I-T204
senescence	B-T103
marker	I-T103
protein	I-T103
-	I-T103
30	I-T103
(	O
sm	B-T103
##p3	I-T103
##0	I-T103
)	O
decreases	O
androgen	B-T103
-	O
independently	O
with	O
aging	B-T038
and	O
is	O
a	O
lactone	B-T103
-	O
hydroly	B-T103
##zing	I-T103
enzyme	I-T103
gluc	B-T103
##onol	I-T103
##act	I-T103
##onas	I-T103
##e	I-T103
(	O
gn	B-T103
##l	I-T103
)	O
that	O
is	O
involved	O
in	O
vitamin	B-T103
c	I-T103
biosynthesis	O
.	O
in	O
the	O
present	O
study	B-T062
,	O
bone	B-T017
properties	O
of	O
sm	B-T017
##p3	I-T017
##0	I-T017
/	I-T017
gn	I-T017
##l	I-T017
knockout	B-T204
(	I-T204
ko	I-T204
)	I-T204
mice	I-T204
with	O
deficiency	O
in	O
vitamin	B-T103
c	I-T103
synthesis	O
were	O
investigated	O
to	O
reveal	O
the	O
effects	O
of	O
sm	B-T103
##p3	I-T103
##0	I-T103
/	I-T103
gn	I-T103
##l	I-T103
and	O
exogenous	O
vitamin	B-T103
c	I-T103
supplementation	B-T103
on	O
bone	B-T038
formation	I-T038
.	O
mineral	O
content	O
(	O
bmc	O
)	O
and	O
mineral	B-T201
density	I-T201
(	O
bmd	B-T201
)	O
of	O
the	O
mandible	B-T017
and	O
femur	B-T017
of	O
sm	B-T017
##p3	I-T017
##0	I-T017
/	I-T017
gn	I-T017
##l	I-T017
ko	B-T204
and	O
wild	B-T204
-	I-T204
type	I-T204
mice	I-T204
at	O
2	O
and	O
3	O
months	O
of	O
age	O
with	O
or	O
without	O
vitamin	B-T103
c	I-T103
supplementation	B-T103
were	O
measured	O
by	O
dual	B-T058
-	I-T058
energy	I-T058
x	I-T058
-	I-T058
ray	I-T058
absorptiometry	I-T058
.	O
body	O
and	O
bone	B-T017
weight	O
of	O
both	O
age	O
groups	O
decreased	O
and	O
became	O
significantly	O
lower	O
than	O
those	O
of	O
wild	B-T204
-	I-T204
type	I-T204
mice	I-T204
.	O
the	O
bones	B-T017
of	O
sm	B-T017
##p3	I-T017
##0	I-T017
/	I-T017
gn	I-T017
##l	I-T017
ko	B-T204
mice	I-T204
were	O
rough	O
and	O
porous	O
,	O
with	O
bmc	O
and	O
bmd	B-T201
significantly	O
below	O
wild	B-T204
-	I-T204
type	I-T204
.	O
oral	B-T082
supplementation	B-T103
with	O
vitamin	B-T103
c	I-T103
eliminated	O
differences	O
in	O
body	O
weight	O
,	O
bone	B-T017
weight	O
,	O
bmc	O
,	O
and	O
bmd	B-T201
between	O
sm	B-T017
##p3	I-T017
##0	I-T017
/	I-T017
gn	I-T017
##l	I-T017
ko	B-T204
and	O
wild	B-T204
-	I-T204
type	I-T204
mice	I-T204
at	O
each	O
age	O
.	O
these	O
results	O
indicate	O
that	O
bone	O
degeneration	O
in	O
sm	B-T017
##p3	I-T017
##0	I-T017
/	I-T017
gn	I-T017
##l	I-T017
ko	B-T204
mice	I-T204
was	O
caused	O
by	O
lack	O
of	O
vitamin	B-T103
c	I-T103
,	O
and	O
that	O
this	O
mouse	B-T204
strain	I-T204
is	O
an	O
appropriate	O
model	B-T204
for	O
bone	O
metabolism	O
in	O
humans	B-T204
,	O
which	O
have	O
no	O
ability	O
to	O
synthesize	O
vitamin	B-T103
c	I-T103
.	O

spermat	B-T038
##ocytic	I-T038
tumor	I-T038
with	O
sarcoma	B-T038
:	O
a	O
rare	O
testicular	B-T038
neoplasm	I-T038
spermat	B-T038
##ocytic	I-T038
tumor	I-T038
,	O
formerly	O
known	O
as	O
spermat	B-T038
##ocytic	I-T038
semin	I-T038
##oma	I-T038
,	O
is	O
an	O
uncommon	O
testicular	B-T038
neoplasm	I-T038
which	O
is	O
a	O
distinct	O
clinicopathologic	O
entity	O
from	O
classic	O
semin	B-T038
##oma	I-T038
.	O
these	O
tumors	B-T038
are	O
not	O
associated	O
with	O
germ	B-T038
cell	I-T038
neoplasia	I-T038
in	O
situ	O
,	O
other	O
germ	B-T038
cell	I-T038
tumors	I-T038
,	O
or	O
isoc	B-T038
##hr	I-T038
##om	I-T038
##osome	I-T038
12p	I-T038
.	O
although	O
typically	O
,	O
these	O
tumors	B-T038
have	O
an	O
excellent	O
prognosis	B-T058
occasional	O
cases	O
are	O
associated	O
with	O
sarcoma	B-T038
and	O
have	O
a	O
very	B-T033
poor	I-T033
prognosis	I-T033
.	O
we	O
present	O
a	O
case	O
of	O
spermat	B-T038
##ocytic	I-T038
tumor	I-T038
with	O
sarcoma	B-T038
showing	O
a	O
chondros	B-T038
##arcoma	I-T038
##to	I-T038
##us	I-T038
component	I-T038
,	O
discuss	O
the	O
pathologic	O
findings	O
and	O
differential	B-T058
diagnosis	I-T058
and	O
provide	O
follow	B-T058
-	I-T058
up	I-T058
information	O
.	O

extended	O
release	O
of	O
flu	B-T103
##rb	I-T103
##ipr	I-T103
##ofen	I-T103
from	O
tro	B-T103
##meth	I-T103
##amine	I-T103
-	O
buffered	B-T103
hp	B-T103
##mc	I-T103
hydrophilic	O
matrix	B-T103
tablets	I-T103
the	O
ph	O
-	O
dependent	O
solubility	O
of	O
a	O
drug	B-T103
can	O
lead	O
to	O
ph	O
-	O
dependent	O
drug	O
release	O
from	O
hydrophilic	O
matrix	B-T103
tablets	I-T103
.	O
adding	O
buffer	O
salts	O
to	O
the	O
formulation	B-T103
to	O
attempt	O
to	O
mitigate	O
this	O
can	O
impair	O
matrix	O
hydration	O
and	O
negatively	B-T033
impact	O
drug	O
release	O
.	O
an	O
evaluation	B-T058
of	O
the	O
buffering	B-T103
of	O
hydrophilic	O
matrix	B-T103
tablets	I-T103
containing	O
a	O
ph	O
-	O
dependent	O
solubility	O
weak	B-T103
acid	I-T103
drug	I-T103
(	O
flu	B-T103
##rb	I-T103
##ipr	I-T103
##ofen	I-T103
)	O
,	O
identified	O
as	O
possessing	O
a	O
deleterious	O
effect	O
on	O
hydroxypropyl	B-T103
methyl	I-T103
##cellulose	I-T103
(	O
hp	B-T103
##mc	I-T103
)	O
solubility	O
,	O
swelling	O
and	O
gelation	O
,	O
with	O
respect	O
to	O
drug	O
dissolution	O
and	O
the	O
characteristics	O
of	O
the	O
hydrophilic	O
matrix	B-T103
gel	I-T103
layer	I-T103
in	O
the	O
presence	O
of	O
tro	B-T103
##meth	I-T103
##amine	I-T103
as	O
a	O
buffer	B-T103
was	O
undertaken	O
.	O
the	O
inclusion	O
of	O
tro	B-T103
##meth	I-T103
##amine	I-T103
as	O
an	O
alkali	B-T103
##zing	I-T103
agent	I-T103
afforded	O
ph	O
-	O
independent	O
flu	B-T103
##rb	I-T103
##ipr	I-T103
##ofen	I-T103
release	O
from	O
matrices	O
based	O
on	O
both	O
hp	B-T103
##mc	I-T103
291	I-T103
##0	I-T103
(	I-T103
e	I-T103
series	I-T103
)	I-T103
and	O
220	B-T103
##8	I-T103
(	I-T103
k	I-T103
series	I-T103
)	I-T103
,	O
while	O
concomitantly	O
decreasing	B-T033
the	O
apparent	O
critical	O
effect	O
on	O
dissolution	O
mediated	O
by	O
this	O
drug	B-T103
with	O
respect	O
to	O
the	O
early	O
pseudo	O
-	O
gel	O
layer	O
formation	O
and	O
functionality	O
.	O
drug	O
release	O
profiles	O
were	O
unaffected	O
by	O
matrix	O
ph	B-T033
-	I-T033
changes	I-T033
resulting	O
from	O
loss	O
of	O
tro	B-T103
##meth	I-T103
##amine	I-T103
over	O
time	O
,	O
suggesting	O
that	O
hp	B-T103
##mc	I-T103
inhibited	O
precipitation	O
of	O
drug	B-T103
from	O
supers	O
##aturated	O
solution	O
in	O
the	O
hydrated	O
matrix	O
.	O
we	O
propose	O
that	O
facilitation	B-T038
of	O
diffusion	O
-	O
based	O
release	O
of	O
potentially	O
deleterious	B-T103
drugs	I-T103
in	O
hydrophilic	O
matrices	O
may	O
be	O
achieved	O
through	O
jud	O
##icious	O
selection	O
of	O
a	O
buffering	B-T103
species	I-T103
.	O

a	O
wnt	B-T038
pathway	I-T038
activator	B-T103
induces	B-T038
apoptosis	I-T038
and	O
cell	B-T038
death	I-T038
in	O
mouse	B-T038
monocytic	I-T038
leukemia	I-T038
cells	B-T017
a	O
wnt	B-T103
agonist	I-T103
,	I-T103
2	B-T103
-	I-T103
amino	I-T103
-	I-T103
4	I-T103
-	I-T103
[	I-T103
3	I-T103
,	I-T103
4	I-T103
-	I-T103
(	I-T103
methylene	I-T103
##di	I-T103
##oxy	I-T103
)	I-T103
benzyl	I-T103
##amino	I-T103
]	I-T103
-	I-T103
6	I-T103
-	I-T103
(	I-T103
3	I-T103
-	I-T103
methoxy	I-T103
##phenyl	I-T103
)	I-T103
pyrimidine	I-T103
,	O
is	O
a	O
cell	B-T038
-	I-T038
permeable	I-T038
pyrimidine	B-T103
compound	I-T103
that	O
has	O
been	O
shown	O
to	O
mimic	O
the	O
effect	O
of	O
wnt	B-T103
.	O
in	O
this	O
study	O
,	O
leukemic	B-T017
mouse	I-T017
cell	I-T017
lines	I-T017
,	O
raw	B-T017
264	I-T017
.	I-T017
7	I-T017
and	O
j	B-T017
##77	I-T017
##4	I-T017
.	I-T017
1	I-T017
,	O
were	O
incubated	O
with	O
the	O
wnt	B-T103
agonist	I-T103
.	O
the	O
wnt	B-T103
agonist	I-T103
showed	O
cell	B-T038
death	I-T038
in	O
the	O
concentration	O
of	O
1	O
-	O
10	O
μm	O
.	O
the	O
wnt	B-T103
agonist	I-T103
did	O
not	O
show	O
inhibition	O
of	O
gsk	B-T103
-	I-T103
3β	I-T103
activity	B-T038
but	O
induced	O
β	B-T038
-	I-T038
catenin	I-T038
accumulation	I-T038
in	O
the	O
nucleus	B-T017
.	O
the	O
wnt	B-T103
agonist	I-T103
showed	O
caspase	B-T038
-	I-T038
independent	I-T038
cell	I-T038
death	I-T038
,	O
but	O
no	O
further	O
involvement	O
in	O
cell	B-T038
death	I-T038
er	I-T038
stress	I-T038
signaling	I-T038
.	O
here	O
we	O
discuss	O
the	O
possible	O
mechanism	O
of	O
wnt	B-T103
agonist	I-T103
-	O
induced	B-T038
apoptotic	I-T038
cell	I-T038
death	I-T038
in	O
raw	B-T017
264	I-T017
.	I-T017
7	I-T017
cells	I-T017
.	O

heterogeneous	O
depression	B-T038
trajectories	O
in	O
multiple	B-T038
sclerosis	I-T038
patients	O
trajectories	O
of	O
depression	B-T038
over	O
time	O
may	O
be	O
heterogeneous	O
in	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
patients	O
.	O
describing	O
these	O
trajectories	O
will	O
help	O
clinicians	B-T097
understand	O
better	O
the	O
progression	O
of	O
depression	B-T038
in	O
ms	B-T038
patients	O
to	O
aid	O
in	O
patient	O
care	O
decisions	O
.	O
latent	O
class	O
growth	O
analysis	O
(	O
lc	O
##ga	O
)	O
was	O
applied	O
to	O
350	O
##7	O
ms	B-T038
patients	O
using	O
an	O
electronic	B-T170
health	I-T170
records	I-T170
(	I-T170
ehr	I-T170
)	I-T170
data	I-T170
base	I-T170
to	O
identify	O
subgroups	B-T098
of	O
ms	B-T038
patients	O
based	O
on	O
self	O
-	O
reported	O
depression	B-T058
screening	I-T058
(	O
ph	O
##q	O
-	O
9	O
)	O
.	O
latent	O
trajectory	O
classes	O
were	O
used	O
for	O
group	B-T098
comparisons	O
based	O
on	O
baseline	O
clinical	O
characteristics	O
.	O
three	O
subgroups	B-T098
were	O
found	O
characterized	O
by	O
high	O
(	O
10	O
.	O
0	O
%	O
[	O
of	O
participants	B-T098
]	O
)	O
,	O
wave	O
##ring	O
above	O
and	O
below	O
moderate	O
(	O
26	O
.	O
2	O
%	O
)	O
and	O
low	O
and	O
variable	O
(	O
63	O
.	O
8	O
%	O
)	O
depression	B-T033
level	I-T033
trajectories	O
.	O
the	O
subpopulation	B-T098
trajectories	O
,	O
respectively	O
,	O
were	O
also	O
characterized	O
by	O
high	O
,	O
moderate	O
and	O
low	O
ms	B-T038
disability	B-T033
at	O
baseline	O
.	O
in	O
contrast	O
,	O
the	O
overall	O
average	O
trajectory	O
was	O
slightly	O
declining	O
and	O
below	O
the	O
moderate	O
depression	B-T038
threshold	O
.	O
the	O
lc	O
##ga	O
approach	O
described	O
in	O
this	O
paper	O
and	O
applied	O
to	O
ms	B-T038
patients	O
provides	O
a	O
template	O
for	O
improved	O
use	O
of	O
an	O
ehr	B-T170
data	I-T170
base	I-T170
for	O
understanding	O
heterogeneous	O
depression	B-T058
screening	I-T058
trajectories	O
.	O
clinicians	B-T097
may	O
use	O
such	O
information	O
to	O
more	O
closely	O
monitor	B-T058
patients	I-T058
that	O
are	O
expected	O
to	O
maintain	O
high	O
or	O
unstable	B-T033
depression	B-T033
levels	I-T033
.	O

angiotensin	B-T033
-	I-T033
converting	I-T033
enzyme	I-T033
insertion	I-T033
/	I-T033
deletion	I-T033
polymorphism	I-T033
association	O
with	O
obesity	B-T038
and	O
some	O
related	O
disorders	B-T038
in	O
egypt	B-T098
##ian	I-T098
females	O
:	O
a	O
case	B-T062
-	I-T062
control	I-T062
observational	I-T062
study	I-T062
according	O
to	O
the	O
who	B-T092
report	B-T170
in	O
2015	O
,	O
obesity	B-T038
is	O
the	O
fifth	O
leading	O
cause	B-T033
of	I-T033
death	I-T033
worldwide	O
,	O
and	O
the	O
prevalence	O
of	O
egypt	B-T098
##ian	I-T098
female	B-T098
obesity	B-T038
is	O
37	O
.	O
5	O
%	O
.	O
since	O
obesity	B-T038
is	O
highly	O
influenced	O
by	O
genetics	O
,	O
and	O
adipose	B-T017
tissue	I-T017
renin	B-T022
-	I-T022
angiotensin	I-T022
system	I-T022
is	O
over	O
-	O
activated	O
in	O
obesity	B-T038
,	O
the	O
effect	O
of	O
angiotensin	B-T033
-	I-T033
converting	I-T033
enzyme	I-T033
(	I-T033
ace	I-T033
)	I-T033
insertion	I-T033
/	I-T033
deletion	I-T033
(	I-T033
i	I-T033
/	I-T033
d	I-T033
)	I-T033
polymorphism	I-T033
on	O
obesity	B-T038
and	O
related	O
disorders	B-T038
was	O
studied	O
in	O
several	O
populations	B-T098
,	O
because	O
of	O
its	O
effect	O
on	O
ace	B-T038
activity	I-T038
.	O
our	O
objective	B-T170
was	O
to	O
study	B-T062
the	O
association	O
of	O
ace	B-T033
i	I-T033
/	I-T033
d	I-T033
polymorphism	I-T033
with	O
obesity	B-T038
and	O
certain	O
related	O
disorders	B-T038
,	O
namely	O
hypertension	B-T038
,	O
insulin	B-T038
resistance	I-T038
and	O
metabolic	B-T038
syndrome	I-T038
,	O
in	O
egypt	B-T098
##ian	I-T098
females	O
.	O
eighty	O
female	B-T098
volunteers	B-T098
were	O
recruited	O
,	O
blood	B-T058
pressure	I-T058
and	O
body	B-T058
measurements	I-T058
were	O
recorded	O
and	O
a	O
fasting	B-T033
blood	B-T031
sample	I-T031
was	O
obtained	O
for	O
the	O
quantitation	O
of	O
glucose	B-T103
,	O
lipid	B-T058
profile	I-T058
,	O
insulin	B-T103
,	I-T103
leptin	B-T103
and	O
identification	O
of	O
ace	B-T033
i	I-T033
/	I-T033
d	I-T033
polymorph	I-T033
##s	I-T033
.	O
subjects	B-T098
were	O
grouped	O
based	O
on	O
hypertension	B-T038
and	O
obesity	O
states	O
.	O
comparisons	O
of	O
continuous	O
parameters	B-T033
were	O
made	O
with	O
independent	O
sample	B-T170
t	I-T170
-	I-T170
test	I-T170
between	O
two	O
groups	O
.	O
the	O
frequencies	O
of	O
ace	B-T103
genotypes	O
and	O
alleles	B-T017
,	O
and	O
the	O
association	O
between	O
gene	O
polymorphism	O
and	O
metabolic	O
parameters	B-T033
were	O
assessed	O
using	O
chi	B-T170
-	I-T170
square	I-T170
or	O
fisher	B-T170
'	I-T170
s	I-T170
exact	I-T170
test	I-T170
.	O
genotype	O
frequencies	O
were	O
in	O
hard	O
##y	O
-	O
we	O
##in	O
##berg	O
equilibrium	O
for	O
all	O
groups	O
.	O
genotype	O
distribution	O
did	O
not	O
differ	O
significantly	O
between	O
controls	O
and	O
cases	O
of	O
all	O
the	O
studied	O
disorders	B-T038
.	O
although	O
dd	B-T033
carriers	I-T033
had	O
apparently	O
higher	O
parameters	B-T033
of	O
blood	B-T038
pressure	I-T038
,	O
lipid	B-T058
profile	I-T058
and	O
insulin	B-T038
resistance	I-T038
,	O
only	O
diastolic	B-T201
blood	I-T201
pressure	I-T201
was	O
almost	O
significant	O
(	O
p	O
=	O
0	O
.	O
05	O
##7	O
)	O
.	O
i	B-T033
-	I-T033
carriers	I-T033
were	O
significantly	O
less	O
susceptible	O
to	O
hypertension	B-T038
than	O
dd	B-T033
carriers	I-T033
having	O
normal	O
waist	O
/	O
hip	O
ratio	O
(	O
p	O
=	O
0	O
.	O
007	O
,	O
or	O
=	O
17	O
.	O
29	O
,	O
ci	O
=	O
1	O
.	O
81	O
-	O
164	O
.	O
96	O
)	O
and	O
normal	O
con	O
##icity	O
index	O
(	O
p	O
=	O
0	O
.	O
024	O
,	O
or	O
=	O
7	O
.	O
00	O
,	O
ci	O
=	O
1	O
.	O
36	O
-	O
35	O
.	O
93	O
)	O
.	O
in	O
dd	B-T033
genotype	I-T033
carriers	I-T033
,	O
a	O
significant	O
association	O
was	O
found	O
between	O
insulin	B-T038
resistance	I-T038
and	O
high	B-T033
body	I-T033
mass	I-T033
index	I-T033
(	O
p	O
=	O
0	O
.	O
004	O
,	O
or	O
=	O
8	O
.	O
89	O
,	O
ci	O
=	O
1	O
.	O
94	O
-	O
40	O
.	O
71	O
)	O
,	O
waist	B-T201
circumference	I-T201
(	O
p	O
=	O
0	O
.	O
003	O
,	O
or	O
=	O
9	O
.	O
63	O
,	O
ci	O
=	O
2	O
.	O
14	O
-	O
43	O
.	O
36	O
)	O
and	O
waist	B-T033
/	I-T033
height	I-T033
ratio	I-T033
(	O
p	O
=	O
0	O
.	O
034	O
,	O
or	O
=	O
6	O
.	O
86	O
,	O
ci	O
=	O
1	O
.	O
25	O
-	O
37	O
.	O
61	O
)	O
,	O
although	O
the	O
variations	O
in	O
percentages	O
between	O
dd	B-T033
and	O
i	B-T033
-	I-T033
carriers	I-T033
were	O
not	O
high	O
enough	O
to	O
conclude	O
an	O
effect	O
of	O
ace	B-T033
i	I-T033
/	I-T033
d	I-T033
on	O
such	O
an	O
association	O
.	O
in	O
this	O
sample	O
of	O
egypt	B-T098
##ian	I-T098
females	O
,	O
ace	B-T033
i	I-T033
/	I-T033
d	I-T033
polymorphism	I-T033
was	O
not	B-T033
significantly	I-T033
associated	O
with	O
obesity	B-T038
nor	O
with	O
any	O
of	O
its	O
related	O
disorders	B-T038
studied	O
.	O
the	O
i	B-T017
allele	I-T017
seemed	O
protective	O
against	O
hypertension	B-T038
in	O
subjects	B-T098
with	O
normal	O
,	O
not	O
high	O
,	O
waist	O
/	O
hip	O
ratio	O
and	O
con	O
##icity	O
index	O
compared	O
to	O
dd	B-T033
genotype	I-T033
carriers	I-T033
.	O

direct	O
effects	O
of	O
glucose	B-T103
,	O
insulin	B-T103
,	O
glp	B-T103
-	I-T103
1	I-T103
,	O
and	O
gip	B-T103
on	O
bulb	B-T082
##ospinal	I-T082
neurons	B-T017
in	O
the	O
rostral	B-T017
ventrolateral	I-T017
medulla	I-T017
in	O
neonatal	O
wistar	B-T204
rats	I-T204
although	O
patients	O
with	O
diabetes	B-T038
mellitus	I-T038
(	O
dm	B-T038
)	O
often	O
exhibit	O
hypertension	B-T038
,	O
the	O
mechanisms	O
responsible	O
for	O
this	O
correlation	O
are	O
not	O
well	O
known	O
.	O
we	O
hypothesized	O
that	O
the	O
bulb	B-T082
##ospinal	I-T082
neurons	B-T017
in	O
the	O
rostral	B-T017
ventrolateral	I-T017
medulla	I-T017
(	O
rv	B-T017
##lm	I-T017
)	O
are	O
affected	O
by	O
the	O
levels	O
of	O
glucose	B-T103
,	O
insulin	B-T103
,	O
or	O
incre	B-T103
##tins	I-T103
(	O
glucagon	B-T103
like	I-T103
peptide	I-T103
-	I-T103
1	I-T103
[	O
glp	B-T103
-	I-T103
1	I-T103
]	O
or	O
glucose	B-T103
-	I-T103
dependent	I-T103
insulin	I-T103
##otropic	I-T103
peptide	I-T103
[	O
gip	B-T103
]	O
)	O
in	O
patients	O
with	O
dm	B-T038
.	O
to	O
investigate	O
whether	O
rv	B-T017
##lm	I-T017
neurons	B-T017
are	O
activated	O
by	O
glucose	B-T103
,	O
insulin	B-T103
,	O
glp	B-T103
-	I-T103
1	I-T103
,	O
or	O
gip	B-T103
,	O
we	O
examined	O
changes	O
in	O
the	O
membrane	B-T038
potentials	I-T038
of	O
bulb	B-T082
##ospinal	I-T082
rv	B-T017
##lm	I-T017
neurons	B-T017
using	O
whole	B-T017
-	I-T017
cell	I-T017
patch	B-T062
-	I-T062
clamp	I-T062
technique	I-T062
during	O
superf	O
##usion	O
with	O
various	O
levels	O
of	O
glucose	B-T103
or	O
these	O
hormones	B-T103
in	O
neonatal	O
wistar	B-T204
rats	I-T204
.	O
a	O
brainstem	B-T017
-	O
spinal	B-T017
cord	I-T017
preparation	O
was	O
used	O
for	O
the	O
experiments	B-T062
.	O
a	O
low	O
level	O
of	O
glucose	B-T103
stimulated	O
bulb	B-T082
##ospinal	I-T082
rv	B-T017
##lm	I-T017
neurons	B-T017
.	O
during	O
insulin	B-T103
superf	O
##usion	O
,	O
almost	O
all	O
the	O
rv	B-T017
##lm	I-T017
neurons	B-T017
were	O
depolarized	B-T038
,	O
while	O
during	O
glp	B-T103
-	I-T103
1	I-T103
or	O
gip	B-T103
superf	O
##usion	O
,	O
almost	O
all	O
the	O
rv	B-T017
##lm	I-T017
neurons	B-T017
were	O
hyperpolar	B-T038
##ized	I-T038
.	O
next	O
,	O
histological	B-T058
examinations	I-T058
were	O
performed	O
to	O
examine	O
transporters	B-T103
for	I-T103
glucose	I-T103
and	O
receptors	B-T103
for	O
insulin	B-T103
,	O
glp	B-T103
-	I-T103
1	I-T103
,	O
and	O
gip	B-T103
on	O
rv	B-T017
##lm	I-T017
neurons	B-T017
.	O
low	O
-	O
level	O
glucose	B-T103
-	O
depolarized	B-T038
rv	B-T017
##lm	I-T017
neurons	B-T017
exhibited	O
the	O
presence	O
of	O
glucose	B-T103
transporter	I-T103
3	I-T103
(	O
glut	B-T103
##3	I-T103
)	O
.	O
meanwhile	O
,	O
insulin	B-T103
-	O
depolarized	B-T038
,	O
glp	B-T103
-	I-T103
1	I-T103
-	O
hyperpolar	B-T038
##ized	I-T038
,	O
and	O
gip	B-T103
-	O
hyperpolar	B-T038
##ized	I-T038
rv	B-T017
##lm	I-T017
neurons	B-T017
showed	O
each	O
of	O
the	O
respective	O
specific	O
receptor	B-T103
.	O
these	O
results	O
indicate	O
that	O
a	O
low	O
level	O
of	O
glucose	B-T103
stimulates	O
bulb	B-T082
##ospinal	I-T082
rv	B-T017
##lm	I-T017
neurons	B-T017
via	O
specific	O
transporters	B-T103
on	O
these	O
neurons	B-T017
,	O
inducing	O
hypertension	B-T038
.	O
furthermore	O
,	O
an	O
increase	O
in	O
insulin	B-T103
or	O
a	O
reduction	O
in	O
incre	B-T103
##tins	I-T103
may	O
also	O
activate	O
the	O
sympathetic	B-T022
nervous	I-T022
system	I-T022
and	O
induce	O
hypertension	B-T038
by	O
activating	O
rv	B-T017
##lm	I-T017
neurons	B-T017
via	O
their	O
own	O
receptors	B-T103
.	O

influence	O
of	O
different	O
levels	O
of	O
lipo	B-T017
##ic	I-T017
acid	I-T017
synthase	I-T017
gene	B-T038
expression	I-T038
on	O
diabetic	B-T038
nephropathy	I-T038
oxidative	B-T038
stress	I-T038
is	O
implicated	O
in	O
the	O
pathogenesis	B-T038
of	O
diabetic	B-T038
nephropathy	I-T038
(	O
dn	B-T038
)	O
but	O
outcomes	O
of	O
many	O
clinical	B-T062
trials	I-T062
are	O
controversial	O
.	O
to	O
define	O
the	O
role	O
of	O
antioxidants	B-T103
in	O
kidney	B-T017
protection	O
during	O
the	O
development	O
of	O
diabetic	B-T038
nephropathy	I-T038
,	O
we	O
have	O
generated	O
a	O
novel	O
genetic	B-T038
antioxidant	I-T038
mouse	I-T038
model	I-T038
with	O
over	B-T038
-	I-T038
or	I-T038
under	I-T038
-	I-T038
expression	I-T038
of	O
lipo	B-T017
##ic	I-T017
acid	I-T017
synthase	I-T017
gene	I-T017
(	O
lia	B-T017
##s	I-T017
)	O
.	O
these	O
models	B-T038
have	O
been	O
mated	B-T038
with	O
ins	B-T204
##2a	I-T204
##ki	I-T204
##ta	I-T204
/	I-T204
+	I-T204
mice	I-T204
,	O
a	O
type	B-T038
i	I-T038
diabetic	I-T038
mouse	B-T038
model	I-T038
.	O
we	O
compare	O
the	O
major	O
pathologic	B-T033
changes	I-T033
and	O
oxidative	B-T038
stress	I-T038
status	O
in	O
two	O
new	O
strains	O
of	O
the	O
mice	B-T204
with	O
controls	O
.	O
our	O
results	O
show	O
that	O
ins	B-T204
##2a	I-T204
##ki	I-T204
##ta	I-T204
/	I-T204
+	I-T204
mice	I-T204
with	O
under	B-T038
-	I-T038
expressed	I-T038
lia	B-T017
##s	I-T017
gene	I-T017
,	O
exhibit	O
higher	O
oxidative	B-T038
stress	I-T038
and	O
more	O
severe	O
dn	B-T038
features	O
(	O
albuminuria	B-T033
,	O
glomerular	B-T033
basement	I-T033
membrane	I-T033
thickening	I-T033
and	O
mesangial	B-T033
matrix	I-T033
expansion	I-T033
)	O
.	O
in	O
contrast	O
,	O
ins	B-T204
##2a	I-T204
##ki	I-T204
##ta	I-T204
/	I-T204
+	I-T204
mice	I-T204
with	O
highly	O
-	O
expressed	B-T038
lia	B-T017
##s	I-T017
gene	I-T017
display	O
lower	O
oxidative	B-T038
stress	I-T038
and	O
less	O
dn	B-T038
pathologic	B-T033
changes	I-T033
.	O
our	O
study	B-T062
demonstrates	O
that	O
strengthening	O
endogenous	O
antioxidant	B-T103
capacity	O
could	O
be	O
an	O
effective	O
strategy	O
for	O
prevention	O
and	O
treatment	O
of	O
dn	B-T038
.	O

melatonin	B-T103
and	O
nitric	B-T103
oxide	I-T103
regulate	B-T038
sunflower	B-T204
seedling	B-T038
growth	I-T038
under	O
salt	B-T038
stress	I-T038
accompanying	O
differential	O
expression	B-T038
of	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
and	O
mn	B-T103
sod	I-T103
salinity	B-T038
results	I-T038
in	O
significant	O
reduction	O
in	O
sunflower	B-T204
(	O
hel	B-T204
##iant	I-T204
##hu	I-T204
##s	I-T204
ann	I-T204
##u	I-T204
##us	I-T204
l	I-T204
.	I-T204
)	O
seedling	B-T038
growth	I-T038
and	O
excessive	O
generation	O
of	O
reactive	B-T103
oxygen	I-T103
species	I-T103
(	O
ros	B-T103
)	O
.	O
present	O
work	O
highlights	O
the	O
possible	O
role	O
of	O
melatonin	B-T103
as	O
an	O
antioxidant	B-T103
through	O
its	O
interaction	O
with	O
nitric	B-T103
oxide	I-T103
(	O
no	B-T103
)	O
,	O
and	O
as	O
an	O
early	O
and	O
long	O
distance	O
nacl	B-T038
-	I-T038
stress	I-T038
sensing	O
signaling	B-T103
molecule	I-T103
in	O
seedling	B-T204
cotyled	B-T204
##ons	I-T204
.	O
exogenous	O
melatonin	B-T103
(	O
15	O
##µ	O
##m	O
)	O
±	O
nacl	B-T103
(	O
120	O
##mm	O
)	O
inhibit	O
seedling	B-T038
growth	I-T038
,	O
which	O
is	O
also	O
correlated	O
with	O
no	B-T103
availability	O
,	O
accumulation	O
of	O
potential	B-T103
superoxide	I-T103
anion	I-T103
(	O
o2	B-T103
(	I-T103
•	I-T103
-	I-T103
)	I-T103
)	O
and	O
peroxynitrite	B-T103
anion	I-T103
(	O
on	B-T103
##oo	I-T103
(	I-T103
-	I-T103
)	I-T103
)	O
,	O
extent	O
of	O
tyrosine	B-T038
-	I-T038
nitr	I-T038
##ation	I-T038
of	O
proteins	B-T103
,	O
spatial	O
localization	O
and	O
activity	B-T038
of	I-T038
superoxide	I-T038
dismutase	I-T038
(	O
sod	B-T103
)	O
isoforms	B-T103
.	O
no	B-T103
acts	O
as	O
a	O
positive	O
modulator	O
of	O
melatonin	B-T103
accumulation	O
in	O
seedling	B-T204
cotyled	B-T204
##ons	I-T204
as	O
a	O
long	B-T038
-	I-T038
distance	I-T038
signaling	I-T038
response	I-T038
.	O
modulation	B-T038
of	I-T038
superoxide	I-T038
anion	I-T038
and	O
peroxynitrite	B-T103
anion	I-T103
content	O
by	O
melatonin	B-T103
highlights	O
its	O
crucial	O
role	O
in	O
combat	O
##ing	O
deleterious	O
effects	O
of	O
ros	B-T103
and	O
reactive	B-T103
nitrogen	I-T103
species	I-T103
(	O
rns	O
)	O
.	O
present	O
findings	O
provide	O
evidence	O
for	O
an	O
interaction	O
between	O
melatonin	B-T103
and	O
no	B-T103
in	O
their	O
effect	O
on	O
seedling	B-T038
growth	I-T038
under	O
salt	B-T038
stress	I-T038
accompanying	I-T038
differential	O
modulation	O
of	O
two	O
sod	B-T103
isoforms	B-T103
,	O
i	O
.	O
e	O
.	O
cu	B-T103
/	I-T103
zn	I-T103
sod	I-T103
and	O
mn	B-T103
sod	I-T103
.	O

methylation	B-T038
status	O
of	O
the	O
promoter	B-T103
region	I-T103
of	O
the	O
human	B-T204
fri	B-T017
##zz	I-T017
##led	I-T017
9	I-T017
gene	I-T017
in	O
acute	B-T038
myeloid	I-T038
leukemia	I-T038
the	O
fz	B-T017
##d	I-T017
##9	I-T017
gene	I-T017
is	O
located	O
at	O
chromosome	O
7	O
##q11	O
.	O
23	O
,	O
and	O
has	O
been	O
indicated	O
to	O
be	O
a	O
tumor	B-T017
suppressor	I-T017
gene	I-T017
.	O
the	O
present	O
study	B-T062
examined	B-T033
the	O
involvement	O
of	O
fz	B-T017
##d	I-T017
##9	I-T017
promoter	B-T103
methylation	B-T038
in	O
the	O
downregulation	B-T038
of	O
fz	B-T017
##d	I-T017
##9	I-T017
expression	B-T038
in	O
leukemia	B-T038
cells	B-T017
.	O
the	O
expression	B-T038
of	O
the	O
fz	B-T017
##d	I-T017
##9	I-T017
gene	I-T017
was	O
absent	O
in	O
various	O
leukemic	B-T038
cell	B-T017
lines	I-T017
,	O
while	O
it	O
was	O
restored	O
following	O
treatment	O
with	O
dna	B-T103
demethyl	I-T103
##ating	I-T103
agent	I-T103
5	B-T103
-	I-T103
aza	I-T103
-	I-T103
2	I-T103
'	I-T103
-	I-T103
deoxy	I-T103
##cytidine	I-T103
.	O
bis	B-T062
##ulf	I-T062
##ite	I-T062
sequencing	I-T062
analysis	I-T062
of	O
the	O
fz	B-T017
##d	I-T017
##9	I-T017
promoter	B-T103
region	I-T103
showed	O
that	O
it	O
was	O
partially	O
methylated	B-T038
in	O
cell	B-T017
lines	I-T017
in	O
which	O
fz	B-T017
##d	I-T017
##9	I-T017
gene	I-T017
was	O
not	O
expressed	B-T038
.	O
thus	O
,	O
dna	B-T038
methylation	I-T038
in	O
the	O
promoter	B-T103
region	I-T103
may	O
lead	O
to	O
inactivation	O
of	O
the	O
fz	B-T017
##d	I-T017
##9	I-T017
gene	I-T017
,	O
which	O
may	O
represent	O
and	O
aberration	O
associated	O
with	O
leukemia	B-T038
,	O
since	O
dna	B-T103
was	O
not	O
methylated	B-T038
in	O
normal	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
.	O
methylation	B-T038
-	O
specific	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
analysis	I-T062
revealed	O
that	O
the	O
promoter	B-T103
region	I-T103
of	O
the	O
fz	B-T017
##d	I-T017
##9	I-T017
gene	I-T017
was	O
frequently	O
methylated	B-T038
in	O
primary	O
or	O
relapse	O
acute	B-T038
myeloid	I-T038
leukemia	I-T038
(	O
52	O
.	O
9	O
%	O
;	O
excluding	O
acute	B-T038
promyelocytic	I-T038
leukemia	I-T038
)	O
;	O
however	O
,	O
methylation	B-T038
was	O
infrequent	O
in	O
b	B-T017
-	I-T017
cell	I-T017
acute	B-T038
lymphocytic	I-T038
leukemia	I-T038
(	O
5	O
.	O
6	O
%	O
)	O
.	O
in	O
conclusion	O
,	O
the	O
present	O
study	B-T062
indicated	O
that	O
the	O
methylation	B-T038
profile	B-T058
of	O
the	O
fz	B-T017
##d	I-T017
##9	I-T017
gene	I-T017
corresponded	O
to	O
that	O
of	O
a	O
candidate	O
tumor	B-T017
-	I-T017
suppressor	I-T017
gene	I-T017
in	O
acute	B-T038
myeloid	I-T038
leukemia	I-T038
.	O

effect	O
of	O
an	O
immunomodulatory	B-T058
regimen	I-T058
for	O
cancer	B-T058
prevention	I-T058
:	O
a	O
case	B-T170
report	I-T170
in	O
the	O
present	B-T033
case	B-T170
study	I-T170
,	O
an	O
immunomodulatory	B-T058
regimen	I-T058
for	O
cancer	B-T058
prevention	I-T058
is	O
reported	B-T058
.	O
a	O
patient	O
with	O
an	O
abnormally	O
high	O
level	O
of	O
the	O
tumor	B-T103
markers	I-T103
,	O
carbohydrate	B-T103
antigen	I-T103
-	I-T103
72	I-T103
##4	I-T103
(	O
ca	B-T103
##72	I-T103
##4	I-T103
)	O
,	O
ca1	B-T103
##9	I-T103
-	I-T103
9	I-T103
and	O
carcinoembryonic	B-T103
antigen	I-T103
(	O
cea	B-T103
)	O
,	O
although	O
without	O
any	O
detectable	B-T201
tumor	B-T038
,	O
was	O
treated	B-T058
with	I-T058
an	O
immunomodulatory	B-T058
therapy	I-T058
featuring	O
an	O
infusion	B-T058
of	O
cytokine	B-T017
-	I-T017
induced	I-T017
autologous	I-T017
killer	I-T017
cells	I-T017
(	O
ci	B-T017
##ks	I-T017
)	O
at	O
the	O
request	O
of	O
the	O
patient	O
.	O
following	O
the	O
therapy	B-T058
,	O
the	O
three	O
tumor	B-T103
markers	I-T103
rapidly	O
decreased	O
to	O
below	O
the	O
normal	O
reference	O
level	O
,	O
although	O
there	O
still	O
were	O
slight	O
fluctuations	O
within	O
a	O
narrow	O
range	O
frequently	O
.	O
the	O
patient	O
was	O
monitored	B-T058
for	O
21	O
months	O
to	O
the	O
present	B-T033
day	O
and	O
no	B-T033
abnormality	I-T033
was	O
observed	O
.	O
the	O
results	O
indicated	O
that	O
this	O
therapy	B-T058
may	O
be	O
applied	O
as	O
a	O
novel	O
strategy	O
that	O
is	O
effective	O
and	O
reliable	O
for	O
cancer	B-T058
prevention	I-T058
.	O
as	O
there	O
is	O
no	O
promising	O
regimen	B-T058
for	O
the	O
prevention	B-T058
of	I-T058
malignancies	I-T058
to	O
date	O
,	O
such	O
a	O
treatment	B-T058
may	O
become	O
a	O
major	O
cancer	B-T038
prophylactic	B-T058
regimen	I-T058
,	O
particularly	O
for	O
patients	O
who	O
are	O
at	O
a	O
high	B-T033
risk	I-T033
of	I-T033
cancer	B-T038
.	O

selection	O
of	O
an	O
artificial	O
diet	B-T168
for	O
laboratory	B-T092
rearing	O
of	O
op	B-T204
##og	I-T204
##ona	I-T204
sacch	I-T204
##ari	I-T204
(	O
lepid	B-T204
##optera	I-T204
:	O
tin	B-T204
##ei	I-T204
##da	I-T204
##e	I-T204
)	O
(	O
bo	O
##je	O
##r	O
,	O
185	O
##6	O
)	O
the	O
ban	B-T204
##ana	I-T204
moth	I-T204
op	I-T204
##og	I-T204
##ona	I-T204
sacch	I-T204
##ari	I-T204
(	O
bo	B-T204
##je	I-T204
##r	I-T204
)	O
(	O
lepid	B-T204
##optera	I-T204
:	O
tin	B-T204
##ei	I-T204
##da	I-T204
##e	I-T204
)	O
is	O
a	O
polyp	B-T204
##ha	I-T204
##go	I-T204
##us	I-T204
pest	I-T204
that	O
can	O
cause	O
serious	O
damage	O
,	O
in	O
particular	O
to	O
ban	B-T168
##ana	I-T168
crops	B-T204
in	O
southern	B-T082
brazil	B-T082
.	O
the	O
insect	B-T204
is	O
a	O
quar	O
##antine	O
pest	B-T204
in	O
several	O
countries	B-T082
,	O
including	O
argentina	B-T082
,	O
the	O
main	O
consumer	B-T098
market	B-T082
for	O
ban	B-T168
##ana	I-T168
##s	I-T168
from	O
southern	B-T082
brazil	B-T082
.	O
little	O
information	O
is	O
available	O
about	O
the	O
biology	B-T091
and	O
ecology	O
of	O
this	O
moth	B-T204
,	O
such	O
as	O
a	O
suitable	O
diet	B-T168
for	O
laboratory	B-T092
rearing	O
.	O
in	O
order	O
to	O
provide	O
support	O
for	O
integrated	O
pest	O
management	O
of	O
the	O
pest	B-T204
,	O
this	O
study	B-T062
furn	O
##ished	O
data	O
for	O
selecting	O
two	O
diets	B-T168
suitable	O
for	O
continuous	O
laboratory	B-T092
rearing	O
of	O
o	B-T204
.	I-T204
sacch	I-T204
##ari	I-T204
,	O
one	O
based	O
on	O
dried	O
bean	B-T168
##s	I-T168
,	O
wheat	B-T168
germ	I-T168
,	O
soy	B-T168
bran	I-T168
,	O
bre	B-T204
##we	I-T204
##r	I-T204
'	I-T204
s	I-T204
yeast	I-T204
,	O
and	O
casein	B-T103
and	O
another	O
diet	B-T168
with	O
wheat	B-T168
germ	I-T168
and	O
casein	B-T103
as	O
protein	B-T103
sources	B-T033
.	O
with	O
both	O
diets	B-T168
,	O
the	O
viability	O
of	O
the	O
egg	B-T017
-	O
adult	O
period	O
exceeded	O
68	O
%	O
,	O
with	O
fertility	B-T038
over	O
338	O
eggs	B-T017
per	O
female	B-T098
.	O
a	O
corrected	O
biotic	O
potential	O
analysis	B-T062
gave	O
similar	O
values	O
for	O
the	O
two	O
diets	B-T168
.	O

risk	B-T033
factors	I-T033
for	O
infection	B-T038
after	O
knee	B-T058
arthroscopy	I-T058
:	O
analysis	B-T062
of	O
59	O
##5	O
,	O
08	O
##3	O
cases	O
from	O
3	O
united	B-T082
states	I-T082
databases	B-T170
to	O
identify	O
and	O
quantify	O
patient	B-T033
-	I-T033
and	O
procedure	B-T033
-	I-T033
related	I-T033
risk	I-T033
factors	I-T033
for	O
post	O
-	O
arthroscopic	O
knee	O
infections	O
using	O
a	O
large	O
dataset	B-T170
.	O
an	O
administrative	B-T170
health	I-T170
care	I-T170
database	I-T170
including	O
8	O
years	O
of	O
records	O
from	O
2	O
large	O
commercial	O
ins	B-T092
##ure	I-T092
##rs	I-T092
and	O
medicare	O
(	O
a	O
5	O
%	O
random	B-T062
sample	I-T062
)	O
was	O
quer	O
##ied	O
to	O
identify	O
all	O
knee	B-T058
arthro	I-T058
##sc	I-T058
##op	I-T058
##ies	I-T058
performed	O
on	O
patients	O
aged	O
at	O
least	O
15	O
years	O
using	O
current	B-T170
procedural	I-T170
terminology	I-T170
(	I-T170
cpt	I-T170
)	I-T170
codes	I-T170
.	O
each	O
cpt	B-T170
code	I-T170
was	O
designated	O
as	O
a	O
high	B-T058
-	I-T058
or	O
low	B-T058
-	I-T058
complexity	I-T058
procedure	I-T058
,	O
with	O
the	O
former	O
typically	O
requiring	O
accessory	O
incisions	B-T058
or	O
increased	O
operative	O
time	O
.	O
deep	O
infections	B-T038
were	O
identified	O
by	O
a	O
cpt	B-T170
code	I-T170
for	O
incision	B-T058
and	O
drainage	B-T058
within	O
90	O
days	O
of	O
surgery	O
.	O
superficial	B-T038
infections	I-T038
were	O
identified	O
by	O
international	B-T170
classification	I-T170
of	I-T170
diseases	I-T170
,	I-T170
ninth	I-T170
revision	I-T170
infection	I-T170
codes	I-T170
without	O
any	O
record	B-T170
of	O
incision	B-T058
and	O
drainage	B-T058
.	O
patients	O
were	O
compared	O
based	O
on	O
age	O
,	O
sex	O
,	O
body	B-T201
mass	I-T201
index	I-T201
,	O
tobacco	O
use	O
,	O
presence	O
of	O
diabetes	B-T038
,	O
and	O
char	O
##ls	O
##on	O
comorbidity	O
index	O
.	O
a	O
total	O
of	O
52	O
##6	O
,	O
53	O
##7	O
patients	O
underwent	O
59	O
##5	O
,	O
08	O
##3	O
arthroscopic	B-T058
knee	I-T058
procedures	I-T058
.	O
deep	O
postoperative	B-T038
infections	I-T038
occurred	O
at	O
a	O
rate	O
of	O
0	O
.	O
22	O
%	O
.	O
superficial	B-T038
infections	I-T038
occurred	O
at	O
a	O
rate	O
of	O
0	O
.	O
29	O
%	O
.	O
tobacco	O
use	O
and	O
morbid	B-T038
obesity	I-T038
were	O
the	O
largest	O
risk	B-T033
factors	I-T033
for	O
deep	B-T038
and	O
superficial	B-T038
infections	I-T038
,	O
respectively	O
(	O
p	O
<	O
.	O
001	O
;	O
relative	O
risk	O
of	O
1	O
.	O
90	O
and	O
2	O
.	O
19	O
,	O
respectively	O
)	O
.	O
there	O
were	O
also	O
higher	O
infection	B-T038
rates	I-T038
among	O
patients	O
undergoing	O
relatively	O
high	B-T058
-	I-T058
complexity	I-T058
arthro	I-T058
##sc	I-T058
##op	I-T058
##ies	I-T058
,	O
men	B-T098
,	O
obese	B-T038
patients	O
,	O
diabetic	B-T038
patients	O
,	O
and	O
younger	O
patients	O
(	O
in	O
order	O
of	O
decreasing	O
relative	O
risk	O
)	O
.	O
increased	O
char	O
##ls	O
##on	O
comorbidity	O
index	O
was	O
associated	O
with	O
superficial	B-T038
and	O
total	B-T038
infections	I-T038
(	O
p	O
<	O
.	O
001	O
)	O
.	O
post	O
-	O
arthroscopic	O
knee	O
infections	O
were	O
more	O
frequent	O
among	O
morbidly	B-T038
obese	I-T038
patients	O
,	O
tobacco	B-T033
users	I-T033
,	O
patients	O
undergoing	O
relatively	O
complex	B-T058
procedures	I-T058
,	O
men	B-T098
,	O
obese	O
patients	O
,	O
diabetic	O
patients	O
,	O
relatively	O
young	O
patients	O
,	O
and	O
patients	O
with	O
increased	O
comorbidity	O
burdens	O
in	O
this	O
study	O
population	O
.	O
this	O
knowledge	O
may	O
allow	O
more	O
informed	O
preoperative	B-T058
counseling	I-T058
,	O
aid	B-T097
surgeons	I-T097
in	O
patient	B-T062
selection	I-T062
,	O
and	O
facilitate	O
infection	O
prevention	O
by	O
targeting	O
individuals	B-T098
with	O
higher	O
inherent	O
risk	O
.	O
level	O
iv	O
,	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
.	O

radiologic	B-T058
assessment	I-T058
of	O
quality	O
of	O
root	B-T058
canal	I-T058
filling	I-T058
##s	I-T058
and	O
periapical	B-T082
status	I-T082
in	O
an	O
austria	B-T098
##n	I-T098
subpopulation	B-T098
-	O
an	O
observational	B-T062
study	I-T062
progress	O
in	O
endodontic	B-T058
techniques	I-T058
and	O
methodological	O
advances	O
have	O
altered	O
root	B-T058
canal	I-T058
therapy	I-T058
over	O
the	O
last	O
decades	O
.	O
these	O
techniques	O
and	O
methods	O
need	O
periodic	B-T170
##al	I-T170
documentation	B-T170
.	O
this	O
observational	B-T062
study	I-T062
determined	O
the	O
current	O
prevalence	O
of	O
endodontic	B-T058
treatments	I-T058
,	I-T058
and	O
investigated	O
the	O
relationship	O
of	O
various	O
factors	O
with	O
the	O
periapical	B-T082
status	I-T082
in	O
a	O
lower	O
austria	B-T098
##n	I-T098
subpopulation	B-T098
.	O
one	O
thousand	O
orthopa	B-T058
##nt	I-T058
##om	I-T058
##ograms	I-T058
of	O
first	O
-	O
time	O
university	B-T092
adult	O
patients	O
radiograph	B-T058
##ed	I-T058
at	O
an	O
outpatient	B-T092
clinic	I-T092
were	O
evaluated	B-T058
.	O
for	O
each	O
tooth	B-T017
,	O
the	O
presence	B-T033
of	O
perir	B-T038
##adic	I-T038
##ular	I-T038
path	I-T038
##osis	I-T038
and	O
/	O
or	O
endodontic	B-T058
treatment	I-T058
was	O
recorded	O
,	O
as	O
was	O
the	O
quality	O
of	O
(	O
post	O
-	O
)	O
endodontic	B-T058
treatment	I-T058
(	O
homogeneity	O
and	O
length	O
of	O
root	B-T058
canal	I-T058
filling	I-T058
##s	I-T058
;	O
preparation	B-T033
failures	I-T033
;	O
posts	B-T074
/	O
screws	B-T074
;	O
api	B-T058
##co	I-T058
##ectomies	I-T058
;	O
coronal	B-T058
restorations	I-T058
)	O
.	O
two	O
evalu	B-T097
##ators	I-T097
,	O
blinded	B-T062
to	O
each	O
other	O
,	O
scored	O
all	O
teeth	B-T017
.	O
in	O
cases	O
of	O
disagreement	O
,	O
they	O
joined	O
for	O
a	O
consensus	O
score	O
.	O
in	O
all	O
,	O
22	O
,	O
58	O
##6	O
teeth	O
were	O
counted	O
.	O
of	O
these	O
,	O
2	O
,	O
90	O
##7	O
teeth	B-T017
(	O
12	O
.	O
9	O
%	O
)	O
had	O
periapical	B-T038
path	I-T038
##osis	I-T038
,	O
while	O
2	O
,	O
50	O
##4	O
teeth	B-T017
had	O
undergone	O
root	B-T058
canal	I-T058
treatment	I-T058
.	O
of	O
the	O
endodontic	B-T038
##ally	I-T038
treated	I-T038
teeth	I-T038
,	O
52	O
%	O
showed	O
no	O
radiographic	O
signs	O
of	O
apical	B-T038
periodontitis	I-T038
,	O
while	O
44	O
.	O
9	O
%	O
had	O
overt	O
apical	O
lesions	O
,	O
and	O
3	O
,	O
1	O
%	O
revealed	O
wide	B-T038
##ned	I-T038
periodontal	I-T038
ligament	I-T038
space	I-T038
.	O
the	O
majority	O
of	O
the	O
root	B-T058
canal	I-T058
filling	I-T058
##s	I-T058
was	O
inhomogeneous	O
(	O
70	O
.	O
4	O
%	O
)	O
;	O
75	O
.	O
4	O
%	O
were	O
rated	O
too	O
short	O
,	O
and	O
3	O
.	O
8	O
%	O
too	O
long	O
.	O
the	O
presence	B-T033
of	O
apical	B-T017
path	B-T038
##osis	I-T038
was	O
significantly	O
correlated	O
(	O
odds	O
ratio	O
(	O
or	O
)	O
2	O
.	O
55	O
##6	O
[	O
confidence	O
interval	O
(	O
ci	O
)	O
2	O
.	O
07	O
##6	O
-	O
3	O
.	O
146	O
]	O
;	O
p	O
<	O
0	O
.	O
0001	O
)	O
with	O
poor	O
root	B-T058
canal	I-T058
filling	I-T058
##s	I-T058
(	O
length	O
and	O
homogeneity	O
)	O
.	O
posts	B-T074
or	O
screws	B-T074
positively	O
affected	O
periapical	B-T082
status	I-T082
(	O
or	O
1	O
.	O
85	O
##3	O
[	O
ci	O
1	O
.	O
219	O
-	O
2	O
.	O
81	O
##9	O
]	O
;	O
p	O
=	O
0	O
.	O
004	O
)	O
,	O
but	O
endodontic	B-T038
##ally	I-T038
treated	I-T038
posterior	I-T038
teeth	I-T038
were	O
infrequently	O
restored	B-T058
(	O
posts	B-T074
,	O
7	O
.	O
5	O
%	O
;	O
screws	B-T074
,	O
2	O
.	O
7	O
%	O
)	O
.	O
best	O
results	O
were	O
found	O
for	O
teeth	B-T017
with	O
both	O
appropriate	O
endodontic	B-T058
treatment	I-T058
and	O
adequate	O
coronal	B-T058
restoration	I-T058
.	O
a	O
high	O
prevalence	O
of	O
perir	B-T033
##adic	I-T033
##ular	I-T033
radiol	I-T033
##uce	I-T033
##nc	I-T033
##ies	I-T033
was	O
observed	O
with	O
root	B-T017
canal	I-T017
filled	I-T017
teeth	I-T017
,	O
along	O
with	O
high	O
numbers	O
of	O
unmet	O
treatment	B-T058
needs	O
.	O
periapical	B-T082
health	O
was	O
associated	O
with	O
adequate	O
root	B-T058
canal	I-T058
obt	I-T058
##uration	I-T058
and	O
high	O
-	O
grade	O
post	O
##end	O
##odontic	O
restorations	O
,	O
and	O
quality	O
regarding	O
these	O
latter	O
aspects	O
is	O
considered	O
mandatory	O
to	O
promote	O
periapical	B-T082
health	O
.	O

endemic	O
hydrothermal	O
vent	O
species	B-T170
identified	O
in	O
the	O
open	O
ocean	O
seed	B-T204
bank	I-T204
hydrothermal	O
vent	O
systems	O
host	O
microbial	O
communities	O
among	O
which	O
several	O
microorganisms	O
have	O
been	O
considered	O
endemic	O
to	O
this	O
type	O
of	O
habitat	B-T082
.	O
it	O
is	O
still	O
unclear	O
how	O
these	O
organisms	O
colon	B-T033
##ize	I-T033
geographically	B-T082
distant	B-T082
hydrothermal	O
environments	B-T082
.	O
based	O
on	O
16s	B-T103
rrna	I-T103
gene	B-T082
sequences	I-T082
,	O
we	O
compare	O
the	O
bacterial	O
communities	O
of	O
sixteen	O
atlantic	B-T082
hydrothermal	O
vent	O
samples	O
with	O
our	O
own	O
and	O
publicly	O
available	O
global	O
open	O
ocean	O
samples	O
.	O
analysing	B-T062
sequences	B-T082
obtained	O
from	O
63	O
million	O
16s	B-T103
rrna	I-T103
genes	B-T017
,	O
the	O
genera	B-T170
we	O
could	O
identify	O
in	O
the	O
open	O
ocean	O
waters	O
contained	O
99	O
.	O
9	O
%	O
of	O
the	O
vent	O
reads	O
.	O
this	O
suggests	O
that	O
previously	O
observed	O
vent	O
exclusive	B-T033
##ness	I-T033
is	O
,	O
in	O
most	O
cases	O
,	O
probably	O
an	O
arte	B-T033
##fact	I-T033
of	O
lower	O
sequencing	B-T058
depth	O
.	O
these	O
findings	B-T033
are	O
a	O
further	O
step	O
towards	O
elucidating	O
the	O
role	B-T170
of	O
the	O
open	O
ocean	O
as	O
a	O
seed	B-T204
bank	I-T204
.	O
they	O
can	O
explain	O
the	O
predic	B-T033
##ament	I-T033
of	O
how	O
species	B-T170
expected	B-T170
to	O
be	O
endemic	O
to	O
vent	O
systems	O
are	O
able	B-T033
to	O
colon	B-T033
##ize	I-T033
geographically	B-T082
distant	B-T082
hydrothermal	O
habitats	B-T082
and	O
contribute	O
to	O
our	O
understanding	B-T038
of	O
whether	O
'	O
every	O
##thi	O
##ng	O
is	O
really	O
every	O
##wh	O
##ere	O
'	O
.	O

a	O
randomized	B-T062
trial	I-T062
of	O
tlr	B-T103
-	I-T103
2	I-T103
agonist	B-T103
cad	B-T103
##i	I-T103
-	I-T103
05	I-T103
targeting	O
desm	B-T103
##ocol	I-T103
##lin	I-T103
-	I-T103
3	I-T103
for	O
advanced	O
non	B-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
randomized	B-T062
controlled	I-T062
trial	I-T062
to	O
evaluate	B-T058
synergy	B-T038
between	O
taxa	B-T103
##ne	I-T103
plus	O
platinum	B-T103
chemotherapy	B-T058
and	O
cad	B-T103
##i	I-T103
-	I-T103
05	I-T103
,	O
a	O
toll	B-T103
like	I-T103
receptor	I-T103
-	I-T103
2	I-T103
agonist	B-T103
targeting	O
desm	B-T103
##ocol	I-T103
##lin	I-T103
-	I-T103
3	I-T103
as	O
a	O
first	B-T058
-	I-T058
line	I-T058
therapy	I-T058
in	O
advanced	O
non	B-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
(	O
nsclc	B-T038
)	O
.	O
patients	O
with	O
advanced	O
nsclc	B-T038
(	O
stage	O
iiib	O
or	O
iv	O
)	O
were	O
randomized	B-T033
to	O
cisplatin	B-T058
-	I-T058
paclitaxel	I-T058
(	O
chemotherapy	B-T058
group	O
,	O
n	O
=	O
112	O
)	O
or	O
cisplatin	B-T058
-	I-T058
paclitaxel	I-T058
plus	O
cad	B-T103
##i	I-T103
-	I-T103
05	I-T103
(	O
chemo	B-T058
##immun	I-T058
##otherapy	I-T058
group	O
,	O
n	O
=	O
109	O
)	O
.	O
cad	B-T103
##i	I-T103
-	I-T103
05	I-T103
was	O
administered	O
a	O
week	O
before	O
chemotherapy	B-T058
and	O
on	O
days	O
8	O
and	O
15	O
of	O
each	O
cycle	B-T058
and	O
every	O
month	O
subsequently	O
for	O
12	O
months	O
or	O
disease	B-T038
progression	I-T038
.	O
overall	O
survival	O
was	O
compared	O
using	O
a	O
log	B-T170
-	I-T170
rank	I-T170
test	I-T170
.	O
computed	B-T058
tomography	I-T058
was	O
carried	O
out	O
at	O
baseline	O
,	O
end	O
of	O
two	O
cycles	B-T058
and	O
four	O
cycles	B-T058
.	O
response	O
rate	O
was	O
evaluated	B-T058
using	O
response	B-T170
evaluation	I-T170
criteria	I-T170
in	I-T170
solid	I-T170
tumors	I-T170
criteria	O
by	O
an	O
independent	B-T097
radiologist	I-T097
.	O
as	O
per	O
intention	B-T062
-	I-T062
to	I-T062
-	I-T062
treat	I-T062
analysis	I-T062
,	O
no	O
survival	O
benefit	O
was	O
observed	O
between	O
two	O
groups	O
[	O
208	O
versus	O
196	O
days	O
;	O
hazard	O
ratio	O
,	O
0	O
.	O
86	O
;	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
0	O
.	O
63	O
-	O
1	O
.	O
19	O
;	O
p	O
=	O
0	O
.	O
380	O
##4	O
]	O
.	O
in	O
a	O
subgroup	B-T062
analysis	I-T062
,	O
improvement	O
in	O
median	O
survival	O
by	O
127	O
days	O
was	O
observed	O
in	O
squamous	B-T038
nsc	I-T038
##c	I-T038
with	O
chemo	B-T058
##immun	I-T058
##otherapy	I-T058
(	O
hazard	O
ratio	O
,	O
0	O
.	O
55	O
;	O
95	O
%	O
ci	O
0	O
.	O
32	O
-	O
0	O
.	O
95	O
;	O
p	O
=	O
0	O
.	O
046	O
)	O
.	O
in	O
patients	O
receiving	O
planned	O
four	O
cycles	B-T058
of	O
chemotherapy	B-T058
,	O
there	O
was	O
improved	O
median	O
overall	O
survival	O
by	O
66	O
days	O
(	O
299	O
versus	O
233	O
days	O
;	O
hazard	O
ratio	O
,	O
0	O
.	O
64	O
;	O
95	O
%	O
ci	O
0	O
.	O
41	O
to	O
0	O
.	O
98	O
;	O
p	O
=	O
0	O
.	O
04	O
)	O
in	O
the	O
chemo	B-T058
##immun	I-T058
##otherapy	I-T058
group	O
compared	O
with	O
the	O
chemotherapy	B-T058
group	O
.	O
this	O
was	O
associated	O
with	O
the	O
improved	O
survival	O
by	O
17	O
.	O
48	O
%	O
at	O
the	O
end	O
of	O
1	O
year	O
,	O
in	O
the	O
chemo	B-T058
##immun	I-T058
##otherapy	I-T058
group	O
.	O
systemic	B-T038
adverse	I-T038
events	I-T038
were	O
identical	O
in	O
both	O
the	O
group	O
s	O
.	O
there	O
was	O
no	O
survival	O
benefit	O
with	O
the	O
addition	O
of	O
cad	B-T103
##i	I-T103
-	I-T103
05	I-T103
to	O
the	O
combination	O
of	O
cisplatin	B-T058
-	I-T058
paclitaxel	I-T058
in	O
patients	O
with	O
advanced	O
nsclc	B-T038
;	O
however	O
,	O
the	O
squamous	B-T017
cell	I-T017
subset	I-T017
did	O
demonstrate	O
a	O
survival	O
advantage	O
.	O

signature	B-T082
of	O
an	O
aggregation	O
-	O
prone	B-T082
conformation	O
of	O
tau	B-T103
the	O
self	O
-	O
assembly	O
of	O
the	O
microtubule	B-T017
associated	O
tau	B-T103
protein	I-T103
into	O
fibrillar	B-T017
cell	I-T017
inclusions	I-T017
is	O
linked	B-T082
to	O
a	O
number	O
of	O
devastating	O
neurodegenerative	B-T038
disorders	I-T038
collectively	O
known	O
as	O
tau	B-T038
##opathies	I-T038
.	O
the	O
mechanism	O
by	O
which	O
tau	B-T103
self	O
-	O
assemble	O
##s	O
into	O
pathological	O
entities	O
is	O
a	O
matter	O
of	O
much	O
debate	O
,	O
largely	O
due	O
to	O
the	O
lack	O
of	O
direct	O
experimental	O
insights	B-T038
into	O
the	O
earliest	O
stages	O
of	O
aggregation	O
.	O
we	O
present	O
pulsed	B-T058
double	I-T058
electron	I-T058
-	I-T058
electron	I-T058
resonance	I-T058
measurements	O
of	O
two	O
key	O
fibril	B-T017
-	O
forming	O
regions	B-T082
of	O
tau	B-T103
,	O
ph	B-T103
##f6	I-T103
and	O
ph	B-T103
##f6	I-T103
*	I-T103
,	O
in	O
transient	O
as	O
aggregation	O
happ	O
##ens	O
.	O
by	O
monitoring	O
the	O
end	O
-	O
to	O
-	O
end	O
distance	O
distribution	O
of	O
these	O
segments	O
as	O
a	O
function	O
of	O
aggregation	O
time	O
,	O
we	O
show	O
that	O
the	O
ph	B-T103
##f6	I-T103
(	I-T103
(	I-T103
*	I-T103
)	I-T103
)	I-T103
regions	B-T082
dramatically	O
extend	O
to	O
distances	O
commens	O
##urate	O
with	O
extended	B-T082
β	B-T082
-	I-T082
strand	I-T082
structures	I-T082
within	O
the	O
earliest	O
stages	O
of	O
aggregation	O
,	O
well	O
before	O
fibril	B-T017
formation	O
.	O
combined	O
with	O
simulations	B-T062
,	O
our	O
experiments	B-T062
show	O
that	O
the	O
extended	B-T082
β	B-T082
-	I-T082
strand	I-T082
conformational	I-T082
state	O
of	O
ph	B-T103
##f6	I-T103
(	I-T103
(	I-T103
*	I-T103
)	I-T103
)	I-T103
is	O
readily	O
populated	O
under	O
aggreg	O
##ating	O
conditions	O
,	O
constituting	O
a	O
defining	O
signature	B-T082
of	O
aggregation	O
-	O
prone	B-T082
tau	B-T103
,	O
and	O
as	O
such	O
,	O
a	O
possible	O
target	O
for	O
therapeutic	B-T058
interventions	I-T058
.	O

abundance	O
and	O
characterization	O
of	O
perfect	O
microsatellites	B-T103
on	O
the	O
cattle	B-T204
y	B-T017
chromosome	I-T017
microsatellites	B-T103
or	O
simple	B-T103
sequence	I-T103
repeats	I-T103
(	O
ssr	B-T103
##s	I-T103
)	O
are	O
found	O
in	O
most	O
organisms	O
and	O
play	O
an	O
important	O
role	O
in	O
genomic	B-T017
organization	I-T017
and	O
function	B-T038
.	O
to	O
characterize	O
the	O
abundance	O
of	O
ssr	B-T103
##s	I-T103
(	O
1	O
-	O
6	O
base	B-T038
-	I-T038
pairs	I-T038
[	O
bp	B-T038
]	O
)	O
on	O
the	O
cattle	B-T204
y	B-T017
chrom	I-T017
##so	I-T017
##me	I-T017
,	O
the	O
relative	O
frequency	O
and	O
density	O
of	O
perfect	O
or	O
unint	O
##err	O
##up	O
##ted	O
ssr	B-T103
##s	I-T103
based	O
on	O
the	O
published	O
y	B-T017
chromosome	I-T017
sequence	B-T082
were	O
examined	B-T033
.	O
a	O
total	O
of	O
17	O
,	O
273	O
perfect	O
ssr	B-T103
##s	I-T103
were	O
found	O
,	O
with	O
total	O
length	O
of	O
324	O
.	O
78	O
kb	O
,	O
indicating	O
that	O
approximately	O
0	O
.	O
75	O
%	O
of	O
the	O
cattle	B-T204
y	B-T017
chromosome	I-T017
sequence	B-T082
(	O
43	O
.	O
30	O
mb	O
)	O
comprises	O
perfect	O
ssr	B-T103
##s	I-T103
,	O
with	O
an	O
average	O
length	B-T082
of	O
18	O
.	O
80	O
bp	B-T038
.	O
the	O
relative	O
frequency	O
and	O
density	O
were	O
398	O
.	O
92	O
loci	O
/	O
mb	O
and	O
750	O
##0	O
.	O
62	O
bp	B-T038
/	O
mb	O
,	O
respectively	O
.	O
the	O
proportions	O
of	O
the	O
six	O
classes	O
of	O
perfect	O
ssr	B-T103
##s	I-T103
were	O
highly	O
variable	O
on	O
the	O
cattle	B-T204
y	B-T017
chromosome	I-T017
.	O
mononucle	B-T103
##otide	I-T103
repeats	I-T103
had	O
a	O
total	O
number	O
of	O
80	O
##73	O
(	O
46	O
.	O
74	O
%	O
)	O
and	O
an	O
average	O
length	B-T082
of	O
15	O
.	O
45	O
bp	B-T038
,	O
and	O
were	O
the	O
most	O
abundant	O
ssr	B-T103
##s	I-T103
class	O
,	O
while	O
the	O
percentages	O
of	O
di	B-T103
-	I-T103
,	O
tetra	B-T103
-	I-T103
,	O
tri	B-T103
-	I-T103
,	O
penta	B-T103
-	I-T103
,	O
and	O
hexa	B-T103
-	I-T103
nucleotide	I-T103
repeats	I-T103
were	O
22	O
.	O
86	O
%	O
,	O
11	O
.	O
98	O
%	O
,	O
11	O
.	O
58	O
%	O
,	O
6	O
.	O
65	O
%	O
,	O
and	O
0	O
.	O
19	O
%	O
,	O
respectively	O
.	O
different	O
classes	O
of	O
ssr	B-T103
##s	I-T103
varied	O
in	O
their	O
repeat	O
number	O
,	O
with	O
the	O
highest	O
being	O
42	O
for	O
dinucleotide	B-T103
##s	I-T103
.	O
results	O
reveal	O
that	O
repeat	O
categories	O
a	B-T103
,	O
ac	B-T082
,	O
at	B-T082
,	O
aac	B-T082
,	O
ag	B-T082
##c	I-T082
,	O
gt	B-T082
##tt	I-T082
,	O
ct	B-T082
##tt	I-T082
,	O
att	B-T082
##t	I-T082
,	O
and	O
aac	B-T082
##t	I-T082
##g	I-T082
predom	O
##inate	O
on	O
the	O
y	B-T017
chromosome	I-T017
.	O
this	O
study	B-T062
provides	O
insight	O
into	O
the	O
organization	O
of	O
cattle	B-T204
y	B-T017
chromosome	I-T017
repetitive	O
dna	B-T103
,	O
as	O
well	O
as	O
information	O
useful	O
for	O
developing	O
more	O
polymorphic	O
cattle	B-T204
y	B-T017
-	I-T017
chromosome	I-T017
-	O
specific	O
ssr	B-T103
##s	I-T103
.	O

modulation	B-T082
of	O
il	B-T103
-	I-T103
6	I-T103
induced	O
rankl	B-T103
expression	B-T038
in	O
arthritic	B-T038
synovi	B-T017
##um	I-T017
by	O
a	O
transcription	B-T103
factor	I-T103
sox	I-T103
##5	I-T103
receptor	B-T103
activator	I-T103
of	I-T103
nuclear	I-T103
factor	I-T103
κb	I-T103
ligand	I-T103
(	O
rankl	B-T103
)	O
is	O
critically	O
involved	O
in	O
bone	B-T038
erosion	I-T038
of	O
rheumatoid	B-T038
arthritis	I-T038
(	O
ra	B-T038
)	O
.	O
we	O
previously	O
reported	O
association	O
between	O
younger	O
age	O
at	O
onset	O
of	O
ra	B-T038
and	O
a	O
rankl	B-T103
promoter	O
snp	B-T082
that	O
conferred	O
an	O
elevated	O
promoter	O
activity	O
via	O
binding	O
to	O
a	O
transcription	B-T103
factor	I-T103
sox	I-T103
##5	I-T103
.	O
here	O
we	O
study	B-T062
the	O
regulation	B-T038
of	O
sox	B-T103
##5	I-T103
levels	O
in	O
relation	O
to	O
rankl	B-T103
expression	B-T038
in	O
ra	B-T038
synovial	B-T017
fibroblasts	B-T017
(	O
sf	B-T017
)	O
and	O
the	O
development	O
of	O
bone	B-T038
erosion	I-T038
in	O
the	O
collagen	B-T038
-	I-T038
induced	I-T038
arthritis	I-T038
(	O
cia	B-T038
)	O
mouse	B-T204
.	O
our	O
data	B-T170
indicated	B-T033
sox	B-T103
##5	I-T103
levels	O
were	O
higher	O
in	O
synovi	B-T017
##um	I-T017
and	O
synovial	B-T031
fluid	I-T031
from	O
ra	B-T038
compared	O
to	O
osteoarthritis	B-T038
patients	O
.	O
pro	O
-	O
inflammatory	O
cytokines	B-T103
upregulated	B-T038
sox	B-T103
##5	I-T103
and	O
rankl	B-T103
expression	B-T038
in	O
both	O
primary	O
ra	B-T038
sf	B-T017
and	O
the	O
rheumatoid	O
synovial	O
fibroblast	O
cell	O
line	O
,	O
mh	B-T017
##7a	I-T017
.	O
overexpression	B-T038
of	O
sox	B-T103
##5	I-T103
resulted	O
in	O
significantly	O
increased	O
rankl	B-T103
levels	O
,	O
while	O
knockdown	B-T062
of	O
sox	B-T017
##5	I-T017
resulted	O
in	O
diminished	O
il	B-T103
-	I-T103
6	I-T103
mediated	O
rankl	B-T103
upregulation	B-T038
in	O
mh	B-T017
##7a	I-T017
cells	I-T017
.	O
chromatin	B-T058
immunoprecipitation	I-T058
(	O
chip	B-T058
)	O
showed	O
approximately	O
3	O
-	O
fold	O
enrichment	O
of	O
rankl	B-T103
-	I-T103
specific	I-T103
dna	I-T103
in	O
anti	B-T103
-	I-T103
sox	I-T103
##5	I-T103
immunoprecip	I-T103
##itate	I-T103
in	O
il	B-T103
-	I-T103
6	I-T103
treated	O
mh	B-T017
##7a	I-T017
cells	I-T017
as	O
compared	O
to	O
untreated	B-T033
cells	I-T033
.	O
locally	O
silencing	B-T038
sox	B-T017
##5	I-T017
gene	I-T017
significantly	O
diminished	O
rankl	B-T103
positive	B-T033
cells	B-T017
and	O
bone	B-T038
erosion	I-T038
in	O
cia	B-T038
mice	B-T204
.	O
these	O
findings	B-T033
suggest	O
sox	B-T103
##5	I-T103
is	O
an	O
important	O
regulator	O
of	O
il	B-T103
-	I-T103
6	I-T103
-	O
induced	O
rankl	B-T103
expression	B-T038
in	O
ra	B-T038
sf	B-T017
.	O

a	O
prime	O
a	O
day	O
keep	O
##s	O
calories	O
away	O
:	O
the	O
effects	O
of	O
supra	O
##lim	O
##inal	O
priming	O
on	O
food	O
consumption	O
and	O
the	O
moder	B-T170
##ating	I-T170
role	I-T170
of	O
gender	O
and	O
eating	B-T170
restraint	I-T170
the	O
link	O
between	O
intentions	B-T038
and	O
action	O
in	O
weight	B-T058
control	I-T058
is	O
weaker	O
than	O
previously	O
thought	O
,	O
so	O
recent	O
research	B-T062
has	O
called	O
for	O
further	O
investigation	O
of	O
ways	O
to	O
improve	O
weight	B-T058
control	I-T058
that	O
bypass	O
conscious	B-T038
intentions	B-T038
.	O
priming	O
has	O
been	O
shown	O
to	O
have	O
effects	O
on	O
individual	O
behavior	O
in	O
a	O
variety	O
of	O
contexts	O
by	O
influencing	O
subc	B-T038
##onscious	I-T038
cognition	B-T038
.	O
this	O
paper	O
investigates	O
the	O
effects	O
of	O
semantic	O
priming	O
using	O
healthy	O
body	B-T038
image	I-T038
,	O
goal	B-T170
-	I-T170
oriented	I-T170
words	I-T170
on	O
food	O
consumption	O
.	O
the	O
moder	B-T170
##ating	I-T170
role	I-T170
of	O
both	O
restrained	B-T170
eating	I-T170
and	O
gender	O
is	O
investigated	O
.	O
161	O
participants	B-T098
were	O
involved	O
in	O
an	O
experiment	B-T062
using	O
a	O
novel	O
version	O
of	O
a	O
scr	O
##amb	O
##led	O
sentence	B-T170
priming	O
game	O
.	O
the	O
outcome	O
measure	O
was	O
the	O
number	O
of	O
kil	O
##ocal	O
##ories	O
consumed	O
,	O
examined	O
using	O
a	O
between	O
subjects	O
anc	O
##ova	O
with	O
priming	O
,	O
gender	O
,	O
restrained	B-T170
eating	I-T170
index	I-T170
,	O
self	B-T062
-	I-T062
reported	I-T062
bmi	B-T201
,	O
and	O
two	O
interaction	O
terms	O
(	O
priming	O
x	O
gender	O
,	O
and	O
priming	O
x	O
restrained	B-T170
eating	I-T170
index	I-T170
)	O
.	O
there	O
was	O
no	O
main	O
effect	O
of	O
priming	O
but	O
there	O
was	O
an	O
interaction	O
of	O
priming	O
with	O
gender	O
.	O
females	O
consumed	O
significantly	O
fewer	O
kil	O
##ocal	O
##ories	O
after	O
being	O
exposed	O
to	O
priming	O
words	B-T170
related	O
to	O
a	O
healthy	O
body	B-T038
image	I-T038
(	O
i	O
.	O
e	O
.	O
[UNK]	O
sl	O
##im	O
[UNK]	O
,	O
[UNK]	O
fit	O
,	O
[UNK]	O
)	O
compared	O
to	O
females	O
receiving	O
the	O
neutral	O
prime	O
,	O
with	O
a	O
medium	O
effect	O
size	O
(	O
d	O
=	O
0	O
.	O
58	O
)	O
.	O
the	O
body	B-T038
image	I-T038
prime	O
did	O
not	O
significantly	O
affect	O
food	B-T038
intake	I-T038
for	O
males	O
,	O
nor	O
did	O
it	O
have	O
a	O
differential	O
effect	O
on	O
restrained	B-T098
eat	I-T098
##ers	I-T098
.	O
this	O
study	O
shows	O
that	O
priming	O
can	O
be	O
an	O
effective	O
method	O
for	O
influencing	O
females	O
to	O
reduce	O
food	B-T038
intake	I-T038
,	O
regardless	O
of	O
whether	O
they	O
are	O
restrained	B-T098
or	O
unres	B-T098
##trained	I-T098
eat	I-T098
##ers	I-T098
.	O
future	O
studies	O
could	O
investigate	O
whether	O
different	O
priming	O
words	B-T170
related	O
to	O
a	O
male	O
'	O
s	O
healthy	O
body	B-T038
image	I-T038
goal	O
(	O
i	O
.	O
e	O
.	O
[UNK]	O
buff	O
,	O
[UNK]	O
[UNK]	O
muscles	B-T017
,	O
[UNK]	O
etc	O
.	O
)	O
would	O
similarly	O
reduce	O
food	B-T038
intake	I-T038
for	O
males	O
.	O

mesothelial	B-T017
cell	I-T017
adherence	O
to	O
vascular	B-T074
prostheses	I-T074
and	O
their	O
subsequent	O
growth	B-T038
in	O
vitro	O
cell	B-T017
seeding	B-T058
may	O
decrease	O
the	O
thromb	B-T038
##ogenicity	I-T038
of	O
implanted	B-T074
vascular	O
grafts	O
,	O
but	O
its	O
application	O
is	O
hampered	O
by	O
the	O
limited	O
availability	O
of	O
autologous	O
endothelial	B-T017
cells	I-T017
.	O
human	B-T204
peritoneal	B-T082
mesothelial	B-T017
cells	I-T017
have	O
blood	B-T038
flow	I-T038
supporting	O
qualities	O
and	O
are	O
readily	O
available	O
.	O
this	O
study	O
investigated	O
the	O
adherence	O
of	O
mesothelial	B-T017
cells	I-T017
to	O
vascular	B-T074
prostheses	I-T074
and	O
their	O
subsequent	O
growth	B-T038
in	O
vitro	O
.	O
circular	B-T082
pieces	O
of	O
various	O
vascular	O
prosthetic	B-T103
materials	I-T103
were	O
seeded	B-T058
with	O
51	B-T103
##ch	I-T103
##rom	I-T103
##ium	I-T103
-	I-T103
labeled	I-T103
mesothelial	B-T017
and	O
endothelial	B-T017
cells	I-T017
and	O
left	O
for	O
either	O
5	O
,	O
15	O
,	O
30	O
,	O
60	O
,	O
and	O
120	O
minutes	O
.	O
the	O
un	O
##att	O
##ached	O
cells	B-T017
were	O
removed	O
and	O
the	O
degree	O
of	O
cell	B-T017
attachment	O
was	O
measured	O
.	O
the	O
number	O
of	O
mesothelial	B-T017
cells	I-T017
to	O
dac	B-T103
##ron	I-T103
increased	O
during	O
the	O
first	O
60	O
min	O
up	O
to	O
35	O
.	O
2	O
%	O
of	O
the	O
seeded	B-T058
inoculum	O
where	O
after	O
a	O
plateau	O
was	O
reached	B-T033
.	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
showed	O
spread	O
##ed	O
mesothelial	B-T017
cells	I-T017
adherent	O
to	O
the	O
dac	B-T103
##ron	I-T103
fibers	I-T103
.	O
a	O
significant	O
increase	O
in	O
adherence	O
was	O
observed	O
after	O
preincubation	B-T058
of	O
dac	B-T103
##ron	I-T103
with	O
10	O
μg	O
/	O
ml	O
fibronectin	B-T103
,	O
but	O
no	O
improvement	O
was	O
found	B-T033
after	O
preincubation	B-T058
with	O
human	B-T204
serum	B-T103
albumin	I-T103
or	O
gelatin	B-T103
.	O
mesothelial	B-T017
cells	I-T017
adhered	O
better	O
to	O
gel	O
##co	O
##ated	O
than	O
to	O
gels	O
##eal	O
##ed	O
or	O
plain	B-T103
dac	I-T103
##ron	I-T103
.	O
the	O
adherence	O
of	O
mesothelial	B-T017
cells	I-T017
to	O
ept	B-T103
##fe	I-T103
(	O
te	B-T103
##fl	I-T103
##on	I-T103
)	O
was	O
significantly	O
poorer	O
.	O
no	B-T033
significant	I-T033
differences	O
in	O
adherence	O
were	O
found	B-T033
between	O
mesothelial	B-T017
and	O
endothelial	B-T017
cells	I-T017
.	O
mesothelial	B-T017
cell	I-T017
growth	B-T038
on	O
dac	B-T103
##ron	I-T103
resulted	O
in	O
a	O
modest	O
increase	O
in	O
the	O
number	O
of	O
viable	O
cells	O
during	O
27	O
days	O
,	O
which	O
implies	O
biocompatibility	O
of	O
dac	B-T103
##ron	I-T103
and	O
mesothelial	B-T017
cells	I-T017
in	O
vitro	O
.	O

measuring	O
nonlinear	O
signal	O
combination	O
using	O
eeg	B-T058
relatively	O
little	O
is	O
known	O
about	O
the	O
processes	O
,	O
both	O
linear	B-T082
and	O
nonlinear	O
,	O
by	O
which	O
signals	O
are	O
combined	O
beyond	O
v1	B-T082
.	O
by	O
presenting	O
two	O
stimulus	O
components	O
simultaneously	O
,	O
flick	B-T033
##ering	I-T033
at	O
different	O
temporal	O
frequencies	O
(	O
frequency	O
tagging	O
)	O
while	O
measuring	O
steady	O
-	O
state	O
visual	B-T038
evoked	I-T038
potentials	I-T038
,	O
we	O
can	O
assess	O
responses	O
to	O
the	O
individual	O
components	O
,	O
including	O
direct	O
measurements	O
of	O
suppression	B-T038
on	O
each	O
other	O
,	O
and	O
various	O
nonlinear	O
responses	O
to	O
their	O
combination	O
found	O
at	O
interm	O
##od	O
##ulation	O
frequencies	O
.	O
the	O
result	B-T033
is	O
a	O
rather	O
rich	O
dataset	B-T170
of	O
frequencies	O
at	O
which	O
responses	O
can	O
be	O
found	O
.	O
we	O
presented	O
pairs	O
of	O
sinusoidal	O
gratings	O
at	O
different	O
temporal	O
frequencies	O
,	O
forming	O
pla	B-T033
##id	I-T033
patterns	I-T033
that	O
were	O
[UNK]	O
coherent	O
[UNK]	O
(	O
looking	B-T082
like	I-T082
a	I-T082
check	I-T082
##er	I-T082
##bo	I-T082
##ar	I-T082
d	O
)	O
and	O
[UNK]	O
nonc	B-T033
##oh	I-T033
##erent	I-T033
[UNK]	O
(	O
looking	O
like	O
a	O
pair	O
of	O
transparent	O
##ly	O
overl	B-T082
##aid	I-T082
gratings	I-T082
)	O
,	O
and	O
found	O
clear	O
interm	O
##od	O
##ulation	O
responses	O
to	O
compound	O
stimuli	O
,	O
indicating	O
nonlinear	O
summation	B-T038
.	O
this	O
might	O
have	O
been	O
attributed	O
to	O
cross	B-T082
-	I-T082
orientation	I-T082
suppression	B-T038
except	O
that	O
the	O
pattern	B-T082
of	O
interm	O
##od	O
##ulation	O
responses	O
differed	O
for	O
coherent	O
and	O
nonc	B-T033
##oh	I-T033
##erent	I-T033
patterns	B-T082
,	O
whereas	O
the	O
effects	O
of	O
suppression	B-T038
(	O
measured	O
at	O
the	O
component	O
frequencies	O
)	O
did	O
not	O
.	O
a	O
two	B-T170
-	I-T170
stage	I-T170
model	I-T170
of	O
nonlinear	O
summation	B-T038
involving	O
conjunction	O
detection	B-T058
with	O
a	O
logical	O
and	B-T170
gate	I-T170
described	O
the	O
data	O
well	O
,	O
capturing	O
the	O
difference	O
between	O
coherent	O
and	O
nonc	B-T033
##oh	I-T033
##erent	I-T033
pla	O
##ids	O
over	O
a	O
wide	O
array	B-T082
of	O
possible	B-T033
response	O
frequencies	O
.	O
multist	O
##im	O
##ulus	O
frequency	O
-	O
tagged	O
eeg	B-T058
in	O
combination	O
with	O
computational	O
modeling	O
may	O
be	O
a	O
very	O
valuable	O
tool	O
in	O
studying	O
the	O
conjunction	O
of	O
these	O
signals	O
.	O
in	O
the	O
current	O
study	B-T062
the	O
results	B-T033
suggest	O
a	O
second	O
-	O
order	O
mechanism	O
responding	O
selectively	O
to	O
coherent	O
pla	B-T033
##id	I-T033
patterns	I-T033
.	O

prevalence	O
and	O
correlates	O
of	O
antibiotic	B-T103
sharing	O
in	O
the	O
philipp	B-T082
##ines	I-T082
:	O
antibiotic	B-T103
misc	B-T038
##onception	I-T038
##s	I-T038
and	O
community	O
-	O
level	O
access	O
to	O
non	O
-	O
medical	O
sources	B-T033
of	O
antibiotics	B-T103
to	O
identify	O
sociodemographic	O
,	O
knowledge	B-T170
and	O
attit	B-T038
##udinal	I-T038
correlates	O
to	O
antibiotic	B-T103
sharing	O
among	O
a	O
community	O
-	O
based	O
sample	O
of	O
adults	O
(	O
age	O
18	O
and	O
older	O
)	O
in	O
a	O
low	B-T033
-	I-T033
income	I-T033
setting	I-T033
of	O
the	O
philipp	B-T082
##ines	I-T082
and	O
to	O
explore	O
community	O
-	O
level	O
data	O
on	O
informal	B-T033
antibiotic	B-T103
distribution	O
in	O
road	O
##side	O
stands	O
(	O
i	O
.	O
e	O
.	O
,	O
sar	O
##i	O
-	O
sar	O
##i	O
stands	O
)	O
.	O
participants	B-T098
(	O
n	O
=	O
307	O
)	O
completed	O
self	O
-	O
administered	O
surveys	B-T170
.	O
correlates	O
to	O
antibiotic	B-T103
sharing	O
were	O
assessed	O
using	O
logistic	B-T062
regression	I-T062
with	O
fir	B-T170
##th	I-T170
'	I-T170
s	I-T170
bias	I-T170
-	I-T170
adjusted	I-T170
estimate	I-T170
s	O
.	O
study	O
staff	B-T097
also	O
visited	O
106	O
road	O
##side	O
stands	O
and	O
collected	B-T033
data	I-T033
on	O
availability	O
and	O
characteristics	O
of	O
antibiotics	B-T103
in	O
the	O
stands	O
.	O
78	O
%	O
had	O
shared	O
antibiotics	B-T103
in	O
their	O
lifetime	O
,	O
most	O
often	O
with	O
family	O
members	O
.	O
in	O
multivariable	O
analysis	O
,	O
agreement	O
with	O
the	O
belief	O
that	O
it	O
is	O
safe	O
to	O
prematurely	O
stop	O
an	O
antibiotic	B-T103
course	O
(	O
or	O
:	O
2	O
.	O
8	O
,	O
ci	O
:	O
1	O
.	O
3	O
-	O
5	O
.	O
8	O
)	O
and	O
concerns	O
about	O
antibiotic	O
side	O
effects	O
(	O
or	O
:	O
2	O
.	O
1	O
,	O
ci	O
:	O
1	O
.	O
1	O
-	O
4	O
.	O
4	O
)	O
were	O
significantly	O
associated	O
with	O
increased	O
odds	O
of	O
reported	O
antibiotic	B-T103
sharing	O
.	O
antibiotic	B-T103
sharing	O
was	O
not	O
associated	O
with	O
sociodemographic	O
characteristics	O
or	O
antibiotic	B-T103
knowledge	B-T170
.	O
antibiotics	B-T103
were	O
widely	O
available	O
in	O
60	O
%	O
of	O
sampled	O
sar	O
##i	O
-	O
sar	O
##i	O
stands	O
,	O
in	O
which	O
59	O
%	O
of	O
antibiotics	B-T103
were	O
missing	B-T033
expiration	I-T033
dates	I-T033
.	O
amoxicillin	B-T103
and	O
cephal	B-T103
##exin	I-T103
were	O
the	O
most	O
commonly	O
available	O
antibiotics	B-T103
for	O
sal	O
##e	O
at	O
the	O
stands	O
(	O
60	O
%	O
and	O
21	O
%	O
,	O
respectively	O
)	O
.	O
antibiotic	B-T103
sharing	O
was	O
common	O
and	O
was	O
associated	O
with	O
misc	B-T038
##onception	I-T038
##s	I-T038
about	O
proper	O
antibiotic	B-T103
use	O
.	O
antibiotics	B-T103
were	O
widely	O
available	O
in	O
sar	O
##i	O
-	O
sar	O
##i	O
stands	O
,	O
and	O
usually	O
without	O
expiration	B-T170
information	I-T170
.	O
this	O
study	O
suggests	O
that	O
multip	O
##ron	O
##ged	O
and	O
locally	O
tailored	O
approaches	O
to	O
cur	O
##bing	O
informal	B-T033
antibiotic	B-T103
access	O
are	O
needed	O
in	O
the	O
philipp	B-T082
##ines	I-T082
and	O
similar	O
southeast	B-T082
-	I-T082
asian	I-T082
countries	I-T082
.	O

epidemiology	B-T091
and	O
risk	B-T033
factors	I-T033
associated	O
with	O
surgical	B-T038
site	I-T038
infection	I-T038
after	O
different	O
types	O
of	O
hepatobiliary	B-T091
and	I-T091
pancreatic	I-T091
surgery	I-T091
surgical	B-T038
site	I-T038
infection	I-T038
(	O
ssi	B-T038
)	O
is	O
one	O
of	O
the	O
most	O
common	O
healthcare	B-T038
-	I-T038
associated	I-T038
infections	I-T038
(	O
hai	B-T038
##s	I-T038
)	O
;	O
however	O
,	O
ssi	B-T038
after	O
hepatobiliary	B-T091
and	I-T091
pancreatic	I-T091
surgery	I-T091
(	O
hb	B-T091
##ps	I-T091
)	O
has	O
not	O
been	O
well	O
investigated	O
in	O
a	O
large	O
cohort	B-T098
of	O
patients	O
.	O
this	O
study	O
analyzed	O
the	O
factors	O
associated	O
with	O
ssi	B-T038
following	O
hb	B-T091
##ps	I-T091
in	O
japan	B-T082
,	O
using	O
a	O
japanese	B-T170
national	I-T170
database	I-T170
.	O
data	O
on	O
hb	B-T091
##ps	I-T091
performed	O
between	O
2012	O
and	O
2014	O
were	O
extracted	B-T062
from	O
a	O
national	B-T170
monitoring	I-T170
system	I-T170
for	O
hai	B-T038
:	O
the	O
japan	B-T058
nosocomial	I-T058
infections	I-T058
surveillance	I-T058
.	O
using	O
multivariate	B-T062
logistic	I-T062
regression	I-T062
,	O
i	O
assessed	O
the	O
factors	O
associated	O
with	O
ssi	B-T038
.	O
the	O
cumulative	O
incidence	O
of	O
ssi	B-T038
following	O
hb	B-T091
##ps	I-T091
was	O
15	O
.	O
6	O
%	O
(	O
287	O
##3	O
/	O
18	O
,	O
398	O
)	O
.	O
the	O
incidence	O
of	O
ssi	B-T038
after	O
pancre	B-T058
##ato	I-T058
##duoden	I-T058
##ectomy	I-T058
was	O
28	O
.	O
0	O
%	O
,	O
which	O
was	O
significantly	O
higher	O
than	O
that	O
after	O
liver	B-T058
resection	I-T058
and	O
other	O
types	O
of	O
hb	B-T091
##ps	I-T091
(	O
8	O
.	O
8	O
and	O
15	O
.	O
5	O
%	O
,	O
respectively	O
)	O
.	O
among	O
the	O
four	O
traditional	O
risk	B-T033
factors	I-T033
,	O
the	O
american	B-T092
society	I-T092
of	I-T092
anesthesiologists	I-T092
score	O
was	O
ineffective	O
for	O
predicting	O
ssi	B-T038
in	O
the	O
final	O
model	B-T170
of	O
all	O
three	O
types	O
of	O
surgery	B-T058
.	O
additional	O
risk	B-T033
factors	I-T033
were	O
identified	O
,	O
including	O
age	O
and	O
male	O
gender	O
.	O
the	O
incidence	O
of	O
and	O
factors	O
associated	O
with	O
ssi	B-T038
after	O
the	O
three	O
types	O
of	O
hb	B-T091
##ps	I-T091
analyzed	O
differed	O
significantly	O
.	O
to	O
accurately	O
compare	O
hospital	B-T092
performance	O
in	O
relation	O
to	O
ssi	B-T038
following	O
hb	B-T091
##ps	I-T091
,	O
the	O
operative	B-T058
procedure	I-T058
category	B-T170
in	O
the	O
surveillance	O
system	O
must	O
be	O
divided	O
into	O
three	O
types	O
.	O

breast	B-T038
cancer	I-T038
detection	O
rate	O
,	O
incidence	O
,	O
prevalence	O
and	O
interval	O
cancer	B-T038
-	O
related	O
mammography	B-T058
screening	I-T058
times	O
among	O
thai	B-T098
women	B-T098
a	O
recent	O
guideline	B-T170
by	O
the	O
american	B-T092
cancer	I-T092
society	I-T092
recommended	O
that	O
mammography	B-T058
(	O
mm	B-T058
##g	I-T058
)	O
should	O
be	O
done	O
for	O
women	B-T098
starting	O
in	O
their	O
mid	O
-	O
40	O
##s	O
.	O
in	O
thailand	B-T082
,	O
information	O
on	O
opportunistic	B-T058
mammography	I-T058
screening	I-T058
is	O
limited	O
and	O
data	O
on	O
the	O
total	O
incidence	O
of	O
breast	B-T038
cancer	I-T038
are	O
also	O
lacking	O
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
estimate	O
the	O
breast	B-T038
cancer	I-T038
detection	B-T058
,	O
incident	O
and	O
prevalence	O
rates	O
among	O
thai	B-T098
women	B-T098
.	O
we	O
retrospectively	O
reviewed	O
the	O
opportunistic	B-T058
mammography	I-T058
screening	I-T058
of	O
normal	O
women	B-T098
between	O
30	O
and	O
80	O
years	O
who	O
underwent	O
the	O
procedure	B-T058
between	O
2001	O
and	O
2010	O
.	O
all	O
cases	O
were	O
followed	O
until	O
2012	O
.	O
the	O
detection	O
rate	O
was	O
calculated	O
for	O
the	O
whole	O
period	O
of	O
observation	B-T062
using	O
'	O
number	O
of	O
women	B-T098
with	O
positive	B-T033
findings	I-T033
'	O
divided	O
by	O
'	O
total	O
number	O
of	O
women	B-T098
screened	B-T058
'	O
.	O
the	O
incidence	O
rate	O
was	O
calculated	O
only	O
at	O
the	O
first	O
mm	B-T058
##g	I-T058
while	O
the	O
subsequ	O
##ence	O
rate	O
was	O
calculated	O
based	O
on	O
all	O
new	O
cases	O
detected	B-T033
at	O
each	O
subsequent	O
mm	B-T058
##g	I-T058
.	O
among	O
the	O
47	O
,	O
430	O
women	B-T098
,	O
there	O
were	O
152	O
,	O
09	O
##1	O
mm	B-T058
##gs	I-T058
or	O
approximately	O
3	O
.	O
2	O
occasions	O
per	O
person	B-T098
(	O
range	O
,	O
1	O
-	O
10	O
)	O
.	O
the	O
average	O
duration	O
of	O
the	O
interval	O
between	O
each	O
subsequ	O
##ence	O
visit	O
was	O
1	O
.	O
8	O
years	O
.	O
overall	O
,	O
breast	B-T038
cancer	I-T038
was	O
detected	B-T033
in	O
54	O
##3	O
women	B-T098
,	O
with	O
a	O
detection	O
rate	O
of	O
10	O
.	O
3	O
per	O
1	O
,	O
000	O
persons	B-T098
.	O
the	O
prevalence	O
rate	O
of	O
breast	B-T038
cancer	I-T038
at	O
the	O
first	O
visit	O
was	O
5	O
.	O
78	O
per	O
1	O
,	O
000	O
person	B-T098
s	O
.	O
the	O
incidence	O
or	O
new	O
cases	O
detected	B-T033
at	O
any	O
follow	O
-	O
up	O
visit	O
was	O
10	O
.	O
4	O
per	O
1	O
,	O
000	O
person	B-T098
s	O
.	O
the	O
overall	O
interval	O
cancer	O
was	O
0	O
.	O
91	O
per	O
1	O
,	O
000	O
women	B-T098
,	O
mainly	O
detected	B-T033
before	O
their	O
second	O
and	O
third	O
mm	B-T058
##g	I-T058
,	O
with	O
a	O
rate	O
of	O
0	O
.	O
0	O
.	O
47	O
and	O
0	O
.	O
76	O
per	O
1	O
,	O
000	O
women	B-T098
.	O
opportunistic	B-T058
mammography	I-T058
screening	I-T058
in	O
thailand	B-T082
detected	B-T033
10	O
cases	O
of	O
breast	B-T038
cancer	I-T038
from	O
each	O
1	O
,	O
000	O
women	B-T098
.	O
this	O
paper	O
indicated	O
a	O
high	O
rate	O
of	O
cancer	B-T058
detection	I-T058
during	O
a	O
two	O
year	O
interval	O
,	O
hence	O
,	O
a	O
screening	B-T058
mamm	I-T058
##ogram	I-T058
should	O
be	O
performed	O
more	O
often	O
.	O

acute	B-T037
kidney	I-T037
injury	I-T037
severity	O
and	O
long	O
-	O
term	O
readmission	B-T058
and	O
mortality	O
after	O
cardiac	B-T058
surgery	I-T058
acute	B-T037
kidney	I-T037
injury	I-T037
(	O
aki	B-T037
)	O
is	O
a	O
common	O
complication	B-T038
after	O
cardiac	B-T058
surgery	I-T058
.	O
while	O
aki	B-T037
severity	O
is	O
known	O
to	O
be	O
associated	O
with	O
increased	O
risk	O
of	O
short	O
-	O
term	O
outcomes	O
,	O
its	O
long	O
-	O
term	O
impact	O
is	O
less	O
well	O
understood	O
.	O
adult	O
patients	O
undergoing	O
isolated	O
coronary	B-T058
artery	I-T058
bypass	I-T058
graft	I-T058
surgery	I-T058
at	O
eight	O
centers	O
were	O
enrolled	O
into	O
the	O
northern	B-T170
new	I-T170
england	I-T170
biomarker	I-T170
registry	I-T170
(	O
n	O
=	O
1	O
,	O
61	O
##0	O
)	O
.	O
patients	O
were	O
excluded	O
if	O
they	O
had	O
renal	B-T038
failure	I-T038
(	O
n	O
=	O
15	O
)	O
or	O
died	B-T033
during	O
index	B-T058
admission	I-T058
(	O
n	O
=	O
38	O
)	O
.	O
severity	O
of	O
aki	B-T037
was	O
defined	O
using	O
the	O
acute	B-T170
kidney	I-T170
injury	I-T170
network	I-T170
(	O
aki	B-T170
##n	I-T170
)	O
.	O
we	O
linked	O
our	O
cohort	O
to	O
national	O
medicare	O
and	O
state	B-T170
all	I-T170
-	I-T170
pay	I-T170
##er	I-T170
claims	I-T170
to	O
ascertain	O
readmissions	B-T058
and	O
to	O
the	O
national	B-T170
death	I-T170
index	I-T170
to	O
ascertain	O
survival	O
.	O
kaplan	O
-	O
meier	O
and	O
multivariate	B-T170
cox	I-T170
proportional	I-T170
hazards	I-T170
modeling	I-T170
was	O
conducted	O
for	O
time	O
to	O
readmission	B-T058
and	O
death	B-T033
over	O
5	O
years	O
.	O
within	O
5	O
years	O
,	O
51	O
##3	O
patients	O
(	O
33	O
.	O
8	O
%	O
)	O
had	O
aki	B-T037
with	O
aki	B-T170
##n	I-T170
stage	O
1	O
(	O
29	O
.	O
9	O
%	O
)	O
and	O
stage	O
2	O
to	O
3	O
(	O
3	O
.	O
9	O
%	O
)	O
.	O
there	O
were	O
62	O
##0	O
readmissions	B-T058
(	O
39	O
.	O
9	O
%	O
)	O
and	O
370	O
deaths	B-T033
(	O
23	O
.	O
8	O
%	O
)	O
.	O
after	O
adjustment	O
,	O
stage	O
1	O
aki	B-T037
patients	O
had	O
a	O
31	O
%	O
increased	O
risk	O
of	O
readmission	B-T058
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
:	O
1	O
.	O
10	O
to	O
1	O
.	O
57	O
)	O
,	O
whereas	O
stage	O
2	O
or	O
3	O
patients	O
had	O
a	O
98	O
%	O
increased	O
risk	O
(	O
95	O
%	O
ci	O
:	O
1	O
.	O
41	O
to	O
2	O
.	O
78	O
)	O
compared	O
with	O
patients	O
having	O
no	B-T033
aki	B-T037
.	O
relative	O
to	O
patients	O
without	O
aki	B-T037
,	O
stage	O
1	O
patients	O
had	O
a	O
56	O
%	O
increased	O
risk	O
of	O
mortality	O
(	O
95	O
%	O
ci	O
:	O
1	O
.	O
14	O
to	O
2	O
.	O
13	O
)	O
,	O
whereas	O
stage	O
2	O
or	O
3	O
patients	O
had	O
a	O
3	O
.	O
5	O
times	O
higher	O
risk	O
(	O
95	O
%	O
ci	O
:	O
2	O
.	O
16	O
to	O
5	O
.	O
60	O
)	O
.	O
severity	O
of	O
aki	B-T037
using	O
the	O
aki	B-T170
##n	I-T170
stage	O
criteria	O
is	O
associated	O
with	O
a	O
significantly	O
increased	O
risk	O
of	O
5	O
-	O
year	O
readmission	B-T058
and	O
mortality	O
.	O
our	O
findings	O
suggest	O
that	O
efforts	O
to	O
reduce	O
aki	B-T037
in	O
the	O
perioperative	O
period	O
may	O
have	O
a	O
significant	O
long	O
-	O
term	O
impact	O
on	O
patients	O
and	O
pay	O
##ers	O
in	O
reducing	O
mortality	O
and	O
health	B-T058
care	I-T058
utilization	I-T058
.	O

investigation	B-T170
on	O
evaluation	B-T058
criteria	O
of	O
back	O
##wash	O
##ing	O
effects	O
for	O
a	O
pilot	B-T062
-	I-T062
scale	I-T062
ba	O
##f	O
treating	O
pet	B-T103
##roch	I-T103
##emic	I-T103
##al	I-T103
wastewater	O
parameters	O
for	O
evaluation	B-T058
criteria	O
of	O
air	O
-	O
water	B-T103
back	O
##wash	O
##ing	O
effect	O
s	O
of	O
a	O
pilot	B-T062
-	I-T062
scale	I-T062
biological	O
aer	O
##ated	O
filter	O
(	O
ba	O
##f	O
)	O
treating	O
pet	B-T103
##roch	I-T103
##emic	I-T103
##al	I-T103
wastewater	O
were	O
investigated	O
.	O
the	O
parameters	O
included	O
the	O
suspended	O
solids	O
(	O
ss	O
)	O
and	O
specific	B-T033
oxygen	I-T033
uptake	I-T033
rate	I-T033
(	O
sour	B-T033
)	O
of	O
the	O
back	O
##wash	O
##ing	O
effluent	O
,	O
recovery	O
of	O
the	O
ba	O
##f	O
after	O
back	O
##wash	O
##ing	O
,	O
and	O
the	O
removal	O
of	O
the	O
biomass	O
/	O
bioactivity	O
attached	O
on	O
the	O
filter	O
media	O
after	O
back	O
##wash	O
##ing	O
.	O
results	O
showed	O
that	O
the	O
weight	O
of	O
the	O
total	O
sludge	O
produced	O
in	O
the	O
back	O
##wash	O
##ing	O
effluent	O
increased	O
with	O
the	O
increase	O
in	O
water	B-T103
-	O
back	O
##wash	O
##ing	O
intensity	O
,	O
while	O
the	O
total	O
sour	B-T033
of	O
back	O
##wash	O
##ing	O
effluent	O
rose	O
notably	O
with	O
the	O
increase	O
of	O
air	O
-	O
back	O
##wash	O
##ing	O
intensity	O
.	O
the	O
optimal	O
back	O
##wash	O
##ing	O
intensity	O
of	O
14	O
l	O
/	O
(	O
m	O
(	O
2	O
)	O
·	O
s	O
)	O
for	O
air	O
and	O
4	O
l	O
/	O
(	O
m	O
(	O
2	O
)	O
·	O
s	O
)	O
for	O
water	B-T103
were	O
obtained	O
.	O
when	O
the	O
ba	O
##f	O
was	O
back	O
##wash	O
##ed	O
on	O
this	O
condition	O
,	O
the	O
ba	O
##f	O
recovered	O
with	O
high	O
average	O
removal	O
of	O
chemical	B-T038
oxygen	I-T038
demand	I-T038
(	O
cod	B-T038
)	O
and	O
ammonia	B-T103
nitrogen	I-T103
[	O
formula	O
:	O
see	O
text	O
]	O
of	O
14	O
.	O
3	O
%	O
and	O
50	O
.	O
3	O
%	O
,	O
respectively	O
.	O
high	O
amount	O
of	O
biomass	O
removal	O
at	O
15	O
.	O
8	O
%	O
and	O
low	O
level	O
of	O
bioactivity	O
removal	O
at	O
8	O
.	O
8	O
%	O
attached	O
on	O
the	O
filter	O
media	O
were	O
also	O
found	O
.	O
concentrations	O
of	O
the	O
benzene	B-T103
,	O
toluene	B-T103
,	O
ethyl	B-T103
##benzene	I-T103
and	O
(	B-T103
o	I-T103
-	I-T103
,	I-T103
m	I-T103
-	I-T103
,	I-T103
p	I-T103
-	I-T103
)	I-T103
xyle	I-T103
##nes	I-T103
(	O
bt	B-T103
##ex	I-T103
)	O
and	O
phenol	B-T103
in	O
the	O
back	O
##wash	O
##ed	O
sludge	O
were	O
analyzed	B-T062
,	O
showing	O
that	O
the	O
back	O
##wash	O
##ing	O
was	O
essential	O
to	O
remove	O
some	O
aromatic	B-T103
compounds	I-T103
adsorbed	B-T058
in	O
the	O
microorganisms	O
.	O

incidence	O
of	O
diabetes	B-T038
mellitus	I-T038
and	O
obesity	B-T038
and	O
the	O
overlap	O
of	O
comorbidities	O
in	O
hiv	B-T033
+	I-T033
hispanics	B-T098
initiating	O
antiretroviral	B-T058
therapy	I-T058
cardiovascular	B-T038
disease	I-T038
(	O
cvd	B-T038
)	O
is	O
a	O
leading	O
health	O
threat	O
for	O
hiv	B-T033
+	I-T033
patients	O
on	O
antiretroviral	B-T058
therapy	I-T058
(	O
art	B-T058
)	O
;	O
cardiometabolic	B-T038
comorbidities	O
are	O
key	O
predictors	B-T033
of	I-T033
risk	I-T033
.	O
data	O
are	O
limited	O
on	O
incidence	O
of	O
metabolic	O
comorbidities	O
in	O
hiv	B-T033
+	I-T033
individuals	B-T098
initiating	O
art	B-T058
in	O
low	O
and	O
middle	O
income	O
countries	B-T082
(	O
lm	B-T082
##ics	I-T082
)	O
,	O
particularly	O
for	O
hispanics	B-T098
.	O
we	O
examined	B-T033
incidence	O
of	O
diabetes	B-T038
and	O
obesity	B-T038
in	O
a	O
prospective	B-T098
cohort	I-T098
of	O
those	O
initiating	O
art	B-T058
in	O
the	O
dom	B-T082
##inic	I-T082
##an	I-T082
republic	I-T082
.	O
participants	B-T098
≥1	O
##8	O
years	O
,	O
initiating	O
art	B-T058
<	O
90	O
days	O
prior	O
to	O
study	B-T062
enrollment	B-T058
,	O
were	O
examined	B-T033
for	O
incidence	O
of	O
impaired	B-T033
fasting	I-T033
glucose	I-T033
(	O
if	B-T033
##g	I-T033
)	O
,	O
diabetes	B-T038
mellitus	I-T038
(	O
dm	B-T038
)	O
,	O
overweight	B-T038
,	I-T038
and	I-T038
obesity	I-T038
.	O
fasting	B-T058
plasma	I-T058
glucose	I-T058
(	O
fpg	B-T058
)	O
100	O
-	O
125	O
##mg	O
/	O
dl	O
defined	O
if	B-T033
##g	I-T033
;	O
fpg	B-T058
≥1	O
##26	O
mg	O
/	O
dl	O
,	O
diagnosis	B-T062
per	O
medical	B-T170
record	I-T170
,	O
or	O
use	O
of	O
hypoglycemic	B-T103
medication	I-T103
defined	O
dm	B-T038
.	O
overweight	B-T038
and	I-T038
obesity	I-T038
were	O
bmi	B-T201
25	O
-	O
30	O
and	O
≥3	O
##0	O
##kg	O
/	O
m2	O
,	O
respectively	O
.	O
dyslipidemia	B-T038
was	O
total	B-T103
cholesterol	I-T103
≥2	O
##40	O
##mg	O
/	O
dl	O
or	O
use	O
of	O
lipid	B-T103
-	I-T103
lowering	I-T103
medication	I-T103
.	O
framingham	O
risk	O
equation	O
was	O
used	B-T033
to	O
determine	O
ten	O
-	O
year	O
cvd	B-T038
risk	B-T058
at	O
the	O
end	B-T062
of	I-T062
observation	I-T062
.	O
of	O
153	O
initiating	O
art	B-T058
,	O
8	O
(	O
6	O
%	O
)	O
had	O
dm	B-T038
and	O
23	O
(	O
16	O
%	O
)	O
had	O
if	B-T033
##g	I-T033
at	O
baseline	O
,	O
6	O
developed	O
dm	B-T038
(	O
28	O
/	O
1000	O
person	B-T098
-	O
years	O
follow	B-T058
up	I-T058
[	O
py	B-T058
##fu	I-T058
]	O
)	O
and	O
46	O
developed	O
if	B-T033
##g	I-T033
(	O
329	O
/	O
1000	O
py	B-T058
##fu	I-T058
)	O
.	O
at	O
baseline	O
,	O
24	O
(	O
18	O
%	O
)	O
were	O
obese	B-T038
and	O
36	O
(	O
27	O
%	O
)	O
were	O
overweight	B-T033
,	O
15	O
became	O
obese	B-T038
(	O
69	O
/	O
1000	O
py	B-T058
##fu	I-T058
)	O
and	O
22	O
became	O
overweight	B-T033
(	O
163	O
/	O
1000	O
py	B-T058
##fu	I-T058
)	O
.	O
median	B-T082
observation	B-T058
periods	O
for	O
the	O
diabetes	B-T038
and	O
obesity	B-T038
analyses	B-T062
were	O
23	O
.	O
5	O
months	O
and	O
24	O
.	O
3	O
months	O
,	O
respectively	O
.	O
increased	O
cvd	B-T038
risk	B-T058
(	O
≥10	O
%	O
10	B-T033
-	I-T033
year	I-T033
framingham	I-T033
risk	I-T033
score	I-T033
)	O
was	O
present	B-T033
for	O
13	O
%	O
of	O
the	O
cohort	B-T098
;	O
79	O
%	O
of	O
the	O
cohort	B-T098
had	O
≥1	O
cardiometabolic	O
comorbidity	O
,	O
48	O
%	O
had	O
≥2	O
,	O
and	O
13	O
%	O
had	O
all	O
three	O
.	O
in	O
this	O
hispanic	B-T098
cohort	B-T098
in	O
an	O
lm	B-T082
##ic	I-T082
,	O
incidences	O
of	O
if	B-T033
##g	I-T033
/	O
dm	B-T038
and	O
overweight	B-T033
/	O
obesity	B-T038
were	O
similar	O
to	O
or	O
higher	O
than	O
that	O
found	B-T033
in	O
high	B-T033
income	I-T033
countries	B-T082
,	O
and	O
cardiometabolic	B-T038
disorders	I-T038
affected	O
three	O
-	O
quarters	O
of	O
those	O
initiating	O
art	B-T058
.	O
care	O
models	O
incorporating	O
cardiovascular	O
risk	O
reduction	B-T058
into	O
hiv	B-T038
treatment	O
programs	O
are	O
needed	O
to	O
prevent	O
cvd	B-T038
-	O
associated	O
mortality	O
in	O
this	O
vulnerable	B-T098
population	I-T098
.	O

hypo	B-T038
##vitamin	I-T038
##osis	I-T038
d	I-T038
and	O
associated	O
cardiometabolic	O
risk	O
in	O
women	B-T098
with	O
pcos	B-T038
women	B-T098
with	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
(	O
pcos	B-T038
)	O
frequently	O
suffer	O
from	O
metabolic	O
disturbances	O
like	O
insulin	B-T038
resistance	I-T038
,	O
hypertension	B-T038
and	O
atherogenic	B-T038
dyslipidemia	I-T038
.	O
accumulating	B-T033
evidences	O
suggest	O
that	O
vitamin	B-T038
d	I-T038
deficiency	I-T038
is	O
common	O
in	O
pcos	B-T038
and	O
may	O
be	O
associated	O
with	O
metabolic	B-T038
and	O
endocrin	O
##al	O
dysfunctions	O
in	O
pcos	B-T038
.	O
thus	O
women	B-T098
with	O
pcos	B-T038
may	O
be	O
at	O
elevated	O
risk	O
of	O
cardiovascular	B-T038
disease	I-T038
.	O
present	O
study	B-T062
aims	O
to	O
evaluate	O
vitamin	B-T103
d	I-T103
status	O
and	O
to	O
assess	O
its	O
association	O
with	O
metabolic	B-T038
and	O
endocrin	O
##al	O
dysregulation	O
##s	O
in	O
women	B-T098
with	O
pcos	B-T038
,	O
which	O
might	O
help	O
in	O
early	O
identification	O
and	O
prevention	O
of	O
future	O
symptomatic	O
cardiac	B-T038
disease	I-T038
.	O
a	O
total	O
of	O
44	O
women	B-T098
with	O
pcos	B-T038
,	O
diagnosed	O
by	O
rot	B-T170
##terdam	I-T170
criteria	I-T170
and	O
45	O
healthy	O
control	O
without	O
pcos	B-T038
,	O
were	O
evaluated	O
for	O
vitamin	B-T103
d	I-T103
and	O
cardiometabolic	B-T033
risk	I-T033
factors	I-T033
,	O
including	O
fasting	B-T033
plasma	I-T033
glucose	I-T033
,	O
insulin	B-T038
resistance	I-T038
,	O
dyslipidemia	B-T038
,	O
hs	B-T033
-	I-T033
crp	I-T033
.	O
that	O
apart	O
,	O
several	O
endocrin	O
##al	O
parameters	O
of	O
hyper	B-T038
##and	I-T038
##rogen	I-T038
##ism	I-T038
were	O
also	O
examined	O
.	O
several	O
correlation	B-T062
studies	I-T062
were	O
determined	O
to	O
establish	O
the	O
role	O
of	O
vitamin	B-T103
d	I-T103
as	O
a	O
cardiometabolic	B-T033
risk	I-T033
factor	I-T033
in	O
pcos	B-T038
.	O
results	O
were	O
expressed	O
as	O
mean	O
##±	O
##sd	O
and	O
were	O
statistically	O
analysed	O
using	O
spss	B-T170
software	I-T170
version	I-T170
16	I-T170
,	O
unpaired	B-T170
student	I-T170
'	I-T170
s	I-T170
t	I-T170
-	I-T170
test	I-T170
and	O
pearson	O
'	O
s	O
correlation	O
coefficient	O
.	O
we	O
found	O
lower	O
levels	O
of	O
vitamin	B-T103
d	I-T103
,	O
which	O
was	O
statistically	O
significant	O
as	O
compared	O
to	O
healthy	O
controls	O
.	O
hyperinsulinemia	B-T038
,	O
rise	O
in	O
insulin	B-T038
resistance	I-T038
and	O
marked	O
dyslipidemia	B-T038
was	O
observed	O
in	O
the	O
present	O
study	B-T062
.	O
another	O
relevant	O
finding	O
was	O
significant	O
correlation	O
of	O
vitamin	B-T103
d	I-T103
with	O
insulin	B-T103
and	O
homeostatic	B-T058
model	I-T058
of	I-T058
assessment	I-T058
-	I-T058
insulin	I-T058
resistance	I-T058
index	I-T058
(	O
homa	B-T058
-	I-T058
ir	I-T058
)	O
.	O
hypo	B-T038
##vitamin	I-T038
##osis	I-T038
d	I-T038
was	O
prevalent	O
in	O
pcos	B-T038
.	O
this	O
was	O
related	O
to	O
metabolic	B-T038
and	O
hormonal	B-T033
disorders	I-T033
in	O
pcos	B-T038
.	O
possibly	O
this	O
combined	O
with	O
impaired	B-T033
fasting	I-T033
glucose	I-T033
,	O
ir	B-T038
and	O
dyslipidemia	B-T038
,	O
could	O
account	O
for	O
cardio	O
vascular	O
risks	O
in	O
pcos	B-T038
.	O
further	O
prospective	O
observational	B-T170
studies	I-T170
and	O
randomized	B-T062
control	I-T062
trials	I-T062
are	O
required	O
to	O
explore	O
the	O
above	O
hypothesis	O
.	O

ventricular	B-T058
pacing	I-T058
site	O
separation	O
by	O
cardiac	B-T082
computed	B-T058
tomography	I-T058
:	O
validation	B-T062
for	O
the	O
prediction	O
of	O
clinical	B-T033
response	I-T033
to	O
cardiac	B-T058
res	I-T058
##ynchronization	I-T058
therapy	I-T058
cardiac	B-T058
res	I-T058
##ynchronization	I-T058
therapy	I-T058
(	O
crt	B-T058
)	O
fails	O
to	O
provide	O
benefit	O
in	O
up	O
to	O
one	O
-	O
third	O
of	O
patients	O
.	O
maximizing	O
the	O
geographic	O
separation	O
of	O
right	O
and	O
left	O
ventricular	B-T058
pacing	I-T058
lead	B-T082
sites	I-T082
has	O
been	O
suggested	O
as	O
one	O
way	O
to	O
improve	B-T033
response	O
.	O
cardiac	B-T058
ct	I-T058
provides	O
an	O
opportunity	O
to	O
explore	O
3	B-T082
-	I-T082
dimensional	I-T082
inter	O
-	O
lead	O
distance	O
(	O
ild	O
)	O
measures	O
for	O
the	O
prediction	O
of	O
crt	B-T058
response	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
associations	O
between	O
standardized	O
measures	O
of	O
ild	O
by	O
cardiac	B-T058
ct	I-T058
and	O
echocardiographic	B-T058
response	O
to	O
crt	B-T058
.	O
forty	O
-	O
two	O
consecutive	O
patients	O
undergoing	O
crt	B-T058
had	O
serial	O
clinical	B-T058
and	O
echocardiographic	B-T058
evaluations	B-T058
performed	O
in	O
addition	O
to	O
a	O
post	O
-	O
procedural	O
cardiac	B-T082
-	O
gated	O
ct	B-T058
with	O
blinded	B-T062
measurement	O
of	O
direct	O
and	O
circumferential	B-T082
(	O
via	O
the	O
myocardium	B-T017
)	O
ild	O
measures	O
.	O
clinical	B-T033
response	I-T033
to	O
crt	B-T058
,	O
the	O
primary	B-T033
clinical	I-T033
outcome	I-T033
,	O
was	O
defined	O
as	O
a	O
≥1	O
##5	O
%	O
reduction	O
in	O
lv	B-T033
##es	I-T033
##v	I-T033
using	O
echocardiography	B-T058
at	O
6	O
-	O
months	O
.	O
the	O
mean	O
age	O
and	O
ejection	B-T033
fraction	I-T033
was	O
63	O
.	O
6	O
±	O
8	O
.	O
9	O
years	O
and	O
25	O
.	O
2	O
±	O
7	O
.	O
8	O
%	O
,	O
respectively	O
.	O
the	O
primary	O
outcome	O
occurred	O
in	O
35	O
of	O
42	O
patients	O
(	O
83	O
%	O
)	O
.	O
both	O
direct	O
and	O
circumferential	B-T082
ct	B-T058
-	O
based	O
ild	O
measures	O
were	O
associated	O
with	O
the	O
primary	O
outcome	O
by	O
univariate	O
analysis	O
.	O
receiver	O
operator	O
characteristic	O
analysis	B-T062
identified	O
circumferential	B-T082
ild	O
to	O
have	O
the	O
strongest	O
predictive	O
accuracy	O
(	O
auc	O
0	O
.	O
78	O
)	O
.	O
inter	O
-	O
and	O
intra	O
-	O
observer	O
reproducibility	O
of	O
ct	B-T058
-	O
derived	O
ild	O
measures	O
was	O
excellent	O
.	O
circumferential	B-T082
ild	O
measures	O
on	O
cardiac	B-T058
ct	I-T058
are	O
predictive	O
of	O
clinical	B-T033
response	I-T033
to	O
crt	B-T058
.	O
incorporation	O
of	O
these	O
measures	O
into	O
the	O
selection	O
of	O
optimal	O
pacing	B-T058
targets	O
,	O
particularly	O
from	O
pre	O
-	O
procedural	O
ct	B-T058
coronary	B-T017
vein	I-T017
imaging	B-T058
may	O
be	O
of	O
therapeutic	O
benefit	O
and	O
warrants	O
further	O
investigation	B-T058
.	O

trajectories	B-T082
of	O
health	O
and	O
behavioral	B-T058
health	I-T058
services	I-T058
use	O
among	O
community	O
corrections	O
-	O
involved	O
rural	B-T033
adults	O
this	O
article	O
seeks	O
to	O
establish	O
time	O
-	O
based	O
trajectories	B-T082
of	O
health	O
and	O
behavioral	B-T058
health	I-T058
services	I-T058
utilization	O
for	O
community	O
corrections	O
-	O
involved	O
(	O
cci	O
)	O
adults	O
and	O
to	O
examine	O
demographic	O
and	O
clinical	O
correlates	O
associated	O
with	O
these	O
trajectories	B-T082
.	O
to	O
accomplish	O
this	O
aim	O
,	O
the	O
authors	O
applied	O
a	O
latent	B-T062
class	I-T062
growth	I-T062
analysis	I-T062
(	O
lc	B-T062
##ga	I-T062
)	O
to	O
services	B-T058
use	O
data	O
from	O
a	O
sample	O
of	O
rural	B-T033
cci	O
adults	O
who	O
reported	O
their	O
medical	O
,	O
mental	B-T038
health	I-T038
,	O
and	O
substance	O
use	O
treatment	O
utilization	O
behavior	O
every	O
60	O
days	O
for	O
1	O
.	O
5	O
years	O
.	O
lc	B-T062
##ga	I-T062
established	O
1	O
.	O
5	O
-	O
year	O
trajectories	B-T082
and	O
demographic	O
correlates	O
of	O
health	B-T058
services	I-T058
among	O
rural	B-T033
cci	O
adults	O
.	O
for	O
medical	B-T058
services	I-T058
,	O
three	O
classes	O
emerged	O
(	O
stable	O
-	O
low	O
users	B-T098
,	O
13	O
%	O
;	O
stable	O
-	O
intermediate	O
users	B-T098
,	O
40	O
%	O
;	O
and	O
stable	O
-	O
high	O
users	B-T098
,	O
47	O
%	O
)	O
.	O
for	O
mental	B-T038
health	I-T038
and	O
substance	O
use	O
services	B-T058
,	O
three	O
classes	O
emerged	O
(	O
stable	O
-	O
low	O
,	O
69	O
%	O
and	O
61	O
%	O
,	O
respectively	O
;	O
low	O
-	O
baseline	O
-	O
increase	O
,	O
10	O
%	O
and	O
12	O
%	O
,	O
respectively	O
;	O
high	O
-	O
baseline	O
decline	O
,	O
21	O
%	O
and	O
28	O
%	O
,	O
respectively	O
)	O
.	O
employment	O
,	O
gender	O
,	O
medication	O
usage	O
,	O
and	O
depression	B-T038
severity	O
predicted	O
membership	O
across	O
all	O
services	B-T058
.	O
results	O
underscore	O
the	O
importance	O
of	O
social	B-T097
workers	I-T097
and	O
other	O
community	B-T058
services	I-T058
providers	B-T097
align	O
##ing	O
health	B-T058
services	I-T058
access	O
with	O
the	O
needs	O
of	O
the	O
cci	O
population	O
,	O
and	O
highlight	O
cci	O
adults	O
as	O
being	O
at	O
risk	O
of	O
unders	O
##erv	O
##ice	O
in	O
critical	O
prevention	B-T058
and	O
intervention	B-T058
domains	I-T058
.	O

bioge	O
##ochemical	O
controls	O
of	O
uranium	B-T103
bioavailability	O
from	O
the	O
dissolved	O
phase	O
in	O
natural	O
freshwater	O
##s	O
to	O
gain	O
insights	O
into	O
the	O
risks	O
associated	O
with	O
uranium	B-T103
(	O
u	B-T103
)	O
mining	O
and	O
processing	O
,	O
we	O
investigated	O
the	O
bioge	O
##ochemical	O
controls	O
of	O
u	B-T103
bioavailability	O
in	O
the	O
model	O
freshwater	O
species	B-T170
lym	B-T204
##na	I-T204
##ea	I-T204
stagn	I-T204
##alis	I-T204
(	O
gastrop	B-T204
##oda	I-T204
)	O
.	O
bioavailability	O
of	O
dissolved	B-T103
u	I-T103
(	I-T103
vi	I-T103
)	I-T103
was	O
characterized	O
in	O
controlled	O
laboratory	B-T092
experiments	B-T062
over	O
a	O
range	O
of	O
water	B-T103
hardness	O
,	O
ph	O
,	O
and	O
in	O
the	O
presence	B-T033
of	O
complex	B-T103
##ing	I-T103
ligands	I-T103
in	O
the	O
form	O
of	O
dissolved	O
natural	O
organic	O
matter	O
(	O
dom	O
)	O
.	O
results	B-T033
show	O
that	O
dissolved	B-T103
u	I-T103
is	O
bioavailable	O
under	O
all	O
the	O
ge	O
##ochemical	O
conditions	O
tested	O
.	O
uranium	B-T103
uptake	B-T038
rates	O
follow	O
first	O
order	O
kinetics	O
over	O
a	O
range	O
encompassing	O
most	O
environmental	B-T082
concentrations	O
.	O
uranium	B-T103
uptake	B-T038
rates	O
in	O
l	B-T204
.	I-T204
stagn	I-T204
##alis	I-T204
ultimately	O
demonstrate	O
saturation	O
uptake	B-T038
kinetics	O
when	O
exposure	O
concentrations	O
exceed	O
100	O
nm	O
,	O
suggesting	O
uptake	B-T038
via	O
a	O
finite	O
number	O
of	O
carriers	O
or	O
ion	B-T103
channels	I-T103
.	O
the	O
lack	O
of	O
a	O
relationship	O
between	O
u	B-T103
uptake	B-T038
rate	O
constants	O
and	O
ca	B-T103
uptake	B-T038
rates	O
suggest	O
that	O
u	B-T103
does	O
not	O
exclusively	O
use	O
ca	B-T103
membrane	B-T103
transporters	I-T103
.	O
in	O
general	O
,	O
u	B-T103
bioavailability	O
decreases	B-T033
with	O
increasing	O
ph	O
,	O
increasing	O
ca	B-T103
and	O
mg	B-T103
concentrations	O
,	O
and	O
when	O
dom	O
is	O
present	B-T033
.	O
competing	O
ions	B-T103
did	O
not	O
affect	O
u	B-T103
uptake	B-T038
rates	O
.	O
speciation	B-T062
modeling	I-T062
that	O
includes	O
formation	O
constants	O
for	O
u	B-T103
ternary	O
complexes	O
reveals	O
that	O
the	O
aqueous	O
concentration	O
of	O
dic	B-T103
##arb	I-T103
##ona	I-T103
##to	I-T103
u	I-T103
species	B-T170
(	O
u	O
##o2	O
(	O
co	O
##3	O
)	O
2	O
(	O
-	O
2	O
)	O
)	O
best	O
predicts	O
u	B-T103
bioavailability	O
to	O
l	B-T204
.	I-T204
stagn	I-T204
##alis	I-T204
,	O
challenging	O
the	O
free	O
-	O
ion	O
activity	O
model	O
postulate	O
.	O

an	O
inhibitory	O
septum	O
to	O
lateral	B-T082
hypothalamus	I-T082
circuit	O
that	O
suppresses	O
feeding	O
feeding	O
behavior	O
is	O
orches	O
##trated	O
by	O
neural	O
circuits	O
primarily	O
residing	O
in	O
the	O
hypothalamus	B-T017
and	O
hind	B-T017
##brain	I-T017
.	O
however	O
,	O
the	O
relative	O
influence	O
of	O
cognitive	O
and	O
emotional	B-T038
brain	O
circuits	O
to	O
the	O
feeding	O
circuitry	O
in	O
the	O
hypothalamus	B-T017
and	O
hind	B-T017
##brain	I-T017
remains	O
unclear	O
.	O
here	O
,	O
using	O
the	O
cell	B-T170
-	I-T170
type	I-T170
selectivity	O
of	O
genetic	B-T062
methods	I-T062
,	O
circuit	B-T058
mapping	I-T058
,	O
and	O
behavior	O
assays	B-T058
,	O
we	O
sought	O
to	O
deciph	O
##er	O
neural	O
circuits	O
ema	O
##nat	O
##ing	O
from	O
the	O
septal	B-T017
nucleus	I-T017
to	O
the	O
lateral	B-T082
hypothalamus	I-T082
(	O
lh	B-T082
)	O
that	O
contribute	O
to	O
neural	O
regulation	O
of	O
food	B-T038
intake	I-T038
in	O
mice	B-T204
.	O
we	O
found	O
that	O
chemo	O
##gene	O
##tic	O
and	O
opto	O
##gene	O
##tic	O
activation	O
of	O
septal	B-T082
vesicular	B-T103
gaba	I-T103
transporter	I-T103
(	O
vg	B-T103
##at	I-T103
)	O
-	O
containing	O
neurons	B-T017
or	O
their	O
projections	O
in	O
the	O
lh	B-T082
reduced	O
food	B-T038
intake	I-T038
in	O
mice	B-T204
.	O
consistently	O
,	O
chemo	O
##gene	O
##tic	O
inhibition	O
of	O
septal	B-T082
vg	B-T103
##at	I-T103
neurons	B-T017
increased	O
food	B-T038
intake	I-T038
.	O
furthermore	O
,	O
we	O
investigated	O
a	O
previously	O
unknown	O
neural	O
circuit	O
originating	O
from	O
septal	B-T082
vg	B-T103
##at	I-T103
neurons	B-T017
to	O
a	O
subset	B-T170
of	O
vg	B-T103
##at	I-T103
neurons	B-T017
in	O
the	O
lh	B-T082
,	O
an	O
area	B-T082
involved	O
in	O
homeostatic	B-T038
and	O
hed	B-T038
##onic	I-T038
control	O
of	O
energy	O
states	O
.	O
collectively	O
,	O
our	O
data	O
reveal	O
an	O
inhibitory	O
sept	B-T082
##ohy	I-T082
##pot	I-T082
##hal	I-T082
##amic	I-T082
feeding	O
circuit	O
that	O
might	O
serve	O
as	O
a	O
therapeutic	O
target	O
for	O
the	O
treatment	O
of	O
eating	B-T038
disorders	I-T038
such	O
as	O
anorexia	B-T038
nervosa	I-T038
.	O
our	O
results	O
demonstrate	O
that	O
top	O
-	O
down	O
projections	O
from	O
the	O
septum	O
to	O
the	O
hypothalamus	B-T017
control	O
food	B-T038
intake	I-T038
negatively	B-T033
.	O
given	O
the	O
known	O
role	O
for	O
both	O
of	O
these	O
brain	B-T082
regions	I-T082
in	O
the	O
control	O
of	O
feeding	O
and	O
emotion	B-T038
-	O
related	O
behaviors	O
,	O
these	O
findings	B-T033
reveal	O
previously	O
unknown	O
neural	O
circuitry	O
that	O
is	O
likely	O
implicated	O
in	O
emotional	O
aspects	O
of	O
food	B-T038
intake	I-T038
and	O
provide	O
new	O
insights	B-T038
into	O
the	O
development	O
of	O
therapeutic	O
targets	O
for	O
the	O
treatment	O
of	O
eating	B-T038
disorders	I-T038
.	O

radiosens	B-T058
##itization	I-T058
of	O
non	B-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
cells	B-T017
and	O
xenografts	B-T058
by	O
the	O
interactive	O
effects	O
of	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
and	O
methoxy	B-T103
##amine	I-T103
the	O
anti	B-T103
-	I-T103
folate	I-T103
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
is	O
a	O
radiosens	B-T103
##itize	I-T103
##r	I-T103
.	O
in	O
pre	B-T170
-	I-T170
clinical	I-T170
models	I-T170
,	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
is	O
more	O
effective	O
along	O
with	O
the	O
base	B-T038
-	I-T038
excision	I-T038
-	I-T038
repair	I-T038
inhibitor	O
methoxy	B-T103
##amine	I-T103
.	O
we	O
tested	O
whether	O
methoxy	B-T103
##amine	I-T103
enhances	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
-	O
mediated	O
radiosens	B-T058
##itization	I-T058
of	O
lung	B-T038
adenocarcinoma	I-T038
cells	O
and	O
xenografts	B-T058
.	O
a549	B-T017
and	O
h1	B-T017
##29	I-T017
##9	I-T017
cells	I-T017
were	O
evaluated	O
for	O
cell	B-T038
cycle	I-T038
distribution	O
by	O
flow	B-T058
cytometry	I-T058
,	O
radiosens	B-T058
##itization	I-T058
by	O
clonogenic	B-T058
assay	I-T058
,	O
and	O
dna	B-T038
repair	I-T038
by	O
neutral	B-T062
comet	I-T062
assay	I-T062
and	O
repair	B-T038
protein	I-T038
activation	O
.	O
h4	B-T017
##60	I-T017
cells	I-T017
were	O
included	O
in	O
some	O
studies	O
.	O
xenografts	B-T058
in	O
nude	B-T204
mice	I-T204
received	B-T033
drug	I-T033
(	O
s	O
)	O
and	O
/	O
or	O
radiation	O
,	O
and	O
tumor	O
growth	O
was	O
monitored	O
by	O
cal	B-T074
##iper	I-T074
and	O
in	O
vivo	O
toxicity	B-T037
by	O
animal	O
weight	O
.	O
exposure	O
to	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
/	O
methoxy	B-T103
##amine	I-T103
for	O
24	O
(	O
h1	B-T017
##29	I-T017
##9	I-T017
,	O
h4	B-T017
##60	I-T017
)	O
or	O
48	O
(	O
a549	B-T017
)	O
hours	O
before	O
irradiation	O
resulted	O
in	O
accumulation	B-T033
of	O
cells	B-T017
near	O
the	O
radiosens	O
##itive	O
g1	O
/	O
s	O
border	O
;	O
dose	O
-	O
enhancement	O
factors	O
of	O
1	O
.	O
62	O
##±0	O
.	O
19	O
,	O
1	O
.	O
97	O
##±0	O
.	O
25	O
,	O
and	O
1	O
.	O
67	O
##±0	O
.	O
30	O
,	O
respectively	O
;	O
reduction	O
of	O
mean	O
inactivation	O
dose	O
by	O
32	O
%	O
,	O
30	O
%	O
,	O
and	O
46	O
%	O
,	O
respectively	O
;	O
and	O
significant	O
reductions	O
of	O
sf	O
##2	O
and	O
sf	O
##4	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
radiosens	B-T058
##itization	I-T058
was	O
associated	O
with	O
rapid	O
dna	B-T038
double	I-T038
-	I-T038
strand	I-T038
-	I-T038
break	I-T038
rej	I-T038
##oin	I-T038
##ing	I-T038
and	O
increased	O
levels	O
of	O
dna	B-T103
-	I-T103
pkc	I-T103
##s	I-T103
.	O
both	O
tumor	O
-	O
growth	O
rate	O
and	O
tumor	O
-	O
growth	O
delay	O
were	O
significantly	O
improved	O
by	O
adding	O
methoxy	B-T103
##amine	I-T103
to	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
pre	O
-	O
irradiation	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
;	O
no	O
mice	B-T204
lost	O
weight	O
during	O
treatment	O
.	O
addition	O
of	O
methoxy	B-T103
##amine	I-T103
to	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
and	O
fractionated	O
radiotherapy	O
may	O
improve	O
outcome	O
for	O
patients	O
with	O
locally	O
advanced	O
non	B-T038
-	I-T038
squamous	I-T038
non	I-T038
-	I-T038
small	I-T038
-	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
.	O

spatio	O
-	O
temporal	O
distribution	O
of	O
bark	B-T204
and	O
amb	B-T204
##ros	I-T204
##ia	I-T204
beetles	B-T204
in	O
a	O
brazilian	B-T082
tropical	O
dry	O
forest	O
bark	B-T204
and	O
the	O
amb	B-T204
##ros	I-T204
##ia	I-T204
beetles	B-T204
dig	O
into	O
host	O
plants	O
and	O
live	O
most	O
of	O
their	O
lives	O
in	O
conceal	O
##ed	O
tunnel	B-T082
##s	I-T082
.	O
we	O
assessed	O
beetle	B-T204
community	O
dynamics	O
in	O
tropical	O
dry	O
forest	O
sites	B-T082
in	O
early	O
,	O
intermediate	O
,	O
and	O
late	O
succession	O
##al	O
stages	O
,	O
evaluating	O
the	O
influence	O
of	O
resource	O
availability	O
and	O
seasonal	O
variations	O
in	O
guil	O
##d	O
structure	O
.	O
we	O
collected	O
a	O
total	O
of	O
76	O
##3	O
beetles	B-T204
from	O
23	O
species	B-T170
,	O
including	O
14	O
bark	B-T204
beetle	B-T204
species	B-T170
,	O
and	O
9	O
amb	B-T204
##ros	I-T204
##ia	I-T204
beetle	B-T204
species	B-T170
.	O
local	B-T082
richness	O
of	O
bark	B-T204
and	O
amb	B-T204
##ros	I-T204
##ia	I-T204
beetles	B-T204
was	O
estimated	O
at	O
31	O
species	B-T170
.	O
bark	B-T204
and	O
amb	B-T204
##ros	I-T204
##ia	I-T204
composition	O
was	O
similar	O
over	O
the	O
succession	O
##al	O
stages	O
gradient	O
,	O
and	O
beta	O
diversity	O
among	O
sites	B-T082
was	O
primarily	O
determined	O
by	O
species	B-T170
turnover	O
,	O
mainly	O
in	O
the	O
bark	B-T204
beetle	B-T204
community	O
.	O
bark	B-T204
beetle	B-T204
richness	O
and	O
abundance	O
were	O
higher	O
at	O
intermediate	O
stages	O
;	O
availability	O
of	O
wood	O
was	O
the	O
main	O
spatial	O
mechanism	O
.	O
climate	O
factors	O
were	O
effectively	O
non	O
-	O
seasonal	O
.	O
amb	B-T204
##ros	I-T204
##ia	I-T204
beetles	B-T204
were	O
not	O
influenced	O
by	O
succession	O
##al	O
stages	O
,	O
however	O
the	O
increase	O
in	O
wood	O
resulted	O
in	O
increased	O
abundance	O
.	O
we	O
found	O
higher	O
richness	O
at	O
the	O
end	O
of	O
the	O
dry	O
and	O
wet	O
seasons	O
,	O
and	O
abundance	O
increased	O
with	O
air	O
moisture	O
and	O
decreased	O
with	O
higher	O
temperatures	O
and	O
greater	O
rainfall	O
.	O
in	O
summary	O
,	O
bark	B-T204
beetle	B-T204
species	B-T170
accumulation	O
was	O
higher	O
at	O
sites	B-T082
with	O
better	O
wood	O
production	O
,	O
while	O
the	O
needs	O
of	O
fungi	B-T204
(	O
host	O
and	O
air	O
moisture	O
)	O
,	O
resulted	O
in	O
a	O
favorable	O
conditions	O
for	O
species	B-T170
accumulation	O
of	O
amb	B-T204
##ros	I-T204
##ia	I-T204
.	O
the	O
overall	O
biological	O
pattern	O
among	O
guil	O
##ds	O
differed	O
from	O
tropical	O
rain	O
forests	O
,	O
showing	O
patterns	O
similar	O
to	O
dry	O
forest	O
areas	O
.	O

detection	B-T058
of	O
am	B-T103
##a	I-T103
-	I-T103
m2	I-T103
in	O
human	B-T204
saliva	B-T031
:	O
potentials	O
in	O
diagnosis	B-T033
and	O
monitoring	B-T058
of	O
primary	B-T038
biliary	I-T038
cholangitis	I-T038
serum	B-T031
anti	B-T103
-	I-T103
mitochondrial	I-T103
antibody	I-T103
type	I-T103
2	I-T103
(	O
am	B-T103
##a	I-T103
-	I-T103
m2	I-T103
)	O
is	O
considered	O
as	O
a	O
pivotal	O
biomarker	B-T201
for	O
the	O
diagnosis	B-T033
of	O
primary	B-T038
biliary	I-T038
cholangitis	I-T038
(	O
pbc	B-T038
)	O
.	O
however	O
,	O
serological	B-T058
tests	I-T058
have	O
many	O
limitations	O
,	O
including	O
incon	O
##ven	O
##ience	O
,	O
invasiveness	O
,	O
and	O
infection	B-T033
risks	I-T033
.	O
thus	O
,	O
a	O
less	O
invasive	O
approach	B-T082
to	O
detect	B-T033
am	B-T058
##a	I-T058
-	I-T058
m2	I-T058
titer	I-T058
is	O
desirable	O
.	O
we	O
examined	O
salivary	B-T031
am	B-T103
##a	I-T103
-	I-T103
m2	I-T103
of	O
potential	O
pbc	B-T038
patients	O
and	O
found	O
that	O
am	B-T103
##a	I-T103
-	I-T103
m2	I-T103
could	O
be	O
detected	B-T033
only	O
in	O
saliva	B-T031
of	O
serum	B-T031
am	B-T033
##a	I-T033
-	I-T033
m2	I-T033
-	I-T033
positive	I-T033
pbc	B-T038
patients	O
,	O
but	O
not	O
in	O
saliva	B-T031
of	O
serum	B-T031
am	B-T033
##a	I-T033
-	I-T033
m2	I-T033
-	I-T033
negative	I-T033
pbc	B-T038
patients	O
,	O
oral	B-T038
lichen	I-T038
plan	I-T038
##us	I-T038
patients	O
(	O
ol	B-T038
##p	I-T038
)	O
patients	O
,	O
or	O
healthy	O
controls	O
.	O
furthermore	O
,	O
the	O
concentration	O
of	O
salivary	B-T031
am	B-T103
##a	I-T103
-	I-T103
m2	I-T103
was	O
positively	O
correlated	O
with	O
the	O
amount	O
of	O
serum	B-T031
am	B-T103
##a	I-T103
-	I-T103
m2	I-T103
in	O
patients	O
.	O
the	O
salivary	B-T031
inflammatory	B-T103
cytokines	I-T103
were	O
increased	O
in	O
the	O
pbc	B-T038
,	O
consistent	O
with	O
the	O
results	O
of	O
serum	B-T031
test	B-T058
.	O
these	O
findings	O
indicated	O
that	O
saliva	B-T031
might	O
be	O
a	O
less	O
invasive	O
and	O
cost	O
-	O
effective	O
medium	O
to	O
accurately	O
test	O
for	O
am	B-T058
##a	I-T058
-	I-T058
m2	I-T058
levels	I-T058
and	O
this	O
is	O
a	O
promising	O
development	O
for	O
the	O
diagnosis	B-T033
and	O
monitoring	B-T058
of	O
pbc	B-T038
.	O

medicare	O
claims	O
indicators	O
of	O
healthcare	B-T058
utilization	O
differences	O
after	O
hospitalization	B-T058
for	O
ischemic	B-T038
stroke	I-T038
:	O
race	B-T098
,	O
gender	O
,	O
and	O
caregiving	O
effects	O
background	O
differences	O
in	O
healthcare	B-T058
utilization	O
after	O
stroke	B-T038
may	O
partly	O
explain	O
race	B-T098
or	O
gender	O
differences	O
in	O
stroke	B-T038
outcomes	O
and	O
identify	O
factors	O
that	O
might	O
reduce	O
post	O
-	O
acute	B-T038
stroke	I-T038
care	O
costs	O
.	O
aim	O
to	O
examine	O
systematic	O
differences	O
in	O
medicare	O
claims	O
for	O
healthcare	B-T058
utilization	O
after	O
hospitalization	B-T058
for	O
ischemic	B-T038
stroke	I-T038
in	O
a	O
us	B-T082
population	B-T098
-	O
based	O
sample	O
.	O
methods	O
claims	O
were	O
examined	B-T033
over	O
a	O
six	O
-	O
month	O
period	O
after	O
hospitalization	B-T058
for	O
279	O
ischemic	B-T038
stroke	I-T038
survivors	O
65	O
years	O
or	O
older	B-T098
from	O
the	O
reasons	O
for	O
geographic	O
and	O
racial	O
differences	O
in	O
stroke	B-T038
(	O
regards	B-T038
)	O
study	O
.	O
statistical	O
analyses	O
examined	B-T033
differences	O
in	O
post	O
-	O
acute	B-T058
healthcare	I-T058
utilization	O
,	O
adjusted	O
for	O
pre	O
-	O
stroke	B-T038
utilization	O
,	O
as	O
a	O
function	O
of	O
race	B-T098
(	O
african	B-T098
-	I-T098
american	I-T098
vs	O
.	O
white	B-T098
)	O
,	O
gender	O
,	O
age	O
,	O
stroke	O
belt	O
residence	B-T082
,	O
income	O
,	O
medicaid	O
dual	O
-	O
eligibility	O
,	O
char	B-T170
##ls	I-T170
##on	I-T170
comorbidity	I-T170
index	I-T170
,	O
and	O
whether	O
the	O
person	B-T098
lived	O
with	O
an	O
available	O
caregiver	B-T097
.	O
results	O
after	O
adjusting	O
for	O
covariates	O
,	O
women	B-T098
were	O
more	O
likely	O
than	O
men	B-T098
to	O
receive	O
home	O
health	O
care	O
and	O
to	O
use	O
emergency	B-T058
department	I-T058
services	I-T058
during	O
the	O
post	O
-	O
acute	B-T058
care	I-T058
period	O
.	O
these	O
effects	O
were	O
maintained	O
even	O
after	O
further	B-T082
adjustment	O
for	O
acute	B-T038
stroke	I-T038
severity	O
.	O
african	B-T098
-	I-T098
americans	I-T098
had	O
more	O
home	O
health	O
care	O
visits	B-T058
than	O
whites	B-T098
among	O
patients	O
who	O
received	O
some	O
home	O
health	O
care	O
.	O
having	O
a	O
co	O
-	O
residing	O
caregiver	B-T097
was	O
associated	O
with	O
reduced	O
acute	B-T058
hospitalization	I-T058
length	O
of	O
stay	O
and	O
fewer	O
post	O
-	O
acute	B-T058
emergency	I-T058
department	I-T058
and	O
primary	O
care	O
physician	O
visits	O
.	O
conclusions	O
under	O
##util	O
##ization	O
of	O
healthcare	O
after	O
stroke	B-T038
does	O
not	O
appear	O
to	O
explain	O
poorer	O
long	O
-	O
term	O
stroke	B-T038
outcomes	O
for	O
women	B-T098
and	O
african	B-T098
-	I-T098
americans	I-T098
in	O
this	O
epidemiological	O
##ly	O
-	O
derived	O
sample	O
.	O
caregiver	B-T097
availability	O
may	O
contribute	O
to	O
reduced	O
formal	O
care	O
and	O
cost	O
during	O
the	O
post	O
-	O
acute	B-T058
period	O
.	O

association	O
of	O
prenatal	O
and	O
early	O
life	O
exposure	O
to	O
tetrachlor	B-T103
##oethylene	I-T103
(	O
pce	B-T103
)	O
with	O
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
and	O
other	O
reproductive	O
disorders	O
in	O
the	O
cape	B-T082
cod	I-T082
health	B-T062
study	I-T062
:	O
a	O
retrospective	B-T062
cohort	I-T062
study	I-T062
tetrachlor	B-T103
##oethylene	I-T103
(	O
pce	B-T103
)	O
is	O
an	O
organic	O
lipophilic	O
solvent	B-T103
with	O
possible	O
neuroendocrine	B-T022
toxicity	O
.	O
the	O
objective	B-T170
of	O
this	O
study	B-T062
was	O
to	O
determine	O
the	O
association	O
of	O
prenatal	O
and	O
early	O
childhood	O
exposure	O
to	O
pce	B-T103
-	O
contaminated	O
drinking	O
water	O
and	O
development	B-T038
of	O
adult	B-T033
-	I-T033
onset	I-T033
polycystic	B-T038
ovary	I-T038
syndrome	I-T038
(	O
pcos	B-T038
)	O
,	O
endometriosis	B-T038
,	O
difficulty	B-T033
conce	I-T033
##iving	I-T033
and	O
miscarriage	B-T038
.	O
five	O
-	O
hundred	O
exposed	O
and	O
331	O
unexposed	B-T098
female	O
participants	B-T098
born	O
between	O
1969	O
and	O
1983	O
completed	O
questionnaires	B-T170
on	O
demographic	O
and	O
lifestyle	O
characteristics	O
,	O
and	O
reproductive	O
disorders	O
.	O
residential	B-T082
locations	I-T082
from	O
the	O
prenatal	O
period	O
through	O
five	O
years	O
of	O
age	O
were	O
used	O
to	O
estimate	O
early	O
life	O
pce	B-T103
exposure	O
with	O
water	B-T170
modeling	I-T170
software	I-T170
.	O
for	O
any	O
early	O
life	O
exposure	O
to	O
pce	B-T103
,	O
the	O
adjusted	O
risk	O
ratio	O
for	O
pcos	B-T038
was	O
0	O
.	O
9	O
(	O
95	O
%	O
ci	O
:	O
0	O
.	O
5	O
-	O
1	O
.	O
6	O
)	O
.	O
no	O
statistically	O
signific	O
##an	O
t	O
associations	O
were	O
observed	O
for	O
increasing	O
levels	O
of	O
exposure	O
with	O
pcos	B-T038
or	O
the	O
other	O
reproductive	O
disorders	O
.	O
no	O
meaningful	O
associations	O
were	O
found	B-T033
among	O
adult	O
women	B-T098
with	O
early	O
life	O
exposure	O
to	O
pce	B-T103
-	O
contaminated	O
drinking	O
water	O
and	O
adult	B-T033
-	I-T033
onset	I-T033
reproductive	O
disorders	O
.	O

thaw	B-T058
-	O
and	O
-	O
use	O
target	B-T017
cells	I-T017
pre	O
-	O
labeled	O
with	O
calc	B-T103
##ein	I-T103
am	I-T103
for	O
antibody	B-T058
-	I-T058
dependent	I-T058
cell	I-T058
-	I-T058
mediated	I-T058
cytotoxicity	I-T058
assays	I-T058
in	O
vitro	O
antibody	B-T058
-	I-T058
dependent	I-T058
cell	I-T058
-	I-T058
mediated	I-T058
cytotoxicity	I-T058
(	I-T058
adc	I-T058
##c	I-T058
)	I-T058
assays	I-T058
are	O
routinely	O
performed	O
to	O
support	O
the	O
research	O
and	O
development	O
of	O
therapeutic	B-T103
antibodies	I-T103
.	O
in	O
adc	B-T058
##c	I-T058
assays	I-T058
,	O
target	B-T017
cells	I-T017
bound	O
by	O
the	O
antibodies	B-T103
are	O
lysed	B-T038
by	O
activated	O
effector	B-T017
cells	I-T017
following	O
interactions	O
between	O
the	O
fc	B-T103
region	I-T103
of	O
the	O
bound	O
antibody	B-T103
and	O
fc	B-T103
##γ	I-T103
receptors	I-T103
on	O
effector	B-T017
cells	I-T017
.	O
target	B-T017
cell	I-T017
lysis	B-T038
is	O
typically	O
measured	O
by	O
quantification	O
of	O
released	O
endogenous	O
enzymes	B-T103
,	O
e	O
.	O
g	O
.	O
,	O
lactate	B-T103
dehydrogenase	I-T103
,	O
or	O
measurement	O
of	O
released	O
exogenous	O
labels	B-T103
,	O
e	O
.	O
g	O
.	O
,	O
(	B-T103
51	I-T103
)	I-T103
cr	I-T103
,	O
europ	B-T103
##ium	I-T103
or	O
calc	B-T103
##ein	I-T103
.	O
adc	B-T058
##c	I-T058
assays	I-T058
based	O
on	O
the	O
detection	O
of	O
exogenous	O
labels	B-T103
released	O
from	O
lysed	B-T038
target	B-T017
cells	I-T017
generally	O
show	O
higher	O
sensitivity	O
and	O
require	O
shorter	O
incubation	B-T033
times	I-T033
.	O
however	O
,	O
target	B-T017
cells	I-T017
are	O
usually	O
labeled	O
immediately	O
prior	O
to	O
assay	B-T058
,	O
which	O
inadvert	O
##ently	O
introduces	O
additional	O
assay	B-T058
variations	O
due	O
to	O
differences	O
in	O
target	B-T017
cell	I-T017
conditions	O
and	O
labeling	B-T058
/	O
handling	B-T058
processes	I-T058
.	O
in	O
this	O
report	O
,	O
we	O
describe	O
the	O
use	O
of	O
thaw	B-T058
-	O
and	O
-	O
use	O
pre	O
-	O
labeled	O
target	B-T017
cells	I-T017
for	O
adc	B-T058
##c	I-T058
assays	I-T058
.	O
thaw	B-T058
-	O
and	O
-	O
use	O
target	B-T017
cells	I-T017
in	O
our	O
experiments	O
were	O
pre	O
-	O
labeled	O
with	O
the	O
fluorescent	B-T103
dye	I-T103
calc	I-T103
##ein	I-T103
am	I-T103
,	O
cryopreserved	B-T058
in	O
single	O
-	O
use	O
aliqu	O
##ots	O
and	O
used	O
directly	O
in	O
assays	B-T058
after	O
thawing	O
.	O
upon	O
thaw	B-T058
,	O
the	O
pre	O
-	O
labeled	O
cells	B-T017
displayed	O
viability	B-T038
and	O
label	B-T103
retention	O
comparable	O
to	O
freshly	O
labeled	O
cells	B-T017
,	O
responded	O
to	O
adc	B-T038
##c	I-T038
mediated	O
by	O
both	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
and	O
engineered	B-T017
natural	I-T017
killer	I-T017
cells	I-T017
,	O
performed	O
stably	O
for	O
at	O
least	O
3	O
years	O
and	O
provided	O
favorable	O
precision	O
and	O
accuracy	O
to	O
adc	B-T058
##c	I-T058
assays	I-T058
.	O
implementation	O
of	O
thaw	B-T058
-	O
and	O
-	O
use	O
pre	O
-	O
labeled	O
target	B-T017
cells	I-T017
in	O
adc	B-T058
##c	I-T058
assays	I-T058
can	O
help	O
to	O
alleviate	O
both	O
cell	B-T058
culture	I-T058
and	O
dye	B-T058
labeling	I-T058
derived	O
variability	O
,	O
increase	O
the	O
flexibility	O
of	O
assay	B-T058
sched	O
##uling	O
and	O
improve	O
assay	O
consistency	O
and	O
robustness	O
.	O

enhanced	O
performance	O
of	O
colorimetric	B-T058
biosens	B-T058
##ing	I-T058
on	O
paper	O
microfluidic	B-T058
platforms	I-T058
through	O
chemical	O
modification	O
and	O
incorporation	O
of	O
nanoparticles	O
this	O
chapter	O
describes	O
two	O
different	O
methodologies	B-T062
used	O
to	O
improve	O
the	O
analytical	O
performance	O
of	O
colorimetric	B-T058
paper	O
-	O
based	O
biosensors	O
.	O
microfluidic	O
paper	O
-	O
based	O
analytical	O
devices	O
(	O
μ	O
##pa	O
##ds	O
)	O
have	O
been	O
produced	O
by	O
a	O
sta	O
##mp	O
##ing	O
process	O
and	O
co2	B-T103
laser	B-T058
ablation	I-T058
and	O
modified	O
,	O
respectively	O
,	O
through	O
an	O
oxidation	O
step	O
and	O
incorporation	O
of	O
silica	B-T103
nanoparticles	O
on	O
the	O
paper	O
structure	O
.	O
both	O
methods	B-T170
are	O
employed	O
in	O
order	O
to	O
overcome	O
the	O
largest	O
problem	B-T033
associated	O
with	O
colorimetric	B-T058
detection	I-T058
,	O
the	O
heterogeneity	O
of	O
the	O
color	O
distribution	O
in	O
the	O
detection	B-T082
zones	I-T082
.	O
the	O
modification	O
steps	O
are	O
necessary	O
to	O
improve	O
the	O
interaction	O
between	O
the	O
paper	O
surface	B-T082
and	O
the	O
selected	O
enzymes	B-T103
.	O
the	O
enhanced	O
performance	O
has	O
ensured	O
reliability	O
for	O
quantitative	O
analysis	B-T062
of	O
clinically	O
relevant	O
compounds	B-T103
.	O

open	B-T062
-	I-T062
label	I-T062
,	I-T062
multicentre	I-T062
safety	I-T062
study	I-T062
of	O
ve	B-T103
##mu	I-T103
##ra	I-T103
##fen	I-T103
##ib	I-T103
in	O
321	O
##9	O
patients	O
with	O
braf	B-T038
(	I-T038
v	I-T038
##600	I-T038
)	I-T038
mutation	I-T038
-	O
positive	B-T033
metastatic	B-T038
melanoma	I-T038
:	O
2	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
data	O
and	O
long	O
-	O
term	O
responders	B-T062
'	I-T062
analysis	I-T062
the	O
orally	B-T082
available	O
braf	B-T103
kinase	I-T103
inhibitor	I-T103
ve	B-T103
##mu	I-T103
##ra	I-T103
##fen	I-T103
##ib	I-T103
is	O
an	O
effective	O
and	O
tolerable	O
treatment	B-T058
option	I-T058
for	O
patients	O
with	O
metastatic	B-T038
melanoma	I-T038
harbour	O
##ing	O
braf	B-T038
(	I-T038
v	I-T038
##600	I-T038
)	I-T038
mutations	I-T038
.	O
we	O
assessed	O
the	O
safety	O
of	O
ve	B-T103
##mu	I-T103
##ra	I-T103
##fen	I-T103
##ib	I-T103
in	O
a	O
large	O
population	B-T098
of	O
patients	O
with	O
few	O
alternative	O
treatment	B-T058
options	I-T058
;	O
we	O
report	O
updated	O
2	O
-	O
year	O
safety	O
.	O
this	O
was	O
an	O
open	B-T062
-	I-T062
label	I-T062
,	I-T062
multicentre	I-T062
study	I-T062
of	O
ve	B-T103
##mu	I-T103
##ra	I-T103
##fen	I-T103
##ib	I-T103
(	O
96	O
##0	O
mg	O
bid	O
)	O
in	O
patients	O
with	O
previously	O
treated	O
or	O
untreated	B-T033
braf	B-T038
mutation	I-T038
-	O
positive	B-T033
metastatic	B-T038
melanoma	I-T038
(	O
cob	B-T074
##as	I-T074
(	I-T074
®	I-T074
)	I-T074
480	I-T074
##0	I-T074
braf	B-T058
v	I-T058
##600	I-T058
mutation	I-T058
test	I-T058
)	O
.	O
the	O
primary	O
end	O
-	O
point	O
was	O
safety	O
;	O
efficacy	O
end	O
-	O
points	O
were	O
secondary	O
.	O
an	O
exploratory	B-T062
analysis	I-T062
was	O
performed	O
to	O
assess	O
safety	O
outcomes	O
in	O
patients	O
with	O
long	O
duration	O
of	O
response	O
(	O
dor	O
)	O
(	O
≥1	O
##2	O
or	O
≥2	O
##4	O
months	O
)	O
.	O
after	O
a	O
median	B-T082
follow	B-T058
-	I-T058
up	I-T058
of	O
32	O
.	O
2	O
months	O
(	O
95	O
%	O
ci	O
,	O
31	O
.	O
1	O
-	O
33	O
.	O
2	O
months	O
)	O
,	O
307	O
##9	O
/	O
321	O
##9	O
patients	O
(	O
96	O
%	O
)	O
had	O
discontinued	B-T033
treatment	I-T033
.	O
adverse	B-T038
events	I-T038
(	O
aes	B-T038
)	O
were	O
largely	O
consistent	O
with	O
previous	O
reports	O
;	O
the	O
most	O
common	O
all	O
-	O
grade	O
treatment	O
-	O
related	O
aes	B-T038
were	O
arth	B-T033
##ral	I-T033
##gia	I-T033
(	O
37	O
%	O
)	O
,	O
alopecia	B-T038
(	O
25	O
%	O
)	O
and	O
hyper	B-T038
##ker	I-T038
##atosis	I-T038
(	O
23	O
%	O
)	O
;	O
the	O
most	O
common	O
grade	O
3	O
/	O
4	O
treatment	O
-	O
related	O
aes	B-T038
were	O
squamous	B-T038
cell	I-T038
carcinoma	I-T038
of	I-T038
the	I-T038
skin	I-T038
(	O
8	O
%	O
)	O
and	O
kerat	B-T038
##oac	I-T038
##anth	I-T038
##oma	I-T038
(	O
8	O
%	O
)	O
.	O
in	O
the	O
exploratory	B-T062
analysis	I-T062
,	O
patients	O
with	O
dor	O
≥1	O
##2	O
months	O
(	O
n	O
=	O
287	O
)	O
or	O
≥2	O
##4	O
months	O
(	O
n	O
=	O
133	O
)	O
were	O
more	O
likely	O
to	O
experience	O
grade	O
3	O
/	O
4	O
aes	B-T038
than	O
the	O
overall	O
population	B-T098
.	O
no	O
new	O
specific	O
safety	O
signals	O
were	O
observed	O
with	O
longer	O
ve	B-T033
##mu	I-T033
##ra	I-T033
##fen	I-T033
##ib	I-T033
exposure	I-T033
.	O
after	O
2	O
years	O
'	O
follow	B-T058
-	I-T058
up	I-T058
,	O
safety	O
was	O
maintained	O
in	O
this	O
large	O
group	O
of	O
patients	O
with	O
braf	B-T038
(	I-T038
v	I-T038
##600	I-T038
)	I-T038
mutation	I-T038
-	O
positive	B-T033
metastatic	B-T038
melanoma	I-T038
who	O
are	O
more	O
representative	O
of	O
routine	O
clinical	O
practice	O
than	O
typical	O
clinical	B-T062
trial	I-T062
populations	B-T098
.	O
these	O
data	O
suggest	O
that	O
long	O
-	O
term	O
ve	B-T103
##mu	I-T103
##ra	I-T103
##fen	I-T103
##ib	I-T103
treatment	O
is	O
effective	O
and	O
tolerable	O
without	O
the	O
development	O
of	O
new	O
safety	O
signals	O
.	O

tyr	B-T103
##phos	I-T103
##tin	I-T103
ag	I-T103
-	I-T103
related	I-T103
compounds	I-T103
attenuate	O
h2o2	B-T103
-	O
induced	O
trp	B-T103
##m2	I-T103
-	O
dependent	O
and	O
-	O
independent	O
cellular	B-T017
responses	O
trp	B-T103
##m2	I-T103
is	O
a	O
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	I-T103
permeable	I-T103
channel	I-T103
that	O
is	O
activated	O
by	O
h2o2	B-T103
.	O
trp	B-T103
##m2	I-T103
-	O
mediated	O
ca	B-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
signaling	I-T038
has	O
been	O
implicated	O
in	O
the	O
aggrav	B-T033
##ation	I-T033
of	O
inflammatory	B-T038
diseases	I-T038
.	O
therefore	O
,	O
the	O
development	O
of	O
trp	B-T103
##m2	I-T103
inhibitors	B-T103
to	O
prevent	O
the	O
aggrav	B-T033
##ation	I-T033
of	O
these	O
diseases	B-T038
is	O
expected	O
.	O
we	O
recently	O
reported	O
that	O
some	O
tyr	B-T103
##phos	I-T103
##tin	I-T103
ag	I-T103
-	I-T103
related	I-T103
compounds	I-T103
inhibited	O
the	O
h2o2	B-T103
-	O
induced	O
activation	O
of	O
trp	B-T103
##m2	I-T103
by	O
scavenging	B-T038
the	I-T038
intracellular	I-T038
hydroxyl	I-T038
radical	I-T038
.	O
in	O
the	O
present	O
study	O
,	O
we	O
examined	O
the	O
effects	O
of	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
on	O
h2o2	B-T103
-	O
induced	O
cellular	B-T017
responses	O
in	O
human	B-T204
monocytic	B-T017
u937	B-T017
cells	I-T017
,	O
which	O
functionally	O
express	B-T038
trp	B-T103
##m2	I-T103
.	O
the	O
effects	O
of	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
on	O
h2o2	B-T103
-	O
induced	O
changes	O
in	O
intracellular	B-T082
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
concentrations	O
,	O
extracellular	B-T103
signal	I-T103
-	I-T103
regulated	I-T103
kinase	I-T103
(	O
erk	B-T103
)	O
activation	O
,	O
and	O
cxcl	B-T103
##8	I-T103
secretion	B-T038
were	O
assessed	O
using	O
u937	B-T017
cells	I-T017
.	O
ca	B-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
influx	I-T038
##es	I-T038
via	O
trp	B-T103
##m2	I-T103
in	O
response	O
to	O
h2o2	B-T103
were	O
blocked	B-T038
by	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
.	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
also	O
inhibited	O
the	O
h2o2	B-T103
-	O
induced	O
activation	O
of	O
erk	B-T103
,	O
and	O
subsequent	O
secretion	B-T038
of	O
cxcl	B-T103
##8	I-T103
mediated	O
by	O
trp	B-T103
##m2	I-T103
-	O
dependent	O
and	O
-	O
independent	O
mechanisms	O
.	O
our	O
results	O
show	O
that	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
inhibit	O
h2o2	B-T103
-	O
induced	O
cxcl	B-T103
##8	I-T103
secretion	B-T038
following	O
erk	B-T103
activation	O
,	O
which	O
is	O
mediated	O
by	O
trp	B-T103
##m2	I-T103
-	O
dependent	O
and	O
-	O
independent	O
mechanisms	O
in	O
u937	B-T017
cells	I-T017
.	O
we	O
previously	O
reported	O
that	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
blocked	B-T038
h2o2	B-T103
-	O
induced	O
trp	B-T103
##m2	I-T103
activation	O
by	O
scavenging	B-T038
the	I-T038
hydroxyl	I-T038
radical	I-T038
.	O
the	O
inhibitory	O
effects	O
of	O
ag	B-T103
-	I-T103
related	I-T103
compounds	I-T103
on	O
trp	B-T103
##m2	I-T103
-	O
independent	O
responses	O
may	O
be	O
due	O
to	O
scavenging	B-T038
of	I-T038
the	I-T038
hydroxyl	I-T038
radical	I-T038
.	O

comparative	B-T058
evaluation	I-T058
of	O
iodine	B-T103
-	I-T103
131	I-T103
meta	I-T103
##iod	I-T103
##obenzyl	I-T103
##guan	I-T103
##idine	I-T103
and	O
18	B-T103
-	I-T103
fluorodeoxyglucose	I-T103
positron	B-T058
emission	I-T058
tomography	I-T058
in	O
assessing	O
neural	B-T038
crest	I-T038
tumors	I-T038
:	O
will	O
they	O
play	O
a	O
complementary	O
role	O
?	O
18	B-T103
-	I-T103
fluorodeoxyglucose	I-T103
positron	B-T058
emission	I-T058
tomography	I-T058
(	O
fdg	B-T058
-	I-T058
pet	I-T058
)	O
has	O
established	O
a	O
role	O
in	O
the	O
evaluation	O
of	O
several	O
malignancies	B-T038
.	O
however	O
,	O
its	O
precise	O
clinical	O
role	O
in	O
the	O
neural	B-T038
crest	I-T038
cell	I-T038
tumors	I-T038
continues	O
to	O
evolve	O
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
compare	O
iodine	B-T103
-	I-T103
131	I-T103
meta	I-T103
##iod	I-T103
##obenzyl	I-T103
##guan	I-T103
##idine	I-T103
(	O
(	B-T103
131	I-T103
)	I-T103
i	I-T103
-	I-T103
mibg	I-T103
)	O
and	O
fdg	B-T058
-	I-T058
pet	I-T058
of	O
head	O
to	O
head	O
in	O
patients	O
with	O
neural	B-T038
crest	I-T038
tumors	I-T038
both	O
qualitatively	O
and	O
semiquantitative	O
##ly	O
and	O
to	O
determine	O
their	O
clinical	B-T033
utility	I-T033
in	O
disease	B-T033
status	I-T033
evaluation	I-T033
and	O
further	B-T058
management	I-T058
.	O
a	O
total	O
of	O
32	O
patients	O
who	O
had	O
undergone	O
(	B-T103
131	I-T103
)	I-T103
i	I-T103
-	I-T103
mibg	I-T103
and	O
fdg	B-T058
-	I-T058
pet	I-T058
prospectively	O
were	O
evaluated	O
and	O
clinicopathological	O
##ly	O
grouped	O
into	O
three	O
categories	O
:	O
neuroblastoma	B-T038
,	O
pheochromocytoma	B-T038
,	O
and	O
medullary	B-T038
carcinoma	I-T038
thyroid	I-T038
.	O
in	O
18	O
patients	O
of	O
neuroblastoma	B-T038
,	O
fdg	B-T058
pet	I-T058
and	O
(	B-T103
131	I-T103
)	I-T103
i	I-T103
-	I-T103
mibg	I-T103
showed	O
patient	B-T033
-	I-T033
specific	I-T033
sensitivity	I-T033
of	O
84	O
%	O
and	O
72	O
%	O
,	O
respectively	O
.	O
the	O
mean	O
maximum	O
standardized	O
uptake	O
value	O
(	O
suvmax	O
)	O
of	O
primary	B-T038
lesions	I-T038
in	O
patients	O
with	O
unfavorable	O
histology	O
was	O
found	O
to	O
be	O
relatively	O
higher	O
than	O
those	O
with	O
favorable	O
histology	O
(	O
5	O
.	O
18	O
±	O
2	O
.	O
38	O
vs	O
.	O
3	O
.	O
21	O
±	O
1	O
.	O
69	O
)	O
.	O
the	O
mean	O
suvmax	O
of	O
two	O
common	O
sites	O
(	O
posterior	B-T017
superior	I-T017
iliac	I-T017
spine	I-T017
[	O
psi	B-T017
##s	I-T017
]	O
and	O
greater	B-T017
troch	I-T017
##anter	I-T017
)	O
was	O
higher	O
in	O
patients	O
with	O
involved	O
marrow	B-T017
than	O
those	O
with	O
unin	O
##vo	O
##lv	O
##ed	O
one	O
(	O
2	O
.	O
36	O
and	O
2	O
.	O
75	O
vs	O
.	O
1	O
.	O
26	O
and	O
1	O
.	O
34	O
,	O
respectively	O
)	O
.	O
the	O
ratio	O
of	O
suvmax	O
of	O
the	O
involved	O
/	O
contralateral	B-T082
normal	I-T082
sites	I-T082
was	O
2	O
.	O
16	O
±	O
1	O
.	O
9	O
.	O
in	O
equivocal	O
bone	B-T033
marrow	I-T033
results	I-T033
,	O
the	O
uptake	O
pattern	O
with	O
suv	O
estimation	O
can	O
depic	O
##t	O
metastatic	O
involvement	O
and	O
help	O
in	O
red	O
##irect	O
##ing	O
the	O
biopsy	B-T201
site	I-T201
.	O
among	O
seven	O
patients	O
of	O
pheochromocytoma	B-T038
,	O
fdg	B-T058
-	I-T058
pet	I-T058
revealed	O
100	O
%	O
patient	B-T033
-	I-T033
specific	I-T033
sensitivity	I-T033
.	O
fdg	B-T058
-	I-T058
pet	I-T058
detected	O
more	O
metastatic	B-T082
foci	I-T082
than	O
(	B-T103
131	I-T103
)	I-T103
i	I-T103
-	I-T103
mibg	I-T103
(	O
18	O
vs	O
.	O
13	O
sites	O
)	O
.	O
in	O
seven	O
patients	O
of	O
medullary	B-T038
carcinoma	I-T038
thyroid	I-T038
,	O
fdg	B-T058
-	I-T058
pet	I-T058
localized	O
residual	O
,	O
recurrent	B-T038
,	O
or	O
metastatic	B-T038
disease	I-T038
with	O
much	O
higher	O
sensitivity	O
(	O
32	O
metastatic	B-T082
foci	I-T082
with	O
72	O
%	O
patient	B-T033
specific	I-T033
sensitivity	I-T033
)	O
than	O
(	B-T103
131	I-T103
)	I-T103
i	I-T103
-	I-T103
mibg	I-T103
,	O
trend	O
##ing	O
along	O
the	O
higher	B-T058
serum	I-T058
calcitonin	I-T058
levels	I-T058
.	O
fdg	B-T058
-	I-T058
pet	I-T058
is	O
not	O
only	O
a	O
good	O
complementary	O
modality	O
in	O
the	O
management	O
of	O
neural	B-T038
crest	I-T038
cell	I-T038
tumors	I-T038
but	O
also	O
it	O
can	O
even	O
be	O
superior	O
,	O
especially	O
in	O
cases	O
of	O
(	B-T103
131	I-T103
)	I-T103
i	I-T103
-	I-T103
mibg	I-T103
non	B-T038
##avi	I-T038
##d	I-T038
tumors	I-T038
.	O

a	O
closer	O
look	O
at	O
school	B-T092
bonding	B-T038
among	O
african	B-T098
american	I-T098
adolescents	O
in	O
low	B-T098
-	I-T098
income	I-T098
communities	I-T098
:	O
a	O
latent	B-T062
class	I-T062
analysis	I-T062
positive	B-T033
school	B-T092
bonding	B-T038
is	O
a	O
significant	O
precursor	O
to	O
students	B-T098
'	O
school	B-T092
success	O
.	O
however	O
,	O
african	B-T098
american	I-T098
youth	O
report	O
lower	O
school	B-T092
success	O
compared	O
with	O
their	O
white	B-T098
counterparts	I-T098
.	O
this	O
study	B-T062
examined	O
correlates	O
of	O
school	B-T092
bonding	B-T038
among	O
63	O
##3	O
african	B-T098
american	I-T098
youth	O
who	O
were	O
recruited	O
from	O
community	O
settings	O
in	O
chicago	B-T082
.	O
major	O
findings	B-T033
indicated	O
that	O
negative	B-T033
peer	I-T033
norms	I-T033
,	O
exposure	O
to	O
community	O
violence	O
,	O
and	O
poor	O
mental	B-T038
health	I-T038
were	O
negatively	B-T033
correlated	O
with	O
school	B-T092
bonding	B-T038
,	O
while	O
parental	O
monitoring	O
,	O
positive	O
self	O
-	O
regard	O
,	O
and	O
future	O
orientation	B-T038
were	O
correlated	O
with	O
higher	O
school	B-T092
motivation	B-T038
.	O
students	B-T098
classified	B-T170
as	O
having	O
high	O
or	O
moderate	O
school	B-T092
bonding	B-T038
were	O
more	O
likely	O
to	O
live	O
with	O
both	O
parents	O
,	O
experience	B-T038
higher	O
levels	O
of	O
parental	O
monitoring	O
,	O
and	O
exhibit	O
positive	O
self	O
-	O
regard	O
.	O
implications	O
are	O
discussed	O
in	O
view	O
of	O
these	O
findings	B-T033
.	O

mesenchymal	B-T017
stromal	I-T017
cells	I-T017
in	O
clinical	O
kidney	B-T058
transplantation	I-T058
:	O
how	O
tolerant	O
can	O
it	O
be	O
?	O
progress	O
in	O
the	O
improvement	O
of	O
short	O
-	O
term	O
and	O
long	O
-	O
term	O
outcomes	O
of	O
kidney	B-T058
transplantation	I-T058
seems	O
to	O
have	O
reached	O
a	O
plateau	O
,	O
partially	O
due	O
to	O
consequences	O
of	O
very	O
efficient	O
,	O
but	O
nonspecific	O
immunosuppressive	B-T103
drugs	I-T103
.	O
in	O
recent	O
years	O
,	O
various	O
forms	O
of	O
cell	B-T058
therapy	I-T058
,	O
including	O
the	O
use	O
of	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
,	O
have	O
been	O
put	O
forward	O
as	O
an	O
alternative	O
strategy	O
for	O
more	O
defined	O
therapy	B-T058
.	O
it	O
is	O
thought	O
that	O
these	O
therapies	B-T058
will	O
not	O
only	O
allow	O
controlled	O
tape	B-T058
##ring	I-T058
of	O
immunosuppressive	B-T103
medication	I-T103
,	O
but	O
might	O
bring	O
us	O
also	O
closer	O
to	O
the	O
amb	O
##ition	O
of	O
generating	O
donor	B-T098
-	O
specific	O
immune	B-T038
regulation	I-T038
and	O
tolerance	B-T038
.	O
different	O
forms	O
of	O
allo	O
##immun	O
##ity	O
,	O
including	O
direct	O
,	O
indirect	O
and	O
semi	O
-	O
direct	O
allo	B-T103
##antigen	I-T103
presentation	O
have	O
to	O
be	O
controlled	O
before	O
donor	B-T098
-	O
specific	O
immune	B-T038
regulation	I-T038
can	O
be	O
reached	O
.	O
several	O
mechanisms	O
have	O
been	O
described	O
how	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
can	O
affect	O
allo	O
##immun	O
##ity	O
.	O
especially	O
,	O
the	O
interaction	B-T038
with	O
professional	O
antigen	B-T017
presenting	I-T017
cells	I-T017
,	O
like	O
dendritic	B-T017
cells	I-T017
,	O
is	O
of	O
critical	O
importance	O
.	O
this	O
review	O
will	O
discuss	O
the	O
current	O
status	O
of	O
ongoing	O
clinical	B-T062
trials	I-T062
with	O
mesenchymal	B-T017
stromal	I-T017
cells	I-T017
in	O
kidney	B-T058
transplantation	I-T058
and	O
specifically	O
concentrate	O
on	O
the	O
possibilities	O
and	O
imposs	O
##ibilities	O
of	O
how	O
these	O
therapeutic	B-T058
strategies	I-T058
can	O
contribute	O
to	O
control	O
of	O
the	O
different	O
forms	O
of	O
allo	O
##re	O
##activity	O
operation	O
in	O
organ	B-T058
transplantation	I-T058
.	O

optimization	O
of	O
early	O
response	B-T058
monitoring	I-T058
and	O
prediction	O
of	O
cancer	B-T038
anti	B-T058
##angi	I-T058
##ogenesis	I-T058
therapy	I-T058
via	O
noninvasive	B-T170
pet	B-T058
molecular	I-T058
imaging	I-T058
strategies	O
of	O
multifactorial	B-T033
biop	O
##ara	O
##meter	O
##s	O
objective	O
:	O
anti	B-T058
##angi	I-T058
##ogenesis	I-T058
therapy	I-T058
(	O
aat	B-T058
)	O
has	O
provided	O
substantial	O
benefits	O
regarding	O
improved	O
outcomes	O
and	O
survival	O
for	O
suitable	O
patients	O
in	O
clinical	O
settings	O
.	O
therefore	O
,	O
the	O
early	O
definition	O
of	O
therapeutic	B-T201
effects	I-T201
is	O
urgently	O
needed	O
to	O
guide	O
cancer	B-T038
aat	B-T058
.	O
we	O
aimed	O
to	O
optimize	O
the	O
early	O
response	B-T058
monitoring	I-T058
and	O
prediction	O
of	O
aat	B-T058
efficacy	O
,	O
as	O
indicated	O
by	O
the	O
multi	O
-	O
targeted	O
anti	B-T103
-	I-T103
angiogenic	I-T103
drug	I-T103
sunitinib	B-T103
in	O
u	B-T038
##87	I-T038
##mg	I-T038
tumors	I-T038
,	O
using	O
noninvasive	B-T170
positron	B-T058
emission	I-T058
computed	I-T058
tomography	I-T058
(	I-T058
pet	I-T058
)	I-T058
molecular	I-T058
imaging	I-T058
strategies	O
of	O
multifactorial	B-T033
biop	O
##ara	O
##meter	O
##s	O
.	O
methods	O
:	O
u	B-T038
##87	I-T038
##mg	I-T038
tumor	I-T038
mice	B-T204
were	O
treated	O
via	O
intragastric	B-T082
injections	B-T058
of	O
sunitinib	B-T103
(	O
80	O
mg	O
/	O
kg	O
)	O
or	O
vehicle	B-T103
for	O
7	O
consecutive	O
days	O
.	O
longitudinal	B-T082
microp	B-T058
##et	I-T058
/	I-T058
ct	I-T058
scans	I-T058
with	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
fdg	I-T103
,	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
fm	I-T103
##iso	I-T103
,	I-T103
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
ml	I-T103
-	I-T103
10	I-T103
and	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
alfa	I-T103
##tide	I-T103
ii	I-T103
were	O
acquired	O
to	O
quantitatively	O
measure	O
metabolism	B-T038
,	O
hypoxia	B-T038
,	O
apoptosis	B-T038
and	O
angiogenesis	B-T038
on	O
days	O
0	O
,	O
1	O
,	O
3	O
,	O
7	O
and	O
13	O
following	O
therapy	B-T058
initiation	O
.	O
tumor	B-T017
tissues	I-T017
from	O
a	O
dedicated	O
group	O
of	O
mice	B-T204
were	O
collected	O
for	O
immunohistochemical	O
(	O
ihc	O
)	O
analysis	O
of	O
key	O
biomarkers	B-T103
(	O
glut	B-T103
-	I-T103
1	I-T103
,	O
ca	B-T103
-	I-T103
ix	I-T103
,	O
tunel	O
,	O
α	B-T103
##ν	I-T103
##β	I-T103
##3	I-T103
and	O
cd31	B-T103
)	O
at	O
the	O
time	O
points	O
of	O
pet	B-T058
imaging	I-T058
.	O
the	O
tumor	B-T082
sizes	I-T082
and	O
mouse	B-T204
weights	O
were	O
measured	O
throughout	O
the	O
study	O
.	O
the	O
tumor	B-T038
uptake	B-T038
(	O
id	O
%	O
/	O
gm	O
##ax	O
)	O
,	O
the	O
ratios	O
of	O
the	O
tumor	B-T038
/	O
muscle	B-T017
(	O
t	B-T038
/	O
m	B-T017
)	O
for	O
each	O
probe	O
,	O
and	O
the	O
tumor	O
growth	O
ratios	O
(	O
tg	O
##r	O
)	O
were	O
calculated	O
and	O
used	O
for	O
statistical	O
analyses	O
of	O
the	O
differences	O
and	O
correlations	O
.	O
results	O
:	O
sunitinib	B-T103
successfully	O
inhibited	O
u	O
##87	O
##mg	O
tumor	O
growth	O
with	O
significant	O
differences	O
in	O
the	O
tumor	B-T082
size	I-T082
from	O
day	O
9	O
after	O
sunitinib	B-T103
treatment	B-T058
compared	O
with	O
the	O
control	O
group	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
the	O
uptake	B-T038
##s	I-T038
of	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
fm	I-T103
##iso	I-T103
(	O
reduced	O
hypoxia	B-T038
)	O
,	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
ml	I-T103
-	I-T103
10	I-T103
(	O
increased	O
apoptosis	B-T038
)	O
and	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
alfa	I-T103
##tide	I-T103
ii	I-T103
(	O
decreased	O
angiogenesis	B-T038
)	O
in	O
the	O
tumor	B-T038
lesions	B-T033
significantly	O
changed	O
during	O
the	O
early	O
stage	O
(	O
days	O
1	O
to	O
3	O
)	O
of	O
sunitinib	B-T103
treatment	B-T058
;	O
however	O
,	O
the	O
uptake	B-T038
of	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
fdg	I-T103
(	O
increased	O
glucose	B-T038
metabolism	I-T038
)	O
was	O
significantly	O
different	O
during	O
the	O
late	O
stage	O
.	O
the	O
pet	B-T058
imaging	I-T058
data	O
of	O
each	O
probe	O
were	O
all	O
confirmed	O
via	O
ex	O
vivo	O
ihc	O
of	O
the	O
relevant	O
biomarkers	B-T103
.	O
notably	O
,	O
the	O
pet	B-T058
imaging	I-T058
of	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
alfa	I-T103
##tide	I-T103
ii	I-T103
and	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
fm	I-T103
##iso	I-T103
was	O
significantly	O
correlated	O
(	O
all	O
p	O
<	O
0	O
.	O
05	O
)	O
with	O
tg	O
##r	O
,	O
whereas	O
the	O
imaging	O
of	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
fdg	I-T103
and	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
ml	I-T103
-	I-T103
10	I-T103
was	O
not	O
significantly	O
correlated	O
with	O
tg	O
##r	O
.	O
conclusion	O
:	O
based	O
on	O
the	O
tumor	B-T038
uptake	B-T038
of	O
the	O
pet	B-T058
probes	O
and	O
their	O
correlations	O
with	O
mvd	O
and	O
tg	O
##r	O
,	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
alfa	I-T103
##tide	I-T103
ii	I-T103
pet	B-T058
may	O
not	O
only	O
monitor	O
the	O
early	O
response	B-T058
but	O
also	O
precisely	O
predict	O
the	O
therapeutic	O
efficacy	O
of	O
the	O
multi	O
-	O
targeted	O
,	O
anti	B-T103
-	I-T103
angiogenic	I-T103
drug	I-T103
sunitinib	B-T103
in	O
u	B-T038
##87	I-T038
##mg	I-T038
tumors	I-T038
.	O
in	O
conclusion	O
,	O
it	O
is	O
feasible	O
to	O
optimize	O
the	O
early	O
response	B-T058
monitoring	I-T058
and	O
efficacy	O
prediction	O
of	O
cancer	B-T038
aat	B-T058
using	O
noninvasive	B-T170
pet	B-T058
molecular	I-T058
imaging	I-T058
strategies	O
of	O
multifactorial	B-T033
biop	O
##ara	O
##meter	O
##s	O
,	O
such	O
as	O
angiogenesis	B-T038
imaging	B-T058
with	O
(	B-T103
18	I-T103
)	I-T103
f	I-T103
-	I-T103
alfa	I-T103
##tide	I-T103
ii	I-T103
,	O
which	O
represents	O
an	O
rgd	B-T103
-	O
based	O
probe	O
.	O

pre	B-T033
-	I-T033
activation	I-T033
negativity	I-T033
(	O
pra	B-T033
##n	I-T033
)	O
in	O
brain	B-T017
potentials	O
to	O
unfolding	B-T038
words	I-T038
we	O
describe	O
an	O
event	B-T038
-	I-T038
related	I-T038
potential	I-T038
(	O
erp	B-T038
)	O
effect	O
termed	O
the	O
[UNK]	O
pre	B-T033
-	I-T033
activation	I-T033
negativity	I-T033
[UNK]	O
(	O
pra	B-T033
##n	I-T033
)	O
,	O
which	O
is	O
proposed	O
to	O
index	B-T170
the	O
degree	O
of	O
pre	O
-	O
activation	O
of	O
up	O
##coming	O
word	O
-	O
internal	B-T082
morph	O
##emes	O
in	O
speech	B-T038
processing	O
.	O
using	O
lexical	O
competition	O
measures	O
based	O
on	O
word	O
-	O
initial	O
speech	O
fragments	O
(	O
wi	O
##fs	O
)	O
,	O
as	O
well	O
as	O
statistical	O
analyses	O
of	O
erp	B-T038
data	O
from	O
three	O
experiments	B-T062
,	O
it	O
is	O
shown	O
that	O
the	O
pra	B-T033
##n	I-T033
is	O
sensitive	O
to	O
lexical	O
competition	O
and	O
that	O
it	O
reflects	O
the	O
degree	O
of	O
predictive	O
certainty	O
:	O
the	O
negativity	B-T033
is	O
larger	O
when	O
there	O
are	O
fewer	O
up	O
##coming	O
lexical	O
competit	B-T098
##ors	I-T098
.	O

targeting	O
hif	B-T103
##2	I-T103
in	O
clear	B-T038
cell	I-T038
renal	I-T038
cell	I-T038
carcinoma	I-T038
inactivation	O
of	O
the	O
von	B-T103
hipp	I-T103
##el	I-T103
-	I-T103
lind	I-T103
##au	I-T103
tumor	I-T103
-	I-T103
suppressor	I-T103
protein	I-T103
(	O
pv	B-T103
##hl	I-T103
)	O
is	O
the	O
signature	B-T033
[UNK]	I-T033
trunc	I-T033
##al	I-T033
[UNK]	I-T033
event	I-T033
in	O
clear	B-T038
cell	I-T038
renal	I-T038
cell	I-T038
carcinoma	I-T038
,	O
which	O
is	O
the	O
most	O
common	O
form	O
of	O
kidney	B-T038
cancer	I-T038
.	O
pv	B-T103
##hl	I-T103
is	O
part	O
of	O
a	O
ubiquitin	B-T103
ligase	I-T103
the	O
targets	O
the	O
α	B-T103
subunit	I-T103
of	O
the	O
hypoxia	B-T103
-	I-T103
inducible	I-T103
factor	I-T103
(	I-T103
hif	I-T103
)	I-T103
transcription	I-T103
factor	I-T103
for	O
destruction	O
when	O
oxygen	O
is	O
available	O
.	O
preclinical	O
studies	B-T062
strongly	O
suggest	O
that	O
deregulation	B-T038
of	O
hif	B-T103
,	O
and	O
particularly	O
hif	B-T103
##2	I-T103
,	O
drives	O
pv	B-T103
##hl	I-T103
-	O
defective	O
renal	B-T038
carcinogenesis	I-T038
.	O
although	O
hif	B-T103
##2	I-T103
##α	I-T103
was	O
classically	O
considered	O
und	O
##rug	O
##ga	O
##ble	O
,	O
structural	O
and	O
chemical	O
work	O
by	O
rick	O
br	O
##ui	O
##ck	O
and	O
kev	O
##in	O
gard	O
##ner	O
at	O
university	B-T092
of	I-T092
texas	I-T092
southwestern	I-T092
laid	O
the	O
foundation	O
for	O
the	O
development	O
of	O
small	B-T103
molecule	I-T103
direct	O
hif	B-T103
##2	I-T103
##α	I-T103
antagonists	I-T103
(	O
pt	B-T103
##23	I-T103
##85	I-T103
and	O
the	O
related	O
tool	O
compound	O
pt	B-T103
##23	I-T103
##99	I-T103
)	O
by	O
pel	B-T092
##oton	I-T092
therapeutics	I-T092
that	O
block	O
the	O
dimerization	B-T038
of	O
hif	B-T103
##2	I-T103
##α	I-T103
with	O
its	O
partner	O
protein	B-T103
ar	I-T103
##nt	I-T103
##1	I-T103
.	O
these	O
compounds	O
inhibit	B-T038
clear	I-T038
cell	I-T038
renal	I-T038
cell	I-T038
carcinoma	I-T038
growth	I-T038
in	O
preclinical	B-T170
models	I-T170
,	O
and	O
pt	B-T103
##23	I-T103
##85	I-T103
has	O
now	O
entered	O
the	O
clinic	B-T092
.	O
nonetheless	O
,	O
the	O
availability	O
of	O
such	B-T103
compounds	I-T103
,	O
together	O
with	O
clustered	B-T103
regularly	I-T103
intersp	I-T103
##aced	I-T103
short	I-T103
pal	I-T103
##ind	I-T103
##romic	I-T103
repeat	I-T103
(	O
crispr	B-T103
)	O
-	O
based	O
gene	B-T062
editing	I-T062
approaches	I-T062
,	O
has	O
revealed	O
a	O
previously	O
un	O
##app	O
##rec	O
##iated	O
heterogeneity	O
among	O
clear	B-T038
cell	I-T038
renal	I-T038
carcinomas	I-T038
and	O
patient	O
-	O
derived	O
xenografts	B-T058
with	O
respect	O
to	O
hif	B-T103
##2	I-T103
dependence	O
,	O
suggesting	O
that	O
predictive	B-T103
biomarkers	I-T103
will	O
be	O
needed	O
to	O
optimize	O
the	O
use	O
of	O
such	B-T103
agents	I-T103
in	O
the	O
clinic	B-T092
.	O

three	O
-	O
dimensional	O
construct	O
##ive	O
interference	O
in	O
steady	O
-	O
state	O
(	O
3d	O
-	O
cis	O
##s	O
)	O
sequences	O
and	O
phase	B-T058
-	I-T058
contrast	I-T058
mri	I-T058
of	O
arrested	B-T038
hydrocephalus	I-T038
to	O
evaluate	O
role	O
of	O
three	O
-	O
dimensional	O
construct	O
##ive	O
interference	O
in	O
steady	O
-	O
state	O
(	O
3d	O
-	O
cis	O
##s	O
)	O
sequences	O
and	O
phase	B-T058
-	I-T058
contrast	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	O
pc	B-T058
-	I-T058
mri	I-T058
)	O
in	O
patients	O
with	O
arrested	B-T038
hydrocephalus	I-T038
.	O
prospective	B-T062
study	I-T062
was	O
conducted	O
on	O
20	O
patients	O
with	O
arrested	B-T038
hydrocephalus	I-T038
.	O
all	O
patients	O
underwent	O
pc	B-T058
-	I-T058
mri	I-T058
and	O
3d	O
-	O
cis	O
##s	O
for	O
assessment	B-T058
of	O
the	O
aqu	B-T082
##ed	I-T082
##uct	I-T082
.	O
axial	B-T082
(	O
through	O
-	O
plane	O
)	O
,	O
sagittal	B-T082
(	O
in	O
-	O
plane	O
)	O
pc	B-T058
-	I-T058
mri	I-T058
and	O
sagittal	B-T082
3d	O
-	O
cis	O
##s	O
were	O
applied	O
to	O
assess	O
the	O
cerebral	B-T082
aqu	I-T082
##ed	I-T082
##uct	I-T082
and	O
the	O
spontaneous	O
third	O
ventricul	O
##ostomy	O
if	O
present	O
.	O
aqu	B-T082
##ed	I-T082
##uctal	I-T082
patency	B-T082
was	O
graded	B-T170
using	O
3d	O
-	O
cis	O
##s	O
and	O
pc	B-T058
-	I-T058
mri	I-T058
.	O
quantitative	B-T058
analysis	I-T058
of	O
flow	O
through	O
the	O
aqu	B-T082
##ed	I-T082
##uct	I-T082
was	O
done	O
using	O
pc	B-T058
-	I-T058
mri	I-T058
.	O
the	O
causes	O
of	O
obstruction	B-T038
were	O
aqu	B-T082
##ed	I-T082
##uctal	I-T082
obstruction	B-T038
in	O
75	O
%	O
(	O
n	O
=	O
15	O
)	O
,	O
3rd	O
ventricular	B-T038
obstruction	I-T038
in	O
5	O
%	O
(	O
n	O
=	O
1	O
)	O
and	O
4th	O
ventricular	B-T038
obstruction	I-T038
in	O
20	O
%	O
(	O
n	O
=	O
4	O
)	O
.	O
the	O
cause	O
of	O
arrest	O
of	O
hydrocephalus	B-T038
was	O
spontaneous	O
third	O
ventricul	O
##ostomy	O
in	O
65	O
%	O
(	O
n	O
=	O
13	O
)	O
,	O
endoscopic	B-T058
third	I-T058
ventricul	I-T058
##ostomy	I-T058
in	O
10	O
%	O
(	O
n	O
=	O
2	O
)	O
,	O
ventricul	B-T074
##o	I-T074
-	I-T074
peritoneal	I-T074
shunt	I-T074
in	O
5	O
%	O
(	O
n	O
=	O
1	O
)	O
and	O
no	O
cause	O
could	O
be	O
detected	B-T033
in	O
20	O
%	O
of	O
patients	O
(	O
n	O
=	O
4	O
)	O
.	O
there	O
is	O
a	O
positive	B-T033
correlation	O
(	O
r	O
=	O
0	O
.	O
80	O
)	O
and	O
moderate	O
agreement	O
(	O
κ	O
=	O
0	O
.	O
50	O
##9	O
)	O
of	O
grading	B-T170
with	O
pc	B-T058
-	I-T058
mri	I-T058
and	O
3d	O
-	O
cis	O
##s	O
sequences	O
.	O
the	O
mean	O
peak	O
systolic	O
velocity	O
of	O
csf	B-T031
was	O
1	O
.	O
86	O
±	O
2	O
.	O
48	O
cm	O
/	O
sec	O
,	O
the	O
stroke	B-T201
volume	I-T201
was	O
6	O
.	O
43	O
±	O
13	O
.	O
81	O
##μ	O
##l	O
/	O
cycle	O
,	O
and	O
the	O
mean	O
flow	O
was	O
0	O
.	O
21	O
±	O
0	O
.	O
32	O
ml	O
/	O
min	O
.	O
we	O
concluded	O
that	O
3d	O
-	O
cis	O
##s	O
and	O
pc	B-T058
-	I-T058
mri	I-T058
are	O
non	O
-	O
invasive	O
sequences	O
for	O
diagnosis	B-T033
of	O
the	O
level	O
and	O
cause	O
of	O
arrested	B-T038
hydrocephalus	I-T038
.	O

endoth	B-T058
##ermal	I-T058
venous	I-T058
ablation	I-T058
of	O
the	O
saphenous	B-T017
vein	I-T017
on	O
patients	O
who	O
are	O
on	O
anticoagulation	B-T058
therapy	I-T058
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
risks	O
of	O
bleeding	B-T038
,	O
deep	B-T038
venous	I-T038
thrombosis	I-T038
(	O
dvt	B-T038
)	O
,	O
endo	B-T038
##venous	I-T038
heat	I-T038
induced	I-T038
thrombosis	I-T038
(	O
eh	B-T038
##it	I-T038
)	O
and	O
failure	O
of	O
ablation	B-T058
on	O
patients	O
who	O
undergo	O
ablation	B-T058
while	O
on	O
oral	B-T058
anticoagulation	I-T058
.	O
we	O
compared	O
378	O
(	O
3	O
.	O
4	O
%	O
)	O
out	O
of	O
112	O
##52	O
patients	O
(	O
group	B-T170
a	I-T170
)	O
who	O
had	O
undergone	O
72	O
##4	O
endo	B-T058
##venous	I-T058
ablation	I-T058
of	O
the	O
saphenous	B-T017
veins	I-T017
from	O
january	O
1	O
,	O
2011	O
to	O
september	O
30	O
,	O
2014	O
while	O
on	O
oral	B-T058
anticoagulation	I-T058
to	O
a	O
randomly	O
selected	O
375	O
patients	O
(	O
group	B-T170
b	I-T170
)	O
who	O
underwent	O
64	O
##1	O
endo	B-T058
##venous	I-T058
ablation	I-T058
in	O
the	O
same	O
time	O
period	O
but	O
were	O
not	O
on	O
anticoagulation	B-T058
.	O
the	O
demographic	O
data	O
,	O
history	B-T033
of	I-T033
dvt	B-T038
,	O
the	O
clinical	O
,	O
etiologic	O
,	O
anatomic	O
,	O
pathologic	O
(	O
cea	O
##p	O
)	O
classification	B-T170
and	O
the	O
vc	O
##ss	O
(	O
venous	O
clinical	O
severity	O
score	O
)	O
scores	O
were	O
analyzed	O
.	O
the	O
indications	O
for	O
anticoagulation	B-T058
,	O
the	O
anticoagulants	B-T103
used	O
were	O
recorded	O
.	O
the	O
primary	O
endpoints	O
were	O
bleeding	B-T038
,	O
development	O
of	O
dvt	B-T038
or	O
eh	B-T038
##it	I-T038
,	O
and	O
failure	O
of	O
ablation	B-T058
.	O
patients	O
in	O
group	B-T170
a	I-T170
were	O
older	O
,	O
had	O
more	O
men	B-T098
,	O
more	O
history	O
of	O
dvt	B-T038
and	O
pe	B-T038
,	O
had	O
higher	O
cea	O
##p	O
and	O
vc	O
##ss	O
scores	O
compared	O
to	O
group	B-T170
b	I-T170
.	O
the	O
type	O
of	O
anticoagulation	B-T058
used	O
was	O
warfarin	B-T103
in	O
77	O
.	O
2	O
%	O
direct	B-T103
oral	I-T103
inhibitors	I-T103
(	O
doi	B-T103
##s	I-T103
)	O
in	O
22	O
.	O
8	O
%	O
.	O
the	O
rate	O
of	O
failure	O
of	O
ablation	B-T058
at	O
3	O
days	O
was	O
39	O
(	O
5	O
.	O
6	O
%	O
)	O
for	O
group	B-T170
a	I-T170
and	O
3	O
(	O
0	O
.	O
5	O
%	O
)	O
for	O
group	B-T170
b	I-T170
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
and	O
at	O
one	O
month	O
it	O
was	O
46	O
(	O
10	O
.	O
1	O
%	O
)	O
vs	O
.	O
27	O
(	O
6	O
.	O
7	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
08	O
##6	O
)	O
.	O
the	O
number	O
of	O
eh	B-T038
##it	I-T038
cases	O
in	O
group	B-T170
a	I-T170
at	O
3	O
days	O
was	O
2	O
(	O
0	O
.	O
3	O
%	O
)	O
,	O
compared	O
to	O
6	O
(	O
0	O
.	O
9	O
%	O
)	O
in	O
group	B-T170
b	I-T170
(	O
p	O
=	O
0	O
.	O
016	O
)	O
and	O
at	O
1	O
month	O
it	O
was	O
0	O
compared	O
to	O
4	O
(	O
1	O
.	O
0	O
%	O
)	O
(	O
p	O
=	O
0	O
.	O
048	O
##3	O
)	O
.	O
the	O
dvt	B-T038
,	O
sv	B-T038
##t	I-T038
,	O
hematoma	B-T038
and	O
wound	B-T038
infection	I-T038
rates	O
were	O
similar	O
in	O
the	O
two	O
groups	O
.	O
ablation	B-T058
of	O
the	O
saphenous	B-T017
veins	I-T017
in	O
patients	O
who	O
are	O
on	O
oral	B-T058
anticoagulation	I-T058
is	O
safe	O
and	O
does	O
not	O
increase	O
the	O
risk	O
of	O
bleeding	B-T038
or	O
hematoma	B-T038
,	O
but	O
it	O
may	O
slightly	O
lower	O
the	O
incidence	O
of	O
eh	B-T038
##it	I-T038
and	O
increase	O
the	O
incidence	O
of	O
failure	O
of	O
ablation	B-T058
.	O

a	O
pilot	B-T062
study	I-T062
of	O
intraocular	B-T058
lens	I-T058
explant	I-T058
##ation	I-T058
in	O
69	O
eyes	B-T017
in	O
chinese	O
patients	O
to	O
study	O
the	O
effects	O
of	O
intraocular	B-T058
lens	I-T058
(	I-T058
iol	I-T058
)	I-T058
explant	I-T058
##ation	I-T058
and	O
demographic	O
characteristics	O
.	O
retrospective	O
non	B-T062
-	I-T062
comparative	I-T062
case	I-T062
series	I-T062
.	O
clinical	B-T170
data	I-T170
recorded	O
from	O
patient	O
charts	O
included	O
the	O
following	O
:	O
demographic	O
,	O
preoperative	B-T058
and	O
postoperative	O
characteristics	O
;	O
complications	B-T038
;	O
surgical	O
methods	O
,	O
and	O
changes	O
in	O
visual	B-T058
acuity	I-T058
.	O
a	O
total	O
of	O
69	O
eyes	B-T017
in	O
67	O
chinese	B-T098
patients	O
who	O
received	O
iol	B-T058
explants	I-T058
were	O
studied	O
.	O
the	O
patients	O
'	O
mean	O
age	O
at	O
the	O
time	O
of	O
explant	O
##ation	O
was	O
46	O
.	O
1	O
years	O
old	O
[	O
sd	O
22	O
.	O
5	O
(	O
6	O
-	O
85	O
)	O
]	O
,	O
and	O
37	O
patients	O
were	O
female	O
(	O
55	O
.	O
2	O
%	O
)	O
.	O
regarding	O
employment	O
,	O
47	O
.	O
8	O
%	O
were	O
farmers	B-T097
,	O
23	O
.	O
9	O
%	O
were	O
retire	B-T097
##d	I-T097
,	O
16	O
.	O
4	O
%	O
were	O
students	B-T098
,	O
4	O
.	O
5	O
%	O
were	O
unemploy	B-T033
##ed	I-T033
,	O
3	O
%	O
were	O
workers	B-T098
,	O
and	O
4	O
.	O
5	O
%	O
were	O
other	O
(	O
including	O
staff	O
members	O
,	O
teachers	B-T097
and	O
officers	O
)	O
.	O
the	O
main	O
reasons	O
for	O
explant	B-T058
##ation	I-T058
were	O
dislocation	B-T037
/	O
dece	B-T033
##nt	I-T033
##ra	I-T033
##tion	I-T033
in	O
41	O
cases	O
(	O
59	O
.	O
4	O
%	O
)	O
and	O
retinal	B-T038
detachment	I-T038
in	O
10	O
cases	O
(	O
14	O
.	O
5	O
%	O
)	O
.	O
the	O
third	O
most	O
prevalent	O
cause	O
was	O
incorrect	B-T033
lens	I-T033
power	I-T033
in	O
7	O
eyes	B-T017
(	O
10	O
.	O
1	O
%	O
)	O
.	O
the	O
remaining	O
reasons	O
were	O
endophthalmitis	B-T038
in	O
6	O
cases	O
(	O
8	O
.	O
7	O
%	O
)	O
,	O
posterior	B-T038
capsular	I-T038
opacity	I-T038
in	O
3	O
eyes	B-T017
(	O
4	O
.	O
3	O
%	O
)	O
,	O
and	O
impacting	O
retinal	B-T058
surgery	I-T058
operation	I-T058
in	O
2	O
cases	O
(	O
2	O
.	O
9	O
%	O
)	O
.	O
the	O
main	O
comorbidities	O
were	O
high	B-T038
myopia	I-T038
in	O
18	O
eyes	B-T017
(	O
26	O
.	O
1	O
%	O
)	O
,	O
trauma	B-T037
in	O
8	O
eyes	B-T017
(	O
11	O
.	O
6	O
%	O
)	O
,	O
retinal	B-T038
detachment	I-T038
in	O
6	O
eyes	B-T017
(	O
8	O
.	O
7	O
%	O
)	O
,	O
congenital	B-T017
cataracts	I-T017
in	O
8	O
eyes	B-T017
(	O
11	O
.	O
6	O
%	O
)	O
,	O
and	O
mar	B-T038
##fa	I-T038
##n	I-T038
'	I-T038
s	I-T038
syndrome	I-T038
in	O
2	O
eyes	B-T017
(	O
2	O
.	O
9	O
%	O
)	O
.	O
the	O
mean	O
time	O
from	O
implantation	O
to	O
explant	O
##ation	O
was	O
4	O
.	O
0	O
##y	O
[	O
sd	O
4	O
.	O
2	O
(	O
0	O
.	O
005	O
-	O
15	O
)	O
]	O
.	O
treatment	B-T058
after	I-T058
explant	I-T058
##ation	I-T058
included	O
posterior	B-T058
chamber	I-T058
iol	I-T058
implantation	I-T058
in	O
44	O
eyes	B-T017
(	O
63	O
.	O
8	O
%	O
)	O
and	O
aph	B-T017
##akia	I-T017
in	O
25	O
eyes	B-T017
(	O
36	O
.	O
2	O
%	O
)	O
.	O
after	B-T033
surgery	I-T033
,	O
the	O
best	B-T033
corrected	I-T033
visual	I-T033
ability	I-T033
(	O
bcva	B-T033
)	O
was	O
improved	O
in	O
50	O
cases	O
(	O
72	O
.	O
5	O
%	O
)	O
,	O
including	O
28	O
patients	O
(	O
40	O
.	O
6	O
%	O
)	O
in	O
whom	O
visual	B-T201
ability	I-T201
was	O
improved	O
by	O
more	O
than	O
two	O
lines	O
.	O
dislocation	B-T037
/	O
dece	B-T033
##nt	I-T033
##ra	I-T033
##tion	I-T033
is	O
the	O
main	O
cause	O
for	O
explant	B-T058
##ation	I-T058
,	O
and	O
high	B-T038
myopia	I-T038
is	O
a	O
main	B-T033
risk	I-T033
factor	I-T033
.	O
posterior	B-T058
chamber	I-T058
iol	I-T058
implantation	I-T058
remains	O
the	O
most	O
elect	O
##ed	O
treatment	B-T058
after	I-T058
explant	I-T058
##ation	I-T058
.	O

p	B-T103
-	I-T103
glycoprotein	I-T103
traffic	O
##s	O
from	O
the	O
nucleus	B-T017
to	O
the	O
plasma	B-T017
membrane	I-T017
in	O
rat	B-T017
brain	I-T017
endothelium	B-T017
during	O
inflammatory	B-T033
pain	I-T033
p	B-T103
-	I-T103
glycoprotein	I-T103
(	O
pgp	B-T103
)	O
,	O
a	O
drug	B-T103
efflux	B-T017
pump	I-T017
in	O
blood	B-T017
-	I-T017
brain	I-T017
barrier	I-T017
endothelial	B-T017
cells	I-T017
,	O
is	O
a	O
major	O
clinical	O
obstacle	O
for	O
effective	O
central	B-T022
nervous	I-T022
system	I-T022
drug	B-T058
delivery	I-T058
.	O
identifying	O
pgp	B-T103
regulatory	O
pathways	O
that	O
can	O
be	O
exploited	O
clinically	O
is	O
critical	O
for	O
improving	O
central	B-T022
nervous	I-T022
system	I-T022
drug	B-T058
delivery	I-T058
.	O
we	O
previously	O
found	O
that	O
pgp	B-T038
activity	I-T038
increases	O
in	O
rat	B-T017
brain	I-T017
microvessels	B-T017
concomitant	O
with	O
decreased	O
central	B-T022
nervous	I-T022
system	I-T022
drug	B-T058
delivery	I-T058
in	O
response	O
to	O
acute	O
peripheral	B-T082
inflammatory	B-T033
pain	I-T033
.	O
in	O
the	O
current	O
study	O
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
pgp	B-T103
traffic	O
##s	O
to	O
the	O
luminal	B-T082
plasma	B-T017
membrane	I-T017
of	O
the	O
microvessel	B-T017
endothelial	B-T017
cells	I-T017
from	O
intracellular	B-T082
stores	O
during	O
peripheral	B-T082
inflammatory	B-T033
pain	I-T033
.	O
using	O
immunofluorescence	B-T058
microscopy	I-T058
,	O
we	O
detected	B-T033
pgp	B-T103
in	O
endothelial	B-T017
cell	I-T017
nuclei	B-T017
and	O
in	O
the	O
luminal	B-T082
plasma	B-T017
membrane	I-T017
in	O
control	B-T204
animals	I-T204
.	O
following	O
peripheral	B-T082
inflammatory	B-T033
pain	I-T033
,	O
luminal	B-T082
pgp	B-T103
staining	B-T058
increased	O
while	O
staining	B-T058
in	O
the	O
nucleus	B-T017
decreased	O
.	O
biochemical	B-T058
analysis	I-T058
of	O
nuclear	B-T017
pgp	B-T103
content	O
confirmed	O
our	O
visual	O
observations	O
.	O
peripheral	B-T082
inflammatory	B-T033
pain	I-T033
also	O
increased	O
endothelial	B-T017
cell	I-T017
luminal	B-T082
staining	B-T058
of	O
polymerase	B-T017
1	I-T017
and	I-T017
transcript	I-T017
release	I-T017
factor	I-T017
/	O
cav	B-T017
##in	I-T017
##1	I-T017
and	O
serum	B-T017
deprivation	I-T017
response	I-T017
protein	I-T017
/	O
cav	B-T017
##in	I-T017
##2	I-T017
,	O
two	O
cave	B-T103
##olar	I-T103
scaffold	I-T103
proteins	I-T103
,	O
without	O
changing	O
caveolin	B-T103
##1	I-T103
or	O
protein	B-T017
kinase	I-T017
c	I-T017
delta	I-T017
binding	I-T017
protein	I-T017
/	O
cav	B-T017
##in	I-T017
##3	I-T017
location	B-T082
.	O
our	O
data	O
(	O
a	O
)	O
indicate	O
that	O
pgp	B-T103
traffic	O
##s	O
from	O
stores	O
in	O
the	O
nucleus	B-T017
to	O
the	O
endothelial	B-T017
cell	I-T017
luminal	O
membrane	O
in	O
response	O
to	O
peripheral	B-T082
inflammatory	B-T033
pain	I-T033
;	O
(	O
b	O
)	O
provide	O
an	O
explanation	O
for	O
our	O
previous	O
observation	B-T062
that	O
peripheral	B-T082
inflammatory	B-T033
pain	I-T033
inhibits	O
central	B-T022
nervous	I-T022
system	I-T022
drug	B-T103
uptake	B-T038
;	O
and	O
(	O
c	O
)	O
suggest	O
a	O
novel	O
regulatory	B-T033
mechanism	I-T033
for	O
pgp	B-T038
activity	I-T038
in	O
rat	B-T017
brain	I-T017
.	O

e3	B-T103
ligase	I-T103
rn	B-T103
##f1	I-T103
##26	I-T103
directly	O
ubiquitin	B-T038
##ates	I-T038
fra	B-T103
##ta	I-T103
##xin	I-T103
,	O
promoting	O
its	O
degradation	O
:	O
identification	O
of	O
a	O
potential	O
therapeutic	O
target	O
for	O
fried	B-T038
##re	I-T038
##ich	I-T038
ataxia	I-T038
fried	B-T038
##re	I-T038
##ich	I-T038
ataxia	I-T038
(	O
fr	B-T038
##da	I-T038
)	O
is	O
a	O
severe	O
genetic	O
neurodegenerative	B-T038
disease	I-T038
caused	O
by	O
reduced	O
expression	B-T038
of	O
the	O
mitochondrial	B-T103
protein	I-T103
fra	B-T103
##ta	I-T103
##xin	I-T103
.	O
to	O
date	O
,	O
there	O
is	O
no	O
therapy	O
to	O
treat	B-T058
this	O
condition	O
.	O
the	O
amount	O
of	O
residual	O
fra	B-T103
##ta	I-T103
##xin	I-T103
critically	O
affects	O
the	O
severity	O
of	O
the	O
disease	B-T038
;	O
thus	O
,	O
attempts	O
to	O
restore	O
physiological	O
fra	B-T103
##ta	I-T103
##xin	I-T103
levels	O
are	O
considered	O
therapeutically	O
relevant	O
.	O
fra	B-T103
##ta	I-T103
##xin	I-T103
levels	O
are	O
controlled	O
by	O
the	O
ubiquitin	B-T038
-	I-T038
proteasome	I-T038
system	I-T038
;	O
therefore	O
,	O
inhibition	O
of	O
the	O
fra	B-T103
##ta	I-T103
##xin	I-T103
e3	B-T103
ligase	I-T103
may	O
represent	O
a	O
strategy	B-T062
to	O
achieve	O
an	O
increase	O
in	O
fra	B-T103
##ta	I-T103
##xin	I-T103
levels	O
.	O
here	O
,	O
we	O
report	O
the	O
identification	O
of	O
the	O
ring	B-T103
e3	I-T103
ligase	I-T103
rn	B-T103
##f1	I-T103
##26	I-T103
as	O
the	O
enzyme	B-T103
that	O
specifically	O
mediates	O
fra	B-T103
##ta	I-T103
##xin	I-T103
ubiquitination	B-T038
and	O
targets	O
it	O
for	O
degradation	O
.	O
rn	B-T103
##f1	I-T103
##26	I-T103
interacts	O
with	O
fra	B-T103
##ta	I-T103
##xin	I-T103
and	O
promotes	O
its	O
ubiquitination	B-T038
in	O
a	O
catalytic	O
activity	O
-	O
dependent	O
manner	O
,	O
both	O
in	B-T082
vivo	I-T082
and	O
in	O
vitro	O
.	O
most	O
importantly	O
,	O
rn	B-T103
##f1	I-T103
##26	I-T103
depletion	O
results	O
in	O
fra	B-T103
##ta	I-T103
##xin	I-T103
accumulation	B-T033
in	O
cells	B-T017
derived	O
from	O
fr	B-T038
##da	I-T038
patients	O
,	O
highlighting	O
the	O
relevance	O
of	O
rn	B-T103
##f1	I-T103
##26	I-T103
as	O
a	O
new	O
therapeutic	O
target	O
for	O
fried	B-T038
##re	I-T038
##ich	I-T038
ataxia	I-T038
.	O

a	O
randomized	B-T062
,	O
head	O
-	O
to	O
-	O
head	O
study	B-T062
of	O
virtual	B-T058
reality	I-T058
exposure	I-T058
therapy	I-T058
for	O
posttraumatic	B-T038
stress	I-T038
disorder	I-T038
virtual	B-T058
reality	I-T058
exposure	I-T058
therapy	I-T058
(	O
vre	B-T058
##t	I-T058
)	O
is	O
one	O
of	O
the	O
few	O
interventions	B-T058
supported	O
by	O
randomized	B-T062
controlled	I-T062
trials	I-T062
for	O
the	O
treatment	B-T058
of	O
combat	B-T038
-	I-T038
related	I-T038
posttraumatic	I-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
in	O
active	O
duty	O
service	O
members	B-T098
.	O
a	O
comparative	B-T062
effectiveness	I-T062
study	I-T062
was	O
conducted	O
to	O
determine	O
if	O
virtual	O
reality	O
technology	O
itself	O
improved	B-T033
outcomes	O
,	O
or	O
if	O
similar	O
results	O
could	O
be	O
achieved	O
with	O
a	O
control	B-T058
exposure	I-T058
therapy	I-T058
(	O
cet	B-T058
)	O
condition	O
.	O
service	O
members	B-T098
with	O
combat	B-T038
-	I-T038
related	I-T038
ptsd	I-T038
were	O
randomly	O
selected	O
to	O
receive	O
nine	O
weeks	O
of	O
vre	B-T058
##t	I-T058
or	O
cet	B-T058
.	O
assess	B-T097
##ors	I-T097
,	O
but	O
not	O
therapists	O
,	O
were	O
blinded	B-T062
.	O
ptsd	B-T038
symptom	B-T033
improvement	O
was	O
assessed	O
one	O
week	O
and	O
3	O
months	O
after	O
the	O
conclusion	O
of	O
treatment	B-T058
using	O
the	O
clinician	B-T170
-	I-T170
administered	I-T170
ptsd	I-T170
scale	I-T170
(	O
caps	B-T170
)	O
.	O
a	O
small	O
crossover	O
component	O
was	O
included	O
.	O
results	O
demonstrated	O
that	O
ptsd	B-T038
symptoms	B-T033
improved	B-T033
with	O
both	O
treatments	B-T058
,	O
but	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
between	O
groups	O
.	O
dropout	B-T098
rates	O
were	O
higher	O
in	O
vre	B-T058
##t	I-T058
.	O
of	O
those	O
who	O
received	O
vre	B-T058
##t	I-T058
,	O
13	O
/	O
42	O
(	O
31	O
%	O
)	O
showed	O
>	O
30	O
%	O
improvement	O
on	O
the	O
caps	B-T170
,	O
versus	O
16	O
/	O
43	O
(	O
37	O
%	O
)	O
who	O
received	O
cet	B-T058
.	O
three	O
months	O
after	O
treatment	B-T058
,	O
>	O
30	O
%	O
improvement	O
was	O
seen	O
in	O
10	O
/	O
33	O
(	O
30	O
%	O
)	O
of	O
vre	B-T058
##t	I-T058
participants	B-T098
and	O
12	O
/	O
33	O
(	O
36	O
%	O
)	O
in	O
cet	B-T058
.	O
participants	B-T098
who	O
crossed	B-T033
over	I-T033
(	O
n	O
=	O
11	O
)	O
showed	O
no	O
statistically	O
significant	O
improvements	O
in	O
a	O
second	O
round	O
of	O
treatment	B-T058
,	O
regardless	O
of	O
condition	O
.	O
this	O
study	B-T062
supported	O
the	O
utility	O
of	O
exposure	B-T058
therapy	I-T058
for	O
ptsd	B-T038
,	O
but	O
did	O
not	O
support	O
additional	O
benefit	O
by	O
the	O
inclusion	O
of	O
virtual	O
reality	O
.	O

aav	B-T005
##9	I-T005
-	O
npc	B-T017
##1	I-T017
significantly	O
ameliorate	B-T033
##s	I-T033
purkinje	B-T017
cell	I-T017
death	B-T038
and	O
behavioral	B-T038
abnormalities	I-T038
in	O
mouse	B-T204
npc	B-T038
disease	I-T038
ni	B-T038
##ema	I-T038
##nn	I-T038
-	I-T038
pick	I-T038
type	I-T038
c	I-T038
(	I-T038
npc	I-T038
)	I-T038
disease	I-T038
is	O
a	O
fatal	O
inherited	O
neurodegenerative	B-T038
disorder	I-T038
caused	O
by	O
loss	B-T033
-	I-T033
of	I-T033
-	I-T033
function	I-T033
mutations	B-T038
in	O
the	O
npc	B-T017
##1	I-T017
or	O
npc	B-T017
##2	I-T017
gene	I-T017
.	O
there	O
is	O
no	O
effective	O
way	O
to	O
treat	O
npc	B-T038
disease	I-T038
.	O
in	O
this	O
study	O
,	O
we	O
used	O
adeno	B-T005
-	I-T005
associated	I-T005
virus	I-T005
(	O
aav	B-T005
)	O
serotype	B-T170
9	I-T170
(	O
aav	B-T005
##9	I-T005
)	O
to	O
deliver	O
a	O
functional	O
npc	B-T017
##1	I-T017
gene	I-T017
systemically	O
into	O
npc	B-T017
##1	I-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
mice	B-T204
at	O
postnatal	B-T058
day	I-T058
4	I-T058
.	O
one	O
single	O
aav	B-T058
##9	I-T058
-	I-T058
npc	I-T058
##1	I-T058
injection	I-T058
resulted	O
in	O
robust	O
npc	B-T017
##1	I-T017
expression	B-T038
in	O
various	O
tissues	B-T017
,	O
including	O
brain	B-T017
,	O
heart	B-T017
,	O
and	O
lung	B-T017
.	O
strikingly	O
,	O
aav	O
##9	O
-	O
mediated	O
npc	O
##1	O
delivery	O
significantly	O
promoted	O
purkinje	B-T017
cell	I-T017
survival	O
,	O
restored	O
locomotor	B-T038
activity	I-T038
and	O
coordination	B-T038
,	O
and	O
increased	O
the	O
lifespan	O
of	O
npc	B-T017
##1	I-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
mice	B-T204
.	O
our	O
work	O
suggests	O
that	O
aav	B-T058
-	I-T058
based	I-T058
gene	I-T058
therapy	I-T058
is	O
a	O
promising	O
means	O
to	O
treat	O
npc	B-T038
disease	I-T038
.	O

improving	O
protein	B-T103
complex	I-T103
prediction	O
by	O
reconstruct	B-T170
##ing	I-T170
a	O
high	O
-	O
confidence	O
protein	O
-	O
protein	O
interaction	O
network	O
of	O
escherichia	B-T007
coli	I-T007
from	O
different	O
physical	O
interaction	O
data	O
sources	O
although	O
different	O
protein	B-T038
-	I-T038
protein	I-T038
physical	I-T038
interaction	I-T038
(	O
ppi	B-T038
)	O
datasets	B-T170
exist	O
for	O
escherichia	B-T007
coli	I-T007
,	O
no	O
common	O
methodology	O
exists	O
to	O
integrate	O
these	O
datasets	B-T170
and	O
extract	O
reliable	O
modules	O
reflecting	O
the	O
existing	O
biological	B-T038
process	I-T038
and	O
protein	B-T103
complexes	I-T103
.	O
naive	B-T170
bayesian	I-T170
formula	I-T170
is	O
the	O
highly	O
accepted	O
method	O
to	O
integrate	O
different	O
ppi	B-T038
datasets	B-T170
into	O
a	O
single	O
weighted	O
ppi	O
network	O
,	O
but	O
detecting	O
proper	O
weights	O
in	O
such	O
network	O
is	O
still	O
a	O
major	O
problem	O
.	O
in	O
this	O
paper	O
,	O
we	O
proposed	O
a	O
new	O
methodology	O
to	O
integrate	O
various	O
physical	B-T038
ppi	I-T038
datasets	B-T170
into	O
a	O
single	O
weighted	O
ppi	O
network	O
in	O
a	O
way	O
that	O
the	O
detected	B-T033
modules	O
in	O
ppi	O
network	O
exhibit	O
the	O
highest	O
similarity	O
to	O
available	O
functional	O
modules	O
.	O
we	O
used	O
the	O
co	B-T058
-	I-T058
expression	I-T058
modules	O
as	O
functional	O
modules	O
,	O
and	O
we	O
shown	O
that	O
direct	O
functional	O
modules	O
detected	B-T033
from	O
gene	B-T170
ontology	I-T170
terms	O
could	O
be	O
used	O
as	O
an	O
alternative	O
dataset	B-T170
.	O
after	O
running	O
this	O
integrating	O
methodology	O
over	O
six	O
different	O
physical	B-T038
ppi	I-T038
datasets	B-T170
,	O
orthologous	O
high	O
-	O
confidence	O
interactions	O
from	O
a	O
related	O
organism	O
and	O
two	O
ap	B-T058
-	I-T058
ms	I-T058
ppi	B-T038
datasets	B-T170
gained	B-T033
high	I-T033
weights	I-T033
in	O
the	O
integrated	O
networks	O
,	O
while	O
the	O
weights	O
for	O
one	O
ap	B-T058
-	I-T058
ms	I-T058
ppi	B-T038
dataset	B-T170
and	O
two	O
other	O
datasets	B-T170
derived	O
from	O
public	B-T170
databases	I-T170
have	O
converge	O
##d	O
to	O
zero	O
.	O
the	O
majority	O
of	O
detected	B-T033
modules	O
shaped	O
around	O
one	O
or	O
few	O
hub	B-T103
protein	I-T103
(	I-T103
s	I-T103
)	I-T103
.	O
still	O
,	O
a	O
large	O
number	O
of	O
highly	O
interacting	O
protein	B-T103
modules	O
were	O
detected	B-T033
which	O
are	O
functionally	O
relevant	O
and	O
are	O
likely	O
to	O
construct	B-T170
protein	B-T103
complexes	I-T103
.	O
we	O
provided	O
a	O
new	O
high	O
confidence	O
protein	B-T103
complex	I-T103
prediction	O
method	O
supported	O
by	O
functional	O
studies	O
and	O
literature	B-T170
mining	O
.	O

a	O
miniature	O
bird	B-T204
-	O
borne	O
passive	O
air	O
sample	O
##r	O
for	O
monitoring	B-T058
halogen	B-T103
##ated	I-T103
flame	I-T103
retard	I-T103
##ants	I-T103
birds	B-T204
have	O
been	O
used	O
intensively	O
as	O
biom	B-T074
##onitor	I-T074
##s	I-T074
of	O
halogen	B-T103
##ated	I-T103
flame	I-T103
retard	I-T103
##ants	I-T103
(	O
hf	B-T103
##rs	I-T103
)	O
,	O
and	O
several	O
studies	B-T062
have	O
reported	O
elevated	O
tissue	B-T017
concentrations	O
and	O
inter	O
-	O
individual	B-T098
variability	O
for	O
these	O
contaminants	O
.	O
while	O
diet	B-T168
is	O
known	O
to	O
be	O
an	O
important	O
exposure	O
pathway	O
for	O
hf	B-T103
##rs	I-T103
in	O
birds	B-T204
,	O
it	O
has	O
been	O
suggested	O
that	O
exposure	O
through	O
air	O
may	O
represent	O
an	O
underestimated	O
source	B-T033
of	O
hf	B-T103
##rs	I-T103
for	O
certain	O
species	B-T170
.	O
however	O
,	O
a	O
method	B-T170
was	O
not	O
available	O
for	O
measuring	O
the	O
atmospheric	O
exposure	O
of	O
individual	B-T098
birds	B-T204
to	O
hf	B-T103
##rs	I-T103
or	O
other	O
semi	O
-	O
volatile	O
contaminants	O
.	O
the	O
goal	B-T170
of	O
this	O
study	B-T062
was	O
to	O
develop	O
a	O
bird	B-T204
-	O
borne	O
passive	O
air	O
sample	O
##r	O
(	O
pas	O
)	O
enabling	O
the	O
determination	B-T058
of	O
individual	B-T098
atmospheric	O
exposure	O
to	O
gas	B-T103
-	O
and	O
particle	B-T103
-	I-T103
phase	I-T103
hf	B-T103
##rs	I-T103
using	O
the	O
ring	B-T204
-	I-T204
bill	I-T204
##ed	I-T204
gu	I-T204
##ll	I-T204
(	O
lar	B-T204
##us	I-T204
del	I-T204
##awa	I-T204
##ren	I-T204
##sis	I-T204
)	O
nestin	O
##g	O
in	O
the	O
mont	O
##re	O
##al	O
area	O
(	O
qc	B-T082
,	O
canada	B-T082
)	O
.	O
the	O
new	O
miniat	O
##urized	O
ellip	B-T082
##tical	I-T082
-	I-T082
shaped	I-T082
pas	O
(	O
mean	O
weight	O
:	O
2	O
.	O
72	O
##g	O
)	O
was	O
tested	O
using	O
two	B-T058
sorbent	I-T058
types	I-T058
during	O
three	O
exposure	O
periods	O
(	O
one	O
,	O
two	O
and	O
three	O
weeks	O
)	O
.	O
results	O
showed	O
that	O
pas	O
using	O
polyurethane	B-T103
foam	I-T103
(	O
pu	B-T103
##f	I-T103
)	O
combined	O
with	O
a	O
glass	B-T103
fiber	I-T103
filter	O
collected	O
all	O
major	O
poly	B-T103
##brom	I-T103
##inated	I-T103
diphenyl	I-T103
ethers	I-T103
(	O
pbdes	B-T103
)	O
and	O
exhibited	O
better	O
performance	O
for	O
collecting	O
highly	O
hydrophobic	O
dec	B-T103
##abd	I-T103
##e	I-T103
mixture	O
congeners	O
compared	O
to	O
the	O
pas	O
using	O
polyd	B-T103
##imethyl	I-T103
##sil	I-T103
##oxane	I-T103
(	O
pdms	B-T103
)	O
.	O
emerging	O
hf	B-T103
##rs	I-T103
including	O
hexa	B-T103
##brom	I-T103
##obenzene	I-T103
,	O
dech	B-T103
##lor	I-T103
##ane	I-T103
60	I-T103
##4	I-T103
component	I-T103
b	I-T103
,	O
and	O
dech	B-T103
##lor	I-T103
##ane	I-T103
plus	I-T103
(	O
dp	B-T103
)	O
isomers	O
also	O
were	O
sampled	B-T058
by	O
the	O
pu	B-T103
##f	I-T103
-	O
based	O
pas	O
.	O
sampling	B-T058
rates	O
for	O
most	O
hf	B-T103
##rs	I-T103
were	O
comparable	O
between	O
the	O
three	O
exposure	O
periods	O
.	O
this	O
novel	O
bird	B-T204
-	O
borne	O
pas	O
provides	O
valuable	O
information	O
on	O
the	O
non	O
-	O
dietary	O
exposure	O
of	O
free	O
-	O
ranging	O
birds	B-T204
to	O
hf	B-T103
##rs	I-T103
.	O

injury	O
surveillance	O
of	O
female	O
adult	O
z	O
##umb	O
##a	O
®	O
dan	B-T097
##cers	I-T097
we	O
sought	O
to	O
describe	O
the	O
patterns	B-T082
of	O
injury	B-T037
and	O
to	O
establish	O
the	O
injury	B-T037
incidence	O
rates	O
associated	O
with	O
z	O
##umb	O
##a	O
®	O
.	O
z	O
##umb	O
##a	O
®	O
dan	B-T097
##cers	I-T097
were	O
invited	O
to	O
complete	O
an	O
anonymous	O
web	O
-	O
based	O
survey	B-T170
containing	O
13	O
demographic	O
background	O
and	O
14	O
(	O
1	O
yr	O
retrospective	O
)	O
injury	B-T037
history	O
questions	B-T170
.	O
inclusion	O
criteria	O
stated	O
that	O
the	O
respondents	B-T098
had	O
to	O
be	O
aged	O
18	O
-	O
64	O
yr	O
and	O
currently	O
involved	O
in	O
group	B-T098
-	O
based	O
classes	B-T170
of	O
z	O
##umb	O
##a	O
®	O
,	O
either	O
as	O
a	O
registered	B-T097
instruct	I-T097
##or	I-T097
or	O
class	B-T170
participant	B-T098
.	O
binomial	O
logistic	O
regression	O
analysis	O
was	O
used	O
to	O
predict	O
the	O
odds	O
of	O
injury	B-T037
during	O
z	O
##umb	O
##a	O
®	O
and	O
mann	B-T170
-	I-T170
whitney	I-T170
tests	I-T170
were	O
employed	O
to	O
ascertain	O
differences	O
between	O
groups	B-T098
.	O
the	O
survey	B-T170
response	O
rate	O
was	O
74	O
%	O
.	O
the	O
final	O
sample	O
of	O
respondents	B-T098
(	O
n	O
=	O
138	O
;	O
female	O
=	O
100	O
%	O
)	O
included	O
19	O
registered	B-T097
instruct	I-T097
##ors	I-T097
and	O
119	O
class	B-T170
participants	B-T098
,	O
of	O
which	O
58	O
%	O
and	O
16	O
%	O
,	O
respectively	O
,	O
sustained	O
≥	O
1	O
injury	B-T037
during	O
z	O
##umb	O
##a	O
®	O
in	O
the	O
past	O
year	O
.	O
the	O
odds	O
of	O
injury	B-T037
was	O
7	O
(	O
95	O
%	O
ci	O
2	O
-	O
19	O
)	O
times	O
greater	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
for	O
registered	B-T097
instruct	I-T097
##ors	I-T097
than	O
for	O
class	B-T170
participants	B-T098
.	O
z	O
##umb	O
##a	O
®	O
dan	B-T097
##cers	I-T097
had	O
a	O
17	O
(	O
95	O
%	O
ci	O
7	O
-	O
28	O
)	O
%	O
greater	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
odds	O
of	O
injury	B-T037
for	O
every	O
1	O
h	O
of	O
non	O
-	O
z	O
##umb	O
##a	O
®	O
-	O
related	O
moderate	O
to	O
vigorous	O
physical	O
activity	O
(	O
mvpa	O
)	O
engagement	O
per	O
week	O
.	O
the	O
injury	B-T037
incidence	O
rate	O
for	O
registered	B-T097
instruct	I-T097
##ors	I-T097
and	O
class	B-T170
participants	B-T098
was	O
5	O
.	O
7	O
(	O
95	O
%	O
ci	O
3	O
.	O
1	O
-	O
8	O
.	O
2	O
)	O
and	O
3	O
.	O
9	O
(	O
95	O
%	O
ci	O
2	O
.	O
5	O
-	O
5	O
.	O
3	O
)	O
injuries	B-T037
per	O
1000	O
h	O
of	O
exposure	O
,	O
respectively	O
.	O
z	O
##umb	O
##a	O
®	O
presents	O
a	O
low	O
risk	O
of	O
injury	B-T037
;	O
for	O
registered	B-T097
instruct	I-T097
##ors	I-T097
,	O
the	O
increased	O
risk	O
of	O
injury	B-T037
is	O
likely	O
due	O
to	O
the	O
high	O
total	O
volume	O
of	O
mvpa	O
participated	O
in	O
weekly	O
.	O

timing	O
of	O
false	O
ring	B-T038
formation	I-T038
in	O
pin	B-T204
##us	I-T204
hal	I-T204
##ep	I-T204
##ensis	I-T204
and	O
arb	B-T204
##ut	I-T204
##us	I-T204
un	I-T204
##ed	I-T204
##o	I-T204
in	O
southern	B-T082
italy	B-T082
:	O
outl	B-T201
##oo	I-T201
##k	I-T201
from	O
an	O
analysis	B-T062
of	O
xyl	B-T038
##ogenesis	I-T038
and	O
tree	B-T204
-	I-T204
ring	I-T204
chron	B-T170
##ologies	I-T170
mediterranean	B-T082
tree	B-T204
rings	I-T204
are	O
characterized	O
by	O
intra	O
-	O
annual	O
density	O
fluctuations	O
(	O
iad	O
##fs	O
)	O
due	O
to	O
partly	O
climate	O
-	O
driven	O
camb	B-T038
##ial	I-T038
activity	I-T038
.	O
iad	O
##fs	O
are	O
used	O
as	O
structural	B-T082
signals	O
to	O
gain	O
information	O
on	O
relations	O
between	B-T082
environmental	B-T082
conditions	O
and	O
eco	B-T038
-	I-T038
physiological	I-T038
processes	O
during	O
xyl	B-T038
##ogenesis	I-T038
,	O
with	O
intra	O
-	O
annual	O
resolution	O
.	O
to	O
reach	O
an	O
unbiased	B-T062
synchronization	O
of	O
the	O
iad	O
##f	O
position	B-T082
within	O
tree	B-T204
rings	B-T082
and	O
seasonal	O
fluctuations	B-T033
in	O
environmental	B-T082
conditions	O
,	O
it	O
is	O
necessary	O
to	O
know	O
the	O
timing	O
of	O
camb	B-T038
##ial	I-T038
activity	I-T038
and	O
wood	O
formation	O
,	O
which	O
are	O
species	O
-	O
and	O
site	O
-	O
specific	O
processes	O
.	O
we	O
applied	O
the	O
microc	O
##oring	O
technique	O
to	O
analyze	B-T062
xyl	B-T038
##ogenesis	I-T038
in	O
pin	B-T204
##us	I-T204
hal	I-T204
##ep	I-T204
##ensis	I-T204
and	O
arb	B-T204
##ut	I-T204
##us	I-T204
un	I-T204
##ed	I-T204
##o	I-T204
.	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
is	O
the	O
first	O
attempt	O
to	O
study	B-T062
xyl	B-T038
##ogenesis	I-T038
in	O
a	O
hard	O
##wood	O
species	B-T170
forming	O
frequent	O
iad	O
##fs	O
.	O
both	O
species	B-T170
co	O
-	O
occur	O
at	O
a	O
site	B-T082
in	O
southern	B-T082
italy	B-T082
characterized	O
by	O
a	O
mediterranean	B-T082
climate	O
.	O
to	O
facilitate	O
tree	B-T062
-	I-T062
ring	I-T062
dating	I-T062
and	O
identification	O
of	O
iad	O
##fs	O
,	O
we	O
performed	O
traditional	O
dendr	O
##oe	O
##co	O
##lo	O
##gic	O
##al	O
analysis	B-T062
.	O
we	O
analyzed	B-T062
xyl	B-T038
##ogenesis	I-T038
during	O
summer	O
,	O
which	O
is	O
considered	O
a	O
constraint	O
for	O
xyl	B-T038
##ogenesis	I-T038
and	O
a	O
trigger	O
for	O
iad	O
##f	O
formation	O
.	O
we	O
followed	O
the	O
different	O
phases	O
of	O
cell	B-T038
development	I-T038
in	O
the	O
current	O
wood	O
increment	O
with	O
the	O
aim	O
of	O
evaluating	O
whether	O
and	O
which	O
type	O
of	O
iad	O
##fs	O
were	O
formed	O
.	O
we	O
additionally	O
analyzed	B-T062
the	O
same	O
phases	O
again	O
in	O
september	O
and	O
in	O
winter	O
to	O
verify	O
the	O
possible	B-T033
formation	O
of	O
iad	O
##fs	O
in	O
fall	O
and	O
whether	O
cell	B-T017
production	B-T038
and	O
differentiation	B-T038
was	O
completed	O
by	O
the	O
end	O
of	O
the	O
calendar	O
year	O
.	O
both	O
species	B-T170
formed	O
the	O
same	O
type	O
of	O
iad	O
##fs	O
(	O
early	O
##wood	O
-	O
like	O
cells	B-T017
within	O
late	O
##wood	O
)	O
,	O
due	O
to	O
temporary	O
growth	O
restoration	B-T033
triggered	O
by	O
rain	O
events	O
during	O
the	O
period	O
of	O
summer	O
drought	O
.	O
at	O
the	O
end	O
of	O
the	O
calendar	O
year	O
,	O
no	O
cells	B-T017
in	O
the	O
phases	O
of	O
enlargement	O
and	O
secondary	B-T017
cell	I-T017
wall	I-T017
deposition	O
occurred	O
.	O
a	B-T204
.	I-T204
un	I-T204
##ed	I-T204
##o	I-T204
was	O
more	O
sensitive	O
than	O
p	B-T204
.	I-T204
hal	I-T204
##ep	I-T204
##ensis	I-T204
because	O
iad	O
##f	O
s	O
were	O
formed	O
earlier	O
in	O
the	O
season	O
and	O
were	O
more	O
frequent	O
in	O
the	O
tree	B-T204
-	I-T204
ring	I-T204
series	O
.	O
the	O
dendr	O
##o	O
-	O
anatomical	O
approach	O
,	O
combining	O
analysis	B-T062
of	O
tree	B-T204
-	I-T204
ring	I-T204
series	O
and	O
of	O
xyl	B-T038
##ogenesis	I-T038
,	O
helped	O
to	O
detect	B-T033
the	O
period	O
of	O
iad	O
##f	O
formation	O
in	O
the	O
two	O
species	B-T170
.	O
results	O
are	O
discussed	O
in	O
functional	O
terms	O
,	O
highlighting	O
the	O
environmental	B-T082
conditions	O
triggering	O
iad	O
##fs	O
,	O
and	O
also	O
in	O
methodological	O
terms	O
,	O
evaluating	O
the	O
applicability	O
of	O
xyl	B-T038
##ogenesis	I-T038
analysis	B-T062
in	O
mediterranean	B-T082
wood	O
##s	O
,	O
especially	O
when	O
the	O
formation	O
of	O
iad	O
##fs	O
is	O
not	O
uniform	O
around	O
the	O
stem	B-T204
.	O

transition	O
from	O
hospital	B-T092
to	O
home	B-T082
in	O
preterm	O
infants	O
and	O
their	O
families	O
when	O
the	O
day	O
of	O
discharge	B-T058
from	O
a	O
neonatal	B-T092
intensive	I-T092
care	I-T092
unit	I-T092
(	O
nicu	B-T092
)	O
comes	O
for	O
the	O
parents	O
of	O
newborn	O
infants	O
,	O
they	O
are	O
filled	O
with	O
long	O
-	O
awa	O
##ited	O
jo	B-T038
##y	I-T038
and	O
happ	B-T038
##iness	I-T038
.	O
they	O
go	O
home	B-T082
feeling	B-T038
as	O
parents	O
,	O
away	O
from	O
scheduled	O
routine	O
##s	O
of	O
the	O
hospital	B-T092
,	O
monitor	O
alarm	O
##s	O
,	O
clinical	O
rounds	O
,	O
numerous	O
tests	B-T058
,	O
and	O
so	O
on	O
.	O
what	O
do	O
we	O
know	O
about	O
what	O
happ	O
##ens	O
after	O
these	O
little	O
patients	O
and	O
their	O
families	O
leave	O
the	O
nicu	B-T092
?	O
what	O
happ	O
##ens	O
from	O
the	O
point	O
of	O
leaving	O
the	O
hospital	B-T092
until	O
when	O
things	O
get	O
sett	O
##led	O
and	O
life	O
becomes	O
perceived	B-T038
as	O
normal	O
?	O
this	O
article	B-T170
presents	O
a	O
short	O
summary	B-T170
of	O
research	B-T062
conducted	O
with	O
the	O
vulnerable	B-T098
population	I-T098
of	O
high	B-T033
-	I-T033
risk	I-T033
and	O
preterm	O
infants	O
and	O
their	O
families	O
postd	B-T058
##isc	I-T058
##har	I-T058
##ge	I-T058
.	O
available	O
evidence	O
suggests	O
that	O
transition	O
to	O
home	B-T082
after	O
hospital	B-T058
discharge	I-T058
,	O
a	O
phenomenon	O
that	O
many	O
families	O
experience	B-T038
,	O
is	O
challenging	O
and	O
requires	O
attention	B-T058
from	O
clinicians	B-T097
and	O
researchers	O
if	O
we	O
are	O
to	O
provide	O
effective	O
,	O
efficient	O
,	O
and	O
high	B-T058
-	I-T058
quality	I-T058
care	I-T058
.	O

a	O
comparison	O
between	O
measured	O
concentration	O
of	O
3h	B-T103
in	O
kal	O
##pa	O
##k	O
##ka	O
##m	O
environment	O
with	O
predicted	O
atmospheric	O
dispersion	O
model	O
the	O
field	B-T082
measurements	O
of	O
3h	B-T103
in	O
the	O
form	O
of	O
ht	B-T103
##o	I-T103
present	O
in	O
air	O
moisture	O
carried	O
out	O
around	O
mad	O
##ra	O
##s	O
atomic	O
power	O
station	O
were	O
compared	O
with	O
predicted	O
values	O
using	O
atmospheric	O
dispersion	O
modeling	O
.	O
air	O
3h	O
samples	O
were	O
collected	O
from	O
different	O
sectors	B-T082
at	O
the	O
site	B-T082
boundary	B-T170
of	O
the	O
operating	O
reactors	O
for	O
the	O
period	O
of	O
2	O
y	O
and	O
compared	O
with	O
gaussian	O
pl	O
##ume	O
model	O
.	O
the	O
predictions	O
were	O
comparable	O
with	O
the	O
measured	O
value	O
.	O
the	O
slight	O
variation	O
observed	O
between	O
the	O
two	O
methods	B-T170
is	O
attributed	O
to	O
the	O
uncertainty	B-T033
involved	O
in	O
the	O
measurement	O
of	O
air	O
3h	B-T103
concentration	O
and	O
in	O
the	O
measurement	O
of	O
site	B-T082
-	I-T082
specific	I-T082
meteorological	O
parameters	O
.	O
the	O
radiation	O
dose	O
impar	O
##ted	O
to	O
members	B-T092
of	I-T092
public	I-T092
due	O
to	O
the	O
levels	O
observed	O
is	O
well	O
within	O
station	O
technical	O
specification	O
limit	O
for	O
3h	B-T103
.	O

does	O
a	O
policy	B-T170
of	O
earlier	O
induction	O
affect	O
labour	B-T038
outcomes	O
in	O
women	B-T098
induced	O
for	O
postm	B-T038
##aturity	I-T038
?	O
a	O
retrospective	O
analysis	B-T062
in	O
a	O
tertiary	B-T092
hospital	I-T092
in	O
the	O
north	B-T082
of	O
england	B-T082
to	O
investigate	O
whether	O
a	O
change	O
in	O
the	O
management	O
of	O
postm	B-T038
##ature	I-T038
pregnancy	I-T038
to	O
earlier	O
induction	O
affects	O
the	O
length	B-T201
of	I-T201
labour	I-T201
and	O
the	O
induction	B-T058
process	I-T058
.	O
secondly	O
,	O
to	O
assess	O
the	O
feasibility	B-T062
of	O
the	O
research	B-T062
process	I-T062
to	O
inform	O
a	O
future	O
larger	B-T062
study	I-T062
.	O
a	O
change	O
in	O
management	O
of	O
postm	B-T038
##ature	I-T038
pregnancy	I-T038
in	O
an	O
nhs	B-T058
hospital	B-T092
in	O
october	O
2013	O
,	O
from	O
induction	B-T058
at	O
42	O
weeks	O
gestation	B-T038
to	O
induction	B-T058
between	O
41	O
-	O
42	O
weeks	O
,	O
provided	O
an	O
opportunity	O
to	O
conduct	O
a	O
retrospective	O
analysis	B-T062
.	O
pre	O
-	O
existing	O
data	O
from	O
the	O
maternity	O
database	B-T170
and	O
case	O
##no	O
##tes	O
were	O
collected	O
and	O
primary	B-T062
outcomes	I-T062
analysed	B-T062
using	O
the	O
mann	B-T170
-	I-T170
whitney	I-T170
test	I-T170
and	O
the	O
hodg	O
##es	O
-	O
le	O
##h	O
##man	O
confidence	O
interval	O
for	O
differences	O
in	O
median	O
##s	O
.	O
a	O
large	B-T082
city	I-T082
based	O
tertiary	B-T092
referral	I-T092
hospital	I-T092
in	O
the	O
north	B-T082
of	O
england	B-T082
.	O
125	O
women	B-T098
induced	O
before	O
the	O
change	O
in	O
policy	B-T170
were	O
compared	O
with	O
309	O
women	B-T098
induced	O
after	O
the	O
change	O
.	O
primary	B-T062
outcomes	I-T062
were	O
length	O
of	O
1st	O
and	O
2nd	O
stage	O
of	O
labour	O
,	O
overall	O
length	B-T201
of	I-T201
labour	I-T201
,	O
length	O
of	O
induction	B-T058
to	O
established	O
labour	B-T038
and	O
length	O
of	O
induction	B-T058
to	O
birth	B-T038
.	O
the	O
median	O
overall	O
length	B-T201
of	I-T201
labour	I-T201
for	O
women	B-T098
induced	O
at	O
42	O
weeks	O
was	O
6	O
.	O
5	O
hours	O
,	O
while	O
for	O
women	B-T098
induced	O
at	O
41	O
-	O
42	O
weeks	O
this	O
was	O
5	O
.	O
2	O
hours	O
.	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
15	O
,	O
95	O
%	O
ci	O
for	O
median	O
difference	O
-	O
0	O
.	O
27	O
to	O
1	O
.	O
93	O
hours	O
)	O
with	O
a	O
small	O
effect	O
size	O
(	O
pearson	O
'	O
s	O
r	O
=	O
-	O
0	O
.	O
08	O
)	O
.	O
the	O
median	O
length	O
of	O
induction	B-T058
to	O
birth	B-T038
was	O
13	O
.	O
6	O
hours	O
for	O
women	B-T098
induced	O
at	O
42	O
weeks	O
and	O
16	O
.	O
5	O
hours	O
for	O
women	B-T098
induced	O
at	O
41	O
-	O
42	O
weeks	O
.	O
this	O
difference	O
was	O
also	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
14	O
,	O
95	O
%	O
ci	O
for	O
median	O
difference	O
-	O
7	O
.	O
25	O
to	O
1	O
.	O
20	O
hours	O
)	O
with	O
a	O
small	O
effect	O
size	O
(	O
pearson	O
'	O
s	O
r	O
=	O
-	O
0	O
.	O
13	O
)	O
.	O
this	O
study	B-T062
demonstrated	O
no	O
statistically	O
significant	O
difference	O
s	O
in	O
length	B-T201
of	I-T201
labour	I-T201
and	O
induction	B-T058
following	O
a	O
change	O
in	O
the	O
management	O
of	O
postm	B-T038
##ature	I-T038
pregnancy	I-T038
to	O
earlier	O
induction	O
.	O
a	O
large	B-T062
study	I-T062
is	O
needed	O
to	O
establish	O
definitively	O
the	O
effects	O
of	O
earlier	O
induction	O
on	O
labour	B-T038
outcomes	O
.	O

transf	B-T058
##emoral	I-T058
aortic	I-T058
valve	I-T058
implantation	I-T058
with	O
the	O
reposition	B-T074
##able	I-T074
lot	I-T074
##us	I-T074
valve	I-T074
for	O
treatment	B-T058
of	O
patients	O
with	O
symptomatic	O
severe	O
aortic	B-T038
stenosis	I-T038
:	O
results	O
from	O
a	O
single	B-T038
-	I-T038
centre	I-T038
experience	I-T038
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
evaluate	B-T058
the	O
procedural	O
and	O
30	O
-	O
day	O
results	O
for	O
the	O
reposition	B-T074
##able	I-T074
lot	I-T074
##us	I-T074
valve	I-T074
in	O
patients	O
undergoing	O
transf	B-T058
##emoral	I-T058
aortic	I-T058
valve	I-T058
implantation	I-T058
in	O
a	O
single	B-T038
-	I-T038
centre	I-T038
experience	I-T038
.	O
we	O
prospectively	O
enrolled	O
110	O
patients	O
with	O
severe	O
symptomatic	O
aortic	B-T038
stenosis	I-T038
(	O
nct0	B-T170
##21	I-T170
##62	I-T170
##06	I-T170
##9	I-T170
)	O
.	O
all	O
procedures	O
were	O
performed	O
without	O
general	B-T058
anaesthesia	I-T058
by	O
the	O
transf	B-T058
##emoral	I-T058
approach	I-T058
.	O
patients	O
were	O
followed	O
for	O
30	O
days	O
.	O
patients	O
received	O
the	O
23	O
mm	O
(	O
n	O
=	O
20	O
)	O
,	O
25	O
mm	O
(	O
n	O
=	O
43	O
)	O
or	O
27	O
mm	O
(	O
n	O
=	O
47	O
)	O
lot	B-T074
##us	I-T074
device	I-T074
.	O
mean	O
overs	O
##izing	O
in	O
relation	O
to	O
annulus	B-T017
or	O
left	B-T017
ventricular	I-T017
outflow	I-T017
tract	I-T017
(	O
lv	B-T017
##ot	I-T017
)	O
did	O
not	O
differ	O
among	O
groups	O
.	O
there	O
was	O
no	O
residual	O
moderate	O
or	O
severe	O
aortic	B-T038
regurgitation	I-T038
.	O
the	O
rate	O
of	O
mild	O
aortic	B-T038
regurgitation	I-T038
was	O
low	O
at	O
9	O
.	O
1	O
%	O
.	O
there	O
was	O
no	O
valve	B-T017
emboli	B-T058
##sa	I-T058
##tion	I-T058
,	O
no	O
need	O
for	O
a	O
second	O
valve	B-T017
and	O
no	B-T033
conversion	I-T033
to	O
surgery	B-T058
.	O
the	O
need	O
for	O
a	O
new	O
pacemaker	B-T058
implantation	I-T058
due	O
to	O
complete	B-T038
(	O
third	B-T038
degree	I-T038
)	O
or	O
type	B-T038
ii	I-T038
(	I-T038
mob	I-T038
##itz	I-T038
)	I-T038
second	I-T038
degree	I-T038
atrioventricular	I-T038
block	I-T038
was	O
24	O
.	O
1	O
%	O
,	O
excluding	O
patients	O
with	O
previously	O
implanted	B-T058
devices	I-T058
.	O
within	O
30	O
days	O
the	O
rates	O
of	O
all	O
-	O
cause	O
mort	O
##al	O
##it	O
y	O
and	O
stroke	B-T038
were	O
low	O
.	O
in	O
patients	O
with	O
severe	O
aortic	B-T038
stenosis	I-T038
,	O
transf	B-T058
##emoral	I-T058
tavi	I-T058
with	O
the	O
reposition	B-T074
##able	I-T074
lot	I-T074
##us	I-T074
valve	I-T074
was	O
associated	O
with	O
a	O
high	O
rate	O
of	O
device	B-T074
success	O
,	O
no	O
moderate	O
or	O
severe	O
residual	O
aortic	B-T038
regurgitation	I-T038
,	O
low	O
rates	O
of	O
major	O
vascular	O
complications	O
and	O
mortality	O
within	O
30	O
days	O
.	O

patient	O
satisfaction	O
with	O
pharmacist	B-T097
-	O
led	O
collaborative	O
follow	B-T058
-	I-T058
up	I-T058
care	I-T058
in	O
an	O
ambulatory	O
rheumatology	B-T092
clinic	I-T092
patient	O
satisfaction	O
is	O
known	O
to	O
increase	O
with	O
pharmacist	B-T097
intervention	B-T058
in	O
general	B-T092
outpatient	I-T092
clinics	I-T092
and	O
with	O
nurse	B-T058
-	I-T058
led	I-T058
care	I-T058
in	O
rheumatology	B-T092
clinics	I-T092
.	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
describe	O
and	O
compare	O
patient	O
satisfaction	O
with	O
two	O
different	O
types	O
of	O
care	B-T058
:	O
a	O
pharmacist	B-T097
physician	B-T097
collaborative	O
model	O
and	O
a	O
traditional	O
physician	O
model	O
in	O
a	O
rheumatology	B-T092
clinic	I-T092
setting	O
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
survey	I-T062
of	O
inflammatory	B-T038
arthritis	I-T038
patients	O
seen	O
during	O
a	O
follow	B-T058
-	I-T058
up	I-T058
visit	I-T058
in	O
ed	O
##mon	O
##ton	O
,	O
alb	O
##ert	O
##a	O
,	O
canada	B-T082
,	O
was	O
conducted	O
over	O
a	O
ten	B-T062
-	I-T062
week	I-T062
period	I-T062
.	O
patient	O
satisfaction	O
was	O
measured	O
using	O
a	O
modified	O
version	O
of	O
the	O
validated	O
le	B-T058
##eds	I-T058
satisfaction	I-T058
questionnaire	I-T058
,	O
which	O
uses	O
a	O
five	O
-	O
point	O
likert	B-T170
scale	I-T170
to	O
measure	O
six	B-T082
dimensions	I-T082
of	O
satisfaction	O
,	O
and	O
compared	O
between	O
the	O
collaborative	B-T058
care	I-T058
and	O
traditional	O
physician	O
models	O
.	O
a	O
total	O
of	O
62	O
patients	O
completed	O
the	O
questionnaire	B-T170
(	O
21	O
collaborative	B-T058
care	I-T058
and	O
41	O
traditional	O
physician	O
model	O
)	O
.	O
the	O
average	O
age	O
of	O
respondents	B-T098
was	O
52	O
years	O
and	O
the	O
majority	O
were	O
female	O
.	O
the	O
mean	B-T170
score	I-T170
for	I-T170
satisfaction	I-T170
across	O
the	O
six	B-T082
dimensions	I-T082
was	O
4	O
.	O
56	O
in	O
the	O
collaborative	B-T092
care	I-T092
group	I-T092
and	O
4	O
.	O
30	O
in	O
the	O
traditional	B-T097
physician	I-T097
group	I-T097
(	O
p	O
=	O
0	O
.	O
02	O
)	O
.	O
patient	O
satisfaction	O
in	O
the	O
collaborative	B-T092
care	I-T092
group	I-T092
was	O
consistently	O
higher	O
across	O
all	O
dimensions	O
.	O
no	O
difference	O
was	O
noted	O
between	O
participants	B-T098
seen	O
for	O
the	O
first	O
time	O
compared	O
with	O
those	O
seen	O
two	O
or	O
more	O
times	O
by	O
the	O
pharmacist	B-T097
.	O
a	O
collaborative	O
care	O
model	O
can	O
exceed	O
the	O
already	O
high	O
expectations	O
for	O
care	B-T058
of	I-T058
patients	I-T058
with	O
inflammatory	B-T038
arthritis	I-T038
.	O
our	O
findings	O
support	O
the	O
role	O
of	O
pharmacists	B-T097
using	O
a	O
collaborative	B-T058
care	I-T058
approach	O
to	O
care	B-T058
for	I-T058
patients	I-T058
in	O
rheumatology	B-T092
clinics	I-T092
.	O

a	O
tract	O
##able	O
method	B-T170
for	O
measuring	O
nanom	O
##aterial	O
risk	O
using	O
bayesian	B-T170
networks	I-T170
while	O
control	O
banding	B-T058
has	O
been	O
identified	O
as	O
a	O
suitable	O
framework	O
for	O
the	O
evaluation	O
and	O
the	O
determination	O
of	O
potential	O
human	B-T204
health	O
risks	O
associated	O
with	O
exposure	O
to	O
nanomaterials	O
(	O
nms	O
)	O
,	O
the	O
approach	O
currently	O
lacks	O
any	O
implementation	O
that	O
enjoy	O
##s	O
widespread	O
support	O
.	O
large	O
inconsistencies	O
in	O
characterisation	O
data	O
,	O
toxicological	B-T038
measurements	O
and	O
exposure	O
scenarios	O
make	O
it	O
difficult	O
to	O
map	O
and	O
compare	O
the	O
risk	O
associated	O
with	O
nms	O
based	O
on	O
physicochemical	O
data	O
,	O
concentration	O
and	O
exposure	O
route	O
.	O
here	O
we	O
demonstrate	O
the	O
use	O
of	O
bayesian	B-T170
networks	I-T170
as	O
a	O
reliable	O
tool	O
for	O
nm	O
risk	O
estimation	O
.	O
this	O
tool	O
is	O
tract	O
##able	O
,	O
accessible	O
and	O
scalable	O
.	O
most	O
importantly	O
,	O
it	O
captures	O
a	O
broad	O
span	O
of	O
data	O
types	O
,	O
from	O
complete	O
,	O
high	O
quality	O
data	B-T170
sets	I-T170
through	O
to	O
data	B-T170
sets	I-T170
with	O
missing	O
data	O
and	O
/	O
or	O
values	O
with	O
a	O
relatively	O
high	O
spread	O
of	O
probability	O
distribution	O
.	O
the	O
tool	O
is	O
able	O
to	O
learn	O
iterative	O
##ly	O
in	O
order	O
to	O
further	O
refine	O
forec	O
##asts	O
as	O
the	O
quality	O
of	O
data	O
available	O
improves	O
.	O
we	O
demonstrate	O
how	O
this	O
risk	O
measurement	O
approach	O
works	O
on	O
nms	O
with	O
varying	O
degrees	O
of	O
risk	O
potential	O
,	O
namely	O
,	O
carbon	B-T103
nanotubes	I-T103
,	O
silver	B-T103
and	O
titanium	B-T103
dioxide	I-T103
.	O
the	O
results	O
afford	O
even	O
non	B-T098
-	I-T098
experts	I-T098
an	O
accurate	O
picture	O
of	O
the	O
occupational	O
risk	O
probabilities	O
associated	O
with	O
these	O
nms	O
and	O
,	O
in	O
doing	O
so	O
,	O
demonstrated	O
how	O
nm	O
risk	O
can	O
be	O
evaluated	O
into	O
a	O
tract	O
##able	O
,	O
quantitative	O
risk	O
compar	O
##ator	O
.	O

accurate	O
lungs	B-T017
segmentation	B-T058
on	O
ct	B-T058
chest	B-T082
images	B-T170
by	O
adaptive	B-T062
appearance	I-T062
-	I-T062
guided	I-T062
shape	I-T062
modeling	I-T062
to	O
accurately	O
segment	B-T058
pathological	O
and	O
healthy	O
lungs	B-T017
for	O
reliable	O
computer	B-T058
-	I-T058
aided	I-T058
disease	I-T058
diagnostics	I-T058
,	O
a	O
stack	B-T082
of	O
chest	B-T082
ct	B-T058
scans	B-T058
is	O
modeled	B-T062
as	O
a	O
sample	O
of	O
a	O
spatially	O
inhomogeneous	O
joint	O
3d	O
markov	O
-	O
gibbs	O
random	O
field	O
(	O
mg	O
##r	O
##f	O
)	O
of	O
voxel	O
-	O
wise	O
lung	B-T017
and	O
chest	B-T082
ct	B-T058
image	B-T170
signals	O
(	O
intensities	O
)	O
.	O
the	O
proposed	O
learn	O
##able	O
mg	O
##r	O
##f	O
integrates	O
two	O
visual	O
appearance	O
sub	O
-	O
models	O
with	O
an	O
adaptive	O
lung	B-T017
shape	O
subm	O
##ode	O
##l	O
.	O
the	O
first	O
-	O
order	O
appearance	O
subm	O
##ode	O
##l	O
accounts	O
for	O
both	O
the	O
original	O
ct	B-T058
image	B-T170
and	O
its	O
gaussian	O
scale	O
space	O
(	O
gss	O
)	O
filtered	O
version	O
to	O
specify	O
local	O
and	O
global	O
signal	O
properties	O
,	O
respectively	O
.	O
each	O
empirical	O
marginal	O
probability	O
distribution	O
of	O
signals	O
is	O
closely	O
approximated	O
with	O
a	O
linear	O
combination	O
of	O
discrete	O
gaussian	O
##s	O
(	O
lc	O
##dg	O
)	O
,	O
containing	O
two	O
positive	O
dominant	O
and	O
multiple	O
sign	O
-	O
alternate	O
sub	O
##ordinate	O
dg	O
##s	O
.	O
the	O
approximation	O
is	O
separated	O
into	O
two	O
lc	O
##dg	O
##s	O
to	O
describe	O
individually	O
the	O
lungs	B-T017
and	O
their	O
background	O
,	O
i	O
.	O
e	O
.	O
,	O
all	O
other	O
chest	B-T082
tissues	B-T017
.	O
the	O
second	O
-	O
order	O
appearance	O
subm	O
##ode	O
##l	O
quantif	O
##ies	O
conditional	O
pairwise	O
intensity	O
dependencies	B-T170
in	O
the	O
nearest	O
voxel	O
26	O
-	O
neighborhood	O
in	O
both	O
the	O
original	O
and	O
gss	O
-	O
filtered	O
images	B-T170
.	O
the	O
shape	O
subm	O
##ode	O
##l	O
is	O
built	O
for	O
a	O
set	O
of	O
training	O
data	O
and	O
is	O
adapted	O
during	O
segmentation	B-T058
using	O
both	O
the	O
lung	B-T017
and	O
chest	B-T082
appearances	O
.	O
the	O
accuracy	O
of	O
the	O
proposed	O
segmentation	B-T058
framework	O
is	O
quantitatively	O
assessed	O
using	O
two	O
public	O
databases	B-T170
(	O
is	B-T170
##bi	I-T170
vessel	I-T170
##12	I-T170
challenge	I-T170
and	O
mic	B-T170
##ca	I-T170
##i	I-T170
lo	I-T170
##la	I-T170
##11	I-T170
challenge	I-T170
)	O
and	O
our	O
own	O
database	B-T170
with	O
,	O
respectively	O
,	O
20	O
,	O
55	O
,	O
and	O
30	O
ct	B-T058
images	B-T170
of	O
various	O
lung	B-T017
pathologies	O
acquired	O
with	O
different	O
scanners	B-T074
and	O
protocols	B-T058
.	O
quantitative	O
assessment	O
of	O
our	O
framework	O
in	O
terms	O
of	O
dic	O
##e	O
similarity	O
coefficients	O
,	O
95	O
-	O
percentile	O
bidirectional	O
ha	O
##us	O
##d	O
##or	O
##ff	O
distances	O
,	O
and	O
percentage	O
volume	O
differences	O
confirms	O
the	O
high	O
accuracy	O
of	O
our	O
model	O
on	O
both	O
our	O
database	B-T170
(	O
98	O
.	O
4	O
##±1	O
.	O
0	O
%	O
,	O
2	O
.	O
2	O
##±1	O
.	O
0	O
mm	O
,	O
0	O
.	O
42	O
##±0	O
.	O
10	O
%	O
)	O
and	O
the	O
vessel	B-T170
##12	I-T170
database	I-T170
(	O
99	O
.	O
0	O
##±0	O
.	O
5	O
%	O
,	O
2	O
.	O
1	O
##±1	O
.	O
6	O
mm	O
,	O
0	O
.	O
39	O
##±0	O
.	O
20	O
%	O
)	O
,	O
respectively	O
.	O
similarly	O
,	O
the	O
accuracy	O
of	O
our	O
approach	O
is	O
further	O
verified	O
via	O
a	O
blind	B-T170
evaluation	B-T170
by	O
the	O
organize	O
##rs	O
of	O
the	O
lo	B-T170
##la	I-T170
##11	I-T170
competition	O
,	O
where	O
an	O
average	O
overlap	O
of	O
98	O
.	O
0	O
%	O
with	O
the	O
expert	O
'	O
s	O
segmentation	B-T058
is	O
yielded	O
on	O
all	O
55	O
subjects	O
with	O
our	O
framework	O
being	O
ranked	O
first	O
among	O
all	O
the	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
techniques	O
compared	O
.	O

the	O
role	O
of	O
the	O
hippocampus	B-T017
and	O
the	O
function	O
of	O
calcitonin	B-T103
gene	I-T103
-	I-T103
related	I-T103
peptide	I-T103
in	O
the	O
mechanism	O
of	O
traumatic	B-T037
brain	I-T037
injury	I-T037
accelerating	O
fracture	B-T038
-	I-T038
healing	I-T038
this	O
research	O
attempts	O
to	O
identify	O
the	O
part	O
the	O
hippocampus	B-T017
plays	O
in	O
accelerated	O
fracture	B-T038
-	I-T038
healing	I-T038
after	O
traumatic	B-T037
brain	I-T037
injury	I-T037
as	O
well	O
as	O
to	O
test	O
functions	O
of	O
calcitonin	B-T103
gene	I-T103
-	I-T103
related	I-T103
peptide	I-T103
(	O
cgrp	B-T103
)	O
during	O
this	O
process	O
.	O
experiments	O
were	O
carried	O
out	O
on	O
male	O
sprague	B-T204
-	I-T204
dawley	I-T204
rats	I-T204
that	O
were	O
split	O
into	O
four	O
groups	O
at	O
random	O
:	O
tbi	B-T037
-	O
fracture	B-T037
group	O
,	O
fracture	B-T037
-	O
only	O
group	O
,	O
tbi	B-T037
-	O
only	O
group	O
,	O
and	O
control	O
group	O
.	O
in	O
the	O
first	O
week	O
,	O
blood	B-T031
specimen	I-T031
would	O
be	O
drawn	O
from	O
rats	B-T204
among	O
the	O
groups	O
except	O
those	O
of	O
the	O
control	O
group	O
at	O
three	O
-	O
time	O
points	O
(	O
24	O
,	O
72	O
and	O
168	O
hours	O
)	O
post	O
-	O
damage	B-T037
.	O
these	O
rats	B-T204
would	O
be	O
assessed	O
from	O
the	O
neurological	O
perspective	O
based	O
on	O
their	O
grades	O
of	O
performance	O
in	O
a	O
sequence	O
of	O
tests	O
24	O
hours	O
before	O
and	O
12	O
hours	O
after	O
brain	B-T037
injury	I-T037
.	O
blood	B-T058
samples	I-T058
were	O
also	O
taken	O
from	O
the	O
control	O
group	O
24	O
hours	O
before	O
the	O
injury	B-T037
,	O
and	O
whole	O
brain	B-T017
tissues	I-T017
in	O
the	O
injured	O
groups	O
were	O
harvested	B-T058
at	O
72	O
and	O
168	O
hours	O
post	O
-	O
injury	B-T037
.	O
we	O
compared	O
the	O
serum	B-T031
cgrp	B-T103
concentration	O
,	O
the	O
distribution	O
of	O
cgrp	B-T103
,	O
the	O
cgrp	B-T103
expression	B-T038
,	O
and	O
the	O
expression	B-T038
of	O
cgrp	B-T103
in	O
the	O
hippocampus	B-T017
,	O
the	O
expression	B-T038
of	O
cgrp	B-T103
in	O
the	O
hippocampus	B-T017
,	O
the	O
expression	B-T038
of	O
cgrp	B-T103
in	O
the	O
hippocampus	B-T017
,	O
and	O
the	O
expression	B-T038
of	O
cgrp	B-T103
in	O
the	O
brain	B-T017
by	O
immunohistochemistry	B-T058
,	O
western	B-T058
blotting	I-T058
,	O
rt	B-T038
-	O
of	O
cgrp	B-T017
rna	B-T038
expression	I-T038
levels	O
.	O
neurological	B-T058
examinations	I-T058
suggested	O
that	O
the	O
functions	O
of	O
the	O
cerebral	B-T017
cortex	I-T017
,	O
cerebellum	B-T017
,	O
and	O
brain	B-T017
stem	I-T017
showed	O
significant	O
differences	O
pre	O
-	O
and	O
post	O
-	O
injury	B-T037
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
elisa	B-T058
analysis	I-T058
indicated	O
a	O
great	O
density	O
of	O
cgrp	B-T103
in	O
tbi	B-T037
-	O
fracture	B-T037
group	O
at	O
different	O
time	O
points	O
.	O
furthermore	O
,	O
in	O
the	O
tbi	B-T037
-	O
fracture	B-T037
group	O
,	O
cgrp	B-T103
in	O
both	O
hippocampus	B-T017
and	O
the	O
whole	B-T017
brain	I-T017
showed	O
a	O
noticeable	O
augment	O
in	O
rt	B-T062
-	I-T062
pcr	I-T062
and	O
western	B-T058
blot	I-T058
analysis	I-T058
at	O
72	O
and	O
168	O
h	O
post	O
-	O
injury	B-T037
,	O
and	O
only	O
in	O
this	O
group	O
,	O
immunohistochemistry	B-T058
analysis	I-T058
indicated	O
that	O
cgrp	B-T103
was	O
present	O
in	O
the	O
hippocampus	B-T017
at	O
168	O
hours	O
post	O
-	O
injury	B-T037
.	O
we	O
observed	O
that	O
the	O
hippocampus	B-T017
and	O
cgrp	B-T103
were	O
responsible	O
for	O
quick	O
bone	O
-	O
healing	O
mechanisms	O
.	O
we	O
suggest	O
a	O
role	O
for	O
the	O
hippocampus	B-T017
in	O
accelerated	O
fracture	B-T038
healing	I-T038
.	O
cgrp	B-T103
expression	B-T038
,	O
as	O
determined	O
by	O
ihc	B-T058
,	O
cann	O
##ot	O
be	O
observed	O
in	O
other	O
groups	O
,	O
indicating	O
that	O
the	O
hippocampus	B-T017
may	O
be	O
the	O
specific	O
component	O
of	O
the	O
brain	B-T017
that	O
responds	O
to	O
[UNK]	O
big	B-T038
stress	I-T038
[UNK]	O
.	O

ren	B-T103
##ier	I-T103
##amycin	I-T103
m	I-T103
attenuates	O
cancer	B-T017
stem	I-T017
cell	I-T017
-	O
like	O
phenotypes	O
in	O
h4	B-T017
##60	I-T017
lung	B-T017
cancer	B-T017
cells	I-T017
cancer	B-T017
stem	I-T017
cells	I-T017
(	O
cscs	B-T017
)	O
are	O
a	O
subpopulation	O
of	O
cancer	B-T017
cells	I-T017
that	O
possess	O
self	B-T038
-	I-T038
renewal	I-T038
and	O
differentiation	B-T038
capacities	O
.	O
cscs	B-T017
contribute	O
to	O
drug	B-T038
-	I-T038
resistance	I-T038
,	O
cancer	O
recurrence	O
and	O
metastasis	B-T038
,	O
thus	O
development	O
of	O
csc	B-T017
-	O
targeted	O
therapeutic	B-T058
strategies	I-T058
has	O
recently	O
received	O
significant	O
attention	O
in	O
cancer	B-T062
research	I-T062
.	O
in	O
this	O
study	B-T062
,	O
the	O
potential	O
efficacy	O
of	O
ren	B-T103
##ier	I-T103
##amycin	I-T103
m	I-T103
(	O
rm	B-T103
)	O
isolated	O
from	O
the	O
sponge	B-T204
x	B-T204
##est	I-T204
##osp	I-T204
##ong	I-T204
##ia	I-T204
species	I-T204
,	O
was	O
examined	B-T033
against	O
lung	B-T017
cscs	B-T017
.	O
colony	B-T058
and	I-T058
spher	I-T058
##oid	I-T058
formation	I-T058
assays	I-T058
,	O
as	O
well	O
as	O
western	B-T058
blotting	I-T058
analysis	I-T058
of	O
lung	B-T017
csc	B-T017
protein	B-T103
markers	B-T103
were	O
employed	O
to	O
determine	O
the	O
csc	B-T017
-	O
like	O
phenotypes	O
of	O
h4	B-T017
##60	I-T017
lung	B-T017
cancer	B-T017
cells	I-T017
after	O
treatment	B-T058
with	O
rm	B-T103
at	O
non	O
-	O
toxic	O
concentrations	O
.	O
rm	B-T103
treatment	B-T058
reduced	O
significantly	O
colony	B-T058
and	I-T058
spher	I-T058
##oid	I-T058
formation	I-T058
of	O
h4	B-T017
##60	I-T017
cells	I-T017
.	O
moreover	O
,	O
the	O
csc	B-T017
markers	B-T103
cd133	B-T103
,	O
cd44	B-T103
and	O
ald	B-T103
##h1	I-T103
##a1	I-T103
of	O
csc	B-T017
-	O
enriched	O
h4	B-T017
##60	I-T017
cells	I-T017
were	O
reduced	O
significantly	O
following	O
rm	B-T103
treatment	B-T058
.	O
rm	B-T103
could	O
be	O
a	O
potent	O
anti	B-T103
-	I-T103
metastatic	I-T103
agent	I-T103
by	O
suppressing	O
lung	B-T017
csc	B-T017
-	O
like	O
phenotypes	O
in	O
h4	B-T017
##60	I-T017
cells	I-T017
.	O

preparation	O
and	O
characterization	O
of	O
gastrointestinal	B-T082
wa	B-T103
##fer	I-T103
formulations	O
many	O
active	B-T103
pharmaceutical	I-T103
ingredients	I-T103
(	O
api	B-T103
)	O
have	O
a	O
very	O
poor	O
or	O
highly	O
variable	O
bioavailability	O
after	O
oral	B-T058
administration	I-T058
.	O
one	O
possibility	O
to	O
overcome	O
this	O
problem	O
might	O
be	O
found	O
in	O
the	O
application	O
of	O
muco	B-T103
##adhes	I-T103
##ive	I-T103
dosage	I-T103
forms	I-T103
like	O
gastrointestinal	B-T082
wa	B-T103
##fer	I-T103
##s	I-T103
.	O
however	O
,	O
a	O
currently	O
uns	O
##olved	O
challenge	O
is	O
the	O
control	O
of	O
the	O
adhesion	O
of	O
the	O
wa	B-T103
##fer	I-T103
to	O
the	O
intestinal	B-T031
mucus	I-T031
.	O
one	O
suggested	O
solution	O
might	O
be	O
the	O
combination	O
of	O
gastrointestinal	B-T082
wa	B-T103
##fer	I-T103
##s	I-T103
and	O
expanding	O
systems	O
.	O
such	O
a	O
combination	O
requires	O
thin	B-T103
and	I-T103
elastic	I-T103
wa	I-T103
##fer	I-T103
##s	I-T103
which	O
are	O
further	O
characterized	O
by	O
an	O
unidirectional	O
drug	O
release	O
.	O
in	O
this	O
study	B-T062
gastrointestinal	B-T082
,	O
two	B-T103
##la	I-T103
##yer	I-T103
##ed	I-T103
wa	I-T103
##fer	I-T103
##s	I-T103
containing	O
a	O
water	O
-	O
insoluble	O
back	O
##ing	O
layer	O
and	O
a	O
drug	O
-	O
loaded	O
,	O
muco	O
##adhes	O
##ive	O
layer	O
were	O
fabricated	O
by	O
casting	O
solvent	O
technique	O
.	O
the	O
back	O
##ing	O
layer	O
consists	O
of	O
eth	B-T103
##oc	I-T103
##el	I-T103
##™	I-T103
standard	I-T103
10	I-T103
prem	I-T103
##ium	I-T103
and	O
the	O
muco	O
##adhes	O
##ive	O
layer	O
was	O
prepared	O
using	O
a	O
mixture	O
of	O
meth	B-T103
##oc	I-T103
##el	I-T103
##™	I-T103
e1	I-T103
##5	I-T103
prem	I-T103
##ium	I-T103
lv	I-T103
,	O
polyvinyl	B-T103
alcohol	I-T103
and	O
macro	B-T103
##go	I-T103
##l	I-T103
400	I-T103
.	O
the	O
wa	B-T103
##fer	I-T103
##s	I-T103
were	O
characterized	O
regarding	O
their	O
appearance	O
,	O
mechanical	O
properties	O
and	O
dissolution	O
profiles	O
as	O
well	O
as	O
the	O
influence	O
of	O
back	O
##ing	O
layer	O
thickness	O
on	O
drug	O
transfer	O
and	O
their	O
ability	O
of	O
unidirectional	O
drug	O
release	O
.	O
the	O
wa	B-T103
##fer	I-T103
##s	I-T103
with	O
back	O
##ing	O
layer	O
thickness	O
of	O
500	B-T103
##μg	I-T103
eth	I-T103
##oc	I-T103
##el	I-T103
™	O
/	O
cm	O
(	O
2	O
)	O
presented	O
adequate	O
mechanical	O
properties	O
,	O
a	O
drug	O
transfer	O
about	O
73	O
%	O
and	O
unidirectional	O
drug	O
release	O
.	O

placental	B-T017
pathologic	O
associations	O
with	O
morbidly	B-T038
adherent	I-T038
placenta	I-T038
:	O
potential	O
insights	O
into	O
pathogenesis	B-T038
the	O
pathology	O
that	O
underlies	O
morbidly	B-T038
adherent	I-T038
placenta	I-T038
(	O
map	B-T038
)	O
is	O
poorly	O
understood	O
.	O
the	O
objective	O
of	O
this	O
study	O
was	O
to	O
describe	O
the	O
placental	B-T017
pathology	O
,	O
especially	O
implantation	B-T082
site	I-T082
pathology	O
,	O
associated	O
with	O
map	B-T038
.	O
this	O
was	O
a	O
single	O
institution	B-T092
,	O
retrospective	B-T062
case	I-T062
-	I-T062
control	I-T062
study	I-T062
design	O
examining	O
placentas	B-T017
of	O
patients	O
who	O
delivered	B-T033
between	O
january	O
2008	O
and	O
september	O
2013	O
.	O
map	B-T038
cases	O
were	O
defined	O
by	O
the	O
need	O
for	O
clinical	O
intervention	B-T058
at	O
delivery	B-T058
beyond	O
spontaneous	O
placental	B-T058
delivery	I-T058
or	O
simple	O
manual	B-T058
extraction	I-T058
of	O
the	O
placenta	B-T017
.	O
controls	O
consisted	O
of	O
patients	O
with	O
placentas	B-T017
sent	O
for	O
examination	B-T058
due	O
to	O
a	O
history	B-T033
of	O
maternal	O
malignancy	B-T038
with	O
no	B-T033
clinical	O
suspicion	O
of	O
accr	B-T038
##eta	I-T038
.	O
placental	B-T017
pathologic	O
findings	O
of	O
maternal	B-T038
vascular	I-T038
underp	I-T038
##er	I-T038
##fusion	I-T038
(	O
mv	B-T038
##u	I-T038
)	O
,	O
acute	B-T033
inflammation	I-T033
,	O
chronic	B-T038
inflammation	I-T038
,	O
fetal	B-T017
vascular	B-T038
obstruction	I-T038
and	O
hemorrhage	B-T038
were	O
recorded	O
and	O
compared	O
using	O
biv	O
##ariable	O
and	O
multivariable	O
analyses	O
.	O
three	O
categories	B-T170
of	O
pathologic	O
changes	O
were	O
seen	O
more	O
commonly	O
in	O
map	B-T038
placentas	B-T017
(	O
n	O
=	O
101	O
)	O
than	O
control	O
placentas	B-T017
(	O
n	O
=	O
110	O
)	O
:	O
chronic	B-T038
basal	I-T038
inflammation	I-T038
,	O
villous	O
changes	O
of	O
mv	B-T038
##u	I-T038
and	O
retro	O
##me	O
##mb	O
##ran	O
##ous	O
and	O
retro	B-T038
##me	I-T038
##mb	I-T038
##ran	I-T038
##ous	I-T038
/	O
interv	B-T038
##ill	I-T038
##ous	I-T038
hemorrhage	I-T038
.	O
in	O
multivariable	O
analyses	O
adjusted	O
for	O
confounders	O
,	O
chronic	B-T038
basal	I-T038
villi	I-T038
##tis	I-T038
(	O
aor	O
5	O
.	O
6	O
,	O
1	O
.	O
73	O
-	O
18	O
.	O
18	O
)	O
,	O
plasma	B-T033
cell	I-T033
decid	I-T033
##uit	I-T033
##is	I-T033
(	O
aor	O
2	O
.	O
63	O
,	O
1	O
.	O
08	O
-	O
6	O
.	O
39	O
)	O
,	O
increased	B-T033
syncytial	I-T033
knot	I-T033
##s	I-T033
(	O
aor	O
3	O
.	O
92	O
,	O
1	O
.	O
57	O
-	O
9	O
.	O
75	O
)	O
,	O
villous	O
agglutination	O
(	O
aor	O
24	O
.	O
85	O
,	O
2	O
.	O
78	O
-	O
221	O
.	O
75	O
)	O
,	O
increased	B-T033
periv	I-T033
##ill	I-T033
##ous	I-T033
fibrin	I-T033
(	O
aor	O
5	O
.	O
08	O
,	O
1	O
.	O
49	O
-	O
17	O
.	O
34	O
)	O
,	O
and	O
the	O
presence	O
of	O
subch	B-T038
##ori	I-T038
##onic	I-T038
/	O
interv	B-T033
##ill	I-T033
##ous	I-T033
thrombi	I-T033
(	O
aor	O
4	O
.	O
01	O
,	O
1	O
.	O
63	O
-	O
9	O
.	O
86	O
)	O
remained	O
associated	O
with	O
map	B-T038
.	O
map	B-T038
is	O
highly	O
associated	O
with	O
evidence	O
of	O
intrap	B-T038
##are	I-T038
##nc	I-T038
##hy	I-T038
##mal	I-T038
placental	I-T038
hemorrhage	I-T038
villous	O
changes	O
of	O
mv	B-T038
##u	I-T038
,	O
and	O
a	O
lympho	B-T033
##plasm	I-T033
##acyt	I-T033
##ic	I-T033
infiltrate	I-T033
at	O
the	O
implantation	B-T082
site	I-T082
.	O
the	O
contribution	O
of	O
this	O
basal	B-T033
chronic	I-T033
inflammatory	I-T033
infiltrate	I-T033
to	O
map	B-T038
requires	O
further	O
investigation	O
.	O

high	O
tacrolimus	B-T103
blood	O
concentrations	O
early	O
after	O
lung	B-T058
transplantation	I-T058
and	O
the	O
risk	O
of	O
kidney	B-T037
injury	I-T037
lung	B-T017
transplant	O
recipients	O
often	O
develop	O
acute	B-T037
kidney	I-T037
injury	I-T037
(	O
aki	B-T037
)	O
evolving	O
into	O
chronic	B-T038
kidney	I-T038
disease	I-T038
(	O
ckd	B-T038
)	O
.	O
the	O
immunosuppress	B-T103
##ant	I-T103
tacrolimus	B-T103
might	O
be	O
associated	O
with	O
the	O
emergence	O
of	O
aki	B-T037
.	O
we	O
analyzed	O
the	O
development	O
and	O
recovery	B-T038
of	O
kidney	B-T037
injury	I-T037
after	O
lung	B-T058
transplantation	I-T058
and	O
related	O
aki	B-T037
to	O
whole	B-T031
-	I-T031
blood	I-T031
tacrolimus	B-T103
trough	O
concentrations	O
and	O
other	O
factors	O
causing	O
kidney	B-T037
injury	I-T037
.	O
we	O
retrospectively	B-T062
studied	I-T062
kidney	B-T037
injury	I-T037
in	O
186	O
lung	B-T058
-	I-T058
transplantation	I-T058
patients	O
at	O
the	O
um	B-T092
##c	I-T092
utr	I-T092
##ech	I-T092
##t	I-T092
between	O
2001	O
and	O
2011	O
.	O
kidney	B-T038
function	I-T038
and	O
whole	B-T031
-	I-T031
blood	I-T031
tacrolimus	B-T103
trough	O
concentrations	O
were	O
determined	O
from	O
day	O
1	O
to	O
14	O
and	O
at	O
1	O
,	O
3	O
,	O
6	O
,	O
and	O
12	O
months	O
postoperative	O
.	O
systemic	B-T038
inflammatory	I-T038
response	I-T038
syndrome	I-T038
(	O
sirs	B-T038
)	O
,	O
septic	B-T038
shock	I-T038
,	O
and	O
nephrot	O
##oxic	O
medications	B-T170
were	O
evaluated	O
as	O
covariates	O
for	O
aki	B-T037
.	O
we	O
analyzed	O
liver	B-T037
injury	I-T037
and	O
drug	B-T038
-	I-T038
drug	I-T038
interactions	I-T038
.	O
aki	B-T037
was	O
present	B-T033
in	O
85	O
(	O
46	O
%	O
)	O
patients	O
.	O
tacrolimus	B-T103
concentrations	O
were	O
supra	B-T033
-	I-T033
therapeutic	I-T033
in	O
135	O
of	O
186	O
patients	O
(	O
73	O
%	O
)	O
.	O
aki	B-T037
in	O
the	O
first	O
week	O
after	O
transplantation	B-T058
was	O
related	O
to	O
supra	B-T033
-	I-T033
therapeutic	I-T033
tacrolimus	B-T103
concentrations	O
(	O
or	O
1	O
.	O
55	O
;	O
95	O
%	O
ci	O
1	O
.	O
06	O
-	O
2	O
.	O
27	O
)	O
,	O
≥3	O
other	O
nephrot	B-T058
##oxic	I-T058
drugs	I-T058
(	O
or	O
1	O
.	O
96	O
;	O
95	O
%	O
ci	O
1	O
.	O
02	O
-	O
3	O
.	O
77	O
)	O
,	O
infection	B-T038
(	O
or	O
2	O
.	O
48	O
;	O
95	O
%	O
ci	O
1	O
.	O
31	O
-	O
4	O
.	O
70	O
)	O
,	O
and	O
cystic	B-T038
fibrosis	I-T038
(	O
or	O
2	O
.	O
17	O
;	O
95	O
%	O
ci	O
1	O
.	O
16	O
-	O
4	O
.	O
06	O
)	O
.	O
recovery	O
rate	O
of	O
aki	B-T037
was	O
lower	O
than	O
expected	O
(	O
19	O
%	O
)	O
,	O
and	O
the	O
cumulative	O
incidence	O
of	O
severe	O
ckd	B-T038
at	O
1	O
year	O
was	O
15	O
%	O
.	O
after	O
lung	B-T058
transplantation	I-T058
,	O
aki	B-T037
is	O
common	O
and	O
often	O
evolve	O
##s	O
into	O
severe	O
ckd	B-T038
,	O
which	O
is	O
a	O
known	O
cause	O
of	O
morbidity	O
and	O
mortality	O
.	O
supra	B-T033
-	I-T033
therapeutic	I-T033
whole	B-T031
-	I-T031
blood	I-T031
tacrolimus	B-T103
trough	O
concentrations	O
are	O
related	O
to	O
the	O
early	O
onset	O
of	O
aki	B-T037
.	O
cons	B-T033
##ci	I-T033
##entious	I-T033
targeting	O
tacrolimus	B-T103
blood	O
concentrations	O
might	O
be	O
vital	O
in	O
the	O
early	O
phase	O
after	O
lung	B-T058
transplantation	I-T058
.	O
what	O
is	O
known	O
about	O
this	O
subject	O
?	O
•	O
lung	B-T017
transplant	O
recipients	O
often	O
develop	O
acute	B-T037
kidney	I-T037
injury	I-T037
evolving	O
into	O
chronic	B-T038
kidney	I-T038
disease	I-T038
increasing	O
both	O
morbidity	O
and	O
mortality	O
.	O
•	O
to	O
date	O
,	O
the	O
pathophysiology	O
of	O
kidney	B-T037
injury	I-T037
after	O
lung	B-T058
transplantation	I-T058
has	O
not	O
been	O
fully	O
elucidated	O
.	O
•	O
the	O
immunosuppress	B-T103
##ant	I-T103
tacrolimus	B-T103
is	O
difficult	O
to	O
dose	O
,	O
especially	O
in	O
the	O
unstable	B-T033
clinical	O
setting	O
,	O
and	O
is	O
nephrot	O
##oxic	O
.	O
•	O
for	O
the	O
first	O
time	O
,	O
supra	B-T033
-	I-T033
therapeutic	I-T033
whole	B-T031
-	I-T031
blood	I-T031
tacrolimus	B-T103
trough	O
concentrations	O
are	O
related	O
to	O
the	O
emergence	O
of	O
acute	B-T037
kidney	I-T037
injury	I-T037
in	O
the	O
first	O
days	O
after	O
lung	B-T058
transplantation	I-T058
.	O
•	O
supra	B-T033
-	I-T033
therapeutic	I-T033
whole	B-T031
-	I-T031
blood	I-T031
tacrolimus	B-T103
trough	O
concentrations	O
often	O
occur	O
early	O
after	O
lung	B-T058
transplantation	I-T058
.	O
•	O
aki	B-T037
after	O
lung	B-T058
transplantation	I-T058
shows	O
low	O
recovery	B-T038
rates	O
.	O

pupillary	O
response	O
abnormalities	B-T033
in	O
depressive	B-T038
disorders	I-T038
depressive	B-T038
disorders	I-T038
lack	O
objective	O
physiological	O
measurements	O
to	O
characterize	O
the	O
affected	O
population	O
and	O
facilitate	O
study	B-T062
of	O
relevant	O
mechanisms	O
.	O
the	O
melan	B-T103
##opsin	I-T103
-	O
mediated	O
light	B-T038
signaling	I-T038
pathway	I-T038
may	O
contribute	O
to	O
seasonal	O
variation	O
and	O
can	O
be	O
measured	O
non	O
-	O
invasively	O
by	O
pupil	B-T058
##lo	I-T058
##metry	I-T058
.	O
we	O
prospectively	B-T062
studied	I-T062
changes	O
in	O
melan	B-T103
##opsin	I-T103
-	O
mediated	O
pupillary	B-T038
constriction	I-T038
in	O
19	O
participants	O
with	O
major	B-T038
depressive	I-T038
disorder	I-T038
(	O
mdd	B-T038
)	O
and	O
10	O
control	O
across	O
the	O
summer	O
and	O
winter	O
sol	O
##st	O
##ices	O
.	O
the	O
melan	B-T103
##opsin	I-T103
-	O
mediated	O
response	O
,	O
as	O
measured	O
by	O
the	O
pupil	B-T033
'	I-T033
s	I-T033
sustained	I-T033
constriction	I-T033
six	O
s	O
after	O
a	O
high	O
intensity	O
blue	O
light	O
stimulus	O
,	O
was	O
marginally	O
attenuated	O
in	O
those	O
with	O
mdd	B-T038
relative	O
to	O
controls	O
(	O
p	O
=	O
0	O
.	O
07	O
##1	O
)	O
.	O
the	O
participants	O
with	O
mdd	B-T038
unexpectedly	O
showed	O
a	O
significantly	O
reduced	O
transient	O
pupillary	O
response	O
to	O
low	O
intensity	O
red	O
(	O
p	O
=	O
0	O
.	O
011	O
)	O
and	O
blue	O
light	O
(	O
p	O
=	O
0	O
.	O
013	O
)	O
,	O
but	O
not	O
high	O
intensity	O
red	O
and	O
blue	O
light	O
.	O
sustained	O
pupillary	B-T038
constriction	I-T038
in	O
response	O
to	O
high	O
intensity	O
blue	O
light	O
was	O
more	O
pronounced	O
with	O
increasing	O
day	O
##light	O
hours	O
(	O
p	O
=	O
0	O
.	O
037	O
)	O
and	O
was	O
more	O
strongly	O
related	O
to	O
objectively	O
measured	O
versus	O
estimated	O
light	O
exposure	O
.	O
melan	B-T103
##opsin	I-T103
-	O
mediated	O
impairments	O
in	O
pupil	O
response	O
may	O
serve	O
as	O
a	O
biological	B-T201
marker	I-T201
for	O
vulnerability	O
to	O
depression	B-T038
in	O
low	O
light	O
conditions	O
.	O
assessment	B-T058
of	O
these	O
and	O
other	O
responses	O
to	O
light	O
stimuli	O
,	O
such	O
as	O
response	O
to	O
low	O
intensity	O
light	O
,	O
may	O
be	O
useful	O
for	O
the	O
study	B-T062
of	O
the	O
neurob	B-T091
##iology	I-T091
of	O
mdd	B-T038
and	O
related	O
mood	B-T038
disorders	I-T038
.	O

fully	O
endoscope	B-T074
-	O
controlled	O
clipping	B-T058
bilateral	B-T038
middle	I-T038
cerebral	I-T038
artery	I-T038
aneurysm	I-T038
via	O
unilateral	B-T058
supra	I-T058
##orbital	I-T058
key	I-T058
##hole	I-T058
approach	I-T058
clipping	B-T058
bilateral	B-T038
middle	I-T038
cerebral	I-T038
artery	I-T038
(	I-T038
bmc	I-T038
##a	I-T038
)	I-T038
aneurysms	I-T038
via	O
unilateral	B-T058
approach	I-T058
in	O
a	O
single	B-T058
-	I-T058
stage	I-T058
operation	I-T058
is	O
considered	O
as	O
a	O
challenge	O
procedure	O
.	O
to	O
our	O
knowledge	O
,	O
there	O
is	O
no	O
study	O
in	O
surgical	B-T058
management	I-T058
of	O
patients	O
with	O
bmc	B-T038
##a	I-T038
aneurysms	I-T038
by	O
fully	O
endoscope	B-T074
-	O
controlled	O
techniques	O
.	O
the	O
author	O
reported	O
a	O
patient	O
with	O
bmc	B-T038
##a	I-T038
aneurysms	I-T038
who	O
underwent	O
aneurysms	B-T058
clipping	I-T058
via	O
a	O
unilateral	B-T058
supra	I-T058
##orbital	I-T058
key	I-T058
##hole	I-T058
approach	I-T058
by	O
endoscope	B-T074
-	O
controlled	O
micron	B-T058
##eu	I-T058
##ros	I-T058
##urgery	I-T058
,	O
and	O
the	O
patient	O
had	O
an	O
uneventful	O
postoperative	O
course	O
without	O
neurologic	O
impairment	B-T038
and	O
complication	B-T038
.	O
furthermore	O
,	O
the	O
author	O
discussed	O
the	O
advantages	O
and	O
adaptation	B-T170
of	O
endoscope	B-T074
-	O
controlled	O
clipping	B-T058
bmc	B-T038
##a	I-T038
aneurysms	I-T038
via	O
unilateral	B-T058
supra	I-T058
##orbital	I-T058
key	I-T058
##hole	I-T058
approach	I-T058
.	O

vestibular	B-T082
-	O
dependent	O
inter	O
-	O
stimulus	O
interval	O
effects	O
on	O
sound	B-T038
evoked	I-T038
potentials	I-T038
of	O
central	B-T082
origin	O
tod	O
##d	O
et	O
al	O
.	O
(	O
2014	O
##ab	O
)	O
have	O
recently	O
demonstrated	O
the	O
presence	B-T033
of	O
vestibular	B-T082
-	O
dependent	O
contributions	O
to	O
auditory	B-T038
evoked	I-T038
potentials	I-T038
(	O
ae	B-T038
##ps	I-T038
)	O
when	O
passing	O
through	O
the	O
vestibular	B-T082
threshold	O
as	O
determined	O
by	O
vestibular	B-T033
evoked	I-T033
myogenic	I-T033
potentials	I-T033
(	O
ve	B-T033
##mp	I-T033
##s	I-T033
)	O
,	O
including	O
a	O
particular	O
deflection	B-T082
labeled	O
as	O
an	O
n	O
##42	O
/	O
p5	O
##2	O
prior	O
to	O
the	O
long	O
-	O
latency	O
ae	B-T038
##ps	I-T038
n1	O
and	O
p2	O
.	O
in	O
this	O
paper	O
we	O
report	B-T058
the	O
results	B-T033
of	O
an	O
experiment	B-T062
to	O
determine	O
the	O
effect	O
of	O
inter	O
-	O
stimulus	O
interval	O
(	O
isi	O
)	O
and	O
regularity	O
on	O
potentials	B-T038
recorded	O
above	B-T082
and	O
below	B-T082
ve	B-T033
##mp	I-T033
threshold	O
.	O
five	O
healthy	O
,	O
right	O
-	O
handed	O
subjects	B-T098
were	O
recruited	O
and	O
evoked	B-T038
potentials	I-T038
were	O
recorded	O
to	O
bin	O
##au	O
##ral	O
##ly	O
presented	O
sound	B-T058
stimulation	I-T058
,	O
above	B-T082
and	O
below	B-T082
vestibular	B-T082
threshold	O
,	O
at	O
seven	O
stimulus	O
rates	O
with	O
isi	O
##s	O
of	O
212	O
,	O
300	O
,	O
42	O
##4	O
,	O
600	O
,	O
84	O
##8	O
,	O
1200	O
and	O
169	O
##6	O
ms	O
.	O
the	O
inner	O
five	O
intervals	O
,	O
i	O
.	O
e	O
.	O
300	O
,	O
42	O
##4	O
,	O
600	O
,	O
84	O
##8	O
,	O
1200	O
ms	O
,	O
were	O
presented	O
twice	O
in	O
both	O
regular	O
and	O
irregular	O
conditions	O
.	O
anova	O
on	O
the	O
global	O
field	O
power	O
(	O
gfp	O
)	O
were	O
conducted	O
for	O
each	O
of	O
four	O
waves	O
,	O
n	O
##42	O
,	O
p5	O
##2	O
,	O
n1	O
and	O
p2	O
with	O
factors	O
of	O
intensity	O
,	O
isi	O
and	O
regularity	O
.	O
both	O
n	O
##42	O
and	O
p5	O
##2	O
waves	O
showed	O
significant	O
anova	O
effects	O
of	O
intensity	O
but	O
no	O
other	O
main	O
effects	O
or	O
interactions	O
.	O
in	O
contrast	O
both	O
n1	O
and	O
p2	O
showed	O
additional	O
effects	O
of	O
isi	O
,	O
as	O
well	O
as	O
intensity	O
,	O
and	O
evidence	O
of	O
non	O
-	O
linear	B-T082
interactions	O
between	O
isi	O
and	O
intensity	O
.	O
a	O
source	B-T062
analysis	I-T062
was	O
carried	O
out	O
consistent	O
with	O
prior	O
work	O
suggesting	O
that	O
when	O
above	B-T082
vestibular	B-T082
threshold	O
,	O
in	O
addition	O
to	O
bilateral	B-T082
superior	B-T082
temporal	B-T017
cortex	I-T017
,	O
ocular	B-T017
,	O
cerebellar	B-T017
and	O
cingulate	B-T017
sources	B-T033
are	O
recruited	O
.	O
further	O
statistical	O
analysis	O
of	O
the	O
source	B-T033
currents	O
indicated	O
that	O
the	O
origin	O
of	O
the	O
interactions	O
with	O
intensity	O
may	O
be	O
the	O
isi	O
sensitivity	O
of	O
the	O
vestibular	B-T082
-	O
dependent	O
sources	B-T033
.	O
this	O
in	O
turn	O
may	O
reflect	O
a	O
specific	O
vestibular	B-T082
preference	O
for	O
stimulus	O
rates	O
associated	O
with	O
locomotion	B-T038
,	O
i	O
.	O
e	O
.	O
rates	O
close	O
to	O
2	O
hz	O
,	O
or	O
isi	O
##s	O
close	O
to	O
500	O
ms	O
,	O
where	O
sacc	B-T082
##ular	I-T082
afferents	B-T082
show	O
increased	O
gain	O
and	O
the	O
corresponding	O
reflexes	B-T038
are	O
most	O
sensitive	O
.	O

determination	O
of	O
the	O
mutant	B-T058
prevention	I-T058
concentration	I-T058
and	O
the	O
mutant	O
selection	O
window	O
of	O
topical	B-T103
antimicrobial	I-T103
agents	I-T103
against	O
prop	B-T007
##ion	I-T007
##ib	I-T007
##acterium	I-T007
acne	I-T007
##s	I-T007
determination	O
of	O
the	O
mutant	B-T058
prevention	I-T058
concentration	I-T058
(	O
mpc	B-T058
)	O
and	O
the	O
mutant	O
selection	O
window	O
(	O
ms	O
##w	O
)	O
of	O
antimicrobial	B-T103
agents	I-T103
used	O
to	O
treat	O
pathogenic	O
bacteria	B-T007
is	O
important	O
in	O
order	O
to	O
apply	O
effective	O
antimicrobial	B-T103
therapies	B-T058
.	O
here	O
,	O
we	O
determined	O
the	O
mpc	B-T058
##s	I-T058
of	O
the	O
major	O
topical	B-T103
antimicrobial	I-T103
agents	I-T103
against	O
prop	B-T007
##ion	I-T007
##ib	I-T007
##acterium	I-T007
acne	I-T007
##s	I-T007
and	O
staphylococcus	B-T007
aureus	I-T007
which	O
cause	O
skin	B-T038
infections	I-T038
and	O
compared	O
their	O
ms	O
##ws	O
.	O
among	O
the	O
mpc	B-T058
##s	I-T058
of	O
nad	B-T103
##ifl	I-T103
##oxacin	I-T103
and	O
clindamycin	B-T103
,	O
the	O
clindamycin	B-T103
mpc	B-T058
was	O
determined	O
to	O
be	O
the	O
lowest	O
against	O
p	B-T007
.	I-T007
acne	I-T007
##s	I-T007
.	O
in	O
contrast	O
,	O
the	O
nad	B-T103
##ifl	I-T103
##oxacin	I-T103
mpc	B-T058
was	O
the	O
lowest	O
against	O
s	B-T007
.	I-T007
aureus	I-T007
.	O
calculations	O
based	O
on	O
the	O
minimum	B-T033
inhibitory	I-T033
concentrations	I-T033
and	O
mpc	B-T058
##s	I-T058
showed	O
that	O
clindamycin	B-T103
has	O
the	O
lowest	O
ms	O
##w	O
against	O
both	O
p	B-T007
.	I-T007
acne	I-T007
##s	I-T007
and	O
s	B-T007
.	I-T007
aureus	I-T007
.	O
nad	B-T103
##ifl	I-T103
##oxacin	I-T103
ms	O
##ws	O
were	O
4	O
-	O
fold	O
higher	O
against	O
p	B-T007
.	I-T007
acne	I-T007
##s	I-T007
than	O
against	O
s	B-T007
.	I-T007
aureus	I-T007
.	O
it	O
is	O
more	O
likely	O
for	O
p	B-T007
.	I-T007
acne	I-T007
##s	I-T007
to	O
acquire	O
resistance	B-T038
to	O
fluoroquinolones	B-T103
than	O
s	B-T007
.	I-T007
aureus	I-T007
.	O
therefore	O
,	O
topical	O
application	O
of	O
clindamycin	B-T103
contributes	O
very	O
little	O
to	O
the	O
emergence	O
of	O
resistant	B-T038
p	B-T007
.	I-T007
acne	I-T007
##s	I-T007
and	O
s	B-T007
.	I-T007
aureus	I-T007
strains	O
.	O

metacarp	B-T058
##oph	I-T058
##ala	I-T058
##ng	I-T058
##eal	I-T058
joint	I-T058
arthrodesis	I-T058
of	O
the	O
thumb	B-T017
-	O
minimum	O
of	O
eight	O
months	O
follow	B-T058
-	I-T058
up	I-T058
disorders	B-T038
of	O
the	O
thumb	B-T082
metacarp	I-T082
##oph	I-T082
##ala	I-T082
##ng	I-T082
##eal	I-T082
(	I-T082
mcp	I-T082
)	I-T082
joint	I-T082
can	O
lead	O
to	O
significant	O
loss	O
of	O
function	O
and	O
pain	B-T033
.	O
thumb	B-T082
mcp	I-T082
arthrodesis	B-T058
following	O
traumatic	B-T037
injuries	I-T037
is	O
inadequate	O
##ly	O
described	O
and	O
recent	O
studies	B-T062
have	O
questioned	O
the	O
outcome	O
of	O
this	O
treatment	B-T058
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
report	B-T058
outcome	O
and	O
disability	B-T033
following	O
thumb	B-T082
mcp	I-T082
joint	I-T082
arthrodesis	B-T058
in	O
the	O
treatment	B-T058
of	O
chronic	B-T038
instability	I-T038
after	O
traumatic	B-T037
injuries	I-T037
.	O
a	O
retrospective	O
review	B-T058
of	O
26	O
patients	O
operated	B-T058
on	O
with	O
mcp	B-T082
joint	I-T082
arthrodesis	B-T058
,	O
median	O
follow	B-T058
-	I-T058
up	I-T058
42	O
months	O
(	O
8	O
-	O
104	O
months	O
)	O
.	O
subjective	O
outcome	O
was	O
assessed	O
using	O
the	O
disabilities	O
of	O
the	O
arm	O
,	O
shoulder	O
,	O
and	O
hand	O
-	O
questionnaire	O
(	O
dash	O
)	O
.	O
in	O
addition	O
,	O
patient	O
satisfaction	O
,	O
pain	B-T033
,	O
stiffness	B-T033
,	O
and	O
impairment	O
of	O
activities	O
of	O
daily	O
living	O
were	O
assessed	O
on	O
a	O
visual	B-T058
analogue	I-T058
scale	I-T058
(	O
vas	B-T058
)	O
followed	O
by	O
a	O
question	O
statin	O
##g	O
whether	O
they	O
would	O
undergo	O
the	O
same	O
procedure	O
again	O
.	O
two	O
patients	O
(	O
7	O
.	O
7	O
%	O
)	O
needed	O
re	B-T058
-	I-T058
operation	I-T058
due	O
to	O
nonunion	B-T033
.	O
four	O
patients	O
(	O
15	O
.	O
4	O
%	O
)	O
needed	O
hardware	B-T058
removal	I-T058
.	O
median	O
dash	O
-	O
score	O
was	O
18	O
(	O
25	O
-	O
75	O
%	O
range	O
6	O
-	O
47	O
)	O
,	O
with	O
lower	O
dash	O
score	O
s	O
being	O
better	O
.	O
score	O
s	O
were	O
significantly	O
worse	O
in	O
gender	O
and	O
age	O
matched	O
individuals	B-T098
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
median	O
vas	B-T058
for	O
pain	B-T033
was	O
3	O
.	O
7	O
(	O
range	O
0	O
-	O
8	O
)	O
.	O
more	O
than	O
50	O
%	O
of	O
patients	O
reported	O
mild	B-T033
,	O
moderate	B-T033
or	O
severe	B-T033
pain	I-T033
,	O
but	O
all	O
patients	O
reported	O
that	O
they	O
were	O
willing	O
to	O
undergo	O
the	O
same	O
procedure	O
again	O
.	O
our	O
data	O
suggest	O
,	O
that	O
patients	O
with	O
post	O
-	O
traumatic	O
thumb	B-T037
injuries	I-T037
managed	O
with	O
thumb	B-T082
mcp	I-T082
joint	I-T082
arthrodesis	B-T058
perform	O
worse	O
than	O
gender	O
and	O
age	O
matched	O
individuals	B-T098
.	O
many	O
lived	O
with	O
pain	B-T033
,	O
but	O
all	O
reported	O
that	O
they	O
were	O
willing	O
to	O
undergo	O
the	O
same	O
procedure	O
again	O
.	O
we	O
suggest	O
that	O
the	O
disability	B-T170
scale	I-T170
by	O
the	O
national	B-T092
board	I-T092
of	I-T092
industrial	I-T092
injuries	I-T092
should	O
be	O
reconsider	O
##ed	O
for	O
patients	O
operated	B-T058
on	O
with	O
thumb	B-T082
mcp	I-T082
arthrodesis	B-T058
.	O

the	O
experience	B-T038
of	O
women	B-T098
veterans	B-T098
coming	O
back	O
from	O
war	O
issues	O
surrounding	O
mental	O
health	O
are	O
common	O
for	O
women	B-T098
veterans	B-T098
who	O
have	O
served	O
in	O
ira	B-T082
##q	I-T082
and	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
war	O
##s	O
.	O
the	O
goal	O
of	O
this	O
phenomenological	O
study	B-T062
was	O
to	O
document	B-T170
themes	O
in	O
the	O
stories	B-T170
gathered	O
from	O
eight	O
women	B-T098
veterans	B-T098
who	O
had	O
come	O
back	O
from	O
war	O
.	O
themes	O
in	O
the	O
stories	B-T170
were	O
:	O
arr	O
##iving	O
with	O
mixed	O
sent	O
##iment	O
##s	O
;	O
evolving	O
to	O
a	O
changed	O
view	B-T038
of	I-T038
self	I-T038
;	O
perme	B-T033
##ating	I-T033
aggrav	I-T033
##ation	I-T033
;	O
confounding	O
broken	O
relationships	O
,	O
frequent	B-T033
deployment	I-T033
##s	I-T033
,	O
and	O
change	O
in	O
military	O
status	O
;	O
remember	B-T038
##ing	I-T038
war	O
experiences	B-T038
;	O
and	O
seeking	B-T033
opportunity	I-T033
for	I-T033
what	I-T033
is	I-T033
possible	I-T033
.	O
mental	O
health	O
issues	O
can	O
be	O
observed	O
in	O
the	O
themes	O
.	O
including	O
story	B-T170
as	O
part	O
of	O
the	O
mental	B-T038
health	I-T038
visit	O
with	O
veterans	B-T098
may	O
be	O
beneficial	O
to	O
veterans	B-T098
as	O
they	O
deal	O
with	O
the	O
transition	O
of	O
coming	O
back	O
.	O

methods	B-T170
to	O
study	B-T062
autophagy	B-T038
in	O
zebrafish	B-T204
autophagy	B-T038
(	O
cellular	B-T038
self	I-T038
-	I-T038
eating	I-T038
)	O
is	O
a	O
highly	O
regulated	O
degradation	B-T038
process	I-T038
of	O
the	O
eukaryotic	B-T017
cell	I-T017
during	O
which	O
parts	O
of	O
the	O
cytoplasm	B-T017
are	O
delivered	O
into	O
,	O
and	O
broken	O
down	O
within	O
,	O
the	O
lysosomal	O
compartment	O
.	O
the	O
process	O
serves	O
as	O
a	O
main	O
route	O
for	O
the	O
elimination	B-T038
of	O
superf	O
##lu	O
##ous	O
and	O
damaged	O
cellular	B-T017
constituents	I-T017
,	O
thereby	O
mediating	O
macromolecular	B-T038
and	O
organ	O
##ellar	O
turnover	O
.	O
in	O
addition	O
to	O
maintaining	O
cellular	B-T038
homeostasis	I-T038
,	O
autophagy	B-T038
is	O
involved	O
in	O
various	O
other	O
cellular	B-T038
and	O
developmental	B-T038
processes	I-T038
by	O
degrading	B-T038
specific	O
regulatory	B-T103
proteins	I-T103
,	O
and	O
contributing	O
to	O
the	O
clearance	O
of	O
intracellular	B-T082
pathogens	O
.	O
the	O
physiological	O
roles	O
and	O
pathological	O
involvement	O
of	O
autophagy	B-T038
can	O
be	O
effectively	O
studied	O
in	O
divergent	O
eukaryotic	B-T204
model	O
systems	O
ranging	O
from	O
yeast	B-T204
to	O
mice	B-T204
.	O
such	O
a	O
tract	O
##able	O
animal	B-T204
model	I-T204
applied	O
only	O
recently	O
for	O
autophagy	B-T038
research	O
##is	O
the	O
zebrafish	B-T204
dan	B-T204
##io	I-T204
rer	I-T204
##io	I-T204
,	O
which	O
also	O
facilitates	O
the	O
analysis	B-T062
of	O
more	O
specific	O
biological	B-T038
processes	I-T038
such	O
as	O
tissue	B-T038
regeneration	I-T038
.	O
in	O
this	O
chapter	O
,	O
we	O
overview	O
the	O
main	O
methods	O
and	O
tools	O
that	O
are	O
used	O
to	O
monitor	O
autophagic	B-T017
structures	I-T017
and	O
to	O
assay	B-T058
autophagic	B-T038
responses	I-T038
in	O
this	O
vertebrate	B-T204
organism	I-T204
.	O
we	O
place	O
emphasis	O
on	O
genetic	B-T062
(	I-T062
functional	I-T062
)	I-T062
approaches	I-T062
applied	O
for	O
exploring	O
novel	O
cellular	B-T038
and	O
developmental	B-T038
roles	I-T038
of	O
the	O
autophagic	B-T038
process	I-T038
.	O

low	B-T092
-	I-T092
volume	I-T092
vs	O
high	B-T092
-	I-T092
volume	I-T092
centers	I-T092
and	O
management	B-T058
of	I-T058
four	B-T038
##ni	I-T038
##er	I-T038
'	I-T038
s	I-T038
gang	I-T038
##rene	I-T038
in	O
washington	B-T082
state	I-T082
four	B-T038
##ni	I-T038
##er	I-T038
'	I-T038
s	I-T038
gang	I-T038
##rene	I-T038
(	O
fg	B-T038
)	O
is	O
a	O
life	B-T033
-	I-T033
threatening	I-T033
infection	I-T033
affecting	O
the	O
perine	B-T082
##um	I-T082
and	O
genital	B-T017
##s	I-T017
.	O
complex	O
patient	B-T058
management	I-T058
often	O
necessitates	O
transfer	O
to	O
tertiary	B-T092
centers	I-T092
.	O
we	O
aimed	O
to	O
characterize	O
hospital	O
transfer	O
patterns	B-T082
and	O
assess	O
morbidity	O
among	O
patients	O
with	O
fg	B-T038
in	O
washington	B-T082
state	I-T082
.	O
the	O
washington	B-T082
state	I-T082
comprehensive	O
hospital	O
abstract	O
reporting	O
system	O
includes	O
claims	O
from	O
all	O
hospital	O
discharges	O
in	O
washington	B-T082
.	O
we	O
identified	O
patients	O
with	O
fg	B-T038
between	O
2007	O
and	O
2013	O
,	O
based	O
on	O
diagnosis	B-T170
and	I-T170
treatment	I-T170
codes	I-T170
.	O
analyses	O
were	O
stratified	O
by	O
center	O
volume	O
(	O
low	B-T092
-	I-T092
volume	I-T092
centers	I-T092
[	O
lv	B-T092
##cs	I-T092
]	O
or	O
high	B-T092
-	I-T092
volume	I-T092
centers	I-T092
[	O
hv	B-T092
##cs	I-T092
]	O
)	O
,	O
and	O
transfer	B-T033
status	I-T033
.	O
variables	O
of	O
interest	O
included	O
number	O
of	O
debridement	B-T058
##s	I-T058
,	O
septic	B-T038
shock	I-T038
,	O
acute	B-T038
renal	I-T038
failure	I-T038
,	O
acute	B-T038
respiratory	I-T038
failure	I-T038
,	O
length	O
of	O
hospitalization	O
,	O
and	O
death	B-T033
.	O
we	O
identified	O
165	O
fg	B-T038
patients	O
.	O
only	O
1	O
hv	B-T092
##c	I-T092
treated	O
more	O
than	O
2	O
fg	B-T038
patients	O
per	O
year	O
.	O
overall	O
mortality	O
was	O
6	O
.	O
7	O
%	O
.	O
most	O
patients	O
(	O
57	O
%	O
)	O
were	O
treated	O
entirely	O
at	O
lv	B-T092
##cs	I-T092
;	O
87	O
%	O
of	O
patients	O
treated	O
at	O
the	O
hv	B-T092
##c	I-T092
were	O
transferred	O
from	O
an	O
lv	B-T092
##c	I-T092
.	O
high	B-T092
-	I-T092
volume	I-T092
center	I-T092
-	O
treated	O
patients	O
had	O
similar	O
baseline	O
comorbidities	O
(	O
p	O
=	O
0	O
.	O
77	O
)	O
and	O
similar	O
mortality	O
(	O
p	O
=	O
0	O
.	O
87	O
)	O
,	O
despite	O
higher	O
rates	O
of	O
septic	B-T038
shock	I-T038
(	O
p	O
<	O
0	O
.	O
01	O
)	O
and	O
respiratory	B-T038
failure	I-T038
(	O
p	O
=	O
0	O
.	O
01	O
)	O
compared	O
with	O
lv	B-T092
##c	I-T092
patients	O
.	O
among	O
hv	B-T092
##c	I-T092
-	O
transferred	B-T058
patients	I-T058
,	O
immediate	O
compared	O
with	O
delayed	O
transfer	O
was	O
associated	O
with	O
fewer	O
debridement	B-T058
##s	I-T058
(	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
lower	O
rates	O
of	O
septic	B-T038
shock	I-T038
(	O
p	O
=	O
0	O
.	O
05	O
)	O
,	O
and	O
acute	B-T038
renal	I-T038
failure	I-T038
(	O
p	O
=	O
0	O
.	O
04	O
)	O
.	O
patients	O
treated	O
at	O
the	O
hv	B-T092
##c	I-T092
were	O
more	O
acutely	O
ill	O
,	O
yet	O
mortality	O
was	O
similar	O
compared	O
with	O
patients	O
treated	O
solely	O
at	O
lv	B-T092
##cs	I-T092
,	O
suggesting	O
a	O
benefit	O
to	O
transfer	O
of	O
high	O
acuity	O
patients	O
.	O
immediate	O
vs	O
delayed	O
transfer	O
may	O
benefit	O
fg	B-T038
health	O
outcomes	O
;	O
however	O
,	O
this	O
may	O
also	O
reflect	O
greater	O
disease	B-T038
acuity	O
of	O
patients	O
with	O
delayed	O
transfer	B-T033
status	I-T033
.	O

complications	B-T038
and	O
near	O
-	O
miss	O
events	O
after	O
hepatectomy	B-T058
for	O
living	B-T058
-	I-T058
related	I-T058
liver	I-T058
donation	I-T058
:	O
an	O
italian	B-T082
single	B-T092
center	I-T092
report	B-T170
of	O
one	O
hundred	O
cases	O
background	O
in	O
healthy	O
individuals	B-T098
,	O
such	O
as	O
liver	B-T098
living	I-T098
donors	I-T098
,	O
potential	O
complications	B-T038
may	O
occur	O
during	O
surgery	B-T058
.	O
reporting	O
such	O
complications	B-T038
and	O
near	O
-	O
miss	O
events	O
is	O
mandatory	O
to	O
improve	O
living	B-T098
donor	I-T098
management	O
and	O
safety	O
.	O
material	O
and	O
methods	O
this	O
retrospective	B-T062
study	I-T062
was	O
performed	O
on	O
a	O
prospective	O
database	B-T170
with	O
the	O
aim	O
of	O
providing	O
a	O
brief	O
analysis	B-T062
of	O
the	O
perioperative	O
,	O
medium	O
-	O
term	O
,	O
and	O
long	O
-	O
term	O
complications	B-T038
,	O
and	O
the	O
near	O
-	O
miss	O
events	O
in	O
a	O
single	B-T092
center	I-T092
series	O
of	O
100	O
consecutive	O
liver	B-T058
resections	I-T058
for	O
adult	O
-	O
to	O
-	O
adult	O
living	B-T098
-	I-T098
donor	I-T098
liver	B-T058
transplantation	I-T058
.	O
results	O
only	O
23	O
.	O
3	O
%	O
of	O
potential	O
living	B-T098
donors	I-T098
underwent	O
surgery	B-T058
.	O
no	B-T033
living	B-T098
donor	I-T098
mortality	O
was	O
reported	O
;	O
29	O
patients	O
(	O
29	O
%	O
)	O
experienced	O
at	O
least	O
one	O
complication	B-T038
.	O
five	O
patients	O
developed	O
mild	O
long	O
-	O
term	O
dysfunction	O
;	O
two	O
abor	O
##ted	O
hepat	B-T058
##ectomies	I-T058
,	O
and	O
there	O
were	O
two	O
near	O
-	O
miss	O
events	O
reported	O
.	O
conclusions	O
a	O
strategy	O
for	O
an	O
accurate	O
assessment	B-T058
of	O
living	B-T098
donor	I-T098
complications	B-T038
and	O
strict	O
selection	O
criterion	O
cann	O
##ot	O
be	O
over	O
##emp	O
##ha	O
##si	O
##zed	O
,	O
as	O
well	O
as	O
the	O
need	O
to	O
continuously	O
update	O
center	B-T092
patient	O
outcome	O
reports	B-T170
.	O

comparison	O
of	O
electrospun	O
and	O
solvent	O
cast	O
poly	B-T103
##la	I-T103
##ct	I-T103
##ic	I-T103
acid	I-T103
(	O
pla	B-T103
)	O
/	O
poly	B-T103
(	I-T103
vinyl	I-T103
alcohol	I-T103
)	I-T103
(	O
pva	B-T103
)	O
inserts	B-T103
as	O
potential	O
ocular	B-T017
drug	B-T103
delivery	I-T103
vehicles	I-T103
the	O
purpose	O
of	O
this	O
work	O
was	O
to	O
develop	O
,	O
characterize	O
and	O
compare	O
electrospun	O
nanofib	O
##er	O
inserts	B-T103
(	O
en	O
##is	O
)	O
and	O
solvent	O
cast	O
polymeric	B-T103
inserts	B-T103
(	O
sci	B-T103
##s	I-T103
)	O
for	O
ocular	B-T017
drug	B-T074
delivery	I-T074
.	O
en	O
##i	O
and	O
sci	B-T103
of	O
1	O
%	O
,	O
5	O
%	O
and	O
10	O
%	O
w	O
/	O
w	O
dexamethasone	B-T103
were	O
fabricated	O
using	O
a	O
blend	O
of	O
poly	B-T103
-	I-T103
lactic	I-T103
acid	I-T103
(	O
pla	B-T103
)	O
and	O
poly	B-T103
-	I-T103
vinyl	I-T103
alcohol	I-T103
(	O
pva	B-T103
)	O
.	O
inserts	B-T103
were	O
characterized	O
for	O
morphology	O
,	O
thickness	O
,	O
ph	O
,	O
drug	O
content	O
,	O
drug	O
crystallinity	O
,	O
in	O
vitro	O
drug	O
release	O
,	O
sterility	O
,	O
dimethyl	B-T103
##form	I-T103
##amide	I-T103
(	O
dmf	B-T103
)	O
and	O
chloroform	B-T103
content	O
,	O
and	O
cytotoxicity	B-T038
.	O
the	O
thickness	O
of	O
1	O
%	O
,	O
5	O
%	O
,	O
and	O
10	O
%	O
dexamethasone	B-T103
-	O
loaded	O
en	O
##is	O
were	O
found	O
to	O
be	O
50	O
##μm	O
,	O
62	O
.	O
5	O
##μm	O
,	O
and	O
93	O
.	O
3	O
##μm	O
,	O
respectively	O
,	O
with	O
good	O
folding	B-T033
endurance	I-T033
.	O
sci	B-T103
##s	I-T103
were	O
brit	B-T033
##tle	I-T033
,	O
with	O
thickness	O
values	O
>	O
200	O
##μm	O
.	O
drug	O
release	O
rates	O
from	O
1	O
%	O
,	O
5	O
%	O
and	O
10	O
%	O
en	O
##is	O
were	O
found	O
to	O
be	O
0	O
.	O
62	O
##μg	O
/	O
h	O
,	O
1	O
.	O
46	O
##μg	O
/	O
h	O
,	O
and	O
2	O
.	O
30	O
##μg	O
/	O
h	O
,	O
respectively	O
,	O
while	O
those	O
from	O
sci	B-T103
##s	I-T103
were	O
err	O
##atic	O
.	O
dmf	B-T103
content	O
in	O
en	O
##is	O
and	O
sci	B-T103
##s	I-T103
were	O
0	O
.	O
007	O
%	O
w	O
/	O
w	O
and	O
0	O
.	O
123	O
%	O
w	O
/	O
w	O
,	O
respectively	O
,	O
while	O
chloroform	B-T103
was	O
not	B-T033
detected	I-T033
.	O
no	B-T033
cytotoxicity	B-T038
was	O
observed	O
from	O
en	O
##is	O
in	O
cultured	B-T017
bovine	B-T204
corneal	B-T017
endothelial	I-T017
cells	I-T017
for	O
up	O
to	O
24h	O
.	O
we	O
conclude	O
that	O
en	O
##is	O
are	O
better	O
than	O
sci	B-T103
##s	I-T103
and	O
could	O
be	O
utilized	O
as	O
a	O
potential	O
delivery	B-T074
system	I-T074
for	O
treating	O
anterior	B-T082
segment	I-T082
ocular	B-T038
diseases	I-T038
.	O

no	O
free	O
bed	O
with	O
ventilator	B-T074
:	O
experience	O
of	O
a	O
public	B-T097
health	I-T097
specialist	I-T097
while	O
the	O
author	B-T097
was	O
dealing	O
with	O
a	O
poor	O
elderly	O
father	O
strugg	O
##ling	O
to	O
shift	O
his	O
grav	O
##ely	O
injured	O
young	O
son	O
to	O
a	O
government	B-T092
hospital	I-T092
due	O
to	O
the	O
high	O
cost	O
of	O
intensive	B-T058
care	I-T058
,	O
her	O
friends	B-T098
across	O
the	O
globe	O
were	O
discussing	O
euthanasia	B-T058
in	O
the	O
social	B-T170
media	I-T170
.	O
while	O
marginal	O
##ised	O
groups	B-T098
of	I-T098
people	I-T098
are	O
strugg	O
##ling	O
to	O
access	O
care	O
in	O
india	B-T082
,	O
friends	B-T098
who	O
have	O
moved	O
to	O
developed	O
parts	O
of	O
the	O
world	O
were	O
discussing	O
one	O
'	O
s	O
choice	O
to	O
live	O
or	O
die	B-T038
!	O
the	O
poor	O
father	O
,	O
after	O
bat	O
##tl	O
##ing	O
to	O
save	O
his	O
son	O
and	O
reaching	O
out	O
to	O
many	O
people	B-T098
for	O
help	O
,	O
could	O
not	O
save	O
him	O
.	O
early	O
treatment	O
might	O
have	O
helped	O
the	O
young	O
boy	O
.	O
the	O
incident	O
left	O
the	O
author	B-T097
thinking	O
about	O
how	O
the	O
poor	O
are	O
den	O
##ied	O
care	O
simply	O
because	O
they	O
cann	O
##ot	O
afford	O
it	O
.	O
others	O
debate	O
when	O
to	O
pull	O
the	O
plug	O
on	O
the	O
patient	O
.	O
…	O
how	O
many	O
families	O
can	O
afford	O
such	O
care	O
in	O
india	B-T082
?	O
when	O
nearly	O
71	O
%	O
of	O
the	O
people	B-T098
are	O
pay	O
##ing	O
out	O
of	O
pocket	O
for	O
healthcare	B-T058
and	O
16	O
%	O
are	O
push	O
##ed	O
below	O
the	O
poverty	O
line	O
every	O
year	O
,	O
can	O
we	O
even	O
think	B-T038
of	O
universal	O
health	O
coverage	O
?	O
it	O
just	O
sounds	O
like	O
a	O
fa	O
##nc	O
##y	O
term	O
to	O
be	O
used	O
at	O
conference	B-T058
##s	I-T058
and	I-T058
meetings	I-T058
because	O
the	O
ground	O
reality	O
is	O
completely	O
different	O
.	O

conditional	B-T058
reprogramming	I-T058
and	O
long	O
-	O
term	O
expansion	B-T038
of	O
normal	B-T017
and	O
tumor	B-T017
cells	I-T017
from	O
human	B-T204
bios	O
##pec	O
##imens	O
historically	O
,	O
it	O
has	O
been	O
difficult	O
to	O
propag	O
##ate	O
cells	B-T017
in	O
vitro	O
that	O
are	O
derived	O
directly	O
from	O
human	B-T204
tumors	B-T038
or	O
healthy	B-T017
tissue	I-T017
.	O
however	O
,	O
in	O
vitro	O
preclinical	B-T170
models	I-T170
are	O
essential	O
tools	O
for	O
both	O
the	O
study	B-T091
of	I-T091
basic	I-T091
cancer	I-T091
biology	I-T091
and	O
the	O
promotion	O
of	O
translational	B-T062
research	I-T062
,	O
including	O
drug	B-T062
discovery	I-T062
and	O
drug	B-T074
target	I-T074
identification	I-T074
.	O
this	O
protocol	B-T058
describes	O
conditional	B-T038
reprogramming	I-T038
(	O
cr	B-T038
)	O
,	O
which	O
involves	O
coculture	B-T058
of	O
irradiated	O
mouse	B-T204
fibroblast	B-T017
feeder	I-T017
cells	I-T017
with	O
normal	B-T017
and	O
tumor	B-T038
human	B-T204
epithelial	B-T017
cells	I-T017
in	O
the	O
presence	O
of	O
a	O
rho	B-T103
kinase	I-T103
inhibitor	B-T103
(	O
y	B-T103
-	I-T103
276	I-T103
##32	I-T103
)	O
.	O
cr	B-T058
cells	B-T017
can	O
be	O
used	O
for	O
various	O
applications	O
,	O
including	O
regenerative	B-T091
medicine	I-T091
,	O
drug	B-T058
sensitivity	I-T058
testing	I-T058
,	O
gene	B-T058
expression	I-T058
profiling	I-T058
and	O
xenograft	B-T058
studies	I-T058
.	O
the	O
method	B-T058
requires	O
a	O
pathologist	B-T097
to	O
differentiate	O
healthy	B-T017
tissue	I-T017
from	O
tumor	B-T017
tissue	I-T017
,	O
and	O
basic	B-T058
tissue	I-T058
culture	I-T058
skills	O
.	O
the	O
protocol	B-T058
can	O
be	O
used	O
with	O
cells	B-T017
derived	O
from	O
both	O
fresh	B-T017
and	O
cryopreserved	B-T017
tissue	I-T017
samples	I-T017
.	O
as	O
approximately	O
1	O
million	O
cells	B-T017
can	O
be	O
generated	O
in	O
7	O
d	O
,	O
the	O
technique	B-T058
is	O
directly	O
applicable	O
to	O
diagnostic	B-T103
and	O
predictive	O
medicine	B-T103
.	O
moreover	O
,	O
the	O
epithelial	B-T017
cells	I-T017
can	O
be	O
propagated	O
ind	O
##ef	O
##ini	O
##te	O
##ly	O
in	O
vitro	O
,	O
yet	O
retain	O
the	O
capacity	O
to	O
become	O
fully	O
differentiated	B-T038
when	O
placed	O
into	O
conditions	B-T082
that	O
mimic	O
their	O
natural	B-T082
environment	I-T082
.	O

effects	O
of	O
a	O
novel	O
phosphodiesterase	B-T103
10	I-T103
##a	I-T103
inhibitor	I-T103
in	O
non	B-T204
-	I-T204
human	I-T204
primates	I-T204
:	O
a	O
therapeutic	O
approach	O
for	O
schizophrenia	B-T038
with	O
improved	O
side	B-T038
effect	I-T038
profile	I-T038
schizophrenia	B-T038
symptoms	B-T033
are	O
associated	O
with	O
alterations	B-T038
in	I-T038
basal	I-T038
ganglia	I-T038
-	I-T038
cortical	I-T038
networks	I-T038
that	O
include	O
the	O
cyclic	B-T103
nucleotides	I-T103
(	O
camp	B-T103
/	O
cgmp	B-T103
)	O
signaling	B-T038
pathways	I-T038
.	O
phosphodiesterase	B-T103
10	I-T103
##a	I-T103
(	I-T103
pde	I-T103
##10	I-T103
##a	I-T103
)	I-T103
inhibitors	I-T103
have	O
been	O
considered	O
as	O
therapeutic	B-T103
agents	I-T103
for	O
schizophrenia	B-T038
because	O
the	O
regulation	B-T038
of	I-T038
camp	I-T038
and	O
cgmp	B-T038
in	O
the	O
striatum	B-T017
by	O
pde	B-T103
##10	I-T103
##a	I-T103
plays	O
an	O
important	O
role	O
in	O
the	O
signaling	B-T038
mechanisms	I-T038
of	O
the	O
striatal	O
-	O
cortical	O
network	O
,	O
and	O
thereby	O
in	O
cognitive	B-T038
function	I-T038
.	O
in	O
the	O
present	O
study	O
we	O
assessed	O
in	O
non	B-T204
-	I-T204
human	I-T204
primates	I-T204
(	O
nh	B-T204
##ps	I-T204
)	O
the	O
effects	O
of	O
a	O
novel	O
pde	B-T103
##10	I-T103
##a	I-T103
inhibitor	I-T103
(	O
fr	B-T103
##m	I-T103
-	I-T103
630	I-T103
##8	I-T103
)	O
that	O
has	O
demonstrated	O
high	O
potency	O
and	O
selectivity	O
for	O
human	B-T103
recombinant	I-T103
pde	I-T103
##10	I-T103
##a	I-T103
in	O
vitro	O
.	O
the	O
behavioral	B-T033
effects	I-T033
of	O
fr	B-T103
##m	I-T103
-	I-T103
630	I-T103
##8	I-T103
in	O
a	O
dose	O
range	O
were	O
determined	O
in	O
rhesus	B-T204
monkeys	I-T204
using	O
a	O
standardized	B-T033
motor	I-T033
disability	I-T033
scale	I-T033
for	O
primates	B-T204
,	O
motor	B-T058
tasks	I-T058
,	O
and	O
the	O
[UNK]	O
drug	O
effects	O
on	O
the	O
nervous	O
system	O
[UNK]	O
(	O
dens	O
)	O
scale	O
.	O
the	O
neuronal	O
metabolic	O
effects	O
of	O
fr	B-T103
##m	I-T103
-	I-T103
630	I-T103
##8	I-T103
were	O
determined	O
with	O
[	B-T058
(	I-T058
18	I-T058
)	I-T058
f	I-T058
]	I-T058
-	I-T058
fluorodeoxyglucose	I-T058
pet	I-T058
imaging	I-T058
.	O
results	O
showed	O
that	O
fr	B-T103
##m	I-T103
-	I-T103
630	I-T103
##8	I-T103
did	O
not	O
have	O
any	O
specific	O
effects	O
on	O
the	O
motor	O
system	O
at	O
s	O
.	O
c	O
.	O
doses	O
up	O
to	O
0	O
.	O
32	O
mg	O
/	O
kg	O
in	O
nh	B-T204
##ps	I-T204
,	O
which	O
induced	O
a	O
significant	O
increase	O
in	O
the	O
fdg	B-T103
-	O
suv	O
in	O
striatum	B-T017
(	O
f	O
16	O
.	O
06	O
##9	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
cortical	B-T082
(	O
f	O
15	O
.	O
181	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
regions	O
.	O
higher	O
doses	O
induced	O
sedation	B-T033
and	O
occasional	B-T033
involuntary	I-T033
movements	I-T033
with	O
clear	O
development	O
of	O
tolerance	B-T033
after	I-T033
repeated	I-T033
exposures	I-T033
.	O
these	O
findings	O
suggest	O
that	O
fr	B-T103
##m	I-T103
-	I-T103
630	I-T103
##8	I-T103
has	O
the	O
adequate	B-T058
pharmacological	I-T058
profile	I-T058
to	O
advance	O
testing	O
in	O
clinical	B-T062
trials	I-T062
and	O
demonstrate	O
antipsychotic	B-T038
efficacy	I-T038
of	O
pde	B-T103
##10	I-T103
##a	I-T103
inhibition	O
for	O
the	O
treatment	O
of	O
schizophrenia	B-T038
patients	O
.	O

structural	O
and	O
trib	O
##ometric	O
characterization	O
of	O
biomimetic	O
##ally	O
inspired	O
synthetic	O
[UNK]	O
insect	B-T204
adhesives	O
[UNK]	O
background	O
:	O
based	O
on	O
previous	O
chemical	B-T058
analyses	I-T058
of	O
insect	B-T204
tars	O
##al	O
adhesives	O
,	O
we	O
prepared	O
12	O
heterogeneous	O
synthetic	O
emulsions	B-T103
mimicking	O
the	O
polar	B-T033
/	I-T033
non	I-T033
-	I-T033
polar	I-T033
principle	I-T033
,	O
analysed	O
their	O
microscopic	B-T082
##al	I-T082
structure	I-T082
and	O
tested	O
their	O
adhesive	O
,	O
friction	O
##al	O
,	O
and	O
rheological	O
properties	O
.	O
results	O
:	O
the	O
prepared	B-T033
emulsions	B-T103
varied	O
in	O
their	O
consistency	O
from	O
solid	O
rubber	B-T103
-	I-T103
like	I-T103
,	O
over	O
soft	O
elastic	O
,	O
to	O
fluid	O
(	O
water	O
##y	O
or	O
oil	O
##y	O
)	O
.	O
with	O
droplet	B-T082
sizes	I-T082
>	O
100	O
nm	O
,	O
all	O
the	O
emulsions	B-T103
belonged	O
to	O
the	O
common	O
type	O
of	O
macro	B-T103
##em	I-T103
##ulsions	I-T103
.	O
the	O
emulsions	B-T103
of	O
the	O
first	O
generation	O
generally	O
showed	O
broader	O
droplet	B-T082
-	I-T082
size	I-T082
ranges	O
compared	O
with	O
the	O
second	O
generation	O
,	O
especially	O
when	O
less	O
defined	O
components	O
such	O
as	O
pet	B-T103
##rol	I-T103
##atum	I-T103
or	O
wax	B-T103
##es	I-T103
were	O
present	O
in	O
the	O
lipophilic	O
fraction	O
of	O
the	O
first	O
generation	O
of	O
emulsions	B-T103
.	O
some	O
of	O
the	O
prepared	B-T033
emulsions	B-T103
showed	O
a	O
yield	B-T033
point	I-T033
and	O
were	O
bin	O
##gh	O
##am	O
fluids	O
.	O
trib	B-T058
##ometric	I-T058
adhesion	I-T058
was	O
tested	O
via	O
probe	B-T058
tack	I-T058
tests	I-T058
.	O
compared	O
with	O
the	O
[UNK]	O
second	O
generation	O
[UNK]	O
(	O
containing	O
less	O
viscous	O
components	O
)	O
,	O
the	O
[UNK]	O
first	O
generation	O
[UNK]	O
emulsions	B-T103
were	O
much	O
more	B-T033
adhesive	I-T033
(	O
31	O
-	O
93	O
mn	O
)	O
,	O
a	O
finding	O
attributable	O
to	O
their	O
highly	O
viscous	O
components	O
,	O
i	O
.	O
e	O
.	O
,	O
wax	B-T103
,	O
pet	B-T103
##rol	I-T103
##atum	I-T103
,	O
gelatin	B-T103
and	O
poly	B-T103
(	I-T103
vinyl	I-T103
alcohol	I-T103
)	I-T103
.	O
in	O
the	O
second	O
generation	O
emulsions	B-T103
,	O
we	O
attained	O
much	O
lower	O
adhesive	O
##ness	O
##es	O
,	O
ranging	O
between	O
1	O
-	O
18	O
mn	O
.	O
the	O
adhesive	O
performance	O
was	O
drastically	O
reduced	O
in	O
the	O
emulsions	B-T103
that	O
contained	O
albumin	B-T103
as	O
the	O
protein	B-T103
component	I-T103
or	O
that	O
lacked	O
protein	B-T103
.	O
trib	B-T058
##ometric	I-T058
shear	I-T058
tests	I-T058
were	O
performed	O
at	O
moderate	O
normal	O
loads	O
.	O
our	O
measured	O
friction	O
forces	O
(	O
4	O
-	O
93	O
mn	O
in	O
the	O
first	O
and	O
0	O
.	O
1	O
-	O
5	O
.	O
8	O
mn	O
in	O
the	O
second	O
generation	O
emulsions	B-T103
)	O
were	O
comparatively	O
low	O
.	O
differences	O
in	O
shear	O
performance	O
were	O
related	O
to	O
the	O
chemical	O
composition	O
and	O
emulsion	B-T103
structure	B-T082
.	O
conclusion	O
:	O
by	O
varying	O
their	O
chemical	O
composition	O
,	O
synthetic	O
heterogeneous	O
adhesive	O
emulsions	B-T103
can	O
be	O
adjusted	O
to	O
have	O
diverse	O
consist	O
##encies	O
and	O
are	O
able	O
to	O
mimic	O
certain	O
rheological	O
and	O
trib	O
##ological	O
properties	O
of	O
natural	O
tars	O
##al	O
insect	B-T204
adhesives	O
.	O

ultra	O
-	O
low	O
activities	O
of	O
a	O
common	O
radiois	B-T103
##oto	I-T103
##pe	I-T103
for	O
perm	O
##ission	O
-	O
free	O
tracking	B-T082
of	O
a	O
dros	B-T204
##ophil	I-T204
##id	I-T204
fly	I-T204
in	O
its	O
natural	B-T082
habitat	I-T082
knowledge	O
of	O
a	O
species	B-T170
'	O
ecology	O
,	O
including	O
its	O
movement	B-T038
in	O
time	O
and	O
space	B-T082
,	O
is	O
key	O
for	O
many	O
questions	O
in	O
biology	B-T091
and	O
conservation	O
.	O
while	O
numerous	O
tools	O
for	O
tracking	B-T082
larger	O
animals	B-T204
are	O
available	O
,	O
mill	B-T204
##ime	I-T204
##tre	I-T204
-	I-T204
sized	I-T204
insects	I-T204
are	O
avers	O
##e	O
to	O
standard	O
tracking	B-T082
and	O
labelling	B-T062
procedures	I-T062
.	O
here	O
,	O
we	O
evaluated	O
the	O
applicability	O
of	O
ultra	O
-	O
low	O
,	O
perm	O
##ission	O
-	O
ex	O
##emp	O
##t	O
activities	O
of	O
the	O
metastable	O
isomer	O
of	O
the	O
radionuclide	B-T103
technetium	B-T103
-	I-T103
99	I-T103
for	O
labelling	B-T062
and	O
field	B-T033
detection	I-T033
of	O
the	O
mountain	B-T082
fly	B-T204
drosophila	B-T204
nigros	I-T204
##par	I-T204
##sa	I-T204
.	O
we	O
demonstrate	O
that	O
an	O
activity	O
of	O
less	O
than	O
10	O
mbq	O
is	O
sufficient	O
to	O
label	B-T062
do	O
##ze	O
##ns	O
of	O
flies	B-T204
and	O
detect	B-T033
single	I-T033
individuals	I-T033
using	O
standard	O
radiation	B-T058
protection	I-T058
monitors	B-T058
.	O
the	O
methodology	O
presented	O
here	O
is	O
applicable	O
to	O
many	O
small	O
-	O
sized	O
,	O
low	B-T033
-	I-T033
mobility	I-T033
animals	B-T204
as	O
well	O
as	O
independent	O
from	O
light	O
and	O
weather	O
conditions	O
and	O
visual	B-T033
contact	I-T033
with	O
the	O
target	O
organism	O
.	O

fabrication	O
of	O
gelatin	B-T103
methacrylate	I-T103
/	O
nano	B-T103
##hydroxy	I-T103
##apatite	I-T103
microg	B-T103
##el	I-T103
arrays	B-T082
for	O
periodontal	B-T058
tissue	I-T058
regeneration	I-T058
periodontitis	B-T038
is	O
a	O
chronic	B-T038
infectious	I-T038
disease	I-T038
and	O
is	O
the	O
major	B-T033
cause	I-T033
of	O
tooth	B-T017
loss	I-T017
and	O
other	O
oral	B-T058
health	I-T058
issues	B-T033
around	O
the	O
world	B-T098
.	O
periodontal	B-T058
tissue	I-T058
regeneration	I-T058
has	O
therefore	O
always	O
been	O
the	O
ultimate	B-T170
goal	I-T170
of	O
dentists	B-T097
and	O
researchers	B-T097
.	O
existing	O
fabrication	O
methods	B-T170
mainly	O
focused	O
on	O
a	O
top	B-T058
-	I-T058
down	I-T058
tissue	I-T058
engineering	I-T058
strategy	O
in	O
which	O
several	O
drawbacks	O
remain	B-T033
,	O
including	O
low	O
throughput	O
and	O
limited	O
diffusion	O
properties	O
resulting	O
from	O
a	O
large	O
sample	O
size	O
.	O
gelatin	B-T103
methacrylate	I-T103
(	O
gel	B-T103
##ma	I-T103
)	O
is	O
a	O
kind	O
of	O
photoc	O
##ross	O
##lin	O
##ka	O
##ble	O
and	O
biocompatible	B-T103
hydrogel	B-T103
,	O
with	O
the	O
capacities	O
of	O
enabling	B-T038
cell	B-T058
encapsulation	I-T058
and	O
regeneration	B-T038
of	I-T038
functional	I-T038
tissues	I-T038
.	O
here	O
,	O
we	O
developed	O
a	O
novel	O
method	O
to	O
fabricate	O
gel	B-T103
##ma	I-T103
/	O
nano	B-T103
##hydroxy	I-T103
##la	I-T103
##pati	I-T103
##te	I-T103
(	O
nh	B-T103
##a	I-T103
)	O
microg	B-T103
##el	I-T103
arrays	B-T082
using	O
a	O
photoc	O
##ross	O
##lin	O
##ka	O
##ble	O
strategy	O
.	O
the	O
viability	B-T038
,	O
proliferation	B-T038
,	O
and	O
osteogenic	B-T038
differentiation	I-T038
and	O
in	B-T082
vivo	I-T082
osteogenesis	B-T038
of	O
human	B-T204
periodontal	B-T017
ligament	I-T017
stem	B-T017
cells	I-T017
(	O
hp	B-T017
##dl	I-T017
##sc	I-T017
##s	I-T017
)	O
encapsulated	O
in	O
microg	B-T103
##els	I-T103
were	O
evaluated	B-T058
.	O
the	O
results	O
suggested	O
that	O
such	O
microg	B-T103
##els	I-T103
provide	O
great	O
potential	O
for	O
periodontal	B-T058
tissue	I-T058
repair	I-T058
and	I-T058
regeneration	I-T058
.	O
microg	B-T103
##el	I-T103
arrays	B-T082
were	O
fabricated	O
by	O
blend	O
##ing	O
different	O
weight	O
ratios	O
of	O
gel	B-T103
##ma	I-T103
and	O
nh	B-T103
##a	I-T103
.	O
hp	B-T017
##dl	I-T017
##sc	I-T017
##s	I-T017
were	O
encapsulated	O
in	O
gel	B-T103
##ma	I-T103
/	O
nh	B-T103
##a	I-T103
microg	B-T103
##els	I-T103
of	O
various	O
ratios	O
for	O
a	O
systematic	O
evaluation	B-T058
of	O
cell	B-T038
viability	I-T038
,	O
proliferation	B-T038
,	O
and	O
osteogenic	B-T038
differentiation	I-T038
.	O
in	B-T082
vivo	I-T082
osteogenesis	B-T038
in	O
nude	B-T204
mice	I-T204
was	O
also	O
studied	O
.	O
the	O
gel	B-T103
##ma	I-T103
/	O
nh	B-T103
##a	I-T103
microg	B-T103
##els	I-T103
exhibited	O
appropriate	O
micro	O
##architect	O
##ure	O
,	O
mechanical	O
strength	O
,	O
and	O
surface	B-T082
roughness	O
,	O
thus	O
enabling	O
cell	B-T038
adhesion	I-T038
and	O
proliferation	B-T038
.	O
additionally	O
,	O
the	O
gel	B-T103
##ma	I-T103
/	O
nh	B-T103
##a	I-T103
microg	B-T103
##els	I-T103
(	O
10	O
%	O
/	O
2	O
%	O
w	O
/	O
v	O
)	O
enhanced	O
the	O
osteogenic	B-T038
differentiation	I-T038
of	O
hp	B-T017
##dl	I-T017
##sc	I-T017
##s	I-T017
by	O
elevating	O
the	O
expression	O
levels	O
of	O
osteogenic	B-T201
biomarker	I-T201
genes	B-T017
,	O
such	O
as	O
alp	B-T017
,	O
bsp	B-T017
,	O
oc	B-T017
##n	I-T017
,	O
and	O
runx2	B-T017
.	O
in	B-T082
vivo	I-T082
ectopic	B-T082
transplantation	B-T058
results	O
showed	O
that	O
gel	B-T103
##ma	I-T103
/	O
nh	B-T103
##a	I-T103
microg	B-T103
##els	I-T103
(	O
10	O
%	O
/	O
2	O
%	O
w	O
/	O
v	O
)	O
increased	O
mineralized	B-T017
tissue	I-T017
formation	O
with	O
abundant	O
vascularization	O
,	O
compared	O
with	O
the	O
1	O
%	O
,	O
3	O
%	O
,	O
and	O
the	O
pure	O
gel	B-T103
##ma	I-T103
group	I-T103
.	O
the	O
gel	B-T103
##ma	I-T103
/	O
nh	B-T103
##a	I-T103
microg	B-T103
##els	I-T103
(	O
10	O
%	O
/	O
2	O
%	O
w	O
/	O
v	O
)	O
facilitated	O
hp	B-T017
##dl	I-T017
##sc	I-T017
##s	I-T017
viability	B-T038
,	O
proliferation	B-T038
,	O
and	O
osteogenic	B-T038
differentiation	I-T038
in	O
vitro	O
and	O
further	B-T082
promoted	O
new	O
bone	B-T038
formation	I-T038
in	B-T082
vivo	I-T082
,	O
suggesting	O
that	O
the	O
gel	B-T103
##ma	I-T103
/	O
nh	B-T103
##a	I-T103
microg	B-T103
##els	I-T103
(	O
10	O
%	O
/	O
2	O
%	O
w	O
/	O
v	O
)	O
provide	O
great	O
potential	O
for	O
periodontal	B-T058
tissue	I-T058
regeneration	I-T058
.	O

kidney	B-T033
transplant	I-T033
recipients	I-T033
after	O
nonre	B-T058
##nal	I-T058
solid	I-T058
organ	I-T058
transplantation	I-T058
show	O
low	O
allo	B-T038
##re	I-T038
##activity	I-T038
but	O
an	O
increased	O
risk	O
of	O
infection	B-T038
the	O
number	O
of	O
kidney	B-T033
transplant	I-T033
recipients	I-T033
(	O
kt	B-T033
##rs	I-T033
)	O
after	O
nonre	B-T058
##nal	I-T058
solid	I-T058
organ	I-T058
transplantation	I-T058
(	O
so	B-T058
##t	I-T058
)	O
has	O
increased	O
to	O
almost	O
5	O
%	O
.	O
knowledge	O
on	O
patient	O
and	O
allograft	B-T058
outcomes	O
,	O
infections	B-T038
,	O
and	O
allo	B-T038
##re	I-T038
##activity	I-T038
,	O
however	O
,	O
remains	O
scarce	O
.	O
we	O
studied	B-T062
40	O
kt	B-T033
##rs	I-T033
after	O
nonre	B-T058
##nal	I-T058
so	I-T058
##t	I-T058
.	O
seven	O
hundred	O
and	O
twenty	O
primary	O
kt	B-T033
##rs	I-T033
and	O
119	O
repeat	O
kt	B-T033
##rs	I-T033
were	O
used	O
for	O
comparison	O
.	O
samples	B-T031
were	O
collected	O
pret	O
##ran	O
##sp	O
##la	O
##nt	O
##ation	O
,	O
at	O
+	O
1	O
,	O
+	O
2	O
,	O
and	O
+	O
3	O
months	O
post	O
-	O
transplantation	O
.	O
allo	B-T038
##re	I-T038
##active	I-T038
and	O
cmv	B-T005
-	I-T005
specific	I-T005
t	B-T017
cells	I-T017
were	O
measured	O
by	O
interferon	B-T058
-	I-T058
γ	I-T058
el	I-T058
##isp	I-T058
##ot	I-T058
assay	I-T058
.	O
patient	O
survival	O
in	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
,	O
primary	O
and	O
repeat	O
kt	B-T033
##rs	I-T033
was	O
comparable	O
.	O
while	O
death	B-T038
-	O
cens	O
##ored	O
allograft	B-T058
survival	O
was	O
comparable	O
between	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
and	O
primary	O
kt	B-T033
##rs	I-T033
,	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
showed	O
superior	O
5	O
-	O
year	O
death	B-T038
-	O
cens	O
##ored	O
allograft	B-T058
survival	O
of	O
92	O
.	O
5	O
%	O
compared	O
to	O
81	O
.	O
2	O
%	O
in	O
repeat	O
kt	B-T033
##rs	I-T033
.	O
interestingly	O
,	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
show	O
less	O
preformed	O
panel	B-T058
-	I-T058
reactive	I-T058
antibodies	I-T058
,	O
frequencies	O
of	O
allo	B-T038
##re	I-T038
##active	I-T038
t	B-T017
cells	I-T017
,	O
and	O
acute	B-T033
rejection	I-T033
##s	I-T033
compared	O
to	O
repeat	O
kt	B-T033
##rs	I-T033
.	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
,	O
however	O
,	O
show	O
higher	O
incidences	O
of	O
ebv	B-T038
viremia	I-T038
and	O
pt	B-T038
##ld	I-T038
,	O
sepsis	B-T038
,	O
and	O
death	B-T038
from	O
sepsis	B-T038
.	O
impaired	O
cmv	B-T005
-	I-T005
specific	I-T005
cellular	B-T038
immunity	I-T038
was	O
associated	O
with	O
more	O
cmv	B-T005
replication	B-T038
compared	O
to	O
repeat	O
kt	B-T033
##rs	I-T033
.	O
our	O
results	O
suggest	O
comparable	O
patient	O
and	O
allograft	B-T058
outcomes	O
in	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
and	O
primary	O
kt	B-T033
##rs	I-T033
.	O
the	O
observed	O
low	O
allo	B-T038
##re	I-T038
##activity	I-T038
may	O
contribute	O
to	O
excellent	O
allograft	B-T058
outcomes	O
.	O
caution	O
should	O
be	O
taken	O
in	O
kt	B-T033
##rs	I-T033
after	O
so	B-T058
##t	I-T058
regarding	O
infectious	O
complications	O
due	O
to	O
over	B-T038
##immun	I-T038
##osupp	I-T038
##ression	I-T038
.	O

abi	B-T103
##ra	I-T103
##terone	I-T103
-	O
induced	O
rhabdomyolysis	B-T038
resulting	O
in	O
acute	B-T037
kidney	I-T037
injury	I-T037
:	O
a	O
case	B-T170
report	I-T170
and	O
review	B-T170
of	I-T170
the	I-T170
literature	I-T170
abi	B-T103
##ra	I-T103
##terone	I-T103
,	O
a	O
cyp	B-T103
##17	I-T103
inhibitor	I-T103
,	O
blocks	O
androgen	B-T038
biosynthesis	I-T038
in	O
multiple	O
tissue	B-T017
types	O
.	O
in	O
combination	O
with	O
prednisone	B-T103
,	O
it	O
is	O
approved	O
as	O
a	O
first	B-T058
-	I-T058
line	I-T058
treatment	I-T058
for	O
metastatic	B-T038
castration	B-T038
-	I-T038
resistant	I-T038
prostate	I-T038
cancer	I-T038
.	O
we	O
present	O
a	O
case	O
of	O
rhabdomyolysis	B-T038
associated	O
with	O
abi	B-T103
##ra	I-T103
##terone	I-T103
therapy	B-T058
resulting	O
in	O
acute	B-T037
on	O
chronic	O
kidney	B-T037
injury	I-T037
in	O
a	O
patient	O
with	O
metastatic	B-T038
castration	B-T038
-	I-T038
resistant	I-T038
prostate	I-T038
cancer	I-T038
.	O
strict	O
monitoring	B-T062
should	O
be	O
employed	O
in	O
patients	O
started	O
on	O
abi	B-T103
##ra	I-T103
##terone	I-T103
who	O
have	O
additional	O
risk	B-T033
factors	I-T033
for	O
developing	O
rhabdomyolysis	B-T038
.	O

gels	B-T103
##olin	I-T103
in	O
on	B-T204
##ych	I-T204
##ophor	I-T204
##a	I-T204
and	O
tard	B-T204
##igr	I-T204
##ada	I-T204
with	O
notes	O
on	O
its	O
variability	O
in	O
the	O
ecd	B-T204
##ys	I-T204
##ozoa	I-T204
rearrangements	O
of	O
the	O
filamentous	B-T103
actin	I-T103
network	I-T103
involve	O
a	O
broad	O
range	O
of	O
actin	B-T103
binding	I-T103
proteins	I-T103
.	O
among	O
these	O
,	O
the	O
gels	B-T103
##olin	I-T103
proteins	I-T103
sever	O
actin	B-T017
filaments	I-T017
,	O
cap	O
their	O
fast	B-T033
growing	I-T033
end	O
and	O
nucle	B-T038
##ate	I-T038
actin	B-T038
assembly	I-T038
in	O
a	O
calcium	B-T103
-	O
dependent	O
manner	O
.	O
here	O
,	O
we	O
focus	O
on	O
the	O
gels	B-T103
##olin	I-T103
of	O
the	O
on	B-T204
##ych	I-T204
##ophor	I-T204
##an	I-T204
perip	B-T204
##ato	I-T204
##ides	I-T204
nov	I-T204
##ae	I-T204
##ze	I-T204
##ala	I-T204
##nd	I-T204
##iae	I-T204
and	O
the	O
eut	B-T204
##ardi	I-T204
##grade	I-T204
hyp	B-T204
##si	I-T204
##bi	I-T204
##us	I-T204
du	I-T204
##ja	I-T204
##rd	I-T204
##ini	I-T204
.	O
from	O
the	O
cdna	B-T103
of	O
p	B-T204
.	I-T204
nov	I-T204
##ae	I-T204
##ze	I-T204
##ala	I-T204
##nd	I-T204
##iae	I-T204
we	O
obtained	O
the	O
complete	O
coding	B-T017
sequence	I-T017
with	O
an	O
open	B-T017
reading	I-T017
frame	I-T017
of	O
217	O
##8	O
bp	B-T038
.	O
it	O
encodes	O
a	O
protein	B-T103
of	O
72	O
##6	O
amino	B-T103
acids	I-T103
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
82	O
,	O
61	O
##0	O
.	O
9	O
##da	O
and	O
a	O
pi	O
of	O
5	O
.	O
57	O
.	O
this	O
sequence	B-T082
is	O
comprised	O
of	O
six	O
segments	B-T082
(	O
s1	O
-	O
s6	O
)	O
.	O
however	O
,	O
analysis	B-T062
of	O
data	O
from	O
tard	B-T170
##ib	I-T170
##ase	I-T170
reveals	O
that	O
the	O
gels	B-T103
##olin	I-T103
of	O
the	O
eut	B-T204
##ardi	I-T204
##grade	I-T204
hyp	B-T204
##si	I-T204
##bi	I-T204
##us	I-T204
du	I-T204
##ja	I-T204
##rd	I-T204
##ini	I-T204
has	O
only	O
three	O
segments	B-T082
(	O
s1	O
-	O
s3	O
)	O
.	O
the	O
coding	B-T017
sequence	I-T017
consist	O
of	O
111	O
##9	O
bp	B-T038
for	O
373	O
amino	B-T103
acids	I-T103
with	O
a	O
calculated	O
molecular	O
mass	O
of	O
42	O
,	O
440	O
.	O
95	O
##da	O
and	O
a	O
pi	O
of	O
6	O
.	O
17	O
.	O
the	O
perip	B-T204
##ato	I-T204
##ides	I-T204
and	O
hyp	B-T204
##si	I-T204
##bi	I-T204
##us	I-T204
gels	B-T103
##olin	I-T103
revealed	O
both	O
conserved	B-T082
binding	B-T103
motifs	I-T103
for	O
g	B-T103
-	I-T103
actin	I-T103
,	O
f	B-T103
-	I-T103
actin	I-T103
and	O
phosphatidylinositol	B-T103
4	I-T103
,	I-T103
5	I-T103
-	I-T103
bisphosphate	I-T103
(	O
pip	B-T103
##2	I-T103
)	O
,	O
along	O
with	O
a	O
full	O
set	O
of	O
type	B-T103
-	I-T103
1	I-T103
and	O
type	B-T103
-	I-T103
2	I-T103
ca	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
binding	B-T103
sites	I-T103
which	O
could	O
result	O
in	O
the	O
binding	B-T038
of	O
eight	O
and	O
four	O
calcium	B-T103
ions	I-T103
,	O
respectively	O
.	O
both	O
gels	B-T103
##olin	I-T103
proteins	I-T103
lack	O
a	O
c	B-T082
-	I-T082
terminal	I-T082
lat	B-T082
##ch	I-T082
-	I-T082
helix	I-T082
indicating	O
a	O
more	O
rapid	O
activation	O
in	O
the	O
submic	O
##rom	O
##olar	O
ca	B-T058
(	I-T058
2	I-T058
+	I-T058
)	I-T058
range	I-T058
.	O
we	O
suggest	O
that	O
a	O
gels	B-T103
##olin	I-T103
with	O
three	O
segments	B-T082
was	O
present	B-T033
in	O
the	O
last	O
common	O
ancestor	O
of	O
the	O
ecd	B-T204
##ys	I-T204
##ozoa	I-T204
##n	I-T204
clade	O
pan	B-T204
##arth	I-T204
##ropo	I-T204
##da	I-T204
(	O
on	B-T204
##ych	I-T204
##ophor	I-T204
##a	I-T204
,	O
tard	B-T204
##igr	I-T204
##ada	I-T204
,	O
arthropod	B-T204
##a	I-T204
)	O
,	O
primarily	O
because	O
the	O
gels	B-T103
##olin	I-T103
of	O
all	O
non	O
-	O
ecd	O
##ys	O
##ozoa	O
studied	B-T062
so	O
far	O
(	O
except	O
chord	B-T204
##ata	I-T204
)	O
reveals	O
this	O
number	O
of	O
segments	B-T082
.	O
mapping	B-T058
of	O
our	O
molecular	B-T170
data	I-T170
onto	O
a	O
well	O
-	O
established	O
phylogeny	O
revealed	O
that	O
the	O
number	O
of	O
gels	B-T103
##olin	I-T103
segments	B-T082
does	O
not	O
correlate	O
with	O
the	O
phylogenetic	O
lineage	O
but	O
rather	O
with	O
particular	O
functional	O
demands	O
to	O
alter	O
the	O
kinetics	O
of	O
actin	B-T038
polymerization	I-T038
.	O

reduced	O
haemodynamic	B-T038
coupling	I-T038
and	O
exercise	O
are	O
associated	O
with	O
vascular	B-T038
stiff	I-T038
##ening	I-T038
in	O
pulmonary	B-T038
arterial	I-T038
hypertension	I-T038
inadequate	O
right	B-T017
ventricular	I-T017
(	O
rv	B-T017
)	O
and	O
pulmonary	B-T017
arterial	I-T017
(	O
pa	B-T017
)	O
functional	O
responses	O
to	O
exercise	O
are	O
important	O
yet	O
poorly	O
understood	O
features	O
of	O
pulmonary	B-T038
arterial	I-T038
hypertension	I-T038
(	O
pah	B-T038
)	O
.	O
this	O
study	B-T062
combined	O
invasive	O
catheter	B-T058
##isation	I-T058
with	O
echocardiography	B-T058
to	O
assess	O
rv	B-T017
afterload	O
,	O
rv	B-T038
function	I-T038
and	O
ventricular	B-T017
-	O
vascular	B-T017
coupling	O
in	O
subjects	B-T098
with	O
pah	B-T038
.	O
twenty	O
-	O
six	O
subjects	B-T098
with	O
pah	B-T038
were	O
prospectively	O
recruited	O
to	O
undergo	O
right	B-T082
heart	I-T082
catheter	B-T058
##isation	I-T058
and	O
doppler	B-T058
echocardiography	I-T058
at	O
rest	O
and	O
during	O
incremental	O
exercise	O
,	O
and	O
cardiac	B-T058
mri	I-T058
at	O
rest	O
.	O
measurements	O
at	O
rest	O
included	O
basic	O
haemodynamic	B-T038
##s	I-T038
,	O
rv	B-T038
function	I-T038
and	O
coupling	O
efficiency	O
(	O
η	O
)	O
.	O
measurements	O
during	O
incremental	O
exercise	O
included	O
pulmonary	B-T033
vascular	I-T033
resistance	I-T033
(	O
z	B-T033
##0	I-T033
)	O
,	O
characteristic	B-T058
impedance	I-T058
(	O
z	B-T058
##c	I-T058
,	O
a	O
measure	O
of	O
proximal	B-T082
pa	B-T017
stiffness	B-T038
)	O
and	O
proximal	B-T082
and	O
distal	B-T082
pa	O
compliance	O
(	O
cpa	O
)	O
.	O
in	O
patients	O
with	O
pah	B-T038
,	O
the	O
proximal	B-T082
pas	B-T017
were	O
significantly	O
stiff	B-T033
##er	I-T033
at	O
maximum	O
exercise	O
(	O
z	B-T058
##c	I-T058
=	O
2	O
.	O
31	O
##±0	O
.	O
38	O
vs	O
1	O
.	O
33	O
##±0	O
.	O
15	O
w	O
##u	O
##×	O
##m	O
(	O
2	O
)	O
at	O
rest	O
;	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
pa	O
compliance	O
was	O
decreased	O
(	O
cpa	O
=	O
0	O
.	O
88	O
##±0	O
.	O
10	O
vs	O
1	O
.	O
32	O
##±0	O
.	O
17	O
ml	O
/	O
mm	O
hg	O
/	O
m	O
(	O
2	O
)	O
at	O
rest	O
;	O
p	O
=	O
0	O
.	O
0002	O
)	O
.	O
z	B-T033
##0	I-T033
did	O
not	O
change	O
with	O
exercise	O
.	O
as	O
a	O
result	O
,	O
the	O
resistance	O
-	O
compliance	O
(	O
rc	O
)	O
time	O
decreased	O
with	O
exercise	O
(	O
0	O
.	O
67	O
##±0	O
.	O
05	O
vs	O
1	O
.	O
00	O
##±0	O
.	O
07	O
s	O
at	O
rest	O
;	O
p	O
<	O
10	O
(	O
-	O
6	O
)	O
)	O
.	O
when	O
patients	O
were	O
grouped	O
according	O
to	O
resting	O
coupling	O
efficiency	O
,	O
those	O
with	O
poorer	O
η	O
exhibited	O
stiff	B-T033
##er	I-T033
proximal	B-T082
pas	B-T017
at	O
rest	O
,	O
a	O
lower	O
maximum	O
exercise	O
level	O
,	O
and	O
more	O
limited	O
cpa	O
reduction	O
at	O
maximum	O
exercise	O
.	O
in	O
pah	B-T038
,	O
exercise	O
causes	O
proximal	B-T082
and	O
distal	B-T082
pa	B-T017
stiff	B-T038
##ening	I-T038
,	O
which	O
combined	O
with	O
preserved	O
z	B-T033
##0	I-T033
results	O
in	O
decreased	O
rc	O
time	O
with	O
exercise	O
.	O
stiff	B-T017
pas	I-T017
at	O
rest	O
may	O
also	O
contribute	O
to	O
poor	O
haemodynamic	B-T038
coupling	I-T038
,	O
reflecting	O
reduced	O
pulmonary	B-T017
vascular	I-T017
reserve	O
that	O
contributes	O
to	O
limit	O
the	O
maximum	O
exercise	O
level	O
tolerated	O
.	O

evidence	O
that	O
vitro	B-T103
##ne	I-T103
##ct	I-T103
##in	I-T103
is	O
a	O
potent	O
migration	B-T103
-	I-T103
enhancing	I-T103
factor	I-T103
for	O
cancer	B-T017
cells	I-T017
chaperone	B-T103
##d	I-T103
by	O
fibrinogen	B-T103
:	O
a	O
novel	O
view	O
of	O
the	O
metastasis	B-T038
of	O
cancer	B-T017
cells	I-T017
to	O
low	O
-	O
fibrinogen	B-T103
lymphatic	B-T022
##s	I-T022
and	O
body	B-T082
cavities	I-T082
diluted	O
(	O
1	O
%	O
)	O
plasma	B-T031
induces	O
migration	B-T038
of	O
malignant	B-T017
cell	I-T017
lines	I-T017
much	O
more	O
strongly	O
than	O
potent	O
pro	O
-	O
metastatic	O
factors	O
.	O
to	O
characterize	O
the	O
factor	O
(	O
s	O
)	O
present	O
in	O
diluted	O
plasma	B-T031
responsible	O
for	O
this	O
phenomenon	O
we	O
performed	O
i	O
)	O
heat	O
inactivation	O
,	O
ii	O
)	O
dialysis	O
,	O
iii	O
)	O
proteinase	B-T103
k	I-T103
treatment	O
,	O
and	O
iv	O
)	O
molecular	O
size	O
filtration	O
studies	O
.	O
we	O
found	O
that	O
this	O
remarkable	O
pro	O
-	O
migratory	O
activity	O
of	O
diluted	O
normal	O
plasma	B-T031
is	O
associated	O
with	O
a	O
~	O
50	O
-	O
100	O
-	O
kd	O
protein	B-T103
that	O
interacts	O
with	O
g	B-T103
##α	I-T103
##i	I-T103
protein	I-T103
-	I-T103
coupled	I-T103
receptors	I-T103
and	O
activates	O
p4	B-T103
##2	I-T103
/	I-T103
44	I-T103
mapk	I-T103
and	O
akt	B-T038
signaling	I-T038
in	O
target	O
cells	B-T017
.	O
since	O
this	O
pro	O
-	O
migratory	O
activity	O
of	O
1	O
%	O
plasma	B-T031
decreases	O
at	O
higher	O
plasma	O
concentrations	O
(	O
>	O
20	O
%	O
)	O
,	O
but	O
is	O
retained	O
in	O
serum	B-T031
,	O
we	O
hypothesized	O
that	O
fibrinogen	B-T103
may	O
be	O
involved	O
as	O
a	O
chaperone	B-T103
of	O
the	O
protein	B-T103
(	I-T103
s	I-T103
)	I-T103
.	O
to	O
identify	O
the	O
pro	B-T103
-	I-T103
migratory	I-T103
protein	I-T103
(	I-T103
s	I-T103
)	I-T103
present	O
in	O
diluted	O
plasma	B-T031
and	O
fibrinogen	B-T103
-	O
depleted	O
serum	B-T031
,	O
we	O
performed	O
gel	B-T058
filtration	I-T058
and	O
hydrophobic	B-T058
interaction	I-T058
chromatography	I-T058
followed	O
by	O
mass	B-T058
spectrometry	I-T058
analysis	I-T058
.	O
we	O
identified	O
several	O
putative	O
protein	B-T103
candidates	O
that	O
were	O
further	O
tested	O
in	O
in	O
vitro	O
experiments	B-T062
.	O
we	O
found	O
that	O
this	O
pro	B-T103
-	I-T103
migratory	I-T103
factor	I-T103
chaperone	B-T103
##d	I-T103
by	O
fibrinogen	B-T103
is	O
vitro	B-T103
##ne	I-T103
##ct	I-T103
##in	I-T103
,	O
which	O
activates	O
upar	O
,	O
and	O
that	O
this	O
effect	O
can	O
be	O
inhibited	O
by	O
fibrinogen	B-T103
.	O
these	O
results	O
provide	O
a	O
novel	O
mechanism	O
for	O
the	O
metastasis	B-T038
of	O
cancer	B-T017
cells	I-T017
to	O
lymphatic	B-T022
##s	I-T022
and	O
body	B-T082
cavities	I-T082
,	O
in	O
which	O
the	O
concentration	O
of	O
fibrinogen	B-T103
is	O
low	O
,	O
and	O
thus	O
suggests	O
that	O
free	O
vitro	B-T103
##ne	I-T103
##ct	I-T103
##in	I-T103
stimulates	O
migration	B-T038
of	O
tumor	B-T017
cells	I-T017
.	O

typical	O
skin	B-T037
injuries	I-T037
in	O
children	O
with	O
autism	B-T038
spectrum	I-T038
disorder	I-T038
pediatric	O
skin	B-T037
injuries	I-T037
have	O
primarily	O
been	O
described	O
in	O
typically	O
developing	O
children	O
.	O
our	O
objectives	B-T170
were	O
to	O
describe	O
the	O
prevalence	O
and	O
pattern	B-T082
of	O
skin	B-T037
injuries	I-T037
of	O
children	O
with	O
autism	B-T038
spectrum	I-T038
disorder	I-T038
(	O
asd	B-T038
)	O
,	O
to	O
describe	O
how	O
this	O
compared	O
with	O
previously	O
demonstrated	O
skin	B-T037
injury	I-T037
locations	B-T033
in	O
typically	O
developing	O
children	O
,	O
and	O
to	O
identify	O
differences	O
in	O
skin	B-T037
injury	I-T037
frequency	O
and	O
locations	B-T033
between	O
autistic	O
children	O
with	O
and	O
without	O
self	O
-	O
injur	O
##ious	O
behaviors	O
(	O
sib	O
##s	O
)	O
.	O
children	O
with	O
asd	B-T038
were	O
recruited	O
between	O
september	O
of	O
2011	O
and	O
september	O
of	O
2014	O
.	O
demographic	O
information	O
was	O
obtained	O
from	O
the	O
caregiver	B-T097
.	O
all	O
skin	B-T037
injuries	I-T037
and	O
their	O
locations	B-T033
were	O
documented	B-T058
.	O
of	O
the	O
41	O
children	O
enrolled	O
,	O
half	O
were	O
reported	O
to	O
have	O
sib	O
##s	O
.	O
the	O
most	O
identified	O
skin	B-T037
injury	I-T037
locations	B-T033
were	O
the	O
legs	B-T017
,	O
knees	B-T017
,	O
and	O
back	B-T082
.	O
children	O
with	O
autism	B-T038
(	O
1	O
)	O
obtain	O
skin	B-T037
injuries	I-T037
frequently	O
and	O
in	O
similar	O
locations	B-T033
as	O
typically	O
developing	O
children	O
and	O
(	O
2	O
)	O
rarely	O
obtain	O
skin	B-T037
injuries	I-T037
to	O
locations	B-T033
that	O
are	O
considered	O
uncommon	O
for	O
accidental	B-T037
injuries	I-T037
despite	O
reports	O
of	O
sib	O
##s	O
.	O

the	O
corneal	B-T017
epithelial	I-T017
barrier	O
and	O
its	O
developmental	O
role	O
in	O
isolating	O
corneal	B-T017
epithelial	I-T017
and	O
conjunctival	B-T017
cells	I-T017
from	O
one	O
another	O
during	O
development	O
,	O
the	O
corneal	B-T017
epithelium	I-T017
(	O
ce	B-T017
)	O
and	O
the	O
conjunctiva	B-T017
are	O
derived	O
from	O
the	O
surface	B-T017
ectoderm	I-T017
.	O
here	O
we	O
have	O
examined	B-T033
how	O
,	O
during	O
development	O
,	O
the	O
cells	B-T017
of	O
these	O
two	O
issues	O
become	O
isolated	O
from	O
each	O
other	O
.	O
epithelia	B-T017
from	O
the	O
anterior	B-T017
eyes	I-T017
of	O
chicken	B-T017
embryos	I-T017
were	O
labeled	B-T103
with	O
the	O
fluorescent	B-T103
,	O
lipophilic	B-T103
dye	I-T103
,	O
1	B-T103
,	I-T103
1	I-T103
'	I-T103
-	I-T103
dio	I-T103
##ct	I-T103
##adecyl	I-T103
-	I-T103
3	I-T103
,	I-T103
3	I-T103
,	I-T103
3	I-T103
'	I-T103
,	I-T103
3	I-T103
'	I-T103
-	I-T103
tetramethyl	I-T103
##ind	I-T103
##ocarb	I-T103
##ocyanine	I-T103
perchlorate	I-T103
(	O
di	B-T103
##i	I-T103
)	O
.	O
di	B-T103
##i	I-T103
was	O
placed	O
on	O
the	O
epithelial	B-T017
surface	I-T017
of	O
the	O
developing	O
anterior	B-T017
eye	I-T017
and	O
its	O
diffusion	O
was	O
monitored	O
by	O
fluorescence	B-T058
microscopy	I-T058
.	O
concomitant	O
morphologic	O
changes	O
in	O
the	O
surface	B-T017
cells	I-T017
of	I-T017
these	I-T017
epithelial	I-T017
were	O
examined	B-T033
by	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
.	O
immunofluorescence	B-T058
was	O
used	O
to	O
analyze	O
the	O
expression	B-T038
of	O
cytokeratin	B-T103
k	I-T103
##3	I-T103
,	O
zo	B-T103
-	I-T103
1	I-T103
,	O
n	B-T103
-	I-T103
cadherin	I-T103
and	O
connexin	B-T103
-	I-T103
43	I-T103
and	O
the	O
function	B-T038
of	O
gap	B-T082
junctions	I-T082
was	O
analyzed	B-T062
using	O
a	O
cut	O
-	O
loading	O
with	O
the	O
fluorescent	B-T103
dye	I-T103
rhodamine	B-T103
-	I-T103
dextran	I-T103
.	O
prior	O
to	O
embryonic	B-T038
day	O
8	O
(	O
e	B-T038
8	O
)	O
,	O
di	B-T103
##i	I-T103
placed	O
on	O
the	O
surface	B-T082
of	O
the	O
ce	B-T017
spread	O
##s	O
throughout	O
all	O
the	O
epithelial	B-T017
cells	I-T017
of	O
the	O
anterior	B-T017
eye	I-T017
.	O
when	O
older	B-T017
eyes	I-T017
were	O
similarly	O
labeled	B-T103
,	O
dye	B-T103
diffusion	O
was	O
restricted	O
to	O
the	O
ce	B-T017
.	O
similarly	O
,	O
diffusion	O
of	O
di	B-T103
##i	I-T103
placed	O
on	O
the	O
conjunctival	B-T017
surface	B-T082
after	O
e	B-T038
8	O
was	O
restricted	O
to	O
the	O
conjunctiva	B-T017
.	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
showed	O
that	O
developmentally	O
(	O
1	O
)	O
physical	O
separations	O
progressively	O
form	O
between	O
the	O
cells	B-T017
of	O
the	O
ce	B-T017
and	O
those	O
of	O
the	O
conjunctiva	B-T017
,	O
and	O
(	O
2	O
)	O
by	O
e	B-T038
8	O
these	O
separations	O
form	O
a	O
ring	B-T017
that	O
completely	O
encompasses	O
the	O
cornea	B-T017
.	O
the	O
functional	O
restriction	O
of	O
gap	B-T082
junctions	I-T082
between	O
these	O
tissues	B-T017
did	O
not	O
occur	O
until	O
e	B-T038
14	O
.	O
during	O
ocular	B-T038
development	I-T038
,	O
a	O
barrier	O
to	O
the	O
diffusion	O
of	O
di	B-T103
##i	I-T103
forms	O
between	O
the	O
contiguous	B-T082
ce	B-T017
and	O
conjunctiva	B-T017
prior	O
to	O
the	O
differential	O
expression	B-T038
of	O
gap	B-T082
junctions	I-T082
within	O
these	O
tissues	B-T017
.	O

prolyl	B-T103
-	I-T103
4	I-T103
-	I-T103
hydroxylase	I-T103
2	I-T103
and	O
3	B-T103
core	O
##gu	O
##la	O
##te	O
murine	B-T103
erythropoietin	B-T103
in	O
brain	B-T017
pericytes	B-T017
a	O
classic	O
response	B-T033
to	O
systemic	O
hypoxia	B-T038
is	O
the	O
increased	O
production	B-T038
of	I-T038
red	I-T038
blood	I-T038
cells	I-T038
due	O
to	O
hypoxia	B-T103
-	I-T103
inducible	I-T103
factor	I-T103
(	O
hif	B-T103
)	O
-	O
mediated	O
induction	O
of	O
erythropoietin	B-T103
(	O
epo	B-T103
)	O
.	O
epo	B-T103
is	O
a	O
glycoprotein	B-T103
hormone	I-T103
that	O
is	O
essential	O
for	O
normal	B-T038
erythropoiesis	I-T038
and	O
is	O
predominantly	O
synthesized	O
by	O
perit	B-T082
##ubular	I-T082
renal	B-T017
interstitial	I-T017
fibroblast	I-T017
-	I-T017
like	I-T017
cells	I-T017
,	O
which	O
express	O
cellular	B-T201
markers	I-T201
characteristic	O
of	O
neuronal	B-T017
cells	I-T017
and	O
pericytes	B-T017
.	O
to	O
investigate	O
whether	O
the	O
ability	O
to	O
synthesize	O
epo	B-T103
is	O
a	O
general	O
functional	O
feature	O
of	O
pericytes	B-T017
,	O
we	O
used	O
conditional	O
gene	B-T062
targeting	I-T062
to	O
examine	O
the	O
von	B-T038
hipp	I-T038
##el	I-T038
-	I-T038
lind	I-T038
##au	I-T038
/	O
prolyl	B-T103
-	I-T103
4	I-T103
-	I-T103
hydroxylase	I-T103
domain	I-T103
(	I-T103
ph	I-T103
##d	I-T103
)	I-T103
/	I-T103
hif	I-T103
axis	O
in	O
cell	B-T017
-	O
expressing	B-T038
neural	B-T103
glial	I-T103
antigen	I-T103
2	I-T103
,	O
a	O
known	O
molecular	B-T201
marker	I-T201
of	O
pericytes	B-T017
in	O
multiple	B-T017
organs	I-T017
.	O
we	O
found	O
that	O
pericytes	B-T017
in	O
the	O
brain	B-T017
synthesized	O
epo	B-T103
in	O
mice	B-T204
with	O
genetic	O
hif	B-T103
activation	O
and	O
were	O
capable	O
of	O
responding	O
to	O
systemic	O
hypoxia	B-T038
with	O
the	O
induction	O
of	O
epo	B-T103
.	O
using	O
high	O
-	O
resolution	O
multiplex	O
in	B-T062
situ	I-T062
hybridization	I-T062
,	O
we	O
determined	O
that	O
brain	B-T017
pericytes	B-T017
represent	O
an	O
important	O
cellular	B-T017
source	I-T017
of	O
epo	B-T103
in	O
the	O
hypoxic	B-T038
brain	B-T017
(	O
up	O
to	O
70	O
%	O
of	O
all	O
epo	B-T103
-	O
expressing	B-T038
cells	B-T017
)	O
.	O
we	O
furthermore	O
determined	O
that	O
epo	B-T103
transcription	B-T038
in	O
brain	B-T017
pericytes	B-T017
was	O
hif	B-T103
-	I-T103
2	I-T103
dependent	O
and	O
coc	O
##ontrol	O
##led	O
by	O
ph	B-T103
##d2	I-T103
and	O
ph	B-T103
##d3	I-T103
,	O
oxygen	B-T103
-	O
and	O
2	B-T103
-	I-T103
oxo	I-T103
##glut	I-T103
##arate	I-T103
-	O
dependent	O
prolyl	B-T103
-	I-T103
4	I-T103
-	I-T103
hydroxylase	I-T103
##s	I-T103
that	O
regulate	O
hif	B-T103
activity	B-T038
.	O
in	O
summary	O
,	O
our	O
studies	O
provide	O
experimental	O
evidence	O
that	O
pericytes	B-T017
in	O
the	O
brain	B-T017
have	O
the	O
ability	O
to	O
function	O
as	O
oxygen	B-T074
sensors	I-T074
and	O
respond	O
to	O
hypoxia	B-T038
with	O
epo	B-T103
synthesis	O
.	O
our	O
findings	O
furthermore	O
suggest	O
that	O
the	O
ability	O
to	O
synthesize	O
epo	B-T103
may	O
represent	O
a	O
functional	O
feature	O
of	O
pericytes	B-T017
in	O
the	O
brain	B-T017
and	O
kidney	B-T017
.	O

conditional	O
knockdown	B-T062
of	O
endogenous	O
micrornas	B-T103
in	O
cho	B-T017
cells	I-T017
using	O
tet	B-T103
-	I-T103
on	I-T103
-	I-T103
sand	I-T103
##i	I-T103
sponge	I-T103
vectors	I-T103
micrornas	B-T103
(	O
mirnas	B-T103
)	O
are	O
small	O
,	O
noncoding	B-T103
rnas	I-T103
of	O
about	O
22	O
nucleotides	B-T103
in	O
length	O
and	O
have	O
proven	O
to	O
be	O
useful	O
targets	O
for	O
genetic	B-T062
modifications	I-T062
for	O
desirable	O
phenotype	O
in	O
the	O
bio	B-T091
##te	I-T091
##ch	I-T091
industry	O
.	O
the	O
use	O
of	O
constitutively	O
expressed	O
[UNK]	O
mirna	B-T103
sponge	I-T103
[UNK]	I-T103
vectors	I-T103
in	O
which	O
multiple	O
,	O
tandem	B-T103
mirna	I-T103
binding	B-T103
sites	I-T103
containing	O
transcripts	B-T103
are	O
transcriptionally	B-T038
regulated	I-T038
by	O
a	O
constitutive	O
promoter	B-T103
for	O
down	B-T038
regulating	I-T038
the	O
levels	O
of	O
endogenous	O
micrornas	B-T103
in	O
chinese	B-T017
hamster	I-T017
ovary	I-T017
(	I-T017
cho	I-T017
)	I-T017
cells	I-T017
has	O
shown	O
to	O
be	O
more	O
advantageous	O
than	O
using	O
synthetic	O
antisense	B-T103
oligonucleotides	I-T103
.	O
the	O
application	O
of	O
mirna	O
sponges	O
in	O
biotechnological	B-T091
processes	O
,	O
however	O
,	O
could	O
be	O
more	O
effective	O
,	O
if	O
expression	B-T038
of	O
mirna	O
sponges	O
could	O
be	O
tuned	O
.	O
in	O
this	O
chapter	O
,	O
we	O
present	O
a	O
method	O
for	O
the	O
generation	O
of	O
stable	O
cho	B-T017
cell	I-T017
lines	I-T017
expressing	B-T038
a	O
tet	O
-	O
on	O
-	O
sand	O
##i	O
-	O
mirna	O
-	O
sponge	O
that	O
is	O
in	O
theory	O
expressed	O
only	O
in	O
the	O
presence	O
of	O
an	O
inducer	O
.	O

a	O
novel	O
combination	O
treatment	O
to	O
stimulate	B-T058
bone	B-T033
healing	I-T033
and	O
regeneration	B-T038
under	O
hypoxic	B-T038
conditions	I-T038
:	O
photob	B-T058
##io	I-T058
##mod	I-T058
##ulation	I-T058
and	O
melatonin	B-T103
melatonin	B-T103
has	O
anabolic	B-T038
effects	I-T038
on	O
the	O
bone	B-T017
,	O
even	O
under	O
hypoxia	B-T038
,	O
and	O
laser	O
irradiation	O
has	O
been	O
shown	O
to	O
improve	O
osteoblastic	B-T038
differentiation	I-T038
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
whether	O
laser	O
irradiation	O
and	O
melatonin	B-T103
would	O
have	O
synergistic	O
effects	O
on	O
osteoblastic	B-T038
differentiation	I-T038
and	O
mineralization	B-T038
under	O
hypoxic	B-T038
conditions	I-T038
.	O
mc	B-T017
##3t3	I-T017
-	I-T017
e1	I-T017
cells	I-T017
were	O
exposed	O
to	O
1	O
%	O
oxygen	B-T033
tension	I-T033
for	O
the	O
hypoxia	B-T038
condition	I-T038
.	O
the	O
cells	B-T017
were	O
divided	O
into	O
four	O
groups	O
:	O
g1	O
-	O
osteoblast	B-T038
differentiation	I-T038
medium	B-T103
only	O
(	O
as	O
the	O
hypoxic	B-T038
condition	I-T038
)	O
,	O
g2	O
-	O
treatment	O
with	O
50	O
μm	O
melatonin	B-T103
only	O
,	O
g3	O
-	O
laser	O
irradiation	O
(	O
80	O
##8	O
nm	O
,	O
80	O
mw	O
,	O
ga	O
##ala	O
##s	O
diode	O
)	O
only	O
,	O
and	O
g4	O
-	O
treatment	O
with	O
50	O
μm	O
melatonin	B-T103
and	O
laser	O
irradiation	O
(	O
80	O
##8	O
nm	O
,	O
80	O
mw	O
,	O
ga	O
##ala	O
##s	O
diode	O
)	O
.	O
immunoblotting	B-T058
showed	O
that	O
oste	B-T103
##rix	I-T103
expression	B-T038
was	O
markedly	O
increased	O
in	O
the	O
melatonin	B-T103
-	O
treated	O
and	O
laser	O
-	O
irradiated	O
cells	B-T017
at	O
48	O
and	O
72	O
h	O
.	O
in	O
addition	O
,	O
alkaline	B-T103
phosphatase	I-T103
activity	O
significantly	O
increased	O
and	O
continued	O
to	O
rise	O
throughout	O
the	O
experiment	B-T062
.	O
ali	B-T058
##z	I-T058
##arin	I-T058
red	I-T058
staining	I-T058
showed	O
markedly	O
increased	O
mineralized	B-T038
nodules	B-T038
as	O
compared	O
with	O
only	O
melatonin	B-T103
-	O
treated	O
or	O
laser	O
-	O
irradiated	O
cells	B-T017
at	O
day	O
7	O
,	O
which	O
significantly	O
increased	O
by	O
day	O
14	O
.	O
moreover	O
,	O
when	O
melatonin	B-T103
-	O
treated	O
cells	B-T017
were	O
laser	O
-	O
irradiated	O
,	O
the	O
differentiation	B-T038
and	O
mineralization	B-T038
of	O
cells	B-T017
were	O
found	O
to	O
involve	O
p38	B-T103
mapk	I-T103
and	O
prk	B-T103
##d1	I-T103
signaling	B-T038
mechanisms	I-T038
.	O
however	O
,	O
the	O
enhanced	O
effects	O
of	O
laser	O
irradiation	O
with	O
melatonin	B-T103
were	O
markedly	O
inhibited	O
when	O
the	O
cells	B-T017
were	O
treated	O
with	O
lu	B-T103
##z	I-T103
##indole	I-T103
,	O
a	O
selective	O
melatonin	B-T103
receptor	I-T103
antagonist	I-T103
.	O
therefore	O
,	O
we	O
concluded	O
that	O
laser	O
irradiation	O
could	O
promote	O
the	O
effect	O
of	O
melatonin	B-T103
on	O
the	O
differentiation	B-T038
and	O
mineralization	B-T038
of	O
mc	B-T017
##3t3	I-T017
-	I-T017
e1	I-T017
cells	I-T017
under	O
hypoxic	B-T038
conditions	I-T038
,	O
and	O
that	O
this	O
process	O
is	O
mediated	O
through	O
melatonin	B-T103
1	I-T103
/	I-T103
2	I-T103
receptors	I-T103
and	O
pk	B-T103
##rd	I-T103
/	O
p38	B-T103
signaling	B-T038
pathways	I-T038
.	O

mid	B-T103
##od	I-T103
##rine	I-T103
and	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
in	O
patients	O
with	O
cirrhosis	B-T038
and	O
refractory	B-T033
or	O
recurrent	O
ascites	O
:	O
a	O
randomised	B-T062
pilot	B-T062
study	I-T062
splanchnic	B-T038
arterial	I-T038
vasodilatation	I-T038
and	O
subsequent	O
sodium	B-T038
and	O
water	B-T033
retention	I-T033
play	O
an	O
important	O
role	O
in	O
cirrhotic	B-T038
ascites	I-T038
.	O
mid	B-T103
##od	I-T103
##rine	I-T103
and	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
have	O
been	O
used	O
separately	O
in	O
these	O
patients	O
.	O
however	O
,	O
there	O
are	O
no	O
reports	O
on	O
the	O
use	O
of	O
combination	B-T058
of	O
mid	B-T103
##od	I-T103
##rine	I-T103
and	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
in	O
the	O
control	O
of	O
ascites	B-T038
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
evaluate	B-T058
the	O
safety	O
and	O
efficacy	O
of	O
mid	B-T103
##od	I-T103
##rine	I-T103
,	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
and	O
their	O
combination	B-T058
in	O
control	O
of	O
refractory	B-T033
or	O
recurrent	O
ascites	O
in	O
cirrhotic	B-T038
##s	I-T038
.	O
fifty	O
cirrhotic	O
patients	O
with	O
refractory	B-T033
or	O
recurrent	O
ascites	O
were	O
randomised	B-T062
to	O
receive	O
mid	B-T103
##od	I-T103
##rine	I-T103
(	O
n	O
=	O
13	O
)	O
,	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
(	O
n	O
=	O
12	O
)	O
or	O
both	O
(	O
n	O
=	O
13	O
)	O
plus	O
standard	O
medical	B-T058
therapy	I-T058
(	O
sm	B-T058
##t	I-T058
)	O
or	O
sm	B-T058
##t	I-T058
alone	O
(	O
n	O
=	O
12	O
)	O
.	O
a	O
significant	B-T033
increase	I-T033
in	I-T033
urinary	I-T033
volume	I-T033
and	O
urinary	B-T038
sodium	I-T038
at	O
1	O
and	O
3	O
months	O
(	O
p	O
<	O
.	O
05	O
)	O
was	O
observed	O
in	O
all	O
groups	B-T098
except	O
sm	B-T058
##t	I-T058
.	O
there	O
was	O
no	O
worsening	O
of	O
renal	B-T033
or	O
hepatic	B-T038
function	I-T038
in	O
any	O
group	B-T098
.	O
there	O
was	O
deterioration	O
of	O
model	B-T170
for	I-T170
end	I-T170
-	I-T170
stage	I-T170
liver	I-T170
disease	I-T170
(	O
meld	B-T170
)	O
in	O
sm	O
##t	O
.	O
mid	B-T103
##od	I-T103
##rine	I-T103
as	O
well	O
as	O
combination	B-T058
of	O
mid	B-T103
##od	I-T103
##rine	I-T103
and	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
but	O
not	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
alone	O
was	O
superior	O
to	O
sm	B-T058
##t	I-T058
in	O
control	O
of	O
ascites	B-T038
at	O
3	O
months	O
(	O
p	O
<	O
.	O
05	O
)	O
.	O
the	O
combination	B-T058
therapy	I-T058
was	O
also	O
superior	O
to	O
mid	B-T103
##od	I-T103
##rine	I-T103
in	O
the	O
control	O
of	O
ascites	B-T038
at	O
1	O
month	O
.	O
the	O
morbidity	O
and	O
mortality	O
were	O
similar	O
in	O
all	O
the	O
groups	B-T098
except	O
sm	B-T058
##t	I-T058
.	O
the	O
results	O
of	O
this	O
pilot	B-T062
study	I-T062
suggest	O
that	O
mid	B-T103
##od	I-T103
##rine	I-T103
and	O
combination	B-T058
with	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
better	O
controls	O
ascites	B-T038
without	O
any	O
renal	B-T038
or	O
hepatic	B-T038
dysfunction	I-T038
.	O
the	O
combination	B-T058
therapy	I-T058
rapidly	O
controls	O
ascites	B-T038
as	O
compared	O
to	O
mid	B-T103
##od	I-T103
##rine	I-T103
or	O
tol	B-T103
##va	I-T103
##pt	I-T103
##an	I-T103
alone	O
.	O

functional	O
result	O
after	O
cochlear	B-T058
implantation	I-T058
in	O
children	O
and	O
adults	O
with	O
single	B-T038
-	I-T038
sided	I-T038
deafness	I-T038
patients	O
with	O
single	B-T038
-	I-T038
sided	I-T038
deafness	I-T038
(	O
ss	B-T038
##d	I-T038
)	O
suffer	O
from	O
reduced	O
bin	O
##au	O
##ral	O
hearing	O
(	O
i	O
.	O
e	O
.	O
,	O
sound	B-T038
localization	I-T038
and	O
speech	B-T038
in	O
noise	B-T038
discrimination	I-T038
)	O
.	O
cochlear	B-T058
implantation	I-T058
has	O
recently	O
been	O
introduced	O
for	O
patients	O
with	O
ss	B-T038
##d	I-T038
,	O
as	O
an	O
alternative	O
to	O
hearing	B-T074
devices	I-T074
that	O
employ	O
contralateral	B-T082
routin	O
##g	O
of	O
the	O
signal	O
.	O
application	B-T058
to	O
children	O
has	O
also	O
been	O
started	O
.	O
we	O
retrospectively	B-T062
analyze	O
a	O
case	O
series	O
of	O
4	O
children	O
and	O
17	O
adults	O
with	O
ss	B-T038
##d	I-T038
,	O
treated	B-T058
with	I-T058
cochlear	B-T058
implantation	I-T058
.	O
the	O
outcome	O
of	O
adult	O
patients	O
was	O
compared	O
with	O
a	O
control	O
group	O
of	O
27	O
patients	O
with	O
bilateral	B-T038
profound	I-T038
hearing	I-T038
loss	I-T038
using	O
a	O
cochlear	B-T074
implant	I-T074
.	O
during	O
12	O
months	O
,	O
the	O
mean	O
speech	O
recognition	O
score	O
increased	O
from	O
30	O
to	O
41	O
%	O
for	O
monos	B-T170
##yll	I-T170
##ab	I-T170
##ic	I-T170
words	I-T170
in	O
adults	O
,	O
and	O
from	O
58	O
to	O
89	O
%	O
for	O
multis	B-T170
##yll	I-T170
##ab	I-T170
##ic	I-T170
numbers	O
.	O
the	O
cochlear	B-T074
implant	I-T074
(	O
ci	B-T074
)	O
improved	B-T033
hearing	I-T033
in	O
noise	O
in	O
all	O
ss	B-T038
##d	I-T038
patients	O
,	O
as	O
was	O
demonstrated	O
by	O
a	O
significant	O
improvement	O
of	O
the	O
speech	B-T201
recept	I-T201
##ion	I-T201
threshold	I-T201
in	O
different	O
speech	O
and	O
noise	O
configurations	O
.	O
sound	B-T038
localization	I-T038
-	O
correlated	O
angle	B-T170
detection	I-T170
error	I-T170
improved	O
with	O
ci	B-T074
use	O
at	O
every	O
time	O
point	O
.	O
the	O
maximum	O
word	B-T038
recognition	I-T038
score	O
for	O
monos	B-T170
##yll	I-T170
##ab	I-T170
##ic	I-T170
words	I-T170
in	O
quiet	O
correlated	O
with	O
the	O
logarithm	O
of	O
the	O
duration	O
of	O
deafness	B-T033
;	O
improvement	O
of	O
the	O
speech	B-T201
recept	I-T201
##ion	I-T201
threshold	I-T201
and	O
rms	B-T170
angle	I-T170
detection	I-T170
error	I-T170
by	O
the	O
ci	B-T074
did	O
not	O
.	O
all	O
ss	B-T038
##d	I-T038
patients	O
benefit	O
##ted	O
from	O
the	O
ci	B-T074
in	O
different	O
hearing	B-T038
situations	O
.	O
patients	O
with	O
ss	B-T038
##d	I-T038
for	O
a	O
long	O
period	O
can	O
improve	O
after	O
cochlear	B-T058
implantation	I-T058
.	O

design	O
and	O
characteristics	O
of	O
cytotoxic	O
fibroblast	B-T103
growth	I-T103
factor	I-T103
1	I-T103
conjugate	B-T103
for	O
fibroblast	B-T103
growth	I-T103
factor	I-T103
receptor	I-T103
-	O
targeted	B-T058
cancer	I-T058
therapy	I-T058
fibroblast	B-T103
growth	I-T103
factor	I-T103
receptors	I-T103
(	O
fgf	B-T103
##rs	I-T103
)	O
are	O
attractive	O
candidate	O
cancer	B-T058
therapy	I-T058
targets	O
as	O
they	O
are	O
overexpressed	B-T038
in	O
multiple	O
types	O
of	O
tumors	B-T038
,	O
such	O
as	O
breast	B-T038
,	O
prostate	B-T038
,	O
bladder	B-T038
,	O
and	O
lung	B-T038
cancer	I-T038
.	O
in	O
this	O
study	O
,	O
a	O
natural	B-T038
ligand	I-T038
of	O
fgf	B-T103
##r	I-T103
,	O
an	O
engineered	B-T103
variant	I-T103
of	O
fibroblast	B-T103
growth	I-T103
factor	I-T103
1	I-T103
(	O
fgf	B-T103
##1	I-T103
##v	I-T103
)	O
,	O
was	O
conjugated	B-T082
to	O
a	O
potent	B-T103
cytotoxic	I-T103
drug	I-T103
,	O
monomethyl	B-T103
aur	I-T103
##ist	I-T103
##atin	I-T103
e	I-T103
(	O
mma	B-T103
##e	I-T103
)	O
,	O
and	O
used	O
as	O
a	O
targeting	B-T038
agent	I-T038
for	O
cancer	B-T017
cells	I-T017
overexpressing	B-T038
fgf	B-T103
##rs	I-T103
,	O
similar	O
to	O
antibodies	B-T103
in	O
antibody	B-T058
-	I-T058
drug	I-T058
conjugates	I-T058
.	O
the	O
fgf	B-T103
##1	I-T103
##v	I-T103
-	I-T103
valine	I-T103
-	I-T103
citrulline	I-T103
-	I-T103
mma	I-T103
##e	I-T103
conjugate	I-T103
showed	O
a	O
favorable	O
stability	B-T038
profile	I-T038
,	O
bound	B-T038
fgf	B-T103
##rs	I-T103
on	O
the	O
cell	B-T017
surface	I-T017
specifically	O
,	O
and	O
efficiently	O
released	O
the	O
drug	B-T103
(	I-T103
mma	I-T103
##e	I-T103
)	I-T103
upon	O
cleavage	B-T038
by	O
the	O
lysosomal	B-T103
protease	I-T103
cathepsin	I-T103
b	I-T103
.	O
importantly	O
,	O
the	O
conjugate	B-T103
showed	O
a	O
prominent	O
cytotoxic	B-T038
effect	I-T038
toward	O
cell	B-T017
lines	I-T017
expressing	O
fgf	B-T103
##r	I-T103
.	O
fgf	B-T103
##1	I-T103
##v	I-T103
-	I-T103
vc	I-T103
##mm	I-T103
##ae	I-T103
was	O
highly	O
cytotoxic	O
at	O
concentrations	O
even	O
an	O
order	O
of	O
magnitude	O
lower	O
than	O
those	O
found	O
for	O
free	O
mma	B-T103
##e	I-T103
.	O
this	O
effect	O
was	O
fgf	B-T103
##r	I-T103
-	O
specific	O
as	O
cells	B-T017
lacking	O
fgf	B-T103
##r	I-T103
did	B-T033
not	I-T033
show	I-T033
any	O
increased	O
mortality	B-T038
.	O

commission	B-T097
##ing	I-T097
through	O
competition	O
and	O
cooperation	O
in	O
the	O
english	B-T098
nhs	B-T058
under	O
the	O
health	O
and	O
social	O
care	O
act	O
2012	O
:	O
evidence	O
from	O
a	O
qualitative	B-T062
study	I-T062
of	O
four	O
clinical	B-T097
commission	I-T097
##ing	I-T097
groups	I-T097
the	O
health	O
and	O
social	O
care	O
act	O
2012	O
(	O
'	O
hsc	O
##a	O
2012	O
'	O
)	O
introduced	O
a	O
new	O
,	O
stat	O
##ut	O
##ory	O
,	O
form	O
of	O
regulation	O
of	O
competition	O
into	O
the	O
national	B-T058
health	I-T058
service	I-T058
(	O
nhs	B-T058
)	O
,	O
while	O
at	O
the	O
same	O
time	O
recogn	O
##ising	O
that	O
cooperation	O
was	O
necessary	O
.	O
nhs	B-T058
england	B-T170
'	I-T170
s	I-T170
policy	I-T170
document	I-T170
,	O
the	O
five	B-T170
year	I-T170
forward	I-T170
view	I-T170
(	O
'	O
5	B-T170
##y	I-T170
##fv	I-T170
'	O
)	O
of	O
2014	O
placed	O
less	O
emphasis	O
on	O
competition	O
without	O
altering	O
the	O
legislation	B-T170
.	O
we	O
explored	O
how	O
commission	B-T062
##ers	I-T062
and	O
providers	O
understand	O
the	O
complex	O
regulatory	B-T170
framework	I-T170
,	O
and	O
how	O
they	O
behave	O
in	O
relation	O
to	O
competition	O
and	O
cooperation	O
.	O
we	O
carried	O
out	O
detailed	O
case	B-T170
studies	I-T170
in	O
four	O
clinical	B-T097
commission	I-T097
##ing	I-T097
groups	I-T097
,	O
using	O
interviews	O
and	O
document	B-T062
##ary	I-T062
analysis	I-T062
to	O
explore	O
the	O
commission	B-T062
##ers	I-T062
'	O
and	O
providers	O
'	O
understanding	O
and	O
experience	O
of	O
competition	O
and	O
cooperation	O
.	O
we	O
conducted	O
42	O
interviews	O
with	O
senior	B-T097
managers	I-T097
in	O
commission	B-T097
##ing	I-T097
organisations	B-T092
and	O
senior	B-T097
managers	I-T097
in	O
nhs	B-T058
and	O
independent	B-T092
provider	I-T092
organisations	I-T092
(	O
acute	B-T092
and	I-T092
community	I-T092
services	I-T092
)	O
.	O
neither	O
commission	B-T062
##ers	I-T062
nor	O
providers	O
fully	O
understand	O
the	O
regulatory	B-T170
regime	I-T170
in	O
respect	O
of	O
competition	O
in	O
the	O
nhs	B-T058
,	O
and	O
have	O
not	O
found	O
that	O
the	O
regulatory	B-T170
authorities	I-T170
have	O
provided	O
adequate	O
guidance	O
.	O
despite	O
the	O
hsc	O
##a	O
2012	O
promoting	O
competition	O
,	O
commission	B-T062
##ers	I-T062
chose	O
mainly	O
to	O
use	O
collaborative	O
strategies	O
to	O
effect	O
major	O
service	O
recon	O
##fig	O
##urations	O
,	O
which	O
is	O
endorsed	O
as	O
a	O
suitable	O
approach	O
by	O
providers	O
.	O
nevertheless	O
,	O
commission	B-T062
##ers	I-T062
are	O
using	O
competitive	O
tender	O
##ing	O
in	O
respect	O
of	O
more	O
peripheral	O
services	O
in	O
order	O
to	O
improve	O
quality	B-T058
of	I-T058
care	I-T058
and	O
value	O
for	O
money	O
.	O
commission	B-T062
##ers	I-T062
regard	O
the	O
use	O
of	O
competition	O
and	O
cooperation	O
as	O
appropriate	O
in	O
the	O
nhs	B-T058
currently	O
,	O
although	O
collaborative	O
strategies	O
appear	O
more	O
helpful	O
in	O
respect	O
of	O
large	O
-	O
scale	O
changes	O
.	O
however	O
,	O
the	O
current	O
regulatory	B-T170
framework	I-T170
contained	O
in	O
the	O
hsc	O
##a	O
2012	O
,	O
particularly	O
since	O
the	O
publication	B-T170
of	O
the	O
5	B-T170
##y	I-T170
##fv	I-T170
,	O
is	O
not	O
clear	O
.	O
better	O
guidance	O
should	O
be	O
issued	O
by	O
the	O
regulatory	B-T170
authorities	I-T170
.	O

pancreatic	B-T017
neuroendocrine	O
cancer	O
with	O
liver	B-T038
metastases	I-T038
and	O
multiple	B-T038
peritoneal	I-T038
metastases	I-T038
:	O
report	O
of	O
one	O
case	O
pancreatic	B-T017
neuroendocrine	O
tumor	O
(	O
pn	O
##et	O
)	O
is	O
a	O
rare	O
pancreatic	B-T038
tumor	I-T038
,	O
with	O
its	O
incidence	O
showing	O
a	O
rising	O
trend	O
in	O
recent	O
years	O
.	O
most	O
of	O
its	O
distant	O
metastases	O
are	O
found	B-T033
in	O
the	O
liver	B-T017
.	O
this	O
article	O
describes	O
a	O
59	O
-	O
year	O
-	O
old	O
male	O
patient	O
with	O
pn	O
##et	O
with	O
liver	B-T038
metastasis	I-T038
and	O
multiple	B-T038
abdominal	I-T038
metastases	I-T038
,	O
focusing	O
on	O
the	O
management	B-T058
of	O
this	O
tumor	B-T038
in	O
its	O
advanced	O
stage	O
.	O

dental	O
enamel	B-T033
defects	I-T033
in	O
german	B-T098
medi	O
##ev	O
##al	O
and	O
early	O
-	O
modern	O
-	O
age	O
populations	B-T098
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
the	O
frequency	O
and	O
type	O
of	O
developmental	B-T033
defects	I-T033
of	I-T033
enamel	I-T033
(	O
dde	B-T033
)	O
in	O
a	O
medi	O
##ev	O
##al	O
and	O
an	O
early	O
-	O
modern	O
-	O
age	O
population	B-T098
from	O
thuring	B-T082
##ia	I-T082
,	I-T082
germany	I-T082
.	O
sixty	O
-	O
six	O
skeleton	B-T022
##s	I-T022
subdivided	O
into	O
31	O
single	O
bur	O
##ials	O
(	O
12	O
(	O
th	O
)	O
/	O
13	O
(	O
th	O
)	O
c	O
.	O
)	O
and	O
35	O
individuals	B-T098
buried	O
in	O
groups	O
(	O
15	O
(	O
th	O
)	O
/	O
16	O
(	O
th	O
)	O
c	O
.	O
)	O
were	O
examined	B-T033
.	O
dde	B-T033
were	O
classified	B-T170
on	O
1	O
,	O
246	O
teeth	B-T017
according	O
to	O
the	O
dde	B-T033
index	B-T170
.	O
molar	B-T038
-	I-T038
incisor	I-T038
-	I-T038
hypo	I-T038
##min	I-T038
##eral	I-T038
##isation	I-T038
(	O
mi	B-T038
##h	I-T038
)	O
,	O
a	O
special	O
type	O
of	O
dde	B-T033
,	O
was	O
recorded	B-T170
according	O
to	O
the	O
european	B-T092
academy	I-T092
of	I-T092
paediatric	I-T092
dentistry	I-T092
(	O
ea	B-T092
##pd	I-T092
)	O
criteria	O
.	O
dde	B-T033
was	O
found	O
in	O
89	O
.	O
4	O
%	O
of	O
the	O
individuals	B-T098
(	O
single	O
bur	O
##ials	O
90	O
.	O
3	O
%	O
and	O
group	O
bur	O
##ials	O
88	O
.	O
6	O
%	O
)	O
.	O
hypoplastic	O
pits	B-T033
were	O
the	O
most	O
frequent	O
defect	O
in	O
primary	B-T017
teeth	I-T017
and	O
linear	B-T038
enamel	I-T038
hypoplasia	I-T038
(	O
le	B-T038
##h	I-T038
)	O
in	O
permanent	B-T017
teeth	I-T017
.	O
13	O
individuals	B-T098
(	O
24	O
.	O
1	O
%	O
)	O
showed	O
at	O
least	O
one	O
hypo	B-T038
##min	I-T038
##eral	I-T038
##ised	I-T038
permanent	B-T017
tooth	I-T017
,	O
12	O
.	O
2	O
%	O
had	O
mi	B-T038
##h	I-T038
on	O
at	O
least	O
one	O
first	O
permanent	B-T017
molar	I-T017
and	O
10	O
.	O
0	O
%	O
in	O
permanent	B-T017
incisors	I-T017
.	O
second	B-T017
primary	I-T017
molars	I-T017
were	O
affected	O
in	O
8	O
.	O
0	O
%	O
of	O
the	O
children	O
and	O
juveniles	O
.	O
no	O
individual	B-T098
suffered	O
from	O
affected	O
molars	B-T017
and	O
incisors	B-T017
in	O
combination	O
.	O
endogenous	O
factors	O
like	O
nutritional	B-T038
deficiencies	I-T038
and	O
health	O
problems	O
in	O
early	O
childhood	O
could	O
have	O
been	O
aetiological	O
reasons	O
of	O
dde	B-T033
and	O
mi	B-T038
##h	I-T038
.	O
the	O
frequency	O
of	O
dde	B-T033
and	O
mi	B-T038
##h	I-T038
might	O
have	O
been	O
masked	B-T062
by	O
extended	B-T082
car	B-T038
##ious	I-T038
lesions	I-T038
,	O
dental	B-T037
wear	I-T037
and	O
ant	B-T033
##e	I-T033
-	I-T033
mortem	I-T033
tooth	B-T017
loss	I-T017
.	O

two	O
-	O
stage	O
reconstructive	B-T058
overlapping	B-T074
stent	I-T074
le	B-T074
##o	I-T074
+	I-T074
and	O
silk	B-T074
for	O
treatment	B-T058
of	O
intracranial	B-T082
circumferential	B-T082
fusiform	B-T017
aneurysms	I-T017
in	O
the	O
posterior	O
circulation	B-T038
intracranial	B-T082
circumferential	B-T082
fusiform	B-T017
aneurysms	I-T017
of	O
the	O
posterior	O
circulation	B-T038
involving	O
arterial	B-T017
branches	I-T017
or	O
perfor	B-T033
##ating	I-T033
vessels	B-T017
are	O
difficult	O
to	O
treat	O
.	O
this	O
article	O
shows	O
an	O
endovascular	O
reconstruction	B-T058
technique	I-T058
not	O
yet	O
described	O
,	O
using	O
a	O
tele	B-T074
##sc	I-T074
##oping	I-T074
self	I-T074
-	I-T074
expand	I-T074
##able	I-T074
stent	I-T074
(	O
le	B-T074
##o	I-T074
+	I-T074
)	O
and	O
flow	B-T074
-	I-T074
diver	I-T074
##ter	I-T074
device	I-T074
(	O
silk	B-T074
)	O
at	O
different	O
surgical	O
times	O
.	O
two	O
patients	O
with	O
circumferential	B-T082
fusiform	B-T017
aneurysm	I-T017
,	O
one	O
being	O
an	O
aneurysm	B-T038
of	O
the	O
segments	O
p2	O
and	O
p3	O
of	O
the	O
posterior	B-T017
cerebral	I-T017
artery	I-T017
,	O
diagnosed	B-T033
after	O
a	O
headache	B-T033
,	O
and	O
the	O
other	O
a	O
partially	O
thromb	B-T038
##osed	I-T038
aneurysm	I-T038
of	O
the	O
lower	B-T082
basilar	B-T017
artery	I-T017
,	O
diagnosed	B-T033
following	O
ischemia	B-T038
of	O
the	O
brain	B-T017
stem	I-T017
.	O
endovascular	O
treatment	B-T058
was	O
performed	O
by	O
means	O
of	O
a	O
vascular	B-T017
reconstruction	B-T058
technique	I-T058
that	O
used	O
at	O
different	O
surgical	O
times	O
:	O
overlapping	B-T058
;	I-T058
a	I-T058
tele	I-T058
##sc	I-T058
##oped	I-T058
self	I-T058
-	I-T058
expand	I-T058
##able	I-T058
stent	I-T058
,	O
le	B-T074
##o	I-T074
+	I-T074
;	O
and	O
a	O
flow	B-T074
-	I-T074
diver	I-T074
##ter	I-T074
device	I-T074
,	O
silk	B-T074
.	O
angiographic	B-T058
control	O
was	O
carried	O
out	O
at	O
6	O
and	O
12	O
months	O
,	O
to	O
evaluate	O
arterial	O
patency	O
,	O
flow	O
maintenance	O
in	O
the	O
arterial	B-T017
branches	I-T017
and	O
perfor	B-T033
##ating	I-T033
vessels	B-T017
,	O
and	O
thrombosis	B-T038
of	O
the	O
aneurysm	B-T038
.	O
the	O
combined	O
use	O
at	O
different	O
surgical	O
times	O
of	O
the	O
self	B-T074
-	I-T074
expand	I-T074
##able	I-T074
stent	I-T074
and	O
flow	B-T074
-	I-T074
diver	I-T074
##ter	I-T074
device	I-T074
was	O
technically	O
successful	O
in	O
both	O
patients	O
.	O
there	O
were	O
no	O
complications	B-T038
during	O
the	O
procedure	O
,	O
nor	O
in	O
the	O
long	O
-	O
term	O
follow	B-T058
-	I-T058
up	I-T058
with	O
full	O
arterial	B-T017
vascular	B-T017
reconstruction	B-T058
,	O
maintenance	O
of	O
cerebral	O
perfusion	O
and	O
complete	O
aneurysm	B-T038
occlusion	O
at	O
the	O
6	O
-	O
and	O
12	O
-	O
month	O
angiographic	B-T058
follow	B-T058
-	I-T058
up	I-T058
.	O
there	O
was	O
no	O
aneurysm	B-T037
recanalization	I-T037
nor	O
intra	B-T038
-	I-T038
stent	I-T038
stenosis	I-T038
.	O
circumferential	B-T082
fusiform	B-T017
aneurysm	I-T017
of	O
the	O
posterior	O
circulation	B-T038
involving	O
arterial	B-T017
branches	I-T017
or	O
perfor	B-T033
##ating	I-T033
vessels	B-T017
to	O
the	O
brain	B-T017
stem	I-T017
may	O
be	O
treated	O
with	O
this	O
arterial	B-T017
reconstruction	B-T058
technique	I-T058
at	O
different	O
surgical	O
times	O
,	O
using	O
the	O
self	B-T074
-	I-T074
expand	I-T074
##able	I-T074
stent	I-T074
called	O
le	B-T074
##o	I-T074
+	I-T074
and	O
the	O
flow	B-T074
-	I-T074
diver	I-T074
##ter	I-T074
device	I-T074
silk	B-T074
,	O
minimizing	O
the	O
risk	O
of	O
complications	B-T038
and	O
failure	O
of	O
the	O
endovascular	O
technique	B-T058
,	O
with	O
the	O
potential	O
for	O
arterial	B-T058
reconstruction	I-T058
with	O
thrombosis	B-T038
of	O
the	O
aneurysm	B-T038
##atic	I-T038
sac	I-T038
,	O
as	O
well	O
as	O
flow	O
maintenance	O
in	O
the	O
el	B-T017
##o	I-T017
##que	I-T017
##nt	I-T017
arteries	I-T017
,	O
in	O
this	O
type	O
of	O
cerebral	B-T038
aneurysm	I-T038
.	O

qu	O
##o	O
vad	O
##is	O
g	B-T038
protein	I-T038
-	I-T038
coupled	I-T038
receptor	I-T038
ligands	I-T038
?	O
a	O
tool	O
for	O
analysis	B-T062
of	O
the	O
emergence	O
of	O
new	O
groups	O
of	O
compounds	B-T103
over	O
time	O
exponential	O
growth	O
in	O
the	O
number	O
of	O
compounds	B-T103
with	O
experimentally	O
verified	O
activity	O
towards	O
particular	O
target	O
has	O
led	O
to	O
the	O
emergence	O
of	O
various	O
databases	B-T170
gathering	O
data	O
on	O
biological	O
activity	O
.	O
in	O
this	O
study	B-T062
,	O
the	O
ligands	B-T103
of	O
family	B-T103
a	I-T103
of	I-T103
the	I-T103
g	I-T103
protein	I-T103
-	I-T103
coupled	I-T103
receptors	I-T103
that	O
are	O
collected	O
in	O
the	O
chem	B-T170
##bl	I-T170
database	I-T170
were	O
examined	B-T033
,	O
and	O
special	O
attention	O
was	O
given	O
to	O
serotonin	B-T103
receptors	I-T103
.	O
sets	O
of	O
compounds	B-T103
were	O
examined	B-T033
in	O
terms	O
of	O
their	O
appearance	O
over	O
time	O
,	O
they	O
were	O
mapped	O
to	O
the	O
chemical	O
space	O
of	O
drugs	B-T103
deposited	O
in	O
drug	O
##bank	O
,	O
and	O
the	O
emergence	O
of	O
structurally	O
new	O
clusters	O
of	O
compounds	O
was	O
indicated	B-T033
.	O
in	O
addition	O
,	O
a	O
tool	O
for	O
detailed	O
analysis	B-T062
of	O
the	O
obtained	O
visualization	B-T170
##s	I-T170
was	O
prepared	B-T033
and	O
made	O
available	O
online	O
at	O
http	B-T170
:	I-T170
/	I-T170
/	I-T170
chem	I-T170
.	I-T170
gm	I-T170
##um	I-T170
.	I-T170
net	I-T170
/	I-T170
visc	I-T170
##hem	I-T170
,	O
which	O
enables	O
the	O
investigation	O
of	O
chemical	B-T170
structures	I-T170
while	O
referring	O
to	O
particular	O
data	O
points	O
depicted	O
in	O
the	O
figures	O
and	O
changes	O
in	O
compounds	B-T103
datasets	B-T170
over	O
time	O
.	O

interprofessional	B-T033
barriers	I-T033
:	O
a	O
study	O
of	O
quality	O
improvement	O
work	O
among	O
nurses	B-T097
and	O
physicians	B-T097
this	O
article	O
studies	O
interprofessional	B-T033
barriers	I-T033
between	O
nurses	B-T097
and	O
physicians	B-T097
in	O
the	O
context	O
of	O
quality	O
improvement	O
work	O
.	O
a	O
total	O
of	O
17	O
nurses	B-T097
and	O
10	O
physicians	B-T097
were	O
interviewed	B-T062
at	O
2	O
hospitals	B-T092
in	O
sweden	B-T082
.	O
the	O
study	O
uncovered	O
a	O
number	O
of	O
barriers	O
relating	O
to	O
both	O
the	O
relative	O
status	O
of	O
each	O
group	O
and	O
their	O
defined	O
areas	O
of	O
responsibility	O
.	O

detection	B-T058
and	O
characterization	O
of	O
flat	B-T038
aberrant	I-T038
crypt	I-T038
foci	I-T038
(	I-T038
flat	I-T038
ac	I-T038
##f	I-T038
)	I-T038
in	O
the	O
novel	O
a	B-T038
/	I-T038
j	I-T038
min	I-T038
/	I-T038
+	I-T038
mouse	I-T038
flat	B-T038
aberrant	I-T038
crypt	I-T038
foci	I-T038
(	O
flat	B-T038
ac	I-T038
##f	I-T038
)	O
and	O
mucin	B-T038
-	I-T038
depleted	I-T038
foci	I-T038
(	O
md	B-T038
##f	I-T038
)	O
have	O
previously	O
been	O
described	O
as	O
pren	B-T038
##e	I-T038
##oplastic	I-T038
colonic	I-T038
lesions	I-T038
.	O
we	O
used	O
the	O
novel	O
a	B-T038
/	I-T038
j	I-T038
min	I-T038
/	I-T038
+	I-T038
mouse	I-T038
model	I-T038
,	O
that	O
demonstrates	O
extensive	O
spontaneous	O
colon	B-T038
carcinogenesis	I-T038
to	O
refine	O
the	O
method	O
of	O
detection	B-T058
of	O
flat	B-T038
ac	I-T038
##f	I-T038
and	O
further	O
characterize	O
and	O
define	O
them	O
as	O
early	O
lesions	B-T033
by	O
histological	B-T058
examination	I-T058
and	O
comparison	O
with	O
md	B-T038
##f	I-T038
.	O
colon	B-T017
##s	I-T017
were	O
stained	B-T058
with	I-T058
methylene	I-T058
blue	I-T058
(	O
mb	B-T103
)	O
for	O
flat	B-T038
ac	I-T038
##f	I-T038
detection	B-T058
and	O
rest	B-T058
##ained	I-T058
with	O
high	B-T103
-	I-T103
iron	I-T103
diamine	I-T103
-	I-T103
alc	I-T103
##ian	I-T103
blue	I-T103
(	O
hi	B-T103
##d	I-T103
-	I-T103
ab	I-T103
)	O
for	O
md	B-T038
##f	I-T038
detection	B-T058
.	O
optimal	O
flat	B-T038
ac	I-T038
##f	I-T038
recognition	O
required	O
at	O
least	O
24	O
h	O
of	O
storage	O
post	O
-	O
mb	B-T058
staining	I-T058
and	O
adherence	O
to	O
a	O
set	O
of	O
characteristics	O
.	O
the	O
fraction	O
of	O
flat	B-T038
ac	I-T038
##f	I-T038
corresponding	O
with	O
md	B-T038
##f	I-T038
was	O
93	O
%	O
.	O
flat	B-T038
ac	I-T038
##f	I-T038
/	O
md	B-T038
##f	I-T038
displayed	O
the	O
same	O
picture	O
of	O
severe	B-T038
dysplasia	I-T038
,	O
lack	O
of	O
mucus	B-T017
and	O
goblet	B-T017
cells	I-T017
and	O
accumulation	B-T033
of	O
cytoplasmic	B-T017
β	B-T103
-	I-T103
catenin	I-T103
.	O
the	O
easily	O
detectable	O
flat	B-T038
ac	I-T038
##f	I-T038
are	O
reliable	O
surface	B-T017
biomarkers	B-T201
of	O
apc	B-T017
-	O
driven	O
colon	B-T038
carcinogenesis	I-T038
.	O

characterizing	O
sexual	B-T038
function	I-T038
in	O
patients	O
with	O
generalized	B-T038
anxiety	I-T038
disorder	I-T038
:	O
a	O
pooled	B-T062
analysis	I-T062
of	O
three	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
studies	B-T062
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
has	O
been	O
shown	O
to	O
reduce	O
core	B-T033
symptoms	I-T033
of	O
generalized	B-T038
anxiety	I-T038
disorder	I-T038
(	O
gad	B-T038
)	O
in	O
three	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	O
-	O
controlled	O
trials	O
.	O
since	O
sexual	B-T038
dysfunction	I-T038
(	O
sd	B-T038
)	O
is	O
not	O
well	O
characterized	O
in	O
gad	B-T038
,	O
a	O
post	B-T062
hoc	I-T062
analysis	I-T062
of	O
these	O
trials	B-T062
was	O
conducted	O
to	O
evaluate	B-T058
the	O
effects	O
of	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
on	O
sexual	B-T038
functioning	I-T038
in	O
gad	B-T038
patients	O
.	O
data	O
were	O
pooled	O
from	O
one	O
fixed	B-T062
-	I-T062
dose	I-T062
trial	I-T062
of	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
20	O
and	O
40	O
mg	O
/	O
day	O
(	O
nct0	B-T170
##16	I-T170
##29	I-T170
##96	I-T170
##6	I-T170
)	O
and	O
two	O
flexible	B-T062
-	I-T062
dose	I-T062
studies	I-T062
of	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
20	O
-	O
40	O
mg	O
/	O
day	O
(	O
nct0	B-T170
##17	I-T170
##66	I-T170
##40	I-T170
##1	I-T170
,	O
nct0	B-T170
##18	I-T170
##44	I-T170
##11	I-T170
##5	I-T170
)	O
in	O
adults	O
with	O
gad	B-T038
.	O
sexual	B-T038
functioning	I-T038
was	O
assessed	O
using	O
the	O
changes	B-T170
in	I-T170
sexual	I-T170
functioning	I-T170
questionnaire	I-T170
(	O
csf	B-T170
##q	I-T170
)	O
.	O
outcomes	B-T062
included	O
mean	O
change	O
from	O
baseline	O
to	O
end	O
of	O
treatment	O
(	O
eot	O
)	O
in	O
csf	B-T033
##q	I-T033
total	I-T033
score	I-T033
and	O
percentage	O
of	O
patients	O
shifting	O
from	O
sd	B-T038
at	O
baseline	O
(	O
csf	B-T033
##q	I-T033
total	I-T033
score	I-T033
≤	O
##47	O
for	O
males	B-T098
,	O
≤	O
##41	O
for	O
females	B-T098
)	O
to	O
normal	O
functioning	O
at	O
eot	O
.	O
treatment	B-T038
-	I-T038
emergent	I-T038
adverse	I-T038
events	I-T038
related	O
to	O
sexual	B-T038
functioning	I-T038
were	O
also	O
analyzed	B-T062
.	O
a	O
total	O
of	O
1	O
,	O
373	O
patients	O
were	O
included	O
in	O
the	O
analyses	B-T062
.	O
sd	B-T038
at	O
baseline	O
was	O
more	O
common	O
in	O
females	B-T098
(	O
placebo	B-T103
,	O
46	O
.	O
4	O
%	O
;	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
,	O
49	O
%	O
)	O
than	O
in	O
males	B-T098
(	O
placebo	B-T103
,	O
35	O
.	O
1	O
%	O
;	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
,	O
40	O
.	O
9	O
%	O
)	O
.	O
csf	B-T033
##q	I-T033
total	I-T033
score	I-T033
improvement	O
was	O
found	O
in	O
both	O
females	B-T098
(	O
placebo	B-T103
,	O
+	O
1	O
.	O
2	O
;	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
,	O
+	O
1	O
.	O
6	O
)	O
and	O
males	B-T098
(	O
placebo	B-T103
,	O
+	O
2	O
.	O
1	O
;	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
,	O
+	O
1	O
.	O
0	O
)	O
,	O
with	O
no	O
statistically	O
significant	O
differences	O
between	O
treatment	O
groups	O
.	O
the	O
percentage	O
of	O
patients	O
who	O
shifted	O
from	O
sd	B-T038
at	O
baseline	O
to	O
normal	O
sexual	B-T038
functioning	I-T038
at	O
eot	O
was	O
higher	O
in	O
males	B-T098
(	O
placebo	B-T103
,	O
40	O
.	O
6	O
%	O
;	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
,	O
35	O
.	O
7	O
%	O
)	O
than	O
in	O
females	B-T098
(	O
placebo	B-T103
,	O
24	O
.	O
9	O
%	O
;	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
,	O
34	O
.	O
9	O
%	O
)	O
;	O
no	O
statistical	O
testing	O
was	O
performed	O
.	O
except	O
for	O
erectile	B-T038
dysfunction	I-T038
and	O
delayed	B-T038
ejaculation	I-T038
in	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
-	O
treated	O
males	B-T098
(	O
2	O
.	O
4	O
%	O
and	O
2	O
.	O
1	O
%	O
,	O
respectively	O
)	O
,	O
no	B-T033
treatment	I-T033
-	I-T033
emergent	I-T033
adverse	I-T033
events	I-T033
related	O
to	O
sexual	B-T038
functioning	I-T038
occurred	O
in	O
≥2	O
%	O
of	O
patients	O
in	O
either	O
treatment	O
group	O
.	O
approximately	O
35	O
%	O
-	O
50	O
%	O
of	O
patients	O
in	O
the	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
gad	B-T038
studies	B-T062
had	O
sd	B-T038
at	O
baseline	O
.	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
and	O
placebo	B-T103
had	O
similar	O
effects	O
on	O
csf	B-T170
##q	I-T170
outcomes	B-T062
in	O
both	O
females	B-T098
and	O
males	B-T098
,	O
indicating	O
a	O
limited	O
adverse	B-T038
impact	I-T038
on	O
sexual	B-T038
functioning	I-T038
with	O
vi	B-T103
##la	I-T103
##zo	I-T103
##d	I-T103
##one	I-T103
.	O

effects	O
of	O
cer	B-T103
##ium	I-T103
and	O
titanium	B-T103
oxide	I-T103
nanoparticles	O
in	O
soil	O
on	O
the	O
nutrient	B-T168
composition	B-T201
of	O
barley	B-T204
(	O
hor	B-T204
##de	I-T204
##um	I-T204
vulgar	I-T204
##e	I-T204
l	I-T204
.	O
)	O
kernel	B-T168
##s	I-T168
the	O
implications	O
of	O
metal	O
nanoparticles	O
(	O
men	O
##ps	O
)	O
are	O
still	O
unknown	O
for	O
many	O
food	B-T204
crops	I-T204
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
effects	O
of	O
cer	B-T103
##ium	I-T103
oxide	I-T103
(	O
nc	B-T103
##e	I-T103
##o	I-T103
##₂	I-T103
)	O
and	O
titanium	B-T103
oxide	I-T103
(	O
nt	B-T103
##io	I-T103
##₂	I-T103
)	O
nanoparticles	O
in	O
soil	O
at	O
0	O
,	O
500	O
and	O
1000	O
mg	O
·	O
kg	O
(	O
-	O
1	O
)	O
on	O
the	O
nutritional	O
parameters	O
of	O
barley	B-T204
(	O
hor	B-T204
##de	I-T204
##um	I-T204
vulgar	I-T204
##e	I-T204
l	I-T204
.	I-T204
)	O
kernel	B-T168
##s	I-T168
.	O
mineral	O
nutrients	O
,	O
amyl	B-T103
##ose	I-T103
,	O
β	B-T103
-	I-T103
glucan	I-T103
##s	I-T103
,	O
amino	B-T103
acid	I-T103
and	O
crude	B-T103
protein	I-T103
(	O
cp	B-T103
)	O
concentrations	O
were	O
measured	O
in	O
kernel	B-T168
##s	I-T168
.	O
whole	O
flour	B-T168
samples	O
were	O
analyzed	O
by	O
icp	B-T058
-	I-T058
aes	I-T058
/	I-T058
ms	I-T058
,	O
hplc	B-T058
and	O
elemental	O
ch	O
##ns	O
analyzer	O
.	O
results	O
showed	O
that	O
ce	B-T103
and	O
ti	B-T103
accumulation	B-T033
under	O
men	O
##ps	O
treatments	O
did	O
not	O
differ	O
from	O
the	O
control	O
treatment	O
.	O
however	O
,	O
nc	B-T103
##e	I-T103
##o	I-T103
##₂	I-T103
and	O
nt	B-T103
##io	I-T103
##₂	I-T103
had	O
an	O
impact	O
on	O
composition	B-T201
and	O
nutritional	O
quality	O
of	O
barley	B-T204
kernel	B-T168
##s	I-T168
in	O
contrasting	O
ways	O
.	O
both	O
men	O
##ps	O
left	O
β	B-T103
-	I-T103
glucan	I-T103
##s	I-T103
unaffected	O
but	O
reduced	O
amyl	B-T103
##ose	I-T103
content	O
by	O
approximately	O
21	O
%	O
.	O
most	O
amino	B-T103
acids	I-T103
and	O
cp	B-T103
increased	O
.	O
among	O
amino	B-T103
acids	I-T103
,	O
lysine	B-T103
followed	O
by	O
proline	B-T103
saw	O
the	O
largest	O
increase	O
(	O
51	O
%	O
and	O
37	O
%	O
,	O
respectively	O
)	O
.	O
potassium	B-T103
and	O
s	B-T103
were	O
both	O
negatively	O
impacted	O
by	O
men	O
##ps	O
,	O
while	O
b	O
was	O
only	O
affected	O
by	O
500	O
mg	O
nc	B-T103
##e	I-T103
##o	I-T103
##₂	I-T103
·	O
kg	O
(	O
-	O
1	O
)	O
.	O
on	O
the	O
contrary	O
zn	B-T058
and	O
mn	B-T058
concentrations	I-T058
were	O
improved	O
by	O
500	O
mg	O
nt	B-T103
##io	I-T103
##₂	I-T103
·	O
kg	O
(	O
-	O
1	O
)	O
,	O
and	O
ca	O
by	O
both	O
nt	B-T103
##io	I-T103
##₂	I-T103
treatments	O
.	O
generally	O
,	O
our	O
findings	O
demonstrated	O
that	O
kernel	B-T168
##s	I-T168
are	O
negatively	B-T033
affected	I-T033
by	O
nc	B-T103
##e	I-T103
##o	I-T103
##₂	I-T103
while	O
nt	B-T103
##io	I-T103
##₂	I-T103
can	O
potentially	O
have	O
beneficial	O
effects	O
.	O
however	O
,	O
both	O
men	O
##ps	O
have	O
the	O
potential	O
to	O
negatively	O
impact	O
malt	B-T168
and	O
feed	O
production	O
.	O

silk	B-T103
i	I-T103
and	O
silk	B-T103
ii	I-T103
studied	B-T062
by	O
fast	B-T058
scanning	I-T058
calorimetry	I-T058
using	O
fast	B-T058
scanning	I-T058
calorimetry	I-T058
(	O
fs	B-T058
##c	I-T058
)	O
,	O
we	O
investigated	O
the	O
glass	O
transition	O
and	O
crystal	B-T103
melting	O
of	O
samples	O
of	O
b	B-T204
.	I-T204
mor	I-T204
##i	I-T204
silk	B-T103
fibro	I-T103
##in	I-T103
containing	O
silk	B-T103
i	I-T103
and	O
/	O
or	O
silk	B-T103
ii	I-T103
crystal	B-T103
s	O
.	O
due	O
to	O
the	O
very	O
short	O
residence	B-T082
times	O
at	O
high	O
temperatures	O
during	O
such	O
measurements	O
,	O
thermal	O
decomposition	O
of	O
silk	B-T103
protein	I-T103
can	O
be	O
significantly	O
suppressed	O
.	O
fs	B-T058
##c	I-T058
was	O
performed	O
at	O
2000	O
##k	O
/	O
s	O
using	O
the	O
met	B-T058
##tle	I-T058
##r	I-T058
flash	I-T058
dsc	I-T058
##1	I-T058
on	O
fibro	B-T103
##in	I-T103
films	O
with	O
masses	O
around	O
130	O
-	O
270	O
##ng	O
.	O
films	O
were	O
prepared	O
with	O
different	O
crystalline	B-T103
fractions	O
(	O
ranging	O
from	O
0	O
.	O
26	O
to	O
0	O
.	O
50	O
)	O
and	O
with	O
different	O
crystal	B-T103
structures	I-T103
(	O
silk	B-T103
i	I-T103
,	O
silk	B-T103
ii	I-T103
,	O
or	O
mixed	O
)	O
by	O
varying	O
the	O
processing	O
conditions	O
.	O
these	O
included	O
water	B-T103
annealing	B-T058
at	O
different	O
temperatures	O
,	O
exposure	O
to	O
50	O
%	O
me	B-T103
##oh	I-T103
in	O
water	B-T103
,	O
or	O
autoc	B-T074
##la	I-T074
##ving	I-T074
.	O
the	O
resulting	O
crystal	B-T103
structure	I-T103
was	O
examined	O
using	O
wide	B-T082
angle	I-T082
x	B-T058
-	I-T058
ray	I-T058
scattering	I-T058
.	O
degree	O
of	O
crystallinity	B-T103
was	O
evaluated	B-T033
from	O
fourier	B-T062
transform	I-T062
infrared	I-T062
(	I-T062
ftir	I-T062
)	I-T062
spectroscopy	I-T062
and	O
from	O
analysis	B-T062
of	O
the	O
heat	O
capacity	O
increment	O
at	O
the	O
glass	O
transition	O
temperature	O
.	O
silk	B-T103
fibro	I-T103
##in	I-T103
films	O
prepared	O
by	O
water	B-T103
annealing	B-T058
at	O
25	O
##°c	O
were	O
the	O
least	O
crystalline	B-T103
and	O
had	O
silk	B-T103
i	I-T103
structure	B-T103
.	O
ftir	B-T062
and	O
fs	B-T058
##c	I-T058
studies	B-T062
showed	O
that	O
films	O
prepared	O
by	O
autoc	B-T074
##la	I-T074
##ving	I-T074
or	O
50	O
%	O
me	B-T103
##oh	I-T103
exposure	O
were	O
the	O
most	O
crystalline	B-T103
and	O
had	O
silk	B-T103
ii	I-T103
structure	B-T103
.	O
intermediate	B-T082
crystalline	B-T103
fraction	O
and	O
mixed	O
silk	B-T103
i	I-T103
/	O
silk	B-T103
ii	I-T103
structure	B-T103
s	O
were	O
found	O
in	O
films	O
prepared	O
by	O
water	B-T103
annealing	B-T058
at	O
37°c	O
.	O
fs	B-T058
##c	I-T058
results	O
indicate	O
that	O
silk	B-T103
i	I-T103
i	I-T103
crystals	B-T103
exhibit	O
endoth	O
##erm	O
##s	O
of	O
narrower	O
width	O
and	O
have	O
higher	O
mean	O
melting	O
temperature	O
tm	O
(	O
ii	O
)	O
=	O
351	O
##±2	O
.	O
6	O
##°c	O
,	O
compared	O
to	O
silk	B-T103
i	I-T103
crystals	B-T103
which	O
melt	O
at	O
tm	O
(	O
i	O
)	O
=	O
292	O
##±3	O
.	O
8	O
##°c	O
.	O
films	O
containing	O
mixed	O
silk	B-T103
i	I-T103
/	O
silk	B-T103
ii	I-T103
structure	B-T103
showed	O
two	O
clearly	O
separated	O
endoth	O
##erm	O
##ic	O
peaks	O
.	O
evidence	O
suggests	O
that	O
the	O
two	O
types	O
of	O
crystal	B-T103
s	O
melt	O
separately	O
and	O
do	O
not	O
thermal	O
ly	O
intercon	O
##vert	O
on	O
the	O
extremely	O
short	O
time	O
scale	O
(	O
0	O
.	O
06	O
##5	O
##s	O
between	O
onset	O
and	O
end	O
of	O
melting	O
)	O
of	O
the	O
fs	B-T058
##c	I-T058
experiment	I-T058
.	O
silk	B-T204
##worm	I-T204
silk	B-T103
is	O
a	O
naturally	O
occurring	O
biomaterial	O
.	O
the	O
fibro	B-T103
##in	I-T103
component	I-T103
of	O
silk	B-T103
forms	I-T103
two	O
types	O
of	O
crystals	B-T103
.	O
silk	B-T103
properties	O
depend	O
upon	O
the	O
amount	O
and	O
type	O
of	O
crystals	B-T103
,	O
and	O
their	O
stability	O
.	O
one	O
measure	O
of	O
stability	O
is	O
crystal	B-T103
melting	O
temperature	O
.	O
crystal	B-T103
s	O
which	O
are	O
more	O
stable	O
have	O
a	O
higher	O
melting	O
temperature	O
.	O
until	O
now	O
,	O
it	O
has	O
been	O
challenging	O
to	O
study	B-T062
thermal	O
behavior	O
of	O
silk	B-T103
crystal	B-T103
s	O
because	O
they	O
degrade	O
at	O
high	O
temperature	O
.	O
to	O
avoid	O
degradation	O
,	O
and	O
study	B-T062
the	O
melting	O
properties	O
of	O
silk	B-T103
biomaterial	O
,	O
we	O
heated	O
silk	B-T103
at	O
a	O
very	O
fast	O
rate	O
of	O
2000	O
##k	O
/	O
s	O
using	O
a	O
special	O
calor	O
##imeter	O
.	O
we	O
have	O
shown	O
that	O
the	O
two	O
crystal	B-T103
types	O
have	O
very	O
different	O
melting	O
temperature	O
s	O
,	O
indicating	O
that	O
one	O
crystal	B-T103
type	O
is	O
much	O
more	O
stable	O
than	O
the	O
other	O
.	O

the	O
influence	O
of	O
liposomal	B-T103
formulation	O
on	O
the	O
incorporation	O
and	O
retention	O
of	O
pna	B-T103
oligomers	I-T103
liposomal	B-T103
formulations	O
composed	O
of	O
phospholipids	B-T103
with	O
different	O
uns	O
##aturation	O
degrees	O
,	O
head	O
groups	O
and	O
at	O
different	O
cholesterol	B-T058
content	I-T058
have	I-T058
been	I-T058
tested	I-T058
for	O
the	O
encapsulation	O
of	O
peptide	B-T103
nucleic	I-T103
acid	I-T103
(	I-T103
pna	I-T103
)	I-T103
oligomers	I-T103
.	O
the	O
best	O
loading	O
capability	O
(	O
177	O
##μg	O
,	O
er	O
%	O
=	O
87	O
.	O
2	O
)	O
was	O
obtained	O
for	O
pure	O
liposomes	B-T103
of	O
phosphatidyl	B-T103
##glycerol	I-T103
(	O
dop	B-T103
##g	I-T103
)	O
with	O
negatively	B-T103
charged	I-T103
head	O
group	O
.	O
the	O
insertion	B-T058
of	O
a	O
10	O
-	O
20	O
%	O
of	O
cholesterol	B-T103
in	O
dop	B-T103
##g	I-T103
based	O
liposomes	B-T103
provides	O
a	O
slight	O
decrease	O
(	O
∼	O
##160	O
##μg	O
)	O
of	O
the	O
pna	B-T103
loading	O
.	O
on	O
the	O
other	O
hand	O
,	O
the	O
cholesterol	B-T103
addition	O
(	O
20	O
-	O
30	O
%	O
)	O
slow	O
##s	O
down	O
the	O
pna	B-T103
'	I-T103
s	I-T103
release	O
(	O
∼	O
##27	O
%	O
)	O
in	O
fetal	B-T103
bovine	I-T103
serum	I-T103
from	O
the	O
liposomal	B-T103
formulation	O
.	O
based	O
on	O
the	O
encapsulation	O
and	O
the	O
release	O
properties	O
,	O
pegylated	B-T103
dop	B-T103
##g	I-T103
liposomes	B-T103
with	O
a	O
percentage	O
of	O
cholesterol	B-T103
of	O
10	O
-	O
20	O
%	O
are	O
the	O
optimal	B-T062
formulation	I-T062
for	O
the	O
loading	O
of	O
pna	B-T103
-	I-T103
a2	I-T103
##10	I-T103
.	O

the	O
neural	O
leg	O
##acy	O
of	O
a	O
single	O
concussion	B-T037
it	O
has	O
been	O
hypothesized	O
that	O
concussion	B-T037
##s	I-T037
impar	O
##t	O
lasting	O
brain	B-T037
damage	I-T037
,	O
even	O
after	O
a	O
patient	O
has	O
oste	O
##ns	O
##ibly	O
recovered	O
.	O
this	O
hypothesis	O
is	O
based	O
largely	O
upon	O
neuropathological	O
studies	B-T062
in	O
deceased	B-T038
athletes	B-T097
,	O
however	O
,	O
leaving	O
open	O
the	O
question	O
of	O
whether	O
it	O
can	O
be	O
detected	B-T058
in	O
vivo	O
.	O
we	O
measured	O
neural	O
responses	O
to	O
speech	B-T038
in	O
colle	B-T098
##gia	I-T098
##te	I-T098
student	I-T098
-	O
athletes	B-T097
with	O
a	O
history	O
of	O
a	O
single	O
concussion	B-T037
from	O
which	O
they	O
had	O
recovered	O
.	O
these	O
student	B-T098
-	O
athletes	B-T097
had	O
weaker	O
responses	O
to	O
speech	B-T038
than	O
age	O
-	O
and	O
position	B-T082
-	O
matched	O
peers	B-T098
.	O
this	O
group	O
difference	O
suggests	O
that	O
concussion	B-T037
##s	I-T037
eng	O
##ender	O
small	O
,	O
but	O
detectable	B-T201
,	O
changes	O
in	O
brain	O
function	O
prior	O
to	O
the	O
emergence	O
of	O
frank	O
behavioral	O
indications	O
.	O

antigen	B-T103
masking	O
during	O
fixation	B-T058
and	O
embedding	B-T058
,	O
dissected	O
antigen	B-T103
masking	O
in	O
routinely	O
processed	O
tissue	B-T017
is	O
a	O
poorly	O
understood	O
process	O
caused	O
by	O
multiple	O
factors	O
.	O
we	O
sought	O
to	O
dissect	O
the	O
effect	O
on	O
antigenicity	B-T038
of	O
each	O
step	O
of	O
processing	O
by	O
using	O
frozen	B-T017
sections	I-T017
as	O
pro	O
##x	O
##ies	O
of	O
the	O
whole	B-T017
tissue	I-T017
.	O
an	O
equivalent	O
extent	O
of	O
antigen	B-T103
masking	O
occurs	O
across	O
variable	O
fixation	B-T058
times	O
at	O
room	O
temperature	O
.	O
most	O
antigens	B-T103
benefit	O
from	O
longer	O
fixation	B-T058
times	O
(	O
>	O
24	O
hr	O
)	O
for	O
optimal	O
detection	B-T033
after	O
antigen	B-T103
retrieval	B-T058
(	O
ar	B-T058
;	O
for	O
example	O
,	O
ki	B-T103
-	I-T103
67	I-T103
,	O
bcl	O
-	O
2	O
,	O
er	O
)	O
.	O
the	O
transfer	O
to	O
a	O
graded	B-T103
alcohol	I-T103
series	O
results	O
in	O
an	O
enhanced	O
staining	B-T033
effect	I-T033
,	O
reproduced	O
by	O
treating	O
the	O
sections	B-T017
with	O
detergents	B-T103
,	O
possibly	O
because	O
of	O
a	O
better	O
access	O
of	O
the	O
polymeric	B-T103
immunohistochemical	O
detection	B-T033
system	O
to	O
tissue	B-T017
structures	B-T082
.	O
a	O
second	O
round	O
of	O
masking	O
occurs	O
upon	O
entering	O
the	O
clearing	B-T103
agent	I-T103
,	O
mostly	O
at	O
the	O
paraffin	B-T103
embedding	B-T058
step	O
.	O
this	O
may	O
depend	O
on	O
the	O
non	O
-	O
free	O
##z	O
##able	O
water	B-T103
removal	O
.	O
ar	B-T058
fully	O
reverse	O
##s	O
the	O
masking	O
due	O
both	O
to	O
the	O
fixation	B-T058
time	O
and	O
the	O
paraffin	B-T103
embedding	B-T058
.	O
ar	B-T058
itself	O
destroy	O
##s	O
some	O
epitopes	B-T103
which	O
do	O
not	O
survive	O
routine	O
processing	O
.	O
processed	O
frozen	B-T017
sections	I-T017
are	O
a	O
tool	O
to	O
investigate	O
fixation	B-T058
and	O
processing	O
requirements	O
for	O
antigens	B-T103
in	O
routine	O
specimens	O
.	O

molecular	B-T058
subtyp	I-T058
##ing	I-T058
of	O
trepon	B-T007
##ema	I-T007
pallidum	I-T007
and	O
associated	O
factors	O
of	O
sero	O
##fast	O
status	O
in	O
early	B-T038
syphilis	I-T038
patients	O
:	O
identified	O
novel	O
genotype	O
and	O
cytokine	B-T103
marker	B-T201
sero	O
##fast	O
,	O
a	O
persistent	O
nont	O
##rep	O
##one	O
##mal	O
serological	O
response	B-T201
observed	O
in	O
early	B-T038
syphilis	I-T038
patients	O
after	O
conventional	B-T058
treatment	I-T058
,	O
remains	O
a	O
concern	O
of	O
clinicians	B-T097
and	O
syphilis	B-T038
patients	O
.	O
no	O
consensus	O
has	O
been	O
established	O
,	O
however	O
,	O
that	O
defines	O
an	O
effective	O
treatment	B-T058
strategy	I-T058
and	O
clar	O
##ifies	O
the	O
pathogenesis	B-T038
.	O
in	O
this	O
study	B-T062
,	O
51	O
##7	O
patients	O
with	O
early	B-T038
syphilis	I-T038
were	O
enrolled	B-T058
and	O
treated	O
.	O
twelve	O
months	O
after	O
treatment	B-T058
,	O
79	O
.	O
3	O
%	O
(	O
410	O
/	O
51	O
##7	O
)	O
of	O
patients	O
achieved	O
serological	O
cure	O
,	O
20	O
.	O
1	O
%	O
(	O
104	O
/	O
51	O
##7	O
)	O
were	O
sero	O
##fast	O
,	O
and	O
0	O
.	O
6	O
%	O
(	O
3	O
/	O
51	O
##7	O
)	O
were	O
serological	O
failures	O
.	O
multivariate	O
analysis	O
demonstrated	O
that	O
older	B-T098
age	I-T098
(	O
>	O
40	O
years	O
)	O
and	O
lower	O
baseline	O
rp	O
##r	O
titer	O
(	O
≤	O
1	O
:	O
8	O
)	O
were	O
associated	O
with	O
sero	O
##fast	O
status	O
.	O
we	O
also	O
identified	O
21	O
t	B-T007
.	I-T007
pallidum	I-T007
molecular	B-T170
subtypes	I-T170
among	O
early	B-T038
syphilis	I-T038
patients	O
and	O
detected	O
a	O
new	O
subtype	B-T170
,	I-T170
14	I-T170
##i	I-T170
/	I-T170
a	I-T170
.	O
we	O
found	O
that	O
the	O
proportion	O
of	O
14	B-T170
##i	I-T170
/	I-T170
a	I-T170
type	I-T170
in	O
sero	O
##fast	O
patients	O
was	O
significantly	O
higher	O
than	O
that	O
in	O
patients	O
with	O
serological	O
cure	O
,	O
predicting	O
an	O
increasing	O
risk	O
of	O
sero	O
##fast	O
status	O
.	O
levels	O
of	O
chem	B-T103
##erin	I-T103
were	O
higher	O
in	O
the	O
serum	B-T031
of	O
sero	O
##fast	O
cases	O
than	O
serological	O
cure	O
cases	O
,	O
potentially	O
indicating	O
a	O
novel	O
cytokine	B-T103
marker	B-T201
for	O
sero	O
##fast	O
in	O
early	B-T038
syphilis	I-T038
patients	O
after	O
therapy	B-T058
.	O
we	O
hope	O
that	O
these	O
results	O
contribute	O
to	O
improve	B-T033
guidelines	B-T170
for	O
the	O
management	B-T058
of	O
syphilis	B-T038
patients	O
who	O
experience	O
sero	O
##fast	O
.	O

direct	B-T082
anterior	I-T082
approach	I-T082
for	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
with	O
a	O
novel	O
mobile	B-T074
traction	I-T074
table	I-T074
-	O
a	O
prospective	B-T062
cohort	I-T062
study	I-T062
the	O
purpose	O
of	O
this	O
prospective	B-T062
cohort	I-T062
study	I-T062
was	O
to	O
clarify	O
the	O
safety	O
and	O
efficacy	O
of	O
total	B-T058
hip	I-T058
arthroplasty	I-T058
via	O
the	O
direct	B-T082
anterior	I-T082
approach	I-T082
in	O
the	O
supine	B-T082
position	I-T082
with	O
a	O
novel	O
mobile	B-T074
traction	I-T074
table	I-T074
.	O
the	O
first	O
experience	O
of	O
consecutive	B-T058
surgeries	I-T058
by	O
a	O
single	B-T097
surgeon	I-T097
using	O
the	O
direct	B-T082
anterior	I-T082
approach	I-T082
with	O
a	O
traction	B-T074
table	I-T074
is	O
described	O
with	O
a	O
two	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
period	O
.	O
of	O
121	O
patients	O
,	O
100	O
patients	O
without	O
previous	B-T033
hip	I-T033
surgeries	I-T033
,	O
severe	B-T017
deformity	I-T017
,	O
or	O
cemented	B-T058
implants	I-T058
were	O
divided	O
into	O
two	O
groups	O
comprising	O
the	O
first	O
50	O
patients	O
and	O
the	O
second	O
50	O
patients	O
.	O
the	O
implant	O
survival	O
rate	O
was	O
99	O
%	O
at	O
the	O
two	O
-	O
year	O
follow	B-T058
-	I-T058
up	I-T058
.	O
revision	B-T058
surgery	I-T058
was	O
required	O
for	O
perip	B-T037
##rosthetic	I-T037
femoral	B-T037
fracture	I-T037
in	O
one	O
patient	O
.	O
the	O
complication	B-T038
rate	O
possibly	O
related	O
to	O
the	O
traction	B-T074
table	I-T074
was	O
5	O
%	O
(	O
5	O
patients	O
)	O
:	O
three	O
anterior	B-T037
dislocations	I-T037
,	O
one	O
perip	B-T037
##rosthetic	I-T037
femoral	B-T037
fracture	I-T037
,	O
and	O
one	O
intraoperative	B-T058
perforation	I-T058
caused	O
by	O
femoral	B-T037
ras	I-T037
##ping	I-T037
.	O
the	O
complication	B-T038
rate	O
tended	O
to	O
decrease	O
in	O
the	O
second	O
group	O
compared	O
to	O
the	O
first	O
group	O
(	O
4	O
%	O
versus	O
6	O
%	O
)	O
.	O
mean	O
surgical	O
time	O
(	O
72	O
.	O
0	O
minutes	O
versus	O
82	O
.	O
5	O
min	O
,	O
p	O
=	O
0	O
.	O
027	O
)	O
,	O
rate	O
of	O
allogeneic	B-T058
blood	I-T058
transfusion	I-T058
(	O
2	O
%	O
versus	O
24	O
%	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
,	O
and	O
cup	O
alignment	O
in	O
the	O
safe	O
zone	O
(	O
100	O
%	O
versus	O
88	O
%	O
,	O
p	O
=	O
0	O
.	O
027	O
)	O
were	O
significantly	O
improved	O
in	O
the	O
second	O
group	O
compared	O
to	O
the	O
first	O
group	O
.	O
the	O
direct	B-T082
anterior	I-T082
approach	I-T082
with	O
a	O
novel	O
mobile	B-T074
traction	I-T074
table	I-T074
showed	O
a	O
positive	B-T033
learning	I-T033
curve	I-T033
for	O
surgical	O
time	O
,	O
rate	O
of	O
allogeneic	B-T058
blood	I-T058
transfusion	I-T058
,	O
and	O
cup	O
alignment	O
in	O
the	O
safe	O
zone	O
.	O

gestational	O
age	O
specific	O
stillbirth	B-T033
risk	O
among	O
indigenous	O
and	O
non	O
-	O
indigenous	O
women	B-T098
in	O
queens	B-T082
##land	I-T082
,	O
australia	B-T082
:	O
a	O
population	B-T062
based	I-T062
study	I-T062
in	O
australia	B-T082
,	O
significant	O
disparity	O
persists	O
in	O
stillbirth	B-T033
rates	O
between	O
aboriginal	O
and	O
torr	B-T098
##es	I-T098
stra	I-T098
##it	I-T098
island	I-T098
##er	I-T098
(	O
indigenous	O
australian	O
)	O
and	O
non	O
-	O
indigenous	O
women	B-T098
.	O
diabetes	B-T038
,	O
hypertension	B-T038
,	O
ant	B-T038
##ep	I-T038
##artum	I-T038
haemorrhage	I-T038
and	O
small	B-T038
-	I-T038
for	I-T038
-	I-T038
gestational	I-T038
age	I-T038
(	O
sga	B-T038
)	O
have	O
been	O
identified	O
as	O
important	O
contributors	O
to	O
higher	O
rates	O
among	O
indigenous	O
women	B-T098
.	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
examine	O
gestational	O
age	O
specific	O
risk	O
of	O
stillbirth	B-T033
associated	O
with	O
these	O
conditions	O
among	O
indigenous	O
and	O
non	O
-	O
indigenous	O
women	B-T098
.	O
retrospective	O
population	B-T062
-	I-T062
based	I-T062
study	I-T062
of	O
all	O
singleton	O
births	O
of	O
at	O
least	O
20	O
weeks	O
gestation	B-T038
or	O
at	O
least	O
400	O
gram	O
##s	O
birthweight	O
in	O
queens	B-T082
##land	I-T082
between	O
july	O
2005	O
and	O
december	O
2011	O
using	O
data	O
from	O
the	O
queens	B-T082
##land	I-T082
perinatal	O
data	B-T062
collection	I-T062
,	O
which	O
is	O
a	O
routinely	B-T170
-	I-T170
maintained	I-T170
database	I-T170
that	O
collect	O
##s	O
data	O
on	O
all	O
births	O
in	O
queens	B-T082
##land	I-T082
.	O
multivariate	B-T062
logistic	I-T062
regression	I-T062
was	O
used	O
to	O
calculate	O
adjusted	O
odds	O
ratios	O
(	O
aor	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
,	O
adjusting	O
for	O
maternal	B-T033
demographic	O
and	O
pregnancy	B-T033
factors	I-T033
.	O
of	O
360	O
##98	O
##7	O
births	O
analysed	B-T062
,	O
202	O
##73	O
(	O
5	O
.	O
6	O
%	O
)	O
were	O
to	O
indigenous	O
women	B-T098
and	O
340	O
##71	O
##4	O
(	O
94	O
.	O
4	O
%	O
)	O
were	O
to	O
non	O
-	O
indigenous	O
women	B-T098
.	O
stillbirth	B-T033
rates	O
were	O
7	O
.	O
9	O
(	O
95	O
%	O
ci	O
6	O
.	O
8	O
-	O
9	O
.	O
2	O
)	O
and	O
4	O
.	O
1	O
(	O
95	O
%	O
ci	O
3	O
.	O
9	O
-	O
4	O
.	O
3	O
)	O
per	O
1000	O
births	O
,	O
respectively	O
.	O
for	O
both	O
indigenous	O
and	O
non	O
-	O
indigenous	O
women	B-T098
across	O
most	O
gestational	O
age	O
groups	O
,	O
ant	B-T038
##ep	I-T038
##artum	I-T038
haemorrhage	I-T038
,	O
sga	B-T038
,	O
pre	O
-	O
existing	O
diabetes	O
and	O
pre	O
-	O
existing	O
hypertension	O
were	O
associated	O
with	O
increased	O
risk	O
of	O
stillbirth	B-T033
.	O
there	O
were	O
mixed	O
results	O
for	O
pre	B-T038
-	I-T038
eclampsia	I-T038
and	O
eclampsia	B-T038
and	O
a	O
consistently	O
raised	O
risk	O
of	O
stillbirth	B-T033
was	O
not	O
seen	O
for	O
gestational	B-T038
diabetes	I-T038
.	O
this	O
study	B-T062
highlights	O
gestational	O
age	O
specific	O
stillbirth	B-T033
risk	O
for	O
indigenous	O
and	O
non	O
-	O
indigenous	O
women	B-T098
;	O
and	O
disparity	O
in	O
risk	O
at	O
term	B-T038
gestation	I-T038
##s	I-T038
.	O
improving	O
access	O
to	O
and	O
utilisation	O
of	O
appropriate	O
and	O
responsive	O
healthcare	B-T058
may	O
help	O
to	O
address	O
disparities	O
in	O
stillbirth	B-T033
risk	O
for	O
indigenous	O
women	B-T098
.	O

the	O
maternal	B-T033
leg	O
##acy	O
:	O
female	O
identity	O
predicts	O
offspring	O
sex	O
ratio	O
in	O
the	O
log	B-T204
##ger	I-T204
##head	I-T204
sea	I-T204
tur	I-T204
##tle	I-T204
in	O
organisms	O
with	O
temperature	O
-	O
dependent	O
sex	B-T038
determination	I-T038
,	O
the	O
incubation	B-T082
environment	I-T082
plays	O
a	O
key	O
role	O
in	O
determining	O
offspring	O
sex	O
ratios	O
.	O
given	O
that	O
global	O
temperatures	O
have	O
warm	O
##ed	O
approximately	O
0	O
.	O
6	O
°c	O
in	O
the	O
last	O
century	O
,	O
it	O
is	O
necessary	O
to	O
consider	O
how	O
organisms	O
will	O
adjust	B-T033
to	O
climate	O
change	O
.	O
to	O
better	O
understand	O
the	O
degree	O
to	O
which	O
mothers	O
influence	O
the	O
sex	O
ratios	O
of	O
their	O
offspring	O
,	O
we	O
use	O
24	O
years	O
of	O
nestin	O
##g	O
data	O
for	O
individual	B-T098
female	O
log	B-T204
##ger	I-T204
##head	I-T204
sea	I-T204
tur	I-T204
##tles	I-T204
(	O
care	B-T204
##tt	I-T204
##a	I-T204
care	I-T204
##tt	I-T204
##a	I-T204
)	O
observed	O
on	O
bal	B-T082
##d	I-T082
head	I-T082
island	I-T082
,	O
north	B-T082
carolina	I-T082
.	O
we	O
find	O
that	O
maternal	B-T033
identity	O
is	O
the	O
best	O
predictor	O
of	O
nest	O
sex	O
ratio	O
in	O
univariate	O
and	O
multivariate	B-T062
predictive	I-T062
models	I-T062
.	O
we	O
find	O
significant	O
variability	O
in	O
estimated	O
nest	O
sex	O
ratios	O
among	O
mothers	O
,	O
but	O
a	O
high	O
degree	O
of	O
consistency	O
within	O
mothers	O
,	O
despite	O
substantial	O
spatial	O
and	O
temporal	O
thermal	O
variation	O
.	O
our	O
results	O
suggest	O
that	O
individual	B-T098
differences	O
in	O
nestin	O
##g	O
preferences	O
are	O
the	O
main	O
driver	O
behind	O
divergence	B-T082
##s	I-T082
in	O
nest	O
sex	O
ratios	O
.	O
as	O
such	O
,	O
a	O
female	O
'	O
s	O
ability	O
to	O
plastic	O
##ally	O
adjust	O
her	O
nest	O
sex	O
ratios	O
in	O
response	O
to	O
environmental	B-T082
conditions	O
is	O
constrained	O
,	O
potentially	O
limiting	O
how	O
individuals	B-T098
behavioral	O
##ly	O
mitigate	O
the	O
effects	O
of	O
environmental	O
change	O
.	O
given	O
that	O
many	O
log	B-T204
##ger	I-T204
##head	I-T204
populations	B-T098
already	O
show	O
female	O
-	O
biased	O
offspring	O
sex	O
ratios	O
,	O
understanding	O
maternal	O
behavioral	O
responses	O
is	O
critical	O
for	O
predicting	O
the	O
future	O
of	O
long	O
-	O
lived	O
species	B-T170
vulnerable	O
to	O
extinction	O
.	O

interaction	O
of	O
lifestyle	O
,	O
behaviour	O
or	O
systemic	B-T038
diseases	I-T038
with	O
dental	B-T038
caries	I-T038
and	O
periodontal	B-T038
diseases	I-T038
:	O
consensus	B-T097
report	I-T097
of	I-T097
group	I-T097
2	I-T097
of	I-T097
the	I-T097
joint	I-T097
ef	I-T097
##p	I-T097
/	I-T097
or	I-T097
##ca	I-T097
workshop	I-T097
on	O
the	O
boundaries	O
between	O
caries	B-T038
and	O
periodontal	B-T038
diseases	I-T038
periodontal	B-T038
diseases	I-T038
and	O
dental	B-T038
caries	I-T038
are	O
the	O
most	O
common	B-T038
diseases	I-T038
of	O
humans	O
and	O
the	O
main	O
cause	O
of	O
tooth	B-T017
loss	I-T017
.	O
both	O
diseases	B-T038
can	O
lead	O
to	O
nutritional	O
compromise	O
and	O
negative	O
impacts	O
upon	O
self	B-T038
-	I-T038
esteem	I-T038
and	O
quality	O
of	O
life	O
.	O
as	O
complex	B-T038
chronic	I-T038
diseases	I-T038
,	O
they	O
share	O
common	B-T033
risk	I-T033
factors	I-T033
,	O
such	O
as	O
a	O
requirement	O
for	O
a	O
pathogenic	O
plaque	O
biofilm	O
,	O
yet	O
they	O
exhibit	O
distinct	B-T038
pathophys	I-T038
##iol	I-T038
##og	I-T038
##ies	I-T038
.	O
multiple	O
exposures	O
contribute	O
to	O
their	O
causal	O
pathways	O
,	O
and	O
susceptibility	B-T201
involves	I-T201
risk	B-T033
factors	I-T033
that	O
are	O
inherited	O
(	O
e	O
.	O
g	O
.	O
genetic	O
variants	O
)	O
,	O
and	O
those	O
that	O
are	O
acquired	O
(	O
e	O
.	O
g	O
.	O
socio	O
-	O
economic	O
factors	O
,	O
biofilm	B-T007
load	O
or	O
composition	O
,	O
smoking	O
,	O
carbohydrate	B-T201
intake	I-T201
)	O
.	O
identification	O
of	O
these	O
factors	O
is	O
crucial	O
in	O
the	O
prevention	O
of	O
both	O
diseases	O
as	O
well	O
as	O
in	O
their	B-T058
management	I-T058
.	O
to	O
systematically	O
appra	O
##ise	O
the	O
scientific	B-T170
literature	I-T170
to	O
identify	O
potential	B-T033
risk	I-T033
factors	I-T033
for	O
caries	B-T038
and	O
periodontal	B-T038
diseases	I-T038
.	O
one	O
systematic	B-T170
review	I-T170
(	O
genetic	O
risk	O
factors	O
)	O
,	O
one	O
narrative	O
review	O
(	O
role	B-T062
of	I-T062
diet	I-T062
and	I-T062
nutrition	I-T062
)	O
and	O
reference	B-T170
documentation	I-T170
for	O
modifiable	B-T033
acquired	I-T033
risk	I-T033
factors	I-T033
common	O
to	O
both	O
disease	O
groups	O
,	O
formed	O
the	O
basis	O
of	O
the	O
report	O
.	O
there	O
is	O
moderately	O
strong	O
evidence	O
for	O
a	O
genetic	B-T033
contribution	I-T033
to	O
periodontal	B-T038
diseases	I-T038
and	O
caries	O
susceptibility	O
,	O
with	O
an	O
attributable	O
risk	O
estimated	O
to	O
be	O
up	O
to	O
50	O
%	O
.	O
the	O
genetics	O
literature	O
for	O
periodontal	B-T038
disease	I-T038
is	O
more	O
substantial	O
than	O
for	O
caries	B-T038
and	O
genes	B-T017
associated	O
with	O
chronic	B-T038
periodontitis	I-T038
are	O
the	O
vitamin	B-T017
d	I-T017
receptor	I-T017
(	O
vdr	B-T017
)	O
,	O
fc	B-T017
gamma	I-T017
receptor	I-T017
iia	I-T017
(	O
fc	B-T017
-	I-T017
γ	I-T017
##ri	I-T017
##ia	I-T017
)	O
and	O
interleukin	B-T017
10	I-T017
(	I-T017
il	B-T017
##10	I-T017
)	I-T017
genes	I-T017
.	O
for	O
caries	B-T038
,	O
genes	B-T017
involved	O
in	O
enamel	B-T033
formation	I-T033
(	O
amel	B-T017
##x	I-T017
,	O
amb	B-T017
##n	I-T017
,	O
en	B-T017
##am	I-T017
,	O
tu	B-T103
##ft	I-T103
,	O
mmp	B-T017
##20	I-T017
,	O
and	O
kl	B-T017
##k	I-T017
##4	I-T017
)	O
,	O
salivary	O
characteristics	O
(	O
aqp	B-T017
##5	I-T017
)	O
,	O
immune	B-T038
regulation	I-T038
and	O
dietary	O
preferences	O
had	O
the	O
largest	O
impact	O
.	O
no	O
common	O
genetic	O
variants	O
were	O
found	O
.	O
ferment	B-T103
##able	I-T103
carbohydrates	I-T103
(	O
sugars	O
and	O
starch	O
##es	O
)	O
were	O
the	O
most	O
relevant	O
common	O
dietary	O
risk	O
factor	O
for	O
both	O
diseases	O
,	O
but	O
associated	O
mechanisms	O
differed	O
.	O
in	O
caries	B-T038
,	O
the	O
fermentation	B-T038
process	I-T038
leads	O
to	O
acid	O
production	O
and	O
the	O
generation	B-T038
of	I-T038
biofilm	I-T038
components	O
such	O
as	O
glucan	B-T103
##s	I-T103
.	O
in	O
periodontitis	B-T038
,	O
glyc	B-T033
##aemia	I-T033
drives	I-T033
oxidative	B-T038
stress	I-T038
and	O
advanced	O
glycation	O
end	O
-	O
products	O
may	O
also	O
trigger	O
a	O
hyper	B-T038
inflammatory	I-T038
state	O
.	O
micronutrient	B-T038
deficiencies	I-T038
,	O
such	O
as	O
for	O
vitamin	B-T103
c	I-T103
,	O
vitamin	B-T103
d	I-T103
or	O
vitamin	B-T103
b12	I-T103
,	O
may	O
be	O
related	O
to	O
the	O
onset	O
and	O
progression	B-T038
of	I-T038
both	I-T038
diseases	I-T038
.	O
functional	B-T168
foods	I-T168
or	O
probiotics	B-T007
could	O
be	O
helpful	O
in	O
caries	B-T058
prevention	I-T058
and	O
periodontal	B-T038
disease	I-T038
management	B-T058
,	O
although	O
evidence	O
is	O
limited	O
and	O
biological	O
mechanisms	O
not	O
fully	O
elucidated	O
.	O
hypo	B-T033
##sa	I-T033
##li	I-T033
##vation	I-T033
,	O
rheumatoid	B-T038
arthritis	I-T038
,	O
smoking	B-T033
/	I-T033
tobacco	I-T033
use	I-T033
,	O
undiagnosed	B-T033
or	O
sub	B-T033
-	I-T033
optimally	I-T033
controlled	I-T033
diabetes	B-T038
and	O
obesity	B-T038
are	O
common	O
acquired	O
risk	B-T033
factors	I-T033
for	O
both	O
caries	B-T038
and	O
periodontal	B-T038
diseases	I-T038
.	O

bi	B-T103
-	I-T103
layered	I-T103
constructs	I-T103
of	O
poly	B-T103
(	I-T103
glycerol	I-T103
-	I-T103
seb	I-T103
##aca	I-T103
##te	I-T103
)	I-T103
-	O
β	B-T103
-	I-T103
tric	I-T103
##alc	I-T103
##ium	I-T103
phosphate	I-T103
for	O
bone	O
-	O
soft	O
tissue	O
interface	O
applications	O
this	O
study	B-T062
aims	O
to	O
establish	O
a	O
facile	O
protocol	B-T170
for	O
the	O
preparation	O
of	O
a	O
bi	O
-	O
layered	O
poly	B-T103
(	I-T103
glycerol	I-T103
-	I-T103
seb	I-T103
##aca	I-T103
##te	I-T103
)	I-T103
(	O
pgs	B-T103
)	O
/	O
β	B-T103
-	I-T103
tric	I-T103
##alc	I-T103
##ium	I-T103
phosphate	I-T103
(	O
β	B-T103
-	I-T103
tcp	I-T103
)	O
construct	B-T103
and	O
to	O
investigate	O
its	O
potential	O
for	O
bone	O
-	O
soft	O
tissue	O
engineering	B-T058
applications	O
.	O
the	O
layered	B-T082
structure	I-T082
was	O
prepared	O
by	O
distrib	O
##uting	O
the	O
ceramic	O
particles	B-T103
within	O
a	O
prep	B-T103
##olymer	I-T103
synthesized	O
in	O
a	O
microwave	O
reactor	O
followed	O
by	O
a	O
cross	O
-	O
linking	O
of	O
the	O
final	O
construct	B-T103
in	O
vacuum	O
(	O
<	O
10	O
##mb	O
##ar	O
)	O
.	O
the	O
vacuum	O
stage	O
led	O
to	O
the	O
separation	O
of	O
cross	O
-	O
linked	O
elast	B-T103
##omer	I-T103
(	O
top	B-T082
)	O
and	O
ceramic	O
(	O
bottom	B-T082
)	O
phases	O
.	O
results	O
showed	O
that	O
addition	O
of	O
β	B-T103
-	I-T103
tcp	I-T103
particles	B-T103
to	O
the	O
elast	B-T103
##omer	I-T103
matrix	I-T103
after	O
the	O
polymerization	O
led	O
to	O
an	O
increase	O
in	O
compression	O
strength	O
(	O
up	O
to	O
14	O
##±2	O
.	O
3m	O
##pa	O
)	O
.	O
tensile	O
strength	O
(	O
σ	O
)	O
,	O
young	O
'	O
s	O
modulus	O
(	O
e	O
)	O
,	O
and	O
elongation	O
at	O
break	O
(	O
%	O
)	O
values	O
were	O
calculated	O
as	O
0	O
.	O
29	O
##±0	O
.	O
03	O
##mp	O
##a	O
and	O
0	O
.	O
21	O
##±0	O
.	O
03	O
;	O
0	O
.	O
38	O
##±0	O
.	O
02	O
and	O
1	O
.	O
95	O
##±0	O
.	O
4	O
;	O
and	O
240	O
##±5	O
##0	O
%	O
and	O
24	O
##±2	O
%	O
for	O
pgs	B-T103
and	O
pgs	B-T103
/	O
β	B-T103
-	I-T103
tcp	I-T103
bi	B-T103
-	I-T103
layered	I-T103
constructs	I-T103
,	O
respectively	O
.	O
morphology	B-T082
was	O
characterized	O
by	O
using	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
(	O
sem	B-T058
)	O
and	O
micro	B-T058
-	I-T058
computed	I-T058
tomography	I-T058
(	O
μ	B-T058
-	I-T058
ct	I-T058
)	O
.	O
tomography	B-T058
data	O
revealed	O
an	O
open	O
porosity	O
of	O
35	O
%	O
for	O
the	O
construct	B-T103
,	O
mostly	O
contributed	O
from	O
the	O
ceramic	O
phase	O
since	O
the	O
elast	B-T103
##omer	I-T103
side	B-T082
has	O
no	O
pore	O
.	O
homogeneous	O
β	B-T103
-	I-T103
tcp	I-T103
distribution	O
within	O
the	O
elast	B-T082
##omeric	I-T082
structure	I-T082
was	O
observed	O
.	O
cell	O
culture	O
studies	O
confirmed	O
biocompatibility	O
with	O
poor	O
elast	B-T103
##omer	I-T103
-	O
side	B-T082
and	O
good	O
bone	B-T017
-	O
side	B-T082
cell	B-T017
attachment	I-T017
.	O
in	O
a	O
further	O
study	O
to	O
investigate	O
the	O
osteogenic	B-T017
properties	O
,	O
the	O
construct	B-T103
were	O
loaded	O
with	O
bmp	B-T103
-	I-T103
2	I-T103
and	O
/	O
or	O
tgf	B-T103
-	I-T103
β1	I-T103
.	O
the	O
pgs	B-T103
/	O
β	B-T103
-	I-T103
tcp	I-T103
bi	B-T103
-	I-T103
layered	I-T103
constructs	I-T103
with	O
improved	O
mechanical	O
and	O
biological	O
properties	O
have	O
the	O
potential	O
to	O
be	O
used	O
in	O
bone	O
-	O
soft	O
tissue	O
interface	O
applications	O
where	O
soft	B-T017
tissue	I-T017
penetration	O
is	O
a	O
problem	B-T033
.	O

trans	B-T082
-	I-T082
oral	I-T082
fine	O
needle	O
aspiration	O
cytology	O
in	O
cervical	B-T017
(	I-T017
c1	I-T017
and	I-T017
c2	I-T017
)	I-T017
vertebral	I-T017
lesions	B-T033
:	O
a	O
novel	O
diagnostic	B-T058
approach	I-T058
fine	O
needle	O
aspiration	O
(	O
fna	O
)	O
cytology	O
is	O
a	O
relatively	O
non	O
-	O
invasive	O
method	O
for	O
diagnosing	B-T033
both	O
superficial	B-T033
and	O
deep	B-T038
-	I-T038
seated	I-T038
neoplastic	I-T038
and	O
non	B-T033
-	I-T033
neoplastic	I-T033
lesions	I-T033
.	O
in	O
this	O
study	O
,	O
we	O
evaluated	O
the	O
diagnostic	O
utility	O
of	O
trans	B-T082
-	I-T082
oral	I-T082
fna	O
in	O
cervical	B-T017
(	I-T017
c1	I-T017
and	I-T017
c2	I-T017
)	I-T017
vertebral	I-T017
and	O
para	B-T082
##vertebral	I-T082
lesions	B-T033
.	O
eighteen	O
fna	O
cases	O
of	O
cervical	B-T017
vertebral	I-T017
and	O
para	B-T082
##vertebral	I-T082
lesions	B-T033
performed	O
by	O
a	O
trans	B-T082
-	I-T082
oral	I-T082
route	I-T082
without	O
any	O
image	O
-	O
guidance	O
between	O
1995	O
and	O
2014	O
were	O
retrieved	O
from	O
the	O
arch	O
##ives	O
of	O
the	O
cytology	B-T091
department	B-T092
at	O
pg	B-T092
##imer	I-T092
,	O
cha	O
##nd	O
##ig	O
##ar	O
##h	O
and	O
reviewed	O
.	O
out	O
of	O
18	O
cases	O
,	O
a	O
definite	O
diagnosis	B-T033
was	O
given	O
in	O
15	O
cases	O
(	O
83	O
.	O
3	O
%	O
)	O
.	O
the	O
commonest	O
diagnosis	B-T033
seen	O
was	O
granulomatous	B-T038
inflammation	I-T038
consistent	O
with	O
tuberculosis	B-T038
(	O
33	O
.	O
3	O
%	O
)	O
.	O
trans	B-T082
-	I-T082
oral	I-T082
fna	O
is	O
a	O
quick	O
,	O
inexpensive	O
and	O
relatively	O
safe	O
outpatient	B-T058
procedure	I-T058
for	O
sampling	O
c1	B-T017
and	I-T017
c2	I-T017
vertebral	I-T017
and	O
para	B-T082
##vertebral	I-T082
lesions	B-T033
,	O
which	O
are	O
clinically	O
and	O
radiologically	B-T091
difficult	O
to	O
approach	O
.	O
it	O
helps	O
in	O
the	O
early	B-T058
diagnosis	I-T058
and	O
management	B-T058
of	I-T058
these	I-T058
patients	I-T058
.	O

similar	O
patterns	B-T082
of	O
neural	O
activity	O
predict	O
memory	B-T038
function	I-T038
during	O
encoding	B-T038
and	O
retrieval	O
neural	B-T017
networks	I-T017
that	O
span	O
the	O
medial	B-T017
temporal	I-T017
lobe	I-T017
(	O
mt	B-T017
##l	I-T017
)	O
,	O
prefrontal	B-T017
cortex	I-T017
,	O
and	O
posterior	B-T017
cortical	I-T017
regions	I-T017
are	O
essential	O
to	O
episodic	B-T038
memory	I-T038
function	I-T038
in	O
humans	B-T204
.	O
encoding	B-T038
and	O
retrieval	O
are	O
supported	O
by	O
the	O
engagement	O
of	O
both	O
distinct	O
neural	B-T017
pathways	I-T017
across	O
the	O
cortex	B-T017
and	O
common	O
structures	B-T082
within	O
the	O
medial	B-T017
temporal	I-T017
lobes	I-T017
.	O
however	O
,	O
the	O
degree	O
to	O
which	O
memory	B-T038
performance	I-T038
can	O
be	O
determined	O
by	O
neural	O
processing	O
that	O
is	O
common	O
to	O
encoding	B-T038
and	O
retrieval	O
remains	O
to	O
be	O
determined	O
.	O
to	O
identify	O
neural	O
signatures	O
of	O
successful	O
memory	B-T038
function	I-T038
,	O
we	O
administered	O
a	O
delayed	O
free	O
-	O
recall	O
task	O
to	O
187	O
neurosurgical	B-T058
patients	O
implanted	B-T058
with	O
subdural	B-T082
or	O
intrap	B-T017
##are	I-T017
##nc	I-T017
##hy	I-T017
##mal	I-T017
depth	B-T074
electrodes	I-T074
.	O
we	O
developed	O
multivariate	B-T170
classifiers	I-T170
to	O
identify	O
patterns	B-T082
of	O
spectral	O
power	O
across	O
the	O
brain	B-T017
that	O
independently	O
predicted	O
successful	O
episodic	B-T038
encoding	I-T038
and	O
retrieval	O
.	O
during	O
encoding	B-T038
and	O
retrieval	O
,	O
patterns	B-T082
of	O
increased	O
high	O
frequency	O
activity	O
in	O
prefrontal	B-T017
,	O
mt	B-T017
##l	I-T017
,	O
and	O
inferior	B-T017
parietal	I-T017
cortices	I-T017
,	O
accompanied	O
by	O
widespread	O
decreases	O
in	O
low	O
frequency	O
power	O
across	O
the	O
brain	B-T017
predicted	O
successful	O
memory	B-T038
function	I-T038
.	O
using	O
a	O
cross	O
-	O
decoding	O
approach	O
,	O
we	O
demonstrate	O
the	O
ability	O
to	O
predict	O
memory	B-T038
function	I-T038
across	O
distinct	O
phases	O
of	O
the	O
free	O
-	O
recall	O
task	O
.	O
furthermore	O
,	O
we	O
demonstrate	O
that	O
classifiers	B-T170
that	O
combine	O
information	O
from	O
both	O
encoding	B-T038
and	O
retrieval	O
states	O
can	O
outper	O
##form	O
task	B-T170
-	I-T170
independent	I-T170
models	I-T170
.	O
these	O
findings	O
suggest	O
that	O
the	O
engagement	O
of	O
a	O
core	O
memory	B-T038
network	I-T038
during	O
either	O
encoding	B-T038
or	O
retrieval	O
shapes	B-T082
the	O
ability	B-T033
to	I-T033
remember	I-T033
the	I-T033
past	I-T033
,	O
despite	O
distinct	O
neural	O
interactions	O
that	O
facilitate	O
encoding	B-T038
and	O
retrieval	O
.	O

tailor	B-T103
-	I-T103
made	I-T103
drug	I-T103
carrier	I-T103
:	O
comparison	O
of	O
formation	O
-	O
dependent	O
physicochemical	O
properties	O
within	O
self	O
-	O
assembled	O
aggregates	O
for	O
an	O
optimal	O
drug	B-T103
carrier	I-T103
self	O
-	O
assembled	O
surfactant	B-T103
aggregates	O
,	O
such	O
as	O
micelles	B-T103
and	O
vesicles	O
,	O
have	O
been	O
investigated	O
for	O
their	O
application	O
as	O
drug	B-T103
carriers	I-T103
in	O
the	O
treatment	B-T058
of	O
various	O
diseases	B-T038
.	O
however	O
,	O
the	O
characteristics	O
that	O
decide	O
which	O
aggregate	O
is	O
the	O
best	O
drug	B-T103
carrier	I-T103
for	O
each	O
disease	B-T038
have	O
not	O
yet	O
been	O
clarified	O
.	O
in	O
order	O
to	O
design	O
an	O
optimal	O
drug	B-T103
carrier	I-T103
for	O
each	O
disease	B-T038
,	O
various	O
kinds	O
of	O
self	O
-	O
assembled	O
aggregates	O
,	O
such	O
as	O
spherical	B-T103
micelles	I-T103
,	O
lens	O
-	O
like	O
vesicles	O
,	O
and	O
tube	O
-	O
like	O
vesicles	O
,	O
were	O
evaluated	O
by	O
[UNK]	O
multiple	O
techniques	O
[UNK]	O
including	O
dynamic	B-T058
light	I-T058
scattering	I-T058
,	O
differential	B-T058
scanning	I-T058
calorimetry	I-T058
,	O
nuclear	B-T058
magnetic	I-T058
resonance	I-T058
spectroscopy	I-T058
,	O
and	O
fluorescence	B-T058
measurement	I-T058
using	O
the	O
la	B-T103
##urd	I-T103
##an	I-T103
probe	B-T074
.	O
these	O
studies	B-T062
led	O
to	O
the	O
comp	O
##ilation	O
of	O
a	O
database	B-T170
on	O
the	O
formation	O
-	O
dependent	O
properties	O
of	O
self	O
-	O
assembled	O
aggregates	O
.	O
as	O
the	O
relationship	O
between	O
physicochemical	O
properties	O
of	O
self	O
-	O
assembled	O
aggregates	O
and	O
their	O
functions	O
as	O
drug	B-T103
carriers	I-T103
have	O
been	O
extensively	O
reported	O
,	O
this	O
database	B-T170
can	O
be	O
utilized	O
for	O
designing	O
an	O
optimal	O
drug	B-T103
carrier	I-T103
,	O
i	O
.	O
e	O
.	O
,	O
a	O
tailor	B-T103
-	I-T103
made	I-T103
drug	I-T103
carrier	I-T103
.	O

consumption	B-T038
of	I-T038
fruits	I-T038
and	I-T038
vegetables	I-T038
associated	O
with	O
other	O
risk	O
behaviors	O
among	O
adolescents	O
in	O
northeast	B-T082
brazil	I-T082
to	O
determine	O
the	O
prevalence	O
of	O
consumption	B-T038
of	I-T038
fruits	I-T038
and	I-T038
vegetables	I-T038
and	O
identify	O
the	O
association	O
with	O
low	O
level	O
of	O
physical	O
activity	O
,	O
exposure	O
to	O
sedentary	O
behavior	O
,	O
consumption	O
of	O
soft	B-T168
drinks	I-T168
and	O
overweight	B-T033
/	O
obesity	B-T038
in	O
adolescents	O
.	O
this	O
is	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
school	I-T062
-	I-T062
based	I-T062
study	I-T062
with	O
a	O
representative	O
sample	O
of	O
39	O
##92	O
students	B-T098
aged	O
14	O
-	O
19	O
years	O
from	O
the	O
state	B-T082
of	I-T082
ser	I-T082
##gi	I-T082
##pe	I-T082
,	O
brazil	B-T082
.	O
the	O
outcome	O
was	O
low	O
consumption	B-T038
of	I-T038
fruits	I-T038
and	I-T038
vegetables	I-T038
(	O
<	O
5	O
serving	O
##s	O
/	O
day	O
)	O
.	O
independent	O
variables	O
were	O
:	O
level	O
of	O
physical	O
activity	O
,	O
sedentary	O
behavior	O
,	O
consumption	O
of	O
soft	B-T168
drinks	I-T168
,	O
and	O
overweight	B-T033
/	O
obesity	B-T038
.	O
global	B-T170
student	I-T170
health	I-T170
survey	I-T170
questionnaire	I-T170
and	O
body	B-T058
mass	I-T058
and	O
height	O
measurements	O
were	O
used	O
,	O
as	O
well	O
as	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
and	O
crude	B-T062
and	I-T062
adjusted	I-T062
binary	I-T062
logistic	I-T062
regression	I-T062
.	O
the	O
significance	B-T062
level	I-T062
adopted	O
was	O
5	O
%	O
.	O
the	O
prevalence	O
of	O
inadequate	O
consumption	B-T038
of	I-T038
fruits	I-T038
and	I-T038
vegetables	I-T038
was	O
high	O
-	O
88	O
.	O
6	O
%	O
(	O
95	O
%	O
ci	O
=	O
87	O
.	O
6	O
-	O
89	O
.	O
5	O
)	O
.	O
higher	O
likelihood	O
of	O
low	O
consumption	B-T038
of	I-T038
fruits	I-T038
and	I-T038
vegetables	I-T038
was	O
verified	O
among	O
boys	O
who	O
were	O
exposed	O
to	O
sedentary	O
behavior	O
(	O
or	O
=	O
1	O
.	O
63	O
;	O
95	O
%	O
ci	O
=	O
1	O
.	O
18	O
-	O
2	O
.	O
24	O
)	O
,	O
who	O
consumed	O
soft	B-T168
drinks	I-T168
(	O
or	O
=	O
3	O
.	O
04	O
;	O
95	O
%	O
ci	O
=	O
2	O
.	O
10	O
-	O
4	O
.	O
40	O
)	O
,	O
with	O
insufficient	O
##ly	O
physical	O
activity	O
(	O
or	O
=	O
1	O
.	O
98	O
;	O
95	O
%	O
ci	O
=	O
1	O
.	O
43	O
-	O
2	O
.	O
73	O
)	O
and	O
girls	O
who	O
consumed	O
soft	B-T168
drinks	I-T168
(	O
or	O
=	O
1	O
.	O
88	O
;	O
95	O
%	O
ci	O
=	O
1	O
.	O
43	O
-	O
2	O
.	O
47	O
)	O
and	O
those	O
with	O
overweight	B-T033
/	O
obesity	B-T038
(	O
or	O
=	O
1	O
.	O
63	O
;	O
95	O
%	O
ci	O
=	O
1	O
.	O
19	O
-	O
2	O
.	O
23	O
)	O
.	O
there	O
is	O
a	O
need	O
of	O
public	O
policies	O
aimed	O
at	O
encouraging	O
the	O
consumption	O
of	O
healthy	O
foods	O
among	O
adolescents	O
.	O

forensic	O
characteristics	O
and	O
phylogenetic	B-T062
analyses	I-T062
of	O
the	O
chinese	B-T098
y	B-T098
##i	I-T098
population	I-T098
via	O
19	O
x	B-T017
-	I-T017
chromosomal	I-T017
str	B-T082
loci	B-T017
the	O
demographic	O
characteristics	O
and	O
genetic	B-T038
polymorphism	I-T038
data	O
of	O
56	O
chinese	B-T098
national	O
##ities	O
or	O
31	O
administrative	B-T092
divisions	I-T092
in	O
chinese	B-T082
mainland	I-T082
have	O
repeatedly	O
been	O
the	O
genetic	B-T062
research	I-T062
hots	B-T082
##pots	I-T082
.	O
while	O
most	O
genetic	B-T062
studies	I-T062
focused	O
on	O
some	O
particular	O
chinese	B-T098
populations	B-T098
based	O
on	O
autosomal	B-T017
or	O
y	B-T017
-	I-T017
chromosomal	I-T017
genetic	B-T038
markers	I-T038
,	O
the	O
forensic	O
characteristics	O
and	O
phylogenetic	B-T062
analyses	I-T062
of	O
the	O
seventh	O
largest	O
chinese	B-T098
population	B-T098
(	O
y	B-T098
##i	I-T098
ethnicity	I-T098
)	O
on	O
the	O
x	B-T017
-	I-T017
chromosomal	I-T017
genetic	B-T038
markers	I-T038
are	O
scarce	O
.	O
here	O
,	O
allele	O
frequencies	O
and	O
forensic	B-T033
statistical	I-T033
parameters	I-T033
for	O
19	O
x	B-T017
-	I-T017
chromosomal	I-T017
short	B-T082
tandem	I-T082
repeat	I-T082
loci	B-T017
(	O
dx	B-T017
##s	I-T017
##74	I-T017
##24	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##01	I-T017
,	O
dx	B-T017
##s	I-T017
##67	I-T017
##89	I-T017
-	I-T017
dx	I-T017
##s	I-T017
##68	I-T017
##09	I-T017
,	O
dx	B-T017
##s	I-T017
##74	I-T017
##23	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##01	I-T017
##34	I-T017
,	O
dx	B-T017
##s1	I-T017
##01	I-T017
##03	I-T017
-	I-T017
hpr	I-T017
##t	I-T017
##b	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##01	I-T017
##01	I-T017
,	O
dx	B-T017
##s1	I-T017
##01	I-T017
##59	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##01	I-T017
##62	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##01	I-T017
##64	I-T017
,	O
dx	B-T017
##s1	I-T017
##01	I-T017
##48	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##01	I-T017
##35	I-T017
-	I-T017
dx	I-T017
##s	I-T017
##83	I-T017
##78	I-T017
,	O
and	O
dx	B-T017
##s	I-T017
##71	I-T017
##32	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##00	I-T017
##79	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##00	I-T017
##74	I-T017
-	I-T017
dx	I-T017
##s1	I-T017
##00	I-T017
##75	I-T017
)	O
of	O
331	O
chinese	B-T098
y	B-T098
##i	I-T098
individuals	I-T098
were	O
obtained	O
.	O
all	O
19	O
x	B-T017
-	I-T017
chromosomal	I-T017
short	B-T082
tandem	I-T082
repeat	I-T082
(	O
str	B-T082
)	O
loci	B-T017
in	O
females	B-T098
were	O
consistent	O
with	O
the	O
hard	O
##y	O
-	O
we	O
##in	O
##berg	O
equilibrium	O
test	O
.	O
a	O
total	O
of	O
214	O
alleles	B-T017
were	O
identified	O
with	O
the	O
corresponding	O
allele	O
frequencies	O
span	O
##ned	O
from	O
0	O
.	O
001	O
##9	O
to	O
0	O
.	O
61	O
##06	O
.	O
the	O
combined	O
pe	O
,	O
pdf	O
,	O
and	O
pd	O
##m	O
were	O
0	O
.	O
999	O
##99	O
##99	O
##21	O
##4	O
,	O
0	O
.	O
999	O
##99	O
##99	O
##99	O
##99	O
##99	O
##99	O
##99	O
##99	O
##99	O
##3	O
,	O
and	O
0	O
.	O
999	O
##99	O
##99	O
##99	O
##99	O
##98	O
,	O
respectively	O
.	O
the	O
high	O
combined	O
mec	O
##k	O
##rug	O
##er	O
,	O
mec	O
##ki	O
##sh	O
##ida	O
,	O
mec	O
##des	O
##mar	O
##ai	O
##s	O
,	O
and	O
mec	O
##des	O
##mar	O
##ai	O
##s	O
du	O
##o	O
were	O
achieved	O
as	O
0	O
.	O
999	O
##99	O
##99	O
##61	O
##76	O
##38	O
,	O
0	O
.	O
999	O
##99	O
##99	O
##99	O
##99	O
##71	O
,	O
0	O
.	O
999	O
##99	O
##99	O
##99	O
##99	O
##71	O
,	O
and	O
0	O
.	O
999	O
##99	O
##99	O
##93	O
##15	O
##38	O
,	O
respectively	O
.	O
the	O
findings	B-T033
suggested	O
that	O
the	O
panel	O
of	O
19	O
x	B-T082
-	I-T082
str	I-T082
loci	B-T017
is	O
highly	O
polymorphic	O
and	O
informative	O
in	O
the	O
y	B-T098
##i	I-T098
ethnic	I-T098
population	I-T098
and	O
can	O
be	O
considered	O
to	O
be	O
a	O
powerful	O
tool	O
in	O
forensic	O
complex	O
kin	O
##sh	O
##ip	O
identification	O
.	O
population	B-T062
differentiation	I-T062
analyses	I-T062
among	O
12	O
populations	B-T098
indicated	O
that	O
significant	O
differences	O
in	O
genetic	B-T017
structure	I-T017
were	O
observed	O
in	O
between	O
the	O
y	B-T098
##i	I-T098
ethnicity	I-T098
and	O
the	O
chinese	B-T098
u	B-T098
##yg	I-T098
##hu	I-T098
##r	I-T098
as	O
well	O
as	O
ka	B-T098
##z	I-T098
##ak	I-T098
##h	I-T098
,	O
and	O
genetic	O
homogeneity	O
existed	O
in	O
similar	O
ethn	B-T098
##o	I-T098
-	I-T098
origin	I-T098
or	O
geographic	O
origin	O
populations	O
.	O

air	O
tamponade	O
of	O
the	O
heart	B-T017
pneum	B-T038
##oper	I-T038
##ica	I-T038
##rd	I-T038
##ium	I-T038
is	O
a	O
rare	B-T038
disease	I-T038
defined	O
as	O
the	O
presence	B-T033
of	O
air	O
or	O
gas	B-T103
in	O
the	O
pericardial	B-T017
sac	I-T017
.	O
among	O
the	O
etiological	O
factors	O
,	O
the	O
following	O
stand	O
out	O
:	O
chest	B-T037
trauma	I-T037
,	O
bar	B-T037
##otr	I-T037
##au	I-T037
##ma	I-T037
,	O
air	O
-	O
containing	O
fistulas	B-T017
between	O
the	O
pericardium	B-T017
and	O
the	O
surrounding	B-T082
structures	B-T082
,	O
secondary	O
gas	O
production	O
by	O
microorganisms	O
growing	O
in	O
the	O
pericardial	B-T017
sac	I-T017
,	O
and	O
iatrogenic	O
factors	O
.	O
until	O
now	O
,	O
spontaneous	O
pneum	B-T038
##oper	I-T038
##ica	I-T038
##rd	I-T038
##ium	I-T038
has	O
been	O
considered	O
a	O
harm	O
##less	O
and	O
temporary	O
state	O
,	O
but	O
a	O
review	O
of	O
clinical	O
cases	O
indicates	O
that	O
the	O
presence	B-T033
of	O
air	O
in	O
the	O
pericardium	B-T017
can	O
lead	O
to	O
cardiac	B-T038
tamponade	I-T038
and	O
life	B-T033
-	I-T033
threatening	I-T033
hemodynamic	B-T038
disturbances	O
.	O
we	O
present	B-T033
the	O
case	O
of	O
an	O
80	O
-	O
year	O
-	O
old	O
patient	O
with	O
a	O
chronic	O
bronch	B-T017
##oper	I-T017
##ica	I-T017
##rd	I-T017
##ial	I-T017
fistula	B-T017
,	O
who	O
suffered	O
from	O
a	O
cardiac	B-T038
arrest	I-T038
due	O
to	O
air	O
tamponade	O
of	O
the	O
heart	B-T017
.	O

sna	B-T103
##i1	I-T103
promotes	O
the	O
development	O
of	O
hcc	B-T038
through	O
the	O
enhancement	O
of	O
proliferation	O
and	O
inhibition	B-T038
of	I-T038
apoptosis	I-T038
sna	B-T103
##i1	I-T103
,	O
a	O
zinc	B-T103
-	I-T103
finger	I-T103
transcription	I-T103
factor	I-T103
,	O
plays	O
an	O
important	O
role	O
in	O
the	O
induction	O
of	O
epithelial	B-T038
-	I-T038
mesenchymal	I-T038
transition	I-T038
(	O
emt	B-T038
)	O
in	O
various	O
cancers	B-T038
.	O
however	O
,	O
the	O
possible	O
functions	O
of	O
sna	B-T103
##i1	I-T103
in	O
the	O
proliferation	O
and	O
apoptosis	B-T038
of	O
hepatocellular	B-T038
carcinoma	I-T038
have	O
not	O
been	O
clearly	O
identified	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
investigated	O
the	O
effects	O
and	O
mechanisms	O
of	O
sna	B-T103
##i1	I-T103
in	O
the	O
proliferation	O
and	O
apoptosis	B-T038
of	O
hepatocellular	B-T038
carcinoma	I-T038
using	O
clinical	O
samples	O
and	O
cell	B-T017
lines	I-T017
.	O
we	O
found	O
that	O
sna	B-T103
##i1	I-T103
is	O
highly	O
expressed	B-T038
in	O
the	O
tissues	B-T017
of	O
liver	B-T038
cancer	I-T038
compared	O
with	O
adjacent	O
nont	B-T017
##umor	I-T017
tissues	I-T017
.	O
sna	B-T103
##i1	I-T103
is	O
also	O
highly	O
expressed	B-T038
in	O
the	O
hepatoma	B-T017
cell	I-T017
lines	I-T017
hepg2	I-T017
,	O
sm	B-T017
##mc	I-T017
-	I-T017
77	I-T017
##21	I-T017
,	O
and	O
bel	B-T017
-	I-T017
74	I-T017
##02	I-T017
compared	O
with	O
the	O
human	B-T017
normal	I-T017
liver	I-T017
cell	I-T017
line	I-T017
l	I-T017
##02	I-T017
.	O
we	O
also	O
observed	O
that	O
sna	B-T103
##i1	I-T103
expression	B-T038
was	O
correlated	O
with	O
distal	B-T038
metastasis	I-T038
,	O
incomplete	O
tumor	B-T038
capsule	I-T038
formation	I-T038
,	O
and	O
histological	B-T201
differentiation	I-T201
in	O
hepatocellular	B-T038
carcinoma	I-T038
(	O
hcc	B-T038
)	O
.	O
moreover	O
,	O
we	O
demonstrated	O
that	O
knockdown	B-T062
of	O
sna	B-T017
##i1	I-T017
via	O
lentiviral	B-T005
vectors	B-T103
of	O
rnai	B-T038
against	O
sna	B-T103
##i	I-T103
inhibited	O
cell	O
proliferation	O
by	O
inducing	O
g1	B-T038
arrest	I-T038
,	O
which	O
was	O
accompanied	O
by	O
the	O
downregulation	B-T038
of	O
cyclin	B-T103
d1	I-T103
but	O
not	O
that	O
of	O
cyclin	B-T103
a	I-T103
.	O
in	O
addition	O
,	O
knockdown	B-T062
of	O
sna	B-T017
##i1	I-T017
promoted	O
apoptosis	B-T038
by	O
decreasing	O
the	O
expression	B-T038
of	O
bcl	B-T103
-	I-T103
2	I-T103
.	O
in	O
conclusion	O
,	O
our	O
findings	O
revealed	O
that	O
sna	B-T103
##i1	I-T103
is	O
involved	O
in	O
the	O
development	O
of	O
hepatocellular	B-T038
carcinoma	I-T038
via	O
regulating	B-T038
the	I-T038
growth	I-T038
and	O
apoptosis	B-T038
of	O
tumor	B-T017
cells	I-T017
.	O

maternal	O
vitamin	B-T103
d	I-T103
levels	O
and	O
the	O
risk	O
of	O
perinatal	B-T038
death	I-T038
to	O
determine	O
the	O
association	O
between	O
maternal	O
vitamin	B-T103
d	I-T103
levels	O
and	O
perinatal	B-T038
death	I-T038
.	O
a	O
retrospective	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
of	O
all	O
non	O
-	O
anomalous	O
,	O
singleton	O
births	B-T038
(	O
≥2	O
##4	O
weeks	O
)	O
with	O
perinatal	B-T038
death	I-T038
compared	O
to	O
a	O
matched	O
control	O
group	O
.	O
only	O
pregnancies	B-T038
with	O
a	O
recorded	O
vitamin	B-T103
d	I-T103
level	O
at	O
book	O
##ing	O
(	O
8	O
-	O
19	O
weeks	O
gestation	B-T038
)	O
were	O
included	O
for	O
analysis	B-T062
.	O
maternal	O
vitamin	B-T103
d	I-T103
levels	O
were	O
categorized	O
into	O
normal	O
,	O
deficient	O
and	O
insufficient	O
cohorts	B-T098
and	O
variables	O
compared	O
between	O
the	O
three	O
groups	B-T098
.	O
there	O
were	O
31	O
perinatal	B-T038
deaths	I-T038
which	O
were	O
compared	O
to	O
111	O
controls	O
.	O
median	O
vitamin	B-T103
d	I-T103
levels	O
were	O
lower	O
in	O
the	O
perinatal	B-T038
death	I-T038
cohort	B-T098
compared	O
to	O
the	O
control	O
group	O
(	O
55	O
nmol	O
/	O
l	O
versus	O
64	O
nmol	O
/	O
l	O
,	O
p	O
=	O
0	O
.	O
43	O
)	O
.	O
there	O
was	O
no	O
significant	O
increase	O
in	O
deaths	B-T038
between	O
the	O
normal	O
and	O
deficient	O
(	O
p	O
=	O
0	O
.	O
33	O
)	O
or	O
insufficient	O
(	O
p	O
=	O
0	O
.	O
09	O
)	O
groups	B-T098
.	O
low	O
maternal	O
vitamin	B-T103
d	I-T103
levels	O
at	O
book	O
##ing	O
were	O
not	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
perinatal	B-T038
dem	I-T038
##ise	I-T038
.	O

effects	O
of	O
morphology	O
and	O
surface	B-T103
hydroxyl	I-T103
on	O
the	O
toxicity	B-T037
of	O
bioc	B-T103
##l	I-T103
in	O
human	B-T204
hac	B-T017
##at	I-T017
cells	I-T017
recently	O
,	O
bismuth	B-T103
oxy	I-T103
##chlor	I-T103
##ide	I-T103
nanomaterials	B-T170
(	O
bioc	B-T103
##ls	I-T103
)	O
are	O
showing	O
great	O
promise	O
in	O
pollutant	B-T103
removal	O
.	O
residues	B-T103
from	O
these	O
environmental	O
remediation	O
##s	O
are	O
potential	O
hazardous	B-T103
materials	I-T103
.	O
unfortunately	O
,	O
human	B-T204
health	B-T058
risks	I-T058
of	O
bioc	B-T103
##ls	I-T103
are	O
still	O
unexplored	O
widely	O
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
focused	O
on	O
the	O
influence	O
of	O
physicochemical	O
properties	O
on	O
the	O
cytotoxicity	B-T038
of	O
bioc	B-T103
##ls	I-T103
toward	O
a	O
human	B-T204
skin	B-T022
derived	O
cell	B-T017
line	I-T017
(	O
hac	B-T017
##at	I-T017
)	O
.	O
results	O
showed	O
that	O
morphology	O
and	O
surface	B-T103
hydroxyl	I-T103
both	O
had	O
a	O
profound	O
effect	O
on	O
the	O
toxicity	B-T037
of	O
bioc	B-T103
##ls	I-T103
.	O
microsphere	B-T082
-	I-T082
shaped	I-T082
bioc	B-T103
##l	I-T103
caused	O
less	O
toxicity	B-T037
than	O
nanoshe	B-T082
##et	I-T082
-	I-T082
shaped	I-T082
bioc	B-T103
##l	I-T103
because	O
of	O
weaker	B-T038
particle	I-T038
-	I-T038
membrane	I-T038
interactions	I-T038
,	O
while	O
the	O
presence	O
of	O
surface	B-T103
hydroxyl	I-T103
on	O
microsphere	B-T082
-	I-T082
shaped	I-T082
bioc	B-T103
##l	I-T103
significantly	O
raised	O
the	O
toxicity	B-T037
owing	O
to	O
the	O
increased	O
interaction	B-T038
with	O
cell	B-T017
membrane	I-T017
.	O
both	O
microsphere	B-T082
-	I-T082
shaped	I-T082
bioc	B-T103
##l	I-T103
with	O
surface	B-T103
hydroxyl	I-T103
and	O
nanoshe	B-T082
##et	I-T082
-	I-T082
shaped	I-T082
bioc	B-T103
##l	I-T103
caused	O
significant	O
cell	B-T017
membrane	I-T017
damage	O
(	O
pi	B-T058
uptake	I-T058
and	O
ldh	B-T058
release	I-T058
)	O
,	O
however	O
,	O
based	O
on	O
the	O
different	O
mechanism	B-T038
.	O
the	O
former	O
may	O
be	O
a	O
predominant	O
[UNK]	B-T038
chemical	I-T038
[UNK]	I-T038
mechanism	I-T038
involved	O
an	O
oxidative	O
stress	O
paradigm	O
,	O
as	O
manifested	O
by	O
elevated	O
ros	B-T103
and	O
depleted	O
gsh	B-T103
,	O
while	O
the	O
latter	O
is	O
mainly	O
due	O
to	O
a	O
direct	O
[UNK]	O
physical	O
[UNK]	O
damage	O
to	O
cell	B-T017
membrane	I-T017
.	O
both	O
[UNK]	O
physical	B-T038
[UNK]	O
and	O
[UNK]	B-T038
chemical	I-T038
[UNK]	I-T038
response	I-T038
led	O
to	O
cell	B-T038
death	I-T038
.	O
furthermore	O
,	O
a	O
set	O
of	O
experiments	B-T062
including	O
mmp	B-T038
collapse	O
,	O
cell	B-T038
cycle	I-T038
arrest	I-T038
,	O
and	O
apoptosis	B-T038
/	O
necrosis	B-T038
were	O
conducted	O
to	O
propose	O
a	O
scenario	O
for	O
toxicological	O
aspects	O
of	O
bioc	B-T103
##ls	I-T103
.	O
data	O
presented	O
here	O
would	O
help	O
to	O
enable	O
the	O
rational	O
design	O
of	O
bioc	B-T103
##ls	I-T103
for	O
either	O
reducing	O
their	O
unintended	O
consequences	O
or	O
increasing	O
their	O
application	O
potentials	O
.	O

total	O
colectomy	B-T058
for	O
colon	B-T037
perforation	I-T037
after	O
ka	B-T103
##y	I-T103
##ex	I-T103
##ala	I-T103
##te	I-T103
administration	B-T058
:	O
a	O
case	O
report	O
and	O
literature	B-T170
review	I-T170
of	O
a	O
rare	O
complication	B-T038
ka	B-T103
##y	I-T103
##ex	I-T103
##ala	I-T103
##te	I-T103
is	O
an	O
ion	B-T103
exchange	I-T103
resin	I-T103
that	O
is	O
commonly	O
used	O
to	O
acutely	O
treat	B-T058
patients	O
with	O
hyperkal	B-T033
##emia	I-T033
.	O
bowel	B-T038
ulceration	I-T038
and	O
necrosis	B-T038
is	O
a	O
rare	O
and	O
uncommon	O
##ly	O
recognized	O
complication	B-T038
of	O
ka	B-T103
##y	I-T103
##ex	I-T103
##ala	I-T103
##te	I-T103
administration	B-T058
.	O
more	O
often	O
,	O
concomitant	O
administration	B-T058
with	O
sorbitol	B-T103
is	O
reported	O
to	O
damage	O
the	O
bowel	B-T017
;	O
however	O
,	O
there	O
are	O
reports	O
of	O
ka	B-T103
##y	I-T103
##ex	I-T103
##ala	I-T103
##te	I-T103
administration	B-T058
causing	O
bowel	B-T038
necrosis	I-T038
without	O
sorbitol	B-T103
.	O
we	O
present	O
a	O
case	O
of	O
a	O
critically	B-T038
ill	I-T038
patient	O
who	O
underwent	O
total	O
colectomy	B-T058
for	O
colonic	O
necrosis	O
secondary	O
to	O
oral	B-T082
ka	B-T103
##y	I-T103
##ex	I-T103
##ala	I-T103
##te	I-T103
administration	B-T058
that	O
was	O
not	O
recognized	O
until	O
late	O
in	O
the	O
pathologic	B-T038
process	I-T038
.	O
we	O
also	O
review	B-T170
the	I-T170
literature	I-T170
to	O
further	O
investigate	O
this	O
progression	B-T038
.	O

association	O
of	O
kidney	B-T038
disease	I-T038
with	O
obstructive	B-T038
sleep	I-T038
apnea	I-T038
in	O
a	O
population	B-T062
study	I-T062
of	O
men	B-T098
to	O
determine	B-T058
the	O
relationship	O
between	O
obstructive	B-T038
sleep	I-T038
apnea	I-T038
(	O
osa	B-T038
)	O
and	O
chronic	B-T038
kidney	I-T038
disease	I-T038
(	O
ckd	B-T038
)	O
.	O
previous	O
population	B-T062
studies	I-T062
of	O
the	O
association	O
are	O
sparse	O
,	O
conflicting	B-T033
and	O
confined	O
largely	O
to	O
studies	B-T062
of	O
administrative	B-T033
data	O
.	O
cross	B-T062
-	I-T062
sectional	I-T062
analysis	I-T062
in	O
unselected	O
participants	B-T098
of	O
the	O
men	O
androgens	O
inflammation	O
lifestyle	O
environment	O
and	O
stress	O
(	O
mail	O
##es	O
)	O
study	O
,	O
aged	O
>	O
40	O
y	O
.	O
renal	B-T017
data	O
were	O
available	O
on	O
81	O
##2	O
men	B-T098
without	O
a	O
prior	O
osa	B-T038
diagnosis	B-T033
who	O
underwent	O
full	O
in	B-T082
-	I-T082
home	I-T082
polysomnography	B-T058
(	O
emb	B-T074
##let	I-T074
##ta	I-T074
x	I-T074
##100	I-T074
)	O
in	O
2010	O
-	O
2011	O
.	O
ckd	B-T038
was	O
defined	O
as	O
an	O
estimated	B-T058
glomerular	I-T058
filtration	I-T058
rate	I-T058
(	O
egfr	B-T058
)	O
<	O
60	O
ml	O
/	O
min	O
/	O
1	O
.	O
73	O
##m2	O
or	O
egfr	B-T058
≥	O
##60	O
and	O
albuminuria	B-T033
(	O
albumin	O
creatinine	O
ratio	O
≥3	O
.	O
0	O
mg	O
/	O
mmol	O
)	O
.	O
ckd	B-T038
[	O
10	O
.	O
5	O
%	O
,	O
n	O
=	O
85	O
(	O
stage	O
1	O
-	O
3	O
,	O
9	O
.	O
7	O
%	O
;	O
stage	O
4	O
-	O
5	O
,	O
0	O
.	O
7	O
%	O
)	O
]	O
of	O
predominantly	O
mild	B-T033
severity	I-T033
showed	O
significant	O
association	O
s	O
with	O
osa	B-T038
(	O
[UNK]	O
)	O
:	O
odds	O
ratio	O
(	O
or	O
)	O
=	O
1	O
.	O
9	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
:	O
1	O
.	O
02	O
-	O
3	O
.	O
5	O
,	O
severe	O
osa	B-T038
(	O
ahi	O
≥3	O
##0	O
/	O
h	O
)	O
:	O
or	O
=	O
2	O
.	O
6	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
1	O
-	O
6	O
.	O
2	O
,	O
and	O
respiratory	O
related	O
arousal	B-T038
index	B-T170
:	O
≥	O
##7	O
.	O
6	O
/	O
h	O
or	O
=	O
2	O
.	O
3	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
1	O
-	O
4	O
.	O
7	O
,	O
but	O
not	O
measures	O
of	O
hypoxemia	B-T033
after	O
adjustment	O
for	O
age	O
,	O
hypertension	B-T038
,	O
diabetes	B-T038
,	O
smoking	O
,	O
obesity	B-T038
,	O
and	O
nsaid	B-T103
use	O
.	O
there	O
was	O
no	O
association	O
of	O
ckd	B-T038
with	O
daytime	B-T033
sleepiness	I-T033
.	O
in	O
men	B-T098
with	O
ckd	B-T038
,	O
those	O
with	O
osa	B-T038
were	O
not	B-T033
significantly	I-T033
more	O
likely	O
to	O
report	B-T058
symptoms	B-T033
(	O
sleepiness	B-T033
,	O
snoring	B-T033
,	O
apnea	B-T038
##s	I-T038
)	O
or	O
be	O
identified	O
with	O
the	O
stop	B-T062
osa	I-T062
screening	I-T062
questionnaire	I-T062
,	O
compared	O
to	O
men	B-T098
without	O
osa	B-T038
.	O
predominantly	O
mild	O
ckd	B-T038
is	O
associated	O
with	O
severe	O
osa	B-T038
and	O
arousal	B-T038
##s	I-T038
.	O
further	O
population	B-T062
studies	I-T062
examining	B-T033
the	O
longitudinal	B-T082
relationship	O
between	O
ckd	B-T038
and	O
osa	B-T038
are	O
warranted	O
.	O
better	O
methods	B-T170
are	O
needed	O
to	O
identify	B-T038
osa	B-T038
in	O
ckd	B-T038
which	O
may	O
have	O
few	O
symptoms	B-T033
.	O

intras	B-T038
##pin	I-T038
##al	I-T038
meningioma	I-T038
with	O
malignant	B-T038
transformation	I-T038
and	O
distant	B-T170
metastasis	I-T170
meningioma	B-T038
is	O
typically	O
considered	O
to	O
be	O
a	O
benign	B-T038
tumor	I-T038
.	O
malignant	B-T038
transformation	I-T038
and	O
metastasis	B-T038
of	O
meningiomas	B-T038
are	O
rare	O
.	O
moreover	O
,	O
most	O
meningiomas	B-T038
are	O
intracranial	B-T082
,	O
and	O
there	O
are	O
few	O
reports	B-T170
on	O
intras	B-T038
##pin	I-T038
##al	I-T038
meningiomas	I-T038
.	O
this	O
report	B-T170
aimed	O
to	O
describe	O
the	O
clinical	O
features	O
and	O
pathological	O
findings	B-T033
of	O
a	O
case	O
of	O
malignant	B-T038
transformation	I-T038
and	O
distant	B-T170
metastasis	I-T170
of	O
intras	B-T038
##pin	I-T038
##al	I-T038
meningioma	I-T038
,	O
with	O
a	O
review	O
of	O
the	O
literature	B-T170
.	O
a	O
44	O
-	O
year	O
-	O
old	O
man	B-T098
with	O
a	O
bilateral	B-T082
lower	B-T033
limb	I-T033
paresis	I-T033
was	O
diagnosed	B-T033
with	O
an	O
intrad	B-T038
##ural	I-T038
extramedullary	I-T038
tumor	I-T038
of	I-T038
the	I-T038
thoracic	I-T038
spine	I-T038
.	O
primary	O
tumor	B-T058
resection	I-T058
was	O
performed	O
,	O
and	O
the	O
histological	B-T033
findings	I-T033
revealed	O
atypical	B-T038
meningioma	I-T038
.	O
the	O
meningioma	B-T038
recurred	O
2	O
years	O
after	O
the	O
primary	O
surgery	B-T058
,	O
and	O
a	O
second	O
resection	B-T058
was	O
performed	O
,	O
but	O
only	O
partial	O
resection	B-T058
was	O
possible	O
because	O
of	O
decreased	O
motor	B-T038
evoked	I-T038
potential	I-T038
.	O
at	O
age	O
48	O
,	O
the	O
patient	O
'	O
s	O
lower	B-T033
limb	I-T033
weakness	I-T033
returned	O
,	O
and	O
a	O
third	O
resection	B-T058
was	O
performed	O
,	O
and	O
the	O
histological	B-T033
finding	I-T033
remained	O
atypical	B-T038
meningioma	I-T038
.	O
at	O
age	O
54	O
,	O
the	O
tumor	B-T038
increased	O
and	O
stereotactic	B-T058
irradiation	I-T058
was	O
performed	O
.	O
at	O
age	O
60	O
,	O
the	O
patient	O
was	O
diagnosed	B-T033
with	O
metastatic	B-T038
tumors	I-T038
of	O
the	O
rib	B-T017
,	O
lumbar	B-T017
vertebra	I-T017
,	O
cervical	B-T017
spine	I-T017
,	O
and	O
sacr	B-T017
##um	I-T017
.	O
biopsy	B-T058
of	O
the	O
rib	B-T017
metastatic	B-T038
tumor	I-T038
was	O
performed	O
,	O
and	O
the	O
histological	B-T033
findings	I-T033
revealed	O
anaplastic	B-T038
meningioma	I-T038
.	O
this	O
case	O
is	O
the	O
first	O
report	B-T170
of	O
an	O
intras	B-T038
##pin	I-T038
##al	I-T038
meningioma	I-T038
that	O
transformed	B-T038
from	O
atypical	B-T038
to	O
anaplastic	B-T038
meningioma	I-T038
with	O
distant	B-T170
hemat	B-T033
##ogenous	I-T033
metastasis	I-T170
.	O

the	O
abb	B-T062
##a	I-T062
study	I-T062
-	O
approach	O
bias	O
modification	O
in	O
bulim	B-T038
##ia	I-T038
nervosa	I-T038
and	O
binge	B-T038
eating	I-T038
disorder	I-T038
:	O
study	O
protocol	O
for	O
a	O
randomised	B-T062
controlled	I-T062
trial	I-T062
the	O
core	O
symptoms	B-T033
of	O
bulim	B-T038
##ia	I-T038
nervosa	I-T038
(	O
bn	B-T038
)	O
and	O
binge	B-T038
eating	I-T038
disorder	I-T038
(	O
bed	B-T038
)	O
are	O
recurrent	B-T033
episodes	I-T033
of	I-T033
binge	I-T033
eating	I-T033
.	O
despite	O
negative	B-T038
psychological	I-T038
and	O
physical	B-T033
consequences	I-T033
,	O
bn	B-T038
/	I-T038
bed	I-T038
patients	O
show	O
uncontrol	O
##lab	O
##le	O
approach	O
tendencies	B-T038
towards	I-T038
food	I-T038
.	O
this	O
cognitive	O
bias	O
occurs	O
at	O
an	O
early	O
stage	O
of	O
information	B-T038
processing	I-T038
.	O
cognitive	O
bias	O
modification	O
(	O
cb	O
##m	O
)	O
directly	O
targets	O
such	O
biases	O
and	O
has	O
been	O
shown	O
to	O
be	O
effective	O
in	O
treating	B-T058
several	O
mental	B-T038
disorders	I-T038
.	O
in	O
alcohol	B-T038
addiction	I-T038
,	O
automatic	O
action	O
tendencies	O
towards	O
alcohol	O
cues	O
and	O
relapse	O
rates	O
were	O
successfully	O
reduced	O
by	O
a	O
specific	O
form	O
of	O
cb	O
##m	O
,	O
termed	O
approach	O
bias	O
modification	O
.	O
based	O
on	O
these	O
findings	O
and	O
data	O
from	O
a	O
proof	B-T062
-	I-T062
of	I-T062
-	I-T062
concept	I-T062
study	I-T062
in	O
people	B-T098
with	O
high	O
levels	O
of	O
food	O
craving	O
,	O
cb	O
##m	O
is	O
considered	O
a	O
promising	O
new	O
treatment	O
approach	O
for	O
bn	B-T038
/	I-T038
bed	I-T038
.	O
given	O
the	O
similarities	O
between	O
bn	B-T038
/	I-T038
bed	I-T038
and	O
addictive	B-T038
disorders	I-T038
,	O
the	O
rationale	O
for	O
using	O
approach	O
bias	O
modification	O
appears	O
to	O
be	O
particularly	O
strong	O
.	O
the	O
aim	O
of	O
the	O
present	O
study	O
is	O
to	O
examine	O
whether	O
,	O
compared	O
to	O
a	O
sham	B-T062
training	I-T062
,	O
computer	O
##ised	O
approach	O
bias	O
modification	O
(	O
10	O
sessions	O
)	O
can	O
reduce	O
binge	B-T033
-	I-T033
eating	I-T033
episodes	I-T033
in	O
bn	B-T038
/	I-T038
bed	I-T038
patients	O
from	O
pre	O
-	O
treatment	O
to	O
follow	O
-	O
up	O
.	O
additionally	O
,	O
we	O
will	O
investigate	O
whether	O
this	O
cb	O
##m	O
programme	O
also	O
reduces	O
global	O
eating	B-T038
disorder	I-T038
psychopathology	I-T038
,	O
trait	O
and	O
cue	O
-	O
elicited	O
food	O
craving	O
,	O
food	B-T038
intake	I-T038
as	O
well	O
as	O
approach	O
and	O
attentional	B-T038
bias	I-T038
towards	O
visual	O
food	O
cues	O
.	O
treatment	O
acceptance	O
will	O
be	O
determined	O
by	O
attrition	O
rates	O
and	O
responses	B-T170
on	O
a	O
feedback	O
form	O
.	O
this	O
is	O
a	O
double	B-T062
-	I-T062
blind	I-T062
,	O
randomised	B-T062
,	O
placebo	O
-	O
controlled	O
,	O
parallel	O
-	O
group	O
superiority	O
trial	O
with	O
two	O
parallel	O
arms	O
.	O
a	O
total	O
of	O
54	O
bn	B-T038
/	I-T038
bed	I-T038
patients	O
will	O
be	O
recruited	O
.	O
approach	O
bias	O
towards	O
food	O
will	O
be	O
retr	O
##ained	O
by	O
a	O
computer	O
task	O
adopting	O
an	O
implicit	O
learning	O
paradigm	O
.	O
patients	O
in	O
the	O
control	O
condition	O
(	O
sham	B-T062
)	O
will	O
conduct	O
a	O
similar	O
task	O
but	O
will	O
not	O
be	O
trained	O
to	O
avoid	O
food	O
cues	O
.	O
methods	O
against	O
bias	O
include	O
public	B-T170
registration	I-T170
,	O
random	B-T062
##isation	I-T062
by	O
a	O
central	B-T097
study	I-T097
office	I-T097
,	O
standard	B-T062
##isation	I-T062
of	I-T062
the	I-T062
treatments	I-T062
and	O
blind	B-T062
##ing	I-T062
of	I-T062
assess	I-T062
##ors	I-T062
.	O
furthermore	O
,	O
the	O
session	O
number	O
and	O
duration	O
will	O
be	O
equivalent	O
in	O
the	O
two	O
conditions	O
.	O
this	O
is	O
the	O
first	O
registered	O
randomised	B-T062
controlled	I-T062
trial	I-T062
of	O
approach	O
bias	O
modification	O
in	O
a	O
clinical	B-T062
bn	I-T062
/	I-T062
bed	I-T062
sample	I-T062
.	O
results	O
from	O
this	O
study	O
will	O
provide	O
an	O
indication	O
of	O
the	O
efficacy	O
of	O
approach	O
bias	O
modification	O
training	O
for	O
bn	B-T038
/	I-T038
bed	I-T038
and	O
the	O
potential	O
mechanisms	O
of	O
action	O
underlying	O
this	O
treatment	B-T058
.	O
dr	O
##ks	O
##000	O
##10	O
##23	O
##1	O
(	O
retrospectively	O
registered	O
on	O
24	O
march	O
2016	O
;	O
first	O
version	O
)	O
.	O

cyclic	B-T038
thrombocytopenia	I-T038
synchron	O
##izing	O
with	O
the	O
menstrual	B-T038
cycle	I-T038
showing	O
periodic	O
phases	O
of	O
thrombocytopenia	B-T038
and	O
rebound	O
thrombocyt	B-T038
##osis	I-T038
a	O
37	O
-	O
year	O
-	O
old	O
woman	B-T098
was	O
admitted	B-T058
to	O
our	O
hospital	B-T092
for	O
purpura	B-T038
involving	O
the	O
extremities	B-T017
and	O
thrombocytopenia	B-T038
.	O
prednisolone	B-T103
(	O
ps	B-T103
##l	I-T103
)	O
was	O
administered	O
based	O
on	O
a	O
diagnosis	B-T033
of	O
idiopathic	B-T038
thrombocytopenic	I-T038
purpura	I-T038
(	O
itp	B-T038
)	O
,	O
but	O
was	O
not	O
effective	O
for	O
maintaining	O
her	O
platelet	B-T058
count	I-T058
within	O
the	O
normal	O
range	O
,	O
which	O
showed	O
cyclic	O
fluctuation	O
corresponding	O
to	O
the	O
menstrual	B-T038
cycle	I-T038
.	O
therefore	O
,	O
we	O
discontinued	B-T033
ps	B-T103
##l	I-T103
,	O
and	O
cyclic	B-T038
thrombocytopenia	I-T038
(	O
ctp	B-T038
)	O
was	O
diagnosed	B-T033
.	O
ctp	B-T038
is	O
a	O
rare	B-T038
disease	I-T038
which	O
is	O
usually	O
treated	O
as	O
itp	B-T038
but	O
with	O
no	B-T033
response	I-T033
.	O
although	O
the	O
exact	O
cause	O
of	O
ctp	B-T038
is	O
uncertain	B-T033
,	O
in	O
our	O
case	O
,	O
a	O
hormonal	O
mechanism	O
may	O
be	O
responsible	O
for	O
fluctuating	O
platelet	B-T058
count	I-T058
.	O

worldwide	B-T082
occurrence	O
of	O
mycotoxins	B-T103
in	O
cereals	B-T168
and	O
cereal	B-T168
-	O
derived	O
food	B-T168
products	I-T168
:	O
public	B-T092
health	O
perspectives	O
of	O
their	O
co	O
-	O
occurrence	O
cereal	B-T168
grains	I-T168
and	O
their	O
processed	O
food	B-T168
products	I-T168
are	O
frequently	O
contaminated	O
with	O
mycotoxins	B-T103
.	O
among	O
many	O
,	O
five	O
major	O
mycotoxins	B-T103
of	O
aflatoxin	B-T103
##s	I-T103
,	O
och	B-T103
##ra	I-T103
##to	I-T103
##xin	I-T103
##s	I-T103
,	O
fum	B-T103
##onis	I-T103
##ins	I-T103
,	O
deoxy	B-T103
##ni	I-T103
##val	I-T103
##enol	I-T103
,	O
and	O
zea	B-T103
##ral	I-T103
##enone	I-T103
are	O
of	O
significant	O
public	B-T092
health	O
concern	O
as	O
they	O
can	O
cause	O
adverse	B-T038
effects	I-T038
in	O
humans	B-T204
.	O
being	O
airborne	O
or	O
soil	O
##borne	O
,	O
the	O
cosm	O
##opol	O
##itan	O
nature	O
of	O
myc	B-T204
##otox	I-T204
##igenic	I-T204
fungi	I-T204
contribute	O
to	O
the	O
worldwide	B-T082
occurrence	O
of	O
mycotoxins	B-T103
.	O
on	O
the	O
basis	O
of	O
the	O
global	O
occurrence	O
data	O
reported	B-T058
during	O
the	O
past	O
10	O
years	O
,	O
the	O
incidences	O
and	O
maximum	O
levels	O
in	O
raw	O
cereal	B-T168
grains	I-T168
were	O
55	O
%	O
and	O
164	O
##2	O
μg	O
/	O
kg	O
for	O
aflatoxin	B-T103
##s	I-T103
,	O
29	O
%	O
and	O
116	O
##4	O
μg	O
/	O
kg	O
for	O
och	B-T103
##ra	I-T103
##to	I-T103
##xin	I-T103
a	I-T103
,	O
61	O
%	O
and	O
71	O
,	O
121	O
μg	O
/	O
kg	O
for	O
fum	B-T103
##onis	I-T103
##ins	I-T103
,	O
58	O
%	O
and	O
41	O
,	O
157	O
μg	O
/	O
kg	O
,	O
for	O
deoxy	B-T103
##ni	I-T103
##val	I-T103
##enol	I-T103
,	O
and	O
46	O
%	O
and	O
304	O
##9	O
μg	O
/	O
kg	O
for	O
zea	B-T103
##ral	I-T103
##enone	I-T103
.	O
the	O
concentrations	O
of	O
mycotoxins	B-T103
tend	O
to	O
be	O
lower	O
in	O
processed	O
food	B-T168
products	I-T168
;	O
the	O
incidences	O
varied	O
depending	O
on	O
the	O
individual	O
mycotoxins	B-T103
,	O
possibly	O
due	O
to	O
the	O
varying	O
stability	O
during	O
processing	O
and	O
distribution	O
of	O
mycotoxins	B-T103
.	O
it	O
should	O
be	O
noted	O
that	O
more	O
than	O
one	O
myc	B-T103
##otoxin	I-T103
,	O
produced	O
by	O
a	O
single	O
or	O
several	O
fungal	B-T204
species	B-T170
,	O
may	O
occur	O
in	O
various	O
combinations	O
in	O
a	O
given	O
sample	O
or	O
food	B-T168
.	O
most	O
studies	B-T062
reported	B-T058
additive	O
or	O
synergistic	O
effects	O
,	O
suggesting	O
that	O
these	O
mixtures	O
may	O
pose	O
a	O
significant	O
threat	O
to	O
public	B-T092
health	O
,	O
particularly	O
to	O
infants	O
and	O
young	O
children	O
.	O
therefore	O
,	O
information	O
on	O
the	O
co	O
-	O
occurrence	O
of	O
mycotoxins	B-T103
and	O
their	O
interactive	O
toxicity	B-T037
is	O
summarized	B-T170
in	O
this	O
paper	O
.	O

addressing	B-T170
holistic	O
health	O
and	O
work	O
empowerment	O
through	O
a	O
body	O
-	O
mind	O
-	O
spirit	O
intervention	O
program	O
among	O
helping	O
professionals	B-T097
in	O
continuous	O
education	O
:	O
a	O
pilot	B-T062
study	I-T062
to	O
examine	O
the	O
effectiveness	O
of	O
a	O
body	O
-	O
mind	O
-	O
spirit	O
(	O
bms	O
)	O
intervention	O
program	O
in	O
improving	O
the	O
holistic	O
well	O
-	O
being	O
and	O
work	O
empowerment	O
among	O
helping	O
professionals	B-T097
in	O
continuous	O
education	O
.	O
forty	O
-	O
four	O
helping	O
professionals	B-T097
,	O
who	O
were	O
in	O
their	O
first	O
-	O
year	O
part	O
-	O
time	O
postgraduate	O
study	O
,	O
participated	O
in	O
the	O
present	O
study	O
.	O
all	O
participants	B-T098
attended	O
a	O
3	O
-	O
day	O
bms	O
intervention	O
program	O
which	O
emphasized	O
a	O
holistic	O
approach	O
to	O
health	O
and	O
well	O
-	O
being	O
.	O
ratings	O
on	O
their	O
levels	O
of	O
physical	B-T033
distress	I-T033
,	O
daily	O
functioning	O
,	O
affect	B-T038
,	O
spirituality	O
,	O
and	O
psycho	O
##lo	O
##gic	O
##a	O
l	O
empowerment	O
at	O
work	O
were	O
compared	O
before	O
and	O
immediately	O
after	O
the	O
intervention	B-T058
.	O
participants	B-T098
reported	O
significantly	O
lower	O
levels	O
of	O
negative	B-T033
affect	I-T033
and	O
physical	B-T033
distress	I-T033
,	O
and	O
were	O
less	O
spiritual	B-T033
##ly	I-T033
dis	I-T033
##orient	I-T033
##ed	I-T033
after	O
the	O
intervention	B-T058
.	O
enhanced	O
levels	O
of	O
daily	O
functioning	O
,	O
positive	B-T038
affect	I-T038
,	O
spiritual	O
resilience	O
,	O
and	O
tra	B-T038
##n	I-T038
##qu	I-T038
##ility	I-T038
were	O
also	O
reported	O
.	O
results	O
also	O
suggested	O
that	O
participants	B-T098
were	O
empower	B-T038
##ed	I-T038
at	O
work	O
,	O
and	O
specifically	O
felt	O
more	O
able	O
to	O
make	O
an	O
impact	O
on	O
work	O
outcomes	O
.	O
the	O
3	O
-	O
day	O
bms	O
intervention	O
program	O
produced	O
a	O
positive	B-T033
and	O
measurable	O
eff	O
##ec	O
t	O
on	O
participants	B-T098
'	O
holistic	O
well	O
-	O
being	O
and	O
empowerment	O
at	O
work	O
.	O
educators	B-T097
in	O
related	O
fields	O
could	O
incorporate	O
holistic	O
practices	B-T038
into	O
the	O
curriculum	B-T170
to	O
better	O
prepare	O
the	O
future	O
practitioners	B-T097
,	O
leading	O
to	O
better	O
outcomes	O
both	O
to	O
the	O
professionals	B-T097
themselves	O
and	O
their	O
clients	O
or	O
patients	O
.	O

surgical	B-T058
guidance	B-T058
via	O
multiplexed	B-T058
molecular	I-T058
imaging	I-T058
of	O
fresh	O
tissues	B-T017
labeled	B-T103
with	O
sers	O
-	O
coded	O
nanoparticles	O
the	O
imaging	B-T058
of	O
dysregulated	O
cell	B-T103
-	I-T103
surface	I-T103
receptors	I-T103
(	O
or	O
biomarkers	B-T201
)	I-T201
is	O
a	O
potential	O
means	O
of	O
identifying	O
the	O
presence	B-T033
of	O
cancer	B-T038
with	O
high	O
sensitivity	O
and	O
specificity	O
.	O
however	O
,	O
due	O
to	O
heterogene	O
##ities	O
in	O
the	O
expression	B-T038
of	I-T038
protein	I-T038
biomarkers	B-T103
in	O
tumors	B-T038
,	O
molecular	B-T058
imaging	I-T058
technologies	B-T058
should	O
ideally	O
be	O
capable	O
of	O
visualizing	O
a	O
multiplexed	O
panel	O
of	O
cancer	B-T103
biomarkers	I-T103
.	O
recently	O
,	O
surface	O
-	O
enhanced	O
raman	O
-	O
scattering	O
(	O
sers	O
)	O
nanoparticles	O
(	O
nps	O
)	O
have	O
attracted	O
wide	O
interest	O
due	O
to	O
their	O
potential	O
for	O
sensitive	O
and	O
multiplexed	O
biomarker	O
detection	B-T058
.	O
in	O
this	O
review	B-T170
,	O
we	O
focus	O
on	O
the	O
most	O
recent	O
advances	O
in	O
tumor	B-T038
imaging	B-T058
using	O
sers	O
-	O
coded	O
nps	O
.	O
a	O
brief	O
introduction	O
of	O
the	O
structure	B-T082
and	O
optical	O
properties	O
of	O
sers	O
nps	O
is	O
provided	O
,	O
followed	O
by	O
a	O
detailed	O
discussion	O
of	O
key	O
imaging	B-T058
issues	O
such	O
as	O
the	O
administration	O
of	O
nps	O
in	O
tissue	B-T017
(	O
topical	B-T082
versus	O
systemic	O
)	O
,	O
the	O
optical	O
configuration	O
and	O
imaging	B-T058
approach	O
of	O
raman	B-T058
imaging	I-T058
systems	I-T058
,	O
spectral	B-T058
dem	I-T058
##ult	I-T058
##ipl	I-T058
##exin	I-T058
##g	I-T058
methods	I-T058
for	O
quantifying	O
np	O
concentrations	O
,	O
and	O
the	O
dis	O
##amb	O
##ig	O
##uation	O
of	O
specific	O
vs	O
.	O
nonspecific	O
sources	O
of	O
contrast	O
through	O
ratio	B-T058
##met	I-T058
##ric	I-T058
imaging	I-T058
of	O
targeted	O
and	O
unt	O
##arget	O
##ed	O
(	O
control	O
)	O
np	O
pairs	O
.	O
finally	O
,	O
future	O
challenges	O
and	O
directions	O
are	O
briefly	O
outlined	O
.	O

percutaneous	B-T058
coronary	I-T058
intervention	I-T058
and	O
heart	B-T058
surgery	I-T058
learning	B-T038
needs	O
of	O
patients	O
in	O
jord	B-T082
##an	I-T082
this	O
study	O
aimed	O
to	O
identify	O
and	O
priori	O
##ti	O
##ze	O
the	O
perceived	B-T038
learning	B-T038
needs	O
of	O
patients	O
who	O
underwent	O
percutaneous	B-T058
coronary	I-T058
intervention	I-T058
or	O
open	B-T058
-	I-T058
heart	I-T058
surgery	I-T058
.	O
identifying	O
learning	B-T038
needs	O
for	O
post	B-T058
-	I-T058
cardiac	I-T058
intervention	I-T058
patients	O
is	O
essential	O
to	O
establish	O
successful	O
health	O
education	O
programmes	O
based	O
on	O
patient	O
central	B-T058
care	I-T058
.	O
a	O
descriptive	O
comparative	O
design	O
was	O
employed	O
on	O
a	O
convenience	O
sample	B-T098
of	O
260	O
patients	O
who	O
underwent	O
a	O
percutaneous	B-T058
coronary	I-T058
intervention	I-T058
and	O
105	O
patients	O
who	O
underwent	O
open	B-T058
-	I-T058
heart	I-T058
surgery	I-T058
patients	O
.	O
participants	B-T098
had	O
completed	O
the	O
patient	O
learning	B-T170
needs	I-T170
scale	I-T170
.	O
data	O
were	O
collected	O
between	O
1	O
october	O
2014	O
and	O
31	O
june	O
2015	O
.	O
patients	O
from	O
the	O
two	O
groups	O
highly	O
request	O
##ing	O
health	O
and	O
recovery	O
related	O
information	O
.	O
they	O
scored	O
all	O
learning	B-T038
need	I-T038
topics	B-T170
as	O
important	O
or	O
highly	O
important	O
for	O
them	O
.	O
the	O
top	O
priority	O
learning	B-T038
need	O
for	O
both	O
patient	O
groups	O
was	O
'	O
information	O
about	O
wound	B-T058
care	I-T058
'	O
,	O
and	O
the	O
lowest	O
priority	O
learning	B-T038
need	O
topic	B-T170
was	O
'	O
physical	O
activity	O
'	O
.	O
the	O
learning	B-T038
needs	O
of	O
both	O
groups	O
were	O
very	O
close	O
,	O
which	O
indicated	O
that	O
educational	O
secondary	O
prevention	O
programmes	O
'	O
content	O
can	O
be	O
prepared	O
in	O
a	O
unified	O
structure	O
for	O
those	O
patients	O
.	O
although	O
,	O
specific	O
head	B-T170
##ings	I-T170
can	O
be	O
used	O
to	O
address	O
the	O
unique	O
needs	O
that	O
emerge	O
from	O
having	O
a	O
specific	O
cardiac	B-T017
interventional	B-T058
procedure	I-T058
.	O
the	O
fact	O
that	O
wound	B-T058
care	I-T058
and	O
medications	B-T058
are	O
areas	O
of	O
highest	O
learning	B-T038
needs	O
for	O
patients	O
requires	O
health	B-T170
policy	I-T170
decision	B-T097
makers	I-T097
to	O
address	O
these	O
topics	B-T170
at	O
the	O
time	O
of	O
hospital	B-T058
discharge	I-T058
.	O
in	O
addition	O
,	O
a	O
policy	B-T170
focus	O
on	O
considering	O
patients	O
'	O
actual	O
learning	B-T038
needs	O
requires	O
establishment	O
and	O
manager	O
##ial	O
support	O
.	O
as	O
patients	O
'	O
learning	B-T038
needs	O
might	O
change	O
later	O
after	O
discharge	B-T058
,	O
the	O
health	B-T058
services	I-T058
should	O
be	O
proactive	O
and	O
focus	O
on	O
continuous	O
support	O
for	O
patients	O
after	O
hospital	B-T058
discharge	I-T058
.	O
secondary	O
prevention	O
programmes	O
should	O
incorporate	O
health	O
education	O
topics	B-T170
based	O
on	O
patients	O
'	O
own	O
views	O
.	O
this	O
can	O
be	O
done	O
by	O
giving	O
higher	O
priority	O
to	O
understand	O
patients	O
'	O
needs	O
,	O
put	O
much	O
more	O
effort	O
into	O
how	O
to	O
meet	O
patients	O
'	O
information	O
needs	O
and	O
to	O
create	O
a	O
more	O
engaging	O
learning	B-T038
environment	B-T082
for	O
patients	O
and	O
their	O
families	O
.	O

polymorphisms	B-T082
in	O
inflammatory	O
mediator	B-T017
genes	I-T017
and	O
risk	O
of	O
preeclampsia	B-T038
in	O
tai	O
##y	O
##uan	O
,	O
china	B-T082
excessive	O
maternal	B-T033
inflammatory	B-T038
response	I-T038
is	O
involved	O
in	O
the	O
pathogenesis	B-T038
of	O
preeclampsia	B-T038
.	O
few	O
epidemiologic	B-T062
studies	I-T062
have	O
investigated	O
the	O
associations	O
between	O
genetic	O
variations	O
in	O
the	O
inflammatory	O
mediator	B-T017
genes	I-T017
and	O
preeclampsia	B-T038
risk	O
,	O
and	O
these	O
studies	B-T062
have	O
reached	O
inconsistent	O
results	O
.	O
we	O
examined	O
31	O
single	B-T082
-	I-T082
nucleotide	I-T082
polymorphisms	I-T082
in	O
il	B-T017
-	I-T017
1a	I-T017
,	O
il	B-T017
-	I-T017
1b	I-T017
,	O
il	B-T103
-	I-T103
1r	I-T103
##1	I-T103
,	O
il	B-T103
-	I-T103
2r	I-T103
##a	I-T103
,	O
il	B-T103
-	I-T103
5	I-T103
##ra	I-T103
,	O
il	B-T017
-	I-T017
6	I-T017
,	O
il	B-T103
-	I-T103
6r	I-T103
,	O
tnf	B-T017
##s	I-T017
##f1	I-T017
##1	I-T017
,	O
tnf	B-T017
##rs	I-T017
##f1	I-T017
##1a	I-T017
,	O
il	B-T017
-	I-T017
28	I-T017
##ra	I-T017
,	O
ira	B-T017
##k	I-T017
##4	I-T017
,	O
and	O
kit	B-T017
genes	I-T017
and	O
the	O
risk	O
of	O
preeclampsia	B-T038
and	O
its	O
clinical	O
subtypes	B-T170
in	O
a	O
nested	B-T062
case	I-T062
-	I-T062
control	I-T062
study	I-T062
including	O
203	O
preeclampsia	B-T038
cases	O
and	O
233	O
controls	O
.	O
we	O
found	O
that	O
il	B-T103
-	I-T103
1r	I-T103
##1	I-T103
,	O
il	B-T103
-	I-T103
5	I-T103
##ra	I-T103
,	O
il	B-T103
-	I-T103
6r	I-T103
,	O
and	O
tnf	B-T017
##s	I-T017
##f1	I-T017
##1	I-T017
were	O
associated	O
with	O
the	O
risk	O
of	O
preeclampsia	B-T038
.	O
although	O
the	O
significant	O
associations	O
observed	O
for	O
preeclampsia	B-T038
overall	O
were	O
mainly	O
seen	O
for	O
late	O
-	O
onset	O
preeclampsia	B-T038
and	O
severe	O
preeclampsia	B-T038
,	O
il	B-T103
-	I-T103
6r	I-T103
(	O
rs22	B-T170
##29	I-T170
##23	I-T170
##8	I-T170
)	O
and	O
tnf	B-T017
##s	I-T017
##f1	I-T017
##1	I-T017
(	O
rs	B-T170
##95	I-T170
##25	I-T170
##64	I-T170
##3	I-T170
)	O
polymorphisms	B-T082
were	O
associated	O
with	O
the	O
risk	O
of	O
early	O
-	O
onset	O
preeclampsia	B-T038
.	O
tnf	B-T017
##s	I-T017
##f1	I-T017
##1	I-T017
(	O
rs22	B-T170
##00	I-T170
##28	I-T170
##7	I-T170
and	O
rs	B-T170
##21	I-T170
##48	I-T170
##0	I-T170
##72	I-T170
)	O
polymorphisms	B-T082
were	O
associated	O
with	O
risk	O
of	O
mild	O
preeclampsia	B-T038
.	O
our	O
study	B-T062
provided	O
the	O
first	O
evidence	O
that	O
genetic	O
variations	O
in	O
inflammatory	O
mediator	B-T017
genes	I-T017
il	B-T103
-	I-T103
1r	I-T103
##1	I-T103
,	O
il	B-T103
-	I-T103
6r	I-T103
,	O
tnf	B-T017
##s	I-T017
##f1	I-T017
##1	I-T017
,	O
and	O
il	B-T103
-	I-T103
5	I-T103
##ra	I-T103
were	O
associated	O
with	O
preeclampsia	B-T038
risk	O
,	O
and	O
the	O
risk	O
varied	O
by	O
preeclampsia	B-T038
subtypes	B-T170
.	O

comparison	O
and	O
outcome	O
analysis	O
of	O
patients	O
with	O
tak	B-T038
##ots	I-T038
##ub	I-T038
##o	I-T038
cardiomyopathy	I-T038
triggered	O
by	O
emotional	B-T038
stress	I-T038
or	O
physical	B-T038
stress	I-T038
background	O
:	O
previous	O
studies	O
revealed	O
that	O
tak	B-T038
##ots	I-T038
##ub	I-T038
##o	I-T038
cardiomyopathy	I-T038
(	O
tt	B-T038
##c	I-T038
)	O
is	O
triggered	O
by	O
physical	B-T038
and	O
emotional	B-T038
stresses	I-T038
.	O
this	O
study	O
was	O
performed	O
to	O
determine	O
the	O
short	O
-	O
and	O
long	O
-	O
term	O
prognostic	O
impact	O
of	O
emotional	B-T038
-	I-T038
and	O
physical	B-T038
stress	I-T038
associated	O
with	O
tt	B-T038
##c	I-T038
.	O
methods	O
and	O
results	O
:	O
our	O
institutional	B-T170
database	I-T170
constituted	O
a	O
collective	O
of	O
84	O
patients	O
diagnosed	B-T033
with	O
tt	B-T038
##c	I-T038
between	O
2003	O
and	O
2015	O
.	O
the	O
patients	O
were	O
divided	O
into	O
two	O
groups	O
as	O
per	O
the	O
presence	O
of	O
emotional	B-T038
stress	I-T038
(	O
n	O
=	O
24	O
,	O
21	O
%	O
)	O
or	O
physical	B-T038
stress	I-T038
(	O
n	O
=	O
60	O
,	O
52	O
.	O
6	O
%	O
)	O
.	O
the	O
endpoint	O
was	O
a	O
composite	O
of	O
in	B-T033
-	I-T033
hospital	I-T033
events	I-T033
(	O
thromboembolic	B-T038
events	I-T038
and	O
life	B-T033
-	I-T033
threatening	I-T033
arrhythmias	B-T033
)	O
,	O
myocardial	B-T038
infarction	I-T038
,	O
all	O
-	O
cause	O
of	O
mortality	O
,	O
re	O
-	O
hospitalization	O
due	O
to	O
heart	B-T038
failure	I-T038
,	O
stroke	B-T038
,	O
and	O
recurrence	O
of	O
tt	B-T038
##c	I-T038
.	O
a	O
kaplan	O
-	O
meier	O
analysis	O
indicated	O
a	O
significantly	O
lower	O
event	O
-	O
free	O
survival	O
rate	O
over	O
a	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
of	O
5	O
years	O
in	O
the	O
emotional	B-T038
group	O
than	O
the	O
physical	B-T038
stress	I-T038
group	O
(	O
log	O
-	O
rank	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
multivariate	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
revealed	O
only	O
emotional	B-T038
stress	I-T038
(	O
hr	O
0	O
.	O
4	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
2	O
-	O
0	O
.	O
9	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
as	O
a	O
negative	B-T033
independent	I-T033
predictor	I-T033
of	O
the	O
primary	O
endpoint	O
.	O
conclusion	O
:	O
rates	O
of	O
in	B-T033
-	I-T033
hospital	I-T033
events	I-T033
and	O
short	O
-	O
as	O
well	O
as	O
long	O
-	O
term	O
events	O
were	O
significantly	O
lower	O
in	O
tt	B-T038
##c	I-T038
patients	O
suffering	B-T038
from	O
emotional	B-T038
stress	I-T038
as	O
compared	O
to	O
patients	O
with	O
physical	B-T038
stress	I-T038
.	O

comparison	O
between	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
and	O
b	B-T058
-	I-T058
mode	I-T058
ultrasound	I-T058
in	O
detecting	B-T033
and	O
estimating	O
the	O
extent	B-T082
of	O
human	B-T204
carotid	B-T038
atherosclerosis	I-T038
in	O
mri	B-T058
studies	I-T058
of	O
carotid	B-T017
plaques	I-T017
,	O
ultrasound	B-T058
is	O
used	O
to	O
find	B-T033
plaques	B-T033
,	O
which	O
are	O
later	O
imaged	B-T170
using	O
mri	B-T058
.	O
the	O
performance	O
in	O
plaque	B-T033
detection	B-T033
has	O
not	O
been	O
compared	O
between	O
the	O
modalities	O
.	O
the	O
aim	O
of	O
the	O
current	O
study	B-T062
was	O
to	O
compare	O
the	O
performance	O
of	O
mri	B-T058
and	O
ultrasound	B-T058
in	O
detecting	B-T033
carotid	B-T017
artery	I-T017
plaques	I-T017
and	O
measuring	O
extent	B-T082
of	O
atherosclerosis	B-T038
.	O
subjects	O
with	O
at	O
least	O
one	O
plaque	B-T033
(	O
height	O
≥2	O
·	O
5	O
mm	O
)	O
on	O
ultrasound	B-T058
were	O
imaged	B-T170
using	O
mri	B-T058
.	O
the	O
number	O
of	O
plaques	B-T033
and	O
their	O
height	O
was	O
measured	O
in	O
both	O
modalities	O
;	O
plaque	B-T033
area	B-T082
and	O
volume	O
were	O
analysed	B-T062
on	O
ultrasound	B-T058
and	O
mri	B-T058
,	O
respectively	O
.	O
thirty	O
-	O
eight	O
subjects	O
were	O
included	O
.	O
mri	B-T058
detected	B-T033
plaques	B-T033
in	O
95	O
%	O
of	O
carotid	B-T017
arteries	I-T017
with	O
a	O
plaque	B-T033
height	O
of	O
≥2	O
·	O
5	O
mm	O
on	O
ultrasound	B-T058
and	O
in	O
all	O
carotid	B-T017
arteries	I-T017
with	O
a	O
plaque	B-T033
exceeding	O
2	O
·	O
5	O
mm	O
.	O
mri	B-T058
detected	B-T033
53	O
%	O
of	O
the	O
plaques	B-T033
with	O
a	O
height	O
below	O
2	O
·	O
5	O
mm	O
.	O
the	O
plaque	B-T033
height	O
measured	O
with	O
both	O
techniques	O
correlated	O
significantly	O
,	O
0	O
·	O
59	O
,	O
p	O
<	O
0	O
·	O
0001	O
.	O
ultrasound	B-T058
-	O
derived	O
plaque	B-T033
height	O
and	O
plaque	B-T033
area	B-T082
correlated	O
similarly	O
to	O
mri	B-T058
-	O
derived	O
plaque	B-T033
volume	O
,	O
r	O
=	O
0	O
·	O
52	O
;	O
p	O
<	O
0	O
·	O
0001	O
and	O
r	O
=	O
0	O
·	O
47	O
;	O
p	O
=	O
0	O
·	O
001	O
,	O
respectively	O
.	O
we	O
conclude	O
that	O
mri	B-T058
has	O
a	O
similar	O
sensitivity	O
to	O
ultrasound	B-T058
in	O
finding	B-T033
carotid	B-T017
artery	I-T017
plaques	I-T017
that	O
are	O
2	O
·	O
5	O
mm	O
or	O
higher	O
.	O
in	O
smaller	O
plaques	B-T033
,	O
mri	B-T058
detects	B-T033
fewer	O
plaques	B-T033
.	O
multiple	B-T017
carotid	I-T017
plaques	I-T017
seen	O
on	O
ultrasound	B-T058
most	O
often	O
are	O
a	O
misinterpre	O
##tation	O
of	O
the	O
anatomy	O
and	O
correspond	O
to	O
a	O
single	B-T033
plaque	I-T033
.	O
plaque	B-T033
height	O
on	O
ultrasound	B-T058
is	O
comparable	O
to	O
plaque	B-T033
height	O
on	O
mri	B-T058
and	O
correlates	O
fairly	O
well	O
with	O
plaque	B-T033
volume	O
on	O
mri	B-T058
making	O
it	O
an	O
interesting	O
proxy	O
for	O
plaque	B-T033
burden	O
.	O

emergency	O
general	O
surgery	O
specific	B-T170
frailty	I-T170
index	I-T170
:	O
a	O
validation	B-T062
study	I-T062
assessment	B-T058
of	O
operative	O
risk	O
in	O
geriatric	O
patients	O
undergoing	O
emergency	O
general	O
surgery	O
(	O
eg	O
##s	O
)	O
is	O
challenging	O
.	O
frailty	B-T033
is	O
an	O
established	O
measure	O
for	O
risk	B-T058
assessment	I-T058
in	O
surgical	O
cases	O
.	O
the	O
aim	O
of	O
our	O
study	B-T062
was	O
to	O
validate	B-T062
a	O
modified	O
15	O
variable	O
emergency	B-T058
general	I-T058
surgery	I-T058
specific	I-T058
frailty	I-T058
index	I-T058
(	O
eg	B-T058
##s	I-T058
##fi	I-T058
)	O
.	O
we	O
prospectively	O
collected	O
geriatric	O
(	O
age	O
>	O
65	O
)	O
emergency	O
general	O
surgery	O
patients	O
for	O
1	O
-	O
year	O
.	O
post	B-T038
-	I-T038
operative	I-T038
complications	I-T038
were	O
collected	O
.	O
frailty	B-T170
index	I-T170
was	O
calculated	B-T058
for	O
200	O
patients	O
based	O
on	O
their	O
pre	O
-	O
admission	O
condition	O
using	O
50	O
-	O
variable	O
modified	O
rock	B-T170
##wood	I-T170
frailty	I-T170
index	I-T170
(	O
fi	B-T170
)	O
.	O
eg	B-T058
##s	I-T058
##fi	I-T058
was	O
developed	O
based	O
on	O
the	O
regression	B-T170
model	I-T170
for	O
complications	B-T038
and	O
the	O
most	O
significant	O
factors	O
in	O
the	O
fi	B-T170
.	O
roc	O
curve	O
analysis	O
was	O
performed	O
to	O
determine	O
cutoff	O
for	O
frail	B-T033
status	O
.	O
we	O
validated	B-T062
our	O
results	O
using	O
60	O
patients	O
for	O
predicting	O
complications	B-T038
.	O
a	O
total	O
of	O
260	O
patients	O
(	O
200	O
developing	O
,	O
60	O
validation	B-T062
)	O
were	O
enrolled	B-T058
in	O
this	O
study	B-T062
.	O
mean	O
age	O
was	O
71	O
±	O
11	O
years	O
,	O
and	O
33	O
%	O
developed	O
complications	B-T038
.	O
most	O
common	O
complications	B-T038
were	O
pneumonia	B-T038
(	O
12	O
%	O
)	O
,	O
uti	B-T038
(	O
9	O
%	O
)	O
,	O
and	O
wound	B-T038
infection	I-T038
(	O
7	O
%	O
)	O
.	O
univariate	O
analysis	O
identified	O
15	O
variables	O
significantly	O
associated	O
with	O
complications	B-T038
that	O
were	O
used	O
to	O
develop	O
the	O
eg	B-T058
##s	I-T058
##fi	I-T058
.	O
a	O
cutoff	O
frailty	B-T033
score	I-T033
of	O
0	O
.	O
325	O
was	O
identified	O
using	O
roc	O
curve	O
analysis	O
for	O
frail	B-T033
status	O
.	O
sixty	O
-	O
patients	O
(	O
frail	B-T033
:	O
18	O
,	O
non	B-T033
-	I-T033
frail	I-T033
:	O
42	O
)	O
were	O
enrolled	B-T058
in	O
the	O
validation	B-T062
cohort	B-T098
.	O
frail	B-T033
patients	O
were	O
more	O
likely	O
to	O
have	O
post	B-T038
-	I-T038
operative	I-T038
complications	I-T038
(	O
47	O
%	O
vs	O
.	O
20	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
compared	O
to	O
nonf	O
##ra	O
##il	O
patients	O
.	O
frail	B-T033
status	O
based	O
on	O
eg	B-T058
##s	I-T058
##fi	I-T058
was	O
a	O
significant	O
predictor	O
of	O
post	B-T038
-	I-T038
operative	I-T038
complications	I-T038
(	O
or	O
=	O
7	O
.	O
3	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
7	O
-	O
19	O
.	O
8	O
;	O
p	O
=	O
0	O
.	O
006	O
)	O
.	O
age	O
was	O
not	O
associated	O
with	O
postoperative	B-T038
complications	I-T038
(	O
or	O
=	O
0	O
.	O
99	O
,	O
95	O
%	O
ci	O
=	O
0	O
.	O
92	O
-	O
1	O
.	O
06	O
;	O
p	O
=	O
0	O
.	O
86	O
)	O
.	O
the	O
15	O
-	O
variable	O
validated	B-T062
eg	B-T058
##s	I-T058
##fi	I-T058
is	O
a	O
simple	O
and	O
reliable	O
bedside	O
tool	O
to	O
determine	O
the	O
frailty	B-T033
status	I-T033
of	O
patients	O
undergoing	O
emergency	O
general	O
surgery	O
.	O
frail	B-T033
status	O
as	O
determined	O
by	O
abstract	O
the	O
eg	B-T058
##s	I-T058
##fi	I-T058
is	O
an	O
independent	O
predictor	O
of	O
post	B-T038
-	I-T038
operative	I-T038
complications	I-T038
and	O
mortality	O
in	O
geriatric	O
emergency	O
general	O
surgery	O
patients	O
.	O
level	O
ii	O
,	O
prognostic	B-T062
studies	I-T062
-	O
investigating	O
the	O
effect	O
of	O
a	O
patient	B-T201
characteristic	I-T201
on	O
the	O
outcome	B-T033
of	I-T033
disease	I-T033
.	O

safety	B-T058
precautions	I-T058
and	O
operating	B-T170
procedures	I-T170
in	O
an	O
(	O
a	O
)	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
laboratory	B-T092
:	O
1	O
.	O
bios	B-T170
##afe	I-T170
##ty	I-T170
level	I-T170
4	I-T170
su	B-T092
##it	I-T092
laboratory	I-T092
suite	B-T170
entry	I-T170
and	I-T170
exit	I-T170
procedures	I-T170
bios	B-T170
##afe	I-T170
##ty	I-T170
level	I-T170
4	I-T170
(	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
)	O
su	B-T092
##it	I-T092
laboratories	I-T092
are	O
specifically	O
designed	O
to	O
study	B-T062
high	O
-	O
consequence	O
pathogens	O
for	O
which	O
neither	O
infection	B-T038
prophyl	B-T058
##ax	I-T058
##es	I-T058
nor	O
treatment	B-T058
options	O
exist	O
.	O
the	O
hallmarks	O
of	O
these	O
laboratories	B-T092
are	O
:	O
custom	O
-	O
designed	O
air	O
##tig	O
##ht	O
door	O
##s	O
,	O
dedicated	O
supply	O
and	O
exhaust	O
airflow	O
systems	O
,	O
a	O
negative	O
-	O
pressure	O
environment	O
,	O
and	O
mandatory	O
use	O
of	O
positive	O
-	O
pressure	O
(	O
[UNK]	O
space	O
[UNK]	O
)	O
su	O
##its	O
.	O
the	O
risk	O
for	O
laboratory	B-T092
specialists	B-T097
working	O
with	O
highly	O
pathogenic	O
agents	O
is	O
minimized	O
through	O
rigorous	O
training	O
and	O
adherence	O
to	O
stringent	O
safety	B-T170
protocols	I-T170
and	O
standard	B-T170
operating	I-T170
procedures	I-T170
.	O
researchers	B-T097
perform	O
the	O
majority	O
of	O
their	O
work	O
in	O
bs	B-T170
##l	I-T170
-	I-T170
2	I-T170
laboratories	B-T092
and	O
switch	O
to	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
su	B-T092
##it	I-T092
laboratories	I-T092
when	O
work	O
with	O
a	O
high	O
-	O
consequence	O
pathogen	O
is	O
required	O
.	O
collab	B-T092
##ora	I-T092
##tors	I-T092
and	O
scientists	B-T097
considering	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
projects	O
should	O
be	O
aware	O
of	O
the	O
challenges	B-T033
associated	O
with	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
research	B-T062
both	O
in	O
terms	O
of	O
experimental	O
technical	O
limitations	O
in	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
laboratory	B-T092
space	B-T082
and	O
the	O
increased	O
duration	O
of	O
such	O
experiments	B-T062
.	O
tasks	O
such	O
as	O
entering	O
and	O
exit	O
##ing	O
the	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
su	B-T092
##it	I-T092
laboratories	I-T092
are	O
considerably	O
more	O
complex	O
and	O
time	O
-	O
consuming	O
compared	O
to	O
bs	B-T170
##l	I-T170
-	I-T170
2	I-T170
and	O
bs	B-T170
##l	I-T170
-	I-T170
3	I-T170
laboratories	B-T092
.	O
the	O
focus	O
of	O
this	O
particular	O
article	B-T170
is	O
to	O
address	B-T170
basic	O
bios	O
##afe	O
##ty	O
concerns	O
and	O
describe	O
the	O
entrance	B-T170
and	I-T170
exit	I-T170
procedures	I-T170
for	O
the	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
laboratory	B-T092
at	O
the	O
nih	B-T092
/	O
ni	B-T092
##aid	I-T092
integrated	O
research	O
facility	O
at	O
fort	O
detr	O
##ick	O
.	O
such	O
procedures	B-T170
include	O
checking	O
external	O
systems	O
that	O
support	O
the	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
laboratory	B-T092
,	O
and	O
insp	O
##ecting	O
and	O
don	O
##ning	O
positive	O
-	O
pressure	O
su	O
##its	O
,	O
entering	O
the	O
laboratory	B-T092
,	O
moving	O
through	O
air	O
pressure	O
-	O
resistant	O
door	O
##s	O
,	O
and	O
connecting	O
to	O
air	B-T074
-	I-T074
supply	I-T074
hos	I-T074
##es	I-T074
.	O
we	O
will	O
also	O
discuss	O
moving	B-T038
within	O
and	O
exit	O
##ing	O
the	O
bs	B-T170
##l	I-T170
-	I-T170
4	I-T170
su	B-T092
##it	I-T092
laboratories	I-T092
,	O
including	O
using	O
the	O
chemical	B-T103
show	O
##er	O
and	O
removing	O
and	O
storing	O
positive	O
-	O
pressure	O
su	O
##its	O
.	O

a	O
completely	O
calcified	O
prostate	B-T017
prostatic	B-T038
calcification	I-T038
and	O
prostatic	B-T038
calculus	I-T038
formation	O
is	O
commonly	O
seen	O
in	O
adult	O
population	B-T098
with	O
chronic	B-T038
prost	I-T038
##atitis	I-T038
,	O
however	O
,	O
gross	O
prostatic	B-T038
calcification	I-T038
which	O
involves	O
more	O
than	O
3	O
cm	O
(	O
2	O
)	O
of	O
the	O
gland	B-T017
is	O
quite	O
rare	O
.	O
we	O
are	O
presenting	O
here	O
one	O
such	O
case	O
in	O
which	O
almost	O
whole	O
glandular	B-T017
prostate	I-T017
was	O
converted	O
into	O
stone	B-T031
which	O
is	O
never	O
reported	O
so	O
far	O
.	O

the	O
correlation	O
of	O
the	O
results	O
of	O
the	O
survey	B-T170
sn	I-T170
##ot	I-T170
-	I-T170
20	I-T170
of	O
objective	O
studies	O
of	O
nasal	B-T033
obstruction	I-T033
and	O
the	O
geometry	O
of	O
the	O
nasal	B-T082
cavities	I-T082
in	O
this	O
paper	O
were	O
verified	O
the	O
correlation	O
between	O
the	O
results	O
of	O
the	O
survey	B-T170
sn	I-T170
##ot	I-T170
-	I-T170
20	I-T170
and	O
the	O
results	B-T033
of	I-T033
the	I-T033
objective	I-T033
tests	I-T033
of	O
nasal	B-T033
obstruction	I-T033
which	O
are	O
rhin	B-T058
##oman	I-T058
##ometry	I-T058
and	O
acoustic	B-T058
rhin	I-T058
##ometry	I-T058
before	O
and	O
after	O
surgical	B-T058
treatment	I-T058
,	O
such	O
as	O
sept	B-T058
##oplasty	I-T058
,	O
sept	B-T058
##ocon	I-T058
##ch	I-T058
##oplasty	I-T058
,	O
ethm	B-T058
##oide	I-T058
##ct	I-T058
##omy	I-T058
and	O
sept	B-T058
##oe	I-T058
##th	I-T058
##mo	I-T058
##ide	I-T058
##ct	I-T058
##omy	I-T058
.	O
the	O
material	O
used	O
in	O
this	O
study	O
was	O
233	O
patients	O
diagnosed	B-T033
routinely	O
in	O
the	O
rhin	B-T058
##oman	I-T058
##ometry	I-T058
laboratory	B-T092
of	O
the	O
department	B-T092
of	I-T092
otolaryng	I-T092
##ology	I-T092
at	O
the	O
medical	B-T092
university	I-T092
of	O
war	O
##sa	O
##w	O
,	O
reporting	O
rhin	B-T038
##ological	I-T038
problems	I-T038
.	O
data	O
were	O
obtained	O
from	O
70	O
women	B-T098
(	O
31	O
,	O
4	O
%	O
)	O
ranging	O
in	O
ages	O
from	O
18	O
to	O
81	O
years	O
of	O
age	O
and	O
153	O
men	B-T098
(	O
68	O
,	O
6	O
%	O
)	O
ranging	O
in	O
ages	O
from	O
16	O
to	O
81	O
years	O
of	O
age	O
.	O
the	O
researches	O
presented	O
in	O
the	O
study	O
were	O
made	O
using	O
the	O
device	O
rhin	B-T074
##ometrics	I-T074
sre	I-T074
210	I-T074
##0	I-T074
which	O
combines	O
the	O
rhin	O
##oman	O
##ometer	O
(	O
rhin	O
##ostr	O
##ea	O
##m	O
)	O
and	O
acoustic	B-T074
rhin	I-T074
##ometer	I-T074
(	O
rhin	B-T074
##osc	I-T074
##an	I-T074
)	O
inter	B-T074
##acoustic	I-T074
##s	I-T074
as	I-T074
(	O
denmark	B-T082
)	O
.	O
survey	B-T170
sn	I-T170
##ot	I-T170
-	I-T170
20	I-T170
(	O
sin	B-T170
##o	I-T170
-	I-T170
nasal	I-T170
outcome	I-T170
test	I-T170
-	I-T170
20	I-T170
)	O
in	O
polish	O
was	O
completed	O
by	O
patients	O
before	O
surgery	O
and	O
during	O
the	O
postoperative	O
control	O
visits	O
.	O
the	O
calculated	O
correlations	O
between	O
the	O
objective	B-T033
parameter	I-T033
,	O
which	O
was	O
the	O
resistance	O
to	O
the	O
flow	B-T033
of	I-T033
air	I-T033
through	I-T033
the	I-T033
nasal	I-T033
cavity	I-T033
,	O
and	O
the	O
subjective	B-T033
feelings	I-T033
of	I-T033
respondents	I-T033
expressed	O
in	O
the	O
survey	B-T170
sn	I-T170
##ot	I-T170
-	I-T170
20	I-T170
were	O
generally	O
weak	O
,	O
and	O
statistical	O
significance	O
was	O
achieved	O
with	O
respect	O
to	O
the	O
first	B-T062
question	I-T062
survey	I-T062
(	O
the	O
severity	B-T033
of	I-T033
the	I-T033
nose	I-T033
obstruction	I-T033
)	O
for	O
all	O
components	O
of	O
resistance	O
flow	O
.	O
the	O
feeling	O
of	O
nasal	B-T033
obstruction	I-T033
is	O
the	O
most	O
reproducible	O
and	O
reliable	O
complaint	O
reported	O
by	O
the	O
patient	O
with	O
rhin	B-T038
##ological	I-T038
problems	I-T038
.	O

involvement	O
of	O
apoptotic	B-T038
pathways	I-T038
in	O
docosahexaenoic	B-T103
acid	I-T103
-	O
induced	O
benefit	O
in	O
prostate	B-T038
cancer	I-T038
:	O
pathway	O
-	O
focused	O
gene	B-T062
expression	I-T062
analysis	I-T062
using	O
rt	B-T062
(	I-T062
2	I-T062
)	I-T062
profile	I-T062
pcr	I-T062
array	I-T062
system	I-T062
present	O
study	O
aimed	O
to	O
better	O
understand	O
the	O
potential	O
apoptotic	B-T038
pathways	I-T038
that	O
involved	O
in	O
docosahexaenoic	B-T103
acid	I-T103
(	O
dha	B-T103
)	O
-	O
induced	O
apoptosis	B-T038
of	O
prostate	B-T038
cancer	I-T038
cells	B-T017
.	O
human	B-T204
prostate	B-T038
cancer	I-T038
du	B-T017
##145	I-T017
cells	I-T017
were	O
treated	O
with	O
different	O
concentrations	O
of	O
fish	B-T103
oil	I-T103
,	O
omega	B-T103
-	I-T103
3	I-T103
pufa	I-T103
(	O
dha	B-T103
,	O
and	O
eicosapentaenoic	B-T103
acid	I-T103
,	O
epa	B-T103
)	O
,	O
or	O
omega	B-T103
-	I-T103
6	I-T103
pufa	I-T103
(	O
arachidonic	B-T103
acid	I-T103
,	O
aa	B-T103
)	O
.	O
cell	B-T038
viability	I-T038
and	O
apoptosis	B-T038
were	O
evaluated	O
by	O
mtt	B-T062
assay	I-T062
and	O
hoechst	O
staining	O
.	O
pathway	O
-	O
focused	O
gene	B-T058
expression	I-T058
profiling	I-T058
of	O
du	B-T017
##145	I-T017
cells	I-T017
was	O
analyzed	O
with	O
the	O
rt	O
(	O
2	O
)	O
profile	O
pcr	O
array	O
system	O
.	O
the	O
results	O
were	O
verified	O
by	O
real	B-T062
time	I-T062
quantitative	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
rt	B-T062
-	I-T062
qpcr	I-T062
)	O
.	O
aa	B-T103
exposure	O
showed	O
no	O
obvious	O
effect	O
on	O
viability	B-T038
of	O
du	B-T017
##145	I-T017
cells	I-T017
.	O
however	O
,	O
exposure	O
with	O
fish	B-T103
oil	I-T103
,	O
epa	B-T103
,	O
or	O
dha	B-T103
for	O
24	O
h	O
significantly	O
affected	O
cell	B-T038
viability	I-T038
.	O
the	O
growth	B-T038
inhibition	I-T038
of	O
dha	B-T103
was	O
more	O
pronounced	O
than	O
that	O
of	O
epa	B-T103
and	O
showed	O
a	O
time	O
-	O
dependent	O
increase	O
.	O
dha	B-T103
exposure	O
caused	O
typical	O
apoptotic	O
characteristics	O
.	O
ten	O
genes	B-T017
were	O
more	O
expressed	O
,	O
while	O
5	O
genes	B-T017
were	O
less	O
expressed	O
following	O
dha	B-T103
exposure	O
.	O
rt	B-T062
-	I-T062
qpcr	I-T062
confirmed	O
the	O
time	O
dependent	O
effect	O
of	O
dha	B-T103
on	O
the	O
expression	O
of	O
these	O
differentially	O
expressed	O
genes	B-T017
.	O
ke	O
##gg	O
pathway	O
analysis	O
showed	O
that	O
dha	B-T103
may	O
induce	O
the	O
apoptosis	B-T038
of	O
cancer	B-T017
cells	I-T017
preferentially	O
through	O
mediating	O
p53	B-T038
,	O
mapk	B-T038
,	O
tnf	B-T038
,	O
pi3k	O
/	O
akt	O
,	O
and	O
nf	B-T038
-	I-T038
κb	I-T038
signaling	I-T038
pathways	I-T038
.	O
our	O
study	O
demonstrated	O
the	O
beneficial	O
action	O
of	O
dha	B-T103
on	O
human	B-T204
prostate	B-T038
carcinoma	I-T038
cell	B-T017
line	I-T017
du	I-T017
##145	I-T017
.	O
the	O
pro	O
-	O
apoptotic	O
effect	O
of	O
dha	B-T103
on	O
du	B-T017
##145	I-T017
cells	I-T017
may	O
involve	O
mediation	O
various	O
pathways	B-T038
,	O
especially	O
p53	B-T038
,	O
mapk	B-T038
,	O
tnf	B-T038
,	O
pi3k	O
/	O
akt	O
,	O
and	O
nf	B-T038
-	I-T038
κb	I-T038
signaling	I-T038
pathways	I-T038
.	O
molecular	B-T038
mechanisms	I-T038
of	O
dha	B-T103
on	O
apoptosis	B-T038
of	O
cancer	B-T017
cells	I-T017
still	O
need	O
to	O
be	O
further	O
clarified	O
.	O

identifying	O
the	O
presence	B-T033
of	O
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
using	O
low	O
-	O
frequency	O
fluctuations	B-T033
in	O
bold	B-T058
signals	I-T058
parkinson	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
pd	B-T038
)	O
is	O
a	O
chronic	O
,	O
progressive	O
,	O
and	O
degenerative	O
neurological	B-T038
disorder	I-T038
that	O
is	O
characterized	O
by	O
the	O
degeneration	O
of	O
dopamine	B-T017
neurons	I-T017
in	O
the	O
substantia	B-T017
nigra	I-T017
and	O
the	O
formation	O
of	O
intracellular	B-T082
lewy	B-T017
inclusion	I-T017
bodies	I-T017
.	O
resting	B-T058
-	I-T058
state	I-T058
functional	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	O
rs	B-T058
-	I-T058
fmri	I-T058
)	O
has	O
demonstrated	O
evidence	O
of	O
changes	O
in	O
metabolic	O
patterns	B-T082
in	O
individuals	B-T098
with	O
pd	B-T038
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
whether	O
the	O
presence	B-T033
of	O
pd	B-T038
could	O
be	O
[UNK]	O
predicted	O
[UNK]	O
based	O
on	O
resting	O
fluctuations	B-T033
in	O
the	O
blood	B-T038
oxygenation	I-T038
level	I-T038
dependent	I-T038
signal	I-T038
.	O
we	O
utilized	O
rs	B-T058
-	I-T058
fmri	I-T058
to	O
measure	O
the	O
amplitude	B-T082
of	O
low	O
-	O
frequency	O
fluctuation	B-T033
(	O
alf	B-T033
##f	I-T033
)	O
and	O
the	O
fractional	O
alf	B-T033
##f	I-T033
(	O
fa	B-T033
##l	I-T033
##ff	I-T033
)	O
in	O
51	O
patients	O
with	O
pd	B-T038
and	O
50	O
age	O
-	O
and	O
sex	O
-	O
matched	O
healthy	O
controls	O
.	O
compared	O
with	O
the	O
healthy	O
controls	O
,	O
the	O
individuals	B-T098
with	O
pd	B-T038
exhibited	O
altered	O
alf	B-T033
##fs	I-T033
in	O
the	O
bilateral	B-T082
lingual	B-T017
gyrus	I-T017
and	O
left	B-T017
putamen	I-T017
and	O
an	O
altered	O
fa	B-T033
##l	I-T033
##ff	I-T033
in	O
the	O
right	B-T082
cerebellum	I-T082
posterior	I-T082
lobe	I-T082
.	O
support	O
vector	O
machines	O
(	O
svm	O
##s	O
)	O
,	O
which	O
comprise	O
a	O
supervised	O
pattern	B-T038
recognition	I-T038
method	B-T170
that	O
enables	O
predictions	O
at	O
the	O
individual	B-T098
level	O
,	O
were	O
trained	O
to	O
separate	O
individuals	B-T098
with	O
pd	B-T038
from	O
healthy	O
controls	O
based	O
on	O
the	O
alf	B-T033
##f	I-T033
and	O
fa	B-T033
##l	I-T033
##ff	I-T033
.	O
using	O
the	O
leave	O
-	O
one	O
-	O
out	O
cross	B-T062
-	I-T062
validation	I-T062
method	I-T062
to	O
analyze	B-T062
our	O
sample	O
,	O
we	O
reliably	O
distinguished	O
the	O
participants	B-T098
with	O
pd	B-T038
from	O
the	O
controls	O
with	O
92	O
%	O
sensitivity	O
and	O
87	O
%	O
specificity	O
.	O
overall	O
,	O
these	O
findings	O
suggest	O
that	O
the	O
svm	O
-	O
neuroimaging	B-T058
approach	O
may	O
be	O
of	O
particular	O
clinical	O
value	O
because	O
it	O
enables	O
the	O
accurate	O
identification	O
of	O
pd	B-T038
at	O
the	O
individual	B-T098
level	O
.	O
rs	B-T058
-	I-T058
fmri	I-T058
should	O
be	O
considered	O
for	O
development	O
as	O
a	O
biomarker	B-T201
and	O
an	O
analytical	O
tool	O
for	O
the	O
evaluation	B-T058
of	O
pd	B-T038
.	O

interleukin	B-T103
-	I-T103
1β	I-T103
induced	O
stress	B-T017
granules	I-T017
seques	O
##ter	O
cox	B-T103
-	I-T103
2	I-T103
mrna	B-T103
and	O
regulates	B-T038
its	O
stability	O
and	O
translation	O
in	O
human	B-T204
oa	B-T038
chondrocytes	B-T017
enhanced	O
and	O
immediate	O
expression	B-T038
of	O
cyclooxygenase	B-T017
-	I-T017
2	I-T017
(	O
cox	B-T017
-	I-T017
2	I-T017
)	O
mrna	B-T103
is	O
observed	O
in	O
il	B-T103
-	I-T103
1β	I-T103
-	O
stimulated	B-T058
oa	B-T038
chondrocytes	B-T017
but	O
the	O
synthesis	B-T038
of	I-T038
protein	I-T038
found	O
significantly	O
delayed	O
.	O
here	O
we	O
investigated	O
the	O
role	O
of	O
stress	B-T017
granules	I-T017
(	O
sg	B-T017
##s	I-T017
)	O
,	O
ribonucle	B-T017
##oprotein	I-T017
complexes	I-T017
that	O
regulate	B-T038
mrna	O
translation	O
,	O
in	O
the	O
delayed	O
translation	O
of	O
cox	B-T017
-	I-T017
2	I-T017
mrnas	B-T103
in	O
il	B-T103
-	I-T103
1β	I-T103
-	O
stimulated	B-T058
oa	B-T038
chondrocytes	B-T017
.	O
stimulation	B-T058
of	O
human	B-T204
chondrocytes	B-T017
with	O
il	B-T103
-	I-T103
1β	I-T103
activated	O
the	O
stress	B-T038
response	I-T038
genes	B-T017
and	O
the	O
phosphorylation	B-T038
of	O
eif	B-T103
##2	I-T103
##α	I-T103
that	O
triggered	O
the	O
assembly	B-T038
of	I-T038
sg	I-T038
##s	I-T038
.	O
using	O
combined	O
immunofluorescence	B-T058
staining	I-T058
of	O
sg	B-T017
##s	I-T017
markers	B-T201
and	O
cox	B-T103
-	I-T103
2	I-T103
protein	I-T103
,	O
rna	B-T103
fluorescence	B-T062
in	I-T062
situ	I-T062
hybridization	I-T062
and	O
rna	B-T103
immunoprecipitation	B-T058
,	O
the	O
cox	B-T017
-	I-T017
2	I-T017
mrnas	B-T103
were	O
found	O
seques	O
##tered	O
in	O
sg	B-T017
##s	I-T017
in	O
il	B-T103
-	I-T103
1β	I-T103
-	O
stimulated	B-T058
oa	B-T038
chondrocytes	B-T017
.	O
no	B-T033
increase	O
in	O
cox	B-T103
-	I-T103
2	I-T103
protein	B-T038
expression	I-T038
was	O
observed	O
during	O
the	O
persistence	O
of	O
sg	B-T017
##s	I-T017
but	O
enhanced	O
expression	B-T038
of	O
cox	B-T103
-	I-T103
2	I-T103
protein	I-T103
was	O
noted	O
upon	O
clearance	O
of	O
the	O
sg	B-T017
##s	I-T017
.	O
inhibition	O
of	O
sg	B-T017
##s	I-T017
clearance	O
blocked	O
cox	B-T017
-	I-T017
2	I-T017
mrna	B-T103
translation	O
whereas	O
blocking	O
the	O
assembly	B-T038
of	I-T038
sg	I-T038
##s	I-T038
by	O
tia	B-T103
-	I-T103
1	I-T103
depletion	O
resulted	O
in	O
rapid	O
and	O
increased	O
production	O
of	O
cox	B-T103
-	I-T103
2	I-T103
and	O
pge2	B-T103
.	O
our	O
findings	O
show	O
for	O
the	O
first	O
time	O
assembly	B-T038
of	I-T038
sg	I-T038
##s	I-T038
and	O
sequestration	O
of	O
cox	B-T017
-	I-T017
2	I-T017
mrnas	B-T103
in	O
human	B-T204
oa	B-T038
chondrocytes	B-T017
under	O
pathological	B-T033
conditions	I-T033
.	O
post	B-T038
-	I-T038
transcriptional	I-T038
regulation	I-T038
of	O
cox	B-T017
-	I-T017
2	I-T017
mrnas	O
translation	O
by	O
sg	B-T017
##s	I-T017
indicates	O
a	O
role	O
in	O
il	B-T103
-	I-T103
1β	I-T103
-	O
mediated	O
catabolic	O
response	O
that	O
could	O
be	O
therapeutically	B-T058
targeted	O
in	O
oa	B-T038
.	O

role	O
of	O
agonistic	B-T103
autoantibodies	I-T103
against	O
type	B-T103
-	I-T103
1	I-T103
angiotensin	I-T103
ii	I-T103
receptor	I-T103
in	O
the	O
pathogenesis	B-T038
of	O
retinopathy	B-T038
in	O
preeclampsia	B-T038
to	O
investigate	O
the	O
mechanism	O
underlying	O
at1	B-T103
-	I-T103
aa	I-T103
-	O
induced	O
retinopathy	B-T038
in	O
severe	O
preeclampsia	B-T038
by	O
measuring	O
the	O
positive	O
rate	O
and	O
titer	O
of	O
at1	B-T103
-	I-T103
aa	I-T103
in	O
plasma	B-T031
from	O
women	B-T098
with	O
severe	B-T038
preeclampsia	I-T038
and	O
normal	O
pregnant	B-T098
women	I-T098
to	O
see	O
whether	O
at1	B-T103
-	I-T103
aa	I-T103
titer	O
was	O
correlated	O
with	O
the	O
grade	O
of	O
retinopathy	B-T038
.	O
a	O
preeclampsia	B-T038
rat	B-T204
model	B-T204
was	O
also	O
established	O
by	O
intravenous	O
injection	O
of	O
at1	B-T103
-	I-T103
aa	I-T103
extracted	O
from	O
the	O
plasma	B-T031
of	O
patient	O
suffering	O
from	O
severe	B-T038
preeclampsia	I-T038
.	O
the	O
results	O
showed	O
that	O
the	O
plasma	B-T031
titer	O
and	O
positive	O
rate	O
of	O
at1	B-T103
-	I-T103
aa	I-T103
were	O
significantly	O
higher	O
in	O
women	B-T098
with	O
severe	B-T038
preeclampsia	I-T038
than	O
normal	O
pregnant	B-T098
women	I-T098
.	O
the	O
antibody	B-T103
titer	O
in	O
cases	O
of	O
severe	O
preeclampsia	B-T038
was	O
associated	O
with	O
the	O
grade	O
of	O
retinopathy	B-T038
,	O
and	O
positively	O
correlated	O
with	O
the	O
level	O
of	O
tnf	B-T103
-	I-T103
α	I-T103
and	O
vegf	B-T103
.	O
the	O
animal	B-T062
experiment	I-T062
results	O
showed	O
that	O
the	O
modeled	B-T204
rats	I-T204
presented	O
symptoms	B-T033
very	O
similar	O
to	O
symptoms	B-T033
of	O
human	B-T204
preeclampsia	B-T038
,	O
including	O
retinopathy	B-T038
.	O
ocular	O
fundus	O
examination	B-T058
showed	O
retinal	B-T033
microvascular	I-T033
abnormalities	I-T033
,	O
hemorrh	B-T038
##aging	I-T038
and	O
leakage	B-T033
in	O
the	O
severe	B-T038
preeclampsia	I-T038
.	O
morphological	O
changes	O
included	O
edema	B-T033
,	O
thickening	B-T033
of	O
the	O
in	B-T017
##l	I-T017
and	O
on	B-T017
##l	I-T017
,	O
and	O
pigment	B-T033
atrophy	I-T033
.	O
tnf	B-T103
-	I-T103
α	I-T103
and	O
vegf	B-T103
levels	O
were	O
increased	O
in	O
the	O
vitreous	B-T031
humor	I-T031
and	O
retina	B-T017
of	O
the	O
model	B-T204
rats	I-T204
.	O
our	O
studies	B-T062
results	O
suggest	O
that	O
abnormal	B-T038
expression	I-T038
of	O
at1	B-T103
-	I-T103
aa	I-T103
could	O
induce	O
damage	O
to	O
retinal	B-T017
capillary	I-T017
endothelial	I-T017
cells	I-T017
and	O
increase	O
vascular	B-T038
permeability	I-T038
,	O
resulting	O
in	O
retinopathy	B-T038
.	O

expert	B-T097
position	B-T170
paper	I-T170
on	O
prolonged	O
dual	B-T058
antiplatelet	I-T058
therapy	I-T058
in	O
secondary	B-T058
prevention	I-T058
following	O
myocardial	B-T038
infarction	I-T038
the	O
protective	O
effect	O
of	O
dual	B-T058
antiplatelet	I-T058
therapy	I-T058
(	O
dapt	B-T058
)	O
following	O
acute	B-T038
coronary	I-T038
syndrome	I-T038
is	O
und	O
##isp	O
##uted	O
,	O
but	O
its	O
duration	O
is	O
subject	O
of	O
debate	O
.	O
several	O
studies	B-T062
show	O
that	O
prolonged	O
therapy	B-T058
provides	O
a	O
clinical	O
benefit	O
in	O
patients	O
following	O
acute	B-T038
coronary	I-T038
syndrome	I-T038
.	O
the	O
aim	O
of	O
this	O
position	B-T170
paper	I-T170
author	O
##ed	O
by	O
austria	B-T098
##n	I-T098
experts	B-T097
is	O
to	O
outline	O
the	O
current	O
evidence	O
and	O
provide	O
an	O
overview	O
of	O
recent	O
studies	B-T062
.	O
it	O
is	O
also	O
intended	O
to	O
serve	O
as	O
a	O
practical	O
guide	O
to	O
identify	O
those	O
patients	O
who	O
may	O
benefit	O
from	O
prolonged	O
dapt	B-T058
.	O

challenging	B-T058
some	O
assumptions	O
about	O
empathy	O
in	O
new	B-T082
zealand	I-T082
little	O
nursing	O
or	O
medical	O
curricula	O
time	O
,	O
if	O
any	O
,	O
is	O
specifically	O
devoted	O
to	O
the	O
enhancement	O
of	O
empathy	O
.	O
if	O
being	O
emp	B-T033
##athic	I-T033
is	O
important	O
in	O
the	O
context	O
of	O
patient	B-T058
care	I-T058
,	O
it	O
is	O
a	O
quality	O
that	O
is	O
already	O
present	O
in	O
students	B-T098
or	O
is	O
learned	O
by	O
students	B-T098
during	O
their	O
practic	O
##um	O
in	O
the	O
company	O
of	O
experienced	B-T038
clinicians	B-T097
.	O
this	O
study	B-T062
aimed	O
to	O
compare	O
self	B-T062
-	I-T062
reported	I-T062
empathy	O
ratings	O
between	O
different	O
groups	B-T098
of	O
medical	B-T097
students	I-T097
and	O
one	O
cohort	B-T098
of	O
nursing	B-T097
students	I-T097
who	O
were	O
either	O
exposed	O
or	O
not	O
exposed	O
to	O
explicit	O
empathy	O
training	O
or	O
learning	B-T038
in	O
clinical	O
settings	O
in	O
the	O
presence	O
of	O
patients	O
.	O
the	O
je	O
##ffer	O
##son	O
scale	O
of	O
physician	O
empathy	O
(	O
js	O
##pe	O
)	O
was	O
completed	O
before	O
and	O
after	O
groups	O
of	O
medical	B-T097
and	O
nursing	B-T097
students	I-T097
had	O
been	O
exposed	O
to	O
various	O
extended	O
periods	O
of	O
practic	O
##um	O
.	O
some	O
medical	B-T097
student	I-T097
cohorts	B-T098
undertook	O
brief	O
empathy	O
training	O
,	O
whereas	O
others	O
had	O
no	O
exposure	O
.	O
the	O
nursing	B-T097
student	I-T097
cohort	B-T098
had	O
no	B-T033
formal	I-T033
,	O
explicit	O
empathy	O
training	O
.	O
irrespective	O
of	O
profession	O
,	O
length	O
of	O
practic	O
##um	O
or	O
exposure	O
to	O
specific	O
empathy	O
training	O
,	O
there	O
were	O
no	O
significant	O
differences	O
in	O
the	O
self	B-T062
-	I-T062
reported	I-T062
js	O
##pe	O
scores	O
across	O
the	O
seven	O
different	O
cohorts	B-T098
of	O
students	B-T098
.	O
empathy	O
is	O
a	O
quality	O
that	O
is	O
already	O
present	B-T033
in	O
students	B-T098
or	O
is	O
learned	B-T038
by	I-T038
students	B-T098
during	O
their	O
practic	O
##um	O
discussion	O
:	O
if	O
empathy	O
is	O
caught	O
rather	O
than	O
taught	O
,	O
then	O
brief	O
efforts	O
to	O
enhance	O
empathy	O
may	O
be	O
fu	O
##tile	O
.	O
to	O
optim	O
##ise	O
the	O
inherent	B-T033
emp	I-T033
##athic	I-T033
qualities	I-T033
of	O
aspir	O
##ant	O
health	B-T097
professionals	I-T097
,	O
explicit	O
consideration	B-T033
should	O
be	O
given	O
to	O
how	O
empathy	O
is	O
influenced	O
by	O
the	O
practic	O
##um	O
experience	B-T038
.	O

chemosens	B-T033
##itivity	I-T033
,	O
cardiovascular	O
risk	O
,	O
and	O
the	O
ventilatory	B-T201
response	I-T201
to	O
exercise	O
in	O
copd	B-T038
copd	B-T038
is	O
associated	O
with	O
elevated	O
cardiovascular	O
risk	O
and	O
a	O
potentiated	O
ventilatory	B-T201
response	I-T201
to	O
exercise	O
.	O
enhanced	O
carotid	O
chemo	B-T017
##rec	I-T017
##eptor	I-T017
(	O
cc	B-T017
)	O
activity	B-T038
/	O
sensitivity	B-T038
is	O
present	O
in	O
other	O
clinical	O
conditions	O
,	O
has	O
been	O
shown	O
to	O
contribute	O
to	O
sympathetic	B-T022
vasoconstrictor	B-T038
outflow	I-T038
,	O
and	O
is	O
predictive	O
of	O
mortality	B-T033
.	O
cc	B-T017
activity	B-T038
/	O
sensitivity	B-T038
,	O
and	O
the	O
resulting	O
functional	O
significance	O
,	O
has	O
not	O
been	O
well	O
examined	O
in	O
copd	B-T038
.	O
we	O
hypothesized	O
that	O
cc	B-T017
activity	B-T038
/	O
sensitivity	B-T038
would	O
be	O
elevated	O
in	O
copd	B-T038
,	O
and	O
related	O
to	O
increased	O
pulse	O
wave	O
velocity	O
(	O
a	O
marker	B-T201
of	O
cv	O
risk	O
)	O
and	O
the	O
ventilatory	B-T201
response	I-T201
to	O
exercise	O
.	O
30	O
copd	B-T038
patients	O
and	O
10	O
healthy	O
age	O
-	O
matched	O
controls	O
were	O
examined	B-T033
.	O
participants	B-T098
performed	O
baseline	O
cardiopulmonary	B-T058
exercise	I-T058
and	O
pulmonary	B-T058
function	I-T058
testing	I-T058
.	O
cc	B-T017
activity	B-T038
was	O
later	O
evaluated	B-T058
by	O
the	O
drop	B-T033
in	I-T033
ventilation	B-T038
with	O
breathing	B-T038
100	O
%	O
o2	B-T103
,	O
and	O
cc	B-T017
sensitivity	B-T038
was	O
then	O
assessed	O
by	O
the	O
ventilatory	B-T058
response	I-T058
to	I-T058
hypoxia	I-T058
(	O
δ	O
##ve	O
/	O
δ	O
##s	O
po2	B-T058
)	O
.	O
peripheral	B-T082
arterial	B-T038
stiffness	I-T038
was	O
subsequently	O
evaluated	B-T058
by	O
measurement	O
of	O
pulse	O
wave	O
velocity	O
(	O
pwv	O
)	O
using	O
appl	B-T058
##anat	I-T058
##ion	I-T058
ton	I-T058
##ometry	I-T058
while	O
the	O
subjects	O
were	O
breathing	B-T038
room	O
air	O
,	O
and	O
then	O
following	O
chemo	B-T017
##rec	I-T017
##eptor	I-T017
inhibition	O
by	O
breathing	B-T038
100	O
%	O
o2	B-T103
for	O
2	O
minutes	O
.	O
cc	B-T017
activity	B-T038
,	O
cc	B-T017
sensitivity	B-T038
,	O
pwv	O
and	O
the	O
ventilatory	B-T201
response	I-T201
to	O
exercise	O
were	O
all	O
increased	O
in	O
copd	B-T038
relative	O
to	O
controls	O
.	O
cc	B-T017
sensitivity	B-T038
was	O
related	O
to	O
pwv	O
;	O
however	O
,	O
neither	O
cc	B-T017
activity	B-T038
nor	O
cc	B-T017
sensitivity	B-T038
was	O
related	O
to	O
the	O
ventilatory	B-T201
response	I-T201
to	O
exercise	O
in	O
copd	B-T038
.	O
cc	B-T017
inhibition	O
by	O
breathing	B-T038
100	O
%	O
o2	B-T103
normalized	O
pwv	O
in	O
copd	B-T038
,	O
while	O
no	O
effect	O
was	O
observed	O
in	O
controls	O
.	O
cc	B-T017
activity	B-T038
and	O
sensitivity	B-T038
are	O
elevated	O
in	O
copd	B-T038
,	O
and	O
appear	O
related	O
to	O
cardiovascular	O
risk	O
;	O
however	O
,	O
cc	B-T017
activity	B-T038
/	O
sensitivity	B-T038
does	O
not	O
contribute	O
to	O
the	O
potentiated	O
ventilatory	B-T201
response	I-T201
to	O
exercise	O
.	O

nf	B-T103
-	I-T103
κb	I-T103
links	O
tlr2	B-T103
and	O
par	B-T103
##1	I-T103
to	O
soluble	O
immunomod	B-T103
##ulator	I-T103
factor	I-T103
secretion	B-T038
in	O
human	B-T204
platelets	B-T017
the	O
primary	O
toll	B-T103
-	I-T103
like	I-T103
receptor	I-T103
(	O
tlr	B-T103
)	O
-	O
mediated	O
immune	B-T038
cell	I-T038
response	I-T038
pathway	I-T038
common	O
for	O
all	O
tlrs	B-T103
is	O
myd88	B-T103
-	O
dependent	O
activation	O
of	O
nf	B-T103
-	I-T103
κb	I-T103
,	O
a	O
seminal	B-T017
transcription	B-T103
factor	I-T103
for	O
many	O
chemokines	B-T103
and	O
cytokines	B-T103
.	O
remarkably	O
,	O
an	B-T017
##ucle	I-T017
##ate	I-T017
platelets	I-T017
express	O
the	O
nf	B-T103
-	I-T103
κb	I-T103
machinery	O
,	O
whose	O
role	O
in	O
platelets	B-T017
remains	O
poorly	O
understood	O
.	O
here	O
,	O
we	O
investigated	O
the	O
contribution	O
of	O
nf	B-T103
-	I-T103
κb	I-T103
in	O
the	O
release	O
of	O
cytokines	B-T103
and	O
serotonin	B-T103
by	O
human	B-T204
platelets	B-T017
,	O
following	O
selective	O
stimulation	O
of	O
tlr2	B-T103
and	O
protease	B-T103
activated	I-T103
receptor	I-T103
1	I-T103
(	O
par	B-T103
##1	I-T103
)	O
,	O
a	O
classical	O
and	O
non	O
-	O
classical	O
pattern	B-T103
-	I-T103
recognition	I-T103
receptor	I-T103
,	O
respectively	O
,	O
able	O
to	O
participate	O
to	O
the	O
innate	O
immune	O
system	O
.	O
we	O
discovered	O
that	O
platelet	B-T017
par	B-T103
##1	I-T103
activation	O
drives	O
the	O
process	O
of	O
nf	B-T103
-	I-T103
κb	I-T103
phosphorylation	B-T038
,	O
in	O
contrast	O
to	O
tlr2	B-T103
activation	B-T038
,	O
which	O
induces	O
a	O
slower	O
phosphorylation	B-T038
process	I-T038
.	O
conversely	O
,	O
platelet	B-T017
par	B-T103
##1	I-T103
and	O
tlr2	B-T103
activation	O
induces	O
similar	O
erk1	B-T038
/	I-T038
2	I-T038
,	O
p38	B-T103
,	O
and	O
akt	B-T103
phosphorylation	B-T038
.	O
moreover	O
,	O
we	O
found	O
that	O
engagement	O
of	O
platelet	B-T017
tlr2	B-T103
with	O
its	O
ligand	B-T103
,	O
pam	B-T103
##3c	I-T103
##sk	I-T103
##4	I-T103
,	O
significantly	O
increases	O
the	O
release	O
of	O
scd	B-T103
##62	I-T103
##p	I-T103
,	O
rantes	B-T103
,	O
and	O
scd	B-T103
##40	I-T103
##l	I-T103
;	O
this	O
effect	O
was	O
attenuated	O
by	O
incubating	B-T058
platelets	B-T017
with	O
a	O
blocking	O
anti	B-T103
-	I-T103
tlr2	I-T103
antibody	I-T103
.	O
this	O
effect	O
appeared	O
selective	O
since	O
no	O
modulation	B-T082
of	O
serotonin	B-T038
secretion	I-T038
was	O
observed	O
following	O
platelet	B-T017
tlr2	B-T103
activation	B-T038
.	O
platelet	B-T017
release	O
of	O
scd	B-T103
##62	I-T103
##p	I-T103
,	O
rantes	B-T103
,	O
and	O
scd	B-T103
##40	I-T103
##l	I-T103
following	O
tlr2	B-T103
or	O
par	B-T103
##1	I-T103
triggering	O
was	O
abolished	O
in	O
the	O
presence	B-T033
of	O
the	O
nf	B-T103
-	I-T103
κb	I-T103
inhibitor	B-T103
bay	B-T103
##11	I-T103
-	I-T103
70	I-T103
##82	I-T103
,	O
while	O
serotonin	B-T038
release	I-T038
following	O
par	B-T103
##1	I-T103
activation	B-T038
was	O
significantly	O
decreased	O
.	O
these	O
new	O
findings	O
support	O
the	O
concept	O
that	O
nf	B-T103
-	I-T103
κb	I-T103
is	O
an	O
important	O
player	O
in	O
platelet	B-T017
immunoreg	B-T038
##ulations	I-T038
and	O
functions	B-T038
.	O

quality	O
improvement	O
of	O
liver	B-T017
ultrasound	B-T058
images	B-T170
using	O
fuzzy	B-T170
techniques	B-T170
liver	B-T017
ultrasound	B-T058
images	B-T170
are	O
so	O
common	O
and	O
are	O
applied	O
so	O
often	O
to	O
diagnose	B-T033
diffuse	B-T038
liver	I-T038
diseases	I-T038
like	O
fatty	B-T038
liver	I-T038
.	O
however	O
,	O
the	O
low	O
quality	O
of	O
such	O
images	B-T170
makes	O
it	O
difficult	O
to	O
analyze	B-T062
them	O
and	O
diagnose	B-T033
diseases	B-T038
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
,	O
therefore	O
,	O
is	O
to	O
improve	O
the	O
contrast	O
and	O
quality	O
of	O
liver	B-T017
ultrasound	B-T058
images	B-T170
.	O
in	O
this	O
study	B-T062
,	O
a	O
number	O
of	O
image	B-T170
contrast	O
enhancement	B-T170
algorithms	I-T170
which	O
are	O
based	O
on	O
fuzzy	B-T170
logic	I-T170
were	O
applied	O
to	O
liver	B-T017
ultrasound	B-T058
images	B-T170
-	O
in	O
which	O
the	O
view	O
of	O
kidney	B-T017
is	O
observable	O
-	O
using	O
mat	B-T170
##lab	I-T170
##20	I-T170
##13	I-T170
##b	I-T170
to	O
improve	O
the	O
image	B-T170
contrast	O
and	O
quality	O
which	O
has	O
a	O
fuzzy	B-T170
definition	B-T170
;	O
just	O
like	O
image	B-T170
contrast	O
improvement	O
algorithms	B-T170
using	O
a	O
fuzzy	B-T170
intensification	O
operator	O
,	O
contrast	O
improvement	O
algorithms	B-T170
applying	O
fuzzy	B-T170
image	B-T170
histogram	B-T170
hyper	I-T170
##bo	I-T170
##li	I-T170
##zation	I-T170
,	O
and	O
contrast	O
improvement	O
algorithms	B-T170
by	O
fuzzy	B-T170
if	B-T170
-	I-T170
then	I-T170
rules	I-T170
.	O
with	O
the	O
measurement	O
of	O
mean	O
squared	O
error	O
and	O
peak	O
signal	O
to	O
noise	O
ratio	O
obtained	O
from	O
different	O
images	B-T170
,	O
fuzzy	B-T170
methods	B-T170
provided	O
better	O
results	O
,	O
and	O
their	O
implementation	O
-	O
compared	O
with	O
histogram	B-T170
equal	I-T170
##ization	I-T170
method	I-T170
-	O
led	O
both	O
to	O
the	O
improvement	O
of	O
contrast	O
and	O
visual	B-T033
quality	I-T033
of	O
images	B-T170
and	O
to	O
the	O
improvement	O
of	O
liver	B-T017
segmentation	B-T170
algorithms	I-T170
results	O
in	O
images	B-T170
.	O
comparison	O
of	O
the	O
four	O
algorithms	B-T170
revealed	O
the	O
power	O
of	O
fuzzy	B-T170
logic	I-T170
in	O
improving	O
image	B-T170
contrast	O
compared	O
with	O
traditional	O
image	O
processing	O
algorithms	B-T170
.	O
moreover	O
,	O
contrast	O
improvement	O
algorithm	O
based	O
on	O
a	O
fuzzy	B-T170
intensification	O
operator	O
was	O
selected	O
as	O
the	O
strongest	O
algorithm	B-T170
considering	O
the	O
measured	O
indicators	O
.	O
this	O
method	B-T170
can	O
also	O
be	O
used	O
in	O
future	O
studies	B-T062
on	O
other	O
ultrasound	B-T058
images	B-T170
for	O
quality	O
improvement	O
and	O
other	O
image	O
processing	O
and	O
analysis	B-T062
applications	O
.	O

a	O
primer	O
on	O
intra	O
##osseous	O
access	O
:	O
history	B-T033
,	O
clinical	B-T033
considerations	I-T033
,	O
and	O
current	B-T074
devices	I-T074
intra	O
##osseous	O
(	O
io	O
)	O
access	O
is	O
a	O
method	B-T170
recommended	O
by	O
the	O
american	B-T092
heart	I-T092
association	I-T092
and	O
the	O
european	B-T092
resuscitation	I-T092
council	I-T092
to	O
administer	O
resusc	B-T103
##itative	I-T103
drugs	I-T103
and	O
fluids	O
when	O
intravenous	B-T082
(	I-T082
iv	I-T082
)	I-T082
access	I-T082
cann	O
##ot	O
be	O
rapidly	O
or	O
easily	O
obtained	O
.	O
many	O
clinicians	B-T097
have	O
limited	B-T170
knowledge	I-T170
or	O
experience	B-T038
with	O
the	O
io	O
route	O
.	O
the	O
purpose	O
of	O
this	O
review	B-T170
was	O
to	O
provide	O
the	O
reader	O
with	O
a	O
succin	B-T170
##ct	I-T170
review	I-T170
of	O
the	O
history	B-T033
,	O
clinical	B-T033
considerations	I-T033
,	O
and	O
devices	B-T074
associated	O
with	O
io	O
access	O
.	O
narrative	O
review	O
.	O
university	O
-	O
based	O
academic	O
research	O
cell	O
.	O
not	O
applicable	O
.	O
not	O
applicable	O
.	O
io	O
access	O
is	O
a	O
lifes	O
##aving	O
bridge	O
to	O
definitive	O
vascular	O
access	O
that	O
may	O
be	O
considered	O
when	O
an	O
iv	B-T082
cann	O
##ot	O
be	O
rapidly	O
attained	O
and	O
the	O
patient	O
'	O
s	O
outcome	O
may	O
be	O
negatively	B-T033
affected	I-T033
without	O
prompt	B-T082
circulatory	I-T082
access	I-T082
.	O
the	O
io	O
route	O
has	O
few	O
contraindications	O
for	O
use	O
and	O
a	O
low	O
rate	O
of	O
serious	B-T038
complications	I-T038
.	O
multiple	O
manual	O
and	O
powered	B-T074
devices	I-T074
that	O
may	O
be	O
placed	O
in	O
several	B-T082
anatomic	I-T082
sites	I-T082
are	O
commercially	O
available	O
.	O
all	O
clinicians	B-T097
who	O
provide	O
acute	B-T058
care	I-T058
or	O
respond	O
to	O
cardiovascular	B-T082
emergencies	B-T038
should	O
obtain	O
training	O
and	O
maintain	O
proficiency	O
in	O
placing	O
and	O
using	O
io	O
devices	B-T074
as	O
the	O
io	O
route	O
is	O
recommended	O
by	O
the	O
major	O
resuscitation	B-T092
organizations	I-T092
as	O
the	O
preferred	O
route	O
of	O
infusion	O
when	O
rapid	O
,	O
reliable	O
iv	B-T082
access	I-T082
is	O
unavailable	O
.	O

association	O
of	O
abdominal	B-T017
fat	I-T017
with	O
serum	B-T031
amylase	B-T103
in	O
an	O
older	B-T098
cohort	B-T098
:	O
the	O
bal	B-T082
##tim	I-T082
##ore	I-T082
longitudinal	B-T062
study	I-T062
of	O
aging	B-T038
abdominal	B-T017
fat	I-T017
is	O
a	O
major	O
determinant	O
of	O
metabolic	B-T038
diseases	I-T038
in	O
older	B-T098
individuals	B-T098
.	O
obesity	B-T038
and	O
diabetes	B-T038
are	O
associated	O
with	O
low	O
serum	B-T033
amylase	I-T033
(	I-T033
sa	I-T033
)	I-T033
levels	I-T033
,	O
but	O
the	O
association	O
between	O
sa	B-T033
and	O
metabolic	B-T038
disease	I-T038
is	O
poorly	O
understood	O
.	O
we	O
investigated	O
the	O
association	O
of	O
low	O
sa	B-T033
with	O
diabetes	B-T038
and	O
sex	O
-	O
specific	O
associations	O
of	O
serum	B-T031
amylase	B-T103
with	O
abdominal	B-T017
fat	I-T017
in	O
older	O
adults	O
.	O
in	O
community	O
-	O
dwelling	O
volunteers	B-T098
from	O
the	O
bal	B-T082
##tim	I-T082
##ore	I-T082
longitudinal	B-T062
study	I-T062
of	O
aging	B-T038
(	O
77	O
##8	O
participants	B-T098
,	O
age	O
66	O
.	O
8	O
##±1	O
##3	O
.	O
6	O
years	O
)	O
,	O
we	O
assessed	O
abdominal	B-T017
fat	I-T017
by	O
computed	B-T058
tomography	I-T058
and	O
diabetes	O
status	O
using	O
the	O
american	B-T092
diabetes	I-T092
association	I-T092
criteria	O
.	O
linear	O
regression	O
analyses	O
assessed	O
the	O
cross	O
-	O
sectional	O
associations	O
between	O
abdominal	B-T017
fat	I-T017
and	O
sa	B-T033
,	O
and	O
logistic	B-T062
regression	I-T062
assessed	O
the	O
odds	O
of	O
diabetes	B-T038
,	O
given	O
low	O
sa	B-T033
.	O
in	O
unadjusted	B-T062
analyses	I-T062
,	O
individuals	B-T098
in	O
the	O
lowest	O
sa	B-T033
quartile	O
(	O
<	O
48	O
##μ	O
/	O
l	O
)	O
had	O
1	O
.	O
97	O
greater	O
odds	O
of	O
diabetes	B-T038
,	O
(	O
95	O
%	O
ci	O
,	O
1	O
.	O
01	O
-	O
3	O
.	O
83	O
)	O
than	O
those	O
in	O
the	O
highest	O
quartile	O
(	O
⩾	O
##80	O
##μ	O
/	O
l	O
)	O
.	O
this	O
association	O
was	O
no	O
longer	O
significant	O
after	O
adjusting	O
for	O
visceral	B-T017
adipose	I-T017
tissue	I-T017
area	I-T017
(	O
vat	B-T017
,	O
dm	O
(	O
2	O
)	O
)	O
,	O
abdominal	B-T017
subcutaneous	I-T017
adipose	I-T017
tissue	I-T017
(	O
sat	B-T017
,	O
dm	O
(	O
2	O
)	O
)	O
or	O
bmi	B-T201
.	O
in	O
adjusted	B-T062
analyses	I-T062
,	O
vat	B-T017
and	O
sat	B-T017
were	O
significantly	O
associated	O
with	O
sa	B-T033
in	O
both	O
sexes	O
.	O
among	O
women	B-T098
,	O
sa	B-T033
was	O
more	O
strongly	O
associated	O
with	O
vat	B-T017
than	O
with	O
sat	B-T017
or	O
bmi	B-T201
;	O
vat	B-T017
(	O
β	O
=	O
-	O
0	O
.	O
117	O
##±0	O
.	O
048	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
sat	B-T017
(	O
β	O
=	O
-	O
0	O
.	O
023	O
##±0	O
.	O
025	O
,	O
p	O
=	O
0	O
.	O
34	O
##6	O
)	O
and	O
bmi	B-T201
(	O
β	O
=	O
-	O
0	O
.	O
005	O
##2	O
##±0	O
.	O
07	O
##5	O
,	O
p	O
=	O
0	O
.	O
49	O
)	O
.	O
the	O
association	O
between	O
sa	B-T103
and	O
diabetes	B-T038
was	O
explained	O
mainly	O
by	O
abdominal	B-T017
visceral	I-T017
fat	I-T017
.	O
in	O
women	B-T098
,	O
sa	B-T103
was	O
more	O
strongly	O
associated	O
with	O
vat	B-T017
than	O
with	O
bmi	B-T201
or	O
sat	B-T017
.	O
these	O
findings	O
provide	O
motivation	O
for	O
future	O
mechanistic	B-T170
studies	I-T170
on	O
sa	B-T103
'	I-T103
s	I-T103
role	O
in	O
metabolic	B-T038
diseases	I-T038
.	O

discovery	O
of	O
orally	B-T082
efficacious	O
phosphoinositide	B-T103
-	I-T103
3	I-T103
-	I-T103
kinase	I-T103
delta	I-T103
inhibitors	B-T103
with	O
improved	B-T033
metabolic	O
stability	O
aberrant	B-T038
signaling	I-T038
of	O
phosphoinositide	B-T103
-	I-T103
3	I-T103
-	I-T103
kinase	I-T103
delta	I-T103
(	O
pi3k	B-T103
-	I-T103
delta	I-T103
)	O
has	O
been	O
implicated	O
in	O
numerous	O
pathologies	B-T038
including	O
hematological	B-T038
malignancies	I-T038
and	O
rheumatoid	B-T038
arthritis	I-T038
.	O
described	O
in	O
this	O
manuscript	O
is	O
the	O
discovery	O
,	O
optimization	O
and	O
in	B-T082
vivo	I-T082
evaluation	B-T058
of	O
a	O
novel	O
series	O
of	O
pyridine	B-T103
-	I-T103
containing	I-T103
pi3k	B-T103
-	I-T103
delta	I-T103
inhibitors	B-T103
.	O
this	O
work	O
led	O
to	O
the	O
discovery	O
of	O
35	B-T103
,	O
a	O
highly	O
selective	O
inhibitor	B-T103
of	O
pi3k	B-T103
-	I-T103
delta	I-T103
which	O
displays	O
an	O
excellent	O
pharmacokinetic	O
profile	O
and	O
is	O
efficacious	O
in	O
a	O
rodent	B-T038
model	I-T038
of	O
rheumatoid	B-T038
arthritis	I-T038
.	O

robust	O
dlp	O
##p	O
with	O
nong	O
##ree	O
##dy	O
ℓ	O
##₁	O
$	O
-	O
norm	O
minimization	O
and	O
maxim	O
##ization	O
recently	O
,	O
discriminant	O
local	O
##ity	O
preserving	O
projection	O
based	O
on	O
l1	O
-	O
norm	O
(	O
dlp	O
##p	O
-	O
l1	O
)	O
was	O
developed	O
for	O
robust	O
subsp	B-T038
##ace	I-T038
learning	I-T038
and	O
image	B-T170
classification	B-T170
.	O
it	O
obtain	O
##s	O
projection	B-T082
vectors	B-T082
by	O
gre	B-T062
##ed	I-T062
##y	I-T062
strategy	I-T062
,	O
i	O
.	O
e	O
.	O
,	O
all	O
projection	B-T082
vectors	B-T082
are	O
optimized	O
individually	O
through	O
maximizing	O
the	O
objective	O
function	O
.	O
thus	O
,	O
the	O
obtained	O
solution	B-T170
does	O
not	O
necessarily	O
best	O
optimize	O
the	O
corresponding	O
trace	B-T170
ratio	I-T170
optimization	I-T170
algorithm	I-T170
,	O
which	O
is	O
the	O
essential	O
objective	O
function	O
for	O
general	O
dimensionality	B-T170
reduction	I-T170
.	O
it	O
results	O
in	O
insufficient	O
recognition	B-T038
accuracy	O
.	O
to	O
tackle	O
this	O
problem	O
,	O
we	O
propose	O
a	O
nong	B-T170
##ree	I-T170
##dy	I-T170
algorithm	I-T170
to	O
solve	O
the	O
trace	B-T170
ratio	I-T170
formula	I-T170
of	O
dlp	O
##p	O
-	O
l1	O
,	O
and	O
analyze	O
its	O
convergence	O
.	O
experimental	O
results	O
on	O
three	O
databases	B-T170
illustrate	O
the	O
effectiveness	O
of	O
our	O
proposed	O
algorithm	B-T170
.	O

international	O
validation	B-T062
of	O
a	O
urinary	B-T031
biomarker	B-T201
panel	B-T058
for	O
identification	O
of	O
active	O
lupus	B-T038
nephritis	I-T038
in	O
children	O
conventional	O
markers	B-T201
of	O
juvenile	B-T038
-	I-T038
onset	I-T038
systemic	I-T038
lupus	I-T038
erythematosus	I-T038
(	O
js	B-T038
##le	I-T038
)	O
disease	O
activity	O
fail	O
to	O
adequately	O
identify	O
lupus	B-T038
nephritis	I-T038
(	O
ln	B-T038
)	O
.	O
while	O
individual	O
novel	O
urine	B-T031
biomarkers	B-T201
are	O
good	O
at	O
detecting	B-T058
ln	B-T038
flare	B-T033
##s	I-T033
,	O
biomarker	B-T201
panels	B-T058
may	O
improve	O
diagnostic	O
accuracy	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
assess	O
the	O
performance	O
of	O
a	O
biomarker	B-T201
panel	B-T058
to	O
identify	O
active	O
ln	B-T038
in	O
two	O
international	O
js	B-T038
##le	I-T038
cohorts	B-T098
.	O
novel	O
urinary	B-T031
biomarkers	B-T201
,	O
namely	O
vascular	B-T103
cell	I-T103
adhesion	I-T103
molecule	I-T103
-	I-T103
1	I-T103
(	O
vcam	B-T103
-	I-T103
1	I-T103
)	O
,	O
monocyte	B-T103
chemoattractant	I-T103
protein	I-T103
1	I-T103
(	O
mcp	B-T103
-	I-T103
1	I-T103
)	O
,	O
lipo	B-T103
##cal	I-T103
##in	I-T103
-	I-T103
like	I-T103
prostaglandin	I-T103
d	I-T103
synthase	I-T103
(	O
lp	B-T103
##gd	I-T103
##s	I-T103
)	O
,	O
transferrin	B-T103
(	O
tf	B-T103
)	O
,	O
cer	B-T103
##uloplasmin	I-T103
,	O
alpha	B-T103
-	I-T103
1	I-T103
-	I-T103
acid	I-T103
glycoprotein	I-T103
(	O
agp	B-T103
)	O
and	O
neutrophil	B-T103
gelatinase	I-T103
-	I-T103
associated	I-T103
lipo	I-T103
##cal	I-T103
##in	I-T103
(	O
ng	B-T103
##al	I-T103
)	O
,	O
were	O
quantified	O
in	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
that	O
included	O
participants	B-T098
of	O
the	O
uk	B-T082
js	B-T038
##le	I-T038
cohort	O
study	O
(	O
cohort	B-T098
1	I-T098
)	O
and	O
validated	O
within	O
the	O
ei	B-T092
##ns	I-T092
##tein	I-T092
lupus	I-T092
cohort	B-T098
(	O
cohort	B-T098
2	I-T098
)	O
.	O
binary	O
logistic	B-T062
regression	I-T062
modelling	I-T062
and	O
receiver	O
operating	O
characteristic	O
curve	O
analysis	O
[	O
area	O
under	O
the	O
curve	O
(	O
auc	O
)	O
]	O
were	O
used	O
to	O
identify	O
and	O
assess	O
combinations	O
of	O
biomarkers	B-T201
for	O
diagnostic	O
accuracy	O
.	O
a	O
total	O
of	O
91	O
js	B-T038
##le	I-T038
patients	O
were	O
recruited	O
across	O
both	O
cohorts	B-T098
,	O
of	O
whom	O
31	O
(	O
34	O
%	O
)	O
had	O
active	O
ln	B-T038
and	O
60	O
(	O
66	O
%	O
)	O
had	O
no	O
ln	B-T038
.	O
urinary	B-T031
agp	B-T103
,	O
cer	B-T103
##uloplasmin	I-T103
,	O
vcam	B-T103
-	I-T103
1	I-T103
,	O
mcp	B-T103
-	I-T103
1	I-T103
and	O
lp	B-T103
##gd	I-T103
##s	I-T103
levels	O
were	O
significantly	O
higher	O
in	O
those	O
patients	O
with	O
active	O
ln	B-T038
than	O
in	O
non	O
-	O
ln	B-T038
patients	O
[	O
all	O
corrected	O
p	O
values	O
(	O
p	O
c	O
)	O
<	O
0	O
.	O
05	O
]	O
across	O
both	O
cohorts	B-T098
.	O
urinary	B-T031
tf	B-T103
also	O
differed	O
between	O
patient	O
groups	O
in	O
cohort	B-T098
2	I-T098
(	O
p	O
c	O
=	O
0	O
.	O
001	O
)	O
.	O
within	O
cohort	B-T098
1	I-T098
,	O
the	O
optimal	O
biomarker	B-T201
panel	B-T058
included	O
agp	B-T103
,	O
cer	B-T103
##uloplasmin	I-T103
,	O
lp	B-T103
##gd	I-T103
##s	I-T103
and	O
tf	B-T103
(	O
auc	O
0	O
.	O
92	O
##0	O
for	O
active	O
ln	B-T038
identification	O
)	O
.	O
these	O
results	O
were	O
validated	O
in	O
cohort	B-T098
2	I-T098
,	O
with	O
the	O
same	O
markers	B-T201
resulting	O
in	O
the	O
optimal	O
urine	B-T031
biomarker	B-T201
panel	B-T058
(	O
auc	O
0	O
.	O
99	O
##1	O
)	O
.	O
in	O
two	O
international	O
js	B-T038
##le	I-T038
cohorts	B-T098
,	O
urinary	B-T031
agp	B-T103
,	O
cer	B-T103
##uloplasmin	I-T103
,	O
lp	B-T103
##gd	I-T103
##s	I-T103
and	O
tf	B-T103
demonstrate	O
an	O
'	O
excellent	O
'	O
ability	O
for	O
accurately	O
identifying	O
active	O
ln	B-T038
in	O
children	O
.	O

medication	O
regimen	O
complexity	O
and	O
prevalence	O
of	O
potentially	O
inappropriate	O
medicines	O
in	O
older	B-T098
patients	O
after	O
hospitalisation	B-T058
background	O
there	O
is	O
a	O
relative	O
paucity	O
of	O
information	O
to	O
characterise	O
potential	O
changes	O
in	O
medication	O
regimen	O
complexity	O
and	O
prevalence	O
of	O
prescribing	B-T058
of	O
potentially	O
inappropriate	O
medications	O
after	O
hospitalisation	B-T058
,	O
both	O
in	O
australia	B-T082
and	O
elsewhere	O
.	O
objective	B-T170
to	O
evaluate	B-T058
medication	O
regimen	O
complexity	O
and	O
the	O
prevalence	O
of	O
potentially	O
inappropriate	O
medications	O
before	O
and	O
after	O
admission	B-T058
to	I-T058
hospital	I-T058
.	O
setting	O
general	B-T092
medical	I-T092
units	I-T092
of	O
a	O
tertiary	B-T092
care	I-T092
hospital	I-T092
in	O
australia	B-T082
.	O
methods	O
retrospective	B-T062
cohort	I-T062
study	I-T062
of	O
patients	O
aged	O
65	O
years	O
and	O
above	O
.	O
medication	B-T058
complexity	O
was	O
measured	O
by	O
using	O
the	O
medication	B-T170
regimen	I-T170
complexity	I-T170
index	I-T170
(	O
mrc	B-T170
##i	I-T170
)	O
.	O
main	O
outcome	O
measure	O
the	O
primary	O
outcome	O
was	O
the	O
change	O
in	O
the	O
medication	B-T170
regimen	I-T170
complexity	I-T170
index	I-T170
for	O
all	O
prescribed	B-T103
medications	I-T103
after	O
hospitalization	B-T058
.	O
results	B-T033
a	O
convenience	B-T062
sample	I-T062
of	O
100	O
patients	O
was	O
included	O
in	O
the	O
study	B-T062
.	O
there	O
was	O
a	O
significant	O
change	O
in	O
the	O
mean	O
medication	B-T058
complexity	O
score	O
(	O
as	O
measured	O
using	O
the	O
mrc	B-T170
##i	I-T170
)	O
,	O
increasing	O
from	O
29	O
at	O
the	O
time	O
of	O
admission	O
to	O
32	O
at	O
the	O
time	O
of	O
discharge	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
factors	O
such	O
as	O
baseline	O
medication	O
regimen	O
complexity	O
(	O
pre	O
-	O
admission	O
mrc	B-T170
##i	I-T170
)	O
and	O
length	O
of	O
stay	O
in	O
the	O
hospitals	O
appear	O
to	O
influence	O
the	O
change	O
in	O
medication	B-T058
complexity	O
.	O
however	O
,	O
the	O
proportion	O
of	O
patients	O
prescribed	O
at	O
least	O
one	O
potentially	O
inappropriate	O
medicine	O
(	O
pim	O
)	O
decreased	O
significantly	O
,	O
from	O
52	O
%	O
pre	B-T058
-	I-T058
hospitalization	I-T058
to	O
42	O
%	O
at	O
discharge	O
(	O
p	O
=	O
0	O
.	O
04	O
)	O
.	O
conclusions	O
relative	O
to	O
the	O
time	O
of	O
admission	O
,	O
overall	O
medication	B-T058
complexity	O
increased	O
and	O
the	O
proportion	O
of	O
patients	O
who	O
were	O
prescribed	O
pim	O
##s	O
decreased	O
after	O
hospitalisation	B-T058
.	O

socioeconomic	O
predictors	O
of	O
adherence	B-T033
behavior	I-T033
among	O
hiv	B-T033
-	I-T033
positive	I-T033
patients	O
receiving	O
antiretroviral	B-T058
therapy	I-T058
in	O
sel	B-T082
##ang	I-T082
##or	I-T082
,	O
malaysia	B-T082
medication	B-T033
adherence	I-T033
remains	O
a	O
critical	O
link	O
between	O
the	O
prescribed	O
art	B-T058
regimen	B-T058
and	O
treatment	O
outcome	O
.	O
several	O
factors	O
may	O
influence	O
adherence	B-T033
behavior	I-T033
.	O
this	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
aimed	O
to	O
highlight	O
socioeconomic	O
predictors	O
of	O
adherence	B-T033
behavior	I-T033
among	O
a	O
cohort	B-T098
of	O
242	O
adult	O
malaysia	B-T098
##n	I-T098
patients	O
receiving	O
antiretroviral	B-T058
therapy	I-T058
in	O
hospital	B-T092
sun	I-T092
##ga	I-T092
##i	I-T092
bul	I-T092
##oh	I-T092
,	O
malaysia	B-T082
,	O
where	O
they	O
were	O
enrolled	O
in	O
a	O
parent	O
study	O
(	O
single	B-T062
-	I-T062
blinded	I-T062
randomized	B-T062
controlled	I-T062
trial	I-T062
)	O
between	O
january	O
and	O
december	O
2014	O
.	O
statistical	O
analysis	O
of	O
secondary	O
data	O
on	O
adherence	B-T033
behavior	I-T033
and	O
sociodemographic	O
characteristics	O
of	O
the	O
patients	O
revealed	O
mean	B-T033
age	I-T033
of	O
33	O
.	O
4	O
years	O
and	O
ranged	O
from	O
18	O
to	O
64	O
years	O
;	O
88	O
.	O
8	O
%	O
were	O
males	O
.	O
a	O
total	O
of	O
224	O
(	O
93	O
%	O
)	O
patients	O
who	O
completed	O
6	O
months	O
'	O
adherence	O
assessment	O
were	O
included	O
in	O
the	O
model	O
.	O
of	O
these	O
,	O
135	O
(	O
60	O
.	O
3	O
%	O
)	O
achieved	B-T033
optimal	O
adherence	O
.	O
multivariate	B-T170
binary	I-T170
logistic	I-T170
regression	I-T170
analysis	I-T170
revealed	O
that	O
patient	O
'	O
s	O
income	O
and	O
ethnicity	O
were	O
significant	O
predictors	O
of	O
adherence	B-T033
behavior	I-T033
.	O
this	O
may	O
be	O
valuable	O
for	O
targeted	O
programm	B-T058
##atic	I-T058
interventions	I-T058
to	O
further	O
enhance	O
successful	B-T201
treatment	I-T201
outcomes	O
among	O
the	O
target	B-T098
population	I-T098
.	O

doxorubicin	B-T103
has	O
dose	O
-	O
dependent	O
toxicity	B-T037
on	O
mouse	B-T204
ovarian	B-T017
follicle	I-T017
development	B-T038
,	O
hormone	B-T038
secretion	I-T038
,	O
and	O
oocyte	B-T038
maturation	I-T038
doxorubicin	B-T103
(	O
dox	B-T103
)	O
,	O
one	O
of	O
the	O
most	O
commonly	O
used	O
anticancer	B-T103
medications	I-T103
,	O
has	O
been	O
reported	O
to	O
affect	O
fertility	B-T038
by	O
damaging	O
ovarian	B-T017
follicles	I-T017
;	O
however	O
,	O
the	O
dose	O
-	O
dependent	O
toxicity	B-T037
of	O
dox	B-T103
on	O
the	O
dynamic	O
follicle	B-T017
development	B-T038
and	O
oocyte	B-T038
maturation	I-T038
has	O
not	O
been	O
well	O
-	O
defined	O
.	O
our	O
objective	B-T170
is	O
to	O
determine	O
the	O
effects	O
of	O
human	B-T204
-	O
relevant	O
exposure	O
levels	O
of	O
dox	B-T103
on	O
follicular	B-T017
functions	O
across	O
developmental	B-T038
time	O
.	O
in	O
vitro	O
cultured	B-T058
multilayer	B-T017
##ed	I-T017
secondary	I-T017
mouse	I-T017
follicles	I-T017
were	O
treated	O
with	O
dox	B-T103
at	O
0	O
,	O
2	O
,	O
20	O
,	O
100	O
,	O
and	O
200	O
nm	O
for	O
24	O
h	O
,	O
and	O
follicle	B-T017
development	B-T038
,	O
hormone	B-T038
secretion	I-T038
,	O
and	O
oocyte	B-T038
maturation	I-T038
were	O
analyzed	O
.	O
dox	B-T103
caused	O
dose	O
-	O
dependent	O
toxicity	B-T037
on	O
follicle	B-T038
growth	I-T038
,	O
survival	O
,	O
and	O
secretion	B-T038
of	O
17β	B-T103
-	I-T103
estradiol	I-T103
(	O
e2	B-T103
)	O
.	O
at	O
200	O
nm	O
,	O
dox	B-T103
induced	O
dna	B-T038
damage	I-T038
and	O
apoptosis	B-T038
in	O
follicle	B-T017
somatic	B-T017
cells	I-T017
first	O
and	O
then	O
in	O
oocytes	B-T017
,	O
which	O
was	O
correlated	O
with	O
the	O
uptake	B-T038
of	O
dox	B-T103
first	O
to	O
the	O
somatic	B-T017
cells	I-T017
followed	O
by	O
germ	B-T017
cells	I-T017
.	O
follicles	B-T017
treated	O
with	O
dox	B-T103
at	O
0	O
,	O
2	O
,	O
and	O
20	O
nm	O
showed	O
similar	O
oocyte	B-T017
metaphase	B-T038
ii	I-T038
(	O
mi	B-T038
##i	I-T038
)	O
percentages	O
after	O
in	O
vitro	O
oocyte	B-T038
maturation	I-T038
;	O
however	O
,	O
20	O
nm	O
dox	B-T103
significantly	O
increased	O
the	O
number	O
of	O
mi	B-T038
##i	I-T038
oocytes	B-T017
with	O
abnormal	B-T033
spindle	B-T017
morphology	O
and	O
chromosome	B-T017
mis	O
##alignment	O
.	O
in	O
an	O
effort	O
to	O
harmon	O
##ize	O
the	O
in	O
vitro	O
study	O
to	O
in	B-T082
vivo	I-T082
treatment	O
,	O
dose	O
-	O
dependent	O
toxicity	B-T037
on	O
oocyte	B-T038
meiotic	I-T038
maturation	I-T038
was	O
found	O
in	O
16	O
-	O
day	O
-	O
old	O
cd	B-T204
-	I-T204
1	I-T204
mice	I-T204
treated	O
with	O
dox	B-T103
at	O
0	O
,	O
0	O
.	O
4	O
,	O
2	O
,	O
and	O
10	O
mg	O
/	O
kg	O
,	O
consistent	O
with	O
the	O
in	O
vitro	O
oocyte	B-T038
maturation	I-T038
outcomes	O
.	O
our	O
study	B-T062
demonstrates	O
that	O
dox	B-T103
has	O
dose	O
-	O
dependent	O
toxicity	B-T037
on	O
ovarian	B-T017
follicle	I-T017
development	B-T038
,	O
hormone	B-T038
secretion	I-T038
,	O
and	O
oocyte	B-T038
maturation	I-T038
,	O
which	O
are	O
three	O
key	O
factors	O
to	O
support	O
the	O
female	B-T038
reproductive	I-T038
and	O
endocrine	B-T038
functions	I-T038
.	O

well	O
,	O
i	O
would	O
##n	O
'	O
t	O
be	O
any	O
worse	O
off	O
,	O
would	O
i	O
,	O
than	O
i	O
am	O
now	O
?	O
a	O
qualitative	B-T062
study	I-T062
of	O
decision	B-T038
-	I-T038
making	I-T038
,	O
hope	B-T038
##s	I-T038
,	O
and	O
real	O
##ities	O
of	O
adults	O
with	O
type	B-T038
1	I-T038
diabetes	I-T038
undergoing	O
islet	B-T058
cell	I-T058
transplantation	I-T058
for	O
selected	O
individuals	B-T098
with	O
type	B-T038
1	I-T038
diabetes	I-T038
,	O
pancreatic	B-T058
islet	I-T058
transplantation	I-T058
(	O
it	B-T058
)	O
prevents	O
recurrent	O
severe	O
hypoglycemia	B-T038
and	O
optimize	B-T058
##s	I-T058
glycemia	I-T058
,	O
although	O
ongoing	O
systemic	B-T058
immunosuppression	I-T058
is	O
needed	O
.	O
our	O
aim	O
was	O
to	O
explore	O
candidates	B-T098
and	O
recipients	O
'	O
expectations	O
of	O
transplantation	B-T058
,	O
their	O
experience	O
of	O
being	O
on	O
the	O
waiting	B-T033
list	I-T033
,	O
and	O
(	O
for	O
recipients	O
)	O
the	O
procedure	O
and	O
life	O
posttransplant	O
.	O
cross	O
-	O
sectional	O
qualitative	O
research	B-T062
design	I-T062
using	O
semistructured	O
interviews	O
with	O
16	O
adults	O
(	O
8	O
pret	O
##ran	O
##sp	O
##la	O
##nt	O
,	O
8	O
posttransplant	O
;	O
from	O
4	O
uk	B-T082
centers	B-T092
(	O
n	O
=	O
13	O
)	O
and	O
1	O
canadian	B-T082
center	B-T092
(	O
n	O
=	O
3	O
)	O
)	O
.	O
interviews	O
were	O
audio	B-T058
-	I-T058
recorded	I-T058
,	O
transcribed	O
,	O
and	O
underwent	O
inductive	B-T062
thematic	I-T062
analysis	I-T062
.	O
interview	B-T098
##ees	I-T098
were	O
aged	O
(	O
mean	O
±	O
sd	O
)	O
52	O
±	O
10	O
years	O
(	O
range	O
,	O
30	O
-	O
64	O
)	O
;	O
duration	O
of	O
diabetes	B-T038
,	O
36	O
±	O
9	O
years	O
(	O
range	O
,	O
21	O
-	O
56	O
)	O
;	O
12	O
(	O
75	O
%	O
)	O
were	O
women	B-T098
.	O
narrative	O
accounts	O
centered	O
on	O
expectations	O
,	O
hope	B-T038
##s	I-T038
,	O
and	O
real	O
##ities	O
;	O
decision	B-T038
-	I-T038
making	I-T038
;	O
waiting	O
and	O
uncertainty	O
;	O
the	O
procedure	O
,	O
hospital	O
stay	O
,	O
and	O
follow	B-T058
-	I-T058
up	I-T058
.	O
expected	O
benefits	O
included	O
fewer	O
severe	O
hypoglycemic	B-T038
episodes	I-T038
,	O
reduced	O
need	O
for	O
insulin	B-T103
,	O
preventing	O
onset	O
/	O
progression	O
of	O
complications	B-T038
and	O
improved	O
psychological	B-T033
well	I-T033
-	I-T033
being	I-T033
.	O
these	O
were	O
realized	O
for	O
most	O
,	O
at	O
least	O
in	O
the	O
short	O
term	O
.	O
most	O
interview	B-T098
##ees	I-T098
described	O
well	O
-	O
informed	O
,	O
shared	O
decision	B-T038
-	I-T038
making	I-T038
with	O
clinicians	B-T097
and	O
family	O
,	O
and	O
managing	O
their	O
expectations	O
.	O
although	O
life	O
[UNK]	O
on	O
the	O
list	O
[UNK]	O
could	O
be	O
stressful	O
,	O
and	O
immunosuppress	B-T103
##ant	I-T103
side	B-T038
effects	I-T038
were	O
severe	O
,	O
interview	B-T098
##ees	I-T098
reported	O
[UNK]	O
no	B-T033
reg	B-T038
##ret	I-T038
##s	I-T038
.	O
[UNK]	O
posttransplant	O
,	O
interview	B-T098
##ees	I-T098
experienced	O
increased	O
confidence	B-T038
,	O
through	O
freedom	B-T033
from	I-T033
hypoglycemia	I-T033
and	O
regained	O
glycemic	B-T058
control	I-T058
,	O
which	O
temper	O
##ed	O
any	O
disapp	O
##oint	O
##ment	O
about	O
continued	O
reliance	O
on	O
insulin	B-T103
.	O
most	O
viewed	O
their	O
transplant	B-T058
as	O
a	O
success	O
,	O
though	O
several	O
reflected	O
upon	O
set	O
##back	O
##s	O
and	O
hidden	O
hope	B-T038
##s	I-T038
for	O
becoming	O
[UNK]	O
insulin	B-T033
-	I-T033
free	I-T033
.	O
[UNK]	O
independently	O
undertaken	O
interviews	O
demonstrated	O
realistic	O
and	O
balanced	O
expectations	O
of	O
it	B-T058
and	O
indicate	O
how	O
to	O
optimize	O
the	O
process	O
and	O
support	O
for	O
future	O
it	B-T058
candidates	B-T098
.	O

active	O
diffusion	O
and	O
microtubule	B-T038
-	I-T038
based	I-T038
transport	I-T038
opp	O
##ose	O
myosin	B-T103
forces	O
to	O
position	B-T082
organelles	B-T017
in	O
cells	B-T017
even	O
distribution	O
of	O
peroxisomes	B-T017
(	O
pos	B-T017
)	O
and	O
lipid	B-T017
droplets	I-T017
(	O
ld	B-T017
##s	I-T017
)	O
is	O
critical	O
to	O
their	O
role	O
in	O
lipid	B-T103
and	O
reactive	B-T103
oxygen	I-T103
species	I-T103
homeostasis	B-T038
.	O
how	O
even	O
distribution	O
is	O
achieved	O
remains	O
elusive	O
,	O
but	O
diffusive	O
motion	O
and	O
directed	O
motility	B-T038
may	O
play	O
a	O
role	O
.	O
here	O
we	O
show	O
that	O
in	O
the	O
fungus	B-T204
us	B-T204
##til	I-T204
##ago	I-T204
may	I-T204
##dis	I-T204
~	O
95	O
%	O
of	O
pos	B-T017
and	O
ld	B-T017
##s	I-T017
undergo	O
diffusive	O
motions	O
.	O
these	O
movements	B-T038
require	O
atp	B-T103
and	O
involve	O
bidirectional	O
early	O
endos	B-T017
##ome	I-T017
motility	B-T038
,	O
indicating	O
that	O
microtubule	B-T017
-	O
associated	O
membrane	B-T017
trafficking	O
enhances	O
diffusion	O
of	O
organelles	B-T017
.	O
when	O
early	O
endos	B-T038
##ome	I-T038
transport	I-T038
is	O
abolished	O
,	O
pos	B-T017
and	O
ld	B-T017
##s	I-T017
drift	O
slowly	O
towards	O
the	O
growing	B-T017
cell	I-T017
end	I-T017
.	O
this	O
pole	B-T038
-	I-T038
ward	I-T038
drift	I-T038
is	O
facilitated	O
by	O
anterograde	O
delivery	O
of	O
secretory	O
cargo	O
to	O
the	O
cell	B-T017
tip	I-T017
by	O
myosin	B-T103
-	I-T103
5	I-T103
.	O
modelling	B-T062
reveals	O
that	O
microtubule	B-T038
-	I-T038
based	I-T038
directed	I-T038
transport	I-T038
and	O
active	O
diffusion	O
support	O
distribution	O
,	O
mobility	B-T038
and	O
mixing	O
of	O
pos	B-T017
.	O
in	O
mammalian	B-T204
cos	B-T017
-	I-T017
7	I-T017
cells	I-T017
,	O
microtubules	B-T017
and	O
f	B-T103
-	I-T103
actin	I-T103
also	O
counteract	O
each	O
other	O
to	O
distrib	O
##ute	O
pos	B-T017
.	O
this	O
highlights	O
the	O
importance	O
of	O
opposing	O
cytoskeletal	B-T017
forces	O
in	O
organelle	B-T017
positioning	B-T082
in	O
eukaryotes	B-T204
.	O

approximate	O
bayesian	O
computation	O
for	O
estimating	O
number	O
concentrations	O
of	O
monod	O
##isperse	O
nanoparticles	O
in	O
suspension	O
by	O
optical	B-T058
microscopy	I-T058
we	O
present	O
an	O
approximate	O
bayesian	O
computation	O
scheme	B-T170
for	O
estimating	O
number	O
concentrations	O
of	O
monod	O
##isperse	O
diffusing	O
nanoparticles	O
in	O
suspension	O
by	O
optical	B-T058
particle	I-T058
tracking	I-T058
microscopy	I-T058
.	O
the	O
method	O
is	O
based	O
on	O
the	O
probability	O
distribution	O
of	O
the	O
time	O
spent	O
by	O
a	O
particle	B-T103
inside	B-T082
a	O
detection	B-T058
region	B-T082
.	O
we	O
validate	O
the	O
method	O
on	O
suspensions	O
of	O
well	O
-	O
controlled	O
reference	O
particles	B-T103
.	O
we	O
illustrate	O
its	O
usefulness	O
with	O
an	O
application	O
in	O
gene	B-T058
therapy	I-T058
,	O
applying	O
the	O
method	O
to	O
estimate	O
number	O
concentrations	O
of	O
plasmid	B-T103
dna	B-T103
molecules	I-T103
and	O
the	O
average	O
number	O
of	O
dna	B-T103
molecules	I-T103
complexed	B-T103
with	O
liposomal	B-T103
drug	B-T074
delivery	I-T074
particles	B-T103
.	O

what	O
can	O
the	O
canadian	B-T098
##s	I-T098
and	O
americans	B-T098
learn	B-T038
from	O
each	O
other	O
'	O
s	O
health	B-T092
care	I-T092
systems	I-T092
?	O
numerous	O
papers	B-T170
have	O
been	O
written	O
comparing	O
the	O
canadian	B-T098
and	O
us	B-T082
healthcare	B-T092
systems	I-T092
,	O
and	O
a	O
number	O
of	O
health	B-T170
policy	I-T170
experts	B-T097
have	O
recommended	O
that	O
the	O
americans	B-T098
implement	O
their	O
single	B-T058
-	I-T058
pay	I-T058
##er	I-T058
system	I-T058
to	O
save	O
12	O
-	O
20	O
%	O
of	O
its	O
healthcare	O
expenditures	O
.	O
this	O
paper	B-T170
is	O
different	O
in	O
that	O
it	O
assumes	O
that	O
neither	O
country	B-T082
will	O
undertake	O
a	O
significant	O
philosoph	O
##ic	O
or	O
structural	B-T082
change	O
in	O
their	O
healthcare	B-T092
system	I-T092
,	O
but	O
there	O
are	O
lessons	O
to	O
be	O
learned	B-T038
that	O
are	O
inherent	O
in	O
one	O
that	O
could	O
be	O
a	O
major	O
breakthrough	O
for	O
the	O
other	O
.	O
following	O
the	O
model	B-T082
in	O
canada	B-T082
and	O
in	O
western	B-T082
europe	I-T082
,	O
the	O
usa	B-T082
could	O
implement	O
universal	O
health	B-T058
insurance	I-T058
so	O
that	O
the	O
32	O
.	O
0	O
million	O
(	O
2015	O
)	O
americans	B-T098
still	O
uninsured	B-T098
would	O
have	O
at	O
least	O
minimal	O
coverage	O
when	O
inc	O
##urr	O
##ing	O
medical	O
expenditures	O
.	O
also	O
,	O
the	O
usa	B-T082
could	O
use	O
smart	O
cards	O
to	O
evaluate	B-T058
eligibility	I-T058
and	O
to	O
process	O
health	O
insurance	O
claims	O
;	O
these	O
changes	O
resulting	O
in	O
an	O
estimated	O
15	O
%	O
reduction	O
in	O
us	B-T082
health	O
expenditures	O
without	O
adversely	O
effect	O
##ing	O
access	O
or	O
quality	B-T058
of	I-T058
care	I-T058
.	O
such	O
a	O
strategy	O
would	O
result	O
in	O
the	O
eventual	O
loss	O
of	O
2	O
.	O
5	O
million	O
white	O
-	O
collar	O
jobs	O
at	O
hospitals	B-T092
,	O
physician	B-T092
offices	I-T092
and	O
insurance	O
companies	O
,	O
a	O
long	O
-	O
term	O
economic	O
gain	O
.	O
only	O
a	O
few	O
would	O
agree	O
with	O
the	O
statement	O
that	O
canada	B-T082
already	O
functions	O
with	O
a	O
multi	B-T092
-	I-T092
pay	I-T092
##er	I-T092
reimbursement	B-T170
system	I-T170
as	O
evidenced	O
by	O
(	O
1	O
)	O
a	O
federal	B-T092
-	O
provincial	B-T082
,	O
tax	O
-	O
supported	O
plan	O
,	O
administered	O
by	O
each	O
of	O
the	O
provinces	B-T082
,	O
providing	O
universal	O
coverage	O
for	O
hospital	B-T092
and	O
physician	B-T058
services	I-T058
and	O
(	O
2	O
)	O
roughly	O
60	O
%	O
of	O
its	O
residents	B-T098
receiving	O
employ	O
##er	O
-	O
paid	O
health	B-T058
insurance	I-T058
benefits	O
,	O
underw	O
##ri	O
##tt	O
##en	O
primarily	O
by	O
invest	O
##or	O
-	O
own	O
##ed	O
plans	O
,	O
that	O
are	O
less	O
than	O
effective	O
to	O
reimburs	O
##e	O
for	O
pharmaceuticals	B-T058
,	O
dental	B-T058
and	O
other	O
healthcare	B-T058
services	I-T058
.	O
what	O
could	O
be	O
learned	O
from	O
the	O
usa	B-T082
and	O
particularly	O
from	O
western	B-T082
european	I-T082
countries	I-T082
is	O
possibly	O
implementing	O
an	O
approach	O
,	O
whereby	O
at	O
least	O
upper	O
-	O
income	O
canadian	B-T098
##s	I-T098
could	O
opt	O
out	O
of	O
their	O
federal	B-T092
-	O
provincial	B-T082
plan	O
and	O
purchase	O
private	B-T092
insurance	O
coverage	O
-	O
being	O
eligible	O
for	O
far	O
more	O
comprehensive	O
[UNK]	O
private	O
[UNK]	O
benefits	O
for	O
hospital	B-T092
,	O
physician	B-T058
,	O
pharmaceutical	B-T058
,	O
dental	B-T058
and	O
other	O
healthcare	B-T058
services	I-T058
.	O
asi	O
##de	O
from	O
generating	O
billion	O
##s	O
of	O
additional	O
needed	O
reven	O
##ues	O
from	O
the	O
private	B-T098
sector	I-T098
,	O
it	O
could	O
(	O
1	O
)	O
help	O
eliminate	O
long	O
wait	O
##s	O
for	O
non	O
-	O
emergent	O
physicians	O
'	O
care	O
by	O
appoint	O
##ing	O
newly	O
min	O
##ted	O
specialists	B-T097
to	O
their	O
medical	B-T097
staff	I-T097
##s	I-T097
;	O
(	O
2	O
)	O
offer	O
prompt	O
admissions	B-T058
for	O
elective	B-T033
cases	I-T033
to	O
[UNK]	O
private	B-T092
[UNK]	O
wing	B-T092
##s	I-T092
of	I-T092
hospitals	I-T092
;	O
(	O
3	O
)	O
increase	O
available	O
funding	O
for	O
what	O
is	O
currently	O
an	O
under	B-T033
##cap	I-T033
##ital	I-T033
##ized	I-T033
system	O
;	O
(	O
4	O
)	O
enhance	O
the	O
system	O
'	O
s	O
sl	B-T033
##ugg	I-T033
##ish	I-T033
operations	O
;	O
and	O
(	O
5	O
)	O
encourage	O
more	O
competition	O
among	O
various	O
providers	O
.	O
although	O
such	O
a	O
two	B-T170
-	I-T170
tier	I-T170
approach	I-T170
,	O
such	O
as	O
available	O
in	O
the	O
usa	B-T082
and	O
elsewhere	O
,	O
is	O
political	O
##ly	O
dead	O
on	O
arrival	O
in	O
canada	B-T082
today	O
,	O
private	O
insurance	O
being	O
already	O
legal	O
and	O
commonly	O
available	O
there	O
.	O
interestingly	O
,	O
this	O
recommended	O
solution	O
is	O
utilized	O
in	O
most	O
western	B-T082
european	I-T082
countries	I-T082
where	O
there	O
is	O
a	O
higher	O
percentage	O
##a	O
than	O
in	O
canada	B-T082
of	O
public	B-T092
(	O
versus	O
private	O
)	O
funding	O
of	O
their	O
total	O
health	O
expenditures	O
.	O
because	O
of	O
various	O
ves	O
##ted	O
interests	O
,	O
attempts	O
to	O
implement	O
any	O
of	O
the	O
aforementioned	O
proposals	O
will	O
undoubtedly	O
result	O
in	O
considerable	O
political	O
ran	B-T038
##cor	I-T038
.	O
there	O
is	O
greater	O
likelihood	O
,	O
however	O
,	O
that	O
the	O
canadian	B-T098
##s	I-T098
because	O
their	O
need	O
to	O
be	O
more	O
effective	O
and	O
efficient	O
in	O
their	O
delivery	B-T058
of	I-T058
care	I-T058
,	O
and	O
their	O
overall	O
long	O
-	O
term	O
fis	O
##cal	O
outl	O
##oo	O
##k	O
will	O
agree	B-T033
to	O
the	O
further	O
priv	O
##atization	O
of	O
their	O
healthcare	B-T092
system	I-T092
before	O
the	O
americans	B-T098
will	O
mand	O
##ate	O
universal	O
access	O
,	O
use	O
the	O
smart	O
card	O
to	O
process	O
insurance	O
eligibility	O
and	O
claims	O
or	O
will	O
imp	O
##ose	O
price	O
controls	O
on	O
high	O
-	O
tec	O
##h	O
services	O
and	O
on	O
pharmaceuticals	B-T103
.	O
copyright	O
©	O
2016	O
john	O
wiley	O
&	O
sons	O
,	O
ltd	O
.	O

central	B-T201
corneal	I-T201
thickness	I-T201
reproducibility	O
among	O
ten	O
different	O
instruments	O
to	O
assess	O
agreement	O
between	O
one	O
ultrasonic	B-T074
(	O
us	B-T074
)	O
and	O
nine	O
optical	O
instruments	O
for	O
the	O
measurement	O
of	O
central	B-T201
corneal	I-T201
thickness	I-T201
(	O
cct	B-T201
)	O
,	O
and	O
to	O
evaluate	B-T058
intra	O
-	O
and	O
inter	O
-	O
operator	O
reproducibility	O
.	O
in	O
this	O
observational	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
,	O
two	O
masked	O
operators	O
measured	O
cct	B-T201
thickness	O
twice	O
in	O
28	O
healthy	O
eyes	B-T017
.	O
we	O
used	O
seven	O
spectral	B-T074
-	I-T074
domain	I-T074
optical	I-T074
coherence	I-T074
tomography	I-T074
(	I-T074
sd	I-T074
-	I-T074
oct	I-T074
)	I-T074
devices	I-T074
,	O
one	O
time	O
-	O
domain	O
oct	O
,	O
one	O
sch	B-T074
##ei	I-T074
##mp	I-T074
##flu	I-T074
##g	I-T074
camera	I-T074
,	O
and	O
one	O
us	B-T074
-	I-T074
based	I-T074
instrument	I-T074
.	O
inter	O
-	O
and	O
intra	O
-	O
operator	O
reproducibility	O
was	O
evaluated	B-T058
by	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
,	O
coefficient	O
of	O
variation	O
(	O
cv	O
)	O
,	O
and	O
bland	O
-	O
altman	O
test	O
analysis	B-T062
.	O
instrument	B-T074
-	O
to	O
-	O
instrument	B-T074
reproducibility	O
was	O
determined	O
by	O
anova	O
for	O
repeated	O
measurements	O
.	O
we	O
also	O
tested	O
how	O
the	O
devices	B-T074
disagre	O
##ed	O
regarding	O
systemic	O
bias	O
and	O
random	O
error	O
using	O
a	O
structural	O
equation	O
model	O
.	O
mean	O
cct	B-T201
of	O
all	O
instruments	B-T074
ranged	O
from	O
53	O
##6	O
±	O
42	O
μm	O
to	O
57	O
##7	O
±	O
40	O
μm	O
.	O
an	O
instrument	B-T074
-	O
to	O
-	O
instrument	B-T074
correlation	B-T170
test	I-T170
showed	O
high	O
values	O
among	O
the	O
10	O
investigated	O
devices	B-T074
(	O
correlation	O
coefficient	O
range	O
0	O
.	O
85	O
##2	O
-	O
0	O
.	O
99	O
##5	O
;	O
p	O
values	O
<	O
0	O
.	O
0001	O
in	O
all	O
cases	O
)	O
.	O
the	O
highest	O
correlation	O
coefficient	O
values	O
were	O
registered	O
between	O
3d	O
oct	O
-	O
2000	O
top	O
##con	O
-	O
spectral	O
oct	O
/	O
sl	O
##o	O
op	O
##ko	O
(	O
0	O
.	O
99	O
##5	O
)	O
and	O
cir	O
##ru	O
##s	O
hd	O
-	O
oct	O
ze	O
##iss	O
-	O
rs	O
-	O
3000	O
nid	O
##ek	O
(	O
0	O
.	O
99	O
##5	O
)	O
,	O
whereas	O
the	O
lowest	O
were	O
seen	O
between	O
ss	O
-	O
1000	O
cas	O
##ia	O
and	O
spectral	O
oct	O
/	O
sl	O
##o	O
op	O
##ko	O
(	O
0	O
.	O
85	O
##2	O
)	O
.	O
icc	O
and	O
cv	O
showed	O
excellent	O
inter	O
-	O
and	O
intra	O
-	O
operator	O
reproducibility	O
for	O
all	O
optic	O
-	O
based	O
devices	B-T074
,	O
except	O
for	O
the	O
us	B-T074
-	O
based	O
device	B-T074
.	O
bland	O
-	O
altman	O
analysis	B-T062
demonstrated	O
low	O
mean	O
biases	O
between	O
operators	O
.	O
despite	O
highlighting	O
good	O
intra	O
-	O
and	O
inter	O
-	O
operator	O
reproducibility	O
,	O
we	O
found	O
that	O
a	O
scale	B-T170
bias	O
between	O
instruments	B-T074
might	O
interfere	O
with	O
thorough	O
cct	B-T201
monitoring	B-T058
.	O
we	O
suggest	O
that	O
optimal	O
monitoring	B-T058
is	O
achieved	O
with	O
the	O
same	O
operator	O
and	O
the	O
same	O
device	B-T074
.	O

developing	O
elite	O
neuros	B-T204
##pora	I-T204
crass	I-T204
##a	I-T204
strains	O
for	O
cellul	B-T103
##osi	I-T103
##c	I-T103
ethanol	B-T038
production	I-T038
using	O
fungal	O
breeding	B-T038
the	O
demand	O
for	O
renewable	O
and	O
sustainable	O
energy	O
has	O
generated	O
considerable	O
interest	B-T038
in	O
the	O
conversion	O
of	O
cellul	B-T103
##osi	I-T103
##c	I-T103
biomass	O
into	O
liquid	O
fuels	O
such	O
as	O
ethanol	B-T103
using	O
a	O
filamentous	B-T204
fungus	I-T204
.	O
while	O
attempts	O
have	O
been	O
made	O
to	O
study	B-T062
cellulose	B-T038
metabolism	I-T038
through	O
the	O
use	O
of	O
knock	B-T038
-	I-T038
out	I-T038
mutants	B-T038
,	O
there	O
have	O
been	O
no	O
systematic	O
effort	O
to	O
characterize	O
natural	O
variation	O
for	O
cellulose	B-T038
metabolism	I-T038
in	O
eco	O
##type	O
##s	O
adapted	O
to	O
different	O
habitats	B-T082
.	O
here	O
,	O
we	O
characterized	O
natural	O
variation	O
in	O
sacch	O
##ari	O
##fi	O
##ca	O
##tion	O
of	O
cellulose	B-T103
and	O
fermentation	B-T038
in	O
73	O
eco	O
##type	O
##s	O
and	O
89	O
laboratory	B-T092
strains	O
of	O
the	O
model	B-T170
fungus	B-T204
neuros	B-T204
##pora	I-T204
crass	I-T204
##a	I-T204
.	O
we	O
observed	O
significant	O
variation	O
in	O
both	O
traits	O
among	O
natural	O
and	O
laboratory	O
generated	O
populations	B-T204
,	O
with	O
some	O
elite	O
strains	O
performing	O
better	O
than	O
the	O
reference	O
strain	O
.	O
in	O
the	O
f1	O
population	O
n3	O
##45	O
,	O
15	O
%	O
of	O
the	O
population	B-T204
outperformed	O
both	O
parents	B-T204
with	O
the	O
top	O
performing	O
strain	O
having	O
10	O
%	O
improvement	O
in	O
ethanol	B-T038
production	I-T038
.	O
these	O
results	O
suggest	O
that	O
natural	O
alleles	B-T017
can	O
be	O
exploited	O
through	O
fungal	O
breeding	B-T038
for	O
developing	O
elite	O
industrial	O
strains	O
for	O
bio	B-T038
##ethanol	I-T038
production	I-T038
.	O

visualization	B-T033
and	O
targeting	O
of	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
human	B-T204
colon	B-T017
cancer	B-T017
stem	I-T017
cells	I-T017
the	O
cancer	B-T017
stem	I-T017
cell	I-T017
(	O
csc	B-T017
)	O
theory	O
highlights	O
a	O
self	B-T038
-	I-T038
renew	I-T038
##ing	I-T038
subpopulation	B-T170
of	O
cancer	B-T017
cells	I-T017
that	O
fuels	O
tumour	O
growth	O
.	O
the	O
existence	O
of	O
human	B-T204
cscs	B-T017
is	O
mainly	O
supported	O
by	O
xeno	B-T058
##transplantation	I-T058
of	O
prospectively	O
isolated	B-T033
cells	I-T033
,	O
but	O
their	O
clonal	B-T017
dynamics	O
and	O
plasticity	O
remain	O
unclear	O
.	O
here	O
,	O
we	O
show	O
that	O
human	B-T204
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
colorectal	B-T017
cancer	I-T017
cells	I-T017
serve	O
as	O
cscs	B-T017
in	O
growing	O
cancer	B-T038
tissues	B-T017
.	O
lineage	O
-	O
tracing	B-T058
experiments	I-T058
with	O
a	O
tamoxifen	B-T103
-	O
inducible	O
cre	B-T103
knock	B-T062
-	I-T062
in	I-T062
allele	B-T017
of	O
lg	B-T103
##r	I-T103
##5	I-T103
reveal	O
the	O
self	B-T038
-	I-T038
renewal	I-T038
and	O
differentiation	B-T038
capacity	O
of	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
tumour	B-T017
cells	I-T017
.	O
selective	O
ablation	B-T058
of	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
cscs	B-T017
in	O
lg	B-T017
##r	I-T017
##5	I-T017
-	O
i	O
caspase	B-T017
##9	I-T017
knock	B-T062
-	I-T062
in	I-T062
organ	B-T017
##oids	I-T017
leads	O
to	O
tumour	O
regression	O
,	O
followed	O
by	O
tumour	O
regrowth	O
driven	O
by	O
re	O
-	O
emerging	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
cscs	B-T017
.	O
kr	B-T017
##t2	I-T017
##0	I-T017
knock	B-T062
-	I-T062
in	I-T062
reporter	B-T017
marks	O
differentiated	B-T038
cancer	B-T017
cells	I-T017
that	O
constantly	O
diminish	O
in	O
tumour	B-T017
tissues	I-T017
,	O
while	O
revert	O
##ing	O
to	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
cscs	B-T017
and	O
contributing	O
to	O
tumour	O
regrowth	O
after	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
csc	B-T017
ablation	B-T058
.	O
we	O
also	O
show	O
that	O
combined	O
chemotherapy	B-T058
potentiates	O
targeting	O
of	O
lg	B-T017
##r	I-T017
##5	I-T017
(	I-T017
+	I-T017
)	I-T017
cscs	B-T017
.	O
these	O
data	O
provide	O
insights	O
into	O
the	O
plasticity	O
of	O
cscs	B-T017
and	O
their	O
potential	O
as	O
a	O
therapeutic	O
target	O
in	O
human	B-T204
colorectal	B-T038
cancer	I-T038
.	O

transforming	B-T103
growth	I-T103
factor	I-T103
beta	I-T103
1	I-T103
(	O
tgf	B-T103
-	I-T103
β1	I-T103
)	O
in	O
thyroid	B-T038
cancer	I-T038
patients	O
:	O
a	O
view	O
from	O
the	O
peripheral	B-T031
blood	I-T031
transforming	B-T103
growth	I-T103
factor	I-T103
beta	I-T103
(	O
tgf	B-T103
-	I-T103
β	I-T103
)	O
plays	O
an	O
important	O
role	O
in	O
many	O
pathophysiological	O
conditions	O
,	O
including	O
cancer	B-T038
.	O
the	O
level	O
of	O
tgf	B-T103
-	I-T103
β	I-T103
in	O
patients	O
with	O
differentiated	B-T038
thyroid	I-T038
cancer	I-T038
(	O
dtc	B-T038
)	O
has	O
not	O
been	O
examined	B-T033
so	O
far	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
measure	O
tgf	B-T103
-	I-T103
β	I-T103
concentration	O
in	O
serum	B-T031
samples	I-T031
and	O
in	O
pha	B-T103
-	O
stimulated	B-T038
whole	B-T031
blood	I-T031
culture	B-T058
in	O
vitro	O
and	O
to	O
analyze	B-T062
possible	O
associations	O
of	O
tgf	B-T103
-	I-T103
β1	I-T103
levels	O
with	O
leukocyte	B-T017
,	O
lymphocyte	B-T017
and	O
platelets	B-T017
counts	B-T058
,	O
the	O
histological	O
type	O
of	O
thyroid	B-T038
cancer	I-T038
,	O
and	O
stage	O
of	O
disease	O
.	O
tgf	B-T103
-	I-T103
β1	I-T103
was	O
measured	O
in	O
22	O
dtc	B-T038
patients	O
and	O
20	O
healthy	O
controls	O
using	O
the	O
du	B-T074
##ose	I-T074
##t	I-T074
elisa	I-T074
development	I-T074
kit	I-T074
for	O
human	B-T103
tgf	I-T103
-	I-T103
β1	I-T103
.	O
the	O
concentration	O
of	O
tgf	B-T103
-	I-T103
β1	I-T103
in	O
serum	B-T031
samples	I-T031
from	O
both	O
groups	B-T098
correlated	O
positively	O
with	O
the	O
platelet	B-T017
counts	B-T058
.	O
there	O
was	O
no	O
statistically	O
significant	O
difference	O
in	O
the	O
serum	O
concentrations	O
of	O
tgf	B-T103
-	I-T103
β1	I-T103
between	O
dtc	B-T038
patients	O
and	O
control	O
subjects	O
,	O
but	O
pha	B-T103
stimulated	B-T038
whole	B-T031
blood	I-T031
cultures	B-T058
of	O
dtc	B-T038
patients	O
produced	O
less	O
tgf	B-T103
-	I-T103
β1	I-T103
than	O
those	O
from	O
controls	O
.	O
additional	O
studies	B-T062
are	O
needed	O
to	O
determine	O
the	O
significance	O
of	O
these	O
in	O
vitro	O
findings	B-T033
.	O

increased	O
acute	O
mortality	O
with	O
chemoradiotherapy	B-T058
for	O
locally	B-T038
advanced	I-T038
head	I-T038
and	I-T038
neck	I-T038
cancer	I-T038
in	O
patients	O
≥	O
##70	O
years	O
concurrent	B-T058
chemoradiotherapy	I-T058
(	O
crt	B-T058
)	O
is	O
the	O
standard	B-T058
of	I-T058
care	I-T058
for	O
many	O
sites	B-T082
of	O
locally	B-T038
advanced	I-T038
head	I-T038
and	I-T038
neck	I-T038
squamous	I-T038
cell	I-T038
carcinomas	I-T038
(	O
la	B-T038
##hn	I-T038
##c	I-T038
)	O
.	O
however	O
,	O
on	O
meta	B-T062
-	I-T062
analysis	I-T062
,	O
the	O
addition	O
of	O
chemotherapy	B-T058
did	O
not	O
improve	O
survival	O
for	O
patients	O
>	O
70	O
years	O
.	O
we	O
hypothesized	O
that	O
elderly	B-T098
patients	O
treated	O
with	O
crt	B-T058
would	O
have	O
increased	O
toxicity	B-T037
without	O
similar	O
improvements	O
in	O
survival	O
.	O
a	O
single	B-T092
-	I-T092
institution	I-T092
,	O
irb	B-T170
-	I-T170
approved	I-T170
retrospective	B-T062
study	I-T062
took	O
place	O
from	O
2005	O
to	O
2012	O
including	O
36	O
##9	O
patients	O
treated	O
with	O
crt	B-T058
for	O
la	B-T038
##hn	I-T038
##c	I-T038
.	O
multivariate	B-T170
models	I-T170
for	O
death	B-T033
at	O
3	O
months	O
and	O
death	B-T033
over	O
time	O
were	O
developed	O
using	O
logistic	B-T062
regression	I-T062
and	O
cox	B-T062
modeling	I-T062
,	O
respectively	O
.	O
patients	O
≥	O
##70	O
years	O
were	O
treated	O
less	O
often	O
with	O
concurrent	O
cisplatin	B-T103
dosed	O
every	O
3	O
weeks	O
(	O
25	O
.	O
5	O
%	O
vs	O
.	O
71	O
.	O
4	O
%	O
,	O
respectively	O
)	O
and	O
more	O
often	O
with	O
weekly	O
carboplatin	B-T103
(	O
31	O
.	O
9	O
%	O
vs	O
.	O
3	O
.	O
4	O
%	O
)	O
than	O
patients	O
<	O
70	O
years	O
(	O
n	O
=	O
322	O
;	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
patients	O
≥	O
##70	O
years	O
experienced	O
increased	O
toxicity	B-T037
during	O
treatment	B-T058
with	O
more	O
frequently	O
hospitalizations	B-T058
(	O
36	O
.	O
2	O
%	O
vs	O
.	O
21	O
.	O
1	O
%	O
;	O
p	O
=	O
0	O
.	O
02	O
)	O
and	O
a	O
lower	O
rate	O
of	O
peg	B-T058
removal	I-T058
at	O
last	O
follow	B-T058
-	I-T058
up	I-T058
or	O
death	B-T033
(	O
77	O
.	O
1	O
%	O
vs	O
.	O
92	O
.	O
9	O
%	O
;	O
p	O
=	O
0	O
.	O
004	O
)	O
.	O
a	O
higher	O
proportion	O
of	O
patients	O
≥	O
##70	O
years	O
died	O
within	O
3	O
months	O
(	O
12	O
.	O
8	O
%	O
vs	O
.	O
2	O
.	O
8	O
%	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
following	O
crt	B-T058
.	O
patients	O
≥	O
##70	O
had	O
an	O
increased	O
risk	O
of	O
death	B-T033
at	O
3	O
months	O
following	O
crt	B-T058
(	O
odds	O
ratio	O
5	O
.	O
19	O
,	O
95	O
%	O
ci	O
1	O
.	O
64	O
-	O
16	O
.	O
41	O
;	O
p	O
=	O
0	O
.	O
005	O
)	O
and	O
worse	O
survival	O
over	O
time	O
(	O
hazard	O
ratio	O
2	O
.	O
30	O
,	O
95	O
%	O
ci	O
1	O
.	O
34	O
-	O
3	O
.	O
93	O
;	O
p	O
=	O
0	O
.	O
002	O
)	O
.	O
patients	O
≥	O
##70	O
years	O
were	O
more	O
often	O
treated	O
with	O
less	O
toxic	O
chemotherapy	B-T058
,	O
yet	O
experienced	O
higher	O
rates	O
of	O
hospitalization	B-T058
during	O
treatment	B-T058
and	O
increased	O
rates	O
of	O
acute	O
mortality	O
following	O
crt	B-T058
.	O
the	O
efficacy	O
of	O
chemoradiotherapy	B-T058
for	O
elderly	B-T098
patients	O
should	O
be	O
evaluated	O
in	O
a	O
prospective	O
setting	O
.	O

physiological	O
properties	O
and	O
behavioral	O
correlates	O
of	O
hippocampal	B-T017
granule	B-T017
cells	I-T017
and	O
moss	B-T017
##y	I-T017
cells	I-T017
the	O
hippocampal	B-T017
dentate	B-T017
gyrus	I-T017
is	O
often	O
viewed	O
as	O
a	O
segreg	O
##ator	O
of	O
upstream	O
information	O
.	O
physiological	B-T038
support	I-T038
for	O
such	O
function	O
has	O
been	O
hampered	O
by	O
a	O
lack	O
of	O
well	O
-	O
defined	O
characteristics	O
that	O
can	O
identify	O
granule	B-T017
cells	I-T017
and	O
moss	B-T017
##y	I-T017
cells	I-T017
.	O
we	O
developed	O
an	O
electrophysiology	O
-	O
based	O
classification	B-T170
of	O
dentate	B-T017
granule	B-T017
cells	I-T017
and	O
moss	B-T017
##y	I-T017
cells	I-T017
in	O
mice	B-T204
that	O
we	O
validated	O
by	O
opto	B-T062
##gene	I-T062
##tic	I-T062
tagging	I-T062
of	O
moss	B-T017
##y	I-T017
cells	I-T017
.	O
granule	B-T017
cells	I-T017
exhibited	O
sparse	O
firing	B-T038
,	O
had	O
a	O
single	O
place	O
field	O
,	O
and	O
showed	O
only	O
modest	O
changes	O
when	O
the	O
mouse	B-T204
was	O
tested	O
in	O
different	O
maze	O
##s	O
in	O
the	O
same	O
room	B-T082
.	O
in	O
contrast	O
,	O
moss	B-T017
##y	I-T017
cells	I-T017
were	O
more	O
active	O
,	O
had	O
multiple	O
place	O
fields	O
and	O
showed	O
stronger	O
rem	O
##apping	O
of	O
place	O
fields	O
under	O
the	O
same	O
conditions	O
.	O
although	O
the	O
granule	B-T017
cell	I-T017
-	O
moss	B-T017
##y	I-T017
cell	I-T017
synapse	B-T082
was	O
strong	O
and	O
facilitating	O
,	O
moss	B-T017
##y	I-T017
cells	I-T017
rarely	O
[UNK]	O
inherited	O
[UNK]	O
place	O
fields	O
from	O
single	O
granule	B-T017
cells	I-T017
.	O
our	O
findings	O
suggest	O
that	O
the	O
granule	B-T017
cells	I-T017
and	O
moss	B-T017
##y	I-T017
cells	I-T017
could	O
be	O
modulated	B-T082
separately	O
and	O
their	O
joint	O
action	O
may	O
be	O
critical	O
for	O
pattern	O
separation	O
.	O

bioinformatic	B-T091
analysis	B-T062
of	O
codon	B-T082
usage	O
and	O
phylogenetic	O
relationships	O
in	O
different	O
genotypes	O
of	O
the	O
hepatitis	B-T005
c	I-T005
virus	I-T005
the	O
hepatitis	B-T005
c	I-T005
virus	I-T005
(	O
hcv	B-T005
)	O
has	O
six	O
major	O
genotypes	O
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
phylogenetically	B-T062
investigate	I-T062
the	O
differences	O
between	O
the	O
genotypes	O
of	O
hcv	B-T005
,	O
and	O
to	O
determine	O
the	O
types	O
of	O
amino	B-T103
acid	I-T103
codon	B-T082
usage	O
in	O
the	O
structure	B-T017
of	I-T017
the	I-T017
virus	I-T017
in	O
order	O
to	O
discover	O
new	O
methods	O
for	O
treatment	B-T058
regimes	I-T058
.	O
the	O
codon	B-T082
usage	O
of	O
the	O
six	O
genotypes	O
of	O
the	O
hcv	B-T005
nucleotide	B-T082
sequence	I-T082
was	O
investigated	O
through	O
the	O
online	O
application	O
available	O
on	O
the	O
website	B-T170
gene	I-T170
infinity	I-T170
.	O
also	O
,	O
phylogenetic	B-T062
analysis	I-T062
and	O
the	O
evolutionary	O
relationship	O
of	O
hcv	B-T005
genotypes	O
were	O
analyzed	B-T062
with	O
meg	B-T170
##a	I-T170
7	I-T170
software	I-T170
.	O
the	O
six	O
genotypes	O
of	O
hcv	B-T005
were	O
divided	O
into	O
two	O
groups	O
based	O
on	O
their	O
codon	B-T082
usage	O
properties	O
.	O
in	O
the	O
first	O
group	O
,	O
genotypes	O
1	O
and	O
5	O
(	O
74	O
.	O
02	O
%	O
)	O
,	O
and	O
in	O
the	O
second	O
group	O
,	O
genotypes	O
2	O
and	O
6	O
(	O
72	O
.	O
43	O
%	O
)	O
were	O
shown	O
to	O
have	O
the	O
most	O
similarity	O
in	O
terms	O
of	O
codon	B-T082
usage	O
.	O
unlike	O
the	O
results	O
with	O
respect	O
to	O
determining	O
the	O
similarity	O
of	O
codon	B-T082
usage	O
,	O
the	O
phylogenetic	B-T062
analysis	I-T062
showed	O
the	O
closest	O
resemblance	O
and	O
correlation	O
between	O
genotypes	O
1	O
and	O
4	O
.	O
the	O
results	O
also	O
showed	O
that	O
hcv	B-T005
has	O
a	O
gc	B-T103
(	O
guanine	B-T103
-	I-T103
cytosine	B-T103
)	O
abundant	O
genome	B-T017
structure	I-T017
and	O
prefer	O
##s	O
codons	B-T082
with	O
gc	O
for	O
translation	O
.	O
genotypes	O
1	O
and	O
4	O
demonstrated	O
remarkable	O
similarity	O
in	O
terms	O
of	O
genome	O
sequences	O
and	O
proteins	B-T103
,	O
but	O
surprisingly	O
,	O
in	O
terms	O
of	O
the	O
preferred	O
codons	B-T082
for	O
gene	B-T038
expression	I-T038
,	O
they	O
showed	O
the	O
greatest	O
difference	O
.	O
more	O
studies	B-T062
are	O
therefore	O
needed	O
to	O
confirm	O
the	O
results	O
and	O
select	O
the	O
best	O
approach	B-T082
for	O
treatment	O
of	O
these	O
genotypes	O
based	O
on	O
their	O
codon	B-T082
usage	O
properties	O
.	O

uncon	O
##ventional	O
protein	B-T038
secretion	I-T038
in	O
plants	B-T204
uncon	O
##ventional	O
protein	B-T038
secretion	I-T038
(	O
ups	B-T038
)	O
describes	O
secretion	B-T038
pathways	I-T038
that	O
bypass	O
one	O
or	O
several	O
of	O
the	O
canonical	O
secretion	B-T038
pit	O
-	O
stop	O
##s	O
on	O
the	O
way	O
to	O
the	O
plasma	B-T017
membrane	I-T017
,	O
and	O
/	O
or	O
involve	O
the	O
secretion	B-T038
of	O
leader	O
##less	O
proteins	B-T103
.	O
so	O
far	O
,	O
alternatives	O
to	O
conventional	O
secretion	B-T038
were	O
primarily	O
observed	O
and	O
studied	B-T062
in	O
yeast	B-T204
and	O
animal	B-T017
cells	I-T017
.	O
the	O
ses	O
##sil	O
##e	O
lifestyle	O
of	O
plants	B-T204
brings	O
with	O
it	O
unique	O
restraint	O
##s	O
on	O
how	O
they	O
adapt	B-T038
to	I-T038
adverse	I-T038
conditions	I-T038
and	O
environmental	B-T082
challenges	I-T082
.	O
recently	O
,	O
attention	B-T038
towards	O
uncon	O
##ventional	O
secretion	B-T038
pathways	I-T038
in	O
plant	B-T017
cells	I-T017
has	O
substantially	O
increased	O
,	O
with	O
the	O
large	O
number	O
of	O
leader	O
##less	O
proteins	B-T103
identified	O
through	O
proteomic	B-T091
studies	I-T091
.	O
while	O
ups	B-T038
pathways	O
in	O
plants	B-T204
are	O
certainly	O
not	O
yet	O
exhaustive	O
##ly	O
researched	O
,	O
an	O
emerging	O
notion	O
is	O
that	O
induction	O
of	O
ups	B-T038
pathways	O
is	O
correlated	O
with	O
pathogenesis	B-T038
and	O
stress	B-T038
responses	I-T038
.	O
given	O
the	O
multitude	O
ups	B-T038
events	O
observed	O
,	O
comprehensively	O
organizing	O
the	O
routes	O
proteins	B-T103
take	O
to	O
the	O
apo	B-T017
##plas	I-T017
##t	I-T017
in	O
defined	O
ups	B-T038
categories	O
is	O
challenging	O
.	O
with	O
the	O
establishment	O
of	O
a	O
larger	O
collection	O
of	O
studied	O
plant	B-T103
proteins	I-T103
taking	O
these	O
ups	B-T038
pathways	O
,	O
a	O
clear	O
##er	O
picture	O
of	O
endo	B-T017
##me	I-T017
##mb	I-T017
##rane	I-T017
trafficking	O
as	O
a	O
whole	O
will	O
emerge	O
.	O
there	O
are	O
several	O
novel	O
enabling	B-T038
technologies	O
,	O
such	O
as	O
vesicle	B-T017
proteomics	B-T091
and	O
chemical	B-T103
genomics	B-T091
,	O
with	O
great	O
potential	O
for	O
dissecting	O
secretion	B-T038
pathways	I-T038
,	O
providing	O
information	O
about	O
the	O
cargo	O
that	O
travel	O
##s	O
along	O
them	O
and	O
the	O
conditions	O
that	O
induce	O
them	O
.	O

liquid	B-T058
chromatography	I-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
-	O
based	O
quantitative	B-T058
proteomics	B-T091
analysis	I-T058
reveals	O
chondro	B-T033
##pro	I-T033
##te	I-T033
##ct	I-T033
##ive	I-T033
effects	I-T033
of	O
astr	B-T103
##agal	I-T103
##oside	I-T103
iv	I-T103
in	O
interleukin	B-T103
-	I-T103
1β	I-T103
-	O
induced	O
sw	B-T017
##13	I-T017
##53	I-T017
chondrocyte	I-T017
-	I-T017
like	I-T017
cells	I-T017
chondrocyte	B-T017
apoptosis	B-T038
played	O
a	O
key	O
role	O
on	O
the	O
progression	B-T038
of	O
osteoarthritis	B-T038
(	O
oa	B-T038
)	O
.	O
safe	O
and	O
effective	O
drugs	B-T058
are	O
urgently	O
needed	O
for	O
the	O
treatment	O
of	O
oa	B-T038
.	O
previous	O
study	O
reported	O
that	O
astr	B-T103
##agal	I-T103
##oside	I-T103
iv	I-T103
(	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
)	O
had	O
exerted	O
a	O
protective	O
effect	O
against	O
articular	O
cartilage	O
degeneration	O
by	O
promoting	O
rapid	O
proliferation	O
of	O
chondrocyte	B-T017
.	O
therefore	O
,	O
the	O
aim	O
of	O
our	O
study	O
is	O
to	O
explore	O
the	O
effects	O
and	O
mechanisms	O
of	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
in	O
chondrocyte	B-T017
apoptosis	B-T038
.	O
iso	B-T058
##baric	I-T058
tags	I-T058
for	I-T058
relative	I-T058
and	I-T058
absolute	I-T058
quantitation	I-T058
(	I-T058
it	I-T058
##ra	I-T058
##q	I-T058
)	I-T058
-	I-T058
based	I-T058
quantitative	I-T058
proteomics	B-T091
was	O
used	O
to	O
quantitatively	O
detect	B-T033
and	O
map	O
proteins	B-T103
in	O
sw	B-T017
##13	I-T017
##53	I-T017
chondrocyte	I-T017
-	I-T017
like	I-T017
cells	I-T017
pre	O
-	O
treated	O
with	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
or	O
interleukin	B-T103
-	I-T103
1β	I-T103
(	O
il	B-T103
-	I-T103
1β	I-T103
)	O
or	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
+	O
il	B-T103
-	I-T103
1β	I-T103
.	O
the	O
it	B-T103
##ra	I-T103
##q	I-T103
-	I-T103
labeled	I-T103
peptides	I-T103
were	O
fractionated	O
by	O
high	B-T058
-	I-T058
accuracy	I-T058
liquid	I-T058
chromatography	I-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
(	O
lc	B-T058
-	I-T058
ms	I-T058
)	O
.	O
cell	B-T038
apoptosis	I-T038
and	O
differentially	B-T103
expressed	I-T103
proteins	I-T103
was	O
detected	B-T033
by	O
flow	B-T058
cytometry	I-T058
(	O
fcm	B-T058
)	O
,	O
quantitative	B-T062
real	I-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
qrt	B-T062
-	I-T062
pcr	I-T062
)	O
,	O
and	O
western	B-T058
blotting	I-T058
,	O
respectively	O
.	O
the	O
apoptosis	B-T038
of	O
the	O
il	B-T103
-	I-T103
1β	I-T103
-	O
induced	O
sw	B-T017
##13	I-T017
##53	I-T017
cells	I-T017
treated	O
with	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
was	O
greatly	O
inhibited	O
.	O
bioinformatics	B-T058
analysis	I-T058
revealed	O
that	O
gamma	B-T103
actin	I-T103
1	I-T103
(	O
act	B-T103
##g1	I-T103
)	O
and	O
yes	B-T103
associated	I-T103
protein	I-T103
1	I-T103
(	O
y	B-T103
##ap1	I-T103
)	O
,	O
participating	O
in	O
the	O
hipp	B-T038
##o	I-T038
signaling	I-T038
pathway	I-T038
and	O
vitro	B-T103
##ne	I-T103
##ct	I-T103
##in	I-T103
(	O
vt	B-T103
##n	I-T103
)	O
and	O
collagen	B-T103
type	I-T103
i	I-T103
alpha	I-T103
1	I-T103
chain	I-T103
(	O
col	B-T103
##1a1	I-T103
)	O
,	O
involving	O
in	O
the	O
extracellular	O
matrix	O
(	O
ecm	O
)	O
-	O
receptor	O
interaction	O
signaling	O
pathway	O
,	O
were	O
all	O
significantly	O
up	B-T038
-	I-T038
regulated	I-T038
in	O
the	O
il	B-T103
-	I-T103
1β	I-T103
-	O
induced	O
sw	B-T017
##13	I-T017
##53	I-T017
cells	I-T017
after	O
treatment	O
with	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
.	O
the	O
qrt	B-T062
-	I-T062
pcr	I-T062
and	O
western	B-T058
blotting	I-T058
results	O
confirmed	O
the	O
up	B-T038
-	I-T038
regulation	I-T038
of	O
these	O
four	O
genes	B-T017
.	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
played	O
a	O
positive	B-T033
role	I-T033
in	O
human	B-T204
osteoarth	B-T038
##ritic	I-T038
chondrocyte	B-T017
apoptosis	I-T038
,	O
possibly	O
through	O
modulation	O
of	O
the	O
hipp	B-T038
##o	I-T038
signaling	I-T038
pathway	I-T038
by	O
up	B-T038
-	I-T038
regulating	I-T038
y	B-T103
##ap1	I-T103
and	O
act	B-T103
##g1	I-T103
expression	B-T038
,	O
and	O
also	O
by	O
up	B-T038
-	I-T038
regulating	I-T038
vt	B-T103
##n	I-T103
and	O
col	B-T103
##1a1	I-T103
,	O
which	O
are	O
involved	O
in	O
the	O
ecm	O
-	O
receptor	O
interaction	O
pathway	O
.	O
taken	O
together	O
,	O
all	O
the	O
results	O
suggested	O
that	O
as	B-T103
##g	I-T103
-	I-T103
iv	I-T103
had	O
a	O
novel	O
therapeutic	O
potential	O
for	O
the	O
treatment	O
of	O
oa	B-T038
.	O

comparisons	O
of	O
safety	O
and	O
clinical	O
outcomes	O
between	O
multiple	B-T058
-	I-T058
level	I-T058
and	O
single	B-T058
-	I-T058
level	I-T058
cervical	I-T058
disk	I-T058
replacement	I-T058
for	O
cervical	B-T038
spondyl	I-T038
##osis	I-T038
:	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T170
-	I-T170
analysis	I-T170
this	O
is	O
a	O
systematic	B-T170
review	I-T170
and	O
meta	B-T170
-	I-T170
analysis	I-T170
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
efficacy	O
and	O
safety	O
of	O
multiple	B-T058
-	I-T058
level	I-T058
cervical	I-T058
disk	I-T058
replacement	I-T058
(	O
cdr	B-T058
)	O
over	O
single	B-T058
-	I-T058
level	I-T058
cdr	I-T058
for	O
the	O
treatment	B-T058
of	O
cervical	B-T038
spondyl	I-T038
##osis	I-T038
.	O
some	O
authors	O
advocate	O
for	O
the	O
multiple	B-T058
-	I-T058
level	I-T058
cdr	I-T058
instead	O
of	O
anterior	B-T082
decompression	B-T058
and	O
fusion	B-T058
in	O
cervical	B-T038
multiple	I-T038
-	I-T038
level	I-T038
spondyl	I-T038
##osis	I-T038
.	O
however	O
,	O
whether	O
the	O
efficacy	O
and	O
safety	O
of	O
multi	B-T058
-	I-T058
level	I-T058
cdr	I-T058
are	O
as	O
favorable	O
as	O
that	O
of	O
single	B-T058
-	I-T058
level	I-T058
cdr	I-T058
remains	O
controversial	O
.	O
medline	B-T170
,	O
embase	B-T170
,	O
and	O
cochrane	B-T170
library	I-T170
databases	I-T170
were	O
searched	O
up	O
to	O
november	O
2015	O
for	O
controlled	B-T062
studies	I-T062
that	O
compared	O
the	O
clinical	O
outcomes	O
of	O
single	B-T058
-	I-T058
level	I-T058
and	O
multiple	B-T058
-	I-T058
level	I-T058
cdr	I-T058
for	O
the	O
treatment	B-T058
of	O
cervical	B-T038
spondyl	I-T038
##osis	I-T038
.	O
the	O
following	O
outcomes	O
were	O
extracted	O
and	O
analyzed	B-T062
:	O
prevalence	O
of	O
heterotopic	B-T038
ossification	I-T038
and	O
reoperation	B-T058
,	O
preoperative	O
and	O
postoperative	O
neck	B-T033
disability	I-T033
index	I-T033
scores	I-T033
,	O
preoperative	O
and	O
postoperative	O
visual	B-T201
analog	I-T201
scale	I-T201
scores	I-T201
,	O
and	O
success	O
rate	O
using	O
the	O
od	B-T170
##om	I-T170
grading	I-T170
system	I-T170
.	O
ten	O
studies	B-T062
involving	O
140	O
##2	O
patients	O
were	O
included	O
:	O
including	O
3	O
randomized	B-T062
controlled	I-T062
trials	I-T062
,	O
5	O
prospective	B-T062
studies	I-T062
,	O
and	O
3	O
retrospective	B-T062
studies	I-T062
.	O
no	O
significant	O
differences	O
between	O
single	B-T058
-	I-T058
level	I-T058
and	O
multiple	B-T058
-	I-T058
level	I-T058
groups	O
were	O
found	O
in	O
terms	O
of	O
the	O
prevalence	O
of	O
heterotopic	B-T038
ossification	I-T038
and	O
reoperation	B-T058
rate	O
,	O
neck	B-T033
disability	I-T033
index	I-T033
score	I-T033
,	O
visual	B-T201
analog	I-T201
scale	I-T201
score	I-T201
,	O
and	O
success	O
rate	O
using	O
the	O
od	B-T170
##om	I-T170
grading	I-T170
system	I-T170
.	O
on	O
the	O
basis	O
of	O
this	O
meta	B-T170
-	I-T170
analysis	I-T170
,	O
clinical	O
outcomes	O
of	O
multiple	B-T058
-	I-T058
level	I-T058
cdr	I-T058
are	O
similar	O
to	O
those	O
of	O
single	B-T058
-	I-T058
level	I-T058
cdr	I-T058
for	O
cervical	B-T038
spondyl	I-T038
##osis	I-T038
,	O
which	O
suggests	O
the	O
multiple	B-T058
-	I-T058
level	I-T058
cdr	I-T058
is	O
as	O
effective	O
and	O
safe	O
as	O
the	O
single	B-T058
-	I-T058
level	I-T058
cdr	I-T058
.	O
nonetheless	O
,	O
more	O
well	O
-	O
designed	O
studies	B-T062
are	O
needed	O
for	O
further	O
evaluation	B-T062
.	O

cost	O
##ing	O
'	O
healthy	B-T168
'	I-T168
food	I-T168
basket	I-T168
##s	I-T168
in	O
australia	B-T082
-	O
a	O
systematic	B-T170
review	I-T170
of	O
food	B-T168
price	O
and	O
afford	O
##ability	O
monitoring	B-T170
tools	I-T170
,	O
protocols	B-T170
and	O
methods	B-T170
to	O
undertake	O
a	O
systematic	B-T170
review	I-T170
to	O
determine	O
similarities	O
and	O
differences	O
in	O
metrics	O
and	O
results	O
between	O
recently	O
and	O
/	O
or	O
currently	O
used	O
tools	B-T170
,	O
protocols	B-T170
and	O
methods	B-T170
for	O
monitoring	B-T058
australian	B-T082
healthy	B-T168
food	I-T168
prices	O
and	O
afford	O
##ability	O
.	O
electronic	B-T170
databases	I-T170
of	O
peer	B-T170
-	I-T170
reviewed	I-T170
literature	I-T170
and	O
online	B-T170
grey	I-T170
literature	I-T170
were	O
systematically	O
searched	O
using	O
the	O
prism	B-T062
##a	I-T062
approach	O
for	O
articles	B-T170
and	O
reports	B-T170
relating	O
to	O
healthy	B-T168
food	I-T168
and	O
diet	B-T170
price	I-T170
assessment	I-T170
tools	I-T170
,	O
protocols	B-T170
,	O
methods	B-T170
and	O
results	O
that	O
utilised	O
retail	O
pri	O
##cing	O
.	O
national	O
,	O
state	B-T082
,	O
regional	B-T082
and	O
local	B-T082
areas	I-T082
of	O
australia	B-T082
from	O
1995	O
to	O
2015	O
.	O
assessment	B-T170
tools	I-T170
,	O
protocols	B-T170
and	O
methods	B-T170
to	O
measure	O
the	O
price	O
of	O
'	B-T168
healthy	I-T168
'	I-T168
foods	I-T168
and	O
diets	B-T168
.	O
the	O
search	O
identified	O
fifty	O
-	O
nine	O
discrete	O
surveys	B-T170
of	O
'	O
healthy	B-T168
'	I-T168
food	I-T168
pri	O
##cing	O
incorporating	O
six	O
major	O
food	B-T170
pri	I-T170
##cing	I-T170
tools	I-T170
(	O
those	O
used	O
in	O
multiple	O
areas	O
and	O
time	O
periods	O
)	O
and	O
five	O
minor	O
food	B-T170
pri	I-T170
##cing	I-T170
tools	I-T170
(	O
those	O
used	O
in	O
a	O
single	B-T082
survey	I-T082
area	I-T082
or	O
time	O
period	O
)	O
.	O
analysis	B-T062
demonstrated	O
methodological	O
differences	O
regarding	O
:	O
included	O
foods	B-T168
;	O
reference	O
households	O
;	O
use	O
of	O
availability	O
and	O
/	O
or	O
quality	O
measures	O
;	O
household	B-T033
income	I-T033
sources	B-T033
;	O
store	O
sampling	B-T170
methods	I-T170
;	O
data	B-T062
collection	I-T062
protocols	B-T170
;	O
analysis	B-T062
methods	I-T062
;	O
and	O
results	O
.	O
'	O
healthy	B-T168
'	I-T168
food	I-T168
price	O
assessment	O
methods	B-T170
used	O
in	O
australia	B-T082
lack	O
compar	O
##ability	O
across	O
all	O
metrics	O
and	O
most	O
do	O
not	O
fully	O
align	O
with	O
a	O
'	O
healthy	B-T168
'	I-T168
diet	I-T168
as	O
recommended	O
by	O
the	O
current	O
australian	B-T170
dietary	I-T170
guidelines	I-T170
.	O
none	O
have	O
been	O
applied	O
nationally	O
.	O
assessment	O
of	O
the	O
price	O
,	O
price	O
differential	O
and	O
afford	O
##ability	O
of	O
healthy	B-T058
(	O
recommended	O
)	O
and	O
current	O
(	O
unhealthy	O
)	O
diets	O
would	O
provide	O
more	O
robust	O
and	O
meaningful	O
data	O
to	O
inform	O
health	O
and	O
fis	O
##cal	O
policy	O
in	O
australia	B-T082
.	O
the	O
inform	B-T170
##as	I-T170
'	O
optimal	O
'	O
approach	O
provides	O
a	O
potential	O
framework	O
for	O
development	O
of	O
these	O
methods	B-T170
.	O

tlr9	B-T017
deficiency	O
leads	O
to	O
accelerated	O
renal	B-T038
disease	I-T038
and	O
myeloid	B-T017
lineage	I-T017
abnormalities	B-T033
in	O
pri	B-T103
##st	I-T103
##ane	I-T103
-	O
induced	O
murine	B-T204
lupus	B-T038
systemic	B-T038
lupus	I-T038
erythematosus	I-T038
(	O
sle	B-T038
)	I-T038
is	O
a	O
chronic	O
,	O
life	B-T033
-	I-T033
threatening	I-T033
autoimmune	B-T038
disorder	I-T038
,	O
leading	O
to	O
multiple	O
organ	B-T017
pathologies	B-T091
and	O
kidney	B-T017
destruction	O
.	O
analyses	O
of	O
numerous	O
murine	B-T204
models	B-T038
of	O
spontaneous	O
sle	B-T038
have	O
revealed	O
a	O
critical	O
role	O
for	O
endosomal	B-T017
tlrs	B-T103
in	O
the	O
production	O
of	O
autoantibodies	B-T103
and	O
development	O
of	O
other	O
clinical	O
disease	B-T038
manifestations	O
.	O
nevertheless	O
,	O
the	O
corresponding	O
tlr9	B-T017
-	O
deficient	O
autoimmune	B-T038
-	O
prone	O
strains	O
consistently	O
develop	O
more	O
severe	O
disease	B-T038
pathology	B-T091
.	O
injection	B-T058
of	O
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
with	O
2	B-T103
,	I-T103
6	I-T103
,	I-T103
10	I-T103
,	I-T103
14	I-T103
-	I-T103
tetramethyl	I-T103
##pe	I-T103
##nt	I-T103
##adecan	I-T103
##e	I-T103
(	O
tmp	B-T103
##d	I-T103
)	O
,	O
commonly	O
known	O
as	O
pri	B-T103
##st	I-T103
##ane	I-T103
,	O
also	O
results	O
in	O
the	O
development	O
of	O
sle	B-T038
-	I-T038
like	I-T038
disease	I-T038
.	O
we	O
now	O
show	O
that	O
tlr9	B-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
injected	B-T058
i	I-T058
.	I-T058
p	I-T058
.	I-T058
with	O
tmp	B-T103
##d	I-T103
develop	O
more	O
severe	O
autoimmunity	B-T038
than	O
do	O
their	O
tlr	B-T103
-	O
sufficient	O
cohorts	O
.	O
early	O
indications	O
include	O
an	O
increased	O
accumulation	B-T033
of	O
tlr	B-T017
##7	I-T017
-	O
expressing	B-T038
ly	B-T103
##6c	I-T103
(	I-T103
hi	I-T103
)	I-T103
inflammatory	O
monocytes	B-T017
at	O
the	O
site	B-T082
of	I-T082
injection	I-T082
,	O
upregulation	B-T038
of	O
ifn	B-T103
-	O
regulated	O
gene	B-T038
expression	I-T038
in	O
the	O
peritoneal	B-T082
cavity	I-T082
,	O
and	O
an	O
increased	O
production	O
of	O
myeloid	B-T017
lineage	I-T017
precursors	I-T017
(	O
common	B-T017
myeloid	I-T017
progenitors	I-T017
and	O
granulocyte	B-T017
myeloid	B-T017
precursors	I-T017
)	O
in	O
the	O
bone	B-T017
marrow	I-T017
.	O
tmp	B-T103
##d	I-T103
-	O
injected	B-T058
tlr9	B-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
develop	O
higher	O
autoantibody	B-T103
titers	O
against	O
rna	B-T103
,	O
neutrophil	B-T017
cytoplasmic	B-T017
ags	B-T103
,	O
and	O
myeloperoxidase	B-T103
than	O
do	O
tmp	B-T103
##d	I-T103
-	O
injected	B-T058
wild	B-T204
-	I-T204
type	I-T204
balb	I-T204
/	I-T204
c	I-T204
mice	I-T204
.	O
the	O
tmp	B-T103
-	O
injected	B-T058
tlr9	B-T017
(	I-T017
-	I-T017
/	I-T017
-	I-T017
)	I-T017
mice	B-T204
,	O
and	O
not	O
the	O
wild	B-T204
-	I-T204
type	I-T204
mice	I-T204
,	O
also	O
develop	O
a	O
marked	O
increase	O
in	O
glomerular	B-T103
igg	I-T103
deposition	O
and	O
infiltrating	O
granulocytes	B-T017
,	O
much	O
more	O
severe	O
glomerulonephritis	B-T038
,	O
and	O
a	O
reduced	O
lifespan	O
.	O
collectively	O
,	O
the	O
data	O
point	O
to	O
a	O
major	O
role	O
for	O
tlr	B-T017
##7	I-T017
in	O
the	O
response	O
to	O
self	B-T103
-	I-T103
antigens	I-T103
in	O
this	O
model	B-T038
of	O
experimental	O
autoimmunity	B-T038
.	O
therefore	O
,	O
the	O
balb	B-T204
/	I-T204
c	I-T204
pri	B-T103
##st	I-T103
##ane	I-T103
model	B-T038
recapit	O
##ulates	O
other	O
tlr	B-T017
##7	I-T017
-	O
driven	O
spontaneous	O
models	B-T038
of	O
sle	B-T038
and	O
is	O
negatively	B-T033
regulated	O
by	O
tlr9	B-T017
.	O

physical	O
activity	O
limits	O
the	O
effects	O
of	O
age	O
and	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
on	O
postural	O
control	O
the	O
aim	O
was	O
to	O
study	O
the	O
possible	O
influence	O
of	O
physical	O
activity	O
on	O
the	O
postural	O
performance	O
of	O
subjects	B-T098
with	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
.	O
the	O
postural	O
performance	O
(	O
i	O
.	O
e	O
.	O
surface	O
area	O
of	O
the	O
center	B-T082
of	I-T082
foot	I-T082
pressure	I-T082
displacement	I-T082
)	O
of	O
3	O
groups	O
was	O
compared	O
:	O
alzheimer	O
active	O
group	O
(	O
aa	O
)	O
,	O
alzheimer	O
non	O
-	O
active	O
group	O
(	O
ana	O
)	O
and	O
healthy	O
non	O
-	O
active	O
group	O
(	O
hn	O
##a	O
)	O
.	O
the	O
aa	B-T098
group	I-T098
'	I-T098
s	I-T098
postural	O
performance	O
was	O
superior	B-T082
to	O
that	O
of	O
the	O
ana	O
and	O
hn	O
##a	O
groups	O
.	O
ad	B-T038
disturbed	O
postural	O
performance	O
but	O
participation	O
in	O
regular	O
physical	O
activity	O
made	O
it	O
possible	O
to	O
limit	O
the	O
disturb	O
##ing	O
effects	O
of	O
ad	B-T038
to	O
a	O
surprising	O
extent	O
,	O
since	O
the	O
postural	O
performance	O
of	O
active	B-T098
ad	I-T098
subjects	I-T098
was	O
also	O
superior	B-T082
to	O
that	O
of	O
healthy	B-T098
subjects	I-T098
.	O

thym	B-T103
##osin	I-T103
β	I-T103
##4	I-T103
:	O
roles	O
in	O
development	O
,	O
repair	B-T038
,	O
and	O
engineering	O
of	O
the	O
cardiovascular	B-T022
system	I-T022
the	O
burden	O
of	O
cardiovascular	B-T038
disease	I-T038
is	O
a	O
growing	O
worldwide	O
issue	O
that	O
demands	O
attention	O
.	O
while	O
many	O
clinical	B-T062
trials	I-T062
are	O
ongoing	O
to	O
test	O
therapies	B-T058
for	O
treating	O
the	O
heart	B-T017
after	O
myocardial	B-T038
infarction	I-T038
(	O
mi	B-T038
)	O
and	O
heart	B-T038
failure	I-T038
,	O
there	O
are	O
few	O
options	O
doctors	B-T097
able	O
to	O
currently	O
give	O
patients	O
to	O
repair	B-T058
the	I-T058
heart	I-T058
.	O
this	O
eventually	O
leads	O
to	O
decreased	O
ventricular	B-T038
contractility	I-T038
and	O
increased	O
systemic	B-T038
disease	I-T038
,	O
including	O
vascular	B-T038
disorders	I-T038
that	O
could	O
result	O
in	O
stroke	B-T038
.	O
small	O
peptides	B-T103
such	O
as	O
thym	B-T103
##osin	I-T103
β	I-T103
##4	I-T103
(	O
t	B-T103
##β	I-T103
##4	I-T103
)	O
are	O
upregulated	O
in	O
the	O
cardiovascular	B-T082
niche	B-T082
during	O
fetal	B-T038
development	I-T038
and	O
after	O
injuries	B-T037
such	O
as	O
mi	B-T038
,	O
providing	O
increased	O
neo	B-T038
##vas	I-T038
##cu	I-T038
##lo	I-T038
##genesis	I-T038
and	O
paracrine	B-T038
signals	I-T038
for	O
endogenous	B-T017
stem	I-T017
cell	I-T017
recruitment	O
to	O
aid	O
in	O
wound	B-T038
repair	I-T038
.	O
new	O
research	B-T062
is	O
looking	O
into	O
the	O
effects	O
of	O
in	B-T082
vivo	I-T082
administration	B-T058
of	O
t	B-T103
##β	I-T103
##4	I-T103
through	O
injections	B-T058
and	O
coatings	B-T103
on	O
implants	B-T074
,	O
as	O
well	O
as	O
its	O
effect	O
on	O
cell	B-T038
differentiation	I-T038
.	O
results	O
so	O
far	O
demonstrate	O
t	B-T103
##β	I-T103
##4	I-T103
administration	B-T058
leads	O
to	O
robust	O
increases	O
in	O
angiogenesis	B-T038
and	O
wound	B-T038
healing	I-T038
in	O
the	O
heart	B-T017
after	O
mi	B-T038
and	O
the	O
brain	B-T017
after	O
stroke	B-T038
,	O
and	O
can	O
differentiate	O
adult	B-T017
stem	I-T017
cells	I-T017
toward	O
the	O
cardiac	B-T017
lineage	O
for	O
implantation	B-T058
to	O
the	O
heart	B-T017
to	O
increase	O
contractility	B-T038
and	O
survival	O
.	O
future	O
work	O
,	O
some	O
of	O
which	O
is	O
currently	O
in	O
clinical	B-T062
trials	I-T062
,	O
will	O
demonstrate	O
the	O
in	B-T082
vivo	I-T082
effect	O
of	O
these	O
therapies	B-T058
on	O
human	B-T204
patients	O
,	O
with	O
the	O
goal	B-T170
of	O
helping	O
the	O
millions	O
of	O
people	B-T098
worldwide	O
affected	O
by	O
cardiovascular	B-T038
disease	I-T038
.	O

high	O
-	O
intensity	O
intermittent	O
training	O
positively	B-T033
affects	O
aerobic	B-T058
and	O
anaerobic	O
performance	O
in	O
jud	O
##o	O
athletes	B-T097
independently	O
of	O
exercise	O
mode	O
the	O
present	O
study	O
investigated	O
the	O
effects	O
of	O
high	O
-	O
intensity	O
intermittent	O
training	O
(	O
hi	O
##it	O
)	O
on	O
lower	B-T017
-	O
and	O
upper	B-T017
-	I-T017
body	I-T017
graded	O
exercise	O
and	O
high	O
-	O
intensity	O
intermittent	O
exercise	O
(	O
hi	O
##ie	O
,	O
four	O
wing	O
##ate	O
bouts	O
)	O
performance	O
,	O
and	O
on	O
physiological	O
and	O
muscle	B-T017
damage	I-T017
markers	B-T033
responses	I-T033
in	O
jud	O
##o	O
athletes	B-T097
.	O
thirty	O
-	O
five	O
subjects	B-T098
were	O
randomly	B-T062
allocated	I-T062
to	O
a	O
control	O
group	O
(	O
n	O
=	O
8	O
)	O
or	O
to	O
one	O
of	O
the	O
following	O
hi	O
##it	O
groups	O
(	O
n	O
=	O
9	O
for	O
each	O
)	O
and	O
tested	B-T170
pre	I-T170
-	I-T170
and	I-T170
post	I-T170
-	O
four	O
weeks	O
(	O
2	O
training	O
d	O
·	O
wk	O
(	O
-	O
1	O
)	O
)	O
:	O
(	O
1	O
)	O
lower	B-T017
-	I-T017
body	I-T017
cycle	O
-	O
ergometer	O
;	O
(	O
2	O
)	O
upper	O
-	O
body	O
cycle	O
-	O
ergometer	O
;	O
(	O
3	O
)	O
uc	O
##hi	O
-	O
ko	O
##mi	O
(	O
jud	O
##o	O
technique	O
entrance	O
)	O
.	O
all	O
hi	O
##it	O
were	O
constituted	O
by	O
two	O
blocks	O
of	O
10	O
sets	O
of	O
20	O
s	O
of	O
all	O
out	O
effort	O
intersp	O
##ersed	O
by	O
10	O
s	O
set	O
intervals	O
and	O
5	O
-	O
min	O
between	O
blocks	O
.	O
for	O
the	O
upper	B-T017
-	I-T017
body	I-T017
group	O
there	O
was	O
an	O
increase	O
in	O
maximal	O
aerobic	O
power	O
in	O
graded	O
upper	B-T017
-	I-T017
body	I-T017
exercise	B-T033
test	I-T033
(	O
12	O
.	O
3	O
%	O
)	O
.	O
the	O
lower	B-T017
-	I-T017
body	I-T017
group	O
increased	O
power	O
at	O
onset	O
blood	O
lactate	O
in	O
graded	O
upper	B-T017
-	I-T017
body	I-T017
exercise	B-T033
test	I-T033
(	O
22	O
.	O
1	O
%	O
)	O
.	O
the	O
uc	O
##hi	O
-	O
ko	O
##mi	O
group	O
increased	O
peak	O
power	O
in	O
upper	B-T017
-	O
(	O
16	O
.	O
7	O
%	O
)	O
and	O
lower	B-T017
-	I-T017
body	I-T017
(	O
8	O
.	O
5	O
%	O
)	O
,	O
while	O
the	O
lower	B-T017
-	I-T017
body	I-T017
group	O
increased	O
lower	B-T017
-	I-T017
body	I-T017
mean	O
power	O
(	O
14	O
.	O
2	O
%	O
)	O
during	O
the	O
hi	O
##ie	O
.	O
there	O
was	O
a	O
decrease	O
in	O
the	O
delta	O
blood	O
lactate	O
for	O
the	O
uc	O
##hi	O
-	O
ko	O
##mi	O
training	O
group	O
and	O
in	O
the	O
third	O
and	O
fourth	O
bouts	O
for	O
the	O
upper	B-T017
-	I-T017
body	I-T017
training	O
group	O
.	O
training	O
induced	O
testosterone	O
-	O
cortisol	O
ratio	O
increased	O
in	O
the	O
lower	B-T017
-	I-T017
body	I-T017
hi	O
##ie	O
for	O
the	O
lower	B-T017
-	I-T017
body	I-T017
(	O
14	O
.	O
9	O
%	O
)	O
and	O
uc	O
##hi	O
-	O
ko	O
##mi	O
(	O
61	O
.	O
4	O
%	O
)	O
training	O
groups	O
.	O
thus	O
,	O
short	O
-	O
duration	O
low	O
-	O
volume	O
hi	O
##it	O
added	O
to	O
regular	O
jud	O
##o	O
training	O
was	O
able	O
to	O
increase	O
upper	B-T017
-	I-T017
body	I-T017
aerobic	O
power	O
,	O
lower	B-T017
-	O
and	O
upper	B-T017
-	I-T017
body	I-T017
hi	O
##ie	O
performance	O
.	O

mental	B-T038
health	I-T038
and	O
associated	O
factors	O
among	O
young	O
offenders	B-T098
in	O
chile	B-T082
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
few	O
studies	O
in	O
latin	B-T082
america	I-T082
have	O
explored	O
mental	B-T038
disorder	I-T038
among	O
young	O
offenders	B-T098
,	O
or	O
variables	O
associated	O
with	O
it	O
.	O
our	O
aim	O
was	O
to	O
test	O
for	O
associations	O
between	O
childhood	O
advers	O
##ity	O
or	O
substance	O
misuse	O
and	O
psychiatric	B-T038
disorders	I-T038
among	O
young	O
offenders	B-T098
.	O
sentence	O
##d	O
adolescent	O
offenders	B-T098
were	O
recruited	O
from	O
young	O
offenders	B-T098
'	I-T098
institutions	O
or	O
community	O
centres	O
provided	O
by	O
the	O
chile	O
##an	O
national	O
service	O
for	O
minor	O
##s	O
.	O
psychiatric	B-T038
disorders	I-T038
were	O
assessed	O
using	O
the	O
mini	B-T058
international	I-T058
neuropsychiatric	I-T058
interview	I-T058
,	O
conducted	O
by	O
trained	B-T097
psychologists	I-T097
.	O
a	O
trained	B-T097
socio	I-T097
##lo	I-T097
##gi	I-T097
##st	I-T097
used	O
an	O
ad	O
hoc	O
interview	O
to	O
collect	O
information	O
about	O
childhood	O
experiences	O
,	O
including	O
parenting	B-T033
,	O
trauma	B-T037
,	O
education	B-T170
and	O
substance	O
misuse	O
.	O
multivariable	B-T062
logistic	I-T062
regressions	I-T062
were	O
used	O
to	O
analyse	O
data	O
.	O
the	O
most	O
prevalent	O
psychiatric	B-T038
disorders	I-T038
among	O
the	O
93	O
##5	O
participants	B-T098
were	O
marijuana	B-T038
dependence	I-T038
disorder	I-T038
,	O
major	B-T038
depressive	I-T038
disorder	I-T038
,	O
and	O
anxiety	B-T038
disorders	I-T038
.	O
substance	B-T038
use	I-T038
disorders	I-T038
were	O
less	O
frequent	O
among	O
young	O
offenders	B-T098
who	O
were	O
serving	O
their	O
sentence	B-T033
in	O
young	O
offenders	B-T098
'	I-T098
institutions	O
than	O
among	O
those	O
serving	O
in	O
community	O
centres	O
and	O
more	O
frequent	O
among	O
those	O
who	O
started	O
to	O
use	B-T038
marijuana	I-T038
at	O
an	O
earlier	O
age	O
.	O
among	O
other	O
variables	O
,	O
childhood	B-T038
maltreatment	I-T038
was	O
related	O
to	O
major	B-T038
depressive	I-T038
disorder	I-T038
,	O
and	O
maternal	B-T038
death	I-T038
to	O
anxiety	B-T038
disorders	I-T038
.	O
higher	O
educational	B-T033
status	I-T033
was	O
related	O
to	O
a	O
lower	O
frequency	O
of	O
depressive	B-T038
and	O
anxiety	B-T038
disorders	I-T038
.	O
our	O
findings	B-T033
suggest	O
that	O
greater	O
efforts	O
must	O
be	O
made	O
to	O
identify	O
vulnerable	O
young	O
people	B-T098
much	O
earlier	O
.	O
few	O
of	O
these	O
young	O
offenders	B-T098
with	O
mental	B-T038
health	I-T038
problems	B-T033
had	O
been	O
well	O
adjusted	O
in	O
health	O
,	O
education	B-T170
or	O
socially	O
before	O
this	O
period	O
of	O
det	O
##ention	O
.	O
©	O
2017	O
the	O
authors	O
.	O
criminal	O
behaviour	O
and	O
mental	O
health	O
published	O
by	O
john	O
wiley	O
&	O
sons	O
ltd	O
.	O

design	O
,	O
synthesis	O
,	O
and	O
cytotoxic	B-T038
evaluation	B-T058
of	O
certain	O
7	B-T103
-	I-T103
chloro	I-T103
-	I-T103
4	I-T103
-	I-T103
(	I-T103
piper	I-T103
##azin	I-T103
-	I-T103
1	I-T103
-	I-T103
yl	I-T103
)	I-T103
quinoline	I-T103
derivatives	B-T103
as	O
vegfr	B-T103
-	I-T103
ii	I-T103
inhibitors	B-T103
signaling	B-T038
pathway	I-T038
inhibition	O
of	O
vegfr	B-T103
-	I-T103
ii	I-T103
is	O
visualized	O
as	O
valuable	O
tool	O
in	O
cancer	B-T038
management	B-T058
.	O
in	O
the	O
current	B-T062
study	I-T062
,	O
the	O
synthesis	O
of	O
novel	O
1	B-T103
-	I-T103
4	I-T103
-	I-T103
(	I-T103
7	I-T103
-	I-T103
chloro	I-T103
##quin	I-T103
##olin	I-T103
-	I-T103
4	I-T103
-	I-T103
yl	I-T103
)	I-T103
piper	I-T103
##azin	I-T103
-	I-T103
1	I-T103
-	I-T103
yl	I-T103
)	I-T103
-	I-T103
2	I-T103
-	I-T103
(	I-T103
n	I-T103
-	I-T103
substituted	I-T103
-	I-T103
amino	I-T103
)	I-T103
-	I-T103
eth	I-T103
##anone	I-T103
derivatives	B-T103
(	O
4a	B-T103
-	I-T103
t	I-T103
)	O
was	O
achieved	O
through	O
the	O
amin	O
##ation	O
of	O
2	B-T103
-	I-T103
chloro	I-T103
-	I-T103
1	I-T103
-	I-T103
(	I-T103
4	I-T103
-	I-T103
(	I-T103
7	I-T103
-	I-T103
chloro	I-T103
##quin	I-T103
##olin	I-T103
-	I-T103
4	I-T103
-	I-T103
yl	I-T103
)	I-T103
piper	I-T103
##azin	I-T103
-	I-T103
1	I-T103
-	I-T103
yl	I-T103
)	I-T103
eth	I-T103
##anone	I-T103
(	I-T103
3	I-T103
)	I-T103
with	O
different	O
secondary	B-T103
amines	I-T103
.	I-T103
the	O
structures	B-T082
of	O
the	O
target	O
compounds	B-T103
were	O
confirmed	O
by	O
ir	B-T058
,	O
(	B-T058
1	I-T058
)	I-T058
h	I-T058
-	I-T058
nmr	I-T058
,	O
(	B-T058
13	I-T058
)	I-T058
c	I-T058
-	I-T058
nmr	I-T058
,	O
hr	B-T058
##ms	I-T058
,	O
and	O
micro	B-T058
##analysis	I-T058
.	O
compounds	B-T103
4a	B-T103
-	I-T103
t	I-T103
were	O
subjected	O
to	O
in	O
vitro	O
anticancer	B-T058
screening	B-T058
against	O
human	B-T038
breast	I-T038
cancer	I-T038
(	O
mcf	B-T017
-	I-T017
7	I-T017
)	O
and	O
prostate	B-T038
cancer	I-T038
(	O
pc	B-T017
##3	I-T017
)	O
cell	B-T017
lines	I-T017
.	O
the	O
highest	O
cytotoxic	B-T038
##ty	I-T038
against	O
both	O
cell	B-T017
lines	I-T017
was	O
displayed	O
by	O
2	B-T103
-	I-T103
(	I-T103
4	I-T103
-	I-T103
(	I-T103
4	I-T103
-	I-T103
bromo	I-T103
##benz	I-T103
##yl	I-T103
)	I-T103
piper	I-T103
##azin	I-T103
-	I-T103
1	I-T103
-	I-T103
yl	I-T103
)	I-T103
-	I-T103
1	I-T103
-	I-T103
(	I-T103
4	I-T103
-	I-T103
(	I-T103
7	I-T103
-	I-T103
chloro	I-T103
##quin	I-T103
##olin	I-T103
-	I-T103
4	I-T103
-	I-T103
yl	I-T103
)	I-T103
piper	I-T103
##azin	I-T103
-	I-T103
1	I-T103
-	I-T103
yl	I-T103
)	I-T103
eth	I-T103
##anone	I-T103
(	I-T103
4	I-T103
##q	I-T103
)	I-T103
,	O
with	O
ic50	O
values	O
of	O
6	O
.	O
50	O
##2	O
and	O
11	O
.	O
75	O
##1	O
μm	O
against	O
mcf	B-T017
-	I-T017
7	I-T017
and	O
pc	B-T017
##3	I-T017
cells	I-T017
,	O
respectively	O
,	O
compared	O
with	O
the	O
standard	O
drug	O
doxorubicin	B-T103
(	O
mcf	B-T017
-	I-T017
7	I-T017
:	O
6	O
.	O
77	O
##4	O
μm	O
,	O
pc	B-T017
##3	I-T017
:	O
7	O
.	O
73	O
##16	O
μm	O
)	O
.	O
due	O
to	O
its	O
notable	O
activity	O
toward	O
mcf	B-T017
-	I-T017
7	I-T017
cells	I-T017
,	O
4	B-T103
##q	I-T103
was	O
further	O
evaluated	O
as	O
vegfr	B-T103
-	I-T103
ii	I-T103
inhibitor	B-T103
,	O
showing	O
an	O
ic50	O
of	O
1	O
.	O
38	O
μm	O
compared	O
to	O
sorafenib	B-T103
(	O
0	O
.	O
33	O
μm	O
)	O
.	O
the	O
docking	B-T038
study	O
proved	O
that	O
4	B-T103
##q	I-T103
has	O
a	O
binding	B-T038
mode	I-T038
aki	O
##n	O
to	O
that	O
of	O
vegfr	B-T103
-	I-T103
ii	I-T103
inhibitors	B-T103
.	O

gender	O
and	O
direction	B-T082
of	O
effect	O
of	O
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
in	O
a	O
longitudinal	B-T062
sample	I-T062
of	O
college	B-T098
students	I-T098
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
are	O
consistently	O
found	O
to	O
be	O
associated	O
but	O
how	O
they	O
relate	O
to	O
each	O
other	O
is	O
unclear	O
.	O
the	O
present	O
study	B-T062
aimed	O
to	O
address	O
limitations	O
in	O
the	O
literature	B-T170
of	O
comorbidity	O
of	O
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
by	O
investigating	O
the	O
direction	B-T082
of	O
effect	O
between	O
the	O
phenotypes	O
and	O
possible	O
gender	O
differences	O
in	O
college	B-T098
students	I-T098
.	O
we	O
utilized	O
data	O
from	O
a	O
large	O
longitudinal	B-T062
study	I-T062
of	O
college	B-T098
students	I-T098
from	O
the	O
united	B-T082
states	I-T082
(	O
n	O
=	O
260	O
##7	O
)	O
.	O
three	O
waves	O
of	O
questionnaire	B-T170
-	I-T170
based	I-T170
data	O
were	O
collected	O
over	O
the	O
first	O
two	O
years	O
of	O
college	O
(	O
in	O
2011	O
-	O
2013	O
)	O
.	O
cross	O
-	O
lag	O
##ged	O
models	O
were	O
applied	O
to	O
examine	O
the	O
possible	O
direction	B-T082
of	O
effect	O
of	O
internalizing	O
symptoms	O
and	O
alcohol	B-T038
problems	I-T038
.	O
possible	O
effects	O
of	O
gender	O
were	O
investigated	O
using	O
multi	O
##group	O
modeling	O
.	O
there	O
were	O
significant	O
correlations	O
between	O
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
.	O
a	O
direction	B-T082
of	O
effect	O
was	O
found	O
between	O
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
but	O
differed	O
between	O
genders	O
.	O
a	O
unidirectional	O
relationship	O
varying	O
with	O
age	O
was	O
identified	O
for	O
males	O
where	O
alcohol	B-T038
problems	I-T038
initially	O
predicted	O
internalizing	O
symptoms	O
followed	O
by	O
internalizing	O
symptoms	O
predicting	O
alcohol	B-T038
problems	I-T038
.	O
for	O
females	O
,	O
a	O
unidirectional	O
relationship	O
existed	O
wherein	O
alcohol	B-T038
problems	I-T038
predicted	O
internalizing	O
symptoms	O
.	O
conclusions	O
/	O
importance	O
:	O
we	O
conclude	O
that	O
the	O
relationship	O
between	O
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
is	O
complex	O
and	O
differ	O
between	O
genders	O
.	O
in	O
males	O
,	O
both	O
phenotypes	O
are	O
predictive	O
of	O
each	O
other	O
,	O
while	O
in	O
females	O
the	O
relationship	O
is	O
driven	O
by	O
alcohol	B-T038
problems	I-T038
.	O
importantly	O
,	O
our	O
study	B-T062
examines	O
a	O
population	O
-	O
based	O
sample	O
,	O
revealing	O
that	O
the	O
observed	O
relationships	O
between	O
alcohol	B-T038
problems	I-T038
and	O
internalizing	O
symptoms	O
are	O
not	O
limited	O
to	O
individuals	B-T098
with	O
clinically	B-T058
diagnosed	I-T058
mental	B-T038
health	I-T038
or	O
substance	B-T038
use	I-T038
problems	I-T038
.	O

acute	B-T037
kidney	I-T037
injury	I-T037
and	O
fluid	B-T038
overload	I-T038
in	O
infants	O
and	O
children	O
after	O
cardiac	B-T058
surgery	I-T058
acute	B-T037
kidney	I-T037
injury	I-T037
is	O
a	O
common	O
and	O
serious	O
complication	B-T038
after	O
congenital	O
heart	O
surgery	O
,	O
particularly	O
among	O
infants	O
.	O
this	O
comorbidity	O
has	O
been	O
independently	O
associated	O
with	O
adverse	B-T038
outcomes	I-T038
including	O
an	O
increase	O
in	O
mortality	O
.	O
postoperative	O
acute	B-T037
kidney	I-T037
injury	I-T037
has	O
a	O
complex	O
pathophysiology	O
with	O
many	O
risk	B-T033
factors	I-T033
,	O
and	O
therefore	O
no	B-T033
single	I-T033
medication	I-T033
or	O
therapy	B-T033
has	O
been	O
demonstrated	O
to	O
be	O
effective	O
for	O
treatment	B-T058
or	O
prevention	O
.	O
however	O
,	O
it	O
has	O
been	O
established	O
that	O
the	O
associated	O
fluid	B-T038
overload	I-T038
is	O
one	O
of	O
the	O
major	O
determinants	O
of	O
morbidity	O
,	O
particularly	O
in	O
infants	O
after	O
cardiac	B-T058
surgery	I-T058
.	O
therefore	O
,	O
in	O
the	O
absence	O
of	O
an	O
intervention	B-T058
to	O
prevent	O
acute	B-T037
kidney	I-T037
injury	I-T037
,	O
much	O
of	O
the	O
effort	O
to	O
improve	O
outcomes	O
has	O
focused	O
on	O
treating	O
and	O
preventing	O
fluid	B-T038
overload	I-T038
.	O
early	O
renal	B-T058
replacement	I-T058
therapy	I-T058
,	O
often	O
in	O
the	O
form	O
of	O
peritoneal	B-T058
dialysis	I-T058
,	O
has	O
been	O
shown	O
to	O
be	O
safe	O
and	O
beneficial	O
in	O
infants	O
with	O
olig	B-T038
##uria	I-T038
after	O
heart	B-T058
surgery	I-T058
.	O
as	O
understanding	O
of	O
the	O
pathophysiology	O
of	O
acute	B-T037
kidney	I-T037
injury	I-T037
and	O
the	O
ability	O
to	O
confident	O
##ly	O
diagnose	B-T033
it	O
earlier	O
continues	O
to	O
evolve	O
,	O
it	O
is	O
likely	O
that	O
novel	O
preventative	O
and	O
therapeutic	B-T058
interventions	I-T058
will	O
be	O
available	O
in	O
the	O
future	O
.	O

advanced	O
interl	B-T074
##ocking	I-T074
systems	I-T074
to	O
improve	B-T033
heavy	O
-	O
load	O
-	O
bearing	O
characteristics	O
of	O
flexible	O
intramedullary	B-T058
nail	I-T058
##ing	I-T058
flexible	O
intramedullary	B-T058
nail	I-T058
##ing	I-T058
(	O
fin	B-T058
)	O
is	O
a	O
minimally	B-T058
invasive	I-T058
and	O
widespread	B-T082
standard	O
method	B-T058
for	O
oste	B-T058
##osynthesis	I-T058
of	O
pediatric	O
long	B-T033
bone	I-T033
fractures	I-T033
.	O
in	O
the	O
case	O
of	O
unstable	B-T037
fractures	I-T037
of	O
the	O
lower	B-T017
extremity	I-T017
,	O
interl	B-T074
##ocking	I-T074
systems	I-T074
need	O
to	O
be	O
used	O
to	O
prevent	O
axial	B-T082
shortening	B-T058
and	O
subsequent	O
perforation	B-T038
of	O
the	O
nail	B-T074
at	O
its	O
insertion	B-T082
site	I-T082
.	O
in	O
the	O
present	O
study	B-T062
,	O
four	O
different	O
screw	B-T074
-	O
fixed	O
interl	B-T074
##ocking	I-T074
systems	I-T074
for	O
fin	B-T058
##s	I-T058
(	O
ho	B-T074
##fer	I-T074
twin	I-T074
##pl	I-T074
##ug	I-T074
with	O
two	O
3	O
-	O
mm	O
titanium	B-T103
interl	B-T074
##ocking	I-T074
screws	I-T074
,	O
ho	B-T074
##fer	I-T074
fix	I-T074
##pl	I-T074
##ug	I-T074
with	O
3	O
-	O
mm	O
titanium	B-T103
interl	B-T074
##ocking	I-T074
screw	I-T074
,	O
ho	B-T074
##fer	I-T074
plug	I-T074
with	O
3	O
.	O
5	O
-	O
mm	O
titanium	B-T103
interl	B-T074
##ocking	I-T074
screw	I-T074
,	O
and	O
ho	B-T074
##fer	I-T074
plug	I-T074
with	O
3	O
-	O
mm	O
titanium	B-T103
interl	B-T074
##ocking	I-T074
screw	I-T074
)	O
in	O
comparison	O
with	O
the	O
commonly	O
used	O
end	O
##er	O
stainless	B-T103
steel	I-T103
nails	B-T074
(	O
locked	O
with	O
3	O
.	O
5	O
-	O
mm	O
screw	B-T074
)	O
were	O
experimentally	O
investigated	O
in	O
cadaveric	B-T017
lamb	B-T204
tibia	B-T017
##e	I-T017
,	O
regarding	O
their	O
load	O
characteristics	O
and	O
failure	O
modes	O
in	O
the	O
case	O
of	O
heavy	O
loading	O
.	O
the	O
specimens	O
were	O
subjected	O
to	O
sequential	O
axial	B-T082
cyclic	O
loading	O
of	O
5000	O
cycles	O
with	O
stepwise	O
increase	O
of	O
the	O
load	O
amplitude	B-T082
until	O
failure	O
.	O
migration	O
of	O
locking	B-T074
screws	I-T074
and	O
internal	B-T082
damage	B-T037
of	O
bone	B-T017
tissue	I-T017
was	O
quantified	O
by	O
micro	B-T058
-	I-T058
computed	I-T058
tomography	I-T058
(	I-T058
ct	I-T058
)	I-T058
imaging	I-T058
.	O
end	B-T074
##er	I-T074
nails	I-T074
failed	O
on	O
average	O
at	O
a	O
peak	O
load	O
of	O
800	O
n	O
,	O
twin	B-T074
##pl	I-T074
##ug	I-T074
##s	I-T074
at	O
136	O
##7	O
n	O
,	O
fix	B-T074
##pl	I-T074
##ug	I-T074
##s	I-T074
at	O
122	O
##2	O
n	O
,	O
plug	B-T074
##s	I-T074
3	O
.	O
5	O
##mm	O
at	O
122	O
##5	O
n	O
and	O
plug	B-T074
##s	I-T074
3	O
.	O
0	O
##mm	O
at	O
97	O
##1	O
n	O
.	O
twin	B-T074
##pl	I-T074
##ug	I-T074
##s	I-T074
,	O
fix	B-T074
##pl	I-T074
##ug	I-T074
##s	I-T074
,	O
and	O
plug	B-T074
##s	I-T074
3	O
.	O
5	O
##mm	O
failed	O
in	O
a	O
slow	O
manner	O
over	O
several	O
hundred	O
loading	O
cycles	O
,	O
whereas	O
end	B-T074
##er	I-T074
nails	I-T074
and	O
plug	B-T074
##s	I-T074
3	O
.	O
0	O
##mm	O
exhibited	O
abrupt	O
failure	O
without	O
any	O
prior	O
indication	O
.	O
our	O
results	O
confirm	O
that	O
axial	B-T082
stability	O
of	O
fin	B-T058
can	O
be	O
further	O
improved	B-T033
by	O
screw	B-T074
-	O
fixed	O
plug	B-T074
##s	I-T074
by	O
simultaneously	O
avoiding	O
shortcomings	O
of	O
an	O
eye	O
-	O
locked	O
system	O
,	O
which	O
the	O
end	B-T074
##er	I-T074
nails	I-T074
are	O
.	O
considering	O
biomechanical	O
results	O
,	O
plug	B-T074
interl	B-T074
##ocking	I-T074
systems	I-T074
with	O
3	O
.	O
5	O
-	O
mm	O
screws	B-T074
should	O
be	O
favored	O
over	O
conventional	O
end	B-T074
##er	I-T074
nails	I-T074
and	O
plug	B-T074
##s	I-T074
with	O
3	O
-	O
mm	O
screws	B-T074
.	O

caribbean	B-T082
massive	B-T204
coral	I-T204
##s	I-T204
not	O
recovering	O
from	O
repeated	O
thermal	O
stress	O
events	O
during	O
2005	O
-	O
2013	O
massive	B-T204
coral	I-T204
bleaching	O
events	O
associated	O
with	O
high	O
sea	B-T082
surface	B-T082
temperatures	O
are	O
forec	O
##ast	O
to	O
become	O
more	O
frequent	O
and	O
severe	O
in	O
the	O
future	O
due	O
to	O
climate	O
change	O
.	O
monitoring	B-T062
colony	O
recovery	O
from	O
bleaching	O
disturbances	O
over	O
multi	O
##y	O
##ear	O
time	O
frames	O
is	O
important	O
for	O
improving	O
predictions	O
of	O
future	O
coral	B-T204
community	O
changes	O
.	O
however	O
,	O
there	O
are	O
currently	O
few	O
multi	B-T062
##y	I-T062
##ear	I-T062
studies	I-T062
describing	O
long	O
-	O
term	O
outcomes	O
for	O
coral	B-T204
colonies	O
following	O
acute	O
bleaching	O
events	O
.	O
we	O
recorded	O
colony	O
pigmentation	O
and	O
size	B-T082
for	O
ble	O
##ached	O
and	O
un	O
##ble	O
##ached	O
groups	O
of	O
co	O
-	O
located	O
conspecific	O
##s	O
of	O
three	O
major	O
reef	B-T204
-	I-T204
building	I-T204
scler	I-T204
##actin	I-T204
##ian	I-T204
coral	B-T204
##s	I-T204
(	O
orb	B-T204
##ice	I-T204
##ll	I-T204
##a	I-T204
frank	I-T204
##si	I-T204
,	O
sider	B-T204
##ast	I-T204
##re	I-T204
##a	I-T204
sider	I-T204
##ea	I-T204
,	O
and	O
step	B-T204
##han	I-T204
##oco	I-T204
##enia	I-T204
mich	I-T204
##elin	I-T204
##i	I-T204
;	O
n	O
=	O
198	O
total	O
)	O
in	O
boc	O
##as	O
del	O
tor	O
##o	O
,	O
pan	B-T082
##ama	I-T082
,	O
during	O
the	O
major	O
2005	O
bleaching	O
event	O
and	O
then	O
monitored	B-T062
pigmentation	O
status	O
and	O
changes	O
live	B-T017
tissue	I-T017
colony	O
size	B-T082
for	O
8	O
years	O
(	O
2005	O
-	O
2013	O
)	O
.	O
coral	B-T204
##s	I-T204
that	O
were	O
ble	O
##ached	O
in	O
2005	O
demonstrated	O
markedly	O
different	O
response	O
trajectories	O
compared	O
to	O
un	O
##ble	O
##ached	O
colony	O
groups	O
,	O
with	O
extensive	O
live	B-T017
tissue	I-T017
loss	O
for	O
ble	O
##ached	O
coral	B-T204
##s	I-T204
of	O
all	O
species	B-T170
following	O
bleaching	O
,	O
with	O
mean	O
live	B-T017
tissue	I-T017
losses	O
per	O
colony	O
9	O
months	O
post	O
##ble	O
##aching	O
of	O
26	O
.	O
2	O
%	O
(	O
±	O
##5	O
.	O
4	O
se	O
)	O
for	O
o	B-T204
.	I-T204
frank	I-T204
##si	I-T204
,	O
35	O
.	O
7	O
%	O
(	O
±	O
##4	O
.	O
7	O
se	O
)	O
for	O
s	B-T204
.	I-T204
mich	I-T204
##elin	I-T204
##i	I-T204
,	O
and	O
11	O
.	O
2	O
%	O
(	O
±	O
##3	O
.	O
9	O
se	O
)	O
for	O
s	B-T204
.	I-T204
sider	I-T204
##ea	I-T204
.	O
two	O
species	B-T170
,	O
o	B-T204
.	I-T204
frank	I-T204
##si	I-T204
and	O
s	B-T204
.	I-T204
mich	I-T204
##elin	I-T204
##i	I-T204
,	O
later	O
recovered	O
to	O
net	O
positive	B-T033
growth	B-T038
,	O
which	O
continued	O
until	O
a	O
second	O
thermal	O
stress	O
event	O
in	O
2010	O
.	O
following	O
this	O
event	O
,	O
all	O
species	B-T170
again	O
lost	O
tissue	B-T017
,	O
with	O
previously	O
un	O
##ble	O
##ached	O
colony	O
species	B-T170
groups	O
experiencing	O
greater	O
declines	O
than	O
conspecific	O
sample	O
groups	O
,	O
which	O
were	O
previously	O
ble	O
##ached	O
,	O
indicating	O
a	O
possible	O
positive	O
acclim	B-T038
##ative	I-T038
response	I-T038
.	O
however	O
,	O
despite	O
this	O
beneficial	O
effect	O
for	O
previously	O
ble	O
##ached	O
coral	B-T204
##s	I-T204
,	O
all	O
groups	O
experienced	O
substantial	O
net	O
tissue	B-T017
loss	O
between	O
2005	O
and	O
2013	O
,	O
indicating	O
that	O
many	O
important	O
caribbean	B-T082
reef	B-T204
-	I-T204
building	I-T204
coral	I-T204
##s	I-T204
will	O
likely	O
suffer	O
continued	O
tissue	B-T017
loss	O
and	O
may	O
be	O
unable	O
to	O
maintain	O
current	O
benthic	O
coverage	O
when	O
faced	O
with	O
future	O
thermal	O
stress	O
forec	O
##ast	O
for	O
the	O
region	B-T082
,	O
even	O
with	O
potential	O
benefits	O
from	O
bleaching	O
-	O
related	O
acclimation	B-T038
.	O

vitamin	B-T103
d	I-T103
receptor	I-T103
activator	I-T103
use	O
and	O
cause	O
-	O
specific	O
death	O
among	O
dialysis	B-T058
patients	O
:	O
a	O
nationwide	O
cohort	O
study	O
using	O
coarse	B-T170
##ned	I-T170
exact	I-T170
matching	I-T170
vitamin	B-T103
d	I-T103
receptor	I-T103
activators	I-T103
(	O
vdr	B-T103
##a	I-T103
)	O
may	O
exert	O
pleiotropic	B-T038
effects	I-T038
on	O
cardiovascular	B-T038
disease	I-T038
,	O
malignancy	B-T038
,	O
and	O
infections	B-T038
among	O
dialysis	B-T058
patients	O
,	O
but	O
recent	O
studies	O
have	O
mainly	O
focused	O
on	O
cardiovascular	B-T033
outcomes	I-T033
.	O
among	O
8	O
,	O
67	O
##5	O
patients	O
who	O
started	O
dialysis	B-T058
in	O
2007	O
and	O
who	O
survived	O
until	O
january	O
1	O
,	O
2010	O
,	O
listed	O
in	O
the	O
renal	B-T062
data	I-T062
registry	I-T062
of	O
the	O
japanese	B-T092
society	I-T092
for	O
dialysis	B-T058
therapy	I-T058
,	O
5	O
,	O
365	O
vdr	B-T103
##a	I-T103
users	O
were	O
matched	O
to	O
3	O
,	O
203	O
non	O
-	O
users	O
based	O
on	O
clinically	O
relevant	O
variables	O
at	O
the	O
end	O
of	O
2009	O
using	O
the	O
coarse	B-T170
##ned	I-T170
exact	I-T170
matching	I-T170
procedure	I-T170
.	O
until	O
december	O
31	O
,	O
2011	O
,	O
a	O
total	O
of	O
1	O
,	O
128	O
deaths	O
occurred	O
,	O
of	O
which	O
46	O
##8	O
(	O
42	O
%	O
)	O
were	O
cardiovascular	B-T038
deaths	I-T038
,	O
229	O
(	O
20	O
%	O
)	O
were	O
infection	B-T033
-	I-T033
related	I-T033
deaths	I-T033
,	O
and	O
141	O
(	O
12	O
%	O
)	O
were	O
malignancy	O
-	O
related	O
deaths	O
.	O
multivariable	B-T062
survival	I-T062
analyses	I-T062
accounting	O
for	O
intra	O
-	O
region	O
correlation	O
revealed	O
that	O
vdr	B-T103
##a	I-T103
use	O
was	O
significantly	O
associated	O
with	O
lower	O
rates	O
of	O
infection	B-T038
-	O
and	O
malignancy	B-T038
-	O
related	O
deaths	O
[	O
sub	O
##ha	O
##z	O
##ard	O
ratio	O
0	O
.	O
62	O
(	O
95	O
%	O
ci	O
,	O
0	O
.	O
52	O
-	O
0	O
.	O
73	O
)	O
and	O
0	O
.	O
70	O
(	O
95	O
%	O
ci	O
,	O
0	O
.	O
50	O
-	O
0	O
.	O
97	O
)	O
,	O
respectively	O
]	O
but	O
not	O
with	O
cardiovascular	B-T038
death	I-T038
[	O
sub	O
##ha	O
##z	O
##ard	O
ratio	O
0	O
.	O
86	O
(	O
95	O
%	O
ci	O
,	O
0	O
.	O
72	O
-	O
1	O
.	O
04	O
)	O
]	O
.	O
future	O
randomized	B-T062
clinical	I-T062
trials	I-T062
with	O
a	O
sufficient	O
sample	O
size	O
and	O
an	O
adequate	O
follow	B-T058
-	I-T058
up	I-T058
period	O
are	O
warranted	O
to	O
test	O
the	O
clinical	O
effectiveness	O
of	O
vdr	B-T103
##a	I-T103
on	O
infection	B-T038
and	O
malignancy	B-T038
,	O
rather	O
than	O
cardiovascular	B-T038
disease	I-T038
,	O
among	O
dialysis	B-T058
patients	O
.	O

the	O
urokinase	B-T103
/	O
urokinase	B-T103
receptor	I-T103
system	O
in	O
mast	B-T017
cells	I-T017
:	O
effects	O
of	O
its	O
functional	O
interaction	O
with	O
fm	B-T103
##l	I-T103
##f	I-T103
receptors	I-T103
mast	B-T017
cell	I-T017
and	O
basophils	B-T017
express	O
the	O
high	B-T103
affinity	I-T103
receptor	I-T103
for	O
ige	B-T103
(	O
fc	B-T103
##ɛ	I-T103
##ri	I-T103
)	O
and	O
are	O
primary	B-T017
effector	I-T017
cells	I-T017
of	O
allergic	B-T038
disorders	I-T038
.	O
the	O
urokinase	B-T103
(	O
upa	B-T103
)	O
-	O
mediated	O
plasminogen	B-T038
activation	I-T038
system	I-T038
is	O
involved	O
in	O
physiological	B-T038
and	O
pathological	B-T038
events	I-T038
based	O
on	O
cell	B-T038
migration	I-T038
and	O
tissue	O
remodelling	O
,	O
such	O
as	O
inflammation	B-T038
,	O
wound	B-T038
healing	I-T038
,	O
angiogenesis	B-T038
and	O
metastasis	B-T038
.	O
upa	B-T103
is	O
a	O
serine	B-T103
protease	I-T103
that	O
binds	O
upar	B-T103
,	O
a	O
high	B-T103
affinity	I-T103
glycosyl	I-T103
-	I-T103
phosphatidyl	I-T103
-	I-T103
inositol	I-T103
(	I-T103
gpi	I-T103
)	I-T103
-	I-T103
anchored	I-T103
receptor	B-T103
.	O
upar	B-T103
focuses	O
upa	B-T103
activity	B-T038
at	O
the	O
cell	B-T017
surface	I-T017
and	O
activates	B-T038
intracellular	I-T038
signaling	I-T038
through	O
lateral	O
interactions	O
with	O
integrins	B-T103
,	O
receptor	B-T103
tyrosine	I-T103
kinases	I-T103
and	O
the	O
g	B-T103
-	I-T103
protein	I-T103
-	I-T103
coupled	I-T103
family	I-T103
of	O
fm	B-T103
##l	I-T103
##f	I-T103
chemotaxis	I-T103
receptors	I-T103
(	O
fp	B-T103
##rs	I-T103
)	O
.	O
we	O
investigated	O
the	O
expression	B-T038
of	O
the	O
upa	B-T103
-	O
upar	B-T103
system	O
and	O
its	O
functional	O
interaction	O
with	O
fp	B-T103
##rs	I-T103
in	O
human	B-T204
mast	B-T017
cells	I-T017
(	O
mcs	B-T017
)	O
.	O
differently	O
from	O
basophils	B-T017
,	O
mcs	B-T017
produced	O
upa	B-T103
that	O
was	O
able	O
to	O
induce	O
their	O
chemotaxis	B-T038
.	O
indeed	O
,	O
mcs	B-T017
also	O
expressed	O
upar	B-T103
,	O
both	O
in	O
the	O
intact	O
and	O
in	O
a	O
cleaved	O
form	O
(	O
di	B-T103
##i	I-T103
-	I-T103
di	I-T103
##ii	I-T103
-	I-T103
upar	I-T103
)	O
that	O
can	O
expose	O
,	O
at	O
the	O
n	O
-	O
terminus	O
,	O
the	O
srs	B-T082
##ry	I-T082
sequence	I-T082
,	O
able	O
to	O
interact	O
with	O
fp	B-T103
##rs	I-T103
and	O
to	O
mediate	O
cell	B-T038
chemotaxis	I-T038
.	O
mcs	B-T017
also	O
expressed	O
mrnas	B-T103
for	O
fp	B-T103
##rs	I-T103
that	O
were	O
functionally	O
active	O
;	O
indeed	O
,	O
upa	B-T103
and	O
a	O
soluble	B-T103
peptide	I-T103
(	O
upar	B-T103
##84	I-T103
-	I-T103
95	I-T103
)	O
,	O
containing	O
the	O
srs	B-T082
##ry	I-T082
chemotactic	I-T082
sequence	I-T082
of	O
upar	B-T103
and	O
able	O
to	O
interact	O
with	O
fp	B-T103
##rs	I-T103
,	O
were	O
able	O
to	O
induce	O
mcs	B-T017
chemotaxis	B-T038
.	O
thus	O
,	O
upa	B-T103
is	O
a	O
potent	O
chemoattractant	B-T103
for	O
mcs	B-T017
acting	O
through	O
the	O
exposure	O
of	O
the	O
chemotactic	B-T038
epitope	B-T103
of	O
upar	B-T103
,	O
that	O
is	O
an	O
endogenous	O
ligand	B-T103
for	O
fp	B-T103
##rs	I-T103
.	O
the	O
same	O
mechanism	O
could	O
be	O
involved	O
in	O
vegf	B-T103
-	I-T103
a	I-T103
secretion	B-T038
by	O
human	B-T204
mcs	B-T017
,	O
also	O
induced	O
by	O
upa	B-T103
and	O
upar	B-T103
##84	I-T103
-	I-T103
95	I-T103
stimulation	B-T038
.	I-T038

the	O
influence	O
of	O
slope	O
on	O
spar	B-T204
##tium	I-T204
jun	I-T204
##ce	I-T204
##um	I-T204
root	B-T204
system	I-T204
:	O
morphological	O
,	O
anatomical	O
and	O
biomechanical	O
adaptation	B-T038
root	B-T204
systems	I-T204
have	O
a	O
pivotal	O
role	O
in	O
plant	B-T204
anchorage	O
and	O
their	O
mechanical	O
interactions	O
with	O
the	O
soil	O
may	O
contribute	O
to	O
soil	O
reinforcement	O
and	O
stabilization	O
of	O
slide	O
-	O
prone	O
slopes	O
.	O
in	O
order	O
to	O
understand	O
the	O
responses	O
of	O
root	B-T204
system	I-T204
to	O
mechanical	O
stress	O
induced	O
by	O
slope	O
,	O
samples	O
of	O
spar	B-T204
##tium	I-T204
jun	I-T204
##ce	I-T204
##um	I-T204
l	I-T204
.	I-T204
,	O
growing	O
in	O
slope	O
and	O
in	O
plane	O
natural	O
conditions	O
,	O
were	O
compared	O
in	O
their	O
morphology	O
,	O
biomechanical	O
properties	O
and	O
anatomical	B-T082
features	I-T082
.	O
soils	O
sampled	O
in	O
slope	O
and	O
plane	O
revealed	O
similar	O
characteristics	O
,	O
with	O
the	O
exception	O
of	O
organic	O
matter	O
content	O
and	O
penetr	O
##ometer	O
resistance	O
,	O
both	O
higher	O
in	O
slope	O
.	O
slope	O
significantly	O
influenced	O
root	B-T204
morphology	O
and	O
in	O
particular	O
the	O
distribution	O
of	O
lateral	B-T082
roots	B-T204
along	O
the	O
soil	O
depth	B-T082
.	O
indeed	O
,	O
first	O
-	O
order	O
lateral	B-T082
roots	B-T204
of	O
plants	B-T204
growing	O
on	O
slope	O
condition	O
showed	O
an	O
asymmetric	B-T082
distribution	O
between	O
up	O
-	O
and	O
down	O
-	O
slope	O
.	O
contr	O
##arily	O
,	O
this	O
asymmetric	B-T082
distribution	O
was	O
not	O
observed	O
in	O
plants	B-T204
growing	O
in	O
plane	O
.	O
the	O
tensile	O
strength	O
was	O
higher	O
in	O
lateral	B-T082
roots	B-T204
growing	O
up	O
-	O
slope	O
and	O
in	O
plane	O
conditions	O
than	O
in	O
those	O
growing	O
down	O
-	O
slope	O
.	O
anatomical	B-T062
investigations	I-T062
revealed	O
that	O
,	O
while	O
roots	B-T204
grown	O
up	O
-	O
slope	O
had	O
higher	O
area	B-T082
covered	O
by	O
xylem	B-T204
fibers	I-T204
,	O
the	O
ratio	O
of	O
xylem	B-T204
and	O
phloem	B-T204
fibers	I-T204
to	O
root	B-T204
diameter	O
did	O
not	O
differ	O
among	O
the	O
three	O
conditions	O
,	O
as	O
also	O
,	O
no	O
differences	O
were	O
found	O
for	O
xylem	B-T204
fiber	I-T204
cell	B-T017
wall	I-T017
thickness	O
.	O
roots	B-T204
growing	O
up	O
-	O
slope	O
were	O
the	O
main	O
contributors	O
to	O
anchorage	O
properties	O
,	O
which	O
included	O
higher	O
strength	O
and	O
higher	O
number	O
of	O
fibers	B-T204
in	O
the	O
xylem	B-T204
##atic	I-T204
tissues	B-T017
.	O
results	O
suggested	O
that	O
a	O
combination	O
of	O
root	B-T204
-	O
specific	O
morphological	O
,	O
anatomical	O
and	O
biomechanical	O
traits	O
,	O
determines	O
anchorage	O
functions	O
in	O
slope	O
conditions	O
.	O

therapeutic	O
applications	O
of	O
crispr	B-T103
rna	B-T103
-	I-T103
guided	I-T103
genome	B-T062
editing	I-T062
the	O
rapid	O
development	O
of	O
programm	B-T103
##able	I-T103
nuclease	I-T103
-	O
based	O
genome	B-T062
editing	I-T062
technologies	O
has	O
enabled	O
targeted	O
gene	B-T017
disruption	O
and	O
correction	B-T058
both	O
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
this	O
revolution	O
opens	O
up	O
the	O
possibility	O
of	O
precise	O
genome	B-T062
editing	I-T062
at	O
target	O
genomic	B-T082
sites	I-T082
to	O
modulate	O
gene	B-T038
function	I-T038
in	O
animals	B-T204
and	O
plants	B-T204
.	O
among	O
several	O
programm	B-T103
##able	I-T103
nuclease	I-T103
##s	I-T103
,	O
the	O
type	B-T103
ii	I-T103
clustered	I-T103
regularly	I-T103
intersp	I-T103
##aced	I-T103
short	I-T103
pal	I-T103
##ind	I-T103
##romic	I-T103
repeats	I-T103
(	O
crispr	B-T103
)	O
-	O
crispr	B-T038
-	I-T038
associated	I-T038
nuclease	I-T038
9	I-T038
(	I-T038
cas9	I-T038
)	I-T038
system	I-T038
has	O
progressed	O
remarkably	O
in	O
recent	O
years	O
,	O
leading	O
to	O
its	O
widespread	O
use	O
in	O
research	B-T062
,	O
medicine	B-T091
and	O
biotechnology	B-T091
.	O
in	O
particular	O
,	O
crispr	B-T038
-	I-T038
cas9	I-T038
shows	O
highly	O
efficient	O
gene	B-T062
editing	I-T062
activity	O
for	O
therapeutic	O
purposes	O
in	O
systems	O
ranging	O
from	O
patient	O
stem	B-T017
cells	I-T017
to	O
animal	B-T204
models	I-T204
.	O
however	O
,	O
the	O
development	O
of	O
therapeutic	O
approaches	O
and	O
delivery	B-T058
methods	I-T058
remains	O
a	O
great	O
challenge	O
for	O
biomedical	B-T091
applications	O
.	O
herein	O
,	O
we	O
review	O
therapeutic	O
applications	O
that	O
use	O
the	O
crispr	B-T038
-	I-T038
cas9	I-T038
system	I-T038
and	O
discuss	O
the	O
possibilities	O
and	O
challenges	O
ahead	O
.	O

selection	O
of	O
a	O
marker	B-T017
gene	I-T017
to	O
construct	O
a	O
reference	B-T092
library	I-T092
for	O
wetland	O
plants	B-T204
,	O
and	O
the	O
application	O
of	O
metab	B-T062
##arc	I-T062
##oding	I-T062
to	O
analyze	B-T062
the	O
diet	B-T168
of	O
winter	O
##ing	O
herbiv	B-T204
##orous	I-T204
water	B-T204
##bir	I-T204
##ds	I-T204
food	B-T168
availability	O
and	O
diet	B-T168
selection	O
are	O
important	O
factors	O
influencing	O
the	O
abundance	O
and	O
distribution	O
of	O
wild	B-T170
water	B-T204
##bir	I-T204
##ds	I-T204
.	O
in	O
order	O
to	O
better	O
understand	O
changes	O
in	O
water	B-T204
##bir	I-T204
##d	I-T204
population	O
,	O
it	O
is	O
essential	O
to	O
figure	O
out	O
what	O
they	O
feed	O
on	O
.	O
however	O
,	O
analyzing	B-T062
their	O
diet	B-T168
could	O
be	O
difficult	O
and	O
inefficient	O
using	O
traditional	O
methods	O
such	O
as	O
micro	B-T058
##his	I-T058
##to	I-T058
##lo	I-T058
##gic	I-T058
observation	I-T058
.	O
here	O
,	O
we	O
addressed	O
this	O
gap	O
of	O
knowledge	O
by	O
investigating	O
the	O
diet	B-T168
of	O
greater	B-T204
white	I-T204
-	I-T204
front	I-T204
##ed	I-T204
go	I-T204
##ose	I-T204
ans	I-T204
##er	I-T204
alb	I-T204
##if	I-T204
##ron	I-T204
##s	I-T204
and	O
bean	B-T204
go	I-T204
##ose	I-T204
ans	I-T204
##er	I-T204
fab	I-T204
##alis	I-T204
,	O
which	O
are	O
obligate	B-T204
herbivores	I-T204
winter	O
##ing	O
in	O
china	B-T082
,	O
mostly	O
in	O
the	O
middle	B-T082
and	O
lower	B-T082
yang	I-T082
##tz	I-T082
##e	I-T082
river	I-T082
flood	I-T082
##pl	I-T082
##ain	I-T082
.	O
first	O
,	O
we	O
selected	O
a	O
suitable	O
and	O
high	O
-	O
resolution	O
marker	B-T017
gene	I-T017
for	O
wetland	O
plants	B-T204
that	O
these	O
ge	B-T204
##ese	I-T204
would	O
consume	O
during	O
the	O
winter	O
##ing	O
period	O
.	O
eight	O
candidate	B-T017
genes	I-T017
were	O
included	O
:	O
rbc	B-T017
##l	I-T017
,	O
rp	B-T017
##oc	I-T017
##1	I-T017
,	O
rp	B-T017
##ob	I-T017
,	O
mat	B-T017
##k	I-T017
,	O
tr	B-T082
##nh	I-T082
-	I-T082
ps	I-T082
##ba	I-T082
,	O
tr	B-T017
##nl	I-T017
(	O
ua	B-T082
##a	I-T082
)	O
,	O
atp	B-T082
##f	I-T082
-	I-T082
atp	I-T082
##h	I-T082
,	O
and	O
ps	B-T082
##b	I-T082
##k	I-T082
-	I-T082
ps	I-T082
##bi	I-T082
.	O
the	O
selection	O
was	O
performed	O
via	O
analysis	B-T062
of	O
representative	O
sequences	B-T082
from	O
nc	B-T092
##bi	I-T092
and	O
comparison	O
of	O
amplification	B-T038
efficiency	O
and	O
resolution	O
power	O
of	O
plant	B-T204
samples	O
collected	O
from	O
the	O
winter	B-T082
##ing	I-T082
area	I-T082
.	O
the	O
tr	B-T017
##nl	I-T017
gene	I-T017
was	O
chosen	O
at	O
last	O
with	O
c	B-T103
/	I-T103
h	I-T103
primers	I-T103
,	O
and	O
a	O
local	B-T082
plant	B-T204
reference	B-T092
library	I-T092
was	O
constructed	B-T170
with	O
this	O
gene	B-T017
.	O
then	O
,	O
utilizing	O
dna	B-T062
metab	I-T062
##arc	I-T062
##oding	I-T062
,	O
we	O
discovered	O
15	O
food	B-T168
items	I-T168
in	O
total	O
from	O
the	O
feces	B-T031
of	O
these	O
birds	B-T204
.	O
of	O
the	O
15	O
unique	O
dietary	B-T168
sequences	B-T082
,	O
10	O
could	O
be	O
identified	O
at	O
spec	B-T170
##ie	I-T170
level	O
.	O
as	O
for	O
greater	B-T204
white	I-T204
-	I-T204
front	I-T204
##ed	I-T204
go	I-T204
##ose	I-T204
,	O
73	O
%	O
of	O
sequences	B-T082
belonged	O
to	O
po	B-T204
##aceae	I-T204
spp	I-T204
.	I-T204
,	O
and	O
26	O
%	O
belonged	O
to	O
care	B-T204
##x	I-T204
spp	I-T204
.	O
in	O
contrast	O
,	O
almost	O
all	O
sequences	B-T082
of	O
bean	B-T204
go	I-T204
##ose	I-T204
belonged	O
to	O
care	B-T204
##x	I-T204
spp	I-T204
.	O
(	O
99	O
%	O
)	O
.	O
using	O
the	O
same	O
samples	O
,	O
micro	B-T058
##his	I-T058
##to	I-T058
##lo	I-T058
##gy	I-T058
provided	O
consistent	O
food	B-T168
composition	I-T168
with	O
metab	B-T062
##arc	I-T062
##oding	I-T062
results	O
for	O
greater	B-T204
white	I-T204
-	I-T204
front	I-T204
##ed	I-T204
go	I-T204
##ose	I-T204
,	O
while	O
13	O
%	O
of	O
po	B-T204
##aceae	I-T204
was	O
recovered	O
for	O
bean	B-T204
go	I-T204
##ose	I-T204
.	O
in	O
addition	O
,	O
two	O
other	O
taxa	O
were	O
discovered	O
only	O
through	O
micro	B-T058
##his	I-T058
##to	I-T058
##lo	I-T058
##gic	I-T058
analysis	I-T058
.	O
although	O
most	O
of	O
the	O
identified	O
taxa	O
matched	O
relatively	O
well	O
between	O
the	O
two	O
methods	O
,	O
dna	B-T062
metab	I-T062
##arc	I-T062
##oding	I-T062
gave	O
taxonomic	O
##ally	O
more	O
detailed	O
information	O
.	O
discrepancies	B-T033
were	O
likely	O
due	O
to	O
biased	O
pcr	B-T062
amplification	B-T038
in	O
metab	B-T062
##arc	I-T062
##oding	I-T062
,	O
low	O
discriminating	O
power	O
of	O
current	O
marker	B-T017
genes	I-T017
for	O
monoc	B-T204
##ots	I-T204
,	O
and	O
biases	O
in	O
micro	B-T058
##his	I-T058
##to	I-T058
##lo	I-T058
##gic	I-T058
analysis	I-T058
.	O
the	O
diet	B-T168
differences	O
between	O
two	O
ge	B-T204
##ese	I-T204
species	B-T170
might	O
indicate	O
deeper	O
ecological	O
significance	O
beyond	O
the	O
scope	O
of	O
this	O
study	B-T062
.	O
we	O
concluded	O
that	O
dna	B-T062
metab	I-T062
##arc	I-T062
##oding	I-T062
provides	O
new	O
perspectives	O
for	O
studies	B-T062
of	O
herbiv	B-T204
##orous	I-T204
water	B-T204
##bir	I-T204
##d	I-T204
diets	B-T168
and	O
inter	O
-	O
specific	O
interactions	O
,	O
as	O
well	O
as	O
new	O
possibilities	O
to	O
investigate	O
interactions	O
between	O
herbivores	B-T204
and	O
plants	B-T204
.	O
in	O
addition	O
,	O
micro	B-T058
##his	I-T058
##to	I-T058
##lo	I-T058
##gic	I-T058
analysis	I-T058
should	O
be	O
used	O
together	O
with	O
metab	B-T062
##arc	I-T062
##oding	I-T062
methods	I-T062
to	O
integrate	O
this	O
information	O
.	O

genomic	B-T058
analysis	I-T058
of	O
nont	B-T007
##ype	I-T007
##able	I-T007
pneum	I-T007
##ococci	I-T007
causing	O
invasive	B-T038
pneumococcal	I-T038
disease	I-T038
in	O
south	B-T082
africa	I-T082
,	O
2003	O
-	O
2013	O
the	O
capsular	O
polysaccharide	O
is	O
the	O
principal	O
virulence	B-T103
factor	I-T103
of	O
streptococcus	B-T007
pneumoniae	I-T007
and	O
a	O
target	O
for	O
current	O
pneumococcal	B-T103
vaccines	I-T103
.	O
however	O
,	O
some	O
pathogenic	B-T033
pneum	B-T007
##ococci	I-T007
are	O
serologically	B-T170
nont	I-T170
##ype	I-T170
##able	I-T170
[	O
nont	B-T007
##ype	I-T007
##able	I-T007
pneum	I-T007
##ococci	I-T007
(	O
ntp	B-T007
##n	I-T007
)	O
]	O
.	O
due	O
to	O
their	O
relative	O
rarity	O
,	O
ntp	B-T007
##n	I-T007
are	O
poorly	O
characterized	O
,	O
and	O
,	O
as	O
such	O
,	O
limited	O
data	O
exist	O
which	O
describe	O
these	O
organisms	O
.	O
we	O
aimed	O
to	O
describe	O
disease	B-T038
and	O
genotypic	O
##ally	O
characterize	O
ntp	B-T007
##n	I-T007
causing	O
invasive	B-T038
pneumococcal	I-T038
disease	I-T038
in	O
south	B-T082
africa	I-T082
.	O
isolates	B-T103
were	O
detected	O
through	O
national	O
,	O
laboratory	B-T092
-	O
based	O
surveillance	O
for	O
invasive	B-T038
pneumococcal	I-T038
disease	I-T038
in	O
south	B-T082
africa	I-T082
and	O
characterized	O
by	O
whole	O
genome	B-T058
analysis	I-T058
.	O
we	O
predicted	O
ancestral	O
serotypes	B-T170
(	O
serotypes	B-T170
from	O
which	O
ntp	B-T007
##n	I-T007
may	O
have	O
originated	O
)	O
for	O
group	O
i	O
ntp	B-T007
##n	I-T007
using	O
multilocus	B-T062
sequence	I-T062
typing	I-T062
and	O
capsular	O
region	O
sequence	B-T058
analyses	I-T058
.	O
antimicrobial	B-T201
resistance	I-T201
patterns	B-T082
and	O
mutations	B-T038
potentially	O
causing	O
nont	B-T170
##ype	I-T170
##ability	I-T170
were	O
identified	O
.	O
from	O
2003	O
-	O
2013	O
,	O
39	O
(	O
0	O
.	O
1	O
%	O
,	O
39	O
/	O
32	O
,	O
82	O
##4	O
)	O
ntp	B-T007
##n	I-T007
were	O
reported	O
.	O
twenty	O
-	O
two	O
(	O
56	O
%	O
)	O
had	O
partial	O
capsular	B-T017
genes	I-T017
(	O
group	O
i	O
)	O
and	O
17	O
(	O
44	O
%	O
)	O
had	O
complete	O
capsular	B-T038
deletion	I-T038
of	O
which	O
15	O
had	O
replacement	O
by	O
other	O
genes	B-T017
(	O
group	O
ii	O
)	O
.	O
seventy	O
-	O
nine	O
percent	O
(	O
31	O
/	O
39	O
)	O
of	O
our	O
ntp	B-T007
##n	I-T007
isolates	B-T103
were	O
derived	O
from	O
encapsulated	O
s	B-T007
.	I-T007
pneumoniae	I-T007
.	O
ancestral	O
serotypes	B-T170
1	O
(	O
27	O
%	O
,	O
6	O
/	O
22	O
)	O
and	O
8	O
(	O
14	O
%	O
,	O
3	O
/	O
22	O
)	O
were	O
most	O
prevalent	O
,	O
and	O
59	O
%	O
(	O
13	O
/	O
22	O
)	O
of	O
ancestral	O
serotypes	B-T170
were	O
serotypes	B-T170
included	O
in	O
the	O
13	B-T103
-	I-T103
valent	I-T103
pneumococcal	I-T103
conjugate	I-T103
vaccine	I-T103
.	O
we	O
identified	O
a	O
variety	O
of	O
mutations	B-T038
within	O
the	O
capsular	O
region	O
of	O
group	O
i	O
ntp	B-T007
##n	I-T007
,	O
some	O
of	O
which	O
may	O
be	O
responsible	O
for	O
the	O
nont	B-T170
##ype	I-T170
##able	I-T170
phenotype	O
.	O
nons	B-T033
##usc	I-T033
##ept	I-T033
##ibility	I-T033
to	O
tetracycline	B-T103
and	O
erythromycin	B-T103
was	O
higher	O
in	O
ntp	B-T007
##n	I-T007
than	O
encapsulated	O
s	B-T007
.	I-T007
pneumoniae	I-T007
.	O
ntp	B-T007
##n	I-T007
are	O
currently	O
a	O
rare	O
cause	O
of	O
invasive	B-T038
pneumococcal	I-T038
disease	I-T038
in	O
south	B-T082
africa	I-T082
and	O
represent	O
a	O
genetically	O
diverse	O
collection	O
of	O
isolates	O
.	O

sc	B-T103
##ute	I-T103
##ll	I-T103
##aria	I-T103
barb	I-T103
##ata	I-T103
d	I-T103
.	I-T103
don	I-T103
extract	I-T103
inhibits	O
the	O
tumor	O
growth	O
through	O
down	B-T038
-	I-T038
regulating	I-T038
of	O
treg	B-T017
cells	I-T017
and	O
manipulating	B-T038
th1	B-T038
/	O
th17	B-T038
immune	I-T038
response	I-T038
in	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
previous	O
studies	O
showed	O
sc	B-T103
##ute	I-T103
##ll	I-T103
##aria	I-T103
barb	I-T103
##ata	I-T103
d	I-T103
.	I-T103
don	I-T103
extract	I-T103
(	O
sb	B-T103
##e	I-T103
)	O
is	O
a	O
potent	O
inhibitor	B-T103
in	O
hepatoma	B-T038
and	O
could	O
improve	O
immune	B-T038
function	I-T038
of	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
.	O
however	O
,	O
the	O
immunomodulatory	B-T038
function	I-T038
of	O
sb	B-T103
##e	I-T103
on	O
the	O
tumor	O
growth	O
of	O
hepatoma	B-T038
remains	O
unclear	O
.	O
this	O
study	B-T062
aimed	O
to	O
investigate	O
the	O
anti	O
-	O
tumor	O
effects	O
of	O
sb	B-T103
##e	I-T103
on	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
and	O
explore	O
the	O
underlying	O
immunomodulatory	B-T038
function	I-T038
.	O
the	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
were	O
treated	O
by	O
sb	B-T103
##e	I-T103
for	O
30	O
days	O
.	O
the	O
effect	O
of	O
sb	B-T103
##e	I-T103
on	O
the	O
proliferation	B-T038
of	O
hepg2	B-T017
cells	I-T017
in	O
vitro	O
,	O
the	O
growth	O
of	O
transplanted	O
tumor	O
,	O
the	O
cytotoxicity	B-T038
of	I-T038
natural	I-T038
killer	I-T038
(	I-T038
nk	I-T038
)	I-T038
cells	I-T038
in	O
spleen	B-T017
,	O
the	O
amount	O
of	O
cd4	B-T103
(	I-T103
+	I-T103
)	I-T103
cd25	I-T103
(	I-T103
+	I-T103
)	I-T103
foxp3	I-T103
(	I-T103
+	I-T103
)	I-T103
treg	I-T103
cells	I-T103
and	O
th17	B-T017
cells	I-T017
in	O
tumor	B-T017
tissue	I-T017
,	O
and	O
the	O
levels	O
of	O
il	B-T103
-	I-T103
10	I-T103
,	O
tgf	B-T103
-	I-T103
β	I-T103
,	O
il	B-T103
-	I-T103
17a	I-T103
,	O
il	B-T103
-	I-T103
2	I-T103
,	O
and	O
ifn	B-T103
-	I-T103
γ	I-T103
in	O
serum	B-T031
of	O
the	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
was	O
observer	O
##ed	O
.	O
il	B-T103
-	I-T103
17a	I-T103
was	O
injected	O
to	O
the	O
sb	B-T103
##e	I-T103
treated	O
mice	B-T204
from	O
day	O
9	O
post	O
h2	O
##2	O
inoculation	B-T058
to	O
examine	O
its	O
effect	O
on	O
tumor	O
growth	O
.	O
sb	B-T103
##e	I-T103
treatment	O
inhibited	O
the	O
proliferation	B-T038
of	O
hepg2	B-T017
cells	I-T017
in	O
vitro	O
with	O
a	O
dose	O
-	O
dependent	O
manner	O
and	O
significantly	O
suppressed	O
the	O
tumor	O
growth	O
of	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
.	O
meanwhile	O
,	O
it	O
increased	O
nk	B-T038
cells	I-T038
'	I-T038
cytotoxicity	I-T038
in	O
spleen	B-T017
,	O
down	B-T038
-	I-T038
regulated	I-T038
the	O
amount	O
of	O
cd4	B-T103
(	I-T103
+	I-T103
)	I-T103
cd25	I-T103
(	I-T103
+	I-T103
)	I-T103
foxp3	I-T103
(	I-T103
+	I-T103
)	I-T103
treg	I-T103
cells	I-T103
and	O
th17	B-T017
cells	I-T017
in	O
tumor	B-T017
tissue	I-T017
,	O
and	O
decreased	O
il	B-T103
-	I-T103
10	I-T103
,	O
tgf	B-T103
-	I-T103
β	I-T103
,	O
and	O
il	B-T103
-	I-T103
17a	I-T103
levels	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
whereas	O
increased	O
il	B-T103
-	I-T103
2	I-T103
and	O
ifn	B-T103
-	I-T103
γ	I-T103
levels	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
the	O
serum	B-T031
of	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
.	O
moreover	O
,	O
administration	O
of	O
recombinant	B-T204
mouse	I-T204
il	B-T103
-	I-T103
17a	I-T103
reversed	O
the	O
anti	O
-	O
tumor	O
effects	O
of	O
sb	B-T103
##e	I-T103
.	O
sb	B-T103
##e	I-T103
could	O
inhibit	O
the	O
proliferation	B-T038
of	O
hepg2	B-T017
cells	I-T017
in	O
vitro	O
.	O
meanwhile	O
,	O
sb	B-T103
##e	I-T103
also	O
could	O
inhibit	O
the	O
growth	B-T038
of	O
h2	O
##2	O
implanted	B-T038
tumor	I-T038
in	O
hepatoma	O
h2	O
##2	O
-	O
bearing	O
mice	B-T204
,	O
and	O
this	O
function	O
might	O
be	O
associated	O
with	O
immunomodulatory	B-T038
activity	I-T038
through	O
down	B-T038
-	I-T038
regulating	I-T038
of	O
treg	B-T017
cells	I-T017
and	O
manipulating	B-T038
th1	B-T038
/	O
th17	B-T038
immune	I-T038
response	I-T038
.	O

optical	B-T062
tw	I-T062
##ee	I-T062
##zer	I-T062
##s	I-T062
studies	B-T062
of	O
transcription	B-T038
by	O
eukaryotic	B-T017
rna	B-T103
polymerases	I-T103
transcription	B-T038
is	O
the	O
first	O
step	O
in	O
the	O
expression	B-T038
of	O
genetic	O
information	O
and	O
it	O
is	O
carried	O
out	O
by	O
large	O
macromolecular	B-T103
enzymes	B-T103
called	O
rna	B-T103
polymerases	I-T103
.	O
transcription	B-T038
has	O
been	O
studied	B-T062
for	O
many	O
years	O
and	O
with	O
a	O
myriad	B-T170
of	O
experimental	O
techniques	O
,	O
ranging	O
from	O
bulk	O
studies	B-T062
to	O
high	B-T058
-	I-T058
resolution	I-T058
transcript	I-T058
sequencing	I-T058
.	O
in	O
this	O
review	B-T170
,	O
we	O
emphasis	O
##e	O
the	O
advantages	O
of	O
using	O
single	O
-	O
molecule	O
techniques	O
,	O
particularly	O
optical	B-T062
tw	I-T062
##ee	I-T062
##zer	I-T062
##s	I-T062
,	O
to	O
study	B-T062
transcription	B-T038
dynamics	O
.	O
we	O
give	O
an	O
overview	O
of	O
the	O
latest	O
results	O
in	O
the	O
single	O
-	O
molecule	O
transcription	B-T038
field	O
,	O
focusing	O
on	O
transcription	B-T038
by	O
eukaryotic	B-T017
rna	B-T103
polymerases	I-T103
.	O
finally	O
,	O
we	O
evaluate	O
recent	O
quantitative	O
models	O
that	O
describe	O
the	O
biophys	B-T091
##ics	I-T091
of	O
rna	B-T103
polymerase	I-T103
translocation	B-T038
and	O
back	O
##trac	O
##king	O
dynamics	O
.	O

on	O
the	O
relation	O
between	O
face	O
and	O
object	O
recognition	O
in	O
developmental	B-T038
pros	I-T038
##opa	I-T038
##gn	I-T038
##osi	I-T038
##a	I-T038
:	O
no	O
dissociation	B-T038
but	O
a	O
systematic	O
association	O
there	O
is	O
an	O
ongoing	O
debate	O
about	O
whether	O
face	O
recognition	O
and	O
object	O
recognition	O
constitute	O
separate	O
domains	O
.	O
clarification	O
of	O
this	O
issue	B-T033
can	O
have	O
important	O
theoretical	O
implications	O
as	O
face	O
recognition	O
is	O
often	O
used	O
as	O
a	O
prime	O
example	O
of	O
domain	O
-	O
specificity	O
in	O
mind	O
and	O
brain	B-T017
.	O
an	O
important	O
source	B-T033
of	O
input	O
to	O
this	O
debate	O
comes	O
from	O
studies	O
of	O
individuals	B-T098
with	O
developmental	B-T038
pros	I-T038
##opa	I-T038
##gn	I-T038
##osi	I-T038
##a	I-T038
,	O
suggesting	O
that	O
face	O
recognition	O
can	O
be	O
selectively	O
impaired	O
.	O
we	O
put	O
the	O
selectivity	O
hypothesis	O
to	O
test	O
by	O
assessing	O
the	O
performance	O
of	O
10	O
individuals	B-T098
with	O
developmental	B-T038
pros	I-T038
##opa	I-T038
##gn	I-T038
##osi	I-T038
##a	I-T038
on	O
demanding	O
tests	O
of	O
visual	B-T038
object	I-T038
processing	I-T038
involving	O
both	O
regular	O
and	O
degraded	B-T033
drawing	B-T170
##s	I-T170
.	O
none	O
of	O
the	O
individuals	B-T098
exhibited	O
a	O
clear	O
dissociation	B-T038
between	O
face	O
and	O
object	O
recognition	O
,	O
and	O
as	O
a	O
group	O
they	O
were	O
significantly	O
more	O
affected	O
by	O
degradation	B-T033
of	O
objects	O
than	O
control	O
participants	B-T098
.	O
importantly	O
,	O
we	O
also	O
find	O
positive	B-T033
correlations	O
between	O
the	O
severity	O
of	O
the	O
face	O
recognition	O
impairment	O
and	O
the	O
degree	O
of	O
impaired	O
performance	O
with	O
degraded	B-T033
objects	O
.	O
this	O
suggests	O
that	O
the	O
face	O
and	O
object	O
deficits	O
are	O
systematically	O
related	O
rather	O
than	O
coincident	O
##al	O
.	O
we	O
conclude	O
that	O
at	O
present	O
,	O
there	O
is	O
no	O
strong	O
evidence	O
in	O
the	O
literature	B-T170
on	O
developmental	B-T038
pros	I-T038
##opa	I-T038
##gn	I-T038
##osi	I-T038
##a	I-T038
supporting	O
domain	O
-	O
specific	O
accounts	O
of	O
face	O
recognition	O
.	O

historical	O
relationships	O
of	O
three	O
en	O
##igm	O
##atic	O
pha	B-T204
##si	I-T204
##ani	I-T204
##d	I-T204
genera	I-T204
(	O
av	B-T204
##es	I-T204
:	O
gall	B-T204
##iform	I-T204
##es	I-T204
)	O
inferred	O
using	O
phylogen	B-T170
##omic	I-T170
and	I-T170
mitogen	I-T170
##omic	I-T170
data	I-T170
the	O
phylogeny	O
of	O
the	O
pha	B-T204
##si	I-T204
##ani	I-T204
##da	I-T204
##e	I-T204
(	O
phe	B-T204
##asant	I-T204
##s	I-T204
,	O
part	B-T204
##ri	I-T204
##dg	I-T204
##es	I-T204
,	O
and	O
all	B-T204
##ies	I-T204
)	O
has	O
been	O
studied	O
extensively	O
.	O
however	O
,	O
these	O
studies	O
have	O
largely	O
ignored	O
three	O
en	O
##igm	O
##atic	O
genera	O
because	O
of	O
scarce	O
dna	B-T103
source	B-T033
material	I-T033
and	O
limited	O
overlapping	O
phylogenetic	B-T170
data	I-T170
:	O
blood	B-T204
phe	I-T204
##asant	I-T204
##s	I-T204
(	O
it	B-T204
##ha	I-T204
##gin	I-T204
##is	I-T204
)	O
,	O
snow	B-T204
part	I-T204
##ri	I-T204
##dg	I-T204
##es	I-T204
(	O
le	B-T204
##r	I-T204
##wa	I-T204
)	O
,	O
and	O
long	B-T204
-	I-T204
bill	I-T204
##ed	I-T204
part	I-T204
##ri	I-T204
##dg	I-T204
##es	I-T204
(	O
rhiz	B-T204
##other	I-T204
##a	I-T204
)	O
.	O
thus	O
,	O
phylogenetic	O
positions	O
of	O
these	O
three	O
genera	O
remain	O
uncertain	O
in	O
what	O
is	O
otherwise	O
a	O
well	O
-	O
resolved	O
phylogeny	O
.	O
previous	O
studies	O
using	O
different	O
data	O
types	O
place	O
le	B-T204
##r	I-T204
##wa	I-T204
and	O
it	B-T204
##ha	I-T204
##gin	I-T204
##is	I-T204
in	O
similar	O
positions	O
,	O
but	O
the	O
absence	O
of	O
overlapping	O
data	O
means	O
the	O
relationship	O
between	O
them	O
could	O
not	O
be	O
inferred	O
.	O
rhiz	B-T204
##other	I-T204
##a	I-T204
was	O
originally	O
described	O
in	O
the	O
genus	O
per	B-T204
##di	I-T204
##x	I-T204
(	O
true	B-T204
part	I-T204
##ri	I-T204
##dg	I-T204
##es	I-T204
)	O
,	O
although	O
a	O
partial	O
cytochrome	B-T103
b	I-T103
(	O
cy	B-T103
##b	I-T103
)	O
sequence	O
suggests	O
it	O
is	O
sister	O
to	O
pu	B-T204
##cr	I-T204
##asia	I-T204
(	O
ko	B-T204
##kl	I-T204
##ass	I-T204
phe	I-T204
##asant	I-T204
)	O
.	O
to	O
identify	O
robust	O
relationships	O
among	O
it	B-T204
##ha	I-T204
##gin	I-T204
##is	I-T204
,	O
le	B-T204
##r	I-T204
##wa	I-T204
,	O
rhiz	B-T204
##other	I-T204
##a	I-T204
,	O
and	O
their	O
pha	B-T204
##si	I-T204
##ani	I-T204
##d	I-T204
relatives	I-T204
,	O
we	O
used	O
36	O
##92	O
ultra	B-T017
-	I-T017
conserved	I-T017
element	I-T017
(	I-T017
uc	I-T017
##e	I-T017
)	I-T017
loci	I-T017
and	O
complete	O
mitogen	B-T017
##omes	I-T017
from	O
19	O
species	B-T170
including	O
previously	O
hypothesized	O
relatives	O
of	O
the	O
three	O
focal	O
genera	O
and	O
representatives	O
from	O
all	O
major	O
pha	B-T204
##si	I-T204
##ani	I-T204
##d	I-T204
clades	I-T204
.	O
we	O
used	O
dna	B-T103
extracted	I-T103
from	O
historical	O
specimen	B-T033
toe	I-T033
##pa	I-T033
##ds	I-T033
for	O
species	O
that	O
lacked	B-T017
fresh	I-T017
tissue	I-T017
in	O
mus	B-T058
##eu	I-T058
##m	I-T058
collections	I-T058
.	O
maximum	O
likelihood	O
and	O
multisp	O
##ecies	O
coales	O
##cent	O
uc	O
##e	O
analyses	O
strongly	O
supported	O
le	B-T204
##r	I-T204
##wa	I-T204
sister	O
to	O
a	O
large	B-T204
clade	I-T204
which	O
included	O
it	B-T204
##ha	I-T204
##gin	I-T204
##is	I-T204
at	O
its	O
base	O
,	O
and	O
also	O
including	O
turkey	B-T204
,	O
gro	B-T204
##use	I-T204
,	O
typical	O
phe	B-T204
##asant	I-T204
##s	I-T204
,	O
tra	B-T204
##go	I-T204
##pan	I-T204
##s	I-T204
,	O
pu	B-T204
##cr	I-T204
##asia	I-T204
,	O
and	O
per	B-T204
##di	I-T204
##x	I-T204
.	O
rhiz	B-T204
##other	I-T204
##a	I-T204
was	O
also	O
in	O
this	O
clade	B-T204
,	O
sister	O
to	O
a	O
diverse	O
group	O
comprising	O
per	B-T204
##di	I-T204
##x	I-T204
,	O
typical	O
phe	B-T204
##asant	I-T204
##s	I-T204
,	O
pu	B-T204
##cr	I-T204
##asia	I-T204
,	O
turkey	B-T204
and	O
gro	B-T204
##use	I-T204
.	O
mitogen	B-T170
##omic	I-T170
gene	I-T170
##alog	I-T170
##ies	I-T170
differed	O
from	O
uc	O
##es	O
topo	O
##lo	O
##gi	O
##es	O
,	O
supporting	O
a	O
sister	O
relationship	O
between	O
it	B-T204
##ha	I-T204
##gin	I-T204
##is	I-T204
and	O
le	B-T204
##r	I-T204
##wa	I-T204
rather	O
than	O
a	O
grade	O
.	O
the	O
position	O
of	O
rhiz	B-T204
##other	I-T204
##a	I-T204
using	O
mitogen	B-T017
##omes	I-T017
depended	O
on	O
analytical	B-T062
choices	I-T062
.	O
unp	O
##art	O
##ition	O
##ed	O
and	O
codon	B-T058
-	I-T058
based	I-T058
analyses	I-T058
placed	O
rhiz	B-T204
##other	I-T204
##a	I-T204
sister	O
to	O
a	O
tra	B-T204
##go	I-T204
##pan	I-T204
clade	I-T204
,	O
whereas	O
a	O
partition	O
##ed	O
dna	B-T170
model	I-T170
of	O
the	O
mitogen	B-T017
##ome	I-T017
was	O
congruent	O
with	O
uc	B-T033
##e	I-T033
results	I-T033
.	O
in	O
all	O
mitogen	B-T058
##ome	I-T058
analyses	I-T058
,	O
pu	B-T204
##cr	I-T204
##asia	I-T204
was	O
sister	O
to	O
a	O
clade	B-T204
including	O
per	B-T204
##di	I-T204
##x	I-T204
and	O
the	O
typical	O
phe	B-T204
##asant	I-T204
##s	I-T204
with	O
high	O
support	O
,	O
in	O
contrast	O
to	O
uc	O
##es	O
and	O
published	B-T170
nuclear	I-T170
intron	I-T170
data	I-T170
.	O
due	O
to	O
the	O
strong	O
support	O
and	O
consistent	O
topology	O
provided	O
by	O
all	O
uc	O
##e	O
analyses	O
,	O
we	O
have	O
identified	O
phylogenetic	O
relationships	O
of	O
these	O
three	O
en	O
##igm	O
##atic	O
,	O
poorly	O
-	O
studied	O
,	O
pha	B-T204
##si	I-T204
##ani	I-T204
##d	I-T204
taxa	I-T204
.	O

a	O
peptide	B-T103
from	O
human	B-T103
β	I-T103
thym	I-T103
##osin	I-T103
as	O
a	O
platform	O
for	O
the	O
development	O
of	O
new	O
anti	B-T103
-	I-T103
biofilm	I-T103
agents	I-T103
for	O
staphylococcus	B-T007
spp	I-T007
.	I-T007
and	O
pseudomonas	B-T007
aeruginosa	I-T007
conventional	O
antibiotics	B-T103
might	O
fail	O
in	O
the	O
treatment	O
of	O
biofilm	B-T007
-	O
associated	O
infections	B-T038
causing	O
infection	B-T038
recurrence	B-T038
and	O
chronic	O
##ity	O
.	O
the	O
search	O
for	O
antimicrobial	B-T103
peptides	I-T103
has	O
been	O
performed	O
with	O
the	O
aim	O
to	O
discover	O
novel	O
anti	B-T103
-	I-T103
infective	I-T103
agents	I-T103
active	O
on	O
pathogens	O
in	O
both	O
planktonic	B-T007
and	O
biofilm	B-T007
associated	O
forms	O
.	O
the	O
fragment	B-T103
9	O
-	O
19	O
of	O
human	B-T103
thym	I-T103
##osin	I-T103
β	I-T103
##4	I-T103
was	O
studied	B-T062
through	O
1	O
μ	O
##s	O
md	O
simulation	O
.	O
two	O
main	O
conformations	B-T082
of	I-T082
the	I-T082
peptide	I-T082
were	O
detected	O
,	O
both	O
constituted	O
by	O
a	O
central	B-T082
hydrophobic	I-T082
core	I-T082
and	O
by	O
the	O
presence	O
of	O
peripheral	B-T082
charged	O
residues	O
suggesting	O
a	O
possible	O
mechanism	O
of	O
interaction	O
with	O
two	O
models	B-T170
of	O
biological	O
membranes	O
,	O
related	O
to	O
eukaryotic	B-T204
or	O
bacterial	O
membrane	O
respectively	O
.	O
in	O
addition	O
,	O
the	O
peptide	B-T103
was	O
chemically	O
synthesized	O
and	O
its	O
antimicrobial	B-T033
activity	I-T033
was	O
tested	O
in	O
vitro	O
against	O
planktonic	B-T007
and	O
biofilm	B-T007
form	O
of	O
a	O
group	O
of	O
reference	O
strains	O
of	O
staphylococcus	B-T007
spp	I-T007
.	I-T007
and	O
one	O
p	B-T007
.	I-T007
aeruginosa	I-T007
strain	O
.	O
the	O
human	B-T103
thym	I-T103
##osin	I-T103
β	I-T103
##4	I-T103
fragment	B-T103
ei	B-T082
##ek	I-T082
##fd	I-T082
##ks	I-T082
##kl	I-T082
##k	I-T082
showed	O
antibacterial	B-T038
activity	I-T038
against	O
staphylococcal	B-T007
strains	O
and	O
pseudomonas	B-T007
aeruginosa	I-T007
atcc	O
154	O
##42	O
at	O
concentrations	O
from	O
12	O
.	O
5	O
to	O
6	O
.	O
2	O
mg	O
/	O
ml	O
and	O
inhibited	O
biofilm	B-T038
formation	I-T038
at	O
sub	O
-	O
inhibitory	O
concentrations	O
(	O
3	O
.	O
1	O
-	O
0	O
.	O
75	O
mg	O
/	O
ml	O
)	O
.	O
the	O
activity	O
of	O
the	O
fragment	B-T103
in	O
inhibiting	O
biofilm	B-T038
formation	I-T038
,	O
could	O
be	O
due	O
to	O
the	O
conformations	B-T082
highlighted	O
by	O
the	O
md	O
simulations	O
,	O
suggesting	O
its	O
interaction	O
with	O
the	O
bacterial	O
membrane	O
.	O
human	B-T103
thym	I-T103
##osin	I-T103
β	I-T103
##4	I-T103
fragment	B-T103
can	O
be	O
considered	O
a	O
promising	O
lead	B-T103
compound	I-T103
to	O
develop	O
novel	O
synthetic	O
or	O
recombinant	B-T103
derivatives	I-T103
with	O
improved	O
pharmaceutical	B-T091
potential	O
.	O

recombinant	B-T103
fibrinogen	B-T103
reveals	O
the	O
differential	O
roles	O
of	O
α	B-T103
-	I-T103
and	O
γ	B-T103
-	I-T103
chain	I-T103
cross	B-T038
-	I-T038
linking	I-T038
and	O
molecular	O
heterogeneity	O
in	O
fibrin	B-T038
clot	I-T038
strain	O
-	O
stiff	O
##ening	O
essential	O
##s	O
fibrinogen	B-T103
circ	O
##ulates	O
in	O
human	B-T204
plasma	B-T031
as	O
a	O
complex	B-T103
mixture	O
of	O
heterogeneous	O
molecular	O
variants	O
.	O
we	O
measured	O
strain	O
-	O
stiff	O
##ening	O
of	O
recombinant	B-T038
##ly	I-T038
produced	O
fibrinogen	B-T103
upon	O
clotting	B-T038
.	O
factor	B-T103
xii	I-T103
##i	I-T103
and	O
molecular	O
heterogeneity	O
alter	O
clot	B-T038
elasticity	O
at	O
the	O
proto	B-T103
##fi	I-T103
##br	I-T103
##il	I-T103
and	O
fiber	B-T017
level	O
.	O
this	O
highlights	O
the	O
hitherto	O
unknown	O
role	O
of	O
molecular	O
composition	O
in	O
fibrin	B-T038
clot	I-T038
mechanics	O
.	O
background	O
fibrin	B-T103
plays	O
a	O
crucial	O
role	O
in	O
haem	B-T038
##ostasis	I-T038
and	O
wound	B-T038
healing	I-T038
by	O
forming	O
strain	O
-	O
stiff	O
##ening	O
fibrous	B-T017
networks	I-T017
that	O
reinforce	O
blood	B-T038
clot	I-T038
##s	I-T038
.	O
the	O
molecular	O
origin	O
of	O
fibrin	B-T103
'	I-T103
s	I-T103
strain	O
-	O
stiff	O
##ening	O
behavior	O
remains	O
poorly	O
understood	O
,	O
primarily	O
because	O
plasma	B-T031
fibrinogen	B-T103
is	O
a	O
complex	B-T103
mixture	O
of	O
heterogeneous	O
molecular	O
variants	O
and	O
is	O
often	O
contaminated	O
by	O
plasma	B-T103
factors	I-T103
that	O
affect	O
clot	B-T038
properties	O
.	O
objectives	O
and	O
methods	O
to	O
facilitate	O
mechanistic	O
dissection	O
of	O
fibrin	B-T103
nonlinear	O
elasticity	O
,	O
we	O
produced	O
a	O
homogeneous	O
recombinant	B-T103
fibrinogen	B-T103
corresponding	O
to	O
the	O
main	O
variant	O
in	O
human	B-T204
plasma	B-T031
,	O
termed	O
rf	B-T103
##ib	I-T103
##61	I-T103
##0	I-T103
.	O
we	O
characterized	O
the	O
structure	B-T082
of	O
rf	B-T103
##ib	I-T103
##61	I-T103
##0	I-T103
clot	B-T038
##s	I-T038
using	O
turb	B-T058
##idi	I-T058
##metry	I-T058
,	O
microscopy	B-T058
and	O
x	B-T058
-	I-T058
ray	I-T058
scattering	I-T058
.	O
we	O
used	O
rhe	O
##ology	O
to	O
measure	O
the	O
strain	O
-	O
stiff	O
##ening	O
behavior	O
of	O
the	O
clot	B-T038
##s	I-T038
and	O
determined	O
the	O
fiber	B-T017
properties	O
by	O
modeling	B-T062
the	O
clot	B-T038
##s	I-T038
as	O
semi	O
-	O
flexible	O
polymer	O
networks	O
.	O
results	O
we	O
show	O
that	O
addition	O
of	O
fx	B-T103
##iii	I-T103
to	O
rf	B-T103
##ib	I-T103
##61	I-T103
##0	I-T103
clot	B-T038
##s	I-T038
causes	O
a	O
dose	O
-	O
dependent	O
stiffness	O
increase	O
at	O
small	O
deformations	O
and	O
renders	O
the	O
strain	O
-	O
stiff	O
##ening	O
response	O
reversible	O
.	O
we	O
find	O
that	O
γ	B-T103
-	I-T103
chain	I-T103
cross	B-T038
-	I-T038
linking	I-T038
contributes	O
to	O
clot	B-T038
elasticity	O
by	O
changing	O
the	O
force	O
-	O
extension	O
behavior	O
of	O
the	O
proto	B-T103
##fi	I-T103
##br	I-T103
##ils	I-T103
,	O
whereas	O
α	B-T103
-	I-T103
chain	I-T103
cross	B-T038
-	I-T038
linking	I-T038
stiff	O
##ens	O
the	O
fibers	B-T017
,	O
as	O
a	O
consequence	O
of	O
tight	O
##er	O
coupling	O
between	O
the	O
constituent	O
proto	B-T103
##fi	I-T103
##br	I-T103
##ils	I-T103
.	O
interestingly	O
,	O
rf	B-T103
##ib	I-T103
##61	I-T103
##0	I-T103
proto	B-T103
##fi	I-T103
##br	I-T103
##ils	I-T103
have	O
a	O
25	O
%	O
larger	O
bending	O
rigidity	O
than	O
plasma	B-T031
-	O
purified	O
fibrin	B-T103
proto	B-T103
##fi	I-T103
##br	I-T103
##ils	I-T103
and	O
a	O
delayed	O
strain	O
-	O
stiff	O
##ening	O
,	O
indicating	O
that	O
molecular	O
heterogeneity	O
influences	O
clot	B-T038
mechanics	O
at	O
the	O
proto	B-T103
##fi	I-T103
##br	I-T103
##il	I-T103
scale	I-T103
.	O
conclusions	O
fibrinogen	B-T103
molecular	O
heterogeneity	O
and	O
fx	B-T103
##iii	I-T103
affect	O
the	O
mechanical	O
function	O
of	O
fibrin	B-T038
clot	I-T038
##s	I-T038
by	O
altering	O
the	O
nonlinear	O
viscoelastic	O
properties	O
at	O
the	O
proto	B-T017
##fi	I-T017
##br	I-T017
##il	I-T017
and	O
fiber	B-T017
scale	I-T017
.	O
this	O
work	O
provides	O
a	O
starting	O
point	O
to	O
investigate	O
the	O
role	O
of	O
molecular	O
heterogeneity	O
of	O
plasma	B-T031
fibrinogen	B-T103
in	O
fibrin	B-T038
clot	I-T038
mechanics	O
and	O
haem	B-T038
##ostasis	I-T038
.	O

combined	O
exposures	B-T037
of	O
whole	O
-	O
body	O
vibration	O
and	O
aw	O
##k	O
##ward	O
posture	O
:	O
a	O
cross	B-T062
sectional	I-T062
investigation	I-T062
among	O
occupational	O
drivers	B-T098
by	O
means	O
of	O
simultaneous	O
field	O
measurements	O
multifactorial	B-T033
workload	O
##s	O
such	O
as	O
whole	O
-	O
body	O
vibration	O
(	O
wb	O
##v	O
)	O
,	O
aw	O
##k	O
##ward	O
posture	O
and	O
heavy	O
lifting	O
are	O
potential	O
predictors	B-T033
for	O
low	B-T033
back	I-T033
pain	I-T033
(	O
lbp	B-T033
)	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
investigate	O
the	O
association	O
between	O
lbp	B-T033
and	O
these	O
exposures	B-T037
among	O
102	O
professional	O
drivers	B-T098
.	O
the	O
combined	O
exposures	B-T037
of	O
wb	O
##v	O
and	O
posture	O
are	O
measured	O
at	O
different	O
workplace	B-T082
##s	I-T082
.	O
health	O
and	O
personal	O
data	O
as	O
well	O
as	O
information	O
about	O
lifting	O
tasks	O
are	O
collected	O
by	O
a	O
questionnaire	B-T170
.	O
the	O
daily	O
vibration	B-T037
exposure	I-T037
value	O
(	O
odds	O
ratio	O
1	O
.	O
69	O
)	O
and	O
an	O
index	O
for	O
aw	O
##k	O
##ward	O
posture	O
(	O
odds	O
ratio	O
1	O
.	O
63	O
)	O
show	O
significant	O
association	O
with	O
the	O
occur	O
##ence	O
of	O
lbp	B-T033
.	O
aw	O
##k	O
##ward	O
posture	O
and	O
heavy	O
lifting	O
appear	O
to	O
be	O
more	O
strongly	O
associated	O
with	O
sick	O
leave	O
than	O
wb	O
##v	O
exposure	B-T037
.	O
furthermore	O
,	O
a	O
combination	O
of	O
the	O
measurement	O
results	O
of	O
wb	O
##v	O
and	O
aw	O
##k	O
##ward	O
posture	O
into	O
one	O
quantity	O
also	O
shows	O
significant	O
correlation	O
to	O
lbp	B-T033
.	O
the	O
combined	O
exposure	B-T037
of	O
wb	O
##v	O
and	O
aw	O
##k	O
##ward	O
posture	O
can	O
be	O
described	O
in	O
terms	O
of	O
the	O
daily	O
vibration	B-T037
exposure	I-T037
and	O
the	O
index	O
for	O
aw	O
##k	O
##ward	O
posture	O
.	O
this	O
facilitates	O
work	B-T082
place	I-T082
assessments	O
and	O
future	O
research	B-T062
in	O
this	O
area	B-T082
.	O
practitioner	O
summary	O
:	O
for	O
the	O
first	O
time	O
,	O
quantitative	O
measures	O
combining	O
whole	O
-	O
body	O
vibration	O
and	O
aw	O
##k	O
##ward	O
posture	O
exposures	B-T037
have	O
shown	O
to	O
correlate	O
with	O
the	O
occurrence	O
of	O
low	B-T033
back	I-T033
pain	I-T033
significantly	O
.	O
this	O
validate	O
##s	O
the	O
proposed	O
quantities	O
and	O
measurement	O
methods	O
,	O
which	O
facilitate	O
workplace	B-T082
assessments	O
and	O
assist	O
in	O
the	O
design	O
of	O
further	O
studies	B-T062
which	O
are	O
necessary	O
to	O
establish	O
a	O
causal	B-T037
exposure	I-T037
-	O
response	O
relationship	O
.	O

correlations	O
between	O
physical	O
activity	O
and	O
neurocognitive	B-T038
domain	I-T038
functions	I-T038
in	O
patients	O
with	O
schizophrenia	B-T038
:	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
neurocognitive	B-T038
dysfunction	I-T038
is	O
a	O
critical	O
target	O
symptom	B-T033
of	O
schizophrenia	B-T038
treatment	B-T058
.	O
a	O
positive	O
correlation	O
between	O
physical	O
activity	O
level	O
and	O
neurocognitive	B-T038
function	I-T038
has	O
been	O
reported	O
in	O
healthy	B-T098
individuals	I-T098
,	O
but	O
it	O
is	O
unclear	O
whether	O
such	O
a	O
correlation	O
exists	O
in	O
patients	O
with	O
schizophrenia	B-T038
and	O
whether	O
the	O
relationship	O
is	O
different	O
according	O
to	O
inpatients	O
or	O
outpatients	O
.	O
this	O
study	B-T062
aimed	O
to	O
examine	B-T058
the	O
differences	O
in	O
the	O
correlations	O
between	O
physical	O
activity	O
and	O
multiple	O
neurocognitive	B-T038
domains	I-T038
in	O
inpatients	O
and	O
outpatients	O
with	O
schizophrenia	B-T038
and	O
obtain	O
suggestions	O
for	O
further	O
study	B-T062
to	O
facilitate	O
this	O
field	O
.	O
twenty	O
-	O
nine	O
patients	O
with	O
schizophrenia	B-T038
were	O
examined	B-T058
(	O
16	O
inpatients	O
and	O
13	O
outpatients	O
,	O
56	O
.	O
0	O
±	O
11	O
.	O
4	O
years	O
of	O
age	O
)	O
.	O
current	O
symptoms	B-T033
were	O
assessed	O
using	O
the	O
positive	B-T033
and	O
negative	B-T033
symptom	B-T170
scale	I-T170
and	O
neurocognitive	B-T038
functions	I-T038
using	O
cogn	O
##itr	O
##ax	O
,	O
which	O
yields	O
a	O
composite	O
neurocognitive	O
index	O
(	O
nci	O
)	O
and	O
11	O
domain	O
scores	O
.	O
after	O
testing	O
,	O
participants	B-T098
wor	O
##e	O
an	O
h	B-T074
##ja	I-T074
-	I-T074
750	I-T074
##c	I-T074
accelerometer	I-T074
for	O
one	O
week	O
to	O
measure	O
physical	O
activity	O
levels	O
and	O
durations	O
.	O
partial	B-T062
correlation	I-T062
analyses	I-T062
were	O
performed	O
between	O
exercise	O
and	O
cognitive	B-T038
parameters	B-T033
.	O
in	O
the	O
outpatient	O
group	O
,	O
higher	O
physical	O
activity	O
was	O
associated	O
with	O
faster	O
motor	O
and	O
psychomotor	B-T038
speeds	O
in	O
outpatients	O
.	O
however	O
,	O
higher	O
physical	O
activity	O
was	O
associated	O
with	O
lower	O
overall	O
nci	O
,	O
attention	B-T038
score	O
,	O
and	O
memory	B-T038
scores	O
in	O
inpatients	O
.	O
although	O
higher	O
physical	O
activity	O
was	O
associated	O
with	O
better	O
neurocognitive	B-T038
functions	I-T038
of	O
outpatients	O
,	O
in	O
inpatients	O
with	O
non	O
-	O
rem	O
##itted	O
schizophrenia	B-T038
,	O
higher	O
physical	O
activity	O
was	O
associated	O
with	O
worsening	O
of	O
several	O
cognitive	B-T038
domains	I-T038
.	O
in	O
a	O
future	O
study	B-T062
examining	B-T058
the	O
relationship	O
between	O
physical	O
activity	O
and	O
neurocognitive	B-T038
function	I-T038
for	O
facilitating	O
this	O
research	O
field	O
,	O
separation	O
between	O
inpatients	O
and	O
outpatients	O
are	O
needed	O
because	O
the	O
relationship	O
is	O
different	O
between	O
inpatients	O
and	O
outpatients	O
.	O

the	O
2016	O
infusion	O
therapy	O
standards	O
of	O
practice	B-T038
approximately	O
every	O
5	O
years	O
,	O
the	O
infusion	B-T092
nurses	I-T092
society	I-T092
publish	O
##es	O
evidence	O
-	O
based	O
practice	O
standards	O
.	O
this	O
article	B-T170
provides	O
an	O
overview	O
of	O
the	O
process	O
used	O
in	O
standards	O
development	O
,	O
describes	O
the	O
format	B-T170
of	O
the	O
standards	O
,	O
and	O
provides	O
a	O
short	O
summary	B-T170
of	O
selected	O
standards	O
as	O
applied	O
to	O
home	B-T058
care	I-T058
.	O
the	O
standards	O
are	O
an	O
important	O
document	B-T170
that	O
should	O
be	O
available	O
to	O
every	O
home	B-T058
care	I-T058
organization	B-T092
that	O
provides	O
home	B-T058
infusion	I-T058
therapy	I-T058
.	O

barriers	O
to	O
access	O
and	O
uptake	O
of	O
antiretroviral	B-T058
therapy	I-T058
among	O
hiv	B-T033
-	I-T033
positive	I-T033
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
in	O
han	O
##oi	O
,	O
vietnam	B-T082
:	O
from	O
hiv	B-T058
testing	I-T058
to	O
treatment	B-T058
little	O
is	O
known	O
about	O
the	O
experiences	B-T038
of	O
vietnam	B-T098
##ese	I-T098
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
in	O
accessing	B-T082
hiv	B-T058
testing	I-T058
and	O
treatment	B-T058
.	O
we	O
aimed	O
to	O
explore	O
barriers	O
to	O
access	O
and	O
uptake	O
of	O
antiretroviral	B-T058
therapy	I-T058
(	O
art	B-T058
)	O
among	O
hiv	B-T033
-	I-T033
positive	I-T033
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
in	O
han	O
##oi	O
.	O
during	O
2015	O
,	O
we	O
conducted	O
qualitative	O
interviews	O
with	O
35	O
participants	B-T098
recruited	O
using	O
snow	B-T062
##ball	I-T062
sampling	I-T062
based	O
on	O
previous	O
research	B-T062
and	O
social	B-T098
networks	I-T098
.	O
key	O
individual	O
imped	O
##iment	O
##s	O
to	O
art	B-T058
uptake	O
included	O
inadequate	O
preparation	O
for	O
a	O
positive	B-T033
diagnosis	B-T033
and	O
the	O
dual	O
stigma	O
##tis	O
##ation	O
of	O
homosexual	O
##ity	O
and	O
hiv	B-T005
and	O
its	O
consequences	B-T062
,	O
leading	O
to	O
fear	B-T038
of	O
disclosure	O
of	O
hiv	B-T033
status	I-T033
.	O
health	B-T092
system	I-T092
barriers	O
included	O
lack	O
of	O
clarity	O
and	O
consistency	O
about	O
how	O
to	O
register	O
for	O
and	O
access	O
art	B-T058
,	O
failure	O
to	O
protect	O
patient	O
confidential	O
##ity	O
and	O
a	O
retic	O
##ence	O
by	O
providers	O
to	O
discuss	O
sexual	B-T038
identity	I-T038
and	O
same	O
-	O
sex	O
issues	O
.	O
results	O
suggest	O
fundamental	O
problems	O
in	O
the	O
way	O
hiv	B-T058
testing	I-T058
is	O
currently	O
delivered	O
in	O
han	O
##oi	O
,	O
including	O
a	O
lack	O
of	O
client	O
-	O
centred	O
counselling	B-T058
,	O
peer	O
support	O
and	O
clear	B-T058
referral	I-T058
pathways	O
.	O
overcoming	O
these	O
barriers	O
will	O
require	O
educ	O
##ating	O
men	B-T098
who	I-T098
have	I-T098
sex	I-T098
with	I-T098
men	I-T098
about	O
the	O
benefits	O
of	O
routine	O
testing	O
,	O
improving	O
access	O
to	O
quality	O
diagnostic	B-T058
services	I-T058
and	O
building	O
a	O
safe	O
,	O
confidential	O
treatment	B-T058
environment	B-T082
for	O
hiv	B-T033
-	I-T033
positive	I-T033
men	B-T098
to	O
access	O
,	O
receive	O
and	O
remain	O
in	O
care	O
.	O

interleukin	B-T103
-	I-T103
21	I-T103
plays	O
a	O
critical	O
role	O
in	O
the	O
pathogenesis	B-T038
and	O
severity	O
of	O
type	B-T038
i	I-T038
autoimmune	I-T038
hepatitis	I-T038
recently	O
,	O
the	O
number	O
of	O
follicular	B-T017
helper	B-T017
t	I-T017
(	I-T017
tf	I-T017
##h	I-T017
)	I-T017
cells	I-T017
expressing	O
interleukin	B-T103
(	I-T103
il	I-T103
)	I-T103
-	I-T103
21	I-T103
was	O
found	O
to	O
increase	O
in	O
peripheral	B-T031
blood	I-T031
of	O
human	B-T204
and	O
murine	B-T204
models	B-T038
of	O
autoimmune	B-T038
hepatitis	I-T038
(	O
ai	B-T038
##h	I-T038
)	O
.	O
il	B-T103
-	I-T103
21	I-T103
,	O
the	O
most	O
recently	O
discovered	O
member	O
of	O
the	O
type	B-T103
-	I-T103
i	I-T103
cytokine	I-T103
family	I-T103
,	O
exerts	O
various	O
effects	O
on	O
the	O
immune	B-T022
system	I-T022
,	O
including	O
b	B-T038
cell	I-T038
activation	I-T038
,	O
plasma	B-T038
cell	I-T038
differentiation	I-T038
,	O
and	O
immunoglobulin	B-T038
production	I-T038
.	O
we	O
aimed	O
to	O
assess	O
the	O
relationship	O
of	O
serum	B-T031
il	B-T103
-	I-T103
21	I-T103
levels	O
in	O
patients	O
with	O
type	B-T038
i	I-T038
ai	I-T038
##h	I-T038
with	O
clinical	O
and	O
laboratory	B-T092
parameters	O
and	O
histology	B-T091
.	O
ninety	O
-	O
two	O
japanese	B-T098
patients	O
with	O
liver	B-T038
disease	I-T038
(	O
22	O
ai	B-T038
##h	I-T038
,	O
20	O
primary	B-T038
biliary	I-T038
cholangitis	I-T038
,	O
19	O
drug	B-T038
-	I-T038
induced	I-T038
liver	I-T038
injury	I-T038
,	O
8	O
acute	B-T038
hepatitis	I-T038
b	I-T038
,	O
8	O
chronic	B-T038
hepatitis	I-T038
c	I-T038
,	O
10	O
non	B-T038
-	I-T038
alcoholic	I-T038
steatohepatitis	I-T038
,	O
5	O
viral	B-T038
hepatitis	I-T038
)	O
and	O
10	O
healthy	B-T098
volunteers	I-T098
were	O
recruited	O
.	O
serum	B-T031
il	B-T103
-	I-T103
21	I-T103
levels	O
were	O
detected	O
by	O
enzyme	B-T058
-	I-T058
linked	I-T058
immunosorbent	I-T058
assay	I-T058
.	O
real	B-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
measured	O
mrna	B-T103
levels	O
of	O
bcl	B-T017
-	I-T017
6	I-T017
,	O
il	B-T017
-	I-T017
21	I-T017
,	O
and	O
cxcr	B-T017
##5	I-T017
(	O
tf	B-T103
##h	I-T103
-	I-T103
related	I-T103
factors	I-T103
)	O
in	O
peripheral	B-T082
mononuclear	O
cells	O
.	O
mean	O
age	O
at	O
diagnosis	B-T033
of	O
ai	B-T038
##h	I-T038
was	O
58	O
.	O
6	O
years	O
,	O
male	B-T033
-	I-T033
to	I-T033
-	I-T033
female	I-T033
ratio	I-T033
was	O
4	O
:	O
18	O
,	O
18	O
.	O
2	O
%	O
of	O
participants	O
had	O
cirrhosis	B-T038
,	O
and	O
22	O
.	O
7	O
%	O
had	O
severe	O
disease	B-T038
.	O
il	B-T103
-	I-T103
21	I-T103
levels	O
were	O
significantly	O
increased	O
in	O
the	O
serum	B-T031
of	O
patients	O
with	O
ai	B-T038
##h	I-T038
compared	O
to	O
those	O
with	O
other	O
liver	O
diseases	O
and	O
controls	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
particularly	O
,	O
serum	B-T031
il	B-T103
-	I-T103
21	I-T103
levels	O
were	O
significantly	O
increased	O
in	O
severe	O
ai	B-T038
##h	I-T038
cases	O
compared	O
to	O
non	O
-	O
severe	O
cases	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
serum	B-T031
il	B-T103
-	I-T103
21	I-T103
levels	O
correlated	O
positively	O
with	O
total	O
serum	B-T031
bilirubin	B-T058
levels	I-T058
(	O
r	O
=	O
0	O
.	O
46	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
grading	B-T033
of	I-T033
necro	I-T033
##inflammatory	I-T033
activity	I-T033
(	O
r	O
=	O
0	O
.	O
68	O
,	O
p	O
<	O
0	O
.	O
005	O
)	O
and	O
negatively	O
with	O
serum	B-T033
albumin	I-T033
levels	I-T033
in	O
patients	O
with	O
ai	B-T038
##h	I-T038
(	O
r	O
=	O
-	O
0	O
.	O
49	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
in	O
patients	O
with	O
biochemical	O
remission	B-T033
of	O
ai	B-T038
##h	I-T038
,	O
serum	B-T031
il	B-T103
-	I-T103
21	I-T103
levels	O
remained	O
elevated	O
and	O
correlated	O
positively	B-T033
with	O
serum	B-T058
igg	I-T058
levels	I-T058
(	O
r	O
=	O
0	O
.	O
84	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
expression	B-T038
of	O
tf	B-T103
##h	I-T103
-	I-T103
related	I-T103
factors	I-T103
,	O
such	O
as	O
bcl	B-T103
-	I-T103
6	I-T103
and	O
il	B-T103
-	I-T103
21	I-T103
,	O
in	O
peripheral	B-T017
blood	I-T017
mononuclear	I-T017
cells	I-T017
of	O
patients	O
with	O
ai	B-T038
##h	I-T038
was	O
significantly	O
higher	O
than	O
that	O
in	O
healthy	B-T098
volunteers	I-T098
.	O
il	B-T103
-	I-T103
21	I-T103
may	O
play	O
an	O
important	O
role	O
in	O
the	O
pathogenesis	B-T038
and	O
severity	O
of	O
ai	B-T038
##h	I-T038
,	O
and	O
may	O
present	O
a	O
promising	O
target	O
for	O
ai	B-T038
##h	I-T038
therapy	O
.	O

penetrating	O
crani	B-T037
##oma	I-T037
##x	I-T037
##ill	I-T037
##ofacial	I-T037
injury	I-T037
caused	I-T037
by	I-T037
a	I-T037
pneumatic	I-T037
nail	I-T037
gun	I-T037
crani	O
##oma	O
##x	O
##ill	O
##ofacial	O
injuries	O
can	O
be	O
complex	O
,	O
requiring	O
a	O
multidisciplinary	O
approach	O
.	O
the	O
primary	O
survey	O
is	O
always	O
the	O
first	O
step	O
in	O
trauma	O
management	O
prior	O
to	O
proceeding	O
with	O
further	O
evaluation	O
and	O
treatment	O
.	O
a	O
26	O
-	O
year	O
-	O
old	O
man	O
presented	O
with	O
a	O
penetrating	O
nail	O
gun	O
injury	O
through	O
the	O
oral	B-T082
and	O
nasal	B-T082
cavities	I-T082
.	O
he	O
did	O
not	O
present	O
in	O
extrem	O
##is	O
but	O
required	O
elective	O
endotracheal	O
intubation	O
for	O
intraoperative	O
assessment	O
and	O
treatment	O
.	O
airway	O
management	O
was	O
enhanced	O
by	O
the	O
use	O
of	O
lingual	B-T058
nerve	I-T058
and	O
inferior	B-T058
alveolar	I-T058
nerve	I-T058
blocks	I-T058
via	O
the	O
va	O
##z	O
##ira	O
##ni	O
-	O
aki	O
##no	O
##si	O
technique	O
to	O
maintain	O
spontaneous	B-T033
respiration	I-T033
while	O
the	O
tongue	B-T017
was	O
distract	B-T033
##ed	I-T033
from	O
the	O
palate	B-T017
.	O
the	O
nail	O
was	O
removed	O
and	O
rapid	O
sequence	O
induction	O
initiated	O
for	O
or	O
##otracheal	O
intubation	O
.	O
local	O
nerve	O
blocks	O
can	O
be	O
an	O
effective	O
tool	O
in	O
the	O
arm	O
##ament	O
##arium	O
of	O
the	O
crani	O
##oma	O
##x	O
##ill	O
##ofacial	O
trauma	O
surgeon	O
in	O
managing	O
blunt	O
and	O
penetrating	O
injuries	O
.	O
we	O
demonstrate	O
its	O
utility	O
in	O
airway	O
management	O
when	O
a	O
penetrating	O
foreign	O
body	O
in	O
the	O
upper	B-T017
airway	I-T017
preclude	O
##s	O
or	O
##otracheal	O
or	O
nas	O
##otracheal	O
intubation	O
.	O

adequacy	O
criteria	O
for	O
thyroid	B-T058
fna	I-T058
evaluated	B-T058
by	O
thin	B-T058
##pre	I-T058
##p	I-T058
slides	I-T058
only	O
adequacy	O
criteria	O
for	O
thyroid	B-T058
fine	I-T058
-	I-T058
needle	I-T058
aspiration	I-T058
(	O
fna	B-T058
)	O
recommended	O
by	O
the	O
bet	B-T058
##he	I-T058
##sd	I-T058
##a	I-T058
system	I-T058
for	I-T058
reporting	I-T058
thyroid	I-T058
cyto	I-T058
##path	I-T058
##ology	I-T058
(	O
tbs	B-T058
)	O
were	O
developed	O
with	O
smears	B-T058
,	O
but	O
they	O
are	O
commonly	O
applied	O
to	O
thin	B-T058
##pre	I-T058
##ps	I-T058
(	O
tps	B-T058
)	O
.	O
this	O
study	O
evaluated	B-T058
adequacy	O
in	O
tps	B-T058
at	O
different	O
diagnostic	O
thresholds	O
.	O
all	O
fna	B-T058
procedures	I-T058
performed	O
between	O
2010	O
and	O
2015	O
with	O
matched	O
surgical	O
specimens	O
were	O
analyzed	B-T062
.	O
cell	B-T058
counts	I-T058
and	O
cytological	O
features	O
were	O
evaluated	B-T058
in	O
all	O
initially	O
nond	B-T033
##ia	I-T033
##gn	I-T033
##ostic	I-T033
(	O
nd	B-T033
)	O
cases	O
.	O
nd	B-T033
cases	O
were	O
reclass	O
##ified	O
into	O
tbs	B-T058
categories	B-T170
by	O
2	O
pathologists	B-T097
,	O
and	O
the	O
results	O
were	O
compared	O
with	O
surgical	O
outcomes	O
.	O
one	O
hundred	O
forty	O
-	O
six	O
of	O
the	O
151	O
cases	O
initially	O
classified	B-T170
as	O
nd	B-T033
were	O
available	O
for	O
review	O
,	O
and	O
they	O
had	O
a	O
mean	O
cell	B-T058
count	I-T058
of	O
60	O
.	O
5	O
(	O
standard	O
deviation	O
,	O
71	O
.	O
4	O
)	O
.	O
interobserver	O
agreement	O
on	O
the	O
reclass	B-T170
##ification	I-T170
of	O
nd	B-T033
cases	O
was	O
moderate	O
(	O
k	O
=	O
0	O
.	O
57	O
)	O
,	O
and	O
consensus	O
yielded	O
48	O
nd	B-T033
cases	O
(	O
33	O
%	O
)	O
,	O
72	O
benign	O
cases	O
(	O
49	O
%	O
)	O
,	O
24	O
cases	O
of	O
atypia	B-T033
of	O
undetermined	B-T033
significance	I-T033
(	O
16	O
%	O
)	O
,	O
and	O
2	O
cases	O
suspicious	B-T033
for	I-T033
malignancy	I-T033
(	O
1	O
%	O
)	O
.	O
lowering	O
the	O
diagnostic	O
threshold	O
to	O
any	O
follicular	B-T017
cells	B-T017
yielded	O
a	O
sensitivity	O
of	O
92	O
%	O
,	O
a	O
specificity	O
of	O
60	O
%	O
,	O
a	O
positive	O
predictive	O
value	O
of	O
59	O
%	O
,	O
a	O
negative	O
predictive	O
value	O
of	O
92	O
%	O
,	O
and	O
a	O
false	B-T033
-	I-T033
negative	I-T033
rate	O
of	O
7	O
.	O
7	O
%	O
,	O
whereas	O
the	O
values	O
for	O
the	O
initially	O
diagnostic	O
cases	O
were	O
93	O
%	O
,	O
58	O
%	O
,	O
59	O
%	O
,	O
93	O
%	O
,	O
and	O
7	O
.	O
7	O
%	O
,	O
respectively	O
.	O
including	O
cases	O
with	O
>	O
60	O
cells	B-T017
but	O
lacking	O
6	O
groups	O
containing	O
at	O
least	O
10	O
cells	B-T017
did	O
not	O
affect	O
test	O
performance	O
.	O
nuclear	B-T038
enlargement	I-T038
,	O
pall	B-T033
##or	I-T033
,	O
groove	B-T082
##s	I-T082
,	O
and	O
the	O
presence	B-T033
of	O
histi	B-T017
##ocyt	I-T017
##oid	I-T017
cells	I-T017
in	O
initially	O
nd	B-T033
fna	B-T058
correlated	O
with	O
malignancy	B-T038
.	O
in	O
thyroid	B-T058
fna	I-T058
examined	B-T033
with	O
tp	B-T058
only	O
,	O
lowering	O
the	O
adequacy	O
threshold	O
and	O
eliminating	O
the	O
requirement	O
of	O
6	O
groups	O
of	O
at	O
least	O
10	O
cells	B-T017
did	O
not	O
significantly	O
affect	O
test	O
performance	O
if	O
cytological	O
features	O
associated	O
with	O
malignancy	B-T038
were	O
absent	O
.	O
cancer	O
cyto	O
##path	O
##ol	O
2017	O
.	O
©	O
2017	O
american	O
cancer	O
society	O
.	O

improvement	O
of	O
older	B-T098
-	O
person	B-T098
-	O
specific	O
qol	O
after	O
hearing	B-T074
aid	I-T074
fitting	B-T058
and	O
its	O
relation	O
to	O
social	B-T033
interaction	I-T033
this	O
study	B-T062
aimed	O
to	O
investigate	O
whether	O
hearing	B-T074
aids	I-T074
use	O
is	O
associated	O
with	O
improvement	O
of	O
older	B-T098
-	O
person	B-T098
-	O
specific	O
qol	O
and	O
whether	O
social	B-T033
interactions	I-T033
modify	O
the	O
association	O
.	O
the	O
who	B-T170
##qol	I-T170
-	I-T170
old	I-T170
questionnaire	I-T170
was	O
answered	B-T170
by	O
105	O
older	B-T098
adults	I-T098
aged	O
60	O
to	O
90	O
years	O
who	O
were	O
newly	O
fitted	B-T058
hearing	B-T074
aids	I-T074
on	O
the	O
day	O
of	O
fitting	B-T058
and	O
at	O
2	O
-	O
6	O
months	O
after	O
##ward	O
.	O
the	O
associations	O
between	O
the	O
daily	O
hours	O
of	O
hearing	B-T074
aid	I-T074
usage	O
and	O
social	O
relations	O
with	O
changes	O
in	O
the	O
who	B-T170
##qol	I-T170
-	I-T170
old	I-T170
total	O
score	O
after	O
hearing	B-T074
aids	I-T074
fitting	B-T058
were	O
estimated	O
adjusting	O
for	O
possible	B-T033
confounders	O
.	O
older	B-T098
persons	B-T098
with	O
hearing	B-T033
loss	I-T033
experienced	O
significant	O
increases	O
in	O
who	B-T170
##qol	I-T170
-	I-T170
old	I-T170
total	O
score	O
after	O
hearing	B-T074
aid	I-T074
fitting	B-T058
.	O
regular	O
use	O
of	O
hearing	B-T074
aid	I-T074
was	O
associated	O
with	O
a	O
greater	O
increase	O
in	O
the	O
total	O
score	O
.	O
the	O
combined	O
categorical	B-T170
variable	O
of	O
social	O
relations	O
and	O
hearing	B-T074
aid	I-T074
usage	O
revealed	O
no	O
separate	O
effects	O
of	O
these	O
two	O
variables	O
,	O
but	O
a	O
combined	O
effect	O
;	O
only	O
those	O
with	O
frequent	O
social	B-T033
interactions	I-T033
who	O
used	O
their	O
hearing	B-T074
aid	I-T074
regularly	O
had	O
a	O
significantly	O
greater	O
increase	O
in	O
who	B-T170
##qol	I-T170
-	I-T170
old	I-T170
total	O
score	O
.	O
this	O
study	B-T062
'	I-T062
s	I-T062
findings	O
indicate	O
that	O
hearing	B-T074
aid	I-T074
fitting	B-T058
may	O
be	O
associated	O
with	O
a	O
subsequent	O
improvement	O
in	O
older	B-T098
-	O
person	B-T098
-	O
specific	O
qol	O
by	O
improvements	O
in	O
hearing	B-T038
due	O
to	O
the	O
hearing	B-T074
aid	I-T074
,	O
and	O
possibly	B-T033
enhanced	O
communication	O
opportunities	O
.	O

comparison	O
of	O
270	O
versus	O
320	O
mg	O
i	O
/	O
ml	O
of	O
iod	O
##ix	O
##anol	O
in	O
1	O
image	B-T058
assessment	I-T058
of	O
both	O
renal	B-T017
arteries	I-T017
and	O
veins	B-T017
with	O
dual	B-T058
-	I-T058
energy	I-T058
spectral	I-T058
ct	I-T058
imaging	I-T058
in	O
late	O
arterial	O
phase	O
and	O
their	O
influence	O
on	O
renal	B-T038
function	I-T038
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
compare	O
the	O
image	O
quality	O
of	O
renal	B-T017
arteries	I-T017
and	O
veins	B-T017
with	O
dual	B-T058
-	I-T058
energy	I-T058
spectral	I-T058
computed	I-T058
tomography	I-T058
(	I-T058
ct	I-T058
)	I-T058
imaging	I-T058
in	O
late	O
arterial	O
phase	O
using	O
270	O
and	O
320	O
mg	O
i	O
/	O
ml	O
of	O
iod	O
##ix	O
##anol	O
and	O
their	O
influence	O
on	O
renal	B-T038
function	I-T038
.	O
a	O
total	O
of	O
106	O
##2	O
patients	O
underwent	O
renal	B-T058
ct	I-T058
angiography	I-T058
with	O
270	O
or	O
320	O
mg	O
i	O
/	O
ml	O
of	O
iod	O
##ix	O
##anol	O
with	O
dual	B-T058
-	I-T058
energy	I-T058
spectral	I-T058
ct	I-T058
imaging	I-T058
in	O
late	O
arterial	O
phase	O
.	O
image	O
quality	O
and	O
their	O
influence	O
on	O
renal	B-T038
function	I-T038
were	O
compared	O
.	O
there	O
were	O
no	O
significant	O
differences	O
of	O
ct	O
value	O
,	O
signal	O
-	O
to	O
-	O
noise	O
ratio	O
,	O
contrast	O
-	O
to	O
-	O
noise	O
ratio	O
,	O
and	O
subjective	O
score	O
of	O
renal	B-T017
vessels	I-T017
between	O
2	O
groups	O
(	O
all	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
the	O
incidence	O
of	O
contrast	B-T038
-	I-T038
induced	I-T038
nephropathy	I-T038
in	O
patients	O
with	O
abnormal	B-T038
renal	I-T038
function	I-T038
using	O
320	O
mg	O
i	O
/	O
ml	O
of	O
iod	O
##ix	O
##anol	O
was	O
significantly	O
higher	O
than	O
using	O
270	O
mg	O
i	O
/	O
ml	O
of	O
iod	O
##ix	O
##anol	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
.	O
the	O
renal	B-T017
arteries	I-T017
and	O
veins	B-T017
can	O
be	O
fully	O
assessed	O
in	O
late	O
arterial	O
phase	O
with	O
270	O
mg	O
i	O
/	O
ml	O
of	O
iod	O
##ix	O
##anol	O
using	O
dual	B-T058
-	I-T058
energy	I-T058
spectral	I-T058
ct	I-T058
scan	I-T058
with	O
better	O
preserved	O
renal	B-T038
function	I-T038
.	O

the	O
indications	O
for	O
laparoscopic	B-T058
pancreatectomy	I-T058
laparoscopic	B-T058
pancreatectomy	I-T058
is	O
not	O
yet	O
established	O
as	O
a	O
routine	B-T058
procedure	I-T058
every	O
##wh	O
##ere	O
in	O
germany	B-T082
or	O
in	O
other	O
countries	B-T082
.	O
few	O
data	O
are	O
available	O
on	O
its	O
short	O
-	O
and	O
long	O
-	O
term	O
outcomes	O
.	O
from	O
2008	O
on	O
##ward	O
,	O
a	O
working	B-T098
group	I-T098
initiated	O
by	O
10	O
centers	B-T092
and	O
currently	O
comprising	O
34	O
centers	B-T092
has	O
gathered	O
data	O
on	O
all	O
cases	O
of	O
laparoscopic	B-T058
pancreatectomy	I-T058
.	O
procedures	B-T058
in	O
which	O
laparoscopy	B-T058
was	O
converted	O
to	O
open	B-T058
surgery	I-T058
are	O
also	O
included	O
.	O
the	O
registry	B-T170
now	O
contains	O
550	O
data	O
sets	O
representing	O
267	O
cases	O
of	O
benign	B-T038
disease	I-T038
,	O
244	O
malignancies	B-T038
,	O
and	O
39	O
borderline	B-T038
tumors	I-T038
.	O
the	O
most	O
common	O
procedure	B-T058
was	O
laparoscopic	B-T058
left	I-T058
pancreatectomy	I-T058
,	O
followed	O
by	O
resection	B-T058
of	O
the	O
head	B-T017
of	I-T017
the	I-T017
pancreas	I-T017
and	O
tumor	B-T038
enucleation	B-T058
.	O
the	O
most	O
common	O
intraoperative	B-T038
complication	I-T038
was	O
hemorrhage	B-T038
,	O
with	O
a	O
frequency	O
of	O
3	O
%	O
.	O
the	O
rate	O
of	O
conversion	O
to	O
open	B-T058
surgery	I-T058
was	O
35	O
%	O
;	O
if	O
mini	B-T058
##la	I-T058
##par	I-T058
##otomies	I-T058
are	O
excluded	O
,	O
the	O
conversion	O
rate	O
was	O
only	O
16	O
%	O
.	O
39	O
%	O
of	O
patients	O
developed	O
a	O
pancreatic	B-T038
fistula	I-T038
after	O
surgery	B-T058
(	O
usually	O
grade	O
a	O
or	O
b	O
,	O
with	O
1	O
.	O
5	O
%	O
grade	O
c	O
)	O
and	O
3	O
%	O
underwent	O
reoperation	B-T058
because	O
of	O
postoperative	B-T038
hemorrhage	I-T038
.	O
the	O
procedure	B-T033
-	I-T033
related	I-T033
mortality	I-T033
was	O
1	O
.	O
3	O
%	O
.	O
91	O
%	O
of	O
the	O
patients	O
reported	O
only	O
very	O
mild	O
postoperative	B-T033
pain	I-T033
.	O
6	O
.	O
7	O
%	O
newly	O
developed	O
diabetes	B-T038
mellitus	I-T038
after	O
the	O
procedure	B-T058
.	O
the	O
patient	O
cohort	B-T098
in	O
the	O
registry	B-T170
consists	O
of	O
persons	B-T098
who	O
were	O
selected	O
to	O
undergo	O
laparoscopic	B-T058
pancreatectomy	I-T058
by	O
the	O
participating	O
hospital	B-T092
teams	O
,	O
and	O
the	O
data	O
are	O
thus	O
inherently	O
affected	O
by	O
selection	O
bias	O
.	O
the	O
operative	B-T058
procedures	I-T058
that	O
they	O
underwent	O
reflect	O
the	O
current	O
practice	O
of	O
laparoscopic	B-T058
pancreatectomy	I-T058
in	O
germany	B-T082
.	O
the	O
complication	B-T038
rates	O
are	O
similar	O
to	O
those	O
of	O
open	B-T058
surgery	I-T058
.	O
selection	O
bias	O
can	O
be	O
avoided	O
only	O
by	O
a	O
randomized	B-T062
trial	I-T062
.	O

intraoperative	O
ketamine	B-T103
reduces	O
immediate	O
postoperative	O
opioid	B-T103
consumption	O
after	O
spinal	B-T058
fusion	I-T058
surgery	I-T058
in	O
chronic	B-T033
pain	I-T033
patients	O
with	O
opioid	B-T103
dependency	O
:	O
a	O
randomized	B-T062
,	O
blinded	B-T062
trial	I-T062
perioperative	O
handling	B-T033
of	O
surgical	O
patients	O
with	O
opioid	B-T103
dependency	O
represents	O
an	O
important	O
clinical	O
problem	B-T033
.	O
animal	B-T204
studies	I-T204
suggest	O
that	O
ketamine	B-T103
attenuates	O
central	B-T038
sensitization	I-T038
and	O
hyperalgesia	B-T033
and	O
thereby	O
reduces	O
postoperative	O
opioid	B-T103
tolerance	O
.	O
we	O
hypothesized	O
that	O
intraoperative	O
ketamine	B-T103
would	O
reduce	O
immediate	O
postoperative	O
opioid	B-T103
consumption	O
compared	O
with	O
placebo	B-T103
in	O
chronic	B-T033
pain	I-T033
patients	O
with	O
opioid	B-T103
dependency	O
undergoing	O
lumbar	B-T058
spinal	I-T058
fusion	I-T058
surgery	I-T058
.	O
primary	O
outcome	O
was	O
morphine	B-T103
consumption	O
0	O
to	O
24	O
hours	O
postoperatively	O
.	O
secondary	O
outcomes	O
were	O
acute	B-T033
pain	I-T033
at	I-T033
rest	I-T033
and	O
during	O
mobilization	B-T058
2	O
to	O
24	O
hours	O
postoperatively	O
(	O
visual	B-T058
analogue	I-T058
scale	I-T058
)	O
,	O
adverse	B-T038
events	I-T038
,	O
and	O
persistent	O
pain	B-T033
6	O
months	O
postoperatively	O
.	O
one	O
hundred	O
fifty	O
patients	O
were	O
randomly	B-T062
assigned	I-T062
to	O
intraoperative	O
s	B-T103
-	I-T103
ketamine	I-T103
bolus	B-T058
0	I-T058
.	I-T058
5	I-T058
mg	I-T058
/	I-T058
kg	I-T058
and	I-T058
infusion	I-T058
0	O
.	O
25	O
mg	O
·	O
kg	O
·	O
h	O
or	O
placebo	B-T103
.	O
postoperatively	O
,	O
patients	O
received	O
their	O
usual	O
opioids	B-T103
,	O
paracetamol	B-T103
and	O
iv	O
patient	B-T058
-	I-T058
controlled	I-T058
analgesia	I-T058
with	O
morphine	B-T103
.	O
in	O
the	O
final	B-T170
analyses	I-T170
,	O
147	O
patients	O
were	O
included	O
.	O
patient	B-T058
-	I-T058
controlled	I-T058
analgesia	I-T058
iv	O
morphine	B-T103
consumption	O
0	O
to	O
24	O
hours	O
postoperatively	O
was	O
significantly	O
reduced	O
in	O
the	O
ketamine	B-T103
group	O
compared	O
with	O
the	O
placebo	B-T103
group	O
:	O
79	O
(	O
47	O
)	O
vs	O
121	O
(	O
53	O
)	O
mg	O
iv	O
,	O
mean	O
difference	O
42	O
mg	O
(	O
95	O
%	O
confidence	O
interval	O
-	O
59	O
to	O
-	O
25	O
)	O
,	O
p	O
<	O
0	O
.	O
001	O
.	O
sedation	B-T033
was	O
significantly	O
reduced	O
in	O
the	O
ketamine	B-T103
group	O
6	O
and	O
24	O
hours	O
postoperatively	O
.	O
there	O
were	O
no	O
significant	O
differences	O
regarding	O
acute	B-T033
pain	I-T033
,	O
nausea	B-T033
,	O
vomiting	B-T033
,	O
hallucinations	B-T038
,	O
or	O
night	B-T033
##mar	I-T033
##es	I-T033
.	O
back	B-T033
pain	I-T033
at	O
6	O
months	O
postoperatively	O
compared	O
with	O
preoperative	O
pain	B-T033
was	O
significantly	O
more	O
improved	B-T033
in	O
the	O
ketamine	B-T103
group	O
compared	O
with	O
the	O
placebo	B-T103
group	O
,	O
p	O
=	O
0	O
.	O
005	O
.	O
in	O
conclusion	O
,	O
intraoperative	O
ketamine	B-T103
significantly	O
reduced	O
morphine	B-T103
consumption	O
0	O
to	O
24	O
hours	O
after	O
lumbar	B-T058
fusion	I-T058
surgery	I-T058
in	O
opioid	B-T103
-	O
dependent	O
patients	O
.	O
the	O
trend	O
regarding	O
less	O
persistent	O
pain	B-T033
6	O
months	O
postoperatively	O
needs	O
further	B-T082
investigation	O
.	O

facilitating	O
factors	O
and	O
barriers	O
to	O
malaria	B-T038
research	B-T062
utilization	O
for	O
policy	O
development	O
in	O
mal	B-T082
##aw	I-T082
##i	I-T082
research	B-T062
on	O
various	O
determinants	O
of	O
health	O
is	O
key	O
in	O
providing	O
evidence	O
for	O
policy	O
development	O
,	O
thereby	O
leading	O
to	O
successful	O
interventions	O
.	O
utilization	O
of	O
research	B-T062
is	O
an	O
intricate	O
process	O
requiring	O
an	O
understanding	O
of	O
contextual	O
factors	O
.	O
the	O
study	O
was	O
conducted	O
to	O
assess	O
enhancing	O
factors	O
and	O
barriers	O
of	O
research	B-T062
utilization	O
for	O
malaria	B-T038
policy	O
development	O
in	O
mal	B-T082
##aw	I-T082
##i	I-T082
.	O
qualitative	O
research	B-T062
approach	O
was	O
used	O
through	O
in	O
-	O
depth	O
interviews	O
with	O
39	O
key	O
informants	O
that	O
included	O
malaria	B-T038
researchers	B-T097
,	O
policy	B-T097
makers	I-T097
,	O
programme	O
managers	B-T097
,	O
and	O
key	B-T098
stakeholders	I-T098
.	O
purpos	B-T062
##ive	I-T062
sampling	I-T062
and	O
snow	B-T062
##ball	I-T062
##ing	I-T062
techniques	I-T062
were	O
used	O
in	O
identifying	O
key	O
informants	O
.	O
interview	O
transcripts	B-T170
were	O
entered	O
in	O
qs	B-T170
##r	I-T170
nv	I-T170
##iv	I-T170
##o	I-T170
11	I-T170
software	I-T170
for	O
coding	O
and	O
analysis	B-T062
.	O
respondents	B-T098
identified	O
global	O
efforts	O
as	O
key	O
in	O
advancing	O
knowledge	B-T062
translation	I-T062
,	O
while	O
local	B-T082
political	O
will	O
has	O
been	O
conduc	O
##ive	O
for	O
research	B-T062
utilization	O
.	O
other	O
factors	O
were	O
availability	O
of	O
research	B-T062
,	O
availability	O
of	O
diverse	O
local	B-T082
researchers	B-T097
and	O
stakeholders	B-T098
supporting	O
knowledge	B-T062
translation	I-T062
.	O
while	O
barriers	O
included	O
:	O
lack	O
of	O
platforms	O
for	O
researcher	B-T097
-	O
public	B-T092
engagement	B-T033
,	O
poli	O
##tics	O
,	O
researchers	B-T097
'	I-T097
lack	O
of	O
communication	O
skills	O
,	O
lack	O
of	O
research	B-T062
collaboration	O
##s	O
,	O
fund	O
##er	O
driven	O
research	O
,	O
unknown	O
world	B-T092
health	I-T092
organization	I-T092
policy	B-T170
position	O
,	O
and	O
the	O
lack	O
of	O
a	O
malaria	B-T038
research	B-T062
rep	O
##ository	O
.	O
overall	O
,	O
the	O
study	O
identified	O
facilitating	O
factors	O
to	O
malaria	B-T038
research	B-T062
utilization	O
for	O
policy	O
development	O
in	O
mal	B-T082
##aw	I-T082
##i	I-T082
.	O
these	O
factors	O
need	O
to	O
be	O
systematically	O
coordinated	O
to	O
address	O
the	O
identified	O
barriers	O
and	O
improve	B-T033
on	O
malaria	B-T038
research	B-T062
utilization	O
in	O
policy	O
development	O
.	O
malaria	B-T038
research	B-T062
can	O
be	O
key	O
in	O
the	O
implementation	O
of	O
evidence	O
-	O
based	O
interventions	O
to	O
reduce	O
the	O
malaria	B-T038
burden	O
and	O
assist	O
in	O
the	O
paradigm	O
shift	O
from	O
malaria	B-T038
control	O
to	O
elimination	O
in	O
mal	B-T082
##aw	I-T082
##i	I-T082
.	O

opioids	B-T103
for	O
chronic	B-T033
pain	I-T033
:	O
the	O
cdc	B-T092
'	I-T092
s	I-T092
12	O
recommendations	O
the	O
centers	B-T092
for	I-T092
disease	I-T092
control	I-T092
and	I-T092
prevention	I-T092
has	O
issued	O
12	O
recommendations	O
to	O
help	O
clinicians	B-T097
prescribe	B-T058
an	O
optimal	O
and	O
safe	O
course	O
of	O
treatment	B-T058
for	O
patients	O
.	O

assessing	O
nitrous	B-T103
oxide	I-T103
effect	O
using	O
electroencephalographic	B-T058
##ally	I-T058
-	O
based	O
depth	B-T033
of	I-T033
anesthesia	I-T033
measures	O
cortical	B-T017
state	B-T170
and	O
cortical	B-T017
input	B-T170
existing	O
electroencephalography	B-T058
(	O
eeg	B-T058
)	O
based	O
depth	B-T033
of	I-T033
anesthesia	I-T033
monitors	O
cann	O
##ot	O
reliably	O
track	O
sedative	B-T103
or	O
anesthetic	B-T103
states	O
during	O
n	B-T103
-	I-T103
methyl	I-T103
-	I-T103
d	I-T103
-	I-T103
aspartate	I-T103
(	I-T103
nmda	I-T103
)	I-T103
receptor	I-T103
antagonist	I-T103
based	O
anesthesia	B-T058
with	O
ketamine	B-T103
or	O
nitrous	B-T103
oxide	I-T103
(	O
n2o	B-T103
)	O
.	O
here	O
,	O
a	O
physiologically	O
-	O
motivated	O
depth	B-T033
of	I-T033
anesthesia	I-T033
monitoring	B-T058
algorithm	B-T170
based	O
on	O
autoreg	B-T170
##ressive	I-T170
-	I-T170
moving	I-T170
-	I-T170
average	I-T170
(	I-T170
arm	I-T170
##a	I-T170
)	I-T170
modeling	I-T170
and	O
derivative	O
measures	O
of	O
interest	O
,	O
cortical	B-T017
state	B-T170
(	O
cs	B-T170
)	O
and	O
cortical	B-T017
input	B-T170
(	O
ci	B-T170
)	O
,	O
is	O
retrospectively	B-T062
applied	O
in	O
an	O
exploratory	O
manner	O
to	O
the	O
nmda	B-T103
receptor	I-T103
antagonist	I-T103
n2o	B-T103
,	O
an	O
adjuvant	B-T103
anesthetic	I-T103
gas	I-T103
used	O
in	O
clinical	O
practice	O
.	O
composite	B-T170
cortical	I-T170
state	I-T170
(	O
ccs	B-T170
)	O
and	O
composite	B-T170
cortical	I-T170
state	I-T170
distance	I-T170
(	O
ccs	B-T170
##d	I-T170
)	O
,	O
two	O
new	O
modifications	B-T033
of	O
cs	B-T170
,	O
along	O
with	O
cs	B-T170
and	O
ci	B-T170
were	O
evaluated	B-T058
on	O
electroencephalographic	B-T058
(	O
eeg	B-T058
)	O
data	O
of	O
healthy	O
control	O
individuals	O
undergoing	O
n2o	B-T103
inhalation	B-T038
up	O
to	O
equilibr	O
##ated	O
peak	O
gas	O
concentrations	O
of	O
20	O
,	O
40	O
or	O
60	O
%	O
n2o	B-T103
/	O
o2	B-T103
.	O
in	O
particular	O
,	O
ccs	B-T170
##d	I-T170
has	O
been	O
devised	O
to	O
vary	O
consistently	O
for	O
increasing	O
levels	O
of	O
anesthetic	B-T033
concentration	I-T033
independent	O
of	O
the	O
anesthetic	B-T103
'	I-T103
s	I-T103
microscopic	O
mode	O
of	O
action	O
for	O
both	O
n2o	B-T103
and	O
propofol	B-T103
.	O
the	O
strongest	O
effects	O
were	O
observed	O
for	O
the	O
60	O
%	O
peak	O
gas	O
concentration	O
group	B-T098
.	O
for	O
the	O
50	O
-	O
60	O
%	O
peak	O
gas	O
levels	O
,	O
individuals	B-T098
showed	O
statistically	O
significant	O
reductions	B-T058
in	O
responsiveness	O
compared	O
to	O
rest	O
,	O
and	O
across	O
the	O
group	B-T098
cs	B-T170
and	O
ccs	B-T170
increased	O
by	O
39	O
and	O
42	O
%	O
,	O
respectively	O
,	O
while	O
ccs	B-T170
##d	I-T170
was	O
found	O
to	O
decrease	O
by	O
398	O
%	O
.	O
on	O
the	O
other	O
hand	O
a	O
clear	O
conclusion	O
regarding	O
the	O
changes	O
in	O
ci	B-T170
could	O
not	O
be	O
reached	O
.	O
these	O
results	O
indicate	O
that	O
,	O
contrary	B-T082
to	O
previous	O
depth	B-T033
of	I-T033
anesthesia	I-T033
monitoring	B-T058
measures	O
,	O
the	O
cs	B-T170
,	O
ccs	B-T170
,	O
and	O
especially	O
ccs	B-T170
##d	I-T170
measures	O
derived	O
from	O
frontal	B-T082
eeg	B-T058
are	O
potentially	O
useful	O
for	O
differentiating	O
gas	O
concentration	O
and	O
responsiveness	O
levels	O
in	O
people	B-T098
under	O
n2o	B-T103
.	O
on	O
the	O
other	O
hand	O
,	O
determining	O
the	O
utility	O
of	O
ci	B-T170
in	O
this	O
regard	O
will	O
require	O
larger	O
sample	O
sizes	O
and	O
potentially	O
higher	O
gas	O
concentrations	O
.	O
future	O
work	O
will	O
assess	O
the	O
sensitivity	O
of	O
cs	B-T170
-	O
based	O
and	O
ci	B-T170
measures	O
to	O
other	O
anesthetics	B-T103
and	O
their	O
utility	O
in	O
a	O
clinical	B-T092
environment	B-T082
.	O

diabetic	B-T038
nephropathy	I-T038
as	O
the	O
cause	O
of	O
end	B-T038
-	I-T038
stage	I-T038
kidney	I-T038
disease	I-T038
reported	O
on	O
the	O
medical	B-T170
evidence	I-T170
form	I-T170
cms	B-T170
##27	I-T170
##28	I-T170
at	O
a	O
single	O
center	B-T092
background	O
:	O
end	B-T038
-	I-T038
stage	I-T038
renal	I-T038
disease	I-T038
(	O
esrd	B-T038
)	O
incidence	O
due	O
to	O
type	B-T170
2	I-T170
diabetic	B-T038
nephropathy	I-T038
(	O
dn	B-T038
)	O
is	O
35	O
-	O
50	O
%	O
,	O
according	O
to	O
the	O
united	B-T170
states	I-T170
renal	I-T170
data	I-T170
system	I-T170
.	O
methods	O
:	O
a	O
single	O
-	O
center	B-T092
,	O
retrospective	B-T062
cohort	I-T062
study	I-T062
to	O
determine	O
incidence	O
and	O
diagnostic	O
accuracy	O
for	O
type	B-T170
2	I-T170
dn	B-T038
as	O
the	O
primary	O
cause	O
of	O
esrd	B-T038
(	O
code	O
250	O
.	O
40	O
)	O
on	O
the	O
center	B-T092
for	I-T092
medicare	I-T092
&	I-T092
medicaid	I-T092
(	O
cms	B-T092
)	O
medical	B-T170
evidence	I-T170
report	I-T170
form	I-T170
(	O
cms	B-T170
##27	I-T170
##28	I-T170
)	O
submitted	O
at	O
renal	B-T058
replacement	I-T058
therapy	I-T058
initiation	O
.	O
all	O
patients	O
≥1	O
##8	O
years	O
of	O
age	O
with	O
a	O
cms	B-T170
##27	I-T170
##28	I-T170
submitted	O
between	O
1	O
march	O
2006	O
and	O
31	O
march	O
2015	O
at	O
a	O
single	O
academic	B-T092
military	I-T092
medical	I-T092
center	I-T092
(	O
esrd	B-T038
network	O
5	O
)	O
were	O
included	O
.	O
medical	B-T170
records	I-T170
of	O
those	O
with	O
a	O
code	O
250	O
.	O
40	O
diagnosis	B-T033
were	O
reviewed	O
to	O
determine	O
whether	O
they	O
met	O
the	O
kidney	B-T092
disease	I-T092
outcomes	I-T092
quality	I-T092
initiative	I-T092
(	O
kd	B-T092
##o	I-T092
##qi	I-T092
)	O
2007	O
criteria	B-T170
for	O
dn	B-T038
.	O
results	O
:	O
esrd	B-T038
incidence	O
secondary	O
to	O
type	B-T170
2	I-T170
dn	B-T038
was	O
18	O
.	O
7	O
%	O
(	O
56	O
/	O
299	O
individual	B-T098
cms	B-T170
##27	I-T170
##28	I-T170
subm	O
##issions	O
over	O
9	O
.	O
09	O
years	O
)	O
.	O
in	O
all	O
,	O
12	O
/	O
56	O
(	O
21	O
.	O
4	O
%	O
)	O
did	O
not	O
meet	O
kd	B-T170
##o	I-T170
##qi	I-T170
criteria	I-T170
for	O
type	B-T170
2	I-T170
dn	B-T038
.	O
although	O
all	O
had	O
diabetes	B-T038
,	O
those	O
not	O
meeting	O
criteria	O
had	O
shorter	O
disease	O
duration	O
(	O
p	O
=	O
0	O
.	O
007	O
)	O
,	O
were	O
more	O
likely	O
to	O
have	O
active	O
urine	B-T031
sediment	I-T031
(	O
p	O
=	O
0	O
.	O
006	O
)	O
,	O
and	O
were	O
less	O
likely	O
to	O
have	O
macro	B-T033
##albumin	I-T033
##uria	I-T033
(	O
p	O
=	O
0	O
.	O
037	O
)	O
or	O
retinopathy	B-T038
(	O
p	O
=	O
0	O
.	O
002	O
)	O
prior	O
to	O
esrd	B-T038
.	O
on	O
exact	O
logistic	B-T062
regression	I-T062
,	O
retinopathy	B-T038
was	O
significantly	O
associated	O
with	O
kd	B-T092
##o	I-T092
##qi	I-T092
-	O
predicted	O
dn	B-T038
[	O
odds	O
ratio	O
=	O
19	O
.	O
16	O
(	O
confidence	O
interval	O
2	O
.	O
76	O
-	O
223	O
.	O
7	O
)	O
,	O
p	O
=	O
0	O
.	O
000	O
##9	O
]	O
.	O
conclusions	O
:	O
in	O
this	O
single	O
-	O
center	B-T092
cohort	B-T062
,	O
21	O
.	O
4	O
%	O
identified	O
as	O
having	O
type	B-T170
2	I-T170
dn	B-T038
as	O
the	O
primary	O
cause	O
of	O
esrd	B-T038
were	O
incorrectly	O
assigned	O
per	O
kd	B-T092
##o	I-T092
##qi	I-T092
2007	O
clinical	O
criteria	B-T170
.	O
if	O
replicated	O
in	O
larger	O
populations	B-T098
,	O
this	O
could	O
have	O
substantial	O
implications	O
regarding	O
the	O
epidemiology	B-T091
of	O
esrd	B-T038
in	O
the	O
usa	B-T082
.	O

selected	O
flavonoid	B-T103
compounds	I-T103
as	O
promising	O
inhibitors	B-T103
of	O
protein	B-T103
kinase	I-T103
ck	B-T103
##2	I-T103
##α	I-T103
and	O
ck	B-T103
##2	I-T103
##α	I-T103
'	I-T103
,	O
the	O
catalytic	B-T082
subunits	I-T082
of	O
ck	B-T103
##2	I-T103
ck	B-T103
##2	I-T103
is	O
a	O
ubiquitous	O
protein	B-T103
kinase	I-T103
involved	O
in	O
many	O
cell	B-T038
functions	I-T038
.	O
during	O
the	O
last	O
years	O
it	O
became	O
an	O
interesting	O
target	O
in	O
cancer	B-T062
research	I-T062
.	O
a	O
series	O
of	O
flavonoid	B-T103
compounds	I-T103
was	O
tested	O
as	O
inhibitors	B-T103
of	O
protein	B-T103
kinase	I-T103
ck	B-T103
##2	I-T103
.	O
several	O
substances	O
were	O
found	O
to	O
be	O
highly	O
active	O
against	O
both	O
catalytic	B-T082
subunits	I-T082
with	O
ic50	O
values	O
below	O
1	O
μm	O
in	O
case	O
of	O
ck	B-T103
##2	I-T103
##α	I-T103
'	I-T103
.	O
the	O
most	O
promising	O
inhibitor	B-T103
we	O
identified	O
is	O
chrys	B-T103
##oe	I-T103
##riol	I-T103
with	O
ic50	O
values	O
of	O
250	O
and	O
34	O
nm	O
for	O
ck	B-T103
##2	I-T103
##α	I-T103
and	O
ck	B-T103
##2	I-T103
##α	I-T103
'	I-T103
,	O
respectively	O
.	O

parental	O
perceptions	B-T038
of	O
children	B-T092
##´	I-T092
##s	I-T092
agency	I-T092
:	O
parental	O
warm	O
##th	O
,	O
school	O
achievement	O
and	O
adjustment	O
the	O
present	O
study	B-T062
examined	O
swedish	B-T098
mothers	O
'	O
and	O
fathers	O
'	O
warm	O
##th	O
towards	O
their	O
children	O
in	O
relation	O
to	O
their	O
children	B-T092
##´	I-T092
##s	I-T092
agency	I-T092
.	O
it	O
also	O
examined	O
the	O
longitudinal	O
relation	O
between	O
agency	B-T092
and	O
children	O
'	O
s	O
externalizing	O
,	O
internalizing	O
,	O
and	O
school	O
achievement	O
.	O
swedish	B-T098
children	O
'	O
s	O
mothers	O
and	O
fathers	O
(	O
n	O
=	O
103	O
)	O
were	O
interviewed	O
at	O
three	O
time	O
points	O
(	O
when	O
children	O
were	O
8	O
,	O
9	O
,	O
and	O
10	O
years	O
old	O
)	O
about	O
their	O
warm	O
##th	O
towards	O
their	O
children	O
,	O
children	B-T092
'	I-T092
s	I-T092
agency	I-T092
,	O
and	O
children	O
'	O
s	O
externalizing	O
and	O
internalizing	O
behaviors	O
and	O
school	O
achievement	O
.	O
parental	O
warm	O
##th	O
at	O
time	O
1	O
was	O
significantly	O
correlated	O
with	O
child	B-T092
agency	I-T092
at	O
time	O
2	O
,	O
which	O
was	O
significantly	O
correlated	O
with	O
child	O
externalizing	O
and	O
internalizing	O
behaviors	O
and	O
academic	O
achievement	O
at	O
time	O
3	O
.	O
there	O
were	O
no	O
differences	O
between	O
girls	O
and	O
boys	O
.	O
results	O
from	O
this	O
study	B-T062
indicate	O
that	O
swedish	B-T098
parents	O
'	O
warm	O
##th	O
is	O
directly	O
related	O
to	O
subsequent	O
perceptions	B-T038
of	O
children	B-T092
'	I-T092
s	I-T092
agency	I-T092
,	O
which	O
in	O
turn	O
are	O
related	O
to	O
subsequently	O
lower	O
child	O
externalizing	O
and	O
internalizing	O
problems	B-T033
and	O
higher	O
academic	O
achievement	O
.	O
these	O
findings	B-T033
held	O
in	O
the	O
context	O
of	O
a	O
three	O
-	O
year	O
longitudinal	B-T062
study	I-T062
and	O
for	O
both	O
boys	O
and	O
girls	O
,	O
suggesting	O
the	O
importance	O
of	O
child	B-T092
agency	I-T092
in	O
the	O
link	O
between	O
parental	O
warm	O
##th	O
and	O
children	O
'	O
s	O
adjustment	O
.	O

protein	B-T103
design	O
for	O
nanos	B-T058
##tructural	I-T058
engineering	I-T058
:	O
concl	O
##uding	O
remark	B-T170
##s	I-T170
and	O
future	O
directions	O
this	O
final	O
chapter	B-T170
aims	O
to	O
summarize	O
the	O
main	O
conclusions	O
of	O
the	O
book	B-T170
and	O
to	O
point	O
to	O
possible	O
directions	O
for	O
further	O
research	B-T062
in	O
the	O
field	O
of	O
protein	B-T103
design	O
for	O
nanos	B-T058
##tructural	I-T058
engineering	I-T058
.	O
even	O
though	O
this	O
research	O
field	O
is	O
still	O
at	O
its	O
infancy	O
,	O
multidisciplinary	O
research	B-T062
efforts	I-T062
in	O
the	O
design	O
of	O
synthetic	O
protein	O
-	O
based	O
nanostructures	O
and	O
functional	O
materials	O
have	O
resulted	O
in	O
significant	O
progress	O
.	O
the	O
chapter	B-T170
##s	I-T170
in	O
this	O
book	B-T170
cover	O
several	O
selected	O
examples	O
of	O
the	O
most	O
recent	O
advances	O
concerning	O
the	O
use	O
of	O
proteins	B-T103
and	O
peptides	B-T103
as	O
building	O
blocks	O
for	O
the	O
fabrication	O
of	O
architectures	O
and	O
functional	O
nanostructures	O
,	O
assemblies	O
,	O
and	O
materials	O
.	O
here	O
,	O
we	O
provide	O
a	O
general	O
overview	O
of	O
the	O
strategies	O
that	O
can	O
be	O
employed	O
to	O
prepare	O
functional	O
protein	B-T103
-	O
based	O
nanostructures	O
,	O
and	O
nanostructured	O
materials	O
and	O
devices	O
.	O
finally	O
,	O
we	O
highlight	O
some	O
of	O
the	O
main	O
aspects	O
to	O
be	O
considered	O
by	O
the	O
research	B-T062
community	O
to	O
set	O
the	O
path	O
for	O
the	O
near	O
future	O
developments	B-T062
.	O

enhancing	O
comparative	B-T062
effectiveness	I-T062
research	I-T062
with	O
automated	O
pediatric	O
pneumonia	B-T038
detection	B-T058
in	O
a	O
multi	B-T092
-	I-T092
institutional	I-T092
clinical	O
rep	O
##ository	O
:	O
a	O
phi	B-T170
##s	I-T170
+	O
pilot	B-T062
study	I-T062
community	B-T038
-	I-T038
acquired	I-T038
pneumonia	I-T038
is	O
a	O
leading	O
cause	O
of	O
pediatric	O
morbidity	O
.	O
administrative	O
data	O
are	O
often	O
used	O
to	O
conduct	O
comparative	B-T062
effectiveness	I-T062
research	I-T062
(	O
cer	B-T062
)	O
with	O
sufficient	O
sample	O
sizes	O
to	O
enhance	O
detection	B-T033
of	O
important	O
outcomes	O
.	O
however	O
,	O
such	O
studies	O
are	O
prone	O
to	O
misclass	O
##ification	O
errors	O
because	O
of	O
the	O
variable	O
accuracy	O
of	O
discharge	B-T033
diagnosis	I-T033
codes	B-T170
.	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
an	O
automated	O
,	O
scalable	O
,	O
and	O
accurate	O
method	B-T170
to	O
determine	O
the	O
presence	B-T033
or	O
absence	O
of	O
pneumonia	B-T038
in	O
children	O
using	O
chest	B-T058
imaging	I-T058
reports	B-T170
.	O
the	O
multi	B-T092
-	I-T092
institutional	I-T092
phi	B-T170
##s	I-T170
+	O
clinical	O
rep	O
##ository	O
was	O
developed	O
to	O
support	O
pediatric	O
cer	B-T062
by	O
expanding	O
an	O
administrative	O
database	B-T170
of	O
children	B-T092
'	I-T092
s	I-T092
hospitals	I-T092
with	O
detailed	O
clinical	O
data	O
.	O
to	O
develop	O
a	O
scalable	O
approach	O
to	O
find	B-T033
patients	O
with	O
bacterial	B-T038
pneumonia	I-T038
more	O
accurately	O
,	O
we	O
developed	O
a	O
natural	O
language	O
processing	O
(	O
nl	O
##p	O
)	O
application	O
to	O
extract	O
relevant	O
information	O
from	O
chest	B-T058
diagnostic	I-T058
imaging	I-T058
reports	B-T170
.	O
domain	O
experts	B-T097
established	O
a	O
reference	O
standard	O
by	O
manually	O
annot	O
##ating	O
282	O
reports	B-T170
to	O
train	O
and	O
then	O
test	O
the	O
nl	O
##p	O
application	O
.	O
findings	O
of	O
pleural	B-T038
effusion	I-T038
,	O
pulmonary	B-T033
infiltrate	I-T033
,	O
and	O
pneumonia	B-T038
were	O
automatically	O
extracted	O
from	O
the	O
reports	B-T170
and	O
then	O
used	O
to	O
automatically	O
classify	B-T170
whether	O
a	O
report	B-T170
was	O
consistent	O
with	O
bacterial	B-T038
pneumonia	I-T038
.	O
compared	O
with	O
the	O
annotated	O
diagnostic	B-T058
imaging	I-T058
reports	B-T170
reference	O
standard	O
,	O
the	O
most	O
accurate	O
implementation	O
of	O
machine	O
learning	O
algorithms	B-T170
in	O
our	O
nl	O
##p	O
application	O
allowed	O
extracting	O
relevant	O
findings	O
with	O
a	O
sensitivity	O
of	O
.	O
93	O
##9	O
and	O
a	O
positive	B-T033
predictive	O
value	O
of	O
.	O
92	O
##5	O
.	O
it	O
allowed	O
classifying	B-T170
reports	B-T170
with	O
a	O
sensitivity	O
of	O
.	O
71	O
,	O
a	O
positive	B-T033
predictive	O
value	O
of	O
.	O
86	O
,	O
and	O
a	O
specificity	O
of	O
.	O
96	O
##2	O
.	O
when	O
compared	O
with	O
each	O
of	O
the	O
domain	O
experts	B-T097
manually	O
annot	O
##ating	O
these	O
reports	B-T170
,	O
the	O
nl	O
##p	O
application	O
allowed	O
for	O
significantly	O
higher	O
sensitivity	O
(	O
.	O
71	O
vs	O
.	O
52	O
##7	O
)	O
and	O
similar	O
positive	B-T033
predictive	O
value	O
and	O
specificity	O
.	O
nl	O
##p	O
-	O
based	O
pneumonia	B-T038
information	O
extraction	O
of	O
pediatric	O
diagnostic	B-T058
imaging	I-T058
reports	B-T170
performed	O
better	O
than	O
domain	O
experts	B-T097
in	O
this	O
pilot	B-T062
study	I-T062
.	O
nl	O
##p	O
is	O
an	O
efficient	O
method	O
to	O
extract	O
information	O
from	O
a	O
large	O
collection	O
of	O
imaging	B-T170
reports	I-T170
to	O
facilitate	O
cer	B-T062
.	O

fabrication	O
and	O
modelling	B-T062
of	O
fractal	B-T082
,	O
biomimetic	B-T082
,	O
micro	B-T082
and	O
nano	B-T082
-	I-T082
topographical	I-T082
surfaces	I-T082
natural	O
surface	O
topo	O
##graph	O
##ies	O
are	O
often	O
self	O
-	O
similar	O
with	O
hierarchical	O
features	O
at	O
the	O
micro	O
and	O
nanoscale	O
,	O
which	O
may	O
be	O
mimicked	O
to	O
overcome	O
modern	O
tissue	B-T058
engineering	I-T058
and	O
biomaterial	B-T103
design	O
limitations	O
.	O
specifically	O
,	O
a	O
cell	O
'	O
s	O
microenvironment	O
within	O
the	O
human	B-T204
body	I-T204
contains	O
highly	O
optimised	O
,	O
fractal	B-T082
topographical	I-T082
cues	I-T082
,	O
which	O
direct	O
##s	O
precise	O
cell	B-T017
behaviour	O
.	O
however	O
,	O
recre	O
##ating	O
biomimetic	B-T082
,	O
fractal	B-T082
topo	I-T082
##graph	I-T082
##ies	I-T082
in	O
vitro	O
is	O
not	O
a	O
trivial	O
process	O
and	O
a	O
number	O
of	O
fabrication	O
methods	O
have	O
been	O
proposed	O
but	O
often	O
fail	O
to	O
precisely	O
control	O
the	O
spatial	O
resolution	O
of	O
features	O
at	O
different	O
lengths	O
scales	O
and	O
hence	O
,	O
to	O
provide	O
true	O
biomimetic	O
properties	O
.	O
here	O
,	O
we	O
propose	O
a	O
method	B-T170
of	O
accurately	O
reproduc	O
##ing	O
the	O
self	O
-	O
similar	O
,	O
micro	B-T082
and	O
nanoscale	B-T082
topography	I-T082
of	O
a	O
human	B-T204
biological	B-T017
tissue	I-T017
into	O
a	O
synthetic	B-T103
polymer	I-T103
through	O
an	O
innovative	O
fabrication	O
process	O
.	O
the	O
biological	B-T017
tissue	I-T017
surface	B-T082
was	O
characterised	O
using	O
atomic	B-T058
force	I-T058
microscopy	I-T058
(	O
afm	B-T058
)	O
to	O
obtain	O
spatial	O
data	O
in	O
x	O
,	O
y	O
and	O
z	O
,	O
which	O
was	O
converted	O
into	O
a	O
gray	O
##sc	O
##ale	O
'	O
digital	O
photo	O
##mas	O
##k	O
'	O
.	O
as	O
a	O
result	O
of	O
mask	O
##less	O
gray	O
##sc	O
##ale	O
optical	O
lith	O
##ography	O
followed	O
by	O
modified	O
deep	O
reactive	O
ion	O
etching	O
and	O
replic	O
##a	O
mold	O
##ing	O
,	O
we	O
were	O
able	O
to	O
accurately	O
reproduce	O
the	O
fractal	B-T082
topography	I-T082
of	O
acellular	B-T017
dermal	I-T017
matrix	I-T017
(	O
adm	B-T017
)	O
into	O
polyd	B-T103
##imethyl	I-T103
##sil	I-T103
##oxane	I-T103
(	O
pdms	B-T103
)	O
.	O
characterisation	O
using	O
afm	B-T058
at	O
three	O
different	O
length	O
scales	O
revealed	O
that	O
the	O
nano	B-T082
and	O
micro	B-T082
-	I-T082
topographical	I-T082
features	O
,	O
in	O
addition	O
to	O
the	O
fractal	O
dimension	O
,	O
of	O
native	O
adm	B-T017
were	O
reproduced	O
in	O
pdms	B-T103
.	O
in	O
conclusion	O
,	O
it	O
has	O
been	O
shown	O
that	O
the	O
fractal	B-T082
topography	I-T082
of	O
biological	B-T082
surfaces	I-T082
can	O
be	O
mimicked	O
in	O
synthetic	O
materials	O
using	O
the	O
novel	O
fabrication	O
process	O
outlined	O
,	O
which	O
may	O
be	O
applied	O
to	O
significantly	O
enhance	O
medical	B-T074
device	I-T074
biocompatibility	O
and	O
performance	O
.	O

technical	O
note	O
:	O
a	O
preliminary	O
comparative	B-T062
study	I-T062
between	O
classical	O
and	O
interventional	B-T091
radiological	I-T091
approaches	I-T091
for	O
multi	O
-	O
phase	O
post	B-T058
-	I-T058
mortem	I-T058
ct	I-T058
angiography	B-T058
multi	O
-	O
phase	O
post	B-T058
-	I-T058
mortem	I-T058
computed	I-T058
tomography	I-T058
angiography	I-T058
(	O
mpm	B-T058
##ct	I-T058
##a	I-T058
)	O
is	O
a	O
new	O
diagnostic	B-T058
tool	I-T058
,	O
used	O
in	O
forensic	B-T091
pathology	I-T091
.	O
on	O
the	O
one	O
hand	O
,	O
this	O
technique	O
allows	O
a	O
better	O
and	O
direct	O
visualization	O
of	O
vascular	B-T038
and	O
solid	B-T017
organ	I-T017
lesions	B-T033
.	O
on	O
the	O
other	O
hand	O
,	O
the	O
invasiveness	O
of	O
the	O
procedure	O
-	O
which	O
requires	O
surgical	B-T033
den	I-T033
##ud	I-T033
##ation	I-T033
(	O
inguinal	B-T082
and	O
/	O
or	O
cervical	B-T082
)	O
and	O
the	O
insertion	B-T058
of	O
surgical	B-T074
cannula	I-T074
##s	I-T074
-	O
leads	O
to	O
many	O
relatives	O
ref	O
##using	O
scientific	B-T058
autops	I-T058
##ies	I-T058
.	O
our	O
hypothesis	O
states	O
that	O
a	O
minimally	O
-	O
invasive	O
procedure	O
combining	O
interventional	B-T058
radiological	I-T058
techniques	I-T058
with	O
mpm	B-T058
##ct	I-T058
##a	I-T058
(	O
replacement	O
of	O
surgical	B-T074
cannula	I-T074
##s	I-T074
by	O
radiological	B-T074
catheters	I-T074
)	O
will	O
improve	B-T033
the	O
approval	O
rate	O
of	O
scientific	B-T058
autops	I-T058
##ies	I-T058
by	O
families	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
feasibility	B-T062
of	O
the	O
minimally	O
-	O
invasive	O
mpm	B-T058
##ct	I-T058
##a	I-T058
approach	O
and	O
to	O
compare	O
its	O
performance	O
to	O
the	O
current	O
reference	O
-	O
standard	O
(	O
the	O
conventional	O
approach	O
)	O
.	O
we	O
included	O
consecutively	O
16	O
corp	B-T017
##se	I-T017
##s	I-T017
divided	O
in	O
two	O
groups	O
according	O
to	O
the	O
contrast	O
enhancement	O
approach	O
:	O
radiological	B-T074
catheters	I-T074
(	O
n	O
=	O
8	O
)	O
,	O
and	O
surgical	B-T074
cannula	I-T074
##s	I-T074
(	O
n	O
=	O
8	O
)	O
.	O
corp	B-T017
##se	I-T017
##s	I-T017
were	O
chosen	O
and	O
assigned	O
randomly	O
from	O
our	O
local	O
data	O
.	O
the	O
quality	O
of	O
the	O
imaging	B-T058
procedure	I-T058
was	O
compared	O
according	O
to	O
four	O
items	O
:	O
global	B-T017
vascular	I-T017
opacification	O
,	O
cerebral	O
venous	O
opacification	O
,	O
and	O
lower	B-T017
limbs	I-T017
opacification	O
(	O
arterial	B-T082
and	O
venous	B-T082
)	O
.	O
a	O
minimally	O
-	O
invasive	O
approach	O
for	O
scientific	B-T058
autops	I-T058
##ies	I-T058
is	O
feasible	O
through	O
a	O
radiological	B-T074
catheter	I-T074
.	O
vascular	B-T017
opacification	O
was	O
optimal	O
in	O
8	O
out	O
of	O
8	O
cases	O
and	O
was	O
no	O
less	O
effective	O
than	O
the	O
control	O
reference	O
group	O
using	O
surgical	B-T074
cannula	I-T074
incision	B-T058
associated	O
with	O
their	O
non	O
-	O
occlusive	O
aspects	O
.	O

family	O
close	B-T033
but	O
friends	B-T098
closer	B-T033
:	O
exploring	O
social	O
support	O
and	O
resilience	O
in	O
older	B-T098
spo	O
##usal	O
dementia	B-T038
carers	B-T097
spo	O
##usal	O
dementia	B-T038
carers	B-T097
have	O
unique	O
support	O
needs	O
;	O
they	O
are	O
likely	O
to	O
dise	O
##ng	O
##age	O
from	O
their	O
existing	O
social	B-T098
networks	I-T098
as	O
they	O
need	O
to	O
dev	O
##ote	O
more	O
time	O
to	O
caring	O
as	O
the	O
disease	B-T038
progresses	I-T038
.	O
previously	O
we	O
showed	O
that	O
support	O
resources	O
can	O
facilitate	O
resilience	O
in	O
carers	B-T097
,	O
but	O
the	O
relationship	O
is	O
complex	O
and	O
varies	O
by	O
relationship	O
type	O
.	O
the	O
current	O
paper	O
aims	O
to	O
explore	O
social	O
support	O
as	O
a	O
key	O
component	O
of	O
resilience	O
to	O
identify	O
the	O
availability	O
,	O
function	O
and	O
perceived	O
functional	O
aspects	O
of	O
support	O
provided	O
to	O
older	B-T098
spo	O
##usal	O
dementia	B-T038
carers	B-T097
.	O
we	O
conducted	O
23	O
in	O
-	O
depth	O
qualitative	O
interviews	O
with	O
spo	O
##usal	O
carers	B-T097
from	O
two	O
care	B-T097
##r	I-T097
support	B-T092
groups	I-T092
and	O
a	O
care	O
home	O
in	O
north	B-T082
west	I-T082
england	I-T082
.	O
family	O
and	O
friends	B-T098
served	O
a	O
wide	O
range	O
of	O
functions	O
but	O
were	O
equally	O
available	O
to	O
resili	B-T098
##ent	I-T098
and	O
non	B-T098
-	I-T098
resili	I-T098
##ent	I-T098
participants	I-T098
.	O
family	B-T058
support	I-T058
was	O
perceived	B-T038
as	O
un	O
##hel	O
##p	O
##ful	O
if	O
it	O
created	O
feelings	B-T038
of	O
over	O
-	O
dependence	O
.	O
participants	B-T098
were	O
less	O
likely	O
to	O
resist	O
involvement	O
of	O
grand	O
##children	O
due	O
to	O
their	O
relatively	O
narrow	O
and	O
low	O
-	O
level	O
support	O
functions	O
.	O
friend	B-T098
support	O
was	O
perceived	B-T038
as	O
most	O
helpful	O
when	O
it	O
derived	O
from	O
those	O
in	O
similar	O
circumstances	O
.	O
neighbour	B-T098
##s	I-T098
played	O
a	O
functionally	O
unique	O
role	O
of	O
crisis	O
management	O
.	O
these	O
perceptions	B-T038
may	O
moderate	O
the	O
effect	O
of	O
support	O
on	O
resilience	O
.	O
family	B-T058
and	O
friend	B-T098
support	O
is	O
not	O
always	O
sufficient	O
to	O
facilitate	O
resilience	O
.	O
support	O
functions	O
facilitate	O
resilience	O
only	O
if	O
they	O
are	O
perceived	B-T038
to	O
match	O
need	O
.	O
implications	B-T033
of	O
these	O
findings	O
are	O
discussed	O
.	O

uridine	B-T103
stimulate	O
lax	B-T103
##ative	I-T103
effect	O
in	O
the	O
lo	B-T103
##per	I-T103
##amide	I-T103
-	O
induced	O
constipation	B-T033
of	O
sd	B-T204
rats	I-T204
through	O
regulation	B-T038
of	O
the	O
mach	B-T103
##rs	I-T103
signaling	B-T038
pathway	I-T038
and	O
mucin	B-T103
secretion	B-T038
uridine	B-T103
(	O
ur	B-T103
##d	I-T103
)	O
,	O
which	O
has	O
been	O
reported	B-T058
as	O
a	O
major	O
component	O
of	O
rna	B-T103
,	O
plays	O
an	O
important	O
role	O
in	O
various	O
biological	B-T038
process	I-T038
including	O
neuroprotection	B-T038
,	O
biochemical	O
modulation	O
and	O
glycolysis	B-T038
,	O
although	O
its	O
role	O
in	O
constipation	B-T033
has	O
yet	O
to	O
be	O
established	O
.	O
therefore	O
,	O
in	O
this	O
study	B-T062
,	O
we	O
investigated	O
the	O
lax	B-T103
##ative	I-T103
effects	O
of	O
ur	B-T103
##d	I-T103
on	O
chronic	O
constipation	B-T033
.	O
the	O
constipation	B-T033
phenotypes	O
and	O
their	O
related	O
mechanisms	O
were	O
investigated	O
in	O
the	O
transverse	B-T017
colon	I-T017
##s	I-T017
of	O
sd	B-T204
rats	I-T204
with	O
lo	B-T103
##per	I-T103
##amide	I-T103
(	O
lo	B-T103
##p	I-T103
)	O
-	O
induced	O
constipation	B-T033
after	O
treatment	B-T058
with	O
100	O
mg	O
/	O
kg	O
of	O
ur	B-T103
##d	I-T103
.	O
the	O
number	O
,	O
weight	O
and	O
water	B-T103
contents	O
of	O
stools	B-T031
were	O
significantly	O
higher	O
in	O
the	O
lo	B-T103
##p	I-T103
+	O
ur	B-T103
##d	I-T103
treated	B-T033
group	O
than	O
the	O
lo	B-T103
##p	I-T103
+	O
vehicle	B-T103
treated	B-T033
group	O
,	O
while	O
food	B-T038
intake	I-T038
and	O
water	B-T038
consumption	I-T038
of	O
the	O
same	O
group	O
were	O
maintained	O
at	O
a	O
constant	O
level	O
.	O
the	O
thickness	O
of	O
the	O
mucosa	B-T017
layer	I-T017
,	O
muscle	B-T017
and	O
flat	B-T082
luminal	I-T082
surface	I-T082
,	O
as	O
well	O
as	O
the	O
number	O
of	O
goblet	B-T017
cells	I-T017
,	O
pan	B-T017
##eth	I-T017
cells	I-T017
and	O
lipid	B-T017
droplets	I-T017
were	O
enhanced	O
in	O
the	O
lo	B-T103
##p	I-T103
+	O
ur	B-T103
##d	I-T103
treated	B-T033
group	O
.	O
furthermore	O
,	O
the	O
expression	B-T038
of	O
the	O
muscarinic	B-T103
acetylcholine	I-T103
receptors	I-T103
m2	I-T103
and	O
m3	B-T103
(	O
mach	B-T103
##r	I-T103
m2	I-T103
and	O
m3	B-T103
)	O
at	O
the	O
transcriptional	B-T038
and	O
translational	B-T038
level	O
was	O
recovered	O
in	O
the	O
lo	B-T103
##p	I-T103
+	O
ur	B-T103
##d	I-T103
treated	B-T033
group	O
,	O
while	O
some	O
markers	B-T201
such	O
as	O
g	B-T103
##α	I-T103
and	O
inositol	O
triphosphate	O
(	O
ip3	O
)	O
in	O
their	O
downstream	B-T082
signaling	B-T038
pathway	I-T038
were	O
completely	O
recovered	O
by	O
ur	B-T103
##d	I-T103
treatment	B-T058
.	O
moreover	O
,	O
the	O
ability	O
for	O
mucin	B-T103
secretion	B-T038
and	O
the	O
expression	B-T038
of	O
membrane	B-T103
water	I-T103
channel	I-T103
(	O
aquaporin	B-T103
##e	I-T103
8	I-T103
,	O
aqp	B-T103
##8	I-T103
)	O
were	O
increased	O
significantly	O
in	O
the	O
lo	B-T103
##p	I-T103
+	O
ur	B-T103
##d	I-T103
treated	B-T033
group	O
compared	O
with	O
lo	B-T103
##p	I-T103
+	O
vehicle	B-T103
treated	B-T033
group	O
.	O
finally	O
,	O
the	O
activity	O
of	O
ur	B-T103
##d	I-T103
was	O
confirmed	O
in	O
primary	B-T017
smooth	I-T017
muscle	I-T017
of	O
rat	B-T204
intestine	B-T017
cells	I-T017
(	O
prism	B-T017
##c	I-T017
)	O
based	O
on	O
g	B-T103
##α	I-T103
expression	B-T038
and	O
ip3	O
concentration	O
.	O
the	O
results	O
of	O
the	O
present	O
study	B-T062
provide	O
the	O
first	O
strong	O
evidence	O
that	O
ur	B-T103
##d	I-T103
can	O
be	O
considered	O
an	O
important	O
candidate	O
for	O
improving	O
chronic	O
constipation	B-T033
induced	O
by	O
lo	B-T103
##p	I-T103
treatment	B-T058
in	O
animal	B-T204
models	I-T204
.	O

is	O
the	O
inactivation	O
of	O
dentin	B-T031
proteases	B-T103
by	O
crosslink	B-T103
##ers	I-T103
reversible	O
?	O
inactivation	O
of	O
dentin	B-T031
proteases	B-T103
by	O
crosslink	B-T103
##ers	I-T103
has	O
been	O
suggested	O
as	O
a	O
way	O
to	O
prevent	O
the	O
degradation	B-T038
of	O
dentin	B-T031
collagen	B-T103
in	O
the	O
hybrid	O
layer	O
.	O
however	O
,	O
it	O
is	O
not	O
known	O
if	O
the	O
inhibition	O
is	O
reversible	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	O
the	O
inactivation	O
effect	O
of	O
various	O
crosslink	B-T103
##ers	I-T103
on	O
dentin	B-T031
protease	B-T103
activity	B-T038
over	O
a	O
period	O
of	O
6	O
months	O
.	O
demineral	B-T103
##ized	I-T103
dentin	I-T103
beams	I-T103
(	O
1	O
##×	O
##2	O
##×	O
##6	O
##mm	O
,	O
n	O
=	O
10	O
/	O
group	O
)	O
were	O
treated	O
with	O
(	O
1	O
)	O
1	O
%	O
glutaraldehyde	B-T103
(	O
ga	B-T103
##1	I-T103
)	O
,	O
(	O
2	O
)	O
5	O
%	O
glutaraldehyde	B-T103
(	O
ga	B-T103
##5	I-T103
)	O
,	O
(	O
3	O
)	O
1	O
%	O
grape	B-T103
seed	I-T103
extract	I-T103
(	O
gs	B-T103
##1	I-T103
)	O
,	O
(	O
4	O
)	O
5	O
%	O
grape	B-T103
seed	I-T103
extract	I-T103
(	O
gs	B-T103
##5	I-T103
)	O
,	O
(	O
5	O
)	O
10	O
%	O
sum	B-T204
##ac	I-T204
ber	I-T204
##ry	I-T204
extract	I-T204
(	O
s	B-T204
)	O
,	O
(	O
6	O
)	O
20	B-T103
##μm	I-T103
curcumin	I-T103
(	O
cr	B-T103
##20	I-T103
)	O
,	O
and	O
(	O
7	O
)	O
200	O
##μm	O
curcumin	B-T103
(	O
cr	B-T103
##200	I-T103
)	O
for	O
5	O
##min	O
.	O
untreated	B-T033
beams	B-T103
served	O
as	O
control	O
.	O
the	O
beams	B-T103
were	O
incubated	B-T058
up	O
to	O
6	O
months	O
and	O
incubation	B-T103
media	I-T103
were	O
used	O
to	O
analyze	B-T062
solubilized	O
tel	B-T103
##opeptide	I-T103
(	O
ict	B-T103
##p	I-T103
and	O
ctx	B-T103
)	O
fragments	B-T103
as	O
indicators	O
of	O
mmp	B-T103
-	O
and	O
cathepsin	B-T103
k	I-T103
-	O
mediated	O
degradation	B-T038
after	O
1	O
,	O
3	O
and	O
6	O
months	O
of	O
incubation	B-T058
.	O
the	O
relative	O
mmp	B-T103
activity	B-T038
of	O
dentin	B-T103
beams	I-T103
was	O
tested	O
using	O
a	O
generic	O
mmp	B-T103
assay	B-T058
.	O
data	O
were	O
analyzed	B-T062
using	O
repeated	O
-	O
measures	O
anova	O
,	O
α	O
=	O
0	O
.	O
05	O
.	O
all	O
treated	O
groups	O
showed	O
significant	O
decrease	O
in	O
ctx	B-T103
release	O
(	O
32	O
.	O
2	O
-	O
46	O
##9	O
.	O
5p	O
##g	O
/	O
mg	O
dentin	B-T031
)	O
and	O
ict	B-T103
##p	I-T103
(	O
1	O
.	O
8	O
-	O
47	O
.	O
6	O
##ng	O
/	O
mg	O
dentin	B-T031
)	O
fragments	B-T103
during	O
the	O
first	O
month	O
of	O
incubation	B-T058
compared	O
to	O
control	O
(	O
115	O
##9	O
##pg	O
/	O
mg	O
and	O
72	O
.	O
9	O
##ng	O
/	O
mg	O
dentin	B-T031
,	O
respectively	O
)	O
.	O
ga	B-T103
##5	I-T103
,	O
gs	B-T103
##5	I-T103
and	O
cr	B-T103
##200	I-T103
maintained	O
their	O
inhibitory	O
effect	O
during	O
6	O
-	O
month	O
incubation	B-T058
.	O
the	O
results	O
were	O
confirmed	O
by	O
dry	O
mass	O
loss	O
and	O
relative	O
mmp	B-T103
activity	B-T038
following	O
6	O
months	O
.	O
the	O
results	O
of	O
this	O
study	B-T062
indicate	O
that	O
the	O
long	O
-	O
term	O
effect	O
is	O
both	O
crosslink	B-T103
##er	I-T103
and	O
dose	O
dependent	O
.	O

application	B-T058
of	O
braf	O
v	O
##600	O
##e	O
mutation	B-T038
-	O
specific	O
immunohistochemistry	B-T058
in	O
diagnosis	B-T033
of	O
gastrointestinal	B-T038
stromal	I-T038
tumors	I-T038
to	O
evaluate	B-T058
the	O
utility	O
of	O
braf	O
v	O
##600	O
##e	O
allele	B-T017
-	O
specific	O
antibody	B-T103
in	O
the	O
diagnosis	B-T033
of	O
gastrointestinal	B-T038
stromal	I-T038
tumors	I-T038
(	O
gist	B-T038
##s	I-T038
)	O
.	O
braf	O
v	O
##600	O
##e	O
mutation	B-T038
-	O
specific	O
immunohistochemistry	B-T058
and	O
braf	B-T017
sequencing	O
were	O
performed	O
in	O
24	O
consecutive	O
gist	B-T038
##s	I-T038
,	O
including	O
14	O
cases	O
of	O
kit	B-T038
or	O
pdgf	B-T038
##ra	I-T038
mutations	I-T038
and	O
10	O
cases	O
of	O
kit	B-T017
/	O
pdgf	B-T017
##ra	I-T017
wild	I-T017
gist	B-T038
##s	I-T038
.	O
gist	B-T038
##s	I-T038
of	O
11	O
men	B-T098
and	O
13	O
women	B-T098
with	O
a	O
mean	O
age	O
54	O
years	O
(	O
range	O
29	O
-	O
75	O
years	O
)	O
were	O
included	O
with	O
tumors	B-T038
arising	O
from	O
stomach	B-T017
(	O
16	O
cases	O
)	O
,	O
small	B-T017
bowel	I-T017
(	O
7	O
cases	O
)	O
,	O
and	O
peritoneal	B-T082
cavity	I-T082
(	O
1	O
case	O
)	O
.	O
strong	O
and	O
diffuse	B-T082
cytoplasmic	B-T017
braf	B-T103
staining	B-T033
was	O
noted	O
in	O
4	O
of	O
24	O
cases	O
(	O
17	O
%	O
)	O
,	O
while	O
1	O
of	O
24	O
cases	O
(	O
4	O
%	O
)	O
showed	O
weak	O
staining	B-T033
,	O
and	O
19	O
of	O
24	O
cases	O
(	O
79	O
%	O
)	O
had	O
no	O
staining	B-T033
.	O
the	O
four	O
cases	O
with	O
strong	O
braf	B-T103
immunost	B-T103
##ain	I-T103
were	O
confirmed	O
to	O
have	O
braf	B-T038
mutations	I-T038
,	O
including	O
3	O
cases	O
in	O
the	O
stomach	B-T017
and	O
1	O
case	O
in	O
the	O
small	B-T017
intestine	I-T017
.	O
all	O
tumors	B-T038
showed	O
spindle	O
cell	O
morphology	O
.	O
only	O
one	O
case	O
had	O
progressive	B-T038
disease	I-T038
.	O
no	O
braf	B-T038
mutations	I-T038
were	O
detected	B-T033
in	O
cases	O
with	O
weak	O
or	O
negative	B-T033
braf	B-T103
immunost	B-T103
##ain	I-T103
.	O
braf	O
v	O
##600	O
##e	O
mutation	B-T038
-	O
specific	O
immunohistochemistry	B-T058
is	O
a	O
highly	O
sensitive	O
and	O
specific	O
marker	B-T201
for	O
detecting	B-T033
braf	B-T038
-	I-T038
mutated	I-T038
gist	B-T038
##s	I-T038
.	O

role	O
of	O
oxidative	B-T038
stress	I-T038
and	O
inflammatory	O
factors	O
in	O
diabetic	B-T038
kidney	I-T038
disease	I-T038
diabetic	B-T038
nephropathy	I-T038
(	O
dn	B-T038
)	O
is	O
a	O
serious	O
complication	B-T038
of	O
diabetes	B-T038
mellitus	I-T038
,	O
and	O
its	O
prevalence	O
has	O
been	O
increasing	O
in	O
developed	O
countries	O
.	O
diabetic	B-T038
nephropathy	I-T038
has	O
become	O
the	O
most	O
common	O
single	O
cause	O
of	O
end	B-T038
-	I-T038
stage	I-T038
renal	I-T038
disease	I-T038
worldwide	B-T098
.	O
oxidative	B-T038
stress	I-T038
and	O
inflammation	B-T038
factors	O
are	O
hypothesized	O
to	O
play	O
a	O
role	O
in	O
the	O
development	O
of	O
late	O
diabetes	B-T038
complications	I-T038
.	O
chronic	B-T038
hyperglycemia	I-T038
increases	O
oxidative	B-T038
stress	I-T038
,	O
significantly	O
modifies	O
the	O
structure	B-T082
and	O
function	B-T038
of	O
proteins	B-T103
and	O
lipids	B-T103
,	O
and	O
induces	O
glyc	O
##oxidation	O
and	O
peroxidation	O
.	O
therefore	O
,	O
hyperglycemia	B-T038
causes	O
auto	O
-	O
oxidation	O
of	O
glucose	B-T103
,	O
glycation	O
of	O
proteins	B-T103
,	O
and	O
activation	O
of	O
poly	O
##ol	O
mechanism	O
.	O
overproduction	O
of	O
intracellular	B-T082
reactive	B-T103
oxygen	I-T103
species	I-T103
contributes	O
to	O
several	O
microvascular	O
and	O
macro	O
##vascular	O
complications	B-T038
of	O
dn	B-T038
.	O
on	O
the	O
other	O
hand	O
,	O
reactive	B-T103
oxygen	I-T103
species	I-T103
modulates	B-T082
signaling	B-T038
cascade	I-T038
of	O
immune	B-T103
factors	I-T103
.	O
an	O
increase	O
in	O
reactive	B-T103
oxygen	I-T103
species	I-T103
can	O
increase	O
the	O
production	O
of	O
inflammatory	O
cytokines	B-T103
,	O
and	O
likewise	O
,	O
an	O
increase	O
in	O
inflammatory	O
cytokines	B-T103
can	O
stimulate	O
the	O
production	O
of	O
free	B-T103
radicals	I-T103
.	O
some	O
studies	B-T062
have	O
shown	O
that	O
kidney	B-T038
inflammation	I-T038
is	O
serious	O
in	O
promoting	O
the	O
development	O
and	O
progression	O
of	O
dn	B-T038
.	O
inflammatory	O
factors	O
which	O
are	O
activated	O
by	O
the	O
metabolic	O
,	O
biochemical	O
,	O
and	O
hemodynamic	B-T038
der	O
##angements	O
are	O
known	O
to	O
exist	O
in	O
the	O
diabetic	B-T038
kidney	I-T038
.	O
this	O
review	B-T170
discusses	O
facts	O
for	O
oxidative	B-T038
stress	I-T038
and	O
inflammatory	O
factors	O
in	O
dn	B-T038
and	O
encompasses	O
the	O
role	O
of	O
immune	B-T017
and	O
inflammatory	B-T017
cells	I-T017
,	O
inflammatory	O
cytokines	B-T103
,	O
and	O
stress	B-T038
oxidative	I-T038
factors	O
.	O

absorption	O
characteristics	O
of	O
vertebrate	B-T204
non	O
-	O
visual	O
ops	B-T103
##in	I-T103
,	I-T103
opn	I-T103
##3	I-T103
most	O
animals	B-T204
possess	O
multiple	O
ops	B-T103
##ins	I-T103
which	O
sense	B-T038
light	O
for	O
visual	O
and	O
non	O
-	O
visual	B-T038
functions	I-T038
.	O
here	O
,	O
we	O
show	O
spectral	O
characteristics	O
of	O
non	O
-	O
visual	O
ops	B-T103
##ins	I-T103
,	O
vertebrate	B-T204
opn	B-T103
##3	I-T103
##s	I-T103
,	O
which	O
are	O
widely	O
distributed	O
among	O
vertebrates	B-T204
.	O
we	O
successfully	O
expressed	B-T038
zebrafish	B-T204
opn	B-T103
##3	I-T103
in	O
mammalian	B-T204
cultured	B-T017
cells	I-T017
and	O
measured	O
its	O
absorption	B-T058
spectrum	I-T058
spectroscopic	I-T058
##ally	I-T058
.	O
when	O
incubated	B-T058
with	O
11	B-T103
-	I-T103
cis	I-T103
retinal	I-T103
,	O
zebrafish	B-T204
opn	B-T103
##3	I-T103
formed	O
a	O
blue	B-T103
-	I-T103
sensitive	I-T103
photop	I-T103
##igm	I-T103
##ent	I-T103
with	O
an	O
absorption	B-T038
maximum	O
around	O
46	O
##5	O
nm	O
.	O
the	O
opn	B-T103
##3	I-T103
converts	O
to	O
an	O
all	B-T103
-	I-T103
trans	I-T103
retinal	I-T103
-	I-T103
bearing	I-T103
photop	O
##roduc	O
##t	O
with	O
an	O
absorption	B-T058
spectrum	I-T058
similar	O
to	O
the	O
dark	B-T038
state	I-T038
following	O
brief	O
blue	O
-	O
light	O
irradiation	O
.	O
the	O
photop	O
##roduc	O
##t	O
experienced	O
a	O
remarkable	O
blue	O
-	O
shift	O
,	O
with	O
changes	O
in	B-T082
position	I-T082
of	O
the	O
isos	O
##best	O
##ic	O
point	O
,	O
during	O
further	O
irradiation	O
.	O
we	O
then	O
used	O
a	O
camp	B-T103
-	O
dependent	O
luciferase	B-T103
reporter	B-T103
assay	B-T058
to	O
investigate	O
light	O
-	O
dependent	O
camp	B-T103
responses	B-T038
in	O
cultured	B-T017
cells	I-T017
expressing	B-T038
zebrafish	B-T204
,	O
puff	B-T204
##er	I-T204
##fish	I-T204
,	O
an	B-T204
##ole	I-T204
and	O
chicken	B-T204
opn	B-T103
##3	I-T103
.	O
the	O
wild	B-T017
type	I-T017
ops	B-T103
##ins	I-T103
did	O
not	O
produce	O
responses	B-T038
,	O
but	O
cells	B-T017
expressing	B-T038
chimera	O
mutants	B-T103
(	O
wt	B-T103
opn	I-T103
##3	I-T103
##s	I-T103
in	O
which	O
the	O
third	B-T082
intracellular	I-T082
loops	B-T082
were	O
replaced	O
with	O
the	O
third	B-T082
intracellular	I-T082
loop	B-T082
of	O
a	O
gs	B-T103
-	I-T103
coupled	I-T103
je	B-T204
##ll	I-T204
##y	I-T204
##fish	I-T204
ops	B-T103
##in	I-T103
)	O
displayed	O
light	O
-	O
dependent	O
changes	O
in	O
camp	B-T103
.	O
the	O
results	O
suggest	O
that	O
opn	B-T103
##3	I-T103
is	O
capable	O
of	O
activating	O
g	B-T103
protein	I-T103
(	I-T103
s	I-T103
)	I-T103
in	O
a	O
light	O
-	O
dependent	O
manner	O
.	O
finally	O
,	O
we	O
used	O
this	O
assay	B-T058
to	O
measure	O
the	O
relative	O
wavelength	O
-	O
dependent	O
response	O
of	O
cells	B-T017
expressing	B-T038
opn	B-T103
##3	I-T103
chimeras	O
to	O
multiple	O
quant	B-T170
##ally	I-T170
-	O
matched	O
stimuli	O
.	O
the	O
inferred	O
spectral	O
sensitivity	O
curve	B-T082
of	O
zebrafish	B-T204
opn	B-T103
##3	I-T103
accurately	O
matched	O
the	O
measured	O
absorption	B-T058
spectrum	I-T058
.	O
we	O
were	O
unable	O
to	O
estimate	O
the	O
spectral	O
sensitivity	O
curve	B-T082
of	O
mouse	B-T204
or	O
an	B-T204
##ole	I-T204
opn	B-T103
##3	I-T103
,	O
but	O
,	O
like	O
zebrafish	B-T204
opn	B-T103
##3	I-T103
,	O
the	O
chicken	B-T204
and	O
puff	B-T204
##er	I-T204
##fish	I-T204
opn	B-T103
##3	I-T103
-	I-T103
ji	I-T103
##l3	I-T103
chimeras	O
also	O
formed	O
blue	B-T103
-	I-T103
sensitive	I-T103
pigments	I-T103
.	O
these	O
findings	O
suggest	O
that	O
vertebrate	B-T204
opn	B-T103
##3	I-T103
##s	I-T103
may	O
form	O
blue	B-T103
-	I-T103
sensitive	I-T103
g	I-T103
protein	I-T103
-	I-T103
coupled	I-T103
pigments	I-T103
.	O
further	O
,	O
we	O
suggest	O
that	O
the	O
method	O
described	O
here	O
,	O
combining	O
a	O
camp	B-T103
-	O
dependent	O
luciferase	B-T103
reporter	B-T103
assay	B-T058
with	O
chimeric	O
ops	B-T103
##ins	I-T103
possessing	O
the	O
third	B-T082
intracellular	I-T082
loop	B-T082
of	O
je	B-T204
##ll	I-T204
##y	I-T204
##fish	I-T204
ops	B-T103
##in	I-T103
,	O
is	O
a	O
versatile	O
approach	O
for	O
estimating	O
absorption	B-T058
spectra	I-T058
of	O
ops	B-T103
##ins	I-T103
with	O
unknown	O
signaling	B-T038
cascades	I-T038
or	O
for	O
which	O
absorption	B-T058
spectra	I-T058
are	O
difficult	O
to	O
obtain	O
.	O

exploring	O
the	O
genetic	O
variability	O
in	O
water	B-T103
use	O
efficiency	O
:	O
evaluation	O
of	O
inter	O
and	O
intra	B-T204
cultivar	I-T204
genetic	O
diversity	O
in	O
grape	B-T204
##vin	I-T204
##es	I-T204
genetic	O
improvement	O
of	O
crop	B-T204
water	B-T103
use	O
efficiency	O
(	O
w	O
##ue	O
)	O
is	O
a	O
general	O
goal	O
because	O
the	O
increasing	O
water	B-T103
scarcity	O
and	O
the	O
trend	O
to	O
a	O
more	O
sustainable	O
agriculture	O
.	O
for	O
grape	B-T204
##vin	I-T204
##es	I-T204
,	O
this	O
subject	O
is	O
relevant	O
and	O
need	O
an	O
urgent	O
response	O
because	O
their	O
wide	O
distribution	O
in	O
semi	O
-	O
arid	O
areas	B-T082
.	O
new	O
cultivars	B-T204
are	O
difficult	O
to	O
introduce	O
in	O
vit	O
##icul	O
##ture	O
due	O
to	O
the	O
narrow	O
dependency	O
of	O
consumer	B-T098
appreciation	O
often	O
linked	O
to	O
a	O
certain	O
particular	O
wine	B-T168
taste	O
.	O
clones	B-T017
of	O
rep	O
##uted	O
cultivars	B-T204
would	O
presumably	O
be	O
more	O
accepted	O
but	O
little	O
is	O
known	O
on	O
the	O
intra	B-T204
-	I-T204
cultivar	I-T204
genetic	O
variability	O
of	O
the	O
w	O
##ue	O
.	O
the	O
present	O
work	O
compares	O
,	O
on	O
the	O
basis	O
of	O
two	O
field	O
assays	O
,	O
the	O
variability	O
of	O
intrinsic	O
water	B-T103
use	O
efficiency	O
(	O
w	O
##ue	O
##i	O
)	O
in	O
a	O
large	O
collection	O
of	O
cultivars	B-T204
in	O
contrast	O
with	O
a	O
collection	O
of	O
clones	B-T017
of	O
temp	B-T204
##ran	I-T204
##ill	I-T204
##o	I-T204
cultivar	I-T204
.	O
the	O
results	O
show	O
that	O
clonal	O
variability	O
of	O
w	O
##ue	O
##i	O
was	O
around	O
80	O
%	O
of	O
the	O
inter	B-T204
-	I-T204
cultivar	I-T204
,	O
thus	O
providing	O
a	O
first	O
assessment	O
on	O
the	O
opportunity	O
for	O
clonal	O
selection	O
by	O
w	O
##ue	O
.	O
plot	O
##ting	O
the	O
w	O
##ue	O
##i	O
data	O
against	O
stem	B-T204
water	B-T103
potential	O
or	O
stomatal	B-T038
conductance	I-T038
it	O
was	O
possible	B-T033
to	O
identify	O
cultivars	B-T204
and	O
clones	B-T017
out	O
of	O
the	O
confidence	O
intervals	O
of	O
this	O
linear	O
regression	O
thus	O
with	O
significantly	O
higher	O
and	O
lower	O
w	O
##ue	O
##i	O
values	O
.	O
the	O
present	O
results	O
contribute	O
to	O
open	O
the	O
expect	O
##ative	O
for	O
a	O
genetic	O
improvement	O
of	O
grape	B-T204
##vin	I-T204
##e	I-T204
w	O
##ue	O
.	O

sub	B-T033
-	I-T033
lethal	I-T033
effects	I-T033
of	O
dietary	B-T168
neon	B-T103
##ico	I-T103
##tin	I-T103
##oid	I-T103
insecticide	I-T103
exposure	O
on	O
honey	B-T204
bee	I-T204
que	I-T204
##en	I-T204
fecundity	B-T038
and	O
colony	B-T017
development	B-T038
many	O
factors	O
can	O
negatively	B-T033
affect	O
honey	B-T204
bee	I-T204
(	O
api	B-T204
##s	I-T204
mell	I-T204
##ifera	I-T204
l	I-T204
.	I-T204
)	O
health	O
including	O
the	O
pervasive	B-T082
use	O
of	O
systemic	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oid	I-T103
insecticides	I-T103
.	O
through	O
direct	O
consumption	B-T038
of	O
contaminated	O
nect	B-T103
##ar	I-T103
and	O
pollen	B-T204
from	O
treated	O
plants	B-T204
,	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oids	I-T103
can	O
affect	O
foraging	O
,	O
learning	B-T038
,	O
and	O
memory	B-T038
in	O
worker	B-T204
bees	I-T204
.	O
less	O
well	O
studied	O
are	O
the	O
potential	O
effects	O
of	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oids	I-T103
on	O
que	B-T204
##en	I-T204
bees	I-T204
,	O
which	O
may	O
be	O
exposed	O
indirectly	O
through	O
troph	O
##all	O
##axis	O
,	O
or	O
food	B-T168
-	O
sharing	O
.	O
to	O
assess	O
effects	O
on	O
que	B-T204
##en	I-T204
productivity	O
,	O
small	O
colonies	B-T017
of	O
different	O
sizes	B-T082
(	O
1500	O
,	O
3000	O
,	O
and	O
700	O
##0	O
bees	B-T204
)	O
were	O
fed	O
imid	B-T103
##aclopr	I-T103
##id	I-T103
(	O
0	O
,	O
10	O
,	O
20	O
,	O
50	O
,	O
and	O
100	O
ppb	O
)	O
in	O
syr	B-T168
##up	I-T168
for	O
three	O
weeks	O
.	O
we	O
found	O
adverse	B-T038
effects	I-T038
of	O
imid	B-T103
##aclopr	I-T103
##id	I-T103
on	O
queens	B-T204
(	O
egg	B-T038
-	I-T038
laying	I-T038
and	O
locomotor	B-T038
activity	I-T038
)	O
,	O
worker	B-T204
bees	I-T204
(	O
foraging	O
and	O
hygi	B-T091
##enic	I-T091
activities	O
)	O
,	O
and	O
colony	B-T017
development	B-T038
(	O
bro	B-T204
##od	I-T204
production	O
and	O
pollen	B-T204
stores	O
)	O
in	O
all	O
treated	O
colonies	B-T017
.	O
some	O
effects	O
were	O
less	O
evident	O
as	O
colony	B-T017
size	B-T082
increased	O
,	O
suggesting	O
that	O
larger	O
colony	B-T017
populations	B-T098
may	O
act	O
as	O
a	O
buffer	O
to	O
pesticide	O
exposure	O
.	O
this	O
study	B-T062
is	O
the	O
first	O
to	O
show	O
adverse	B-T038
effects	I-T038
of	O
imid	B-T103
##aclopr	I-T103
##id	I-T103
on	O
que	B-T204
##en	I-T204
bee	I-T204
fecundity	B-T038
and	O
behavior	O
and	O
improves	O
our	O
understanding	B-T038
of	O
how	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oids	I-T103
may	O
impair	O
short	O
-	O
term	O
colony	B-T017
functioning	O
.	O
these	O
data	O
indicate	O
that	O
risk	O
-	O
mitigation	O
efforts	O
should	O
focus	O
on	O
reducing	O
neon	B-T103
##ico	I-T103
##tin	I-T103
##oid	I-T103
exposure	O
in	O
the	O
early	O
spring	O
when	O
colonies	B-T017
are	O
smallest	O
and	O
queens	B-T204
are	O
most	O
vulnerable	O
to	O
exposure	O
.	O

expressing	O
sexuality	O
in	O
nursing	B-T092
homes	I-T092
.	O
the	O
experience	O
of	O
older	B-T098
women	I-T098
:	O
a	O
qualitative	B-T062
study	I-T062
in	O
nursing	B-T092
homes	I-T092
,	O
a	O
number	O
of	O
barriers	O
to	O
the	O
expression	O
of	O
sexuality	O
exist	O
,	O
such	O
as	O
the	O
lack	B-T033
of	I-T033
privacy	I-T033
,	O
certain	O
attitudes	B-T038
on	O
beha	O
##l	O
##f	O
of	O
the	O
staff	B-T097
and	O
the	O
family	O
,	O
the	O
lack	O
of	O
a	O
sexual	B-T098
partner	I-T098
,	O
and	O
physical	B-T033
limitations	I-T033
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
describe	O
the	O
lived	O
experience	O
of	O
sexuality	O
in	O
elderly	B-T098
spanish	I-T098
women	I-T098
residing	O
in	O
nursing	B-T092
homes	I-T092
.	O
a	O
qualitative	B-T062
phenomenological	I-T062
approach	I-T062
was	O
followed	O
.	O
data	O
were	O
collected	B-T062
over	O
an	O
18	O
-	O
month	O
period	O
between	O
2013	O
and	O
2015	O
.	O
purpose	O
##ful	O
sampling	O
was	O
conducted	O
with	O
spanish	B-T098
residents	I-T098
in	O
nursing	B-T092
homes	I-T092
in	O
mad	B-T082
##ri	I-T082
##d	I-T082
.	O
data	O
were	O
collected	O
using	O
unst	O
##ruc	O
##ture	O
##d	O
and	O
semi	O
-	O
structured	O
interviews	O
.	O
the	O
data	O
were	O
analyzed	B-T062
using	O
thematic	B-T062
analysis	I-T062
.	O
twenty	O
female	O
residents	B-T098
participated	O
.	O
three	O
main	O
themes	O
emerged	O
from	O
the	O
data	O
:	O
a	O
)	O
expressing	O
sexuality	O
,	O
b	O
)	O
sexuality	O
as	O
a	O
duty	B-T058
and	O
c	O
)	O
respect	O
##ing	O
vow	O
##s	O
.	O
female	O
residents	B-T098
reported	O
key	O
elements	O
influencing	O
how	O
they	O
manage	O
their	O
sexuality	O
in	O
nursing	B-T092
homes	I-T092
.	O
these	O
results	O
serve	O
to	O
improve	O
our	O
understanding	O
regarding	O
the	O
expression	O
of	O
sexuality	O
in	O
older	O
female	O
nursing	B-T092
home	I-T092
residents	B-T098
.	O

association	O
of	O
radio	O
##mics	O
and	O
metabolic	O
tumor	O
volumes	O
in	O
radiation	O
treatment	O
of	O
glioblastoma	B-T038
multiforme	I-T038
to	O
build	O
a	O
framework	O
for	O
investigation	B-T058
of	O
the	O
associations	O
between	O
imaging	B-T058
,	O
clinical	O
target	O
volumes	O
(	O
ct	O
##vs	O
)	O
,	O
and	O
metabolic	O
tumor	O
volumes	O
(	O
mt	O
##vs	O
)	O
features	O
for	O
better	O
understanding	O
of	O
the	O
underlying	O
information	O
in	O
the	O
ct	O
##vs	O
and	O
dependencies	O
between	O
these	O
volumes	O
.	O
high	O
-	O
throughput	O
extraction	O
of	O
imaging	B-T058
and	O
metabol	B-T091
##omic	I-T091
quantitative	O
features	O
from	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
(	O
mri	B-T058
)	O
and	O
magnetic	B-T058
resonance	I-T058
spectroscopic	I-T058
imaging	I-T058
of	O
glioblastoma	B-T038
multiforme	I-T038
(	O
gbm	B-T038
)	O
results	O
in	O
tens	O
of	O
variables	O
per	O
patient	O
.	O
in	O
radiation	O
therapy	O
of	O
gbm	B-T038
the	O
relevant	O
metabolic	O
tumor	O
volumes	O
(	O
mt	O
##vs	O
)	O
are	O
related	O
to	O
aberrant	O
levels	O
of	O
n	B-T103
-	I-T103
acetyl	I-T103
aspartate	I-T103
(	O
naa	B-T103
)	O
and	O
choline	B-T103
(	O
cho	B-T103
)	O
.	O
the	O
corresponding	O
clinical	O
target	O
volumes	O
(	O
ct	O
##vs	O
)	O
for	O
radiation	O
therapy	O
are	O
based	O
on	O
contrast	B-T058
-	I-T058
enhanced	I-T058
t1	I-T058
-	I-T058
weighted	I-T058
(	O
ce	B-T058
-	I-T058
t1	I-T058
##w	I-T058
)	O
and	O
t2	B-T058
-	I-T058
weighted	I-T058
(	I-T058
t2	I-T058
##w	I-T058
)	I-T058
/	I-T058
fluid	I-T058
-	I-T058
attenuated	I-T058
inversion	I-T058
recovery	I-T058
mri	I-T058
.	O
necrotic	B-T033
portions	I-T033
,	O
enhancing	B-T033
lesion	I-T033
,	O
and	O
edema	B-T033
were	O
manually	O
contour	O
##ed	O
on	O
ce	B-T170
-	I-T170
t1	I-T170
##w	I-T170
/	O
t2	B-T170
##w	I-T170
images	I-T170
for	O
17	O
gbm	B-T038
patients	O
.	O
clinical	O
target	O
volumes	O
and	O
mt	O
##vs	O
for	O
naa	B-T103
(	O
mt	O
##v	O
##na	O
##a	O
)	O
and	O
cho	B-T103
(	O
mt	O
##vc	O
##ho	O
)	O
were	O
constructed	O
.	O
imaging	B-T058
and	O
metabolic	B-T201
features	I-T201
related	O
to	O
size	B-T082
,	O
shape	B-T082
,	O
and	O
signal	O
intensities	O
of	O
the	O
volumes	O
were	O
extracted	O
.	O
tumors	B-T038
were	O
also	O
scored	O
categorical	O
##ly	O
for	O
10	O
semantic	O
imaging	O
traits	O
by	O
a	O
neuroradi	B-T097
##ologist	I-T097
.	O
all	O
features	O
were	O
investigated	O
for	O
redundancy	O
.	O
two	O
-	O
way	O
correlations	O
between	O
imaging	B-T170
and	O
ct	O
##vs	O
/	O
mt	O
##vs	O
features	O
were	O
visualized	O
as	O
heat	O
##map	O
##s	O
.	O
associations	O
between	O
mt	O
##v	O
##na	O
##a	O
and	O
mt	O
##vc	O
##ho	O
and	O
imaging	O
features	O
were	O
studied	O
using	O
spearman	B-T170
correlation	I-T170
.	O
forty	O
-	O
eight	O
imaging	O
features	O
were	O
extracted	O
per	O
patient	O
.	O
half	O
of	O
the	O
imaging	O
traits	O
were	O
replaced	O
with	O
automatically	O
extracted	O
continuous	O
variables	O
.	O
twenty	O
features	O
were	O
extracted	O
from	O
ct	O
##vs	O
and	O
mt	O
##vs	O
.	O
a	O
series	O
of	O
semantic	O
imaging	O
traits	O
were	O
replaced	O
with	O
automatically	O
extracted	O
continuous	O
variables	O
.	O
there	O
were	O
multiple	O
(	O
22	O
)	O
significant	O
correlations	O
of	O
imaging	O
measures	O
with	O
ct	O
##vs	O
/	O
mt	O
##v	O
##na	O
##a	O
,	O
whereas	O
there	O
were	O
only	O
6	O
with	O
ct	O
##vs	O
/	O
mt	O
##vc	O
##ho	O
.	O
a	O
framework	O
for	O
investigation	O
of	O
code	O
##pe	O
##nd	O
##encies	O
between	O
mri	B-T058
and	O
magnetic	B-T058
resonance	I-T058
spectroscopic	I-T058
imaging	I-T058
radio	O
##mic	O
features	O
and	O
ct	O
##vs	O
/	O
mt	O
##vs	O
has	O
been	O
established	O
.	O
the	O
mt	O
##v	O
for	O
naa	B-T103
was	O
found	O
to	O
be	O
closely	O
associated	O
with	O
mri	B-T058
volumes	O
,	O
whereas	O
very	O
few	O
imaging	O
features	O
were	O
related	O
to	O
mt	O
##vc	O
##ho	O
,	O
indicating	O
that	O
cho	B-T103
provides	O
additional	O
information	O
to	O
imaging	B-T058
.	O

laparoscopic	B-T058
approach	I-T058
for	O
thermo	B-T058
##ablation	I-T058
microwave	I-T058
in	O
the	O
treatment	B-T058
of	O
hepatocellular	B-T038
carcinoma	I-T038
:	O
a	O
single	O
center	O
experience	B-T038
the	O
surgical	B-T058
therapy	I-T058
of	O
choice	O
for	O
hepatocellular	B-T038
carcinoma	I-T038
(	O
hcc	B-T038
)	O
is	O
liver	B-T058
transplantation	I-T058
(	O
lt	B-T058
)	O
or	O
hepatic	B-T058
resection	I-T058
,	O
although	O
only	O
a	O
small	O
percentage	O
of	O
patients	O
can	O
undergo	O
these	O
procedures	O
.	O
microwave	B-T058
thermal	I-T058
ablation	I-T058
(	O
mw	B-T058
##ta	I-T058
)	O
can	O
be	O
an	O
effective	O
alternative	O
treatment	B-T058
for	O
hcc	B-T038
that	O
complicate	O
##s	O
a	O
cirrhotic	B-T038
liver	I-T038
disease	I-T038
,	O
either	O
as	O
a	O
final	O
procedure	O
or	O
for	O
down	B-T058
##st	I-T058
##aging	I-T058
patients	O
on	O
the	O
waiting	O
list	O
for	O
lt	B-T058
,	O
or	O
in	O
combination	O
with	O
res	B-T058
##ective	I-T058
surgery	B-T058
to	O
achieve	O
oncological	B-T038
radical	O
##ity	O
.	O
the	O
purpose	O
of	O
this	O
retrospective	B-T062
study	I-T062
was	O
to	O
evaluate	B-T058
experience	B-T038
with	O
the	O
laparoscopic	B-T058
approach	I-T058
of	O
mw	B-T058
##ta	I-T058
at	O
our	O
center	O
.	O
in	O
a	O
cohort	B-T098
of	O
35	O
consecutive	O
patients	O
undergoing	O
mw	B-T058
##ta	I-T058
with	O
laparoscopic	B-T058
approach	I-T058
between	O
january	O
,	O
2013	O
and	O
may	O
,	O
2016	O
,	O
we	O
reviewed	O
the	O
demographic	B-T062
data	I-T062
,	O
the	O
barc	B-T170
##el	I-T170
##ona	I-T170
clinic	I-T170
liver	I-T170
cancer	I-T170
stage	I-T170
,	O
the	O
severity	O
of	O
cirrhotic	B-T038
liver	I-T038
disease	I-T038
,	O
the	O
size	B-T082
of	O
the	O
ablated	B-T058
lesion	B-T033
,	O
the	O
duration	O
of	O
the	O
procedure	O
,	O
and	O
complications	O
occurring	O
within	O
90	O
days	O
of	O
surgery	B-T058
.	O
mw	B-T058
##ta	I-T058
was	O
performed	O
by	O
applying	O
one	O
to	O
three	O
hepatic	B-T082
parenchymal	B-T017
insertions	B-T058
(	O
mean	O
1	O
.	O
8	O
)	O
per	O
patient	O
.	O
the	O
mean	O
duration	O
of	O
surgery	B-T058
was	O
163	O
±	O
18	O
minutes	O
.	O
there	O
was	O
no	O
blood	B-T033
loss	I-T033
in	O
any	O
of	O
the	O
procedures	O
.	O
complete	O
necrosis	B-T038
on	O
ct	B-T058
scan	I-T058
was	O
achieved	O
in	O
26	O
/	O
35	O
patients	O
(	O
75	O
%	O
)	O
.	O
the	O
mean	O
hospital	O
stay	O
was	O
4	O
.	O
6	O
(	O
range	O
2	O
-	O
7	O
)	O
days	O
;	O
major	O
complications	O
were	O
post	O
##ablation	O
syndrome	B-T038
in	O
2	O
/	O
35	O
(	O
5	O
.	O
7	O
%	O
)	O
,	O
peritoneal	B-T031
fluid	I-T031
in	O
4	O
/	O
35	O
(	O
11	O
.	O
4	O
%	O
)	O
,	O
and	O
transient	O
jaundice	B-T038
in	O
1	O
/	O
35	O
(	O
2	O
.	O
8	O
%	O
)	O
patients	O
.	O
there	O
was	O
no	B-T033
mortality	I-T033
.	O
laparoscopic	B-T058
mw	B-T058
##ta	I-T058
is	O
a	O
safe	O
and	O
effective	O
treatment	B-T058
for	O
unresectable	B-T201
hcc	B-T038
and	O
when	O
a	O
percutaneous	B-T082
procedure	O
is	O
not	O
feasible	O
.	O

anti	O
-	O
inflammatory	O
properties	O
of	O
ment	B-T103
##hol	I-T103
and	O
ment	B-T103
##ho	I-T103
##ne	I-T103
in	O
schistosoma	B-T038
mansoni	I-T038
infection	I-T038
schistosomiasis	B-T038
is	O
a	O
parasitic	B-T038
disease	I-T038
caused	O
by	O
several	O
species	B-T170
of	O
trem	B-T204
##ato	I-T204
##de	I-T204
worms	I-T204
and	O
it	O
is	O
believed	O
that	O
more	O
than	O
261	O
million	O
people	B-T098
are	O
affected	O
worldwide	O
.	O
new	O
drug	B-T091
development	I-T091
has	O
become	O
essential	O
because	O
there	O
is	O
a	O
risk	O
of	O
the	O
parasite	B-T204
becoming	O
resistant	B-T038
to	O
pra	B-T103
##z	I-T103
##iqu	I-T103
##ant	I-T103
##el	I-T103
,	O
the	O
only	O
drug	B-T103
available	O
for	O
this	O
infection	B-T038
.	O
this	O
study	B-T062
evaluated	B-T058
parasit	O
##ological	O
,	O
immunological	O
and	O
histological	O
parameters	B-T033
in	O
mice	B-T204
infected	B-T033
with	O
schistosoma	B-T204
mansoni	I-T204
and	O
treated	B-T058
with	I-T058
an	O
herbal	B-T103
commercial	I-T103
medicine	I-T103
.	O
this	O
drug	B-T103
consists	O
of	O
ment	B-T103
##hol	I-T103
(	O
30	O
-	O
55	O
%	O
)	O
and	O
ment	B-T103
##ho	I-T103
##ne	I-T103
(	O
14	O
-	O
32	O
%	O
)	O
.	O
a	O
60	O
day	O
treatment	B-T058
regimen	I-T058
with	O
the	O
herbal	B-T103
medicine	I-T103
decreased	O
the	O
number	O
of	O
s	B-T204
.	I-T204
mansoni	I-T204
eggs	B-T204
in	O
the	O
feces	B-T031
,	O
liver	B-T017
,	O
and	O
intestine	B-T017
and	O
reduced	O
the	O
number	O
of	O
hepatic	B-T038
granulomas	I-T038
.	O
we	O
observed	O
a	O
reduction	B-T058
of	O
84	O
%	O
in	O
blood	B-T038
eosinophilia	I-T038
and	O
a	O
decrease	O
in	O
the	O
il	B-T103
-	I-T103
4	I-T103
and	O
il	B-T103
-	I-T103
10	I-T103
blood	B-T031
levels	I-T031
after	O
treatment	B-T058
.	O
therefore	O
,	O
we	O
propose	O
that	O
schistosomiasis	B-T038
treatment	B-T058
with	O
this	O
herbal	B-T103
medicine	I-T103
for	O
60	O
days	O
has	O
an	O
immunomodulatory	O
and	O
anti	O
-	O
inflammatory	O
action	O
in	O
this	O
animal	B-T204
model	I-T204
for	O
schistosomiasis	B-T038
thus	O
contributing	O
to	O
the	O
decrease	O
in	O
physi	O
##o	O
pathological	O
effects	O
caused	O
by	O
s	B-T038
.	I-T038
mansoni	I-T038
infection	I-T038
.	O

effects	O
of	O
binge	O
-	O
like	O
ethanol	O
exposure	O
during	O
adolescence	O
on	O
the	O
febrile	B-T033
response	O
in	O
rats	B-T204
ethanol	O
(	O
etoh	O
)	O
exposure	O
during	O
different	O
phases	O
of	O
life	O
may	O
increase	O
the	O
risk	B-T033
of	I-T033
infections	I-T033
and	O
cause	O
alterations	O
in	O
the	O
central	B-T022
nervous	I-T022
system	I-T022
.	O
the	O
present	O
study	O
investigated	O
the	O
effects	O
of	O
binge	O
-	O
like	O
etoh	O
exposure	O
in	O
adolescent	O
rats	B-T204
on	O
the	O
febrile	B-T033
response	O
that	O
was	O
induced	O
by	O
lipopolysaccharide	B-T103
(	O
lps	B-T103
)	O
and	O
interleukin	B-T103
-	I-T103
1β	I-T103
(	O
il	B-T103
-	I-T103
1β	I-T103
)	O
.	O
male	O
rats	B-T204
were	O
exposed	O
to	O
etoh	O
from	O
postnatal	O
days	O
25	O
to	O
38	O
in	O
a	O
binge	O
-	O
like	O
pattern	O
.	O
fever	B-T033
was	O
induced	O
by	O
lps	B-T103
(	O
5	O
and	O
50	O
μg	O
/	O
kg	O
,	O
intraperitoneally	B-T082
)	O
and	O
evaluated	O
on	O
postnatal	O
days	O
51	O
and	O
63	O
,	O
or	O
by	O
il	B-T103
-	I-T103
β	I-T103
(	O
3	O
ng	O
)	O
and	O
evaluated	O
on	O
postnatal	O
day	O
51	O
.	O
hematological	B-T091
parameters	O
,	O
the	O
status	O
of	O
peritoneal	B-T017
macrophages	I-T017
,	O
and	O
plasma	B-T031
and	O
cerebrospinal	O
il	B-T103
-	I-T103
1β	I-T103
levels	O
were	O
also	O
evaluated	O
on	O
postnatal	O
day	O
51	O
.	O
etoh	O
exposure	O
during	O
adolescence	O
did	O
not	O
alter	O
normal	B-T033
body	I-T033
temperature	I-T033
.	O
however	O
,	O
a	O
significant	O
reduction	O
in	O
the	O
febrile	B-T033
response	O
that	O
was	O
induced	O
by	O
lps	B-T103
at	O
both	O
doses	O
was	O
observed	O
on	O
postnatal	O
day	O
51	O
.	O
however	O
,	O
no	O
changes	O
in	O
the	O
febrile	B-T033
response	O
were	O
observed	O
on	O
postnatal	O
day	O
63	O
in	O
etoh	O
-	O
exposed	O
animals	B-T204
.	O
the	O
febrile	B-T033
response	O
that	O
was	O
induced	O
by	O
intracerebroventricular	B-T082
il	B-T103
-	I-T103
1β	I-T103
also	O
significantly	O
decreased	O
in	O
animals	B-T204
that	O
received	O
binge	O
-	O
like	O
etoh	O
exposure	O
during	O
adolescence	O
.	O
acute	O
oral	O
treatment	O
with	O
etoh	B-T103
24	O
h	O
prior	O
to	O
lps	B-T103
administration	B-T058
did	O
not	O
alter	O
the	O
febrile	B-T033
response	O
that	O
was	O
induced	O
by	O
lps	B-T103
.	O
binge	O
-	O
like	O
etoh	O
exposure	O
during	O
adolescence	O
did	O
not	O
alter	O
hematological	B-T091
parameters	O
or	O
the	O
number	O
or	O
viability	B-T038
of	O
peritoneal	B-T017
macrophages	I-T017
.	O
binge	O
-	O
like	O
etoh	O
exposure	O
did	O
not	O
alter	O
plasma	B-T031
il	B-T103
-	I-T103
1β	I-T103
levels	O
but	O
reduced	O
the	O
cerebrospinal	B-T031
fluid	I-T031
levels	O
of	O
this	O
cytokine	B-T103
.	O
these	O
results	O
suggest	O
that	O
binge	O
-	O
like	O
etoh	O
exposure	O
during	O
adolescence	O
causes	O
changes	O
in	O
the	O
central	B-T022
nervous	I-T022
system	I-T022
that	O
can	O
impair	O
the	O
febrile	B-T033
response	O
that	O
can	O
be	O
observed	O
after	O
the	O
cessation	O
of	O
etoh	O
exposure	O
.	O
these	O
changes	O
were	O
reversible	O
and	O
appeared	O
to	O
involve	O
the	O
lps	B-T103
/	O
il	B-T103
-	I-T103
1β	I-T103
system	O
.	O

targeting	O
accuracy	O
of	O
single	B-T082
-	I-T082
isoc	I-T082
##enter	I-T082
intensity	B-T058
-	I-T058
modulated	I-T058
radiosurgery	B-T058
for	O
multiple	O
lesions	B-T033
to	O
investigate	O
the	O
targeting	O
accuracy	O
of	O
intensity	B-T058
-	I-T058
modulated	I-T058
srs	B-T058
(	O
im	B-T058
##rs	I-T058
)	O
plans	B-T170
designed	O
to	O
simultaneously	O
treat	O
multiple	O
brain	B-T017
metastases	B-T038
with	O
a	O
single	B-T082
isoc	I-T082
##enter	I-T082
.	O
a	O
home	B-T103
-	I-T103
made	I-T103
acrylic	I-T103
phantom	O
able	O
to	O
support	O
a	O
film	O
(	O
eb	O
##t3	O
)	O
in	O
its	O
coronal	B-T082
plane	I-T082
was	O
used	O
.	O
the	O
phantom	O
was	O
ct	B-T058
scanned	I-T058
and	O
three	O
cop	O
##la	O
##nar	O
small	O
targets	O
(	O
a	O
central	B-T082
and	O
two	O
peripheral	B-T082
)	O
were	O
outlined	O
in	O
the	O
ecl	B-T058
##ips	I-T058
##e	I-T058
system	I-T058
.	O
peripheral	B-T082
targets	O
were	O
6	O
cm	O
apart	O
from	O
the	O
central	B-T082
one	O
.	O
a	O
reference	O
im	B-T058
##rs	I-T058
plan	B-T170
was	O
designed	O
to	O
simultaneously	O
treat	O
the	O
three	O
targets	O
,	O
but	O
only	O
a	O
single	B-T082
isoc	I-T082
##enter	I-T082
located	O
at	O
the	O
center	O
of	O
the	O
central	B-T082
target	O
was	O
used	O
.	O
after	O
positioning	B-T082
the	O
phantom	O
on	O
the	O
lin	B-T074
##ac	I-T074
using	O
the	O
room	B-T082
lasers	O
,	O
a	O
cbct	B-T058
scan	I-T058
was	O
acquired	O
and	O
the	O
reference	O
plan	B-T170
were	O
mapped	O
on	O
it	O
,	O
by	O
placing	O
the	O
planned	O
isoc	B-T082
##enter	I-T082
at	O
the	O
intersection	O
of	O
the	O
landmarks	O
used	O
in	O
the	O
film	O
showing	O
the	O
lin	B-T074
##ac	I-T074
isoc	B-T082
##enter	I-T082
.	O
the	O
mapped	O
plan	B-T170
was	O
then	O
recalc	O
##ulated	O
and	O
delivered	O
.	O
the	O
film	O
dose	B-T058
distribution	I-T058
was	O
derived	O
using	O
a	O
cloud	B-T170
computing	I-T170
application	I-T170
(	O
www	B-T170
.	I-T170
radio	I-T170
##ch	I-T170
##romic	I-T170
.	I-T170
com	I-T170
)	O
that	O
uses	O
a	O
triple	O
-	O
channel	O
dosimetry	B-T058
algorithm	B-T170
.	O
comparison	O
of	O
dose	B-T058
distributions	I-T058
using	O
the	O
gamma	O
index	O
(	O
5	O
%	O
/	O
1	O
mm	O
)	O
were	O
performed	O
over	O
a	O
5	O
×	O
5	O
cm	O
(	O
2	O
)	O
region	O
centered	O
over	O
each	O
target	O
.	O
2d	O
shifts	O
required	O
to	O
get	O
the	O
best	O
gamma	O
passing	O
rates	O
on	O
the	O
peripheral	B-T082
target	O
regions	O
were	O
compared	O
with	O
the	O
reported	O
ones	O
for	O
the	O
central	B-T082
target	O
.	O
the	O
experiment	B-T062
was	O
repeated	O
ten	O
times	O
in	O
different	O
sessions	B-T058
.	O
average	O
2d	O
shifts	O
required	O
to	O
achieve	O
optimal	O
gamma	O
passing	O
rates	O
(	O
99	O
%	O
,	O
97	O
%	O
,	O
99	O
%	O
)	O
were	O
0	O
.	O
7	O
mm	O
(	O
sd	O
:	O
0	O
.	O
3	O
mm	O
)	O
,	O
0	O
.	O
8	O
mm	O
(	O
sd	O
:	O
0	O
.	O
4	O
mm	O
)	O
and	O
0	O
.	O
8	O
mm	O
(	O
sd	O
:	O
0	O
.	O
3	O
mm	O
)	O
,	O
for	O
the	O
central	B-T082
and	O
the	O
two	O
peripheral	B-T082
targets	O
,	O
respectively	O
.	O
no	O
statistical	O
differences	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
were	O
found	O
for	O
targeting	O
accuracy	O
between	O
the	O
central	B-T082
and	O
the	O
two	O
peripheral	B-T082
targets	O
.	O
the	O
study	B-T062
revealed	O
a	O
targeting	O
accuracy	O
within	O
1	O
mm	O
for	O
off	O
-	O
isoc	B-T082
##enter	I-T082
targets	O
within	O
6	O
cm	O
of	O
the	O
lin	B-T074
##ac	I-T074
isoc	B-T082
##enter	I-T082
,	O
when	O
a	O
single	B-T082
-	I-T082
isoc	I-T082
##enter	I-T082
im	B-T058
##rs	I-T058
plan	B-T170
is	O
designed	O
.	O

quantifying	O
nonlinear	O
contributions	O
to	O
cortical	B-T058
responses	I-T058
evoked	I-T058
by	O
continuous	B-T058
wrist	I-T058
manipulation	I-T058
cortical	B-T058
responses	I-T058
to	O
continuous	B-T038
stimuli	I-T038
as	O
recorded	O
using	O
either	O
magnet	B-T058
##o	I-T058
-	I-T058
or	O
electroencephalography	B-T058
(	O
eeg	B-T058
)	O
have	O
shown	O
power	O
at	O
harmonic	O
##s	O
of	O
the	O
stimulated	O
frequency	O
,	O
indicating	O
nonlinear	O
behavior	O
.	O
even	O
though	O
the	O
selection	O
of	O
analysis	B-T062
techniques	O
depends	O
on	O
the	O
linearity	B-T082
of	O
the	O
system	O
under	O
study	O
,	O
the	O
importance	O
of	O
nonlinear	O
contributions	O
to	O
cortical	B-T058
responses	I-T058
has	O
not	O
been	O
formally	O
addressed	O
.	O
the	O
goal	B-T170
of	I-T170
this	I-T170
paper	I-T170
is	O
to	O
quantify	O
the	O
nonlinear	O
contributions	O
to	O
the	O
cortical	B-T058
response	I-T058
obtained	O
from	O
continuous	O
sensory	B-T058
stimulation	I-T058
.	O
eeg	B-T058
was	O
used	O
to	O
record	O
the	O
cortical	B-T058
response	I-T058
evoked	I-T058
by	O
continuous	B-T033
movement	I-T033
of	I-T033
the	I-T033
wrist	I-T033
joint	I-T033
of	O
healthy	O
subjects	O
applied	O
with	O
a	O
robotic	O
manip	O
##ulator	O
.	O
multis	O
##ine	O
stimulus	O
signals	O
(	O
i	O
.	O
e	O
.	O
,	O
the	O
sum	O
of	O
several	O
sinus	B-T082
##oids	I-T082
)	O
elicit	O
a	O
periodic	O
cortical	B-T058
response	I-T058
and	O
allow	O
to	O
assess	O
the	O
nonlinear	O
contributions	O
to	O
the	O
response	O
.	O
wrist	B-T058
dynamics	I-T058
(	O
relation	O
between	O
joint	B-T082
angle	I-T082
and	O
torque	O
)	O
were	O
successfully	O
linear	B-T082
##ized	I-T082
,	O
explaining	O
99	O
%	O
of	O
the	O
response	O
.	O
in	O
contrast	O
,	O
the	O
cortical	B-T058
response	I-T058
revealed	O
a	O
highly	O
nonlinear	O
relation	O
;	O
where	O
most	O
power	O
(	O
∼	O
80	O
%	O
)	O
occurred	O
at	O
non	O
-	O
stimulated	O
frequencies	O
.	O
moreover	O
,	O
only	O
10	O
%	O
of	O
the	O
response	O
could	O
be	O
explained	O
using	O
a	O
nonparametric	O
linear	O
model	O
.	O
these	O
results	O
indicate	O
that	O
the	O
recorded	O
evoked	B-T058
cortical	I-T058
responses	I-T058
are	O
governed	O
by	O
nonlinear	O
##ities	O
and	O
that	O
linear	B-T082
methods	O
do	O
not	O
suff	O
##ice	O
when	O
describing	O
the	O
relation	O
between	O
mechanical	O
stimulus	O
and	O
cortical	O
response	O
.	O

eliminating	O
cancer	B-T017
stem	I-T017
cells	I-T017
in	O
cml	B-T038
with	O
combination	O
transcriptional	B-T038
therapy	B-T058
leukemia	B-T038
stem	B-T017
cells	I-T017
(	O
ls	B-T017
##cs	I-T017
)	O
are	O
resistant	O
to	O
current	O
therapies	B-T058
used	O
to	O
treat	O
chronic	B-T038
myeloid	I-T038
leukemia	I-T038
(	O
cml	B-T038
)	O
.	O
abr	O
##ah	O
##am	O
et	O
al	O
.	O
(	O
2016	O
)	O
have	O
identified	O
a	O
molecular	B-T038
network	I-T038
critical	O
for	O
cml	B-T038
ls	B-T017
##c	I-T017
survival	B-T038
and	O
propose	O
that	O
simultaneously	O
targeting	O
two	O
of	O
their	O
major	O
transcriptional	B-T103
regulators	I-T103
,	O
p53	B-T017
and	O
c	B-T103
-	I-T103
myc	I-T103
,	O
may	O
facilitate	O
their	O
eradication	B-T038
.	O

the	O
impact	O
of	O
adjunctive	B-T058
guan	B-T103
##fa	I-T103
##cine	I-T103
extended	B-T103
release	I-T103
on	O
stimulant	B-T103
adherence	O
in	O
children	O
/	O
adolescents	O
with	O
attention	B-T038
-	I-T038
deficit	I-T038
/	O
hyperactivity	B-T038
disorder	I-T038
to	O
assess	O
stimulant	B-T103
adherence	O
among	O
children	O
/	O
adolescents	O
with	O
attention	B-T038
-	I-T038
deficit	I-T038
/	O
hyperactivity	B-T038
disorder	I-T038
(	O
adhd	B-T038
)	O
augmenting	B-T103
stimulants	B-T103
with	O
guan	B-T103
##fa	I-T103
##cine	I-T103
extended	I-T103
-	I-T103
release	I-T103
(	O
g	B-T103
##xr	I-T103
)	O
.	O
inclusion	O
criteria	O
:	O
6	O
-	O
17	O
years	O
,	O
≥1	O
adhd	B-T038
diagnosis	B-T033
,	O
≥1	O
long	B-T103
-	I-T103
acting	I-T103
and	O
/	O
or	O
short	B-T103
-	I-T103
acting	I-T103
stimulant	I-T103
with	O
g	B-T103
##xr	I-T103
augmentation	B-T058
.	O
modified	O
medication	O
possess	O
##ion	O
ratio	O
(	O
mmp	O
##r	O
;	O
days	O
medication	B-T058
available	O
/	O
days	O
in	O
period	O
,	O
excluding	O
medication	B-T058
hol	O
##ida	O
##ys	O
)	O
was	O
assessed	O
;	O
mmp	O
##r	O
<	O
0	O
.	O
80	O
nonadh	O
##erent	O
.	O
regression	B-T170
models	B-T170
assessed	O
change	O
in	O
mmp	O
##r	O
adjusting	O
for	O
demographic	O
and	O
clinical	O
characteristics	O
.	O
among	O
patients	O
nonadh	O
##erent	O
to	O
stimulants	B-T103
pre	O
-	O
augmentation	B-T058
(	O
n	O
=	O
165	O
)	O
,	O
unadjusted	O
mean	O
(	O
sd	O
)	O
pre	O
-	O
and	O
post	O
-	O
stimulant	B-T103
mmp	O
##rs	O
were	O
0	O
.	O
68	O
(	O
0	O
.	O
11	O
)	O
and	O
0	O
.	O
87	O
(	O
0	O
.	O
16	O
)	O
.	O
adjusted	O
mean	O
change	O
in	O
mmp	O
##r	O
was	O
0	O
.	O
20	O
for	O
long	B-T103
-	I-T103
acting	I-T103
versus	O
0	O
.	O
18	O
for	O
short	B-T103
-	I-T103
acting	I-T103
stimulants	I-T103
(	O
p	O
=	O
0	O
.	O
34	O
)	O
.	O
among	O
patients	O
nonadh	O
##erent	O
to	O
stimulants	B-T103
,	O
g	B-T103
##xr	I-T103
augmentation	B-T058
was	O
associated	O
with	O
increased	O
stimulant	B-T103
adherence	O
.	O

results	O
of	O
a	O
multicenter	B-T062
,	O
randomized	B-T062
,	O
controlled	B-T170
trial	I-T170
of	O
a	O
hydrogen	B-T103
peroxide	I-T103
-	O
based	O
kit	B-T074
versus	O
a	O
benzoyl	B-T103
peroxide	I-T103
-	O
based	O
kit	B-T074
in	O
mild	O
-	O
to	O
-	O
moderate	O
acne	B-T038
objective	O
:	O
to	O
evaluate	B-T058
the	O
efficacy	O
and	O
tolerability	B-T062
of	O
a	O
novel	O
hydrogen	B-T103
peroxide	I-T103
-	O
based	O
regimen	B-T058
versus	O
a	O
benzoyl	B-T103
peroxide	I-T103
-	O
based	O
regimen	B-T058
in	O
mild	O
-	O
to	O
-	O
moderate	O
acne	B-T038
.	O
methods	B-T170
:	O
in	O
this	O
eight	O
-	O
week	O
multicenter	B-T062
study	I-T062
,	O
patients	O
were	O
randomized	B-T062
to	O
either	O
a	O
hydrogen	B-T103
peroxide	I-T103
-	O
based	O
or	O
a	O
benzoyl	B-T103
peroxide	I-T103
-	O
based	O
regimen	B-T058
.	O
the	O
primary	O
outcome	O
measure	O
of	O
clinical	B-T033
response	I-T033
was	O
assessed	O
using	O
the	O
global	B-T058
acne	I-T058
grading	I-T058
system	I-T058
(	O
gag	B-T058
##s	I-T058
)	O
at	O
baseline	O
,	O
four	O
weeks	O
,	O
and	O
eight	O
weeks	O
.	O
at	O
week	O
8	O
,	O
a	O
patient	O
self	B-T170
-	I-T170
satisfaction	I-T170
questionnaire	I-T170
was	O
administered	O
.	O
investigators	B-T097
were	O
also	O
quer	B-T170
##ied	I-T170
at	O
that	O
time	O
regarding	O
assessment	B-T058
of	O
tolerability	B-T062
and	O
cosmetic	O
acceptability	O
.	O
tolerability	B-T062
was	O
also	O
measured	O
at	O
each	O
visit	B-T058
.	O
results	O
:	O
both	O
treatment	B-T058
regimens	I-T058
were	O
associated	O
with	O
improvement	O
of	O
gag	O
##s	O
score	O
at	O
week	O
8	O
compared	O
to	O
baseline	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
gag	O
##s	O
score	O
did	O
not	O
differ	O
significantly	O
between	O
the	O
two	O
regimens	B-T058
over	O
the	O
same	O
period	O
(	O
p	O
=	O
0	O
.	O
77	O
##65	O
)	O
.	O
no	B-T033
significant	I-T033
adverse	I-T033
events	I-T033
were	O
reported	B-T058
or	O
observed	O
in	O
either	O
treatment	B-T062
arm	I-T062
.	O
both	O
patients	O
and	O
investigators	B-T097
found	O
both	O
regimens	B-T058
to	O
be	O
similarly	O
effective	O
and	O
cosmetic	O
##ally	O
acceptable	O
.	O
conclusion	O
:	O
a	O
novel	O
hydrogen	B-T103
peroxide	I-T103
-	O
based	O
regimen	B-T058
was	O
shown	O
to	O
be	O
comparable	O
in	O
efficacy	O
,	O
safety	O
,	O
and	O
cosmetic	O
acceptability	O
to	O
a	O
benzoyl	B-T103
peroxide	I-T103
-	O
based	O
regimen	B-T058
in	O
the	O
treatment	B-T058
of	O
mild	O
-	O
to	O
-	O
moderate	O
acne	B-T038
.	O

pcv	B-T062
##m	I-T062
##z	I-T062
##m	I-T062
:	O
using	O
the	O
probabilistic	B-T062
classification	I-T062
vector	I-T062
machines	I-T062
model	I-T062
combined	I-T062
with	I-T062
a	I-T062
ze	I-T062
##r	I-T062
##ni	I-T062
##ke	I-T062
moments	I-T062
descrip	O
##tor	O
to	O
predict	O
protein	B-T038
-	I-T038
protein	I-T038
interactions	I-T038
from	O
protein	B-T082
sequences	I-T082
protein	B-T038
-	I-T038
protein	I-T038
interactions	I-T038
(	O
ppis	B-T038
)	O
are	O
essential	O
for	O
most	O
living	O
organisms	O
'	O
process	O
.	O
thus	O
,	O
detecting	O
ppis	B-T038
is	O
extremely	O
important	O
to	O
understand	O
the	O
molecular	O
mechanisms	O
of	O
biological	O
systems	O
.	O
although	O
many	O
ppis	B-T038
data	O
have	O
been	O
generated	O
by	O
high	O
-	O
throughput	O
technologies	O
for	O
a	O
variety	O
of	O
organisms	O
,	O
the	O
whole	O
inter	O
##ato	O
##m	O
is	O
still	O
far	O
from	O
complete	O
.	O
in	O
addition	O
,	O
the	O
high	O
-	O
throughput	O
technologies	O
for	O
detecting	O
ppis	B-T038
has	O
some	O
un	O
##av	O
##oid	O
##able	O
defects	O
,	O
including	O
time	O
consumption	O
,	O
high	O
cost	O
,	O
and	O
high	O
error	O
rate	O
.	O
in	O
recent	O
years	O
,	O
with	O
the	O
development	O
of	O
machine	O
learning	O
,	O
computational	B-T062
methods	I-T062
have	O
been	O
broadly	O
used	O
to	O
predict	O
ppis	B-T038
,	O
and	O
can	O
achieve	O
good	O
prediction	O
rate	O
.	O
in	O
this	O
paper	O
,	O
we	O
present	O
here	O
pcv	B-T062
##m	I-T062
##z	I-T062
##m	I-T062
,	O
a	O
computational	B-T062
method	I-T062
based	O
on	O
a	O
probabilistic	O
classification	O
vector	O
machines	O
(	O
pcv	O
##m	O
)	O
model	O
and	O
ze	B-T170
##r	I-T170
##ni	I-T170
##ke	I-T170
moments	I-T170
(	I-T170
z	I-T170
##m	I-T170
)	I-T170
descrip	I-T170
##tor	I-T170
for	O
predicting	O
the	O
ppis	B-T038
from	O
protein	B-T103
amino	B-T082
acids	I-T082
sequences	I-T082
.	O
specifically	O
,	O
a	O
ze	B-T170
##r	I-T170
##ni	I-T170
##ke	I-T170
moments	I-T170
(	I-T170
z	I-T170
##m	I-T170
)	I-T170
descrip	I-T170
##tor	I-T170
is	O
used	O
to	O
extract	O
protein	B-T103
evolutionary	O
information	O
from	O
position	O
-	O
specific	O
scoring	O
matrix	O
(	O
pss	O
##m	O
)	O
generated	O
by	O
position	B-T170
-	I-T170
specific	I-T170
iter	I-T170
##ated	I-T170
basic	I-T170
local	I-T170
alignment	I-T170
search	I-T170
tool	I-T170
(	I-T170
psi	I-T170
-	I-T170
blast	I-T170
)	I-T170
.	O
then	O
,	O
pcv	O
##m	O
classifier	O
is	O
used	O
to	O
infer	O
the	O
interactions	B-T038
among	O
protein	B-T103
.	O
when	O
performed	O
on	O
ppis	B-T038
datasets	O
of	O
yeast	B-T204
and	O
h	B-T007
.	I-T007
pylori	I-T007
,	O
the	O
proposed	O
method	O
can	O
achieve	O
the	O
average	O
prediction	O
accuracy	O
of	O
94	O
.	O
48	O
%	O
and	O
91	O
.	O
25	O
%	O
,	O
respectively	O
.	O
in	O
order	O
to	O
further	O
evaluate	O
the	O
performance	O
of	O
the	O
proposed	O
method	O
,	O
the	O
state	B-T170
-	I-T170
of	I-T170
-	I-T170
the	I-T170
-	I-T170
art	I-T170
support	O
vector	O
machines	O
(	O
svm	O
)	O
classifier	O
is	O
used	O
and	O
compares	O
with	O
the	O
pcv	O
##m	O
model	O
.	O
experimental	B-T033
results	I-T033
on	O
the	O
yeast	B-T204
dataset	O
show	O
that	O
the	O
performance	O
of	O
pcv	O
##m	O
classifier	O
is	O
better	O
than	O
that	O
of	O
svm	O
classifier	O
.	O
the	O
experimental	B-T033
results	I-T033
indicate	O
that	O
our	O
proposed	O
method	O
is	O
robust	O
,	O
powerful	O
and	O
feasible	O
,	O
which	O
can	O
be	O
used	O
as	O
a	O
helpful	O
tool	O
for	O
proteomics	B-T062
research	I-T062
.	O

crude	O
4	B-T103
-	I-T103
methyl	I-T103
##cycl	I-T103
##ohex	I-T103
##ane	I-T103
##meth	I-T103
##anol	I-T103
(	O
mch	B-T103
##m	I-T103
)	O
did	O
not	O
cause	O
skin	B-T033
irritation	I-T033
in	O
humans	B-T204
in	O
48	O
-	O
h	O
patch	B-T058
test	I-T058
crude	O
4	B-T103
-	I-T103
methyl	I-T103
##cycl	I-T103
##ohex	I-T103
##ane	I-T103
##meth	I-T103
##anol	I-T103
(	O
mch	B-T103
##m	I-T103
)	O
is	O
an	O
industrial	O
chemical	B-T103
used	O
to	O
wash	O
and	O
clean	O
coal	B-T103
.	O
on	O
january	O
9	O
##th	O
,	O
2014	O
approximately	O
10	O
,	O
000	O
gall	O
##ons	O
of	O
a	O
mixture	O
containing	O
crude	O
mch	B-T103
##m	I-T103
were	O
released	O
into	O
the	O
el	O
##k	O
river	O
near	O
char	B-T082
##les	I-T082
##ton	I-T082
,	O
west	B-T082
virgin	I-T082
##ia	I-T082
,	O
contamin	O
##ating	O
the	O
local	B-T082
water	O
supply	O
.	O
following	O
the	O
spill	O
,	O
residents	B-T098
reported	B-T058
numerous	O
health	O
complaints	O
,	O
and	O
sought	O
medical	B-T033
attention	I-T033
for	O
ail	B-T033
##ments	I-T033
including	O
rash	B-T033
##es	I-T033
and	O
itch	B-T033
##ing	I-T033
.	O
the	O
relationship	O
between	O
the	O
complaints	O
and	O
the	O
spill	O
were	O
unknown	O
,	O
as	O
such	O
symptoms	B-T033
are	O
reported	B-T058
frequently	O
in	O
the	O
background	O
.	O
in	O
this	O
study	B-T062
,	O
the	O
primary	O
irritation	B-T033
potential	O
of	O
crude	O
mch	B-T103
##m	I-T103
was	O
evaluated	O
in	O
206	O
individuals	B-T098
who	O
underwent	O
48	O
hour	O
semi	O
-	O
occluded	O
patch	B-T058
testing	I-T058
.	O
mch	B-T103
##m	I-T103
concentrations	O
assessed	O
in	O
this	O
study	B-T062
were	O
1	O
,	O
5	O
,	O
15	O
,	O
and	O
100	O
ppm	O
.	O
no	O
appreciable	O
skin	B-T201
reactions	I-T201
were	O
observed	O
in	O
individuals	B-T098
at	O
any	O
concentration	O
.	O
three	O
of	O
the	O
five	O
concentrations	O
evaluated	O
were	O
above	O
the	O
highest	O
measured	O
concentration	O
of	O
mch	B-T103
##m	I-T103
in	O
the	O
tap	B-T103
water	I-T103
of	O
residents	B-T098
in	O
west	B-T082
virgin	I-T082
##ia	I-T082
(	O
3	O
.	O
7	O
ppm	O
)	O
.	O
the	O
results	O
of	O
this	O
study	B-T062
suggest	O
that	O
crude	O
mch	B-T103
##m	I-T103
would	O
not	O
be	O
a	O
dermal	O
irr	B-T103
##itant	I-T103
for	O
the	O
vast	O
majority	O
,	O
if	O
not	O
all	O
,	O
potentially	O
exposed	O
persons	B-T098
at	O
the	O
concentrations	O
in	O
the	O
water	B-T103
reported	B-T058
after	O
the	O
spill	O
.	O

exposure	B-T033
to	I-T033
suicidal	I-T033
behaviors	I-T033
:	O
a	O
common	O
suicide	B-T033
risk	B-T033
factor	I-T033
or	O
a	O
personal	O
negative	O
life	O
event	O
?	O
numerous	O
suicide	B-T033
risk	B-T033
factors	I-T033
have	O
been	O
proposed	O
but	O
not	O
adequately	O
validated	O
for	O
epidemiology	O
,	O
treatment	B-T058
and	O
prevention	O
efforts	O
.	O
exposures	B-T033
to	I-T033
suicidal	I-T033
behaviors	I-T033
(	O
es	B-T033
##b	I-T033
)	O
,	O
from	O
family	O
and	O
friend	B-T098
suicide	B-T033
attempts	I-T033
and	O
completion	B-T033
##s	I-T033
,	O
were	O
tested	O
for	O
validity	O
as	O
a	O
suicidal	B-T033
risk	B-T033
factor	I-T033
and	O
also	O
for	O
measurement	O
and	O
construct	O
adequacy	O
.	O
an	O
anonymous	O
online	B-T170
survey	B-T170
yielded	O
71	O
##3	O
participants	B-T098
(	O
aged	O
18	O
-	O
71	O
)	O
,	O
who	O
reported	O
es	B-T033
##b	I-T033
,	O
completed	O
the	O
suicidal	B-T170
affect	I-T170
-	I-T170
behavior	I-T170
-	I-T170
cognition	I-T170
scale	I-T170
(	O
sab	B-T170
##cs	I-T170
)	O
,	O
and	O
comprised	O
a	O
broad	O
spectrum	O
on	O
those	O
variables	O
.	O
tests	B-T170
of	O
dimensionality	B-T082
and	O
internal	O
consistency	O
showed	O
the	O
four	O
es	B-T033
##b	I-T033
variables	O
(	O
attempts	B-T033
/	O
completion	B-T033
##s	I-T033
through	O
family	O
/	O
friends	B-T098
)	O
were	O
independent	O
and	O
did	O
not	O
form	O
a	O
common	O
factor	O
or	O
an	O
identifiable	O
es	B-T033
##b	I-T033
latent	O
trait	O
.	O
es	B-T033
##b	I-T033
variables	O
were	O
,	O
however	O
,	O
associated	O
with	O
demographic	B-T033
and	O
psychiatric	O
histories	O
.	O
a	O
battery	O
of	O
tests	B-T170
revealed	O
no	O
meaningful	O
associations	O
between	O
es	B-T033
##b	I-T033
and	O
total	O
suicidal	O
##ity	O
or	O
suicide	B-T033
risk	B-T033
factors	I-T033
(	O
social	O
support	O
,	O
depression	B-T038
,	O
anxiety	B-T033
,	O
stress	B-T033
,	O
satisfaction	O
with	O
life	O
and	O
emotional	B-T038
stability	I-T038
)	O
.	O
in	O
addition	O
,	O
in	O
contrast	O
to	O
previous	O
reports	B-T170
,	O
young	O
adults	O
(	O
n	O
=	O
200	O
;	O
aged	O
18	O
-	O
20	O
)	O
showed	O
no	O
increased	O
suicidal	O
##ity	O
due	O
to	O
es	B-T033
##b	I-T033
.	O
results	O
showed	O
no	O
validity	O
for	O
es	B-T033
##b	I-T033
as	O
a	O
common	O
risk	B-T033
factor	I-T033
for	O
suicidal	O
##ity	O
or	O
other	O
psychopathology	O
,	O
or	O
as	O
a	O
latent	O
trait	O
.	O
es	B-T033
##b	I-T033
showed	O
evidence	O
as	O
a	O
personal	O
negative	O
life	O
event	O
with	O
individual	B-T098
effects	O
and	O
interpretations	B-T170
.	O

simultaneously	O
targeting	O
myofibrob	B-T038
##last	I-T038
contractility	I-T038
and	O
extracellular	B-T017
matrix	I-T017
cross	O
-	O
linking	O
as	O
a	O
therapeutic	O
concept	O
in	O
airway	B-T017
fibrosis	B-T038
fibrosis	B-T038
after	O
solid	B-T058
organ	I-T058
transplantation	I-T058
is	O
considered	O
an	O
irreversible	O
process	O
and	O
remains	O
the	O
major	O
cause	O
of	O
graft	B-T038
dysfunction	I-T038
and	O
death	B-T038
with	O
limited	O
therapies	B-T058
.	O
this	O
remodeling	O
is	O
characterized	O
by	O
aberrant	O
accumulation	B-T033
of	O
contractile	B-T017
myofibroblasts	I-T017
that	O
deposit	O
excessive	O
extracellular	B-T017
matrix	I-T017
(	O
ecm	B-T017
)	O
and	O
increase	O
tissue	O
stiffness	O
.	O
studies	B-T062
demonstrate	O
,	O
however	O
,	O
that	O
a	O
stiff	B-T033
ecm	B-T017
itself	O
promotes	O
fibroblast	B-T017
-	O
to	O
-	O
myofibrob	B-T017
##last	I-T017
differentiation	B-T038
,	O
stimulating	O
further	O
ecm	B-T017
production	O
.	O
this	O
creates	O
a	O
positive	O
feedback	O
loop	O
that	O
perpet	O
##uates	O
fibrosis	B-T038
.	O
we	O
hypothesized	O
that	O
simultaneously	O
targeting	O
myofibrob	B-T038
##last	I-T038
contractility	I-T038
with	O
relaxin	B-T103
and	O
ecm	B-T017
stiffness	B-T033
with	O
lys	B-T103
##yl	I-T103
oxidase	I-T103
inhibitors	B-T103
could	O
break	O
the	O
feedback	B-T038
loop	I-T038
,	O
reversing	O
established	O
fibrosis	B-T038
.	O
to	O
test	O
this	O
,	O
we	O
used	O
the	O
orthotopic	B-T058
tracheal	I-T058
transplantation	I-T058
(	O
ot	B-T058
##t	I-T058
)	O
mouse	B-T038
model	I-T038
,	O
which	O
develops	O
robust	O
fibrotic	O
airway	B-T017
remodeling	O
.	O
mice	B-T204
with	O
established	O
fibrosis	B-T038
were	O
treated	O
with	O
saline	O
,	O
mono	B-T058
-	I-T058
,	O
or	O
combination	B-T058
therapies	I-T058
.	O
although	O
mono	B-T058
##therap	I-T058
##ies	I-T058
had	O
no	O
effect	O
,	O
combining	B-T103
these	I-T103
agents	I-T103
decreased	O
collagen	B-T103
deposition	O
and	O
promoted	O
re	B-T038
-	I-T038
epithelial	I-T038
##ization	I-T038
of	O
remod	B-T033
##eled	I-T033
airways	I-T033
.	O
relaxin	B-T103
inhibited	O
myofibrob	B-T017
##last	I-T017
differentiation	B-T038
and	O
contraction	B-T038
in	O
a	O
matrix	B-T017
-	O
stiffness	B-T033
-	O
dependent	O
manner	O
through	O
prostaglandin	B-T103
e2	I-T103
(	O
pge2	B-T103
)	O
.	O
furthermore	O
,	O
the	O
effect	O
of	O
combination	B-T058
therapy	I-T058
was	O
lost	O
in	O
pge2	B-T103
receptor	I-T103
knockout	B-T204
and	O
pge2	B-T103
-	O
inhibited	O
ot	B-T058
##t	I-T058
mice	B-T204
.	O
this	O
study	B-T062
revealed	O
the	O
important	O
synergistic	O
roles	O
of	O
cellular	B-T038
contractility	I-T038
and	O
tissue	O
stiffness	O
in	O
the	O
maintenance	O
of	O
fibrotic	O
tissue	B-T017
and	O
suggests	O
a	O
new	O
therapeutic	O
principle	O
for	O
fibrosis	B-T038
.	O

differing	O
rates	O
of	O
antibody	B-T103
acquisition	O
to	O
mer	B-T204
##ozoite	I-T204
antigens	B-T103
in	O
malaria	B-T038
:	O
implications	O
for	O
immunity	B-T038
and	O
surveillance	B-T058
antibodies	B-T103
play	O
a	O
key	O
role	O
in	O
acquired	B-T038
human	I-T038
immunity	I-T038
to	O
plasmodium	B-T038
falciparum	I-T038
(	I-T038
pf	I-T038
)	I-T038
malaria	I-T038
and	O
target	O
mer	B-T204
##ozoites	I-T204
to	O
reduce	O
or	O
prevent	O
blood	B-T031
-	O
stage	O
replication	B-T038
and	O
the	O
development	O
of	O
disease	B-T038
.	O
mer	B-T204
##ozoites	I-T204
present	O
a	O
complex	O
array	O
of	O
antigens	B-T103
to	O
the	O
immune	B-T022
system	I-T022
,	O
and	O
currently	O
,	O
there	O
is	O
only	O
a	O
partial	O
understanding	O
of	O
the	O
targets	O
of	O
protective	O
antibodies	B-T103
and	O
how	O
responses	B-T038
to	O
different	O
antigens	B-T103
are	O
acquired	O
and	O
boost	O
##ed	O
.	O
we	O
hypothesized	O
that	O
there	O
would	O
be	O
differences	O
in	O
the	O
rate	O
of	O
acquisition	O
of	O
antibodies	B-T103
to	O
different	O
antigens	B-T103
and	O
how	O
well	O
they	O
are	O
boost	O
##ed	O
by	O
infection	B-T038
,	O
which	O
impacts	O
the	O
acquisition	O
of	O
immunity	B-T038
.	O
we	O
examined	O
responses	B-T038
to	O
a	O
range	O
of	O
mer	B-T204
##ozoite	I-T204
antigens	B-T103
in	O
2	O
different	O
cohorts	O
of	O
children	O
and	O
adults	O
with	O
different	O
age	O
structures	O
and	O
levels	O
of	O
malaria	B-T038
exposure	O
.	O
overall	O
,	O
antibodies	B-T103
were	O
associated	O
with	O
age	O
,	O
exposure	O
,	O
and	O
active	O
infection	B-T038
,	O
and	O
the	O
repertoire	O
of	O
responses	B-T038
increased	O
with	O
age	O
and	O
active	O
infection	B-T038
.	O
however	O
,	O
rates	O
of	O
antibody	B-T103
acquisition	O
varied	O
between	O
antigens	B-T103
and	O
different	O
regions	O
within	O
an	O
antigen	B-T103
following	O
exposure	O
to	O
malaria	B-T038
,	O
supporting	O
our	O
hypothesis	O
.	O
antigen	B-T103
-	O
specific	O
responses	B-T038
could	O
be	O
broadly	O
classified	O
into	O
early	O
response	B-T038
types	O
in	O
which	O
antibodies	B-T103
were	O
acquired	O
early	O
in	O
childhood	O
exposure	O
and	O
late	O
response	B-T038
types	O
that	O
appear	O
to	O
require	O
substantially	O
more	O
exposure	O
for	O
the	O
development	O
of	O
substantial	O
levels	O
.	O
we	O
identified	O
antigen	B-T103
-	O
specific	O
responses	B-T038
that	O
were	O
effectively	O
boost	O
##ed	O
after	O
recent	O
infection	B-T038
,	O
whereas	O
other	O
responses	B-T038
were	O
not	O
.	O
these	O
findings	O
advance	O
our	O
understanding	O
of	O
the	O
acquisition	O
of	O
human	B-T204
immunity	B-T038
to	O
malaria	B-T038
and	O
are	O
relevant	O
to	O
the	O
development	O
of	O
malaria	B-T103
vaccines	I-T103
targeting	O
mer	B-T204
##ozoite	I-T204
antigens	B-T103
and	O
the	O
selection	O
of	O
antigens	B-T103
for	O
use	O
in	O
malaria	B-T038
surveillance	B-T058
.	O

predictors	O
of	O
neurologic	B-T038
and	O
nonne	B-T033
##uro	I-T033
##lo	I-T033
##gic	I-T033
death	I-T033
in	O
patients	O
with	O
brain	B-T038
metastasis	I-T038
initially	O
treated	O
with	O
up	B-T058
##front	I-T058
stereotactic	I-T058
radiosurgery	I-T058
without	O
whole	B-T058
-	I-T058
brain	I-T058
radiation	I-T058
therapy	I-T058
in	O
this	O
study	B-T062
we	O
attempted	O
to	O
discern	O
the	O
factors	O
predictive	O
of	O
neurologic	B-T038
death	I-T038
in	O
patients	O
with	O
brain	B-T038
metastasis	I-T038
treated	O
with	O
up	B-T058
##front	I-T058
stereotactic	I-T058
radiosurgery	I-T058
(	O
srs	B-T058
)	O
without	O
whole	B-T058
brain	I-T058
radiation	I-T058
therapy	I-T058
(	O
wb	B-T058
##rt	I-T058
)	O
while	O
accounting	O
for	O
the	O
competing	O
risk	O
of	O
nonne	B-T033
##uro	I-T033
##lo	I-T033
##gic	I-T033
death	I-T033
.	O
we	O
performed	O
a	O
retrospective	O
single	B-T092
-	I-T092
institution	I-T092
analysis	B-T062
of	O
patients	O
with	O
brain	B-T038
metastasis	I-T038
treated	O
with	O
up	O
##front	O
srs	B-T058
without	O
wb	B-T058
##rt	I-T058
.	O
competing	O
risks	O
analysis	O
was	O
performed	O
to	O
estimate	O
the	O
subd	O
##istribution	O
hazard	O
ratios	O
(	O
hrs	O
)	O
for	O
neurologic	B-T038
and	O
nonne	B-T033
##uro	I-T033
##lo	I-T033
##gic	I-T033
death	I-T033
for	O
predictor	O
variables	O
of	O
interest	O
.	O
of	O
73	O
##8	O
patients	O
treated	O
with	O
up	B-T058
##front	I-T058
srs	I-T058
alone	O
,	O
neurologic	B-T038
death	I-T038
occurred	O
in	O
226	O
(	O
30	O
.	O
6	O
%	O
)	O
,	O
while	O
nonne	B-T033
##uro	I-T033
##lo	I-T033
##gic	I-T033
death	I-T033
occurred	O
in	O
309	O
(	O
41	O
.	O
9	O
%	O
)	O
.	O
multivariate	O
competing	O
risks	O
analysis	O
identified	O
an	O
increased	O
hazard	O
of	O
neurologic	B-T038
death	I-T038
associated	O
with	O
diagnosis	B-T170
-	I-T170
specific	I-T170
graded	I-T170
prognostic	I-T170
assessment	I-T170
(	O
ds	B-T170
-	I-T170
gpa	I-T170
)	O
≤	O
2	O
(	O
p	O
=	O
.	O
005	O
)	O
,	O
melanoma	B-T038
histology	B-T058
(	O
p	O
=	O
.	O
009	O
)	O
,	O
and	O
increased	O
number	O
of	O
brain	B-T038
metastases	I-T038
(	O
p	O
<	O
.	O
001	O
)	O
,	O
while	O
there	O
was	O
a	O
decreased	O
hazard	O
associated	O
with	O
higher	O
srs	B-T058
dose	O
(	O
p	O
=	O
.	O
004	O
)	O
.	O
targeted	B-T103
agents	I-T103
were	O
associated	O
with	O
a	O
decreased	O
hr	O
of	O
neurologic	B-T038
death	I-T038
in	O
the	O
first	O
1	O
.	O
5	O
years	O
(	O
p	O
=	O
.	O
04	O
)	O
but	O
not	O
afterwards	O
.	O
an	O
increased	O
hazard	O
of	O
nonne	B-T033
##uro	I-T033
##lo	I-T033
##gic	I-T033
death	I-T033
was	O
seen	O
with	O
increasing	O
age	O
(	O
p	O
=	O
.	O
03	O
)	O
,	O
nonm	B-T058
##ela	I-T058
##no	I-T058
##ma	I-T058
histology	I-T058
(	O
p	O
<	O
.	O
001	O
)	O
,	O
presence	O
of	O
extracranial	B-T038
disease	I-T038
(	O
p	O
<	O
.	O
001	O
)	O
,	O
and	O
progressive	O
systemic	B-T038
disease	I-T038
(	O
p	O
=	O
.	O
004	O
)	O
.	O
melanoma	B-T038
,	O
ds	B-T170
-	I-T170
gpa	I-T170
,	O
number	O
of	O
brain	B-T038
metastases	I-T038
,	O
and	O
srs	B-T058
dose	O
are	O
predictive	O
of	O
neurologic	B-T038
death	I-T038
,	O
while	O
age	O
,	O
nonm	B-T058
##ela	I-T058
##no	I-T058
##ma	I-T058
histology	I-T058
,	O
and	O
more	O
advanced	O
systemic	B-T038
disease	I-T038
are	O
predictive	O
of	O
nonne	B-T033
##uro	I-T033
##lo	I-T033
##gic	I-T033
death	I-T033
.	O
targeted	B-T103
agents	I-T103
appear	O
to	O
delay	O
neurologic	B-T038
death	I-T038
.	O

dry	B-T033
skin	I-T033
conditions	O
are	O
related	O
to	O
the	O
recovery	O
rate	O
of	O
skin	O
temperature	O
after	O
cold	O
stress	B-T038
rather	O
than	O
to	O
blood	B-T038
flow	I-T038
cutaneous	B-T082
blood	B-T038
flow	I-T038
plays	O
an	O
important	O
role	O
in	O
the	O
thermoreg	B-T038
##ulation	I-T038
,	O
oxygen	B-T201
supply	I-T201
,	O
and	O
nutritional	B-T058
support	I-T058
necessary	O
to	O
maintain	O
the	O
skin	B-T022
.	O
however	O
,	O
there	O
is	O
little	O
evidence	O
for	O
a	O
link	O
between	O
blood	B-T038
flow	I-T038
and	O
skin	B-T038
physiology	I-T038
.	O
therefore	O
,	O
we	O
conducted	O
surveys	B-T170
of	O
healthy	B-T098
volunteers	I-T098
to	O
determine	O
the	O
relationship	O
(	O
s	O
)	O
between	O
dry	B-T033
skin	I-T033
properties	O
and	O
cutaneous	B-T082
vascular	B-T201
function	I-T201
.	O
water	O
content	O
of	O
the	O
stratum	B-T017
corneum	I-T017
,	O
trans	B-T033
##epid	I-T033
##ermal	I-T033
water	I-T033
loss	I-T033
,	O
and	O
visual	O
dry	O
##ness	O
score	O
were	O
investigated	O
as	O
dry	B-T033
skin	I-T033
parameters	B-T033
.	O
cutaneous	B-T082
blood	B-T038
flow	I-T038
in	O
the	O
resting	B-T033
state	I-T033
,	O
the	O
recovery	O
rate	O
(	O
rr	O
)	O
of	O
skin	O
temperature	O
on	O
the	O
hand	B-T017
after	O
a	O
cold	B-T058
-	I-T058
stress	I-T058
test	I-T058
,	O
and	O
the	O
responsiveness	O
of	O
facial	B-T017
skin	I-T017
blood	B-T038
flow	I-T038
to	O
local	B-T058
cooling	I-T058
were	O
examined	B-T033
as	O
indices	B-T170
of	O
cutaneous	B-T082
vascular	B-T201
functions	I-T201
.	O
the	O
relationships	O
between	O
dry	B-T033
skin	I-T033
parameters	B-T033
and	O
cutaneous	B-T082
vascular	B-T201
functions	I-T201
were	O
assessed	O
.	O
the	O
rr	O
correlated	O
negatively	O
with	O
the	O
visual	O
dry	O
##ness	O
score	O
of	O
skin	B-T022
on	O
the	O
leg	B-T017
but	O
correlated	O
positively	O
with	O
water	O
content	O
of	O
the	O
stratum	B-T017
corneum	I-T017
on	O
the	O
arm	O
.	O
no	O
significant	O
correlation	O
between	O
the	O
resting	B-T033
state	I-T033
of	O
blood	B-T038
flow	I-T038
and	O
dry	B-T033
skin	I-T033
parameters	B-T033
was	O
observed	O
.	O
in	O
both	O
the	O
face	B-T082
and	O
the	O
body	B-T204
,	O
deterioration	O
in	O
skin	B-T033
dry	I-T033
##ness	I-T033
from	O
summer	O
to	O
winter	O
was	O
significant	O
in	O
subjects	O
with	O
low	O
rr	O
.	O
the	O
rr	O
correlated	O
well	O
with	O
the	O
responsiveness	O
of	O
facial	B-T017
skin	I-T017
blood	B-T038
flow	I-T038
to	O
local	B-T058
cooling	I-T058
,	O
indicating	B-T033
that	O
the	O
rr	O
affects	O
systemic	O
dry	B-T033
skin	I-T033
conditions	O
.	O
these	O
results	O
suggest	O
that	O
the	O
rr	O
but	O
not	O
blood	B-T038
flow	I-T038
at	O
the	O
resting	B-T033
state	I-T033
is	O
associated	O
with	O
dry	B-T033
skin	I-T033
conditions	O
and	O
is	O
involved	O
in	O
skin	O
homeostasis	B-T038
during	O
seasonal	O
environmental	O
changes	O
.	O

protective	O
effects	O
of	O
dip	B-T103
##eptidyl	I-T103
peptidase	I-T103
-	I-T103
4	I-T103
inhibitors	I-T103
on	O
progression	B-T038
of	O
diabetic	B-T038
retinopathy	I-T038
in	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
to	O
investigate	O
the	O
effects	O
of	O
dip	B-T103
##eptidyl	I-T103
peptidase	I-T103
-	I-T103
4	I-T103
inhibitors	I-T103
(	O
dpp	B-T103
##4	I-T103
)	O
on	O
the	O
progression	B-T038
of	O
diabetic	B-T038
retinopathy	I-T038
(	O
dr	B-T038
)	O
in	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
based	O
on	O
the	O
dr	B-T038
severity	O
scale	O
.	O
the	O
medical	B-T170
records	I-T170
of	O
82	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
enrolled	O
from	O
2005	O
to	O
2015	O
were	O
retrospectively	O
reviewed	O
.	O
fundus	B-T058
photographs	I-T058
were	O
graded	B-T170
using	O
early	B-T170
treatment	I-T170
diabetic	I-T170
retinopathy	I-T170
study	I-T170
methods	I-T170
.	O
the	O
associations	O
between	O
baseline	O
risk	B-T033
factors	I-T033
and	O
progression	B-T038
of	O
dr	B-T038
were	O
investigated	O
.	O
seven	O
of	O
28	O
patients	O
treated	O
with	O
dpp	B-T103
##4	I-T103
inhibitors	I-T103
and	O
26	O
of	O
54	O
treated	O
with	O
other	O
hypoglycemic	B-T103
agents	I-T103
showed	O
progression	B-T038
of	O
retinopathy	B-T038
,	O
defined	O
as	O
one	O
or	O
more	O
steps	O
on	O
the	O
early	O
treatment	O
diabetic	O
retinopathy	O
study	O
scale	O
(	O
p	O
=	O
0	O
.	O
043	O
)	O
.	O
only	O
treatment	O
with	O
dpp	B-T103
##4	I-T103
inhibitors	I-T103
significantly	O
reduced	O
the	O
progression	B-T038
of	O
dr	B-T038
in	O
patients	O
after	O
propensity	O
score	O
matching	O
(	O
p	O
=	O
0	O
.	O
009	O
)	O
.	O
treatment	O
with	O
dpp	B-T103
##4	I-T103
inhibitors	I-T103
was	O
associated	O
with	O
a	O
lower	O
risk	O
of	O
dr	B-T038
progression	B-T038
(	O
p	O
=	O
0	O
.	O
011	O
)	O
.	O
treatment	O
with	O
dpp	B-T103
##4	I-T103
inhibitors	I-T103
was	O
the	O
independent	O
protective	O
factor	O
against	O
the	O
progression	B-T038
of	O
dr	B-T038
,	O
asi	O
##de	O
from	O
improving	B-T033
glycemic	I-T033
control	I-T033
.	O
this	O
is	O
the	O
first	O
study	O
to	O
show	O
the	O
benefits	O
of	O
dpp	B-T103
##4	I-T103
inhibitors	I-T103
in	O
reducing	O
dr	B-T038
progression	B-T038
,	O
and	O
provides	O
encouraging	O
preliminary	O
data	O
for	O
further	O
evaluation	B-T058
of	O
dpp	B-T103
##4	I-T103
inhibitors	I-T103
in	O
the	O
progression	B-T038
of	O
dr	B-T038
in	O
a	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	O
-	O
controlled	O
trial	O
.	O

surviving	O
moment	O
to	O
moment	O
:	O
the	O
experience	B-T038
of	O
living	O
in	O
a	O
state	B-T033
of	O
amb	B-T038
##ivalence	I-T038
for	O
those	O
with	O
recurrent	O
suicide	B-T033
attempts	I-T033
this	O
qualitative	B-T062
study	I-T062
aimed	O
to	O
capture	O
the	O
experience	B-T038
of	O
living	O
in	O
the	O
amb	B-T038
##ivalent	I-T038
space	I-T038
between	O
life	O
and	O
death	O
for	O
adults	O
with	O
recurrent	O
suicide	B-T033
attempts	I-T033
(	O
rsa	B-T033
)	O
.	O
it	O
sought	O
to	O
expand	B-T082
upon	O
an	O
earlier	O
study	B-T062
that	O
explored	O
the	O
processes	B-T038
involved	O
in	O
transition	O
##ing	O
away	O
from	O
rsa	B-T033
among	O
adults	O
,	O
which	O
revealed	O
that	O
occupying	O
this	O
amb	B-T038
##ivalent	I-T038
space	I-T038
is	O
a	O
crucial	O
part	O
of	O
this	O
process	O
.	O
interpret	B-T062
##ive	I-T062
phenomenological	I-T062
analysis	I-T062
(	O
ipa	B-T062
)	O
was	O
used	O
.	O
this	O
methodology	O
was	O
designed	O
to	O
explore	O
the	O
lived	B-T038
experiences	I-T038
and	O
meaning	B-T038
making	I-T038
and	O
enabled	O
interpretation	O
of	O
the	O
multidimensional	B-T082
subjective	O
experiences	B-T038
of	O
rsa	B-T033
participants	B-T098
.	O
in	O
-	O
depth	O
semi	O
-	O
structured	O
interviews	O
were	O
conducted	O
with	O
eight	O
adult	B-T098
women	I-T098
with	O
a	O
history	O
of	O
rsa	B-T033
who	O
had	O
participated	O
in	O
a	O
therapeutic	B-T058
intervention	I-T058
at	O
the	O
research	B-T062
site	B-T082
(	O
skills	O
for	O
safer	O
living	O
:	O
a	O
psychosocial	O
/	O
psycho	O
##ed	O
##uc	O
##ational	O
intervention	O
for	O
people	B-T098
with	O
recurrent	O
suicide	B-T033
attempts	I-T033
[	O
sf	O
##s	O
##l	O
/	O
pis	B-T033
##a	I-T033
]	O
)	O
.	O
the	O
six	O
stages	O
of	O
ipa	B-T062
were	O
followed	O
to	O
analyse	B-T062
the	O
interview	O
data	O
.	O
analysis	B-T062
revealed	O
the	O
super	O
##ordinate	O
theme	O
,	O
'	O
surviving	O
moment	O
to	O
moment	O
'	O
,	O
which	O
refers	O
to	O
a	O
preca	B-T033
##rio	I-T033
##us	I-T033
state	I-T033
of	O
making	B-T038
decisions	I-T038
about	O
one	O
'	O
s	O
life	O
and	O
destin	O
##y	O
on	O
a	O
moment	O
-	O
to	O
-	O
moment	O
basis	O
without	O
clear	O
commitment	O
to	O
either	O
life	O
or	O
death	O
.	O
two	O
sub	O
##ordinate	O
themes	O
were	O
identified	O
:	O
'	O
deciding	O
not	O
to	O
die	O
in	O
the	O
moment	O
'	O
when	O
the	O
participants	B-T098
were	O
more	O
invest	O
##ed	O
in	O
dying	O
than	O
living	O
and	O
'	O
deciding	O
to	O
live	O
in	O
the	O
moment	O
'	O
when	O
they	O
were	O
more	O
invest	O
##ed	O
in	O
living	O
than	O
dying	O
.	O
the	O
study	B-T062
illuminated	O
the	O
complex	O
process	O
of	O
making	B-T038
decisions	I-T038
about	O
ones	O
'	O
destin	O
##y	O
on	O
a	O
moment	O
-	O
to	O
-	O
moment	O
basis	O
.	O
it	O
revealed	O
the	O
tor	O
##ment	O
experienced	B-T038
when	O
occupying	O
this	O
state	B-T033
,	O
while	O
paradoxically	O
,	O
also	O
revealing	O
how	O
ind	B-T033
##ec	I-T033
##ision	I-T033
about	O
life	O
and	O
death	O
provided	O
a	O
life	O
##line	O
opportunity	O
for	O
those	O
with	O
rsa	B-T033
.	O
clinicians	B-T097
who	O
recognize	O
the	O
subtle	O
distinction	O
##s	O
associated	O
with	O
this	O
in	O
-	O
between	O
state	B-T033
can	O
tailor	O
their	O
interventions	B-T058
accordingly	O
.	O
surviving	O
moment	O
to	O
moment	O
is	O
characterized	O
by	O
a	O
state	B-T033
of	O
emotional	B-T033
flux	I-T033
and	O
uncertainty	B-T033
about	O
one	O
'	O
s	O
destin	O
##y	O
,	O
where	O
the	O
person	B-T098
has	O
not	O
fully	O
committed	O
to	O
either	O
life	O
or	O
death	O
.	O
within	O
this	O
state	B-T033
,	O
there	O
are	O
two	O
interl	B-T038
##ink	I-T038
##ed	I-T038
subp	I-T038
##roc	I-T038
##ess	I-T038
##es	I-T038
,	O
whereby	O
the	O
person	B-T098
is	O
lean	O
##ing	O
more	O
towards	O
death	O
or	O
life	O
.	O
a	O
critical	O
feature	O
in	O
working	O
with	O
this	O
client	O
group	O
is	O
to	O
recognize	O
their	O
ambiguity	O
and	O
the	O
fragility	B-T033
and	O
temporal	B-T038
##ity	I-T038
of	O
their	O
decisions	B-T038
about	O
their	O
destin	O
##y	O
.	O
the	O
practitioner	B-T097
has	O
an	O
opportunity	O
to	O
be	O
a	O
catalyst	O
in	O
the	O
momentum	O
towards	O
life	O
by	O
demonstrating	O
understanding	B-T038
of	O
this	O
survival	O
strugg	B-T033
##le	I-T033
and	O
tailoring	B-T058
intervention	I-T058
to	O
fit	O
with	O
the	O
nu	B-T038
##anced	I-T038
processes	I-T038
within	O
this	O
state	B-T033
.	O

short	O
-	O
term	O
variability	O
of	O
vitamin	B-T103
d	I-T103
-	O
related	O
biomarkers	B-T201
quantifying	O
the	O
variability	O
of	O
biomarkers	B-T201
is	O
important	O
,	O
as	O
high	O
within	O
-	O
person	O
variability	O
can	O
lead	O
to	O
misclass	B-T170
##ification	I-T170
of	O
individuals	B-T098
.	O
short	O
-	O
term	O
variability	O
of	O
important	O
markers	B-T201
of	O
vitamin	B-T038
d	I-T038
metabolism	I-T038
is	O
relatively	O
unknown	O
.	O
a	O
repeatability	B-T062
study	I-T062
was	O
conducted	O
in	O
160	O
atherosclerosis	B-T038
risk	O
in	O
communities	B-T098
study	I-T098
participants	I-T098
(	O
60	O
%	O
female	O
,	O
28	O
%	O
black	B-T098
,	O
mean	O
age	O
76	O
years	O
)	O
.	O
fasting	B-T033
serum	B-T031
was	O
drawn	O
at	O
2	O
time	O
points	O
,	O
a	O
median	O
of	O
6	O
(	O
range	O
3	O
-	O
13	O
)	O
weeks	O
apart	O
.	O
vitamin	B-T103
d	I-T103
binding	I-T103
protein	I-T103
(	O
vd	B-T103
##bp	I-T103
)	O
and	O
25	B-T103
-	I-T103
hydroxyvitamin	I-T103
d	I-T103
[	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
]	O
were	O
measured	O
by	O
lc	B-T058
-	I-T058
ms	I-T058
,	O
fibroblast	B-T103
growth	I-T103
factor	I-T103
(	O
fgf	B-T103
##23	I-T103
)	O
and	O
parathyroid	B-T103
hormone	I-T103
(	O
pth	B-T103
)	O
by	O
enzyme	B-T058
-	I-T058
linked	I-T058
immunoassay	I-T058
,	O
and	O
calcium	B-T103
and	O
phosphorus	B-T103
by	O
roch	B-T058
##e	I-T058
cob	I-T058
##as	I-T058
6000	I-T058
.	O
free	O
and	O
bioavailable	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
were	O
calculated	O
.	O
we	O
calculated	O
the	O
within	O
-	O
person	O
cv	O
(	O
cv	O
##w	O
)	O
,	O
intraclass	O
correlation	O
coefficient	O
(	O
icc	O
)	O
,	O
spearman	O
rank	O
correlation	O
coefficient	O
(	O
r	O
)	O
,	O
and	O
percent	O
reclass	O
##ified	O
.	O
the	O
cv	O
##w	O
was	O
lowest	O
for	O
calcium	B-T103
(	O
2	O
.	O
0	O
%	O
)	O
,	O
albumin	B-T103
(	O
3	O
.	O
6	O
%	O
)	O
,	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
(	O
6	O
.	O
9	O
%	O
)	O
,	O
vd	B-T103
##bp	I-T103
(	O
7	O
.	O
0	O
%	O
)	O
and	O
phosphorus	B-T103
(	O
7	O
.	O
6	O
%	O
)	O
;	O
intermediate	B-T033
for	O
free	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
(	O
9	O
.	O
0	O
%	O
)	O
and	O
bioavailable	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
(	O
9	O
.	O
9	O
%	O
)	O
;	O
and	O
highest	O
for	O
pth	B-T103
(	O
16	O
.	O
7	O
%	O
)	O
and	O
fgf	B-T103
##23	I-T103
(	O
17	O
.	O
8	O
%	O
)	O
.	O
reclass	B-T170
##ification	I-T170
was	O
highest	O
for	O
pth	B-T103
,	O
vd	B-T103
##bp	I-T103
,	O
and	O
phosphorus	B-T103
(	O
all	O
7	O
.	O
5	O
%	O
)	O
.	O
the	O
icc	O
and	O
r	O
were	O
highest	O
(	O
≥	O
##0	O
.	O
80	O
)	O
for	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
,	O
free	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
,	O
bioavailable	O
25	B-T103
(	I-T103
oh	I-T103
)	I-T103
d	I-T103
and	O
pth	B-T103
,	O
but	O
somewhat	O
lower	O
(	O
approximately	O
0	O
.	O
60	O
-	O
0	O
.	O
75	O
)	O
for	O
the	O
other	O
biomarkers	B-T201
.	O
six	O
-	O
week	O
short	O
-	O
term	O
variability	O
,	O
as	O
assessed	O
by	O
cv	O
##w	O
,	O
was	O
quite	O
low	O
for	O
vd	B-T103
##bp	I-T103
,	O
calcium	B-T103
and	O
phosphorus	B-T103
,	O
but	O
fairly	O
high	O
for	O
fgf	B-T103
##23	I-T103
and	O
pth	B-T103
.	O
as	O
such	O
,	O
multiple	O
measurements	O
of	O
fgf	B-T103
##23	I-T103
and	O
pth	B-T103
may	O
be	O
needed	O
to	O
minimize	O
misclass	B-T170
##ification	I-T170
.	O
these	O
results	O
provide	O
insight	B-T038
into	O
the	O
extent	O
of	O
potential	O
misclass	B-T170
##ification	I-T170
of	O
vitamin	B-T103
d	I-T103
markers	B-T201
in	O
research	B-T062
and	O
clinical	O
settings	O
.	O

co	O
-	O
delivery	O
of	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
and	O
mir	B-T103
-	I-T103
21	I-T103
antisense	I-T103
oligonucleotide	I-T103
by	O
lipid	B-T103
-	O
polymer	B-T103
hybrid	O
nanoparticles	O
and	O
effects	O
on	O
glioblastoma	B-T038
cells	B-T017
combination	B-T058
therapy	I-T058
using	O
anticancer	B-T103
drugs	I-T103
and	O
nucleic	B-T103
acid	I-T103
is	O
a	O
more	O
promising	O
strategy	O
to	O
overcome	O
multidrug	O
resistance	O
in	O
cancer	B-T038
and	O
to	O
enhance	O
apoptosis	B-T038
.	O
in	O
this	O
study	B-T062
,	O
lipid	B-T103
-	O
polymer	B-T103
hybrid	O
nanoparticles	O
(	O
lp	B-T103
##ns	I-T103
)	O
,	O
which	O
contain	O
both	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
and	O
mir	B-T103
-	I-T103
21	I-T103
antisense	I-T103
oligonucleotide	I-T103
(	O
anti	B-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
)	O
,	O
have	O
been	O
developed	O
for	O
treatment	O
of	O
glioblastoma	B-T038
,	O
the	O
most	O
aggressive	O
type	O
of	O
brain	B-T038
tumor	I-T038
.	O
prepared	O
lp	B-T103
##ns	I-T103
have	O
been	O
well	O
characterized	O
by	O
particle	O
size	O
distribution	O
and	O
zeta	O
potential	O
measurements	O
,	O
determination	O
of	O
encapsulation	O
efficiency	O
,	O
and	O
in	O
vitro	O
release	B-T062
experiments	I-T062
.	O
morphology	O
of	O
lp	B-T103
##ns	I-T103
was	O
determined	O
by	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
.	O
lp	B-T103
##ns	I-T103
had	O
a	O
hydrodynamic	O
size	B-T082
below	O
100	O
nm	O
and	O
exhibited	O
sustained	O
release	O
of	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
up	O
to	O
10	O
h	O
.	O
encapsulation	O
of	O
pem	B-T103
##etr	I-T103
##ex	I-T103
##ed	I-T103
in	O
lp	B-T103
##ns	I-T103
increased	O
cellular	B-T038
uptake	I-T038
from	O
6	O
%	O
to	O
78	O
%	O
.	O
results	O
of	O
confocal	B-T058
microscopy	I-T058
analysis	I-T058
have	O
shown	O
that	O
co	O
-	O
delivery	O
of	O
anti	B-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
significantly	O
improved	O
accumulation	B-T033
of	O
lp	B-T103
##ns	I-T103
in	O
the	O
nucleus	B-T017
of	O
u	B-T017
##87	I-T017
##mg	I-T017
cells	I-T017
.	O
nevertheless	O
,	O
more	O
effective	O
cytotoxicity	B-T038
results	O
could	O
not	O
be	O
obtained	O
due	O
to	O
low	O
concentration	O
of	O
anti	B-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
,	O
loaded	O
in	O
lp	B-T103
##ns	I-T103
.	O
we	O
expect	O
that	O
the	O
effective	O
drug	B-T074
delivery	I-T074
systems	I-T074
can	O
be	O
obtained	O
with	O
higher	O
concentration	O
of	O
anti	B-T103
-	I-T103
mir	I-T103
-	I-T103
21	I-T103
for	O
the	O
treatment	B-T058
of	O
glioblastoma	B-T038
.	O

ldl	B-T103
particle	O
number	O
and	O
size	O
and	O
cardiovascular	B-T082
risk	O
:	O
any	O
##thi	O
##ng	O
new	O
under	O
the	O
sun	O
?	O
we	O
provide	O
here	O
an	O
up	O
-	O
to	O
-	O
date	O
perspective	O
on	O
the	O
potential	O
use	O
of	O
ldl	B-T103
particle	O
number	O
and	O
size	O
as	O
complementary	O
risk	B-T033
factors	I-T033
to	O
predict	O
and	O
manage	O
cardiovascular	B-T038
disease	I-T038
(	O
cvd	B-T038
)	O
risk	O
in	O
the	O
clinical	O
real	O
##m	O
.	O
studies	B-T062
show	O
that	O
a	O
significant	O
proportion	O
of	O
the	O
population	B-T098
has	O
discordant	O
ldl	B-T103
particle	O
number	O
and	O
cholesterol	B-T103
indices	B-T170
[	O
non	B-T103
-	I-T103
hdl	I-T103
cholesterol	I-T103
(	O
hdl	B-T103
-	I-T103
c	I-T103
)	O
]	O
.	O
data	O
also	O
show	O
that	O
risk	O
prediction	O
may	O
be	O
improved	O
when	O
using	O
information	O
on	O
ldl	B-T103
particle	O
number	O
in	O
patients	O
with	O
discordant	O
particle	O
number	O
and	O
cholesterol	B-T103
data	O
.	O
yet	O
,	O
most	O
of	O
the	O
current	O
cvd	B-T038
guidelines	B-T170
conclude	O
that	O
ldl	B-T103
particle	O
number	O
is	O
not	O
superior	O
to	O
cholesterol	B-T103
indices	B-T170
,	O
including	O
non	B-T103
-	I-T103
hdl	I-T103
-	I-T103
c	I-T103
concentrations	O
,	O
in	O
predicting	O
cvd	B-T038
risk	O
.	O
ldl	B-T103
particle	O
size	O
,	O
on	O
the	O
other	O
hand	O
,	O
has	O
not	O
been	O
independently	O
associated	O
with	O
cvd	B-T038
risk	O
after	O
adjustment	O
for	O
other	O
risk	B-T033
factors	I-T033
such	O
as	O
ldl	B-T103
cholesterol	I-T103
,	O
triglycerides	B-T103
,	O
and	O
hdl	B-T103
-	I-T103
c	I-T103
and	O
that	O
routine	O
use	O
of	O
information	O
pertaining	O
to	O
particle	O
size	O
to	O
determine	O
and	O
manage	O
patients	O
'	O
risk	O
is	O
not	O
yet	O
justified	O
.	O
additional	O
studies	B-T062
are	O
required	O
to	O
sett	O
##le	O
the	O
debate	O
on	O
which	O
of	O
cholesterol	B-T103
indices	B-T170
and	O
ldl	B-T103
particle	O
number	O
is	O
the	O
best	O
predictor	O
of	O
cvd	B-T038
risk	O
,	O
and	O
if	O
such	O
measures	O
should	O
be	O
integrated	O
in	O
clinical	B-T058
practice	I-T058
.	O

a	O
longitudinal	B-T062
study	I-T062
assessing	O
child	O
##care	O
services	O
'	O
adoption	O
of	O
obesity	B-T038
prevention	O
policies	O
and	O
practices	O
despite	O
ongoing	O
investment	O
##s	O
to	O
improve	O
the	O
obes	B-T038
##ogenic	I-T038
environments	B-T082
of	O
child	O
##care	O
settings	O
,	O
little	O
is	O
known	O
regarding	O
how	O
these	O
services	O
have	O
changed	O
their	O
physical	O
activity	O
and	O
nutrition	B-T062
-	I-T062
promoting	I-T062
practices	I-T062
.	O
this	O
study	O
aims	O
to	O
describe	O
changes	O
in	O
the	O
proportion	O
of	O
australian	B-T098
child	O
##care	O
services	O
that	O
have	O
adopted	O
best	O
-	O
practice	O
healthy	B-T058
eating	I-T058
and	O
physical	O
activity	O
practices	O
between	O
2006	O
and	O
2013	O
and	O
to	O
assess	O
whether	O
adoption	O
varied	O
by	O
socio	O
-	O
economic	O
status	O
and	O
local	O
##ity	O
.	O
a	O
randomly	B-T062
selected	I-T062
sample	I-T062
of	O
nom	O
##inated	O
supervis	B-T097
##ors	I-T097
(	O
n	O
=	O
35	O
##8	O
)	O
from	O
child	O
##care	O
services	O
located	O
in	O
new	B-T082
south	I-T082
wales	I-T082
,	O
australia	B-T082
,	O
participated	O
in	O
a	O
telephone	O
survey	O
in	O
2006	O
,	O
2009	O
,	O
2010	O
and	O
2013	O
.	O
supervis	B-T097
##ors	I-T097
reported	O
on	O
their	O
service	O
'	O
s	O
adoption	O
of	O
six	O
practices	O
:	O
(	O
i	O
)	O
having	O
written	O
nutrition	B-T062
and	O
physical	O
activity	O
policies	B-T170
;	O
(	O
ii	O
)	O
staff	B-T097
trained	O
in	O
physical	O
activity	O
and	O
nutrition	B-T062
in	O
the	O
past	O
year	O
;	O
(	O
iii	O
)	O
scheduled	O
time	O
for	O
fundamental	O
movement	B-T038
skills	O
and	O
(	O
iv	O
)	O
outdoor	O
play	O
;	O
(	O
v	O
)	O
weekly	O
or	O
less	O
screen	B-T033
time	I-T033
opportun	I-T033
##iti	I-T033
##e	I-T033
s	O
;	O
and	O
(	O
vi	O
)	O
serving	O
only	O
non	B-T168
-	I-T168
sweet	I-T168
##ened	I-T168
beverages	I-T168
.	O
a	O
significant	O
increase	O
in	O
the	O
prevalence	O
of	O
services	O
adopting	O
all	O
but	O
one	O
practice	O
,	O
between	O
2006	O
and	O
2013	O
was	O
identified	O
.	O
ninety	O
one	O
percent	O
of	O
services	O
adopted	O
four	O
or	O
more	O
practices	O
,	O
a	O
significant	O
increase	O
from	O
38	O
%	O
in	O
2006	O
.	O
there	O
were	O
no	O
differences	O
in	O
the	O
proportion	O
of	O
services	O
adopting	O
each	O
practice	O
by	O
local	O
##ity	O
and	O
socio	O
-	O
economic	O
status	O
.	O
government	B-T092
investment	O
in	O
obesity	B-T038
prevention	O
programmes	O
can	O
equ	O
##itably	O
improve	O
child	O
##care	O
service	O
'	O
s	O
adoption	O
of	O
healthy	B-T058
eating	I-T058
and	O
physical	O
activity	O
promoting	O
practices	O
on	O
a	O
jur	B-T170
##isd	I-T170
##iction	I-T170
-	O
wide	O
basis	O
.	O
the	O
establishment	O
of	O
a	O
routine	O
system	O
to	O
monitor	O
adoption	O
of	O
a	O
broader	O
range	O
of	O
practices	O
by	O
child	O
##care	O
services	O
is	O
warranted	O
.	O

impact	O
of	O
an	O
educational	B-T058
intervention	I-T058
to	O
improve	B-T033
antibiotic	B-T103
prescribing	B-T058
for	O
nurse	B-T097
practitioners	I-T097
in	O
a	O
pediatric	O
urgent	B-T092
care	I-T092
center	I-T092
up	O
to	O
21	O
%	O
of	O
pediatric	B-T058
visits	I-T058
result	O
in	O
an	O
antibiotic	B-T103
prescription	B-T058
,	O
and	O
a	O
large	O
portion	O
of	O
these	O
are	O
unnecessary	O
.	O
to	O
determine	O
if	O
educational	O
sessions	O
would	O
reduce	O
inappropriate	O
antibiotic	B-T103
use	O
.	O
intervention	B-T170
study	I-T170
evaluating	B-T058
antibiotic	B-T103
prescribing	B-T058
following	O
educational	O
sessions	O
for	O
urinary	B-T038
tract	I-T038
infection	I-T038
,	O
skin	B-T038
and	O
soft	B-T038
tissue	I-T038
infection	I-T038
,	O
pharyng	B-T038
##itis	I-T038
,	O
upper	B-T038
respiratory	I-T038
tract	I-T038
infection	I-T038
,	O
acute	B-T038
otitis	I-T038
media	I-T038
,	O
and	O
acute	B-T038
bacterial	I-T038
sinusitis	I-T038
.	O
a	O
total	O
of	O
26	O
out	O
of	O
43	O
(	O
60	O
%	O
)	O
nurse	B-T097
practitioners	I-T097
in	O
4	O
urgent	B-T092
care	I-T092
centers	I-T092
were	O
enrolled	B-T058
in	O
the	O
study	B-T062
.	O
the	O
rate	O
of	O
inappropriate	O
antibiotic	B-T103
use	O
among	O
all	O
conditions	O
was	O
10	O
%	O
before	O
and	O
8	O
%	O
after	O
the	O
intervention	B-T058
(	O
p	O
=	O
.	O
02	O
)	O
.	O
a	O
decrease	O
in	O
inappropriate	O
antibiotic	B-T103
prescribing	B-T058
was	O
seen	O
after	O
the	O
educational	O
session	O
(	O
p	O
<	O
.	O
01	O
)	O
.	O
the	O
most	O
common	O
reasons	O
for	O
inappropriate	O
antibiotic	B-T103
prescribing	B-T058
were	O
too	O
broad	O
(	O
41	O
%	O
)	O
,	O
wrong	O
dosage	O
(	O
22	O
%	O
)	O
,	O
and	O
not	B-T033
indicated	I-T033
(	O
17	O
%	O
)	O
.	O
educational	O
sessions	O
led	O
to	O
improvement	O
in	O
overall	O
inappropriate	O
antibiotic	B-T103
use	O
.	O
additional	O
stew	O
##ards	O
##hip	O
interventions	B-T058
are	O
needed	O
to	O
further	O
reduce	O
unnecessary	O
antibiotic	B-T103
use	O
.	O

novel	O
biomarkers	B-T201
for	O
patients	O
with	O
idiopathic	O
acute	B-T038
anterior	I-T038
uveitis	I-T038
:	O
neutrophil	B-T017
to	O
lymphocyte	B-T017
ratio	O
and	O
platelet	B-T017
to	O
lymphocyte	B-T017
ratio	O
to	O
assess	O
the	O
levels	O
of	O
the	O
neutrophil	B-T017
to	O
lymphocyte	B-T017
ratio	O
(	O
n	B-T017
/	O
l	B-T017
)	O
and	O
the	O
platelet	B-T017
to	O
lymphocyte	B-T017
ratio	O
(	O
p	B-T017
/	O
l	B-T017
)	O
in	O
patients	O
with	O
idiopathic	O
acute	B-T038
anterior	I-T038
uveitis	I-T038
(	O
aa	B-T038
##u	I-T038
)	O
and	O
to	O
compare	O
with	O
healthy	O
controls	O
.	O
thirty	O
-	O
six	O
male	B-T098
patients	O
with	O
idiopathic	O
aa	B-T038
##u	I-T038
and	O
36	O
male	B-T098
healthy	O
subjects	B-T098
were	O
enrolled	O
in	O
this	O
retrospective	B-T062
study	I-T062
.	O
complete	O
ophthalm	B-T058
##ological	I-T058
examination	I-T058
and	O
complete	O
blood	B-T058
count	I-T058
measurements	I-T058
results	O
of	O
all	O
subjects	B-T098
were	O
evaluated	B-T058
.	O
there	O
was	O
a	O
significant	O
difference	O
in	O
n	B-T017
/	O
l	B-T017
and	O
p	B-T017
/	O
l	B-T017
between	O
idiopathic	O
aa	B-T038
##u	I-T038
and	O
control	O
groups	O
(	O
p	O
=	O
0	O
.	O
006	O
,	O
p	O
=	O
0	O
.	O
022	O
)	O
.	O
also	O
,	O
correlation	B-T062
analysis	I-T062
revealed	O
a	O
significant	O
correlation	O
between	O
c	B-T103
-	I-T103
reactive	I-T103
protein	I-T103
(	O
crp	B-T103
)	O
and	O
n	B-T017
/	O
l	B-T017
(	O
p	O
=	O
0	O
.	O
002	O
;	O
r	O
=	O
0	O
.	O
46	O
##1	O
)	O
.	O
our	O
study	B-T062
for	O
the	O
first	O
time	O
provides	O
evidence	O
of	O
n	B-T017
/	O
l	B-T017
and	O
p	B-T017
/	O
l	B-T017
may	O
be	O
useful	O
biomarkers	B-T201
in	O
patients	O
with	O
idiopathic	O
aa	B-T038
##u	I-T038
.	O
n	B-T017
/	O
l	B-T017
is	O
correlated	O
with	O
crp	B-T103
,	O
so	O
it	O
can	O
be	O
a	O
useful	O
biomarker	B-T201
to	O
predict	O
the	O
prognosis	B-T058
in	O
idiopathic	O
aa	B-T038
##u	I-T038
.	O

balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
immunized	B-T058
with	O
a	O
combination	O
of	O
virus	B-T017
-	I-T017
like	I-T017
particles	I-T017
incorporating	O
kaposi	B-T005
sarcoma	I-T005
-	I-T005
associated	I-T005
herpesvirus	I-T005
(	O
ks	B-T005
##h	I-T005
##v	I-T005
)	O
envelope	O
glycoproteins	B-T103
gp	I-T103
##k	I-T103
##8	I-T103
.	I-T103
1	I-T103
,	O
gb	B-T103
,	O
and	O
gh	B-T103
/	O
gl	B-T103
induced	O
comparable	O
serum	B-T031
neutralizing	B-T103
antibody	I-T103
activity	B-T038
to	O
uv	O
-	O
inactivated	O
ks	B-T005
##h	I-T005
##v	I-T005
infection	O
with	O
kaposi	B-T005
sarcoma	I-T005
-	I-T005
associated	I-T005
herpesvirus	I-T005
(	O
ks	B-T005
##h	I-T005
##v	I-T005
)	O
is	O
estimated	O
to	O
account	O
for	O
over	O
44	O
,	O
000	O
new	O
cases	O
of	O
kaposi	B-T038
sarcoma	I-T038
annually	O
,	O
with	O
84	O
%	O
occurring	O
in	O
africa	B-T082
,	O
where	O
the	O
virus	B-T005
is	O
endemic	O
.	O
to	O
date	O
,	O
there	O
is	O
no	O
prophylactic	B-T103
vaccine	I-T103
against	O
ks	B-T005
##h	I-T005
##v	I-T005
.	O
ks	B-T005
##h	I-T005
##v	I-T005
gp	B-T103
##k	I-T103
##8	I-T103
.	I-T103
1	I-T103
,	O
gb	B-T103
,	O
and	O
gh	B-T103
/	O
gl	B-T103
glycoproteins	I-T103
,	O
implicated	O
in	O
the	O
virus	B-T005
entry	O
into	O
host	B-T017
cells	I-T017
,	O
are	O
attractive	O
vaccine	B-T103
targets	O
for	O
eliciting	O
potent	O
neutralizing	B-T103
antibodies	I-T103
(	O
nab	B-T103
##s	I-T103
)	O
against	O
virus	B-T038
infection	I-T038
.	O
we	O
incorporated	O
gp	B-T103
##k	I-T103
##8	I-T103
.	I-T103
1	I-T103
,	O
gb	B-T103
,	O
or	O
gh	B-T103
/	O
gl	B-T103
on	O
the	O
surface	O
of	O
virus	B-T017
-	I-T017
like	I-T017
particles	I-T017
(	O
vl	B-T017
##ps	I-T017
)	O
and	O
characterized	O
these	O
vl	B-T017
##ps	I-T017
for	O
their	O
composition	O
,	O
size	O
,	O
and	O
functionality	O
.	O
to	O
determine	O
which	O
viral	B-T017
glycoprotein	I-T017
(	I-T017
s	I-T017
)	I-T017
elicit	O
the	O
most	O
effective	O
serum	B-T031
-	O
nab	B-T103
##s	I-T103
,	O
we	O
immunized	B-T058
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
with	O
gp	B-T103
##k	I-T103
##8	I-T103
.	I-T103
1	I-T103
,	O
gb	B-T103
,	O
or	O
gh	B-T103
/	O
gl	B-T103
vl	B-T017
##ps	I-T017
individually	O
or	O
in	O
combination	O
.	O
neutralizing	B-T103
antibody	I-T103
assay	O
revealed	O
that	O
sera	O
from	O
mice	B-T204
immunized	B-T058
with	O
the	O
vl	B-T017
##ps	I-T017
inhibited	O
ks	B-T005
##h	I-T005
##v	I-T005
infection	B-T038
of	O
hek	B-T017
-	I-T017
293	I-T017
cells	I-T017
in	O
a	O
dose	O
-	O
dependent	O
manner	O
.	O
as	O
a	O
single	O
immuno	B-T103
##gen	I-T103
,	O
gp	B-T103
##k	I-T103
##8	I-T103
.	I-T103
1	I-T103
vl	B-T017
##ps	I-T017
stimulated	O
comparable	O
nab	B-T103
activity	O
to	O
that	O
of	O
uv	O
-	O
inactivated	O
ks	B-T005
##h	I-T005
##v	I-T005
(	O
uv	B-T005
-	I-T005
ks	I-T005
##h	I-T005
##v	I-T005
)	O
.	O
in	O
contrast	O
,	O
uv	B-T005
-	I-T005
ks	I-T005
##h	I-T005
##v	I-T005
stimulated	O
higher	O
titers	O
of	O
nab	O
compared	O
to	O
gb	B-T103
(	O
p	O
=	O
0	O
.	O
031	O
##6	O
)	O
or	O
gh	B-T103
/	O
gl	B-T103
(	O
p	O
=	O
0	O
.	O
048	O
##6	O
)	O
.	O
mice	B-T204
immunized	B-T058
with	O
the	O
combination	O
of	O
gb	B-T103
and	O
gh	B-T103
/	O
gl	B-T103
vl	B-T017
##ps	I-T017
had	O
a	O
better	O
nab	O
response	O
than	O
those	O
immunized	B-T058
with	O
either	O
gb	B-T103
(	O
p	O
=	O
0	O
.	O
026	O
##8	O
)	O
,	O
or	O
gh	B-T103
/	O
gl	O
(	O
p	O
=	O
0	O
.	O
039	O
##7	O
)	O
as	O
single	O
vl	B-T017
##p	I-T017
immuno	B-T103
##gens	I-T103
.	O
immunization	B-T058
with	O
any	O
vl	B-T017
##p	I-T017
combination	O
stimulated	O
comparable	O
nab	B-T103
activity	O
to	O
uv	B-T005
-	I-T005
ks	I-T005
##h	I-T005
##v	I-T005
serum	B-T031
.	O
our	O
data	O
provide	O
the	O
first	O
evidence	O
that	O
ks	B-T005
##h	I-T005
##v	I-T005
gp	B-T103
##k	I-T103
##8	I-T103
.	I-T103
1	I-T103
,	O
gb	B-T103
,	O
and	O
gh	B-T103
/	O
gl	B-T103
glycoproteins	I-T103
can	O
be	O
incorporated	O
onto	O
the	O
surface	O
of	O
vl	B-T017
##ps	I-T017
and	O
used	O
as	O
prophylactic	B-T103
vaccine	I-T103
candidates	O
,	O
with	O
potential	O
to	O
prevent	O
ks	B-T005
##h	I-T005
##v	I-T005
infection	B-T038
.	O

mim	B-T005
##ivirus	I-T005
##es	I-T005
and	O
the	O
human	B-T204
interferon	B-T103
system	B-T022
:	O
viral	B-T038
ev	I-T038
##asion	I-T038
of	O
classical	O
antiviral	B-T038
activities	I-T038
,	O
but	O
inhibition	O
by	O
a	O
novel	O
interferon	B-T103
-	I-T103
β	I-T103
regulated	B-T038
immunomodulatory	B-T058
pathway	O
in	O
this	O
review	B-T170
we	O
discuss	O
the	O
role	O
of	O
mim	B-T005
##ivirus	I-T005
##es	I-T005
as	O
potential	O
human	B-T204
pathogens	O
focusing	O
on	O
clinical	O
and	O
evolutionary	B-T038
evidence	O
.	O
we	O
also	O
propose	O
a	O
novel	O
antiviral	B-T038
immunomodulatory	B-T103
pathway	O
controlled	O
by	O
interferon	B-T103
-	I-T103
β	I-T103
(	O
ifn	B-T103
-	I-T103
β	I-T103
)	O
and	O
mediated	O
by	O
immune	B-T103
-	I-T103
responsive	I-T103
gene	I-T103
1	I-T103
(	O
ir	B-T103
##g1	I-T103
)	O
and	O
it	B-T103
##aco	I-T103
##nic	I-T103
acid	I-T103
,	O
its	O
product	O
.	O
acanth	B-T005
##amoeba	I-T005
polyp	I-T005
##ha	I-T005
##ga	I-T005
mim	I-T005
##ivirus	I-T005
(	O
ap	B-T005
##mv	I-T005
)	O
was	O
isolated	O
from	O
amoeb	B-T204
##ae	I-T204
in	O
a	O
hospital	B-T092
while	O
investigating	O
a	O
pneumonia	B-T038
outbreak	O
.	O
mim	B-T005
##ivirus	I-T005
ubiquit	O
##y	O
and	O
role	O
as	O
prot	O
##ist	O
pathogens	O
are	O
well	O
understood	O
,	O
and	O
its	O
putative	B-T082
status	O
as	O
a	O
human	B-T204
pathogen	O
has	O
been	O
gaining	O
strength	O
as	O
more	O
evidence	O
is	O
being	O
found	O
.	O
the	O
study	B-T062
of	O
ap	B-T005
##mv	I-T005
and	O
human	B-T204
cells	B-T017
interaction	B-T038
revealed	O
that	O
the	O
virus	B-T005
is	O
able	O
to	O
ev	B-T038
##ade	I-T038
the	O
ifn	B-T103
system	B-T022
by	O
inhibiting	O
the	O
regulation	B-T038
of	O
interferon	B-T103
-	O
stimulated	O
genes	B-T017
,	O
suggesting	O
that	O
the	O
virus	B-T005
and	O
humans	B-T204
have	O
had	O
host	B-T038
-	I-T038
pathogen	I-T038
interactions	I-T038
.	O
it	O
also	O
has	O
shown	O
that	O
the	O
virus	B-T005
is	O
capable	O
of	O
growing	O
on	O
ifn	B-T103
-	I-T103
α2	I-T103
,	O
but	O
not	O
on	O
ifn	B-T103
-	I-T103
β	I-T103
-	O
treated	O
cells	B-T017
,	O
hin	O
##ting	O
at	O
an	O
exclusive	O
ifn	B-T103
-	I-T103
β	I-T103
antiviral	B-T038
pathway	O
.	O
our	O
hypothesis	O
based	O
on	O
preliminary	O
data	O
and	O
published	B-T170
articles	I-T170
is	O
that	O
ifn	B-T103
-	I-T103
β	I-T103
preferentially	O
upreg	B-T038
##ulates	I-T038
ir	B-T103
##g1	I-T103
in	I-T103
human	I-T103
macroph	B-T017
##agic	I-T017
cells	I-T017
,	O
which	O
in	O
turn	O
produces	O
it	B-T103
##aco	I-T103
##nic	I-T103
acid	I-T103
.	O
this	O
metabolite	B-T103
links	O
metabolism	B-T038
to	O
antiviral	B-T038
activity	I-T038
by	O
inactivating	O
the	O
virus	B-T005
,	O
in	O
a	O
novel	O
immunomodulatory	B-T058
pathway	O
relevant	O
for	O
ap	B-T005
##mv	I-T005
infections	B-T038
and	O
probably	O
to	O
other	O
infectious	B-T038
diseases	I-T038
as	O
well	O
.	O

mapping	O
circulating	O
serum	B-T031
mirnas	B-T103
to	O
their	O
immune	O
-	O
related	O
target	O
mrnas	B-T103
evidence	O
suggests	O
that	O
circulating	O
serum	B-T031
micrornas	B-T103
(	O
mirnas	B-T103
)	O
might	O
preferentially	O
target	O
immune	O
-	O
related	O
mrnas	B-T103
.	O
if	O
this	O
were	O
the	O
case	O
,	O
we	O
hypothesized	O
that	O
immune	O
-	O
related	O
mrnas	B-T103
would	O
have	O
more	O
predicted	O
serum	B-T031
mirna	B-T038
binding	I-T038
sites	B-T082
than	O
other	O
mrnas	B-T103
and	O
,	O
reciprocal	O
##ly	O
,	O
that	O
serum	B-T031
mirnas	B-T103
would	O
have	O
more	O
immune	O
-	O
related	O
mrna	B-T103
targets	O
than	O
non	O
-	O
serum	B-T031
mirnas	B-T103
.	O
we	O
developed	O
a	O
consensus	O
target	O
predictor	O
using	O
the	O
random	O
forest	O
framework	O
and	O
calculated	O
the	O
number	O
of	O
predicted	O
mirna	B-T103
-	O
mrna	B-T103
interactions	B-T038
in	O
various	O
subsets	B-T170
of	O
mirnas	B-T103
(	O
serum	B-T031
,	O
non	O
-	O
serum	B-T031
)	O
and	O
mrnas	B-T103
(	O
immune	O
related	O
,	O
non	O
##immune	O
related	O
)	O
.	O
immune	O
-	O
related	O
mrnas	B-T103
were	O
predicted	O
to	O
be	O
targeted	O
by	O
serum	B-T031
mirna	B-T103
more	O
than	O
other	O
mrnas	B-T103
.	O
moreover	O
,	O
serum	B-T031
mirnas	B-T103
were	O
predicted	O
to	O
target	O
many	O
more	O
immune	O
-	O
related	O
mrna	B-T103
targets	O
than	O
non	O
-	O
serum	B-T031
mirnas	B-T103
;	O
however	O
,	O
these	O
two	O
biases	O
in	O
immune	O
-	O
related	O
mrnas	B-T103
and	O
serum	B-T031
mirnas	B-T103
appear	O
to	O
be	O
completely	O
independent	O
.	O
immune	O
-	O
related	O
mrnas	B-T103
have	O
more	O
mirna	B-T038
binding	I-T038
sites	B-T082
in	O
general	O
,	O
not	O
just	O
for	O
serum	B-T031
mirnas	B-T103
;	O
likewise	O
,	O
serum	B-T031
mirnas	B-T103
target	O
many	O
more	O
mrnas	B-T103
than	O
non	O
-	O
serum	B-T031
mirnas	B-T103
overall	O
,	O
regardless	O
of	O
whether	O
they	O
are	O
immune	O
related	O
or	O
not	O
.	O
nevertheless	O
,	O
these	O
two	O
independent	O
phenomena	O
result	O
in	O
a	O
significantly	O
larger	O
number	O
of	O
predicted	O
serum	B-T031
mirna	B-T103
-	O
immune	O
mrna	B-T103
interactions	B-T038
than	O
would	O
be	O
expected	O
by	O
chance	O
.	O

determination	O
of	O
volatile	B-T103
organic	I-T103
compounds	I-T103
exhaled	B-T038
by	O
cell	B-T017
lines	I-T017
derived	O
from	O
hematological	B-T038
malignancies	I-T038
background	O
:	O
the	O
gas	B-T103
human	B-T204
exhaled	B-T038
contains	O
many	O
volatile	B-T103
organic	I-T103
compounds	I-T103
(	O
vocs	B-T103
)	O
,	O
which	O
is	O
related	O
to	O
the	O
health	O
status	O
of	O
body	B-T204
.	O
analysis	B-T062
of	O
vocs	B-T103
has	O
been	O
proposed	O
as	O
a	O
noninvasive	B-T170
diagnostic	B-T058
tool	I-T058
for	O
certain	O
cancers	B-T038
.	O
detailed	O
research	O
on	O
the	O
vocs	B-T103
in	O
gas	B-T103
exhaled	B-T038
by	O
cell	B-T017
can	O
characterize	O
cell	B-T170
type	I-T170
specific	O
metabolites	B-T103
and	O
may	O
be	O
helpful	O
to	O
detect	O
the	O
cancer	B-T103
markers	I-T103
in	O
clinical	O
practice	O
.	O
methods	O
:	O
solid	B-T058
phase	I-T058
microextraction	I-T058
-	O
gas	B-T058
chromatography	I-T058
-	O
mass	B-T058
spectrometry	I-T058
was	O
used	O
to	O
detect	O
vocs	B-T103
in	O
the	O
headspace	O
of	O
tissue	O
culture	O
flask	O
in	O
non	B-T038
-	I-T038
hodgkin	I-T038
'	I-T038
s	I-T038
lymphoma	I-T038
cell	B-T017
line	I-T017
je	I-T017
##ko	I-T017
and	O
acute	B-T038
mononuclear	I-T038
leukemia	I-T038
cell	B-T017
line	I-T017
sh	I-T017
##i	I-T017
-	I-T017
1	I-T017
,	O
to	O
elaborate	O
the	O
characteristic	O
gaseous	B-T103
biomarkers	B-T103
of	O
hematological	B-T038
malignancies	I-T038
.	O
while	O
macrophage	B-T017
cells	I-T017
and	O
lymphocytic	B-T017
cells	I-T017
were	O
acted	O
as	O
control	O
.	O
the	O
blank	O
group	O
was	O
only	O
the	O
rpm	B-T103
##i	I-T103
164	I-T103
##0	I-T103
medium	I-T103
containing	O
10	O
%	O
fetal	B-T103
calf	I-T103
serum	I-T103
that	O
without	O
cells	B-T017
.	O
results	O
:	O
comparing	O
to	O
control	O
group	O
,	O
the	O
concentration	O
of	O
dimethyl	B-T103
sulph	I-T103
##ide	I-T103
,	O
2	B-T103
,	I-T103
4	I-T103
-	I-T103
dimethyl	I-T103
-	I-T103
hept	I-T103
##ane	I-T103
,	O
methyl	B-T103
##benzene	I-T103
,	O
o	B-T103
-	I-T103
xyle	I-T103
##ne	I-T103
,	O
dodec	B-T103
##ane	I-T103
and	O
1	B-T103
,	I-T103
3	I-T103
-	I-T103
di	I-T103
##tert	I-T103
-	I-T103
butyl	I-T103
##benzene	I-T103
in	O
je	B-T017
##ko	I-T017
cells	I-T017
were	O
relatively	O
higher	O
,	O
while	O
the	O
concentration	O
of	O
ethanol	B-T103
,	O
hexa	B-T103
##nal	I-T103
and	O
benz	B-T103
##aldehyde	I-T103
was	O
lower	O
.	O
in	O
sh	B-T017
##i	I-T017
-	I-T017
1	I-T017
cells	I-T017
,	O
the	O
levels	O
of	O
2	B-T103
,	I-T103
4	I-T103
-	I-T103
dimethyl	I-T103
-	I-T103
hept	I-T103
##ane	I-T103
,	O
benzene	B-T103
,	O
4	B-T103
-	I-T103
methyl	I-T103
##de	I-T103
##can	I-T103
##e	I-T103
,	O
chloroform	B-T103
,	O
3	B-T103
,	I-T103
7	I-T103
-	I-T103
dimethyl	I-T103
dodec	I-T103
##ane	I-T103
and	O
hexa	B-T103
##de	I-T103
##can	I-T103
##e	I-T103
were	O
significantly	O
elevated	O
,	O
but	O
the	O
levels	O
of	O
hexa	B-T103
##no	I-T103
##l	I-T103
and	O
cyclohex	B-T103
##anol	I-T103
were	O
distinctly	O
reduced	O
.	O
conclusions	O
:	O
this	O
pilot	B-T062
study	I-T062
revealed	O
that	O
the	O
malignant	B-T038
hematological	I-T038
cells	B-T017
could	O
change	O
the	O
components	O
of	O
vocs	B-T103
in	O
the	O
cell	B-T058
culture	I-T058
flask	I-T058
in	O
a	O
cell	B-T170
type	I-T170
specific	O
pattern	O
.	O
the	O
traits	O
of	O
vocs	B-T103
in	O
our	O
setting	O
offered	O
new	O
strategy	O
for	O
hematological	B-T038
malignancies	I-T038
tracing	O
,	O
and	O
would	O
act	O
as	O
potential	O
biomarkers	B-T103
in	O
diagnosis	B-T033
of	O
malignant	O
hematological	B-T038
diseases	I-T038
.	O

synthesis	O
,	O
characterization	O
and	O
drug	B-T103
loading	O
property	O
of	O
mono	B-T103
##meth	I-T103
##oxy	I-T103
-	I-T103
poly	I-T103
(	I-T103
ethylene	I-T103
glycol	I-T103
)	I-T103
-	I-T103
poly	I-T103
(	I-T103
ε	I-T103
-	I-T103
cap	I-T103
##rolactone	I-T103
)	I-T103
-	I-T103
poly	I-T103
(	I-T103
d	I-T103
,	I-T103
l	I-T103
-	I-T103
lactide	I-T103
)	I-T103
(	I-T103
mp	I-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
)	I-T103
copolymers	I-T103
amphiphilic	B-T103
block	I-T103
copolymers	I-T103
have	O
attracted	O
a	O
great	O
deal	O
of	O
attention	O
in	O
drug	B-T074
delivery	I-T074
systems	I-T074
.	O
in	O
this	O
work	O
,	O
a	O
series	O
of	O
mono	B-T103
##meth	I-T103
##oxy	I-T103
-	I-T103
poly	I-T103
(	I-T103
ethylene	I-T103
glycol	I-T103
)	I-T103
-	I-T103
poly	I-T103
(	I-T103
ε	I-T103
-	I-T103
cap	I-T103
##rolactone	I-T103
-	I-T103
co	I-T103
-	I-T103
d	I-T103
,	I-T103
l	I-T103
-	I-T103
lactide	I-T103
)	I-T103
(	I-T103
mp	I-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
)	I-T103
copolymers	I-T103
with	O
variable	O
composition	O
of	O
poly	B-T103
(	I-T103
ε	I-T103
-	I-T103
cap	I-T103
##rolactone	I-T103
)	I-T103
(	O
pcl	B-T103
)	O
and	O
poly	B-T103
(	I-T103
d	I-T103
,	I-T103
l	I-T103
-	I-T103
lactide	I-T103
)	I-T103
(	O
pdl	B-T103
##la	I-T103
)	O
were	O
prepared	O
via	O
ring	B-T038
-	I-T038
opening	I-T038
copolymer	I-T038
##ization	I-T038
of	O
ε	B-T103
-	I-T103
cl	I-T103
and	O
d	B-T103
,	I-T103
l	I-T103
-	I-T103
la	I-T103
in	O
the	O
presence	O
of	O
mp	B-T103
##eg	I-T103
and	O
stan	B-T103
##no	I-T103
##us	I-T103
oct	I-T103
##oate	I-T103
.	O
the	O
structure	B-T082
and	O
molecular	O
weight	O
were	O
characterized	O
by	O
nuclear	O
magnetic	O
resonance	O
(	O
nmr	O
)	O
and	O
gel	B-T058
permeation	I-T058
chromatography	I-T058
(	O
gpc	B-T058
)	O
.	O
the	O
crystallinity	B-T103
,	O
hydrophilic	O
##ity	O
,	O
thermal	O
stability	O
and	O
hydrolytic	O
degradation	O
behavior	O
were	O
investigated	O
in	O
detail	O
,	O
respectively	O
.	O
the	O
results	O
showed	O
that	O
the	O
prepared	O
amphiphilic	B-T103
mp	I-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
copolymers	I-T103
have	O
adjustable	O
properties	O
by	O
altering	O
the	O
composition	O
of	O
pcl	B-T103
##a	I-T103
,	O
which	O
make	O
it	O
convenient	O
for	O
clinical	O
applications	O
.	O
besides	O
,	O
the	O
drug	B-T103
loading	O
properties	O
were	O
also	O
studied	O
.	O
docetaxel	B-T103
(	O
dt	B-T103
##x	I-T103
)	O
could	O
be	O
entrapped	O
in	O
mp	B-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
micelles	B-T103
with	O
high	O
loading	O
capacity	O
and	O
encapsulation	O
efficiency	O
.	O
and	O
all	O
lyophilized	O
dt	B-T103
##x	I-T103
-	O
loaded	O
mp	B-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
micelles	B-T103
except	O
mp	B-T103
##eg	I-T103
-	I-T103
pcl	I-T103
micelles	B-T103
were	O
readily	O
re	O
-	O
dissolved	O
in	O
normal	B-T103
saline	I-T103
at	O
25	O
°c	O
.	O
in	O
addition	O
,	O
dt	B-T103
##x	I-T103
-	O
loaded	O
mp	B-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
micelles	B-T103
showed	O
a	O
slightly	O
enhanced	O
antitumor	O
activity	O
compared	O
with	O
free	O
dt	B-T103
##x	I-T103
.	O
furthermore	O
,	O
dt	B-T103
##x	I-T103
micelles	B-T103
exhibited	O
a	O
slower	O
and	O
sustained	O
release	O
behavior	O
in	O
vitro	O
,	O
and	O
higher	O
dt	B-T103
##x	I-T103
concentration	O
and	O
longer	O
retention	O
time	O
in	B-T082
vivo	I-T082
.	O
the	O
results	O
suggested	O
that	O
the	O
mp	B-T103
##eg	I-T103
-	I-T103
pcl	I-T103
##a	I-T103
copolymer	I-T103
with	O
the	O
adjustable	O
ratio	O
of	O
pcl	B-T103
to	O
pdl	B-T103
##la	I-T103
may	O
be	O
a	O
promising	O
drug	B-T103
delivery	I-T103
carrier	I-T103
for	O
dt	B-T103
##x	I-T103
.	O

vascular	B-T017
smooth	I-T017
muscle	I-T017
cell	I-T017
peroxisome	B-T103
proliferator	I-T103
-	I-T103
activated	I-T103
receptor	I-T103
γ	I-T103
protects	O
against	O
endothelin	B-T103
-	I-T103
1	I-T103
-	O
induced	O
oxidative	B-T038
stress	I-T038
and	O
inflammation	B-T038
peroxisome	B-T103
proliferator	I-T103
-	I-T103
activated	I-T103
receptor	I-T103
γ	I-T103
(	O
pparγ	B-T103
)	O
agonists	B-T103
reduce	O
blood	B-T038
pressure	I-T038
and	O
vascular	B-T037
injury	I-T037
in	O
hypertensive	B-T033
rodents	B-T204
.	O
pparγ	B-T103
inactivation	B-T038
in	O
vascular	B-T017
smooth	I-T017
muscle	I-T017
cells	I-T017
(	O
vsmc	B-T017
)	O
enhances	O
vascular	B-T037
injury	I-T037
.	O
transgenic	B-T204
mice	I-T204
overexpressing	B-T038
endothelin	B-T103
(	I-T103
et	I-T103
)	I-T103
-	I-T103
1	I-T103
selectively	O
in	O
the	O
endothelium	B-T017
(	B-T103
ee	I-T103
##t	I-T103
-	I-T103
1	I-T103
)	I-T103
exhibit	O
endothelial	B-T038
dysfunction	I-T038
,	O
increased	O
oxidative	B-T038
stress	I-T038
and	O
inflammation	B-T038
.	O
we	O
hypothesized	O
that	O
inactivation	B-T038
of	O
the	O
pparγ	B-T017
gene	I-T017
in	O
vsmc	B-T017
(	O
sm	B-T017
##pp	I-T017
##ar	I-T017
##γ	I-T017
)	O
would	O
exagger	O
##ate	O
et	B-T103
-	I-T103
1	I-T103
-	O
induced	O
vascular	B-T037
injury	I-T037
.	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
,	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
and	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
mice	B-T204
were	O
treated	B-T033
with	O
tamoxifen	B-T103
for	O
5	O
days	O
and	O
studied	B-T062
4	O
weeks	O
later	O
.	O
sbp	B-T201
was	O
higher	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
and	O
unaffected	O
by	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
inactivation	B-T038
.	O
mesenteric	B-T017
artery	I-T017
vasodilator	B-T038
##y	I-T038
responses	O
to	O
acetylcholine	B-T103
were	O
impaired	O
only	O
in	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
.	O
n	B-T103
-	I-T103
nitro	I-T103
-	I-T103
l	I-T103
-	I-T103
arginine	I-T103
methyl	I-T103
ester	I-T103
abrogated	O
relaxation	O
responses	O
,	O
and	O
the	O
ed	B-T017
##nr	I-T017
##a	I-T017
/	O
ed	B-T017
##nr	I-T017
##b	I-T017
mrna	B-T103
ratio	O
was	O
decreased	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
,	O
which	O
could	O
indicate	O
that	O
nitric	B-T103
oxide	I-T103
production	O
was	O
enhanced	O
by	O
et	B-T103
-	I-T103
1	I-T103
stimulation	O
of	O
endothelin	B-T103
type	I-T103
b	I-T103
receptors	I-T103
.	O
mesenteric	B-T017
artery	I-T017
media	O
/	O
lumen	O
was	O
greater	O
only	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
.	O
mesenteric	B-T017
artery	I-T017
reactive	B-T103
oxygen	I-T103
species	I-T103
increased	O
in	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
and	O
were	O
further	O
enhanced	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
.	O
perivascular	B-T082
fat	B-T017
monocyte	I-T017
/	O
macrophage	B-T017
infiltration	B-T038
was	O
higher	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
and	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
and	O
increased	O
further	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
.	O
spleen	B-T017
cd11b	O
cells	O
were	O
increased	O
in	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
and	O
further	O
enhance	O
d	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
,	O
whereas	O
ly	B-T017
-	I-T017
6	I-T017
##c	I-T017
monocytes	I-T017
increased	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
and	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
but	O
not	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
.	O
spleen	B-T017
t	B-T017
regulatory	I-T017
lymphocytes	I-T017
increased	O
in	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
and	O
decreased	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
,	O
and	O
decreased	O
further	O
in	O
ee	B-T103
##t	I-T103
-	I-T103
1	I-T103
/	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
.	O
vsmc	B-T017
pparγ	B-T103
inactivation	B-T038
exagger	O
##ates	O
et	B-T103
-	I-T103
1	I-T103
-	O
induced	O
vascular	B-T037
injury	I-T037
,	O
supporting	O
a	O
protective	O
role	O
for	O
pparγ	B-T103
in	O
hypertension	B-T038
through	O
modulation	B-T082
of	O
pro	B-T103
-	I-T103
oxidant	I-T103
and	O
proinflammatory	O
pathways	B-T038
.	O
paradoxically	O
,	O
et	B-T103
-	I-T103
1	I-T103
overexpression	B-T038
preserved	O
endothelial	B-T017
function	O
in	O
sm	B-T103
##pp	I-T103
##ar	I-T103
##γ	I-T103
mice	B-T204
,	O
presumably	O
by	O
enhancing	O
nitric	B-T103
oxide	I-T103
through	O
stimulation	O
of	O
endothelin	B-T103
type	I-T103
b	I-T103
receptors	I-T103
.	O

anterior	B-T074
single	I-T074
implants	I-T074
with	O
different	O
neck	O
designs	O
:	O
5	O
year	O
results	O
of	O
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
the	O
design	O
of	O
the	O
implant	B-T074
neck	I-T074
might	O
be	O
significant	O
for	O
preservation	B-T058
of	O
marginal	B-T082
bone	B-T017
.	O
to	O
compare	O
the	O
5	O
-	O
year	O
radiographic	O
and	O
clinical	O
outcome	O
of	O
single	B-T074
anterior	I-T074
implants	I-T074
provided	O
with	O
a	O
smooth	O
neck	O
,	O
a	O
rough	O
neck	O
or	O
a	O
scal	O
##lo	O
##ped	O
rough	O
neck	O
.	O
93	O
patients	O
with	O
a	O
missing	O
anterior	B-T082
tooth	B-T017
in	O
the	O
maxilla	B-T017
were	O
included	O
.	O
at	O
random	O
,	O
patients	O
received	O
an	O
implant	B-T074
with	O
a	O
1	O
.	O
5	O
mm	O
smooth	O
neck	O
(	O
[UNK]	O
smooth	O
group	O
[UNK]	O
)	O
,	O
a	O
rough	O
neck	O
with	O
groove	O
##s	O
(	O
[UNK]	O
rough	O
group	O
[UNK]	O
)	O
or	O
a	O
scal	O
##lo	O
##ped	O
rough	O
neck	O
with	O
groove	O
##s	O
(	O
[UNK]	O
scal	O
##lo	O
##ped	O
group	O
[UNK]	O
)	O
.	O
implants	B-T074
were	O
installed	O
in	O
healed	B-T082
sites	I-T082
.	O
follow	B-T058
-	I-T058
up	I-T058
visits	I-T058
were	O
conducted	O
after	O
final	O
crown	O
delivery	O
and	O
1	O
year	O
and	O
5	O
years	O
later	O
.	O
scal	O
##lo	O
##ped	O
implants	B-T074
showed	O
significantly	O
more	O
initial	O
marginal	B-T082
bone	B-T038
resorption	I-T038
.	O
the	O
total	O
amount	O
of	O
bone	B-T038
loss	I-T038
was	O
1	O
.	O
26	O
±	O
0	O
.	O
90	O
mm	O
in	O
the	O
smooth	O
group	O
,	O
1	O
.	O
20	O
±	O
1	O
.	O
1	O
mm	O
in	O
the	O
rough	O
group	O
and	O
2	O
.	O
28	O
±	O
0	O
.	O
97	O
mm	O
in	O
the	O
scal	O
##lo	O
##ped	O
group	O
(	O
p	O
<	O
.	O
05	O
)	O
.	O
survival	O
rates	O
were	O
96	O
.	O
2	O
%	O
for	O
the	O
smooth	O
and	O
scal	O
##lo	O
##ped	O
group	O
and	O
100	O
%	O
for	O
the	O
rough	O
group	O
.	O
scal	O
##lo	O
##ped	O
implants	B-T074
showed	O
deeper	B-T082
pocket	I-T082
depths	I-T082
,	O
more	O
bleeding	B-T038
and	O
more	O
technical	O
complications	O
.	O
there	O
were	O
no	O
differences	O
in	O
esthetic	O
outcome	O
nor	O
in	O
patient	O
satisfaction	O
.	O
for	O
anterior	B-T082
single	O
tooth	B-T038
replacements	I-T038
,	O
scal	O
##lo	O
##ped	O
implants	B-T074
show	O
less	O
favorable	O
radiographic	O
and	O
clinical	O
outcome	O
compared	O
to	O
regular	O
implants	B-T074
with	O
a	O
smooth	O
neck	O
or	O
rough	O
neck	O
.	O

adenoviral	B-T005
delivery	B-T058
of	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
-	I-T103
α	I-T103
and	O
interleukin	B-T103
-	I-T103
2	I-T103
enables	O
successful	O
adoptive	B-T058
cell	I-T058
therapy	I-T058
of	O
immunosuppressive	B-T103
melanoma	B-T038
adoptive	B-T058
t	I-T058
-	I-T058
cell	I-T058
transfer	I-T058
is	O
a	O
promising	O
treatment	O
approach	O
for	O
metastatic	B-T038
cancer	I-T038
,	O
but	O
efficacy	O
in	O
solid	B-T038
tumors	I-T038
has	O
only	O
been	O
achieved	O
with	O
toxic	O
pre	O
-	O
and	O
postcon	O
##dition	O
##ing	O
regimens	O
.	O
thus	O
,	O
adoptive	B-T058
t	I-T058
-	I-T058
cell	I-T058
therapies	I-T058
would	O
benefit	O
from	O
complementary	O
modalities	O
that	O
enable	O
their	O
full	O
potential	O
without	O
excessive	O
toxicity	O
.	O
we	O
aimed	O
to	O
improve	O
the	O
efficacy	O
and	O
safety	O
of	O
adoptive	B-T058
t	I-T058
-	I-T058
cell	I-T058
transfer	I-T058
by	O
using	O
adenoviral	B-T103
vectors	I-T103
for	O
direct	O
delivery	O
of	O
immunomodulatory	B-T058
murine	B-T204
cytokines	B-T103
into	O
b16	B-T017
.	I-T017
ova	I-T017
melanoma	B-T038
tumors	B-T038
with	O
concomitant	O
t	B-T103
-	I-T103
cell	I-T103
receptor	I-T103
transgenic	B-T058
ot	I-T058
-	I-T058
i	I-T058
t	I-T058
-	I-T058
cell	I-T058
transfer	I-T058
.	O
armed	O
adenovirus	B-T005
##es	I-T005
expressed	O
high	O
local	O
and	O
low	O
systemic	O
levels	O
of	O
cytokine	B-T103
when	O
injected	O
into	O
b16	B-T017
.	I-T017
ova	I-T017
tumors	B-T038
,	O
suggesting	O
safety	O
of	O
virus	B-T058
-	I-T058
mediated	I-T058
cytokine	B-T103
delivery	I-T058
.	O
antitumor	O
efficacy	O
was	O
significantly	O
enhanced	O
with	O
adenovirus	B-T005
##es	I-T005
coding	O
for	O
murine	B-T204
interleukin	B-T103
-	I-T103
2	I-T103
(	O
mil	B-T103
-	I-T103
2	I-T103
)	O
and	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
-	I-T103
α	I-T103
(	O
mt	B-T103
##nf	I-T103
##α	I-T103
)	O
when	O
compared	O
with	O
t	B-T058
-	I-T058
cell	I-T058
transfer	I-T058
alone	O
or	O
viruses	B-T005
alone	O
.	O
further	O
improvement	O
in	O
efficacy	O
was	O
achieved	O
with	O
a	O
triple	O
combination	O
of	O
mil	B-T103
-	I-T103
2	I-T103
,	O
mt	B-T103
##nf	I-T103
##α	I-T103
,	O
and	O
ot	B-T017
-	I-T017
i	I-T017
t	I-T017
-	I-T017
cells	I-T017
.	O
mechanistic	O
studies	O
suggest	O
that	O
mil	B-T103
-	I-T103
2	I-T103
has	O
an	O
important	O
role	O
in	O
activating	O
t	B-T017
-	I-T017
cells	I-T017
at	O
the	O
tumor	B-T038
,	O
while	O
mt	B-T103
##nf	I-T103
##α	I-T103
induces	O
chemokine	B-T103
expression	B-T038
.	O
furthermore	O
,	O
adenovirus	B-T005
treatments	B-T058
enhanced	O
tumor	B-T038
-	O
infiltration	O
of	O
ot	B-T017
-	I-T017
i	I-T017
t	I-T017
-	I-T017
cells	I-T017
as	O
demonstrated	O
by	O
spect	B-T058
/	I-T058
ct	I-T058
imaging	I-T058
of	O
(	B-T017
111	I-T017
)	I-T017
in	I-T017
-	I-T017
labeled	I-T017
cells	I-T017
.	O
our	O
results	O
suggest	O
the	O
utility	O
of	O
cytokine	B-T103
-	I-T103
coding	I-T103
adenovirus	B-T005
##es	I-T005
for	O
improving	O
the	O
efficacy	O
of	O
adoptive	B-T058
t	I-T058
-	I-T058
cell	I-T058
therapies	I-T058
.	O

aura	B-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
endop	I-T007
##hy	I-T007
##tic	I-T007
##a	I-T007
sp	I-T007
.	I-T007
nov	I-T007
.	I-T007
,	O
a	O
novel	O
endop	B-T204
##hy	I-T204
##tic	I-T204
bacterium	I-T204
isolated	O
from	O
roots	B-T204
of	O
ana	B-T204
##ba	I-T204
##sis	I-T204
el	I-T204
##ati	I-T204
##or	I-T204
(	I-T204
c	I-T204
.	I-T204
a	I-T204
.	I-T204
me	I-T204
##y	I-T204
.	I-T204
)	I-T204
sch	I-T204
##isc	I-T204
##h	I-T204
##k	I-T204
an	O
orange	O
-	O
colour	O
##ed	O
,	O
aerobic	O
,	O
motile	O
and	O
short	B-T007
-	I-T007
rods	I-T007
bacterial	I-T007
strain	I-T007
,	O
designated	O
eg	B-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
,	O
was	O
isolated	O
from	O
the	O
surface	O
-	O
sterilized	O
root	B-T204
of	O
a	O
halo	B-T204
##ph	I-T204
##yte	I-T204
ana	B-T204
##ba	I-T204
##sis	I-T204
el	I-T204
##ati	I-T204
##or	I-T204
(	I-T204
c	I-T204
.	I-T204
a	I-T204
.	I-T204
me	I-T204
##y	I-T204
.	I-T204
)	I-T204
sch	I-T204
##isc	I-T204
##h	I-T204
##k	I-T204
collected	O
from	O
ur	B-T082
##um	I-T082
##qi	I-T082
,	O
xi	B-T082
##n	I-T082
##jiang	I-T082
province	I-T082
,	O
north	B-T082
-	I-T082
west	I-T082
china	I-T082
.	O
growth	B-T038
occurred	O
at	O
5	O
-	O
35	O
°c	O
(	O
optimum	O
30	O
°c	O
)	O
,	O
at	O
ph	O
6	O
.	O
0	O
-	O
9	O
.	O
0	O
(	O
optimum	O
ph	O
7	O
.	O
0	O
)	O
,	O
and	O
in	O
the	O
presence	O
of	O
0	O
-	O
6	O
%	O
nacl	B-T103
(	O
w	O
/	O
v	O
)	O
(	O
optimum	O
0	O
-	O
1	O
%	O
)	O
.	O
phylogenetic	O
tree	O
based	O
on	O
16s	B-T103
rrna	I-T103
gene	B-T082
sequences	I-T082
indicated	O
that	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
formed	O
a	O
distinct	O
lineage	O
in	O
the	O
cluster	O
that	O
comprised	O
the	O
genera	B-T007
aura	I-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
and	O
aure	B-T007
##im	I-T007
##onas	I-T007
in	O
the	O
family	B-T007
aura	I-T007
##nt	I-T007
##im	I-T007
##onad	I-T007
##aceae	I-T007
.	O
the	O
16s	B-T103
rrna	I-T103
gene	B-T082
sequence	I-T082
of	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
shared	O
the	O
highest	O
similarities	O
to	O
those	O
of	O
aura	B-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
coral	I-T007
##ici	I-T007
##da	I-T007
dsm	I-T007
147	I-T007
##90	I-T007
##t	I-T007
(	O
97	O
.	O
15	O
%	O
)	O
and	O
aura	B-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
mang	I-T007
##ano	I-T007
##xy	I-T007
##da	I-T007
##ns	I-T007
dsm	I-T007
218	I-T007
##71	I-T007
##t	I-T007
(	O
97	O
.	O
15	O
%	O
)	O
.	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
contained	O
q	B-T103
-	I-T103
10	I-T103
as	O
the	O
dominant	O
isopren	B-T103
##oid	I-T103
quinone	I-T103
.	O
the	O
major	O
cellular	O
fatty	B-T103
acids	I-T103
were	O
c18	O
:	O
1	O
7	O
##c	O
(	O
66	O
.	O
4	O
%	O
)	O
and	O
c1	B-T103
##9	I-T103
:	I-T103
0	I-T103
8	I-T103
##c	I-T103
cyclo	I-T103
(	O
23	O
.	O
3	O
%	O
)	O
.	O
the	O
polar	O
lipid	B-T103
profile	I-T103
of	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
contained	O
diphosph	B-T103
##atidyl	I-T103
##glycerol	I-T103
,	O
phosphatidyl	B-T103
##glycerol	I-T103
,	O
phosphatidylcholine	B-T103
,	O
phosphatidylethanolamine	B-T103
as	O
major	O
components	O
,	O
similarly	O
to	O
the	O
members	O
of	O
the	O
genus	B-T007
aura	I-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
.	O
the	O
dna	B-T103
g	O
+	O
c	O
content	O
of	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
was	O
66	O
.	O
8	O
mol	O
%	O
.	O
the	O
dna	B-T103
-	O
dna	B-T103
relatedness	O
between	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
and	O
aura	B-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
coral	I-T007
##ici	I-T007
##da	I-T007
dsm	I-T007
147	I-T007
##90	I-T007
##t	I-T007
was	O
24	O
.	O
7	O
±	O
2	O
.	O
9	O
%	O
.	O
on	O
the	O
basis	O
of	O
the	O
phylogenetic	B-T062
analysis	I-T062
,	O
chemot	O
##ax	O
##onomic	O
data	O
and	O
phenotypic	O
characteristics	O
,	O
strain	B-T007
eg	I-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
represents	O
a	O
novel	O
species	O
of	O
the	O
genus	B-T007
aura	I-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
,	O
for	O
which	O
the	O
name	O
aura	B-T007
##nt	I-T007
##im	I-T007
##onas	I-T007
endop	I-T007
##hy	I-T007
##tic	I-T007
##a	I-T007
sp	I-T007
.	I-T007
nov	I-T007
.	I-T007
is	O
proposed	O
.	O
the	O
type	O
strain	B-T007
is	O
eg	B-T007
##i	I-T007
650	I-T007
##03	I-T007
##37	I-T007
##t	I-T007
(	O
=	O
kc	B-T007
##tc	I-T007
52	I-T007
##29	I-T007
##6	I-T007
##t	I-T007
=	O
cpc	B-T007
##c	I-T007
100	I-T007
##90	I-T007
##4	I-T007
##t	I-T007
)	O
.	O

discovery	O
of	O
<	B-T204
i	I-T204
>	I-T204
neo	I-T204
##pan	I-T204
##orp	I-T204
##a	I-T204
chi	I-T204
##ll	I-T204
##co	I-T204
##tt	I-T204
##i	I-T204
<	I-T204
/	I-T204
i	I-T204
>	I-T204
by	I-T204
##ers	I-T204
(	O
mec	B-T204
##optera	I-T204
:	O
panor	B-T204
##pi	I-T204
##da	I-T204
##e	I-T204
)	O
from	O
tib	B-T082
##et	I-T082
,	O
china	B-T082
,	O
with	O
discussion	O
of	O
its	O
generic	O
status	O
neo	B-T204
##pan	I-T204
##orp	I-T204
##a	I-T204
chi	I-T204
##ll	I-T204
##co	I-T204
##tt	I-T204
##i	I-T204
by	I-T204
##ers	I-T204
,	O
1971	O
was	O
originally	O
described	O
from	O
kat	O
##h	O
##man	O
##du	O
in	O
nepal	B-T082
and	O
is	O
now	O
found	O
to	O
be	O
distributed	O
in	O
gy	O
##iro	O
##ng	O
,	O
tib	B-T082
##et	I-T082
in	O
china	B-T082
.	O
the	O
species	O
is	O
redes	O
##cribed	O
and	O
illustrated	O
based	O
on	O
new	O
material	O
from	O
china	B-T082
and	O
nepal	B-T082
.	O
the	O
generic	O
status	O
of	O
this	O
species	B-T170
is	O
briefly	O
discussed	O
.	O

intra	O
##ty	O
##mp	O
##anic	O
steroid	B-T103
delivery	O
by	O
an	O
indwelling	B-T074
catheter	I-T074
in	O
refractory	B-T038
severe	I-T038
sudden	I-T038
sensorineural	I-T038
hearing	I-T038
loss	I-T038
many	O
studies	O
over	O
the	O
last	O
decade	O
showed	O
favorable	O
outcomes	O
with	O
intra	O
##ty	O
##mp	O
##anic	O
(	O
it	O
)	O
steroid	B-T058
treatment	I-T058
,	O
alone	O
as	O
salvage	B-T058
treatment	I-T058
or	O
in	O
combination	O
with	O
conventional	O
systemic	B-T058
therapy	I-T058
(	O
st	B-T058
)	O
.	O
however	O
,	O
in	O
severe	O
to	O
profound	O
sensorineural	B-T038
hearing	I-T038
loss	I-T038
resistant	O
to	O
st	B-T058
,	O
the	O
optimal	O
infusion	B-T058
mode	I-T058
,	O
the	O
type	O
and	O
concentration	O
of	O
the	O
solution	O
,	O
the	O
preferable	O
drug	B-T103
,	O
its	O
total	O
amount	O
,	O
and	O
the	O
duration	O
and	O
fractionation	B-T058
of	O
the	O
treatment	B-T058
are	O
still	O
debated	O
.	O
aim	O
of	O
the	O
study	O
was	O
to	O
investigate	O
the	O
feasibility	O
and	O
the	O
outcomes	O
of	O
a	O
direct	O
and	O
constant	O
it	O
delivery	O
of	O
dexamethasone	B-T103
(	O
dex	B-T103
)	O
by	O
means	O
of	O
a	O
new	O
indwelling	B-T074
catheter	I-T074
.	O
a	O
prospective	B-T062
case	I-T062
-	I-T062
control	I-T062
study	I-T062
in	O
a	O
tertiary	B-T092
referral	I-T092
university	I-T092
hospital	I-T092
.	O
ninety	O
-	O
nine	O
subjects	B-T098
treated	O
with	O
st	B-T058
only	O
and	O
28	O
with	O
additional	O
it	O
dex	B-T103
have	O
been	O
included	O
in	O
the	O
study	O
.	O
a	O
4	B-T074
fr	I-T074
catheter	I-T074
inserted	B-T058
in	O
a	O
sub	O
-	O
annular	O
fashion	O
with	O
a	O
minimal	O
poster	O
##o	O
-	O
inferior	O
tympan	B-T058
##otomy	I-T058
through	O
and	O
endoc	B-T082
##anal	I-T082
##ar	I-T082
approach	I-T082
under	O
local	B-T058
anesthesia	I-T058
.	O
dex	B-T103
4	O
##mg	O
/	O
ml	O
delivered	O
daily	O
,	O
up	O
to	O
7	O
days	O
.	O
daily	O
bone	B-T058
and	I-T058
air	I-T058
-	I-T058
conducted	I-T058
pure	I-T058
tone	I-T058
and	O
speech	B-T058
audio	I-T058
##metry	I-T058
were	O
performed	O
with	O
a	O
follow	O
-	O
up	O
at	O
1	O
,	O
3	O
,	O
6	O
months	O
after	O
treatment	B-T058
.	O
twenty	O
-	O
one	O
out	O
of	O
28	O
patients	O
(	O
75	O
%	O
)	O
refractory	O
to	O
st	B-T058
gained	O
on	O
average	O
24	O
.	O
0	O
##db	O
##±2	O
##0	O
.	O
5d	O
##b	O
hl	B-T033
after	O
it	O
-	O
dex	B-T103
,	O
compared	O
to	O
35	O
.	O
4	O
%	O
(	O
average	O
6	O
.	O
7	O
##db	O
##±1	O
##6	O
.	O
6	O
##db	O
hl	B-T033
)	O
of	O
those	O
receiving	O
only	O
medical	O
st	B-T058
(	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
no	O
significant	O
side	B-T038
effects	I-T038
were	O
noted	O
.	O
in	O
severe	O
to	O
profound	O
sudden	B-T033
deafness	I-T033
refractory	O
to	O
conventional	O
st	B-T058
,	O
the	O
daily	O
perfusion	B-T058
of	O
4	O
##mg	O
/	O
ml	O
dex	B-T103
through	O
an	O
intra	O
##ty	O
##mp	O
##anic	O
catheter	B-T074
is	O
an	O
easy	O
,	O
well	O
accepted	O
procedure	O
that	O
enables	O
patients	O
to	O
receive	O
a	O
drug	B-T103
in	O
the	O
middle	B-T082
ear	I-T082
in	O
a	O
repeatable	B-T058
or	O
sustained	B-T103
form	I-T103
,	O
with	O
minimal	O
discomfort	B-T062
and	I-T062
a	I-T062
partial	I-T062
rescue	I-T062
(	O
67	O
.	O
86	O
%	O
)	O
and	O
a	O
speech	O
recognition	O
gain	O
of	O
39	O
%	O
.	O

ontology	O
-	O
based	O
high	O
-	O
level	O
context	O
inference	B-T038
for	O
human	O
behavior	O
identification	O
recent	O
years	O
have	O
witnessed	O
a	O
huge	O
progress	O
in	O
the	O
automatic	O
identification	O
of	O
individual	B-T098
primitive	B-T170
##s	I-T170
of	O
human	O
behavior	O
,	O
such	O
as	O
activities	O
or	O
locations	B-T082
.	O
however	O
,	O
the	O
complex	O
nature	O
of	O
human	O
behavior	O
demands	O
more	O
abstract	O
contextual	O
information	O
for	O
its	O
analysis	O
.	O
this	O
work	O
presents	O
an	O
ontology	O
-	O
based	O
method	B-T170
that	O
combines	O
low	O
-	O
level	O
primitive	B-T170
##s	I-T170
of	O
behavior	O
,	O
namely	O
activity	O
,	O
locations	B-T082
and	O
emotions	B-T038
,	O
unprecedented	O
to	O
date	O
,	O
to	O
intelligent	O
##ly	O
derive	O
more	O
meaningful	O
high	O
-	O
level	O
context	O
information	O
.	O
the	O
paper	O
contributes	O
with	O
a	O
new	O
open	O
ontology	O
describing	O
both	O
low	O
-	O
level	O
and	O
high	O
-	O
level	O
context	O
information	O
,	O
as	O
well	O
as	O
their	O
relationships	O
.	O
furthermore	O
,	O
a	O
framework	O
building	O
on	O
the	O
developed	O
ontology	O
and	O
reasoning	O
models	B-T170
is	O
presented	O
and	O
evaluated	O
.	O
the	O
proposed	O
method	O
proves	O
to	O
be	O
robust	O
while	O
identifying	O
high	O
-	O
level	O
contexts	O
even	O
in	O
the	O
event	O
of	O
erroneous	O
##ly	O
-	O
detected	B-T033
low	O
-	O
l	O
ev	O
##el	O
context	O
s	O
.	O
despite	O
reasonable	O
inference	B-T038
times	O
being	O
obtained	O
for	O
a	O
relevant	O
set	B-T038
of	O
users	B-T098
and	O
instances	O
,	O
additional	O
work	O
is	O
required	O
to	O
scale	O
to	O
long	O
-	O
term	O
scenarios	O
with	O
a	O
large	O
number	O
of	O
users	B-T098
.	O

an	O
ion	O
-	O
gating	O
multin	O
##ano	O
##cha	O
##nn	O
##el	O
system	O
based	O
on	O
a	O
copper	B-T103
-	O
responsive	O
self	O
-	O
cleav	B-T082
##ing	I-T082
dna	B-T103
##zyme	I-T103
we	O
developed	O
an	O
ion	O
-	O
gating	O
nanoc	O
##han	O
##nel	O
composite	O
system	O
by	O
immobil	O
##izing	O
a	O
cu	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
-	O
responsive	O
self	O
-	O
cleav	B-T082
##ing	I-T082
dna	B-T103
##zyme	I-T103
into	O
pet	B-T103
con	B-T103
##ical	I-T103
multin	I-T103
##ano	I-T103
##cha	I-T103
##nn	I-T103
##els	I-T103
,	O
which	O
could	O
control	O
the	O
ion	B-T038
transport	I-T038
by	O
regulating	B-T038
the	O
surface	B-T082
charge	O
density	O
of	O
the	O
channels	B-T103
.	O

stalk	B-T017
versus	O
base	B-T017
invasion	B-T033
in	O
pt	B-T033
##1	I-T033
papillary	B-T038
cancers	I-T038
of	I-T038
the	I-T038
bladder	I-T038
:	O
improved	O
subst	O
##aging	O
system	O
predicting	O
risk	O
of	O
progression	B-T038
pathologic	B-T033
stage	I-T033
t1	I-T033
(	O
pt	B-T033
##1	I-T033
)	O
bladder	B-T038
cancers	I-T038
are	O
a	O
clinically	O
heterogeneous	O
group	O
.	O
however	O
,	O
current	O
staging	B-T170
guidelines	O
for	O
superficial	B-T082
##ly	I-T082
invasive	B-T038
cancers	I-T038
do	O
not	O
acknowled	O
##ge	O
the	O
variability	O
in	O
type	O
and	O
extent	O
of	O
lamina	B-T033
propria	I-T033
invasion	I-T033
in	O
papillary	B-T038
urothelial	I-T038
carcinomas	I-T038
(	O
pu	B-T038
##c	I-T038
)	O
,	O
and	O
historically	O
proposed	O
subst	O
##aging	O
systems	O
showed	O
either	O
high	O
inter	O
-	O
observer	O
variation	O
or	O
limited	O
value	O
in	O
predicting	O
patient	B-T058
outcomes	I-T058
.	O
herein	O
we	O
reapp	O
##ra	O
##ise	O
pt	B-T033
##1	I-T033
pu	B-T038
##c	I-T038
subst	O
##aging	O
,	O
aiming	O
to	O
identify	O
a	O
novel	O
scheme	B-T170
which	O
is	O
reproducible	O
and	O
prognostic	B-T170
##ally	I-T170
meaningful	O
.	O
stage	B-T033
pt	I-T033
##1	I-T033
pu	B-T038
##c	I-T038
diagnosed	B-T033
during	O
years	O
1999	O
-	O
2015	O
were	O
retrospectively	B-T062
reviewed	I-T062
and	O
characterized	O
as	O
focal	B-T082
invasion	B-T038
confined	O
to	O
papillary	B-T017
stalk	I-T017
,	O
focal	B-T082
invasion	B-T033
of	O
tumor	B-T038
base	B-T017
,	O
or	O
extensive	O
invasion	B-T033
of	O
tumor	B-T038
base	B-T017
.	O
cases	O
with	O
concurrent	O
flat	B-T033
carcinoma	I-T033
in	I-T033
-	I-T033
situ	I-T033
,	O
angio	B-T033
##lymph	I-T033
##atic	I-T033
invasion	I-T033
,	O
absent	O
muscular	B-T017
##is	I-T017
propria	I-T017
,	O
or	O
clinically	O
advanced	O
disease	O
were	O
excluded	O
.	O
we	O
calculated	O
cumulative	O
incidence	O
of	O
recurrence	B-T033
,	O
progression	B-T038
,	O
and	O
death	B-T038
by	O
tumor	B-T170
subtype	I-T170
and	O
evaluated	B-T058
differential	B-T033
risks	I-T033
using	O
log	B-T170
-	I-T170
rank	I-T170
tests	I-T170
and	O
kaplan	O
-	O
meier	O
curves	O
stratified	O
by	O
type	O
and	O
extent	B-T201
of	I-T201
invasion	I-T201
.	O
among	O
62	O
patients	O
satisfying	O
inclusion	O
criteria	O
,	O
22	O
of	O
29	O
patients	O
with	O
base	B-T017
extensive	O
invasion	B-T033
progressed	O
while	O
4	O
of	O
13	O
with	O
base	B-T017
focal	B-T082
and	O
0	O
of	O
20	O
with	O
stalk	B-T017
only	O
invasion	B-T033
progressed	O
.	O
there	O
was	O
strong	O
evidence	O
that	O
base	B-T017
extensive	O
patients	O
had	O
higher	O
risk	O
of	O
progression	B-T038
and	O
death	B-T038
due	O
to	O
bladder	B-T038
cancer	I-T038
than	O
base	B-T017
focal	B-T082
or	O
stalk	B-T017
only	O
counterparts	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
however	O
,	O
tumor	B-T170
subtype	I-T170
was	O
not	O
significantly	O
associated	O
with	O
risk	O
of	O
recurrence	B-T033
(	O
p	O
=	O
0	O
.	O
21	O
)	O
.	O
we	O
propose	O
an	O
innovative	O
subst	O
##aging	O
approach	O
for	O
reporting	O
site	O
and	O
extent	O
of	O
lamina	B-T033
propria	I-T033
invasion	I-T033
in	O
patients	O
with	O
pt	B-T033
##1	I-T033
pu	B-T038
##c	I-T038
allowing	O
patient	O
stratification	O
for	O
risk	O
of	O
progression	B-T038
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

a	O
systematic	B-T170
review	I-T170
investigating	O
psychosocial	O
aspects	O
of	O
egg	O
sharing	O
in	O
the	O
united	B-T082
kingdom	I-T082
and	O
their	O
potential	O
effects	O
on	O
egg	O
donation	O
numbers	O
this	O
review	B-T170
aims	O
to	O
provide	O
an	O
up	O
-	O
to	O
-	O
date	O
knowledge	B-T170
of	O
the	O
psychosocial	O
aspects	O
of	O
egg	O
donation	O
from	O
the	O
perspectives	O
of	O
the	O
egg	B-T098
share	I-T098
donor	I-T098
and	O
their	O
recipient	B-T098
.	O
it	O
explores	O
the	O
motives	O
,	O
experiences	B-T038
and	O
attitudes	B-T038
of	O
egg	B-T098
share	I-T098
##rs	I-T098
and	O
their	O
views	O
towards	O
donor	B-T098
an	O
##onym	O
##ity	O
and	O
disclosure	O
.	O
conclusions	O
are	O
made	O
on	O
how	O
these	O
findings	B-T033
can	O
guide	B-T170
clinical	I-T170
practice	I-T170
and	O
improve	O
egg	O
sharing	O
numbers	O
.	O
a	O
systematic	O
search	O
of	O
peer	B-T170
-	I-T170
reviewed	I-T170
journals	I-T170
of	O
four	O
computerized	O
databases	O
was	O
undertaken	O
.	O
eleven	O
studies	B-T062
were	O
included	O
in	O
the	O
review	B-T170
.	O
psychosocial	O
aspects	O
towards	O
donation	O
were	O
positive	B-T033
from	O
the	O
egg	B-T098
share	I-T098
donor	I-T098
and	O
recipient	B-T098
.	O
concerns	O
raised	O
were	O
whether	O
participating	O
in	O
the	O
egg	O
sharing	O
scheme	B-T170
would	O
impact	O
on	O
their	O
success	O
rates	O
,	O
as	O
well	O
as	O
frustr	B-T038
##ation	I-T038
expressed	O
by	O
a	O
minority	B-T098
regarding	O
the	O
lack	B-T033
of	I-T033
knowledge	I-T033
of	O
egg	O
sharing	O
outside	O
of	O
fertility	B-T038
clinics	B-T092
.	O
the	O
2005	O
legisl	O
##ative	O
changes	O
in	O
the	O
uk	B-T082
have	O
not	O
caused	O
the	O
anticipated	O
dramatic	O
decrease	O
in	O
egg	O
donation	O
;	O
however	O
,	O
oocyte	B-T058
donation	I-T058
still	O
falls	O
short	O
of	O
demand	B-T058
.	O
egg	O
sharing	O
provides	O
a	O
practical	O
option	O
for	O
more	O
patients	O
to	O
access	O
ivf	B-T058
,	O
whilst	O
also	O
providing	O
more	O
donor	B-T098
oocytes	I-T098
.	O
improved	O
information	O
provision	O
will	O
result	O
in	O
greater	O
awareness	B-T038
of	O
egg	O
sharing	O
,	O
with	O
the	O
potential	O
to	O
recruit	O
more	O
donors	O
and	O
meet	O
the	O
needs	O
of	O
recipients	B-T098
currently	O
on	O
long	O
waiting	B-T170
lists	I-T170
.	O

the	O
use	O
of	O
oxford	B-T092
nanop	I-T092
##ore	I-T092
native	O
barc	B-T062
##oding	I-T062
for	O
complete	O
genome	B-T082
assembly	I-T082
the	O
oxford	B-T092
nanop	I-T092
##ore	I-T092
technologies	I-T092
mini	B-T074
##on	I-T074
(	I-T074
tm	I-T074
)	I-T074
is	O
a	O
mobile	O
dna	O
sequence	O
##r	O
that	O
can	O
produce	O
long	B-T082
read	I-T082
sequences	I-T082
with	O
a	O
short	O
turn	O
-	O
around	O
time	O
.	O
here	O
we	O
report	B-T170
the	O
first	O
demonstration	O
of	O
single	B-T082
contig	I-T082
genome	I-T082
assembly	I-T082
using	O
oxford	B-T092
nanop	I-T092
##ore	I-T092
native	O
barc	B-T062
##oding	I-T062
when	O
applied	O
to	O
a	O
multiplexed	B-T017
library	I-T017
of	O
12	O
samples	O
and	O
combined	O
with	O
existing	O
illumina	O
short	B-T170
-	I-T170
read	I-T170
data	I-T170
.	O
this	O
pav	O
##es	O
the	O
way	O
for	O
the	O
closure	B-T062
of	O
multiple	O
bacterial	B-T017
genomes	I-T017
from	O
a	O
single	O
mini	B-T074
##on	I-T074
(	I-T074
tm	I-T074
)	I-T074
sequencing	O
run	O
,	O
given	O
the	O
availability	O
of	O
existing	O
short	B-T170
-	I-T170
read	I-T170
data	I-T170
.	O
the	O
strain	O
we	O
used	O
,	O
mh	O
##o	O
_	O
001	O
,	O
represents	O
the	O
important	O
community	O
-	O
acquired	O
methicillin	O
resistant	O
staphylococcus	B-T007
aureus	I-T007
lineage	O
usa	O
##30	O
##0	O
.	O
using	O
a	O
hybrid	O
assembly	B-T082
of	O
existing	O
short	O
read	O
and	O
barc	B-T082
##oded	I-T082
long	I-T082
read	I-T082
sequences	I-T082
from	O
multiplexed	O
data	O
,	O
we	O
completed	O
a	O
genome	B-T017
of	O
the	O
s	B-T007
.	I-T007
aureus	I-T007
usa	O
##30	O
##0	O
strain	O
mh	O
##o	O
_	O
001	O
.	O
the	O
long	B-T170
-	I-T170
read	I-T170
data	I-T170
represented	O
only	O
~	O
5	O
-	O
10	O
%	O
of	O
an	O
average	O
mini	B-T074
##on	I-T074
(	I-T074
tm	I-T074
)	I-T074
run	O
(	O
~	O
7	O
##x	O
genomic	B-T017
coverage	O
)	O
,	O
but	O
,	O
using	O
standard	O
tools	B-T170
,	O
this	O
was	O
sufficient	O
to	O
complete	O
the	O
circular	B-T017
chromosome	I-T017
of	O
s	B-T007
.	I-T007
aureus	I-T007
strain	O
mh	O
##o	O
_	O
001	O
(	O
2	O
.	O
86	O
mb	O
)	O
and	O
two	O
complete	O
plasmids	B-T103
(	O
27	O
kb	O
and	O
3	O
kb	O
)	O
.	O
minor	O
differences	O
were	O
noted	O
when	O
compared	O
to	O
usa	O
##30	O
##0	O
reference	O
genome	B-T017
,	O
usa	B-T017
##30	I-T017
##0	I-T017
_	I-T017
fp	I-T017
##r3	I-T017
##75	I-T017
##7	I-T017
,	O
including	O
the	O
translocation	B-T038
,	O
loss	O
and	O
gain	O
of	O
mobile	B-T103
genetic	I-T103
elements	I-T103
.	O
here	O
we	O
demonstrate	O
that	O
mini	B-T074
##on	I-T074
(	I-T074
tm	I-T074
)	I-T074
reads	O
,	O
multiplexed	O
using	O
native	O
barc	B-T062
##oding	I-T062
,	O
can	O
be	O
used	O
in	O
combination	O
with	O
short	B-T170
-	I-T170
read	I-T170
data	I-T170
,	O
to	O
fully	O
complete	O
a	O
bacterial	B-T017
genome	I-T017
.	O
the	O
ability	O
to	O
complete	O
multiple	O
genomes	B-T017
,	O
for	O
which	O
short	B-T170
-	I-T170
read	I-T170
data	I-T170
is	O
already	O
available	B-T033
,	O
from	O
a	O
single	O
mini	B-T074
##on	I-T074
(	I-T074
tm	I-T074
)	I-T074
run	O
is	O
set	O
to	O
impact	O
on	O
our	O
understanding	B-T038
of	O
accessory	O
genome	B-T017
content	I-T017
,	O
plasmid	B-T103
diversity	O
and	O
genome	B-T017
rearrangements	B-T038
.	O

shared	B-T038
decision	I-T038
making	I-T038
in	O
the	O
uk	B-T082
:	O
moving	O
towards	O
wider	O
uptake	O
shared	B-T038
decision	I-T038
making	I-T038
(	O
sd	B-T038
##m	I-T038
)	O
is	O
firmly	O
on	O
the	O
policy	B-T170
agenda	O
in	O
the	O
uk	B-T082
and	O
a	O
recent	O
legal	O
ru	O
##ling	O
has	O
confirmed	O
its	O
importance	O
.	O
policym	B-T097
##akers	I-T097
,	O
ethi	B-T097
##ci	I-T097
##st	I-T097
##s	I-T097
,	O
professional	B-T097
regulators	I-T097
and	O
societies	B-T092
,	O
patient	B-T092
organisations	I-T092
and	O
now	O
the	O
courts	O
are	O
committed	O
to	O
ensuring	O
that	O
sd	B-T038
##m	I-T038
becomes	O
the	O
norm	O
throughout	O
the	O
nhs	B-T058
,	O
but	O
an	O
unfavourable	O
economic	O
climate	O
makes	O
this	O
especially	O
challenging	O
.	O
considerable	O
progress	O
has	O
been	O
made	O
over	O
the	O
last	O
few	O
years	O
,	O
with	O
new	O
learning	B-T038
from	O
demonstration	O
sites	B-T082
,	O
various	O
initiatives	B-T038
in	O
capacity	B-T058
building	I-T058
and	O
training	O
,	O
wider	O
availability	O
of	O
patient	O
decision	B-T170
aids	I-T170
,	O
and	O
important	O
leadership	O
initiatives	B-T038
.	O
enth	B-T038
##us	I-T038
##iasm	I-T038
for	O
this	O
way	O
of	O
working	O
is	O
growing	O
among	O
clinicians	B-T097
,	O
patients	O
and	O
managers	B-T097
,	O
but	O
it	O
could	O
be	O
underm	O
##ined	O
if	O
sd	B-T038
##m	I-T038
comes	O
to	O
be	O
seen	O
primarily	O
as	O
a	O
means	O
of	O
cost	O
control	O
.	O

evaluation	B-T058
of	O
the	O
vi	B-T058
##da	I-T058
##s	I-T058
anti	I-T058
-	I-T058
hcv	I-T058
assay	I-T058
for	O
detection	B-T058
of	O
hepatitis	B-T038
c	I-T038
virus	I-T038
infection	I-T038
anti	B-T103
-	I-T103
hepatitis	I-T103
c	I-T103
virus	I-T103
antibody	I-T103
(	O
anti	B-T103
-	I-T103
hcv	I-T103
)	O
assays	B-T058
are	O
recommended	O
for	O
screening	B-T058
hcv	B-T098
-	I-T098
infected	I-T098
persons	I-T098
.	O
the	O
vi	B-T058
##da	I-T058
##s	I-T058
anti	I-T058
-	I-T058
hcv	I-T058
assay	I-T058
(	O
biom	O
##eri	O
##eu	O
##x	O
,	O
france	B-T082
)	O
,	O
based	O
on	O
the	O
enzyme	B-T058
-	I-T058
linked	I-T058
fluorescence	I-T058
test	I-T058
principle	O
,	O
was	O
recently	O
introduced	O
in	O
korea	B-T082
.	O
we	O
evaluated	O
the	O
clinical	O
performance	O
of	O
the	O
vi	B-T058
##da	I-T058
##s	I-T058
assay	I-T058
.	O
one	O
hundred	O
hcv	B-T033
-	I-T033
positive	I-T033
and	O
1	O
,	O
002	O
hcv	B-T033
-	I-T033
negative	I-T033
blood	B-T031
samples	I-T031
confirmed	O
by	O
architect	B-T058
anti	I-T058
-	I-T058
hcv	I-T058
(	O
abb	O
##ott	O
laboratories	O
,	O
usa	B-T082
)	O
and	O
cob	B-T062
##as	I-T062
taqman	I-T062
hcv	I-T062
real	I-T062
-	I-T062
time	I-T062
pcr	I-T062
(	O
roch	B-T092
##e	I-T092
diagnostics	I-T092
,	O
usa	B-T082
)	O
or	O
the	O
proc	B-T058
##le	I-T058
##ix	I-T058
ultr	I-T058
##io	I-T058
plus	I-T058
assay	I-T058
(	O
gen	O
-	O
probe	O
incorporated	O
,	O
usa	B-T082
)	O
were	O
obtained	O
from	O
the	O
human	O
serum	O
bank	O
(	O
hs	O
##b	O
)	O
and	O
tested	O
by	O
vi	O
##da	O
##s	O
.	O
in	O
case	O
of	O
discrep	B-T033
##ant	I-T033
results	I-T033
,	O
we	O
conducted	O
a	O
recombinant	B-T058
immunoblot	I-T058
assay	I-T058
(	O
rib	B-T058
##a	I-T058
)	O
.	O
the	O
agreement	O
rates	O
for	O
known	O
hcv	B-T033
-	I-T033
positive	I-T033
and	O
hcv	B-T033
-	I-T033
negative	I-T033
samples	B-T031
between	O
the	O
vi	B-T058
##da	I-T058
##s	I-T058
assay	I-T058
and	O
the	O
hs	O
##b	O
testing	O
were	O
100	O
%	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
:	O
96	O
.	O
4	O
-	O
100	O
%	O
)	O
and	O
99	O
.	O
5	O
%	O
(	O
95	O
%	O
ci	O
:	O
98	O
.	O
8	O
-	O
99	O
.	O
8	O
%	O
)	O
,	O
respectively	O
.	O
one	O
of	O
the	O
five	O
discrep	B-T033
##ant	I-T033
samples	B-T031
was	O
positive	B-T033
for	O
core	B-T103
2	I-T103
+	I-T103
and	O
ns	B-T103
##3	I-T103
-	I-T103
2	I-T103
2	I-T103
+	I-T103
reactivity	O
,	O
two	O
samples	B-T031
were	O
negative	B-T033
,	O
and	O
the	O
other	O
two	O
were	O
indeterminate	O
regarding	O
ns	B-T103
##4	I-T103
2	I-T103
+	I-T103
reactivity	O
in	O
rib	B-T058
##a	I-T058
.	O
we	O
observed	O
a	O
significant	O
but	O
weak	O
positive	O
correlation	O
between	O
the	O
titers	O
of	O
vi	O
##da	O
##s	O
and	O
architect	B-T058
assays	I-T058
(	O
r	O
=	O
0	O
.	O
315	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
.	O
the	O
vi	B-T058
##da	I-T058
##s	I-T058
anti	I-T058
-	I-T058
hcv	I-T058
assay	I-T058
,	O
developed	O
on	O
the	O
vi	O
##da	O
##s	O
automated	B-T058
immunoassay	I-T058
platform	I-T058
based	O
on	O
the	O
ready	O
-	O
to	O
-	O
use	O
,	O
single	O
-	O
sample	O
test	O
concept	O
may	O
be	O
useful	O
in	O
small	O
-	O
to	O
-	O
medium	O
-	O
sized	O
laboratories	B-T092
.	O
it	O
showed	O
good	O
agreement	O
with	O
architect	B-T058
anti	I-T058
-	I-T058
hcv	I-T058
and	O
cob	B-T062
##as	I-T062
pcr	I-T062
assays	I-T062
and	O
is	O
therefore	O
useful	O
for	O
detection	O
of	O
hcv	B-T038
infection	I-T038
.	O
weakly	B-T033
test	I-T033
-	I-T033
positive	I-T033
(	I-T033
ambiguous	I-T033
)	I-T033
samples	B-T031
require	O
additional	O
testing	O
by	O
another	O
anti	B-T103
-	I-T103
hcv	I-T103
,	O
rib	B-T058
##a	I-T058
,	O
or	O
hcv	B-T058
rna	I-T058
assay	I-T058
.	O

association	O
between	O
xr	B-T017
##cc1	I-T017
and	O
er	B-T017
##cc1	I-T017
single	B-T082
-	I-T082
nucleotide	I-T082
polymorphisms	I-T082
and	O
the	O
efficacy	O
of	O
concurrent	B-T058
radio	I-T058
##chem	I-T058
##otherapy	I-T058
in	O
patients	O
with	O
esophageal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
single	B-T082
-	I-T082
nucleotide	I-T082
polymorphisms	I-T082
(	O
snps	B-T082
)	O
in	O
x	B-T017
-	I-T017
ray	I-T017
repair	I-T017
cross	I-T017
-	I-T017
complement	I-T017
##ing	I-T017
1	I-T017
-	I-T017
39	I-T017
##9	I-T017
(	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
)	O
or	O
excision	B-T017
repair	I-T017
cross	I-T017
-	I-T017
complementation	I-T017
group	I-T017
1	I-T017
-	I-T017
118	I-T017
(	O
er	B-T017
##cc1	I-T017
-	I-T017
118	I-T017
)	O
and	O
the	O
short	O
-	O
term	O
efficacy	O
of	O
radio	B-T058
##chem	I-T058
##otherapy	I-T058
,	O
tumor	B-T038
metastasis	I-T038
and	O
relapse	O
,	O
as	O
well	O
as	O
the	O
survival	B-T201
time	I-T201
in	O
patients	O
with	O
esophageal	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
escc	B-T038
)	O
.	O
taqman	B-T062
probe	I-T062
-	I-T062
based	I-T062
quantitative	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
qpcr	B-T062
)	O
was	O
conducted	O
to	O
examine	B-T033
the	O
levels	O
of	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
and	O
er	B-T017
##cc1	I-T017
-	I-T017
118	I-T017
snps	B-T082
in	O
the	O
peripheral	B-T031
blood	I-T031
of	O
50	O
patients	O
with	O
pathologically	O
confirmed	B-T033
escc	B-T038
.	O
in	O
addition	O
,	O
the	O
associations	O
between	O
different	O
genotypes	O
and	O
short	O
-	O
term	O
therapeutic	O
efficacy	O
[	O
the	O
complete	B-T033
remission	I-T033
(	O
cr	B-T033
)	O
rate	O
]	O
,	O
tumor	B-T038
metastasis	I-T038
and	O
relapse	O
,	O
as	O
well	O
as	O
the	O
survival	B-T201
time	I-T201
following	O
concurrent	B-T058
radio	I-T058
##chem	I-T058
##otherapy	I-T058
,	O
were	O
determined	O
.	O
a	O
total	O
of	O
50	O
escc	B-T038
patients	O
who	O
received	O
concurrent	B-T058
radio	I-T058
##chem	I-T058
##otherapy	I-T058
were	O
enrolled	O
.	O
it	O
was	O
found	O
that	O
the	O
short	O
-	O
term	O
therapeutic	O
efficacy	O
(	O
cr	B-T033
rate	O
)	O
was	O
higher	O
in	O
the	O
group	O
of	O
patients	O
carrying	O
the	O
homozygous	B-T038
mutation	I-T038
of	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
(	O
a	B-T103
/	O
a	B-T103
genotype	O
)	O
than	O
in	O
the	O
group	O
of	O
patients	O
without	O
the	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
mutation	B-T038
(	O
g	B-T103
/	O
g	B-T103
genotype	O
)	O
.	O
in	O
addition	O
,	O
the	O
cr	B-T033
rate	O
was	O
significantly	O
increased	O
in	O
patients	O
carrying	O
one	O
or	O
two	O
er	B-T017
##cc1	I-T017
-	I-T017
118	I-T017
c	O
alleles	B-T017
(	O
c	B-T103
/	O
c	B-T103
or	O
c	B-T103
/	O
t	B-T103
genotype	O
)	O
compared	O
with	O
patients	O
lacking	O
the	O
c	B-T103
allele	B-T017
(	O
t	B-T103
/	O
t	B-T103
genotype	O
)	O
.	O
the	O
differences	O
were	O
statistically	O
significant	O
(	O
a	B-T103
/	O
a	B-T103
vs	O
.	O
g	B-T103
/	O
g	B-T103
,	O
p	O
=	O
0	O
.	O
014	O
;	O
t	B-T103
t	B-T103
vs	O
.	O
c	B-T103
/	O
t	B-T103
+	O
c	B-T103
/	O
c	B-T103
,	O
p	O
=	O
0	O
.	O
040	O
)	O
.	O
during	O
the	O
follow	B-T033
-	I-T033
up	I-T033
period	I-T033
,	O
the	O
group	O
of	O
patients	O
carrying	O
the	O
homozygous	B-T038
mutation	I-T038
of	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
(	O
a	B-T103
/	O
a	B-T103
genotype	O
)	O
exhibited	O
a	O
markedly	O
reduced	O
risk	O
of	O
metastasis	B-T038
and	O
relapse	O
compared	O
with	O
the	O
group	O
of	O
patients	O
carrying	O
non	O
-	O
mutated	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
(	O
g	B-T103
/	O
g	B-T103
genotype	O
;	O
p	O
=	O
0	O
.	O
031	O
)	O
.	O
by	O
contrast	O
,	O
er	B-T017
##cc1	I-T017
-	I-T017
118	I-T017
snp	B-T082
was	O
not	O
associated	O
with	O
the	O
risk	O
of	O
metastasis	B-T038
and	O
recurrence	O
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
the	O
combined	O
results	O
of	O
univariate	O
and	O
multivariate	B-T170
cox	I-T170
regression	I-T170
analysis	I-T170
showed	O
that	O
the	O
snp	B-T082
in	O
er	B-T017
##cc1	I-T017
-	I-T017
118	I-T017
was	O
closely	O
associated	O
with	O
survival	B-T201
time	I-T201
.	O
the	O
mean	O
survival	O
time	O
was	O
significantly	O
prolonged	O
in	O
patients	O
carrying	O
1	O
or	O
2	O
c	B-T103
alleles	B-T017
(	O
c	B-T103
/	O
c	B-T103
or	O
c	B-T103
/	O
t	B-T103
genotype	O
)	O
compared	O
with	O
patients	O
lacking	O
the	O
c	B-T103
allele	B-T017
(	O
t	B-T103
/	O
t	B-T103
genotype	O
)	O
[	O
t	B-T103
/	O
t	B-T103
vs	O
.	O
c	B-T103
/	O
c	B-T103
,	O
hr	O
=	O
12	O
.	O
96	O
,	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
=	O
3	O
.	O
08	O
-	O
54	O
.	O
61	O
,	O
p	O
<	O
0	O
.	O
001	O
;	O
t	B-T103
t	B-T103
vs	O
.	O
c	B-T103
/	O
t	B-T103
+	O
c	B-T103
/	O
c	B-T103
,	O
hr	O
=	O
11	O
.	O
71	O
,	O
95	O
%	O
ci	O
=	O
3	O
.	O
06	O
-	O
44	O
.	O
83	O
,	O
p	O
<	O
0	O
.	O
001	O
]	O
.	O
however	O
,	O
xr	B-T017
##cc1	I-T017
-	I-T017
39	I-T017
##9	I-T017
snp	B-T082
had	O
no	O
effect	O
on	O
survival	B-T201
time	I-T201
(	O
p	O
>	O
0	O
.	O
05	O
)	O
.	O
xr	B-T017
##cc	I-T017
##l	I-T017
-	I-T017
39	I-T017
##9	I-T017
snp	B-T082
was	O
associated	O
with	O
the	O
short	O
-	O
term	O
therapeutic	O
efficacy	O
(	O
the	O
cr	B-T033
rate	O
)	O
and	O
tumor	B-T038
metastasis	I-T038
/	O
relapse	O
in	O
escc	B-T038
patients	O
who	O
received	O
the	O
docetaxel	B-T058
plus	I-T058
cisplatin	I-T058
(	I-T058
tp	I-T058
)	I-T058
regimen	I-T058
-	O
based	O
concurrent	B-T058
radio	I-T058
##chem	I-T058
##otherapy	I-T058
.	O
by	O
contrast	O
,	O
er	B-T017
##cc1	I-T017
-	I-T017
118	I-T017
snp	B-T082
was	O
significantly	O
associated	O
with	O
the	O
short	O
-	O
term	O
therapeutic	O
efficacy	O
(	O
the	O
cr	B-T033
rate	O
)	O
and	O
survival	B-T201
time	I-T201
in	O
escc	B-T038
patients	O
who	O
received	O
tp	B-T058
regimen	I-T058
-	O
based	O
concurrent	B-T058
radio	I-T058
##chem	I-T058
##otherapy	I-T058
.	O

gambling	B-T038
disorders	I-T038
,	O
gambling	O
type	O
preferences	O
,	O
and	O
psychiatric	O
comorbidity	O
among	O
the	O
thai	B-T098
general	I-T098
population	I-T098
:	O
results	O
of	O
the	O
2013	O
national	O
mental	O
health	O
survey	O
background	O
and	O
aims	O
to	O
estimate	O
the	O
prevalence	O
of	O
problem	O
and	O
pathological	B-T038
gambling	I-T038
,	O
gender	O
and	O
age	O
-	O
group	O
differences	O
in	O
gambling	O
types	O
,	O
and	O
comorbidities	O
with	O
other	O
psychiatric	B-T038
disorders	I-T038
among	O
the	O
thai	B-T098
general	I-T098
population	I-T098
.	O
methods	O
analysis	O
was	O
conducted	O
on	O
4	O
,	O
72	O
##7	O
participants	B-T098
of	O
thailand	B-T082
'	I-T082
s	I-T082
2013	O
national	O
mental	O
health	O
survey	O
,	O
a	O
multistage	B-T170
stratified	I-T170
cluster	I-T170
survey	I-T170
,	O
using	O
the	O
composite	B-T170
international	I-T170
diagnostic	I-T170
interview	I-T170
.	O
diagnoses	B-T033
of	O
problem	O
and	O
pathological	B-T038
gambling	I-T038
and	O
other	O
psychiatric	B-T038
disorders	I-T038
were	O
based	O
on	O
the	O
dsm	B-T170
-	I-T170
iv	I-T170
-	I-T170
tr	I-T170
criteria	I-T170
with	O
the	O
following	O
additional	O
criteria	O
for	O
gamb	O
##lers	O
:	O
more	O
than	O
10	O
lifetime	O
gambling	O
episodes	O
and	O
a	O
single	O
year	O
loss	O
of	O
at	O
least	O
365	O
us	O
##d	O
from	O
gambling	O
.	O
results	O
the	O
estimated	O
lifetime	O
prevalence	O
rates	O
of	O
pathological	B-T038
and	O
problem	O
gambling	O
were	O
0	O
.	O
90	O
%	O
[	O
95	O
%	O
confidence	O
interval	O
(	O
ci	O
)	O
:	O
0	O
.	O
51	O
-	O
1	O
.	O
29	O
]	O
and	O
1	O
.	O
14	O
%	O
(	O
95	O
%	O
ci	O
:	O
0	O
.	O
58	O
-	O
1	O
.	O
70	O
)	O
,	O
respectively	O
.	O
the	O
most	O
popular	O
type	O
of	O
gambling	O
was	O
playing	O
lot	O
##ter	O
##ies	O
[	O
69	O
.	O
5	O
%	O
,	O
standard	O
error	O
(	O
se	O
)	O
=	O
1	O
.	O
9	O
]	O
,	O
the	O
prevalence	O
of	O
which	O
was	O
significantly	O
higher	O
among	O
females	O
and	O
older	B-T098
age	I-T098
groups	I-T098
.	O
the	O
most	O
common	O
psychiatric	B-T038
disorders	I-T038
seen	O
among	O
pathological	B-T038
gamb	I-T038
##lers	I-T038
were	O
alcohol	B-T038
abuse	I-T038
(	O
57	O
.	O
4	O
%	O
)	O
,	O
nicotine	B-T038
dependence	I-T038
(	O
49	O
.	O
5	O
%	O
)	O
,	O
and	O
any	O
drug	B-T038
use	I-T038
disorder	I-T038
(	O
16	O
.	O
2	O
%	O
)	O
.	O
pathological	B-T038
gambling	I-T038
was	O
highly	O
prevalent	O
among	O
those	O
who	O
ever	O
experienced	O
major	B-T038
depressive	I-T038
episodes	I-T038
(	O
5	O
.	O
5	O
%	O
)	O
,	O
any	O
drug	B-T038
dependence	I-T038
(	O
5	O
.	O
1	O
%	O
)	O
,	O
and	O
intermittent	B-T038
explosive	I-T038
disorder	I-T038
(	O
4	O
.	O
8	O
%	O
)	O
.	O
the	O
association	O
between	O
pathological	B-T038
gambling	I-T038
was	O
strongest	O
with	O
a	O
history	O
of	O
major	B-T038
depressive	I-T038
episode	I-T038
[	O
adjusted	O
odds	O
ratio	O
(	O
aor	O
)	O
=	O
10	O
.	O
4	O
,	O
95	O
%	O
ci	O
:	O
2	O
.	O
80	O
-	O
38	O
.	O
4	O
]	O
.	O
conclusion	O
the	O
study	O
confirms	O
the	O
recognition	B-T038
of	O
gambling	B-T038
disorders	I-T038
as	O
a	O
public	B-T170
health	I-T170
concern	O
in	O
thailand	B-T082
and	O
suggests	O
a	O
need	O
for	O
culturally	O
specific	O
preventive	O
measures	O
for	O
pathological	B-T038
gamb	I-T038
##lers	I-T038
and	O
those	O
with	O
a	O
history	O
of	O
substance	B-T038
use	I-T038
disorders	I-T038
or	O
major	B-T038
depression	I-T038
.	O

polysaccharide	B-T103
-	O
specific	O
memory	B-T017
b	I-T017
cells	I-T017
predict	O
protection	O
against	O
experimental	O
human	B-T204
pneumococcal	B-T007
carriage	B-T033
we	O
have	O
previously	O
demonstrated	O
that	O
experimental	O
pneumococcal	B-T007
carriage	B-T033
enhances	O
immunity	B-T038
and	O
protects	O
healthy	O
adults	O
against	O
carriage	B-T033
re	O
##ac	O
##quis	O
##ition	O
after	O
rech	B-T058
##all	I-T058
##enge	I-T058
with	O
a	O
homologous	O
strain	O
.	O
to	O
investigate	O
the	O
role	O
of	O
naturally	O
acquired	O
pneumococcal	B-T103
protein	I-T103
and	O
polysaccharide	B-T103
(	O
ps	B-T103
)	O
-	O
specific	O
immunity	B-T038
in	O
protection	O
against	O
carriage	B-T033
acquisition	O
using	O
a	O
heterologous	B-T038
challenge	I-T038
model	O
.	O
we	O
identified	O
healthy	B-T098
volunteers	I-T098
that	O
were	O
naturally	O
colonized	B-T017
with	O
pneum	B-T007
##ococcus	I-T007
and	O
,	O
after	O
clearance	O
of	O
their	O
natural	O
carriage	B-T033
episode	O
,	O
challenged	O
them	O
with	O
a	O
heterologous	O
6b	B-T007
strain	I-T007
.	O
in	O
another	O
cohort	B-T098
of	O
volunteers	B-T098
we	O
assessed	O
6b	B-T103
##ps	I-T103
-	O
specific	O
,	O
psp	B-T103
##a	I-T103
-	O
specific	O
,	O
and	O
psp	B-T103
##c	I-T103
-	O
specific	O
igg	B-T103
and	O
iga	B-T103
plasma	B-T017
and	O
memory	B-T017
b	I-T017
-	I-T017
cell	I-T017
populations	I-T017
before	O
and	O
7	O
,	O
14	O
,	O
and	O
35	O
days	O
after	O
experimental	O
pneumococcal	B-T007
inoculation	B-T058
.	O
heterologous	B-T038
challenge	I-T038
with	O
6b	B-T007
resulted	O
in	O
50	O
%	O
carriage	B-T033
among	O
volunteers	B-T098
with	O
previous	O
natural	O
pneumococcal	B-T007
carriage	B-T033
.	O
protection	O
from	O
carriage	B-T033
was	O
associated	O
with	O
a	O
high	O
number	O
of	O
circulating	O
6b	B-T103
##ps	I-T103
igg	B-T103
-	O
secreting	B-T038
memory	B-T017
b	I-T017
cells	I-T017
at	O
baseline	O
.	O
there	O
were	O
no	O
associations	O
between	O
protection	O
from	O
carriage	B-T033
and	O
baseline	O
levels	O
of	O
6b	B-T103
##ps	I-T103
igg	B-T103
in	O
serum	B-T031
or	O
nasal	B-T031
wash	I-T031
,	O
psp	B-T103
##a	I-T103
-	O
specific	O
,	O
or	O
psp	B-T103
##c	I-T103
-	O
specific	O
memory	B-T017
b	I-T017
cells	I-T017
or	O
plasma	B-T017
cells	I-T017
.	O
in	O
volunteers	B-T098
who	O
did	O
not	B-T033
develop	I-T033
carriage	B-T033
,	O
the	O
number	O
of	O
circulating	O
6b	B-T103
##ps	I-T103
memory	B-T017
b	I-T017
cells	I-T017
decreased	O
and	O
the	O
number	O
of	O
6b	B-T103
##ps	I-T103
plasma	B-T017
cells	I-T017
increased	O
postin	B-T033
##oc	I-T033
##ulation	I-T033
.	O
our	O
data	O
indicate	O
that	O
naturally	O
acquired	O
ps	B-T103
-	O
specific	O
memory	B-T017
b	I-T017
cells	I-T017
,	O
but	O
not	B-T033
levels	I-T033
of	O
circulating	O
igg	B-T103
at	O
time	O
of	O
pneumococcal	B-T007
exposure	O
,	O
are	O
associated	O
with	O
protection	O
against	O
carriage	B-T033
acquisition	O
.	O

isolation	B-T058
of	I-T058
cells	I-T058
specialized	O
in	O
anticancer	B-T103
alkaloid	B-T038
metabolism	I-T038
by	O
fluorescence	B-T058
-	I-T058
activated	I-T058
cell	I-T058
sorting	I-T058
plant	B-T204
specialized	O
metabolism	B-T038
often	O
presents	O
a	O
complex	O
cell	B-T017
-	O
specific	O
compartment	B-T038
##ation	I-T038
essential	O
to	O
accomplish	O
the	O
biosynthesis	O
of	O
valuable	O
plant	B-T204
natural	B-T103
products	I-T103
.	O
hence	O
,	O
the	O
disclosure	O
and	O
potential	O
manipulation	O
of	O
such	O
pathways	O
may	O
depend	O
on	O
the	O
capacity	O
to	O
isolate	B-T058
and	O
characterize	O
specific	O
cell	B-T170
types	I-T170
.	O
cath	B-T204
##aran	I-T204
##th	I-T204
##us	I-T204
rose	I-T204
##us	I-T204
is	O
the	O
source	O
of	O
several	O
medicinal	B-T103
terp	B-T103
##enoid	I-T103
indole	I-T103
alkaloids	I-T103
,	O
including	O
the	O
low	O
-	O
level	O
anticancer	B-T103
vinblastine	B-T103
and	O
vincristine	B-T103
,	O
for	O
which	O
the	O
late	O
biosynthetic	O
steps	O
occur	O
in	O
specialized	O
mesop	B-T017
##hy	I-T017
##ll	I-T017
cells	I-T017
called	O
idi	B-T017
##oblasts	I-T017
.	O
here	O
,	O
the	O
optical	O
,	O
fluorescence	O
,	O
and	O
alkaloid	B-T103
-	O
accumulating	B-T033
properties	O
of	O
c	B-T204
.	I-T204
rose	I-T204
##us	I-T204
leaf	B-T204
idi	B-T017
##oblasts	I-T017
are	O
characterized	O
,	O
and	O
a	O
methodology	O
for	O
the	O
isolation	B-T058
of	O
idi	B-T017
##oblast	I-T017
protoplasts	B-T017
by	O
fluorescence	B-T058
-	I-T058
activated	I-T058
cell	I-T058
sorting	I-T058
is	O
established	O
,	O
taking	O
advantage	O
of	O
the	O
distinctive	O
autofluorescence	B-T058
of	O
these	O
cells	B-T017
.	O
this	O
achievement	O
represents	O
a	O
crucial	O
step	O
for	O
the	O
development	O
of	O
differential	O
om	B-T062
##ic	I-T062
strategies	I-T062
leading	O
to	O
the	O
identification	O
of	O
candidate	B-T017
genes	I-T017
putative	O
##ly	O
involved	O
in	O
the	O
biosynthesis	O
,	O
pathway	O
regulation	B-T038
,	O
and	O
transmembrane	B-T038
transport	I-T038
leading	O
to	O
the	O
anticancer	B-T033
alkaloids	B-T103
from	O
c	B-T204
.	I-T204
rose	I-T204
##us	I-T204
.	O

methylation	B-T038
dynamics	O
during	O
foll	B-T038
##icul	I-T038
##ogenesis	I-T038
and	O
early	O
embryo	B-T038
development	I-T038
in	O
sheep	B-T204
genome	B-T017
-	O
wide	O
dna	B-T038
methylation	I-T038
reprogramming	O
occurs	O
during	O
mammalian	B-T204
gamet	B-T038
##ogenesis	I-T038
and	O
early	O
embryogenesis	B-T038
.	O
post	O
-	O
fertilization	B-T038
demethylation	B-T038
of	O
paternal	O
and	O
maternal	B-T033
genomes	B-T017
is	O
considered	O
to	O
occur	O
by	O
an	O
active	O
and	O
passive	O
mechanism	O
respectively	O
,	O
in	O
most	O
mammals	B-T204
but	O
sheep	B-T204
;	O
in	O
this	O
species	O
no	O
loss	O
of	O
methylation	B-T038
was	O
observed	O
in	O
either	O
pron	B-T017
##ucle	I-T017
##us	I-T017
.	O
post	O
-	O
fertilization	B-T038
reprogramming	O
relies	O
on	O
methyl	B-T103
##ating	I-T103
and	O
demethyl	B-T103
##ating	I-T103
enzymes	I-T103
and	O
co	O
-	O
factors	O
that	O
are	O
stored	O
during	O
oocyte	B-T038
growth	I-T038
,	O
concurrently	O
with	O
the	O
re	B-T038
-	I-T038
methylation	I-T038
of	O
the	O
oocyte	B-T017
itself	O
.	O
the	O
crucial	O
remodelling	O
of	O
the	O
oocyte	B-T017
epigenetic	O
bag	O
##ga	O
##ge	O
often	O
overlaps	O
with	O
potential	O
interfering	O
events	O
such	O
as	O
exposure	O
to	O
assisted	O
reproduction	B-T058
technologies	I-T058
or	O
environmental	O
changes	O
.	O
here	O
,	O
we	O
report	O
a	O
temporal	O
analysis	O
of	O
methylation	B-T038
dynamics	O
during	O
foll	B-T038
##icul	I-T038
##ogenesis	I-T038
and	O
early	O
embryo	B-T038
development	I-T038
in	O
sheep	B-T204
.	O
we	O
characterized	O
global	O
dna	B-T038
methylation	I-T038
and	O
hydroxymethyl	B-T038
##ation	I-T038
by	O
immunofluorescence	B-T058
and	O
relatively	O
quantified	O
the	O
expression	B-T038
of	O
the	O
enzymes	B-T103
and	O
co	O
-	O
factors	O
mainly	O
responsible	O
for	O
their	O
remodelling	O
(	O
dna	B-T103
methyltransferase	I-T103
##s	I-T103
(	O
dnmt	B-T103
##s	I-T103
)	O
,	O
ten	B-T103
-	I-T103
eleven	I-T103
translocation	I-T103
(	I-T103
tet	I-T103
)	I-T103
proteins	I-T103
and	O
methyl	B-T082
-	I-T082
cpg	I-T082
-	I-T082
binding	I-T082
domain	I-T082
(	O
mb	B-T082
##d	I-T082
)	O
proteins	B-T103
)	O
.	O
our	O
results	O
illustrate	O
for	O
the	O
first	O
time	O
the	O
patterns	O
of	O
hydroxymethyl	B-T038
##ation	I-T038
during	O
oocyte	B-T038
growth	I-T038
.	O
we	O
observed	O
different	O
patterns	O
of	O
methylation	B-T038
and	O
hydroxymethyl	B-T038
##ation	I-T038
between	O
the	O
two	O
parental	B-T017
pron	I-T017
##ucle	I-T017
##i	I-T017
,	O
suggesting	O
that	O
male	B-T017
pron	I-T017
##ucle	I-T017
##us	I-T017
undergoes	O
active	O
demethylation	B-T038
also	O
in	O
sheep	B-T204
.	O
finally	O
,	O
we	O
describe	O
gene	B-T017
-	O
specific	O
accumulation	O
dynamics	O
for	O
methyl	B-T103
##ating	I-T103
and	O
demethyl	B-T103
##ating	I-T103
enzymes	I-T103
during	O
oocyte	B-T038
growth	I-T038
and	O
observe	O
patterns	O
of	O
expression	B-T038
associated	O
with	O
developmental	O
competence	O
in	O
a	O
differential	O
model	O
of	O
oocyte	B-T017
potential	O
.	O
our	O
work	O
contributes	O
to	O
the	O
understanding	O
of	O
the	O
methylation	B-T038
dynamics	O
during	O
foll	B-T038
##icul	I-T038
##ogenesis	I-T038
and	O
early	O
embryo	B-T038
development	I-T038
and	O
improves	O
the	O
overall	O
picture	O
of	O
early	O
rearrangements	O
that	O
will	O
originate	O
the	O
embryo	B-T017
epigen	B-T017
##ome	I-T017
.	O

the	O
chinese	O
herbal	O
mixture	O
tie	B-T103
##n	I-T103
-	I-T103
hs	I-T103
##ie	I-T103
##n	I-T103
liquid	I-T103
augments	O
the	O
anticancer	O
immunity	B-T038
in	O
tumor	B-T017
cell	I-T017
-	O
vaccinated	B-T033
mice	B-T204
background	O
the	O
chinese	O
herbal	O
mixture	O
,	O
tie	B-T103
##n	I-T103
-	I-T103
hs	I-T103
##ie	I-T103
##n	I-T103
liquid	I-T103
(	O
th	B-T103
##l	I-T103
)	O
,	O
has	O
been	O
used	O
as	O
an	O
anticancer	O
dietary	B-T168
supplement	I-T168
for	O
more	O
than	O
20	O
years	O
.	O
our	O
previous	O
studies	B-T062
have	O
shown	O
that	O
th	B-T103
##l	I-T103
can	O
modulate	B-T082
immune	B-T038
response	I-T038
and	O
inhibit	O
tumor	O
growth	O
.	O
in	O
this	O
study	B-T062
,	O
we	O
further	O
evaluated	B-T058
the	O
effect	O
of	O
th	B-T103
##l	I-T103
on	O
anticancer	O
immune	B-T038
response	I-T038
in	O
mice	B-T204
vaccinated	B-T033
with	O
γ	O
-	O
ray	O
-	O
irradiated	O
tumor	B-T017
cells	I-T017
.	O
methods	O
the	O
antitumor	O
effect	O
of	O
th	B-T103
##l	I-T103
was	O
determined	O
in	O
mice	B-T204
vaccinated	B-T033
with	O
low	B-T017
-	I-T017
tumorigenic	I-T017
ct	I-T017
-	I-T017
26	I-T017
-	I-T017
low	I-T017
colon	I-T017
cancer	I-T017
cells	I-T017
or	O
γ	B-T058
-	I-T058
ray	I-T058
-	I-T058
irradiated	I-T058
high	B-T017
-	I-T017
tumorigenic	I-T017
ct	I-T017
-	I-T017
26	I-T017
-	I-T017
high	I-T017
colon	I-T017
cancer	I-T017
cells	I-T017
.	O
the	O
number	O
of	O
natural	B-T017
killer	I-T017
(	I-T017
nk	I-T017
)	I-T017
cells	I-T017
and	O
t	B-T017
lymphocytes	I-T017
in	O
the	O
spleen	B-T017
was	O
analyzed	B-T062
by	O
flow	B-T058
cytometry	I-T058
.	O
the	O
tumor	B-T038
-	O
killing	B-T038
activities	O
of	O
nk	B-T017
cells	I-T017
and	O
cytotoxic	B-T017
t	I-T017
lymphocytes	I-T017
(	O
ctls	B-T017
)	O
were	O
analyzed	B-T062
by	O
flow	B-T058
cytometry	I-T058
using	O
y	B-T017
##ac	I-T017
-	I-T017
1	I-T017
and	O
ct	B-T017
-	I-T017
26	I-T017
-	I-T017
high	I-T017
cells	I-T017
,	O
respectively	O
,	O
as	O
target	O
cells	B-T017
.	O
the	O
levels	O
of	O
ifn	B-T103
-	I-T103
γ	I-T103
,	O
il	B-T103
-	I-T103
2	I-T103
,	O
and	O
tnf	B-T103
-	I-T103
α	I-T103
were	O
determined	O
by	O
elisa	B-T058
.	O
results	O
th	B-T103
##l	I-T103
suppressed	O
the	O
growth	B-T038
of	O
ct	B-T017
-	I-T017
26	I-T017
-	I-T017
high	I-T017
tumor	I-T017
in	O
mice	B-T204
previously	O
vaccinated	B-T033
with	O
low	B-T017
-	I-T017
tumorigenic	I-T017
ct	I-T017
-	I-T017
26	I-T017
-	I-T017
low	I-T017
cells	I-T017
or	O
γ	B-T058
-	I-T058
irradiated	I-T058
ct	B-T017
-	I-T017
26	I-T017
-	I-T017
high	I-T017
cells	I-T017
.	O
th	B-T103
##l	I-T103
increased	O
the	O
populations	O
of	O
nk	B-T017
cells	I-T017
and	O
cd4	B-T017
+	I-T017
t	I-T017
lymphocytes	I-T017
in	O
the	O
spleen	B-T017
and	O
enhanced	O
the	O
tumor	B-T038
-	O
killing	B-T038
activities	O
of	O
nk	B-T017
cells	I-T017
and	O
ctl	B-T017
in	O
mice	B-T204
vaccinated	B-T033
with	O
γ	B-T058
-	I-T058
irradiated	I-T058
ct	B-T017
-	I-T017
26	I-T017
-	I-T017
high	I-T017
cells	I-T017
.	O
th	B-T103
##l	I-T103
increased	O
the	O
production	O
of	O
ifn	B-T103
-	I-T103
γ	I-T103
,	O
il	B-T103
-	I-T103
2	I-T103
,	O
and	O
tnf	B-T103
-	I-T103
α	I-T103
in	O
mice	B-T204
vaccinated	B-T033
with	O
γ	B-T058
-	I-T058
irradiated	I-T058
ct	B-T017
-	I-T017
26	I-T017
-	I-T017
high	I-T017
cells	I-T017
.	O
conclusion	O
th	B-T103
##l	I-T103
can	O
enhance	O
the	O
antitumor	O
immune	B-T038
responses	I-T038
in	O
mice	B-T204
vaccinated	B-T033
with	O
killed	O
tumor	B-T017
cells	I-T017
.	O
these	O
results	O
suggest	O
that	O
th	B-T103
##l	I-T103
may	O
be	O
used	O
as	O
a	O
complementary	B-T091
medicine	I-T091
for	O
cancer	B-T038
patients	O
previously	O
treated	O
with	O
killed	B-T103
tumor	I-T103
cell	I-T103
vaccines	I-T103
,	O
radiotherapy	B-T058
,	O
or	O
chemotherapy	B-T058
.	O

higher	B-T033
risk	I-T033
of	I-T033
revision	O
for	O
infection	B-T038
using	O
systemic	O
clindamycin	B-T103
prophylaxis	B-T058
than	O
with	O
clo	B-T103
##xa	I-T103
##cil	I-T103
##lin	I-T103
background	O
and	O
purpose	O
-	O
clindamycin	B-T103
has	O
not	O
been	O
compared	O
with	O
other	O
antibiotics	B-T103
for	O
prophylaxis	B-T058
in	O
arthroplasty	B-T058
.	O
since	O
2009	O
,	O
the	O
swedish	B-T170
knee	B-T058
arthroplasty	I-T058
register	I-T170
(	O
sk	B-T170
##ar	I-T170
)	O
has	O
been	O
collecting	O
information	O
on	O
the	O
prophylactic	B-T058
antibiotic	I-T058
regime	I-T058
used	O
at	O
every	O
individual	B-T098
operation	O
.	O
in	O
sweden	B-T082
,	O
when	O
there	O
is	O
allergy	B-T038
to	O
penicillin	B-T103
,	O
clindamycin	B-T103
has	O
been	O
the	O
recommended	O
alternative	O
.	O
we	O
examined	O
whether	O
there	O
were	O
differences	O
in	O
the	O
rate	O
of	O
revision	O
due	O
to	O
infection	B-T038
depending	O
on	O
which	O
antibiotic	B-T103
was	O
used	O
as	O
systemic	O
prophylaxis	B-T058
.	O
patients	O
and	O
methods	O
-	O
patients	O
who	O
had	O
a	O
total	B-T058
knee	I-T058
arthroplasty	I-T058
(	O
tka	B-T058
)	O
performed	O
due	O
to	O
osteoarthritis	B-T038
(	O
oa	B-T038
)	O
during	O
the	O
years	O
2009	O
-	O
2015	O
were	O
included	O
in	O
the	O
study	O
.	O
information	O
on	O
which	O
antibiotic	B-T103
was	O
used	O
was	O
available	O
for	O
80	O
,	O
018	O
operations	O
(	O
55	O
,	O
530	O
patients	O
)	O
.	O
survival	B-T170
statistics	I-T170
were	O
used	O
to	O
calculate	O
the	O
rate	O
of	O
revision	O
due	O
to	O
infection	B-T038
until	O
the	O
end	O
of	O
2015	O
,	O
comparing	O
the	O
group	O
of	O
patients	O
who	O
received	O
clo	B-T103
##xa	I-T103
##cil	I-T103
##lin	I-T103
with	O
those	O
who	O
received	O
clindamycin	B-T103
as	O
systemic	O
prophylaxis	B-T058
.	O
results	O
-	O
clo	B-T103
##xa	I-T103
##cil	I-T103
##lin	I-T103
was	O
used	O
in	O
90	O
%	O
of	O
the	O
cases	O
,	O
clindamycin	B-T103
in	O
7	O
%	O
,	O
and	O
cephalosporins	B-T103
in	O
2	O
%	O
.	O
the	O
risk	O
of	O
being	O
revised	O
due	O
to	O
infection	B-T038
was	O
higher	O
when	O
clindamycin	B-T103
was	O
used	O
than	O
when	O
clo	B-T103
##xa	I-T103
##cil	I-T103
##lin	I-T103
was	O
used	O
(	O
rr	O
=	O
1	O
.	O
5	O
,	O
95	O
%	O
ci	O
:	O
1	O
.	O
2	O
-	O
2	O
.	O
0	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
revision	O
rate	O
for	O
other	O
causes	O
(	O
p	O
=	O
0	O
.	O
2	O
)	O
.	O
interpretation	B-T170
-	O
we	O
advis	O
##e	O
that	O
patients	O
reporting	O
allergic	B-T038
reaction	I-T038
to	O
penicillin	B-T103
should	O
have	O
their	O
allergic	O
history	O
explored	O
.	O
in	O
the	O
absence	O
of	O
a	O
clear	O
history	O
of	O
type	B-T038
-	I-T038
i	I-T038
allergic	I-T038
reaction	I-T038
(	O
e	O
.	O
g	O
.	O
urticaria	B-T038
,	O
anaphylaxis	B-T038
,	O
or	O
bronch	B-T038
##ospasm	I-T038
)	O
,	O
we	O
suggest	O
the	O
use	O
of	O
a	O
third	B-T103
-	I-T103
generation	I-T103
cephalosporin	I-T103
instead	O
of	O
clindamycin	B-T103
as	O
perioperative	O
prophylaxis	B-T058
when	O
undergoing	O
a	O
tk	B-T058
##r	I-T058
.	O
no	O
recommendation	O
can	O
be	O
given	O
regarding	O
patients	O
with	O
type	B-T038
-	I-T038
1	I-T038
allergy	I-T038
.	O

development	O
and	O
validation	B-T062
of	O
a	O
new	O
reliable	O
method	B-T058
for	O
the	O
diagnosis	B-T033
of	O
avian	B-T204
bot	B-T037
##uli	I-T037
##sm	I-T037
liver	B-T017
is	O
a	O
reliable	O
matrix	B-T031
for	O
laboratory	B-T058
confirmation	O
of	O
avian	B-T204
bot	B-T037
##uli	I-T037
##sm	I-T037
using	O
real	B-T062
-	I-T062
time	I-T062
pcr	I-T062
.	O
here	O
,	O
we	O
developed	O
,	O
optimized	O
,	O
and	O
validated	B-T062
the	O
analytical	B-T062
steps	O
preceding	O
pcr	B-T062
to	O
maximize	O
the	O
detection	B-T033
of	O
clostridium	B-T007
botulinum	I-T007
group	I-T007
iii	I-T007
in	O
avian	B-T204
liver	B-T017
.	O
these	O
pre	O
-	O
pcr	B-T062
steps	O
included	O
enrichment	B-T103
incubation	B-T058
of	O
the	O
whole	O
liver	B-T017
(	O
maximum	O
25	O
g	O
)	O
at	O
37°c	O
for	O
at	O
least	O
24	O
h	O
in	O
an	O
anaerobic	B-T074
chamber	I-T074
and	O
dna	B-T062
extraction	I-T062
using	O
an	O
enzymatic	B-T058
digestion	I-T058
step	O
followed	O
by	O
a	O
dna	O
purification	O
step	O
.	O
conditions	O
of	O
sample	O
storage	O
before	O
analysis	B-T062
appear	O
to	O
have	O
a	O
strong	O
effect	O
on	O
the	O
detection	B-T033
of	O
group	B-T007
iii	I-T007
c	I-T007
.	I-T007
botulinum	I-T007
strains	I-T007
and	O
our	O
results	O
recommend	O
storage	O
at	O
temperatures	O
below	O
-	O
18	O
##°c	O
.	O
short	O
-	O
term	O
storage	O
at	O
5	O
##°c	O
is	O
possible	O
for	O
up	O
to	O
24	O
h	O
,	O
but	O
a	O
decrease	O
in	O
sensitivity	O
was	O
observed	O
at	O
48	O
h	O
of	O
storage	O
at	O
this	O
temperature	O
.	O
analysis	B-T062
of	O
whole	O
livers	B-T017
(	O
maximum	O
25	O
g	O
)	O
is	O
required	O
and	O
pooling	O
samples	O
before	O
enrichment	B-T058
culturing	I-T058
must	O
be	O
avoided	O
.	O
pooling	O
is	O
however	O
possible	O
before	O
or	O
after	O
dna	B-T062
extraction	I-T062
under	O
certain	O
conditions	O
.	O
whole	O
livers	B-T017
should	O
be	O
10	O
-	O
fold	O
diluted	O
in	O
enrichment	B-T103
medium	I-T103
and	O
homogen	O
##ized	O
using	O
a	O
puls	O
##ifier	O
##®	O
blend	O
##er	O
(	O
microg	O
##en	O
,	O
sur	B-T082
##rey	I-T082
,	O
uk	B-T082
)	O
instead	O
of	O
a	O
conventional	O
pad	O
##dle	O
blend	O
##er	O
.	O
spiked	B-T017
liver	I-T017
samples	O
showed	O
a	O
limit	O
of	O
detection	B-T033
of	O
5	O
spores	B-T007
/	O
g	O
liver	B-T017
for	O
types	B-T007
c	I-T007
and	O
d	B-T007
and	O
250	O
spores	B-T007
/	O
g	O
for	O
type	B-T007
e	I-T007
.	O
using	O
the	O
method	B-T058
developed	O
here	O
,	O
the	O
analysis	B-T062
of	O
268	O
samples	O
from	O
73	O
suspected	O
outbreaks	O
showed	O
100	O
%	O
specificity	O
and	O
95	O
.	O
35	O
%	O
sensitivity	O
compared	O
with	O
other	O
pcr	B-T062
-	O
based	O
methods	B-T058
considered	O
as	O
reference	O
.	O
the	O
mosaic	B-T007
type	I-T007
c	I-T007
/	O
d	B-T007
was	O
the	O
most	O
common	O
neurotoxin	B-T103
type	O
found	O
in	O
examined	O
samples	O
,	O
which	O
included	O
both	O
wild	B-T204
and	O
domestic	B-T204
birds	I-T204
.	O

the	O
bac	O
##hel	O
##ore	O
##tt	O
##e	O
:	O
female	O
si	B-T204
##ame	I-T204
##se	I-T204
fight	I-T204
##ing	I-T204
fish	I-T204
avoid	O
males	O
exposed	O
to	O
an	O
estrogen	B-T103
mimic	O
due	O
to	O
improper	O
disposal	O
and	O
a	O
lack	O
of	O
removal	O
during	O
the	O
wastewater	O
treatment	O
process	O
,	O
endocrine	O
disrupting	O
chemicals	B-T103
enter	O
aquatic	O
ecosystems	O
where	O
they	O
exert	O
detrimental	O
effects	O
on	O
fish	B-T204
behavior	O
and	O
physiology	B-T038
.	O
perhaps	O
the	O
most	O
well	O
-	O
studied	O
and	O
prevalent	O
ed	B-T103
##c	I-T103
is	O
17	B-T103
##α	I-T103
-	I-T103
ethi	I-T103
##n	I-T103
##yles	I-T103
##tra	I-T103
##di	I-T103
##ol	I-T103
(	O
ee	B-T103
##2	I-T103
)	O
,	O
an	O
active	O
ingredient	B-T103
in	O
oral	B-T103
contraceptives	I-T103
,	O
which	O
is	O
known	O
to	O
cause	O
dramatic	O
reductions	O
in	O
male	O
-	O
typical	O
behaviors	O
.	O
while	O
it	O
is	O
likely	O
that	O
alterations	O
in	O
male	O
courts	O
##hip	O
behavior	O
decrease	O
reproductive	B-T038
fitness	I-T038
,	O
this	O
is	O
rarely	O
explicitly	O
examined	O
.	O
to	O
this	O
end	O
,	O
whether	O
ee	B-T103
##2	I-T103
exposure	O
reduces	O
male	O
attractiveness	O
to	O
female	O
si	B-T204
##ame	I-T204
##se	I-T204
fight	I-T204
##ing	I-T204
fish	I-T204
,	O
bet	B-T204
##ta	I-T204
splen	I-T204
##den	I-T204
##s	I-T204
,	O
was	O
investigated	O
by	O
showing	O
females	O
video	B-T170
images	B-T170
of	O
exposed	B-T098
and	O
unexposed	B-T098
males	O
.	O
females	O
were	O
randomly	O
assigned	O
to	O
one	O
of	O
two	O
exposure	O
conditions	O
(	O
exposed	O
to	O
ee	B-T103
##2	I-T103
,	O
control	O
)	O
and	O
each	O
subject	O
then	O
viewed	O
four	O
different	O
video	B-T170
combinations	O
of	O
male	O
conspecific	O
##s	O
(	O
court	O
##ing	O
exposed	B-T098
+	O
exposed	B-T098
;	O
court	O
##ing	O
unexposed	B-T098
+	O
unexposed	B-T098
;	O
court	O
##ing	O
unexposed	B-T098
+	O
exposed	B-T098
;	O
swimming	O
unexposed	B-T098
+	O
exposed	B-T098
)	O
.	O
females	O
,	O
regardless	O
of	O
whether	O
or	O
not	O
they	O
were	O
exposed	O
to	O
ee	B-T103
##2	I-T103
,	O
directed	O
markedly	O
less	O
behavior	O
towards	O
exposed	B-T098
males	O
,	O
especially	O
when	O
they	O
viewed	O
an	O
exposed	B-T098
male	O
and	O
an	O
unexposed	B-T098
male	O
simultaneously	O
.	O
these	O
findings	O
demonstrate	O
that	O
ee	B-T103
##2	I-T103
can	O
have	O
significant	O
individual	O
-	O
and	O
population	B-T098
-	I-T098
level	I-T098
consequences	O
on	O
fitness	O
by	O
disrupting	O
sexual	O
selection	O
and	O
,	O
ultimately	O
,	O
the	O
success	O
of	O
exposed	B-T098
males	O
.	O

tooth	B-T037
wear	I-T037
as	O
a	O
means	O
to	O
quantify	O
intra	O
-	O
specific	O
variations	O
in	O
diet	B-T168
and	O
chewing	B-T038
movements	B-T038
in	O
mammals	B-T204
,	O
tooth	B-T017
function	O
,	O
and	O
its	O
efficiency	O
,	O
depends	O
both	O
on	O
the	O
mechanical	O
properties	O
of	O
the	O
food	B-T168
and	O
on	O
chewing	B-T038
dynamics	O
.	O
these	O
aspects	O
have	O
rarely	O
been	O
studied	B-T062
in	O
combination	O
and	O
/	O
or	O
at	O
the	O
intra	O
-	O
specific	O
level	O
.	O
here	O
we	O
applied	O
3d	B-T082
dental	B-T017
surface	B-T082
texture	O
analysis	B-T062
to	O
a	O
sample	O
of	O
field	B-T204
vol	I-T204
##es	I-T204
(	O
microt	B-T204
##us	I-T204
agre	I-T204
##st	I-T204
##is	I-T204
)	O
trapped	O
from	O
finnish	B-T082
lap	I-T082
##land	I-T082
at	O
different	O
seasons	O
and	O
localities	B-T082
to	O
test	O
for	O
inter	B-T098
-	I-T098
population	I-T098
variations	O
.	O
we	O
also	O
explored	O
intra	B-T098
-	I-T098
individual	I-T098
variation	O
in	O
chewing	B-T038
dynamics	O
by	O
analysing	B-T062
two	O
facets	B-T082
on	O
the	O
second	B-T017
upper	I-T017
molars	I-T017
.	O
our	O
results	O
confirm	O
that	O
the	O
two	O
localities	B-T082
have	O
similar	O
environments	B-T082
and	O
that	O
the	O
vol	B-T204
##es	I-T204
feed	O
on	O
the	O
same	O
items	O
there	O
.	O
on	O
the	O
other	O
hand	O
,	O
the	O
texture	O
data	O
suggest	O
that	O
diets	B-T168
are	O
seasonal	O
##ly	O
variable	O
,	O
probably	O
due	O
to	O
varying	O
concentrations	O
of	O
abr	B-T103
##asi	I-T103
##ves	I-T103
.	O
lastly	O
,	O
the	O
texture	O
##s	O
on	O
the	O
buccal	B-T082
facets	I-T082
are	O
more	O
isotropic	O
and	O
their	O
direction	B-T082
devi	B-T082
##ates	I-T082
more	O
from	O
the	O
mesial	B-T082
chewing	B-T038
direction	B-T082
than	O
the	O
lingual	B-T017
facets	B-T082
.	O
we	O
interpret	O
these	O
results	O
as	O
reflecting	O
food	B-T168
,	O
rather	O
than	O
chewing	B-T038
,	O
movements	B-T038
,	O
where	O
food	B-T168
particles	I-T168
are	O
more	O
guided	O
on	O
the	O
lingual	B-T017
side	O
of	O
the	O
molars	B-T017
.	O
this	O
has	O
implications	O
for	O
the	O
application	O
of	O
dental	B-T037
microw	I-T037
##ear	I-T037
analysis	B-T062
to	O
fossil	O
##s	O
:	O
only	O
homologous	O
facets	B-T082
can	O
be	O
compared	O
,	O
even	O
when	O
the	O
molar	B-T017
row	O
seems	O
to	O
constitute	O
a	O
functional	O
unit	O
.	O

clinical	B-T033
value	I-T033
of	O
pathologic	B-T058
examination	I-T058
of	O
non	B-T017
-	I-T017
neoplastic	I-T017
kidney	I-T017
in	O
patients	O
with	O
upper	B-T022
urinary	I-T022
tract	I-T022
malignancies	B-T038
while	O
surgical	B-T058
resection	I-T058
remains	O
the	O
standard	O
of	O
care	O
in	O
the	O
treatment	B-T058
of	O
upper	B-T022
urinary	I-T022
tract	I-T022
malignancies	B-T038
,	O
nephrectomy	B-T058
is	O
a	O
risk	B-T033
factor	I-T033
for	O
the	O
development	O
of	O
chronic	B-T038
kidney	I-T038
disease	I-T038
(	O
ckd	B-T038
)	O
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
whether	O
histologic	O
evaluation	B-T058
of	O
non	B-T017
-	I-T017
neoplastic	I-T017
kidney	I-T017
could	O
enable	O
early	O
identification	O
of	O
unrecognized	O
kidney	B-T038
disease	I-T038
and	O
could	O
be	O
of	O
prognostic	B-T170
value	O
in	O
predicting	O
postoperative	O
renal	B-T017
outcomes	O
.	O
we	O
retrospectively	B-T062
analyzed	I-T062
51	O
patients	O
with	O
upper	B-T022
urinary	I-T022
tract	I-T022
malignancies	B-T038
who	O
received	O
unin	B-T058
##eph	I-T058
##rect	I-T058
##omy	I-T058
or	O
unin	B-T058
##eph	I-T058
##rou	I-T058
##ret	I-T058
##ere	I-T058
##ct	I-T058
##omy	I-T058
.	O
a	O
thorough	O
pathologic	O
evaluation	B-T058
of	O
non	B-T017
-	I-T017
neoplastic	I-T017
kidney	I-T017
including	O
special	B-T058
stains	I-T058
,	O
immunofluorescence	B-T058
,	O
and	O
electron	B-T058
microscopic	I-T058
studies	I-T058
was	O
performed	O
.	O
the	O
degree	O
of	O
parenchymal	B-T017
changes	O
was	O
graded	O
from	O
0	O
to	O
15	O
.	O
of	O
51	O
patients	O
,	O
only	O
13	O
showed	O
normal	O
kidney	B-T017
pathology	B-T091
.	O
fifteen	O
patients	O
showed	O
glomerular	O
abnormalities	O
,	O
14	O
showed	O
diabetic	B-T038
nephropathy	I-T038
,	O
and	O
11	O
showed	O
vascular	B-T017
nephropathy	B-T058
.	O
there	O
was	O
one	O
case	O
each	O
of	O
reflux	B-T038
nephropathy	I-T038
and	O
chronic	B-T038
pyelonephritis	I-T038
.	O
the	O
median	O
histologic	O
score	O
was	O
5	O
points	O
.	O
only	O
25	O
.	O
4	O
%	O
of	O
patients	O
had	O
≤	O
3	O
points	O
.	O
score	O
more	O
than	O
5	O
was	O
observed	O
in	O
47	O
.	O
1	O
%	O
of	O
patients	O
.	O
postoperative	O
estimated	B-T058
glomerular	I-T058
filtration	I-T058
rate	I-T058
(	O
egfr	B-T058
)	O
at	O
3	O
to	O
36	O
months	O
were	O
obtained	O
from	O
90	O
.	O
2	O
%	O
of	O
patients	O
,	O
and	O
of	O
those	O
,	O
34	O
.	O
8	O
%	O
had	O
de	O
novo	O
ckd	B-T038
.	O
since	O
no	O
one	O
had	O
ckd	B-T038
in	O
partial	O
nephr	O
##ectomized	O
patients	O
,	O
we	O
determined	O
risk	B-T033
factors	I-T033
for	O
ckd	B-T038
in	O
radical	O
nephr	O
##ectomized	O
patients	O
.	O
cox	B-T170
regression	I-T170
analysis	I-T170
revealed	O
that	O
postoperative	O
aki	B-T037
,	O
preoperative	O
egfr	B-T058
,	O
and	O
histologic	O
score	O
of	O
non	B-T017
-	I-T017
neoplastic	I-T017
kidney	I-T017
were	O
the	O
independent	O
predictors	O
for	O
ckd	B-T038
.	O
we	O
conclude	O
that	O
routine	O
pathologic	O
evaluation	B-T058
of	O
non	B-T017
-	I-T017
neoplastic	I-T017
kidney	I-T017
provides	O
valuable	O
diagnostic	O
and	O
prognostic	B-T170
information	O
.	O

quantitative	O
regulation	B-T038
of	O
histone	B-T103
variant	I-T103
h2	I-T103
##a	I-T103
.	I-T103
z	I-T103
during	O
cell	B-T038
cycle	I-T038
by	O
ubiquitin	B-T038
proteasome	I-T038
system	I-T038
and	O
sumo	B-T017
-	I-T017
targeted	I-T017
ubiquitin	I-T017
ligase	I-T017
##s	I-T017
quantitative	O
control	O
of	O
histones	B-T103
and	O
histone	B-T103
variants	I-T103
during	O
cell	B-T038
cycle	I-T038
is	O
relevant	O
to	O
their	O
epigenetic	B-T038
functions	I-T038
.	O
we	O
found	O
that	O
the	O
level	O
of	O
yeast	B-T103
histone	I-T103
variant	I-T103
h2	I-T103
##a	I-T103
.	I-T103
z	I-T103
in	O
the	O
g2	B-T038
/	I-T038
m	I-T038
-	I-T038
phase	I-T038
is	O
actively	O
kept	O
low	O
by	O
the	O
ubiquitin	B-T038
proteasome	I-T038
system	I-T038
and	O
sumo	B-T017
-	I-T017
targeted	I-T017
ubiquitin	I-T017
ligase	I-T017
##s	I-T017
.	O
overexpression	B-T038
of	O
h2	B-T103
##a	I-T103
.	I-T103
z	I-T103
induced	B-T038
defects	I-T038
in	I-T038
mitotic	I-T038
progression	I-T038
,	O
suggesting	O
functional	O
importance	O
of	O
this	O
quantitative	O
control	O
.	O

clinical	O
features	O
of	O
smokers	B-T033
with	O
radiological	B-T058
emphysema	B-T038
but	O
without	O
airway	B-T017
limitation	O
the	O
clinical	O
characteristics	O
of	O
patients	O
with	O
emphysema	B-T038
but	O
without	O
airway	B-T017
limitations	O
remain	O
unknown	O
.	O
the	O
goal	B-T170
of	O
this	O
study	B-T062
was	O
to	O
compare	O
the	O
clinical	O
features	O
of	O
current	B-T033
and	O
former	B-T033
smokers	I-T033
without	O
airflow	B-T038
limitation	O
who	O
have	O
radiologic	B-T058
emphysema	B-T038
on	O
chest	B-T058
ct	I-T058
scans	I-T058
vs	O
a	O
control	O
group	O
of	O
current	B-T033
and	O
ex	B-T033
-	I-T033
smokers	I-T033
without	O
emphysema	B-T038
.	O
subjects	O
enrolled	O
had	O
anthropometric	O
characteristics	O
recorded	O
,	O
provided	O
a	O
medical	B-T033
history	I-T033
,	O
and	O
underwent	O
low	O
-	O
dose	O
chest	B-T058
ct	I-T058
scanning	I-T058
.	O
the	O
following	O
parameters	B-T033
were	O
also	O
evaluated	O
:	O
pulmonary	B-T058
function	I-T058
tests	I-T058
including	O
diffusion	B-T058
capacity	I-T058
for	I-T058
carbon	I-T058
monoxide	I-T058
(	O
dl	B-T058
##co	I-T058
)	O
,	O
the	O
modified	O
medical	B-T170
research	I-T170
council	I-T170
dyspnea	I-T170
score	I-T170
,	O
copd	B-T170
assessment	I-T170
test	I-T170
(	O
cat	B-T170
)	O
,	O
and	O
6	B-T058
-	I-T058
min	I-T058
walk	I-T058
test	I-T058
(	O
6m	B-T058
##wt	I-T058
)	O
.	O
a	O
comparison	O
was	O
conducted	O
between	O
those	O
with	O
and	O
without	O
ct	B-T058
-	O
confirmed	B-T033
emphysema	B-T038
.	O
of	O
the	O
203	O
subjects	O
,	O
154	O
had	O
emphysema	B-T038
,	O
and	O
49	O
did	O
not	O
.	O
adjusted	O
group	B-T098
comparisons	O
revealed	O
that	O
a	O
higher	O
proportion	O
of	O
patients	O
with	O
emphysema	B-T038
according	O
to	O
low	O
-	O
dose	O
chest	B-T058
ct	I-T058
scanning	I-T058
had	O
an	O
abnormal	B-T033
dl	I-T033
##co	I-T033
value	O
(	O
<	O
80	O
%	O
)	O
(	O
46	O
%	O
vs	O
19	O
%	O
;	O
p	O
=	O
.	O
02	O
)	O
,	O
a	O
decrease	O
in	O
percentage	O
of	O
oxygen	B-T038
saturation	I-T038
>	O
4	O
%	O
during	O
the	O
6m	B-T058
##wt	I-T058
(	O
8	O
.	O
5	O
%	O
vs	O
0	O
;	O
p	O
=	O
.	O
04	O
)	O
,	O
and	O
an	O
altered	O
quality	O
of	O
life	O
(	O
cat	B-T170
score	O
≥	O
10	O
)	O
(	O
32	O
%	O
vs	O
14	O
%	O
;	O
p	O
=	O
.	O
01	O
)	O
.	O
a	O
detailed	O
analysis	B-T062
of	O
the	O
cat	B-T170
questionnaire	I-T170
items	O
revealed	O
that	O
more	O
patients	O
with	O
emphysema	B-T038
had	O
a	O
score	O
≥	O
1	O
in	O
the	O
[UNK]	O
chest	B-T033
tight	I-T033
##ness	I-T033
[UNK]	O
(	O
p	O
=	O
.	O
05	O
)	O
and	O
[UNK]	O
limitation	O
when	O
doing	O
activities	O
at	O
home	B-T082
[UNK]	O
(	O
p	O
<	O
.	O
01	O
)	O
items	O
compared	O
with	O
those	O
with	O
no	B-T033
emphysema	I-T033
.	O
they	O
also	O
experienced	O
significantly	O
more	O
exacerbations	B-T033
in	O
the	O
previous	O
year	O
(	O
0	O
.	O
19	O
vs	O
0	O
.	O
04	O
;	O
p	O
=	O
.	O
02	O
)	O
.	O
a	O
significant	O
proportion	O
of	O
smokers	B-T033
with	O
emphysema	B-T038
according	O
to	O
low	O
-	O
dose	O
chest	B-T058
ct	I-T058
scanning	I-T058
but	O
without	O
airway	B-T017
limitation	O
had	O
alterations	O
in	O
their	O
quality	O
of	O
life	O
,	O
number	O
of	O
exacerbations	B-T033
,	O
dl	B-T058
##co	I-T058
values	O
,	O
and	O
oxygen	B-T038
saturation	I-T038
during	O
the	O
6m	B-T058
##wt	I-T058
test	I-T058
.	O

f	B-T103
##yn	I-T103
regulates	O
multip	O
##olar	O
-	O
bipolar	B-T082
transition	O
and	O
neurite	B-T038
morphogenesis	I-T038
of	O
migrating	B-T038
neurons	I-T038
in	O
the	O
developing	B-T038
neocortex	I-T038
f	B-T103
##yn	I-T103
is	O
a	O
non	B-T033
-	I-T033
receptor	I-T033
protein	B-T103
tyrosine	I-T103
kinase	I-T103
that	O
belongs	O
to	O
src	B-T103
family	I-T103
kinases	I-T103
.	O
f	B-T103
##yn	I-T103
plays	O
a	O
critical	O
role	O
in	O
neuronal	B-T038
migration	I-T038
,	O
but	O
the	O
mechanism	O
remains	O
unclear	O
.	O
here	O
,	O
we	O
reported	O
that	O
suppression	B-T038
of	O
f	B-T103
##yn	I-T103
expression	B-T038
in	O
mouse	B-T017
cerebral	I-T017
cortex	I-T017
led	O
to	O
migration	B-T033
defects	I-T033
of	O
both	O
early	O
-	O
born	O
and	O
late	O
-	O
born	O
neurons	B-T017
.	O
morphological	B-T082
analysis	B-T062
showed	O
that	O
loss	O
of	O
f	B-T103
##yn	I-T103
function	O
impaired	O
multip	O
##olar	O
-	O
bipolar	B-T082
transition	O
of	O
newly	O
generated	O
neurons	B-T017
and	O
neurite	B-T038
formation	I-T038
in	O
the	O
early	O
phase	O
of	O
migration	B-T038
.	O
moreover	O
,	O
f	B-T103
##yn	I-T103
inhibition	B-T038
increased	O
the	O
length	O
of	O
leading	B-T038
process	I-T038
and	O
decreased	O
the	O
branching	B-T082
number	O
of	O
the	O
migrating	B-T038
cortical	I-T038
neurons	I-T038
.	O
together	O
,	O
these	O
results	O
indicate	O
that	O
f	B-T103
##yn	I-T103
controls	O
neuronal	B-T038
migration	I-T038
by	O
regulating	B-T038
the	O
cytoskeletal	B-T017
dynamics	O
and	O
multip	O
##olar	O
-	O
bipolar	B-T082
transition	O
of	O
newly	O
generated	O
neurons	B-T017
during	O
cortical	B-T038
development	I-T038
.	O

effect	O
of	O
xeno	B-T058
##transplantation	I-T058
site	B-T082
on	O
microrna	B-T103
expression	B-T038
of	O
human	B-T204
colon	B-T038
cancer	I-T038
stem	B-T017
cells	I-T017
cancer	B-T017
stem	I-T017
cells	I-T017
(	O
cscs	B-T017
)	O
have	O
a	O
high	O
tumorigenic	B-T038
ability	O
to	O
form	O
patient	B-T038
-	I-T038
derived	I-T038
tumor	I-T038
xenografts	I-T038
(	O
pd	B-T038
##xs	I-T038
)	O
.	O
pd	B-T038
##xs	I-T038
are	O
an	O
attractive	O
pre	B-T170
-	I-T170
clinical	I-T170
model	I-T170
,	O
but	O
gene	B-T038
expression	I-T038
and	O
biological	O
behavior	O
of	O
cancer	B-T017
cells	I-T017
in	O
the	O
tumor	B-T038
will	O
change	O
during	O
establishment	O
and	O
passage	O
of	O
pd	B-T038
##xs	I-T038
.	O
human	B-T204
colon	B-T038
cancer	I-T038
pd	B-T038
##x	I-T038
was	O
established	O
and	O
passage	B-T058
##d	I-T058
either	O
subcutaneously	B-T082
or	O
orthotopic	B-T082
##ally	I-T082
into	O
the	O
murine	B-T204
intestine	B-T017
.	O
histology	B-T091
and	O
flow	B-T058
cytometric	I-T058
profile	B-T058
of	O
the	O
surgical	B-T058
specimen	O
and	O
the	O
pd	B-T038
##x	I-T038
were	O
analyzed	B-T062
.	O
cscs	B-T017
were	O
then	O
isolated	O
from	O
the	O
tumors	B-T038
and	O
their	O
microrna	B-T103
(	O
mirna	B-T103
)	O
expression	B-T038
was	O
analyzed	B-T062
by	O
semi	B-T058
-	I-T058
quantitative	I-T058
polymerase	I-T058
chain	I-T058
reaction	I-T058
.	O
the	O
surgical	B-T058
specimens	O
and	O
pd	B-T038
##xs	I-T038
were	O
histologically	B-T091
similar	O
.	O
the	O
size	B-T082
of	O
csc	B-T017
population	B-T098
increased	O
and	O
expression	B-T038
of	O
mirna	B-T103
s	O
in	O
cscs	B-T017
changed	O
in	O
the	O
passage	B-T058
##d	I-T058
pd	B-T038
##xs	I-T038
.	O
expression	B-T038
of	O
oncogenic	B-T103
mirnas	B-T103
was	O
highly	O
up	B-T038
-	I-T038
regulated	I-T038
in	O
the	O
cscs	B-T017
of	O
the	O
orthotopic	B-T082
##ally	I-T082
passage	B-T058
##d	I-T058
pd	B-T038
##xs	I-T038
.	O
the	O
xeno	B-T058
##transplantation	I-T058
site	B-T082
and	O
the	O
number	O
of	O
tumor	B-T038
passages	B-T058
affect	B-T038
the	O
mirna	B-T103
expression	B-T038
of	O
human	B-T204
colon	B-T017
cscs	B-T017
.	O

the	B-T170
dan	I-T170
##iel	I-T170
k	I-T170
.	I-T170
in	I-T170
##ou	I-T170
##y	I-T170
##e	I-T170
college	I-T170
of	I-T170
pharmacy	I-T170
scr	I-T170
##ipt	I-T170
##s	I-T170
:	O
po	B-T168
##ha	I-T168
ber	I-T168
##ry	I-T168
(	O
phys	B-T204
##alis	I-T204
peru	I-T204
##vian	I-T204
##a	I-T204
)	O
with	O
potential	O
anti	O
-	O
inflammatory	O
and	O
cancer	B-T058
prevention	I-T058
activities	O
the	B-T092
dan	I-T092
##iel	I-T092
k	I-T092
.	I-T092
in	I-T092
##ou	I-T092
##y	I-T092
##e	I-T092
college	I-T092
of	I-T092
pharmacy	I-T092
,	O
during	O
a	O
historic	O
event	O
in	O
spring	O
2016	O
,	O
graduate	B-T098
##d	I-T098
the	O
first	O
two	O
students	B-T098
in	O
the	O
pacific	B-T082
region	I-T082
to	O
ear	O
##n	O
a	O
ph	B-T170
##d	I-T170
in	O
pharmaceutical	B-T091
sciences	I-T091
at	O
the	O
university	B-T092
of	I-T092
haw	I-T092
##ai	I-T092
'	I-T092
i	I-T092
at	O
hil	B-T082
##o	I-T082
.	O
the	O
college	B-T092
offers	O
ph	B-T170
##d	I-T170
programs	O
in	O
these	O
five	O
disciplines	O
:	O
cancer	B-T091
biology	I-T091
,	O
medicinal	B-T091
chemistry	I-T091
,	O
pharmaceu	B-T062
##tics	I-T062
,	O
pharmac	B-T091
##ogn	I-T091
##os	I-T091
##y	I-T091
,	O
and	O
pharmacology	B-T091
.	O
one	O
of	O
the	O
pharmac	B-T091
##ogn	I-T091
##os	I-T091
##y	I-T091
diss	B-T170
##ert	I-T170
##ations	I-T170
focused	O
on	O
plant	B-T204
-	I-T204
derived	I-T204
natural	B-T103
products	I-T103
with	O
potential	O
anti	O
-	O
inflammatory	O
and	O
cancer	B-T038
chemopreventive	O
activities	O
.	O
phys	B-T204
##alis	I-T204
peru	I-T204
##vian	I-T204
##a	I-T204
(	O
pp	B-T204
)	O
l	O
.	O
originated	O
in	O
tropical	O
south	B-T082
america	I-T082
.	O
it	O
has	O
become	O
natural	O
##ized	O
and	O
is	O
found	O
readily	O
on	O
the	O
island	B-T082
of	I-T082
haw	I-T082
##ai	I-T082
'	I-T082
i	I-T082
.	O
the	O
edible	B-T168
fruits	B-T168
are	O
commonly	O
known	O
as	O
cape	B-T204
go	I-T204
##ose	I-T204
##berry	I-T204
or	O
po	B-T204
##ha	I-T204
in	O
haw	B-T082
##ai	I-T082
'	I-T082
i	I-T082
.	O
in	O
part	O
of	O
our	O
study	O
,	O
three	O
new	O
with	B-T103
##anol	I-T103
##ides	I-T103
,	O
phys	B-T103
##aper	I-T103
##uv	I-T103
##in	I-T103
g	I-T103
(	O
1	O
)	O
,	O
phys	B-T103
##aper	I-T103
##uv	I-T103
##ins	I-T103
i	I-T103
-	I-T103
j	I-T103
(	O
2	O
-	O
3	O
)	O
,	O
along	O
with	O
four	O
known	O
with	B-T103
##anol	I-T103
##ides	I-T103
,	O
namely	O
,	O
4	B-T103
##β	I-T103
-	I-T103
hydroxy	I-T103
##with	I-T103
##anol	I-T103
##ide	I-T103
e	I-T103
(	O
4	O
)	O
,	O
with	B-T103
##aper	I-T103
##uv	I-T103
##in	I-T103
c	I-T103
(	O
5	O
)	O
,	O
and	O
phys	B-T103
##alact	I-T103
##one	I-T103
(	O
6	O
)	O
,	O
coagul	B-T103
##in	I-T103
(	O
7	O
)	O
were	O
isolated	O
from	O
the	O
aerial	B-T204
parts	I-T204
of	O
p	B-T204
.	I-T204
peru	I-T204
##vian	I-T204
##a	I-T204
.	O
in	O
addition	O
,	O
two	O
known	O
compounds	B-T103
,	O
ph	B-T103
##ype	I-T103
##ru	I-T103
##no	I-T103
##li	I-T103
##de	I-T103
f	I-T103
(	O
8	O
)	O
,	O
and	O
with	B-T103
##anol	I-T103
##ide	I-T103
s	I-T103
(	O
9	O
)	O
,	O
were	O
isolated	O
and	O
identified	O
from	O
the	O
po	B-T168
##ha	I-T168
ber	I-T168
##ry	I-T168
fruits	I-T168
.	O
the	O
structures	B-T082
and	O
absolute	B-T082
stereochemistry	I-T082
of	O
new	O
compounds	O
from	O
po	B-T204
##ha	I-T204
were	O
elucidated	O
by	O
several	O
spectroscopy	O
methods	O
:	O
nuclear	B-T058
magnetic	I-T058
resonance	I-T058
(	I-T058
nmr	I-T058
)	I-T058
spectroscopy	I-T058
,	O
x	B-T058
-	I-T058
ray	I-T058
diffraction	I-T058
,	O
and	O
mass	B-T058
spectrometry	I-T058
analyses	B-T062
.	O
all	O
isolated	O
po	B-T204
##ha	I-T204
compounds	B-T103
(	O
aerial	B-T204
parts	I-T204
and	O
fruits	B-T168
)	O
were	O
evaluated	O
for	O
their	O
anti	O
-	O
inflammatory	O
activity	O
with	O
lipopolysaccharide	B-T103
(	O
lps	B-T103
)	O
-	O
activated	O
murine	B-T204
macrophage	B-T017
raw	I-T017
264	I-T017
.	I-T017
7	I-T017
cells	I-T017
,	O
and	O
tumor	B-T103
necrosis	I-T103
factor	I-T103
alpha	I-T103
(	O
tnf	B-T103
-	I-T103
α	I-T103
)	O
-	O
activated	O
nuclear	B-T103
factor	I-T103
-	I-T103
kappa	I-T103
b	I-T103
(	O
nf	B-T103
-	I-T103
κb	I-T103
)	O
with	O
transfected	O
human	B-T017
embryonic	I-T017
kidney	I-T017
cells	I-T017
293	I-T017
.	O
most	O
of	O
the	O
isolated	O
natural	B-T103
compounds	I-T103
showed	O
activity	O
with	O
these	O
assays	B-T058
.	O
additional	O
studies	O
were	O
performed	O
with	O
models	B-T170
of	O
colon	B-T038
cancer	I-T038
.	O
specifically	O
,	O
4	B-T103
##β	I-T103
-	I-T103
hydroxy	I-T103
##with	I-T103
##anol	I-T103
##ide	I-T103
e	I-T103
(	O
4h	B-T103
##we	I-T103
)	O
inhibited	O
the	O
growth	B-T038
of	O
colon	B-T038
cancer	I-T038
monolayer	B-T058
and	O
spher	B-T017
##oid	I-T017
cultures	B-T058
.	O
the	O
compound	B-T103
induced	O
cell	B-T038
cycle	I-T038
arrest	I-T038
at	O
low	O
concentrations	O
and	O
apoptosis	B-T038
at	O
higher	O
concentrations	O
.	O
these	O
data	O
suggest	O
the	O
ingestion	B-T038
of	O
po	B-T168
##ha	I-T168
ber	I-T168
##ries	I-T168
may	O
have	O
some	O
effect	O
on	O
the	O
prevalence	O
of	O
colon	B-T038
cancer	I-T038
.	O
additionally	O
,	O
po	B-T168
##ha	I-T168
isolates	B-T103
compounds	I-T103
were	O
evaluated	O
for	O
their	O
growth	B-T038
inhibitory	I-T038
effects	I-T038
with	O
u	B-T038
##25	I-T038
##1	I-T038
##mg	I-T038
glioblastoma	I-T038
and	O
mda	B-T038
-	I-T038
mb	I-T038
-	I-T038
231	I-T038
breast	I-T038
cancer	I-T038
cells	I-T038
that	O
harbor	O
aberrant	O
##ly	O
-	O
active	O
signal	B-T103
transducer	I-T103
and	I-T103
activation	I-T103
of	I-T103
transcription	I-T103
3	I-T103
(	I-T103
stat3	I-T103
)	I-T103
,	O
compared	O
to	O
normal	O
nih	B-T017
-	I-T017
3t3	I-T017
mouse	I-T017
fibroblasts	I-T017
.	O
this	O
work	O
has	O
led	O
to	O
the	O
fil	O
##ing	O
of	O
three	O
provisional	B-T170
patent	I-T170
##s	I-T170
with	O
the	O
university	B-T092
of	I-T092
haw	I-T092
##ai	I-T092
'	I-T092
i	I-T092
office	I-T092
of	I-T092
technology	I-T092
transfer	I-T092
and	I-T092
economic	I-T092
development	I-T092
.	O

comparison	O
of	O
a	O
new	O
visual	B-T058
style	I-T058
##t	I-T058
(	I-T058
disc	I-T058
##opo	I-T058
)	I-T058
-	I-T058
guided	I-T058
laryngeal	B-T058
mask	I-T058
airway	I-T058
placement	I-T058
vs	O
conventional	B-T058
blind	I-T058
technique	I-T058
:	O
a	O
prospective	O
randomized	B-T062
study	O
to	O
compare	O
the	O
ease	O
of	O
laryngeal	B-T058
mask	I-T058
airway	I-T058
(	I-T058
lm	I-T058
##a	I-T058
)	I-T058
insertion	I-T058
and	O
fiber	B-T082
##optic	I-T082
view	I-T082
of	O
lm	B-T074
##a	I-T074
after	O
placement	O
using	O
the	O
disc	B-T058
##opo	I-T058
visual	I-T058
style	I-T058
##t	I-T058
-	I-T058
guided	I-T058
insertion	I-T058
and	O
conventional	B-T058
blind	I-T058
technique	I-T058
.	O
prospective	O
,	O
randomized	B-T062
controlled	B-T062
study	I-T062
.	O
operating	B-T092
room	I-T092
in	O
a	O
university	B-T092
hospital	I-T092
.	O
one	O
hundred	O
adult	O
patients	O
scheduled	O
for	O
elective	B-T058
surgery	I-T058
under	O
lm	B-T074
##a	I-T074
general	B-T058
anesthesia	I-T058
were	O
enrolled	O
.	O
patients	O
were	O
randomly	B-T062
allocated	O
to	O
2	O
groups	O
:	O
gl	O
##ma	O
group	O
using	O
a	O
visual	B-T058
style	I-T058
##t	I-T058
-	I-T058
guided	I-T058
technique	I-T058
(	O
n	O
=	O
50	O
)	O
and	O
blm	O
##a	O
group	O
using	O
standard	O
blind	B-T058
technique	I-T058
(	O
n	O
=	O
50	O
)	O
.	O
correct	O
placement	O
of	O
the	O
lm	B-T074
##a	I-T074
was	O
confirmed	O
using	O
clinical	O
test	O
along	O
with	O
fiber	O
##optic	O
assessment	B-T058
.	O
un	O
##bl	O
##ind	O
##ed	O
data	O
were	O
collected	O
about	O
the	O
insertion	B-T058
time	O
,	O
the	O
first	O
attempt	O
success	O
rate	O
,	O
the	O
lm	B-T074
##a	I-T074
position	B-T082
adjustment	O
rate	O
,	O
fiber	B-T082
##optic	I-T082
view	I-T082
of	O
lm	B-T074
##a	I-T074
anatomical	B-T082
position	I-T082
,	O
hemodynamic	B-T038
responses	I-T038
,	O
and	O
the	O
adverse	O
insertion	B-T058
responses	O
(	O
buck	B-T037
##ing	I-T037
,	O
breath	B-T033
##holding	I-T033
,	O
and	O
laryng	B-T037
##ospasm	I-T037
)	O
.	O
blinded	O
data	O
were	O
recorded	O
about	O
postoperative	O
airway	B-T038
morbidity	I-T038
(	O
visible	O
blood	B-T031
staining	I-T031
on	O
lm	B-T074
##a	I-T074
at	O
removal	O
,	O
sor	B-T033
##e	I-T033
throat	I-T033
,	O
and	O
ho	B-T033
##arse	I-T033
##ness	I-T033
)	O
.	O
insertion	B-T058
was	O
more	O
frequently	O
successful	O
at	O
the	O
first	O
attempt	O
in	O
gl	O
##ma	O
than	O
that	O
in	O
blm	O
##a	O
group	O
(	O
100	O
%	O
vs	O
92	O
%	O
;	O
p	O
=	O
.	O
041	O
)	O
.	O
the	O
time	O
taken	O
for	O
establishing	O
effective	O
airway	O
was	O
shorter	O
in	O
gl	O
##ma	O
than	O
that	O
in	O
blm	O
##a	O
(	O
54	O
.	O
8	O
vs	O
62	O
.	O
9	O
seconds	O
;	O
p	O
=	O
.	O
001	O
)	O
.	O
the	O
patients	O
in	O
blm	O
##a	O
group	O
required	O
more	O
read	O
##ju	O
##st	O
##ment	O
and	O
rein	B-T058
##se	I-T058
##rt	I-T058
##ion	I-T058
than	O
those	O
in	O
gl	O
##ma	O
group	O
(	O
38	O
%	O
vs	O
0	O
%	O
;	O
p	O
=	O
.	O
000	O
)	O
.	O
the	O
fiber	B-T082
##optic	I-T082
view	I-T082
was	O
significantly	O
better	O
in	O
gl	O
##ma	O
group	O
(	O
p	O
<	O
.	O
001	O
)	O
.	O
no	O
difference	O
between	O
the	O
2	O
groups	O
existed	O
regarding	O
hemodynamic	B-T038
stress	I-T038
responses	I-T038
,	O
incidences	O
of	O
adverse	O
insertion	B-T058
responses	O
,	O
and	O
postoperative	O
airway	B-T038
morbidity	I-T038
.	O
by	O
direct	O
visualizing	O
the	O
whole	O
process	O
of	O
lm	B-T074
##a	I-T074
insertion	B-T058
,	O
the	O
disc	B-T058
##opo	I-T058
visual	I-T058
style	I-T058
##t	I-T058
increases	O
the	O
success	O
rate	O
and	O
accuracy	O
rate	O
of	O
lm	B-T074
##a	I-T074
placement	O
without	O
increasing	O
hemodynamic	B-T038
stress	I-T038
response	I-T038
or	O
incidences	O
of	O
adverse	B-T038
events	I-T038
.	O

molecular	O
simulation	O
study	B-T062
on	O
concentration	O
effects	O
of	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
with	O
pop	B-T103
##c	I-T103
bilayer	B-T017
the	O
interactions	B-T038
between	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
and	O
pop	B-T103
##c	I-T103
(	B-T103
1	I-T103
-	I-T103
palmitoyl	I-T103
-	I-T103
2	I-T103
-	I-T103
ole	I-T103
##oyl	I-T103
-	I-T103
sn	I-T103
-	I-T103
glycero	I-T103
-	I-T103
3	I-T103
-	I-T103
phospho	I-T103
##choline	I-T103
)	I-T103
bilayer	B-T017
were	O
studied	B-T062
using	O
all	O
-	O
atom	O
molecular	O
dynamics	O
simulation	O
method	B-T170
.	O
four	O
pop	B-T103
##c	I-T103
bilayer	B-T017
systems	O
with	O
different	O
number	O
of	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
molecules	O
were	O
constructed	O
to	O
simulate	O
different	O
drug	B-T103
concentration	O
.	O
the	O
free	O
energy	O
of	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
passing	O
across	O
pure	O
pop	B-T103
##c	I-T103
bilayer	B-T017
has	O
two	O
minim	O
##a	O
(	O
at	O
z	O
∼	O
##1	O
.	O
2n	O
##m	O
or	O
1	O
.	O
6	O
##nm	O
)	O
.	O
as	O
for	O
the	O
high	O
concentration	O
model	B-T170
,	O
the	O
minimum	O
of	O
the	O
free	O
energy	O
profile	O
slightly	O
shifts	O
to	O
the	O
bilayer	B-T017
center	B-T082
.	O
moreover	O
,	O
the	O
energy	O
change	O
from	O
bulk	O
water	O
to	O
pop	B-T103
##c	I-T103
bilayer	B-T017
increases	O
while	O
the	O
central	B-T082
barrier	B-T038
to	O
cross	O
the	O
hydrophobic	O
core	O
of	O
bilayer	B-T017
slightly	O
decreases	O
,	O
suggesting	O
that	O
increasing	O
drug	B-T103
concentration	O
makes	O
it	O
favorable	B-T033
for	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
to	O
partition	O
into	O
the	O
bilayer	B-T017
and	O
easier	O
to	O
pass	O
across	O
bi	B-T017
##aly	I-T017
##er	I-T017
center	B-T082
.	O
energy	O
analysis	B-T062
show	O
that	O
the	O
stabilization	O
between	O
the	O
selected	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
and	O
other	O
pre	O
-	O
inserted	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
molecule	O
is	O
mainly	O
due	O
to	O
van	O
der	O
waals	O
interaction	O
energy	O
.	O
the	O
predicted	O
permeability	O
of	O
ro	B-T103
##fe	I-T103
##co	I-T103
##x	I-T103
##ib	I-T103
in	O
high	O
concentration	O
model	B-T170
slightly	O
weak	O
##ens	O
as	O
compared	O
with	O
low	O
concentration	O
model	B-T170
.	O

identifying	O
research	B-T062
priorities	I-T062
with	O
nurses	B-T097
at	O
a	O
tertiary	O
children	O
'	O
s	O
hospital	B-T092
in	O
the	O
united	B-T082
kingdom	I-T082
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
undertake	O
a	O
research	B-T062
priority	I-T062
setting	O
exercise	O
with	O
the	O
aim	O
of	O
maximizing	O
efficiency	O
and	O
impact	O
in	O
research	B-T062
activity	I-T062
undertaken	O
by	O
nurses	B-T097
at	O
one	O
children	O
'	O
s	O
tertiary	O
healthcare	B-T092
institution	I-T092
by	O
ensuring	O
the	O
clinical	B-T097
staff	I-T097
directly	O
shaped	O
a	O
coherent	O
,	O
transparent	O
and	O
consensus	O
driven	O
nurse	O
-	O
led	O
research	O
agenda	O
.	O
in	O
round	O
1	O
,	O
the	O
research	O
topics	O
of	O
147	O
nurses	B-T097
were	O
elicited	O
using	O
a	O
modified	B-T062
nominal	I-T062
group	I-T062
technique	I-T062
as	O
the	O
consensus	B-T170
method	I-T170
.	O
the	O
number	O
of	O
participants	B-T098
in	O
the	O
24	O
separate	O
discussions	O
ranged	O
from	O
3	O
to	O
21	O
,	O
generating	O
lists	O
of	O
between	O
6	O
and	O
23	O
topics	O
.	O
in	O
round	O
2	O
,	O
nurses	B-T097
from	O
the	O
clinical	O
areas	O
ranked	B-T170
topics	O
of	O
importance	O
resulting	O
in	O
a	O
set	O
of	O
four	O
to	O
five	O
priorities	B-T062
.	O
in	O
round	O
3	O
,	O
the	O
division	B-T097
##al	I-T097
heads	I-T097
of	O
nursing	B-T091
consulted	O
with	O
staff	B-T097
in	O
all	O
of	O
their	O
clinical	O
areas	O
to	O
each	O
final	O
##ize	O
their	O
five	O
division	B-T062
##al	I-T062
priorities	I-T062
.	O
the	O
nursing	B-T097
research	I-T097
working	I-T097
group	I-T097
discussed	O
and	O
refined	O
the	O
divisions	B-T062
'	I-T062
priorities	I-T062
and	O
vo	O
##ted	O
on	O
the	O
final	O
list	O
to	O
agree	O
the	O
top	O
five	O
research	B-T062
priorities	I-T062
for	O
the	O
organization	B-T092
.	O
a	O
total	O
of	O
269	O
research	O
topics	O
were	O
initially	O
generated	O
.	O
following	O
three	O
rounds	O
of	O
ranking	B-T170
and	O
priori	O
##tizing	O
,	O
five	O
priorities	B-T062
were	O
agreed	O
at	O
division	B-T092
##al	I-T092
level	I-T092
,	O
and	O
from	O
these	O
,	O
the	O
five	O
top	O
organizational	B-T062
priorities	I-T062
were	O
selected	O
.	O
these	O
were	O
(	O
i	O
)	O
understanding	O
and	O
improving	O
all	O
aspects	O
of	O
the	O
patient	O
jour	O
##ney	O
through	O
the	O
hospital	B-T092
system	I-T092
;	O
(	O
ii	O
)	O
play	O
;	O
(	O
iii	O
)	O
staff	O
wellbeing	O
,	O
patient	B-T058
care	I-T058
and	O
productivity	O
;	O
(	O
iv	O
)	O
team	O
work	O
-	O
linking	O
to	O
a	O
more	O
efficient	O
service	O
;	O
and	O
(	O
v	O
)	O
supporting	O
parents	O
/	O
parent	O
pathway	O
.	O
division	O
##al	O
priorities	B-T062
have	O
been	O
disseminated	O
widely	O
to	O
clinical	B-T058
teams	I-T058
to	O
inform	O
a	O
patient	O
-	O
specific	O
nurse	O
-	O
led	O
research	O
agenda	O
.	O
organizational	B-T062
priorities	I-T062
agreed	O
upon	O
have	O
been	O
disseminated	O
through	O
management	O
structures	O
and	O
processes	O
to	O
ensure	O
engagement	O
at	O
all	O
levels	O
.	O
a	O
subgroup	B-T097
of	O
the	O
nursing	B-T097
research	I-T097
working	I-T097
group	I-T097
has	O
been	O
dele	O
##ga	O
##ted	O
to	O
take	O
this	O
work	O
forward	O
so	O
that	O
the	O
agreed	O
priorities	B-T062
continue	O
to	O
contribute	O
towards	O
shaping	O
nurse	B-T062
-	I-T062
led	I-T062
research	I-T062
activity	I-T062
,	O
thereby	O
going	O
some	O
way	O
to	O
inform	O
and	O
embed	O
an	O
evidence	O
-	O
based	O
culture	O
of	O
inquiry	O
.	O

impact	O
of	O
strategic	O
##ally	O
located	O
white	B-T038
matter	I-T038
hyperint	I-T038
##ensities	I-T038
on	O
cognition	B-T038
in	O
memory	B-T092
clinic	I-T092
patients	O
with	O
small	B-T038
vessel	I-T038
disease	I-T038
studies	O
on	O
the	O
impact	O
of	O
small	B-T038
vessel	I-T038
disease	I-T038
(	O
sv	B-T038
##d	I-T038
)	O
on	O
cognition	B-T038
generally	O
focus	B-T082
on	O
white	B-T038
matter	I-T038
hyperint	I-T038
##ensity	I-T038
(	O
wm	B-T038
##h	I-T038
)	O
volume	O
.	O
the	O
extent	B-T082
to	O
which	O
wm	B-T038
##h	I-T038
location	B-T082
relates	O
to	O
cognitive	B-T038
performance	I-T038
has	O
received	O
less	O
attention	B-T038
,	O
but	O
is	O
likely	O
to	O
be	O
functionally	O
important	O
.	O
we	O
examined	O
the	O
relation	O
between	O
wm	B-T038
##h	I-T038
location	B-T082
and	O
cognition	B-T038
in	O
a	O
memory	B-T092
clinic	I-T092
cohort	B-T098
of	O
patients	O
with	O
sporadic	O
sv	B-T038
##d	I-T038
.	O
a	O
total	O
of	O
167	O
patients	O
with	O
sv	B-T038
##d	I-T038
were	O
recruited	O
from	O
memory	B-T092
clinics	I-T092
.	O
assumption	B-T062
-	I-T062
free	I-T062
region	I-T062
of	I-T062
interest	I-T062
-	I-T062
based	I-T062
analyses	I-T062
based	O
on	O
major	O
white	B-T017
matter	I-T017
tracts	B-T017
and	O
voxel	O
-	O
wise	O
analyses	B-T062
were	O
used	O
to	O
determine	O
the	O
association	O
between	O
wm	B-T038
##h	I-T038
location	B-T082
and	O
executive	B-T038
functioning	I-T038
,	O
visu	B-T038
##omotor	I-T038
speed	I-T038
and	O
memory	B-T038
.	O
region	B-T062
of	I-T062
interest	I-T062
-	I-T062
based	I-T062
analyses	I-T062
showed	O
that	O
wm	B-T038
##hs	I-T038
located	B-T082
particularly	O
within	B-T082
the	O
anterior	B-T017
thalamic	I-T017
radiation	I-T017
and	O
forceps	B-T017
minor	I-T017
were	O
inversely	O
associated	O
with	O
both	O
executive	B-T038
functioning	I-T038
and	O
visu	B-T038
##omotor	I-T038
speed	I-T038
,	O
independent	O
of	O
total	O
wm	B-T038
##h	I-T038
volume	O
.	O
memory	B-T038
was	O
significantly	O
associated	O
with	O
wm	B-T038
##h	I-T038
volume	O
in	O
the	O
forceps	B-T017
minor	I-T017
,	O
independent	O
of	O
total	O
wm	B-T038
##h	I-T038
volume	O
.	O
an	O
independent	B-T062
assumption	I-T062
-	I-T062
free	I-T062
voxel	I-T062
-	I-T062
wise	I-T062
analysis	I-T062
identified	O
strategic	O
voxel	O
##s	O
in	O
these	O
same	O
tracts	B-T017
.	O
region	B-T062
of	I-T062
interest	I-T062
-	I-T062
based	I-T062
analyses	I-T062
showed	O
that	O
wm	B-T038
##h	I-T038
volume	O
within	B-T082
the	O
anterior	B-T017
thalamic	I-T017
radiation	I-T017
explained	O
6	O
.	O
8	O
%	O
of	O
variance	O
in	O
executive	B-T038
functioning	I-T038
,	O
compared	O
to	O
3	O
.	O
9	O
%	O
for	O
total	O
wm	B-T038
##h	I-T038
volume	O
;	O
wm	B-T038
##h	I-T038
volume	O
within	B-T082
the	O
forceps	B-T017
minor	I-T017
explained	O
4	O
.	O
6	O
%	O
of	O
variance	O
in	O
visu	B-T038
##omotor	I-T038
speed	I-T038
and	O
4	O
.	O
2	O
%	O
of	O
variance	O
in	O
memory	B-T038
,	O
compared	O
to	O
1	O
.	O
8	O
%	O
and	O
1	O
.	O
3	O
%	O
respectively	O
for	O
total	O
wm	B-T038
##h	I-T038
volume	O
.	O
our	O
findings	B-T033
identify	O
the	O
anterior	B-T017
thalamic	I-T017
radiation	I-T017
and	O
forceps	B-T017
minor	I-T017
as	O
strategic	O
white	B-T017
matter	I-T017
tracts	B-T017
in	O
which	O
wm	B-T038
##hs	I-T038
are	O
most	O
strongly	O
associated	O
with	O
cognitive	B-T038
impairment	I-T038
in	O
memory	B-T092
clinic	I-T092
patients	O
with	O
sv	B-T038
##d	I-T038
.	O
wm	B-T038
##h	I-T038
volumes	O
in	O
individual	O
tracts	B-T017
explained	O
more	O
variance	O
in	O
cognition	B-T038
than	O
total	O
wm	B-T038
##h	I-T038
burden	O
,	O
emphasizing	O
the	O
importance	O
of	O
lesion	O
location	O
when	O
addressing	O
the	O
functional	O
consequences	O
of	O
wm	B-T038
##hs	I-T038
.	O

systematic	B-T062
mapping	I-T062
of	O
functional	O
enhancer	B-T103
-	O
promoter	B-T103
connections	O
with	O
crispr	B-T058
interference	I-T058
gene	B-T038
expression	I-T038
in	O
mammals	B-T204
is	O
regulated	B-T038
by	O
noncoding	B-T103
elements	I-T103
that	O
can	O
affect	O
physiology	B-T038
and	O
disease	B-T038
,	O
yet	O
the	O
functions	O
and	O
target	B-T017
genes	I-T017
of	O
most	O
noncoding	B-T103
elements	I-T103
remain	O
unknown	O
.	O
we	O
present	O
a	O
high	O
-	O
throughput	O
approach	O
that	O
uses	O
clustered	B-T058
regularly	I-T058
intersp	I-T058
##aced	I-T058
short	I-T058
pal	I-T058
##ind	I-T058
##romic	I-T058
repeats	I-T058
(	I-T058
crispr	B-T103
)	I-T058
interference	I-T058
(	O
crispr	B-T058
##i	I-T058
)	O
to	O
discover	O
regulatory	B-T103
elements	I-T103
and	O
identify	O
their	O
target	B-T017
genes	I-T017
.	O
we	O
assess	O
>	O
1	O
meg	O
##aba	O
##se	O
of	O
sequence	B-T082
in	O
the	O
vicinity	O
of	O
two	O
essential	O
transcription	B-T103
factors	I-T103
,	O
myc	B-T103
and	O
gata	B-T103
##1	I-T103
,	O
and	O
identify	O
nine	O
distal	B-T082
enhancers	B-T103
that	O
control	O
gene	B-T038
expression	I-T038
and	O
cellular	B-T038
proliferation	I-T038
.	O
quantitative	O
features	O
of	O
chromatin	B-T103
state	O
and	O
chromosome	B-T017
conformation	B-T033
distinguish	O
the	O
seven	O
enhancers	B-T103
that	O
regulate	O
myc	B-T103
from	O
other	O
elements	B-T082
that	O
do	O
not	O
,	O
suggesting	O
a	O
strategy	O
for	O
predicting	O
enhancer	B-T103
-	O
promoter	B-T103
connectivity	O
.	O
this	O
crispr	B-T058
##i	I-T058
-	O
based	O
approach	O
can	O
be	O
applied	O
to	O
dissect	O
transcriptional	B-T038
networks	I-T038
and	O
interpret	O
the	O
contributions	O
of	O
noncoding	O
genetic	O
variation	O
to	O
human	B-T204
disease	B-T038
.	O

effect	O
of	O
constitutive	B-T038
inactivation	I-T038
of	O
the	O
myo	B-T017
##st	I-T017
##atin	I-T017
gene	I-T017
on	O
the	O
gain	O
in	O
muscle	B-T038
strength	I-T038
during	O
postnatal	B-T038
growth	I-T038
in	O
two	O
murine	B-T204
models	B-T204
the	O
effect	O
of	O
constitutive	B-T038
inactivation	I-T038
of	O
the	O
gene	B-T017
encoding	I-T017
myo	I-T017
##st	I-T017
##atin	I-T017
on	O
the	O
gain	O
in	O
muscle	B-T038
performance	I-T038
during	O
postnatal	B-T038
growth	I-T038
has	O
not	O
been	O
well	O
characterized	O
.	O
we	O
analyzed	O
2	O
murine	B-T204
myo	B-T017
##st	I-T017
##atin	I-T017
knockout	O
(	O
ko	O
)	O
models	O
,	O
(	O
i	O
)	O
the	O
le	B-T204
##e	I-T204
model	I-T204
(	O
ko	B-T204
(	I-T204
le	I-T204
##e	I-T204
)	O
)	O
and	O
(	O
ii	O
)	O
the	O
gro	B-T204
##be	I-T204
##t	I-T204
model	I-T204
(	O
ko	B-T204
(	I-T204
gro	I-T204
##be	I-T204
##t	I-T204
)	I-T204
)	O
,	O
and	O
measured	O
the	O
contraction	B-T038
of	O
tibialis	B-T017
anterior	I-T017
muscle	I-T017
in	B-T082
situ	I-T082
.	O
absolute	B-T038
maximal	I-T038
isometric	I-T038
force	I-T038
was	O
increased	O
in	O
6	O
-	O
month	O
-	O
old	O
ko	B-T204
(	I-T204
le	I-T204
##e	I-T204
)	I-T204
and	O
ko	B-T204
(	I-T204
gro	I-T204
##be	I-T204
##t	I-T204
)	I-T204
mice	I-T204
,	O
as	O
compared	O
to	O
wild	B-T204
-	I-T204
type	I-T204
mice	I-T204
.	O
similarly	O
,	O
absolute	B-T038
maximal	I-T038
power	I-T038
was	O
increased	O
in	O
6	O
-	O
month	O
-	O
old	O
ko	B-T204
(	I-T204
le	I-T204
##e	I-T204
)	I-T204
mice	I-T204
.	O
in	O
contrast	O
,	O
specific	O
maximal	B-T038
force	I-T038
(	O
relative	O
maximal	B-T038
force	I-T038
per	O
unit	O
of	O
muscle	B-T017
mass	B-T033
was	O
decreased	O
in	O
all	O
6	O
-	O
month	O
-	O
old	O
male	O
and	O
female	O
ko	B-T204
mice	I-T204
,	O
except	O
in	O
6	O
-	O
month	O
-	O
old	O
female	O
ko	B-T204
(	I-T204
gro	I-T204
##be	I-T204
##t	I-T204
)	I-T204
mice	I-T204
,	O
whereas	O
specific	O
maximal	O
power	O
was	O
reduced	O
only	O
in	O
male	O
ko	B-T204
(	I-T204
le	I-T204
##e	I-T204
)	I-T204
mice	I-T204
.	O
genetic	B-T038
inactivation	I-T038
of	O
myo	B-T017
##st	I-T017
##atin	I-T017
increases	O
maximal	B-T038
force	I-T038
and	O
power	O
,	O
but	O
in	O
return	O
it	O
reduces	O
muscle	B-T017
quality	O
,	O
particularly	O
in	O
male	O
mice	B-T204
.	O
muscle	O
nerve	O
55	O
:	O
254	O
-	O
261	O
,	O
2017	O
.	O

acute	O
sensitivity	O
of	O
the	O
ver	B-T204
##nal	I-T204
pool	I-T204
fair	I-T204
##y	I-T204
shrimp	I-T204
,	O
branch	B-T204
##ine	I-T204
##ct	I-T204
##a	I-T204
ly	I-T204
##nc	I-T204
##hi	I-T204
(	O
an	B-T204
##ostr	I-T204
##aca	I-T204
;	O
branch	B-T204
##ine	I-T204
##ct	I-T204
##idae	I-T204
)	O
,	O
and	O
surrogate	O
species	B-T170
to	O
10	O
chemicals	B-T103
ver	B-T204
##nal	I-T204
pool	I-T204
fair	I-T204
##y	I-T204
shrimp	I-T204
,	O
branch	B-T204
##ine	I-T204
##ct	I-T204
##a	I-T204
ly	I-T204
##nc	I-T204
##hi	I-T204
,	O
(	O
branch	B-T204
##iop	I-T204
##oda	I-T204
;	O
an	B-T204
##ostr	I-T204
##aca	I-T204
)	O
and	O
other	O
fair	B-T204
##y	I-T204
shrimp	I-T204
species	B-T170
have	O
been	O
listed	O
as	O
threatened	B-T098
or	O
endangered	B-T098
under	O
the	O
us	O
endangered	O
species	O
act	O
.	O
because	O
few	O
data	O
exist	O
about	O
the	O
sensitivity	O
of	O
branch	B-T204
##ine	I-T204
##ct	I-T204
##a	I-T204
spp	B-T170
.	I-T170
to	O
toxic	B-T037
effects	I-T037
of	O
contaminants	O
,	O
it	O
is	O
difficult	O
to	O
determine	O
whether	O
they	O
are	O
adequately	B-T204
protected	I-T204
by	O
water	O
quality	O
criteria	O
.	O
a	O
series	O
of	O
acute	B-T058
(	I-T058
24	I-T058
-	I-T058
h	I-T058
)	I-T058
lethality	I-T058
/	I-T058
immobilization	I-T058
tests	I-T058
was	O
conducted	O
with	O
3	O
species	B-T170
of	O
fair	B-T204
##y	I-T204
shrimp	I-T204
(	O
b	B-T204
.	I-T204
ly	I-T204
##nc	I-T204
##hi	I-T204
,	O
branch	B-T204
##ine	I-T204
##ct	I-T204
##a	I-T204
lind	I-T204
##ah	I-T204
##li	I-T204
,	O
and	O
tha	B-T204
##mn	I-T204
##oc	I-T204
##ephal	I-T204
##us	I-T204
plat	I-T204
##y	I-T204
##urus	I-T204
)	O
and	O
10	O
chemicals	B-T103
with	O
varying	O
modes	O
of	O
toxic	B-T103
action	I-T103
:	O
ammonia	B-T103
,	O
potassium	B-T103
,	O
chloride	B-T103
,	O
sulfate	B-T103
,	O
chromium	B-T103
(	I-T103
vi	I-T103
)	I-T103
,	O
copper	B-T103
,	O
nickel	B-T103
,	O
zinc	B-T103
,	O
ala	B-T103
##chlor	I-T103
,	O
and	O
met	B-T103
##olac	I-T103
##hl	I-T103
##or	I-T103
.	O
the	O
same	O
chemicals	B-T103
were	O
tested	O
in	O
48	O
-	O
h	O
tests	B-T058
with	O
other	O
branch	B-T204
##iop	I-T204
##ods	I-T204
(	O
the	O
clad	B-T204
##oc	I-T204
##era	I-T204
##ns	I-T204
daph	B-T204
##nia	I-T204
magna	I-T204
and	O
cer	B-T204
##iod	I-T204
##aph	I-T204
##nia	I-T204
dub	I-T204
##ia	I-T204
)	O
and	O
an	O
amphip	B-T204
##od	I-T204
(	O
hyal	B-T204
##ella	I-T204
azt	I-T204
##eca	I-T204
)	O
,	O
and	O
in	O
96	O
-	O
h	O
tests	B-T058
with	O
snails	B-T204
(	O
phys	B-T204
##a	I-T204
gyr	I-T204
##ina	I-T204
and	O
lym	B-T204
##na	I-T204
##ea	I-T204
stagn	I-T204
##alis	I-T204
)	O
.	O
median	O
effect	O
concentrations	O
(	O
ec50	O
##s	O
)	O
for	O
b	B-T204
.	I-T204
ly	I-T204
##nc	I-T204
##hi	I-T204
were	O
strongly	O
correlated	O
(	O
r	O
(	O
2	O
)	O
=	O
0	O
.	O
97	O
##5	O
)	O
with	O
ec50	O
##s	O
for	O
the	O
commercially	O
available	O
fair	B-T204
##y	I-T204
shrimp	I-T204
species	B-T170
t	B-T204
.	I-T204
plat	I-T204
##y	I-T204
##urus	I-T204
for	O
most	O
chemicals	B-T103
tested	O
.	O
comparison	O
of	O
ec50	O
##s	O
for	O
fair	B-T204
##y	I-T204
shrimp	I-T204
and	O
ec50	O
##s	O
for	O
invertebrate	B-T204
taxa	I-T204
tested	O
concurrently	O
and	O
with	O
other	O
published	O
toxicity	B-T037
data	O
indicated	O
that	O
fair	B-T204
##y	I-T204
shrimp	I-T204
were	O
relatively	O
sensitive	O
to	O
potassium	B-T103
and	O
several	O
trace	B-T103
metals	I-T103
compared	O
with	O
other	O
invertebrate	B-T204
taxa	I-T204
,	O
although	O
clad	B-T204
##oc	I-T204
##era	I-T204
##ns	I-T204
,	O
amphip	B-T204
##ods	I-T204
,	O
and	O
mussels	B-T204
had	O
similar	O
broad	O
toxic	O
##ant	O
sensitivity	O
.	O
intersp	B-T170
##ecies	I-T170
correlation	I-T170
estimation	I-T170
models	I-T170
for	O
predicting	O
toxicity	B-T037
to	O
fair	B-T204
##y	I-T204
shrimp	I-T204
from	O
surrogate	O
species	B-T170
indicated	O
that	O
models	B-T170
with	O
clad	B-T204
##oc	I-T204
##era	I-T204
##ns	I-T204
and	O
freshwater	B-T204
mussels	I-T204
as	O
surrogate	O
##s	O
produced	O
the	O
best	O
predictions	O
of	O
the	O
sensitivity	O
of	O
fair	B-T204
##y	I-T204
shrimp	I-T204
to	O
contaminants	O
.	O
the	O
results	O
of	O
these	O
studies	B-T062
indicate	O
that	O
fair	B-T204
##y	I-T204
shrimp	I-T204
are	O
relatively	O
sensitive	O
to	O
a	O
range	O
of	O
toxic	O
##ants	O
,	O
but	O
endangered	O
species	O
act	O
-	O
listed	O
fair	B-T204
##y	I-T204
shrimp	I-T204
of	O
the	O
genus	B-T204
branch	I-T204
##ine	I-T204
##ct	I-T204
##a	I-T204
were	O
not	O
consistently	O
more	O
sensitive	O
than	O
other	O
fair	B-T204
##y	I-T204
shrimp	I-T204
taxa	I-T204
.	O
environ	O
toxic	O
##ol	O
chem	O
2016	O
;	O
999	O
##9	O
:	O
1	O
-	O
10	O
.	O
published	O
2016	O
wiley	O
periodicals	O
inc	O
.	O
on	O
beha	O
##l	O
##f	O
of	O
set	O
##ac	O
.	O
this	O
article	O
is	O
a	O
us	O
government	O
work	O
and	O
,	O
as	O
such	O
,	O
is	O
in	O
the	O
public	O
domain	O
in	O
the	O
united	O
states	O
of	O
america	O
.	O

the	O
added	O
value	O
of	O
cardiac	B-T033
index	I-T033
and	O
pulse	B-T038
pressure	I-T038
variation	O
monitoring	B-T058
to	O
mean	B-T033
arterial	I-T033
pressure	I-T033
-	O
guided	B-T058
volume	I-T058
therapy	I-T058
in	O
moderate	O
-	O
risk	O
abdominal	O
surgery	O
(	O
cog	B-T058
##ui	I-T058
##de	I-T058
)	O
:	O
a	O
pragmatic	B-T062
multicentre	B-T062
randomised	B-T062
controlled	I-T062
trial	I-T062
there	O
is	O
disagreement	O
regarding	O
the	O
benefits	O
of	O
goal	B-T058
-	I-T058
directed	I-T058
therapy	I-T058
in	O
moderate	O
-	O
risk	O
abdominal	O
surgery	O
.	O
therefore	O
,	O
we	O
tested	B-T170
the	O
hypothesis	O
that	O
the	O
addition	O
of	O
non	O
-	O
invasive	O
cardiac	B-T033
index	I-T033
and	O
pulse	B-T038
pressure	I-T038
variation	O
monitoring	B-T058
to	O
mean	B-T033
arterial	I-T033
pressure	I-T033
-	O
based	O
goal	B-T058
-	I-T058
directed	I-T058
therapy	I-T058
would	O
reduce	O
the	O
incidence	O
of	O
postoperative	B-T038
complications	I-T038
in	O
patients	O
having	O
moderate	O
-	O
risk	O
abdominal	O
surgery	O
.	O
in	O
this	O
pragmatic	B-T062
multicentre	B-T062
randomised	B-T062
controlled	I-T062
trial	I-T062
,	O
we	O
randomly	B-T062
allocated	I-T062
244	O
patients	O
by	O
envelope	B-T170
drawing	I-T170
in	O
a	O
1	O
:	O
1	O
fashion	O
,	O
stratified	O
per	O
centre	O
.	O
all	O
patients	O
had	O
mean	B-T033
arterial	I-T033
pressure	I-T033
,	O
cardiac	B-T033
index	I-T033
and	O
pulse	B-T038
pressure	I-T038
variation	O
measured	O
continuously	O
.	O
in	O
one	O
group	O
,	O
healthcare	B-T097
professionals	I-T097
were	O
blinded	B-T062
to	O
cardiac	B-T033
index	I-T033
and	O
pulse	B-T038
pressure	I-T038
variation	O
values	O
and	O
were	O
asked	O
to	O
guide	O
haemodynamic	B-T058
therapy	I-T058
only	O
based	O
on	O
mean	B-T033
arterial	I-T033
pressure	I-T033
(	O
control	O
group	O
)	O
.	O
in	O
the	O
second	O
group	O
,	O
cardiac	B-T033
index	I-T033
and	O
pulse	B-T038
pressure	I-T038
variation	O
values	O
were	O
displayed	O
and	O
kept	O
within	O
target	O
ranges	O
following	O
a	O
pre	B-T170
-	I-T170
defined	I-T170
algorithm	I-T170
(	O
ci	O
-	O
ppv	O
group	O
)	O
.	O
the	O
primary	B-T103
endpoint	I-T103
was	O
the	O
incidence	O
of	O
postoperative	B-T038
complications	I-T038
within	O
30	O
days	O
.	O
one	O
hundred	O
and	O
seventy	O
-	O
five	O
patients	O
were	O
eligible	O
for	O
final	O
analysis	B-T062
.	O
overall	O
complication	B-T038
rates	I-T038
were	O
similar	O
(	O
42	O
/	O
94	O
(	O
44	O
.	O
7	O
%	O
)	O
vs	O
.	O
38	O
/	O
81	O
(	O
46	O
.	O
9	O
%	O
)	O
in	O
the	O
control	O
and	O
ci	O
-	O
ppv	O
groups	O
,	O
respectively	O
;	O
p	O
=	O
0	O
.	O
95	O
)	O
.	O
the	O
ci	O
-	O
ppv	O
group	O
had	O
lower	O
mean	O
(	O
sd	O
)	O
pulse	B-T038
pressure	I-T038
variation	O
values	O
(	O
9	O
.	O
5	O
(	O
2	O
.	O
0	O
)	O
%	O
vs	O
.	O
11	O
.	O
9	O
(	O
4	O
.	O
6	O
)	O
%	O
;	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
higher	O
mean	O
(	O
sd	O
)	O
cardiac	B-T033
indices	I-T033
(	O
2	O
.	O
76	O
(	O
0	O
.	O
62	O
)	O
l	O
min	O
(	O
-	O
1	O
)	O
.	O
m	O
(	O
-	O
2	O
)	O
vs	O
.	O
2	O
.	O
53	O
(	O
0	O
.	O
66	O
)	O
l	O
min	O
(	O
-	O
1	O
)	O
.	O
m	O
(	O
-	O
2	O
)	O
;	O
p	O
=	O
0	O
.	O
004	O
)	O
than	O
the	O
control	O
group	O
.	O
in	O
moderate	O
-	O
risk	O
abdominal	O
surgery	O
,	O
we	O
observed	O
no	O
additional	B-T170
value	I-T170
of	O
cardiac	B-T033
index	I-T033
and	O
pulse	B-T038
pressure	I-T038
variation	O
-	O
guided	B-T058
haemodynamic	I-T058
therapy	I-T058
to	O
mean	B-T033
arterial	I-T033
pressure	I-T033
-	O
guided	B-T058
volume	I-T058
therapy	I-T058
with	O
regard	O
to	O
postoperative	B-T038
complications	I-T038
.	O

direct	O
contact	O
with	O
perivascular	B-T017
tumor	B-T017
cells	I-T017
enhances	O
integrin	B-T103
α	I-T103
##v	I-T103
##β	I-T103
##3	I-T103
signaling	B-T038
and	O
migration	B-T038
of	O
endothelial	B-T017
cells	I-T017
the	O
secretion	B-T038
of	O
soluble	O
pro	B-T103
-	I-T103
angiogenic	I-T103
factors	I-T103
by	O
tumor	B-T017
cells	I-T017
and	O
stromal	B-T017
cells	I-T017
in	O
the	O
perivascular	B-T017
niche	O
promotes	O
the	O
aggressive	B-T038
angiogenesis	I-T038
that	O
is	O
typical	O
of	O
glioblastoma	B-T038
(	O
gbm	B-T038
)	O
.	O
here	O
,	O
we	O
show	O
that	O
angiogenesis	B-T038
also	O
can	O
be	O
promoted	O
by	O
a	O
direct	O
interaction	O
between	O
brain	B-T017
tumor	B-T017
cells	I-T017
,	O
including	O
tumor	B-T017
cells	I-T017
with	O
cancer	B-T017
stem	I-T017
-	O
like	O
properties	O
(	O
cscs	B-T017
)	O
,	O
and	O
endothelial	B-T017
cells	I-T017
(	O
ecs	B-T017
)	O
.	O
as	O
shown	O
in	O
vitro	O
,	O
this	O
direct	O
interaction	O
is	O
mediated	O
by	O
binding	B-T038
of	O
integrin	B-T103
α	I-T103
##v	I-T103
##β	I-T103
##3	I-T103
expressed	O
on	O
ecs	B-T017
to	O
the	O
rgd	B-T103
-	I-T103
peptide	I-T103
in	O
l1	B-T103
##cam	I-T103
expressed	B-T038
on	O
cscs	B-T017
.	O
it	O
promotes	O
both	O
ec	B-T017
network	B-T038
formation	I-T038
and	O
enhances	O
directed	O
migration	B-T038
toward	O
basic	O
fibroblast	B-T103
growth	I-T103
factor	I-T103
.	O
activation	O
of	O
α	B-T103
##v	I-T103
##β	I-T103
##3	I-T103
and	O
bone	B-T103
marrow	I-T103
tyrosine	I-T103
kinase	I-T103
on	I-T103
chromosome	I-T103
x	I-T103
(	O
bm	B-T103
##x	I-T103
)	O
is	O
required	O
for	O
migration	B-T038
stimulated	O
by	O
direct	O
binding	B-T038
but	O
not	O
for	O
migration	B-T038
stimulated	O
by	O
soluble	O
factors	O
.	O
rgd	B-T103
-	I-T103
peptide	I-T103
treatment	O
of	O
mice	B-T204
with	O
established	O
intracerebral	B-T082
gbm	B-T038
xenografts	B-T103
significantly	O
reduced	O
the	O
percentage	O
of	O
sox2	B-T103
-	O
positive	O
tumor	B-T017
cells	I-T017
and	O
cscs	B-T017
in	O
close	O
proximity	O
to	O
ecs	B-T017
,	O
decreased	O
integrin	B-T103
α	I-T103
##v	I-T103
##β	I-T103
##3	I-T103
and	O
bm	B-T103
##x	I-T103
activation	O
and	O
p1	B-T103
##30	I-T103
##ca	I-T103
##s	I-T103
phosphorylation	B-T038
in	O
the	O
ecs	B-T017
,	O
and	O
reduced	O
the	O
vessel	B-T017
surface	B-T082
area	I-T082
.	O
these	O
results	O
reveal	O
a	O
previously	O
unrecognized	O
aspect	O
of	O
the	O
regulation	B-T038
of	O
angiogenesis	B-T038
in	O
gbm	B-T038
that	O
can	O
impact	O
therapeutic	O
anti	B-T103
-	I-T103
angiogenic	I-T103
targeting	O
.	O

omega	B-T103
3	I-T103
fatty	I-T103
acids	I-T103
reduce	O
bone	B-T038
resorption	I-T038
while	O
promoting	B-T038
bone	I-T038
generation	I-T038
in	O
rat	B-T204
apical	B-T038
periodontitis	I-T038
this	O
study	O
evaluated	B-T058
the	O
effects	O
of	O
the	O
dietary	B-T168
supplement	I-T168
omega	B-T103
3	I-T103
polyunsaturated	I-T103
fatty	I-T103
acids	I-T103
(	O
ω	B-T103
-	I-T103
3	I-T103
pufas	I-T103
)	O
on	O
pulp	B-T038
exposure	I-T038
-	O
induced	O
apical	B-T038
periodontitis	I-T038
(	O
ap	B-T038
)	O
in	O
rats	B-T204
.	O
twenty	O
-	O
eight	O
male	O
rats	B-T204
were	O
divided	O
into	O
groups	B-T098
:	O
control	O
untreated	B-T033
rats	B-T204
(	O
c	O
)	O
,	O
control	O
rats	B-T204
treated	O
with	O
ω	B-T103
-	I-T103
3	I-T103
pufas	I-T103
alone	O
(	O
c	O
-	O
o	O
)	O
,	O
rats	B-T204
with	O
pulp	B-T038
exposure	I-T038
-	O
induced	O
ap	B-T038
,	O
and	O
rats	B-T204
with	O
pulp	B-T038
exposure	I-T038
-	O
induced	O
ap	B-T038
treated	O
with	O
ω	B-T103
-	I-T103
3	I-T103
pufas	I-T103
(	O
ap	B-T038
-	O
o	O
)	O
.	O
the	O
ω	B-T103
-	I-T103
3	I-T103
pufas	I-T103
were	O
administered	B-T058
orally	I-T058
,	O
once	O
a	O
day	O
,	O
for	O
15	O
days	O
before	O
pulp	B-T038
exposure	I-T038
and	O
,	O
subsequently	O
,	O
30	O
days	O
after	O
pulp	B-T038
exposure	I-T038
.	O
rats	B-T204
were	O
killed	O
30	O
days	O
after	O
pulp	B-T038
exposure	I-T038
,	O
and	O
jaw	B-T017
##s	I-T017
were	O
subjected	O
to	O
histologic	O
and	O
immunohistochemical	O
analyses	B-T062
.	O
immunohistochemical	O
analyses	B-T062
were	O
performed	O
to	O
detect	O
tartrate	B-T103
-	I-T103
resistant	I-T103
acid	I-T103
phosphatase	I-T103
-	O
positive	B-T033
osteoclasts	B-T017
and	O
osteocalcin	B-T103
-	O
positive	B-T033
osteoblasts	B-T017
on	O
the	O
bone	B-T082
surface	I-T082
of	O
periapical	B-T082
area	I-T082
.	O
results	O
were	O
statistically	O
evaluated	B-T058
by	O
using	O
analysis	O
of	O
variance	O
and	O
tukey	O
hone	O
##st	O
##ly	O
significant	O
difference	O
,	O
and	O
p	O
<	O
.	O
05	O
was	O
considered	O
statistically	O
significant	O
.	O
the	O
bone	B-T038
resorption	I-T038
lesion	B-T033
was	O
significantly	O
larger	O
in	O
the	O
ap	B-T038
group	O
compared	O
with	O
ap	B-T038
-	O
o	O
,	O
c	O
,	O
and	O
c	O
-	O
o	O
groups	B-T098
(	O
p	O
<	O
.	O
05	O
)	O
.	O
the	O
level	O
of	O
inflammatory	B-T038
cell	I-T038
infiltration	I-T038
was	O
significantly	O
elevated	O
,	O
and	O
the	O
number	O
of	O
tartrate	B-T103
-	I-T103
resistant	I-T103
acid	I-T103
phosphatase	I-T103
-	O
positive	B-T033
osteoclasts	B-T017
was	O
significantly	O
higher	O
in	O
the	O
periapical	B-T082
lesions	B-T033
of	O
the	O
ap	B-T038
group	O
compared	O
with	O
ap	B-T038
-	O
o	O
,	O
c	O
,	O
and	O
c	O
-	O
o	O
groups	B-T098
(	O
p	O
<	O
.	O
05	O
)	O
.	O
the	O
number	O
of	O
osteocalcin	B-T103
-	O
positive	B-T033
osteoblasts	B-T017
was	O
significantly	O
increased	O
in	O
the	O
ap	B-T038
-	O
o	O
group	O
compared	O
with	O
the	O
ap	B-T038
group	O
(	O
p	O
>	O
.	O
05	O
)	O
.	O
supplementation	B-T058
with	O
ω	B-T103
-	I-T103
3	I-T103
pufas	I-T103
not	O
only	O
suppresses	O
bone	B-T038
resorption	I-T038
but	O
also	O
promotes	B-T038
new	I-T038
bone	I-T038
formation	I-T038
in	O
the	O
periapical	B-T082
area	I-T082
of	O
rats	B-T204
with	O
ap	B-T038
in	O
conjunction	O
with	O
downregulation	B-T038
of	O
inflammatory	B-T038
cell	I-T038
infiltration	I-T038
into	O
the	O
lesion	B-T033
.	O

her	B-T103
##g1	I-T103
potassium	B-T103
channel	I-T103
expression	B-T038
in	O
potentially	O
malignant	B-T038
disorders	I-T038
of	O
the	O
oral	B-T017
mucosa	I-T017
and	O
prognostic	B-T170
relevance	O
in	O
oral	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
her	B-T103
##g1	I-T103
potassium	B-T103
channel	I-T103
plays	O
a	O
critical	O
role	O
in	O
the	O
cell	B-T038
proliferation	I-T038
.	O
her	B-T103
##g1	I-T103
protein	I-T103
expression	B-T038
was	O
analyzed	B-T062
by	O
immunohistochemistry	B-T058
(	O
ihc	B-T058
)	O
in	O
62	O
patients	O
with	O
oral	B-T038
leuk	I-T038
##opl	I-T038
##akia	I-T038
##s	I-T038
and	O
100	O
patients	O
with	O
oral	B-T038
squamous	I-T038
cell	I-T038
carcinomas	I-T038
(	O
oscc	B-T038
)	O
.	O
her	B-T017
##g1	I-T017
mrna	B-T103
levels	O
were	O
assessed	O
by	O
real	B-T062
-	I-T062
time	I-T062
reverse	I-T062
transcriptase	I-T062
-	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
(	O
rt	B-T062
-	I-T062
pcr	I-T062
)	O
in	O
22	O
patients	O
with	O
primary	O
head	B-T038
and	I-T038
neck	I-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
hnscc	B-T038
)	O
.	O
statistically	O
significant	O
associations	O
were	O
found	O
between	O
her	B-T103
##g1	I-T103
expression	B-T038
and	O
tobacco	O
consumption	O
,	O
disease	O
stage	O
,	O
tumor	B-T038
differentiation	B-T038
,	O
tumor	B-T038
recurrence	I-T038
,	O
and	O
reduced	O
survival	O
.	O
there	O
was	O
no	O
association	O
between	O
her	B-T103
##g1	I-T103
expression	B-T038
and	O
the	O
risk	O
of	O
progression	B-T038
from	O
oral	B-T038
leuk	I-T038
##opl	I-T038
##akia	I-T038
to	O
oscc	B-T038
.	O
in	O
addition	O
,	O
a	O
high	O
proportion	O
of	O
tumors	B-T038
(	O
80	O
%	O
)	O
showed	O
increased	O
her	B-T017
##g1	I-T017
mrna	B-T103
levels	O
compared	O
to	O
normal	B-T017
mucosa	I-T017
from	O
non	O
##on	O
##co	O
##lo	O
##gic	O
patients	O
.	O
aberrant	O
her	B-T103
##g1	I-T103
expression	B-T038
increases	O
as	O
oral	O
tumorigenesis	B-T038
progresses	I-T038
from	O
oral	O
hyperplasia	O
to	O
oscc	B-T038
.	O
increased	O
her	B-T017
##g1	I-T017
mrna	B-T103
levels	O
were	O
also	O
frequently	O
detected	B-T033
in	O
oscc	B-T038
and	O
other	O
hnscc	B-T038
subs	B-T082
##ites	I-T082
.	O
her	B-T103
##g1	I-T103
expression	B-T038
emerges	O
as	O
a	O
clinically	O
relevant	O
feature	O
during	O
tumor	B-T038
progression	I-T038
and	O
a	O
potential	O
poor	O
prognostic	B-T170
biomarker	B-T201
for	O
oscc	B-T038
.	O
©	O
2016	O
wiley	O
periodicals	O
,	O
inc	O
.	O
head	O
neck	O
38	O
:	O
170	O
##8	O
-	O
171	O
##6	O
,	O
2016	O
.	O

fam	O
##ous	O
faces	O
and	O
voice	O
##s	O
:	O
differential	O
profiles	B-T082
in	O
early	O
right	B-T017
and	O
left	B-T017
semantic	B-T038
dementia	I-T038
and	O
in	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
fam	O
##ous	O
face	O
and	O
voice	O
recognition	O
is	O
reported	O
to	O
be	O
impaired	O
both	O
in	O
semantic	B-T038
dementia	I-T038
(	O
sd	B-T038
)	O
and	O
in	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
(	O
ad	B-T038
)	O
,	O
although	O
more	O
severely	O
in	O
the	O
former	O
.	O
in	O
ad	B-T038
a	O
coexistence	O
of	O
perceptual	B-T038
impairment	O
in	O
face	O
and	O
voice	O
processing	B-T038
has	O
also	O
been	O
reported	O
and	O
this	O
could	O
contribute	O
to	O
the	O
altered	O
performance	O
in	O
complex	O
semantic	O
tasks	O
.	O
on	O
the	O
other	O
hand	O
,	O
in	O
sd	B-T038
both	O
face	O
and	O
voice	O
recognition	O
disorders	B-T038
could	O
be	O
related	O
to	O
the	O
prevalence	O
of	O
atrophy	B-T038
in	O
the	O
right	B-T017
temporal	I-T017
lobe	I-T017
(	O
rt	B-T017
##l	I-T017
)	O
.	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
was	O
twofold	O
:	O
(	O
1	O
)	O
to	O
investigate	O
fam	O
##ous	O
faces	O
and	O
voice	O
##s	O
recognition	O
in	O
sd	B-T038
and	O
ad	B-T038
to	O
verify	O
if	O
the	O
two	O
diseases	B-T038
show	O
a	O
differential	O
pattern	B-T082
of	O
impairment	O
,	O
resulting	O
from	O
disruption	O
of	O
different	O
cognitive	B-T038
mechanisms	O
;	O
(	O
2	O
)	O
to	O
check	O
if	O
face	O
and	O
voice	O
recognition	O
disorders	B-T038
prevail	O
in	O
patients	O
with	O
atrophy	B-T038
mainly	O
affecting	O
the	O
rt	B-T017
##l	I-T017
.	O
to	O
avoid	O
the	O
potential	O
influence	O
of	O
primary	O
perceptual	B-T038
problems	B-T033
in	O
face	O
and	O
voice	O
recognition	O
,	O
a	O
pool	O
of	O
patients	O
suffering	O
from	O
early	O
sd	B-T038
and	O
ad	B-T038
were	O
administered	O
a	O
detailed	O
set	O
of	O
tests	B-T058
exploring	O
face	O
and	O
voice	O
perception	B-T038
.	O
thirteen	O
sd	B-T038
(	O
8	O
with	O
prevalence	O
of	O
right	B-T017
and	O
5	O
with	O
prevalence	O
of	O
left	B-T017
temporal	I-T017
atrophy	B-T038
)	O
and	O
25	O
ce	O
patients	O
,	O
who	O
did	O
not	O
show	O
visual	O
and	O
auditory	O
perceptual	B-T038
impairment	O
,	O
were	O
finally	O
selected	O
and	O
were	O
administered	O
an	O
experimental	O
battery	B-T170
exploring	O
fam	O
##ous	O
face	O
and	O
voice	O
recognition	O
and	O
naming	B-T170
.	O
twelve	O
sd	B-T038
patients	O
underwent	O
cerebral	B-T017
pet	B-T058
imaging	I-T058
and	O
were	O
classified	O
in	O
right	B-T017
and	O
left	B-T017
sd	B-T038
according	O
to	O
the	O
onset	O
modality	O
and	O
to	O
the	O
prevalent	O
decrease	O
in	O
fdg	B-T103
uptake	I-T103
in	O
right	B-T017
or	O
left	B-T017
temporal	I-T017
lobe	I-T017
respectively	O
.	O
correlation	O
of	O
pet	B-T058
imaging	I-T058
and	O
fam	O
##ous	O
face	O
and	O
voice	O
recognition	O
was	O
performed	O
.	O
results	O
showed	O
a	O
differential	O
performance	O
profile	B-T082
in	O
the	O
two	O
diseases	B-T038
,	O
because	O
ad	B-T038
patients	O
were	O
significantly	O
impaired	O
in	O
the	O
naming	B-T170
tests	I-T170
,	O
but	O
showed	O
preserved	O
recognition	B-T038
,	O
whereas	O
sd	B-T038
patients	O
were	O
profoundly	O
impaired	O
both	O
in	O
naming	B-T170
and	O
in	O
recognition	O
of	O
fam	O
##ous	O
faces	O
and	O
voice	O
##s	O
.	O
furthermore	O
,	O
face	O
and	O
voice	O
recognition	O
disorders	B-T038
prevail	O
##ed	O
in	O
sd	B-T038
patients	O
with	O
rt	B-T017
##l	I-T017
atrophy	B-T038
,	O
who	O
also	O
showed	O
a	O
conceptual	O
impairment	O
on	O
the	O
pyr	B-T170
##amid	I-T170
##s	I-T170
and	I-T170
palm	I-T170
trees	I-T170
test	I-T170
more	O
important	O
in	O
the	O
pict	O
##orial	O
than	O
in	O
the	O
verbal	O
modality	O
.	O
finally	O
,	O
in	O
12	O
sd	B-T038
patients	O
in	O
whom	O
pet	B-T058
was	O
available	O
,	O
a	O
strong	O
correlation	O
between	O
fdg	B-T103
uptake	I-T103
and	O
face	O
-	O
to	O
-	O
name	O
and	O
voice	O
-	O
to	O
-	O
name	O
matching	O
data	O
was	O
found	O
in	O
the	O
right	B-T017
but	O
not	O
in	O
the	O
left	B-T017
temporal	I-T017
lobe	I-T017
.	O
the	O
data	O
support	O
the	O
hypothesis	O
of	O
a	O
different	O
cognitive	B-T038
basis	O
for	O
impairment	O
of	O
face	O
and	O
voice	O
recognition	O
in	O
the	O
two	O
dementia	B-T038
##s	I-T038
and	O
suggest	O
that	O
the	O
pattern	B-T082
of	O
impairment	O
in	O
sd	B-T038
may	O
be	O
due	O
to	O
a	O
loss	O
of	O
semantic	O
representations	O
,	O
while	O
a	O
defect	O
of	O
semantic	O
control	O
,	O
with	O
impaired	O
naming	B-T170
and	O
preserved	B-T038
recognition	I-T038
might	O
be	O
hypothesized	O
in	O
ad	B-T038
.	O
furthermore	O
,	O
the	O
correlation	O
between	O
face	O
and	O
voice	O
recognition	O
disorders	B-T038
and	O
rt	B-T017
##l	I-T017
damage	B-T037
are	O
consistent	O
with	O
the	O
hypothesis	O
assuming	O
that	O
in	O
the	O
rt	B-T017
##l	I-T017
person	B-T098
-	O
specific	O
knowledge	B-T170
may	O
be	O
mainly	O
based	O
upon	O
non	B-T038
-	I-T038
verbal	I-T038
representations	I-T038
.	O

sepsis	B-T038
clinical	O
criteria	O
in	O
emergency	B-T092
department	I-T092
patients	O
admitted	B-T058
to	O
an	O
intensive	B-T092
care	I-T092
unit	I-T092
:	O
an	O
external	B-T062
validation	I-T062
study	I-T062
of	O
quick	B-T033
sequential	I-T033
organ	I-T033
failure	I-T033
assessment	I-T033
quick	B-T033
sequential	I-T033
organ	I-T033
failure	I-T033
assessment	I-T033
(	O
qs	B-T033
##of	I-T033
##a	I-T033
)	O
is	O
a	O
prognostic	O
score	O
for	O
patients	O
with	O
sepsis	B-T038
.	O
our	O
aim	O
was	O
to	O
compare	O
the	O
area	O
under	O
the	O
receiver	O
operating	O
curve	O
(	O
aur	O
##oc	O
)	O
,	O
sensitivity	O
,	O
specificity	O
,	O
and	O
likelihood	O
ratios	O
of	O
qs	B-T033
##of	I-T033
##a	I-T033
vs	O
.	O
systemic	B-T038
inflammation	I-T038
response	I-T038
syndrome	I-T038
(	O
sirs	B-T038
)	O
in	O
predicting	O
in	O
-	O
hospital	O
mortality	O
among	O
emergency	B-T092
department	I-T092
(	O
ed	B-T092
)	O
patients	O
with	O
suspected	B-T038
infection	I-T038
admitted	B-T058
to	O
intensive	B-T092
care	I-T092
units	I-T092
(	O
icus	B-T092
)	O
.	O
we	O
conducted	O
a	O
retrospective	B-T062
cohort	I-T062
chart	I-T062
review	I-T062
study	I-T062
of	O
ed	B-T092
patients	O
admitted	B-T058
to	O
an	O
icu	B-T092
with	O
suspected	B-T038
infection	I-T038
from	O
august	O
1	O
,	O
2012	O
to	O
february	O
28	O
,	O
2015	O
.	O
we	O
included	O
all	O
patients	O
with	O
body	B-T031
fluid	I-T031
cultures	I-T031
sampled	I-T031
either	O
during	O
their	O
ed	B-T092
stay	O
without	O
antibiotic	B-T058
administration	I-T058
or	O
within	O
24	O
h	O
of	O
antibiotics	B-T058
administered	I-T058
in	O
the	O
ed	B-T092
.	O
trained	B-T097
chart	I-T097
abstract	I-T097
##ors	I-T097
blinded	O
to	O
the	O
study	B-T062
hypothesis	O
double	O
-	O
entered	O
data	O
from	O
each	O
patient	O
'	O
s	O
electronic	B-T170
medical	I-T170
record	I-T170
including	O
demographic	O
characteristics	O
,	O
vital	B-T201
signs	I-T201
,	O
laboratory	B-T058
study	I-T058
results	I-T058
,	O
physical	B-T058
examination	I-T058
findings	B-T033
,	O
and	O
in	O
-	O
hospital	O
mortality	O
.	O
we	O
then	O
calculated	O
the	O
aur	O
##oc	O
,	O
sensitivity	O
,	O
specificity	O
,	O
and	O
likelihood	O
ratios	O
for	O
qs	B-T033
##of	I-T033
##a	I-T033
and	O
sirs	B-T038
for	O
predicting	O
in	O
-	O
hospital	O
mortality	O
.	O
of	O
214	O
patients	O
admitted	B-T058
to	O
an	O
icu	B-T092
with	O
presumed	B-T038
sepsis	I-T038
,	O
39	O
(	O
18	O
.	O
2	O
%	O
)	O
died	O
during	O
hospitalization	O
.	O
the	O
aur	O
##oc	O
value	O
was	O
0	O
.	O
65	O
(	O
95	O
%	O
confidence	O
interval	O
[	O
ci	O
]	O
0	O
.	O
56	O
-	O
0	O
.	O
74	O
)	O
for	O
sirs	B-T038
vs	O
.	O
0	O
.	O
66	O
(	O
95	O
%	O
ci	O
0	O
.	O
57	O
-	O
0	O
.	O
76	O
)	O
for	O
qs	B-T033
##of	I-T033
##a	I-T033
;	O
2	O
+	O
qs	B-T033
##of	I-T033
##a	I-T033
criteria	O
predicted	O
in	O
-	O
hospital	O
mortality	O
with	O
89	O
.	O
7	O
%	O
sensitivity	O
,	O
27	O
.	O
4	O
%	O
specificity	O
,	O
1	O
.	O
2	O
positive	O
likelihood	O
ratio	O
,	O
and	O
0	O
.	O
4	O
negative	O
likelihood	O
ratio	O
.	O
among	O
ed	B-T092
patients	O
admitted	B-T058
to	O
an	O
icu	B-T092
,	O
the	O
sirs	B-T038
and	O
qs	B-T033
##of	I-T033
##a	I-T033
criteria	O
had	O
comparable	O
prognostic	O
value	O
for	O
predicting	O
in	O
-	O
hospital	O
mortality	O
.	O
these	O
prognostic	O
values	O
are	O
similar	O
to	O
those	O
reported	O
by	O
the	O
sepsis	B-T170
-	I-T170
3	I-T170
guidelines	I-T170
for	O
icu	B-T092
encounters	B-T170
.	O

the	O
psychometric	B-T058
costs	I-T058
of	O
applic	B-T098
##ants	I-T098
'	O
fak	O
##ing	O
:	O
examining	O
measurement	O
invariance	O
and	O
retest	B-T062
correlations	I-T062
across	O
response	B-T038
conditions	I-T038
this	O
study	O
examines	O
the	O
stability	O
of	O
the	O
response	B-T038
process	I-T038
and	O
the	O
rank	O
-	O
order	O
of	O
respondents	B-T098
responding	B-T038
to	O
3	O
personality	B-T170
scales	I-T170
in	O
4	O
different	O
response	B-T038
conditions	I-T038
.	O
applic	B-T098
##ants	I-T098
to	O
the	O
university	B-T092
college	I-T092
of	I-T092
teacher	I-T092
education	I-T092
st	B-T082
##yr	I-T082
##ia	I-T082
(	O
n	O
=	O
243	O
)	O
completed	O
personality	B-T170
scales	I-T170
as	O
part	O
of	O
their	O
college	B-T170
admission	I-T170
process	I-T170
.	O
half	O
a	O
year	O
later	O
,	O
they	O
ret	O
##oo	O
##k	O
the	O
same	O
personality	B-T170
scales	I-T170
in	O
1	O
of	O
3	O
randomly	O
assigned	O
experimental	O
response	B-T038
conditions	I-T038
:	O
hone	O
##st	O
,	O
fak	O
##ing	O
-	O
good	O
,	O
or	O
reproduce	O
.	O
longitudinal	B-T062
means	I-T062
and	O
covariance	O
structure	O
analyses	O
showed	O
that	O
applic	B-T098
##ants	I-T098
'	O
response	B-T038
processes	I-T038
could	O
be	O
partially	O
reproduced	O
after	O
half	O
a	O
year	O
,	O
and	O
respondents	B-T098
seemed	O
to	O
rely	O
on	O
an	O
hone	O
##st	O
response	B-T038
behavior	I-T038
as	O
a	O
frame	O
of	O
reference	O
.	O
additionally	O
,	O
applic	B-T098
##ants	I-T098
'	O
fak	O
##ing	O
behavior	O
and	O
instructed	O
fak	O
##ing	O
(	O
fak	O
##ing	O
-	O
good	O
)	O
caused	O
differences	O
in	O
the	O
latent	O
retest	B-T062
correlations	I-T062
and	O
consistently	O
affected	O
measurement	O
properties	O
.	O
the	O
varying	O
latent	O
retest	B-T062
correlations	I-T062
indicated	B-T033
that	O
fak	O
##ing	O
can	O
dist	O
##ort	O
respondents	B-T098
'	O
rank	O
-	O
order	O
and	O
thus	O
the	O
fair	O
##ness	O
of	O
subsequent	O
selection	B-T038
decisions	I-T038
,	O
depending	O
on	O
the	O
kind	O
of	O
fak	O
##ing	O
behavior	O
.	O
instructed	O
fak	O
##ing	O
(	O
fak	O
##ing	O
-	O
good	O
)	O
even	O
affected	O
weak	O
measurement	O
invariance	O
,	O
whereas	O
applic	B-T098
##ants	I-T098
'	O
fak	O
##ing	O
behavior	O
did	O
not	O
.	O
consequently	O
,	O
correlations	O
with	O
personality	B-T170
scales	I-T170
-	O
which	O
can	O
be	O
utilized	O
for	O
predictive	O
validity	O
-	O
may	O
be	O
readily	O
interpreted	O
for	O
applic	B-T098
##ants	I-T098
.	O
fak	O
##ing	O
behavior	O
also	O
introduced	O
a	O
uniform	O
bias	O
,	O
implying	O
that	O
the	O
classically	O
observed	O
mean	O
raw	O
score	O
differences	O
may	O
not	O
be	O
readily	O
interpreted	O
.	O

assessment	O
of	O
genetic	O
relationship	O
among	O
rhod	B-T204
##odend	I-T204
##ron	I-T204
cultivars	O
using	O
amplified	B-T062
fragment	I-T062
length	I-T062
polymorphism	I-T062
and	O
inter	O
-	O
simple	O
sequence	O
repeat	O
markers	B-T082
genetic	O
relationships	O
of	O
17	O
rhod	B-T204
##odend	I-T204
##ron	I-T204
cultivars	O
,	O
china	B-T082
,	O
were	O
assessed	O
using	O
inter	O
-	O
simple	O
sequence	O
repeat	O
(	O
iss	O
##r	O
)	O
and	O
amplified	B-T062
fragment	I-T062
length	I-T062
polymorphism	I-T062
(	O
afl	B-T062
##p	I-T062
)	O
markers	B-T082
.	O
a	O
total	O
of	O
133	O
bands	O
were	O
obtained	O
using	O
nine	O
selected	O
iss	O
##r	O
primers	B-T103
,	O
129	O
(	O
96	O
.	O
99	O
%	O
)	O
of	O
which	O
were	O
polymorphic	O
;	O
267	O
bands	O
were	O
amplified	O
by	O
four	O
afl	B-T062
##p	I-T062
primer	B-T103
pairs	I-T103
,	O
251	O
(	O
94	O
.	O
01	O
%	O
)	O
of	O
which	O
exhibited	O
polymorphism	O
.	O
based	O
on	O
these	O
polymorphic	O
products	O
,	O
a	O
cluster	B-T062
analysis	I-T062
revealed	O
similarities	O
between	O
the	O
results	O
of	O
the	O
iss	O
##r	O
and	O
afl	B-T062
##p	I-T062
.	O
all	O
of	O
the	O
cultivars	O
were	O
clustered	O
into	O
two	O
major	O
branches	O
;	O
one	O
branch	O
contained	O
the	O
same	O
four	O
cultivars	O
,	O
and	O
the	O
other	O
cultivars	O
were	O
separated	O
into	O
different	O
groups	O
in	O
the	O
other	O
branch	O
.	O
the	O
cluster	O
results	O
showed	O
that	O
the	O
genetic	O
relationships	O
of	O
the	O
17	O
cultivars	O
were	O
partly	O
related	O
to	O
their	O
morphological	B-T082
characteristics	O
,	O
particularly	O
the	O
flowering	B-T038
phase	O
.	O
therefore	O
,	O
the	O
results	O
of	O
this	O
study	B-T062
support	O
the	O
classification	B-T170
of	O
rhod	B-T204
##odend	I-T204
##ron	I-T204
cultivars	O
according	O
to	O
flowering	B-T038
phase	O
.	O
in	O
addition	O
,	O
the	O
cluster	O
results	O
can	O
be	O
used	O
to	O
select	O
suitable	O
parents	O
for	O
breeding	B-T038
.	O

skeletal	B-T017
muscle	I-T017
metabolic	O
adaptations	B-T038
to	O
endurance	O
exercise	O
training	O
are	O
attain	O
##able	O
in	O
mice	B-T204
with	O
simvastatin	B-T103
treatment	B-T058
we	O
tested	O
the	O
hypothesis	O
that	O
a	O
6	O
-	O
week	O
regimen	B-T058
of	O
simvastatin	B-T103
would	O
attenuate	O
skeletal	B-T017
muscle	I-T017
adaptation	B-T038
to	O
low	O
-	O
intensity	O
exercise	O
.	O
male	O
c57bl	B-T204
/	I-T204
6j	I-T204
wild	I-T204
##type	I-T204
mice	I-T204
were	O
subjected	O
to	O
6	O
-	O
weeks	O
of	O
voluntary	O
wheel	O
running	O
or	O
normal	O
cage	O
activities	O
with	O
or	O
without	O
simvastatin	B-T103
treatment	B-T058
(	O
20	O
mg	O
/	O
kg	O
/	O
d	O
,	O
n	O
=	O
7	O
-	O
8	O
per	O
group	O
)	O
.	O
adaptations	B-T038
in	O
in	O
vivo	O
fatigue	B-T033
resistance	O
were	O
determined	O
by	O
a	O
treadmill	B-T058
running	I-T058
test	I-T058
,	O
and	O
by	O
ankle	B-T017
plantar	I-T017
##flex	I-T017
##or	I-T017
contractile	B-T038
assessment	O
.	O
the	O
tibialis	B-T017
anterior	I-T017
,	O
gastrocnemius	B-T017
,	O
and	O
plantar	B-T017
##is	I-T017
muscles	I-T017
were	O
evaluated	B-T058
for	O
exercised	O
-	O
induced	O
mitochondrial	B-T017
adaptations	B-T038
(	O
i	O
.	O
e	O
.	O
,	O
biogenesis	O
,	O
function	O
,	O
autophagy	B-T038
)	O
.	O
there	O
was	O
no	O
difference	O
in	O
weekly	O
wheel	O
running	O
distance	O
between	O
control	O
and	O
simvastatin	B-T103
-	O
treated	O
mice	B-T204
(	O
p	O
=	O
0	O
.	O
51	O
)	O
.	O
trained	O
mice	B-T204
had	O
greater	O
treadmill	O
running	O
distance	O
(	O
296	O
%	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
ankle	B-T017
plantar	I-T017
##flex	I-T017
##or	I-T017
contractile	B-T038
fatigue	B-T033
resistance	O
(	O
9	O
%	O
,	O
p	O
<	O
0	O
.	O
05	O
)	O
compared	O
to	O
sedentary	O
mice	B-T204
,	O
independent	O
of	O
simvastatin	B-T103
treatment	B-T058
.	O
at	O
the	O
cellular	B-T017
level	I-T017
,	O
trained	O
mice	B-T204
had	O
greater	O
mitochondrial	B-T038
biogenesis	I-T038
(	O
e	O
.	O
g	O
.	O
,	O
~	O
2	O
-	O
fold	O
greater	O
pgc	B-T103
##1	I-T103
##α	I-T103
expression	B-T038
,	O
p	O
<	O
0	O
.	O
05	O
)	O
and	O
mitochondrial	B-T017
content	O
(	O
e	O
.	O
g	O
.	O
,	O
25	O
%	O
greater	O
citrate	B-T103
synthase	I-T103
activity	B-T038
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
independent	O
of	O
simvastatin	B-T103
treatment	B-T058
.	O
mitochondrial	B-T017
autophagy	B-T038
-	O
related	O
protein	B-T103
contents	O
were	O
greater	O
in	O
trained	O
mice	B-T204
(	O
e	O
.	O
g	O
.	O
,	O
40	O
%	O
greater	O
bn	B-T103
##ip	I-T103
##3	I-T103
,	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
independent	O
of	O
simvastatin	B-T103
treatment	B-T058
.	O
however	O
,	O
dr	B-T103
##p1	I-T103
,	O
a	O
marker	B-T201
of	O
mitochondrial	B-T038
fission	I-T038
,	O
was	O
less	O
in	O
simvastatin	B-T103
treated	O
mice	B-T204
,	O
independent	O
of	O
exercise	O
training	O
,	O
and	O
there	O
was	O
a	O
significant	O
interaction	O
between	O
training	O
and	O
statin	O
treatment	B-T058
(	O
p	O
<	O
0	O
.	O
022	O
)	O
for	O
lc3	B-T103
-	I-T103
ii	I-T103
protein	I-T103
content	O
,	O
a	O
marker	B-T201
of	O
autophagy	B-T038
flux	O
.	O
these	O
data	O
indicate	O
that	O
whole	B-T017
body	I-T017
and	O
skeletal	B-T017
muscle	I-T017
adaptations	B-T038
to	O
endurance	O
exercise	O
training	O
are	O
attain	O
##able	O
with	O
simvastatin	B-T103
treatment	B-T058
,	O
but	O
simvastatin	B-T103
may	O
have	O
side	B-T038
effects	I-T038
on	O
muscle	B-T017
mitochondrial	B-T017
maintenance	O
via	O
autophagy	B-T038
,	O
which	O
could	O
have	O
long	O
-	O
term	O
implications	O
on	O
muscle	B-T017
health	O
.	O

effects	O
of	O
heat	O
treatment	O
on	O
conformation	B-T082
and	O
cell	B-T038
growth	I-T038
activity	O
of	O
alpha	B-T103
-	I-T103
lact	I-T103
##albumin	I-T103
and	O
beta	B-T103
-	I-T103
lact	I-T103
##oglobulin	I-T103
from	O
market	B-T082
milk	B-T168
heat	O
processes	O
,	O
low	O
temperature	O
for	O
long	O
time	O
(	O
lt	O
##lt	O
)	O
paste	O
##urization	O
and	O
ultra	B-T058
-	I-T058
heat	I-T058
treatment	I-T058
(	I-T058
uh	I-T058
##t	I-T058
)	I-T058
sterilization	I-T058
,	O
are	O
essential	O
for	O
commercial	O
market	B-T082
milk	B-T168
to	O
improve	O
the	O
shelf	O
life	O
of	O
raw	O
milk	B-T168
and	O
ensure	O
microbial	O
safety	O
.	O
we	O
evaluated	O
the	O
effects	O
of	O
heat	O
experience	O
on	O
the	O
molecular	O
properties	O
of	O
α	B-T103
-	I-T103
lact	I-T103
##albumin	I-T103
(	O
α	B-T103
-	I-T103
la	I-T103
)	O
and	O
β	B-T103
-	I-T103
lact	I-T103
##oglobulin	I-T103
(	O
β	B-T103
-	I-T103
lg	I-T103
)	O
isolated	O
from	O
four	O
types	O
of	O
market	B-T082
milk	B-T168
such	O
as	O
lt	O
##lt	O
-	O
a	O
(	O
66	O
##°c	O
for	O
30	O
min	O
)	O
,	O
lt	O
##lt	O
-	O
b	O
(	O
65	O
##°c	O
for	O
30	O
min	O
)	O
,	O
uh	B-T058
##t	I-T058
-	I-T058
i	I-T058
(	O
130	O
##°c	O
for	O
2	O
s	O
,	O
indirect	O
heating	O
)	O
and	O
uh	B-T058
##t	I-T058
-	I-T058
d	I-T058
(	O
135	O
##°c	O
for	O
2	O
s	O
,	O
direct	O
heating	O
)	O
samples	O
.	O
we	O
examined	O
molecular	B-T082
conformations	I-T082
using	O
circular	B-T058
dichroism	I-T058
spectrum	I-T058
measurement	I-T058
and	O
cell	B-T038
growth	I-T038
activity	O
using	O
the	O
ws	B-T062
##t	I-T062
-	I-T062
1	I-T062
method	I-T062
for	O
the	O
proteins	B-T103
.	O
α	B-T103
-	I-T103
la	I-T103
isolated	O
from	O
each	O
of	O
these	O
four	O
types	O
of	O
market	B-T082
milk	B-T168
displayed	O
no	B-T033
significant	I-T033
structural	B-T103
difference	O
as	O
compared	O
to	O
raw	O
milk	O
α	B-T103
-	I-T103
la	I-T103
,	O
while	O
α	B-T103
-	I-T103
la	I-T103
of	O
uh	B-T058
##t	I-T058
-	I-T058
i	I-T058
only	O
inhibited	O
cell	B-T038
growth	I-T038
of	O
an	O
intestinal	B-T017
epithelial	B-T017
cell	I-T017
line	I-T017
more	O
potently	O
than	O
raw	O
milk	O
α	B-T103
-	I-T103
la	I-T103
.	O
in	O
the	O
case	O
of	O
β	B-T103
-	I-T103
lg	I-T103
,	O
only	O
the	O
uh	B-T058
##t	I-T058
-	I-T058
i	I-T058
sample	O
demonstrated	O
a	O
drastic	O
change	O
in	O
structure	B-T103
,	O
while	O
it	O
did	B-T033
not	I-T033
exhibit	I-T033
any	O
cytotoxicity	B-T038
.	O
we	O
found	O
that	O
cell	B-T038
viability	I-T038
effects	O
of	O
α	B-T103
-	I-T103
la	I-T103
and	O
β	B-T103
-	I-T103
lg	I-T103
are	O
attributable	O
to	O
the	O
type	O
of	O
uh	B-T058
##t	I-T058
;	O
indirect	O
and	O
direct	O
.	O
these	O
findings	B-T033
indicate	O
that	O
the	O
effect	O
of	O
heat	O
treatment	O
on	O
whey	B-T168
proteins	I-T168
should	O
carefully	O
be	O
investigated	O
further	O
.	O

potassium	B-T038
depletion	I-T038
stimulates	O
na	B-T103
-	I-T103
cl	I-T103
cotrans	I-T103
##porter	I-T103
via	O
phosphorylation	B-T038
and	O
inactivation	O
of	O
the	O
ubiquitin	B-T103
ligase	I-T103
kel	B-T103
##ch	I-T103
-	I-T103
like	I-T103
3	I-T103
kel	B-T103
##ch	I-T103
-	I-T103
like	I-T103
3	I-T103
(	O
kl	B-T103
##hl	I-T103
##3	I-T103
)	O
is	O
a	O
component	B-T103
of	O
an	O
e3	B-T103
ubiquitin	I-T103
ligase	I-T103
complex	I-T103
that	O
regulates	B-T038
blood	B-T038
pressure	I-T038
by	O
targeting	O
with	B-T103
-	I-T103
no	I-T103
-	I-T103
lysine	I-T103
(	I-T103
w	I-T103
##nk	I-T103
)	I-T103
kinases	I-T103
for	O
degradation	O
.	O
mutations	B-T038
in	O
kl	B-T103
##hl	I-T103
##3	I-T103
cause	O
constitutively	O
increased	B-T033
renal	I-T033
salt	I-T033
reabsorption	I-T033
and	O
impaired	O
k	B-T103
(	I-T103
+	I-T103
)	I-T103
secretion	B-T038
,	O
resulting	O
in	O
hypertension	B-T038
and	O
hyperkal	B-T033
##emia	I-T033
.	O
although	O
clinical	B-T062
studies	I-T062
have	O
shown	O
that	O
dietary	B-T168
k	I-T168
(	I-T168
+	I-T168
)	I-T168
intake	O
affects	O
blood	B-T038
pressure	I-T038
,	O
the	O
mechanisms	O
have	O
been	O
obscure	O
.	O
in	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
the	O
kl	B-T103
##hl	I-T103
##3	I-T103
ubiquitin	B-T103
ligase	I-T103
complex	B-T103
is	O
involved	O
in	O
the	O
low	O
-	O
k	B-T103
(	I-T103
+	I-T103
)	I-T103
-	O
mediated	O
activation	O
of	O
na	B-T103
-	I-T103
cl	I-T103
cotrans	I-T103
##porter	I-T103
(	O
ncc	B-T103
)	O
in	O
the	O
kidney	B-T017
.	O
in	O
the	O
distal	B-T017
conv	I-T017
##ol	I-T017
##uted	I-T017
tubules	I-T017
of	O
mice	B-T204
eating	B-T038
a	O
low	B-T058
-	I-T058
k	I-T058
(	I-T058
+	I-T058
)	I-T058
diet	I-T058
,	O
we	O
found	O
increased	O
kl	B-T103
##hl	I-T103
##3	I-T103
phosphorylation	B-T038
at	O
s4	O
##33	O
(	B-T103
kl	I-T103
##hl	I-T103
##3	I-T103
(	I-T103
s4	I-T103
##33	I-T103
-	I-T103
p	I-T103
)	I-T103
)	I-T103
,	O
a	O
modification	B-T033
that	O
impairs	O
w	B-T103
##nk	I-T103
binding	O
,	O
and	O
also	O
reduced	O
total	O
kl	B-T103
##hl	I-T103
##3	I-T103
levels	O
.	O
these	O
changes	O
are	O
accompanied	O
by	O
the	O
accumulation	B-T033
of	O
the	O
target	O
substrate	O
w	B-T103
##nk	I-T103
##4	I-T103
,	O
and	O
activation	O
of	O
the	O
downstream	B-T082
kinases	B-T103
spa	I-T103
##k	I-T103
(	O
ste	B-T103
##20	I-T103
/	O
sps	B-T103
##1	I-T103
-	O
related	O
proline	B-T103
-	I-T103
alanine	I-T103
-	I-T103
rich	I-T103
protein	I-T103
kinase	I-T103
)	O
and	O
os	B-T103
##r1	I-T103
(	O
oxidative	B-T103
stress	I-T103
-	I-T103
responsive	I-T103
1	I-T103
)	O
,	O
resulting	O
in	O
ncc	B-T103
phosphorylation	B-T038
and	O
its	O
accumulation	B-T033
at	O
the	O
plasma	B-T017
membrane	I-T017
.	O
increased	O
phosphorylation	B-T038
of	O
s4	O
##33	O
was	O
explained	O
by	O
increased	O
levels	O
of	O
active	O
,	O
phosphorylated	O
protein	B-T103
kinase	I-T103
c	I-T103
(	O
but	O
not	O
protein	B-T103
kinase	I-T103
a	I-T103
)	O
,	O
which	O
directly	O
phosphoryl	B-T038
##ates	I-T038
s4	O
##33	O
.	O
moreover	O
,	O
in	O
hek	B-T017
cells	I-T017
expressing	B-T038
kl	B-T103
##hl	I-T103
##3	I-T103
and	O
w	B-T103
##nk	I-T103
##4	I-T103
,	O
we	O
showed	O
that	O
the	O
activation	O
of	O
protein	B-T103
kinase	I-T103
c	I-T103
by	O
phorbol	B-T103
12	I-T103
-	I-T103
myristate	I-T103
13	I-T103
-	I-T103
acetate	I-T103
induces	O
kl	B-T103
##hl	I-T103
##3	I-T103
(	I-T103
s4	I-T103
##33	I-T103
-	I-T103
p	I-T103
)	I-T103
and	O
increases	O
w	B-T103
##nk	I-T103
##4	I-T103
levels	O
by	O
abrog	O
##ating	O
its	O
ubiquitination	B-T038
.	O
these	O
data	O
demonstrate	O
the	O
role	O
of	O
kl	B-T103
##hl	I-T103
##3	I-T103
in	O
low	O
-	O
k	B-T103
(	I-T103
+	I-T103
)	I-T103
-	O
mediated	O
induction	O
of	O
ncc	B-T103
;	O
this	O
physiologic	B-T038
adaptation	I-T038
reduces	O
distal	B-T082
electro	B-T038
##genic	I-T038
na	B-T038
(	I-T038
+	I-T038
)	I-T038
reabsorption	I-T038
,	O
preventing	O
further	O
renal	B-T017
k	B-T103
(	I-T103
+	I-T103
)	I-T103
loss	O
but	O
promoting	O
increased	O
blood	B-T038
pressure	I-T038
.	O

the	O
erbb	B-T103
##3	I-T103
receptor	I-T103
tyrosine	I-T103
kinase	I-T103
negatively	O
regulates	B-T038
pan	B-T017
##eth	I-T017
cells	I-T017
by	O
pi3k	B-T103
-	O
dependent	O
suppression	B-T038
of	O
at	B-T017
##oh	I-T017
##1	I-T017
pan	B-T017
##eth	I-T017
cells	I-T017
(	O
pcs	B-T017
)	O
,	O
a	O
secretory	B-T017
population	I-T017
located	O
at	O
the	O
base	O
of	O
the	O
intestinal	O
crypt	O
,	O
support	O
the	O
intestinal	B-T017
stem	B-T017
cells	I-T017
(	O
isc	B-T017
)	O
with	O
growth	B-T103
factors	I-T103
and	O
participate	O
in	O
innate	O
immunity	O
by	O
releasing	O
antimicrobial	B-T103
peptides	I-T103
,	O
including	O
lysozyme	B-T103
and	O
def	B-T103
##ensin	I-T103
##s	I-T103
.	O
pc	B-T017
dysfunction	O
is	O
associated	O
with	O
disorders	B-T038
such	O
as	O
crohn	B-T038
'	I-T038
s	I-T038
disease	I-T038
and	O
necrotizing	B-T038
enterocolitis	I-T038
,	O
but	O
the	O
specific	O
pathways	B-T038
regulating	B-T038
pc	B-T017
development	B-T038
and	O
function	B-T038
are	O
not	O
fully	O
understood	O
.	O
here	O
we	O
tested	O
the	O
role	O
of	O
the	O
neur	B-T103
##eg	I-T103
##ulin	I-T103
receptor	I-T103
erbb	I-T103
##3	I-T103
in	O
control	O
of	O
pc	B-T017
differentiation	B-T038
and	O
the	O
isc	B-T022
niche	I-T022
.	O
intestinal	B-T017
epithelial	O
erbb	B-T017
##3	I-T017
knockout	B-T062
caused	O
precocious	O
appearance	O
of	O
pcs	B-T017
as	O
early	O
as	O
postnatal	O
day	O
7	O
,	O
and	O
substantially	O
increased	O
the	O
number	O
of	O
mature	O
pcs	B-T017
in	O
adult	B-T204
mouse	I-T204
ileum	B-T017
.	O
erbb	B-T103
##3	I-T103
loss	O
had	O
no	O
effect	O
on	O
other	O
secretory	O
lineages	O
,	O
but	O
increased	O
expression	B-T038
of	O
the	O
isc	B-T017
marker	O
lg	B-T103
##r	I-T103
##5	I-T103
.	O
erbb	B-T103
##3	I-T103
-	O
null	O
intestines	B-T017
had	O
elevated	O
levels	O
of	O
the	O
at	B-T017
##oh	I-T017
##1	I-T017
transcription	B-T103
factor	I-T103
,	O
which	O
is	O
required	O
for	O
secretory	O
fate	O
determination	O
,	O
while	O
at	B-T103
##oh	I-T103
##1	I-T103
(	I-T103
+	I-T103
)	I-T103
cells	B-T017
had	O
reduced	O
erbb	B-T017
##3	I-T017
,	O
suggesting	O
reciprocal	O
negative	B-T033
regulation	B-T038
.	O
erbb	B-T103
##3	I-T103
-	O
null	O
intestinal	B-T017
progenitor	I-T017
cells	I-T017
showed	O
reduced	O
activation	O
of	O
the	O
pi3k	O
-	O
akt	O
and	O
erk	B-T038
mapk	I-T038
pathways	I-T038
.	O
inhibiting	O
these	O
pathways	B-T038
in	O
ht2	B-T017
##9	I-T017
cells	I-T017
increased	O
levels	O
of	O
at	B-T017
##oh	I-T017
##1	I-T017
and	O
the	O
pc	B-T017
marker	O
ly	B-T017
##z	I-T017
.	O
conversely	O
,	O
erbb	B-T103
##3	I-T103
activation	O
suppressed	B-T038
ly	B-T017
##z	I-T017
and	O
at	B-T017
##oh	I-T017
##1	I-T017
in	O
a	O
pi3k	B-T103
-	O
dependent	O
manner	O
.	O
expansion	O
of	O
the	O
pc	B-T017
compartment	O
in	O
erbb	B-T103
##3	I-T103
-	O
null	O
intestines	B-T017
was	O
accompanied	O
with	O
elevated	O
er	B-T038
stress	I-T038
and	O
inflammation	B-T038
markers	B-T201
,	O
raising	O
the	O
possibility	O
that	O
negative	B-T033
regulation	B-T038
of	O
pcs	B-T017
by	O
erbb	B-T103
##3	I-T103
is	O
necessary	O
to	O
maintain	O
homeostasis	B-T038
.	O
taken	O
together	O
,	O
our	O
data	O
suggest	O
that	O
erbb	B-T103
##3	I-T103
restrict	O
##s	O
pc	B-T017
numbers	O
through	O
pi3k	B-T103
-	O
mediated	O
suppression	B-T038
of	O
at	B-T017
##oh	I-T017
##1	I-T017
levels	O
leading	O
to	O
inhibition	O
of	O
pc	B-T017
differentiation	B-T038
,	O
with	O
important	O
implications	O
for	O
regulation	B-T038
of	O
the	O
isc	B-T022
niche	I-T022
.	O

comparing	O
time	B-T038
perception	I-T038
among	O
morphine	B-T103
-	O
derived	O
drugs	B-T103
addicts	O
and	O
controls	O
the	O
aim	O
of	O
the	O
present	O
study	B-T062
is	O
to	O
compare	O
time	B-T038
perception	I-T038
among	O
drug	B-T033
addicts	I-T033
and	O
controls	O
.	O
30	O
drug	B-T033
addicts	I-T033
were	O
selected	O
,	O
and	O
30	O
non	B-T098
-	I-T098
addic	I-T098
##t	I-T098
individuals	I-T098
were	O
selected	O
as	O
the	O
control	O
group	O
.	O
the	O
two	O
groups	O
performed	O
three	O
tests	B-T170
of	O
time	O
reproduction	B-T038
,	O
time	O
estimation	O
,	O
and	O
time	O
discrimination	B-T038
.	O
there	O
was	O
a	O
significant	O
difference	O
between	O
the	O
addicts	O
group	O
and	O
the	O
control	O
group	O
regarding	O
the	O
error	O
of	O
time	O
reproduction	B-T038
and	O
time	O
estimation	O
.	O
the	O
addic	O
##t	O
group	O
in	O
comparison	O
to	O
the	O
control	O
group	O
had	O
a	O
lower	O
under	O
-	O
reproduction	B-T038
and	O
a	O
higher	O
over	O
-	O
reproduction	B-T038
error	O
,	O
and	O
also	O
a	O
lower	O
under	O
-	O
estimation	B-T038
and	O
higher	O
over	O
-	O
estimation	B-T038
error	O
.	O
however	O
,	O
regarding	O
time	O
discrimination	B-T038
,	O
no	O
significant	O
difference	O
was	O
observed	O
between	O
the	O
errors	O
committed	O
by	O
both	O
groups	O
.	O
on	O
the	O
other	O
hand	O
,	O
when	O
showing	O
images	B-T170
of	O
drug	O
consumption	O
tools	O
and	O
normal	O
images	B-T170
with	O
same	O
durations	O
,	O
the	O
normal	O
group	O
believed	O
that	O
the	O
images	B-T170
related	O
to	O
drug	O
consumption	O
tools	O
were	O
shown	O
for	O
a	O
shorter	O
period	O
of	O
time	O
.	O
time	B-T038
perception	I-T038
is	O
different	O
between	O
morphine	B-T103
-	O
derived	O
drugs	B-T103
addicts	O
and	O
controls	O
.	O

a	O
missense	B-T038
variant	O
,	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
(	I-T017
p	I-T017
.	I-T017
arg	I-T017
##45	I-T017
##7	I-T017
##gl	I-T017
##n	I-T017
)	I-T017
,	I-T017
of	I-T017
creb	I-T017
##r	I-T017
##f	I-T017
and	O
body	B-T201
mass	I-T201
index	I-T201
in	O
ocean	O
##ic	O
populations	O
it	O
has	O
been	O
suggested	O
that	O
a	O
'	O
thr	O
##ift	O
##y	O
'	O
genotype	O
hypothesis	O
can	O
account	O
for	O
high	O
prevalence	O
of	O
obesity	B-T038
in	O
the	O
island	B-T082
populations	B-T098
of	O
ocean	B-T082
##ia	I-T082
.	O
a	O
recent	O
genome	B-T062
-	I-T062
wide	I-T062
association	I-T062
study	I-T062
revealed	O
that	O
a	O
missense	B-T038
variant	O
,	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
(	I-T017
p	I-T017
.	I-T017
arg	I-T017
##45	I-T017
##7	I-T017
##gl	I-T017
##n	I-T017
)	I-T017
,	I-T017
of	I-T017
the	I-T017
creb	I-T017
##r	I-T017
##f	I-T017
gene	I-T017
(	O
encoding	O
creb	B-T103
##3	I-T103
regulatory	I-T103
factor	I-T103
)	O
was	O
associated	O
with	O
an	O
excessive	O
increase	O
in	O
body	B-T201
mass	I-T201
index	I-T201
(	O
bmi	B-T201
)	O
in	O
sam	B-T098
##oa	I-T098
##ns	I-T098
.	O
in	O
the	O
present	O
study	O
,	O
the	O
association	O
of	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
with	O
an	O
increase	O
in	O
bmi	B-T201
was	O
examined	B-T033
in	O
four	O
austr	O
##ones	O
##ian	O
(	O
an	O
)	O
-	O
speaking	O
populations	B-T098
in	O
ocean	B-T082
##ia	I-T082
.	O
we	O
found	O
that	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
was	O
frequently	O
observed	O
(	O
frequency	O
of	O
0	O
.	O
15	O
)	O
in	O
tong	B-T098
##ans	I-T098
(	O
polyn	B-T098
##esia	I-T098
##ns	I-T098
)	O
,	O
and	O
was	O
strongly	O
associated	O
with	O
higher	O
bmi	B-T201
(	O
p	O
=	O
6	O
.	O
1	O
×	O
10	O
(	O
-	O
4	O
)	O
)	O
.	O
a	O
single	O
copy	O
of	O
the	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
allele	B-T017
increased	O
bmi	B-T201
by	O
3	O
.	O
09	O
kg	O
m	O
(	O
-	O
2	O
)	O
after	O
adjustment	O
of	O
age	O
and	O
sex	O
.	O
no	B-T033
significant	I-T033
association	O
was	O
detected	B-T058
in	O
the	O
other	O
three	O
an	O
-	O
speaking	O
populations	B-T098
(	O
melan	B-T098
##esia	I-T098
##ns	I-T098
and	O
micron	B-T098
##esia	I-T098
##ns	I-T098
)	O
living	O
in	O
sol	B-T082
##omon	I-T082
islands	I-T082
.	O
this	O
was	O
probably	O
due	O
to	O
the	O
low	O
allele	O
frequency	O
(	O
0	O
.	O
02	O
-	O
0	O
.	O
06	O
)	O
of	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
as	O
well	O
as	O
small	O
sample	O
size	O
.	O
the	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
allele	B-T017
was	O
not	O
found	O
in	O
both	O
an	O
-	O
speaking	O
and	O
non	O
-	O
an	O
-	O
speaking	O
melan	B-T098
##esia	I-T098
##ns	I-T098
living	O
in	O
pap	B-T082
##ua	I-T082
new	I-T082
guinea	I-T082
.	O
our	O
results	O
suggest	O
that	O
rs	B-T017
##37	I-T017
##38	I-T017
##63	I-T017
##82	I-T017
##8	I-T017
-	I-T017
a	I-T017
of	I-T017
creb	I-T017
##r	I-T017
##f	I-T017
,	O
a	O
promising	O
thr	O
##ift	O
##y	O
variant	O
,	O
arose	O
in	O
recent	O
ancestor	O
##s	O
of	O
an	O
-	O
speaking	O
polyn	B-T098
##esia	I-T098
##ns	I-T098
.	O
journal	O
of	O
human	O
genetics	O
advance	O
online	O
publication	O
,	O
13	O
april	O
2017	O
;	O
doi	O
:	O
10	O
.	O
103	O
##8	O
/	O
jh	O
##g	O
.	O
2017	O
.	O
44	O
.	O

first	O
and	O
second	O
generation	O
des	B-T074
##s	I-T074
reduce	O
diabetes	B-T038
adverse	B-T038
effect	I-T038
on	O
mortality	O
and	O
re	B-T058
-	I-T058
intervention	I-T058
in	O
multiv	B-T017
##essel	I-T017
coronary	B-T038
disease	I-T038
:	O
9	O
-	O
year	O
analysis	B-T062
diabetes	B-T038
port	O
##ends	O
an	O
increased	O
risk	O
of	O
adverse	B-T038
early	O
and	O
late	O
outcomes	O
in	O
patients	O
undergoing	O
pci	B-T058
.	O
in	O
this	O
study	B-T062
,	O
we	O
aimed	O
to	O
investigate	O
if	O
the	O
adverse	B-T038
effect	I-T038
of	O
diabetes	B-T038
mellitus	I-T038
(	O
dm	B-T038
)	O
on	O
early	O
and	O
late	O
pci	B-T058
outcomes	O
is	O
reduced	O
with	O
drug	B-T074
-	I-T074
eluting	I-T074
(	O
des	B-T074
)	O
compared	O
to	O
bare	B-T074
-	I-T074
metal	I-T074
(	I-T074
bms	I-T074
)	I-T074
stents	I-T074
.	O
we	O
reviewed	O
the	O
mount	B-T092
sin	I-T092
##ai	I-T092
bet	I-T092
##h	I-T092
israel	I-T092
hospital	I-T092
first	O
pci	B-T058
experience	O
for	O
multiv	B-T017
##essel	I-T017
coronary	B-T038
artery	I-T038
disease	I-T038
(	O
cad	B-T038
,	O
1998	O
-	O
2009	O
)	O
.	O
patients	O
were	O
excluded	O
if	O
they	O
had	O
single	B-T038
-	I-T038
vessel	I-T038
cad	I-T038
,	O
emergency	O
,	O
no	B-T033
stent	B-T074
,	O
prior	O
bypass	B-T058
graft	I-T058
or	O
myocardial	B-T038
infarction	I-T038
<	O
24h	O
.	O
diabetes	B-T038
-	O
effect	O
was	O
derived	O
from	O
9	O
-	O
year	O
all	O
-	O
cause	O
mortality	O
and	O
re	B-T058
-	I-T058
intervention	I-T058
risk	O
-	O
adjusted	O
hazard	O
ratios	O
[	O
ahr	O
(	O
95	O
%	O
confidence	O
intervals	O
)	O
]	O
for	O
des	B-T074
(	O
n	O
=	O
267	O
##9	O
;	O
48	O
%	O
three	B-T038
-	I-T038
vessel	I-T038
;	O
39	O
%	O
dm	B-T038
)	O
and	O
bms	B-T074
(	O
n	O
=	O
265	O
##1	O
;	O
40	O
%	O
three	B-T038
-	I-T038
vessel	I-T038
;	O
33	O
%	O
dm	B-T038
)	O
and	O
then	O
stratified	O
based	O
on	O
stent	B-T074
(	O
des	B-T074
/	O
bms	B-T074
)	O
and	O
vessel	B-T038
disease	I-T038
(	O
two	B-T038
/	O
three	B-T038
)	O
.	O
diabetes	B-T038
-	O
effect	O
on	O
mortality	O
was	O
lower	O
for	O
des	B-T074
(	O
ahr	O
##dm	O
/	O
nod	O
##m	O
=	O
1	O
.	O
41	O
[	O
1	O
.	O
14	O
-	O
1	O
.	O
74	O
]	O
)	O
versus	O
bms	B-T074
(	O
ahr	O
##dm	O
/	O
nod	O
##m	O
=	O
1	O
.	O
71	O
[	O
1	O
.	O
50	O
-	O
2	O
.	O
01	O
]	O
)	O
,	O
but	O
this	O
was	O
predominantly	O
driven	O
by	O
two	B-T038
-	I-T038
vessel	I-T038
patients	O
.	O
this	O
diabetes	B-T038
effect	O
was	O
similar	O
for	O
first	O
(	O
des	B-T074
##1	I-T074
:	O
ahr	O
##dm	O
/	O
nod	O
##m	O
=	O
1	O
.	O
43	O
[	O
1	O
.	O
14	O
-	O
1	O
.	O
79	O
]	O
)	O
and	O
second	O
(	O
des	B-T074
##2	I-T074
:	O
ahr	O
##dm	O
/	O
nod	O
##m	O
=	O
1	O
.	O
53	O
[	O
0	O
.	O
77	O
-	O
3	O
.	O
07	O
]	O
)	O
generation	O
des	B-T074
.	O
re	B-T058
-	I-T058
intervention	I-T058
comparisons	O
were	O
similarly	O
increased	O
by	O
diabetes	B-T038
in	O
all	O
sub	B-T098
-	I-T098
cohorts	I-T098
.	O
our	O
analysis	B-T062
of	O
a	O
large	O
real	O
-	O
world	O
pci	B-T058
series	O
indicates	O
that	O
diabetes	B-T038
is	O
associated	O
with	O
worse	B-T033
9	O
-	O
year	O
mortality	O
irrespective	O
of	O
stent	B-T074
type	O
,	O
albeit	O
this	O
is	O
mitigated	O
to	O
varying	O
degrees	O
with	O
des	B-T074
,	O
particularly	O
in	O
des	B-T074
##2	I-T074
and	O
in	O
case	O
of	O
2	B-T038
-	I-T038
vessel	I-T038
disease	I-T038
.	O
a	O
complementary	O
stent	B-T074
-	O
effect	O
analysis	B-T062
confirmed	B-T033
des	B-T074
-	O
to	O
-	O
bms	B-T074
and	O
des	B-T074
##2	I-T074
-	O
to	O
-	O
des	B-T074
##1	I-T074
superiority	O
in	O
both	O
diabetics	B-T033
and	O
non	B-T033
-	I-T033
diabetics	I-T033
.	O

mildly	O
raised	O
tricuspid	O
regurg	O
##itant	O
velocity	O
2	O
.	O
5	O
-	O
3	O
.	O
0	O
m	O
/	O
s	O
in	O
pregnant	B-T098
women	I-T098
with	O
sickle	B-T038
cell	I-T038
disease	I-T038
is	O
not	O
associated	O
with	O
poor	O
obstetric	O
outcome	O
-	O
an	O
observational	B-T062
cross	I-T062
-	I-T062
sectional	I-T062
study	I-T062
pulmonary	B-T038
hypertension	I-T038
is	O
associated	O
with	O
36	O
%	O
mortality	O
in	O
pregnancy	B-T038
,	O
and	O
6	O
-	O
10	O
%	O
of	O
patients	O
with	O
sickle	B-T038
cell	I-T038
disease	I-T038
have	O
pulmonary	B-T038
hypertension	I-T038
.	O
tricuspid	O
regurg	O
##itant	O
velocity	O
≥2	O
.	O
5	O
m	O
/	O
s	O
on	O
echocardiography	B-T058
is	O
a	O
well	O
validated	O
means	O
of	O
screening	B-T058
for	O
pulmonary	B-T038
hypertension	I-T038
in	O
the	O
non	B-T033
-	I-T033
pregnant	I-T033
population	B-T098
.	O
this	O
is	O
a	O
pilot	B-T062
study	I-T062
to	O
determine	O
if	O
this	O
is	O
a	O
useful	O
non	O
-	O
invasive	O
screening	B-T058
test	I-T058
for	O
pulmonary	B-T038
hypertension	I-T038
in	O
pregnancy	B-T038
,	O
and	O
whether	O
raised	O
tricuspid	O
regurg	O
##itant	O
velocity	O
≥2	O
.	O
5	O
m	O
/	O
s	O
was	O
associated	O
with	O
poor	O
outcomes	O
.	O
this	O
is	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
over	O
a	O
five	O
-	O
year	O
period	O
in	O
a	O
tertiary	B-T092
referral	I-T092
centre	I-T092
with	O
a	O
specialised	O
multidisciplinary	B-T092
clinic	I-T092
for	O
pregnant	B-T098
women	I-T098
with	O
sickle	B-T038
cell	I-T038
disease	I-T038
.	O
women	B-T098
with	O
sickle	B-T038
cell	I-T038
disease	I-T038
,	O
no	O
prior	O
pulmonary	B-T038
hypertension	I-T038
and	O
singleton	O
pregnancies	B-T038
who	O
had	O
echocardiography	B-T058
with	O
a	O
measurable	O
tricuspid	O
regurg	O
##itant	O
velocity	O
in	O
pregnancy	B-T038
were	O
included	O
.	O
there	O
were	O
34	O
pregnancies	B-T038
,	O
of	O
which	O
eight	O
had	O
tricuspid	O
regurg	O
##itant	O
velocity	O
≥2	O
.	O
5	O
m	O
/	O
s	O
.	O
there	O
were	O
no	B-T033
significant	I-T033
differences	O
in	O
their	O
characteristics	O
,	O
sickle	B-T017
cell	I-T017
-	O
related	O
complications	B-T038
or	O
medical	O
co	O
-	O
morbidities	O
.	O
the	O
women	B-T098
with	O
tricuspid	O
regurg	O
##itant	O
velocity	O
≥2	O
.	O
5	O
m	O
/	O
s	O
had	O
similar	O
obstetric	O
and	O
perinatal	O
outcomes	O
as	O
those	O
with	O
a	O
tricuspid	O
regurg	O
##itant	O
velocity	O
<	O
2	O
.	O
5	O
m	O
/	O
s	O
.	O

improved	B-T033
protocol	B-T170
for	O
the	O
isolation	B-T058
of	O
naive	O
follicular	B-T017
dendritic	I-T017
cells	I-T017
follicular	B-T017
dendritic	I-T017
cells	I-T017
(	O
fd	B-T017
##cs	I-T017
)	O
in	O
lymphoid	B-T017
organs	I-T017
play	O
an	O
important	O
role	O
in	O
the	O
humoral	B-T038
immune	I-T038
response	I-T038
.	O
however	O
,	O
because	O
the	O
isolation	B-T058
of	O
fd	B-T017
##cs	I-T017
is	O
difficult	O
due	O
to	O
their	O
very	O
small	O
population	O
size	O
and	O
fragility	B-T038
under	O
mechanical	O
and	O
chemical	O
stresses	O
,	O
the	O
genetic	O
and	O
biochemical	O
characteristics	O
of	O
fd	B-T017
##cs	I-T017
remain	O
unclear	O
.	O
previously	O
,	O
we	O
identified	O
fd	B-T017
##cs	I-T017
as	O
icam	B-T103
-	I-T103
1	I-T103
(	I-T103
+	I-T103
)	I-T103
cells	B-T017
in	O
the	O
cd45	B-T103
(	B-T033
-	I-T033
)	I-T033
non	B-T017
-	I-T017
hematopoietic	I-T017
cell	I-T017
fraction	I-T017
from	O
naive	O
mouse	B-T017
spleen	I-T017
after	O
cell	B-T058
separation	I-T058
by	O
means	O
of	O
digestion	O
with	O
a	O
combination	O
of	O
enzymes	B-T103
.	O
in	O
the	O
present	O
study	O
,	O
using	O
a	O
new	O
combination	O
of	O
enzymes	B-T103
,	O
we	O
found	O
that	O
fd	B-T017
##cs	I-T017
are	O
highly	O
enriched	O
in	O
the	O
cd45	B-T103
(	B-T033
-	I-T033
)	I-T033
icam	B-T103
-	I-T103
1	I-T103
(	I-T103
+	I-T103
)	I-T103
cd2	B-T103
##1	I-T103
/	O
35	B-T103
(	I-T103
+	I-T103
)	I-T103
cell	B-T017
fraction	I-T017
.	O
cd45	B-T103
(	B-T033
-	I-T033
)	I-T033
icam	B-T103
-	I-T103
1	I-T103
(	I-T103
+	I-T103
)	I-T103
cd2	B-T103
##1	I-T103
/	O
35	B-T103
(	I-T103
+	I-T103
)	I-T103
cells	B-T017
in	O
the	O
mouse	B-T017
spleen	I-T017
retained	O
an	O
antigen	B-T103
administered	O
in	B-T082
vivo	I-T082
for	O
more	O
than	O
7	O
days	O
.	O
moreover	O
,	O
cd45	B-T103
(	B-T033
-	I-T033
)	I-T033
icam	B-T103
-	I-T103
1	I-T103
(	I-T103
+	I-T103
)	I-T103
cd2	B-T103
##1	I-T103
/	O
35	B-T103
(	I-T103
+	I-T103
)	I-T103
cells	B-T017
isolated	O
from	O
the	O
spleen	B-T017
of	I-T017
mice	I-T017
administered	O
with	O
a	O
cognate	B-T103
antigen	I-T103
enhanced	O
the	O
survival	B-T038
and	O
proliferation	O
of	O
antigen	B-T017
-	I-T017
specific	I-T017
b	I-T017
cells	I-T017
in	O
vitro	O
.	O
our	O
improved	B-T033
protocol	B-T170
for	O
the	O
isolation	B-T058
of	O
naive	O
fd	B-T017
##cs	I-T017
will	O
be	O
useful	O
for	O
the	O
analysis	B-T062
of	O
fd	B-T017
##cs	I-T017
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
.	O

joint	O
model	O
imp	O
##utation	O
to	O
estimate	O
the	O
treatment	B-T033
effect	I-T033
on	O
long	O
-	O
term	O
survival	O
using	O
auxiliary	O
events	O
clinical	B-T062
trial	I-T062
duration	O
may	O
be	O
a	O
concern	O
in	O
clinical	B-T062
research	I-T062
,	O
especially	O
in	O
cancer	B-T062
trials	I-T062
where	O
the	O
endpoint	B-T201
is	O
overall	O
survival	O
.	O
a	O
surrogate	O
endpoint	O
can	O
be	O
used	O
as	O
an	O
auxiliary	O
variable	O
to	O
analyze	B-T062
the	O
treatment	B-T033
effect	I-T033
earlier	O
.	O
at	O
an	O
early	O
time	O
point	O
,	O
the	O
high	O
number	O
of	O
cens	O
##ored	O
observations	B-T062
can	O
be	O
compensated	O
by	O
the	O
imp	O
##utation	O
of	O
the	O
un	B-T033
##obs	I-T033
##erved	I-T033
deaths	B-T033
times	O
.	O
we	O
propose	O
to	O
use	O
predictions	O
of	O
the	O
risk	O
of	O
death	B-T038
from	O
a	O
joint	O
model	O
for	O
a	O
recurrent	O
event	O
and	O
a	O
terminal	O
event	O
,	O
which	O
account	O
for	O
disease	B-T038
relapse	I-T038
information	O
.	O
two	O
imp	O
##utation	O
methods	O
were	O
compared	O
:	O
sampling	B-T062
from	O
the	O
estimated	O
parametric	O
distribution	O
of	O
the	O
survival	B-T201
time	I-T201
and	O
sampling	B-T062
using	O
its	O
nonparametric	O
estimation	O
.	O
the	O
treatment	B-T033
effect	I-T033
and	O
its	O
standard	O
error	O
were	O
estimated	O
via	O
multiple	O
imp	O
##utation	O
##s	O
.	O
the	O
performances	O
of	O
the	O
two	O
methods	B-T170
were	O
compared	O
in	O
terms	O
of	O
bias	O
in	O
the	O
estimates	O
,	O
standard	O
errors	O
,	O
and	O
coverage	O
probability	O
.	O
both	O
methods	B-T170
were	O
then	O
retrospectively	O
applied	O
to	O
two	O
randomized	B-T062
clinical	I-T062
trials	I-T062
studying	O
the	O
effect	O
of	O
adjuvant	O
chemotherapy	B-T058
in	O
breast	B-T038
cancer	I-T038
patients	O
.	O

the	O
nanocomposite	O
nature	O
of	O
bone	B-T017
drives	O
its	O
strength	O
and	O
damage	O
resistance	O
in	O
human	B-T017
bone	I-T017
,	O
an	O
amorphous	O
mineral	B-T103
serves	O
as	O
a	O
precursor	O
to	O
the	O
formation	O
of	O
a	O
highly	O
substituted	O
nanocryst	O
##alline	O
apatite	B-T103
.	O
however	O
,	O
the	O
precise	O
role	O
of	O
this	O
amorphous	O
mineral	B-T103
remains	O
unknown	O
.	O
here	O
,	O
we	O
show	O
by	O
using	O
transmission	B-T058
electron	I-T058
microscopy	I-T058
that	O
100	O
-	O
300	O
nm	O
amorphous	O
calcium	B-T103
phosphate	I-T103
regions	B-T082
are	O
present	O
in	O
the	O
disordered	O
phase	O
of	O
trabecular	B-T017
bone	I-T017
.	O
nanom	B-T062
##echanical	I-T062
experiments	I-T062
on	O
cylindrical	B-T082
samples	O
,	O
with	O
diameters	O
between	O
250	O
nm	O
and	O
3	O
,	O
000	O
nm	O
,	O
of	O
the	O
bone	B-T017
'	I-T017
s	I-T017
ordered	O
and	O
disordered	O
phases	O
revealed	O
a	O
transition	O
from	O
plastic	O
deformation	B-T033
to	O
brit	B-T033
##tle	I-T033
failure	B-T037
and	O
at	O
least	O
a	O
factor	O
-	O
of	O
-	O
2	O
higher	O
strength	O
in	O
the	O
smaller	O
samples	O
.	O
we	O
postulate	O
that	O
this	O
transition	O
in	O
failure	O
mechanism	O
is	O
caused	O
by	O
the	O
suppression	O
of	O
extra	B-T017
##fi	I-T017
##br	I-T017
##illar	I-T017
shear	B-T058
##ing	I-T058
in	O
the	O
smaller	O
samples	O
,	O
and	O
that	O
the	O
emergent	O
smaller	O
-	O
is	O
-	O
stronger	O
size	O
effect	O
is	O
related	O
to	O
the	O
sample	O
-	O
size	O
scaling	O
of	O
the	O
distribution	O
of	O
flaw	O
##s	O
.	O
our	O
findings	B-T033
should	O
help	O
in	O
the	O
understanding	O
of	O
the	O
multi	O
-	O
scale	O
nature	O
of	O
bone	B-T017
and	O
provide	O
insights	O
into	O
the	O
biom	B-T038
##ineral	I-T038
##ization	I-T038
process	O
.	O

clinical	O
characteristics	O
of	O
genital	O
chlamydia	O
infection	O
in	O
pelvic	B-T038
inflammatory	I-T038
disease	I-T038
chlamydia	B-T038
infection	I-T038
in	O
acute	B-T038
pelvic	I-T038
inflammatory	I-T038
disease	I-T038
(	O
pid	B-T038
)	O
is	O
associated	O
with	O
serious	O
complications	B-T038
including	O
ectopic	B-T038
pregnancy	I-T038
,	O
tubal	B-T038
infertility	I-T038
,	O
fit	B-T038
##z	I-T038
-	I-T038
hu	I-T038
##gh	I-T038
-	I-T038
cur	I-T038
##tis	I-T038
syndrome	I-T038
and	O
tub	B-T038
##o	I-T038
-	I-T038
ovarian	I-T038
abscess	I-T038
(	O
to	B-T038
##a	I-T038
)	O
.	O
this	O
study	B-T062
compared	O
clinical	B-T170
and	O
laboratory	B-T170
data	I-T170
between	O
pid	B-T038
with	O
and	O
without	O
chlamydia	B-T038
infection	I-T038
.	O
the	O
medical	B-T170
records	I-T170
of	O
49	O
##7	O
women	B-T098
who	O
were	O
admitted	O
with	O
pid	B-T038
between	O
2002	O
and	O
2011	O
were	O
reviewed	O
.	O
the	O
patients	O
were	O
divided	O
into	O
two	O
groups	B-T098
(	O
pid	B-T038
with	O
and	O
without	O
chlamydia	B-T038
infection	I-T038
)	O
,	O
which	O
were	O
compared	O
in	O
terms	O
of	O
the	O
patients	O
'	O
characteristics	O
,	O
clinical	O
presentation	O
,	O
and	O
laboratory	B-T033
findings	I-T033
,	O
including	O
inflammatory	O
markers	B-T201
.	O
the	O
chlamydia	B-T098
and	O
non	B-T098
-	I-T098
chlamydia	I-T098
groups	I-T098
comprised	O
175	O
and	O
322	O
women	B-T098
,	O
respectively	O
.	O
the	O
patients	O
in	O
the	O
chlamydia	B-T098
group	I-T098
were	O
younger	O
and	O
had	O
a	O
higher	O
rate	O
of	O
to	B-T038
##a	I-T038
,	O
a	O
longer	O
mean	O
hospital	O
stay	O
,	O
and	O
had	O
undergone	O
more	O
surgeries	B-T058
than	O
the	O
patients	O
in	O
the	O
non	B-T098
-	I-T098
chlamydia	I-T098
group	I-T098
.	O
the	O
erythrocyte	B-T033
sedimentation	I-T033
rate	I-T033
(	O
esr	B-T033
)	O
,	O
c	B-T103
-	I-T103
reactive	I-T103
protein	I-T103
(	O
crp	B-T103
)	O
,	O
and	O
ca	B-T103
-	I-T103
125	I-T103
level	O
were	O
higher	O
in	O
the	O
chlamydia	B-T098
group	I-T098
than	O
in	O
the	O
non	B-T098
-	I-T098
chlamydia	I-T098
group	I-T098
,	O
but	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
white	O
blood	O
cell	O
count	O
between	O
the	O
two	O
groups	B-T098
.	O
the	O
ca	B-T103
-	I-T103
125	I-T103
level	O
was	O
the	O
strongest	O
predictor	O
of	O
chlamydia	B-T038
infection	I-T038
,	O
followed	O
by	O
the	O
esr	B-T033
and	O
crp	B-T103
level	O
.	O
the	O
area	B-T082
under	O
the	O
receiving	O
operating	O
curve	O
for	O
ca	B-T103
-	I-T103
125	I-T103
,	O
esr	B-T033
,	O
and	O
crp	B-T103
was	O
0	O
.	O
80	O
##4	O
,	O
0	O
.	O
75	O
##5	O
,	O
and	O
0	O
.	O
66	O
##3	O
,	O
respectively	O
.	O
chlamydia	B-T038
infection	I-T038
in	O
acute	B-T038
pid	I-T038
is	O
associated	O
with	O
increased	O
level	O
of	O
inflammatory	O
markers	B-T201
,	O
such	O
as	O
ca	B-T103
-	I-T103
125	I-T103
,	O
esr	B-T033
and	O
crp	B-T103
,	O
incidence	O
of	O
to	B-T038
##a	I-T038
,	O
operation	B-T058
risk	O
,	O
and	O
longer	O
hospitalization	B-T058
.	O

synovial	B-T038
sarcoma	I-T038
of	O
the	O
hypop	B-T082
##har	I-T082
##yn	I-T082
##x	I-T082
in	O
a	O
pediatric	O
patient	O
:	O
case	B-T170
report	I-T170
synovial	B-T038
sarcoma	I-T038
(	O
ss	B-T038
)	O
is	O
uncommon	O
high	O
grade	O
soft	B-T017
tissue	I-T017
sarcoma	B-T038
,	O
accounting	O
for	O
less	O
than	O
10	O
%	O
of	O
all	O
head	B-T038
and	I-T038
neck	I-T038
sarcomas	I-T038
.	O
also	O
,	O
about	O
10	O
%	O
of	O
ss	B-T038
occur	O
within	O
the	O
head	B-T082
&	O
neck	B-T082
.	O
in	O
the	O
pediatric	O
population	B-T098
,	O
ss	B-T038
is	O
an	O
extremely	O
rare	O
head	B-T038
&	I-T038
neck	I-T038
malignancy	I-T038
.	O
we	O
present	O
a	O
case	O
of	O
sixteen	O
years	O
old	O
boy	O
diagnosed	B-T033
with	O
ss	B-T038
situated	O
of	O
the	O
hypop	B-T082
##har	I-T082
##yn	I-T082
##x	I-T082
treated	B-T058
by	I-T058
surgical	B-T058
excision	I-T058
and	O
post	B-T033
operative	I-T033
radio	B-T058
-	O
chemotherapy	B-T058
.	O
this	O
anatomical	B-T082
location	I-T082
brings	O
additional	O
functional	O
challenges	B-T058
(	O
swallowing	B-T038
,	O
phon	B-T038
##ation	I-T038
,	O
respiration	B-T038
)	O
,	O
especially	O
in	O
the	O
pediatric	O
population	B-T098
.	O
pre	O
-	O
operative	O
and	O
even	O
post	B-T033
-	I-T033
operative	I-T033
histopathological	O
diagnosis	B-T033
of	O
ss	B-T038
remains	O
difficult	O
.	O
optimal	O
treatment	B-T058
of	O
head	B-T082
&	O
neck	B-T082
ss	B-T038
has	O
to	O
balance	O
functional	O
and	O
oncologic	B-T091
aspects	O
.	O
ss	B-T038
is	O
an	O
extremely	O
rare	O
head	B-T038
&	I-T038
neck	I-T038
malignancy	I-T038
in	O
pediatric	O
population	B-T098
.	O
it	O
has	O
multifaceted	B-T082
challenges	B-T058
including	O
pre	O
and	O
post	B-T033
-	I-T033
operative	I-T033
histopathological	O
diagnosis	B-T033
and	O
optimal	O
modality	O
of	O
treatment	B-T058
.	O
clinical	B-T170
judgment	I-T170
,	O
especially	O
in	O
the	O
pediatric	O
population	B-T098
,	O
needs	O
to	O
balance	O
tumor	B-T033
free	I-T033
margins	I-T033
and	O
organ	B-T058
preservation	I-T058
in	O
head	B-T082
and	O
neck	B-T082
region	B-T082
.	O

us	B-T103
##3	I-T103
and	O
us	B-T103
##9	I-T103
proteins	B-T103
contribute	O
to	O
the	O
stromal	B-T033
invasion	I-T033
of	O
bovine	B-T005
herpesvirus	I-T005
1	I-T005
in	O
the	O
respiratory	B-T017
mucosa	I-T017
bovine	O
herpesvirus	O
1	O
(	O
bh	O
##v	O
-	O
1	O
)	O
infection	O
may	O
lead	O
to	O
conjunctivitis	B-T038
,	O
upper	B-T017
respiratory	I-T017
tract	I-T017
problems	B-T033
,	O
pneumonia	B-T038
,	O
genital	B-T038
disorders	I-T038
and	O
abortion	B-T033
.	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
is	O
able	O
to	O
spread	O
quickly	O
in	O
a	O
plaque	B-T033
-	O
wise	O
manner	O
and	O
invade	O
by	O
bre	B-T037
##aching	I-T037
the	O
basement	B-T017
membrane	I-T017
(	B-T017
bm	I-T017
)	I-T017
barrier	O
in	O
the	O
respiratory	B-T017
mucosa	I-T017
.	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
us	B-T103
##3	I-T103
,	O
a	O
serine	B-T103
/	I-T103
threonine	I-T103
kinase	I-T103
,	O
induces	O
a	O
dramatic	O
cytoskeletal	B-T038
reorganization	I-T038
and	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
us	B-T103
##9	I-T103
,	O
a	O
tail	B-T103
-	I-T103
anchored	I-T103
membrane	I-T103
protein	I-T103
,	O
is	O
required	O
for	O
axonal	B-T038
transport	I-T038
of	O
viruses	B-T005
in	O
neurons	B-T017
.	O
in	O
this	O
study	B-T062
,	O
we	O
investigated	O
the	O
role	O
of	O
us	B-T103
##3	I-T103
and	O
us	B-T103
##9	I-T103
during	O
bh	O
##v	O
-	O
1	O
infection	O
in	O
the	O
respiratory	B-T017
mucosa	I-T017
.	O
first	O
,	O
we	O
constructed	O
and	O
characterized	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
us	B-T017
##3	I-T017
null	B-T005
,	O
us	B-T017
##9	I-T017
null	B-T005
and	O
revert	B-T005
##ant	I-T005
viruses	I-T005
.	O
then	O
,	O
we	O
analysed	B-T062
the	O
viral	B-T038
replication	I-T038
and	O
plaque	B-T033
size	B-T082
(	O
latitude	O
)	O
in	O
mad	B-T017
##in	I-T017
-	I-T017
dar	I-T017
##by	I-T017
bovine	I-T017
kidney	I-T017
(	O
md	B-T017
##b	I-T017
##k	I-T017
)	O
cells	B-T017
and	O
the	O
respiratory	B-T017
mucosa	I-T017
as	O
well	O
as	O
viral	B-T038
penetration	I-T038
depth	O
undern	O
##ea	O
##th	O
the	O
bm	B-T017
of	O
the	O
respiratory	B-T017
mucosa	I-T017
when	O
inoculated	B-T058
with	O
these	O
recombinant	B-T005
viruses	I-T005
.	O
knockout	B-T038
of	O
us	B-T017
##3	I-T017
resulted	O
in	O
a	O
1	O
log10	O
reduction	O
in	O
viral	O
titre	O
and	O
plaque	B-T033
size	B-T082
(	O
latitude	O
)	O
in	O
md	B-T017
##b	I-T017
##k	I-T017
cells	I-T017
and	O
the	O
trachea	B-T017
mucosa	I-T017
.	O
there	O
were	O
no	B-T033
defects	O
in	O
the	O
cell	B-T038
-	I-T038
to	I-T038
-	I-T038
cell	I-T038
spread	I-T038
observed	O
for	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
us	B-T017
##9	I-T017
null	B-T005
virus	I-T005
.	O
both	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
us	B-T017
##3	I-T017
null	B-T005
and	O
us	B-T017
##9	I-T017
null	B-T005
viruses	I-T005
showed	O
a	O
significant	O
reduction	O
of	O
plaque	B-T033
penetration	O
undern	O
##ea	O
##th	O
the	O
bm	B-T017
;	O
however	O
,	O
penetration	O
was	O
not	O
completely	O
inhibited	O
.	O
in	O
conclusion	O
,	O
the	O
current	O
findings	B-T062
demonstrated	O
that	O
us	B-T017
##3	I-T017
and	O
us	B-T017
##9	I-T017
play	O
an	O
important	O
role	O
in	O
the	O
invasion	B-T033
of	O
bh	B-T005
##v	I-T005
-	I-T005
1	I-T005
through	O
the	O
bm	B-T017
of	O
the	O
respiratory	B-T017
mucosa	I-T017
,	O
which	O
shows	O
the	O
way	O
forward	O
for	O
research	B-T062
-	O
based	O
attenuation	O
of	O
viruses	B-T005
in	O
order	O
to	O
make	O
safer	O
and	O
better	O
-	O
performing	O
vaccines	B-T103
.	O

air	O
pollution	O
,	O
neighbourhood	O
and	O
maternal	B-T033
-	O
level	O
factors	O
modify	O
the	O
effect	O
of	O
smoking	O
on	O
birth	O
weight	O
:	O
a	O
multilevel	B-T062
analysis	I-T062
in	O
british	B-T082
columbia	I-T082
,	O
canada	B-T082
maternal	B-T033
smoking	O
during	O
pregnancy	B-T038
negatively	B-T033
impacts	O
fetal	B-T038
growth	I-T038
,	O
but	O
the	O
effect	O
is	O
not	O
homogenous	B-T082
across	O
the	O
population	O
.	O
we	O
sought	O
to	O
determine	O
how	O
the	O
relationship	O
between	O
cigarette	O
use	O
and	O
fetal	B-T038
growth	I-T038
is	O
modified	B-T033
by	O
the	O
social	O
and	O
physical	B-T082
environment	I-T082
.	O
birth	O
records	O
with	O
covariates	O
were	O
obtained	O
from	O
the	O
bc	B-T170
perinatal	I-T170
database	I-T170
registry	I-T170
(	O
n	O
=	O
232	O
,	O
291	O
)	O
.	O
maternal	B-T033
smoking	B-T201
status	I-T201
was	O
self	B-T062
-	I-T062
reported	I-T062
as	O
the	O
number	O
of	O
cigarettes	O
smoked	O
per	O
day	O
usually	O
at	O
the	O
first	B-T058
prenatal	I-T058
care	I-T058
visit	I-T058
.	O
census	O
dissemination	B-T082
areas	B-T082
(	O
das	B-T082
)	O
were	O
used	O
as	O
neighbourhood	O
-	O
level	O
units	O
and	O
linked	O
to	O
individual	B-T098
births	B-T038
using	O
residential	O
postal	O
codes	O
to	O
assign	O
exposure	O
to	O
particulate	B-T103
air	O
pollution	O
(	O
pm2	O
.	O
5	O
)	O
and	O
neighbourhood	O
-	O
level	O
attributes	O
such	O
as	O
socioeconomic	O
status	O
(	O
ses	O
)	O
,	O
proportion	O
of	O
post	O
-	O
secondary	O
education	O
,	O
immigrant	B-T098
density	O
and	O
living	O
in	O
a	O
rural	O
place	O
.	O
random	O
coefficient	O
models	B-T170
were	O
used	O
with	O
cigarettes	O
/	O
day	O
modeled	B-T170
with	O
a	O
random	O
slope	O
to	O
estimate	O
its	O
between	O
-	O
da	B-T082
variability	O
and	O
test	O
cross	O
-	O
level	O
interactions	O
with	O
the	O
neighbourhood	O
-	O
level	O
variables	O
on	O
continuous	O
birth	O
weight	O
.	O
a	O
significant	O
negative	B-T033
and	O
non	O
-	O
linear	O
association	O
was	O
found	O
between	O
maternal	B-T033
smoking	O
and	O
birth	O
weight	O
.	O
there	O
was	O
significant	O
between	O
-	O
da	B-T082
intercept	O
variability	O
in	O
birth	O
weight	O
as	O
well	O
as	O
between	O
-	O
da	B-T082
slope	O
variability	O
of	O
maternal	B-T033
smoking	O
on	O
birth	O
weight	O
of	O
which	O
68	O
and	O
30	O
%	O
respectively	O
was	O
explained	O
with	O
the	O
inclusion	O
of	O
da	B-T082
-	O
level	O
variables	O
and	O
their	O
cross	O
-	O
level	O
interactions	O
.	O
high	O
da	B-T082
-	O
level	O
ses	O
had	O
a	O
strong	O
positive	B-T033
association	O
with	O
birth	O
weight	O
but	O
the	O
effect	O
was	O
moderated	O
with	O
increased	O
cigarettes	O
/	O
day	O
.	O
conversely	O
,	O
heavy	B-T033
smokers	I-T033
showed	O
the	O
largest	O
increases	O
in	O
birth	O
weight	O
with	O
rising	O
neighbourhood	O
education	B-T033
levels	I-T033
.	O
increased	O
levels	O
of	O
pm2	B-T103
.	I-T103
5	I-T103
and	O
immigrant	B-T098
density	O
were	O
negatively	B-T033
associated	O
with	O
birth	O
weight	O
,	O
but	O
showed	O
positive	B-T033
interactions	O
with	O
increased	O
levels	O
of	O
smoking	O
.	O
older	O
maternal	O
age	O
and	O
suspected	O
drug	B-T038
or	O
alcohol	O
use	O
both	O
had	O
negative	B-T033
interactions	O
with	O
increased	O
levels	O
of	O
maternal	B-T033
smoking	O
.	O
maternal	B-T033
smoking	O
had	O
a	O
negative	B-T033
and	O
non	O
-	O
linear	O
dose	O
-	O
response	O
association	O
with	O
birth	O
weight	O
which	O
was	O
highly	O
variable	O
between	O
neighbourhood	O
s	O
and	O
evidence	O
of	O
effect	O
modification	B-T033
with	O
neighbourhood	O
-	O
level	O
factors	O
.	O
these	O
results	O
suggest	O
that	O
focusing	O
exclusively	O
on	O
individual	B-T098
behaviours	O
may	O
have	O
limited	O
success	O
in	O
improving	O
outcomes	O
without	O
addressing	O
the	O
contextual	B-T038
influences	O
at	O
the	O
neighbourhood	O
-	O
level	O
.	O
further	O
studies	B-T062
are	O
needed	O
to	O
corroborate	O
our	O
findings	B-T033
and	O
to	O
understand	B-T038
how	O
neighbourhood	O
-	O
level	O
attributes	O
interact	O
with	O
smoking	O
to	O
affect	B-T038
birth	B-T201
outcomes	I-T201
.	O

itp	B-T017
##r3	I-T017
gene	I-T017
haplotype	O
is	O
associated	O
with	O
cervical	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
risk	O
in	O
taiwanese	B-T098
women	B-T098
host	B-T091
immuno	I-T091
##gene	I-T091
##tic	I-T091
background	O
plays	O
an	O
important	O
role	O
in	O
human	B-T038
papillomavirus	I-T038
(	I-T038
hpv	I-T038
)	I-T038
infection	I-T038
and	O
cervical	B-T038
cancer	I-T038
development	I-T038
.	O
inositol	B-T017
1	I-T017
,	I-T017
4	I-T017
,	I-T017
5	I-T017
-	I-T017
triphosphate	I-T017
receptor	I-T017
type	I-T017
3	I-T017
(	O
itp	B-T017
##r3	I-T017
)	O
is	O
essential	O
for	O
both	O
immune	B-T038
activation	I-T038
and	O
cancer	B-T038
pathogenesis	B-T038
.	O
we	O
aim	O
to	O
investigate	O
if	O
itp	B-T017
##r3	I-T017
genetic	B-T038
polymorphisms	I-T038
are	O
associated	O
with	O
the	O
risk	O
of	O
cervical	O
cancer	O
in	O
taiwanese	B-T098
women	B-T098
.	O
itp	B-T017
##r3	I-T017
rs	B-T082
##37	I-T082
##48	I-T082
##0	I-T082
##79	I-T082
a	I-T082
/	I-T082
g	I-T082
and	O
rs22	B-T082
##29	I-T082
##63	I-T082
##4	I-T082
c	I-T082
/	I-T082
t	I-T082
polymorphisms	I-T082
were	O
genotyped	O
in	O
a	O
hospital	B-T062
-	I-T062
based	I-T062
study	I-T062
of	O
46	O
##2	O
women	B-T098
with	O
cervical	B-T038
squamous	I-T038
cell	I-T038
carcinoma	I-T038
(	O
csc	B-T038
##c	I-T038
)	O
and	O
92	O
##1	O
age	O
-	O
matched	O
healthy	O
control	O
women	B-T098
.	O
the	O
presence	O
and	O
genotypes	O
of	O
hpv	B-T005
in	O
csc	B-T038
##c	I-T038
was	O
determined	O
.	O
no	O
significant	O
association	O
of	O
individual	O
itp	B-T017
##r3	I-T017
variants	B-T017
were	O
found	O
among	O
controls	O
,	O
csc	B-T038
##c	I-T038
,	O
and	O
hpv	B-T033
-	I-T033
16	I-T033
positive	I-T033
csc	B-T038
##c	I-T038
.	O
however	O
,	O
we	O
found	O
a	O
significant	O
association	O
of	O
haplotype	O
at	O
between	O
csc	B-T038
##c	I-T038
and	O
controls	O
(	O
or	O
=	O
2	O
.	O
28	O
,	O
95	O
%	O
ci	O
1	O
.	O
31	O
-	O
3	O
.	O
97	O
,	O
p	O
=	O
2	O
.	O
83	O
×	O
10	O
-	O
3	O
)	O
and	O
the	O
or	O
increased	O
further	O
in	O
csc	B-T038
##c	I-T038
patients	O
infected	O
with	O
hpv	B-T005
-	I-T005
16	I-T005
(	O
or	O
=	O
2	O
.	O
89	O
,	O
95	O
%	O
ci	O
1	O
.	O
55	O
-	O
5	O
.	O
37	O
,	O
p	O
=	O
4	O
.	O
54	O
×	O
10	O
-	O
4	O
)	O
.	O
the	O
linkage	B-T062
disequilibrium	I-T062
analysis	I-T062
demonstrated	O
that	O
itp	B-T017
##r3	I-T017
association	B-T062
with	O
csc	B-T038
##c	I-T038
was	O
independent	O
of	O
hla	B-T017
-	I-T017
drb1	I-T017
alleles	B-T017
.	O
in	O
conclusion	O
,	O
these	O
findings	O
suggest	O
that	O
at	O
haplotype	O
in	O
the	O
itp	B-T017
##r3	I-T017
gene	I-T017
may	O
serve	O
as	O
a	O
potential	B-T038
marker	I-T038
for	O
genetic	O
susceptibility	O
to	O
csc	B-T038
##c	I-T038
.	O

in	B-T082
vivo	I-T082
3	B-T082
-	I-T082
dimensional	I-T082
strain	O
mapping	O
confirms	O
large	O
optic	B-T017
nerve	I-T017
head	I-T017
deformations	B-T017
following	O
horizontal	B-T038
eye	I-T038
movements	I-T038
to	O
measure	O
lamina	B-T017
cri	I-T017
##br	I-T017
##osa	I-T017
(	O
lc	B-T017
)	O
strains	B-T017
(	O
deformations	B-T017
)	O
following	O
abduction	B-T038
and	O
adduction	O
in	O
healthy	B-T098
subjects	I-T098
and	O
to	O
compare	O
them	O
with	O
those	O
resulting	O
from	O
a	O
relatively	O
high	O
acute	O
intraocular	B-T038
pressure	I-T038
(	O
iop	B-T038
)	O
elevation	B-T082
.	O
a	O
total	O
of	O
16	O
eyes	B-T017
from	O
8	O
healthy	B-T098
subjects	I-T098
were	O
included	O
.	O
among	O
the	O
16	O
eyes	B-T017
,	O
11	O
had	O
perip	B-T033
##apillary	I-T033
atrophy	I-T033
(	O
ppa	B-T033
)	O
.	O
for	O
each	O
subject	O
,	O
both	O
optic	B-T017
nerve	I-T017
heads	I-T017
(	O
on	B-T017
##hs	I-T017
)	O
were	O
imaged	B-T170
using	O
optical	B-T058
coherence	I-T058
tomography	I-T058
(	O
oct	B-T058
)	O
at	O
baseline	O
(	O
twice	O
)	O
,	O
in	O
different	O
gaze	B-T074
positions	B-T082
(	O
adduction	O
and	O
abduction	B-T038
of	O
20	O
##°	O
)	O
and	O
following	O
an	O
acute	O
iop	B-T038
elevation	B-T082
of	O
approximately	O
20	O
mm	O
hg	B-T103
from	O
baseline	O
(	O
via	O
ophthalm	B-T058
##odynam	I-T058
##ometry	I-T058
)	O
.	O
strains	B-T017
of	O
lc	B-T017
for	O
all	O
loading	O
scenarios	O
were	O
mapped	O
using	O
a	O
three	B-T082
-	I-T082
dimensional	I-T082
tracking	B-T082
algorithm	B-T170
.	O
in	O
all	O
16	O
eyes	B-T017
,	O
lc	B-T017
strains	B-T017
induced	O
by	O
adduction	O
and	O
abduction	B-T038
were	O
5	O
.	O
83	O
%	O
±	O
3	O
.	O
78	O
%	O
and	O
3	O
.	O
93	O
%	O
±	O
2	O
.	O
57	O
%	O
,	O
respectively	O
,	O
and	O
both	O
significantly	O
higher	O
than	O
the	O
control	O
strains	B-T017
measured	O
from	O
the	O
repeated	O
baseline	O
acquisition	O
##s	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
strains	B-T017
of	O
lc	B-T017
in	O
adduction	O
were	O
on	O
average	O
higher	O
than	O
those	O
in	O
abduction	B-T038
,	O
but	O
the	O
difference	O
was	O
not	O
statistically	O
significant	O
(	O
p	O
=	O
0	O
.	O
07	O
)	O
.	O
strains	B-T017
of	O
lc	B-T017
induced	O
by	O
iop	B-T038
elevations	B-T082
(	O
on	O
average	O
21	O
.	O
13	O
±	O
7	O
.	O
61	O
mm	O
hg	B-T103
)	O
were	O
6	O
.	O
41	O
%	O
±	O
3	O
.	O
21	O
%	O
and	O
significantly	O
higher	O
than	O
the	O
control	O
strains	B-T017
(	O
p	O
<	O
0	O
.	O
0005	O
)	O
.	O
gaze	B-T074
-	O
induced	O
lc	B-T017
strains	B-T017
in	O
the	O
ppa	B-T033
group	O
were	O
on	O
average	O
larger	O
than	O
those	O
in	O
the	O
non	O
-	O
ppa	O
group	O
;	O
however	O
,	O
the	O
relationship	O
was	O
not	O
statistically	O
significant	O
.	O
our	O
results	O
confirm	O
that	O
horizontal	B-T038
eye	I-T038
movements	I-T038
generate	O
significant	O
on	B-T017
##h	I-T017
strains	B-T017
,	O
which	O
is	O
consistent	O
with	O
our	O
previous	O
estimations	B-T038
using	O
finite	B-T170
element	I-T170
analysis	I-T170
.	O
further	B-T062
studies	I-T062
are	O
needed	O
to	O
explore	O
a	O
possible	B-T033
link	O
between	O
on	B-T017
##h	I-T017
strains	B-T017
induced	O
by	O
eye	B-T038
movements	I-T038
and	O
axonal	B-T033
loss	I-T033
in	O
optic	B-T038
neuropathies	I-T038
.	O

comparative	O
epidemiologic	O
characteristics	O
of	O
pertussis	B-T038
in	O
10	O
central	B-T082
and	O
eastern	B-T082
european	I-T082
countries	I-T082
,	O
2000	O
-	O
2013	O
we	O
undertook	O
an	O
epidemiological	B-T062
survey	I-T062
of	O
the	O
annual	O
incidence	O
of	O
pertussis	B-T038
reported	B-T058
from	O
2000	O
to	O
2013	O
in	O
ten	O
central	B-T082
and	O
eastern	B-T082
european	I-T082
countries	I-T082
to	O
ascertain	O
whether	O
increased	O
pertussis	B-T038
reports	B-T170
in	O
some	O
countries	B-T082
share	O
common	O
underlying	O
drivers	O
or	O
whether	O
there	O
are	O
specific	O
features	O
in	O
each	O
country	B-T082
.	O
the	O
annual	O
incidence	O
of	O
pertussis	B-T038
in	O
the	O
participating	O
countries	B-T082
was	O
obtained	O
from	O
relevant	O
government	B-T092
institutions	I-T092
and	O
/	O
or	O
national	B-T092
surveillance	I-T092
systems	I-T092
.	O
we	O
reviewed	O
the	O
changes	O
in	O
the	O
pertussis	B-T038
incidence	O
rates	O
in	O
each	O
country	B-T082
to	O
explore	O
differences	O
and	O
/	O
or	O
similarities	O
between	O
countries	B-T082
in	O
relation	O
to	O
pertussis	B-T038
surveillance	O
;	O
case	O
definitions	O
for	O
detection	B-T033
and	O
confirmation	O
of	O
pertussis	B-T038
;	O
incidence	O
and	O
number	O
of	O
cases	O
of	O
pertussis	B-T038
by	O
year	O
,	O
overall	O
and	O
by	O
age	O
group	O
;	O
population	B-T098
by	O
year	O
,	O
overall	O
and	O
by	O
age	O
group	O
;	O
pertussis	B-T038
immunization	B-T058
schedule	I-T058
and	O
coverage	O
,	O
and	O
switch	O
from	O
whole	B-T103
-	I-T103
cell	I-T103
pertussis	I-T103
vaccines	I-T103
(	O
wp	B-T103
)	O
to	O
acellular	B-T103
pertussis	I-T103
vaccines	I-T103
(	O
ap	B-T103
)	O
.	O
there	O
was	O
heterogeneity	O
in	O
the	O
reported	B-T058
annual	O
incidence	O
rates	O
and	O
trends	O
observed	O
across	O
countries	B-T082
.	O
reported	B-T058
pertussis	B-T038
incidence	O
rates	O
varied	O
considerably	O
,	O
ranging	O
from	O
0	O
.	O
01	O
to	O
96	O
per	O
100	O
,	O
000	O
population	B-T098
,	O
with	O
the	O
highest	O
rates	O
generally	O
reported	B-T058
in	O
est	B-T082
##onia	I-T082
and	O
the	O
lowest	O
in	O
hung	B-T082
##ary	I-T082
and	O
ser	B-T082
##bia	I-T082
.	O
the	O
greatest	O
burden	O
appears	O
for	O
the	O
most	O
part	O
in	O
infants	O
(	O
<	O
1	O
year	O
)	O
in	O
bul	B-T082
##gar	I-T082
##ia	I-T082
,	O
hung	B-T082
##ary	I-T082
,	O
lat	B-T082
##vi	I-T082
##a	I-T082
,	O
roman	B-T082
##ia	I-T082
,	O
and	O
ser	B-T082
##bia	I-T082
,	O
but	O
not	O
in	O
the	O
other	O
participating	O
countries	B-T082
where	O
the	O
burden	O
may	O
have	O
shifted	O
to	O
older	O
children	O
,	O
though	O
surveillance	O
of	O
adults	O
may	O
be	O
inappropriate	O
.	O
there	O
was	O
no	O
consistent	O
pattern	O
associated	O
with	O
the	O
switch	O
from	O
wp	B-T103
to	O
ap	B-T103
vaccines	I-T103
on	O
reported	B-T058
pertussis	B-T038
incidence	O
rates	O
.	O
the	O
heterogeneity	O
in	O
reported	B-T058
data	O
may	O
be	O
related	O
to	O
a	O
number	O
of	O
factors	O
including	O
surveillance	O
system	O
characteristics	O
or	O
capabilities	O
,	O
different	O
case	O
definitions	O
,	O
type	O
of	O
pertussis	B-T038
confirmation	B-T058
tests	I-T058
used	O
,	O
public	B-T092
awareness	O
of	O
the	O
disease	B-T038
,	O
as	O
well	O
as	O
real	O
differences	O
in	O
the	O
magnitude	O
of	O
the	O
disease	B-T038
,	O
or	O
a	O
combination	O
of	O
these	O
factors	O
.	O
our	O
study	O
highlights	O
the	O
need	O
to	O
standardize	O
pertussis	B-T038
detection	B-T033
and	O
confirmation	O
in	O
surveillance	B-T062
programs	I-T062
across	O
europe	B-T082
,	O
complemented	O
with	O
carefully	O
-	O
designed	O
seroprevalence	B-T062
studies	I-T062
using	O
the	O
same	O
protocols	B-T170
and	O
methodologies	B-T062
.	O

insurance	O
coverage	O
and	O
utilization	O
at	O
a	O
sexually	B-T092
transmitted	I-T092
disease	I-T092
clinic	I-T092
in	O
a	O
medicaid	O
expansion	O
state	B-T082
in	O
rhod	B-T082
##e	I-T082
island	I-T082
,	O
the	O
patient	B-T170
protection	I-T170
and	I-T170
affordable	I-T170
care	I-T170
act	I-T170
has	O
led	O
to	O
over	O
95	O
%	O
of	O
the	O
state	B-T082
'	I-T082
s	I-T082
population	O
being	O
insured	O
.	O
we	O
evaluated	B-T058
insurance	O
coverage	O
and	O
barriers	B-T033
to	O
insurance	B-T058
use	O
among	O
patients	O
presenting	O
for	O
services	B-T058
at	O
the	O
rhod	B-T082
##e	I-T082
island	I-T082
sexually	B-T092
transmitted	I-T092
disease	I-T092
(	I-T092
std	I-T092
)	I-T092
clinic	I-T092
.	O
we	O
analyzed	B-T062
factors	O
associated	O
with	O
insurance	O
coverage	O
and	O
utilization	O
among	O
patients	O
presenting	O
for	O
std	B-T038
services	B-T058
between	O
july	O
and	O
december	O
2015	O
.	O
a	O
total	O
of	O
69	O
##2	O
patients	O
had	O
insurance	O
information	O
available	O
;	O
of	O
those	O
,	O
40	O
%	O
were	O
uninsured	B-T098
.	O
patients	O
without	B-T098
insurance	I-T098
were	O
more	O
likely	O
than	O
those	O
with	O
insurance	B-T058
to	O
be	O
non	O
##wh	O
##ite	O
(	O
50	O
%	O
among	O
uninsured	B-T098
,	O
compared	O
with	O
40	O
%	O
among	O
insured	O
;	O
p	O
=	O
0	O
.	O
014	O
)	O
and	O
hispanic	B-T098
or	O
latino	B-T098
/	I-T098
a	I-T098
(	O
25	O
%	O
,	O
compared	O
with	O
16	O
%	O
;	O
p	O
=	O
0	O
.	O
006	O
)	O
,	O
and	O
less	O
likely	O
to	O
be	O
men	B-T098
who	O
have	O
sex	B-T038
with	O
men	B-T098
(	O
27	O
%	O
,	O
compared	O
with	O
39	O
%	O
;	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
of	O
those	O
with	O
health	B-T058
insurance	I-T058
,	O
26	O
%	O
obtained	O
coverage	O
as	O
a	O
result	O
of	O
the	O
affordable	B-T170
care	I-T170
act	I-T170
,	O
and	O
56	O
%	O
of	O
those	O
were	O
previously	O
uninsured	B-T098
.	O
among	O
uninsured	B-T098
individuals	I-T098
,	O
barriers	B-T033
to	O
obtaining	O
health	B-T058
insurance	I-T058
included	O
cost	O
and	O
unemployment	B-T033
.	O
among	O
those	O
with	O
insurance	O
,	O
43	O
%	O
reported	O
willingness	B-T033
to	O
use	O
insurance	B-T058
for	O
std	B-T038
services	B-T058
.	O
barriers	B-T033
to	O
insurance	B-T058
use	O
included	O
concerns	O
about	O
an	O
##onym	O
##ity	O
and	O
out	O
-	O
of	O
-	O
pocket	O
costs	O
.	O
despite	O
expanded	O
insurance	B-T058
access	O
,	O
many	O
individuals	B-T098
presenting	O
to	O
the	O
rhod	B-T082
##e	I-T082
island	I-T082
std	B-T092
clinic	I-T092
were	O
uninsured	B-T098
.	O
among	O
those	O
who	O
were	O
insured	O
,	O
significant	O
barriers	B-T033
still	O
existed	O
to	O
using	O
insurance	B-T058
.	O
std	B-T092
clinics	I-T092
continue	O
to	O
play	O
an	O
important	O
role	O
in	O
providing	O
safety	B-T058
-	I-T058
net	I-T058
std	B-T038
services	B-T058
in	O
states	B-T082
with	O
low	O
uninsured	B-T098
rates	O
.	O
both	O
public	B-T092
and	O
private	B-T092
ins	B-T092
##ure	I-T092
##rs	I-T092
are	O
needed	O
to	O
address	O
financial	O
barriers	O
and	O
optimize	O
payment	O
structures	B-T082
for	O
services	B-T058
.	O

testing	O
the	O
ret	B-T017
and	O
sem	B-T017
##a3	I-T017
##d	I-T017
genetic	O
interaction	O
in	O
mouse	B-T204
enteric	B-T038
nervous	I-T038
system	I-T038
development	I-T038
for	O
most	O
multi	B-T038
##genic	I-T038
disorders	I-T038
,	O
clinical	O
manifestation	O
(	O
penetrance	O
)	O
and	O
presentation	O
(	O
express	O
##ivity	O
)	O
are	O
likely	O
to	O
be	O
an	O
outcome	O
of	O
genetic	O
interaction	O
between	O
multiple	O
susceptibility	B-T017
genes	I-T017
.	O
here	O
,	O
using	O
gene	O
knockout	O
##s	O
in	O
mice	B-T204
we	O
evaluated	O
genetic	O
interaction	O
between	O
loss	O
of	O
ret	B-T017
and	O
loss	O
of	O
sem	B-T017
##a3	I-T017
##d	I-T017
,	O
two	O
hirs	B-T017
##ch	I-T017
##spr	I-T017
##ung	I-T017
disease	I-T017
susceptibility	B-T017
genes	I-T017
.	O
we	O
interc	O
##ross	O
##ed	O
ret	B-T017
and	O
sem	B-T017
##a3	I-T017
##d	I-T017
double	O
null	O
heterozygotes	O
to	O
generate	O
mice	O
with	O
the	O
nine	O
possible	O
genotypes	O
and	O
assessed	O
survival	O
by	O
counting	B-T058
various	I-T058
genotypes	I-T058
,	O
my	B-T017
##enteric	I-T017
plexus	I-T017
presence	O
by	O
acetylcholinesterase	B-T058
staining	I-T058
and	O
embryonic	O
day	O
12	O
.	O
5	O
(	O
e1	O
##2	O
.	O
5	O
)	O
intestine	B-T082
transcriptome	I-T082
by	O
rna	B-T082
-	I-T082
sequencing	I-T082
.	O
survival	O
rates	O
of	O
ret	B-T017
wild	B-T017
##type	I-T017
,	O
null	O
heterozyg	O
##ote	O
and	O
null	O
homozyg	O
##ote	O
mice	B-T204
at	O
e1	O
##2	O
.	O
5	O
,	O
birth	B-T038
and	O
weaning	B-T033
were	O
not	O
influenced	O
by	O
the	O
genotypes	O
at	O
sem	B-T017
##a3	I-T017
##d	I-T017
locus	B-T082
and	O
vice	O
-	O
versa	O
.	O
loss	O
of	O
my	B-T017
##enteric	I-T017
plexus	I-T017
was	O
observed	O
only	O
in	O
all	O
ret	B-T017
null	O
homozygotes	O
,	O
irrespective	O
of	O
the	O
genotypes	O
at	O
sem	B-T017
##a3	I-T017
##d	I-T017
locus	B-T082
,	O
and	O
sem	B-T017
##a3	I-T017
##d	I-T017
null	O
heterozyg	O
##ote	O
and	O
homozyg	O
##ote	O
mice	O
had	O
normal	O
intestinal	O
innervation	O
.	O
as	O
compared	O
to	O
wild	B-T017
##type	I-T017
mice	I-T017
intestinal	I-T017
gene	B-T038
expression	I-T038
,	O
loss	O
of	O
ret	B-T017
in	O
null	O
homozygotes	O
led	O
to	O
differential	O
expression	B-T038
of	I-T038
∼	I-T038
##30	I-T038
##0	I-T038
genes	I-T038
,	I-T038
whereas	O
loss	O
of	O
sem	B-T017
##a3	I-T017
##d	I-T017
in	O
null	O
homozygotes	O
had	O
no	O
major	O
consequence	O
and	O
there	O
was	O
no	O
evidence	O
supporting	O
major	O
interaction	O
between	O
the	O
two	O
genes	O
influencing	O
intestine	B-T082
transcriptome	I-T082
.	O
overall	O
,	O
given	O
the	O
null	B-T038
alleles	I-T038
and	O
phenotypic	B-T058
assays	I-T058
used	O
,	O
we	O
did	O
not	O
find	O
evidence	O
for	O
genetic	O
interaction	O
between	O
ret	B-T017
and	O
sem	B-T017
##a3	I-T017
##d	I-T017
affecting	O
survival	O
,	O
presence	O
of	O
my	B-T017
##enteric	I-T017
plexus	I-T017
or	O
intestine	B-T082
transcriptome	I-T082
.	O

development	O
of	O
the	O
pediatric	B-T170
quality	I-T170
of	I-T170
life	I-T170
inventory	I-T170
neurofibromatosis	B-T038
type	I-T038
1	I-T038
module	B-T170
items	O
for	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
:	O
qualitative	O
methods	O
health	O
-	O
related	O
quality	O
of	O
life	O
(	O
hrqol	O
)	O
is	O
arg	O
##ua	O
##bl	O
##y	O
one	O
of	O
the	O
most	O
important	O
measures	O
in	O
evaluating	B-T058
effectiveness	O
of	O
clinical	B-T058
treatments	I-T058
.	O
at	O
present	O
,	O
there	O
is	O
no	O
disease	B-T038
-	O
specific	O
outcome	O
measure	O
to	O
assess	O
the	O
hrqol	O
of	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
with	O
neurofibromatosis	B-T038
type	I-T038
1	I-T038
(	O
nf1	B-T038
)	O
.	O
this	O
study	B-T062
aimed	O
to	O
develop	O
the	O
items	O
and	O
support	O
the	O
content	O
validity	O
for	O
the	O
pediatric	B-T170
quality	I-T170
of	I-T170
life	I-T170
inventory	I-T170
##™	I-T170
(	O
ped	B-T170
##s	I-T170
##ql	I-T170
##™	I-T170
)	O
nf1	B-T038
module	B-T170
for	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
.	O
the	O
iterative	B-T033
process	O
included	O
multip	O
##ha	O
##se	O
qualitative	O
methods	O
including	O
a	O
literature	B-T170
review	I-T170
,	O
survey	B-T170
of	O
expert	O
opinions	O
,	O
semi	O
-	O
structured	O
interviews	O
,	O
cognitive	O
interviews	O
and	O
pilot	B-T062
testing	I-T062
.	O
fifteen	O
domains	O
were	O
derived	O
from	O
the	O
qualitative	O
methods	O
,	O
with	O
content	O
saturation	O
achieved	O
,	O
resulting	O
in	O
115	O
items	O
.	O
the	O
domains	O
include	O
skin	B-T022
,	O
pain	B-T033
,	O
pain	B-T033
impact	O
,	O
pain	B-T058
management	I-T058
,	O
cognitive	B-T038
functioning	I-T038
,	O
speech	B-T038
,	O
fine	O
motor	O
,	O
balance	O
,	O
vision	B-T038
,	O
perceived	B-T038
physical	B-T033
appearance	I-T033
,	O
communication	O
,	O
worry	B-T033
,	O
treatment	B-T058
,	O
medicines	B-T103
and	O
gastrointestinal	B-T033
symptoms	I-T033
.	O
this	O
study	O
is	O
limited	O
because	O
all	O
participants	B-T098
are	O
recruited	O
from	O
a	O
single	O
-	O
site	B-T082
.	O
qualitative	O
methods	O
support	O
the	O
content	O
validity	O
for	O
the	O
ped	B-T170
##s	I-T170
##ql	I-T170
##™	I-T170
nf1	B-T038
module	B-T170
for	O
children	O
,	O
adolescents	O
and	O
young	O
adults	O
.	O
the	O
ped	B-T170
##s	I-T170
##ql	I-T170
##™	I-T170
nf1	B-T038
module	B-T170
is	O
now	O
undergoing	O
national	O
multis	O
##ite	O
field	O
testing	O
for	O
the	O
psychometric	B-T058
validation	B-T062
of	O
the	O
instrument	B-T170
development	O
.	O

human	B-T103
cath	I-T103
##elic	I-T103
##idin	I-T103
ll	I-T103
-	I-T103
37	I-T103
enhance	O
the	O
antib	B-T033
##io	I-T033
##fil	I-T033
##m	I-T033
effect	I-T033
of	O
egcg	B-T103
on	O
streptococcus	B-T007
mutans	I-T007
streptococcus	B-T007
mutans	I-T007
forms	O
biofilms	B-T007
as	O
a	O
resistance	O
mechanism	O
against	O
antimicrobial	B-T103
agents	I-T103
in	O
the	O
human	B-T204
oral	B-T082
cavity	I-T082
.	O
we	O
recently	O
showed	O
that	O
human	B-T103
cath	I-T103
##elic	I-T103
##idin	I-T103
ll	I-T103
-	I-T103
37	I-T103
exhibits	O
inhibitory	O
effects	O
on	O
biofilm	B-T038
formation	I-T038
of	O
s	B-T007
.	I-T007
mutans	I-T007
through	O
interaction	O
with	O
lipo	B-T103
##te	I-T103
##ich	I-T103
##oic	I-T103
acid	I-T103
(	O
lta	B-T103
)	O
,	O
but	O
without	O
antibacterial	B-T033
or	O
biofilm	B-T007
dispersal	B-T082
abilities	I-T082
.	O
(	B-T103
-	I-T103
)	I-T103
-	I-T103
epig	I-T103
##all	I-T103
##oca	I-T103
##te	I-T103
##ch	I-T103
##in	I-T103
gallate	I-T103
(	O
egcg	B-T103
)	O
is	O
the	O
most	O
abundant	O
constituent	O
of	O
tea	B-T168
catechin	B-T103
##s	I-T103
that	O
has	O
the	O
greatest	O
anti	B-T033
-	I-T033
infective	I-T033
potential	I-T033
to	O
inhibit	B-T038
the	I-T038
growth	I-T038
of	O
various	O
microorganisms	O
and	O
biofilm	B-T038
formation	I-T038
.	O
therefore	O
,	O
in	O
this	O
study	O
,	O
we	O
evaluated	B-T058
whether	O
ll	B-T103
-	I-T103
37	I-T103
interacts	O
with	O
egcg	B-T103
to	O
enhance	O
the	O
antib	B-T033
##io	I-T033
##fil	I-T033
##m	I-T033
effect	I-T033
of	O
egcg	B-T103
on	O
s	B-T007
.	I-T007
mutans	I-T007
biofilm	B-T038
formation	I-T038
.	O
clinical	O
s	B-T007
.	I-T007
mutans	I-T007
strains	O
(	O
n	O
=	O
10	O
)	O
isolated	O
from	O
children	O
'	O
s	O
saliva	B-T031
were	O
tested	O
in	O
a	O
biofilm	B-T038
formation	I-T038
assay	B-T058
.	O
the	O
antib	B-T033
##io	I-T033
##fil	I-T033
##m	I-T033
effect	I-T033
of	O
egcg	B-T103
with	O
and	O
without	O
ll	B-T103
-	I-T103
37	I-T103
was	O
analyzed	B-T062
by	O
the	O
minimum	O
biofilm	B-T007
eradication	O
concentration	O
assay	B-T058
and	O
confirmed	O
using	O
field	O
emission	B-T058
-	I-T058
scanning	I-T058
electron	I-T058
microscopy	I-T058
.	O
in	O
addition	O
,	O
the	O
interaction	O
among	O
egcg	B-T103
,	O
ll	B-T103
-	I-T103
37	I-T103
,	O
and	O
lta	B-T103
of	O
s	B-T007
.	I-T007
mutans	I-T007
was	O
determined	O
using	O
quartz	B-T062
crystal	I-T062
microb	I-T062
##ala	I-T062
##nc	I-T062
##e	I-T062
analysis	I-T062
.	O
egcg	B-T103
killed	O
100	O
%	O
of	O
planktonic	B-T007
s	B-T007
.	I-T007
mutans	I-T007
within	O
5	O
h	O
,	O
inhibited	O
biofilm	B-T038
formation	I-T038
within	O
24	O
h	O
,	O
and	O
reduced	O
bacteria	B-T007
cells	I-T007
in	O
preformed	O
biofilms	B-T007
within	O
3	O
h	O
at	O
a	O
concentration	O
of	O
0	O
.	O
2	O
mg	O
/	O
ml	O
.	O
however	O
,	O
egcg	B-T103
did	O
not	O
appear	O
to	O
interact	O
with	O
lta	B-T103
.	O
ll	B-T103
-	I-T103
37	I-T103
effectively	O
enhanced	O
the	O
bactericidal	B-T038
activity	I-T038
of	O
egcg	B-T103
against	O
biofilm	B-T038
formation	I-T038
and	O
preformed	O
biofilms	B-T007
as	O
determined	O
by	O
quantitative	O
crystal	B-T103
violet	I-T103
staining	B-T058
and	O
field	O
emission	B-T058
-	I-T058
scanning	I-T058
electron	I-T058
microscopy	I-T058
.	O
in	O
addition	O
,	O
quartz	B-T062
crystal	I-T062
microb	I-T062
##ala	I-T062
##nc	I-T062
##e	I-T062
analysis	I-T062
revealed	O
that	O
ll	B-T103
-	I-T103
37	I-T103
interacted	O
with	O
egcg	B-T103
and	O
promoted	O
binding	B-T038
between	O
egcg	B-T103
and	O
lta	B-T103
of	O
s	B-T007
.	I-T007
mutans	I-T007
.	O
we	O
show	O
that	O
ll	B-T103
-	I-T103
37	I-T103
enhances	O
the	O
antib	B-T033
##io	I-T033
##fil	I-T033
##m	I-T033
effect	I-T033
of	O
egcg	B-T103
on	O
s	B-T007
.	I-T007
mutans	I-T007
.	O
this	O
finding	O
provides	O
new	O
knowledge	O
for	O
dental	B-T058
treatment	I-T058
by	O
using	O
ll	B-T103
-	I-T103
37	I-T103
as	O
a	O
potential	O
antib	B-T103
##io	I-T103
##fil	I-T103
##m	I-T103
compound	I-T103
.	O

developing	O
understanding	B-T038
of	O
object	O
fall	B-T033
:	O
going	O
beyond	O
inhibitory	O
processes	O
a	O
study	B-T062
is	O
reported	B-T170
where	O
118	O
participants	B-T098
aged	O
between	O
10	O
years	O
and	O
early	O
20	O
##s	O
dre	O
##w	O
the	O
trajectories	O
they	O
expected	B-T170
objects	O
to	O
follow	O
as	O
they	O
fell	B-T033
.	O
the	O
younger	O
participants	B-T098
typically	O
anticipated	O
backward	B-T082
trajectories	O
during	O
fall	B-T033
from	O
moving	B-T038
carriers	O
while	O
forward	B-T082
but	O
non	O
-	O
para	O
##bo	O
##lic	O
trajectories	O
were	O
relatively	O
more	O
frequent	O
amongst	O
the	O
older	B-T098
participants	I-T098
.	O
both	O
patterns	B-T082
suggest	O
strong	O
socio	O
##cu	O
##lt	O
##ural	O
influences	O
,	O
with	O
implications	O
for	O
models	B-T170
that	O
regard	O
development	O
in	O
this	O
area	O
as	O
purely	O
the	O
inhibition	O
of	O
principles	O
established	O
in	O
infancy	O
.	O
statement	O
of	O
contribution	O
what	O
is	O
already	O
known	O
on	O
this	O
subject	O
?	O
research	B-T062
with	O
infants	O
demonstrates	O
an	O
early	O
-	O
established	O
belief	O
that	O
dropped	O
objects	O
fall	B-T033
straight	B-T082
down	B-T082
.	O
the	O
erroneous	O
expectations	O
that	O
pre	O
-	O
school	O
##ers	O
hold	O
about	O
object	O
fall	B-T033
are	O
consistent	O
with	O
failure	O
to	O
inhibit	O
the	O
presump	O
##tion	O
of	O
straight	B-T082
-	O
down	B-T082
fall	B-T033
,	O
in	O
contexts	O
where	O
it	O
is	O
inappropriate	O
.	O
what	O
does	O
this	O
study	B-T062
add	O
?	O
the	O
research	B-T062
replicates	O
and	O
extends	O
research	B-T062
with	O
older	B-T098
participants	I-T098
,	O
which	O
indicates	O
errors	O
that	O
cann	O
##ot	O
be	O
explained	B-T058
via	O
failed	O
inhibition	O
of	O
straight	B-T082
-	O
down	B-T082
fall	B-T033
.	O
it	O
is	O
the	O
first	O
study	B-T062
to	O
trace	O
patterns	B-T082
of	O
errors	O
across	O
late	O
childhood	O
,	O
adolescence	O
and	O
early	O
adulthood	O
.	O
a	O
consequence	O
of	O
the	O
findings	B-T033
is	O
that	O
adequate	O
modelling	O
in	O
developmental	B-T091
psychology	I-T091
must	O
consider	O
multilayer	O
##ed	O
interactions	O
between	O
prior	O
representations	O
and	O
socio	O
##cu	O
##lt	O
##ural	O
experiences	B-T038
.	O

classification	B-T170
of	O
edible	B-T168
oils	I-T168
based	O
on	O
atr	B-T062
-	I-T062
ftir	I-T062
spectral	O
information	O
during	O
a	O
long	O
heating	O
treatment	O
identification	O
of	O
oil	B-T168
type	O
and	O
its	O
qc	O
are	O
important	O
concerns	O
in	O
food	B-T092
control	I-T092
laboratories	I-T092
.	O
classifying	B-T170
edible	B-T168
oils	I-T168
that	O
have	O
not	O
been	O
used	O
(	O
i	O
.	O
e	O
.	O
,	O
un	O
##he	O
##ated	O
)	O
with	O
the	O
aid	O
of	O
vibrational	B-T058
spectroscopy	I-T058
has	O
previously	O
been	O
reported	O
.	O
however	O
,	O
the	O
classification	B-T170
of	O
used	O
(	O
i	O
.	O
e	O
.	O
,	O
heat	O
-	O
treated	O
)	O
oils	B-T168
needs	O
special	O
attention	O
.	O
the	O
effect	O
of	O
long	O
heating	O
times	O
on	O
the	O
classification	B-T170
of	O
four	O
kinds	O
of	O
edible	B-T168
oils	I-T168
(	O
can	B-T103
##ola	I-T103
,	O
corn	B-T103
,	O
fr	B-T168
##ying	I-T168
,	O
and	O
sunflower	B-T103
)	O
based	O
on	O
attenuated	B-T062
total	I-T062
reflectance	I-T062
(	I-T062
atr	I-T062
)	I-T062
-	I-T062
ftir	I-T062
spectra	I-T062
was	O
surveyed	O
.	O
the	O
sampling	O
was	O
done	O
on	O
the	O
oils	B-T168
during	O
a	O
36	O
h	O
heating	O
process	O
(	O
at	O
170	O
##°c	O
)	O
.	O
the	O
atr	B-T062
-	I-T062
ftir	I-T062
spectra	I-T062
of	O
the	O
samples	O
were	O
collected	O
in	O
the	O
range	O
of	O
4000	O
-	O
550	O
cm	O
-	O
1	O
.	O
interval	O
extended	O
canonical	O
vari	O
##ates	O
analysis	O
(	O
ec	O
##va	O
)	O
,	O
as	O
a	O
variable	O
selection	O
and	O
classification	B-T170
tool	O
,	O
was	O
used	O
to	O
determine	O
the	O
best	O
intervals	O
during	O
the	O
heating	O
procedure	O
for	O
classification	B-T170
.	O
principal	O
component	O
analysis	O
discriminate	O
analysis	O
,	O
partial	O
least	O
-	O
squares	O
discriminate	O
analysis	O
,	O
and	O
ec	O
##va	O
were	O
performed	O
on	O
the	O
selected	O
intervals	O
and	O
on	O
the	O
total	O
heating	O
time	O
.	O
the	O
effect	O
of	O
auto	B-T033
##sc	I-T033
##alin	I-T033
##g	I-T033
and	O
mean	B-T033
-	I-T033
center	I-T033
##ing	I-T033
,	O
as	O
data	B-T170
prepro	I-T170
##cessing	I-T170
methods	I-T170
,	O
was	O
also	O
investigated	O
.	O
the	O
ec	O
##va	O
method	O
resulted	O
in	O
the	O
best	O
performances	O
for	O
classification	B-T170
,	O
with	O
a	O
94	O
%	O
cross	O
-	O
validated	O
none	O
##r	O
##ro	O
##r	O
rate	O
(	O
one	O
misclass	O
##ification	O
)	O
for	O
the	O
heating	O
process	O
times	O
of	O
24	O
-	O
27	O
and	O
33	O
-	O
36	O
h	O
.	O

persistent	B-T103
organic	I-T103
pollutants	I-T103
(	O
pop	B-T103
##s	I-T103
)	O
in	O
the	O
atmosphere	O
of	O
three	O
chile	O
##an	O
cities	B-T082
using	O
passive	O
air	O
sample	O
##rs	O
in	O
this	O
study	B-T062
passive	O
air	O
sample	O
##rs	O
containing	O
polyurethane	B-T103
foam	I-T103
(	O
pu	B-T103
##f	I-T103
)	O
disks	B-T074
were	O
deployed	O
in	O
three	O
cities	B-T082
across	O
chile	B-T082
;	O
sant	B-T082
##ia	I-T082
##go	I-T082
(	O
st	B-T082
##g	I-T082
)	O
(	O
n	O
=	O
5	O
,	O
sampling	B-T082
sites	I-T082
)	O
,	O
conce	B-T082
##pc	I-T082
##i	I-T082
##ο	I-T082
##n	I-T082
(	O
con	B-T082
)	O
(	O
n	O
=	O
6	O
)	O
and	O
tem	B-T082
##uc	I-T082
##o	I-T082
(	O
tem	B-T082
)	O
(	O
n	O
=	O
6	O
)	O
from	O
2008	O
to	O
2009	O
.	O
polychlorinated	B-T103
biphenyls	I-T103
(	O
pcbs	B-T103
)	O
(	O
7	O
indicator	O
congeners	O
)	O
,	O
chlorinated	B-T103
pesticides	I-T103
hexa	B-T103
##chlor	I-T103
##ocycl	I-T103
##ohex	I-T103
##anes	I-T103
(	O
hch	B-T103
##s	I-T103
)	O
,	O
dichloro	B-T103
##di	I-T103
##phenyl	I-T103
trichlor	I-T103
##oe	I-T103
##th	I-T103
##anes	I-T103
(	O
ddt	B-T103
##s	I-T103
)	O
and	O
flame	B-T103
retard	I-T103
##ants	I-T103
such	O
as	O
poly	B-T103
##brom	I-T103
##inated	I-T103
diphenyl	I-T103
ethers	I-T103
(	O
pbdes	B-T103
)	O
were	O
determined	O
by	O
gas	B-T058
chromatography	I-T058
coupled	I-T058
mass	I-T058
spectrometry	I-T058
(	O
gc	B-T058
/	I-T058
ms	I-T058
)	O
.	O
a	O
sampling	O
rate	O
(	O
r	O
)	O
typical	O
of	O
urban	O
sites	O
(	O
4	O
##m	O
(	O
3	O
)	O
/	O
day	O
)	O
was	O
used	O
to	O
estimate	O
the	O
atmospheric	O
concentrations	O
of	O
individual	O
compounds	O
.	O
pcb	B-T103
concentrations	O
in	O
the	O
air	O
(	O
pg	O
/	O
m	O
(	O
3	O
)	O
)	O
ranged	O
from	O
~	O
1	O
-	O
10	O
(	O
tem	B-T082
)	O
,	O
~	O
1	O
-	O
40	O
(	O
st	B-T082
##g	I-T082
)	O
and	O
4	O
-	O
30	O
(	O
con	B-T082
)	O
.	O
higher	O
molecular	O
weight	O
pcbs	B-T103
(	O
pcb	B-T103
-	O
153	O
,	O
-	O
180	O
)	O
were	O
detected	B-T033
at	O
industrial	B-T082
sites	I-T082
(	O
in	O
conce	B-T082
##pc	I-T082
##ion	I-T082
)	O
.	O
the	O
hch	B-T103
##s	I-T103
showed	O
a	O
prevalence	O
of	O
γ	B-T103
-	I-T103
hch	I-T103
across	O
all	O
sites	B-T082
,	O
indicative	O
of	O
inputs	O
from	O
the	O
use	O
of	O
lind	B-T103
##ane	I-T103
but	O
a	O
limited	O
use	O
of	O
technical	O
hch	B-T103
##s	I-T103
in	O
chile	B-T082
.	O
ddt	B-T103
##s	I-T103
were	O
detected	B-T033
with	O
a	O
prevalence	O
of	O
p	B-T103
,	I-T103
p	I-T103
'	I-T103
-	I-T103
dde	I-T103
accounting	O
for	O
~	O
50	O
%	O
of	O
the	O
total	O
ddt	B-T103
##s	I-T103
.	O
pb	B-T103
##de	I-T103
concentrations	O
in	O
air	O
(	O
pg	O
/	O
m	O
(	O
3	O
)	O
)	O
ranged	O
from	O
1	O
to	O
55	O
(	O
st	B-T082
##g	I-T082
)	O
,	O
0	O
.	O
5	O
to	O
20	O
(	O
con	B-T082
)	O
and	O
from	O
0	O
.	O
4	O
to	O
10	O
(	O
tem	B-T082
)	O
,	O
and	O
were	O
generally	O
similar	O
to	O
those	O
reported	B-T170
for	O
many	O
other	O
urban	O
areas	O
globally	O
.	O
the	O
pattern	B-T082
of	O
pbdes	B-T103
was	O
different	O
among	O
the	O
three	O
cities	B-T082
;	O
however	O
,	O
pb	B-T103
##de	I-T103
-	O
209	O
was	O
dominant	O
at	O
most	O
of	O
the	O
sites	B-T082
.	O
these	O
results	O
represent	O
one	O
of	O
the	O
few	O
assessments	B-T058
of	O
air	O
concentrations	O
of	O
pop	B-T103
##s	I-T103
across	O
different	O
urban	O
areas	O
within	O
the	O
same	O
country	B-T082
.	O
these	O
data	O
will	O
support	O
chile	O
##an	O
commitment	O
##s	O
as	O
a	O
sign	O
##atory	O
to	O
the	O
stock	O
##holm	O
convention	O
on	O
pop	B-T103
##s	I-T103
and	O
for	O
reporting	B-T062
as	O
a	O
member	B-T097
country	B-T082
of	O
the	O
group	B-T082
of	I-T082
latin	I-T082
america	I-T082
and	I-T082
caribbean	I-T082
countries	I-T082
(	I-T082
gr	I-T082
##ula	I-T082
##c	I-T082
)	I-T082
region	I-T082
.	O

acoustic	B-T038
startle	I-T038
response	I-T038
in	O
rats	B-T204
predicts	O
inter	B-T098
-	I-T098
individual	I-T098
variation	O
in	O
fear	B-T038
extinction	B-T038
although	O
a	O
large	O
portion	O
of	O
the	O
population	B-T098
is	O
exposed	O
to	O
a	O
traumatic	O
event	O
at	O
some	O
point	O
,	O
only	O
a	O
small	O
percentage	O
of	O
the	O
population	B-T098
develops	O
post	B-T038
-	I-T038
traumatic	I-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
,	O
suggesting	O
the	O
presence	O
of	O
predisposing	O
factors	O
.	O
abnormal	B-T033
acoustic	B-T038
startle	I-T038
response	I-T038
(	O
as	B-T038
##r	I-T038
)	O
has	O
been	O
shown	O
to	O
be	O
associated	O
with	O
ptsd	B-T038
,	O
implicating	O
it	O
as	O
a	O
potential	O
predictor	O
of	O
the	O
development	B-T038
of	O
ptsd	B-T038
-	O
like	O
behavior	O
.	O
since	O
poor	O
extinction	B-T038
and	O
retention	O
of	O
extinction	B-T038
learning	I-T038
are	O
characteristic	O
of	O
ptsd	B-T038
patients	O
,	O
it	O
is	O
of	O
interest	O
to	O
determine	O
if	O
abnormal	B-T033
as	B-T038
##r	I-T038
is	O
predictive	O
of	O
development	B-T038
of	O
such	O
deficits	O
.	O
to	O
determine	O
whether	O
baseline	O
as	B-T038
##r	I-T038
has	O
utility	O
in	O
predicting	O
the	O
development	B-T038
of	O
ptsd	B-T038
-	O
like	O
behavior	O
,	O
the	O
relationship	O
between	O
baseline	O
as	B-T038
##r	I-T038
and	O
freezing	O
behavior	O
following	O
pav	O
##lo	O
##vian	O
fear	O
conditioning	O
was	O
examined	O
in	O
a	O
group	O
of	O
adult	O
,	O
male	O
sprague	B-T204
-	I-T204
dawley	I-T204
rats	I-T204
.	O
baseline	O
acoustic	B-T038
startle	I-T038
response	I-T038
(	O
as	B-T038
##r	I-T038
)	O
was	O
assessed	O
preceding	O
exposure	O
to	O
a	O
pav	O
##lo	O
##vian	O
fear	O
conditioning	O
paradigm	O
where	O
freezing	O
behavior	O
was	O
measured	O
during	O
fear	O
conditioning	O
,	O
extinction	B-T038
training	O
,	O
and	O
extinction	B-T038
testing	O
.	O
although	O
there	O
was	O
no	O
relationship	O
between	O
baseline	O
as	B-T038
##r	I-T038
and	O
fear	B-T038
memory	B-T038
following	O
conditioning	O
,	O
rats	B-T204
with	O
low	O
baseline	O
as	B-T038
##r	I-T038
had	O
significantly	O
lower	O
magnitude	O
of	O
retention	B-T038
of	O
the	O
extinction	B-T038
memory	B-T038
than	O
rats	B-T204
with	O
high	O
baseline	O
as	B-T038
##r	I-T038
.	O
the	O
results	O
suggest	O
that	O
baseline	O
as	B-T038
##r	I-T038
has	O
value	O
as	O
a	O
predictive	O
index	B-T170
of	O
the	O
development	B-T038
of	O
a	O
ptsd	B-T038
-	O
like	O
phenotype	O
.	O

the	O
business	O
of	O
health	B-T091
physics	I-T091
-	O
jobs	O
in	O
a	O
changing	O
market	O
the	O
health	B-T091
physics	I-T091
profession	O
was	O
born	O
abrupt	O
##ly	O
when	O
once	O
rare	O
and	O
prec	O
##ious	O
radioactive	B-T103
materials	I-T103
became	O
common	O
##place	O
.	O
the	O
technological	O
advancements	O
that	O
triggered	O
an	O
industrial	O
complex	O
and	O
ended	O
world	O
war	O
ii	O
demand	O
##ed	O
radiation	O
safety	O
on	O
an	O
unprecedented	B-T170
scale	I-T170
.	O
until	O
then	O
,	O
protective	O
measures	O
against	O
radiation	O
were	O
largely	O
absent	O
in	O
laboratories	B-T092
.	O
over	O
the	O
subsequent	O
decades	O
,	O
health	B-T097
physic	I-T097
##ists	I-T097
began	O
protecting	B-T058
people	I-T058
and	O
the	O
environment	O
in	O
a	O
wide	O
range	O
of	O
settings	O
including	O
medical	B-T058
,	O
research	B-T062
,	O
and	O
industrial	O
.	O
the	O
use	O
of	O
radioactive	O
materials	O
and	O
radiation	O
-	O
generating	O
devices	O
is	O
prevalent	B-T082
today	I-T082
.	O
radiation	O
doses	O
occur	O
continuously	O
including	O
during	O
air	O
##line	O
flight	O
##s	O
,	O
in	O
our	O
homes	O
,	O
during	O
medical	B-T058
procedures	I-T058
,	O
and	O
in	O
energy	O
production	O
.	O
radiation	O
is	O
integral	O
to	O
numerous	O
applications	O
including	O
those	O
in	O
medicine	B-T091
,	O
dentistry	B-T091
,	O
manufacturing	O
,	O
construction	O
,	O
scientific	O
research	O
,	O
nuclear	O
electric	O
power	O
generation	O
,	O
and	O
oil	O
and	O
gas	O
exploration	O
.	O
activities	O
that	O
were	O
once	O
ground	O
##break	O
##ing	O
have	O
now	O
become	O
routine	O
and	O
scr	B-T170
##ipt	I-T170
##ed	I-T170
.	O
at	O
higher	O
doses	O
,	O
health	O
effects	O
are	O
understood	O
and	O
avoided	O
.	O
instruments	B-T074
for	I-T074
the	I-T074
detection	I-T074
and	I-T074
measurement	I-T074
of	I-T074
radiation	I-T074
are	O
at	O
times	O
smart	O
##er	O
than	O
their	O
users	O
.	O
iron	O
##ically	O
,	O
the	O
same	O
health	B-T091
physics	I-T091
community	O
that	O
has	O
been	O
successful	O
in	O
demonstrating	O
that	O
exposures	B-T037
to	I-T037
radiation	I-T037
and	O
to	O
radioactive	B-T103
materials	I-T103
can	O
be	O
effectively	B-T058
managed	I-T058
is	O
shrink	O
##ing	O
at	O
an	O
increasingly	O
rapid	O
rate	O
.	O
this	O
paper	O
highlights	O
the	O
creation	O
of	O
past	O
and	O
current	O
jobs	O
,	O
predicts	O
the	O
future	O
opportunities	O
in	O
the	O
profession	O
,	O
and	O
makes	O
recommendations	O
necessary	O
to	O
protect	O
the	O
disappear	B-T091
##ing	I-T091
specialties	I-T091
.	O

a	O
standardized	O
approach	O
for	O
the	O
assessment	B-T058
and	O
treatment	B-T058
of	O
internationally	O
adopted	O
children	O
with	O
a	O
previously	O
repaired	O
anorectal	B-T017
malformation	I-T017
(	O
arm	B-T017
)	O
a	O
significant	O
number	O
of	O
internationally	O
adopted	O
children	O
have	O
congenital	B-T017
birth	I-T017
defects	I-T017
.	O
as	O
a	O
specialist	O
center	O
for	O
colorectal	B-T082
diagnoses	B-T058
,	O
we	O
evaluate	O
such	O
children	O
with	O
an	O
anorectal	B-T017
malformation	I-T017
(	O
arm	B-T017
)	O
and	O
have	O
found	O
that	O
a	O
significant	O
number	O
need	O
a	O
reoperation	B-T058
.	O
knowledge	O
of	O
the	O
common	O
complications	B-T038
following	O
arm	B-T017
surgery	B-T058
has	O
led	O
us	O
to	O
develop	O
treatment	B-T058
algorithms	B-T170
for	O
patients	O
with	O
unknown	O
past	B-T033
medical	I-T033
and	O
surgical	O
history	O
,	O
a	O
situation	O
typically	O
encountered	O
in	O
the	O
adopted	B-T033
population	B-T098
.	O
the	O
results	O
of	O
investigations	B-T058
,	O
indications	O
,	O
and	O
rate	O
of	O
reoperation	B-T058
were	O
assessed	O
for	O
adopted	O
children	O
with	O
an	O
arm	B-T017
evaluated	O
between	O
2014	O
and	O
2016	O
.	O
56	O
patients	O
(	O
28	O
males	O
)	O
were	O
identified	O
.	O
76	O
.	O
8	O
%	O
required	O
reoper	B-T058
##ative	I-T058
surgery	I-T058
.	O
mis	O
##lo	O
##ca	O
##tion	O
of	O
the	O
an	B-T017
##us	I-T017
outside	B-T082
the	O
sphincter	B-T017
complex	O
was	O
seen	O
in	O
50	O
%	O
of	O
males	O
and	O
39	O
.	O
3	O
%	O
of	O
females	O
.	O
anal	B-T017
stricture	I-T017
,	O
rectal	B-T038
prolapse	I-T038
,	O
retained	O
vaginal	B-T017
septum	I-T017
,	O
and	O
a	O
stricture	B-T038
##d	I-T038
vaginal	B-T082
intr	I-T082
##oi	I-T082
##t	I-T082
##us	I-T082
were	O
also	O
common	O
.	O
the	O
reoper	B-T058
##ative	I-T058
surgery	I-T058
rate	O
in	O
the	O
internationally	O
adopted	O
child	O
with	O
an	O
arm	B-T017
is	O
high	O
.	O
complete	O
,	O
systematic	O
evaluation	O
of	O
these	O
children	O
is	O
required	O
to	O
identify	O
complications	B-T038
following	O
initial	O
repair	B-T058
.	O
development	O
of	O
mechanisms	O
to	O
improve	O
the	O
primary	O
surgical	B-T058
care	I-T058
these	O
children	O
receive	O
is	O
needed	O
.	O

directing	B-T038
traffic	I-T038
on	I-T038
dna	I-T038
-	O
how	O
transcription	B-T103
factors	I-T103
relieve	O
or	O
induce	O
transcriptional	B-T038
interference	I-T038
transcriptional	B-T038
interference	I-T038
(	O
ti	B-T038
)	O
is	O
increasingly	O
recognized	O
as	O
a	O
widespread	B-T082
mechanism	O
of	O
gene	B-T038
control	I-T038
,	O
particularly	O
given	O
the	O
pervasive	O
nature	O
of	O
transcription	B-T038
,	O
both	O
sense	O
and	O
antisense	B-T103
,	O
across	O
all	O
kingdom	B-T170
##s	I-T170
of	O
life	O
.	O
here	O
,	O
we	O
discuss	O
how	O
transcription	B-T103
factor	I-T103
binding	O
kinetics	O
strongly	O
influence	O
the	O
ability	O
of	O
a	O
transcription	B-T103
factor	I-T103
to	O
relieve	O
or	O
induce	O
ti	B-T038
.	O

pem	B-T103
##br	I-T103
##oli	I-T103
##z	I-T103
##umab	I-T103
for	O
the	O
treatment	B-T058
of	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
in	O
the	O
last	O
years	O
,	O
a	O
spectac	O
##ular	O
development	O
of	O
immuno	B-T103
##therap	I-T103
##eutic	I-T103
agents	I-T103
aimed	O
at	O
the	O
pd	B-T103
-	I-T103
1	I-T103
/	O
pd	O
-	O
l1	O
axis	O
has	O
taken	O
place	O
.	O
this	O
development	O
of	O
these	O
checkpoint	B-T103
inhibitors	I-T103
has	O
greatly	O
influenced	O
our	O
approach	O
to	O
the	O
treatment	B-T058
of	O
lung	B-T038
cancer	I-T038
in	O
first	B-T058
and	O
second	B-T058
line	I-T058
.	O
the	O
limited	O
toxicity	B-T037
profile	O
and	O
the	O
ability	O
to	O
treat	B-T058
for	O
prolonged	O
periods	O
,	O
even	O
in	O
smokers	B-T033
,	O
is	O
a	O
wel	O
##com	O
##e	O
expansion	O
of	O
the	O
therapeutic	O
arsen	O
##al	O
of	O
the	O
onc	B-T097
##ologist	I-T097
.	O
areas	O
covered	O
:	O
this	O
review	B-T170
highlights	O
the	O
results	O
of	O
recent	O
clinical	B-T062
trials	I-T062
on	O
pem	B-T103
##br	I-T103
##oli	I-T103
##z	I-T103
##umab	I-T103
for	O
the	O
treatment	B-T058
of	O
non	B-T038
-	I-T038
small	I-T038
cell	I-T038
lung	I-T038
cancer	I-T038
.	O
the	O
authors	B-T097
discuss	O
both	O
first	B-T058
and	O
second	B-T058
line	I-T058
treatment	I-T058
with	O
pem	B-T103
##br	I-T103
##oli	I-T103
##z	I-T103
##umab	I-T103
as	O
monotherapy	B-T058
and	O
in	O
combination	B-T058
therapies	I-T058
.	O
additionally	O
,	O
implications	O
of	O
the	O
pd	O
-	O
l1	O
immunohistochemistry	B-T058
assay	I-T058
with	O
the	O
22	B-T103
##c3	I-T103
antibody	I-T103
and	O
its	O
use	O
in	O
clinical	B-T062
practice	I-T062
and	O
trials	B-T062
is	O
discussed	O
.	O
expert	O
commentary	O
:	O
a	O
higher	O
overall	B-T033
response	I-T033
,	O
overall	O
survival	O
and	O
a	O
moderate	O
toxicity	B-T037
profile	O
is	O
observed	O
with	O
the	O
use	O
of	O
pem	B-T103
##br	I-T103
##oli	I-T103
##z	I-T103
##umab	I-T103
,	O
compared	O
to	O
chemotherapy	B-T058
,	O
in	O
both	O
first	B-T058
and	O
second	B-T058
line	I-T058
.	O
these	O
promising	O
results	O
have	O
already	O
translated	O
into	O
the	O
registration	B-T058
of	O
pem	B-T103
##br	I-T103
##oli	I-T103
##z	I-T103
##umab	I-T103
in	O
first	B-T058
and	O
second	B-T058
line	I-T058
in	O
patients	O
with	O
a	O
high	O
expression	B-T038
of	O
pd	O
-	O
l1	O
.	O
however	O
,	O
as	O
pd	O
-	O
l1	O
staining	B-T058
does	O
not	O
sufficiently	O
discriminate	O
responders	B-T033
from	O
non	B-T033
-	I-T033
responders	I-T033
for	O
all	O
checkpoint	B-T103
inhibitors	I-T103
,	O
there	O
still	O
is	O
a	O
need	O
for	O
a	O
better	O
predictive	O
biomarker	B-T201
.	O

loss	O
of	O
snf	B-T017
##5	I-T017
induces	O
formation	O
of	O
an	O
aberrant	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
complex	I-T017
the	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
chromatin	B-T017
remodeling	I-T017
complex	I-T017
is	O
highly	O
conserved	O
from	O
yeast	B-T204
to	O
human	B-T204
,	O
and	O
aberrant	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
complexes	I-T017
contribute	O
to	O
human	B-T204
disease	B-T038
.	O
the	O
snf	B-T017
##5	I-T017
/	I-T017
sma	I-T017
##r	I-T017
##cb	I-T017
##1	I-T017
/	I-T017
in	I-T017
##i1	I-T017
subunit	O
of	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
is	O
a	O
tumor	B-T017
suppressor	I-T017
frequently	O
lost	O
in	O
pediatric	O
rhabd	B-T038
##oid	I-T038
cancers	I-T038
.	O
we	O
examined	O
the	O
effects	O
of	O
snf	B-T017
##5	I-T017
loss	O
on	O
the	O
composition	B-T033
,	O
nucleosome	B-T038
binding	I-T038
,	O
recruitment	O
,	O
and	O
remodeling	O
activities	O
of	O
yeast	B-T204
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
.	O
the	O
snf	B-T017
##5	I-T017
subunit	O
is	O
shown	O
by	O
crosslinking	B-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
(	O
cx	B-T058
-	I-T058
ms	I-T058
)	O
and	O
subunit	O
deletion	B-T058
analysis	I-T058
to	O
interact	O
with	O
the	O
atpase	B-T082
domain	I-T082
of	O
snf	B-T103
##2	I-T103
and	O
to	O
form	O
a	O
subm	B-T038
##od	I-T038
##ule	I-T038
consisting	O
of	O
snf	B-T017
##5	I-T017
,	O
sw	B-T017
##p	I-T017
##82	I-T017
,	O
and	O
taf	B-T017
##14	I-T017
.	O
snf	B-T017
##5	I-T017
promotes	O
binding	B-T038
of	O
the	O
snf	B-T103
##2	I-T103
atpase	B-T082
domain	I-T082
to	O
nucle	B-T038
##osomal	I-T038
dna	I-T038
and	O
enhances	O
the	O
catalytic	O
and	O
nucleosome	O
remodeling	O
activities	O
of	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
.	O
snf	B-T017
##5	I-T017
is	O
also	O
required	O
for	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
recruitment	O
by	O
acidic	B-T103
transcription	I-T103
factors	I-T103
.	O
rna	B-T058
-	I-T058
seq	I-T058
analysis	I-T058
suggests	O
that	O
both	O
the	O
recruitment	O
and	O
remodeling	O
functions	O
of	O
snf	B-T017
##5	I-T017
are	O
required	O
in	B-T082
vivo	I-T082
for	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
regulation	B-T038
of	I-T038
gene	I-T038
expression	I-T038
.	O
thus	O
,	O
loss	O
of	O
snf	B-T017
##5	I-T017
alters	O
the	O
structure	B-T082
and	O
function	O
of	O
sw	B-T017
##i	I-T017
/	I-T017
snf	I-T017
.	O

identification	O
of	O
in	B-T103
-	I-T103
chain	I-T103
-	I-T103
functionalized	I-T103
compounds	I-T103
and	O
methyl	B-T103
-	I-T103
branched	I-T103
alkanes	I-T103
in	O
cut	B-T204
##icular	I-T204
wax	B-T103
##es	I-T103
of	O
tritic	B-T204
##um	I-T204
aes	I-T204
##tiv	I-T204
##um	I-T204
cv	I-T204
.	I-T204
bet	I-T204
##hl	I-T204
##e	I-T204
##hem	I-T204
in	O
this	O
work	O
,	O
cut	B-T204
##icular	I-T204
wax	B-T103
##es	I-T103
from	O
flag	B-T204
leaf	I-T204
blade	B-T204
##s	I-T204
and	O
pedunc	B-T204
##les	I-T204
of	O
tritic	B-T204
##um	I-T204
aes	I-T204
##tiv	I-T204
##um	I-T204
cv	I-T204
.	I-T204
bet	I-T204
##hl	I-T204
##e	I-T204
##hem	I-T204
were	O
investigated	O
in	O
search	O
for	O
novel	O
wax	B-T103
compounds	I-T103
.	O
seven	O
wax	B-T103
compound	I-T103
classes	B-T170
were	O
detected	B-T033
that	O
had	O
previously	O
not	O
been	O
reported	O
,	O
and	O
their	O
structures	B-T170
were	O
elucidated	O
using	O
gas	B-T058
chromatography	I-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
of	O
various	O
derivatives	B-T103
.	O
six	O
of	O
the	O
classes	O
were	O
identified	O
as	O
series	O
of	O
homologs	O
differing	O
by	O
two	O
methylene	O
units	O
,	O
while	O
the	O
seventh	O
was	O
a	O
homologous	O
series	O
with	O
homologs	O
with	O
single	O
methylene	O
unit	O
differences	O
.	O
in	O
the	O
wax	B-T103
##es	I-T103
of	O
flag	B-T204
leaf	I-T204
blade	B-T204
##s	I-T204
,	O
secondary	O
alcohols	O
(	O
predominantly	O
c2	O
##7	O
and	O
c3	O
##3	O
)	O
,	O
primary	B-T103
/	O
secondary	B-T103
diol	I-T103
##s	I-T103
(	O
predominantly	O
c2	B-T103
##8	I-T103
)	O
and	O
esters	B-T103
of	I-T103
primary	I-T103
/	O
secondary	B-T103
diol	I-T103
##s	I-T103
(	O
predominantly	O
c5	B-T103
##0	I-T103
,	O
combining	O
c2	B-T103
##8	I-T103
diol	I-T103
with	O
c2	B-T103
##2	I-T103
acid	I-T103
)	O
were	O
found	O
,	O
all	O
sharing	O
similar	O
secondary	O
hydroxyl	O
group	O
positions	O
at	O
and	O
around	O
c	O
-	O
12	O
or	O
ω	O
-	O
12	O
.	O
7	B-T103
-	I-T103
and	O
8	B-T103
-	I-T103
hydroxy	I-T103
-	I-T103
2	I-T103
-	I-T103
alk	I-T103
##anol	I-T103
esters	I-T103
(	O
predominantly	O
c3	B-T103
##5	I-T103
)	O
,	O
7	B-T103
-	I-T103
and	O
8	B-T103
-	I-T103
oxo	I-T103
-	I-T103
2	I-T103
-	I-T103
alk	I-T103
##anol	I-T103
esters	I-T103
(	O
predominantly	O
c3	B-T103
##5	I-T103
)	O
,	O
and	O
4	B-T103
-	I-T103
alkyl	I-T103
##but	I-T103
##an	I-T103
-	I-T103
4	I-T103
-	I-T103
ol	I-T103
##ides	I-T103
(	O
predominantly	O
c2	B-T103
##8	I-T103
)	O
were	O
found	O
both	O
in	O
flag	B-T204
leaf	I-T204
and	O
pedunc	B-T204
##le	I-T204
wax	B-T103
mixtures	O
.	O
finally	O
,	O
a	O
series	O
of	O
even	O
-	O
and	O
odd	O
-	O
number	O
##ed	O
alk	O
##ane	O
homologs	O
was	O
identified	O
in	O
both	O
leaf	B-T204
and	O
pedunc	B-T204
##le	I-T204
wax	B-T103
##es	I-T103
,	O
with	O
an	O
internal	O
methyl	O
branch	O
preferentially	O
on	O
c	B-T103
-	I-T103
11	I-T103
and	O
c	B-T103
-	I-T103
13	I-T103
of	I-T103
homologs	I-T103
with	I-T103
even	I-T103
total	I-T103
carbon	I-T103
number	I-T103
and	O
on	O
c	B-T103
-	I-T103
12	I-T103
of	I-T103
odd	I-T103
-	I-T103
number	I-T103
##ed	I-T103
homologs	I-T103
.	O
biosynthetic	B-T038
pathways	I-T038
are	O
suggested	O
for	O
all	O
compounds	O
,	O
based	O
on	O
common	O
structural	B-T170
features	O
and	O
matching	O
chain	O
length	O
profiles	O
with	O
other	O
wheat	B-T204
wax	B-T103
compound	I-T103
classes	O
.	O

understanding	B-T038
the	O
interrelations	O
##hip	O
between	O
the	O
synthesis	B-T038
of	O
urea	B-T103
and	O
gluconeogenesis	B-T038
by	O
formula	O
##ting	O
an	O
overall	O
balanced	O
equation	O
it	O
is	O
well	O
known	O
that	O
a	O
strong	O
metabolic	O
interrelations	O
##hip	O
exists	O
between	O
urea	B-T038
##genesis	I-T038
and	O
gluconeogenesis	B-T038
.	O
in	O
this	O
paper	O
,	O
we	O
present	O
a	O
detailed	O
,	O
overall	O
equation	O
,	O
describing	O
a	O
possible	O
metabolic	O
link	B-T082
between	O
urea	B-T038
##genesis	I-T038
and	O
gluconeogenesis	B-T038
.	O
we	O
adopted	O
a	O
guided	B-T082
approach	I-T082
in	O
which	O
we	O
strongly	O
suggest	O
that	O
students	B-T098
,	O
when	O
faced	O
with	O
the	O
problem	B-T033
of	O
obtaining	O
the	O
overall	O
equation	O
of	O
a	O
metabolic	O
pathway	O
,	O
carefully	O
account	O
for	O
all	O
atoms	B-T103
and	O
charges	O
of	O
the	O
single	O
reactions	O
,	O
as	O
well	O
as	O
the	O
cellular	B-T038
localization	I-T038
##s	I-T038
of	O
the	O
substrates	O
,	O
and	O
the	O
related	O
transport	B-T038
systems	O
.	O
if	O
this	O
suggestion	O
is	O
always	O
taken	O
into	O
account	O
,	O
a	O
balanced	O
,	O
overall	O
equation	O
of	O
a	O
metabolic	O
pathway	O
will	O
be	O
obtained	O
,	O
which	O
strongly	O
facilitates	O
the	O
discussion	O
of	O
its	O
physiological	O
role	O
.	O
unfortunately	O
,	O
text	B-T170
##book	I-T170
##s	I-T170
often	O
report	B-T170
unbalanced	O
overall	O
equations	O
of	O
metabolic	O
pathways	O
,	O
including	O
urea	B-T038
##genesis	I-T038
and	O
gluconeogenesis	B-T038
.	O
most	O
likely	O
the	O
reason	O
is	O
that	O
metabolism	B-T038
and	O
enzym	O
##ology	O
have	O
been	O
neglected	O
for	O
about	O
three	O
decades	O
,	O
owing	O
to	O
the	O
remarkable	O
advances	O
of	O
molecular	B-T091
biology	I-T091
and	O
molecular	B-T091
genetics	I-T091
.	O
in	O
this	O
paper	B-T170
,	O
we	O
strongly	O
suggest	O
that	O
students	B-T098
,	O
when	O
faced	O
with	O
the	O
problem	O
of	O
obtaining	O
the	O
overall	O
reaction	O
of	O
a	O
metabolic	O
pathway	O
,	O
carefully	O
control	O
if	O
the	O
single	O
reactions	O
are	O
properly	O
balanced	O
for	O
atoms	B-T103
and	O
charges	O
.	O
following	O
this	O
suggestion	O
,	O
we	O
were	O
able	O
to	O
obtain	O
an	O
overall	O
equation	O
describing	O
the	O
metabolic	O
interrelations	O
##hip	O
between	O
urea	B-T038
##genesis	I-T038
and	O
gluconeogenesis	B-T038
,	O
in	O
which	O
urea	B-T103
and	O
glucose	B-T103
are	O
the	O
final	O
products	O
.	O
the	O
aim	O
is	O
to	O
better	O
rational	O
##ize	O
this	O
topic	O
and	O
to	O
convinc	O
##e	O
students	B-T098
and	O
teachers	B-T097
that	O
metabolism	B-T038
is	O
an	O
important	O
and	O
rewarding	O
chapter	O
of	O
human	O
physiology	O
.	O

the	O
use	O
of	O
a	O
software	B-T170
-	O
assisted	O
method	B-T170
to	O
estimate	O
fetal	O
weight	O
at	O
and	O
near	O
term	B-T038
using	O
magnetic	B-T058
resonance	I-T058
imaging	I-T058
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
apply	O
a	O
semi	O
-	O
automated	O
calculation	O
method	B-T170
of	O
fetal	B-T017
body	O
volume	O
and	O
,	O
thus	O
,	O
of	O
magnetic	O
resonance	O
-	O
estimated	O
fetal	O
weight	O
(	O
mr	O
-	O
ef	O
##w	O
)	O
prior	O
to	O
planned	O
delivery	B-T038
and	O
to	O
evaluate	B-T058
whether	O
the	O
technique	O
of	O
measurement	O
could	O
be	O
simplified	O
while	O
remaining	O
accurate	O
.	O
mr	O
-	O
ef	O
##w	O
was	O
calculated	O
using	O
a	O
semi	O
-	O
automated	O
method	B-T170
at	O
38	O
.	O
6	O
weeks	O
of	O
gestation	B-T038
in	O
36	O
patients	O
and	O
compared	O
to	O
the	O
picture	B-T074
arch	I-T074
##iving	I-T074
and	I-T074
communication	I-T074
system	I-T074
(	O
pac	B-T074
##s	I-T074
)	O
.	O
per	O
patient	O
,	O
8	O
sequences	O
were	O
acquired	O
with	O
a	O
slice	O
thickness	O
of	O
4	O
-	O
8	O
mm	O
and	O
an	O
intersection	B-T082
gap	I-T082
of	O
0	O
,	O
4	O
,	O
8	O
,	O
12	O
,	O
16	O
,	O
or	O
20	O
mm	O
.	O
the	O
median	B-T082
absolute	O
relative	O
errors	O
for	O
mr	O
-	O
ef	O
##w	O
and	O
the	O
time	O
of	O
plan	O
##imetric	O
measurements	O
were	O
calculated	O
for	O
all	O
8	O
sequences	O
and	O
for	O
each	O
method	B-T170
(	O
assisted	O
vs	O
.	O
pac	B-T074
##s	I-T074
)	O
,	O
and	O
the	O
difference	O
between	O
the	O
methods	B-T170
was	O
calculated	O
.	O
the	O
median	B-T082
delivery	O
weight	O
was	O
3	O
,	O
280	O
g	O
.	O
the	O
overall	O
median	B-T082
relative	O
error	O
for	O
all	O
288	O
mr	O
-	O
ef	O
##w	O
calculations	O
was	O
2	O
.	O
4	O
%	O
using	O
the	O
semi	O
-	O
automated	O
method	B-T170
and	O
2	O
.	O
2	O
%	O
for	O
the	O
pac	B-T074
##s	I-T074
method	B-T170
.	O
measurements	O
did	O
not	O
differ	O
between	O
the	O
8	O
sequences	O
using	O
the	O
assisted	O
method	B-T170
(	O
p	O
=	O
0	O
.	O
313	O
)	O
or	O
the	O
pac	B-T074
##s	I-T074
(	O
p	O
=	O
0	O
.	O
118	O
)	O
,	O
while	O
the	O
time	O
of	O
plan	O
##imetric	O
measurement	O
decreased	O
significantly	O
with	O
a	O
larger	O
gap	B-T082
(	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
in	O
the	O
assisted	O
method	B-T170
compared	O
to	O
the	O
pac	B-T074
##s	I-T074
method	B-T170
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
our	O
simplified	O
mr	O
-	O
ef	O
##w	O
measurement	O
showed	O
a	O
dramatic	O
decrease	O
in	O
time	O
of	O
plan	O
##imetric	O
measurement	O
without	O
a	O
decrease	O
in	O
the	O
accuracy	O
of	O
weight	O
estimates	O
.	O

anti	B-T038
-	I-T038
tumor	I-T038
activity	I-T038
of	O
sl	B-T103
##4	I-T103
against	O
breast	B-T017
cancer	I-T017
cells	I-T017
:	O
induction	O
of	O
g2	B-T038
/	I-T038
m	I-T038
arrest	I-T038
through	O
modulation	O
of	O
the	O
mapk	B-T103
-	O
dependent	O
p21	B-T103
signaling	B-T038
pathway	I-T038
sl	B-T103
##4	I-T103
,	O
a	O
chalc	B-T103
##one	I-T103
-	O
based	O
compound	B-T103
,	O
has	O
been	O
shown	O
to	O
retard	O
tumor	B-T033
invasion	I-T033
and	O
angiogenesis	B-T038
by	O
suppressing	O
hif	B-T103
##1	I-T103
activity	O
and	O
to	O
induce	O
apoptosis	B-T038
by	O
promoting	O
ros	B-T103
release	O
.	O
here	O
,	O
we	O
report	B-T170
that	O
sl	B-T103
##4	I-T103
is	O
able	O
to	O
inhibit	O
the	O
proliferation	B-T038
of	O
different	O
types	O
of	O
breast	B-T017
cancer	I-T017
cell	I-T017
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
by	O
inducing	O
g2	B-T038
/	I-T038
m	I-T038
cell	I-T038
cycle	I-T038
arrest	I-T038
.	O
our	O
results	O
showed	O
that	O
sl	B-T103
##4	I-T103
exhibited	O
strong	O
anti	B-T103
-	I-T103
proliferative	I-T103
activity	O
in	O
several	O
human	B-T204
breast	B-T038
cancer	I-T038
cell	B-T017
lines	I-T017
,	O
with	O
ic50	O
values	O
lower	O
than	O
1	O
.	O
3	O
μm	O
.	O
further	O
studies	B-T062
indicated	B-T033
that	O
sl	B-T103
##4	I-T103
induced	O
g2	B-T038
/	I-T038
m	I-T038
arrest	I-T038
in	O
these	O
cell	B-T017
lines	I-T017
.	O
mechanistically	O
,	O
sl	B-T103
##4	I-T103
reduces	O
the	O
expression	B-T038
of	O
cyclin	B-T103
a2	I-T103
and	O
cdc	B-T103
##25	I-T103
##c	I-T103
and	O
decreases	O
the	O
activity	O
of	O
the	O
cdc	B-T103
##2	I-T103
/	O
cyclin	B-T103
b1	I-T103
complex	B-T103
.	O
notably	O
,	O
sl	B-T103
##4	I-T103
treatment	B-T058
resulted	O
in	O
an	O
obvious	O
increase	O
in	O
p21	B-T017
mrna	B-T103
and	O
protein	B-T103
levels	O
through	O
activation	B-T038
of	O
mapk	B-T038
signaling	I-T038
pathways	I-T038
,	O
but	O
not	O
the	O
tgf	B-T038
-	I-T038
β	I-T038
pathway	I-T038
.	O
sp	B-T103
##600	I-T103
##125	I-T103
and	O
pd	B-T103
##980	I-T103
##59	I-T103
,	O
specific	O
inhibitors	B-T103
of	O
jnk	B-T103
kinase	I-T103
and	O
erk	B-T103
kinase	I-T103
,	O
significantly	O
blocked	O
the	O
sl	B-T103
##4	I-T103
-	O
induced	O
g2	B-T038
/	I-T038
m	I-T038
phase	I-T038
arrest	I-T038
and	O
upregulation	B-T038
of	O
p21	B-T103
.	O
furthermore	O
,	O
sl	B-T103
##4	I-T103
suppressed	O
the	O
growth	B-T038
of	O
established	O
breast	B-T038
tumors	I-T038
in	O
nude	B-T204
mice	I-T204
through	O
upregulation	B-T038
of	O
p21	B-T103
and	O
downregulation	B-T038
of	O
cdc	B-T103
##25	I-T103
##c	I-T103
,	O
and	O
displayed	O
a	O
good	O
safety	O
profile	O
.	O
taken	O
together	O
,	O
these	O
findings	B-T033
demonstrate	O
the	O
potential	O
value	O
of	O
sl	B-T103
##4	I-T103
as	O
a	O
novel	O
multi	B-T103
-	I-T103
target	I-T103
anti	I-T103
-	I-T103
tumor	I-T103
drug	I-T103
candidate	I-T103
.	O

endoscopic	B-T058
endo	B-T082
##nas	I-T082
##al	I-T082
surgery	B-T058
for	O
remission	B-T033
of	O
cushing	B-T038
'	I-T038
s	I-T038
disease	I-T038
caused	O
by	O
ectopic	B-T082
intrac	O
##aver	O
##no	O
##us	O
macro	B-T038
##adenoma	I-T038
:	O
case	B-T170
report	I-T170
and	O
literature	B-T170
review	I-T170
complete	O
surgical	B-T058
resection	I-T058
of	O
an	O
acth	B-T038
-	I-T038
secreting	I-T038
pituitary	I-T038
adenoma	I-T038
is	O
the	O
gold	O
standard	O
of	O
treatment	B-T058
of	O
cushing	B-T038
'	I-T038
s	I-T038
disease	I-T038
.	O
ectopic	B-T082
location	B-T082
of	O
these	O
adenomas	B-T038
is	O
an	O
extremely	O
rare	O
condition	O
that	O
may	O
compromise	O
the	O
diagnosis	B-T033
and	O
surgical	B-T058
success	O
.	O
we	O
present	O
the	O
first	O
case	O
of	O
an	O
ectopic	B-T082
intrac	O
##aver	O
##no	O
##us	O
acth	B-T038
-	I-T038
secreting	I-T038
macro	I-T038
##adenoma	I-T038
totally	O
resected	O
with	O
endoscopic	B-T058
endo	B-T082
##nas	I-T082
##al	I-T082
surgery	B-T058
(	O
ee	B-T058
##s	I-T058
)	O
.	O
a	O
36	O
year	O
old	O
female	O
presented	O
with	O
cushing	B-T038
syndrome	I-T038
.	O
increased	O
acth	B-T103
,	O
serum	B-T103
cortisol	I-T103
and	O
free	O
urine	O
cortisol	O
levels	O
were	O
identified	O
,	O
however	O
the	O
pituitary	B-T058
mri	I-T058
failed	O
to	O
reveal	O
a	O
pituitary	B-T038
tumor	I-T038
;	O
instead	O
,	O
a	O
paras	B-T033
##ellar	I-T033
lesion	I-T033
in	O
the	O
left	O
cavernous	B-T082
sinus	I-T082
(	O
cs	B-T082
)	O
was	O
noticed	O
.	O
inferior	B-T058
pet	I-T058
##ros	I-T058
##al	I-T058
sinus	I-T058
sampling	I-T058
demonstrated	O
a	O
significant	O
central	B-T082
-	O
to	O
-	O
peripheral	B-T082
and	O
lateral	O
##ized	O
left	O
-	O
sided	O
acth	B-T103
gradient	O
.	O
the	O
patient	O
underwent	O
ee	B-T058
##s	I-T058
.	O
no	B-T033
tumor	I-T033
was	O
found	O
in	O
the	O
sel	B-T017
##la	I-T017
,	O
however	O
,	O
the	O
left	O
cs	B-T082
was	O
widely	O
explored	O
and	O
a	O
tumor	B-T038
was	O
found	O
lateral	B-T082
to	O
the	O
parac	O
##li	O
##val	O
segment	O
of	O
the	O
carotid	B-T017
artery	I-T017
.	O
there	O
were	O
no	B-T033
complications	B-T038
following	O
ee	B-T058
##s	I-T058
.	O
pathology	B-T091
confirmed	O
the	O
diagnosis	B-T033
of	O
an	O
acth	B-T038
-	I-T038
secreting	I-T038
adenoma	I-T038
.	O
during	O
the	O
immediately	O
postoperative	O
course	O
serum	B-T103
cortisol	I-T103
levels	O
dropped	O
below	O
5	O
mcg	O
/	O
dl	O
.	O
postoperative	O
mri	B-T058
demonstrated	O
complete	O
tumor	B-T058
resection	I-T058
.	O
at	O
20	O
months	O
follow	B-T058
-	I-T058
up	I-T058
,	O
the	O
patient	O
remains	O
in	O
clinical	O
and	O
biochemical	O
remission	B-T033
of	O
cushing	B-T038
'	I-T038
s	I-T038
disease	I-T038
.	O
only	O
12	O
cases	O
of	O
ectopic	B-T082
intrac	O
##aver	O
##no	O
##us	O
acth	B-T038
-	I-T038
secreting	I-T038
adenomas	I-T038
have	O
been	O
reported	O
to	O
date	O
and	O
all	O
were	O
micro	B-T038
##adenoma	I-T038
##s	I-T038
.	O
the	O
presence	O
of	O
an	O
ectopic	B-T082
acth	B-T038
-	I-T038
secreting	I-T038
macro	I-T038
##adenoma	I-T038
in	O
the	O
cs	B-T082
represents	O
a	O
surgical	B-T058
challenge	O
.	O
ee	B-T058
##s	I-T058
is	O
the	O
ideal	O
approach	O
for	O
complete	O
resection	B-T058
of	O
ectopic	B-T082
intrac	O
##aver	O
##no	O
##us	O
adenomas	B-T038
allowing	O
for	O
a	O
wide	O
exploration	B-T058
of	O
the	O
cs	B-T082
with	O
no	B-T033
surgical	B-T058
complications	B-T038
.	O

an	O
analysis	B-T062
of	O
systematic	O
elemental	B-T103
changes	O
in	O
decomp	B-T017
##osing	I-T017
bone	I-T017
the	O
aim	O
of	O
this	O
pilot	B-T062
study	I-T062
was	O
to	O
investigate	O
compositional	B-T201
changes	O
in	O
bone	B-T017
during	O
decomposition	O
.	O
elemental	B-T103
concentrations	O
of	O
barium	B-T103
,	O
calcium	B-T103
,	O
iron	B-T103
,	O
potassium	B-T103
,	O
magnesium	B-T103
,	O
zinc	B-T103
and	O
phosphorus	B-T103
in	O
porcine	B-T204
bone	B-T017
(	O
as	O
an	O
experimental	O
analog	B-T103
for	O
human	B-T204
bone	B-T017
)	O
were	O
analyzed	B-T062
by	O
inductively	O
coupled	O
plasma	O
optical	O
emission	O
spectroscopy	O
(	O
icp	O
-	O
oes	O
)	O
.	O
the	O
samples	O
were	O
taken	O
from	O
porcine	B-T204
bone	B-T017
subjected	O
to	O
shallow	O
bur	O
##ial	O
and	O
surface	B-T082
deposition	O
##s	O
at	O
28	O
-	O
day	O
intervals	O
for	O
a	O
period	O
of	O
140	O
days	O
.	O
results	O
indicated	B-T033
that	O
icp	O
-	O
oes	O
elemental	B-T103
profiling	O
has	O
potential	O
to	O
be	O
developed	O
as	O
a	O
forensic	B-T058
test	I-T058
for	O
determining	O
whether	O
a	O
bone	O
sample	O
originates	O
from	O
the	O
early	O
stages	O
of	O
soft	B-T017
tissue	I-T017
put	B-T038
##ref	I-T038
##action	I-T038
.	O
significant	O
changes	O
in	O
iron	B-T103
,	O
sodium	B-T103
and	O
potassium	B-T103
concentrations	O
were	O
found	B-T033
over	O
140	O
days	O
.	O
these	O
elements	B-T103
are	O
known	O
to	O
be	O
primarily	O
associated	O
with	O
proteins	B-T103
and	O
/	O
or	O
tissue	B-T031
fluids	I-T031
within	O
the	O
bone	B-T017
.	O
changes	O
in	O
their	O
respective	O
concentrations	O
may	O
therefore	O
be	O
linked	O
to	O
dehydration	B-T033
over	O
time	O
and	O
in	O
turn	O
may	O
be	O
indicative	O
of	O
time	O
since	O
deposition	O
.	O

reduced	B-T033
chest	I-T033
and	O
abdominal	B-T017
wall	I-T017
mobility	O
and	O
their	O
relationship	O
to	O
lung	B-T038
function	I-T038
,	O
respiratory	O
muscle	B-T038
strength	I-T038
,	O
and	O
exercise	B-T201
tolerance	I-T201
in	O
subjects	O
with	O
copd	B-T038
advanced	O
air	B-T038
-	I-T038
flow	I-T038
limitation	O
in	O
patients	O
with	O
copd	B-T038
leads	O
to	O
a	O
reduction	O
in	O
vital	B-T201
capacity	I-T201
,	O
respiratory	O
muscle	B-T038
strength	I-T038
,	O
and	O
exercise	B-T201
capacity	I-T201
.	O
however	O
,	O
its	O
impact	O
on	O
chest	B-T082
and	O
abdominal	B-T017
wall	I-T017
mobility	O
is	O
unknown	O
.	O
this	O
study	O
aimed	O
to	O
ascertain	O
the	O
prevalence	O
of	O
patients	O
with	O
copd	B-T038
with	O
reduced	B-T033
chest	I-T033
and	O
abdominal	B-T017
wall	I-T017
mobility	O
and	O
to	O
investigate	O
the	O
effect	O
of	O
reduced	B-T033
chest	I-T033
and	O
abdominal	B-T017
wall	I-T017
mobility	O
on	O
pulmonary	B-T038
function	I-T038
,	O
respiratory	O
muscle	B-T038
strength	I-T038
,	O
and	O
exercise	B-T201
capacity	I-T201
.	O
in	O
51	O
elderly	B-T098
male	O
subjects	O
with	O
copd	B-T038
,	O
chest	B-T082
and	O
abdominal	B-T017
wall	I-T017
mobility	O
,	O
fvc	B-T033
,	O
fev1	B-T058
,	O
fev1	B-T058
/	I-T058
fvc	I-T058
,	O
maximal	B-T058
inspiratory	I-T058
pressure	I-T058
(	O
pim	B-T058
##ax	I-T058
)	O
,	O
maximal	B-T058
expiratory	I-T058
pressure	I-T058
(	O
pem	B-T058
##ax	I-T058
)	O
,	O
and	O
the	O
6	B-T058
-	I-T058
min	I-T058
walk	I-T058
distance	I-T058
(	O
6m	B-T058
##w	I-T058
##d	I-T058
)	O
were	O
assessed	O
.	O
chest	B-T017
and	O
abdominal	B-T017
wall	I-T017
mobility	O
were	O
measured	O
using	O
the	O
breathing	B-T038
movement	B-T058
scale	I-T058
(	O
0	O
-	O
8	O
)	O
at	O
the	O
3	O
regions	B-T082
(	O
upper	B-T082
chest	I-T082
,	O
lower	B-T082
chest	I-T082
,	O
and	O
abdomen	B-T082
)	O
.	O
reduced	B-T033
mobility	I-T033
was	O
defined	O
as	O
a	O
value	O
lower	O
than	O
the	O
lower	O
limit	O
of	O
the	O
normal	O
scale	O
.	O
the	O
unpaired	B-T170
t	I-T170
test	I-T170
,	O
mann	B-T170
-	I-T170
whitney	I-T170
test	I-T170
,	O
and	O
multiple	O
regression	O
analysis	O
were	O
performed	O
.	O
the	O
percentages	O
of	O
subjects	O
with	O
reduced	B-T033
mobility	I-T033
were	O
78	O
%	O
for	O
the	O
upper	B-T082
chest	I-T082
,	O
76	O
%	O
for	O
the	O
lower	B-T082
chest	I-T082
,	O
and	O
53	O
%	O
for	O
the	O
abdomen	B-T082
.	O
the	O
subjects	O
with	O
reduced	B-T033
mobility	I-T033
had	O
significantly	O
low	O
fvc	B-T033
,	O
fev1	B-T058
,	O
and	O
6m	B-T058
##w	I-T058
##d	I-T058
in	O
each	O
region	B-T082
and	O
significantly	O
low	O
fev1	B-T058
/	I-T058
fvc	I-T058
,	O
pim	B-T058
##ax	I-T058
,	O
and	O
pem	B-T058
##ax	I-T058
in	O
the	O
abdominal	B-T082
region	I-T082
compared	O
with	O
those	O
with	O
nonre	O
##duced	O
mobility	O
.	O
fvc	B-T033
and	O
6m	B-T058
##w	I-T058
##d	I-T058
were	O
independently	O
associated	O
with	O
the	O
scale	O
values	O
in	O
each	O
region	B-T082
and	O
with	O
the	O
abdominal	B-T082
scale	O
value	O
,	O
respectively	O
.	O
the	O
majority	O
of	O
subjects	O
with	O
copd	B-T038
had	O
reduced	B-T033
chest	I-T033
and	O
abdominal	B-T017
wall	I-T017
mobility	O
,	O
which	O
was	O
independently	O
associated	O
with	O
fvc	B-T033
.	O
even	O
though	O
abdominal	B-T017
wall	I-T017
mobility	O
was	O
relatively	O
preserved	O
compared	O
with	O
chest	B-T017
wall	I-T017
mobility	O
,	O
it	O
was	O
also	O
independently	O
associated	O
with	O
6m	B-T058
##w	I-T058
##d	I-T058
.	O

drg	B-T017
##1	I-T017
is	O
a	O
potential	O
oncogene	B-T017
in	O
lung	B-T038
adenocarcinoma	I-T038
and	O
promotes	O
tumor	B-T038
progression	I-T038
via	O
spindle	B-T038
checkpoint	I-T038
signaling	I-T038
regulation	B-T038
developmentally	O
regulated	O
gtp	B-T103
binding	I-T103
protein	I-T103
1	I-T103
(	O
drg	B-T103
##1	I-T103
)	O
,	O
a	O
member	O
of	O
the	O
drg	B-T103
family	I-T103
,	O
plays	O
important	O
roles	O
in	O
regulating	B-T038
cell	I-T038
growth	I-T038
.	O
however	O
,	O
the	O
molecular	O
basis	O
of	O
drg	B-T103
##1	I-T103
in	O
cell	B-T038
proliferation	I-T038
regulation	I-T038
and	O
the	O
relationship	O
between	O
drg	B-T103
##1	I-T103
and	O
tumor	B-T038
progression	I-T038
remain	O
poorly	O
understood	O
.	O
here	O
,	O
we	O
demonstrate	O
that	O
drg	B-T103
##1	I-T103
is	O
elevated	O
in	O
lung	B-T038
adenocarcinomas	I-T038
while	O
weakly	O
expressed	B-T038
in	O
adjacent	O
lung	B-T017
tissues	B-T017
.	O
drg	B-T017
##1	I-T017
knockdown	B-T062
causes	O
growth	B-T038
inhibition	I-T038
of	O
tumor	B-T017
cells	I-T017
by	O
significantly	O
increasing	O
the	O
proportion	O
of	O
cells	B-T017
in	O
m	B-T038
phase	I-T038
.	O
overexpression	B-T038
of	O
drg	B-T103
##1	I-T103
leads	O
to	O
chromosome	B-T017
miss	B-T038
##eg	I-T038
##reg	I-T038
##ation	I-T038
which	O
is	O
an	O
important	O
index	O
for	O
tumorigenesis	B-T038
.	O
interestingly	O
,	O
ectopic	B-T038
of	O
drg	B-T017
##1	I-T017
reduces	O
taxol	B-T103
induced	O
apoptosis	B-T038
of	O
lung	B-T038
adenocarcinoma	I-T038
cells	B-T017
.	O
mechanistic	O
analyses	B-T062
confirm	O
that	O
drg	B-T103
##1	I-T103
localizes	B-T082
at	O
mitotic	B-T017
spindles	I-T017
in	O
dividing	B-T017
cells	I-T017
and	O
binds	B-T038
to	O
spindle	B-T038
checkpoint	I-T038
signaling	I-T038
proteins	B-T103
in	B-T082
vivo	I-T082
.	O
these	O
studies	B-T062
highlight	O
the	O
expanding	O
role	O
of	O
drg	B-T017
##1	I-T017
in	O
tumorigenesis	B-T038
and	O
reveal	O
a	O
mechanism	O
of	O
drg	B-T017
##1	I-T017
in	O
taxol	B-T103
resistance	O
.	O

isolation	B-T058
and	O
prebiotic	B-T103
activity	O
of	O
water	O
-	O
soluble	O
polysaccharides	B-T103
fractions	O
from	O
the	O
bam	B-T168
##bo	I-T168
##o	I-T168
shoots	I-T168
(	O
phyll	B-T204
##ost	I-T204
##ach	I-T204
##ys	I-T204
pra	I-T204
##ec	I-T204
##ox	I-T204
)	O
the	O
water	O
-	O
soluble	O
polysaccharides	B-T103
from	O
bam	B-T168
##bo	I-T168
##o	I-T168
shoots	I-T168
(	O
phyll	B-T204
##ost	I-T204
##ach	I-T204
##ys	I-T204
pra	I-T204
##ec	I-T204
##ox	I-T204
)	O
(	O
wb	B-T103
##p	I-T103
)	O
were	O
isolated	O
,	O
and	O
the	O
characterization	B-T170
##s	I-T170
as	O
well	O
as	O
prebiotic	B-T103
activities	O
were	O
investigated	O
.	O
the	O
yield	O
of	O
wb	B-T103
##p	I-T103
was	O
7	O
.	O
58	O
##±0	O
.	O
31	O
%	O
under	O
optimal	O
hot	B-T103
-	I-T103
water	I-T103
extraction	B-T058
conditions	O
.	O
two	O
fractions	O
,	O
i	O
.	O
e	O
.	O
,	O
wb	B-T103
##p	I-T103
-	I-T103
1	I-T103
and	O
wb	B-T103
##p	I-T103
-	I-T103
2	I-T103
with	O
molecular	O
weight	O
of	O
83	O
.	O
50	O
##kd	O
##a	O
and	O
80	O
.	O
08	O
##kd	O
##a	O
,	O
respectively	O
,	O
were	O
purified	O
by	O
chromatography	B-T058
.	O
both	O
the	O
polysaccharides	B-T103
fractions	O
were	O
identified	O
as	O
hetero	B-T103
##po	I-T103
##lys	I-T103
##accharides	I-T103
-	I-T103
protein	I-T103
complexes	I-T103
composed	O
of	O
15	O
kinds	O
of	O
common	O
amino	B-T103
acids	I-T103
in	O
protein	B-T103
part	O
and	O
rhamn	B-T103
##ose	I-T103
,	O
arabin	B-T103
##ose	I-T103
,	O
xylose	B-T103
,	O
mannose	B-T103
,	O
glucose	B-T103
and	O
galactose	B-T103
in	O
different	O
molar	O
ratios	O
in	O
polysaccharide	B-T103
part	O
.	O
the	O
existence	O
of	O
α	O
-	O
and	O
β	O
-	O
glycos	O
##idic	O
linkages	O
between	O
the	O
sugar	B-T103
units	O
was	O
confirmed	O
by	O
ftir	B-T062
and	O
nmr	B-T058
spectra	I-T058
.	O
compared	O
with	O
the	O
blank	O
control	O
and	O
the	O
reference	O
of	O
fos	O
,	O
wb	B-T103
##p	I-T103
-	I-T103
1	I-T103
and	O
wb	B-T103
##p	I-T103
-	I-T103
2	I-T103
significantly	O
increased	O
the	O
numbers	O
of	O
bifidobacterium	B-T007
adolescent	I-T007
##is	I-T007
and	O
bifidobacterium	B-T007
bifid	I-T007
##um	I-T007
(	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
which	O
contributed	O
to	O
the	O
production	O
of	O
organic	B-T103
acids	I-T103
,	O
suggesting	O
that	O
the	O
polysaccharides	B-T103
have	O
potential	O
prebiotic	B-T103
properties	O
.	O

measurement	O
of	O
fid	B-T033
##get	I-T033
##ing	I-T033
in	O
patients	O
with	O
anorexia	B-T038
nervosa	I-T038
using	O
a	O
novel	O
sho	O
##e	O
-	O
based	O
monitor	B-T074
to	O
objectively	O
assess	O
seated	B-T033
non	O
-	O
exercise	O
physical	O
activity	O
in	O
patients	O
with	O
anorexia	B-T038
nervosa	I-T038
(	O
an	B-T038
)	O
relative	O
to	O
healthy	O
controls	O
(	O
hcs	O
)	O
and	O
examine	O
the	O
associations	O
between	O
this	O
physical	O
activity	O
,	O
eating	B-T038
disorder	I-T038
pathology	B-T038
,	O
and	O
levels	O
of	O
anxiety	B-T033
and	O
depression	B-T038
.	O
eleven	O
inpatients	O
with	O
an	B-T038
and	O
10	O
hcs	O
wor	O
##e	O
a	O
sho	O
##e	O
-	O
based	O
accelerometer	B-T074
(	O
smart	B-T074
##sh	I-T074
##oe	I-T074
)	O
at	O
three	O
time	O
points	O
:	O
a	O
)	O
while	O
eating	O
lun	O
##ch	O
,	O
b	O
)	O
filling	O
out	O
questionnaires	O
,	O
and	O
c	O
)	O
wat	O
##ching	O
television	O
for	O
1h	O
.	O
across	O
all	O
three	O
tasks	O
,	O
patients	O
with	O
an	B-T038
were	O
significantly	O
more	O
active	O
than	O
hcs	O
,	O
thereby	O
engaging	O
in	O
a	O
greater	O
degree	O
of	O
rest	B-T033
##less	I-T033
or	O
fid	B-T033
##get	I-T033
##ing	I-T033
behavior	O
.	O
degree	O
of	O
physical	O
activity	O
was	O
positively	B-T033
correlated	I-T033
with	O
eating	B-T038
disorder	I-T038
psychopathology	B-T091
in	O
the	O
sample	O
with	O
an	B-T038
,	O
and	O
a	O
trend	O
towards	O
a	O
positive	B-T033
association	I-T033
between	O
physical	O
activity	O
and	O
levels	O
of	O
depression	B-T038
and	O
anxiety	B-T033
was	O
also	O
found	O
in	O
this	O
sample	O
.	O
among	O
individuals	B-T098
with	O
an	B-T038
,	O
physical	O
activity	O
was	O
not	B-T033
significantly	O
correlated	O
with	O
bmi	B-T201
,	O
duration	O
of	O
illness	O
,	O
or	O
number	O
of	O
days	O
since	O
hospital	B-T058
admission	I-T058
.	O
use	O
of	O
a	O
minimally	O
invasive	O
,	O
sho	O
##e	O
-	O
based	O
monitor	B-T074
revealed	O
patients	O
with	O
an	B-T038
engaged	O
in	O
a	O
greater	O
degree	O
of	O
fid	B-T033
##get	I-T033
##ing	I-T033
relative	O
to	O
hcs	O
during	O
quiet	O
,	O
seated	B-T033
tasks	O
and	O
this	O
heightened	O
activity	O
was	O
related	O
to	O
measures	O
of	O
pathology	B-T038
.	O
non	O
-	O
exercise	O
physical	O
activity	O
,	O
including	O
fid	B-T033
##get	I-T033
##ing	I-T033
,	O
may	O
warrant	O
further	O
clinical	O
attention	O
in	O
this	O
patient	O
population	O
.	O

extracorporeal	B-T058
membrane	I-T058
oxygenation	I-T058
outcomes	O
in	O
children	O
with	O
hem	B-T038
##ophag	I-T038
##ocytic	I-T038
lympho	I-T038
##his	I-T038
##ti	I-T038
##ocytosis	I-T038
pediatric	O
patients	O
with	O
hem	B-T038
##ophag	I-T038
##ocytic	I-T038
lympho	I-T038
##his	I-T038
##ti	I-T038
##ocytosis	I-T038
(	O
hl	B-T038
##h	I-T038
)	O
may	O
develop	O
refractory	O
respiratory	B-T038
or	O
cardiac	B-T038
failure	I-T038
that	O
warrants	O
consideration	B-T033
for	O
extracorporeal	B-T058
membrane	I-T058
oxygenation	I-T058
(	O
ecmo	B-T058
)	O
support	B-T074
.	O
the	O
purposes	O
of	O
this	O
study	B-T062
were	O
to	O
describe	O
the	O
use	O
and	O
outcomes	O
of	O
ecmo	B-T058
in	O
pediatric	O
hl	B-T038
##h	I-T038
patients	O
,	O
to	O
identify	O
risk	B-T033
factors	I-T033
for	O
hospital	O
mortality	O
and	O
to	O
compare	O
their	O
ecmo	B-T058
use	O
and	O
outcomes	O
to	O
the	O
ecmo	B-T058
population	B-T098
as	O
a	O
whole	O
.	O
pediatric	O
patients	O
(	O
⩽	O
18	O
years	O
)	O
with	O
a	O
diagnosis	B-T033
of	O
hl	B-T038
##h	I-T038
in	O
the	O
extracorporeal	O
life	O
support	O
organization	O
(	O
els	O
##o	O
)	O
registry	B-T170
were	O
included	O
.	O
between	O
1983	O
and	O
2014	O
,	O
data	O
for	O
30	O
children	O
with	O
hl	B-T038
##h	I-T038
were	O
available	O
in	O
the	O
els	O
##o	O
registry	B-T170
and	O
all	O
were	O
included	O
in	O
this	O
study	B-T062
.	O
all	O
cases	O
occurred	O
in	O
the	O
last	O
decade	O
.	O
of	O
the	O
30	O
hl	B-T038
##h	I-T038
patients	O
,	O
24	O
(	O
80	O
%	O
)	O
had	O
a	O
respiratory	B-T038
indication	O
for	O
ecmo	B-T058
and	O
six	O
(	O
20	O
%	O
)	O
had	O
a	O
cardiac	B-T038
indication	O
(	O
of	O
which	O
4	O
were	O
e	B-T082
-	O
cpr	B-T058
and	O
2	O
cardiac	B-T038
failure	I-T038
)	O
.	O
of	O
the	O
24	O
respiratory	B-T038
ecmo	B-T058
patients	O
,	O
63	O
%	O
were	O
placed	O
on	O
va	O
ecmo	O
.	O
compared	O
with	O
all	O
pediatric	O
patients	O
in	O
the	O
els	O
##o	O
registry	B-T170
during	O
the	O
study	O
period	O
(	O
n	O
=	O
17	O
,	O
007	O
)	O
,	O
hl	B-T038
##h	I-T038
patients	O
had	O
worse	O
hospital	O
survival	O
(	O
non	O
-	O
hl	O
##h	O
59	O
%	O
vs	O
hl	B-T038
##h	I-T038
30	O
%	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
.	O
in	O
pediatric	O
hl	B-T038
##h	I-T038
patients	O
,	O
no	O
pre	O
-	O
ecmo	B-T058
risk	B-T033
factors	I-T033
for	O
mortality	O
were	O
identified	O
.	O
the	O
development	O
of	O
a	O
hemorrhagic	O
complication	B-T038
on	O
ecmo	B-T058
was	O
associated	O
with	O
decreased	O
mortality	O
(	O
p	O
=	O
0	O
.	O
01	O
)	O
.	O
comparing	O
hl	B-T038
##h	I-T038
patients	O
with	O
respiratory	B-T038
failure	I-T038
to	O
patients	O
with	O
other	O
immune	B-T201
compromised	I-T201
conditions	I-T201
,	O
the	O
overall	O
survival	O
rate	O
is	O
similar	O
(	O
hl	B-T038
##h	I-T038
38	O
%	O
vs	O
.	O
non	O
-	O
hl	O
##h	O
immune	B-T201
compromised	I-T201
31	O
%	O
,	O
p	O
=	O
0	O
.	O
64	O
)	O
.	O
hl	B-T038
##h	I-T038
is	O
an	O
uncommon	O
indication	O
for	O
ecmo	B-T058
and	O
these	O
patients	O
have	O
increased	O
mortality	O
compared	O
to	O
the	O
overall	O
pediatric	O
ecmo	B-T058
population	B-T098
.	O
these	O
data	O
should	O
be	O
factor	O
##ed	O
into	O
decision	B-T038
-	I-T038
making	I-T038
when	O
considering	O
ecmo	B-T058
for	O
pediatric	O
hl	B-T038
##h	I-T038
patients	O
.	O

spatio	B-T062
-	I-T062
temporal	I-T062
history	I-T062
of	O
hiv	O
-	O
1	O
crf	O
##35	O
_	O
ad	O
in	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
and	O
iran	B-T082
hiv	B-T005
-	I-T005
1	I-T005
circulating	I-T005
recombinant	I-T005
form	I-T005
35	I-T005
_	I-T005
ad	I-T005
(	O
crf	O
##35	O
_	O
ad	O
)	O
has	O
an	O
important	O
position	O
in	O
the	O
epidemiological	B-T091
profile	O
of	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
and	O
iran	B-T082
.	O
despite	O
the	O
presence	O
of	O
this	O
clade	O
in	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
and	O
iran	B-T082
for	O
over	O
a	O
decade	O
,	O
our	O
understanding	O
of	O
its	O
origin	O
and	O
dissemination	O
patterns	O
is	O
limited	O
.	O
in	O
this	O
study	O
,	O
we	O
performed	O
a	O
bayesian	O
phyl	O
##oge	O
##ographic	O
analysis	O
to	O
reconstruct	O
the	O
spatio	O
-	O
temporal	O
dispersion	O
pattern	O
of	O
this	O
clade	O
using	O
eligible	O
crf	O
##35	O
_	O
ad	O
gag	B-T082
and	I-T082
pol	I-T082
sequences	I-T082
available	O
in	O
the	O
los	B-T082
ala	I-T082
##mo	I-T082
##s	I-T082
hiv	B-T170
database	I-T170
(	O
432	O
sequences	B-T082
available	O
from	O
iran	B-T082
,	O
16	O
sequences	B-T082
available	O
from	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
,	O
and	O
a	O
single	O
crf	O
##35	O
_	O
ad	O
-	O
like	O
pol	B-T082
sequence	I-T082
available	O
from	O
usa	B-T082
)	O
.	O
bayesian	B-T170
markov	I-T170
chain	I-T170
monte	I-T170
carlo	I-T170
algorithm	I-T170
was	O
implemented	O
in	O
be	B-T170
##ast	I-T170
v1	I-T170
.	I-T170
8	I-T170
.	I-T170
1	I-T170
.	O
between	O
-	O
country	O
dispersion	O
rates	O
were	O
tested	O
with	O
bayesian	B-T170
stochastic	I-T170
search	I-T170
variable	I-T170
selection	I-T170
method	I-T170
and	O
were	O
considered	O
significant	O
where	O
bayes	O
factor	O
values	O
were	O
greater	O
than	O
three	O
.	O
the	O
findings	O
suggested	O
that	O
crf	O
##35	O
_	O
ad	O
sequences	B-T082
were	O
genetically	O
similar	O
to	O
parental	B-T082
sequences	I-T082
from	O
kenya	B-T082
and	O
uganda	B-T082
,	O
and	O
to	O
a	O
set	O
of	O
subtype	O
a1	O
sequences	B-T082
available	O
from	O
af	B-T082
##gh	I-T082
##an	I-T082
refugees	B-T098
living	O
in	O
pakistan	B-T082
.	O
our	O
results	O
also	O
showed	O
that	O
across	O
all	O
phylogen	O
##ies	O
,	O
af	B-T082
##gh	I-T082
##an	I-T082
and	O
iranian	B-T082
crf	O
##35	O
_	O
ad	O
sequences	B-T082
formed	O
a	O
monophyletic	O
cluster	O
(	O
posterior	O
clade	O
cred	O
##ibility	O
>	O
0	O
.	O
7	O
)	O
.	O
the	O
divergence	O
date	O
of	O
this	O
cluster	O
was	O
estimated	O
to	O
be	O
between	O
1990	O
and	O
1992	O
.	O
within	O
this	O
cluster	O
,	O
a	O
bidirectional	O
dispersion	O
of	O
the	O
virus	B-T005
was	O
observed	O
across	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
and	O
iran	B-T082
.	O
we	O
could	O
not	O
clearly	O
identify	O
if	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
or	O
iran	B-T082
first	O
established	O
or	O
received	O
this	O
epidemic	B-T038
,	O
as	O
the	O
root	O
location	O
of	O
this	O
cluster	O
could	O
not	O
be	O
robustly	O
estimated	O
.	O
three	O
crf	O
##35	O
_	O
ad	O
sequences	B-T082
from	O
af	B-T082
##gh	I-T082
##an	I-T082
refugees	B-T098
living	B-T082
in	I-T082
pakistan	B-T082
nested	O
among	O
af	B-T082
##gh	I-T082
##an	I-T082
and	O
iranian	B-T082
crf	O
##35	O
_	O
ad	O
branches	O
.	O
however	O
,	O
the	O
crf	O
##35	O
_	O
ad	O
-	O
like	O
sequence	B-T082
available	O
from	O
usa	B-T082
diverged	O
independently	O
from	O
kenya	B-T082
##n	I-T082
subtype	O
a1	O
sequences	B-T082
,	O
suggesting	O
it	O
not	O
to	O
be	O
a	O
true	O
crf	O
##35	O
_	O
ad	O
lineage	O
.	O
potential	O
factors	O
contributing	O
to	O
viral	B-T005
exchange	O
between	O
af	B-T082
##gh	I-T082
##ani	I-T082
##st	I-T082
##an	I-T082
and	O
iran	B-T082
could	O
be	O
injection	O
drug	O
networks	O
and	O
mass	O
migration	O
of	O
af	B-T082
##gh	I-T082
##an	I-T082
refugees	B-T098
and	O
labour	O
##s	O
to	O
iran	B-T082
,	O
which	O
calls	O
for	O
extensive	O
preventive	O
efforts	O
.	O

developmental	O
hypoxia	B-T038
has	O
negligible	O
effects	O
on	O
long	O
-	O
term	O
hypoxia	B-T038
tolerance	O
and	O
aerobic	B-T038
metabolism	I-T038
of	O
atlantic	B-T204
salmon	I-T204
(	O
sal	B-T204
##mo	I-T204
sal	I-T204
##ar	I-T204
)	O
exposure	O
to	O
developmental	O
hypoxia	B-T038
can	O
have	O
long	O
-	O
term	O
impacts	O
on	O
the	O
physiological	B-T038
performance	O
of	O
fish	B-T204
because	O
of	O
irreversible	O
plasticity	O
.	O
wild	B-T170
and	O
captive	B-T033
-	I-T033
reared	I-T033
atlantic	B-T204
salmon	I-T204
(	O
sal	B-T204
##mo	I-T204
sal	I-T204
##ar	I-T204
)	O
can	O
be	O
exposed	O
to	O
hypoxic	B-T038
conditions	O
during	O
development	O
and	O
continue	O
to	O
experience	O
fluctuating	O
oxygen	B-T103
levels	O
as	O
juveniles	O
and	O
adults	O
.	O
here	O
,	O
we	O
examine	B-T033
whether	O
developmental	O
hypoxia	B-T038
impacts	O
subsequent	O
hypoxia	B-T038
tolerance	O
and	O
aerobic	O
performance	O
of	O
atlantic	B-T204
salmon	I-T204
.	O
individuals	B-T204
at	O
8	O
##°c	O
were	O
exposed	O
to	O
50	O
%	O
(	O
hypoxia	B-T038
)	O
or	O
100	O
%	O
(	O
normoxia	O
)	O
dissolved	B-T038
oxygen	I-T038
(	I-T038
do	I-T038
)	I-T038
saturation	I-T038
(	O
as	O
percent	O
of	O
air	O
saturation	O
)	O
from	O
fertilization	O
for	O
∼	O
##100	O
d	O
(	O
800	O
degree	O
days	O
)	O
and	O
then	O
raised	O
in	O
normoxic	O
conditions	O
for	O
a	O
further	O
15	O
mo	O
.	O
at	O
18	O
mo	O
after	O
fertilization	O
,	O
aerobic	O
scope	O
was	O
calculated	O
in	O
normoxia	O
(	O
100	O
%	O
do	B-T103
)	O
and	O
acute	O
(	O
18	O
h	O
)	O
hypoxia	B-T038
(	O
50	O
%	O
do	B-T103
)	O
from	O
the	O
difference	O
between	O
the	O
minimum	O
and	O
maximum	O
oxygen	B-T201
consumption	I-T201
rates	O
(	O
[	O
formula	O
:	O
see	O
text	O
]	O
and	O
[	O
formula	O
:	O
see	O
text	O
]	O
,	O
respectively	O
)	O
at	O
10	O
##°c	O
.	O
hypoxia	B-T038
tolerance	O
was	O
determined	O
as	O
the	O
do	B-T103
at	O
which	O
loss	B-T033
of	I-T033
equilibrium	I-T033
(	O
lo	B-T033
##e	I-T033
)	O
occurred	O
in	O
a	O
constantly	O
decreasing	B-T033
do	B-T103
environment	O
.	O
there	O
was	O
no	O
difference	O
in	O
[	O
formula	O
:	O
see	O
text	O
]	O
,	O
[	O
formula	O
:	O
see	O
text	O
]	O
,	O
or	O
aerobic	O
scope	O
between	O
fish	B-T204
raised	O
in	O
hypoxia	B-T038
or	O
normoxia	O
.	O
there	O
was	O
some	O
evidence	O
that	O
hypoxia	B-T038
tolerance	O
was	O
lower	O
(	O
higher	O
do	B-T103
at	O
lo	B-T033
##e	I-T033
)	O
in	O
hypoxia	B-T038
-	O
raised	O
fish	B-T204
compared	O
with	O
those	O
raised	O
in	O
normoxia	O
,	O
but	O
the	O
magnitude	O
of	O
the	O
effect	O
was	O
small	O
(	O
12	O
.	O
52	O
%	O
do	B-T103
vs	O
.	O
11	O
.	O
73	O
%	O
do	B-T103
at	O
lo	B-T033
##e	I-T033
)	O
.	O
acute	O
hypoxia	B-T038
significantly	O
reduced	O
aerobic	O
scope	O
by	O
reducing	O
[	O
formula	O
:	O
see	O
text	O
]	O
,	O
while	O
[	O
formula	O
:	O
see	O
text	O
]	O
remained	O
unchanged	B-T033
.	O
interestingly	O
,	O
acute	O
hypoxia	B-T038
uncovered	O
individual	B-T204
-	O
level	O
relationships	O
between	O
do	B-T103
at	O
lo	B-T033
##e	I-T033
and	O
[	O
formula	O
:	O
see	O
text	O
]	O
,	O
[	O
formula	O
:	O
see	O
text	O
]	O
,	O
and	O
aerobic	O
scope	O
.	O
we	O
discuss	O
our	O
findings	O
in	O
the	O
context	O
of	O
developmental	O
trajectories	O
and	O
the	O
role	O
of	O
aerobic	O
performance	O
in	O
hypoxia	B-T038
tolerance	O
.	O

the	O
benefits	O
of	O
combination	B-T058
therapy	I-T058
with	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
and	O
reb	B-T103
##ami	I-T103
##pi	I-T103
##de	I-T103
in	O
symptom	B-T033
improvement	O
in	O
reflux	B-T038
esophagitis	I-T038
:	O
an	O
international	O
multicenter	B-T062
study	I-T062
to	O
investigate	O
the	O
effects	O
of	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
and	O
reb	B-T103
##ami	I-T103
##pi	I-T103
##de	I-T103
combination	B-T058
therapy	I-T058
on	O
symptomatic	B-T033
improvement	O
in	O
patients	O
with	O
reflux	B-T038
esophagitis	I-T038
.	O
a	O
total	O
of	O
50	O
##1	O
patients	O
with	O
reflux	B-T038
esophagitis	I-T038
were	O
randomized	B-T062
into	O
one	O
of	O
the	O
following	O
two	O
treatment	B-T058
regimens	I-T058
:	O
40	O
mg	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
plus	O
300	O
mg	O
reb	B-T103
##ami	I-T103
##pi	I-T103
##de	I-T103
daily	O
(	O
combination	B-T058
therapy	I-T058
group	O
)	O
or	O
40	O
mg	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
daily	O
(	O
monotherapy	B-T058
group	O
)	O
.	O
we	O
used	O
a	O
symptom	B-T033
questionnaire	B-T170
that	O
evaluated	O
heart	B-T033
##burn	I-T033
,	O
acid	O
regurgitation	O
,	O
and	O
four	O
upper	B-T038
gastrointestinal	I-T038
symptoms	I-T038
.	O
the	O
primary	O
efficacy	O
end	O
point	O
was	O
the	O
mean	O
decrease	O
in	O
the	O
total	O
symptom	O
score	O
.	O
the	O
mean	O
decreases	O
in	O
the	O
total	O
symptom	O
score	O
at	O
4	O
weeks	O
were	O
estimated	O
to	O
be	O
-	O
18	O
.	O
1	O
##±1	O
##3	O
.	O
8	O
in	O
the	O
combination	B-T058
therapy	I-T058
group	O
and	O
-	O
15	O
.	O
1	O
##±1	O
##1	O
.	O
9	O
in	O
the	O
monotherapy	B-T058
group	O
(	O
p	O
=	O
0	O
.	O
011	O
)	O
.	O
changes	O
in	O
reflux	B-T038
symptom	B-T033
s	O
from	O
baseline	O
after	O
4	O
weeks	O
of	O
treatment	B-T058
were	O
-	O
8	O
.	O
4	O
##±6	O
.	O
6	O
in	O
the	O
combination	B-T058
therapy	I-T058
group	O
and	O
-	O
6	O
.	O
8	O
##±5	O
.	O
9	O
in	O
the	O
monotherapy	B-T058
group	O
(	O
p	O
=	O
0	O
.	O
009	O
)	O
.	O
over	O
a	O
4	O
-	O
week	O
treatment	B-T058
course	O
,	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
and	O
reb	B-T103
##ami	I-T103
##pi	I-T103
##de	I-T103
combination	B-T058
therapy	I-T058
was	O
more	O
effective	O
in	O
decreasing	B-T033
the	O
symptoms	B-T033
of	O
reflux	B-T038
esophagitis	I-T038
than	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
monotherapy	B-T058
.	O

mechanisms	O
of	O
ear	B-T017
trauma	B-T037
and	O
reconstructive	B-T058
techniques	O
in	O
105	O
consecutive	O
patients	O
acquired	O
auricular	B-T017
deformities	B-T017
may	O
diminish	O
facial	O
esthetic	O
##s	O
and	O
cause	O
psychological	O
distress	O
.	O
the	O
aim	O
of	O
this	O
article	O
is	O
to	O
provide	O
an	O
overview	O
of	O
the	O
type	O
of	O
injuries	B-T037
and	O
applied	B-T058
reconstructive	I-T058
techniques	O
in	O
a	O
large	O
academic	B-T092
hospital	I-T092
in	O
the	O
netherlands	B-T082
.	O
a	O
retrospective	O
chart	O
review	O
was	O
conducted	O
for	O
the	O
last	O
105	O
patients	O
who	O
underwent	O
auricular	B-T017
reconstruction	B-T058
for	O
an	O
acquired	B-T017
deformity	I-T017
.	O
data	O
concerning	O
gender	O
,	O
affected	O
side	O
,	O
cause	B-T033
of	I-T033
injury	I-T033
,	O
anatomical	B-T082
region	I-T082
,	O
the	O
previous	O
and	O
further	O
surgeries	B-T058
,	O
type	O
of	O
cartilage	B-T017
,	O
and	O
skin	B-T074
cover	I-T074
used	I-T074
were	O
collected	O
and	O
analyzed	B-T062
.	O
105	O
patients	O
were	O
included	O
.	O
acquired	O
auricular	B-T017
deformities	B-T017
were	O
mainly	O
caused	O
by	O
bite	B-T037
injuries	I-T037
(	O
22	O
%	O
)	O
,	O
traffic	B-T037
accidents	I-T037
(	O
17	O
%	O
)	O
,	O
burns	B-T037
(	O
9	O
.	O
5	O
%	O
)	O
,	O
and	O
post	B-T058
-	I-T058
ot	I-T058
##oplasty	I-T058
complications	B-T038
(	O
9	O
.	O
5	O
%	O
)	O
.	O
the	O
upper	B-T017
third	I-T017
of	I-T017
the	I-T017
aur	I-T017
##icle	I-T017
was	O
most	O
often	O
injured	O
(	O
41	O
%	O
)	O
,	O
followed	O
by	O
the	O
entire	B-T017
aur	I-T017
##icle	I-T017
(	O
19	O
%	O
)	O
.	O
70	O
%	O
of	O
cases	O
required	O
reconstruction	B-T058
with	O
cost	B-T017
##al	I-T017
cartilage	I-T017
.	O
the	O
most	O
common	O
form	O
of	O
cutaneous	B-T082
cover	I-T082
was	O
a	O
post	B-T058
##au	I-T058
##ric	I-T058
##ular	I-T058
skin	I-T058
flap	I-T058
(	O
40	O
%	O
of	O
cases	O
)	O
.	O
this	O
study	B-T062
gives	O
a	O
complete	O
overview	O
of	O
causes	O
and	O
treatment	O
of	O
acquired	O
auricular	B-T017
deformities	B-T017
.	O
the	O
results	O
are	O
comparable	O
with	O
the	O
results	O
of	O
similar	O
studies	B-T062
found	O
in	O
literature	B-T170
.	O
bite	B-T037
wounds	I-T037
are	O
the	O
leading	O
cause	O
of	O
acquired	O
auricular	B-T017
injuries	B-T037
.	O
the	O
upper	B-T017
third	I-T017
is	O
most	O
commonly	O
affected	O
.	O
in	O
the	O
largest	O
percentage	O
of	O
reconstructions	B-T058
,	O
cost	B-T017
##al	I-T017
cartilage	I-T017
and	O
a	O
post	B-T017
##au	I-T017
##ric	I-T017
##ular	I-T017
flap	I-T017
were	O
used	O
to	O
correct	O
the	O
deformity	B-T017
.	O

basal	B-T038
and	O
maximal	O
metabolic	O
rates	O
differ	O
in	O
their	O
response	O
to	O
rapid	O
temperature	O
change	O
among	O
avian	B-T204
species	B-T170
in	O
birds	B-T204
,	O
acclimation	B-T038
and	O
acclim	B-T038
##atization	I-T038
to	O
temperature	O
are	O
associated	O
with	O
changes	O
in	O
basal	B-T038
(	O
bm	B-T038
##r	I-T038
)	O
,	O
summ	O
##it	O
(	O
ms	O
##um	O
)	O
and	O
maximal	O
(	O
mmr	O
)	O
metabolic	O
rates	O
but	O
little	O
is	O
known	O
about	O
the	O
rate	O
at	O
which	O
species	B-T170
adjust	O
their	O
phenotype	O
to	O
short	O
-	O
term	O
temperature	O
variations	O
.	O
our	O
aims	O
were	O
(	O
1	O
)	O
to	O
determine	O
the	O
pattern	B-T082
of	O
metabolic	O
adjustments	O
following	O
a	O
rapid	O
temperature	O
change	O
,	O
(	O
2	O
)	O
to	O
determine	O
whether	O
performance	O
varies	O
at	O
similar	O
rates	O
during	O
exposure	O
to	O
warm	O
or	O
cold	O
environments	O
,	O
and	O
(	O
3	O
)	O
to	O
determine	O
if	O
bm	B-T038
##r	I-T038
,	O
ms	O
##um	O
and	O
mmr	O
change	O
at	O
comparable	O
rates	O
during	O
thermal	O
acclimation	B-T038
.	O
we	O
measured	O
these	O
parameters	O
in	O
white	B-T204
-	I-T204
throat	I-T204
##ed	I-T204
spar	I-T204
##rows	I-T204
(	O
zo	B-T204
##no	I-T204
##trich	I-T204
##ia	I-T204
alb	I-T204
##ico	I-T204
##ll	I-T204
##is	I-T204
)	O
,	O
black	B-T204
-	I-T204
capped	I-T204
chick	I-T204
##ade	I-T204
##es	I-T204
(	O
po	B-T204
##ec	I-T204
##ile	I-T204
atri	I-T204
##cap	I-T204
##illus	I-T204
)	O
,	O
and	O
snow	B-T204
bun	I-T204
##ting	I-T204
##s	I-T204
(	O
ple	B-T204
##ct	I-T204
##roph	I-T204
##ena	I-T204
##x	I-T204
niv	I-T204
##alis	I-T204
)	O
after	O
acclimation	B-T038
to	O
10	O
°c	O
(	O
day	O
0	O
)	O
and	O
on	O
the	O
4th	O
and	O
8th	O
days	O
of	O
acclimation	B-T038
to	O
either	O
-	O
5	O
or	O
28	O
°c	O
.	O
birds	B-T204
changed	O
their	O
metabolic	O
phenotype	O
within	O
8	O
days	O
with	O
patterns	B-T082
differing	O
among	O
species	B-T170
.	O
spar	B-T204
##rows	I-T204
expressed	O
the	O
expected	O
metabolic	O
increases	O
in	O
the	O
cold	O
and	O
decreases	O
at	O
thermo	O
##ne	O
##utr	O
##ality	O
while	O
performance	O
in	O
chick	B-T204
##ade	I-T204
##es	I-T204
and	O
bun	B-T204
##ting	I-T204
##s	I-T204
was	O
not	O
influenced	O
by	O
temperature	O
but	O
changed	O
over	O
time	O
with	O
inverse	O
patterns	B-T082
.	O
our	O
results	O
suggest	O
that	O
bm	B-T038
##r	I-T038
varies	O
at	O
comparable	O
rates	O
in	O
warm	O
and	O
cold	O
environments	O
but	O
changes	O
faster	O
than	O
ms	O
##um	O
and	O
mmr	O
,	O
likely	O
due	O
to	O
limitations	O
in	O
the	O
rate	O
of	O
change	O
in	O
organ	O
size	O
and	O
function	O
.	O
they	O
also	O
suggest	O
that	O
maximal	O
metabolic	O
capacity	O
is	O
lost	O
faster	O
in	O
a	O
warm	O
environment	O
than	O
it	O
is	O
gained	O
in	O
a	O
cold	O
environment	O
.	O
with	O
the	O
expected	O
increase	O
in	O
temperature	O
stochastic	O
##ity	O
at	O
northern	B-T082
latitude	I-T082
##s	I-T082
,	O
a	O
loss	O
of	O
thermo	O
##genic	O
capacity	O
during	O
warm	O
winter	O
days	O
could	O
,	O
therefore	O
,	O
be	O
detrimental	O
if	O
birds	B-T204
are	O
slow	O
to	O
read	O
##ju	O
##st	O
their	O
phenotype	O
with	O
the	O
return	O
of	O
cold	O
days	O
.	O

mir	B-T017
221	I-T017
/	O
222	B-T017
as	O
new	O
players	O
in	O
tamoxifen	B-T103
resistance	B-T038
breast	B-T038
cancer	I-T038
is	O
the	O
most	O
frequent	O
cancer	B-T038
in	O
women	B-T098
.	O
despite	O
advances	O
in	O
early	B-T058
detection	I-T058
and	O
treatment	B-T058
,	O
it	O
has	O
the	O
second	O
highest	O
mortality	O
rate	O
after	O
lung	B-T038
cancer	I-T038
.	O
around	O
85	O
%	O
of	O
breast	B-T038
carcinomas	I-T038
are	O
er	B-T033
+	I-T033
;	O
thus	O
,	O
anti	B-T103
##estr	I-T103
##ogens	I-T103
like	O
tamoxifen	B-T103
are	O
beneficial	O
.	O
although	O
,	O
tamoxifen	B-T103
is	O
useful	O
for	O
many	O
patients	O
,	O
ple	O
##nt	O
##y	O
of	O
patients	O
respond	B-T033
poorly	I-T033
to	O
initial	O
therapy	B-T058
or	O
recurrence	O
occurs	O
in	O
about	O
30	O
%	O
of	O
cases	O
,	O
because	O
tamoxifen	B-T103
resistance	B-T038
happ	O
##ens	O
.	O
drug	B-T038
resistance	I-T038
remains	O
a	O
major	O
clinical	O
obstacle	O
to	O
successful	B-T201
treatment	I-T201
of	O
breast	B-T038
cancer	I-T038
and	O
more	O
than	O
90	O
%	O
of	O
unsuccessful	B-T033
treatments	I-T033
are	O
because	O
of	O
acquired	O
resistance	B-T038
and	O
multidrug	O
resistance	O
(	O
mdr	O
)	O
is	O
a	O
major	O
contributor	O
.	O
micrornas	B-T103
are	O
members	O
of	O
a	O
novel	O
class	O
of	O
short	O
noncoding	B-T103
rnas	I-T103
.	O
besides	O
to	O
their	O
various	O
roles	O
in	O
gene	B-T038
expression	I-T038
,	O
mirnas	B-T103
are	O
considered	O
as	O
important	O
cancer	B-T038
therapeutic	B-T103
targets	I-T103
and	O
biomarkers	B-T201
.	O
since	O
2005	O
,	O
when	O
mirna	B-T103
deregulation	O
was	O
first	O
reported	O
in	O
breast	B-T038
cancer	I-T038
,	O
more	O
than	O
1000	O
reports	B-T170
have	O
been	O
published	O
about	O
mirnas	B-T103
.	O
increasing	O
number	O
of	O
studies	B-T062
showed	O
the	O
importance	O
of	O
mirnas	B-T103
in	O
anti	B-T058
##estr	I-T058
##ogen	I-T058
therapy	I-T058
,	O
especially	O
on	O
tamoxifen	B-T103
;	O
thus	O
,	O
it	O
is	O
not	O
surprising	O
that	O
these	O
tin	O
##y	O
molecules	O
are	O
involved	O
in	O
drug	B-T038
resistance	I-T038
.	O
due	O
to	O
the	O
pivotal	O
role	O
of	O
these	O
known	O
rna	B-T103
molecules	I-T103
,	O
in	O
this	O
review	O
,	O
we	O
tried	O
to	O
illustrate	O
the	O
importance	O
of	O
the	O
mirnas	B-T103
as	O
a	O
new	O
player	O
in	O
breast	B-T038
cancer	I-T038
pathogenesis	B-T038
.	O
we	O
have	O
also	O
focused	O
on	O
cancer	B-T038
drug	B-T038
resistance	I-T038
mechanisms	O
highlighting	O
the	O
role	O
of	O
important	O
onc	B-T103
##om	I-T103
##irs	I-T103
,	O
mir	B-T017
221	I-T017
/	O
222	B-T017
,	O
involved	O
in	O
cell	B-T038
cycle	I-T038
deregulation	I-T038
in	O
breast	B-T038
cancer	I-T038
.	O
the	O
relationship	O
between	O
these	O
onc	B-T103
##om	I-T103
##irs	I-T103
with	O
resistance	B-T038
to	O
tamoxifen	B-T103
is	O
also	O
emphasized	O
.	O

bacteria	B-T007
from	O
wheat	B-T204
and	O
cuc	B-T204
##urb	I-T204
##it	I-T204
plant	B-T204
roots	I-T204
metabol	B-T038
##ize	I-T038
pahs	B-T103
and	O
aromatic	B-T103
root	B-T204
exudates	O
:	O
implications	O
for	O
rhiz	O
##odegrad	O
##ation	O
the	O
chemical	O
interaction	O
between	O
plants	B-T204
and	O
bacteria	B-T007
in	O
the	O
root	B-T204
zone	B-T082
can	O
lead	O
to	O
soil	O
decontamination	O
.	O
bacteria	B-T007
which	O
degrade	O
pahs	B-T103
have	O
been	O
isolated	O
from	O
the	O
rhizosphere	O
##s	O
of	O
plant	B-T204
species	B-T170
with	O
varied	O
biological	O
traits	O
,	O
however	O
,	O
it	O
is	O
not	O
known	O
what	O
phytochemical	B-T103
##s	I-T103
promote	O
contaminant	O
degradation	O
.	O
one	O
monoc	B-T204
##ot	I-T204
and	O
two	O
dic	B-T204
##otyl	I-T204
##ed	I-T204
##on	I-T204
plants	I-T204
were	O
grown	B-T038
in	O
pah	B-T103
-	O
contaminated	O
soil	O
from	O
a	O
manufactured	O
gas	O
plant	O
(	O
mg	O
##p	O
)	O
site	B-T082
.	O
a	O
phyto	B-T058
##to	I-T058
##x	I-T058
##icity	I-T058
assay	I-T058
confirmed	O
greater	O
soil	O
decontamination	O
in	O
rhizosphere	O
##s	O
when	O
compared	O
to	O
bulk	O
soil	O
controls	O
.	O
bacteria	B-T007
were	O
isolated	O
from	O
plant	B-T204
roots	I-T204
(	O
rhiz	B-T007
##obacteria	I-T007
)	O
and	O
selected	O
for	O
growth	B-T038
on	O
anthracene	B-T103
and	O
chrys	B-T103
##ene	I-T103
on	O
pah	B-T103
-	O
amended	O
plates	O
.	O
rhizosphere	O
isolates	B-T103
metabolized	B-T038
3	O
-	O
and	O
4	O
-	O
ring	O
pahs	B-T103
and	O
pah	B-T103
catabolic	O
intermediates	O
in	O
liquid	B-T058
incubations	I-T058
.	O
aromatic	B-T103
root	B-T204
exudate	O
compounds	O
,	O
namely	O
flavonoids	B-T103
and	O
simple	B-T103
phenols	I-T103
,	O
were	O
also	O
substrates	O
for	O
isolated	O
rhiz	B-T007
##obacteria	I-T007
.	O
in	O
particular	O
,	O
the	O
phenolic	B-T103
compounds	I-T103
-	O
mor	B-T103
##in	I-T103
,	O
caffe	B-T103
##ic	I-T103
acid	I-T103
,	O
and	O
protoc	B-T103
##atech	I-T103
##ui	I-T103
##c	I-T103
acid	I-T103
-	O
appear	O
to	O
be	O
linked	O
to	O
bacterial	B-T007
degradation	O
of	O
3	O
-	O
and	O
4	O
-	O
ring	O
pahs	B-T103
in	O
the	O
rhizosphere	O
.	O

microrna	B-T017
101	I-T017
##b	I-T017
is	O
downregulated	B-T038
in	O
the	O
prefrontal	B-T017
cortex	I-T017
of	O
a	O
genetic	B-T170
model	I-T170
of	O
depression	B-T038
and	O
targets	O
the	O
glutamate	B-T103
transporter	I-T103
slc	B-T103
##1a1	I-T103
(	O
ea	B-T103
##at	I-T103
##3	I-T103
)	O
in	O
vitro	O
micrornas	B-T103
(	O
mirnas	B-T103
)	O
are	O
small	O
regulatory	O
molecules	O
that	O
cause	O
translational	B-T038
repression	I-T038
by	O
base	B-T038
pairing	I-T038
with	I-T038
target	I-T038
mrnas	I-T038
.	O
cumulative	O
evidence	O
suggests	O
that	O
changes	O
in	O
mirna	B-T017
expression	B-T038
may	O
in	O
part	O
underlie	O
the	O
pathophysiology	O
and	O
treatment	B-T058
of	O
neuropsychiatric	O
disorders	O
,	O
including	O
major	B-T038
depressive	I-T038
disorder	I-T038
(	O
mdd	B-T038
)	O
.	O
a	O
mirna	B-T017
expression	B-T038
assay	B-T058
that	O
can	O
simultaneously	O
detect	O
42	O
##3	O
rat	O
mirnas	B-T017
(	O
mir	O
##ba	O
##se	O
v	O
.	O
17	O
)	O
was	O
used	O
to	O
profile	B-T058
the	O
prefrontal	B-T017
cortex	I-T017
(	O
pfc	B-T017
)	O
of	O
a	O
genetic	B-T170
rat	I-T170
model	I-T170
of	O
mdd	B-T038
(	O
the	O
fl	B-T170
##inder	I-T170
##s	I-T170
sensitive	I-T170
line	I-T170
[	O
fs	B-T170
##l	I-T170
]	O
)	O
and	O
the	O
controls	O
,	O
the	O
fl	B-T170
##inder	I-T170
##s	I-T170
resistant	I-T170
line	I-T170
(	O
fr	B-T170
##l	I-T170
)	O
.	O
gene	B-T038
expression	I-T038
data	O
from	O
the	O
pfc	B-T017
of	O
fs	B-T170
##l	I-T170
/	O
fr	B-T170
##l	I-T170
animals	B-T204
(	O
ge	O
##o	O
accession	O
no	O
.	O
gs	O
##e2	O
##03	O
##88	O
)	O
were	O
used	O
to	O
guide	O
mrna	B-T103
target	O
selection	O
.	O
luciferase	B-T058
reporter	I-T058
assays	I-T058
were	O
used	O
to	O
verify	O
mirna	B-T017
targets	O
in	O
vitro	O
.	O
we	O
identified	O
23	O
mirnas	B-T017
that	O
were	O
downregulated	B-T038
in	O
the	O
pfc	B-T017
of	O
the	O
fs	B-T170
##l	I-T170
model	I-T170
compared	O
with	O
controls	O
.	O
interestingly	O
,	O
one	O
of	O
the	O
identified	O
mirnas	B-T017
(	O
mir	B-T017
-	I-T017
101	I-T017
##b	I-T017
)	O
is	O
highly	O
conserved	O
between	O
rat	B-T204
and	O
human	B-T204
and	O
was	O
recently	O
found	O
to	O
be	O
downregulated	B-T038
in	O
the	O
pfc	B-T017
of	O
depressed	B-T033
suicide	B-T033
subjects	O
.	O
using	O
a	O
combination	O
of	O
in	O
silico	O
and	O
in	O
vitro	O
analyses	B-T062
,	O
we	O
found	O
that	O
mir	B-T017
-	I-T017
101	I-T017
##b	I-T017
targets	O
the	O
neuronal	B-T017
glutamate	B-T103
transporter	I-T103
slc	B-T103
##1a1	I-T103
(	O
also	O
known	O
as	O
ea	B-T103
##ac	I-T103
##1	I-T103
or	O
ea	B-T103
##at	I-T103
##3	I-T103
)	O
.	O
accordingly	O
,	O
both	O
mrna	B-T103
and	O
protein	B-T033
levels	I-T033
of	O
slc	B-T103
##1a1	I-T103
were	O
found	O
to	O
be	O
upregulated	B-T038
in	O
the	O
pfc	B-T017
of	O
the	O
fs	B-T170
##l	I-T170
model	I-T170
.	O
besides	O
providing	O
a	O
list	O
of	O
novel	O
mirnas	B-T017
associated	O
with	O
depression	B-T033
-	I-T033
like	I-T033
states	I-T033
,	O
this	O
preclinical	B-T062
study	I-T062
replicated	O
the	O
human	B-T204
association	O
of	O
mir	B-T017
-	I-T017
101	I-T017
with	O
depression	B-T038
.	O
in	O
addition	O
,	O
since	O
one	O
of	O
the	O
targets	O
of	O
mir	B-T017
-	I-T017
101	I-T017
##b	I-T017
appears	O
to	O
be	O
a	O
glutamate	B-T103
transporter	I-T103
,	O
our	O
preclinical	O
data	O
support	O
the	O
hypothesis	O
of	O
a	O
glutamatergic	B-T103
dysregulation	B-T033
being	O
implicated	O
in	O
the	O
etiology	O
of	O
depression	B-T038
.	O

structure	O
of	O
the	O
bacterial	O
plant	B-T204
-	O
ferred	B-T103
##oxin	I-T103
receptor	B-T103
fus	B-T103
##a	I-T103
iron	B-T103
is	O
a	O
limiting	O
nutrient	B-T168
in	O
bacterial	B-T038
infection	I-T038
put	O
##ting	O
it	O
at	O
the	O
centre	O
of	O
an	O
evolutionary	O
arms	O
race	O
between	O
host	O
and	O
pathogen	O
.	O
gram	B-T007
-	I-T007
negative	I-T007
bacteria	I-T007
utilize	O
ton	B-T103
##b	I-T103
-	O
dependent	O
outer	B-T017
membrane	I-T017
receptors	B-T103
to	O
obtain	O
iron	B-T103
during	O
infection	B-T038
.	O
these	O
receptors	B-T103
acquire	O
iron	B-T103
either	O
in	O
concert	O
with	O
soluble	O
iron	B-T103
-	I-T103
scavenging	I-T103
sider	I-T103
##ophores	I-T103
or	O
through	O
direct	O
interaction	O
and	O
extraction	B-T058
from	O
host	O
proteins	B-T103
.	O
characterization	O
of	O
these	O
receptors	B-T103
provides	O
invaluable	O
insight	O
into	O
pathogenesis	B-T038
.	O
however	O
,	O
only	O
a	O
subset	O
of	O
virulence	B-T038
-	O
related	O
ton	B-T103
##b	I-T103
-	O
dependent	O
receptors	B-T103
have	O
been	O
currently	O
described	O
.	O
here	O
we	O
report	O
the	O
discovery	O
of	O
fus	B-T103
##a	I-T103
,	O
a	O
new	O
class	O
of	O
ton	B-T103
##b	I-T103
-	O
dependent	O
receptor	B-T103
,	O
which	O
is	O
utilized	O
by	O
phyto	B-T007
##path	I-T007
##ogenic	I-T007
pect	I-T007
##obacterium	I-T007
spp	I-T007
.	I-T007
to	O
obtain	O
iron	B-T103
from	O
plant	B-T204
ferred	B-T103
##oxin	I-T103
.	O
through	O
the	O
crystal	B-T103
structure	I-T103
of	O
fus	B-T103
##a	I-T103
we	O
show	O
that	O
binding	B-T038
of	O
ferred	B-T103
##oxin	I-T103
occurs	O
through	O
specialized	O
extracellular	B-T017
loops	I-T017
that	O
form	O
extensive	O
interactions	O
with	O
ferred	B-T103
##oxin	I-T103
.	O
the	O
function	O
of	O
fus	B-T103
##a	I-T103
and	O
the	O
presence	O
of	O
homologues	B-T082
in	O
clinically	O
important	O
pathogens	O
suggests	O
that	O
small	O
iron	B-T103
-	I-T103
containing	I-T103
proteins	I-T103
represent	O
an	O
iron	B-T103
source	B-T033
for	O
bacterial	O
pathogens	O
.	O

host	B-T204
plant	I-T204
affects	O
the	O
sexual	O
attractiveness	O
of	O
the	O
female	O
white	B-T204
-	I-T204
spotted	I-T204
long	I-T204
##ico	I-T204
##r	I-T204
##n	I-T204
beetle	I-T204
,	O
an	B-T204
##opl	I-T204
##ophor	I-T204
##a	I-T204
mal	I-T204
##asia	I-T204
##ca	I-T204
an	B-T204
##opl	I-T204
##ophor	I-T204
##a	I-T204
mal	I-T204
##asia	I-T204
##ca	I-T204
(	O
cole	B-T204
##optera	I-T204
:	O
cer	B-T204
##amb	I-T204
##yc	I-T204
##idae	I-T204
)	O
is	O
a	O
serious	O
pest	O
that	O
destroy	O
##s	O
various	O
landscape	B-T082
and	O
crop	B-T204
trees	B-T204
in	O
japan	B-T082
.	O
we	O
evaluated	O
the	O
prec	O
##op	O
##ulatory	O
responses	O
of	O
three	O
different	O
a	B-T204
.	I-T204
mal	I-T204
##asia	I-T204
##ca	I-T204
populations	B-T098
collected	O
from	O
mand	B-T204
##arin	I-T204
orange	I-T204
,	O
will	B-T204
##ow	I-T204
and	O
blue	B-T204
##berry	I-T204
trees	I-T204
.	O
most	O
of	O
the	O
males	O
accepted	O
mate	O
##s	O
from	O
within	O
the	O
same	O
host	B-T204
plant	I-T204
population	B-T098
as	O
well	O
as	O
females	O
from	O
the	O
will	B-T204
##ow	I-T204
and	O
blue	B-T204
##berry	I-T204
populations	O
.	O
however	O
,	O
significant	O
number	O
of	O
males	O
from	O
the	O
blue	B-T204
##berry	I-T204
and	O
will	B-T204
##ow	I-T204
populations	B-T098
rejected	O
females	O
from	O
the	O
mand	B-T204
##arin	I-T204
orange	I-T204
population	O
immediately	O
after	O
touch	O
##ing	O
them	O
with	O
their	O
antenna	B-T017
##e	I-T017
.	O
because	O
all	O
three	O
of	O
the	O
female	O
populations	B-T098
produced	O
contact	O
sex	B-T103
pheromone	I-T103
##s	I-T103
on	O
their	O
el	B-T017
##yt	I-T017
##ra	I-T017
,	O
the	O
females	O
of	O
the	O
mand	B-T204
##arin	I-T204
orange	I-T204
population	O
were	O
predicted	O
to	O
possess	O
extra	O
chemicals	B-T103
that	O
repell	O
##ed	O
the	O
males	O
of	O
the	O
other	O
two	O
populations	O
.	O
β	B-T103
-	I-T103
ele	I-T103
##men	I-T103
##e	I-T103
was	O
identified	O
as	O
a	O
key	O
component	O
that	O
was	O
only	O
found	O
in	O
mand	B-T204
##arin	I-T204
orange	I-T204
-	O
fed	O
females	O
and	O
induced	O
a	O
rejection	O
response	O
in	O
will	B-T204
##ow	I-T204
-	O
fed	O
males	O
.	O
our	O
results	O
represent	O
the	O
first	O
example	O
of	O
a	O
female	O
-	O
acquired	O
repell	O
##ent	O
against	O
conspecific	O
males	O
of	O
different	O
host	B-T204
plant	I-T204
populations	O
,	O
indicating	O
that	O
the	O
host	B-T204
plant	I-T204
greatly	O
affects	O
the	O
female	O
'	O
s	O
sexual	O
attractiveness	O
.	O

antiviral	B-T033
activities	I-T033
of	O
selected	O
antimalarial	B-T103
##s	I-T103
against	O
dengue	B-T005
virus	I-T005
type	I-T005
2	I-T005
and	O
zik	B-T005
##a	I-T005
virus	I-T005
in	O
a	O
previous	O
study	B-T062
,	I-T062
twelve	O
antimalarial	B-T103
compounds	I-T103
,	O
am	B-T103
##odia	I-T103
##quine	I-T103
(	O
aq	B-T103
)	O
and	O
derivatives	B-T103
,	O
were	O
shown	O
to	O
have	O
potent	O
anti	B-T033
-	I-T033
dengue	I-T033
viral	I-T033
(	I-T033
denv	I-T033
)	I-T033
activity	I-T033
by	O
using	O
the	O
stable	O
denv	B-T005
##2	I-T005
ren	B-T103
##illa	I-T103
luciferase	I-T103
reporter	B-T017
replic	B-T103
##on	I-T103
expressing	B-T038
bh	B-T017
##k	I-T017
-	I-T017
21	I-T017
cells	I-T017
,	O
infectivity	O
(	O
plaque	O
)	O
,	O
and	O
the	O
qrt	B-T062
-	I-T062
pcr	I-T062
assays	I-T062
.	O
in	O
this	O
study	B-T062
,	O
we	O
performed	O
molecular	B-T062
modeling	I-T062
on	O
these	O
compounds	B-T103
to	O
determine	O
their	O
stereo	O
-	O
electronic	O
properties	O
required	O
for	O
optimal	O
antiviral	B-T033
activity	I-T033
.	O
based	O
on	O
the	O
similarity	O
of	O
calculated	O
stereo	O
-	O
electronic	O
profiles	O
,	O
specifically	O
the	O
electrostatic	O
potential	O
profiles	O
of	O
the	O
compounds	B-T103
,	O
and	O
in	O
silico	O
screening	O
of	O
related	O
compounds	B-T103
from	O
literature	B-T170
,	O
we	O
identified	O
three	O
additional	O
compounds	B-T103
,	O
quin	B-T103
##acrine	I-T103
(	O
qc	B-T103
)	O
,	O
me	B-T103
##fl	I-T103
##oquine	I-T103
(	O
m	B-T103
##q	I-T103
)	O
,	O
and	O
gsk3	B-T103
##69	I-T103
##79	I-T103
##6	I-T103
.	O
analysis	O
of	O
their	O
antiviral	B-T033
activities	I-T033
indicated	O
that	O
all	O
three	B-T103
compounds	I-T103
have	O
high	O
anti	B-T033
-	I-T033
denv	I-T033
activity	I-T033
in	O
the	O
denv	B-T005
##2	I-T005
replic	B-T103
##on	I-T103
expressing	B-T038
cells	B-T017
with	O
ec50	O
values	O
of	O
5	O
.	O
30	O
±	O
1	O
.	O
31	O
μm	O
(	O
qc	B-T103
)	O
,	O
3	O
.	O
22	O
±	O
0	O
.	O
37	O
μm	O
(	O
m	B-T103
##q	I-T103
)	O
,	O
and	O
5	O
.	O
06	O
±	O
0	O
.	O
86	O
μm	O
(	O
gsk3	B-T103
##69	I-T103
##79	I-T103
##6	I-T103
)	O
.	O
the	O
infectivity	O
assays	O
revealed	O
the	O
ec50	O
values	O
of	O
7	O
.	O
09	O
±	O
1	O
.	O
67	O
μm	O
(	O
qc	B-T103
)	O
,	O
4	O
.	O
36	O
±	O
0	O
.	O
31	O
μm	O
(	O
m	B-T103
##q	I-T103
)	O
and	O
3	O
.	O
03	O
±	O
0	O
.	O
35	O
μm	O
(	O
gsk3	B-T103
##69	I-T103
##79	I-T103
##6	I-T103
)	O
.	O
the	O
mode	O
of	O
action	O
of	O
these	O
compounds	B-T103
is	O
through	O
inhibition	O
of	O
autophagy	B-T038
,	O
thereby	O
affecting	O
denv	B-T005
##2	I-T005
replication	B-T038
.	O
moreover	O
,	O
these	O
compounds	B-T103
also	O
showed	O
antiviral	B-T033
activity	I-T033
against	O
the	O
rapidly	O
emerging	O
zik	B-T005
##a	I-T005
virus	I-T005
(	O
zikv	B-T005
)	O
with	O
ec50	O
values	O
of	O
2	O
.	O
27	O
±	O
0	O
.	O
14	O
μm	O
(	O
qc	B-T103
)	O
,	O
3	O
.	O
95	O
±	O
0	O
.	O
21	O
μm	O
(	O
m	B-T103
##q	I-T103
)	O
,	O
and	O
2	O
.	O
57	O
±	O
0	O
.	O
09	O
μm	O
(	O
gsk3	B-T103
##69	I-T103
##79	I-T103
##6	I-T103
)	O
.	O

variation	B-T062
analysis	I-T062
of	O
prim	B-T017
##1	I-T017
gene	I-T017
in	O
chinese	B-T098
patients	O
with	O
primary	B-T038
ovarian	I-T038
insufficiency	I-T038
insights	O
into	O
common	O
genetic	O
susceptibility	O
between	O
primary	B-T038
ovarian	I-T038
insufficiency	I-T038
(	O
po	B-T038
##i	I-T038
)	O
and	O
natural	B-T038
or	O
early	B-T038
menopause	I-T038
have	O
delivered	O
an	O
innovative	O
way	O
of	O
assessing	O
the	O
genetic	O
mechanisms	O
involved	O
in	O
po	B-T038
##i	I-T038
.	O
prim	B-T017
##1	I-T017
plays	O
a	O
crucial	O
role	O
in	O
dna	B-T038
replication	I-T038
by	O
synthesizing	O
rna	B-T103
primers	I-T103
for	O
ok	B-T103
##az	I-T103
##aki	I-T103
fragments	I-T103
.	O
it	O
is	O
closely	O
associated	O
with	O
age	O
at	O
natural	B-T038
menopause	I-T038
,	O
early	B-T038
menopause	I-T038
and	O
po	B-T038
##i	I-T038
in	O
european	B-T098
women	B-T098
.	O
in	O
this	O
study	B-T062
,	O
we	O
aimed	O
to	O
investigate	O
whether	O
mutations	B-T038
in	O
prim	B-T017
##1	I-T017
contribute	O
to	O
po	B-T038
##i	I-T038
in	O
chinese	B-T098
women	B-T098
.	O
all	O
exons	B-T103
and	O
exon	B-T103
-	I-T103
intron	I-T103
boundaries	I-T103
of	O
prim	B-T017
##1	I-T017
gene	I-T017
were	O
sequenced	B-T058
in	O
192	O
han	O
chinese	O
women	B-T098
with	O
non	O
-	O
syndromic	O
po	B-T038
##i	I-T038
.	O
no	O
plausible	O
mutations	B-T038
were	O
identified	O
.	O
the	O
results	O
suggest	O
that	O
the	O
perturbations	O
in	O
prim	B-T017
##1	I-T017
gene	I-T017
are	O
not	O
a	O
common	O
explanation	O
for	O
po	B-T038
##i	I-T038
in	O
chinese	B-T098
women	B-T098
.	O

associations	O
of	O
neuro	B-T017
##d2	I-T017
polymorphisms	O
and	O
change	O
of	O
cognitive	B-T038
dysfunctions	I-T038
in	O
schizophrenia	B-T038
and	O
schiz	B-T038
##oa	I-T038
##ffe	I-T038
##ct	I-T038
##ive	I-T038
disorder	I-T038
after	O
eight	O
weeks	O
of	O
antipsychotic	B-T103
treatment	B-T058
neuro	B-T017
##d2	I-T017
is	O
a	O
neuros	B-T082
##pecific	I-T082
helix	I-T082
-	I-T082
loop	I-T082
-	I-T082
helix	I-T082
transcription	B-T103
factor	I-T103
which	O
has	O
an	O
impact	O
on	O
the	O
regulation	B-T038
of	O
glutamatergic	B-T103
and	O
gabaergic	B-T103
genes	B-T017
.	O
we	O
investigated	O
an	O
association	O
of	O
neuro	B-T017
##d2	I-T017
with	O
neurocognitive	B-T038
dysfunctions	I-T038
in	O
schizophrenia	B-T038
and	O
schiz	B-T038
##oa	I-T038
##ffe	I-T038
##ct	I-T038
##ive	I-T038
disorder	I-T038
patients	O
before	O
and	O
during	O
treatment	B-T058
with	O
different	O
second	B-T103
-	I-T103
generation	I-T103
antipsychotics	I-T103
.	O
patients	O
were	O
genotyped	O
for	O
four	O
different	O
polymorphisms	O
of	O
the	O
neuro	B-T017
##d2	I-T017
gene	B-T017
(	O
(	O
rs	O
##98	O
##89	O
##35	O
##4	O
(	O
a	O
/	O
g	O
)	O
,	O
rs	O
##187	O
##70	O
##32	O
(	O
c	O
/	O
t	O
)	O
,	O
rs	O
##12	O
##45	O
##36	O
##82	O
(	O
c	O
/	O
t	O
)	O
and	O
rs	O
##11	O
##0	O
##78	O
##91	O
##8	O
(	O
c	O
/	O
g	O
)	O
)	O
.	O
cognitive	B-T038
function	I-T038
was	O
assessed	O
at	O
baseline	O
and	O
week	O
8	O
.	O
results	O
of	O
individual	O
neuropsychological	B-T058
tests	I-T058
were	O
assigned	O
to	O
six	O
cognitive	B-T170
domains	I-T170
(	O
reaction	O
time	O
and	O
quality	O
;	O
executive	B-T038
function	I-T038
;	O
working	O
,	O
verbal	B-T038
and	O
visual	B-T038
memory	I-T038
)	O
and	O
a	O
general	O
cognitive	O
index	B-T170
.	O
167	O
patients	O
were	O
included	O
in	O
the	O
study	B-T062
.	O
the	O
neuro	B-T017
##d2	I-T017
exon	O
##ic	O
polymorphism	O
rs	O
##11	O
##0	O
##78	O
##91	O
##8	O
showed	O
significant	O
associations	O
with	O
verbal	B-T038
memory	I-T038
and	O
executive	B-T038
functions	I-T038
,	O
whereas	O
the	O
neuro	B-T017
##d2	I-T017
polymorphism	O
rs	O
##12	O
##45	O
##36	O
##82	O
was	O
significantly	O
associated	O
with	O
working	O
and	O
verbal	B-T038
memory	I-T038
,	O
executive	B-T038
functions	I-T038
and	O
with	O
a	O
cognitive	O
index	B-T170
.	O
significant	O
associations	O
were	O
found	O
at	O
baseline	O
and	O
after	O
eight	O
weeks	O
.	O
moreover	O
,	O
significant	O
associations	O
between	O
the	O
change	O
in	O
neuropsychological	B-T058
test	I-T058
results	O
during	O
antipsychotic	B-T103
treatment	B-T058
and	O
the	O
neuro	B-T017
##d2	I-T017
polymorphisms	O
rs	O
##11	O
##0	O
##78	O
##91	O
##8	O
and	O
rs	O
##12	O
##45	O
##36	O
##82	O
were	O
observed	O
.	O
our	O
findings	O
suggest	O
that	O
the	O
neuro	B-T017
##d2	I-T017
gene	I-T017
could	O
play	O
a	O
role	O
in	O
the	O
pathophysiology	O
of	O
neurocognitive	B-T038
dysfunctions	I-T038
as	O
well	O
as	O
in	O
the	O
change	O
of	O
cognitive	B-T033
symptoms	I-T033
under	O
antipsychotic	B-T103
treatment	B-T058
in	O
schizophrenia	B-T038
and	O
schiz	B-T038
##oa	I-T038
##ffe	I-T038
##ct	I-T038
##ive	I-T038
disorder	I-T038
.	O

high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
-	O
associated	O
sphingosine	B-T103
-	I-T103
1	I-T103
-	I-T103
phosphate	I-T103
activity	O
in	O
heterozygous	B-T038
familial	I-T038
hypercholesterol	I-T038
##aemia	I-T038
patients	O
with	O
heterozygous	B-T038
familial	I-T038
hypercholesterol	I-T038
##aemia	I-T038
(	O
fh	B-T038
)	O
suffer	B-T033
from	O
high	B-T033
plasma	I-T033
cholesterol	I-T033
and	O
an	O
environment	B-T082
of	O
increased	O
oxidative	B-T038
stress	I-T038
.	O
we	O
examined	O
its	O
potential	O
effects	O
on	O
high	B-T103
-	I-T103
density	I-T103
lipoprotein	I-T103
(	O
hdl	B-T103
)	O
-	O
associated	O
sphingosine	B-T103
-	I-T103
1	I-T103
-	I-T103
phosphate	I-T103
(	O
s1p	B-T103
)	O
content	O
(	O
hdl	B-T103
-	O
s1p	B-T103
)	O
and	O
hdl	B-T103
-	O
mediated	O
protection	B-T038
against	I-T038
oxidative	I-T038
stress	I-T038
,	O
both	O
with	O
and	O
without	O
statin	O
treatment	O
.	O
in	O
a	O
case	B-T062
-	I-T062
control	I-T062
study	I-T062
,	O
hdl	B-T103
was	O
isolated	O
from	O
12	O
fh	B-T038
patients	O
with	O
and	O
without	O
statin	O
treatment	O
and	O
from	O
12	O
healthy	O
controls	O
.	O
the	O
hdl	B-T103
-	O
s1p	B-T103
content	O
and	O
the	O
capacity	O
of	O
hdl	B-T103
to	O
protect	O
cardiomyocytes	B-T017
against	O
oxidative	B-T038
stress	I-T038
in	O
vitro	O
were	O
measured	O
.	O
hdl	B-T103
-	O
associated	O
s1p	B-T103
was	O
significantly	O
correlated	O
with	O
cell	B-T038
protection	I-T038
,	O
but	O
not	O
with	O
hdl	B-T103
-	I-T103
cholesterol	I-T103
or	O
apolipoprotein	B-T103
ai	I-T103
.	O
the	O
latter	O
did	O
not	O
correlate	O
with	O
hdl	B-T103
-	O
mediated	O
cell	B-T038
protection	I-T038
.	O
neither	O
the	O
hdl	B-T103
-	O
s1p	B-T103
content	O
nor	O
hdl	B-T103
protective	O
capacity	O
differed	O
between	O
nont	O
##re	O
##ated	O
fh	B-T038
patients	O
and	O
controls	O
.	O
the	O
relative	O
amounts	O
of	O
apolipoprotein	B-T103
ai	I-T103
and	O
apolipoprotein	B-T103
m	I-T103
were	O
similar	O
between	O
controls	O
and	O
fh	B-T038
patients	O
.	O
statin	O
treatment	O
had	O
no	O
effect	O
on	O
any	O
of	O
these	O
measures	O
.	O
the	O
fh	B-T038
environment	B-T082
is	O
not	O
detrimental	O
to	O
hdl	B-T103
-	O
s1p	B-T103
content	O
or	O
hdl	B-T103
-	O
s1p	B-T103
-	O
mediated	O
cell	B-T038
protection	I-T038
.	O
statin	O
treatment	O
does	O
not	O
modulate	O
hdl	B-T103
function	O
in	O
this	O
regard	O
.	O

concordant	O
but	O
varied	O
phenotypes	O
among	O
duchenne	B-T038
muscular	I-T038
dystrophy	I-T038
patient	O
-	O
specific	O
myoblasts	B-T017
derived	O
using	O
a	O
human	B-T204
ips	B-T017
##c	I-T017
-	O
based	O
model	B-T038
duchenne	B-T038
muscular	I-T038
dystrophy	I-T038
(	O
dmd	B-T038
)	O
remains	O
an	O
intractable	O
genetic	B-T038
disease	I-T038
.	O
alth	O
##og	O
##h	O
there	O
are	O
several	O
animal	B-T038
models	I-T038
of	O
dmd	B-T038
,	O
there	O
is	O
no	O
human	B-T017
cell	I-T017
model	O
that	O
carries	O
patient	O
-	O
specific	O
dystrophin	B-T017
mutations	B-T038
.	O
here	O
,	O
we	O
present	O
a	O
human	B-T204
dmd	B-T038
model	B-T038
using	O
human	B-T017
induced	I-T017
pluripotent	I-T017
stem	I-T017
cells	I-T017
(	O
hips	B-T017
##cs	I-T017
)	O
.	O
our	O
model	O
reveals	O
concordant	O
disease	B-T038
-	O
related	O
phenotypes	O
with	O
patient	O
-	O
dependent	O
variation	O
,	O
which	O
are	O
partially	O
reversed	O
by	O
genetic	O
and	O
pharmacological	O
approaches	O
.	O
our	O
[UNK]	O
chemical	B-T103
-	I-T103
compound	I-T103
-	O
based	O
[UNK]	O
strategy	B-T062
successfully	O
direct	O
##s	O
hips	B-T017
##cs	I-T017
into	O
expand	O
##able	O
myoblasts	B-T017
,	O
which	O
exhibit	O
a	O
myogenic	B-T038
transcriptional	I-T038
program	O
,	O
forming	O
striated	O
contractile	B-T017
myofib	B-T017
##ers	I-T017
and	O
participating	O
in	O
muscle	B-T033
regeneration	I-T033
in	B-T082
vivo	I-T082
.	O
dmd	B-T038
-	O
hips	B-T017
##c	I-T017
-	O
derived	O
myoblasts	B-T017
show	O
disease	B-T038
-	O
related	O
phenotypes	O
with	O
patient	O
-	O
to	O
-	O
patient	O
variability	O
,	O
including	O
aberrant	O
expression	O
of	O
inflammation	B-T038
or	O
immune	B-T017
-	I-T017
response	I-T017
genes	I-T017
and	O
collagens	B-T103
,	O
increased	O
bmp	B-T038
/	O
tgfβ	B-T038
signaling	I-T038
,	O
and	O
reduced	O
fusion	O
competence	O
.	O
furthermore	O
,	O
by	O
genetic	O
correction	O
and	O
pharmacological	O
[UNK]	O
dual	O
-	O
smad	B-T103
[UNK]	O
inhibition	B-T038
,	O
the	O
dmd	B-T038
-	O
hips	B-T017
##c	I-T017
-	O
derived	O
myoblasts	B-T017
and	O
genetically	O
corrected	O
isogenic	O
myoblasts	B-T017
form	O
[UNK]	O
rescued	O
[UNK]	O
multi	O
-	O
nucleated	O
myotubes	B-T017
.	O
in	O
conclusion	O
,	O
our	O
findings	O
demonstrate	O
the	O
feasibility	O
of	O
establishing	O
a	O
human	B-T204
[UNK]	O
dmd	B-T038
-	O
in	O
-	O
a	O
-	O
dish	O
[UNK]	O
model	B-T038
using	O
hips	B-T017
##c	I-T017
-	O
based	O
disease	B-T038
modeling	I-T038
.	O

ho	O
##uns	O
##field	O
unit	O
recovery	O
in	O
clinical	O
cone	B-T058
beam	I-T058
ct	I-T058
images	O
of	O
the	O
thorax	B-T082
acquired	O
for	O
image	B-T058
guided	I-T058
radiation	I-T058
therapy	I-T058
a	O
comprehensive	O
arte	O
##fact	O
correction	O
method	B-T170
for	O
clinical	O
cone	B-T058
beam	I-T058
ct	I-T058
(	O
cbct	B-T058
)	O
images	O
acquired	O
for	O
image	B-T058
guided	I-T058
radiation	I-T058
therapy	I-T058
(	O
ig	B-T058
##rt	I-T058
)	O
on	O
a	O
commercial	O
system	O
is	O
presented	O
.	O
the	O
method	B-T170
is	O
demonstrated	O
to	O
reduce	O
arte	O
##fact	O
##s	O
and	O
recover	O
ct	B-T058
-	O
like	O
ho	O
##uns	O
##field	O
units	O
(	O
hu	O
)	O
in	O
reconstructed	O
cbct	B-T058
images	O
of	O
five	O
lung	B-T038
cancer	I-T038
patients	O
.	O
projection	O
image	O
based	O
arte	O
##fact	O
corrections	O
of	O
image	O
lag	O
,	O
detector	O
scatter	O
,	O
body	O
scatter	O
and	O
beam	B-T033
hard	I-T033
##ening	I-T033
are	O
described	O
and	O
applied	O
to	O
cbct	B-T058
images	O
of	O
five	O
lung	B-T038
cancer	I-T038
patients	O
.	O
image	O
quality	O
is	O
evaluated	B-T058
through	O
visual	O
appearance	O
of	O
the	O
reconstructed	O
images	O
,	O
hu	O
-	O
correspondence	O
with	O
the	O
planning	O
ct	B-T058
images	O
,	O
and	O
total	O
volume	O
hu	O
error	O
.	O
arte	O
##fact	O
##s	O
are	O
reduced	O
and	O
ct	B-T058
-	O
like	O
hus	O
are	O
recovered	O
in	O
the	O
arte	O
##fact	O
corrected	O
cbct	B-T058
images	O
.	O
visual	B-T058
inspection	I-T058
confirms	B-T033
that	O
arte	O
##fact	O
##s	O
are	O
indeed	O
suppressed	O
by	O
the	O
proposed	O
method	B-T170
,	O
and	O
the	O
hu	O
root	O
mean	O
square	O
difference	O
between	O
reconstructed	O
cbct	B-T058
##s	I-T058
and	O
the	O
reference	O
ct	B-T058
images	O
are	O
reduced	O
by	O
31	O
%	O
when	O
using	O
the	O
arte	O
##fact	O
corrections	O
compared	O
to	O
the	O
standard	O
clinical	O
cbct	B-T058
reconstruction	O
.	O
a	O
versatile	O
arte	O
##fact	O
correction	O
method	B-T170
for	O
clinical	O
cbct	B-T058
images	O
acquired	O
for	O
ig	B-T058
##rt	I-T058
has	O
been	O
developed	O
.	O
hu	O
values	O
are	O
recovered	O
in	O
the	O
corrected	O
cbct	B-T058
images	O
.	O
the	O
proposed	O
method	B-T170
relies	O
on	O
post	B-T170
processing	I-T170
of	O
clinical	O
projection	O
images	O
,	O
and	O
does	O
not	O
require	O
patient	O
specific	O
optim	O
##isation	O
.	O
it	O
is	O
thus	O
a	O
powerful	O
tool	B-T170
for	O
image	O
quality	O
improvement	O
of	O
large	O
numbers	O
of	O
cbct	B-T058
images	O
.	O

conservation	O
education	O
and	O
habitat	B-T082
restoration	O
for	O
the	O
endangered	B-T098
sag	B-T204
##all	I-T204
##a	I-T204
ca	I-T204
##ec	I-T204
##ilia	I-T204
##n	I-T204
(	O
bo	B-T204
##ule	I-T204
##ng	I-T204
##er	I-T204
##ula	I-T204
ni	I-T204
##ed	I-T204
##en	I-T204
##i	I-T204
)	O
in	O
sag	B-T082
##all	I-T082
##a	I-T082
hill	I-T082
,	O
kenya	B-T082
the	O
sag	B-T204
##all	I-T204
##a	I-T204
ca	I-T204
##ec	I-T204
##ilia	I-T204
##n	I-T204
(	O
bo	B-T204
##ule	I-T204
##ng	I-T204
##er	I-T204
##ula	I-T204
ni	I-T204
##ed	I-T204
##en	I-T204
##i	I-T204
)	O
is	O
an	O
endangered	B-T098
amphibian	B-T204
endemic	O
to	O
sag	B-T082
##all	I-T082
##a	I-T082
hill	I-T082
in	O
the	O
tai	B-T082
##ta	I-T082
hill	I-T082
##s	I-T082
.	O
this	O
bur	B-T204
##rowing	I-T204
worm	I-T204
-	O
like	O
species	B-T170
prefer	O
##s	O
soft	O
soil	O
with	O
high	O
moisture	O
and	O
organic	O
matter	O
.	O
the	O
major	O
threats	O
to	O
the	O
sag	B-T204
##all	I-T204
##a	I-T204
ca	I-T204
##ec	I-T204
##ilia	I-T204
##n	I-T204
are	O
soil	O
erosion	O
caused	O
by	O
steep	O
slopes	O
,	O
bare	O
ground	B-T082
and	O
water	O
sip	O
##ho	O
##ning	O
/	O
soil	O
hard	O
##ening	O
from	O
exotic	B-T204
euc	I-T204
##aly	I-T204
##pt	I-T204
##us	I-T204
trees	I-T204
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
get	O
a	O
better	O
understanding	B-T038
of	O
the	O
local	B-T082
people	B-T098
'	I-T098
s	I-T098
attitude	B-T038
towards	O
this	O
species	B-T170
and	O
how	O
they	O
can	O
contribute	O
to	O
its	O
continued	O
conservation	O
through	O
restoration	O
of	O
its	O
remaining	O
habitat	B-T082
.	O
in	O
this	O
study	B-T062
,	O
it	O
was	O
found	B-T033
that	O
96	O
%	O
of	O
sag	B-T082
##all	I-T082
##a	I-T082
people	B-T098
are	O
aware	B-T038
of	O
the	O
species	B-T170
,	O
its	O
habits	O
and	O
its	O
association	O
with	O
soils	O
high	O
in	O
organic	O
matter	O
.	O
it	O
was	O
also	O
found	B-T033
that	O
96	O
%	O
of	O
sag	B-T082
##all	I-T082
##a	I-T082
people	B-T098
use	O
organic	O
manure	O
from	O
cow	B-T204
du	B-T031
##ng	I-T031
in	O
their	O
farms	B-T082
.	O
habitat	B-T082
restoration	O
through	O
plant	O
##ing	O
of	O
indigenous	B-T082
plants	B-T204
was	O
found	B-T033
to	O
be	O
ongoing	O
,	O
especially	O
on	O
compounds	B-T103
of	O
public	B-T092
institutions	I-T092
as	O
well	O
as	O
on	O
private	O
lands	O
.	O
although	O
drought	O
was	O
found	B-T033
to	O
be	O
a	O
challenge	O
for	O
seedlings	B-T204
development	O
especially	O
on	O
the	O
low	O
elevation	B-T082
sites	B-T082
,	O
destruction	O
by	O
livestock	B-T204
especially	O
during	O
the	O
dry	O
season	O
is	O
also	O
a	O
major	O
threat	O
.	O
in	O
this	O
study	B-T062
,	O
it	O
was	O
recommended	O
that	O
any	O
future	O
habitat	B-T082
restoration	O
initiative	B-T038
should	O
include	O
strong	O
chain	O
-	O
link	O
fen	O
##cing	O
to	O
protect	O
the	O
seedlings	B-T204
from	O
livestock	B-T204
activity	O
.	O
recognizing	O
that	O
the	O
preferred	O
habitats	B-T082
for	O
the	O
species	B-T170
are	O
in	O
the	O
valley	B-T082
##s	I-T082
,	O
systematic	O
plant	O
##ing	O
of	O
key	B-T204
##st	I-T204
##one	I-T204
plant	I-T204
species	B-T170
such	O
as	O
fig	B-T204
trees	I-T204
(	O
fic	B-T204
##us	I-T204
)	O
creates	O
the	O
best	O
micro	B-T082
##ha	I-T082
##bi	I-T082
##ta	I-T082
##ts	I-T082
.	O
these	O
are	O
better	O
than	O
general	B-T082
wood	O
##lot	O
##s	O
of	O
indigenous	B-T082
trees	B-T204
.	O

iodine	B-T103
storage	I-T103
and	O
metabolism	B-T038
of	O
mild	O
to	O
moderate	O
iodine	B-T038
-	I-T038
deficient	I-T038
pregnant	B-T038
rats	B-T204
severe	B-T038
iodine	I-T038
deficiency	I-T038
during	O
pregnancy	O
results	O
in	O
neurodevelopmental	B-T038
disorders	I-T038
in	O
children	O
,	O
while	O
the	O
consequences	O
of	O
mild	B-T038
to	I-T038
moderate	I-T038
iodine	I-T038
deficiency	I-T038
(	O
mm	B-T038
##id	I-T038
)	O
are	O
uncertain	B-T033
.	O
the	O
concentration	B-T058
of	I-T058
iodine	I-T058
in	O
the	O
thyroid	B-T017
is	O
the	O
most	O
accurate	O
indicator	O
of	O
iodine	B-T103
nutrition	I-T103
.	O
this	O
study	O
aimed	O
to	O
evaluate	O
whether	O
the	O
iodine	B-T103
stores	I-T103
in	O
the	O
thyroid	B-T017
cover	I-T017
the	O
needs	O
of	O
the	O
mother	O
and	O
the	O
fetus	O
in	O
iodine	B-T103
-	O
sufficient	O
and	O
mm	B-T038
##id	I-T038
conditions	O
by	O
inductively	B-T058
coupled	I-T058
plasma	I-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
.	O
one	O
hundred	O
four	O
-	O
week	O
-	O
old	O
female	B-T204
wistar	I-T204
rats	I-T204
were	O
randomly	O
divided	O
into	O
mm	B-T038
##id	I-T038
(	O
low	B-T033
iodine	I-T033
intake	I-T033
[	O
l	O
]	O
)	O
and	O
normal	B-T033
(	O
normal	B-T033
iodine	I-T033
intake	I-T033
[	O
n	O
]	O
)	O
groups	O
.	O
the	O
rats	B-T204
were	O
fed	O
for	O
the	O
next	O
three	O
months	O
,	O
and	O
after	O
pregnancy	O
they	O
were	O
further	O
divided	B-T170
into	I-T170
two	I-T170
subgroups	I-T170
,	O
respectively	O
:	O
low	B-T033
iodine	I-T033
pregnancy	B-T038
(	O
lp	B-T033
)	O
and	O
low	B-T033
iodine	I-T033
pregnancy	B-T038
with	O
iodine	B-T168
supplement	I-T168
(	O
lp	B-T168
+	I-T168
)	O
,	O
and	O
normal	B-T033
iodine	I-T033
intake	I-T033
pregnancy	B-T038
(	O
np	B-T038
)	O
and	O
normal	B-T033
iodine	I-T033
intake	I-T033
pregnancy	B-T038
with	O
iodine	B-T168
supplement	I-T168
(	O
np	B-T168
+	I-T168
)	O
.	O
the	O
iodine	O
intake	O
of	O
pregnant	B-T038
rats	B-T204
in	O
the	O
np	B-T168
+	I-T168
and	O
lp	B-T168
+	I-T168
groups	I-T168
was	O
twice	O
as	O
much	O
as	O
in	O
the	O
np	B-T033
and	O
lp	B-T033
groups	I-T033
.	O
the	O
rats	B-T204
were	O
sacrificed	O
on	O
gestational	O
day	O
15	O
and	O
postnatal	O
day	O
7	O
.	O
the	O
iodine	B-T058
concentration	I-T058
in	O
the	O
thyroid	B-T017
of	O
the	O
maternal	B-T033
and	O
newborn	B-T033
rats	B-T204
,	O
maternal	O
serum	O
,	O
placenta	B-T017
,	O
and	O
amniotic	B-T031
fluid	I-T031
were	O
determined	O
by	O
inductively	B-T058
coupled	I-T058
plasma	I-T058
-	I-T058
mass	I-T058
spectrometry	I-T058
.	O
the	O
concentration	B-T058
of	I-T058
iodine	I-T058
in	O
the	O
thyroid	B-T017
of	O
the	O
n	B-T033
group	I-T033
was	O
significantly	O
higher	O
than	O
that	O
in	O
the	O
l	B-T033
group	I-T033
before	O
pregnancy	O
.	O
the	O
concentration	B-T058
of	I-T058
iodine	I-T058
in	O
the	O
maternal	B-T058
thyroid	I-T058
##s	I-T058
of	O
the	O
lp	B-T033
group	I-T033
decreased	O
during	O
pregnancy	O
,	O
whereas	O
that	O
of	O
the	O
np	B-T033
group	I-T033
did	O
not	O
change	O
significantly	O
.	O
there	O
was	O
no	O
significant	O
difference	O
in	O
the	O
iodine	B-T058
concentration	I-T058
in	O
the	O
thyroid	B-T017
of	O
mothers	O
and	O
offspring	O
between	O
the	O
np	B-T033
and	O
np	B-T168
+	I-T168
groups	I-T168
,	O
but	O
it	O
was	O
significant	O
between	O
lp	B-T038
and	O
lp	B-T168
+	I-T168
groups	I-T168
.	O
the	O
concentration	B-T058
of	I-T058
iodine	I-T058
in	O
amniotic	B-T031
fluid	I-T031
was	O
significantly	O
different	O
between	O
the	O
four	O
groups	O
.	O
there	O
is	O
sufficient	O
iodine	B-T103
storage	I-T103
in	O
the	O
thyroid	B-T017
of	O
maternal	B-T033
rats	B-T204
with	O
normal	O
iodine	O
intake	O
during	O
pregnancy	O
,	O
and	O
there	O
is	O
no	O
need	O
for	O
iodine	B-T058
supplementation	I-T058
.	O
however	O
,	O
iodine	B-T103
stores	I-T103
are	O
insufficient	O
in	O
rats	B-T204
with	O
mm	B-T038
##id	I-T038
.	O
iodine	B-T058
supplementation	I-T058
can	O
increase	O
the	O
iodine	B-T058
concentration	I-T058
in	O
the	O
thyroid	B-T017
of	O
maternal	B-T033
rats	B-T204
with	O
mm	B-T038
##id	I-T038
and	O
their	O
offspring	O
,	O
as	O
well	O
as	O
in	O
the	O
amniotic	B-T031
fluid	I-T031
during	O
pregnancy	O
.	O

assessment	B-T058
and	O
classification	B-T170
of	O
protocol	B-T033
deviations	I-T033
deviations	B-T033
from	O
the	O
approved	O
trial	B-T170
protocol	I-T170
are	O
common	O
during	O
clinical	B-T062
trials	I-T062
.	O
they	O
have	O
been	O
conventionally	O
classified	B-T170
as	O
deviations	B-T033
or	O
violations	B-T062
,	O
depending	O
on	O
their	O
impact	O
on	O
the	O
trial	B-T062
.	O
a	O
new	O
method	O
has	O
been	O
proposed	O
by	O
which	O
deviations	B-T033
are	O
classified	B-T170
in	O
five	O
grades	B-T170
from	I-T170
1	I-T170
to	I-T170
5	I-T170
.	O
a	O
deviation	B-T033
of	O
grade	B-T033
1	I-T033
has	O
no	B-T033
impact	O
on	O
the	O
subjects	B-T098
'	I-T098
well	B-T033
-	I-T033
being	I-T033
or	O
on	O
the	O
quality	O
of	O
data	O
.	O
at	O
the	O
maximum	O
,	O
a	O
deviation	B-T033
grade	B-T170
5	I-T170
leads	O
to	O
the	O
death	B-T033
of	O
the	O
subject	B-T098
.	O
this	O
method	O
of	O
classification	B-T170
was	O
applied	O
to	O
deviations	B-T033
noted	O
in	O
the	O
center	O
over	O
the	O
last	O
3	O
years	O
.	O
it	O
was	O
observed	O
that	O
most	O
deviations	B-T033
were	O
of	O
grades	B-T170
1	I-T170
and	I-T170
2	I-T170
,	O
with	O
fewer	O
falling	O
in	O
grades	B-T170
3	I-T170
and	I-T170
4	I-T170
.	O
there	O
were	O
no	O
deviations	B-T033
that	O
led	O
to	O
the	O
death	B-T033
of	I-T033
the	I-T033
subject	I-T033
(	O
grade	O
5	O
)	O
.	O
this	O
method	O
of	O
classification	B-T170
would	O
help	O
trial	B-T062
managers	B-T097
decide	O
on	O
the	O
action	O
to	O
be	O
taken	O
on	O
the	O
occurrence	O
of	O
deviations	B-T033
,	O
which	O
would	O
be	O
based	O
on	O
their	O
impact	O
.	O

longitudinal	B-T062
study	I-T062
of	O
bovine	B-T204
rotavirus	B-T005
group	I-T005
a	I-T005
in	O
newborn	B-T204
calves	B-T204
from	O
vaccinated	B-T033
and	O
un	B-T033
##vac	I-T033
##cinated	I-T033
dairy	O
herds	O
reports	O
of	O
rotavirus	B-T005
excretion	B-T031
in	O
calves	B-T204
usually	O
result	O
from	O
cross	B-T062
-	I-T062
sectional	I-T062
studies	I-T062
,	O
and	O
in	O
face	O
of	O
the	O
conflicting	O
results	O
regarding	O
protection	B-T058
of	O
calves	B-T204
born	B-T038
to	O
vaccinated	B-T033
dams	B-T204
against	O
diarrhea	B-T033
,	O
the	O
aim	O
of	O
the	O
present	O
study	O
was	O
to	O
evaluate	O
rotavirus	B-T005
excretion	B-T031
in	O
dairy	B-T204
calves	I-T204
born	O
to	O
vaccinated	B-T033
or	O
un	B-T033
##vac	I-T033
##cinated	I-T033
dams	B-T204
,	O
to	O
identify	O
the	O
genotypes	O
of	O
bovine	B-T204
rotavirus	B-T005
group	I-T005
a	I-T005
(	O
rv	B-T005
##a	I-T005
)	O
strains	O
isolated	O
from	O
these	O
animals	B-T204
as	O
well	O
as	O
to	O
investigate	O
characteristics	O
of	O
the	O
disease	B-T038
in	O
naturally	O
occurring	O
circumstances	O
throughout	O
the	O
first	B-T033
month	I-T033
of	I-T033
life	I-T033
.	O
five	O
hundred	O
fifty	O
-	O
two	O
fecal	B-T031
samples	I-T031
were	O
taken	O
from	O
56	O
calves	B-T204
,	O
28	O
from	O
each	O
farm	B-T082
and	O
,	O
in	O
the	O
vaccinated	B-T033
herd	O
,	O
11	O
/	O
281	O
samples	B-T031
(	O
3	O
.	O
91	O
%	O
)	O
taken	O
from	O
six	O
different	O
calves	B-T204
tested	B-T033
positive	I-T033
for	O
rv	B-T005
##a	I-T005
while	O
in	O
the	O
un	B-T033
##vac	I-T033
##cinated	I-T033
herd	O
,	O
3	O
/	O
271	O
samples	B-T031
(	O
1	O
.	O
11	O
%	O
)	O
taken	O
from	O
3	O
different	O
calves	B-T204
tested	B-T033
positive	I-T033
.	O
the	O
genotyping	O
of	O
the	O
vp	B-T017
##7	I-T017
genes	I-T017
showed	O
91	O
.	O
2	O
%	O
nucleotide	B-T082
sequence	I-T082
identity	O
to	O
g6	O
genotype	O
(	O
nc	O
##dv	O
strain	O
)	O
,	O
and	O
for	O
the	O
vp	B-T017
##4	I-T017
gene	I-T017
,	O
strains	O
from	O
the	O
vaccinated	B-T033
herd	O
were	O
96	O
.	O
6	O
%	O
related	O
to	O
b2	O
##23	O
strain	O
,	O
while	O
strains	O
from	O
the	O
un	B-T033
##vac	I-T033
##cinated	I-T033
herd	O
were	O
88	O
%	O
related	O
to	O
p	O
[	O
5	O
]	O
genotype	O
(	O
uk	O
strain	O
)	O
.	O
genotypes	O
found	O
in	O
this	O
study	O
were	O
g6	O
##p	O
[	O
11	O
]	O
in	O
the	O
vaccinated	B-T033
herd	O
and	O
g6	O
##p	O
[	O
5	O
]	O
in	O
the	O
un	B-T033
##vac	I-T033
##cinated	I-T033
herd	O
.	O
all	O
calves	B-T204
infected	B-T033
with	O
rotavirus	B-T005
presented	O
an	O
episode	O
of	O
diarrhea	B-T033
in	O
the	O
first	O
month	O
of	O
life	O
,	O
and	O
the	O
discrepancy	O
between	O
the	O
genotypes	O
found	O
in	O
the	O
commercial	B-T103
vaccine	I-T103
(	O
g6	O
##p	O
[	O
1	O
]	O
and	O
g1	O
##0	O
##p	O
[	O
11	O
]	O
)	O
and	O
the	O
rotavirus	B-T005
strains	O
circulating	O
in	O
both	O
vaccinated	B-T033
and	O
un	B-T033
##vac	I-T033
##cinated	I-T033
herds	O
show	O
the	O
importance	O
of	O
keeping	O
constant	O
surveillance	B-T058
in	O
order	O
to	O
avoid	O
potential	O
causes	O
of	O
vaccination	B-T058
failure	B-T033
.	O

recovery	O
from	O
alcohol	B-T038
dependence	I-T038
:	O
do	O
smoking	O
indicators	O
predict	O
abstinence	O
?	O
there	O
is	O
inconsistent	O
evidence	O
about	O
the	O
potential	O
influence	O
of	O
smoking	O
on	O
recovery	O
from	O
alcohol	B-T038
dependence	I-T038
.	O
our	O
study	B-T058
aimed	O
at	O
assessing	O
the	O
impact	O
of	O
smoking	O
-	O
behavior	O
on	O
relapse	O
during	O
a	O
12	O
months	O
follow	B-T058
-	I-T058
up	I-T058
period	O
following	O
a	O
detoxification	B-T058
in	O
patients	O
with	O
alcohol	O
use	O
disorder	O
(	O
aud	O
)	O
.	O
three	O
hundred	O
patients	O
with	O
aud	O
(	O
74	O
.	O
9	O
%	O
smoking	O
)	O
were	O
recruited	O
from	O
two	O
inpatient	O
detoxification	B-T092
units	I-T092
in	O
psychiatric	B-T092
hospitals	I-T092
in	O
germany	B-T082
and	O
their	O
alcohol	O
consumption	O
was	O
prospectively	O
followed	O
for	O
1	O
year	O
.	O
data	O
on	O
different	O
indicators	O
of	O
smoking	O
behavior	O
was	O
gathered	O
.	O
cox	B-T170
regression	I-T170
model	I-T170
was	O
used	O
to	O
evaluate	B-T058
potential	O
risk	B-T033
factors	I-T033
on	O
time	O
to	O
relapse	O
of	O
alcohol	O
consumption	O
.	O
two	O
hundred	O
seventy	O
-	O
nine	O
participants	B-T098
(	O
n	O
=	O
279	O
)	O
were	O
included	O
in	O
the	O
final	O
analysis	B-T062
.	O
smoking	O
increased	O
the	O
risk	O
for	O
alcohol	O
relapse	O
(	O
hazard	O
ratio	O
=	O
3	O
.	O
96	O
##2	O
,	O
95	O
%	O
ci	O
1	O
.	O
58	O
##2	O
-	O
9	O
.	O
92	O
##1	O
)	O
.	O
however	O
,	O
this	O
increased	O
risk	O
is	O
slightly	O
reduced	O
with	O
higher	O
numbers	O
of	O
daily	O
consumed	B-T033
cigarettes	I-T033
(	O
hazard	O
ratio	O
per	O
cigarette	B-T033
=	O
.	O
98	O
##6	O
,	O
95	O
%	O
ci	O
.	O
97	O
##6	O
-	O
.	O
99	O
##5	O
)	O
.	O
smoking	B-T033
reduced	I-T033
the	O
probability	O
of	O
maintaining	O
alcohol	O
abstinence	O
significantly	O
,	O
whereas	O
higher	O
number	O
of	O
cigarettes	B-T033
smoked	I-T033
daily	O
diminished	O
the	O
increased	O
risk	O
of	O
alcohol	O
relapse	O
in	O
alcohol	B-T038
-	I-T038
dependent	I-T038
patients	O
.	O
coordinated	O
psychiatric	O
and	O
substance	B-T038
abuse	I-T038
interventions	B-T058
for	O
different	O
subgroups	B-T170
of	O
patients	O
with	O
aud	O
in	O
the	O
post	O
-	O
acute	O
treatment	O
phase	O
are	O
necessary	O
.	O
individualized	O
treatment	O
planning	O
is	O
especially	O
important	O
in	O
smoking	O
patients	O
with	O
aud	O
who	O
are	O
vulnerable	O
for	O
a	O
relapse	O
to	O
alcohol	O
drinking	O
and	O
for	O
somatic	O
complications	B-T038
.	O
our	O
findings	B-T033
might	O
support	O
individualized	O
treatment	B-T170
plans	I-T170
.	O
(	O
am	O
j	O
addic	O
##t	O
2017	O
;	O
xx	O
:	O
1	O
-	O
8	O
)	O
.	O

double	B-T103
-	I-T103
network	I-T103
hydrogel	I-T103
with	O
tunable	O
mechanical	O
performance	O
and	O
biocompatibility	O
for	O
the	O
fabrication	B-T170
of	O
stem	B-T017
cells	I-T017
-	O
encapsulated	B-T103
fibers	I-T103
and	O
3d	O
assemble	O
fabrication	B-T170
of	O
cell	B-T017
-	O
encapsulated	B-T103
fibers	I-T103
could	O
greatly	O
contribute	O
to	O
tissue	B-T058
engineering	I-T058
and	O
regenerative	B-T091
medicine	I-T091
.	O
however	O
,	O
existing	O
methods	O
suffered	O
from	O
not	O
only	O
un	O
##av	O
##oid	O
##ability	O
of	O
cell	O
damaging	O
conditions	O
and	O
/	O
or	O
sophisticated	O
equipment	O
,	O
but	O
also	O
unavail	O
##ability	O
of	O
proper	O
materials	O
to	O
satisfy	O
both	O
mechanical	O
and	O
biological	O
expectations	O
.	O
in	O
this	O
work	O
,	O
a	O
simple	O
method	O
is	O
proposed	O
to	O
prepare	O
cell	B-T017
-	O
encapsulated	B-T103
fibers	I-T103
with	O
tunable	O
mechanical	O
strength	O
and	O
stretching	O
behavior	O
as	O
well	O
as	O
diameter	O
and	O
microstructure	O
.	O
the	O
hydrogel	B-T103
fibers	B-T103
are	O
made	O
from	O
optimal	O
combination	O
of	O
alginate	B-T103
and	O
poly	B-T103
(	I-T103
n	I-T103
-	I-T103
iso	I-T103
-	I-T103
propyl	I-T103
##acrylamide	I-T103
)	I-T103
-	I-T103
poly	I-T103
(	I-T103
ethylene	I-T103
glycol	I-T103
)	I-T103
,	O
characteristics	O
of	O
double	B-T103
-	I-T103
network	I-T103
hydrogel	I-T103
,	O
with	O
enough	O
stiffness	B-T033
and	O
flexibility	O
to	O
create	O
a	O
variety	O
of	O
three	B-T082
dimensional	I-T082
structures	I-T082
like	O
parallel	O
helical	O
and	O
different	O
knot	O
##s	O
without	O
crack	O
.	O
furthermore	O
,	O
such	O
hydrogel	B-T103
fibers	B-T103
exhibit	O
better	O
compatibility	O
as	O
indicated	B-T033
by	O
the	O
viability	O
,	O
proliferation	O
and	O
expression	O
of	O
pluripotency	O
markers	B-T201
of	O
embryonic	B-T017
stem	I-T017
cells	I-T017
encapsulated	O
after	O
4	O
-	O
day	O
culture	B-T058
.	O
the	O
double	B-T103
-	I-T103
network	I-T103
hydrogel	I-T103
possesses	B-T038
specific	O
quick	O
responses	O
to	O
either	O
of	O
alginate	B-T103
lyase	I-T103
,	O
edta	B-T103
or	O
lower	O
environmental	O
temperature	O
which	O
facilitate	O
the	O
option	O
##al	O
degradation	O
of	O
fibers	B-T103
or	O
fibrous	O
assemblies	O
to	O
release	O
the	O
cells	B-T017
encapsulated	O
for	O
subsequent	O
assay	B-T058
or	O
treatment	B-T058
.	O

dt	B-T058
mri	I-T058
microstructural	O
cortical	B-T017
lesion	B-T038
damage	O
does	O
not	O
explain	O
cognitive	B-T038
impairment	I-T038
in	O
ms	B-T038
we	O
combined	O
double	B-T058
inversion	I-T058
recovery	I-T058
(	O
dir	B-T058
)	O
and	O
diffusion	B-T058
tensor	I-T058
(	I-T058
dt	I-T058
)	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	I-T058
mri	I-T058
)	I-T058
to	O
quantify	O
the	O
severity	O
of	O
cortical	B-T017
lesion	B-T038
(	O
cl	B-T038
)	O
microstructural	O
tissue	B-T017
abnormalities	B-T017
in	O
a	O
large	O
cohort	B-T098
of	O
relapse	O
-	O
onset	O
multiple	B-T038
sclerosis	I-T038
(	O
ms	B-T038
)	O
patients	O
and	O
its	O
contribution	O
to	O
cognitive	B-T038
dysfunction	I-T038
.	O
dir	B-T058
,	O
dt	B-T058
,	O
dual	B-T058
-	I-T058
echo	I-T058
,	O
and	O
three	B-T082
-	I-T082
dimensional	I-T082
(	O
3d	B-T082
)	O
t1	B-T058
-	I-T058
weighted	I-T058
scans	I-T058
were	O
acquired	O
from	O
149	O
ms	B-T038
patients	O
and	O
40	O
controls	O
.	O
cognitively	B-T038
impaired	I-T038
(	O
ci	B-T038
)	O
patients	O
had	O
⩾	O
##2	O
abnormal	B-T033
neuropsychological	B-T058
tests	I-T058
.	O
diffusivity	O
values	O
in	O
cl	B-T038
##s	I-T038
,	O
cortex	B-T017
,	O
white	B-T033
matter	I-T033
(	I-T033
wm	I-T033
)	I-T033
lesions	I-T033
,	O
and	O
normal	B-T017
-	I-T017
appearing	I-T017
(	I-T017
na	I-T017
)	I-T017
wm	I-T017
were	O
assessed	O
.	O
predictors	O
of	O
cognitive	B-T038
impairment	I-T038
were	O
identified	O
using	O
a	O
random	B-T062
forest	I-T062
analysis	I-T062
.	O
compared	O
to	O
controls	O
,	O
ms	B-T038
patients	O
had	O
lower	O
normalized	O
brain	O
volume	O
(	O
nb	O
##v	O
)	O
,	O
gray	O
matter	O
volume	O
(	O
gm	O
##v	O
)	O
,	O
wm	B-T033
volume	I-T033
,	O
lower	O
fractional	O
anisotropy	O
(	O
fa	O
)	O
,	O
and	O
higher	O
mean	O
diffusivity	O
in	O
cortex	B-T017
and	O
normal	B-T017
-	I-T017
appearing	I-T017
white	I-T017
matter	I-T017
(	O
na	B-T017
##w	I-T017
##m	I-T017
)	O
.	O
a	O
total	O
of	O
44	O
(	O
29	O
.	O
5	O
%	O
)	O
patients	O
were	O
ci	B-T038
.	O
compared	O
to	O
cognitively	O
preserved	O
(	O
cp	O
)	O
,	O
ci	B-T038
patients	O
had	O
higher	O
t2	O
wm	O
lesion	O
volume	O
(	O
lv	O
)	O
,	O
lower	O
nb	O
##v	O
and	O
gm	O
##v	O
,	O
and	O
more	O
severe	O
diffusivity	O
abnormalities	B-T017
in	O
wm	B-T033
lesions	I-T033
,	O
cortex	B-T017
,	O
and	O
na	B-T017
##w	I-T017
##m	I-T017
.	O
cl	B-T038
measures	O
did	O
not	B-T033
differ	I-T033
between	O
ci	O
and	O
cp	O
patients	O
.	O
cortex	B-T017
fa	O
,	O
age	O
,	O
disease	O
duration	O
,	O
t2	O
wm	O
lv	O
,	O
and	O
gm	O
##v	O
best	O
predicted	O
ms	B-T038
-	O
related	O
cognitive	B-T038
impairment	I-T038
(	O
c	O
-	O
statistic	O
=	O
0	O
.	O
88	O
)	O
.	O
[UNK]	O
diffuse	B-T082
[UNK]	O
gm	B-T017
and	O
na	B-T017
##w	I-T017
##m	I-T017
damage	O
and	O
wm	B-T033
lesions	I-T033
,	O
rather	O
than	O
intrinsic	B-T082
cl	B-T038
damage	O
,	O
contribute	O
to	O
cognitive	B-T038
impairment	I-T038
in	O
ms	B-T038
.	O

sedation	B-T058
of	O
patients	O
with	O
disorders	B-T038
of	I-T038
consciousness	I-T038
during	O
neuroimaging	B-T058
:	O
effects	O
on	O
resting	B-T058
state	I-T058
functional	I-T058
brain	I-T058
connectivity	I-T058
to	O
reduce	O
head	B-T038
movement	I-T038
during	O
resting	B-T058
state	I-T058
functional	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
,	O
post	O
-	O
coma	O
patients	O
with	O
disorders	B-T038
of	I-T038
consciousness	I-T038
(	O
doc	B-T038
)	O
are	O
frequently	O
sed	B-T058
##ated	I-T058
with	O
propofol	B-T103
.	O
however	O
,	O
little	O
is	O
known	O
about	O
the	O
effects	O
of	O
this	O
sedation	B-T058
on	O
the	O
brain	B-T082
connectivity	I-T082
patterns	I-T082
in	O
the	O
damaged	B-T037
brain	I-T037
essential	O
for	O
differential	B-T058
diagnosis	I-T058
.	O
in	O
this	O
study	B-T062
,	O
we	O
aimed	O
to	O
assess	O
these	O
effects	O
.	O
using	O
resting	B-T058
state	I-T058
functional	I-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
3t	O
data	O
obtained	O
over	O
several	O
years	O
of	O
scanning	B-T058
patients	O
for	O
diagnostic	O
and	O
research	B-T062
purposes	O
,	O
we	O
employed	O
a	O
seed	O
-	O
based	O
approach	O
to	O
examine	O
resting	O
state	O
connectivity	O
in	O
higher	O
-	O
order	O
(	O
default	O
mode	O
,	O
bilateral	B-T082
external	O
control	O
,	O
and	O
salience	O
)	O
and	O
lower	O
-	O
order	O
(	O
auditory	O
,	O
sensorimotor	O
,	O
and	O
visual	O
)	O
resting	O
state	O
networks	O
and	O
connectivity	O
with	O
the	O
thalamus	B-T017
,	O
in	O
20	O
healthy	O
uns	B-T033
##ed	I-T033
##ated	I-T033
controls	O
,	O
8	O
uns	B-T033
##ed	I-T033
##ated	I-T033
patients	O
with	O
doc	B-T038
,	O
and	O
8	O
patients	O
with	O
doc	B-T038
sed	B-T058
##ated	I-T058
with	O
propofol	B-T103
.	O
the	O
doc	B-T038
groups	O
were	O
matched	O
for	O
age	O
at	O
onset	O
,	O
etiology	O
,	O
time	B-T033
spent	I-T033
in	O
doc	B-T038
,	O
diagnosis	B-T033
,	O
standardized	O
behavioral	O
assessment	O
scores	O
,	O
movement	B-T038
intensities	O
,	O
and	O
pattern	O
of	O
structural	B-T037
brain	I-T037
injury	I-T037
(	O
as	O
assessed	O
with	O
t1	B-T058
-	I-T058
based	I-T058
voxel	I-T058
-	I-T058
based	I-T058
morphometry	I-T058
)	O
.	O
doc	B-T038
were	O
associated	O
with	O
severely	O
impaired	O
resting	O
state	O
network	O
connectivity	O
in	O
all	O
but	O
the	O
visual	O
network	O
.	O
thalamic	B-T017
connectivity	O
to	O
higher	O
-	O
order	O
network	O
regions	O
was	O
also	O
reduced	O
.	O
propofol	B-T103
administration	B-T058
to	O
patients	O
was	O
associated	O
with	O
minor	O
further	O
decreases	O
in	O
thalamic	B-T017
and	O
insular	B-T017
connectivity	O
.	O
our	O
findings	O
indicate	O
that	O
connectivity	O
decreases	O
associated	O
with	O
propofol	B-T103
sedation	B-T058
,	O
involving	O
the	O
thalamus	B-T017
and	O
insula	B-T017
,	O
are	O
relatively	O
small	O
compared	O
with	O
those	O
already	O
caused	O
by	O
doc	B-T038
-	O
associated	O
structural	B-T037
brain	I-T037
injury	I-T037
.	O
nonetheless	O
,	O
given	O
the	O
known	O
importance	O
of	O
the	O
thalamus	B-T017
in	O
brain	B-T038
arousal	I-T038
,	O
its	O
disruption	O
could	O
well	O
reflect	O
the	O
diminished	O
movement	B-T038
obtained	O
in	O
these	O
patients	O
.	O
however	O
,	O
more	O
research	B-T062
is	O
needed	O
on	O
this	O
topic	O
to	O
fully	O
address	O
the	O
research	O
question	O
.	O

effect	O
of	O
magnesium	B-T058
supplementation	I-T058
on	O
depression	B-T038
status	B-T033
in	O
depressed	B-T038
patients	O
with	O
magnesium	B-T038
deficiency	I-T038
:	O
a	O
randomized	B-T062
,	O
double	B-T062
-	I-T062
blind	I-T062
,	O
placebo	B-T062
-	I-T062
controlled	I-T062
trial	I-T062
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
determine	O
the	O
effect	O
of	O
magnesium	B-T058
supplementation	I-T058
on	O
the	O
depression	B-T038
status	B-T033
of	O
depressed	B-T038
patients	O
suffering	B-T033
from	O
magnesium	B-T038
deficiency	I-T038
.	O
sixty	B-T033
depressed	I-T033
people	I-T033
suffering	B-T033
from	O
hypo	B-T033
##ma	I-T033
##gn	I-T033
##ese	I-T033
##mia	I-T033
participated	O
in	O
this	B-T062
trial	I-T062
.	O
the	O
individuals	B-T098
were	O
randomly	B-T062
categorized	I-T062
into	O
two	O
groups	O
of	O
30	O
members	O
;	O
one	O
receiving	O
two	O
250	O
-	O
mg	O
tablets	B-T103
of	I-T103
magnesium	I-T103
oxide	I-T103
(	O
mg	B-T103
)	O
daily	O
and	O
the	O
other	O
receiving	O
placebo	B-T103
(	O
pg	B-T103
)	O
for	O
8	O
wk	O
.	O
the	O
beck	B-T058
depression	I-T058
inventory	I-T058
-	I-T058
ii	I-T058
was	O
conducted	O
and	O
the	O
concentration	O
of	O
serum	B-T058
magnesium	I-T058
was	I-T058
measured	I-T058
.	O
at	O
the	O
end	O
of	O
intervention	O
,	O
88	O
.	O
5	O
%	O
of	O
the	O
mg	B-T103
and	O
48	O
.	O
1	O
%	O
of	O
the	O
pg	B-T103
(	O
p	O
=	O
0	O
.	O
002	O
)	O
had	O
a	O
normal	B-T033
level	I-T033
of	I-T033
magnesium	I-T033
.	O
the	O
mean	O
changes	B-T033
of	I-T033
serum	I-T033
magnesium	I-T033
were	O
significantly	O
different	O
across	O
the	O
two	O
groups	O
.	O
after	O
the	O
intervention	O
,	O
the	O
mean	B-T201
beck	I-T201
score	I-T201
significantly	O
declined	O
.	O
however	O
,	O
in	O
the	O
mg	B-T103
,	O
this	O
reduction	O
was	O
more	O
significant	O
than	O
in	O
the	O
pg	B-T103
(	O
p	O
=	O
0	O
.	O
02	O
)	O
,	O
so	O
that	O
the	O
mean	O
changes	O
in	O
this	O
group	O
experienced	O
15	O
.	O
65	O
±	O
8	O
.	O
9	O
reduction	O
,	O
but	O
in	O
the	O
pg	B-T103
,	O
it	O
declined	O
by	O
10	O
.	O
40	O
±	O
7	O
.	O
9	O
.	O
daily	O
consumption	O
of	O
500	O
mg	O
magnesium	B-T103
oxide	I-T103
tablets	I-T103
for	O
≥	O
##8	O
wk	O
by	O
depressed	B-T038
patients	O
suffering	B-T033
from	O
magnesium	B-T038
deficiency	I-T038
leads	O
to	O
improvements	O
in	O
depression	B-T038
status	B-T033
and	O
magnesium	B-T033
levels	I-T033
.	O
therefore	O
,	O
assessment	B-T058
of	I-T058
the	I-T058
magnesium	I-T058
serum	I-T058
and	O
resolving	O
this	O
deficiency	B-T038
positively	O
influence	O
the	O
treatment	B-T058
of	O
depressed	B-T038
patients	O
.	O

intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
versus	O
intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
plus	O
methotrexate	B-T103
in	O
oligo	B-T038
##articular	I-T038
juvenile	I-T038
idiopathic	I-T038
arthritis	I-T038
:	O
a	O
multicentre	B-T062
,	O
prospective	B-T062
,	O
randomised	B-T062
,	O
open	B-T062
-	I-T062
label	I-T062
trial	I-T062
little	O
evidence	O
-	O
based	O
information	O
is	O
available	O
to	O
guide	B-T170
the	O
treatment	B-T058
of	O
oligo	B-T038
##articular	I-T038
juvenile	I-T038
idiopathic	I-T038
arthritis	I-T038
.	O
we	O
aimed	O
to	O
investigate	O
whether	O
oral	O
methotrexate	O
increases	O
the	O
efficacy	O
of	O
intra	B-T058
-	I-T058
articular	I-T058
corticosteroid	I-T058
therapy	I-T058
.	O
we	O
did	O
this	O
prospective	B-T062
,	O
open	B-T062
-	I-T062
label	I-T062
,	O
randomised	B-T062
trial	I-T062
at	O
ten	O
hospitals	B-T092
in	O
italy	B-T082
.	O
using	O
a	O
conceal	O
##ed	O
computer	B-T170
-	I-T170
generated	I-T170
list	I-T170
,	O
children	O
younger	O
than	O
18	O
years	O
with	O
oligo	B-T082
##articular	I-T082
-	O
onset	O
disease	O
were	O
randomly	O
assigned	O
(	O
1	O
:	O
1	O
)	O
to	O
intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
alone	O
or	O
in	O
combination	O
with	O
oral	O
methotrexate	O
(	O
15	O
mg	O
/	O
m	O
(	O
2	O
)	O
;	O
maximum	O
20	O
mg	O
)	O
.	O
corticosteroids	B-T103
used	O
were	O
triamcinolone	B-T103
hexa	I-T103
##cet	I-T103
##onide	I-T103
(	O
shoulder	B-T082
,	O
elbow	B-T082
,	O
wrist	B-T082
,	O
knee	B-T082
,	O
and	O
tib	B-T082
##io	I-T082
##tal	I-T082
##ar	I-T082
joints	I-T082
)	O
or	O
methylprednisolone	B-T103
acetate	I-T103
(	O
ie	O
,	O
subt	B-T082
##ala	I-T082
##r	I-T082
and	O
tars	B-T082
##al	I-T082
joints	I-T082
)	O
.	O
we	O
did	O
not	O
mask	O
patients	O
or	O
investigators	B-T097
to	O
treatment	B-T058
assignments	O
.	O
our	O
primary	O
outcome	O
was	O
the	O
proportion	O
of	O
patients	O
in	O
the	O
intention	B-T062
-	I-T062
to	I-T062
-	I-T062
treat	I-T062
population	B-T098
who	O
had	O
remission	B-T033
of	O
arthritis	B-T038
in	O
all	O
injected	B-T058
joints	B-T082
at	O
12	O
months	O
.	O
this	O
trial	B-T062
is	O
registered	B-T058
with	O
european	O
union	O
clinical	O
trials	O
register	O
,	O
eud	B-T170
##ra	I-T170
##ct	I-T170
number	I-T170
2008	O
-	O
006	O
##74	O
##1	O
-	O
70	O
.	O
between	O
july	O
7	O
,	O
2009	O
,	O
and	O
march	O
31	O
,	O
2013	O
,	O
we	O
screened	O
226	O
participants	B-T098
and	O
randomly	O
assigned	O
102	O
to	O
intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
alone	O
and	O
105	O
to	O
intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
plus	O
methotrexate	B-T103
.	O
33	O
(	O
32	O
%	O
)	O
patients	O
assigned	O
to	O
intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
alone	O
and	O
39	O
(	O
37	O
%	O
)	O
assigned	O
to	O
intra	B-T082
-	I-T082
articular	I-T082
corticosteroids	B-T103
and	O
methotrexate	B-T103
therapy	B-T058
had	O
remission	B-T033
of	O
arthritis	B-T038
in	O
all	O
injected	B-T058
joints	B-T082
(	O
p	O
=	O
0	O
·	O
48	O
)	O
.	O
adverse	B-T038
events	I-T038
were	O
recorded	O
for	O
20	O
(	O
17	O
%	O
)	O
patients	O
who	O
received	O
methotrexate	B-T103
,	O
which	O
led	O
to	O
permanent	O
treatment	B-T058
discontinuation	B-T033
in	O
two	O
patients	O
(	O
one	O
due	O
to	O
increased	B-T033
liver	I-T033
transaminase	I-T033
##s	I-T033
and	O
one	O
due	O
to	O
gastrointestinal	B-T033
discomfort	I-T033
)	O
.	O
no	B-T033
patient	O
had	O
a	O
serious	O
adverse	B-T038
event	I-T038
.	O
concomitant	O
administration	O
of	O
methotrexate	B-T103
did	O
not	O
augment	O
the	O
effectiveness	O
of	O
intra	B-T058
-	I-T058
articular	I-T058
corticosteroid	I-T058
therapy	I-T058
.	O
future	B-T062
studies	I-T062
are	O
needed	O
to	O
define	O
the	O
optimal	O
therapeutic	B-T058
strategies	I-T058
for	O
oligo	B-T038
##articular	I-T038
juvenile	I-T038
idiopathic	I-T038
arthritis	I-T038
.	O
italian	B-T092
agency	I-T092
of	I-T092
drug	I-T092
evaluation	I-T092
.	O

microbiome	O
##s	O
of	O
mur	B-T204
##ice	I-T204
##a	I-T204
californ	I-T204
##ica	I-T204
and	O
m	B-T204
.	I-T204
fru	I-T204
##tic	I-T204
##osa	I-T204
:	O
comparative	O
analyses	O
of	O
two	O
co	O
-	O
occurring	O
eastern	B-T082
pacific	I-T082
oct	B-T204
##ocor	I-T204
##als	I-T204
oct	B-T204
##ocor	I-T204
##als	I-T204
are	O
sources	O
of	O
novel	O
but	O
underst	B-T062
##udied	I-T062
microbial	O
diversity	O
.	O
conversely	O
,	O
scler	B-T204
##actin	I-T204
##ian	I-T204
or	O
reef	O
-	O
building	O
coral	O
microbiome	O
##s	O
have	O
been	O
heavily	O
examined	B-T033
in	O
light	O
of	O
the	O
threats	O
of	O
climate	O
change	O
.	O
mur	B-T204
##ice	I-T204
##a	I-T204
californ	I-T204
##ica	I-T204
and	O
mur	B-T204
##ice	I-T204
##a	I-T204
fru	I-T204
##tic	I-T204
##osa	I-T204
are	O
two	O
co	B-T170
-	I-T170
occurring	I-T170
species	I-T170
of	O
gor	B-T204
##go	I-T204
##nia	I-T204
##n	I-T204
oct	I-T204
##ocor	I-T204
##al	I-T204
abundantly	B-T033
found	I-T033
in	O
the	O
kel	B-T204
##p	I-T204
forests	O
of	O
southern	B-T082
california	I-T082
,	O
and	O
thus	O
provide	O
an	O
excellent	O
basis	O
to	O
determine	O
if	O
oct	B-T204
##ocor	I-T204
##al	I-T204
microbiome	O
##s	O
are	O
host	O
specific	O
.	O
using	O
illumina	B-T170
mis	I-T170
##e	I-T170
##q	I-T170
amplicon	I-T170
sequencing	I-T170
and	O
replicate	O
samples	O
,	O
we	O
evaluated	O
the	O
microbiome	O
##s	O
collected	O
from	O
multiple	O
colonies	O
of	O
both	O
species	B-T170
of	O
mur	B-T204
##ice	I-T204
##a	I-T204
to	O
measure	O
both	O
inter	B-T017
-	I-T017
and	O
intra	B-T017
-	I-T017
colony	I-T017
microbiome	O
vari	O
##abilities	O
.	O
in	O
addition	O
,	O
microbiome	O
##s	O
from	O
overlying	O
sea	O
water	O
and	O
nearby	O
zo	B-T204
##anth	I-T204
##ids	I-T204
(	O
another	O
benthic	B-T204
invertebrate	I-T204
)	O
were	O
also	O
included	O
in	O
the	O
analysis	B-T062
to	O
evaluate	O
whether	O
bacterial	O
taxa	O
specifically	O
associate	O
with	O
oct	B-T204
##ocor	I-T204
##als	I-T204
.	O
this	O
is	O
also	O
the	O
first	B-T170
report	I-T170
of	O
microbiome	O
##s	O
from	O
these	O
species	B-T170
of	O
mur	B-T204
##ice	I-T204
##a	I-T204
.	O
we	O
show	O
that	O
microbiome	O
##s	O
isolated	O
from	O
each	O
sample	O
type	O
are	O
distinct	O
,	O
and	O
specifically	O
,	O
that	O
oct	B-T204
##ocor	I-T204
##al	I-T204
species	B-T170
type	O
had	O
the	O
greatest	O
effect	O
on	O
predicting	O
the	O
composition	B-T201
of	O
the	O
mur	B-T204
##ice	I-T204
##a	I-T204
microbiome	O
.	O
bacterial	O
taxa	O
contributing	O
to	O
compositional	O
differences	O
include	O
distinct	O
strains	O
of	O
mycoplasma	B-T007
associated	O
with	O
either	O
m	B-T204
.	I-T204
californ	I-T204
##ica	I-T204
or	O
m	B-T204
.	I-T204
fru	I-T204
##tic	I-T204
##osa	I-T204
,	O
an	O
abundance	O
of	O
spiroch	B-T007
##ae	I-T007
##tes	I-T007
observed	O
on	O
m	B-T204
.	I-T204
californ	I-T204
##ica	I-T204
,	O
and	O
a	O
greater	O
diversity	O
of	O
γ	B-T007
-	I-T007
proteobacteria	I-T007
associated	O
with	O
m	B-T204
.	I-T204
fru	I-T204
##tic	I-T204
##osa	I-T204
.	O
many	O
of	O
the	O
bacterial	O
taxa	O
contributing	O
to	O
these	O
differences	O
are	O
known	O
for	O
their	O
presence	B-T033
in	O
photos	B-T204
##ymb	I-T204
##ion	I-T204
##t	I-T204
-	I-T204
containing	I-T204
invertebrate	I-T204
microbiome	O
##s	O
.	O

evaluation	B-T058
of	O
response	O
from	O
ax	B-T103
##itinib	I-T103
per	O
response	B-T170
evaluation	I-T170
criteria	I-T170
in	I-T170
solid	I-T170
tumors	I-T170
versus	O
cho	O
##i	O
criteria	O
in	O
previously	O
treated	B-T033
patients	O
with	O
metastatic	B-T038
renal	I-T038
cell	I-T038
carcinoma	I-T038
ax	B-T103
##itinib	I-T103
,	O
a	O
selective	O
and	O
potent	O
tyrosine	B-T103
kinase	I-T103
inhibitor	I-T103
of	O
vascular	B-T103
endothelial	I-T103
growth	I-T103
factor	I-T103
receptors	I-T103
,	O
was	O
available	O
to	O
patients	O
from	O
canada	B-T082
and	O
australia	B-T082
,	O
prior	O
to	O
regulatory	O
approval	B-T170
of	O
ax	B-T103
##itinib	I-T103
in	O
these	O
countries	B-T082
,	O
for	O
treatment	B-T058
of	O
clear	B-T038
-	I-T038
cell	I-T038
metastatic	I-T038
renal	I-T038
cell	I-T038
carcinoma	I-T038
(	O
mrc	B-T038
##c	I-T038
)	O
after	O
failure	O
of	O
one	O
prior	O
systemic	O
regimen	B-T058
.	O
this	O
single	B-T062
-	I-T062
arm	I-T062
,	O
open	B-T062
-	I-T062
label	I-T062
study	I-T062
of	O
ax	B-T103
##itinib	I-T103
evaluated	O
the	O
efficacy	B-T062
,	O
safety	B-T062
,	O
and	O
quality	O
of	O
life	O
(	O
qol	O
)	O
in	O
patients	O
with	O
mrc	B-T038
##c	I-T038
whose	O
disease	B-T038
progressed	B-T038
after	O
one	O
prior	O
systemic	O
first	B-T058
-	I-T058
line	I-T058
regimen	I-T058
.	O
primary	O
objective	O
was	O
objective	O
response	O
rate	O
evaluated	B-T058
per	O
response	B-T170
evaluation	I-T170
criteria	I-T170
in	I-T170
solid	I-T170
tumors	I-T170
(	O
rec	B-T170
##ist	I-T170
)	O
and	O
cho	O
##i	O
criteria	O
.	O
progression	O
-	O
free	O
survival	O
,	O
overall	O
survival	O
,	O
safety	B-T062
,	O
and	O
qol	O
were	O
secondary	O
end	O
points	O
.	O
due	O
to	O
the	O
small	O
study	B-T062
size	O
,	O
analyses	O
comprised	O
of	O
descriptive	O
statistics	B-T062
.	O
fifteen	O
patients	O
were	O
recruited	O
,	O
five	O
from	O
canada	B-T082
and	O
ten	O
from	O
australia	B-T082
,	O
over	O
a	O
limited	O
recruitment	O
period	O
.	O
thirteen	O
patients	O
received	O
sunitinib	B-T103
as	O
prior	O
therapy	B-T058
.	O
all	O
patients	O
had	O
clear	B-T038
-	I-T038
cell	I-T038
carcinoma	I-T038
,	O
eleven	O
had	O
prior	O
nephrectomy	B-T058
.	O
liver	B-T017
,	O
lung	B-T017
,	O
and	O
lymph	B-T017
nodes	I-T017
were	O
the	O
most	O
frequent	O
sites	O
of	O
metastases	B-T038
;	O
one	O
patient	O
had	O
brain	B-T038
metastasis	I-T038
.	O
median	O
time	O
on	O
ax	B-T103
##itinib	I-T103
was	O
118	O
.	O
0	O
days	O
(	O
range	O
:	O
3	O
.	O
5	O
-	O
64	O
##5	O
.	O
0	O
days	O
)	O
;	O
estimated	O
survival	O
probability	O
at	O
12	O
months	O
was	O
57	O
.	O
8	O
%	O
.	O
two	O
(	O
13	O
.	O
3	O
%	O
)	O
patients	O
had	O
objective	O
responses	O
per	O
rec	B-T170
##ist	I-T170
versus	O
nine	O
(	O
60	O
.	O
0	O
%	O
)	O
per	O
cho	O
##i	O
criteria	O
.	O
six	O
patients	O
had	O
progressive	B-T038
disease	B-T038
based	O
on	O
rec	B-T170
##ist	I-T170
versus	O
three	O
per	O
cho	O
##i	O
criteria	O
.	O
nine	O
(	O
60	O
.	O
0	O
%	O
)	O
events	O
of	O
progression	B-T038
or	O
death	B-T038
occurred	O
by	O
the	O
end	O
of	O
study	B-T062
,	O
and	O
three	O
patients	O
continued	O
to	O
receive	O
the	O
study	B-T062
drug	B-T103
.	O
fatigue	B-T033
(	O
33	O
%	O
)	O
and	O
diarrhea	B-T033
(	O
20	O
%	O
)	O
were	O
the	O
most	O
common	O
grade	O
≥3	O
all	O
-	O
causality	O
,	O
treatment	B-T058
-	O
emergent	O
adverse	B-T038
events	I-T038
.	O
the	O
mean	O
change	O
in	O
european	B-T082
quality	O
of	O
life	O
-	O
5	O
dimensions	O
score	O
from	O
baseline	O
to	O
end	O
of	O
treatment	B-T058
was	O
-	O
0	O
.	O
08	O
##37	O
.	O
the	O
small	O
number	O
of	O
patients	O
and	O
lack	O
of	O
a	O
compar	O
##ator	O
arm	O
limit	O
the	O
ability	O
to	O
draw	O
definitive	O
conclusions	O
;	O
however	O
,	O
safety	B-T062
and	O
efficacy	B-T062
profiles	O
of	O
ax	B-T103
##itinib	I-T103
were	O
consistent	O
with	O
reports	O
from	O
previous	O
studies	B-T062
in	O
patients	O
with	O
mrc	B-T038
##c	I-T038
,	O
and	O
patients	O
generally	O
maintained	O
qol	O
.	O
the	O
size	O
##able	O
difference	O
observed	O
in	O
objective	O
response	O
rate	O
by	O
rec	B-T170
##ist	I-T170
versus	O
cho	O
##i	O
criteria	O
merits	O
further	O
research	B-T062
.	O

beyond	O
neutral	O
and	O
for	O
##bi	O
##dd	O
##en	O
links	O
:	O
morphological	B-T082
matches	O
and	O
the	O
assembly	O
of	O
mutual	O
##istic	O
haw	B-T204
##k	I-T204
##mo	I-T204
##th	I-T204
-	O
plant	B-T204
networks	O
a	O
major	O
challenge	O
in	O
evolutionary	O
ecology	O
is	O
to	O
understand	O
how	O
co	O
-	O
evolutionary	O
processes	O
shape	O
patterns	B-T082
of	O
interactions	O
between	O
species	B-T170
at	O
community	O
level	O
.	O
pollination	B-T038
of	O
flowers	B-T204
with	O
long	B-T204
cor	I-T204
##oll	I-T204
##a	I-T204
tubes	I-T204
by	O
long	B-T204
-	I-T204
tongue	I-T204
##d	I-T204
haw	I-T204
##k	I-T204
##mo	I-T204
##ths	I-T204
has	O
been	O
inv	O
##oked	O
as	O
a	O
show	O
##ca	O
##se	O
model	O
of	O
co	B-T038
-	I-T038
evolution	I-T038
.	O
recently	O
,	O
optimal	O
foraging	O
models	O
have	O
predicted	O
that	O
there	O
might	O
be	O
a	O
close	O
association	O
between	O
mouth	O
##parts	O
'	O
length	O
and	O
the	O
cor	B-T204
##oll	I-T204
##a	I-T204
depth	B-T082
of	O
the	O
visited	O
flowers	B-T204
,	O
thus	O
favour	O
##ing	O
trait	O
convergence	O
and	O
specialization	O
at	O
community	O
level	O
.	O
here	O
,	O
we	O
assessed	O
whether	O
haw	B-T204
##k	I-T204
##mo	I-T204
##ths	I-T204
more	O
frequently	O
poll	B-T204
##inate	I-T204
plants	I-T204
with	O
floral	B-T170
tube	I-T170
lengths	O
similar	O
to	O
their	O
prob	B-T204
##osc	I-T204
##is	I-T204
lengths	O
(	O
morphological	B-T082
match	O
hypothesis	O
)	O
against	O
abundance	O
-	O
based	O
processes	O
(	O
neutral	O
hypothesis	O
)	O
and	O
ecological	O
trait	O
mismatches	O
constraints	O
(	O
for	O
##bi	O
##dd	O
##en	O
links	O
hypothesis	O
)	O
,	O
and	O
how	O
these	O
processes	O
structure	B-T082
haw	B-T204
##k	I-T204
##mo	I-T204
##th	I-T204
-	O
plant	B-T204
mutual	O
##istic	O
networks	O
from	O
five	O
communities	O
in	O
four	O
bioge	B-T082
##ographical	I-T082
regions	I-T082
of	O
south	B-T082
america	I-T082
.	O
we	O
found	O
convergence	O
in	O
morphological	B-T082
traits	O
across	O
the	O
five	O
communities	O
and	O
that	O
the	O
distribution	O
of	O
morphological	B-T082
differences	O
between	O
haw	B-T204
##k	I-T204
##mo	I-T204
##ths	I-T204
and	O
plants	B-T204
is	O
consistent	O
with	O
expectations	O
under	O
the	O
morphological	B-T082
match	O
hypothesis	O
in	O
three	O
of	O
the	O
five	O
communities	O
.	O
in	O
the	O
two	O
remaining	O
communities	O
,	O
which	O
are	O
eco	O
##ton	O
##es	O
between	O
two	O
distinct	O
bioge	B-T082
##ographical	I-T082
areas	I-T082
,	O
interactions	O
are	O
better	O
predicted	O
by	O
the	O
neutral	O
hypothesis	O
.	O
our	O
findings	O
are	O
consistent	O
with	O
the	O
idea	O
that	O
diffuse	O
co	B-T038
-	I-T038
evolution	I-T038
drives	O
the	O
evolution	B-T038
of	O
extremely	O
long	B-T204
prob	I-T204
##osc	I-T204
##ises	I-T204
and	O
flower	B-T204
tubes	I-T204
,	O
and	O
highlight	O
the	O
importance	O
of	O
morphological	B-T082
traits	O
,	O
beyond	O
the	O
for	O
##bi	O
##dd	O
##en	O
links	O
hypothesis	O
,	O
in	O
structuring	O
interactions	O
between	O
mutual	O
##istic	O
partners	O
,	O
revealing	O
that	O
the	O
role	O
of	O
niche	O
-	O
based	O
processes	O
can	O
be	O
much	O
more	O
complex	O
than	O
previously	O
known	O
.	O

assessment	O
of	O
groundwater	B-T082
vulnerability	O
in	O
the	O
da	O
##ule	O
aqu	O
##ifer	O
,	O
ec	B-T082
##ua	I-T082
##d	I-T082
##or	I-T082
,	O
using	O
the	O
susceptibility	B-T058
index	I-T058
method	I-T058
the	O
gu	B-T082
##aya	I-T082
##s	I-T082
region	I-T082
in	O
ec	B-T082
##ua	I-T082
##d	I-T082
##or	I-T082
is	O
economically	O
very	O
important	O
,	O
producing	O
68	O
%	O
of	O
the	O
national	B-T204
crops	I-T204
.	O
the	O
main	O
agricultural	O
activities	O
threat	O
##en	O
the	O
groundwater	B-T082
there	O
##in	O
with	O
nitrate	B-T103
contamination	O
given	O
the	O
large	O
fertil	B-T103
##iser	I-T103
and	O
water	B-T103
needs	O
.	O
the	O
present	O
work	O
tests	O
the	O
applicability	O
of	O
the	O
susceptibility	B-T058
index	I-T058
assessment	I-T058
method	I-T058
in	O
evaluating	O
the	O
impact	O
of	O
agricultural	O
activities	O
on	O
groundwater	B-T082
quality	O
,	O
using	O
as	O
a	O
case	O
study	O
an	O
aqu	O
##ifer	O
of	O
the	O
gu	B-T082
##aya	I-T082
##s	I-T082
river	B-T082
basin	I-T082
in	O
ec	B-T082
##ua	I-T082
##d	I-T082
##or	I-T082
.	O
the	O
index	O
adapt	O
##s	O
four	O
parameters	O
of	O
the	O
drastic	B-T058
method	I-T058
and	O
incorporated	O
a	O
new	O
land	O
use	O
parameter	O
.	O
results	O
show	O
that	O
the	O
areas	B-T082
highly	O
vulnerable	O
to	O
contamination	O
are	O
located	O
in	O
irrigation	O
peri	B-T082
##meter	I-T082
##s	I-T082
of	O
dominant	O
pad	B-T082
##dy	I-T082
fields	I-T082
associated	O
with	O
the	O
high	O
rech	O
##arge	O
rates	O
in	O
the	O
all	B-T103
##uv	I-T103
##ial	I-T103
deposits	I-T103
.	O
respectively	O
,	O
moderately	O
vulnerable	O
and	O
low	O
-	O
vulnerability	O
areas	B-T082
correspond	O
to	O
aquatic	O
environments	O
and	O
forests	O
,	O
semi	B-T082
-	I-T082
natural	I-T082
zones	I-T082
and	O
water	O
bodies	O
.	O
one	O
of	O
the	O
main	O
contributions	O
of	O
the	O
da	O
##ule	O
aqu	O
##ifer	O
vulnerability	O
is	O
likely	O
its	O
wide	B-T082
,	O
flat	B-T082
topography	I-T082
.	O
a	O
great	O
part	O
of	O
the	O
aqu	O
##ifer	O
is	O
at	O
high	O
risk	O
of	O
contamination	O
by	O
nitrate	B-T103
##s	I-T103
if	O
a	O
code	O
of	O
good	O
agricultural	O
practices	O
is	O
not	O
applied	O
.	O
therefore	O
the	O
implementation	O
of	O
a	O
monitoring	B-T033
network	I-T033
to	I-T033
control	I-T033
the	O
nitrate	B-T103
##s	I-T103
concentrations	O
is	O
the	O
first	O
step	O
to	O
assure	O
groundwater	B-T082
quality	O
for	O
drinking	O
purposes	O
.	O

epigenetic	B-T062
editing	I-T062
of	O
asc	B-T017
##l1	I-T017
gene	I-T017
in	O
neural	B-T017
stem	I-T017
cells	I-T017
by	O
opto	B-T062
##gene	I-T062
##tics	I-T062
enzymes	B-T103
involved	O
in	O
epigenetic	B-T038
processes	I-T038
such	O
as	O
methyltransferase	B-T103
##s	I-T103
or	O
demethyl	B-T103
##ases	I-T103
are	O
becoming	O
highly	O
utilized	O
for	O
their	O
persistent	B-T103
dna	I-T103
or	O
histone	B-T038
modifying	I-T038
efficacy	O
.	O
herein	O
,	O
we	O
have	O
developed	O
an	O
opto	B-T062
##gene	I-T062
##tic	I-T062
tool	B-T170
##box	I-T170
fused	O
to	O
the	O
catalytic	B-T082
domain	I-T082
(	O
cd	B-T082
)	O
of	O
dna	B-T103
-	I-T103
methyltransferase	I-T103
##3a	I-T103
(	O
dnmt	B-T103
##3a	I-T103
-	O
cd	B-T082
)	O
or	O
ten	B-T103
-	I-T103
eleven	I-T103
dioxygenase	I-T103
-	I-T103
1	I-T103
(	O
tet	B-T103
##1	I-T103
-	O
cd	B-T082
)	O
for	O
loci	B-T082
-	O
specific	O
alteration	B-T038
of	O
the	O
methylation	B-T038
state	O
at	O
the	O
promoter	B-T103
of	O
asc	B-T017
##l1	I-T017
(	O
mas	B-T017
##h1	I-T017
)	O
,	O
a	O
candidate	B-T017
prone	I-T017
##uron	I-T017
gene	I-T017
.	O
opto	B-T103
##gene	I-T103
##tical	I-T103
protein	I-T103
pairs	I-T103
,	O
cry	B-T103
##2	I-T103
linked	O
to	O
dnmt	B-T103
##3a	I-T103
-	O
cd	B-T082
or	O
tet	B-T103
##1	I-T103
-	O
cd	B-T082
and	O
ci	B-T103
##b1	I-T103
fused	O
to	O
a	O
transcription	B-T103
activator	I-T103
-	I-T103
like	I-T103
element	I-T103
(	O
tal	B-T103
##e	I-T103
)	O
loc	O
##ating	O
an	O
asc	B-T017
##l1	I-T017
promoter	B-T103
region	I-T103
,	O
were	O
designed	O
for	O
site	B-T082
specific	I-T082
epigenetic	B-T062
editing	I-T062
.	O
a	O
differentially	O
methylated	O
region	O
at	O
the	O
asc	B-T017
##l1	I-T017
promoter	B-T103
,	O
isolated	O
from	O
murine	B-T204
dorsal	B-T017
root	I-T017
ganglion	I-T017
(	O
hyper	B-T038
##methyl	I-T038
##ated	I-T038
)	O
and	O
striated	O
cells	B-T017
(	O
hypo	B-T038
##methyl	I-T038
##ated	I-T038
)	O
,	O
was	O
targeted	O
with	O
these	O
opto	B-T103
##gene	I-T103
##tic	I-T103
-	I-T103
epigenetic	I-T103
constructs	I-T103
.	O
optimized	O
blue	O
-	O
light	O
illumination	B-T058
triggered	O
the	O
co	O
-	O
localization	O
of	O
tal	B-T103
##e	I-T103
constructs	I-T103
with	O
dnmt	B-T103
##3a	I-T103
-	O
cd	B-T082
or	O
tet	B-T103
##1	I-T103
-	O
cd	B-T082
fusion	B-T103
proteins	I-T103
at	O
the	O
targeted	O
site	O
of	O
the	O
asc	B-T017
##l1	I-T017
promoter	B-T103
.	O
we	O
found	O
that	O
this	O
spatiotemporal	O
association	O
of	O
the	O
fusion	B-T103
proteins	I-T103
selectively	O
alters	O
the	O
methylation	B-T038
state	O
and	O
also	O
regulates	B-T038
gene	B-T038
activity	I-T038
.	O
this	O
proof	O
of	O
concept	O
developed	O
herein	O
holds	O
imm	O
##ense	O
promise	O
for	O
the	O
ability	O
to	O
regulate	B-T038
gene	B-T038
activity	I-T038
via	O
epigenetic	B-T062
modulation	I-T062
with	O
spatiotemporal	O
precision	O
.	O

assessment	B-T058
of	O
vascular	B-T074
stent	I-T074
heating	O
with	O
repetitive	B-T058
transcranial	I-T058
magnetic	I-T058
stimulation	I-T058
a	O
high	O
proportion	O
of	O
patients	O
with	O
stroke	B-T038
do	O
not	O
qual	O
##ify	O
for	O
repetitive	B-T058
transcranial	I-T058
magnetic	I-T058
stimulation	I-T058
(	O
rtms	B-T058
)	O
clinical	B-T062
studies	I-T062
due	O
to	O
the	O
presence	O
of	O
metallic	B-T074
stents	I-T074
.	O
the	O
ultimate	O
concern	O
is	O
that	O
any	O
metal	B-T103
could	O
become	O
heated	O
due	O
to	O
ed	O
##dy	O
currents	O
.	O
however	O
,	O
to	O
date	O
,	O
no	O
clinical	B-T170
safety	I-T170
data	I-T170
are	O
available	O
regarding	O
the	O
risk	O
of	O
metallic	B-T074
stents	I-T074
heating	O
with	O
rtms	B-T058
.	O
we	O
tested	O
the	O
safety	B-T062
of	O
common	O
rtms	B-T058
protocols	B-T170
(	O
1	O
hz	O
and	O
10	O
hz	O
)	O
with	O
stents	B-T074
used	O
commonly	O
in	O
stroke	B-T038
,	O
nit	B-T103
##inol	I-T103
and	O
el	B-T103
##gi	I-T103
##lo	I-T103
##y	I-T103
.	O
in	O
our	O
method	O
,	O
stents	B-T074
were	O
tested	B-T170
in	O
gel	O
##led	O
saline	O
at	O
2	O
different	O
locations	B-T082
:	O
at	B-T082
the	I-T082
center	I-T082
and	O
at	O
the	O
lobe	B-T017
of	O
the	O
coil	B-T074
.	O
in	O
addition	O
,	O
at	O
each	O
location	B-T082
,	O
stent	B-T074
heating	O
was	O
evaluated	B-T058
in	O
3	O
different	O
orientations	B-T082
:	O
parallel	O
to	O
the	O
long	B-T082
axis	I-T082
of	O
coil	B-T074
,	O
parallel	O
to	O
the	O
short	B-T082
axis	I-T082
of	O
the	O
coil	B-T074
,	O
and	O
perpendicular	B-T082
to	O
the	O
plane	O
of	O
the	O
coil	B-T074
.	O
we	O
found	O
that	O
stents	B-T074
did	O
not	O
heat	O
to	O
more	O
than	O
1	O
##°c	O
with	O
either	O
1	O
hz	O
rtms	B-T058
or	O
10	O
hz	O
rtms	B-T058
in	O
any	O
configuration	O
or	O
orientation	B-T082
.	O
heating	O
in	O
general	O
was	O
greater	O
at	O
the	O
lobe	B-T017
when	O
the	O
stent	B-T074
was	O
oriented	B-T082
perpendicular	B-T082
##ly	I-T082
.	O
our	O
study	O
represents	O
a	O
new	O
method	O
for	O
ex	O
vivo	O
quantification	O
of	O
stent	B-T074
heating	O
.	O
we	O
have	O
found	O
that	O
heating	O
of	O
stents	B-T074
was	O
well	O
below	O
the	O
food	B-T092
and	I-T092
drug	I-T092
administration	I-T092
standards	B-T170
of	O
2	O
##°c	O
.	O
thus	O
,	O
our	O
study	O
pav	O
##es	O
the	O
way	O
for	O
in	B-T082
vivo	I-T082
testing	O
of	O
rtms	B-T058
(	O
≤	O
##10	O
hz	O
)	O
in	O
the	O
presence	O
of	O
implanted	B-T074
magnetic	B-T058
resonance	I-T058
imaging	I-T058
-	O
compatible	O
stents	B-T074
in	O
animal	B-T204
studies	I-T204
.	O
when	O
planning	O
human	B-T204
safety	B-T062
studies	I-T062
though	O
,	O
geometry	O
,	O
orientation	B-T082
,	O
and	O
location	B-T082
relative	O
to	O
the	O
coil	B-T074
would	O
be	O
important	O
to	O
consider	O
as	O
well	O
.	O

chemical	O
composition	O
and	O
amino	B-T103
acid	I-T103
digestibility	O
of	O
soybean	B-T168
meal	I-T168
produced	O
in	O
the	O
united	B-T082
states	I-T082
,	O
china	B-T082
,	O
argentina	B-T082
,	O
brazil	B-T082
,	O
or	O
india	B-T082
an	O
experiment	O
was	O
conducted	O
to	O
compare	O
nutritional	O
composition	O
of	O
soybean	B-T168
meal	I-T168
(	O
sb	B-T168
##m	I-T168
)	O
produced	O
in	O
china	B-T082
,	O
argentina	B-T082
,	O
brazil	B-T082
,	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
,	O
or	O
india	B-T082
and	O
the	O
apparent	O
ileal	O
digestibility	O
(	O
aid	O
)	O
and	O
the	O
standardized	O
ileal	O
digestibility	O
(	O
sid	O
)	O
of	O
cp	B-T103
and	O
aa	B-T103
in	O
these	O
sb	B-T168
##m	I-T168
when	O
fed	O
to	O
growing	O
pigs	B-T204
.	O
five	O
sources	O
of	O
sb	B-T168
##m	I-T168
from	O
china	B-T082
,	O
argentina	B-T082
,	O
brazil	B-T082
,	O
and	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
,	O
and	O
4	O
sources	O
from	O
india	B-T082
were	O
collected	O
for	O
a	O
total	O
of	O
24	O
sources	O
of	O
sb	B-T168
##m	I-T168
.	O
all	O
samples	O
were	O
analyzed	O
for	O
energy	O
,	O
dm	O
,	O
and	O
nutrients	B-T168
,	O
and	O
each	O
source	O
was	O
included	O
in	O
a	O
corn	B-T103
##st	I-T103
##arch	I-T103
based	I-T103
diet	I-T103
in	O
which	O
sb	B-T168
##m	I-T168
was	O
the	O
only	O
aa	B-T103
contributing	O
ingredient	B-T103
.	O
an	O
n	B-T168
-	I-T168
free	I-T168
diet	I-T168
was	O
also	O
formulated	O
.	O
twenty	O
-	O
five	O
barr	O
##ows	O
(	O
initial	O
bw	O
:	O
30	O
.	O
53	O
±	O
1	O
.	O
73	O
kg	O
)	O
were	O
equipped	O
with	O
a	O
t	O
-	O
cannula	O
in	O
the	O
distal	B-T082
ileum	I-T082
and	O
randomly	O
allo	O
##tt	O
##ed	O
to	O
a	O
25	O
×	O
8	O
you	B-T062
##den	I-T062
square	I-T062
design	I-T062
with	O
25	O
diets	B-T168
and	O
8	O
periods	O
.	O
results	O
indicate	O
that	O
the	O
concentration	O
of	O
cp	B-T103
was	O
greater	O
(	O
<	O
0	O
.	O
05	O
)	O
in	O
sb	B-T168
##m	I-T168
from	O
brazil	B-T082
and	O
india	B-T082
(	O
49	O
.	O
3	O
and	O
49	O
.	O
5	O
%	O
,	O
respectively	O
)	O
than	O
in	O
sb	B-T168
##m	I-T168
from	O
china	B-T082
,	O
argentina	B-T082
,	O
or	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
(	O
45	O
.	O
1	O
,	O
46	O
.	O
7	O
,	O
and	O
47	O
.	O
3	O
%	O
,	O
respectively	O
,	O
as	O
-	O
fed	O
basis	O
)	O
.	O
the	O
concentration	O
of	O
most	O
indispensable	O
aa	B-T103
followed	O
the	O
same	O
pattern	O
as	O
cp	B-T103
with	O
the	O
exception	O
that	O
sb	B-T168
##m	I-T168
from	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
contained	O
more	O
(	O
<	O
0	O
.	O
05	O
)	O
indispensable	O
aa	B-T103
than	O
sb	B-T168
##m	I-T168
from	O
china	B-T082
or	O
argentina	B-T082
.	O
however	O
,	O
sb	B-T168
##m	I-T168
from	O
india	B-T082
contained	O
more	O
(	O
<	O
0	O
.	O
05	O
)	O
trypsin	B-T103
inhibitors	I-T103
than	O
sb	B-T168
##m	I-T168
from	O
the	O
other	O
countries	B-T082
.	O
a	O
greater	O
(	O
<	O
0	O
.	O
05	O
)	O
aid	O
and	O
sid	O
of	O
cp	B-T103
and	O
most	O
aa	B-T103
was	O
observed	O
in	O
sb	B-T168
##m	I-T168
from	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
compared	O
with	O
sb	B-T168
##m	I-T168
from	O
brazil	B-T082
,	O
argentina	B-T082
,	O
and	O
india	B-T082
,	O
but	O
there	O
were	O
no	O
differences	O
between	O
sb	B-T168
##m	I-T168
from	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
and	O
sb	B-T168
##m	I-T168
from	O
china	B-T082
.	O
however	O
,	O
because	O
of	O
the	O
lower	O
concentration	O
of	O
aa	B-T103
in	O
sb	B-T168
##m	I-T168
from	O
china	B-T082
,	O
the	O
concentration	O
of	O
standardized	O
ileal	O
digestib	O
##le	O
aa	B-T103
in	O
sb	B-T168
##m	I-T168
from	O
china	B-T082
was	O
less	O
(	O
<	O
0	O
.	O
05	O
)	O
than	O
in	O
sb	B-T168
##m	I-T168
from	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
soybean	O
meal	O
from	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	O
or	O
brazil	B-T082
had	O
less	O
(	O
<	O
0	O
.	O
05	O
)	O
variability	O
in	O
sid	O
values	O
than	O
sb	B-T168
##m	I-T168
from	O
argentina	B-T082
,	O
china	B-T082
,	O
or	O
india	B-T082
.	O
in	O
conclusion	O
,	O
the	O
sid	O
of	O
cp	B-T103
and	O
aa	B-T103
is	O
dependent	O
on	O
the	O
country	B-T082
where	O
the	O
sb	B-T168
##m	I-T168
is	O
produced	O
.	O
this	O
difference	O
and	O
the	O
variability	O
within	O
each	O
country	B-T082
should	O
be	O
evaluated	O
when	O
formula	B-T058
##ting	I-T058
diets	I-T058
for	O
pigs	B-T204
.	O

peptide	B-T103
-	O
mediated	O
interference	O
of	O
pb	B-T103
##2	I-T103
-	O
eif	B-T103
##4	I-T103
##g1	I-T103
interaction	B-T038
inhibits	O
influenza	B-T005
a	I-T005
viruses	I-T005
'	O
replication	B-T038
in	O
vitro	O
and	O
in	O
vivo	O
influenza	B-T005
viruses	I-T005
are	O
obligate	B-T204
parasites	I-T204
that	O
hi	B-T038
##ja	I-T038
##ck	I-T038
the	I-T038
host	I-T038
cellular	I-T038
system	I-T038
.	O
previous	O
results	O
have	O
shown	O
that	O
the	O
influenza	B-T103
virus	I-T103
pb	I-T103
##2	I-T103
subunit	O
confers	O
a	O
dependence	O
of	O
host	B-T103
eukaryotic	I-T103
translation	I-T103
initiation	I-T103
factor	I-T103
4	I-T103
-	I-T103
γ	I-T103
1	I-T103
(	O
eif	B-T103
##4	I-T103
##g1	I-T103
)	O
for	O
viral	B-T038
mrna	I-T038
translation	I-T038
.	O
here	O
,	O
we	O
demonstrated	O
that	O
peptide	B-T103
-	O
mediated	O
interference	O
of	O
the	O
pb	B-T103
##2	I-T103
-	O
eif	B-T103
##4	I-T103
##g1	I-T103
interaction	B-T038
inhibited	O
virus	B-T038
replication	I-T038
in	O
vitro	O
and	O
in	O
vivo	O
.	O
remarkably	O
,	O
intranasal	B-T058
administration	I-T058
of	O
the	O
peptide	B-T103
provided	O
100	O
%	O
protection	O
against	O
lethal	B-T033
challenges	B-T058
of	O
influenza	B-T005
a	I-T005
viruses	I-T005
in	O
balb	B-T204
/	I-T204
c	I-T204
mice	I-T204
,	O
including	O
h1n1	B-T005
,	O
h5n1	B-T005
,	O
and	O
h7	B-T005
##n	I-T005
##9	I-T005
influenza	I-T005
virus	I-T005
subtypes	I-T005
.	O
mapping	B-T062
of	O
the	O
pb	B-T103
##2	I-T103
protein	I-T103
indicated	O
that	O
the	O
eif	B-T103
##4	I-T103
##g1	I-T103
binding	B-T103
sites	I-T103
reside	O
##d	O
within	O
the	O
pb	B-T103
##2	I-T103
cap	I-T103
-	O
binding	B-T038
domain	I-T038
.	O
virtual	B-T170
docking	I-T170
analysis	I-T170
suggested	O
that	O
the	O
inhibitory	O
peptide	B-T103
associated	O
with	O
the	O
conserved	O
amino	B-T103
acid	I-T103
residues	I-T103
that	O
were	O
essential	O
to	O
pb	B-T103
##2	I-T103
cap	B-T058
-	I-T058
binding	I-T058
activity	I-T058
.	O
overall	O
,	O
our	O
results	O
identified	O
the	O
pb	B-T103
##2	I-T103
-	O
eif	B-T103
##4	I-T103
##g1	I-T103
interactive	B-T103
site	I-T103
as	O
a	O
drug	B-T103
##ga	I-T103
##ble	I-T103
target	O
for	O
influenza	B-T038
therapeutics	B-T058
.	O

demonstration	O
and	O
validation	B-T062
of	O
a	O
new	O
pressure	O
-	O
based	O
mri	B-T074
-	O
safe	O
pain	B-T033
tolerance	I-T033
device	B-T074
one	O
of	O
the	O
barriers	O
to	O
studying	O
the	O
behavioral	O
and	O
emotional	B-T038
effects	O
of	O
pain	B-T033
using	O
functional	B-T058
magnetic	I-T058
resonance	I-T058
imaging	I-T058
(	O
fmri	B-T058
)	O
is	O
the	O
absence	O
of	O
a	O
commercially	O
available	O
,	O
mri	B-T074
-	O
compatible	O
,	O
pressure	O
-	O
based	O
alg	B-T074
##ometer	I-T074
to	O
elicit	O
pain	B-T033
.	O
the	O
present	O
study	O
sought	O
to	O
address	O
this	O
barrier	O
through	O
creation	O
and	O
validation	O
of	O
a	O
novel	O
mri	B-T074
-	O
safe	O
apparatus	B-T074
capable	O
of	O
delivering	O
incremental	O
,	O
measurable	O
amounts	O
of	O
pressure	O
inside	O
a	O
scanning	B-T074
bore	I-T074
.	O
we	O
introduced	O
an	O
mr	O
-	O
safe	O
device	B-T074
used	O
to	O
administer	O
pressure	O
-	O
based	O
pain	B-T033
.	O
to	O
test	B-T058
against	O
a	O
commercially	O
available	O
,	O
mri	B-T074
-	O
incompatible	O
alg	B-T074
##ometer	I-T074
(	O
alg	B-T074
##omed	I-T074
)	O
,	O
199	O
participants	O
reported	O
their	O
pain	B-T033
tolerance	I-T033
for	O
both	O
devices	O
.	O
a	O
second	O
experiment	O
tested	B-T058
the	O
validity	O
of	O
pressure	O
-	O
based	O
pain	B-T033
in	O
an	O
mri	B-T074
environment	B-T082
by	O
comparing	O
brain	B-T017
activation	O
with	O
established	O
neural	B-T017
networks	I-T017
for	O
pain	B-T033
.	O
10	O
participants	O
performed	O
an	O
identical	O
procedure	O
to	O
test	B-T058
for	O
pain	B-T033
tolerance	O
while	O
being	O
scanned	B-T058
in	O
a	O
7	O
##t	O
mri	B-T074
scanner	I-T074
.	O
results	O
support	O
the	O
validity	O
and	O
reliability	O
of	O
our	O
novel	O
device	B-T074
.	O
in	O
study	O
1	O
,	O
pain	B-T033
tolerance	I-T033
with	O
this	O
device	B-T074
was	O
strongly	O
correlated	O
with	O
pain	B-T033
tolerance	I-T033
as	O
measured	O
by	O
a	O
commercially	O
available	O
alg	B-T074
##ometer	I-T074
(	O
r	O
=	O
0	O
.	O
78	O
)	O
.	O
in	O
study	O
2	O
,	O
this	O
device	B-T074
yielded	O
bold	B-T038
activation	O
within	O
the	O
insula	B-T017
(	O
ba	B-T017
13	I-T017
)	O
and	O
anterior	B-T017
cingulate	I-T017
gyrus	I-T017
(	O
ba	B-T082
24	I-T082
)	O
;	O
as	O
pressure	O
increased	O
,	O
activation	O
in	O
these	O
areas	O
parametric	O
##ally	O
increased	O
.	O
these	O
findings	O
correspond	O
to	O
other	O
studies	O
using	O
thermal	O
,	O
electrical	O
,	O
or	O
mechanical	B-T058
pain	B-T033
applications	I-T033
.	O
behavioral	O
and	O
functional	O
data	O
demonstrate	O
that	O
this	O
new	O
device	B-T074
is	O
a	O
valid	O
method	O
of	O
administering	B-T058
pressure	O
-	O
related	O
pain	B-T033
in	O
mri	B-T074
environments	B-T082
.	O
our	O
novel	O
mri	B-T074
-	O
safe	O
device	B-T074
is	O
a	O
valid	O
instrument	B-T074
to	O
measure	O
and	O
administer	O
pressure	O
-	O
based	O
pain	B-T033
.	O

prescription	B-T170
of	O
opioids	B-T103
for	O
breath	B-T033
##lessness	I-T033
in	O
end	O
-	O
stage	O
copd	B-T038
:	O
a	O
national	O
population	B-T062
-	I-T062
based	I-T062
study	I-T062
low	O
-	O
dose	O
opioids	B-T103
can	O
relieve	O
breath	B-T033
##lessness	I-T033
but	O
may	O
be	O
under	O
##used	O
in	O
late	O
-	O
stage	O
copd	B-T038
due	O
to	O
fear	B-T038
of	O
complications	B-T038
,	O
contributing	O
to	O
poor	O
symptom	B-T058
control	I-T058
.	O
we	O
aimed	O
to	O
study	B-T062
the	O
period	O
prevalence	O
and	O
indications	O
of	O
opioids	B-T103
actually	O
prescribed	O
in	O
people	B-T098
with	O
end	O
-	O
stage	O
copd	B-T038
.	O
the	O
study	B-T062
was	O
a	O
longitudinal	B-T062
,	O
population	B-T062
-	I-T062
based	I-T062
study	I-T062
of	O
patients	O
starting	O
long	B-T058
-	I-T058
term	I-T058
oxygen	I-T058
therapy	I-T058
(	O
lt	B-T058
##ot	I-T058
)	O
for	O
copd	B-T038
between	O
october	O
1	O
,	O
2005	O
and	O
june	O
30	O
,	O
2009	O
in	O
sweden	B-T082
.	O
a	O
random	O
sample	O
(	O
n	O
=	O
2	O
,	O
000	O
)	O
of	O
their	O
dispens	B-T058
##ed	I-T058
opioid	B-T103
prescriptions	B-T170
was	O
obtained	O
from	O
the	O
national	B-T170
prescribed	I-T170
drugs	I-T170
register	I-T170
from	O
91	O
days	O
before	O
starting	O
lt	B-T058
##ot	I-T058
until	O
the	O
first	O
of	O
lt	B-T058
##ot	I-T058
withdrawal	O
,	O
death	B-T038
,	O
or	O
study	O
end	O
(	O
december	O
31	O
,	O
2009	O
)	O
.	O
we	O
analyzed	O
medication	O
type	O
,	O
dispens	O
##ed	O
quantity	O
,	O
date	B-T033
of	I-T033
dispensing	I-T033
,	O
and	O
indications	O
categorized	O
as	O
pain	B-T033
,	O
breath	B-T033
##lessness	I-T033
,	O
other	O
,	O
or	O
unknown	O
.	O
in	O
total	O
,	O
2	O
,	O
249	O
copd	B-T038
patients	O
(	O
59	O
%	O
women	B-T098
)	O
were	O
included	O
.	O
during	O
a	O
median	O
follow	B-T058
-	I-T058
up	I-T058
of	O
1	O
.	O
1	O
(	O
interquartile	O
range	O
0	O
.	O
6	O
-	O
2	O
.	O
0	O
)	O
years	O
,	O
1	O
,	O
034	O
patients	O
(	O
46	O
%	O
)	O
were	O
dispens	B-T058
##ed	I-T058
≥1	O
opioid	B-T103
prescription	B-T058
(	O
n	O
=	O
13	O
,	O
72	O
##2	O
prescriptions	B-T058
)	O
.	O
the	O
most	O
frequently	O
prescribed	O
opioids	B-T103
were	O
tramadol	B-T103
(	O
23	O
%	O
)	O
,	O
oxy	B-T103
##co	I-T103
##d	I-T103
##one	I-T103
(	O
23	O
%	O
)	O
,	O
morphine	B-T103
(	O
16	O
%	O
)	O
,	O
and	O
code	B-T103
##ine	I-T103
(	O
16	O
%	O
)	O
.	O
average	O
dispens	O
##ed	O
quantity	O
was	O
9	O
.	O
3	O
(	O
interquartile	O
range	O
3	O
.	O
7	O
-	O
16	O
.	O
7	O
)	O
defined	O
daily	O
doses	O
per	O
prescription	B-T058
.	O
in	O
the	O
random	O
sample	O
,	O
the	O
most	O
commonly	O
stated	O
indication	O
was	O
pain	B-T033
(	O
97	O
%	O
)	O
,	O
with	O
only	O
2	O
%	O
for	O
breath	B-T033
##lessness	I-T033
and	O
1	O
%	O
for	O
other	O
reasons	O
.	O
despite	O
evidence	O
that	O
supported	O
the	O
use	O
of	O
opioids	B-T103
for	O
the	O
relief	O
of	O
breath	B-T033
##lessness	I-T033
pred	O
##ating	O
this	O
study	B-T062
,	O
opioids	B-T103
are	O
rarely	O
prescribed	O
to	O
relieve	O
breath	B-T033
##lessness	I-T033
in	O
oxygen	B-T038
-	I-T038
dependent	I-T038
copd	B-T038
,	O
potentially	O
contributing	O
to	O
less	O
-	O
than	O
-	O
optimal	O
symptom	B-T058
control	I-T058
.	O
this	O
study	B-T062
creates	O
a	O
baseline	O
against	O
which	O
to	O
compare	O
future	O
changes	O
in	O
morphine	B-T103
prescribing	O
in	O
this	O
setting	O
.	O

repetitive	O
and	O
prolonged	O
omega	B-T103
-	I-T103
3	I-T103
fatty	I-T103
acid	I-T103
treatment	B-T058
after	O
traumatic	B-T037
brain	I-T037
injury	I-T037
enhances	O
long	O
-	O
term	O
tissue	B-T017
restoration	B-T058
and	O
cognitive	B-T058
recovery	I-T058
traumatic	B-T037
brain	I-T037
injury	I-T037
(	O
tbi	B-T037
)	O
is	O
one	O
of	O
the	O
most	O
disabling	O
clinical	O
conditions	O
that	O
could	O
lead	O
to	O
neurocognitive	B-T038
disorders	I-T038
in	O
survivors	O
.	O
our	O
group	B-T098
and	O
others	B-T098
previously	O
reported	B-T170
that	O
prophylactic	B-T058
enrichment	I-T058
of	O
dietary	O
omega	B-T103
-	I-T103
3	I-T103
polyunsaturated	I-T103
fatty	I-T103
acids	I-T103
(	O
n	B-T103
-	I-T103
3	I-T103
pufas	I-T103
)	O
markedly	O
ameliorate	O
cognitive	B-T038
deficits	I-T038
after	O
tbi	B-T037
.	O
however	O
,	O
it	O
remains	O
unclear	O
whether	O
a	O
clinically	O
relevant	O
therapeutic	B-T058
regimen	I-T058
with	O
n	B-T103
-	I-T103
3	I-T103
pufas	I-T103
administered	O
after	O
tbi	B-T037
would	O
still	O
offer	O
significant	O
improvement	O
of	O
long	O
-	O
term	O
cognitive	B-T058
recovery	I-T058
.	O
in	O
the	O
present	O
study	B-T062
,	O
we	O
employed	O
the	O
decline	O
of	O
spatial	O
cognitive	B-T038
function	I-T038
as	O
a	O
main	O
outcome	O
after	O
tbi	B-T037
to	O
investigate	O
the	O
therapeutic	O
efficacy	O
of	O
post	O
-	O
tbi	B-T037
n	B-T103
-	I-T103
3	I-T103
pufa	I-T103
treatment	B-T058
and	O
the	O
underlying	O
mechanisms	O
.	O
mice	B-T204
were	O
subjected	O
to	O
sham	B-T058
operation	I-T058
or	O
controlled	O
cortical	B-T017
impact	O
,	O
followed	O
by	O
random	O
assignment	O
to	O
receive	O
the	O
following	O
four	O
treatments	B-T058
:	O
(	O
1	O
)	O
vehicle	B-T103
control	O
;	O
(	O
2	O
)	O
daily	O
intraperitoneal	B-T058
injections	I-T058
of	O
n	B-T103
-	I-T103
3	I-T103
pufas	I-T103
for	O
2	O
weeks	O
,	O
beginning	O
2	O
h	O
after	O
tbi	B-T037
;	O
(	O
3	O
)	O
fish	B-T168
oil	I-T168
dietary	I-T168
supplementation	B-T058
throughout	O
the	O
study	B-T062
,	O
beginning	O
1	O
day	O
after	O
tbi	B-T037
;	O
or	O
(	O
4	O
)	O
combination	O
of	O
treatments	B-T058
(	O
2	O
)	O
and	O
(	O
3	O
)	O
.	O
spatial	O
cognitive	O
deficits	O
and	O
chronic	O
brain	B-T017
tissue	I-T017
loss	O
,	O
as	O
well	O
as	O
endogenous	O
brain	B-T058
repair	I-T058
processes	I-T058
such	O
as	O
neurogenesis	B-T038
,	O
angiogenesis	B-T038
,	O
and	O
oligodend	B-T038
##rogenesis	I-T038
,	O
were	O
evaluated	O
up	O
to	O
35	O
days	O
after	O
tbi	B-T037
.	O
the	O
results	O
revealed	O
prominent	O
spatial	O
cognitive	B-T038
deficits	I-T038
and	O
massive	O
tissue	B-T017
loss	O
caused	O
by	O
tbi	B-T037
.	O
among	O
all	O
mice	B-T204
receiving	O
post	B-T037
-	I-T037
tbi	I-T037
n	B-T103
-	I-T103
3	I-T103
pufa	I-T103
treatments	B-T058
,	O
the	O
combined	O
treatment	B-T058
of	O
fish	B-T168
oil	I-T168
dietary	I-T168
supplement	B-T168
and	O
n	B-T103
-	I-T103
3	I-T103
pufa	I-T103
injections	B-T103
demonstrated	O
a	O
reproducible	O
beneficial	O
effect	O
in	O
attenuating	O
cognitive	B-T038
deficits	I-T038
although	O
without	O
reducing	O
gross	O
tissue	B-T017
loss	O
.	O
mechanistically	O
,	O
the	O
combined	O
treatment	B-T058
promoted	O
post	B-T037
-	I-T037
tbi	I-T037
restorative	O
processes	O
in	O
the	O
brain	B-T017
,	O
including	O
generation	O
of	O
immature	B-T017
neurons	I-T017
,	O
microvessels	B-T017
,	O
and	O
oligodendrocytes	B-T017
,	O
each	O
of	O
which	O
was	O
significantly	O
correlated	O
with	O
the	O
improved	B-T033
cognitive	O
recovery	O
.	O
these	O
results	O
indicated	B-T033
that	O
repetitive	O
and	O
prolonged	O
n	B-T103
-	I-T103
3	I-T103
pufa	I-T103
treatments	B-T058
after	O
tbi	B-T037
are	O
capable	O
of	O
enhancing	O
brain	B-T017
remodeling	O
and	O
could	O
be	O
developed	O
as	O
a	O
potential	O
therapy	B-T058
to	O
treat	O
tbi	B-T037
victims	O
in	O
the	O
clinic	B-T092
.	O

beneficial	O
effects	O
of	O
dark	B-T168
cho	I-T168
##co	I-T168
##la	I-T168
##te	I-T168
on	O
exercise	O
capacity	O
in	O
sedentary	O
subjects	B-T098
:	O
underlying	O
mechanisms	O
.	O
a	O
double	B-T062
blind	I-T062
,	O
randomized	B-T062
,	O
placebo	B-T062
controlled	I-T062
trial	B-T062
in	O
heart	B-T038
failure	I-T038
patients	O
the	O
consumption	B-T038
of	O
(	B-T103
-	I-T103
)	I-T103
-	I-T103
epic	I-T103
##atechin	I-T103
(	O
(	B-T103
-	I-T103
)	I-T103
-	I-T103
epi	I-T103
)	O
-	O
rich	O
coc	B-T168
##oa	I-T168
can	O
restore	O
skeletal	B-T017
muscle	I-T017
(	O
sk	B-T017
##m	I-T017
)	O
mitochondrial	B-T017
structure	B-T082
and	O
decrease	O
biomarkers	B-T201
of	O
oxidative	B-T038
stress	I-T038
.	O
however	O
,	O
nothing	O
is	O
known	O
about	O
its	O
effects	O
on	O
exercise	O
capacity	O
and	O
underlying	O
mechanisms	O
in	O
normal	O
,	O
sedentary	O
subjects	B-T098
.	O
twenty	O
normal	O
,	O
sedentary	O
subjects	B-T098
(	O
∼	O
##50	O
years	O
old	O
)	O
were	O
randomized	B-T062
to	O
placebo	B-T058
or	O
dark	B-T168
cho	I-T168
##co	I-T168
##la	I-T168
##te	I-T168
(	O
dc	B-T168
)	O
groups	O
and	O
consumed	O
20	O
g	O
of	O
the	O
products	O
for	O
3	O
months	O
.	O
subjects	B-T098
underwent	O
before	O
and	O
after	O
treatment	B-T058
,	O
bicycle	B-T058
erg	I-T058
##ometry	I-T058
to	O
assess	O
vo2	B-T033
max	I-T033
and	O
work	O
,	O
sk	B-T058
##m	I-T058
biopsy	I-T058
to	O
assess	O
changes	O
in	O
mitochondrial	B-T017
density	O
,	O
function	O
and	O
oxidative	B-T038
stress	I-T038
and	O
blood	B-T058
sampling	I-T058
to	O
assess	O
metabolic	O
endpoints	O
.	O
seventeen	O
subjects	B-T098
completed	O
the	O
trial	B-T062
.	O
in	O
the	O
dc	B-T168
group	O
(	O
n	O
=	O
9	O
)	O
,	O
vo2	B-T033
max	I-T033
increased	O
(	O
17	O
%	O
increase	O
,	O
p	O
=	O
0	O
.	O
05	O
##6	O
)	O
as	O
well	O
as	O
maximum	O
work	O
(	O
wat	O
##ts	O
)	O
achieved	O
(	O
p	O
=	O
0	O
.	O
026	O
)	O
with	O
no	O
changes	O
with	O
placebo	B-T058
(	O
n	O
=	O
8	O
)	O
.	O
the	O
dc	B-T168
group	O
evidenced	O
increases	O
in	O
hdl	B-T103
levels	O
(	O
p	O
=	O
0	O
.	O
005	O
)	O
and	O
decreased	O
triglycerides	B-T103
(	O
p	O
=	O
0	O
.	O
07	O
)	O
.	O
with	O
dc	B-T168
,	O
sk	B-T017
##m	I-T017
evidenced	O
significant	O
increases	O
in	O
protein	B-T103
levels	O
for	O
lk	B-T103
##b1	I-T103
,	O
ampk	B-T103
and	O
pgc	B-T103
##1	I-T103
##α	I-T103
and	O
in	O
their	O
active	O
forms	O
(	O
phosphorylated	B-T038
ampk	B-T103
and	O
lk	B-T103
##b1	I-T103
)	O
as	O
well	O
as	O
in	O
citrate	B-T038
synthase	I-T038
activity	I-T038
while	O
no	O
changes	O
were	O
observed	O
in	O
mitochondrial	B-T017
density	O
.	O
with	O
dc	B-T168
,	O
significant	O
increases	O
in	O
sk	B-T017
##m	I-T017
reduced	O
glutathione	B-T103
levels	O
and	O
decreases	O
in	O
protein	B-T038
carbonyl	I-T038
##ation	I-T038
were	O
observed	O
.	O
improvements	O
in	O
maximum	O
work	O
achieved	O
and	O
vo2	B-T033
max	I-T033
may	O
be	O
due	O
to	O
dc	B-T168
activation	O
of	O
upstream	O
control	O
systems	O
and	O
enhancement	O
of	O
sk	B-T017
##m	I-T017
mitochondria	B-T017
efficiency	O
.	O
larger	O
clinical	B-T062
studies	I-T062
are	O
warranted	O
to	O
confirm	O
these	O
observations	B-T062
.	O

burden	O
of	O
cervical	B-T038
cancer	I-T038
and	O
role	O
of	O
screening	B-T058
in	O
india	B-T082
cervical	B-T038
cancer	I-T038
is	O
a	O
major	O
cause	O
of	O
cancer	O
mortality	O
in	O
women	B-T098
and	O
more	O
than	O
a	O
quarter	O
of	O
its	O
global	O
burden	O
is	O
contributed	O
by	O
developing	O
countries	O
.	O
in	O
india	B-T082
,	O
in	O
spite	O
of	O
alarm	O
##ingly	O
high	O
figures	O
,	O
there	O
is	O
no	O
nationwide	O
government	O
-	O
sponsored	O
screening	O
program	O
.	O
this	O
study	B-T062
was	O
conducted	O
to	O
assess	O
the	O
burden	O
of	O
cervical	B-T038
cancer	I-T038
in	O
india	B-T082
and	O
review	O
the	O
performance	O
characteristics	O
of	O
available	O
cervical	B-T038
cancer	I-T038
screening	B-T058
tools	O
,	O
so	O
as	O
to	O
provide	O
evidence	O
-	O
based	O
recommendations	O
for	O
application	O
of	O
most	O
practically	O
suited	O
screening	B-T058
test	I-T058
to	O
be	O
used	O
in	O
resource	O
-	O
poor	O
field	O
settings	O
.	O
medline	B-T170
and	O
web	O
of	O
science	O
electronic	O
database	O
were	O
searched	O
from	O
january	O
1990	O
to	O
december	O
2015	O
,	O
using	O
the	O
keywords	B-T170
such	O
as	O
[UNK]	O
cervical	B-T038
cancer	I-T038
[UNK]	O
,	O
[UNK]	O
screening	B-T058
[UNK]	O
,	O
[UNK]	O
early	B-T058
detection	I-T058
[UNK]	O
,	O
[UNK]	O
cervical	B-T058
cytology	I-T058
[UNK]	O
and	O
[UNK]	O
visual	B-T058
inspection	I-T058
[UNK]	O
,	O
and	O
their	O
corresponding	O
mesh	B-T170
terms	I-T170
in	O
combination	O
with	O
bo	O
##ole	O
##an	O
operators	O
[UNK]	O
or	O
,	O
and	O
.	O
[UNK]	O
two	O
authors	B-T097
independently	O
selected	O
studies	B-T062
that	O
are	O
published	B-T170
in	O
english	O
and	O
conducted	O
in	O
india	B-T082
.	O
a	O
total	O
of	O
11	O
studies	B-T062
were	O
found	B-T033
to	O
be	O
relevant	O
and	O
eligible	O
to	O
be	O
included	O
in	O
the	O
present	B-T033
study	B-T062
.	O
in	O
india	B-T082
,	O
cervical	B-T038
cancer	I-T038
contributes	O
to	O
approximately	O
6	O
-	O
29	O
%	O
of	O
all	O
cancers	B-T038
in	O
women	B-T098
.	O
the	O
age	O
-	O
adjusted	O
incidence	O
rate	O
of	O
cervical	B-T038
cancer	I-T038
varies	O
widely	O
among	O
registries	B-T170
;	O
highest	O
is	O
23	O
.	O
07	O
/	O
100	O
,	O
000	O
in	O
mi	O
##zo	O
##ra	O
##m	O
state	O
and	O
the	O
lowest	O
is	O
4	O
.	O
91	O
/	O
100	O
,	O
000	O
in	O
dib	O
##rug	O
##ar	O
##h	O
district	O
.	O
the	O
pooled	O
estimates	O
of	O
sensitivity	O
and	O
specificity	O
of	O
visual	B-T058
inspection	I-T058
with	I-T058
acetic	I-T058
acid	I-T058
(	O
via	B-T058
)	O
,	O
magn	B-T058
##ified	I-T058
via	I-T058
,	O
visual	B-T058
inspection	I-T058
with	I-T058
lu	I-T058
##go	I-T058
##l	I-T058
'	I-T058
s	I-T058
iodine	I-T058
(	O
vi	B-T058
##li	I-T058
)	O
,	O
cytology	B-T058
(	O
pap	B-T058
smear	I-T058
)	O
,	O
and	O
human	B-T058
papillomavirus	I-T058
dna	I-T058
were	O
found	O
to	O
be	O
67	O
.	O
65	O
%	O
and	O
84	O
.	O
32	O
%	O
,	O
65	O
.	O
36	O
%	O
and	O
85	O
.	O
76	O
%	O
,	O
78	O
.	O
27	O
%	O
and	O
87	O
.	O
10	O
%	O
,	O
62	O
.	O
11	O
%	O
and	O
93	O
.	O
51	O
%	O
,	O
and	O
77	O
.	O
81	O
%	O
and	O
91	O
.	O
54	O
%	O
,	O
respectively	O
.	O
in	O
developing	O
countries	O
because	O
of	O
lack	O
of	O
necessary	O
infrastructure	B-T170
and	O
quality	O
control	O
,	O
high	O
-	O
quality	O
cytology	B-T058
screening	I-T058
may	O
not	O
be	O
feasible	O
for	O
wide	O
-	O
scale	O
implementation	O
.	O
hence	O
,	O
cervical	B-T038
cancer	I-T038
screening	B-T058
program	O
based	O
on	O
visual	B-T058
screening	I-T058
test	I-T058
such	O
as	O
via	B-T058
/	O
vi	B-T058
##li	I-T058
should	O
be	O
adopted	O
as	O
an	O
integral	O
part	O
of	O
primary	O
health	B-T058
-	I-T058
care	I-T058
setup	I-T058
in	O
resource	O
-	O
poor	O
countries	B-T082
like	O
india	B-T082
.	O

mucosal	B-T017
igm	B-T103
antibody	I-T103
with	O
d	B-T103
-	I-T103
mannose	I-T103
affinity	O
in	O
fu	B-T204
##gu	I-T204
tak	I-T204
##ifug	I-T204
##u	I-T204
rub	I-T204
##ri	I-T204
##pes	I-T204
is	O
utilized	O
by	O
a	O
mono	B-T204
##gene	I-T204
##an	I-T204
parasite	B-T204
hetero	B-T204
##bo	I-T204
##thr	I-T204
##ium	I-T204
ok	I-T204
##am	I-T204
##oto	I-T204
##i	I-T204
for	O
host	B-T038
recognition	I-T038
how	O
parasites	B-T204
recognize	B-T038
their	O
definitive	O
hosts	O
is	O
a	O
my	O
##st	O
##ery	O
;	O
however	O
,	O
parasitism	O
is	O
reportedly	O
initiated	O
by	O
recognition	B-T038
of	O
certain	O
molecules	O
on	O
host	B-T017
surfaces	I-T017
.	O
fish	B-T204
ect	B-T204
##oparas	I-T204
##ites	I-T204
make	O
initial	B-T033
contact	I-T033
with	O
their	O
hosts	O
at	O
body	O
surfaces	O
,	O
such	O
as	O
skin	B-T022
and	O
gills	B-T017
,	O
which	O
are	O
covered	O
with	O
mucosa	B-T017
that	O
are	O
similar	O
to	O
those	O
of	O
mammalian	B-T017
gut	I-T017
##s	I-T017
.	O
fish	B-T204
are	O
among	O
the	O
most	O
primitive	B-T204
vertebrates	I-T204
with	O
immune	B-T022
systems	I-T022
that	O
are	O
equivalent	O
to	O
those	O
in	O
mammals	B-T204
,	O
and	O
they	O
produce	O
and	O
secrete	B-T038
igm	B-T103
into	O
mucus	B-T031
.	O
in	O
this	O
study	O
,	O
we	O
showed	O
that	O
the	O
mono	B-T204
##gene	I-T204
##an	I-T204
parasite	B-T204
hetero	B-T204
##bo	I-T204
##thr	I-T204
##ium	I-T204
ok	I-T204
##am	I-T204
##oto	I-T204
##i	I-T204
utilizes	O
igm	B-T103
to	O
recognize	O
its	O
host	O
,	O
fu	B-T204
##gu	I-T204
tak	I-T204
##ifug	I-T204
##u	I-T204
rub	I-T204
##ri	I-T204
##pes	I-T204
onc	I-T204
##om	I-T204
##ira	I-T204
##ci	I-T204
##di	I-T204
##a	I-T204
are	O
infective	B-T204
larvae	I-T204
of	O
h	B-T204
.	I-T204
ok	I-T204
##am	I-T204
##oto	I-T204
##i	I-T204
that	O
shed	O
their	O
cilia	B-T017
and	O
metamorph	B-T038
##ose	I-T038
into	O
juveniles	O
when	O
exposed	O
to	O
purified	O
d	B-T103
-	I-T103
mannose	I-T103
-	O
binding	O
fractions	O
from	O
fu	B-T204
##gu	I-T204
mucus	B-T031
.	O
using	O
liquid	B-T058
chromatography	I-T058
-	I-T058
tandem	I-T058
mass	I-T058
spectrometry	I-T058
analysis	I-T058
,	O
proteins	B-T103
contained	O
in	O
the	O
fraction	O
were	O
identified	O
as	O
d	B-T103
-	I-T103
mannose	I-T103
-	O
specific	O
igm	B-T103
with	O
two	O
d	B-T103
-	I-T103
mannose	I-T103
-	O
binding	O
lectins	B-T103
.	O
however	O
,	O
although	O
dec	B-T038
##iliation	I-T038
was	O
significantly	O
induced	O
by	O
igm	B-T103
and	O
was	O
inhibited	O
by	O
d	B-T103
-	I-T103
mannose	I-T103
or	O
a	O
specific	O
ab	B-T103
against	O
fu	B-T204
##gu	I-T204
igm	B-T103
,	O
other	O
lectins	B-T103
had	O
no	O
effect	O
,	O
and	O
igm	B-T103
without	O
d	B-T103
-	I-T103
mannose	I-T103
affinity	O
induced	O
dec	B-T038
##iliation	I-T038
to	O
a	O
limited	O
degree	O
.	O
subsequent	O
immunofluorescent	B-T058
staining	I-T058
experiments	I-T058
showed	O
that	O
fu	B-T204
##gu	I-T204
d	B-T103
-	I-T103
mannose	I-T103
-	O
specific	O
igm	B-T103
binds	O
ciliated	B-T017
epidermal	I-T017
cells	I-T017
of	O
onc	B-T204
##om	I-T204
##ira	I-T204
##ci	I-T204
##di	I-T204
##um	I-T204
.	O
these	O
observations	O
suggest	O
that	O
dec	B-T038
##iliation	I-T038
is	O
triggered	O
by	O
binding	O
of	O
fu	B-T204
##gu	I-T204
igm	B-T103
to	O
cell	B-T103
surface	I-T103
ags	I-T103
via	O
ag	B-T103
binding	I-T103
sites	I-T103
.	O
moreover	O
,	O
concentrations	O
of	O
d	B-T103
-	I-T103
mannose	I-T103
-	O
binding	O
igm	B-T103
in	O
gill	B-T031
mucus	I-T031
were	O
sufficient	O
to	O
induce	O
dec	B-T038
##iliation	I-T038
in	O
vitro	O
,	O
indicating	O
that	O
h	B-T204
.	I-T204
ok	I-T204
##am	I-T204
##oto	I-T204
##i	I-T204
parasites	I-T204
initially	O
use	O
host	O
abs	B-T103
to	O
colon	B-T033
##ize	I-T033
host	O
gills	B-T017
.	O

defining	O
categories	B-T170
of	O
action	O
##ability	O
for	O
secondary	O
findings	B-T033
in	O
next	B-T058
-	I-T058
generation	I-T058
sequencing	I-T058
next	B-T058
-	I-T058
generation	I-T058
sequencing	I-T058
is	O
increasingly	O
used	O
in	O
clinical	O
practice	O
for	O
the	O
diagnosis	B-T033
of	O
mendelian	B-T038
diseases	I-T038
.	O
because	O
of	O
the	O
high	O
likelihood	O
of	O
secondary	O
findings	B-T033
associated	O
with	O
this	O
technique	O
,	O
the	O
process	O
of	O
informing	B-T058
patients	I-T058
is	O
bes	O
##et	O
with	O
new	O
challenges	O
.	O
one	O
of	O
them	O
is	O
regarding	O
the	O
type	O
of	O
secondary	O
findings	B-T033
that	O
ou	O
##gh	O
##t	O
to	O
be	O
disclosed	O
to	O
patients	O
.	O
the	O
aim	O
of	O
this	O
research	B-T062
is	O
to	O
propose	O
a	O
practical	O
implementation	O
of	O
the	O
notion	O
of	O
action	O
##ability	O
,	O
a	O
common	O
criteria	O
justify	O
##ing	O
the	O
disclosure	O
of	O
secondary	O
findings	B-T033
but	O
whose	O
interpretation	B-T170
varies	O
greatly	O
among	O
professionals	B-T097
.	O
we	O
distinguish	O
three	O
types	O
of	O
action	O
##ability	O
corresponding	O
to	O
(	O
1	O
)	O
well	O
-	O
established	O
medical	O
actions	O
,	O
(	O
2	O
)	O
patient	O
-	O
initiated	O
health	O
-	O
related	O
actions	O
and	O
(	O
3	O
)	O
life	B-T038
-	I-T038
plan	I-T038
decisions	I-T038
.	O
we	O
argue	O
that	O
action	O
##ability	O
depends	O
on	O
the	O
characteristics	O
of	O
the	O
mutation	B-T038
or	O
gene	B-T017
and	O
on	O
the	O
values	O
of	O
patients	O
.	O
in	O
discussing	O
the	O
return	O
of	O
secondary	O
findings	B-T033
,	O
it	O
is	O
important	O
that	O
the	O
physician	B-T097
tri	O
##es	O
to	O
get	O
an	O
impression	O
of	O
the	O
specific	O
situation	O
and	O
values	O
of	O
patients	O
.	O
regarding	O
variants	B-T017
of	O
uncertain	O
clinical	B-T033
significance	I-T033
in	O
action	O
##able	O
genes	B-T017
,	O
we	O
found	O
that	O
different	O
understanding	O
##s	O
of	O
autonomy	O
lead	O
to	O
different	O
conclusions	O
and	O
that	O
,	O
for	O
some	O
of	O
them	O
,	O
it	O
may	O
be	O
legitim	O
##ate	O
to	O
refr	O
##ain	O
from	O
returning	O
uncertain	O
information	O
.	O

air	B-T103
pollutant	I-T103
exposure	O
within	O
a	O
few	O
days	O
of	O
delivery	B-T058
and	O
placental	B-T038
abrupt	I-T038
##ion	I-T038
in	O
japan	B-T082
placental	B-T038
abrupt	I-T038
##ion	I-T038
is	O
an	O
emergency	B-T038
obstetric	I-T038
complication	I-T038
.	O
although	O
the	O
etiology	O
of	O
abrupt	B-T038
##ion	I-T038
is	O
not	O
fully	O
understood	O
,	O
acute	O
stimuli	O
,	O
such	O
as	O
ischemia	B-T038
and	O
/	O
or	O
inflammation	B-T038
,	O
are	O
associated	O
with	O
rupture	B-T038
of	I-T038
the	I-T038
decidual	I-T038
artery	I-T038
,	O
resulting	O
in	O
placental	B-T038
separation	I-T038
.	O
ischemia	B-T038
and	O
inflammation	B-T038
are	O
acute	O
biologic	O
effects	O
of	O
air	O
pollution	O
.	O
using	O
a	O
case	B-T062
-	I-T062
crossover	I-T062
design	I-T062
,	O
we	O
tested	O
the	O
hypothesis	O
that	O
a	O
short	O
-	O
term	O
increase	O
in	O
exposure	O
to	O
air	B-T103
pollutants	I-T103
is	O
a	O
potential	O
trigger	B-T201
of	O
placental	B-T038
abrupt	I-T038
##ion	I-T038
.	O
we	O
received	O
data	O
for	O
western	B-T082
japan	I-T082
(	O
ky	B-T082
##ush	I-T082
##u	I-T082
-	I-T082
ok	I-T082
##ina	I-T082
##wa	I-T082
districts	I-T082
)	O
from	O
the	O
japan	B-T170
perinatal	I-T170
registry	I-T170
network	I-T170
database	I-T170
.	O
from	O
2005	O
to	O
2010	O
,	O
82	O
##1	O
singleton	O
pregnant	B-T098
women	I-T098
with	O
placental	B-T038
abrupt	I-T038
##ion	I-T038
were	O
identified	O
.	O
we	O
assigned	O
daily	O
concentrations	O
of	O
air	B-T103
pollutants	I-T103
,	O
including	O
nitrogen	B-T103
dioxide	I-T103
(	O
no2	B-T103
)	O
,	O
suspended	B-T103
particulate	I-T103
matter	I-T103
,	O
ozone	B-T103
,	O
and	O
sulfur	B-T103
dioxide	I-T103
(	O
so2	B-T103
)	O
,	O
from	O
the	O
nearest	O
monitoring	O
station	O
to	O
the	O
respective	O
delivery	B-T058
hospital	B-T092
of	O
each	O
woman	B-T098
.	O
because	O
information	O
on	O
the	O
onset	O
day	O
of	O
abrupt	B-T038
##ion	I-T038
was	O
not	O
obtained	O
,	O
we	O
assumed	O
the	O
case	O
day	O
to	O
be	O
1	O
day	O
before	O
the	O
day	O
of	O
delivery	B-T058
.	O
exposure	O
to	O
no2	B-T103
at	O
2	O
days	O
'	O
lag	O
was	O
associated	O
with	O
placental	B-T038
abrupt	I-T038
##ion	I-T038
(	O
temperature	O
adjusted	O
odds	O
ratio	O
per	O
10	O
ppb	O
increase	O
=	O
1	O
.	O
4	O
;	O
95	O
%	O
confidence	O
interval	O
=	O
1	O
.	O
1	O
,	O
1	O
.	O
8	O
)	O
.	O
the	O
association	O
patterns	O
were	O
similar	O
,	O
when	O
we	O
restricted	O
to	O
participants	B-T098
who	O
delivered	B-T058
by	O
emergency	B-T058
cesarean	I-T058
(	O
1	O
.	O
4	O
,	O
1	O
.	O
1	O
,	O
1	O
.	O
9	O
)	O
,	O
or	O
who	O
delivered	B-T058
after	O
35	O
weeks	O
of	O
gestation	O
(	O
1	O
.	O
4	O
,	O
1	O
.	O
0	O
,	O
2	O
.	O
0	O
)	O
.	O
there	O
was	O
no	B-T033
association	I-T033
with	O
suspended	B-T103
particulate	I-T103
matter	I-T103
,	O
ozone	B-T103
,	O
or	O
so2	B-T103
.	O
we	O
observed	O
an	O
association	O
between	O
no2	B-T103
exposure	O
at	O
2	O
days	O
before	O
the	O
day	O
of	O
delivery	B-T058
and	O
placental	B-T038
abrupt	I-T038
##ion	I-T038
in	O
pregnant	B-T098
japanese	I-T098
women	I-T098
.	O

the	O
impact	O
of	O
deployment	O
on	O
parental	O
,	O
family	O
and	O
child	O
adjustment	O
in	O
military	O
families	O
since	O
9	O
/	O
11	O
,	O
military	B-T097
service	I-T097
in	O
the	O
united	B-T082
states	I-T082
has	O
been	O
characterized	O
by	O
war	O
##time	O
deployment	O
##s	O
and	O
reint	O
##eg	O
##ra	O
##tion	O
challenges	O
that	O
contribute	O
to	O
a	O
context	O
of	O
stress	B-T033
for	O
military	O
families	O
.	O
research	B-T062
indicates	O
the	O
negative	B-T033
impact	I-T033
of	O
war	O
##time	O
deployment	O
on	O
the	O
well	O
being	O
of	O
service	B-T097
members	B-T098
,	O
military	B-T097
spouses	O
,	O
and	O
children	O
.	O
yet	O
,	O
few	O
studies	O
have	O
considered	O
how	O
parental	O
deployment	O
##s	O
may	O
affect	O
adjustment	O
in	O
young	O
children	O
and	O
their	O
families	O
.	O
using	O
deployment	B-T170
records	I-T170
and	O
parent	O
-	O
reported	B-T170
measures	O
from	O
primary	O
caregiving	O
(	O
n	O
=	O
68	O
##0	O
)	O
and	O
military	B-T097
(	O
n	O
=	O
310	O
)	O
parents	O
,	O
we	O
examined	O
the	O
influence	O
of	O
deployment	O
on	O
adjustment	O
in	O
military	O
families	O
with	O
children	O
ages	O
0	O
-	O
10	O
years	O
.	O
greater	O
deployment	O
exposure	O
was	O
related	O
to	O
impaired	O
family	O
functioning	O
and	O
marital	B-T033
instability	B-T033
.	O
parental	O
depressive	B-T038
and	O
posttraumatic	B-T038
stress	I-T038
symptoms	I-T038
were	O
associated	O
with	O
impairments	O
in	O
social	O
emotional	B-T033
adjustment	O
in	O
young	O
children	O
,	O
increased	O
anxiety	B-T033
in	O
early	O
childhood	O
,	O
and	O
adjustment	O
problems	O
in	O
school	O
-	O
age	O
children	O
.	O
conversely	O
,	O
parental	O
sensitivity	B-T038
was	O
associated	O
with	O
improved	O
social	O
and	O
emotional	B-T033
outcomes	I-T033
across	O
childhood	O
.	O
these	O
findings	B-T033
provide	O
guidance	O
to	O
developing	O
preventive	O
approaches	O
for	O
military	O
families	O
with	O
young	O
children	O
.	O

do	O
dynamic	B-T170
global	I-T170
vegetation	I-T170
models	I-T170
capture	O
the	O
seasonality	O
of	O
carbon	O
fluxes	O
in	O
the	O
amazon	B-T082
basin	I-T082
?	O
a	O
data	O
-	O
model	B-T170
interc	O
##omp	O
##aris	O
##on	O
to	O
predict	O
forest	O
response	O
to	O
long	O
-	O
term	O
climate	O
change	O
with	O
high	O
confidence	O
requires	O
that	O
dynamic	B-T170
global	I-T170
vegetation	I-T170
models	I-T170
(	O
dg	B-T170
##v	I-T170
##ms	I-T170
)	O
be	O
successfully	O
tested	O
against	O
ecosystem	O
response	O
to	O
short	O
-	O
term	O
variations	O
in	O
environmental	B-T082
drivers	I-T082
,	O
including	O
regular	O
seasonal	O
patterns	O
.	O
here	O
,	O
we	O
used	O
an	O
integrated	O
dataset	B-T170
from	O
four	O
forests	O
in	O
the	O
bras	B-T170
##il	I-T170
flux	I-T170
network	I-T170
,	O
spanning	O
a	O
range	O
of	O
dry	O
-	O
season	O
intensities	O
and	O
lengths	O
,	O
to	O
determine	O
how	O
well	O
four	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
models	B-T170
(	O
ib	B-T170
##is	I-T170
,	O
ed	B-T170
##2	I-T170
,	O
ju	B-T170
##les	I-T170
,	O
and	O
cl	B-T170
##m	I-T170
##3	I-T170
.	I-T170
5	I-T170
)	O
simulated	O
the	O
seasonality	O
of	O
carbon	O
exchanges	O
in	O
amazon	B-T082
##ian	I-T082
tropical	O
forests	O
.	O
we	O
found	O
that	O
most	O
dg	B-T170
##v	I-T170
##ms	I-T170
poorly	O
represented	O
the	O
annual	O
cycle	O
of	O
gross	O
primary	O
productivity	O
(	O
gp	O
##p	O
)	O
,	O
of	O
photosynthetic	O
capacity	O
(	O
pc	O
)	O
,	O
and	O
of	O
other	O
fluxes	O
and	O
pools	O
.	O
models	B-T170
simulated	O
consistent	O
dry	O
-	O
season	O
declines	O
in	O
gp	O
##p	O
in	O
the	O
equatorial	B-T082
amazon	I-T082
(	O
man	B-T082
##au	I-T082
##s	I-T082
k	I-T082
##34	I-T082
,	O
sant	B-T082
##are	I-T082
##m	I-T082
k	I-T082
##67	I-T082
,	O
and	O
ca	B-T082
##x	I-T082
##i	I-T082
##uan	I-T082
##a	I-T082
ca	I-T082
##x	I-T082
)	O
;	O
a	O
contrast	O
to	O
observed	O
gp	O
##p	O
increases	O
.	O
model	B-T170
simulated	O
dry	O
-	O
season	O
gp	O
##p	O
reductions	O
were	O
driven	O
by	O
an	O
external	O
environmental	B-T082
factor	O
,	O
'	O
soil	B-T033
water	I-T033
stress	I-T033
'	O
and	O
consequently	O
by	O
a	O
constant	O
or	O
decreasing	O
photosynthetic	O
infrastructure	O
(	O
pc	O
)	O
,	O
while	O
observed	O
dry	O
-	O
season	O
gp	O
##p	O
resulted	O
from	O
a	O
combination	O
of	O
internal	O
biological	O
(	O
leaf	B-T204
-	O
flush	O
and	O
absc	B-T038
##ission	I-T038
and	O
increased	O
pc	O
)	O
and	O
environmental	B-T082
(	O
incom	O
##ing	O
radiation	O
)	O
causes	O
.	O
moreover	O
,	O
we	O
found	O
models	B-T170
generally	O
overestimated	O
observed	O
seasonal	O
net	O
ecosystem	O
exchange	O
(	O
ne	O
##e	O
)	O
and	O
respiration	B-T038
(	O
re	B-T038
)	O
at	O
equatorial	O
locations	O
.	O
in	O
contrast	O
,	O
a	O
southern	B-T082
amazon	I-T082
forest	O
(	O
ja	O
##ru	O
r	O
##ja	O
)	O
exhibited	O
dry	O
-	O
season	O
declines	O
in	O
gp	O
##p	O
and	O
re	B-T038
consistent	O
with	O
most	O
dg	B-T170
##v	I-T170
##ms	I-T170
simulations	B-T062
.	O
while	O
water	O
limitation	O
was	O
represented	O
in	O
models	B-T170
and	O
the	O
primary	O
driver	O
of	O
seasonal	O
photosynthesis	O
in	O
southern	B-T082
amazon	I-T082
##ia	I-T082
,	O
changes	O
in	O
internal	O
biophysical	B-T038
processes	I-T038
,	O
light	B-T038
-	I-T038
harvesting	I-T038
adaptations	O
(	O
e	O
.	O
g	O
.	O
,	O
variations	O
in	O
leaf	B-T170
area	I-T170
index	I-T170
(	O
la	B-T170
##i	I-T170
)	O
and	O
increasing	O
leaf	B-T204
-	O
level	O
assimilation	B-T038
rate	O
related	O
to	O
leaf	O
dem	O
##ography	O
)	O
,	O
and	O
allocation	O
lag	O
##s	O
between	O
leaf	B-T204
and	O
wood	B-T204
,	O
dominated	O
equatorial	B-T082
amazon	I-T082
carbon	O
flux	O
dynamics	O
and	O
were	O
deficient	O
or	O
absent	O
from	O
current	O
model	B-T170
formulations	O
.	O
correctly	O
simulating	O
flux	O
seasonality	O
at	O
tropical	O
forests	O
requires	O
a	O
greater	O
understanding	O
and	O
the	O
incorporation	O
of	O
internal	O
biophysical	B-T038
mechanisms	I-T038
in	O
future	O
model	O
developments	O
.	O

the	O
consum	O
##ma	O
##tory	O
and	O
motivational	B-T038
behaviors	O
for	O
natural	O
rewards	B-T038
following	O
long	O
-	O
term	O
withdrawal	B-T058
from	O
morphine	B-T103
:	O
no	O
an	B-T038
##hed	I-T038
##onia	I-T038
but	O
persistent	O
maladaptive	B-T033
behaviors	I-T033
for	O
high	O
-	O
value	O
rewards	B-T038
the	O
negative	O
affective	O
state	O
,	O
e	O
.	O
g	O
.	O
,	O
an	B-T038
##hed	I-T038
##onia	I-T038
,	O
emerges	O
after	O
abstinence	O
from	O
abused	B-T103
drugs	I-T103
may	O
be	O
linked	O
to	O
the	O
motivational	B-T038
processes	O
of	O
drug	B-T033
craving	I-T033
and	O
relapse	O
.	O
although	O
an	B-T038
##hed	I-T038
##onia	I-T038
diminishes	O
over	O
time	O
with	O
drug	O
abstinence	O
,	O
it	O
is	O
not	O
yet	O
rather	O
explicit	O
whether	O
an	B-T038
##hed	I-T038
##onia	I-T038
exists	O
or	O
not	O
following	O
protracted	O
withdrawal	B-T058
.	O
the	O
behavioral	O
responses	O
to	O
natural	O
rewards	B-T038
were	O
examined	O
after	O
2	O
to	O
3	O
weeks	O
withdrawal	B-T058
from	O
morphine	B-T103
.	O
male	O
rats	B-T204
were	O
pretreated	O
with	O
either	O
a	O
binge	O
-	O
like	O
morphine	B-T103
paradigm	O
or	O
daily	O
saline	B-T058
injection	I-T058
for	O
5	O
days	O
.	O
the	O
consum	O
##ma	O
##tory	O
and	O
motivational	B-T038
behaviors	O
for	O
three	O
natural	O
rewards	B-T038
(	O
sucrose	B-T103
solutions	I-T103
4	O
,	O
15	O
,	O
and	O
60	O
%	O
,	O
social	O
stimulus	O
:	O
male	O
rat	B-T204
,	O
and	O
sexual	O
stimulus	O
:	O
estrous	B-T038
female	O
rat	B-T204
)	O
were	O
examined	O
under	O
varied	O
testing	O
conditions	O
.	O
the	O
morphine	B-T103
-	O
withdrawn	B-T058
rats	B-T204
significantly	O
increased	O
their	O
intake	O
of	O
15	O
%	O
sucrose	B-T103
solution	I-T103
during	O
the	O
1	O
-	O
h	O
consumption	O
test	O
and	O
their	O
operant	B-T038
responding	I-T038
for	O
15	O
%	O
sucrose	B-T103
solution	I-T103
under	O
a	O
progressive	O
ratio	O
(	O
pr	O
)	O
schedule	O
of	O
reinforcement	O
.	O
when	O
obtaining	O
a	O
reinforce	O
##r	O
was	O
associated	O
with	O
a	O
0	O
.	O
5	O
ma	O
foot	B-T017
shock	B-T058
under	O
a	O
pr	B-T062
-	I-T062
punishment	I-T062
schedule	I-T062
,	O
the	O
morphine	B-T103
-	O
withdrawn	B-T058
rats	B-T204
showed	O
a	O
higher	O
performance	O
for	O
60	O
%	O
sucrose	B-T103
solution	I-T103
.	O
meanwhile	O
,	O
the	O
morphine	B-T103
-	O
withdrawn	B-T058
rats	B-T204
displayed	O
a	O
higher	O
motivation	B-T038
to	O
sexual	O
stimulus	O
during	O
the	O
free	O
-	O
approach	O
test	O
and	O
more	O
approaching	O
behaviors	O
towards	O
sexual	O
stimulus	O
in	O
a	O
conflict	B-T058
-	I-T058
based	I-T058
approach	I-T058
test	I-T058
(	O
concurrent	O
presence	O
of	O
reward	B-T038
and	O
aversive	O
stimulus	O
)	O
.	O
no	B-T033
an	B-T038
##hed	I-T038
##onia	I-T038
-	O
like	O
behavior	O
but	O
sensitized	O
behaviors	O
for	O
natural	O
rewards	B-T038
were	O
found	O
after	O
long	O
-	O
term	O
morphine	B-T103
withdrawal	B-T058
.	O
notably	O
,	O
the	O
morphine	B-T103
-	O
withdrawn	B-T058
rats	B-T204
displayed	O
persistent	O
motivated	B-T038
behaviors	O
for	O
high	O
-	O
value	O
rewards	B-T038
(	O
60	O
%	O
sucrose	B-T103
and	O
sexual	O
stimulus	O
)	O
in	O
the	O
conflict	O
tests	O
suggesting	O
impairments	O
in	O
inhibitory	O
control	O
in	O
morphine	B-T103
-	O
treated	O
rats	B-T204
.	O

prevalence	O
of	O
high	B-T033
-	I-T033
risk	I-T033
human	B-T038
papillomavirus	I-T038
infection	I-T038
among	O
women	O
in	O
sh	B-T082
##aa	I-T082
##n	I-T082
##x	I-T082
##i	I-T082
province	B-T082
of	O
china	B-T082
:	O
a	O
hospital	B-T092
-	O
based	O
investigation	B-T058
this	O
study	O
aimed	O
to	O
investigate	O
the	O
characteristics	O
of	O
female	O
high	B-T038
-	I-T038
risk	I-T038
human	I-T038
papillomavirus	I-T038
(	I-T038
hr	I-T038
-	I-T038
hpv	I-T038
)	I-T038
infection	I-T038
in	O
sh	B-T082
##aa	I-T082
##n	I-T082
##x	I-T082
##i	I-T082
province	B-T082
of	O
china	B-T082
.	O
a	O
total	O
of	O
14	O
111	O
women	O
were	O
enrolled	O
for	O
hpv	B-T005
genotyping	O
test	O
,	O
and	O
a	O
cytology	B-T058
,	O
and	O
/	O
or	O
cervix	B-T058
biopsy	I-T058
were	O
performed	O
in	O
partial	O
women	O
.	O
of	O
these	O
women	O
,	O
the	O
hpv	B-T038
infection	I-T038
rate	O
was	O
30	O
.	O
21	O
%	O
,	O
and	O
26	O
.	O
73	O
%	O
were	O
caused	O
by	O
hr	B-T005
-	I-T005
hpv	I-T005
.	O
the	O
most	O
common	O
hr	B-T005
-	I-T005
hpv	I-T005
genotypes	O
were	O
hpv	B-T005
-	I-T005
16	I-T005
,	O
hpv	B-T005
-	I-T005
58	I-T005
,	O
hpv	B-T005
-	I-T005
52	I-T005
,	O
hpv	B-T005
-	I-T005
18	I-T005
,	O
and	O
hpv	B-T005
-	I-T005
31	I-T005
.	O
the	O
prevalence	O
of	O
hr	B-T005
-	I-T005
hpv	I-T005
among	O
women	O
older	O
than	O
50	O
years	O
was	O
significantly	O
higher	O
than	O
the	O
other	O
groups	O
(	O
p	O
<	O
0	O
.	O
05	O
)	O
.	O
the	O
main	O
carcinogenic	B-T103
genotypes	O
were	O
hpv	B-T005
-	I-T005
16	I-T005
,	O
hpv	B-T005
-	I-T005
18	I-T005
,	O
hpv	B-T005
-	I-T005
58	I-T005
,	O
hpv	B-T005
-	I-T005
52	I-T005
,	O
and	O
hpv	B-T005
-	I-T005
31	I-T005
.	O
hpv	B-T005
-	I-T005
16	I-T005
and	O
hpv	B-T005
-	I-T005
18	I-T005
combined	O
caused	O
80	O
.	O
79	O
%	O
of	O
cervical	B-T038
cancer	I-T038
cases	O
.	O
the	O
infection	B-T038
with	O
multiple	O
hr	B-T005
-	I-T005
hpv	I-T005
##s	I-T005
was	O
not	B-T033
a	O
risk	B-T033
factor	I-T033
for	O
cervical	B-T038
lesions	I-T038
.	O
in	O
conclusion	O
,	O
hpv	B-T038
infection	I-T038
was	O
common	O
among	O
women	O
in	O
sh	B-T082
##aa	I-T082
##n	I-T082
##x	I-T082
##i	I-T082
province	B-T082
.	O
women	O
older	O
than	O
50	O
years	O
were	O
a	O
high	O
-	O
risk	O
group	O
for	O
hr	B-T038
-	I-T038
hpv	I-T038
infection	I-T038
and	O
cervical	B-T038
cancer	I-T038
.	O
hpv	B-T005
-	I-T005
16	I-T005
and	O
hpv	B-T005
-	I-T005
18	I-T005
were	O
the	O
main	O
carcinogenic	B-T103
genotypes	O
in	O
this	O
region	B-T082
.	O

heart	B-T201
rate	I-T201
variability	O
:	O
pre	O
-	O
deployment	O
predictor	O
of	O
post	O
-	O
deployment	O
ptsd	B-T038
symptoms	B-T033
heart	B-T201
rate	I-T201
variability	O
is	O
a	O
physiological	O
measure	O
associated	O
with	O
autonomic	B-T022
nervous	I-T022
system	I-T022
activity	O
.	O
this	O
study	B-T062
hypothesized	O
that	O
lower	O
pre	O
-	O
deployment	O
hrv	B-T038
would	O
be	O
associated	O
with	O
higher	O
post	O
-	O
deployment	O
post	B-T038
-	I-T038
traumatic	I-T038
stress	I-T038
disorder	I-T038
(	O
ptsd	B-T038
)	O
symptoms	B-T033
.	O
three	O
-	O
hundred	O
-	O
forty	O
-	O
three	O
army	B-T097
national	I-T097
guard	I-T097
soldiers	I-T097
enrolled	O
in	O
the	O
warr	B-T062
##iors	I-T062
achieving	I-T062
resilience	I-T062
(	I-T062
war	I-T062
)	I-T062
study	I-T062
were	O
analyzed	O
.	O
the	O
primary	O
outcome	O
was	O
ptsd	B-T038
symptom	B-T033
severity	O
using	O
the	O
ptsd	B-T038
checklist	B-T170
-	O
military	B-T097
version	B-T170
(	O
pcl	B-T170
)	O
measured	O
at	O
baseline	O
,	O
3	O
-	O
and	O
12	O
-	O
month	O
post	O
-	O
deployment	O
.	O
heart	B-T201
rate	I-T201
variability	O
predictor	O
variables	O
included	O
:	O
high	O
frequency	O
power	O
(	O
hf	O
)	O
and	O
standard	O
deviation	O
of	O
the	O
normal	O
cardiac	B-T038
inter	I-T038
-	I-T038
beat	I-T038
interval	O
(	O
sd	O
##nn	O
)	O
.	O
generalized	O
linear	B-T170
mixed	I-T170
models	I-T170
revealed	O
that	O
the	O
pre	O
-	O
deployment	O
pcl	B-T170
*	O
ln	O
(	O
hf	O
)	O
interaction	O
term	O
was	O
significant	O
(	O
p	O
<	O
0	O
.	O
0001	O
)	O
.	O
pre	O
-	O
deployment	O
sd	O
##nn	O
was	O
not	O
a	O
significant	O
predictor	O
of	O
post	O
-	O
deployment	O
pcl	B-T170
.	O
covariates	O
included	O
age	O
,	O
pre	O
-	O
deployment	O
pcl	B-T170
,	O
race	B-T098
/	O
ethnicity	B-T098
,	O
marital	O
status	O
,	O
tobacco	O
use	O
,	O
childhood	B-T038
abuse	I-T038
,	O
pre	O
-	O
deployment	O
traumatic	B-T037
brain	I-T037
injury	I-T037
,	O
and	O
previous	O
combat	B-T082
zone	I-T082
deployment	O
.	O
pre	O
-	O
deployment	O
heart	B-T201
rate	I-T201
variability	O
predicts	O
post	O
-	O
deployment	O
ptsd	B-T038
symptoms	B-T033
in	O
the	O
context	O
of	O
higher	O
pre	O
-	O
deployment	O
pcl	B-T170
scores	O
.	O

comparison	O
of	O
pulse	O
wave	O
velocity	O
derived	O
from	O
accelerometer	B-T074
and	O
reflective	B-T058
photo	I-T058
-	I-T058
plethysm	I-T058
##ography	I-T058
signals	I-T058
placed	O
at	O
the	O
carotid	B-T017
and	O
femoral	B-T017
artery	I-T017
carotid	B-T017
-	O
femoral	B-T017
pulse	O
wave	O
velocity	O
is	O
an	O
established	O
measure	O
to	O
assess	O
cardiovascular	O
risk	O
and	O
an	O
interesting	O
surrogate	O
parameter	O
towards	O
non	B-T201
-	I-T201
invasive	I-T201
continuous	I-T201
blood	I-T201
pressure	I-T201
inference	I-T201
.	O
due	O
to	O
progress	O
in	O
sensing	O
technologies	O
for	O
wearable	O
wrist	O
worn	O
sensors	O
,	O
there	O
are	O
low	O
cost	O
sensor	O
combinations	O
of	O
photo	B-T058
-	I-T058
plethysm	I-T058
##ography	I-T058
and	O
high	B-T074
fidelity	I-T074
accelerometer	I-T074
s	I-T074
available	O
offering	O
access	O
to	O
pulse	B-T058
information	I-T058
from	O
larger	B-T017
arteries	I-T017
complemented	O
by	O
blood	B-T201
volume	I-T201
changes	O
in	O
the	O
superficial	B-T017
tissue	I-T017
.	O
in	O
this	O
work	O
we	O
compare	O
pulse	O
wave	O
velocities	O
derived	O
from	O
accelerometer	B-T074
and	O
reflective	B-T058
photo	I-T058
-	I-T058
plethysm	I-T058
##ography	I-T058
signals	I-T058
placed	O
at	O
the	O
carotid	B-T017
and	O
femoral	B-T017
artery	I-T017
.	O
we	O
discuss	O
the	O
different	O
underlying	O
physiological	B-T038
processes	I-T038
for	O
the	O
two	O
sensing	O
principles	O
and	O
present	O
experimental	B-T033
results	I-T033
obtained	O
in	O
a	O
study	B-T062
with	O
healthy	B-T098
subjects	I-T098
.	O

high	O
throughput	O
resistance	B-T038
profiling	O
of	O
plasmodium	B-T038
falciparum	I-T038
infections	I-T038
based	O
on	O
custom	B-T062
dual	I-T062
index	I-T062
##ing	I-T062
and	O
illumina	B-T062
next	I-T062
generation	I-T062
sequencing	I-T062
-	I-T062
technology	I-T062
genetic	B-T038
polymorphisms	I-T038
in	O
p	B-T204
.	I-T204
falciparum	I-T204
can	O
be	O
used	O
to	O
indicate	O
the	O
parasite	B-T204
'	I-T204
s	I-T204
susceptibility	B-T033
to	O
antimalarial	B-T103
drugs	I-T103
as	O
well	O
as	O
its	O
geographical	B-T082
origin	I-T082
.	O
both	O
of	O
these	O
factors	O
are	O
key	O
to	O
monitoring	B-T058
development	O
and	O
spread	O
of	O
antimalarial	B-T038
drug	I-T038
resistance	I-T038
.	O
in	O
this	O
study	O
,	O
we	O
combine	O
multiplex	B-T058
pcr	I-T058
,	O
custom	B-T062
designed	I-T062
dual	I-T062
index	I-T062
##ing	I-T062
and	O
mis	B-T170
##e	I-T170
##q	I-T170
sequencing	B-T058
for	O
high	O
throughput	O
snp	B-T082
-	O
profiling	O
of	O
45	O
##7	O
malaria	B-T038
infections	B-T038
from	O
guinea	B-T082
-	I-T082
bis	I-T082
##sa	I-T082
##u	I-T082
,	O
at	O
the	O
cost	O
of	O
10	O
us	O
##d	O
per	O
sample	O
.	O
by	O
amplify	B-T038
##ing	I-T038
and	O
sequencing	B-T058
15	O
genetic	O
fragments	O
,	O
we	O
cover	O
20	O
resistance	B-T038
-	O
conferring	O
snps	B-T082
occurring	O
in	O
pfc	B-T017
##rt	I-T017
,	O
pf	B-T017
##md	I-T017
##r1	I-T017
,	O
pf	B-T017
##dh	I-T017
##fr	I-T017
,	O
pf	B-T017
##dh	I-T017
##ps	I-T017
,	O
as	O
well	O
as	O
the	O
entire	O
length	O
of	O
pf	B-T017
##k1	I-T017
##3	I-T017
,	O
and	O
the	O
mitochondrial	B-T017
barc	B-T170
##ode	I-T170
for	O
parasite	B-T204
origin	B-T033
.	O
snps	B-T082
of	O
interest	O
were	O
sequenced	O
with	O
an	O
average	O
depth	O
of	O
2	O
,	O
043	O
reads	O
,	O
and	O
bases	O
were	O
called	O
for	O
the	O
various	O
snp	B-T082
-	O
positions	B-T082
with	O
a	O
p	O
-	O
value	O
below	O
0	O
.	O
05	O
,	O
for	O
89	O
.	O
8	O
-	O
100	O
%	O
of	O
samples	O
.	O
the	O
snp	B-T082
data	O
indicates	O
that	O
artemisinin	B-T038
resistance	I-T038
-	O
conferring	O
snps	B-T082
in	O
pf	B-T017
##k1	I-T017
##3	I-T017
are	O
absent	O
from	O
the	O
studied	O
area	O
of	O
guinea	B-T082
-	I-T082
bis	I-T082
##sa	I-T082
##u	I-T082
,	O
while	O
the	O
pf	B-T017
##md	I-T017
##r1	I-T017
86	O
n	O
allele	O
is	O
found	O
at	O
a	O
high	O
prevalence	O
.	O
the	O
mitochondrial	B-T017
barc	B-T170
##odes	I-T170
are	O
un	O
##ani	O
##mo	O
##us	O
and	O
accommodate	O
a	O
west	B-T033
african	I-T033
origin	I-T033
of	O
the	O
parasites	B-T204
.	O
with	O
this	O
method	B-T170
,	O
very	O
reliable	O
high	O
throughput	O
surveillance	B-T058
of	O
antimalarial	B-T038
drug	I-T038
resistance	I-T038
becomes	O
more	O
affordable	O
than	O
ever	O
before	O
.	O

design	O
,	O
synthesis	O
and	O
anti	B-T038
-	I-T038
tumor	I-T038
activity	I-T038
study	B-T062
of	O
novel	O
histone	B-T103
deacetylase	I-T103
inhibitors	I-T103
containing	O
is	B-T103
##atin	I-T103
-	O
based	O
caps	O
and	O
o	B-T103
-	I-T103
phenyle	I-T103
##ned	I-T103
##ia	I-T103
##min	I-T103
##e	I-T103
-	O
based	O
zinc	O
binding	O
groups	O
as	O
a	O
hot	O
topic	O
of	O
epigenetic	B-T091
studies	I-T091
,	O
histone	B-T103
deacetylase	I-T103
##s	I-T103
(	O
hdac	B-T103
##s	I-T103
)	O
are	O
related	O
to	O
lot	O
##s	O
of	O
diseases	B-T038
,	O
especially	O
cancer	B-T038
.	O
further	O
researches	B-T062
indicated	O
that	O
different	O
hdac	B-T103
isoforms	I-T103
played	O
various	O
roles	O
in	O
a	O
wide	O
range	O
of	O
tumor	O
types	O
.	O
herein	O
a	O
novel	O
series	O
of	O
hdac	B-T103
inhibitors	I-T103
with	O
is	B-T103
##atin	I-T103
-	O
based	O
caps	O
and	O
o	B-T103
-	I-T103
phenyle	I-T103
##ned	I-T103
##ia	I-T103
##min	I-T103
##e	I-T103
-	O
based	O
zinc	O
binding	O
groups	O
have	O
been	O
designed	O
and	O
synthesized	O
through	O
scaffold	B-T058
hop	I-T058
##ping	I-T058
strategy	I-T058
.	O
among	O
these	O
compounds	B-T103
,	O
the	O
most	O
potent	O
compound	B-T103
9	I-T103
##n	I-T103
exhibited	O
similar	O
if	O
not	O
better	O
hdac	B-T103
inhibition	B-T038
and	O
antiproliferative	B-T038
activities	I-T038
against	O
multiple	O
tumor	B-T017
cell	I-T017
lines	I-T017
compared	O
with	O
the	O
positive	O
control	O
enti	B-T103
##no	I-T103
##st	I-T103
##at	I-T103
(	O
ms	B-T103
-	I-T103
275	I-T103
)	O
.	O
additionally	O
,	O
compared	O
with	O
ms	B-T103
-	I-T103
275	I-T103
(	O
ic50	O
values	O
for	O
hdac	B-T103
##1	I-T103
,	O
2	B-T103
and	O
3	B-T103
were	O
0	O
.	O
163	O
,	O
0	O
.	O
39	O
##6	O
and	O
0	O
.	O
60	O
##5	O
##µ	O
##m	O
,	O
respectively	O
)	O
,	O
compound	B-T103
9	I-T103
##n	I-T103
with	O
ic50	O
values	O
of	O
0	O
.	O
032	O
,	O
0	O
.	O
256	O
and	O
0	O
.	O
311	O
##µ	O
##m	O
for	O
hdac	B-T103
##1	I-T103
,	O
2	B-T103
and	O
3	B-T103
respectively	O
,	O
showed	O
a	O
moderate	O
hdac	B-T103
##1	I-T103
selectivity	O
.	O

soy	O
##mi	O
##l	O
##k	O
residue	O
(	O
ok	B-T103
##ara	I-T103
)	O
as	O
a	O
natural	O
immobilization	O
carrier	O
for	O
lactobacillus	B-T007
plantarum	I-T007
cells	B-T017
enhances	O
soy	O
##mi	O
##l	O
##k	O
fermentation	B-T038
,	O
gluc	B-T103
##osi	I-T103
##di	I-T103
##c	I-T103
isoflav	I-T103
##one	I-T103
bioc	O
##onv	O
##ersion	O
,	O
and	O
cell	B-T038
survival	I-T038
under	O
simulated	O
gastric	O
and	O
intestinal	B-T017
conditions	O
cell	B-T017
immobilization	I-T017
is	O
an	O
alternative	O
to	O
micro	B-T058
##encaps	I-T058
##ulation	I-T058
for	O
the	O
maintenance	O
of	O
cells	B-T017
in	O
a	O
liquid	O
medium	O
.	O
however	O
,	O
artificial	O
immobilization	O
carriers	O
are	O
expensive	O
and	O
pose	O
a	O
high	O
safety	O
risk	O
.	O
ok	B-T103
##ara	I-T103
,	O
a	O
food	B-T168
-	I-T168
grade	I-T168
byproduc	O
##t	O
from	O
soy	O
##mi	O
##l	O
##k	O
production	O
,	O
is	O
rich	O
in	O
prebiotic	B-T103
##s	I-T103
.	O
lactobacilli	B-T007
could	O
provide	O
health	O
enhancing	O
effects	O
to	O
the	O
host	O
.	O
this	O
study	B-T062
aimed	O
to	O
evaluate	O
the	O
potential	O
of	O
ok	B-T103
##ara	I-T103
as	O
a	O
natural	O
immobil	O
##izer	O
for	O
l	B-T017
.	I-T017
plantarum	I-T017
70	I-T017
##81	I-T017
##0	I-T017
cells	I-T017
.	O
the	O
study	O
also	O
aimed	O
to	O
evaluate	O
the	O
effects	O
of	O
ok	B-T103
##ara	I-T103
-	I-T103
immobilized	I-T103
l	B-T017
.	I-T017
plantarum	I-T017
70	I-T017
##81	I-T017
##0	I-T017
cells	I-T017
(	O
il	B-T017
)	O
on	O
soy	O
##mi	O
##l	O
##k	O
fermentation	B-T038
,	O
gluc	B-T103
##osi	I-T103
##di	I-T103
##c	I-T103
isoflav	I-T103
##one	I-T103
bioc	O
##onv	O
##ersion	O
,	O
and	O
cell	B-T017
resistance	O
to	O
simulated	O
gastric	O
and	O
intestinal	B-T017
stresses	B-T038
.	O
scanning	B-T058
electron	I-T058
microscopy	I-T058
(	O
sem	B-T058
)	O
was	O
used	O
to	O
show	O
cells	B-T017
adherence	O
to	O
the	O
surface	B-T082
of	O
ok	B-T103
##ara	I-T103
.	O
lactic	B-T103
acid	I-T103
,	O
acetic	B-T103
acid	I-T103
and	O
isoflav	B-T103
##one	I-T103
analyses	B-T062
in	O
unf	O
##erm	O
##ented	O
and	O
fermented	B-T168
soy	O
##mi	O
##l	O
##k	O
were	O
performed	O
by	O
hplc	B-T058
with	I-T058
uv	I-T058
detection	I-T058
.	O
viability	O
and	O
growth	O
kinetics	O
of	O
immobilized	B-T017
and	O
free	B-T017
l	I-T017
.	I-T017
plantarum	I-T017
70	I-T017
##81	I-T017
##0	I-T017
cells	I-T017
(	O
fl	B-T017
)	O
were	O
followed	O
during	O
soy	O
##mi	O
##l	O
##k	O
fermentation	B-T038
.	O
moreover	O
,	O
changes	O
in	O
ph	B-T033
,	O
titr	B-T033
##able	I-T033
acidity	I-T033
and	O
viscosity	O
were	O
measured	O
by	O
conventional	B-T170
methods	I-T170
.	O
for	O
in	O
vitro	O
testing	O
of	O
simulated	O
gastrointestinal	B-T082
resistance	O
,	O
fermented	B-T168
soy	O
##mi	O
##l	O
##k	O
was	O
inoculated	B-T058
with	O
fl	B-T017
or	O
il	B-T017
and	O
an	O
aliqu	O
##ot	O
incubated	B-T058
into	O
acidic	O
mrs	O
broth	O
which	O
was	O
convenient	O
##ly	O
prepared	O
to	O
simulate	O
gastric	O
,	O
pancreatic	B-T031
juice	I-T031
##s	I-T031
and	O
bile	B-T103
salts	I-T103
.	O
survival	O
to	O
simulated	O
gastric	O
and	O
intestinal	B-T017
stresses	B-T038
was	O
evaluated	O
by	O
plate	B-T058
count	I-T058
of	I-T058
colony	I-T058
forming	I-T058
units	I-T058
on	O
mrs	B-T103
agar	I-T103
.	O
sem	B-T058
revealed	O
that	O
the	O
lactobacilli	B-T007
cells	B-T017
attached	O
and	O
bound	O
to	O
the	O
surface	B-T082
of	O
ok	B-T103
##ara	I-T103
.	O
compared	O
with	O
fl	B-T017
,	O
il	B-T017
exhibited	O
a	O
significantly	O
higher	O
specific	O
growth	O
rate	O
,	O
shorter	O
lag	O
phase	O
of	O
growth	B-T038
,	O
higher	O
production	O
##s	O
of	O
lactic	B-T103
and	O
acetic	B-T103
acids	I-T103
,	O
a	O
faster	O
decrease	O
in	O
ph	B-T033
and	O
increase	O
in	O
titr	B-T033
##able	I-T033
acidity	I-T033
,	O
and	O
a	O
higher	O
soy	O
##mi	O
##l	O
##k	O
viscosity	O
.	O
similarly	O
,	O
il	B-T017
in	O
soy	O
##mi	O
##l	O
##k	O
showed	O
higher	O
production	O
##s	O
of	O
da	B-T103
##ize	I-T103
##in	I-T103
and	O
genistein	B-T103
compared	O
with	O
the	O
control	O
.	O
compared	O
with	O
fl	B-T017
,	O
il	B-T017
showed	O
reinforced	O
resistance	O
to	O
simulated	O
##ga	O
##st	O
##ric	O
and	O
intestinal	B-T017
stresses	B-T038
in	O
vitro	O
that	O
included	O
low	B-T033
ph	I-T033
,	O
low	B-T033
ph	I-T033
plus	I-T033
pepsin	B-T103
,	O
pancre	B-T103
##atin	I-T103
,	O
and	O
bile	B-T103
salt	I-T103
.	O
our	O
results	O
indicate	O
that	O
ok	B-T103
##ara	I-T103
is	O
a	O
new	O
potential	O
immobilization	O
carrier	O
to	O
enhance	O
the	O
growth	B-T038
and	O
gluc	B-T103
##osi	I-T103
##di	I-T103
##c	I-T103
isoflav	I-T103
##one	I-T103
bioc	O
##onv	O
##ersion	O
activities	O
of	O
l	B-T007
.	I-T007
plantarum	I-T007
in	O
soy	O
##mi	O
##l	O
##k	O
and	O
improve	B-T033
cell	B-T038
surviv	I-T038
##ability	I-T038
following	O
simulated	O
gastric	O
and	O
intestinal	B-T017
conditions	O
.	O

grasp	B-T038
##ing	I-T038
at	O
the	O
mo	B-T082
##on	I-T082
:	O
enhancing	O
access	B-T082
to	O
career	O
##s	O
in	O
the	O
health	B-T091
professions	I-T091
a	O
former	O
hh	B-T092
##s	I-T092
secret	B-T097
##ary	I-T097
reflects	B-T038
on	O
what	O
'	O
s	O
needed	O
to	O
enable	O
more	O
minorities	B-T098
to	O
become	O
doctors	B-T097
and	O
other	O
health	B-T097
professionals	I-T097
.	O

hemodynamic	B-T038
correlates	O
of	O
transient	B-T038
cognitive	I-T038
impairment	I-T038
after	O
transient	B-T038
ischemic	I-T038
attack	I-T038
and	O
minor	B-T038
stroke	I-T038
:	O
a	O
transcranial	B-T058
doppler	I-T058
study	I-T058
transient	B-T038
cognitive	I-T038
impairment	I-T038
(	O
tc	B-T038
##i	I-T038
)	O
on	O
the	O
mini	B-T058
mental	I-T058
state	I-T058
evaluation	I-T058
score	O
is	O
common	O
after	O
transient	B-T038
ischemic	I-T038
attack	I-T038
/	O
minor	B-T038
stroke	I-T038
and	O
might	O
identify	O
patients	O
at	O
increased	O
risk	O
of	O
dementia	B-T038
.	O
we	O
aimed	O
to	O
replicate	O
tc	B-T038
##i	I-T038
using	O
the	O
mont	B-T170
##re	I-T170
##al	I-T170
cognitive	I-T170
assessment	I-T170
(	O
mo	B-T170
##ca	I-T170
)	O
,	O
compare	O
it	O
with	O
persistent	B-T038
mild	I-T038
cognitive	I-T038
impairment	I-T038
(	O
pm	B-T038
##ci	I-T038
)	O
,	O
and	O
to	O
determine	O
whether	O
global	O
cerebral	B-T017
hemodynamic	B-T038
changes	O
could	O
explain	O
transient	O
impairment	O
.	O
consecutive	O
patients	O
with	O
transient	B-T038
ischemic	I-T038
attack	I-T038
/	O
minor	B-T038
stroke	I-T038
(	O
nih	O
##ss	O
≤	O
3	O
)	O
were	O
assessed	O
with	O
the	O
mo	B-T170
##ca	I-T170
and	O
transcranial	B-T058
doppler	I-T058
ultrasound	I-T058
acutely	O
and	O
at	O
1	O
month	O
.	O
we	O
compared	O
patients	O
with	O
tc	B-T038
##i	I-T038
(	O
baseline	O
mo	B-T170
##ca	I-T170
<	O
26	O
with	O
≥	O
2	O
points	O
increase	O
at	O
1	O
month	O
)	O
,	O
pm	B-T038
##ci	I-T038
(	O
mo	B-T170
##ca	I-T170
<	O
26	O
with	O
<	O
2	O
points	O
increase	O
)	O
,	O
and	O
no	B-T033
cognitive	I-T033
impairment	I-T033
(	O
nci	B-T033
;	O
mo	B-T170
##ca	I-T170
≥	O
26	O
)	O
.	O
of	O
326	O
patients	O
,	O
46	O
(	O
14	O
.	O
1	O
%	O
)	O
had	O
pm	B-T038
##ci	I-T038
,	O
98	O
(	O
30	O
.	O
1	O
%	O
)	O
tc	B-T038
##i	I-T038
,	O
and	O
182	O
(	O
55	O
.	O
8	O
%	O
)	O
nci	B-T033
.	O
at	O
baseline	O
,	O
tc	B-T038
##i	I-T038
patients	O
had	O
higher	B-T033
systolic	I-T033
blood	I-T033
pressure	I-T033
(	O
150	O
.	O
95	O
±	O
21	O
.	O
52	O
vs	O
144	O
.	O
86	O
±	O
22	O
.	O
44	O
mmhg	O
,	O
p	O
=	O
0	O
.	O
02	O
)	O
and	O
lower	O
cerebral	O
blood	O
flow	O
velocities	O
,	O
particularly	O
end	O
-	O
diastolic	O
velocity	O
(	O
30	O
.	O
16	O
±	O
9	O
.	O
63	O
vs	O
35	O
.	O
02	O
±	O
9	O
.	O
01	O
cm	O
/	O
s	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
mean	B-T033
flow	I-T033
velocity	I-T033
(	O
48	O
.	O
95	O
±	O
12	O
.	O
72	O
vs	O
54	O
±	O
12	O
.	O
46	O
cm	O
/	O
s	O
,	O
p	O
=	O
0	O
.	O
001	O
)	O
than	O
those	O
with	O
nci	B-T033
,	O
but	O
similar	O
clinical	O
and	O
hemodynamic	B-T038
profiles	B-T058
to	O
those	O
with	O
pm	B-T038
##ci	I-T038
.	O
systolic	B-T033
bp	I-T033
fell	I-T033
between	O
baseline	O
and	O
1	O
month	O
(	O
mean	O
reduction	B-T058
=	O
14	O
.	O
01	O
±	O
21	O
.	O
26	O
mmhg	O
)	O
and	O
end	O
-	O
diastolic	O
velocity	O
and	O
mean	B-T033
flow	I-T033
velocity	I-T033
increased	O
(	O
mean	O
increase	O
=	O
+	O
2	O
.	O
42	O
±	O
6	O
.	O
41	O
and	O
1	O
.	O
89	O
±	O
8	O
.	O
77	O
cm	O
/	O
s	O
,	O
respectively	O
)	O
,	O
but	O
these	O
changes	O
did	O
not	O
differ	O
between	O
patients	O
with	O
tc	B-T038
##i	I-T038
,	O
pm	B-T038
##ci	I-T038
,	O
and	O
nci	B-T033
.	O
tc	B-T038
##i	I-T038
is	O
detectable	B-T201
with	O
the	O
mo	B-T170
##ca	I-T170
after	O
transient	B-T038
ischemic	I-T038
attack	I-T038
and	O
minor	B-T038
stroke	I-T038
and	O
has	O
similar	O
clinical	O
and	O
hemodynamic	B-T038
profile	B-T058
to	O
pm	B-T038
##ci	I-T038
.	O
however	O
,	O
tc	B-T038
##i	I-T038
does	O
not	O
appear	O
to	O
be	O
due	O
to	O
exaggerated	O
acute	O
reversible	O
global	O
hemodynamic	B-T038
changes	O
.	O

biochemical	O
characteristics	O
of	O
at	B-T103
##fa	I-T103
##r2	I-T103
,	O
a	O
fatty	B-T103
acid	I-T103
reductase	I-T103
from	O
arabidopsis	B-T204
thaliana	I-T204
that	O
reduces	O
fatty	B-T103
acyl	I-T103
-	I-T103
coa	I-T103
and	O
-	O
acp	B-T103
substrates	I-T103
into	O
fatty	B-T103
alcohols	I-T103
fatty	B-T103
alcohols	I-T103
and	O
derivatives	B-T103
are	O
important	O
for	O
proper	O
deposition	O
of	O
a	O
functional	O
pollen	B-T017
wall	I-T017
.	O
mutations	B-T038
in	O
specific	O
genes	B-T017
encoding	O
fatty	B-T103
acid	I-T103
reductase	I-T103
##s	I-T103
(	O
far	B-T103
)	O
responsible	O
for	O
fatty	B-T103
alcohol	I-T103
production	O
cause	O
abnormal	B-T033
development	O
of	O
pollen	B-T204
.	O
a	O
disrupted	O
at	B-T017
##fa	I-T017
##r2	I-T017
(	I-T017
ms	I-T017
##2	I-T017
)	I-T017
gene	I-T017
in	O
arabidopsis	B-T204
thaliana	I-T204
results	O
in	O
pollen	B-T204
developing	O
an	O
abnormal	B-T033
ex	B-T017
##ine	I-T017
layer	I-T017
and	O
a	O
reduced	B-T033
fertility	I-T033
phenotype	O
.	O
at	B-T103
##fa	I-T103
##r2	I-T103
has	O
been	O
shown	O
to	O
be	O
targeted	O
to	O
chloroplasts	B-T017
and	O
in	O
a	O
purified	O
form	O
to	O
be	O
specific	O
for	O
acyl	B-T103
-	I-T103
acp	I-T103
substrates	I-T103
.	O
here	O
,	O
we	O
present	O
data	O
on	O
the	O
in	O
vitro	O
and	O
in	O
plant	B-T204
##a	I-T204
characterization	O
##s	O
of	O
at	B-T103
##fa	I-T103
##r2	I-T103
from	O
a	B-T204
.	I-T204
thaliana	I-T204
and	O
show	O
that	O
this	O
enzyme	B-T103
has	O
the	O
ability	O
to	O
use	O
both	O
,	O
c16	B-T103
:	I-T103
0	I-T103
-	I-T103
acp	I-T103
and	O
c16	B-T103
:	I-T103
0	I-T103
-	I-T103
coa	I-T103
,	O
as	O
substrates	O
to	O
produce	O
c16	B-T103
:	I-T103
0	I-T103
-	I-T103
alcohol	I-T103
.	O
our	O
results	O
further	O
show	O
that	O
at	B-T103
##fa	I-T103
##r2	I-T103
is	O
highly	O
similar	O
in	O
properties	O
and	O
substrate	O
specificity	O
to	O
at	B-T103
##fa	I-T103
##r	I-T103
##6	I-T103
for	O
which	O
in	O
vitro	O
data	O
has	O
been	O
published	O
,	O
and	O
which	O
is	O
also	O
a	O
chloroplast	B-T017
localized	B-T082
enzyme	B-T103
.	O
this	O
suggests	O
that	O
although	O
at	B-T103
##fa	I-T103
##r2	I-T103
is	O
the	O
major	O
enzyme	B-T103
responsible	O
for	O
ex	B-T017
##ine	I-T017
layer	I-T017
functionality	O
,	O
at	B-T103
##fa	I-T103
##r	I-T103
##6	I-T103
might	O
provide	O
functional	O
redundancy	O
to	O
at	B-T103
##fa	I-T103
##r2	I-T103
.	O

novel	O
observations	B-T062
in	O
11	O
hetero	B-T038
##res	I-T038
##istan	I-T038
##t	I-T038
vancomycin	B-T103
-	I-T103
intermediate	I-T103
methicillin	B-T007
-	I-T007
resistant	I-T007
staphylococcus	I-T007
aureus	I-T007
strains	I-T007
from	O
south	B-T082
india	I-T082
we	O
report	O
here	O
the	O
draft	O
genome	B-T082
sequences	I-T082
of	O
11	O
hetero	B-T038
##res	I-T038
##istan	I-T038
##t	I-T038
vancomycin	B-T007
-	I-T007
intermediate	I-T007
staphylococcus	I-T007
aureus	I-T007
(	I-T007
hv	I-T007
##isa	I-T007
)	I-T007
strains	I-T007
from	O
bloodstream	B-T038
infection	I-T038
.	O
all	O
strains	O
harbor	O
mutations	B-T038
in	O
vr	B-T017
##as	I-T017
##r	I-T017
,	O
gras	B-T017
##r	I-T017
,	O
walk	B-T017
##r	I-T017
,	O
and	O
/	O
or	O
tca	B-T017
##ra	I-T017
##b	I-T017
and	O
are	O
often	O
implicated	O
as	O
the	O
frequently	O
mutated	B-T038
candidate	O
genes	B-T017
in	O
hv	B-T007
##isa	I-T007
phenotypes	O
.	O

serum	B-T031
levels	O
of	O
genomic	B-T103
dna	I-T103
of	O
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
are	O
elevated	O
in	O
scleroderma	B-T038
patients	O
recent	O
studies	O
have	O
indicated	O
that	O
various	O
nucleic	B-T103
acids	I-T103
are	O
present	O
in	O
human	B-T204
sera	B-T031
,	O
and	O
attracted	O
attention	O
for	O
their	O
potential	O
as	O
novel	O
disease	O
markers	O
in	O
many	O
human	B-T204
diseases	B-T038
.	O
in	O
this	O
study	O
,	O
we	O
tried	O
to	O
evaluate	O
the	O
possibility	O
that	O
dna	B-T103
and	O
rna	B-T103
of	O
collagens	B-T017
exist	O
in	O
human	B-T204
sera	B-T031
,	O
and	O
determined	O
whether	O
their	O
serum	B-T031
levels	O
can	O
be	O
useful	O
biomarkers	B-T201
in	O
scleroderma	B-T038
patients	O
.	O
the	O
rna	B-T103
or	O
dna	B-T103
of	O
collagens	B-T017
were	O
purified	O
from	O
sera	B-T031
,	O
and	O
detected	B-T033
by	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
or	O
quantitated	O
by	O
real	B-T062
-	I-T062
time	I-T062
polymerase	I-T062
chain	I-T062
reaction	I-T062
.	O
among	O
approximately	O
18	O
360	B-T017
bases	I-T017
of	I-T017
full	I-T017
-	I-T017
length	I-T017
α1	I-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
,	O
various	O
regions	B-T017
were	O
detected	B-T033
by	O
polymerase	B-T062
chain	I-T062
reaction	I-T062
in	O
human	B-T204
sera	B-T031
.	O
however	O
,	O
α2	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
,	O
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
rna	B-T103
or	O
α2	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
rna	B-T103
were	O
not	B-T033
detectable	I-T033
.	O
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
in	O
sera	B-T031
was	O
quantitative	O
using	O
our	O
method	O
.	O
the	O
levels	O
of	O
serum	B-T031
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
were	O
significantly	O
increased	O
in	O
scleroderma	B-T038
patients	O
compared	O
with	O
healthy	O
control	O
subjects	B-T098
or	O
systemic	B-T038
lupus	I-T038
erythematosus	I-T038
patients	O
.	O
according	O
to	O
the	O
receiver	O
-	O
operator	O
curve	O
analysis	O
,	O
serum	B-T031
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
levels	O
were	O
shown	O
to	O
be	O
effective	O
as	O
a	O
diagnostic	B-T201
marker	I-T201
of	O
scleroderma	B-T038
.	O
furthermore	O
,	O
when	O
we	O
determined	O
the	O
association	O
of	O
serum	B-T031
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
levels	O
with	O
clinical	O
/	O
laboratory	B-T092
features	O
in	O
scleroderma	B-T038
patients	O
,	O
those	O
with	O
elevated	O
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
levels	O
showed	O
significantly	O
higher	O
prevalence	O
of	O
pit	B-T038
##ting	I-T038
scars	I-T038
/	O
ulcers	B-T038
.	O
in	O
summary	O
,	O
elevation	O
of	O
serum	B-T031
α1	B-T017
(	I-T017
i	I-T017
)	I-T017
collagen	I-T017
dna	B-T103
levels	O
in	O
scleroderma	B-T038
patients	O
may	O
be	O
useful	O
as	O
the	O
diagnostic	B-T201
marker	I-T201
,	O
reflecting	O
the	O
presence	O
of	O
vasculopathy	B-T038
.	O
jo	O
##u	O
rna	B-T103

contralateral	B-T082
superior	B-T038
cerebellar	I-T038
artery	I-T038
syndrome	I-T038
:	O
a	O
consequence	O
of	O
brain	B-T017
herniation	I-T017
vascular	B-T017
compromise	O
is	O
a	O
well	O
-	O
known	O
consequence	O
of	O
brain	B-T017
herniation	I-T017
syndromes	B-T038
.	O
trans	B-T082
##ten	I-T082
##tor	I-T082
##ial	I-T082
brain	B-T017
herniation	I-T017
most	O
often	O
involves	O
posterior	B-T017
cerebral	I-T017
arteries	I-T017
.	O
however	O
,	O
isolated	O
involvement	O
of	O
contralateral	B-T082
superior	B-T017
cerebellar	I-T017
artery	I-T017
(	O
sca	B-T017
)	O
during	O
unilateral	B-T082
imp	O
##ending	O
brain	B-T017
herniation	I-T017
is	O
reported	B-T058
only	O
once	O
and	O
we	O
present	O
another	O
case	O
of	O
this	O
exceeding	O
##ly	O
rare	O
entity	O
.	O
a	O
24	O
-	O
year	O
-	O
old	O
man	B-T098
was	O
referred	O
to	O
us	O
with	O
imp	O
##ending	O
herniation	B-T017
due	O
to	O
a	O
multil	B-T082
##oc	I-T082
##ulated	I-T082
hydrocephalus	B-T038
,	O
and	O
during	O
the	O
course	B-T038
of	I-T038
illness	I-T038
,	O
he	O
developed	O
an	O
isolated	O
sca	B-T017
ischemia	B-T038
in	O
the	O
opposite	O
side	O
of	O
the	O
most	O
dilated	B-T033
entrapped	O
horn	B-T017
.	O
in	O
the	O
current	O
article	B-T170
we	O
discuss	O
the	O
probable	O
pathophysiologic	O
mechanisms	O
of	O
this	O
phenomenon	O
,	O
as	O
well	O
as	O
recommend	O
##ing	O
more	O
inclusive	O
brain	B-T017
studies	O
in	O
cases	O
suspected	O
of	O
kern	B-T038
##oh	I-T038
##an	I-T038
-	I-T038
wol	I-T038
##t	I-T038
##man	I-T038
notch	I-T038
phenomenon	I-T038
in	O
unilateral	B-T082
brain	B-T017
herniation	I-T017
.	O
the	O
rationale	O
for	O
this	O
commentary	B-T170
is	O
that	O
contralateral	B-T082
sca	B-T017
transient	B-T038
ischemia	I-T038
or	O
infarct	B-T038
might	O
be	O
the	O
under	B-T033
##diagnosed	I-T033
underlying	O
path	B-T038
##ome	I-T038
##cha	I-T038
##nis	I-T038
##m	I-T038
of	O
ipsilateral	B-T082
hemiparesis	B-T033
occurring	O
in	O
many	O
cases	O
of	O
this	O
some	O
##ho	O
##w	O
vag	O
##ue	O
phenomenon	O
.	O

pathways	B-T038
and	O
genes	B-T017
associated	O
with	O
immune	B-T022
dysfunction	B-T038
in	O
sheep	B-T204
parat	B-T038
##uberculosis	I-T038
multi	B-T033
##ba	I-T033
##cil	I-T033
##la	I-T033
##ry	I-T033
and	O
pauc	B-T033
##ib	I-T033
##acil	I-T033
##la	I-T033
##ry	I-T033
parat	B-T038
##uberculosis	I-T038
are	O
both	O
caused	O
by	O
mycobacterium	B-T007
avium	I-T007
subspecies	I-T007
parat	I-T007
##uberculosis	I-T007
.	O
multi	B-T033
##ba	I-T033
##cil	I-T033
##la	I-T033
##ry	I-T033
lesions	B-T033
are	O
composed	O
largely	O
of	O
infected	B-T033
epithelioid	B-T017
macrophages	I-T017
and	O
pauc	B-T033
##ib	I-T033
##acil	I-T033
##la	I-T033
##ry	I-T033
lesions	B-T033
contain	O
t	B-T017
cells	I-T017
but	O
few	O
bacteria	B-T007
.	O
multi	B-T033
##ba	I-T033
##cil	I-T033
##la	I-T033
##ry	I-T033
disease	B-T038
is	O
similar	O
to	O
human	O
lepr	B-T038
##omatous	I-T038
leprosy	I-T038
,	O
with	O
variable	O
/	O
high	O
levels	O
of	O
antibody	B-T103
and	O
a	O
dysfunctional	O
immune	B-T038
response	I-T038
.	O
animals	B-T204
with	O
pauc	B-T033
##ib	I-T033
##acil	I-T033
##la	I-T033
##ry	I-T033
disease	B-T038
have	O
high	O
cell	B-T038
-	I-T038
mediated	I-T038
immunity	I-T038
and	O
variable	O
levels	O
of	O
antibody	B-T103
.	O
this	O
study	O
aims	O
to	O
characterize	O
the	O
immunological	B-T038
dysfunction	I-T038
using	O
trus	B-T170
##e	I-T170
##q	I-T170
analysis	B-T062
of	O
the	O
ile	B-T082
##oca	I-T082
##ecal	I-T082
lymph	B-T017
node	I-T017
that	O
drain	O
##s	O
disease	B-T038
lesions	B-T033
.	O
immune	B-T022
dysfunction	B-T038
is	O
highlighted	O
by	O
repression	B-T038
of	O
tcr	B-T017
/	O
cd3	B-T017
genes	I-T017
,	O
t	B-T103
cell	I-T103
co	I-T103
-	I-T103
receptors	I-T103
/	O
co	B-T103
-	I-T103
stimulator	I-T103
##s	I-T103
,	O
t	B-T038
cell	I-T038
activation	I-T038
and	O
signal	B-T038
-	I-T038
transduction	I-T038
genes	B-T017
.	O
inflammation	B-T038
was	O
an	O
acute	B-T038
phase	I-T038
response	I-T038
and	O
chronic	B-T038
inflammation	I-T038
,	O
with	O
little	O
evidence	O
of	O
acute	B-T033
inflammation	I-T033
.	O
the	O
high	O
levels	O
of	O
immunoglobulin	B-T103
and	O
plasma	B-T017
cell	I-T017
transcripts	B-T103
is	O
consistent	O
with	O
the	O
anti	B-T038
-	I-T038
map	I-T038
antibody	I-T038
responses	I-T038
in	O
parat	B-T038
##uberculosis	I-T038
sheep	B-T204
.	O
also	O
notable	O
was	O
the	O
overwhelming	O
reduction	O
in	O
mast	B-T017
cell	I-T017
transcripts	B-T103
,	O
potentially	O
affecting	O
dc	B-T038
activation	I-T038
of	I-T038
the	I-T038
immune	I-T038
response	I-T038
.	O
this	O
study	O
also	O
shows	O
that	O
there	O
were	O
no	O
fundamental	O
differences	O
in	O
the	O
gene	B-T038
expression	I-T038
patterns	O
in	O
multi	B-T033
##ba	I-T033
##cil	I-T033
##la	I-T033
##ry	I-T033
and	O
pauc	B-T033
##ib	I-T033
##acil	I-T033
##la	I-T033
##ry	I-T033
disease	B-T038
,	O
no	O
shift	O
in	O
t	B-T017
cell	I-T017
genes	B-T017
from	O
th1	B-T017
to	O
th2	B-T017
pattern	O
but	O
rather	O
an	O
incremental	O
decline	O
into	O
immune	B-T022
dysfunction	B-T038
leading	O
to	O
multi	B-T033
##ba	I-T033
##cil	I-T033
##la	I-T033
##ry	I-T033
pathology	B-T038
.	O

an	O
automated	O
,	O
pharmacist	B-T097
-	O
driven	O
initiative	B-T038
improves	B-T033
quality	B-T058
of	I-T058
care	I-T058
for	O
staphylococcus	B-T038
aureus	I-T038
bacteremia	I-T038
infectious	B-T038
diseases	I-T038
(	O
id	B-T038
)	O
consultation	B-T058
and	O
antimicrobial	B-T058
stew	I-T058
##ards	I-T058
##hip	I-T058
intervention	I-T058
have	O
been	O
shown	O
to	O
improve	B-T033
the	O
management	B-T058
of	O
staphylococcus	B-T038
aureus	I-T038
bacteremia	I-T038
(	O
sab	B-T038
)	O
.	O
as	O
the	O
workload	O
of	O
antimicrobial	B-T058
stew	I-T058
##ards	I-T058
##hip	I-T058
programs	I-T058
(	O
asp	B-T058
##s	I-T058
)	O
continues	O
to	O
increase	O
,	O
asp	B-T058
##s	I-T058
must	O
find	O
a	O
way	O
to	O
maximize	O
the	O
efficiency	O
of	O
the	O
program	O
while	O
optimizing	O
patient	O
outcomes	O
.	O
the	O
objective	O
of	O
this	O
study	B-T062
was	O
to	O
evaluate	B-T058
the	O
impact	O
of	O
incorporating	O
health	B-T091
informatics	I-T091
into	O
the	O
management	B-T058
of	O
sab	B-T038
via	O
a	O
pharmacist	B-T097
-	O
driven	O
initiative	B-T038
.	O
retrospective	O
,	O
single	O
-	O
center	O
quasi	O
-	O
experimental	O
study	B-T062
of	O
hospitalized	O
patients	O
with	O
sab	B-T038
.	O
during	O
the	O
intervention	B-T058
period	O
,	O
pharmacists	B-T097
were	O
alert	O
##ed	O
to	O
patients	O
with	O
sab	B-T038
via	O
a	O
patient	O
scoring	B-T074
tool	I-T074
integrated	O
into	O
the	O
electronic	B-T170
medical	I-T170
record	I-T170
.	O
pharmacists	B-T097
utilized	O
the	O
scoring	B-T074
tool	I-T074
and	O
the	O
institution	B-T092
'	I-T092
s	I-T092
evidence	O
-	O
based	O
practice	O
guideline	B-T170
to	O
make	O
standardized	O
recommendations	O
to	O
promote	O
adherence	O
to	O
sab	B-T038
quality	B-T058
-	I-T058
of	I-T058
-	I-T058
care	I-T058
measures	O
and	O
encourage	O
id	B-T038
consultation	B-T058
.	O
the	O
primary	O
outcome	O
was	O
overall	O
compliance	B-T033
along	O
with	O
adherence	O
to	O
individual	B-T098
quality	B-T058
-	I-T058
of	I-T058
-	I-T058
care	I-T058
components	O
.	O
secondary	O
clinical	O
outcomes	O
were	O
also	O
analyzed	B-T062
.	O
84	O
patients	O
were	O
identified	O
for	O
study	B-T062
inclusion	O
,	O
45	O
in	O
the	O
pre	O
-	O
intervention	B-T058
and	O
39	O
in	O
the	O
intervention	B-T058
group	O
.	O
as	O
a	O
whole	O
,	O
all	O
four	O
quality	B-T058
-	I-T058
of	I-T058
-	I-T058
care	I-T058
components	O
for	O
the	O
management	B-T058
of	O
sab	B-T038
were	O
significantly	O
more	O
frequently	O
adhered	O
to	O
in	O
the	O
intervention	B-T058
group	O
(	O
68	O
.	O
9	O
%	O
vs	O
.	O
92	O
.	O
3	O
%	O
;	O
p	O
=	O
0	O
.	O
008	O
)	O
.	O
the	O
incidence	O
of	O
id	B-T038
consult	B-T058
improved	B-T033
significantly	O
by	O
almost	O
20	O
%	O
in	O
the	O
intervention	B-T058
group	O
(	O
75	O
.	O
6	O
%	O
vs	O
.	O
94	O
.	O
9	O
%	O
,	O
p	O
=	O
0	O
.	O
015	O
)	O
.	O
no	O
statistically	O
significant	O
differences	O
in	O
duration	O
of	O
bacteremia	B-T038
,	O
length	O
-	O
of	O
-	O
stay	O
,	O
infection	B-T038
-	O
related	O
length	O
-	O
of	O
-	O
stay	O
,	O
or	O
readmission	B-T058
were	O
observed	O
between	O
the	O
groups	O
.	O
the	O
incidence	O
of	O
all	O
-	O
cause	O
mortality	O
was	O
6	O
-	O
fold	O
higher	O
in	O
the	O
pre	O
-	O
intervention	B-T058
group	O
compared	O
to	O
the	O
intervention	B-T058
group	O
(	O
15	O
.	O
6	O
%	O
vs	O
.	O
2	O
.	O
6	O
%	O
,	O
p	O
=	O
0	O
.	O
06	O
##3	O
)	O
.	O
an	O
automated	O
,	O
pharmacist	B-T097
-	O
driven	O
intervention	B-T058
for	O
the	O
management	B-T058
of	O
patients	O
with	O
sab	B-T038
demonstrated	O
a	O
significant	O
improvement	O
in	O
patients	O
receiving	O
an	O
id	B-T038
consult	B-T058
,	O
targeted	O
antimicrobial	B-T103
therapy	I-T103
,	O
and	O
adherence	O
to	O
all	O
sab	B-T038
quality	B-T058
-	I-T058
of	I-T058
-	I-T058
care	I-T058
measures	O
.	O
as	O
antimicrobial	B-T058
stew	I-T058
##ards	I-T058
##hip	I-T058
becomes	O
a	O
mandatory	O
aspect	O
of	O
healthcare	B-T058
in	O
all	O
hospitals	B-T092
in	O
the	O
u	B-T082
.	I-T082
s	I-T082
.	I-T082
,	O
asp	B-T058
##s	I-T058
will	O
be	O
forced	O
to	O
find	B-T033
ways	O
to	O
provide	O
more	O
efficient	O
,	O
impact	O
##ful	O
,	O
disease	B-T038
state	O
-	O
based	O
patient	B-T058
care	I-T058
.	O
our	O
study	B-T062
provides	O
the	O
framework	O
for	O
and	O
data	O
to	O
support	O
this	O
intervention	B-T058
in	O
one	O
of	O
the	O
most	O
clinically	O
important	O
infectious	B-T038
diseases	I-T038
.	O

utilization	O
pattern	B-T082
and	O
drug	O
use	O
of	O
traditional	B-T091
chinese	I-T091
medicine	I-T091
,	O
western	B-T091
medicine	I-T091
,	O
and	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
treatments	B-T058
for	O
allergic	B-T038
rhinitis	I-T038
under	O
the	O
national	O
health	O
insurance	O
program	O
in	O
taiwan	B-T082
patients	O
in	O
taiwan	B-T082
with	O
allergic	B-T038
rhinitis	I-T038
seek	O
not	O
only	O
western	B-T091
medicine	I-T091
treatment	B-T058
but	O
also	O
traditional	B-T091
chinese	I-T091
medicine	I-T091
treatment	B-T058
or	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
treatment	B-T058
.	O
various	O
studies	O
have	O
conducted	O
pairwise	O
comparison	O
on	O
traditional	B-T091
chinese	I-T091
medicine	I-T091
,	O
western	B-T091
medicine	I-T091
,	O
and	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
treatments	B-T058
.	O
however	O
,	O
none	O
conducted	O
simultaneous	O
analysis	B-T062
of	O
the	O
three	O
treatments	B-T058
.	O
this	O
study	O
analyzed	B-T062
patients	O
with	O
allergic	B-T038
rhinitis	I-T038
receiving	O
the	O
three	O
treatments	B-T058
to	O
identify	O
differences	O
in	O
demographic	O
characteristic	O
and	O
medical	O
use	O
and	O
thereby	O
to	O
determine	O
drug	O
use	O
patterns	O
of	O
different	O
treatments	B-T058
.	O
the	O
national	B-T170
health	I-T170
insurance	I-T170
research	I-T170
database	I-T170
was	O
the	O
data	O
source	O
,	O
and	O
included	O
patients	O
were	O
those	O
diagnosed	B-T033
with	O
allergic	B-T038
rhinitis	I-T038
(	O
international	B-T170
classification	I-T170
of	I-T170
diseases	I-T170
,	I-T170
ninth	I-T170
revision	I-T170
,	O
clinical	B-T170
modification	I-T170
codes	I-T170
470	I-T170
-	I-T170
47	I-T170
##8	I-T170
)	O
.	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
and	O
tukey	B-T170
student	I-T170
##ized	I-T170
range	I-T170
(	I-T170
hone	I-T170
##st	I-T170
significant	I-T170
difference	I-T170
)	I-T170
test	I-T170
were	O
conducted	O
to	O
investigate	O
the	O
differences	O
among	O
the	O
three	O
treatments	B-T058
.	O
visit	O
frequency	O
for	O
allergic	B-T038
rhinitis	I-T038
treatment	B-T058
was	O
higher	O
in	O
female	B-T098
than	O
male	B-T098
patients	O
,	O
regardless	O
of	O
treatment	B-T058
with	O
traditional	B-T091
chinese	I-T091
medicine	I-T091
,	O
western	B-T091
medicine	I-T091
,	O
or	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
.	O
persons	B-T098
aged	O
0	O
-	O
19	O
years	O
ranked	O
the	O
highest	O
in	O
proportion	O
of	O
visits	B-T058
for	O
allergic	B-T038
rhinitis	I-T038
.	O
traditional	B-T091
chinese	I-T091
medicine	I-T091
treatment	B-T058
had	O
more	O
medical	O
items	O
per	O
person	B-T098
-	I-T098
time	I-T098
and	O
daily	O
drug	O
cost	O
per	O
person	B-T098
-	I-T098
time	I-T098
and	O
had	O
the	O
lowest	O
total	O
expenditure	O
per	O
person	B-T098
-	I-T098
time	I-T098
.	O
in	O
contrast	O
,	O
western	B-T091
medicine	I-T091
had	O
the	O
lowest	O
daily	O
drug	O
cost	O
per	O
person	B-T098
-	I-T098
time	I-T098
and	O
the	O
highest	O
total	O
expenditure	O
per	O
person	B-T098
-	I-T098
time	I-T098
.	O
the	O
total	O
expenditure	O
per	O
person	B-T098
-	I-T098
time	I-T098
,	O
daily	O
drug	O
cost	O
per	O
person	B-T098
-	I-T098
time	I-T098
,	O
and	O
medical	O
items	O
per	O
person	B-T098
-	I-T098
time	I-T098
of	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
treatment	B-T058
lay	O
between	O
those	O
seen	O
with	O
traditional	B-T091
chinese	I-T091
medicine	I-T091
and	O
western	B-T091
medicine	I-T091
treatments	B-T058
.	O
although	O
only	O
6	O
.	O
82	O
%	O
of	O
patients	O
with	O
allergic	B-T038
rhinitis	I-T038
chose	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
treatment	B-T058
,	O
the	O
visit	O
frequency	O
per	O
person	O
-	O
year	O
of	O
integrated	B-T091
chinese	I-T091
-	I-T091
western	I-T091
medicine	I-T091
ranked	O
highest	O
.	O
in	O
addition	O
,	O
multiple	O
-	O
composition	O
medicines	B-T103
were	O
used	O
more	O
frequently	O
than	O
single	O
-	O
composition	O
medicines	B-T103
,	O
and	O
mar	B-T103
hu	I-T103
##ang	I-T103
(	O
eph	B-T204
##ed	I-T204
##ra	I-T204
sin	I-T204
##ica	I-T204
stap	I-T204
##f	I-T204
)	O
was	O
seldom	O
used	O
to	O
decrease	O
the	O
risk	O
of	O
combining	O
medications	B-T103
.	O

blood	B-T038
pressure	I-T038
and	O
all	B-T033
-	I-T033
cause	I-T033
mortality	I-T033
by	O
level	O
of	O
cognitive	B-T038
function	I-T038
in	O
the	O
elderly	B-T098
:	O
results	O
from	O
a	O
population	B-T062
-	I-T062
based	I-T062
study	I-T062
in	O
rural	B-T082
greece	I-T082
this	O
study	B-T062
aimed	O
to	O
investigate	O
whether	O
the	O
effect	O
of	O
blood	B-T038
pressure	I-T038
(	O
bp	B-T038
)	O
on	O
mortality	B-T033
differs	O
by	O
levels	O
of	O
cognitive	B-T038
function	I-T038
.	O
the	O
associations	O
of	O
brachial	B-T082
systolic	B-T201
bp	I-T201
,	O
diastolic	B-T201
bp	I-T201
,	O
mean	B-T033
arterial	I-T033
pressure	I-T033
(	O
map	B-T033
)	O
,	O
and	O
pulse	B-T038
pressure	I-T038
with	O
all	B-T033
-	I-T033
cause	I-T033
mortality	I-T033
were	O
prospectively	B-T033
explored	I-T033
(	O
follow	B-T058
-	I-T058
up	I-T058
7	O
.	O
0	O
##±2	O
.	O
2	O
years	O
)	O
in	O
660	O
community	O
-	O
dwelling	O
individuals	B-T098
(	O
≥	O
##60	O
years	O
)	O
using	O
adjusted	B-T170
cox	I-T170
models	I-T170
,	O
stratified	O
by	O
cognitive	B-T038
impairment	I-T038
(	O
mini	B-T058
-	I-T058
mental	I-T058
state	I-T058
examination	I-T058
[	O
mmse	B-T058
]	O
<	O
24	O
)	O
.	O
no	O
association	O
between	O
brachial	B-T082
bp	B-T038
variables	O
and	O
mortality	B-T033
was	O
shown	O
for	O
the	O
total	O
sample	O
in	O
quartiles	O
analysis	O
;	O
however	O
,	O
map	B-T033
in	O
the	O
highest	O
quartile	O
,	O
compared	O
with	O
the	O
second	O
,	O
was	O
associated	O
with	O
mortality	B-T033
(	O
hazard	O
ratio	O
,	O
1	O
.	O
85	O
;	O
95	O
%	O
confidence	O
intervals	O
,	O
1	O
.	O
09	O
-	O
3	O
.	O
12	O
)	O
among	O
cognitively	B-T038
impaired	I-T038
individuals	B-T098
.	O
the	O
fractional	B-T062
-	I-T062
polynomial	I-T062
##s	I-T062
approach	I-T062
for	O
bp	B-T038
confirmed	B-T033
this	O
finding	B-T033
and	O
further	B-T082
showed	O
,	O
solely	O
in	O
the	O
mmse	B-T058
<	O
24	O
subc	O
##oh	O
##ort	O
,	O
u	O
-	O
shaped	O
trends	O
of	O
map	B-T033
and	O
systolic	B-T201
bp	I-T201
,	O
with	O
increased	O
mortality	O
risk	O
in	O
extremely	O
low	O
or	O
high	O
values	O
;	O
no	O
such	O
pattern	B-T082
was	O
evident	O
for	O
patients	O
with	O
mmse	B-T058
≥2	O
##4	O
.	O
elderly	B-T098
individuals	B-T098
with	O
cognitive	B-T038
impairment	I-T038
might	O
be	O
more	O
susceptible	O
to	O
the	O
detrimental	B-T038
effects	I-T038
of	O
low	O
and	O
elevated	O
map	B-T033
and	O
systolic	B-T201
bp	I-T201
.	O

clinicopathological	B-T058
and	O
immunohistochemical	O
characteristics	O
of	O
verruc	B-T038
##iform	I-T038
xanth	I-T038
##oma	I-T038
of	O
the	O
lower	B-T017
gingiva	I-T017
:	O
a	O
case	B-T170
report	I-T170
verruc	B-T038
##iform	I-T038
xanth	I-T038
##oma	I-T038
(	O
v	B-T038
##x	I-T038
)	O
is	O
a	O
rare	O
benign	B-T038
lesion	I-T038
and	O
mainly	O
effects	O
the	O
oral	B-T017
mucosa	I-T017
.	O
this	O
slow	B-T033
-	I-T033
growing	I-T033
asymptomatic	B-T033
lesion	B-T038
typically	O
develops	O
along	O
the	O
gingival	B-T082
margin	I-T082
of	O
the	O
masticatory	O
mucosa	B-T017
,	O
followed	O
by	O
the	O
hard	B-T017
palate	I-T017
,	O
tongue	B-T017
,	O
buccal	B-T017
mucosa	I-T017
,	O
floor	B-T082
of	I-T082
the	I-T082
mouth	I-T082
,	O
alveolar	B-T082
mucosa	I-T082
,	O
soft	B-T017
palate	I-T017
and	O
junction	B-T082
between	O
the	O
hard	B-T017
and	O
soft	B-T017
palate	I-T017
.	O
moreover	O
,	O
this	O
lesion	B-T038
can	O
also	O
affect	O
the	O
skin	B-T022
and	O
genital	B-T017
organs	I-T017
.	O
clinically	O
,	O
v	B-T038
##x	I-T038
generally	O
presents	O
a	O
ses	B-T033
##sil	I-T033
##e	I-T033
or	O
pedunc	B-T033
##ulated	I-T033
appearance	I-T033
,	O
forming	O
a	O
pap	B-T033
##ule	I-T033
or	O
single	O
plaque	O
with	O
verruc	B-T038
##ous	I-T038
or	O
papilloma	B-T038
##to	I-T038
##us	I-T038
mucosal	B-T017
growth	B-T038
.	O
the	O
colour	O
(	O
white	O
,	O
pink	O
,	O
grey	O
,	O
or	O
yellow	O
)	O
depends	O
on	O
the	O
thickness	O
of	O
the	O
overlying	O
epidermis	B-T017
.	O
in	O
fact	O
,	O
the	O
clinical	O
findings	B-T033
of	O
v	B-T038
##x	I-T038
are	O
similar	O
to	O
those	O
of	O
verruc	B-T038
##ous	I-T038
carcinoma	I-T038
and	O
other	O
benign	B-T038
tumours	I-T038
,	O
such	O
as	O
squamous	B-T038
papilloma	I-T038
,	O
verruc	B-T038
##a	I-T038
vulgaris	I-T038
and	O
mucosal	B-T038
fibro	I-T038
##ma	I-T038
.	O
for	O
this	O
reason	O
,	O
clinical	O
and	O
histopathological	O
examinations	B-T058
are	O
essential	O
for	O
accurate	B-T058
differential	I-T058
diagnosis	I-T058
.	O
histologically	O
,	O
v	B-T038
##x	I-T038
is	O
characterized	O
by	O
para	B-T038
##ker	I-T038
##atosis	I-T038
,	O
ret	B-T017
##e	I-T017
ridge	I-T017
##s	I-T017
of	O
uniform	O
depth	O
and	O
the	O
accumulation	B-T033
of	O
foam	B-T017
cells	I-T017
,	O
which	O
are	O
also	O
called	O
[UNK]	O
xanth	B-T017
##oma	I-T017
cells	I-T017
[UNK]	O
.	O
here	O
,	O
we	O
describe	O
the	O
clinicopathological	B-T058
and	O
immunohistochemical	O
findings	B-T033
of	O
a	O
v	B-T038
##x	I-T038
located	O
on	O
the	O
lower	B-T017
gingiva	I-T017
of	O
a	O
64	O
-	O
year	O
-	O
old	O
male	O
patient	O
.	O

using	O
melan	B-T103
##opsin	I-T103
to	O
study	B-T062
g	B-T038
protein	I-T038
signaling	I-T038
in	O
cortical	B-T017
neurons	B-T017
our	O
understanding	B-T038
of	O
g	B-T103
protein	I-T103
-	I-T103
coupled	I-T103
receptors	I-T103
(	O
gpcrs	B-T103
)	O
in	O
the	O
central	B-T022
nervous	I-T022
system	I-T022
(	O
cns	B-T022
)	O
has	O
been	O
hampered	O
by	O
the	O
limited	O
availability	O
of	O
tools	O
allowing	O
for	O
the	O
study	B-T062
of	O
their	O
signaling	B-T038
with	O
precise	O
temporal	O
control	O
.	O
to	O
overcome	O
this	O
,	O
we	O
tested	O
the	O
utility	O
of	O
the	O
bis	O
##ta	O
##ble	O
mammalian	B-T204
ops	B-T103
##in	I-T103
melan	B-T103
##opsin	I-T103
to	O
examine	O
g	B-T038
protein	I-T038
signaling	I-T038
in	O
cns	B-T022
neurons	B-T017
.	O
specifically	O
,	O
we	O
used	O
biol	B-T062
##istic	I-T062
(	O
gene	O
gun	O
)	O
approaches	O
to	O
transf	B-T103
##ect	I-T103
melan	I-T103
##opsin	I-T103
into	O
cortical	B-T017
pyramidal	B-T017
cells	I-T017
maintained	O
in	O
organ	B-T058
##otypic	I-T058
slice	I-T058
culture	I-T058
.	O
whole	B-T062
cell	I-T062
recordings	I-T062
from	O
transfected	B-T017
neurons	I-T017
indicated	O
that	O
application	O
of	O
blue	O
light	O
effectively	O
activated	O
the	O
transfected	B-T103
melan	I-T103
##opsin	I-T103
to	O
elicit	O
the	O
canonical	O
biphasic	O
modulation	O
of	O
membrane	B-T017
excitability	B-T033
previously	O
associated	O
with	O
the	O
activation	O
of	O
gpcrs	B-T103
coupling	O
to	O
g	B-T103
##α	I-T103
##q	I-T103
-	I-T103
11	I-T103
remarkably	O
,	O
full	O
mimic	O
##ry	O
of	O
exogenous	O
agonist	B-T103
concentration	O
could	O
be	O
obtained	O
with	O
pulses	O
as	O
short	O
as	O
a	O
few	O
millis	O
##econds	O
,	O
suggesting	O
that	O
their	O
triggering	O
required	O
a	O
single	O
melan	B-T103
##opsin	I-T103
activation	O
-	O
deactivation	O
cycle	O
.	O
the	O
resulting	O
temporal	O
control	O
over	O
melan	B-T103
##opsin	I-T103
activation	O
allowed	O
us	O
to	O
compare	O
the	O
activation	O
kinetics	O
of	O
different	O
components	O
of	O
the	O
electrophysiological	B-T038
response	O
.	O
we	O
also	O
replaced	O
the	O
intracellular	B-T082
loops	B-T082
of	O
melan	B-T103
##opsin	I-T103
with	O
those	O
of	O
the	O
5	B-T103
-	I-T103
ht2	I-T103
##a	I-T103
receptor	I-T103
to	O
create	O
a	O
light	O
-	O
activated	O
gpcr	B-T103
capable	O
of	O
interacting	O
with	O
the	O
5	B-T103
-	I-T103
ht2	I-T103
##a	I-T103
receptor	I-T103
interacting	O
proteins	B-T103
.	O
the	O
resulting	O
chimera	B-T103
expressed	O
weak	O
activity	O
but	O
validated	B-T062
the	O
potential	O
usefulness	O
of	O
melan	B-T103
##opsin	I-T103
as	O
a	O
tool	O
for	O
the	O
study	B-T062
of	O
g	B-T038
protein	I-T038
signaling	I-T038
in	O
cns	B-T022
neurons	B-T017
.	O

oxidative	B-T038
stress	I-T038
and	O
immunos	B-T038
##enes	I-T038
##cence	I-T038
in	O
spleen	B-T017
of	O
obese	B-T204
mice	I-T204
can	O
be	O
reversed	O
by	O
2	B-T103
-	I-T103
hydroxy	I-T103
##ole	I-T103
##ic	I-T103
acid	I-T103
we	O
aimed	O
to	O
investigate	O
the	O
effects	O
of	O
obesity	B-T038
on	O
oxidative	B-T038
stress	I-T038
and	O
leukocyte	B-T017
function	B-T038
in	O
spleen	B-T017
of	O
mice	B-T204
,	O
and	O
to	O
assess	O
whether	O
supplementation	B-T058
with	O
2	B-T103
-	I-T103
hydroxy	I-T103
##ole	I-T103
##ic	I-T103
acid	I-T103
(	O
2	B-T103
-	I-T103
oh	I-T103
##oa	I-T103
)	O
or	O
n	B-T103
-	I-T103
3	I-T103
polyunsaturated	I-T103
fatty	I-T103
acids	I-T103
(	O
pufa	B-T103
)	O
could	O
reverse	O
those	O
effects	O
.	O
female	O
icr	B-T204
/	I-T204
cd1	I-T204
mice	I-T204
(	O
8	O
weeks	O
old	O
,	O
n	O
=	O
24	O
)	O
received	O
an	O
obes	B-T168
##ogenic	I-T168
diet	I-T168
(	O
22	O
%	O
fat	B-T103
for	O
4	O
weeks	O
and	O
60	O
%	O
fat	B-T103
for	O
14	O
weeks	O
)	O
.	O
after	O
6	O
weeks	O
,	O
mice	B-T204
were	O
split	O
in	O
three	O
groups	O
(	O
n	O
=	O
8	O
/	O
group	O
)	O
:	O
no	O
supplementation	O
,	O
2	O
-	O
oh	O
##oa	O
supplementation	O
(	O
1500	O
mg	O
kg	O
(	O
-	O
1	O
)	O
)	O
and	O
n	O
-	O
3	O
pufa	O
supplementation	O
(	O
epa	B-T103
+	O
dha	B-T103
,	O
3000	O
mg	O
kg	O
(	O
-	O
1	O
)	O
diet	O
)	O
.	O
eight	O
mice	B-T204
were	O
fed	O
standard	O
diet	B-T168
for	O
the	O
whole	O
duration	O
of	O
the	O
study	B-T062
(	O
control	O
group	O
)	O
.	O
at	O
the	O
end	O
of	O
the	O
experiment	B-T062
,	O
the	O
following	O
variables	O
were	O
assessed	O
in	O
spleens	B-T017
:	O
levels	O
of	O
reduced	B-T103
(	O
gsh	B-T103
)	O
and	O
oxidized	B-T103
(	I-T103
gssg	I-T103
)	I-T103
glutathione	I-T103
,	O
gsh	B-T103
/	O
gssg	B-T103
,	O
xanthine	B-T038
oxidase	I-T038
(	I-T038
x	I-T038
##o	I-T038
)	I-T038
activity	I-T038
,	O
lipid	B-T038
peroxidation	I-T038
,	O
lymphocyte	B-T038
chemotaxis	I-T038
,	O
natural	B-T038
killer	I-T038
(	I-T038
nk	I-T038
)	I-T038
activity	I-T038
and	O
mitogen	B-T103
(	O
con	B-T103
##a	I-T103
and	O
lps	B-T103
)	O
-	O
induced	O
lymphocyte	B-T038
proliferation	I-T038
.	O
obese	O
animals	B-T204
presented	O
higher	O
gssg	B-T103
levels	O
(	O
p	O
=	O
0	O
.	O
003	O
)	O
,	O
gssg	B-T103
/	O
gsh	B-T103
ratio	O
(	O
p	O
=	O
0	O
.	O
013	O
)	O
,	O
lipid	B-T038
peroxidation	I-T038
(	O
p	O
=	O
0	O
.	O
004	O
)	O
,	O
x	B-T038
##o	I-T038
activity	I-T038
(	O
p	O
=	O
0	O
.	O
015	O
)	O
and	O
lymphocyte	B-T038
chemotaxis	I-T038
(	O
p	O
<	O
0	O
.	O
001	O
)	O
,	O
and	O
lower	O
nk	B-T038
activity	I-T038
(	O
p	O
=	O
0	O
.	O
003	O
)	O
and	O
proliferation	O
in	O
response	O
to	O
con	B-T103
##a	I-T103
(	O
p	O
<	O
0	O
.	O
001	O
)	O
than	O
controls	O
.	O
2	B-T103
-	I-T103
oh	I-T103
##oa	I-T103
reversed	O
totally	O
or	O
partially	O
most	O
of	O
the	O
changes	O
(	O
body	O
weight	O
,	O
fat	O
content	O
,	O
gssg	B-T103
levels	O
,	O
gsh	B-T103
/	O
gssg	B-T103
,	O
lipid	B-T038
peroxidation	I-T038
,	O
chemotaxis	B-T038
and	O
proliferation	B-T038
,	O
all	O
p	O
<	O
0	O
.	O
05	O
)	O
,	O
while	O
n	B-T103
-	I-T103
3	I-T103
pufa	I-T103
reversed	O
the	O
increase	O
in	O
x	B-T038
##o	I-T038
activity	I-T038
(	O
p	O
=	O
0	O
.	O
032	O
)	O
.	O
in	O
conclusion	O
,	O
2	B-T103
-	I-T103
oh	I-T103
##oa	I-T103
,	O
and	O
to	O
a	O
lesser	O
extent	O
n	B-T103
-	I-T103
3	I-T103
pufa	I-T103
,	O
could	O
ameliorate	O
the	O
oxidative	B-T038
stress	I-T038
and	O
alteration	O
of	O
leukocyte	B-T017
function	B-T038
in	O
spleen	B-T017
of	O
obese	B-T204
mice	I-T204
.	O
our	O
findings	B-T033
support	O
a	O
link	O
between	O
obesity	B-T038
and	O
immunos	B-T038
##enes	I-T038
##cence	I-T038
and	O
suggest	O
a	O
potential	O
therapeutic	O
tool	O
for	O
obesity	B-T038
-	O
related	O
immune	B-T038
dysfunction	I-T038
.	O
this	O
article	O
is	O
protected	O
by	O
copyright	O
.	O
all	O
rights	O
reserved	O
.	O

body	O
burden	O
of	O
heavy	B-T103
metals	I-T103
among	O
hiv	O
high	B-T098
risk	I-T098
population	I-T098
in	O
usa	B-T082
hiv	O
high	B-T098
risk	I-T098
population	I-T098
may	O
face	O
not	O
only	O
the	O
threat	O
of	O
hiv	B-T038
infection	I-T038
but	O
also	O
a	O
higher	O
chance	O
of	O
exposure	B-T037
to	I-T037
environmental	I-T037
contaminants	I-T037
.	O
however	O
,	O
no	O
previous	O
studies	B-T062
have	O
examined	O
the	O
body	O
burden	O
of	O
environmental	B-T103
pollutants	I-T103
including	O
heavy	B-T103
metals	I-T103
among	O
hiv	O
high	B-T098
risk	I-T098
populations	I-T098
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
investigate	O
whether	O
adults	O
aged	O
20	O
-	O
59	O
years	O
old	O
at	O
high	B-T033
risk	I-T033
of	I-T033
hiv	B-T038
infection	I-T038
have	O
higher	O
blood	B-T033
levels	I-T033
of	I-T033
heavy	I-T033
metals	I-T033
compared	O
to	O
those	O
with	O
low	O
risk	O
of	O
hiv	B-T038
infection	I-T038
in	O
united	B-T082
states	I-T082
.	O
we	O
used	O
the	O
national	B-T062
health	I-T062
and	I-T062
nutrition	I-T062
examination	I-T062
survey	I-T062
(	O
nh	B-T062
##anes	I-T062
)	O
1999	O
-	O
2010	O
to	O
compare	O
exposures	O
to	O
heavy	B-T103
metals	I-T103
including	O
cadmium	B-T103
,	O
lead	B-T103
,	O
and	O
total	O
mercury	B-T103
by	O
hiv	O
risk	B-T033
status	I-T033
.	O
the	O
results	O
showed	O
that	O
people	B-T098
at	O
high	B-T033
risk	I-T033
of	I-T033
hiv	O
had	O
higher	O
blood	B-T033
concentrations	I-T033
of	O
all	O
heavy	B-T103
metals	I-T103
compared	O
to	O
their	O
counterparts	O
with	O
lower	O
hiv	O
risks	O
.	O
in	O
multivariate	O
linear	O
regression	O
models	O
,	O
hiv	O
risk	O
status	O
was	O
significantly	O
associated	O
with	O
increased	O
blood	B-T058
cadmium	I-T058
,	O
lead	B-T058
,	O
and	O
total	B-T058
mercury	I-T058
after	O
adjusting	O
for	O
age	O
,	O
sex	O
,	O
race	B-T098
,	O
education	O
,	O
and	O
poverty	O
income	O
ratio	O
.	O
our	O
study	B-T062
suggests	O
that	O
people	B-T098
at	O
high	B-T033
risk	I-T033
of	I-T033
hiv	O
have	O
significantly	O
higher	O
body	O
burden	O
of	O
heavy	B-T103
metals	I-T103
including	O
cadmium	B-T103
,	O
lead	B-T103
,	O
and	O
mercury	B-T103
compared	O
to	O
those	O
with	O
low	O
risk	O
of	O
hiv	O
.	O
further	O
longitudinal	B-T062
study	I-T062
collecting	O
more	O
pollutants	B-T103
are	O
warranted	O
to	O
determine	O
the	O
potential	O
health	O
effects	O
of	O
these	O
elevated	O
pollutants	B-T103
on	O
both	O
hiv	B-T038
-	I-T038
infected	I-T038
and	O
hiv	O
high	B-T098
-	I-T098
risk	I-T098
populations	I-T098
.	O

cultivation	B-T058
of	O
four	O
microalgae	B-T204
species	B-T170
in	O
the	O
effluent	O
of	O
anaerobic	O
digest	O
##er	O
for	O
biod	B-T103
##ies	I-T103
##el	I-T103
production	O
this	O
study	B-T062
investigated	O
if	O
an	O
effluent	O
from	O
anaerobic	O
digestion	O
(	O
ad	O
)	O
system	O
can	O
be	O
used	O
as	O
a	O
nutrients	B-T168
source	B-T033
for	O
the	O
microalgae	B-T204
cultivation	B-T058
,	O
and	O
in	O
so	O
doing	O
,	O
if	O
the	O
effluent	O
can	O
be	O
properly	O
treated	O
.	O
nitrogen	B-T103
and	O
phosphorus	B-T103
in	O
the	O
ad	O
effluent	O
well	O
supported	O
microal	B-T204
##gal	I-T204
growth	B-T038
,	O
and	O
their	O
removal	O
efficiency	O
reached	O
>	O
97	O
.	O
9	O
%	O
and	O
99	O
.	O
2	O
%	O
,	O
respectively	O
.	O
among	O
four	O
different	O
algal	B-T204
species	B-T170
tested	O
,	O
micr	B-T204
##actin	I-T204
##ium	I-T204
iner	I-T204
##mu	I-T204
##m	I-T204
particularly	O
sto	O
##od	O
out	O
,	O
showing	O
the	O
highest	O
biomass	O
and	O
fam	B-T103
##e	I-T103
productivity	O
:	O
0	O
.	O
16	O
##gl	O
(	O
-	O
1	O
)	O
d	O
(	O
-	O
1	O
)	O
with	O
3	O
.	O
23	O
##gl	O
(	O
-	O
1	O
)	O
of	O
dry	O
cell	B-T017
weight	O
,	O
and	O
0	O
.	O
04	O
##gl	O
(	O
-	O
1	O
)	O
d	O
(	O
-	O
1	O
)	O
with	O
27	O
.	O
54	O
%	O
(	O
w	O
/	O
w	O
)	O
of	O
fam	B-T103
##e	I-T103
contents	O
,	O
respectively	O
.	O
as	O
the	O
concentrations	O
of	O
the	O
nutrients	B-T168
decreased	O
over	O
time	O
,	O
the	O
fam	B-T103
##e	I-T103
contents	O
were	O
increased	O
and	O
its	O
quality	O
as	O
well	O
,	O
satisfying	O
several	O
biod	B-T103
##ies	I-T103
##el	I-T103
quality	O
standards	O
.	O
this	O
study	B-T062
supports	O
that	O
the	O
ad	O
effluent	O
can	O
indeed	O
serve	O
as	O
a	O
cheap	O
and	O
nutrient	B-T168
-	O
rich	O
medium	O
for	O
microalgae	B-T204
cultivation	B-T058
,	O
and	O
equally	O
importantly	O
,	O
microalgae	B-T204
can	O
be	O
a	O
work	O
##able	O
treatment	O
option	O
for	O
it	O
.	O

propensity	O
score	O
matched	O
comparison	O
of	O
partial	O
to	O
whole	O
gland	B-T017
cryotherapy	B-T058
for	O
intermediate	B-T033
-	I-T033
risk	I-T033
prostate	B-T038
cancer	I-T038
:	O
an	O
analysis	B-T062
of	O
the	O
cold	B-T170
registry	I-T170
data	I-T170
to	O
compare	O
the	O
oncological	B-T038
and	O
functional	O
outcomes	O
of	O
partial	O
versus	O
whole	O
-	O
gland	B-T017
cryotherapy	B-T058
for	O
men	B-T098
with	O
intermediate	B-T033
-	I-T033
risk	I-T033
prostate	B-T038
cancer	I-T038
.	O
men	B-T098
with	O
intermediate	B-T033
-	I-T033
risk	I-T033
prostate	B-T038
cancer	I-T038
treated	B-T058
with	I-T058
primary	O
prostate	B-T058
cryotherapy	I-T058
from	O
1993	O
-	O
2013	O
were	O
selected	O
from	O
the	O
cryo	B-T170
on	I-T170
-	I-T170
line	I-T170
data	I-T170
registry	I-T170
for	O
a	O
1	O
:	O
1	O
matched	B-T062
comparison	O
between	O
those	O
undergoing	O
whole	O
-	O
gland	B-T017
and	O
partial	O
prostate	B-T058
cryotherapy	I-T058
(	O
targeted	B-T058
-	I-T058
ablation	I-T058
,	O
unilateral	B-T058
/	I-T058
bilateral	I-T058
nerve	I-T058
-	I-T058
sparing	I-T058
ablation	I-T058
##s	I-T058
)	O
.	O
a	O
propensity	O
score	O
was	O
developed	O
based	O
on	O
age	O
,	O
pre	B-T031
-	I-T031
biopsy	I-T031
serum	I-T031
psa	B-T103
,	O
biopsy	O
gleason	O
score	O
,	O
clinical	O
stage	O
,	O
prostate	O
volume	O
,	O
neoadjuvant	B-T058
androgen	I-T058
deprivation	I-T058
status	O
,	O
year	O
of	O
surgery	B-T058
and	O
pre	O
-	O
treatment	O
potency	O
.	O
outcomes	O
were	O
biochemical	B-T170
progression	O
-	O
free	O
survival	O
(	O
bp	O
##fs	O
)	O
using	O
astr	O
##o	O
and	O
pho	O
##en	O
##ix	O
criteria	O
,	O
12	O
-	O
month	O
continence	B-T038
(	O
strictly	O
pad	O
-	O
free	O
)	O
and	O
sexual	B-T038
function	I-T038
(	O
potency	O
sufficient	O
for	O
sexual	B-T038
intercourse	I-T038
)	O
.	O
after	O
propensity	O
score	O
-	O
matching	B-T062
,	O
bp	O
##fs	O
was	O
compared	O
using	O
kaplan	O
-	O
meier	O
analysis	O
and	O
functional	O
outcomes	O
using	O
chi	B-T170
-	I-T170
square	I-T170
tests	I-T170
.	O
in	O
all	O
,	O
89	O
##7	O
men	B-T098
were	O
identified	O
(	O
73	O
##1	O
whole	O
-	O
gland	B-T017
and	O
166	O
partial	O
)	O
.	O
post	O
-	O
matching	O
,	O
166	O
pairs	O
of	O
men	B-T098
were	O
analysed	B-T062
(	O
mean	O
follow	B-T058
-	I-T058
up	I-T058
31	O
months	O
)	O
.	O
the	O
2	O
/	O
5	O
year	O
bp	O
##fs	O
rate	O
was	O
87	O
.	O
2	O
%	O
/	O
76	O
.	O
4	O
%	O
for	O
whole	O
-	O
gland	B-T017
vs	O
.	O
80	O
.	O
7	O
%	O
/	O
70	O
.	O
0	O
%	O
for	O
partial	O
ablation	B-T058
using	O
pho	O
##en	O
##ix	O
(	O
p	O
=	O
0	O
.	O
26	O
)	O
and	O
72	O
.	O
3	O
%	O
/	O
69	O
.	O
6	O
%	O
for	O
whole	O
gland	B-T017
vs	O
.	O
82	O
.	O
1	O
%	O
/	O
75	O
.	O
0	O
%	O
for	O
partial	O
ablation	B-T058
using	O
astr	O
##o	O
criteria	O
(	O
p	O
=	O
0	O
.	O
10	O
)	O
.	O
of	O
164	O
pairs	O
,	O
the	O
12	O
-	O
month	O
continence	B-T038
rate	O
was	O
similar	O
94	O
.	O
1	O
%	O
vs	O
.	O
95	O
.	O
1	O
%	O
(	O
p	O
=	O
0	O
.	O
80	O
##3	O
)	O
.	O
of	O
139	O
pairs	O
,	O
the	O
12	O
-	O
month	O
rate	O
of	O
successful	O
intercourse	B-T038
was	O
29	O
.	O
5	O
%	O
for	O
whole	O
-	O
gland	B-T017
and	O
46	O
.	O
8	O
%	O
for	O
partial	O
ablation	B-T058
(	O
or	O
2	O
.	O
1	O
,	O
p	O
=	O
0	O
.	O
003	O
)	O
.	O
the	O
incidence	O
of	O
post	O
-	O
treatment	O
urinary	B-T033
retention	I-T033
was	O
6	O
.	O
0	O
%	O
and	O
6	O
.	O
6	O
%	O
(	O
p	O
=	O
0	O
.	O
88	O
)	O
following	O
whole	O
-	O
gland	B-T017
and	O
partial	O
ablation	B-T058
respectively	O
and	O
that	O
of	O
rect	B-T038
##our	I-T038
##eth	I-T038
##ral	I-T038
fistula	I-T038
was	O
1	O
.	O
2	O
%	O
and	O
0	O
%	O
(	O
p	O
=	O
0	O
.	O
50	O
)	O
conclusion	O
:	O
partial	O
ablation	B-T058
results	O
in	O
better	O
post	O
-	O
treatment	O
sexual	B-T038
function	I-T038
compared	O
to	O
whole	O
-	O
gland	B-T017
ablation	B-T058
in	O
men	B-T098
with	O
intermediate	B-T033
-	I-T033
risk	I-T033
prostate	B-T038
cancer	I-T038
.	O
we	O
did	O
not	O
observe	O
a	O
difference	O
in	O
early	O
bp	O
##fs	O
between	O
the	O
two	O
groups	O
.	O

chronic	B-T033
exposure	I-T033
to	I-T033
haloperidol	B-T103
and	O
olanzapine	B-T103
leads	O
to	O
common	O
and	O
divergent	O
shape	B-T033
changes	I-T033
in	O
the	O
rat	B-T204
hippocampus	B-T017
in	O
the	O
absence	O
of	O
grey	B-T017
-	I-T017
matter	I-T017
volume	O
loss	O
one	O
of	O
the	O
most	O
consistently	O
reported	O
brain	B-T017
abnormalities	I-T017
in	O
schizophrenia	B-T038
(	O
sc	B-T038
##z	I-T038
)	O
is	O
decreased	O
volume	B-T033
and	I-T033
shape	I-T033
deformation	I-T033
of	O
the	O
hippocampus	B-T017
.	O
however	O
,	O
the	O
potential	O
contribution	O
of	O
chronic	B-T103
antipsychotic	I-T103
medication	I-T103
exposure	B-T033
to	O
these	O
phenomena	O
remains	O
unclear	O
.	O
we	O
examined	O
the	O
effect	O
of	O
chronic	B-T033
exposure	I-T033
(	O
8	O
weeks	O
)	O
to	O
clinically	O
relevant	O
doses	O
of	O
either	O
haloperidol	B-T103
(	O
hal	B-T103
)	O
or	O
olanzapine	B-T103
(	O
ol	B-T103
##z	I-T103
)	O
on	O
adult	O
rat	B-T204
hippocampal	B-T082
volume	B-T033
and	I-T033
shape	I-T033
using	O
ex	O
vivo	O
structural	B-T058
mri	I-T058
with	O
the	O
brain	B-T017
retained	I-T017
inside	I-T017
the	I-T017
crani	I-T017
##um	I-T017
to	O
prevent	O
distortions	B-T017
due	O
to	O
dissection	B-T058
,	O
followed	O
by	O
tensor	B-T058
-	I-T058
based	I-T058
morphometry	I-T058
(	O
tb	B-T058
##m	I-T058
)	O
and	O
elastic	B-T062
surface	I-T062
-	I-T062
based	I-T062
shape	I-T062
deformation	I-T062
analysis	I-T062
.	O
the	O
volume	O
of	O
the	O
hippocampus	B-T017
was	O
also	O
measured	O
post	B-T058
-	I-T058
mortem	I-T058
from	O
brain	B-T017
tissue	I-T017
sections	O
in	O
each	O
group	O
.	O
chronic	B-T033
exposure	I-T033
to	O
either	O
hal	B-T103
or	O
ol	B-T103
##z	I-T103
had	O
no	O
effect	O
on	O
the	O
volume	O
of	O
the	O
hippocampus	B-T017
,	O
even	O
at	O
exploratory	B-T058
thresholds	I-T058
,	O
which	O
was	O
confirmed	O
post	B-T058
-	I-T058
mortem	I-T058
.	O
in	O
contrast	O
,	O
shape	B-T062
deformation	I-T062
analysis	I-T062
revealed	O
that	O
chronic	O
hal	B-T103
and	O
ol	B-T103
##z	I-T103
exposure	B-T033
lead	O
to	O
both	O
common	O
and	O
divergent	B-T033
shape	I-T033
deformations	I-T033
(	O
q	O
=	O
0	O
.	O
05	O
,	O
fd	O
##r	O
-	O
corrected	O
)	O
in	O
the	O
rat	B-T204
hippocampus	B-T017
.	O
in	O
particular	O
,	O
in	O
the	O
dorsal	B-T017
hippocampus	I-T017
,	O
hal	B-T103
exposure	B-T033
led	O
to	O
inward	B-T033
shape	I-T033
deformation	I-T033
,	O
whereas	O
ol	B-T103
##z	I-T103
exposure	B-T033
led	O
to	O
outward	B-T033
shape	I-T033
deformation	I-T033
.	O
interestingly	O
,	O
outward	B-T033
shape	I-T033
deformations	I-T033
that	O
were	O
common	O
to	O
both	O
drugs	B-T103
occurred	O
in	O
the	O
ventral	B-T017
hippocampus	I-T017
.	O
these	O
effects	O
remained	O
significant	O
after	O
controlling	O
for	O
hippocampal	B-T017
volume	O
suggesting	O
true	O
shape	B-T033
changes	I-T033
.	O
chronic	B-T033
exposure	I-T033
to	O
either	O
hal	B-T103
or	O
ol	B-T103
##z	I-T103
leads	O
to	O
both	O
common	O
and	O
divergent	O
effects	O
on	O
rat	B-T204
hippocampal	B-T017
shape	I-T017
in	O
the	O
absence	O
of	O
volume	O
change	O
.	O
the	O
implications	O
of	O
these	O
findings	O
for	O
the	O
clinic	O
are	O
discussed	O
.	O

tr	B-T204
##ump	I-T204
'	I-T204
s	I-T204
got	O
the	O
right	O
idea	O
i	O
am	O
a	O
us	B-T082
nursing	B-T097
student	I-T097
and	O
feel	B-T038
that	O
ob	B-T170
##ama	I-T170
##care	I-T170
is	O
a	O
bad	O
idea	O
.	O
i	O
'	O
m	O
disapp	O
##oint	O
##ed	O
that	O
pres	O
##ident	O
tr	B-T204
##ump	I-T204
was	O
not	B-T033
able	I-T033
to	I-T033
get	I-T033
rid	I-T033
of	I-T033
it	O
last	O
month	O
.	O

simvastatin	B-T103
promotes	O
hematoma	B-T038
absorption	O
and	O
reduces	O
hydrocephalus	B-T038
following	O
intraventricular	B-T038
hemorrhage	I-T038
in	O
part	O
by	O
upreg	B-T038
##ulating	I-T038
cd36	B-T017
we	O
previously	O
found	O
that	O
hematoma	B-T038
worsen	B-T033
##s	I-T033
hydrocephalus	B-T038
after	O
intraventricular	B-T038
hemorrhage	I-T038
(	O
iv	B-T038
##h	I-T038
)	O
via	O
increasing	O
iron	B-T038
deposition	I-T038
and	O
aggrav	O
##ating	O
ependym	B-T017
##al	I-T017
cilia	B-T017
injury	B-T037
;	O
therefore	O
,	O
promoting	O
hematoma	B-T038
absorption	O
may	O
be	O
a	O
promising	O
strategy	O
for	O
iv	B-T038
##h	I-T038
.	O
recently	O
,	O
some	O
investigations	O
imply	O
that	O
simvastatin	B-T103
has	O
the	O
ability	O
of	O
accelerating	O
hematoma	B-T038
absorption	O
.	O
thus	O
,	O
this	O
study	O
was	O
designed	O
to	O
examine	O
the	O
efficacy	O
of	O
simvastatin	B-T103
for	O
iv	B-T038
##h	I-T038
in	O
rats	B-T204
.	O
intracerebral	B-T038
hemorrhage	I-T038
with	O
ventricular	O
extension	O
was	O
induced	O
in	O
adult	O
male	O
sprague	B-T204
-	I-T204
dawley	I-T204
rats	I-T204
after	O
autologous	O
blood	O
injection	O
.	O
simvastatin	B-T103
or	O
vehicle	B-T103
was	O
administered	B-T058
orally	I-T058
at	O
1	O
day	O
after	O
iv	B-T038
##h	I-T038
and	O
then	O
daily	O
for	O
1	O
week	O
.	O
mri	B-T058
studies	I-T058
were	O
performed	O
to	O
measure	O
the	O
volumes	B-T058
of	O
intracranial	B-T082
hematoma	B-T038
and	O
lateral	B-T082
ventricle	I-T082
at	O
days	O
1	O
,	O
3	O
,	O
7	O
,	O
14	O
,	O
and	O
28	O
after	O
iv	B-T038
##h	I-T038
.	O
motor	B-T038
and	O
neurocognitive	B-T038
functions	I-T038
were	O
assessed	O
at	O
days	O
1	O
to	O
7	O
and	O
23	O
to	O
28	O
,	O
respectively	O
.	O
iron	B-T038
deposition	I-T038
,	O
iron	B-T103
-	O
related	O
protein	B-T038
expression	I-T038
,	O
ependym	O
##al	O
damage	O
,	O
and	O
histology	O
were	O
detected	B-T033
at	O
day	O
28	O
.	O
expression	B-T038
of	O
cd36	B-T017
scavenger	B-T103
receptor	I-T103
(	O
facilitating	O
phagocytosis	B-T038
)	O
was	O
examined	B-T033
at	O
day	O
3	O
after	O
iv	B-T038
##h	I-T038
using	O
western	B-T058
blotting	I-T058
and	O
immunofluorescence	B-T058
.	O
simvastatin	B-T103
significantly	O
increased	O
hematoma	B-T038
absorption	O
ratio	O
,	O
reduced	O
ventricular	O
volume	O
,	O
and	O
attenuated	B-T033
neurological	I-T033
dysfunction	I-T033
post	O
-	O
iv	B-T038
##h	I-T038
.	O
in	O
addition	O
,	O
less	B-T033
iron	I-T033
accumulation	I-T033
and	O
more	O
cilia	B-T017
survival	O
was	O
observed	O
in	O
the	O
simvastatin	B-T103
group	O
when	O
compared	O
with	O
the	O
control	O
.	O
what	O
'	O
s	O
more	O
,	O
higher	O
expression	B-T038
of	O
cd36	B-T017
was	O
detected	B-T033
around	O
the	O
hematoma	B-T038
after	O
simvastatin	B-T103
administration	B-T058
.	O
simvastatin	B-T103
significantly	O
enhanced	O
brain	B-T017
hematoma	B-T038
absorption	O
,	O
alleviated	B-T038
hydrocephalus	I-T038
,	O
and	O
improved	B-T033
neurological	O
recovery	B-T038
after	O
experimental	O
iv	B-T038
##h	I-T038
,	O
which	O
may	O
in	O
part	O
by	O
upreg	B-T038
##ulating	I-T038
cd36	B-T017
expression	B-T038
.	O
our	O
data	O
suggest	O
that	O
early	O
simvastatin	B-T103
use	O
may	O
be	O
a	O
novel	O
therapy	B-T058
for	O
iv	B-T038
##h	I-T038
patients	O
.	O

effects	O
of	O
display	O
curvature	B-T082
,	O
display	O
zone	B-T082
,	O
and	O
task	O
duration	O
on	O
leg	O
##ibility	O
and	O
visual	B-T038
fatigue	I-T038
during	O
visual	O
search	O
task	O
this	O
study	O
examined	O
the	O
effects	O
of	O
display	O
curvature	B-T082
(	O
400	O
,	O
600	O
,	O
1200	O
mm	O
,	O
and	O
flat	B-T082
)	O
,	O
display	O
zone	B-T082
(	O
5	O
zones	B-T082
)	O
,	O
and	O
task	O
duration	O
(	O
15	O
and	O
30	O
min	O
)	O
on	O
leg	O
##ibility	O
and	O
visual	B-T038
fatigue	I-T038
.	O
each	O
participant	B-T098
completed	O
two	O
15	O
-	O
min	O
visual	O
search	O
task	O
sets	O
at	O
each	O
curvature	B-T082
setting	B-T082
.	O
the	O
600	O
-	O
mm	O
and	O
1200	O
-	O
mm	O
settings	B-T082
yielded	O
better	O
results	O
than	O
the	O
flat	B-T082
setting	B-T082
in	O
terms	O
of	O
leg	O
##ibility	O
and	O
perceived	O
visual	B-T038
fatigue	I-T038
.	O
relative	O
to	O
the	O
corresponding	O
centre	B-T082
zone	B-T082
,	O
the	O
outer	O
##most	O
zones	B-T082
of	O
the	O
1200	O
-	O
mm	O
and	O
flat	B-T082
settings	B-T082
showed	O
a	O
decrease	O
of	O
8	O
%	O
-	O
37	O
%	O
in	O
leg	O
##ibility	O
,	O
whereas	O
those	O
of	O
the	O
flat	B-T082
setting	B-T082
showed	O
an	O
increase	O
of	O
26	O
%	O
-	O
45	O
%	O
in	O
perceived	B-T038
visual	B-T038
fatigue	I-T038
.	O
across	O
curvature	B-T082
s	O
,	O
leg	O
##ibility	O
decreased	O
by	O
2	O
%	O
-	O
8	O
%	O
,	O
whereas	O
perceived	B-T038
visual	B-T038
fatigue	I-T038
increased	O
by	O
22	O
%	O
during	O
the	O
second	O
task	O
set	O
.	O
the	O
two	O
task	O
sets	O
induced	O
an	O
increase	O
of	O
102	O
%	O
in	O
the	O
eye	O
complaint	O
score	O
and	O
a	O
decrease	O
of	O
0	O
.	O
3	O
hz	O
in	O
the	O
critical	B-T033
fusion	I-T033
frequency	I-T033
,	O
both	O
of	O
which	O
indicated	O
an	O
increase	O
in	O
visual	B-T038
fatigue	I-T038
.	O
in	O
summary	O
,	O
a	O
curvature	B-T082
of	O
around	O
600	O
mm	O
,	O
central	B-T082
display	O
zones	B-T082
,	O
and	O
frequent	O
breaks	B-T082
are	O
recommended	O
to	O
improve	B-T033
leg	O
##ibility	O
and	O
reduce	O
visual	B-T038
fatigue	I-T038
.	O

evaluation	O
of	O
nutr	B-T033
##aceu	I-T033
##tical	I-T033
and	O
antin	B-T033
##utrition	I-T033
##al	I-T033
properties	I-T033
in	O
bar	B-T204
##n	I-T204
##ya	I-T204
##rd	I-T204
and	O
finger	B-T168
mill	I-T168
##et	I-T168
varieties	O
grown	O
in	O
him	O
##ala	O
##yan	O
region	O
five	O
elite	O
varieties	O
of	O
bar	B-T204
##n	I-T204
##ya	I-T204
##rd	I-T204
(	O
echin	B-T204
##och	I-T204
##lo	I-T204
##a	I-T204
fru	I-T204
##ment	I-T204
##acea	I-T204
)	O
and	O
finger	B-T204
(	O
ele	B-T204
##us	I-T204
##ine	I-T204
cor	I-T204
##aca	I-T204
##na	I-T204
)	O
growing	O
at	O
northwest	O
##ern	O
him	O
##ala	O
##ya	O
were	O
investigated	O
for	O
nutr	B-T033
##aceu	I-T033
##tical	I-T033
and	O
antin	B-T033
##utrition	I-T033
##al	I-T033
properties	I-T033
.	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
contained	O
higher	O
amount	O
of	O
crude	B-T103
fiber	I-T103
,	O
total	B-T168
dietary	I-T168
fiber	I-T168
,	O
tryptophan	B-T103
content	O
,	O
total	B-T103
carotenoids	I-T103
,	O
α	B-T103
-	I-T103
tocopherol	I-T103
compared	O
to	O
the	O
finger	B-T168
mill	I-T168
##et	I-T168
whereas	O
the	O
finger	B-T168
mill	I-T168
##et	I-T168
contains	O
higher	O
amount	O
of	O
methionine	B-T103
and	O
ascorbic	B-T103
acid	I-T103
as	O
compared	O
to	O
the	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
.	O
the	O
secondary	B-T103
metabolites	I-T103
of	O
biological	B-T038
functions	I-T038
were	O
analyzed	O
and	O
found	O
that	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
contained	O
the	O
higher	O
amount	O
of	O
polyphenols	B-T103
,	O
tann	B-T103
##ins	I-T103
and	O
ortho	B-T103
-	I-T103
dihydroxy	I-T103
phenol	I-T103
content	O
compared	O
to	O
finger	B-T168
mill	I-T168
##et	I-T168
.	O
among	O
antin	B-T103
##ut	I-T103
##itional	I-T103
compounds	I-T103
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
contained	O
lower	O
phyt	B-T103
##ic	I-T103
acid	I-T103
content	O
compare	O
to	O
finger	B-T168
mill	I-T168
##et	I-T168
whereas	O
no	O
significant	O
difference	O
in	O
trypsin	B-T038
inhibition	I-T038
activity	I-T038
of	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
and	O
finger	B-T168
mill	I-T168
##et	I-T168
varieties	O
were	O
found	O
.	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
contained	O
higher	O
acid	B-T103
phosphatase	I-T103
,	O
α	B-T103
-	I-T103
galactosidase	I-T103
and	O
α	B-T038
-	I-T038
amylase	I-T038
inhibitor	I-T038
activity	I-T038
compared	O
to	O
finger	B-T168
mill	I-T168
##et	I-T168
.	O
finger	B-T168
mill	I-T168
##et	I-T168
seeds	I-T168
contained	O
about	O
10	O
-	O
13	O
folds	O
higher	O
calcium	B-T103
content	O
and	O
double	O
amount	O
of	O
manganese	B-T103
content	O
in	O
comparison	O
to	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
seeds	I-T168
.	O
present	O
study	O
suggests	O
that	O
bar	B-T168
##n	I-T168
##ya	I-T168
##rd	I-T168
mill	I-T168
##et	I-T168
varieties	O
studied	O
under	O
present	O
investigation	O
were	O
found	O
nutritional	O
##ly	O
superior	O
compared	O
to	O
finger	B-T168
mill	I-T168
##et	I-T168
varieties	O
.	O

fine	O
structure	O
of	O
interleukin	B-T103
18	I-T103
(	I-T103
il	I-T103
-	I-T103
18	I-T103
)	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
in	O
the	O
retrosp	B-T017
##len	I-T017
##ial	I-T017
cortex	I-T017
and	O
its	O
changes	O
in	O
il	B-T017
##18	I-T017
knockout	B-T204
mice	I-T204
interleukin	B-T103
18	I-T103
(	O
il	B-T103
-	I-T103
18	I-T103
)	O
participates	O
in	O
the	O
inflammatory	O
immune	B-T038
response	I-T038
of	O
lymphocytes	B-T017
.	O
delay	O
in	O
learning	O
or	O
memory	O
are	O
common	O
in	O
the	O
il	B-T017
-	I-T017
18	I-T017
knockout	B-T204
mouse	I-T204
.	O
many	O
il	B-T103
-	I-T103
18	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
are	O
found	O
in	O
the	O
retrosp	B-T017
##len	I-T017
##ial	I-T017
cortex	I-T017
(	O
rs	B-T017
##c	I-T017
)	O
and	O
the	O
sub	B-T017
##icul	I-T017
##um	I-T017
.	O
these	O
neurons	B-T017
also	O
contain	O
the	O
il	B-T103
-	I-T103
18	I-T103
receptor	I-T103
.	O
we	O
determined	O
the	O
location	O
and	O
the	O
ultrastructure	O
of	O
the	O
il	B-T103
-	I-T103
18	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
in	O
the	O
rs	B-T017
##c	I-T017
and	O
observed	O
changes	O
in	O
the	O
il	B-T103
-	I-T103
18	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
of	O
the	O
il	B-T017
-	I-T017
18	I-T017
knockout	B-T204
mouse	I-T204
.	O
the	O
il	B-T103
-	I-T103
18	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
were	O
found	O
specifically	O
in	O
layer	O
v	O
of	O
the	O
granular	O
rs	O
##c	O
.	O
they	O
were	O
medium	O
-	O
sized	O
neurons	B-T017
with	O
a	O
light	O
oval	B-T017
nucleus	I-T017
and	O
had	O
little	O
cytoplasm	B-T017
with	O
many	O
free	B-T017
ribosomes	I-T017
,	O
rough	O
endoplasmic	B-T017
reticulum	I-T017
and	O
many	O
mitochondria	B-T017
,	O
but	O
no	O
niss	B-T017
##l	I-T017
bodies	I-T017
.	O
the	O
number	O
of	O
ax	B-T082
##osoma	I-T082
##tic	I-T082
terminals	I-T082
was	O
about	O
six	O
per	O
section	O
.	O
the	O
il	B-T103
-	I-T103
18	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
were	O
not	O
found	O
in	O
the	O
rs	B-T017
##c	I-T017
in	O
the	O
il	B-T017
-	I-T017
18	I-T017
knockout	B-T204
mouse	I-T204
at	O
5	O
or	O
9	O
weeks	O
of	O
age	O
.	O
however	O
,	O
many	O
small	O
electron	O
-	O
dense	O
neurons	B-T017
were	O
found	O
in	O
layer	O
v	O
.	O
both	O
the	O
nucleus	B-T017
and	O
cytoplasm	B-T017
were	O
electron	O
-	O
dense	O
,	O
but	O
not	O
necrotic	O
.	O
the	O
mitochondria	B-T017
and	O
rough	B-T017
endoplasmic	I-T017
reticulum	I-T017
were	O
swollen	B-T033
.	O
the	O
il	B-T103
-	I-T103
18	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
were	O
presumed	O
to	O
be	O
degen	B-T033
##erating	I-T033
.	O
the	O
degeneration	B-T038
of	O
the	O
il	B-T103
##18	I-T103
-	I-T103
receptor	I-T103
-	O
immunoreactive	B-T022
neurons	B-T017
in	O
the	O
rs	B-T017
##c	I-T017
may	O
cause	O
the	O
abnormal	B-T038
behaviors	I-T038
of	O
the	O
il	B-T017
-	I-T017
18	I-T017
knockout	B-T204
mice	I-T204
.	O

km	O
##ap	O
-	O
o	O
framework	O
for	O
care	B-T058
management	I-T058
research	B-T062
of	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
to	O
review	O
impacts	O
of	O
interventions	B-T058
involving	O
self	B-T058
-	I-T058
management	I-T058
education	I-T058
,	O
health	O
coa	O
##ching	O
,	O
and	O
motivational	B-T058
interviewing	I-T058
for	O
type	B-T038
2	I-T038
diabetes	I-T038
.	O
a	O
thorough	O
review	O
of	O
the	O
scientific	B-T170
literature	I-T170
on	O
diabetes	B-T038
care	B-T058
and	I-T058
management	I-T058
was	O
executed	O
by	O
a	O
research	B-T062
team	O
.	O
this	O
article	B-T170
summarizes	O
important	O
findings	O
in	O
regard	O
to	O
the	O
validity	O
of	O
developing	O
a	O
comprehensive	O
behavioral	O
system	O
as	O
a	O
framework	O
for	O
empirical	O
investigation	B-T058
.	O
the	O
behavioral	O
system	O
framework	O
consists	O
of	O
patients	O
'	O
knowledge	O
(	O
k	O
)	O
,	O
motivation	B-T038
(	O
m	B-T038
)	O
,	O
attitude	B-T038
(	O
a	B-T038
)	O
,	O
and	O
practice	B-T038
(	O
p	B-T038
)	O
as	O
predictor	O
variables	O
for	O
diabetes	B-T038
care	B-T170
outcomes	I-T170
(	O
o	B-T170
)	O
.	O
care	B-T058
management	I-T058
strategies	O
or	O
health	O
education	O
programs	O
serve	O
as	O
the	O
intervention	B-T058
variable	O
that	O
directly	O
influences	O
k	O
,	O
m	B-T038
,	O
a	B-T038
,	O
and	O
p	B-T038
and	O
then	O
indirectly	O
affects	O
the	O
variability	O
in	O
patient	O
care	B-T170
outcomes	I-T170
of	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
.	O
this	O
review	B-T170
contributes	O
to	O
the	O
understanding	O
of	O
the	O
km	O
##ap	O
-	O
o	O
framework	O
and	O
how	O
it	O
can	O
guide	O
the	O
care	B-T058
management	I-T058
of	O
patients	O
with	O
type	B-T038
2	I-T038
diabetes	I-T038
.	O
it	O
will	O
allow	O
the	O
tailoring	O
of	O
interventions	B-T058
to	O
be	O
more	O
effective	O
through	O
knowledge	O
enhancement	O
,	O
increased	B-T038
motivation	I-T038
,	O
attit	B-T038
##udinal	I-T038
changes	O
,	O
and	O
improved	B-T033
preventive	B-T058
practice	I-T058
to	O
reduce	O
the	O
progression	B-T038
of	O
type	B-T038
2	I-T038
diabetes	I-T038
and	O
comorbidities	O
.	O
furthermore	O
,	O
the	O
use	O
of	O
health	O
information	O
technology	O
for	O
enhancing	O
changes	O
in	O
km	O
##ap	O
and	O
communications	O
is	O
advocated	O
in	O
health	B-T058
promotion	I-T058
and	O
development	O
.	O

bacteria	B-T007
and	O
ho	B-T204
##ver	I-T204
##flies	I-T204
(	O
dip	B-T204
##tera	I-T204
:	O
syr	B-T204
##phi	I-T204
##da	I-T204
##e	I-T204
)	O
in	O
tree	B-T017
hollow	I-T017
##s	I-T017
from	O
the	O
ib	O
##erian	O
mediterranean	O
forest	O
sap	B-T204
##rox	I-T204
##ylic	I-T204
insect	I-T204
communities	I-T204
inhab	B-T082
##iting	I-T082
tree	B-T017
hollow	I-T017
##s	I-T017
in	O
mediterranean	O
forests	O
depend	O
on	O
a	O
combination	O
of	O
physical	O
characteristics	O
and	O
interactions	O
occurring	O
between	O
community	B-T170
member	I-T170
species	I-T170
.	O
despite	O
the	O
need	O
to	O
preserve	O
these	O
organisms	O
,	O
little	O
is	O
known	O
about	O
their	O
interrelations	O
##hips	O
,	O
in	O
particular	O
those	O
relationships	O
between	O
sap	B-T204
##rox	I-T204
##ylic	I-T204
insects	I-T204
and	O
microbiota	O
occurring	O
in	O
these	O
micro	B-T082
##ha	I-T082
##bi	I-T082
##ta	I-T082
##ts	I-T082
.	O
in	O
tree	B-T017
hollow	I-T017
##s	I-T017
of	O
quer	B-T204
##cus	I-T204
rot	I-T204
##und	I-T204
##ifolia	I-T204
lam	I-T204
##ark	I-T204
that	O
hold	O
water	O
and	O
contain	O
dead	B-T204
leaves	I-T204
,	O
abundant	O
microbial	O
populations	O
can	O
be	O
found	O
.	O
developing	O
on	O
them	O
are	O
the	O
larvae	B-T204
of	O
mall	B-T204
##ota	I-T204
dus	I-T204
##met	I-T204
##i	I-T204
and	O
##re	O
##u	O
,	O
192	O
##6	O
(	O
dip	B-T204
##tera	I-T204
:	O
syr	B-T204
##phi	I-T204
##da	I-T204
##e	I-T204
)	O
,	O
a	O
vulnerable	B-T170
species	I-T170
(	O
iu	B-T170
##cn	I-T170
category	I-T170
:	O
marc	B-T098
##os	I-T098
-	I-T098
gar	I-T098
##ci	I-T098
##a	I-T098
and	O
quin	B-T098
##to	I-T098
2011	O
)	O
.	O
this	O
study	O
provides	O
the	O
first	O
data	O
on	O
the	O
microbiota	O
living	B-T082
inside	I-T082
the	O
gut	B-T017
of	O
the	O
larvae	B-T204
of	O
m	B-T204
.	I-T204
dus	I-T204
##met	I-T204
##i	I-T204
,	O
as	O
well	O
as	O
the	O
microbiota	O
in	O
the	O
hollow	B-T082
where	O
these	O
larvae	B-T204
develop	B-T038
.	O
bacteria	B-T007
were	O
identified	O
by	O
amplification	O
and	O
partial	O
sequencing	O
of	O
the	O
v1	O
-	O
v3	O
regions	O
and	O
the	O
complete	O
nucleotide	B-T082
sequence	I-T082
of	O
16s	B-T103
rrna	I-T103
genes	I-T103
.	O
we	O
found	O
eight	O
species	B-T007
of	I-T007
bacteria	I-T007
living	B-T082
in	I-T082
tree	B-T017
hollow	I-T017
##s	I-T017
and	O
three	O
species	B-T170
in	B-T017
the	I-T017
gut	I-T017
of	O
m	B-T204
.	I-T204
dus	I-T204
##met	I-T204
##i	I-T204
larvae	B-T204
:	O
bacillus	B-T007
cereus	I-T007
,	O
bacillus	B-T007
to	I-T007
##y	I-T007
##one	I-T007
##ns	I-T007
##is	I-T007
,	O
and	O
lys	B-T007
##ini	I-T007
##ba	I-T007
##cil	I-T007
##lu	I-T007
##s	I-T007
sph	I-T007
##aer	I-T007
##icus	I-T007
the	O
filter	B-T033
-	I-T033
feeding	I-T033
mechanism	I-T033
characteristic	I-T033
of	O
m	B-T204
.	I-T204
dus	I-T204
##met	I-T204
##i	I-T204
larvae	B-T204
is	O
selective	O
in	O
enabling	O
ingestion	B-T038
of	O
bacteria	B-T007
only	O
above	O
2	O
.	O
1	O
µm	O
in	O
diameter	O
.	O

the	O
relationships	O
between	O
rug	O
##by	O
players	B-T098
'	I-T098
tackle	O
training	O
attitudes	B-T038
and	O
behaviour	O
and	O
their	O
match	B-T038
tackle	I-T038
attitudes	I-T038
and	O
behaviour	O
the	O
tackle	O
event	O
in	O
rug	O
##by	O
is	O
a	O
technical	O
and	O
physical	O
cont	O
##est	O
between	O
opposing	O
players	B-T098
.	O
a	O
player	B-T098
'	I-T098
s	I-T098
ability	O
to	O
tolerate	O
and	O
cont	O
##est	O
during	O
a	O
tackle	O
is	O
a	O
prerequisite	O
for	O
safe	O
participation	O
and	O
success	O
in	O
rug	O
##by	O
.	O
little	O
is	O
known	O
about	O
the	O
relationship	O
between	O
tackle	O
training	O
and	O
tack	O
##ling	O
in	O
matches	O
in	O
rug	O
##by	O
union	O
.	O
therefore	O
,	O
we	O
investigated	O
the	O
relationships	O
between	O
players	B-T098
'	I-T098
training	B-T038
attitudes	I-T038
and	O
behaviour	O
and	O
their	O
match	B-T038
attitudes	I-T038
and	O
behaviour	O
for	O
tack	O
##ling	O
in	O
rug	O
##by	O
union	O
.	O
a	O
questionnaire	B-T170
was	O
designed	O
to	O
assess	O
attitude	B-T038
(	O
importance	O
)	O
and	O
behaviours	O
(	O
frequency	O
and	O
quantity	O
)	O
among	O
junior	O
(	O
under	O
19	O
)	O
players	B-T098
on	O
a	O
5	B-T170
-	I-T170
point	I-T170
likert	I-T170
scale	I-T170
.	O
questionnaires	B-T170
were	O
handed	O
out	O
to	O
220	O
players	B-T098
(	O
10	O
schools	B-T092
)	O
at	O
a	O
tourn	O
##ament	O
and	O
75	O
%	O
(	O
9	O
schools	B-T092
,	O
n	O
=	O
164	O
)	O
were	O
returned	O
for	O
analysis	B-T062
.	O
associations	B-T038
between	O
training	B-T038
attitudes	I-T038
and	O
behaviours	O
were	O
tested	O
using	O
the	O
χ	B-T170
(	I-T170
2	I-T170
)	I-T170
test	I-T170
,	I-T170
cr	I-T170
##amer	I-T170
'	I-T170
s	I-T170
v	I-T170
and	I-T170
τ	I-T170
-	I-T170
b	I-T170
.	O
the	O
more	O
time	O
spent	O
on	O
emphasis	O
##ing	O
proper	O
technique	O
to	O
prevent	O
injuries	B-T037
in	O
training	O
,	O
the	O
more	O
important	O
players	B-T098
rated	O
'	O
own	O
safety	O
'	O
(	O
τ	O
-	O
b	O
=	O
0	O
.	O
21	O
,	O
moderate	O
,	O
z	O
=	O
3	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
,	O
'	O
going	O
for	O
the	O
ball	O
only	O
'	O
(	O
τ	O
-	O
b	O
=	O
0	O
.	O
27	O
,	O
moderate	O
,	O
z	O
=	O
4	O
.	O
6	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
'	O
stay	O
##ing	O
on	O
feet	O
'	O
(	O
τ	O
-	O
b	O
=	O
0	O
.	O
23	O
,	O
moderate	O
,	O
z	O
=	O
3	O
.	O
6	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
in	O
match	O
play	O
.	O
the	O
more	O
time	O
spent	O
on	O
emphasis	O
##ing	O
proper	O
technique	O
to	O
improve	B-T033
performance	O
in	O
training	O
,	O
the	O
more	O
important	O
players	B-T098
rated	O
actions	O
'	O
going	O
for	O
ball	O
only	O
'	O
(	O
τ	O
-	O
b	O
=	O
0	O
.	O
23	O
,	O
moderate	O
,	O
z	O
=	O
3	O
.	O
7	O
,	O
p	O
<	O
0	O
.	O
001	O
)	O
and	O
'	O
preventing	O
the	O
ball	O
carrier	O
from	O
retaining	O
position	B-T082
'	O
(	O
τ	O
-	O
b	O
=	O
0	O
.	O
20	O
,	O
moderate	O
,	O
z	O
=	O
3	O
.	O
1	O
,	O
p	O
<	O
0	O
.	O
01	O
)	O
in	O
match	O
play	O
.	O
this	O
is	O
the	O
first	O
study	B-T062
to	O
report	O
on	O
the	O
relationships	O
between	O
players	B-T098
'	O
training	B-T038
attitudes	I-T038
and	O
behaviour	O
and	O
their	O
match	B-T038
attitudes	I-T038
and	O
behaviour	O
s	O
for	O
tack	O
##ling	O
in	O
rug	O
##by	O
union	O
.	O
the	O
importance	O
of	O
tackle	O
training	O
to	O
prevent	O
injury	B-T037
,	O
and	O
the	O
amount	O
of	O
time	O
spent	O
on	O
technique	O
to	O
prevent	O
injuries	B-T037
,	O
was	O
associated	O
with	O
behaviours	O
that	O
reduce	O
the	O
risk	B-T033
of	I-T033
injury	I-T033
in	O
matches	O
.	O

gut	O
microbiome	O
alterations	O
in	O
patients	O
with	O
stage	O
4	O
hepatitis	B-T038
c	I-T038
hepatitis	B-T005
c	I-T005
virus	I-T005
(	O
hcv	B-T005
)	O
causes	O
debilitating	O
liver	B-T038
diseases	I-T038
,	O
which	O
may	O
progress	O
to	O
cirrhosis	B-T038
and	O
cancer	B-T038
,	O
and	O
claims	O
500	O
,	O
000	O
annual	O
lives	O
worldwide	O
.	O
while	O
hcv	B-T005
epidemiology	B-T062
,	O
pathophysiology	B-T038
,	O
and	O
therapy	O
are	O
being	O
deeply	O
studied	O
,	O
rare	O
attention	O
is	O
given	O
to	O
reciprocal	B-T038
interactions	I-T038
between	O
hcv	B-T038
infection	I-T038
,	O
hcv	B-T005
-	O
induced	O
chronic	B-T038
liver	I-T038
diseases	I-T038
,	O
and	O
the	O
human	B-T204
gut	O
microbiome	O
.	O
as	O
egypt	B-T082
has	O
the	O
world	B-T098
'	I-T098
s	I-T098
highest	O
prevalence	O
of	O
hcv	B-T038
infections	I-T038
,	O
we	O
launched	O
this	O
study	B-T062
to	O
monitor	O
differences	O
in	O
the	O
gut	O
microbial	O
community	O
composition	B-T201
of	O
egypt	B-T098
##ian	I-T098
hcv	B-T005
patients	O
that	O
may	O
affect	O
,	O
or	O
result	O
from	O
,	O
the	O
patients	O
'	O
liver	B-T017
state	O
.	O
to	O
this	O
end	O
,	O
we	O
analyzed	O
stool	B-T031
samples	I-T031
from	O
six	O
stage	O
4	O
-	O
hcv	B-T005
patients	O
and	O
eight	O
healthy	B-T098
individuals	I-T098
by	O
high	O
-	O
throughput	O
16s	B-T058
rrna	I-T058
gene	I-T058
sequencing	I-T058
using	O
illumina	B-T074
mis	I-T074
##e	I-T074
##q	I-T074
.	O
overall	O
,	O
the	O
alpha	O
-	O
diversity	O
of	O
the	O
healthy	B-T098
persons	I-T098
'	I-T098
gut	O
microbiome	O
##s	O
was	O
higher	O
than	O
those	O
of	O
the	O
hcv	B-T005
patients	O
.	O
whereas	O
members	O
of	O
phylum	B-T007
bacter	I-T007
##oide	I-T007
##tes	I-T007
were	O
more	O
abundant	O
in	O
hcv	B-T005
patients	O
,	O
healthy	B-T098
individuals	I-T098
had	O
higher	O
abundance	O
of	O
firm	B-T007
##ic	I-T007
##utes	I-T007
,	O
proteobacteria	B-T007
,	O
and	O
actin	B-T007
##obacteria	I-T007
.	O
genus	B-T170
-	O
level	O
analysis	B-T062
showed	O
differential	O
abundance	O
of	O
prev	B-T007
##ote	I-T007
##ll	I-T007
##a	I-T007
and	O
faecal	B-T007
##ib	I-T007
##acterium	I-T007
(	O
higher	O
in	O
hcv	B-T005
patients	O
)	O
vs	O
.	O
rumin	B-T007
##ococcus	I-T007
and	O
clostridium	B-T007
(	O
healthy	O
group	O
)	O
,	O
indicating	O
that	O
the	O
higher	O
abundance	O
of	O
bacter	B-T007
##oide	I-T007
##tes	I-T007
in	O
hcv	B-T005
patients	O
is	O
most	O
likely	O
due	O
to	O
prev	B-T007
##ote	I-T007
##ll	I-T007
##a	I-T007
over	O
##ab	O
##und	O
##ance	O
.	O
the	O
probiotic	B-T007
genus	I-T007
,	O
bifidobacterium	B-T007
,	O
was	O
only	O
observed	O
in	O
the	O
microbiota	O
##s	O
of	O
healthy	B-T098
individuals	I-T098
.	O
to	O
the	O
best	O
of	O
our	O
knowledge	O
,	O
this	O
study	B-T062
provides	O
a	O
first	O
overview	O
of	O
major	O
phyl	B-T170
##a	I-T170
and	O
genera	B-T170
differentiating	O
stage	O
4	O
-	O
hcv	B-T005
patients	O
from	O
healthy	B-T098
individuals	I-T098
and	O
suggests	O
possible	O
microbiome	O
remodeling	O
in	O
chronic	B-T038
hepatitis	I-T038
c	I-T038
,	O
possibly	O
shaped	O
by	O
bacterial	B-T038
translocation	I-T038
as	O
well	O
as	O
the	O
liver	B-T017
'	I-T017
s	I-T017
impaired	B-T033
role	I-T033
in	O
digestion	B-T038
and	O
protein	B-T038
synthesis	I-T038
.	O
future	O
studies	O
will	O
investigate	O
the	O
microbiome	O
composition	B-T201
and	O
functional	O
capabilities	O
in	O
more	O
patients	O
while	O
tracing	O
some	O
potential	O
biomarker	B-T201
taxa	O
(	O
e	O
.	O
g	O
.	O
,	O
prev	B-T007
##ote	I-T007
##ll	I-T007
##a	I-T007
,	O
faecal	B-T007
##ib	I-T007
##acterium	I-T007
vs	O
.	O
bifidobacterium	B-T007
)	O
.	O

loc	O
##ating	O
the	O
seventh	B-T017
cervical	I-T017
spin	I-T017
##ous	I-T017
process	I-T017
:	O
development	O
and	O
validation	O
of	O
a	O
multivariate	B-T170
model	I-T170
using	O
palpation	B-T058
and	O
personal	O
information	O
the	O
aim	O
of	O
this	O
study	O
was	O
to	O
develop	O
and	O
validate	O
a	O
multivariate	B-T170
prediction	I-T170
model	I-T170
,	O
guided	O
by	O
palpation	B-T058
and	O
personal	O
information	O
,	O
for	O
loc	O
##ating	O
the	O
seventh	B-T017
cervical	I-T017
spin	I-T017
##ous	I-T017
process	I-T017
(	O
c7	B-T017
##sp	I-T017
)	O
.	O
a	O
single	B-T062
-	I-T062
blinded	I-T062
,	I-T062
cross	I-T062
-	I-T062
sectional	I-T062
study	I-T062
at	O
a	O
primary	B-T092
to	I-T092
tertiary	I-T092
health	I-T092
care	I-T092
center	I-T092
was	O
conducted	O
for	O
model	O
development	O
and	O
temporal	B-T062
validation	I-T062
.	O
one	O
-	O
hundred	O
sixty	O
participants	B-T098
were	O
prospectively	O
included	O
for	O
model	O
development	O
(	O
n	O
=	O
80	O
)	O
and	O
time	O
-	O
split	O
validation	O
stages	O
(	O
n	O
=	O
80	O
)	O
.	O
the	O
c7	B-T017
##sp	I-T017
was	O
located	O
using	O
the	O
thorax	B-T058
-	I-T058
rib	I-T058
static	I-T058
method	I-T058
(	O
tr	B-T058
##sm	I-T058
)	O
.	O
participants	B-T098
underwent	O
chest	B-T058
radiography	I-T058
for	O
assessment	O
of	O
the	O
inner	B-T082
body	B-T017
structure	I-T017
located	O
with	O
tr	B-T058
##sm	I-T058
and	O
using	O
radio	B-T074
-	I-T074
opaque	I-T074
markers	I-T074
placed	O
over	O
the	O
skin	B-T022
.	O
age	O
,	O
sex	O
,	O
height	O
,	O
body	O
mass	O
,	O
body	B-T201
mass	I-T201
index	I-T201
,	O
and	O
vertex	O
-	O
marker	O
dist	O
##anc	O
e	O
(	O
dv	O
-	O
m	O
)	O
were	O
used	O
to	O
predict	O
the	O
distance	O
from	O
the	O
c7	B-T017
##sp	I-T017
to	O
the	O
vertex	B-T082
(	O
dv	O
-	O
c7	O
)	O
.	O
multivariate	B-T170
linear	I-T170
regression	I-T170
modeling	I-T170
,	O
limits	O
of	O
agreement	O
plot	O
,	O
histogram	O
of	O
residues	O
,	O
receiver	O
operating	O
characteristic	O
curves	O
,	O
and	O
confusion	B-T170
tables	I-T170
were	O
analyzed	O
.	O
the	O
multivariate	B-T170
linear	I-T170
prediction	I-T170
model	I-T170
for	O
dv	O
-	O
c7	O
(	O
in	O
centi	O
##meter	O
##s	O
)	O
was	O
dv	O
-	O
c7	O
=	O
0	O
.	O
98	O
##6	O
##dv	O
-	O
m	O
+	O
0	O
.	O
018	O
(	O
mass	O
)	O
+	O
0	O
.	O
014	O
(	O
age	O
)	O
-	O
1	O
.	O
008	O
.	O
receiver	O
operating	O
characteristic	O
curves	O
had	O
better	O
discrimination	O
of	O
dv	O
-	O
c7	O
(	O
area	O
under	O
the	O
curve	O
=	O
0	O
.	O
66	O
##1	O
;	O
95	O
%	O
confidence	O
interval	O
=	O
0	O
.	O
54	O
##1	O
-	O
0	O
.	O
78	O
##2	O
;	O
p	O
=	O
.	O
015	O
)	O
than	O
dv	O
-	O
m	O
(	O
area	O
under	O
the	O
curve	O
=	O
0	O
.	O
480	O
;	O
95	O
%	O
confidence	O
interval	O
=	O
0	O
.	O
345	O
-	O
0	O
.	O
61	O
##4	O
;	O
p	O
=	O
.	O
76	O
##1	O
)	O
,	O
with	O
respective	O
cutoff	O
points	O
at	O
23	O
.	O
40	O
cm	O
(	O
sensitivity	O
=	O
41	O
%	O
,	O
specificity	O
=	O
63	O
%	O
)	O
and	O
24	O
.	O
75	O
cm	O
(	O
sensitivity	O
=	O
69	O
%	O
,	O
specificity	O
=	O
52	O
%	O
)	O
.	O
the	O
c7	B-T017
##sp	I-T017
was	O
correctly	O
located	O
more	O
often	O
when	O
using	O
predicted	O
dv	O
-	O
c7	O
in	O
the	O
validation	O
sample	O
than	O
when	O
using	O
the	O
tr	B-T058
##sm	I-T058
in	O
the	O
development	O
sample	O
:	O
n	O
=	O
53	O
(	O
66	O
%	O
)	O
vs	O
n	O
=	O
32	O
(	O
40	O
%	O
)	O
,	O
p	O
<	O
.	O
001	O
.	O
better	O
accuracy	O
was	O
obtained	O
when	O
loc	O
##ating	O
the	O
c7	B-T017
##sp	I-T017
by	O
use	O
of	O
a	O
multivariate	B-T170
model	I-T170
that	O
incorporates	O
palpation	B-T058
and	O
personal	O
information	O
.	O

light	O
##weight	O
open	B-T017
-	I-T017
cell	I-T017
scaffolds	I-T017
from	O
sea	B-T204
urchin	I-T204
spines	B-T103
with	O
superior	O
material	O
properties	O
for	O
bone	B-T058
defect	I-T058
repair	I-T058
sea	B-T204
urchin	I-T204
spines	B-T103
(	O
hetero	B-T204
##centr	I-T204
##ot	I-T204
##us	I-T204
mamm	I-T204
##illa	I-T204
##t	I-T204
##us	I-T204
)	O
,	O
with	O
a	O
hierarchical	O
open	B-T017
-	I-T017
cell	I-T017
structure	I-T017
similar	O
to	O
that	O
of	O
human	B-T204
trabecular	B-T017
bone	I-T017
and	O
superior	O
mechanical	O
property	O
(	O
compressive	O
strength	O
∼	O
##43	O
.	O
4	O
mpa	O
)	O
suitable	O
for	O
mach	O
##ining	O
to	O
shape	O
,	O
were	O
explored	O
for	O
potential	O
applications	O
of	O
bone	B-T058
defect	I-T058
repair	I-T058
.	O
finite	B-T170
element	I-T170
analyses	I-T170
reveal	O
that	O
the	O
compressive	O
stress	B-T033
concentrates	O
along	O
the	O
dense	O
growth	B-T038
rings	I-T038
and	O
dissip	B-T082
##ates	I-T082
through	O
str	O
##ut	O
structures	B-T017
of	I-T017
the	I-T017
stereo	I-T017
##ms	I-T017
,	O
indicating	O
that	O
the	O
ex	O
##quis	O
##ite	O
meso	B-T082
##st	I-T082
##ruc	I-T082
##tures	I-T082
play	O
an	O
important	O
role	O
in	O
high	O
strength	O
-	O
to	O
-	O
weight	O
ratios	O
.	O
the	O
fracture	B-T037
strength	O
of	O
magnesium	B-T103
-	O
substituted	B-T103
tric	I-T103
##alc	I-T103
##ium	I-T103
phosphate	I-T103
(	B-T103
β	I-T103
-	I-T103
tcm	I-T103
##p	I-T103
)	I-T103
scaffolds	I-T103
produced	O
by	O
hydrothermal	O
conversion	O
of	O
urchin	B-T204
spines	B-T103
is	O
about	O
9	O
.	O
3	O
mpa	O
,	O
comparable	O
to	O
that	O
of	O
human	B-T204
trabecular	B-T017
bone	I-T017
.	O
new	O
bone	B-T017
forms	O
along	O
outer	O
surfaces	B-T082
of	O
β	B-T103
-	I-T103
tcm	I-T103
##p	I-T103
scaffolds	I-T103
after	O
implantation	B-T058
in	O
rabbit	B-T204
femoral	B-T037
defects	I-T037
for	O
one	O
month	O
and	O
grows	B-T038
into	O
the	O
majority	O
of	O
the	O
inner	O
open	B-T082
-	I-T082
cell	I-T082
spaces	I-T082
post	O
##oper	O
##ation	O
in	O
three	O
month	O
s	O
,	O
showing	O
tight	O
interface	O
between	O
the	O
scaffold	B-T103
and	O
regenerative	B-T038
bone	I-T038
tissue	I-T038
.	O
fusion	B-T058
of	O
be	B-T204
##agle	I-T204
lumbar	B-T082
facet	I-T082
joints	I-T082
using	O
a	O
ti	B-T103
-	I-T103
6a	I-T103
##l	I-T103
-	I-T103
4	I-T103
##v	I-T103
cage	I-T103
and	O
β	B-T103
-	I-T103
tcm	I-T103
##p	I-T103
scaffold	I-T103
can	O
be	O
completed	O
within	O
seven	O
months	O
with	O
obvious	O
biodegradation	O
of	O
the	O
β	B-T103
-	I-T103
tcm	I-T103
##p	I-T103
scaffold	I-T103
,	O
which	O
is	O
nearly	O
completely	O
degraded	O
and	O
replaced	O
by	O
newly	O
formed	O
bone	B-T017
ten	O
months	O
after	O
implantation	B-T058
.	O
thus	O
,	O
sea	B-T204
urchin	I-T204
spines	B-T103
suitable	O
for	O
mach	O
##ining	O
to	O
shape	O
have	O
advantages	O
for	O
production	O
of	O
biodegradable	O
artificial	B-T103
grafts	I-T103
for	O
bone	B-T058
defect	I-T058
repair	I-T058
.	O

types	O
of	O
internal	B-T092
facilitation	I-T092
activities	O
in	O
hospitals	B-T092
implementing	B-T058
evidence	I-T058
-	I-T058
based	I-T058
interventions	I-T058
implementation	O
models	B-T170
,	O
frameworks	O
,	O
and	O
theories	O
recognize	O
the	O
importance	O
of	O
activities	O
that	O
facilitate	O
implementation	O
success	O
.	O
however	O
,	O
little	O
is	O
known	O
about	O
internal	B-T092
facilitation	I-T092
activities	O
that	O
hospital	B-T097
personnel	I-T097
engage	O
in	O
during	O
implementation	O
efforts	O
.	O
the	O
aim	O
of	O
the	O
study	B-T062
was	O
to	O
examine	O
internal	B-T092
facilitation	I-T092
activities	O
at	O
10	O
critical	B-T092
access	I-T092
hospitals	I-T092
in	O
rural	B-T082
io	I-T082
##wa	I-T082
during	O
their	O
implementation	O
of	O
teams	B-T092
##te	I-T092
##pps	I-T092
,	O
a	O
patient	B-T058
safety	I-T058
intervention	B-T058
,	O
and	O
to	O
identify	O
characteristics	O
that	O
distinguish	O
different	O
types	O
of	O
facilitation	B-T092
activities	O
.	O
we	O
followed	O
10	O
critical	B-T092
access	I-T092
hospitals	I-T092
for	O
2	O
years	O
after	O
the	O
onset	O
of	O
implementation	O
,	O
conducting	O
quarter	O
##ly	O
interviews	O
with	O
key	O
informants	O
.	O
on	O
the	O
basis	O
of	O
the	O
transcripts	B-T170
from	O
the	O
first	O
two	O
quarters	O
,	O
a	O
coding	O
template	O
was	O
developed	O
using	O
inductive	B-T062
analyses	I-T062
.	O
the	O
template	O
was	O
then	O
applied	O
ded	O
##uctive	O
##ly	O
to	O
code	O
all	O
interview	O
transcripts	B-T170
.	O
using	O
comparative	O
analysis	O
,	O
we	O
examined	O
the	O
characteristics	O
that	O
distinguish	O
between	O
the	O
facilitation	B-T092
types	O
.	O
we	O
identified	O
four	O
types	O
of	O
facilitation	B-T092
activities	O
-	O
leadership	O
,	O
bu	O
##y	O
-	O
in	O
,	O
custom	O
##ization	O
,	O
and	O
accountability	O
.	O
individuals	B-T098
and	O
teams	O
engaged	O
in	O
different	O
types	O
of	O
facilitation	B-T092
activities	O
,	O
both	O
in	O
a	O
planned	O
and	O
an	O
ad	B-T033
hoc	I-T033
manner	I-T033
.	O
these	O
activities	O
targeted	O
at	O
both	O
people	B-T098
and	O
practices	B-T038
and	O
exhibited	O
varying	O
temporal	O
patterns	O
(	O
start	O
and	O
peak	O
time	O
)	O
.	O
there	O
are	O
four	O
types	O
of	O
facilitation	B-T092
activities	O
that	O
hospitals	B-T092
engage	O
in	O
while	O
implementing	O
evidence	B-T091
-	I-T091
based	I-T091
practices	I-T091
,	O
offering	O
a	O
parsim	O
##oni	O
##ous	O
way	O
to	O
characterize	O
facilitation	B-T092
activities	O
.	O
new	O
theoretical	O
and	O
empirical	B-T062
research	O
opportunities	O
are	O
discussed	O
.	O
understanding	O
the	O
types	O
of	O
facilitation	B-T092
activities	O
and	O
their	O
distinguishing	O
characteristics	O
can	O
assist	O
managers	B-T097
in	O
planning	O
and	O
exec	O
##uting	O
implementation	O
##s	O
of	O
evidence	B-T091
-	I-T091
based	I-T091
interventions	I-T091
.	O

variety	O
of	O
dna	B-T038
replication	I-T038
activity	I-T038
among	O
cyanobacteria	B-T007
correlates	O
with	O
distinct	O
respiration	B-T038
activity	I-T038
in	O
the	O
dark	O
cyanobacteria	B-T007
exhibit	O
light	O
-	O
dependent	O
cell	B-T038
growth	I-T038
since	O
most	O
of	O
their	O
cellular	B-T017
energy	O
is	O
obtained	O
by	O
photosynthesis	O
.	O
in	O
synech	B-T007
##ococcus	I-T007
elong	I-T007
##atus	I-T007
pcc	I-T007
79	I-T007
##42	I-T007
,	O
one	O
of	O
the	O
model	O
cyanobacteria	B-T007
,	O
dna	B-T038
replication	I-T038
depends	O
on	O
photosynthetic	B-T038
electron	I-T038
transport	I-T038
.	O
however	O
,	O
the	O
critical	O
signal	O
for	O
the	O
regulatory	B-T038
mechanism	O
of	O
dna	B-T038
replication	I-T038
has	O
not	O
been	O
identified	O
.	O
in	O
addition	O
,	O
conservation	O
of	O
this	O
regulatory	O
mechanism	O
has	O
not	O
been	O
investigated	O
among	O
cyanobacteria	B-T007
.	O
to	O
understand	O
this	O
regulatory	B-T038
signal	O
and	O
its	O
dependence	O
on	O
light	O
,	O
we	O
examined	O
the	O
regulation	B-T038
of	O
dna	B-T038
replication	I-T038
under	O
both	O
light	O
and	O
dark	O
conditions	O
among	O
three	O
model	O
cyanobacteria	B-T007
,	O
s	B-T007
.	I-T007
elong	I-T007
##atus	I-T007
pcc	I-T007
79	I-T007
##42	I-T007
,	O
synech	B-T007
##ocystis	I-T007
sp	I-T007
.	I-T007
pcc	I-T007
68	I-T007
##03	I-T007
and	O
ana	B-T007
##ba	I-T007
##ena	I-T007
sp	I-T007
.	I-T007
pcc	I-T007
71	I-T007
##20	I-T007
.	O
interestingly	O
,	O
dna	B-T038
replication	I-T038
activity	I-T038
in	O
synech	B-T007
##ocystis	I-T007
and	O
ana	B-T007
##ba	I-T007
##ena	I-T007
was	O
retained	O
when	O
cells	B-T017
were	O
transferred	B-T033
to	I-T033
the	O
dark	O
,	O
although	O
it	O
was	O
drastically	O
decreased	O
in	O
s	B-T007
.	I-T007
elong	I-T007
##atus	I-T007
.	O
glycogen	B-T038
metabolism	I-T038
and	O
respiration	B-T038
were	O
higher	O
in	O
synech	B-T007
##ocystis	I-T007
and	O
ana	B-T007
##ba	I-T007
##ena	I-T007
than	O
in	O
s	B-T007
.	I-T007
elong	I-T007
##atus	I-T007
in	O
the	O
dark	O
.	O
moreover	O
,	O
dna	B-T038
replication	I-T038
activity	I-T038
in	O
synech	B-T007
##ocystis	I-T007
and	O
ana	B-T007
##ba	I-T007
##ena	I-T007
was	O
reduced	O
to	O
the	O
same	O
level	O
as	O
that	O
in	O
s	B-T007
.	I-T007
elong	I-T007
##atus	I-T007
by	O
inhibition	O
of	O
respiratory	O
electron	B-T038
transport	I-T038
after	O
transfer	O
to	O
the	O
dark	O
.	O
these	O
results	O
demonstrate	O
that	O
there	O
is	O
disparity	B-T033
in	O
dna	B-T038
replication	I-T038
occurring	O
in	O
the	O
dark	O
among	O
cyanobacteria	B-T007
,	O
which	O
is	O
caused	O
by	O
the	O
difference	O
in	O
activity	O
of	O
respiratory	O
electron	B-T038
transport	I-T038
.	O

structural	B-T082
basis	O
for	O
simvastatin	B-T103
competitive	B-T038
antagonism	I-T038
of	O
complement	B-T103
receptor	I-T103
3	I-T103
the	O
complement	B-T103
system	I-T103
is	O
an	O
important	O
part	O
of	O
the	O
innate	O
immune	O
response	O
to	O
infection	B-T038
but	O
may	O
also	O
cause	O
severe	B-T033
complications	I-T033
during	O
inflammation	B-T038
.	O
small	B-T103
molecule	I-T103
antagonists	B-T103
to	O
complement	B-T103
receptor	I-T103
3	I-T103
(	O
cr	B-T103
##3	I-T103
)	O
have	O
been	O
widely	O
sought	O
,	O
but	O
a	O
structural	B-T082
basis	O
for	O
their	O
mode	O
of	O
action	O
is	O
not	O
available	O
.	O
we	O
report	B-T170
here	O
on	O
the	O
structure	B-T082
of	O
the	O
human	B-T204
cr	B-T103
##3	I-T103
ligand	B-T082
-	I-T082
binding	I-T082
i	I-T082
domain	I-T082
in	O
complex	B-T103
with	O
simvastatin	B-T103
.	O
simvastatin	B-T103
targets	O
the	O
metal	B-T103
ion	O
-	O
dependent	O
adhesion	O
site	O
of	O
the	O
open	O
,	O
ligand	B-T038
-	I-T038
binding	I-T038
conformation	B-T082
of	O
the	O
cr	B-T103
##3	I-T103
i	B-T082
domain	I-T082
by	O
direct	O
contact	O
with	O
the	O
chelate	B-T103
##d	I-T103
mg	I-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
ion	I-T103
.	O
simvastatin	B-T103
antagonize	B-T033
##s	I-T033
i	B-T082
domain	I-T082
binding	I-T082
to	O
the	O
complement	B-T103
fragments	I-T103
ic	B-T103
##3b	I-T103
and	O
c3	B-T103
##d	I-T103
but	O
not	O
to	O
intercellular	B-T103
adhesion	I-T103
molecule	I-T103
-	I-T103
1	I-T103
.	O
by	O
virtue	O
of	O
the	O
i	B-T082
domain	I-T082
'	I-T082
s	I-T082
wide	O
distribution	B-T082
in	O
binding	B-T038
kinetics	I-T038
to	O
ligands	B-T103
,	O
it	O
was	O
possible	B-T033
to	O
identify	O
ligand	B-T038
binding	I-T038
kinetics	B-T038
as	O
discrimin	O
##ator	O
for	O
simvastatin	B-T103
antagonism	B-T038
.	O
in	O
static	O
cellular	B-T058
experiments	B-T062
,	O
15	O
-	O
25	O
μm	O
simvastatin	B-T103
reduced	O
adhesion	O
by	O
k562	B-T017
cells	I-T017
expressing	O
recombinant	O
cr	B-T103
##3	I-T103
and	O
by	O
primary	O
human	B-T204
monocytes	B-T017
,	O
with	O
an	O
endogenous	O
expression	O
of	O
this	O
receptor	B-T103
.	O
application	B-T058
of	O
force	O
to	O
adhering	O
monocytes	B-T017
potentiated	O
the	O
effects	O
of	O
simvastatin	B-T103
where	O
only	O
a	O
50	O
-	O
100	O
nm	O
concentration	O
of	O
the	O
drug	B-T103
reduced	O
the	O
adhesion	O
by	O
20	O
-	O
40	O
%	O
compared	O
with	O
untreated	O
cells	B-T017
.	O
the	O
ability	O
of	O
simvastatin	B-T103
to	O
target	O
cr	B-T103
##3	I-T103
in	O
its	O
ligand	B-T038
binding	I-T038
-	O
activated	O
conformation	B-T082
is	O
a	O
novel	O
mechanism	O
to	O
explain	O
the	O
known	O
anti	O
-	O
inflammatory	O
effects	O
of	O
this	O
compound	B-T103
,	O
in	O
particular	O
because	O
this	O
cr	B-T103
##3	I-T103
conformation	B-T082
is	O
found	O
in	O
pro	O
-	O
inflammatory	O
environments	B-T082
.	O
our	O
report	B-T170
points	O
to	O
new	O
designs	O
of	O
cr	B-T103
##3	I-T103
antagonists	B-T103
and	O
opens	O
new	O
perspectives	O
and	O
identifies	B-T033
drug	O
##ga	O
##ble	O
receptors	B-T103
from	O
characterization	O
of	O
the	O
ligand	B-T038
binding	I-T038
kinetics	B-T038
in	O
the	O
presence	O
of	O
antagonists	B-T103
.	O

the	O
abundance	O
of	O
endo	B-T007
##fu	I-T007
##ng	I-T007
##al	I-T007
bacterium	I-T007
rhiz	B-T007
##obium	I-T007
radio	I-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
(	O
syn	O
.	O
agrobacterium	B-T007
tum	I-T007
##efaciens	I-T007
)	O
increases	O
in	O
its	O
fungal	O
host	O
pir	B-T204
##iform	I-T204
##ospora	I-T204
indica	I-T204
during	O
the	O
trip	O
##artite	O
seb	B-T204
##acin	I-T204
##ale	I-T204
##an	I-T204
symbiosis	O
with	O
higher	B-T204
plants	I-T204
rhiz	B-T007
##obium	I-T007
radio	I-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
(	O
syn	O
.	O
agrobacterium	B-T007
tum	I-T007
##efaciens	I-T007
,	O
syn	O
.	O
[UNK]	O
agrobacterium	B-T007
fab	I-T007
##rum	I-T007
[UNK]	O
)	O
is	O
an	O
endo	B-T007
##fu	I-T007
##ng	I-T007
##al	I-T007
bacterium	I-T007
of	O
the	O
fungal	O
mutual	O
##ist	O
pir	B-T204
##iform	I-T204
##ospora	I-T204
(	O
syn	O
.	O
ser	B-T204
##end	I-T204
##ip	I-T204
##ita	I-T204
)	O
indica	B-T204
(	O
bas	B-T204
##idi	I-T204
##omyc	I-T204
##ota	I-T204
)	O
,	O
which	O
together	O
form	O
a	O
trip	O
##artite	O
seb	B-T204
##acin	I-T204
##ale	I-T204
##an	I-T204
symbiosis	O
with	O
a	O
broad	O
range	O
of	O
plants	B-T204
.	O
r	B-T007
.	I-T007
radio	I-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
strain	O
f4	O
(	O
rr	O
##f4	O
)	O
,	O
isolated	O
from	O
p	B-T204
.	I-T204
indica	I-T204
dsm	I-T204
118	I-T204
##27	I-T204
,	O
induces	O
growth	B-T038
promotion	O
and	O
systemic	B-T038
resistance	I-T038
in	O
cereal	B-T168
crops	B-T204
,	O
including	O
barley	B-T204
and	O
wheat	B-T204
,	O
suggesting	O
that	O
r	B-T007
.	I-T007
radio	I-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
contributes	O
to	O
a	O
successful	O
symbiosis	O
.	O
here	O
,	O
we	O
studied	O
the	O
impact	O
of	O
endo	B-T007
##ba	I-T007
##ct	I-T007
##eria	I-T007
on	O
the	O
morphology	O
and	O
the	O
beneficial	O
activity	O
of	O
p	B-T204
.	I-T204
indica	I-T204
during	O
interactions	O
with	O
plants	B-T204
.	O
low	O
numbers	O
of	O
endo	B-T007
##ba	I-T007
##ct	I-T007
##eria	I-T007
were	O
detected	B-T033
in	O
the	O
ax	B-T058
##enic	I-T058
##ally	I-T058
grown	I-T058
p	B-T204
.	I-T204
indica	I-T204
(	O
long	O
term	O
lab	B-T058
-	I-T058
cultured	I-T058
,	O
lc	B-T204
##pir	I-T204
##i	I-T204
)	O
whereas	O
myc	B-T204
##elia	I-T204
colon	B-T033
##izing	I-T033
the	O
plant	B-T204
root	I-T204
contained	O
increased	O
numbers	O
of	O
bacteria	B-T007
.	O
higher	O
numbers	O
of	O
endo	B-T007
##ba	I-T007
##ct	I-T007
##eria	I-T007
were	O
also	O
found	O
in	O
ax	B-T058
##enic	I-T058
cultures	I-T058
of	O
p	B-T204
.	I-T204
indica	I-T204
that	O
was	O
freshly	O
re	O
-	O
isolated	O
(	O
rip	B-T204
##ir	I-T204
##i	I-T204
)	O
from	O
plant	B-T204
roots	I-T204
,	O
though	O
numbers	O
dropped	O
during	O
repeated	O
ax	B-T058
##enic	I-T058
re	I-T058
-	I-T058
cultivation	I-T058
.	O
prolonged	O
treatments	B-T058
of	O
p	B-T204
.	I-T204
indica	I-T204
cultures	B-T058
with	O
various	O
antibiotics	B-T103
could	O
not	O
completely	O
eliminate	O
the	O
bacterium	B-T007
,	O
though	O
the	O
number	O
of	O
detectable	B-T201
endo	B-T007
##ba	I-T007
##ct	I-T007
##eria	I-T007
decreased	O
significantly	O
,	O
resulting	O
in	O
partial	B-T033
-	I-T033
cured	I-T033
p	B-T204
.	I-T204
indica	I-T204
(	O
pcp	B-T204
##ir	I-T204
##i	I-T204
)	O
.	O
pcp	B-T204
##ir	I-T204
##i	I-T204
showed	O
reduced	O
growth	B-T038
in	O
ax	B-T058
##enic	I-T058
cultures	I-T058
and	O
poor	O
sporulation	B-T038
.	O
consistent	O
with	O
this	O
,	O
pcp	B-T204
##ir	I-T204
##i	I-T204
also	O
showed	O
reduced	O
plant	B-T038
growth	I-T038
promotion	O
and	O
reduced	O
systemic	B-T038
resist	I-T038
##anc	I-T038
e	O
against	O
powder	B-T204
##y	I-T204
mild	I-T204
##ew	I-T204
infection	B-T038
as	O
compared	O
with	O
rip	B-T204
##ir	I-T204
##i	I-T204
and	O
lc	B-T204
##pir	I-T204
##i	I-T204
.	O
these	O
results	O
are	O
consistent	O
with	O
the	O
assumption	O
that	O
the	O
endo	B-T007
##ba	I-T007
##ct	I-T007
##eri	I-T007
##um	I-T007
r	B-T007
.	I-T007
radio	I-T007
##ba	I-T007
##ct	I-T007
##er	I-T007
improves	B-T033
p	B-T204
.	I-T204
indica	I-T204
'	I-T204
s	I-T204
fitness	O
and	O
thus	O
contributes	O
to	O
the	O
success	O
of	O
the	O
trip	O
##artite	O
seb	B-T204
##acin	I-T204
##ale	I-T204
##an	I-T204
symbiosis	O
.	O

enhancing	O
doctors	B-T097
'	I-T097
competencies	O
in	O
communication	O
with	O
and	O
activation	O
of	O
older	B-T098
patients	O
:	O
the	O
promoting	O
active	O
aging	B-T038
(	O
prac	B-T058
##ta	I-T058
)	O
computer	B-T058
-	I-T058
based	I-T058
intervention	I-T058
study	I-T058
demographic	O
changes	O
over	O
the	O
past	O
decades	O
call	O
for	O
the	O
promotion	O
of	O
health	O
and	O
disease	O
prevention	O
for	O
older	B-T098
patients	O
,	O
as	O
well	O
as	O
strategies	O
to	O
enhance	O
their	O
independence	O
,	O
productivity	O
,	O
and	O
quality	O
of	O
life	O
.	O
our	O
objective	O
was	O
to	O
examine	O
the	O
effects	O
of	O
a	O
computer	B-T058
-	I-T058
based	I-T058
educational	I-T058
intervention	I-T058
designed	O
for	O
general	B-T097
practitioners	I-T097
(	O
gps	B-T097
)	O
to	O
promote	O
active	O
aging	B-T038
.	O
the	O
promoting	O
active	O
aging	B-T038
(	O
prac	B-T058
##ta	I-T058
)	O
study	O
consisted	O
of	O
a	O
baseline	B-T170
questionnaire	I-T170
,	O
implementation	O
of	O
an	O
intervention	B-T058
,	O
and	O
a	O
follow	B-T170
-	I-T170
up	I-T170
questionnaire	I-T170
that	O
was	O
administered	O
1	O
month	O
after	O
the	O
intervention	B-T058
.	O
a	O
total	O
of	O
151	O
primary	B-T092
care	I-T092
facilities	I-T092
(	O
response	O
rate	O
151	O
/	O
76	O
##7	O
,	O
19	O
.	O
7	O
%	O
)	O
and	O
50	O
##3	O
gps	B-T097
(	O
response	O
rate	O
50	O
##3	O
/	O
99	O
##6	O
,	O
50	O
.	O
5	O
%	O
)	O
agreed	O
to	O
participate	O
in	O
the	O
baseline	B-T062
assessment	I-T062
.	O
at	O
the	O
follow	B-T062
-	I-T062
up	I-T062
,	O
39	O
##3	O
gps	B-T097
filled	O
in	O
the	O
questionnaires	B-T170
(	O
response	O
rate	O
,	O
39	O
##3	O
/	O
50	O
##3	O
,	O
78	O
.	O
1	O
%	O
)	O
,	O
but	O
not	O
all	O
of	O
them	O
took	O
part	O
in	O
the	O
intervention	B-T058
.	O
the	O
final	O
study	O
group	O
of	O
225	O
gps	B-T097
participated	O
in	O
3	O
study	O
conditions	O
:	O
e	O
-	O
learning	O
(	O
knowledge	B-T038
plus	O
skills	O
modelling	B-T170
,	O
n	O
=	O
42	O
)	O
,	O
a	O
pdf	B-T170
article	I-T170
(	O
knowledge	B-T038
only	O
,	O
n	O
=	O
89	O
)	O
,	O
and	O
control	O
(	O
no	O
intervention	B-T058
,	O
n	O
=	O
94	O
)	O
.	O
we	O
measured	O
the	O
outcome	O
as	O
scores	O
on	O
the	O
patients	O
expectations	B-T170
scale	I-T170
,	O
communication	B-T170
scale	I-T170
,	O
attitude	B-T170
toward	I-T170
treatment	I-T170
and	I-T170
health	I-T170
scale	I-T170
,	O
and	O
self	B-T170
-	I-T170
efficacy	I-T170
scale	I-T170
.	O
gps	B-T097
participating	O
in	O
e	O
-	O
learning	O
demonstrated	O
a	O
significant	O
rise	O
in	O
their	O
perception	B-T038
of	O
older	B-T098
patients	O
'	O
expectations	O
for	O
disease	B-T170
explanation	I-T170
(	O
wal	O
##d	O
χ	O
(	O
2	O
)	O
=	O
19	O
.	O
7	O
,	O
p	O
<	O
.	O
001	O
)	O
and	O
in	O
perception	B-T038
of	O
motivational	B-T038
aspect	O
of	O
older	B-T098
patients	O
'	O
attitude	O
toward	O
treatment	O
and	O
health	O
(	O
wal	O
##d	O
χ	O
(	O
2	O
)	O
=	O
8	O
.	O
9	O
,	O
p	O
=	O
.	O
03	O
)	O
in	O
comparison	O
with	O
both	O
the	O
control	O
and	O
pdf	O
article	O
groups	O
.	O
we	O
observed	O
additional	O
between	O
-	O
group	O
differences	O
at	O
the	O
level	O
of	O
statistical	O
trend	O
.	O
gps	B-T097
participating	O
in	O
the	O
pdf	B-T170
article	I-T170
intervention	B-T058
demonstrated	O
a	O
decline	O
in	O
self	O
-	O
assessed	O
communication	O
,	O
both	O
at	O
the	O
level	O
of	O
global	O
scoring	O
(	O
wal	O
##d	O
χ	O
(	O
2	O
)	O
=	O
34	O
.	O
5	O
,	O
p	O
<	O
.	O
001	O
)	O
and	O
at	O
the	O
level	O
of	O
20	O
of	O
26	O
specific	O
behaviors	O
(	O
all	O
p	O
<	O
.	O
05	O
)	O
.	O
factors	O
moder	O
##ating	O
the	O
effects	O
of	O
the	O
intervention	B-T058
were	O
the	O
number	O
of	O
patients	O
per	O
gp	B-T097
and	O
the	O
facility	O
'	O
s	O
organizational	B-T170
structure	I-T170
.	O
both	O
methods	O
were	O
suitable	O
,	O
but	O
in	O
different	O
areas	B-T082
and	O
under	O
different	O
conditions	O
.	O
the	O
key	O
benefit	O
of	O
the	O
pdf	B-T170
article	I-T170
intervention	B-T058
was	O
raising	O
doctors	B-T097
'	O
reflection	O
on	O
limitations	O
in	O
their	O
communication	O
skills	O
,	O
whereas	O
e	O
-	O
learning	O
was	O
more	O
effective	O
in	O
changing	O
their	O
perception	O
of	O
older	B-T098
patients	O
'	O
proactive	O
attitude	O
,	O
especially	O
among	O
gps	B-T097
working	O
in	O
private	B-T092
##ly	I-T092
own	I-T092
##ed	I-T092
facilities	I-T092
and	O
having	O
a	O
greater	O
number	O
of	O
assigned	O
patients	O
.	O
although	O
we	O
did	O
not	O
achieve	O
all	O
expected	O
effects	O
of	O
the	O
prac	B-T058
##ta	I-T058
intervention	I-T058
,	O
both	O
its	O
forms	O
seem	O
promising	O
in	O
terms	O
of	O
enhancing	O
the	O
competencies	O
of	O
doctors	B-T097
in	O
communication	O
with	O
and	O
activation	O
of	O
older	B-T098
patients	O
.	O

depression	B-T038
,	O
anxiety	B-T038
,	O
stress	B-T038
,	O
and	O
their	O
associated	O
factors	O
among	O
corp	B-T098
##s	I-T098
members	I-T098
serving	O
in	O
ke	O
##bb	O
##i	O
state	O
depression	B-T038
,	O
anxiety	B-T038
and	O
stress	B-T038
,	O
are	O
not	O
only	O
health	B-T033
problems	I-T033
by	O
themselves	O
,	O
but	O
also	O
associated	O
with	O
other	O
negative	B-T033
health	O
consequences	O
.	O
the	O
national	B-T092
youth	I-T092
service	I-T092
is	O
usually	O
characterized	O
by	O
a	O
number	O
of	O
new	O
challenges	O
and	O
experiences	B-T038
which	O
may	O
require	O
life	O
style	O
adjustments	O
by	O
the	O
corp	B-T098
##s	I-T098
member	I-T098
.	O
however	O
,	O
no	O
previous	O
study	O
on	O
psychological	B-T038
factors	I-T038
has	O
been	O
conducted	O
among	O
corp	B-T098
##s	I-T098
members	I-T098
.	O
this	O
study	B-T062
was	O
conducted	O
to	O
determine	O
the	O
prevalence	O
of	O
depression	B-T038
,	O
anxiety	B-T038
and	O
,	O
stress	B-T038
and	O
their	O
associated	O
factors	O
among	O
corp	B-T098
##s	I-T098
members	I-T098
serving	O
in	O
ke	O
##bb	O
##i	O
state	O
.	O
a	O
cross	B-T062
-	I-T062
sectional	I-T062
study	I-T062
was	O
conducted	O
among	O
264	O
corp	B-T098
##s	I-T098
members	I-T098
from	O
four	O
local	O
government	O
areas	O
of	O
the	O
state	B-T082
.	O
selection	O
of	O
the	O
local	O
government	O
areas	O
and	O
the	O
individual	O
participants	B-T098
was	O
by	O
simple	B-T062
random	I-T062
sampling	I-T062
.	O
data	O
was	O
collected	O
from	O
may	O
to	O
june	O
2014	O
using	O
a	O
self	B-T170
-	I-T170
administered	I-T170
questionnaire	I-T170
.	O
data	O
analysis	O
used	O
chi	B-T170
-	I-T170
square	I-T170
test	I-T170
to	O
identify	O
the	O
relationship	O
between	O
categorical	O
variables	O
and	O
multivariate	B-T062
logistic	I-T062
regression	I-T062
to	O
identify	O
the	O
independent	O
factors	O
for	O
depression	B-T038
,	O
anxiety	B-T038
and	O
stress	B-T038
each	O
.	O
the	O
response	O
rate	O
was	O
97	O
%	O
.	O
most	O
of	O
the	O
respondents	B-T098
were	O
males	O
(	O
63	O
.	O
6	O
%	O
)	O
,	O
single	B-T098
(	O
85	O
.	O
5	O
%	O
)	O
,	O
and	O
above	O
20	O
years	O
of	O
age	O
(	O
71	O
.	O
6	O
%	O
)	O
.	O
the	O
overall	O
prevalences	O
of	O
depression	B-T038
,	O
anxiety	B-T038
and	O
stress	B-T038
among	O
the	O
respondents	B-T098
were	O
36	O
.	O
4	O
%	O
,	O
54	O
.	O
5	O
%	O
and	O
18	O
.	O
2	O
%	O
respectively	O
.	O
the	O
independent	O
factors	O
for	O
depression	B-T038
were	O
;	O
being	O
from	O
the	O
north	B-T082
central	I-T082
(	O
or	O
=	O
5	O
.	O
99	O
;	O
95	O
%	O
ci	O
:	O
2	O
.	O
194	O
-	O
16	O
.	O
35	O
##4	O
)	O
or	O
south	B-T082
-	I-T082
south	I-T082
;	O
and	O
the	O
perception	B-T038
of	O
ear	O
##ning	O
enough	O
income	O
(	O
or	O
=	O
2	O
.	O
98	O
##7	O
;	O
95	O
%	O
ci	O
:	O
1	O
.	O
06	O
##2	O
-	O
8	O
.	O
400	O
)	O
.	O
for	O
anxiety	B-T038
,	O
male	O
gender	O
(	O
or	O
=	O
0	O
.	O
41	O
##1	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
169	O
-	O
0	O
.	O
999	O
)	O
;	O
and	O
being	O
from	O
the	O
north	B-T082
central	I-T082
were	O
significant	O
risk	B-T033
factors	I-T033
(	O
or	O
=	O
3	O
.	O
73	O
##1	O
;	O
95	O
%	O
ci	O
:	O
1	O
.	O
450	O
-	O
9	O
.	O
59	O
##9	O
)	O
.	O
being	O
above	O
26	O
years	O
of	O
age	O
was	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
stress	B-T038
(	O
or	O
=	O
0	O
.	O
08	O
##3	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
018	O
-	O
0	O
.	O
38	O
##1	O
)	O
.	O
also	O
,	O
those	O
who	O
had	O
ever	O
school	B-T033
##ed	I-T033
outside	O
their	O
towns	O
of	O
residence	B-T082
were	O
less	O
likely	O
to	O
be	O
stressed	B-T038
compared	O
to	O
those	O
who	O
had	O
never	O
(	O
or	O
=	O
0	O
.	O
30	O
;	O
95	O
%	O
ci	O
:	O
0	O
.	O
110	O
-	O
0	O
.	O
85	O
##5	O
)	O
.	O
all	O
other	O
factors	O
did	O
not	O
show	O
any	O
significant	O
association	O
with	O
any	O
of	O
the	O
outcome	O
variables	O
in	O
multivariate	O
analysis	O
.	O
in	O
conclusion	O
,	O
the	O
prevalences	O
of	O
depression	B-T038
,	O
anxiety	B-T038
and	O
stress	B-T038
are	O
high	O
among	O
corp	B-T098
##s	I-T098
members	I-T098
serving	O
in	O
ke	O
##bb	O
##i	O
state	O
.	O
there	O
is	O
need	O
to	O
expand	O
the	O
scope	O
of	O
this	O
study	B-T062
to	O
a	O
national	O
level	O
so	O
as	O
to	O
get	O
a	O
big	O
##ger	O
picture	O
of	O
the	O
problem	B-T033
.	O

enc	O
##aged	O
chir	B-T204
##onom	I-T204
##us	I-T204
rip	I-T204
##arius	I-T204
larvae	B-T204
in	O
assessment	O
of	O
trace	B-T103
metal	I-T103
bioavailability	O
and	O
transfer	O
in	O
a	O
landfill	B-T103
leachate	I-T103
collection	O
pond	B-T082
household	O
wastes	B-T103
may	O
constitute	O
a	O
vector	O
of	O
environmental	O
contamination	O
when	O
buried	O
,	O
in	O
particular	O
through	O
degradation	O
and	O
production	O
of	O
leachate	B-T103
##s	I-T103
containing	O
significant	O
trace	B-T103
metal	I-T103
(	O
tm	B-T103
)	O
concentrations	O
that	O
may	O
constitute	O
a	O
serious	O
risk	O
to	O
bio	O
##ta	O
.	O
the	O
objectives	B-T170
of	O
this	O
study	B-T062
were	O
to	O
assess	O
the	O
bioavailability	O
and	O
transfer	O
potential	O
of	O
various	O
tms	B-T103
present	B-T033
in	O
water	B-T103
and	O
sediments	O
in	O
a	O
reservoir	B-T082
receiving	O
landfill	B-T103
leachate	I-T103
##s	I-T103
.	O
an	O
active	O
biom	O
##onitoring	O
approach	O
was	O
adopted	O
consisting	O
of	O
exposing	O
naive	O
laboratory	O
organisms	O
in	O
cages	O
deployed	O
in	B-T082
the	I-T082
field	I-T082
.	O
aquatic	O
insects	O
such	O
as	O
chir	B-T204
##onom	I-T204
##us	I-T204
rip	I-T204
##arius	I-T204
larvae	B-T204
are	O
good	O
candidates	O
since	O
they	O
represent	O
key	O
organisms	O
in	O
the	O
trophic	O
functioning	O
of	O
aquatic	O
ecosystems	O
.	O
the	O
results	O
show	O
that	O
water	B-T103
,	O
suspended	O
particles	B-T103
,	O
and	O
sediments	O
were	O
significant	O
ly	O
contaminated	O
by	O
various	O
tms	B-T103
(	O
as	B-T103
,	O
cd	B-T103
,	O
cu	B-T103
,	O
ni	B-T103
,	O
pb	B-T103
,	O
and	O
zn	B-T103
)	O
.	O
their	O
contribution	O
to	O
the	O
transfer	O
of	O
tms	B-T103
depends	O
,	O
however	O
,	O
on	O
the	O
specific	O
element	B-T103
considered	O
,	O
e	O
.	O
g	O
.	O
,	O
cd	B-T103
in	O
sediments	O
or	O
pb	B-T103
in	O
both	O
suspended	O
particles	B-T103
and	O
sediments	O
.	O
the	O
internal	O
fate	O
of	O
tms	B-T103
was	O
investigated	O
according	O
to	O
their	O
fractionation	B-T058
between	O
an	O
insoluble	O
and	O
a	O
cytosolic	B-T017
fraction	O
.	O
this	O
approach	O
revealed	O
different	O
detoxification	B-T058
strategies	O
capable	O
of	O
preventing	O
the	O
induction	O
of	O
deleterious	B-T038
effects	I-T038
at	O
the	O
individual	B-T098
scale	O
.	O
however	O
,	O
the	O
accumulation	B-T033
of	O
several	O
tms	B-T103
in	O
c	B-T204
.	I-T204
rip	I-T204
##arius	I-T204
larvae	B-T204
tissues	B-T017
may	O
also	O
represent	O
a	O
significant	O
load	O
potentially	O
transfer	O
##able	O
to	O
higher	O
trophic	O
levels	O
.	O

chronic	B-T058
enzyme	I-T058
replacement	I-T058
to	O
the	O
brain	B-T017
of	O
a	O
late	B-T038
infantile	I-T038
neuronal	I-T038
cer	I-T038
##oid	I-T038
lipof	I-T038
##usc	I-T038
##inos	I-T038
##is	I-T038
mouse	B-T204
has	O
differential	O
effects	O
on	O
phenotypes	O
of	O
disease	B-T038
late	B-T038
infantile	I-T038
neuronal	I-T038
cer	I-T038
##oid	I-T038
lipof	I-T038
##usc	I-T038
##inos	I-T038
##is	I-T038
(	O
linc	B-T038
##l	I-T038
)	O
is	O
a	O
fatal	O
inherited	O
neurodegenerative	B-T038
disease	I-T038
caused	O
by	O
loss	O
of	O
lysosomal	B-T103
protease	I-T103
trip	I-T103
##eptidyl	I-T103
peptidase	I-T103
1	I-T103
(	O
tpp	B-T103
##1	I-T103
)	O
.	O
we	O
have	O
investigated	O
the	O
effects	O
of	O
chronic	O
intrathecal	O
(	O
it	O
)	O
administration	O
using	O
enzyme	B-T058
replacement	I-T058
therapy	I-T058
(	O
ert	B-T058
)	O
to	O
the	O
brain	B-T017
of	O
an	O
linc	B-T038
##l	I-T038
mouse	B-T038
model	I-T038
,	O
in	O
which	O
locomotor	B-T038
function	I-T038
declines	O
dramatically	O
prior	O
to	O
early	B-T033
death	I-T033
.	O
median	O
lifespan	O
was	O
significantly	O
extended	O
from	O
126	O
days	O
to	O
>	O
259	O
days	O
when	O
chronic	O
it	O
treatment	O
was	O
initiated	O
before	O
the	O
onset	O
of	O
disease	B-T038
.	O
while	O
treated	O
animals	B-T204
lived	O
longer	O
and	O
showed	O
little	O
sign	O
of	O
locomotor	B-T033
dysfunction	I-T033
as	O
measured	O
by	O
stride	O
length	O
,	O
some	O
or	O
all	O
(	O
depending	O
on	O
regimen	O
)	O
still	O
died	B-T038
prematurely	O
.	O
one	O
explanation	O
is	O
that	O
cerebrospinal	B-T031
fluid	I-T031
(	O
csf	B-T031
)	O
-	O
mediated	O
delivery	O
may	O
not	O
deliver	O
tpp	B-T103
##1	I-T103
to	O
all	O
brain	B-T082
regions	I-T082
.	O
morphological	B-T082
studies	B-T062
support	O
this	O
,	O
showing	O
delivery	O
of	O
tpp	B-T103
##1	I-T103
to	O
ventral	B-T082
,	O
but	O
not	O
deeper	O
and	O
dorsal	B-T082
regions	I-T082
.	O
when	O
it	O
treatment	O
is	O
initiated	O
in	O
severely	O
affected	O
linc	B-T038
##l	I-T038
mice	B-T204
,	O
lifespan	O
was	O
extended	O
modestly	O
in	O
most	O
but	O
dramatically	O
extended	O
in	O
approximately	O
one	O
-	O
third	O
of	O
the	O
cohort	B-T098
.	O
treatment	O
improved	O
locomotor	B-T038
function	I-T038
in	O
these	O
severely	O
compromised	O
animals	B-T204
after	O
it	O
had	O
declined	O
to	O
the	O
point	O
at	O
which	O
animals	B-T204
normally	O
die	B-T038
.	O
this	O
indicates	O
that	O
some	O
pathology	B-T038
in	O
linc	B-T038
##l	I-T038
is	O
reversible	O
and	O
does	O
not	O
simply	O
reflect	O
neuronal	B-T038
death	I-T038
.	O

api	B-T103
##xa	I-T103
##ban	I-T103
5	O
mg	O
twice	O
daily	O
and	O
clinical	O
outcomes	O
in	O
patients	O
with	O
atrial	B-T038
fibrillation	I-T038
and	O
advanced	O
age	O
,	O
low	O
body	O
weight	O
,	O
or	O
high	O
creatinine	B-T103
:	O
a	O
secondary	O
analysis	O
of	O
a	O
randomized	B-T062
clinical	I-T062
trial	I-T062
in	O
the	O
api	B-T103
##xa	I-T103
##ban	I-T103
for	O
reduction	O
of	O
stroke	B-T038
and	O
other	O
thromboembolic	B-T038
complications	I-T038
in	O
atrial	B-T038
fibrillation	I-T038
(	O
ar	B-T062
##ist	I-T062
##ot	I-T062
##le	I-T062
)	O
trial	B-T062
,	O
the	O
standard	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
was	O
5	O
mg	O
twice	O
daily	O
;	O
patients	O
with	O
at	O
least	O
2	O
dose	O
-	O
reduction	O
criteria	O
-	O
80	O
years	O
or	O
older	O
,	O
weight	O
60	O
kg	O
or	O
less	O
,	O
and	O
creatinine	B-T033
level	I-T033
1	O
.	O
5	O
mg	O
/	O
dl	O
or	O
higher	O
-	O
received	O
a	O
reduced	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
of	O
2	O
.	O
5	O
mg	O
twice	O
daily	O
.	O
little	O
is	O
known	O
about	O
patients	O
with	O
1	O
dose	O
-	O
reduction	O
criterion	O
who	O
received	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
.	O
to	O
determine	O
the	O
frequency	O
of	O
1	O
dose	O
-	O
reduction	O
criterion	O
and	O
whether	O
the	O
effects	O
of	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
on	O
stroke	B-T038
or	O
systemic	O
embolism	O
and	O
bleeding	B-T038
varied	O
among	O
patients	O
with	O
1	O
or	O
no	O
dose	O
-	O
reduction	O
criteria	O
.	O
among	O
18	O
201	O
patients	O
in	O
the	O
ar	B-T062
##ist	I-T062
##ot	I-T062
##le	I-T062
trial	I-T062
,	O
17	O
322	O
were	O
included	O
in	O
this	O
analysis	B-T062
.	O
annual	O
##ized	O
event	O
rates	O
of	O
stroke	B-T038
or	O
systemic	O
embolism	O
and	O
major	O
bleeding	B-T038
and	O
hazard	O
ratios	O
(	O
hrs	O
)	O
and	O
95	O
%	O
cis	O
were	O
evaluated	B-T058
.	O
interactions	O
between	O
the	O
effects	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
vs	O
warfarin	B-T103
and	O
the	O
presence	O
of	O
1	O
or	O
no	O
dose	O
-	O
reduction	O
criteria	O
were	O
assessed	O
.	O
the	O
first	O
patient	O
was	O
enrolled	O
in	O
the	O
ar	B-T062
##ist	I-T062
##ot	I-T062
##le	I-T062
trial	I-T062
on	O
december	O
19	O
,	O
2006	O
,	O
and	O
follow	B-T058
-	I-T058
up	I-T058
was	O
completed	O
on	O
january	O
30	O
,	O
2011	O
.	O
data	O
were	O
analyzed	O
from	O
january	O
2015	O
to	O
may	O
30	O
,	O
2016	O
.	O
analysis	B-T062
of	O
major	O
bleeding	B-T038
included	O
events	O
during	O
study	B-T062
drug	B-T058
treatment	I-T058
.	O
analysis	B-T062
of	O
stroke	B-T038
or	O
systemic	O
embolism	O
was	O
based	O
on	O
intention	O
to	O
treat	O
.	O
of	O
the	O
patients	O
with	O
1	O
or	O
no	O
dose	O
-	O
reduction	O
criteria	O
assigned	O
to	O
receive	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
or	O
warfarin	B-T103
,	O
39	O
##66	O
had	O
1	O
dose	O
-	O
reduction	O
criterion	O
;	O
these	O
patients	O
had	O
higher	O
rates	O
of	O
stroke	B-T038
or	O
systemic	O
embolism	O
(	O
hr	O
,	O
1	O
.	O
47	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
20	O
-	O
1	O
.	O
81	O
)	O
and	O
major	O
bleeding	B-T038
(	O
hr	O
,	O
1	O
.	O
89	O
;	O
95	O
%	O
ci	O
,	O
1	O
.	O
62	O
-	O
2	O
.	O
20	O
)	O
compared	O
with	O
those	O
with	O
no	O
dose	O
-	O
reduction	O
criteria	O
(	O
n	O
=	O
13	O
356	O
)	O
.	O
the	O
benefit	O
of	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
(	O
n	O
=	O
86	O
##65	O
)	O
compared	O
with	O
warfarin	B-T103
(	O
n	O
=	O
86	O
##57	O
)	O
on	O
stroke	B-T038
or	O
systemic	O
embolism	O
in	O
patients	O
with	O
1	O
dose	O
-	O
reduction	O
criterion	O
(	O
hr	O
,	O
0	O
.	O
94	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
66	O
-	O
1	O
.	O
32	O
)	O
and	O
no	O
dose	O
-	O
reduction	O
criterion	O
(	O
hr	O
,	O
0	O
.	O
77	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
62	O
-	O
0	O
.	O
97	O
)	O
were	O
similar	O
(	O
p	O
for	O
interaction	O
=	O
.	O
36	O
)	O
.	O
similarly	O
,	O
the	O
benefit	O
of	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
compared	O
with	O
warfarin	B-T103
on	O
major	O
bleeding	B-T038
in	O
patients	O
with	O
1	O
dose	O
-	O
reduction	O
criterion	O
(	O
hr	O
,	O
0	O
.	O
68	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
53	O
-	O
0	O
.	O
87	O
)	O
and	O
no	O
dose	O
-	O
reduction	O
criterion	O
(	O
hr	O
,	O
0	O
.	O
72	O
;	O
95	O
%	O
ci	O
,	O
0	O
.	O
60	O
-	O
0	O
.	O
86	O
)	O
were	O
similar	O
(	O
p	O
for	O
interaction	O
=	O
.	O
71	O
)	O
.	O
similar	O
patterns	O
were	O
seen	O
for	O
each	O
dose	O
-	O
reduction	O
criterion	O
and	O
across	O
the	O
spectrum	O
of	O
age	O
,	O
body	O
weight	O
,	O
creatinine	B-T033
level	I-T033
,	O
and	O
creatinine	B-T103
clearance	B-T201
.	O
patients	O
with	O
atrial	B-T038
fibrillation	I-T038
and	O
isolated	O
advanced	O
age	O
,	O
low	O
body	O
weight	O
,	O
or	O
renal	B-T033
dysfunction	I-T033
have	O
a	O
higher	O
risk	O
of	O
stroke	B-T038
or	O
systemic	O
embolism	O
and	O
major	O
bleeding	B-T038
but	O
show	O
consistent	O
benefits	O
with	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
vs	O
warfarin	B-T103
compared	O
with	O
patients	O
without	O
these	O
characteristics	O
.	O
the	O
5	O
mg	O
twice	O
daily	O
dose	O
of	O
api	B-T103
##xa	I-T103
##ban	I-T103
is	O
safe	O
,	O
efficacious	O
,	O
and	O
appropriate	O
for	O
patients	O
with	O
only	O
1	O
dose	O
-	O
reduction	O
criterion	O
.	O
clinicaltrials	O
.	O
gov	O
identifier	O
:	O
nct00	O
##41	O
##29	O
##84	O
.	O

structured	B-T082
instruction	B-T170
with	O
modified	O
story	O
##book	O
##s	O
to	O
teach	O
morph	O
##osyn	O
##ta	O
##x	O
and	O
vocabulary	B-T170
to	O
preschool	O
##ers	O
who	O
are	O
deaf	O
/	O
hard	O
of	O
hearing	O
children	O
who	O
are	O
deaf	O
/	O
hard	O
of	O
hearing	O
(	O
d	O
/	O
hh	O
)	O
are	O
at	O
risk	O
for	O
diminished	O
morph	O
##osyn	O
##ta	O
##ct	O
##ical	O
and	O
vocabulary	B-T170
development	O
.	O
the	O
purpose	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
effects	O
of	O
repeated	O
reading	O
combined	O
with	O
structured	B-T082
instruction	B-T170
.	O
targets	O
were	O
a	O
morph	O
##osyn	O
##ta	O
##ct	O
##ical	O
form	O
and	O
novel	O
vocabulary	B-T170
words	I-T170
.	O
participants	B-T098
were	O
3	O
preschool	O
##ers	O
who	O
are	O
d	O
/	O
hh	O
who	O
were	O
receiving	O
instruction	B-T170
with	O
an	O
oral	B-T082
approach	O
.	O
data	O
from	O
a	O
multiple	O
baseline	B-T062
design	I-T062
indicated	O
that	O
all	O
children	O
acquired	O
the	O
targeted	O
skills	O
and	O
demonstrated	O
high	O
levels	O
of	O
generalization	B-T038
of	O
these	O
skills	O
to	O
untrained	B-T033
context	O
.	O
implications	O
for	O
teaching	O
young	O
children	O
who	O
are	O
d	O
/	O
hh	O
using	O
repeated	O
story	O
##book	O
reading	O
are	O
discussed	O
.	O

flexible	O
coordination	O
of	O
stationary	O
and	O
mobile	O
convers	O
##ations	O
with	O
gaze	B-T033
:	O
resource	O
allocation	O
among	O
multiple	O
joint	O
activities	O
gaze	B-T033
is	O
instrumental	O
in	O
coordinating	O
face	O
-	O
to	O
-	O
face	O
social	B-T033
interactions	I-T033
.	O
but	O
little	O
is	O
known	O
about	O
gaze	B-T033
use	O
when	O
social	B-T033
interactions	I-T033
co	O
-	O
occur	O
with	O
other	O
joint	O
activities	O
.	O
we	O
investigated	O
the	O
case	O
of	O
walking	O
while	O
talk	O
##ing	O
.	O
we	O
assessed	O
how	O
gaze	B-T033
get	O
##s	O
allocated	O
among	O
various	O
targets	B-T098
in	O
mobile	O
convers	O
##ations	O
,	O
whether	O
allocation	O
of	O
gaze	B-T033
to	O
other	O
targets	B-T098
affects	B-T038
convers	O
##ational	O
coordination	O
,	O
and	O
whether	O
reduced	O
availability	O
of	O
gaze	B-T033
for	O
convers	O
##ational	O
coordination	O
affects	B-T038
convers	O
##ational	O
performance	O
and	O
content	O
.	O
in	O
an	O
experimental	B-T062
study	I-T062
,	O
pairs	O
were	O
videotap	O
##ed	O
in	O
four	O
conditions	O
of	O
mobility	B-T033
(	O
standing	B-T082
still	I-T082
,	O
talk	O
##ing	O
while	O
walking	B-T058
along	I-T058
a	I-T058
straight	I-T058
-	I-T058
line	I-T058
it	I-T058
##ine	I-T058
##ra	I-T058
##ry	I-T058
,	O
talk	O
##ing	O
while	O
walking	O
along	O
a	O
complex	O
it	O
##ine	O
##ra	O
##ry	O
,	O
or	O
walking	O
along	O
a	O
complex	O
it	O
##ine	O
##ra	O
##ry	O
with	O
no	B-T033
convers	I-T033
##ational	I-T033
task	O
)	O
.	O
gaze	B-T033
to	O
partners	B-T098
was	O
substantially	O
reduced	O
in	O
mobile	O
convers	O
##ations	O
,	O
but	O
gaze	B-T033
was	O
still	O
used	O
to	O
coordinate	O
convers	O
##ation	O
via	O
displays	O
of	O
mutual	O
orientation	B-T082
,	O
and	O
convers	O
##ational	O
performance	O
and	O
content	O
was	O
not	O
different	O
between	O
stationary	O
and	O
mobile	O
conditions	O
.	O
results	B-T033
expand	O
the	O
phenomena	O
of	O
multi	O
##ta	O
##sk	O
##ing	O
to	O
joint	O
activities	O
.	O

effects	O
of	O
arg	B-T103
##an	I-T103
oil	I-T103
on	O
the	O
mitochondrial	B-T038
function	I-T038
,	O
antioxidant	B-T022
system	I-T022
and	O
the	O
activity	B-T038
of	O
nadph	B-T103
-	O
generating	O
enzymes	B-T103
in	O
acrylamide	B-T103
treated	B-T058
rat	B-T204
brain	B-T017
arg	B-T103
##an	I-T103
oil	I-T103
(	O
ao	B-T103
)	O
is	O
rich	O
in	O
minor	O
compounds	B-T103
such	O
as	O
polyphenols	B-T103
and	O
tocopherol	B-T103
##s	I-T103
which	O
are	O
powerful	O
antioxidants	B-T103
.	O
acrylamide	B-T103
(	O
acr	B-T103
)	O
has	O
been	O
classified	B-T170
as	O
a	O
neurotoxic	O
agent	O
in	O
animals	B-T204
and	O
humans	B-T204
.	O
mitochondrial	B-T017
oxidative	B-T038
stress	I-T038
and	O
dysfunction	B-T033
is	O
one	O
of	O
the	O
most	O
probable	O
molecular	O
mechanisms	O
of	O
neurodegenerative	B-T038
diseases	I-T038
.	O
female	O
sprague	B-T204
dawley	I-T204
rats	I-T204
were	O
exposed	O
to	O
acr	B-T103
(	O
50	O
##mg	O
/	O
kg	O
i	O
.	O
p	O
.	O
three	O
times	O
a	O
week	O
)	O
,	O
ao	B-T103
(	O
6m	O
##l	O
/	O
kg	O
,	O
o	O
.	O
p	O
,	O
per	O
day	O
)	O
or	O
together	O
for	O
30	O
##days	O
.	O
the	O
activities	O
of	O
cytosolic	B-T017
enzymes	B-T103
such	O
as	O
xanthine	B-T103
oxidase	I-T103
(	O
x	B-T103
##o	I-T103
)	O
,	O
glucose	B-T103
6	I-T103
-	I-T103
phosphate	I-T103
dehydrogenase	I-T103
(	O
g6pd	B-T103
##h	I-T103
)	O
,	O
glutathione	B-T103
-	I-T103
s	I-T103
-	I-T103
transferase	I-T103
(	O
gst	B-T103
)	O
,	O
mitochondrial	B-T017
oxidative	B-T038
stress	I-T038
,	O
oxidative	B-T038
phosphorylation	I-T038
(	O
ox	B-T038
##phos	I-T038
)	O
and	O
tric	B-T038
##arboxylic	I-T038
acid	I-T038
cycle	I-T038
(	O
tca	B-T038
)	O
enzymes	B-T103
,	O
mitochondrial	B-T017
metabolic	B-T038
function	I-T038
,	O
adenosine	B-T103
triphosphate	I-T103
(	O
atp	B-T103
)	O
level	O
and	O
acetylcholinesterase	B-T038
(	I-T038
ache	I-T038
)	I-T038
activity	I-T038
were	O
assessed	O
in	O
rat	B-T204
brain	B-T017
.	O
cytosolic	B-T017
and	O
mitochondrial	B-T017
antioxidant	B-T103
enzymes	I-T103
were	O
significantly	O
diminished	O
in	O
the	O
brains	B-T017
of	O
rats	B-T204
treated	B-T058
with	I-T058
acr	B-T103
compared	O
to	O
those	O
in	O
control	O
.	O
besides	O
,	O
acr	B-T103
treatment	B-T058
resulted	O
in	O
a	O
significant	O
reduction	O
in	O
brain	B-T017
atp	B-T103
level	O
,	O
mitochondrial	B-T017
metabolic	B-T038
function	I-T038
,	O
ox	B-T038
##phos	I-T038
and	O
tca	B-T038
enzymes	B-T103
.	O
administration	B-T058
of	O
ao	B-T103
restored	O
both	O
the	O
cytosolic	B-T017
and	O
mitochondrial	B-T017
oxidative	B-T038
stress	I-T038
by	O
normal	B-T062
##izing	I-T062
nicotinamide	B-T103
adenine	I-T103
dinucleotide	I-T103
phosphate	I-T103
(	O
nadph	B-T103
)	O
generating	O
enzymes	B-T103
.	O
in	O
addition	O
,	O
improved	B-T033
mitochondrial	B-T038
function	I-T038
primarily	O
enhancing	O
nicotinamide	B-T103
adenine	I-T103
dinucleotide	I-T103
(	O
nadh	B-T103
)	O
generated	O
enzymes	B-T038
activities	I-T038
and	O
atp	B-T103
level	O
in	O
the	O
mitochondria	B-T017
.	O
the	O
reason	O
for	O
ao	B-T103
'	I-T103
s	I-T103
obvious	O
beneficial	O
effects	O
in	O
this	O
study	B-T062
may	O
be	O
due	O
to	O
synergistic	O
effects	O
of	O
its	O
different	O
bioactive	O
compounds	O
which	O
is	O
especially	O
effective	O
on	O
mitochondria	B-T017
.	O
modulation	B-T082
of	O
the	O
brain	B-T017
mitochondrial	B-T038
functions	I-T038
and	O
antioxidant	B-T022
systems	I-T022
by	O
ao	B-T103
may	O
lead	O
to	O
the	O
development	O
of	O
new	O
mitochondria	B-T017
-	O
targeted	B-T038
antioxidants	B-T103
in	O
the	O
future	O
.	O

punc	B-T038
##h	I-T038
injury	B-T037
self	B-T037
-	I-T037
harm	I-T037
in	O
young	O
people	O
punc	B-T038
##h	I-T038
injuries	B-T037
are	O
a	O
form	O
of	O
self	B-T037
-	I-T037
harm	I-T037
characterised	O
by	O
the	O
intentional	O
act	O
of	O
striking	O
an	O
object	O
with	O
a	O
closed	O
fist	O
.	O
we	O
aimed	O
to	O
describe	O
the	O
characteristics	O
and	O
trends	O
in	O
young	O
people	O
presenting	O
with	O
injuries	B-T037
sustained	O
via	O
the	O
punc	B-T038
##h	I-T038
mechanism	O
.	O
a	O
comprehensive	O
retrospective	B-T062
review	I-T062
of	O
medical	B-T170
records	I-T170
was	O
completed	O
of	O
all	O
young	O
people	O
aged	O
10	O
-	O
18	O
years	O
presenting	O
to	O
our	O
central	B-T092
london	I-T092
emergency	I-T092
department	I-T092
over	O
a	O
12	O
-	O
month	O
period	O
.	O
a	O
subset	B-T170
of	I-T170
the	I-T170
total	I-T170
group	I-T170
was	O
identified	O
as	O
the	O
punc	B-T038
##h	I-T038
injury	B-T037
subgroup	B-T170
.	O
a	O
total	O
of	O
78	O
punc	B-T038
##h	I-T038
injury	B-T037
presentations	O
were	O
identified	O
.	O
in	O
this	O
subgroup	B-T170
,	O
the	O
male	O
:	O
female	O
ratio	O
is	O
4	O
.	O
57	O
:	O
1	O
;	O
37	O
.	O
18	O
%	O
of	O
presentations	O
were	O
associated	O
with	O
a	O
fracture	B-T037
(	O
n	O
=	O
29	O
)	O
and	O
35	O
.	O
90	O
%	O
(	O
n	O
=	O
28	O
)	O
of	O
patients	O
re	O
-	O
presented	O
following	O
another	O
punc	B-T038
##h	I-T038
injury	B-T037
,	O
as	O
a	O
victim	B-T033
of	I-T033
violence	I-T033
,	O
or	O
by	O
other	O
psychiatric	O
presentation	O
.	O
in	O
conclusion	O
,	O
a	O
male	B-T033
preponder	I-T033
##ance	I-T033
was	O
observed	O
,	O
with	O
frequent	O
re	O
-	O
presentations	O
,	O
often	O
in	O
high	B-T033
-	I-T033
risk	I-T033
circumstances	O
.	O
an	O
opportunity	O
for	O
screening	B-T058
,	O
including	O
mental	B-T038
health	I-T038
,	O
social	O
and	O
substance	O
misuse	O
,	O
was	O
identified	O
.	O
further	O
research	B-T062
is	O
needed	O
to	O
enable	O
targeted	O
effective	O
interventions	B-T058
in	O
this	O
group	O
.	O

experience	B-T038
is	O
instrumental	O
in	O
tuning	O
a	O
link	O
between	O
language	O
and	O
cognition	B-T038
:	O
evidence	O
from	O
6	O
-	O
to	O
7	O
-	O
month	O
-	O
old	O
infants	O
'	O
object	O
categorization	B-T170
at	O
birth	O
,	O
infants	O
not	O
only	O
prefer	O
listening	B-T038
to	O
human	B-T204
vocal	O
##izations	O
,	O
but	O
also	O
have	O
begun	O
to	O
link	O
these	O
vocal	O
##izations	O
to	O
cognition	B-T038
:	O
for	O
infants	O
as	O
young	O
as	O
three	O
months	O
of	O
age	O
,	O
listening	B-T038
to	O
human	B-T204
language	O
supports	O
object	O
categorization	B-T170
,	O
a	O
core	B-T082
cognitive	O
capacity	O
.	O
this	O
precocious	O
link	B-T082
is	O
initially	O
broad	B-T082
:	O
at	O
3	O
and	O
4	O
months	O
,	O
vocal	O
##izations	O
of	O
both	O
humans	B-T204
and	O
nonhuman	B-T204
primates	I-T204
support	O
categorization	B-T170
.	O
but	O
by	O
6	O
months	O
,	O
infants	O
have	O
narrow	O
##ed	O
the	O
link	O
:	O
only	O
human	B-T204
vocal	O
##izations	O
support	O
object	O
categorization	B-T170
.	O
here	O
we	O
ask	O
what	O
guides	O
infants	O
as	O
they	O
tune	O
their	O
initially	O
broad	B-T082
link	O
to	O
a	O
more	O
precise	O
one	O
,	O
engaged	O
only	O
by	O
the	O
vocal	O
##izations	O
of	O
our	O
species	B-T170
.	O
across	O
three	O
studies	B-T062
,	O
we	O
use	O
a	O
novel	O
exposure	O
paradigm	O
to	O
examine	O
the	O
effects	O
of	O
experience	B-T038
.	O
we	O
document	O
that	O
merely	O
exposing	O
infants	O
to	O
nonhuman	B-T204
primate	I-T204
vocal	O
##izations	O
enables	B-T038
infants	O
to	O
preserve	O
the	O
early	O
-	O
established	O
link	O
between	O
this	O
signal	O
and	O
categorization	B-T170
.	O
in	O
contrast	O
,	O
exposing	O
infants	O
to	O
backward	O
speech	B-T038
-	O
a	O
signal	O
that	O
fails	O
to	O
support	O
categorization	B-T170
at	O
any	O
age	O
-	O
offers	O
no	O
such	O
advantage	O
.	O
our	O
findings	B-T033
reveal	O
the	O
power	O
of	O
early	O
experience	B-T038
as	O
infants	O
specify	O
which	O
signals	O
,	O
from	O
an	O
initially	O
broad	B-T082
set	O
,	O
they	O
will	O
continue	O
to	O
link	O
to	O
cognition	B-T038
.	O

py	B-T038
##oderma	I-T038
gang	I-T038
##ren	I-T038
##osum	I-T038
:	O
a	O
clinician	B-T097
'	I-T097
s	I-T097
night	B-T033
##mar	I-T033
##e	I-T033
py	B-T038
##oderma	I-T038
gang	I-T038
##ren	I-T038
##osum	I-T038
(	O
pg	B-T038
)	O
is	O
a	O
rare	B-T038
disease	I-T038
and	O
that	O
affecting	O
specifically	O
the	O
sole	B-T082
of	I-T082
the	I-T082
foot	I-T082
,	O
is	O
even	O
rare	O
##r	O
.	O
here	O
,	O
we	O
report	B-T170
the	O
case	O
of	O
a	O
54	O
-	O
year	O
-	O
old	O
female	O
admitted	B-T058
with	O
a	O
painful	B-T033
ulcer	B-T038
on	O
the	O
sole	B-T082
of	I-T082
the	I-T082
right	I-T082
foot	I-T082
which	O
was	O
initially	O
treated	B-T058
with	I-T058
empirical	O
antibiotics	B-T103
and	O
debridement	B-T058
.	O
the	O
disease	B-T038
was	O
found	O
to	O
spread	O
rapidly	O
after	O
each	O
debridement	B-T058
.	O
the	O
culture	O
reports	O
were	O
negative	B-T033
;	O
rheumatology	B-T091
workup	B-T058
and	O
doppler	B-T058
study	I-T058
were	O
within	O
normal	B-T033
limits	I-T033
.	O
a	O
clinical	O
suspicion	O
of	O
pg	B-T038
was	O
made	O
and	O
was	O
confirmed	O
with	O
tissue	O
biopsy	O
.	O
she	O
was	O
started	B-T058
on	I-T058
oral	I-T058
steroids	I-T058
following	O
which	O
she	O
dramatically	O
improved	B-T033
.	O
thus	O
,	O
when	O
a	O
patient	O
presents	O
with	O
a	O
rapidly	O
expanding	O
painful	B-T033
ulcer	B-T038
in	O
a	O
vascular	B-T017
limb	I-T017
that	O
is	O
refractory	O
to	O
antibiotic	B-T058
treatment	I-T058
and	O
exacerb	O
##ating	O
on	O
debridement	B-T058
,	O
it	O
is	O
imperative	O
to	O
consider	O
the	O
possibility	O
of	O
pg	B-T038
.	O

design	O
of	O
a	O
candidate	O
vibrational	O
signal	O
for	O
mating	B-T038
disruption	O
against	O
the	O
glassy	B-T204
-	I-T204
wing	I-T204
##ed	I-T204
sharp	I-T204
##sh	I-T204
##oo	I-T204
##ter	I-T204
,	O
homa	B-T204
##lo	I-T204
##dis	I-T204
##ca	I-T204
vitr	I-T204
##ip	I-T204
##enn	I-T204
##is	I-T204
the	O
glassy	B-T204
-	I-T204
wing	I-T204
##ed	I-T204
sharp	I-T204
##sh	I-T204
##oo	I-T204
##ter	I-T204
(	O
gw	B-T204
##ss	I-T204
)	O
,	O
homa	B-T204
##lo	I-T204
##dis	I-T204
##ca	I-T204
vitr	I-T204
##ip	I-T204
##enn	I-T204
##is	I-T204
,	O
is	O
an	O
important	O
pest	B-T204
of	O
grape	B-T204
##vin	I-T204
##es	I-T204
due	O
to	O
its	O
ability	O
to	O
transmit	O
xyle	B-T007
##ll	I-T007
##a	I-T007
fast	I-T007
##idi	I-T007
##osa	I-T007
,	O
the	O
causal	O
agent	O
of	O
pie	B-T038
##r	I-T038
##ce	I-T038
'	I-T038
s	I-T038
disease	I-T038
.	O
gw	B-T204
##ss	I-T204
mating	B-T038
communication	O
is	O
based	O
on	O
vibrational	O
signals	O
;	O
therefore	O
,	O
vibrational	O
mating	B-T038
disruption	O
could	O
be	O
an	O
alternative	O
to	O
insecticides	B-T103
for	O
suppression	O
of	O
gw	B-T204
##ss	I-T204
population	B-T098
.	O
our	O
objectives	B-T170
were	O
to	O
identify	O
spectral	O
features	O
of	O
female	O
signal	O
that	O
elicit	O
male	O
signaling	B-T038
,	O
design	O
disruptive	O
signals	O
able	O
to	O
alter	O
male	O
perception	B-T038
and	O
acceptance	O
of	O
a	O
female	O
,	O
and	O
determine	O
the	O
signal	O
intensity	O
required	O
for	O
future	O
field	O
applications	O
.	O
results	O
showed	O
that	O
male	O
responses	O
to	O
play	O
##back	O
of	O
modified	O
female	O
signals	O
were	O
significantly	O
reduced	O
by	O
60	O
-	O
75	O
%	O
when	O
part	O
of	O
the	O
female	O
signal	O
spectral	O
components	O
above	O
or	O
below	O
400	O
hz	O
were	O
deleted	O
.	O
play	O
##back	O
bioassays	B-T058
showed	O
that	O
transmission	O
of	O
an	O
80	O
hz	O
pure	O
frequency	O
tone	O
to	O
plants	B-T204
completely	O
suppressed	O
male	O
signaling	B-T038
to	O
female	O
signal	O
play	O
##back	O
,	O
even	O
if	O
the	O
disruptive	O
signal	B-T082
amplitude	I-T082
was	O
10	O
db	O
lower	O
than	O
the	O
female	O
signal	O
play	O
##back	O
.	O
although	O
the	O
mechanism	O
underlying	O
cessation	O
of	O
male	O
signaling	B-T038
activity	O
in	O
the	O
presence	B-T033
of	O
disruption	O
is	O
not	O
yet	O
understood	O
,	O
results	O
suggest	O
that	O
an	O
80	O
hz	O
vibrational	O
signal	O
should	O
be	O
tested	O
in	O
laboratory	B-T092
and	O
field	O
experiments	O
to	O
assess	O
its	O
efficacy	O
in	O
disrupting	O
mating	B-T038
of	O
gw	B-T204
##ss	I-T204
.	O

stem	B-T017
cell	I-T017
registry	O
programme	O
for	O
patients	O
with	O
ischemic	B-T038
cardiomyopathy	I-T038
undergoing	O
coronary	B-T058
artery	I-T058
bypass	I-T058
grafting	I-T058
:	O
what	O
benefits	O
does	O
it	O
derive	O
?	O
standardization	B-T062
of	O
stem	O
cell	O
therapy	O
requires	O
application	O
of	O
appropriate	O
methods	B-T062
to	O
evaluate	B-T058
safety	O
and	O
efficac	O
y	O
,	O
including	O
long	O
-	O
term	O
pharmac	B-T062
##ovi	I-T062
##gi	I-T062
##la	I-T062
##nc	I-T062
##e	I-T062
.	O
to	O
accomplish	O
this	O
objective	B-T170
,	O
a	O
long	O
-	O
term	O
registry	B-T170
programme	I-T170
was	O
installed	O
.	O
we	O
analysed	O
150	O
patients	O
with	O
ischemic	B-T038
cardiomyopathy	I-T038
,	O
who	O
received	O
intram	B-T017
##y	I-T017
##ocardial	I-T017
cd133	B-T017
+	I-T017
bone	I-T017
marrow	I-T017
mononuclear	I-T017
stem	I-T017
cell	I-T017
treatment	B-T058
combined	O
with	O
coronary	B-T058
artery	I-T058
bypass	I-T058
grafting	I-T058
(	O
cabg	B-T058
)	O
or	O
cabg	B-T058
alone	O
.	O
the	O
mortality	O
rate	O
,	O
major	O
adverse	B-T033
cerebral	I-T033
and	O
cardiac	B-T033
events	I-T033
,	O
and	O
functional	O
outcome	O
parameters	O
were	O
evaluated	B-T058
for	O
the	O
time	O
period	O
up	O
to	O
14	O
years	O
follow	B-T058
-	I-T058
up	I-T058
.	O
as	O
a	O
result	O
,	O
we	O
have	O
stratified	O
the	O
patient	O
population	B-T098
(	O
96	O
patients	O
)	O
into	O
responders	B-T033
and	O
non	B-T033
-	I-T033
responders	I-T033
.	O
furthermore	O
,	O
the	O
analysis	B-T062
of	O
relevant	O
predictors	O
of	O
good	B-T033
response	I-T033
to	O
cd133	B-T017
+	I-T017
bone	I-T017
marrow	I-T017
mononuclear	I-T017
stem	I-T017
cell	I-T017
treatment	B-T058
was	O
performed	O
.	O
several	O
positive	O
tendencies	O
related	O
to	O
stem	B-T058
cells	I-T058
transplantation	I-T058
were	O
demonstrated	O
.	O
first	O
,	O
no	B-T033
significant	I-T033
difference	O
in	O
major	O
adverse	B-T033
cardiovascular	I-T033
and	O
cerebral	B-T033
events	I-T033
was	O
observed	O
between	O
stem	B-T017
cell	I-T017
and	O
control	O
group	O
up	O
to	O
14	O
years	O
follow	B-T058
-	I-T058
up	I-T058
.	O
second	O
,	O
an	O
improvement	O
of	O
left	B-T201
ventricle	I-T201
ejection	I-T201
fraction	I-T201
(	O
lvef	B-T201
)	O
in	O
stem	B-T017
cell	I-T017
group	O
retained	O
for	O
5	O
years	O
in	O
contrast	O
with	O
cabg	B-T058
-	O
only	O
group	O
,	O
where	O
no	O
significant	O
changes	O
in	O
lvef	B-T201
after	O
2	O
years	O
were	O
observed	O
.	O
in	O
addition	O
,	O
lvef	B-T201
under	O
30	O
%	O
and	O
left	B-T058
ventricle	I-T058
end	I-T058
diastolic	I-T058
diameter	I-T058
above	O
60	O
mm	O
were	O
independent	O
predictors	O
of	O
functional	O
response	O
to	O
cd133	B-T017
+	I-T017
cell	I-T017
therapy	B-T058
.	O
participants	B-T098
with	O
overt	B-T038
heart	I-T038
failure	I-T038
benefit	O
most	O
from	O
cabg	B-T058
combined	O
with	O
intram	B-T017
##y	I-T017
##ocardial	I-T017
injection	B-T058
of	O
cd133	B-T017
+	I-T017
bone	I-T017
marrow	I-T017
mononuclear	I-T017
cell	I-T017
within	O
the	O
group	O
.	O
an	O
improvement	O
lvef	B-T201
in	O
stem	B-T017
cell	I-T017
group	O
remained	O
for	O
5	O
years	O
in	O
contrast	O
with	O
the	O
cabg	B-T058
-	O
only	O
group	O
.	O
the	O
patients	O
,	O
in	O
whom	O
the	O
improvement	O
of	O
both	O
lvef	B-T201
and	O
lv	B-T058
##ed	I-T058
was	O
observed	O
,	O
have	O
benefited	O
by	O
increased	O
life	O
expectancy	O
.	O

yersinia	B-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
isolates	B-T103
recovered	O
from	O
diseased	B-T038
atlantic	B-T204
salmon	I-T204
(	O
sal	B-T204
##mo	I-T204
sal	I-T204
##ar	I-T204
)	O
in	O
scotland	B-T082
are	O
more	O
diverse	O
than	O
those	O
from	O
rainbow	B-T204
trout	I-T204
(	O
onc	B-T204
##orh	I-T204
##ynchus	I-T204
my	I-T204
##ki	I-T204
##ss	I-T204
)	O
and	O
represent	O
distinct	O
subpopulations	B-T098
yersinia	B-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
is	O
the	O
etiological	O
agent	O
of	O
enteric	B-T038
red	I-T038
##mo	I-T038
##uth	I-T038
(	O
erm	B-T038
)	O
disease	B-T038
of	O
farm	O
##ed	O
salmon	B-T204
##ids	I-T204
.	O
enteric	B-T038
red	I-T038
##mo	I-T038
##uth	I-T038
disease	I-T038
is	O
traditionally	O
associated	O
with	O
rainbow	B-T204
trout	I-T204
(	O
onc	B-T204
##orh	I-T204
##ynchus	I-T204
my	I-T204
##ki	I-T204
##ss	I-T204
,	O
wal	B-T204
##ba	I-T204
##um	I-T204
)	O
,	O
but	O
its	O
incidence	O
in	O
atlantic	B-T204
salmon	I-T204
(	O
sal	B-T204
##mo	I-T204
sal	I-T204
##ar	I-T204
)	O
is	O
increasing	O
.	O
yersinia	B-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
isolates	B-T103
recovered	O
from	O
diseased	B-T038
atlantic	B-T204
salmon	I-T204
have	O
been	O
poorly	O
characterized	O
,	O
and	O
very	O
little	O
is	O
known	O
about	O
the	O
relationship	O
of	O
the	O
isolates	B-T103
associated	O
with	O
these	O
two	O
species	B-T170
.	O
phenotypic	O
approaches	O
were	O
used	O
to	O
characterize	O
109	O
y	B-T007
.	I-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
isolates	B-T103
recovered	O
over	O
a	O
14	O
-	O
year	O
period	O
from	O
infected	B-T033
atlantic	B-T204
salmon	I-T204
in	O
scotland	B-T082
;	O
26	O
isolates	B-T103
from	O
infected	B-T033
rainbow	B-T204
trout	I-T204
were	O
also	O
characterized	O
.	O
bio	B-T058
##ty	I-T058
##ping	I-T058
,	O
serot	B-T058
##yp	I-T058
##ing	I-T058
,	O
and	O
comparison	O
of	O
outer	B-T017
membrane	I-T017
protein	B-T033
profiles	I-T033
identified	O
19	O
y	B-T007
.	I-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
clones	B-T017
associated	O
with	O
atlantic	B-T204
salmon	I-T204
but	O
only	O
five	O
associated	O
with	O
rainbow	B-T204
trout	I-T204
;	O
none	O
of	O
the	O
atlantic	B-T204
salmon	I-T204
clones	B-T017
occurred	O
in	O
rainbow	B-T204
trout	I-T204
and	O
vice	O
versa	O
these	O
findings	B-T033
suggest	O
that	O
distinct	O
subpopulations	B-T098
of	O
y	B-T007
.	I-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
are	O
associated	O
with	O
each	O
species	B-T170
.	O
a	O
new	O
o	B-T170
serotype	I-T170
(	O
designated	O
o	O
##8	O
)	O
was	O
identified	O
in	O
56	B-T170
bio	I-T170
##type	I-T170
1	I-T170
atlantic	B-T204
salmon	I-T204
isolates	B-T103
and	O
was	O
the	O
most	O
common	O
serotype	B-T170
identified	O
from	O
2006	O
to	O
2011	O
and	O
in	O
2014	O
,	O
suggesting	O
an	O
increased	O
prevalence	O
during	O
the	O
time	O
period	O
sampled	O
.	O
rainbow	B-T204
trout	I-T204
isolates	B-T103
were	O
represented	O
almost	O
exclusively	O
by	O
the	O
same	O
bio	B-T170
##type	I-T170
2	I-T170
,	O
serotype	B-T170
o1	I-T170
clone	O
that	O
has	O
been	O
responsible	O
for	O
the	O
majority	O
of	O
erm	B-T038
outbreaks	O
in	O
this	O
species	B-T170
within	O
the	O
united	B-T082
kingdom	I-T082
since	O
the	O
1980s	O
.	O
however	O
,	O
the	O
identification	O
of	O
two	O
bio	B-T170
##type	I-T170
2	I-T170
,	O
serotype	B-T170
o	I-T170
##8	I-T170
isolates	B-T103
in	O
rainbow	B-T204
trout	I-T204
suggests	O
that	O
vaccines	B-T103
containing	O
serotypes	B-T170
o1	I-T170
and	I-T170
o	I-T170
##8	I-T170
should	O
be	O
evaluated	O
in	O
both	O
rainbow	B-T204
trout	I-T204
and	O
atlantic	B-T204
salmon	I-T204
for	O
application	O
in	O
scotland	B-T082
.	O
vaccination	B-T058
plays	O
an	O
important	O
role	O
in	O
protecting	O
atlantic	B-T204
salmon	I-T204
against	O
the	O
bacterial	B-T007
pathogen	O
yersinia	B-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
,	O
but	O
,	O
in	O
recent	O
years	O
,	O
there	O
has	O
been	O
an	O
increasing	O
incidence	O
of	O
vaccine	B-T103
breakdown	O
in	O
salmon	B-T204
.	O
this	O
is	O
largely	O
because	O
current	O
vaccines	B-T103
are	O
aimed	O
at	O
rainbow	B-T204
trout	I-T204
and	O
are	O
based	O
on	O
serotypes	B-T170
specific	O
for	O
this	O
species	B-T170
.	O
a	O
wider	O
range	O
of	O
serotypes	B-T170
is	O
responsible	O
for	O
infection	B-T038
in	O
atlantic	B-T204
salmon	I-T204
,	O
but	O
very	O
little	O
is	O
known	O
about	O
the	O
diversity	O
of	O
these	O
strains	B-T204
and	O
their	O
relationships	O
to	O
those	O
recovered	O
from	O
rainbow	B-T204
trout	I-T204
.	O
in	O
the	O
present	O
study	O
,	O
we	O
demonstrate	O
that	O
y	B-T007
.	I-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
isolates	B-T103
recovered	O
from	O
diseased	B-T038
atlantic	B-T204
salmon	I-T204
in	O
scotland	B-T082
are	O
more	O
diverse	O
than	O
those	O
from	O
rainbow	B-T204
trout	I-T204
;	O
furthermore	O
,	O
isolates	B-T103
from	O
the	O
two	O
species	B-T170
represent	O
distinct	O
subpopulations	B-T098
.	O
in	O
addition	O
,	O
a	O
new	O
o	B-T170
serotype	I-T170
was	O
identified	O
that	O
is	O
responsible	O
for	O
a	O
significant	O
proportion	O
of	O
the	O
disease	B-T038
in	O
atlantic	B-T204
salmon	I-T204
.	O
our	O
findings	B-T033
are	O
likely	O
to	O
have	O
important	O
implications	O
for	O
the	O
development	B-T062
of	I-T062
improved	I-T062
vaccines	I-T062
against	O
y	B-T007
.	I-T007
ru	I-T007
##ck	I-T007
##eri	I-T007
.	O

correlation	O
between	O
preoperative	O
physical	B-T033
signs	I-T033
and	O
functional	O
outcomes	O
after	O
lamin	B-T058
##oplasty	I-T058
for	O
ossification	B-T038
of	I-T038
the	I-T038
posterior	I-T038
longitudinal	I-T038
ligament	I-T038
ossification	B-T038
of	I-T038
the	I-T038
posterior	I-T038
longitudinal	I-T038
ligament	I-T038
(	O
op	B-T038
##ll	I-T038
)	O
can	O
cause	O
myelopathy	B-T038
that	O
is	O
often	O
managed	O
surgically	B-T058
.	O
knowledge	B-T038
of	O
predictors	O
of	O
surgical	B-T058
outcomes	O
can	O
provide	O
decision	O
support	O
to	O
surgeons	B-T097
.	O
the	O
aims	O
of	O
this	O
study	B-T062
were	O
to	O
investigate	O
the	O
relationships	O
between	O
preoperative	O
physical	B-T033
signs	I-T033
and	O
postoperative	O
functional	O
outcomes	O
in	O
patients	O
with	O
op	B-T038
##ll	I-T038
and	O
to	O
clarify	O
whether	O
physical	B-T033
signs	I-T033
could	O
predict	O
functional	O
outcomes	O
.	O
fifty	O
-	O
five	O
patients	O
with	O
op	B-T038
##ll	I-T038
who	O
had	O
undergone	O
cervical	B-T058
lamin	I-T058
##oplasty	I-T058
were	O
included	O
in	O
this	O
study	B-T062
.	O
six	O
physical	B-T033
signs	I-T033
including	O
hyperre	B-T033
##flex	I-T033
##ia	I-T033
,	O
bab	B-T033
##ins	I-T033
##ki	I-T033
sign	I-T033
,	O
sensory	B-T038
disturbance	I-T038
,	O
grip	O
strength	O
,	O
10	O
-	O
s	O
grip	O
and	O
release	O
test	O
,	O
and	O
bladder	B-T038
dysfunction	I-T038
,	O
and	O
four	O
other	O
factors	O
including	O
age	O
,	O
duration	O
of	O
symptoms	O
,	O
history	O
of	O
minor	B-T037
trauma	I-T037
and	O
preoperative	O
japanese	O
orthopaedic	O
association	O
(	O
jo	O
##a	O
)	O
score	O
were	O
investigated	O
as	O
potential	O
predictive	O
prognostic	B-T201
factors	I-T201
using	O
both	O
univariate	O
and	O
multivariate	O
analyses	O
.	O
the	O
mean	O
recovery	O
rate	O
of	O
jo	O
##a	O
score	O
was	O
62	O
.	O
5	O
±	O
32	O
.	O
5	O
%	O
.	O
the	O
neurological	O
recovery	O
rate	O
was	O
negatively	B-T033
associated	O
with	O
age	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
,	O
the	O
duration	O
of	O
symptoms	O
(	O
p	O
=	O
0	O
.	O
002	O
)	O
and	O
bab	B-T033
##ins	I-T033
##ki	I-T033
sign	I-T033
(	O
p	O
=	O
0	O
.	O
007	O
)	O
,	O
whereas	O
it	O
was	O
positively	B-T033
correlated	O
with	O
grip	O
strength	O
(	O
p	O
=	O
0	O
.	O
011	O
)	O
.	O
multiple	B-T170
logistic	I-T170
regression	I-T170
analyses	I-T170
revealed	O
that	O
age	O
(	O
odds	O
ratio	O
:	O
0	O
.	O
89	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
81	O
-	O
0	O
.	O
99	O
)	O
and	O
bab	B-T033
##ins	I-T033
##ki	I-T033
sign	I-T033
(	O
odds	O
ratio	O
:	O
0	O
.	O
18	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
04	O
-	O
0	O
.	O
89	O
)	O
were	O
factors	O
associated	O
with	O
functional	O
outcomes	O
.	O
satisfactory	O
functional	O
outcomes	O
could	O
be	O
expected	B-T170
for	O
patients	O
who	O
are	O
young	O
and	O
do	O
not	O
exhibit	O
the	O
bab	B-T033
##ins	I-T033
##ki	I-T033
sign	I-T033
,	O
showing	O
that	O
the	O
bab	B-T033
##ins	I-T033
##ki	I-T033
sign	I-T033
could	O
be	O
useful	O
as	O
an	O
indicator	O
of	O
the	O
window	O
of	O
opportunity	O
for	O
achieving	O
satisfactory	O
functional	O
outcomes	O
.	O

avulsion	B-T037
##s	I-T037
of	O
triceps	B-T017
brach	I-T017
##ii	I-T017
:	O
associated	O
injuries	B-T037
and	O
surgical	B-T058
treatment	I-T058
;	O
a	O
case	O
series	O
this	O
study	B-T062
reports	O
the	O
clinical	O
presentations	O
,	O
intra	O
-	O
operative	O
findings	B-T033
,	O
type	O
of	O
the	O
treatments	B-T058
,	O
outcome	O
of	O
the	O
treatment	B-T058
and	O
specially	O
associated	O
injuries	B-T037
in	O
patients	O
with	O
the	O
avulsion	B-T037
of	O
the	O
distal	B-T082
end	I-T082
of	O
the	O
triceps	B-T017
brach	I-T017
##ii	I-T017
(	I-T017
tb	I-T017
)	I-T017
tendon	I-T017
.	O
we	O
studied	O
6	O
patients	O
with	O
rupture	B-T037
or	O
avulsion	B-T037
of	O
the	O
distal	B-T082
end	I-T082
of	O
the	O
tb	B-T017
tendon	I-T017
.	O
the	O
medical	B-T170
records	I-T170
,	O
imaging	B-T170
files	I-T170
,	O
clinical	O
outcomes	O
at	O
the	O
final	O
follow	B-T058
up	I-T058
visit	I-T058
were	O
reviewed	O
.	O
the	O
clinical	O
outcomes	O
were	O
assessed	O
by	O
mayo	B-T170
elbow	I-T170
score	I-T170
at	O
the	O
final	O
follow	B-T058
-	I-T058
up	I-T058
visit	I-T058
.	O
all	O
patients	O
were	O
male	O
,	O
4	O
of	O
them	O
having	O
injury	B-T037
in	O
the	O
left	B-T017
hand	I-T017
as	O
the	O
non	O
-	O
dominant	O
hand	B-T017
.	O
mean	O
age	O
of	O
them	O
was	O
34	O
.	O
5	O
years	O
.	O
all	O
cases	O
had	O
small	O
bony	O
fle	B-T037
##ck	I-T037
in	O
the	O
posterior	O
of	O
elbow	B-T082
in	O
lateral	B-T058
radiograph	I-T058
.	O
three	O
patients	O
had	O
associated	O
injuries	B-T037
-	O
including	O
intra	B-T082
-	I-T082
articular	I-T082
fractures	B-T037
and	O
medial	O
collateral	O
ligament	O
rupture	O
.	O
in	O
one	O
case	O
v	B-T058
-	I-T058
y	I-T058
plas	I-T058
##ty	I-T058
of	O
the	O
distal	B-T082
tb	B-T017
was	O
done	O
.	O
in	O
4	O
patients	O
the	O
results	O
of	O
surgery	B-T058
were	O
excellent	O
,	O
one	O
was	O
good	O
and	O
one	O
was	O
fair	O
.	O
although	O
tb	B-T017
tendon	I-T017
rupture	B-T037
is	O
rare	O
,	O
it	O
should	O
be	O
-	O
considered	O
in	O
differential	O
diagnosis	B-T062
of	O
the	O
upper	O
-	O
extremity	O
trauma	O
and	O
its	O
associated	O
injuries	B-T037
should	O
be	O
addressed	O
properly	O
.	O

association	O
of	O
ck	B-T017
##ip	I-T017
-	I-T017
1	I-T017
p21	I-T017
##a	I-T017
polymorphism	B-T082
with	O
risk	O
of	O
chronic	B-T038
heart	I-T038
failure	I-T038
in	O
a	O
chinese	B-T098
population	I-T098
pathological	O
cardiac	B-T038
hypertrophy	I-T038
is	O
an	O
independent	O
risk	B-T033
factor	I-T033
for	O
chronic	B-T038
heart	I-T038
failure	I-T038
.	O
casein	B-T103
kinase	I-T103
-	I-T103
2	I-T103
interacting	I-T103
protein	I-T103
-	I-T103
1	I-T103
(	O
ck	B-T103
##ip	I-T103
-	I-T103
1	I-T103
)	O
can	O
inhibit	O
pathological	O
cardiac	B-T038
hypertrophy	I-T038
.	O
therefore	O
,	O
we	O
investigated	O
whether	O
ck	B-T017
##ip	I-T017
-	I-T017
1	I-T017
nonsyn	B-T082
##onymous	I-T082
polymorphism	I-T082
rs	I-T082
##23	I-T082
##06	I-T082
##23	I-T082
##5	I-T082
(	O
pro	B-T038
##21	I-T038
##ala	I-T038
)	O
contributes	O
to	O
risk	O
and	O
prognosis	B-T058
of	O
chronic	B-T038
heart	I-T038
failure	I-T038
in	O
a	O
chinese	B-T098
population	I-T098
.	O
a	O
total	O
of	O
92	O
##3	O
adult	O
patients	O
with	O
chronic	B-T038
heart	I-T038
failure	I-T038
and	O
102	O
##0	O
age	O
-	O
and	O
gender	O
-	O
matched	O
healthy	O
controls	O
were	O
recruited	O
.	O
ck	B-T017
##ip	I-T017
-	I-T017
1	I-T017
rs	I-T017
##23	I-T017
##06	I-T017
##23	I-T017
##5	I-T017
polymorphism	B-T082
was	O
genotyped	B-T058
using	O
pcr	B-T062
-	O
restriction	B-T058
fragment	I-T058
length	I-T058
polymorphism	I-T058
.	O
additional	O
follow	B-T058
-	I-T058
up	I-T058
data	O
for	O
140	O
chronic	B-T038
heart	I-T038
failure	I-T038
patients	O
was	O
evaluated	B-T058
.	O
the	O
rs	B-T017
##23	I-T017
##06	I-T017
##23	I-T017
##5	I-T017
g	B-T017
allele	I-T017
was	O
associated	O
with	O
an	O
increased	O
risk	O
of	O
chronic	B-T038
heart	I-T038
failure	I-T038
(	O
or	O
=	O
1	O
.	O
38	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
09	O
-	O
1	O
.	O
75	O
,	O
p	O
=	O
0	O
.	O
007	O
)	O
,	O
especially	O
in	O
patients	O
with	O
hypertension	B-T038
(	O
or	O
=	O
1	O
.	O
45	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
09	O
-	O
1	O
.	O
75	O
,	O
p	O
=	O
0	O
.	O
006	O
)	O
and	O
coronary	B-T038
heart	I-T038
disease	I-T038
(	O
or	O
=	O
1	O
.	O
41	O
,	O
95	O
%	O
ci	O
=	O
1	O
.	O
09	O
-	O
1	O
.	O
83	O
,	O
p	O
=	O
0	O
.	O
010	O
)	O
after	O
adjustment	O
for	O
multiple	O
cardiovascular	O
risk	B-T033
factors	I-T033
.	O
however	O
,	O
rs	B-T017
##23	I-T017
##06	I-T017
##23	I-T017
##5	I-T017
polymorphism	B-T082
was	O
not	O
associated	O
with	O
cardiovascular	O
mortality	O
in	O
chronic	B-T038
heart	I-T038
failure	I-T038
(	O
p	O
=	O
0	O
.	O
87	O
##5	O
)	O
.	O
ck	B-T017
##ip	I-T017
-	I-T017
1	I-T017
rs	I-T017
##23	I-T017
##06	I-T017
##23	I-T017
##5	I-T017
polymorphism	B-T082
may	O
be	O
a	O
risk	B-T033
factor	I-T033
for	O
chronic	B-T038
heart	I-T038
failure	I-T038
in	O
a	O
chinese	O
han	O
population	O
.	O

structural	B-T058
modification	I-T058
of	O
lipopolysaccharide	B-T103
conferred	O
by	O
mcr	B-T017
-	I-T017
1	I-T017
in	O
gram	B-T007
-	I-T007
negative	I-T007
es	I-T007
##ka	I-T007
##pe	I-T007
pathogens	O
mcr	B-T017
-	I-T017
1	I-T017
was	O
initially	O
reported	O
as	O
the	O
first	O
plasmid	B-T103
-	O
mediated	O
colistin	B-T103
resistance	O
gene	O
in	O
clinical	B-T103
isolates	I-T103
of	O
escherichia	B-T007
coli	I-T007
and	O
klebsiella	B-T007
pneumoniae	I-T007
in	O
china	B-T082
and	O
has	O
subsequently	O
been	O
identified	O
worldwide	O
in	O
various	O
species	B-T170
of	O
the	O
family	B-T007
enterobacteriaceae	I-T007
mcr	B-T017
-	I-T017
1	I-T017
encodes	O
a	O
phospho	B-T038
##ethanolamine	I-T038
transferase	I-T038
,	O
and	O
its	O
expression	B-T038
has	O
been	O
shown	O
to	O
generate	O
phospho	B-T103
##ethanolamine	I-T103
-	O
modified	O
bis	B-T103
-	I-T103
phosphorylated	I-T103
hexa	I-T103
-	I-T103
acyl	I-T103
##ated	I-T103
lipid	I-T103
a	I-T103
in	O
e	B-T007
.	I-T007
coli	I-T007
here	O
,	O
we	O
investigated	O
the	O
effects	O
of	O
mcr	B-T017
-	I-T017
1	I-T017
on	O
colistin	B-T103
susceptibility	B-T033
and	O
on	O
lipopolysaccharide	B-T103
structures	B-T082
in	O
laboratory	B-T092
and	O
clinical	O
strains	O
of	O
the	O
gram	B-T007
-	I-T007
negative	I-T007
es	I-T007
##ka	I-T007
##pe	I-T007
(	O
enterococcus	B-T007
faecium	I-T007
,	O
staphylococcus	B-T007
aureus	I-T007
,	O
k	B-T007
.	I-T007
pneumoniae	I-T007
,	O
acinetobacter	B-T007
baumannii	I-T007
,	O
pseudomonas	B-T007
aeruginosa	I-T007
,	O
and	O
enterobacter	B-T007
species	I-T007
)	O
pathogens	O
,	O
which	O
are	O
often	O
treated	O
clinically	O
by	O
colistin	B-T103
.	O
the	O
effects	O
of	O
mcr	B-T017
-	I-T017
1	I-T017
on	O
colistin	B-T103
resistance	O
were	O
determined	O
using	O
mic	B-T058
assays	I-T058
of	O
laboratory	B-T092
and	O
clinical	O
strains	O
of	O
e	B-T007
.	I-T007
coli	I-T007
,	O
k	B-T007
.	I-T007
pneumoniae	I-T007
,	O
a	B-T007
.	I-T007
baumannii	I-T007
,	O
and	O
p	B-T007
.	I-T007
aeruginosa	I-T007
lipid	B-T103
a	I-T103
structural	B-T082
changes	O
resulting	O
from	O
mcr	B-T103
-	I-T103
1	I-T103
were	O
analyzed	O
by	O
mass	B-T058
spectrometry	I-T058
.	O
the	O
introduction	O
of	O
mcr	B-T017
-	I-T017
1	I-T017
led	O
to	O
colistin	B-T103
resistance	O
in	O
e	B-T007
.	I-T007
coli	I-T007
,	O
k	B-T007
.	I-T007
pneumoniae	I-T007
,	O
and	O
a	B-T007
.	I-T007
baumannii	I-T007
but	O
only	O
moderately	O
reduced	O
susceptibility	B-T033
in	O
p	B-T007
.	I-T007
aeruginosa	I-T007
phospho	B-T103
##ethanolamine	I-T103
modification	B-T033
of	O
lipid	B-T103
a	I-T103
was	O
observed	O
consistently	O
for	O
all	O
four	O
species	B-T170
.	O
these	O
findings	O
highlight	O
the	O
risk	O
of	O
colistin	B-T103
resistance	O
as	O
a	O
consequence	O
of	O
mcr	B-T017
-	I-T017
1	I-T017
expression	B-T038
among	O
es	B-T007
##ka	I-T007
##pe	I-T007
pathogens	O
,	O
especially	O
in	O
k	B-T007
.	I-T007
pneumoniae	I-T007
and	O
a	B-T007
.	I-T007
baumannii	I-T007
furthermore	O
,	O
the	O
observation	O
that	O
lipid	B-T103
a	I-T103
structures	B-T082
were	O
modified	O
despite	O
only	O
modest	O
increases	O
in	O
colistin	B-T103
mics	B-T058
in	O
some	O
instances	O
suggests	O
more	O
sophisticated	O
surveillance	B-T062
methods	I-T062
may	O
need	O
to	O
be	O
developed	O
to	O
track	O
the	O
dissemination	B-T082
of	O
mcr	B-T017
-	I-T017
1	I-T017
or	O
plasmid	B-T103
-	O
mediated	O
phospho	B-T038
##ethanolamine	I-T038
transferase	I-T038
##s	I-T038
in	O
general	O
.	O

temporal	O
and	O
spatial	O
variability	O
of	O
fungal	B-T017
structures	I-T017
and	O
host	B-T038
responses	I-T038
in	O
an	O
incompatible	B-T038
ru	I-T038
##st	I-T038
-	I-T038
wheat	I-T038
interaction	I-T038
information	O
about	O
temporal	O
and	O
spatial	O
variability	O
of	O
fungal	B-T017
structures	I-T017
and	O
host	B-T038
responses	I-T038
is	O
scarce	O
in	O
comparison	O
to	O
the	O
vast	O
amount	O
of	O
genetic	O
,	O
biochemical	O
,	O
and	O
physiological	O
studies	B-T062
of	O
host	B-T038
-	I-T038
pathogen	I-T038
interactions	I-T038
.	O
in	O
this	O
study	B-T062
,	O
we	O
used	O
avi	O
##ru	O
##len	O
##t	O
wild	B-T017
type	I-T017
and	O
virulent	O
mutant	B-T017
isolates	B-T103
of	O
pu	B-T204
##cc	I-T204
##inia	I-T204
str	I-T204
##ii	I-T204
##form	I-T204
##is	I-T204
to	O
characterize	O
the	O
interactions	O
in	O
wheat	B-T168
carrying	O
yellow	B-T204
ru	I-T204
##st	I-T204
yr	B-T204
##2	I-T204
resistance	B-T038
.	O
both	O
conventional	O
and	O
advanced	O
microscopic	O
techniques	O
were	O
used	O
for	O
a	O
detailed	O
study	B-T062
of	O
morphology	O
and	O
growth	B-T038
of	O
fungal	O
colonies	B-T017
and	O
associated	O
host	B-T038
cell	I-T038
responses	I-T038
.	O
the	O
growth	B-T038
of	O
the	O
wild	B-T017
type	I-T017
isolates	B-T103
was	O
highly	O
restricted	O
due	O
to	O
hypersensitive	B-T038
response	I-T038
(	O
hr	B-T038
,	O
plant	B-T204
cell	B-T038
death	I-T038
)	O
indicated	B-T033
by	O
autofluorescence	B-T058
and	O
change	O
in	O
the	O
shape	B-T082
of	O
the	O
affected	O
plant	B-T017
cells	I-T017
.	O
the	O
host	B-T038
response	I-T038
appeared	O
post	O
-	O
ha	B-T017
##ust	I-T017
##orial	I-T017
,	O
but	O
large	O
variation	O
in	O
the	O
time	O
and	O
stage	O
of	O
arrest	B-T038
was	O
observed	O
for	O
individual	B-T098
fungal	O
colonies	B-T017
,	O
probably	O
due	O
to	O
a	O
delay	O
between	B-T082
detection	B-T058
and	O
response	O
.	O
some	O
colonies	B-T017
were	O
stopped	O
right	O
after	O
the	O
formation	O
of	O
the	O
primary	B-T038
infection	I-T038
hyphae	B-T204
whereas	O
others	O
formed	O
highly	O
branched	B-T082
myc	B-T204
##elia	I-T204
.	O
hr	B-T038
was	O
first	O
observed	O
in	O
host	B-T017
cells	I-T017
in	O
direct	O
contact	O
with	O
fungal	B-T017
structures	I-T017
,	O
after	O
which	O
the	O
defense	B-T038
responses	I-T038
spread	O
to	O
adjacent	B-T082
host	B-T017
cells	I-T017
,	O
and	O
eventually	O
led	O
to	O
enc	O
##ase	O
##ment	O
of	O
the	O
fungal	O
colony	B-T017
.	O
several	O
cells	B-T017
with	O
hr	B-T038
contained	O
ha	B-T017
##ust	I-T017
##oria	I-T017
,	O
which	O
were	O
small	O
and	O
under	O
##develop	O
##ed	O
,	O
but	O
some	O
cells	B-T017
contained	O
normal	O
sized	B-T082
ha	B-T017
##ust	I-T017
##oria	I-T017
without	O
signs	B-T033
of	O
hypersensitivity	B-T038
.	O
the	O
growth	B-T038
of	O
the	O
virulent	O
mutants	B-T017
in	O
the	O
resistant	O
plants	B-T204
was	O
similar	O
to	O
the	O
growth	B-T038
in	O
plants	B-T204
without	O
yr	B-T204
##2	I-T204
resistance	B-T038
,	O
which	O
is	O
a	O
strong	O
indication	O
that	O
the	O
incompatible	O
phenotype	O
was	O
associated	O
with	O
yr	B-T204
##2	I-T204
.	O
the	O
interaction	O
between	B-T082
p	B-T204
.	I-T204
str	I-T204
##ii	I-T204
##form	I-T204
##is	I-T204
and	O
wheat	B-T168
with	O
yr	B-T204
##2	I-T204
resistance	B-T038
was	O
highly	O
variable	O
in	O
time	O
and	O
space	O
,	O
which	O
demonstrate	O
that	O
histological	B-T091
studies	B-T062
are	O
important	O
for	O
a	O
deeper	B-T038
understanding	I-T038
of	O
host	B-T038
-	I-T038
pathogen	I-T038
interactions	I-T038
and	O
plant	B-T204
defense	B-T038
mechanisms	O
in	O
general	B-T082
.	O

intra	B-T082
-	I-T082
articular	I-T082
implantation	B-T058
of	O
collagen	B-T103
scaffold	O
carriers	B-T074
is	O
safe	B-T082
in	O
both	O
native	O
and	O
arthro	B-T038
##fi	I-T038
##br	I-T038
##otic	I-T038
rabbit	B-T204
knee	B-T082
joints	I-T082
sustained	O
intra	B-T082
-	I-T082
articular	I-T082
delivery	O
of	O
pharmacological	O
agents	O
is	O
an	O
attractive	O
modality	O
but	O
requires	O
use	O
of	O
a	O
safe	B-T082
carrier	B-T074
that	O
would	O
not	O
induce	O
cartilage	B-T037
damage	I-T037
or	O
fibrosis	B-T038
.	O
collagen	B-T103
scaffolds	O
are	O
widely	O
available	O
and	O
could	O
be	O
used	O
intra	B-T082
-	I-T082
articular	I-T082
##ly	I-T082
,	O
but	O
no	O
investigation	B-T058
has	O
looked	O
at	O
the	O
safety	O
of	O
collagen	B-T103
scaffolds	O
within	O
synovial	B-T082
joints	I-T082
.	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
determine	O
the	O
safety	O
of	O
collagen	B-T103
scaffold	O
implantation	B-T058
in	O
a	O
validated	B-T062
in	B-T082
vivo	I-T082
animal	B-T204
model	O
of	O
knee	B-T038
arthro	I-T038
##fi	I-T038
##br	I-T038
##osis	I-T038
.	O
a	O
total	O
of	O
96	O
rabbits	B-T204
were	O
randomly	O
and	O
equally	O
assigned	O
to	O
four	O
different	O
groups	O
:	O
arthro	B-T058
##to	I-T058
##my	I-T058
alone	O
;	O
arthro	B-T058
##to	I-T058
##my	I-T058
and	O
collagen	B-T103
scaffold	O
placement	B-T058
;	O
contracture	B-T017
surgery	B-T058
;	O
and	O
contracture	B-T017
surgery	B-T058
and	O
collagen	B-T103
scaffold	O
placement	B-T058
.	O
animals	B-T204
were	O
killed	O
in	O
equal	O
numbers	O
at	O
72	O
hours	O
,	O
two	O
weeks	O
,	O
eight	O
weeks	O
,	O
and	O
24	O
weeks	O
.	O
joint	B-T017
contracture	I-T017
was	O
measured	O
,	O
and	O
cartilage	B-T017
and	O
synovial	O
samples	O
underwent	O
histological	B-T058
analysis	I-T058
.	O
animals	B-T204
that	O
underwent	O
arthro	B-T058
##to	I-T058
##my	I-T058
had	O
equivalent	O
joint	B-T017
contracture	I-T017
##s	I-T017
regardless	O
of	O
scaffold	O
implantation	B-T058
(	O
-	O
13	O
.	O
9	O
##°	O
versus	O
-	O
10	O
.	O
9	O
##°	O
,	O
equivalence	O
limit	O
15	O
##°	O
)	O
.	O
animals	B-T204
that	O
underwent	O
surgery	B-T058
to	O
induce	O
contracture	B-T017
did	O
not	O
demonstrate	O
equivalent	O
joint	B-T017
contracture	I-T017
s	I-T017
with	O
(	O
41	O
.	O
8	O
##°	O
)	O
or	O
without	O
(	O
53	O
.	O
9	O
##°	O
)	O
collagen	B-T103
scaffold	O
implantation	B-T058
.	O
chond	B-T082
##ral	I-T082
damage	O
occurred	O
in	O
similar	O
rates	O
with	O
(	O
11	O
of	O
48	O
)	O
and	O
without	O
(	O
nine	O
of	O
48	O
)	O
scaffold	O
implantation	B-T058
.	O
no	O
significant	O
difference	O
in	O
synovitis	B-T038
was	O
noted	O
between	O
groups	O
.	O
absorption	O
of	O
the	O
collagen	B-T103
scaffold	O
occurred	O
within	O
eight	O
weeks	O
in	O
all	O
animals	B-T204
conclusion	O
:	O
our	O
data	O
suggest	O
that	O
intra	B-T082
-	I-T082
articular	I-T082
implantation	B-T058
of	O
a	O
collagen	B-T103
sponge	O
does	O
not	O
induce	O
synovitis	B-T038
or	O
cartilage	B-T037
damage	I-T037
.	O
implantation	B-T058
in	O
a	O
native	O
joint	B-T082
does	O
not	O
seem	O
to	O
induce	O
contracture	B-T017
.	O
implantation	B-T058
of	O
the	O
collagen	B-T103
sponge	O
in	O
a	O
rabbit	B-T204
knee	O
model	O
of	O
contracture	B-T017
may	O
decrease	O
the	O
severity	O
of	O
the	O
contracture	B-T017
.	O
cit	O
##e	O
this	O
article	O
:	O
j	O
.	O
a	O
.	O
walker	O
,	O
t	O
.	O
j	O
.	O
ew	O
##ald	O
,	O
e	O
.	O
lew	O
##all	O
##en	O
,	O
a	O
.	O
van	O
wi	O
##j	O
##ne	O
##n	O
,	O
a	O
.	O
d	O
.	O
hans	O
##se	O
##n	O
,	O
b	O
.	O
f	O
.	O
mor	O
##rey	O
,	O
m	O
.	O
e	O
.	O
mor	O
##rey	O
,	O
m	O
.	O
p	O
.	O
abd	O
##el	O
,	O
j	O
.	O
san	O
##che	O
##z	O
-	O
so	O
##te	O
##lo	O
.	O
intra	O
-	O
articular	O
implantation	O
of	O
collagen	O
scaffold	O
carriers	O
is	O
safe	O
in	O
both	O
native	O
and	O
arthro	O
##fi	O
##br	O
##otic	O
rabbit	O
knee	O
joints	O
.	O
bone	O
joint	O
res	O
2016	O
;	O
6	O
:	O
162	O
-	O
171	O
.	O
doi	O
:	O
10	O
.	O
130	O
##2	O
/	O
204	O
##6	O
-	O
375	O
##8	O
.	O
63	O
.	O
bj	O
##r	O
-	O
2016	O
-	O
019	O
##3	O
.	O

involvement	O
of	O
intracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
signaling	B-T038
in	O
ltp	B-T038
at	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
-	O
ca1	B-T017
pyramidal	I-T017
cell	I-T017
synapse	I-T017
physiological	O
significance	O
of	O
synaptic	B-T038
zn	I-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
signaling	I-T038
was	O
examined	O
at	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
-	O
ca1	B-T017
pyramidal	I-T017
cell	I-T017
synapses	I-T017
.	O
in	B-T082
vivo	I-T082
long	B-T038
-	I-T038
term	I-T038
potentiation	I-T038
(	O
ltp	B-T038
)	O
at	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
-	O
ca1	B-T017
pyramidal	I-T017
cell	I-T017
synapses	I-T017
was	O
induced	O
using	O
a	O
recording	O
electrode	B-T074
attached	O
to	O
a	O
microdialysis	B-T058
probe	B-T074
and	O
the	O
recording	O
region	O
was	O
locally	O
perfused	B-T058
with	O
artificial	B-T103
cerebrospinal	I-T103
fluid	I-T103
(	O
acs	B-T103
##f	I-T103
)	O
via	O
the	O
microdialysis	B-T058
probe	B-T074
.	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
ltp	B-T038
was	O
not	O
attenuated	O
under	O
perfusion	B-T058
with	O
ca	B-T103
##ed	I-T103
##ta	I-T103
(	O
10	O
mm	O
)	O
,	O
an	O
extracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
chelator	O
,	O
but	O
attenuated	O
under	O
perfusion	B-T058
with	O
zn	B-T103
##af	I-T103
-	I-T103
2d	I-T103
##a	I-T103
(	O
50	O
μm	O
)	O
,	O
an	O
intracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
chelator	O
,	O
suggesting	O
that	O
intracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
signaling	B-T038
is	O
required	O
for	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
ltp	B-T038
.	O
even	O
in	O
rat	B-T017
brain	I-T017
slices	I-T017
bath	O
##ed	O
in	O
ca	B-T103
##ed	I-T103
##ta	I-T103
in	O
acs	B-T103
##f	I-T103
,	O
intracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
level	O
,	O
which	O
was	O
measured	O
with	O
intracellular	B-T017
zn	B-T103
##af	I-T103
-	I-T103
2	I-T103
,	O
was	O
increased	O
in	O
the	O
stratum	O
lacun	O
##osum	O
-	O
molecular	O
##e	O
where	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
-	O
ca1	B-T017
pyramidal	I-T017
cell	I-T017
synapses	I-T017
were	O
contained	O
after	O
tet	B-T058
##anic	I-T058
stimulation	I-T058
.	O
these	O
results	O
suggest	O
that	O
intracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
signaling	B-T038
,	O
which	O
originates	O
in	O
internal	O
stores	O
/	O
proteins	B-T103
,	O
is	O
involved	O
in	O
ltp	B-T038
at	O
perfor	B-T017
##ant	I-T017
pathway	I-T017
-	O
ca1	B-T017
pyramidal	I-T017
cell	I-T017
synapses	I-T017
.	O
because	O
the	O
influx	B-T038
of	O
extracellular	B-T017
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
,	O
which	O
originates	O
in	O
presynaptic	B-T038
zn	I-T038
(	I-T038
2	I-T038
+	I-T038
)	I-T038
release	I-T038
,	O
is	O
involved	O
in	O
ltp	B-T038
at	O
sch	B-T017
##aff	I-T017
##er	I-T017
collateral	I-T017
-	O
ca1	B-T017
pyramidal	I-T017
cell	I-T017
synapses	I-T017
,	O
synapse	B-T082
-	O
dependent	O
zn	B-T103
(	I-T103
2	I-T103
+	I-T103
)	I-T103
dynamics	O
may	O
be	O
involved	O
in	O
plasticity	B-T038
of	O
postsynaptic	O
ca1	B-T017
pyramidal	I-T017
cells	I-T017
.	O

giant	B-T017
ant	B-T038
##roch	I-T038
##oa	I-T038
##nal	I-T038
polyp	I-T038
-	O
a	O
rare	O
presentation	O
ant	B-T038
##roch	I-T038
##oa	I-T038
##nal	I-T038
polyp	I-T038
(	O
acp	B-T038
)	O
,	O
also	O
called	O
as	O
kill	B-T038
##ian	I-T038
polyp	I-T038
,	O
is	O
an	O
infrequent	O
,	O
benign	B-T033
lesion	I-T033
of	O
maxillary	B-T017
origin	O
in	O
non	O
-	O
atopic	O
patients	O
.	O
the	O
ant	B-T038
##roch	I-T038
##oa	I-T038
##nal	I-T038
polyp	I-T038
is	O
shaped	O
according	O
to	O
the	O
anatomical	O
constraints	O
of	O
the	O
lateral	B-T082
nasal	I-T082
wall	I-T082
,	O
particularly	O
the	O
middle	B-T017
meat	I-T017
##us	I-T017
and	O
antrum	B-T017
,	O
resembling	O
typically	O
a	O
dum	B-T082
##bb	I-T082
##ell	I-T082
.	O
here	O
presenting	O
a	O
common	O
problem	B-T033
with	O
unusual	O
presentation	O
.	O

data	B-T170
set	I-T170
of	O
interact	B-T038
##omes	I-T038
and	O
metabolic	O
pathways	O
of	O
proteins	B-T103
differentially	O
expressed	B-T038
in	O
brains	B-T017
with	O
alzheimer	B-T038
׳	I-T038
s	I-T038
disease	I-T038
alzheimer	B-T038
׳	I-T038
s	I-T038
disease	I-T038
is	O
one	O
of	O
the	O
main	O
causes	O
of	O
dementia	B-T038
in	O
the	O
elderly	B-T098
and	O
its	O
frequency	O
is	O
on	O
the	O
rise	O
worldwide	B-T098
.	O
it	O
is	O
considered	O
the	O
result	O
of	O
complex	O
interactions	O
between	O
genetic	O
and	O
environmental	O
factors	O
,	O
being	O
many	O
of	O
them	O
unknown	O
.	O
therefore	O
,	O
there	O
is	O
a	O
dir	O
##e	O
necessity	O
for	O
the	O
identification	O
of	O
novel	O
molecular	B-T103
players	I-T103
for	O
the	O
understanding	O
of	O
this	O
disease	B-T038
.	O
in	O
this	O
data	O
article	B-T170
we	O
determined	O
the	O
protein	B-T038
expression	I-T038
profiles	O
of	O
whole	O
protein	B-T103
extracts	O
from	O
cortex	B-T082
regions	I-T082
of	I-T082
brains	I-T082
from	O
patients	O
with	O
alzheimer	B-T038
׳	I-T038
s	I-T038
disease	I-T038
in	O
comparison	O
to	O
a	O
normal	B-T017
brain	I-T017
.	O
we	O
identified	O
72	O
##1	O
it	B-T103
##ra	I-T103
##q	I-T103
-	I-T103
labeled	I-T103
polypeptides	B-T103
with	O
more	O
than	O
95	O
%	O
in	O
confidence	O
.	O
we	O
analyzed	B-T062
all	O
proteins	B-T103
that	O
changed	O
in	O
their	O
expression	O
level	O
and	O
located	O
them	O
in	O
the	O
ke	O
##gg	O
metabolic	O
pathways	O
,	O
as	O
well	O
as	O
in	O
the	O
mitochondrial	B-T017
complexes	I-T017
of	I-T017
the	I-T017
electron	I-T017
transport	I-T017
chain	I-T017
and	O
atp	B-T103
synthase	I-T103
.	O
in	O
addition	O
,	O
we	O
analyzed	B-T062
the	O
over	B-T103
-	I-T103
and	I-T103
sub	I-T103
-	I-T103
expressed	I-T103
polypeptides	I-T103
through	O
ipa	B-T170
software	I-T170
,	O
specifically	O
core	B-T170
i	I-T170
and	I-T170
biomarkers	I-T170
i	I-T170
modules	I-T170
.	O
data	O
in	O
this	O
article	B-T170
is	O
related	O
to	O
the	O
research	B-T062
article	B-T170
[UNK]	O
identification	O
of	O
proteins	B-T103
that	O
are	O
differentially	O
expressed	B-T038
in	O
brains	B-T017
with	O
alzheimer	B-T038
'	I-T038
s	I-T038
disease	I-T038
using	O
it	B-T058
##ra	I-T058
##q	I-T058
labeling	I-T058
and	O
tandem	B-T062
mass	I-T062
spectrometry	I-T062
[UNK]	O
(	O
min	O
##ja	O
##re	O
##z	O
et	O
al	O
.	O
,	O
2016	O
)	O
[	O
1	O
]	O
.	O

prospective	O
evaluation	B-T058
of	O
opioid	O
consumption	O
after	O
distal	B-T037
radius	I-T037
fracture	I-T037
repair	B-T058
surgery	I-T058
pain	B-T058
management	I-T058
and	O
opioid	O
consumption	O
after	O
distal	B-T037
radius	I-T037
fracture	I-T037
(	O
dr	B-T037
##f	I-T037
)	O
open	O
reduction	O
and	O
internal	O
fixation	O
(	O
ori	O
##f	O
)	O
are	O
highly	O
variable	O
and	O
poorly	O
understood	O
.	O
to	O
optimize	B-T058
postoperative	O
opioid	B-T103
dosage	O
and	O
better	O
understand	O
opioid	O
consumption	O
patterns	O
after	O
dr	B-T037
##f	I-T037
-	O
ori	O
##f	O
,	O
we	O
conducted	O
a	O
prospective	B-T062
study	I-T062
with	O
the	O
hypothesis	O
that	O
opioid	O
consumption	O
would	O
increase	O
with	O
worsening	O
fracture	B-T037
classification	B-T170
and	O
various	O
patient	O
demographics	O
.	O
all	O
patients	O
who	O
underwent	O
dr	B-T037
##f	I-T037
-	O
ori	O
##f	O
were	O
consecutively	O
enrolled	O
over	O
a	O
6	O
-	O
month	O
period	O
.	O
information	O
collected	O
included	O
patient	O
demographics	O
,	O
fracture	O
type	O
,	O
anesthesia	B-T170
type	I-T170
,	O
amount	O
and	O
type	O
of	O
opioid	B-T103
prescribed	O
,	O
number	O
of	O
pill	B-T103
##s	I-T103
taken	O
,	O
reason	O
for	O
stopping	O
,	O
and	O
adverse	B-T038
events	I-T038
.	O
statistical	O
analysis	O
was	O
performed	O
.	O
ninety	O
-	O
eight	O
patients	O
(	O
79	O
female	B-T098
,	O
19	O
male	B-T098
)	O
were	O
eligible	O
for	O
the	O
study	O
.	O
mean	O
age	O
was	O
58	O
years	O
.	O
of	O
the	O
98	O
patients	O
,	O
45	O
received	O
general	B-T058
anesthesia	I-T058
,	O
and	O
53	O
received	O
regional	O
anesthesia	O
with	O
a	O
single	O
-	O
shot	O
peripheral	B-T058
nerve	I-T058
block	I-T058
.	O
mean	O
opioid	O
consumption	O
(	O
morphine	B-T103
equivalence	O
)	O
over	O
a	O
mean	O
of	O
4	O
.	O
8	O
postoperative	O
days	O
(	O
range	O
,	O
0	O
-	O
16	O
days	O
)	O
was	O
58	O
.	O
5	O
mg	O
(	O
range	O
,	O
0	O
-	O
280	O
mg	O
)	O
.	O
there	O
were	O
no	B-T033
significant	I-T033
differences	O
in	O
opioid	O
consumption	O
between	O
the	O
general	B-T058
and	O
regional	O
anesthesia	O
groups	O
.	O
mean	O
opioid	O
consumption	O
for	O
the	O
3	O
fracture	O
-	O
type	O
groups	O
(	O
ao	B-T170
/	I-T170
ota	I-T170
[	I-T170
arb	I-T170
##eit	I-T170
##s	I-T170
##ge	I-T170
##me	I-T170
##ins	I-T170
##cha	I-T170
##ft	I-T170
fur	I-T170
oste	I-T170
##osynth	I-T170
##ese	I-T170
##fr	I-T170
##agen	I-T170
/	I-T170
orthopaedic	I-T170
trauma	I-T170
association	I-T170
]	I-T170
classification	I-T170
)	O
was	O
57	O
.	O
7	O
mg	O
(	O
class	B-T170
a	I-T170
)	O
,	O
60	O
.	O
3	O
mg	O
(	O
class	B-T170
b	I-T170
)	O
,	O
and	O
62	O
.	O
0	O
mg	O
(	O
class	B-T170
c	I-T170
)	O
.	O
demographic	B-T062
analysis	I-T062
revealed	O
an	O
inverse	O
relationship	O
between	O
age	O
and	O
opioid	O
use	O
.	O
similarly	O
,	O
there	O
was	O
a	O
trend	O
toward	O
more	O
opioid	O
consumption	O
among	O
self	O
-	O
pay	O
and	O
medicaid	O
patients	O
.	O
opioid	O
consumption	O
after	O
dr	B-T037
##f	I-T037
-	O
ori	O
##f	O
was	O
equivalent	O
for	O
general	B-T058
and	O
regional	O
anesthesia	O
.	O
a	O
significant	O
relationship	O
was	O
found	O
between	O
increasing	B-T033
age	I-T033
and	O
decreasing	B-T033
opioid	O
consumption	O
.	O
worsening	O
fracture	B-T170
classification	I-T170
and	O
self	O
-	O
payment	O
/	O
medicaid	O
payment	O
trend	O
##ed	O
toward	O
increasing	O
opioid	O
consumption	O
.	O
mean	O
overall	O
opioid	O
consumption	O
(	O
morphine	B-T103
equivalence	O
)	O
was	O
58	O
.	O
5	O
mg	O
,	O
or	O
14	O
.	O
6	O
pill	B-T103
##s	I-T103
of	O
oxy	B-T103
##co	I-T103
##d	I-T103
##one	I-T103
/	I-T103
acetaminophen	I-T103
5	O
/	O
325	O
mg	O
.	O
surgeons	B-T097
should	O
take	O
these	O
findings	O
into	O
account	O
when	O
optimizing	B-T058
opioid	B-T103
prescribing	O
after	O
dr	B-T037
##f	I-T037
repair	B-T058
.	O

mob	B-T058
##erg	I-T058
pick	I-T058
##ing	I-T058
-	I-T058
up	I-T058
test	I-T058
in	O
patients	O
with	O
hand	B-T038
osteoarthritis	I-T038
clinical	O
measurement	O
.	O
the	O
mob	B-T058
##erg	I-T058
pick	I-T058
-	I-T058
up	I-T058
test	I-T058
(	O
mp	B-T058
##ut	I-T058
)	O
was	O
previously	O
used	O
to	O
evaluate	O
functional	B-T033
performance	I-T033
in	O
patients	O
with	O
hand	B-T017
inflammatory	B-T038
disease	I-T038
.	O
this	O
is	O
the	O
first	O
study	O
using	O
the	O
mp	B-T058
##ut	I-T058
in	O
hand	B-T038
osteoarthritis	I-T038
(	O
oa	B-T038
)	O
.	O
compare	O
the	O
functional	B-T033
performance	I-T033
(	O
mp	B-T058
##ut	I-T058
)	O
in	O
hand	B-T038
oa	I-T038
patients	O
and	O
healthy	O
controls	O
.	O
fifty	O
hand	B-T038
oa	I-T038
patients	O
and	O
50	O
controls	O
were	O
assessed	O
using	O
the	O
mp	B-T058
##ut	I-T058
,	O
aus	B-T170
##can	I-T170
and	O
coch	B-T170
##in	I-T170
questionnaires	I-T170
,	O
grip	O
and	O
pin	B-T058
##ch	I-T058
strength	I-T058
,	O
pain	B-T033
using	O
a	O
visual	B-T058
analog	I-T058
scale	I-T058
and	O
a	O
likert	B-T170
scale	I-T170
regarding	O
difficulty	O
to	O
perform	O
mp	B-T058
##ut	I-T058
.	O
in	O
the	O
mp	B-T058
##ut	I-T058
evaluation	B-T058
,	O
the	O
oa	B-T038
group	O
presented	O
a	O
statistically	O
significant	O
difference	O
from	O
the	O
control	O
group	O
.	O
the	O
oa	B-T038
group	O
spent	O
more	O
time	O
exec	O
##uting	O
test	B-T170
.	O
the	O
grip	O
and	O
pin	B-T058
##ch	I-T058
strength	I-T058
measurements	I-T058
showed	O
higher	O
values	O
for	O
the	O
control	O
group	O
.	O
the	O
oa	B-T038
group	O
reported	O
a	O
greater	O
difficulty	O
than	O
the	O
control	O
group	O
in	O
performing	O
the	O
test	B-T170
.	O
the	O
mp	B-T058
##ut	I-T058
is	O
a	O
short	O
and	O
easy	O
to	O
apply	O
test	B-T170
,	O
which	O
can	O
be	O
safely	O
used	O
to	O
assess	O
the	O
functional	B-T033
performance	I-T033
of	O
the	O
hand	B-T038
oa	I-T038
.	O
ii	O
.	O

cd8	B-T103
##4	I-T103
mediates	O
cll	B-T038
-	O
microenvironment	O
interactions	B-T038
chronic	B-T038
lymphocytic	I-T038
leukemia	I-T038
(	O
cll	B-T038
)	O
is	O
a	O
malignant	B-T038
disease	I-T038
of	O
small	O
mature	B-T017
lymphocytes	I-T017
.	O
signals	O
from	O
the	O
cll	B-T038
microenvironment	O
promote	O
progression	B-T038
of	I-T038
the	I-T038
disease	I-T038
and	O
induce	O
drug	B-T038
resistance	I-T038
.	O
this	O
phenomenon	O
is	O
largely	O
dependent	O
on	O
direct	O
contact	O
between	O
the	O
malignant	B-T038
b	I-T038
cells	I-T038
and	O
stromal	B-T017
cells	I-T017
.	O
cd8	B-T103
##4	I-T103
belongs	O
to	O
the	O
signaling	B-T103
lymphocyte	I-T103
activation	I-T103
molecule	I-T103
family	I-T103
of	O
immunore	B-T103
##cept	I-T103
##ors	I-T103
,	O
which	O
self	B-T038
-	I-T038
associates	I-T038
,	O
forming	O
an	O
orthogonal	O
homo	O
##phi	O
##lic	O
dimer	O
.	O
we	O
therefore	O
hypothesized	O
that	O
cd8	B-T103
##4	I-T103
may	O
bridge	O
between	O
cll	B-T038
cells	B-T017
and	O
their	O
microenvironment	O
,	O
promoting	O
cell	B-T038
survival	I-T038
.	O
our	O
in	O
vitro	O
results	O
show	O
that	O
cd8	B-T038
##4	I-T038
expressed	I-T038
on	O
cll	B-T038
cells	B-T017
interact	O
with	O
cd8	B-T038
##4	I-T038
expressed	I-T038
on	O
cells	B-T017
in	O
their	O
microenvironment	O
,	O
inducing	O
cell	B-T038
survival	I-T038
in	O
both	O
sides	O
.	O
blocking	O
cd8	B-T103
##4	I-T103
in	O
vitro	O
and	O
in	B-T082
vivo	I-T082
disrupt	O
the	O
interaction	O
of	O
cll	B-T038
cells	B-T017
with	O
their	O
microenvironment	O
,	O
resulting	O
in	O
induced	O
cell	B-T038
death	I-T038
.	O
thus	O
,	O
our	O
findings	B-T033
suggest	O
novel	O
therapeutic	O
strategies	O
based	O
on	O
the	O
blockade	B-T103
of	O
this	O
cd8	B-T103
##4	I-T103
-	O
dependent	O
survival	B-T038
pathway	B-T038
.	O

factors	O
affecting	O
the	O
formation	O
of	O
nitrogen	B-T058
##ous	I-T058
disinfection	I-T058
by	B-T103
-	I-T103
products	I-T103
during	O
chlor	O
##ination	O
of	O
aspartic	B-T103
acid	I-T103
in	O
drinking	O
water	O
the	O
formation	O
of	O
emerging	O
nitrogen	B-T058
##ous	I-T058
disinfection	I-T058
by	B-T103
-	I-T103
products	I-T103
(	O
n	B-T103
-	I-T103
dbp	I-T103
##s	I-T103
)	O
from	O
the	O
chlor	O
##ination	O
of	O
aspartic	B-T103
acid	I-T103
(	O
asp	B-T103
)	O
was	O
investigated	O
.	O
the	O
yield	O
of	O
dichloro	B-T103
##acet	I-T103
##onitrile	I-T103
(	O
dca	B-T103
##n	I-T103
)	O
was	O
higher	O
than	O
other	O
n	B-T103
-	I-T103
dbp	I-T103
##s	I-T103
,	O
such	O
as	O
dichloro	B-T103
##acetamide	I-T103
(	O
dca	B-T103
##cam	I-T103
)	O
and	O
chloro	B-T103
##pic	I-T103
##rin	I-T103
(	O
tc	B-T103
##nm	I-T103
)	O
during	O
the	O
chlor	O
##ination	O
of	O
asp	B-T103
.	O
the	O
formation	O
of	O
dca	B-T103
##n	I-T103
,	O
dca	B-T103
##cam	I-T103
,	O
and	O
tc	B-T103
##nm	I-T103
all	O
showed	O
a	O
trend	O
of	O
first	O
increasing	O
and	O
then	O
decreasing	B-T033
during	O
the	O
chlor	O
##ination	O
of	O
asp	B-T103
with	O
increasing	O
contact	O
time	O
.	O
the	O
dosage	O
of	O
chlorine	B-T103
had	O
an	O
impact	O
on	O
the	O
formation	O
of	O
dca	B-T103
##n	I-T103
,	O
dca	B-T103
##cam	I-T103
,	O
and	O
tc	B-T103
##nm	I-T103
.	O
the	O
highest	O
yields	O
of	O
dca	B-T103
##n	I-T103
and	O
dca	B-T103
##cam	I-T103
appeared	O
when	O
the	O
cl	B-T103
##2	I-T103
/	O
asp	B-T103
molar	O
ratio	O
was	O
about	O
20	O
,	O
the	O
yield	O
of	O
tc	B-T103
##nm	I-T103
increased	O
with	O
increasing	O
the	O
cl	B-T103
##2	I-T103
/	O
asp	B-T103
molar	O
ratio	O
from	O
5	O
to	O
30	O
and	O
tc	B-T103
##nm	I-T103
was	O
not	O
produced	O
when	O
the	O
ratio	O
was	O
less	O
than	O
5	O
.	O
cyano	B-T103
##gen	I-T103
chloride	I-T103
(	O
cn	B-T103
##cl	I-T103
)	O
was	O
detected	O
when	O
the	O
cl	B-T103
##2	I-T103
/	O
asp	B-T103
molar	O
ratio	O
was	O
lower	O
than	O
5	O
.	O
n	B-T103
-	I-T103
dbp	I-T103
##s	I-T103
formation	O
was	O
influenced	O
by	O
ph	O
.	O
dca	B-T103
##n	I-T103
formation	O
increased	O
with	O
increasing	O
ph	O
from	O
5	O
to	O
6	O
and	O
then	O
decreased	O
with	O
increasing	O
ph	O
from	O
6	O
to	O
9	O
,	O
but	O
dca	B-T103
##cam	I-T103
and	O
tc	B-T103
##nm	I-T103
increased	O
with	O
increasing	O
ph	O
from	O
5	O
to	O
8	O
and	O
then	O
decreased	O
.	O
higher	O
temperatures	O
reduced	O
the	O
formation	O
of	O
dca	B-T103
##n	I-T103
and	O
dca	B-T103
##cam	I-T103
,	O
but	O
increased	O
tc	B-T103
##nm	I-T103
formation	O
.	O
dca	B-T103
##n	I-T103
and	O
dca	B-T103
##cam	I-T103
formation	O
decreased	O
,	O
and	O
relatively	O
stable	O
tc	B-T103
##nm	I-T103
formation	O
increased	O
,	O
with	O
increasing	O
free	O
chlorine	B-T103
contact	O
time	O
during	O
chlor	O
##amination	O
.	O
n	B-T103
-	I-T103
nitroso	I-T103
##di	I-T103
##methyl	I-T103
##amine	I-T103
(	O
nd	B-T103
##ma	I-T103
)	O
was	O
produced	O
during	O
chlor	O
##amination	O
of	O
asp	B-T103
and	O
increased	O
with	O
prolonged	O
chlor	O
##amination	O
contact	O
time	O
.	O
the	O
presence	O
of	O
bromide	B-T103
ions	I-T103
enhanced	O
the	O
yields	O
of	O
halo	B-T103
##acet	I-T103
##onitrile	I-T103
##s	I-T103
and	O
shifted	O
n	B-T103
-	I-T103
dbp	I-T103
##s	I-T103
to	O
more	O
brom	B-T103
##inated	I-T103
species	I-T103
.	O

passive	B-T062
case	I-T062
detection	I-T062
of	O
malaria	B-T038
in	O
rat	O
##ana	O
##ki	O
##ri	O
province	O
(	O
camb	O
##odia	O
)	O
to	O
detect	B-T033
villages	B-T082
at	O
higher	O
risk	O
for	O
malaria	B-T038
camb	O
##odia	O
reduced	O
malaria	B-T038
incidence	O
by	O
more	O
than	O
75	O
%	O
between	O
2000	O
and	O
2015	O
,	O
a	O
target	O
of	O
the	O
mill	B-T170
##enn	I-T170
##ium	I-T170
development	I-T170
goal	I-T170
6	I-T170
.	O
the	O
camb	O
##odia	O
##n	O
government	B-T092
aims	O
to	O
eliminate	O
all	O
forms	O
of	O
malaria	B-T038
by	O
202	O
##5	O
.	O
the	O
country	B-T082
'	I-T082
s	I-T082
malaria	B-T038
incidence	O
is	O
highly	O
variable	O
at	O
provincial	O
level	O
,	O
but	O
less	O
is	O
known	O
at	O
village	B-T082
level	O
.	O
this	O
study	B-T062
used	O
passive	B-T062
case	I-T062
detection	I-T062
(	O
pcd	B-T062
)	O
data	O
at	O
village	B-T082
level	O
in	O
rat	O
##ana	O
##ki	O
##ri	O
province	O
from	O
2010	O
to	O
2014	O
to	O
describe	O
incidence	O
trends	O
and	O
identify	O
high	B-T033
-	I-T033
risk	I-T033
areas	I-T033
of	I-T033
malaria	B-T038
to	O
be	O
primarily	O
targeted	O
towards	O
malaria	B-T038
elimination	O
.	O
in	O
2010	O
,	O
the	O
camb	O
##odia	O
##n	O
malaria	B-T038
programme	B-T170
created	O
a	O
malaria	B-T170
information	I-T170
system	I-T170
(	O
mis	B-T170
)	O
to	O
capture	O
malaria	B-T038
information	O
at	O
village	B-T082
level	O
through	O
pcd	B-T062
by	O
village	B-T082
malaria	B-T097
workers	I-T097
and	O
health	B-T092
facilities	I-T092
.	O
the	O
mis	B-T170
data	O
of	O
rat	O
##ana	O
##ki	O
##ri	O
province	O
2010	O
-	O
2014	O
were	O
used	O
to	O
calculate	O
annual	O
incidence	O
rates	O
by	O
plasmodium	B-T204
species	I-T204
at	O
province	O
and	O
commun	O
##e	O
levels	O
.	O
for	O
estimating	O
the	O
trend	O
at	O
provincial	O
level	O
only	O
villages	B-T082
reporting	B-T058
each	O
year	O
were	O
selected	O
.	O
the	O
commun	O
##al	O
incidences	O
and	O
the	O
number	O
of	O
cases	O
per	O
village	B-T082
were	O
visualized	O
on	O
a	O
map	O
per	O
plasmodium	B-T204
species	I-T204
and	O
per	O
year	O
.	O
analysis	O
of	O
spatial	O
clustering	O
of	O
village	B-T082
malaria	B-T038
cases	O
by	O
plasmodium	B-T204
species	I-T204
was	O
performed	O
by	O
year	O
.	O
overall	O
,	O
malaria	B-T038
annual	O
incidence	O
rates	O
per	O
1000	O
inhabitants	O
decreased	O
from	O
86	O
(	O
2010	O
)	O
to	O
30	O
(	O
2014	O
)	O
.	O
falciparum	B-T204
incidence	O
decreased	O
(	O
by	O
79	O
%	O
in	O
2014	O
compared	O
to	O
2010	O
;	O
ci	O
95	O
%	O
76	O
-	O
82	O
%	O
)	O
more	O
rapidly	O
than	O
vivax	B-T204
incidence	O
(	O
by	O
19	O
%	O
in	O
2014	O
compared	O
to	O
2010	O
;	O
ci	O
95	O
%	O
5	O
-	O
32	O
%	O
)	O
.	O
there	O
were	O
ten	O
to	O
16	O
significant	O
spatial	O
clusters	O
each	O
year	O
.	O
big	O
clusters	O
tended	O
to	O
extend	B-T082
along	O
the	O
camb	O
##odia	O
##n	O
-	O
vietnam	O
##ese	O
border	O
and	O
along	O
the	O
ses	O
##an	O
river	O
.	O
three	O
clusters	O
appeared	O
throughout	O
all	O
years	O
(	O
2010	O
-	O
2014	O
)	O
:	O
one	O
with	O
21	O
villages	B-T082
appeared	O
each	O
year	O
,	O
the	O
second	O
shr	O
##unk	O
progressively	O
from	O
2012	O
to	O
2014	O
and	O
the	O
third	O
was	O
split	O
into	O
two	O
smaller	O
clusters	O
in	O
2013	O
and	O
2014	O
.	O
the	O
decline	O
of	O
malaria	B-T038
burden	O
can	O
be	O
attributed	O
to	O
intensive	O
malaria	O
control	O
activities	O
implemented	O
in	O
the	O
areas	B-T082
:	O
distribution	O
of	O
a	O
long	O
-	O
lasting	O
insectic	B-T074
##idal	I-T074
net	I-T074
per	O
person	B-T098
and	O
early	B-T058
diagnosis	I-T058
and	O
prompt	O
treatment	O
.	O
dihydro	B-T103
-	I-T103
artemisinin	I-T103
piper	B-T103
##a	I-T103
##quine	I-T103
was	O
the	O
only	O
first	B-T058
-	I-T058
line	I-T058
treatment	I-T058
for	O
all	O
malaria	B-T038
cases	O
.	O
no	O
radical	O
treatment	O
with	O
prim	B-T103
##a	I-T103
##quine	I-T103
was	O
provided	O
for	O
plasmodium	B-T204
vivax	I-T204
cases	O
,	O
which	O
could	O
explain	O
the	O
slow	O
decrease	O
of	O
p	B-T204
.	I-T204
vivax	I-T204
due	O
to	O
relapses	O
.	O
to	O
achieve	O
malaria	B-T038
elimination	O
by	O
202	O
##5	O
,	O
priority	O
should	O
be	O
given	O
to	O
the	O
control	O
of	O
stable	O
malaria	O
clusters	O
appearing	O
over	O
time	O
.	O

thyroid	B-T038
cancer	I-T038
burden	O
in	O
central	B-T082
and	O
south	B-T082
america	I-T082
incidence	O
of	O
thyroid	B-T038
cancer	I-T038
(	O
tc	B-T038
)	O
is	O
rapidly	O
increasing	O
worldwide	O
,	O
but	O
little	O
is	O
known	O
about	O
the	O
tc	B-T038
burden	O
in	O
central	B-T082
and	O
south	B-T082
america	I-T082
(	O
csa	B-T082
)	O
.	O
we	O
describe	O
the	O
geographic	B-T082
patterns	I-T082
and	O
trends	O
of	O
tc	B-T038
by	O
sex	O
in	O
csa	B-T082
.	O
we	O
obtained	O
regional	O
-	O
and	O
national	O
-	O
level	O
incidence	O
data	O
from	O
48	O
population	B-T170
-	I-T170
based	I-T170
cancer	I-T170
registries	I-T170
in	O
13	O
countries	B-T082
and	O
nationwide	O
cancer	O
deaths	O
from	O
the	O
who	B-T092
mortality	O
database	B-T170
for	O
18	O
countries	B-T082
.	O
we	O
estimated	O
world	B-T098
population	O
age	O
-	O
standardized	O
incidence	O
rates	O
(	O
as	O
##rs	O
)	O
and	O
age	O
-	O
standardized	O
mortality	O
rates	O
(	O
asm	O
##rs	O
)	O
per	O
100	O
,	O
000	O
person	B-T098
-	O
years	O
.	O
we	O
calculated	O
as	O
##rs	O
by	O
histological	B-T201
subtype	I-T201
.	O
we	O
estimated	O
the	O
annual	O
percentage	O
change	O
(	O
ea	O
##pc	O
)	O
to	O
describe	O
time	O
trends	O
.	O
between	O
csa	B-T082
countries	B-T082
,	O
tc	B-T038
incidence	O
and	O
mortality	O
rates	O
varied	O
from	O
8	O
-	O
fold	O
to	O
12	O
-	O
fold	O
and	O
from	O
2	O
-	O
fold	O
to	O
5	O
-	O
fold	O
,	O
respectively	O
.	O
in	O
2003	O
-	O
2007	O
,	O
the	O
highest	O
tc	B-T038
as	O
##rs	O
in	O
females	O
and	O
males	O
were	O
in	O
ec	B-T082
##ua	I-T082
##d	I-T082
##or	I-T082
(	O
16	O
.	O
0	O
and	O
3	O
.	O
5	O
,	O
respectively	O
)	O
,	O
brazil	B-T082
(	O
14	O
.	O
4	O
and	O
3	O
.	O
4	O
)	O
,	O
cost	B-T082
##a	I-T082
ri	I-T082
##ca	I-T082
(	O
12	O
.	O
6	O
and	O
2	O
.	O
1	O
)	O
and	O
colombia	B-T082
(	O
10	O
.	O
7	O
and	O
2	O
.	O
5	O
)	O
.	O
the	O
highest	O
asm	O
##rs	O
were	O
in	O
ec	B-T082
##ua	I-T082
##d	I-T082
##or	I-T082
,	O
colombia	B-T082
,	O
mexico	B-T082
,	O
peru	B-T082
and	O
pan	B-T082
##ama	I-T082
(	O
0	O
.	O
68	O
-	O
0	O
.	O
91	O
in	O
females	O
and	O
0	O
.	O
41	O
-	O
0	O
.	O
48	O
in	O
males	O
)	O
.	O
papillary	B-T038
tc	I-T038
was	O
the	O
most	O
commonly	O
diagnosed	B-T033
histological	B-T201
subtype	I-T201
,	O
following	O
the	O
same	O
incidence	O
pattern	O
as	O
overall	O
tc	B-T038
.	O
in	O
argen	O
##tine	O
##an	O
,	O
brazilian	O
,	O
chile	O
##an	O
and	O
cost	O
##a	O
ri	O
##can	O
females	O
tc	B-T038
incidence	O
increased	O
by	O
2	O
.	O
2	O
-	O
17	O
.	O
9	O
%	O
annually	O
,	O
and	O
papillary	B-T038
tc	I-T038
increased	O
by	O
9	O
.	O
1	O
-	O
15	O
.	O
0	O
%	O
annually	O
,	O
while	O
mortality	O
remained	O
stable	O
between	O
1997	O
and	O
2008	O
.	O
in	O
males	O
,	O
trends	O
in	O
tc	B-T038
were	O
stable	O
.	O
tc	B-T038
occurred	O
more	O
frequently	O
in	O
females	O
than	O
in	O
males	O
.	O
the	O
overall	O
high	O
incidence	O
and	O
low	O
mortality	O
of	O
tc	B-T038
suggest	O
identification	O
of	O
subclinical	B-T038
disease	I-T038
due	O
to	O
improved	O
detection	B-T170
methods	I-T170
.	O

a	O
tobramycin	B-T103
vector	I-T103
enhances	O
synergy	B-T033
and	O
efficacy	O
of	O
efflux	B-T103
pump	I-T103
inhibitors	I-T103
against	O
multidrug	O
-	O
resistant	O
gram	B-T007
-	I-T007
negative	I-T007
bacteria	I-T007
drug	B-T038
efflux	I-T038
mechanisms	O
interact	B-T038
synergistically	O
with	O
the	O
outer	B-T017
membrane	I-T017
permeability	B-T038
barrier	B-T038
of	O
gram	B-T007
-	I-T007
negative	I-T007
bacteria	I-T007
,	O
leading	O
to	O
intrinsic	B-T082
resistance	O
that	O
presents	O
a	O
major	O
challenge	B-T058
for	O
antibiotic	B-T103
drug	B-T062
development	I-T062
.	O
efflux	B-T103
pump	I-T103
inhibitors	I-T103
(	O
epis	B-T103
)	O
which	O
block	O
the	O
efflux	B-T038
of	O
antibiotics	B-T103
synerg	O
##ize	O
antibiotics	B-T103
,	O
but	O
the	O
clinical	B-T062
development	I-T062
of	O
epi	B-T103
/	O
antibiotic	B-T103
combination	B-T058
therapy	I-T058
to	O
treat	B-T058
multidrug	O
-	O
resistant	O
(	O
mdr	O
)	O
gram	B-T038
-	I-T038
negative	I-T038
infections	I-T038
has	O
been	O
challenging	B-T058
.	O
this	O
is	O
in	O
part	O
caused	O
by	O
the	O
ineff	B-T033
##iciency	I-T033
of	O
current	O
epis	B-T103
to	O
penetrate	O
the	O
outer	B-T017
membrane	I-T017
and	O
resist	O
efflux	B-T038
.	O
we	O
demonstrate	O
that	O
conjugation	B-T038
of	O
a	O
tobramycin	B-T103
(	O
tob	B-T103
)	O
vector	O
to	O
epis	B-T103
like	O
nm	B-T103
##p	I-T103
,	O
paroxetine	B-T103
,	O
or	O
dbp	B-T201
enhances	O
synergy	B-T033
and	O
efficacy	O
of	O
epis	B-T103
in	O
combination	O
with	O
tetracycline	B-T103
antibiotics	I-T103
against	O
mdr	O
gram	B-T007
-	I-T007
negative	I-T007
bacteria	I-T007
including	O
pseudomonas	B-T007
aeruginosa	I-T007
.	O
besides	O
potentiating	B-T038
tetracycline	B-T103
antibiotics	I-T103
,	O
tob	B-T103
-	O
epi	B-T103
conjugates	O
can	O
also	O
suppress	O
resistance	O
development	O
to	O
the	O
tetracycline	B-T103
antibiotic	I-T103
minocycline	B-T103
,	O
thereby	O
providing	O
a	O
strategy	O
to	O
develop	O
more	O
effective	O
adjuvants	B-T103
to	O
rescue	O
tetracycline	B-T103
antibiotics	I-T103
from	O
resistance	O
in	O
mdr	O
gram	B-T007
-	I-T007
negative	I-T007
bacteria	I-T007
.	O

homocysteine	B-T103
as	O
a	O
peripheral	B-T082
biomarker	B-T201
in	O
bipolar	B-T038
disorder	I-T038
:	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
bipolar	B-T038
disorder	I-T038
(	O
bd	B-T038
)	O
is	O
a	O
psychiatric	B-T038
disorder	I-T038
with	O
an	O
uncertain	B-T033
aetiology	O
.	O
recently	O
,	O
special	O
attention	O
has	O
been	O
given	O
to	O
homocysteine	B-T103
(	O
hcy	B-T103
)	O
,	O
as	O
it	O
has	O
been	O
suggested	O
that	O
alterations	O
in	O
1	B-T038
-	I-T038
carbon	I-T038
metabolism	I-T038
might	O
be	O
implicated	O
in	O
diverse	O
psychiatric	B-T038
disorders	I-T038
.	O
however	O
,	O
there	O
is	O
uncertainty	B-T033
regarding	O
possible	O
alterations	O
in	O
peripheral	B-T082
hcy	B-T103
levels	O
in	O
bd	B-T038
.	O
this	O
study	O
comprises	O
a	O
meta	B-T062
-	I-T062
analysis	I-T062
comparing	O
serum	B-T058
and	O
plasma	B-T058
hcy	I-T058
levels	I-T058
in	O
persons	B-T098
with	O
bd	B-T038
and	O
healthy	O
controls	O
.	O
we	O
conducted	O
a	O
systematic	O
search	O
for	O
all	O
eligible	O
english	O
and	O
non	O
-	O
english	O
peer	B-T170
-	I-T170
reviewed	I-T170
articles	I-T170
.	O
nine	O
cross	B-T062
-	I-T062
sectional	I-T062
studies	I-T062
were	O
included	O
in	O
the	O
meta	B-T062
-	I-T062
analyses	I-T062
,	O
providing	O
data	O
on	O
154	O
##7	O
participants	B-T098
.	O
random	O
-	O
effects	O
meta	B-T062
-	I-T062
analysis	I-T062
showed	O
that	O
serum	B-T058
and	O
plasma	B-T058
levels	I-T058
of	I-T058
hcy	I-T058
were	O
increased	O
in	O
subjects	O
with	O
bd	B-T038
in	O
either	O
mania	B-T038
or	O
euth	B-T038
##ymia	I-T038
when	O
compared	O
to	O
healthy	O
controls	O
,	O
with	O
a	O
large	O
effect	O
size	O
in	O
the	O
mania	B-T038
group	B-T098
(	O
g	O
=	O
0	O
.	O
98	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
8	O
-	O
1	O
.	O
17	O
,	O
p	O
<	O
0	O
.	O
001	O
,	O
n	O
=	O
49	O
##5	O
)	O
and	O
a	O
small	O
effect	O
in	O
the	O
euth	B-T038
##ymia	I-T038
group	B-T098
(	O
g	O
=	O
0	O
.	O
3	O
,	O
95	O
%	O
ci	O
:	O
0	O
.	O
11	O
-	O
0	O
.	O
48	O
,	O
p	O
=	O
0	O
.	O
002	O
,	O
n	O
=	O
105	O
##2	O
)	O
.	O
our	O
meta	B-T062
-	I-T062
analysis	I-T062
provides	O
evidence	O
that	O
hcy	B-T033
levels	I-T033
are	I-T033
elevated	I-T033
in	O
persons	B-T098
with	O
bd	B-T038
during	O
mania	B-T038
and	O
euth	B-T038
##ymia	I-T038
.	O
peripheral	B-T082
hcy	B-T103
could	O
be	O
considered	O
as	O
a	O
potential	O
biomarker	B-T201
in	O
bd	B-T038
,	O
both	O
of	O
trait	O
(	O
since	O
it	O
is	O
increased	O
in	O
euth	B-T038
##ymia	I-T038
)	O
,	O
and	O
also	O
of	O
state	O
(	O
since	O
its	O
increase	O
is	O
more	O
accent	O
##uated	O
in	O
mania	B-T038
)	O
.	O
longitudinal	B-T062
studies	I-T062
are	O
needed	O
to	O
clarify	O
the	O
relationship	O
between	O
bipolar	B-T038
disorder	I-T038
and	O
hcy	B-T103
,	O
as	O
well	O
as	O
the	O
usefulness	O
of	O
peripheral	B-T082
hcy	B-T103
as	O
both	O
a	O
trait	O
and	O
state	O
biomarker	B-T201
in	O
bd	B-T038
.	O

metabolomics	B-T091
,	O
nutrition	B-T033
,	O
and	O
potential	O
biomarkers	B-T201
of	O
food	O
quality	O
,	O
intake	O
,	O
and	O
health	O
status	O
diet	B-T168
,	O
dietary	B-T062
patterns	I-T062
,	O
and	O
other	O
environmental	O
factors	O
such	O
as	O
exposure	O
to	O
toxins	B-T103
are	O
playing	O
an	O
important	O
role	O
in	O
the	O
prevention	O
/	O
development	O
of	O
many	O
diseases	B-T038
,	O
like	O
obesity	B-T038
,	O
type	B-T038
2	I-T038
diabetes	I-T038
,	O
and	O
consequently	O
on	O
the	O
health	O
status	O
of	O
individuals	B-T098
.	O
a	O
major	O
challenge	O
nowadays	O
is	O
to	O
identify	O
novel	O
biomarkers	B-T201
to	O
detect	B-T033
as	O
early	O
as	O
possible	O
metabolic	O
dysfunction	O
and	O
to	O
predict	O
evolution	O
of	O
health	O
status	O
in	O
order	O
to	O
refine	O
nutritional	O
advice	O
##s	O
to	O
specific	O
population	B-T098
groups	I-T098
.	O
omics	O
technologies	O
such	O
as	O
genomics	B-T091
,	O
transcriptomic	O
##s	O
,	O
proteomics	B-T091
,	O
and	O
metabolomics	B-T091
coupled	O
with	O
statistical	B-T170
and	O
bioinformatics	B-T170
tools	I-T170
have	O
already	O
shown	O
great	O
potential	O
in	O
this	O
research	O
field	O
even	O
if	O
so	O
far	O
only	O
few	O
biomarkers	B-T201
have	O
been	O
validated	O
.	O
for	O
the	O
past	O
two	O
decades	O
,	O
important	O
analytical	B-T058
techniques	I-T058
have	O
been	O
developed	O
to	O
detect	B-T033
as	O
many	O
metabolites	B-T103
as	O
possible	O
in	O
human	B-T204
biof	B-T031
##lu	I-T031
##ids	I-T031
such	O
as	O
urine	B-T031
,	O
blood	B-T031
,	O
and	O
saliva	B-T031
.	O
in	O
the	O
field	O
of	O
food	O
science	O
and	O
nutrition	B-T091
,	O
many	O
studies	B-T062
have	O
been	O
carried	O
out	O
for	O
food	B-T168
authentic	O
##ity	O
,	O
quality	O
,	O
and	O
safety	O
,	O
as	O
well	O
as	O
for	O
food	O
processing	O
.	O
furthermore	O
,	O
metabol	B-T091
##omic	I-T091
investigations	O
have	O
been	O
carried	O
out	O
to	O
discover	O
new	O
early	O
biomarkers	B-T201
of	O
metabolic	O
dysfunction	O
and	O
predictive	O
biomarkers	B-T201
of	O
developing	O
pathologies	B-T091
(	O
obesity	B-T038
,	O
metabolic	B-T038
syndrome	I-T038
,	O
type	B-T038
-	I-T038
2	I-T038
diabetes	I-T038
,	O
etc	O
.	O
)	O
.	O
great	O
emphasis	O
is	O
also	O
placed	O
in	O
the	O
development	O
of	O
methodologies	B-T062
to	O
identify	O
and	O
validate	O
biomarkers	B-T201
of	O
nutrients	B-T168
exposure	O
.	O

visualization	O
for	O
understanding	O
uncertainty	B-T033
in	O
activation	O
volumes	O
for	O
deep	B-T058
brain	I-T058
stimulation	I-T058
we	O
have	O
created	O
the	O
neuros	B-T170
##timulation	I-T170
uncertainty	I-T170
view	I-T170
##er	I-T170
(	I-T170
nu	I-T170
##view	I-T170
or	I-T170
ν	I-T170
##view	I-T170
)	I-T170
tool	I-T170
for	O
exploring	O
data	O
arising	O
from	O
deep	B-T058
brain	I-T058
stimulation	I-T058
(	O
dbs	B-T058
)	O
.	O
simulated	B-T062
volume	O
of	O
tissue	O
activated	O
(	O
vta	O
)	O
,	O
using	O
clinical	B-T058
electrode	I-T058
placement	I-T058
##s	I-T058
,	O
are	O
recorded	O
along	O
with	O
patient	O
outcomes	O
in	O
the	O
unified	B-T170
parkinson	I-T170
'	I-T170
s	I-T170
disease	I-T170
rating	I-T170
scale	I-T170
(	O
upd	B-T170
##rs	I-T170
)	O
.	O
the	O
data	O
is	O
volumetric	O
and	O
sparse	O
,	O
with	O
multi	O
-	O
value	O
patient	O
results	O
for	O
each	O
activated	O
voxel	O
in	O
the	O
simulation	B-T062
.	O
ν	O
##view	O
provides	O
a	O
collection	O
of	O
visual	B-T170
methods	I-T170
to	O
explore	O
the	O
activated	O
tissue	B-T017
to	O
enhance	O
understanding	O
of	O
electrode	B-T074
usage	O
for	O
improved	O
therapy	B-T058
with	O
dbs	B-T058
.	O

predicting	O
changes	O
in	O
adaptive	O
functioning	O
and	O
behavioral	O
adjustment	O
following	O
treatment	B-T058
for	O
a	O
pediatric	B-T038
brain	I-T038
tumor	I-T038
:	O
a	O
report	B-T201
from	O
the	O
brain	B-T017
radiation	B-T097
investig	I-T097
##ative	I-T097
study	I-T097
consortium	I-T097
children	O
are	O
at	O
risk	O
for	O
behavioral	O
and	O
adaptive	O
difficulties	O
following	O
pediatric	B-T038
brain	I-T038
tumor	I-T038
.	O
this	O
study	B-T062
explored	O
whether	O
familial	O
/	O
demographic	O
,	O
developmental	O
,	O
diagnostic	O
,	O
or	O
treatment	B-T058
-	O
related	O
variables	O
best	O
predict	O
posttreatment	O
behavioral	O
and	O
adaptive	O
functioning	O
.	O
participants	B-T098
included	O
40	O
children	O
(	O
mean	O
age	O
=	O
12	O
.	O
76	O
years	O
,	O
sd	O
=	O
4	O
.	O
01	O
)	O
posttreatment	O
(	O
mean	O
time	O
since	O
diagnosis	B-T033
=	O
1	O
.	O
99	O
years	O
,	O
sd	O
=	O
0	O
.	O
21	O
)	O
for	O
pediatric	B-T038
brain	I-T038
tumor	I-T038
.	O
parents	O
rated	O
children	O
'	O
s	O
behavioral	O
adjustment	O
and	O
adaptive	O
functioning	O
and	O
provided	O
demographic	O
and	O
developmental	O
histories	B-T033
.	O
diagnostic	B-T033
and	O
treatment	B-T058
-	O
related	O
information	O
was	O
abstracted	O
from	O
medical	B-T170
records	I-T170
.	O
ratings	O
of	O
adaptive	O
and	O
behavioral	O
functioning	O
approximately	O
2	O
years	O
postd	B-T033
##ia	I-T033
##gn	I-T033
##osis	I-T033
were	O
within	O
the	O
average	O
range	O
,	O
although	O
the	O
percentage	O
of	O
children	O
exceeding	O
clinical	O
cutoff	O
##s	O
for	O
impairment	O
in	O
adaptive	O
skills	O
exceeded	O
expectation	O
,	O
particularly	O
practical	O
skills	O
.	O
prem	O
##orbid	O
behavior	O
problems	O
and	O
tumor	B-T082
size	I-T082
predicted	O
posttreatment	O
adaptive	O
functioning	O
.	O
after	O
accounting	O
for	O
adaptive	O
functioning	O
near	O
diagnosis	B-T033
,	O
prem	O
##orbid	O
behavior	O
problems	O
predicted	O
declines	O
in	O
adaptive	O
functioning	O
2	O
years	O
postd	B-T033
##ia	I-T033
##gn	I-T033
##osis	I-T033
.	O
after	O
accounting	O
for	O
adjustment	O
near	O
diagnosis	B-T033
,	O
no	O
variables	O
predicted	O
declines	O
in	O
behavioral	O
adjustment	O
.	O
children	O
may	O
be	O
vulnerable	O
to	O
reduced	O
adaptive	O
functioning	O
following	O
pediatric	B-T038
brain	I-T038
tumor	I-T038
treatment	B-T058
,	O
especially	O
in	O
practical	O
skills	O
.	O
assessing	O
pred	B-T033
##ia	I-T033
##gn	I-T033
##osis	I-T033
functioning	O
and	O
diagnostic	B-T033
and	O
treatment	B-T058
-	O
related	O
variables	O
may	O
improve	B-T033
our	O
ability	O
to	O
predict	O
those	O
at	O
greatest	O
risk	O
,	O
although	O
those	O
factors	O
may	O
be	O
less	O
helpful	O
in	O
identifying	O
children	O
likely	O
to	O
develop	O
behavioral	O
difficulties	O
.	O
screening	B-T058
of	O
these	O
factors	O
in	O
tertiary	B-T058
care	I-T058
and	O
long	O
-	O
term	O
follow	B-T058
-	I-T058
up	I-T058
settings	O
may	O
improve	B-T033
identification	O
of	O
those	O
at	O
greatest	O
need	O
for	O
support	O
services	O
.	O

pre	O
-	O
existing	O
renal	B-T017
lesions	B-T033
revealed	O
after	O
renal	B-T017
trauma	B-T037
,	O
difficulties	O
in	O
diagnosis	B-T062
and	O
accountability	O
:	O
about	O
14	O
cases	O
pre	O
-	O
existing	O
renal	B-T017
lesions	B-T033
(	O
per	B-T033
##l	I-T033
)	O
may	O
interfere	O
with	O
the	O
path	O
##o	O
-	O
physiology	O
of	O
trauma	B-T037
,	O
alter	O
the	O
radiographic	B-T058
imaging	I-T058
and	O
influence	O
the	O
therapeutic	B-T058
approach	O
.	O
the	O
aims	O
of	O
this	O
study	B-T062
were	O
to	O
record	O
the	O
per	B-T033
##l	I-T033
found	O
incidentally	O
during	O
blunt	O
renal	B-T017
trauma	B-T037
,	O
to	O
specify	O
the	O
place	O
for	O
effective	O
conservative	B-T058
management	I-T058
and	O
to	O
determin	O
the	O
estimated	O
partial	O
permanent	O
disability	O
(	O
ppd	O
)	O
.	O
the	O
medical	B-T170
records	I-T170
of	O
14	O
patients	O
with	O
per	B-T033
##l	I-T033
and	O
blunt	O
renal	B-T017
trauma	B-T037
were	O
reviewed	O
.	O
in	O
each	O
patient	O
,	O
pre	O
-	O
existing	O
renal	B-T017
abnormalities	O
,	O
clinical	O
symptoms	B-T033
,	O
ct	B-T058
scan	I-T058
study	B-T062
findings	B-T033
,	O
associated	O
injuries	B-T037
,	O
therapeutic	B-T058
approach	O
,	O
the	O
accountability	O
criteria	O
and	O
the	O
estimated	O
ppd	O
were	O
recorded	O
.	O
there	O
were	O
11	O
men	B-T098
and	O
3	O
women	B-T098
with	O
a	O
mean	O
age	O
of	O
35	O
,	O
6	O
years	O
(	O
range	O
19	O
-	O
66	O
years	O
)	O
.	O
renal	B-T017
trauma	B-T037
was	O
due	O
to	O
a	O
traffic	B-T037
accident	I-T037
in	O
8	O
patients	O
.	O
renal	B-T017
damage	O
appeared	O
to	O
be	O
disproportionate	O
to	O
the	O
severity	O
of	O
the	O
trauma	B-T037
(	O
minor	O
trauma	B-T037
)	O
.	O
they	O
had	O
a	O
lower	O
rate	O
of	O
associated	O
trauma	B-T037
to	O
other	O
abdominal	B-T017
organs	I-T017
(	O
four	O
patients	O
only	O
)	O
.	O
urinary	B-T031
stones	I-T031
were	O
present	O
in	O
5	O
patients	O
,	O
pelv	B-T038
##i	I-T038
-	I-T038
ureteric	I-T038
junction	I-T038
obstruction	I-T038
in	O
3	O
,	O
horses	B-T017
##ho	I-T017
##e	I-T017
kid	I-T017
##n	I-T017
##y	I-T017
in	O
3	O
,	O
ectopic	B-T017
kidney	I-T017
in	O
2	O
and	O
upper	O
urinary	O
tract	O
carcinoma	O
in	O
one	O
case	O
.	O
early	O
nephrectomy	B-T058
was	O
required	O
in	O
three	O
cases	O
for	O
hemodynamic	B-T038
instability	I-T038
.	O
ureteral	B-T074
stenting	I-T074
was	O
indicated	O
in	O
3	O
cases	O
.	O
six	O
patients	O
were	O
operated	B-T058
later	O
because	O
of	O
their	O
underlying	O
renal	B-T017
pathology	B-T058
.	O
a	O
conservative	B-T058
treatment	I-T058
was	O
possible	O
only	O
in	O
7	O
of	O
cases	O
.	O
the	O
ppd	O
related	O
to	O
renal	B-T017
trauma	B-T037
vari	O
##de	O
from	O
0	O
to	O
13	O
%	O
in	O
all	O
cases	O
.	O
per	B-T033
##l	I-T033
may	O
complicate	O
a	O
negligible	O
renal	B-T017
trauma	B-T037
while	O
in	O
some	O
cases	O
they	O
may	O
be	O
of	O
vital	O
importance	O
for	O
the	O
patient	O
'	O
s	O
final	O
outcome	O
.	O
the	O
imaging	O
findings	B-T033
are	O
crucial	O
but	O
may	O
be	O
conf	O
##using	O
.	O
the	O
therapeutic	B-T058
approach	O
is	O
,	O
to	O
a	O
large	O
extent	O
,	O
dependent	O
on	O
the	O
type	O
of	O
per	B-T033
##l	I-T033
and	O
the	O
severity	O
of	O
damage	O
,	O
and	O
is	O
often	O
conservative	O
in	O
the	O
hem	B-T033
##o	I-T033
-	I-T033
dynamically	I-T033
stable	I-T033
patient	O
.	O
accountability	O
link	O
may	O
be	O
difficult	O
to	O
establish	O
and	O
the	O
ppd	O
depends	O
on	O
the	O
per	B-T033
##l	I-T033
and	O
the	O
renal	B-T037
injuries	I-T037
severity	O
.	O
we	O
have	O
no	O
involvement	O
with	O
funding	O
in	O
this	O
case	O
.	O
ethical	O
approval	O
:	O
not	O
required	O
conflicts	O
of	O
interest	O
:	O
none	O
.	O

es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
-	O
or	O
rab	B-T103
##eprazole	I-T103
-	O
based	O
triple	O
therapy	B-T058
eradicate	O
##d	O
helicobacter	B-T007
pylori	I-T007
compar	O
##ably	O
regardless	O
of	O
clarithromycin	B-T103
susceptibility	O
and	O
cyp2c19	B-T017
genotypes	O
the	O
aim	O
of	O
this	O
study	B-T062
was	O
to	O
assess	O
the	O
efficacy	O
of	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
-	O
based	O
triple	O
therapy	B-T058
compared	O
with	O
rab	B-T103
##eprazole	I-T103
-	O
based	O
triple	O
therapy	B-T058
according	O
to	O
cyp2c19	B-T017
genotype	O
and	O
clarithromycin	B-T103
susceptibility	O
status	O
for	O
first	O
-	O
line	O
eradication	B-T058
therapy	I-T058
of	I-T058
helicobacter	I-T058
pylori	I-T058
(	O
h	B-T007
.	I-T007
pylori	I-T007
)	O
in	O
japan	B-T082
.	O
we	O
enrolled	O
219	O
h	B-T007
.	I-T007
pylori	I-T007
-	O
infected	O
patients	O
,	O
and	O
randomly	O
allocated	O
patients	O
to	O
the	O
eac	O
group	O
(	O
es	B-T103
##ome	I-T103
##pr	I-T103
##azole	I-T103
20	O
mg	O
,	O
clarithromycin	B-T103
200	O
mg	O
,	O
amoxicillin	B-T103
750	O
mg	O
for	O
one	O
week	O
,	O
with	O
all	O
drugs	B-T103
given	O
twice	O
daily	O
)	O
or	O
rac	O
group	O
(	O
rab	B-T103
##eprazole	I-T103
10	O
mg	O
,	O
clarithromycin	B-T103
200	O
mg	O
,	O
amoxicillin	B-T103
750	O
mg	O
for	O
one	O
week	O
,	O
with	O
all	O
drugs	B-T103
given	O
twice	O
daily	O
)	O
.	O
the	O
h	B-T007
.	I-T007
pylori	I-T007
eradication	O
rate	O
according	O
to	O
the	O
pp	B-T062
analyses	I-T062
was	O
75	O
.	O
0	O
%	O
(	O
95	O
%	O
ci	O
:	O
65	O
.	O
2	O
-	O
82	O
.	O
8	O
%	O
)	O
in	O
the	O
eac	O
group	O
and	O
71	O
.	O
4	O
%	O
(	O
95	O
%	O
ci	O
:	O
61	O
.	O
4	O
-	O
79	O
.	O
1	O
%	O
)	O
in	O
the	O
rac	O
group	O
.	O
there	O
were	O
no	O
statistically	O
significant	O
differences	O
.	O
the	O
eradication	O
rates	O
of	O
the	O
clarithromycin	B-T038
-	I-T038
resistant	I-T038
/	O
-	O
sensitive	O
strains	B-T007
were	O
,	O
respectively	O
,	O
45	O
.	O
0	O
%	O
(	O
95	O
%	O
ci	O
:	O
30	O
.	O
7	O
-	O
60	O
.	O
2	O
%	O
)	O
/	O
98	O
.	O
0	O
%	O
(	O
95	O
%	O
ci	O
:	O
88	O
.	O
7	O
-	O
100	O
%	O
)	O
in	O
the	O
eac	O
group	O
and	O
39	O
.	O
5	O
%	O
(	O
95	O
%	O
ci	O
:	O
25	O
.	O
6	O
-	O
55	O
.	O
3	O
%	O
)	O
/	O
93	O
.	O
5	O
%	O
(	O
95	O
%	O
ci	O
:	O
81	O
.	O
9	O
-	O
98	O
.	O
4	O
%	O
)	O
in	O
the	O
rac	O
group	O
.	O
the	O
eradication	O
rate	O
of	O
the	O
clarithromycin	B-T103
-	O
sensitive	O
strains	B-T007
was	O
significantly	O
higher	O
than	O
that	O
of	O
the	O
resistant	B-T038
strains	I-T038
in	O
both	O
groups	O
.	O
in	O
conclusion	O
,	O
eac	O
and	O
rac	O
therapies	B-T058
show	O
a	O
comparable	O
efficacy	O
regardless	O
of	O
the	O
cyp2c19	B-T017
genotype	O
and	O
clarithromycin	B-T103
susceptibility	O
status	O
in	O
japan	B-T082
.	O

total	B-T033
energy	I-T033
expenditure	I-T033
in	O
obese	B-T038
ku	B-T092
##wa	I-T092
##iti	I-T092
primary	I-T092
school	I-T092
children	O
assessed	O
by	O
the	O
doubly	O
-	O
labeled	O
water	O
technique	O
the	O
aim	O
of	O
this	O
pilot	B-T062
study	I-T062
was	O
to	O
assess	O
body	O
composition	O
and	O
total	B-T033
energy	I-T033
expenditure	I-T033
(	O
tee	B-T033
)	O
in	O
35	O
obese	B-T038
7	O
-	O
9	O
years	O
old	O
ku	B-T098
##wa	I-T098
##iti	I-T098
children	O
(	O
18	O
girls	O
and	O
17	O
boys	O
)	O
.	O
total	B-T033
body	I-T033
water	I-T033
(	O
tb	B-T033
##w	I-T033
)	O
and	O
tee	B-T033
were	O
assessed	O
by	O
doubly	O
-	O
labeled	O
water	O
technique	O
.	O
tb	B-T033
##w	I-T033
was	O
derived	O
from	O
the	O
intercept	O
of	O
the	O
elimination	B-T033
rate	I-T033
of	O
deuterium	B-T103
and	O
tee	B-T033
from	O
the	O
difference	O
in	O
elimination	B-T033
rates	I-T033
of	O
(	B-T103
18	I-T103
)	I-T103
o	I-T103
and	O
deuterium	B-T103
.	O
tb	B-T033
##w	I-T033
was	O
used	O
to	O
estimate	O
fat	B-T033
-	I-T033
free	I-T033
mass	I-T033
(	O
ffm	B-T033
)	O
,	O
using	O
hydration	O
factors	O
for	O
different	O
ages	O
and	O
gender	O
.	O
fat	O
mass	O
(	O
fm	O
)	O
was	O
calculated	O
as	O
the	O
difference	O
between	O
body	O
weight	O
and	O
ffm	B-T033
.	O
body	O
weight	O
was	O
not	O
statistically	O
different	O
but	O
tb	B-T033
##w	I-T033
was	O
significantly	O
higher	O
(	O
p	O
=	O
0	O
.	O
018	O
)	O
in	O
boys	O
(	O
44	O
.	O
9	O
%	O
±	O
3	O
.	O
3	O
%	O
)	O
than	O
girls	O
(	O
42	O
.	O
4	O
%	O
±	O
3	O
.	O
0	O
%	O
)	O
,	O
while	O
girls	O
had	O
significantly	O
higher	O
estimated	O
fm	O
(	O
45	O
.	O
2	O
±	O
3	O
.	O
9	O
weight	O
%	O
versus	O
41	O
.	O
6	O
%	O
±	O
4	O
.	O
3	O
%	O
;	O
p	O
=	O
0	O
.	O
014	O
)	O
.	O
tee	B-T033
was	O
significantly	O
higher	O
in	O
boys	O
(	O
239	O
##5	O
±	O
34	O
##9	O
kcal	O
/	O
day	O
)	O
compared	O
with	O
girls	O
(	O
1978	O
±	O
169	O
kcal	O
/	O
day	O
)	O
;	O
p	O
=	O
0	O
.	O
001	O
.	O
estimated	O
physical	O
activity	O
level	O
(	O
pal	O
)	O
was	O
significantly	O
higher	O
in	O
boys	O
;	O
1	O
.	O
61	O
±	O
0	O
.	O
167	O
versus	O
1	O
.	O
51	O
±	O
0	O
.	O
87	O
##0	O
;	O
p	O
=	O
0	O
.	O
034	O
.	O
our	O
results	O
provide	O
the	O
first	O
dataset	B-T170
of	O
tee	B-T033
in	O
7	O
-	O
9	O
years	O
old	O
obese	B-T038
ku	B-T098
##wa	I-T098
##iti	I-T098
children	O
and	O
highlight	O
important	O
gender	O
differences	O
to	O
be	O
considered	O
during	O
the	O
development	O
of	O
school	O
based	O
interventions	O
targeted	O
to	O
combat	O
childhood	B-T038
obesity	I-T038
.	O

accounting	O
for	O
linkage	O
disequilibrium	O
in	O
genome	O
scans	O
for	O
selection	B-T038
without	O
individual	O
genotypes	O
:	O
the	O
local	B-T062
score	I-T062
approach	I-T062
detecting	B-T062
genomic	I-T062
footprint	I-T062
##s	I-T062
of	O
selection	B-T038
is	O
an	O
important	O
step	O
in	O
the	O
understanding	O
of	O
evolution	B-T038
.	O
accounting	O
for	O
linkage	O
disequilibrium	O
in	O
genome	O
scans	O
increases	O
detection	B-T058
power	O
,	O
but	O
haplotype	O
-	O
based	O
methods	O
require	O
individual	O
genotypes	O
and	O
are	O
not	O
applicable	O
on	O
pool	B-T201
-	I-T201
sequenced	I-T201
samples	I-T201
.	O
we	O
propose	O
to	O
take	O
advantage	O
of	O
the	O
local	B-T062
score	I-T062
approach	I-T062
to	O
account	O
for	O
linkage	O
disequilibrium	O
in	O
genome	O
scans	O
for	O
selection	B-T038
,	O
cum	O
##ulating	O
(	O
possibly	O
small	O
)	O
signals	B-T038
from	O
single	O
markers	B-T038
over	O
a	O
genomic	O
segment	O
,	O
to	O
clearly	O
pin	O
##point	O
a	O
selection	B-T038
signal	B-T038
.	O
using	O
computer	O
simulations	O
,	O
we	O
demonstrate	O
that	O
this	O
approach	O
detects	B-T033
selection	B-T038
with	O
higher	O
power	O
than	O
several	O
state	O
-	O
of	O
-	O
the	O
-	O
art	O
single	B-T038
-	I-T038
marker	I-T038
,	O
window	O
##ing	O
or	O
haplotype	O
-	O
based	O
approaches	O
.	O
we	O
illustrate	O
this	O
on	O
two	O
benchmark	O
data	B-T170
sets	I-T170
including	O
individual	O
genotypes	O
,	O
for	O
which	O
we	O
obtain	O
similar	O
results	O
with	O
the	O
local	B-T062
score	I-T062
and	O
one	O
haplotype	O
-	O
based	O
approach	O
.	O
finally	O
,	O
we	O
apply	O
the	O
local	B-T062
score	I-T062
approach	I-T062
to	O
pool	B-T170
-	I-T170
seq	I-T170
data	I-T170
obtained	O
from	O
a	O
divergent	O
selection	B-T038
experiment	B-T062
on	O
behaviour	O
in	O
quail	B-T204
and	O
obtain	O
precise	O
and	O
biologically	O
coherent	O
selection	B-T038
signals	B-T038
:	O
while	O
competing	O
methods	O
fail	O
to	O
highlight	O
any	O
clear	O
selection	B-T038
signature	O
,	O
our	O
method	O
detects	B-T033
several	O
regions	O
involving	O
genes	B-T017
known	O
to	O
act	O
on	O
social	O
responsiveness	O
or	O
autistic	B-T033
traits	I-T033
.	O
although	O
we	O
focus	O
here	O
on	O
the	O
detection	B-T033
of	O
positive	B-T033
selection	B-T038
from	O
multiple	B-T170
population	I-T170
data	I-T170
,	O
the	O
local	B-T062
score	I-T062
approach	I-T062
is	O
general	O
and	O
can	O
be	O
applied	O
to	O
other	O
genome	O
scans	O
for	O
selection	B-T038
or	O
other	O
genome	B-T062
##wide	I-T062
analyses	I-T062
such	O
as	O
gwas	B-T062
.	O

comparison	O
of	O
esophageal	B-T201
,	O
rectal	B-T033
,	O
and	O
gastrointestinal	O
temperatures	O
during	O
passive	O
rest	O
after	O
exercise	O
in	O
the	O
heat	O
:	O
the	O
influence	O
of	O
hydration	B-T033
it	O
is	O
unknown	O
how	O
valid	O
esophageal	B-T201
,	O
rectal	B-T033
,	O
and	O
gastrointestinal	O
temperatures	O
(	O
tes	B-T201
,	O
tre	B-T033
,	O
and	O
tg	O
##i	O
)	O
compare	O
after	O
exercise	O
-	O
induced	O
hyperthermia	B-T033
in	O
various	O
hydration	B-T033
states	I-T033
.	O
the	O
purpose	O
of	O
this	O
study	B-T062
was	O
to	O
examine	O
the	O
differences	O
between	O
tes	B-T201
,	O
tre	B-T033
,	O
and	O
tg	O
##i	O
during	O
passive	O
rest	O
following	O
exercise	O
-	O
induced	O
hyperthermia	B-T033
under	O
two	O
different	O
hydration	B-T033
states	I-T033
:	O
eu	B-T033
##hydr	I-T033
##ated	I-T033
(	O
eu	B-T033
)	O
and	O
hypo	B-T038
##hydr	I-T038
##ated	I-T038
(	O
hy	B-T038
)	O
.	O
randomized	B-T062
-	I-T062
crossover	I-T062
design	I-T062
.	O
controlled	O
laboratory	B-T092
setting	I-T092
.	O
nine	O
recreational	O
##ly	O
active	O
male	O
participants	B-T098
(	O
mean	O
##±	O
sd	O
;	O
age	O
,	O
24	O
##±4	O
;	O
height	O
,	O
177	O
.	O
3	O
##±	O
##9	O
.	O
9	O
##cm	O
;	O
body	O
mass	O
,	O
76	O
.	O
7	O
##±1	O
##1	O
.	O
6	O
##kg	O
;	O
body	B-T201
fat	I-T201
,	O
14	O
.	O
7	O
##±5	O
.	O
8	O
%	O
)	O
.	O
participants	B-T098
completed	O
two	O
trials	B-T062
(	O
eu	B-T033
and	O
hy	B-T038
)	O
consisting	O
of	O
a	O
bout	O
of	O
treadmill	O
exercise	O
(	O
a	O
10	O
minute	O
walk	O
ranging	O
4	O
.	O
8	O
-	O
7	O
.	O
2k	O
##m	O
·	O
hr	O
(	O
-	O
1	O
)	O
at	O
a	O
5	O
%	O
grade	B-T170
followed	O
by	O
a	O
20	O
minute	O
jo	O
##g	O
ranging	O
8	O
.	O
0	O
-	O
12	O
.	O
1	O
##k	O
##m	O
·	O
hr	O
(	O
-	O
1	O
)	O
at	O
a	O
1	O
%	O
grade	O
)	O
in	O
a	O
hot	O
environment	O
(	O
ambient	O
temperature	O
,	O
39	O
.	O
3	O
##±1	O
.	O
0	O
##°c	O
;	O
relative	O
humidity	O
,	O
37	O
.	O
6	O
##±6	O
.	O
0	O
%	O
;	O
wet	O
bulb	O
globe	O
temperature	O
,	O
31	O
.	O
3	O
##±1	O
.	O
5	O
##°c	O
)	O
followed	O
by	O
passive	O
rest	O
.	O
root	O
mean	O
squared	O
difference	O
(	O
rms	O
##d	O
)	O
was	O
used	O
to	O
compare	O
the	O
variance	O
of	O
temperature	O
readings	O
at	O
corresponding	O
time	O
points	O
for	O
tre	B-T033
vs	O
tg	O
##i	O
,	O
tre	B-T033
vs	O
tes	B-T201
,	O
and	O
tg	O
##i	O
vs	O
tes	B-T201
in	O
eu	B-T033
and	O
hy	B-T038
.	O
rms	O
##d	O
values	O
were	O
compared	O
using	O
three	O
-	O
way	O
repeated	O
measures	O
anova	O
.	O
post	O
hoc	O
analysis	B-T062
of	O
significant	O
main	O
effects	O
was	O
done	O
using	O
tukey	B-T170
'	I-T170
s	I-T170
hsd	I-T170
with	O
significance	O
set	O
at	O
p	O
<	O
0	O
.	O
05	O
.	O
rms	O
##d	O
values	O
(	O
°c	O
)	O
for	O
all	O
device	B-T074
comparisons	O
were	O
significantly	O
different	O
in	O
eu	B-T033
(	O
tre	B-T033
-	O
tg	O
##i	O
,	O
0	O
.	O
11	O
##±0	O
.	O
12	O
;	O
tre	B-T033
-	O
tes	B-T201
,	O
1	O
.	O
58	O
##±1	O
.	O
01	O
;	O
tg	O
##i	O
-	O
tes	B-T201
,	O
2	O
.	O
04	O
##±1	O
.	O
19	O
)	O
than	O
hy	B-T038
(	O
tre	B-T033
-	O
tg	O
##i	O
,	O
0	O
.	O
22	O
##±0	O
.	O
28	O
;	O
tre	B-T033
-	O
tes	B-T201
,	O
1	O
.	O
27	O
##±0	O
.	O
61	O
;	O
tg	O
##i	O
-	O
tes	B-T201
,	O
1	O
.	O
16	O
##±0	O
.	O
76	O
)	O
(	O
p	O
<	O
0	O
.	O
01	O
)	O
.	O
across	O
the	O
45	O
-	O
minute	O
bout	O
of	O
passive	O
rest	O
,	O
there	O
were	O
no	O
differences	O
in	O
tre	B-T033
,	O
tg	O
##i	O
and	O
tes	B-T201
between	O
eu	B-T033
and	O
hy	B-T038
trials	B-T062
(	O
p	O
=	O
0	O
.	O
46	O
##8	O
)	O
.	O
during	O
passive	O
rest	O
after	O
exercise	O
in	O
the	O
heat	O
,	O
tre	B-T033
and	O
tg	O
##i	O
were	O
in	O
good	O
agreement	O
when	O
tracking	O
body	O
temperature	O
,	O
with	O
a	O
better	O
agreement	O
appearing	O
in	O
those	O
maintaining	O
a	O
state	O
of	O
eu	B-T033
##hydration	I-T033
versus	O
those	O
who	O
became	O
hypo	B-T038
##hydr	I-T038
##ated	I-T038
during	O
exercise	O
;	O
however	O
,	O
this	O
small	O
difference	O
does	O
not	O
appear	O
to	O
be	O
of	O
clinical	B-T033
significance	I-T033
.	O

